PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ozawa, S; Matsubayashi, M; Nanaura, H; Yanagita, M; Mori, K; Asanuma, K; Kajiwara, N; Hayashi, K; Ohashi, H; Kasahara, M; Yokoi, H; Kataoka, H; Mori, E; Nakagawa, T				Ozawa, Shota; Matsubayashi, Masaya; Nanaura, Hitoki; Yanagita, Motoko; Mori, Kiyoshi; Asanuma, Katsuhiko; Kajiwara, Nobuyuki; Hayashi, Kazuyuki; Ohashi, Hiroshi; Kasahara, Masato; Yokoi, Hideki; Kataoka, Hiroaki; Mori, Eiichiro; Nakagawa, Takahiko			Proteolytic cleavage of Podocin by Matriptase exacerbates podocyte injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chronic kidney disease; Matriptase; hepatocyte growth factor activator inhibitor type 1; Podocin; podocyte; kidney; podocyte; protease; protease inhibitor; diabetic nephropathy	SERINE-PROTEASE INHIBITOR; MATRIX METALLOPROTEINASES; DIABETIC-NEPHROPATHY; RENAL DEVELOPMENT; TISSUE FACTOR; MOUSE MODEL; MATRIX-METALLOPROTEINASE-9; EXPRESSION; HAI-1; MICE	Podocyte injury is a critical step toward the progression of renal disease and is often associated with a loss of slit diaphragm proteins, including Podocin. Although there is a possibility that the extracellular domain of these slit diaphragm proteins can be a target for a pathological proteolysis, the precise mechanism driving the phenomenon remains unknown. Here we show that Matriptase, a membrane-anchored protein, was activated at podocytes in CKD patients and mice, whereas Matriptase inhibitors slowed the progression of mouse kidney disease. The mechanism could be accounted for by an imbalance favoring Matriptase over its cognate inhibitor, hepatocyte growth factor activator inhibitor type 1 (HAI-1), because conditional depletion of HAI-1 in podocytes accelerated podocyte injury in mouse model. Matriptase was capable of cleaving Podocin, but such a reaction was blocked by either HAI-1 or dominant-negative Matriptase. Furthermore, the N terminus of Podocin, as a consequence of Matriptase cleavage of Podocin, translocated to nucleoli, suggesting that the N terminus of Podocin might be involved in the process of podocyte injury. Given these observations, we propose that the proteolytic cleavage of Podocin by Matriptase could potentially cause podocyte injury and that targeting Matriptase could be a novel therapeutic strategy for CKD patients.	[Ozawa, Shota; Yanagita, Motoko; Mori, Kiyoshi; Asanuma, Katsuhiko; Nakagawa, Takahiko] Kyoto Univ, TMK Project, Med Innovat Ctr, Kyoto, Japan; [Yanagita, Motoko; Yokoi, Hideki] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto, Japan; [Yanagita, Motoko] Kyoto Univ, Inst Adv Study Human Biol, Kyoto, Japan; [Ozawa, Shota] Mitsubishi Tanabe Pharma Corp, Res Unit Innovat Med Sci, Saitama, Japan; [Matsubayashi, Masaya; Nanaura, Hitoki; Mori, Eiichiro; Nakagawa, Takahiko] Nara Med Univ, Dept Future Basic Med, Kashihara, Nara, Japan; [Kasahara, Masato] Nara Med Univ, Inst Clin & Translat Sci, Kashihara, Nara, Japan; [Mori, Kiyoshi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Mol & Clin Pharmacol, Shizuoka, Japan; [Asanuma, Katsuhiko] Chiba Univ, Dept Nephrol, Chiba, Japan; [Kajiwara, Nobuyuki; Hayashi, Kazuyuki] Ikeda City Hosp, Dept Nephrol, Ikeda, Osaka, Japan; [Ohashi, Hiroshi] Ikeda City Hosp, Dept Pathol, Ikeda, Osaka, Japan; [Kataoka, Hiroaki] Miyazaki Univ, Dept Pathol, Kihara, Miyazaki, Japan	Kyoto University; Kyoto University; Kyoto University; Mitsubishi Tanabe Pharma Corporation; Nara Medical University; Nara Medical University; University of Shizuoka; Chiba University; University of Miyazaki	Nakagawa, T (corresponding author), Kyoto Univ, TMK Project, Med Innovat Ctr, Kyoto, Japan.; Mori, E; Nakagawa, T (corresponding author), Nara Med Univ, Dept Future Basic Med, Kashihara, Nara, Japan.	emori@naramed-u.ac.jp; nakagawt@gmail.com	Yanagita, Motoko/AAJ-7731-2021; Yokoi, Hideki/AAV-9038-2021; Yokoi, Hideki/R-1289-2016; Mori, Kiyoshi/N-1267-2014	Yokoi, Hideki/0000-0001-8343-9737; Yokoi, Hideki/0000-0001-8343-9737; Yanagita, Motoko/0000-0002-0339-9008; Mori, Kiyoshi/0000-0002-7285-8351	JSPS (Japan Society for the Promotion of Science) KAKENHI [JP26460274, JP17H07031, JP20H03199, JP18H06202, JP19K21306, JP20K16583]; AMED (Japan Agency for Medical Research and Development) Brain/MINDS Beyond Grant [JP20dm0307032]; Suzuken Co., Ltd.; MSD Lifescience Foundation; Novartis Research Grants; Fuji Yakuhin Co., Ltd.; Takeda Science Foundation; Kanzawa Medical Research Foundation; Uehara Memorial Foundation; Nakatomi Foundation; Konica Minolta Science and Technology Foundation; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Senshin Medical Research Foundation; Terumo Foundation for Life Sciences and Arts; Nara Kidney Disease Research Foundation; TMK Project	JSPS (Japan Society for the Promotion of Science) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED (Japan Agency for Medical Research and Development) Brain/MINDS Beyond Grant; Suzuken Co., Ltd.; MSD Lifescience Foundation; Novartis Research Grants; Fuji Yakuhin Co., Ltd.; Takeda Science Foundation(Takeda Science Foundation (TSF)); Kanzawa Medical Research Foundation(Kanzawa Medical Research Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); Nakatomi Foundation; Konica Minolta Science and Technology Foundation(Konica Minolta Science and Technology Foundation); Naito Foundation(Naito Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Senshin Medical Research Foundation(SENSHIN Medical Research Foundation); Terumo Foundation for Life Sciences and Arts; Nara Kidney Disease Research Foundation; TMK Project	This work was supported by Grants from the TMK Project; JSPS (Japan Society for the Promotion of Science) KAKENHI JP26460274 (to T. N.), JP17H07031 (to E. M.), JP20H03199 (to E. M.), JP18H06202 (to H. N.), JP19K21306 (to H. N.), and JP20K16583 (to H. N.); AMED (Japan Agency for Medical Research and Development) Brain/MINDS Beyond Grant JP20dm0307032 (to E. M.); funds from Suzuken Co., Ltd. (to T. N.); funds from the MSD Lifescience Foundation (to T. N. and E. M.); Novartis Research Grants (to T. N. and E. M.); funds from Fuji Yakuhin Co., Ltd. (to T. N. and E. M.), the Takeda Science Foundation (to E. M.), the Kanzawa Medical Research Foundation (to E. M.), the Uehara Memorial Foundation (to E. M.), the Nakatomi Foundation (to E. M.), the Konica Minolta Science and Technology Foundation (to E. M.), the Naito Foundation (to E. M.), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to E. M.), the Senshin Medical Research Foundation (to E. M.), the Terumo Foundation for Life Sciences and Arts (to E. M.), and the Nara Kidney Disease Research Foundation (to E. M.); and unrestricted funds (to E. M.) from Dr. Taichi Noda (KTX Corp., Aichi, Japan) and Dr. Yasuhiro Horii (Koseikai, Nara, Japan).	Badeanlou L, 2011, NAT MED, V17, P1490, DOI 10.1038/nm.2461; Bardou O, 2016, AM J RESP CRIT CARE, V193, P847, DOI 10.1164/rccm.201502-0299OC; Brinkkoetter PT, 2013, NAT REV NEPHROL, V9, P328, DOI 10.1038/nrneph.2013.78; Carney TJ, 2007, DEVELOPMENT, V134, P3461, DOI 10.1242/dev.004556; Colombo E, 2012, ACS MED CHEM LETT, V3, P530, DOI 10.1021/ml3000534; Ebihara I, 1998, AM J KIDNEY DIS, V32, P544, DOI 10.1016/S0272-6386(98)70015-0; Eddy AA, 2009, THROMB HAEMOSTASIS, V101, P656, DOI 10.1160/TH08-12-0779; Fox C, 2016, SCI REP-UK, V6, DOI 10.1038/srep20101; Guan Y, 2017, J PHARMACOL SCI, V135, P81, DOI 10.1016/j.jphs.2017.09.002; Harris JJ, 2013, J PATHOL, V229, P660, DOI 10.1002/path.4149; Hayata M, 2012, AM J PHYSIOL-RENAL, V303, pF1126, DOI 10.1152/ajprenal.00706.2011; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Jiang YH, 2017, ACS CHEM BIOL, V12, P1217, DOI 10.1021/acschembio.6b01088; Kawaguchi M, 2011, AM J PATHOL, V179, P1815, DOI 10.1016/j.ajpath.2011.06.038; Lelongt B, 2001, CURR OPIN NEPHROL HY, V10, P7, DOI 10.1097/00041552-200101000-00002; Lenz O, 2000, J AM SOC NEPHROL, V11, P574, DOI 10.1681/ASN.V113574; Li SY, 2014, KIDNEY INT, V86, P358, DOI 10.1038/ki.2014.67; McMillan JI, 1996, J CLIN INVEST, V97, P1094, DOI 10.1172/JCI118502; MURAKAWA M, 1992, ANN HEMATOL, V64, P249, DOI 10.1007/BF01738305; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Oberst M, 2001, AM J PATHOL, V158, P1301, DOI 10.1016/S0002-9440(10)64081-3; Rigothier C, 2016, J CELL BIOCHEM, V117, P2737, DOI 10.1002/jcb.25571; Saleem M, 2006, CANCER EPIDEM BIOMAR, V15, P217, DOI 10.1158/1055-9965.EPI-05-0737; Sales KU, 2010, NAT GENET, V42, P676, DOI 10.1038/ng.629; Schaffner F, 2008, SEMIN THROMB HEMOST, V34, P147, DOI 10.1055/s-2008-1079254; Shimomura T, 1997, J BIOL CHEM, V272, P6370, DOI 10.1074/jbc.272.10.6370; Tanabe K, 2012, AM J PHYSIOL-RENAL, V302, pF1151, DOI 10.1152/ajprenal.00596.2011; Tanabe LM, 2017, FEBS J, V284, P1421, DOI 10.1111/febs.13971; Ueda S, 2015, FREE RADICAL BIO MED, V87, P181, DOI 10.1016/j.freeradbiomed.2015.06.028; Vogel LK, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-176; Wang Y, 2000, KIDNEY INT, V58, P1797, DOI 10.1046/j.1523-1755.2000.00342.x; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181; Yaddanapudi S, 2011, J CLIN INVEST, V121, P3965, DOI 10.1172/JCI58552; Yokoi H, 2010, NEPHROL DIAL TRANSPL, V25, P2120, DOI 10.1093/ndt/gfq029	34	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2020	295	47					16002	16012		10.1074/jbc.RA120.013721	http://dx.doi.org/10.1074/jbc.RA120.013721			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PA5ED	32907879	hybrid, Green Published			2022-12-26	WOS:000595657900018
J	Griffin, SM; Pickard, MR; Hawkins, CP; Williams, AC; Fricker, RA				Griffin, Sile M.; Pickard, Mark R.; Hawkins, Clive P.; Williams, Adrian C.; Fricker, Rosemary A.			Nicotinamide restricts neural precursor proliferation to enhance catecholaminergic neuronal subtype differentiation from mouse embryonic stem cells	PLOS ONE			English	Article							TYROSINE-HYDROXYLASE EXPRESSION; MIDBRAIN; DOPAMINE	Emerging evidence indicates that a strong relationship exists between brain regenerative therapies and nutrition. Early life nutrition plays an important role during embryonic brain development, and there are clear consequences to an imbalance in nutritional factors on both the production and survival of mature neuronal populations and the infant's risk of diseases in later life. Our research and that of others suggest that vitamins play a fundamental role in the formation of neurons and their survival. There is a growing body of evidence that nicotinamide, the water-soluble amide form of vitamin B-3, is implicated in the conversion of pluripotent stem cells to clinically relevant cells for regenerative therapies. This study investigated the ability of nicotinamide to promote the development of mature catecholaminergic neuronal populations (associated with Parkinson's disease) from mouse embryonic stem cells, as well as investigating the underlying mechanisms of nicotinamide's action. Nicotinamide selectively enhanced the production of tyrosine hydroxylase-expressing neurons and serotonergic neurons from mouse embryonic stem cell cultures (Sox1GFP knock-in 46C cell line). A 5-Ethynyl-2 '-deoxyuridine (EdU) assay ascertained that nicotinamide, when added in the initial phase, reduced cell proliferation. Nicotinamide drove tyrosine hydroxylase-expressing neuron differentiation as effectively as an established cocktail of signalling factors, reducing the proliferation of neural progenitors and accelerating neuronal maturation, neurite outgrowth and neurotransmitter expression. These novel findings show that nicotinamide enhanced and enriched catecholaminergic differentiation and inhibited cell proliferation by directing cell cycle arrest in mouse embryonic stem cell cultures, thus driving a critical neural proliferation-to-differentiation switch from neural progenitors to neurons. Further research into the role of vitamin metabolites in embryogenesis will significantly advance cell-based regenerative medicine, and help realize their role as crucial developmental signalling molecules in brain development.	[Griffin, Sile M.; Hawkins, Clive P.; Fricker, Rosemary A.] Keele Univ, Keele Med Sch, Keele, Staffs, England; [Griffin, Sile M.; Hawkins, Clive P.; Fricker, Rosemary A.] Keele Univ, Inst Sci & Technol Med, Keele, Staffs, England; [Pickard, Mark R.] Univ Chester, Univ Ctr Shrewsbury, Chester Med Sch, Shrewsbury, Salop, England; [Hawkins, Clive P.] Royal Stoke Univ Hosp, Dept Neurol, Stoke On Trent, Staffs, England; [Williams, Adrian C.] Univ Birmingham, Dept Neurosci, Birmingham, W Midlands, England	Keele University; Keele University; Royal Stoke University Hospital; University of Birmingham	Griffin, SM (corresponding author), Keele Univ, Keele Med Sch, Keele, Staffs, England.; Griffin, SM (corresponding author), Keele Univ, Inst Sci & Technol Med, Keele, Staffs, England.	silemgriffin@gmail.com	Fricker, Rosemary/ABC-3301-2021	Griffin, Sile/0000-0002-6670-5084; Fricker, Rosemary/0000-0001-8768-510X	Queen Elizabeth Hospital, Birmingham Charity; Keele University ACORN studentship	Queen Elizabeth Hospital, Birmingham Charity; Keele University ACORN studentship	This work was supported by the Queen Elizabeth Hospital, Birmingham Charity funding for laboratory consumables and reagents and the Keele University ACORN studentship to support PhD student fees and stipend. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI [10.1055/s-0043-115953, DOI 10.1055/S-0043-115953]; [Anonymous], 2012, KIDNEY INT, V2, ps1; Bagga V, 2008, CELL TRANSPLANT, V17, P763, DOI 10.3727/096368908786516774; Brady M, 2019, HIV MED, V20, pS2, DOI 10.1111/hiv.12718; Cimadamore F, 2009, STEM CELLS, V27, P1772, DOI 10.1002/stem.107; Fricker RA, 2018, INT J TRYPTOPHAN RES, V11, DOI 10.1177/1178646918776658; Gonzalez HF, 2016, ARCH ARGENT PEDIATR, V114, P570, DOI [10.5546/aap.2016.eng.570, 10.5546/aap.2016.570]; Griffin SM, 2013, NEUROREPORT, V24, P1041, DOI 10.1097/WNR.0000000000000071; Hazim RA, 2019, EXP EYE RES, V179, P18, DOI 10.1016/j.exer.2018.10.009; Jaeger I, 2011, DEVELOPMENT, V138, P4363, DOI 10.1242/dev.066746; Janesick A, 2015, CELL MOL LIFE SCI, V72, P1559, DOI 10.1007/s00018-014-1815-9; Jiang FX, 2017, STEM CELLS, V35, P1341, DOI 10.1002/stem.2567; Kim MJ, 2009, FEBS LETT, V583, P1183, DOI 10.1016/j.febslet.2009.03.007; Kim TE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071469; Lee JY, 2009, NEUROSCI LETT, V461, P163, DOI 10.1016/j.neulet.2009.06.005; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; LOVENBERG W, 1979, SCIENCE, V204, P624, DOI 10.1126/science.432666; Maiese K, 2003, TRENDS PHARMACOL SCI, V24, P228, DOI 10.1016/S0165-6147(03)00078-6; Mattei D, 2019, CURR NUTR REP, V8, P99, DOI 10.1007/s13668-019-0268-z; Maxwell SL, 2005, DEV BIOL, V282, P467, DOI 10.1016/j.ydbio.2005.03.028; Meng Y, 2018, STEM CELL REP, V11, P1347, DOI 10.1016/j.stemcr.2018.10.023; Orme RP, 2010, J NEUROSCI METH, V191, P75, DOI 10.1016/j.jneumeth.2010.06.009; Parmar M, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-86; Parmar M, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.156117; Parsons RB, 2003, NEUROSCI LETT, V342, P13, DOI 10.1016/S0304-3940(03)00218-0; Politis M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003391; Prado EL, 2014, NUTR REV, V72, P267, DOI 10.1111/nure.12102; Riemens RJM, 2018, PROG NEUROBIOL, V168, P42, DOI 10.1016/j.pneurobio.2018.04.003; Smits SM, 2003, EUR J NEUROSCI, V18, P1731, DOI 10.1046/j.1460-9568.2003.02885.x; Soliman MA, 2017, MOL PSYCHIATR, V22, P1241, DOI 10.1038/mp.2017.40; Sperber H, 2015, NAT CELL BIOL, V17, P1523, DOI 10.1038/ncb3264; Vaca P, 2008, EXP CELL RES, V314, P969, DOI 10.1016/j.yexcr.2007.11.019; Weiss R, 2015, INNATE IMMUN-LONDON, V21, P813, DOI 10.1177/1753425915602545; Williams A, 2005, PARKINSONISM RELAT D, V11, P413, DOI 10.1016/j.parkreldis.2005.05.011; Williams AC, 2005, MED HYPOTHESES, V65, P353, DOI 10.1016/j.mehy.2005.01.042; Williams AC, 2020, INT J TRYPTOPHAN RES, V13, DOI 10.1177/1178646920910159; Williams Adrian C, 2012, Curr Gerontol Geriatr Res, V2012, P302875, DOI 10.1155/2012/302875; Yan YP, 2005, STEM CELLS, V23, P781, DOI 10.1634/stemcells.2004-0365; Yang SF, 2015, TRANSPL P, V47, P2041, DOI 10.1016/j.transproceed.2015.05.019; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	41	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0233477	10.1371/journal.pone.0233477	http://dx.doi.org/10.1371/journal.pone.0233477			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925933	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000572318000022
J	Moffat, J; Chalmers, G; Reid-Smith, R; Mulvey, MR; Agunos, A; Calvert, J; Cormier, A; Ricker, N; Weese, JS; Boerlin, P				Moffat, Jonathan; Chalmers, Gabhan; Reid-Smith, Richard; Mulvey, Michael R.; Agunos, Agnes; Calvert, Julie; Cormier, Ashley; Ricker, Nicole; Weese, J. Scott; Boerlin, Patrick			Resistance to extended-spectrum cephalosporins in Escherichia coli and other Enterobacterales from Canadian turkeys	PLOS ONE			English	Article							BETA-LACTAMASE; ANTIMICROBIAL RESISTANCE; FOOD ANIMALS; PLASMIDS; SALMONELLA; IDENTIFICATION; EPIDEMIOLOGY; SURVEILLANCE; GENES	The goal of this study was to determine the frequency of resistance to extended-spectrum cephalosporins (ESCs) inEscherichia coliand otherEnterobacteralesfrom turkeys in Canada and characterize the associated resistance determinants. Pooled fecal samples were collected in 77 turkey farms across British Columbia, Quebec, and Ontario. Isolates were obtained with and without selective enrichment cultures and compared to isolates from diagnostic submissions of suspected colibacillosis cases in Ontario. Isolates were identified using MALDI-TOF and susceptibility to ESCs was assessed by disk diffusion. The presence ofbla(CMY),bla(CTX-M),bla(TEM,)andbla(SHV)was tested by PCR. Transformation experiments were used to characterizebla(CMY)plasmids. Genome sequencing with short and long reads was performed on a representative sample ofbla(CTX-M)-positive isolates to assess isolates relatedness and characterizebla(CTX-M)plasmids. For the positive enrichment cultures (67% of total samples), 93% (587/610) were identified asE.coli, with only a few otherEnterobacteralesspecies identified. The frequency of ESC resistance was low inE.coliisolates from diagnostic submission (4%) and fecal samples without selective enrichment (5%). Of the ESC-resistantEnterobacteralesisolates from selective enrichments, 71%, 18%, 14%, and 8% were positive forbla(CMY),bla(TEM,)bla(CTX-M,)andbla(SHV), respectively. IncI1 followed by IncK were the main incompatibility groups identified forbla(CMY)plasmids. Thebla(CTX-M-1)gene was found repeatedly on IncI1 plasmids of the pMLST type 3, whilebla(CTX-M-15),bla(CTX-M-55), andbla(CTX-M-65)were associated with a variety of IncF plasmids. Clonal spread of strains carryingbla(CTX-M)genes between turkey farms was observed, as well as the presence of an epidemicbla(CTX-M-1)plasmid in unrelatedE.colistrains. In conclusion,Enterobacteralesresistant to ESCs were still widespread at low concentration in turkey feces two years after the cessation of ceftiofur use. Althoughbla(CMY-2)is the main ESC resistance determinant inE.colifrom Canadian turkeys,bla(CTX-M)genes also occur which are often carried by multidrug resistance plasmids. Both clonal spread and horizontal gene transfer are involved in parallel in the spread ofbla(CTX-M)genes inEnterobacteralesfrom Canadian turkeys.	[Moffat, Jonathan; Chalmers, Gabhan; Mulvey, Michael R.; Calvert, Julie; Cormier, Ashley; Ricker, Nicole; Weese, J. Scott; Boerlin, Patrick] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON, Canada; [Reid-Smith, Richard; Agunos, Agnes] Publ Hlth Agcy Canada, Ctr Foodborne Environm & Zoonot Infect Dis, Guelph, ON, Canada; [Mulvey, Michael R.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada	University of Guelph; Public Health Agency of Canada; Public Health Agency of Canada	Boerlin, P (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON, Canada.	pboerlin@uoguelph.ca		Agunos, Agnes/0000-0003-2357-3509	Natural Science and Engineering Research Council [201503962]; Ontario Ministry of Agriculture Food and Rural Affairs; Canadian Poultry Research Council	Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Agriculture Food and Rural Affairs; Canadian Poultry Research Council	This study was supported by funding from the following sources: ~ Natural Science and Engineering Research Council (https://www.nserccrsng.gc.ca/index_eng.asp), grant number 201503962 to PB. ~ The Ontario Ministry of Agriculture Food and Rural Affairs (http://www.omafra.gov.on.ca/english/) to AA ~ The Canadian Poultry Research Council (http://cp-rc.ca/) to PB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KJ, 2002, CAN J VET RES, V66, P137; [Anonymous], 2019, OIE LIST ANT AG VET; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Bourely C, 2018, VET MICROBIOL, V223, P72, DOI 10.1016/j.vetmic.2018.07.025; Brinas L, 2002, ANTIMICROB AGENTS CH, V46, P3156, DOI 10.1128/AAC.46.10.3156-3163.2002; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Chalmers G, 2017, VET MICROBIOL, V203, P149, DOI 10.1016/j.vetmic.2017.02.005; Chicken Farmers of Canada, 2018, AMU STRAT PRESCR CHA, P48; Chicken Farmers of Canada, 2016, RESP ANT US CAN CHIC; CIPARS, 2020, M02 CLIN LAB STAND I, P1; Clinical and Laboratory Standards Institute, 2018, M100 CLIN LAB STAND, V27th; Cormier A, 2019, VET MICROBIOL, V231, P71, DOI 10.1016/j.vetmic.2019.02.031; Cormier AC, 2020, MICROB DRUG RESIST, V26, P300, DOI 10.1089/mdr.2019.0112; Cottell JL, 2013, ANTIMICROB AGENTS CH, V57, P1096, DOI 10.1128/AAC.01750-12; Denisuik AJ, 2013, J ANTIMICROB CHEMOTH, V68, pi57, DOI 10.1093/jac/dkt027; GYLES C, 1974, J INFECT DIS, V130, P40, DOI 10.1093/infdis/130.1.40; Gyohda A, 2004, ADV BIOPHYS, V38, P183, DOI 10.1016/S0065-227X(04)80166-7; Khashayar B, 2009, THESIS; Kolmogorov M, 2019, NAT BIOTECHNOL, V37, P540, DOI 10.1038/s41587-019-0072-8; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Kozak GK, 2009, APPL ENVIRON MICROB, V75, P559, DOI 10.1128/AEM.01821-08; Lucas P, 2018, VET MICROBIOL, V224, P100, DOI 10.1016/j.vetmic.2018.08.005; Manges AR, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00135-18; Martin LC, 2012, APPL ENVIRON MICROB, V78, P1285, DOI 10.1128/AEM.06498-11; Mataseje LF, 2012, J ANTIMICROB CHEMOTH, V67, P1359, DOI 10.1093/jac/dks046; Maurya AP, 2016, INDIAN J MED MICROBI, V34, P33, DOI 10.4103/0255-0857.174110; Mulvey MR, 2009, VET MICROBIOL, V134, P279, DOI 10.1016/j.vetmic.2008.08.018; Mulvey MR, 2004, ANTIMICROB AGENTS CH, V48, P1204, DOI 10.1128/AAC.48.4.1204-1214.2004; Pouget JG, 2013, APPL ENVIRON MICROB, V79, P3864, DOI 10.1128/AEM.00355-13; Provence DL, 1994, METHODS GEN MOL BACT, P337; Roer L, 2017, J ANTIMICROB CHEMOTH, V72, P1922, DOI 10.1093/jac/dkx092; Ronco T, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3415-6; Tadesse DA, 2018, MICROB DRUG RESIST, V24, P939, DOI 10.1089/mdr.2018.0206; Vaser R, 2017, GENOME RES, V27, P737, DOI 10.1101/gr.214270.116; Verrette L, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.00037-19; Vounba P, 2019, MICROB DRUG RESIST, V25, P1111, DOI 10.1089/mdr.2018.0403; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; WHO, 2019, WHO ADV GROUP INT SU; Wick RR, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005595; Wick Ryan R, 2015, Bioinformatics, V31, P3350, DOI 10.1093/bioinformatics/btv383; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhang P., 2017, THESIS	46	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0236442	10.1371/journal.pone.0236442	http://dx.doi.org/10.1371/journal.pone.0236442			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925914	Green Published, gold			2022-12-26	WOS:000572318000048
J	Park, H; Hwang, E; Jang, M; Yoon, C				Park, Hyunhee; Hwang, Eunsong; Jang, Miyeon; Yoon, Chungsik			Exposure assessment of elemental carbon, polycyclic aromatic hydrocarbons and crystalline silica at the underground excavation sites for top-down construction buildings	PLOS ONE			English	Article							DIESEL-ENGINE EXHAUST; HEALTH-RISK ASSESSMENT; OCCUPATIONAL-EXPOSURE; NITROGEN-DIOXIDE; DUST; PAHS; EMISSIONS; MINERS; QUARTZ	Enclosed underground excavation worksite has an environment with poor ventilation and exposure to hazardous substances from diesel engine exhaust and construction materials. The objective of this study was to evaluate the exposure level of elemental carbon (EC), organic carbon (OC), total carbon (TC), polycyclic aromatic hydrocarbons (PAHs), dust and crystalline silica (CS) during underground excavation work for top down construction buildings. Active local air sampling for EC, OC, and TC (n = 105), PAHs (n = 50), dust (n = 34) and CS (n = 34) was conducted from inside and outside the excavator at underground excavation workshop in four different construction sites. EC, OC, TC and CS were sampled with each respirable and total particulates. EC, OC, and TC were collected on quartz-filter and analyzed using the thermal optical transmittance method. PAHs was collected on polytetrafluorethylene filter with XAD-2 and analyzed using liquid chromatography with fluorescence detector. CS and particulates were collected on poly vinyl chloride filter and analyzed using fourier-transform infrared spectroscopy. The geometric mean of respirable EC, OC, TC, total PAHs, respirable dust and respirable CS were 8.69 mu g/m(3), 34.32 mu g/m(3), 44.96 mu g/m(3), 6.818 mu g/m(3)0.13 mg/m(3)and 0.02 mg/m(3)from inside the excavator and 33.20 mu g/m(3), 46.53 mu g/m(3), 78.21 mu g/m(3), 3.934 mu g/m(3), 0.9 mg/m(3)and 0.08 mg/m(3)from outside the excavator (underground excavation workshop), respectively. The EC and RCS concentration from outside the excavator is significantly higher than that of inside the excavator (p<0.01). The worksite with rock ground, higher vehicle density, blasting and enclosed environments had higher exposure to EC than other sites (p<0.05). There was no significant difference of EC concentration between total and respirable particulates. In top down construction sites, EC concentrations during underground excavation work exceeded recommended exposure limits as 20 mu g/m(3), accounted for about 50% of the total sample, and the level of concentration of RCS exceeded 1.5 times of occupational exposure limit, 0.05 mg/m(3). Efforts are needed to minimize exposure to diesel engine exhaust and silica in underground excavation sites. Management of diesel engine vehicle, supply of fresh air and ventilation and introducing water facilities to create wet environment in underground worksites are strongly suggested.	[Park, Hyunhee; Hwang, Eunsong; Jang, Miyeon] Occupat Safety & Hlth Res Inst, Work Environm Res Bur, Ulsan, South Korea; [Park, Hyunhee; Yoon, Chungsik] Seoul Natl Univ, Grad Sch Publ Hlth, Dept Occupat Hlth, Seoul, South Korea	Seoul National University (SNU)	Yoon, C (corresponding author), Seoul Natl Univ, Grad Sch Publ Hlth, Dept Occupat Hlth, Seoul, South Korea.	csyoon@snu.ac.kr		Park, Hyunhee/0000-0003-1506-9505	Occupational Safety & Health Research Institute (OSHRI); Korea Occupational Safety & Health Agency(KOSHA); OSHRI [2017-OSHRI-1061]	Occupational Safety & Health Research Institute (OSHRI); Korea Occupational Safety & Health Agency(KOSHA); OSHRI	This work was supported by the Occupational Safety & Health Research Institute (OSHRI), Korea Occupational Safety & Health Agency(KOSHA) and funded by the research project(No. 2017-OSHRI-1061) of the OSHRI (URL: http://oshri.kosha.or.kr/eoshri/index.do).The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; [Anonymous], DHHS NIOSH PUBLICATI, V2002-129; [Anonymous], 2013, IARC MON EV CARC RIS; Bakke B, 2001, AIHAJ, V62, P457, DOI 10.1080/15298660108984647; Bakke Berit, 2002, Appl Occup Environ Hyg, V17, P783, DOI 10.1080/10473220290096032; Bal C, 2018, AM J IND MED, V61, P471, DOI 10.1002/ajim.22830; Bello A, 2019, ANN WORK EXPOS HEAL, V63, P34, DOI 10.1093/annweh/wxy089; Birch ME, 2003, NIOSH MANUAL ANAL ME; Boffetta P, 1997, CANCER CAUSE CONTROL, V8, P444, DOI 10.1023/A:1018465507029; Boffetta P, 2002, HEI SPECIAL REPORT R, P57; Bosch R., 2015, REV SAMPLING EVALUAT; Brodny J, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091846; Coble JB, 2010, ANN OCCUP HYG, V54, P747, DOI 10.1093/annhyg/meq024; Dutch Expert Committee on Occupational Safety (DECOS), 2019, DIES ENG EXH HLTH BA; Echt A, 1995, APPL OCCUP ENV HYG, V10, P431; Flanagan ME, 2003, AIHA J, V64, P319, DOI 10.1202/1542-8125(2003)64<319:SDEDSC>2.0.CO;2; Galea KS, 2016, ANN OCCUP HYG, V60, P263, DOI 10.1093/annhyg/mev067; Garrido A, 2014, ATMOS ENVIRON, V99, P474, DOI 10.1016/j.atmosenv.2014.10.011; Groves J, 2000, ANN OCCUP HYG, V44, P435, DOI 10.1093/annhyg/44.6.435; Hedmer M, 2017, ANN WORK EXPOS HEAL, V61, P539, DOI 10.1093/annweh/wxx024; Hu YD, 2007, SCI TOTAL ENVIRON, V382, P240, DOI 10.1016/j.scitotenv.2007.04.038; Jamsawang P, 2017, COMPUT GEOTECH, V88, P174, DOI 10.1016/j.compgeo.2017.03.018; Kang PS, 2012, J KOREAN SOC STEEL C, V24, P52; Kim HS, 2013, J LAPAROENDOSC ADV S, V23, P323, DOI 10.1089/lap.2012.0389; Kim Sang Il, 2016, [Journal of Korean Society of Occupational and Environmental Hygiene, 한국산업보건학회지], V26, P38, DOI 10.15269/JKSOEH.2016.26.1.38; Kittelson DB, 1998, J AEROSOL SCI, V29, P575, DOI 10.1016/S0021-8502(97)10037-4; Lee JS, 2005, THESIS, P14; Lee K., 2004, THESIS; Lee N, 2016, J KOREAN SOC OCCUP E, V26, P219; Lewne M, 2007, ANN OCCUP HYG, V51, P693, DOI 10.1093/annhyg/mem046; Li PH, 2013, ENVIRON SCI-PROC IMP, V15, P623, DOI 10.1039/c2em30708a; Lumens MEGL, 2001, ANN OCCUP HYG, V45, P585, DOI 10.1016/S0003-4878(01)00025-4; Marr LC, 1999, ENVIRON SCI TECHNOL, V33, P3091, DOI 10.1021/es981227l; McDonald JD, 2004, ENVIRON SCI TECHNOL, V38, P2513, DOI 10.1021/es035024v; Miguel AH, 1998, ENVIRON SCI TECHNOL, V32, P450, DOI 10.1021/es970566w; Na KS, 2004, ATMOS ENVIRON, V38, P1345, DOI 10.1016/j.atmosenv.2003.11.023; NIOSH, 2016, DIES PART MATT EL CA; NIOSH, 1998, POL AR HYDR HPLC ISS; NIOSH, 2003, SLICA RESP CRYST IR; Normohammadi M, 2016, SAF HEALTH WORK-KR, V7, P251, DOI 10.1016/j.shaw.2015.12.006; Pronk A, 2009, J EXPO SCI ENV EPID, V19, P443, DOI 10.1038/jes.2009.21; Radnoff D, 2014, J OCCUP ENVIRON HYG, V11, P557, DOI 10.1080/15459624.2014.887205; Rappaport SM, 2003, ANN OCCUP HYG, V47, P111, DOI 10.1093/annhyg/meg025; Rhim HC, 2012, J CIV ENG MANAG, V18, P735, DOI 10.3846/13923730.2012.723397; Stewart PA, 2010, ANN OCCUP HYG, V54, P728, DOI 10.1093/annhyg/meq022; Szyszka-Sommerfeld L, 2018, INT J PAEDIATR DENT, V28, P257, DOI [10.1111/ipd.12349, DOI 10.1111/IPD.12349]; Taxell P, 2017, TOXICOL SCI, V158, P243, DOI 10.1093/toxsci/kfx110; Tsai PJ, 2001, SCI TOTAL ENVIRON, V278, P137, DOI 10.1016/S0048-9697(01)00643-X; Vermeulen R, 2014, ENVIRON HEALTH PERSP, V122, P172, DOI 10.1289/ehp.1306880; Vermeulen R, 2010, ANN OCCUP HYG, V54, P762, DOI 10.1093/annhyg/meq023; Woskie SR, 2002, AIHAJ, V63, P447, DOI 10.1080/15428110208984733; Zhao Y, 2016, 2016 2ND INTERNATIONAL CONFERENCE ON SOCIAL SCIENCE, MANAGEMENT AND ECONOMICS (SSME 2016), P6, DOI 10.1109/WCNC.2016.7565056; 임호섭, 2004, [Journal of Korean Society of Occupational and Environmental Hygiene, 한국산업보건학회지], V14, P134	53	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0239010	10.1371/journal.pone.0239010	http://dx.doi.org/10.1371/journal.pone.0239010			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925951	gold, Green Published			2022-12-26	WOS:000572318000017
J	Ruzmi, R; Ahmad-Hamdani, MS; Mazlan, N				Ruzmi, Rabiatuladawiyah; Ahmad-Hamdani, Muhammad Saiful; Mazlan, Norida			Ser-653-Asn substitution in the acetohydroxyacid synthase gene confers resistance in weedy rice to imidazolinone herbicides in Malaysia	PLOS ONE			English	Article							ORYZA-SATIVA L.; RED RICE; CLEARFIELD(R) RICE; INHIBITOR HERBICIDES; TARGET-SITE; ALS GENE; PLANT; IMAZETHAPYR; TOLERANCE; FLOW	The continuous and sole dependence on imidazolinone (IMI) herbicides for weedy rice control has led to the evolution of herbicide resistance in weedy rice populations across various countries growing IMI herbicide-resistant rice (IMI-rice), including Malaysia. A comprehensive study was conducted to elucidate occurrence, level, and mechanisms endowing resistance to IMI herbicides in putative resistant (R) weedy rice populations collected from three local Malaysian IMI-rice fields. Seed bioassay and whole-plant dose-response experiments were conducted using commercial IMI herbicides. Based on the resistance index (RI) quantification in both experiments, the cross-resistance pattern of R and susceptible (S) weedy rice populations and control rice varieties (IMI-rice variety MR220CL2 and non-IMI-rice variety MR219) to imazapic and imazapyr was determined. A molecular investigation was carried out by comparing the acetohydroxyacid synthase (AHAS) gene sequences of the R and S populations and the MR220CL2 and MR219 varieties. The AHAS gene sequences of R weedy rice were identical to those of MR220CL2, exhibiting a Ser-653-Asn substitution, which was absent in MR219 and S plants.In vitroassays were conducted using analytical grade IMI herbicides of imazapic (99.3%) and imazapyr (99.6%) at seven different concentrations. The results demonstrated that the AHAS enzyme extracted from the R populations and MR220CL2 was less sensitive to IMI herbicides than that from S and MR219, further supporting that IMI herbicide resistance was conferred by target-site mutation. In conclusion, IMI resistance in the selected populations of Malaysian weedy rice could be attributed to a Ser-653-Asn mutation that reduced the sensitivity of the target site to IMI herbicides. To our knowledge, this study is the first to show the resistance mechanism in weedy rice from Malaysian rice fields.	[Ruzmi, Rabiatuladawiyah; Ahmad-Hamdani, Muhammad Saiful] Univ Putra Malaysia, Fac Agr, Dept Crop Sci, Seri Kembangan, Selangor, Malaysia; [Ahmad-Hamdani, Muhammad Saiful] Univ Putra Malaysia, Inst Trop Agr & Food Secur, Lab Climate Smart Food Crop Prod, Seri Kembangan, Selangor, Malaysia; [Mazlan, Norida] Univ Putra Malaysia, Fac Agr, Dept Agr Technol, Seri Kembangan, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Ahmad-Hamdani, MS (corresponding author), Univ Putra Malaysia, Fac Agr, Dept Crop Sci, Seri Kembangan, Selangor, Malaysia.; Ahmad-Hamdani, MS (corresponding author), Univ Putra Malaysia, Inst Trop Agr & Food Secur, Lab Climate Smart Food Crop Prod, Seri Kembangan, Selangor, Malaysia.	s_ahmad@upm.edu.my		Ahmad Hamdani, Muhammad Saiful/0000-0002-6233-5143	Universiti Putra Malaysia GP-IPS Research Grant [GP-IPS/2016/9492300]; Fundamental Research Grant Scheme under the Ministry of Education Malaysia [07-01-18-1961FR (5540086)]	Universiti Putra Malaysia GP-IPS Research Grant; Fundamental Research Grant Scheme under the Ministry of Education Malaysia	This research was funded by Universiti Putra Malaysia GP-IPS Research Grant (GP-IPS/2016/9492300) and Fundamental Research Grant Scheme under the Ministry of Education Malaysia 07-01-18-1961FR (5540086).	Andres A, 2014, WEED RES, V54, P492, DOI 10.1111/wre.12099; [Anonymous], 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-018-0474-7; [Anonymous], 1998, WEED TECHNOL, V12, P789; Avila LA, 2005, PEST MANAG SCI, V61, P171, DOI 10.1002/ps.966; Azmi M, 1998, MANUAL IDENTIFICATIO; Burgos NR, 2015, WEED SCI, V63, P152, DOI 10.1614/WS-D-14-00019.1; Busconi M, 2012, PLANT BIOLOGY, V14, P751, DOI 10.1111/j.1438-8677.2012.00570.x; Cassol GV, 2015, CIENC RURAL, V45, P1557, DOI 10.1590/0103-8478cr20140896; Charlesworth D, 2001, CURR OPIN GENET DEV, V11, P685, DOI 10.1016/S0959-437X(00)00254-9; Diebold RS, 2003, WEED SCI, V51, P312, DOI 10.1614/0043-1745(2003)051[0312:MRTIAA]2.0.CO;2; Dilipkumar M, 2018, PLANTA DANINHA, V36, DOI [10.1590/s0100-83582018360100058, 10.1590/S0100-83582018360100058]; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Duary B., 2008, INDIAN J WEED SCI, V40, P124; Duggleby RG, 2008, PLANT PHYSIOL BIOCH, V46, P309, DOI 10.1016/j.plaphy.2007.12.004; Engku AK, 2016, PLANT SOIL ENVIRON, V62, P16, DOI 10.17221/616/2015-PSE; Gaines TA, 2010, P NATL ACAD SCI USA, V107, P1029, DOI 10.1073/pnas.0906649107; Garcia MD, 2017, P NATL ACAD SCI USA, V114, pE1091, DOI 10.1073/pnas.1616142114; Heap Ian., 2020, INT SURVEY HERBICIDE; Hurd C., 2001, WEED CONTROL METHODS; Iwakami S, 2014, WEED BIOL MANAG, V14, P43, DOI 10.1111/wbm.12031; Jiang ZX, 2012, THEOR APPL GENET, V124, P309, DOI 10.1007/s00122-011-1706-5; Kaloumenos NS, 2013, PESTIC BIOCHEM PHYS, V105, P177, DOI 10.1016/j.pestbp.2013.01.008; Knezevic SZ, 2007, WEED TECHNOL, V21, P840, DOI 10.1614/WT-06-161.1; Kuk YI, 2008, WEED SCI, V56, P1, DOI 10.1614/WS-07-073.1; Lamego FP, 2009, WEED SCI, V57, P474, DOI 10.1614/WS-09-056.1; Mangold J, 2013, INVAS PLANT SCI MANA, V6, P554, DOI 10.1614/IPSM-D-13-00016.1; Markus C, 2018, PEST MANAG SCI, V74, P275, DOI 10.1002/ps.4727; McCourt JA, 2006, P NATL ACAD SCI USA, V103, P569, DOI 10.1073/pnas.0508701103; Merotto A, 2009, J AGR FOOD CHEM, V57, P1389, DOI 10.1021/jf802758c; Muhammad Saiful A. H., 2015, 25th Asian-Pacific Weed Science Society Conference, Hyderabad, India, 13-16 October 2015. Proceedings, Volume II (oral papers), P13; Nurul Farahidayu Jaafar, 2014, Research on Crops, V15, P754, DOI 10.5958/2348-7542.2014.01408.9; Patzoldt W.L., 2001, P N CENT WEED SCI SO, V56, P67; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; Rajguru SN, 2005, WEED SCI, V53, P567, DOI 10.1614/WS-04-111R1.1; Rosche W.A., 2001, ENCY GENETICS, P197, DOI [10.1006/rwgn.2001.0118, DOI 10.1006/RWGN.2001.0118]; Roso AC, 2010, FIELD CROP RES, V119, P175, DOI 10.1016/j.fcr.2010.07.006; Ruzmi R, 2017, WEED BIOL MANAG, V17, P3, DOI 10.1111/wbm.12112; Sales MA, 2008, WEED SCI, V56, P485, DOI 10.1614/WS-07-165.1; Sartori GMS, 2013, PLANTA DANINHA, V31, P631, DOI 10.1590/S0100-83582013000300015; Scarabel L, 2012, AGRONOMY-BASEL, V2, P371, DOI 10.3390/agronomy2040371; Shivrain VK, 2010, WEED RES, V50, P289, DOI 10.1111/j.1365-3180.2010.00780.x; Shivrain VK, 2007, CROP PROT, V26, P349, DOI 10.1016/j.cropro.2005.09.019; Shivrain VK, 2010, CROP PROT, V29, P336, DOI 10.1016/j.cropro.2009.10.002; Chauhan BS, 2013, CROP PROT, V48, P51, DOI 10.1016/j.cropro.2013.02.015; Song BK, 2014, MOL ECOL, V23, P5003, DOI 10.1111/mec.12922; Song XL, 2009, PEST MANAG SCI, V65, P862, DOI 10.1002/ps.1766; Sudianto E, 2016, WEED SCI, V64, P501, DOI 10.1614/WS-D-15-00168.1; Sudianto E, 2013, CROP PROT, V49, P40, DOI 10.1016/j.cropro.2013.02.013; Tan SY, 2005, PEST MANAG SCI, V61, P246, DOI 10.1002/ps.993; Tardif FJ, 2006, NEW PHYTOL, V169, P251, DOI 10.1111/j.1469-8137.2005.01596.x; Tranel PJ, 2009, BIOSCIENCE, V59, P207, DOI 10.1525/bio.2009.59.3.5; Tranel PJ, 2002, WEED SCI, V50, P700, DOI 10.1614/0043-1745(2002)050[0700:RROWTA]2.0.CO;2; Tranel PJ, 2017, MUTATIONS HERBICIDE; Vasilakoglou I, 2005, WEED BIOL MANAG, V5, P46, DOI 10.1111/j.1445-6664.2005.00157.x; Vencill WK, 2012, WEED SCI, V60, P2, DOI 10.1614/WS-D-11-00206.1; Washburn B. E., 2000, Native Plants Journal, V1, P61; Wenefrida I, 2007, CAN J PLANT SCI, V87, P659, DOI 10.4141/P05-086; Yu Q, 2014, PEST MANAG SCI, V70, P1340, DOI 10.1002/ps.3710; Yu Q, 2010, J EXP BOT, V61, P3925, DOI 10.1093/jxb/erq205; Zhou Q, 2007, PESTIC BIOCHEM PHYS, V89, P89, DOI 10.1016/j.pestbp.2007.04.004	60	4	4	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0227397	10.1371/journal.pone.0227397	http://dx.doi.org/10.1371/journal.pone.0227397			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925921	gold, Green Published			2022-12-26	WOS:000572318000035
J	Zipf, L; Primack, RB; Rothendler, M				Zipf, Lucy; Primack, Richard B.; Rothendler, Matthew			Citizen scientists and university students monitor noise pollution in cities and protected areas with smartphones	PLOS ONE			English	Article							SCIENCE DATA; ACCURACY	Noise pollution can cause increased stress, cognitive impairment and illness in humans and decreased fitness and altered behavior in wildlife. Maps of noise pollution are used to visualize the distribution of noise across a landscape. These maps are typically created by taking a relatively small number of sound measurements or simulated on the basis of theoretical models. However, smartphones with inexpensive sound measuring apps can be used to monitor noise and create dense maps of real-world noise measurements. Public concern with noise can make monitoring noise pollution with smartphones an engaging and educational citizen science activity. We demonstrate a method utilizing single-day citizen science noise mapping events and a university lab to collect noise data in urban environments and protected areas. Using this approach, we collected hundreds of noise measurements with participants that we used to create noise maps. We found this method was successful in engaging volunteers and students and producing usable noise data. The described methodology has potential applications for biological research, citizen science engagement, and teaching.	[Zipf, Lucy; Primack, Richard B.; Rothendler, Matthew] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA	Boston University	Zipf, L (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	lzipf@bu.edu			Boston University	Boston University	This work had no source of funding. LZ and RBP were supported through Boston University and MR volunteered.	[Anonymous], 2013, CREATING SIGNIFICANT; ANSI, 1983, S141983 ANSI; Baker GM, 2014, PARK SCI; Barber JR, 2011, LANDSCAPE ECOL, V26, P1281, DOI 10.1007/s10980-011-9646-7; Barber JR, 2010, TRENDS ECOL EVOL, V25, P180, DOI 10.1016/j.tree.2009.08.002; Boakes EH, 2016, SCI REP-UK, V6, DOI 10.1038/srep33051; Bonney R, 2014, SCIENCE, V343, P1436, DOI 10.1126/science.1251554; Bottollier-Depois JF, 2017, EPJ WEB C, DOI [10.1051/epjconf/201715308002, DOI 10.1051/EPJC0NF/201715308002]; Buxton RT, 2019, FRONT ECOL ENVIRON, V17, P559, DOI 10.1002/fee.2112; Buxton RT, 2017, SCIENCE, V356, P531, DOI 10.1126/science.aah4783; Crall AW, 2011, CONSERV LETT, V4, P433, DOI 10.1111/j.1755-263X.2011.00196.x; Crall AW, 2010, BIOL INVASIONS, V12, P3419, DOI 10.1007/s10530-010-9740-9; Dehnen-Schmutz K, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0359-9; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Francis CD, 2013, FRONT ECOL ENVIRON, V11, P305, DOI 10.1890/120183; Ganzevoort W, 2017, BIODIVERS CONSERV, V26, P2821, DOI 10.1007/s10531-017-1391-z; Goines L, 2007, SOUTH MED J, V100, P287, DOI 10.1097/SMJ.0b013e3180318be5; Golumbic YN, 2020, ENVIRON COMMUN, V14, P465, DOI 10.1080/17524032.2019.1687101; Hammer MS, 2014, ENVIRON HEALTH PERSP, V122, P115, DOI 10.1289/ehp.1307272; Hirth M, 2015, PHYS TEACH, V53, P120, DOI 10.1119/1.4905819; Ising H, 2004, NOISE HEAL; Kardous CA, 2014, J ACOUST SOC AM, V135, pEL186, DOI 10.1121/1.4865269; Keller O, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19194264; Klein P., 2014, Physics Education, V49, P412, DOI 10.1088/0031-9120/49/4/412; Kleist NJ, 2018, P NATL ACAD SCI USA, V115, pE648, DOI 10.1073/pnas.1709200115; Kong QK, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501055; Krathwohl DR, 2002, THEOR PRACT, V41, P212, DOI 10.1207/s15430421tip4104_2; Lim CC, 2019, ENVIRON INT, V131, DOI 10.1016/j.envint.2019.105022; Lundmark C, 2003, BIOSCIENCE, V53, P329, DOI 10.1641/0006-3568(2003)053[0329:BGIBB]2.0.CO;2; Maisonneuve Nicolas, 2010, Information Polity, V15, P51, DOI 10.3233/IP-2010-0200; Maisonneuve N, 2009, DG 09 P 10 ANN INT C; Merchan CI, 2014, LANDSCAPE URBAN PLAN, V123, P1, DOI 10.1016/j.landurbplan.2013.11.006; Murphy E, 2014, ENV NOISE POLLUTION, DOI [10.1016/C2012-0-13587-0, DOI 10.1016/C2012-0-13587-0]; Murphy E, 2016, APPL ACOUST, V106, P16, DOI 10.1016/j.apacoust.2015.12.012; Nast DR, 2014, NOISE HEALTH, V16, P251, DOI 10.4103/1463-1741.140495; O'Neill T, 2005, SCHOOL SCI MATH, V105, P292, DOI 10.1111/j.1949-8594.2005.tb18130.x; Rana R, 2015, PERVASIVE MOB COMPUT, V17, P1, DOI 10.1016/j.pmcj.2014.02.001; Ratnieks FLW, 2016, METHODS ECOL EVOL, V7, P1226, DOI 10.1111/2041-210X.12581; Roy HE, 2012, NERC CTR ECOLOGY HYD, P1; Santini S., 2009, P 2009 6 INT C NETWO, P1, DOI [10.1109/INSS.2009.5409957, DOI 10.1109/INSS.2009.5409957]; Shim E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161835; Silvia S., 2008, P WORKSH REAL WORLD, P61, DOI [10.1145/1435473.1435490, DOI 10.1145/1435473.1435490]; Smith SDA, 2019, MOLLUSCAN RES, V39, P214, DOI 10.1080/13235818.2019.1594600; Stansfeld SA, 2003, BRIT MED BULL, V68, P243, DOI 10.1093/bmb/ldg033; Stevens M., 2010, WORKSH UBIQ CROWD; van Strien AJ, 2013, J APPL ECOL, V50, P1450, DOI 10.1111/1365-2664.12158; Warren PS, 2006, ANIM BEHAV, V71, P491, DOI 10.1016/j.anbehav.2005.07.014; Wess T, 2017, HERIT SCI, V5, DOI 10.1186/s40494-017-0148-z; Wilson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065408; Zappatore M., 2017, J COMMUN SOFTW SYS, V13, P53, DOI [10.24138/jcomss.v13i2.373, DOI 10.24138/JCOMSS.V13I2.373]	50	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0236785	10.1371/journal.pone.0236785	http://dx.doi.org/10.1371/journal.pone.0236785			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915789	gold, Green Published			2022-12-26	WOS:000571887500108
J	Illius, AW; Lievaart-Peterson, K; McNeilly, TN; Savill, NJ				Illius, Andrew W.; Lievaart-Peterson, Karianne; McNeilly, Tom N.; Savill, Nicholas J.			Epidemiology and control of maedi-visna virus: Curing the flock	PLOS ONE			English	Article							CAPRINE ARTHRITIS; MVV-INFECTION; VISNA/MAEDI VIRUS; SHEEP; TRANSMISSION; LENTIVIRUSES; COLOSTRUM; ELISA; SEROCONVERSION; INFERENCE	Maedi-visna (MV) is a complex lentiviral disease syndrome characterised by long immunological and clinical latencies and chronic progressive inflammatory pathology. Incurable at the individual level, it is widespread in most sheep-keeping countries, and is a cause of lost production and poor animal welfare. Culling seropositive animals is the main means of control, but it might be possible to manage virus transmission effectively if its epidemiology was better quantified. We derive a mathematical epidemiological model of the temporal distributions of seroconversion probabilities and estimate susceptibility, transmission rate and latencies in three serological datasets. We demonstrate the existence of epidemiological latency, which has not explicitly been recognised in the SRLV literaure. This time delay between infection and infectiousness apparently exceeds the delay between infection and seroconversion. Poor body condition was associated with more rapid seroconversion, but not with a higher probability of infection. We estimate transmission rates amongst housed sheep to be at about 1,000 times faster than when sheep were at grass, when transmission was negligible. Maternal transmission has only a small role in transmission, because lambs from infected ewes have a low probability of being infected directly by them, and only a small proportion of lambs need be retained to maintain flock size. Our results show that MV is overwhelmingly a disease of housing, where sheep are kept in close proximity. Prevalence of MV is likely to double each year from an initial low incidence in housed flocks penned in typically-sized groups of sheep (c. 50) for even a few days per year. Ewes kept entirely at grass are unlikely to experience transmission frequently enough for MV to persist, and pre-existing infection should die out as older ewes are replaced, thereby essentially curing the flock.	[Illius, Andrew W.] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Lievaart-Peterson, Karianne] GD Anim Hlth, Pentlands Sci Pk, Deventer, Netherlands; [McNeilly, Tom N.] Pentlands Sci Pk, Moredun Res Inst, Penicuik, Midlothian, Scotland; [Savill, Nicholas J.] Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland	University of Edinburgh; Moredun Research Institute; University of Edinburgh	Savill, NJ (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland.	nick.savill@ed.ac.uk		McNeilly, Tom/0000-0001-6469-0512	Scottish Government Rural Affairs, Food and the Environment (RAFE) Strategic Research Portfolio	Scottish Government Rural Affairs, Food and the Environment (RAFE) Strategic Research Portfolio	TNM receives funding from the Scottish Government Rural Affairs, Food and the Environment (RAFE) Strategic Research Portfolio 2016-2021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DS, 1983, AM J VET RES, V44, P1670; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alvarez V, 2006, RES VET SCI, V80, P226, DOI 10.1016/j.rvsc.2005.05.008; Alvarez V, 2005, RES VET SCI, V78, P237, DOI 10.1016/j.rvsc.2004.09.006; ANDERSON R M, 1991; Arnarson H, 2017, COMP IMMUNOL MICROB, V55, P6, DOI 10.1016/j.cimid.2017.08.003; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Berriatua E, 2003, PREV VET MED, V60, P265, DOI 10.1016/S0167-5877(03)00163-6; Blacklaws BA, 2004, VET MICROBIOL, V101, P199, DOI 10.1016/j.vetmic.2004.04.006; Blacklaws BA, 2012, COMP IMMUNOL MICROB, V35, P259, DOI 10.1016/j.cimid.2011.12.003; Bowles D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087823; Broughton-Neiswanger LE, 2010, INFECT GENET EVOL, V10, P998, DOI 10.1016/j.meegid.2010.06.007; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Caroline L, 2010, CURR HIV RES, V8, P94, DOI 10.2174/157016210790416415; DEBOER GF, 1979, RES VET SCI, V26, P202, DOI 10.1016/S0034-5288(18)32917-5; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Friel N, 2008, J R STAT SOC B, V70, P589, DOI 10.1111/j.1467-9868.2007.00650.x; Galassi M., GNU SCI LIB REFERENC; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; GENDELMAN HE, 1986, J VIROL, V58, P67, DOI 10.1128/JVI.58.1.67-74.1986; Gibson L., 2018, Livestock, V23, P238, DOI 10.12968/live.2018.23.5.238; Girolami M, 2008, THEOR COMPUT SCI, V408, P4, DOI 10.1016/j.tcs.2008.07.005; Heaton MP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002467; Herrmann-Hoesing L. M., 2012, Open Journal of Veterinary Medicine, V2, P113; Herrmann-hoesing LM, 2008, OVINE PROGR PNEUMONI; Herrmann-Hoesing LM, 2007, VIROLOGY, V362, P226, DOI 10.1016/j.virol.2006.12.021; HOUWERS DJ, 1983, VET MICROBIOL, V8, P179, DOI 10.1016/0378-1135(83)90064-0; HOUWERS DJ, 1987, J VET MED B, V34, P421, DOI 10.1111/j.1439-0450.1987.tb00416.x; HOUWERS DJ, 1987, J IMMUNOL METHODS, V98, P151, DOI 10.1016/0022-1759(87)90449-2; HOUWERS DJ, 1989, RES VET SCI, V46, P5, DOI 10.1016/S0034-5288(18)31108-1; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Leginagoikoa I, 2006, RES VET SCI, V80, P235, DOI 10.1016/j.rvsc.2005.05.003; Leginagoikoa I, 2010, RES VET SCI, V88, P415, DOI 10.1016/j.rvsc.2009.11.006; Iratxe L, 2006, VET RES, V37, P767, DOI 10.1051/vetres:2006034; Lerondelle C, 1999, VET RES, V30, P467; Leroux C, 1997, ARCH VIROL, V142, P1125, DOI 10.1007/s007050050147; McNeilly TN, 2008, J VIROL, V82, P1526, DOI 10.1128/JVI.02148-07; McNeilly TN, 2007, J GEN VIROL, V88, P670, DOI 10.1099/vir.0.82434-0; MEDLEY GF, 1987, NATURE, V328, P719, DOI 10.1038/328719a0; Niesalla H, 2008, J GEN VIROL, V89, P1329, DOI 10.1099/vir.0.2008/000133-0; Palsson P A, 1972, J Clin Pathol Suppl (R Coll Pathol), V6, P115, DOI 10.1136/jcp.s3-6.1.115; Perez M, 2010, VET J, V186, P221, DOI 10.1016/j.tvjl.2009.07.031; Peterson K, 2007, THESIS, P64; Pritchard G.C., 2007, DIS SHEEP, P217; RIMSTAD E, 1993, AM J VET RES, V54, P1858; Savill NJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000416; SIHVONEN L, 1984, VET MICROBIOL, V9, P205, DOI 10.1016/0378-1135(84)90038-5; SIHVONEN L, 1980, ACTA VET SCAND, V21, P689; Thormar H, 2005, AIDS REV, V7, P233; Torsteinsdottir S, 2003, RES VET SCI, V75, P245, DOI 10.1016/S0034-5288(03)00098-5; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Villoria M, 2013, SMALL RUMINANT RES, V110, P155, DOI 10.1016/j.smallrumres.2012.11.025	53	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238781	10.1371/journal.pone.0238781	http://dx.doi.org/10.1371/journal.pone.0238781			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911525	Green Published, gold			2022-12-26	WOS:000571885900047
J	Kropp, KN; Schaufele, TJ; Fatho, M; Volkmar, M; Conradi, R; Theobald, M; Wolfel, T; Wolfel, C				Kropp, Korbinian N.; Schaeufele, Tim J.; Fatho, Martina; Volkmar, Michael; Conradi, Roland; Theobald, Matthias; Woelfel, Thomas; Woelfel, Catherine			A bicistronic vector backbone for rapid seamless cloning and chimerization of alpha beta T-cell receptor sequences	PLOS ONE			English	Article							ENHANCED ANTITUMOR-ACTIVITY; GENE-THERAPY; HUMAN-LYMPHOCYTES; HUMAN-MELANOMA; HUMAN TCR; EXPRESSION; IMMUNOTHERAPY	To facilitate preclinical testing of T-cell receptors (TCRs) derived from tumor-reactive T-cell clones it is necessary to develop convenient and rapid cloning strategies for the generation of TCR expression constructs. Herein, we describe a pDONR (TM) 221 vector backbone allowing to generate Gateway (TM) compatible entry clones encoding optimized bicistronic alpha beta TCR constructs. It harbors P2A-linked TCR constant regions and head-to-head-oriented recognition sites of the Type IIS restriction enzymes BsmBI and BsaI for seamless cloning of the TCR alpha and TCR beta V(D)J regions, respectively. Additional well-established TCR optimizations were incorporated to enhance TCR functionality. This included replacing of the human alpha beta TCR constant regions with their codon-optimized murine counterparts for chimerization, addition of a second interchain disulfide bond and arrangement of the TCR chains in the order beta-P2A-alpha. We exemplified the utility of our vector backbone by cloning and functional testing of three melanoma-reactive TCRs in primary human T cells.	[Kropp, Korbinian N.; Schaeufele, Tim J.; Fatho, Martina; Theobald, Matthias; Woelfel, Thomas; Woelfel, Catherine] Johannes Gutenberg Univ Mainz, Internal Med 3, Univ Canc Ctr UCT, Res Ctr & Mmunotherapy FZI,Univ Med Ctr UMC, Mainz, Germany; [Kropp, Korbinian N.; Schaeufele, Tim J.; Fatho, Martina; Theobald, Matthias; Woelfel, Thomas; Woelfel, Catherine] German Canc Consortium DKTK, Partner Site Frankfurt Mainz, Mainz, Germany; [Volkmar, Michael] German Canc Res Ctr, Div Mol Oncol Gastrointestinal Tumors, Heidelberg, Germany; [Volkmar, Michael] Helmholtz Inst Translat Oncol Mainz HI TRON Mainz, Mainz, Germany; [Conradi, Roland] Johannes Gutenberg Univ Mainz, Univ Med Ctr UMC, Transfus Ctr, Mainz, Germany	Johannes Gutenberg University of Mainz; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Johannes Gutenberg University of Mainz	Kropp, KN (corresponding author), Johannes Gutenberg Univ Mainz, Internal Med 3, Univ Canc Ctr UCT, Res Ctr & Mmunotherapy FZI,Univ Med Ctr UMC, Mainz, Germany.; Kropp, KN (corresponding author), German Canc Consortium DKTK, Partner Site Frankfurt Mainz, Mainz, Germany.	korbinian.kropp@unimedizin-mainz.de		Kropp, Korbinian/0000-0001-8104-7166	Mainz Research School of Translational Biomedicine (TransMed); German Cancer Consortium (DKTK)	Mainz Research School of Translational Biomedicine (TransMed); German Cancer Consortium (DKTK)	The project was supported by funds from the Mainz Research School of Translational Biomedicine (TransMed), https://www.unimedizinmainz.de/transmed/home.html, no grant number (to K.N.K.) and the German Cancer Consortium (DKTK), https://dktk.dkfz.de/de/home, project NeoATT, no grant number (to T.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CLIN DIABETOLOGY, V2, pA12; Bialer G, 2010, J IMMUNOL, V184, P6232, DOI 10.4049/jimmunol.0902047; Birkholz K, 2009, J IMMUNOL METHODS, V346, P45, DOI 10.1016/j.jim.2009.05.001; Boria I, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-50; Cheo DL, 2004, GENOME RES, V14, P2111, DOI 10.1101/gr.2512204; Cohen CJ, 2007, CANCER RES, V67, P3898, DOI 10.1158/0008-5472.CAN-06-3986; Cohen CJ, 2006, CANCER RES, V66, P8878, DOI 10.1158/0008-5472.CAN-06-1450; Coren LV, 2015, BIOTECHNIQUES, V58, P135, DOI 10.2144/000114265; Davis JL, 2010, CLIN CANCER RES, V16, P5852, DOI 10.1158/1078-0432.CCR-10-1280; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Goff SL, 2010, J IMMUNOTHER, V33, P840, DOI 10.1097/CJI.0b013e3181f05b91; Govers C, 2010, TRENDS MOL MED, V16, P77, DOI 10.1016/j.molmed.2009.12.004; Hu ZT, 2018, BLOOD, V132, P1911, DOI 10.1182/blood-2018-04-843763; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kessels HWHG, 2001, NAT IMMUNOL, V2, P957, DOI 10.1038/ni1001-957; Koste L, 2014, GENE THER, V21, P533, DOI 10.1038/gt.2014.25; Kuball J, 2005, IMMUNITY, V22, P117, DOI 10.1016/j.immuni.2004.12.005; Kuball J, 2007, BLOOD, V109, P2331, DOI 10.1182/blood-2006-05-023069; Leisegang M, 2008, J MOL MED, V86, P573, DOI 10.1007/s00109-008-0317-3; Leisegang M, 2016, J CLIN INVEST, V126, P854, DOI 10.1172/JCI83465; Lennerz V, 2005, P NATL ACAD SCI USA, V102, P16013, DOI 10.1073/pnas.0500090102; Matta H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18606-1; Mensali N, 2019, CANCER IMMUNOL IMMUN, V68, P1235, DOI 10.1007/s00262-019-02356-2; Mestermann K, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau5907; Moore T, 2018, CANCER IMMUNOL IMMUN, V67, P311, DOI 10.1007/s00262-017-2073-0; Morgan RA, 2003, J IMMUNOL, V171, P3287, DOI 10.4049/jimmunol.171.6.3287; Morris EC, 2005, P NATL ACAD SCI USA, V102, P7934, DOI 10.1073/pnas.0500357102; Okamoto S, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.52; Pavey S, 2004, ONCOGENE, V23, P4060, DOI 10.1038/sj.onc.1207563; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Scholten KBJ, 2006, CLIN IMMUNOL, V119, P135, DOI 10.1016/j.clim.2005.12.009; Sommermeyer D, 2010, J IMMUNOL, V184, P6223, DOI 10.4049/jimmunol.0902055; Suguitan Jr AL, 2011, PLOS ONE, V6; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577	35	1	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2020	15	9							e0238875	10.1371/journal.pone.0238875	http://dx.doi.org/10.1371/journal.pone.0238875			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR4MY	32903281	Green Published, gold			2022-12-26	WOS:000571539500007
J	Valentine, JC; Worth, LJ; Verspoor, KM; Hall, L; Yeoh, DK; Thursky, KA; Clark, JE; Haeusler, GM				Valentine, Jake C.; Worth, Leon J.; Verspoor, Karin M.; Hall, Lisa; Yeoh, Daniel K.; Thursky, Karin A.; Clark, Julia E.; Haeusler, Gabrielle M.			Classification performance of administrative coding data for detection of invasive fungal infection in paediatric cancer patients	PLOS ONE			English	Article							DIAGNOSIS; SURVEILLANCE; DEFINITIONS; HEMATOLOGY; GUIDELINES; SOCIETY; DISEASE	Background Invasive fungal infection (IFI) detection requires application of complex case definitions by trained staff. Administrative coding data (ICD-10-AM) may provide a simplified method for IFI surveillance, but accuracy of case ascertainment in children with cancer is unknown. Objective To determine the classification performance of ICD-10-AM codes for detecting IFI using a gold-standard dataset (r-TERIFIC) of confirmed IFIs in paediatric cancer patients at a quaternary referral centre (Royal Children's Hospital) in Victoria, Australia from 1(st)April 2004 to 31(st)December 2013. Methods ICD-10-AM codes denoting IFI in paediatric patients (<18-years) with haematologic or solid tumour malignancies were extracted from the Victorian Admitted Episodes Dataset and linked to the r-TERIFIC dataset. Sensitivity, positive predictive value (PPV) and the F(1)scores of the ICD-10-AM codes were calculated. Results Of 1,671 evaluable patients, 113 (6.76%) had confirmed IFI diagnoses according to gold-standard criteria, while 114 (6.82%) cases were identified using the codes. Of the clinical IFI cases, 68 were in receipt of >= 1 ICD-10-AM code(s) for IFI, corresponding to an overall sensitivity, PPV and F(1)score of 60%, respectively. Sensitivity was highest for proven IFI (77% [95% CI: 58-90]; F-1= 47%) and invasive candidiasis (83% [95% CI: 61-95]; F-1= 76%) and lowest for other/unspecified IFI (20% [95% CI: 5.05-72%]; F-1= 5.00%). The most frequent misclassification was coding of invasive aspergillosis as invasive candidiasis. Conclusion ICD-10-AM codes demonstrate moderate sensitivity and PPV to detect IFI in children with cancer. However, specific subsets of proven IFI and invasive candidiasis (codes B37.x) are more accurately coded.	[Valentine, Jake C.; Worth, Leon J.; Verspoor, Karin M.; Hall, Lisa; Yeoh, Daniel K.; Thursky, Karin A.; Haeusler, Gabrielle M.] Peter MacCallum Canc Ctr, Natl Ctr Infect Canc, Melbourne, Vic, Australia; [Valentine, Jake C.; Haeusler, Gabrielle M.] Royal Childrens Hosp, Paediat Integrated Canc Serv, Parkville, Vic, Australia; [Valentine, Jake C.; Worth, Leon J.; Thursky, Karin A.; Haeusler, Gabrielle M.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia; [Worth, Leon J.; Thursky, Karin A.; Haeusler, Gabrielle M.] Peter MacCallum Canc Ctr, Dept Infect Dis, Melbourne, Vic, Australia; [Verspoor, Karin M.] Univ Melbourne, Sch Comp & Informat Syst, Parkville, Vic, Australia; [Hall, Lisa] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Yeoh, Daniel K.] Perth Childrens Hosp, Dept Infect Dis, Perth, WA, Australia; [Clark, Julia E.] Queensland Childrens Hosp, Infect Management Serv, Brisbane, Qld, Australia; [Haeusler, Gabrielle M.] Royal Childrens Hosp, Dept Gen Med, Infect Dis Unit, Parkville, Vic, Australia	Peter Maccallum Cancer Center; Royal Children's Hospital Melbourne; Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; University of Queensland; Royal Children's Hospital Melbourne	Valentine, JC (corresponding author), Peter MacCallum Canc Ctr, Natl Ctr Infect Canc, Melbourne, Vic, Australia.; Valentine, JC (corresponding author), Royal Childrens Hosp, Paediat Integrated Canc Serv, Parkville, Vic, Australia.; Valentine, JC (corresponding author), Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia.	Jake.Valentine@petermac.org	thursky, karin/AAV-4524-2021; Verspoor, Karin/G-6034-2016; Clark, Julia/A-8214-2012; Valentine, Jake C/L-7569-2018	Verspoor, Karin/0000-0002-8661-1544; Clark, Julia/0000-0001-7746-0599; Valentine, Jake C/0000-0002-3076-9182; thursky, karin/0000-0002-7400-232X	Australian Government Research Training Program Scholarship - University of Melbourne [290465]; Cardinal Health Infection Control Scholarship - Australasian College for Infection Prevention and Control; Gilead Sciences, Inc [IN-AU-131-1314]	Australian Government Research Training Program Scholarship - University of Melbourne; Cardinal Health Infection Control Scholarship - Australasian College for Infection Prevention and Control; Gilead Sciences, Inc(Gilead Sciences)	J.C.V. was supported by an Australian Government Research Training Program Scholarship (grant number: 290465) awarded by the University of Melbourne (URL: https://www.education.gov.au/research-training-program) and a Cardinal Health Infection Control Scholarship awarded by the Australasian College for Infection Prevention and Control (URL: https://www.cardinalhealth.com/en.html). The TERIFIC study was supported by an Investigator Initiated Grant (grant number: IN-AU-131-1314) from Gilead Sciences, Inc. (https://www.gilead.com/). The funders had no role in study design, data collection and analysis, decision to publish, preparation or review of the manuscript.	Alonso V, 2020, HEALTH INF MANAG J, V49, P28, DOI 10.1177/1833358319826351; [Anonymous], 2019, VICT ADD AUSTR COD S, P1; [Anonymous], 2007, NAT STAT ETH COND HU; [Anonymous], 2019, VICT PAED ONC CAR PA, P1; Arvanitis M, 2014, CLIN MICROBIOL REV, V27, P490, DOI 10.1128/CMR.00091-13; Assareh H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147087; Bal ZS, 2015, MYCOSES, V58, P225, DOI 10.1111/myc.12303; Bartlett AW, 2019, PEDIATR BLOOD CANCER, V66, DOI 10.1002/pbc.27564; Becker SO, 2007, STATA J, V7, P71, DOI 10.1177/1536867X0700700104; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Blyth CC, 2017, SUPPORT CARE CANCER, V25, P3289, DOI 10.1007/s00520-017-3681-0; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Chang DC, 2008, INFECT CONT HOSP EP, V29, P25, DOI 10.1086/524324; Connell L, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001711; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Doktorchik C, 2020, HEALTH INF MANAG J, V49, P19, DOI 10.1177/1833358319855031; Donnelly JP, 2020, CLIN INFECT DIS, V71, P1367, DOI 10.1093/cid/ciz1008; Duntsch I, 2019, J PHYS CONF SER, V1229, DOI 10.1088/1742-6596/1229/1/012055; Elkafrawy P., 2015, INT J COMPUT APPL, V114, P1, DOI DOI 10.5120/20083-1666; Gould WW, 1991, STATA TECHNICAL B, V1, P106; Hage CA, 2019, AM J RESP CRIT CARE, V200, P535, DOI 10.1164/rccm.201906-1185ST; Hay P, 2020, HEALTH INF MANAG J, V49, P69, DOI 10.1177/1833358319854185; Heslop L, 2019, INT J NURS PRACT, V25, DOI 10.1111/ijn.12775; Jhung MA, 2009, CLIN INFECT DIS, V49, P949, DOI 10.1086/605086; Kontoyiannis DP, 2010, CLIN INFECT DIS, V50, P1091, DOI 10.1086/651263; Nguyen Q, 2005, HLTH INF MANAG, V34, P88; Ridder HG, 2007, HEALTH SERV RES, V42, P2120, DOI 10.1111/j.1475-6773.2007.00723.x; Ruhnke M, 2012, ANN ONCOL, V23, P823, DOI 10.1093/annonc/mdr407; Shepheard J, 2018, HEALTH INF MANAG J, V47, P3, DOI 10.1177/1833358317712312; Sundararajan V, 2015, INT J QUAL HEALTH C, V27, P328, DOI 10.1093/intqhc/mzv037; Thun S, 2018, BUNDESGESUNDHEITSBLA, V61, P812, DOI 10.1007/s00103-018-2759-2; Tsitsikas DA, 2012, MED MYCOL, V50, P538, DOI 10.3109/13693786.2011.630040; Valentine JC, 2020, AUST NZ J PUBL HEAL, V44, P245, DOI 10.1111/1753-6405.12985; Valentine JC, 2020, SUPPORT CARE CANCER, V28, P6023, DOI 10.1007/s00520-020-05439-4; Valentine JC, 2020, MYCOSES, V63, P162, DOI 10.1111/myc.13033; Valentine JC, 2019, INT J EPIDEMIOL, V48, P1768, DOI 10.1093/ije/dyz162; Valentine JC, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3901-y; Wang SS, 2019, PEDIATR BLOOD CANCER, V66, DOI 10.1002/pbc.27915	38	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2020	15	9							e0238889	10.1371/journal.pone.0238889	http://dx.doi.org/10.1371/journal.pone.0238889			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR4MY	32903280	gold, Green Published			2022-12-26	WOS:000571539500017
J	Mulinganya, G; Malembaka, EB; Akonkwa, ML; Mukendi, DM; Birindwa, EK; Balemba, GM; Temmerman, M; Tambwe, AM; Criel, B; Balaluka, GB				Mulinganya, Guy; Malembaka, Espoir Bwenge; Akonkwa, Melissa Lukula; Mukendi, Dieudonne Mpunga; Birindwa, Etienne Kajibwami; Balemba, Ghislain Maheshe; Temmerman, Marleen; Tambwe, Albert Mwembo; Criel, Bart; Balaluka, Ghislain Bisimwa			Applying the Robson classification to routine facility data to understand the Caesarean section practice in conflict settings of South Kivu, eastern DR Congo	PLOS ONE			English	Article							ARMED CONFLICT; MORTALITY; DELIVERY; OUTCOMES; TRENDS	Introduction Sub-Saharan Africa has low Caesarean (CS) levels, despite a global increase in CS use. In conflict settings, the pattern of CS use is unclear because of scanty data. We aimed to examine the opportunity of using routine facility data to describe the CS use in conflict settings. Methods We conducted a facility-based cross-sectional study in 8 health zones (HZ) of South Kivu province in eastern DR Congo. We reviewed patient hospital records, maternity registers and operative protocol books, from January to December 2018. Data on direct conflict fatalities were obtained from the Uppsala Conflict Data Program. Based on conflict intensity and chronicity (expressed as a 6-year cumulative conflict death rate), HZ were classified as unstable (higher conflict death rate), intermediate and stable (lower conflict death rate). To describe the Caesarean section practice, we used the Robson classification system. Based on parity, history of previous CS, onset of labour, foetal lie and presentation, number of neonates and gestational age, the Robson classification categorises deliveries into 10 mutually exclusive groups. We performed a descriptive analysis of the relative contribution of each Robson group to the overall CS rate in the conflict stratum. Results Among the 29,600 deliveries reported by health facilities, 5,520 (18.6%) were by CS; 5,325 (96.5%) records were reviewed, of which 2,883 (54.1%) could be classified. The overall estimated population CS rate was 6.9%. The proportion of health facility deliveries that occurred in secondary hospitals was much smaller in unstable health zones (22.4%) than in intermediate (40.25) or stable health zones (43.0%). Robson groups 5 (previous CS, single cephalic, >= 37 weeks), 1 (nulliparous, single cephalic, >= 37 weeks, spontaneous labour) and 3 (multiparous, no previous CS, single cephalic, >= 37 weeks, spontaneous labour) were the leading contributors to the overall CS rate; and represented 75% of all CS deliveries. In unstable zones, previous CS (27.1%) and abnormal position of the fetus (breech, transverse lie, 3.3%) were much less frequent than in unstable and intermediate (44.3% and 6.0% respectively) and stable (46.7%and 6.2% respectively). Premature delivery and multiple pregnancy were more prominent Robson groups in unstable zones. Conclusion In South Kivu province, conflict exposure is linked with an uneven estimated CS rate at HZ level with at high-risks women in conflict affected settings likely to have lower access to CS compared to low-risk mothers in stable health zones.	[Mulinganya, Guy; Birindwa, Etienne Kajibwami] Univ Catholique Bukavu, Fac Med, Dept Gynecol & Obstet, Bukavu, DEM REP CONGO; [Mulinganya, Guy; Temmerman, Marleen] Univ Ghent, Fac Med & Hlth Sci, Ghent, Belgium; [Mulinganya, Guy; Akonkwa, Melissa Lukula; Mukendi, Dieudonne Mpunga; Tambwe, Albert Mwembo; Criel, Bart; Balaluka, Ghislain Bisimwa] Renforcement Inst Polit Sante Basees Evidence, Lubumbashi, DEM REP CONGO; [Malembaka, Espoir Bwenge; Akonkwa, Melissa Lukula; Balemba, Ghislain Maheshe; Balaluka, Ghislain Bisimwa] Univ Catholique Bukavu, Fac Med, ERSP, Ecole Reg Sante Publ, Bukavu, DEM REP CONGO; [Malembaka, Espoir Bwenge] Catholic Univ Louvain, Inst Hlth & Soc, Ecole Sante Publ, IRSS, Brussels, Belgium; [Mukendi, Dieudonne Mpunga] Univ Kinshasa, Sch Publ Hlth, Kinshasa, DEM REP CONGO; [Balemba, Ghislain Maheshe] Univ Catholique Bukavu, Fac Med, Dept Radiol, Bukavu, DEM REP CONGO; [Temmerman, Marleen] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Sch Med, Nairobi, Kenya; [Tambwe, Albert Mwembo] Univ Lubumbashi, Ecole Sante Publ, Lubumbashi, DEM REP CONGO; [Criel, Bart] Inst Trop Med, Antwerp, Belgium; [Balaluka, Ghislain Bisimwa] Univ Cinquantenaire Lwiro, Lwiro, DEM REP CONGO	Ghent University; Universite Catholique Louvain; Universite de Kinshasa; Aga Khan University; Institute of Tropical Medicine (ITM)	Malembaka, EB (corresponding author), Univ Catholique Bukavu, Fac Med, ERSP, Ecole Reg Sante Publ, Bukavu, DEM REP CONGO.; Malembaka, EB (corresponding author), Catholic Univ Louvain, Inst Hlth & Soc, Ecole Sante Publ, IRSS, Brussels, Belgium.	esbwenge@gmail.com	Mpunga, Dieudonné/GXE-9943-2022	Malembaka, Espoir Bwenge/0000-0001-9306-0253; BISIMWA BALALUKA, Ghislain/0000-0003-4799-1115	European Union	European Union(European Commission)	The data collection for this study was financially supported by the European Union-funded RISPEC program (Renforcement Institutionnel des Politiques de Sante basees sur l'Evidence en RD Congo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aembe B, 2019, DISASTERS, V43, pS187, DOI 10.1111/disa.12336; Ahuka OL, 2004, INT J GYNECOL OBSTET, V84, P91, DOI 10.1016/S0020-7292(03)00328-X; [Anonymous], 2011, DEMOGRAPHIC HLTH CON; [Anonymous], 2014, ENQ DEM SANT REP DEM; Betran AP, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0043-6; BETRAN AP, 2016, PLOS ONE, V11, DOI DOI 10.1371/JOURNAL.PONE.0148343; Bishop D, 2019, LANCET GLOB HEALTH, V7, pE513, DOI 10.1016/S2214-109X(19)30036-1; Boerma T, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001300; Boerma T, 2018, LANCET, V392, P1341, DOI 10.1016/S0140-6736(18)31928-7; Borton J., 2009, FUTURE HUMANITARIAN; Cavallaro FL, 2013, B WORLD HEALTH ORGAN, V91, P914, DOI 10.2471/BLT.13.117598; Coghlan B, 2006, LANCET, V367, P44, DOI 10.1016/S0140-6736(06)67923-3; Congo Research Group, 2019, CONG FORG NUMB AFR L; Dialogue I-C, 2002, POLITICAL NEGOTIATIO; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Human Rights Watch, 2019, WORLD REP; INS, 2019, ENQ GRAPP IND MULT 2; Kacerauskiene J, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1625-9; Kandala NB, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-266; Kandala NB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-261; Keasley J, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000377; Lancet Global Health, 2019, LANCET GLOB HEALTH, V7, pe1; Litorp H, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-107; Macaulay S, 2019, J OBSTET GYNAECOL RE, V45, P217, DOI 10.1111/jog.13801; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Mukendi DM, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0772-z; Nakamura-Pereira M, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0228-7; Nobles J, 2015, DEMOGRAPHY, V52, P15, DOI 10.1007/s13524-014-0362-1; Poirier T, 2012, INT J EDUC DEV, V32, P341, DOI 10.1016/j.ijedudev.2011.06.001; Robson MS, 2001, FETAL MATERN MED REV, V12, P23, DOI [DOI 10.1017/S0965539501000122, 10.1017/S0965539501000122]; Smits J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025239; Sobhy S, 2019, LANCET, V393, P1973, DOI 10.1016/S0140-6736(18)32386-9; Tanaka K, 2017, OBSTET GYNECOL INT, V2017, DOI 10.1155/2017/5648938; UNOCHA, 2019, RD CONG SUD KIV QUI; Verkoren W., 2012, J PEACEBUILDING DEV, V7, P81, DOI DOI 10.1080/15423166.2012.719353; Vogel JP, 2015, LANCET GLOB HEALTH, V3, pE260, DOI 10.1016/S2214-109X(15)70094-X; Vogel JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070549; World Health Organization Human, 2017, ROBS CLASS IMPL MAN; World Health Organization Human Reproduction Programme 10 April 2015, 2015, Reprod Health Matters, V23, P149, DOI 10.1016/j.rhm.2015.07.007; Ye JF, 2014, BIRTH-ISS PERINAT C, V41, P237, DOI 10.1111/birt.12104	40	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0237450	10.1371/journal.pone.0237450	http://dx.doi.org/10.1371/journal.pone.0237450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ6EE	32898139	Green Published, gold			2022-12-26	WOS:000570962500022
J	Stroman, DA; Kreuter, UP; Wonkka, CL				Stroman, Dianne A.; Kreuter, Urs P.; Wonkka, Carissa L.			Landowner perceptions of woody plants and prescribed fire in the Southern Plains, USA	PLOS ONE			English	Article							LAND-OWNERSHIP MOTIVATIONS; MANAGEMENT; TEXAS; LIABILITY; CONSERVATION; DRIVERS; BURN	Grassland environments face a number of threats including land use change, changing climate and encroachment of woody plants. In the Southern Plains of the United States, woody plant encroachment threatens traditional agricultural grazing economies in addition to grassland dependent wildlife species. Numerous studies have examined the physical drivers of conversion from grassland to woodland but social drivers may be equally important to understanding the causes of and prescriptions for environmental degradation. In this paper, we report the results of a survey of landowners in the Southern Plains of Texas and Oklahoma in which we asked participants to estimate the current amount of woody plant cover on their land, their preferred amount of woody plant cover and about their perspectives regarding the use of prescribed fire for managing woody plants. Prescribed fire is ecologically and economically one of the most effective tools for maintaining grasslands but many landowners do not use this tool due to lack of knowledge, lack of resources and concerns over safety and legal liability. We found that while most of our respondents did express a desire for less woody plant cover on their land, woody plant preference did not affect landowner's use of prescribed fire. However, belonging to a prescribed burn association and owning larger properties were correlated with increased use of prescribed fire. Woody plant cover preference was significantly influenced by landownership motivations, with hunters and other recreational motivated landowners preferring more trees and ranchers preferring fewer. This is important because throughout most of our study area, there has been a steady shift from agricultural production to amenity or recreational landownership, a trend that may undermine efforts to restore or maintain open grasslands. Future outreach efforts to promote prescribed fire to maintain grasslands should more actively support prescribed burn associations, which is an effective vehicle for increasing prescribed fire use by private landowners.	[Stroman, Dianne A.] Collin Coll, Dept Environm Sci, Frisco, TX 75035 USA; [Kreuter, Urs P.] Texas A&M Univ, Dept Ecol & Conservat Biol, College Stn, TX USA; [Wonkka, Carissa L.] USDA ARS, Northern Plains Agr Lab, Sidney, MT USA	Texas A&M University System; Texas A&M University College Station; United States Department of Agriculture (USDA)	Stroman, DA (corresponding author), Collin Coll, Dept Environm Sci, Frisco, TX 75035 USA.	dstroman@collin.edu			National Science Foundation Dynamics of Coupled Human and Natural Systems Program [DEB-1413900]	National Science Foundation Dynamics of Coupled Human and Natural Systems Program	UK received finding from the National Science Foundation Dynamics of Coupled Human and Natural Systems Program (Contact #DEB-1413900). The sponsors did not play a role in the study design, data collection and analysis, decision to publish or preparation of this manuscript. the funder URL can be found at: https://www.nsf.gov/pubs/2018/nsf18503/nsf18503.htm.	[Anonymous], 2017, J ENDOCRINOL METAB D, V22, pS1; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; ARCHER S, 1995, CLIMATIC CHANGE, V29, P91, DOI 10.1007/BF01091640; ARMSTRONG JS, 1977, J MARKETING RES, V14, P396, DOI 10.2307/3150783; Becerra TA, 2013, RANGELAND ECOL MANAG, V66, P529, DOI 10.2111/REM-D-12-00174.1; Berg MD, 2015, RANGELAND ECOL MANAG, V68, P315, DOI 10.1016/j.rama.2015.05.004; Bertone G, 2019, PHYS REV D, V100, DOI 10.1103/PhysRevD.100.123013; Brockway DG, 2009, FORESTRY, V82, P299, DOI 10.1093/forestry/cpp010; Brunson MW, 2008, RANGELAND ECOL MANAG, V61, P137, DOI 10.2111/07-063.1; Cardiovascular Disease and Risk Management, 2019, DIABETES CARE, V2, pS103, DOI 10.2337/dc19-S010; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Dillman D. A., 2000, MAIL INTERNET SURVEY, V2; Eburn M, 2017, INT J WILDLAND FIRE, V26, P999, DOI [10.1071/WF17070, 10.1071/wf17070]; Harr RN, 2014, ECOL SOC, V19, DOI 10.5751/ES-06404-190241; Hartfield KA, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10040632; Huxman TE, 2005, ECOLOGY, V86, P308, DOI 10.1890/03-0583; Jackson-Smith D, 2005, SOC NATUR RESOUR, V18, P587, DOI 10.1080/08941920590959578; Juzwik J, 2011, PLANT DIS, V95, P888, DOI 10.1094/PDIS-12-10-0944; Kahneman D., 2011, THINKING FAST SLOW; Kreuter UP, 2008, RANGELAND ECOL MANAG, V61, P456, DOI 10.2111/07-144.1; Kreuter UP, 2019, RANGELAND ECOL MANAG, V72, P959, DOI 10.1016/j.rama.2019.08.004; Lee AC, 2001, J AGR RESOUR ECON, V26, P478; Liew D. van, 2012, The Open Agriculture Journal, V6, P17, DOI 10.2174/1874331501206010017; Loomis JB, 2001, J FOREST, V99, P18; Moore GW, 2016, ECOL APPL, V26, P602, DOI 10.1890/15-0330; Morton LW, 2010, RANGELAND ECOL MANAG, V63, P645, DOI 10.2111/REM-D-09-00041.1; Olenick KL, 2005, ECOL ECON, V53, P247, DOI 10.1016/j.ecolecon.2004.09.016; Schmitt N, 1996, PSYCHOL ASSESSMENT, V8, P350, DOI 10.1037/1040-3590.8.4.350; Sorice MG, 2012, J ARID ENVIRON, V80, P56, DOI 10.1016/j.jaridenv.2012.01.004; Sorice MG, 2014, J ENVIRON MANAGE, V133, P144, DOI 10.1016/j.jenvman.2013.11.029; StataCorp, 2015, STAT STAT SOFTW REL; Sutherland LA, 2011, SOCIOL RURALIS, V51, P238, DOI 10.1111/j.1467-9523.2011.00536.x; TOLEDO D, 2012, RANGELANDS, V34; Toledo D, 2014, J ENVIRON MANAGE, V132, P323, DOI 10.1016/j.jenvman.2013.11.014; Twidwell D, 2014, APPL VEG SCI, V17, P42, DOI 10.1111/avsc.12044; Twidwell D, 2013, FRONT ECOL ENVIRON, V11, pE64, DOI 10.1890/130015; Weir JR, 2019, RANGELAND ECOL MANAG, V72, P533, DOI 10.1016/j.rama.2018.11.010; Weir JR, 2016, GRASSROOTS NATL ALLI; Wonkka CL, 2015, ECOL APPL, V25, P2382, DOI 10.1890/14-1791.1	39	2	2	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238688	10.1371/journal.pone.0238688	http://dx.doi.org/10.1371/journal.pone.0238688			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ6EE	32898171	gold, Green Published			2022-12-26	WOS:000570962500033
J	Asmamaw, M; Mereta, ST; Ambelu, A				Asmamaw, Mengistu; Mereta, Seid Tiku; Ambelu, Argaw			The role of local knowledge in enhancing the resilience of dinki watershed social-ecological system, central highlands of Ethiopia	PLOS ONE			English	Article							CLIMATE-CHANGE; ADAPTATION; MANAGEMENT	This study was designed to explore the role of local knowledge (LK) in enhancing the resilience of Dinki watershed in the central highlands of Ethiopia. The data were collected through focus group discussions, key informant interviews, and household surveys. The qualitative data were analyzed through thematic analysis. Whereas descriptive statistics and logistic regression were used for quantitative data analyses. The result showed that the majority of the respondents have local knowledge and used in their daily activities. Furthermore, the LK is reported to have the adaptive capacity in managing land resource degradation, treating disease, mitigating food insecurity, and enhancing social capital, among others. Likewise, the logistic regression analysis showed that age, gender, and education status of the household head were significantly correlated (p<0.05) to knowledge level, indicating their predictive power for the acquisition of LK. Accordingly, old-aged (60+ years) male respondents who attended primary education were higher to acquire LK than their counterparts. The result realized that the adaptive roles (land resource management, medication, climate change adaptation, etc.) of local knowledge systems could contribute to enhancing resilience. More importantly, the presence of social mechanisms is insurance to maintain LK. Thus, both intergenerational and intragenerational information gaps are filled with education and promotion on the roles of local knowledge systems. Besides, local-decision options should participate in custodians to share their experiences, that could contribute to sustaining ecosystem resilience.	[Asmamaw, Mengistu; Mereta, Seid Tiku; Ambelu, Argaw] Jimma Univ, Dept Environm Hlth Sci & Technol, Jimma, Ethiopia; [Asmamaw, Mengistu] Debre Berhan Univ, Dept Biol, Debre Berhan, Ethiopia	Jimma University	Asmamaw, M (corresponding author), Jimma Univ, Dept Environm Hlth Sci & Technol, Jimma, Ethiopia.; Asmamaw, M (corresponding author), Debre Berhan Univ, Dept Biol, Debre Berhan, Ethiopia.	mengistuasmamaw21@gmail.com	Mereta, Seid Tiku/HIA-0661-2022; Asmamaw, Mengistu/ABD-8054-2021; Ambelu, Argaw/GQA-6114-2022; Ambelu, Argaw/V-8317-2018	Asmamaw, Mengistu/0000-0001-9656-748X; Ambelu, Argaw/0000-0003-1898-4100; Ambelu, Argaw/0000-0003-1898-4100; Mereta, Seid Tiku/0000-0001-8036-4995	Debre Berhan University, Ethiopia; Jimma University, Ethiopia; International Foundation for Science (IFS), Stockholm, Sweden [1-1-A-6055-1]	Debre Berhan University, Ethiopia; Jimma University, Ethiopia; International Foundation for Science (IFS), Stockholm, Sweden(International Foundation for Science)	Financial support for this study was partly obtained from Debre Berhan and Jimma Universities, Ethiopia as well as from the International Foundation for Science (IFS), Stockholm, Sweden, through a grant N0.-1-1-A-6055-1 (by Asmamaw M.).	Abah J., 2015, AM J ED RES, V3, P668, DOI DOI 10.12691/EDUCATION-3-6-1; Adal Y., 2002, 5 ETH EC ASS ETH EC; Adekannbi J, 2014, S AFRICAN J INFO MGM, V16, P1; Adger WN, 2005, GLOBAL ENVIRON CHANG, V15, P77, DOI [10.1016/j.gloenvcha.2004.12.005, 10.1016/j.gloenvcha.2005.03.001]; Aerts R, 2016, SCI TOTAL ENVIRON, V551, P404, DOI 10.1016/j.scitotenv.2016.02.034; Ajani E., 2013, ASIAN J AGR EXT EC S; Amsalu A, 2006, THESIS; [Anonymous], 2012, REDOX SIGNALING, V17, P1; [Anonymous], 2015, URBAN RAPID RAIL TRA; [Anonymous], 2016, INT J ACED REASEARCH; [Anonymous], 2017, COMMUN MATH STAT, V5, P1, DOI DOI 10.1007/S40304-017-0103-Z; Asmamaw M., 2015, INT J ENV PROT POLIC, V3, P181, DOI [10.11648/j.ijepp.20150306.11, DOI 10.11648/J.IJEPP.20150306.11]; Asmamaw M, 2020, CLIM DEV, V12, P814, DOI 10.1080/17565529.2019.1698405; Berkes F, 2000, ECOL APPL, V10, P1251, DOI 10.1890/1051-0761(2000)010[1251:ROTEKA]2.0.CO;2; Berkes F., 1995, Biodiversity conservation: problems and policies. Papers from the Biodiversity Programme, Beijer International Institute of Ecological Economics, Royal Swedish Academy of Sciences., P281; Berkes F., 2008, SACRED ECOLOGY, DOI [10.1558/jsrnc.v3i1.157, DOI 10.1558/JSRNC.V3I1.157]; Birhane E., 2006, J DRYLANDS, V2, P134; Boafo Yaw Agyeman, 2016, International Journal of Biodiversity Science Ecosystem Services & Management, V12, P24, DOI 10.1080/21513732.2015.1124454; Chikaire J., 2012, J AGR SCI-CAMBRIDGE, V1, P201; Colding Johan, 2003, Tropical Ecology, V44, P25; Daniel W.W., 2013, BIOSTATISTICS FDN AN, P958, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; GADGIL M, 1993, AMBIO, V22, P151; Gibson, 2012, J FAMILY THEORY REV, V4, P148, DOI DOI 10.1111/J.1756-2589.2012.00119.X; Gomez-Baggethun E, 2013, ECOL SOC, V18, DOI 10.5751/ES-06288-180472; Gomez-Baggethun E, 2012, GLOBAL ENVIRON CHANG, V22, P640, DOI 10.1016/j.gloenvcha.2012.02.005; IBM, 2015, IBM STAT PROD SERV S; Kothari CR., 2004, RES METHODOLOGY RES, V2nd; Legesse A., 2013, ACTA GEOGRAPHICA TRO; Liu WT, 2014, ECOL SOC, V19, DOI 10.5751/ES-06843-190421; Lulekal E, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-63; Maddala G. S., 1983, LTD DEPENDENT QUALIT; Mantyka-Pringle CS, 2014, J APPL ECOL, V51, P572, DOI 10.1111/1365-2664.12236; Matarrita-Cascante D, 2013, ENVIRON PLANN A, V45, P1387, DOI 10.1068/a45361; Mathez-Stiefel SL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/959285; McCarter J, 2014, ECOL SOC, V19, DOI 10.5751/ES-06741-190339; Nakashima D., 2002, ENCY GLOBAL ENV CHAN, V5, P314; Nalau J, 2018, WEATHER CLIM SOC, V10, P851, DOI 10.1175/WCAS-D-18-0032.1; Nyumba TO, 2018, METHODS ECOL EVOL, V9, P20, DOI 10.1111/2041-210X.12860; Olsson P, 2001, ECOSYSTEMS, V4, P85, DOI 10.1007/s100210000061; Ostrom E, 2005, UNDERSTANDING INSTITUTIONAL DIVERSITY, P1; Pretty J., 2009, CONSERV SOC, V7, P100, DOI [10.4103/0972-4923.58642, DOI 10.4103/0972-4923.58642]; Pretty J, 2011, ENVIRON CONSERV, V38, P127, DOI 10.1017/S0376892910000937; Reyes-Garcia V, 2010, INT J EDUC DEV, V30, P305, DOI 10.1016/j.ijedudev.2009.11.007; Salam MA, 2000, AGROFOREST SYST, V50, P77, DOI 10.1023/A:1006403101782; Tengo M, 2014, AMBIO, V43, P579, DOI 10.1007/s13280-014-0501-3; Tobiko K, 2013, 18 IAP ANN C GEN M, P1; UNESCO, 2009, LEARNING KNOWING IND; Walubengo D, 2005, ENV MANAGEMENT KENYA	48	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238460	10.1371/journal.pone.0238460	http://dx.doi.org/10.1371/journal.pone.0238460			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ7QN	32886702	gold, Green Published			2022-12-26	WOS:000571064300050
J	Roady, R; Hayes, TL; Kemker, R; Gonzales, A; Kanan, C				Roady, Ryne; Hayes, Tyler L.; Kemker, Ronald; Gonzales, Ayesha; Kanan, Christopher			Are open set classification methods effective on large-scale datasets?	PLOS ONE			English	Article								Supervised classification methods often assume the train and test data distributions are the same and that all classes in the test set are present in the training set. However, deployed classifiers often require the ability to recognize inputs from outside the training set as unknowns. This problem has been studied under multiple paradigms including out-of-distribution detection and open set recognition. For convolutional neural networks, there have been two major approaches: 1) inference methods to separate knowns from unknowns and 2) feature space regularization strategies to improve model robustness to novel inputs. Up to this point, there has been little attention to exploring the relationship between the two approaches and directly comparing performance on large-scale datasets that have more than a few dozen categories. Using the ImageNet ILSVRC-2012 large-scale classification dataset, we identify novel combinations of regularization and specialized inference methods that perform best across multiple open set classification problems of increasing difficulty level. We find that input perturbation and temperature scaling yield significantly better performance on large-scale datasets than other inference methods tested, regardless of the feature space regularization strategy. Conversely, we find that improving performance with advanced regularization schemes during training yields better performance when baseline inference techniques are used; however, when advanced inference methods are used to detect open set classes, the utility of these combersome training paradigms is less evident.	[Roady, Ryne; Hayes, Tyler L.; Kemker, Ronald; Kanan, Christopher] Rochester Inst Technol, Rochester, NY 14623 USA; [Gonzales, Ayesha] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Kanan, Christopher] Paige, New York, NY 10036 USA; [Kanan, Christopher] Cornell Tech, New York, NY 10044 USA	Rochester Institute of Technology; Case Western Reserve University	Kanan, C (corresponding author), Rochester Inst Technol, Rochester, NY 14623 USA.; Kanan, C (corresponding author), Paige, New York, NY 10036 USA.; Kanan, C (corresponding author), Cornell Tech, New York, NY 10044 USA.	rpr3697@rit.edu		Hayes, Tyler/0000-0002-0875-7994	DARPA/MTO Lifelong Learning Machines program [W911NF-18-2-0263]; AFOSR [FA9550-18-1-0121]; NSF [1909696]	DARPA/MTO Lifelong Learning Machines program; AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF))	TH and CK were supported during this work in part by DARPA/MTO Lifelong Learning Machines program [W911NF-18-2-0263], AFOSR grant [FA9550-18-1-0121], and NSF award #1909696. Additionally, CK was employed by a commercial company, Paige, New York during the preparation of this work. This funder provided support in the form of salaries, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal C. C., 2001, SIGMOD Record, V30, P37, DOI 10.1145/376284.375668; Angiulli F, 2002, P EUR C PRINC DAT MI; Nguyen A, 2015, PROC CVPR IEEE, P427, DOI 10.1109/CVPR.2015.7298640; [Anonymous], 2013, PEDIAT DENT, V35, pE157; Bartlett PL, 2008, J MACH LEARN RES, V9, P1823; Bay SD, 2003, P ACM SPEC INT GROUP; Bendale A, 2016, PROC CVPR IEEE, P1563, DOI 10.1109/CVPR.2016.173; Bendale A, 2015, PROC CVPR IEEE, P1893, DOI 10.1109/CVPR.2015.7298799; Cohen G, 2017, IEEE IJCNN, P2921, DOI 10.1109/IJCNN.2017.7966217; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DeVries Terrance, 2018, ARXIV180204865; Dhamija A.R., 2018, ADV NEURAL INFORM PR, P9157; El-Yaniv R, 2010, J MACH LEARN RES, V11, P1605; Erfani SM, 2016, PATTERN RECOGN, V58, P121, DOI 10.1016/j.patcog.2016.03.028; Fellbaum C, 2010, THEORY AND APPLICATIONS OF ONTOLOGY: COMPUTER APPLICATIONS, P231, DOI 10.1007/978-90-481-8847-5_10; Gal Y, 2016, PR MACH LEARN RES, V48; Goodfellow IJ, 2014, ADV NEUR IN, V27, P2672, DOI 10.1145/3422622; Goodfellow Ian J., 2015, ICLR; Griffin G., 2007, 7694 CALT; Guo CA, 2017, PR MACH LEARN RES, V70; Hayes TL, 2019, P IEEE INT C ROB AUT; Hayes Tyler L, 2020, EUR C COMP VIS, P466, DOI [10.1007/978-3-030-58598-3_28, 10.1007/978-3-030-58598-3\_28, DOI 10.1007/978-3-030-58598-3]; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Hendrycks D., 2018, ICLR; Hendrycks Dan, 2017, INT C LEARN REPR; Herbei R, 2006, CAN J STAT, V34, P709, DOI 10.1002/cjs.5550340410; Hu J., 2017, ARXIV170901507; Kemker Ronald, 2018, P INT C LEARN REPR I, P2; Kingma Diederik P., 2013, ABS13126114 CORR; Knorr E. M., 1998, Proceedings of the Twenty-Fourth International Conference on Very-Large Databases, P392; Krueger D., 2017, ARXIV PREPRINT ARXIV; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lee K., 2017, ARXIV171109325; Lee K, 2018, ADV NEUR IN, V31; Liang Shiyu, 2018, P INT C LEARN REPR I; Lin TY, 2014, LECT NOTES COMPUT SC, V8693, P740, DOI 10.1007/978-3-319-10602-1_48; Murphy KP, 2012, MACHINE LEARNING: A PROBABILISTIC PERSPECTIVE, P1; Nalisnick Eric T., 2019, INT C LEARN REPR ICL; Neal L, 2018, LECT NOTES COMPUT SC, V11210, P620, DOI 10.1007/978-3-030-01231-1_38; Nilsback ME, 2008, SIXTH INDIAN CONFERENCE ON COMPUTER VISION, GRAPHICS & IMAGE PROCESSING ICVGIP 2008, P722, DOI 10.1109/ICVGIP.2008.47; Oza P., 2019, DEEP CNN BASED MULTI; Parisi GI, 2019, NEURAL NETWORKS, V113, P54, DOI 10.1016/j.neunet.2019.01.012; Perera P, 2019, IEEE T IMAGE PROCESS, V28, P5450, DOI 10.1109/TIP.2019.2917862; Platt JC, 2000, ADV NEUR IN, P61; Ren SQ, 2015, ADV NEUR IN, V28, DOI 10.1109/TPAMI.2016.2577031; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Scheirer WJ, 2014, IEEE T PATTERN ANAL, V36, P2317, DOI 10.1109/TPAMI.2014.2321392; Scheirer WJ, 2011, IEEE T PATTERN ANAL, V33, P1689, DOI 10.1109/TPAMI.2011.54; Scholkopf B, 2001, NEURAL COMPUT, V13, P1443, DOI 10.1162/089976601750264965; Scholkopf B., 2000, ADV NEUR INF PROC SY; Schroff F, 2015, PROC CVPR IEEE, P815, DOI 10.1109/CVPR.2015.7298682; Shu L., 2018, ARXIV PREPRINT ARXIV; Shu L, 2017, P C EMP METH NAT LAN; Sriperumbudur BK, 2010, J MACH LEARN RES, V11, P1517; Szegedy Christian, 2014, ARXIV; Taigman Y, 2014, PROC CVPR IEEE, P1701, DOI 10.1109/CVPR.2014.220; Wen Qin, 2010, Proceedings of the 2010 WASE International Conference on Information Engineering (ICIE 2010), P40, DOI 10.1109/ICIE.2010.105; Xiao H., 2017, ARXIV; Yosinski J, 2014, ADV NEUR IN, V27; Yu Y, 2017, P INT JOINT C ART IN; Zhou BL, 2018, IEEE T PATTERN ANAL, V40, P1452, DOI 10.1109/TPAMI.2017.2723009	61	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238302	10.1371/journal.pone.0238302	http://dx.doi.org/10.1371/journal.pone.0238302			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886692	Green Submitted, gold, Green Published			2022-12-26	WOS:000571064300058
J	Henson, P; Pearson, JF; Keshavan, M; Torous, J				Henson, Philip; Pearson, John F.; Keshavan, Matcheri; Torous, John			Impact of dynamic greenspace exposure on symptomatology in individuals with schizophrenia	PLOS ONE			English	Article							MENTAL-HEALTH; SPACE; WOMEN	There are currently many tools available for capturing and defining the context of one's environment. Digital phenotyping, the use of technology and sensors to capture moment-to-moment behavior, has shown potential in quantifying the lived experience of mental illness and in the identification of individualized targets related to recovery. Environmental data suggests that greenspace may have a restorative capacity on mental health. In this paper, we explore the relationship of greenspace derived from geolocation with self-reported symptomatology from individuals with schizophrenia as well as healthy controls. Individuals with schizophrenia had less exposure to greenspace than controls, but their exposure demonstrated a dosage effect: high greenspace environments were associated with lower symptoms for anxiety (Cohen's d = -0.70), depression (d = -0.97), and psychosis (d = -0.94), whereas effect sizes for healthy controls were all negligible or small (d < 0.38). The notion that greenspace may have a more pronounced effect on individuals with mental illness presents both potential areas for recovery as well as implications for health care policy, especially in cities with a broad range of greenspace environments.	[Henson, Philip; Keshavan, Matcheri; Torous, John] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Psychiat, Boston, MA 02115 USA; [Pearson, John F.] Univ Utah, Dept Anesthesiol, Salt Lake City, UT USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Utah System of Higher Education; University of Utah	Torous, J (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Psychiat, Boston, MA 02115 USA.	jtorous@bidmc.harvard.edu		Torous, John/0000-0002-5362-7937; Pearson, John/0000-0003-1759-9518	NIMH [K23MH116130-02]	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	JT is supported by a career development award from the NIMH: K23MH116130-02.	[Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; [Anonymous], 2019, ENCEPHALE S2, V45, pS47; Beyer KMM, 2014, INT J ENV RES PUB HE, V11, P3453, DOI 10.3390/ijerph110303453; Collins RM, 2020, LANDSCAPE URBAN PLAN, V201, DOI 10.1016/j.landurbplan.2020.103823; Dadvand P, 2018, ENVIRON HEALTH PERSP, V126, DOI [10.1289/EHP1876, 10.1289/ehp1876]; de Vries S, 2013, SOC SCI MED, V94, P26, DOI 10.1016/j.socscimed.2013.06.030; Depp CA, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0182-1; DeVylder JE, 2018, JAMA PSYCHIAT, V75, P678, DOI 10.1001/jamapsychiatry.2018.0577; Dzhambov A, 2018, ENVIRON RES, V160, P47, DOI 10.1016/j.envres.2017.09.015; Expert Panel on Neurologic Imaging, 2017, J AM COLL RADIOL, V14, pS550; Kondo MC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030445; Kriegler FJ, 1969, PREPROCESSING TRANSF; Kristine E, 2018, SCHIZOPHR RES, V199, P142, DOI 10.1016/j.schres.2018.03.026; Markevych I, 2017, ENVIRON RES, V158, P301, DOI 10.1016/j.envres.2017.06.028; McCormick R, 2017, J PEDIATR NURS, V37, P3, DOI 10.1016/j.pedn.2017.08.027; McEachan RRC, 2016, J EPIDEMIOL COMMUN H, V70, P253, DOI 10.1136/jech-2015-205954; Mennis J, 2018, LANDSCAPE URBAN PLAN, V174, P1, DOI 10.1016/j.landurbplan.2018.02.008; Obuchi Mikio, 2020, Proc ACM Interact Mob Wearable Ubiquitous Technol, V4, DOI 10.1145/3381001; Olszewska-Guizzo A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17020394; Sundquist K, 2004, BRIT J PSYCHIAT, V184, P293, DOI 10.1192/bjp.184.4.293; Twohig-Bennett C, 2018, ENVIRON RES, V166, P628, DOI 10.1016/j.envres.2018.06.030	23	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238498	10.1371/journal.pone.0238498	http://dx.doi.org/10.1371/journal.pone.0238498			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ7QD	32881899	Green Published, gold			2022-12-26	WOS:000571063300101
J	Iftimie, S; Lopez-Azcona, AF; Vicente-Miralles, M; Descarrega-Reina, R; Hernandez-Aguilera, A; Riu, F; Simo, JM; Garrido, P; Joven, J; Camps, J; Castro, A				Iftimie, Simona; Lopez-Azcona, Ana F.; Vicente-Miralles, Manuel; Descarrega-Reina, Ramon; Hernandez-Aguilera, Anna; Riu, Francesc; Simo, Josep M.; Garrido, Pedro; Joven, Jorge; Camps, Jordi; Castro, Antoni			Risk factors associated with mortality in hospitalized patients with SARS-CoV-2 infection. A prospective, longitudinal, unicenter study in Reus, Spain	PLOS ONE			English	Article							PNEUMONIA; COVID-19	Spain is one of the countries that has suffered the most from the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the strain that causes coronavirus disease 2019 (COVID-19). However, there is a lack of information on the characteristics of this disease in the Spanish population. The objective of this study has been to characterize our patients from an epidemiological point of view and to identify the risk factors associated with mortality in our geographical area. We performed a prospective, longitudinal study on 188 hospitalized cases of SARS-Cov-2 infection inHospital Universitari de Sant Joan, in Reus, Spain, admitted between 15(th)March 2020 and 30(th)April 2020. We recorded demographic data, signs and symptoms and comorbidities. We also calculated the Charlson and McCabe indices. A total of 43 deaths occurred during the study period. Deceased patients were older than the survivors (77.7 +/- 13.1vs. 62.8 +/- 18.4 years;p< 0.001). Logistic regression analyses showed that fever, pneumonia, acute respiratory distress syndrome, diabetes mellitus and cancer were the variables that showed independent and statistically significant associations with mortality. The Charlson index was more efficient than the McCabe index in discriminating between deceased and survivors. This is one of the first studies to describe the factors associated with mortality in patients infected with SARS-CoV-2 in Spain, and one of the few in the Mediterranean area. We identified the main factors independently associated with mortality in our population. Further studies are needed to complete and confirm our findings.	[Iftimie, Simona; Lopez-Azcona, Ana F.; Vicente-Miralles, Manuel; Descarrega-Reina, Ramon; Castro, Antoni] Univ Rovira & Virgili, Inst Invest Sanitaria Pere Virgili, Dept Internal Med, Hosp Univ St Joan, Reus, Spain; [Hernandez-Aguilera, Anna; Joven, Jorge; Camps, Jordi] Univ Rovira & Virgili, Inst Invest Sanitaria Pere Virgili, Unitat Recerca Biomed, Hosp Univ St Joan, Reus, Spain; [Hernandez-Aguilera, Anna; Riu, Francesc] Univ Rovira & Virgili, Inst Invest Sanitaria Pere Virgili, Dept Pathol, Hosp Univ St Joan, Reus, Spain; [Simo, Josep M.] Lab Referencia Camp Tarragona & Terres Ebre, Reus, Spain; [Garrido, Pedro] Univ Rovira & Virgili, Inst Invest Sanitaria Pere Virgili, Intens Care Unit, Hosp Univ St Joan, Reus, Spain	Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV)	Camps, J (corresponding author), Univ Rovira & Virgili, Inst Invest Sanitaria Pere Virgili, Unitat Recerca Biomed, Hosp Univ St Joan, Reus, Spain.	jcamps@grupsagessa.com	Iftimie, Simona/GLU-5446-2022	Iftimie, Simona/0000-0003-0714-8414; Camps, Jordi/0000-0002-3165-3640	Fundacio la Marato de TV3, Barcelona, Spain [201807-10]	Fundacio la Marato de TV3, Barcelona, Spain	This study was supported by a grant from the Fundacio la Marato de TV3 (201807-10), Barcelona, Spain to JC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Institute of Ultrasound in Medicine, 2020, J ULTRASOUND MED, V21, pE1; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], 2015, MEDICINE BALTIMORE, V94, pe1435; [Anonymous], 2008, SOUTH MED J, DOI DOI 10.1097/SMJ.0b013e318181d5b5; Badawi A, 2016, J PUBLIC HEALTH RES, V5, P130, DOI 10.4081/jphr.2016.733; Baig AM, 2020, CNS NEUROSCI THER, V26, P499, DOI 10.1111/cns.13372; BERKMAN LF, 1992, ANN INTERN MED, V117, P1003, DOI 10.7326/0003-4819-117-12-1003; Chen L, 2020, BRIT J OPHTHALMOL, V104, P748, DOI 10.1136/bjophthalmol-2020-316304; Farsalinos K, 2020, INTERN EMERG MED, V15, P845, DOI 10.1007/s11739-020-02355-7; Horby P, 2020, NEW ENGL J MED, DOI [10.1101/2020.06.22.20137273:24, DOI 10.1056/NEJMOA2021436, 10.1101/2020.06.22.20137273]; Huang R, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008280; Itelman E, 2020, ISR MED ASSOC J, V22, P269; Jin YF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12040372; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Leung C, 2020, MECH AGEING DEV, V188, DOI 10.1016/j.mad.2020.111255; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Liu K, 2020, J INFECTION, V80, pE14, DOI 10.1016/j.jinf.2020.03.005; Lovato A., 2020, ENT-EAR NOSE THROAT, DOI [DOI 10.7150/ijbs.45472, DOI 10.1177/0145561320920762]; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; Nikpouraghdam M, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104378; Olds JL, 2020, FEBS J, V287, P3651, DOI 10.1111/febs.15303; Penlioglou T, 2020, DIABETES THER, V11, P1195, DOI 10.1007/s13300-020-00830-0; Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9; Santamaria L, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820002782; Shu J, 2008, SOUTH MED J, V101, P1086, DOI 10.1097/SMJ.0b013e31818005fc; Sidaway P, 2020, NAT REV CLIN ONCOL, V17, P336, DOI 10.1038/s41571-020-0366-2; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sun HY, 2020, J AM GERIATR SOC, V68, pE19, DOI 10.1111/jgs.16533; Tindle HA, 2020, NICOTINE TOB RES, V22, P1669, DOI 10.1093/ntr/ntaa077; Veronese N, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00170; Wu P, 2020, JAMA OPHTHALMOL, V138, P575, DOI 10.1001/jamaophthalmol.2020.1291; Xu X, 2020, EUR J NUCL MED MOL I, V47, P1275, DOI 10.1007/s00259-020-04735-9; Yang JK, 2006, DIABETIC MED, V23, P623, DOI 10.1111/j.1464-5491.2006.01861.x; Yu J, 2020, JAMA ONCOL, V6, P1108, DOI 10.1001/jamaoncol.2020.0980; Zhang L, 2020, ANN ONCOL, V31, P894, DOI 10.1016/j.annonc.2020.03.296; Zhang S, 2020, INT J INFECT DIS, V93, P201, DOI 10.1016/j.ijid.2020.02.033; Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; ZWEIG MH, 1993, CLIN CHEM, V39, P561; THORAX	41	24	24	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0234452	10.1371/journal.pone.0234452	http://dx.doi.org/10.1371/journal.pone.0234452			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881860	Green Published, Green Submitted, gold			2022-12-26	WOS:000571063300099
J	Lee, JI; Hur, JM; You, J; Lee, DH				Lee, Jung Il; Hur, Jeong Min; You, Jooyoung; Lee, Duk Hee			Functional recovery with histomorphometric analysis of nerves and muscles after combination treatment with erythropoietin and dexamethasone in acute peripheral nerve injury	PLOS ONE			English	Article							SCIATIC-NERVE; WALLERIAN DEGENERATION; ENHANCED RECOVERY; CRUSH INJURY; IN-VIVO; REGENERATION; RAT; METHYLPREDNISOLONE; GLUCOCORTICOIDS; BETAMETHASONE	Introduction Peripheral nerve injury (PNI) often leads to significant functional loss in patients and poses a challenge to physicians since treatment options for improving functional outcomes are limited. Recent studies suggest that erythropoietin and glucocoticoids have beneficial effects as mediators of neuro-regenerative processes. We hypothesized that combination treatment with erythropoietin and glucocoticoids would have a synergistic effect on functional outcome after PNI. Materials and methods Sciatic nerve crush injury was simulated in ten-week-old male C57BL/6 mice. The mice were divided into four groups according to the type of drugs administered (control, erythropoietin, dexamethasone, and erythropoietin with dexamethasone). Motor functional recovery was monitored by walking track analysis at serial time points up to 28 days after injury. Morphological analysis of the nerve was performed by immunofluorescent staining for neurofilament (NF) heavy chain and myelin protein zero (P0) in cross-sectional and whole-mount nerve preparations. Additionally, morphological analysis of the muscle was performed by Hematoxylin and eosin staining. Results Combination treatment with erythropoietin and dexamethasone significantly improved the sciatic functional index at 3, 7, 14, and 28 days after injury. Fluorescence microscopy of cross sectional nerve revealed that the combination treatment increased the ratio of P0/NF-expressing axons. Furthermore, confocal microscopy of the whole-mount nerve revealed that the combination treatment increased the fluorescence intensity of P0 expression. The cross-sectional area and minimum Feret's diameter of the muscle fibers were significantly larger in the mice which received combination treatment than those in the controls. Conclusion Our results demonstrated that combination treatment with erythropoietin and dexamethasone accelerates functional recovery and reduces neurogenic muscle atrophy caused by PNI in mice, which may be attributed to the preservation of myelin and Schwann cell re-myelination. These findings may provide practical therapeutic options for patients with acute PNI.	[Lee, Jung Il; Hur, Jeong Min; You, Jooyoung] Hanyang Univ, Dept Orthoped Surg, Guri Hosp, Guri, South Korea; [Lee, Jung Il] Hanyang Univ, Coll Med, Seoul, South Korea; [Lee, Duk Hee] Ewha Womans Univ, Dept Emergency Med, Mokdong Hosp, Seoul, South Korea; [Lee, Duk Hee] Ewha Womans Univ, Coll Med, Seoul, South Korea	Hanyang University; Hanyang University; Ewha Womans University; Ewha Womans University	Lee, JI (corresponding author), Hanyang Univ, Dept Orthoped Surg, Guri Hosp, Guri, South Korea.; Lee, JI (corresponding author), Hanyang Univ, Coll Med, Seoul, South Korea.	osjungil@gmail.com	Lee, Jung Il/AAH-2547-2021	Lee, Jung Il/0000-0002-1110-5030; Lee, Duk Hee/0000-0001-5992-5284	National Research Foundation of Korea (NRF) - Korea government (MSIT) [NRF-2019R1H1A1035586]	National Research Foundation of Korea (NRF) - Korea government (MSIT)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT). (NRF-2019R1H1A1035586).	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Al-Bishri A, 2005, J ORAL MAXIL SURG, V63, P973, DOI 10.1016/j.joms.2004.10.010; Al-Bishri A, 2008, BRIT J ORAL MAX SURG, V46, P455, DOI 10.1016/j.bjoms.2008.01.020; Bahlmann FH, 2004, BLOOD, V103, P921, DOI 10.1182/blood-2003-04-1284; BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; Berkingali N, 2008, HEARING RES, V243, P121, DOI 10.1016/j.heares.2008.07.003; Bernstein DT, 2016, INJURY, V47, P1819, DOI 10.1016/j.injury.2016.05.034; Boivin A, 2007, J NEUROSCI, V27, P12565, DOI 10.1523/JNEUROSCI.3027-07.2007; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Campana WM, 2006, EUR J NEUROSCI, V23, P617, DOI 10.1111/j.1460-9568.2006.04606.x; Campana WM, 2003, EUR J NEUROSCI, V18, P1497, DOI 10.1046/j.1460-9568.2003.02875.x; Hernandez CC, 2017, NEURAL REGEN RES, V12, P1381, DOI 10.4103/1673-5374.215240; Cervellini I, 2013, MOL MED, V19, P223, DOI 10.2119/molmed.2013.00013; Cetin A, 2006, EUR SPINE J, V15, P1539, DOI 10.1007/s00586-006-0091-2; Chan JR, 1998, P NATL ACAD SCI USA, V95, P10459, DOI 10.1073/pnas.95.18.10459; Chan KM, 2014, EXP NEUROL, V261, P826, DOI 10.1016/j.expneurol.2014.09.006; Desarnaud F, 2000, BRAIN RES, V865, P12, DOI 10.1016/S0006-8993(00)02130-2; Diem R, 2005, BRAIN, V128, P375, DOI 10.1093/brain/awh365; Elfar JC, 2008, J BONE JOINT SURG AM, V90A, P1644, DOI 10.2106/JBJS.G.00557; Feng X, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/627923; Galloway EB, 2000, LARYNGOSCOPE, V110, P1907, DOI 10.1097/00005537-200011000-00026; Gao W, 2017, ARCH ORAL BIOL, V80, P101, DOI 10.1016/j.archoralbio.2017.03.025; Geary MB, 2017, MUSCLE NERVE, V56, P143, DOI 10.1002/mus.25459; Gorio A, 2005, P NATL ACAD SCI USA, V102, P16379, DOI 10.1073/pnas.0508479102; Govindappa PK, 2020, INT IMMUNOPHARMACOL, V82, DOI 10.1016/j.intimp.2020.106330; Grasso G, 2007, J NEUROSURG-SPINE, V7, P645, DOI 10.3171/SPI-07/12/645; Hassan K, 2004, CLIN NEPHROL, V61, P127; Inoue G, 2010, GLIA, V58, P399, DOI 10.1002/glia.20931; JUNGTESTAS I, 1992, J STEROID BIOCHEM, V41, P621, DOI 10.1016/0960-0760(92)90394-X; Kang JR, 2011, J AM ACAD ORTHOP SUR, V19, pS28, DOI 10.5435/00124635-201102001-00006; Keswani SC, 2004, ANN NEUROL, V56, P815, DOI 10.1002/ana.20285; Lykissas MG, 2007, J NEUROSCI METH, V164, P107, DOI 10.1016/j.jneumeth.2007.04.008; Merola A, 2002, J ORTHOP TRAUMA, V16, P155, DOI 10.1097/00005131-200203000-00003; Modrak M, 2020, J NEUROSCI RES, V98, P780, DOI 10.1002/jnr.24538; Modrak M, 2017, NEURAL REGEN RES, V12, P1268, DOI 10.4103/1673-5374.213544; Mohammadi R, 2013, J ORAL MAXIL SURG, V71, P786, DOI 10.1016/j.joms.2012.08.009; Mohammadi R, 2013, INJURY, V44, P565, DOI 10.1016/j.injury.2012.10.013; Morisaki S, 2010, GLIA, V58, P954, DOI 10.1002/glia.20977; NEUBERGER TJ, 1994, J NEUROSCI RES, V38, P300, DOI 10.1002/jnr.490380308; Noble J, 1998, J TRAUMA, V45, P116, DOI 10.1097/00005373-199807000-00025; Ostrowski D, 2011, NEUROSCIENCE, V188, P95, DOI 10.1016/j.neuroscience.2011.05.018; Pakravan M, 2016, AM J DRUG ALCOHOL AB, V42, P633, DOI 10.1080/00952990.2016.1198800; Rotter R, 2012, J TRAUMA ACUTE CARE, V72, P1567, DOI 10.1097/TA.0b013e318246498f; Shishido H, 2002, SPINE, V27, P581, DOI 10.1097/00007632-200203150-00005; Sun HZ, 2012, ARCH MED SCI, V8, P924, DOI 10.5114/aoms.2012.31623; Sundem L, 2016, J HAND SURG-AM, V41, P999, DOI 10.1016/j.jhsa.2016.08.002; Vardimon L, 1999, J NEUROBIOL, V40, P513, DOI 10.1002/(SICI)1097-4695(19990915)40:4<513::AID-NEU8>3.0.CO;2-D; Varejao ASP, 2001, J NEUROSCI METH, V108, P1, DOI 10.1016/S0165-0270(01)00378-8; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; WILCKE O, 1989, Neurosurgical Review, V12, P55, DOI 10.1007/BF01790625; Wu Y, 2007, EUR J PHARMACOL, V564, P47, DOI 10.1016/j.ejphar.2007.02.020; Yin ZS, 2010, AM J NEURORADIOL, V31, P509, DOI 10.3174/ajnr.A1820; Yu YM, 2004, NEUROREPORT, V15, P2103, DOI 10.1097/00001756-200409150-00021; Yue L, 2019, MUSCLE NERVE, V60, P192, DOI 10.1002/mus.26516; Zamani N, 2018, CUTAN OCUL TOXICOL, V37, P186, DOI 10.1080/15569527.2017.1373121; Zhu TS, 2008, BRAIN RES, V1206, P20, DOI 10.1016/j.brainres.2008.02.051	56	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238208	10.1371/journal.pone.0238208	http://dx.doi.org/10.1371/journal.pone.0238208			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881928	gold, Green Published			2022-12-26	WOS:000571063300069
J	Pomposello, MM; Nemes, K; Mosovsky, K				Pomposello, Michelle M.; Nemes, Kaitlyn; Mosovsky, Kara			Dietary antioxidant seleno-L-methionine protects macrophages infected withBurkholderia thailandensis	PLOS ONE			English	Article							BURKHOLDERIA-PSEUDOMALLEI; GAMMA-INTERFERON; ACTIVATION; RESISTANCE; INFLAMMATION; MELIOIDOSIS; NEUTROPHILS; MECHANISMS; EXPRESSION; SURVIVAL	Burkholderia pseudomalleiis a facultative intracellular pathogen and the causative agent of melioidosis, a potentially life-threatening disease endemic in Southeast Asia and Northern Australia. Treatment of melioidosis is a long and costly process and the pathogen is inherently resistant to several classes of antibiotics, therefore there is a need for new treatments that can help combat the pathogen. Previous work has shown that the combination of interferon-gamma, an immune system activator, and the antibiotic ceftazidime synergistically reduced the bacterial burden of RAW 264.7 macrophages that had been infected with eitherB.pseudomalleiorBurkholderia thailandensis. The mechanism of the interaction was found to be partially dependent on interferon-gamma-induced production of reactive oxygen species inside the macrophages. To further confirm the role of reactive oxygen species in the effectiveness of the combination treatment, we investigated the impact of the antioxidant and reactive oxygen species scavenger, seleno-L-methionine, on intracellular and extracellular bacterial burden of the infected macrophages. In a dose-dependent manner, high concentrations of seleno-L-methionine (1000 mu M) were protective towards infected macrophages, resulting in a reduction of bacteria, on its own, that exceeded the reduction caused by the antibiotic alone and rivaled the effect of ceftazidime and interferon-gamma combined. Seleno-L-methionine treatment also resulted in improved viability of infected macrophages compared to untreated controls. We show that the protective effect of seleno-L-methionine was partly due to its inhibition of bacterial growth. In summary, our study shows a role for high dose seleno-L-methionine to protect and treat macrophages infected withB.thailandensis.	[Pomposello, Michelle M.; Nemes, Kaitlyn; Mosovsky, Kara] Moravian Coll, Dept Biol Sci, Bethlehem, PA 18018 USA		Mosovsky, K (corresponding author), Moravian Coll, Dept Biol Sci, Bethlehem, PA 18018 USA.	mosovskyk@moravian.edu			Department of Biological Sciences; Ervin J. Rokke Endowment for Student-Faculty Research through Moravian College	Department of Biological Sciences; Ervin J. Rokke Endowment for Student-Faculty Research through Moravian College	The work of MMP, KN, and KM was funded by the Department of Biological Sciences and The Ervin J. Rokke Endowment for Student-Faculty Research through Moravian College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alert Drovers, 2006, DROVERS MAGAZINE, V7, P19; Allwood EM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00170; [Anonymous], 2016, J ELECTROMYOGRAPHY K, V27, pI; [Anonymous], 2005, NEW POLITICAL SCI, V27, P3; [Anonymous], 2017, J PROSTHET DENT, V11, pe1; [Anonymous], 2019, CIRCULATION, V2019; [Anonymous], 2016, DIABETES CARE S1, V39, pS1, DOI 10.2337/dc16-S001; Aribi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135515; Arjes HA, 2014, CURR BIOL, V24, P2149, DOI 10.1016/j.cub.2014.07.055; Bast A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003986; Bi CL, 2016, EUR J PHARMACOL, V780, P159, DOI 10.1016/j.ejphar.2016.03.044; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; BRODIE AE, 1985, TOXICOL APPL PHARM, V77, P381, DOI 10.1016/0041-008X(85)90177-2; BROWN AE, 1991, J INFECT DIS, V163, P1145, DOI 10.1093/infdis/163.5.1145; Buijs J, 2008, CLIN MICROBIOL INFEC, V14, P344, DOI 10.1111/j.1469-0691.2007.01940.x; Burtnick MN, 2008, INFECT IMMUN, V76, P2991, DOI 10.1128/IAI.00263-08; Chantratita N, 2011, P NATL ACAD SCI USA, V108, P17165, DOI 10.1073/pnas.1111020108; Chen K, 2005, ANTIMICROB AGENTS CH, V49, P1002, DOI 10.1128/AAC.49.3.1002-1009.2005; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Currie BJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000900; Easton A, 2007, J INFECT DIS, V195, P99, DOI 10.1086/509810; French CT, 2011, P NATL ACAD SCI USA, V108, P12095, DOI 10.1073/pnas.1107183108; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Gould IM, 1997, J ANTIMICROB CHEMOTH, V40, P495, DOI 10.1093/jac/40.4.495; Griffith O W, 1981, Methods Enzymol, V77, P59; Hardy G, 2012, NUTR CLIN PRACT, V27, P21, DOI 10.1177/0884533611434116; Huang TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054431; Huang Z, 2012, ANTIOXID REDOX SIGN, V16, P705, DOI 10.1089/ars.2011.4145; Justice SS, 2008, NAT REV MICROBIOL, V6, P162, DOI 10.1038/nrmicro1820; Lauw FN, 1999, J INFECT DIS, V180, P1878, DOI 10.1086/315155; Laws TR, 2011, MICROB PATHOGENESIS, V51, P471, DOI 10.1016/j.micpath.2011.07.002; Lewis ERG, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw070; Mattmiller SA, 2013, J NUTR SCI, V2, DOI 10.1017/jns.2013.17; Merritt Adam J, 2017, Curr Trop Med Rep, V4, P185, DOI 10.1007/s40475-017-0124-4; Miyagi K, 1997, INFECT IMMUN, V65, P4108, DOI 10.1128/IAI.65.10.4108-4113.1997; Monsen ER, 2000, J AM DIET ASSOC, V100, P637, DOI 10.1016/S0002-8223(00)00189-9; Mosovsky K, 2014, ANTIMICROB AGENTS CH, V58, P5954, DOI 10.1128/AAC.02781-14; Narayanan A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061703; Nelson SM, 2011, J NUTR, V141, P1754, DOI 10.3945/jn.111.141176; Propst KL, 2010, ANTIMICROB AGENTS CH, V54, P1785, DOI 10.1128/AAC.01513-09; Rahmanto AS, 2012, IUBMB LIFE, V64, P863, DOI 10.1002/iub.1084; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Reyes L, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8110546; Rhodes KA, 2016, DRUG RESIST UPDATE, V28, P82, DOI 10.1016/j.drup.2016.07.003; Safir N, 2003, CLIN CHEM LAB MED, V41, P1005, DOI 10.1515/CCLM.2003.154; Santanirand P, 1999, INFECT IMMUN, V67, P3593, DOI 10.1128/IAI.67.7.3593-3600.1999; Schrauzer GN, 2000, J NUTR, V130, P1653, DOI 10.1093/jn/130.7.1653; SPRATT BG, 1975, P NATL ACAD SCI USA, V72, P2999, DOI 10.1073/pnas.72.8.2999; Sun GW, 2005, CELL MICROBIOL, V7, P1447, DOI 10.1111/j.1462-5822.2005.00569.x; Vunta H, 2008, MOL NUTR FOOD RES, V52, P1316, DOI 10.1002/mnfr.200700346; Wainwright M, 1999, LETT APPL MICROBIOL, V29, P224, DOI 10.1046/j.1365-2672.1999.00602.x; Wang CM, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-55; Wang JY, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007105; Wiersinga WJ, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2017.107; Wiersinga WJ, 2009, CURR OPIN INFECT DIS, V22, P102, DOI 10.1097/QCO.0b013e328322e727; WONG KT, 1995, HISTOPATHOLOGY, V26, P51, DOI 10.1111/j.1365-2559.1995.tb00620.x	56	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238174	10.1371/journal.pone.0238174	http://dx.doi.org/10.1371/journal.pone.0238174			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881891	gold, Green Published			2022-12-26	WOS:000571063300029
J	Zhang, Q; Hu, XJ; Su, ZY; Song, ZH				Zhang, Qiang; Hu, Xiaojian; Su, Ziyi; Song, Zhihong			3D car-detection based on a Mobile Deep Sensor Fusion Model and real-scene applications	PLOS ONE			English	Article							VISUAL INTERVENTION INFLUENCE; RUTTING MITIGATION; VEHICLE DETECTION	Unmanned vehicles need to make a comprehensive perception of the surrounding environmental information during driving. Perception of automotive information is of significance. In the field of automotive perception, the sterevision of car-detection plays a vital role and sterevision can calculate the length, width, and height of a car, making the car more specific. However, under the existing technology, it is impossible to obtain accurate detection in a complex environment by relying on a single sensor. Therefore, it is particularly important to study the complex sensing technology based on multi-sensor fusion. Recently, with the development of deep learning in the field of vision, a mobile sensor-fusion method based on deep learning is proposed and applied in this paper--Mobile Deep Sensor Fusion Model (MDSFM). The content of this article is as follows. It does a data processing that projects 3D data to 2D data, which can form a dataset suitable for the model, thereby training data more efficiently. In the modules of LiDAR, it uses a revised squeezeNet structure to lighten the model and reduce parameters. In the modules of cameras, it uses the improved design of detecting module in R-CNN with a Mobile Spatial Attention Module (MSAM). In the fused part, it uses a dual-view deep fusing structure. And then it selects images from the KITTI's datasets for validation to test this model. Compared with other recognized methods, it shows that our model has a fairly good performance. Finally, it implements a ROS program on the experimental car and our model is in good condition. The result shows that it can improve performance of detecting easy cars significantly through MDSFM. It increases the quality of the detected data and improves the generalized ability of car-detection model. It improves contextual relevance and preserves background information. It remains stable in driverless environments. It is applied in the realistic scenario and proves that the model has a good practical value.	[Zhang, Qiang; Hu, Xiaojian] Southeast Univ, Jiangsu Key Lab Urban ITS, Nanjing, Jiangsu, Peoples R China; [Zhang, Qiang; Hu, Xiaojian; Su, Ziyi] Southeast Univ, Jiangsu Prov Collaborat Innovat Ctr Modern Urban, Nanjing, Jiangsu, Peoples R China; [Zhang, Qiang; Hu, Xiaojian; Su, Ziyi] Southeast Univ, Sch Transportat, Nanjing, Jiangsu, Peoples R China; [Su, Ziyi] Nanjing Traff Safety Res Inst, Nanjing, Jiangsu, Peoples R China; [Song, Zhihong] Anhui Keli Informat Ind Co Ltd, Hefei, Anhui, Peoples R China	Southeast University - China; Southeast University - China; Southeast University - China	Hu, XJ (corresponding author), Southeast Univ, Jiangsu Key Lab Urban ITS, Nanjing, Jiangsu, Peoples R China.; Hu, XJ (corresponding author), Southeast Univ, Jiangsu Prov Collaborat Innovat Ctr Modern Urban, Nanjing, Jiangsu, Peoples R China.; Hu, XJ (corresponding author), Southeast Univ, Sch Transportat, Nanjing, Jiangsu, Peoples R China.	huxiaojian@seu.edu.cn			Anhui Science and Technology Major Project [17030901054]; Fundamental Research Funds for the Central Universities	Anhui Science and Technology Major Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This article is supported by Anhui Science and Technology Major Project (No. 17030901054) and the Fundamental Research Funds for the Central Universities, CHD.	Ali MAH, 2019, IEEE T VEH TECHNOL, V68, P2176, DOI 10.1109/TVT.2019.2893878; [Anonymous], 2018, P ASM INT MECH ENG; Asvadi A, 2018, PATTERN RECOGN LETT, V115, P20, DOI 10.1016/j.patrec.2017.09.038; Aycard O, 2011, IEEE INT VEH SYM, P863, DOI 10.1109/IVS.2011.5940518; Chavez-Garcia RO, 2016, IEEE T INTELL TRANSP, V17, P525, DOI 10.1109/TITS.2015.2479925; Chen XZ, 2017, PROC CVPR IEEE, P6526, DOI 10.1109/CVPR.2017.691; Dai JF, 2016, ADV NEUR IN, V29; Deibe D, 2019, INT J GEOGR INF SCI, V33, P593, DOI 10.1080/13658816.2018.1549734; Dimitrievski M, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19020391; Forrest N.landola, 2019, ARXIV160207360; Huang RY, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18061770; Javanmardi E, 2019, IATSS RES, V43, P1, DOI 10.1016/j.iatssr.2018.05.001; Jia Zi-yong, 2017, Journal of Academy of Armored Force Engineering, V31, P88, DOI 10.3969/j.issn.1672-1497.2017.06.016; Ku J, 2018, IEEE INT C INT ROBOT, P5750, DOI 10.1109/IROS.2018.8594049; Liao QH, 2018, 2018 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS (ROBIO), P200, DOI 10.1109/ROBIO.2018.8665256; Lim K, 2019, 2019 16 IEEE ANN CON; Liu B, 2019, OPTOELECTRONIC ENG, V46, P21; Liu BS, 2019, SCI CHINA INFORM SCI, V62, DOI 10.1007/s11432-019-9932-3; Mousavian A, 2017, PROC CVPR IEEE, P5632, DOI 10.1109/CVPR.2017.597; Peng C, 2017, PROC CVPR IEEE, P1743, DOI 10.1109/CVPR.2017.189; Qi CR, 2018, PROC CVPR IEEE, P918, DOI 10.1109/CVPR.2018.00102; Qin Z, 2019, ARXIV190311752; Song W, 2018, HUM-CENT COMPUT INFO, V8, DOI 10.1186/s13673-018-0152-7; Stanislas L, 2019, IEEE J OCEANIC ENG, V44, P343, DOI 10.1109/JOE.2018.2868488; [王会 Wang Hui], 2018, [激光与红外, Laser and Infrared], V48, P1458; Wu G, 2019, INT J PAVEMENT ENG, V20, P734, DOI 10.1080/10298436.2017.1334460; Wu JQ, 2019, TRANSPORT RES REC, V2673, P627, DOI 10.1177/0361198119843855; Xia W, 2017, P SPIE; Xu DF, 2018, PROC CVPR IEEE, P244, DOI 10.1109/CVPR.2018.00033; Zeng YM, 2018, IEEE ROBOT AUTOM LET, V3, P3434, DOI 10.1109/LRA.2018.2852843; Zhang MF, 2019, IEEE T VEH TECHNOL, V68, P7431, DOI 10.1109/TVT.2019.2926787; Zhang ZY, 2019, TRANSPORT RES REC, V2673, P62, DOI 10.1177/0361198119844457; Zhu XY, 2019, INT J PAVEMENT ENG, V20, P573, DOI 10.1080/10298436.2017.1316646	36	2	2	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0236947	10.1371/journal.pone.0236947	http://dx.doi.org/10.1371/journal.pone.0236947			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881926	Green Published, gold			2022-12-26	WOS:000571063300072
J	Larson-Casey, JL; Gu, LL; Fiehn, O; Carter, AB				Larson-Casey, Jennifer L.; Gu, Linlin; Fiehn, Oliver; Carter, A. Brent			Cadmium-mediated lung injury is exacerbated by the persistence of classically activated macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						macrophage; metal; lung injury; redox regulation; peroxisome proliferator-activated receptor (PPAR); cadmium	DEPENDENT GENE-EXPRESSION; KAPPA-B; PPAR-GAMMA; ALVEOLAR MACROPHAGES; ALTERNATIVE ACTIVATION; URINARY CADMIUM; HYPOXIA; PROTEIN; DEGRADATION; HIF-1-ALPHA	Heavy metals released into the environment have a significant effect on respiratory health. Lung macrophages are important in mounting an inflammatory response to injury, but they are also involved in repair of injury. Macrophages develop mixed phenotypes in complex pathological conditions and polarize to a predominant phenotype depending on the duration and stage of injury and/or repair. Little is known about the reprogramming required for lung macrophages to switch between these divergent functions; therefore, understanding the mechanism(s) by which macrophages promote metabolic reprogramming to regulate lung injury is essential. Here, we show that lung macrophages polarize to a pro-inflammatory, classically activated phenotype after cadmium-mediated lung injury. Because metabolic adaptation provides energy for the diverse macrophage functions, these classically activated macrophages show metabolic reprogramming to glycolysis. RNA-Seq revealed up-regulation of glycolytic enzymes and transcription factors regulating glycolytic flux in lung macrophages from cadmium-exposed mice. Moreover, cadmium exposure promoted increased macrophage glycolytic function with enhanced extracellular acidification rate, glycolytic metabolites, and lactate excretion. These observations suggest that cadmium mediates the persistence of classically activated lung macrophages to exacerbate lung injury.	[Larson-Casey, Jennifer L.; Gu, Linlin; Carter, A. Brent] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Fiehn, Oliver] Univ Calif Davis, NIH, West Coast Metab Ctr, Davis, CA 95616 USA; [Carter, A. Brent] Birmingham Vet Adm Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; University of California System; University of California Davis	Larson-Casey, JL (corresponding author), Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA.	jennifercasey@uabmc.edu		Carter, A. Brent/0000-0001-6002-4715; Larson-Casey, Jennifer L./0000-0001-7238-7986	Parker B. Francis fellowship; American Lung Association [RG-507440]; National Institutes of Health [2R01ES015981-12, P42ES027723]; Department of Veteran Affairs [1 I01 CX001715-01]; Comprehensive Cancer Center Core Grant [P30CA031148]	Parker B. Francis fellowship; American Lung Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veteran Affairs(US Department of Veterans Affairs); Comprehensive Cancer Center Core Grant	This work was supported by a Parker B. Francis fellowship and American Lung Association Grant RG-507440 (to J. L. C.), National Institutes of Health Grants 2R01ES015981-12 and P42ES027723, and Department of Veteran Affairs Grant 1 I01 CX001715-01 (to A. B. C.), and Comprehensive Cancer Center Core Grant P30CA031148. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bigger JW, 1944, LANCET, V2, P497; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; BrougHolub E, 1997, INFECT IMMUN, V65, P1139, DOI 10.1128/IAI.65.4.1139-1146.1997; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Carter AB, 1999, J BIOL CHEM, V274, P30858, DOI 10.1074/jbc.274.43.30858; Carter AB, 1998, AM J RESP CELL MOL, V18, P384, DOI 10.1165/ajrcmb.18.3.2972; Carter KB, 2000, J BIOL CHEM, V275, P27858; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chun YS, 2000, EUR J BIOCHEM, V267, P4198, DOI 10.1046/j.1432-1327.2000.01453.x; Cox JN, 2016, AM J PHYSIOL-LUNG C, V311, pL754, DOI 10.1152/ajplung.00022.2016; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Crossno JT, 2007, AM J PHYSIOL-LUNG C, V292, pL885, DOI 10.1152/ajplung.00258.2006; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Faroon O., 2012, TOXICOLOGICAL PROFIL; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Genovese T, 2005, EUR RESPIR J, V25, P225, DOI 10.1183/09031936.05.00049704; Grommes J, 2012, EUR RESPIR J, V40, P416, DOI 10.1183/09031936.00091011; Gu LL, 2017, FASEB J, V31, P3072, DOI 10.1096/fj.201601371R; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; He C, 2013, J BIOL CHEM, V288, P20745, DOI 10.1074/jbc.M112.410720; Hendrick DJ, 2004, THORAX, V59, P184, DOI 10.1136/thx.2003.018432; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Jing Y, 2012, TOXICOL SCI, V125, P10, DOI 10.1093/toxsci/kfr256; Kheirollahi V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10839-0; Knapp S, 2003, AM J RESP CRIT CARE, V167, P171, DOI 10.1164/rccm.200207-698OC; Lampe BJ, 2008, ENVIRON HEALTH PERSP, V116, P1226, DOI 10.1289/ehp.11265; Larson-Casey JL, 2019, J CLIN INVEST, V129, P4962, DOI [10.1172/JCl127959, 10.1172/JCI127959]; Larson-Casey JL, 2018, AM J RESP CRIT CARE, V198, P1288, DOI 10.1164/rccm.201712-2388OC; Larson-Casey JL, 2016, IMMUNITY, V44, P582, DOI 10.1016/j.immuni.2016.01.001; Larson-Casey JL, 2014, J BIOL CHEM, V289, P36204, DOI 10.1074/jbc.M114.593285; Link H, 2015, NAT METHODS, V12, P1091, DOI [10.1038/NMETH.3584, 10.1038/nmeth.3584]; Lottes RG, 2015, AM J PHYSIOL-LUNG C, V308, pL953, DOI 10.1152/ajplung.00335.2014; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; Mannino DM, 2004, THORAX, V59, P194, DOI 10.1136/thorax.2003.012054; Murthy S, 2009, AM J PHYSIOL-LUNG C, V297, pL846, DOI 10.1152/ajplung.90590.2008; Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367; Nesto RW, 2004, DIABETES CARE, V27, P256, DOI 10.2337/diacare.27.1.256; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Raja R, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4902-y; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Satarug S, 2010, ENVIRON HEALTH PERSP, V118, P182, DOI 10.1289/ehp.0901234; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tephly LA, 2007, AM J PHYSIOL-LUNG C, V293, pL1143, DOI 10.1152/ajplung.00114.2007; Tojo K, 2018, FASEB J, V32, P2258, DOI 10.1096/fj.201700888R; UNEP, 2008, INT REV SCI INF CAD; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Wang YD, 2004, FREE RADICAL BIO MED, V36, P1434, DOI 10.1016/j.freeradbiomed.2004.03.010	51	13	13	3	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2020	295	46					15754	15766		10.1074/jbc.RA120.013632	http://dx.doi.org/10.1074/jbc.RA120.013632			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OY6NO	32917723	hybrid, Green Published			2022-12-26	WOS:000594361600025
J	Cao, YL; Jiang, KL; Wu, JX; Yu, FH; Du, W; Xu, TY				Cao, Yingli; Jiang, Kailun; Wu, Jingxian; Yu, Fenghua; Du, Wen; Xu, Tongyu			Inversion modeling of japonica rice canopy chlorophyll content with UAV hyperspectral remote sensing	PLOS ONE			English	Article							EXTREME LEARNING-MACHINE; REGRESSION	Chlorophyll content is an important indicator of the growth status of japonica rice. The objective of this paper is to develop an inversion model that can predict japonica rice chlorophyll content by using hyperspectral image of rice canopy collected with unmanned aerial vehicle (UAV). UAV-based hyperspectral remote sensing can provide timely and cost-effective monitoring of chlorophyll content over a large region. The study was based on hyperspectral data collected at the Shenyang Agricultural College Academician Japonica Rice Experimental Base in 2018 and 2019. In order to extract the salient information embedded in the high-dimensional hyperspectral data, we first perform dimension reduction by using a successive projection algorithm (SPA). The SPA extracts the characteristic hyperspectral bands that are used as input to the inversion model. The characteristic bands extracted by SPA are 410 nm, 481 nm, 533 nm, 702 nm, and 798 nm, respectively. The inversion model is developed by using an extreme learning machine (ELM), the parameters of which are optimized by using particle swarm optimization (PSO). The PSO-ELM algorithm can accurately model the nonlinear relationship between hyperspectral data and chlorophyll content. The model achieves a coefficient of determination R-2= 0.791 and a root mean square error of RMSE = 8.215 mg/L. The model exhibits good predictive ability and can provide data support and model reference for research on nutrient diagnosis of japonica rice.	[Cao, Yingli; Jiang, Kailun; Yu, Fenghua; Du, Wen; Xu, Tongyu] Shenyang Agr Univ, Dept Informat & Elect Engn, Shenyang, Peoples R China; [Cao, Yingli; Jiang, Kailun; Yu, Fenghua; Du, Wen; Xu, Tongyu] Liaoning Engn Res Ctr Informat Technol Agr, Shenyang, Peoples R China; [Wu, Jingxian] Univ Arkansas, Dept Elect Engn, Fayetteville, AR 72701 USA	Shenyang Agricultural University; University of Arkansas System; University of Arkansas Fayetteville	Xu, TY (corresponding author), Shenyang Agr Univ, Dept Informat & Elect Engn, Shenyang, Peoples R China.; Xu, TY (corresponding author), Liaoning Engn Res Ctr Informat Technol Agr, Shenyang, Peoples R China.	yatongmu@163.com	于, 丰华/GZA-3529-2022	于, 丰华/0000-0001-6545-9873	National Key R&D Program of China	National Key R&D Program of China	The work for YC and JK was supported by National Key R&D Program of China	de Almeida VE, 2018, TALANTA, V181, P38, DOI 10.1016/j.talanta.2017.12.064; Feng S, 2019, SPECTROSC SPECT ANAL, V39, P3281, DOI 10.3964/j.issn.1000-0593(2019)10-3281-07; Fu YY, 2013, SPECTROSC SPECT ANAL, V33, P1315, DOI [10.3964/j.issn.1000-0593(2013)05-1315-05, 10.3964/j.issn.1000-0593(2013)05-4315-05]; [高继平 Gao Jiping], 2017, [沈阳农业大学学报, Journal of Shenyang Agricultural University], V48, P145; Han Du, 2020, J CLEANER PRODUCTION, DOI 10.1016/j.jclepro.2020.122248; Huang GB, 2012, IEEE T SYST MAN CY B, V42, P513, DOI 10.1109/TSMCB.2011.2168604; Irteza SM, 2016, INT ARCH PHOTOGRAMM, V41, P911, DOI 10.5194/isprsarchives-XLI-B8-911-2016; Jiang HL, 2015, SPECTROSC SPECT ANAL, V35, P975, DOI 10.3964/j.issn.1000-0593(2015)04-0975-07; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kjaer A, 2017, AM J POTATO RES, V94, P573, DOI 10.1007/s12230-017-9595-z; Kong WP, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17122711; Liu Mingbo, 2014, Infrared and Laser Engineering, V43, P1265; Liu YanDe, 2018, Transactions of the Chinese Society of Agricultural Engineering, V34, P180; MAO Bo-hui, 2017, NONGYE GONGCHENG XUE, V33, P164; Nijat Kasim, 2017, Transactions of the Chinese Society of Agricultural Engineering, V33, P208; Niu QingLin, 2018, Transactions of the Chinese Society of Agricultural Engineering, V34, P73; Olatunji SO, 2014, INFORM FUSION, V16, P29, DOI 10.1016/j.inffus.2012.06.001; Pei HaoJie, 2017, Transactions of the Chinese Society of Agricultural Engineering, V33, P74; Romero M, 2018, COMPUT ELECTRON AGR, V147, P109, DOI 10.1016/j.compag.2018.02.013; Song YD, 2013, EXPERT SYST APPL, V40, P5477, DOI 10.1016/j.eswa.2013.04.025; Sun Hong, 2018, Transactions of the Chinese Society of Agricultural Engineering, V34, P149; Sun Y, 2017, FOOD CHEM, V235, P194, DOI 10.1016/j.foodchem.2017.05.064; Wang Hao, 2018, Acta Veterinaria et Zootechnica Sinica, V49, P121; Xie Kai, 2017, CHINESE AGR SCI B, V33, P117; [徐晋 Xu Jin], 2016, [遥感技术与应用, Remote Sensing Technology and Application], V31, P74; Yao YunJun, 2008, Transactions of the Chinese Society of Agricultural Engineering, V24, P301; Yu FH, 2017, INT J AGR BIOL ENG, V10, P150, DOI 10.25165/j.ijabe.20171004.3076; Yu FH, 2016, INT J AGR BIOL ENG, V9, P132, DOI 10.3965/j.ijabe.20160905.2266; Zhang J.H, 2010, CHINESE AGR SCI B, V26, P78; Zhao XiaoQing, 2017, Transactions of the Chinese Society of Agricultural Engineering, V33, P110; Zhu MY, 2019, SPECTROSC SPECT ANAL, V39, P1898, DOI 10.3964/j.issn.1000-0593(2019)06-1898-07	31	5	6	10	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238530	10.1371/journal.pone.0238530	http://dx.doi.org/10.1371/journal.pone.0238530			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915830	Green Published, gold			2022-12-26	WOS:000571887500128
J	Gambini, A; Rodriguez, MD; Rodriguez, MB; Briski, O; Bragulat, APF; Demergassi, N; Losinno, L; Salamone, DF				Gambini, Andres; Duque Rodriguez, Matteo; Belen Rodriguez, Maria; Briski, Olinda; Flores Bragulat, Ana P.; Demergassi, Natalia; Losinno, Luis; Salamone, Daniel F.			Horse ooplasm supportsin vitropreimplantation development of zebra ICSI and SCNT embryos without compromising YAP1 and SOX2 expression pattern	PLOS ONE			English	Article							INTRACYTOPLASMIC SPERM INJECTION; CELL NUCLEAR TRANSFER; EQUUS-PRZEWALSKII; EQUINE OOCYTES; IN-VITRO; FERTILIZATION; TRANSCRIPTION; AGGREGATION; COMPETENCE; MARES	Several equids have gone extinct and many extant equids are currently considered vulnerable to critically endangered. This work aimed to evaluate whether domestic horse oocytes support preimplantation development of zebra embryos obtained by intracytoplasmic sperm injection (ICSI, zebroid) and cloning, and to study the Hippo signaling pathway during the lineage specification of trophectoderm cells and inner cell mass cells. We first showed that zebra and horse sperm cells induce porcine oocyte activation and recruit maternal SMARCA4 during pronuclear formation. SMARCA4 recruitment showed to be independent of the genetic background of the injected sperm. No differences were found in blastocyst rate of ICSI hybrid (zebra spermatozoon into horse egg) embryos relative to the homospecific horse control group. Interestingly, zebra cloned blastocyst rate was significantly higher at day 8. Moreover, most ICSI and cloned horse and zebra blastocysts showed a similar expression pattern of SOX2 and nuclear YAP1 with the majority of the nuclei positive for YAP1, and most SOX2+ nuclei negative for YAP1. Here we demonstrated that horse oocytes support zebra preimplantation development of both, ICSI and cloned embryos, without compromising development to blastocyst, blastocyst cell number neither the expression of SOX2 and YAP1. Our results support the use of domestic horse oocytes as a model to studyin vitrozebra embryos on behalf of preservation of valuable genetic.	[Gambini, Andres] Univ Buenos Aires, Fac Agron, Catedra Prod Equina, Buenos Aires, DF, Argentina; [Gambini, Andres; Duque Rodriguez, Matteo; Belen Rodriguez, Maria; Briski, Olinda; Flores Bragulat, Ana P.; Salamone, Daniel F.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Duque Rodriguez, Matteo; Belen Rodriguez, Maria; Briski, Olinda; Salamone, Daniel F.] Univ Buenos Aires, Fac Agron, Catedra Fisiol Anim, Buenos Aires, DF, Argentina; [Flores Bragulat, Ana P.; Losinno, Luis] Univ Nacl Rio Cuarto, Fac Agron & Vet, Catedra Prod Equina, Rio 4, Cordoba, Argentina; [Demergassi, Natalia] Fdn Temaiken, Belen De Escobar, Buenos Aires, Argentina; [Demergassi, Natalia] Ecoparque, Gerencia Bienestar Anim, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Universidad Nacional Rio Cuarto	Gambini, A (corresponding author), Univ Buenos Aires, Fac Agron, Catedra Prod Equina, Buenos Aires, DF, Argentina.; Gambini, A (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.	gambini@agro.uba.ar	Brancaccio, Audreana/ABE-8910-2020; Salamone, Daniel F/G-1096-2019; Gambini, Andres/H-9119-2019	Salamone, Daniel F/0000-0003-0858-0313; Gambini, Andres/0000-0002-3652-2068	UBACyT from the University of Buenos Aires [20020170200009BA-2018]	UBACyT from the University of Buenos Aires	AG. 20020170200009BA-2018. UBACyT from the University of Buenos Aires. http://cyt.rec.uba.ar.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WR, 1997, J HERED, V88, P384, DOI 10.1093/oxfordjournals.jhered.a023123; Andres G, 2014, J ANIM SCI, V92, P561, DOI 10.2527/jas.2013-7026; [Anonymous], 2017, GOVT TECHNOLOGY, V30, P8; [Anonymous], 2017, COSMOS HIST J NATURA, V13, P156; [Anonymous], 2017, CANC DISCOVERY, V7, pOF12; BAVISTER BD, 1977, BIOL REPROD, V16, P228, DOI 10.1095/biolreprod16.2.228; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; Camillo F, 2003, REPROD DOMEST ANIM, V38, P380, DOI 10.1046/j.1439-0531.2003.00444.x; Carey TS, 2015, MOL CELL BIOL, V35, P4158, DOI 10.1128/MCB.00546-15; Chazaud C, 2016, DEVELOPMENT, V143, P1063, DOI 10.1242/dev.128314; Choi YH, 2011, REPRODUCTION, V142, P529, DOI 10.1530/REP-11-0145; Choi YH, 2002, REPRODUCTION, V123, P455, DOI 10.1530/rep.0.1230455; Colleoni S, 2009, REPROD FERT DEVELOP, V21, P228, DOI 10.1071/RDv21n1Ab262; Comizzoli P, 2019, BIOL REPROD, V101, P514, DOI 10.1093/biolre/ioz031; Cuervo-Arango J, 2019, THERIOGENOLOGY, V135, P181, DOI 10.1016/j.theriogenology.2019.06.020; Desmarais JA, 2011, REPRODUCTION, V141, P321, DOI 10.1530/REP-09-0536; Dominko T, 1999, BIOL REPROD, V60, P1496, DOI 10.1095/biolreprod60.6.1496; Eckersley-Maslin MA, 2018, NAT REV MOL CELL BIO, V19, P436, DOI 10.1038/s41580-018-0008-z; Fernandez-Gonzalez R, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00346; Firmage Edwin, 1999, J STUD OLD TESTAM, V82, P97; Folch J, 2009, THERIOGENOLOGY, V71, P1026, DOI 10.1016/j.theriogenology.2008.11.005; From the Board, 2016, LEGAL ISS EC INTEGRA, V43, P1; Galli C, 2003, NATURE, V424, P635, DOI 10.1038/424635a; Gambini A, 2020, DEV CELL, V53, P545, DOI 10.1016/j.devcel.2020.04.018; Gambini A, 2016, THERIOGENOLOGY, V86, P1081, DOI 10.1016/j.theriogenology.2016.03.040; Gambini A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110998; Gambini A, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.098855; Hinrichs K, 2018, REPROD DOMEST ANIM, V53, P4, DOI 10.1111/rda.13259; Jin L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62102-y; Kang YN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26280-0; Kydd J, 2010, EQUINE VET J, V17, P80, DOI [10.1111/j.2042-3306.1985.tb04601.x, DOI 10.1111/J.2042-3306.1985.TB04601.X]; Lagutina I, 2005, REPRODUCTION, V130, P559, DOI 10.1530/rep.1.00772; Lanza R P, 2000, Cloning, V2, P79, DOI 10.1089/152045500436104; Lee JW, 2003, BIOL REPROD, V68, P1341, DOI 10.1095/biolreprod.102.009001; Linklater WL, 2000, BIOL REV, V75, P1, DOI 10.1017/S0006323199005411; Loi P, 2001, NAT BIOTECHNOL, V19, P962, DOI 10.1038/nbt1001-962; Moro LN, 2015, REPRODUCTION, V150, P1, DOI 10.1530/REP-15-0048; Morris LH, 2019, REPROD FERT DEVELOP, V31, P1771, DOI 10.1071/RD19301; Niemann H, 2016, THERIOGENOLOGY, V86, P80, DOI 10.1016/j.theriogenology.2016.04.021; Nishihara H, 2006, P NATL ACAD SCI USA, V103, P9929, DOI 10.1073/pnas.0603797103; Orlando L, 2015, CURR BIOL, V25, pR973, DOI 10.1016/j.cub.2015.09.005; Poirier M, 2020, BIOL REPROD, V102, P211, DOI 10.1093/biolre/ioz168; Pukazhenthi BS, 2016, REPROD FERT DEVELOP, V28, P1133, DOI 10.1071/RD15412; Salamone DF, 2017, REPRODUCTION, V154, pF111, DOI [10.1530/REP-17-0357, 10.1530/rep-17-0357]; Salgado RM, 2018, J ASSIST REPROD GEN, V35, P825, DOI 10.1007/s10815-018-1174-9; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHORT RV, 1974, CYTOGENET CELL GENET, V13, P465, DOI 10.1159/000130300; SILBER SJ, 1995, REPROD FERT DEVELOP, V7, P281, DOI 10.1071/RD9950281; Smits K, 2012, REPROD DOMEST ANIM, V47, P239, DOI 10.1111/j.1439-0531.2012.02082.x; SUMMERS PM, 1987, J REPROD FERTIL, V80, P13, DOI 10.1530/jrf.0.0800013; Sun F, 2007, ZYGOTE, V15, P129, DOI 10.1017/S096719940600400X; Teixeira TVD, 2019, REPROD FERT DEVELOP, V31, P1885, DOI 10.1071/RD19239; Torres-Padilla ME, 2006, J CELL BIOL, V174, P329, DOI 10.1083/jcb.200603146; Tribulo P, 2017, BIOL REPROD, V96, P1129, DOI 10.1093/biolre/iox048; Vajta G, 2000, MOL REPROD DEV, V55, P256, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;256::AID-MRD3&gt;3.0.CO;2-7; Vieira LA, 2013, ANIM REPROD SCI, V136, P280, DOI 10.1016/j.anireprosci.2012.10.027; Wicklow E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004618; Woods GL, 2003, SCIENCE, V301, P1063, DOI 10.1126/science.1086743	58	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238948	10.1371/journal.pone.0238948	http://dx.doi.org/10.1371/journal.pone.0238948			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915925	Green Published, gold			2022-12-26	WOS:000571887500134
J	Noureen, N; Shah, FA; Lisec, J; Usman, H; Khalid, M; Munir, R; Zaidi, N				Noureen, Naila; Shah, Farhad Ali; Lisec, Jan; Usman, Hina; Khalid, Mohammad; Munir, Rimsha; Zaidi, Nousheen			Revisiting the association between human leukocyte antigen and end-stage renal disease	PLOS ONE			English	Article							CLASS-I; POLYMORPHISMS; RISK	Multiple works have studied possible associations between human leukocyte antigen (HLA) alleles and end stage renal disease (ESRD) showing, however, contradictory and inconsistent results. Here, we revisit the association between ESRD and HLA antigens, comparing HLA polymorphism (at HLA-A, -B, -C, -DRB1, -DQB1 and DQA1 loci) in ESRD patients (n = 497) and controls (n = 672). Our data identified several HLA alleles that displayed a significant positive or negative association with ESRD. We also determined whether heterozygosity or homozygosity of the ESRD-associated HLA alleles at different loci could modify the prevalence of the disease. Few HLA allele combinations displayed significant associations with ESRD, among which A*3_26 combination showed the highest strength of association (OR = 4.488, P <= 0.05) with ESRD. Interestingly, the age of ESRD onset was not affected by HLA allele combinations at different loci. We also performed an extensive literature analysis to determine whether the association of HLA to ESRD can be similar across different ethnic groups. Our analysis showed that at least certain HLA alleles, HLA-A*11, HLA-DRB1*11, and HLA-DRB1*4, display a significant association with ESRD in different ethnic groups. The findings of our study will help in determining possible protective or susceptible roles of various HLA alleles in ESRD.	[Noureen, Naila; Shah, Farhad Ali; Munir, Rimsha; Zaidi, Nousheen] Univ Punjab, Canc Biol Lab, MMG, Lahore, Pakistan; [Noureen, Naila; Shah, Farhad Ali; Munir, Rimsha; Zaidi, Nousheen] Univ Punjab, Canc Res Ctr CRC, Lahore, Pakistan; [Lisec, Jan] Bundesanstalt Mat Forsch & Prufung BAM, Dept Analyt Chem, Berlin, Germany; [Usman, Hina] Women Univ Multan, MMG, Multan, Pakistan; [Khalid, Mohammad; Munir, Rimsha] Hormone Lab, Lahore, Pakistan	University of Punjab; University of Punjab; Federal Institute for Materials Research & Testing	Zaidi, N (corresponding author), Univ Punjab, Canc Biol Lab, MMG, Lahore, Pakistan.; Zaidi, N (corresponding author), Univ Punjab, Canc Res Ctr CRC, Lahore, Pakistan.	nosheen.nmg@pu.edu.pk		Zaidi, Nousheen/0000-0002-3896-0088; Lisec, Jan/0000-0003-1220-2286	Alexander von Humboldt Foundation (Georg Forster Research Fellowship for Experienced Researchers); Higher Education Commission Pakistan; University of the Punjab under Projects for Cancer research Centre	Alexander von Humboldt Foundation (Georg Forster Research Fellowship for Experienced Researchers)(Alexander von Humboldt Foundation); Higher Education Commission Pakistan(Higher Education Commission of Pakistan); University of the Punjab under Projects for Cancer research Centre	This work was financially supported by Alexander von Humboldt Foundation (Georg Forster Research Fellowship for Experienced Researchers awarded to N. Zaidi), Higher Education Commission Pakistan (PI: N. Zaidi), and University of the Punjab under Projects for Cancer research Centre (PI: N. Zaidi). Funding bodies did not play any role in study designing; data collection, analysis, & interpretation, or manuscript writing.	Ademovic-Sazdanic D, 2019, GENETIKA-BELGRADE, V51, P607, DOI 10.2298/GENSR1902607A; Cao Q., 2014, REG ANESTH PAIN MED, V9; Dai CS, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0165-7; Ha N.T., 2019, TRANSPLANTATION P; Hamdi N.M., 2014, REG ANESTH PAIN MED, V9; Hamdi N.M., 2017, DIABETOLOGIE STOF S2, V12, pe0190127; Hernandez-Rivera JCH, 2019, GAC MED MEX, V155, P223, DOI 10.24875/GMM.M19000265; Karnes JH, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8708; Kawamoto R, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-79; Kodaz H, 2017, EURASIAN J MED ONCOL, V1, P1, DOI 10.14744/ejmo.2017.22931; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Moatter T, 2010, Indian J Hum Genet, V16, P149, DOI 10.4103/0971-6866.73408; Mohyuddin A, 2002, TISSUE ANTIGENS, V59, P492, DOI 10.1034/j.1399-0039.2002.590606.x; Mosaad YM, 2014, RENAL FAILURE, V36, P1317, DOI 10.3109/0886022X.2014.937672; Nassar MY, 2017, IRAN J IMMUNOL, V14, P240, DOI IJIv14i3A7; Pan QQ, 2019, HUM IMMUNOL, V80, P943, DOI 10.1016/j.humimm.2019.09.001; Raza A, 2013, IMMUNOL INVEST, V42, P691, DOI 10.3109/08820139.2013.806541; Rivera P. S., 2012, Inmunologia, V31, P37, DOI 10.1016/j.inmuno.2011.12.001; Robson KJ, 2018, NAT REV NEPHROL, V14, P636, DOI 10.1038/s41581-018-0057-8; WEYAND CM, 1992, J CLIN INVEST, V89, P2033, DOI 10.1172/JCI115814; Zafar Naqi, 1996, JPMA (Journal of the Pakistan Medical Association), V46, P12	21	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238878	10.1371/journal.pone.0238878	http://dx.doi.org/10.1371/journal.pone.0238878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915858	gold, Green Submitted, Green Published			2022-12-26	WOS:000571887500009
J	Espanol, AJ; Salem, A; Di Bari, M; Cristofaro, I; Sanchez, Y; Tata, AM; Sales, ME				Espanol, Alejandro J.; Salem, Agustina; Di Bari, Maria; Cristofaro, Ilaria; Sanchez, Yamila; Tata, Ada M.; Sales, Maria E.			The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M-2 receptor subtype	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MUSCARINIC RECEPTORS; MULTIDRUG-RESISTANCE; COLON-CANCER; ACTIVATION; EGFR; PROLIFERATION; ANGIOGENESIS; EXPRESSION; LUNG	Triple negative tumors are more aggressive than other breast cancer subtypes and there is a lack of specific therapeutic targets on them. Since muscarinic receptors have been linked to tumor progression, we investigated the effect of metronomic therapy employing a traditional anti-cancer drug, paclitaxel plus muscarinic agonists at low doses on this type of tumor. We observed that MDA-MB231 tumor cells express muscarinic receptors, while they are absent in the non-tumorigenic MCF-10A cell line, which was used as control. The addition of carbachol or arecaidine propargyl ester, a non-selective or a selective subtype 2 muscarinic receptor agonist respectively, plus paclitaxel reduces cell viability involving a down-regulation in the expression of ATP "binding cassette" G2 drug transporter and epidermal growth factor receptor. We also detected an inhibition of tumor cell migration and anti-angiogenic effects produced by those drug combinationsin vitroandin vivo(in NUDE mice) respectively. Our findings provide substantial evidence about subtype 2 muscarinic receptors as therapeutic targets for the treatment of triple negative tumors.	[Espanol, Alejandro J.; Salem, Agustina; Sanchez, Yamila; Sales, Maria E.] Consejo Nacl Invest Cient & Tecn, Ctr Pharmacol & Bot Studies CEFYBO, Buenos Aires, DF, Argentina; [Espanol, Alejandro J.; Salem, Agustina; Sanchez, Yamila; Sales, Maria E.] Univ Buenos Aires, Sch Med, Dept Pharmacol, Buenos Aires, DF, Argentina; [Espanol, Alejandro J.; Di Bari, Maria; Cristofaro, Ilaria; Tata, Ada M.] Sapienza Univ Rome, Dept Biol & Biotechnol Charles Darwin, Rome, Italy; [Tata, Ada M.] Sapienza Univ Rome, Ctr Neurobiol Daniel Bovet, Rome, Italy	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Sapienza University Rome; Sapienza University Rome	Espanol, AJ (corresponding author), Consejo Nacl Invest Cient & Tecn, Ctr Pharmacol & Bot Studies CEFYBO, Buenos Aires, DF, Argentina.; Espanol, AJ (corresponding author), Univ Buenos Aires, Sch Med, Dept Pharmacol, Buenos Aires, DF, Argentina.; Espanol, AJ; Tata, AM (corresponding author), Sapienza Univ Rome, Dept Biol & Biotechnol Charles Darwin, Rome, Italy.; Tata, AM (corresponding author), Sapienza Univ Rome, Ctr Neurobiol Daniel Bovet, Rome, Italy.	aespan_1999@yahoo.com; adamaria.tata@uniroma1.it		Espanol, Alejandro/0000-0001-8222-4259	ANPCyT PICT [2396]; Agencia Nacional de Promocion Cientifica y Tecnologica; CONICET PIP [201501 00239]; Consejo Nacional de Investigaciones Cientificas y Tecnicas; UBA UBACYT, Universidad de Buenos Aires [20020130100168BA]	ANPCyT PICT(ANPCyT); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); CONICET PIP(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UBA UBACYT, Universidad de Buenos Aires	AJE; ANPCyT PICT 2015-2017, 2396. Agencia Nacional de Promocion Cientifica y Tecnologica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MES, CONICET PIP 2015-2017, 201501 00239; Consejo Nacional de Investigaciones Cientificas y Tecnicas; UBA UBACYT 2014-2017, 20020130100168BA Universidad de Buenos Aires. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandrini F, 2015, INT IMMUNOPHARMACOL, V29, P105, DOI 10.1016/j.intimp.2015.05.032; Baig AM, 2017, ANTI-CANCER DRUG, V28, P75, DOI 10.1097/CAD.0000000000000432; Basu M, 2013, CANCER-AM CANCER SOC, V119, P2524, DOI 10.1002/cncr.28024; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai XJ, 2017, ONCOTARGET, V8, P84248, DOI 10.18632/oncotarget.20539; Chavez Kathryn J, 2010, Breast Dis, V32, P35, DOI 10.3233/BD-2010-0307; CHEN TR, 1977, EXP CELL RES, V104, P255, DOI 10.1016/0014-4827(77)90089-1; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cristofaro I, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030657; Curtis MJ, 2018, BRIT J PHARMACOL, V175, P987, DOI 10.1111/bph.14153; Dai XX, 2018, CANCER MANAG RES, V10, P3069, DOI 10.2147/CMAR.S159660; Davel Lilia E., 2004, Angiogenesis, V7, P45, DOI 10.1023/B:AGEN.0000037329.45326.a8; Dei Tos Angelo Paolo, 2013, EJC Suppl, V11, P23, DOI 10.1016/j.ejcsup.2013.07.027; Di Bari M, 2015, NEUROCHEM INT, V90, P261, DOI 10.1016/j.neuint.2015.09.008; Doherty MR, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1136-x; Sales ME, 2016, CURR PHARM DESIGN, V22, P2170, DOI 10.2174/1381612822666160229115317; Espanol AJ, 2004, INT J MOL MED, V13, P311; Farhana L, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0439-4; Fiszman GL, 2007, CANCER BIOL THER, V6, P1106, DOI 10.4161/cbt.6.7.4330; Fiszman Gabriel L., 2008, Current Immunology Reviews, V4, P176, DOI 10.2174/157339508785160732; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Hanahan D, 2000, J CLIN INVEST, V105, P1045, DOI 10.1172/JCI9872; Hu T, 2016, WORLD J GASTROENTERO, V22, P6876, DOI 10.3748/wjg.v22.i30.6876; Islam MS, 2020, J CELL PHYSIOL, V235, P8114, DOI 10.1002/jcp.29466; Espanol AJ, 2015, INT IMMUNOPHARMACOL, V29, P87, DOI 10.1016/j.intimp.2015.03.018; Espanol AJ, 2013, ANTI-CANCER AGENT ME, V13, P1273, DOI 10.2174/18715206113139990136; Ji XM, 2017, CANCER LETT, V386, P24, DOI 10.1016/j.canlet.2016.10.031; Lee MJ, 2016, J CANCER RES CLIN, V142, P125, DOI 10.1007/s00432-015-2009-z; Li CR, 2015, MOL CANCER THER, V14, P2049, DOI 10.1158/1535-7163.MCT-15-0155; Liu BH, 2015, BRAIN RES, V1611, P93, DOI 10.1016/j.brainres.2015.03.023; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; MONTE M, 1994, FREE RADICAL BIO MED, V17, P259, DOI 10.1016/0891-5849(94)90081-7; Pacini L, 2014, CANCER BIOL THER, V15, P1489, DOI 10.4161/15384047.2014.955740; Paleari L, 2008, SEMIN CANCER BIOL, V18, P211, DOI 10.1016/j.semcancer.2007.12.009; Pelegrina LT, 2013, J CLIN IMMUNOL, V33, P427, DOI 10.1007/s10875-012-9804-y; Pollock NI, 2015, CLIN CANCER RES, V21, P4597, DOI 10.1158/1078-0432.CCR-14-3338; Said AH, 2017, BIOCHEM J, V474, P647, DOI 10.1042/BCJ20160704; Sales ME, 2019, CURR CLIN PHARMACOL, V14, P91, DOI 10.2174/1574884714666181203095437; Schettini F, 2016, CANCER TREAT REV, V46, P20, DOI 10.1016/j.ctrv.2016.03.012; Schmitt NC, 2015, MOL CANCER THER, V14, P2103, DOI 10.1158/1535-7163.MCT-15-0305; Spindel ER, 2016, CURR PHARM DESIGN, V22, P2152, DOI 10.2174/1381612822666160127114237; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Turner TH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58438-0; Yotsumoto F, 2013, MOL CANCER RES, V11, P506, DOI 10.1158/1541-7786.MCR-12-0428; Zhang L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/357485	46	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0226450	10.1371/journal.pone.0226450	http://dx.doi.org/10.1371/journal.pone.0226450			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911509	Green Published, gold, Green Submitted			2022-12-26	WOS:000571885900049
J	Bergmann-Hug, K; Fricker, M; Hausmann, O; Helbling, A; Jorg, L				Bergmann-Hug, Katrin; Fricker, Michael; Hausmann, Oliver; Helbling, Arthur; Jorg, Lukas			Sensitization to Hymenoptera venom in pollen allergic patients: Frequency and involvement of cross-reacting carbohydrate determinants (CCD)	PLOS ONE			English	Article							IGE; ANTIBODIES; DIAGNOSIS; COMMON	Sensitization to Hymenoptera venom in patients without a history of systemic allergic reactions to Hymenoptera stings is frequently found and can be due to the presence of specific IgE to cross-reactive carbohydrate determinants (CCD). This study investigates 105 pollen allergic subjects for the presence of specific IgE to honeybee or wasp venom, pollen, the MUXF3 carbohydrate epitope from bromelain and recombinant Hymenoptera venom components. In addition, in a subgroup of patients (n = 10) a basophil activation test (BAT) using bee and wasp venom was performed. Specific IgE to Hymenoptera venom was detected in 45.7% of the pollen allergic subjects and in 26.7% of the non-atopic controls, both without a history of systemic allergic reactions to Hymenoptera stings. The high sensitization rate in atopic patients could partially be explained by cross-sensitization between pollen and Hymenoptera venom due to specific IgE to CCDs. In our study population, only 20% showed a sensitization to CCDs. Primary sensitization due to sting exposure, high total IgE values or unspecific binding and detection of low affinity antibodies in the test procedure could be reasons. Thus, determination of specific IgE to Hymenoptera venom in patients without a history of systemic allergic reactions as screening test is not recommended.	[Bergmann-Hug, Katrin; Helbling, Arthur] Spite Netz Bern AG, Clin Internal Med, Zieglerspital, Allergy Unit, Bern, Switzerland; [Bergmann-Hug, Katrin; Fricker, Michael; Hausmann, Oliver; Helbling, Arthur; Jorg, Lukas] Univ Bern, Bern Univ Hosp, Inselspital, Dept Rheumatol Immunol & Allergol, Bern, Switzerland; [Fricker, Michael] Praxisgemeinschaft Morigen, Morigen, Switzerland; [Hausmann, Oliver] ADR AC GmbH, Adverse Drug React Anal & Consulting, Bern, Switzerland; [Hausmann, Oliver] Lowenpraxis Luzern, Luzern, Switzerland	University of Bern; University Hospital of Bern	Jorg, L (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Dept Rheumatol Immunol & Allergol, Bern, Switzerland.	lukas.joerg@insel.ch		Jorg, Lukas/0000-0003-1512-4279	Ulrich Mueller Gierok Allergy Foundation Bern, Switzerland; laboratory ADR-AC GmBH	Ulrich Mueller Gierok Allergy Foundation Bern, Switzerland; laboratory ADR-AC GmBH	This study was funded by Ulrich Mueller Gierok Allergy Foundation Bern, Switzerland. The funding was granted to KB and AH. The funder provided only support for laboratory costs and material, but not for salaries for the authors. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. In 2019 this foundation was closed. The laboratory ADR-AC GmBH, a specialized laboratory offering basophil activation tests for routine diagnostics in Switzerland, performed all basophil activation tests in this study.	AALBERSE RC, 1981, J ALLERGY CLIN IMMUN, V68, P356, DOI 10.1016/0091-6749(81)90133-0; Altmann F, 2016, ALLERGO J, V25, P18, DOI 10.1007/s40629-016-0112-6; Alvela-Suarez L, 2019, J INVEST ALLERG CLIN, V29, P213, DOI 10.18176/jiaci.0309; [Anonymous], 2004, J R COLL PHYS EDINB, V34, P137; [Anonymous], 2019, BRAIN STIMUL MAR; Bilo BM, 2005, ALLERGY, V60, P1339, DOI 10.1111/j.1398-9995.2005.00963.x; Blank S, 2019, ALLERGO J INT; Eberlein B, 2012, J ALLERGY CLIN IMMUN, V130, P155, DOI 10.1016/j.jaci.2012.02.008; Frick M, 2015, ALLERGY, V70, P1665, DOI 10.1111/all.12725; Heinzerling Lucie, 2013, Clin Transl Allergy, V3, P3, DOI 10.1186/2045-7022-3-3; Hemmer W, 2004, CLIN EXP ALLERGY, V34, P460, DOI 10.1111/j.1365-2222.2004.01897.x; Hemmer W, 2018, J ALLERGY CLIN IMMUN, V141, P372, DOI 10.1016/j.jaci.2017.04.028; Jappe U, 2006, ALLERGY, V61, P1220, DOI 10.1111/j.1398-9995.2006.01232.x; Mari A, 2002, INT ARCH ALLERGY IMM, V129, P286, DOI 10.1159/000067591; Schafer T, 1996, ALLERGY, V51, P372; Stoevesandt J, 2018, CLIN EXP ALLERGY, V48, P1735, DOI 10.1111/cea.13237; STRUPLER W, 1997, ALLERGO J S1, V6, P7; Sturm GJ, 2014, J ALLERGY CLIN IMMUN, V133, P1635, DOI 10.1016/j.jaci.2013.10.046; Sturm GJ, 2009, INT ARCH ALLERGY IMM, V148, P261, DOI 10.1159/000161586; Yokoi H, 2017, ASIA PAC ALLERGY, V7, P29, DOI 10.5415/apallergy.2017.7.1.29	20	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238740	10.1371/journal.pone.0238740	http://dx.doi.org/10.1371/journal.pone.0238740			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ6EE	32898145	Green Published, gold			2022-12-26	WOS:000570962500043
J	Blazhenkova, O; Dogerlioglu-Demir, K				Blazhenkova, Olesya; Dogerlioglu-Demir, Kivilcim			The shape of the pill: Perceived effects, evoked bodily sensations and emotions	PLOS ONE			English	Article							SCHEMA CONGRUITY; PRODUCT DESIGN; MENTAL-IMAGERY; PREFERENCE; EXPECTATIONS; RECOGNITION; PERCEPTION; MECHANISMS; AESTHETICS; COLORS	Current research examined the differential effects of pills' shape (angular vs. curvy) on the perceived efficacy of the medicine, evoked bodily sensations and emotions. We investigated these effects by using different types of angular vs. curved stimuli: abstract drawn shapes (Study 1), 3D-printed mockup pills (Study 2) and photographs of the existing pills (Study 3). Participants were asked to imagine 'taking' angular and curved pills. They had to focus on the bodily sensations and report the evoked activations/deactivations in different body parts. Across three studies, we found that the angular pills evoke overall more activations in the body compared to curvy pills. We further reported differences in the topography of angular vs. curved pills'-triggered sensations in different body parts. Our results also revealed that angularity is linked with an energizing effect while roundness is associated with a calming effect. The shape effects were demonstrated not only in self-reported energized vs. calm subjective feelings but also in performance on a timed cognitive test. Compared to incongruent designs, pill designs (angular vs. curved) congruent with proposed drug benefits (energizing vs. calming) were perceived as more effective. Moreover, we found differences in emotions triggered by pills of different shapes. The present research provided new findings on angularity vs. curvature perception that may be valuable for cognitive psychology, marketing, pharmaceutical and supplements industry, and other applied fields.	[Blazhenkova, Olesya] Sabanci Univ, Fac Arts & Social Sci, Istanbul, Turkey; [Dogerlioglu-Demir, Kivilcim] Sabanci Univ, Sabanci Business Sch, Istanbul, Turkey	Sabanci University; Sabanci University	Blazhenkova, O (corresponding author), Sabanci Univ, Fac Arts & Social Sci, Istanbul, Turkey.	olesya.blazhenkova@sabanciuniv.edu	Blazhenkova, Olesya/H-8367-2016	Blazhenkova, Olesya/0000-0002-9513-7258	Sabanci University	Sabanci University(Sabanci University)	The authors received no specific funding for this work. All expenses regarding 3D printing of pills were paid from the researchers' Individual Research Fund provided by Sabanci University.	Aggarwal P, 2007, J CONSUM RES, V34, P468, DOI 10.1086/518544; [Anonymous], 2014, DIABETES CARE, V38, pS1; ARONOFF J, 1992, J PERS SOC PSYCHOL, V62, P1050, DOI 10.1037/0022-3514.62.6.1050; Bar M, 2007, NEUROPSYCHOLOGIA, V45, P2191, DOI 10.1016/j.neuropsychologia.2007.03.008; Bar M, 2006, PSYCHOL SCI, V17, P645, DOI 10.1111/j.1467-9280.2006.01759.x; BASSILI JN, 1979, J PERS SOC PSYCHOL, V37, P2049, DOI 10.1037/0022-3514.37.11.2049; Basulto D, 2015, ARCHIT REV, V237, P34; Becker L, 2011, FOOD QUAL PREFER, V22, P17, DOI 10.1016/j.foodqual.2010.06.007; BLACKWELL B, 1972, LANCET, V1, P1279; Blazhenkova O, 2017, CURVED VS ANGULAR SH; Blazhenkova O., 2017, PREFERENCES ANGULAR; Blazhenkova O, 2018, PERCEPTION, V47, P67, DOI 10.1177/0301006617731048; BUCKALEW LW, 1982, PERCEPT MOTOR SKILL, V55, P915, DOI 10.2466/pms.1982.55.3.915; BUCKALEW LW, 1982, J CLIN PSYCHOPHARM, V2, P245; Carbon CC, 2010, ACTA PSYCHOL, V134, P233, DOI 10.1016/j.actpsy.2010.02.004; Doyle JR, 2006, J CONSUM PSYCHOL, V16, P112, DOI 10.1207/s15327663jcp1602_2; Ekstrom R.B., 1976, MANUAL KIT FACTOR RE; Ganis G, 2004, COGNITIVE BRAIN RES, V20, P226, DOI 10.1016/j.cogbrainres.2004.02.012; Ghoshal T, 2016, PSYCHOLOGY OF DESIGN: CREATING CONSUMER APPEAL, P91; Goyanes A, 2015, INT J PHARMACEUT, V494, P657, DOI 10.1016/j.ijpharm.2015.04.069; Hevner K, 1935, J APPL PSYCHOL, V19, P385, DOI 10.1037/h0055538; Horton WS, 2003, PSYCHON B REV, V10, P104, DOI 10.3758/BF03196473; HUSSAIN MZ, 1972, BRIT J PSYCHIAT, V120, P507, DOI 10.1192/bjp.120.558.507; Ilyuk Veronika., 2014, INNOVATION MARKETING, P315; ISHAI A, 1995, SCIENCE, V268, P1772, DOI 10.1126/science.7792605; Jamroz W, 2018, PHARM RES-DORDR, V35, DOI 10.1007/s11095-018-2454-x; Jiang YW, 2016, J CONSUM RES, V42, P709, DOI 10.1093/jcr/ucv049; Khan A, 2010, PSYCHOPHARMACOLOGY, V211, P113, DOI 10.1007/s00213-010-1874-z; Kocher S, 2019, J CONSUM BEHAV, V18, P179, DOI 10.1002/cb.1756; Kohler W, 1929, GESTALT PSYCHOL LIVE; Kotler P., 1984, J BUS STRAT, V5, P16, DOI [10.1108/eb039054, DOI 10.1108/EB039054]; Kotta S, 2018, CURR PHARM DESIGN, V24, P5039, DOI 10.2174/1381612825666181206123828; Leder H, 2011, PERCEPTION, V40, P649, DOI 10.1068/p6845; Lorenz V., 1986, B VOLCANOL, V48, P265, DOI [DOI 10.1007/BF01081755, 10.1007/BF01081755]; Luffarelli J, 2019, J MARKETING RES, V56, P89, DOI 10.1177/0022243718820548; Lundholm H, 1921, PSYCHOL REV, V28, P43, DOI 10.1037/h0072647; Mandler G, 1981, STRUCTURE VALUE ACCO; MEYERSLEVY J, 1989, J CONSUM RES, V16, P39, DOI 10.1086/209192; Munar E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141106; Notman N, 2018, INDOOR AIR, V28, P789, DOI 10.1111/ina.12498; Nummenmaa L, 2014, P NATL ACAD SCI USA, V111, P646, DOI 10.1073/pnas.1321664111; Palmer SE, 2013, ANNU REV PSYCHOL, V64, P77, DOI 10.1146/annurev-psych-120710-100504; Palumbo L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140043; Pearson J, 2015, TRENDS COGN SCI, V19, P590, DOI 10.1016/j.tics.2015.08.003; PILDITCH C, 1976, CHASQUI, V6, P77, DOI 10.2307/29739284; Poffenberger AT, 1924, J APPL PSYCHOL, V8, P187, DOI 10.1037/h0073513; Ramachandran VS, 2001, P ROY SOC B-BIOL SCI, V268, P979, DOI 10.1098/rspb.2000.1576; SCHAPIRA K, 1970, BMJ-BRIT MED J, V2, P446, DOI 10.1136/bmj.2.5707.446; Schlegel K, 2014, PSYCHOL ASSESSMENT, V26, P666, DOI 10.1037/a0035246; Shiv B, 2005, J MARKETING RES, V42, P383, DOI 10.1509/jmkr.2005.42.4.383; Silvia P.J., 2009, EMPIR STUD ARTS, V27, P25, DOI [DOI 10.2190/EM.27.1.B, 10.2190/em.27.1.b]; Silvia PJ, 2010, PSYCHOL AESTHET CREA, V4, P75, DOI 10.1037/a0017081; The Sedona Conference, 2010, SEDONA C J, V11, P267; Turner SA, 2006, EMOTION, V6, P670, DOI 10.1037/1528-3542.6.4.670; Veryzer RW, 1995, ADV CONSUM RES, V22, P641; Westerman SJ, 2012, PSYCHOL MARKET, V29, P595, DOI 10.1002/mar.20546; Zhang YL, 2006, PERS SOC PSYCHOL B, V32, P794, DOI 10.1177/0146167206286626; Zwaan RA, 2016, PSYCHON B REV, V23, P1028, DOI 10.3758/s13423-015-0864-x	58	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238378	10.1371/journal.pone.0238378	http://dx.doi.org/10.1371/journal.pone.0238378			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ6EE	32898184	gold, Green Published			2022-12-26	WOS:000570962500020
J	Nielsen, S; Hansen, JF; Hay, G; Cowan, S; Jepsen, P; Omland, LH; Krarup, HB; Soholm, J; Lazarus, JV; Weis, N; Ovrehus, A; Christensen, PB				Nielsen, Stine; Hansen, Janne Fuglsang; Hay, Gordon; Cowan, Susan; Jepsen, Peter; Omland, Lars Haukali; Krarup, Henrik Bygum; Soholm, Jacob; Lazarus, Jeffrey, V; Weis, Nina; Ovrehus, Anne; Christensen, Peer Brehm			Hepatitis C prevalence in Denmark in 2016-An updated estimate using multiple national registers	PLOS ONE			English	Article							PROBLEM DRUG-USE; GENERAL-POPULATION; PREGNANT-WOMEN	Background Chronic hepatitis C (CHC) can be eliminated as a public health threat by meeting the WHO targets: 90% of patients diagnosed and 80% treated by 2030. To achieve and monitor progress towards elimination, an updated estimate of the size of the CHC population is needed, but Denmark has no complete national CHC register. By combining existing registers in 2007, we estimated the population living with CHC to be 16,888 (0.38% of the adult population). Aim To estimate the population living with diagnosed and undiagnosed CHC in Denmark on 31 December 2016. Among additional aims were to estimate the proportion of patients attending specialised clinical care. Methods People with diagnosed CHC were identified from four national registers. The total diagnosed population was estimated by capture-recapture analysis. The undiagnosed population was estimated by comparing the register data with data from two cross-sectional surveys. Results The population living with diagnosed CHC in Denmark was 7,581 persons (95%CI: 7,416-12,661) of which 6,116 (81%) were identified in the four registers. The estimated undiagnosed fraction was 24%, so the total CHC infected population was 9,975 corresponding to 0.21% of the adult population (95%CI: 9,758-16,659; 0.21%-0.36%). Only 48% of diagnosed patients had received specialised clinical care. Conclusion CHC prevalence in Denmark is declining and 76% of patients have been diagnosed. Linking diagnosed patients to care and increasing efforts to test people with former or current drug use will be necessary to achieve CHC elimination.	[Nielsen, Stine; Hansen, Janne Fuglsang; Soholm, Jacob; Ovrehus, Anne; Christensen, Peer Brehm] Odense Univ Hosp, Dept Infect Dis, Odense, Denmark; [Hay, Gordon] Liverpool John Moores Univ, Ctr Publ Hlth, Liverpool, Merseyside, England; [Cowan, Susan] Statens Serum Inst, Dept Infect Dis Epidemiol & Prevent, Copenhagen, Denmark; [Jepsen, Peter] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Jepsen, Peter] Aarhus Univ Hosp, Dept Hepatol & Gastroenterol, Aarhus, Denmark; [Omland, Lars Haukali] Copenhagen Univ Hosp, Rigshosp, Dept Infect Dis, Copenhagen, Denmark; [Krarup, Henrik Bygum] Aalborg Univ Hosp, Dept Mol Diagnost, Aalborg, Denmark; [Krarup, Henrik Bygum] Aalborg Univ Hosp, Dept Med Gastroenterol, Aalborg, Denmark; [Lazarus, Jeffrey, V] Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain; [Weis, Nina] Copenhagen Univ Hosp, Dept Infect Dis, Hvidovre, Denmark; [Weis, Nina] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Ovrehus, Anne; Christensen, Peer Brehm] Univ Southern Denmark, Fac Hlth Sci, Dept Clin Res, Odense, Denmark	University of Southern Denmark; Odense University Hospital; Liverpool John Moores University; Statens Serum Institut; Aarhus University; Aarhus University; Rigshospitalet; University of Copenhagen; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; University of Copenhagen; University of Copenhagen; University of Southern Denmark	Christensen, PB (corresponding author), Odense Univ Hosp, Dept Infect Dis, Odense, Denmark.; Christensen, PB (corresponding author), Univ Southern Denmark, Fac Hlth Sci, Dept Clin Res, Odense, Denmark.	Peer.christensen@dadlnet.dk	Weis, Nina/GLT-4232-2022; Lazarus, Jeffrey V./R-6248-2018; Hay, Gordon/K-3310-2015	Lazarus, Jeffrey V./0000-0001-9618-2299; Hay, Gordon/0000-0002-8346-9618; Christensen, Peer Brehm/0000-0003-1394-058X; Omland, Lars Haukali/0000-0002-5338-8948; Nielsen, Stine/0000-0002-5931-5379; Jepsen, Peter/0000-0002-6641-1430; Krarup, Henrik/0000-0001-5294-2428; Ovrehus, Anne Lindebo Holm/0000-0002-2594-6500	MSD Denmark	MSD Denmark	The study was supported by an unrestricted grant from MSD Denmark URL: https://www.msd.dk/home.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, ANN EP REP 2018 SURV; Christensen MW, 2006, SCAND J GASTROENTERO, V41, P149, DOI 10.1080/00365520510024070; Christensen PB, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-178; Cooke GS, ACCELERATING ELIMINA, P2468; Danish Health Authority, 2019, 3 DAN HLTH AUTH; Francis B., 1993, GLIM SYSTEM RELEASE; Garvey P, 2017, EUROSURVEILLANCE, V22, P31, DOI 10.2807/1560-7917.ES.2017.22.30.30579; Gemmell I, 2004, J EPIDEMIOL COMMUN H, V58, P758, DOI 10.1136/2003.008755; Hansen Nanna, 2008, Ugeskr Laeger, V170, P1567; Harris RJ, 2019, J VIRAL HEPATITIS, V26, P541, DOI 10.1111/jvh.13063; Hofstraat SHI, 2017, EPIDEMIOL INFECT, V145, P2873, DOI [10.1017/S0950268817001947, 10.1017/s0950268817001947]; Hook EB, 1995, EPIDEMIOL REV, V17, P243, DOI 10.1093/oxfordjournals.epirev.a036192; Koopsen J, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S0950268819000359, 10.1017/s0950268819000359]; Kraus L, 2003, ADDICTION, V98, P471, DOI 10.1046/j.1360-0443.2003.00326.x; Litzroth A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-018-6347-z; Millbourn C, 2017, J HEPATOL, V66, pS404, DOI 10.1016/S0168-8278(17)31167-4; Nickelsen TN, 2002, DAN MED J, V164, P7; Obel N, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-25; Ovrehus A, 2019, ELIMINATION HEPATITI; Ovrehus A, 2019, ADDICTION, V114, P494, DOI 10.1111/add.14479; Razavi H, 2017, LANCET GASTROENTEROL, V2, P325, DOI 10.1016/S2468-1253(17)30045-6; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Smith S, 2019, JHEP REP, V1, P81, DOI 10.1016/j.jhepr.2019.04.002; Soholm J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220297; StatBank Denmark, 2019, STAT DENM; Stevens GA, 2016, LANCET, V388, pE19, DOI 10.1016/S0140-6736(16)30388-9; WHO/Europe, 2017, ACT PLAN HLTH SECT R; World Health Organization, 2016, GLOB HLTH SECT STRAT; YIP PSF, 1995, AM J EPIDEMIOL, V142, P1059, DOI 10.1093/oxfordjournals.aje.a117559	31	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238203	10.1371/journal.pone.0238203	http://dx.doi.org/10.1371/journal.pone.0238203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881877	Green Published, Green Accepted			2022-12-26	WOS:000571063300073
J	Sattler, FR; Mert, M; Sankaranarayanan, I; Mack, WJ; Galle-Treger, L; Gonzalez, E; Baronikian, L; Lee, K; Jahani, PS; Hodis, HN; Dieli-Conwright, C; Akbari, O				Sattler, Fred R.; Mert, Melissa; Sankaranarayanan, Ishwarya; Mack, Wendy J.; Galle-Treger, Lauriane; Gonzalez, Evelyn; Baronikian, Lilit; Lee, Kyuwan; Jahani, Pedram Shafiei; Hodis, Howard N.; Dieli-Conwright, Christina; Akbari, Omid			Feasibility of quantifying change in immune white cells in abdominal adipose tissue in response to an immune modulator in clinical obesity	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; DIPEPTIDYL PEPTIDASE-4 INHIBITOR; MACROPHAGE INFILTRATION; CARDIOVASCULAR RISK; METABOLIC SYNDROME; INFLAMMATION; SITAGLIPTIN; EXPRESSION; GLUCOSE; CD40	Background Obesity is often associated with inflammation in adipose tissue (AT) with release of mediators of atherogenesis. We postulated that it would be feasible to collect sufficient abdominal AT to quantify changes in a broad array of adaptive and innate mononuclear white cells in obese non-diabetic adults in response to a dipeptidyl protease inhibitor (DPP4i), known to inhibit activation of immune white cells. Methods Adults 18-55 years-of-age were screened for abdominal obesity and insulin resistance or impaired glucose tolerance but without known inflammatory conditions. Twenty-one eligible participants consented for study and were randomized 3:1 to receive sitagliptin (DPP4i) at 100mg or matching placebo daily for 28 days. Abdominal AT collected by percutaneous biopsy and peripheral blood mononuclear cell fractions were evaluated before and after treatment; plasma was stored for batch testing. Results Highly sensitive C-reactive protein, a global marker of inflammation, was not elevated in the study population. Innate lymphoid cells (ILC) type 3 (ILC-3) in abdominal AT decreased with active treatment compared with placebo (p = 0.04). Other immune white cells in AT and peripheral blood mononuclear cell (PBMC) fractions did not change with treatment compared to placebo (p>0.05); although ILC-2 declined in PBMCs (p = 0.007) in the sitagliptin treatment group. Two circulating biomarkers of atherogenesis, interferon-inducible protein-10 (IP-10) and sCD40L declined in plasma (p = 0.02 and p = 0.07, respectively) in the active treatment group, providing indirect validation of a net reduction in inflammation. Conclusions In this pilot study, two cell types of the innate lymphoid system, ILC-3 in AT and ILC-2 PBMCs declined during treatment and as did circulating biomarkers of atherogenesis. Changes in other immune cells were not demonstrable. The study showed that sufficient abdominal AT could be obtained to quantify white cells of both innate and adaptive immunity and to demonstrate changes during therapy with an immune inhibitor. Trial registration ClinicalTrials.gov identifier (NCT number): NCT02576	[Sattler, Fred R.; Gonzalez, Evelyn; Baronikian, Lilit; Hodis, Howard N.] Univ Southern Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90007 USA; [Mert, Melissa; Mack, Wendy J.] Univ Southern Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90007 USA; [Sankaranarayanan, Ishwarya; Galle-Treger, Lauriane; Jahani, Pedram Shafiei; Akbari, Omid] Univ Southern Calif, Dept Mol Microbiol & Immunol, Keck Sch Med, Los Angeles, CA 90007 USA; [Lee, Kyuwan; Dieli-Conwright, Christina] Univ Southern Calif, Ostrow Sch Dent, Div Phys Therapy & Biokinesiol, Los Angeles, CA 90007 USA; [Lee, Kyuwan] City Hope Natl Med Ctr, Dept Populat Sci, Beckman Res Inst, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Dieli-Conwright, Christina] Harvard Med Sch, Div Populat Sci, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; City of Hope; Beckman Research Institute of City of Hope; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Sattler, FR (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90007 USA.	fsattler@usc.edu			Whittier Foundation; Diabetes and Obesity Research Institute of the University of Southern California Keck School of Medicine	Whittier Foundation; Diabetes and Obesity Research Institute of the University of Southern California Keck School of Medicine	1. This study received partial grant support for pilot projects from the Whittier Foundation administered by the the Department of Molecular Microbiology and Immunology of the University of Southern California Keck School of Medicine. 2. This study received partial grant support for pilot projects from the the Diabetes and Obesity Research Institute of the University of Southern California Keck School of Medicine. Both awards were based on internal, institutional, competitive, and blinded peer review. There were no grant numbers for these awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation/review of the manuscript. Sitagliptin and matching placebo were provided gratis by Merck. No reports were required or expectations for manuscript review. There are no plans to send any manuscripts to Merck.	Alderete TL, 2015, INT J OBESITY, V39, P183, DOI 10.1038/ijo.2014.90; Allan DSJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03256-0; Altara R, 2016, J CARDIOVASC TRANSL, V9, P302, DOI 10.1007/s12265-016-9703-3; Altara R, 2016, CLIN SCI, V130, P463, DOI 10.1042/CS20150666; Altara R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141394; Apovian CM, 2008, ARTERIOSCL THROM VAS, V28, P1654, DOI 10.1161/ATVBAHA.108.170316; Asghar A, 2017, CELL IMMUNOL, V315, P18, DOI 10.1016/j.cellimm.2017.03.001; Best C, 2015, J CLIN ENDOCR METAB, V100, P2621, DOI 10.1210/jc.2015-1531; Biswas P, 2003, BLOOD, V101, P4452, DOI 10.1182/blood-2002-10-3056; Bock G, 2010, CLIN ENDOCRINOL, V73, P189, DOI 10.1111/j.1365-2265.2009.03764.x; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Cremona A, 2012, TRUSTS TRUSTEES, V18, P363, DOI 10.1093/tandt/tts033; Despres Jean-Pierre, 1993, Nutrition Research Reviews, V6, P137, DOI 10.1079/NRR19930010; Devaraj S, 2006, DIABETES, V55, P774, DOI 10.2337/diabetes.55.03.06.db05-1417; Farb MG, 2011, J AM COLL CARDIOL, V58, P232, DOI 10.1016/j.jacc.2011.01.051; Galle-Treger L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08449-x; Gokulakrishnan K, 2006, METABOLISM, V55, P237, DOI 10.1016/j.metabol.2005.08.019; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Gyllenhammer LE, 2016, OBESITY, V24, P1274, DOI 10.1002/oby.21507; Hagman DK, 2012, J IMMUNOL METHODS, V386, P50, DOI 10.1016/j.jim.2012.08.018; Hasnain SZ, 2014, NAT MED, V20, P1417, DOI 10.1038/nm.3705; Herman GA, 2006, J CLIN ENDOCR METAB, V91, P4612, DOI 10.1210/jc.2006-1009; Horton DB, 2001, ANN NY ACAD SCI, V947, P329; Hunter G R, 1994, Obes Res, V2, P563; Kawamura A, 2003, CIRC J, V67, P851, DOI 10.1253/circj.67.851; KAZAZI F, 1989, J GEN VIROL, V70, P2661, DOI 10.1099/0022-1317-70-10-2661; Le KA, 2011, DIABETES, V60, P2802, DOI 10.2337/db10-1263; Lemieux S, 1996, AM J CLIN NUTR, V64, P685, DOI 10.1093/ajcn/64.5.685; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lombardi V, 2016, J ALLERGY CLIN IMMUN, V138, P305, DOI 10.1016/j.jaci.2015.12.1325; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; Maazi H, 2015, IMMUNITY, V42, P538, DOI 10.1016/j.immuni.2015.02.007; Mach F, 1998, NATURE, V394, P200, DOI 10.1038/28204; Mach F, 1998, ATHEROSCLEROSIS, V137, pS89, DOI 10.1016/S0021-9150(97)00309-2; Makdissi A, 2012, J CLIN ENDOCR METAB, V97, P3333, DOI 10.1210/jc.2012-1544; Matsubara J, 2012, J AM COLL CARDIOL, V59, P265, DOI 10.1016/j.jacc.2011.07.053; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Neville Lewis F., 1997, Cytokine and Growth Factor Reviews, V8, P207, DOI 10.1016/S1359-6101(97)00015-4; O'Rourke RW, 2012, METABOLISM, V61, P1152, DOI 10.1016/j.metabol.2012.01.018; O'Sullivan TE, 2016, IMMUNITY, V45, P428, DOI 10.1016/j.immuni.2016.06.016; Poggi M, 2011, ARTERIOSCL THROM VAS, V31, P2251, DOI 10.1161/ATVBAHA.111.231357; Rothenbacher D, 2006, ARTERIOSCL THROM VAS, V26, P194, DOI 10.1161/01.ATV.0000191633.52585.14; Satoh-Asahara N, 2013, METABOLISM, V62, P347, DOI 10.1016/j.metabol.2012.09.004; Schonbeck U, 2001, CIRCULATION, V104, P2266, DOI 10.1161/hc4401.099447; Schonbeck U, 2001, CIRC RES, V89, P1092, DOI 10.1161/hh2401.101272; Schulz KF, 2005, LANCET, V365, P1348, DOI 10.1016/S0140-6736(05)61034-3; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Upadhyay V, 2012, NAT IMMUNOL, V13, P947, DOI 10.1038/ni.2403; van den Borne P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/893106; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Wang XT, 2014, NATURE, V514, P237, DOI 10.1038/nature13564	56	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0237496	10.1371/journal.pone.0237496	http://dx.doi.org/10.1371/journal.pone.0237496			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881912	gold, Green Published			2022-12-26	WOS:000571063300047
J	Wenz, L; Levermann, A; Willner, SN; Otto, C; Kuhla, K				Wenz, Leonie; Levermann, Anders; Willner, Sven Norman; Otto, Christian; Kuhla, Kilian			Post-Brexit no-trade-deal scenario: Short-term consumer benefit at the expense of long-term economic development	PLOS ONE			English	Article							MODEL; ORIGINS; CHAINS; IMPACT; COSTS	After the United Kingdom has left the European Union it remains unclear whether the two parties can successfully negotiate and sign a trade agreement within the transition period. Ongoing negotiations, practical obstacles and resulting uncertainties make it highly unlikely that economic actors would be fully prepared to a "no-trade-deal" situation. Here we provide an economic shock simulation of the immediate aftermath of such a post-Brexit no-trade-deal scenario by computing the time evolution of more than 1.8 million interactions between more than 6,600 economic actors in the global trade network. We find an abrupt decline in the number of goods produced in the UK and the EU. This sudden output reduction is caused by drops in demand as customers on the respective other side of the Channel incorporate the new trade restriction into their decision-making. As a response, producers reduce prices in order to stimulate demand elsewhere. In the short term consumers benefit from lower prices but production value decreases with potentially severe socio-economic consequences in the longer term.	[Wenz, Leonie; Levermann, Anders; Willner, Sven Norman; Otto, Christian; Kuhla, Kilian] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Wenz, Leonie] Mercator Res Inst Global Commons & Climate Change, Berlin, Germany; [Wenz, Leonie] Univ Calif Berkeley, Dept Agr & Resource Econ, Berkeley, CA 94720 USA; [Levermann, Anders] Columbia Univ, New York, NY USA; [Levermann, Anders; Kuhla, Kilian] Univ Potsdam, Inst Phys, Potsdam, Germany	Potsdam Institut fur Klimafolgenforschung; University of California System; University of California Berkeley; Columbia University; University of Potsdam	Wenz, L (corresponding author), Potsdam Inst Climate Impact Res, Potsdam, Germany.; Wenz, L (corresponding author), Mercator Res Inst Global Commons & Climate Change, Berlin, Germany.; Wenz, L (corresponding author), Univ Calif Berkeley, Dept Agr & Resource Econ, Berkeley, CA 94720 USA.	leonie.wenz@pik-potsdam.de	Levermann, Anders/G-4666-2011	Levermann, Anders/0000-0003-4432-4704; Willner, Sven/0000-0001-6798-6247; Wenz, Leonie/0000-0002-8500-1568	Ciriacy-Wantrup Fellowship programme at UC Berkeley LW:Volkswagen foundation (Europe and global challenges); German Federal Ministry of Education and Research [01LA1817C, 01LA1829A]; German Academic Scholarship Foundation	Ciriacy-Wantrup Fellowship programme at UC Berkeley LW:Volkswagen foundation (Europe and global challenges); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Academic Scholarship Foundation	LW: S.V. Ciriacy-Wantrup Fellowship programme at UC Berkeley LW:Volkswagen foundation (Europe and global challenges) SW & CO: German Federal Ministry of Education and Research (Grants 01LA1817C and 01LA1829A) KK: German Academic Scholarship Foundation The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acemoglu D, 2012, ECONOMETRICA, V80, P1977, DOI 10.3982/ECTA9623; Alex Hunt, 2019, BBC; [Anonymous], 2009, EC RESILIENCE DISAST; Bardoscia M, 2017, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/aa6688; Brakman S, 2018, CONSEQUENCES BREXIT, P55; Carvalho Vasco M., 2014, SUPPLY CHAIN DISRUPT; Chandrakumar C, 2020, INT J LIFE CYCLE ASS, V25, P1323, DOI 10.1007/s11367-019-01673-z; Chen W, 2018, PAP REG SCI, V97, P25, DOI 10.1111/pirs.12334; den Baumen HSI, 2014, NAT HAZARD EARTH SYS, V14, P2749, DOI 10.5194/nhess-14-2749-2014; Dhingra S, 2017, NATL INST ECON REV, V242, pR24, DOI 10.1177/002795011724200112; Gabaix X, 2011, ECONOMETRICA, V79, P733, DOI 10.3982/ECTA8769; Giammetti R, 2020, WORLD ECON, V43, P840, DOI 10.1111/twec.12920; Gualdi S, 2016, J ECON DYN CONTROL, V73, P61, DOI 10.1016/j.jedc.2016.09.012; Hallegatte S, 2008, RISK ANAL, V28, P779, DOI 10.1111/j.1539-6924.2008.01046.x; Hallegatte S, 2014, RISK ANAL, V34, P152, DOI 10.1111/risa.12090; Han MY, 2018, J GEOGR SCI, V28, P1263, DOI 10.1007/s11442-018-1524-7; IJtsma P, 2018, FISC STUD, V39, P651, DOI 10.1111/1475-5890.12176; Inoue H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213648; Kajitani Y, 2018, ECON SYST RES, V30, P289, DOI 10.1080/09535314.2017.1369010; Koks EE, 2016, ECON SYST RES, V28, P429, DOI 10.1080/09535314.2016.1232701; Lenzen M, 2012, NATURE, V486, P109, DOI 10.1038/nature11145; Lenzen M, 2018, NAT CLIM CHANGE, V8, P522, DOI 10.1038/s41558-018-0141-x; Lenzen M, 2013, ECON SYST RES, V25, P20, DOI 10.1080/09535314.2013.769938; Lenzen M, 2012, ENVIRON SCI TECHNOL, V46, P8374, DOI 10.1021/es300171x; Levermann A, 2014, NATURE, V506, P27, DOI 10.1038/506027a; Los B, 2017, MISMATCH LOCAL VOTIN, V3404; Maluck J, 2018, FRONT PHYS-LAUSANNE, V6, DOI 10.3389/fphy.2018.00134; Maluck J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133310; Oita A, 2016, NAT GEOSCI, V9, P111, DOI 10.1038/NGEO2635; Otto C, 2017, J ECON DYN CONTROL, V83, P232, DOI 10.1016/j.jedc.2017.08.001; Sampson T, 2017, J ECON PERSPECT, V31, P163, DOI 10.1257/jep.31.4.163; Steenge A. E., 2007, ECON SYST RES, V19, P205, DOI [10.1080/09535310701330308, DOI 10.1080/09535310701330308]; Ward PJ, 2017, NAT CLIM CHANGE, V7, P642, DOI [10.1038/nclimate3350, 10.1038/NCLIMATE3350]; Wenz L, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501026; Wenz L, 2015, ECON SYST RES, V27, P194, DOI 10.1080/09535314.2014.987731; Wenz Leonie, 2014, Environment Systems & Decisions, V34, P525, DOI 10.1007/s10669-014-9521-6; Wiedmann T, 2011, ECOL ECON, V70, P1937, DOI 10.1016/j.ecolecon.2011.06.014; Willner SN, 2018, NAT CLIM CHANGE, V8, P594, DOI 10.1038/s41558-018-0173-2	38	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0237500	10.1371/journal.pone.0237500	http://dx.doi.org/10.1371/journal.pone.0237500			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ7QD	32881890	Green Published, gold			2022-12-26	WOS:000571063300060
J	Kim, JY; Bai, YT; Jayne, LA; Abdulkader, F; Gandhi, M; Perreau, T; Parikh, SV; Gardner, DS; Davidson, AJ; Sander, V; Song, MA; Bajwa, A; Pabla, NS				Kim, Ji Young; Bai, Yuntao; Jayne, Laura A.; Abdulkader, Ferdos; Gandhi, Megha; Perreau, Tayla; Parikh, Samir V.; Gardner, David S.; Davidson, Alan J.; Sander, Veronika; Song, Min-Ae; Bajwa, Amandeep; Pabla, Navjot Singh			SOX9 promotes stress-responsive transcription of VGF nerve growth factor inducible gene in renal tubular epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acute kidney injury (AKI); renal tubular epithelial cells (RTECs); VGF nerve growth factor inducible; Sox9 (sex-determining region Y (SRY); box 9); RNA sequencing (RNA-seq); ischemia; cisplatin; and rhabdomyolysis; kidney; cell death; cell signaling; transcriptomics; transcription factor; acute kidney injury	ACUTE KIDNEY INJURY; PEPTIDE TLQP-21; RECEPTOR C3AR1; PATHOPHYSIOLOGY; DEATH; IDENTIFICATION; NEPHROTOXICITY; ENHANCEMENT; CONTRIBUTES; ACTIVATION	Acute kidney injury (AKI) is a common clinical condition associated with diverse etiologies and abrupt loss of renal function. In patients with sepsis, rhabdomyolysis, cancer, and cardiovascular disorders, the underlying disease or associated therapeutic interventions can cause hypoxia, cytotoxicity, and inflammatory insults to renal tubular epithelial cells (RTECs), resulting in the onset of AKI. To uncover stress-responsive disease-modifying genes, here we have carried out renal transcriptome profiling in three distinct murine models of AKI. We find that Vgf nerve growth factor inducible gene up-regulation is a common transcriptional stress response in RTECs to ischemia-, cisplatin-, and rhabdomyolysis-associated renal injury. The Vgf gene encodes a secretory peptide precursor protein that has critical neuroendocrine functions; however, its role in the kidneys remains unknown. Our functional studies show that RTEC-specific Vgf gene ablation exacerbates ischemia-, cisplatin-, and rhabdomyolysis-associated AKI in vivo and cisplatin-induced RTEC cell death in vitro. Importantly, aggravation of cisplatin-induced renal injury caused by Vgf gene ablation is partly reversed by TLQP-21, a Vgf-derived peptide. Finally, in vitro and in vivo mechanistic studies showed that injury-induced Vgf up-regulation in RTECs is driven by the transcriptional regulator Sox9. These findings reveal a crucial downstream target of the Sox9-directed transcriptional program and identify Vgf as a stress-responsive protective gene in kidney tubular epithelial cells.	[Kim, Ji Young; Bai, Yuntao; Jayne, Laura A.; Abdulkader, Ferdos; Gandhi, Megha; Pabla, Navjot Singh] Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmacol, 500 W 12Th Ave, Columbus, OH 43210 USA; [Kim, Ji Young; Bai, Yuntao; Jayne, Laura A.; Abdulkader, Ferdos; Gandhi, Megha; Song, Min-Ae; Pabla, Navjot Singh] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA; [Perreau, Tayla; Davidson, Alan J.; Sander, Veronika] Univ Auckland, Dept Mol Med & Pathol, Auckland, New Zealand; [Parikh, Samir V.] Ohio State Univ, Wexner Med Ctr, Columbus, OH USA; [Gardner, David S.] Univ Nottingham, Sch Vet Med & Sci, Loughborough, Leics, England; [Song, Min-Ae] Ohio State Univ, Coll Publ Hlth, Div Environm Hlth Sci, Columbus, OH USA; [Bajwa, Amandeep] Univ Tennessee, James D Eason Transplant Inst, Transplant Res Inst, Dept Surg,Coll Med,Hlth Sci Ctr, Memphis, TN USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Auckland; University System of Ohio; Ohio State University; University of Nottingham; University System of Ohio; Ohio State University; University of Tennessee System; University of Tennessee Health Science Center	Kim, JY; Pabla, NS (corresponding author), Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmacol, 500 W 12Th Ave, Columbus, OH 43210 USA.; Kim, JY; Pabla, NS (corresponding author), Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA.	kim.6494@osu.edu; pabla.2@osu.edu	Song, Min-Ae/AAF-9672-2021; Sander, Veronika/R-5190-2019; Gardner, David S/A-7484-2010	Sander, Veronika/0000-0002-2918-833X; Gardner, David S/0000-0002-6490-2412; Bajwa, Amandeep/0000-0003-0517-8871; Kim, Ji Young/0000-0002-3736-9050; Pabla, Navjot/0000-0001-9408-0539	Ohio State University Comprehensive Cancer Center, National Institutes of Health (NIH) [R01DK117183]; American Heart Association Scientist Development Grant [17SDG33440070]; American Heart Association [18POST33990282]; Health Research Council of New Zealand [17/425]; National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK069403]; United States Army Medical Research and Development Command [W81XWH-17-1-0610]	Ohio State University Comprehensive Cancer Center, National Institutes of Health (NIH); American Heart Association Scientist Development Grant(American Heart Association); American Heart Association(American Heart Association); Health Research Council of New Zealand(Health Research Council of New Zealand); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); United States Army Medical Research and Development Command(United States Department of DefenseUnited States ArmyUnited States Army Medical Research & Development Command (USAMRDC))	This study was supported by funds from the Ohio State University Comprehensive Cancer Center, National Institutes of Health (NIH) Grant R01DK117183 (to A. B.), American Heart Association Scientist Development Grant 17SDG33440070 (to N. S. P.), and American Heart Association postdoctoral fellowship 18POST33990282 (to Y. B.). Studies in the Davidson laboratory were supported by the Health Research Council of New Zealand (17/425), the National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK069403), and the United States Army Medical Research and Development Command (W81XWH-17-1-0610). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alder J, 2003, J NEUROSCI, V23, P10800; Arany I, 2004, AM J PHYSIOL-RENAL, V287, pF543, DOI 10.1152/ajprenal.00112.2004; Bajwa A, 2010, J AM SOC NEPHROL, V21, P955, DOI 10.1681/ASN.2009060662; Bajwa A, 2009, CURR DRUG TARGETS, V10, P1196, DOI 10.2174/138945009789753174; Bartolomucci A, 2007, GENES NUTR, V2, P169, DOI 10.1007/s12263-007-0047-0; Basile David P., 2014, Cardiovascular & Hematological Disorders - Drug Targets, V14, P3; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Bosch X, 2009, NEW ENGL J MED, V361, P62, DOI 10.1056/NEJMra0801327; Bullen A, 2017, NEPHRON, V137, P260, DOI 10.1159/000477830; Cero C, 2017, MOL METAB, V6, P148, DOI 10.1016/j.molmet.2016.10.005; Cero C, 2014, STRUCTURE, V22, P1744, DOI 10.1016/j.str.2014.10.001; Chang-Panesso M, 2019, J CLIN INVEST, V129, P5501, DOI 10.1172/JCI125519; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Chen YC, 2013, J BIOL CHEM, V288, P34638, DOI 10.1074/jbc.M113.510917; Cummings BS, 2002, J PHARMACOL EXP THER, V302, P8, DOI 10.1124/jpet.302.1.8; Digby JLM, 2020, AM J PHYSIOL-RENAL, V318, pF971, DOI 10.1152/ajprenal.00597.2019; El Gaamouch F, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-0357-x; Fairbanks CA, 2014, PAIN, V155, P1229, DOI 10.1016/j.pain.2014.03.012; Forbes TA, 2018, AM J HUM GENET, V102, P816, DOI 10.1016/j.ajhg.2018.03.014; Gardner DS, 2016, AM J PHYSIOL-RENAL, V310, pF259, DOI 10.1152/ajprenal.00389.2015; Guo ZK, 2018, NEUROPEPTIDES, V71, P97, DOI 10.1016/j.npep.2018.06.003; Hahm S, 1999, NEURON, V23, P537, DOI 10.1016/S0896-6273(00)80806-5; Hannedouche S, 2013, J BIOL CHEM, V288, P27434, DOI 10.1074/jbc.M113.497214; Hohmeier HE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0224344; Hunsberger JG, 2007, NAT MED, V13, P1476, DOI 10.1038/nm1669; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Inoue T, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00945; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jang HR, 2009, CLIN IMMUNOL, V130, P41, DOI 10.1016/j.clim.2008.08.016; Jankowski J, 2018, J AM SOC NEPHROL, V29, P1887, DOI 10.1681/ASN.2017121306; Kang HM, 2016, CELL REP, V14, P861, DOI 10.1016/j.celrep.2015.12.071; Kang HM, 2015, NAT MED, V21, P37, DOI 10.1038/nm.3762; Kaushal GP, 2016, KIDNEY INT, V89, P779, DOI 10.1016/j.kint.2015.11.021; Kim JY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15638-6; Kim JY, 2020, BIOCHEM PHARMACOL, V177, DOI 10.1016/j.bcp.2020.113939; Kishi S, 2019, J CLIN INVEST, V129, P4797, DOI 10.1172/JCI122313; Kumar S, 2018, KIDNEY INT, V93, P27, DOI 10.1016/j.kint.2017.07.030; Kumar S, 2015, CELL REP, V12, P1325, DOI 10.1016/j.celrep.2015.07.034; Lewis JE, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00003; Linkermann A, 2014, J AM SOC NEPHROL, V25, P2689, DOI 10.1681/ASN.2014030262; Liu J, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94716; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Pabla N, 2015, P NATL ACAD SCI USA, V112, P5231, DOI 10.1073/pnas.1424313112; Pabla N, 2011, J CLIN INVEST, V121, P2709, DOI 10.1172/JCI45586; Pabla N, 2009, AM J PHYSIOL-RENAL, V296, pF505, DOI 10.1152/ajprenal.90545.2008; Paragas N, 2011, NAT MED, V17, P216, DOI 10.1038/nm.2290; Peerapornratana S, 2019, KIDNEY INT, V96, P1083, DOI 10.1016/j.kint.2019.05.026; Peng Q, 2012, J AM SOC NEPHROL, V23, P1474, DOI 10.1681/ASN.2011111072; Przepiorski A, 2018, STEM CELL REP, V11, P470, DOI 10.1016/j.stemcr.2018.06.018; Rabb H, 2016, J AM SOC NEPHROL, V27, P371, DOI 10.1681/ASN.2015030261; Ralto KM, 2020, NAT REV NEPHROL, V16, P99, DOI 10.1038/s41581-019-0216-6; Ramesh G, 2002, J CLIN INVEST, V110, P835, DOI 10.1172/JCI200215606; Rosner MH, 2017, NEW ENGL J MED, V376, P1770, DOI 10.1056/NEJMra1613984; Sahu BS, 2019, CELL REP, V28, P2567, DOI 10.1016/j.celrep.2019.07.101; Salton SRJ, 2000, FRONT NEUROENDOCRIN, V21, P199, DOI 10.1006/frne.2000.0199; Severini C, 2008, J NEUROCHEM, V104, P534, DOI 10.1111/j.1471-4159.2007.05068.x; Sharfuddin AA, 2011, NAT REV NEPHROL, V7, P189, DOI 10.1038/nrneph.2011.16; Shimazawa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015307; Soliman N, 2019, PAIN REP, V4, DOI 10.1097/PR9.0000000000000786; Sprowl JA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10880; Stephens SB, 2017, CELL REP, V20, P2480, DOI 10.1016/j.celrep.2017.08.050; Stephens SB, 2012, CELL METAB, V16, P33, DOI 10.1016/j.cmet.2012.05.011; Takeuchi H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34585-3; Thakker-Varia S, 2009, BEHAV BRAIN RES, V197, P262, DOI 10.1016/j.bbr.2008.10.006; van Oosterwijk JG, 2018, J CLIN INVEST, V128, P369, DOI 10.1172/JCI91893; Wang Y, 2017, NAT REV NEPHROL, V13, P697, DOI 10.1038/nrneph.2017.119; Zuk A, 2016, ANNU REV MED, V67, P293, DOI 10.1146/annurev-med-050214-013407	68	5	5	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2020	295	48					16328	16341		10.1074/jbc.RA120.015110	http://dx.doi.org/10.1074/jbc.RA120.015110			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PE7CE	32887795	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000598519500013
J	San Emeterio, J; Pollack, L				San Emeterio, Josue; Pollack, Lois			Visualizing a viral genome with contrast variation small angle X-ray scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						plus-stranded RNA virus; RNA virus; RNA folding; RNA structure; bacteriophage MS2; virus assembly; virus structure; X-ray scattering; small-angle X-ray scattering (SAXS); contrast variation SAXS	SINGLE-STRANDED RNA; MS2 BACTERIOPHAGE; PROTEIN; SPECIFICITY; FOLLOWS	Despite the threat to human health posed by some single-stranded RNA viruses, little is understood about their assembly. The goal of this work is to introduce a new tool for watching an RNA genome direct its own packaging and encapsidation by proteins. Contrast variation small-angle X-ray scattering (CV-SAXS) is a powerful tool with the potential to monitor the changing structure of a viral RNA through this assembly process. The proteins, though present, do not contribute to the measured signal. As a first step in assessing the feasibility of viral genome studies, the structure of encapsidated MS2 RNA was exclusively detected with CV-SAXS and compared with a structure derived from asymmetric cryo-EM reconstructions. Additional comparisons with free RNA highlight the significant structural rearrangements induced by capsid proteins and invite the application of time-resolved CV-SAXS to reveal interactions that result in efficient viral assembly.	[San Emeterio, Josue; Pollack, Lois] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA	Cornell University	Pollack, L (corresponding author), Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.	lp26@cornell.edu			National Science Foundation [DBI-1930046]; National Institutes of Health [T32GM008267]; Colman Fellowship program; NIGMS, National Institutes of Health [9 P41 GM103622]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colman Fellowship program; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation Award DBI-1930046 (to L. P.), the National Institutes of Health Grant T32GM008267 (to J. S. E.), and the Colman Fellowship program. This project was supported by NIGMS, National Institutes of Health, Grant 9 P41 GM103622. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aksyuk AA, 2011, VIRUSES-BASEL, V3, P172, DOI 10.3390/v3030172; Asor R, 2019, ACS NANO, V13, P7610, DOI 10.1021/acsnano.9b00648; Basnak G, 2010, J MOL BIOL, V395, P924, DOI 10.1016/j.jmb.2009.11.018; Bleckley S, 2012, RNA, V18, P1309, DOI 10.1261/rna.032326.112; Buck J, 2007, P NATL ACAD SCI USA, V104, P15699, DOI 10.1073/pnas.0703182104; Bunka DHJ, 2011, J MOL BIOL, V413, P51, DOI 10.1016/j.jmb.2011.07.063; Chen H, 2012, P NATL ACAD SCI USA, V109, P799, DOI 10.1073/pnas.1119057109; Chen YJ, 2017, P NATL ACAD SCI USA, V114, P334, DOI 10.1073/pnas.1611118114; Chevreui M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05426-8; Dai XH, 2017, NATURE, V541, P112, DOI 10.1038/nature20589; Das R, 2003, J MOL BIOL, V332, P311, DOI 10.1016/S0022-2836(03)00854-4; Dent KC, 2013, STRUCTURE, V21, P1225, DOI 10.1016/j.str.2013.05.012; Dika C, 2011, APPL ENVIRON MICROB, V77, P4939, DOI 10.1128/AEM.00407-11; Dragnea B, 2019, P NATL ACAD SCI USA, V116, P22420, DOI 10.1073/pnas.1915986116; Drozdetski AV, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.028101; Duda RL, 2009, J MOL BIOL, V391, P471, DOI 10.1016/j.jmb.2009.06.035; Dykeman EC, 2013, J MOL BIOL, V425, P3235, DOI 10.1016/j.jmb.2013.06.005; Felletti M, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1395; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Ganser LR, 2019, NAT REV MOL CELL BIO, V20, P474, DOI 10.1038/s41580-019-0136-0; Garmann RF, 2019, P NATL ACAD SCI USA, V116, P22485, DOI 10.1073/pnas.1909223116; Gopal A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105875; Grahn E, 2001, RNA, V7, P1616; Ha T, 1999, P NATL ACAD SCI USA, V96, P9077, DOI 10.1073/pnas.96.16.9077; Hopkins JB, 2017, J APPL CRYSTALLOGR, V50, P1545, DOI 10.1107/S1600576717011438; Kler S, 2013, ACS CHEM BIOL, V8, P2753, DOI 10.1021/cb4005518; Kler S, 2012, J AM CHEM SOC, V134, P8823, DOI 10.1021/ja2110703; Koning R, 2003, J MOL BIOL, V332, P415, DOI 10.1016/S0022-2836(03)00846-5; Koning RI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12524; Kuzmanovic DA, 2006, J MOL BIOL, V355, P1095, DOI 10.1016/j.jmb.2005.11.040; Kuzmanovic DA, 2003, STRUCTURE, V11, P1339, DOI 10.1016/j.str.2003.09.021; Lee MK, 2010, P NATL ACAD SCI USA, V107, P9192, DOI 10.1073/pnas.1001195107; Mylon SE, 2010, LANGMUIR, V26, P1035, DOI 10.1021/la902290t; Nguyen TH, 2011, SOFT MATTER, V7, P10449, DOI 10.1039/c1sm06092a; Patel N, 2017, P NATL ACAD SCI USA, V114, P12255, DOI 10.1073/pnas.1706951114; Patel N, 2015, P NATL ACAD SCI USA, V112, P2227, DOI 10.1073/pnas.1420812112; PEABODY DS, 1993, EMBO J, V12, P595, DOI 10.1002/j.1460-2075.1993.tb05691.x; Perkett MR, 2016, J CHEM PHYS, V145, DOI 10.1063/1.4955187; Perlmutter JD, 2015, ANNU REV PHYS CHEM, V66, P217, DOI 10.1146/annurev-physchem-040214-121637; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plumridge A, 2018, NUCLEIC ACIDS RES, V46, P7354, DOI 10.1093/nar/gky363; Rieder R, 2007, CHEMBIOCHEM, V8, P896, DOI 10.1002/cbic.200700057; Rodgers ML, 2016, RNA, V22, P225, DOI 10.1261/rna.052233.115; Rolfsson O, 2008, COMPUT MATH METHOD M, V9, P339, DOI 10.1080/17486700802168445; Rolfsson O, 2016, J MOL BIOL, V428, P431, DOI 10.1016/j.jmb.2015.11.014; Rolfsson O, 2010, J MOL BIOL, V401, P309, DOI 10.1016/j.jmb.2010.05.058; Russell R, 2002, P NATL ACAD SCI USA, V99, P4266, DOI 10.1073/pnas.072589599; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Shakeel S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-016-0011-z; Stockley P.G., 2016, BACTERIOPHAGE, V6, pe1157666, DOI [10.1080/21597081.2016.1157666, DOI 10.1080/21597081.2016.1157666]; Stockley PG, 2007, J MOL BIOL, V369, P541, DOI 10.1016/j.jmb.2007.03.020; SUGIYAMA T, 1967, J MOL BIOL, V25, P455, DOI 10.1016/0022-2836(67)90198-2; Sun YY, 2017, P NATL ACAD SCI USA, V114, P13708, DOI 10.1073/pnas.1716614114; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tokuda Joshua M, 2016, Biophys Rev, V8, P139, DOI 10.1007/s12551-016-0196-8; Toropova K, 2008, J MOL BIOL, V375, P824, DOI 10.1016/j.jmb.2007.08.067; Tuukkanen AT, 2016, IUCRJ, V3, P440, DOI 10.1107/S2052252516016018; Twarock R, 2019, ANNU REV BIOPHYS, V48, P495, DOI 10.1146/annurev-biophys-052118-115611; van den Worm SHE, 2006, J MOL BIOL, V363, P858, DOI 10.1016/j.jmb.2006.08.053; Welty R, 2020, J MOL BIOL, V432, P991, DOI 10.1016/j.jmb.2019.12.010; ZIPPER P, 1975, FEBS LETT, V56, P283, DOI 10.1016/0014-5793(75)81110-0; ZIPPER P, 1971, EUR J BIOCHEM, V18, P1, DOI 10.1111/j.1432-1033.1971.tb01206.x	64	3	3	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2020	295	47					15923	15932		10.1074/jbc.RA120.013961	http://dx.doi.org/10.1074/jbc.RA120.013961			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PA5ED	32913117	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000595657900012
J	Rodriguez, AA; Wojtaszek, JL; Greer, BH; Haldar, T; Gates, KS; Williams, RS; Eichman, BF				Rodriguez, Alyssa A.; Wojtaszek, Jessica L.; Greer, Briana H.; Haldar, Tuhin; Gates, Kent S.; Williams, R. Scott; Eichman, Brandt F.			An autoinhibitory role for the GRF zinc finger domain of DNA glycosylase NEIL3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						base excision repair (BER); DNA glycosylase; interstrand DNA cross-link; GRF; zinc finger; DNA repair; DNA-binding protein; DNA damage; crystallography; nucleic acid enzymology; DNA&#8211; protein interaction; X-ray crystallography	INTERSTRAND CROSS-LINKS; ESCHERICHIA-COLI DNA; SINGLE-STRANDED-DNA; VIII-LIKE PROTEINS; ABASIC SITES; STRUCTURAL-CHARACTERIZATION; ADENINE RESIDUES; GENETIC-VARIANTS; TOPOISOMERASE-I; QUADRUPLEX DNA	The NEIL3 DNA glycosylase maintains genome integrity during replication by excising oxidized bases from single-stranded DNA (ssDNA) and unhooking interstrand cross-links (ICLs) at fork structures. In addition to its N-terminal catalytic glycosylase domain, NEIL3 contains two tandem C-terminal GRF-type zinc fingers that are absent in the other NEIL paralogs. ssDNA binding by the GRF-ZF motifs helps recruit NEIL3 to replication forks converged at an ICL, but the nature of DNA binding and the effect of the GRF-ZF domain on catalysis of base excision and ICL unhooking is unknown. Here, we show that the tandem GRF-ZFs of NEIL3 provide affinity and specificity for DNA that is greater than each individual motif alone. The crystal structure of the GRF domain shows that the tandem ZF motifs adopt a flexible head-to-tail configuration well-suited for binding to multiple ssDNA conformations. Functionally, we establish that the NEIL3 GRF domain inhibits glycosylase activity against monoadducts and ICLs. This autoinhibitory activity contrasts GRF-ZF domains of other DNA-processing enzymes, which typically use ssDNA binding to enhance catalytic activity, and suggests that the C-terminal region of NEIL3 is involved in both DNA damage recruitment and enzymatic regulation.	[Rodriguez, Alyssa A.; Greer, Briana H.; Eichman, Brandt F.] Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Rodriguez, Alyssa A.; Greer, Briana H.; Eichman, Brandt F.] Vanderbilt Univ, Ctr Struct Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Wojtaszek, Jessica L.; Williams, R. Scott] NIEHS, Genome Integr & Struct Biol Lab, NIH, US Dept HHS, POB 12233, Res Triangle Pk, NC 27709 USA; [Haldar, Tuhin; Gates, Kent S.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA	Vanderbilt University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Missouri System; University of Missouri Columbia	Eichman, BF (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.; Eichman, BF (corresponding author), Vanderbilt Univ, Ctr Struct Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.; Williams, RS (corresponding author), NIEHS, Genome Integr & Struct Biol Lab, NIH, US Dept HHS, POB 12233, Res Triangle Pk, NC 27709 USA.	williamsrs@niehs.nih.gov; brandt.eichman@vanderbilt.edu	Haldar, Tuhin/GLU-3939-2022; Classen, Scott/AAY-8176-2020	Eichman, Brandt/0000-0002-0965-2297; Rodriguez, Alyssa/0000-0001-8689-572X; Haldar, Tuhin/0000-0002-1824-2783; Wojtaszek, Jessica/0000-0002-9108-2886	National Institutes of Health [R01GM131071, P01CA092584]; NIEHS, National Institute of Health Intramural Program [1Z01ES102765]; Vanderbilt Molecular Biophysics Training Program [T32GM08320]; National Science Foundation Graduate Research Fellowship [DGE-1445197]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS, National Institute of Health Intramural Program; Vanderbilt Molecular Biophysics Training Program; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	This work was supported by National Institutes of Health Grants R01GM131071 and P01CA092584 (to B. F. E.) and NIEHS, National Institute of Health Intramural Program Grant 1Z01ES102765 (to R. S. W.). A. A. R. was supported by Vanderbilt Molecular Biophysics Training Program Grant T32GM08320 and National Science Foundation Graduate Research Fellowship DGE-1445197. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Science Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albelazi MS, 2019, GENES-BASEL, V10, DOI 10.3390/genes10040315; Alvarez-Quilon A, 2020, MOL CELL, V78, P1152, DOI 10.1016/j.molcel.2020.05.021; Bradley NP, 2020, NUCLEIC ACIDS RES, V48, P7005, DOI 10.1093/nar/gkaa346; Catalano MJ, 2015, J AM CHEM SOC, V137, P3933, DOI 10.1021/jacs.5b00669; Chakraborty A, 2015, J BIOL CHEM, V290, P24636, DOI 10.1074/jbc.M115.658146; Chen SH, 2012, J BIOL CHEM, V287, P19346, DOI 10.1074/jbc.M112.363044; Clauson C, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012732; Das A, 2004, J BIOL CHEM, V279, P47132, DOI 10.1074/jbc.M406224200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Sousa JF, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317694552; Ehlers CL, 2016, GENES BRAIN BEHAV, V15, P568, DOI 10.1111/gbb.12297; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farkas SA, 2014, EPIGENOMICS-UK, V6, P179, DOI [10.2217/EPI.14.7, 10.2217/epi.14.7]; Grin IR, 2011, BIOCHEMISTRY-MOSCOW+, V76, P80, DOI 10.1134/S000629791101010X; Grishin NV, 2000, J MOL BIOL, V299, P1165, DOI 10.1006/jmbi.2000.3841; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; He W, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13101016; Hildrestrand GA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-45; Jalland CMO, 2016, SCI REP-UK, V6, DOI 10.1038/srep37844; Kauffmann A, 2008, ONCOGENE, V27, P565, DOI 10.1038/sj.onc.1210700; Klattenhoff AW, 2017, ONCOTARGET, V8, P112942, DOI 10.18632/oncotarget.22896; Krokeide SZ, 2009, PROTEIN EXPRES PURIF, V65, P160, DOI 10.1016/j.pep.2008.11.014; Krokeide SZ, 2013, DNA REPAIR, V12, P1159, DOI 10.1016/j.dnarep.2013.04.026; Li N, 2020, NUCLEIC ACIDS RES, V48, P3014, DOI 10.1093/nar/gkaa038; Li PY, 2018, NEUROPHARMACOLOGY, V134, P208, DOI 10.1016/j.neuropharm.2017.11.011; Liu MM, 2013, MUTAT RES-FUND MOL M, V743, P4, DOI 10.1016/j.mrfmmm.2012.12.003; Liu MM, 2013, STRUCTURE, V21, P247, DOI 10.1016/j.str.2012.12.008; Liu MM, 2012, PROTEIN EXPRES PURIF, V84, P130, DOI 10.1016/j.pep.2012.04.022; Liu MM, 2010, P NATL ACAD SCI USA, V107, P4925, DOI 10.1073/pnas.0908307107; Massaad MJ, 2016, J CLIN INVEST, V126, P4219, DOI 10.1172/JCI85647; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Morland I, 2002, NUCLEIC ACIDS RES, V30, P4926, DOI 10.1093/nar/gkf618; Mullins EA, 2019, TRENDS BIOCHEM SCI, V44, P765, DOI 10.1016/j.tibs.2019.04.006; Mullins EA, 2017, P NATL ACAD SCI USA, V114, P4400, DOI 10.1073/pnas.1703066114; Mumbrekar KD, 2017, INT J RADIAT ONCOL, V97, P118, DOI 10.1016/j.ijrobp.2016.09.017; Nejad MI, 2020, DNA REPAIR, V86, DOI 10.1016/j.dnarep.2019.102752; Neurauter CG, 2012, DNA REPAIR, V11, P401, DOI 10.1016/j.dnarep.2012.01.007; Olsen MB, 2017, CELL REP, V18, P82, DOI 10.1016/j.celrep.2016.12.009; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Price NE, 2015, NUCLEIC ACIDS RES, V43, P3434, DOI 10.1093/nar/gkv174; Price NE, 2014, J AM CHEM SOC, V136, P3483, DOI 10.1021/ja410969x; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Regnell CE, 2012, CELL REPORTS, V2, P503, DOI 10.1016/j.celrep.2012.08.008; Rognlien AGW, 2015, PEDIATR RES, V77, P326, DOI 10.1038/pr.2014.193; Rumsey WL, 2017, MUTAGENESIS, V32, P343, DOI 10.1093/mutage/gew063; Sejersted Y, 2011, P NATL ACAD SCI USA, V108, P18802, DOI 10.1073/pnas.1106880108; Semlow DR, 2016, CELL, V167, P498, DOI 10.1016/j.cell.2016.09.008; Skarpengland T, 2016, SCI REP-UK, V6, DOI 10.1038/srep28337; Skarpengland T, 2015, DNA REPAIR, V28, P21, DOI 10.1016/j.dnarep.2015.01.013; Takao M, 2009, GENES CELLS, V14, P261, DOI 10.1111/j.1365-2443.2008.01271.x; Tan KM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1073; Tangye SG, 2016, J CLIN INVEST, V126, P4065, DOI 10.1172/JCI90831; TSEDINH YC, 1991, J BIOL CHEM, V266, P14317; Wallace BD, 2017, P NATL ACAD SCI USA, V114, P304, DOI 10.1073/pnas.1610011114; Wang S, 2016, NUCLEIC ACIDS RES, V44, P187, DOI 10.1093/nar/gkv949; Wu RA, 2019, NATURE, V567, P267, DOI 10.1038/s41586-019-1002-0; Yang LX, 2016, CHINESE MED J-PEKING, V129, P1955, DOI 10.4103/0366-6999.187851; Yang ZY, 2017, NUCLEIC ACIDS RES, V45, P6275, DOI 10.1093/nar/gkx394; YU LP, 1995, BIOCHEMISTRY-US, V34, P7622, DOI 10.1021/bi00023a008; Zhang HL, 1996, J BIOL CHEM, V271, P9039, DOI 10.1074/jbc.271.15.9039; Zhang HK, 2010, ONCOL REP, V23, P445, DOI 10.3892/or_00000654; Zhou J, 2017, CELL REP, V20, P2044, DOI 10.1016/j.celrep.2017.08.020; Zhou J, 2015, NUCLEIC ACIDS RES, V43, P4039, DOI 10.1093/nar/gkv252; Zhou J, 2013, J BIOL CHEM, V288, P27263, DOI 10.1074/jbc.M113.479055	65	8	8	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2020	295	46					15566	15575		10.1074/jbc.RA120.015541	http://dx.doi.org/10.1074/jbc.RA120.015541			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OY6NO	32878989	hybrid, Green Published			2022-12-26	WOS:000594361600012
J	Zheng, HT; Zhang, HY; Chen, ST; Li, MY; Fu, T; Yang, ZM				Zheng, Hong-Tao; Zhang, Hai-Yi; Chen, Si-Ting; Li, Meng-Yuan; Fu, Tao; Yang, Zeng-Ming			The detrimental effects of stress-induced glucocorticoid exposure on mouse uterine receptivity and decidualization	FASEB JOURNAL			English	Article						collagen; corticosterone; decidualization; receptivity; stress	MESSENGER-RIBONUCLEIC-ACID; RESTRAINT STRESS; BLASTOCYST IMPLANTATION; EPITHELIAL TRANSITION; EMBRYO IMPLANTATION; PERINATAL-PERIOD; GENE-EXPRESSION; MATERNAL STRESS; EARLY-PREGNANCY; PRETERM BIRTH	Glucocorticoids (GCs), stress-induced steroid hormones, are released by adrenal cortex and essential for stress adaptation. Recently, there has been renewed interest in the relationship between GCs and pregnancy following the discovery that glucocorticoid receptor is necessary for implantation. It has been widely recognized that stress is detrimental to pregnancy. However, effects of stress-induced GC exposure on uterine receptivity and decidualization are still poorly understood. This study aims to explore the effects of GCs exposure on uterine receptivity, decidualization, and their underlying mechanisms in mice. Single prolonged stress (SPS) and corticosterone (Cort) injection models were used to analyze effects of GC exposure on early pregnancy, respectively. SPS or Cort injection inhibits embryo implantation by interfering Lif signaling and stimulating the uterine deposition of collagen types I, III, and IV on day 4 of pregnancy. Uterine decidualization is also attenuated by SPS or Cort injection through suppressing Cox-2 expression. Cort-induced collagen disorder also suppresses decidualization through regulating mesenchymal-epithelial transition. Our data should shed lights for a better understanding for the effects of GCs on embryo implantation for clinical research.	[Zheng, Hong-Tao; Zhang, Hai-Yi; Chen, Si-Ting; Li, Meng-Yuan; Fu, Tao; Yang, Zeng-Ming] South China Agr Univ, Coll Vet Med, Guangzhou 510642, Peoples R China	South China Agricultural University	Yang, ZM (corresponding author), South China Agr Univ, Coll Vet Med, Guangzhou 510642, Peoples R China.	zmyang@scau.edu.cn			National Key Research and Development Program of China [2018YFC1004403]; National Nature Science Foundation of China [31871511, 31671563]	National Key Research and Development Program of China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Key Research and Development Program of China, Grant/Award Number: 2018YFC1004403; National Nature Science Foundation of China, Grant/Award Number: 31871511 and 31671563	Adams NR, 2015, ADV ANAT EMBRYOL CEL, V216, P27, DOI 10.1007/978-3-319-15856-3_3; Adiguzel D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216814; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; BENEDIKTSSON R, 1993, LANCET, V341, P339, DOI 10.1016/0140-6736(93)90138-7; BLANKENSHIP TN, 1995, ANAT REC, V243, P27, DOI 10.1002/ar.1092430105; Castro-Vale I, 2016, NEUROSCI BIOBEHAV R, V63, P143, DOI 10.1016/j.neubiorev.2016.02.005; Chen JR, 2000, ENDOCRINOLOGY, V141, P4365, DOI 10.1210/en.141.12.4365; Cheng JG, 2001, P NATL ACAD SCI USA, V98, P8680, DOI 10.1073/pnas.151180898; Cohen M, 2006, PLACENTA, V27, P783, DOI 10.1016/j.placenta.2005.08.006; Cook N, 2018, J AFFECT DISORDERS, V225, P18, DOI 10.1016/j.jad.2017.07.045; Copper RL, 1996, AM J OBSTET GYNECOL, V175, P1286, DOI 10.1016/S0002-9378(96)70042-X; Csemiczky G, 2000, ACTA OBSTET GYN SCAN, V79, P113, DOI 10.1034/j.1600-0412.2000.079002113.x; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Deslauriers J, 2018, BIOL PSYCHIAT, V83, P895, DOI 10.1016/j.biopsych.2017.11.019; Diao HL, 2011, BIOL REPROD, V84, P255, DOI 10.1095/biolreprod.110.086942; Du LL, 2017, HYPERTENS RES, V40, P67, DOI 10.1038/hr.2016.97; Endo Toshiaki, 2006, Reproductive Medicine and Biology, V5, P235, DOI 10.1111/j.1447-0578.2006.00147.x; FARRAR JD, 1992, BIOL REPROD, V46, P1095, DOI 10.1095/biolreprod46.6.1095; Gong S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117503; Goulet S, 2007, J CELL PHYSIOL, V210, P167, DOI 10.1002/jcp.20836; GRAHAM MF, 1995, GASTROENTEROLOGY, V109, P1454, DOI 10.1016/0016-5085(95)90630-4; Horejs CM, 2016, EUR J CELL BIOL, V95, P427, DOI 10.1016/j.ejcb.2016.06.002; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Hurst PR, 1997, REPROD FERT DEVELOP, V9, P403, DOI 10.1071/R97003; Jamaluddin MFB, 2018, ENDOCRINOLOGY, V159, P1106, DOI 10.1210/en.2017-03018; JOHNSON DC, 1980, BIOL REPROD, V22, P1136, DOI 10.1093/biolreprod/22.5.1136; Kimura F, 2001, GYNECOL ENDOCRINOL, V15, P426, DOI 10.1080/713602980; Kondoh E, 2009, HUM REPROD, V24, P945, DOI 10.1093/humrep/den461; Laukova M, 2014, ENDOCRINOLOGY, V155, P3920, DOI 10.1210/en.2014-1192; Lee B, 2016, KOREAN J PHYSIOL PHA, V20, P357, DOI 10.4196/kjpp.2016.20.4.357; Lei W, 2012, J BIOL CHEM, V287, P15174, DOI 10.1074/jbc.M111.308023; Li QN, 2018, HUM REPROD, V33, P2285, DOI 10.1093/humrep/dey322; Li QX, 2011, SCIENCE, V331, P912, DOI 10.1126/science.1197454; Li SY, 2017, FEBS LETT, V591, P1394, DOI 10.1002/1873-3468.12645; Liang YX, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18643-w; Liberzon I, 1999, J NEUROENDOCRINOL, V11, P11; Liberzon I, 1997, PSYCHONEUROENDOCRINO, V22, P443, DOI 10.1016/S0306-4530(97)00044-9; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Liu GH, 2014, STRESS, V17, P494, DOI 10.3109/10253890.2014.966263; Matsuo M, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqz005; Neggers Y, 2006, ACTA OBSTET GYN SCAN, V85, P277, DOI 10.1080/00016340600566121; Oefner CM, 2015, PLACENTA, V36, P59, DOI 10.1016/j.placenta.2014.10.012; OIKARINEN A, 1987, BIOCHEM J, V245, P235, DOI 10.1042/bj2450235; Pawar S, 2015, MOL ENDOCRINOL, V29, P1362, DOI 10.1210/me.2015-1142; Pawar S, 2013, MOL ENDOCRINOL, V27, P1996, DOI 10.1210/me.2013-1206; POIANI GJ, 1994, AM J RESP CRIT CARE, V149, P994, DOI 10.1164/ajrccm.149.4.8143066; RABIN DS, 1990, BIOL REPROD, V42, P74, DOI 10.1095/biolreprod42.1.74; RAHIMA A, 1977, J REPROD FERTIL, V49, P161, DOI 10.1530/jrf.0.0490161; Rhen T, 2003, FASEB J, V17, P1849, DOI 10.1096/fj.02-1099com; Salleh N, 2014, SCI WORLD J, DOI 10.1155/2014/968141; Sandeep TC, 2001, TRENDS ENDOCRIN MET, V12, P446, DOI 10.1016/S1043-2760(01)00499-4; Shapiro GD, 2013, J PERINAT MED, V41, P631, DOI 10.1515/jpm-2012-0295; Silver RM, 2013, AM J EPIDEMIOL, V177, P228, DOI 10.1093/aje/kws384; Singh M, 2011, J ENDOCRINOL, V210, P5, DOI 10.1530/JOE-10-0461; Spiess K, 2007, CONNECT TISSUE RES, V48, P99, DOI 10.1080/03008200601166194; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Sun JY, 2018, CELL CYCLE, V17, P1591, DOI 10.1080/15384101.2018.1471316; Sun XF, 2013, MOL ENDOCRINOL, V27, P1492, DOI 10.1210/me.2013-1086; Tan XW, 2017, HUM REPROD, V32, P1583, DOI 10.1093/humrep/dex217; Thiruchelvam U, 2016, J LEUKOCYTE BIOL, V99, P1165, DOI 10.1189/jlb.5A0215-061RR; Torche F, 2011, DEMOGRAPHY, V48, P1473, DOI 10.1007/s13524-011-0054-z; Tranguch S, 2005, CELL MOL LIFE SCI, V62, P1964, DOI 10.1007/s00018-005-5230-0; Tsartsara E, 2006, J PSYCHOSOM OBST GYN, V27, P173, DOI 10.1080/01674820600646198; Valsamakis G, 2019, PSYCHONEUROENDOCRINO, V100, P48, DOI 10.1016/j.psyneuen.2018.09.031; Vasquez YM, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007787; Vermeer H, 2003, J CLIN ENDOCR METAB, V88, P277, DOI 10.1210/jc.2002-020354; Vignato J, 2017, J CLIN NURS, V26, P3859, DOI 10.1111/jocn.13800; Wang HT, 2009, INT J MOL MED, V24, P227, DOI 10.3892/ijmm_00000225; Wang TS, 2015, BIOL OPEN, V4, P893, DOI 10.1242/bio.011890; Wetendorf M, 2014, INT J DEV BIOL, V58, P95, DOI 10.1387/ijdb.140069mw; Whirledge S, 2017, TRENDS ENDOCRIN MET, V28, P399, DOI 10.1016/j.tem.2017.02.005; Whirledge SD, 2015, P NATL ACAD SCI USA, V112, P15166, DOI 10.1073/pnas.1508056112; White CA, 2007, P NATL ACAD SCI USA, V104, P19357, DOI 10.1073/pnas.0710110104; WIEBOLD JL, 1986, J REPROD FERTIL, V78, P185, DOI 10.1530/jrf.0.0780185; Wu SP, 2018, TRENDS ENDOCRIN MET, V29, P481, DOI 10.1016/j.tem.2018.04.001; Zhang XH, 2013, REPROD SCI, V20, P354, DOI 10.1177/1933719112472738; Zhao LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080472; Zheng HT, 2020, J ENDOCRINOL, V244, P177, DOI 10.1530/JOE-19-0349; Zuo RJ, 2015, J BIOL CHEM, V290, P21280, DOI 10.1074/jbc.M115.656629	79	6	6	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14200	14216		10.1096/fj.201902911RR	http://dx.doi.org/10.1096/fj.201902911RR		SEP 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32918762				2022-12-26	WOS:000570679100001
J	Oueidat, H; Charafeddine, L; Nimer, H; Hussein, H; Nabulsi, M				Oueidat, Hala; Charafeddine, Lama; Nimer, Hana; Hussein, Hiba; Nabulsi, Mona			Knowledge and attitudes of Lebanese women towards Baby Friendly Hospital Initiative practices	PLOS ONE			English	Article							HUMAN-MILK; FEED	Background The World Health Organization and United Nations Children's Fund launched the Baby Friendly Hospital Initiative (BFHI) to encourage best infant breastfeeding practices immediately after birth. In Lebanon, few hospitals are currently accredited as Baby Friendly. Aim To assess the knowledge of Lebanese women of BFHI steps, and to explore their attitudes towards Baby Friendly Hospitals, Skin-to-Skin Contact and Kangaroo Care practices. Methods A cross-sectional survey of a random sample of healthy pregnant women from Lebanon's six governorates. Results The mean (SD) age of the participants (N = 517) was 28.6 (4.7) years. Most participants were unfamiliar with the terms Baby Friendly hospital (93.7%), skin-to-skin contact or kangaroo care (75%), or were inadequately instructed on how to initiate (54.2%) or continue (46.2%) breastfeeding. However, when provided with information about the benefits of BFHI practices, most mothers (> 90%) stated that they would deliver in Baby Friendly hospitals. About 68.4% of mothers refused to give donor human milk to their sick premature infants because of religious beliefs. Knowledge of Baby Friendly hospitals was significantly associated with university education (p= 0.029), higher monthly income (p= 0.042), and previous experiences of skin-to-skin contact (p<0.001), rooming in (p= 0.037), or breastfeeding support (p= 0.036). Conclusion There is a need for national awareness campaigns that address both the numerous advantages of the BFHI practices and Lebanese women's knowledge gaps about these practices. Such knowledge will help scale up the implementation of BFHI practices in hospitals in Lebanon, thus increasing breastfeeding rates and positively impacting the health of infants and mothers.	[Oueidat, Hala; Charafeddine, Lama; Nimer, Hana; Hussein, Hiba; Nabulsi, Mona] Amer Univ Beirut, Dept Pediat & Adolescent Med, Beirut, Lebanon	American University of Beirut	Nabulsi, M (corresponding author), Amer Univ Beirut, Dept Pediat & Adolescent Med, Beirut, Lebanon.	mn04@aub.edu.lb	Nabulsi, Mona/A-8002-2016	Nabulsi, Mona/0000-0001-7415-6436				Akik C, 2017, J PUBLIC HEALTH POL, V38, P314, DOI 10.1057/s41271-017-0077-9; Al-Jawaldeh A, 2018, CHILDREN-BASEL, V5, DOI 10.3390/children5030041; al-Naqeeb N A, 2000, J Hum Lact, V16, P346, DOI 10.1177/089033440001600412; American College of Obstetricians and Gynecologists' Committee on Obstetric Practice, 2016, Obstet Gynecol, V127, pe86, DOI 10.1097/AOG.0000000000001318; [Anonymous], 2012, ISBT SCI SERIES, V7, P173; Batal Malek, 2005, J Pediatr Nurs, V20, P53, DOI 10.1016/j.pedn.2004.09.004; BouDiab S, 2018, APPETITE, V123, P23, DOI 10.1016/j.appet.2017.12.002; Conde-Agudelo A, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002771.pub4; Doshmangir L, 2019, BREASTFEED MED, V14, P298, DOI 10.1089/bfm.2019.0002; Ergin A, 2018, MATERN CHILD HLTH J, V22, P454, DOI 10.1007/s10995-018-2433-1; Hsu HT, 2012, BREASTFEED MED, V7, P118, DOI 10.1089/bfm.2011.0006; Kabakian-Khasholian T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223687; Khalil A, 2016, ACTA PAEDIATR, V105, P462, DOI 10.1111/apa.13308; Martens P J, 2000, J Hum Lact, V16, P309, DOI 10.1177/089033440001600407; McMillan B, 2008, PSYCHOL HEALTH, V23, P767, DOI 10.1080/08870440701615260; Merten S, 2005, PEDIATRICS, V116, pE702, DOI 10.1542/peds.2005-0537; Moore ER, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003519.pub4; Nabulsi M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218467; Nabulsi Mona, 2011, BMC Pediatr, V11, P75, DOI 10.1186/1471-2431-11-75; Radwan H, 2016, FOOD NUTR BULL, V37, P73, DOI 10.1177/0379572115624289; UNICEF, 1990, INN DECL PROT PROM S; United Nations' Children's Fund (UNICEF), 2015, STAT WORLDS CHILDR 2; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Wallenborn JT, 2018, BREASTFEED MED, V13, P106, DOI 10.1089/bfm.2017.0133; WHO/UNICEF, 2006, INF YOUNG CHILD FEED; WHO/UNICEF, 1993, BREASTF COUNC TRAIN; WHO UNICEF, 1989, PROT PROM SUPP BREAS; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED; World Health Organization, 2017, NAT IMPL BAB FRINDL; Yotebieng M, 2015, LANCET GLOB HEALTH, V3, pE546, DOI 10.1016/S2214-109X(15)00012-1	30	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238730	10.1371/journal.pone.0238730	http://dx.doi.org/10.1371/journal.pone.0238730			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915827	gold, Green Published			2022-12-26	WOS:000571887500055
J	Yin, HP; Ma, XC; He, YL; Liang, RJ; Wang, YX; Zhang, M; Mao, L; Jing, MX				Yin, Hongpo; Ma, Xiaochen; He, Yanli; Liang, Rujiang; Wang, Yongxin; Zhang, Mei; Mao, Lu; Jing, Mingxia			Effect of an outpatient copayment scheme on health outcomes of hypertensive adults in a community-managed population in Xinjiang, China	PLOS ONE			English	Article							FACILITY QUALITY IMPROVEMENT; DIFFERENCE-IN-DIFFERENCES; BLOOD-PRESSURE; INSURANCE-COVERAGE; BURDEN; STROKE; MORTALITY; NIGERIA; EQ-5D; RISK	Hypertension remains the leading risk factor for death and disability in China, and the ability of hypertensive patients to pay for outpatient care and medication has become a critical issue. To report the effect of an outpatient copayment scheme on health outcomes of hypertensive adults in a community-managed population in Xinjiang, we compared changes in outcomes between insured and uninsured groups from baseline to the first follow-up appointment in a community-managed hypertensive population and evaluated these changes based on propensity score matching and the difference-in-difference method. A total of 1,095 individuals in a community-managed hypertension population were selected for investigation at baseline, among which 805 (73.5%) had follow-up data and 749 (68.4%) were included in our analysis. After accounting for the self-reported severity of hypertension and individual characteristics, there were statistically significant improvements in drug treatment of hypertension and self-reported health. We also found increases in drug treatment for hypertension between groups, after correcting for confounding variables (Odds Ratio, OR 8.05, 95% Confidence interval, CI, 1.31-49.35), and in self-reported health between groups after correcting confounders (OR 1.96, 95% CI, 1.12 to 3.42). Adjusted estimates (confounding variables) were corrected for age, sex, income, marital status, education level, employment, family size, self-reported severity of hypertension, course of hypertension, and number of medications. As a result, decreased outpatient copayment was associated with an increase in antihypertensive treatment coverage, and an improvement in self-reported health among community-managed hypertensive populations in Xinjiang, China.	[Yin, Hongpo; He, Yanli; Liang, Rujiang; Wang, Yongxin; Zhang, Mei; Mao, Lu; Jing, Mingxia] Shihezi Univ, Sch Med, Dept Publ Hlth, Shihezi, Xinjiang, Peoples R China; [Ma, Xiaochen] Peking Univ, China Ctr Hlth Dev Studies, Beijing, Peoples R China	Shihezi University; Peking University	Jing, MX (corresponding author), Shihezi Univ, Sch Med, Dept Publ Hlth, Shihezi, Xinjiang, Peoples R China.	jingmngxia163@163.com			National Natural Science Foundation of China [71363047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was funded by the National Natural Science Foundation of China, grant number 71363047.(http://www.nsfc.gov.cn/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya A, 2013, WORLD BANK RES OBSER, V28, P236, DOI 10.1093/wbro/lks009; article GG, 2017, STAT COMM 2016; Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Bureau. XPaCCHRaSS, 2016, OP FURTH IMPR LEV ME; CALDWELL JR, 1970, J CHRON DIS, V22, P579, DOI 10.1016/0021-9681(70)90034-2; China. NBoSo, 2015, CHIN STAT YB 2015; COLLINS R, 1994, BRIT MED BULL, V50, P272, DOI 10.1093/oxfordjournals.bmb.a072892; D?az Y., 2013, IMPACT UNIVERSAL COV; De Geest Sabina, 2003, Eur J Cardiovasc Nurs, V2, P323; Dimick JB, 2014, JAMA-J AM MED ASSOC, V312, P2401, DOI 10.1001/jama.2014.16153; Doiron D, 2015, APPL ECON, V47, P180, DOI 10.1080/00036846.2014.967382; Donald SG, 2007, REV ECON STAT, V89, P221, DOI 10.1162/rest.89.2.221; Erlangga D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219731; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Freeman JD, 2008, MED CARE, V46, P1023, DOI 10.1097/MLR.0b013e318185c913; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Gao Y., 2014, THESIS; Guo S.Y., 2014, PROPENSITY SCORE ANA; Hadley J, 2007, JAMA-J AM MED ASSOC, V297, P1073, DOI 10.1001/jama.297.10.1073; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Hendriks ME, 2016, INT J CARDIOL, V202, P477, DOI 10.1016/j.ijcard.2015.09.036; Hendriks ME, 2014, JAMA INTERN MED, V174, P555, DOI 10.1001/jamainternmed.2013.14458; Institute for Health Metrics and Evaluation (IHME), 2015, GBD COMP DAT VIS; Kiiskinen U, 1998, J HYPERTENS, V16, P1103, DOI 10.1097/00004872-199816080-00004; Kim AS, 2011, CIRCULATION, V124, P314, DOI 10.1161/CIRCULATIONAHA.111.018820; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2016, JAMA INTERN MED, V176, P524, DOI 10.1001/jamainternmed.2016.0190; Li YC, 2017, INT J CARDIOL, V227, P516, DOI 10.1016/j.ijcard.2016.10.110; Liu GG, 2014, VALUE HEALTH, V17, P597, DOI 10.1016/j.jval.2014.05.007; Liu Ming, 2014, Beijing Da Xue Xue Bao Yi Xue Ban, V46, P782; Lu JP, 2017, LANCET, V390, P2549, DOI [10.1016/S0140-6736(17)32478-9, 10.1016/s0140-6736(17)32478-9]; Maridell'Olmo M, 2010, WORLD BANK PUBLICATI, V25, P441; Mechanisms Clinical Strategies., 2015, 12 INT C AD PD NIC F, V15, P1, DOI DOI 10.1520/D6415; Miilunpalo S, 1997, J CLIN EPIDEMIOL, V50, P517, DOI 10.1016/S0895-4356(97)00045-0; Olsen MH, 2016, LANCET, V388, P2665, DOI 10.1016/S0140-6736(16)31134-5; Osborne NH, 2015, JAMA-J AM MED ASSOC, V313, P496, DOI 10.1001/jama.2015.25; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Ryan AM, 2015, HEALTH SERV RES, V50, P1211, DOI 10.1111/1475-6773.12270; Shea DG, 1997, IND LABOR RELATI JUL; Sommers BD, 2017, NEW ENGL J MED, V377, P586, DOI 10.1056/NEJMsb1706645; Stryjewski TP, 2014, HEALTH SERV RES, V49, P2086, DOI 10.1111/1475-6773.12196; Thomas H, 2018, GLOB HEART, V13, P143, DOI 10.1016/j.gheart.2018.09.511; Wang J, 2017, J STROKE CEREBROVASC, V26, P509, DOI 10.1016/j.jstrokecerebrovasdis.2016.12.002; Wang ZW, 2018, CIRCULATION, V137, P2344, DOI 10.1161/CIRCULATIONAHA.117.032380; World Health Organization. WPRO, WPRO GLOB STAT REP N; Wouters OJ, 2016, HEALTH ECON POLICY L, V11, P321, DOI 10.1017/S1744133116000025; Xi B, 2014, INT J CARDIOL, V174, P736, DOI 10.1016/j.ijcard.2014.04.098; Xiang-Jun LI, 2014, CHINESE HLTH EC; Xue XD, 2015, CHINESE J HLTH POLIC; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15083-4	51	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238980	10.1371/journal.pone.0238980	http://dx.doi.org/10.1371/journal.pone.0238980			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9MU	32915916	Green Published, gold			2022-12-26	WOS:000571887500078
J	Yuan, HL; Tang, YC; Sun, WJ; Liu, L				Yuan, Hongli; Tang, Yongchuan; Sun, Wenjuan; Liu, Li			A detection method for android application security based on TF-IDF and machine learning	PLOS ONE			English	Article							MALWARE DETECTION; BEHAVIORS; FRAMEWORK; TAXONOMY	Android is the most widely used mobile operating system (OS). A large number of third-party Android application (app) markets have emerged. The absence of third-party market regulation has prompted research institutions to propose different malware detection techniques. However, due to improvements of malware itself and Android system, it is difficult to design a detection method that can efficiently and effectively detect malicious apps for a long time. Meanwhile, adopting more features will increase the complexity of the model and the computational cost of the system. Permissions play a vital role in the security of the Android apps. Term Frequency-Inverse Document Frequency (TF-IDF) is used to assess the importance of a word for a file set in a corpus. The static analysis method does not need to run the app. It can efficiently and accurately extract the permissions from an app. Based on this cognition and perspective, in this paper, a new static detection method based on TF-IDF and Machine Learning is proposed. The system permissions are extracted in Android application package's (Apk's) manifest file. TF-IDF algorithm is used to calculate the permission value (PV) of each permission and the sensitivity value of apk (SVOA) of each app. The SVOA and the number of the used permissions are learned and tested by machine learning. 6070 benign apps and 9419 malware are used to evaluate the proposed approach. The experiment results show that only use dangerous permissions or the number of used permissions can't accurately distinguish whether an app is malicious or benign. For malware detection, the proposed approach achieve up to 99.5% accuracy and the learning and training time only needs 0.05s. For malware families detection, the accuracy is 99.6%. The results indicate that the method for unknown/new sample's detection accuracy is 92.71%. Compared against other state-of-the-art approaches, the proposed approach is more effective by detecting malware and malware families.	[Yuan, Hongli; Sun, Wenjuan; Liu, Li] Anhui Xinhua Univ, Inst Informat Engn, Hefei, Anhui, Peoples R China; [Tang, Yongchuan] Chongqing Univ, Sch Big Data & Software Engn, Chongqing, Peoples R China; [Sun, Wenjuan] Univ Sci & Technol China, Dept Modern Mech, Hefei, Anhui, Peoples R China	Anhui Xinhua University; Chinese Academy of Sciences; Chongqing University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Yuan, HL (corresponding author), Anhui Xinhua Univ, Inst Informat Engn, Hefei, Anhui, Peoples R China.; Tang, YC (corresponding author), Chongqing Univ, Sch Big Data & Software Engn, Chongqing, Peoples R China.	yuanhongli@axhu.edu.cn; tangyongchuan@cqu.edu.cn	Tang, Yongchuan/G-8970-2019	Tang, Yongchuan/0000-0003-2568-9628	Natural Science Foundation of the Anhui Provincial Education Office [KJ2017A621, KJ2014A096]; Quality Engineering Project of Anhui Xinhua University [2016JPKCX05]; Quality engineering projects of colleges and universities in Anhui [2017JYXM0533]	Natural Science Foundation of the Anhui Provincial Education Office; Quality Engineering Project of Anhui Xinhua University; Quality engineering projects of colleges and universities in Anhui	The work was partially supported by Natural Science Foundation of the Anhui Provincial Education Office (Grant No.KJ2017A621, Grant No. KJ2014A096), Quality Engineering Project of Anhui Xinhua University (Grant No. 2016JPKCX05), Quality engineering projects of colleges and universities in Anhui (Grant No.2017JYXM0533).	Afonso VM, 2015, J COMPUT VIROL HACKI, V11, P9, DOI 10.1007/s11416-014-0226-7; Aizawa A, 2003, INFORM PROCESS MANAG, V39, P45, DOI 10.1016/S0306-4573(02)00021-3; Alaa Ahmed M, 2019, PLoS One, V14, pe0213653, DOI 10.1371/journal.pone.0213653; Allix K, 2016, EMPIR SOFTW ENG, V21, P183, DOI 10.1007/s10664-014-9352-6; [Anonymous], 2019, ANDROID OS MARKET SH; Arnatovi YL, 2018, IEEE ACCESS, V6, P12382, DOI 10.1109/ACCESS.2018.2808340; Arp D, 2014, 21ST ANNUAL NETWORK AND DISTRIBUTED SYSTEM SECURITY SYMPOSIUM (NDSS 2014), DOI 10.14722/ndss.2014.23247; Arzt S, 2014, ACM SIGPLAN NOTICES, V49, P259, DOI [10.1145/2594291.2594299, 10.1145/2666356.2594299]; Avdiienko V, 2015, 2015 IEEE/ACM 37TH IEEE INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING, VOL 1, P426, DOI 10.1109/ICSE.2015.61; Bartel A, 2014, IEEE T SOFTWARE ENG, V40, P617, DOI 10.1109/TSE.2014.2322867; Bartel A, 2012, IEEE INT CONF AUTOM, P274, DOI 10.1145/2351676.2351722; Benito CJ, 2018, MACH VISION APPL, V30, P959; Chen S, 2016, ASIA CCS'16: PROCEEDINGS OF THE 11TH ACM ASIA CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY, P377, DOI 10.1145/2897845.2897860; Chen Z, 2017, INFORM SCI, P346; Dash SK, 2016, 2016 IEEE SYMPOSIUM ON SECURITY AND PRIVACY WORKSHOPS (SPW 2016), P252, DOI 10.1109/SPW.2016.25; Du Y, 2017, IEEE ACCESS, V5, P17478, DOI 10.1109/ACCESS.2017.2720160; Enck W, 2009, CCS'09: PROCEEDINGS OF THE 16TH ACM CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY, P235; Faruki P., 2017, IEEE COMMUNICATIONS, V17, P998; Geneiatakis D, 2015, COMPUT SECUR, V49, P192, DOI 10.1016/j.cose.2014.10.005; Hong TP, 2013, APPL INTELL, V38, P502, DOI 10.1007/s10489-012-0377-5; Li J, 2018, IEEE T IND INFORM, V14, P3216, DOI 10.1109/TII.2017.2789219; Liu X, 2020, IEEE T MOBILE COMPUT, V19, P1184, DOI 10.1109/TMC.2019.2903186; Lu L., 2012, P 2012 ACM C COMP CO, P229, DOI DOI 10.1145/2382196.2382223; Lyvas C, 2018, COMPUT SECUR, V77, P472, DOI 10.1016/j.cose.2018.05.007; Mahmood R, 2014, 22ND ACM SIGSOFT INTERNATIONAL SYMPOSIUM ON THE FOUNDATIONS OF SOFTWARE ENGINEERING (FSE 2014), P599, DOI 10.1145/2635868.2635896; Milosevic N, 2017, COMPUT ELECTR ENG, V61, P266, DOI 10.1016/j.compeleceng.2017.02.013; Onwuzurike L, 2019, ACM T PRIV SECUR, V22, DOI 10.1145/3313391; Onwuzurike L, 2018, ANN CONF PRIV SECUR, P163; Qi GJ, 2017, KDD'17: PROCEEDINGS OF THE 23RD ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P987, DOI 10.1145/3097983.3098113; Rashidi B, 2017, COMPUT SECUR, V65, P90, DOI 10.1016/j.cose.2016.11.006; Sadeghi A, 2017, IEEE T SOFTWARE ENG, V43, P492, DOI 10.1109/TSE.2016.2615307; Sanz B., 2014, P 2014 INT JOINT C S, DOI [10.1007/978-3-319-01854-6_48, DOI 10.1007/978-3-319-01854-6_48]; Sanz B, 2013, ADV INTELL SYST, V189, P289; Sellwood J., 2013, SPSM, P55; Sheen S, 2015, NEUROCOMPUTING, V151, P905, DOI 10.1016/j.neucom.2014.10.004; Su D, 2017, ANOMADROID PROFILING, P691; Suarez-Tangil G, 2017, PROCEEDINGS OF THE SEVENTH ACM CONFERENCE ON DATA AND APPLICATION SECURITY AND PRIVACY (CODASPY'17), P309, DOI 10.1145/3029806.3029825; Suarez-Tangil G, 2014, EXPERT SYST APPL, V41, P1104, DOI 10.1016/j.eswa.2013.07.106; Tuncay GS, 2018, 25TH ANNUAL NETWORK AND DISTRIBUTED SYSTEM SECURITY SYMPOSIUM (NDSS 2018), DOI 10.14722/ndss.2018.23210; Wang W, 2019, IEEE ACCESS, V7, P67602, DOI 10.1109/ACCESS.2019.2918139; Wang W, 2014, IEEE T INF FOREN SEC, V9, P1869, DOI 10.1109/TIFS.2014.2353996; Wei XT, 2012, 28TH ANNUAL COMPUTER SECURITY APPLICATIONS CONFERENCE (ACSAC 2012), P31; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Yang GL, 2018, 25TH ANNUAL NETWORK AND DISTRIBUTED SYSTEM SECURITY SYMPOSIUM (NDSS 2018), DOI 10.14722/ndss.2018.23236; Yang Kun, 2014, P 9 S INFORM COMPUTE, P531, DOI [10.1145/2590296.2590316, DOI 10.1145/2590296.2590316]; Yerima SY, 2014, IET INFORM SECUR, V8, P25, DOI 10.1049/iet-ifs.2013.0095; Yuan ZL, 2016, TSINGHUA SCI TECHNOL, V21, P114; Zhang Rui, 2014, Journal of Computer Applications, V34, P1322; Zhang W, 2011, EXPERT SYST APPL, V38, P2758, DOI 10.1016/j.eswa.2010.08.066; Zhang Y, 2014, IEEE T INF FOREN SEC, V9, P1828, DOI 10.1109/TIFS.2014.2347206; Zhang Yuan, 2013, PROC 20 ACM C COMPUT, P611, DOI DOI 10.1145/2508859.2516689; Zhao YF, 2016, 2016 IEEE FIRST INTERNATIONAL CONFERENCE ON DATA SCIENCE IN CYBERSPACE (DSC 2016), P61, DOI 10.1109/DSC.2016.45	55	9	10	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238694	10.1371/journal.pone.0238694	http://dx.doi.org/10.1371/journal.pone.0238694			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915836	Green Published, gold			2022-12-26	WOS:000571887500051
J	Koponen, A; Pan, GP; Kivela, AM; Ralko, A; Taskinen, JH; Arora, A; Kosonen, R; Kari, OK; Ndika, J; Ikonen, E; Cho, W; Yan, DG; Olkkonen, VM				Koponen, Annika; Pan, Guoping; Kivela, Annukka M.; Ralko, Arthur; Taskinen, Juuso H.; Arora, Amita; Kosonen, Riikka; Kari, Otto K.; Ndika, Joseph; Ikonen, Elina; Cho, Wonhwa; Yan, Daoguang; Olkkonen, Vesa M.			ORP2, a cholesterol transporter, regulates angiogenic signaling in endothelial cells	FASEB JOURNAL			English	Article						angiogenesis; cholesterol trafficking; Osbpl2; VEGF receptor	OXYSTEROL-BINDING-PROTEIN; GROWTH-FACTOR; VE-CADHERIN; SUPPRESSES ANGIOGENESIS; MAMMALIAN TARGET; UP-REGULATION; LIPID RAFTS; MEMBRANE; RECEPTOR; TRAFFICKING	Oxysterol-binding protein-related protein 2 (ORP2), a cholesterol-PI(4,5)P(2)countercurrent transporter, was recently identified as a novel regulator of plasma membrane (PM) cholesterol and PI(4,5)P(2)content in HeLa cells. Here, we investigate the role of ORP2 in endothelial cell (EC) cholesterol and PI(4,5)P(2)distribution, angiogenic signaling, and angiogenesis. We show that ORP2 knock-down modifies the distribution of cholesterol accessible to a D4H probe, between late endosomes and the PM. Depletion of ORP2 from ECs inhibits their angiogenic tube formation capacity, alters the gene expression of angiogenic signaling pathways such as VEGFR2, Akt, mTOR, eNOS, and Notch, and reduces EC migration, proliferation, and cell viability. We show that ORP2 regulates the integrity of VEGFR2 at the PM in a cholesterol-dependent manner, the depletion of ORP2 resulting in proteolytic cleavage by matrix metalloproteinases, and reduced activity of VEGFR2 and its downstream signaling. We demonstrate that ORP2 depletion increases the PM PI(4,5)P(2)coincident with altered F-actin morphology, and reduces both VEGFR2 and cholesterol in buoyant raft membranes. Moreover, ORP2 knock-down suppresses the expression of the lipid raft-associated proteins VE-cadherin and caveolin-1. Analysis of the retinal microvasculature in ORP2 knock-out mice generated during this study demonstrates the subtle alterations of morphology characterized by reduced vessel length and increased density of tip cells and perpendicular sprouts. Gene expression changes in the retina suggest disturbance of sterol homeostasis, downregulation of VE-cadherin, and a putative disturbance of Notch signaling. Our data identifies ORP2 as a novel regulator of EC cholesterol and PI(4,5)P(2)homeostasis and cholesterol-dependent angiogenic signaling.	[Koponen, Annika; Kivela, Annukka M.; Taskinen, Juuso H.; Arora, Amita; Kosonen, Riikka; Ikonen, Elina; Olkkonen, Vesa M.] Minerva Fdn, Biomed 2U, Tukholmankatu 8, FI-00290 Helsinki, Finland; [Pan, Guoping; Yan, Daoguang] Jinan Univ, Dept Biol, Guangzhou, Peoples R China; [Ralko, Arthur; Cho, Wonhwa] Univ Illinois, Dept Chem, Chicago, IL USA; [Kari, Otto K.] Univ Helsinki, Div Pharmaceut Biosci, Fac Pharm, Drug Res Program, Helsinki, Finland; [Ndika, Joseph] Univ Helsinki, Human Microbiome Res, Fac Med, Helsinki, Finland; [Ikonen, Elina; Olkkonen, Vesa M.] Univ Helsinki, Dept Anat, Fac Med, Helsinki, Finland	Jinan University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Helsinki; University of Helsinki; University of Helsinki	Olkkonen, VM (corresponding author), Minerva Fdn, Biomed 2U, Tukholmankatu 8, FI-00290 Helsinki, Finland.	vesa.olkkonen@helsinki.fi	Ndika, Joseph/AAI-1074-2020	Ndika, Joseph/0000-0003-0669-1300; Taskinen, Juuso/0000-0002-4348-9550	Academy of Finland (Suomen Akatemia) [285223, 322647, 282192, 307415]; Sigrid Juselius Foundation; Magnus Ehrnrooth Foundation; Finnish Foundation for Cardiovascular Research; Emil Aaltonen Foundation; Ida Montin Foundation; National Institutes of Health [R35GM122530]; NSFC, China [8170438, 91439122]; Leducq Foundation for Cardiovascular Research	Academy of Finland (Suomen Akatemia)(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Magnus Ehrnrooth Foundation; Finnish Foundation for Cardiovascular Research; Emil Aaltonen Foundation; Ida Montin Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC, China(National Natural Science Foundation of China (NSFC)); Leducq Foundation for Cardiovascular Research(Leducq Foundation)	Academy of Finland (Suomen Akatemia), Grant/Award Number: 285223, 322647, 282192 and 307415; The Sigrid Juselius Foundation; The Magnus Ehrnrooth Foundation; The Finnish Foundation for Cardiovascular Research; The Emil Aaltonen Foundation; The Ida Montin Foundation; The National Institutes of Health, Grant/Award Number: R35GM122530; NSFC, China, Grant/Award Number: 8170438 and 91439122; The Leducq Foundation for Cardiovascular Research.	Abhinand CS, 2016, J CELL COMMUN SIGNAL, V10, P347, DOI 10.1007/s12079-016-0352-8; Abraham S, 2009, CURR BIOL, V19, P668, DOI 10.1016/j.cub.2009.02.057; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Basagiannis D, 2016, J BIOL CHEM, V291, P16892, DOI 10.1074/jbc.M116.730309; Benedito R, 2012, NATURE, V484, P110, DOI 10.1038/nature10908; Bentley K, 2014, NAT CELL BIOL, V16, P309, DOI 10.1038/ncb2926; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Calay D, 2010, J INVEST DERMATOL, V130, P1136, DOI 10.1038/jid.2009.415; Calera MR, 2004, EXP CELL RES, V300, P248, DOI 10.1016/j.yexcr.2004.07.007; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016/S0968-0004(03)00193-2; Davies Elizabeth Michele, 2019, Advances in Biological Regulation, V71, P69, DOI 10.1016/j.jbior.2018.11.008; Endapally S, 2019, METHODS MOL BIOL, V1949, P153, DOI 10.1007/978-1-4939-9136-5_12; Escajadillo T, 2016, MOL CELL ENDOCRINOL, V427, P73, DOI 10.1016/j.mce.2016.03.006; Fang LH, 2013, NATURE, V498, P118, DOI 10.1038/nature12166; Gaengel K, 2012, DEV CELL, V23, P587, DOI 10.1016/j.devcel.2012.08.005; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Hamada K, 2005, GENE DEV, V19, P2054, DOI 10.1101/gad.1308805; Head SA, 2017, ACS CHEM BIOL, V12, P174, DOI 10.1021/acschembio.6b00849; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hilpela P, 2004, CURR TOP MICROBIOL, V282, P117; Hynynen R, 2005, BIOCHEM J, V390, P273, DOI 10.1042/BJ20042082; Ikonen E, 2018, CURR OPIN CELL BIOL, V53, P77, DOI 10.1016/j.ceb.2018.06.002; Im E, 2006, EMBO J, V25, P2075, DOI 10.1038/sj.emboj.7601100; Kallio MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-507; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Kanerva K, 2013, DEV CELL, V27, P249, DOI 10.1016/j.devcel.2013.09.016; Kentala H, 2018, CELL MOL LIFE SCI, V75, P4041, DOI 10.1007/s00018-018-2850-8; Kentala H, 2018, FASEB J, V32, P1281, DOI 10.1096/fj.201700604R; Kentala H, 2016, INT REV CEL MOL BIO, V321, P299, DOI 10.1016/bs.ircmb.2015.09.006; Koponen A, 2019, BIOCHIMIE, V158, P90, DOI 10.1016/j.biochi.2018.12.013; Lai CJ, 2017, FASEB J, V31, P5568, DOI 10.1096/fj.201700374R; Laitinen S, 2002, J LIPID RES, V43, P245; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawson ND, 2003, GENE DEV, V17, P1346, DOI 10.1101/gad.1072203; Liao HJ, 2002, J BIOL CHEM, V277, P9335, DOI 10.1074/jbc.M109955200; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu SL, 2018, MOL CELL, V71, P1092, DOI 10.1016/j.molcel.2018.07.035; Liu SL, 2014, ANGEW CHEM INT EDIT, V53, P14387, DOI 10.1002/anie.201408153; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lyu JF, 2018, INT J BIOL SCI, V14, P1175, DOI 10.7150/ijbs.26011; Lyu JF, 2017, CANCER LETT, V409, P91, DOI 10.1016/j.canlet.2017.09.009; Mao RF, 2017, CIRC RES, V120, P1727, DOI 10.1161/CIRCRESAHA.116.309754; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Mesmin B, 2009, BBA-MOL CELL BIOL L, V1791, P636, DOI 10.1016/j.bbalip.2009.03.002; Mohamed A, 2019, NUCLEIC ACIDS RES, V47, pD459, DOI 10.1093/nar/gky948; Mungamuri SK, 2006, CANCER RES, V66, P4715, DOI 10.1158/0008-5472.CAN-05-3830; Noghero A, 2012, ARTERIOSCL THROM VAS, V32, P2280, DOI 10.1161/ATVBAHA.112.250621; Pan WJ, 2012, BLOOD, V120, P489, DOI 10.1182/blood-2012-02-408328; Potente M, 2017, ANNU REV PHYSIOL, V79, P43, DOI 10.1146/annurev-physiol-021115-105134; Sigoillot FD, 2012, NAT METHODS, V9, P363, DOI [10.1038/NMETH.1898, 10.1038/nmeth.1898]; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Swendeman S, 2008, CIRC RES, V103, P916, DOI 10.1161/CIRCRESAHA.108.184416; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; Tran J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151556; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Wang BT, 2011, P NATL ACAD SCI USA, V108, P15201, DOI 10.1073/pnas.1103746108; Wang H, 2019, MOL CELL, V73, P458, DOI 10.1016/j.molcel.2018.11.014; Weber-Boyvat M, 2015, CELL MOL LIFE SCI, V72, P1967, DOI 10.1007/s00018-014-1786-x; Xu J, 2010, P NATL ACAD SCI USA, V107, P4764, DOI 10.1073/pnas.0910872107; Yamamoto H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7429; Yoon Y, 2011, NAT CHEM, V3, P868, DOI [10.1038/NCHEM.1163, 10.1038/nchem.1163]; Zarkada G, 2015, P NATL ACAD SCI USA, V112, P761, DOI 10.1073/pnas.1423278112; Zhang C, 2019, EXP CELL RES, V383, DOI 10.1016/j.yexcr.2019.111512; Zhang Li, 2012, Subcell Biochem, V59, P177, DOI 10.1007/978-94-007-3015-1_6; Zhao KX, 2020, MOL BIOL CELL, V31, P793, DOI 10.1091/mbc.E19-12-0697; Zhu Laurence, 2015, Methodist Debakey Cardiovasc J, V11, P160, DOI 10.14797/mdcj-11-3-160	69	6	6	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14671	14694		10.1096/fj.202000202R	http://dx.doi.org/10.1096/fj.202000202R		SEP 2020	24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32914503				2022-12-26	WOS:000570302100001
J	Pan, Z; Yang, K; Wang, HB; Xiao, YS; Zhang, M; Yu, X; Xu, T; Bai, T; Zhu, HC				Pan, Zhou; Yang, Kang; Wang, Huibo; Xiao, Yusha; Zhang, Ming; Yu, Xi; Xu, Tao; Bai, Tao; Zhu, Hengcheng			MFAP4 deficiency alleviates renal fibrosis through inhibition of NF-kappa B and TGF-beta/Smad signaling pathways	FASEB JOURNAL			English	Article						inflammation; MFAP4; NF-kappa B pathway; renal fibrosis; TGF-beta; Smad	GROWTH-FACTOR-BETA; PROTEIN 4 MFAP4; IN-VIVO; INFLAMMATION; MECHANISMS; EXPRESSION; GENE	Renal fibrosis, which is characterized by excessive extracellular matrix (ECM) accumulation in the renal tubulointerstitium, can lead to chronic kidney disease (CKD). The role of microfiber-associated protein 4 (MFAP4), which is an ECM protein that interacts with elastin and collagen, in renal fibrosis has not been investigated. The aim of this study was to examine the role of MFAP4 in the pathogenesis of renal fibrosis and the underlying mechanism using in vivo and in vitro models. The MFAP4(-/-)mice were subjected to unilateral ureteral obstruction (UUO) to elucidate the role of MFAP4 in renal fibrosis in vivo. Compared to the wild-type mice, the MFAP4(-/-)mice exhibited decreased protein expression of p-p65 and p-IKB alpha and ECM deposition after UUO. The MFAP4(-/-)mice exhibited attenuated nuclear translocation of p65 (the hub subunit of nuclear factor (NF)-kappa B signaling pathway), suppressed activation of transforming growth factor (TGF)-beta/Smad pathways, and downregulated expression of fibronectin, collagen I, and plasminogen activator inhibitor-1. The knockdown of MFAP4 mitigated the TGF-beta-induced upregulated expression of fibronectin, collagen I, and plasminogen activator inhibitor-1 in the human proximal tubular epithelial cells (HK-2). Compared to the HK-2 cells transfected with sh-MFAP4, the HK-2 cells co-transfected with sh-MFAP4 and Ad-MFAP4 exhibited severe inflammatory response and increased fibrosis-related proteins expression. Mechanistically, the knockdown of MFAP4 inhibited the activation of NF-kappa B and TGF-beta/Smad signaling pathways and downregulated the expression of fibrosis-related proteins. The findings of this study indicate that MFAP4 is involved in UUO-induced renal fibrosis through regulation of NF-kappa B and TGF-beta/Smad pathways.	[Pan, Zhou; Yang, Kang; Yu, Xi; Xu, Tao; Bai, Tao; Zhu, Hengcheng] Wuhan Univ, Renmin Hosp, Dept Urol, 238 Jie Fang Ave, Wuhan 430060, Hubei, Peoples R China; [Wang, Huibo] Three Gorges Univ Peoples Hosp, Peoples Hosp Yichang 1, Dept Cardiol, Yichang, Peoples R China; [Xiao, Yusha] Wuhan Univ, Zhongnan Hosp, Res Ctr Digest Dis, Dept Gen Surg, Wuhan, Peoples R China; [Zhang, Ming] Wuhan Univ Sci & Technol, Puren Hosp, Dept Orthoped Trauma, Wuhan, Peoples R China	Wuhan University; Wuhan University; Wuhan University of Science & Technology	Zhu, HC (corresponding author), Wuhan Univ, Renmin Hosp, Dept Urol, 238 Jie Fang Ave, Wuhan 430060, Hubei, Peoples R China.	zhcheng2018@outlook.com						Bracht T, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0952-3; Chou DHI, 1996, J IMMUNOL, V156, P4354; Christensen AF, 2019, APMIS, V127, P588, DOI 10.1111/apm.12974; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Duffield JS, 2014, J CLIN INVEST, V124, P2299, DOI 10.1172/JCI72267; Fujihara CK, 2007, AM J PHYSIOL-RENAL, V292, pF92, DOI 10.1152/ajprenal.00184.2006; Guo W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153434; Holm AT, 2015, AM J PHYSIOL-LUNG C, V308, pL1114, DOI 10.1152/ajplung.00351.2014; Humphreys BD, 2018, ANNU REV PHYSIOL, V80, P309, DOI 10.1146/annurev-physiol-022516-034227; ISAKA Y, 1993, J CLIN INVEST, V92, P2597, DOI 10.1172/JCI116874; Johansson SL, 2014, RESP MED, V108, P1336, DOI 10.1016/j.rmed.2014.06.003; Kasamatsu S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00164; Khan SB, 2005, KIDNEY INT, V67, P1812, DOI 10.1111/j.1523-1755.2005.00279.x; Liu B, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-017-0760-6; Liu P, 2014, DIABETES RES CLIN PR, V105, P206, DOI 10.1016/j.diabres.2014.04.020; Lu QL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10116-0; Lv WS, 2018, EUR J PHARMACOL, V820, P65, DOI 10.1016/j.ejphar.2017.12.016; Melenovsky V, 2018, KIDNEY BLOOD PRESS R, V43, P1437, DOI 10.1159/000493657; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Meng XM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00082; Meng XM, 2012, KIDNEY INT, V81, P266, DOI 10.1038/ki.2011.327; Molleken C, 2009, HEPATOLOGY, V49, P1257, DOI 10.1002/hep.22764; Moon JA, 2006, KIDNEY INT, V70, P1234, DOI 10.1038/sj.ki.5001775; Pilecki B, 2016, J BIOL CHEM, V291, P1103, DOI 10.1074/jbc.M115.681775; Pilecki B, 2015, THORAX, V70, P862, DOI 10.1136/thoraxjnl-2014-206609; Schlosser A, 2016, ARTERIOSCL THROM VAS, V36, P122, DOI 10.1161/ATVBAHA.115.306672; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Thomsen T, 2011, MOL IMMUNOL, V48, P369, DOI 10.1016/j.molimm.2010.09.019; Toyoshima T, 1999, J HISTOCHEM CYTOCHEM, V47, P1049, DOI 10.1177/002215549904700809; Toyoshima T, 2008, CELL TISSUE RES, V332, P271, DOI 10.1007/s00441-008-0587-7; Webster AC, 2017, LANCET, V389, P1238, DOI 10.1016/S0140-6736(16)32064-5; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181; Wulf-Johansson H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082243; Yamaguchi Junna, 2015, F1000Res, V4, DOI 10.12688/f1000research.6970.1; Yang K, 2020, J CELL MOL MED, V24, P5740, DOI 10.1111/jcmm.15236; Zhang M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.206; Zhang XL, 2019, ARCH MED SCI, V15, P632, DOI 10.5114/aoms.2018.74953; Zhou XJ, 2017, INT IMMUNOPHARMACOL, V42, P18, DOI 10.1016/j.intimp.2016.11.006	38	13	13	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14250	14263		10.1096/fj.202001026R	http://dx.doi.org/10.1096/fj.202001026R		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32905637	hybrid			2022-12-26	WOS:000568306000001
J	Jha, R; Li, D; Wu, QL; Ferguson, KE; Forghani, P; Gibson, GC; Xu, CH				Jha, Rajneesh; Li, Dong; Wu, Qingling; Ferguson, Katherine E.; Forghani, Parvin; Gibson, Gregory C.; Xu, Chunhui			A long non-coding RNAGATA6-AS1adjacent toGATA6is required for cardiomyocyte differentiation from human pluripotent stem cells	FASEB JOURNAL			English	Article						cardiomyocyte; differentiation; hiPSC; hPSC; lncRNA; RNA-seq	GATA TRANSCRIPTION FACTORS; GENE-EXPRESSION; RNAS; HEART; DISCOVERY; LNCRNAS	Long noncoding RNAs (lncRNAs) are crucial in many cellular processes, yet relatively few have been shown to regulate human cardiomyocyte differentiation. Here, we demonstrate an essential role of GATA6 antisense RNA 1 (GATA6-AS1)in cardiomyocyte differentiation from human pluripotent stem cells (hPSCs).GATA6-AS1is adjacent to cardiac transcription factorGATA6. We found thatGATA6-AS1was nuclear-localized and transiently upregulated along withGATA6during the early stage of cardiomyocyte differentiation. The knockdown ofGATA6-AS1did not affect undifferentiated cell pluripotency but inhibited cardiomyocyte differentiation, as indicated by no or few beating cardiomyocytes and reduced expression of cardiomyocyte-specific proteins. Upon cardiac induction, the knockdown ofGATA6-AS1decreasedGATA6expression, altered Wnt-signaling gene expression, and reduced mesoderm development. Further characterization of the intergenic region between genomic regions ofGATA6-AS1andGATA6indicated that the expression ofGATA6-AS1andGATA6were regulated by a bidirectional promoter within the intergenic region. Consistently,GATA6-AS1andGATA6were co-expressed in several human tissues including the heart, similar to the mirror expression pattern ofGATA6-AS1andGATA6during cardiomyocyte differentiation. Overall, these findings reveal a previously unrecognized and functional role of lncRNAGATA6-AS1in controlling human cardiomyocyte differentiation.	[Jha, Rajneesh; Li, Dong; Wu, Qingling; Forghani, Parvin; Xu, Chunhui] Emory Univ, Sch Med, Dept Pediat, Div Pediat Cardiol, Atlanta, GA USA; [Jha, Rajneesh; Li, Dong; Wu, Qingling; Forghani, Parvin; Xu, Chunhui] Childrens Healthcare Atlanta, Atlanta, GA USA; [Wu, Qingling; Xu, Chunhui] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Wu, Qingling; Xu, Chunhui] Emory Univ, Atlanta, GA 30322 USA; [Ferguson, Katherine E.; Gibson, Gregory C.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA	Emory University; Children's Healthcare of Atlanta (CHOA); University System of Georgia; Georgia Institute of Technology; Emory University; University System of Georgia; Georgia Institute of Technology	Xu, CH (corresponding author), Emory Univ, Sch Med, Dept Pediat, 2015 Uppergate Dr, Atlanta, GA 30322 USA.	chunhui.xu@emory.edu		Forghani, Parvin/0000-0001-9727-3344	CASIS [GA-2017-266]; NIH/NIAAA [R21AA025723]; NIH/NHLBI [R01HL136345]; Emory University	CASIS; NIH/NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Emory University	CASIS, Grant/Award Number: GA-2017-266; NIH/NIAAA, Grant/Award Number: R21AA025723; NIH/NHLBI, Grant/Award Number: R01HL136345; Emory University	Afouda BA, 2008, DEVELOPMENT, V135, P3185, DOI 10.1242/dev.026443; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Britanova O, 2005, EUR J NEUROSCI, V21, P658, DOI 10.1111/j.1460-9568.2005.03897.x; Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dinger ME, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000176; Elliott DA, 2011, NAT METHODS, V8, P1037, DOI [10.1038/NMETH.1740, 10.1038/nmeth.1740]; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Frank S, 2019, CELL STEM CELL, V24, P318, DOI 10.1016/j.stem.2018.11.005; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Guo XD, 2018, CELL STEM CELL, V22, P893, DOI 10.1016/j.stem.2018.04.013; Herriges MJ, 2014, GENE DEV, V28, P1363, DOI 10.1101/gad.238782.114; Jha R, 2017, STEM CELL REP, V9, P513, DOI 10.1016/j.stemcr.2017.07.006; Jha R, 2016, SCI REP-UK, V6, DOI 10.1038/srep30956; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Kodo K, 2009, P NATL ACAD SCI USA, V106, P13933, DOI 10.1073/pnas.0904744106; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Liu JL, 2017, DEV CELL, V42, P333, DOI 10.1016/j.devcel.2017.07.023; Liu Q, 2017, CIRC RES, V121, P376, DOI 10.1161/CIRCRESAHA.116.310456; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo S, 2016, CELL STEM CELL, V18, P637, DOI 10.1016/j.stem.2016.01.024; Marques AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r124; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Molkentin JD, 2000, DEV BIOL, V217, P301, DOI 10.1006/dbio.1999.9544; Mondal T, 2010, GENOME RES, V20, P899, DOI 10.1101/gr.103473.109; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Neumann P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02431-1; Ono K, 2018, CIRC J, V82, P1231, DOI 10.1253/circj.CJ-18-0169; Ounzain S, 2015, J MOL CELL CARDIOL, V89, P17, DOI 10.1016/j.yjmcc.2015.09.013; Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617; R Development Core Team, 2014, R LANG ENV STAT COMP; Ronaldson-Bouchard K, 2018, NATURE, V556, P239, DOI 10.1038/s41586-018-0016-3; Schonrock N, 2012, CIRC RES, V111, P1349, DOI 10.1161/CIRCRESAHA.112.268953; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Tian Y, 2010, DEV CELL, V18, P275, DOI 10.1016/j.devcel.2010.01.008; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Tsoi LC, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0570-4; van Berlo JH, 2010, CIRC RES, V107, P1032, DOI 10.1161/CIRCRESAHA.110.220764; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao RO, 2005, MOL CELL BIOL, V25, P2622, DOI 10.1128/MCB.25.7.2622-2631.2005; Zhao R, 2008, DEV BIOL, V317, P614, DOI 10.1016/j.ydbio.2008.03.013	47	8	8	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14336	14352		10.1096/fj.202000206R	http://dx.doi.org/10.1096/fj.202000206R		SEP 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32888237	Green Accepted			2022-12-26	WOS:000568280900001
J	Baik, I; Park, SI				Baik, Inkyung; Park, Sang Ick			Associations of alcohol consumption and physical activity with lean type 2 diabetes mellitus among Korean adults: A prospective cohort study	PLOS ONE			English	Article							RISK	Data on the association between alcohol consumption and the risk of type 2 diabetes mellitus (T2DM) have accumulated, but little has been reported about this association in terms of lean T2DM. The present study analyzed 10-year longitudinal data to investigate the association between alcohol consumption and T2DM risk among lean individuals. This prospective study included 2,366 male and female Koreans aged 40-69 years who were free of DM and had a body mass index (BMI) <23 kg/m(2)during the baseline period between 2001 and 2012. Information on alcohol consumption, BMI, and incident cases of T2DM were identified by interviews and health examinations. To analyze the association between alcohol consumption and T2DM risk, Cox proportional hazard regression analysis was used. Alcohol drinkers consuming at least 16 g/day of alcohol (2 units/day) who maintained a BMI <23 kg/m(2)over 10 years had a significantly higher T2DM risk even after controlling for BMI and potential risk factors. Compared with lifetime abstainers, multivariate hazard ratios (HR) [95% confidence interval] of T2DM were 1.74 [1.02, 2.95] for 16-30 g/day, 2.09 [1.16, 3.77] for 31-60 g/day, and 1.94 [1.07, 3.51] for >60g/day among alcohol drinkers. No protective effect of moderate alcohol consumption <16 g/day on T2DM risk was observed. Age, parental history of DM, and physical inactivity were also significant risk factors for lean T2DM. Alcohol consumption of at least 2 units/day increased T2DM risk among lean individuals. Abstaining from alcohol and physical activity may be beneficial for the prevention of lean T2DM.	[Baik, Inkyung] Kookmin Univ, Coll Sci & Technol, Dept Foods & Nutr, Seoul, South Korea; [Park, Sang Ick] Korea Natl Inst Hlth, Ctr Biomed Sci, Cheongju, South Korea	Kookmin University; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science	Baik, I (corresponding author), Kookmin Univ, Coll Sci & Technol, Dept Foods & Nutr, Seoul, South Korea.	ibaik@kookmin.ac.kr			National Research Foundation of Korea Grant - Korean Government [NRF-2019R1A2C2084000]	National Research Foundation of Korea Grant - Korean Government	National Research Foundation of Korea Grant funded by the Korean Government (NRF-2019R1A2C2084000) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albano E, 2006, P NUTR SOC, V65, P278, DOI 10.1079/PNS2006496; Baik I, 2008, AM J CLIN NUTR, V87, P1455, DOI 10.1093/ajcn/87.5.1455; Baik I, 2010, J AM DIET ASSOC, V110, P1018, DOI 10.1016/j.jada.2010.04.013; Baliunas DO, 2009, DIABETES CARE, V32, P2123, DOI 10.2337/dc09-0227; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Centers for Disease Control and Prevention, 2017, NAT DIAB STAT REP 20; Coleman NJ, 2014, J DIABETES COMPLICAT, V28, P500, DOI 10.1016/j.jdiacomp.2013.11.010; Dembele K, 2009, CELL BIOL TOXICOL, V25, P141, DOI 10.1007/s10565-008-9067-9; George AM, 2015, WORLD J DIABETES, V6, P613, DOI 10.4239/wjd.v6.i4.613; Gujral UP, 2018, DIABETES RES CLIN PR, V146, P34, DOI 10.1016/j.diabres.2018.09.011; Hartmann B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183235; Kim JY, 2010, J BIOL CHEM, V285, P37251, DOI 10.1074/jbc.M110.142315; Kim Y, 2017, INT J EPIDEMIOL, V46, P1350, DOI 10.1093/ije/dyx105; Knott C, 2015, DIABETES CARE, V38, P1804, DOI 10.2337/dc15-0710; Kong XM, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003841; Korean Diabetes Association, 2018, DIAB FACT SHEET KOR; Langenberg C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001647; Li XH, 2016, AM J CLIN NUTR, V103, P818, DOI 10.3945/ajcn.115.114389; Ministry of Health and Welfare, 2016, KOR HLTH STAT 2015 K; Munukutla S, 2016, ALCOHOL CLIN EXP RES, V40, P686, DOI 10.1111/acer.13008; Perry JRB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002741; Scott RA, 2013, DIABETOLOGIA, V56, P60, DOI 10.1007/s00125-012-2715-x; Timpson NJ, 2009, DIABETES, V58, P505, DOI 10.2337/db08-0906	23	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238641	10.1371/journal.pone.0238641	http://dx.doi.org/10.1371/journal.pone.0238641			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881937	Green Published, gold			2022-12-26	WOS:000571063300026
J	Braganca, CE; Kraut, DA				Braganca, Christopher Eric; Kraut, Daniel Adam			Mode of targeting to the proteasome determines GFP fate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proteasome; protein unfolding; protein degradation; ATP-dependent protease; ATPases associated with diverse cellular activities (AAA); enzyme kinetics; pre&#8211; steady-state kinetics; enzyme mechanism	UBIQUITIN/PROTEASOME-DEPENDENT PROTEOLYSIS; UBIQUITINATED PROTEINS ACTIVATE; DEGRADATION; IMPAIRMENT; PATHWAY; BINDING; ABILITY; SYSTEM	The ubiquitin-proteasome system is the canonical pathway for protein degradation in eukaryotic cells. GFP is frequently used as a reporter in proteasomal degradation assays. However, there are multiple variants of GFP in use, and these variants have different intrinsic stabilities. Further, there are multiple means by which substrates are targeted to the proteasome, and these differences could also affect the proteasome's ability to unfold and degrade substrates. Herein we investigate how the fate of GFP variants of differing intrinsic stabilities is determined by the mode of targeting to the proteasome. We compared two targeting systems: linear Ub(4) degrons and the UBL domain from yeast Rad23, both of which are commonly used in degradation experiments. Surprisingly, the UBL degron allows for degradation of the most stable sGFP-containing substrates, whereas the Ub(4) degron does not. Destabilizing the GFP by circular permutation allows degradation with either targeting signal, indicating that domain stability and mode of targeting combine to determine substrate fate. Difficult-to-unfold substrates are released and re-engaged multiple times, with removal of the degradation initiation region providing an alternative clipping pathway that precludes unfolding and degradation; the UBL degron favors degradation of even difficult-to-unfold substrates, whereas the Ub(4) degron favors clipping. Finally, we show that the ubiquitin receptor Rpn13 is primarily responsible for the enhanced ability of the proteasome to degrade stable UBL-tagged substrates. Our results indicate that the choice of targeting method and reporter protein are critical to the design of protein degradation experiments.	[Braganca, Christopher Eric; Kraut, Daniel Adam] Villanova Univ, Dept Chem, Villanova, PA 19085 USA	Villanova University	Kraut, DA (corresponding author), Villanova Univ, Dept Chem, Villanova, PA 19085 USA.	daniel.kraut@villanova.edu		Kraut, Daniel/0000-0002-4428-5832	Beckman Scholars Program; National Science Foundation [1515229, 1935596]	Beckman Scholars Program; National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by the Beckman Scholars Program and the National Science Foundation under Grants 1515229 and 1935596 (to D. A. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arquier N, 2006, BIOCHEM J, V393, P471, DOI 10.1042/BJ20050675; Bashore C, 2015, NAT STRUCT MOL BIOL, V22, P712, DOI 10.1038/nsmb.3075; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Beskow A, 2009, J MOL BIOL, V394, P732, DOI 10.1016/j.jmb.2009.09.050; Cundiff MD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50857-y; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Gautam AKS, 2018, METHODS MOL BIOL, V1844, P321, DOI 10.1007/978-1-4939-8706-1_21; Greussing R, 2012, JOVE-J VIS EXP, DOI 10.3791/3327; Grice GL, 2016, CELL MOL LIFE SCI, V73, P3497, DOI 10.1007/s00018-016-2255-5; Heessen S, 2003, FEBS LETT, V555, P397, DOI 10.1016/S0014-5793(03)01296-1; Henderson A, 2011, J BIOL CHEM, V286, P17495, DOI 10.1074/jbc.M110.212027; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Khmelinskii A, 2012, NAT BIOTECHNOL, V30, P708, DOI 10.1038/nbt.2281; Koodathingal P, 2009, J BIOL CHEM, V284, P18674, DOI 10.1074/jbc.M900783200; Kraut DA, 2012, ACS CHEM BIOL, V7, P1444, DOI 10.1021/cb3001155; Lu Y, 2015, SCIENCE, V348, DOI 10.1126/science.1250834; Martinez-Fonts K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13906-8; Maynard CJ, 2009, P NATL ACAD SCI USA, V106, P13986, DOI 10.1073/pnas.0906463106; McKinnon C, 2016, ACTA NEUROPATHOL, V131, P411, DOI 10.1007/s00401-015-1508-y; Moura DMN, 2019, MOL BIOCHEM PARASIT, V227, P15, DOI 10.1016/j.molbiopara.2018.11.001; Nager AR, 2011, J MOL BIOL, V413, P4, DOI 10.1016/j.jmb.2011.07.041; Olivares AO, 2018, ANNU REV PHYSIOL, V80, P413, DOI 10.1146/annurev-physiol-021317-121303; Olivares AO, 2016, NAT REV MICROBIOL, V14, P33, DOI 10.1038/nrmicro.2015.4; Olszewski MM, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0283-z; Peth A, 2013, J BIOL CHEM, V288, P7781, DOI 10.1074/jbc.M112.441907; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Reichard EL, 2016, J BIOL CHEM, V291, P18547, DOI 10.1074/jbc.M116.720151; Shi Y, 2016, SCIENCE, V351, DOI 10.1126/science.aad9421; Snoberger A, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00018; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Thibaudeau TA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03509-0; Tomita T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16003-3; Trauth J, 2020, AIMS BIOPHYS, V7, P90, DOI 10.3934/biophy.2020008; Wang SH, 2017, DEVELOPMENT, V144, P2694, DOI 10.1242/dev.150094; Yu HQ, 2016, EMBO J, V35, P1522, DOI 10.15252/embj.201593147	39	5	5	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2020	295	47					15892	15901		10.1074/jbc.RA120.015235	http://dx.doi.org/10.1074/jbc.RA120.015235			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PA5ED	32913119	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000595657900009
J	Gutierrez-Munoz, C; Mendez-Barbero, N; Svendsen, P; Sastre, C; Fernandez-Laso, V; Quesada, P; Egido, J; Escola-Gil, JC; Martin-Ventura, JL; Moestrup, SK; Blanco-Colio, LM				Gutierrez-Munoz, Carmen; Mendez-Barbero, Nerea; Svendsen, Pia; Sastre, Cristina; Fernandez-Laso, Valvanera; Quesada, Patricia; Egido, Jesus; Escola-Gil, Joan C.; Martin-Ventura, Jose L.; Moestrup, Soren K.; Blanco-Colio, Luis M.			CD163 deficiency increases foam cell formation and plaque progression in atherosclerotic mice	FASEB JOURNAL			English	Article						atherosclerosis; CD163; inflammation; TWEAK	NECROSIS-FACTOR-ALPHA; SCAVENGER RECEPTOR; ALTERNATIVE ACTIVATION; HUMAN MONOCYTES; M2 MACROPHAGES; HEMOGLOBIN; TWEAK; ANGIOGENESIS; INFLAMMATION; EXPRESSION	Atherosclerosis is an inflammatory disease characterized by the accumulation of macrophages in the vessel wall. Macrophages depend on their polarization to exert either pro-inflammatory or anti-inflammatory effects. Macrophages of the anti-inflammatory phenotype express high levels of CD163, a scavenger receptor for the hemoglobin-haptoglobin complex. CD163 can also bind to the pro-inflammatory cytokine TWEAK. UsingApoE-deficient orApoE/CD163double-deficient mice we aim to investigate the involvement of CD163 in atherosclerosis development and its capacity to neutralize the TWEAK actions.ApoE/CD163double-deficient mice displayed a more unstable plaque phenotype characterized by an increased lipid and macrophage content, plaque size, and pro-inflammatory cytokine expression. In vitro experiments demonstrated that the absence of CD163 in M2-type macrophages-induced foam cell formation through upregulation of CD36 expression. Moreover, exogenous TWEAK administration increased atherosclerotic lesion size, lipids, and macrophages content inApoE(-/-)/CD163(-/-)compared withApoE(-/-)/CD163(+/+)mice. Treatment with recombinant CD163 was able to neutralize the proatherogenic effects of TWEAK inApoE/CD163 double-deficient mice. Recombinant CD163 abolished the pro-inflammatory actions of TWEAK on vascular smooth muscle cells, decreasing NF-kB activation, cytokines and metalloproteinases expression, and macrophages migration. In conclusion, CD163-expressing macrophages serve as a protective mechanism to prevent the deleterious effects of TWEAK on atherosclerotic plaque development and progression.	[Gutierrez-Munoz, Carmen; Mendez-Barbero, Nerea; Fernandez-Laso, Valvanera; Quesada, Patricia; Martin-Ventura, Jose L.; Blanco-Colio, Luis M.] Jimenez Diaz Univ Hosp, IIS Fdn, Vasc Res Lab, Av Reyes Catolicos 2, Madrid 28040, Spain; [Mendez-Barbero, Nerea; Fernandez-Laso, Valvanera; Martin-Ventura, Jose L.; Blanco-Colio, Luis M.] Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain; [Svendsen, Pia] Aarhus Univ Hosp, Dept Clin Med, Aarhus, Denmark; [Sastre, Cristina] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Egido, Jesus] IIS Fdn Jimenez Diaz, Renal Vasc & Diabet Res Lab, Madrid, Spain; [Egido, Jesus; Escola-Gil, Joan C.] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [Escola-Gil, Joan C.] Inst Invest Biomed IIB St Pau, Barcelona, Spain; [Moestrup, Soren K.] Univ Southern Denmark, Dept Mol Med, Oddense, Denmark; [Moestrup, Soren K.] Aarhus Univ, Dept Biomed, Aarhus, Denmark	Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Aarhus University; Harvard University; Massachusetts General Hospital; Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Southern Denmark; Aarhus University	Blanco-Colio, LM (corresponding author), Jimenez Diaz Univ Hosp, IIS Fdn, Vasc Res Lab, Av Reyes Catolicos 2, Madrid 28040, Spain.	lblanco@fjd.es	Escolà-Gil, Joan Carles/H-9522-2014	Escola-Gil, Joan Carles/0000-0001-9021-2485	Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III [ISCiii/FEDER PI16/01419, PI19/00128]; Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM); Cardiovascular Disease (CIBERCV), Spain	Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM); Cardiovascular Disease (CIBERCV), Spain	This work was supported by Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (ISCiii/FEDER PI16/01419, PI19/00128) and Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM) and Cardiovascular Disease (CIBERCV), Spain.	Akahori H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8792; Blanco-Colio LM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00003; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Bover LC, 2007, J IMMUNOL, V178, P8183, DOI 10.4049/jimmunol.178.12.8183; Boyle JJ, 2012, CIRC RES, V110, P20, DOI 10.1161/CIRCRESAHA.111.247577; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Escola-Gil JC, 2013, BBA-MOL CELL BIOL L, V1831, P691, DOI 10.1016/j.bbalip.2013.01.003; Etzerodt A, 2013, ANTIOXID REDOX SIGN, V18, P2254, DOI 10.1089/ars.2012.4605; Etzerodt A, 2010, J LEUKOCYTE BIOL, V88, P1201, DOI 10.1189/jlb.0410235; Finn AV, 2012, J AM COLL CARDIOL, V59, P166, DOI 10.1016/j.jacc.2011.10.852; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Greaves DR, 2009, J LIPID RES, V50, pS282, DOI 10.1194/jlr.R800066-JLR200; Guo L, 2018, J CLIN INVEST, V128, P1106, DOI 10.1172/JCI93025; Harada N, 2002, BIOCHEM BIOPH RES CO, V299, P488, DOI 10.1016/S0006-291X(02)02670-0; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Leitinger N, 2013, ARTERIOSCL THROM VAS, V33, P1120, DOI 10.1161/ATVBAHA.112.300173; Levy AP, 2007, CIRC RES, V101, P106, DOI 10.1161/CIRCRESAHA.107.149435; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Lynch CN, 1999, J BIOL CHEM, V274, P8455, DOI 10.1074/jbc.274.13.8455; Moller HJ, 2012, SCAND J CLIN LAB INV, V72, P1, DOI 10.3109/00365513.2011.626868; Moller HJ, 2010, IMMUNOBIOLOGY, V215, P406, DOI 10.1016/j.imbio.2009.05.003; Moreno JA, 2010, ARTERIOSCL THROM VAS, V30, P1253, DOI 10.1161/ATVBAHA.110.203364; Moreno JA, 2009, ATHEROSCLEROSIS, V207, P103, DOI 10.1016/j.atherosclerosis.2009.04.033; Munoz-Garcia B, 2006, STROKE, V37, P2044, DOI 10.1161/01.STR.0000230648.00027.00; Munoz-Garcia B, 2011, CARDIOVASC RES, V89, P225, DOI 10.1093/cvr/cvq278; Munoz-Garcia B, 2009, ARTERIOSCL THROM VAS, V29, P2061, DOI 10.1161/ATVBAHA.109.194852; Pamukcu B, 2011, THROMB RES, V128, P117, DOI 10.1016/j.thromres.2011.03.025; PULFORD K, 1992, IMMUNOLOGY, V75, P588; Rahman K, 2017, J CLIN INVEST, V127, P2904, DOI 10.1172/JCI75005; Rekhter MD, 2002, CARDIOVASC RES, V54, P36, DOI 10.1016/S0008-6363(01)00537-5; Rosenfeld ME, 2000, ARTERIOSCL THROM VAS, V20, P2587, DOI 10.1161/01.ATV.20.12.2587; Sastre C, 2014, J CELL MOL MED, V18, P721, DOI 10.1111/jcmm.12221; Schaer CA, 2006, CIRC RES, V99, P943, DOI 10.1161/01.RES.0000247067.34173.1b; Schapira K, 2009, ARTERIOSCL THROM VAS, V29, P2021, DOI 10.1161/ATVBAHA.109.195040; STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462; Stoll G, 2006, STROKE, V37, P1923, DOI 10.1161/01.STR.0000226901.34927.10; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Tarin C, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000723; Tarin C, 2015, SCI REP-UK, V5, DOI 10.1038/srep17135; Timmermann M, 2005, FREE RADICAL BIO MED, V39, P98, DOI 10.1016/j.freeradbiomed.2005.02.031; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Zheng TS, 2008, J LEUKOCYTE BIOL, V84, P338, DOI 10.1189/jlb.0308165	45	8	9	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14960	14976		10.1096/fj.202000177R	http://dx.doi.org/10.1096/fj.202000177R		SEP 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32924185	hybrid, Green Published			2022-12-26	WOS:000570666300001
J	Rademacher, M; Kuhn, H; Borchert, A				Rademacher, Marlena; Kuhn, Hartmut; Borchert, Astrid			Systemic deficiency of mouse arachidonate 15-lipoxygenase induces defective erythropoiesis and transgenic expression of the human enzyme rescues this phenotype	FASEB JOURNAL			English	Article						biomembranes; differentiation; eicosanoids; lipid peroxidation; redox equilibrium; reticulocytes	FLOW-CYTOMETRIC DETECTION; RABBIT RETICULOCYTES; MESSENGER-RNA; PHOSPHATIDYLSERINE EXPRESSION; LIPOXYGENASE PRODUCTS; OXIDATIVE STRESS; 12/15-LIPOXYGENASE; MITOCHONDRIA; MATURATION; MEMBRANES	Arachidonic acid 15-lipoxygenases (ALOX15) are lipid peroxidizing enzymes, which has previously been implicated in the maturational breakdown of intracellular organelles and plasma membrane remodeling during reticulocyte-erythrocyte transition. ConventionalAlox15(-/-)mice are viable, develop normally but do not exhibit a major defective erythropoietic phenotype. To characterize the putative in vivo relevance of Alox15 for red blood cell development, we explored the impact of systemic inactivation of theAlox15gene on mouse erythropoiesis. We found thatAlox15(-/-)mice exhibited reduced erythrocyte counts, elevated reticulocyte counts and red cell hyperchromia. The structure of the plasma membrane ofAlox15(-/-)erythrocytes is altered and a significant share of the red cells was present as echinocytes and/or acanthocytes. An increased share of the Alox15(-/-)erythrocytes cells were annexin V positive, which indicates a loss of plasma membrane asymmetry. Erythrocytes ofAlox15(-/-)mice were more susceptible to osmotic hemolysis and exhibited a reduced ex vivo life span. When we transgenically expressed human ALOX15 inAlox15(-/-)mice under the control of the aP2 promoter the defective erythropoietic system was rescued and the impaired osmotic resistance was normalized. Together these data suggest the involvement Alox15 in the maturational remodeling of the plasma membrane during red cell development.	[Rademacher, Marlena; Kuhn, Hartmut; Borchert, Astrid] Charite Univ Med Berlin, Chariteplatz 1,CCO Bldg,Virchowweg 6, D-10117 Berlin, Germany; [Rademacher, Marlena; Kuhn, Hartmut; Borchert, Astrid] Free Univ Berlin, Humboldt Univ Berlin, Chariteplatz 1,CCO Bldg,Virchowweg 6, D-10117 Berlin, Germany; [Rademacher, Marlena; Kuhn, Hartmut; Borchert, Astrid] Berlin Inst Hlth, Inst Biochem, Chariteplatz 1,CCO Bldg,Virchowweg 6, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health	Borchert, A (corresponding author), Charite Univ Med Berlin, Chariteplatz 1,CCO Bldg,Virchowweg 6, D-10117 Berlin, Germany.; Borchert, A (corresponding author), Free Univ Berlin, Humboldt Univ Berlin, Chariteplatz 1,CCO Bldg,Virchowweg 6, D-10117 Berlin, Germany.; Borchert, A (corresponding author), Berlin Inst Hlth, Inst Biochem, Chariteplatz 1,CCO Bldg,Virchowweg 6, D-10117 Berlin, Germany.	astrid.borchert@charite.de		Borchert, Astrid/0000-0003-3551-5592	Deutsche Forschungsgemeinschaft (DFG) [Ku 961/11-1, Ku 961/13-1, Ku 961/14-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: Ku 961/11-1, Ku 961/13-1 and Ku 961/14-1	Bauche IB, 2007, ENDOCRINOLOGY, V148, P1539, DOI 10.1210/en.2006-0838; Bigdelou P, 2020, JOVE-J VIS EXP, DOI 10.3791/60659; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brash AR, 2007, FEBS J, V274, P3494, DOI 10.1111/j.1742-4658.2007.05909.x; Cozza G, 2017, FREE RADICAL BIO MED, V112, P1, DOI 10.1016/j.freeradbiomed.2017.07.010; DUBIEL W, 1989, RBC-CELL BIOL REV, V21, P505; Epp N, 2007, J CELL BIOL, V177, P173, DOI 10.1083/jcb.200612116; Foretz M, 2010, FEBS LETT, V584, P3667, DOI 10.1016/j.febslet.2010.07.041; Fulda S, 2016, BIOL CHEM, V397, P657, DOI 10.1515/hsz-2016-0102; Funk CD, 1996, J BIOL CHEM, V271, P23338, DOI 10.1074/jbc.271.38.23338; Funk CD, 2002, PROSTAG OTH LIPID M, V68-9, P303, DOI 10.1016/S0090-6980(02)00036-9; Galadari S, 2017, FREE RADICAL BIO MED, V104, P144, DOI 10.1016/j.freeradbiomed.2017.01.004; Gutteridge JMC, 2018, BIOCHEM BIOPH RES CO, V502, P183, DOI 10.1016/j.bbrc.2018.05.045; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; HOHNE M, 1983, BIOMED BIOCHIM ACTA, V42, P1129; Ivanov I, 2015, GENE, V573, P1, DOI 10.1016/j.gene.2015.07.073; Vallejo MJ, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4586068; Kim TS, 2015, J CLIN INVEST, V125, P3965, DOI 10.1172/JCI81919; Kinder M, 2010, BLOOD, V115, P5012, DOI 10.1182/blood-2009-09-243139; King MJ, 2013, INT J LAB HEMATOL, V35, P237, DOI 10.1111/ijlh.12070; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; KROSCHWALD P, 1986, BIOMED BIOCHIM ACTA, V45, P1237; KROSCHWALD P, 1989, BIOCHEM BIOPH RES CO, V160, P954, DOI 10.1016/0006-291X(89)92528-X; KUHN H, 1990, EUR J BIOCHEM, V191, P221, DOI 10.1111/j.1432-1033.1990.tb19113.x; KUHN H, 1990, J BIOL CHEM, V265, P18351; KUHN H, 1990, J BIOL CHEM, V265, P1454; Kuhn H, 2018, PROG LIPID RES, V72, P55, DOI 10.1016/j.plipres.2018.09.002; Kuhn H, 2015, BBA-MOL CELL BIOL L, V1851, P308, DOI 10.1016/j.bbalip.2014.10.002; Kumar TR, 2009, METHODS MOL BIOL, V590, P335, DOI 10.1007/978-1-60327-378-7_22; Kutzner L, 2017, BBA-MOL CELL BIOL L, V1862, P666, DOI 10.1016/j.bbalip.2017.04.001; Lang E, 2015, SCI REP-UK, V5, DOI 10.1038/srep17316; Mhatre M, 2004, J ALZHEIMERS DIS, V6, P147; Middleton MK, 2006, J EXP MED, V203, P2529, DOI 10.1084/jem.20061444; NADEL JA, 1991, J CLIN INVEST, V87, P1139, DOI 10.1172/JCI115110; Nakano M, 2005, GENES CELLS, V10, P47, DOI 10.1111/j.1365-2443.2005.00814.x; O'Connell KE, 2015, COMPARATIVE MED, V65, P96; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; OSTARECKLEDERER A, 1994, EMBO J, V13, P1476, DOI 10.1002/j.1460-2075.1994.tb06402.x; Poeckel D, 2009, J BIOL CHEM, V284, P21077, DOI 10.1074/jbc.M109.000901; Raabe BM, 2011, J AM ASSOC LAB ANIM, V50, P680; RAPOPORT S, 1985, FEBS LETT, V180, P249, DOI 10.1016/0014-5793(85)81080-2; RAPOPORT SM, 1986, BIOCHIM BIOPHYS ACTA, V864, P471, DOI 10.1016/0304-4157(86)90006-7; RAPOPORT SM, 1979, EUR J BIOCHEM, V96, P545, DOI 10.1111/j.1432-1033.1979.tb13068.x; Schewe T, 1981, Methods Enzymol, V71 Pt C, P430; SCHEWE T, 1975, FEBS LETT, V60, P149, DOI 10.1016/0014-5793(75)80439-X; SCHEWE T, 1986, ADV ENZYMOL RAMB, V58, P191; SCHEWE T, 1990, BIOMED BIOCHIM ACTA, V49, pS42; Sun DX, 1996, J BIOL CHEM, V271, P24055, DOI 10.1074/jbc.271.39.24055; Taylor PR, 2012, BLOOD, V119, P6173, DOI 10.1182/blood-2012-02-410928; THIELE BJ, 1982, EUR J BIOCHEM, V129, P133, DOI 10.1111/j.1432-1033.1982.tb07031.x; Tsiftsoglou AS, 2009, IUBMB LIFE, V61, P800, DOI 10.1002/iub.226; van Leyen K, 1998, NATURE, V395, P392, DOI 10.1038/26500; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Yaribeygi H, 2018, CNS NEUROL DISORD-DR, V17, P207, DOI 10.2174/1871527317666180425122557; Zhang LX, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101284	56	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14318	14335		10.1096/fj.202000408RR	http://dx.doi.org/10.1096/fj.202000408RR		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32918502	Green Published, hybrid			2022-12-26	WOS:000570675200001
J	Shen, BZ; Cao, ZJ; Wu, YL; Yi, W; Zhu, ZY; Lv, ZH; Zhu, CL; Yu, Y				Shen, Bingzheng; Cao, Zhijian; Wu, Yingliang; Yi, Wei; Zhu, Zhanyong; Lv, Zhihua; Zhu, Chengliang; Yu, Yan			Purlisin, a toxin-like defensin derived from clinical pathogenic fungusPurpureocillium lilacinumwith both antimicrobial and potassium channel inhibitory activities	FASEB JOURNAL			English	Article						antibacterial effect; hKv1; 3 blocker; purlisin-NT; purlisin-CT; toxin-like peptide	IMMUNE-RESPONSES; PLECTASIN; PEPTIDES; INSIGHTS; FUNGI; MODE; SKIN	Clinical fungal infections always cause a negative impact on human health. Moreover, during the interaction of pathogenic fungi with the environment and host, many biologically active substances are produced. Here, we report a new toxin-like defensin of purlisin derived from a clinical pathogenic isolate ofPurpureocillium lilacinum. The analysis of its genomic and mRNA sequences revealed an open reading frame of 444 bp without introns. The deduced precursor peptide was composed of 147 amino acids, and the mature peptide were identified at protein level by LC-ESI-Q-TOF-MS/MS. After posttranslational processing, the precursor peptide of purlisin was split into two independent peptides. The two mature defensins, purlisin-NT and purlisin-CT, are consisting of 36 and 38 amino acid residues, which can form three and four intramolecular disulfide bonds, respectively. The results of circular dichroism and homology modeling revealed that they adopted a representative cysteine-stabilized alpha-helical and beta-sheet motif. The purlisin-NT showed a dose-dependent selective inhibition of immune-relatedhKv1.3 target channel with IC(50)value of 0.2 +/- 0.04 mu M but no obvious antibacterial activity, while the purlisin-CT displayed antimicrobial activities against gram-positive bacteria as well as clinical isolates of MRSA and low affinities for potassium channels. Our findings suggest that purlisin-NT with immunosuppressive effects and purlisin-CT possessing antibacterial activities are adapted to the survival and pathogenicity of clinicalP lilacinumis. Moreover, they can also be used as templates for the design of novel antibacterial peptide and immunosuppressive agents.	[Shen, Bingzheng] Wuhan Univ, Dept Pharm, Renmin Hosp, Wuhan, Peoples R China; [Shen, Bingzheng; Cao, Zhijian; Wu, Yingliang] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Peoples R China; [Yi, Wei] Wuhan Univ, Dept Neurosurg, Renmin Hosp, Wuhan, Peoples R China; [Zhu, Zhanyong] Wuhan Univ, Dept Plast Surg, Renmin Hosp, Wuhan, Peoples R China; [Lv, Zhihua; Zhu, Chengliang] Wuhan Univ, Dept Clin Lab, Renmin Hosp, Wuhan, Peoples R China; [Yu, Yan] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Gastroenterol, Tongji Med Coll, 1095 Jie Fang Ave, Wuhan 430030, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Wuhan University; Wuhan University; Huazhong University of Science & Technology	Yu, Y (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Gastroenterol, Tongji Med Coll, 1095 Jie Fang Ave, Wuhan 430030, Peoples R China.	yyu_hust@yeah.net			National Natural Science Foundation of China [31700086, 81900476, 81601691]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 31700086, 81900476 and 81601691	Accelrys Software Inc, 2012, DISC STUD MOD ENV RE; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Bueno-Pallero FA, 2018, J INVERTEBR PATHOL, V154, P85, DOI 10.1016/j.jip.2018.04.004; Cabezas-Cruz A, 2019, TICKS TICK-BORNE DIS, V10, DOI 10.1016/j.ttbdis.2019.101269; Chew R, 2016, CAN J OPHTHALMOL, V51, P382, DOI 10.1016/j.jcjo.2016.05.013; CORNET B, 1995, STRUCTURE, V3, P435, DOI 10.1016/S0969-2126(01)00177-0; Dash TS, 2019, STRUCTURE, V27, P315, DOI 10.1016/j.str.2018.10.022; Dias RD, 2015, PEPTIDES, V72, P64, DOI 10.1016/j.peptides.2015.04.017; Essig A, 2014, J BIOL CHEM, V289, P34953, DOI 10.1074/jbc.M114.599878; Feng J, 2013, J BIOL CHEM, V288, P12544, DOI 10.1074/jbc.M112.433888; Fiedler Z, 2007, BIOCONTROL, V52, P547, DOI 10.1007/s10526-006-9052-2; Franzoi M, 2017, BIOCHEMISTRY-US, V56, P4992, DOI 10.1021/acs.biochem.7b00697; Gan GL, 2008, J BIOL CHEM, V283, P24177, DOI 10.1074/jbc.M800179200; Holland DB, 2009, FEMS MICROBIOL LETT, V290, P149, DOI 10.1111/j.1574-6968.2008.01402.x; Jin L, 2007, J CHEM INF MODEL, V47, P1967, DOI 10.1021/ci700178w; Jung S, 2009, J BIOL CHEM, V284, P1896, DOI 10.1074/jbc.M804713200; Kirk R, 2008, TLS-TIMES LIT SUPPL, P10; Koo GC, 1997, J IMMUNOL, V158, P5120; Krishna S, 2012, CURR OPIN MICROBIOL, V15, P28, DOI 10.1016/j.mib.2011.11.003; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lang YG, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20171282; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu SP, 2008, CHEMBIOCHEM, V9, P964, DOI 10.1002/cbic.200700560; Luo XD, 2019, J BIOCHEM MOL TOXIC, V33, DOI 10.1002/jbt.22244; Lysek H, 1996, ACTA U PALACKI OLOMU, V40, P83; Madio B, 2019, MAR DRUGS, V17, DOI 10.3390/md17060325; Mikov A N, 2015, Bioorg Khim, V41, P511; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Norton RS, 2017, NEUROPHARMACOLOGY, V127, P124, DOI 10.1016/j.neuropharm.2017.07.002; Oeemig JS, 2012, J BIOL CHEM, V287, P42361, DOI 10.1074/jbc.M112.382028; Parisi K, 2019, SEMIN CELL DEV BIOL, V88, P107, DOI 10.1016/j.semcdb.2018.02.004; Raghavan Ramya, 2018, Curr Med Mycol, V4, P36, DOI 10.18502/cmm.4.2.62; Richardson MD., 2012, FUNGAL INFECT DIAGNO, V4th ed.; Santussi WM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00984; Sathoff AE, 2019, MOL PLANT MICROBE IN, V32, P507, DOI 10.1094/MPMI-08-18-0229-CR; Shen BZ, 2018, PEPTIDES, V107, P61, DOI 10.1016/j.peptides.2018.08.003; STIRLING G R, 1991, Australasian Plant Pathology, V20, P149, DOI 10.1071/APP9910149; Trinh SA, 2017, TRANSPL INFECT DIS, V19, DOI 10.1111/tid.12689; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wu JJ, 2018, PEPTIDES, V99, P82, DOI 10.1016/j.peptides.2017.11.009; Xiang F, 2015, TOXINS, V7, P34, DOI 10.3390/toxins7010034; Xie JL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01084; Yang N, 2019, APPL MICROBIOL BIOT, V103, P5193, DOI 10.1007/s00253-019-09785-0; Yang WS, 2015, CELL MOL LIFE SCI, V72, P845, DOI 10.1007/s00018-014-1715-z; Ye F, 2016, TOXINS, V8, DOI 10.3390/toxins8040115; Zhao YH, 2019, MOLECULES, V24, DOI 10.3390/molecules24112045; Zhao YH, 2019, TOXICON, V157, P101, DOI 10.1016/j.toxicon.2018.11.304; Zhu SY, 2008, MOL IMMUNOL, V45, P828, DOI 10.1016/j.molimm.2007.06.354; Zhu SY, 2012, P NATL ACAD SCI USA, V109, P8495, DOI 10.1073/pnas.1201263109	49	4	4	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15093	15107		10.1096/fj.202000029RR	http://dx.doi.org/10.1096/fj.202000029RR		SEP 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32918769				2022-12-26	WOS:000570692500001
J	Herrero, C; Villar, A				Herrero, Carmen; Villar, Antonio			A synthetic indicator on the impact of COVID-19 on the community's health	PLOS ONE			English	Article								The expansion of Covid-19 has severely hit the community's health all over the world, killing hundreds of thousands of people, subjecting health systems to an enormous stress (besides derailing economic activities and altering personal and social behavior). Two elements are essential to monitor the evolution of the pandemic as well as to analyze the effectiveness of the response measures: reliable data and useful indicators. We present an indicator that helps to assess the impact of Covid-19 on the community's health, combining two different components: the extent of the pandemics (i.e. the share of the population affected) and its severity (the intensity of the disease on those affected). The severity measure derives from the application of an evaluation protocol that allows comparing population distributions based on the proportions of those affected with different health conditions. We illustrate the functioning of this indicator over a case study regarding the situation of the Italian regions on March 9 (the beginning of the confinement) and April 8, 2020, one month later.	[Herrero, Carmen] Univ Alicante, Dept Econ, Alicante, Spain; [Villar, Antonio] Univ Pablo de Olavide, Dept Econ, Seville, Spain	Universitat d'Alacant; Universidad Pablo de Olavide	Villar, A (corresponding author), Univ Pablo de Olavide, Dept Econ, Seville, Spain.	avillar@upo.es		Villar, Antonio/0000-0002-2670-7552; Herrero, Carmen/0000-0002-5261-3277	Spanish Ministerio de Economia, Industria y Competitividad [ECO201565820P]; Generalitat Valenciana; Spanish Ministerio de Economia, Industria y Competitividad (MINECO/FEDER) [ECO2015-65408-R]	Spanish Ministerio de Economia, Industria y Competitividad(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Spanish Ministerio de Economia, Industria y Competitividad (MINECO/FEDER)	Carmen Herrero acknowledges financial support from the Spanish Ministerio de Economia, Industria y Competitividad under project ECO201565820P and Generalitat Valenciana. Antonio Villar acknowledges financial support from the Spanish Ministerio de Economia, Industria y Competitividad under project ECO2015-65408-R (MINECO/FEDER).	[Anonymous], 2020, CLIN J SPORT MED, V29, pe111; Berman A., 1994, SOC IND APPL MATH; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Chakravarty SR., 2009, INEQUALITY POLARIZAT, DOI 10.1007/978-0-387-79253-8; European Centre for Disease Prevention and Control, 2020, STRAT SURV COVID 19; Flaxman S., 2020, NATURE; Garcia-Basteiro AL, 2020, LANCET RESP MED, V8, P440, DOI 10.1016/S2213-2600(20)30162-4; Giovannetti G, 2020, MEASURING IMPACT COV; Herrero C, 2018, SOC INDIC RES, V140, P1279, DOI 10.1007/s11205-017-1818-7; Herrero C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084784; Lipsitch M, 2020, NEW ENGL J MED, V382, P1194, DOI 10.1056/NEJMp2002125; Reed C, 2013, EMERG INFECT DIS, V19, P85, DOI 10.3201/eid1901.120124; U.S. Department of Health and Human Services, 2017, OFF ASS SECR PREP H; Villar A, 2017, LECT INEQUALITY POVE; West JD, 2010, COLL RES LIBR, V71, P236, DOI 10.5860/0710236; World Health Organization, 2017, PAND INFL SEV ASS PI	16	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238970	10.1371/journal.pone.0238970	http://dx.doi.org/10.1371/journal.pone.0238970			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915873	Green Published, gold, Green Submitted			2022-12-26	WOS:000571887500053
J	Pinto, CE; Awade, M; Watanabe, MTC; Brito, RM; Costa, WF; Maia, UM; Imperatriz-Fonseca, VL; Giannini, TC				Pinto, Carlos Eduardo; Awade, Marcelo; Coutinho Watanabe, Mauricio Takashi; Brito, Rafael M.; Costa, Wilian F.; Maia, Ulysses M.; Imperatriz-Fonseca, Vera L.; Giannini, Tereza Cristina			Size and isolation of naturally isolated habitats do not affect plant-bee interactions: A case study of ferruginous outcrops within the eastern Amazon forest	PLOS ONE			English	Article							ASYMMETRIC SPECIALIZATION; POLLINATION SYNDROMES; ISLAND BIOGEOGRAPHY; ECOLOGICAL ASPECTS; FLOWER EVOLUTION; FLORAL TRAITS; FRAGMENTATION; MATRIX; DIVERSITY; RESPONSES	Pollination may be severely affected by the decreasing size and increasing isolation of habitat patches. However, most studies that have considered the effects of these two variables on plant-pollinator interactions have been carried out in areas that have undergone anthropogenic fragmentation, and little is known about their effects in natural habitats. The Carajas National Forest and Campos Ferruginosos National Park are two protected areas in the eastern Amazon where one can find isolated ferruginous outcrops characterized by iron-rich soil and herbaceous-shrub vegetation surrounded by Amazon forest. These patches of canga provide an opportunity to analyze plant-pollinator interactions in naturally fragmented areas. Our objective was to test whether the size and isolation of naturally isolated outcrops located in Carajas affect plant-pollinator interactions by using pollination syndromes and interaction networks. We determined the pollination syndromes of 771 plant species that occurred in eleven canga patches and performed field work to analyze plant-pollinator networks in nine canga patches. The structure of the plant-pollinator networks was not affected by the size or isolation of the canga patches. Generalist species were present in all canga areas, indicating that they are important in maintaining the plant communities in isolated canga patches. The lack of significance related to the distance between canga patches suggests that the forest does not prevent pollinator movement between canga patches.	[Pinto, Carlos Eduardo; Awade, Marcelo; Coutinho Watanabe, Mauricio Takashi; Brito, Rafael M.; Costa, Wilian F.; Maia, Ulysses M.; Giannini, Tereza Cristina] Inst Tecnol Vale, Belem, Para, Brazil; [Maia, Ulysses M.; Imperatriz-Fonseca, Vera L.] Univ Sao Paulo, Inst Biociencias, Sao Paulo, SP, Brazil; [Giannini, Tereza Cristina] Univ Fed Para, Belem, Para, Brazil	Instituto Tecnologico Vale Desenvolvimento Sustentavel; Universidade de Sao Paulo; Universidade Federal do Para	Pinto, CE (corresponding author), Inst Tecnol Vale, Belem, Para, Brazil.	eduepronto@gmail.com	Giannini, Tereza Cristina/AAA-2958-2019; Imperatriz-Fonseca, Vera Lucia/AAU-7633-2021; pinto, carlos/AAD-2153-2021; Maia, Ulysses Madureira/ABG-3304-2020; Costa, Wilian França/A-6011-2018; Imperatriz-Fonseca, Vera Lucia/H-5582-2012	Giannini, Tereza Cristina/0000-0001-9830-1204; Imperatriz-Fonseca, Vera Lucia/0000-0002-1079-2158; pinto, carlos/0000-0002-4898-6839; Maia, Ulysses Madureira/0000-0003-0940-9331; Costa, Wilian França/0000-0003-2557-7386; Imperatriz-Fonseca, Vera Lucia/0000-0002-1079-2158; Reis, AlessanRSS/0000-0001-8486-7469	CNPQ [402713/2018-4, 300464/2016-9]; FAPESPA [ICAAF 019/2016]; CNPq CNPq -Brazilian National Council for Scientific and Technological Development [402713/2018-4]	CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); CNPq CNPq -Brazilian National Council for Scientific and Technological Development(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	CEP and TCG received grants CEP received grants from CNPQ (300464/2016-9) and FAPESPA (ICAAF 019/2016) TCG received grants from CNPq(402713/2018-4) CNPq -Brazilian National Council for Scientific and Technological Development http://cnpq.br/FAPESPA -Para ' Research Foundation http://www.fapespa.pa.gov.br/NO -The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; Aizen MA, 2003, ECOL STU AN, V162, P111; Aizen MA, 2016, ECOL LETT, V19, P29, DOI 10.1111/ele.12539; Aizen MA, 2012, SCIENCE, V335, P1486, DOI 10.1126/science.1215320; [Anonymous], 2016, AM J KIDNEY DIS, V67, pA4; [Anonymous], 2012, REGEN MED S3, V7, pS14; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; beda A., 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0127296; Berry O, 2005, CONSERV BIOL, V19, P855, DOI 10.1111/j.1523-1739.2005.00161.x; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bolker B., 2017, BBMLE TOOLS GEN MAXI; Bolker BM, 2008, ECOLOGICAL MODELS DA; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chacoff NP, 2012, J ANIM ECOL, V81, P190, DOI 10.1111/j.1365-2656.2011.01883.x; Dalsgaard B, 2008, OIKOS, V117, P789, DOI 10.1111/j.0030-1299.2008.16537.x; Dormann C.F., 2008, BIPARTITE PACKAGE VE; FAEGRI K, 1979, P244; Fahrig L, 2017, ANNU REV ECOL EVOL S, V48, P1, DOI 10.1146/annurev-ecolsys-110316-022612; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fletcher RJ, 2018, BIOL CONSERV, V226, P9, DOI 10.1016/j.biocon.2018.07.022; Fontaine C, 2006, PLOS BIOL, V4, P129, DOI 10.1371/journal.pbio.0040001; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Girao LC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000908; Guimaraes PR, 2011, ECOL LETT, V14, P877, DOI 10.1111/j.1461-0248.2011.01649.x; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Hadley AS, 2014, ECOLOGY, V95, P2202, DOI 10.1890/13-0929.1; Haila Y, 2002, ECOL APPL, V12, P321, DOI 10.1890/1051-0761(2002)012[0321:ACGOFR]2.0.CO;2; JENNERSTEN O, 1988, CONSERV BIOL, V2, P359, DOI 10.1111/j.1523-1739.1988.tb00200.x; Johnson SD, 2000, TRENDS ECOL EVOL, V15, P140, DOI 10.1016/S0169-5347(99)01811-X; JORDANO P, 1987, AM NAT, V129, P657, DOI 10.1086/284665; Kang H, 2003, AM J BOT, V90, P865, DOI 10.3732/ajb.90.6.865; Kolb A, 2008, BIOL CONSERV, V141, P2540, DOI 10.1016/j.biocon.2008.07.015; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Kunin WE, 1997, J ECOL, V85, P225, DOI 10.2307/2960653; Lanes EC, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00532; Lefsky MA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023971; Legendre P., 2012, NUMERICAL ECOLOGY; Machado IC, 2004, ANN BOT-LONDON, V94, P365, DOI 10.1093/aob/mch152; Mayfield MM, 2005, ECOLOGY, V86, P2365, DOI 10.1890/05-0141; Miller JED, 2015, ECOLOGY, V96, P3323, DOI 10.1890/15-0245.1; Moser D, 2015, DIVERS DISTRIB, V21, P1319, DOI 10.1111/ddi.12353; Mota Nara Furtado de Oliveira, 2018, Rodriguésia, V69, P1435, DOI 10.1590/2175-7860201869336; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Olesen JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026455; R Core Team, 2021, R LANGUAGE ENV STAT; Ramalho CE, 2018, J VEG SCI, V29, P285, DOI 10.1111/jvs.12615; RATHCKE BJ, 1993, CURR SCI INDIA, V65, P273; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Rosch V, 2013, J APPL ECOL, V50, P387, DOI 10.1111/1365-2664.12056; Rosas-Guerrero V, 2014, ECOL LETT, V17, P388, DOI 10.1111/ele.12224; Russildi G, 2016, BIODIVERS CONSERV, V25, P375, DOI 10.1007/s10531-016-1056-3; Saturni FT, 2016, AGR ECOSYST ENVIRON, V235, P1, DOI 10.1016/j.agee.2016.10.008; Schneider G, 2016, OECOLOGIA, V182, P1141, DOI 10.1007/s00442-016-3710-6; Sisk TD, 1997, ECOL APPL, V7, P1170, DOI 10.1890/1051-0761(1997)007[1170:BAIPWM]2.0.CO;2; Smith AC, 2011, ECOGRAPHY, V34, P103, DOI 10.1111/j.1600-0587.2010.06201.x; Souza PWM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211095; Souza PWM, 2016, J ENVIRON MANAGE, V167, P175, DOI 10.1016/j.jenvman.2015.11.039; Spiesman BJ, 2013, ECOLOGY, V94, P2688, DOI 10.1890/13-0977.1; Stang M, 2006, OIKOS, V112, P111, DOI 10.1111/j.0030-1299.2006.14199.x; Stang M, 2007, OECOLOGIA, V151, P442, DOI 10.1007/s00442-006-0585-y; Trojelsgaard K, 2013, J BIOGEOGR, V40, P2020, DOI 10.1111/jbi.12165; VANDERPIJL L, 1960, EVOLUTION, V14, P403, DOI 10.2307/2405990; VANDERPIJL L, 1961, EVOLUTION, V15, P44, DOI 10.2307/2405842; Vazquez DP, 2005, OIKOS, V108, P421, DOI 10.1111/j.0030-1299.2005.13619.x; Vazquez DP, 2004, ECOLOGY, V85, P1251, DOI 10.1890/03-3112; Vogel S, 1954, BOT STUD, V1, P1; Vranckx G, 2012, CONSERV BIOL, V26, P228, DOI 10.1111/j.1523-1739.2011.01778.x; Watling JI, 2011, GLOBAL ECOL BIOGEOGR, V20, P209, DOI 10.1111/j.1466-8238.2010.00586.x; Williams Geoff, 1994, Australian Zoologist, V29, P177; 2014, REG ANESTH PAIN MED, V9	72	2	2	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238685	10.1371/journal.pone.0238685	http://dx.doi.org/10.1371/journal.pone.0238685			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915824	Green Published, gold			2022-12-26	WOS:000571887500109
J	Kabakleh, Y; Zhang, JP; Lv, MM; Li, J; Yang, SL; Swai, J; Li, HY				Kabakleh, Yasira; Zhang, Jing-ping; Lv, Mengmeng; Li, Juan; Yang, Silan; Swai, Joel; Li, Hui-Yuan			Burnout and associated occupational stresses among Chinese nurses: A cross-sectional study in three hospitals	PLOS ONE			English	Article							EFFORT-REWARD IMBALANCE; SELF-ESTEEM; JOB DISSATISFACTION; WORK; HEALTH; QUALITY; FEMALE; SCALE	Background There is literature scarcity relating to burnout and other work stresses in relation to Chinese nursing-workforce performance. Objectives To assess the relationship between self-esteem versus burnout; and effort-reward ratio versus favorability to the work environment, among Chinese nurses. Methods We employed four validated questionnaires in the assessment burnout, self-esteem, effort-reward ratio, and favorability of nursing workplace; Maslach-Burnout Inventory (MBI), Rosenberg's self-esteem (RS), Effort-Reward imbalance (ERI) and Work-Environment Scale questionnaires (WES). Linear and ordinal regression models were utilized to assess the relationships between the variables. Analyses were conducted by using SPSS at a 95% level of significance. Results We assessed 487 (Mean age: 38.8 +/- 7.1 years) nurses from three hospitals. Higher self-esteem was associated with a lower level of emotional exhaustion (Unstandardized coefficient: -0.579, p-Value<0.001); and a lower level of depersonalization (Unstandardized coefficient: -0.212, p-Value = 0.001). The relationship between self-esteem and personal achievement did not reach statistical significance. A higher effort-reward ratio was associated with less likelihood that nurses would consider their work environment favorable (Logit estimate of -0.832, p-Value = 0.014). Conclusion Lower self-esteem is associated with increased burnout. A higher effort-reward ratio is associated with an enhanced perception work environment as unfavorable. We recommend psychosocial intervention programs and amendments in nursing policies to improve effort-reward imbalance among Chinese nurses.	[Kabakleh, Yasira; Zhang, Jing-ping; Lv, Mengmeng; Li, Juan; Yang, Silan] Cent South Univ, Xiangya Sch Nursing, Changsha, Hunan, Peoples R China; [Kabakleh, Yasira] Aleppo Univ, Dept Nursing Serv Management, Aleppo, Syria; [Swai, Joel] Cent South Univ, Dept Nephrol & Rheumatol, Xiangya Hosp 3, Changsha, Hunan, Peoples R China; [Swai, Joel] Benjamin Mkapa Hosp, Dept Nephrol, Dodoma City, Dodoma Region, Tanzania; [Li, Hui-Yuan] Chinese Univ Hong Kong, Nether Sole Sch Nursing, Shatin, Hong Kong, Peoples R China	Central South University; Central South University; Chinese University of Hong Kong	Zhang, JP (corresponding author), Cent South Univ, Xiangya Sch Nursing, Changsha, Hunan, Peoples R China.	jpzhang1965@csc.edu.cn	SWAI, JOEL/AAR-3191-2020; LI, Huiyuan/GZK-8715-2022	SWAI, JOEL/0000-0001-5363-3977; Lyu, Mengmeng/0000-0002-5311-5341; Li, Juan/0000-0003-3820-3877; Kabakleh, Yasira/0000-0001-5247-6789				Aasa U, 2005, SCAND J CARING SCI, V19, P251, DOI 10.1111/j.1471-6712.2005.00333.x; Akers AL, 2009, HUM MOL GENET, V18, P919, DOI 10.1093/hmg/ddn430; [Anonymous], 2014, Microwave Journal (Euro-Global Edition), V57, P214; [Anonymous], 2009, SURVEY RES METHODS; Bakker AB, 2000, J ADV NURS, V31, P884, DOI 10.1046/j.1365-2648.2000.01361.x; Berg AM, 2005, OCCUP MED-OXFORD, V55, P113, DOI 10.1093/occmed/kqi023; CHENG ST, 1995, PERCEPT MOTOR SKILL, V81, P431, DOI 10.1177/003151259508100214; Chiang HY, 2009, J CLIN NURS, V18, P919, DOI 10.1111/j.1365-2702.2008.02433.x; Colindres CV, 2018, INT NURS REV, V65, P190, DOI 10.1111/inr.12409; Dyrbye LN, 2019, BMC NURS, V18, DOI 10.1186/s12912-019-0382-7; Erkorkmaz U, 2018, JCPSP-J COLL PHYSICI, V28, P549, DOI 10.29271/jcpsp.2018.07.549; Ferrario M, 2005, Med Lav, V96, P191; Griep RH, 2009, INT ARCH OCC ENV HEA, V82, P1163, DOI 10.1007/s00420-009-0460-3; Heinen MM, 2013, INT J NURS STUD, V50, P174, DOI 10.1016/j.ijnurstu.2012.09.019; Jachens L, 2019, DISASTERS, V43, P67, DOI 10.1111/disa.12288; Jia S F, 2020, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V38, P199, DOI 10.3760/cma.j.cn121094-20180914-00398; Kanai-Pak M, 2008, J CLIN NURS, V17, P3324, DOI 10.1111/j.1365-2702.2008.02639.x; Kim SY, 2018, PSYCHIAT INVEST, V15, P156, DOI 10.30773/pi.2017.05.31.1; Kocalevent RD, 2020, PSYCHOTHER PSYCH MED, V70, P319, DOI 10.1055/a-1068-9843; Koinis A, 2015, HEALTH PSYCHOL RES, V3, P12, DOI 10.4081/hpr.2015.1984; Kong WW, 2020, HEALTH QUAL LIFE OUT, V18, DOI 10.1186/s12955-020-01295-2; Kupcewicz E, 2017, ANAL RELATION BURNOU; Lahoud N, 2019, J NERV MENT DIS, V207, P642, DOI 10.1097/NMD.0000000000001017; Lake ET, 2002, RES NURS HEALTH, V25, P176, DOI 10.1002/nur.10032; Li J, 2005, INT ARCH OCC ENV HEA, V78, P198, DOI 10.1007/s00420-004-0581-7; Li JEK, 2003, 55 FALL C KOR SOC PR; Lou JH, 2011, J CLIN NURS, V20, P864, DOI 10.1111/j.1365-2702.2010.03387.x; Gomez-Urquiza JL, 2017, CRIT CARE NURSE, V37, pE1, DOI 10.4037/ccn2017508; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Metcalfe C., 2001, STAT MED, V20, P324, DOI DOI 10.1002/1097-0258(20010130)20:2<324::AID-SIM635>3.0.CO;2-O; Jurado MDM, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00424; Ogbolu Y, 2015, APPL NURS RES, V28, P341, DOI 10.1016/j.apnr.2015.02.006; Panatik SAB, 2012, PROCD SOC BEHV, V40, P591, DOI 10.1016/j.sbspro.2012.03.235; POWERS S, 1986, EDUC PSYCHOL MEAS, V46, P251, DOI 10.1177/0013164486461030; Pradas-Hernandez L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195039; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Russo G, 2018, HUM RESOUR HEALTH, V16, DOI 10.1186/s12960-018-0276-x; Santos Sérgio Valverde Marques dos, 2017, Rev. Latino-Am. Enfermagem, V25, pe2872, DOI 10.1590/1518-8345.1632.2872; Schreuder JAH, 2010, INT J NURS STUD, V47, P569, DOI 10.1016/j.ijnurstu.2009.10.002; Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037/1076-8998.1.1.27; Sterud T, 2008, BMC EMERG MED, V8, DOI 10.1186/1471-227X-8-16; The Lancet HIV, 2016, LANCET HIV, V3, pe191; Topa G, 2016, J NURS MANAGE, V24, P834, DOI 10.1111/jonm.12394; Wang QQ, 2019, J NURS MANAGE, V27, P1835, DOI 10.1111/jonm.12884; Weyers S, 2006, SCAND J CARING SCI, V20, P26, DOI 10.1111/j.1471-6712.2006.00376.x; Wickramasinghe Nuwan Darshana, 2018, BMC Psychol, V6, P52, DOI 10.1186/s40359-018-0267-7	46	1	1	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238699	10.1371/journal.pone.0238699	http://dx.doi.org/10.1371/journal.pone.0238699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9ME	32911512	gold, Green Published			2022-12-26	WOS:000571885900035
J	Borges, NC; de Deus, JM; Guimaraes, RA; Conde, DM; Bachion, MM; de Moura, LA; Pereira, LV				Borges, Natalia Carvalho; de Deus, Jose Miguel; Guimaraes, Rafael Alves; Conde, Delio Marques; Bachion, Maria Marcia; de Moura, Louise Amalia; Pereira, Lilian Varanda			The incidence of chronic pain following Cesarean section and associated risk factors: A cohort of women followed up for three months	PLOS ONE			English	Article							PERSISTENT PAIN; POSTSURGICAL PAIN; HOSPITAL ANXIETY; PREVALENCE; DISORDERS; DELIVERY; SMOKING; MOOD	Background Chronic post-surgical pain (CPSP) is one of the post-surgical complications of a Cesarean section. Despite the high rates of Cesarean section worldwide, the incidence of CPSP and the risk factors for this condition remain relatively unknown. The objective of this study was to calculate the incidence of CPSP in women submitted to Cesarean section and to analyze the associated risk factors. Materials and methods A prospective cohort of 621 women undergoing Cesarean section was recruited preoperatively. Potential presurgical (sociodemographic, clinical and lifestyle-related characteristics) and post-surgical risk factors (the presence and intensity of pain) risk factors were analyzed. Pain was measured at 24 hours and 7, 30, 60 and 90 days after surgery. Following discharge from hospital, data were collected by telephone. The outcome measure was self-reported pain three months after a Cesarean section. The risk factors for chronic pain were analyzed using the log-binomial regression model (a generalized linear model). Results A total of 462 women were successfully contacted 90 days following surgery. The incidence of CPSP was 25.5% (95%CI: 21.8-29.7). Risk factors included presurgical anxiety (adjusted relative risk [RR] 1.03; 95%CI: 1.01-1.05), smoking (adjusted RR 2.22; 95%CI: 1.27-3.88) and severe pain in the early postoperative period (adjusted RR 2.79; 95%CI: 1.29-6.00). Conclusion One in four women submitted to Cesarean section may develop CPSP; however, the risk factors identified here are modifiable and preventable. Preventive strategies directed towards controlling anxiety, reducing smoking during pregnancy and managing pain soon after hospital discharge are recommended.	[Borges, Natalia Carvalho; Guimaraes, Rafael Alves; Bachion, Maria Marcia; de Moura, Louise Amalia; Pereira, Lilian Varanda] Univ Fed Goias, Sch Nursing, Goiania, Go, Brazil; [de Deus, Jose Miguel; Conde, Delio Marques] Univ Fed Goias, Dept Obstet & Gynecol, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias	Borges, NC (corresponding author), Univ Fed Goias, Sch Nursing, Goiania, Go, Brazil.	nataliacb.enf@gmail.com	Conde, Délio Marques/O-9732-2018; Bachion, Maria/AGM-7062-2022	Conde, Délio Marques/0000-0003-2062-960X; Borges, Natalia/0000-0002-1371-0066; Reis, AlessanRSS/0000-0001-8486-7469	Fundacao de Amparo a Pesquisa do Estado de Goias -FAPEG [201410267000318]; FAPEG [88887.162732/2018-00]	Fundacao de Amparo a Pesquisa do Estado de Goias -FAPEG(Fundacao de Amparo a Pesquisa do Estado do Goias (FAPEG)); FAPEG(Fundacao de Amparo a Pesquisa do Estado do Goias (FAPEG))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Goias -FAPEG (www.fapeg.go.gov.br), grant number: 201410267000318 to LVP. NCB received a PhD scholarship from FAPEG, grant number: 88887.162732/2018-00. The funder had no role in study design, data collection and analysis, decision to publish or prepare the manuscript.	American College of Obstetricians and Gynecologists, 2018, OBSTET GYNECOL, V132, pe35, DOI DOI 10.1097/AOG.0000000000002683; [Anonymous], 2013, ONTARIOS TRANSP TECH, V19, P3; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1, DOI [DOI 10.5230/jgc.2019.19.e8, DOI 10.1186/s12877-019-1185-0]; [Anonymous], 2017, INT J MOL SCI, V18, pE961; [Anonymous], 2016, BIOMED RES INT, V3, P1; Assocham India Ladies League, 2013, CHALLENGES WOMEN MOD, P1; Betran AP, 2016, BJOG-INT J OBSTET GY, V123, P667, DOI 10.1111/1471-0528.13526; BETRAN AP, 2016, PLOS ONE, V11, DOI DOI 10.1371/JOURNAL.PONE.0148343; Biaggio AMB, 1977, MANUAL INVENTARIO AN; Boerma T, 2018, LANCET, V392, P1341, DOI 10.1016/S0140-6736(18)31928-7; Borsook D, 2010, NEUROSCIENTIST, V16, P171, DOI 10.1177/1073858409349902; Botega NJ, 1995, REV SAUDE PUBL, V29, P355, DOI 10.1590/S0034-89101995000500004; Cancado TOD, 2012, REV BRAS ANESTESIOL, V62, P762, DOI 10.1016/S0034-7094(12)70177-0; Ditre JW, 2011, PSYCHOL BULL, V137, P1065, DOI 10.1037/a0025544; EU, 2016, FAZ, P1, DOI DOI 10.5194/ACP16-150752016; Gan TJ, 2014, CURR MED RES OPIN, V30, P149, DOI 10.1185/03007995.2013.860019; Kainu JP, 2010, INT J OBSTET ANESTH, V19, P4, DOI 10.1016/j.ijoa.2009.03.013; Kainu JP, 2016, ANESTH ANALG, V123, P1535, DOI 10.1213/ANE.0000000000001619; Lavand'homme P, 2015, PRESSE MED, V44, P486, DOI 10.1016/j.lpm.2014.09.025; Liu TT, 2013, ANAESTH INTENS CARE, V41, P496, DOI 10.1177/0310057X1304100410; Marcolino José Álvaro Marques, 2007, Rev. Bras. Anestesiol., V57, P52, DOI 10.1590/S0034-70942007000100006; Moriyama K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155114; Mutschler I, 2012, NEUROSCI LETT, V520, P204, DOI 10.1016/j.neulet.2012.03.095; Nardi N, 2013, ANN FR ANESTH, V32, P772, DOI 10.1016/j.annfar.2013.08.007; Niklasson B, 2015, ACTA OBSTET GYN SCAN, V94, P622, DOI 10.1111/aogs.12613; Nikolajsen L, 2004, ACTA ANAESTH SCAND, V48, P111, DOI 10.1111/j.1399-6576.2004.00271.x; Nugraha B, 2019, PAIN, V160, P88, DOI 10.1097/j.pain.0000000000001433; Ortner CM, 2014, REGION ANESTH PAIN M, V39, P478, DOI 10.1097/AAP.0000000000000158; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; Parkerson HA, 2013, EXPERT REV NEUROTHER, V13, P1407, DOI 10.1586/14737175.2013.859524; Pasquali L., 1994, PSICOL-TEOR PESQUI, V10, P411; Pokkinen SM, 2015, EUR J ANAESTH, V32, P718, DOI 10.1097/EJA.0000000000000318; Richebe P, 2018, ANESTHESIOLOGY, V129, P590, DOI 10.1097/ALN.0000000000002238; Richez B, 2015, J PAIN, V16, P1136, DOI 10.1016/j.jpain.2015.08.001; Searle R. D., 2009, CONTINUING ED ANAEST, V10, P12; Setala P, 2016, ACTA ANAESTH SCAND, V60, P520, DOI 10.1111/aas.12659; Shahin AY, 2009, INT J GYNECOL OBSTET, V104, P135, DOI 10.1016/j.ijgo.2008.09.012; Sipila R, 2012, BRIT J CANCER, V107, P1459, DOI 10.1038/bjc.2012.445; Sng BL, 2009, ANAESTH INTENS CARE, V37, P748, DOI 10.1177/0310057X0903700513; Spielberger CD, 2010, STATE TRAIT ANXIETY, P348; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Treede RD, 2019, PAIN, V160, P19, DOI 10.1097/j.pain.0000000000001384; Uguz F, 2019, PSYCHIAT RES, V272, P316, DOI 10.1016/j.psychres.2018.12.129; Viswasam K, 2019, J AFFECT DISORDERS, V255, P27, DOI 10.1016/j.jad.2019.05.016; WACHOLDER S, 1986, AM J EPIDEMIOL, V123, P174, DOI 10.1093/oxfordjournals.aje.a114212; Wang LZ, 2018, INT J OBSTET ANESTH, V34, P21, DOI 10.1016/j.ijoa.2018.01.009; Weis CA, 2018, J OBSTET GYNAECOL CA, V40, P1038, DOI 10.1016/j.jogc.2017.10.032; Werner MU, 2014, BRIT J ANAESTH, V113, P1, DOI 10.1093/bja/aeu012; Williamson T, 2013, EMERG THEMES EPIDEMI, V10, DOI 10.1186/1742-7622-10-14; Yimer H, 2019, J OBSTET GYNAECOL CA, V41, P840, DOI 10.1016/j.jogc.2018.04.006; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	52	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238634	10.1371/journal.pone.0238634	http://dx.doi.org/10.1371/journal.pone.0238634			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ7QN	32886704	gold, Green Published			2022-12-26	WOS:000571064300011
J	Vazquez, CB; Alonso-Hearn, M; Juste, RA; Canive, M; Iglesias, T; Iglesias, N; Amado, J; Vicente, F; Balseiro, A; Casais, R				Blanco Vazquez, Cristina; Alonso-Hearn, Marta; Juste, Ramon A.; Canive, Maria; Iglesias, Tania; Iglesias, Natalia; Amado, Javier; Vicente, Fernando; Balseiro, Ana; Casais, Rosa			Detection of latent forms ofMycobacterium aviumsubsp.paratuberculosisinfection using host biomarker-based ELISAs greatly improves paratuberculosis diagnostic sensitivity	PLOS ONE			English	Article							AVIUM SUBSP-PARATUBERCULOSIS; FECAL CULTURE; HISTOPATHOLOGICAL CLASSIFICATION; JOHNES-DISEASE; GENE; METALLOPROTEINASES; MACROPHAGES; INDUCTION; PROFILES; TISSUE	Bovine paratuberculosis (PTB) is a chronic granulomatous enteritis, caused byMycobacterium aviumsubsp.paratuberculosis(MAP), responsible for important economic losses in the dairy industry. Current diagnostic methods have low sensitivities for detection of latent forms of MAP infection, defined by focal granulomatous lesions and scarce humoral response or MAP presence. In contrast, patent infections correspond to multifocal and diffuse types of enteritis where there is increased antibody production, and substantial mycobacterial load. Our previous RNA-Seq analysis allowed the selection of five candidate biomarkers overexpressed in peripheral blood of MAP infected Holstein cows with focal (ABCA13 and MMP8) and diffuse (FAM84A, SPARC and DES) lesions vs. control animals with no detectable PTB-associated lesions in intestine and regional lymph nodes. The aim of the current study was to assess the PTB diagnostic potential of commercial ELISAs designed for the specific detection of these biomarkers. The ability of these ELISAs to identify animals with latent and/or patent forms of MAP infection was investigated using serum from naturally infected cattle (n = 88) and non-infected control animals (n = 67). ROC analysis revealed that the ABCA13-based ELISA showed the highest diagnostic accuracy for the detection of infected animals with focal lesions (AUC 0.837, sensitivity 79.25% and specificity 88.06%) and with any type of histological lesion (AUC 0.793, sensitivity 69.41% and specificity 86.57%) improving on the diagnostic performance of the popular IDEXX ELISA and other conventional diagnostic methods. SPARC and MMP8 showed the highest diagnostic accuracy for the detection of animals with multifocal (AUC 0.852) and diffuse lesions (AUC 0.831), respectively. In conclusion, our results suggest that quantification of ABCA13, SPARC and MMP8 by ELISA has the potential for implementation as a diagnostic tool to reliably identify MAP infection, greatly improving early detection of MAP latent infections when antibody responses and fecal shedding are undetectable using conventional diagnostic methods.	[Blanco Vazquez, Cristina; Iglesias, Natalia; Balseiro, Ana; Casais, Rosa] Serv Reg Invest & Desarrollo Agroalimentario SERI, Deva Gijon, Asturias, Spain; [Alonso-Hearn, Marta; Juste, Ramon A.; Canive, Maria] NEIKER Inst Vasco Invest & Desarrollo Agrario, Anim Hlth Dept, Derio, Bizkaia, Spain; [Juste, Ramon A.; Vicente, Fernando] Serv Reg Invest & Desarrollo Agroalimentario SERI, Villaviciosa, Asturias, Spain; [Iglesias, Tania] Univ Oviedo, Serv Cient Tecn, Unidad Consultoria Estat, Campus Gijon, Asturias, Spain; [Amado, Javier] Lab Sanidad Anim Principado Asturias LSAPA, Dept Microbiol & Parasitol, Gijon, Asturias, Spain; [Balseiro, Ana] Univ Leon, Fac Vet, Inst Ganaderia Montana CSIC ULE, Dept Anim Hlth, Leon, Spain	Servicio Regional Investigacion Desarrollo Agroalimentario - SERIDA; Servicio Regional Investigacion Desarrollo Agroalimentario - SERIDA; University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-ULE - Instituto de Ganaderia de Montana (IGM); Universidad de Leon	Casais, R (corresponding author), Serv Reg Invest & Desarrollo Agroalimentario SERI, Deva Gijon, Asturias, Spain.	rosacg@serida.org	Balseiro, Ana/O-1794-2019; Vicente, Fernando/C-7784-2011; Iglesias Besteiro, Natalia/ABE-8945-2021; CASAIS, ROSA/C-1405-2014	Balseiro, Ana/0000-0002-5121-7264; Vicente, Fernando/0000-0002-8370-2790; CASAIS, ROSA/0000-0001-8349-5878; Canive, Maria/0000-0002-5492-7173; Iglesias Besteiro, Natalia/0000-0002-6701-4840; Blanco Vazquez, Cristina/0000-0002-4501-2537; , Tania Iglesias/0000-0002-0208-4880; Alonso-Hearn, Marta/0000-0001-5979-347X	National Institute for Agricultural Research (INIA) [RTA-2014-00009-C02-02]; Spanish Ministry of Science, Innovation and Universities (MICINN) [RTI2018-094192-R-C22]; European Regional Development Funds (FEDER); Plan of Science, Technology and Innovation of the Principality of Asturias [PCTI 20182020, IDI2018000237]; INIA	National Institute for Agricultural Research (INIA)(Instituto de Investigacion Agropecuaria (INIA)); Spanish Ministry of Science, Innovation and Universities (MICINN); European Regional Development Funds (FEDER)(European Commission); Plan of Science, Technology and Innovation of the Principality of Asturias; INIA(Instituto de Investigacion Agropecuaria (INIA))	This study was funded by 1) The National Institute for Agricultural Research (INIA, www.inia.es/inia/), project code: RTA-2014-00009-C02-02, R.C received this award, 2) The Spanish Ministry of Science, Innovation and Universities (MICINN, https://sede.micinn.gob.es/), project code: RTI2018-094192-R-C22, R.C received this award, both projects were co-funded by The European Regional Development Funds (FEDER) and 3) Plan of Science, Technology and Innovation of the Principality of Asturias, Regional funds PCTI 20182020 (www.ficyt.es/pcti/), project code: IDI2018000237), R.C. and F.V. received this award. We acknowledge INIA for the scholarship of Cristina Blanco Va ' zquez and Maria Canive. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht C, 2007, PFLUG ARCH EUR J PHY, V453, P581, DOI 10.1007/s00424-006-0047-8; Alonso-Hearn M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51328-0; [Anonymous], 2016, THE TOTAL AUDIENCE R; Araujo TM, 2016, MOL CYTOGENET, V9, DOI 10.1186/s13039-016-0260-x; Balseiro A, 2008, J COMP PATHOL, V138, P180, DOI 10.1016/j.jcpa.2008.01.003; Balseiro A, 2019, COMP IMMUNOL MICROB, V62, P88, DOI 10.1016/j.cimid.2018.12.001; Barkema HW, 2018, TRANSBOUND EMERG DIS, V65, P125, DOI 10.1111/tbed.12723; Bastida Felix, 2011, J Immune Based Ther Vaccines, V9, P8, DOI 10.1186/1476-8518-9-8; BENEDICTUS G, 1987, VET REC, V121, P142, DOI 10.1136/vr.121.7.142; Bo M, 2018, CLIN EXP RHEUMATOL, V36, P376; Bo M, 2020, J TRANSL AUTOIMMUN, V3, DOI 10.1016/j.jtauto.2020.100048; Bo M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19957-z; Britton LE, 2016, VET J, V209, P32, DOI 10.1016/j.tvjl.2015.10.033; Capsel RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154685; Cha SB, 2013, J MICROBIOL BIOTECHN, V23, P1167, DOI 10.4014/jmb.1302.02021; Chai AB, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0526-9; Chen YY, 2017, MOL MED REP, V15, P483, DOI 10.3892/mmr.2016.5998; Clark DL, 2008, J DAIRY SCI, V91, P2620, DOI 10.3168/jds.2007-0902; Cossu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018482; Dargatz DA, 2001, J AM VET MED ASSOC, V218, P1163, DOI 10.2460/javma.2001.218.1163; David J, 2014, VET RES, V45, DOI 10.1186/s13567-014-0096-5; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Feller M, 2007, LANCET INFECT DIS, V7, P607, DOI 10.1016/S1473-3099(07)70211-6; Fowler ME, 1997, J CAMEL PRACT RES, V4, P99; Garry F, 2011, VET CLIN N AM-FOOD A, V27, P599, DOI 10.1016/j.cvfa.2011.07.006; Gonzalez J, 2005, J COMP PATHOL, V133, P184, DOI 10.1016/j.jcpa.2005.04.007; Hempel RJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153932; Hlavac V, 2013, PHARMACOGENOMICS, V14, P515, DOI [10.2217/PGS.13.26, 10.2217/pgs.13.26]; Hlavata I, 2012, MUTAGENESIS, V27, P187, DOI 10.1093/mutage/ger075; Holla LI, 2012, ARCH ORAL BIOL, V57, P188, DOI 10.1016/j.archoralbio.2011.08.018; Jessup David A., 1999, P616; Kudahl A, 2004, PREV VET MED, V62, P119, DOI 10.1016/j.prevetmed.2003.11.008; Kudahl AB, 2011, J DAIRY SCI, V94, P3824, DOI 10.3168/jds.2010-3933; Kuenstner JT, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00208; Lin JJ, 2015, VET IMMUNOL IMMUNOP, V163, P146, DOI 10.1016/j.vetimm.2014.12.001; Malvisi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164461; Mameli G, 2016, SCI REP-UK, V6, DOI 10.1038/srep22401; McKenna SLB, 2005, VET MICROBIOL, V110, P105, DOI 10.1016/j.vetmic.2005.07.010; Muller MP, 2005, CLIN INFECT DIS, V40, P1079, DOI 10.1086/428577; Niegowska M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22266; Nielsen SS, 2008, VET MICROBIOL, V129, P217, DOI 10.1016/j.vetmic.2007.12.011; Nielsen SS, 2006, J DAIRY SCI, V89, P569, DOI 10.3168/jds.S0022-0302(06)72120-8; Nymoen DA, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0317-1; Palacios A, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-1941-6; Park HE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178336; Purdie AC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44670-w; Roderfeld M, 2012, MICROBES INFECT, V14, P545, DOI 10.1016/j.micinf.2012.01.004; Rotta G, 2008, J EXP MED, V205, P657, DOI 10.1084/jem.20071734; Seth M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005478; Sevilla IA, 2014, APPL ENVIRON MICROB, V80, P3757, DOI 10.1128/AEM.01026-14; Shaughnessy RG, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62843-w; Shin MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138770; Shin MK, 2015, J MICROBIOL BIOTECHN, V25, P255, DOI 10.4014/jmb.1408.08059; Stehman SM, 1996, VET CLIN N AM-FOOD A, V12, P441, DOI 10.1016/S0749-0720(15)30416-3; Taniguchi Y, 2020, J VET MED SCI, V82, P541, DOI 10.1292/jvms.18-0724; Ugarte-Gil CA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061333, 10.1371/journal.pone.0069514]; van den Esker MH, 2019, VET SCI, V6, DOI 10.3390/vetsci6030059; VAZQUEZ P, 2014, VET MED INT, V2014, DOI DOI 10.1155/2014/321327; Wells SJ, 2006, CLIN VACCINE IMMUNOL, V13, P1125, DOI 10.1128/CVI.00236-06; Whitlock RH, 2000, VET MICROBIOL, V77, P387, DOI 10.1016/S0378-1135(00)00324-2; Windsor PA, 2015, VET MICROBIOL, V181, P161, DOI 10.1016/j.vetmic.2015.07.019; Yokoyama K, 2018, J CLIN MED, V7, DOI 10.3390/jcm7120522; You QM, 2012, VET IMMUNOL IMMUNOP, V148, P243, DOI 10.1016/j.vetimm.2012.05.002	63	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0236336	10.1371/journal.pone.0236336	http://dx.doi.org/10.1371/journal.pone.0236336			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881863	Green Published, gold			2022-12-26	WOS:000571063300013
J	Daboul, J; Weghorst, L; DeAngelis, C; Plecha, SC; Saul-McBeth, J; Matson, JS				Daboul, Judy; Weghorst, Logan; DeAngelis, Cara; Plecha, Sarah C.; Saul-McBeth, Jessica; Matson, Jyl S.			Characterization ofVibrio choleraeisolates from freshwater sources in northwest Ohio	PLOS ONE			English	Article							RTX TOXIN GENE; VIBRIO-CHOLERAE; VIRULENCE FACTORS; CHESAPEAKE BAY; NON-O1; O1; HEMOLYSIN; IDENTIFICATION; SEROGROUPS; EVOLUTION	Vibrio choleraeis a natural inhabitant of aquatic ecosystems worldwide, typically residing in coastal or brackish water. While more than 200 serogroups have been identified, only serogroups O1 and O139 have been associated with epidemic cholera. However, infections other than cholera can be caused by nonepidemic, non-O1/non-O139V.choleraestrains, including gastroenteritis and extraintestinal infections. WhileV.choleraecan also survive in freshwater, that is typically only observed in regions of the world where cholera is endemic. We recently isolatedV.choleraefrom several locations in lakes and rivers in northwest Ohio. These isolates were all found to be non-O1/non-O139V.choleraestrains, that would not cause cholera. However, these isolates contained a variety of virulence genes, includingctxA,rtxA,rtxC,hlyA, andompU. Therefore, it is possible that some of these isolates have the potential to cause gastroenteritis or other infections in humans. We also investigated the relative motility of the isolates and their ability to form biofilms as this is important forV.choleraesurvival in the environment. We identified one isolate that forms very robust biofilms, up to 4x that of our laboratory strains. Finally, we investigated the susceptibility of these isolates to a panel of antibiotics. We found that many of the isolates showed decreased susceptibility to some of the antibiotics tested, which could be of concern. While we do not know if these isolates are pathogenic to humans, increased surveillance to better understand the public health risk to the local community should be considered.	[Daboul, Judy; Weghorst, Logan; DeAngelis, Cara; Plecha, Sarah C.; Saul-McBeth, Jessica; Matson, Jyl S.] Univ Toledo, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA; [DeAngelis, Cara] NIAID, Lab Bacteriol, Rocky Mt Labs, NIH, Hamilton, MT USA; [Plecha, Sarah C.] Univ Detroit, Mercy Sch Dent, Div Integrated Biomed Sci, Detroit, MI 48221 USA; [Saul-McBeth, Jessica] Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA	University System of Ohio; University of Toledo; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Detroit Mercy; University System of Ohio; University of Toledo	Matson, JS (corresponding author), Univ Toledo, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA.	jyl.matson@utoledo.edu			University of Toledo; UT Medical Student Research Program	University of Toledo; UT Medical Student Research Program	This study was supported by startup funds from the University of Toledo (JSM). JD and LW were supported by funds from the UT Medical Student Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	a R-M, 2020, J CLIN MED, V9; Alam M, 2006, APPL ENVIRON MICROB, V72, P2849, DOI 10.1128/AEM.72.4.2849-2855.2006; [Anonymous], 2015, JMIR MED INFORM, V3, pe22; Baker-Austin C, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0005-8; Ceccarelli D, 2015, APPL ENVIRON MICROB, V81, P1909, DOI 10.1128/AEM.03540-14; Chakraborty DC, 2011, J BIOL CHEM, V286, P34542, DOI 10.1074/jbc.M111.241851; Choi S, 2010, J APPL MICROBIOL, V108, P1015, DOI 10.1111/j.1365-2672.2009.04502.x; Chow KH, 2001, J CLIN MICROBIOL, V39, P2594, DOI 10.1128/JCM.39.7.2594-2597.2001; Coelho A, 2000, INFECT IMMUN, V68, P1700, DOI 10.1128/IAI.68.3.1700-1705.2000; Daboul J, 2020, BIORXIV2020043007056; DALSGAARD A, 1995, J CLIN MICROBIOL, V33, P2715, DOI 10.1128/JCM.33.10.2715-2722.1995; Durham-Colleran MW, 2010, MICROB ECOL, V59, P457, DOI 10.1007/s00248-009-9586-9; Faruque SM, 2003, TRENDS MICROBIOL, V11, P505, DOI 10.1016/j.tim.2003.09.003; Faruque SM, 2003, P NATL ACAD SCI USA, V100, P1304, DOI 10.1073/pnas.0337468100; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Figueroa-Arredondo P, 2001, INFECT IMMUN, V69, P1613, DOI 10.1128/IAI.69.3.1613-1624.2001; Goel AK, 2005, FOLIA MICROBIOL, V50, P448, DOI 10.1007/BF02931428; HERRINGTON DA, 1988, J EXP MED, V168, P1487, DOI 10.1084/jem.168.4.1487; Hossain ZZ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00222; Huhulescu S, 2007, WIEN KLIN WOCHENSCHR, V119, P235, DOI 10.1007/s00508-006-0747-2; Huq A, 2012, CURR PROTOC MICROBIO; ICHINOSE Y, 1987, INFECT IMMUN, V55, P1090, DOI 10.1128/IAI.55.5.1090-1093.1987; Institute. CaLS, 2015, M45 CLSI; Jiang SC, 2000, APPL ENVIRON MICROB, V66, P140, DOI 10.1128/AEM.66.1.140-147.2000; Kaysner C. A, 2004, BACTERIOLOGICAL ANAL; Lin W, 1999, P NATL ACAD SCI USA, V96, P1071, DOI 10.1073/pnas.96.3.1071; Lindeberg YL, 2018, TROP MED INT HEALTH, V23, P2, DOI 10.1111/tmi.13003; Lutz C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00375; Mathur J, 2004, INFECT IMMUN, V72, P3577, DOI 10.1128/IAI.72.6.3577-3583.2004; Mathur J, 2007, MOL MICROBIOL, V63, P848, DOI 10.1111/j.1365-2958.2006.05544.x; NAIR GB, 1988, MICROBIAL ECOL, V15, P203, DOI 10.1007/BF02011713; Nandi B, 2000, J CLIN MICROBIOL, V38, P4145, DOI 10.1128/JCM.38.11.4145-4151.2000; Olivier V, 2007, INFECT IMMUN, V75, P5035, DOI 10.1128/IAI.00506-07; Queen J, 2012, INFECT IMMUN, V80, P2905, DOI 10.1128/IAI.00356-12; RADER AE, 1988, INFECT IMMUN, V56, P1414, DOI 10.1128/IAI.56.6.1414-1419.1988; Rahman MH, 2008, DNA CELL BIOL, V27, P347, DOI 10.1089/dna.2008.0737; Rivera ING, 2001, APPL ENVIRON MICROB, V67, P2421, DOI 10.1128/AEM.67.6.2421-2429.2001; Sakib SN, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00795-17; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Satchell KJF, 2007, INFECT IMMUN, V75, P5079, DOI 10.1128/IAI.00525-07; Schirmeister F, 2014, EUR J CLIN MICROBIOL, V33, P767, DOI 10.1007/s10096-013-2011-9; Silva AJ, 2016, PLOS NEGLECT TROP D, V10, DOI [10.1371/journal.pntd.0004330, 10.1371/journal.pntd.0005172]; Singh DV, 2001, APPL ENVIRON MICROB, V67, P910, DOI 10.1128/AEM.67.2.910-921.2001; Trubiano JA, 2014, INTERN MED J, V44, P508, DOI 10.1111/imj.12409; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Yang JS, 2018, MOL IMMUNOL, V93, P47, DOI 10.1016/j.molimm.2017.11.005	46	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238438	10.1371/journal.pone.0238438	http://dx.doi.org/10.1371/journal.pone.0238438			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881972	Green Published, gold, Green Submitted			2022-12-26	WOS:000571063300056
J	Badu-Apraku, B; Adewale, S; Paterne, AA; Gedil, M; Toyinbo, J; Asiedu, R				Badu-Apraku, Baffour; Adewale, Samuel; Paterne, Agre Angelot; Gedil, Melaku; Toyinbo, Johnson; Asiedu, Robert			Identification of QTLs for grain yield and other traits in tropical maize under Striga infestation	PLOS ONE			English	Article							AGRONOMIC TRAITS; RESISTANCE; TOLERANCE; LOCI; POPULATIONS; RESPONSES; SELECTION; SORGHUM; R/QTL; LINES	Strigais an important biotic factor limiting maize production in sub-Saharan Africa and can cause yield losses as high as 100%. Marker-assisted selection (MAS) approaches hold a great potential for improvingStrigaresistance but requires identification and use of markers associated withStrigaresistance for adequate genetic gains from selection. However, there is no report on the discovery of quantitative trait loci (QTL) for resistance toStrigain maize under artificial field infestation. In the present study, 198 BC(1)S(1)families obtained from a cross involving TZEEI 29 (Strigaresistant inbred line) and TZEEI 23 (Strigasusceptible inbred line) plus the two parental lines were screened under artificialStriga-infested conditions at twoStriga-endemic locations in Nigeria in 2018, to identify QTL associated withStrigaresistance indicator traits, including grain yield, ears per plant,Strigadamage and number of emergedStrigaplants. Genetic map was constructed using 1,386 DArTseq markers distributed across the 10 maize chromosomes, covering 2076 cM of the total genome with a mean spacing of 0.11 cM between the markers. Using composite interval mapping (CIM), fourteen QTL were identified for keyStrigaresistance/tolerance indicator traits: 3 QTL for grain yield, 4 for ears per plant and 7 forStrigadamage at 10 weeks after planting (WAP), across environments. Putative candidate genes which encode major transcription factor families WRKY, bHLH, AP2-EREBPs, MYB, and bZIP involved in plant defense signaling were detected forStrigaresistance/tolerance indicator traits. The QTL detected in the present study would be useful for rapid transfer ofStrigaresistance/tolerance genes intoStrigasusceptible but high yielding maize genotypes using MAS approaches after validation. Further studies on validation of the QTL in different genetic backgrounds and in different environments would help verify their reproducibility and effective use in breeding forStrigaresistance/tolerance.	[Badu-Apraku, Baffour; Adewale, Samuel; Paterne, Agre Angelot; Gedil, Melaku; Toyinbo, Johnson; Asiedu, Robert] Int Inst Trop Agr IITA, Ibadan, Nigeria	CGIAR; International Institute of Tropical Agriculture (IITA)	Badu-Apraku, B (corresponding author), Int Inst Trop Agr IITA, Ibadan, Nigeria.	b.baduapraku@cgiar.org	Gedil, Melaku/H-9445-2019; Asiedu, Robert/AAV-6512-2021; AGRE, Paterne/ABE-3426-2021	Gedil, Melaku/0000-0002-6258-6014; Asiedu, Robert/0000-0001-8943-2376; AGRE, Paterne/0000-0003-1231-2530; BADU-APRAKU, BAFFOUR/0000-0003-0113-5487	Bill AMP; Melinda Gates Foundation [OPP1134248]; Integrated Genotyping Service and Support (IGSS) platform grant of BecA-ILRI, Kenya [PJ-002507]	Bill AMP; Melinda Gates Foundation(CGIAR); Integrated Genotyping Service and Support (IGSS) platform grant of BecA-ILRI, Kenya	This study was supported by the Bill & Melinda Gates Foundation [OPP1134248] as well as the Integrated Genotyping Service and Support (IGSS) platform grant (ref. number PJ-002507) of BecA-ILRI, Kenya. All the authors received salaries from the International Institute of Tropical Agriculture (IITA), Nigeria through the funding support of the Bill & Melinda Gates Foundation [OPP1134248]. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors are grateful to Ana Luisa Garcia-Oliveira and Clay Sneller for their roles in funding acquisition and technical contributions, as well as the IITA Maize Improvement Program, (particularly Dr A. Talabi and V. Oladipo) and the Bioscience Center staff for technical assistance during the evaluation of field trials and DNA extraction, respectively.	Adewale SA, 2020, BMC PLANT BIOL, V20, DOI 10.1186/s12870-020-02360-0; Akanvou L., 1997, African Crop Science Journal, V5, P1; Akinwale R. O., 2013, African Crop Science Journal, V21, P1; Amusan IO, 2010, THESIS; Arends D, 2010, BIOINFORMATICS, V26, P2990, DOI 10.1093/bioinformatics/btq565; Awata LAO, 2020, GENES-BASEL, V11, DOI 10.3390/genes11010032; Badu-Apraku B, 2007, J CROP IMPROV, V20, P107, DOI 10.1300/J411v20n01_06; Badu-Apraku B, 2007, MAYDICA, V52, P205; Badu-Apraku B, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1740-z; Badu-Apraku B, 2011, FIELD CROP RES, V121, P186, DOI 10.1016/j.fcr.2010.12.011; Badu-Apraku B, 2010, CAN J PLANT SCI, V90, P831, DOI 10.4141/CJPS10059; Badu-Apraku B., 2017, ADV GENETIC ENHANCEM; Badu-Apraku B, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10081168; BERNER DK, 1995, PLANT DIS, V79, P652, DOI 10.1094/PD-79-0652; Bo KL, 2015, THEOR APPL GENET, V128, P25, DOI 10.1007/s00122-014-2410-z; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; DeVries J., 2000, BREEDING STRIGA RESI, P73; Ejeta G, 1991, RES B, VRB-991; Ertiro BT, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020543; Samayoa LF, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0652-9; Frost DL, 1997, PLANT CELL ENVIRON, V20, P483, DOI 10.1046/j.1365-3040.1997.d01-87.x; Gedil M, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01430; Gelli M, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1064-9; Gethi JG, 2004, CROP SCI, V44, P2068, DOI 10.2135/cropsci2004.2068; Gowda M, 2017, QUALITY ASSURANCE QU, P13; Gowda M, 2015, THEOR APPL GENET, V128, P1957, DOI 10.1007/s00122-015-2559-0; Gurney AL, 2006, NEW PHYTOL, V169, P199, DOI 10.1111/j.1469-8137.2005.01560.x; Han SY, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01012; Haussmann BIG, 2000, FIELD CROP RES, V66, P195, DOI 10.1016/S0378-4290(00)00076-9; Hermans C, 2013, METALLOMICS, V5, P1170, DOI 10.1039/c3mt20223b; Holland J. B., 2003, Plant Breeding Reviews, V22, P9, DOI 10.1002/9780470650202.ch2; Jiang JJ, 2017, J INTEGR PLANT BIOL, V59, P86, DOI 10.1111/jipb.12513; Kim S. L., 1991, Combating striga in Africa: proceedings of the international workshop held in Ibadan, Nigeria, 22-24 August 1988., P96; KIM SK, 1994, CROP SCI, V34, P900, DOI 10.2135/cropsci1994.0011183X003400040012x; Kling JG, 1999, BREEDING STRIGA RESI, P103; Kountche BA, 2019, PLANTS PEOPLE PLANET, V1, P107, DOI 10.1002/ppp3.32; Lagoke S. T. O., 1991, Combating striga in Africa: proceedings of the international workshop held in Ibadan, Nigeria, 22-24 August 1988., P3; Li CH, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3170-8; Li HY, 2016, PLANT CELL PHYSIOL, V57, P1153, DOI 10.1093/pcp/pcw064; Li N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030671; Liu XW, 2018, HORTIC RES-ENGLAND, V5, DOI 10.1038/s41438-018-0036-z; Lubberstedt T, 1997, CROP SCI, V37, P921, DOI 10.2135/cropsci1997.0011183X003700030037x; Maschietto V, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-0970-1; Meraj TA, 2020, GENES-BASEL, V11, DOI 10.3390/genes11040346; Milne I, 2010, BIOINFORMATICS, V26, P3133, DOI 10.1093/bioinformatics/btq580; Mutuku JM, 2015, PLANT PHYSIOL, V168, P1152, DOI 10.1104/pp.114.256404; Nikolic A, 2013, GENETIKA-BELGRADE, V45, P341, DOI 10.2298/GENSR1302341N; Oswald A, 2005, CROP PROT, V24, P333, DOI 10.1016/j.cropro.2004.09.003; Pandian BA, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9050454; Pierce S, 2003, WEED RES, V43, P139, DOI 10.1046/j.1365-3180.2003.00325.x; Ramekar RV, 2018, BREEDING SCI, V68, P465, DOI 10.1270/jsbbs.18017; Ribeiro PF, 2018, CROP SCI, V58, P321, DOI 10.2135/cropsci2017.02.0117; Rodenburg J., 2006, International Rice Commission Newsletter, V55, P45; Rodenburg J, 2005, FIELD CROP RES, V93, P34, DOI 10.1016/j.fcr.2004.09.004; Rodenburg J, 2011, WEED RES, V51, P438, DOI 10.1111/j.1365-3180.2011.00871.x; Sansaloni CP, 2011, BMC P S7, V5, P54, DOI [10.1186/1753-6561-5-S7-P54, DOI 10.1186/1753-6561-5-S7-P54]; SAS Institute Inc, 2011, STAT AN SOFTW SAS US; Sauter M, 2015, J EXP BOT, V66, P5160, DOI 10.1093/jxb/erv071; Silva IT, 2015, THESIS; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Snedecor G.W., 1989, AMES IOWA STATE U PR; Soil Survey Staff, 1999, SOIL TAX BAS SYST SO, V2, P436, DOI DOI 10.1111/J.1475-2743.2001.TB00008.X; Song SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003653; ten Berge HFM, 2019, GLOB FOOD SECUR-AGR, V23, P9, DOI 10.1016/j.gfs.2019.02.001; Tesfaye K, 2015, INT J CLIM CHANG STR, V7, P247, DOI 10.1108/IJCCSM-01-2014-0005; The Lancet Global Health, 2016, LANCET GLOB HLTH, V4, pe427; TRACHSEL S, 2016, PLOS ONE, V0011; VANOOIJEN JW, 1992, THEOR APPL GENET, V84, P803, DOI 10.1007/BF00227388; Veit B, 1998, NATURE, V393, P166, DOI 10.1038/30239; Wang AY, 2012, CAN J PLANT SCI, V92, P249, DOI [10.4141/CJPS2011-108, 10.4141/cjps2011-108]; Wang BB, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00101; Wanlayaporn K., 2013, American Journal of Plant Sciences, V4, P878, DOI 10.4236/ajps.2013.44108; Weng YQ, 2015, THEOR APPL GENET, V128, P1747, DOI 10.1007/s00122-015-2544-7; Xu J, 2015, J INTEGR AGR, V14, P1673, DOI 10.1016/S2095-3119(14)60980-1; Xu S., 2009, INT J PLANT GENOM, V410825, P1, DOI [DOI 10.1155/2009/410825, 10.1155/2009/410825]; Yallou CG, 2009, PLANT BREEDING, V128, P143, DOI 10.1111/j.1439-0523.2008.01583.x; Yan YW, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00274; Zhang D, 2018, PLANT CELL, V30, P360, DOI 10.1105/tpc.17.00791; Zhao FL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21136-z; Zhao XQ, 2018, CROP SCI, V58, P507, DOI 10.2135/cropsci2016.12.0991	80	7	7	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0239205	10.1371/journal.pone.0239205	http://dx.doi.org/10.1371/journal.pone.0239205			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925954	gold, Green Published			2022-12-26	WOS:000572318000010
J	Plant, EP; Manukyan, H; Laassri, M; Ye, ZP				Plant, Ewan P.; Manukyan, Hasmik; Laassri, Majid; Ye, Zhiping			Insights from the comparison of genomic variants from two influenza B viruses grown in the presence of human antibodies in cell culture	PLOS ONE			English	Article							A VIRUS; RNA; NUCLEOPROTEIN; CONSERVATION; MECHANISMS; EVOLUTION; SEQUENCE	Understanding the extent and limitation of viral genome evolution can provide insight about potential drug and vaccine targets. Influenza B Viruses (IBVs) infect humans in a seasonal manner and causes significant morbidity and mortality. IBVs are negative-sense single-stranded RNA viruses with a segmented genome and can be divided into two antigenically distinct lineages. The two lineages have been circulating and further evolving for almost four decades. The immune response to IBV infection can lead to antibodies that target the strain causing the infection. Some antibodies are cross-reactive and are able to bind strains from both lineages but, because of antigenic drift and immunodominance, both lineages continue to evolve and challenge human health. Here we investigate changes in the genomes of an IBVs from each lineage after passage in tissue culture in the presence of human sera containing polyclonal antibodies directed toward antigenically and temporally distinct viruses. Our previous analysis of the fourth segment, which encodes the major surface protein HA, revealed a pattern of change in which signature sequences from one lineage mutated to the signature sequences of the other lineage. Here we analyze genes from the other genomic segments and observe that most of the quasispecies' heterogeneity occurs at the same loci in each lineage. The nature of the variants at these loci are investigated and possible reasons for this pattern are discussed. This work expands our understanding of the extent and limitations of genomic change in IBV.	[Plant, Ewan P.; Manukyan, Hasmik; Laassri, Majid; Ye, Zhiping] US FDA, Off Vaccine Res & Review, Silver Spring, MD 20993 USA; [Manukyan, Hasmik] US FDA, Off Biostat & Epidemiol, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Plant, EP (corresponding author), US FDA, Off Vaccine Res & Review, Silver Spring, MD 20993 USA.	ewan.plant@fda.hhs.gov	Plant, Ewan/AAB-1911-2020	Plant, Ewan/0000-0003-0166-5939; Laassri, Majid/0000-0002-0110-5504				Aills L, 2008, SURG OBES RELAT DI S, V4, pS73; Ambrose CS, 2012, HUM VACC IMMUNOTHER, V8, P81, DOI 10.4161/hv.8.1.17623; [Anonymous], 2017, J ONCOL PRACT, V13, pe353; [Anonymous], 2017, JLSRF, V3, pA104; [Anonymous], 2015, ALZHEIMERS DEMENTI S, V11, pP121; [Anonymous], 2019, CANC DISCOV, V10, pOF5; [Anonymous], 2018, J CANC RES THER, V14, pS622; [Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 2014, J NURS REGUL, V5, pS3; Arunkumar GA, 2019, J VIROL, V93, DOI 10.1128/JVI.01696-18; Bhatt S, 2011, MOL BIOL EVOL, V28, P2443, DOI 10.1093/molbev/msr044; BRIEDIS DJ, 1982, VIROLOGY, V116, P581, DOI 10.1016/0042-6822(82)90150-7; BRIEDIS DJ, 1981, VIROLOGY, V112, P417, DOI 10.1016/0042-6822(81)90289-0; Brower-Sinning R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r18; Chai N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14234; Chen RB, 2008, J MOL EVOL, V66, P655, DOI 10.1007/s00239-008-9119-z; Civetta A, 2016, GENOME BIOL EVOL, V8, P986, DOI 10.1093/gbe/evw061; Dadonaite B, 2019, NAT MICROBIOL, V4, P1781, DOI 10.1038/s41564-019-0513-7; De Groot AS, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00442; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Doud MB, 2016, VIRUSES, V8, P6; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Estrada LD, 2019, J IMMUNOL, V202, P392, DOI 10.4049/jimmunol.1801054; Fox A, 2018, DRUGS, V78, P1297, DOI 10.1007/s40265-018-0958-7; Gog JR, 2007, NUCLEIC ACIDS RES, V35, P1897, DOI 10.1093/nar/gkm087; Gumpper RH, 2019, J VIROL, V93, DOI 10.1128/JVI.01775-18; Hatta M, 2003, J VIROL, V77, P6050, DOI 10.1128/JVI.77.10.6050-6054.2003; Henry C, 2018, TRENDS IMMUNOL, V39, P70, DOI 10.1016/j.it.2017.08.003; Hirano D, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/7251793; Hom N, 2019, J VIROL, V93, DOI 10.1128/JVI.00161-19; HORVATH CM, 1990, EMBO J, V9, P2639, DOI 10.1002/j.1460-2075.1990.tb07446.x; Houser K, 2015, CELL HOST MICROBE, V17, P295, DOI 10.1016/j.chom.2015.02.012; Jambrina E, 1997, VIROLOGY, V235, P209, DOI 10.1006/viro.1997.8682; Keleta L, 2008, J VIROL, V82, P11599, DOI 10.1128/JVI.01393-08; Kim MH, 2019, ANTIVIR RES, V163, P19, DOI 10.1016/j.antiviral.2019.01.002; Leahy MB, 2001, J VIROL, V75, P7042, DOI 10.1128/JVI.75.15.7042-7049.2001; Leidner AJ, 2019, VACCINE, V37, P226, DOI 10.1016/j.vaccine.2018.11.056; Liu Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08165-y; Ramirez-Salinas GL, 2020, ARCH VIROL, V165, P891, DOI 10.1007/s00705-020-04537-2; LONDO DR, 1983, J VIROL, V47, P642, DOI 10.1128/JVI.47.3.642-648.1983; McCrone JT, 2018, ELIFE, V7, DOI 10.7554/eLife.35962; Mezhenskaya D, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0572-3; Moncla LH, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008191; Nobusawa E, 2006, J VIROL, V80, P3675, DOI 10.1128/JVI.80.7.3675-3678.2006; OXFORD JS, 1984, VIRUS RES, V1, P241, DOI 10.1016/0168-1702(84)90042-X; Pauly MD, 2017, ELIFE, V6, DOI 10.7554/eLife.26437; Pavesi A, 2019, VIROLOGY, V532, P39, DOI 10.1016/j.virol.2019.03.017; Ping JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021740; RACANIELLO VR, 1979, J VIROL, V29, P361, DOI 10.1128/JVI.29.1.361-373.1979; RITCHEY MB, 1976, J VIROL, V18, P738, DOI 10.1128/JVI.18.2.738-744.1976; Rowell J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215321; Rutvisuttinunt W, 2015, J CLIN VIROL, V68, P16, DOI 10.1016/j.jcv.2015.04.010; Seitz C, 2010, J GEN VIROL, V91, P1754, DOI 10.1099/vir.0.020370-0; SHAW MW, 1983, P NATL ACAD SCI-BIOL, V80, P4879, DOI 10.1073/pnas.80.16.4879; Shen CG, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam5752; Sheng ZZ, 2018, J GEN VIROL, V99, P475, DOI 10.1099/jgv.0.001018; Simonyan V, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw022; Simonyan V, 2014, GENES-BASEL, V5, P957, DOI 10.3390/genes5040957; Suguitan Jr AL, 2011, PLOS ONE, V6; Sun W, 2019, HUMANS J VIROL, V93; The Lancet Global Health, 2018, LANCET GLOB HLTH, V6, pE593; The WHO Alliance for Maternal and Newborn Health Improvement late pregnancy dating study group, 2020, LANCET GLOB HLTH, V8, pe545; Trucchi C, 2019, EXPERT OPIN BIOL TH, V19, P671, DOI 10.1080/14712598.2019.1604671; Vahey MD, 2019, ELIFE, V8, DOI 10.7554/eLife.43764; Valesano AL, 2020, J VIROL, V94, DOI 10.1128/JVI.01710-19; Vasin AV, 2014, VIRUS RES, V185, P53, DOI 10.1016/j.virusres.2014.03.015; Virk RK, 2020, P NATL ACAD SCI USA, V117, P619, DOI 10.1073/pnas.1916585116; Wasik BR, 2019, J VIROL, V93, DOI 10.1128/JVI.01039-19; Yang S, 2017, ANAL CHEM, V89, P9508, DOI 10.1021/acs.analchem.7b02514; Yoshihara K, 2020, INFECT GENET EVOL, V81, DOI 10.1016/j.meegid.2020.104264; Zhao L, 2019, VIRUS EVOL, V5, DOI 10.1093/ve/vez008; 2013, SURG OBES RELAT DIS, V9; 2018, CURR OPIN TOXICOL, V10	73	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0239015	10.1371/journal.pone.0239015	http://dx.doi.org/10.1371/journal.pone.0239015			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925936	gold, Green Published			2022-12-26	WOS:000572318000028
J	Winthorst, WH; Bos, EH; Roest, AM; de Jonge, P				Winthorst, Wim H.; Bos, Elisabeth H.; Roest, Annelieke M.; de Jonge, Peter			Seasonality of mood and affect in a large general population sample	PLOS ONE			English	Article							MENTAL-HEALTH-SURVEY; NEGATIVE AFFECT SCHEDULE; 16-ITEM QUICK INVENTORY; REPORT QIDS-SR; DEPRESSIVE SYMPTOMATOLOGY; AFFECTIVE-DISORDER; PSYCHOMETRIC PROPERTIES; MAJOR DEPRESSION; POSITIVE AFFECT; ANXIETY	Mood and behaviour are thought to be under considerable influence of the seasons, but evidence is not unequivocal. The purpose of this study was to investigate whether mood and affect are related to the seasons, and what is the role of neuroticism in this association. In a national internet-based crowdsourcing project in the Dutch general population, individuals were invited to assess themselves on several domains of mental health. ANCOVA was used to test for differences between the seasons in mean scores on the Positive and Negative Affect Schedule (PANAS) and Quick Inventory of Depressive Symptomatology (QIDS). Within-subject seasonal differences were tested as well, in a subgroup that completed the PANAS twice. The role of neuroticism as a potential moderator of seasonality was examined. Participants (n = 5,282) scored significantly higher on positive affect (PANAS) and lower on depressive symptoms (QIDS) in spring compared to summer, autumn and winter. They also scored significantly lower on negative affect in spring compared to autumn. Effect sizes were small or very small. Neuroticism moderated the effect of the seasons, with only participants higher on neuroticism showing seasonality. There was no within-subject seasonal effect for participants who completed the questionnaires twice (n = 503), nor was neuroticism a significant moderator of this within-subjects effect. The findings of this study in a general population sample participating in an online crowdsourcing study do not support the widespread belief that seasons influence mood to a great extent. For, as far as the seasons did influence mood, this only applied to highly neurotic participants and not to low-neurotic participants. The underlying mechanism of cognitive attribution may explain the perceived relation between seasonality and neuroticism.	[Winthorst, Wim H.] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Dept Psychiat, Groningen, Netherlands; [Bos, Elisabeth H.; Roest, Annelieke M.; de Jonge, Peter] Univ Groningen, Dept Dev Psychol, Groningen, Netherlands	University of Groningen; University of Groningen	Winthorst, WH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Dept Psychiat, Groningen, Netherlands.	w.h.winthorst@umcg.nl	; de Jonge, Peter/L-6395-2013	Roest, Annelieke/0000-0002-7997-8559; de Jonge, Peter/0000-0002-0866-6929	VICI grant from the Netherlands Organization for Scientific Research (NWO-ZonMW) [91812607]; University Medical Center Groningen	VICI grant from the Netherlands Organization for Scientific Research (NWO-ZonMW)(Netherlands Organization for Scientific Research (NWO)); University Medical Center Groningen	This study was funded by a VICI grant (no: 91812607) received by Peter de Jonge from the Netherlands Organization for Scientific Research (NWO-ZonMW) and by the University Medical Center Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1946, PUBLIC HLTH REPORTS, V61, P1259; Bevelander KE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087756; Blaauw FJ, 2018, NONEXISTENT AVERAGE; Blazer DG, 1998, BRIT J PSYCHIAT, V172, P164, DOI 10.1192/bjp.172.2.164; Brabham DC, 2014, AM J PREV MED, V46, P179, DOI 10.1016/j.amepre.2013.10.016; Centraal bureau voor de Satistiek, 2018, ZORG STIJG 2017 MET; Crawford JR, 2009, BRIT J CLIN PSYCHOL, V48, P163, DOI 10.1348/014466508X377757; Crocker PRE, 1997, J SPORT EXERCISE PSY, V19, P91, DOI 10.1123/jsep.19.1.91; de Graaf R, 2005, AM J EPIDEMIOL, V162, P654, DOI 10.1093/aje/kwi264; de Graaf R, 2002, AM J PSYCHIAT, V159, P620, DOI 10.1176/appi.ajp.159.4.620; de Graaf R, 2010, INT J METH PSYCH RES, V19, P125, DOI 10.1002/mpr.317; DePaoli LC, 2000, J SOC BEHAV PERS, V15, P561; Doran CM, 2019, AUST HEALTH REV, V43, P43, DOI 10.1071/AH16115; Estelles-Arolas E, 2012, J INF SCI, V38, P189, DOI 10.1177/0165551512437638; FORNARI VM, 1994, COMPR PSYCHIAT, V35, P450, DOI 10.1016/0010-440X(94)90228-3; Ghadirian AM, 1999, GEN HOSP PSYCHIAT, V21, P354, DOI 10.1016/S0163-8343(99)00028-6; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Hansen V, 2008, EPIDEMIOL PSICHIAT S, V17, P120, DOI 10.1017/S1121189X00002815; Harald B, 2012, J AFFECT DISORDERS, V139, P126, DOI 10.1016/j.jad.2011.07.015; Hill RD, 2005, INT J GERIATR PSYCH, V20, P429, DOI 10.1002/gps.1300; Hoekstra H, 2014, NEO FFI 3 PERSOONLIJ; Hoorelbeke K, 2019, BEHAV RES THER, V116, P1, DOI 10.1016/j.brat.2019.01.007; KASPER S, 1989, ARCH GEN PSYCHIAT, V46, P823; Kessler RC, 1996, BRIT J PSYCHIAT, V168, P17, DOI 10.1192/S0007125000298371; LoBello SG, 2019, J BEHAV THER EXP PSY, V62, P72, DOI 10.1016/j.jbtep.2018.09.003; Lonigan CJ, 2003, J CONSULT CLIN PSYCH, V71, P465, DOI 10.1037/0022-006X.71.3.465; Lukmanji A, 2019, J AFFECT DISORDERS, V255, P142, DOI 10.1016/j.jad.2019.05.040; Magnusson A, 2000, AM J PSYCHIAT, V157, P234, DOI 10.1176/appi.ajp.157.2.234; Martinez ME, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007327; Meesters Y, 2016, Tijdschr Psychiatr, V58, P48; Melvin GA, 2000, PSYCHOL REP, V86, P1209, DOI 10.2466/PR0.86.3.1209-1212; Mersch PPA, 2004, J AFFECT DISORDERS, V80, P209, DOI 10.1016/S0165-0327(03)00114-9; Mersch PPA, 1999, BIOL PSYCHIAT, V45, P1013, DOI 10.1016/S0006-3223(98)00220-0; Murray G, 2013, BIPOLAR DISORD, V15, P808, DOI 10.1111/bdi.12111; MURRAY GW, 1995, PERS INDIV DIFFER, V19, P613, DOI 10.1016/0191-8869(95)00105-F; Noteboom A, 2016, J AFFECT DISORDERS, V190, P156, DOI 10.1016/j.jad.2015.09.020; Oyane NMF, 2008, J AFFECT DISORDERS, V105, P147, DOI 10.1016/j.jad.2007.05.002; Partonen T, 2010, SEASONAL AFFECTIVE D, V2nd; Peeters F.P.M.L, 1996, TIJDSCHR PSYCHIAT, V38, P240; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Reilly TJ, 2015, J PSYCHIATR RES, V60, P132, DOI 10.1016/j.jpsychires.2014.09.008; Rohan KJ, 2003, J CONSULT CLIN PSYCH, V71, P22, DOI 10.1037/0022-006X.71.1.22; Rosellini AJ, 2011, ASSESSMENT, V18, P27, DOI 10.1177/1073191110382848; ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Rush AJ, 2006, BIOL PSYCHIAT, V59, P493, DOI 10.1016/j.biopsych.2005.08.022; Scholtens S, 2015, INT J EPIDEMIOL, V44, P1172, DOI 10.1093/ije/dyu229; Schulte-van Maaren YWM, 2013, J AFFECT DISORDERS, V149, P342, DOI 10.1016/j.jad.2013.02.009; Sher L, 2004, COMPR PSYCHIAT, V45, P51, DOI 10.1016/j.comppsych.2003.09.007; Silk JS, 2007, DEV PSYCHOPATHOL, V19, P841, DOI 10.1017/S0954579407000417; Skitka LJ, 2006, ANNU REV PSYCHOL, V57, P529, DOI 10.1146/annurev.psych.57.102904.190048; SPSS Inc, 2017, STAT PACK SOC SCI SP; Steinhardt M, 2008, J AM COLL HEALTH, V56, P445, DOI 10.3200/JACH.56.44.445-454; Traffanstedt MK, 2016, CLIN PSYCHOL SCI, V4, P825, DOI 10.1177/2167702615615867; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Van Der Krieke L, 2016, INT J METH PSYCH RES, V25, P123, DOI 10.1002/mpr.1495; Watson D, 2005, J RES PERS, V39, P46, DOI 10.1016/j.jrp.2004.09.006; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WATSON D, 1988, J ABNORM PSYCHOL, V97, P346, DOI 10.1037/0021-843X.97.3.346; Westrin Asa, 2007, Ann Clin Psychiatry, V19, P239; Winlder D, 2017, J AFFECT DISORDERS, V208, P54, DOI 10.1016/j.jad.2016.08.041; Winthorst WH, 2017, BJPSYCH OPEN, V3, P196, DOI 10.1192/bjpo.bp.116.004960; Winthorst WH, 2014, DEPRESS ANXIETY, V31, P517, DOI 10.1002/da.22130; Winthorst WH, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-198; Wirz-Justice A, 2019, EUR ARCH PSY CLIN N, V269, P833, DOI 10.1007/s00406-018-0921-3; Young MA, 2017, CLIN PSYCHOL SCI, V5, P750, DOI 10.1177/2167702616689086	67	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0239033	10.1371/journal.pone.0239033	http://dx.doi.org/10.1371/journal.pone.0239033			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NS5RK	32925966	Green Published, gold			2022-12-26	WOS:000572318000042
J	Chen, T; Zhu, J; Wang, YH				Chen, Tao; Zhu, Jie; Wang, Yu-Hai			RNF216 mediates neuronal injury following experimental subarachnoid hemorrhage through the Arc/Arg3.1-AMPAR pathway	FASEB JOURNAL			English	Article						AMPA receptors; Arc/Arg3.1; RNF216; subarachnoid hemorrhage	METABOTROPIC GLUTAMATE RECEPTORS; DELAYED CEREBRAL-ISCHEMIA; EARLY BRAIN-INJURY; AMPA RECEPTOR; RNA INTERFERENCE; POSTSYNAPTIC DENSITY; NMDA RECEPTOR; 4 TLR4; VASOSPASM; TRIAD3A	Subarachnoid hemorrhage (SAH), mostly caused by aneurysm rupture, is a pathological condition associated with oxidative stress and neuroinflammation. Toll-like receptors (TLRs) are a family of key regulators of neuroinflammation, and RNF216 is an E3 ubiquitin-protein ligase that regulates TLRs via ubiquitination and proteolytic degradation. However, the role of RNF216 in SAH has not been determined. In this study, we investigated the biological function of RNF216 in experimental SAH models both in vitro and in vivo. The expression of RNF216 was found to be upregulated in cortical neurons after oxyhemoglobin (OxyHb) treatment, and increased RNF216 expression was also observed in brain tissues in the single-hemorrhage model of SAH. Downregulation of RNF216 expression by short interfering RNA (siRNA) transfection significantly reduced cytotoxicity and apoptosis after OxyHb exposure. The results of western blot showed that the RNF216-mediated neuronal injury in vitro was associated with the regulation of the Arc-AMPAR pathway, which was related to intracellular Ca2+ dysfunction, as evidenced by Ca2+ imaging. In addition, knockdown of RNF216 in vivo using intraventricular injection of siRNA was found to attenuate brain injury and neuroinflammation via the Arc-AMPAR pathway after SAH in the animal model. In summary, we demonstrated that silence of RNF216 expression protects against neuronal injury and neurological dysfunction in experimental SAH models. These data support for the first time that RNF216 may represent a novel candidate for therapies against SAH.	[Chen, Tao; Zhu, Jie; Wang, Yu-Hai] Anhui Med Univ, Dept Neurosurg, Hosp PLA 904, Med Sch, Wuxi 214044, Jiangsu, Peoples R China	Anhui Medical University	Chen, T; Wang, YH (corresponding author), Anhui Med Univ, Dept Neurosurg, Hosp PLA 904, Med Sch, Wuxi 214044, Jiangsu, Peoples R China.	fmmuchentao@163.com; prof_wyh101@163.com			NSFC | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund) [81701932]; National Natural Science Foundation of China (NSFC) [81871598, 81601719]; Wuxi Health Commission's major project in translational medicine [ZZ001]	NSFC | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Wuxi Health Commission's major project in translational medicine	NSFC | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund), Grant/Award Number: 81701932; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81871598 and 81601719; Wuxi Health Commission's major project in translational medicine, Grant/Award Number: ZZ001	Arenz C, 2003, NATURWISSENSCHAFTEN, V90, P345, DOI 10.1007/s00114-003-0441-4; Bogason ET, 2014, NEUROSURGERY, V74, P227, DOI 10.1227/NEU.0000000000000240; Chang DTW, 2006, NEUROSCIENCE, V141, P727, DOI 10.1016/j.neuroscience.2006.01.034; Chen F, 2001, AM J PATHOL, V159, P387, DOI 10.1016/S0002-9440(10)61708-7; Chen T, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-019-2198-5; Chen T, 2017, NEUROSCI LETT, V661, P23, DOI 10.1016/j.neulet.2017.09.024; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Chen YJ, 2015, NEUROSCI LETT, V588, P131, DOI 10.1016/j.neulet.2015.01.005; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Colak A, 2009, CENT EUR NEUROSURG, V70, P187, DOI 10.1055/s-0029-1202357; Fearns C, 2006, J BIOL CHEM, V281, P34592, DOI 10.1074/jbc.M604019200; Feng D, 2014, NEUROSCIENCE, V268, P21, DOI 10.1016/j.neuroscience.2014.02.053; Han HY, 2018, METHODS MOL BIOL, V1706, P293, DOI 10.1007/978-1-4939-7471-9_16; Han SM, 2014, J CEREBR BLOOD F MET, V34, P108, DOI 10.1038/jcbfm.2013.170; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Hayman EG, 2017, NEUROCRIT CARE, V26, P301, DOI 10.1007/s12028-016-0354-7; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Inage YW, 2000, PEDIATR NEUROL, V23, P42, DOI 10.1016/S0887-8994(00)00142-9; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Jacobsen A, 2014, ACTA NEUROL SCAND, V130, P156, DOI 10.1111/ane.12258; Jung CS, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/560305; Kooijman E, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-2; Kumar SS, 2002, J NEUROSCI, V22, P3005, DOI 10.1523/JNEUROSCI.22-08-03005.2002; Kumar V, 2012, J BIOL CHEM, V287, P5412, DOI 10.1074/jbc.M111.301366; Leonoudakis D, 2008, J NEUROSCI, V28, P2119, DOI 10.1523/JNEUROSCI.5159-07.2008; Li FF, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00012; Li YY, 2015, J ASIAN CERAM SOC, V3, P1, DOI [10.1016/j.jascer.2014.12.002, 10.1016/j.jascer.2014.12.0022]; Lu Y, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1118-4; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; Ma CX, 2015, NEUROL MED-CHIR, V55, P878, DOI 10.2176/nmc.oa.2015-0077; Ma CX, 2015, J NEUROL SCI, V359, P67, DOI 10.1016/j.jns.2015.10.018; Mabb AM, 2014, NEURON, V82, P1299, DOI 10.1016/j.neuron.2014.05.016; Margolin DH, 2013, NEW ENGL J MED, V368, P1992, DOI 10.1056/NEJMoa1215993; Masilamoni GJ, 2018, CURR OPIN PHARMACOL, V38, P72, DOI 10.1016/j.coph.2018.03.004; Melnick AF, 2019, BIOL REPROD, V100, P1132, DOI 10.1093/biolre/ioz006; Miyazaki T, 2012, BRAIN RES, V1435, P1, DOI 10.1016/j.brainres.2011.11.033; Nicoletti E, 2011, NEUROPHARMACOLOGY, V60, P1017, DOI 10.1016/j.neuropharm.2010.10.022; Okuno H, 2012, CELL, V149, P886, DOI 10.1016/j.cell.2012.02.062; Turan N, 2018, WORLD NEUROSURG, V110, pE150, DOI 10.1016/j.wneu.2017.10.118; Wadhwa R, 2004, MUTAT RES-REV MUTAT, V567, P71, DOI 10.1016/j.mrrev.2004.06.002; Wan H, 2014, EXPERT OPIN PHARMACO, V15, P231, DOI 10.1517/14656566.2014.865724; Whitehead G, 2017, NEUROPHARMACOLOGY, V112, P221, DOI 10.1016/j.neuropharm.2016.08.022; Wilkerson JR, 2014, CELL REP, V7, P1589, DOI 10.1016/j.celrep.2014.04.035; Will O, 2007, GASTROENTEROLOGY, V132, P527, DOI 10.1053/j.gastro.2006.11.043; Zhang ZY, 2018, EXP NEUROL, V301, P13, DOI 10.1016/j.expneurol.2017.12.005	46	13	13	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15080	15092		10.1096/fj.201903151RRRR	http://dx.doi.org/10.1096/fj.201903151RRRR		SEP 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32918771	Bronze			2022-12-26	WOS:000570684600001
J	Muyyarikkandy, MS; McLeod, M; Maguire, M; Mahar, R; Kattapuram, N; Zhang, CE; Surugihalli, C; Muralidaran, V; Vavilikolanu, K; Mathews, CE; Merritt, ME; Sunny, NE				Muyyarikkandy, Muhammed S.; McLeod, Marc; Maguire, Meghan; Mahar, Rohit; Kattapuram, Nathan; Zhang, Christine; Surugihalli, Chaitra; Muralidaran, Vaishna; Vavilikolanu, Kruthi; Mathews, Clayton E.; Merritt, Matthew E.; Sunny, Nishanth E.			Branched chain amino acids and carbohydrate restriction exacerbate ketogenesis and hepatic mitochondrial oxidative dysfunction during NAFLD	FASEB JOURNAL			English	Article						fatty liver; hepatic insulin resistance; lipogenesis; liver mitochondria	NONALCOHOLIC FATTY LIVER; TCA CYCLE; DIET; GLUCOSE; ADAPTATION; METABOLISM; STRESS; HUMANS; MICE; ACETOACETATE	Mitochondrial adaptation during non-alcoholic fatty liver disease (NAFLD) include remodeling of ketogenic flux and sustained tricarboxylic acid (TCA) cycle activity, which are concurrent to onset of oxidative stress. Over 70% of obese humans have NAFLD and ketogenic diets are common weight loss strategies. However, the effectiveness of ketogenic diets toward alleviating NAFLD remains unclear. We hypothesized that chronic ketogenesis will worsen metabolic dysfunction and oxidative stress during NAFLD. Mice (C57BL/6) were kept (for 16-wks) on either a low-fat, high-fat, or high-fat diet supplemented with 1.5X branched chain amino acids (BCAAs) by replacing carbohydrate calories (ketogenic). The ketogenic diet induced hepatic lipid oxidation and ketogenesis, and produced multifaceted changes in flux through the individual steps of the TCA cycle. Higher rates of hepatic oxidative fluxes fueled by the ketogenic diet paralleled lower rates of de novo lipogenesis. Interestingly, this metabolic remodeling did not improve insulin resistance, but induced fibrogenic genes and inflammation in the liver. Under a chronic "ketogenic environment," the hepatocyte diverted more acetyl-CoA away from lipogenesis toward ketogenesis and TCA cycle, a milieu which can hasten oxidative stress and inflammation. In summary, chronic exposure to ketogenic environment during obesity and NAFLD has the potential to aggravate hepatic mitochondrial dysfunction.	[Muyyarikkandy, Muhammed S.; Maguire, Meghan; Kattapuram, Nathan; Zhang, Christine; Surugihalli, Chaitra; Muralidaran, Vaishna; Vavilikolanu, Kruthi; Sunny, Nishanth E.] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [McLeod, Marc; Mahar, Rohit; Mathews, Clayton E.; Merritt, Matthew E.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	University System of Maryland; University of Maryland College Park; State University System of Florida; University of Florida	Sunny, NE (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.	nsunny@umd.edu	Muyyarikkandy, Muhammed/AAG-3402-2020	Muyyarikkandy, Muhammed/0000-0003-3405-5440; MAHAR, ROHIT/0000-0002-9801-4173; Merritt, Matthew/0000-0003-4617-9651; Kattapuram, Nathan/0000-0002-6766-7235	HHS | National Institutes of Health (NIH) [RO1-DK-112865, P41-122698, 5U2CDK119889, R01-105346]	HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS | National Institutes of Health (NIH), Grant/Award Number: RO1-DK-112865, P41-122698, 5U2CDK119889 and R01-105346	Abbasi J, 2018, JAMA-J AM MED ASSOC, V319, P215, DOI 10.1001/jama.2017.20639; Anekwe CV, 2020, CUREUS, V12, DOI 10.7759/cureus.6605; Antoniewicz MR, 2006, METAB ENG, V8, P324, DOI 10.1016/j.ymben.2006.01.004; Begriche K, 2013, HEPATOLOGY, V58, P1497, DOI 10.1002/hep.26226; Belopolsky Y, 2020, J TRANSL INTERN MED, V8, P26, DOI 10.2478/jtim-2020-0005; Boland ML, 2018, WORLD J GASTROENTERO, V24, P1748, DOI 10.3748/wjg.v24.i16.1748; Caprio M, 2019, J ENDOCRINOL INVEST, V42, P1365, DOI 10.1007/s40618-019-01061-2; Cotter DG, 2014, J CLIN INVEST, V124, P5175, DOI 10.1172/JCI76388; Crown SB, 2015, METAB ENG, V28, P151, DOI 10.1016/j.ymben.2015.01.001; Delgado TC, 2009, NMR BIOMED, V22, P310, DOI 10.1002/nbm.1327; Duarte JAG, 2014, J LIPID RES, V55, P2541, DOI 10.1194/jlr.M052308; Ericksen RE, 2019, CELL METAB, V29, P1151, DOI 10.1016/j.cmet.2018.12.020; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Fletcher JA, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127737; Forrester SJ, 2018, CIRC RES, V122, P877, DOI 10.1161/CIRCRESAHA.117.311401; Garbow JR, 2011, AM J PHYSIOL-GASTR L, V300, pG956, DOI 10.1152/ajpgi.00539.2010; Green CR, 2016, NAT CHEM BIOL, V12, P15, DOI [10.1038/nchembio.1961, 10.1038/NCHEMBIO.1961]; Jain SK, 1998, FREE RADICAL BIO MED, V25, P1083, DOI 10.1016/S0891-5849(98)00140-3; Jain SK, 2002, DIABETES, V51, P2287, DOI 10.2337/diabetes.51.7.2287; Joshi S, 2019, JAMA INTERN MED, V179, P1163, DOI 10.1001/jamainternmed.2019.2633; Kanikarla-Marie P, 2015, CELL PHYSIOL BIOCHEM, V35, P364, DOI 10.1159/000369702; Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004; Kosinski C, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050517; Kujala UM, 2016, FRONT MED-LAUSANNE, V3, P1, DOI 10.3389/fmed.2016.00057; Lerin C, 2016, MOL METAB, V5, P926, DOI 10.1016/j.molmet.2016.08.001; Li T, 2017, CELL METAB, V25, P374, DOI 10.1016/j.cmet.2016.11.005; Luukkonen PK, 2020, P NATL ACAD SCI USA, V117, P7347, DOI 10.1073/pnas.1922344117; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Moore MP, 2020, APPL PHYSIOL NUTR ME, V45, P35, DOI 10.1139/apnm-2019-0042; Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623; Nishikata N, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.1; Noguchi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012057; Patterson RE, 2016, AM J PHYSIOL-ENDOC M, V310, pE484, DOI 10.1152/ajpendo.00492.2015; Puchalska P, 2017, CELL METAB, V25, P262, DOI 10.1016/j.cmet.2016.12.022; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Ragavan M, 2017, AM J PHYSIOL-HEART C, V312, pH1215, DOI 10.1152/ajpheart.00016.2017; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Rosenbaum M, 2019, OBESITY, V27, P971, DOI 10.1002/oby.22468; Satapati S, 2016, J CLIN INVEST, V126, P1605, DOI 10.1172/JCI86695; Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382; Schmid AI, 2011, DIABETES CARE, V34, P448, DOI 10.2337/dc10-1076; Schugar RC, 2012, CURR OPIN CLIN NUTR, V15, P374, DOI 10.1097/MCO.0b013e3283547157; Sunny NE, 2011, J ANIM SCI, V89, P3945, DOI 10.2527/jas.2011-3985; Sunny NE, 2017, TRENDS ENDOCRIN MET, V28, P250, DOI 10.1016/j.tem.2016.11.006; Sunny NE, 2015, AM J PHYSIOL-ENDOC M, V309, pE311, DOI 10.1152/ajpendo.00161.2015; Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004; Sunny NE, 2010, AM J PHYSIOL-ENDOC M, V298, pE1226, DOI 10.1152/ajpendo.00033.2010; Trimboli P, 2020, REV ENDOCR METAB DIS, V21, P1, DOI 10.1007/s11154-020-09546-9; Xin LJ, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00062; Young JD, 2014, BIOINFORMATICS, V30, P1333, DOI 10.1093/bioinformatics/btu015; Young JD, 2008, BIOTECHNOL BIOENG, V99, P686, DOI 10.1002/bit.21632; Zhang FY, 2016, EBIOMEDICINE, V13, P157, DOI 10.1016/j.ebiom.2016.10.013; Zhenyukh O, 2018, J CELL MOL MED, V22, P4948, DOI 10.1111/jcmm.13759	53	11	11	3	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14832	14849		10.1096/fj.202001495R	http://dx.doi.org/10.1096/fj.202001495R		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32918763	Green Accepted			2022-12-26	WOS:000570677900001
J	Haas, C; Hachadoorian, L; Kimbrough, SO; Miller, P; Murphy, F				Haas, Christian; Hachadoorian, Lee; Kimbrough, Steven O.; Miller, Peter; Murphy, Frederic			Seed-Fill-Shift-Repair: A redistricting heuristic for civic deliberation	PLOS ONE			English	Article							PARTISAN BIAS; POLITICAL-GEOGRAPHY; COMPACTNESS; GERRYMANDERS; OPTIMIZATION; ALGORITHMS; CLASSROOM; FUTURE; TOOLS; CITY	Political redistricting is the redrawing of electoral district boundaries. It is normally undertaken to reflect population changes. The process can be abused, in what is called gerrymandering, to favor one party or interest group over another, resulting thereby in broadly undemocratic outcomes that misrepresent the views of the voters. Gerrymandering is especially vexing in the United States. This paper introduces an algorithm, with an implementation, for creating districting plans (whether for political redistricting or for other districting applications). The algorithm, Seed-Fill-Shift-Repair (SFSR), is demonstrated for Congressional redistricting in American states. SFSR is able to create thousands of valid redistricting plans, which may then be used as points of departure for public deliberation regarding how best to redistrict a given polity. The main objectives of this paper are: (i) to present SFSR in a broadly accessible form, including code that implements it and test data, so that it may be used for both civic deliberations by the public and for research purposes. (ii) to make the case for what SFSR essays to do, which is to approach redistricting, and districting generally, from a constraint satisfaction perspective and from the perspective of producing a plurality of feasible solutions that may then serve in subsequent deliberations. To further these goals, we make the code publicly available. The paper presents, for illustration purposes, a corpus of 11,206 valid redistricting plans for the Commonwealth of Pennsylvania (produced by SFSR), using the 2017 American Community Survey, along with descriptive statistics. Also, the paper presents 1,000 plans for each of the states of Arizona, Michigan, North Carolina, Pennsylvania, and Wisconsin, using the 2018 American Community Survey, along with descriptive statistics on these plans and the computations involved in their creation.	[Haas, Christian] Univ Nebraska, Coll Informat Sci & Technol, Omaha, NE USA; [Hachadoorian, Lee] Temple Univ, Geog & Urban Studies, Philadelphia, PA USA; [Kimbrough, Steven O.] Univ Penn, Operat Informat & Decis, Philadelphia, PA 19104 USA; [Miller, Peter] NYU, Brennan Ctr Justice, Sch Law, New York, NY USA; [Murphy, Frederic] Temple Univ, Fox Sch Business, Philadelphia, PA USA	University of Nebraska System; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; New York University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Kimbrough, SO (corresponding author), Univ Penn, Operat Informat & Decis, Philadelphia, PA 19104 USA.	kimbrough@wharton.upenn.edu		Miller, Peter/0000-0003-3929-8417; Haas, Christian/0000-0002-2690-5962				Aaron Kaufman, 2018, MEAUSRE COMPACTNESS; Altman M, 1998, SOC SCI HIST, V22, P159, DOI 10.2307/1171534; Altman M, 2005, SOC SCI COMPUT REV, V23, P334, DOI 10.1177/08944:19305275855; Altman M., 1997, Rutgers Computer & Technology Law Journal, V23, P81; Altman M, 1998, POLIT GEOGR, V17, P989, DOI 10.1016/S0962-6298(98)00015-8; Altman M, 2009, J STAT SOFTW, V10, P2; Altman Micah, 2010, DUKE J CONSTITUTIONA, V5, P69; [Anonymous], 2015, J INT ASS PROVIDE S1, V14, pS3; [Anonymous], 2016, FORTUNE, V15, pF29; Ansolabehere Stephen, 2016, OHIO STATE LAW J, V77, P741; BIRGE JR, 1983, SOC SCI RES, V12, P205, DOI 10.1016/0049-089X(83)90012-1; Boatright RG, 2013, PS-POLIT SCI POLIT, V46, P387, DOI 10.1017/S1049096513000103; Bogart WT, 2000, J URBAN ECON, V47, P280, DOI 10.1006/juec.1999.2142; Bozkaya B, 2003, EUR J OPER RES, V144, P12, DOI 10.1016/S0377-2217(01)00380-0; Bozkaya B, 2011, INTERFACES, V41, P534, DOI 10.1287/inte.1110.0544; Browdy MH., 1990, YALE LAW POLICY REV, V8, P163; Bullock Charles S., 2010, REDISTRICTING MOST P; BUTLER D, 1985, ELECT STUD, V4, P197, DOI 10.1016/0261-3794(85)90014-9; Cain Bruce., 1984, REAPPORTIONMENT PUZZ; Caughey D, 2017, ELECT LAW J, V16, P453, DOI 10.1089/elj.2017.0452; Cervas JR, 2020, POLIT GEOGR, V76, DOI 10.1016/j.polgeo.2019.102069; Chen JW, 2017, ELECT LAW J, V16, P443, DOI 10.1089/elj.2017.0455; Chen JW, 2016, ELECT STUD, V44, P329, DOI 10.1016/j.electstud.2016.06.014; Chen JW, 2013, Q J POLIT SCI, V8, P239, DOI 10.1561/100.00012033; Chikina M, 2017, P NATL ACAD SCI USA, V114, P2860, DOI 10.1073/pnas.1617540114; Chou C, 2014, SOC SCI COMPUT REV, V32, P534, DOI 10.1177/0894439313484262; Chou C, 2012, PROCEEDINGS OF THE FOURTEENTH INTERNATIONAL CONFERENCE ON GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P1071, DOI 10.1145/2330163.2330312; Cirincione C, 2000, POLIT GEOGR, V19, P189, DOI 10.1016/S0962-6298(99)00047-5; DeFord D, 2019, ARXIV191105725PHYSIC; di Cortona PG, 1999, MONOGRAPHS DISCRETE; Doherty D, 2014, PS-POLIT SCI POLIT, V47, P490, DOI 10.1017/S1049096514000432; ENGSTROM RL, 1977, LEGIS STUD QUART, V2, P465, DOI 10.2307/439420; Fifield B, 2020, J COMPUT GRAPH STAT, V29, P715, DOI 10.1080/10618600.2020.1739532; Forman SL, 2003, LECT NOTES COMPUT SC, V2724, P2072; Garg Priyeshu, 2019, CRYPTOSLATE     0108; Gopalan R, 2013, INTERFACES, V43, P477, DOI 10.1287/inte.2013.0697; Grofman B, 2007, ELECT LAW J, V6, P2, DOI 10.1089/elj.2006.6002; Hachadoorian L, 2019, END PARTISAN GERRYMA; Hachadoorian L, 2020, POLITICAL GEOMETRY; Handley L., 2008, REDISTRICTING COMP P; Hayes D, 2009, AM J POLIT SCI, V53, P1006, DOI 10.1111/j.1540-5907.2009.00413.x; HESS SW, 1965, OPER RES, V13, P998, DOI 10.1287/opre.13.6.998; Hood MV, 2010, SOC SCI QUART, V91, P344, DOI 10.1111/j.1540-6237.2010.00696.x; HORN DL, 1993, POLIT GEOGR, V12, P103, DOI 10.1016/0962-6298(93)90031-2; JENKINS MA, 1972, ECON GEOGR, V41, P95; Kalcsics J., 2015, LOCATION SCI, P595, DOI DOI 10.1007/978-3-319-13111-5_23; Kalcsics J., 2005, TOP, V13, P1, DOI [10. 1007/BF02578982., DOI 10.1007/BF02578982]; Kimbrough SO, 2016, BUSINESS ANAL DECISI; KING G, 1987, AM POLIT SCI REV, V81, P1251, DOI 10.2307/1962588; KING G, 1990, LEGIS STUD QUART, V15, P159, DOI 10.2307/440124; Levitt J, 2011, REAPPORTIONMENT REDI, P15; Liu YY, 2016, SWARM EVOL COMPUT, V30, P78, DOI 10.1016/j.swevo.2016.04.004; Lublin David., 1999, PARADOX REPRESENTATI; Mac Donald K, 2012, ELECT LAW J, V11, P472, DOI 10.1089/elj.2012.1148; MACEACHREN AM, 1985, GEOGR ANN B, V67, P53, DOI 10.2307/490799; Macmillan W., 2001, J GEOGRAPHICAL SYSTE, V3, P167, DOI DOI 10.1007/PL00011473; Macmillan W, 1994, SPATIAL ANAL GIS; Magleby DB, 2018, POLIT ANAL, V26, P147, DOI 10.1017/pan.2017.37; Marriott K, 1998, PROGRAMMING CONSTRAI; Matei SA, 2015, COMPUT SOC SCI, P3, DOI 10.1007/978-3-319-18552-1_1; Mattingly J. C., 2014, REDISTRICTING WILL P; McDonald MD, 2015, ELECT LAW J, V14, P312, DOI 10.1089/elj.2015.0358; McGhee E, 2017, ELECT LAW J, V16, P417, DOI 10.1089/elj.2017.0453; McGhee E, 2014, LEGIS STUD QUART, V39, P55, DOI 10.1111/lsq.12033; Micah Altman, 2015, JIGSAW PUZZLE POLITI, P1; Miller P, 2018, PS-POLIT SCI POLIT, V51, P664, DOI 10.1017/S1049096518000410; Miller P, 2018, ELECT LAW J, V17, P21, DOI 10.1089/elj.2016.0425; Monmonier Mark, 1995, DRAWING LINE TALES M; Monmonier Mark, 2001, BUSHMANDERS BULLWINK; NAGEL SS, 1965, STANFORD LAW REV, V17, P863, DOI 10.2307/1226994; NIEMI RG, 1990, J POLIT, V52, P1155, DOI 10.2307/2131686; O'Loughlin J, 1982, POLITICAL GEOGRAPHER, V1, P327; OHare WP, 2019, SPRINGERBRIEF POPUL, P1, DOI 10.1007/978-3-030-10973-8; Openshaw S, 1977, SPATIAL REPRESENTATI, P96; OWEN G, 1988, POLIT GEOGR QUART, V7, P5, DOI 10.1016/0260-9827(88)90032-8; Ramachandran G, 2018, ELECT LAW J, V17, P286, DOI 10.1089/elj.2018.0503; Ricca F, 2008, EUR J OPER RES, V189, P1409, DOI 10.1016/j.ejor.2006.08.065; Rincon-Garcia EA, 2013, J APPL RES TECHNOL, V11, P324, DOI 10.1016/S1665-6423(13)71542-6; Sakaguchi T, 2008, REDISTRICTING COMP P, P150; Schram A, 2015, MANAGE SCI, V61, P1531, DOI 10.1287/mnsc.2014.2073; Stephanopoulos NO, 2018, STANFORD LAW REV, V70, P1503; Stephanopoulos NO, 2015, U CHICAGO LAW REV, V82, P831; Stephanopoulos NO, 2013, U CHICAGO LAW REV, V80, P769; TAYLOR PJ, 1976, ENVIRON PLANN A, V8, P43, DOI 10.1068/a080043; Taylor S.L., 2014, DIFFERENT DEMOCRACY; THORESON JD, 1967, BEHAV SCI, V12, P237, DOI 10.1002/bs.3830120309; VICKREY W, 1961, POLIT SCI QUART, V76, P105, DOI 10.2307/2145973; Wang SSH, 2016, STANFORD LAW REV, V68, P1263; Williams JC, 1995, PAP REG SCI, V74, P13; YOUNG HP, 1988, LEGIS STUD QUART, V13, P105, DOI 10.2307/439947	95	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0237935	10.1371/journal.pone.0237935	http://dx.doi.org/10.1371/journal.pone.0237935			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9MU	32915791	Green Published, gold			2022-12-26	WOS:000571887500071
J	Jayarathne, I; Cohen, M; Amarakeerthi, S				Jayarathne, Isuru; Cohen, Michael; Amarakeerthi, Senaka			Person identification from EEG using various machine learning techniques with inter-hemispheric amplitude ratio	PLOS ONE			English	Article							ASYMMETRY; BRAIN; IMAGERY; CORTEX; TASKS	Association between electroencephalography (EEG) and individually personal information is being explored by the scientific community. Though person identification using EEG is an attraction among researchers, the complexity of sensing limits using such technologies in real-world applications. In this research, the challenge has been addressed by reducing the complexity of the brain signal acquisition and analysis processes. This was achieved by reducing the number of electrodes, simplifying the critical task without compromising accuracy. Event-related potentials (ERP), a.k.a. time-locked stimulation, was used to collect data from each subject's head. Following a relaxation period, each subject was visually presented a random four-digit number and then asked to think of it for 10 seconds. Fifteen trials were conducted with each subject with relaxation and visual stimulation phases preceding each mental recall segment. We introduce a novel derived feature, dubbed Inter-Hemispheric Amplitude Ratio (IHAR), which expresses the ratio of amplitudes of laterally corresponding electrode pairs. The feature was extracted after expanding the training set using signal augmentation techniques and tested with several machine learning (ML) algorithms, including Linear Discriminant Analysis (LDA), Support Vector Machine (SVM), and k-Nearest Neighbor (kNN). Most of the ML algorithms showed 100% accuracy with 14 electrodes, and according to our results, perfect accuracy can also be achieved using fewer electrodes. However, AF3, AF4, F7, and F8 electrode combination with kNN classifier which yielded 99.0 +/- 0.8% testing accuracy is the best for person identification to maintain both user-friendliness and performance. Surprisingly, the relaxation phase manifested the highest accuracy of the three phases.	[Jayarathne, Isuru; Cohen, Michael] Univ Aizu, Spatial Media Grp, Aizu Wakamatsu, Fukushima, Japan; [Amarakeerthi, Senaka] Univ Sri Jayewardenepura, Dept Informat & Commun Technol, Nugegoda, Sri Lanka	University of Aizu; University Sri Jayewardenepura	Jayarathne, I (corresponding author), Univ Aizu, Spatial Media Grp, Aizu Wakamatsu, Fukushima, Japan.	d8191101@u-aizu.ac.jp	Jayarathne, Isuru/AAK-7492-2021; Cohen, Michael/AAG-8852-2020	Jayarathne, Isuru/0000-0002-1597-4794; Cohen, Michael/0000-0001-8941-1575				Almehmadi A, 2013, INT CONF COMM INF T, P49, DOI 10.1109/ICCITechnology.2013.6579521; Alyasseri ZAA, 2018, INT J INTEGR ENG, V10, P102, DOI 10.30880/ijie.2018.10.07.010; Amari S, 1999, NEURAL NETWORKS, V12, P783, DOI 10.1016/S0893-6080(99)00032-5; [Anonymous], 2018, BNJ M; Arnau-Gonzalez P, 2018, IEEE T AFF COMP, V37, P277; BENNETT JE, 1977, PSYCHOPHYSIOLOGY, V14, P293, DOI 10.1111/j.1469-8986.1977.tb01178.x; BIRBAUMER N, 1990, PHYSIOL REV, V70, P1, DOI 10.1152/physrev.1990.70.1.1; Chan A. D. C., 2007, P CMBES, V1, P1; Chen YY, 2016, IEEE T INF FOREN SEC, V11, P2635, DOI 10.1109/TIFS.2016.2577551; Chuang EY, 2013, INT C INSTR COMMUN, P1, DOI 10.1109/ICICI-BME.2013.6698451; Chun CA, 2016, BRIT J PSYCHOL, V107, P397, DOI 10.1111/bjop.12146; Coan JA, 2004, BIOL PSYCHOL, V67, P7, DOI 10.1016/j.biopsycho.2004.03.002; Das K, 2009, IEEE ENG MED BIO, P2490, DOI 10.1109/IEMBS.2009.5334858; Davidson R.J., 1996, BRAIN ASYMMETRY; Davidson RJ, 2004, BIOL PSYCHOL, V67, P219, DOI 10.1016/j.biopsycho.2004.03.008; Del Pozo-Banos M, 2014, EXPERT SYST APPL, V41, P6537, DOI 10.1016/j.eswa.2014.05.013; Falzon O, 2017, IEEE ENG MED BIO, P4159, DOI 10.1109/EMBC.2017.8037772; Fukami T, 2018, INT J INNOV COMPUT I, V14, P2091, DOI 10.24507/ijicic.14.06.2091; Geethanjali P., 2012, 2012 9th International Conference on Fuzzy Systems and Knowledge Discovery, P1136, DOI 10.1109/FSKD.2012.6234336; GOLDSTEIN L, 1972, PHYSIOL BEHAV, V8, P811, DOI 10.1016/0031-9384(72)90289-2; Harmon-Jones E, 1997, J ABNORM PSYCHOL, V106, P159, DOI 10.1037/0021-843X.106.1.159; Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428; InteraXon Inc, MUS MED MAD EAS; James G., 2013, INTRO STAT LEARNING, V112; Jayarathne I., 2016, INF TECHN EL MOB COM, P1, DOI DOI 10.1109/IEM-CON.2016.7746325; Jayarathne I, 2017, INT CONF AWARE SCI, P324; Kaewwit C, 2017, J INF COMMUN TECHNOL, V16, P354; Kaiser V, 2012, STROKE, V43, P2735, DOI 10.1161/STROKEAHA.112.665489; Koutras A, 2018, LECT NOTES COMPUT SC, V11141, P682, DOI 10.1007/978-3-030-01424-7_67; Ledoux H, 2005, DEVELOPMENTS IN SPATIAL DATA HANDLING, P97, DOI 10.1007/3-540-26772-7_8; LEMAY M, 1977, J NEUROL SCI, V32, P243, DOI 10.1016/0022-510X(77)90239-8; Leski JM, 2005, SIGNAL PROCESS, V85, P781, DOI 10.1016/j.sigpro.2004.12.001; Mika S., 1999, Neural Networks for Signal Processing IX: Proceedings of the 1999 IEEE Signal Processing Society Workshop (Cat. No.98TH8468), P41, DOI 10.1109/NNSP.1999.788121; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Moharnmadi G, 2006, PROC WRLD ACAD SCI E, V11, P281; Ong Z. Y., 2018, 2018 INT C COMP APPR, P1, DOI [10.1109/ICASSDA.2018.8477604, DOI 10.1109/ICASSDA.2018.8477604]; Palaniappan R, 2003, ICICS-PCM 2003, VOLS 1-3, PROCEEDINGS, P1442; Poulos M, 1999, INT CONF ACOUST SPEE, P1117, DOI 10.1109/ICASSP.1999.759940; Poulos M., 1999, ICECS'99. Proceedings of ICECS '99. 6th IEEE International Conference on Electronics, Circuits and Systems (Cat. No.99EX357), P1005, DOI 10.1109/ICECS.1999.813403; Poulos M., 1999, ICECS'99. Proceedings of ICECS '99. 6th IEEE International Conference on Electronics, Circuits and Systems (Cat. No.99EX357), P283, DOI 10.1109/ICECS.1999.812278; Poulos M, 2002, METHOD INFORM MED, V41, P64; Poulos M., 1998, 9 EUROPEAN SIGNAL PR, P1; Riffenburgh R.H., 1957, LINEAR DISCRIMINANT; Roohi-Azizi Mahtab, 2017, Med J Islam Repub Iran, V31, P53, DOI 10.14196/mjiri.31.53; Ruiz-Blondet MV, 2016, IEEE T INF FOREN SEC, V11, P1618, DOI 10.1109/TIFS.2016.2543524; Savic I, 2008, P NATL ACAD SCI USA, V105, P9403, DOI 10.1073/pnas.0801566105; Singhal GK, 2007, 2007 BIOMETRICS SYMPOSIUM, P156; Smith SW, 1997, SCI ENG GUIDE DIGITA; Strickland E, IEEE SPECTRUM; Thomas KP, 2018, CIRC SYST SIGNAL PR, V37, P277, DOI 10.1007/s00034-017-0551-4; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Um T.T., 2017, P 19 ACM INT C MULT, P216, DOI 10.1145/3136755.3136817; WADA JA, 1975, ARCH NEUROL-CHICAGO, V32, P239, DOI 10.1001/archneur.1975.00490460055007; Wang YC, 2019, INT J ADV MANUF TECH, V105, P4059, DOI 10.1007/s00170-018-1927-8; Watkins KE, 2001, CEREB CORTEX, V11, P868, DOI 10.1093/cercor/11.9.868; WHEELER RE, 1993, PSYCHOPHYSIOLOGY, V30, P82, DOI 10.1111/j.1469-8986.1993.tb03207.x; Xu Huang, 2012, 2012 International Symposium on Communications and Information Technologies (ISCIT), P1021, DOI 10.1109/ISCIT.2012.6380841; Yang S, 2019, IEEE ACCESS, V7, P49604, DOI 10.1109/ACCESS.2019.2910752; Yazdani A, 2008, INT CONF SIGN PROCES, P1678	59	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238872	10.1371/journal.pone.0238872	http://dx.doi.org/10.1371/journal.pone.0238872			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915850	gold, Green Published			2022-12-26	WOS:000571887500018
J	Singer, M; Ashimatey, BS; Zhou, X; Chu, ZD; Wang, RK; Kashani, AH				Singer, Maxwell; Ashimatey, Bright S.; Zhou, Xiao; Chu, Zhongdi; Wang, Ruikang; Kashani, Amir H.			Impaired layer specific retinal vascular reactivity among diabetic subjects	PLOS ONE			English	Article							ARTERIOLAR DIAMETER; OXYGEN REACTIVITY; BLOOD-FLOW; INDIVIDUALS; RETINOPATHY; MELLITUS; VELOCITY; NO	Purpose To investigate layer specific retinal vascular reactivity (RVR) in capillaries of diabetic subjects without DR or with only mild non-proliferative diabetic retinopathy (NPDR). Methods A previously described nonrebreathing apparatus was used to deliver room air, 5% CO2, or 100% O(2)to 41 controls and 22 diabetic subjects (with mild or no NPDR) while simultaneously acquiring fovea-centered 3x3mm(2)Swept-Source Optical Coherence Tomography Angiography (SS-OCTA) images. Vessel skeleton density (VSD) and vessel diameter index (VDI) were calculated for each gas condition for the superficial retinal layer (SRL) and deep retinal layer (DRL). The superficial layer analysis excluded arterioles and venules. Data analysis was performed using mixed factorial analysis of covariance stratified by diabetic status. All models were adjusted for age, gender, and hypertension, and statistical significance for multiple comparisons from posthoc comparisons were defined at pResults Among controls, there was a significant difference in capillary VSD between all gas conditions (p<0.001). This difference was present in both the SRL and DRL. Among diabetics, there was no significant difference in response to CO(2)conditions in the SRL (p = 0.072), and a blunted response to both CO2(p = 0.9) and O(2)in the DRL (p = 0.019). A significant gas effect was detected in the capillary VDI in the SRL of controls (p = 0.001), which was driven by higher VDI in the oxygen condition compared to that of carbon dioxide. Conclusions Impairment in RVR in diabetic subjects is characterized by a paradoxical response to CO(2)in both the SRL and DRL as well as an attenuated response to O(2)in the DRL. These layer and gas specific impairments in diabetics seem to occur early in the disease and to be driven primarily at the capillary level.	[Singer, Maxwell; Ashimatey, Bright S.; Kashani, Amir H.] Univ Southern Calif, USC Roski Eye Inst, Dept Ophthalmol, Keck Sch Med, Los Angeles, CA 90007 USA; [Zhou, Xiao; Chu, Zhongdi; Wang, Ruikang] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Wang, Ruikang] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; [Kashani, Amir H.] Univ Southern Calif, USC Ginsburg Inst Biomed Therapeut, Keck Sch Med, Los Angeles, CA 90007 USA	University of Southern California; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Southern California	Kashani, AH (corresponding author), Univ Southern Calif, USC Roski Eye Inst, Dept Ophthalmol, Keck Sch Med, Los Angeles, CA 90007 USA.; Kashani, AH (corresponding author), Univ Southern Calif, USC Ginsburg Inst Biomed Therapeut, Keck Sch Med, Los Angeles, CA 90007 USA.	ahkashan@usc.edu	Wang, Ruikang/L-3889-2019	Wang, Ruikang/0000-0001-5169-8822; Ashimatey, Bright Senyo/0000-0002-1319-1008	Tai Family Research Scholars Fund; Research to Prevent Blindness; National Eye Institute [R01EY030564, K08EY027006]; Carl Zeiss Meditec, Inc., Dublin, CA	Tai Family Research Scholars Fund; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Carl Zeiss Meditec, Inc., Dublin, CA	This study was supported by the Tai Family Research Scholars Fund (MS), an unrestricted grant from Research to Prevent Blindness, https://www.rpbusa.org/rpb (AK) to the USC Roski Eye Institute, the National Eye Institute (R01EY030564, K08EY027006) (AK), and by Carl Zeiss Meditec, Inc., Dublin, CA, 94568 (AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An L, 2010, OPT EXPRESS, V18, P8220, DOI 10.1364/OE.18.008220; [Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Ashimatey BS, 2019, INVEST OPHTH VIS SCI, V60, P2468, DOI 10.1167/iovs.18-26417; Carnevali A, 2017, ACTA DIABETOL, V54, P695, DOI 10.1007/s00592-017-0996-8; Chapman N, 2000, CLIN SCI, V99, P483, DOI 10.1042/CS20000099; Chu ZD, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.6.066008; COGAN DG, 1961, ARCH OPHTHALMOL-CHIC, V66, P366, DOI 10.1001/archopht.1961.00960010368014; Dimitrova G, 2019, OPHTHALMOLOGICA, V241, P179, DOI 10.1159/000495624; Duan A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02344-5; Fondi K, 2017, DIABETOLOGIA, V60, P1534, DOI 10.1007/s00125-017-4309-0; Gilmore ED, 2007, INVEST OPHTH VIS SCI, V48, P1744, DOI 10.1167/iovs.06-1016; GRUNWALD JE, 1984, OPHTHALMOLOGY, V91, P1447; Kashani AH, 2017, PROG RETIN EYE RES, V60, P66, DOI 10.1016/j.preteyeres.2017.07.002; Klefter ON, 2015, ACTA OPHTHALMOL, V93, P232, DOI 10.1111/aos.12553; Kushner-Lenhoff S, 2020, JOVE-J VIS EXP, DOI 10.3791/60948; Lorenzi M, 2008, DIABETOLOGIA, V51, P361, DOI 10.1007/s00125-007-0872-0; Meshi A, 2019, RETINA-J RET VIT DIS, V39, P2022, DOI 10.1097/IAE.0000000000002258; Mizutani M, 1996, J CLIN INVEST, V97, P2883, DOI 10.1172/JCI118746; Palkovits S, 2014, INVEST OPHTH VIS SCI, V55, P4707, DOI 10.1167/iovs.14-14593; PATEL V, 1994, CLIN SCI, V86, P689, DOI 10.1042/cs0860689; Puro DG, 2012, PROG RETIN EYE RES, V31, P258, DOI 10.1016/j.preteyeres.2012.01.001; Reif R, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/509783; Rose K, 2014, INVEST OPHTH VIS SCI, V55, P4266, DOI 10.1167/iovs.14-14022; Scarinci F, 2018, ACTA OPHTHALMOL, V96, pe264, DOI 10.1111/aos.13510; Simonett JM, 2017, ACTA OPHTHALMOL, V95, pe751, DOI 10.1111/aos.13404; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; SNMMI Newsline, 2016, J NUCL MED, V57, p19N, DOI DOI 10.1167/iovs.15-18904; Spaide RF, 2018, PROG RETIN EYE RES, V64, P1, DOI 10.1016/j.preteyeres.2017.11.003; Tayyari F, 2009, INVEST OPHTH VIS SCI, V50, P4814, DOI 10.1167/iovs.09-3373; Trick GL, 2006, INVEST OPHTH VIS SCI, V47, P1612, DOI 10.1167/iovs.05-0833; Venkataraman ST, 2010, INVEST OPHTH VIS SCI, V51, P2043, DOI 10.1167/iovs.09-3630; Wang RK, 2010, OPT LETT, V35, P1467, DOI 10.1364/OL.35.001467; Yezhuvath US, 2009, NMR BIOMED, V22, P779, DOI 10.1002/nbm.1392; Yu DY, 2019, PROG RETIN EYE RES, V70, P23, DOI 10.1016/j.preteyeres.2019.01.001; Zhang AQ, 2015, BIOMED OPT EXPRESS, V6, P4130, DOI 10.1364/BOE.6.004130; Zhang QQ, 2017, OPHTHALMOL RETINA, V1, P124, DOI 10.1016/j.oret.2016.08.005	37	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0233871	10.1371/journal.pone.0233871	http://dx.doi.org/10.1371/journal.pone.0233871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915787	Green Published, Green Submitted, gold			2022-12-26	WOS:000571887500033
J	Slatculescu, AM; Clow, KM; McKay, R; Talbot, B; Logan, JJ; Thickstun, CR; Jardine, CM; Ogden, NH; Knudby, AJ; Kulkarni, MA				Slatculescu, Andreea M.; Clow, Katie M.; McKay, Roman; Talbot, Benoit; Logan, James J.; Thickstun, Charles R.; Jardine, Claire M.; Ogden, Nicholas H.; Knudby, Anders J.; Kulkarni, Manisha A.			Species distribution models for the eastern blacklegged tick,Ixodes scapularis, and the Lyme disease pathogen,Borrelia burgdorferi, in Ontario, Canada	PLOS ONE			English	Article							VECTOR-IXODES-SCAPULARIS; BORRELIA-BURGDORFERI; CLIMATE-CHANGE; ANAPLASMA-PHAGOCYTOPHILUM; PASSIVE SURVEILLANCE; MAXIMUM-ENTROPY; BORNE PATHOGENS; RANGE EXPANSION; ACARI IXODIDAE; TICKS	The blacklegged tick,Ixodes scapularis, is established in several regions of Ontario, Canada, and continues to spread into new geographic areas across the province at a rapid rate. This poses a significant public health risk sinceI.scapularistransmits the Lyme disease-causing bacterium,Borrelia burgdorferi, and other pathogens of potential public health concern. The objective of this study was to develop species distribution models forI.scapularisandB.burgdorferito predict and compare the potential distributions of the tick vector and the Lyme disease pathogen as well as the ecological factors most important for species establishment. Ticks were collected via tick dragging at 120 sites across southern, central, and eastern Ontario between 2015 and 2018 and tested for tick-borne pathogens. A maximum entropy (Maxent) approach was used to model the potential distributions ofI.scapularisandB.burgdorferi. Two independent datasets derived from tick dragging at 25 new sites in 2019 and ticks submitted by the public to local health units between 2015 and 2017 were used to validate the predictive accuracy of the models. The model forI.scapularisshowed high suitability for blacklegged ticks in eastern Ontario and some regions along the shorelines of the Great Lakes, and moderate suitability near Algonquin Provincial Park and the Georgian Bay with good predictive accuracy (tick dragging 2019: AUC = 0.898; ticks from public: AUC = 0.727). The model forB.burgdorferishowed a similar predicted distribution but was more constrained to eastern Ontario, particularly between Ottawa and Kingston, and along Lake Ontario, with similarly good predictive accuracy (tick dragging 2019: AUC = 0.958; ticks from public: AUC = 0.863. The ecological variables most important for predicting the distributions ofI.scapularisandB.burgdorferiincluded elevation, distance to deciduous and coniferous forest, proportions of agricultural land, water, and infrastructure, mean summer/spring temperature, and cumulative annual degree days above 0 degrees C. Our study presents a novel application of species distribution modelling forI.scapularisandB.burgdorferiin Ontario, Canada, and provides an up to date projection of their potential distributions for public health knowledge users.	[Slatculescu, Andreea M.; McKay, Roman; Talbot, Benoit; Logan, James J.; Thickstun, Charles R.; Kulkarni, Manisha A.] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Clow, Katie M.] Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON, Canada; [Jardine, Claire M.] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON, Canada; [Jardine, Claire M.] Univ Guelph, Ontario Vet Coll, Canadian Wildlife Hlth Cooperat, Guelph, ON, Canada; [Ogden, Nicholas H.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Publ Hlth Risk Sci Div, St Hyacinthe, PQ, Canada; [Knudby, Anders J.] Univ Ottawa, Dept Geog Environm & Geomat, Ottawa, ON, Canada	University of Ottawa; University of Guelph; University of Guelph; University of Guelph; Public Health Agency of Canada; University of Ottawa	Slatculescu, AM (corresponding author), Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.	aslat086@uottawa.ca		Slatculescu, Andreea/0000-0001-5234-2211	Public Health Agency of Canada (PHAC); Natural Sciences & Engineering Research Council (NSERC); Canadian Institutes for Health Research (CIHR); PHAC; NSERC; Canadian Wildlife Health Cooperative; Ontario Ministry of Research and Innovation	Public Health Agency of Canada (PHAC); Natural Sciences & Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); PHAC; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Wildlife Health Cooperative; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	This project was funded by grants from the Public Health Agency of Canada (PHAC), Natural Sciences & Engineering Research Council (NSERC) and Canadian Institutes for Health Research (CIHR) to MAK, as well as grants from PHAC, NSERC and the Canadian Wildlife Health Cooperative to KMC and CMJ. MAK holds and Early Researcher Award from the Ontario Ministry of Research and Innovation.	Aenishaenslin C, 2017, TICKS TICK-BORNE DIS, V8, P112, DOI 10.1016/j.ttbdis.2016.10.006; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2018, SURV LYM DIS; [Anonymous], 2006, FIELD EXCHANGE, V29, P22; [Anonymous], 2016, PREV CHRONIC DIS, V13, pE40; [Anonymous], 2002, MED NET, V8, P9; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2017, LANCET GLOB HEALTH, V5, pe428; Beckmann S, 2019, TICKS TICK-BORNE DIS, V10, P1162, DOI 10.1016/j.ttbdis.2019.06.011; Brown JL, 2014, METHODS ECOL EVOL, V5, P694, DOI 10.1111/2041-210X.12200; BURGDORFER W, 1986, ZBL BAKT-INT J MED M, V263, P15; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Chen DM, 2015, ISPRS INT J GEO-INF, V4, P105, DOI 10.3390/ijgi4010105; Clow KM, 2017, TICKS TICK-BORNE DIS, V8, P554, DOI 10.1016/j.ttbdis.2017.03.003; Clow KM, 2016, VECTOR-BORNE ZOONOT, V16, P215, DOI 10.1089/vbz.2015.1890; Courtney JW, 2004, J CLIN MICROBIOL, V42, P3164, DOI 10.1128/JCM.42.7.3164-3168.2004; Dibernardo A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-183; Duan RY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112764; Ehrmann S, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2590-x; Eisen RJ, 2008, J MED ENTOMOL, V45, P181, DOI 10.1603/0022-2585(2008)45[181:SMOHRO]2.0.CO;2; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Estrada-Pena A, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00029; Ferrell AM, 2017, EXP APPL ACAROL, V71, P371, DOI 10.1007/s10493-017-0116-z; Gabriele-Rivet V, 2017, J MED ENTOMOL, V54, P862, DOI 10.1093/jme/tjx036; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hamer SA, 2010, ECOHEALTH, V7, P47, DOI 10.1007/s10393-010-0287-0; Harris SE, 2017, MOL ECOL, V26, P6336, DOI 10.1111/mec.14369; Johnson TL, 2016, J MED ENTOMOL, V53, P598, DOI 10.1093/jme/tjw008; KEIRANS JE, 1989, J MED ENTOMOL, V26, P435, DOI 10.1093/jmedent/26.5.435; Keirans JE, 1996, J MED ENTOMOL, V33, P297, DOI 10.1093/jmedent/33.3.297; Kulkarni MA., 2018, CAN COMMUN DIS REP, V44, P6; Kulkarni MA, 2019, EMERG INFECT DIS, V25, P328, DOI 10.3201/eid2502.180771; Leighton PA, 2012, J APPL ECOL, V49, P457, DOI 10.1111/j.1365-2664.2012.02112.x; Leithead MD, 2010, OECOLOGIA, V164, P1095, DOI 10.1007/s00442-010-1769-z; Lindquist E.E., 2016, BIOL SURVEY CANADA M, V7; Lindsay LR, 1999, J MED ENTOMOL, V36, P8; Mak S, 2010, J MED ENTOMOL, V47, P99, DOI 10.1603/033.047.0114; McKay R., 2019, TICKS TICK-BORNE DIS, P101361; McKenney DW, 2011, B AM METEOROL SOC, V92, P1611, DOI 10.1175/2011BAMS3132.1; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Ministry of Natural Resources and Forestry, 2019, FOR REG; Nelder M P, 2018, Can Commun Dis Rep, V44, P231, DOI 10.14745/ccdr.v44i10a01; Nelder MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105358; Ogden NH, 2008, J THEOR BIOL, V254, P621, DOI 10.1016/j.jtbi.2008.06.020; Ogden NH, 2008, APPL ENVIRON MICROB, V74, P1780, DOI 10.1128/AEM.01982-07; Ogden NH, 2006, J MED ENTOMOL, V43, P600, DOI 10.1603/0022-2585(2006)43[600:ISTCBP]2.0.CO;2; Ogden N H, 2014, CANADA COMMUNICABLE, V40-5; Ogden NH, 2005, INT J PARASITOL, V35, P375, DOI 10.1016/j.ijpara.2004.12.013; Ogden NH, 2014, ENVIRON HEALTH PERSP, V122, P631, DOI 10.1289/ehp.1307799; Ogden NH, 2013, J APPL ECOL, V50, P510, DOI [10.1111/1365-2664.12050, 10.1111/]; Ogden NH, 2009, CAN MED ASSOC J, V180, P1221, DOI 10.1503/cmaj.080148; Ogden NH, 2016, TRENDS PARASITOL, V32, P646, DOI 10.1016/j.pt.2016.04.015; Ontario Agency for Health Protection and Promotion, 2015, TICK DRAGG STAND OP; Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2019, ONT LYM DIS EST RISK; Phillips S.J., 2004, 21 INT C MACH LEARN; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Tran PM, 2013, ECOHEALTH, V10, P394, DOI 10.1007/s10393-013-0890-y; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227; Ripoche M., 2018, INT J ENV RES PUB HE, V15, P19; Ripoche M., 2018, J MED ENTOMOL; Rooney TP, 2001, FORESTRY, V74, P201, DOI 10.1093/forestry/74.3.201; Rydzewski J, 2011, VECTOR-BORNE ZOONOT, V11, P1351, DOI 10.1089/vbz.2010.0160; Schwartz AM, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6622a1; Simon JA, 2014, EVOL APPL, V7, P750, DOI 10.1111/eva.12165; Soucy JPR, 2018, VECTOR-BORNE ZOONOT, V18, P235, DOI 10.1089/vbz.2017.2234; Talbot B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50858-x; Werden L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085640; Yost AC, 2008, ECOL INFORM, V3, P375, DOI 10.1016/j.ecoinf.2008.08.004	69	18	18	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238126	10.1371/journal.pone.0238126	http://dx.doi.org/10.1371/journal.pone.0238126			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915794	gold, Green Published			2022-12-26	WOS:000571887500029
J	Wnuk, A; Oleksy, T; Maison, D				Wnuk, Anna; Oleksy, Tomasz; Maison, Dominika			The acceptance of Covid-19 tracking technologies: The role of perceived threat, lack of control, and ideological beliefs	PLOS ONE			English	Article							RIGHT-WING AUTHORITARIANISM; COMPENSATORY CONTROL; HUMAN-RIGHTS; INTERGROUP RELATIONS; AGE-DIFFERENCES; ATTITUDES; SUPPORT; HELPLESSNESS; CONSEQUENCES; PERCEPTIONS	New technological solutions play an important role in preventing the spread of Covid-19. Many countries have implemented tracking applications or other surveillance systems, which may raise concerns about privacy and civil rights violations but may be also perceived by citizens as a way to reduce threat and uncertainty. Our research examined whether feelings evoked by the pandemic (perceived threat and lack of control) as well as more stable ideological views predict the acceptance of such technologies. In two studies conducted in Poland, we found that perceived personal threat and lack of personal control were significantly positively related to the acceptance of surveillance technologies, but their predictive value was smaller than that of individual differences in authoritarianism and endorsement of liberty. Moreover, we found that the relationship between the acceptance of surveillance technologies and both perceived threat and lack of control was particularly strong among people high in authoritarianism. Our research shows that the negative feelings evoked by the unprecedented global crisis may inspire positive attitudes towards helpful but controversial surveillance technologies but that they do so to a lesser extent than ideological beliefs.	[Wnuk, Anna] Univ Warsaw, Robert B Zajonc Inst Social Studies, Warsaw, Poland; [Oleksy, Tomasz; Maison, Dominika] Univ Warsaw, Fac Psychol, Warsaw, Poland	University of Warsaw; University of Warsaw	Wnuk, A (corresponding author), Univ Warsaw, Robert B Zajonc Inst Social Studies, Warsaw, Poland.	anna.wnuk@psych.uw.edu.pl	Wnuk, Anna/ABA-8651-2021	Oleksy, Tomasz/0000-0002-3499-9874	Faculty of Psychology, University of Warsaw - Ministry of Science and Higher Education; Polish National Science Centre [2018/30/E/HS6/00379]	Faculty of Psychology, University of Warsaw - Ministry of Science and Higher Education; Polish National Science Centre	This paper was supported by the funds from the Faculty of Psychology, University of Warsaw granted by the Ministry of Science and Higher Education in the form of a subsidy for maintaining and developing the research potential in 2020 (DM); www.gov.pl/web/science.Preparation of this manuscript was financed from the funds of the Polish National Science Centre No 2018/30/E/HS6/00379 (AW); www.ncn.gov.pl.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037/0021-843X.87.1.49; Agamben G., 2005, STATE EXCEPTION, DOI DOI 10.1215/9780822386735; Alaa Ahmed M, 2019, PLoS One, V14, pe0213653, DOI 10.1371/journal.pone.0213653; Altemeyer B., 1988, ENEMIES FREEDOM UNDE; Altschuler S, 2020, WASHINGTON POST; [Anonymous], 2014, DAGSTUHL REPORTS, V4, P78, DOI DOI 10.4236/WJCMP.2014.42012; [Anonymous], 2012, REGEN MED S3, V7, pS14; Arning K, 2007, COMPUT HUM BEHAV, V23, P2904, DOI 10.1016/j.chb.2006.06.005; Becker JC, 2011, GROUP PROCESS INTERG, V14, P871, DOI 10.1177/1368430211407643; Bozzoli C, 2011, EUR J POLIT ECON, V27, pS89, DOI 10.1016/j.ejpoleco.2011.06.005; Breckenridge JN, 2012, J SOC ISSUES, V68, P559, DOI 10.1111/j.1540-4560.2012.01763.x; Bukowski M, 2017, GROUP PROCESS INTERG, V20, P909, DOI 10.1177/1368430216638529; Capraro V, 2020, J BEHAV EC POLICY, V4, P45, DOI [DOI 10.31234/OSF.IO/TG7VZ, 10.31234/osf.io/tg7vz]; Carriere KR, 2019, J SOC POLIT PSYCHOL, V7, P8, DOI 10.5964/jspp.v7i1.897; Carriere KR, 2018, CAMB HANDB PSYCHOL, P626; Charness G, 2012, J ECON BEHAV ORGAN, V83, P50, DOI 10.1016/j.jebo.2011.06.007; Chavez JM, 2009, ANN AM ACAD POLIT SS, V623, P78, DOI 10.1177/0002716208331014; Cohrs JC, 2005, PEACE CONFL, V11, P293, DOI 10.1207/s15327949pac1103_5; Cohrs JC, 2007, POLIT PSYCHOL, V28, P441, DOI 10.1111/j.1467-9221.2007.00581.x; Cohrs J.Christopher., 2005, ANAL SOC ISS PUB POL, V5, P263, DOI DOI 10.1111/J.1530-2415.2005.00071.X; Creed PA, 2012, J APPL SOC PSYCHOL, V42, P689, DOI 10.1111/j.1559-1816.2011.00798.x; Crowson HM, 2008, J SOC PSYCHOL, V148, P293, DOI 10.3200/SOCP.148.3.293-310; Crowson HM, 2009, SOC PSYCHOL-GERMANY, V40, P93, DOI 10.1027/1864-9335.40.2.93; David Y., 2016, PEACE CONFLICT STUDI, V23, P1; EU, 2020, COVID 19 COMM SETS O; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Fischer P, 2007, J EXP SOC PSYCHOL, V43, P964, DOI 10.1016/j.jesp.2006.10.004; Fogel J, 2009, COMPUT HUM BEHAV, V25, P153, DOI 10.1016/j.chb.2008.08.006; Fritsche I, 2008, J PERS SOC PSYCHOL, V95, P524, DOI 10.1037/a0012666; Fritsche I, 2017, J SOC ISSUES, V73, P117, DOI 10.1111/josi.12207; Fritsche I, 2011, SOC ISS POLICY REV, V5, P101, DOI 10.1111/j.1751-2409.2011.01027.x; Fritsche I, 2013, J EXP SOC PSYCHOL, V49, P19, DOI 10.1016/j.jesp.2012.07.014; Funke F, 2005, POLIT PSYCHOL, V26, P195, DOI 10.1111/j.1467-9221.2005.00415.x; Giglio M, ATLANTIC; Goichman R, ISRAELI MALLS REQUIR; Greenaway KH, 2014, BRIT J SOC PSYCHOL, V53, P422, DOI 10.1111/bjso.12049; Hetherington MJ, 2011, AM J POLIT SCI, V55, P546, DOI 10.1111/j.1540-5907.2011.00514.x; Hodson G, 2006, COLLATERAL DAMAGE PS, P109; Huddy L, 2007, ANN AM ACAD POLIT SS, V614, P131, DOI 10.1177/0002716207305951; Jost JT, 2008, PERSPECT PSYCHOL SCI, V3, P126, DOI 10.1111/j.1745-6916.2008.00070.x; Jost JT, 2017, SOC COGNITION, V35, P324, DOI 10.1521/soco.2017.35.4.324; Kachanoff F, 2020, MEASURING 2 DISTINCT; Kay AC, 2008, J PERS SOC PSYCHOL, V95, P18, DOI 10.1037/0022-3514.95.1.18; Kay AC, 2009, CURR DIR PSYCHOL SCI, V18, P264, DOI 10.1111/j.1467-8721.2009.01649.x; Knight C, 2010, BRIT J MANAGE, V21, P717, DOI 10.1111/j.1467-8551.2009.00683.x; Kossowska M, 2011, BRIT J PSYCHOL, V102, P245, DOI 10.1348/000712610X517262; Krueger BS, 2020, ASSESSING DIMENSIONS; Kruglanski A, CONVERSATION; Lahav G, 2012, POLIT BEHAV, V34, P477, DOI 10.1007/s11109-011-9171-z; Landau MJ, 2015, PSYCHOL BULL, V141, P694, DOI 10.1037/a0038703; Maison D, 2019, INT SERIES CONSUMER; McFarland Sam., 2005, J HUMAN RIGHTS, V4, P305, DOI DOI 10.1080/14754830500257539; Morris MG, 2000, PERS PSYCHOL, V53, P375, DOI 10.1111/j.1744-6570.2000.tb00206.x; Muthen B., 2010, MPLUS USERS GUIDE; Oesterreich D, 2005, POLIT PSYCHOL, V26, P275, DOI 10.1111/j.1467-9221.2005.00418.x; RODIN J, 1977, J PERS SOC PSYCHOL, V35, P897, DOI 10.1037/0022-3514.35.12.897; Ross AGP, 2015, INT J INFECT DIS, V38, P89, DOI 10.1016/j.ijid.2015.07.016; ROTHBAUM F, 1982, J PERS SOC PSYCHOL, V42, P5, DOI 10.1037/0022-3514.42.1.5; Scheppele Kim, 2003, J CONST L, V6, P1001; Shepherd S, 2011, J EXP SOC PSYCHOL, V47, P949, DOI 10.1016/j.jesp.2011.03.026; Singer N., 2020, NEW YORK TIMES; Skinner EA, 1996, J PERS SOC PSYCHOL, V71, P549, DOI 10.1037/0022-3514.71.3.549; Steenkamp L. A, CONVERSATION; Stephan WG, 1999, INT J INTERCULT REL, V23, P613, DOI 10.1016/S0147-1767(99)00012-7; Stollberg J, 2017, CURR ISS SOC PSYCHOL, P133; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Wainwright O., 2020, GUARDIAN; Wang CJ, 2020, JAMA-J AM MED ASSOC, V323, P1341, DOI 10.1001/jama.2020.3151; Wilkinson RG, 2017, EUR J SOC PSYCHOL, V47, P11, DOI 10.1002/ejsp.2275; Wong W, CONVERSATION; World Economic Forum, 2019, OUTBR READ BUS IMP; Zastrow Mark, 2020, Nature, DOI 10.1038/d41586-020-00740-y; 2007, J ALLERGY CLIN IMM S, V5	73	33	33	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238973	10.1371/journal.pone.0238973	http://dx.doi.org/10.1371/journal.pone.0238973			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9MU	32915908	gold, Green Published			2022-12-26	WOS:000571887500044
J	Siebers, HL; Eschweiler, J; Pinz, J; Tingart, M; Rath, B				Siebers, Hannah Lena; Eschweiler, Joerg; Pinz, Jan; Tingart, Markus; Rath, Bjoern			The effect of a knee brace in dynamic motion-An instrumented gait analysis	PLOS ONE			English	Article							MEDIAL COMPARTMENT OSTEOARTHRITIS; VALGUS KNEE; JOINT; KINEMATICS; FORCES	Background Osteoarthritis (OA) is a common problem in the older population. To reduce pain and stress in the affected knee joint compartment, a functional knee brace is often prescribed by physicians to protect it from high loads. Objectives An instrumented gait analysis should evaluate how the 4-point knee orthosis for varus or valgus load relief (M.4s OA) changes the kinematics of the knee, especially in the frontal plane. Methods 17 healthy participants took part and were analyzed with an inertial sensor system (MyoMotion) giving continuous, objective information on the anatomical angles. The measurements were made both without wearing a knee brace and with the brace in different settings. Results The results show a significant reduction in the maximum knee abduction and raised knee adduction. The knee brace, with a strong adjustment in varus or valgus orientation, caused a shift of maximum ab-/adduction in the proposed direction in 69% and 75% of the dynamic tests, respectively. The knee motion in the frontal plane shows individual movement patterns. Conclusion The use of the brace leads to significant changes in the knee's movement. Patient-specific movement patterns may explain different effects of functional knee braces on individual persons. Inertial sensors have been shown to be a low-cost, easy-to-use option for individual movement analysis and further personalized therapy.	[Siebers, Hannah Lena; Eschweiler, Joerg; Pinz, Jan; Tingart, Markus] Univ Hosp RWTH Aachen, Dept Orthoped Surg, Aachen, Germany; [Rath, Bjoern] Klinikum Wels Grieskirchen, Dept Orthoped Surg, Wels, Austria	RWTH Aachen University; RWTH Aachen University Hospital	Siebers, HL (corresponding author), Univ Hosp RWTH Aachen, Dept Orthoped Surg, Aachen, Germany.	hsiebers@ukaachen.de	Rath, Björn/AAF-3938-2022; Rath, Björn/AFI-8239-2022					Al-Zahrani Y, 2014, THESIS; Aminian K, 2004, COMPUT ANIMAT VIRT W, V15, P79, DOI 10.1002/cav.2; [Anonymous], 2013, CISC VIS NETW IND GL, P1; Arazpour M, 2013, PROSTHET ORTHOT INT, V37, P481, DOI 10.1177/0309364613478964; Balasubramanian S., 2013, COMP ANGLE MEASUREME; Brouwer RW, 2006, OSTEOARTHR CARTILAGE, V14, P777, DOI 10.1016/j.joca.2006.02.004; Brouwer RW, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004020.pub2, 10.1002/14651858.CD004019.pub2]; CHAO EY, 1983, J BIOMECH, V16, P219, DOI 10.1016/0021-9290(83)90129-X; Cloete T, 2010, IEEE ENG MED BIO, P5125, DOI 10.1109/IEMBS.2010.5626196; Feehan NL, 2012, J PROS ORTHO, V24, P39, DOI DOI 10.1097/JPO.0B013-318240AF8D; Fibel KH, 2015, WORLD J CLIN CASES, V3, P89, DOI 10.12998/wjcc.v3.i2.89; Folb S., 2015, MYOMOTION USER GUIDE; Frigo C, 1998, MED BIOL ENG COMPUT, V36, P179, DOI 10.1007/BF02510740; Giori NJ, 2004, J REHABIL RES DEV, V41, P187, DOI 10.1682/JRRD.2004.02.0187; Glyn-Jones S, 2015, LANCET, V386, P376, DOI 10.1016/S0140-6736(14)60802-3; Gohal C, 2018, SPORTS HEALTH, V10, P500, DOI 10.1177/1941738118763913; Guo LJ, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17092091; Hacker SP, 2019, PROSTHET ORTHOT INT, V43, P309, DOI 10.1177/0309364618824443; Haladik JA, 2014, KNEE SURG SPORT TR A, V22, P2715, DOI 10.1007/s00167-013-2596-7; Holl WH, 2010, ENVIRON GEOCHEM HLTH, V32, P287, DOI 10.1007/s10653-010-9307-9; HORLICK SG, 1993, CLIN J SPORT MED, V3, P251, DOI DOI 10.1097/00042752-199310000-00006; Jafarnezhadgero AA, 2018, GAIT POSTURE, V59, P104, DOI 10.1016/j.gaitpost.2017.09.040; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; LAFORTUNE MA, 1992, J BIOMECH, V25, P347, DOI 10.1016/0021-9290(92)90254-X; Lee PY, 2016, BMJ OPEN SPORT EXERC, V2, pe000195, DOI 10.1136/bmjsem-2016-000195; Markolf KL, 2019, MED ENG PHYS, V67, P73, DOI 10.1016/j.medengphy.2019.03.009; Moyer RF, 2015, OSTEOARTHR CARTILAGE, V23, P178, DOI 10.1016/j.joca.2014.11.018; Muller-Rath R, 2011, Z ORTHOP UNFALLCHIR, V149, P160, DOI 10.1055/s-0030-1249794; Mundt M, 2017, ISBS C; Pagani CHF, 2013, J ELECTROMYOGR KINES, V23, P490, DOI 10.1016/j.jelekin.2012.10.007; Perry J., 1992, GAIT ANAL NORMAL PAT; Raja K, 2011, AM J PHYS MED REHAB, V90, P247, DOI 10.1097/PHM.0b013e318206386b; Rampp A, 2015, IEEE T BIO-MED ENG, V62, P1089, DOI 10.1109/TBME.2014.2368211; Ramsey DK, 2007, J BONE JOINT SURG AM, V89A, P2398, DOI 10.2106/JBJS.F.01136; Richards JD, 2005, J BONE JOINT SURG BR, V87B, P937, DOI 10.1302/0301-620X.87B7.16005; Sessa S, 2015, HEALTHC TECHNOL LETT, V2, P58, DOI 10.1049/htl.2014.0103; Toda Y, 2001, J RHEUMATOL, V28, P2705; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646	38	3	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238722	10.1371/journal.pone.0238722	http://dx.doi.org/10.1371/journal.pone.0238722			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911488	Green Published, gold			2022-12-26	WOS:000571885900019
J	Syed, NK; Syed, MH; Meraya, AM; Albarraq, AA; Al-kasim, MA; Alqahtani, S; Makeen, HA; Yasmeen, A; Banji, OJF; Elnaem, MH				Syed, Nabeel Kashan; Syed, Mamoon Hussain; Meraya, Abdulkarim M.; Albarraq, Ahmed A.; Al-kasim, Mohamed Ahmed; Alqahtani, Saad; Makeen, Hafiz Antar; Yasmeen, Ayesha; Banji, Otilia J. F.; Elnaem, Mohamed Hassan			The association of dietary behaviors and practices with overweight and obesity parameters among Saudi university students	PLOS ONE			English	Article							WATCHING TELEVISION; PHYSICAL-ACTIVITY; ADULT-POPULATION; PREVALENCE; CHILDREN; WEIGHT; ADOLESCENTS; NUTRITION; HABITS	Background Western dietary habits, coupled with a sedentary lifestyle, are potential contributors to the prevalence and rapid increase in the incidence of obesity in Saudi Arabia. This study aimed to investigate the association between students' weight status and their eating behaviors and practices. Another aim was to assess students' awareness of the health risks associated with obesity. Methods A cross-sectional survey was conducted among a sample of 416 (53% male and 47% female) undergraduate students, aged 18-26 years old, between January 6 and April 6, 2019, from colleges of Health Sciences at Jazan University in the Kingdom of Saudi Arabia (K.S.A). Students completed a self-administered questionnaire and recorded their measured anthropometric parameters. Results The prevalence of overweight (20.4%) and obesity (14.9%) were relatively high among the participants. There were statistically significant associations between Body Mass Index (BMI) and the different settings of food consumption (i.e., dining on a table (or) in the Islamic way: squatting on the ground) (p<0.001)). BMI was also associated with students' dietary habits regarding consuming food, snacks, and drinking carbonated beverages while watching television (p<0.001), as well as consuming the same pattern of food/drink while watching television, playing video games on mobile phones or computers (p<0.001). Nearly most of the students were oblivious to the fact that metabolic syndrome, reproductive disorders, respiratory disorders along with liver and gallbladder diseases are some of the health risks associated with obesity. Conclusion The prevalence of obesity and overweight were reasonably high in our study sample and were affected by several factors related to students' eating behaviors and practices. This warrants the need for rigorous and frequent health education interventions on healthy eating behaviors, dietary practices, with an emphasis on the importance of adopting an active, healthy lifestyle.	[Syed, Nabeel Kashan; Syed, Mamoon Hussain; Meraya, Abdulkarim M.; Albarraq, Ahmed A.; Al-kasim, Mohamed Ahmed; Alqahtani, Saad; Makeen, Hafiz Antar; Yasmeen, Ayesha; Banji, Otilia J. F.] Jazan Univ, Fac Pharm, Dept Clin Pharm, Pharm Practice Res Unit, Gizan, Saudi Arabia; [Elnaem, Mohamed Hassan] Int Islamic Univ, Fac Pharm, Dept Pharm Practice, Kuantan, Pahang, Malaysia	Jazan University; International Islamic University Malaysia	Syed, NK (corresponding author), Jazan Univ, Fac Pharm, Dept Clin Pharm, Pharm Practice Res Unit, Gizan, Saudi Arabia.	nsyed@jazanu.edu.sa	Elnaem, Mohamed Hassan/O-9248-2017; Syed, Nabeel Kashan/ABF-6843-2020	Elnaem, Mohamed Hassan/0000-0003-0873-6541; Syed, Nabeel Kashan/0000-0003-1315-8985; Albarraq, Ahmed A./0000-0003-2212-5173				Al-Hazzaa HM, 2007, ASIA PAC J CLIN NUTR, V16, P462; Al-Kandari YY, 2006, OBES REV, V7, P147, DOI 10.1111/j.1467-789X.2006.00231.x; Al-Nozha MM, 2005, SAUDI MED J, V26, P824; Al-Rethaiaa AS, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-39; Al-Riyami AA, 2003, SAUDI MED J, V24, P641; AlNuaim AA, 1997, J COMMUN HEALTH, V22, P211, DOI 10.1023/A:1025177108996; Alqarni S.M., 2016, J OBES EAT DISORD, V2, P2, DOI [10.21767/2471-8203.100025, DOI 10.21767/2471-8203.100025]; Alsaif MA, 2002, NUTR RES, V22, P1243, DOI 10.1016/S0271-5317(02)00439-6; Amin TT, 2008, EUR J NUTR, V47, P310, DOI 10.1007/s00394-008-0727-6; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2015, BMJ, V2015, ph1887; Antonio G, 2005, DIGEST DIS SCI, V50, P1, DOI 10.1007/s10620-005-1268-y; Bani IA, 1999, J COMMUN HEALTH, V24, P467, DOI 10.1023/A:1018798723532; bin Zaal AA, 2009, NUTR HOSP, V24, P437; Butler SM, 2004, AM J HEALTH BEHAV, V28, P24, DOI 10.5993/AJHB.28.1.3; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Carter AO, 2004, J HEALTH POPUL NUTR, V22, P75; DeBate RD, 2001, ADOLESCENCE, V36, P819; Deliens T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-53; El Ansari W, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-28; El-Hazmi MAF, 2002, J TROP PEDIATRICS, V48, P172, DOI 10.1093/tropej/48.3.172; Huang TTK, 2003, J AM COLL HEALTH, V52, P83, DOI 10.1080/07448480309595728; Liang T, 2009, PUBLIC HEALTH NUTR, V12, P2457, DOI 10.1017/S1368980009005564; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Mahfouz AA, 2008, J TROP PEDIATRICS, V54, P120, DOI 10.1093/tropej/fmm089; Malinauskas BM, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-35; Musaiger A. O., 2003, Nutrition & Food Science, V33, P145, DOI 10.1108/00346650310488480; Musaiger AO, 2001, ANN HUM BIOL, V28, P346, DOI 10.1080/030144601300119151; Neutzling MB, 2000, INT J OBESITY, V24, P869, DOI 10.1038/sj.ijo.0801245; Silliman K., 2004, CALIF J HLTH PROMOT, V2, P10, DOI [DOI 10.32398/cjhp.v2i2.1729, 10.32398/cjhp.v2i2.1729, DOI 10.32398/CJHP.V2I2.1729]; Tumin R, 2017, J ACAD NUTR DIET, V117, P937, DOI 10.1016/j.jand.2017.01.009; Vioque J, 2000, INT J OBESITY, V24, P1683, DOI 10.1038/sj.ijo.0801434; Yahia N, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-32	33	24	24	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238458	10.1371/journal.pone.0238458	http://dx.doi.org/10.1371/journal.pone.0238458			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9ME	32911507	gold, Green Published, Green Accepted			2022-12-26	WOS:000571885900036
J	Farrera-Soler, L; Daguer, JP; Barluenga, S; Vadas, O; Cohen, P; Pagano, S; Yerly, S; Kaiser, L; Vuilleumier, N; Winssinger, N				Farrera-Soler, Lluc; Daguer, Jean-Pierre; Barluenga, Sofia; Vadas, Oscar; Cohen, Patrick; Pagano, Sabrina; Yerly, Sabine; Kaiser, Laurent; Vuilleumier, Nicolas; Winssinger, Nicolas			Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma	PLOS ONE			English	Article							CORONAVIRUS SPIKE PROTEIN; SYNDROME SARS CORONAVIRUS; S2 DOMAIN; ANTIBODIES; VIRUS; IMMUNIZATION; RESPONSES; SITE; PNA	A novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) is the source of a current pandemic (COVID-19) with devastating consequences in public health and economic stability. Using a peptide array to map the antibody response of plasma from healing patients (12) and heathy patients (6), we identified three immunodominant linear epitopes, two of which correspond to key proteolytic sites on the spike protein (S1/S2 and S2') known to be critical for cellular entry. We show biochemical evidence that plasma positive for the epitope adjacent to the S1/S2 cleavage site inhibits furin-mediated proteolysis of spike.	[Farrera-Soler, Lluc; Daguer, Jean-Pierre; Barluenga, Sofia; Winssinger, Nicolas] Univ Geneva, Fac Sci, Dept Organ Chem, NCCR Chem Biol, Geneva, Switzerland; [Vadas, Oscar] Univ Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland; [Cohen, Patrick; Pagano, Sabrina; Yerly, Sabine; Kaiser, Laurent; Vuilleumier, Nicolas] Geneva Univ Hosp, Diagnost Dept, Div Lab Med, Geneva, Switzerland; [Cohen, Patrick; Pagano, Sabrina; Yerly, Sabine; Kaiser, Laurent; Vuilleumier, Nicolas] Fac Med, Geneva, Switzerland; [Kaiser, Laurent] Geneva Univ Hosp, Div Infect Dis, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva	Winssinger, N (corresponding author), Univ Geneva, Fac Sci, Dept Organ Chem, NCCR Chem Biol, Geneva, Switzerland.	Nicolas.Winssinger@unige.ch	; Winssinger, Nicolas/B-6710-2017	Daguer, Jean Pierre/0000-0003-0131-1102; Kaiser, Laurent/0000-0002-0857-2252; Winssinger, Nicolas/0000-0003-1636-7766; Barluenga, Sofia/0000-0003-3830-1178	University of Geneva	University of Geneva	The work was funded by research funds from the University of Geneva and the departement d'instruction public (DIP) du canton de Geneve.	Ahmad TA., 2016, TRIALS VACCINOL, V5, P71, DOI [10.1016/j.trivac.2016.04.003, DOI 10.1016/J.TRIVAC.2016.04.003]; Ahmed SF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12030254; Alsaadi EAJ, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11090825; Babcock GJ, 2004, J VIROL, V78, P4552, DOI 10.1128/JVI.78.9.4552-4560.2004; Berry JD, 2010, MABS-AUSTIN, V2, P53, DOI 10.4161/mabs.2.1.10788; Bhattacharya M, 2020, J MED VIROL, V92, P618, DOI 10.1002/jmv.25736; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Chou THW, 2005, VIROLOGY, V334, P134, DOI 10.1016/j.virol.2005.01.035; Chouikhi D, 2012, CHEM-EUR J, V18, P12698, DOI 10.1002/chem.201201337; Cohen J, 2020, SCIENCE, V367, P234, DOI 10.1126/science.367.6475.234; Coutard B, 2020, ANTIVIR RES, V176, DOI 10.1016/j.antiviral.2020.104742; Cyranoski D, 2020, NATURE, V581, P22, DOI 10.1038/d41586-020-01315-7; Deng J., MAPPING IMMUNODOMINA, P2020, DOI [10.1101/2020.04.23.056853, DOI 10.1101/2020.04.23.056853]; Fast E, 2020, BIORXIV, DOI [10.1101/2020.02.19.955484, DOI 10.1101/2020.02.19.955484]; Gao Ang, 2020, bioRxiv, DOI 10.1101/2020.05.14.095885; Garber K, 2020, NAT BIOTECHNOL, V38, P773, DOI 10.1038/d41587-020-00016-w; Giansanti A., 2020, IDENTIFICATION CONSE, DOI [10.1101/2020.05.14.095133, DOI 10.1101/2020.05.14.095133]; Graham BS, 2020, SCIENCE, V368, P945, DOI 10.1126/science.abb8923; Grifoni A, 2020, CELL HOST MICROBE, V27, P671, DOI 10.1016/j.chom.2020.03.002; Guo JP, 2004, VIROLOGY, V324, P251, DOI 10.1016/j.virol.2004.04.017; Harris JL, 2005, CHEM-EUR J, V11, P6792, DOI 10.1002/chem.200500305; He YX, 2004, J IMMUNOL, V173, P4050, DOI 10.4049/jimmunol.173.6.4050; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; JACOB CO, 1985, EMBO J, V4, P3339, DOI 10.1002/j.1460-2075.1985.tb04086.x; Jaimes JA, 2020, J MOL BIOL, V432, P3309, DOI 10.1016/j.jmb.2020.04.009; Jegouic SM, 2020, RECOMBINANT SARS COV, DOI [10.1101/2020.05.21.109298, DOI 10.1101/2020.05.21.109298]; Jiang H.-W., 2020, GLOBAL PROFILING SAR, DOI 10.1101/2020.03.20.20039495; Khan A., 2020, DESIGN EPITOPE BASED, DOI [10.1101/2020.05.03.074930, DOI 10.1101/2020.05.03.074930]; Kleine-Weber H., 2020, CELL, DOI [DOI 10.1101/2020.01.31.929042, 10.1016/j.cell.2020.02.05, 10.1101/2020.01.31.929042]; Krishnamurthy HK, 2020, ANTIBODY PROFILING P; Li L., 2020, BIORXIV, DOI 10.1101/2020.02.25.965434.; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Luczo JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29944-z; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Madu IG, 2009, J VIROL, V83, P7411, DOI 10.1128/JVI.00079-09; Marchetti A., 2020, ANTIB REP, V3, P219, DOI [10.24450/journals/abrep.2020.e219, DOI 10.24450/JOURNALS/ABREP.2020.E219, DOI 10.1101/2020.05.08.084103]; Menachery VD, 2020, J VIROL, V94, DOI 10.1128/JVI.01774-19; Meng T., 2020, INSERT SEQUENCE SARS, DOI 10.1101/2020.02.08.926006; Mitra D., 2020, MULTIEPITOPE BASED P, DOI [10.1101/2020.04.23.055467., DOI 10.1101/2020.04.23.055467]; Miyoshi-Akiyama T, 2011, J INFECT DIS, V203, P1574, DOI 10.1093/infdis/jir084; Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018; Parvez S, 2020, PREDICTION T B CELL; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Poh CM, 2020, BIORXIV, DOI [10.1101/2020.03.30.015461, DOI 10.1101/2020.03.30.015461]; Sawyer LA, 2000, ANTIVIR RES, V47, P57, DOI 10.1016/S0166-3542(00)00111-X; Seydoux Emilie, 2020, bioRxiv, DOI 10.1101/2020.05.12.091298; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Stringhini S, 2020, LANCET, V396, P313, DOI 10.1016/S0140-6736(20)31304-0; Tang T, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104792; van den Brink EN, 2005, J VIROL, V79, P1635, DOI 10.1128/JVI.79.3.1635-1644.2005; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19; Wang C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15001-9; Wang HY, 2020, ACS CENTRAL SCI, V6, P2238, DOI 10.1021/acscentsci.0c00742; Wang QD, 2016, ACS INFECT DIS, V2, P361, DOI 10.1021/acsinfecdis.6b00006; Wang Q, 2020, VIROL SIN, V35, P337, DOI 10.1007/s12250-020-00212-7; Watanabe Y, 2020, SCIENCE, V369, P330, DOI 10.1126/science.abb9983; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Wrobel AG, 2020, NAT STRUCT MOL BIOL, V27, P763, DOI 10.1038/s41594-020-0468-7; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Wu Y, 2020, SCIENCE, V368, P1274, DOI 10.1126/science.abc2241; Wu YL, 2020, CELL HOST MICROBE, V27, P891, DOI 10.1016/j.chom.2020.04.023; Xia S, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav4580; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269; Zambaldo C, 2015, CURR OPIN CHEM BIOL, V26, P8, DOI 10.1016/j.cbpa.2015.01.005; Zheng M, 2020, CELL MOL IMMUNOL, V17, P536, DOI 10.1038/s41423-020-0385-z; Zhong XF, 2005, J VIROL, V79, P3401, DOI 10.1128/JVI.79.6.3401-3408.2005; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zhou T, 2004, J VIROL, V78, P7217, DOI 10.1128/JVI.78.13.7217-7226.2004; Zhu Y, 2020, DESIGN POTENT MEMBRA, DOI [10.1101/2020.03.26.009233, DOI 10.1101/2020.03.26.009233]	72	36	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2020	15	9							e0238089	10.1371/journal.pone.0238089	http://dx.doi.org/10.1371/journal.pone.0238089			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR4MY	32903266	Green Published, gold, Green Submitted			2022-12-26	WOS:000571539500023
J	Gormley, AM; Warburton, B				Gormley, Andrew M.; Warburton, Bruce			Refining kill-trap networks for the control of small mammalian predators in invaded ecosystems	PLOS ONE			English	Article							NEW-ZEALAND; HOME-RANGE; INVASIVE PREDATORS; FERAL CATS; ISLAND; MANAGEMENT; IMPACT; STOAT; DIET	Population control of invasive mammal pests is an ongoing process in many conservation projects. In New Zealand, introduced wild domestic cats and mustelids have a severe impact on biodiversity, and methods to reduce and maintain predator populations to low levels have been developed involving poisoning and trapping. Such conservation efforts often run on limited funds, so ways to minimize costs while not compromising their effectiveness are constantly being sought. Here we report on a case example in a 150 km(2)area in the North Island, New Zealand, where high predator numbers were reduced by 70-80% in an initial 'knockdown' trapping program, using the full set of traps available in the fixed network and frequent checks, and then maintained at low density using maintenance trapping with less frequent checking. We developed and applied a simulation model of predator captures, based on trapping data, to investigate the effect on control efficacy of varying numbers of trap sites and numbers of traps per site. Included in the simulations were captures of other, non-target, introduced mammals. Simulations indicated that there are potentially significant savings to be made, at least in the maintenance phase of a long-term predator control programme, by first reducing the number of traps in large-scale networks without dramatically reducing efficacy, and then, possibly, re-locating traps according to spatial heterogeneity in observed captures of the target species.	[Gormley, Andrew M.; Warburton, Bruce] Landcare Res Manaaki Whenua, Lincoln, New Zealand	Landcare Research - New Zealand	Gormley, AM (corresponding author), Landcare Res Manaaki Whenua, Lincoln, New Zealand.	gormleya@landcareresearch.co.nz			Hawke's Bay Regional Council; Aotearoa Foundation; Manaaki Whenua - Landcare Research	Hawke's Bay Regional Council; Aotearoa Foundation; Manaaki Whenua - Landcare Research	This study was jointly funded by Hawke's Bay Regional Council (https://www.hbrc.govt.nz), the Aotearoa Foundation (http://www.poutiri.co.nz/partners/the-aotearoa-foundation/), and Manaaki Whenua - Landcare Research (https://www.landcareresearch.co.nz); all funding bodies based in New Zealand. The funding bodies had no direct influence on the decision to publish, and were neither involved in the analysis nor influenced data presentation or interpretation. All funding was co-awarded to AMG and BW.	Anon, 2018, POUTIRI AO TANE CAPE, V2015-2018; Ball SJ, 2005, WILDLIFE RES, V32, P217, DOI 10.1071/WR03125; Beaumont MA, 2010, ANNU REV ECOL EVOL S, V41, P379, DOI 10.1146/annurev-ecolsys-102209-144621; Bonesi L, 2007, BIOL CONSERV, V136, P636, DOI 10.1016/j.biocon.2007.01.008; Brown S, 2012, NEW ZEAL J ZOOL, V39, P229, DOI 10.1080/03014223.2011.625957; Byrom AE, 2015, NZ VET J, V63, P97; Carter A, 2016, BIOL INVASIONS, V18, P1723, DOI 10.1007/s10530-016-1115-4; Cerfonteyn M, 2016, ANTARCT SCI, V28, P51, DOI 10.1017/S0954102015000474; Choquenot D, 2001, BIOL CONSERV, V99, P29, DOI 10.1016/S0006-3207(00)00186-5; Courchamp F, 1999, ECOL APPL, V9, P112, DOI 10.1890/1051-0761(1999)009[0112:MTBCOA]2.0.CO;2; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; Doherty TS, 2015, BIOL CONSERV, V190, P60, DOI 10.1016/j.biocon.2015.05.013; Etherington TR, 2009, ECOLOGICAL NETWORKS, P17; Fitzgerald BM, 1986, NEW ZEAL J ECOL, V9, P97; Gebhardt K., 2009, P 13 WILDLIFE DAMAGE, V112, P132; Gillies CA, 2003, NEW ZEAL J ZOOL, V30, P399, DOI 10.1080/03014223.2003.9518349; Glen AS, 2013, BIOL INVASIONS, V15, P2589, DOI 10.1007/s10530-013-0495-y; Glen AS, 2014, LC1956 HAW BAY REG 1; Goldson SL, 2015, J ROY SOC NEW ZEAL, V45, P31, DOI 10.1080/03036758.2014.1000343; Gormley AM, 2018, TRANSBOUND EMERG DIS, V65, P186, DOI 10.1111/tbed.12647; Graham CA, 2012, WILDLIFE RES, V39, P661, DOI 10.1071/WR12008; Harding EK, 2001, CONSERV BIOL, V15, P1114, DOI 10.1046/j.1523-1739.2001.0150041114.x; Hilton GM, 2010, IBIS, V152, P443, DOI 10.1111/j.1474-919X.2010.01031.x; Jones C, 2015, WILDLIFE SOC B, V39, P341, DOI 10.1002/wsb.543; King CM., 2005, HDB NZ MAMMALS; LANGHAM NPE, 1991, WILDLIFE RES, V18, P741, DOI 10.1071/WR9910741; Manoukis NC, 2014, SCI REP-UK, V4, DOI 10.1038/srep07015; MURPHY EC, 1994, NEW ZEAL J ECOL, V18, P11; Murphy EC, 1995, NEW ZEAL J ECOL, V19, P97; Norbury G, 2014, AUSTRAL ECOL, V39, P795, DOI 10.1111/aec.12147; NPCA, 2009, BEST PRACT PUBL A, VA4.2; Parkes J, 2003, NEW ZEAL J ZOOL, V30, P335, DOI 10.1080/03014223.2003.9518346; Parkes JP, 2017, NEW ZEAL J ECOL, V41, P151, DOI 10.20417/nzjecol.41.1; Perry GLW, 2017, J APPL ECOL, V54, P1238, DOI 10.1111/1365-2664.12827; Rayner MJ, 2007, P NATL ACAD SCI USA, V104, P20862, DOI 10.1073/pnas.0707414105; Reardon JT, 2002, NEW ZEAL J ECOL, V36, P141; Russell JC, 2016, NEW ZEAL J ECOL, V40, P197; Russell JC, 2015, BIOSCIENCE, V65, P520, DOI 10.1093/biosci/biv012; Short MJ, 2001, BIOL CONSERV, V98, P139, DOI 10.1016/S0006-3207(00)00148-8; Smith DHV, 2015, NEW ZEAL J ECOL, V39, P286; Tompkins DM, 2007, WILDLIFE RES, V34, P67, DOI 10.1071/WR05109; Walls GY, 1989, 667 DEP SCI IDN RES; Warburton B, 2017, KARAREHE KINO; Warburton B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120373	44	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238732	10.1371/journal.pone.0238732	http://dx.doi.org/10.1371/journal.pone.0238732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ6EE	32898194	gold, Green Published			2022-12-26	WOS:000570962500011
J	Wang, XY; Lin, Y; Liu, S; Zhu, Y; Lu, KF; Broering, R; Lu, MJ				Wang, Xueyu; Lin, Yong; Liu, Shi; Zhu, Ying; Lu, Kefeng; Broering, Ruth; Lu, Mengji			O-GlcNAcylation modulates HBV replication through regulating cellular autophagy at multiple levels	FASEB JOURNAL			English	Article						Akt; mTOR signaling; autophagy; autophagosome-lysosome fusion; ER stress; HBV; O-GlcNAcylation	HEPATITIS-C VIRUS; N-ACETYLGLUCOSAMINE; GLCNAC TRANSFERASE; ADENOVIRUS TYPE-2; ER STRESS; B-VIRUS; GLYCOSYLATION; MACHINERY; INDUCTION; PROTEINS	O-GlcNAcylation is a form of posttranslational modification, and serves various functions, including modulation of location, stability, and activity for the modified proteins.O-linked-N-acetylglucosamine (O-GlcNAc) transferase (OGT) is an essential cellular enzyme that posttranslationally modifies the cellular proteins withO-GlcNAc moiety. Early studies reported that the decreasedO-GlcNAcylation regulates cellular autophagy, a process relevant for hepatitis B virus replication (HBV) and assembly. Therefore, we addressed the question howO-GlcNAcylation regulates cellular autophagy and HBV replication. Inhibition of OGT activity with a small molecule inhibitor OSMI-1 or silencing OGT significantly enhanced HBV replication and HBsAg production in hepatoma cells and primary human hepatocytes (PHHs). Western blotting analysis showed that inhibition ofO-GlcNAcylation-induced endoplasmic reticulum (ER) stress and cellular autophagy, two processes subsequently leading to enhanced HBV replication. Importantly, the numbers of autophagosomes and the levels of autophagic markers LC3-II and SQSTM1/p62 in hepatoma cells were elevated after inhibition ofO-GlcNAcylation. Further analysis revealed that inhibition ofO-GlcNAcylation blocked autophagosome-lysosome fusion and thereby prevented autophagic degradation of HBV virions and proteins. Moreover, OSMI-1 further promoted HBV replication by inducing autophagosome formation via inhibiting theO-GlcNAcylation of Akt and mTOR. In conclusion, decreasedO-GlcNAcylation enhanced HBV replication through increasing autophagosome formation at multiple levels, including triggering ER-stress, Akt/mTOR inhibition, and blockade of autophagosome-lysosome fusion.	[Wang, Xueyu; Lin, Yong; Liu, Shi; Lu, Mengji] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Hufelandstr 55, D-45122 Essen, Germany; [Lin, Yong] Chongqing Med Univ, Chinese Minist Educ, Key Lab Mol Biol Infect Dis, Chongqing, Peoples R China; [Liu, Shi; Zhu, Ying] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Peoples R China; [Lu, Kefeng] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Dept Neurosurg,State Key Lab Biotherapy, Chengdu, Peoples R China; [Broering, Ruth] Univ Duisburg Essen, Univ Hosp Essen, Dept Gastroenterol & Hepatol, Essen, Germany	University of Duisburg Essen; Chongqing Medical University; Wuhan University; Sichuan University; University of Duisburg Essen	Lu, MJ (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Hufelandstr 55, D-45122 Essen, Germany.	mengji.lu@uni-due.de	Broering, Ruth/W-9401-2019; Lu, Mengji/ABF-9410-2020; Wang, Xueyu/AAC-1669-2022	Broering, Ruth/0000-0002-7125-3246; 	Deutsche Forschungsgemeinschaft [TRR60]; University Duisburg-Essen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University Duisburg-Essen	Deutsche Forschungsgemeinschaft, Grant/Award Number: TRR60; University Duisburg-Essen	Ait-Goughoulte M, 2008, J VIROL, V82, P2241, DOI 10.1128/JVI.02093-07; Alejandro EU, 2015, CELL REP, V13, P2527, DOI 10.1016/j.celrep.2015.11.020; Angelova M, 2015, J VIROL, V89, P8474, DOI 10.1128/JVI.01002-15; Brimble S, 2010, CURR SIGNAL TRANSD T, V5, P12, DOI 10.2174/157436210790226465; European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021; GONZALEZ SA, 1991, VIROLOGY, V182, P8, DOI 10.1016/0042-6822(91)90642-O; GREIS KD, 1994, J VIROL, V68, P8339, DOI 10.1128/JVI.68.12.8339-8349.1994; Guo B, 2014, NAT CELL BIOL, V16, P1215, DOI 10.1038/ncb3066; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Heath JM, 2014, CIRC RES, V114, P1094, DOI 10.1161/CIRCRESAHA.114.302968; Jang I, 2015, BBA-MOL CELL RES, V1853, P1860, DOI 10.1016/j.bbamcr.2015.04.017; Jensen RV, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020404; Jochmann R, 2013, GLYCOBIOLOGY, V23, P1114, DOI 10.1093/glycob/cwt028; Jochmann R, 2009, J VIROL, V83, P3704, DOI 10.1128/JVI.01384-08; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kang ES, 2008, EXP CELL RES, V314, P2238, DOI 10.1016/j.yexcr.2008.04.014; Khakpoor A, 2009, J GEN VIROL, V90, P1093, DOI 10.1099/vir.0.007914-0; Ko YC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-12; Ku NO, 2010, NAT CELL BIOL, V12, P876, DOI 10.1038/ncb2091; Lefebvre T, 2016, CELL CYCLE, V15, P1954, DOI 10.1080/15384101.2016.1192449; Li JH, 2011, J VIROL, V85, P6319, DOI 10.1128/JVI.02627-10; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Lima VV, 2009, J AM SOC HYPERTENS, V3, P374, DOI 10.1016/j.jash.2009.09.004; Lin YH, 2019, ADV CIV ENG, V2019, DOI 10.1155/2019/5858094; Lin Y, 2019, FASEB J, V33, P6023, DOI 10.1096/fj.201801995RR; Lin Y, 2019, PROTEIN CELL, V10, P60, DOI 10.1007/s13238-018-0555-2; Lin Y, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12709; Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007; Mariappa D, 2013, EMBO J, V32, P612, DOI 10.1038/emboj.2013.26; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; Mishra S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-1; MULLIS KG, 1990, J VIROL, V64, P5317, DOI 10.1128/JVI.64.11.5317-5323.1990; NOVELLI A, 1991, VIROLOGY, V185, P365, DOI 10.1016/0042-6822(91)90784-9; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Panyasrivanit M, 2009, J GEN VIROL, V90, P448, DOI 10.1099/vir.0.005355-0; Park SY, 2005, EXP MOL MED, V37, P220, DOI 10.1038/emm.2005.30; Rahman AMA, 2013, ACS CHEM BIOL, V8, P2053, DOI 10.1021/cb4004173; Rao XJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9468; Ruan HB, 2013, MOL CELL PROTEOMICS, V12, P3489, DOI 10.1074/mcp.R113.029751; Schroder BA, 2010, PROTEOMICS, V10, P4053, DOI 10.1002/pmic.201000196; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; SHI J, 2015, SCI REP UK, V5; Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464; Tang H, 2009, HEPATOLOGY, V49, P60, DOI 10.1002/hep.22581; Wan YS, 2017, CELL MOL IMMUNOL, V14, P607, DOI 10.1038/cmi.2017.1; Wang JW, 2019, HEPATOLOGY, V69, P974, DOI 10.1002/hep.30248; Wang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037427; Wang XY, 2020, CELL MICROBIOL, V22, DOI 10.1111/cmi.13131; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Wu J, 2007, HEPATOLOGY, V46, P1769, DOI 10.1002/hep.21897; Xu WQ, 2017, J HEPATOL, V67, P310, DOI 10.1016/j.jhep.2017.03.017; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Zhang XY, 2018, DEV CELL, V45, P245, DOI 10.1016/j.devcel.2018.03.023; Zhang XY, 2011, HEPATOLOGY, V53, P1476, DOI 10.1002/hep.24195	54	14	14	4	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14473	14489		10.1096/fj.202001168RR	http://dx.doi.org/10.1096/fj.202001168RR		SEP 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32892442	hybrid			2022-12-26	WOS:000568297800001
J	Yoon, H; Kim, EK; Ko, YH				Yoon, Heejei; Kim, Eung Kweon; Ko, Young Hyeh			SLAMF1 contributes to cell survival through the AKT signaling pathway in Farage cells	PLOS ONE			English	Article							HUMAN B-LYMPHOCYTES; FAMILY-MEMBER BIM; DOWN-REGULATION; EXPRESSION; BCL-2; VIRUS; ACTIVATION; RESISTANCE; RECEPTORS; INFECTION	SLAMF1 is often overexpressed in Epstein Barr virus (EBV)-infected B cell tumors. However, its role in the pathogenesis of EBV-infected B cell tumors remains largely unknown. Here, we generated SLAMF1-deficient EBV+ tumor cells and examined the effect of its deficiency on cell proliferation and cell survival. There were no significant differences in cell proliferation and cell cycle distribution for short periods between the SLAMF1-deficient and wild-type cells. However, the deficient cells were more resistant to an AKT inhibitor (MK-2206). When the both cells were co-cultured and repeatedly exposed to the limitations in nutrition and growth factors, the SLAMF1-deficient cells were gradually decreased. We observed that levels of phospho-AKT were differentially regulated according to the nutritional status between the SLAMF1-deficient and wild-type cells. A decrease in phospho-AKT was observed in SLAMF1-deficient cells as well as an increase in pro-apoptotic Bim just before cell passage, which may have been due to the loss of SLAMF1 under poor growth condition. Overall, SLAMF1 is not a strong survival factor, but it seems to be necessary for cell survival in unfavorable growth condition.	[Yoon, Heejei] Sungkyunkwan Univ, Clin Med Res Ctr, Sch Med, Seoul, South Korea; [Yoon, Heejei; Kim, Eung Kweon] Yonsei Univ, Coll Med, Corneal Dystrophy Res Inst, Dept Ophthalmol, Seoul, South Korea; [Ko, Young Hyeh] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Pathol, Seoul, South Korea	Sungkyunkwan University (SKKU); Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); Samsung Medical Center	Yoon, H (corresponding author), Sungkyunkwan Univ, Clin Med Res Ctr, Sch Med, Seoul, South Korea.; Yoon, H (corresponding author), Yonsei Univ, Coll Med, Corneal Dystrophy Res Inst, Dept Ophthalmol, Seoul, South Korea.; Ko, YH (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Pathol, Seoul, South Korea.	yhko310@skku.edu; namayoon@gmail.com		Kim, Eung Kweon/0000-0002-1453-8042	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT AMP; Future Planning [2014R1A2A2A01007826]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT AMP; Future Planning	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2014R1A2A2A01007826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfredsson J, 2005, CELL DEATH DIFFER, V12, P136, DOI 10.1038/sj.cdd.4401537; Berger SB, 2010, NAT IMMUNOL, V11, P920, DOI 10.1038/ni.1931; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Clybouw C, 2005, J IMMUNOL, V175, P2968, DOI 10.4049/jimmunol.175.5.2968; De Salort J, 2011, IMMUNOL LETT, V134, P129, DOI 10.1016/j.imlet.2010.09.021; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Ersing I, 2013, VIRUSES-BASEL, V5, P1587, DOI 10.3390/v5061587; Ghigna MR, 2013, PATHOBIOLOGY, V80, P53, DOI 10.1159/000339722; Gordiienko I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185940; Granato A, 2014, J IMMUNOL, V192, P5761, DOI 10.4049/jimmunol.1300749; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ma CS, 2011, ANN NY ACAD SCI, V1217, P32, DOI 10.1111/j.1749-6632.2010.05824.x; Marquitz AR, 2011, VIROLOGY, V412, P392, DOI 10.1016/j.virol.2011.01.028; Mikhalap SV, 2004, BLOOD, V104, P4063, DOI 10.1182/blood-2004-04-1273; Mikhalap SV, 1999, J IMMUNOL, V162, P5719; Nagy N, 2000, INT J CANCER, V88, P439, DOI 10.1002/1097-0215(20001101)88:3<439::AID-IJC17>3.0.CO;2-#; Paschos K, 2012, NUCLEIC ACIDS RES, V40, P7233, DOI 10.1093/nar/gks391; Shinjyo T, 2001, MOL CELL BIOL, V21, P854, DOI 10.1128/MCB.21.3.854-864.2001; SIDORENKO SP, 1993, J IMMUNOL, V151, P4614; Sintes J, 2011, IMMUNOL CELL BIOL, V89, P161, DOI 10.1038/icb.2010.145; Sionov RV, 2015, ONCOTARGET, V6, P23058, DOI 10.18632/oncotarget.5492; Takeda S, 2014, CANCER SCI, V105, P211, DOI 10.1111/cas.12324; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Villunger A, 2003, BLOOD, V101, P2393, DOI 10.1182/blood-2002-07-2132; Yoon H, 2017, ONCOTARGET, V8, P24621, DOI 10.18632/oncotarget.15600; Yoon H, 2015, GENE CHROMOSOME CANC, V54, P383, DOI 10.1002/gcc.22249	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238791	10.1371/journal.pone.0238791	http://dx.doi.org/10.1371/journal.pone.0238791			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886706	gold, Green Published			2022-12-26	WOS:000571064300002
J	Fekadu, SA; Assem, AS; Adimassu, NF				Fekadu, Sofonias Addis; Assem, Abel Sinshaw; Adimassu, Nebiyat Feleke			Prevalence of pterygium and its associated factors among adults aged 18 years and above in Gambella town, Southwest Ethiopia, May 2019	PLOS ONE			English	Article							RISK-FACTORS; POPULATION; EYE; EPIDEMIOLOGY	Introduction A pterygium is a wing-shaped fibro-vascular growth of conjunctiva on the superficial cornea/conjunctiva. It is an elastotic degeneration of conjunctival stroma mainly due to Ultraviolet light exposure. The prevalence of pterygium varies in different environmental conditions. Its magnitude varies widely from 1.1% to 53% globally and in Ethiopia, it reaches from 8.8% to 38.7%. Objective To determine the prevalence of pterygium and its associated factors among adults aged 18 years and above in Gambella town, Southwest Ethiopia, 2019. Methods and materials A community based cross-sectional study was conducted from April 15 to May 3, 2019, in Gambella town. A total of 402 study participants were selected using a systematic random sampling technique. A pre-tested semi-structured questionnaire, torch, and magnifying loops were used to collect data. The data was entered into epidemiological information 7.1 and exported to statistical package for social science version 20 for analysis. The binary and multivariate logistic regression analysis model was fitted to identify factors associated with pterygium. Odds ratio with respected 95% CI was used to identify the direction and strength of association. Results A total of 400 participants were examined with a response rate of 99.50%. The mean age of the study participants was 39.9 +/- 9.8years. The prevalence of pterygium among adults aged 18 years and above in Gambella town was 127(31.80%), (95% CI: 27.3, 36.3). male sex (AOR = 2.10 (95% CI: 1.26, 3.45), sunlight exposure (AOR = 6.86 (95% CI: 4.00, 11.79) and outdoor works (AOR = 2.10 (95% CI: 1.21, 3.60) were positively associated with pterygium whereas wearing sunglass/hat was a protective factor. Conclusion The prevalence of pterygium was high among adults living in Gambella town. Wearing sunglass/hat and reducing exposure time to the sun was important to reduce the development of pterygium in adults.	[Fekadu, Sofonias Addis; Assem, Abel Sinshaw; Adimassu, Nebiyat Feleke] Univ Gondar, Coll Med & Hlth Sci, Dept Optometry, Gondar, Ethiopia	University of Gondar	Fekadu, SA (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Dept Optometry, Gondar, Ethiopia.	addissofi2007@gmail.com		behar cohen, francine/0000-0001-8571-9513				Alemayehu TK, 2019, PREVALENCE ASS FACTO; Anbesse DH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174450; Backes C, 2019, J EXPO SCI ENV EPID, V29, P753, DOI 10.1038/s41370-018-0087-0; Beijing T, 2007, PREVALENCE FACTORS A, P1184; Bull S, 2013, J EMPIR RES HUM RES, V8, P1, DOI 10.1525/jer.2013.8.4.1; Cajucom-Uy H, 2010, BRIT J OPHTHALMOL, V94, P977, DOI 10.1136/bjo.2008.150847; Chalkia AK, 2013, INT J MOL MED, V32, P539, DOI 10.3892/ijmm.2013.1438; Chen T, 2015, INVEST OPHTH VIS SCI, V56, P1109, DOI 10.1167/iovs.14-15994; Chorley AC, 2015, AEROSP MED HUM PERF, V86, P953, DOI 10.3357/AMHP.4357.2015; De Smedt SK, 2012, OPHTHALMOLOGY, V119, P1766, DOI 10.1016/j.ophtha.2012.03.041; Durkin SR, PREVALENCE SEVERITY, P25; Fotouhi A, 2009, PREVALENCE RISK FACT, V2009, P1125; Gazzard G, 2002, BRIT J OPHTHALMOL, V86, P1341, DOI 10.1136/bjo.86.12.1341; Godfrey D. J., 2003, PHYS MED BIOL, V48, pR65; Hashemi H, 2017, J CURR OPHTHALMOL, V29, P194, DOI 10.1016/j.joco.2016.09.002; Hyung T, 2008, KOREAN NATL HLTH NUT, V2013, P962; Jiao WZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/658648; Liu L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003787; Lu J, 2009, EYE, V23, P421, DOI 10.1038/sj.eye.6703005; Marmamula S, 2013, INVEST OPHTH VIS SCI, V54, P5359, DOI 10.1167/iovs.13-12529; McCarty CA, 2000, BRIT J OPHTHALMOL, V84, P289, DOI 10.1136/bjo.84.3.289; Modenese A, 2018, INT J ENV RES PUBLIC; Nemet AY, 2016, SEMIN OPHTHALMOL, V31, P446, DOI 10.3109/08820538.2014.962169; Oliva Matthew S., 2005, International Ophthalmology Clinics, V45, P1; Paula JS, 2006, EYE, V20, P533, DOI 10.1038/sj.eye.6701917; Prevalence SOF, 2019, STUD PREV RISK FACT, V426, P75; Pyo EY, 2016, KOREA NATL HLTH NUTR, P1; Resnikoff S, 2002, B WORLD HEALTH ORGAN, V82, P844; Rezvan F, 2012, PREVALENCE DETERMINA, P5; Rezvan F, 2018, SURV OPHTHALMOL, V63, P719, DOI 10.1016/j.survophthal.2018.03.001; Saw S, 2009, PTERYGIUM PREVALENCE, V6586; Shiroma H, 2009, AM J OPHTHALMOL, V148, P766, DOI 10.1016/j.ajo.2009.06.006; SONG PG, 2017, PLOS ONE, V12, DOI DOI 10.1371/journal.pone.0174587; Tano T, 2013, ACTA OPHTHALMOL, V91, pE232, DOI 10.1111/aos.12044; Ukponmwan C U, 2007, East Afr Med J, V84, P516; Viso E, 2011, PREVALENCE PINGUECUL, P350; Wang YH, 2020, BMC OPHTHALMOL, V20, DOI 10.1186/s12886-020-1324-6; Wong TYIN, 2001, PREVALENCE RISK FACT, V9394; Wu Kaili, 2002, Yan Ke Xue Bao, V18, P181; Yasemi M, 2017, ELECT PHYS, P5914; 2008, EFSA J, V6	41	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0237891	10.1371/journal.pone.0237891	http://dx.doi.org/10.1371/journal.pone.0237891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881888	gold, Green Published			2022-12-26	WOS:000571063300046
J	Huebner, M; Perperoglou, A				Huebner, Marianne; Perperoglou, Aris			Sex differences and impact of body mass on performance from childhood to senior athletes in Olympic weightlifting	PLOS ONE			English	Article							AGE; TRACK; GROWTH; GENDER; TRENDS	Background Olympic weightlifting requires technical skills, explosive power, strength, and coordination. Weightlifters can be competitive within a range of morphological characteristics due to competition body weight classes. To date no studies have examined when sex differences arise in weightlifting and the impact of body mass on performances at different ages. Objectives To examine when sex-related differences emerge, to quantify the influence of body mass on performances at different ages, and to estimate the age at peak performance. Methods Competitions results from USA Weightlifting National Championships, Youth, Junior, and Senior from 2014 to 2019 were collected for weightlifters aged 6 to 30. Results At age 10 the median total weight lifted was 51kg and 54kg, respectively, for girls and boys. From age 10 to 12 a gender gap emerges with a sex difference of 11.7% at age 14 at 55kg body mass. At age 25 the sex-related performance difference is smaller for lighter athletes (23.6% at 69kg body mass) and larger for heavier athletes (29.9% at 81kg body mass). The median peak age for men is 26.5 years (95% CI: 25.7, 27.3) and for women 25.9 years (95% CI: 24.7, 27.3). Conclusion We quantified the impact of body weight and age and sex differences for youth and young adults, ages 6 to 30 years old, participating in national level Olympic weightlifting competitions in the United States. Body weight at younger ages has less impact on performance compared to older ages, and boys and girls perform similarly. When reaching the ages typically associated with the onset of puberty, boys' performances rapidly increase and the gap between genders widens. Women achieve peak performance at a similar age than men. Such results may help to establish progression trajectories for talented athletes and inform coaches, athletes and national governing bodies.	[Huebner, Marianne] Michigan State Univ, Dept Stat & Probabil, E Lansing, MI 48824 USA; [Perperoglou, Aris] Newcastle Univ, Sch Math Stat & Phys, Newcastle Upon Tyne, Tyne & Wear, England	Michigan State University; Newcastle University - UK	Huebner, M (corresponding author), Michigan State Univ, Dept Stat & Probabil, E Lansing, MI 48824 USA.	huebner@msu.edu		Huebner, Marianne/0000-0002-9694-9231; Reis, AlessanRSS/0000-0001-8486-7469; Perperoglou, Aris/0000-0003-1355-2800				[Anonymous], 2019, CANCER DISCOV, V10, pOF5; Boccia G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170744; Chae YK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006523; Ganse B, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01100; Garhammer J., 1985, INT J SPORT BIOMECH, V1, P122, DOI DOI 10.1123/IJSB.1.2.122; Garhammer J., 1993, J STRENGTH COND RES, V7, P76, DOI DOI 10.1519/00124278-199305000-00002; Gava P, 2019, EUR J TRANSL MYOL, V29, P218, DOI 10.4081/ejtm.2019.8327; Handelsman DJ, 2017, CLIN ENDOCRINOL, V87, P68, DOI 10.1111/cen.13350; Handelsman DJ, 2016, ANN CLIN BIOCHEM, V53, P377, DOI 10.1177/0004563215610589; Haugen TA, 2018, INT J SPORT PHYSIOL, V13, P1122, DOI 10.1123/ijspp.2017-0682; Hirsch KR, 2016, J STRENGTH COND RES, V30, P1231, DOI 10.1519/JSC.0000000000001203; Hollings SC, 2014, INT J SPORTS SCI COA, V9, P651, DOI 10.1260/1747-9541.9.4.651; Huebner M, 2019, MED SCI SPORT EXER, V51, P2302, DOI 10.1249/MSS.0000000000002037; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Lepers R, 2013, SPORTS MED, V43, P851, DOI 10.1007/s40279-013-0067-4; MALINA RM, 1988, ANNU REV ANTHROPOL, V17, P187, DOI 10.1146/annurev.an.17.100188.001155; Malina RM, 2010, J HUM KINET, V24, P79, DOI 10.2478/v10078-010-0023-4; MELTZER DE, 1994, MED SCI SPORT EXER, V26, P1053; Perperoglou A, 2021, STAT MODEL, V21, P546, DOI 10.1177/1471082X20940156; Schnabel SK, 2013, STAT-US, V2, P171, DOI 10.1002/sta4.27; Senefeld JW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225724; Solberg PA, 2019, INT J SPORT PHYSIOL, V14, P1357, DOI 10.1123/ijspp.2019-0093; Storey A, 2012, SPORTS MED, V42, P769, DOI 10.2165/11633000-000000000-00000; Tanaka H, 2008, J PHYSIOL-LONDON, V586, P55, DOI 10.1113/jphysiol.2007.141879; The DJ, 2003, MED SCI SPORT EXER, V35, P1216, DOI 10.1249/01.MSS.0000074582.55220.1C; Thibault V, 2010, J SPORT SCI MED, V9, P214; Tonnessen E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129014	27	10	10	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238369	10.1371/journal.pone.0238369	http://dx.doi.org/10.1371/journal.pone.0238369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881924	Green Published, gold			2022-12-26	WOS:000571063300020
J	Jahn, M; Rekowski, J; Janosi, RA; Kribben, A; Canbay, A; Katsounas, A				Jahn, Michael; Rekowski, Jan; Janosi, Rolf Alexander; Kribben, Andreas; Canbay, Ali; Katsounas, Antonios			Score performance of SAPS 2 and SAPS 3 in combination with biomarkers IL-6, PCT or CRP	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; RESPIRATORY-DISTRESS-SYNDROME; C-REACTIVE PROTEIN; HOSPITAL MORTALITY; CRITICALLY-ILL; ORGAN FAILURE; CARDIOGENIC-SHOCK; APACHE-III; INTERLEUKIN-6; PROCALCITONIN	Objective We aimed to evaluate the effects of combining the Simplified-Acute-Physiology-Score (SAPS) 2 or the SAPS 3 with Interleukin-6 (IL-6) or Procalcitonin (PCT) or C-Reactive Protein (CRP) concentrations for predicting in-hospital mortality. Material and methods This retrospective study was conducted in an interdisciplinary 22-bed intensive care unit (ICU) at a German university hospital. Within an 18-month period, SAPS 2 and SAPS 3 were calculated for 514 critically ill patients that were admitted to the internal medicine department. To evaluate discrimination performance, the area under the receiver operating characteristic curves (AUROCs) and the 95% confidence intervals (95% CIs) were calculated for each score, exclusively or in combination with IL-6 or PCT or CRP. DeLong test was used to compare different AUROCs. Results The SAPS 2 exhibited a better discrimination performance than SAPS 3 with AUROCs of 0.81 (95% CI, 0.76-0.86) and 0.72 (95% CI, 0.66-0.78), respectively. Overall, combination of the SAPS 2 with IL-6 showed the best discrimination performance (AUROC 0.82; 95% CI, 0.77-0.87), albeit not significantly different from SAPS2. IL-6 performed better than PCT and CRP with AUROCs of 0.75 (95% CI, 0.69-0.81), 0.72 (95% CI, 0.66-0.77) and 0.65 (95% CI, 0.59-0.72), respectively. Performance of the SAPS 3 improved significantly when combined with IL-6 (AUROC 0.76; 95% CI, 0.69-0.81) or PCT (AUROC 0.73; 95% CI, 0.67-0.78). Conclusions Our analysis provided evidence that the risk stratification performance of the SAPS 3 and, to a lesser degree, also of the SAPS 2 can increase when combined with IL-6. A more accurate detection of aberrant or dysregulated systemic immunological responses (by IL-6) may explain the higher performance achieved by SAPS 3 + IL-6 vs. SAPS 3. Thus, implementation of IL-6 in critical care scores can improve prediction outcomes, especially in patients experiencing acute inflammatory conditions; however, statistical results may vary across hospital types and/or patient populations with different case mix.	[Jahn, Michael; Kribben, Andreas] Univ Duisburg Essen, Univ Hosp Essen, Dept Nephrol, Essen, Germany; [Rekowski, Jan] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Janosi, Rolf Alexander] Univ Duisburg Essen, Univ Hosp Essen, West German Heart & Vasc Ctr, Dept Cardiol & Vasc Med, Essen, Germany; [Canbay, Ali; Katsounas, Antonios] Ruhr Univ Bochum, Univ Klinikum Knappschaftskrankenhaus Bochum GmbH, Dept Med, Bochum, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; Ruhr University Bochum	Jahn, M (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Nephrol, Essen, Germany.	Michael.Jahn@uk-essen.de	Katsounas, Antonios/AAA-7947-2022	Katsounas, Antonios/0000-0002-5179-0327; Jahn, Michael/0000-0002-7493-205X; Rekowski, Jan/0000-0002-5207-3864; Reis, AlessanRSS/0000-0001-8486-7469				Allyn J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164828; [Anonymous], 2011, WEATHER, V66, pi, DOI 10.1002/wea.699; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; Aziz N, 2016, CYTOKINE, V84, P17, DOI 10.1016/j.cyto.2016.05.010; Bell K, 2003, ANAESTH INTENS CARE, V31, P629, DOI 10.1177/0310057X0303100603; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Bown MJ, 2004, EUR J VASC ENDOVASC, V28, P274, DOI 10.1016/j.ejvs.2004.05.008; Brunkhorst FM, 1999, CRIT CARE MED, V27, P2172, DOI 10.1097/00003246-199910000-00016; Burge T., 2005, PHILOS TOPICS, V33, P1, DOI [DOI 10.5840/PHILT0PICS20053311, 10.5840/philtopics20053311, DOI 10.5840/PHILTOPICS20053311]; Castelli GP, 2004, CRIT CARE, V8, pR234, DOI 10.1186/cc2877; Cohen L, 2019, CLIN BIOCHEM, V65, P38, DOI 10.1016/j.clinbiochem.2019.01.001; Cooke CR, 2013, CRIT CARE MED, V41, P886, DOI 10.1097/CCM.0b013e31827bfc3c; Cuschieri J, 2010, SHOCK, V34, P346, DOI 10.1097/SHK.0b013e3181d8e687; EC, 2016, OFF J EUR UNION L, V45, P3; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Falcao ALE, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0488-9; Fischer CP, 2006, EXERC IMMUNOL REV, V12, P6; Geppert A, 2002, CRIT CARE MED, V30, P1987, DOI 10.1097/00003246-200209000-00007; Geppert A, 2006, CRIT CARE MED, V34, P2035, DOI 10.1097/01.CCM.0000228919.33620.D9; Giannoudis PV, 2004, J BONE JOINT SURG BR, V86B, P313, DOI 10.1302/0301-620X.86B3.15035; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harbarth S, 2001, AM J RESP CRIT CARE, V164, P396, DOI 10.1164/ajrccm.164.3.2009052; Haveman JW, 2006, CRIT CARE, V10, DOI 10.1186/cc5017; Higgins TL, 2007, CRIT CARE MED, V35, P827, DOI 10.1097/01.CCM.0000257337.63529.9F; Jahn M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222164; Jain S, 2018, PANCREATOLOGY; Jawa Randeep S, 2011, J Intensive Care Med, V26, P73, DOI 10.1177/0885066610395679; Karzai W, 1997, INFECTION, V25, P329, DOI 10.1007/BF01740811; Katsounas A, 2016, J CRIT CARE, V33, P180, DOI 10.1016/j.jcrc.2016.01.013; Keegan MT, 2012, CHEST, V142, P851, DOI 10.1378/chest.11-2164; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; KUSHNER I, 1994, BAILLIERE CLIN RHEUM, V8, P513, DOI 10.1016/S0950-3579(05)80113-X; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LEMESHOW S, 1993, JAMA-J AM MED ASSOC, V270, P2478, DOI 10.1001/jama.270.20.2478; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lucena JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077229; Marshall JC, 2017, J CRIT CARE, V37, P270, DOI 10.1016/j.jcrc.2016.07.015; Meynaar IA, 2011, CRIT CARE RES PRACT, V2011, DOI 10.1155/2011/594645; Mors K, 2016, IMMUNOBIOLOGY, V221, P904, DOI 10.1016/j.imbio.2016.03.005; Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5; Poncet A, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1673-6; Poole D, 2012, INTENS CARE MED, V38, P1280, DOI 10.1007/s00134-012-2578-0; Qiao Z, 2018, EUR J TRAUMA EMERG S, V44, P679, DOI 10.1007/s00068-017-0880-9; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; Reinhart K, 2006, CRIT CARE CLIN, V22, P503, DOI 10.1016/j.ccc.2006.03.003; Relja B, 2016, INJURY, V47, P640, DOI 10.1016/j.injury.2016.01.016; RICHES P, 1992, J IMMUNOL METHODS, V153, P125, DOI 10.1016/0022-1759(92)90314-J; Sari R, 2004, J ENDOCRINOL INVEST, V27, P106, DOI 10.1007/BF03346253; Schlosser HG, 2007, J NEUROSURG ANESTH, V19, P5, DOI 10.1097/01.ana.0000211026.18926.89; Schuetz P, 2013, CRIT CARE, V17, DOI 10.1186/cc12787; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Takahashi W, 2016, SHOCK, V46, P254, DOI 10.1097/SHK.0000000000000616; Ugarte H, 1999, CRIT CARE MED, V27, P498, DOI 10.1097/00003246-199903000-00024; Ventetuolo CE, 2008, CLIN CHEST MED, V29, P591, DOI 10.1016/j.ccm.2008.07.001; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wang J, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000018001; Watanabe E, 2005, CRIT CARE MED, V33, P89, DOI 10.1097/01.CCM.0000150025.79100.7D; Winfield RD, 2012, SHOCK, V37, P253, DOI 10.1097/SHK.0b013e3182449c0e; Zou SH, 2017, OPEN LIFE SCI, V12, P425, DOI 10.1515/biol-2017-0050; [No title captured]	62	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238587	10.1371/journal.pone.0238587	http://dx.doi.org/10.1371/journal.pone.0238587			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881963	gold, Green Published			2022-12-26	WOS:000571063300052
J	Lin, SH; Sampson, JN; Grunewald, TGP; Surdez, D; Reynaud, S; Mirabeau, O; Karlins, E; Rubio, RA; Zaidi, S; Grossetete-Lalami, S; Ballet, S; Lapouble, E; Laurence, V; Michon, J; Pierron, G; Kovar, H; Kontny, U; Gonzalez-Neira, A; Alonso, J; Patino-Garcia, A; Corradini, N; Berard, PM; Miller, J; Freedman, ND; Rothman, N; Carter, BD; Dagnall, CL; Burdett, L; Jones, K; Manning, M; Wyatt, K; Zhou, WY; Yeager, M; Cox, DG; Hoover, RN; Khan, J; Armstrong, GT; Leisenring, WM; Bhatia, S; Robison, LL; Kulozik, AE; Kriebel, J; Meitinger, T; Metzler, M; Krumbholz, M; Hartmann, W; Strauch, K; Kirchner, T; Dirksen, U; Mirabello, L; Tucker, MA; Tirode, F; Morton, LM; Chanock, SJ; Delattre, O; Machiela, MJ				Lin, Shu-Hong; Sampson, Joshua N.; Gruenewald, Thomas G. P.; Surdez, Didier; Reynaud, Stephanie; Mirabeau, Olivier; Karlins, Eric; Rubio, Rebeca Alba; Zaidi, Sakina; Grossetete-Lalami, Sandrine; Ballet, Stelly; Lapouble, Eve; Laurence, Valerie; Michon, Jean; Pierron, Gaelle; Kovar, Heinrich; Kontny, Udo; Gonzalez-Neira, Anna; Alonso, Javier; Patino-Garcia, Ana; Corradini, Nadege; Berard, Perrine Marec; Miller, Jeremy; Freedman, Neal D.; Rothman, Nathaniel; Carter, Brian D.; Dagnall, Casey L.; Burdett, Laurie; Jones, Kristine; Manning, Michelle; Wyatt, Kathleen; Zhou, Weiyin; Yeager, Meredith; Cox, David G.; Hoover, Robert N.; Khan, Javed; Armstrong, Gregory T.; Leisenring, Wendy M.; Bhatia, Smita; Robison, Leslie L.; Kulozik, Andreas E.; Kriebel, Jennifer; Meitinger, Thomas; Metzler, Markus; Krumbholz, Manuela; Hartmann, Wolfgang; Strauch, Konstantin; Kirchner, Thomas; Dirksen, Uta; Mirabello, Lisa; Tucker, Margaret A.; Tirode, Franck; Morton, Lindsay M.; Chanock, Stephen J.; Delattre, Olivier; Machiela, Mitchell J.			Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma	PLOS ONE			English	Article							GENOMIC LANDSCAPE; CANCER; PROSTATE; DESIGN; EGR2	Background Ewing sarcoma (EwS) is a rare, aggressive solid tumor of childhood, adolescence and young adulthood associated with pathognomonic EWSR1-ETS fusion oncoproteins altering transcriptional regulation. Genome-wide association studies (GWAS) have identified 6 common germline susceptibility loci but have not investigated low-frequency inherited variants with minor allele frequencies below 5% due to limited genotyped cases of this rare tumor. Methods We investigated the contribution of rare and low-frequency variation to EwS susceptibility in the largest EwS genome-wide association study to date (733 EwS cases and 1,346 unaffected controls of European ancestry). Results We identified two low-frequency variants, rs112837127 and rs2296730, on chromosome 20 that were associated with EwS risk (OR = 0.186 and 2.038, respectively; P-value < 5x10(-8)) and located near previously reported common susceptibility loci. After adjusting for the most associated common variant at the locus, only rs112837127 remained a statistically significant independent signal (OR = 0.200, P-value = 5.84x10(-8)). Conclusions These findings suggest rare variation residing on common haplotypes are important contributors to EwS risk. Impact Motivate future targeted sequencing studies for a comprehensive evaluation of low-frequency and rare variation around common EwS susceptibility loci.	[Lin, Shu-Hong; Sampson, Joshua N.; Karlins, Eric; Freedman, Neal D.; Rothman, Nathaniel; Dagnall, Casey L.; Burdett, Laurie; Jones, Kristine; Manning, Michelle; Wyatt, Kathleen; Zhou, Weiyin; Yeager, Meredith; Hoover, Robert N.; Mirabello, Lisa; Tucker, Margaret A.; Morton, Lindsay M.; Chanock, Stephen J.; Machiela, Mitchell J.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Gruenewald, Thomas G. P.; Rubio, Rebeca Alba] Ludwig Maximilians Univ LMU, Max Eder Res Grp Pediat Sarcoma Biol, Munich, Germany; [Gruenewald, Thomas G. P.] German Canc Consortium DKTK, Div Translat Pediat Sarcoma Res, German Canc Res Ctr DKFZ, Heidelberg, Germany; [Gruenewald, Thomas G. P.] Heidelberg Univ Hosp, Inst Pathol, Heidelberg, Germany; [Surdez, Didier; Mirabeau, Olivier; Zaidi, Sakina; Grossetete-Lalami, Sandrine; Tirode, Franck; Delattre, Olivier] PSL Univ, Inst Curie, Equipe Labellises LNCC, Inserm U830, Paris, France; [Reynaud, Stephanie; Mirabeau, Olivier; Zaidi, Sakina; Grossetete-Lalami, Sandrine; Ballet, Stelly; Lapouble, Eve; Laurence, Valerie; Michon, Jean; Pierron, Gaelle; Tirode, Franck; Delattre, Olivier] Inst Curie, SIREDO Oncol Ctr, Paris, France; [Karlins, Eric; Dagnall, Casey L.; Burdett, Laurie; Jones, Kristine; Manning, Michelle; Wyatt, Kathleen; Zhou, Weiyin; Yeager, Meredith] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Canc Genom Res Lab, Frederick, MD USA; [Kovar, Heinrich] St Anna Kinderkrebsforsch, Childrens Canc Res Inst, Vienna, Austria; [Kontny, Udo] Uniklin RWTH Aachen, Div Pediat Hematol Oncol & Stem Cell Transplantat, Aachen, Germany; [Gonzalez-Neira, Anna] Spanish Natl Canc Res Ctr, Human Genotyping Unit CeGen, Human Canc Genet Programme, Madrid, Spain; [Alonso, Javier] Inst Salud Carlos III, Unidad Tumores Solidos Infantiles IIER ISCIII, Majadahonda, Spain; [Alonso, Javier] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras CB06 07, Majadahonda, Spain; [Patino-Garcia, Ana] Univ Clin Navarra, Lab Pediat, Ctr Appl Med Res CIMA, Program Solid Tumors, Pamplona, Spain; [Patino-Garcia, Ana] Navarras Hlth Res Inst IdiSNA, Pamplona, Spain; [Corradini, Nadege; Berard, Perrine Marec] Univ Lyon, Leon Berard Canc Ctr, Inst Paediat Haematol & Oncol, Lyon, France; [Miller, Jeremy] Informat Management Serv Inc, Calverton, MD USA; [Carter, Brian D.] Amer Canc Soc, Behav & Epidemiol Res Grp, Atlanta, GA 30329 USA; [Cox, David G.] Inst Natl Sante & Rech Med INSERM, Paris, France; [Khan, Javed] NCI, Genet Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Armstrong, Gregory T.; Robison, Leslie L.] St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, 332 N Lauderdale St, Memphis, TN 38105 USA; [Leisenring, Wendy M.] Fred Hutchinson Canc Res Ctr, Canc Prevent & Clin Stat Programs, 1124 Columbia St, Seattle, WA 98104 USA; [Bhatia, Smita] Univ Alabama Birmingham, Inst Canc Outcomes & Survivorship, Birmingham, AL USA; [Kulozik, Andreas E.] Heidelberg Univ, Dept Pediat Oncol Hematol & Immunol, Heidelberg, Germany; [Kulozik, Andreas E.] Heidelberg Univ, Hopp Children Canc Ctr, Heidelberg, Germany; [Kriebel, Jennifer] German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Kriebel, Jennifer] German Res Ctr Environm Hlth, Inst Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Kriebel, Jennifer] German Ctr Diabet Res DZD, Neuherberg, Germany; [Meitinger, Thomas] Helmholtz Zentrum Munchen, Inst Human Genet, German Res Ctr Environm Hlth, Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Metzler, Markus] Univ Hosp Erlangen, Dept Paediat & Adolescent Med, Erlangen, Germany; [Krumbholz, Manuela; Hartmann, Wolfgang] Univ Hosp Munster, Gerhard Domagk Inst Pathol, Div Translat Pathol, Munster, Germany; [Strauch, Konstantin] Ludwig Maximilians Univ Munchen, Inst Genet Epidemiol, Munich, Germany; [Kirchner, Thomas] Ludwig Maximilians Univ Munchen, Inst Pathol, Fac Med, Munich, Germany; [Dirksen, Uta] Univ Hosp Essen, West German Canc Ctr, Pediat 3, Essen, Germany; [Dirksen, Uta] Ctr Essen, German Canc Consortium DKTK, Heidelberg, Germany	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Saint Anna Children's Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Centro Nacional de Investigaciones Oncologicas (CNIO); Instituto de Salud Carlos III; Instituto de Investigacion de Enfermedades Raras (IIER); Instituto de Salud Carlos III; University of Navarra; UNICANCER; Centre Leon Berard; Information Management Services, Inc.; American Cancer Society; Institut National de la Sante et de la Recherche Medicale (Inserm); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); St Jude Children's Research Hospital; Fred Hutchinson Cancer Center; University of Alabama System; University of Alabama Birmingham; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Erlangen Nuremberg; University of Munster; University of Munich; University of Munich; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ)	Machiela, MJ (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	mitchell.machiela@nih.gov	Morton, Lindsay/AAE-7495-2022; TIRODE, Franck/HHS-7070-2022; Metzler, Markus/AAS-2066-2021; Machiela, Mitchell J/H-7335-2019; Alonso, Javier/B-6012-2013; Freedman, Neal David/B-9741-2015; Surdez, Didier/ABG-4565-2020; Gonzalez-Neira, Anna/C-5791-2015; Armstrong, Gregory/N-8096-2018; Dirksen, Uta/AGX-8472-2022; Tirode, Franck/B-4586-2009	Morton, Lindsay/0000-0001-9767-2310; Metzler, Markus/0000-0002-4523-1676; Machiela, Mitchell J/0000-0001-6538-9705; Alonso, Javier/0000-0002-6287-8391; Freedman, Neal David/0000-0003-0074-1098; Gonzalez-Neira, Anna/0000-0002-5421-2020; Cox, David/0000-0003-2047-4687; LIN, SHU-HONG/0000-0002-4020-7714; Tirode, Franck/0000-0003-4731-7817; Karlins, Eric/0000-0002-7541-393X; Carter, Brian/0000-0003-1166-6521	National Cancer Institute [CA55727]; Intramural Research Program of the National Institutes of Health, National Cancer Institute; Intramural Research Program of the American Cancer Society; Institut Curie; Inserm; Ligue Nationale Contre le Cancer; Agence Nationale de la Recherche [ANR-10-EQPX-03]; European PROVABES [ERA-649]; ASSET [FP7-HEALTH-2010-259348]; FP7 grant "EURO EWING Consortium" [602856]; Courir pour Mathieu; Dans les pas du Geant; Les Bagouzamanon; Enfants et Sante; M la vie avec Lisa; Lulu et les petites bouilles de lune; les Amis de Claire; l'Etoile de Martin; Societe Francaise de lutte contre les Cancers et les leucemies de l'Enfant et de l'adolescent; Verein zur Forderung von Wissenschaft und Forschung an der Medizinischen Fakultat der LMU Munchen (WiFoMed); LMU Munich's Institutional Strategy LMU excellent within the framework of the German Excellence Initiative; Mehr LEBEN fur krebskranke Kinder -Bettina-Bra u-Stiftung; Wilhelm Sander-Foundation [2016.167.1]; Barbara and Hubertus Trettner foundation; Gert and Susanna Mayer foundation; Matthias-Lackas foundation; Friedrich-Baur foundation; Dr. Leopold and Carmen Ellinger foundation; Dr. Rolf M. Schwiete foundation; Deutsche Forschungsgemeinschaft (DFG) [391665916]; Barbara and Wilfried Mohr foundation; SMARCB1 e.V. assoication; German Cancer Aid [DKH-70112257, 108128]; SiRIC [INCa-DGOS-4654]; European Commission Seventh Framework Program FP7HEALTH "Euro Ewing Consortium EEC" [EU-FP7 602856]; "Schornsteinfeger helfen krebskranken Kindern" Foundation; Trettner Foundation; ERA-Net-TRANSCAN consortium under the European Commission Seventh Framework Program FP7-HEALTH [01KT1310]; Euro Ewing Consortium EEC under the European Commission Seventh Framework Program FP7-HEALTH [EU-FP7 602856]; Instituto de Salud Carlos III [PI16CIII/00026]; Asociacion Pablo Ugarte; Fundacion Sonrisa de Alex; ASION-La Hucha de Tomas; Sociedad Espanola de Hematologia y Oncologia Pediatricas; Cancer Center Support (CORE) [CA21765]; American Lebanese-Syrian Associated Charities (ALSAC); Helmholtz Zentrum Munchen-German Research Center for Environmental Health - German Federal Ministry of Education and Research (BMBF); State of Bavaria; Munich Center of Health Sciences (MC-Health); Ludwig-Maximilians-Universitat; Gobierno de Navarra, Proyectos de Biomedicina [54/2018]; Fundacion Caja Navarra/La Caixa	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the American Cancer Society; Institut Curie; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de la Recherche(French National Research Agency (ANR)); European PROVABES; ASSET; FP7 grant "EURO EWING Consortium"; Courir pour Mathieu; Dans les pas du Geant; Les Bagouzamanon; Enfants et Sante; M la vie avec Lisa; Lulu et les petites bouilles de lune; les Amis de Claire; l'Etoile de Martin; Societe Francaise de lutte contre les Cancers et les leucemies de l'Enfant et de l'adolescent; Verein zur Forderung von Wissenschaft und Forschung an der Medizinischen Fakultat der LMU Munchen (WiFoMed); LMU Munich's Institutional Strategy LMU excellent within the framework of the German Excellence Initiative; Mehr LEBEN fur krebskranke Kinder -Bettina-Bra u-Stiftung; Wilhelm Sander-Foundation; Barbara and Hubertus Trettner foundation; Gert and Susanna Mayer foundation; Matthias-Lackas foundation; Friedrich-Baur foundation; Dr. Leopold and Carmen Ellinger foundation; Dr. Rolf M. Schwiete foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Barbara and Wilfried Mohr foundation; SMARCB1 e.V. assoication; German Cancer Aid(Deutsche Krebshilfe); SiRIC; European Commission Seventh Framework Program FP7HEALTH "Euro Ewing Consortium EEC"; "Schornsteinfeger helfen krebskranken Kindern" Foundation; Trettner Foundation; ERA-Net-TRANSCAN consortium under the European Commission Seventh Framework Program FP7-HEALTH; Euro Ewing Consortium EEC under the European Commission Seventh Framework Program FP7-HEALTH; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Asociacion Pablo Ugarte; Fundacion Sonrisa de Alex; ASION-La Hucha de Tomas; Sociedad Espanola de Hematologia y Oncologia Pediatricas; Cancer Center Support (CORE); American Lebanese-Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); Helmholtz Zentrum Munchen-German Research Center for Environmental Health - German Federal Ministry of Education and Research (BMBF); State of Bavaria; Munich Center of Health Sciences (MC-Health); Ludwig-Maximilians-Universitat; Gobierno de Navarra, Proyectos de Biomedicina; Fundacion Caja Navarra/La Caixa	This work was supported by the National Cancer Institute (CA55727, G.T. Armstrong, Principal Investigator), with additional funding for genotyping from the Intramural Research Program of the National Institutes of Health, National Cancer Institute and the Intramural Research Program of the American Cancer Society. This work was supported by grants from the Institut Curie, the Inserm, the Ligue Nationale Contre le Cancer (Equipe labellisee, Carte d'Identite des Tumeurs program and Recherche Epidemiologique 2009 program), the ANR-10-EQPX-03 from the Agence Nationale de la Recherche, the European PROVABES (ERA-649 NET TRANSCAN JTC-2011), and ASSET (FP7-HEALTH-2010-259348) projects. This research was supported by FP7 grant "EURO EWING Consortium" No. 602856 and the following associations: Courir pour Mathieu, Dans les pas du Geant, Les Bagouzamanon, Enfants et Sante, M la vie avec Lisa, Lulu et les petites bouilles de lune, les Amis de Claire, l'Etoile de Martin and the Societe Francaise de lutte contre les Cancers et les leucemies de l'Enfant et de l'adolescent. The laboratory of T. G. P. Grunewald is supported by grants from the `Verein zur Forderung von Wissenschaft und Forschung an der Medizinischen Fakultat der LMU Munchen (WiFoMed)', by LMU Munich's Institutional Strategy LMU excellent within the framework of the German Excellence Initiative, the `Mehr LEBEN fur krebskranke Kinder -Bettina-Bra u-Stiftung', the Wilhelm Sander-Foundation (2016.167.1), the Barbara and Hubertus Trettner foundation, the Gert and Susanna Mayer foundation, the Matthias-Lackas foundation, the Friedrich-Baur foundation, the Dr. Leopold and Carmen Ellinger foundation, the Dr. Rolf M. Schwiete foundation, the Deutsche Forschungsgemeinschaft (DFG 391665916), the Barbara and Wilfried Mohr foundation, the SMARCB1 e.V. assoication, and by the German Cancer Aid (DKH-70112257). D. Surdez is supported by SiRIC (Grant INCa-DGOS-4654). The Metzler lab received grants from the European Commission Seventh Framework Program FP7HEALTH "Euro Ewing Consortium EEC", project number EU-FP7 602856, the "Schornsteinfeger helfen krebskranken Kindern" Foundation and the Trettner Foundation. The group of U. Dirksen is supported by the German Cancer Aid grant 108128, the Barbara and Hubertus Trettner foundation, the Gert and Susanna Mayer foundation; ERA-Net-TRANSCAN consortium ' PROVABES ' (01KT1310), and Euro Ewing Consortium EEC, project number EU-FP7 602856, both funded under the European Commission Seventh Framework Program FP7-HEALTH (http://cordis.europa.eu/); This work was supported by the Instituto de Salud Carlos III (PI16CIII/00026) and the Asociacion Pablo Ugarte, Fundacion Sonrisa de Alex, ASION-La Hucha de Tomas, Sociedad Espanola de Hematologia y Oncologia Pediatricas. Support to St. Jude Children's Research Hospital also provided by the Cancer Center Support (CORE) grant (CA21765, C. Roberts, Principal Investigator) and the American Lebanese-Syrian Associated Charities (ALSAC). The KORA study was initiated and financed by the Helmholtz Zentrum Munchen-German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ. The laboratory of A.P. Garcia is supported by Gobierno de Navarra, Proyectos de Biomedicina 2018. Ref. 54/2018 and Fundacion Caja Navarra/La Caixa to Ninos Contra el Ca ' ncer.; Leidos Biomedical Research Inc. and Information Management Services, Inc. provided support in the form of salaries for authors J.M., E.K., C.L.D., L.B., K.J., M.M., K.W., W.Z., and M.Y., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander TA, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-3340-1; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; [Anonymous], 2014, R LANG ENV STAT COMP; AURIAS A, 1983, NEW ENGL J MED, V309, P496; Boulay G, 2017, CELL, V171, P163, DOI 10.1016/j.cell.2017.07.036; Brohl AS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004475; Calle EE, 2002, CANCER-AM CANCER SOC, V94, P2490, DOI 10.1002/cncr.101970; Castano-Vinyals G, 2008, OCCUP ENVIRON MED, V65, P56, DOI 10.1136/oem.2007.034348; Chen ZZ, 2018, CANCER LETT, V430, P88, DOI 10.1016/j.canlet.2018.05.023; Crompton BD, 2014, CANCER DISCOV, V4, P1326, DOI 10.1158/2159-8290.CD-13-1037; Daremipouran MR, 2019, CANCER GENOM PROTEOM, V16, P245, DOI 10.21873/cgp.20129; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; Grunewald TGP, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0003-x; Grunewald TGP, 2015, NAT GENET, V47, P1073, DOI 10.1038/ng.3363; Guillon N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004932; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jawad MU, 2009, CANCER-AM CANCER SOC, V115, P3526, DOI 10.1002/cncr.24388; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Machiela MJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05537-2; Machiela MJ, 2018, BIOINFORMATICS, V34, P887, DOI 10.1093/bioinformatics/btx561; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; MEHTA CR, 1985, J AM STAT ASSOC, V80, P969, DOI 10.2307/2288562; Musa J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12071-2; O'Connell J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004234; Parine NR, 2019, J ONCOL, V2019, DOI 10.1155/2019/7091815; Pedersen EA, 2016, CANCER RES, V76, P5040, DOI 10.1158/0008-5472.CAN-15-3422; Postel-Vinay S, 2012, NAT GENET, V44, P323, DOI 10.1038/ng.1085; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Stewart B, 2014, WORLD CANC REPORT 20; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Tirode F, 2014, CANCER DISCOV, V4, P1342, DOI 10.1158/2159-8290.CD-14-0622; Toomey EC, 2010, ONCOGENE, V29, P4504, DOI 10.1038/onc.2010.205; Troisi R, 2006, BRIT J CANCER, V95, P1603, DOI 10.1038/sj.bjc.6603474; von Levetzow C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019305; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551; Zhu JH, 2018, EBIOMEDICINE, V33, P88, DOI 10.1016/j.ebiom.2018.06.018	37	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0237792	10.1371/journal.pone.0237792	http://dx.doi.org/10.1371/journal.pone.0237792			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881892	Green Published, gold			2022-12-26	WOS:000571063300022
J	Murri, R; Segala, FV; Del Vecchio, P; Cingolani, A; Taddei, E; Micheli, G; Fantoni, M				Murri, Rita; Segala, Francesco Vladimiro; Del Vecchio, Pierluigi; Cingolani, Antonella; Taddei, Eleonora; Micheli, Giulia; Fantoni, Massimo		COVID II Columbus Grp	Social media as a tool for scientific updating at the time of COVID pandemic: Results from a national survey in Italy	PLOS ONE			English	Article								In the face of the rapid evolution of the COVID-19 pandemic, healthcare professionals on the frontline are in urgent need of frequent updates in the accomplishment of their practice. Hence, clinicians started to search for prompt, valid information on sources that are parallel to academic journals. Aim of this work is to investigate the extent of this phenomenon. We administered an anonymous online cross-sectional survey to 645 Italian clinicians. Target of the survey were all medical figures potentially involved in the management of COVID-19 cases. 369 questionnaires were returned. 19.5% (n = 72) of respondents were younger than 30 years-old; 49,3% (n = 182) worked in Infectious Diseases, Internal Medicine or Respiratory Medicine departments, 11.5% (n = 42) in Intensive Care Unit and 7.4% (n = 27) were general practitioner. 70% (n = 261) of respondents reported that their use of social media to seek medical information increased during the pandemic. 39.3% (n = 145) consistently consulted Facebook groups and 53.1% (n = 196) Whatsapp chats. 47% (n = 174) of respondents reported that information shared on social media had a consistent impact on their daily practice. In the present study, we found no difference in social media usage between age groups or medical specialties. Given the urgent need for scientific update during the present pandemic, these findings may help understanding how clinicians access new evidences and implement them in their daily practice.	[Murri, Rita; Cingolani, Antonella; Taddei, Eleonora; Fantoni, Massimo] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Lab & Infettivolog, Rome, Italy; [Murri, Rita; Cingolani, Antonella; Taddei, Eleonora; Fantoni, Massimo] Univ Cattolica Sacro Cuore, Dipartimento Sicurezza & Bioet, Rome, Italy; [Segala, Francesco Vladimiro; Del Vecchio, Pierluigi; Micheli, Giulia] Univ Cattolica Sacro Cuore, Rome, Italy; Fdn Policlin Univ A Gemelli IRCCS, Unita Operat Complessa Pneumol, Dipartimento Sci Med & Chirurg, Rome, Italy; [COVID II Columbus Grp] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Invecchiamento Neurol Ortoped &, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Segala, FV (corresponding author), Univ Cattolica Sacro Cuore, Rome, Italy.	fvsegala@gmail.com	Fantoni, Massimo/AAB-7371-2022; Micheli, Giulia/GZB-2756-2022	Del Vecchio, Pierluigi/0000-0003-4421-912X; FANTONI, Massimo/0000-0001-6913-8460; Segala, Francesco Vladimiro/0000-0001-5276-2603; Taddei, Eleonora/0000-0002-5983-4291; Micheli, Giulia/0000-0001-7996-8345				[Anonymous], 2002, Bull World Health Organ, V80, P983; [Anonymous], 2020, CELL PRESS CORONAVIR; [Anonymous], 2020, BMJS CORONAVIRUS COV; [Anonymous], 2020, NEW ENGLAND J MED CO; Bastani Peivand, 2020, J Med Internet Res, DOI 10.2196/18932; Dye C, 2016, B WORLD HEALTH ORGAN, V94, P158, DOI 10.2471/BLT.16.170860; Fernandez-Luque L, 2018, INT J MED INFORM, V114, P136, DOI 10.1016/j.ijmedinf.2018.01.015; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Johansson MA, 2020, NATURE, V579, P29, DOI [10.1038/d41586-020-00614-3, 10.1038/d41586-020-00613-4]; Kouzy R, 2020, CUREUS, V12, DOI 10.7759/cureus.7255; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Sell TK, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08697-3; Slominski AT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009907; Societa Italiana Malattie e Tropicali, LIN GUID GEST TER SU; Ventola C Lee, 2014, P T, V39, P491; Yan J, 2019, APPL ENERG, V240, pA1, DOI 10.1016/j.apenergy.2018.03.001	16	8	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238414	10.1371/journal.pone.0238414	http://dx.doi.org/10.1371/journal.pone.0238414			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881933	Green Published, gold			2022-12-26	WOS:000571063300096
J	Oh, SW; Yang, JH; Kim, MG; Cho, WY; Jo, SK				Oh, Se Won; Yang, Ji Hyun; Kim, Myung-Gyu; Cho, Won Yong; Jo, Sang Kyung			Renal hyperfiltration as a risk factor for chronic kidney disease: A health checkup cohort study	PLOS ONE			English	Article							GLOMERULAR HYPERFILTRATION; MARKER; ASSOCIATION; OBESITY	Introduction Renal hyperfiltration (RHF) has been found to be an independent predictor of adverse cardiovascular outcome. However, it remains uncertain whether it is precursor of chronic kidney disease (CKD) in a healthy population. Materials and methods To determine relative risks and identify the predictor of incident proteinuria and decline of estimated glomerular filtration rate (eGFR) in subjects with RHF. A total of 55,992 subjects aged >= 20 years who underwent health check-up during 2004-2017 were included. Among them, 16,946 subjects who completed at least two health checkups were analyzed. Results A total of 949 (5.6%) subjects developed proteinuria and 98 (0.6%) subjects showed >= 30% of eGFR decline. The risk of incident proteinuria was significantly higher in those with RHF (RR: 1.644; 95% CI: 1.064-2.541). Those with RHF showed 8.720 fold (95% CI: 4.205-18.081) increased risk for >= 30% decline. ESR, CRP, and monocyte count showed reversed J shaped curve according to the increase of eGFR. The adjusted mean of monocyte count was significantly higher in participants with eGFR >= 90ml/min/1.73m(2)or < 60ml/min/1.73m(2)compared to that in patients with eGFR 75-89ml/min/1.73m(2). Compared to subjects with the lowest tertile of monocyte and no RHF, those with the highest tertile of monocyte count in the RHF group had 3.314-fold (95% CI: 1.893-5.802) higher risk of incident proteinuria and 3.822-fold (95% CI, 1.327-11.006) risk of 30% eGFR decline. Conclusions RHF had significantly increased risk of developing proteinuria and CKD in healthy subjects. Higher monocyte count might be used as a predictor of CKD in subjects with RHF.	[Oh, Se Won; Yang, Ji Hyun; Kim, Myung-Gyu; Cho, Won Yong; Jo, Sang Kyung] Korea Univ, Dept Internal Med, Div Nephrol, Anam Hosp,Coll Med, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine)	Jo, SK (corresponding author), Korea Univ, Dept Internal Med, Div Nephrol, Anam Hosp,Coll Med, Seoul, South Korea.	sang-kyung@korea.ac.kr	Oh, Se Won/G-2632-2017	Oh, Se Won/0000-0003-3795-9322; Kim, Myung Gyu/0000-0001-8807-2452; Yang, Jihyun/0000-0002-8616-238X; Jo, Sang Kyung/0000-0002-0496-0258				Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Bowe B, 2017, CLIN J AM SOC NEPHRO, V12, P603, DOI 10.2215/CJN.09710916; Chagnac A, 2008, NEPHROL DIAL TRANSPL, V23, P3946, DOI 10.1093/ndt/gfn379; Delanaye P, 2017, NEPHRON, V136, P302, DOI 10.1159/000469669; Ficociello LH, 2009, DIABETES CARE, V32, P889, DOI 10.2337/dc08-1560; Ganda A, 2013, CIRCULATION, V127, P988, DOI 10.1161/CIRCULATIONAHA.112.000682; Gregg LP, 2018, AM J NEPHROL, V47, P395, DOI 10.1159/000488806; Hall-Baker Patsy A., 2011, Morbidity and Mortality Weekly Report, V58, P1; Har R, 2013, DIABETOLOGIA, V56, P1166, DOI 10.1007/s00125-013-2857-5; Heine GH, 2012, NAT REV NEPHROL, V8, P362, DOI 10.1038/nrneph.2012.41; Helal I, 2012, NAT REV NEPHROL, V8, P293, DOI 10.1038/nrneph.2012.19; Keller CK, 1996, J AM SOC NEPHROL, V7, P2627; Maeda I, 2011, CLIN J AM SOC NEPHRO, V6, P2462, DOI 10.2215/CJN.00700111; Palatini P, 2012, AM J HYPERTENS, V25, P1011, DOI 10.1038/ajh.2012.73; Palatini P, 2012, NEPHROL DIAL TRANSPL, V27, P1708, DOI 10.1093/ndt/gfs037; Park M, 2015, J AM SOC NEPHROL, V26, P1426, DOI 10.1681/ASN.2014010115; Reboldi G, 2018, KIDNEY INT, V93, P195, DOI 10.1016/j.kint.2017.07.013; Rogacev KS, 2011, EUR HEART J, V32, P84, DOI 10.1093/eurheartj/ehq371; Sasson AN, 2012, WORLD J DIABETES, V3, P1, DOI 10.4239/wjd.v3.i1.1; Tomaszewski M, 2007, KIDNEY INT, V71, P816, DOI 10.1038/sj.ki.5002160; Zeller A, 2005, J HUM HYPERTENS, V19, P205, DOI 10.1038/sj.jhh.1001803	22	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238177	10.1371/journal.pone.0238177	http://dx.doi.org/10.1371/journal.pone.0238177			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881893	Green Published, gold			2022-12-26	WOS:000571063300036
J	Rudolph, MJ; Davis, SA; Tumer, NE; Li, XP				Rudolph, Michael J.; Davis, Simon A.; Tumer, Nilgun E.; Li, Xiao-Ping			Structural basis for the interaction of Shiga toxin 2a with a C-terminal peptide of ribosomal P stalk proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						toxin; Shiga toxin; ribosome; ribosomal stalk; ribosome inactivating protein; P1; P2 protein; bacterial toxin; RIP; Escherichia coli; E; coli; translation	HEMOLYTIC-UREMIC SYNDROME; ESCHERICHIA-COLI; INACTIVATING PROTEIN; ACTIVE-SITE; BINDING; TRICHOSANTHIN; RICIN; DEPURINATION; PATHOGENESIS; INSIGHTS	The principal virulence factor of human pathogenic enterohemorrhagic Escherichia coli is Shiga toxin (Stx). Shiga toxin 2a (Stx2a) is the subtype most commonly associated with severe disease outcomes such as hemorrhagic colitis and hemolytic uremic syndrome. The catalytic A1 subunit (Stx2A1) binds to the conserved elongation factor binding C-terminal domain (CTD) of ribosomal P stalk proteins to inhibit translation. Stx2a holotoxin also binds to the CTD of P stalk proteins because the ribosome-binding site is exposed. We show here that Stx2a binds to an 11-mer peptide (P11) mimicking the CTD of P stalk proteins with low micromolar affinity. We cocrystallized Stx2a with P11 and defined their interactions by X-ray crystallography. We found that the last six residues of P11 inserted into a shallow pocket on Stx2A1 and interacted with Arg-172, Arg-176, and Arg-179, which were previously shown to be critical for binding of Stx2A1 to the ribosome. Stx2a formed a distinct P11-binding mode within a different surface pocket relative to ricin toxin A subunit and trichosanthin, suggesting different ribosome recognition mechanisms for each ribosome inactivating protein (RIP). The binding mode of Stx2a to P11 is also conserved among the different Stx subtypes. Furthermore, the P stalk protein CTD is flexible and adopts distinct orientations and interaction modes depending on the structural differences between the RIPs. Structural characterization of the Stx2a-ribosome complex is important for understanding the role of the stalk in toxin recruitment to the sarcin/ricin loop and may provide a new target for inhibitor discovery.	[Rudolph, Michael J.; Davis, Simon A.] New York Struct Biol Ctr, New York, NY USA; [Tumer, Nilgun E.; Li, Xiao-Ping] Rutgers State Univ, Dept Plant Biol, New Brunswick, NJ USA	Rutgers State University New Brunswick	Tumer, NE; Li, XP (corresponding author), Rutgers State Univ, Dept Plant Biol, New Brunswick, NJ USA.	xpli@sebs.rutgers.edu; tumer@sebs.rutgers.edu		LI, XIAOPING/0000-0003-2928-8397	NIAID, National Institutes of Health [AI141635, AI072425]	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health, Grants AI141635 (to X.-P. L.) and AI072425 (to N. E. T.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ballesta JPG, 1996, PROG NUCLEIC ACID RE, V55, P157, DOI 10.1016/S0079-6603(08)60193-2; Basu D, 2016, INFECT IMMUN, V84, P3290, DOI 10.1128/IAI.00630-16; Bergan J, 2012, TOXICON, V60, P1085, DOI 10.1016/j.toxicon.2012.07.016; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Chan DSB, 2007, NUCLEIC ACIDS RES, V35, P1660, DOI 10.1093/nar/gkm065; Chiou JC, 2011, INT J BIOCHEM CELL B, V43, P1792, DOI 10.1016/j.biocel.2011.08.018; Choi AKH, 2015, TOXINS, V7, P638, DOI 10.3390/toxins7030638; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Fan XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep37803; Fraser ME, 2006, ACTA CRYSTALLOGR F, V62, P627, DOI 10.1107/S1744309106021968; Fraser ME, 2004, J BIOL CHEM, V279, P27511, DOI 10.1074/jbc.M401939200; Grela P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05675-5; Grela P, 2010, BIOCHEMISTRY-US, V49, P924, DOI 10.1021/bi901811s; The HC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002055; Imai H, 2015, GENES CELLS, V20, P613, DOI 10.1111/gtc.12256; Ishijima N, 2017, SCI REP-UK, V7, DOI 10.1038/srep43136; Ito K, 2014, NUCLEIC ACIDS RES, V42, P14042, DOI 10.1093/nar/gku1248; JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Lee KM, 2013, NUCLEIC ACIDS RES, V41, P8776, DOI 10.1093/nar/gkt636; Li XP, 2020, ACS INFECT DIS, V6, P1894, DOI 10.1021/acsinfecdis.0c00127; Li XP, 2018, TOXINS, V10, DOI 10.3390/toxins10090371; Li XP, 2017, TOXINS, V9, DOI 10.3390/toxins9040133; Li XP, 2013, J BIOL CHEM, V288, P30270, DOI 10.1074/jbc.M113.510966; Li XP, 2009, BIOCHEMISTRY-US, V48, P3853, DOI 10.1021/bi802371h; LINGWOOD CA, 1987, J BIOL CHEM, V262, P8834; May KL, 2013, TOXICON, V69, P143, DOI 10.1016/j.toxicon.2013.02.001; McCluskey AJ, 2008, J MOL BIOL, V378, P375, DOI 10.1016/j.jmb.2008.02.014; McCluskey AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031191; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mochizuki M, 2012, GENES CELLS, V17, P273, DOI 10.1111/j.1365-2443.2012.01586.x; Murakami R, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00067-18; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nomura N, 2012, P NATL ACAD SCI USA, V109, P3748, DOI 10.1073/pnas.1112934109; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PICKERING LK, 1994, PEDIATR INFECT DIS J, V13, P459, DOI 10.1097/00006454-199406000-00001; Shi WW, 2016, TOXINS, V8, DOI 10.3390/toxins8100296; Siegler R, 2005, CURR OPIN PEDIATR, V17, P200, DOI 10.1097/01.mop.0000152997.66070.e9; Siegler RL, 2003, PEDIATR NEPHROL, V18, P92, DOI 10.1007/s00467-002-1035-7; Spooner RA, 2012, CURR TOP MICROBIOL, V357, P19, DOI 10.1007/82_2011_154; Stahl AL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004619; Suh JK, 1998, BIOCHEMISTRY-US, V37, P9394, DOI 10.1021/bi980424u; Tanzawa T, 2018, NUCLEIC ACIDS RES, V46, P3232, DOI 10.1093/nar/gky115; Tchorzewski M, 2002, INT J BIOCHEM CELL B, V34, P911, DOI 10.1016/S1357-2725(02)00012-2; Too PHM, 2009, NUCLEIC ACIDS RES, V37, P602, DOI 10.1093/nar/gkn922; von Seidlein L, 2006, PLOS MED, V3, P1556, DOI 10.1371/journal.pmed.0030353; WADDELL T, 1988, BIOCHEM BIOPH RES CO, V152, P674, DOI 10.1016/S0006-291X(88)80091-3; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wong YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049608; Yang YH, 2010, J MOL BIOL, V395, P897, DOI 10.1016/j.jmb.2009.10.051; Zhou YJ, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20192022; Zhou YJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42912	54	4	4	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2020	295	46					15588	15596		10.1074/jbc.AC120.015070	http://dx.doi.org/10.1074/jbc.AC120.015070			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OY6NO	32878986	Green Published, hybrid			2022-12-26	WOS:000594361600014
J	Long, RB; Krumlauf, K; Young, AM				Long, Rachel B.; Krumlauf, Kristi; Young, Anna M.			Characterizing trends in human-wildlife conflicts in the American Midwest using wildlife rehabilitation records	PLOS ONE			English	Article							COTTONTAIL RABBITS; CANINE-DISTEMPER; RISK-FACTORS; HOME-RANGE; MORTALITY; TERRESTRIAL; ECOLOGY; SURVEILLANCE; POPULATIONS; MORBIDITY	Human-wildlife conflict is difficult to measure, but the analysis of records from wildlife rehabilitation facilities has shown potential as a technique for characterizing human impacts on wildlife. To examine the value of wildlife rehabilitation records for characterizing local human-wildlife conflicts and prevalence of select wildlife diseases, we reviewed 45,668 records representing over 280 species admitted to a wildlife rehabilitation facility over a 10-year period (2005-2014). We identified the most frequently recorded causes of admission for commonly admitted species, and evaluated how causes of admission may vary across taxa throughout the year. Our analyses support the value of wildlife rehabilitation facility data for characterizing some pressures from human-wildlife conflict and select disease trends for certain taxa, as well as utility for informing topics to emphasize in local conservation education efforts. For example, orphaned neonatal wildlife accounted for the largest proportion of admissions to this facility, and highlights a opportunity for conservation education regarding when wildlife is truly orphaned and requires professional intervention. Additionally, domestic dog attack cases accounted for a proportion of admissions comparable to that of domestic cat attacks, demonstrating a need for the conversation surrounding the impact of domestic pets on local wildlife to expand to include dogs in addition to cats.	[Long, Rachel B.; Young, Anna M.] Otterbein Univ, Dept Biol & Earth Sci, Westerville, OH 43081 USA; [Krumlauf, Kristi] Ohio Wildlife Ctr, Columbus, OH USA; [Long, Rachel B.] Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA	Otterbein University; University System of Ohio; Ohio State University	Long, RB (corresponding author), Otterbein Univ, Dept Biol & Earth Sci, Westerville, OH 43081 USA.; Long, RB (corresponding author), Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA.	long.1742@osu.edu		Long, Rachel/0000-0003-0426-6669; Young, Anna/0000-0003-3321-1878	Otterbein University Vernon L. Pack Community Service Research Fellowship; Otterbein University Student Research Fund; Otterbein University Faculty Scholarship Development Committee	Otterbein University Vernon L. Pack Community Service Research Fellowship; Otterbein University Student Research Fund; Otterbein University Faculty Scholarship Development Committee	This study was funded by the Otterbein University Vernon L. Pack Community Service Research Fellowship (awarded to RBL), the Otterbein University Student Research Fund (awarded to RBL), and the Otterbein University Faculty Scholarship Development Committee (awarded to AY). https://www.otterbein.edu/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Molina-Lopez RA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181331; Anis E, 2020, J ZOO WILDLIFE MED, V50, P790, DOI 10.1638/2019-0052; [Anonymous], 2017, J ONCOL PRACT, V13, pe353; [Anonymous], 2020, CANC DISCOV, V10, pOF8; Aresco MJ, 2005, J WILDLIFE MANAGE, V69, P549, DOI 10.2193/0022-541X(2005)069[0549:MMTRHM]2.0.CO;2; Arzel C, 2006, J ORNITHOL, V147, P167, DOI 10.1007/s10336-006-0054-8; Beckerman AP, 2007, ANIM CONSERV, V10, P320, DOI 10.1111/j.1469-1795.2007.00115.x; Bond BT, 2001, J WILDLIFE MANAGE, V65, P1004, DOI 10.2307/3803049; British Wildlife Rehabilitation Council, FIND REH, P1; Brown JD, 2002, J WILDLIFE DIS, V38, P699, DOI 10.7589/0090-3558-38.4.699; Burke RL, 2011, CHELONIAN CONSERV BI, V10, P256, DOI 10.2744/CCB-0855.1; Burton D.L., 2004, P 4 INT URB WILDL S, P171; Chomel BB, 2007, EMERG INFECT DIS, V13, P6, DOI 10.3201/eid1301.060480; Clevenger AP, 2003, BIOL CONSERV, V109, P15, DOI 10.1016/S0006-3207(02)00127-1; Collins C, 2011, ANIM CONSERV, V14, P474, DOI 10.1111/j.1469-1795.2011.00458.x; Deem SL, 2000, J ZOO WILDLIFE MED, V31, P441, DOI 10.1638/1042-7260(2000)031[0441:CDITCA]2.0.CO;2; Deem SL, 1998, J ZOO WILDLIFE MED, V29, P160; Glista DJ, 2008, HERPETOL CONSERV BIO, V3, P77; Glista DJ, 2009, LANDSCAPE URBAN PLAN, V91, P1, DOI 10.1016/j.landurbplan.2008.11.001; Gnat S, 2015, LETT APPL MICROBIOL, V61, P446, DOI 10.1111/lam.12471; Grogan A, 2013, VET REC OPEN, V172; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hughes J, 2013, BIOL CONSERV, V157, P341, DOI 10.1016/j.biocon.2012.07.005; Jacques CN, 2009, J WILDLIFE MANAGE, V73, P1282, DOI 10.2193/2009-039; Kelly TR, 2014, CONSERV BIOL, V28, P1721, DOI 10.1111/cobi.12342; Klem D, 2009, WILSON J ORNITHOL, V121, P126, DOI 10.1676/08-068.1; Le Souef A, 2015, J WILDLIFE DIS, V51, P380, DOI 10.7589/2014-08-203; Lednicky JA, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-2; Loss Scott R., 2013, NATURE COMMUNICATION, V4; Loyd KAT, 2017, WILDLIFE SOC B, V41, P55, DOI 10.1002/wsb.737; Malecki RA, 2001, J WILDLIFE MANAGE, V65, P242, DOI 10.2307/3802903; Marchini S., 2014, APPL ECOLOGY HUMAN D, P189, DOI DOI 10.1007/978-3-642-54751-5_13; Mcruer DL, 2017, J WILDLIFE MANAGE, V81, P163, DOI 10.1002/jwmg.21181; Messmer TA, 2000, INT BIODETER BIODEGR, V45, P97, DOI 10.1016/S0964-8305(00)00045-7; Molina-Lopez RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060242; Molina-Lopez RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024603; Moyers SC, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0090; Mullineaux E, 2014, J SMALL ANIM PRACT, V55, P293, DOI 10.1111/jsap.12213; Ohio Department of Health, 2018, AN RAB TABL MAPS OH; Ohio Department of Transportation, 2015, TRAFF MON ANN COMP F; Ohio Division of Wildlife, 2020, 2020 2021 PERM WILDL; Ohio Division of Wildlife, 2020, DIS WILDL CONJ BIRDS; Randall NJ, 2012, J WILDLIFE DIS, V48, P646, DOI 10.7589/0090-3558-48.3.646; Ryser-Degiorgis MP, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-223; SPALDING MG, 1993, J ZOO WILDLIFE MED, V24, P271; Stallknecht DE, 2007, CURR TOP MICROBIOL, V315, P445; Stitt T, 2007, CAN VET J, V48, P83; Taylor-Brown A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0206958; Townsend JM, 2013, ECOL INDIC, V34, P168, DOI 10.1016/j.ecolind.2013.04.017; TRENT TT, 1974, J WILDLIFE MANAGE, V38, P459, DOI 10.2307/3800877; Tribe Andrew, 2000, Human Dimensions of Wildlife, V5, P69; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Wimberger K, 2010, ANIM WELFARE, V19, P501; Young JK, 2011, BIOSCIENCE, V61, P125, DOI 10.1525/bio.2011.61.2.7	54	8	8	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238805	10.1371/journal.pone.0238805	http://dx.doi.org/10.1371/journal.pone.0238805			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915855	gold, Green Published			2022-12-26	WOS:000571887500021
J	Moustaqim-Barrette, A; Papamihali, K; Mamdani, Z; Williams, S; Buxton, JA				Moustaqim-Barrette, Amina; Papamihali, Kristi; Mamdani, Zahra; Williams, Sierra; Buxton, Jane A.			Accessing Take-Home Naloxone in British Columbia and the role of community pharmacies: Results from the analysis of administrative data	PLOS ONE			English	Article							OPIOID OVERDOSE; PROGRAM	Introduction British Columbia's (BC) Take-Home Naloxone (THN) program provides naloxone to bystanders for use in cases of suspected opioid overdose. This study seeks to provide trends and analysis from the provincial BC THN program since inception in 2012 to the end of 2018. Materials and methods BC THN shipment and distribution records from 2012-2018 were retrieved. Frequency distributions were used to describe characteristics of individuals accessing the program. To evaluate correlates of distribution after the addition of hundreds of pharmacy distribution sites, an analytic sample was limited to records from 2018, and multivariate logistic regression was used to evaluate correlates of collecting naloxone at a pharmacy site. Results Since program inception to the end of 2018, there were 398,167 naloxone kits shipped to distribution sites, 149,999 kits reported distributed, and 40,903 kits reported used to reverse an overdose in BC. There was a significant increasing trend in the number of naloxone kits used to reverse an overdose over time (p<0.01), and more than 90% of kits that were reported used were distributed to persons at risk of an overdose. Individuals not personally at risk of overdose had higher odds of collecting naloxone at a pharmacy site, compared to other community sites (including harm reduction supply distribution sites, peer led organizations, drop-in centers, and supportive housing sites) (Adjusted Odds Ratio (AOR): 2.69; 95% CI: 2.50-2.90). Conclusions This study documents thousands of opioid overdose reversals facilitated through the BC THN program. While those at highest risk of overdose may preferentially access naloxone through community sites, naloxone distribution through pharmacies has allowed the BC THN program to expand dramatically, increasing naloxone availability through longer opening hours on evenings and weekends. and in rural and remote regions. A diversity of naloxone distribution sites and strategies is crucial to prevent rising opioid overdose deaths.	[Moustaqim-Barrette, Amina; Papamihali, Kristi; Mamdani, Zahra; Williams, Sierra; Buxton, Jane A.] BC Ctr Dis Control, Vancouver, BC, Canada; [Buxton, Jane A.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada	University of British Columbia	Buxton, JA (corresponding author), BC Ctr Dis Control, Vancouver, BC, Canada.; Buxton, JA (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.	jane.buxton@bccdc.ca		Moustaqim-Barrette, Amina/0000-0003-1601-1604; Mamdani, Zahra/0000-0002-3158-9618; Williams, Sierra/0000-0002-1094-7324	British Columbia Ministry of Health; Canadian Research Initiative in Substance Misuse (CRISM); Canadian Institute of Health Research (CIHR)	British Columbia Ministry of Health; Canadian Research Initiative in Substance Misuse (CRISM); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	The BC THN program is made possible with funding from the British Columbia Ministry of Health. Author AMB is supported by the Canadian Research Initiative in Substance Misuse (CRISM) and the Canadian Institute of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amina Moustaqim-Barrette, 2019, TAKE HOME NALOXONE R, P33; Amina Moustaqim-Barrette Tara Elton-Marshall, 2019, ENV SCAN NALOXONE AC; Andrea Woo, 2020, VIRUS MEASURES MAY B; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; [Anonymous], 2017, TRANSFUSION, V57, p3A; BC Centre for Disease Control, 2020, TRAIN RES; BC Centre on Substance Use (BCCSU), 2020, COVID 19 INF OP AG T; BC Coroners Service, ILL DRUG TOX DEATHS; Boyer EW, 2012, NEW ENGL J MED, V367, P146, DOI 10.1056/NEJMra1202561; Bozat-Emre S, 2018, HEALTH PROMOT CHRON, V38, P252, DOI 10.24095/hpcdp.38.6.06; Canada H, 2020, EX PRACT PHARM PRESC; Choremis B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223589; Coroners Service BC, 2019, ILL DRUG OV DEATHS B; Coroners Service of BC, 2020, ILL DRUG TOX DEATHS; Freeman LK, 2017, CAN J PUBLIC HEALTH, V108, pE398, DOI [10.17269/cjph.108.5989, 10.17269/CJPH.108.5989]; Health Canada, 2018, OV NAT DAT OP REL HA; Hosmer DW, 2013, WILEY SER PROBAB ST, P89; Irvine MA, 2019, ADDICTION, V114, P1602, DOI 10.1111/add.14664; Irvine MA, 2018, LANCET PUBLIC HEALTH, V3, pE218, DOI 10.1016/S2468-2667(18)30044-6; Kim HK, 2015, EXPERT OPIN DRUG SAF, V14, P1137, DOI 10.1517/14740338.2015.1037274; Leece PN, 2013, CAN J PUBLIC HEALTH, V104, pE200, DOI 10.17269/cjph.104.3788; Lindsay Bethany, 2020, CBC NEWS; McDonald R, 2016, ADDICTION, V111, P1177, DOI 10.1111/add.13326; Ministry of Health, CURR HLTH TOP PROV B; Pearce LA, 2019, INT J PRISON HEALTH, V15, P46, DOI 10.1108/IJPH-12-2017-0058; The R Foundation, 2019, R R PROJ STAT COMP; World Health Organization (WHO), 2020, WHO ANNOUNCES COVID; Zahra Mamdani, 2019, EVALUATION BRIT COLU; Zaller ND, 2013, SUBST USE MISUSE, V48, P590, DOI 10.3109/10826084.2013.793355; Zhang ZH, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.02.15	30	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238618	10.1371/journal.pone.0238618	http://dx.doi.org/10.1371/journal.pone.0238618			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9MU	32915834	gold, Green Published			2022-12-26	WOS:000571887500039
J	Pan, CP; Wang, YQ; Tao, L; Zhang, H; Deng, QX; Yang, ZW; Chi, ZH; Yang, YM				Pan, Cuiping; Wang, Yongqing; Tao, Lian; Zhang, Hui; Deng, Qunxian; Yang, Zhiwu; Chi, Zhuoheng; Yang, Yunmiao			Single-molecule real-time sequencing of the full-length transcriptome of loquat under low-temperature stress	PLOS ONE			English	Article							ERIOBOTRYA-JAPONICA LINDL.; SUGAR METABOLISM; RNA-SEQ; PROTEIN; DATABASE; TOOL; GENERATION; PROGRAM; FRUIT	In this study, third-generation full-length (FL) transcriptome sequencing was performed of loquat using single-molecule real-time(SMRT) sequencing from the pooled cDNA of embryos of young loquat fruit under different low temperatures (three biological replicates for treatments of 1 degrees C, -1 degrees C, and -3 degrees C, for 12 h or 24 h) and the control group(three biological replicates for treatments of room temperature), Illumina sequencing was used to correct FL transcriptome sequences. A total of 3 PacBio Iso-Seq libraries (1-2 kb, 2-3 kb and 3-6 kb) and 21 Illumina transcriptome libraries were constructed, a total of 13.41 Gb of clean reads were generated, which included 215,636 reads of insert (ROIs) and 121,654 FL, non-chimaric (FLNC) reads. Transcript clustering analysis of the FLNC reads revealed 76,586 consensus isoforms, and a total of 12,520 high-quality transcript sequences corrected with non-FL sequences were used for subsequent analysis. After the redundant reads were removed, 38,435 transcripts were obtained. A total of 27,905 coding DNA sequences (CDSs) were identified, and 407 long non-coding RNAs (lncRNAs) were ultimately predicted. Additionally, 24,832 simple sequence repeats (SSRs) were identified, and a total of 1,295 alternative splicing (AS) events were predicted. Furthermore, 37,993 transcripts were annotated in eight functional databases. This is the first study to perform SMRT sequencing of the FL transcriptome of loquat. The obtained transcriptomic data are conducive for further exploration of the mechanism of loquat freezing injury and thus serve as an important theoretical basis for generating new loquat material and for identifying new ways to improve loquat cold resistance.	[Pan, Cuiping; Wang, Yongqing; Zhang, Hui; Deng, Qunxian; Yang, Zhiwu; Chi, Zhuoheng; Yang, Yunmiao] Sichuan Agr Univ, Coll Hort, Wenjiang, Sichuan, Peoples R China; [Tao, Lian] Sichuan Acad Agr Sci, Hort Inst, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Academy of Agricultural Sciences (SAAS)	Wang, YQ (corresponding author), Sichuan Agr Univ, Coll Hort, Wenjiang, Sichuan, Peoples R China.	yqw14@sicau.edu.cn						Abdel-Ghany SE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11706; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bayega A, 2018, METHODS MOL BIOL, V1783, P121, DOI 10.1007/978-1-4939-7834-2_6; Bush SJ, 2018, GENET SEL EVOL, V50, DOI 10.1186/s12711-018-0391-0; Cao SF, 2013, FOOD CHEM, V136, P139, DOI 10.1016/j.foodchem.2012.07.113; Chao Q, 2019, PLANT BIOTECHNOL J, V17, P206, DOI 10.1111/pbi.12958; Cui J, 2020, PHYTOPATHOLOGY, V110, P456, DOI 10.1094/PHYTO-04-19-0137-R; Cui J, 2017, PLANT J, V89, P577, DOI 10.1111/tpj.13408; [邓泱泱 DENG Yangyang], 2006, [计算机工程, Computer Engineering], V32, P71; Ding JH, 2012, P NATL ACAD SCI USA, V109, P2654, DOI 10.1073/pnas.1121374109; Ding N, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1179-z; Dufresne F, 2014, MOL ECOL, V23, P40, DOI 10.1111/mec.12581; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gong R, 2015, GENET MOL RES, V14, P9423, DOI 10.4238/2015.August.14.6; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hadjipieri M, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1041-3; Hong M, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9120874; Jiang SA, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01924; Jing DL, 2020, PHYSIOL PLANTARUM, V168, P893, DOI 10.1111/ppl.13029; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Li Guifen, 2016, Horticultural Plant Journal, V2, P315, DOI 10.1016/j.hpj.2017.02.001; Li KQ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184646; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin SK, 2018, GENES-BASEL, V9, DOI 10.3390/genes9120639; Liu C, 2019, SCI HORTIC-AMSTERDAM, V246, P328, DOI 10.1016/j.scienta.2018.10.068; Liu C, 2018, GENOME, V61, P437, DOI 10.1139/gen-2017-0232; Liu HL, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5442-6; Liu WX, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00026; Liu XX, 2017, MOL ECOL RESOUR, V17, P1243, DOI 10.1111/1755-0998.12670; Papadakis IE, 2018, J PLANT PHYSIOL, V231, P337, DOI 10.1016/j.jplph.2018.10.012; Pegueroles C, 2019, RNA BIOL, V16, P320, DOI 10.1080/15476286.2019.1572438; Rhoads A, 2015, GENOM PROTEOM BIOINF, V13, P278, DOI 10.1016/j.gpb.2015.08.002; Severing E, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1362-x; Shin SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068824; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Song HW, 2017, FOOD CHEM, V232, P434, DOI 10.1016/j.foodchem.2017.04.045; Song HW, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111837; Spannagl M, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-35; Su WB, 2017, SCI HORTIC-AMSTERDAM, V224, P142, DOI 10.1016/j.scienta.2017.06.012; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Wang B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11708; Wang L, 2020, FOOD CHEM, V315, DOI 10.1016/j.foodchem.2020.126295; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Wang MJ, 2018, NEW PHYTOL, V217, P163, DOI 10.1111/nph.14762; Wang SH, 2017, SCI HORTIC-AMSTERDAM, V218, P48, DOI 10.1016/j.scienta.2017.02.002; Wang TT, 2017, PLANT J, V91, P684, DOI 10.1111/tpj.13597; Wang YQ, 2014, P NATL ACAD SCI USA, V111, P10359, DOI 10.1073/pnas.1409457111; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Workman RE, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy009; Wu HW, 2018, NEW PHYTOL, V219, P1480, DOI 10.1111/nph.15231; Xu HX, 2017, J PLANT RES, V130, P893, DOI 10.1007/s10265-017-0942-4; Xu HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087575; Yang Q, 2011, J HORTIC SCI BIOTECH, V86, P221, DOI 10.1080/14620316.2011.11512751; Zeng DG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35066-3; Zhao XY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07500-7; Zheng Y, 2016, MOL PLANT, V9, P1667, DOI 10.1016/j.molp.2016.09.014	61	5	5	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238942	10.1371/journal.pone.0238942	http://dx.doi.org/10.1371/journal.pone.0238942			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915882	gold, Green Published			2022-12-26	WOS:000571887500146
J	Soubeyrand, S; Ribaud, M; Baudrot, V; Allard, D; Pommeret, D; Roques, L				Soubeyrand, Samuel; Ribaud, Melina; Baudrot, Virgile; Allard, Denis; Pommeret, Denys; Roques, Lionel			COVID-19 mortality dynamics: The future modelled as a (mixture of) past(s)	PLOS ONE			English	Article								Discrepancies in population structures, decision making, health systems and numerous other factors result in various COVID-19-mortality dynamics at country scale, and make the forecast of deaths in a country under focus challenging. However, mortality dynamics of countries that are ahead of time implicitly include these factors and can be used as real-life competing predicting models. We precisely propose such a data-driven approach implemented in a publicly available web app timely providing mortality curves comparisons and real-time short-term forecasts for about 100 countries. Here, the approach is applied to compare the mortality trajectories of second-line and front-line European countries facing the COVID-19 epidemic wave. Using data up to mid-April, we show that the second-line countries generally followed relatively mild mortality curves rather than fast and severe ones. Thus, the continuation, after mid-April, of the COVID-19 wave across Europe was likely to be mitigated and not as strong as it was in most of the front-line countries first impacted by the wave (this prediction is corroborated by posterior data).	[Soubeyrand, Samuel; Ribaud, Melina; Baudrot, Virgile; Allard, Denis; Roques, Lionel] INRAE, BioSP, Avignon, France; [Pommeret, Denys] Univ Lyon, ISFA LSAF EA2429, UCBL, Lyon, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Soubeyrand, S (corresponding author), INRAE, BioSP, Avignon, France.	samuel.soubeyrand@inra.fr		Roques, Lionel/0000-0001-6647-7221; Soubeyrand, Samuel/0000-0003-2447-3067				Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Hu Z., 2020, ARXIV2020200207112; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Li CL, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.10.2000199; Liu ZH, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9030050; Maier BF, 2020, SCIENCE, V368, P742, DOI 10.1126/science.abb4557; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9; Roques L, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00274; Roques L, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9050097; Sebastiani G, 2020, EUR J EPIDEMIOL, V35, P341, DOI 10.1007/s10654-020-00631-6; Spiteri G, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.9.2000178; Zeng Tianyu., 2020, 200204945 ARXIV	13	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238410	10.1371/journal.pone.0238410	http://dx.doi.org/10.1371/journal.pone.0238410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915815	Green Published, gold			2022-12-26	WOS:000571887500130
J	Yamasaki, C; Ishida, Y; Yanagi, A; Yoshizane, Y; Kojima, Y; Ogawa, Y; Kageyama, Y; Iwasaki, Y; Ishida, S; Chayama, K; Tateno, C				Yamasaki, Chihiro; Ishida, Yuji; Yanagi, Ami; Yoshizane, Yasumi; Kojima, Yuha; Ogawa, Yuko; Kageyama, Yutaka; Iwasaki, Yumiko; Ishida, Seiichi; Chayama, Kazuaki; Tateno, Chise			Culture density contributes to hepatic functions of fresh human hepatocytes isolated from chimeric mice with humanized livers: Novel, long-term, functional two-dimensionalin vitrotool for developing new drugs	PLOS ONE			English	Article							CONSTITUTIVE ANDROSTANE RECEPTOR; PREGNANE-X-RECEPTOR; IN-VITRO EVALUATION; ACTIVATED RECEPTOR; CYP2B6 GENE; C VIRUS; DIFFERENTIAL REGULATION; ENHANCER MODULE; MOUSE; CYTOCHROME-P450	Chimeric mice with humanized livers are considered a useful animal model for predicting human (h-) drug metabolism and toxicity. In this study, the characteristics of fresh h-hepatocytes (cFHHs, PXB-cells(R)) isolated from chimeric mice (PXB-mice(R)) were evaluatedin vitroto confirm their utility for drug development. cFHHs cultured at high density (2.13 x 10(5)cells/cm(2)) displayed stable production of h-albumin and cytochrome P450 (CYP) 3A activities for at least 21 days. The mRNA expression levels of 10 of 13 CYP, UDP-glucuronosyltransferase (UGT), and transporters were maintained at >10% of the levels of freshly isolated cFHHs after 21 days. From 1 week, many bile canaliculi were observed between cFHHs, and the accumulation of the multidrug resistance-associated protein and bile salt export pump substrates in these bile canaliculi was clearly inhibited by cyclosporin A. Microarray analysis of cFHHs cultured at high density and at low density (0.53 x 10(5)cells/cm(2)) revealed that high density culture maintained high expressions of some transcription factors (HNF4 alpha, PXR, and FXR) perhaps involved in the high CYP, UGT and transporter gene expressions of cFHHs. These results strongly suggest that cFHHs could be a novelin vitrotool for drug development studies.	[Yamasaki, Chihiro; Ishida, Yuji; Yanagi, Ami; Yoshizane, Yasumi; Kojima, Yuha; Ogawa, Yuko; Kageyama, Yutaka; Iwasaki, Yumiko; Tateno, Chise] PhoenixBio Co Ltd, Higashihiroshima, Hiroshima, Japan; [Ishida, Yuji; Tateno, Chise] Hiroshima Univ, Res Ctr Hepatol & Gastroenterol, Hiroshima, Japan; [Ishida, Seiichi] Natl Inst Hlth Sci, Dept Pharmacol, Kawasaki, Kanagawa, Japan; [Chayama, Kazuaki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Metab, Appl Life Sci, Higashihiroshima, Hiroshima, Japan; [Ishida, Seiichi] Sojo Univ, Fac Biotechnol & Life Sci, Kumamoto, Japan	PHOENIXBIO CO. LTD.; Hiroshima University; National Institute of Health Sciences - Japan; Hiroshima University; Sojo University	Tateno, C (corresponding author), PhoenixBio Co Ltd, Higashihiroshima, Hiroshima, Japan.; Tateno, C (corresponding author), Hiroshima Univ, Res Ctr Hepatol & Gastroenterol, Hiroshima, Japan.	chise.mukaidani@phoenixbio.co.jp		Chayama, Kazuaki/0000-0002-5530-5341	Research on Development of New Drugs from Japan's Agency for Medical Research and Development, AMED	Research on Development of New Drugs from Japan's Agency for Medical Research and Development, AMED	This research was supported by the Research on Development of New Drugs from Japan's Agency for Medical Research and Development, AMED. PhoenixBio Co., Ltd. also provided support for this study in the form of salaries for: CY, YI, AY, YY, YK, YO, YK, YI, CT. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, AM J PHYSIOL-CELL PH, V277, pC1; [Anonymous], 2014, INT J AMBIENT SYST A, V2, P11, DOI DOI 10.5121/IJASA.2014.2402; [Anonymous], 2013, J IND ECOL, V22, P23; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Bell CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep25187; Benet M, 2010, J BIOL CHEM, V285, P28457, DOI 10.1074/jbc.M110.118364; Burk O, 2004, J BIOL CHEM, V279, P38379, DOI 10.1074/jbc.M404949200; Cairns W, 1996, J BIOL CHEM, V271, P25269, DOI 10.1074/jbc.271.41.25269; Chan TS, 2013, DRUG METAB DISPOS, V41, P2024, DOI 10.1124/dmd.113.053397; Chen YP, 2005, J PHARMACOL EXP THER, V314, P1125, DOI 10.1124/jpet.105.087072; Corchero J, 2001, MOL PHARMACOL, V60, P1260, DOI 10.1124/mol.60.6.1260; CUNHA GR, 1984, STAIN TECHNOL, V59, P7, DOI 10.3109/10520298409113823; Ding X, 2006, J BIOL CHEM, V281, P26540, DOI 10.1074/jbc.M600931200; DUNN JCY, 1989, FASEB J, V3, P174, DOI 10.1096/fasebj.3.2.2914628; Faucette SR, 2006, J PHARMACOL EXP THER, V317, P1200, DOI 10.1124/jpet.105.098160; Foster JR, 2012, TOXICOL PATHOL, V40, P1106, DOI 10.1177/0192623312447542; Godoy P, 2013, ARCH TOXICOL, V87, P1315, DOI 10.1007/s00204-013-1078-5; Gomez-Lechon MJ, 2010, CURR PHARM DESIGN, V16, P1963, DOI 10.2174/138161210791208910; Goodwin B, 2001, MOL PHARMACOL, V60, P427; GRANT MH, 1987, BIOCHEM PHARMACOL, V36, P2311, DOI 10.1016/0006-2952(87)90596-X; Greuet J, 1997, HEPATOLOGY, V25, P1166, DOI 10.1002/hep.510250520; Hasegawa M, 2012, DRUG METAB DISPOS, V40, P474, DOI 10.1124/dmd.111.042754; Hasegawa M, 2011, BIOCHEM BIOPH RES CO, V405, P405, DOI 10.1016/j.bbrc.2011.01.042; Hengstler JG, 2000, DRUG METAB REV, V32, P81, DOI 10.1081/DMR-100100564; Hewitt NJ, 2007, DRUG METAB REV, V39, P159, DOI 10.1080/03602530601093489; Hiraga N, 2007, FEBS LETT, V581, P1983, DOI 10.1016/j.febslet.2007.04.021; IBEANU GC, 1995, BIOCHEMISTRY-US, V34, P8028, DOI 10.1021/bi00025a008; Ishida Y, 2015, AM J PATHOL, V185, P1275, DOI 10.1016/j.ajpath.2015.01.028; Jigorel E, 2006, DRUG METAB DISPOS, V34, P1756, DOI 10.1124/dmd.106.010033; Gomez-Lechon MJ, 2010, METHODS MOL BIOL, V640, P389, DOI 10.1007/978-1-60761-688-7_21; Jover R, 2001, HEPATOLOGY, V33, P668, DOI 10.1053/jhep.2001.22176; Kakuni M, 2014, INT J MOL SCI, V15, P58, DOI 10.3390/ijms15010058; Kakuni M, 2012, TOXICOL LETT, V214, P9, DOI 10.1016/j.toxlet.2012.08.001; Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200; Kimura T, 2008, J GEN VIROL, V89, P2108, DOI 10.1099/vir.0.83658-0; Laemmle A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153358; Le Vee M, 2006, EUR J PHARM SCI, V28, P109, DOI 10.1016/j.ejps.2006.01.004; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Miyamoto M, 2019, XENOBIOTICA, V49, P1379, DOI 10.1080/00498254.2019.1579394; Nakazawa K, 2010, BIOCHEM ENG J, V53, P85, DOI 10.1016/j.bej.2010.09.013; Nishimura M, 2003, BIOL PHARM BULL, V26, P1052; Ohtsuki S, 2014, DRUG METAB DISPOS, V42, P1039, DOI 10.1124/dmd.114.057646; Oscarson M, 2006, CLIN PHARMACOL THER, V80, P440, DOI 10.1016/j.clpt.2006.08.013; Saini SPS, 2005, HEPATOLOGY, V41, P497, DOI 10.1002/hep.20570; Sanoh S, 2015, XENOBIOTICA, V45, P605, DOI 10.3109/00498254.2015.1007112; Sanoh S, 2012, DRUG METAB DISPOS, V40, P322, DOI 10.1124/dmd.111.040923; Schwabedissen HEMZ, 2010, HEPATOLOGY, V52, P1797, DOI 10.1002/hep.23876; Schwabedissen HEMZ, 2009, MOL PHARMACEUT, V6, P1644, DOI 10.1021/mp9000298; Smetanina MA, 2011, TOXICOL APPL PHARM, V255, P76, DOI 10.1016/j.taap.2011.05.019; Soars MG, 2007, CHEM-BIOL INTERACT, V168, P2, DOI 10.1016/j.cbi.2006.11.002; Steinberg P, 1999, DRUG METAB DISPOS, V27, P1415; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Sugatani J, 2001, HEPATOLOGY, V33, P1232, DOI 10.1053/jhep.2001.24172; TANAKA K, 1978, J BIOCHEM-TOKYO, V84, P937, DOI 10.1093/oxfordjournals.jbchem.a132207; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; Tateno C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142145; Tateno C, 2013, LAB INVEST, V93, P54, DOI 10.1038/labinvest.2012.158; Tirona RG, 2003, NAT MED, V9, P220, DOI 10.1038/nm815; Tsuge M, 2005, HEPATOLOGY, V42, P1046, DOI 10.1002/hep.20892; Wang HY, 2003, J BIOL CHEM, V278, P31547, DOI 10.1074/jbc.M212532200; Watari R, 2018, J TOXICOL SCI, V43, P521, DOI 10.2131/jts.43.521; Wilkening S, 2003, DRUG METAB DISPOS, V31, P1035, DOI 10.1124/dmd.31.8.1035; Yamada T, 2014, TOXICOL SCI, V142, P137, DOI 10.1093/toxsci/kfu173; Yamasaki C, 2006, J HEPATOL, V44, P749, DOI 10.1016/j.jhep.2005.10.028; Yamasaki C, 2010, DRUG METAB PHARMACOK, V25, P539, DOI 10.2133/dmpk.DMPK-10-RG-047; Yang X, 2010, GENOME RES, V20, P1020, DOI 10.1101/gr.103341.109	66	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0237809	10.1371/journal.pone.0237809	http://dx.doi.org/10.1371/journal.pone.0237809			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915792	Green Published, gold			2022-12-26	WOS:000571887500061
J	Ho, BK; Omar, MA; Sooryanarayana, R; Ghazali, SS; Abidin, SBIZ; Krishnapillai, A; Ariaratnam, S; Tohit, NM; Majid, NLBA; Yusof, MFB				Ho, Bee Kiau; Omar, Mohd Azahadi; Sooryanarayana, Rajini; Ghazali, Sazlina Shariff; Abidin, Sheleaswani bte Inche Zainal; Krishnapillai, Ambigga; Ariaratnam, Suthahar; Tohit, Noorlaili Mohd; Majid, Nur Liana bt Abdul; Yusof, Muhammad Fadhli bin Mohd			Trends in population blood pressure and prevalence, awareness, treatment and control of hypertension among older persons: The 2006 & 2015 National Health and Morbidity Survey in Malaysia	PLOS ONE			English	Article							US ADULTS; URBAN	Background Hypertension is one of the most important risk factors for cardiovascular diseases. Thus, it is an important public health challenge worldwide. In Malaysia, only a few studies have focused on the trends of hypertension specifically for the aging population. In view of the rapid growth of the elderly population in Malaysia, there is an urgent need to explore the condition of hypertension in this aging population. Hence, the objectives of this study were to determine the trends of population mean systolic and diastolic blood pressure (BP) levels, the prevalence, awareness, treatment and control of hypertension, and its' associated factors among older persons in two cross-sectional national surveys that were conducted in 2006 and 2015 in Malaysia. Methods This was a subanalysis of secondary data collected from the two cross-sectional national population-based surveys conducted in Malaysia in 2006 and 2015. Adults aged 60 and older who had participated in these two surveys were included in the study. Results A total of 4954 (2295 males and 2659 females) and 3790 (1771 males and 2019 females) respondents completed the hypertension module surveys in 2006 and 2015, respectively. The mean age of the respondents was 68.5 +/- 6.9 years in 2006 and 68.6 +/- 7.1 years in 2015 and the difference was not significant. The prevalence of hypertension significantly reduced from 73.8% in 2006 to 69.2% in 2015 (p<0.001). Among the respondents with hypertension, the awareness, treatment and control of hypertension significantly increased from 49.7% to 60.2%, 86.7% to 91.5% and 23.3% to 44.8%, respectively, from 2006 to 2015. Logistic regression analysis showed that female sex and unemployed/retiree were significantly associated with higher hypertension prevalence in both 2006 and 2015. Being unemployed/ retiree was significantly associated with higher awareness of hypertension in both 2006 and 2015. In both 2006 and 2015, Chinese ethnicity were significantly associated with higher awareness and control of hypertension. Conclusions The mean population BP levels and hypertension prevalence among the elderly population in Malaysia have reduced significantly over the past decade. Although the awareness, treatment and control of hypertension among older adults have improved significantly, the awareness and control rates remain suboptimal. As population aging is inevitable, appropriate public health programs and optimal treatment strategies targeting this vulnerable group are urgently needed to improve the overall awareness and control of hypertension and to prevent hypertension-related complications.	[Ho, Bee Kiau] Bandar Bot Hlth Ctr, Klang, Selangor, Malaysia; [Omar, Mohd Azahadi; Majid, Nur Liana bt Abdul; Yusof, Muhammad Fadhli bin Mohd] Natl Inst Hlth, Sect Biostat & Data Repository, Minist Hlth Malaysia, Shah Alam, Selangor, Malaysia; [Sooryanarayana, Rajini; Abidin, Sheleaswani bte Inche Zainal] Family Hlth Dev Div, Minist Hlth, Putrajaya, Malaysia; [Ghazali, Sazlina Shariff] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Family Med, Seri Kembangan, Selangor, Malaysia; [Ghazali, Sazlina Shariff] Univ Putra Malaysia, Malaysian Res Inst Ageing MyAgeingTM, Seri Kembangan, Selangor, Malaysia; [Krishnapillai, Ambigga] Natl Def Univ Malaysia, Fac Med & Def Hlth, Dept Family Med, Kuala Lumpur, Malaysia; [Ariaratnam, Suthahar] Univ Technol MARA UiTM, Fac Med, Dept Psychiat, Selayang Campus, Batu Caves, Selangor, Malaysia; [Tohit, Noorlaili Mohd] Univ Kebangsaan Malaysia, Fac Med, Dept Family Med, Kuala Lumpur, Malaysia	Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Pertahanan Nasional Malaysia; Universiti Kebangsaan Malaysia	Ho, BK (corresponding author), Bandar Bot Hlth Ctr, Klang, Selangor, Malaysia.	bkho@hotmail.com	Ariaratnam, Suthahar/ABA-6210-2021	Ariaratnam, Suthahar/0000-0001-8524-6576	Ministry of Health Malaysia [P41-251-17000000500(0050099), NMRR-141064-21877]	Ministry of Health Malaysia	The NHMS 2006 (P41-251-17000000500(0050099) and NHMS 2015 (NMRR-141064-21877) were fully funded by the Ministry of Health Malaysia.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; [Anonymous], 2002, MOD PATHOL, V15, P87; Behncke S, 2012, HEALTH ECON, V21, P282, DOI 10.1002/hec.1712; Bromfield SG, 2014, J CLIN HYPERTENS, V16, P270, DOI 10.1111/jch.12281; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; COOK NR, 1995, ARCH INTERN MED, V155, P701, DOI 10.1001/archinte.155.7.701; Department of Statistic Malaysia, STAT CAUS DEATH; Department of Statistics Malaysia, 2016, POPULATION DEMOGRAPH; Dickinson HO, 2006, J HYPERTENS, V24, P215, DOI 10.1097/01.hjh.0000199800.72563.26; FACT, 2017, CRACK DIG PIR; Fezeu L, 2010, J EPIDEMIOL COMMUN H, V64, P360, DOI 10.1136/jech.2008.086355; Guessous I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039877; Guo FJ, 2012, J AM COLL CARDIOL, V60, P599, DOI 10.1016/j.jacc.2012.04.026; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Kiau Bo Bee, 2013, Med J Malaysia, V68, P332; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Liew SJ, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025869; Ma WJ, 2012, AM J HYPERTENS, V25, P590, DOI 10.1038/ajh.2012.11; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Mills KT, 2015, J HYPERTENS, V33, pE2, DOI 10.1097/01.hjh.0000469726.59998.cc; Naing C, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002417; Nguyen QN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042825; Ogedegbe G, 2008, J CLIN HYPERTENS, V10, P644, DOI 10.1111/j.1751-7176.2008.08329.x; Ostchega Y, 2007, J AM GERIATR SOC, V55, P1056, DOI 10.1111/j.1532-5415.2007.01215.x; Pereira M, 2012, BLOOD PRESSURE, V21, P220, DOI 10.3109/08037051.2012.666380; Pereira M, 2009, J HYPERTENS, V27, P963, DOI 10.1097/HJH.0b013e3283282f65; Rahman M, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-017-0101-5; Rothwell PM, 2010, LANCET NEUROL, V9, P469, DOI 10.1016/S1474-4422(10)70066-1; Seow LSE, 2015, J CLIN GERONTOL GERI, V6, P125, DOI 10.1016/j.jcgg.2015.05.002; The seventh Report of the Joint National Committee on Prevention, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI DOI 10.1001/JAMA.289.19.2560; Xi B, 2012, INT J CARDIOL, V158, P326, DOI 10.1016/j.ijcard.2012.04.140; Zhang WJ, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081701; Zhao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061779	33	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238780	10.1371/journal.pone.0238780	http://dx.doi.org/10.1371/journal.pone.0238780			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9ME	32911521	Green Published, gold			2022-12-26	WOS:000571885900046
J	Gupta, S; Bromley, J; Saffarian, S				Gupta, Shilpa; Bromley, Josh; Saffarian, Saveez			High-speed imaging of ESCRT recruitment and dynamics during HIV virus like particle budding	PLOS ONE			English	Article							PROTEIN RECRUITMENT; PLASMA-MEMBRANE; TSG101; PATHWAY; SITES; RNA; P6	Endosomal sorting complexes required for transport proteins (ESCRT) catalyze the fission of cellular membranes during budding of membrane away from the cytosol. Here we have used Total Internal Reflection Fluorescence (TIRF) microscopy to visualize the recruitment of ESCRTs specifically, ALIX, CHMP4b and VPS4 onto the budding HIV Gag virus-like particles (VLPs). We imaged the budding VLPs with 200 millisecond time resolution for 300 frames. Our data shows three phases for ESCRT dynamics: 1) recruitment in which subunits of ALIX, CHMP4b and VPS4 are recruited with constant proportions on the budding sites of HIV Gag virus like particles for nearly 10 seconds, followed by 2) disassembly of ALIX and CHMP4b while VPS4 signal remains constant for nearly 20 seconds followed by 3) disassembly of VPS4. We hypothesized that the disassembly observed in step 2 was catalyzed by VPS4 and powered by ATP hydrolysis. To test this hypothesis, we performed ATP depletion using (-) glucose medium, deoxyglucose and oligomycin. Imaging ATP depleted cells, we show that the disassembly of CHMP4b and ALIX observed in step 2 is ATP dependent. ATP depletion resulted in the recruitment of approximately 2-fold as many subunits of all ESCRTs. Resuming ATP production in cells, resulted in disassembly of the full ESCRT machinery which had been locked in place during ATP depletion. With some caveats, our experiments provide insight into the formation of the ESCRT machinery at the budding site of HIV during budding.	[Gupta, Shilpa; Saffarian, Saveez] Univ Utah, Ctr Cell & Genome Sci, Salt Lake City, UT 84112 USA; [Gupta, Shilpa; Saffarian, Saveez] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Bromley, Josh; Saffarian, Saveez] Univ Utah, Dept Phys & Astron, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Saffarian, S (corresponding author), Univ Utah, Ctr Cell & Genome Sci, Salt Lake City, UT 84112 USA.; Saffarian, S (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.; Saffarian, S (corresponding author), Univ Utah, Dept Phys & Astron, Salt Lake City, UT 84112 USA.	saffarian@physics.utah.edu		Saffarian, Saveez/0000-0002-9186-1230	NIH [R01AI150474]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by NIH grant R01AI150474 to SS.	Adell MAY, 2017, ELIFE, V6, DOI 10.7554/eLife.31652; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Badwal SPS, 2018, WIRES ENERGY ENVIRON, V7, DOI 10.1002/wene.286; Balasubramaniam M, 2011, PHYSIOLOGY, V26, P236, DOI 10.1152/physiol.00051.2010; Baumgartel V, 2011, NAT CELL BIOL, V13, P469, DOI 10.1038/ncb2215; Bendjennat M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005657; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Bleck M, 2014, P NATL ACAD SCI USA, V111, P12211, DOI 10.1073/pnas.1321655111; Caillat C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9781; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Cashikar AG, 2014, STRUCTURE CELLULAR E; Dussupt V, 2011, J VIROL, V85, P2304, DOI 10.1128/JVI.01562-10; Dussupt V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000339; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Effantin G, 2013, CELL MICROBIOL, V15, P213, DOI 10.1111/cmi.12041; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hendrix J, 2015, J CELL BIOL, V210, P629, DOI 10.1083/jcb.201504006; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Henne WM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016766; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; Ivanchenko S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000652; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; Jouvenet N, 2011, NAT CELL BIOL, V13, P394, DOI 10.1038/ncb2207; Ku PI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096950; Ku PI, 2013, BIOPHYS J, V105, P2262, DOI 10.1016/j.bpj.2013.09.047; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Maity S, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau7198; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Pedersen M, 2019, EUR BIOPHYS J BIOPHY, V48, P15, DOI 10.1007/s00249-018-1324-0; Prescher J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004677; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Sardo L, 2015, J VIROL, V89, P10832, DOI 10.1128/JVI.01146-15; Schoneberg J, 2018, SCIENCE, V362, P1423, DOI 10.1126/science.aat1839; Schur FKM, 2015, NATURE, V517, P505, DOI 10.1038/nature13838; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Usami Y, 2009, BIOCHEM SOC T, V37, P181, DOI 10.1042/BST0370181; Van Engelenburg SB, 2014, SCIENCE, V343, P653, DOI 10.1126/science.1247786; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1	46	8	8	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0237268	10.1371/journal.pone.0237268	http://dx.doi.org/10.1371/journal.pone.0237268			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886660	gold, Green Published			2022-12-26	WOS:000571064300008
J	Jacobi, CJ; Thiel, D; Allum, N				Jacobi, Christopher Justin; Thiel, Darren; Allum, Nick			Enabling and constraining successful reablement: Individual and neighbourhood factors	PLOS ONE			English	Article							HOME-CARE REABLEMENT; SOCIOECONOMIC-STATUS; OLDER-ADULTS; HEALTH; DEPRIVATION; PROGRAM; SERVICE; INCOME; FRAIL; EXPERIENCES	Using multilevel logistic regression to analyse management data of reablement episodes collected by Essex County Council, a UK local authority, this article identifies constraining and enabling factors for successful reablement. Overall, 59.5% of reablement clients were classed as able to care for themselves when assessed after 13 weeks following the reablement intervention (N = 8,118). Several age-related, disability, referral, and social factors were found to constrain reablement, but some of the largest constraining effects were neighbourhood deprivation as measured through the Index of Multiple Deprivation and, particularly, unfavourable geodemographic profiles as measured through Experian Mosaic consumer classifications. The results suggest that in order to optimise reablement, programmes should consider broader social and environmental influences on reablement rather than only individual and organisational aspects. Reablement might also be better tailored and intensified for client groups with particular underlying disabilities and for those displaying specific geodemographic characteristics.	[Jacobi, Christopher Justin] Univ Oxford, Nuffield Coll, Dept Sociol, Oxford, Oxon, England; [Thiel, Darren; Allum, Nick] Univ Essex, Dept Sociol, Colchester, Essex, England	University of Oxford; University of Essex	Jacobi, CJ (corresponding author), Univ Oxford, Nuffield Coll, Dept Sociol, Oxford, Oxon, England.	chris.jacobi@nuffield.ox.ac.uk	thiel, darren/GQZ-1552-2022	Thiel, Darren/0000-0003-4531-5420; Jacobi, Christopher Justin/0000-0002-0752-8428	University of Essex [FR1213187, 1368980]	University of Essex	Funding for initial analyses of the dataset was provided by an internal grant from the University of Essex under its Frontrunner Scheme (https://www1.essex.ac.uk/frontrunners/).The award (FR1213187) was jointly hosted and managed by DT (Department of Sociology). CJJ was selected as the recipient of the student funds of the award. All co-authors were all based at the University of Essex at the beginning of the project. CJJ's ESRC studentship grant (1368980) at the University of Oxford supported training in statistical methods. The funding bodies did not play any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. There was no additional external funding received for this study.	Adler NE, 1999, ANN NY ACAD SCI, V896, P3, DOI 10.1111/j.1749-6632.1999.tb08101.x; [Anonymous], 2002, Aging Male, V5, P1; Aspinal F, 2016, AGE AGEING, V45, P574, DOI 10.1093/ageing/afw094; Avellar S, 2007, EFFECTS MARRIAGE HLT; Beresford B, 2019, HEALTH SOC CARE COMM, V27, P1438, DOI 10.1111/hsc.12814; Bernard P, 2007, SOC SCI MED, V65, P1839, DOI 10.1016/j.socscimed.2007.05.037; Bodker MN, 2019, SOCIOL HEALTH ILL, V41, P1358, DOI 10.1111/1467-9566.12946; Bodker MN, 2019, HEALTH SOC CARE COMM, V27, pE871, DOI 10.1111/hsc.12815; Bragstad Line Kildal, 2012, Int J Integr Care, V12, pe4; Cochrane A, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010825.pub2; Diez-Roux AV, 1998, AM J PUBLIC HEALTH, V88, P216, DOI 10.2105/AJPH.88.2.216; Doh D, 2020, AGEING SOC, V40, P1371, DOI 10.1017/S0144686X18001770; Duran AC, 2013, HEALTH PLACE, V23, P39, DOI 10.1016/j.healthplace.2013.05.001; Eliassen M, 2019, J INTERPROF CARE, V33, P512, DOI 10.1080/13561820.2018.1541877; FEINSTEIN JS, 1993, MILBANK Q, V71, P279, DOI 10.2307/3350401; Fransham M, 2019, APPL SPAT ANAL POLIC, V12, P275, DOI 10.1007/s12061-017-9242-6; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Gill TM, 2002, NEW ENGL J MED, V347, P1068, DOI 10.1056/NEJMoa020423; Gitlin LN, 2006, J AM GERIATR SOC, V54, P809, DOI 10.1111/j.1532-5415.2006.00703.x; Glendinning C., 2010, HOME CARE REABLEMENT; Glendinning C, 2008, J INTEGR CARE, V16, P32, DOI 10.1108/14769018200800031; Hjelle KM, 2017, HEALTH SOC CARE COMM, V25, P1581, DOI 10.1111/hsc.12324; Hjelle KM, 2016, J MULTIDISCIP HEALTH, V9, P575, DOI 10.2147/JMDH.S115588; Hu FW, 2020, GERIATR GERONTOL INT, V20, P436, DOI 10.1111/ggi.13891; Jeon YH, 2018, INT PSYCHOGERIATR, V30, P915, DOI 10.1017/S1041610217001533; Johnson NJ, 2000, ANN EPIDEMIOL, V10, P224, DOI 10.1016/S1047-2797(99)00052-6; Jokela M, 2015, J EPIDEMIOL COMMUN H, V69, P899, DOI 10.1136/jech-2014-204513; Jokstad K, 2019, HEALTH SOC CARE COMM, V27, P907, DOI 10.1111/hsc.12708; Kawachi I., 2003, NEIGHBORHOODS HLTH; Kennedy BP, 1998, BRIT MED J, V317, P917; King AII, 2012, HEALTH SOC CARE COMM, V20, P365, DOI 10.1111/j.1365-2524.2011.01039.x; Langeland E, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1038-x; Legg L, 2016, CLIN REHABIL, V30, P741, DOI 10.1177/0269215515603220; Lewin G, 2014, HEALTH SOC CARE COMM, V22, P328, DOI 10.1111/hsc.12092; Lewin G, 2013, HEALTH SOC CARE COMM, V21, P69, DOI 10.1111/j.1365-2524.2012.01088.x; Lewin Gill F, 2013, Clin Interv Aging, V8, P1273, DOI 10.2147/CIA.S49164; Liaaen J, 2019, INT J OLDER PEOPLE N, V14, DOI 10.1111/opn.12270; Limited Experian, 2007, EXP DEM DAT 2004 200; Limited Experian, 2004, MOSAIC UK CONS CLASS; Malomo F, 2018, OCEAN COAST MANAGE, V151, P92, DOI 10.1016/j.ocecoaman.2017.10.018; Markle-Reid M, 2006, J ADV NURS, V54, P381, DOI 10.1111/j.1365-2648.2006.03817.x; Michael Stepner, 2017, MAPTILE STATA MODULE; Moe A, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2715-0; Moe C, 2018, HEALTH SOC CARE COMM, V26, P113, DOI 10.1111/hsc.12471; Moon G, 2019, SOC SCI MED, V227, P47, DOI 10.1016/j.socscimed.2018.06.029; MOSAIC E, 2010, EXPERIAN MOSAIC; Newbronner L, 2007, RES LONGER TERM EFFE; Nnoaham KE, 2010, J PUBLIC HEALTH-UK, V32, P572, DOI 10.1093/pubmed/fdq025; Noble M, 2006, ENVIRON PLANN A, V38, P169, DOI 10.1068/a37168; O'Campo P, 2009, HEALTH PLACE, V15, P56, DOI 10.1016/j.healthplace.2008.02.004; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Pilkington G., 2013, J CARE SERVICES MANA, V2, P354, DOI [10.1179/csm.2008.2.4.354, DOI 10.1179/CSM.2008.2.4.354]; Plane J, 2013, SOC SCI MED, V99, P1, DOI 10.1016/j.socscimed.2013.10.008; Pooley A, 2017, ALMSHOUSE REIMAGINED; Poulos Christopher J, 2017, Alzheimers Dement (N Y), V3, P450, DOI 10.1016/j.trci.2017.06.005; Reidy H, 2013, EVALUATION SOUTHWARK; Robles TF, 2003, PHYSIOL BEHAV, V79, P409, DOI 10.1016/S0031-9384(03)00160-4; ROUX AVD, 2003, NEIGHBORHOODS HLTH, P45, DOI DOI 10.1093/ACPROF:OSO/9780195138382.003.0003; Ryburn B, 2009, HEALTH SOC CARE COMM, V17, P225, DOI 10.1111/j.1365-2524.2008.00809.x; Sharma A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-755; Sims-Gould J, 2017, J AM MED DIR ASSOC, V18, P653, DOI 10.1016/j.jamda.2016.12.070; Slater P, 2018, J INTEGR CARE, V26, P140, DOI 10.1108/JICA-11-2017-0042; Tessier Annie, 2016, Healthc Policy, V11, P49; Tinetti ME, 2002, JAMA-J AM MED ASSOC, V287, P2098, DOI 10.1001/jama.287.16.2098; UK Department of Health, 2012, CARING FOR OUR FUTUR; Wami WM, 2019, HEALTH PLACE, V57, P238, DOI 10.1016/j.healthplace.2019.05.005; Warwickshire Observatory, 2012, US MOS BETT UND HOUS; Webber R., 2001, J TARGETING MEASUREM, V10, P55; Wilde A, 2012, HEALTH SOC CARE COMM, V20, P583, DOI 10.1111/j.1365-2524.2012.01072.x; Williams R, 2012, STATA J, V12, P308, DOI 10.1177/1536867X1201200209; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816	71	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0237432	10.1371/journal.pone.0237432	http://dx.doi.org/10.1371/journal.pone.0237432			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ7QN	32886657	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000571064300033
J	Sok, S; Hong, R; Chhoun, P; Chann, N; Tuot, S; Mun, P; Brody, C; Yi, SY				Sok, Say; Hong, Reaksmey; Chhoun, Pheak; Chann, Navy; Tuot, Sovannary; Mun, Phalkun; Brody, Carinne; Yi, Siyan			HIV risks and recent HIV testing among transgender women in Cambodia: Findings from a national survey	PLOS ONE			English	Article							SOCIAL MEDIA; BEHAVIORS; SEX; GAY; ACCEPTABILITY; MEN	Background Globally, the prevalence of HIV among transgender women remains much higher than that of the general population, and a large proportion of them are unaware of their HIV status. Transgender women are exposed to gender-based violence and social stigma and discrimination in different settings that may create significant barriers to receiving HIV prevention and care services. This study aimed to identify factors associated with recent HIV testing among transgender women in Cambodia. Methods We conducted a cross-sectional survey in 2016 among 1375 transgender women recruited from 13 provinces using a peer-based social network recruitment method. We used a structured questionnaire for face-to-face interviews and performed rapid HIV/syphilis testing onsite. We used a multiple logistic regression analysis to identify factors associated with recent HIV testing. Results Of the total, 49.2% of the participants reported having an HIV test in the past six months. After controlling for other covariates, the odds of having an HIV test in the past six months was significantly lower among students (AOR 0.36, 95% CI 0.20-0.65), participants who perceived that they were unlikely to be HIV infected (AOR 0.50, 95% CI 0.32-0.78), and participants who reported always using condoms with male non-commercial partners in the past three months (AOR 0.65, 95% CI 0.49-0.85) relative to their respective reference group. The odds of having an HIV test in the past six months was significantly higher among participants who had been reached by community-based HIV services (AOR 5.01, 95% CI 3.29-7.65) and received HIV education (AOR 1.65, 95% CI 1.06-2.58) in the past six months relative to their respective reference group. Conclusions Despite the widely available free HIV testing services, more than half of transgender women in this study had not received an HIV test in the past six months. Our findings suggest that a tailored and comprehensive combination prevention program, in which HIV testing is linked to care continuum and beyond, maybe an essential next step. Social media may have the potential to be promoted and utilized among transgender women populations in order to improve HIV testing and other prevention measures.	[Sok, Say; Chhoun, Pheak; Tuot, Sovannary; Yi, Siyan] KHANA Ctr Populat Hlth Res, Phnom Penh, Cambodia; [Hong, Reaksmey] ActionAid Cambodia, Phnom Penh, Cambodia; [Chann, Navy; Mun, Phalkun; Brody, Carinne] Natl Ctr HIV AIDS Dermatol & STD, Phnom Penh, Cambodia; [Yi, Siyan] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Yi, Siyan] Natl Univ Hlth Syst, Singapore, Singapore; [Yi, Siyan] Touro Univ Calif, Ctr Global Hlth Res, Vallejo, CA 94592 USA; [Yi, Siyan] Natl Inst Publ Hlth, Sch Publ Hlth, Phnom Penh, Cambodia	National University of Singapore; National University of Singapore; Touro University California	Yi, SY (corresponding author), KHANA Ctr Populat Hlth Res, Phnom Penh, Cambodia.; Yi, SY (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.; Yi, SY (corresponding author), Natl Univ Hlth Syst, Singapore, Singapore.; Yi, SY (corresponding author), Touro Univ Calif, Ctr Global Hlth Res, Vallejo, CA 94592 USA.; Yi, SY (corresponding author), Natl Inst Publ Hlth, Sch Publ Hlth, Phnom Penh, Cambodia.	ephsyi@nus.edu.sg	Chhoun, Pheak/AAR-3361-2021	Chhoun, Pheak/0000-0001-6369-0190; Brody, Carinne/0000-0001-9376-5528	President's Emergency Plan for AIDS Relief (PEPFAR) through the HIV/AIDS Flagship Project; United States Agency for International Development (USAID) through the HIV/AIDS Flagship Project	President's Emergency Plan for AIDS Relief (PEPFAR) through the HIV/AIDS Flagship Project; United States Agency for International Development (USAID) through the HIV/AIDS Flagship Project(United States Agency for International Development (USAID))	The National Integrated Biological and Behavioral Survey among Transgender Women in Cambodia 2016 was funded by the President's Emergency Plan for AIDS Relief (PEPFAR) and the United States Agency for International Development (USAID) through the HIV/AIDS Flagship Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asante KO, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-17; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Chhim S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015390; Douglas KA, 1997, J AM COLL HEALTH, V46, P55, DOI 10.1080/07448489709595589; Gyasi RM, 2018, J HIV-AIDS SOC SERV, V17, P127, DOI 10.1080/15381501.2017.1407730; Herbst JH, 2008, AIDS BEHAV, V12, P1, DOI 10.1007/s10461-007-9299-3; Bustamante MJ, 2017, INT J STD AIDS, V28, P133, DOI 10.1177/0956462416630674; Kaplan RL, 2016, J INT AIDS SOC, V19, P17, DOI 10.7448/IAS.19.3.20787; Khalili J, 2015, AM J PUBLIC HEALTH, V105, P1114, DOI 10.2105/AJPH.2014.302448; Lindley LL, 2003, AIDS EDUC PREV, V15, P413, DOI 10.1521/aeap.15.6.413.24039; Lippman SA, 2016, AIDS BEHAV, V20, P928, DOI 10.1007/s10461-015-1236-2; Liu KL, BROS KHMER BEHAV RIS, V360; Mun P, 2016, INTEGRATED BIOL BEHA; National Center for HIV/AIDS, 2013, ANN REP 2012; National Center for HIV/AIDS, 2016, ANN REP 2016; Nemoto T, 2004, AM J PUBLIC HEALTH, V94, P1193, DOI 10.2105/AJPH.94.7.1193; Nemoto T, 2012, AIDS CARE, V24, P210, DOI 10.1080/09540121.2011.597709; Opeiario D, 2008, JAIDS-J ACQ IMM DEF, V48, P97, DOI 10.1097/QAI.0b013e31816e3971; Pal K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166129; Peltzer Karl, 2004, Indian J Med Sci, V58, P95; Prabawanti C, 2011, AIDS BEHAV, V15, P663, DOI 10.1007/s10461-010-9790-0; Rhodes SD, 2016, CLIN INFECT DIS, V62, P1450, DOI 10.1093/cid/ciw127; Richardson D., 2000, Culture, Health & Sexuality, V2, P33, DOI 10.1080/136910500300859; Salazar X, 2016, J INT AIDS SOC, V19, P75, DOI 10.7448/IAS.19.3.20790; Schulden JD, 2008, PUBLIC HEALTH REP, V123, P101, DOI 10.1177/00333549081230S313; Shaikh S, 2016, J INT AIDS SOC S2, V19, P20787, DOI [10.7448/IAS.19.3.20787, DOI 10.7448/IAS.19.3.20787]; Silva-Santisteban A, 2016, J INT AIDS SOC, V19, P65, DOI 10.7448/IAS.19.3.20799; SS V et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, 2020, CIRCULATION, V2020, pe1; Tso LS, 2016, CURR OPIN PSYCHOL, V9, P6, DOI 10.1016/j.copsyc.2015.09.019; Weissman A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152906; World Health Organization, 2015, POL BRIEF TRANSG PEO; Yi SY, 2020, DRUG ALCOHOL DEPEN, V207, DOI 10.1016/j.drugalcdep.2019.107802; Yi SY, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-0974-6; Yi SY, 2018, INT J MENT HEALTH SY, V12, DOI 10.1186/s13033-018-0206-2; Yi S, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21580; Yi SY, 2017, BMC INT HEALTH HUM R, V17, DOI 10.1186/s12914-017-0122-6; Yi SY, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1857-9; Yi SY, 2015, BMC INFECT DIS, V15, DOI [10.1186/s12879-015-0954-4, 10.1186/s12889-015-2096-4]; Yi SY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-477; Young SD, 2013, ANN INTERN MED, V159, P318, DOI 10.7326/0003-4819-159-5-201309030-00005; 2017, COLORECTAL DIS, V19, pE394	41	3	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238314	10.1371/journal.pone.0238314	http://dx.doi.org/10.1371/journal.pone.0238314			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ7QN	32886693	Green Published, gold			2022-12-26	WOS:000571064300010
J	Zhu, X; Qi, X; Yang, YM; Tian, WL; Liu, WJ; Jiang, ZL; Li, SZ; Zhu, XJ				Zhu, Xiong; Qi, Xin; Yang, Yeming; Tian, Wanli; Liu, Wenjing; Jiang, Zhilin; Li, Shuzhen; Zhu, Xianjun			Loss of the ER membrane protein complex subunit Emc3 leads to retinal bipolar cell degeneration in aged mice	PLOS ONE			English	Article							DOPAMINE-DEPENDENT SENSITIZATION; TRANSGENE EXPRESSION; MOUSE MODEL; ZIKA VIRUS; NEUROPROTECTION; IDENTIFICATION; ASTROCYTES; REQUIRES; MUTATION; TARGETS	The endoplasmic reticulum (ER) membrane protein complex (EMC) is a conserved protein complex involved in inserting the transmembrane domain of membrane proteins into membranes in the ER. EMC3 is an essential component of EMC and is important for rhodopsin synthesis in photoreceptor cells. However, the in vivo function ofEmc3in bipolar cells (BCs) has not been determined. To explore the role ofEmc3in BCs, we generated a BC-specificEmc3knockout mouse model (namedEmc3cKO) using the Purkinje cell protein 2 (Pcp2) Cre line. Although normal electroretinography (ERG) b-waves were observed inEmc3cKO mice at 6 months of age,Emc3cKO mice exhibited reduced b-wave amplitudes at 12 months of age, as determined by scotopic and photopic ERG, and progressive death of BCs, whereas the ERG a-wave amplitudes were preserved. PKCa staining of retinal cryosections fromEmc3cKO mice revealed death of rod BCs. Loss ofEmc3led to the presence of the synaptic protein mGLuR6 in the outer nuclear layer (ONL). Immunostaining analysis of presynaptic protein postsynaptic density protein 95 (PSD95) revealed rod terminals retracted to the ONL inEmc3cKO mice at 12 months of age. In addition, deletion ofEmc3resulted in elevated glial fibrillary acidic protein, indicating reactive gliosis in the retina. Our data demonstrate that loss ofEmc3in BCs leads to decreased ERG response, increased astrogliosis and disruption of the retinal inner nuclear layer in mice of 12 months of age. Taken together, our studies indicate thatEmc3is not required for the development of BCs but is important for long-term survival of BCs.	[Zhu, Xiong; Yang, Yeming; Tian, Wanli; Liu, Wenjing; Jiang, Zhilin; Zhu, Xianjun] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Prenatal Diag Ctr, Sch Med,Sichuan Prov Key Lab Human Dis Gene Study, Chengdu, Sichuan, Peoples R China; [Qi, Xin] Sichuan Univ, West China Hosp, Neurosurg Res Lab, Chengdu, Sichuan, Peoples R China; [Li, Shuzhen; Zhu, Xianjun] Shangqiu First Peoples Hosp, Dept Ophthalmol, Shangqiu, Henan, Peoples R China	Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Sichuan University	Zhu, XJ (corresponding author), Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Prenatal Diag Ctr, Sch Med,Sichuan Prov Key Lab Human Dis Gene Study, Chengdu, Sichuan, Peoples R China.; Li, SZ; Zhu, XJ (corresponding author), Shangqiu First Peoples Hosp, Dept Ophthalmol, Shangqiu, Henan, Peoples R China.	lishuzhensqy@163.com; xjzhu@uestc.edu.cn	yang, yang/HGT-7999-2022; Yang, Ye/GZM-4812-2022; Lang, Ming/HIK-0758-2022	Zhu, Xianjun/0000-0002-2531-7552	National Natural Science Foundation of China [81770950]; Department of Science and Technology of Sichuan Province [2020JDYH0027, 2019ZYD002, 2018JZ0019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Sichuan Province	This study was supported by the National Natural Science Foundation of China in the form of a grant awarded to XJZ (81770950) and the Department of Science and Technology of Sichuan Province (http://kjt.sc.gov.cn/) in the form of grants also awarded to XJZ (2020JDYH0027, 2019ZYD002, 2018JZ0019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, DIABETOL KLIN SA, V4, pA1; Ball SL, 2003, VISUAL NEUROSCI, V20, P267, DOI 10.1017/S0952523803203059; Ball SL, 2002, INVEST OPHTH VIS SCI, V43, P1595; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Cao Y, 2009, J NEUROSCI, V29, P9301, DOI 10.1523/JNEUROSCI.1367-09.2009; Chang B, 2006, VISUAL NEUROSCI, V23, P11, DOI 10.1017/S095252380623102X; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Cuenca N, 2005, EUR J NEUROSCI, V22, P1057, DOI 10.1111/j.1460-9568.2005.04300.x; Dhingra A, 2000, J NEUROSCI, V20, P9053; Dhingra Anuradha, 2012, Wiley Interdiscip Rev Membr Transp Signal, V1, P641; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Garwood CJ, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.50; Guangzhou Municipal Government Leg, 2006, GOV INFORM Q, V23, P11, DOI 10.1016/j.giq.2006.02.006; Guna A, 2018, SCIENCE, V359, P470, DOI 10.1126/science.aao3099; Hasan N, 2016, VISUAL NEUROSCI, V33, DOI 10.1017/S0952523816000055; Herrmann R, 2011, NEURON, V72, P101, DOI 10.1016/j.neuron.2011.07.030; HEYNEN H, 1985, VISION RES, V25, P1365, DOI 10.1016/0042-6989(85)90214-7; Koulen P, 1998, J NEUROSCI, V18, P10136; Lahiri S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001969; Li YJ, 2013, AUTOPHAGY, V9, P150, DOI 10.4161/auto.22742; Lin DL, 2019, CELL REP, V27, P1666, DOI 10.1016/j.celrep.2019.04.051; Liu ZW, 2016, PROG NEUROBIOL, V144, P103, DOI 10.1016/j.pneurobio.2015.09.008; Lu Q, 2013, MOL VIS, V19, P1310; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631; Mori T, 2010, GLIA, V58, P300, DOI 10.1002/glia.20924; NAKAJIMA Y, 1993, J BIOL CHEM, V268, P11868; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; Pardue MT, 1998, INVEST OPHTH VIS SCI, V39, P2443; Perry VH, 2003, NAT REV NEUROSCI, V4, P103, DOI 10.1038/nrn1032; Pinto LH, 2007, VISUAL NEUROSCI, V24, P111, DOI 10.1017/S0952523807070149; Rao A, 2007, J NEUROSCI, V27, P14199, DOI 10.1523/JNEUROSCI.4934-07.2007; Richard M, 2013, P NATL ACAD SCI USA, V110, pE1055, DOI 10.1073/pnas.1216154110; Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028; Shen X, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.408; Shurtleffn MJ, 2018, ELIFE, V7, DOI 10.7554/eLife.37018; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; Tagawa Y, 1999, J NEUROSCI, V19, P2568; Tang XF, 2017, J CLIN INVEST, V127, P4314, DOI 10.1172/JCI94152; Taylor MR, 2005, GENETICS, V170, P263, DOI 10.1534/genetics.104.036434; Travis AM, 2018, J NEUROSCI, V38, P723, DOI 10.1523/JNEUROSCI.1994-17.2017; Xiong LY, 2020, CELL DEATH DIFFER, V27, P646, DOI 10.1038/s41418-019-0378-6; Yang YM, 2019, J NEUROCHEM, V148, P400, DOI 10.1111/jnc.14643; Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625; [No title captured]	47	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238435	10.1371/journal.pone.0238435	http://dx.doi.org/10.1371/journal.pone.0238435			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886670	Green Published, gold			2022-12-26	WOS:000571064300009
J	Martins, AM; Sarto, DAQS; Caproni, KD; Silva, J; Silva, J; Souza, PS; dos Santos, L; Urena, MJE; Carvalho, MDD; Boas, BMV; Miranda, LPA; Garcia, JAD				Martins, Angela Maria; Quintino Silva Sarto, Danielle Aparecida; Caproni, Karine de Paula; Silva, Janaina; Silva, Jaqueline; Souza, Paulo Sergio; dos Santos, Leandro; Espino Urena, Marcos Javier; de Souza Carvalho, Maria das Gracas; Vilas Boas, Brigida Monteiro; Ardisson Miranda, Lidiane Paula; Dias Garcia, Jose Antonio			Grape juice attenuates left ventricular hypertrophy in dyslipidemic mice	PLOS ONE			English	Article							NITROSO-N-ACETYLCYSTEINE; RED WINE CONSUMPTION; MATRIX METALLOPROTEINASES; INFLAMMATORY BIOMARKERS; DENSITY-LIPOPROTEIN; LDL; INSULIN; OXIDATION; ATHEROSCLEROSIS; ANTHOCYANINS	Objective We evaluated the effects of grape juice (Vitis labruscaL.) on dyslipidemia, resistance to insulin, and left ventricular hypertrophy (LVH) in mice homozygous for the absence of the LDL receptor gene (LDLr -/-) under a hyperlipidemic diet. Methodology We divided 30 male mice (3 months old) into three groups (n = 10); the HL group was fed a high-fat diet, the HLU group received a high-fat diet and 2 g/kg/day of grape juice, and the HLS group was fed a high-fat diet and simvastatin (20 mg/kg/day). We assessed the blood pressure profile of the mice. We also determined the levels of C-reactive protein (CRP) and lipid profile, glycemic and insulinemic profiles, and calculated the HOMA-IR. Cardiomyocyte hypertrophy, interstitial collagen deposit, and the expression of CD40 ligand (CD40L) and metalloproteinases 2 and 9 were assessed immunohistologically. Results After 60 days, the mice treated with grape juice showed similar results as those of the group treated with simvastatin. The use of grape fruit attenuated dyslipidemia and insulin resistance and significantly increased the levels of high cholesterol density lipoproteins (HDLc). The antioxidant potential of phenolic compounds associated with the increase in HDLc levels in the mice of the HLU group prevented the development of LVH and arterial hypertension since it inhibited the inflammatory response induced by the CD40 pathway and its ligand CD40L. Consequently, there was a lower expression of MMP-2 and MMP-9 and lower serum levels of CRP. Conclusion Grape juice has a hypolipidemic and cardiac protective potential, presenting a similar effect as that of simvastatin through a direct antioxidant action of phenolic compounds, or indirectly, via antioxidant action and anti-inflammatory activity of the HDLc. These results suggest that grape juice is a functional food possessing a high potential to prevent cardiovascular diseases.	[Martins, Angela Maria; Quintino Silva Sarto, Danielle Aparecida; Caproni, Karine de Paula; Vilas Boas, Brigida Monteiro; Dias Garcia, Jose Antonio] Fed Inst Educ Sci & Technol South Minas Gerais, Machado, MG, Brazil; [Silva, Janaina; Silva, Jaqueline; Souza, Paulo Sergio] Fed Inst Educ Sci & Technol South Minas Gerais, Muzambinho, MG, Brazil; [dos Santos, Leandro] Rural Fed Univ Pernambuco, Acad Unity Serra Talhada, Serra Talhada, PE, Brazil; [Espino Urena, Marcos Javier] Autonomous Univ Santo Domingo, Santo Domingo, Dominican Rep; [Espino Urena, Marcos Javier] Dominican Inst Agr & Forestry Res, Santo Domingo, Dominican Rep; [de Souza Carvalho, Maria das Gracas; Ardisson Miranda, Lidiane Paula; Dias Garcia, Jose Antonio] Jose do Rosario Vellano Univ, Alfenas, MG, Brazil	Instituto Federal do Sul de Minas Gerais; Instituto Federal do Sul de Minas Gerais; Universidade Federal Rural de Pernambuco (UFRPE); Universidad Autonoma de Santo Domingo	Carvalho, MDD (corresponding author), Jose do Rosario Vellano Univ, Alfenas, MG, Brazil.	maria_roots@hotmail.com	Boas, Brígida M. Vilas/Q-6954-2016; Garcia, José Antonio Dias/AAM-6712-2021	Boas, Brígida M. Vilas/0000-0001-9010-2972; Martins, Angela/0000-0002-1499-3459; Souza Carvalho, Maria das Gracas/0000-0001-8726-6327; Silva, Janaina/0000-0002-8782-1148; Reis, AlessanRSS/0000-0001-8486-7469	CNPq; FAPEMIG; Federal Institute of Education, Science and Technology of the South of Minas Gerais	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Federal Institute of Education, Science and Technology of the South of Minas Gerais	To CNPq and FAPEMIG for financial support, and to the Federal Institute of Education, Science and Technology of the South of Minas Gerais and to Universidade Jose ' do Rosa ' rio Vellano for support in carrying out the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers AR, 2004, ARTERIOSCL THROM VAS, V24, pE179, DOI 10.1161/01.ATV.0000143479.97844.af; Antonopoulos AS, 2012, THROMB HAEMOSTASIS, V108, P840, DOI 10.1160/TH12-05-0337; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Avellone G, 2006, EUR J CLIN NUTR, V60, P41, DOI 10.1038/sj.ejcn.1602265; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brownsey RW, 1997, CARDIOVASC RES, V34, P3, DOI 10.1016/S0008-6363(97)00051-5; Campo VL, 2007, QUIM NOVA, V30, P425, DOI 10.1590/S0100-40422007000200033; Cardoso Luciana Marques, 2011, Rev. colomb. cienc. quim. farm., V40, P116; Chang YC, 2006, FOOD CHEM TOXICOL, V44, P1015, DOI 10.1016/j.fct.2005.12.006; Christison J, 1996, BIOCHEM J, V314, P739, DOI 10.1042/bj3140739; Ciz M, 2008, PHYSIOL RES, V57, P393, DOI 10.33549/physiolres.931088; Cogni AL, 2013, ARQ BRAS CARDIOL, V100, P315, DOI 10.5935/abc.20130049; Cosme F, 2018, BEVERAGES, V4, DOI 10.3390/beverages4010022; Epstein M, 2005, AM J KIDNEY DIS, V45, P2, DOI 10.1053/j.ajkd.2004.08.040; Estruch R, 2004, ATHEROSCLEROSIS, V175, P117, DOI 10.1016/j.atherosclerosis.2004.03.006; Faria A, 2006, J AGR FOOD CHEM, V54, P2392, DOI 10.1021/jf0526487; Fontenelle LC, 2018, BRAZ J PHARM SCI, V54, DOI 10.1590/s2175-97902018000100139; Francis FJ, 2000, CEREAL FOOD WORLD, V45, P208; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Garcia JAD, 2008, J CARDIOVASC PHARM, V51, P78, DOI 10.1097/FJC.0b013e31815c39d4; Garcia JAD, 2011, REV PORT CARDIOL, V30, P763, DOI 10.1016/S0870-2551(11)70024-5; Gelbmann CM, 2003, GUT, V52, P1448, DOI 10.1136/gut.52.10.1448; Genda S, 2002, J AM COLL CARDIOL, V40, P1339, DOI 10.1016/S0735-1097(02)02156-3; Giehl MR, 2007, SCI MED, V17, P145; Gurak P. D, 2008, REV CIENCIAS EXATAS, V27, P1; Haskell-Ramsay CF, 2017, EUR J NUTR, V56, P2621, DOI 10.1007/s00394-017-1454-7; Hayek T, 1997, ARTERIOSCL THROM VAS, V17, P2744, DOI 10.1161/01.ATV.17.11.2744; Hedrick CC, 2001, J LIPID RES, V42, P563; Horton DB, 2001, ANN NY ACAD SCI, V947, P239; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kagami S, 2008, INT ARCH ALLERGY IMM, V146, P61, DOI 10.1159/000126063; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Krieger MH, 2006, NITRIC OXIDE-BIOL CH, V14, P12, DOI 10.1016/j.niox.2005.07.011; Li YY, 2000, CARDIOVASC RES, V46, P214, DOI 10.1016/S0008-6363(00)00003-1; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lorga AM, 2013, ARQ BRAS CARDIOL, V101, P1, DOI [10.5935/abc.2013S009, 10.5935/abc.2013S006, 10.5935/abc.2013S012]; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macheix JJ, 1990, MAIN PHENOLICS FRUIT; Mitjans M, 2004, J AGR FOOD CHEM, V52, P7297, DOI 10.1021/jf049403z; Napoli C, 2008, HEART VESSELS, V23, P124, DOI 10.1007/s00380-007-1015-8; Navab M, 2004, J LIPID RES, V45, P993, DOI 10.1194/jlr.R400001-JLR200; Philipps RP, 2000, P NATL ACAD SCI USA, V97, P6930, DOI 10.1073/pnas.97.13.6930; Polvakova V, 2010, INT J CARDIOL, V151, P18, DOI [10.1016/j.ijcard.2010.04.053, DOI 10.1016/J.IJCARD.2010.04.053]; Pregnolatto W, 1985, METODOS FISICO QUIMI; Reddy ST, 2001, ARTERIOSCL THROM VAS, V21, P542, DOI 10.1161/01.ATV.21.4.542; Samuelsson AM, 2006, AM J PHYSIOL-HEART C, V291, pH787, DOI 10.1152/ajpheart.00974.2005; Sautter Cláudia K., 2005, Food Sci. Technol (Campinas), V25, P437, DOI 10.1590/S0101-20612005000300008; Schaefer EJ, 2002, AM J CLIN NUTR, V75, P191, DOI 10.1093/ajcn/75.2.191; Spinale FG, 2002, CIRC RES, V90, P520, DOI 10.1161/01.RES.0000013290.12884.A3; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Sykiotis GP, 2001, MOL ENDOCRINOL, V15, P1864, DOI 10.1210/me.15.11.1864; Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681; Tian J, 2006, BIOCHEM BIOPH RES CO, V345, P1004, DOI 10.1016/j.bbrc.2006.04.180; Trinder P., 1969, ANN CLIN BIOCHEM, V6, p24?27, DOI DOI 10.1177/000456326900600108; Vaccari N. F., 2009, Revista de Ciencias Agroveterinarias, V8, P71; Vishnevetsky D, 2004, ANN PHARMACOTHER, V38, P1500, DOI 10.1345/aph.1D611; Wang SH, 2017, SCI REP-UK, V7, DOI 10.1038/srep39982; Woo MN, 2009, FOOD CHEM TOXICOL, V47, P2076, DOI 10.1016/j.fct.2009.05.041; Zhang YL, 2009, ARTERIOSCL THROM VAS, V29, P1764, DOI 10.1161/ATVBAHA.109.192609	61	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238163	10.1371/journal.pone.0238163	http://dx.doi.org/10.1371/journal.pone.0238163			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881885	Green Published, gold			2022-12-26	WOS:000571063300065
J	Edwards, MJ; Becker, KA; Gripp, B; Hoffmann, M; Keitsch, S; Wilker, B; Soddemann, M; Gulbins, A; Carpinteiro, E; Patel, SH; Wilson, GC; Pohlmann, S; Walter, S; Fassbender, K; Ahmad, SA; Carpinteiro, A; Gulbins, E				Edwards, Michael J.; Becker, Katrin Anne; Gripp, Barbara; Hoffmann, Markus; Keitsch, Simone; Wilker, Barbara; Soddemann, Matthias; Gulbins, Anne; Carpinteiro, Elisa; Patel, Sameer H.; Wilson, Gregory C.; Poehlmann, Stefan; Walter, Silke; Fassbender, Klaus; Ahmad, Syed A.; Carpinteiro, Alexander; Gulbins, Erich			Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						SARS-CoV-2; sphingosine; ACE2; spike; infection; human nasal epithelial cells; sphingolipid; virus entry; receptor; epithelium; infectious disease; nasal epithelial cells	STAPHYLOCOCCUS-AUREUS; EPITHELIAL-CELLS; SUSCEPTIBILITY; INFLAMMATION; METABOLISM; INFECTION; BASES	Sphingosine has been shown to prevent and eliminate bacterial infections of the respiratory tract, but it is unknown whether sphingosine can be also employed to prevent viral infections. To test this hypothesis, we analyzed whether sphingosine regulates the infection of cultured and freshly isolated ex vivo human epithelial cells with pseudoviral particles expressing SARS-CoV-2 spike (pp-VSV-SARS-CoV-2 spike) that served as a bona fide system mimicking SARS-CoV-2 infection. We demonstrate that exogenously applied sphingosine suspended in 0.9% NaCl prevents cellular infection with pp-SARS-CoV-2 spike. Pretreatment of cultured Vero epithelial cells or freshly isolated human nasal epithelial cells with low concentrations of sphingosine prevented adhesion of and infection with pp-VSV-SARS-CoV-2 spike. Mechanistically, we demonstrate that sphingosine binds to ACE2, the cellular receptor of SARS-CoV-2, and prevents the interaction of the receptor-binding domain of the viral spike protein with ACE2. These data indicate that sphingosine prevents at least some viral infections by interfering with the interaction of the virus with its receptor. Our data also suggest that further preclinical and finally clinical examination of sphingosine is warranted for potential use as a prophylactic or early treatment for coronavirus disease-19.	[Edwards, Michael J.; Patel, Sameer H.; Wilson, Gregory C.; Ahmad, Syed A.; Gulbins, Erich] Univ Cincinnati, Sch Med, Dept Surg, Cincinnati, OH 45221 USA; [Becker, Katrin Anne; Keitsch, Simone; Wilker, Barbara; Soddemann, Matthias; Gulbins, Anne; Carpinteiro, Elisa; Carpinteiro, Alexander; Gulbins, Erich] Univ Duisburg Essen, Univ Hosp Essen, Inst Mol Biol, Essen, Germany; [Carpinteiro, Alexander] Univ Duisburg Essen, Univ Hosp Essen, Dept Hematol, Essen, Germany; [Gripp, Barbara] Sana Klinikum Remscheid GmbH, Zentrum Seel Gesundheit Kindes & Jugendalters, Remscheid, Germany; [Hoffmann, Markus; Poehlmann, Stefan] Leibniz Inst Primate Res, Infect Biol Unit, German Primate Ctr, Gottingen, Germany; [Hoffmann, Markus; Poehlmann, Stefan] Univ Gottingen, Fac Biol & Psychol, Gottingen, Germany; [Walter, Silke; Fassbender, Klaus] Univ Hosp Saarland, Dept Neurol, Homburg, Germany	University System of Ohio; University of Cincinnati; University of Duisburg Essen; University of Duisburg Essen; Deutsches Primatenzentrum (DPZ); University of Gottingen; Universitatsklinikum des Saarlandes	Gulbins, E (corresponding author), Univ Cincinnati, Sch Med, Dept Surg, Cincinnati, OH 45221 USA.; Gulbins, E (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Mol Biol, Essen, Germany.	erich.gulbins@uni-due.de	Hoffmann, Markus/J-7836-2018; Pöhlmann, Stefan/H-2395-2011	Hoffmann, Markus/0000-0003-4603-7696; Pöhlmann, Stefan/0000-0001-6086-9136; Walter, Silke/0000-0002-1176-2911; Fassbender, Klaus/0000-0003-3596-868X	Deutsche Forschungsgemeinschaft [Gu-335-35/1]; Bundesministerium fuer Bildung und Forschung, RAPID Consortium [01KI1723D]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fuer Bildung und Forschung, RAPID Consortium	This work was supported by Deutsche Forschungsgemeinschaft Grant Gu-335-35/1 and Bundesministerium fuer Bildung und Forschung, RAPID Consortium Grant 01KI1723D (to S. P.).	Azuma MM, 2018, BIOCHEM BIOPH RES CO, V495, P2383, DOI 10.1016/j.bbrc.2017.12.137; BIBEL DJ, 1992, J INVEST DERMATOL, V98, P269, DOI 10.1111/1523-1747.ep12497842; Carstens Henning, 2019, Cell Physiol Biochem, V53, P1015, DOI 10.33594/000000194; Coant Nicolas, 2017, Advances in Biological Regulation, V63, P122, DOI 10.1016/j.jbior.2016.10.002; Fischer CL, 2013, SKIN PHARMACOL PHYS, V26, P36, DOI 10.1159/000343175; Grassme H, 2005, J BIOL CHEM, V280, P26256, DOI 10.1074/jbc.M500835200; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Grassme H, 2017, CELL HOST MICROBE, V21, P707, DOI 10.1016/j.chom.2017.05.001; Gulbins E, 2006, AM J PHYSIOL-REG I, V290, pR11, DOI 10.1152/ajpregu.00416.2005; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Kleine-Weber H, 2019, J VIROL, V93, DOI 10.1128/JVI.01381-18; Kolesnick RN, 2000, J CELL PHYSIOL, V184, P285; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Lang J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15072-8; Miller ME, 2012, J VIROL, V86, P7473, DOI 10.1128/JVI.00136-12; Muraglia KA, 2019, NATURE, V567, P405, DOI 10.1038/s41586-019-1018-5; Peng HM, 2015, J MOL MED, V93, P675, DOI 10.1007/s00109-014-1246-y; Pewzner-Jung Y, 2014, EMBO MOL MED, V6, P1205, DOI 10.15252/emmm.201404075; Rentsch MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025858; Seitz AP, 2019, J MOL MED, V97, P1195, DOI 10.1007/s00109-019-01800-1; Simonis A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004160; Tabazavareh ST, 2016, CELL PHYSIOL BIOCHEM, V38, P2094, DOI 10.1159/000445567; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Verhaegh R, 2020, J BIOL CHEM, V295, P7686, DOI 10.1074/jbc.RA119.012325; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang QH, 2020, CELL, V181, P894, DOI 10.1016/j.cell.2020.03.045; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]	30	21	21	4	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2020	295	45					15174	15182		10.1074/jbc.RA120.015249	http://dx.doi.org/10.1074/jbc.RA120.015249			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OU9JM	32917722	hybrid, Green Published			2022-12-26	WOS:000591839400001
J	Bodewes, R; Reijnen, L; Kerkhof, J; Cremer, J; Schmitz, D; van Binnendijk, R; Veldhuijzen, IK				Bodewes, Rogier; Reijnen, Linda; Kerkhof, Jeroen; Cremer, Jeroen; Schmitz, Dennis; van Binnendijk, Rob; Veldhuijzen, Irene K.			Molecular epidemiology of mumps viruses in the Netherlands, 2017-2019	PLOS ONE			English	Article							TOOL	Mumps cases continue to occur, also in countries with a relatively high vaccination rate. The last major outbreaks of mumps in the Netherlands were in 2009-2012 and thereafter, only small clusters and single cases were reported. Molecular epidemiology can provide insights in the circulation of mumps viruses. The aims of the present study were to analyze the molecular epidemiology of mumps viruses in the Netherlands in 2017-2019 and to compare the phylogenetic trees built from sequence data of near complete mumps virus genomes or from the SH gene and non-coding regions (SH+NCRs). To this end, Sanger sequence data from SH+NCRs were analyzed from 82 mumps genotype G viruses. In addition, near complete genomes were obtained from 10 mumps virus isolates using next-generation sequencing. Analysis of SH+NCRs sequences of mumps genotype G viruses revealed the presence of two major genetic lineages in the Netherlands, which was confirmed by analysis of near complete genomes. Comparison of phylogenetic trees built with SH+NCRs or near complete genomes indicated that the topology was similar, while somewhat longer branches were present in the phylogenetic tree with near complete genomes. These results confirm that analysis of SH + NCRs sequence data is a useful approach for molecular surveillance. Furthermore, data from recent mumps genotype G viruses might indicate (intermittent) circulation of mumps genotype G viruses in the Netherlands in 2017-2019.	[Bodewes, Rogier; Reijnen, Linda; Kerkhof, Jeroen; Cremer, Jeroen; Schmitz, Dennis; van Binnendijk, Rob; Veldhuijzen, Irene K.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment	Bodewes, R (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.	rogier.bodewes@rivm.nl		Veldhuijzen, Irene/0000-0002-3132-4070; Bodewes, Rogier/0000-0002-0689-7889				Alkam D, 2019, INFECT GENET EVOL, V75, DOI 10.1016/j.meegid.2019.103965; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P217; Barrabeig I, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4496-z; Bodewes R, 2019, INFECT GENET EVOL, V69, P230, DOI 10.1016/j.meegid.2019.02.005; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Dittrich S, 2011, VACCINE, V29, P9271, DOI 10.1016/j.vaccine.2011.09.072; Gavilan AM, 2018, EUROSURVEILLANCE, V23, P15, DOI 10.2807/1560-7917.ES.2018.23.15.17-00349; Gouma S, 2016, INFECT GENET EVOL, V45, P145, DOI 10.1016/j.meegid.2016.08.033; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Hasan MR, 2016, J CLIN MICROBIOL, V54, P919, DOI 10.1128/JCM.03050-15; Hirasing R A, 1993, Ned Tijdschr Geneeskd, V137, P1498; Jin L, 2005, ARCH VIROL, V150, P1903, DOI 10.1007/s00705-005-0563-4; Jin L, 2015, REV MED VIROL, V25, P85, DOI 10.1002/rmv.1819; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Moncla L, REAL TIME TRACKING M; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; PHILIP RN, 1995, AM J EPIDEMIOL, V142, P233, DOI 10.1093/oxfordjournals.aje.a117631; Philip RN, 1995, AM J EPIDEMIOL, V142, P233; Rambaut A., 2018, FIGTREE V1 4 4 I EVO; Sagulenko P, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vex042; Sane J, 2014, EMERG INFECT DIS, V20, P643, DOI 10.3201/eid2004.131681; Schurink-van't Klooster T., 2019, NATL IMMUNISATION PR; Stapleton PJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47740-1; Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256; Uchida K, 2005, J MED VIROL, V75, P470, DOI 10.1002/jmv.20291; Wohl S, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000611; Zamir CS, 2015, HUM VACC IMMUNOTHER, V11, P1413, DOI 10.1080/21645515.2015.1021522	30	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0233143	10.1371/journal.pone.0233143	http://dx.doi.org/10.1371/journal.pone.0233143			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925979	gold, Green Published, Green Submitted			2022-12-26	WOS:000572318000013
J	Marcelli, B; Karsens, H; Nijland, M; Oudshoorn, R; Kuipers, OP; Kok, J				Marcelli, Barbara; Karsens, Harma; Nijland, Mark; Oudshoorn, Ruben; Kuipers, Oscar P.; Kok, Jan			Employing lytic phage-mediated horizontal gene transfer in Lactococcus lactis	PLOS ONE			English	Article							LACTOSE METABOLISM; FLAVOR FORMATION; MULTIPLEX PCR; ACID BACTERIA; TRANSDUCTION; PLASMID; DNA; IDENTIFICATION; INDUSTRIAL; PROPHAGES	Lactococcus lactisis a lactic acid bacterium widely used as a starter culture in the manufacture of dairy products, especially a wide variety of cheeses. Improved industrial strains would help to manufacture better food products that can meet the industry's and consumer's demands with respect to e.g. quality, taste, texture and shelf life. Bacteriophage infection ofL.lactisstarter cultures represents one of the main causes of fermentation failure and consequent economic losses for the dairy industry. In this study, however, we aim at employing bacteriophages for beneficial purposes. We developed an experimental setup to assess whether phage-mediated horizontal gene transfer could be used to enhance the genetic characteristics ofL.lactisstrains in accordance with the European law regarding the use of genetically modified organisms (GMOs) in the food industry. Although we could not show the transfer of chromosomal DNA we did successfully transduce two dissimilar plasmids fromL.lactisstrain MG1363 to one of its derivatives employing three different lactococcal bacteriophages.	[Marcelli, Barbara; Karsens, Harma; Nijland, Mark; Oudshoorn, Ruben; Kuipers, Oscar P.; Kok, Jan] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Genet, Groningen, Netherlands	University of Groningen	Kok, J (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Genet, Groningen, Netherlands.	jan.kok@rug.nl	Kuipers, Oscar/B-6752-2009	Kuipers, Oscar/0000-0001-5596-7735; Nijland, Mark/0000-0001-5995-2717	Dutch Ministry of Economic Affairs	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This work was carried out within the BE-Basic R&D Program, which was granted an FES subsidy from the Dutch Ministry of Economic Affairs.	ALLEN LK, 1963, J DAIRY RES, V30, P351, DOI 10.1017/S0022029900011547; Ammann A, 2008, J BACTERIOL, V190, P3083, DOI 10.1128/JB.01448-07; Ayad EHE, 2001, J APPL MICROBIOL, V90, P59, DOI 10.1046/j.1365-2672.2001.01219.x; Baugher JL, 2014, APPL ENVIRON MICROB, V80, P3508, DOI 10.1128/AEM.04092-13; BIRKELAND NK, 1993, APPL ENVIRON MICROB, V59, P1966, DOI 10.1128/AEM.59.6.1966-1968.1993; BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; BOYCE JD, 1995, APPL ENVIRON MICROB, V61, P4089, DOI 10.1128/AEM.61.11.4089-4098.1995; Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365; Bron PA, 2019, CURR OPIN BIOTECH, V56, P61, DOI 10.1016/j.copbio.2018.09.004; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Chandry PS, 2002, FEMS MICROBIOL LETT, V216, P85, DOI 10.1111/j.1574-6968.2002.tb11419.x; Clokie Martha Rj, 2011, Bacteriophage, V1, P31, DOI 10.4161/bact.1.1.14942; Coil D, 2015, BIOINFORMATICS, V31, P587, DOI 10.1093/bioinformatics/btu661; del Rio B, 2007, FOOD MICROBIOL, V24, P75, DOI 10.1016/j.fm.2006.03.001; Derkx PMF, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S5; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Deveau H, 2006, APPL ENVIRON MICROB, V72, P4338, DOI 10.1128/AEM.02517-05; Diaz-Munoz SL, 2014, ADV APPL MICROBIOL, V89, P135, DOI 10.1016/B978-0-12-800259-9.00004-4; Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015; Fresco LO, 2013, SCIENCE, V339, P883, DOI 10.1126/science.1236010; Garneau JR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07910-5; GASSON MJ, 1983, J BACTERIOL, V154, P1; Hayes Maria, 2007, Biotechnology Journal, V2, P426, DOI 10.1002/biot.200600246; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Labrie S, 2000, APPL ENVIRON MICROB, V66, P987, DOI 10.1128/AEM.66.3.987-994.2000; Lang A, 2017, CURR OPIN MICROBIOL, V38, pV, DOI 10.1016/j.mib.2017.09.018; LEENHOUTS KJ, 1990, APPL ENVIRON MICROB, V56, P2726, DOI 10.1128/AEM.56.9.2726-2735.1990; LEENHOUTS KJ, 1991, APPL ENVIRON MICROB, V57, P2568, DOI 10.1128/AEM.57.9.2568-2575.1991; Licandro-Seraut H, 2012, APPL ENVIRON MICROB, V78, P5417, DOI 10.1128/AEM.00531-12; Lillehaug D, 1997, J APPL MICROBIOL, V83, P85, DOI 10.1046/j.1365-2672.1997.00193.x; Madeira F, 2019, NUCL ACIDS RES; MAGUIN E, 1992, J BACTERIOL, V174, P5633, DOI 10.1128/JB.174.17.5633-5638.1992; Mahony J, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00007; Marcelli B, 2019, APPL ENV MICROBIOL; MCKAY LL, 1973, J BACTERIOL, V115, P810, DOI 10.1128/JB.115.3.810-815.1973; MERCENIER A, 1988, MOL GEN GENET, V212, P386, DOI 10.1007/BF00334713; OLSON NF, 1990, FEMS MICROBIOL LETT, V87, P131, DOI 10.1111/j.1574-6968.1990.tb04884.x; Overkamp W, 2013, APPL ENVIRON MICROB, V79, P6481, DOI 10.1128/AEM.02033-13; Overmars L, 2015, BIOINFORMATICS, V31, P2867, DOI 10.1093/bioinformatics/btv249; POWELL IB, 1992, J GEN MICROBIOL, V138, P945, DOI 10.1099/00221287-138-5-945; Schuster H.Bacteriophages, 1962, ANGEW CHEM, V74, P164; Smit G, 2005, FEMS MICROBIOL REV, V29, P591, DOI 10.1016/j.femsre.2005.04.002; SNOOK RJ, 1981, APPL ENVIRON MICROB, V42, P897, DOI 10.1128/AEM.42.5.897-903.1981; Song AAL, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0669-x; Thierauf Anne, 2009, V501, P267, DOI 10.1007/978-1-60327-164-6_23; Wegmann U, 2012, MICROBIOL-SGM, V158, P2936, DOI 10.1099/mic.0.062554-0	46	3	3	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0238988	10.1371/journal.pone.0238988	http://dx.doi.org/10.1371/journal.pone.0238988			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925946	Green Published, gold			2022-12-26	WOS:000572318000047
J	Ruiz-Cabello, NM; Angulo, LMD; Sanchez, CC; Moglie, F; Garcia, SG				Ruiz-Cabello, Miguel N.; Angulo, Luis M. Diaz; Cobos Sanchez, Clemente; Moglie, Franco; Garcia, Salvador G.			Performance of parallel FDTD method for shared- and distributed-memory architectures: Application tobioelectromagnetics	PLOS ONE			English	Article							EXPOSURE SYSTEM; REVERBERATION; EFFICIENT	This work provides an in-depth computational performance study of the parallel finite-difference time-domain (FDTD) method. The parallelization is done at various levels including: shared- (OpenMP) and distributed- (MPI) memory paradigms and vectorization on three different architectures: Intel's Knights Landing, Skylake and ARM's Cavium ThunderX2. This study contributes to prove, in a systematic manner, the well-established claim within the Computational Electromagnetic community, that the main factor limiting FDTD performance, in realistic problems, is the memory bandwidth. Consequently a memory bandwidth threshold can be assessed depending on the problem size in order to attain optimal performance. Finally, the results of this study have been used to optimize the workload balancing of simulation of a bioelectromagnetic problem consisting in the exposure of a human model to a reverberation chamber-like environment.	[Ruiz-Cabello, Miguel N.; Garcia, Salvador G.] Univ Granada, Dept Electromagnet & Phys Matter, Granada, Spain; [Angulo, Luis M. Diaz] Sci & Technol Facil Council, Hartree Ctr S16, Daresbury Lab, Sci Tech Daresbury, Warrington, Cheshire, England; [Cobos Sanchez, Clemente] Univ Cadiz, Dept Ingn Automat, Cadiz, Spain; [Moglie, Franco] Univ Politecn Marche, Dipartimento Ingn Informaz, Ancona, Italy	University of Granada; STFC Daresbury Laboratory; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); Universidad de Cadiz; Marche Polytechnic University	Ruiz-Cabello, NM (corresponding author), Univ Granada, Dept Electromagnet & Phys Matter, Granada, Spain.	mcabello@ugr.es	Mariani primiani, Valter/HDL-7097-2022	Cobos Sanchez, Clemente/0000-0003-0299-5358; Ruiz - Cabello Nunez, Miguel David/0000-0001-9039-6181				Abstracts of the American Society of Hematology, 2003, BLOOD, V2003, p1a; Andreuccetti D., 1997, CALCULATION DIELECTR; Angulo LD, 2010, J ELECTROMAGNET WAVE, V24, P815, DOI 10.1163/156939310791036322; [Anonymous], 2019, MARENOSTRUM4 USERS G; Cabello MR, 2016, IEEE MICROW WIREL CO, V26, P553, DOI 10.1109/LMWC.2016.2588579; Capstick MH, 2017, IEEE T ELECTROMAGN C, V59, P1041, DOI 10.1109/TEMC.2017.2649885; Cessenat O, 2013, ARXIV13014539; Cruciani S, 2012, ASIA-PAC INT SYM ELE, P685, DOI 10.1109/APEMC.2012.6237915; Dey S, 1999, IEEE T MICROW THEORY, V47, P1737, DOI 10.1109/22.788616; Gabriel C, 1996, AIR FORCE MATERIEL C; Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002; Gomez Martin R., 2006, ELECTROMAGNETIC FIEL; Gosselin MC, 2004, PHYS MED BIOL, P5287; Gutierrez GG, 2016, IEEE T ELECTROMAGN C, V58, P401, DOI 10.1109/TEMC.2016.2514379; Hill DA, 1998, IEEE T ELECTROMAGN C, V40, P209, DOI 10.1109/15.709418; Hwang K, 2011, ADV COMPUTER ARCHITE; Jung KB, 2008, ELECTROMAGN BIOL MED, V27, P73, DOI 10.1080/15368370701878895; Ladbury J, 2004, TECH REP, P818; Lihong Zhang, 2012, 2012 2nd International Conference on Consumer Electronics, Communications and Networks (CECNet), P2342, DOI 10.1109/CECNet.2012.6201608; Mamedov Yusif A., 2006, COMMUN THEOR PHYS, V26, P137; Miller RG., 2019, WOMBAT GETTING START; Moglie F, 2006, IEEE T ELECTROMAGN C, V48, P195, DOI 10.1109/TEMC.2006.870793; Moglie F., 2011, Progress In Electromagnetics Research B, V29, P251, DOI 10.2528/PIERB11022506; Roden JA, 2000, MICROW OPT TECHN LET, V27, P334, DOI 10.1002/1098-2760(20001205)27:5<334::AID-MOP14>3.0.CO;2-A; Rodriguez G, 2008, INT J HIGH PERFORM C, V22, P81, DOI 10.1177/1094342006085022; Ruiz Cabello Miguel, 2018, NUMERICAL ASSESSMENT, P153; Sodani A, 2016, IEEE MICRO, V36, P34, DOI 10.1109/MM.2016.25; Sullivan, 2015, FERTILIZING BIOSOLID; Taflove A, 2013, ARTECH HSE ANTENN PR, P1; Taflove A., 2005, COMPUTATIONAL ELECTR, V3rd; YEE KS, 1966, IEEE T ANTENN PROPAG, VAP14, P302; Yu Wenhua, 2006, PARALLEL FINITE DIFF	32	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238115	10.1371/journal.pone.0238115	http://dx.doi.org/10.1371/journal.pone.0238115			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915812	gold, Green Published			2022-12-26	WOS:000571887500015
J	Scrimgeour, LA; Potz, BA; Gheit, AA; Liu, YH; Shi, GB; Pfeiffer, M; Colantuono, BJ; Sodha, NR; Abid, MR; Sellke, FW				Scrimgeour, Laura A.; Potz, Brittany A.; Gheit, Ahmad Aboul; Liu, Yuhong; Shi, Guangbin; Pfeiffer, Melissa; Colantuono, Bonnie J.; Sodha, Neel R.; Abid, M. Ruhul; Sellke, Frank W.			Intravenous injection of extracellular vesicles to treat chronic myocardial ischemia	PLOS ONE			English	Article							CARDIOMYOCYTE APOPTOSIS; CELLS; STRESS; EXOSOMES; PATHWAY	Background Mesenchymal stem cell-derived extracellular vesicles (EVs) appear to be a very exciting treatment option for heart disease. Here, we used a swine model of chronic myocardial ischemia to evaluate the efficacy of a less-invasive method of injection of EVs via a peripheral intravenous route. Methods Sixteen Yorkshire swine underwent placement of an ameroid constrictor on the left circumflex (LCx) artery at age 11 weeks to induce chronic myocardial ischemia. Two weeks later, they were divided into two groups: control (CON; n = 8), and intravenous injection of EVs (EVIV; n = 8). At 18 weeks of age, animals underwent final analysis and euthanasia. The chronically ischemic myocardium (LCx territory) was harvested for analysis. Results Intravenous injection (IV) of EVs induced several pro-angiogenic markers such as MAPK, JNK but not Akt. Whereas IV injections of EVs decreased VEGFR2 expression and inhibited apoptotic signaling (caspase 3), they increased expression of VEGFR1 that is believed to be anti-angiogenic. Injection of EVs did not result in an increase in vessel density and blood flow when compared to the control group. Conclusions Although IV injection of EVs upregulated several pro-angiogenic signaling pathways, it failed to induce changes in vascular density in the chronically ischemic myocardium. Thus, a lack of increase in vascular density at the doses tested failed to elicit a functional response in ischemic myocardium.	[Scrimgeour, Laura A.; Potz, Brittany A.; Gheit, Ahmad Aboul; Liu, Yuhong; Shi, Guangbin; Pfeiffer, Melissa; Colantuono, Bonnie J.; Sodha, Neel R.; Abid, M. Ruhul; Sellke, Frank W.] Brown Univ, Rhode Isl Hosp, Dept Surg, Cardiovasc Res Ctr,Div Cardiothorac Surg,Warren A, Providence, RI 02903 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Sellke, FW (corresponding author), Brown Univ, Rhode Isl Hosp, Dept Surg, Cardiovasc Res Ctr,Div Cardiothorac Surg,Warren A, Providence, RI 02903 USA.	fsellke@lifespan.org			National Heart, Lung, and Blood Institute (NHLBI) [R01HL46716, RO1HL12883101A1]; American Heart Association [14GRNT20460291]; NHLBI [1R01HL133624-01A1]; NIH/NIGMS [2T32 GM065085-12, 2T32 GM065085-13]	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this research was provided by the National Heart, Lung, and Blood Institute (NHLBI) [R01HL46716 (F.W.S.), RO1HL12883101A1 (F.W.S.]; American Heart Association Grantin-Aid 14GRNT20460291 and NHLBI 1R01HL133624-01A1 (to M.R.A.); NIH/NIGMS Training Grant 2T32 GM065085-12 (B.A.P.) and 2T32 GM065085-13 (L.A.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslan F, 2013, STEM CELL RES, V10, P301, DOI 10.1016/j.scr.2013.01.002; Bartunek J, 2017, EUR HEART J, V38, P648, DOI 10.1093/eurheartj/ehw543; Bazzazi H, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005332; Bolli R, 2013, CIRCULATION, V128, P122, DOI 10.1161/CIRCULATIONAHA.112.001075; Bronckaers A, 2014, PHARMACOL THERAPEUT, V143, P181, DOI 10.1016/j.pharmthera.2014.02.013; Chappell JC, 2016, CARDIOVASC RES, V111, P84, DOI 10.1093/cvr/cvw091; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Gao YX, 2018, BIOORG MED CHEM LETT, V28, P394, DOI 10.1016/j.bmcl.2017.12.031; Grisanti LA, 2014, J MOL CELL CARDIOL, V72, P39, DOI 10.1016/j.yjmcc.2014.02.009; Kraitchman DL, 2005, CIRCULATION, V112, P1451, DOI 10.1161/CIRCULATIONAHA.105.537480; Lai RC, 2010, STEM CELL RES, V4, P214, DOI 10.1016/j.scr.2009.12.003; Malliaras K, 2014, J AM COLL CARDIOL, V63, P110, DOI 10.1016/j.jacc.2013.08.724; Moon MR, 2001, ANN THORAC SURG, V72, P2003, DOI 10.1016/S0003-4975(01)03144-7; Moran AE, 2014, CIRCULATION, V129, P1493, DOI 10.1161/CIRCULATIONAHA.113.004046; Natsumeda M, 2017, J AM COLL CARDIOL, V70, P2504, DOI 10.1016/j.jacc.2017.09.036; Phinney DG, 2017, STEM CELLS, V35, P851, DOI 10.1002/stem.2575; Potz BA, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008344; Ram E, 2018, EUR J CARDIO-THORAC, V54, P717, DOI 10.1093/ejcts/ezy115; Rose BA, 2017, J BIOL CHEM, V292, P12787, DOI 10.1074/jbc.M117.784553; Scrimgeour LA, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012617; Timmers L, 2008, STEM CELL RES, V1, P129, DOI 10.1016/j.scr.2008.02.002; Wang YJ, 2015, INT J CARDIOL, V192, P61, DOI 10.1016/j.ijcard.2015.05.020; Wu RR, 2018, STEM CELLS, V36, P482, DOI 10.1002/stem.2778	23	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238879	10.1371/journal.pone.0238879	http://dx.doi.org/10.1371/journal.pone.0238879			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915887	gold, Green Published			2022-12-26	WOS:000571887500012
J	Kim, G; Lee, SG; Han, SS; Jung, J; Jeong, HS; Hyun, JK; Rhee, DK; Kim, HM; Lee, S				Kim, Gyuhee; Lee, Seong-Gyu; Han, Seungsu; Jung, Jaeeun; Jeong, Hyeong Seop; Hyun, Jae-kyung; Rhee, Dong-Kwon; Kim, Ho Min; Lee, Sangho			ClpL is a functionally active tetradecameric AAA plus chaperone, distinct from hexameric/dodecameric ones	FASEB JOURNAL			English	Article						chaperone; ClpL; Hsp100; S; pneumoniae; tetradecamer	CRYO-EM STRUCTURE; ESCHERICHIA-COLI; MOLECULAR CHAPERONE; ATPASE CYCLE; MIDDLE DOMAIN; PROTEIN; BINDING; HSP104; OLIGOMERIZATION; DYNAMICS	AAA+ (ATPases associated with diverse cellular activities) chaperones are involved in a plethora of cellular activities to ensure protein homeostasis. The function of AAA+ chaperones is mostly modulated by their hexameric/dodecameric quaternary structures. Here we report the structural and biochemical characterizations of a tetradecameric AAA+ chaperone, ClpL fromStreptococcus pneumoniae. ClpL exists as a tetradecamer in solution in the presence of ATP. The cryo-EM structure of ClpL at 4.5 angstrom resolution reveals a striking tetradecameric arrangement. Solution structures of ClpL derived from small-angle X-ray scattering data suggest that the tetradecameric ClpL could assume a spiral conformation found in active hexameric/dodecameric AAA+ chaperone structures. Vertical positioning of the middle domain accounts for the head-to-head arrangement of two heptameric rings. Biochemical activity assays with site-directed mutagenesis confirmed the critical roles of residues both in the integrity of the tetradecameric arrangement and activities of ClpL. Non-conserved Q321 and R670 are crucial in the heptameric ring assembly of ClpL. These results establish that ClpL is a functionally active tetradecamer, clearly distinct from hexameric/dodecameric AAA+ chaperones.	[Kim, Gyuhee; Han, Seungsu; Jung, Jaeeun; Lee, Sangho] Sungkyunkwan Univ, Dept Biol Sci, Suwon 16419, South Korea; [Lee, Seong-Gyu; Kim, Ho Min] Inst Basic Sci IBS, Ctr Biomol & Cellular Struct, Daejeon 34141, South Korea; [Lee, Seong-Gyu; Kim, Ho Min] Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Jeong, Hyeong Seop; Hyun, Jae-kyung] Korea Basic Sci Inst, Cheongju, South Korea; [Rhee, Dong-Kwon] Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea; [Hyun, Jae-kyung] Okinawa Inst Sci & Technol Grad Univ, Okinawa, Japan; [Lee, Sangho] Sungkyunkwan Univ, Biomed Inst Convergence SKKU, Suwon, South Korea	Sungkyunkwan University (SKKU); Institute for Basic Science - Korea (IBS); Korea Advanced Institute of Science & Technology (KAIST); Korea Basic Science Institute (KBSI); Sungkyunkwan University (SKKU); Okinawa Institute of Science & Technology Graduate University; Sungkyunkwan University (SKKU)	Lee, S (corresponding author), Sungkyunkwan Univ, Dept Biol Sci, Suwon 16419, South Korea.; Kim, HM (corresponding author), Inst Basic Sci IBS, Ctr Biomol & Cellular Struct, Daejeon 34141, South Korea.	kimhm@ibs.re.kr; sangholee@skku.edu	Hyun, Jaekyung/AAK-2521-2020	Hyun, Jaekyung/0000-0003-2914-537X	National Research Foundation of Korea (NRF) [NRF-2018R1A2B6004367, NRF-2017R1A5A1014560]; Rural Development Agency [PJ01367602]; Institute of Basic Science [IBS-R030-C1]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Rural Development Agency; Institute of Basic Science	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2018R1A2B6004367 and NRF-2017R1A5A1014560; Rural Development Agency, Grant/Award Number: PJ01367602; Institute of Basic Science, Grant/Award Number: IBS-R030-C1	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akoev V, 2004, PROTEIN SCI, V13, P567, DOI 10.1110/ps.03422604; Barnett ME, 2000, J BIOL CHEM, V275, P37565, DOI 10.1074/jbc.M005211200; Bin Masood T, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0545-9; Biter AB, 2012, P NATL ACAD SCI USA, V109, P12515, DOI 10.1073/pnas.1207040109; Carroni Marta, 2017, Elife, V6, DOI 10.7554/eLife.30120; Carroni M, 2014, ELIFE, V3, DOI 10.7554/eLife.02481; Corrales FJ, 1996, P NATL ACAD SCI USA, V93, P4509, DOI 10.1073/pnas.93.9.4509; DeSantis ME, 2014, J BIOL CHEM, V289, P848, DOI 10.1074/jbc.M113.520759; Deville C, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701726; Doyle SM, 2013, NAT REV MOL CELL BIO, V14, P617, DOI 10.1038/nrm3660; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Duran EC, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00054; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ewens CA, 2016, STRUCTURE, V24, P657, DOI 10.1016/j.str.2016.03.018; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gates SN, 2017, SCIENCE, V357, P273, DOI 10.1126/science.aan1052; Grant T, 2018, ELIFE, V7, DOI 10.7554/eLife.35383; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; HAYERHARTL MK, 1995, SCIENCE, V269, P836, DOI 10.1126/science.7638601; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Ishikawa T, 2001, P NATL ACAD SCI USA, V98, P4328, DOI 10.1073/pnas.081543698; Kater L, 2020, NAT STRUCT MOL BIOL, V27, P142, DOI 10.1038/s41594-019-0364-1; Kedzierska S, 2003, BIOCHEMISTRY-US, V42, P14242, DOI 10.1021/bi035573d; Kim KI, 2000, J MOL BIOL, V303, P655, DOI 10.1006/jmbi.2000.4165; Kirstein J, 2009, NAT REV MICROBIOL, V7, P589, DOI 10.1038/nrmicro2185; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee S, 2004, J STRUCT BIOL, V146, P99, DOI 10.1016/j.jsb.2003.11.016; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Li T, 2015, BIOCHEM J, V470, P39, DOI 10.1042/BJ20141457; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lipinska N, 2013, J BIOL CHEM, V288, P2857, DOI 10.1074/jbc.M112.387589; Liu J, 2013, J BIOL CHEM, V288, P17597, DOI 10.1074/jbc.M113.458752; Lopez KE, 2020, NAT STRUCT MOL BIOL, V27, P406, DOI 10.1038/s41594-020-0409-5; Miller JM, 2018, J STRUCT BIOL, V201, P52, DOI 10.1016/j.jsb.2017.11.003; Miyata T, 2000, J STRUCT BIOL, V131, P83, DOI 10.1006/jsbi.2000.4290; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Park SS, 2015, FEBS J, V282, P1352, DOI 10.1111/febs.13228; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Puchades C, 2020, NAT REV MOL CELL BIO, V21, P43, DOI 10.1038/s41580-019-0183-6; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Ripstein ZA, 2020, ELIFE, V9, DOI 10.7554/eLife.52158; Rizo AN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10150-y; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rohrwild M, 1997, NAT STRUCT BIOL, V4, P133, DOI 10.1038/nsb0297-133; Saeed IA, 2009, INT J BIOL MACROMOL, V45, P236, DOI 10.1016/j.ijbiomac.2009.05.010; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schuck P, 2014, ANALYST, V139, P79, DOI 10.1039/c3an01507f; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Shorter J, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a034033; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Sweeny EA, 2016, J MOL BIOL, V428, P1870, DOI 10.1016/j.jmb.2015.11.016; Thomas JG, 2000, MOL MICROBIOL, V36, P1360, DOI 10.1046/j.1365-2958.2000.01951.x; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang F, 2011, NATURE, V471, P331, DOI 10.1038/nature09780; Wang RYR, 2016, ELIFE, V5, DOI 10.7554/eLife.17219; Yamasaki T, 2015, J BIOL CHEM, V290, P9789, DOI 10.1074/jbc.M114.617696; Yokom AL, 2016, NAT STRUCT MOL BIOL, V23, P830, DOI 10.1038/nsmb.3277; Yu HJ, 2018, P NATL ACAD SCI USA, V115, pE9560, DOI 10.1073/pnas.1810648115; Zhang XD, 2008, NAT STRUCT MOL BIOL, V15, P1223, DOI 10.1038/nsmb.1501; Zheng JX, 2020, BMC MICROBIOL, V20, DOI 10.1186/s12866-020-1719-9; Zolkiewski M, 1999, J BIOL CHEM, V274, P28083, DOI 10.1074/jbc.274.40.28083; Zolkiewski M, 1999, PROTEIN SCI, V8, P1899, DOI 10.1110/ps.8.9.1899; Zolkiewski M, 2012, ARCH BIOCHEM BIOPHYS, V520, P1, DOI 10.1016/j.abb.2012.01.012	70	3	3	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14353	14370		10.1096/fj.202000843R	http://dx.doi.org/10.1096/fj.202000843R		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32910525				2022-12-26	WOS:000570574700001
J	Rodrigues, YC; Furlaneto, IP; Maciel, AHP; Quaresma, AJPG; de Matos, ECO; Conceicao, ML; Vieira, MCD; Brabo, GLD; Sarges, EDNF; Lima, LNGC; Lima, KVB				Rodrigues, Yan Correa; Furlaneto, Ismari Perini; Pinto Maciel, Arthur Henrique; Pires Garcia Quaresma, Ana Judith; Oliveira de Matos, Eliseth Costa; Conceicao, Marilia Lima; da Silva Vieira, Marcelo Cleyton; da Cunha Brabo, Giulia Leao; Nascimento Falcao Sarges, Edilene do Socorro; Godim Costa Lima, Luana Nepomuceno; Batista Lima, Karla Valeria			High prevalence of atypical virulotype and genetically diverse background among Pseudomonas aeruginosa isolates from a referral hospital in the Brazilian Amazon	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; III SECRETION SYSTEM; INTENSIVE-CARE-UNIT; RIO-DE-JANEIRO; ANTIBIOTIC-RESISTANCE; VIRULENCE FACTORS; POPULATION-STRUCTURE; GENES; INFECTIONS; DISSEMINATION	Pseudomonas aeruginosais an opportunistic pathogen causing different types of infections, particularly in intensive care unit patients. Characteristics that favor its persistence artificial environments are related to its high adaptability, wide arsenal of virulence factors and resistance to several antimicrobial classes. Among the several virulence determinants, T3SS stands as the most important due to the clinical impact ofexoSandexoUgenes in patient's outcome. The molecular characterization ofP.aeruginosaisolates helps in the comprehension of transmission dynamics and enhance knowledge of virulence and resistance roles in infection process. In the present study, we investigated virulence and resistance properties and the genetic background ofP.aeruginosaisolated from ICUs patients at a referral hospital in Brazilian Amazon. A total of 54P.aeruginosaisolates were characterized by detecting 19 virulence-related genes, antimicrobial susceptibility testing, molecular detection of beta-lactamase-encoding genes and genotyping by MLST and rep-PCR. Our findings showed high prevalence of virulence-related markers, where 53.7% of the isolates presented at least 17 genes among the 19 investigated (P= 0.01). The rareexoS(+)/exoU(+)cytotoxic virulotype was detected in 55.6% of isolates. Antimicrobial susceptibility testing revealed percentages of antibiotic resistance above 50% to carbapenems, cephalosporins and fluoroquinolones associated to MDR/XDR isolates. Isolates harboring bothbla(SPM-1)andbla(OXA)genes were also detected. Genotyping methods demonstrated a wide genetic diversity of strains spread among the different intensive care units, circulation of international MDR/XDR high-risk clones (ST111, ST235, ST244 and ST277) and emergence of seven novel MLST lineages. Finally, our findings highlight the circulation of strains with high virulence potential and resistance to antimicrobials and may be useful on comprehension of pathogenicity process, treatment guidance and establishment of strategies to control the spread of epidemicP.aeruginosastrains.	[Rodrigues, Yan Correa; Conceicao, Marilia Lima; Nascimento Falcao Sarges, Edilene do Socorro; Godim Costa Lima, Luana Nepomuceno; Batista Lima, Karla Valeria] Univ Estado Para UEPA, Ctr Ciencias Biol & Saude, Programa Posgrad Biol Parasitaria Amazonia, Belem, Para, Brazil; [Furlaneto, Ismari Perini] Ctr Univ Para CESUPA, Programa Posgrad Educ Saude, Belem, Para, Brazil; [Pinto Maciel, Arthur Henrique; Pires Garcia Quaresma, Ana Judith; da Silva Vieira, Marcelo Cleyton; da Cunha Brabo, Giulia Leao; Godim Costa Lima, Luana Nepomuceno; Batista Lima, Karla Valeria] Minist Saude, Lab Biol Mol, Secao Bacteriol & Micol, Inst Evandro Chagas IEC, Ananindeua, Para, Brazil; [Oliveira de Matos, Eliseth Costa] Univ Estado Para UEPA, Ctr Ciencias Biol & Saude, Dept Patol, Belem, Para, Brazil	Universidade do Estado do Para (UEPA); Centro Universitario do Estado do Para (CESUPA); Instituto Evandro Chagas; Universidade do Estado do Para (UEPA)	Lima, KVB (corresponding author), Univ Estado Para UEPA, Ctr Ciencias Biol & Saude, Programa Posgrad Biol Parasitaria Amazonia, Belem, Para, Brazil.; Lima, KVB (corresponding author), Minist Saude, Lab Biol Mol, Secao Bacteriol & Micol, Inst Evandro Chagas IEC, Ananindeua, Para, Brazil.	yan.13@hotmail.com; karlalima@iec.gov.br	Rodrigues, Yan/ABA-8295-2021; CORRÊA RODRIGUES, YAN/AAC-9201-2022; Lima, Karla Valéria/AAF-8256-2021; Lima da Conceicao, Marilia/G-4045-2018	Rodrigues, Yan/0000-0002-9922-4797; CORRÊA RODRIGUES, YAN/0000-0002-9922-4797; Lima, Karla Valéria/0000-0001-5807-0392; Lima da Conceicao, Marilia/0000-0002-3162-142X; Reis, AlessanRSS/0000-0001-8486-7469	Fundacao de Amparo a Pesquisa do Para/Universidade do Estado do Para (FAPESPA/UEPA) [004/2019]; Programa Institucional de Bolsas de Iniciacao Cientifica/Instituto Evandro Chagas - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (PIBIC/IEC-CNPq); Instituto Evandro Chagas/Ministerio da Saude/Secretaria de Vigilancia em Saude (IEC/MS/SVS)	Fundacao de Amparo a Pesquisa do Para/Universidade do Estado do Para (FAPESPA/UEPA); Programa Institucional de Bolsas de Iniciacao Cientifica/Instituto Evandro Chagas - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (PIBIC/IEC-CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Evandro Chagas/Ministerio da Saude/Secretaria de Vigilancia em Saude (IEC/MS/SVS)	This research was supported by funding from Fundacao de Amparo a Pesquisa do Para/Universidade do Estado do Para (FAPESPA/UEPA) [Cooperation grant No 004/2019], Programa Institucional de Bolsas de Iniciacao Cientifica/Instituto Evandro Chagas - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (PIBIC/IEC-CNPq) and Instituto Evandro Chagas/Ministerio da Saude/Secretaria de Vigilancia em Saude (IEC/MS/SVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboushleib HM, 2015, J INFECT DEV COUNTR, V9, P1091, DOI 10.3855/jidc.6492; Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; [Anonymous], 2008, BIOESTAT 5 0 APLICAC; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2019, CANC DISCOV, V10, pOF5; [Anonymous], 2017, J ADOLESCENT HEALT S, V61, pS1; Ballok AE, 2013, J BACTERIOL, V195, P4013, DOI 10.1128/JB.00339-13; Berezin EN, 2014, J INFECT DEV COUNTR, V8, P942, DOI 10.3855/jidc.4590; Bert F, 2002, J ANTIMICROB CHEMOTH, V50, P11, DOI 10.1093/jac/dkf069; Bonnet R, 2000, ANTIMICROB AGENTS CH, V44, P1936, DOI 10.1128/AAC.44.7.1936-1942.2000; Bradbury RS, 2010, J MED MICROBIOL, V59, P881, DOI 10.1099/jmm.0.018283-0; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Braga IA, 2018, J HOSP INFECT, V99, P318, DOI 10.1016/j.jhin.2018.03.003; Cabot G, 2016, ANTIMICROB AGENTS CH, V60, P7415, DOI 10.1128/AAC.01720-16; Cacci LC, 2016, MEM I OSWALDO CRUZ, V111, P551, DOI 10.1590/0074-02760160116; Chen Y, 2014, EUR J CLIN MICROBIOL, V33, P1181, DOI 10.1007/s10096-014-2063-5; Cho HH, 2014, ANN LAB MED, V34, P286, DOI 10.3343/alm.2014.34.4.286; Cho HH, 2013, ANN CLIN LAB SCI, V43, P414; Clinical and Laboratory Standards Institute, 2018, M100S28 CLSI; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; Santos ICD, 2019, INFECT GENET EVOL, V73, P411, DOI 10.1016/j.meegid.2019.05.015; Dekimpe V, 2009, MICROBIOL-SGM, V155, P712, DOI 10.1099/mic.0.022764-0; del Barrio-Tofino E, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.02352-17; Du X, 2010, MOL CELL BIOL, V30, P3444, DOI 10.1128/MCB.00813-09; Fazeli N, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.15722; Feil EJ, 2004, CURR OPIN MICROBIOL, V7, P308, DOI 10.1016/j.mib.2004.04.002; Silva KDFD, 2017, BURNS, V43, P137, DOI 10.1016/j.burns.2016.07.002; Finlayson EA, 2011, W INDIAN MED J, V60, P24; Finnan S, 2004, J CLIN MICROBIOL, V42, P5783, DOI 10.1128/JCM.42.12.5783-5792.2004; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Gales AC, 2003, J ANTIMICROB CHEMOTH, V52, P699, DOI 10.1093/jac/dkg416; Garey KW, 2008, J CHEMOTHERAPY, V20, P714, DOI 10.1179/joc.2008.20.6.714; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Gomez-Zorrilla S, 2016, INT J ANTIMICROB AG, V47, P368, DOI 10.1016/j.ijantimicag.2016.02.010; Haque M, 2018, INFECT DRUG RESIST, V11, P2321, DOI 10.2147/IDR.S177247; Hassuna NA, 2020, INFECT DRUG RESIST, V13, P587, DOI 10.2147/IDR.S233694; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hermes DM, 2013, J MED MICROBIOL, V62, P1184, DOI 10.1099/jmm.0.059220-0; Hong DJ, 2015, INFECT CHEMOTHER, V47, P81, DOI 10.3947/ic.2015.47.2.81; Horna G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47303-4; Hu PW, 2017, INFECT GENET EVOL, V55, P288, DOI 10.1016/j.meegid.2017.09.010; Jabalameli F, 2012, BURNS, V38, P1192, DOI 10.1016/j.burns.2012.07.030; Kipnis E, 2006, MED MALADIES INFECT, V36, P78, DOI 10.1016/j.medmal.2005.10.007; Kos VN, 2015, ANTIMICROB AGENTS CH, V59, P427, DOI 10.1128/AAC.03954-14; Laarman AJ, 2012, J IMMUNOL, V188, P386, DOI 10.4049/jimmunol.1102162; Labarca JA, 2016, CRIT REV MICROBIOL, V42, P276, DOI 10.3109/1040841X.2014.940494; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Liu HQ, 2018, INFECT DRUG RESIST, V11, P45, DOI 10.2147/IDR.S152162; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; Lomaestro BM, 2006, CLIN INFECT DIS, V43, pE26, DOI 10.1086/505598; Lombardi C, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00573; Lomholt JA, 2001, INFECT IMMUN, V69, P6284, DOI 10.1128/IAI.69.10.6284-6295.2001; Lopez CA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16497-w; Luna CM, 2014, CRIT CARE RES PRACT, V2014, DOI 10.1155/2014/480463; Maatallah M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082069; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Martins AF, 2007, INFECTION, V35, P457, DOI 10.1007/s15010-007-6289-3; Matsumoto K, 2004, BIOL CHEM, V385, P1007, DOI 10.1515/BC.2004.131; Miranda CC, 2015, J APPL MICROBIOL, V118, P1276, DOI 10.1111/jam.12792; Mitov I, 2010, BRAZ J MICROBIOL, V41, P588, DOI 10.1590/S1517-83822010000300008; Morales-Espinosa R, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00313; Mulet X, 2013, ANTIMICROB AGENTS CH, V57, P5527, DOI 10.1128/AAC.01481-13; Najafi K, 2015, J PURE APPL MICROBIO, V9, P383; Nordmann P, 2011, J CLIN MICROBIOL, V49, P718, DOI 10.1128/JCM.01773-10; de Matos ECO, 2018, REV SOC BRAS MED TRO, V51, P415, DOI 10.1590/0037-8682-0506-2017; de Matos ECO, 2016, REV SOC BRAS MED TRO, V49, P305, DOI 10.1590/0037-8682-0446-2015; Oliver A, 2015, DRUG RESIST UPDATE, V21-22, P41, DOI 10.1016/j.drup.2015.08.002; Parkins MD, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00019-18; Pellegrino FLPC, 2002, J CLIN MICROBIOL, V40, P2420, DOI 10.1128/JCM.40.7.2420-2424.2002; Pena C, 2015, CLIN INFECT DIS, V60, P539, DOI 10.1093/cid/ciu866; Goncalves DCPS, 2009, REV SOC BRAS MED TRO, V42, P411, DOI 10.1590/S0037-86822009000400010; Pobiega M, 2018, POSTEP HIG MED DOSW, V72, P751, DOI 10.5604/01.3001.0012.2426; Poirel L, 2000, ANTIMICROB AGENTS CH, V44, P891, DOI 10.1128/AAC.44.4.891-897.2000; Poirel L, 2012, INFECT GENET EVOL, V12, P883, DOI 10.1016/j.meegid.2012.02.008; Pons MN, 2018, MINER RESOUR REV, P53, DOI 10.1007/978-3-319-61899-9_4; Recio R, 2020, EUR J CLIN MICROBIOL, V39, P671, DOI 10.1007/s10096-019-03780-z; Royer S, 2015, BRAZ J INFECT DIS, V19, P350, DOI 10.1016/j.bjid.2015.03.009; Ruiz-Roldan L, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8060178; Russotto V, 2015, INFECT DRUG RESIST, V8, P287, DOI 10.2147/IDR.S48810; Sabharwal N, 2014, INT J MOL EPIDEMIOL, V5, P125; Sader Helio S., 2004, Braz J Infect Dis, V8, P25, DOI 10.1590/S1413-86702004000100004; Sawa T, 2020, MICROBIOL IMMUNOL, V64, P331, DOI 10.1111/1348-0421.12776; Sawa T, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0668-9; SCHURR MJ, 1994, J BACTERIOL, V176, P3375, DOI 10.1128/jb.176.11.3375-3382.1994; Senturk S, 2012, J INFECT DEV COUNTR, V6, P501; Silveira MC, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6650-9; Stacey SD, 2016, J BACTERIOL, V198, P1812, DOI 10.1128/JB.00133-16; Suarez C, 2009, J INFECTION, V58, P285, DOI 10.1016/j.jinf.2009.02.010; Treepong P, 2018, CLIN MICROBIOL INFEC, V24, P258, DOI 10.1016/j.cmi.2017.06.018; Wolska K, 2009, POL J MICROBIOL, V58, P255; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; WOZNIAK DJ, 1994, J BACTERIOL, V176, P6007, DOI 10.1128/jb.176.19.6007-6014.1994; Yezli S, 2015, J MED MICROBIOL, V64, P127, DOI 10.1099/jmm.0.077834-0; Zhu H, 2006, CURR EYE RES, V31, P297, DOI 10.1080/02713680500536746	94	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238741	10.1371/journal.pone.0238741	http://dx.doi.org/10.1371/journal.pone.0238741			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911510	Green Published, gold			2022-12-26	WOS:000571885900055
J	Randau, TM; Jaenisch, M; Haffer, H; Schomig, F; Kasapovic, A; Olejniczak, K; Flechtenmacher, J; Perka, C; Wirtz, DC; Pumberger, M				Randau, Thomas M.; Jaenisch, Max; Haffer, Henryk; Schoemig, Friederike; Kasapovic, Adnan; Olejniczak, Katharina; Flechtenmacher, Johannes; Perka, Carsten; Wirtz, Dieter C.; Pumberger, Matthias			Collateral effect of COVID-19 on orthopedic and trauma surgery	PLOS ONE			English	Article								Objectives The purpose of this study was to assess the impact of the COVID-19 pandemic on orthopedic and trauma surgery in private practices and hospitals in Germany. Design In this cross-sectional study, an online-based anonymous survey was conducted from April 2th to April 16(th)2020. Setting The survey was conducted among 15.0000 of 18.000 orthopedic and trauma surgeons in Germany, both in private practices and hospitals. Participants All members of the German Society of Orthopedic and Trauma Surgery (DGOU) and the Professional Association for Orthopedic and Trauma Surgery (BVOU). were invited by e-mail to participate in the survey. Main outcome measures Out of 50 questions 42 were designed to enquire a certain dimension of the pandemic impact and contribute to one of six indices, namely "Preparedness", "Resources", "Reduction", "Informedness", "Concern", and "Depletion". Data was analyzed in multiple stepwise regression, aiming to identify those factors that independently influenced the indices. Results 858 orthopedic and trauma surgeons participated in the survey throughout Germany. In the multiple regression analysis, being employed at a hospital was identified as an independent positive predictor in the indices for "Preparedness", "Resources", and "Informedness" and an independent negative predictor regarding "Depletion". Self-employment was found to be an independent positive predictor of the financial index "Depletion". Female surgeons were identified as an independent variable for a higher level of "Concern". Conclusions The study confirms a distinct impact of the COVID-19 pandemic on orthopedic and trauma surgery in Germany. The containment measures are largely considered appropriate despite severe financial constraints. A substantial lack of personal protective equipment (PPE) is reported. The multiple regression analysis shows that self-employed surgeons are more affected by this shortage as well as by the financial consequences than surgeons working in hospitals. What are the new findings The COVID-19 pandemic has a profound impact on orthopedic and trauma surgery as an unrelated specialty. Self-employed surgeons are affected especially by a shortage of PPE and financial consequences. How might it impact on clinical practice in the near future Political and financial support can now be applied more focused to subgroups in the field of orthopedics and trauma surgery with an increased demand for support. A special emphasis should be set on the support of self-employed surgeons which are a more affected by the shortage of PPE and financial consequences than surgeons working in hospitals.	[Randau, Thomas M.; Jaenisch, Max; Kasapovic, Adnan; Wirtz, Dieter C.] Univ Hosp Bonn, Dept Orthoped & Trauma Surg, Bonn, Germany; [Haffer, Henryk; Schoemig, Friederike; Perka, Carsten; Pumberger, Matthias] Charite Univ Med Berlin, Ctr Musculoskeletal Surg, Berlin, Germany; [Olejniczak, Katharina] Univ Bonn, Ctr Evaluat & Methods, Bonn, Germany; [Flechtenmacher, Johannes] Profess Assoc Orthoped & Trauma Surg, Berlin, Germany	University of Bonn; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bonn	Pumberger, M (corresponding author), Charite Univ Med Berlin, Ctr Musculoskeletal Surg, Berlin, Germany.	matthias.pumberger@charite.de	Randau, Thomas/AAY-8690-2021; Perka, Carsten/ABG-6505-2021; Randau, Thomas Martin/AEP-9749-2022	Randau, Thomas Martin/0000-0002-5224-9639; Pumberger, Matthias/0000-0002-0885-7370; Jaenisch, Max/0000-0001-5998-0224; Haffer, Henryk/0000-0002-5614-5431; Perka, Carsten/0000-0002-0993-581X	Executive Board of German Society for Orthopedic and Trauma surgery (DGOU); Executive Board of Professional Association of Orthopedic and Trauma Surgery (BVOU); German Research Foundation (DFG); Open Access Publication Funds of Charite - Universitatsmedizin Berlin	Executive Board of German Society for Orthopedic and Trauma surgery (DGOU); Executive Board of Professional Association of Orthopedic and Trauma Surgery (BVOU); German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Funds of Charite - Universitatsmedizin Berlin	The authors warmly thank the German Society for Orthopedic and Trauma surgery (DGOU) and the Professional Association of Orthopedic and Trauma Surgery (BVOU) and in particular the Executive Board of both associations for their support. We acknowledge the helpful support the Department of Craniomaxillofacial Surgery, University Hospital Bonn, Germany and the Center for Development Research, University Hospital Bonn, Germany for their advice on and help with STATA and multiple regression models. The authors would like to thank the participants of the survey for their time and effort. We acknowledge support from the German Research Foundation (DFG) and the Open Access Publication Funds of Charite - Universitatsmedizin Berlin.	Anoushiravani A, 2020, J BONE JOINT SURG; Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397; Federal Statistical Office of Germany, 20 MOST FREQUENT SUR; German Federal Ministry of Health, LAW RED BURD GERM HO; German Medical Association, STAT DISTR SPEC GERM; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Johns Hopkins University & Medicine Coronavirus Resource Center, COVID19 INF DEATHS G; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Mavrogenis AF, 2020, INT ORTHOP; McLean CP, 2009, CLIN PSYCHOL REV, V29, P496, DOI 10.1016/j.cpr.2009.05.003; Negri S, 2021, INT J SURG PATHOL, V29, P120, DOI 10.1177/1066896920927794; German IJS, 2020, MATERIALS, V13, DOI 10.3390/ma13030695; Tian Q, 2020, GEROSCIENCE, V42, P1377, DOI 10.1007/s11357-020-00227-8; Wirtz DC, 2020, Z ORTHOP UNFALLCHIR, V158, P163, DOI 10.1055/a-0876-4652; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	17	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238759	10.1371/journal.pone.0238759	http://dx.doi.org/10.1371/journal.pone.0238759			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ6EE	32898179	gold, Green Published			2022-12-26	WOS:000570962500008
J	Wang, WW; Wang, YM; Li, K; Tadagavadi, R; Friedrichs, WE; Budatha, M; Reeves, WB				Wang, Wei Wei; Wang, Yamei; Li, Kang; Tadagavadi, Raghu; Friedrichs, William E.; Budatha, Madhusudhan; Reeves, W. Brian			IL-10 from dendritic cells but not from T regulatory cells protects against cisplatin-induced nephrotoxicity	PLOS ONE			English	Article							INFLAMMATION; MACROPHAGES; EXPRESSION; ENDOTOXIN; NECROSIS; INJURY	Interleukin-10 (IL-10), a cytokine with anti-inflammatory effects, is produced by renal parenchymal cells and bone marrow derived cells. Both endogenous and exogenous IL-10 are protective in cisplatin-induced acute kidney injury. However, the source of endogenous IL-10 in cisplatin-induced nephrotoxicity is not clear. Bone marrow chimera experiments in IL10-KO mice indicated that bone marrow derived cells were the primary source of IL-10 in cisplatin nephrotoxicity. Cell specific deletion of IL-10 in T regulatory cells and dendritic cells was accomplished using Foxp3 and CD11c driven cre recombination inIL10(flox/flox)mice, respectively. Upon treatment with cisplatin, both theIL10(flox/flox)and the Foxp3(YFP-Cre)xIL10(flox/flox)mice developed similar degrees of kidney injury. However, mice with the dendritic cell deletion of IL-10 showed more severe structural and functional changes in the kidney compared to theIL10(flox/flox)mice. These results indicate that IL-10 from dendritic cells but not from T regulatory cells offers significant endogenous protection against cisplatin induced nephrotoxicity.	[Wang, Wei Wei; Wang, Yamei; Li, Kang; Friedrichs, William E.; Budatha, Madhusudhan; Reeves, W. Brian] Univ Texas San Antonio, Long Sch Med, Dept Med, Div Nephrol, San Antonio, TX 78229 USA; [Wang, Wei Wei; Tadagavadi, Raghu; Reeves, W. Brian] Penn State Hershey Coll Med, Div Nephrol, Hershey, PA 17033 USA; [Tadagavadi, Raghu] Legend Biotech, Piscataway, NJ USA	University of Texas System; University of Texas at San Antonio (UTSA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Budatha, M; Reeves, WB (corresponding author), Univ Texas San Antonio, Long Sch Med, Dept Med, Div Nephrol, San Antonio, TX 78229 USA.; Reeves, WB (corresponding author), Penn State Hershey Coll Med, Div Nephrol, Hershey, PA 17033 USA.	ReevesW@uthscsa.edu; budatha@uthscsa.edu			National Institute of Diabetes and Digestive and Kidney Diseases [DK-081876, DK-108185]	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (DK-081876 and DK-108185) to W.B.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Alikhan MA, 2018, CLIN TRANSL IMMUNOL, V7, DOI 10.1002/cti2.1004; Alikhan MA, 2016, J AM SOC NEPHROL, V27, P706, DOI 10.1681/ASN.2014090927; Bamboat ZM, 2010, J CLIN INVEST, V120, P559, DOI 10.1172/JCI40008; Cao Q, 2015, J AM SOC NEPHROL, V26, P349, DOI 10.1681/ASN.2013121336; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Deng JP, 2001, KIDNEY INT, V60, P2118, DOI 10.1046/j.1523-1755.2001.00043.x; Dhande I, 2013, HYPERTENSION, V61, P1218, DOI 10.1161/HYPERTENSIONAHA.111.00422; Faubel S, 2007, J PHARMACOL EXP THER, V322, P8, DOI 10.1124/jpet.107.119792; Hedrich CM, 2010, IMMUNOL RES, V47, P185, DOI 10.1007/s12026-009-8150-5; Kitching AR, 2002, CLIN EXP IMMUNOL, V128, P36, DOI 10.1046/j.1365-2249.2002.01793.x; Laouar Y, 2008, P NATL ACAD SCI USA, V105, P10865, DOI 10.1073/pnas.0805058105; Lee H, 2010, KIDNEY INT, V78, P1100, DOI 10.1038/ki.2010.139; Lu L, 2012, AM J NEPHROL, V35, P181, DOI 10.1159/000335582; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Mu W, 2005, J AM SOC NEPHROL, V16, P3651, DOI 10.1681/ASN.2005030297; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Nelson PJ, 2012, J AM SOC NEPHROL, V23, P194, DOI 10.1681/ASN.2011070680; Ramesh G, 2003, AM J PHYSIOL-RENAL, V285, pF610, DOI 10.1152/ajprenal.00101.2003; Ramesh G, 2002, J CLIN INVEST, V110, P835, DOI 10.1172/JCI200215606; Ramesh G, 2007, AM J PHYSIOL-RENAL, V293, pF325, DOI 10.1152/ajprenal.00158.2007; Ramesh G, 2007, AM J PHYSIOL-RENAL, V292, pF812, DOI 10.1152/ajprenal.00277.2006; Sakai K, 2019, LAB INVEST, V99, P671, DOI 10.1038/s41374-018-0162-0; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Tadagavadi RK, 2015, TOXINS, V7, P3245, DOI 10.3390/toxins7083245; Tadagavadi RK, 2010, J AM SOC NEPHROL, V21, P53, DOI 10.1681/ASN.2009040407; Tadagavadi RK, 2010, J IMMUNOL, V185, P4904, DOI 10.4049/jimmunol.1000383; Yin ZN, 2002, J IMMUNOL, V169, P2148, DOI 10.4049/jimmunol.169.4.2148; Zhang B, 2007, KIDNEY INT, V72, P37, DOI 10.1038/sj.ki.5002242; Zhang BZ, 2008, J AM SOC NEPHROL, V19, P923, DOI 10.1681/ASN.2007090982	29	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238816	10.1371/journal.pone.0238816	http://dx.doi.org/10.1371/journal.pone.0238816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ6EE	32898157	gold, Green Published			2022-12-26	WOS:000570962500003
J	Wang, B; Ding, XM; Ding, CG; Tesch, G; Zheng, J; Tian, PX; Ricardo, SR; Shen, HH; Xue, WJ				Wang, Bo; Ding, Xiaoming; Ding, Chenguang; Tesch, Greg; Zheng, Jin; Tian, PuXun; Ricardo, Sharon; Shen, Hsin-Hui; Xue, Wujun			WNT1-inducible-signaling pathway protein 1 regulates the development of kidney fibrosis through the TGF-beta 1 pathway	FASEB JOURNAL			English	Article						kidney fibrosis; TGF-beta 1; WISP1; UUO model	MESENCHYMAL STEM-CELLS; TGF-BETA; RENAL FIBROSIS; GROWTH-FACTOR; WISP-1; WNT; PROLIFERATION; FIBROGENESIS; BLOCKADE; THERAPY	Fibrosis is a pathological feature of chronic kidney disease and its progression correlates with declining renal function. Kidney fibrosis is driven by multiple profibrotic factors. This project examined the regulatory function of WNT1-inducible-signaling pathway protein 1 (WISP1) in the development of kidney fibrosis. Induction of WISP1 by transforming growth factor beta 1 (TGF-beta 1), and the role of WISP1 in TGF-beta 1/Smad signaling and fibrotic responses, was examined in multiple kidney cells. Kidney expression of WISP1 was examined in mouse models of unilateral ureter obstruction (UUO) and streptozotocin-induced diabetic nephropathy. WISP1 antibody was administered to UUO mice during the induction of kidney injury and the impact on kidney fibrosis was examined. WISP1 expression was upregulated in both mouse models. TGF-beta 1-induced expression of WISP1 and profibrotic genes in cultured kidney cells via TGF-beta R1. Recombinant WISP1-induced expression of TGF-beta R1 in kidney cells. Suppression of WISP1 by shRNA or neutralizing antibody reduced TGF-beta 1-mediated activation of Smad3, fibrotic gene expression, and fibroblast proliferation. Treatment with WISP1 antibody inhibited the development of kidney fibrosis in UUO mice. WISP1 mediates the profibrotic effects of TGF-beta 1 in kidney cells and in kidney disease. Pharmacological blockade of WISP1 exhibits potential as a novel therapy for inhibiting kidney fibrosis.	[Wang, Bo; Ding, Xiaoming; Ding, Chenguang; Zheng, Jin; Tian, PuXun; Xue, Wujun] Xi An Jiao Tong Univ, Affiliated Hosp 1, Nephropathy Hosp, Dept Kidney Transplantat, Xian 710061, Shaanxi, Peoples R China; [Wang, Bo; Shen, Hsin-Hui] Monash Univ, Dept Mat Sci & Engn, Clayton, Vic, Australia; [Tesch, Greg] Monash Univ, Dept Nephrol, Clayton, Vic, Australia; [Tesch, Greg] Monash Med Ctr, Dept Med, Clayton, Vic, Australia; [Ricardo, Sharon] Monash Univ, Dept Pharmacol, Monash Biomed Discovery Inst, Clayton, Vic, Australia	Xi'an Jiaotong University; Monash University; Monash University; Monash University; Monash University	Wang, B; Xue, WJ (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Nephropathy Hosp, Dept Kidney Transplantat, Xian 710061, Shaanxi, Peoples R China.	bo.wang@monash.edu; xwujun126@xjtu.edu.cn		Shen, Hsin-Hui/0000-0002-8541-4370; Ricardo, Sharon/0000-0003-1724-3669	National Natural Science Foundation of China (NSFC) [81670681, 81970670]; Fundamental Research Funds for the Central Universities [xjj2018091]; Clinical Research Award of the First Affiliated Hospital of Xi'an Jiaotong University [XJTU1AF-CRF-2019-008]; Special Supportive Program for Organ Transplantation by COTDF [2019JYJH04]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Clinical Research Award of the First Affiliated Hospital of Xi'an Jiaotong University; Special Supportive Program for Organ Transplantation by COTDF	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81670681 and 81970670; Fundamental Research Funds for the Central Universities, Grant/Award Number: xjj2018091; Clinical Research Award of the First Affiliated Hospital of Xi'an Jiaotong University, Grant/Award Number: XJTU1AF-CRF-2019-008; Special Supportive Program for Organ Transplantation by COTDF, Grant/Award Number: 2019JYJH04	Chow FY, 2004, NEPHROL DIAL TRANSPL, V19, P2987, DOI 10.1093/ndt/gfh441; Colston JT, 2007, AM J PHYSIOL-HEART C, V293, pH1839, DOI 10.1152/ajpheart.00428.2007; Edeling M, 2016, NAT REV NEPHROL, V12, P426, DOI 10.1038/nrneph.2016.54; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; French DM, 2004, AM J PATHOL, V165, P855, DOI 10.1016/S0002-9440(10)63348-2; Gu LB, 2013, LAB INVEST, V93, P450, DOI 10.1038/labinvest.2013.4; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Huuskes BM, 2015, FASEB J, V29, P540, DOI 10.1096/fj.14-254789; Ihn H, 2002, CURR OPIN RHEUMATOL, V14, P681, DOI 10.1097/00002281-200211000-00009; Jian YC, 2014, CLIN LAB, V60, P29, DOI 10.7754/Clin.Lab.2013.121035; Klee S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20547; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Lan HY, 2012, SEMIN NEPHROL, V32, P236, DOI 10.1016/j.semnephrol.2012.04.002; Lemos DR, 2018, J AM SOC NEPHROL, V29, P1690, DOI 10.1681/ASN.2017121283; Li XF, 2015, ARCH MED SCI, V11, P647, DOI 10.5114/aoms.2015.52371; Lipson KE, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S24; Maarouf OH, 2016, J AM SOC NEPHROL, V27, P781, DOI 10.1681/ASN.2014121188; Mason RM, 2009, J CELL COMMUN SIGNAL, V3, P95, DOI 10.1007/s12079-009-0038-6; McGaraughty S, 2017, J AM SOC NEPHROL, V28, P3616, DOI 10.1681/ASN.2017010013; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Murahovschi V, 2015, DIABETES, V64, P856, DOI 10.2337/db14-0444; Nguyen TQ, 2008, J AM SOC NEPHROL, V19, P2098, DOI 10.1681/ASN.2007111261; Parada C, 2013, MOL CELL BIOL, V33, P3482, DOI 10.1128/MCB.00615-13; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x; Tan RJ, 2014, KIDNEY INT SUPPL, V4, P84, DOI 10.1038/kisup.2014.16; Terryn S, 2007, AM J PHYSIOL-RENAL, V293, pF476, DOI 10.1152/ajprenal.00363.2006; Tesch GH, 2007, NEPHROLOGY, V12, P261, DOI 10.1111/j.1440-1797.2007.00796.x; Wang B, 2016, MOL THER, V24, P1290, DOI 10.1038/mt.2016.90; Wang B, 2014, KIDNEY INT, V85, P352, DOI 10.1038/ki.2013.372; Wang B, 2011, DIABETES, V60, P280, DOI 10.2337/db10-0892; Wang SN, 2005, FASEB J, V19, P1, DOI 10.1096/fj.04-2370com; Wang SN, 2001, KIDNEY INT, V60, P96, DOI 10.1046/j.1523-1755.2001.00776.x; Wright LH, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.95824; Xu LF, 2000, GENE DEV, V14, P585; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhong X, 2017, AM J TRANSL RES, V9, P2920	37	6	6	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14507	14520		10.1096/fj.202000953R	http://dx.doi.org/10.1096/fj.202000953R		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32896021				2022-12-26	WOS:000568303400001
J	Ciancio, A; Kampfen, F; Kohler, IV; Bennett, D; de Bruin, WB; Darling, J; Kapteyn, A; Maurer, J; Kohler, HP				Ciancio, Alberto; Kampfen, Fabrice; Kohler, Iliana, V; Bennett, Daniel; de Bruin, Wandi Bruine; Darling, Jill; Kapteyn, Arie; Maurer, Jurgen; Kohler, Hans-Peter			Know your epidemic, know your response: Early perceptions of COVID-19 and self-reported social distancing in the United States	PLOS ONE			English	Article								As COVID-19 is rapidly unfolding in the United States, it is important to understand how individuals perceive the health and economic risks of the pandemic. In the absence of a readily available medical treatment, any strategy to contain the virus in the US will depend on the behavioral response of US residents. In this paper, we study individual's perceptions on COVID-19 and social distancing during the week of March 10-16, 2020, a week when COVID-19 was officially declared to be a pandemic by WHO and when new infections in the US were more than doubling every three days. Using a nationally representative sample of 5,414 respondents 18+ years of age from the Understanding America Study (UAS), we find that perceptions about COVID-19 health risks and economic consequences in the US population were largely pessimistic and highly variable by age and education. US residents who are young and do not have a college degree perceived alowerrisk of getting infected but a higher probability of running out of money than others. Most individuals reported taking some steps to distance themselves from others but important differences emerge by gender and by source of information on COVID-19. Using state and day fixed-effect regressions, we show that perceptions of the health risks closely followed the number of COVID-19 cases in the country, and perceptions of the economic consequences and the prevalence of social distancing were driven upwards by both national and state-level cases. Unless addressed by effective health communication that reaches individuals across all social strata, variations in perceptions about COVID-19 epidemic raise concerns about the ability of the US to implement and sustain the widespread and restrictive policies that are required to curtail the pandemic.	[Ciancio, Alberto; Kampfen, Fabrice; Kohler, Iliana, V; Kohler, Hans-Peter] Univ Penn, Populat Aging Res Ctr, Philadelphia, PA 19104 USA; [Ciancio, Alberto; Kampfen, Fabrice; Kohler, Iliana, V; Kohler, Hans-Peter] Univ Penn, Populat Studies Ctr, Philadelphia, PA 19104 USA; [Ciancio, Alberto; Maurer, Jurgen] Univ Lausanne, Dept Econ, Vaud, Switzerland; [Bennett, Daniel; de Bruin, Wandi Bruine; Darling, Jill; Kapteyn, Arie] Univ Southern Calif, Ctr Econ & Social Res, Los Angeles, CA 90007 USA	University of Pennsylvania; University of Pennsylvania; University of Lausanne; University of Southern California	Ciancio, A; Kohler, HP (corresponding author), Univ Penn, Populat Aging Res Ctr, Philadelphia, PA 19104 USA.; Ciancio, A; Kohler, HP (corresponding author), Univ Penn, Populat Studies Ctr, Philadelphia, PA 19104 USA.; Ciancio, A (corresponding author), Univ Lausanne, Dept Econ, Vaud, Switzerland.	ciancio@sas.upenn.edu; hpkohler@pop.upenn.edu	Bruine de Bruin, Wandi/N-8588-2018	Bruine de Bruin, Wandi/0000-0002-1601-789X; Kampfen, Fabrice/0000-0001-7304-7473; Ciancio, Alberto/0000-0001-5346-0885	Population Aging Research Center (PARC) and Population Studies Center (PSC) at the University of Pennsylvania - U.S. National Institutes of Health [NIA P30AG12836, NICHD R24 HD044964]; University of Southern California's Center for Economic and Social Research; USC's Schaeffer Center for Health Policy and Economics; Swedish Foundation for the Humanities and the Social Sciences (Riksbankens Jubileumsfond) Program on Science and Proven Experience 'Science and Proven Experience'	Population Aging Research Center (PARC) and Population Studies Center (PSC) at the University of Pennsylvania - U.S. National Institutes of Health; University of Southern California's Center for Economic and Social Research; USC's Schaeffer Center for Health Policy and Economics; Swedish Foundation for the Humanities and the Social Sciences (Riksbankens Jubileumsfond) Program on Science and Proven Experience 'Science and Proven Experience'	We gratefully acknowledge the support of the Population Aging Research Center (PARC) and Population Studies Center (PSC) at the University of Pennsylvania, which are funded by the U.S. National Institutes of Health through grants NIA P30AG12836 and NICHD R24 HD044964 respectively to HPK. Data collection was funded and conducted by the University of Southern California's Center for Economic and Social Research to AK. Wandi Bruine de Bruin was supported by USC's Schaeffer Center for Health Policy and Economics, and the Swedish Foundation for the Humanities and the Social Sciences (Riksbankens Jubileumsfond) Program on Science and Proven Experience 'Science and Proven Experience' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Alattar L., 2018, SOC SECUR B, V78, P13; Angrisani M., 2019, ECONOMETRICS COMPLEX, V39, P3, DOI [10.1108/S0731-905320190000039001, DOI 10.1108/S0731-905320190000039001]; Angrisani M, 2019, SAMPLING WEIGHTING U; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Bennett D, 2015, J DEV ECON, V112, P1, DOI 10.1016/j.jdeveco.2014.09.006; Bruine de Bruin W., 2020, J GERONTOLOGY B; Brune de Bruin W., 2020, AM J PREVENTIVE MED; Ciancio A, 2020, 202039 PSCPARC U PEN; Dalton C.B., 2020, MED J AUSTRALIA, V212, P1, DOI DOI 10.2139/SSRN.3549276; Delavande A, 2009, DEMOGR RES, V20, P817, DOI 10.4054/DemRes.2009.20.31; Diamantopoulous, 2012, J ACAD MARKET SCI, DOI [10.1007/s11747-010-0244-z, DOI 10.1007/S11747-010-0244-Z]; Fang H, 2020, HUMAN MOBILITY RESTR, DOI [10.3386/w26906, DOI 10.3386/W26906]; Ferguson N. M., 2020, REPORT 9 IMPACT NONP, V10, DOI [10.25561/77482, DOI 10.1007/S11538-020-00726-X]; Hanage W, 2020, WASHINGTON POST; Huang ZY, 2020, COMMUNITY MENT HLT J, V56, P355, DOI 10.1007/s10597-019-00469-7; Johns Hopkins University Center for Systems Science and Engineering, 2020, NOV COR COVID 19 CAS; Kapteyn A, 2020, SURV RES METHODS-GER, V14, P179, DOI 10.18148/srm/2020.v14i2.7737; Kennedy Courtney, 2020, ASSESSING RISKS ONLI; Kristof Nicholas, 2020, NY TIMES; Mansoor S, 2020, DATA SUGGESTS MANY N; Milne G.J., 2020, EFFECTIVENESS SOCIAL, DOI 10.1101/2020.03.20.20040055; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Russell TW, 2020, ESTIMATING INFECT CA; Science Media Centre, 2020, EXP REACT WHO DIR GE; UAS, 2020, UND AM STUD MARCH 20; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548; Yeager DS, 2011, PUBLIC OPIN QUART, V75, P709, DOI 10.1093/poq/nfr020; Zhang Y, 2020, IMPACT SOCIAL DISTAN, DOI DOI 10.1101/2020.03.04.20031187	30	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238341	10.1371/journal.pone.0238341	http://dx.doi.org/10.1371/journal.pone.0238341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ7QN	32886671	Green Published, gold, Green Accepted			2022-12-26	WOS:000571064300054
J	Guerreiro, EM; Ovstebo, R; Thiede, B; Costea, DE; Soland, TM; Galtung, HK				Guerreiro, Eduarda M.; Ovstebo, Reidun; Thiede, Bernd; Costea, Daniela Elena; Soland, Tine M.; Galtung, Hilde Kanli			Cancer cell line-specific protein profiles in extracellular vesicles identified by proteomics	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; PANCREATIC-CANCER; SIALOMUCIN COMPLEX; TUMOR PROGRESSION; MUC4 EXPRESSION; POOR-PROGNOSIS; GENE ONTOLOGY; EXOSOMES; MICROENVIRONMENT; PATHOGENESIS	Extracellular vesicles (EVs), are important for intercellular communication in both physiological and pathological processes. To explore the potential of cancer derived EVs as disease biomarkers for diagnosis, monitoring, and treatment decision, it is necessary to thoroughly characterize their biomolecular content. The aim of the study was to characterize and compare the protein content of EVs derived from three different cancer cell lines in search of a specific molecular signature, with emphasis on proteins related to the carcinogenic process. Oral squamous cell carcinoma (OSCC), pancreatic ductal adenocarcinoma (PDAC) and melanoma brain metastasis cell lines were cultured in CELLine AD1000 flasks. EVs were isolated by ultrafiltration and size-exclusion chromatography and characterized. Next, the isolated EVs underwent liquid chromatography-mass spectrometry (LC-MS) analysis for protein identification. Functional enrichment analysis was performed for a more general overview of the biological processes involved. More than 600 different proteins were identified in EVs from each particular cell line. Here, 14%, 10%, and 24% of the identified proteins were unique in OSCC, PDAC, and melanoma vesicles, respectively. A specific protein profile was discovered for each cell line, e.g., EGFR in OSCC, Muc5AC in PDAC, and FN1 in melanoma vesicles. Nevertheless, 25% of all the identified proteins were common to all cell lines. Functional enrichment analysis linked the proteins in each data set to biological processes such as "biological adhesion", "cell motility", and "cellular component biogenesis". EV proteomics discovered cancer-specific protein profiles, with proteins involved in processes promoting tumor progression. In addition, the biological processes associated to the melanoma-derived EVs were distinct from the ones linked to the EVs isolated from OSCC and PDAC. The malignancy specific biomolecular cues in EVs may have potential applications as diagnostic biomarkers and in therapy.	[Guerreiro, Eduarda M.; Soland, Tine M.; Galtung, Hilde Kanli] Univ Oslo, Fac Dent, Inst Oral Biol, Oslo, Norway; [Ovstebo, Reidun] Oslo Univ Hosp, Dept Med Biochem, Blood Cell Res Grp, Oslo, Norway; [Thiede, Bernd] Univ Oslo, Dept Biosci, Oslo, Norway; [Costea, Daniela Elena] Univ Bergen, Ctr Canc Biomarkers CCBio, Bergen, Norway; [Costea, Daniela Elena] Univ Bergen, Gade Lab Pathol, Dept Clin Med, Bergen, Norway; [Costea, Daniela Elena] Haukeland Hosp, Dept Pathol, Bergen, Norway; [Soland, Tine M.] Oslo Univ Hosp, Dept Pathol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; University of Oslo	Galtung, HK (corresponding author), Univ Oslo, Fac Dent, Inst Oral Biol, Oslo, Norway.	h.k.galtung@odont.uio.no	Galtung, Hilde/ABD-9199-2020; Costea, Daniela Elena/AAB-9705-2020; Søland, Tine/AAQ-4859-2021	Soland, Tine Merete/0000-0003-1687-3247	Stiftelsen til tannlegevitenskapens fremme; Faculty of Dentistry, University of Oslo; Nansenfondet; Research Council of Norway through its Centers of Excellence funding scheme [22325]; Helse Vest [911902/2013, 912260/2019]	Stiftelsen til tannlegevitenskapens fremme; Faculty of Dentistry, University of Oslo; Nansenfondet; Research Council of Norway through its Centers of Excellence funding scheme; Helse Vest	This research has been funded by "Stiftelsen til tannlegevitenskapens fremme", www.unifor.no (EMG, HKG, TMS), Faculty of Dentistry, University of Oslo (HKG, TMS), Nansenfondet, www.unifor.no (HG, TMS), and Research Council of Norway through its Centers of Excellence funding scheme, www.nfr.no; DEC (Grant No. 22325) and Helse Vest (Grant No. 911902/2013 and 912260/2019) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abels ER, 2016, CELL MOL NEUROBIOL, V36, P301, DOI 10.1007/s10571-016-0366-z; Adamczyk KA, 2011, LIFE SCI, V89, P304, DOI 10.1016/j.lfs.2011.06.020; Adamo A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00446; Ang KK, 2002, CANCER RES, V62, P7350; [Anonymous], 2016, LANCET ONCOL, V17, pe198; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; [Anonymous], **DATA OBJECT**; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Badwal SPS, 2018, WIRES ENERGY ENVIRON, V7, DOI 10.1002/wene.286; BISHOP JM, 1991, CELL, V64, P235, DOI 10.1016/0092-8674(91)90636-D; Boone B, 2011, J CUTAN PATHOL, V38, P492, DOI 10.1111/j.1600-0560.2011.01673.x; Chekenya M, 2008, ONCOGENE, V27, P5182, DOI 10.1038/onc.2008.157; Chen F, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0278-7; Chen J, 2019, MOL MED REP, V20, P903, DOI 10.3892/mmr.2019.10314; Choi S, 2008, J DENT RES, V87, P14, DOI 10.1177/154405910808700104; Dalla Pozza E, 2018, SEMIN CELL DEV BIOL, V78, P62, DOI 10.1016/j.semcdb.2017.06.027; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Geng Y, 2012, ANN BIOMED ENG, V40, P790, DOI 10.1007/s10439-011-0463-6; Guerreiro EM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204276; Hamada T, 2012, CANCER-AM CANCER SOC, V118, P5251, DOI 10.1002/cncr.27542; Hamada T, 2012, INT J CANCER, V130, P1768, DOI 10.1002/ijc.26187; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hartung F, 2017, ONCOTARGET, V8, P102161, DOI 10.18632/oncotarget.22240; Herraiz C, 2018, SEMIN CELL DEV BIOL, V78, P73, DOI 10.1016/j.semcdb.2017.06.021; Hoshi H, 2013, INT J ONCOL, V42, P887, DOI 10.3892/ijo.2013.1760; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Hu DY, 2019, WORLD J SURG ONCOL, V17, DOI 10.1186/s12957-019-1574-z; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jethwa SA, 2016, J CELL SCI, V129, P3948, DOI 10.1242/jcs.184424; Ji H, 2013, PROTEOMICS, V13, P1672, DOI 10.1002/pmic.201200562; Jonckheere Nicolas, 2010, Cancers (Basel), V2, P1794, DOI 10.3390/cancers2041794; Kalluri R, 2016, J CLIN INVEST, V126, P1208, DOI 10.1172/JCI81135; Kalra H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001450; Kanada M, 2016, TRENDS CANCER, V2, P84, DOI 10.1016/j.trecan.2015.12.005; Kanemoto S, 2016, BIOCHEM BIOPH RES CO, V480, P166, DOI 10.1016/j.bbrc.2016.10.019; Kaur S, 2017, AM J GASTROENTEROL, V112, P172, DOI 10.1038/ajg.2016.482; Kaur S, 2013, NAT REV GASTRO HEPAT, V10, P607, DOI 10.1038/nrgastro.2013.120; Komatsu M, 1999, CANCER RES, V59, P2229; Komatsu M, 2000, INT J CANCER, V87, P480, DOI 10.1002/1097-0215(20000815)87:4<480::AID-IJC4>3.0.CO;2-6; Lazar I, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12380; Levi E, 2004, J CLIN PATHOL, V57, P456, DOI 10.1136/jcp.2003.013292; Li BF, 2019, ONCOTARGETS THER, V12, P3207, DOI 10.2147/OTT.S195703; Liotta L A, 1991, Semin Cancer Biol, V2, P111; Liu SL, 2019, TRANSL CANCER RES, V8, P298, DOI 10.21037/tcr.2019.01.03; Lundgren DH, 2010, EXPERT REV PROTEOMIC, V7, P39, DOI 10.1586/EPR.09.69; Maas SLN, 2017, TRENDS CELL BIOL, V27, P172, DOI 10.1016/j.tcb.2016.11.003; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Merchant ML, 2017, NAT REV NEPHROL, V13, P731, DOI 10.1038/nrneph.2017.148; Meves A, 2015, J CLIN ONCOL, V33, P2509, DOI 10.1200/JCO.2014.60.7002; Morita Y, 2015, CLIN EXP METASTAS, V32, P739, DOI 10.1007/s10585-015-9741-2; Moschovis D, 2016, WORLD J GASTRO ONCOL, V8, P725, DOI 10.4251/wjgo.v8.i10.725; Nolte-'t Hoen E, 2016, P NATL ACAD SCI USA, V113, P9155, DOI 10.1073/pnas.1605146113; Nordin JZ, 2015, NANOMED-NANOTECHNOL, V11, P879, DOI 10.1016/j.nano.2015.01.003; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Pan S, 2015, PROTEOMICS, V15, P2705, DOI 10.1002/pmic.201400476; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; Park SY, 2007, ARCH PATHOL LAB MED, V131, P1561; Pathan M, 2019, NUCLEIC ACIDS RES, V47, pD516, DOI 10.1093/nar/gky1029; Rahbarghazi R, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0390-y; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Rilla K, 2019, MATRIX BIOL, V75-76, P201, DOI 10.1016/j.matbio.2017.10.003; Ronquist KG, 2019, CLIN CHIM ACTA, V488, P116, DOI 10.1016/j.cca.2018.10.044; Rosa-Fernandes L, 2017, FRONT CHEM, V5, DOI 10.3389/fchem.2017.00102; Sadovska L, 2015, ANTICANCER RES, V35, P6379; Saitou M, 2005, J CLIN PATHOL, V58, P845, DOI 10.1136/jcp.2004.023572; Schmidt A, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S2-S3; Shin SJ, 2013, P NATL ACAD SCI USA, V110, P19414, DOI 10.1073/pnas.1309720110; Sundaram GM, 2017, J EXP MED, V214, P2889, DOI 10.1084/jem.20170354; Szvicsek Z, 2019, CELL MOL LIFE SCI, V76, P2463, DOI 10.1007/s00018-019-03052-1; Tai YL, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0533-x; Tinder TL, 2008, J IMMUNOL, V181, P3116, DOI 10.4049/jimmunol.181.5.3116; Verdera HC, 2017, J CONTROL RELEASE, V266, P100, DOI 10.1016/j.jconrel.2017.09.019; Vereecken P, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/260643; Wei Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14041; Weinstein David, 2014, J Clin Aesthet Dermatol, V7, P13; Westgaard A, 2009, HISTOPATHOLOGY, V54, P337, DOI 10.1111/j.1365-2559.2009.03227.x; Willms E, 2016, SCI REP-UK, V6, DOI 10.1038/srep22519; Winck FV, 2015, SCI REP-UK, V5, DOI 10.1038/srep16305; Wong JWH, 2008, BRIEF BIOINFORM, V9, P156, DOI 10.1093/bib/bbm046; Yamada N, 2006, INT J CANCER, V119, P1850, DOI 10.1002/ijc.22047; Yamanaka Y, 1992, Nihon Ika Daigaku Zasshi, V59, P51; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Yang JB, 2004, J CELL BIOL, V165, P881, DOI 10.1083/jcb.200403174; Yang JB, 2009, CANCER RES, V69, P7538, DOI 10.1158/0008-5472.CAN-08-4626; Yu LH, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00099; Yuan Y, 2016, ONCOL REP, V35, P2499, DOI 10.3892/or.2016.4660; Zanotti L, 2017, LARYNGOSCOPE, V127, pE408, DOI 10.1002/lary.26797; Zhang HY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15016; Zhao QC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-154	92	15	15	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238591	10.1371/journal.pone.0238591	http://dx.doi.org/10.1371/journal.pone.0238591			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886718	Green Published, gold			2022-12-26	WOS:000571064300001
J	Tougma, SA; Yameogo, WNZ; Dahourou, DL; Kagone, IAS; Compaore, TR; Kabore, A; Kagone, T; Drabo, MK; Meda, N				Tougma, Serge Alain; Yameogo, W. Noelie Zoungrana; Dahourou, Desire Lucien; Kagone, Ida Adeline Salou; Compaore, T. Rebeca; Kabore, Ahmed; Kagone, Therese; Drabo, Maxime K.; Meda, Nicolas			Dengue virus infection and pregnancy outcomes during the 2017 outbreak in Ouagadougou, Burkina Faso: A retrospective cohort study	PLOS ONE			English	Article							FEVER; RISK	Introduction Dengue fever is a re-emerging pathology in Burkina Faso. It affects everyone and pregnant women are not left out. The objective of this study was to estimate the burden of dengue fever and to assess its effects on pregnancy outcomes in hospitalized pregnant women during the 2017 outbreak in Ouagadougou, Burkina Faso. Method This was a retrospective cohort study including febrile pregnant women from five health facilities in Ouagadougou. The study was carried out from July 1st to December 31st, 2017. A logistic stepwise regression was performed to identify the pregnancy adverse outcomes risk factors. Results Our study included 424 pregnant women at a mean age of 27.1 years old (Standard deviation: 6.23 years). Overall 28.54% (121/424) were infected with dengue virus. During follow-up, 29.01% (123/424) presented an adverse pregnancy outcome. Adjusted for gestational age and clinical symptoms, the risk of adverse pregnancy outcome was twice as high among dengue infected women as compared to uninfected women with an adjusted Odds Ratio (aOR) = 2.09 (1.08-4.05). The risk of the adverse pregnancy outcome was higher in the third trimester of pregnancy with aOR = 1.66 (1.02-2.72) in dengue fever infected women. Conclusion Dengue fever is a risk factor for adverse pregnancy outcomes, especially in the third trimester in Burkina Faso. The implementation of effective anti-vectorial control interventions and better management of dengue fever during pregnancy are needed to improve pregnancy outcomes.	[Tougma, Serge Alain; Kabore, Ahmed; Meda, Nicolas] Univ Joseph Ki Zerbo, Ouagadougou, Burkina Faso; [Tougma, Serge Alain; Kagone, Ida Adeline Salou] Minist Hlth, Ouagadougou, Burkina Faso; [Yameogo, W. Noelie Zoungrana] Tingandogo Univ Teaching Hosp CHU T, Ouagadougou, Burkina Faso; [Dahourou, Desire Lucien; Compaore, T. Rebeca; Drabo, Maxime K.] Inst Rech Sci Sante IRSS, Ouagadougou, Burkina Faso; [Dahourou, Desire Lucien; Kagone, Therese; Meda, Nicolas] Ctr Muraz, Bobo Dioulasso, Burkina Faso	Centre Muraz	Tougma, SA (corresponding author), Univ Joseph Ki Zerbo, Ouagadougou, Burkina Faso.; Tougma, SA (corresponding author), Minist Hlth, Ouagadougou, Burkina Faso.	sergetougma@gmail.com	DAHOUROU, Désiré Lucien/AAC-5059-2019	kabore, Ahmed/0000-0001-9347-8043; TOUGMA, Serge Alain/0000-0001-7846-8103; DAHOUROU, Desire Lucien/0000-0002-9261-4573				Amarasinghe A, 2011, EMERG INFECT DIS, V17, P1349, DOI 10.3201/eid1708.101515; [Anonymous], 2017, J MOL BIOMARKERS DIA, V8, P1, DOI [10.4172/2155-9929.S2-026, DOI 10.4172/2155-9929.S2-026, DOI 10.5334/LABPHON.19]; [Anonymous], 2017, FUEL CELLS B, V2017, P6; [Anonymous], 2017, INT J GYNECOL OBSTET, DOI DOI 10.1002/IJGO.12245; [Anonymous], 2017, INDIAN J HEMATOL BLO, V33, pS113; Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Carles G, 2000, J Gynecol Obstet Biol Reprod (Paris), V29, P758; Carles G, 1999, CLIN INFECT DIS, V28, P637, DOI 10.1086/515144; Carles G, 2016, LANCET INFECT DIS, V16, P765, DOI 10.1016/S1473-3099(16)00130-4; Collenberg E, 2006, J MED VIROL, V78, P683, DOI 10.1002/jmv.20593; An DTM, 2014, GLOBAL HEALTH ACTION, V7, P15, DOI 10.3402/gha.v7.23074; Friedman EE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003226; Guo CC, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00317; Hanf M, 2014, TROP MED INT HEALTH, V19, P153, DOI 10.1111/tmi.12240; Machado CR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002217; Menendez C, 2008, PLOS MED, V5, P220, DOI 10.1371/journal.pmed.0050044; Ministere de la Sante, 2017, PLAN LUTT ARB BURK F; Nigam A, 2016, INDIAN J MED SPEC, V7, P145, DOI 10.1016/j.injms.2016.09.003; Paixao ES, 2017, LANCET INFECT DIS, V17, P957, DOI 10.1016/S1473-3099(17)30366-3; Paixao ES, 2016, LANCET INFECT DIS, V16, P857, DOI 10.1016/S1473-3099(16)00088-8; Ridde V, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002859; Selvaretnam AAP, 2016, ASIAN PAC J TROP BIO, V6, P633, DOI 10.1016/j.apjtb.2016.05.008; Singla N, 2016, J CLIN DIAGN RES, V10, pDC12, DOI 10.7860/JCDR/2016/22482.9011; Singla N, 2015, ASIAN PAC J TROP MED, V8, P206, DOI 10.1016/S1995-7645(14)60316-3; Sirinavin S, 2004, PEDIATR INFECT DIS J, V23, P1042, DOI 10.1097/01.inf.0000143644.95692.0e; Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc; Tarnagda Z, 2018, EMERG INFECT DIS, V24, P170, DOI 10.3201/eid2401.170973; Were F, 2012, PAEDIATR INT CHILD H, V32, P18, DOI 10.1179/2046904712Z.00000000048; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; World Health Organization, 2011, COMPR GUID PREV CONT; Xiong YQ, 2017, J CLIN VIROL, V94, P42, DOI 10.1016/j.jcv.2017.07.008	32	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238431	10.1371/journal.pone.0238431	http://dx.doi.org/10.1371/journal.pone.0238431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886677	Green Published, gold			2022-12-26	WOS:000571064300015
J	Zhang, ZJ; Xiao, WF; Qiu, JR; Xin, Y; Liu, QP; Chen, HZ; Fu, YP; Ma, HS; Chen, WY; Huang, YQ; Ruan, SL; Yan, JL				Zhang, Zijie; Xiao, Wenfei; Qiu, Jieren; Xin, Ya; Liu, Qinpo; Chen, Huizhe; Fu, Yaping; Ma, Huasheng; Chen, Wenyue; Huang, Yuqin; Ruan, Songlin; Yan, Jianli			Nystose regulates the response of rice roots to cold stress via multiple signaling pathways: A comparative proteomics analysis	PLOS ONE			English	Article							PLASMA-MEMBRANE; CHILLING TOLERANCE; FRUCTAN METABOLISM; HEAT-STRESS; ACCLIMATION; RSOSPR10; ACID; OLIGOSACCHARIDES; ACCUMULATION; PRESERVATION	Small fructans improve plant tolerance for cold stress. However, the underlying molecular mechanisms are poorly understood. Here, we have demonstrated that the small fructan tetrasaccharide nystose improves the cold stress tolerance of primary rice roots. Roots developed from seeds soaked in nystose showed lower browning rate, higher root activity, and faster growth compared to seeds soaked in water under chilling stress. Comparative proteomics analysis of nystose-treated and control roots identified a total of 497 differentially expressed proteins. GO classification and KEGG pathway analysis documented that some of the upregulated differentially expressed proteins were implicated in the regulation of serine/threonine protein phosphatase activity, abscisic acid-activated signaling, removal of superoxide radicals, and the response to oxidative stress and defense responses. Western blot analysis indicated that nystose promotes the growth of primary rice roots by increasing the level of RSOsPR10, and the cold stress-induced change in RSOsPR10levelis regulated by jasmonate, salicylic acid, and abscisic acid signaling pathways in rice roots. Furthermore, OsMKK4-dependentmitogen-activated protein kinase signaling cascades may be involved in the nystose-induced cold tolerance of primary rice roots. Together, these results indicate that nystose acts as an immunostimulator of the response to cold stress by multiple signaling pathways.	[Zhang, Zijie; Xiao, Wenfei; Qiu, Jieren; Xin, Ya; Ma, Huasheng; Chen, Wenyue; Huang, Yuqin; Ruan, Songlin; Yan, Jianli] Hangzhou Acad Agr Sci, Inst Crop Sci, Hangzhou, Peoples R China; [Zhang, Zijie; Liu, Qinpo; Ruan, Songlin] Zhejiang Agr & Forestry Univ, Coll Agr & Food Sci, Hangzhou, Peoples R China; [Chen, Huizhe; Fu, Yaping] Chinese Acad Agr Sci, China Natl Rice Res Inst, Natl Key Lab Rice Biol, Hangzhou, Peoples R China; [Huang, Yuqin] Zhejiang Univ, Coll Agr & Biotechnol, Hangzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Zhejiang A&F University; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Zhejiang University	Ruan, SL; Yan, JL (corresponding author), Hangzhou Acad Agr Sci, Inst Crop Sci, Hangzhou, Peoples R China.; Ruan, SL (corresponding author), Zhejiang Agr & Forestry Univ, Coll Agr & Food Sci, Hangzhou, Peoples R China.	ruansl1@hotmail.com; yjl7784@163.com		Huang, Yuqing/0000-0003-0608-827X	National Key R&D Program of China [2017YFD0200900]; Active Design Project of Hangzhou Agricultural and Social Development Scientific Research [20172015A02]; Project 454 of Hangzhou Great Science and Technology innovation [20131812A02]; Science and Technology Innovation and Demonstration extension Fund of Hangzhou Academy of Agricultural Sciences [2019HNCT28]; Ministry of Science and Technology, Hangzhou Science and Technology Bureau; Hangzhou Academy of Agricultural Sciences	National Key R&D Program of China; Active Design Project of Hangzhou Agricultural and Social Development Scientific Research; Project 454 of Hangzhou Great Science and Technology innovation; Science and Technology Innovation and Demonstration extension Fund of Hangzhou Academy of Agricultural Sciences; Ministry of Science and Technology, Hangzhou Science and Technology Bureau; Hangzhou Academy of Agricultural Sciences	This work was sponsored by National Key R&D Program of China (No.2017YFD0200900) grant to DQ and SR, Active Design Project of Hangzhou Agricultural and Social Development Scientific Research (No. 20172015A02) grant to WX, Project 454 of Hangzhou Great Science and Technology innovation (No. 20131812A02) grant to SR, Science and Technology Innovation and Demonstration extension Fund of Hangzhou Academy of Agricultural Sciences (No.2019HNCT28) grant to SR. We also received funding from the Ministry of Science and Technology, Hangzhou Science and Technology Bureau and Hangzhou Academy of Agricultural Sciences.	[Anonymous], 2018, MED LETT DRUGS THER, V60, P7; BIELESKI RL, 1993, PLANT PHYSIOL, V103, P213, DOI 10.1104/pp.103.1.213; Bolouri Moghaddam MR, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00022; Bolouri Moghaddam MR, 2012, J EXP BOT, V63, P3989, DOI 10.1093/jxb/ers129; CHANDLER PM, 1994, ANNU REV PLANT PHYS, V45, P113, DOI 10.1146/annurev.pp.45.060194.000553; Cheabu S, 2018, RICE SCI, V25, P218, DOI 10.1016/j.rsci.2018.06.005; Cui SX, 2005, PROTEOMICS, V5, P3162, DOI 10.1002/pmic.200401148; Demel RA, 1998, BBA-BIOMEMBRANES, V1375, P36, DOI 10.1016/S0005-2736(98)00138-2; Ding YL, 2019, NEW PHYTOL, V222, P1690, DOI 10.1111/nph.15696; Dorffling K, 1997, EUPHYTICA, V93, P1, DOI 10.1023/A:1002946622376; DUNIGAN DD, 1995, BIOTECHNIQUES, V19, P640; Griffin NM, 2010, NAT BIOTECHNOL, V28, P83, DOI 10.1038/nbt.1592; Hashimoto M, 2004, PLANT CELL PHYSIOL, V45, P550, DOI 10.1093/pcp/pch063; HENDRY GAF, 1993, NEW PHYTOL, V123, P3; Hincha DK, 2003, BBA-BIOMEMBRANES, V1612, P172, DOI 10.1016/S0005-2736(03)00116-0; Hincha DK, 2002, GLYCOBIOLOGY, V12, P103, DOI 10.1093/glycob/12.2.103; Huang LB, 2005, ANN BOT-LONDON, V96, P755, DOI 10.1093/aob/mci228; Ikehashi H, 2018, RICE SCI, V25, P117, DOI 10.1016/j.rsci.2018.01.001; Ji XM, 2007, NEW PHYTOL, V173, P50, DOI 10.1111/j.1469-8137.2006.01896.x; Kawamura Y, 2003, PLANT J, V36, P141, DOI 10.1046/j.1365-313X.2003.01864.x; Konstantinova T, 2002, PLANT SCI, V163, P157, DOI 10.1016/S0168-9452(02)00090-0; Kosova K, 2007, BIOL PLANTARUM, V51, P601, DOI 10.1007/s10535-007-0133-6; KOSTER KL, 1992, PLANT PHYSIOL, V98, P108, DOI 10.1104/pp.98.1.108; Kumar K, 2008, PLANT PHYSIOL BIOCH, V46, P891, DOI 10.1016/j.plaphy.2008.05.014; Li P, 2011, P NATL ACAD SCI USA, V108, P3436, DOI 10.1073/pnas.1018665108; Liu JY, 2018, J INTEGR PLANT BIOL, V60, P780, DOI 10.1111/jipb.12657; LYNCH DV, 1987, PLANT PHYSIOL, V83, P761, DOI 10.1104/pp.83.4.761; Neilson KA, 2011, PROTEOMICS, V11, P1696, DOI 10.1002/pmic.201000727; NOMURA M, 1995, EUPHYTICA, V83, P247, DOI 10.1007/BF01678137; Passardi F, 2004, TRENDS PLANT SCI, V9, P534, DOI 10.1016/j.tplants.2004.09.002; Pennycooke JC, 2005, ENVIRON EXP BOT, V53, P225, DOI 10.1016/j.envexpbot.2004.04.002; PILONSMITS EAH, 1995, PLANT PHYSIOL, V107, P125, DOI 10.1104/pp.107.1.125; Pollock C, 2003, J EXP BOT, V54, P489, DOI 10.1093/jxb/erg037; POLLOCK CJ, 1991, ANNU REV PLANT PHYS, V42, P77, DOI 10.1146/annurev.pp.42.060191.000453; Puebla AF, 1997, NEW PHYTOL, V136, P123, DOI 10.1046/j.1469-8137.1997.00728.x; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Slewinski TL, 2012, J EXP BOT, V63, P4647, DOI 10.1093/jxb/ers124; Takahashi D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00090; Takeuchi K, 2016, PLANT CELL TISS ORG, V127, P35, DOI 10.1007/s11240-016-1027-0; Takeuchi K, 2011, PLANT CELL PHYSIOL, V52, P1686, DOI 10.1093/pcp/pcr105; Uemura M, 2006, PHYSIOL PLANTARUM, V126, P81, DOI 10.1111/j.1399-3054.2005.00594.x; Valluru R, 2008, J EXP BOT, V59, P2905, DOI 10.1093/jxb/ern164; Valluru R, 2008, TRENDS PLANT SCI, V13, P409, DOI 10.1016/j.tplants.2008.05.008; Van den Ende Wim, 2002, ScientificWorldJournal, V2, P1281; Van den Ende W, 2009, J EXP BOT, V60, P9, DOI 10.1093/jxb/ern297; Vereyken IJ, 2001, BBA-BIOMEMBRANES, V1510, P307, DOI 10.1016/S0005-2736(00)00363-1; Vergauwen R, 2000, J EXP BOT, V51, P1261, DOI 10.1093/jexbot/51.348.1261; Wang Shi-qiang, 2016, Chinese Journal of Rice Science, V30, P313, DOI 10.16819/j.1001-7216.2016.5187; Wang YL, 2019, RICE SCI, V26, P1, DOI 10.1016/j.rsci.2018.06.009; Watson W., 2011, CLIN IMMUNOL S1, V7, pS7; Zhang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043274; Zhao JL, 2015, PHYSIOL PLANTARUM, V154, P381, DOI 10.1111/ppl.12291; Zhou Yan, 2018, Scientia Agricultura Sinica, V51, P2060	53	3	4	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238381	10.1371/journal.pone.0238381	http://dx.doi.org/10.1371/journal.pone.0238381			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881942	gold, Green Published			2022-12-26	WOS:000571063300105
J	Moffatt, J; Mitrenga, KJ; Alderson-Day, B; Moseley, P; Fernyhough, C				Moffatt, Jamie; Mitrenga, Kaja Julia; Alderson-Day, Ben; Moseley, Peter; Fernyhough, Charles			Inner experience differs in rumination and distraction without a change in electromyographical correlates of inner speech	PLOS ONE			English	Article							INTRUSIVE MEMORIES; HOSPITAL ANXIETY; DEPRESSION; MOOD; VARIETIES; VOICES; MOTOR; QUESTIONNAIRE; VALIDATION; DIALOGUE	Ruminative thought is a style of thinking which involves repetitively focusing upon one's own negative mood, its causes and its consequences. The negative effects of rumination are well-documented, but comparatively little is known about how rumination is experienced. The evaluative nature of rumination suggests that it could involve more inner speech than non-ruminative states. The present study (N= 31) combined facial electromyography and self-report questionnaires to determine the type of inner experience that occurs in rumination. The results showed that induced rumination involved similar levels of muscle activity related to inner speech as periods of induced distraction. However, experience sampling and questionnaire responses showed that rumination involved more verbal thought, and also involved more evaluative and dialogic inner speech than distraction. These findings contribute to the understanding of inner speech as a flexible phenomenon and confirms the importance of employing multiple methods to investigate inner speech. Future research should clarify the link between inner speech in rumination and its negative effects on wellbeing.	[Moffatt, Jamie; Mitrenga, Kaja Julia; Alderson-Day, Ben; Moseley, Peter; Fernyhough, Charles] Univ Durham, Psychol Dept, Durham, England; [Moffatt, Jamie] Univ Sussex, Sch Psychol, Brighton, E Sussex, England; [Moseley, Peter] Northumbria Univ, Dept Psychol, Newcastle Upon Tyne, Tyne & Wear, England	Durham University; University of Sussex; Northumbria University	Mitrenga, KJ (corresponding author), Univ Durham, Psychol Dept, Durham, England.	kaja.j.mitrenga@durham.ac.uk	Moffatt, Jamie/AAJ-4434-2021; Fernyhough, Charles/A-1057-2010	Fernyhough, Charles/0000-0002-3822-710X; Mitrenga, Kaja/0000-0003-0033-9998; Moffatt, Jamie/0000-0003-4778-6066; Moseley, Peter/0000-0002-9284-2509	Wellcome Trust [WT098455, WT108720, WT209513]	Wellcome Trust(Wellcome TrustEuropean Commission)	This research was supported by the Wellcome Trust, grants WT098455, WT108720 and WT209513 (https://wellcome.ac.uk/).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderson-Day B, 2018, CONSCIOUS COGN, V65, P48, DOI 10.1016/j.concog.2018.07.001; Alderson-Day B, 2017, CONSCIOUS COGN, V49, P98, DOI 10.1016/j.concog.2017.01.003; Alderson-Day B, 2015, PSYCHOL BULL, V141, P931, DOI 10.1037/bul0000021; Alderson-Day B, 2014, CONSCIOUS COGN, V27, P288, DOI 10.1016/j.concog.2014.05.010; [Anonymous], 2013, J LABEL COMPD RADIOP, V56, pS88, DOI 10.1002/jlcr.3058; Aspinwall LG, 1999, MOTIV EMOTION, V23, P221, DOI 10.1023/A:1021367331817; Aziz-Zadeh L, 2005, J COGNITIVE NEUROSCI, V17, P928, DOI 10.1162/0898929054021157; Ben Alderson-Day,, 2014, CONSCIOUS COGN, V24, P113, DOI 10.1016/j.concog.2013.12.012; BJELLAND I, 2002, J PSYCHOSOM RES, V0052; Donaldson C, 2004, PSYCHOL MED, V34, P1309, DOI 10.1017/S0033291704001904; Douilliez C, 2014, CAN J BEHAV SCI, V46, P185, DOI 10.1037/a0033185; Everdell IT, 2007, PERCEPTION, V36, P1535, DOI 10.1068/p5852; Fernyhough C, 2004, NEW IDEAS PSYCHOL, V22, P49, DOI 10.1016/j.newideapsych.2004.09.001; Fernyhough C, 2008, DEV REV, V28, P225, DOI 10.1016/j.dr.2007.03.001; Goldwin M, 2013, COGNITIVE THER RES, V37, P680, DOI 10.1007/s10608-012-9507-y; Goldwin M, 2012, COGNITIVE THER RES, V36, P840, DOI 10.1007/s10608-011-9428-1; Hertel PT, 1998, J ABNORM PSYCHOL, V107, P166, DOI 10.1037/0021-843X.107.1.166; Holmes EA, 2006, BEHAV THER, V37, P237, DOI 10.1016/j.beth.2006.02.002; Holmes EA, 2009, J ABNORM PSYCHOL, V118, P76, DOI 10.1037/a0012590; Hurlburt RT, 2015, CONSCIOUS COGN, V31, P148, DOI 10.1016/j.concog.2014.11.002; Joormann J, 2004, J ABNORM PSYCHOL, V113, P179, DOI 10.1037/0021-843X.113.2.179; Lapatki BG, 2010, PSYCHOPHYSIOLOGY, V47, P299, DOI 10.1111/j.1469-8986.2009.00935.x; Lawrence HR, 2018, COGNITIVE THER RES, V42, P421, DOI 10.1007/s10608-018-9890-0; LeMoult J, 2014, BIOL PSYCHOL, V100, P50, DOI 10.1016/j.biopsycho.2014.05.001; Livesay J, 1996, PERCEPT MOTOR SKILL, V83, P1355, DOI 10.2466/pms.1996.83.3f.1355; Lyubomirsky S, 2003, COGNITIVE THER RES, V27, P309, DOI 10.1023/A:1023918517378; LYUBOMIRSKY S, 1995, J PERS SOC PSYCHOL, V69, P176, DOI 10.1037/0022-3514.69.1.176; McCarthy-Jones S, 2011, CONSCIOUS COGN, V20, P1586, DOI 10.1016/j.concog.2011.08.005; McLaughlin KA, 2007, BEHAV THER, V38, P23, DOI 10.1016/j.beth.2006.03.003; Morin A, 2011, PROCD SOC BEHV, V30, DOI 10.1016/j.sbspro.2011.10.331; Moritz S, 2014, COGNITION EMOTION, V28, P1047, DOI 10.1080/02699931.2013.868342; Myin-Germeys I, 2018, WORLD PSYCHIATRY, V17, P123, DOI 10.1002/wps.20513; Nalborczyk L, 2017, BIOL PSYCHOL, V127, P53, DOI 10.1016/j.biopsycho.2017.04.013; Newby JM, 2012, BRIT J CLIN PSYCHOL, V51, P197, DOI 10.1111/j.2044-8260.2011.02020.x; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; NOLENHOEKSEMA S, 1993, COGNITION EMOTION, V7, P561, DOI 10.1080/02699939308409206; NOLENHOEKSEMA S, 1991, J ABNORM PSYCHOL, V100, P569, DOI 10.1037/0021-843X.100.4.569; NOLENHOEKSEMA S, 1991, J PERS SOC PSYCHOL, V61, P115, DOI 10.1037/0022-3514.61.1.115; Oppenheim GM, 2010, MEM COGNITION, V38, P1147, DOI 10.3758/MC.38.8.1147; Park RJ, 2004, J CHILD PSYCHOL PSYC, V45, P996, DOI 10.1111/j.1469-7610.2004.t01-1-00291.x; Rouder JN, 2017, PSYCHOL METHODS, V22, P304, DOI 10.1037/met0000057; Sanchez A, 2014, EMOTION, V14, P85, DOI 10.1037/a0034500; SMITH SM, 1947, ANESTHESIOLOGY, V8, P1, DOI 10.1097/00000542-194701000-00001; Stepp CE, 2012, J SPEECH LANG HEAR R, V55, P1232, DOI 10.1044/1092-4388(2011/11-0214); Tappan MB, 1997, DEV REV, V17, P78, DOI 10.1006/drev.1996.0422; van Boxtel A., 2010, P MEAS BEH 2010 EIND, P104, DOI DOI 10.1145/1931344.1931382; Wagenmakers EJ, 2018, PSYCHON B REV, V25, P58, DOI [10.3758/s13423-017-1323-7, 10.3758/s13423-017-1343-3]; Watkins E, 2002, J NEUROL NEUROSUR PS, V72, P400, DOI 10.1136/jnnp.72.3.400; Watkins ER, 2008, PSYCHOL BULL, V134, P163, DOI 10.1037/0033-2909.134.2.163; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Williams AD, 2010, BEHAV THER, V41, P38, DOI 10.1016/j.beth.2008.12.003; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	52	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0238920	10.1371/journal.pone.0238920	http://dx.doi.org/10.1371/journal.pone.0238920			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NS5RK	32925961	gold, Green Accepted, Green Published			2022-12-26	WOS:000572318000024
J	Sharma, IP; Lepcha, NT; Lhamo, T; Ellwein, LB; Pokharel, GP; Das, T; Sapkota, YD; Dorji, T; Peldon, S				Sharma, Indra Prasad; Lepcha, Nor Tshering; Lhamo, Tshering; Ellwein, Leon B.; Pokharel, Gopal Prasad; Das, Taraprasad; Sapkota, Yuddha Dhoj; Dorji, Tandin; Peldon, Sonam			Visual impairment and refractive error in school children in Bhutan: The findings from the Bhutan School Sight Survey (BSSS 2019)	PLOS ONE			English	Article							GLOBAL PREVALENCE; OCULAR MORBIDITY; TEMPORAL TRENDS; MYOPIA; POPULATION; DISTRICT	Purpose To estimate the nationwide prevalence of visual impairment and associated refractive error in school children in Bhutan. Methods The sample of this prospective cross-sectional national survey comprised of randomly selected classes in levels IV-IX (age 10 to 15 years) from schools throughout Bhutan. The examination included measurement of visual acuity (VA), evaluation of ocular motility, refraction under cycloplegia, examination of the external eye, media and fundus. The principal cause of impairment was determined for eyes with uncorrected VA <= 6/12. The main outcome measures were distance VA and cycloplegic refractive error. Results With a sampling frame of 1967 class-based clusters from 190 schools, 160 classes in 103 schools were randomly selected; 4985 (98.5%) of 5060 enumerated children were examined. The prevalence of uncorrected, presenting, and best-corrected visual impairment (VA <= 6/12) in the better eye was 14.5%, 12.8%, and 0.34%, respectively. Refractive error was the principal cause (94.2%) of impaired vision and 88% of children who could achieve VA >= 6/9 with best correction were without necessary spectacles. The prevalence of myopia (<= -0.5 D) was 6.64% and was associated with female gender (P = 0.004), urban schooling (P = 0.002), and greater parental education (P<0.001). The prevalence of hyperopia (>= +2.0 D) was 2.17% and was significantly associated with lower class-level (P = 0.033), and female gender (P = 0.025). The overall prevalence of astigmatism (>= 0.75 D) was 9.75%. Conclusions Reduced vision because of uncorrected refractive error is a public health problem among school-age children in Bhutan. Effective school eye health strategies are needed to eliminate this easily treatable cause of visual impairment.	[Sharma, Indra Prasad; Lepcha, Nor Tshering; Lhamo, Tshering] JDW Natl Referral Hosp, Gyalyum Kesang Choeden Wangchuck Natl Eye Ctr, Thimphu, Bhutan; [Ellwein, Leon B.] NEI, NIH, Bethesda, MD 20892 USA; [Pokharel, Gopal Prasad] Nepal Eye Hosp, Kathmandu, Nepal; [Das, Taraprasad] Int Agcy Prevent Blindness, South East Asia Reg Off, Hyderabad, India; [Sapkota, Yuddha Dhoj] Int Agcy Prevent Blindness, Kathmandu, Nepal; [Dorji, Tandin; Peldon, Sonam] Minist Hlth, Healthcare Diagnost Div, Dept Med Serv, Thimphu, Bhutan	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Sharma, IP (corresponding author), JDW Natl Referral Hosp, Gyalyum Kesang Choeden Wangchuck Natl Eye Ctr, Thimphu, Bhutan.	indrapsharma@gmail.com		Das, Taraprasad/0000-0002-1295-4528; /0000-0001-8815-794X	Lions Club International Foundation (LCIF) SightFirst Research Grant [SFP 2053/UND]	Lions Club International Foundation (LCIF) SightFirst Research Grant	This work was supported by Lions Club International Foundation (LCIF) SightFirst Research Grant (SFP 2053/UND). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Adhikari Srijana, 2013, Oman J Ophthalmol, V6, P175, DOI 10.4103/0974-620X.122272; [Anonymous], 2017, HOUS POP CENS BHUT 2; Bourne RRA, 2017, LANCET GLOB HEALTH, V5, pE888, DOI 10.1016/S2214-109X(17)30293-0; Dandona R, 2002, INVEST OPHTH VIS SCI, V43, P615; Garner LF, 1999, OPTOMETRY VISION SCI, V76, P282, DOI 10.1097/00006324-199905000-00014; Goh PP, 2005, OPHTHALMOLOGY, V112, P678, DOI 10.1016/j.ophtha.2004.10.048; He MG, 2005, OPTOMETRY VISION SCI, V82, P229, DOI 10.1097/01.OPX.0000159362.48835.16; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; He MG, 2007, OPHTHALMOLOGY, V114, P374, DOI 10.1016/j.ophtha.2006.08.020; Holden BA, 2016, OPHTHALMOLOGY, V123, P1036, DOI 10.1016/j.ophtha.2016.01.006; Leesberg, 2012, THE NEW HOLLSTEIN, V1, plvi; Maul E, 2000, AM J OPHTHALMOL, V129, P445, DOI 10.1016/S0002-9394(99)00454-7; Murthy GVS, 2002, INVEST OPHTH VIS SCI, V43, P623; Naidoo KS, 2003, INVEST OPHTH VIS SCI, V44, P3764, DOI 10.1167/iovs.03-0283; Negrel AD, 2000, AM J OPHTHALMOL, V129, P421, DOI 10.1016/S0002-9394(99)00455-9; Nepal BP, 2003, BRIT J OPHTHALMOL, V87, P531, DOI 10.1136/bjo.87.5.531; Pant M, 2014, OPHTHAL EPIDEMIOL, V21, P356, DOI 10.3109/09286586.2014.964035; Pokharel GP, 2000, AM J OPHTHALMOL, V129, P436, DOI 10.1016/S0002-9394(99)00453-5; Salomao SR, 2008, INVEST OPHTH VIS SCI, V49, P4308, DOI 10.1167/iovs.08-2073; Sapkota YD, 2008, OPHTHAL EPIDEMIOL, V15, P17, DOI 10.1080/09286580701772011; Shrestha GS., 2011, J OPTOM, V4, P49, DOI [10.1016/S1888-4296(11)70041-3, DOI 10.1016/S1888-4296(11)70041-3]; Shrestha Rajesh Kishor, 2006, Nepal Med Coll J, V8, P43; Shrestha RK, 2017, J NEPAL MED ASSOC, V56, P206, DOI [10.31729/jnma.3170, DOI 10.31729/JNMA.3170]; Xiong SY, 2017, ACTA OPHTHALMOL, V95, P551, DOI 10.1111/aos.13403; Zhao JL, 2000, AM J OPHTHALMOL, V129, P427, DOI 10.1016/S0002-9394(99)00452-3	26	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0239117	10.1371/journal.pone.0239117	http://dx.doi.org/10.1371/journal.pone.0239117			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925975	gold, Green Published			2022-12-26	WOS:000572318000049
J	Bongiovanni, D; Tosello, V; Saccomani, V; Dalla Santa, S; Amadori, A; Zanovello, P; Piovan, E				Bongiovanni, Deborah; Tosello, Valeria; Saccomani, Valentina; Dalla Santa, Silvia; Amadori, Alberto; Zanovello, Paola; Piovan, Erich			Crosstalk between Hedgehog pathway and the glucocorticoid receptor pathway as a basis for combination therapy in T-cell acute lymphoblastic leukemia	ONCOGENE			English	Article							FLOOR PLATE; TRANSCRIPTION; ACTIVATION; MECHANISM; AGONISTS; ROLES; GLI2; HES1	Notwithstanding intensified therapy, a considerable fraction of T-cell acute lymphoblastic leukemia (T-ALL) patients face a dismal prognosis due to primary resistance to treatment and relapse, raising the need for more efficient and targeted therapies. Hedgehog (HH) signaling is a major developmental pathway frequently deregulated in cancer, for which a role in T-ALL is emerging. Mounting evidence suggests that ligand-independent activation of HH pathway occurs in cancer including T-ALL, emphasizing the necessity of dissecting the complex interplay between HH and other signaling pathways regulating activation. In this work, we present a therapeutically relevant crosstalk between HH signaling and the glucocorticoid receptor (NR3C1) pathway acting at the level of GLI1 transcription factor. GLI inhibitor GANT61 and dexamethasone were shown to exert a synergistic anti-leukemic effect in vitro in T-ALL cell lines and patient-derived xenografts. Mechanistically, dexamethasone-activated NR3C1 impaired GLI1 function by dynamically modulating the recruitment of PCAF acetyltransferase and HDAC1 deacetylase. Increased GLI1 acetylation was associated with compromised transcriptional activity and reduced protein stability. In summary, our study identifies a novel crosstalk between GLI1 and NR3C1 signaling pathway which could be exploited in HH-dependent malignancies to increase therapeutic efficacy.	[Bongiovanni, Deborah; Saccomani, Valentina; Dalla Santa, Silvia; Amadori, Alberto; Zanovello, Paola; Piovan, Erich] Univ Padua, Dipartimento Sci Chirurg Oncol & Gastroenterol, Padua, Italy; [Tosello, Valeria; Amadori, Alberto; Piovan, Erich] Ist Oncol Veneto IOV IRCCS, UOC Immunol & Diagnost Mol Oncol, Padua, Italy	University of Padua; IRCCS Istituto Oncologico Veneto (IOV)	Piovan, E (corresponding author), Univ Padua, Dipartimento Sci Chirurg Oncol & Gastroenterol, Padua, Italy.; Piovan, E (corresponding author), Ist Oncol Veneto IOV IRCCS, UOC Immunol & Diagnost Mol Oncol, Padua, Italy.	erich.piovan@unipd.it	Piovan, Erich/L-1444-2016	Piovan, Erich/0000-0002-4241-563X; Bongiovanni, Deborah/0000-0001-8693-4776	Italian Foundation for Cancer Research (Fondazione AIRC) [22233]; Progetto di Ricerca di Ateneo (Universita di Padova) [SID19_01]; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR); Istituto Oncologico Veneto 5 x 1000 fund	Italian Foundation for Cancer Research (Fondazione AIRC); Progetto di Ricerca di Ateneo (Universita di Padova); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Istituto Oncologico Veneto 5 x 1000 fund	This work was supported by the Italian Foundation for Cancer Research (Fondazione AIRC) grants to EP (IG2018#22233); Progetto di Ricerca di Ateneo (SID19_01; Universita di Padova) to EP. Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) Ex 60% to EP; Istituto Oncologico Veneto 5 x 1000 fund to EP.	Amakye D, 2013, NAT MED, V19, P1410, DOI 10.1038/nm.3389; Belver L, 2016, NAT REV CANCER, V16, P494, DOI 10.1038/nrc.2016.63; Burns MA, 2018, LEUKEMIA, V32, P2126, DOI 10.1038/s41375-018-0097-x; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Coni S, 2017, SCI REP-UK, V7, DOI 10.1038/srep44079; Coni S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065718; Crompton T, 2007, NAT REV IMMUNOL, V7, P726, DOI 10.1038/nri2151; Dagklis A, 2016, BLOOD, V128, P2642, DOI 10.1182/blood-2016-03-703454; Dagklis A, 2015, HAEMATOLOGICA, V100, pE102, DOI 10.3324/haematol.2014.119248; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; Ding Q, 1998, DEVELOPMENT, V125, P2533; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Gallet A, 2011, TRENDS CELL BIOL, V21, P238, DOI 10.1016/j.tcb.2010.12.005; Gruber W, 2018, INT J CANCER, V142, P968, DOI 10.1002/ijc.31117; Gulino A, 2012, VITAM HORM, V88, P211, DOI 10.1016/B978-0-12-394622-5.00009-2; Hegde GV, 2008, MOL CANCER RES, V6, P1928, DOI 10.1158/1541-7786.MCR-08-0142; Heine VM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002731; Heine VM, 2009, J CLIN INVEST, V119, P267, DOI 10.1172/JCI36376; HOECK W, 1989, J BIOL CHEM, V264, P14396; Hou XM, 2014, BIOCHIMIE, V101, P50, DOI 10.1016/j.biochi.2013.12.019; Hunger SP, 2015, NEW ENGL J MED, V373, P1541, DOI 10.1056/NEJMra1400972; Inaba H, 2010, LANCET ONCOL, V11, P1096, DOI 10.1016/S1470-2045(10)70114-5; Ingram WJ, 2008, ONCOGENE, V27, P1489, DOI 10.1038/sj.onc.1210767; Kassel O, 2007, MOL CELL ENDOCRINOL, V275, P13, DOI 10.1016/j.mce.2007.07.003; Malatesta M, 2013, CANCER RES, V73, P6323, DOI 10.1158/0008-5472.CAN-12-4660; Matise MP, 1998, DEVELOPMENT, V125, P2759; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Nieuwenhuis E, 2005, CLIN GENET, V67, P193, DOI 10.1111/j.1399-0004.2004.00360.x; Niewiadomski P, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020147; Pak E, 2016, DEV CELL, V38, P333, DOI 10.1016/j.devcel.2016.07.026; Pandolfi S, 2015, EXPERT REV MOL MED, V17, DOI 10.1017/erm.2015.3; Persson M, 2002, GENE DEV, V16, P2865, DOI 10.1101/gad.243402; Petrova R, 2014, DEVELOPMENT, V141, P3445, DOI 10.1242/dev.083691; Pietrobono S, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00556; Ramsbottom SA, 2016, J DEV BIOL, V4, DOI 10.3390/jdb4030023; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; SCHMIDT TJ, 1994, RECEPTOR, V4, P229; Schrappe M, 2011, BLOOD, V118, P2077, DOI 10.1182/blood-2011-03-338707; Schreck KC, 2010, CLIN CANCER RES, V16, P6060, DOI 10.1158/1078-0432.CCR-10-1624; Schwartz JR, 2010, MOL CELL ENDOCRINOL, V320, P76, DOI 10.1016/j.mce.2010.02.014; Tosello V, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7100160; Wang JB, 2011, VITAM HORM, V87, P207, DOI 10.1016/B978-0-12-386015-6.00030-5; Wang JB, 2010, P NATL ACAD SCI USA, V107, P9323, DOI 10.1073/pnas.0910712107; Wang Y, 2012, CHEM BIOL, V19, P972, DOI 10.1016/j.chembiol.2012.06.012; Wu FJ, 2017, CELL CHEM BIOL, V24, P252, DOI 10.1016/j.chembiol.2017.02.010; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916	49	4	4	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 15	2020	39	42					6544	6555		10.1038/s41388-020-01453-2	http://dx.doi.org/10.1038/s41388-020-01453-2		SEP 2020	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	OA9HI	32917954	Green Published			2022-12-26	WOS:000568475200003
J	Hartman, CJ; Mester, JC; Hare, PM; Cohen, AI				Hartman, Colin J.; Mester, Joseph C.; Hare, Patrick M.; Cohen, Alan, I			Novel inactivation of the causative fungal pathogen of white-nose syndrome with methoxsalen plus ultraviolet A or B radiation	PLOS ONE			English	Article							PSORIASIS; PSORALEN; THERAPY; UVA; PHOTOCHEMOTHERAPY; FUROCOUMARINS; IRRADIATION; BACTERIA	White-nose syndrome is a fungal disease responsible for the rapid decline of North American bat populations. This study addressed a novel method for inactivatingPseudogymnoascus destructans, the causative agent of WNS, using ultraviolet A (UVA) or B (UVB) radiation in combination with methoxsalen, a photosensitizer from the furanocoumarin family of compounds. Fungal spore suspensions were diluted in micromolar concentrations of methoxsalen (50-500 mu M), then exposed to fixed doses of UVA radiation (500-5000 mJ/cm(2)), followed by plating on germination media. These plates were examined for two to four weeks for evidence of spore germination or inactivation, along with resultant growth or inhibition ofP.destructanscolonies. Pretreatment of fungal spores with low doses of methoxsalen resulted in a UVA dose-dependent inactivation of theP.destructansspores. All doses of methoxsalen paired with 500 mJ/cm(2) of UVA led to an approximate two-log(10)(similar to 99%) reduction in spore viability, and when paired with 1000 mJ/cm(2), a four-log(10) or greater (>99.99%) reduction in spore viability was observed. Additionally, actively growingP.destructanscolonies treated directly with methoxsalen and either UVA or UVB radiation demonstrated UV dose-dependent inhibition and termination of colony growth. This novel approach of using a photosensitizer in combination with UV radiation to control fungal growth may have broad, practical application in the future.	[Hartman, Colin J.; Mester, Joseph C.; Cohen, Alan, I] Northern Kentucky Univ, Dept Biol Sci, Highland Hts, KY 41099 USA; [Hare, Patrick M.] Northern Kentucky Univ, Dept Chem & Biochem, Highland Hts, KY USA	Northern Kentucky University; Northern Kentucky University	Mester, JC (corresponding author), Northern Kentucky Univ, Dept Biol Sci, Highland Hts, KY 41099 USA.	mesterj1@nku.edu			Northern Kentucky University Research Foundation Award SL2017; Dorothy Westerman Herrmann Undergraduate Research Award; Student Undergraduate Research and Creative Activity Award	Northern Kentucky University Research Foundation Award SL2017; Dorothy Westerman Herrmann Undergraduate Research Award; Student Undergraduate Research and Creative Activity Award	This work was funded by a Dorothy Westerman Herrmann Undergraduate Research Award to CJH, a Student Undergraduate Research and Creative Activity Award to CJH, and a Northern Kentucky University Research Foundation Award SL2017 (https://inside.nku.edu/gero/research/board.html) to JCM and AIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitay-Laish I, 2018, ACTA DERM-VENEREOL, V98, P951, DOI 10.2340/00015555-3013; [Anonymous], 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-018-0474-7; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; [Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 2014, CANC DISCOV, V4, pOF1; Archier E, 2012, J EUR ACAD DERMATOL, V26, P11, DOI 10.1111/j.1468-3083.2012.04519.x; Begum M, 2009, INT J FOOD MICROBIOL, V129, P74, DOI 10.1016/j.ijfoodmicro.2008.11.020; Bernard RF, 2019, CONSERV SCI PRACT, V1, DOI 10.1111/csp2.106; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; BOND CA, 1981, AM J HOSP PHARM, V38, P990, DOI 10.1093/ajhp/38.7.990; Borderie F, 2014, INT BIODETER BIODEGR, V93, P118, DOI 10.1016/j.ibiod.2014.05.014; Boyce JM, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0111-x; Brasch J, 2006, MYCOSES, V49, P1, DOI 10.1111/j.1439-0507.2005.01169.x; Camp RJ, 2019, CONDOR, V121, DOI 10.1093/condor/duz007; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; de Gruijl FR, 2000, METHOD ENZYMOL, V319, P359; de Menezes HD, 2014, J PHOTOCH PHOTOBIO B, V131, P74, DOI 10.1016/j.jphotobiol.2014.01.008; Dunnick JK, 1989, 359 NTP TR; Eichenfield LF, 2014, J AM ACAD DERMATOL, V70, P338, DOI 10.1016/j.jaad.2013.10.010; Eskew EA, 2013, EMERG INFECT DIS, V19, P379, DOI 10.3201/eid1093.120707; Frank CL, 2019, FRONT ZOOL, V16, DOI 10.1186/s12983-019-0340-y; Gasparro F P, 2000, Am J Clin Dermatol, V1, P337, DOI 10.2165/00128071-200001060-00002; GIBBS NK, 1988, J PHOTOCH PHOTOBIO B, V2, P109, DOI 10.1016/1011-1344(88)85040-1; Goodrich S, 2017, KENT AC SCI ANN M MU; Gorgus E, 2010, FOOD CHEM TOXICOL, V48, P93, DOI 10.1016/j.fct.2009.09.021; Grossweiner L I, 1984, Natl Cancer Inst Monogr, V66, P47; Grundmann-Kollmann M, 2002, BRIT J CLIN PHARMACO, V54, P535, DOI 10.1046/j.1365-2125.2002.01692.x; HAMERSKI D, 1988, EUR J BIOCHEM, V171, P369, DOI 10.1111/j.1432-1033.1988.tb13800.x; Hartman C, 2017, KENT AC SCI ANN M MU; HEARST JE, 1984, Q REV BIOPHYS, V17, P1, DOI 10.1017/S0033583500005242; Hermanson GT, 2013, BIOCONJUGATE TECHNIQUES, 3RD EDITION, P1, DOI 10.1016/B978-0-12-382239-0.00001-7; Holden WM, 2014, FUNGAL BIOL-UK, V118, P48, DOI 10.1016/j.funbio.2013.11.001; Serrano-Perez JJ, 2008, J PHYS CHEM B, V112, P14002, DOI 10.1021/jp805523d; Kim DK, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01340-18; Kitamura N, 2005, J PHOTOCH PHOTOBIO C, V6, P168, DOI 10.1016/j.jphotochemrev.2005.08.002; Lai CF, 2008, ANAL CHEM, V80, P8790, DOI 10.1021/ac801520m; Loope L., 2016, GUIDANCE DOCUMENT RA; LOWE NJ, 1986, J AM ACAD DERMATOL, V14, P754, DOI 10.1016/S0190-9622(86)70089-3; Marroquin CM, 2017, NORTHEAST NAT, V24, P54, DOI 10.1656/045.024.0105; Martel A, 2020, CONSERV LETT, V13, DOI 10.1111/conl.12707; Meteyer CU, 2012, VIRULENCE, V3, P583, DOI 10.4161/viru.22330; Mustapha A, 2018, AM J INFECT CONTROL, V46, P584, DOI [10.1016/j.ajic.2017.10.025, 10.1016/j.ajic.2017.09.019]; Nguyen MN, 2010, PLOS ONE, V5, pe9907; OGINSKY EL, 1959, J BACTERIOL, V78, P821, DOI 10.1128/JB.78.6.821-833.1959; Oxsoralen-Ultra (Methoxsalen Capsules): Uses Dosage Side Effects Interactions Warning [Internet], OXS ULTR METH CAPS U; Palmer JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02441-z; PARRISH JA, 1974, NEW ENGL J MED, V291, P1207, DOI 10.1056/NEJM197412052912301; PARSONS BJ, 1980, PHOTOCHEM PHOTOBIOL, V32, P813, DOI 10.1111/j.1751-1097.1980.tb04061.x; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; PubChem, PSOR; PubChem, SOD HYP; PubChem, 8 METH; Schmidt BR, 2009, AMPHIBIA-REPTILIA, V30, P313, DOI 10.1163/156853809788795245; Silva EBF, 2014, J PHOTOCH PHOTOBIO B, V130, P260, DOI 10.1016/j.jphotobiol.2013.11.012; Silva OP, 2015, PHARMACOGN MAG, V11, P170, DOI 10.4103/0973-1296.149734; STERN RS, 1991, ARCH DERMATOL, V127, P347, DOI 10.1001/archderm.127.3.347; Stern RS, 1997, NEW ENGL J MED, V336, P1041, DOI 10.1056/NEJM199704103361501; Timonen JM, 2018, J HETEROCYCLIC CHEM, V55, P2590, DOI 10.1002/jhet.3318; Turner GG, 2014, J WILDLIFE DIS, V50, P566, DOI 10.7589/2014-03-058; Valenzuela-Sanchez A, 2018, TRANSBOUND EMERG DIS, V65, P309, DOI 10.1111/tbed.12775; Verant Michelle L., 2014, BMC Physiology, V14, P10, DOI 10.1186/s12899-014-0010-4; Veras L, 2016, ASIA-PAC J CLIN ONCO, V12, pe196, DOI 10.1111/ajco.12129; Wentworth A, 2019, ASS SE BIOL ANN M ME; WHO, 2006, COMP DRINK WAT QUAL, P39; WHO, WHO UV RAD; Wibbelt G, 2010, EMERG INFECT DIS, V16, P1237, DOI 10.3201/eid1608.100002; Wolf P, 2016, BRIT J DERMATOL, V174, P11, DOI 10.1111/bjd.14341; Woodhams DC, 2012, DIS AQUAT ORGAN, V98, P11, DOI 10.3354/dao02429; Xiao Y, 2018, WATER RES, V141, P279, DOI 10.1016/j.watres.2018.05.021	69	2	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0239001	10.1371/journal.pone.0239001	http://dx.doi.org/10.1371/journal.pone.0239001			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915896	gold, Green Published			2022-12-26	WOS:000571887500082
J	Hayashi, M; Abe, K; Fujita, M; Takahashi, A; Sekine, H; Ohira, H				Hayashi, Manabu; Abe, Kazumichi; Fujita, Masashi; Takahashi, Atsushi; Sekine, Hideharu; Ohira, Hiromasa			Association between serum ficolin-1 level and disease progression in primary biliary cholangitis	PLOS ONE			English	Article							URSODEOXYCHOLIC ACID THERAPY; LECTIN-COMPLEMENT PATHWAY; CIRRHOSIS; INNATE; SYSTEM; PREDICT; RISK; C3; INFLAMMATION; RECOGNITION	Pattern recognition molecules (PRMs) in the complement system contribute to homeostasis as mediators of complement activation. The contribution of PRMs to primary biliary cholangitis (PBC) is unknown. In the current study, we aimed to assess the association between PRMs and the clinical findings of PBC. A total of 122 PBC patients and 20 healthy controls were enrolled. We measured four different PRMs (mannose-binding lectin [MBL], ficolin-1, ficolin-2 and ficolin-3) using stored sera, and retrospectively analyzed the associations between PRMs and laboratory findings, histological findings, and the development of cirrhosis-related conditions. Ficolin-1 levels were significantly higher in the PBC patients than in the healthy controls (152 ng/mL vs 102 ng/mL, P = 0.034), but no significant differences were observed regarding MBL, ficolin-2, and ficolin-3 levels. Ficolin-1 was significantly correlated with alkaline phosphatase (ALP). Low ficolin-1 levels were significantly associated with the development of cirrhosis-related conditions independent for histological stage and ALP levels (hazard ratio: 0.933; 95% confidence interval: 0.875-0.994; P = 0.032). Patients with low levels of ficolin-1 (< 77 ng/mL) had a significantly increased rate of developing cirrhosis-related conditions. Low ficolin-1 levels were associated with disease progression independent of histological stage and ALP levels in patients with PBC.	[Hayashi, Manabu; Abe, Kazumichi; Fujita, Masashi; Takahashi, Atsushi; Ohira, Hiromasa] Fukushima Med Univ, Dept Gastroenterol, Fukushima, Japan; [Hayashi, Manabu; Sekine, Hideharu] Fukushima Med Univ, Dept Immunol, Fukushima, Japan	Fukushima Medical University; Fukushima Medical University	Hayashi, M (corresponding author), Fukushima Med Univ, Dept Gastroenterol, Fukushima, Japan.; Hayashi, M (corresponding author), Fukushima Med Univ, Dept Immunol, Fukushima, Japan.	m884884@fmu.ac.jp			AbbVie GK (Tokyo, Japan)	AbbVie GK (Tokyo, Japan)(AbbVie)	M.H. received funding from AbbVie GK (Tokyo, Japan). The funder provided material support for purchase of equipment for experiments and proofreading fee. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Altorjay I, 2010, J HEPATOL, V53, P484, DOI 10.1016/j.jhep.2010.03.028; Ammitzboll CG, 2013, ARTHRITIS RHEUM-US, V65, P3045, DOI 10.1002/art.38179; [Anonymous], 2013, BONE MARROW TRANSPL, V48, P452; [Anonymous], 1998, DISCOVER MAGAZINE, V19, p56 ; Bossen L, 2020, LIVER INT, V40, P1408, DOI 10.1111/liv.14466; Bottazzi B, 2016, J HEPATOL, V64, P1416, DOI 10.1016/j.jhep.2016.02.029; Cieslinski JZ, 2018, LUPUS, V27, P372, DOI 10.1177/0961203317722846; Corpechot C, 2005, GASTROENTEROLOGY, V128, P297, DOI 10.1053/j.gastro.2004.11.009; Corpechot C, 2000, HEPATOLOGY, V32, P1196, DOI 10.1053/jhep.2000.20240; Corpechot C, 2011, J HEPATOL, V55, P1361, DOI 10.1016/j.jhep.2011.02.031; Endo Y, 1996, GENOMICS, V36, P515, DOI 10.1006/geno.1996.0497; European Association for the Study of the Liver, 2017, J HEPATOL, V67, P145, DOI [10.1016/j.jhep.2017.03.022, DOI 10.1016/J.JHEP.2017.03.022]; Fickert P, 2017, J HEPATOL, V67, P619, DOI 10.1016/j.jhep.2017.04.026; Foldi I, 2017, LIVER INT, V37, P1023, DOI 10.1111/liv.13368; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; GARRED P, 1993, LIVER, V13, P305; Garred P, 2016, IMMUNOL REV, V274, P74, DOI 10.1111/imr.12468; Hayashi M, 2018, MED MOL MORPHOL, V51, P176, DOI 10.1007/s00795-018-0184-0; Hein E, 2015, MOL IMMUNOL, V63, P209, DOI 10.1016/j.molimm.2014.07.003; Honore C, 2008, MOL IMMUNOL, V45, P2782, DOI 10.1016/j.molimm.2008.02.005; Honore C, 2010, J LEUKOCYTE BIOL, V88, P145, DOI 10.1189/jlb.1209802; Hummelshoj T, 2008, MOL IMMUNOL, V45, P1623, DOI 10.1016/j.molimm.2007.10.006; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Kasperkiewicz K, 2017, IMMUNOL CELL BIOL, V95, P666, DOI 10.1038/icb.2017.31; Katayama M, 2019, INT IMMUNOL, V31, P23, DOI 10.1093/intimm/dxy056; Kirschfink M, 1997, IMMUNOPHARMACOLOGY, V38, P51, DOI 10.1016/S0162-3109(97)00057-X; Kouser L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00317; Lammers WJ, 2015, GASTROENTEROLOGY, V149, P1804, DOI 10.1053/j.gastro.2015.07.061; Li JL, 2005, J BIOL CHEM, V280, P7427, DOI 10.1074/jbc.M411473200; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Liu Y, 2005, J IMMUNOL, V175, P3150, DOI 10.4049/jimmunol.175.5.3150; Lleo A, 2017, HEPATOL INT, V11, P485, DOI 10.1007/s12072-017-9830-1; Lleo A, 2010, HEPATOLOGY, V52, P987, DOI 10.1002/hep.23783; Ma YJ, 2013, J IMMUNOL, V191, P1324, DOI 10.4049/jimmunol.1300382; Mao TK, 2005, HEPATOLOGY, V42, P802, DOI 10.1002/hep.20859; Munthe-Fog L, 2012, GENES IMMUN, V13, P515, DOI 10.1038/gene.2012.27; Muso E, 2013, AUTOIMMUNITY, V46, P513, DOI 10.3109/08916934.2013.822073; Namisaki T, 2017, EUR J GASTROEN HEPAT, V29, P23, DOI 10.1097/MEG.0000000000000765; Pereira JG, 2017, ANN HEPATOL, V16, P780, DOI 10.5604/01.3001.0010.2789; Plawecki M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160879; Popov Y, 2010, AM J PHYSIOL-GASTR L, V298, pG323, DOI 10.1152/ajpgi.00394.2009; Reuveni D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01852; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; SCHEUER PJ, 1967, P ROY SOC MED, V60, P1257, DOI 10.1177/003591576706001205; Schmitt J, 2012, BIOCHEM BIOPH RES CO, V418, P445, DOI 10.1016/j.bbrc.2012.01.036; Selmi C, 2011, LANCET, V377, P1600, DOI 10.1016/S0140-6736(10)61965-4; SHIMODA S, 1995, J EXP MED, V181, P1835, DOI 10.1084/jem.181.5.1835; Shimoda S, 2010, HEPATOLOGY, V51, P567, DOI 10.1002/hep.23318; Tanaka A, 2017, LIVER INT, V37, P500, DOI 10.1111/liv.13344; Tanha N, 2017, CLIN RHEUMATOL, V36, P335, DOI 10.1007/s10067-016-3508-2; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; Troldborg A, 2019, J CLIN IMMUNOL, V39, P421, DOI 10.1007/s10875-019-00627-2; Troldborg A, 2018, J RHEUMATOL, V45, P1136, DOI 10.3899/jrheum.171033; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Walport MJ, 2002, ARTHRITIS RES THER, V4, pS279, DOI 10.1186/ar586; Watanabe H, 2012, MOD RHEUMATOL, V22, P899, DOI 10.1007/s10165-012-0616-y; Windbichler M, 2004, INFECT IMMUN, V72, P5247, DOI 10.1128/IAI.72.9.5247-5252.2004; Yoon T, 2020, TOHOKU J EXP MED, V251, P117, DOI 10.1620/tjem.251.117	59	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238300	10.1371/journal.pone.0238300	http://dx.doi.org/10.1371/journal.pone.0238300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915797	Green Published, gold			2022-12-26	WOS:000571887500151
J	Moller, AP; Hongisto, K; Korpimaki, E				Moller, Anders Pape; Hongisto, Kari; Korpimaki, Erkki			Predation risk in relation to brain size in alternative prey of pygmy owls varies depending on the abundance of main prey	PLOS ONE			English	Article							TENGMALMS OWLS; BEHAVIOR; POPULATIONS; MECHANISMS; CHOICE; FEMALE	Large brains in prey may select for adoption of anti-predator behavior that facilitates escape. Prey species with relatively large brains have been shown to be less likely to fall prey to predators. This results in the prediction that individuals that have been captured by predators on average should have smaller brains than sympatric conspecifics. We exploited the fact that Eurasian pygmy owlsGlaucidium passerinumhoard small mammals and birds in cavities and nest-boxes for over-winter survival, allowing for comparison of the phenotype of prey with that of live conspecifics. In Northern Europe, main prey of pygmy owls are voles of the generaMyodesandMicrotus, while forest birds and shrews are the most important alternative prey. Large fluctuations (amplitude 100-200-fold) in vole populations induce rapid numerical responses of pygmy owls to main prey populations, which in turn results in varying predation pressure on small birds. We found, weighed and measured 153 birds in food-stores of pygmy owls and mist-netted, weighed and measured 333 live birds of 12 species in central-western Finland during two autumns with low (2017) and high (2018) pygmy owl predation risk. In two autumns, individuals with large brains were captured later compared to individuals with small brains, consistent with the hypothesis that such individuals survived for longer. Avian prey of pygmy owls had smaller heads than live birds in autumn 2018 when predation risk by pygmy owls was high. This difference in head size was not significant in 2017 when predation risk by pygmy owls was reduced. Finally, avian survivors were in better body condition than avian prey individuals. These findings are consistent with the hypothesis that pygmy owls differentially prey on birds in poor condition with small brains. These findings are consistent with the hypothesis that predation risk imposed by pygmy owls on small birds in boreal forests varies depending on the abundance of the main prey (voles).	[Moller, Anders Pape] Univ Paris Saclay, Univ Paris Sud, Ecol Systemat Evolut, CNRS,AgroParisTech, St Aubin, France; [Hongisto, Kari] Tieteenkatu, Tampere, Finland; [Korpimaki, Erkki] Univ Turku, Dept Biol, Sect Ecol, Turku, Finland	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Turku	Moller, AP (corresponding author), Univ Paris Saclay, Univ Paris Sud, Ecol Systemat Evolut, CNRS,AgroParisTech, St Aubin, France.	anders.moller@u-psud.fr						Al Rubaiee Z, 2018, CURR ZOOL, V64, P277, DOI 10.1093/cz/zox030; ALLMAN J, 1993, P NATL ACAD SCI USA, V90, P118, DOI 10.1073/pnas.90.1.118; Bonaparte KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023775; Caro Tim, 2005, pXIII; Cooper Jr W. E., 2015, ESCAPING PREDATORS I; Crawley M. J., 1992, NATURAL ENEMIEPOPU; Dukas R, 2004, BRAIN BEHAV EVOLUT, V63, P197, DOI 10.1159/000076781; Dutour M, 2016, ANIM BEHAV, V119, P119, DOI 10.1016/j.anbehav.2016.06.024; Edmunds NB, 2016, ECOL LETT, V19, P948, DOI 10.1111/ele.12633; Falconer D. S., 1996, INTRO QUANTITATIVE G; Garamszegi, 2014, MODERN PHYLOGENETIC, P553; Gibbons JW, 2004, BIOSCIENCE, V54, P447, DOI 10.1641/0006-3568(2004)054[0447:PTSTAI]2.0.CO;2; Jaatinen K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48153-w; Jerison HJ., 1973, EVOLUTION BRAIN INTE; KELLOMAKI E, 1977, Ornis Fennica, V54, P1; Kenward R, 2010, THE GOSHAWK; Konig C, 2008, OWLS WORLD; KORPIMAKI E, 1985, OIKOS, V45, P281, DOI 10.2307/3565716; Korpimaki E, 2005, P ROY SOC B-BIOL SCI, V272, P193, DOI 10.1098/rspb.2004.2860; KORPIMAKI E, 1987, IBIS, V129, P499, DOI 10.1111/j.1474-919X.1987.tb08237.x; KORPIMAKI E, 1989, OIKOS, V54, P154, DOI 10.2307/3565261; Kotrschal A, 2015, ECOL LETT, V18, P646, DOI 10.1111/ele.12441; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Marcin A, 2005, ARDEA, V93, P101; Masoero G, 2020, OECOLOGIA, V192, P699, DOI 10.1007/s00442-020-04607-x; Masoero G, 2018, BEHAV ECOL SOCIOBIOL, V72, DOI 10.1007/s00265-018-2571-x; Moller AP, 2019, ANIM BIODIV CONSERV, V42, P135, DOI 10.32800/abc.2019.42.0135; Moller AP, 2014, J EVOLUTION BIOL, V27, P34, DOI 10.1111/jeb.12272; Moller AP, 2013, J EVOLUTION BIOL, V26, P1143, DOI 10.1111/jeb.12147; Moller AP, 2010, J EVOLUTION BIOL, V23, P625, DOI 10.1111/j.1420-9101.2009.01928.x; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; Morosinotto C, 2017, ECOL MONOGR, V87, P4, DOI 10.1002/ecm.1238; Newton I., 2010, SPARROWHAWK; Nishida Y, 2019, ANIM BEHAV, V152, P29, DOI 10.1016/j.anbehav.2019.04.002; Salo P, 2010, ECOL MONOGR, V80, P531, DOI 10.1890/09-1260.1; Samia DSM, 2015, SCI REP-UK, V5, DOI 10.1038/srep11913; SAS, 2012, JMP 10 2; Schaller GB., 2009, DEER TIGER; Shultz S, 2010, BEHAV ECOL, V21, P1073, DOI 10.1093/beheco/arq108; Shultz S, 2006, BIOL LETTERS, V2, P505, DOI 10.1098/rsbl.2006.0519; SOLHEIM R, 1984, ANN ZOOL FENN, V21, P301; SUHONEN J, 1993, OIKOS, V66, P94, DOI 10.2307/3545200; Svensson L.A., 2006, IDENTIFICATION GUIDE; Terraube J, 2017, GLOBAL CHANGE BIOL, V23, P1361, DOI 10.1111/gcb.13408; van der Bijl W, 2016, BIOESSAYS, V38, P568, DOI 10.1002/bies.201500166; Vander Wall SB., 1990, FOOD HOARDING ANIMAL; Walsh MR, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1075; YOSEF R, 1989, AUK, V106, P418	48	1	1	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0236155	10.1371/journal.pone.0236155	http://dx.doi.org/10.1371/journal.pone.0236155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915780	Green Published, gold			2022-12-26	WOS:000571887500045
J	Motola, G; Hafez, HM; Bruggemann-Schwarze, S				Motola, Gerzon; Hafez, Hafez Mohamed; Brueggemann-Schwarze, Sarah			Efficacy of six disinfection methods against extended-spectrum beta-lactamase (ESBL) producingE.colion eggshellsin vitro	PLOS ONE			English	Article							RESISTANT ESCHERICHIA-COLI; HATCHING EGG; CEPHALOSPORIN-RESISTANT; CAMPYLOBACTER SPP.; HYDROGEN-PEROXIDE; RETAIL CHICKEN; POULTRY; PREVALENCE; MEAT; FORMALDEHYDE	The presence of extended-spectrum beta-lactamase (ESBL) producingEscherichia colion poultry products is an important issue for veterinary and human health due to the zoonotic infection risk for producers and consumers. The present study focuses on testing the efficacy of six different disinfection methods on eggshell samples, aiming to reduce ESBL producingE.colicontamination on the hatching egg. Sterile eggshell cutouts were artificially contaminated with 10(8)cfu/ml CTX-M-1 producingE.coliand used as a carrier model to analyze the efficacy of six disinfection methods. The contaminated samples were separated into two groups; 1) contaminated and disinfected, 2) contaminated and non-disinfected. Six independent disinfection protocols were performed following product specifications and protocols. Each eggshell sample was separately crushed, and the total viable bacterial count was calculated to determine the disinfection efficacy. Five out of six tested methods (formaldehyde gassing, hydrogen peroxide + alcohol spray, essential oils spray, peracetic acid foam, and low energetic electron radiation) demonstrated a reduction or completely eliminated the initial ESBL producingE.colicontamination. One method (essential oils as cold fog) only partly reached the expected efficacy threshold (reduction of >10(2)cfu/ml) and the result differed significantly when compared to the reference method i.e. formaldehyde gassing.	[Motola, Gerzon; Hafez, Hafez Mohamed; Brueggemann-Schwarze, Sarah] Free Univ Berlin, Inst Poultry Dis, Dept Vet Med, Berlin, Germany	Free University of Berlin	Bruggemann-Schwarze, S (corresponding author), Free Univ Berlin, Inst Poultry Dis, Dept Vet Med, Berlin, Germany.	sarah.brueggemann@fu-berlin.de		Motola, Gerzon/0000-0001-8564-0282	German Federal Ministry of Food and Agriculture [2817701014]	German Federal Ministry of Food and Agriculture	This study was funded by the German Federal Ministry of Food and Agriculture (grant 2817701014) as part of the EsRAM research consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu AG, 2013, BRAZ J MICROBIOL, V44, P469, DOI 10.1590/S1517-83822013005000038; Apostolakos I, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217174; Atanassova V, 1999, INT J FOOD MICROBIOL, V51, P187, DOI 10.1016/S0168-1605(99)00120-8; Beninati C, 2015, CZECH J FOOD SCI, V33, P97, DOI 10.17221/428/2014-CJFS; Berrang ME, 1997, J APPL POULTRY RES, V6, P298, DOI 10.1093/japr/6.3.298; Berrang ME, 1999, J APPL POULTRY RES, V8, P499, DOI 10.1093/japr/8.4.499; Blanc V, 2006, VET MICROBIOL, V118, P299, DOI 10.1016/j.vetmic.2006.08.002; Casella T, 2017, INT J FOOD MICROBIOL, V257, P271, DOI 10.1016/j.ijfoodmicro.2017.07.005; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Copur G, 2010, AFR J BIOTECHNOL, V9, P2531; Dhillon RHP, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/625170; Dierikx CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079005; Climaco WLD, 2018, PESQUI AGROPECU BRAS, V53, P1177, DOI [10.1590/S0100-204X2018001000011, 10.1590/s0100-204x2018001000011]; Egea P, 2011, EUR J CLIN MICROBIOL, V30, P1045, DOI 10.1007/s10096-011-1168-3; Ewers C, 2003, BERL MUNCH TIERARZTL, V116, P381; Falgenhauer L, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03358; Hammerum AM, 2009, CLIN INFECT DIS, V48, P916, DOI 10.1086/597292; Hasman H, 2005, J ANTIMICROB CHEMOTH, V56, P115, DOI 10.1093/jac/dki190; Hering J, 2016, PREV VET MED, V125, P154, DOI 10.1016/j.prevetmed.2016.01.003; Hering J, 2014, PREV VET MED, V116, P129, DOI 10.1016/j.prevetmed.2014.06.014; Hille K, 2017, PREV VET MED, V142, P39, DOI 10.1016/j.prevetmed.2017.05.003; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2006, IARC Monogr Eval Carcinog Risks Hum, V88, P1; Jensen LB, 2006, J ANTIMICROB CHEMOTH, V57, P793, DOI 10.1093/jac/dkl048; Keita A, 2016, POULTRY SCI, V95, P1609, DOI 10.3382/ps/pew058; Kemmett K, 2014, AVIAN PATHOL, V43, P37, DOI 10.1080/03079457.2013.866213; KRAFT AA, 1958, POULTRY SCI, V37, P638, DOI 10.3382/ps.0370638; Laube H, 2013, APPL ENVIRON MICROB, V79, P4815, DOI 10.1128/AEM.00856-13; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Mevius D.J.K., 2009, MONITORING ANTIMICRO; Mezhoud H, 2016, AVIAN PATHOL, V45, P493, DOI 10.1080/03079457.2016.1167837; Naghili H, 2013, VET RES FORUM; Nordenskjold J., 2010, STUDY MICROFLORA EGG; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Pernot EF, 1909, INVESTIGATION MORTAL; Petersen A, 2006, VET MICROBIOL, V116, P120, DOI 10.1016/j.vetmic.2006.03.015; Pol Marquer TR, MEAT PRODUCTION STAT; Projahn M, 2016, APPL ENVIRON MICROB, P02364, DOI [10.1128/aem.02364-16, DOI 10.1128/AEM.02364-16]; Radhouani H, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00023; Rawat D, 2010, J GLOB INFECT DIS, V2, P263, DOI 10.4103/0974-777X.68531; Saliu EM, 2017, ANIM HEALTH RES REV, V18, P46, DOI 10.1017/S1466252317000020; Sander JE, 1999, AVIAN DIS, V43, P227, DOI 10.2307/1592612; Scott T. A., 1993, Journal of Applied Poultry Research, V2, P1, DOI 10.1093/japr/2.1.1; Seiffert SN, 2013, DRUG RESIST UPDATE, V16, P22, DOI 10.1016/j.drup.2012.12.001; SHELDON BW, 1991, POULTRY SCI, V70, P1092, DOI 10.3382/ps.0701092; Sokovnin SY, 2018, J PHYS CONF SER, V1115, DOI 10.1088/1742-6596/1115/2/022034; Stuart JC, 2012, INT J FOOD MICROBIOL, V154, P212, DOI 10.1016/j.ijfoodmicro.2011.12.034; Tebrun W, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232825; Turblin V., 2011, GOOD QUALITY CHICKS; Weiss DE, 2002, RADIAT PHYS CHEM, V63, P581, DOI 10.1016/S0969-806X(01)00597-7; WHISTLER PE, 1989, POULTRY SCI, V68, P1345, DOI 10.3382/ps.0681345; WHISTLER PE, 1989, POULTRY SCI, V68, P1068, DOI 10.3382/ps.0681068; WILLIAMS JE, 1970, AVIAN DIS, V14, P386, DOI 10.2307/1588482; Wu GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075392; Zhao CW, 2001, APPL ENVIRON MICROB, V67, P5431, DOI 10.1128/AEM.67.12.5431-5436.2001; Zimmermann K., 2013, THESIS; Zurfluh K, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00519	56	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238860	10.1371/journal.pone.0238860	http://dx.doi.org/10.1371/journal.pone.0238860			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32916695	gold, Green Published			2022-12-26	WOS:000571887500079
J	Duxbury, S; Haynie, DL				Duxbury, Scott; Haynie, Dana L.			The responsiveness of criminal networks to intentional attacks: Disrupting darknet drug trade	PLOS ONE			English	Article							SOCIAL NETWORKS; VULNERABILITY; ROBUSTNESS; RESILIENCE; EMERGENCE	Physical, technological, and social networks are often at risk of intentional attack. Despite the wide-spanning importance of network vulnerability, very little is known about how criminal networks respond to attacks or whether intentional attacks affect criminal activity in the long-run. To assess criminal network responsiveness, we designed an empirically-grounded agent-based simulation using population-level network data on 16,847 illicit drug exchanges between 7,295 users of an active darknet drug market and statistical methods for simulation analysis. We consider three attack strategies: targeted attacks that delete structurally integral vertices, weak link attacks that delete large numbers of weakly connected vertices, and signal attacks that saturate the network with noisy signals. Results reveal that, while targeted attacks are effective when conducted at a large-scale, weak link and signal attacks deter more potential drug transactions and buyers when only a small portion of the network is attacked. We also find that intentional attacks affect network behavior. When networks are attacked, actors grow more cautious about forging ties, connecting less frequently and only to trustworthy alters. Operating in tandem, these two processes undermine long-term network robustness and increase network vulnerability to future attacks.	[Duxbury, Scott] Univ N Carolina, Dept Sociol, Chapel Hill, NC 27515 USA; [Haynie, Dana L.] Ohio State Univ, Dept Sociol, Columbus, OH 43210 USA	University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; Ohio State University	Duxbury, S (corresponding author), Univ N Carolina, Dept Sociol, Chapel Hill, NC 27515 USA.	duxbury@email.unc.edu		Duxbury, Scott/0000-0002-2071-8357	National Science Foundation [GRT00046370, 1949037]	National Science Foundation(National Science Foundation (NSF))	The study is funded by the National Science Foundation, Grants: GRT00046370 and 1949037. PI: DLH. NSF website: https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5369.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2016, J HEALTH SOC BEHAV, V57, P22, DOI 10.1177/0022146515627848; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Aldridge J, 2018, ADDICTION, V113, P789, DOI 10.1111/add.13899; [Anonymous], 2005, CRIMINOL PUBLIC POL, DOI DOI 10.1111/J.1745-9133.2005.00306.X; [Anonymous], 2018, BMJ, V361, pk2475; [Anonymous], 2017, INNOV SURG SCI, V2, P1, DOI DOI 10.5334/gjgl.276; Bail CA, 2018, P NATL ACAD SCI USA, V115, P9216, DOI 10.1073/pnas.1804840115; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barratt MJ, 2016, INT J DRUG POLICY, V35, P50, DOI 10.1016/j.drugpo.2016.04.006; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Caulkins JP, 2010, CRIME JUSTICE, V39, P213, DOI 10.1086/652386; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Diviak T, 2019, TRENDS ORGAN CRIME, V22, P274, DOI 10.1007/s12117-018-9334-y; Duijn PAC, 2014, SCI REP-UK, V4, DOI 10.1038/srep04238; Duxbury SW, 2019, CRIMINOLOGY, V57, P314, DOI 10.1111/1745-9125.12203; Duxbury SW, 2018, SOC NETWORKS, V52, P238, DOI 10.1016/j.socnet.2017.09.002; Faust K, 2019, ANNU REV CRIMINOL, V2, P99, DOI 10.1146/annurev-criminol-011518-024701; Gallo E, 2015, P NATL ACAD SCI USA, V112, P3647, DOI 10.1073/pnas.1415883112; Gallos LK, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.188701; Gerdes L, 2015, DISRUPTING DISMANTLI, P39; Gilbert N., 2005, SIMULATION SOCIAL SC; Holme P, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066109; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Liu B., 2012, SENTIMENT ANAL OPINI; Lusseau D, 2004, P ROY SOC B-BIOL SCI, V271, pS477, DOI 10.1098/rsbl.2004.0225; Malm A, 2011, J RES CRIME DELINQ, V48, P271, DOI 10.1177/0022427810391535; Morselli C, 2009, STUD ORGANIZE CRIME, V8, P1, DOI 10.1007/978-0-387-09526-4; Morselli C, 2008, CRIMINOLOGY, V46, P71, DOI 10.1111/j.1745-9125.2008.00103.x; Natarajan M, 2006, J QUANT CRIMINOL, V22, P171, DOI 10.1007/s10940-006-9007-x; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Papachristos A.V., 2013, CRIME NETWORKS, P97, DOI DOI 10.2139/SSRN.2159899; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Schaefer DR, 2013, HEALTH EDUC BEHAV, V40, p24S, DOI 10.1177/1090198113493091; Shiraki Y, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036101; Snijders TAB, 2017, ANNU REV STAT APPL, V4, P343, DOI 10.1146/annurev-statistics-060116-054035; Snijders TAB, 2015, SOCIOL METHOD RES, V44, P222, DOI 10.1177/0049124113494573; Soska K, 2015, PROCEEDINGS OF THE 24TH USENIX SECURITY SYMPOSIUM, P33; Vazquez A, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.015101; Wood G, 2017, SOC NETWORKS, V48, P1, DOI 10.1016/j.socnet.2016.07.001; Wu J, 2007, J PHYS A-MATH THEOR, V40, P2665, DOI 10.1088/1751-8113/40/11/005	42	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238019	10.1371/journal.pone.0238019	http://dx.doi.org/10.1371/journal.pone.0238019			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9ME	32911485	gold, Green Published			2022-12-26	WOS:000571885900037
J	Gaur, P; Saini, S; Ray, K; Asanbekovna, KN; Akunov, A; Maripov, A; Sarybaev, A; Singh, SB; Kumar, B; Vats, P				Gaur, Priya; Saini, Supriya; Ray, Koushik; Asanbekovna, Kushubakova Nadira; Akunov, Almaz; Maripov, Abdirashit; Sarybaev, Akpay; Singh, Shashi Bala; Kumar, Bhuvnesh; Vats, Praveen			Temporal transcriptome analysis suggest modulation of multiple pathways and gene network involved in cell-cell interaction during early phase of high altitude exposure	PLOS ONE			English	Article							ACUTE MOUNTAIN-SICKNESS; ENDOTHELIAL-CELLS; HYPOXIA; PRESSURE; ADHESION; EXPRESSION; KINASE	High altitude (HA) conditions induce several physiological and molecular changes, prevalent in individuals who are unexposed to this environment. Individuals exposed towards HA hypoxia yields physiological and molecular orchestration to maintain adequate tissue oxygen delivery and supply at altitude. This study aimed to understand the temporal changes at altitude of 4,111m. Physiological parameters and transcriptome study was conducted at high altitude day 3, 7, 14 and 21. We observed changes in differentially expressed gene (DEG) at high altitude time points along with altered BP, HR, SpO(2), mPAP. Physiological changes and unsupervised learning of DEG's discloses high altitude day 3 as distinct time point. Gene enrichment analysis of ontologies and pathways indicate cellular dynamics and immune response involvement in early day exposure and later stable response. Major clustering of genes involved in cellular dynamics deployed into broad categories: cell-cell interaction, blood signaling, coagulation system, and cellular process. Our data reveals genes and pathways perturbed for conditions like vascular remodeling, cellular homeostasis. In this study we found the nodal point of the gene interactive network and candidate gene controlling many cellular interactive pathways VIM, CORO1A, CD37, STMN1, RHOC, PDE7B, NELL1, NRP1 and TAGLN and the most significant among them i.e. VIM gene was identified as top hub gene. This study suggests a unique physiological and molecular perturbation likely to play a critical role in high altitude associated pathophysiological condition during early exposure compared to later time points.	[Gaur, Priya; Saini, Supriya; Ray, Koushik; Kumar, Bhuvnesh; Vats, Praveen] Def Inst Physiol & Allied Sci, Delhi, India; [Asanbekovna, Kushubakova Nadira; Akunov, Almaz; Maripov, Abdirashit; Sarybaev, Akpay] Kyrgyz Indian Mt Biomed Res Ctr, Bishkek, Kyrgyz Republic, Kyrgyzstan; [Singh, Shashi Bala] Natl Inst Pharmaceut Educ & Res, Hyderabad, Telangana, India	Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS); National Institute of Pharmaceutical Education & Research, Hyderabad; National Institute of Pharmaceutical Education & Research (NIPER)	Vats, P (corresponding author), Def Inst Physiol & Allied Sci, Delhi, India.; Sarybaev, A (corresponding author), Kyrgyz Indian Mt Biomed Res Ctr, Bishkek, Kyrgyz Republic, Kyrgyzstan.	ak_sar777@mail.ru; drvatsp@gmail.com	Maripov, Abdirashit/CAG-2602-2022; Singh, Shashi Bala/AAS-9889-2021; Kushubakova, Nadira/CAG-2576-2022	Kushubakova, Nadira/0000-0001-6874-7125	Kyrgyz Indian Mountain Biomedical Research Centre VAT [02602200910159]	Kyrgyz Indian Mountain Biomedical Research Centre VAT	Name: Prof Akpay Sarybaev Funder name: Kyrgyz Indian Mountain Biomedical Research Centre VAT number (KIMBMRC): 02602200910159.	Aldashev AA, 2002, AM J RESP CRIT CARE, V166, P1396, DOI 10.1164/rccm.200204-345OC; Anand RJ, 2007, J LEUKOCYTE BIOL, V82, P1257, DOI 10.1189/jlb.0307195; [Anonymous], 2011, THER ADV MED ONCOL, V3, pS7; [Anonymous], 2005, AM J PHYSIOL-HEART C, V289, pH1898; ATKINS P, 1970, BRIT J SURG, V57, P583, DOI 10.1002/bjs.1800570809; Basnyat B, 2003, LANCET, V361, P1967, DOI 10.1016/S0140-6736(03)13591-X; Basu CK, 2007, WILD ENVIRON MED, V18, P106, DOI 10.1580/06-WEME-OR-025R1.1; Beall CM, 2003, LANCET, V362, pS14, DOI 10.1016/S0140-6736(03)15058-1; Bertoni A, 2002, J BIOL CHEM, V277, P25715, DOI 10.1074/jbc.M202791200; Boos CJ, 2016, HIGH ALT MED BIOL, V17, P25, DOI 10.1089/ham.2015.0098; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Burkhart JM, 2014, CIRC RES, V114, P1204, DOI 10.1161/CIRCRESAHA.114.301598; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Calbet JAL, 2002, J PHYSIOL-LONDON, V545, P715, DOI 10.1113/jphysiol.2002.029108; Carbone C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020431; Chemla D, 2004, CHEST, V126, P1313, DOI 10.1378/chest.126.4.1313; COLICE GL, 1985, J APPL PHYSIOL, V58, P724, DOI 10.1152/jappl.1985.58.3.724; Ekambaram P, 2011, CANCER METAST REV, V30, P397, DOI 10.1007/s10555-011-9297-9; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Gaur P, 2018, ENDOCRINE, V59, P466, DOI 10.1007/s12020-018-1529-0; Glaser-Gabay L, 2011, MICROVASC RES, V82, P221, DOI 10.1016/j.mvr.2011.07.006; Gnecchi-Ruscone GA, 2018, GENOME BIOL EVOL, V10, P2919, DOI 10.1093/gbe/evy233; Goldfarb-Rumyantzev AS, 2014, NEPHROL DIAL TRANSPL, V29, P497, DOI 10.1093/ndt/gft051; Guijarro Morales A, 1990, An Med Interna, V7, P375; Haseloff RF, 2006, PROTEOMICS, V6, P1803, DOI 10.1002/pmic.200500182; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Imray C, 2010, PROG CARDIOVASC DIS, V52, P467, DOI 10.1016/j.pcad.2010.02.003; Jha PK, 2018, THROMB HAEMOSTASIS, V118, P1279, DOI 10.1055/s-0038-1657770; Jin NJ, 2000, AM J RESP CELL MOL, V23, P593, DOI 10.1165/ajrcmb.23.5.3921; JONES RL, 1985, ADV EXP MED BIOL, V192, P67; Ju JLA, 2017, MOL CANCER RES, V15, P723, DOI 10.1158/1541-7786.MCR-16-0338; Julian RJ, 2007, POULTRY SCI, V86, P1006, DOI 10.1093/ps/86.5.1006; Khalili AA, 2015, INT J MOL SCI, V16, P18149, DOI 10.3390/ijms160818149; Kiouptsi K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07988-x; Liu TG, 2010, AM J PHYSIOL-CELL PH, V299, pC363, DOI 10.1152/ajpcell.00057.2010; Lundeberg J, 2018, HIGH ALT MED BIOL, V19, P249, DOI 10.1089/ham.2017.0144; MacInnis MJ, 2010, HIGH ALT MED BIOL, V11, P349, DOI 10.1089/ham.2010.1030; Malle C, 2016, HIGH ALT MED BIOL, V17, P359, DOI 10.1089/ham.2016.0022; Marks L, 2006, J SOC GYNECOL INVEST, V13, P399, DOI 10.1016/j.jsgi.2006.05.001; MCDONALD TP, 1978, BLOOD, V51, P165; Mortimer HJ, 2007, PULM PHARMACOL THER, V20, P718, DOI 10.1016/j.pupt.2006.08.007; Netzer NC, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00081; Ortiz-Prado E, 2019, AM J BLOOD RES, V9, P1; Paralikar Swapnil J, 2010, Indian J Occup Environ Med, V14, P6, DOI 10.4103/0019-5278.64608; Petousi N, 2014, J APPL PHYSIOL, V116, P875, DOI 10.1152/japplphysiol.00605.2013; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Roach RC, 2018, HIGH ALT MED BIOL, V19, P4, DOI 10.1089/ham.2017.0164; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Saini S, 2019, FUNCT INTEGR GENOMIC, V19, P205, DOI 10.1007/s10142-018-0637-5; Savourey G, 2003, EUR J APPL PHYSIOL, V89, P122, DOI 10.1007/s00421-002-0789-8; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Stefanini L, 2016, J MOL MED, V94, P13, DOI 10.1007/s00109-015-1346-3; Stefanini L, 2012, ARTERIOSCL THROM VAS, V32, P434, DOI 10.1161/ATVBAHA.111.239194; Tsuruta D, 2003, J CELL SCI, V116, P4977, DOI 10.1242/jcs.00823; Wei CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep26770; West JB, 2006, INTEGR COMP BIOL, V46, P25, DOI 10.1093/icb/icj005; Xu YP, 2017, HYPERTENS RES, V40, P552, DOI 10.1038/hr.2017.2; Zhang D, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-73	59	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238117	10.1371/journal.pone.0238117	http://dx.doi.org/10.1371/journal.pone.0238117			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911517	gold, Green Published			2022-12-26	WOS:000571885900009
J	Mendes, RR; Takano, HK; Leal, JF; Souza, AS; Morran, S; Oliveira, RS; Adegas, FS; Gaines, TA; Dayan, FE				Mendes, Rafael R.; Takano, Hudson K.; Leal, Jessica F.; Souza, Amanda S.; Morran, Sarah; Oliveira Jr, Rubem S.; Adegas, Fernando S.; Gaines, Todd A.; Dayan, Franck E.			Evolution of EPSPS double mutation imparting glyphosate resistance in wild poinsettia (Euphorbia heterophylla L.)	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTION; BIOTYPES; SEQUESTRATION; TRANSLOCATION; INHIBITORS; SYNTHASE	The evolution of glyphosate resistance (GR) in weeds is an increasing problem. Glyphosate has been used intensively on wild poinsettia (Euphorbia heterophyllaL.) populations for at least 20 years in GR crops within South America. We investigated the GR mechanisms in a wild poinsettia population from a soybean field in southern Brazil. The GR population required higher glyphosate doses to achieve 50% control (LD50) and 50% dry mass reduction (MR50) compared to a glyphosate susceptible (GS) population. The ratio between the LD(50)and MR(50)of GR and GS resulted in resistance factors (RF) of 6.9-fold and 6.1-fold, respectively. Shikimate accumulated 6.7 times more in GS than in GR when leaf-discs were incubated with increasing glyphosate concentrations. No differences were found between GR and GS regarding non-target-site mechanisms. Neither population metabolized glyphosate to significant levels following treatment with 850 g ha(-1)glyphosate. Similar levels of(14)C-glyphosate uptake and translocation were observed between the two populations. No differences inEPSPSexpression were found between GS and GR. Two target site mutations were found in allEPSPSalleles of homozygous resistant plants: Thr102Ile+Pro106Thr (TIPT-mutation). Heterozygous individuals harbored both alleles, wild-type and TIPT. Half of GR individuals were heterozygous, suggesting that resistance is still evolving in the population. A genotyping assay was developed based on the Pro106Thr mutation, demonstrating high efficiency to identify homozygous, heterozygous or wild-typeEPSPSsequences across different plants. This is the first report of glyphosate-resistant wild-poinsettia harboring anEPSPSdouble mutation (TIPT) in the same plant.	[Mendes, Rafael R.; Oliveira Jr, Rubem S.] Univ Estadual Maringa, Agron Dept, Maringa, PR, Brazil; [Takano, Hudson K.; Morran, Sarah; Gaines, Todd A.; Dayan, Franck E.] Colorado State Univ, Dept Agr Biol, Ft Collins, CO 80523 USA; [Leal, Jessica F.; Souza, Amanda S.] Rural Fed Univ Rio de Janeiro, Seropedica, RJ, Brazil; [Adegas, Fernando S.] Embrapa Soybean, Londrina, Parana, Brazil	Universidade Estadual de Maringa; Colorado State University; Universidade Federal Rural do Rio de Janeiro (UFRRJ); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Dayan, FE (corresponding author), Colorado State Univ, Dept Agr Biol, Ft Collins, CO 80523 USA.	franck.dayan@colostate.edu	Takano, Hudson K/I-5118-2016; Dayan, Franck E/AAB-6565-2022; Gaines, Todd/A-8998-2008; Leal, Jéssica Ferreira Lourenço/ABE-5413-2021	Takano, Hudson K/0000-0002-8018-3868; Dayan, Franck E/0000-0001-6964-2499; Gaines, Todd/0000-0003-1485-7665; Reis, AlessanRSS/0000-0001-8486-7469	CAPES, Coordenacao de Aperfeicoamento de Pessoal de Ni'vel Superior, Brazil [001]; USDA National Institute of Food and Agriculture (Hatch Project) [1016591, COL00785]	CAPES, Coordenacao de Aperfeicoamento de Pessoal de Ni'vel Superior, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); USDA National Institute of Food and Agriculture (Hatch Project)	This research was partially funded by CAPES, Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior, Brazil (funding code 001 -https://www.capes.gov.br/), and the USDA National Institute of Food and Agriculture (Hatch Project 1016591, COL00785 -https://usda.gov/).No additional external funding was received.	Aarestrup JR, 2008, GENET MOL RES, V7, P217, DOI 10.4238/vol7-1gmr421; Agostinetto D, 2019, BIOSCI J, V35, P1060, DOI 10.14393/BJ-v35n4a2019-42118; Beckie HJ, 2017, PEST MANAG SCI, V73, P1045, DOI 10.1002/ps.4543; Brusamarello AP, 2020, WEED RES, V60, P278, DOI 10.1111/wre.12425; Cruz-Lopez R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00560; Dayan FE, 2015, WEED SCI, V63, P23, DOI 10.1614/WS-D-13-00063.1; de Carvalho LB, 2011, WEED SCI, V59, P171, DOI 10.1614/WS-D-10-00113.1; Delye C, 2015, WEED SCI, V63, P91, DOI 10.1614/WS-D-13-00096.1; Duke SO, 2008, PEST MANAG SCI, V64, P319, DOI 10.1002/ps.1518; Frigo MJ, 2009, WEED SCI, V57, P54, DOI 10.1614/WS-08-096.1; Gaines TA, 2020, MUTATIONS HERBICIDE; Gaines TA, 2019, NEW PHYTOL, V223, P1770, DOI 10.1111/nph.15858; Gaines TA, 2010, P NATL ACAD SCI USA, V107, P1029, DOI 10.1073/pnas.0906649107; Ge X, 2012, J AGR FOOD CHEM, V60, P1243, DOI 10.1021/jf203472s; Ge X, 2010, PEST MANAG SCI, V66, P345, DOI 10.1002/ps.1911; Ghanizadeh H, 2016, J AGR SCI TECH-IRAN, V18, P1041; Grodzinski, 2020, COMPREHENSIVE BIOTEC, P36; Han HP, 2017, PLANT CELL ENVIRON, V40, P3031, DOI 10.1111/pce.13067; Heap I, 2018, PEST MANAG SCI, V74, P1040, DOI 10.1002/ps.4760; Heap Ian., 2020, INT SURVEY HERBICIDE; Li JB, 2018, J AGR FOOD CHEM, V66, P7880, DOI 10.1021/acs.jafc.8b01651; Lucio FR, 2019, WEED TECHNOL, V33, P217, DOI 10.1017/wet.2018.97; Mendes RR, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10081057; Mendes RR, 2020, WEED SCI, V68, P437, DOI 10.1017/wsc.2020.42; Meschede D.K., 2002, Planta daninha, V20, P381, DOI 10.1590/S0100-83582002000300008; Moretti ML, 2018, PEST MANAG SCI, V74, P1079, DOI 10.1002/ps.4569; Nandula VK, 2013, WEED SCI, V61, P374, DOI 10.1614/WS-D-12-00155.1; Ngo TD, 2018, PEST MANAG SCI, V74, P1101, DOI 10.1002/ps.4573; Palma-Bautista C, 2019, J AGR FOOD CHEM, V67, P1052, DOI 10.1021/acs.jafc.8b06105; Pan L, 2019, PLANT PHYSIOL, V181, P1519, DOI 10.1104/pp.19.00979; Patterson EL, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00752; Perotti VE, 2019, PEST MANAG SCI, V75, P1242, DOI 10.1002/ps.5303; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; RODRIGUES B.N., 2018, GUIA HERBICIDAS, V7th; Rojano-Delgado AM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51682-z; Sammons RD, 2014, PEST MANAG SCI, V70, P1367, DOI 10.1002/ps.3743; Sarangi D, 2017, SCI REP-UK, V7, DOI 10.1038/srep44913; Shaner DL, 2005, WEED SCI, V53, P769, DOI 10.1614/WS-05-009R.1; Takano HK, 2020, PEST MANAG SCI, V76, P95, DOI 10.1002/ps.5535; Trezzi MM, 2005, J ENVIRON SCI HEAL B, V40, P101, DOI 10.1081/PFC-200034254; Van Horn CR, 2018, PEST MANAG SCI, V74, P1071, DOI 10.1002/ps.4567; Vargas L, 2013, PLANTA DANINHA, V31, P427, DOI 10.1590/S0100-83582013000200021; Vargas L, 2011, PLANTA DANINHA, V29, P1121, DOI 10.1590/S0100-83582011000500020; Vidal R.A., 2004, Planta daninha, V22, P403, DOI 10.1590/S0100-83582004000300010; Vidal RA, 2007, J FOOD AGRIC ENVIRON, V5, P265; Vila-Aiub MM, 2012, PEST MANAG SCI, V68, P430, DOI 10.1002/ps.2286; WILSON AK, 1981, TROP PEST MANAGE, V27, P32, DOI 10.1080/09670878109414169; Yu Q, 2015, PLANT PHYSIOL, V167, P1440, DOI 10.1104/pp.15.00146	48	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238818	10.1371/journal.pone.0238818	http://dx.doi.org/10.1371/journal.pone.0238818			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32913366	gold, Green Published			2022-12-26	WOS:000571885900029
J	Majmundar, M; Kansara, T; Lenik, JM; Park, H; Ghosh, K; Doshi, R; Shah, P; Kumar, A; Amin, H; Chaudhari, S; Habtes, I				Majmundar, Monil; Kansara, Tikal; Lenik, Joanna Marta; Park, Hansang; Ghosh, Kuldeep; Doshi, Rajkumar; Shah, Palak; Kumar, Ashish; Amin, Hossam; Chaudhari, Shobhana; Habtes, Imnett			Efficacy of corticosteroids in non-intensive care unit patients with COVID-19 pneumonia from the New York Metropolitan region	PLOS ONE			English	Article							RESPIRATORY SYNDROME; THERAPY; GLUCOCORTICOIDS; OUTCOMES	Introduction The role of systemic corticosteroid as a therapeutic agent for patients with COVID-19 pneumonia is controversial. Objective The purpose of this study was to evaluate the effect of corticosteroids in non-intensive care unit (ICU) patients with COVID-19 pneumonia complicated by acute hypoxemic respiratory failure (AHRF). Methods This was a single-center retrospective cohort study, from 16(th) March, 2020 to 30(th) April, 2020; final follow-up on 10(th) May, 2020. 265 patients consecutively admitted to the non-ICU wards with laboratory-confirmed COVID-19 pneumonia were screened for inclusion. 205 patients who developed AHRF (SpO(2)/FiO(2)<= 440 or PaO2/FiO(2)<= 300) were only included in the final study. Direct admission to the Intensive care unit (ICU), patients developing composite primary outcome within 24 hours of admission, and patients who never became hypoxic during their stay in the hospital were excluded. Patients were divided into two cohorts based on corticosteroid. The primary outcome was a composite of ICU transfer, intubation, or in-hospital mortality. Secondary outcomes were ICU transfer, intubation, in-hospital mortality, discharge, length of stay, and daily trend of SpO(2)/FiO(2)(SF) ratio from the index date. Cox-proportional hazard regression was implemented to analyze the time to event outcomes. Result Among 205 patients, 60 (29.27%) were treated with corticosteroid. The mean age was similar to 57 years, and similar to 75% were men. Thirteen patients (22.41%) developed a primary composite outcome in the corticosteroid cohort vs. 54 (37.5%) patients in the non-corticosteroid cohort (P = 0.039). The adjusted hazard ratio (HR) for the development of the composite primary outcome was 0.15 (95% CI, 0.07-0.33; P <0.001). The adjusted hazard ratio for ICU transfer was 0.16 (95% CI, 0.07 to 0.34; P < 0.001), intubation was 0.31 (95% CI, 0.14 to 0.70; P- 0.005), death was 0.53 (95% CI, 0.22 to 1.31; P- 0.172), composite of death or intubation was 0.31 (95% CI, 0.15 to 0.66; P- 0.002) and discharge was 3.65 (95% CI, 2.20 to 6.06; P<0.001). The corticosteroid cohort had increasing SpO(2)/FiO(2) over time compared to the non-corticosteroid cohort who experience decreasing SpO(2)/FiO(2) over time. Conclusion Among non-ICU patients hospitalized with COVID-19 pneumonia complicated by AHRF, treatment with corticosteroid was associated with a significantly lower risk of the primary composite outcome of ICU transfer, intubation, or in-hospital death, composite of intubation or death and individual components of the primary outcome.	[Majmundar, Monil; Kansara, Tikal; Lenik, Joanna Marta; Park, Hansang; Ghosh, Kuldeep; Shah, Palak; Chaudhari, Shobhana] New York Med Coll, Metropolitan Hosp, Dept Internal Med, New York, NY 10595 USA; [Doshi, Rajkumar] Univ Nevada, Reno Sch Med, Dept Internal Med, Reno, NV 89557 USA; [Kumar, Ashish] St Johns Med Coll Hosp, Dept Crit Care Med, Bengaluru, Karnataka, India; [Amin, Hossam; Habtes, Imnett] New York Med Coll, Metropolitan Hosp, Dept Internal Med, Div Pulm & Crit Care, New York, NY USA	Metropolitan Hospital Center; New York Medical College; Nevada System of Higher Education (NSHE); University of Nevada Reno; St. John's National Academy of Health Sciences; St. John's Medical College; Metropolitan Hospital Center; New York Medical College	Majmundar, M (corresponding author), New York Med Coll, Metropolitan Hosp, Dept Internal Med, New York, NY 10595 USA.	monilmajmundar1804@gmail.com	Majmundar, Monil/AAA-3148-2020; Kumar, Ashish/GRR-3470-2022; Kumar, Ashish/GRJ-3967-2022; Doshi, Rajkumar/G-7744-2017; Kumar, Ashish/X-5704-2018	Majmundar, Monil/0000-0002-5389-5878; Kumar, Ashish/0000-0002-4476-3494; Doshi, Rajkumar/0000-0002-5618-2750; Kumar, Ashish/0000-0003-4249-0055				[Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; Arabi YM, 2018, AM J RESP CRIT CARE, V197, P757, DOI 10.1164/rccm.201706-1172OC; Auyeung TW, 2005, J INFECTION, V51, P98, DOI 10.1016/j.jinf.2004.09.008; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Channappanavar R, 2017, SEMIN IMMUNOPATHOL, V39, P529, DOI 10.1007/s00281-017-0629-x; Chen RC, 2006, CHEST, V129, P1441, DOI 10.1378/chest.129.6.1441; Czock D, 2005, CLIN PHARMACOKINET, V44, P61, DOI 10.2165/00003088-200544010-00003; Gangopadhyay KK., 2020, ROLE CORTICOSTEROIDS, DOI [DOI 10.1101/2020.04.17.20069773, 10.1101/2020.04.17.20069773]; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Hui DS, 2018, AM J RESP CRIT CARE, V197, P700, DOI 10.1164/rccm.201712-2371ED; Li H, 2017, INFLUENZA OTHER RESP, V11, P345, DOI 10.1111/irv.12456; Ni YN, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2395-8; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Siemieniuk RAC, 2015, ANN INTERN MED, V163, P519, DOI 10.7326/M15-0715; Stern A, 2017, COCHRANE DB SYST REV, P1, DOI 10.1002/14651858.CD007720.pub3; Thompson BT, 2003, CRIT CARE MED, V31, pS253, DOI 10.1097/01.CCM.0000057900.19201.55; World Health Organization, GLOB SURV HUM INF CO; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Zhao JP, 2020, ZHONGHUA JIE HE HE H, V43, pE007, DOI [10.3760/cma.j.issn.1001-0939.2020.03.008, 10.1016/S0140-6736(20)30361-5]; Zhou Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58796-9	23	24	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2020	15	9							e0238827	10.1371/journal.pone.0238827	http://dx.doi.org/10.1371/journal.pone.0238827			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR4MY	32903258	Green Published, Green Submitted, gold			2022-12-26	WOS:000571539500014
J	Marinello, WP; Mohseni, ZS; Cunningham, SJ; Crute, C; Huang, R; Zhang, JJ; Feng, LP				Marinello, William P.; Mohseni, Zahra S.; Cunningham, Sarah J.; Crute, Christine; Huang, Rong; Zhang, Jun J.; Feng, Liping			Perfluorobutane sulfonate exposure disrupted human placental cytotrophoblast cell proliferation and invasion involving in dysregulating preeclampsia related genes	FASEB JOURNAL			English	Article						invasion; PFBS; placenta cytotrophoblast; preeclampsia; proliferation	EPITHELIAL-MESENCHYMAL TRANSITION; POLYFLUOROALKYL SUBSTANCES PFASS; INTRAUTERINE GROWTH RESTRICTION; EXTRAVILLOUS TROPHOBLAST CELLS; ADRENOMEDULLIN MESSENGER-RNA; ACTIVATED PROTEIN-KINASE; PERFLUOROOCTANE SULFONATE; PERFLUORINATED COMPOUNDS; 1ST TRIMESTER; PERFLUOROALKYL ACIDS	We reported that maternal PFBS, an emerging pollutant, exposure is positively associated with preeclampsia which can result from aberrant trophoblasts invasion and subsequent placental ischemia. In this study, we investigated the effects of PFBS on trophoblasts proliferation/invasion and signaling pathways. We exposed a human trophoblast line, HTR8/SVneo, to PFBS. Cell viability, proliferation, and cell cycle were evaluated by the MTS assay, Ki-67 staining, and flow cytometry, respectively. We assessed cell migration and invasion with live-cell imaging-based migration assay and matrigel invasion assay, respectively. Signaling pathways were examined by Western blot, RNA-seq, and qPCR. PFBS exposure interrupted cell proliferation and invasion in a dose-dependent manner. PFBS (100 mu M) did not cause cell death but instead significant cell proliferation without cell cycle disruption. PFBS (10 and 100 mu M) decreased cell migration and invasion, while PFBS (0.1 mu M) significantly increased cell invasion but not migration. Further, RNA-seq analysis identified dysregulated HIF-1 alpha target genes that are relevant to cell proliferation/invasion and preeclampsia, while Western Blot data showed the activation of HIF-1 alpha, but not Notch, ERK1/2, (PI3K)AKT, and P38 pathways. PBFS exposure altered trophoblast cell proliferation/invasion which might be mediated by preeclampsia-related genes, suggesting a possible association between prenatal PFBS exposure and adverse placentation.	[Marinello, William P.; Mohseni, Zahra S.; Crute, Christine; Feng, Liping] Duke Univ, Sch Med, Dept Obstet & Gynecol, Durham, NC USA; [Cunningham, Sarah J.] Duke Univ, Univ Program Genet & Genom, Durham, NC USA; [Crute, Christine] Duke Univ, Nicholas Sch Environm, Integrated Toxicol & Environm Hlth Program, Durham, NC 27708 USA; [Huang, Rong; Zhang, Jun J.; Feng, Liping] Jiao Tong Univ, MOE Shanghai Key Lab Childrens Environm Hlth, Xinhua Hosp, Sch Med, Shanghai, Peoples R China	Duke University; Duke University; Duke University; Shanghai Jiao Tong University	Feng, LP (corresponding author), Duke Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Med Ctr, Box 103208, Durham, NC 27710 USA.	liping.feng@duke.edu	Marinello, William/AAR-8203-2020	Marinello, William/0000-0002-7248-3908	Fogarty International Center of the National Institutes of Health [1K01TW010828-01]; Ministry of Science and Technology of China [2014CB943300]; National Natural Science Foundation of China [81803246]	Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fogarty International Center of the National Institutes of Health under Award Number 1K01TW010828-01 (PI: Liping Feng) and the Ministry of Science and Technology of China under Award Number 2014CB943300 (PI: Jun J. Zhang). National Natural Science Foundation of China (81803246, PI: Rong Huang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We acknowledge Emi Yuan, a summer working student, performed the quantitate PCR to confirm RNA-seq results and Junjiao Song, a visiting scholar, performed Western Blot for HIF-1 alpha.	Al-Ghafra A, 2006, MOL HUM REPROD, V12, P181, DOI 10.1093/molehr/gal016; Albini A, 2016, CANCER RES, V76, P4595, DOI 10.1158/0008-5472.CAN-16-1971; Alexander BT, 2001, HYPERTENSION, V37, P485, DOI 10.1161/01.HYP.37.2.485; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Anin Sheba Anin, 2004, Hum Fertil (Camb), V7, P169, DOI 10.1080/14647270400006911; Apelberg BJ, 2007, ENVIRON HEALTH PERSP, V115, P1670, DOI 10.1289/ehp.10334; Appel S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103216; Arimoto-Ishida E, 2009, ENDOCRINOLOGY, V150, P4306, DOI 10.1210/en.2008-1662; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Barrett SL, 2008, PRENATAL DIAG, V28, P28, DOI 10.1002/pd.1898; Bechi N, 2013, TOXICOL IN VITRO, V27, P995, DOI 10.1016/j.tiv.2013.01.013; Behr AC, 2018, TOXICOL LETT, V291, P51, DOI 10.1016/j.toxlet.2018.03.029; Beiswenger TR, 2012, REPROD SCI, V19, P526, DOI 10.1177/1933719111426600; Benskin JP, 2011, ENVIRON SCI TECHNOL, V45, P7188, DOI 10.1021/es2011176; Bishop T, 2015, CIRC RES, V117, P65, DOI 10.1161/CIRCRESAHA.117.305109; Boc-Zalewska A, 2011, GINEKOL POL, V82, P585; Boc-Zalewska A, 2011, GINEKOL POL, V82, P178; Butt AJ, 2003, J BIOL CHEM, V278, P29676, DOI 10.1074/jbc.M301965200; Butt CM, 2010, SCI TOTAL ENVIRON, V408, P2936, DOI 10.1016/j.scitotenv.2010.03.015; Campo J, 2016, ENVIRON RES, V147, P503, DOI 10.1016/j.envres.2016.03.010; Caniggia I, 1999, J CLIN INVEST, V103, P1641, DOI 10.1172/JCI6380; Castiglioni S, 2015, J HAZARD MATER, V282, P51, DOI 10.1016/j.jhazmat.2014.06.007; Chakraborty C, 2003, MOL CELL ENDOCRINOL, V201, P63, DOI 10.1016/S0303-7207(02)00431-8; Chen FJ, 2018, ECOTOX ENVIRON SAFE, V158, P223, DOI 10.1016/j.ecoenv.2018.04.032; Chen L, 2012, MOL CELL BIOCHEM, V365, P263, DOI 10.1007/s11010-012-1267-1; Chen T, 2012, REPROD TOXICOL, V33, P538, DOI 10.1016/j.reprotox.2011.03.003; Conder JM, 2008, ENVIRON SCI TECHNOL, V42, P995, DOI 10.1021/es070895g; Corsini E, 2012, TOXICOL APPL PHARM, V258, P248, DOI 10.1016/j.taap.2011.11.004; Crocker IP, 2005, J PATHOL, V206, P476, DOI 10.1002/path.1801; Crosley EJ, 2014, REPROD BIOL ENDOCRIN, V12, P1, DOI 10.1186/1477-7827-12-123; Darakhshan S, 2019, PREGNANCY HYPERTENS, V17, P36, DOI 10.1016/j.preghy.2019.05.001; Darrow LA, 2013, ENVIRON HEALTH PERSP, V121, P1207, DOI 10.1289/ehp.1206372; DaSilva-Arnold SC, 2018, BIOL REPROD, V99, P409, DOI 10.1093/biolre/ioy042; De Villiers CP, 2018, CLIN CHEM LAB MED, V56, P65, DOI 10.1515/cclm-2017-0356; Dikensoy E, 2009, HYPERTENS PREGNANCY, V28, P383, DOI 10.3109/10641950802629634; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duan HL, 2017, CLIN LAB, V63, P921, DOI 10.7754/Clin.Lab.2016.161103; Fedorova L, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-15; Feng XJ, 2017, TOXICOL SCI, V155, P409, DOI 10.1093/toxsci/kfw219; Fromme H, 2009, INT J HYG ENVIR HEAL, V212, P239, DOI 10.1016/j.ijheh.2008.04.007; Gebbink WA, 2016, CHEMOSPHERE, V144, P2384, DOI 10.1016/j.chemosphere.2015.10.116; Giesy JP, 2001, ENVIRON SCI TECHNOL, V35, P1339, DOI 10.1021/es001834k; Giesy JP, 2002, ENVIRON SCI TECHNOL, V36, p146A, DOI 10.1021/es022253t; Glynn A, 2012, ENVIRON SCI TECHNOL, V46, P9071, DOI 10.1021/es301168c; Gorrochategui E, 2014, TOXICOL APPL PHARM, V277, P124, DOI 10.1016/j.taap.2014.03.012; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Grandjean P, 2012, JAMA-J AM MED ASSOC, V307, P391, DOI 10.1001/jama.2011.2034; Gratton RJ, 2003, J CLIN ENDOCR METAB, V88, P6048, DOI 10.1210/jc.2003-030323; Grill S, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-70; Gupta SK, 2016, AM J REPROD IMMUNOL, V75, P361, DOI 10.1111/aji.12436; Gyllenhammar I, 2018, ENVIRON SCI TECHNOL, V52, P7101, DOI 10.1021/acs.est.8b00770; Haddad JJ, 2002, RESP RES, V3, DOI 10.1186/rr190; Haiminen N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024182; Hatipoglu OF, 2009, J BIOL CHEM, V284, P16325, DOI 10.1074/jbc.M109.001313; Hiden U, 2018, HISTOCHEM CELL BIOL, V149, P31, DOI 10.1007/s00418-017-1608-y; Highet AR, 2015, EUR J CELL BIOL, V94, P589, DOI 10.1016/j.ejcb.2015.10.004; Houde M, 2006, ENVIRON SCI TECHNOL, V40, P3463, DOI 10.1021/es052580b; Houde M, 2011, ENVIRON SCI TECHNOL, V45, P7962, DOI 10.1021/es104326w; Huang R, 2019, ENVIRON HEALTH-GLOB, V18, DOI 10.1186/s12940-018-0445-3; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Hunkapiller NM, 2011, DEVELOPMENT, V138, P2987, DOI 10.1242/dev.066589; James JL, 2006, HUM REPROD UPDATE, V12, P137, DOI 10.1093/humupd/dmi043; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Johnson SK, 2009, WORLD J GASTROENTERO, V15, P3355, DOI 10.3748/wjg.15.3355; Jonkman JEN, 2014, CELL ADHES MIGR, V8, P440, DOI 10.4161/cam.36224; Kalem MN, 2018, HYPERTENS PREGNANCY, V37, P9, DOI 10.1080/10641955.2017.1397690; Kannan K, 2005, ARCH ENVIRON CON TOX, V48, P559, DOI 10.1007/s00244-004-0133-x; Karrman A, 2007, ENVIRON HEALTH PERSP, V115, P226, DOI 10.1289/ehp.9491; Kersey PJ, 2012, NUCLEIC ACIDS RES, V40, pD91, DOI 10.1093/nar/gkr895; Koyama S, 2011, BBA-GEN SUBJECTS, V1810, P836, DOI 10.1016/j.bbagen.2011.06.013; Krantz D, 2004, AM J OBSTET GYNECOL, V191, P1452, DOI 10.1016/j.ajog.2004.05.068; Kraus DM, 2014, REPROD SCI, V21, P63, DOI 10.1177/1933719113488456; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lan X, 2017, ONCOTARGET, V8, P51507, DOI 10.18632/oncotarget.17882; Lash GE, 2007, PLACENTA, V28, P390, DOI 10.1016/j.placenta.2006.06.001; Lau C, 2004, TOXICOL APPL PHARM, V198, P231, DOI 10.1016/j.taap.2003.11.031; Lau C, 2003, TOXICOL SCI, V74, P382, DOI 10.1093/toxsci/kfg122; Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128; Lawrence JB, 1999, P NATL ACAD SCI USA, V96, P3149, DOI 10.1073/pnas.96.6.3149; Lenhart PM, 2014, AM J PERINAT, V31, P327, DOI 10.1055/s-0033-1349345; Li HS, 2003, HYPERTENSION, V42, P895, DOI 10.1161/01.HYP.0000095613.41961.6E; Li YN, 2019, ENVIRON INT, V123, P87, DOI 10.1016/j.envint.2018.11.036; Lindstrom AB, 2011, ENVIRON SCI TECHNOL, V45, P8015, DOI 10.1021/es1039425; Liu L, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.419; Liu YW, 2018, CELL RES, V28, P819, DOI 10.1038/s41422-018-0066-y; Lou QQ, 2013, ECOTOXICOLOGY, V22, P1133, DOI 10.1007/s10646-013-1100-y; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Masoud GN, 2015, ACTA PHARM SIN B, V5, P378, DOI 10.1016/j.apsb.2015.05.007; McKinnon T, 2001, J CLIN ENDOCR METAB, V86, P3665, DOI 10.1210/jc.86.8.3665; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Miyake H, 2000, CANCER RES, V60, P3058; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Naile JE, 2012, CHEMOSPHERE, V86, P270, DOI 10.1016/j.chemosphere.2011.09.044; Nicola C, 2008, ENDOCRINOLOGY, V149, P1243, DOI 10.1210/en.2007-1136; Nishizawa H, 2008, MOL HUM REPROD, V14, P595, DOI 10.1093/molehr/gan054; NOVA A, 1991, AM J OBSTET GYNECOL, V165, P724, DOI 10.1016/0002-9378(91)90317-K; Onogi A, 2011, PLACENTA, V32, P665, DOI 10.1016/j.placenta.2011.06.023; Parsons JR, 2008, REV ENVIRON CONTAM T, V196, P53, DOI 10.1007/978-0-387-78444-1_2; Pelch KE, 2019, ENVIRON INT, V130, DOI 10.1016/j.envint.2019.05.045; Pihl K, 2008, PRENATAL DIAG, V28, P1131, DOI 10.1002/pd.2141; Qiu Q, 2004, MOL HUM REPROD, V10, P677, DOI 10.1093/molehr/gah088; Qiu Q, 2004, REPRODUCTION, V128, P355, DOI 10.1530/rep.1.00234; Quinete N, 2010, ARCH ENVIRON CON TOX, V59, P20, DOI 10.1007/s00244-009-9451-3; Rahman MF, 2014, WATER RES, V50, P318, DOI 10.1016/j.watres.2013.10.045; Rath G, 2016, J CLIN LAB ANAL, V30, P75, DOI 10.1002/jcla.21819; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Renner R, 2006, ENVIRON SCI TECHNOL, V40, P12, DOI 10.1021/es062612a; Ritter SK, 2010, CHEM ENG NEWS, V88, P12; Russell DL, 2015, MATRIX BIOL, V44-46, P54, DOI 10.1016/j.matbio.2015.03.007; Slotkin TA, 2008, ENVIRON HEALTH PERSP, V116, P716, DOI 10.1289/ehp.11253; Smart B. E., 1994, ORGANOFLUORINE CHEM, P57, DOI DOI 10.1007/978-1-4899-1202-2_3; Smith GCS, 2002, J CLIN ENDOCR METAB, V87, P1762, DOI 10.1210/jc.87.4.1762; Song XF, 2018, ENVIRON INT, V113, P50, DOI 10.1016/j.envint.2018.01.010; Stahl Thorsten, 2011, Environmental Sciences Europe, V23, P38, DOI 10.1186/2190-4715-23-38; Stein CR, 2009, AM J EPIDEMIOL, V170, P837, DOI 10.1093/aje/kwp212; Sun R, 2018, ECOTOX ENVIRON SAFE, V149, P88, DOI 10.1016/j.ecoenv.2017.11.012; Szabo S, 2015, PATHOL ONCOL RES, V21, P659, DOI 10.1007/s12253-014-9872-9; Tal R, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102723; Tan MJ, 2012, MOL CANCER RES, V10, P677, DOI 10.1158/1541-7786.MCR-11-0519; Tortorella MD, 2009, CURR PHARM DESIGN, V15, P2359, DOI 10.2174/138161209788682433; Tucker EK, 2018, REPROD TOXICOL, V78, P60, DOI 10.1016/j.reprotox.2018.03.008; Vicovac L, 1996, ACTA ANAT, V156, P202; Wang B, 2017, ENVIRON INT, V102, P207, DOI 10.1016/j.envint.2017.03.003; Wang B, 2016, ENVIRON INT, V97, P7, DOI 10.1016/j.envint.2016.10.008; WANG C, 2018, FRONT PHARMACOL, V9; Wang YW, 2019, ENVIRON SCI POLLUT R, V26, P2691, DOI 10.1007/s11356-018-3686-3; Wang ZY, 2015, ENVIRON INT, V75, P172, DOI 10.1016/j.envint.2014.11.013; Whigham CA, 2019, PREGNANCY HYPERTENS, V16, P16, DOI 10.1016/j.preghy.2019.02.003; Xie SW, 2013, ENVIRON INT, V59, P336, DOI 10.1016/j.envint.2013.06.015; Xie SW, 2013, ENVIRON INT, V52, P1, DOI 10.1016/j.envint.2012.11.004; Xu XL, 2010, AM J PATHOL, V177, P424, DOI 10.2353/ajpath.2010.090512; Xu XB, 2015, J BIOL CHEM, V290, P16653, DOI 10.1074/jbc.M115.636944; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912; Zhang N, 2015, PLACENTA, V36, P575, DOI 10.1016/j.placenta.2015.02.008; Zhang TT, 2018, EXP THER MED, V15, P4615, DOI 10.3892/etm.2018.6027; Zhang W, 2011, ECOTOX ENVIRON SAFE, V74, P1787, DOI 10.1016/j.ecoenv.2011.04.027; Zhao PJ, 2016, SCI TOTAL ENVIRON, V568, P57, DOI 10.1016/j.scitotenv.2016.05.221; Zhao WX, 2017, BIOL OPEN, V6, P1123, DOI 10.1242/bio.025767; Zhu Y, 2016, SCI TOTAL ENVIRON, V559, P166, DOI 10.1016/j.scitotenv.2016.03.187; Ziello Jennifer E, 2007, Yale J Biol Med, V80, P51; Zushi Y, 2012, CLEAN TECHNOL ENVIR, V14, P9, DOI 10.1007/s10098-011-0375-z	143	11	11	7	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14182	14199		10.1096/fj.202000716RR	http://dx.doi.org/10.1096/fj.202000716RR		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32901980	Green Accepted			2022-12-26	WOS:000568306900001
J	Wekesa, P; Kataka, J; Owuor, K; Nyabiage, L; Miruka, F; Wanjohi, S; Omondi, S				Wekesa, Paul; Kataka, Jaquin; Owuor, Kevin; Nyabiage, Lennah; Miruka, Fredrick; Wanjohi, Stella; Omondi, Samuel			Time to HIV testing of sexual contacts identified by HIV-positive index clients in Siaya County, Kenya	PLOS ONE			English	Article							ASSISTED PARTNER SERVICES; SUB-SAHARAN AFRICA; NOTIFICATION; PROGRAM	There are no studies on time to test since notification among identified sexual contacts of HIV-positive index clients using program data in Siaya County and Kenya. We sought to understand time to HIV testing by contact characteristics after identification to inform targeted testing interventions. We retrospectively analyzed data from adult (aged >= 18 years) sexual contacts identified by HIV-positive index clients from 117 health facilities in Siaya County (June 2017-August 2018). We used Chi-square tests to assess for differences in characteristics of contacts by HIV testing. We performed Cox proportional hazards analysis and time to HIV testing of contacts analysis including time-varying covariates (cluster-adjusted by facility) to assess characteristics (age, sex, and relationship to index client) associated with time to HIV-testing since notification. Sexual contacts not tested were right censored at last follow-up date. We calculated hazard ratios with 95% confidence intervals to evaluate characteristics associated with time to testing. Of the 6,845 contacts included in this analysis, 3,858 (56.4%) were men. Most were aged 25-34 years (3,209 [46.9%]). Median time to contact testing was 14.5 days (interquartile range, 2.5-62). On multivariable analysis, contacts aged 18-24 years (aHR, 1.32 [95% CI: 1.01-1.73], p = 0.040) and 25-34 years (aHR, 1.18 [95% CI: 1.01-1.39], p = 0.038) had shorter time to HIV testing than those aged 35-44 years. Married polygamous (aHR, 1.12 [95% CI: 1.01-1.25], p = 0.039) and single contacts (aHR, 1.17 [95% CI: 1.08-1.27], p <0.001) had shorter time to HIV testing than married monogamous contacts. Non-spouse sexual contacts had shorter time to HIV testing than spouses, (aHR, 1.23 [95% CI: 1.15-1.32], p <0.001). We recommend enhanced differentiated partner services targeting older adults, married monogamous, and spouse sexual contacts to facilitate early diagnosis, same day treatment, and prevention in Western Kenya and sub-Saharan Africa at large.	[Wekesa, Paul; Kataka, Jaquin; Owuor, Kevin; Wanjohi, Stella] Ctr Hlth Solut, Nairobi, Kenya; [Nyabiage, Lennah; Miruka, Fredrick] Ctr Dis Control & Prevent, Div Global HIV & TB, Kisumu, Kenya; [Omondi, Samuel] Minist Hlth, Cty Dept Hlth, Siaya, Kenya		Wekesa, P (corresponding author), Ctr Hlth Solut, Nairobi, Kenya.	pwekesa@chskenya.org	Wekesa, Paul/ABB-3714-2021	, Paul/0000-0001-9274-7731	President's Emergency Plan for AIDS Relief (PEPFAR) through Centers for Disease Control and Prevention (CDC) [1NU2GGH001946]	President's Emergency Plan for AIDS Relief (PEPFAR) through Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through Centers for Disease Control and Prevention (CDC under the terms of cooperative agreement 1NU2GGH001946) to PW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein KT, 2014, PUBLIC HEALTH REP, V129, P50, DOI 10.1177/00333549141291S108; Bocour A, 2013, AIDS, V27, P2961, DOI 10.1097/QAD.0000000000000031; Brown LB, 2012, AIDS BEHAV, V16, P1148, DOI 10.1007/s10461-011-0094-9; Brown LB, 2011, JAIDS-J ACQ IMM DEF, V56, P437, DOI 10.1097/QAI.0b013e318202bf7d; Cherutich P, 2017, LANCET HIV, V4, pE74, DOI 10.1016/S2352-3018(16)30214-4; Dalal S, 2017, AIDS, V31, P1867, DOI 10.1097/QAD.0000000000001555; Goyette MS, 2018, JAIDS-J ACQ IMM DEF, V78, P16, DOI [10.1097/QAI.0000000000001638, 10.1097/qai.0000000000001638]; Green N, 2017, AIDS, V31, P287, DOI 10.1097/QAD.0000000000001308; Guthrie BL, 2007, CURR HIV RES, V5, P416, DOI 10.2174/157016207781023992; Henley C, 2013, SEX TRANSM DIS, V40, P909, DOI 10.1097/OLQ.0000000000000032; Hogben M, 2017, LANCET HIV, V4, pE55, DOI 10.1016/S2352-3018(16)30211-9; Hosseinipour MC, 2013, SEX TRANSM DIS, V40, P915, DOI 10.1097/OLQ.0000000000000060; Kenya National Bureau of Statistics (KNBS), 2019, 2019 KEN POP HOUS CE, V1; Ministry of Health, 2018, KEN HIV EST REP 2018; Myers RS, 2016, SEX TRANSM DIS, V43, P690, DOI 10.1097/OLQ.0000000000000529; National AIDS and STI Control Programme (NASCOP), 2020, KENPHIA 2018 PREL RE, V1; Payne C, 2017, ANN GLOB HEALTH, V83, P162, DOI [10.1016/j.aogh.2017.03.363., DOI 10.1016/J.AOGH.2017.03.363]; Plotkin M, 2018, AIDS BEHAV, V22, P102, DOI 10.1007/s10461-017-1936-x; Rutstein SE, 2014, HEALTH POLICY PLANN, V29, P115, DOI 10.1093/heapol/czs140; Sharma M, 2018, AIDS, V32, P233, DOI 10.1097/QAD.0000000000001697; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Song W, 2017, PUBLIC HEALTH REP, V132, P455, DOI 10.1177/0033354917710943; The Lancet Public H, 2018, LANCET PUBLIC HLTH, V3, pe153, DOI 10.1016/S2468-2667(18)30053-7; WHO, 2016, GUID HIV SELF TEST P	24	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238794	10.1371/journal.pone.0238794	http://dx.doi.org/10.1371/journal.pone.0238794			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ6EE	32898159	gold, Green Published			2022-12-26	WOS:000570962500017
J	Daou, D; Tamim, H; Nabulsi, M				Daou, Dayane; Tamim, Hani; Nabulsi, Mona			Assessing the impact of professional lactation support frequency, duration and delivery form on exclusive breastfeeding in Lebanese mothers	PLOS ONE			English	Article							ARABIC VERSION; VALIDATION	Background The optimal frequency, duration, and form of professional lactation support needed to continue exclusive breastfeeding (EBF) for six months have not yet been specifically identified. This study investigates the association between six-month EBF and the frequency, duration, and form (face-to-face vs. telephone contact) of professional lactation support in a cohort of Lebanese mothers, and explores barriers to EBF during the first six months postpartum. Methods An observational study was nested in a breastfeeding support randomized controlled trial. Secondary analysis of data from 159 trial participants who received professional lactation support was conducted. (1) Six-month EBF with professional lactation support frequency, duration, and form was investigated using bivariate and multivariate regression analyses. (2) Barriers to breastfeeding were explored using content analysis of narrative data collected about breastfeeding mothers by the lactation experts. Results Six-month EBF was achieved by 57/159 (35.8%) participants. Professional lactation support was received by more mothers continuing six months of EBF (100% vs. 83.3%,p= 0.001). In crude analysis, those mothers had a higher number of overall contacts with lactation experts (mean +/- SD of 9.5 +/- 2.9 vs. 7.0 +/- 4.4,p= 0.001), and longer duration of face-to-face contacts (mean +/- SD of 261.9 +/- 209.1 vs. 201.0 +/- 117.4 minutes,p= 0.035). In adjusted analysis, frequencies of overall and of telephone contacts with the lactation experts were positively associated with six-month EBF (OR = 1.15;95% CI: 1.04 to 1.27,p= 0.007; OR = 1.12;95% CI: 1.00 to 1.26,p= 0.05; respectively). Participants discontinuing EBF early were described as inexperienced, lacking breastfeeding knowledge, concerned about milk insufficiency, and showing negative attitudes towards night feeds. Conclusion Need-based telephone contact augmenting face-to-face professional lactation support may positively influence six-month EBF. Early identification of mothers at risk for early discontinuation of EBF can help tailor interventions specific to their concerns.	[Daou, Dayane] Amer Univ Beirut, Dept Anesthesiol, Beirut, Lebanon; [Tamim, Hani] Amer Univ Beirut, Fac Med, Clin Res Inst, Biostat Unit, Beirut, Lebanon; [Nabulsi, Mona] Amer Univ Beirut, Dept Pediat & Adolescent Med, Beirut, Lebanon	American University of Beirut; American University of Beirut; American University of Beirut	Nabulsi, M (corresponding author), Amer Univ Beirut, Dept Pediat & Adolescent Med, Beirut, Lebanon.	mn04@aub.edu.lb	Nabulsi, Mona/A-8002-2016	Nabulsi, Mona/0000-0001-7415-6436				Akik C, 2017, J PUBLIC HEALTH POL, V38, P314, DOI 10.1057/s41271-017-0077-9; Al-Sahab B, 2008, PUBLIC HEALTH NUTR, V11, P1350, DOI 10.1017/S1368980008003005; American College of Obstetricians and Gynecologists' Committee on Obstetric Practice, 2016, Obstet Gynecol, V127, pe86, DOI 10.1097/AOG.0000000000001318; [Anonymous], 2013, BMC P S6, V7, pO1; [Anonymous], 2006, INF YOUNG CHILD FEED; Balogun Olukunmi O, 2016, Cochrane Database Syst Rev, V11, pCD001688; Balogun OO, 2015, MATERN CHILD NUTR, V11, P433, DOI 10.1111/mcn.12180; Bengtsson M., 2016, NURSINGPLUS OPEN, V2, P8, DOI [10.1016/j.npls.2016.01.001, DOI 10.1016/J.NPLS.2016.01.001]; BouDiab S, 2018, APPETITE, V123, P23, DOI 10.1016/j.appet.2017.12.002; Charafeddine L, 2016, J HUM LACT, V32, P309, DOI 10.1177/0890334415586192; Haile ZT, 2017, J MIDWIFERY WOM HEAL, V62, P562, DOI 10.1111/jmwh.12657; Hamade H, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-702; Kim SK, 2017, INT J NURS STUD, V80, P94, DOI 10.1016/j.ijnurstu.2018.01.004; Lumbiganon Pisake, 2016, Cochrane Database Syst Rev, V12, pCD006425, DOI 10.1002/14651858.CD006425.pub4; Nabulsi M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218467; Nabulsi Mona, 2011, BMC Pediatr, V11, P75, DOI 10.1186/1471-2431-11-75; Patel S, 2016, J HUM LACT, V32, P530, DOI 10.1177/0890334415618668; Renfrew MJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001141.pub4; Tamim H, 2016, J HUM LACT, V32, P682, DOI 10.1177/0890334416663474; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; von Elm E, 2008, ANN INTERN MED, V82, P251, DOI DOI 10.7326/0003-4819-147-8-200710160-00010; WHO & UNICEF (World Health Organization & UNICEF), 1993, BREASTF COUNS TRAIN; World Health Organization, 2018, PROT PROM SUPP BREAS; World Health Organization, 2001, WHO INF FEED REC	24	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238735	10.1371/journal.pone.0238735	http://dx.doi.org/10.1371/journal.pone.0238735			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886727	Green Published, gold			2022-12-26	WOS:000571064300039
J	Hargrave, A; Courson, JA; Pham, V; Landry, P; Magadi, S; Shankar, P; Hanlon, S; Das, A; Rumbaut, RE; Smith, CW; Burns, AR				Hargrave, Aubrey; Courson, Justin A.; Pham, Vanna; Landry, Paul; Magadi, Sri; Shankar, Pooja; Hanlon, Sam; Das, Apoorva; Rumbaut, Rolando E.; Smith, C. Wayne; Burns, Alan R.			Corneal dysfunction precedes the onset of hyperglycemia in a mouse model of diet-induced obesity	PLOS ONE			English	Article							HIGH-FAT DIET; DELTA-T-CELLS; ADIPOSE-TISSUE INFLAMMATION; CONFOCAL MICROSCOPY; EPITHELIAL ABRASION; INSULIN-RESISTANCE; NEUROPATHY; IL-17; COMPLICATIONS; ADIPOGENESIS	Purpose The purpose of this study was to use a mouse model of diet-induced obesity to determine if corneal dysfunction begins prior to the onset of sustained hyperglycemia and if the dysfunction is ameliorated by diet reversal. Methods Six-week-old male C57BL/6 mice were fed a high fat diet (HFD) or a normal diet (ND) for 5-15 weeks. Diet reversal (DiR) mice were fed a HFD for 5 weeks, followed by a ND for 5 or 10 weeks. Corneal sensitivity was determined using aesthesiometry. Corneal cytokine expression was analyzed using a 32-plex Luminex assay. Excised corneas were prepared for immunofluorescence microscopy to evaluate diet-induced changes and wound healing. For wounding studies, mice were fed a HFD or a ND for 10 days prior to receiving a central 2mm corneal abrasion. Results After 10 days of HFD consumption, corneal sensitivity declined. By 10 weeks, expression of corneal inflammatory mediators increased and nerve density declined. While diet reversal restored nerve density and sensitivity, the corneas remained in a heightened inflammatory state. After 10 days on the HFD, corneal circadian rhythms (limbal neutrophil accumulation, epithelial cell division andRev-erb alpha expression) were blunted. Similarly, leukocyte recruitment after wounding was dysregulated and accompanied by delays in wound closure and nerve recovery. Conclusion In the mouse, obesogenic diet consumption results in corneal dysfunction that precedes the onset of sustained hyperglycemia. Diet reversal only partially ameliorated this dysfunction, suggesting a HFD diet may have a lasting negative impact on corneal health that is resistant to dietary therapeutic intervention.	[Hargrave, Aubrey; Courson, Justin A.; Pham, Vanna; Landry, Paul; Magadi, Sri; Shankar, Pooja; Hanlon, Sam; Das, Apoorva; Burns, Alan R.] Univ Houston, Coll Optometry, Houston, TX 77004 USA; [Rumbaut, Rolando E.; Burns, Alan R.] Baylor Coll Med, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Rumbaut, Rolando E.; Smith, C. Wayne] Michael E DeBakey VA Med Ctr, Ctr Translat Res Inflammatory Dis CTRID, Houston, TX USA; [Hargrave, Aubrey] Stanford Univ, Dept Ophthalmol, Palo Alto, CA 94304 USA	University of Houston System; University of Houston; Baylor College of Medicine; Baylor College of Medicine; Stanford University	Hargrave, A (corresponding author), Univ Houston, Coll Optometry, Houston, TX 77004 USA.; Hargrave, A (corresponding author), Stanford Univ, Dept Ophthalmol, Palo Alto, CA 94304 USA.	aubreych@stanford.edu	Courson, Justin/AAW-9273-2021; Courson, Justin/AAK-4802-2021	Courson, Justin/0000-0002-1036-097X; 	NIH [EY018239, P30EY007551, HL079368]; NEI; U.S. Dept. of Veterans Affairs Merit Review Award [I01 BX002551]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); U.S. Dept. of Veterans Affairs Merit Review Award(US Department of Veterans Affairs)	This study was supported by NIH (https://www.nih.gov/grants-funding) and NEI (https://www.nei.nih.gov/grants-and-training) funding: NIH EY018239 (ARB, CWS and RER), P30EY007551 (ARB) and HL079368 (RER). Additional support from the U.S. Dept. of Veterans Affairs Merit Review Award I01 BX002551 (RER) (https://www.research.va.gov/services/shared_ docs/resources.cfm#5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2014, OBES REV, V15, P49, DOI 10.1111/obr.12123; Adrover JM, 2016, TRENDS IMMUNOL, V37, P334, DOI 10.1016/j.it.2016.03.005; Ahmed M, 2010, CYTOKINE GROWTH F R, V21, P449, DOI 10.1016/j.cytogfr.2010.10.005; Alamri AS, 2019, INVEST OPHTH VIS SCI, V60, P209, DOI 10.1167/iovs.18-25788; [Anonymous], 2016, LIT JOURNALISM STUDI, V8, P178; Azmi S, 2015, DIABETES CARE, V38, P1502, DOI 10.2337/dc14-2733; Bastian O, 2011, J LEUKOCYTE BIOL, V89, P669, DOI 10.1189/jlb.0810446; Bikbova G, 2012, CURR DIABETES REV, V8, P294, DOI 10.2174/157339912800840479; Brake DK, 2006, AM J PHYSIOL-CELL PH, V291, pC1232, DOI 10.1152/ajpcell.00008.2006; Brake Danett K., 2008, V456, P221, DOI 10.1007/978-1-59745-245-8_16; Cai GW, 2008, CYTOKINE, V44, P242, DOI 10.1016/j.cyto.2008.08.006; Camell C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075147; Casanova-Acebes M, 2018, J EXP MED, V215, P2778, DOI 10.1084/jem.20181468; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; Chen WL, 2009, OPHTHALMOLOGY, V116, P1038, DOI 10.1016/j.ophtha.2009.01.002; Chen X, 2015, DIABETES CARE, V38, P1138, DOI 10.2337/dc14-2422; Cheung KP, 2012, IMMUNOL RES, V52, P182, DOI 10.1007/s12026-011-8261-7; Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]; Efron N, 2012, INVEST OPHTH VIS SCI, V53, P8075, DOI 10.1167/iovs.12-11308; Fujisaka S, 2013, DIABETOLOGIA, V56, P1403, DOI 10.1007/s00125-013-2885-1; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Galgani M, 2010, J LEUKOCYTE BIOL, V87, P17, DOI 10.1189/jlb.0809530; Gao F, 2016, EXP THER MED, V12, P1705, DOI 10.3892/etm.2016.3511; Gislette T, 2010, THESCIENTIFICWORLDJO, V10, P2265, DOI 10.1100/tsw.2010.212; Gonzalez-Gonzalez O, 2017, INVEST OPHTH VIS SCI, V58, P404, DOI 10.1167/iovs.16-20033; Grupcheva CN, 2002, CLIN EXP OPHTHALMOL, V30, P187, DOI 10.1046/j.1442-9071.2002.00507.x; Himes RW, 2010, FASEB J, V24, P731, DOI 10.1096/fj.09-141929; Huhtinen M, 2002, BRIT J OPHTHALMOL, V86, P412, DOI 10.1136/bjo.86.4.412; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; IWATSUKA H, 1970, ENDOCRINOL JAPON, V17, P23; JACKSON H, 1960, BRIT MED J, V2, P713, DOI 10.1136/bmj.2.5200.713; Jhun JY, 2012, EXP MOL MED, V44, P424, DOI 10.3858/emm.2012.44.7.047; JONES NP, 1986, BRIT MED J, V292, P188, DOI 10.1136/bmj.292.6514.188; Kaji Y, 2005, BRIT J OPHTHALMOL, V89, P254, DOI 10.1136/bjo.2004.055541; Kang YE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154003; KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422; Kellermayer R, 2011, FASEB J, V25, P1449, DOI 10.1096/fj.10-172205; Kitade H, 2012, DIABETES, V61, P1680, DOI 10.2337/db11-1506; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Laibson PR, 2010, EYE CONTACT LENS, V36, P315, DOI 10.1097/ICL.0b013e3181f18ff7; Lee BC, 2014, BBA-MOL BASIS DIS, V1842, P446, DOI 10.1016/j.bbadis.2013.05.017; Li YF, 2013, MMWR-MORBID MORTAL W, V62, P209; Li Z, 2007, AM J PATHOL, V171, P838, DOI 10.2353/ajpath.2007.070008; Li ZJ, 2006, INVEST OPHTH VIS SCI, V47, P4794, DOI 10.1167/iovs.06-0381; Li ZJ, 2006, INVEST OPHTH VIS SCI, V47, P1947, DOI 10.1167/iovs.05-1193; Li ZJ, 2011, AM J PATHOL, V178, P1106, DOI 10.1016/j.ajpath.2010.12.001; Liew PX, 2019, PHYSIOL REV, V99, P1223, DOI 10.1152/physrev.00012.2018; Liu J, 2017, MUCOSAL IMMUNOL, V10, P1145, DOI 10.1038/mi.2016.139; Liu Q, 2012, AM J PATHOL, V181, P452, DOI 10.1016/j.ajpath.2012.04.010; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Lutty GA, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12979; Maione F, 2009, BIOCHEM PHARMACOL, V77, P878, DOI 10.1016/j.bcp.2008.11.011; Mancuso P, 2016, IMMUNOTARGETS THER, V5, P47, DOI 10.2147/ITT.S73223; Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018; Mehta P, 2015, J LEUKOCYTE BIOL, V97, P121, DOI 10.1189/jlb.3A0414-211RR; O'donnell C, 2012, CLIN EXP OPTOM, V95, P328, DOI 10.1111/j.1444-0938.2012.00738.x; Oliveira AG, 2013, OBESITY, V21, P2545, DOI 10.1002/oby.20402; Pan LP, 2013, PEDIATRICS, V132, P1006, DOI 10.1542/peds.2013-2145; Pini M, 2010, J LEUKOCYTE BIOL, V87, P51, DOI 10.1189/jlb.0309188; Pritchard N, 2015, CORNEA, V34, P756, DOI 10.1097/ICO.0000000000000447; Reidy JJ, 2000, CORNEA, V19, P767, DOI 10.1097/00003226-200011000-00001; Roh SG, 2007, BIOCHEM BIOPH RES CO, V362, P1013, DOI 10.1016/j.bbrc.2007.08.104; Saika S, 1998, CURR EYE RES, V17, P1049, DOI 10.1076/ceyr.17.11.1049.5227; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Spadea L, 2012, CLIN OPHTHALMOL, V6, P1775, DOI 10.2147/OPTH.S37384; Sumarac-Dumanovic M, 2009, INT J OBESITY, V33, P151, DOI 10.1038/ijo.2008.216; Tavakoli Mitra, 2013, J Diabetes Sci Technol, V7, P1179; Tavakoli M, 2010, DIABETES CARE, V33, P1792, DOI 10.2337/dc10-0253; Taylor KR, 2011, J INVEST DERMATOL, V131, P2409, DOI 10.1038/jid.2011.241; Taylor KR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011422; Wakuta M, 2007, INVEST OPHTH VIS SCI, V48, P590, DOI 10.1167/iovs.05-1168; Wang F, 2012, AM J PATHOL, V181, P2058, DOI 10.1016/j.ajpath.2012.08.029; Wang JL, 2012, ATHEROSCLEROSIS, V223, P342, DOI 10.1016/j.atherosclerosis.2012.06.003; Watanabe H, 2002, JPN J OPHTHALMOL, V46, P130, DOI 10.1016/S0021-5155(01)00487-7; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Winer S, 2009, EUR J IMMUNOL, V39, P2629, DOI 10.1002/eji.200838893; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Wu HZ, 2010, ARTERIOSCL THROM VAS, V30, P186, DOI 10.1161/ATVBAHA.109.198044; Wu HZ, 2009, CIRCULATION, V119, P2708, DOI 10.1161/CIRCULATIONAHA.108.823740; Yin J, 2011, INVEST OPHTH VIS SCI, V52, P6589, DOI 10.1167/iovs.11-7709; Yorek MS, 2015, J PERIPHER NERV SYST, V20, P24, DOI 10.1111/jns.12111; Zhang DC, 2015, NATURE, V525, P528, DOI 10.1038/nature15367; Zhang WY, 2017, EXP EYE RES, V154, P22, DOI 10.1016/j.exer.2016.11.006; Ziegler D, 2014, DIABETES, V63, P2454, DOI 10.2337/db13-1819; Zuniga LA, 2010, J IMMUNOL, V185, P6947, DOI 10.4049/jimmunol.1001269; 2012, DRUG DISCOV TODAY-TE, V9	88	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238750	10.1371/journal.pone.0238750	http://dx.doi.org/10.1371/journal.pone.0238750			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886728	Green Published, gold			2022-12-26	WOS:000571064300014
J	Cobo-Calvo, A; Ruiz, A; Richard, C; Blondel, S; Cavagna, S; Strazielle, N; Ghersi-Egea, JF; Giraudon, P; Marignier, R				Cobo-Calvo, Alvaro; Ruiz, Anne; Richard, Chloe; Blondel, Sandrine; Cavagna, Sylvie; Strazielle, Nathalie; Ghersi-Egea, Jean-Francois; Giraudon, Pascale; Marignier, Romain			Purified IgG from aquaporin-4 neuromyelitis optica spectrum disorder patients alters blood-brain barrier permeability	PLOS ONE			English	Article							CHEMOKINE PROFILES; INJURY; INTERLEUKIN-6; CYTOKINE	Background Neuromyelitis optica spectrum disorders (NMOSD) is a primary astrocytopathy driven by antibodies directed against the aquaporin-4 water channel located at the end-feet of the astrocyte. Although blood-brain barrier (BBB) breakdown is considered one of the key steps for the development and lesion formation, little is known about the molecular mechanisms involved. The aim of the study was to evaluate the effect of human immunoglobulins from NMOSD patients (NMO-IgG) on BBB properties. Methods Freshly isolated brain microvessels (IBMs) from rat brains were used as a study model. At first, analysis of the secretome profile from IBMs exposed to purified NMO-IgG, to healthy donor IgG (Control-IgG), or non-treated, was performed. Second, tight junction (TJ) proteins expression in fresh IBMs and primary cultures of brain microvascular endothelial cells (BMEC) was analysed by Western blotting (Wb) after exposition to NMO-IgG and Control-IgG. Finally, functional BBB properties were investigated evaluating the presence of rat-IgG in tissue lysate from brain using Wb in the rat-model, and the passage of NMO-IgG and sucrose in a bicameral model. Results We found that NMO-IgG induces functional and morphological BBB changes, including: 1) increase of pro-inflammatory cytokines production (CXCL-10 [IP-10], IL-6, IL-1RA, IL-1 beta and CXCL-3) in IBMs when exposed to NMO-IgG; 2) decrease of Claudin-5 levels by 25.6% after treatment of fresh IBMs by NMO-IgG compared to Control-IgG (p = 0.002), and similarly, decrease of Claudin-5 by at least 20% when BMEC were cultured with NMO-IgG from five different patients; 3) a higher level of rat-IgG accumulated in periventricular regions of NMO-rats compared to Control-rats and an increase in the permeability of BBB after NMO-IgG treatment in the bicameral model. Conclusion Human NMO-IgG induces both structural and functional alterations of BBB properties, suggesting a direct role of NMO-IgG on modulation of BBB permeability in NMOSD.	[Cobo-Calvo, Alvaro; Marignier, Romain] Hosp Civils Lyon, Serv Neurol Sclerose Plaques Pathol Myeline & Neu, Hop Neurol Pierre Wertheimer, Lyon, France; [Cobo-Calvo, Alvaro; Marignier, Romain] Hosp Civils Lyon, Ctr Reference Malad Inflammatoires Rares Cerveau, Hop Neurol Pierre Wertheimer, Lyon, France; [Cobo-Calvo, Alvaro; Ruiz, Anne; Richard, Chloe; Cavagna, Sylvie; Strazielle, Nathalie; Ghersi-Egea, Jean-Francois; Giraudon, Pascale; Marignier, Romain] Ctr Rech Neurosci Lyon, U1028 INSERM, CNRS, UMR5292,UCBL, Bron, France; [Cobo-Calvo, Alvaro; Blondel, Sandrine] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Ctr Esclerosi Multiple Catalunya Cemcat, Dept Neurol Neuroimmunol, Barcelona, Spain; [Strazielle, Nathalie; Ghersi-Egea, Jean-Francois] CRNL, BIP Facil, Lyon, France	CHU Lyon; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Institut National de la Sante et de la Recherche Medicale (Inserm)	Cobo-Calvo, A (corresponding author), Hosp Civils Lyon, Serv Neurol Sclerose Plaques Pathol Myeline & Neu, Hop Neurol Pierre Wertheimer, Lyon, France.; Cobo-Calvo, A (corresponding author), Hosp Civils Lyon, Ctr Reference Malad Inflammatoires Rares Cerveau, Hop Neurol Pierre Wertheimer, Lyon, France.; Cobo-Calvo, A (corresponding author), Ctr Rech Neurosci Lyon, U1028 INSERM, CNRS, UMR5292,UCBL, Bron, France.; Cobo-Calvo, A (corresponding author), Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Ctr Esclerosi Multiple Catalunya Cemcat, Dept Neurol Neuroimmunol, Barcelona, Spain.	acobo@cem-cat.org		Cobo-Calvo, Alvaro/0000-0002-2574-0721	Fundacion Alfonso Martin Escudero; Instituto de Salud Carlos III, Spain [JR19/00007]	Fundacion Alfonso Martin Escudero; Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III)	A. Cobo-Calvo was supported by a grant from the Fundacion Alfonso Martin Escudero and from Instituto de Salud Carlos III, Spain; JR19/00007 for this study.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Al Feteisi H, 2018, J NEUROCHEM, V146, P670, DOI 10.1111/jnc.14446; Araki M, 2014, NEUROLOGY, V82, P1302, DOI 10.1212/WNL.0000000000000317; Asgari N, 2015, ANN CLIN TRANSL NEUR, V2, P857, DOI 10.1002/acn3.221; Barros PO, 2016, CLIN EXP IMMUNOL, V183, P480, DOI 10.1111/cei.12733; Barros PO, 2013, HUM IMMUNOL, V74, P1080, DOI 10.1016/j.humimm.2013.06.016; Chihara N, 2011, P NATL ACAD SCI USA, V108, P3701, DOI 10.1073/pnas.1017385108; Fife BT, 2001, J IMMUNOL, V166, P7617, DOI 10.4049/jimmunol.166.12.7617; Gazzin S, 2008, J COMP NEUROL, V510, P497, DOI 10.1002/cne.21808; Hillebrand S, 2019, ACTA NEUROPATHOL, V137, P467, DOI 10.1007/s00401-018-1950-8; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Kaplin AI, 2005, J CLIN INVEST, V115, P2731, DOI 10.1172/JCI25141; Langdon KD, 2018, J CEREBR BLOOD F MET, V38, P1727, DOI 10.1177/0271678X17739219; Ly H, 2017, ANN NEUROL, V82, P208, DOI 10.1002/ana.24992; Marignier R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0577-8; Marignier R, 2013, NEUROLOGY, V80, P2194, DOI 10.1212/WNL.0b013e318296e917; Misu T, 2013, ACTA NEUROPATHOL, V125, P815, DOI 10.1007/s00401-013-1116-7; Miyata S, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00390; Parinitha MS, 2014, J CLIN DIAGN RES, V8, pZJ1, DOI 10.7860/JCDR/2014/9657.4699; Ratelade J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027412; Sato DK, 2014, ANN NEUROL, V76, P305, DOI 10.1002/ana.24208; Schaefer CP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192340; Shimizu F, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai9111; Shimizu F, 2012, J NEUROL NEUROSUR PS, V83, P288, DOI 10.1136/jnnp-2011-300434; Sozen T, 2009, STROKE, V40, P2519, DOI 10.1161/STROKEAHA.109.549592; Strazielle Nathalie, 2003, Methods Mol Med, V89, P291; Takeshita Y, 2017, NEUROL-NEUROIMMUNOL, V4, DOI 10.1212/NXI.0000000000000311; Tasaki A, 2014, J NEUROL NEUROSUR PS, V85, P419, DOI 10.1136/jnnp-2013-305907; Uzawa A, 2013, CLIN CHIM ACTA, V421, P181, DOI 10.1016/j.cca.2013.03.020; Uzawa A, 2010, MULT SCLER J, V16, P1443, DOI 10.1177/1352458510379247; Vincent T, 2008, J IMMUNOL, V181, P5730, DOI 10.4049/jimmunol.181.8.5730; Wang YG, 2016, NEUROIMMUNOMODULAT, V23, P352, DOI 10.1159/000464135; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729; Yamamura T, 2019, NEW ENGL J MED, V381, P2114, DOI 10.1056/NEJMoa1901747	34	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238301	10.1371/journal.pone.0238301	http://dx.doi.org/10.1371/journal.pone.0238301			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881954	Green Published, Green Submitted, gold			2022-12-26	WOS:000571063300111
J	Gefaell, J; Prieto, T; Abdelaziz, M; Alvarez, I; Anton, J; Arroyo, J; Bella, JL; Botella, M; Bugallo, A; Claramonte, V; Gijon, J; Lizarte, E; Maroto, RM; Megias, M; Mila, B; Ramon, C; Vila, M; Rolan-Alvarez, E				Gefaell, Juan; Prieto, Tamara; Abdelaziz, Mohamed; Alvarez, Ines; Anton, Josefa; Arroyo, Juan; Bella, Jose L.; Botella, Miguel; Bugallo, Anxela; Claramonte, Vicente; Gijon, Jose; Lizarte, Emilio; Maroto, Rosa M.; Megias, Manuel; Mila, Borja; Ramon, Cori; Vila, Marta; Rolan-Alvarez, Emilio			Acceptance and knowledge of evolutionary theory among third-year university students in Spain	PLOS ONE			English	Article							RELIGION INDEX; BIOLOGY; EDUCATION; BELIEFS; MATE	The theory of evolution is one of the greatest scientific achievements in the intellectual history of humankind, yet it is still contentious within certain social groups. Despite being as robust and evidence-based as any other notable scientific theory, some people show a strong reluctance to accept it. In this study, we used the Measure of Acceptance of the Theory of Evolution (MATE) and Knowledge of Evolution Exam (KEE) questionnaires with university students from four academic degree programs (Chemistry, English, History, and Biology) of ten universities from Spain to measure, respectively, acceptance and knowledge of evolutionary theory among third-year undergraduate students (n(MATE)= 978;n(KEE)= 981). Results show that acceptance of evolution is relatively high (87.2%), whereas knowledge of the theory is moderate (5.4 out of 10) although there are differences across degrees (Biology>Chemistry>History>English), and even among various universities (ranging from 4.71 to 5.81). Statistical analysis reveals that knowledge of evolutionary theory among Biology students is partially explained by the relative weight of evolutionary themes within the curriculum, suggesting that an increase in the number of hours dedicated to this topic could have a direct influence on students' knowledge of it. We also found that religion may have a significant-although relatively small-negative influence on evolutionary theory acceptance. The moderate knowledge of evolution in our undergraduate students, together with the potential problem of acceptance in certain groups, suggests the need for a revision of the evolutionary concepts in the teaching curricula of our students since primary school.	[Gefaell, Juan; Megias, Manuel; Rolan-Alvarez, Emilio] Univ Vigo, Fac Biol, Campus Vigo, Vigo, Spain; [Prieto, Tamara] Univ Vigo, Ctr Invest Biomed CINBIO, Campus Vigo, Vigo, Spain; [Abdelaziz, Mohamed] Univ Granada, Dept Genet, Avda Fuentenueva, Granada, Spain; [Alvarez, Ines] CSIC, Real Jardin Bot, Pza Murillo, Madrid, Spain; [Anton, Josefa] Univ Alicante, Dept Fisiol Genet & Microbiol, Alicante, Spain; [Arroyo, Juan] Univ Seville, Dept Biol Vegetal & Ecol, Seville, Spain; [Bella, Jose L.] Univ Autonoma Madrid, Fac Ciencias, Dept Biol Genet, Madrid, Spain; [Botella, Miguel; Maroto, Rosa M.] Univ Granada, Dept Med Legal Toxicol & Antropol Fis, Parque Tecnol Salud,Av Invest, Granada, Spain; [Bugallo, Anxela] Univ A Coruna, Dept Pedag & Didact, Campus Elvina, La Coruna, Spain; [Claramonte, Vicente] Univ Valencia, Fac Filosofia & Ciencias Educ, Dept Filosofia, Unidad Docente Log & Filosofia Ciencia, Valencia, Spain; [Gijon, Jose; Lizarte, Emilio] Univ Granada, Dept Didact & Org Escolar, Campus Cartuja, Granada, Spain; [Mila, Borja] CSIC, Museo Nacl Ciencias Nat, Madrid, Spain; [Ramon, Cori] Univ Illes Balears, Dept Biol, Carretera Valldemossa, Palma De Mallorca, Illes Balears, Spain; [Vila, Marta] Univ A Coruna, Fac Ciencias, Dept Biol, Campus Zapateira, La Coruna, Spain	Universidade de Vigo; Universidade de Vigo; CINBIO; University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; Universitat d'Alacant; University of Sevilla; Autonomous University of Madrid; University of Granada; Universidade da Coruna; University of Valencia; University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Universitat de les Illes Balears; Universidade da Coruna	Rolan-Alvarez, E (corresponding author), Univ Vigo, Fac Biol, Campus Vigo, Vigo, Spain.	rolan@uvigo.es	Rolán-Alvarez, Emilio/F-3809-2016; Bugallo-Rodríguez, Anxela/A-7553-2012; Vila Taboada, Marta/F-6118-2016	Rolán-Alvarez, Emilio/0000-0001-8396-278X; Bugallo-Rodríguez, Anxela/0000-0002-8059-7083; Vila Taboada, Marta/0000-0002-8803-9174; Gefaell, Juan/0000-0002-0452-6726; Lizarte Simon, Emilio Jesus/0000-0002-9964-7271; Prieto, Tamara/0000-0002-1181-9156; Alvarez, Ines/0000-0002-5982-5424	Xunta de Galicia [ED431C 2016-037]; FONDOS FEDER ("unha maneira de facer Europa"); Spain's Ministerio de Economia, Industria y Competitividad; Agencia Estatal de Investigacion [CGL2016-75904-C2-1-P]	Xunta de Galicia(Xunta de GaliciaEuropean Commission); FONDOS FEDER ("unha maneira de facer Europa"); Spain's Ministerio de Economia, Industria y Competitividad; Agencia Estatal de Investigacion	This work was supported by Xunta de Galicia (ED431C 2016-037), FONDOS FEDER ("unha maneira de facer Europa"), and Spain's Ministerio de Economia, Industria y Competitividad, Agencia Estatal de Investigacion (CGL2016-75904-C2-1-P), Dr. Emilio RolanAlvarez.	Anderson DL, 2002, J RES SCI TEACH, V39, P952, DOI 10.1002/tea.10053; [Anonymous], 2018, AM J TRANSPLANT S1, V18, P10, DOI DOI 10.1109/JSEN.2018.2870228; [Anonymous], 2012, COMPUTER FRAUD SECUR, V6, P3; Athanasiou K, 2012, INT J SCI EDUC, V34, P903, DOI 10.1080/09500693.2011.586072; Barnes M.E., 2019, EVOL EDUC OUTREACH, V12, P4, DOI [10.1186/s12052-019-0096-z, DOI 10.1186/s12052-019-0096-z]; Beniermann A, 2019, EMPIRICAL STUDIES AT; Bowler Peter, 2003, EVOLUTION HIST IDEA, V3rd; Buss D. M., 2015, EVOLUTIONARY PSYCHOL; Campbell BC, 2017, EVOL EDUC OUTREACH, V10, P1, DOI DOI 10.1186/s12052-017-0068-0; Carvajal-Rodriguez A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-209; Cavallo AML, 2008, AM BIOL TEACH, V70, P522, DOI 10.1662/0002-7685-70.9.522; Cetin F., 2011, REPORTS NATL CTR SCI, V31, P11; Cofré Hernán L, 2013, Estud. pedagóg., V39, P67; Coyne J. A., 2009, WHY EVOLUTION IS TRU; Deniz H., 2016, ELECT J SCI ED, V20, P21, DOI DOI 10.1002/TEA.20223; Deniz H, 2008, J RES SCI TEACH, V45, P420, DOI 10.1002/tea.20223; Dennett Daniel C., 1995, DARWINS DANGEROUS ID; DOBZHANSKY T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; Dubochet J, 2011, BIOESSAYS, V33, P240, DOI 10.1002/bies.201000142; Dupre J, 2000, CRIT QUART, V42, P18, DOI 10.1111/1467-8705.00306; Dupre J., 2005, DARWINS LEGACY WHAT; Glaze AL, 2015, INT J SCI MATH EDUC, V13, P1189, DOI 10.1007/s10763-014-9541-1; Gro&beta;schedl J., 2014, EVOL EDUC OUTREACH, V7, P1, DOI [10.1186/s12052-014-0018-z, DOI 10.1186/s12052-014-0018-z]; Ha M., 2015, EVOL EDUC OUTREACH, V8, P1, DOI DOI 10.1186/s12052-015-0040-9; Ha M, 2012, J RES SCI TEACH, V49, P95, DOI 10.1002/tea.20449; Halpern D.F., 2012, SEX DIFFERENCES COGN, V4th; Hawley P.H., 2011, EVOLUTION ED OUTREAC, V4, P117, DOI DOI 10.1007/S12052-010-0294-1; Hull David L., 1983, DARWIN HIS CRITICS R; IBM Corporation, 2017, IBM SPSS STAT WINDOW; Jensen J.L., 2015, EVOL EDUC OUTREACH, V8, P23, DOI [10.1186/s12052-015-0051-6, DOI 10.1186/s12052-015-0051-6]; Kalinowski ST, 2016, CBE-LIFE SCI EDUC, V15, DOI 10.1187/cbe.15-06-0134; Kelemen D., 2012, EVOLUTION CHALLENGES, P66, DOI [DOI 10.1093/ACPROF:OSO/9780199730421.003.0004, 10.1093/acprof:oso/9780199730421.001.0001/acprof-9780199730421-chapter-4]; Koenig H, 1997, AM J PSYCHIAT, V154, P885; Koenig HG, 2010, RELIGIONS, V1, P78, DOI 10.3390/rel1010078; MARDIA KV, 1971, BIOMETRIKA, V58, P105, DOI 10.1093/biomet/58.1.105; McComas WF., 2017, SCH SCI REV, V98, P71; Mead L.S., 2019, EVOL EDUC OUTREACH, V12, P5, DOI [10.1186/s12052-019-0097-y, DOI 10.1186/s12052-019-0097-y]; Mead R, 2018, NAT ECOL EVOL, V2, P388, DOI 10.1038/s41559-017-0442-x; Metzger K.J., 2018, EVOL EDUC OUTREACH, V11, P1, DOI [10.1186/s12052-018-0084-8, DOI 10.1186/s12052-018-0084-8]; Miller JD, 2006, SCIENCE, V313, P765, DOI 10.1126/science.1126746; Moore R., 2009, J EFFECTIVE TEACHING, V9, P4; Moore R, 2011, AM BIOL TEACH, V73, P222, DOI 10.1525/abt.2011.73.4.7; Nadelson LS, 2009, EVOL PSYCHOL-US, V7, P490, DOI 10.1177/147470490900700401; Nadelson LS, 2012, EVO ED OUTREACH, V3, P82; National Academies of Science, 2008, SCI EV CREAT; Nehm RH, 2012, AM BIOL TEACH, V74, P92, DOI 10.1525/abt.2012.74.2.6; Nehm RH, 2011, J RES SCI TEACH, V48, P237, DOI 10.1002/tea.20400; Perlman RL, 2013, Evolution and Medicine, P1; R Core Team, R LANG ENV STAT COMP; RICE JW, 2015, EVOL EDUC OUTREACH, V8, pNIL1, DOI DOI 10.1186/s12052-015-0036-5; Rissler L. J., 2014, EVOL EDUC OUTREACH, V7, P1, DOI [DOI 10.1186/s12052-014-0024-1, 10.1186/s12052-014-0024-1]; Romine W.L., 2018, EVOL EDUC OUTREACH, V11, P1, DOI [10.1186/s12052-018-0093-7, DOI 10.1186/s12052-018-0093-7]; Romine WL, 2017, J RES SCI TEACH, V54, P642, DOI 10.1002/tea.21380; Rosenberg A., 2000, DARWINISM PHILOS SOC, P172; Ruse M, 1985, TAKING DARWIN SERIOU; Ruse M., 2000, CAN DARWINIAN BE CHR, DOI [10.1017/CBO9780511803079, DOI 10.1017/CBO9780511803079]; Rutledge M.L., 1999, SCH SCI MATH, V99, P13, DOI [10.1111/j.1949-8594.1999.tb17441.x, DOI 10.1111/j.1949-8594.1999.tb17441.x, DOI 10.1111/J.1949-8594.1999.TB17441.X]; Rutledge ML., 2011, J COLL SCI TEACH, V41, P38; Sbeglia G.C., 2018, EVOL EDUC OUTREACH, V11, P1, DOI [10.1186/s12052-018-0091-9, DOI 10.1186/s12052-018-0091-9]; Singer P, 1999, DARWINIAN LEFT POLIT; Smith MU, 2016, J RES SCI TEACH, V53, P1289, DOI 10.1002/tea.21328; Sober E., 2011, OXFORD STUDIES PHILO, P187; Sokal R.R., 2012, BIOMETRY; Stamos David N., 2008, EVOLUTION BIG QUESTI; Truong JM, 2018, AM BIOL TEACH, V80, P106, DOI 10.1525/abt.2018.80.2.106; Underwood A.J., 1981, Oceanography and Marine Biology an Annual Review, V19, P513; Vazquez-Ben L, 2018, REV EUREKA ENSEN DIV, V15, DOI 10.25267/Rev_Eureka_ensen_divulg_cienc.2018.v15.i3.3101; Walter E. M., 2013, EVOLUTION ED OUTREAC, V6, P26, DOI DOI 10.1186/1936-6434-6-26; WILLIAMS GC, 1991, Q REV BIOL, V66, P1, DOI 10.1086/417048; Yousuf A., 2011, EVOL EDUC OUTREACH, V4, P580, DOI [10.1007/s12052-011-0376-8, DOI 10.1007/S12052-011-0376-8]	70	1	1	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238345	10.1371/journal.pone.0238345	http://dx.doi.org/10.1371/journal.pone.0238345			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ7QD	32881957	Green Published, gold			2022-12-26	WOS:000571063300051
J	Ortiz, MS; Cabieses, B; Oyarte, M; Repetto, P				Ortiz, Manuel S.; Cabieses, Baltica; Oyarte, Marcela; Repetto, Paula			Disentangling socioeconomic inequalities of type 2 diabetes mellitus in Chile: A population-based analysis	PLOS ONE			English	Article							EPIDEMIOLOGIC TRANSITION; HEALTH-CARE	Introduction Chile experiences a growing prevalence of DM2 in its adult population over time. The country has prioritised the diagnosis and treatment of DM2 through a universal health care package, largely focused on the clinical dimensions of the disease. We analysed the significance of socioeconomic variables in the prevalence of DM2, as well as its related dimensions of presence of complications (diabetic foot and ophthalmologic complications), attendance to health checks and acquisition of recommended lifestyle changes due to this condition. Methods Secondary analysis of the national health survey (ENS) 2016-2017 (n = 6,233 respondents). Crude and income-adjusted odds of reporting DM2 was estimated, as well as the relationship between complications due to diabetes and a number of clinical and sociodemographic variables using weighted log-linear multiple regression models. Results We found a clear social gradient of the prevalence of DM2 by household income quintiles and educational level in the adult population. Income quintile and educational level gradients remained significantly associated with the presence of complications and attendance to health checks. We found no significant association, however; between income quintile and reported lifestyle change. The association between complications due to DM2 and socioeconomic variables, particularly income, remained relevant even after adjusting for all sociodemographic variables. Conclusion This is the first study to analyse the association between DM2 and socioeconomic variables in Chile, useful for monitoring and policy planning. Income was strongly associated with DM2 prevalence and with related clinical variables (complications and attendance to health checks). Age, health care provision and educational level were also relevant factors, but lost significance in the fully adjusted model.	[Ortiz, Manuel S.] Univ La Frontera, Dept Psicol, Temuco, Chile; [Cabieses, Baltica] Univ Desarrollo, Fac Med Clin Alemana, Inst Ciencias & Innovac Med ICIM, Santiago, Chile; [Oyarte, Marcela] Inst Salud Publ Chile, Santiago, Chile; [Repetto, Paula] Pontificia Univ Catolica Chile, Escuela Psicol, Santiago, Chile	Universidad de La Frontera; Universidad del Desarrollo; Pontificia Universidad Catolica de Chile	Cabieses, B (corresponding author), Univ Desarrollo, Fac Med Clin Alemana, Inst Ciencias & Innovac Med ICIM, Santiago, Chile.	bcabieses@udd.cl	repetto, paula/E-5525-2015; Repetto, Paula/ABC-5982-2021; Ortiz, Manuel/G-1044-2019; Cabieses, Baltica/V-5024-2017	Repetto, Paula/0000-0002-0331-7375; Ortiz, Manuel/0000-0002-7749-0699; Cabieses, Baltica/0000-0003-0756-1954	Fondecyt Regular [1180463]; ANID/Conicyt, Chile	Fondecyt Regular(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ANID/Conicyt, Chile	M.O. Fondecyt Regular 1180463, ANID/Conicyt, Chile. www.anid.cl The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albala C, 1995, PUBLIC HEALTH, V109, P431, DOI 10.1016/S0033-3506(95)80048-4; American Diabetes Association, ADA GUID EV MAN YOUT; Arteaga Oscar, 2002, Cad. Saúde Pública, V18, P1053, DOI 10.1590/S0102-311X2002000400011; Arteaga Óscar, 2002, Rev Panam Salud Publica, V11, P374, DOI 10.1590/S1020-49892002000500012; Cerda J, 2008, REV CHIL PEDIATR-CHI, V79, P481; Chilean Ministry of Health, 2004, IMP PIL AUGE AT SAL; Chilean Ministry of Health, 2000, POL SAL MET MIN 2000; Diaz-Martinez X, 2017, REV MED CHILE, V145, P1394, DOI 10.4067/s0034-98872017001101394; Gonzalez-Aguero M, 2020, MED ANTHROPOL Q, V34, P210, DOI 10.1111/maq.12555; Hsu CC, 2012, DIABETES CARE, V35, P2286, DOI 10.2337/dc11-2052; Imkampe AK, 2011, EUR J PUBLIC HEALTH, V21, P484, DOI 10.1093/eurpub/ckq106; Infante A, 2000, Rev Panam Salud Publica, V8, P13, DOI 10.1590/S1020-49892000000700005; International Diabetes Federation, 2016, DIABETES ATLAS; International Monetary Fund, REP SEL COUNTR CONT; Juonala M, 2019, OBES RES CLIN PRACT; Lopez R, 2006, REV MED CHILE, V134, P549; Mardones F, 2004, REV MED CHILE, V132, P865; Leiva AM, 2018, NUTR HOSP, V35, P400, DOI 10.20960/nh.1434; MINSAL, 2010, GUIA CLIN 2010 DIAB; MINSAL, 2014, ENF RIESG PREV ENF C; Nadeau KJ, 2016, DIABETES CARE, V39, P1635, DOI 10.2337/dc16-1066; OMS, 2016, DIAB FACT SHEET 2016; Ortiz MS, 2019, DIABETES RES CLIN PR, V156, DOI 10.1016/j.diabres.2019.107795; Poblete F, 2018, REV MED CHILE, V146, P1135, DOI 10.4067/S0034-98872018001001135; Torres-Aviles F, 2010, ACTA DIABETOL, V47, P251, DOI 10.1007/s00592-010-0189-1; Vega J, 2003, REV MED CHILE, V131, P669; 2018, LANCET, V392, pP2325	27	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238534	10.1371/journal.pone.0238534	http://dx.doi.org/10.1371/journal.pone.0238534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ7QD	32881894	Green Published, gold			2022-12-26	WOS:000571063300095
J	Barreto, IMLG; Urbano, SA; Oliveira, CAA; Macedo, CS; Borba, LHF; Chags, BME; Rangel, AHN				Barreto, Icaro M. L. G.; Urbano, Stela A.; Oliveira, Chiara A. A.; Macedo, Claudia S.; Borba, Luiz H. F.; Chags, Bruna M. E.; Rangel, Adriano H. N.			Chemical composition and lipid profile of mare colostrum and milk of the quarter horse breed	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; LACTATION; YIELD; PROTEIN	The objective of this study was to characterize the chemical composition and lipid profile of colostrum and milk of purebred Quarter Horse mares. Thirty-four (34) purebred mares were selected, which were then separated into groups according to age, birth order and lactation stage. Colostrum samples were collected in the first six hours after delivery and milk samples from the 7(th)postpartum day, with intervals of 14 days until the end of lactation. The samples were refrigerated and sent to the Milk Laboratory of the University (Laboleite-UFRN), where they were analyzed for chemical composition. Colostrum was assessed by refractometry. The lipid profile was determined by gas chromatography through a separation of methyl esters. The data were tabulated and subjected to descriptive statistics and analysis of variance by the F-Test, and the groups were compared by the Tukey test using a significance level of 5%. There was high protein content and reduced lactose content for the colostrum of the Quarter Horse mares, differing from other breeds. The milk composition was not influenced by the mares' age. However, variations in the lactation stage and in the birth order of the Quarter Horse mares altered the milk's chemical composition. There is variation in the lipid composition of milk according to the lactation stage, without changing the characteristic profile of the mares' milk or diminishing the nutritional quality of the lipid fraction.	[Barreto, Icaro M. L. G.; Urbano, Stela A.; Macedo, Claudia S.; Borba, Luiz H. F.; Chags, Bruna M. E.; Rangel, Adriano H. N.] Univ Fed Rio Grande do Norte, Natal, RN, Brazil; [Oliveira, Chiara A. A.] Univ Fed Bahia, Salvador, BA, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal da Bahia	Chags, BME (corresponding author), Univ Fed Rio Grande do Norte, Natal, RN, Brazil.	brunam.emerenciano@gmail.com		Chagas, Bruna/0000-0003-0344-550X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	I declare that during this specific study we not received funds for financing this research. This work is part of the first author's Master Dissertation. The author Icaro Marcell Lopes Gomes Barreto received a master's degree fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).	[Anonymous], 2011, QPEDIA, V5, P6; [Anonymous], 2002, AM J KIDNEY DIS S1, V2, pS1; Bruckmaier RM, 2005, DOMEST ANIM ENDOCRIN, V29, P268, DOI 10.1016/j.domaniend.2005.02.023; BURNS HD, 1992, J EQUINE VET SCI, V12, P118, DOI 10.1016/S0737-0806(06)81293-1; Claeys WL, 2014, FOOD CONTROL, V42, P188, DOI 10.1016/j.foodcont.2014.01.045; Csapo J., 2009, Acta Universitatis Sapientiae - Alimentaria, V2, P133; CSAPO J, 1995, INT DAIRY J, V5, P393, DOI 10.1016/0958-6946(94)00008-D; Curadi, 2003, ANN FACOLTA MED VET, V56, P97; Dankow R., 2006, Archiv fur Tierzucht, V49, P201; Egito AS, 2001, INT DAIRY J, V11, P885, DOI 10.1016/S0958-6946(01)00123-6; Fessas D, 2001, EUR J BIOCHEM, V268, P5439, DOI 10.1046/j.0014-2956.2001.02484.x; Freitas MS, 2001, ARQ BRAS MED VET ZOO, V53, P708, DOI 10.1590/S0102-09352001000600017; GalvaoJunior JGB., 2010, ACTA VET BRAS, V4, P25, DOI [10.21708/avb.2010.4.1.1452, DOI 10.21708/AVB.2010.4.1.1452]; GIBBS PG, 1982, J ANIM SCI, V54, P496, DOI 10.2527/jas1982.543496x; Kramer JKG, 2002, LIPIDS, V37, P823, DOI 10.1007/s11745-002-0967-2; Malacarne M, 2002, INT DAIRY J, V12, P869, DOI 10.1016/S0958-6946(02)00120-6; Markiewicz-Keszycka M, 2014, INT DAIRY J, V38, P31, DOI 10.1016/j.idairyj.2014.04.003; Nath LC, 2010, JAVMA-J AM VET MED A, V236, P1085, DOI 10.2460/javma.236.10.1085; Pecka E, 2012, ANIM SCI J, V83, P162, DOI 10.1111/j.1740-0929.2011.00930.x; Pieszka M, 2016, ANN ANIM SCI, V16, P33, DOI 10.1515/aoas-2015-0041; Pikul J, 2008, J DAIRY RES, V75, P302, DOI 10.1017/S0022029908003336; Pikul J, 2008, LIVEST SCI, V113, P285, DOI 10.1016/j.livsci.2007.06.005; POOLANDERSON K, 1994, J ANIM SCI, V72, P1661, DOI 10.2527/1994.7271661x; RANGEL A. H. N., 2008, REV VERDE AGROECOLOG, V3, P36; Reis A. de P., 2007, Revista do Instituto Adolfo Lutz, V66, P130; Ribeiro AB, 2008, REV CAATINGA, V22, P46; Salam R. V., 2009, ACTA UNIVERSITARIS S, V2, P119; Salimei E, 2002, REPROD NUTR DEV, V42, P65, DOI 10.1051/rnd:2002007; Salimei E, 2012, INT DAIRY J, V24, P130, DOI 10.1016/j.idairyj.2011.11.008; Santos Edson Mauro, 2006, Revista Portuguesa de Ciencias Veterinarias, V101, P17; Santos EM, 2005, REV BRAS ZOOTECN, V34, P627, DOI 10.1590/S1516-35982005000200032; Teodoro RL, 2000, REV BRAS ZOOTECN, V29, P2248	32	9	10	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0238921	10.1371/journal.pone.0238921	http://dx.doi.org/10.1371/journal.pone.0238921			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925944	Green Published, gold			2022-12-26	WOS:000572318000026
J	Cho, A; Lee, YK; Park, HC				Cho, AJin; Lee, Young-Ki; Park, Hayne Cho			Impact of electrolyte-rich dialysate during continuous renal replacement therapy on serum phosphate and potassium in ICU patients	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; HYPOPHOSPHATEMIA; HEMODIAFILTRATION; HEMOFILTRATION; HEMODIALYSIS; FAILURE	Background Hypophosphatemia and hypokalemia occur frequently during continuous renal replacement therapy (CRRT). We evaluated serum phosphate and potassium levels in patients administered three different types of dialysis solution. Methods The study population consisted of 324 intensive care unit patients who underwent CRRT between January 2015 and December 2018. Patients were divided into three groups: group 1 (n = 105) received Hemosol B0 (no potassium or phosphate); group 2 (n = 78) received Hemosol B0 and potassium-containing solution (MultiBic); and group 3 (n = 141) received phosphate- and potassium-containing solution (Phoxilium), Hemosol B2, Prismasol 2, and Prismasol 4. A different protocol was followed in each group. Results The incidence rate of hypophosphatemia was 55% lower in group 3 compared to group 1 (incidence rate ratio (IRR) 0.45, 95% confidence interval (CI): 0.33 to 0.61) and 61% lower compared to group 2 (IRR 0.39, 95% CI: 0.29 to 0.53). Group 3 also had a 50% lower incidence rate of hypokalemia compared to group 1 (IRR 0.50, 95% CI: 0.29 to 0.88). The negative slope in phosphate level in group 3 was greater than that in group 1 (ss = 0.19, 95% CI: 0.02 to 0.37, p = 0.032), while the negative slope in the potassium level was greater in group 2 than in group 1(ss = 0.10, 95% CI: 0.03 to 0.17, p = 0.008). Additional intravenous calcium was not used in any case, and most cases of acid-base disturbances were well controlled. Conclusions The use of phosphate- and potassium-containing with a proper CRRT protocol prevented decreases in serum phosphate and potassium levels, thus also preventing hypophosphatemia and hypokalemia, and additional replacement during CRRT.	[Cho, AJin; Lee, Young-Ki; Park, Hayne Cho] Hallym Univ, Kangnam Sacred Heart Hosp, Dept Internal Med, Coll Med, Seoul, South Korea	Hallym University	Lee, YK (corresponding author), Hallym Univ, Kangnam Sacred Heart Hosp, Dept Internal Med, Coll Med, Seoul, South Korea.	km2071@hallym.or.kr						Baldwin I, 2007, INTENS CARE MED, V33, P830, DOI 10.1007/s00134-007-0596-0; Bellomo R., 1998, Annals Academy of Medicine Singapore, V27, P426; Bellomo R, 1998, KIDNEY INT, V53, pS125; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Besnard N, 2016, BLOOD PURIFICAT, V42, P18, DOI 10.1159/000444248; BOLLAERT PE, 1995, CHEST, V107, P1698, DOI 10.1378/chest.107.6.1698; Broman M, 2011, ACTA ANAESTH SCAND, V55, P39, DOI 10.1111/j.1399-6576.2010.02338.x; Brunelli SM, 2007, J AM SOC NEPHROL, V18, P1999, DOI 10.1681/ASN.2007020143; Chua HR, 2013, J CRIT CARE, V884, pe7; Demirjian S, 2011, NEPHROL DIAL TRANSPL, V26, P3508, DOI 10.1093/ndt/gfr075; Geerse DA, 2010, CRIT CARE, V14, DOI 10.1186/cc9215; Godaly G, 2016, CLIN KIDNEY J, V9, P205, DOI 10.1093/ckj/sfv133; JACOB HS, 1971, NEW ENGL J MED, V285, P1446, DOI 10.1056/NEJM197112232852602; Marik PE, 1996, ARCH SURG-CHICAGO, V131, P1043, DOI 10.1001/archsurg.1996.01430220037007; Morimatsu H, 2002, INT J ARTIF ORGANS, V25, P512, DOI 10.1177/039139880202500605; OGNIBENE A, 1994, SOUTHERN MED J, V87, P65, DOI 10.1097/00007611-199401000-00014; Shor R, 2006, ANN CLIN LAB SCI, V36, P67; Tan HK, 2001, INT J ARTIF ORGANS, V24, P186, DOI 10.1177/039139880102400403; Tongyoo S, 2018, J INT MED RES, V46, P1254, DOI 10.1177/0300060517744427; Uchino S, 2007, INTENS CARE MED, V33, P1563, DOI 10.1007/s00134-007-0754-4; ZAZZO JF, 1995, INTENS CARE MED, V21, P826, DOI 10.1007/BF01700966	21	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238867	10.1371/journal.pone.0238867	http://dx.doi.org/10.1371/journal.pone.0238867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915900	gold, Green Published			2022-12-26	WOS:000571887500066
J	Carrillo-Vega, MF; Salinas-Escudero, G; Garcia-Pena, C; Gutierrez-Robledo, LM; Parra-Rodriguez, L				Fernanda Carrillo-Vega, Maria; Salinas-Escudero, Guillermo; Garcia-Pena, Carmen; Miguel Gutierrez-Robledo, Luis; Parra-Rodriguez, Lorena			Early estimation of the risk factors for hospitalization and mortality by COVID-19 in Mexico	PLOS ONE			English	Article								Background Due to a high prevalence of chronic non-degenerative diseases, it is suspected that COVID 19 poses a high risk of fatal complications for the Mexican population. The present study aims to estimate the risk factors for hospitalization and death in the Mexican population infected by SARS-CoV-2. Methods and findings We used the publicly available data released by the Epidemiological Surveillance System for Viral Respiratory Diseases of the Mexican Ministry of Health (Secretaria de Salud, SSA). All records of positive SARS-CoV-2 cases were included. Two multiple logistic regression models were fitted to estimate the association between hospitalization and mortality, with other covariables. Data on 10,544 individuals (57.68% men), with mean age 46.47 +/- 15.62, were analyzed. Men were about 1.54 times more likely to be hospitalized than women (p<0.001, 95% C.I. 1.37-1.74); individuals aged 50-74 and >= 74 were more likely to be hospitalized than people aged 25-49 (OR 2.05, p<0.001, 95% C.I. 1.81-2.32, and OR 3.84, p<0.001, 95% C.I. 2.90-5.15, respectively). People with hypertension, obesity, and diabetes were more likely to be hospitalized than people without these comorbidities (p<0.01). Men had more risk of death in comparison to women (OR = 1.53, p<0.001, 95% C.I. 1.30-1.81) and individuals aged 50-74 and >= 75 were more likely to die than people aged 25-49 (OR 1.96, p<0.001, 95% C.I. 1.63-2.34, and OR 3.74, p<0.001, 95% C.I. 2.80-4.98, respectively). Hypertension, obesity, and diabetes presented in combination conveyed a higher risk of dying in comparison to not having these diseases (OR = 2.10; p<0.001, 95% C.I. 1.50-2.93). Hospitalization, intubation and pneumonia entail a higher risk of dying (OR 5.02, p<0.001, 95% C.I. 3.88-6.50; OR 4.27, p<0.001, 95% C.I. 3.26-5.59, and OR = 2.57; p<0.001, 95% C.I. 2.11-3.13, respectively). Our study's main limitation is the lack of information on mild (asymptomatic) or moderate cases of COVID-19. Conclusions The present study points out that in Mexico, where an important proportion of the population has two or more chronic conditions simultaneously, a high mortality rate is a serious risk for those infected by SARS-CoV-2.	[Fernanda Carrillo-Vega, Maria; Garcia-Pena, Carmen; Miguel Gutierrez-Robledo, Luis; Parra-Rodriguez, Lorena] Inst Nacl Geriatria, Res Dept, Mexico City, DF, Mexico; [Salinas-Escudero, Guillermo] Hosp Infantil Mexico Dr Federico Gomez, Ctr Econ & Social Studies Hlth, Mexico City, DF, Mexico	Hospital Infantil de Mexico Federico Gomez	Parra-Rodriguez, L (corresponding author), Inst Nacl Geriatria, Res Dept, Mexico City, DF, Mexico.	parra.lrn@gmail.com		Salinas Escudero, Guillermo/0000-0003-4573-4844; Parra-Rodriguez, Lorena/0000-0002-1107-1571	Secretaria de Educacion, Ciencia, Tecnologia e Innovacion de la Ciudad de Mexico [CM-SECTEI/041/2020]	Secretaria de Educacion, Ciencia, Tecnologia e Innovacion de la Ciudad de Mexico	This project was supported by a grant from the Secretaria de Educacion, Ciencia, Tecnologia e Innovacion de la Ciudad de Mexico CM-SECTEI/041/2020 "Red colaborativa de Investigacion Traslacional para el Envejecimiento Saludable de la Ciudad de Mexico" (RECITES). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, OPTICS EXPRESS, V27, pA581; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Cai JH, 2020, CLIN INFECT DIS, V71, P1547, DOI 10.1093/cid/ciaa198; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Donders F, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10040243; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Lam CM, 2004, BJOG-INT J OBSTET GY, V111, P771, DOI 10.1111/j.1471-0528.2004.00199.x; Li LQ, 2020, J MED VIROL, V92, P577, DOI 10.1002/jmv.25757; Lippi G, 2020, J MED VIROL, V92, P1759, DOI 10.1002/jmv.25860; Panamerican Health Organization, 2020, 2 PAN HLTH ORG; Porcheddu R, 2020, J INFECT DEV COUNTR, V14, P125, DOI 10.3855/jidc.12600; Ren LL, 2020, CHINESE MED J-PEKING, V133, P1015, DOI 10.1097/CM9.0000000000000722; Rojas-Martinez R, 2020, SALUD PUBLICA MEXICO, V54, P7; *SECR SAL, 2020, BAS DAT COVID 19; Secretaria de Salud, 2020, NOT COM C MEX 2020; Wang DW, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02895-6; Wang TB, 2020, LANCET, V395, pE52, DOI 10.1016/S0140-6736(20)30558-4; Wang WE, 2020, J MED VIROL, V92, P441, DOI 10.1002/jmv.25689; Wenham C, 2020, LANCET, V395, P846, DOI 10.1016/S0140-6736(20)30526-2; World Health Organization, 2020, 90 WHO; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	24	51	51	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238905	10.1371/journal.pone.0238905	http://dx.doi.org/10.1371/journal.pone.0238905			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915872	gold, Green Published			2022-12-26	WOS:000571887500063
J	Gugliuzzo, A; Criscione, G; Biondi, A; Aiello, D; Vitale, A; Polizzi, G; Garzia, GT				Gugliuzzo, Antonio; Criscione, Giulio; Biondi, Antonio; Aiello, Dalia; Vitale, Alessandro; Polizzi, Giancarlo; Garzia, Giovanna Tropea			Seasonal changes in population structure of the ambrosia beetleXylosandrus compactusand its associated fungi in a southern Mediterranean environment	PLOS ONE			English	Article							COLEOPTERA-CURCULIONIDAE SCOLYTINAE; BLACK TWIG BORER; BEETLE XYLOSANDRUS-COMPACTUS; TREE CERATONIA-SILIQUA; TOMATO PINWORM; EICHHOFF; SPREAD; MANAGEMENT; RESISTANCE; DIVERSITY	Exotic ambrosia beetles are increasing in Europe due to global trade and global warming. Among these xylomycetophagous insects,Xylosandrus compactus(Eichhoff) (Coleoptera: Curculionidae) is a serious threat for several Mediterranean host plants. Carob trees growing in Sicily (Italy) have been extensively attacked by beetles leading to rapid tree decline. AlthoughX.compactushas been found in Europe for several years, most aspects of its ecology are still unknown. We thus studied the population structure and dynamics ofX.compactus, together with its twig size preference during a sampling of infested carob trees in south east Sicily. In addition, fungi associated with insects or galleries were isolated and characterized. The results showed that, in this newly-colonized environment and host plant, adultX.compactusoverwinters inside twigs and starts to fly and reproduce in mid spring, completing five generations before overwintering in late fall. The mean diameter of carob twigs infested by the beetle varied significantly over the seasons, with the insect tending to infest larger twigs as season progresses. The mean number of adults/gallery was 19.21, ranging from 6 to 28. The minimum temperature significantly affected the overwintering adult mortality.Ambrosiella xyleboriandFusarium solaniwere the main symbionts associated with the pest in this study.Acremoniumsp. was instead recorded for the first time in Europe insideX.compactusgalleries. Several other fungi species were also found for the first time in association withX.compactus. Our findings provide useful insights into the sustainable management of this noxious pest.	[Gugliuzzo, Antonio; Criscione, Giulio; Biondi, Antonio; Aiello, Dalia; Vitale, Alessandro; Polizzi, Giancarlo; Garzia, Giovanna Tropea] Univ Catania, Dept Agr Food & Environm Di3A, Catania, Italy	University of Catania	Garzia, GT (corresponding author), Univ Catania, Dept Agr Food & Environm Di3A, Catania, Italy.	giovanna.tropeagarzia@unict.it	Polizzi, Giancarlo/ABF-2256-2021; Gugliuzzo, Antonio/R-8131-2019; BIONDI, Antonio/I-6381-2012	Gugliuzzo, Antonio/0000-0002-4118-2280; BIONDI, Antonio/0000-0002-1982-7716; VITALE, Alessandro/0000-0002-7339-4034; Tropea Garzia, Giovanna/0000-0002-2161-7021	Regione Siciliana, Assessorato Regionale dell'Agricoltura, dello Sviluppo Rurale e della Pesca Mediterranea, Dipartimento Regionale dell'Agricoltura, Servizio 4 Servizio Fitosanitario Regionale e Lotta alla Contraffazione; University of Catania [5A725192026]	Regione Siciliana, Assessorato Regionale dell'Agricoltura, dello Sviluppo Rurale e della Pesca Mediterranea, Dipartimento Regionale dell'Agricoltura, Servizio 4 Servizio Fitosanitario Regionale e Lotta alla Contraffazione; University of Catania	This work was supported by the Regione Siciliana, Assessorato Regionale dell'Agricoltura, dello Sviluppo Rurale e della Pesca Mediterranea, Dipartimento Regionale dell'Agricoltura, Servizio 4 Servizio Fitosanitario Regionale e Lotta alla Contraffazione and by the University of Catania through the research agreements "Difesa fitosanitaria nei confronti dello scolitide del Carrubo Xylosandrus compactus (Eichhoff)"(5A725192026) and the project "Emergent Pests and Pathogens and Relative Sustainable Strategies", respectively. Antonio Gugliuzzo received a PhD grant (PhD course in Agricultural Food and Environmental Science) from the University of Catania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Aiello D, 2019, PHYTOPATHOL MEDITERR, V58, P699, DOI [10.13128/Phyto-10880, 10.14601/Phyto-10880]; Alamouti SM, 2009, MYCOL RES, V113, P822, DOI 10.1016/j.mycres.2009.03.003; [Anonymous], 2007, PERIPATETIKOS, V6, P59; Bateman C, 2016, ENVIRON ENTOMOL, V45, P883, DOI 10.1093/ee/nvw070; BATRA LR, 1967, MYCOLOGIA, V59, P976, DOI 10.2307/3757271; Baumel A, 2018, PLANT ECOL EVOL, V151, P185, DOI 10.5091/plecevo.2018.1423; BHAT S S, 1988, Journal of Coffee Research, V18, P54; Biedermann PHW, 2020, ANNU REV ENTOMOL, V65, P431, DOI 10.1146/annurev-ento-011019-024910; Biedermann PHW, 2019, TRENDS ECOL EVOL, V34, P914, DOI 10.1016/j.tree.2019.06.002; Biedermann PHW, 2009, ENVIRON ENTOMOL, V38, P1096, DOI 10.1603/022.038.0417; Biondi A, 2018, ANNU REV ENTOMOL, V63, P239, DOI 10.1146/annurev-ento-031616-034933; Bosso L., 2012, Journal of Plant Pathology, V94; BRADER L., 1964, Mededelingen van de Landbouwhogeschool, V64, P1; Bras A, 2019, J PEST SCI, V92, P1187, DOI 10.1007/s10340-019-01111-x; Chong JH, 2009, J AGR URBAN ENTOMOL, V26, P199, DOI 10.3954/1523-5475-26.4.199; Contarini M, 2020, EPPO B; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Di Guardo M, 2019, TREE GENET GENOMES, V15, DOI 10.1007/s11295-019-1345-6; Egonyu JP, 2016, AFR ZOOL, V51, P121, DOI 10.1080/15627020.2016.1215262; Egonyu JP, 2018, ARTHROPOD-PLANT INTE, V12, P9, DOI 10.1007/s11829-017-9552-2; Faccoli M, 2016, INSECTS DIS MEDITERR, DOI [10.1007/978-3-319-24744-1, DOI 10.1007/978-3-319-24744-1_11, DOI 10.1007/978-3-319-24744-1]; Ferrauto G, 2013, INT J FOOD SCI TECH, V48, P1596, DOI 10.1111/ijfs.12129; Francardi V., 2012, GIORNATE FITOPATOLOG, P443; Francardi V, 2017, REDIA, V100, P149, DOI 10.19263/REDIA-100.17.19; Garonna AP, 2012, ZOOTAXA, P64; Gebhardt H, 2005, MYCOL RES, V109, P687, DOI 10.1017/S0953756205002777; Greco EB, 2015, J INTEGR PEST MANAG, V6, DOI 10.1093/jipm/pmv007; Guarnaccia V., 2018, Fungal Systematics and Evolution, V1, P131, DOI 10.3114/fuse.2018.01.06; Guedes RNC, 2019, J PEST SCI, V92, P1329, DOI 10.1007/s10340-019-01086-9; Gugliuzzo A., 2019, Bulletin OEPP, V49, P340, DOI 10.1111/epp.12564; Gugliuzzo A, 2019, PHYTOPARASITICA, V47, P605, DOI 10.1007/s12600-019-00766-7; Gugliuzzo A, 2019, INSECTS, V10, DOI 10.3390/insects10030082; Hara A.H., 1977, THESIS; HARA AH, 1979, P HAWAII ENTOMOL SOC, V23, P55; Harrington TC, 2009, TEXAS FOREST SERVICE, P21; Hofstetter RW, 2006, OECOLOGIA, V147, P679, DOI 10.1007/s00442-005-0312-0; Hulcr J, 2011, J CHEM ECOL, V37, P1374, DOI 10.1007/s10886-011-0046-x; Javal M, 2019, J PEST SCI, V92, P173, DOI 10.1007/s10340-017-0917-1; Kirkendall LR, 2010, ZOOKEYS, P227, DOI 10.3897/zookeys.56.529; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kuo H-C., 2010, THESIS; Lawrence DP, 2018, IMA FUNGUS, V9, P333, DOI 10.5598/imafungus.2018.09.02.07; Lesieur V, 2019, J PEST SCI, V92, P189, DOI 10.1007/s10340-018-0993-x; Li Y, 2019, INSECT SCI, V26, P732, DOI 10.1111/1744-7917.12590; Lombard L, 2015, STUD MYCOL, P189, DOI 10.1016/j.simyco.2014.12.002; Malfa S. la, 2012, Acta Horticulturae, P207; Marini L, 2011, BIOL INVASIONS, V13, P2275, DOI 10.1007/s10530-011-0039-2; Mayers CG, 2020, PERSOONIA, V44, P41, DOI 10.3767/persoonia.2020.44.02; Mayers CG, 2015, FUNGAL BIOL-UK, V119, P1075, DOI 10.1016/j.funbio.2015.08.002; Meurisse N, 2019, J PEST SCI, V92, P13, DOI 10.1007/s10340-018-0990-0; MUTHAPPA B N, 1981, Journal of Coffee Research, V11, P54; NGOAN ND, 1976, ANN ENTOMOL SOC AM, V69, P872, DOI 10.1093/aesa/69.5.872; O'Donnell K, 2008, J CLIN MICROBIOL, V46, P2477, DOI 10.1128/JCM.02371-07; Paine TD, 1997, ANNU REV ENTOMOL, V42, P179, DOI 10.1146/annurev.ento.42.1.179; Pennacchio Fabrizio, 2003, Redia, V86, P77; Pennacchio F, 2012, REDIA, V95, P67; Philippe V, 2020, FOOD CONTROL; Poland TM, 2019, J PEST SCI, V92, P37, DOI 10.1007/s10340-018-1004-y; Rabaglia RJ, 2006, ANN ENTOMOL SOC AM, V99, P1034, DOI 10.1603/0013-8746(2006)99[1034:ROAXCC]2.0.CO;2; Ranger CM, 2018, P NATL ACAD SCI USA, V115, P4447, DOI 10.1073/pnas.1716852115; Roques Alain, 2009, V3, P63; Savarino G., 2009, Industrie Alimentari, V48, P36; Seebens H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14435; Rodriguez-Flores MS, 2019, J PEST SCI, V92, P557, DOI 10.1007/s10340-018-1042-5; Skelton J, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2018.2127; Vaes-Petignat Sibylle, 2014, NeoBiota, V22, P23; Vannini A., 2017, Bulletin OEPP, V47, P100, DOI 10.1111/epp.12358; Vetek G, 2018, ENTOMOL GEN, V38, P3, DOI 10.1127/entomologia/2018/0631; Viruel J, 2020, J BIOGEOGR, V47, P460, DOI 10.1111/jbi.13726; VONARX JA, 1965, MYCOPATH MYCOL APPL, V25, P309; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zandigiacomo P., 1998, NOTIZIARIO ERSA, V11, P11	73	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0239011	10.1371/journal.pone.0239011	http://dx.doi.org/10.1371/journal.pone.0239011			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915885	Green Published, gold			2022-12-26	WOS:000571887500098
J	Muscillo, A; Pin, P; Razzolini, T				Muscillo, Alessio; Pin, Paolo; Razzolini, Tiziano			Covid19: Unless one gets everyone to act, policies may be ineffective or even backfire	PLOS ONE			English	Article								The diffusion of Covid-19 has called governments and public health authorities to interventions aiming at limiting new infections and containing the expected number of critical cases and deaths. Most of these measures rely on the compliance of people, who are asked to reduce their social contacts to a minimum. In this note we argue that individuals' adherence to prescriptions and reduction of social activity may not be efficacious if not implemented robustly on all social groups, especially on those characterized by intense mixing patterns. Actually, it is possible that, if those who have many contacts have reduced them proportionally less than those who have few, then the effect of a policy could have backfired: the disease has taken more time to die out, up to the point that it has become endemic. In a nutshell, unless one gets everyone to act, and specifically those who have more contacts, a policy may even be counterproductive.	[Muscillo, Alessio; Pin, Paolo; Razzolini, Tiziano] Univ Siena, Dept Econ & Stat, Siena, Italy; [Pin, Paolo] Bocconi Univ, IGIER, Milan, Italy; [Pin, Paolo] Bocconi Univ, BIDSA, Milan, Italy; [Razzolini, Tiziano] IZA, Bonn, Germany	University of Siena; Bocconi University; Bocconi University; IZA Institute Labor Economics	Pin, P (corresponding author), Univ Siena, Dept Econ & Stat, Siena, Italy.; Pin, P (corresponding author), Bocconi Univ, IGIER, Milan, Italy.; Pin, P (corresponding author), Bocconi Univ, BIDSA, Milan, Italy.	paolo.pin@unisi.it		Razzolini, Tiziano/0000-0002-9562-3627; Pin, Paolo/0000-0001-9907-4947; Muscillo, Alessio/0000-0002-2648-4272	Italian Ministry of Education Progetti di Rilevante Interesse Nazionale (PRIN) [2017ELHNNJ]	Italian Ministry of Education Progetti di Rilevante Interesse Nazionale (PRIN)(Ministry of Education, Universities and Research (MIUR))	We gratefully acknowledge funding from the Italian Ministry of Education Progetti di Rilevante Interesse Nazionale (PRIN) grant 2017ELHNNJ.	Anderson Roy M, 2020, LANCET; Belot M, 2020, 6 COUNTRY SURVEY COV; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Galea S., 2020, JAMA INTERNAL MED; Hale T., 2020, OXFORD COVID 19 GOVT; Jackson Matthew O, 2010, SOCIAL EC NETWORKS; Kang HY, 2017, PHYS LETT A, V381, P3945, DOI 10.1016/j.physleta.2017.09.040; Koo Joel R, 2020, LANCET; Lagorio C, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.026102; Li KZ, 2019, COMMUN NONLINEAR SCI, V66, P84, DOI 10.1016/j.cnsns.2018.06.020; Pastor-Satorras R, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066117; Pfefferbaum Betty, 2020, NEW ENGLAND J MED; Yu-Tao Xiang, 2020, JAMA PSYCHIAT	13	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0237057	10.1371/journal.pone.0237057	http://dx.doi.org/10.1371/journal.pone.0237057			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32916692	Green Published, Green Submitted, gold			2022-12-26	WOS:000571887500150
J	Dudel, C; Riffe, T; Acosta, E; van Raalte, A; Strozza, C; Myrskyla, M				Dudel, Christian; Riffe, Tim; Acosta, Enrique; van Raalte, Alyson; Strozza, Cosmo; Myrskyla, Mikko			Monitoring trends and differences in COVID-19 case-fatality rates using decomposition methods: Contributions of age structure and age-specific fatality	PLOS ONE			English	Article								The population-level case-fatality rate (CFR) associated with COVID-19 varies substantially, both across countries at any given time and within countries over time. We analyze the contribution of two key determinants of the variation in the observed CFR: the age-structure of diagnosed infection cases and age-specific case-fatality rates. We use data on diagnosed COVID-19 cases and death counts attributable to COVID-19 by age for China, Germany, Italy, South Korea, Spain, the United States, and New York City. We calculate the CFR for each population at the latest data point and also for Italy, Germany, Spain, and New York City over time. We use demographic decomposition to break the difference between CFRs into unique contributions arising from the age-structure of confirmed cases and the age-specific case-fatality. In late June 2020, CFRs varied from 2.2% in South Korea to 14.0% in Italy. The age-structure of detected cases often explains more than two-thirds of cross-country variation in the CFR. In Italy, the CFR increased from 4.2% to 14.0% between March 9 and June 30, 2020, and more than 90% of the change was due to increasing age-specific case-fatality rates. The importance of the age-structure of confirmed cases likely reflects several factors, including different testing regimes and differences in transmission trajectories; while increasing age-specific case-fatality rates in Italy could indicate other factors, such as the worsening health outcomes of those infected with COVID-19. Our findings lend support to recommendations for data to be disaggregated by age, and potentially other variables, to facilitate a better understanding of population-level differences in CFRs. They also show the need for well-designed seroprevalence studies to ascertain the extent to which differences in testing regimes drive differences in the age-structure of detected cases.	[Dudel, Christian; Riffe, Tim; Acosta, Enrique; van Raalte, Alyson; Myrskyla, Mikko] Max Planck Inst Demog Res, Rostock, Germany; [Strozza, Cosmo] Sapienza Univ Rome, Rome, Italy; [Strozza, Cosmo] Univ Southern Denmark, Interdisciplinary Ctr Populat Dynam, Odense, Denmark; [Myrskyla, Mikko] Univ Helsinki, Populat Res Unit, Helsinki, Finland	Max Planck Society; Sapienza University Rome; University of Southern Denmark; University of Helsinki	Dudel, C (corresponding author), Max Planck Inst Demog Res, Rostock, Germany.	dudel@demogr.mpg.de	van Raalte, Alyson/AHA-6190-2022; Acosta, Enrique/ABA-6537-2020	van Raalte, Alyson/0000-0002-0676-8921; Acosta, Enrique/0000-0001-6250-4018; Strozza, Cosmo/0000-0001-8825-2971; Riffe, Tim/0000-0002-2673-4622; Dudel, Christian/0000-0002-2985-6684; Reis, AlessanRSS/0000-0001-8486-7469	European Research Council [716323]; Social Sciences and Humanities Research Council; Fonds de recherche du Que'bec -Societeet culture	European Research Council(European Research Council (ERC)European Commission); Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC)); Fonds de recherche du Que'bec -Societeet culture	AvR received funding from the European Research Council (Grant #716323; https://erc.europa.eu/).EA was financially supported by the Social Sciences and Humanities Research Council (https://www.sshrc-crsh.gc.ca) and the Fonds de recherche du Que ' bec -Societeet culture (http://www.scientifique-en-chef.gouv.qc.ca/lescientifique-en-chef/les-fonds-de-recherche-du-quebec/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All other authors received no specific funding for this work.	Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Baud D, 2020, LANCET INFECT DIS, V20, P773, DOI 10.1016/S1473-3099(20)30195-X; Bayer C., 2020, CEPR DISCUSSION PAPE; Bergeron-Boucher MP, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16173093; Chen YY, 2012, J AFFECT DISORDERS, V136, P868, DOI 10.1016/j.jad.2011.09.019; Cohen J, 2020, SCIENCE, V367, P1287, DOI 10.1126/science.367.6484.1287; del Rio C, 2020, JAMA-J AM MED ASSOC, V323, P1339, DOI 10.1001/jama.2020.3072; Dowd JB, 2020, P NATL ACAD SCI USA, V117, P9696, DOI 10.1073/pnas.2004911117; Dykstra PA, 2018, INNOV AGING, V2, DOI 10.1093/geroni/igx032; Esteve A, 2020, P NATL ACAD SCI USA, V117, P16118, DOI 10.1073/pnas.2008764117; Ghio D., 2020, DEMOGRAPHIC ADJUSTME, DOI [10.1101/2020.03.23.20040998, DOI 10.1101/2020.03.23.20040998]; Horiuchi S, 2008, DEMOGRAPHY, V45, P785; Iacovou M, ISER WORKING PAPER S, V2010-10.; Kashnitsky I, 2020, WORLD DEV, V136, DOI 10.1016/j.worlddev.2020.105170; KITAGAWA EM, 1955, J AM STAT ASSOC, V50, P1168, DOI 10.2307/2281213; Lazzerini M, 2020, LANCET GLOB HEALTH, V8, pE641, DOI 10.1016/S2214-109X(20)30110-8; Leon DA, 2020, LANCET, V395, pE81, DOI 10.1016/S0140-6736(20)30933-8; Lipsitch M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003846; Nepomuceno MR, 2020, P NATL ACAD SCI USA, V117, P13881, DOI 10.1073/pnas.2008760117; Oltermann P, 2020, THE GUARDIAN    0322; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Priese A, 2020, EURONEWS; Rajgor DD, 2020, LANCET INFECT DIS, V20, P776, DOI 10.1016/S1473-3099(20)30244-9; Reher DS, 1998, POPUL DEV REV, V24, P203, DOI 10.2307/2807972; Riffe T, 2020, COVERAGE DB DATABASE; Rizzi S, 2015, AM J EPIDEMIOL, V182, P138, DOI 10.1093/aje/kwv020; Roser M, 2020, WHY DID RENEWABLES B; Vaillant L, 2009, EUROSURVEILLANCE, V14, P2; World Health Organization, 2020, POP BAS AG STRAT SER, DOI DOI 1278667/RETRIEVE; Wu JM, 2022, CRIT REV FOOD SCI, V62, P783, DOI [10.1080/10408398.2020.1828813, 10.1038/s41591-020-0822-7]; Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017	32	59	64	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238904	10.1371/journal.pone.0238904	http://dx.doi.org/10.1371/journal.pone.0238904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32913365	Green Submitted, Green Published, gold			2022-12-26	WOS:000571885900048
J	Zhang, QL; Cai, SW; Guo, LP; Zhao, GJ				Zhang, Qianlu; Cai, Shiwei; Guo, Liping; Zhao, Guojun			Propofol induces mitochondrial-associated protein LRPPRC and protects mitochondria against hypoxia in cardiac cells	PLOS ONE			English	Article							OXIDATIVE STRESS; LRP130; HYPERTROPHY; SLIRP	Background Hypoxia-induced oxidative stress is one of the main mechanisms of myocardial injury, which frequently results in cardiomyocyte death and precipitates life-threatening heart failure. Propofol (2,6-diisopropylphenol), which is used to sedate patients during surgery, was shown to strongly affect the regulation of physiological processes, including hypoxia-induced oxidative stress. However, the exact mechanism is still unclear. Methods Expression of LRPPRC, SLIRP, and Bcl-2 after propofol treatment was measured by RT-qPCR and western blot analyses. The effects of propofol under hypoxia were determine by assessing mitochondrial homeostasis and mitochondrial function, including the ATP level and mitochondrial mass. Autophagy/mitophagy was measured by detecting the presence of LC3B, and autophagosomes were observed by transmission microscopy Results Propofol treatment inhibited cleaved caspase-9 and caspase-3, indicating its inhibitory roles in mitochondrial-related apoptosis. Propofol treatment also transcriptionally activated LRPPRC, a mitochondrial-associated protein that exerts multiple functions by maintaining mitochondrial homeostasis, in a manner dependent on the presence of hypoxia-induced factor (HIF)-1 alpha transcriptional activity in H9C2 and primary rat cardiomyocytes. LRPPRC induced by propofol maintained the mitochondrial membrane potential (MMP) and promoted mitochondrial function, including ATP synthesis and transcriptional activity. Furthermore, LRPPRC induced by propofol contributes, at least partially, to the inhibition of apoptotic cell death induced by hypoxia. Conclusion Taken together, our results indicate that LRPPRC may have a protective antioxidant effect by maintaining mitochondrial homoeostasis induced by propofol and provide new insight into the protective mechanism of propofol against oxidative stress.	[Zhang, Qianlu] Univ South China, Dept Anesthesiol, Affiliated Hosp 1, Hengyang, Hunan, Peoples R China; [Cai, Shiwei] Univ South China, Cardiovasc Surg, Affiliated Hosp 1, Hengyang, Hunan, Peoples R China; [Guo, Liping; Zhao, Guojun] Guangzhou Med Univ, Qingyuan City Peoples Hosp, Affiliated Hosp 6, Qingyuan, Guangdong, Peoples R China	University of South China; University of South China; Guangzhou Medical University	Zhao, GJ (corresponding author), Guangzhou Med Univ, Qingyuan City Peoples Hosp, Affiliated Hosp 6, Qingyuan, Guangdong, Peoples R China.	zzhcsu@163.com			National Natural Science Foundation of China [81601103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by research grants from the National Natural Science Foundation of China [81601103].	[Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Bekeredjian R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011693; GHISO NS, 1994, IN VITRO CELL DEV-AN, V30A, P744, DOI 10.1007/BF02631295; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Hatchell EC, 2006, MOL CELL, V22, P657, DOI 10.1016/j.molcel.2006.05.024; Hoenig MR, 2008, CURR VASC PHARMACOL, V6, P292, DOI 10.2174/157016108785909779; Hsing CH, 2011, NEPHROL DIAL TRANSPL, V26, P1162, DOI 10.1093/ndt/gfq572; Huang MLH, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/6392763; Lagouge M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005423; Marik PE, 2005, PHARMACOTHERAPY, V25, p28S, DOI 10.1592/phco.2005.25.5_Part_2.28S; Michaud M, 2011, INT J ONCOL, V38, P169, DOI 10.3892/ijo_00000836; Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Spahr H, 2016, NUCLEIC ACIDS RES, V44, P6868, DOI 10.1093/nar/gkw575; Takimoto E, 2007, HYPERTENSION, V49, P241, DOI 10.1161/01.HYP.0000254415.31362.a7; Trisciuoglio D, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.357; Tsuchiya N, 2002, EUR J BIOCHEM, V269, P2927, DOI 10.1046/j.1432-1033.2002.02966.x; Xie CL, 2015, KOREAN J ANESTHESIOL, V68, P488, DOI 10.4097/kjae.2015.68.5.488; Yuan XY, 2018, ANESTH ANALG, V126, P308, DOI 10.1213/ANE.0000000000002288; Zheng GD, 2018, BRAZ J MED BIOL RES, V51, DOI [10.1590/1414-431x20187655, 10.1590/1414-431X20187655]; Zou J, 2013, BIOCHEM J, V454, P447, DOI 10.1042/BJ20130306; 2014, REG ANESTH PAIN MED, V9	25	6	7	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238857	10.1371/journal.pone.0238857	http://dx.doi.org/10.1371/journal.pone.0238857			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ6EE	32898195	gold, Green Published			2022-12-26	WOS:000570962500006
J	Roses, MM; Dalla Torre, EG				Roses, Mor M.; Dalla Torre, Emanuele G.			Dicke model	PLOS ONE			English	Review								TheDicke modelis a fundamental model of, which describes the interaction betweenand. In the Dicke model, thelightcomponent is described as a single quantum mode, while thematteris described as a set of. When the coupling between the light and matter crosses a critical value, the Dicke model shows a mean-fieldto a. This transition belongs to theand was realized experimentally inexperiments. Although the superradiant transition bears some analogy with theinstability, these two transitions belong to different universality classes.	[Roses, Mor M.; Dalla Torre, Emanuele G.] Bar Ilan Univ, Dept Phys, Ramat Gan, Israel	Bar Ilan University	Dalla Torre, EG (corresponding author), Bar Ilan Univ, Dept Phys, Ramat Gan, Israel.	emanuele.dalla-torre@biu.ac.il		Roses, Mor M./0000-0003-2637-1750	Israel Science Foundation [151/19, 154/19]	Israel Science Foundation(Israel Science Foundation)	This work is supported by the Israel Science Foundation, grants number 151/19 and 154/19.	Baumann K, 2010, NATURE, V464, P1301, DOI 10.1038/nature09009; Black AT, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.203001; DICKE RH, 1954, PHYS REV, V93, P99, DOI 10.1103/PhysRev.93.99; Dimer F, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.013804; Garraway BM, 2011, PHILOS T R SOC A, V369, P1137, DOI 10.1098/rsta.2010.0333; GROSS M, 1982, PHYS REP, V93, P301, DOI 10.1016/0370-1573(82)90102-8; HEPP K, 1973, ANN PHYS-NEW YORK, V76, P360, DOI 10.1016/0003-4916(73)90039-0; Kirton P, 2019, ADV QUANTUM TECHNOL, V2, DOI 10.1002/qute.201800043; Klinder J, 2015, P NATL ACAD SCI USA, V112, P3290, DOI 10.1073/pnas.1417132112; Kockum AF, 2019, NAT REV PHYS, V1, P19, DOI 10.1038/s42254-018-0006-2; Larson J, 2017, J PHYS A-MATH THEOR, V50, DOI 10.1088/1751-8121/aa65dc; Nagy D, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.130401; Ritsch H, 2013, REV MOD PHYS, V85, P553, DOI 10.1103/RevModPhys.85.553; Scully Marlan O, 1997, QUANTUM OPT, DOI [10.1017/CBO9780511813993, DOI 10.1017/CB09780511813993]; Zhang ZQ, 2018, PHYS REV A, V97, DOI 10.1103/PhysRevA.97.043858; Zhang ZQ, 2017, OPTICA, V4, P424, DOI 10.1364/OPTICA.4.000424	16	6	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0235197	10.1371/journal.pone.0235197	http://dx.doi.org/10.1371/journal.pone.0235197			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886669	Green Published, gold			2022-12-26	WOS:000571064300062
J	Cascio, A; Colomba, C; Di Carlo, P; Serra, N; Lo Re, G; Gambino, A; Lo Casto, A; Guglielmi, G; Veronese, N; Lagalla, R; Sergi, C				Cascio, Antonio; Colomba, Claudia; Di Carlo, Paola; Serra, Nicola; Lo Re, Giuseppe; Gambino, Angelo; Lo Casto, Antonio; Guglielmi, Giuseppe; Veronese, Nicola; Lagalla, Roberto; Sergi, Consolato			Low bone mineral density in HIV-positive young Italians and migrants	PLOS ONE			English	Article							PREVALENCE; OSTEOPOROSIS; POPULATION; RISK	Background Human immunodeficiency virus (HIV) infected individuals may have osteoporosis. We aimed to evaluate the bone mineral density (BMD) in naive antiretroviral (ARV) treated HIV positive patients comparing native Italian group (ItG) to a Migrants group (MiG) upon arrival in Italy. Methods We conducted a cross-sectional study on 83 HIV patients less than 50 years old. We used the dual-energy X-ray absorptiometry (DXA) within six months from the HIV diagnosis. Participants were categorized as having low BMD if the femoral neck or total lumbar spine Z-score was- 2 or less. Results MiG showed low BMD more often than ItG (37.5% vs.13.6%), especially for the female gender (16.7% vs. 0.0%). A low CD4 rate (<200 cells/mu l) was most often detected in MiG than ItG. In particular, we found most often male Italians with abnormal CD4 than male migrants (67.8% vs. 33.3%) and vice versa for females (30.5% vs. 66.7%). We found an abnormal bone mineral density at the lumbar site. Low BMD at the lumbar site was more frequently observed in female migrants than female Italians. Both male and female migrants had a Z-score value significantly lower than male and female Italians, respectively. By logistic regression low vitamin-D level was positively correlated to low BMD in ItG only. All data were verified and validated using a triple code identifier. Conclusions Both DXA and vitamin-D evaluation should be offered after the diagnosis of HIV infection. Lumbar site low BMD is an initial condition of bone loss in HIV young patients, especially in female migrants. Vitamin D levels and supplementation may be considered after HIV diagnosis independently of age to improve bone health.	[Cascio, Antonio; Colomba, Claudia; Di Carlo, Paola] Univ Hosp, Dept Hlth Promot & Child Hlth, Palermo, Italy; [Serra, Nicola] Univ Federico II Naples, Dept Mol Med & Med Biotechnol, Naples, Italy; [Lo Re, Giuseppe; Gambino, Angelo; Lagalla, Roberto] Univ Hosp Paolo Giaccone, Dept Biopathol & Biotechnol DiBiMed, Palermo, Italy; [Lo Casto, Antonio] Univ Palermo, Dept Biomed Neurosci & Adv Diagnost BIND, Palermo, Italy; [Guglielmi, Giuseppe] Univ Foggia, Dept Radiol, Foggia, Italy; [Guglielmi, Giuseppe] Sci Inst Casa Sollievo della Sofferenza Hosp, Dept Radiol, Foggia, Italy; [Veronese, Nicola] CNR, Neurosci Inst, Aging Branch, Padua, Italy; [Sergi, Consolato] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Sergi, Consolato] Stollery Childrens Hosp, Edmonton, AB, Canada	University of Naples Federico II; University of Palermo; Policlinico Paolo Giaccone; University of Palermo; University of Foggia; IRCCS Casa Sollievo Della Sofferenza; Consiglio Nazionale delle Ricerche (CNR); University of Alberta; Stollery Children's Hospital	Sergi, C (corresponding author), Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada.; Sergi, C (corresponding author), Stollery Childrens Hosp, Edmonton, AB, Canada.	sergi@ualberta.ca	Di Carlo, Paola/S-2456-2017; Veronese, Nicola/K-4343-2018; Sergi, Consolato/A-1126-2009	Di Carlo, Paola/0000-0003-4418-5855; Veronese, Nicola/0000-0002-9328-289X; 	University of Palermo, Italy [D40001D05-0002]	University of Palermo, Italy	This study was funded by an intramural grant of the University of Palermo, Italy (Grant ID #: D40001D05-0002).	[Anonymous], 2013, J NUTRITIONAL SCI VI, V59, pSl; Atteritano M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010119; Bailey JF, 2016, J ANAT, V229, P82, DOI 10.1111/joa.12451; Brunner J, 2011, KLIN PADIATR, V223, P246, DOI 10.1055/s-0030-1270514; Camoni L, 2015, AIDS RES HUM RETROV, V31, P282, DOI [10.1089/aid.2014.0154, 10.1089/AID.2014.0154]; Cavalli L, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1248-8; Chantler S, 2012, OSTEOPOROSIS INT, V23, P533, DOI 10.1007/s00198-011-1570-9; Chisati EM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227893; Messina OD, 2019, AGING CLIN EXP RES, V31, P807, DOI 10.1007/s40520-019-01191-w; Demeke T, 2019, SCAND J PRIM HEALTH, V37, P174, DOI 10.1080/02813432.2019.1608043; Denova-Gutierrez E, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121922; Di Carlo P, 2016, PATIENT PREFER ADHER, V10, DOI 10.2147/PPA.S90456; Goh SSL, 2018, OSTEOPOROSIS INT, V29, P1683, DOI 10.1007/s00198-018-4379-y; Greig JM, 2014, CURR OPIN INFECT DIS, V27, P46, DOI 10.1097/QCO.0000000000000033; Klemm P, 2020, J BONE MINER METAB, V38, P378, DOI 10.1007/s00774-019-01070-4; Knappe F, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16203904; Kyvernitakis I, 2018, OSTEOPOROSIS INT, V29, P135, DOI 10.1007/s00198-017-4239-1; Maggiorella MT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59084-2; Mgodi NM, 2015, ARCH OSTEOPOROS, V10, DOI 10.1007/s11657-015-0206-7; Mirza FS, 2018, J ENDOCRINOL INVEST, V41, P881, DOI 10.1007/s40618-017-0812-x; Petta S, 2012, ANTIVIR THER, V17, P823, DOI 10.3851/IMP2100; Prinapori R, 2013, NEW MICROBIOL, V36, P345; Sergi C, 2001, ARCH PEDIAT ADOL MED, V155, P967, DOI 10.1001/archpedi.155.8.967; Sergi C., 2001, Pathologica (Genoa), V93, P201; Sergi C, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00093; Serra N, 2017, PHARM ONLINE, V1, P51; Shafran SD, 2019, HIV MED, V20, P1, DOI 10.1111/hiv.12755; STRAND MM, 1979, AM STAT, V33, P81, DOI 10.2307/2683226; Tomazic J, 2007, WIEN KLIN WOCHENSCHR, V119, P639, DOI 10.1007/s00508-007-0844-x; Varenna M, 2003, OSTEOPOROSIS INT, V14, P734, DOI 10.1007/s00198-003-1438-8; Vecchi V. Li, 2015, Journal of AIDS and Clinical Research, V6, P438; Vecchi VL, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-192; WHO, 2016, STRAT ACT PLAN REF M; WHO, 1994, ASS FRACT RISK ITS; Wimalawansa SJ, 2018, J STEROID BIOCHEM, V180, P4, DOI 10.1016/j.jsbmb.2017.12.009; World Health Organization, 2004, SEL PRACT REC CONTR, P1; Zhang MY, 2016, NUTRIENTS, V8, DOI 10.3390/nu8110722	37	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0237984	10.1371/journal.pone.0237984	http://dx.doi.org/10.1371/journal.pone.0237984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881882	Green Published, gold			2022-12-26	WOS:000571063300059
J	Azad, AK; Zhabyeyev, P; Vanhaesebroeck, B; Eitzen, G; Oudit, GY; Moore, RB; Murray, AG				Azad, Abul K.; Zhabyeyev, Pavel; Vanhaesebroeck, Bart; Eitzen, Gary; Oudit, Gavin Y.; Moore, Ronald B.; Murray, Allan G.			Inactivation of endothelial cell phosphoinositide 3-kinase beta inhibits tumor angiogenesis and tumor growth	ONCOGENE			English	Article							ANTIANGIOGENIC AGENT SUNITINIB; VASCULAR DEVELOPMENT; MEDIATES RESISTANCE; P110-ALPHA ISOFORM; THERAPY; CARCINOMA; PATHWAY; OXYGENATION; METASTASIS; EXPRESSION	Angiogenesis inhibitors, such as the receptor tyrosine kinase (RTK) inhibitor sunitinib, target vascular endothelial growth factor (VEGF) signaling in cancers. However, only a fraction of patients respond, and most ultimately develop resistance to current angiogenesis inhibitor therapies. Activity of alternative pro-angiogenic growth factors, acting via RTK or G-protein coupled receptors (GPCR), may mediate VEGF inhibitor resistance. The phosphoinositide 3-kinase (PI3K)beta isoform is uniquely coupled to both RTK and GPCRs. We investigated the role of endothelial cell (EC) PI3K beta in tumor angiogenesis. Pro-angiogenic GPCR ligands were expressed by patient-derived renal cell carcinomas (PD-RCC), and selective inactivation of PI3K beta reduced PD-RCC-stimulated EC spheroid sprouting. EC-specific PI3K beta knockout (Epsilon C-beta KO) in mice potentiated the sunitinib-induced reduction in subcutaneous growth of LLC1 and B16F10, and lung metastasis of B16F10 tumors. Compared to single-agent sunitinib treatment, tumors in sunitinib-treated Epsilon C-beta KO mice showed a marked decrease in microvessel density, and reduced new vessel formation. The fraction of perfused mature tumor microvessels was increased in Epsilon C-beta KO mice suggesting immature microvessels were most sensitive to combined sunitinib and PI3K beta inactivation. Taken together, EC PI3K beta inactivation with sunitinib inhibition reduces microvessel turnover and decreases heterogeneity of the tumor microenvironment, hence PI3K beta inhibition may be a useful adjuvant antiangiogenesis therapy with sunitinib.	[Azad, Abul K.; Zhabyeyev, Pavel; Oudit, Gavin Y.; Murray, Allan G.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Zhabyeyev, Pavel; Oudit, Gavin Y.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Vanhaesebroeck, Bart] UCL, UCL Canc Inst, London, England; [Eitzen, Gary] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada; [Moore, Ronald B.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of London; University College London; University of Alberta; University of Alberta	Murray, AG (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.	allan.murray@ualberta.ca	Moore, Ronald Brian/AET-3015-2022		Translational Research Fellowship award from the Department of Medicine at the University of Alberta; Canadian Cancer Society Research Institute	Translational Research Fellowship award from the Department of Medicine at the University of Alberta; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	AKA was supported by a Translational Research Fellowship award from the Department of Medicine at the University of Alberta. Operating funding was provided by the Canadian Cancer Society Research Institute to AGM. The authors acknowledge the technical assistance of Jessica DesAulniers.	Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549; Ackah E, 2005, J CLIN INVEST, V115, P2119, DOI 10.1172/JCI24726; Nieto MA, 2017, NAT CELL BIOL, V19, P416, DOI 10.1038/ncb3520; Bergerot P, 2019, MOL CANCER THER, V18, P2185, DOI 10.1158/1535-7163.MCT-18-1399; Bilanges B, 2019, NAT REV MOL CELL BIO, V20, P515, DOI 10.1038/s41580-019-0129-z; Brabletz T, 2018, NAT REV CANCER, V18, P128, DOI 10.1038/nrc.2017.118; Bridgeman VL, 2017, J PATHOL, V241, P362, DOI 10.1002/path.4845; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Charo DN, 2009, AM J PHYSIOL-HEART C, V297, pH1904, DOI 10.1152/ajpheart.00686.2009; Choueiri TK, 2017, NEW ENGL J MED, V376, P354, DOI 10.1056/NEJMra1601333; de Palma M, 2017, NAT REV CANCER, V17, P457, DOI 10.1038/nrc.2017.51; del Toro R, 2010, BLOOD, V116, P4025, DOI 10.1182/blood-2010-02-270819; Ebos JML, 2007, P NATL ACAD SCI USA, V104, P17069, DOI 10.1073/pnas.0708148104; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Gougis P, 2017, CRIT REV ONCOL HEMAT, V119, P75, DOI 10.1016/j.critrevonc.2017.08.010; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Grepin R, 2012, ONCOGENE, V31, P1683, DOI 10.1038/onc.2011.360; Grepin R, 2014, CANCER RES, V74, P873, DOI 10.1158/0008-5472.CAN-13-1267; Grunstein J, 1999, CANCER RES, V59, P1592; Haddad G, 2014, BLOOD, V124, P2142, DOI 10.1182/blood-2014-02-557975; Hamada K, 2005, GENE DEV, V19, P2054, DOI 10.1101/gad.1308805; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang D, 2010, CANCER RES, V70, P1063, DOI 10.1158/0008-5472.CAN-09-3965; Huang JH, 2002, J BIOL CHEM, V277, P10760, DOI 10.1074/jbc.M110219200; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jahangiri A, 2013, CLIN CANCER RES, V19, P1773, DOI 10.1158/1078-0432.CCR-12-1281; Jimenez-Valerio G, 2016, CURR DRUG TARGETS, V17, P1728, DOI 10.2174/1389450117666160301101425; Kasai A, 2008, ARTERIOSCL THROM VAS, V28, P1717, DOI 10.1161/ATVBAHA.108.163402; Kryczek I, 2005, CANCER RES, V65, P465; Lyons YA, 2017, ONCOTARGET, V8, P96496, DOI [10.19632/oncotarget.20410, 10.18632/oncotarget.20410]; Ma Shaolin, 2018, F1000Res, V7, P326, DOI 10.12688/f1000research.11771.1; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Mastrella G, 2019, CANCER RES, V79, P2298, DOI 10.1158/0008-5472.CAN-18-0881; Mateo J, 2017, CLIN CANCER RES, V23, P5981, DOI 10.1158/1078-0432.CCR-17-0725; Matsumoto S, 2011, CANCER RES, V71, P6350, DOI 10.1158/0008-5472.CAN-11-2025; McDermott DF, 2018, NAT MED, V24, P749, DOI 10.1038/s41591-018-0053-3; Nowak-Sliwinska P, 2018, ANGIOGENESIS, V21, P425, DOI 10.1007/s10456-018-9613-x; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Phung TL, 2006, CANCER CELL, V10, P159, DOI 10.1016/j.ccr.2006.07.003; Seaman S, 2007, CANCER CELL, V11, P539, DOI 10.1016/j.ccr.2007.04.017; Sennino B, 2012, NAT REV CANCER, V12, P699, DOI 10.1038/nrc3366; Shojaei F, 2010, CANCER RES, V70, P10090, DOI 10.1158/0008-5472.CAN-10-0489; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Soler A, 2013, J EXP MED, V210, P1937, DOI 10.1084/jem.20121571; Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445; Strasser GA, 2010, BLOOD, V115, P5102, DOI 10.1182/blood-2009-07-230284; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Terry S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103044; Thomas JS, 2015, CRIT REV ONCOL HEMAT, V96, P527, DOI 10.1016/j.critrevonc.2015.07.009; Vanhaesebroeck B, 2016, J MOL MED, V94, P5, DOI 10.1007/s00109-015-1352-5; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Yuan F, 1996, P NATL ACAD SCI USA, V93, P14765, DOI 10.1073/pnas.93.25.14765; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244; Zhou L, 2016, ONCOGENE, V35, P2687, DOI 10.1038/onc.2015.343	57	8	8	1	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 8	2020	39	41					6480	6492		10.1038/s41388-020-01444-3	http://dx.doi.org/10.1038/s41388-020-01444-3		SEP 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	OA1JL	32879446	Green Submitted			2022-12-26	WOS:000565482600001
J	Mascuch, SJ; Fakhretaha-Aval, S; Bowman, JC; Ma, MTH; Thomas, G; Bommarius, B; Ito, C; Zhao, LJ; Newnam, GP; Matange, KR; Thapa, HR; Barlow, B; Donegan, RK; Nguyen, NA; Saccuzzo, EG; Obianyor, CT; Karunakaran, SC; Pollet, P; Rothschild-Mancinelli, B; Mestre-Fos, S; Guth-Metzler, R; Bryksin, AV; Petrov, AS; Hazell, M; Ibberson, CB; Penev, PI; Mannino, RG; Lam, WA; Garcia, AJ; Kubanek, J; Agarwal, V; Hud, NV; Glass, JB; Williams, LD; Lieberman, RL				Mascuch, Samantha J.; Fakhretaha-Aval, Sara; Bowman, Jessica C.; Ma, Minh Thu H.; Thomas, Gwendell; Bommarius, Bettina; Ito, Chieri; Zhao, Liangjun; Newnam, Gary P.; Matange, Kavita R.; Thapa, Hem R.; Barlow, Brett; Donegan, Rebecca K.; Nguyen, Nguyet A.; Saccuzzo, Emily G.; Obianyor, Chiamaka T.; Karunakaran, Suneesh C.; Pollet, Pamela; Rothschild-Mancinelli, Brooke; Mestre-Fos, Santi; Guth-Metzler, Rebecca; Bryksin, Anton V.; Petrov, Anton S.; Hazell, Mallory; Ibberson, Carolyn B.; Penev, Petar I.; Mannino, Robert G.; Lam, Wilbur A.; Garcia, Andres J.; Kubanek, Julia; Agarwal, Vinayak; Hud, Nicholas V.; Glass, Jennifer B.; Williams, Loren Dean; Lieberman, Raquel L.			A blueprint for academic laboratories to produce SARS-CoV-2 quantitative RT-PCR test kits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						reverse transcriptase; ribonuclease inhibitor; DNA polymerase; virus; formulation; SARS-CoV-2; reverse transcription; polymerase chain reaction (PCR); infectious disease; protein purification; RNA; coronavirus; RT-qPCR	REVERSE-TRANSCRIPTASE; RIBONUCLEASE INHIBITOR; PURIFICATION; PERFORMANCE	Widespread testing for the presence of the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals remains vital for controlling the COVID-19 pandemic prior to the advent of an effective treatment. Challenges in testing can be traced to an initial shortage of supplies, expertise, and/or instrumentation necessary to detect the virus by quantitative RT-PCR (RT-qPCR), the most robust, sensitive, and specific assay currently available. Here we show that academic biochemistry and molecular biology laboratories equipped with appropriate expertise and infrastructure can replicate commercially available SARS-CoV-2 RT-qPCR test kits and backfill pipeline shortages. The Georgia Tech COVID-19 Test Kit Support Group, composed of faculty, staff, and trainees across the biotechnology quad at Georgia Institute of Technology, synthesized multiplexed primers and probes and formulated a master mix composed of enzymes and proteins produced in-house. Our in-house kit compares favorably with a commercial product used for diagnostic testing. We also developed an environmental testing protocol to readily monitor surfaces for the presence of SARS-CoV-2. Our blueprint should be readily reproducible by research teams at other institutions, and our protocols may be modified and adapted to enable SARS-CoV-2 detection in more resource-limited settings.	[Mascuch, Samantha J.; Ibberson, Carolyn B.; Penev, Petar I.; Agarwal, Vinayak] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Fakhretaha-Aval, Sara; Bowman, Jessica C.; Ma, Minh Thu H.; Thomas, Gwendell; Ito, Chieri; Zhao, Liangjun; Newnam, Gary P.; Matange, Kavita R.; Thapa, Hem R.; Barlow, Brett; Donegan, Rebecca K.; Nguyen, Nguyet A.; Saccuzzo, Emily G.; Karunakaran, Suneesh C.; Pollet, Pamela; Rothschild-Mancinelli, Brooke; Mestre-Fos, Santi; Guth-Metzler, Rebecca; Petrov, Anton S.; Hazell, Mallory; Kubanek, Julia; Agarwal, Vinayak; Hud, Nicholas V.; Williams, Loren Dean; Lieberman, Raquel L.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Bowman, Jessica C.; Bommarius, Bettina; Zhao, Liangjun; Bryksin, Anton V.; Garcia, Andres J.; Kubanek, Julia; Agarwal, Vinayak; Hud, Nicholas V.; Glass, Jennifer B.; Williams, Loren Dean; Lieberman, Raquel L.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Bommarius, Bettina; Obianyor, Chiamaka T.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Lam, Wilbur A.] Georgia Inst Technol, Inst Elect & Nanotechnol, Atlanta, GA 30332 USA; [Garcia, Andres J.] Georgia Inst Technol, Sch Mech Engn, Atlanta, GA 30332 USA; [Glass, Jennifer B.] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Mannino, Robert G.; Lam, Wilbur A.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Mannino, Robert G.; Lam, Wilbur A.] Emory Univ, Atlanta, GA 30322 USA; [Lam, Wilbur A.] Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA USA; [Lam, Wilbur A.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Emory University; Children's Healthcare of Atlanta (CHOA); Emory University	Williams, LD; Lieberman, RL (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.; Glass, JB; Williams, LD; Lieberman, RL (corresponding author), Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.; Glass, JB (corresponding author), Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA.	covid-test-support@gatech.edu	Mestre, Santi/AAD-5171-2021; Guth-Metzler, Rebecca/GWQ-5211-2022	Thomas, Gwendell/0000-0002-2079-8668; Bommarius, Bettina/0000-0002-1283-0218; Mascuch, Samantha/0000-0002-8906-3213; Guth-Metzler, Rebecca/0000-0002-6639-4423; Fakhretaha-Aval, Sara/0000-0002-1901-8820; Ma, Minh Thu/0000-0002-5403-8464; Penev, Petar/0000-0002-9027-3824; Matange, Kavita/0000-0001-5808-7477; Bowman, Jessica/0000-0002-6219-2680; Zhao, Liangjun/0000-0002-0792-1473	State of Georgia COVID-19 Testing Task Force Method Development and Supply Chain Stabilization Studies Proposal (COVID-19 Tech Support Group); Georgia Institute of Technology; NASA [80NSSC18K1139, 80NSSC19K0477]; National Institutes of Health [U54EB027690]	State of Georgia COVID-19 Testing Task Force Method Development and Supply Chain Stabilization Studies Proposal (COVID-19 Tech Support Group); Georgia Institute of Technology; NASA(National Aeronautics & Space Administration (NASA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the State of Georgia COVID-19 Testing Task Force Method Development and Supply Chain Stabilization Studies Proposal (COVID-19 Tech Support Group) and Georgia Institute of Technology. This work was also supported in part by NASA Grants 80NSSC18K1139 and 80NSSC19K0477. R. G. M. and W. A. M. were supported by National Institutes of Health Grant U54EB027690. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amen AM, 2020, NAT BIOTECHNOL, V38, P791, DOI 10.1038/s41587-020-0583-3; ARAKAWA T, 1985, BIOPHYS J, V47, P411, DOI 10.1016/S0006-3495(85)83932-1; Arezi B, 2009, NUCLEIC ACIDS RES, V37, P473, DOI 10.1093/nar/gkn952; Arumugam A., 2020, POTENTIAL USE UNPROC, DOI [10.1101/2020.04.06.028811, DOI 10.1101/2020.04.06.028811]; BACHMANN B, 1990, NUCLEIC ACIDS RES, V18, P1309, DOI 10.1093/nar/18.5.1309; Beltran-Pavez C., 2020, J VIROL METHODS; Bhadra S., 2020, BIORXIV, DOI [10.1101/2020.03.29/013342, DOI 10.1101/2020.03.29/013342]; Bhadra S., 2020, BIORXIV, DOI [10.1101/2020.05.27.120238, DOI 10.1101/2020.05.27.120238]; BLACKBURN P, 1979, J BIOL CHEM, V254, P2484; Bloom Joshua S, 2021, medRxiv, DOI 10.1101/2020.08.04.20167874; CHOU Q, 1992, NUCLEIC ACIDS RES, V20, P1717, DOI 10.1093/nar/20.7.1717; Das D, 2004, STRUCTURE, V12, P819, DOI 10.1016/j.str.2004.02.032; Davalieva K, 2009, Prilozi, V30, P57; DESAI UJ, 1995, BIOTECHNIQUES, V19, P780; Ellefson JW, 2016, SCIENCE, V352, P1590, DOI 10.1126/science.aaf5409; ENGELKE DR, 1990, ANAL BIOCHEM, V191, P396, DOI 10.1016/0003-2697(90)90238-5; Esbin MN, 2020, RNA, V26, P771, DOI 10.1261/rna.076232.120; Farell Eric M, 2012, BMC Res Notes, V5, P257, DOI 10.1186/1756-0500-5-257; Graham T. G. W., 2020, BEARMIX VERSION 2 BA; Green Michael R, 2018, Cold Spring Harb Protoc, V2018, DOI 10.1101/pdb.prot095125; Guo WH, 2011, PROTEIN EXPRES PURIF, V77, P185, DOI 10.1016/j.pep.2011.01.015; Hill SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130888; HOFSTEENGE J, 1988, BIOCHEMISTRY-US, V27, P8537, DOI 10.1021/bi00423a006; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; HUFF JW, 1964, BIOCHEMISTRY-US, V3, P501, DOI 10.1021/bi00892a006; Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3; Klink TA, 2001, PROTEIN EXPRES PURIF, V22, P174, DOI 10.1006/prep.2001.1422; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; Kuusela S, 1998, NUCLEOS NUCLEOT NUCL, V17, P2417, DOI 10.1080/07328319808004328; Lopez G., 2020, VOX 0501; Lu XY, 2020, EMERG INFECT DIS, V26, P1654, DOI 10.3201/eid2608.201246; Madrigal Alexis C., 2020, THE ATLANTIC 0321; Mann CCD, 2019, CELL REP, V27, P1165, DOI 10.1016/j.celrep.2019.03.098; Moore C, 2008, J VIROL METHODS, V153, P84, DOI 10.1016/j.jviromet.2008.08.001; Nagai M, 1998, BIOCHEM MOL BIOL INT, V44, P157; Park GW, 2017, JOVE-J VIS EXP, DOI 10.3791/55205; Patel R, 2020, MBIO, V11, DOI 10.1128/mBio.00722-20; Roux Kenneth H, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.ip66; SELLNER LN, 1992, NUCLEIC ACIDS RES, V20, P1487, DOI 10.1093/nar/20.7.1487; Siurkus J, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-65; Siurkus J, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-31; Smyrlaki I., 2020, MASSIVE RAPID COVID, DOI [10.1101/2020.04.17.20067348, DOI 10.1101/2020.04.17.20067348]; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Thapa HR, 2020, ACS CHEM BIOL, V15, P1662, DOI 10.1021/acschembio.0c00299; United States Centers for Disease Control, 2020, CDC00600019 US CDC; United States Food and Drug Administration, 2020, OPTI SARS COV 2 RT P; Wang Y, 2004, NUCLEIC ACIDS RES, V32, P1197, DOI 10.1093/nar/gkh271; Willman D., 2020, WASH POST; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Yeung AT, 2004, BIOTECHNIQUES, V36, P266, DOI 10.2144/04362RR01; Zeng FL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20169-8; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	54	9	9	0	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2020	295	46					15438	15453		10.1074/jbc.RA120.015434	http://dx.doi.org/10.1074/jbc.RA120.015434			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OY6NO	32883809	Green Published, hybrid			2022-12-26	WOS:000594361600002
J	Yang, WB; Yaggie, RE; Schaeffer, AJ; Klumpp, DJ				Yang, Wenbin; Yaggie, Ryan E.; Schaeffer, Anthony J.; Klumpp, David J.			AOAH remodels arachidonic acid-containing phospholipid pools in a model of interstitial cystitis pain: A MAPP Network study	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; MEMBRANE-LIPIDS; PELVIC PAIN; METABOLISM; GENE; CRF; IDENTIFICATION; DEPRESSION; INHIBITORS; MICROGLIA	Interstitial cystitis/bladder pain syndrome (IC) is a debilitating condition of chronic pelvic pain with unknown etiology. Recently, we used a genetic approach in a murine model of IC to identify the lipase acyloxyacyl hydrolase (AOAH) as a modulator of pelvic pain. We found that AOAH-deficient mice have elevated pelvic pain responses, and AOAH immunoreactivity was detected along the bladder-brain axis. Lipidomic analyses identified arachidonic acid (AA) and its metabolite PGE(2)as significantly elevated in the sacral spinal cord of AOAH-deficient mice, suggesting AA is a substrate for AOAH. Here, we quantified the effects of AOAH on phospholipids containing AA. Spinal cord lipidomics revealed increased AA-containing phosphatidylcholine in AOAH-deficient mice and concomitantly decreased AA-phosphatidylethanolamine, consistent with decreased CoA-independent transferase activity (CoIT). Overexpression of AOAH in cell cultures similarly altered distribution of AA in phospholipid pools, promoted AA incorporation, and resulted in decreased membrane fluidity. Finally, administration of a PGE(2)receptor antagonist reduced pelvic pain in AOAH-deficient mice. Together, these findings suggest that AOAH represents a potential CoA-independent AA transferase that modulates CNS pain pathways at the level of phospholipid metabolism.	[Yang, Wenbin; Yaggie, Ryan E.; Schaeffer, Anthony J.; Klumpp, David J.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Klumpp, David J.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Klumpp, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA.; Klumpp, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA.	d-klumpp@northwestern.edu			NIH/NIDDK, National Institute of Diabetes and Digestive and Kidney and Diseases [R01 DK103769, U01 DK82342]; National Institute of Diabetes and Digestive and Kidney Diseases [U01 DK82342]	NIH/NIDDK, National Institute of Diabetes and Digestive and Kidney and Diseases; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge support from NIH/NIDDK, National Institute of Diabetes and Digestive and Kidney and Diseases, https://www.niddk.nih.gov (R01 DK103769 to D.J.K.; U01 DK82342 to D.J.K.; U01 DK82342 to A.J.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A.J.S. U01 DK82342 National Institute of Diabetes and Digestive and Kidney Diseases https://www.niddk.nih.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiniga LM, 2019, AM J PHYSIOL-REG I, V317, pR289, DOI 10.1152/ajpregu.00029.2019; [Anonymous], 2018, AM J PHYSL CELL PHYS, V314, pC404; ARATO M, 1989, BIOL PSYCHIAT, V25, P355, DOI 10.1016/0006-3223(89)90183-2; Astudillo AM, 2011, J BIOL CHEM, V286, P35299, DOI 10.1074/jbc.M111.277137; Bar KJ, 2004, J NEUROSCI, V24, P642, DOI 10.1523/JNEUROSCI.0882-03.2004; Barnes KC, 2006, J ALLERGY CLIN IMMUN, V118, P70, DOI 10.1016/j.jaci.2006.03.036; BERNARDINI R, 1989, NEUROENDOCRINOLOGY, V50, P708, DOI 10.1159/000125303; Berry SH, 2011, J UROLOGY, V186, P540, DOI 10.1016/j.juro.2011.03.132; Binder EB, 2010, MOL PSYCHIATR, V15, P574, DOI 10.1038/mp.2009.141; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blumenthal D, 2015, SCI REP-UK, V5, DOI 10.1038/srep11655; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; CAMBRONERO JC, 1992, J NEUROIMMUNOL, V39, P57, DOI 10.1016/0165-5728(92)90174-J; Cao PP, 2019, ANN ALLERG ASTHMA IM, V122, P33, DOI 10.1016/j.anai.2018.10.014; Chen G, 2018, NEURON, V100, P1292, DOI 10.1016/j.neuron.2018.11.009; Clemens JQ, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-57; Elliott E, 2010, NAT NEUROSCI, V13, P1351, DOI 10.1038/nn.2642; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Gamper M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-199; Harrison M, 2013, NEUROIMAGE, V68, P22, DOI 10.1016/j.neuroimage.2012.11.048; Ivanova PT, 2007, METHOD ENZYMOL, V432, P21, DOI 10.1016/S0076-6879(07)32002-8; Johnson SA, 2006, BEHAV BRAIN RES, V168, P280, DOI 10.1016/j.bbr.2005.11.019; Katafuchi T, 1997, J AUTONOM NERV SYST, V67, P200, DOI 10.1016/S0165-1838(97)00115-X; Kawahara K, 2015, BBA-MOL CELL BIOL L, V1851, P414, DOI 10.1016/j.bbalip.2014.07.008; Lai H, 2015, UROLOGY, V85, P1454, DOI 10.1016/j.urology.2015.03.007; Landis JR, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-58; Lee AS, 2013, GENE, V527, P440, DOI 10.1016/j.gene.2013.05.069; Leslie CC, 2004, BIOCHEM CELL BIOL, V82, P1, DOI 10.1139/o03-080; Lu MF, 2003, J EXP MED, V197, P1745, DOI 10.1084/jem.20030420; Machado-Carvalho L, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0100-7; Monjazeb AM, 2005, PROSTAG LEUKOTR ESS, V73, P463, DOI 10.1016/j.plefa.2005.07.009; MUNFORD RS, 1992, J BIOL CHEM, V267, P10116; MUNFORD RS, 1995, J LIPID RES, V36, P1653; Nakayama Y, 2004, BRAIN RES, V1010, P62, DOI 10.1016/j.brainres.2004.03.002; NEMEROFF CB, 1984, SCIENCE, V226, P1342, DOI 10.1126/science.6334362; Nenninger A, 2014, MOL MICROBIOL, V92, P1142, DOI 10.1111/mmi.12619; Noutsi P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158313; ORTH DN, 1983, J CLIN INVEST, V71, P587, DOI 10.1172/JCI110804; Palazzo E, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-82; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; Rudick CN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002096; Rudick Charles N, 2009, BMC Urol, V9, P16, DOI 10.1186/1471-2490-9-16; Sacerdoti D, 2015, PROSTAG OTH LIPID M, V120, P80, DOI 10.1016/j.prostaglandins.2015.05.008; Sarcina M, 2003, FEBS LETT, V553, P295, DOI 10.1016/S0014-5793(03)01031-7; Shindou H, 2013, J BIOCHEM, V154, P21, DOI 10.1093/jb/mvt048; Sonnweber T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113285; STAAB JF, 1994, J BIOL CHEM, V269, P23736; Thion MS, 2018, CELL, V172, P500, DOI 10.1016/j.cell.2017.11.042; Tillman TS, 2003, CELL BIOCHEM BIOPHYS, V38, P161, DOI 10.1385/CBB:38:2:161; Wada N, 2013, INT J UROL, V20, P235, DOI 10.1111/j.1442-2042.2012.03126.x; Wang LY, 2012, CIRC-CARDIOVASC GENE, V5, P234, DOI 10.1161/CIRCGENETICS.111.961763; Wang SS, 2008, MOL PSYCHIATR, V13, P786, DOI 10.1038/mp.2008.38; WINKLER JD, 1995, J PHARMACOL EXP THER, V274, P1338; Yamashita A, 2014, PROG LIPID RES, V53, P18, DOI 10.1016/j.plipres.2013.10.001; Yang WB, 2018, AM J PHYSIOL-RENAL, V315, pF36, DOI 10.1152/ajprenal.00075.2017; Yang WB, 2012, AM J PHYSIOL-RENAL, V303, pF350, DOI 10.1152/ajprenal.00077.2012; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039247	57	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0235384	10.1371/journal.pone.0235384	http://dx.doi.org/10.1371/journal.pone.0235384			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925915	gold, Green Published			2022-12-26	WOS:000572318000038
J	Kurano, M; Tsukamoto, K; Hara, M; Tsuneyama, K; Nishikawa, T; Ikeda, H; Yatomi, Y				Kurano, Makoto; Tsukamoto, Kazuhisa; Hara, Masumi; Tsuneyama, Koichi; Nishikawa, Takako; Ikeda, Hitoshi; Yatomi, Yutaka			Modulation of sphingosine 1-phosphate by hepatobiliary cholesterol handling	FASEB JOURNAL			English	Article						Niemann-Pick C1-like 1 protein; hepatobiliary cholesterol handling; sphingosine 1-phosphate; apolipoprotein M; ceramides; glycero-lysophospholipids; ABCG5; 8	M GENE-EXPRESSION; IN-VIVO; SPHINGOSINE-1-PHOSPHATE; RECEPTOR; LIVER; OVEREXPRESSION; SECRETION; NPC1L1; MICE; SPHINGOLIPIDS	Hepatobiliary cholesterol handling, mediated by Niemann-Pick C1-like 1 protein (NPC1L1) and ABCG5/8, is well-known to contribute to the homeostasis of cholesterol. We attempted to elucidate the impact of hepatobiliary cholesterol handling on the homeostasis of sphingolipids and lysophospholipids, especially sphingosine 1-phosphate (S1P). We induced the overexpression of NPC1L1 or ABCG5/8 in the mouse liver. Hepatic NPC1L1 overexpression increased the plasma and hepatic S1P levels, while it decreased the biliary S1P levels, and all of these changes were inhibited by ezetimibe. The ability of HDL to activate Akt in the endothelial cells was augmented by hepatic NPC1L1 overexpression. NPC1L1-mediated S1P transport was confirmed by both in vitro and in vivo studies conducted using C(17)S1P, an exogenous S1P analog. Upregulation of apolipoprotein M (apoM) was involved in these modulations, although apoM was not necessary for these modulations. Moreover, the increase in the plasma S1P levels also observed in ABCG5/8-overexpressing mice was dependent on the elevation of the plasma apoM levels. In regard to other sphingolipids and lysophospholipids, ceramides were similarly modulated by NPC1L1 to S1P, while other lipids were differently influenced by NPC1L1 or ABCG5/8 from S1P. Hepatobiliary cholesterol handling might also regulate the functional lipids, such as S1P.	[Kurano, Makoto; Nishikawa, Takako; Ikeda, Hitoshi; Yatomi, Yutaka] Univ Tokyo, Dept Clin Lab Med, Tokyo, Japan; [Tsukamoto, Kazuhisa] Teikyo Univ, Dept Internal Med, Sch Med, Tokyo, Japan; [Hara, Masumi] Teikyo Univ, Mizonokuchi Hosp, Dept Med 4, Sch Med, Kawasaki, Kanagawa, Japan; [Tsuneyama, Koichi] Tokushima Univ, Inst Biomed Sci, Dept Pathol & Lab Med, Grad Sch, Tokushima, Japan	University of Tokyo; Teikyo University; Teikyo University; Tokushima University	Kurano, M; Yatomi, Y (corresponding author), Univ Tokyo, Dept Clin Lab Med, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kurano-tky@umin.ac.jp; yatoyuta-tky@umin.ac.jp		Tsuneyama, Koichi/0000-0002-0670-9868; Yatomi, Yutaka/0000-0003-1719-4297	Japan Agency for Medical Research and Development (AMED); MSD Life Science Foundation; Public Interest Incorporated Foundation; AMED [15H05906]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MSD Life Science Foundation; Public Interest Incorporated Foundation; AMED	Japan Agency for Medical Research and Development (AMED); MSD Life Science Foundation, Public Interest Incorporated Foundation, Grant/Award Number: N/A; AMED, a Grant-in-Aid for Scientific Research on Innovative Areas, Grant/Award Number: 15H05906	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; ANGELICO M, 1991, GASTROENTEROLOGY, V101, P228, DOI 10.1016/0016-5085(91)90482-Z; Burg N, 2018, ARTHRITIS RHEUMATOL, V70, P1879, DOI 10.1002/art.40558; Cartier A, 2020, P NATL ACAD SCI USA, V117, P3157, DOI 10.1073/pnas.1906246117; Cartier A, 2019, SCIENCE, V366, P323, DOI 10.1126/science.aar5551; Christensen PM, 2016, FASEB J, V30, P2351, DOI 10.1096/fj.201500064; Christoffersen C, 2011, P NATL ACAD SCI USA, V108, P9613, DOI 10.1073/pnas.1103187108; Janiurek MM, 2019, ELIFE, V8, DOI 10.7554/eLife.49405; Kidambi S, 2008, XENOBIOTICA, V38, P1119, DOI [10.1080/00498250802007930, 10.1080/00498250802007930 ]; Kimura T, 2006, J BIOL CHEM, V281, P37457, DOI 10.1074/jbc.M605823200; Kosters A, 2003, J HEPATOL, V38, P710, DOI 10.1016/S0168-8278(03)00093-X; Kramer W, 2000, FEBS LETT, V487, P293, DOI 10.1016/S0014-5793(00)02372-3; Kurano M, 2020, DIABETES, V69, P867, DOI 10.2337/db19-0811; Kurano M, 2019, BIOCHEM J, V476, P3565, DOI 10.1042/BCJ20190498; Kurano M, 2019, FASEB J, V33, P5181, DOI 10.1096/fj.201801748R; Kurano M, 2018, THROMB HAEMOSTASIS, V118, P1021, DOI 10.1055/s-0038-1641750; Kurano M, 2018, BIOCHEM J, V475, P2009, DOI 10.1042/BCJ20180052; Kurano M, 2018, BBA-MOL CELL BIOL L, V1863, P191, DOI 10.1016/j.bbalip.2017.12.004; Kurano M, 2018, J ATHEROSCLER THROMB, V25, P16, DOI 10.5551/jat.RV17010; Kurano M, 2017, ARTERIOSCL THROM VAS, V37, P506, DOI 10.1161/ATVBAHA.116.308692; Kurano M, 2016, BRIT J PHARMACOL, V173, P222, DOI 10.1111/bph.13360; Kurano M, 2015, METABOLISM, V64, P588, DOI 10.1016/j.metabol.2015.01.011; Kurano M, 2015, J BIOL CHEM, V290, P2477, DOI 10.1074/jbc.M114.596445; Kurano M, 2013, ATHEROSCLEROSIS, V229, P102, DOI 10.1016/j.atherosclerosis.2013.04.024; Kurano M, 2012, J LIPID RES, V53, P2275, DOI 10.1194/jlr.M026575; Kurano M, 2011, J ATHEROSCLER THROMB, V18, P373, DOI 10.5551/jat.6999; Lorenzatti AJ, 2020, EUR CARDIOL REV, V15, P29, DOI 10.15420/ecr.2019.06; Luo GH, 2005, BBA-MOL CELL BIOL L, V1734, P198, DOI 10.1016/j.bbalip.2005.02.005; Luo GH, 2014, BIOCHEM BIOPH RES CO, V445, P203, DOI 10.1016/j.bbrc.2014.01.170; Magaye RR, 2019, CELL MOL LIFE SCI, V76, P1107, DOI 10.1007/s00018-018-2984-8; Makide K, 2014, J LIPID RES, V55, P1986, DOI 10.1194/jlr.R046920; Matanes F, 2019, ADV EXP MED BIOL, V1159, P109, DOI 10.1007/978-3-030-21162-2_7; Mishima Y, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20181288; Morita Y, 2019, LIPIDS, V54, P487, DOI 10.1002/lipd.12175; Mosialou I, 2010, J BIOL CHEM, V285, P30719, DOI 10.1074/jbc.M110.131771; Nagahashi M, 2016, J LIPID RES, V57, P1636, DOI 10.1194/jlr.R069286; Nojiri T, 2014, J DIABETES INVEST, V5, P639, DOI 10.1111/jdi.12232; Park WJ, 2020, MOL CELLS, V43, P419, DOI 10.14348/molcells.2020.0054; Proia RL, 2015, J CLIN INVEST, V125, P1379, DOI 10.1172/JCI76369; Sakai E, 2020, J APPL LAB MED, V5, P656, DOI 10.1093/jalm/jfaa022; Takuwa Y, 2012, BIOFACTORS, V38, P329, DOI 10.1002/biof.1030; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Venteclef N, 2008, J BIOL CHEM, V283, P3694, DOI 10.1074/jbc.M706382200; Wenniger LMD, 2010, DIGEST LIVER DIS, V42, P409, DOI 10.1016/j.dld.2010.03.015; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286; Yatomi Y, 2018, P JPN ACAD B-PHYS, V94, P373, DOI 10.2183/pjab.94.025; Yuyama K, 2014, BBA-MOL CELL BIOL L, V1841, P793, DOI 10.1016/j.bbalip.2013.08.002; Zhang X, 2008, BIOCHEM BIOPH RES CO, V371, P114, DOI 10.1016/j.bbrc.2008.04.017; Zhang XY, 2007, BBA-MOL CELL BIOL L, V1771, P879, DOI 10.1016/j.bbalip.2007.04.020; Zheng L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105681	50	4	4	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14655	14670		10.1096/fj.202001397R	http://dx.doi.org/10.1096/fj.202001397R		SEP 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32918529	Bronze			2022-12-26	WOS:000570583500001
J	Liu, P; Yu, QG; Tang, L; Kong, WH; Zhu, ZR; Xiao, P; Wang, X; Zhou, W; Liu, MQ				Liu, Pan; Yu, Qigui; Tang, Li; Kong, Wen-Hua; Zhu, Ze-Rong; Xiao, Peng; Wang, Xia; Zhou, Wang; Liu, Man-Qing			Anti-HIV-1 antibodies based confirmatory results in Wuhan, China, 2012-2018	PLOS ONE			English	Article							RECENT HIV-1 INFECTION; TESTING ALGORITHM; WESTERN BLOTS; INDETERMINATE; ASSAY; SEROCONVERSION; SEX; MEN	The number, intensity and order of emergence of HIV-1 specific antibodies in serum or plasma were associated with the stage of HIV-1 infection. In this study, we retrospectively analyzed the HIV-1 confirmatory results tested by western blot (WB) or recombination immunoblot assay (RIBA) in Wuhan, 2012-2018, to access the profiles of HIV-1 specific antibodies. A total of 14432 HIV-suspected serum or plasma samples collected from local hospitals and other HIV screening laboratories were further screened by two 4(th)generation enzyme-linked immunosorbent assay (ELISA) kits in our laboratory, of which 11068 specimens (76.69%) had at least one positive ELISA result and thereby were finally confirmed with WB or RIBA. RIBA had identified 652 (81.09%) positive and 13 (1.62%) indeterminate cases from July 1, 2014 to January 7, 2015, while WB had identified 8358 (81.43%) positive and 643 (6.26%) indeterminate cases in the other times during 2012-2018. The indeterminate rate of WB was significant higher than that of RIBA (p<0.001). Although the number of HIV-1 infected subjects increased significantly from 2012 (n = 911) to 2018 (n = 1578), the positive rate of HIV-1 antibodies decreased markedly from 70.08% in 2012 to 58.79% in 2018 (p<0.001). The most commonly observed antibody profile was gp160+gp120+p66+(p55+)p51+gp41+p31+p24+p17+ (4131, 49.43%) for WB-MP and gp160+gp120+gp41+p31+p24+p17+ (382, 58.59%) for RIBA-WANTAI, and the absence of reactivity to three possible serologic markers for recent HIV-1 infection, p31, p66, and p51, increased significantly from 2012 to 2018, with the overall rate of 17.03%, 9.40%, and 15.15%, respectively. The suspected acute HIV-1 infection was also observed to be increased in recent years, with an overall rate of 1.00%. Our results indicated the detection rate had decreased for HIV-1 infection, but increased for suspected recent and acute HIV-1 infection during 2012-2018, reflecting the efforts of intervention among high risk population.	[Liu, Pan; Yu, Qigui; Tang, Li; Kong, Wen-Hua; Zhu, Ze-Rong; Xiao, Peng; Wang, Xia; Zhou, Wang; Liu, Man-Qing] Wuhan Ctr Dis Control & Prevent, Wuhan, Hubei, Peoples R China		Liu, MQ (corresponding author), Wuhan Ctr Dis Control & Prevent, Wuhan, Hubei, Peoples R China.	liumq33@hotmail.com	Liu, Man-Qing/M-9598-2014	Liu, Man-Qing/0000-0002-9754-3102	Hubei Province Health and Family Planning Scientific Research Project [WJ2019M014]	Hubei Province Health and Family Planning Scientific Research Project	This study was supported by the Hubei Province Health and Family Planning Scientific Research Project (No: WJ2019M014 to M-QL) received by Dr. Man-Qing Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, MMWR-MORBID MORTAL W, V62, P489; [Anonymous], 2015, BMJ, V2015, ph1887; [Anonymous], 2015, NAT GUID DET HIV AID; Beyrer C, 2016, LANCET, V388, P198, DOI 10.1016/S0140-6736(16)30781-4; Brostrom M, 2014, AIDS RES HUM RETROV, V30, pA87, DOI 10.1089/aid.2014.5159a.abstract; BUSCH MP, 1991, TRANSFUSION, V31, P129, DOI 10.1046/j.1537-2995.1991.31291142943.x; CELUM CL, 1994, ARCH INTERN MED, V154, P1129, DOI 10.1001/archinte.154.10.1129; Chen Q, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201953; Chow EPF, 2012, HIV MED, V13, P255, DOI 10.1111/j.1468-1293.2011.00974.x; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Duri K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-7; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Gretch DR, 1997, HEPATOLOGY, V26, pS43, DOI 10.1002/hep.510260708; Hecht FM, 2002, 14 INT AIDS C 7 12 J; Huang JG, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4390318; Kline RL, 1996, J CLIN MICROBIOL, V34, P2650, DOI 10.1128/JCM.34.11.2650-2653.1996; Kong WH, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01322; Krajden M, 2014, J CLIN VIROL, V61, P132, DOI 10.1016/j.jcv.2014.06.024; Li Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-58; Liu MQ, 2016, J MED VIROL, V88, P1462, DOI 10.1002/jmv.24490; Liu MQ, 2013, J MED VIROL, V85, P1687, DOI 10.1002/jmv.23627; Ning Tielin, 2019, Zhonghua Yufang Yixue Zazhi, V53, P323, DOI 10.3760/cma.j.issn.0253-9624.2019.03.017; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Schupbach J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-254; Sudha T, 2006, Indian J Dermatol Venereol Leprol, V72, P357; The PLOS Medicine Editors, 2007, PLOS MED, V4, pe147, DOI 10.1371/journal.pmed.0040147; Tuaillon E, 2017, J CLIN VIROL, V95, P47, DOI 10.1016/j.jcv.2017.08.003; Uneke CJ, 2007, AIDS PATIENT CARE ST, V21, P169, DOI 10.1089/apc.2006.0089; Wang Ji-bao, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P998; Wang Zeng-qiang, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P430; Wu SL, 2019, VIROL SIN, V34, P358, DOI 10.1007/s12250-019-00130-3; Yan H, 2014, SCI REP-UK, V4, DOI 10.1038/srep04512; Yang H, 2018, IEEE T MAGN, V54, DOI 10.1109/TMAG.2017.2766442; Zhao Q G, 2016, Zhonghua Liu Xing Bing Xue Za Zhi, V37, P1105, DOI 10.3760/cma.j.issn.0254-6450.2016.08.010	35	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238282	10.1371/journal.pone.0238282	http://dx.doi.org/10.1371/journal.pone.0238282			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915788	gold, Green Published			2022-12-26	WOS:000571887500100
J	Maung, K; Ramalingam, S; Chaudhry, M; Ren, Y; Jung, SH; Romero, K; Corbet, K; Chao, NJ; Choi, T; Diehl, AM; Diehl, L; Gasparetto, C; Horwitz, M; Long, GD; Lopez, RD; Rizzieri, DA; Sarantopoulos, S; Sullivan, KM; Bashir, MR; Sung, AD				Maung, Ko; Ramalingam, Sendhilnathan; Chaudhry, Mohammad; Ren, Yi; Jung, Sin-Ho; Romero, Kristi; Corbet, Kelly; Chao, Nelson J.; Choi, Taewoong; Diehl, Anna Mae; Diehl, Louis; Gasparetto, Cristina; Horwitz, Mitchell; Long, Gwynn Douglas; Lopez, Richard D.; Rizzieri, David A.; Sarantopoulos, Stefanie; Sullivan, Keith M.; Bashir, Mustafa R.; Sung, Anthony D.			Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; RISK-FACTORS; MICROBIOTA; TRANSPLANT; BLOCKADE; OBESITY; INDEX; ST2	Allogeneic-HCT (allo-HCT), while potentially curative, can result in significant complications including graft versus host disease (GVHD). Prior studies suggest that metabolic syndrome may be one risk factor for GVHD. We hypothesized that hepatic steatosis on pre-HCT computed tomography (CT) scans may be a marker for development of GVHD and poor outcomes in allo-HCT. In this retrospective study, we reviewed the pre-HCT CT scans and transplant outcome data of patients who underwent allo-HCT at Duke University Medical Center from 2009 to 2017. The presence of steatosis was confirmed using CT attenuation measurements. We then assessed the association between pre-HCT hepatic steatosis and HCT-related outcomes including GVHD. 80 patients who had pre-HCT CT scans were included in the study. Pre-transplant hepatic steatosis was associated with the development of chronic GVHD (OR 4.2, p = 0.02), but was not associated with acute GVHD (OR 1.3, p = 0.7), non-relapse mortality (p = 0.81) or overall survival (p = 0.74). Based on this single center retrospective study, pre-transplant hepatic steatosis is associated with development of chronic GVHD. Further, prospective study with other imaging modalities including non-contrasted CT scans is needed to determine if this association is reproducible.	[Maung, Ko; Ramalingam, Sendhilnathan; Romero, Kristi; Corbet, Kelly; Chao, Nelson J.; Choi, Taewoong; Diehl, Louis; Gasparetto, Cristina; Horwitz, Mitchell; Long, Gwynn Douglas; Lopez, Richard D.; Rizzieri, David A.; Sarantopoulos, Stefanie; Sullivan, Keith M.; Sung, Anthony D.] Duke Univ, Dept Med, Div Hematol Malignancies & Cell Therapy, Sch Med, Durham, NC 27710 USA; [Chaudhry, Mohammad; Bashir, Mustafa R.] Duke Univ, Dept Radiol, Sch Med, Durham, NC USA; [Ren, Yi] Duke Univ, Duke Canc Inst, Biostat Shared Resources, Durham, NC USA; [Jung, Sin-Ho] Duke Univ, Dept Biostat & Bioinformat, Sch Med, Durham, NC USA; [Chao, Nelson J.; Choi, Taewoong; Diehl, Louis; Gasparetto, Cristina; Horwitz, Mitchell; Long, Gwynn Douglas; Lopez, Richard D.; Rizzieri, David A.; Sarantopoulos, Stefanie; Sullivan, Keith M.; Sung, Anthony D.] Duke Univ, Duke Canc Inst, Durham, NC USA; [Diehl, Anna Mae] Duke Univ, Dept Med, Div Gastroenterol, Sch Med, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	Sung, AD (corresponding author), Duke Univ, Dept Med, Div Hematol Malignancies & Cell Therapy, Sch Med, Durham, NC 27710 USA.	anthony.sung@duke.edu	choi, taewoong/AAE-8314-2021; Sung, Anthony/GPT-4489-2022		NIH T32 trainee grant [HL007057]; ASH Scholar Award; NIA [P30AG028716-13]	NIH T32 trainee grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ASH Scholar Award; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Ko Maung was supported by NIH T32 trainee grant #HL007057. Anthony Sung was supported by the ASH Scholar Award and NIA P30AG028716-13 Mini#6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABHYANKAR S, 1993, TRANSPLANTATION, V56, P1518, DOI 10.1097/00007890-199312000-00045; Anasetti C, 2008, BEST PRACT RES CL HA, V21, P691, DOI 10.1016/j.beha.2008.10.002; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; ANTIN JH, 1994, BLOOD, V84, P1342, DOI 10.1182/blood.V84.4.1342.bloodjournal8441342; Antin JH, 2002, BLOOD, V100, P3479, DOI 10.1182/blood-2002-03-0985; Arai Y, 2016, BONE MARROW TRANSPL, V51, P96, DOI 10.1038/bmt.2015.205; Armenian SH, 2019, JNCI-J NATL CANCER I, V111, P837, DOI 10.1093/jnci/djy231; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chen X, 2009, BLOOD, V114, P891, DOI 10.1182/blood-2009-01-197178; Fargion S, 2014, WORLD J GASTROENTERO, V20, P13306, DOI 10.3748/wjg.v20.i37.13306; Fuji S, 2014, BONE MARROW TRANSPL, V49, P1505, DOI 10.1038/bmt.2014.178; Fuji S, 2009, BIOL BLOOD MARROW TR, V15, P73, DOI 10.1016/j.bbmt.2008.10.029; GALE RP, 1987, BRIT J HAEMATOL, V67, P397, DOI 10.1111/j.1365-2141.1987.tb06160.x; Gooley TA, 2010, NEW ENGL J MED, V363, P2091, DOI 10.1056/NEJMoa1004383; Hahn T, 2008, J CLIN ONCOL, V26, P5728, DOI 10.1200/JCO.2008.17.6545; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Horan JT, 2011, J CLIN ONCOL, V29, P805, DOI 10.1200/JCO.2010.32.5001; Kaste Sue C, 2015, Biol Blood Marrow Transplant, V21, P1132, DOI 10.1016/j.bbmt.2015.02.023; Kodama Y, 2007, AM J ROENTGENOL, V188, P1307, DOI 10.2214/AJR.06.0992; Lau LHS, 2018, ADV EXP MED BIOL, V1061, P111, DOI 10.1007/978-981-10-8684-7_9; Lawrence DA, 2012, AM J ROENTGENOL, V199, P44, DOI 10.2214/AJR.11.7838; Lee SS, 2014, WORLD J GASTROENTERO, V20, P7392, DOI 10.3748/wjg.v20.i23.7392; McCarthy PL, 1996, TRANSPLANTATION, V62, P626, DOI 10.1097/00007890-199609150-00015; Negrin KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107265; Paczesny S, 2009, BLOOD, V113, P273, DOI 10.1182/blood-2008-07-167098; Paschos P, 2009, HIPPOKRATIA, V13, P9; Piper C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00163; Ponce DM, 2015, BLOOD, V125, P199, DOI 10.1182/blood-2014-06-584789; Robin M, 2013, BONE MARROW TRANSPL, V48, P1296, DOI 10.1038/bmt.2013.50; Sorror ML, 2005, BLOOD, V106, P2912, DOI 10.1182/blood-2005-05-2004; Staffas A, 2017, BLOOD, V129, P927, DOI 10.1182/blood-2016-09-691394; Tawara I, 2011, CLIN CANCER RES, V17, P77, DOI 10.1158/1078-0432.CCR-10-1198; Uslusoy HS, 2009, WORLD J GASTROENTERO, V15, P1863, DOI 10.3748/wjg.15.1863; Vander Lugt MT, 2013, NEW ENGL J MED, V369, P529, DOI 10.1056/NEJMoa1213299; Velasquez MT, 2018, METAB SYNDR RELAT D, V16, P321, DOI 10.1089/met.2017.0163; Wieckowska A, 2008, AM J GASTROENTEROL, V103, P1372, DOI 10.1111/j.1572-0241.2007.01774.x	37	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238824	10.1371/journal.pone.0238824	http://dx.doi.org/10.1371/journal.pone.0238824			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915853	gold, Green Published			2022-12-26	WOS:000571887500139
J	Ramchandran, K; Fiedorowicz, J; Chen, ZY; Bu, YL; Bechara, A; Andreasen, NC				Ramchandran, Kanchna; Fiedorowicz, Jess; Chen, Zhaoying; Bu, Yilin; Bechara, Antoine; Andreasen, Nancy C.			Patients on the psychosis spectrum employ an alternate brain network to engage in complex decision-making	PLOS ONE			English	Article							IOWA GAMBLING TASK; SALIENCE NETWORK; SCHIZOPHRENIA; DOPAMINE; HYPOTHESIS; UNPLEASANT; FRAMEWORK; PLEASANT; REWARD; PET	Brain reward processing mechanisms that underlie complex decision-making are compromised in psychosis. The goal of this research was to advance our understanding of the underlying (1) neural mechanisms and (2) discrete neuro-economic/motivational processes that may be altered in complex decision-making in euthymic patients on the psychosis spectrum (PPS). Utilizing a functional magnetic resonance neuroimaging (fmri) paradigm of a well-validated laboratory measure of complex decision-making (Iowa Gambling Task-IGT), the brain activation patterns of a target group of PPS were compared to a demographically matched healthy comparison group (HMC). These two groups were also evaluated on real-life decision outcomes on day of scan. PPS primarily activate the Dorsal Attentional Network (DAN) in real-life decision outcomes and in achieving similar levels of performance on the IGT as the HMC, in-spite of dysregulated dopamine-based brain-reward circuit and salience network fmri activation patterns. However, PPS report more significant negative outcomes of their decision-making in real-life, compared to HMC. The differential engagement of brain networks by PPS on the IGT appear to be moderated by antipsychotic, dopamine antagonist, medication lifetime/daily dose levels. These findings may also be mediated by extent of dysregulation in brain reward circuitry and salience network associated with psychosis severity in the target PPS group. This is also evident in case studies of unmedicated PPS. We conclude by suggesting that the brain may adapt to this dysregulation by co-opting the DAN network, which is implicated in the related function of problem-solving, towards complex decision-making. The extent of utilization of the DAN network in complex decision-making may be moderated by psychosis severity.	[Ramchandran, Kanchna; Bu, Yilin; Andreasen, Nancy C.] Univ Iowa, Iowa City, IA 52242 USA; [Fiedorowicz, Jess] Univ Ottawa, Ottawa, ON, Canada; [Fiedorowicz, Jess] Ottawa Hosp, Ottawa, ON, Canada; [Chen, Zhaoying; Bechara, Antoine] Boston Univ, Boston, MA 02215 USA; [Bechara, Antoine] Univ Southern Calif, Los Angeles, CA 90007 USA	University of Iowa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Boston University; University of Southern California	Ramchandran, K (corresponding author), Univ Iowa, Iowa City, IA 52242 USA.	kanchna-ramchandran@uiowa.edu	Fiedorowicz, Jess/I-2512-2019	Fiedorowicz, Jess/0000-0003-2057-4071; Bechara, Antoine/0000-0001-5127-2549	Brain and Behavior Research Foundation [19,402]; Nellie Ball Foundation [18,518,500]	Brain and Behavior Research Foundation; Nellie Ball Foundation	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research has been funded by grants from the Brain and Behavior Research Foundation, Grant ID No. 19,402; and a grant from Nellie Ball Foundation, ID No. 18,518,500.	Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; [Anonymous], 1994, TRYBUNA, V50, P7; Association A.P., 2013, DIAGNOSTIC STAT MANU; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; Bechara A., 2007, IOWA GAMBLING TASK P; Boorman ED, 2009, NEURON, V63, P721, DOI 10.1016/j.neuron.2009.09.014; Buckner RL, 2014, CEREB CORTEX, V24, P773; Carta F, 2019, SCIENCE, V363, P248, DOI 10.1126/science.aav0581; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Chand GB, 2016, NEUROIMAGE, V134, P85, DOI 10.1016/j.neuroimage.2016.04.018; Cole MW, 2012, J NEUROSCI, V32, P8988, DOI 10.1523/JNEUROSCI.0536-12.2012; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Crespo-Facorro B, 2001, JAMA-J AM MED ASSOC, V286, P427, DOI 10.1001/jama.286.4.427; Cuthbert B, 2010, PSYCHIATRY, V73, P311, DOI 10.1521/psyc.2010.73.4.311; Cuthbert BN, 2010, SCHIZOPHRENIA BULL, V36, P1061, DOI 10.1093/schbul/sbq108; Damasio A., 1999, NATURE, V401, P847; de Bruin WB, 2007, J PERS SOC PSYCHOL, V92, P938, DOI 10.1037/0022-3514.92.5.938; Dowd EC, 2010, BIOL PSYCHIAT, V67, P902, DOI 10.1016/j.biopsych.2009.10.020; Evans A. C., 1993, 1993 IEEE C NUCL SCI; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; Glimcher PW, 2013, NEUROECONOMICS DECIS; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Halfmann K, 2014, NEUROPSYCHOLOGY, V28, P870, DOI 10.1037/neu0000120; Heinz A, 2010, SCHIZOPHRENIA BULL, V36, P472, DOI 10.1093/schbul/sbq031; Ho BC, 2011, ARCH GEN PSYCHIAT, V68, P128, DOI 10.1001/archgenpsychiatry.2010.199; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Morris Sarah E, 2012, Dialogues Clin Neurosci, V14, P29; Mukherjee D, 2014, CLIN PSYCHOL SCI, V2, P767, DOI 10.1177/2167702614531580; Neuroscience Damasio A., 2009, NEUROECONOMICS DECIS, P209; Oakes TR, 2005, NEUROIMAGE, V28, P529, DOI 10.1016/j.neuroimage.2005.05.058; Paradiso S, 1999, AM J PSYCHIAT, V156, P1618, DOI 10.1176/ajp.156.10.1618; Paradiso S, 2003, AM J PSYCHIAT, V160, P1775, DOI 10.1176/appi.ajp.160.10.1775; Ramchandran K, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00497; Schlagenhauf F, 2009, BIOL PSYCHIAT, V65, P1032, DOI 10.1016/j.biopsych.2008.12.016; Schultz W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-24; SEEMAN P, 1975, P NATL ACAD SCI USA, V72, P4376, DOI 10.1073/pnas.72.11.4376; Tost H, 2010, NEUROSCI BIOBEHAV R, V34, P689, DOI 10.1016/j.neubiorev.2009.06.005; Uddin LQ, 2015, NAT REV NEUROSCI, V16, P55, DOI 10.1038/nrn3857; Walter H, 2009, PSYCHOPHARMACOLOGY, V206, P121, DOI 10.1007/s00213-009-1586-4; Waters-Wood SM, 2012, J INT NEUROPSYCH SOC, V18, P927, DOI 10.1017/S135561771200063X; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; Wotruba D, 2014, SCHIZOPHRENIA BULL, V40, P1095, DOI 10.1093/schbul/sbt161; Xiao L, 2013, J CLIN EXP NEUROPSYC, V35, P518, DOI 10.1080/13803395.2013.789484; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	51	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238774	10.1371/journal.pone.0238774	http://dx.doi.org/10.1371/journal.pone.0238774			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9MU	32915832	Green Published, gold			2022-12-26	WOS:000571887500132
J	Wu, KL; Shih, CP; Chan, JS; Chung, CH; Lin, HC; Tsao, CH; Lin, FH; Chien, WC; Hsiao, PJ				Wu, Kun-Lin; Shih, Cheng-Ping; Chan, Jenq-Shyong; Chung, Chi-Hsiang; Lin, Hung-Che; Tsao, Chang-Huei; Lin, Fu-Huang; Chien, Wu-Chien; Hsiao, Po-Jen			Investigation of the relationship between sensorineural hearing loss and associated comorbidities in patients with chronic kidney disease: A nationwide, population-based cohort study	PLOS ONE			English	Article							INSURANCE RESEARCH DATABASE; NONTRADITIONAL RISK-FACTORS; CARBONIC-ANHYDRASE; RENAL-FAILURE; GUINEA-PIGS; HEALTH; PREVALENCE; ATPASE; ADULTS	Hearing impairment was observed in patients with chronic kidney disease (CKD). Our purpose was to investigate the relationship between sensorineural hearing loss (SNHL) and associated comorbidities in the CKD population. We conducted a retrospective, population-based study to examine the risk of developing SNHL in patients with CKD. Population-based data from 2000-2010 from the Longitudinal Health Insurance Database of the Taiwan National Health Insurance Research Database was used in this study. The population sample comprised 185,430 patients who were diagnosed with CKD, and 556,290 without CKD to determine SNHL risk factors. Cox proportional hazard regression analysis demonstrated the CKD group had a significantly increased risk of SNHL compared with the non-CKD group [adjusted hazard ratio (HR), 3.42; 95% confidence interval (CI), 3.01-3.90,p< 0.001]. In the CKD group, the risk of SNHL (adjusted HR, 5.92) was higher among patients undergoing hemodialysis than among those not undergoing hemodialysis (adjusted HR, 1.40). Furthermore, subgroup analysis revealed an increased risk of SNHL in patients with CKD and comorbidities, including heart failure (adjusted HR, 7.48), liver cirrhosis (adjusted HR, 4.12), type 2 diabetes mellitus (adjusted HR, 3.98), hypertension (adjusted HR, 3.67), and chronic obstructive pulmonary disease (adjusted HR, 3.45). CKD is an independent risk of developing SNHL. Additionally, hemodialysis for uremia can increase the risk of SNHL. Cardiovascular, lung, liver, and metabolic comorbidities in CKD patients may further aggravate the risk of SNHL by inter-organ crosstalk. We should pay attention to SNHL in this high-risk population.	[Wu, Kun-Lin; Chan, Jenq-Shyong; Hsiao, Po-Jen] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan; [Wu, Kun-Lin; Chan, Jenq-Shyong; Hsiao, Po-Jen] Taoyuan Armed Forces Gen Hosp, Dept Internal Med, Div Nephrol, Taoyuan, Taiwan; [Wu, Kun-Lin] Natl Cent Univ, Inst Syst Biol & Bioinformat, Dept Biomed Sci & Engn, Taoyuan, Taiwan; [Shih, Cheng-Ping; Lin, Hung-Che] Natl Def Med Ctr, Triserv Gen Hosp, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan; [Chung, Chi-Hsiang; Tsao, Chang-Huei; Chien, Wu-Chien] Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan; [Chung, Chi-Hsiang; Lin, Fu-Huang; Chien, Wu-Chien] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Tsao, Chang-Huei] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei, Taiwan; [Hsiao, Po-Jen] Fu Jen Catholic Univ, Big Data Res Ctr, Taipei, Taiwan; [Hsiao, Po-Jen] Natl Cent Univ, Dept Life Sci, Taoyuan, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Central University; National Defense Medical Center; Tri-Service General Hospital; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Fu Jen Catholic University; National Central University	Hsiao, PJ (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan.; Hsiao, PJ (corresponding author), Taoyuan Armed Forces Gen Hosp, Dept Internal Med, Div Nephrol, Taoyuan, Taiwan.; Chien, WC (corresponding author), Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan.; Chien, WC (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.; Hsiao, PJ (corresponding author), Fu Jen Catholic Univ, Big Data Res Ctr, Taipei, Taiwan.; Hsiao, PJ (corresponding author), Natl Cent Univ, Dept Life Sci, Taoyuan, Taiwan.	chienwu@ndmctsgh.edu.tw; a2005a660820@yahoo.com.tw	Chung, Chi-Hsiang/AAY-3386-2021		Research Fund of the Taoyuan Armed Forces General Hospital [AFTYGH-109-009]; TriService General Hospital [TSGH-B-109010]	Research Fund of the Taoyuan Armed Forces General Hospital; TriService General Hospital	This study was supported by grants from the Research Fund of the Taoyuan Armed Forces General Hospital (AFTYGH-109-009) and TriService General Hospital (TSGH-B-109010).	ADLER D, 1980, ACTA OTO-LARYNGOL, V90, P55, DOI 10.3109/00016488009131697; Agrawal Y, 2008, ARCH INTERN MED, V168, P1522, DOI 10.1001/archinte.168.14.1522; Antonelli A R, 1990, Acta Otolaryngol Suppl, V476, P54; ARNOLD W, 1975, ARCH OTO-RHINO-LARYN, V211, P217, DOI 10.1007/BF00455288; Arroyo V, 1996, HEPATOLOGY, V23, P164, DOI 10.1053/jhep.1996.v23.ajhep0230164; Bayat A, 2019, INT J CHRONIC OBSTR, V14, P149, DOI 10.2147/COPD.S182730; BAZZI C, 1995, NEPHROL DIAL TRANSPL, V10, P1865; Blanche P, 2015, BIOMETRICS, V71, P102, DOI 10.1111/biom.12232; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep25855; Chen HR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183087; Chen J, 2016, NEPHROL DIAL TRANSPL, V31, P1145, DOI 10.1093/ndt/gfv418; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; CHUAN JH, 1985, ACTA OTO-LARYNGOL, P1; Cruz DN, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/351291; DIPAOLO B, 1988, CLIN NEPHROL, V29, P253; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Erkan AF, 2015, HERZ, V40, P481, DOI 10.1007/s00059-013-4020-y; Fraser SDS, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0189-z; Gaddam S, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0315-0; GATES GA, 1993, ARCH OTOLARYNGOL, V119, P156; GATLAND D, 1991, J ROY SOC MED, V84, P587; Gines P, 2009, NEW ENGL J MED, V361, P1279, DOI 10.1056/NEJMra0809139; Helzner EP, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0696-0; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Hsiao PJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0185693; Hsiao PJ, 2017, CLIN EXP NEPHROL, V21, P694, DOI 10.1007/s10157-016-1330-4; Hsiao PJ, 2015, COMPLEMENT THER MED, V23, P363, DOI 10.1016/j.ctim.2015.03.002; Hsieh CY, 2019, CLIN EPIDEMIOL, V11, P349, DOI 10.2147/CLEP.S196293; Husain-Syed F, 2015, J AM COLL CARDIOL, V65, P2433, DOI 10.1016/j.jacc.2015.04.024; ICHIMIYA I, 1994, ACTA OTO-LARYNGOL, V114, P167, DOI 10.3109/00016489409126037; IKEDA K, 1987, ACTA OTO-LARYNGOL, P40; Kamenski G, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008247; KLIGERMAN AB, 1981, LARYNGOSCOPE, V91, P583, DOI 10.1288/00005537-198104000-00011; Levine Robert A, 2015, Handb Clin Neurol, V129, P409, DOI 10.1016/B978-0-444-62630-1.00023-8; Lin C, 2013, LARYNGOSCOPE, V123, P767, DOI 10.1002/lary.23669; Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868; Lin YY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02426-4; MAKITA Z, 1991, NEW ENGL J MED, V325, P836, DOI 10.1056/NEJM199109193251202; Muntner P, 2005, J AM SOC NEPHROL, V16, P529, DOI 10.1681/ASN.2004080656; Nordvik O, 2018, BMC EAR NOSE THROAT, V18, DOI 10.1186/s12901-018-0051-6; Nosadini R, 2006, DIABETES, V55, P234, DOI 10.2337/diabetes.55.1.234; Nozu K, 2019, CLIN EXP NEPHROL, V23, P158, DOI 10.1007/s10157-018-1629-4; Ohashi T, 1999, ANN OTO RHINOL LARYN, V108, P955, DOI 10.1177/000348949910801006; Persson F, 2018, KIDNEY INT SUPPL, V8, P2, DOI 10.1016/j.kisu.2017.10.003; Remuzzi G, 2002, NEW ENGL J MED, V346, P1145, DOI 10.1056/NEJMcp011773; RIZVI SS, 1980, ARCH OTOLARYNGOL, V106, P751; Ronco C, 2012, J AM COLL CARDIOL, V60, P1031, DOI 10.1016/j.jacc.2012.01.077; RYBAK LP, 1982, J OTOLARYNGOL, V11, P127; Schade DS, 2018, DIABETES CARE, V41, P2495, DOI 10.2337/dc18-0625; Sterling MR, 2018, JAMA INTERN MED, V178, P843, DOI 10.1001/jamainternmed.2018.1317; Sterling MR, 2018, JAMA OTOLARYNGOL, V144, P273, DOI 10.1001/jamaoto.2017.2979; Thodi C, 2006, NEPHROL DIAL TRANSPL, V21, P3023, DOI 10.1093/ndt/gfl472; Toyoda K, 2014, LANCET NEUROL, V13, P823, DOI 10.1016/S1474-4422(14)70026-2; Velazquez RF, 2003, HEPATOLOGY, V37, P520, DOI 10.1053/jhep.2003.50093; Verduijn M, 2011, NEPHROL DIAL TRANSPL, V26, P56, DOI 10.1093/ndt/gfq661; Vilayur E, 2010, AM J KIDNEY DIS, V56, P661, DOI 10.1053/j.ajkd.2010.05.015; Yang JH, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1471-2	58	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238913	10.1371/journal.pone.0238913	http://dx.doi.org/10.1371/journal.pone.0238913			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915865	Green Published, gold			2022-12-26	WOS:000571887500013
J	Yamamoto, M; Takamiya, A; Sawada, K; Yoshimura, M; Kitazawa, M; Liang, K; Fujita, T; Mimura, M; Kishimoto, T				Yamamoto, Mao; Takamiya, Akihiro; Sawada, Kyosuke; Yoshimura, Michitaka; Kitazawa, Momoko; Liang, Kuo-ching; Fujita, Takanori; Mimura, Masaru; Kishimoto, Taishiro			Using speech recognition technology to investigate the association between timing-related speech features and depression severity	PLOS ONE			English	Article							PAUSE-TIME; ACOUSTIC MEASURES; RATING-SCALE; RETARDATION; FLUOXETINE	Background There are no reliable and validated objective biomarkers for the assessment of depression severity. We aimed to investigate the association between depression severity and timing-related speech features using speech recognition technology. Method Patients with major depressive disorder (MDD), those with bipolar disorder (BP), and healthy controls (HC) were asked to engage in a non-structured interview with research psychologists. Using automated speech recognition technology, we measured three timing-related speech features: speech rate, pause time, and response time. The severity of depression was assessed using the Hamilton Depression Rating Scale 17-item version (HAMD-17). We conducted the current study to answer the following questions: 1) Are there differences in speech features among MDD, BP, and HC? 2) Do speech features correlate with depression severity? 3) Do changes in speech features correlate with within-subject changes in depression severity? Results We collected 1058 data sets from 241 individuals for the study (97 MDD, 68 BP, and 76 HC). There were significant differences in speech features among groups; depressed patients showed slower speech rate, longer pause time, and longer response time than HC. All timing-related speech features showed significant associations with HAMD-17 total scores. Longitudinal changes in speech rate correlated with changes in HAMD-17 total scores. Conclusions Depressed individuals showed longer response time, longer pause time, and slower speech rate than healthy individuals, all of which were suggestive of psychomotor retardation. Our study suggests that speech features could be used as objective biomarkers for the assessment of depression severity.	[Yamamoto, Mao; Takamiya, Akihiro; Sawada, Kyosuke; Yoshimura, Michitaka; Kitazawa, Momoko; Liang, Kuo-ching; Fujita, Takanori; Mimura, Masaru; Kishimoto, Taishiro] Keio Univ, Dept Neuropsychiat, Sch Med, Tokyo, Japan	Keio University	Kishimoto, T (corresponding author), Keio Univ, Dept Neuropsychiat, Sch Med, Tokyo, Japan.	tkishimoto@keio.jp	Takamiya, Akihiro/AAE-8592-2021; Yoshimura, Michitaka/AAG-3562-2021	Takamiya, Akihiro/0000-0003-2985-6673; Yoshimura, Michitaka/0000-0002-0853-9313	Japan Agency for Medical Research and Development (AMED) [JP19he11020004]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This research was supported by the Japan Agency for Medical Research and Development (AMED) under Grant Number JP19he11020004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert M, 2001, J AFFECT DISORDERS, V66, P59, DOI 10.1016/S0165-0327(00)00335-9; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bennabi D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/158746; Cannizzaro M, 2004, BRAIN COGNITION, V56, P30, DOI 10.1016/j.bandc.2004.05.003; Cohen AS, 2014, SCHIZOPHR RES, V160, P173, DOI 10.1016/j.schres.2014.10.032; Cummins N, 2015, SPEECH COMMUN, V71, P10, DOI 10.1016/j.specom.2015.03.004; Dantchev N, 1998, J CLIN PSYCHIAT, V59, P19; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; DUCHIN SW, 1987, J COMMUN DISORD, V20, P245, DOI 10.1016/0021-9924(87)90022-0; Flament MF, 1999, INT CLIN PSYCHOPHARM, V14, P259; Goeleven E, 2006, J AFFECT DISORDERS, V93, P149, DOI 10.1016/j.jad.2006.03.007; GREDEN JF, 1980, BIOL PSYCHIAT, V15, P575; GREDEN JF, 1981, BIOL PSYCHIAT, V16, P851; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HARDY P, 1984, J AFFECT DISORDERS, V6, P123, DOI 10.1016/0165-0327(84)90014-4; Herrero MT, 2002, CHILD NERV SYST, V18, P386, DOI 10.1007/s00381-002-0604-1; HICKIE I, 1995, BIOL PSYCHIAT, V37, P151, DOI 10.1016/0006-3223(94)00174-2; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; Kishimoto T, 2019, PROJECT OBJECTIVE ME; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Mundt JC, 2007, J NEUROLINGUIST, V20, P50, DOI 10.1016/j.jneuroling.2006.04.001; Mundt JC, 2012, BIOL PSYCHIAT, V72, P580, DOI 10.1016/j.biopsych.2012.03.015; Naismith S, 2002, AM J PSYCHIAT, V159, P2096, DOI 10.1176/appi.ajp.159.12.2096; NILSONNE A, 1988, ACTA PSYCHIAT SCAND, V77, P253, DOI 10.1111/j.1600-0447.1988.tb05118.x; Nock MK, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000123; Parker G., 1996, MELANCHOLIA DISORDER; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Sobin C, 1998, J NEUROPSYCH CLIN N, V10, P85, DOI 10.1176/jnp.10.1.85; Steffens DC, 1998, BIOL PSYCHIAT, V43, P705, DOI 10.1016/S0006-3223(98)00084-5; SZABADI E, 1976, BRIT J PSYCHIAT, V129, P592, DOI 10.1192/bjp.129.6.592; Taylor BP, 2006, AM J PSYCHIAT, V163, P73, DOI 10.1176/appi.ajp.163.1.73; WILLIAMS JBW, 1988, ARCH GEN PSYCHIAT, V45, P742; World Health Organization CCfDSM, ATC INDEX WITH DDDS; Yang Y, 2013, IEEE T AFFECT COMPUT, V4, P142, DOI 10.1109/T-AFFC.2012.38	35	5	5	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238726	10.1371/journal.pone.0238726	http://dx.doi.org/10.1371/journal.pone.0238726			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9MU	32915846	Green Published, gold			2022-12-26	WOS:000571887500104
J	Aizawa, E; Dumeau, CE; Freimann, R; Di Minin, G; Wutz, A				Aizawa, Eishi; Dumeau, Charles-Etienne; Freimann, Remo; Di Minin, Giulio; Wutz, Anton			Polyploidy of semi-cloned embryos generated from parthenogenetic haploid embryonic stem cells	PLOS ONE			English	Article							MICE; DERIVATION; GROWTH; GENOME	In mammals, the fusion of two gametes, an oocyte and a spermatozoon, during fertilization forms a totipotent zygote. There has been no reported case of adult mammal development by natural parthenogenesis, in which embryos develop from unfertilized oocytes. The genome and epigenetic information of haploid gametes are crucial for mammalian development. Haploid embryonic stem cells (haESCs) can be established from uniparental blastocysts and possess only one set of chromosomes. Previous studies have shown that sperm or oocyte genome can be replaced by haESCs with or without manipulation of genomic imprinting for generation of mice. Recently, these remarkable semi-cloning methods have been applied for screening of key factors of mouse embryonic development. While haESCs have been applied as substitutes of gametic genomes, the fundamental mechanism how haESCs contribute to the genome of totipotent embryos is unclear. Here, we show the generation of fertile semi-cloned mice by injection of parthenogenetic haESCs (phaESCs) into oocytes after deletion of two differentially methylated regions (DMRs), theIG-DMR andH19-DMR. For characterizing the genome of semi-cloned embryos further, we establish ESC lines from semi-cloned blastocysts. We report that polyploid karyotypes are observed in semi-cloned ESCs (scESCs). Our results confirm that mitotically arrested phaESCs yield semi-cloned embryos and mice when theIG-DMR andH19-DMR are deleted. In addition, we highlight the occurrence of polyploidy that needs to be considered for further improving the development of semi-cloned embryos derived by haESC injection.	[Aizawa, Eishi; Dumeau, Charles-Etienne; Freimann, Remo; Di Minin, Giulio; Wutz, Anton] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Inst Mol Hlth Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Wutz, A (corresponding author), Swiss Fed Inst Technol, Swiss Fed Inst Technol, Inst Mol Hlth Sci, Zurich, Switzerland.	awutz@ethz.ch		Freimann, Remo/0000-0002-8955-2842; Di Minin, Giulio/0000-0003-4356-6939; Dumeau, Charles-Etienne/0000-0002-6916-7277	Swiss National Science Foundation [31003A_152814/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	AW, grant 31003A_152814/1 from the Swiss National Science Foundation, WEB page: www.snf.ch The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2001, ZYGOTE, V9, P153, DOI 10.1017/S0967199401001162; Campos PB, 2009, J VIS EXP; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; EGLITIS MA, 1981, J EMBRYOL EXP MORPH, V66, P91; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Imai H, 2020, ZYGOTE, V2020, P1; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; KAUFMAN MH, 1990, DEVELOPMENT, V110, P1121; Kawahara M, 2007, NAT BIOTECHNOL, V25, P1045, DOI 10.1038/nbt1331; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; Kono T, 1996, NAT GENET, V13, P91, DOI 10.1038/ng0596-91; Leeb M, 2014, CELL STEM CELL, V14, P385, DOI 10.1016/j.stem.2013.12.008; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Li Q, 2018, NAT CELL BIOL, V20, P1315, DOI 10.1038/s41556-018-0202-4; Li W, 2012, NATURE, V490, P407, DOI 10.1038/nature11435; Li ZK, 2018, CELL STEM CELL, V23, P665, DOI 10.1016/j.stem.2018.09.004; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Monfort A, 2015, CELL REP, V12, P554, DOI 10.1016/j.celrep.2015.06.067; Nacpil ML., 2016, DIDASKALIA, V26, P135; NAGY A, 1990, DEVELOPMENT, V110, P815; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Pettitt SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061520; Plasschaert RN, 2014, DEVELOPMENT, V141, P1805, DOI 10.1242/dev.101428; Postlmayr A, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.175141; Potapova T, 2017, BIOLOGY-BASEL, V6, DOI 10.3390/biology6010012; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Tguiko O, 2019, DEV BIOL, V447, P3, DOI 10.1016/j.ydbio.2018.01.014; Wan HF, 2013, CELL RES, V23, P1330, DOI 10.1038/cr.2013.126; Wu YX, 2016, CELL RES, V26, P131, DOI 10.1038/cr.2015.132; Yamazaki W, 2015, ZYGOTE, V23, P874, DOI 10.1017/S0967199414000550; Yang H, 2012, CELL, V149, P605, DOI 10.1016/j.cell.2012.04.002; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhong CQ, 2015, CELL STEM CELL, V17, P221, DOI 10.1016/j.stem.2015.06.005	35	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0233072	10.1371/journal.pone.0233072	http://dx.doi.org/10.1371/journal.pone.0233072			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911495	Green Submitted, Green Published, gold			2022-12-26	WOS:000571885900013
J	Sakurai, T; Okuyama, Y; Kobayashi, S; Phung, HT; Asao, A; Kawabe, T; Ndhlovu, LC; Riccardi, C; Kudo, H; Wada, M; Nio, M; So, T; Ishii, N				Sakurai, Tsuyoshi; Okuyama, Yuko; Kobayashi, Shuhei; Phung, Hai The; Asao, Atsuko; Kawabe, Takeshi; Ndhlovu, Lishomwa C.; Riccardi, Carlo; Kudo, Hironori; Wada, Motoshi; Nio, Masaki; So, Takanori; Ishii, Naoto			GITR controls intestinal inflammation by suppressing IL-15-dependent NK cell activity	FASEB JOURNAL			English	Article						inflammatory bowel disease; innate immunity; natural killer cells; TNFRSF	NATURAL-KILLER-CELLS; DEXTRAN SULFATE SODIUM; EXPERIMENTAL COLITIS; BOWEL-DISEASE; PROTEIN LIGAND; LAMINA PROPRIA; RECEPTOR; INNATE; ACTIVATION; EXPRESSION	Glucocorticoid-induced TNFR family related gene (GITR) is a member of the TNFR superfamily that is expressed on cells of the immune system. Although the protective and pathogenic roles of GITR in T cell immunity are well characterized, the role of GITR in innate immunity in the intestinal tissues has not been well clarified. In this study, using a dextran sulfate sodium (DSS)-induced colitis model in mice, we found that GITR-deficiency rendered mice more susceptible to acute intestinal inflammation and that a significantly higher number of activated natural killer (NK) cells was accumulated in the colonic lamina propria ofGitr(-/-)mice as compared to wild-type mice. Additionally,Rag2(-/-)Gitr(-/-)mice, which lack T cells but have NK cells, also displayed more severe colonic inflammation thanRag2(-/-)mice. In contrast, an anti-GITR agonistic antibody significantly alleviated colitis inRag2(-/-)mice. Engagement of GITR inhibited IL-15-mediated activating signaling events in NK cells, which include cell activation and proliferation, and production of cytokines and cytotoxic granules. Taken together, our results provide the first evidence that GITR negatively controls intestinal inflammation through NK cell functions.	[Sakurai, Tsuyoshi; Okuyama, Yuko; Kobayashi, Shuhei; Phung, Hai The; Asao, Atsuko; Kawabe, Takeshi; So, Takanori; Ishii, Naoto] Tohoku Univ, Grad Sch Med, Dept Microbiol & Immunol, Sendai, Miyagi 9808575, Japan; [Sakurai, Tsuyoshi; Kudo, Hironori; Wada, Motoshi; Nio, Masaki] Tohoku Univ, Grad Sch Med, Dept Pediat Surg, Sendai, Miyagi, Japan; [Ndhlovu, Lishomwa C.] Univ Hawaii, John A Burns Sch Med, Hawaii Ctr AIDS, Dept Trop Med, Manoa, HI USA; [Riccardi, Carlo] Perugia Univ, Med Sch, Pharmacol Sect, Dept Clin & Expt Med, Perugia, Italy; [So, Takanori] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Lab Mol Cell Biol, Toyama, Japan	Tohoku University; Tohoku University; University of Hawaii System; University of Hawaii Manoa; University of Perugia; University of Toyama	Okuyama, Y; Ishii, N (corresponding author), Tohoku Univ, Grad Sch Med, Dept Microbiol & Immunol, Sendai, Miyagi 9808575, Japan.	y.okuyama@med.tohoku.ac.jp; ishiin@med.tohoku.ac.jp	So, Takanori/R-6175-2019	So, Takanori/0000-0003-3004-8526; sakurai, tsuyoshi/0000-0001-9242-537X; Riccardi, Carlo/0000-0001-9257-3997	JSPS KAKENHI [16K15508]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Shimon Sakaguchi (Osaka University) and Takeshi Takahashi for the gift of the DTA-1 antibody. We also thank the Biomedical Research Core and the Institute for Animal Experimentation (Tohoku University Graduate School of Medicine) for technical support. This work was supported by JSPS KAKENHI Grant Number 16K15508 (NI).	Azuma M, 2010, CRIT REV IMMUNOL, V30, P547, DOI 10.1615/CritRevImmunol.v30.i6.40; Baltz KM, 2008, BLOOD, V112, P3735, DOI 10.1182/blood-2008-03-143016; Baltz KM, 2007, FASEB J, V21, P2442, DOI 10.1096/fj.06-7724com; Buechele C, 2012, LEUKEMIA, V26, P991, DOI 10.1038/leu.2011.313; Chen S, 2008, EUR J IMMUNOL, V38, P2229, DOI 10.1002/eji.200838167; Clouthier DL, 2014, CYTOKINE GROWTH F R, V25, P91, DOI 10.1016/j.cytogfr.2013.12.003; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Fathollahi A, 2018, INFLAMM RES, V67, P727, DOI 10.1007/s00011-018-1162-7; Gotthardt D, 2017, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00694; Gu L, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/265868; Hall LJ, 2013, MUCOSAL IMMUNOL, V6, P1016, DOI 10.1038/mi.2012.140; Holgersen K, 2015, J CROHNS COLITIS, V9, P492, DOI 10.1093/ecco-jcc/jjv050; Ito R, 2006, CLIN EXP IMMUNOL, V146, P330, DOI 10.1111/j.1365-2249.2006.03214.x; Kiesler P, 2015, CELL MOL GASTROENTER, V1, P154, DOI 10.1016/j.jcmgh.2015.01.006; Lee SK, 2006, IMMUNOLOGY, V119, P479, DOI 10.1111/j.1365-2567.2006.02459.x; Liao GX, 2012, GASTROENTEROLOGY, V142, P582, DOI 10.1053/j.gastro.2011.11.031; Liu BY, 2008, J BIOL CHEM, V283, P8202, DOI 10.1074/jbc.M708944200; Marcais A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00450; Middleton D, 2002, TRANSPL IMMUNOL, V10, P147, DOI 10.1016/S0966-3274(02)00062-X; Motta AC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-93; Murata K, 2002, J IMMUNOL, V169, P4628, DOI 10.4049/jimmunol.169.8.4628; Nagashima H, 2018, J ALLERGY CLIN IMMUN, V141, P1939, DOI 10.1016/j.jaci.2018.01.028; Nocentini G, 2009, ADV EXP MED BIOL, V647, P156, DOI 10.1007/978-0-387-89520-8_11; Patel M, 2005, EUR J IMMUNOL, V35, P3581, DOI 10.1002/eji.200535421; Patidar M, 2016, CYTOKINE GROWTH F R, V31, P49, DOI 10.1016/j.cytogfr.2016.06.001; Ronchetti S, 2002, BLOOD, V100, P350, DOI 10.1182/blood-2001-12-0276; Ronchetti S, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/171520; Santucci L, 2007, GUT, V56, P52, DOI 10.1136/gut.2006.091181; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Schmiedel BJ, 2013, MOL THER, V21, P877, DOI 10.1038/mt.2013.11; Schulthess J, 2012, IMMUNITY, V37, P108, DOI 10.1016/j.immuni.2012.05.013; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Steel AW, 2011, ALIMENT PHARM THER, V33, P115, DOI 10.1111/j.1365-2036.2010.04499.x; Takayama T, 2010, GASTROENTEROLOGY, V139, P882, DOI 10.1053/j.gastro.2010.05.040; Tomizawa R, 2011, CLIN EXP IMMUNOL, V165, P141, DOI 10.1111/j.1365-2249.2011.04414.x; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Waldner MJ, 2010, INFLAMM BOWEL DIS, V16, P559, DOI 10.1002/ibd.21107; Wallace KL, 2014, WORLD J GASTROENTERO, V20, P6, DOI 10.3748/wjg.v20.i1.6; Wang F, 2017, ONCOTARGET, V8, P98945, DOI 10.18632/oncotarget.22132; Wang SJ, 2012, AM J PATHOL, V180, P1059, DOI 10.1016/j.ajpath.2011.11.018; Xu YH, 2008, J NEUROIMMUNOL, V200, P53, DOI 10.1016/j.jneuroim.2008.06.008; Yadav PK, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/348530; Yoshihara K, 2006, GUT, V55, P334, DOI 10.1136/gut.2005.076000	43	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14820	14831		10.1096/fj.202001675R	http://dx.doi.org/10.1096/fj.202001675R		SEP 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32910505	Bronze			2022-12-26	WOS:000568315200001
J	Nguyen, NPT; Hoang, TD; Tran, VT; Vu, CT; Fodjo, JNS; Colebunders, R; Dunne, MP; Van Vo, T				Nhan Phuc Thanh Nguyen; Tuyen Dinh Hoang; Vi Thao Tran; Cuc Thi Vu; Fodjo, Joseph Nelson Siewe; Colebunders, Robert; Dunne, Michael P.; Thang Van Vo			Preventive behavior of Vietnamese people in response to the COVID-19 pandemic	PLOS ONE			English	Article								We sought to evaluate the adherence of Vietnamese adults to Coronavirus Disease 2019 (COVID-19) preventive measures, and gain insight into the effects of the epidemic on the daily lives of Vietnamese people. An online questionnaire was administered from March 31 to April 6, 2020. The questionnaire assessed personal preventive behavior (such as physical distancing, wearing a face mask, cough etiquette, regular handwashing and using an alcohol hand sanitizer, body temperature check, and disinfecting mobile phones) and community preventive behavior (such as avoiding meetings, large gatherings, going to the market, avoiding travel in a vehicle/bus with more than 10 persons, and not traveling outside of the local area during the lockdown). A total adherence score was calculated by summing the scores of the 9 personal and the 11 community prevention questions. In total, 2175 respondents completed the questionnaire; mean age: 31.4 +/- 10.7; (range: 18-69); 66.9% were women; 54.2% were health professionals and 22.8% were medical students. The mean adherence scores for personal and community preventive measures were 7.23 +/- 1.63 (range 1-9) and 9.57 +/- 1.12 (range 1-11), respectively. Perceived adaptation of the community to lockdown (Beta (beta) = 2.64, 95% Confidence Interval (CI) 1.25-4.03), fears/worries concerning one's health (beta = 2.87, 95% CI 0.04-5.70), residing in large cities (beta = 19.40, 95% CI 13.78-25.03), access to official COVID-19 information sources (beta = 16.45, 95% CI 6.82-26.08), and working in healthcare/medical students (beta = 22.53, 95% CI 16.00-29.07) were associated with a higher adherence score to anti-COVID instructions. In conclusion, this study confirmed a high degree of adherence to personal and community preventive behavior among Vietnamese people. Our findings are consistent with the epidemiology of COVID-19 in Vietnam, where there have been few infections and no recorded deaths up to the first week of July 2020.	[Nhan Phuc Thanh Nguyen; Vi Thao Tran; Cuc Thi Vu; Dunne, Michael P.; Thang Van Vo] Hue Univ, Univ Med & Pharm, Inst Community Hlth Res, Hue, Vietnam; [Tuyen Dinh Hoang; Thang Van Vo] Hue Univ, Univ Med & Pharm, Fac Publ Hlth, Hue, Vietnam; [Fodjo, Joseph Nelson Siewe; Colebunders, Robert] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [Dunne, Michael P.] Queensland Univ Technol, Fac Hlth, Brisbane, Qld, Australia	Hue University; Hue University; University of Antwerp; Queensland University of Technology (QUT)	Van Vo, T (corresponding author), Hue Univ, Univ Med & Pharm, Inst Community Hlth Res, Hue, Vietnam.; Van Vo, T (corresponding author), Hue Univ, Univ Med & Pharm, Fac Publ Hlth, Hue, Vietnam.	vovanthang147@hueuni.edu.vn		Hoang Dinh, Tuyen/0000-0002-9725-4212; Nguyen, Nhan/0000-0001-8826-9757; Siewe Fodjo, Joseph Nelson/0000-0003-3544-1239; Vu, Thi Cuc/0000-0002-0239-3042; Colebunders, Robert/0000-0002-1919-1340; VO VAN, THANG/0000-0003-2018-0371	Institute for Community Health Research, University of Medicine and Pharmacy, Hue University, Vietnam; Global Health Institute, University of Antwerp, Belgium (from VLIRUOS)	Institute for Community Health Research, University of Medicine and Pharmacy, Hue University, Vietnam; Global Health Institute, University of Antwerp, Belgium (from VLIRUOS)	This study received financial support from the Institute for Community Health Research, University of Medicine and Pharmacy, Hue University, Vietnam and Global Health Institute, University of Antwerp, Belgium (R Colebunders received funding from VLIRUOS for establishing the ICPcovid website).	Alfonso S, 2020, PSICOL-REFLEX CRIT, V33, DOI 10.1186/s41155-020-00142-z; [Anonymous], 2020, BMJ-BRIT MED J, V369, pm2170, DOI 10.1136/bmj.m2170; Burgess A, 2012, SOCIOL HEALTH ILL, V34, P1184, DOI 10.1111/j.1467-9566.2012.01466.x; Dolitzsch C, 2020, GLOBAL STUDY COVID 1; Feng S, 2020, LANCET RESP MED, V8, P434, DOI 10.1016/S2213-2600(20)30134-X; Hanoi Department of Justice, 2020, LEV SANCT VIOL PREV; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Ki Dong Park, 2020, WHO WAS IMPRESSED PR; Mniszewski SM, 2014, INTEL SYST REF LIBR, V52, P97, DOI 10.1007/978-3-642-39149-1_8; Muto K., 2020, JAPANESE CITIZENS BE, DOI [10.1101/2020.03.31.20048876, DOI 10.1101/2020.03.31.20048876]; Vietnamese Ministry of Health, 2020, TIM COV 19 VIETN 202; Vietnamese Ministry of Health, 2020, INF COVID 19 2020; Vietnamese Ministry of Health, 2020, COV 19 UPD APR 10 20; Vietnamese Ministry of Health, 2020, PRIM MIN CHAIR GOV M; Vietnamese Ministry of Health, 2020, IN ID MAIN SOURC INF; World Health Organization (WHO), ADV US MASKS CONT CO; Xu JB, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020244; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	18	40	40	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2020	15	9							e0238830	10.1371/journal.pone.0238830	http://dx.doi.org/10.1371/journal.pone.0238830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR4MY	32903286	Green Published, gold, Green Submitted			2022-12-26	WOS:000571539500005
J	Castro, SA; Rojas, P; Vila, I; Habit, E; Pizarro-Konczak, J; Abades, S; Jaksic, FM				Castro, Sergio A.; Rojas, Pablo; Vila, Irma; Habit, Evelyn; Pizarro-Konczak, Jaime; Abades, Sebastian; Jaksic, Fabian M.			Partitioning beta-diversity reveals that invasions and extinctions promote the biotic homogenization of Chilean freshwater fish fauna	PLOS ONE			English	Article							SPECIES INVASIONS; NULL MODEL; BIODIVERSITY; COMPONENTS; RICHNESS; TURNOVER; FUTURE; DIFFERENTIATION; INTRODUCTIONS; CONSEQUENCES	Aim Exotic species' introductions together with extinction of native species represent the main mechanisms driving biotic homogenization of freshwater fish assemblages around the world. While generally ichtyofaunistic realms transit towards biotic homogenization, for conservation purposes it is essential to understand what specific mechanisms are promoting it on particular areas or regions. Here, we report the occurrence of biotic homogenization in 29 Chilean watersheds, analyzing its beta-diversity (including turnover and nestedness) and predicting future trends. Location Continental Chile (18(o)-56(o)S). Methods We determined fish composition per basin for historical and current assemblages; extant native, exotic, and extinct species were recorded as 1 (presence) or 0 (absence) in two matrices basins x species. For each matrix, we calculated the turnover (beta(sim)), nestedness (beta(nes)), and beta-diversity (beta(sor)); then, we obtained Delta beta(sim), Delta beta(nes), and Delta beta(sor), as the arithmetical difference between basin pairs over time. In addition, we search for explanatory variables correlating Delta beta(sim), Delta beta(nes), and Delta beta(sor)with geographical and land use variables. Finally, simulating events of species introduction (i.e., invasion) and extinction, we generated 15 hypothetical assemblages, looking to establish future trends towards biotic change in Chilean basins. Results Species turnover and beta-diversity significantly decreased from historical to current assemblages (Delta beta(sim)= -0.084; Delta beta(sor)= -0.061, respectively), while the species nestedness did not show significant changes (Delta beta(nes)= 0.08). Biotic changes have been driven mainly by the introduction of 28 exotic species, with a minor role of extinctions (one species) and translocations (0 species) of native species. Changes in beta-diversity were negatively correlated with area, elevation, and geographical distance between basins but not with land-use nor human population. Finally, the analysis of 15 future assemblages predicts a significant decrease of beta-diversity and turnover, and an increase for species nestedness, this time promoted by an increase in the extinction of native species. Main conclusion Chilean basins show a significant decrease of the distributional beta-diversity and species turnover of the freshwater fish fauna, evidencing a trend towards biotic homogenization. This trend is shared with other Neotropical basins; however, specific mechanisms driving it show different magnitude. Changes in the beta-diversity components do not show correlation with variables associated to land use, thus suggesting that casual introductions of freshwater fishes in Chile follow an opportunistic mode related to commercial use. According to future scenarios simulated, biotic homogenization should increase further, mainly as consequence of increased native extinctions.	[Castro, Sergio A.] Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Lab Ecol & Biodiversidad, Santiago, Chile; [Castro, Sergio A.; Jaksic, Fabian M.] Pontificia Univ Catolica Chile, Ctr Appl Ecol & Sustainabil, Santiago, Chile; [Rojas, Pablo; Vila, Irma] Univ Chile, Dept Ciencias Ecol, Lab Limnol, Santiago, Chile; [Habit, Evelyn] Univ Concepcion, Fac Ciencias Ambientales & Ctr Ciencias Ambiental, Dept Sistemas Acuat, Concepcion, Chile; [Pizarro-Konczak, Jaime] Univ Santiago Chile, Dept Ingn Geograf, Santiago, Chile; [Abades, Sebastian] Univ Mayor, Fac Ciencias, Ctr Genom & Bioinformat, Santiago, Chile	Universidad de Santiago de Chile; Pontificia Universidad Catolica de Chile; Universidad de Chile; Universidad de Concepcion; Universidad de Santiago de Chile; Universidad Mayor	Castro, SA (corresponding author), Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Lab Ecol & Biodiversidad, Santiago, Chile.; Castro, SA (corresponding author), Pontificia Univ Catolica Chile, Ctr Appl Ecol & Sustainabil, Santiago, Chile.	sergio.castro@usach.cl	Jaksic, Fabian M/G-1705-2014	Jaksic, Fabian M/0000-0003-0098-0291; Abades, Sebastian/0000-0001-5704-4037	CONICYT/PIA/BASAL [FB 0002]; FONDECYT [1140543]	CONICYT/PIA/BASAL(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	S.A. Castro and F. M. Jaksic thank grant CONICYT/PIA/BASAL FB 0002. I. Vila thanks FONDECYT 1140543.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Alo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071577; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; [Anonymous], 2017, DRUG SAF UPDATE, DOI DOI 10.1186/s13104-016-2345-3; ARRATIA G, 1981, MUSEO NACL HIST NATU, V34, P3; Arratia G, 2017, PEERJ, V5, DOI 10.7717/peerj.2991; Baeten L, 2012, BIODIVERS CONSERV, V21, P1399, DOI 10.1007/s10531-012-0251-0; Baiser B, 2012, P ROY SOC B-BIOL SCI, V279, P4772, DOI 10.1098/rspb.2012.1651; Baselga A, 2007, BIOLOGY LETT, V3, P642, DOI 10.1098/rsbl.2007.0449; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Basulto S., 2003, LARGO VIAJE SALMONES; Camus P, 2009, PISCICULTURA CHILE E; Castano-Sanchez A, 2018, J FRESHWATER ECOL, V33, P347, DOI 10.1080/02705060.2018.1503101; Castro SA, 2014, INVASIONES BIOL CHIL, P415; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; Clavero M, 2006, ECOL APPL, V16, P2313, DOI 10.1890/1051-0761(2006)016[2313:HDAIRO]2.0.CO;2; Ding CZ, 2017, DIVERS DISTRIB, V23, P171, DOI 10.1111/ddi.12507; Direccion General de Aguas Santiago de Chile DGA, 2010, DAT INT ANT GEN; Dong X, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00497.1; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Dyer Brian S., 2000, Estudios Oceanologicos, V19, P77; Erinnerung Konstruierte, 2004, BTHZ, V21, P3; Essl F, 2015, DIVERS DISTRIB, V21, P534, DOI 10.1111/ddi.12312; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Habit E., 2015, Ecosistemas, V24, P43, DOI 10.7818/ECOS.2015.24-1.08; Habit Evelyn, 2006, Gayana (Concepc.), V70, P100; Habit E, 2012, DIVERS DISTRIB, V18, P1153, DOI 10.1111/j.1472-4642.2012.00906.x; Habit E, 2010, GLOBAL ECOL BIOGEOGR, V19, P697, DOI 10.1111/j.1466-8238.2010.00541.x; Hermoso V, 2012, DIVERS DISTRIB, V18, P236, DOI 10.1111/j.1472-4642.2011.00828.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Iriarte JA, 2005, REV CHIL HIST NAT, V78, P143, DOI 10.4067/S0716-078X2005000100010; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; Legendre P, 2014, GLOBAL ECOL BIOGEOGR, V23, P1324, DOI 10.1111/geb.12207; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; Leprieur F, 2008, DIVERS DISTRIB, V14, P291, DOI 10.1111/j.1472-4642.2007.00409.x; Leprieur F, 2009, J BIOGEOGR, V36, P1899, DOI 10.1111/j.1365-2699.2009.02107.x; Liu CL, 2017, DIVERS DISTRIB, V23, P556, DOI 10.1111/ddi.12541; Lockwood J, 2001, BIOTIC HOMOGENIZATIO; Longman EK, 2018, GLOBAL ECOL BIOGEOGR, V27, P77, DOI 10.1111/geb.12677; Marr SM, 2010, DIVERS DISTRIB, V16, P606, DOI 10.1111/j.1472-4642.2010.00669.x; Matsuzaki SS, 2013, GLOBAL ECOL BIOGEOGR, V22, P1071, DOI 10.1111/geb.12067; McKinney Michael L., 2005, Proceedings of the California Academy of Sciences, V56, P119; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; MEA, 2005, EC HUM WELL BEING SY, DOI DOI 10.1119/1.2344558; MoreiraMunoz A, 2011, PLANT VEG, V5, P1; Munoz-Ramirez CP, 2015, LIMNOLOGICA, V53, P10, DOI 10.1016/j.limno.2015.04.004; Olden JD, 2006, GLOBAL ECOL BIOGEOGR, V15, P113, DOI 10.1111/j.1466-822x.2006.00214.x; Olden JD, 2004, ECOLOGY, V85, P1867, DOI 10.1890/03-3131; Olden JD, 2003, AM NAT, V162, P442, DOI 10.1086/378212; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; Olden JD, 2008, GLOBAL ECOL BIOGEOGR, V17, P25, DOI 10.1111/j.1466-8238.2007.00340.x; Olden JD, 2006, J BIOGEOGR, V33, P2027, DOI 10.1111/j.1365-2699.2006.01572.x; Olden JD, 2018, NEOBIOTA, P23, DOI 10.3897/neobiota.37.22552; Olden Julian D., 2011, P224; Pardo R, 2009, ENVIRON BIOL FISH, V86, P353, DOI 10.1007/s10641-009-9532-1; Peredo-Parada M, 2009, GAYANA, V73, P119; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Poff NL, 2007, P NATL ACAD SCI USA, V104, P5732, DOI 10.1073/pnas.0609812104; Pool TK, 2012, DIVERS DISTRIB, V18, P366, DOI 10.1111/j.1472-4642.2011.00836.x; Rahel FJ, 2000, SCIENCE, V288, P854, DOI 10.1126/science.288.5467.854; Rahel FJ, 2002, ANNU REV ECOL SYST, V33, P291, DOI 10.1146/annurev.ecolsys.33.010802.150429; Revenga C, 2005, PHILOS T ROY SOC B, V360, P397, DOI 10.1098/rstb.2004.1595; Rojas P, 2019, GLOB ECOL CONSERV, V19, DOI 10.1016/j.gecco.2019.e00658; Rooney TP, 2007, BIOL CONSERV, V134, P447, DOI 10.1016/j.biocon.2006.07.008; Rosenblad KC, 2017, ECOGRAPHY, V40, P1040, DOI 10.1111/ecog.02652; Sax DF, 2008, P NATL ACAD SCI USA, V105, P11490, DOI 10.1073/pnas.0802290105; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Socolar JB, 2016, TRENDS ECOL EVOL, V31, P67, DOI 10.1016/j.tree.2015.11.005; Sommerwerk N, 2017, J BIOGEOGR, V44, P1781, DOI 10.1111/jbi.13019; Soto D, 2006, REV CHIL HIST NAT, V79, P97; Soto MA, 2018, REV CHIL HIST NAT, V91, DOI 10.1186/s40693-018-0078-5; Taylor EB, 2004, CAN J FISH AQUAT SCI, V61, P68, DOI 10.1139/F03-141; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Toussaint A, 2016, BIOL INVASIONS, V18, P1295, DOI 10.1007/s10530-016-1067-8; Vargas PV, 2015, REV CHIL HIST NAT, V88, DOI [10.1186/s40693-015-0046-2, 10.1186/S40693-015-0046-2]; Veliz D, 2012, REV CHIL HIST NAT, V85, P49, DOI 10.4067/S0716-078X2012000100004; Vellend M, 2001, J VEG SCI, V12, P545, DOI 10.2307/3237006; VILA I, 1999, B MUSEO NACL HIST NA, V48, P61; Vila I, BIODIVERSIDAD CHILE, P306; Vila I., 2018, BIODIVERSIDAD CHILE, P161; Villeger S, 2015, DIVERS DISTRIB, V21, P223, DOI 10.1111/ddi.12242; Villeger S, 2011, P NATL ACAD SCI USA, V108, P18003, DOI 10.1073/pnas.1107614108; Zeng L, 2017, ECOL EVOL, V7, P3904, DOI 10.1002/ece3.2920	85	6	6	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238767	10.1371/journal.pone.0238767	http://dx.doi.org/10.1371/journal.pone.0238767			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ6EE	32898173	gold, Green Published			2022-12-26	WOS:000570962500037
J	Li, Q; Jin, RR; Zhang, SH; Sun, XH; Wu, JH				Li, Qian; Jin, Ruiri; Zhang, Shenghai; Sun, Xinghuai; Wu, Jihong			Transient receptor potential vanilloid four channels modulate inhibitory inputs through differential regulation of GABA and glycine receptors in rat retinal ganglion cells	FASEB JOURNAL			English	Article						GABA(A)receptor; glycine receptor; inhibitory input; retinal ganglion cell; TRPV4	TRPV4 CHANNELS; CALCIUM HOMEOSTASIS; ACTIVATION; EXPRESSION; APOPTOSIS; NEURONS; LOCALIZATION; TRANSMISSION; EXCITABILITY; PRESSURE	The transient receptor potential vanilloid 4 (TRPV4) channel is widely distributed in the retina. Activation of the TRPV4 channel enhances excitatory signaling from bipolar cells to retinal ganglion cells (RGCs), thereby increasing RGC firing rate and membrane excitability. In this study, we investigated the effect of TRPV4 channel activation on the miniature inhibitory postsynaptic current (mIPSC) in rat RGCs. Our results showed that perfusion with HC-067047, a TRPV4-channel antagonist, significantly reduced the amplitude of RGC mIPSCs. Extracellular application of the TRPV4 channel agonist GSK1016790A (GSK101) enhanced the frequency and amplitude of mIPSCs in ON- and OFF-type RGCs; pre-application of HC-067047 blocked the effect of GSK101 on mIPSCs. Furthermore, TRPV4 channels were able to enhance the frequency and amplitude of glycine receptor (GlyR)-mediated mIPSCs and inhibit the frequency of type A gamma-aminobutyric acid receptor (GABA(A)R)-mediated mIPSCs. Upon intracellular administration or intravitreal injection of GSK101, TRPV4 channel activation reduced the release of presynaptic glycine and enhanced the function and expression of postsynaptic GlyRs; however, it inhibited presynaptic release of GABA, but did not affect postsynaptic GABA(A)Rs. Our study results provide insight regarding the effect of TRPV4 channel activation on RGCs and offer a potential interventional target for retinal diseases involving TRPV4 channels.	[Li, Qian; Sun, Xinghuai; Wu, Jihong] Fudan Univ, Eye Inst, Eye & ENT Hosp, Shanghai, Peoples R China; [Li, Qian; Zhang, Shenghai; Sun, Xinghuai; Wu, Jihong] Shanghai Key Lab Visual Impairment & Restorat, Shanghai, Peoples R China; [Li, Qian; Zhang, Shenghai; Sun, Xinghuai; Wu, Jihong] Fudan Univ, NHC Key Lab Myopia, Shanghai, Peoples R China; [Li, Qian; Zhang, Shenghai; Sun, Xinghuai; Wu, Jihong] Chinese Acad Med Sci, Key Lab Myopia, Shanghai, Peoples R China; [Jin, Ruiri] Nanchang Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanchang, Jiangxi, Peoples R China	Fudan University; Fudan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Nanchang University	Sun, XH; Wu, JH (corresponding author), Fudan Univ, Coll Med, Inst Eye, Eye & ENT Hosp, 83 Fenyang Rd, Shanghai 200031, Peoples R China.	xhsun@shmu.edu.cn; jihongwu@fudan.edu.cn			National Natural Science Foundation of China (NSFC) [31800872, 81790641, 81770925]; Shanghai Science and Technology Development Foundation (Shanghai Science and Technology Development Fund) [17YF1401800]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Development Foundation (Shanghai Science and Technology Development Fund)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31800872, 81790641 and 81770925; Shanghai Science and Technology Development Foundation (Shanghai Science and Technology Development Fund), Grant/Award Number: 17YF1401800	Zamarripa DA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13621-8; Baratchi S, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00006; Benfenati V, 2007, NEUROSCIENCE, V148, P876, DOI 10.1016/j.neuroscience.2007.06.039; Boycott B, 1999, INVEST OPHTH VIS SCI, V40, P1313; Ciura S, 2018, CELL REP, V23, P2245, DOI 10.1016/j.celrep.2018.04.090; Cortright DN, 2009, CURR PHARM DESIGN, V15, P1736, DOI 10.2174/138161209788186308; Cui P, 2017, NEUROSCIENCE, V355, P71, DOI 10.1016/j.neuroscience.2017.04.046; DOI M, 1995, J COMP NEUROL, V356, P368, DOI 10.1002/cne.903560305; Dong LD, 2015, J NEUROSCI, V35, P5409, DOI 10.1523/JNEUROSCI.4376-14.2015; Du JL, 2000, J NEUROPHYSIOL, V84, P666, DOI 10.1152/jn.2000.84.2.666; Duan L, 2009, J PHYSIOL-LONDON, V587, P4063, DOI 10.1113/jphysiol.2009.174797; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Fucile S, 2000, NEURON, V28, P571, DOI 10.1016/S0896-6273(00)00134-3; Gao F, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1576-3; Glykys J, 2006, J NEUROPHYSIOL, V95, P2796, DOI 10.1152/jn.01122.2005; GRASSI F, 1992, BRAIN RES, V594, P115, DOI 10.1016/0006-8993(92)91035-D; HAMILL OP, 1992, P NATL ACAD SCI USA, V89, P7462, DOI 10.1073/pnas.89.16.7462; Harmon TC, 2020, J NEUROSCI, V40, P3063, DOI 10.1523/JNEUROSCI.2322-19.2020; Heathcote HR, 2019, BRIT J PHARMACOL, V176, P3297, DOI 10.1111/bph.14762; Hong ZW, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00077; Howell RD, 2016, J PHYSIOL-LONDON, V594, P3651, DOI 10.1113/JP272124; Iuso A, 2016, CHANNELS, V10, P172, DOI 10.1080/19336950.2016.1140956; Jiang LL, 2011, EUR J CELL BIOL, V90, P333, DOI 10.1016/j.ejcb.2010.10.003; Jo AO, 2015, J NEUROSCI, V35, P13525, DOI 10.1523/JNEUROSCI.1987-15.2015; Jung C, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aam6558; Kavalali ET, 2015, NAT REV NEUROSCI, V16, P5, DOI 10.1038/nrn3875; Krizaj D, 2016, ADV EXP MED BIOL, V854, P693, DOI 10.1007/978-3-319-17121-0_92; Lechner SG, 2011, NEURON, V69, P332, DOI 10.1016/j.neuron.2010.12.028; Li Q, 2020, NEUROPHARMACOLOGY, V170, DOI 10.1016/j.neuropharm.2020.108016; Li Q, 2017, BRAIN STRUCT FUNCT, V222, P813, DOI 10.1007/s00429-016-1248-3; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Loukin S, 2010, J BIOL CHEM, V285, P27176, DOI 10.1074/jbc.M110.143370; Lu T, 2008, NEURON, V57, P524, DOI 10.1016/j.neuron.2007.12.010; Lu Y, 2012, NEUROCHEM INT, V61, P649, DOI 10.1016/j.neuint.2012.07.005; Marc RE, 2000, J COMP NEUROL, V425, P560, DOI 10.1002/1096-9861(20001002)425:4<560::AID-CNE7>3.0.CO;2-D; Matsumoto H, 2018, J NEUROSCI, V38, P8745, DOI 10.1523/JNEUROSCI.0897-18.2018; Molchanova SM, 2018, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00442; Morgan JL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-8; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Nilius B, 2013, EMBO REP, V14, P152, DOI 10.1038/embor.2012.219; PEICHL L, 1989, J COMP NEUROL, V286, P120, DOI 10.1002/cne.902860108; Phuong TTT, 2017, J PHYSIOL-LONDON, V595, P6869, DOI 10.1113/JP275052; Popova E, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/149187; Popova E, 2014, CURR NEUROPHARMACOL, V12, P509, DOI 10.2174/1570159X13999150122165018; Qi MW, 2018, CELL PHYSIOL BIOCHEM, V45, P1084, DOI 10.1159/000487350; Reiter B, 2006, FASEB J, V20, P1802, DOI 10.1096/fj.06-5772com; Ryskamp DA, 2016, SCI REP-UK, V6, DOI 10.1038/srep30583; Ryskamp DA, 2014, J NEUROSCI, V34, P15689, DOI 10.1523/JNEUROSCI.2540-14.2014; Ryskamp DA, 2011, J NEUROSCI, V31, P7089, DOI 10.1523/JNEUROSCI.0359-11.2011; Scarnati MS, 2018, ELIFE, V7, DOI 10.7554/eLife.36697; Shibasaki K, 2007, J NEUROSCI, V27, P1566, DOI 10.1523/JNEUROSCI.4284-06.2007; SHIN DH, 1989, ARCH OPHTHALMOL-CHIC, V107, P1599, DOI 10.1001/archopht.1989.01070020677026; Sigal IA, 2004, INVEST OPHTH VIS SCI, V45, P4378, DOI 10.1167/iovs.04-0133; Son A, 2018, J MOL ENDOCRINOL, V61, P207, DOI 10.1530/JME-18-0051; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Taylor L, 2017, EXP EYE RES, V154, P10, DOI 10.1016/j.exer.2016.11.002; Thou XJ, 2019, J NEUROSCI, V39, P1484, DOI 10.1523/JNEUROSCI.1685-18.2018; Tian W, 2009, P NATL ACAD SCI USA, V106, P14034, DOI 10.1073/pnas.0904084106; ULLRICH B, 1994, J PHYSIOL-PARIS, V88, P249, DOI 10.1016/0928-4257(94)90088-4; Wang CT, 2007, J NEUROSCI, V27, P9130, DOI 10.1523/JNEUROSCI.1293-07.2007; Wang XH, 2016, BRAIN STRUCT FUNCT, V221, P301, DOI 10.1007/s00429-014-0908-4; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Yu YC, 2006, J NEUROSCI, V26, P696, DOI 10.1523/JNEUROSCI.3653-05.2006	66	2	2	2	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14521	14538		10.1096/fj.201902937RR	http://dx.doi.org/10.1096/fj.201902937RR		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32892440				2022-12-26	WOS:000568292300001
J	Liu, LY; Zhang, L; Pan, J; Niu, JH; Yuan, XY; Hu, SZ; Liu, CM; Shad, N; Huang, JH; Deng, BL; Deng, WP; Liu, XJ; Zhang, WY; Liu, YQ				Liu, Liangying; Zhang, Ling; Pan, Jun; Niu, Jiehui; Yuan, Xinyue; Hu, Sizhe; Liu, Chunmei; Shad, Nasir; Huang, Jiahui; Deng, Bangliang; Deng, Wenping; Liu, Xiaojun; Zhang, Wenyuan; Liu, Yuanqiu			Soil C-N-P pools and stoichiometry as affected by intensive management ofcamellia oleiferaplantations	PLOS ONE			English	Article							EMISSIONS; ACIDIFICATION; NITROGEN; RATIOS; CO2	Intensive management ofC.oleiferahas produced many pureC.oleiferaplantations. The transmission ofC.oleiferaplantation will potentially affect soil C, N, and P pools as well as their stoichiometric characteristics both in top soil layer and vertical soil profile due to the intensive management. To understand changes in vertical pools and stoichiometric characteristics of soil C, N, and P as affected by intensive management ofC.oleiferaplantations, both mixed and pureC.oleiferaplantations were studied. We conducted studies in five locations in Jiangxi, China with both pure and mixedC.oleiferaplantations, to compare changes in vertical pools and stoichiometry of C, N, and P. Both C and N pools were significantly different between mixed and pure plantation types ofC.oleifera. However, the ratio of C:N, C:P, and N:P was consistently higher in mixed plantations with C:P and N:P altered but C:N ratio did not change with soil depth. The intensive management significantly impact both C and N pools and the stoichiometry of C, N, and P. Intensive management ofC.oleiferaplantations decreased both C and N pools, especially at the depth of 30-50 cm soil layer.C.oleiferaplantation alteration from mixed to pure should be considered in future forest management practice considering the substantial effects on soil element cycling and distribution along vertical soil profile.	[Liu, Liangying; Zhang, Ling; Pan, Jun; Niu, Jiehui; Yuan, Xinyue; Hu, Sizhe; Liu, Chunmei; Shad, Nasir; Huang, Jiahui; Deng, Bangliang; Deng, Wenping; Liu, Xiaojun; Zhang, Wenyuan; Liu, Yuanqiu] Jiangxi Agr Univ, Coll Forestry, Jiangxi Prov Key Lab Silviculture, Nanchang, Jiangxi, Peoples R China	Jiangxi Agricultural University	Liu, YQ (corresponding author), Jiangxi Agr Univ, Coll Forestry, Jiangxi Prov Key Lab Silviculture, Nanchang, Jiangxi, Peoples R China.	liuyq404@163.com	Zhang, Ling/AAH-2429-2020; Shad, Nasir/AAT-6905-2021	Shad, Nasir/0000-0002-8442-1392	National Natural Science Foundation of China [41967017, 31960303]; Jiangxi Education Department [GJJ160348]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangxi Education Department	This research was funded by the National Natural Science Foundation of China, Grant Numbers 41967017 and 31960303, and the Jiangxi Education Department, Project Number GJJ160348.	Alekseeva T, 2011, ENVIRON GEOCHEM HLTH, V33, P137, DOI 10.1007/s10653-010-9327-5; Brancalion PHS, 2019, ECOL APPL, V29, DOI 10.1002/eap.1847; Bui EN, 2013, PLANT SOIL, V373, P553, DOI 10.1007/s11104-013-1823-9; Chen JH, 2019, GEODERMA, V354, DOI 10.1016/j.geoderma.2019.113894; Deng BL, 2019, ENVIRON SCI POLLUT R, V26, P4070, DOI 10.1007/s11356-018-3900-3; Deng BL, 2020, J SOIL SEDIMENT, V20, P3062, DOI 10.1007/s11368-019-02552-8; Deng BL, 2020, CHEMOSPHERE, V246, DOI 10.1016/j.chemosphere.2019.125608; Deng BL, 2019, FORESTS, V10, DOI 10.3390/f10121076; Deng BL, 2016, J SOIL SEDIMENT, V16, P777, DOI 10.1007/s11368-015-1307-z; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Hou JY, 2019, FOREST POLICY ECON, V98, P82, DOI 10.1016/j.forpol.2017.10.014; Hu YW, 2017, CATENA, V154, P12, DOI 10.1016/j.catena.2017.02.014; Jiao SY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226887; Kirkby CA, 2011, GEODERMA, V163, P197, DOI 10.1016/j.geoderma.2011.04.010; Li SY, 2016, AGR ECOSYST ENVIRON, V233, P60, DOI 10.1016/j.agee.2016.08.036; Li WC, 2020, APPL SOIL ECOL, V150, DOI 10.1016/j.apsoil.2019.103436; Liu CX, 2018, FORESTS, V9, DOI 10.3390/f9080487; Liu J, 2017, APPL SOIL ECOL, V113, P29, DOI 10.1016/j.apsoil.2017.01.010; Liu XS, 2019, PLANT SOIL, V438, P85, DOI 10.1007/s11104-019-04010-3; Lu R., 1999, SOIL AGROCHEMICAL AN, P146; Pan P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191952; Penuelas J, 2012, GLOBAL CHANGE BIOL, V18, P3, DOI 10.1111/j.1365-2486.2011.02568.x; Qiao Y, 2020, GEODERMA, V370, DOI 10.1016/j.geoderma.2020.114357; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Shi SW, 2016, PLANT SOIL, V407, P323, DOI 10.1007/s11104-016-2889-y; Tian HQ, 2010, BIOGEOCHEMISTRY, V98, P139, DOI 10.1007/s10533-009-9382-0; Tipping E, 2016, BIOGEOCHEMISTRY, V130, P117, DOI 10.1007/s10533-016-0247-z; von Oheimb G, 2010, ECOSYSTEMS, V13, P317, DOI 10.1007/s10021-010-9320-y; Xie JY, 2019, FORESTS, V10, DOI 10.3390/f10090742; You MY, 2020, CATENA, V185, DOI 10.1016/j.catena.2019.104302; Zhang L, 2018, NITROGEN AGR UPDATES; Zhang L, 2018, SCI TOTAL ENVIRON, V642, P781, DOI 10.1016/j.scitotenv.2018.06.111; Zhang L, 2016, PEDOSPHERE, V26, P567, DOI 10.1016/S1002-0160(15)60066-2; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092301	35	1	1	8	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238227	10.1371/journal.pone.0238227	http://dx.doi.org/10.1371/journal.pone.0238227			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886691	Green Published, gold			2022-12-26	WOS:000571064300063
J	de Queiroz, RS; Saquetto, MB; Martinez, BP; Cazeta, BBR; Hodgson, C; Gomes-Neto, M				de Queiroz, Rodrigo Santos; Saquetto, Micheli Bernardone; Martinez, Bruno Prata; Reis Cazeta, Bianca Bigogno; Hodgson, Carol; Gomes-Neto, Mansueto			Progressive active mobilization with dose control and training load in critically ill patients (PROMOB): Protocol for a randomized controlled trial	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; CRITICAL ILLNESS; MUSCLE STRENGTH; REHABILITATION; EXPLANATION; MORTALITY; CONSENSUS; EXERCISE; OUTCOMES; SCORE	The dose of progressive active mobilization is still uncertain. The purpose of this study is to identify if the addition of a protocol of progressive active mobilization with dose and training load control to usual care is effective in reducing the length of stay in intensive care unit (ICU) and the improvement of the functioning, incidence of ICU-acquired weakness (ICUAW), mechanical ventilation duration and mortality rate in patients hospitalized in ICU. It is Double-blind randomised clinical trial. The setting for this trial will be medical and surgical ICU of a university hospital. The study participants will be 118 patients aged> 18 years admitted to ICU for less than 72 hours. Participants will be randomized to either an experimental or control group. The experimental group will undertake addition of a protocol of progressive active mobilization with dose and training load control to usual care, while the control group will undertake only usual care. The primary outcome will be length of ICU stay. The secondary outcomes will be Cross-sectional area and muscle thickness of the rectus femoris and biceps brachii, Change in muscle strength from the baseline, Functional Status, incidence of ICUAW, Days with mechanical ventilation and Mortality. All statistical analyses will be conducted following intention-to-treat principles. It has a detailed description of the dose of exercise, was designed with the strictest methodological criteria. These characteristics allow to investigate with greater certainty the results progressive active mobilization in critical patients, allowing replication and future combinations in meta-analyzes.	[de Queiroz, Rodrigo Santos; Reis Cazeta, Bianca Bigogno] Univ Fed Bahia, Program Med & Hlth, Fac Med, Salvador, BA, Brazil; [Saquetto, Micheli Bernardone; Martinez, Bruno Prata; Gomes-Neto, Mansueto] Univ Fed Bahia, Inst Hlth Sci, Dept Phys Therapy, Salvador, BA, Brazil; [Hodgson, Carol] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic, Australia	Universidade Federal da Bahia; Universidade Federal da Bahia; Monash University	de Queiroz, RS (corresponding author), Univ Fed Bahia, Program Med & Hlth, Fac Med, Salvador, BA, Brazil.	rsquerioz@uesb.edu.br	Gomes-Neto, Mansueto/I-5235-2014	Gomes-Neto, Mansueto/0000-0002-0717-9694; Reis, AlessanRSS/0000-0001-8486-7469; Saquetto, Micheli/0000-0003-3211-8102	Brazilian National Research Council (CNPQ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]	Brazilian National Research Council (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The study received funding support from the Brazilian National Research Council (CNPQ) and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. http://www.cnpq.br/https://www.capes.gov.br/B.B.R.C received a scholarship NO. The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 1999, BRIT MED J, V319, P703, DOI 10.1136/bmj.319.7211.703; Baldwin CE, 2013, J CRIT CARE, V28, P77, DOI 10.1016/j.jcrc.2012.03.001; Beach LJ, 2017, J CRIT CARE, V40, P189, DOI 10.1016/j.jcrc.2017.04.006; BORG G, 1985, EUR J APPL PHYSIOL O, V54, P343, DOI 10.1007/BF02337176; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Castro-Avila AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130722; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Connolly B, 2016, THORAX, V71, P881, DOI 10.1136/thoraxjnl-2015-208273; Cuthbertson BH, 2016, AM J RESP CRIT CARE, V194, P132, DOI 10.1164/rccm.201602-0257ED; De Jonghe B, 2002, JAMA-J AM MED ASSOC, V288, P2859, DOI 10.1001/jama.288.22.2859; de Queiroz RS, 2018, HEART LUNG, V47, P253, DOI 10.1016/j.hrtlng.2018.03.003; Doig GS, 2005, J CRIT CARE, V20, P187, DOI 10.1016/j.jcrc.2005.04.005; Doiron KA, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010754.pub2; Dong ZH, 2014, WORLD J EMERG MED, V5, P48, DOI [10.5847/wjem.j.1920-8642.2014.01.008, 10.5847/wjem.j.issn.1920-8642.2014.01.008]; Grimm A, 2013, CRIT CARE, V17, DOI 10.1186/cc13050; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hashem MD, 2016, CHEST, V150, P722, DOI 10.1016/j.chest.2016.03.003; Hermans G, 2012, MUSCLE NERVE, V45, P18, DOI 10.1002/mus.22219; Hickmann CE, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0184-y; Hodgson CL, 2016, CRIT CARE MED, V44, P1145, DOI 10.1097/CCM.0000000000001643; Hodgson CL, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0658-y; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Kim J, 2014, CLIN ORTHOP SURG, V6, P103, DOI 10.4055/cios.2014.6.1.103; MAHONEY F I, 1965, Md State Med J, V14, P61; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Moss M, 2016, AM J RESP CRIT CARE, V193, P1101, DOI 10.1164/rccm.201505-1039OC; Randelli P, 2008, ARTHROSCOPY, V24, P834, DOI 10.1016/j.arthro.2008.01.011; Rhea MR, 2003, MED SCI SPORT EXER, V35, P456, DOI 10.1249/01.MSS.0000053727.63505.D4; Schaller SJ, 2016, LANCET, V388, P1377, DOI 10.1016/S0140-6736(16)31637-3; Schujmann DS, 2020, CRIT CARE MED, V48, P491, DOI 10.1097/CCM.0000000000004181; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Severgnini P, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0192-x; Seymour JM, 2009, THORAX, V64, P418, DOI 10.1136/thx.2008.103986; Slade SC, 2016, BRIT J SPORT MED, V50, P1428, DOI 10.1136/bjsports-2016-096651; Tabata I, 1996, MED SCI SPORT EXER, V28, P1327, DOI 10.1097/00005768-199610000-00018; Thrush A, 2012, PHYS THER, V92, P1536, DOI 10.2522/ptj.20110412; Tipping CJ, 2017, INTENS CARE MED, V43, P171, DOI 10.1007/s00134-016-4612-0; Vanpee G, 2014, CRIT CARE MED, V42, P701, DOI 10.1097/CCM.0000000000000030; Young P, 2012, CRIT CARE RESUSC, V14, P211; Zhang G., 2018, J EMERGENCY CRITICAL, V2, P9, DOI [10.21037/jeccm.2018.01.04, DOI 10.21037/JECCM.2018.01.04]	40	0	0	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238352	10.1371/journal.pone.0238352	http://dx.doi.org/10.1371/journal.pone.0238352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881921	Green Published, gold			2022-12-26	WOS:000571063300003
J	Hare, A; Evans, W; Pocock, K; Weekes, C; Gimenez, I				Hare, Alex; Evans, Wiley; Pocock, Katie; Weekes, Carrie; Gimenez, Iria			Contrasting marine carbonate systems in two fjords in British Columbia, Canada: Seawater buffering capacity and the response to anthropogenic CO2 invasion	PLOS ONE			English	Article							NET COMMUNITY PRODUCTION; DEEP-WATER RENEWAL; OCEAN ACIDIFICATION; CALCIUM-CARBONATE; INORGANIC CARBON; ORGANIC-CARBON; SATURATION STATES; TOTAL ALKALINITY; COASTAL WATERS; SURFACE-WATER	The carbonate system in two contrasting fjords, Rivers Inlet and Bute Inlet, on the coast of British Columbia, Canada, was evaluated to characterize the mechanisms driving carbonate chemistry dynamics and assess the impact of anthropogenic carbon. Differences in the character of deep water exchange between these fjords were inferred from their degree of exposure to continental shelf water and their salinity relationships with total alkalinity and total dissolved inorganic carbon, which determined seawater buffering capacity. Seawater buffering capacity differed between fjords and resulted in distinct carbonate system characteristics with implications on calcium carbonate saturation states and sensitivity to increasing anthropogenic carbon inputs. Saturation states of both aragonite and calcite mineral phases of calcium carbonate were seasonally at or below saturation throughout the entire water column in Bute Inlet, while only aragonite was seasonally under-saturated in portions of the water column in Rivers Inlet. The mean annual saturation states of aragonite in Rivers Inlet and calcite in Bute Inlet deep water layers have declined to below saturation within the last several decades due to anthropogenic carbon accumulation, and similar declines to undersaturation are projected in their surface layers as anthropogenic carbon continues to accumulate. This study demonstrates that the degree of fjord water exposure to open shelf water influences the uptake and sensitivity to anthropogenic carbon through processes affecting seawater buffering capacity, and that reduced uptake but greater sensitivity occurs where distance to ocean source waters and freshwater dilution are greater.	[Hare, Alex; Evans, Wiley; Pocock, Katie; Weekes, Carrie; Gimenez, Iria] Hakai Inst, Heriot Bay, BC, Canada; [Gimenez, Iria] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	Hakai Institute; University of British Columbia	Hare, A (corresponding author), Hakai Inst, Heriot Bay, BC, Canada.	alex.hare@hakai.org		Gimenez, Iria/0000-0001-5916-4446	Tula Foundation	Tula Foundation	This study was funded by the Tula Foundation (https://tula.org/).The funding organization did not participate in the design, data collection, analyses, decision to publish, or preparation of this manuscript.	ALABACK PB, 1991, REV CHIL HIST NAT, V64, P399; [Anonymous], 2018, LANCET HAEMATOL, V5, pE127, DOI 10.1016/S2352-3026(18)30037-1; Beckwith ST, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00169; Bednarsek N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0123; Bednarsek N, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00227; Bianucci L, 2018, ELEMENTA-SCI ANTHROP, V6, DOI 10.1525/elementa.151; Busch DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105884; Cai WJ, 1998, GEOCHIM COSMOCHIM AC, V62, P473, DOI 10.1016/S0016-7037(97)00363-3; Carignan KS, 2013, BATHYMETRIC DIGITAL, P8; Carter BR, 2019, GLOBAL BIOGEOCHEM CY, V33, P597, DOI 10.1029/2018GB006154; Carter BR, 2017, GLOBAL BIOGEOCHEM CY, V31, P306, DOI 10.1002/2016GB005485; Carter BR, 2014, BIOGEOSCIENCES, V11, P7349, DOI 10.5194/bg-11-7349-2014; Chierici M, 2009, BIOGEOSCIENCES, V6, P2421, DOI 10.5194/bg-6-2421-2009; Dickson A.G., 2007, GUIDE BEST PRACTICES; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; Edmunds PJ, 2016, BIOSCIENCE, V66, P350, DOI 10.1093/biosci/biw023; Egleston ES, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2008GB003407; Ericson Y, 2019, CONT SHELF RES, V181, P1, DOI 10.1016/j.csr.2019.04.013; Evans W, 2014, BIOGEOSCIENCES, V11, P365, DOI 10.5194/bg-11-365-2014; Fassbender AJ, 2017, ESTUAR COAST, V40, P404, DOI 10.1007/s12237-016-0168-z; Fassbender AJ, 2011, CONT SHELF RES, V31, P1180, DOI 10.1016/j.csr.2011.04.006; Feely RA, 2004, J OCEANOGR, V60, P45, DOI 10.1023/B:JOCE.0000038317.01279.aa; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Feely RA, 2018, CONT SHELF RES, V152, P50, DOI 10.1016/j.csr.2017.11.002; Feely RA, 2016, ESTUAR COAST SHELF S, V183, P260, DOI 10.1016/j.ecss.2016.08.043; Feely RA, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004157; Feely RA, 2010, ESTUAR COAST SHELF S, V88, P442, DOI 10.1016/j.ecss.2010.05.004; Fitzer SC, 2014, SCI REP-UK, V4, DOI 10.1038/srep06218; Foreman MGG, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC006995; Fransson A, 2015, J GEOPHYS RES-OCEANS, V120, P2413, DOI 10.1002/2014JC010320; Friis K, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015898; Gruber N, 1996, GLOBAL BIOGEOCHEM CY, V10, P809, DOI 10.1029/96GB01608; Haigh R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117533; Hodal M., 2011, NET PHYS TRANSPORTS; Hopwood MJ, 2019, CRYOSPHERE, DOI [10.5194/tc-12-1433-2018, DOI 10.5194/TC-12-1433-2018]; Ianson D, 2016, GEOPHYS RES LETT, V43, P5793, DOI 10.1002/2016GL068996; Institute H, 2018, WATER COLUMN CO2 SYS; Jackson JM, 2018, GEOPHYS RES LETT, V45, P9757, DOI 10.1029/2018GL078971; Jiang LQ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55039-4; Johannessen SC, 2003, ESTUAR COAST SHELF S, V56, P845, DOI 10.1016/S0272-7714(02)00303-7; Johannessen SC, 2014, LIMNOL OCEANOGR, V59, P211, DOI 10.4319/lo.2014.59.1.0211; Jones DC, 2014, GLOBAL BIOGEOCHEM CY, V28, P1163, DOI 10.1002/2014GB004813; Knepel K, 2008, 31115011H LACH INSTR; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Lee K, 2001, LIMNOL OCEANOGR, V46, P1287, DOI 10.4319/lo.2001.46.6.1287; Lutz M, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2000GB001383; Masson D, 2002, ESTUAR COAST SHELF S, V54, P115, DOI 10.1006/ecss.2001.0833; Masui T, 2011, CLIMATIC CHANGE, V109, P59, DOI 10.1007/s10584-011-0150-5; Mathis JT, 2010, BIOGEOSCIENCES, V7, P1769, DOI 10.5194/bg-7-1769-2010; Matsumoto K, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002397; McDougall TJ, 2011, GETTING STARTD TEOS; Meire L, 2015, BIOGEOSCIENCES, V12, P2347, DOI 10.5194/bg-12-2347-2015; Millero FJ, 2010, MAR FRESHWATER RES, V61, P139, DOI 10.1071/MF09254; Morrison J, 2012, ATMOS OCEAN, V50, P1, DOI 10.1080/07055900.2011.637667; MUCCI A, 1983, AM J SCI, V283, P780, DOI 10.2475/ajs.283.7.780; Murray JW, 2015, LIMNOL OCEANOGR, V60, P957, DOI 10.1002/lno.10062; Oliver AA, 2017, BIOGEOSCIENCES, V14, P3743, DOI 10.5194/bg-14-3743-2017; Omar AM, 2016, OCEAN SCI, V12, P937, DOI 10.5194/os-12-937-2016; Pacella SR, 2018, P NATL ACAD SCI USA, V115, P3870, DOI 10.1073/pnas.1703445115; Pawlowicz R, 2007, ATMOS OCEAN, V45, P173, DOI 10.3137/ao.450401; PICKARD GL, 1961, J FISH RES BOARD CAN, V18, P907, DOI 10.1139/f61-062; Reisdorph SC, 2014, ESTUAR COAST SHELF S, V144, P8, DOI 10.1016/j.ecss.2014.03.018; Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y; Rysgaard S, 2012, MAR CHEM, V128, P26, DOI 10.1016/j.marchem.2011.11.002; Rysgaard S, 2011, TELLUS B, V63, P823, DOI 10.1111/j.1600-0889.2011.00571.x; Sabine CL, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001639; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Schiebel R, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001459; Shadwick EH, 2019, J GEOPHYS RES-OCEANS, V124, P7626, DOI 10.1029/2019JC015246; Tabata S., 1954, PHYS OCEANOGRAPHY BU; Thomson R. E., 1981, CAN SPEC PUBL FISH A, V56, P291; Torres R, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006344; Tucker S., 2010, 31114272A LACH INSTR; UPPSTROM LR, 1974, DEEP-SEA RES, V21, P161, DOI 10.1016/0011-7471(74)90074-6; Van Heuven, 2011, ORNLCDIAC105B USDA C; Waldbusser GG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128376; Waldbusser GG, 2015, NAT CLIM CHANGE, V5, P273, DOI 10.1038/NCLIMATE2479; WATABE N, 1981, PROG CRYST GROWTH CH, V4, P99, DOI 10.1016/0146-3535(81)90050-2; Water Survey of Canada, 2019, HIST HYDR DAT SEARCH; Wessel P, 1996, J GEOPHYS RES-SOL EA, V101, P8741, DOI 10.1029/96JB00104; Wittmann AC, 2013, NAT CLIM CHANGE, V3, P995, DOI 10.1038/NCLIMATE1982; Yang B, 2015, MAR CHEM, V176, P199, DOI 10.1016/j.marchem.2015.09.008	82	8	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238432	10.1371/journal.pone.0238432	http://dx.doi.org/10.1371/journal.pone.0238432			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881918	Green Published, gold			2022-12-26	WOS:000571063300062
J	Rowe, RD; Odoi, A; Paulsen, D; Moncayo, AC; Fryxell, RTT				Rowe, R. D.; Odoi, A.; Paulsen, D.; Moncayo, A. C.; Fryxell, R. T. Trout			Spatial-temporal clusters of host-seekingAedes albopictus,Aedes japonicus, andAedes triseriatus collections in a La Crosse virus endemic county (Knox County, Tennessee, USA)	PLOS ONE			English	Article							WEST-NILE-VIRUS; JAPONICUS-JAPONICUS; EASTERN TENNESSEE; AEDES-ALBOPICTUS; SCAN STATISTICS; HOST-SEEKING; ENCEPHALITIS; MOSQUITOS; TRANSMISSION; INFECTION	A bite from a La Crosse virus (LACV) infectedAedesmosquito can cause La Crosse encephalitis (LACE), which is a neuro-invasive disease that disproportionately affects children under the age of 16 in Southern Appalachia. The three vectors for LACV areAedes albopictus(Skuse),Ae.japonicus(Theobald), andAe.triseriatus(Say). Localized maps of the geographic distribution of vectors are practical tools for mosquito management personnel to target areas with high mosquito abundance. This study hypothesized that LACV vectors have unique species-specific spatial and temporal clusters. To test this, 44 sites were identified in Knox County, Tennessee for their land use/type. At each site, host-seeking mosquitoes were collected approximately every other week from May-October 2018. Spatial clusters of host-seeking mosquito collections for each of the three mosquito species were investigated using Kulldorff's spatial scan statistic, specifying a retrospective space-time Bernoulli model. Most vector clusters were identified in south-central Knox County while the seasonality of clusters varied by mosquito species. Clusters ofAe.albopictuswere observed throughout the entire study period while clusters ofAe.japonicusandAe.triseriatusonly occurred May-June. The findings indicate that the relative abundance of LACV vectors were more abundant in south-central Knox County compared to the rest of the county. Of interest, these clusters spatially overlapped with previous LACE diagnosed cases. These findings are useful in guiding decisions on targeted mosquito control in Knox County and may be applied to other counties within Southern Appalachia.	[Rowe, R. D.; Paulsen, D.; Fryxell, R. T. Trout] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA; [Odoi, A.] Univ Tennessee, Dept Biomed & Diagnost Serv, Knoxville, TN USA; [Moncayo, A. C.] Tennessee Dept Hlth, Nashville, TN USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville; Tennessee Department Health	Fryxell, RTT (corresponding author), Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA.	Rfryxell@utk.edu	Odoi, Agricola/I-9532-2019	Odoi, Agricola/0000-0001-5050-6737; Trout Fryxell, Rebecca/0000-0003-2133-0220	Tennessee Department of Health	Tennessee Department of Health	Funding was provided by the Tennessee Department of Health.	[Anonymous], 2017, Hepatol Int, V11, P1, DOI 10.1007/s12072-016-9783-9; ASTM, 2013, E8E8M ASTM ASTM INT, DOI [10.1520/D3418-15.2, DOI 10.1520/D3418-15.2, 10.1520/F2792-12A, 10.1520/F2944, DOI 10.1520/E0008]; beda A., 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0127296; Bevins SN, 2008, BIOL INVASIONS, V10, P1109, DOI 10.1007/s10530-007-9188-8; Bewick S, 2016, EMERG INFECT DIS, V22, P1921, DOI 10.3201/eid2211.160308; Byrd BD, 2018, MMWR-MORBID MORTAL W, V67, P1104, DOI 10.15585/mmwr.mm6739a8; Caldwell ND, 2005, J AM MOSQUITO CONTR, V21, P322, DOI 10.2987/8756-971X(2005)21[322:FCOOJJ]2.0.CO;2; Caldwell ND, 2004, SEASONAL ABUNDANCE M; Center for Disease Control (CDC), 2019, SYMPT TREATM CROSS V; Chae Y.K., 2009, PLOS ONE, V4, pe6523; Darsie W, 2005, IDENTIFICATION GEOGR; de Lima MS, 2015, STAT SINICA, V25, P225, DOI 10.5705/ss.2013.220w; Erwin PC, 2002, AM J EPIDEMIOL, V155, P1060, DOI 10.1093/aje/155.11.1060; Gaensbauer JT, 2014, PEDIATRICS, V134, pE642, DOI 10.1542/peds.2014-0498; Gerhardt RR, 2001, EMERG INFECT DIS, V7, P807; Grosjean P., PASTECS PACKAGE ANAL; Haddow A. D., 2009, PLOS ONE, V4, P2003; Haddow AD, 2009, J VECTOR ECOL, V34, P70, DOI [10.1111/j.1948-7134.2009.00009.x, 10.3376/038.034.0109]; Harris MC, 2015, EMERG INFECT DIS, V21, P646, DOI 10.3201/eid2104.140734; Harrison BA, 2016, MOSQUITOES MID ATLAN, P201; Jones TF, 1999, CLIN INFECT DIS, V28, P93, DOI 10.1086/515087; Kaufman MG, 2015, INVASION BIOL AEDES, P213; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M, 2018, SATSCANTM USER GUIDE; Lambert AJ, 2005, J CLIN MICROBIOL, V43, P1885, DOI 10.1128/JCM.43.4.1885-1889.2005; Lambert AJ, 2015, EMERG INFECT DIS, V21, P833, DOI 10.3201/eid2105.141992; Leisnham PT, 2012, ECOHEALTH, V9, P217, DOI 10.1007/s10393-012-0773-7; McJunkin JE, 2001, NEW ENGL J MED, V344, P801, DOI 10.1056/NEJM200103153441103; Moore JP, 1998, ENTOMOL NEWS, V109, P363; Mostashari F, 2003, EMERG INFECT DIS, V9, P641; PANTUWAT.S, 1972, AM J TROP MED HYG, V21, P476, DOI 10.4269/ajtmh.1972.21.476; Peyton EL, 1999, J AM MOSQUITO CONTR, V15, P238; R Core Team, 2021, R LANGUAGE ENV STAT; RStudio Team, 2019, RSTUDIO INT DEV R; Sugumaran R, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-43; Urquhart C, 2017, J AM MOSQUITO CONTR, V33, P233, DOI 10.2987/16-6620R.1; Urquhart C, 2016, J AM MOSQUITO CONTR, V32, P24, DOI 10.2987/8756-971X-32.1.24; Verdonschot PFM, 2014, LIMNOLOGICA, V45, P69, DOI 10.1016/j.limno.2013.11.002; WATTS DM, 1973, SCIENCE, V182, P1140, DOI 10.1126/science.182.4117.1140; Westby KM, 2015, J AM MOSQUITO CONTR, V31, P233, DOI 10.2987/moco-31-03-233-241.1; Zhang TL, 2012, STAT MED, V31, P762, DOI 10.1002/sim.4404	41	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0237322	10.1371/journal.pone.0237322	http://dx.doi.org/10.1371/journal.pone.0237322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881929	gold, Green Published			2022-12-26	WOS:000571063300102
J	Trabulus, S; Karaca, C; Balkan, II; Dincer, MT; Murt, A; Ozcan, SG; Karaali, R; Mete, B; Bakir, A; Kuskucu, MA; Altiparmak, MR; Tabak, F; Seyahi, N				Trabulus, Sinan; Karaca, Cebrail; Balkan, Ilker Inanc; Dincer, Mevlut Tamer; Murt, Ahmet; Ozcan, Seyda Gul; Karaali, Ridvan; Mete, Bilgul; Bakir, Alev; Kuskucu, Mert Ahmet; Altiparmak, Mehmet Riza; Tabak, Fehmi; Seyahi, Nurhan			Kidney function on admission predicts in-hospital mortality in COVID-19	PLOS ONE			English	Article							CORONAVIRUS; INJURY	Background Recent data have suggested the presence of a reciprocal relationship between COVID-19 and kidney function. To date, most studies have focused on the effect of COVID-19 on kidney function, whereas data regarding kidney function on the COVID-19 prognosis is scarce. Therefore, in this study, we aimed to investigate the association between eGFR on admission and the mortality rate of COVID-19. Methods We recruited 336 adult consecutive patients (male: 57.1%, mean age: 55.0 +/- 16.0 years) that were hospitalized with the diagnosis of COVID-19 in a tertiary care university hospital. Data were collected from the electronic health records of the hospital. On admission, eGFR was calculated using the CKD-EPI formula. Acute kidney injury was defined according to the KDIGO criteria. Binary logistic regression and Cox regression analyses were used to assess the relationship between eGFR on admission and in-hospital mortality of COVID-19. Results Baseline eGFR was under 60 mL/min/1.73m(2)in 61 patients (18.2%). Acute kidney injury occurred in 29.2% of the patients. In-hospital mortality rate was calculated as 12.8%. Age-adjusted and multivariate logistic regression analysis (p: 0.005, odds ratio: 0.974, CI: 0.956-0.992) showed that baseline eGFR was independently associated with mortality. Additionally, age-adjusted Cox regression analysis revealed a higher mortality rate in patients with an eGFR under 60 mL/min/1.73m(2). Conclusions On admission eGFR seems to be a prognostic marker for mortality in patients with COVID-19. We recommend that eGFR be measured in all patients on admission and used as an additional tool for risk stratification. Close follow-up should be warranted in patients with a reduced eGFR.	[Trabulus, Sinan; Karaca, Cebrail; Dincer, Mevlut Tamer; Murt, Ahmet; Altiparmak, Mehmet Riza; Seyahi, Nurhan] Istanbul Univ Cerrahpasa, Cerrahpasa Med Fac, Dept Nephrol, Istanbul, Turkey; [Balkan, Ilker Inanc; Karaali, Ridvan; Mete, Bilgul; Tabak, Fehmi] Istanbul Univ Cerrahpasa, Cerrahpasa Med Fac, Dept Infect Dis & Clin Microbiol, Istanbul, Turkey; [Ozcan, Seyda Gul] Istanbul Univ Cerrahpasa, Cerrahpasa Med Fac, Dept Internal Med, Istanbul, Turkey; [Bakir, Alev] Halic Univ, Dept Biostat & Med Informat, Istanbul, Turkey; [Kuskucu, Mert Ahmet] Istanbul Univ Cerrahpasa, Cerrahpasa Med Fac, Dept Microbiol, Istanbul, Turkey	Istanbul University - Cerrahpasa; Istanbul University - Cerrahpasa; Istanbul University - Cerrahpasa; Halic University; Istanbul University - Cerrahpasa	Seyahi, N (corresponding author), Istanbul Univ Cerrahpasa, Cerrahpasa Med Fac, Dept Nephrol, Istanbul, Turkey.	nseyahi@yahoo.com	Ozcan, Seyda Gul/AAE-4457-2022; Dincer, Mevlut Tamer/AAA-8435-2020; Trabulus, Sinan/AAC-3572-2021; Altiparmak, Mehmet Riza/AAC-2508-2021; Karaca, Cebrail/GPC-8845-2022; balkan, ilker inanc/AAI-1578-2019; Murt, Ahmet/AAC-2423-2021; BAKIR, Alev/AAF-6907-2021; BAKIR, Alev/AAZ-8403-2021; KARAALİ, Rıdvan/AAQ-1018-2020	Ozcan, Seyda Gul/0000-0002-4341-5252; Karaca, Cebrail/0000-0003-0969-7708; balkan, ilker inanc/0000-0002-8977-5931; BAKIR, Alev/0000-0003-0664-5822; KARAALİ, Rıdvan/0000-0003-2440-7529; Seyahi, Nurhan/0000-0001-7427-618X; /0000-0002-1948-2914; Altiparmak, Mehmet Riza/0000-0002-3579-1100				a R-M, 2020, J CLIN MED, V9; Anadolu Agency, 2020, TURK DEATH TOLL COR; [Anonymous], 2012, KIDNEY INT SUPPL, V2, P1, DOI [10.1038/kisup.2012.1, DOI 10.1038/KISUP.2012.1]; Association ERA-EDTA, 2020, COVID 19 NEWS INF; Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]; Chen YT, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03009-y; Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005; Chou CY, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000174; European Centre for Disease Prevention and Control, 2020, CAS DEF COR DIS 2019; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Gupta N, 2019, THROMB RES, V181, P77, DOI 10.1016/j.thromres.2019.07.013; Henry BM, 2020, INT UROL NEPHROL, V52, P1193, DOI 10.1007/s11255-020-02451-9; Hirsch JS, 2020, KIDNEY INT, V98, P209, DOI 10.1016/j.kint.2020.05.006; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; [李仲平 Li Zhongping], 2020, [中国软科学, China Soft Science], P1; Ministry of Health of Turkey, 2018, TURK HLTH STAT YB 20; Nalesso F, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051529; Pei GC, 2020, J AM SOC NEPHROL, V31, P1157, DOI 10.1681/ASN.2020030276; Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2013400, 10.1056/NEJMc2011400]; SARDU C, 2020, J CLIN MED, V9, DOI [10.20944/preprints202004.0204.v1, DOI 10.3390/JCM9051417]; Su H, 2020, KIDNEY INT, V98, P219, DOI 10.1016/j.kint.2020.04.003; Wang LW, 2020, AM J NEPHROL, V51, P343, DOI 10.1159/000507471; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]	25	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238680	10.1371/journal.pone.0238680	http://dx.doi.org/10.1371/journal.pone.0238680			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881976	Green Published, Green Submitted, gold			2022-12-26	WOS:000571063300064
J	Zhou, XT; Jia, LD; Duan, MZ; Chen, X; Qiao, CL; Ma, JQ; Zhang, C; Jing, FY; Zhang, SS; Yang, B; Zhang, LY; Li, JN				Zhou, Xin-Tong; Jia, Le-Dong; Duan, Mou-Zheng; Chen, Xue; Qiao, Cai-Lin; Ma, Jin-Qi; Zhang, Chao; Jing, Fu-Yu; Zhang, Sheng-Sen; Yang, Bo; Zhang, Li-Yuan; Li, Jia-Na			Genome-wide identification and expression profiling of thecarotenoid cleavage dioxygenase(CCD) gene family inBrassica napusL	PLOS ONE			English	Article							CAROTENOID-CLEAVAGE DIOXYGENASE; FUNCTIONAL-CHARACTERIZATION; ARABIDOPSIS-THALIANA; OXIDATIVE CLEAVAGE; BETA-CAROTENE; FLOWER COLOR; PROTEIN; CLONING; YELLOW; BIOSYNTHESIS	Carotenoid cleavage dioxygenase (CCD), a key enzyme in carotenoid metabolism, cleaves carotenoids to form apo-carotenoids, which play a major role in plant growth and stress responses.CCDgenes had not previously been systematically characterized inBrassica napus(rapeseed), an important oil crop worldwide. In this study, we identified 30BnCCDgenes and classified them into nine subgroups based on a phylogenetic analysis. We identified the chromosomal locations, gene structures, andcis-promoter elements of each of these genes and performed a selection pressure analysis to identify residues under selection. Furthermore, we determined the subcellular localization, physicochemical properties, and conserved protein motifs of the encoded proteins. All the CCD proteins contained a retinal pigment epithelial membrane protein (RPE65) domain. qRT-PCR analysis of expression of 20 representativeBnCCDgenes in 16 tissues of theB.napuscultivar Zhong Shuang 11 ('ZS11') revealed that members of theBnCCDgene family possess a broad range of expression patterns. This work lays the foundation for functional studies of theBnCCDgene family.	[Zhou, Xin-Tong; Jia, Le-Dong; Duan, Mou-Zheng; Chen, Xue; Qiao, Cai-Lin; Ma, Jin-Qi; Zhang, Chao; Jing, Fu-Yu; Zhang, Sheng-Sen; Yang, Bo; Zhang, Li-Yuan; Li, Jia-Na] Southwest Univ, Coll Agron & Biotechnol, Chongqing Rapeseed Engn Res Ctr, Chongqing, Peoples R China; [Zhou, Xin-Tong; Jia, Le-Dong; Duan, Mou-Zheng; Chen, Xue; Qiao, Cai-Lin; Ma, Jin-Qi; Zhang, Chao; Jing, Fu-Yu; Zhang, Sheng-Sen; Yang, Bo; Zhang, Li-Yuan; Li, Jia-Na] Southwest Univ, Acad Agr Sci, Chongqing, Peoples R China	Southwest University - China; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Southwest University - China	Li, JN (corresponding author), Southwest Univ, Coll Agron & Biotechnol, Chongqing Rapeseed Engn Res Ctr, Chongqing, Peoples R China.; Li, JN (corresponding author), Southwest Univ, Acad Agr Sci, Chongqing, Peoples R China.	ljn1950@swu.edu.cn	Ma, Jinqi/AAO-9319-2020	Ma, Jinqi/0000-0001-5674-4023	Ministry of Science and Technology of the Peoples Republic of China (The National Key Research and Development Plan) [2018YFD0100504-05, 2016YFD0101305]; National Natural Science Foundation of China [31830067, U1302266]; Ministry of Education of the People's Republic of China (111 Project) [B12006]; Ministry of Education of the People's Republic of China (National Undergraduate Training Program for Innovation and Entrepreneurship) [201810635080]	Ministry of Science and Technology of the Peoples Republic of China (The National Key Research and Development Plan); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of the People's Republic of China (111 Project); Ministry of Education of the People's Republic of China (National Undergraduate Training Program for Innovation and Entrepreneurship)	JNL was funded to undertake research by Ministry of Science and Technology of the Peoples Republic of China (http://www.most.gov.cn/) (The National Key Research and Development Plan, 2018YFD0100504-05, 2016YFD0101305) (The National Natural Science Foundation of China, 31830067, U1302266). JNL was funded to undertake research by Ministry of Education of the People's Republic of China (http://www.moe.gov.cn/) (The 111 Project, B12006). XTZ was funded to do research by Ministry of Education of the People's Republic of China (National Undergraduate Training Program for Innovation and Entrepreneurship, 201810635080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian A, 2012, SCIENCE NEW YORK NY, V6074; Altschul SFM T.L., 1997, NUCL ACIDS RES, P25; [Anonymous], 2015, US NATURE MED, V21, P100, DOI [10.1038/nm0215-100, DOI 10.1038/NM0215-100]; [Anonymous], 2012, CAROTENOID BIOSYNTHE; [Anonymous], 2005, AM PROSPECT, V16, pA1; [Anonymous], 2002, FEDERAL TRADE CO JUL, pi; [Anonymous], 2013, CLIN DIABETOLOGY, V2, pA12; [Anonymous], 2014, NEUROSURG FOCUS, V36, pA1; [Anonymous], 2006, PLOS MED, V3, pe252; Bailey TL, 2006, NUCL ACIDS RES S2; Britton G, 1995, FASEB J, V9, P1551, DOI 10.1096/fasebj.9.15.8529834; Campbell R, 2010, PLANT PHYSIOL, V154, P656, DOI 10.1104/pp.110.158733; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Cheng F, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.24; Cheng F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-136; Chernys JT, 2000, PLANT PHYSIOL, V124, P343, DOI 10.1104/pp.124.1.343; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Elisabeth G, 2003, NUCL ACIDS RES, P13; Falchi R, 2013, PLANT J, V76, P175, DOI 10.1111/tpj.12283; Feng C, 2011, BMC MICROBIOL, V11, DOI [10.1186/1471-2180-11-189, 10.1186/1471-2229-11-136]; Finn RD, 2009, NUCL ACIDS RES S1; Galpaz N, 2006, PLANT CELL, V18, P1947, DOI 10.1105/tpc.105.039966; Garcia-Limones C, 2008, J AGR FOOD CHEM, V56, P9277, DOI 10.1021/jf801096t; Gonzalez-Jorge S, 2013, PLANT CELL, V25, P4812, DOI 10.1105/tpc.113.119677; Gonzalez-Verdejo CI, 2015, PLANT FOOD HUM NUTR, V70, P200, DOI 10.1007/s11130-015-0482-9; Guo CL, 2014, J EXP BOT, V65, P1513, DOI 10.1093/jxb/eru007; HAMEL CP, 1993, J BIOL CHEM, V268, P15751; Holger S, 2006, J BIOL CHEM, V281, P9845, DOI 10.1074/jbc.M511668200; Huang FC, 2009, J EXP BOT, V60, P3011, DOI 10.1093/jxb/erp137; Ilg A, 2010, PLANTA, V232, P691, DOI 10.1007/s00425-010-1205-y; Jo YD, 2016, SCI HORTIC-AMSTERDAM, V212, P49, DOI 10.1016/j.scienta.2016.09.035; Johnson JD, 2009, FREE RADICAL BIO MED, V47, P321, DOI 10.1016/j.freeradbiomed.2009.05.008; Kiefer C, 2001, J BIOL CHEM, V276, P14110, DOI 10.1074/jbc.M011510200; Kim Y, 2016, J PLANT GROWTH REGUL, V35, P202, DOI 10.1007/s00344-015-9520-y; Kj L, 2000, METHODS, V25; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lange BM, 2003, PLANT MOL BIOL, V51, P925, DOI 10.1023/A:1023005504702; Lashbrooke JG, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-156; Ledger SE, 2010, NEW PHYTOL, V188, P803, DOI 10.1111/j.1469-8137.2010.03394.x; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Lin H, 2009, PLANT CELL, V21, P1512, DOI 10.1105/tpc.109.065987; Liu H, 2013, PLANT BREEDING, V132, P417, DOI 10.1111/pbr.12043; Lu K, 2019, WHOLE GENOME RESEQUE; Ng CY, 2016, ENVIRON IMPACT ASSES, V61, P1, DOI 10.1016/j.eiar.2016.06.006; Norman JMV, 2010, PLANT J, V49, P619; Ohmiya A, 2009, PLANT BIOTECHNOL-NAR, V26, P351, DOI 10.5511/plantbiotechnology.26.351; Paiva SAR, 1999, J AM COLL NUTR, V18, P426, DOI 10.1080/07315724.1999.10718880; Paul H, 2007, NUCL ACIDS RES S2; Rameau C, 2010, CR BIOL, V333, P344, DOI 10.1016/j.crvi.2010.01.012; Schwartz SH, 2001, J BIOL CHEM, V276, P25208, DOI 10.1074/jbc.M102146200; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Shu H, 2016, CHINESE AGR SCI B; Simkin AJ, 2004, PLANT J, V40, P882, DOI 10.1111/j.1365-313X.2004.02263.x; Simkin AJ, 2004, PLANT PHYSIOL, V136, P3504, DOI 10.1104/pp.104.049718; Son S, 2016, PLANTA, V244, P429, DOI 10.1007/s00425-016-2518-2; Sui XW, 2013, ARCH BIOCHEM BIOPHYS, V539, P203, DOI 10.1016/j.abb.2013.06.012; Suzuki S, 2007, PLANT CELL REP, V26, P951, DOI 10.1007/s00299-006-0302-7; Tan BC, 2003, PLANT J, V35, P44, DOI 10.1046/j.1365-313X.2003.01786.x; Tian XW, 2015, J PLANT GROWTH REGUL, V34, P465, DOI 10.1007/s00344-015-9481-1; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Ureshino K, 2016, EUPHYTICA, V207, P401, DOI 10.1007/s10681-015-1557-2; Vallabhaneni R, 2010, ARCH BIOCHEM BIOPHYS, V504, P104, DOI 10.1016/j.abb.2010.07.019; Walter MH, 2011, NAT PROD REP, V28, P663, DOI 10.1039/c0np00036a; Wang Z, 2018, ACTA BOT BOREALI OCC; Wei YP, 2016, PLANT MOL BIOL REP, V34, P512, DOI 10.1007/s11105-015-0943-1; Xia X, 2013, WORK CONF REVERSE EN, P72, DOI 10.1109/WCRE.2013.6671282; Xie XN, 2010, ANNU REV PHYTOPATHOL, V48, P93, DOI 10.1146/annurev-phyto-073009-114453; Xu PP, 2017, PLANT SCI, V256, P16, DOI 10.1016/j.plantsci.2016.11.012; Xue-Zhong XU, 2018, ACTA AGRONOMICA SINI; Yoshioka S, 2012, EUPHYTICA, V184, P377, DOI 10.1007/s10681-011-0602-z; Zdobnov EM, 2001, BIOINFORMATICS, P9; Zhang B, 2015, NEW PHYTOL, V206, P1513, DOI 10.1111/nph.13335; Zhang M, 2018, MOL PLANT BREEDING; Zhang M, 2009, J PLANT PHYSIOL, V166, P1241, DOI 10.1016/j.jplph.2009.01.013; Zhang YM, 2008, J PLANT GROWTH REGUL, V27, P151, DOI 10.1007/s00344-008-9041-z; Zhuan-Di WU, 2016, SCI AGR SINICA; [No title captured]	79	11	11	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238179	10.1371/journal.pone.0238179	http://dx.doi.org/10.1371/journal.pone.0238179			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881902	Green Published, gold			2022-12-26	WOS:000571063300037
J	Langendorf, CG; O'Brien, MT; Ngoei, KRW; McAloon, LM; Dhagat, U; Hoque, A; Ling, NXY; Dite, TA; Galic, S; Loh, K; Parker, MW; Oakhill, JS; Kemp, BE; Scott, JW				Langendorf, Christopher G.; O'Brien, Matthew T.; Ngoei, Kevin R. W.; McAloon, Luke M.; Dhagat, Urmi; Hoque, Ashfaqul; Ling, Naomi X. Y.; Dite, Toby A.; Galic, Sandra; Loh, Kim; Parker, Michael W.; Oakhill, Jonathan S.; Kemp, Bruce E.; Scott, John W.			CaMKK2 is inactivated by cAMP-PKA signaling and 14-3-3 adaptor proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ca2+-calmodulin&#8211; dependent protein kinase kinase-2 (CaMKK2); calmodulin (CaM); cyclic AMP (cAMP); protein kinase A (PKA); inhibition mechanism; adaptor protein; 14-3-3; Ca2+-calmodulin&#8211; dependent protein kinase (CaMK); 14-3-3 protein; Ca2+; calmodulin; CaMKK2; cAMP; PKA	KINASE KINASE; PROSTATE-CANCER; BINDING; PHOSPHORYLATION; CALMODULIN; RECOGNITION; BETA; INHIBITION; ACTIVATION; RESISTANCE	The calcium-calmodulin-dependent protein kinase kinase-2 (CaMKK2) is a key regulator of cellular and whole-body energy metabolism. It is known to be activated by increases in intracellular Ca2+, but the mechanisms by which it is inactivated are less clear. CaMKK2 inhibition protects against prostate cancer, hepatocellular carcinoma, and metabolic derangements induced by a high-fat diet; therefore, elucidating the intracellular mechanisms that inactivate CaMKK2 has important therapeutic implications. Here we show that stimulation of cAMP-dependent protein kinase A (PKA) signaling in cells inactivates CaMKK2 by phosphorylation of three conserved serine residues. PKA-dependent phosphorylation of Ser(495) directly impairs calcium-calmodulin activation, whereas phosphorylation of Ser(100) and Ser(511) mediate recruitment of 14-3-3 adaptor proteins that hold CaMKK2 in the inactivated state by preventing dephosphorylation of phospho-Ser(495). We also report the crystal structure of 14-3-3 zeta bound to a synthetic diphosphorylated peptide that reveals how the canonical (Ser(511)) and noncanonical (Ser(100)) 14-3-3 consensus sites on CaMKK2 cooperate to bind 14-3-3 proteins. Our findings provide detailed molecular insights into how cAMP-PKA signaling inactivates CaMKK2 and reveals a pathway to inhibit CaMKK2 with potential for treating human diseases.	[Langendorf, Christopher G.; O'Brien, Matthew T.; Ngoei, Kevin R. W.; McAloon, Luke M.; Dhagat, Urmi; Hoque, Ashfaqul; Ling, Naomi X. Y.; Dite, Toby A.; Galic, Sandra; Loh, Kim; Parker, Michael W.; Oakhill, Jonathan S.; Kemp, Bruce E.; Scott, John W.] Univ Melbourne, St Vincents Inst, Fitzroy, Vic, Australia; [Langendorf, Christopher G.; O'Brien, Matthew T.; Ngoei, Kevin R. W.; McAloon, Luke M.; Dhagat, Urmi; Hoque, Ashfaqul; Ling, Naomi X. Y.; Dite, Toby A.; Galic, Sandra; Loh, Kim; Parker, Michael W.; Oakhill, Jonathan S.; Kemp, Bruce E.; Scott, John W.] Univ Melbourne, Dept Med, Fitzroy, Vic, Australia; [Dhagat, Urmi; Parker, Michael W.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic, Australia; [Oakhill, Jonathan S.; Kemp, Bruce E.; Scott, John W.] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Melbourne, Vic, Australia; [Scott, John W.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Dite, Toby A.] Univ Dundee, Prot Phosphorylat & Ubiquitylat Unit, Sch Life Sci, Dundee, Scotland	St. Vincent's Institute of Medical Research; University of Melbourne; University of Melbourne; University of Melbourne; Australian Catholic University; Florey Institute of Neuroscience & Mental Health; University of Dundee	Scott, JW (corresponding author), Univ Melbourne, St Vincents Inst, Fitzroy, Vic, Australia.; Scott, JW (corresponding author), Univ Melbourne, Dept Med, Fitzroy, Vic, Australia.; Scott, JW (corresponding author), Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Melbourne, Vic, Australia.; Scott, JW (corresponding author), Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia.	jscott@svi.edu.au	Hoque, Ashfaqul/AAL-8462-2020; Scott, John W/AAA-2676-2021; Galic, Sandra/C-6098-2014; Oakhill, Jon/F-5724-2011	Hoque, Ashfaqul/0000-0003-2384-2983; Scott, John W/0000-0002-1896-9798; Galic, Sandra/0000-0002-7611-5619; Ling, Naomi/0000-0001-6240-4092; Loh, Kim/0000-0003-3781-1926; Langendorf, Christopher/0000-0002-9049-5283; Oakhill, Jon/0000-0002-9475-1440	National Health and Medical Research Council [1138102, 1145265]; Jack Brockhoff Foundation [JBF-4206]; Australian Research Council [DP170101196]; Victorian Government's Operational Infrastructure Support Program; Australian Cancer Research Foundation toward the ACRF Rational Drug Discovery Centre	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Jack Brockhoff Foundation; Australian Research Council(Australian Research Council); Victorian Government's Operational Infrastructure Support Program; Australian Cancer Research Foundation toward the ACRF Rational Drug Discovery Centre	This work was supported by National Health and Medical Research Council Grants 1138102 (to J. W. S.) and 1145265 (to J. S. O.) and the Jack Brockhoff Foundation Grant JBF-4206, 2016 (to C. G. L.). C. G. L. is a National Health and Medical Research Council Early Career Research Fellow and M. W. P. a National Health and Medical Research Council Senior Principal Research Fellow. B. E. K. was a National Health and Medical Research Council Fellow supported by the Australian Research Council (DP170101196). This project was supported in part by the Victorian Government's Operational Infrastructure Support Program. MS data were acquired at the Mass Spectrometry and Proteomics Facility, Bio21, University of Melbourne. We acknowledge the funding support of the Australian Cancer Research Foundation toward the ACRF Rational Drug Discovery Centre.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Aragao D, 2018, J SYNCHROTRON RADIAT, V25, P885, DOI 10.1107/S1600577518003120; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Davare MA, 2004, J BIOL CHEM, V279, P52191, DOI 10.1074/jbc.M409873200; Edelman AM, 1996, J BIOL CHEM, V271, P10806, DOI 10.1074/jbc.271.18.10806; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Frigo DE, 2011, CANCER RES, V71, P528, DOI 10.1158/0008-5472.CAN-10-2581; Gocher AM, 2017, J BIOL CHEM, V292, P14188, DOI 10.1074/jbc.M117.778464; Green MF, 2011, J BIOL CHEM, V286, P28066, DOI 10.1074/jbc.M111.251504; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hayes MR, 2011, CELL METAB, V13, P320, DOI 10.1016/j.cmet.2011.02.001; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Hofer AM, 2012, CURR MED CHEM, V19, P5768; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Ichimura T, 2008, FEBS LETT, V582, P661, DOI 10.1016/j.febslet.2008.01.037; Kalabova D, 2020, FEBS J, V287, P3494, DOI 10.1111/febs.15215; KEMP BE, 1977, J BIOL CHEM, V252, P4888; Kosowska A, 2017, ENDOCR CONNECT, V6, P856, DOI 10.1530/EC-17-0294; Kostelecky B, 2009, EMBO REP, V10, P983, DOI 10.1038/embor.2009.150; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Lin FM, 2015, HEPATOLOGY, V62, P505, DOI 10.1002/hep.27832; Ling NXY, 2020, BIPOLAR DISORD, V22, P841, DOI 10.1111/bdi.12901; London E, 2014, ENDOCRINOLOGY, V155, P3397, DOI 10.1210/en.2014-1122; Marcelo KL, 2016, TRENDS ENDOCRIN MET, V27, P706, DOI 10.1016/j.tem.2016.06.001; Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158; Matsuoka Y, 1996, J BIOL CHEM, V271, P25157, DOI 10.1074/jbc.271.41.25157; Matsushita M, 1999, J BIOL CHEM, V274, P10086, DOI 10.1074/jbc.274.15.10086; Molzan M, 2012, J MOL BIOL, V423, P486, DOI 10.1016/j.jmb.2012.08.009; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Nakanishi A, 2017, J BIOL CHEM, V292, P19804, DOI 10.1074/jbc.M117.805085; Nomiyama T, 2014, DIABETES, V63, P3891, DOI 10.2337/db13-1169; O'Brien MT, 2017, SCI REP-UK, V7, DOI 10.1038/srep43264; O'Byrne SN, 2020, MOLECULES, V25, DOI 10.3390/molecules25020325; Penfold L, 2018, CANCER RES, V78, P6747, DOI 10.1158/0008-5472.CAN-18-0585; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Psenakova K, 2018, BBA-GEN SUBJECTS, V1862, P1612, DOI 10.1016/j.bbagen.2018.04.006; Racioppi L, 2012, J BIOL CHEM, V287, P31658, DOI 10.1074/jbc.R112.356485; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Schreyer SA, 2001, DIABETES, V50, P2555, DOI 10.2337/diabetes.50.11.2555; Scott JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep14436; Spengler K, 2020, BIOCHEM J, V477, P3453, DOI 10.1042/BCJ20200555; Stevers LM, 2018, J AM CHEM SOC, V140, P14498, DOI 10.1021/jacs.8b09618; Stevers LM, 2016, P NATL ACAD SCI USA, V113, pE1152, DOI 10.1073/pnas.1516631113; Tokumitsu H, 1997, BIOCHEMISTRY-US, V36, P12823, DOI 10.1021/bi971348i; Wayman GA, 1997, J BIOL CHEM, V272, P16073, DOI 10.1074/jbc.272.26.16073; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wong R, 2014, J NEUROSCI, V34, P13371, DOI 10.1523/JNEUROSCI.1008-14.2014; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	52	17	17	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2020	295	48					16239	16250		10.1074/jbc.RA120.013756	http://dx.doi.org/10.1074/jbc.RA120.013756			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PE7CE	32913128	hybrid, Green Published			2022-12-26	WOS:000598519500006
J	Norris, JM; Simpson, BS; Freeman, A; Kirkham, A; Whitaker, HC; Emberton, M				Norris, Joseph M.; Simpson, Benjamin S.; Freeman, Alex; Kirkham, Alex; Whitaker, Hayley C.; Emberton, Mark			Conspicuity of prostate cancer on multiparametric magnetic resonance imaging: A cross-disciplinary translational hypothesis	FASEB JOURNAL			English	Article						conspicuity theory; multiparametric MRI; prostate cancer	PREDICTING BIOCHEMICAL RECURRENCE; MULTI-PARAMETRIC MRI; RADICAL PROSTATECTOMY; TUMOR ANGIOGENESIS; PROGRESSION; ANTIGEN; BIOPSY; EXPRESSION; RISK; ASSOCIATION	Pre-biopsy multiparametric magnetic resonance imaging (mpMRI) has transformed the risk stratification and diagnostic approach for suspected prostate cancer. The majority of clinically significant prostate cancers are visible on pre-biopsy mpMRI, however, there are a subset of significant tumors that are not detected by mpMRI. The radiobiological mechanisms underpinning mpMRI-visibility and invisibility of these cancers remain uncertain. Emerging evidence suggests that mpMRI-visible tumors are enriched with molecular features associated with increased disease aggressivity and poor clinical prognosis, which is supported by short-term endpoints, such as biochemical recurrence following surgery. Furthermore, at the histopathological level, mpMRI-visible tumors appear to exhibit increased architectural and vascular density compared to mpMRI-invisible disease. It seems probable that the genomic, pathological, radiological, and clinical features of mpMRI-visible and mpMRI-invisible prostate cancers are interrelated. Here, we propose a novel cross-disciplinary theory that links genomic and molecular evidence with cellular and histopathological appearances, elucidating both the mpMRI visibility and clinical status of significant prostate cancer.	[Norris, Joseph M.; Simpson, Benjamin S.; Whitaker, Hayley C.; Emberton, Mark] UCL, UCL Div Surg & Intervent Sci, 3rd Floor,Charles Bell House,43-45 Foley St, London W1W 7TS, England; [Norris, Joseph M.; Emberton, Mark] Univ Coll London Hosp NHS Fdn Trust, Dept Urol, London, England; [Freeman, Alex] Univ Coll London Hosp NHS Fdn Trust, Dept Pathol, London, England; [Kirkham, Alex] Univ Coll London Hosp NHS Fdn Trust, Dept Radiol, London, England	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Norris, JM (corresponding author), UCL, UCL Div Surg & Intervent Sci, 3rd Floor,Charles Bell House,43-45 Foley St, London W1W 7TS, England.	joseph.norris@ucl.ac.uk			Medical Research Council (MRC) [MR/S00680X/1]; Rosetrees Trust; MRC [MR/S00680X/1] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rosetrees Trust(Rosetrees Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Joseph M. Norris is funded by the Medical Research Council (MRC) (Grant Reference: MR/S00680X/1). Benjamin S. Simpson is funded by the Rosetrees Trust	Adamis S, 2014, EJSO-EUR J SURG ONC, V40, P496, DOI 10.1016/j.ejso.2014.02.221; Ahdoot M, 2020, NEW ENGL J MED, V382, P917, DOI 10.1056/NEJMoa1910038; Ahmed HU, 2017, LANCET, V389, P815, DOI 10.1016/S0140-6736(16)32401-1; Amin A, 2020, J UROLOGY, V203, P910, DOI 10.1097/JU.0000000000000693; Beksac AT, 2018, J UROLOGY, V200, P1241, DOI 10.1016/j.juro.2018.06.041; Bill-Axelson A, 2018, NEW ENGL J MED, V379, P2319, DOI 10.1056/NEJMoa1807801; Bono AV, 2002, PROSTATE CANCER P D, V5, P123, DOI 10.1038/sj.pcan.4500572; Borren A, 2014, ACTA ONCOL, V53, P88, DOI 10.3109/0284186X.2013.837581; Branca G, 2017, ONCOL REV, V11, DOI 10.4081/oncol.2017.317; Chesnut GT, 2020, EUR UROL, V77, P501, DOI 10.1016/j.eururo.2019.12.009; Coffey N, 2015, J MAGN RESON IMAGING, V41, P1639, DOI 10.1002/jmri.24694; Dasgupta P, 2019, BJU INT, V124, P1, DOI 10.1111/bju.14815; De Jaeger K, 1998, INT J RADIAT ONCOL, V42, P717, DOI 10.1016/S0360-3016(98)00323-X; Downes MR, 2016, ACAD RADIOL, V23, P1412, DOI 10.1016/j.acra.2016.07.013; Drost FJH, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012663.pub2; Dulaney CR, 2017, ONCOTARGET, V8, P68038, DOI 10.18632/oncotarget.19145; Eggener SE, 2011, J UROLOGY, V185, P869, DOI 10.1016/j.juro.2010.10.057; Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663; Fraser M, 2017, NATURE, V541, P359, DOI 10.1038/nature20788; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hattori S, 2014, BJU INT, V113, P741, DOI 10.1111/bju.12329; Hong MKH, 2011, PATHOLOGY, V43, P138, DOI 10.1097/PAT.0b013e3283420155; Houlahan KE, 2019, EUR UROL, V76, P18, DOI 10.1016/j.eururo.2018.12.036; Hricak H, 2003, SEMIN ONCOL, V30, P616, DOI 10.1016/S0093-7754(03)00359-2; Jambor I, 2020, J MAGN RESON IMAGING, V51, P1075, DOI 10.1002/jmri.26928; Johnson DC, 2019, EUR UROL, V75, P712, DOI 10.1016/j.eururo.2018.11.031; Kasivisvanathan V, 2018, NEW ENGL J MED, V378, P1767, DOI 10.1056/NEJMoa1801993; Kesch C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35058-3; Kweldam CF, 2018, TRANSL ANDROL UROL, V7, P145, DOI 10.21037/tau.2017.12.33; Laufer M, 2000, UROLOGY, V55, P309, DOI 10.1016/S0090-4295(99)00465-3; Lavallee LT, 2011, CUAJ-CAN UROL ASSOC, V5, P397, DOI 10.5489/cuaj.11061; Lee JJ, 2015, PROSTATE, V75, P183, DOI 10.1002/pros.22903; Lenkinski RE, 2008, MAGN RESON MATER PHY, V21, P411, DOI 10.1007/s10334-008-0133-3; Li P, 2018, THERANOSTICS, V8, P1752, DOI 10.7150/thno.23180; Li ZP, 2005, WORLD J GASTROENTERO, V11, P1287, DOI 10.3748/wjg.v11.i9.1287; McCann SM, 2016, AM J ROENTGENOL, V206, P559, DOI 10.2214/AJR.15.14967; Melegh Z, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112676; Meng AX, 2005, RADIOTHER ONCOL, V76, P168, DOI 10.1016/j.radonc.2005.06.025; Ming M, 2012, CANCER LETT, V319, P125, DOI 10.1016/j.canlet.2012.01.003; Miyai K, 2019, MODERN PATHOL, V32, P1536, DOI 10.1038/s41379-019-0292-y; Moul JW, 2000, J UROLOGY, V163, P1632, DOI 10.1016/S0022-5347(05)67511-8; Norris J, 2020, NPJ CLIM ATMOS SCI, V3, DOI 10.1038/s41612-019-0105-5; Norris JM, 2019, EUR J SURG ONCOL, V45, P2203; Norris JM, 2020, EUR UROL, V78, P163, DOI 10.1016/j.eururo.2020.04.029; Norris JM, 2020, BJU INT, V126, P237, DOI 10.1111/bju.15085; Norris JM, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034611; Norris JM, 2020, BJU INT, V125, P340, DOI 10.1111/bju.14919; Park JJ, 2014, AM J ROENTGENOL, V202, pW459, DOI 10.2214/AJR.13.11381; Parry MA, 2019, EUR UROL ONCOL, V2, P1, DOI 10.1016/j.euo.2018.08.005; Petit JH, 2006, CANCER-AM CANCER SOC, V107, P2180, DOI 10.1002/cncr.22243; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Preda A, 2004, J MAGN RESON IMAGING, V20, P865, DOI 10.1002/jmri.20184; Radtke JP, 2015, J UROLOGY, V193, P87, DOI 10.1016/j.juro.2014.07.098; Schieda N, 2014, EUR RADIOL, V24, P1349, DOI 10.1007/s00330-014-3150-9; Shikanov S, 2012, PROSTATE CANCER P D, V15, P106, DOI 10.1038/pcan.2011.55; Stavrinides V, 2020, EUR UROL, V78, P443, DOI 10.1016/j.eururo.2020.03.035; Sun Y, 2019, BRIT J RADIOL, V92, DOI 10.1259/bjr.20190373; Switlyk MD, 2019, AM J ROENTGENOL, V212, P1206, DOI 10.2214/AJR.18.20743; Tom MC, 2019, J UROLOGY, V202, P710, DOI 10.1097/JU.0000000000000316; Tonttila PP, 2019, BJU INT, V124, P992, DOI 10.1111/bju.14812; Truong M, 2018, J UROLOGY, V199, P106, DOI 10.1016/j.juro.2017.07.037; Turkbey B, 2009, AM J ROENTGENOL, V193, P304, DOI 10.2214/AJR.09.2869; van Houdt PJ, 2020, J MAGN RESON IMAGING, V51, P1235, DOI 10.1002/jmri.26933; WISE J, 2018, BMJ-BRIT MED J, V363, DOI DOI 10.1136/BMJ.K5290; Yang LJ, 2018, EBIOMEDICINE, V31, P182, DOI 10.1016/j.ebiom.2018.04.019	65	6	6	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14150	14159		10.1096/fj.202001466R	http://dx.doi.org/10.1096/fj.202001466R		SEP 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32920937	Green Published			2022-12-26	WOS:000570733200001
J	Kumar, R; Malagon, DA; Carter, ED; Miller, DL; Bohanon, ML; Cusaac, JPW; Peterson, AC; Gray, MJ				Kumar, Rajeev; Malagon, Daniel A.; Carter, Edward Davis; Miller, Debra L.; Bohanon, Markese L.; Cusaac, Joseph Patrick W.; Peterson, Anna C.; Gray, Matthew J.			Experimental methodologies can affect pathogenicity of Batrachochytrium salamandrivorans infections	PLOS ONE			English	Article							NOTOPHTHALMUS-VIRIDESCENS; FUNGAL PATHOGEN; CHYTRID FUNGUS; SURVIVAL-DATA; DENDROBATIDIS; CHYTRIDIOMYCOSIS; BIODIVERSITY; DISEASE; STRESS; NEWTS	Controlled experiments are one approach to understanding the pathogenicity of etiologic agents to susceptible hosts. The recently discovered fungal pathogen,Batrachochytrium salamandrivorans(Bsal), has resulted in a surge of experimental investigations because of its potential to impact global salamander biodiversity. However, variation in experimental methodologies could thwart knowledge advancement by introducing confounding factors that make comparisons difficult among studies. Thus, our objective was to evaluate if variation in experimental methods changed inferences made on the pathogenicity ofBsal. We tested whether passage duration ofBsalculture, exposure method of the host toBsal(water bath vs. skin inoculation),Bsalculturing method (liquid vs. plated), host husbandry conditions (aquatic vs. terrestrial), and skin swabbing frequency influenced diseased-induced mortality in a susceptible host species, the eastern newt (Notophthalmus viridescens). We found that disease-induced mortality was faster for eastern newts when exposed to a low passage isolate, when newts were housed in terrestrial environments, and if exposure to zoospores occurred via water bath. We did not detect differences in disease-induced mortality between culturing methods or swabbing frequencies. Our results illustrate the need to standardize methods amongBsalexperiments. We provide suggestions for futureBsalexperiments in the context of hypothesis testing and discuss the ecological implications of our results.	[Kumar, Rajeev; Malagon, Daniel A.; Carter, Edward Davis; Miller, Debra L.; Bohanon, Markese L.; Cusaac, Joseph Patrick W.; Peterson, Anna C.; Gray, Matthew J.] Univ Tennessee, Ctr Wildlife Hlth, Inst Agr, Knoxville, TN 37996 USA; [Miller, Debra L.] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Gray, MJ (corresponding author), Univ Tennessee, Ctr Wildlife Hlth, Inst Agr, Knoxville, TN 37996 USA.	mgray11@utk.edu		Carter, Edward/0000-0001-6187-9010; Gray, Matthew/0000-0001-8243-9217; Malagon, Daniel/0000-0003-2831-4370	National Science Foundation Division of Environmental Biology (EEID Grant) [1814520]; USDA National Institute of Food and Agriculture [1012932]	National Science Foundation Division of Environmental Biology (EEID Grant); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This work was partially supported by the National Science Foundation Division of Environmental Biology (EEID Grant #1814520) and USDA National Institute of Food and Agriculture (Hatch Project 1012932) awarded to MJG and DLM. The sponsors did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. URLs: https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5269 https://nifa.usda.gov.	[Anonymous], 2017, EUR GERIATR MED, V8, pS98; [Anonymous], 2014, R LANG ENV STAT COMP; Blooi M, 2013, J CLIN MICROBIOL, V51, P4173, DOI 10.1128/JCM.02313-13; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Carter ED, 2020, CONSERV LETT, V13, DOI 10.1111/conl.12675; Ellison AR, 2017, G3-GENES GENOM GENET, V7, P269, DOI 10.1534/g3.116.035873; Fitzpatrick LD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31800-z; GILL DE, 1978, ECOL MONOGR, V48, P145, DOI 10.2307/2937297; Graham SP, 2012, HORM BEHAV, V62, P146, DOI 10.1016/j.yhbeh.2012.06.001; Gray MJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005251; Hodgson EW, 2015, J EXT, V53; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Jager KJ, 2008, KIDNEY INT, V74, P560, DOI 10.1038/ki.2008.217; Johnson PTJ, 2015, ECOL LETT, V18, P1119, DOI 10.1111/ele.12479; Langhammer PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077630; Longo AV, 2019, BIOL INVASIONS, V21, P2233, DOI 10.1007/s10530-019-01973-3; Martel A, 2014, SCIENCE, V346, P630, DOI 10.1126/science.1258268; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Ohmer MEB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03605-z; Ossiboff RJ, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00304; Refsnider JM, 2015, G3-GENES GENOM GENET, V5, P2291, DOI 10.1534/g3.115.021808; Richgels KLD, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150616; Roe AW, 2008, J HERPETOL, V42, P22, DOI 10.1670/07-040.1; Rollins-Smith LA, 2017, DEV COMP IMMUNOL, V66, P111, DOI 10.1016/j.dci.2016.07.002; Rosenblum EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049924; Sabino-Pinto J, 2015, AMPHIBIA-REPTILIA, V36, P411, DOI 10.1163/15685381-00003008; Sauer EL, 2020, ECOLOGY, V101, DOI 10.1002/ecy.2979; Scheele B, 2019, SCIENCE, V363, P1459, DOI 10.1126/science.aav0379; Schmidt BR, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160801; Stegen G, 2017, NATURE, V544, P353, DOI 10.1038/nature22059; Nguyen TT, 2017, AMPHIBIA-REPTILIA, V38, P554, DOI 10.1163/15685381-00003125; Therneau T.M., 2000, MODELING SURVIVAL DA; Thomas V, 2018, TRANSBOUND EMERG DIS, V65, pe478, DOI 10.1111/tbed.12787; Van Rooij P, 2015, VET RES, V46, DOI 10.1186/s13567-015-0266-0; Voyles J, 2014, ECOL EVOL, V4, P3633, DOI 10.1002/ece3.1199; WALTERS PJ, 1977, PHYSIOL ZOOL, V50, P88, DOI 10.1086/physzool.50.2.30152549; Yap TA, 2015, SCIENCE, V349, P481, DOI 10.1126/science.aab1052	38	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0235370	10.1371/journal.pone.0235370	http://dx.doi.org/10.1371/journal.pone.0235370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915779	Green Published, Green Submitted, gold			2022-12-26	WOS:000571887500019
J	Li, HT; Liang, SQ; Yu, Y; Wang, Y; Cheng, YY; Yang, HC; Tong, XG				Li, Haitao; Liang, Siquan; Yu, Yang; Wang, Yue; Cheng, Yuanyuan; Yang, Hechao; Tong, Xiaoguang			Effect of Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) on balance performance in Parkinson's disease	PLOS ONE			English	Article							POSTURAL CONTROL; GAIT	Purpose To study the effect of STN-DBS on balance performance of Parkinson's disease. Method 16 idiopathic PD patients treated with bilateral STN-DBS (DBS Group) and 20 PD patients treated with Levodopa (Medicine group) were included in the study. Clinical material including Levodopa Equivalent Daily Dose (LEDD, mg/day), life quality (PDQ-39) were collected. For DBS group and Medicine group, The motor disability (Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale, MDS-UPDRSIII) and balance performance (MDS-UPDRS 3.12, Berg Balance Scale BBS) and the Limits of Stability (LoS) (target acquisition percentage, trunk swing angle standard deviation, time) in state of Med-Off/Med-On at preoperation, postoperation, 6 months postoperation and 12 months postoperation were evaluated. Repeated ANOVA was used to analyze the effect of STN-DBS on balance performance. Result The Clinical material (age, gender, duration, LEDD preoperation, PDQ39), motor disability (Med-on/Med-Off), balance performance (Med-on/Med-Off) and LoS preoperation had no differences in DBS-group and Medical-group (P>0.05). During the follow up, LEDD, PDQ39, Motor disability (MDS-UPDRSIII), balance performance (MDS-UPDRS 3.12, BBS) in Medicine-group had no significant changes in both Med-Off and Med-On. For DBS-group, immediately improvement of motor disability (MDS-UPDRSIII), LoS (target acquisition percentage, trunk swing angle standard deviation, time) and LEDD were observed postoperation (P<0.05); PDQ39, balance performance (MDS-UPDRS 3.12, BBS) began to improve at 6 months and 12 months postoperation. Repeated ANOVA showed that DBS could significantly improve the motor disability, balance performance and LoS in PD. Conclusion STN-DBS could improve the balance performance of PD patients in H&Y3.	[Li, Haitao; Liang, Siquan; Tong, Xiaoguang] Tianjin Huanhu Hosptial, Dept Neurosurg, Tianjin, Peoples R China; [Yu, Yang; Wang, Yue; Cheng, Yuanyuan] Tianjin Huanhu Hosptial, Dept Neurol Rehabil, Tianjin, Peoples R China; [Yang, Hechao] Tianjin Huanhu Hosptial, Dept Psychol, Tianjin, Peoples R China		Liang, SQ; Tong, XG (corresponding author), Tianjin Huanhu Hosptial, Dept Neurosurg, Tianjin, Peoples R China.	liangsiquan@163.com; tongxghh@163.com						Bekkers EMJ, 2017, GAIT POSTURE, V56, P134, DOI 10.1016/j.gaitpost.2017.05.009; Bloem BR, 1996, MOVEMENT DISORD, V11, P509, DOI 10.1002/mds.870110506; Canning CG, 2014, NEURODEGENER DIS MAN, V4, P203, DOI [10.2217/nmt.14.22, 10.2217/NMT.14.22]; Collomb-Clerc A, 2015, NEUROPHYSIOL CLIN, V45, P371, DOI 10.1016/j.neucli.2015.07.001; Dayal V, 2017, J PARKINSON DIS, V7, P235, DOI 10.3233/JPD-171077; De la Casa-Fages B, 2017, GAIT POSTURE, V52, P374, DOI 10.1016/j.gaitpost.2016.12.025; Debu B, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0828-4; Hamani C, 2016, STEREOT FUNCT NEUROS, V94, P298, DOI 10.1159/000449010; Lau B, 2019, NEUROLOGY, V92, pE2559, DOI 10.1212/WNL.0000000000007562; Li Guang-Ying, 2017, Shengli Xuebao, V69, P611, DOI 10.13294/j.aps.2017.0066; Nowacki A, 2019, NEUROBIOL DIS, V128, P75, DOI 10.1016/j.nbd.2018.08.015; Palakurthi B, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9090239; Schulz-Schaeffer WJ, 2015, MOVEMENT DISORD, V30, P368, DOI 10.1002/mds.26081; Shahidi GA, 2017, IRAN J NEUROL, V16, P107; Shivitz N, 2006, MOVEMENT DISORD, V21, P1088, DOI 10.1002/mds.20905; Thevathasan W, 2018, MOVEMENT DISORD, V33, P10, DOI 10.1002/mds.27098	16	5	5	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238936	10.1371/journal.pone.0238936	http://dx.doi.org/10.1371/journal.pone.0238936			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915893	gold, Green Published			2022-12-26	WOS:000571887500118
J	Ma, KCK; Zardi, GI; McQuaid, CD; Nicastro, KR				Ma, Kevin C. K.; Zardi, Gerardo, I; McQuaid, Christopher D.; Nicastro, Katy R.			Historical and contemporary range expansion of an invasive mussel,Semimytlius algosus, in Angola and Namibia despite data scarcity in an infrequently surveyed region	PLOS ONE			English	Article							SCALE-DEPENDENT PATTERNS; SEMIMYTILUS-ALGOSUS; INTERTIDAL MUSSELS; SOUTH-AFRICA; COAST; MARINE; RECRUITMENT; COMMUNITIES; OYSTERS; SHIFT	Understanding the spread of invasive species in many regions is difficult because surveys are rare. Here, historical records of the invasive marine mussel,Semimytilus algosus, on the shores of Angola and Namibia are synthesised to re-construct its invasive history. Since this mussel was first discovered in Namibia about 90 years ago, it has spread throughout the western coast of southern Africa. By the late 1960s, the species was well established across a range of 1005 km of coastline in southern Angola and northern Namibia. Although only coarse spatial resolution data are available since the 1990s, the distribution ofS.algosusclearly increased substantially over the subsequent decades. Today, the species is distributed over 2785 km of coastline, appearing in southern Namibia in 2014, whence it spread across the border to northern South Africa in 2017, and in northern Angola in 2015. Conspicuously, its current range appears to be relatively contiguous across at least 810 km of shore in southern Angola and throughout Namibia, with isolated, spatially disjunct occurrences towards the southern and northern limits of its distribution. Despite there being few occurrence records that are unevenly distributed spatially and temporally, data for the distributional patterns ofS.algosusin Angola and Namibia provide invaluable insights into how marine invasive species spread in developing regions that are infrequently monitored.	[Ma, Kevin C. K.; Zardi, Gerardo, I; McQuaid, Christopher D.; Nicastro, Katy R.] Rhodes Univ, Dept Zool & Entomol, Grahamstown, Eastern Cape, South Africa	Rhodes University	Ma, KCK (corresponding author), Rhodes Univ, Dept Zool & Entomol, Grahamstown, Eastern Cape, South Africa.	k.ma@ru.ac.za	Nicastro, Katy R/ABI-1531-2020; Nicastro, Katy/AAY-3692-2021; Ma, Kevin C. K./K-8215-2019	Nicastro, Katy R/0000-0002-7071-141X; Ma, Kevin C. K./0000-0003-1678-077X	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation [64801]; Foundation for Science and Technology (FCT) [UID/Multi/04326/2019]	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study is supported by the South African Research Chairs Initiative of the Department of Science and Technology and the National Research Foundation (Grant No. 64801) to CDM and the Portuguese National Funds from the Foundation for Science and Technology (FCT) under project UID/Multi/04326/2019 to GIR and KRN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1990, CROSS CURRENTS YB CE, P75; Assis J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128124; BARNARD K. H., 1964, ANN S AFRICAN MUS, V47, P361; Bigatti G, 2014, BIOINVASIONS REC, V3, P241, DOI 10.3391/bir.2014.3.4.05; Blamey LK, 2012, J EXP MAR BIOL ECOL, V420, P33, DOI 10.1016/j.jembe.2012.03.022; Bolton JJ, 2012, AFR J MAR SCI, V34, P147, DOI 10.2989/1814232X.2012.675125; Bownes SJ, 2006, J EXP MAR BIOL ECOL, V338, P140, DOI 10.1016/j.jembe.2006.07.006; Bownes SJ, 2009, MAR BIOL, V156, P991, DOI 10.1007/s00227-009-1143-z; Branch GM, 2004, J EXP MAR BIOL ECOL, V300, P189, DOI 10.1016/j.jembe.2003.12.007; Branch GM, 2002, W COAST BIODIVERSITY; Bustamante RH., 1994, THESIS; Cunha RL, 2014, ECOL EVOL, V4, P2070, DOI 10.1002/ece3.1033; de Greef K, 2013, AFR J MAR SCI, V35, P307, DOI 10.2989/1814232X.2013.829789; EMANUEL BP, 1992, S AFR J MARINE SCI, V12, P341; Haingura IH, 2018, THESIS; Hancock ZB, 2017, ZOOKEYS, P1, DOI 10.3897/zookeys.706.19848; Harris JM, 1998, S AFR J ZOOL, V33, P1; Harris L, 2013, J COAST CONSERV, V17, P143, DOI 10.1007/s11852-012-0226-z; Haupt TM, 2010, AFR ZOOL, V45, P52, DOI 10.3377/004.045.0101; KENSLEY B, 1973, Cimbebasia Series A, V2, P113; KENSLEY B, 1980, Cimbebasia Series A, V5, P201; Kensley B, 1970, Ann. S. Afr. Mus., V57, P123; Kensley B, 1970, S. Afr. Mus., V57, P15; Kirkman SP, 2019, BIODIVERSITY OF ANGOLA: SCIENCE & CONSERVATION: A MODERN SYNTHESIS, P43, DOI 10.1007/978-3-030-03083-4_3; Kochmann J, 2008, J EXP MAR BIOL ECOL, V364, P1, DOI 10.1016/j.jembe.2008.05.015; Kohler S, 2009, ESTUAR COAST SHELF S, V84, P361, DOI 10.1016/j.ecss.2009.03.035; Kreiner A, 2019, REPORT COASTAL BIODI; Lamy ME., 1931, B MUSEUM NATURAL HIS, V23, P304; Lange G, 2014, AFR J MAR SCI, V36, P313, DOI 10.2989/1814232X.2014.948913; Lange G., 2013, THESIS; Lombard A.T., 2004, S AFRICAN NATL SPATI, V4; Ma KCK, 2020, AFR J MAR SCI; Ma KCK, 2020, REG STUD MAR SCI, V34, DOI 10.1016/j.rsma.2020.101049; McQuaid CD, 2015, OCEANOGR MAR BIOL, V53, P127; Mead A, 2011, J NAT HIST, V45, P2463, DOI 10.1080/00222933.2011.595836; Mead A, 2011, BIOL INVASIONS, V13, P1991, DOI 10.1007/s10530-011-0016-9; NaGISA Project, 2018, NAT GEOGR SHOR AR NA; Navarrete SA, 2008, ECOLOGY, V89, P1308, DOI 10.1890/07-0728.1; Nickles M., 1950, MANUELS OUESTAFRICAI, Vsecons; Nunez MA, 2010, BIOL INVASIONS, V12, P707, DOI 10.1007/s10530-009-9517-1; Ojaveer H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202383; PENRITH M L, 1970, Cimbebasia Series A, V1, P191; PENRITH M-L, 1970, Cimbebasia Series A, V1, P243; Pestana LB, 2017, MAR POLLUT BULL, V125, P426, DOI 10.1016/j.marpolbul.2017.09.041; Pulfrich A., 2013, INTERTIDAL ROCKY SHO; Pulfrich A., 2014, INTERTIDAL ROCKY SHO; Pulfrich A., 2017, INTERTIDAL ROCKY SHO; Pulfrich A., 2016, INTERTIDAL ROCKY SHO; Pulfrich A., 2015, INTERTIDAL ROCKY SHO; Pulfrich A., 2018, INTERTIDAL ROCKY SHO; Pysek P, 2008, TRENDS ECOL EVOL, V23, P237, DOI 10.1016/j.tree.2008.02.002; Reaugh KE., 2006, THESIS; Reaugh-Flower K, 2011, MAR ECOL PROG SER, V434, P101, DOI 10.3354/meps09169; Robinson TB, 2007, MAR ECOL PROG SER, V340, P163, DOI 10.3354/meps340163; Skein L, 2020, MAR ENVIRON RES, V157, DOI 10.1016/j.marenvres.2020.104929; Skein L, 2018, AFR ZOOL, V53, P47, DOI 10.1080/15627020.2018.1448720; Skein L, 2018, BEHAV ECOL, V29, P353, DOI 10.1093/beheco/arx172; Soot-Ryen J., 1955, Allan Hancock Pacific Expedition, V20, P1; Sousa R, 2009, BIOL INVASIONS, V11, P2367, DOI 10.1007/s10530-009-9422-7; South African Museum, 2018, MOLL COLL; van Erkom Schurink C., 1991, THESIS; Voisin M, 2005, P NATL ACAD SCI USA, V102, P5432, DOI 10.1073/pnas.0501754102; Zeeman SCF., 2016, THESIS; Zeeman Z, 2020, BIOL INVASIONS, V22, P2309, DOI 10.1007/s10530-020-02257-x; Zeeman Z, 2018, MAR ECOL PROG SER, V607, P113, DOI 10.3354/meps12794	65	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0239167	10.1371/journal.pone.0239167	http://dx.doi.org/10.1371/journal.pone.0239167			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915915	Green Published, gold			2022-12-26	WOS:000571887500017
J	Muri, L; Oberhansli, S; Buri, M; Le, ND; Grandgirard, D; Bruggmann, R; Muri, RM; Leib, SL				Muri, Lukas; Oberhansli, Simone; Buri, Michelle; Ngoc Dung Le; Grandgirard, Denis; Bruggmann, Remy; Muri, Rene M.; Leib, Stephen L.			Repetitive transcranial magnetic stimulation activates glial cells and inhibits neurogenesis after pneumococcal meningitis	PLOS ONE			English	Article							AGGRAVATES HIPPOCAMPAL APOPTOSIS; THETA-BURST STIMULATION; NEURAL STEM-CELLS; BACTERIAL-MENINGITIS; LEARNING-DEFICITS; FIELD STIMULATION; DENTATE GYRUS; BRAIN-DAMAGE; MOUSE MODEL; RAT	Pneumococcal meningitis (PM) causes damage to the hippocampus, a brain structure critically involved in learning and memory. Hippocampal injury-which compromises neurofunctional outcome-occurs as apoptosis of progenitor cells and immature neurons of the hippocampal dentate granule cell layer thereby impairing the regenerative capacity of the hippocampal stem cell niche. Repetitive transcranial magnetic stimulation (rTMS) harbours the potential to modulate the proliferative activity of this neuronal stem cell niche. In this study, specific rTMS protocols-namely continuous and intermittent theta burst stimulation (cTBS and iTBS)-were applied on infant rats microbiologically cured from PM by five days of antibiotic treatment. Following two days of exposure to TBS, differential gene expression was analysed by whole transcriptome analysis using RNAseq. cTBS provoked a prominent effect in inducing differential gene expression in the cortex and the hippocampus, whereas iTBS only affect gene expression in the cortex. TBS induced polarisation of microglia and astrocytes towards an inflammatory phenotype, while reducing neurogenesis, neuroplasticity and regeneration. cTBS was further found to induce the release of pro-inflammatory cytokinesin vitro. We conclude that cTBS intensified neuroinflammation after PM, which translated into increased release of pro-inflammatory mediators thereby inhibiting neuroregeneration.	[Muri, Lukas; Buri, Michelle; Ngoc Dung Le; Grandgirard, Denis; Leib, Stephen L.] Univ Bern, Inst Infect Dis, Neuroinfect Lab, Bern, Switzerland; [Muri, Lukas; Buri, Michelle; Ngoc Dung Le] Univ Bern, Grad Sch Cellular & Biomed Sci GCB, Bern, Switzerland; [Oberhansli, Simone; Bruggmann, Remy] Univ Bern, Interfac Bioinformat Unit, Bern, Switzerland; [Oberhansli, Simone; Bruggmann, Remy] Univ Bern, SIB Swiss Inst Bioinformat, Bern, Switzerland; [Muri, Rene M.] Univ Bern, Dept Neurol, Bern, Switzerland	University of Bern; University of Bern; University of Bern; Swiss Institute of Bioinformatics; University of Bern; University of Bern	Leib, SL (corresponding author), Univ Bern, Inst Infect Dis, Neuroinfect Lab, Bern, Switzerland.	stephen.leib@ifik.unibe.ch	Grandgirard, Denis/AAB-8786-2020; Leib, Stephen L/A-7866-2011	Grandgirard, Denis/0000-0002-4151-5196; Leib, Stephen L/0000-0002-1106-6123; Muri, Lukas/0000-0001-8630-4272; Bruggmann, Remy/0000-0001-5629-6363	Swiss National Science Foundation [189136]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a grant from the Swiss National Science Foundation (Grant 189136 to SLL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; [Anonymous], 2015, J CROHNS COLITIS S1, V9, pS15; Arias-Carrion O, 2004, J NEUROSCI RES, V78, P16, DOI 10.1002/jnr.20235; Baker CA, 2003, P NATL ACAD SCI USA, V100, P675, DOI 10.1073/pnas.0237313100; Bally L, 2016, ANTIMICROB AGENTS CH, V60, P1841, DOI 10.1128/AAC.02429-15; Baranger K, 2014, PROG BRAIN RES, V214, P313, DOI 10.1016/B978-0-444-63486-3.00014-1; Cazzoli D, 2012, BRAIN, V135, P3426, DOI 10.1093/brain/aws182; Chan P, 1999, J NEUROSCI RES, V55, P238, DOI 10.1002/(SICI)1097-4547(19990115)55:2<238::AID-JNR11>3.0.CO;2-T; Chen YH, 2015, PHARMACOL BIOCHEM BE, V136, P39, DOI 10.1016/j.pbb.2015.07.005; Cullen CL, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00026; Czeh B, 2002, BIOL PSYCHIAT, V52, P1057, DOI 10.1016/S0006-3223(02)01457-9; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; David Y, 2009, J NEUROSCI, V29, P10588, DOI 10.1523/JNEUROSCI.2323-09.2009; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Erni ST, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00570; Fang ZY, 2010, ELECTROMAGN BIOL MED, V29, P113, DOI 10.3109/15368378.2010.500568; Fujiki M, 1997, MOL BRAIN RES, V44, P301, DOI 10.1016/S0169-328X(96)00232-X; GEORGE MS, 1995, NEUROREPORT, V6, P1853, DOI 10.1097/00001756-199510020-00008; Gerber J, 2001, ACTA NEUROPATHOL, V101, P499; Grandgirard D, 2007, DEV NEUROSCI-BASEL, V29, P134, DOI 10.1159/000096218; Grandgirard D, 2007, ACTA NEUROPATHOL, V114, P609, DOI 10.1007/s00401-007-0304-8; Hofer S, 2011, J NEUROPATH EXP NEUR, V70, P890, DOI 10.1097/NEN.0b013e3182303f31; Hoffmann O, 2007, INFECT IMMUN, V75, P4289, DOI 10.1128/IAI.01679-06; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Klein M, 2019, CLIN MICROBIOL INFEC, V25, DOI 10.1016/j.cmi.2018.03.039; Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54; Koedel U, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000461; Kozlova EN, 1999, GLIA, V27, P249, DOI 10.1002/(SICI)1098-1136(199909)27:3<249::AID-GLIA6>3.3.CO;2-5; Leib SL, 2003, PEDIATR RES, V54, P353, DOI 10.1203/01.PDR.0000079185.67878.72; Leib SL, 2000, INFECT IMMUN, V68, P615, DOI 10.1128/IAI.68.2.615-620.2000; Li Z, 2010, INDIAN J BIOCHEM BIO, V47, P359; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liebetanz D, 2003, J PSYCHIATR RES, V37, P277, DOI 10.1016/S0022-3956(03)00017-7; Liechti FD, 2015, FUTURE MICROBIOL, V10, P1195, DOI 10.2217/fmb.15.43; Liechti FD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113607; Liechti FD, 2014, INFECT IMMUN, V82, P1710, DOI 10.1128/IAI.00073-14; Loeffler JM, 2001, J INFECT DIS, V183, P247, DOI 10.1086/317921; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020455; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Mook-Kanamori BB, 2011, CLIN MICROBIOL REV, V24, P557, DOI 10.1128/CMR.00008-11; Muri L, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1549-6; Muri L, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.00220-19, 10.1128/aac.00220-19]; Muri L, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1272-8; Muri RM, 2016, THER RTMS NEUROL PRI, DOI [10.1007/978-3-319-25721-1_8, DOI 10.1007/978-3-319-25721-1_8]; Nau R, 1999, J NEUROPATH EXP NEUR, V58, P265, DOI 10.1097/00005072-199903000-00006; PascualLeone A, 1996, LANCET, V348, P233, DOI 10.1016/S0140-6736(96)01219-6; Perny M, 2016, J NEUROSCI, V36, P7740, DOI 10.1523/JNEUROSCI.0554-16.2016; Post A, 1999, EUR J NEUROSCI, V11, P3247, DOI 10.1046/j.1460-9568.1999.00747.x; Ptak R, 2013, FRONT HUM NEUROSCI, V7, DOI [10.3389/fnhum.2013.00254, 10.3389/fnhum.2013.00248]; Raus S, 2013, NEUROTOX RES, V23, P79, DOI 10.1007/s12640-012-9333-8; Ridding MC, 2007, NAT REV NEUROSCI, V8, P559, DOI 10.1038/nrn2169; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Sherafat MA, 2012, J MOL NEUROSCI, V48, P144, DOI 10.1007/s12031-012-9791-8; Slepko N, 1996, GLIA, V16, P241; Spreer A, 2006, PEDIATR RES, V60, P210, DOI 10.1203/01.pdr.0000227553.47378.9f; Takenaga K, 2006, GLIA, V53, P313, DOI 10.1002/glia.20284; Ueyama E, 2011, PSYCHIAT CLIN NEUROS, V65, P77, DOI 10.1111/j.1440-1819.2010.02170.x; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; Vazana U, 2016, J NEUROSCI, V36, P7727, DOI 10.1523/JNEUROSCI.0587-16.2016; Wagner T, 2007, ANNU REV BIOMED ENG, V9, P527, DOI 10.1146/annurev.bioeng.9.061206.133100; Walker DG, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0139-9; Wang HN, 2014, J PSYCHIATR RES, V51, P79, DOI 10.1016/j.jpsychires.2014.01.004; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Weissberg I, 2015, NEUROBIOL DIS, V78, P115, DOI 10.1016/j.nbd.2015.02.029; Wellmer A, 2000, NEUROSCI LETT, V296, P137, DOI 10.1016/S0304-3940(00)01645-1; Wittwer M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-176; Zhang Y, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-11; Zysset-Burri DC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-393	73	4	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0232863	10.1371/journal.pone.0232863	http://dx.doi.org/10.1371/journal.pone.0232863			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915781	Green Published, gold, Green Submitted			2022-12-26	WOS:000571887500102
J	Reynolds, WJ; Hanson, PS; Critchley, A; Griffiths, B; Chavan, B; Birch-Machin, MA				Reynolds, Wil J.; Hanson, Peter S.; Critchley, Adam; Griffiths, Ben; Chavan, Bhaven; Birch-Machin, Mark A.			Exposing human primary dermal fibroblasts to particulate matter induces changes associated with skin aging	FASEB JOURNAL			English	Article						aging; oxidative stress; pollution	ARYL-HYDROCARBON RECEPTOR; URBAN AIR-POLLUTION; EXPOSURE; CANCER; RISK; PROLIFERATION; ULTRAVIOLET; EXPRESSION; DISEASES; LUNG	With a large proportion of the world's population living in areas where air quality does not meet current WHO guidelines, combined with the knowledge that pollutants can interact with human skin, it is now of even greater importance that the effects of air pollutant exposure on human skin be investigated. To evaluate the damaging effects of a known component of air pollution (particulate matter) on human primary dermal fibroblasts. These studies were undertaken by exposing primary human dermal fibroblasts to different concentrations of particulate matter and analyzing the effects over time using resazurin reduction assays. Immunofluorescence microscopy was used to determine if particulate matter caused activation of the aryl hydrocarbon receptor, and phosphorylation of histone H2AX, a known marker of double-strand DNA breaks. Dot blotting was also used to analyze expression changes in secreted MMP-1, MMP-3, and TGF beta. Particulate matter was found to dose-dependently increase cellular viability, activate the aryl hydrocarbon receptor, increase double-strand DNA breaks, and increase the expression of MMP-1, MMP-3, and TGF beta. With the potential of air pollutants such as particulate matter to not only modulate the expression of proteins implicated in skin aging, but also affect cells at a genetic level, brings a pressing need for further investigation so protective strategies can be implemented.	[Reynolds, Wil J.; Birch-Machin, Mark A.] Newcastle Univ, Translat & Clin Res Inst, Dermatol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Hanson, Peter S.] Newcastle Univ, Translat & Clin Res Inst, Campus Ageing & Vitality, Newcastle Upon Tyne, Tyne & Wear, England; [Critchley, Adam; Griffiths, Ben] Royal Victoria Infirm, Newcastle Upon Tyne, Tyne & Wear, England; [Chavan, Bhaven] Croda Europe Ltd, Snaith, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Birch-Machin, MA (corresponding author), Newcastle Univ, Translat & Clin Res Inst, Dermatol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	mark.birch-machin@ncl.ac.uk		Griffiths, Ben/0000-0002-8745-1861	UK Research and Innovation/Biotechnology and Biological Sciences Research Council; BBSRC [2314361] Funding Source: UKRI	UK Research and Innovation/Biotechnology and Biological Sciences Research Council; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	UK Research and Innovation/Biotechnology and Biological Sciences Research Council	Afaq F, 2009, J INVEST DERMATOL, V129, P2396, DOI 10.1038/jid.2009.85; Beelen R, 2008, EPIDEMIOLOGY, V19, P702, DOI 10.1097/EDE.0b013e318181b3ca; Bonnier F, 2015, TOXICOL IN VITRO, V29, P124, DOI 10.1016/j.tiv.2014.09.014; Campaner AB, 2006, J INVEST DERMATOL, V126, P1168, DOI 10.1038/sj.jid.5700200; Castano-Vinyals G, 2008, OCCUP ENVIRON MED, V65, P56, DOI 10.1136/oem.2007.034348; Chen X, 2012, TISSUE ENG PT A, V18, P2528, DOI [10.1089/ten.tea.2012.0094, 10.1089/ten.TEA.2012.0094]; Codriansky KA, 2009, PHOTOCHEM PHOTOBIOL, V85, P1356, DOI 10.1111/j.1751-1097.2009.00592.x; de Jesus RM, 2018, J BRAZIL CHEM SOC, V29, P1268, DOI 10.21577/0103-5053.20170223; Debacq-Chainlaux F, 2005, J CELL SCI, V118, P743, DOI 10.1242/jcs.01651; Forecast MD, 2018, ORBIS RES, V1, P178; Hudson L, 2020, FASEB J, V34, P3874, DOI 10.1096/fj.201902351RR; Jin SP, 2018, J DERMATOL SCI, V91, P175, DOI 10.1016/j.jdermsci.2018.04.015; KADUNCE DP, 1991, ANN INTERN MED, V114, P840, DOI 10.7326/0003-4819-114-10-840; Kim KE, 2016, LIFE SCI, V152, P126, DOI 10.1016/j.lfs.2016.03.039; Koohgoli R, 2017, EXP DERMATOL, V26, P384, DOI 10.1111/exd.13257; Krstic J, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/654594; Lademann J, 2005, J INVEST DERM SYMP P, V10, P301, DOI 10.1111/j.1087-0024.2005.10121.x; Laing S, 2010, AM J PHYSIOL-CELL PH, V299, pC736, DOI 10.1152/ajpcell.00529.2009; Ngoc LTN, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121458; Lee S, 2015, CHEMOSPHERE, V139, P23, DOI 10.1016/j.chemosphere.2015.05.033; Magnani ND, 2016, TOXICOL SCI, V149, P227, DOI 10.1093/toxsci/kfv230; Mancebo SE, 2015, J EUR ACAD DERMATOL, V29, P2326, DOI 10.1111/jdv.13250; MENICHINI E, 1992, SCI TOTAL ENVIRON, V116, P109, DOI 10.1016/0048-9697(92)90368-3; Ono Y, 2013, EXP DERMATOL, V22, P349, DOI 10.1111/exd.12148; Phalen Robert F, 2004, Nonlinearity Biol Toxicol Med, V2, P259, DOI 10.1080/15401420490900245; Piao MJ, 2015, BIOMOL THER, V23, P557, DOI 10.4062/biomolther.2015.054; Pittayapruek P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060868; Podhorecka M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/920161; Quan, 2016, COSMETICS, V3, P28, DOI [10.3390/cosmetics3030028, DOI 10.3390/COSMETICS3030028]; Rosso James Del, 2016, J Clin Aesthet Dermatol, V9, pS2; Ruchirawat M, 2007, TOXICOL LETT, V168, P200, DOI 10.1016/j.toxlet.2006.09.013; Ruckerl R, 2011, INHAL TOXICOL, V23, P555, DOI 10.3109/08958378.2011.593587; Sighom JRN, 2017, FUTURE INTERNET, V9, DOI 10.3390/fi9030023; Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x; Takai S, 2003, J PHARMACOL EXP THER, V305, P17, DOI 10.1124/jpet.102.045179; Tigges J, 2014, MECH AGEING DEV, V138, P26, DOI 10.1016/j.mad.2014.03.004; Valacchi G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131097; Vierkotter A, 2010, J INVEST DERMATOL, V130, P2719, DOI 10.1038/jid.2010.204; World Health Organization, 2018, AMB AIR POLL GLOB AS, P131; Xu QF, 2016, CHINESE MED J-PEKING, V129, P2853, DOI 10.4103/0366-6999.194654; Zorin V, 2019, AGING-US, V11, P4536, DOI 10.18632/aging.102067	41	7	7	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14725	14735		10.1096/fj.202001357R	http://dx.doi.org/10.1096/fj.202001357R		SEP 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32915475	hybrid, Green Published			2022-12-26	WOS:000570521700001
J	Balde, A; Lievre, L; Maiga, AI; Diallo, F; Maiga, IA; Costagliola, D; Abgrall, S				Balde, Aliou; Lievre, Laurence; Maiga, Almoustapha Issiaka; Diallo, Fodie; Maiga, Issouf Alassane; Costagliola, Dominique; Abgrall, Sophie			Re-engagement in care of people living with HIV lost to follow-up after initiation of antiretroviral therapy in Mali: Who returns to care?	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; INFECTED PATIENTS; TREATMENT PROGRAM; EASTERN AFRICA; RETENTION; MORTALITY; SURVIVAL; OUTCOMES; IMPACT	Objectives We assessed cumulative incidence rates of and factors associated with re-engagement in HIV care for PLHIV lost to follow-up in Mali. Methods HIV-1-infected individuals lost to follow-up before 31/12/2013, >= 18 years old, who started ART from 2006 to 2012 at one of 16 care centres were considered. Loss to follow-up (LTFU) was defined as an interruption of >= 6 months during follow-up. The re-engagement in care in PLHIV lost to follow-up before 31/12/2013 was defined as having at least one clinical visit after LTFU. The cumulative incidence rates of re-engagement in care was estimated by Kaplan-Meier and its predictive factors were assessed using Cox models. Socio-demographic characteristics, clinical and immune status, period, region, centre expertise level, and distance from home at the start of ART plus a combined variable of duration of ART until LTFU and 12-month change in CD4 count were assessed. Multiple imputation was used to deal with missing data. Results We included 3,650 PLHIV lost to follow-up before December 2013, starting ART in nine outpatient clinics and seven hospitals (5+2 in Bamako and 4+5 in other regions): 35% male, median (IQR) age 35 (29-43), and duration of ART until LTFU 11 months (5-22). Among these PLHIV, 1,975 (54%) were definitively LTFU and 1,675 (46%) subsequently returned to care. The cumulative incidence rates of re-engagement in care rose from 39.0% at one year to 47.0% at three years after LTFU. Predictors of re-engagement in care were starting ART with WHO stage 1-2 and CD4 counts >= 200 cells/mu L, being treated for >= 12 months with CD4 count gain >= 50 cells/mu L, or being followed in Bamako. People followed at regional hospitals or outpatient clinics >= 5 km away, or being treated for >= 12 months with CD4 count gain < 50 cells/mu L were less likely to return to care. Conclusions Starting ART with a higher CD4 count, better gain in CD4 count, and being followed either in Bamako or close to home in the regions were associated with re-engagement in care.	[Balde, Aliou; Lievre, Laurence; Costagliola, Dominique; Abgrall, Sophie] Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, IPLESP, INSERM, Paris, France; [Maiga, Almoustapha Issiaka] Univ Sci Tech & Technol Bamako USTTB, Unite Depidemiol Mol Resistance VIH ARV, Ctr Rech & Format VIH SIDA & TB SEREFO, Bamako, Mali; [Diallo, Fodie] Assoc Rech Commun Accompagnement Domicile Personn, Bamako, Mali; [Maiga, Issouf Alassane] Ensemble Solidarite Therapeut Hospitaliere Reseau, Bamako, Mali; [Abgrall, Sophie] Univ Paris Sud, Univ Paris Saclay, Hop Antoine Beclere, AP HP,Serv Med Interne,Clamart,INSERM, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Science & Technology of Bamako; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Balde, A (corresponding author), Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, IPLESP, INSERM, Paris, France.	aliou.balde@iplesp.upmc.fr	Costagliola, Dominique/H-5849-2011	Costagliola, Dominique/0000-0003-0765-0869; Balde, Aliou/0000-0001-5956-698X	Sorbonne Universite (ex Universite Pierre et Marie-Curie, UPMC, Paris 6)	Sorbonne Universite (ex Universite Pierre et Marie-Curie, UPMC, Paris 6)	We would like to thank all the participants of the Malian ART programme and research assistants from Mali and France.; Aliou BALDE is supported by a doctoral contract from Sorbonne Universite (ex Universite Pierre et Marie-Curie, UPMC, Paris 6). All authors declare no conflict of interest, although some authors have, at some stage in the past, received funding from a variety of pharmaceutical companies for research, travel grants, speaking engagements or consultancy fees.	Ambia J, 2019, TROP MED INT HEALTH, V24, P747, DOI 10.1111/tmi.13236; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Avila D, 2014, JAIDS-J ACQ IMM DEF, V65, pE8, DOI 10.1097/QAI.0b013e3182a39979; Balde A, 2019, HIV MED, V20, P47, DOI 10.1111/hiv.12668; Bershetyn A, 2017, CLIN INFECT DIS, V64, P1547, DOI 10.1093/cid/cix191; Beyersmann J, 2009, STAT MED, V28, P956, DOI 10.1002/sim.3516; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Brinkhof MWG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014149; Camlin CS, 2016, AIDS, V30, P495, DOI 10.1097/QAD.0000000000000931; Cellule Sectorielle de Lutte contre le VIH Sida du Ministere de la Sante et de l'Hygiene Publique (CSLS/MSHP), 2015, RAPP TRIM PRIS CHARG; Cellule Sectorielle de Lutte contre le VIH Sida du Ministere de la Sante et de l'Hygiene Publique (CSLS/MSHP), 2013, POL PROT PRIS CHARG; Chammartin F, 2018, CLIN INFECT DIS, V67, P1643, DOI 10.1093/cid/ciy347; Chi BH, 2011, J PHYS ACT HEALTH, V8, pe1001111; Cornell M, 2014, JAIDS-J ACQ IMM DEF, V67, pE67, DOI 10.1097/QAI.0000000000000269; COX DR, 1975, BIOMETRIKA, V62, P269, DOI 10.2307/2335362; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; Fox MP, 2010, TROP MED INT HEALTH, V15, P405, DOI 10.1111/j.1365-3156.2010.02473.x; Geng EH, 2016, CLIN INFECT DIS, V62, P935, DOI 10.1093/cid/civ1004; Geng EH, 2010, TROP MED INT HEALTH, V15, P63, DOI 10.1111/j.1365-3156.2010.02507.x; Grimes RM, 2016, J AIDS CLIN RES, V7; Grimsrud A, 2016, J EPIDEMIOL COMMUN H, V70, P549, DOI 10.1136/jech-2015-206629; Hickey MD, 2016, AIDS CARE, V28, P1386, DOI 10.1080/09540121.2016.1179253; Hughes RA, 2019, INT J EPIDEMIOL; Hurley EA, 2018, J HEALTH COMMUN, V23, P129, DOI 10.1080/10810730.2017.1417513; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2018, LAT STAT STAT AIDS E; Mberi MN, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0912-2; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V59, P86, DOI 10.1097/QAI.0b013e318236f7d2; Nabaggala Maria Sarah, 2018, BMC Res Notes, V11, P762, DOI 10.1186/s13104-018-3865-9; Ndawinz JD, 2013, J ANTIMICROB CHEMOTH, V68, P1388, DOI 10.1093/jac/dkt011; Rachlis B, 2015, JAIDS-J ACQ IMM DEF, V68, pE46, DOI 10.1097/QAI.0000000000000492; Raguin G, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0149-9; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rubin DB, 2004, MULTIPLE IMPUTATION; Secretariat permanent du PRODESS cellule de planification et de statistique secteur sante developpement social et promotion de la famille, PROGR DEV SOC SAN PR; Shepherd BE, 2013, AM J EPIDEMIOL, V178, P819, DOI 10.1093/aje/kwt030; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; van Buuren S, 2011, J STAT SOFTW, V45, P1; Verguet S, 2013, J INFECT DIS, V207, P72, DOI 10.1093/infdis/jis635; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Zurcher K, 2017, TROP MED INT HEALTH, V22, P375, DOI 10.1111/tmi.12843	42	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238687	10.1371/journal.pone.0238687	http://dx.doi.org/10.1371/journal.pone.0238687			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911516	Green Published, gold			2022-12-26	WOS:000571885900017
J	Liu, G; Zhang, H; Zhu, WB; Peng, YQ; Ding, R; Fan, ML; Fan, LQ; Li, WN				Liu, Gang; Zhang, Huan; Zhu, Wen-Bing; Peng, Yang-Qin; Ding, Rui; Fan, Meng-Lin; Fan, Li-Qing; Li, Wei-Na			HIV prevalence among 338,432 infertile individuals in Hunan, China, 2012-2018: A cross-sectional study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MEN; SEX; INFECTION; TRANSMISSION; EXPERIENCES; EPIDEMIC; FEMALE; WOMEN; HBV	Background The prevalence of human immunodeficiency virus (HIV) varies markedly among different risk groups in China, spreading fromhigh-risk populations to the general population. Indeed, China is in a critical period of HIV/acquired immunodeficiency syndrome (AIDS) prevention and control; however, data regarding HIV testing, infection and coinfection among infertile couples are lacking. This study aimed to estimate the HIV/AIDS prevalence to identify risk factors among infertile couples in Hunan, China. Methods A cross-sectional hospital-based study was conducted to evaluate the prevalence of HIV/other infections (hepatitis B virus (HBV), hepatitis C virus (HCV), syphilis, andChlamydia trachomatis,Neisseria gonorrhoeae, andMycoplasma genitalium(MG) infections) among 338,432 infertile individuals in Hunan, China, from 2012 to 2018. We calculated linear trends in prevalence using bivariate linear regression. Results The overall prevalence rates of HIV, chlamydia, gonorrhea, MG, syphilis, and HBV and HCV antibody positivity in this study were 0.04%, 1.73%, 0.05%, 2.60%, 2.15%, 12.01% and 0.56%, respectively. The predominant infection was HBV, followed by MG, syphilis, and chlamydia. Only 1.13% of the participants (382/338432) reported sexually transmitted disease (STD) signs and symptoms suggesting genital tract infection. However, from 2012-2018, the variation in HIV prevalence was not significant (beta = 0.000,P-TREND= 0.907). The characteristics of the HIV-infected infertile population have not shifted dramatically, with women accounting for 32.56% of HIV cases in China. Overall, 87.60% of HIV-infected individuals have a relatively low education. In total, 37.98% of HIV-positive patients engage in high-risk behaviors. Conclusions This study expands upon existing knowledge of HIV prevalence in the infertile Chinese population. However, much work is needed to achieve popularization of prevention knowledge and change concept. Routine HIV screening is urgently needed for all adults with high-risk behaviors.	[Liu, Gang; Zhu, Wen-Bing; Ding, Rui; Fan, Li-Qing] Cent South Univ, Sch Basic Med Sci, Inst Reprod & Stem Cell Engn, Changsha, Hunan, Peoples R China; [Zhang, Huan; Peng, Yang-Qin; Fan, Meng-Lin; Fan, Li-Qing; Li, Wei-Na] Reprod & Genet Hosp CITIC Xiangya, Changsha, Hunan, Peoples R China; [Zhang, Huan; Peng, Yang-Qin; Fan, Meng-Lin; Fan, Li-Qing; Li, Wei-Na] Clin Res Ctr Reprod & Genet Hunan Prov, Changsha, Peoples R China; [Li, Wei-Na] Hunan Guangxiu Hitech Life Technol Co Ltd, Changsha, Peoples R China	Central South University; Central South University	Li, WN (corresponding author), Reprod & Genet Hosp CITIC Xiangya, Changsha, Hunan, Peoples R China.; Li, WN (corresponding author), Clin Res Ctr Reprod & Genet Hunan Prov, Changsha, Peoples R China.; Li, WN (corresponding author), Hunan Guangxiu Hitech Life Technol Co Ltd, Changsha, Peoples R China.	liweinaking@126.com		li, weina/0000-0002-8728-3167	Clinical Scientific Research Special Grant from the Chinese Medical Association [17020410710]; Fundamental Research Funds for the Central Universities of Central South University [502211905]	Clinical Scientific Research Special Grant from the Chinese Medical Association; Fundamental Research Funds for the Central Universities of Central South University	This study was supported by the Clinical Scientific Research Special Grant from the Chinese Medical Association (grant number 17020410710, Wei-Na Li) and the Fundamental Research Funds for the Central Universities of Central South University (grant number 502211905, Rui Ding). The funder (Hunan Guangxiu Hi-tech Life Technology Co., Ltd) provided support in the form of a salary for the author (Wei-Na Li) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not affect the role of these authors in our research. The specific roles of the authors are articulated in the `author contributions' section.	Adesiyun AG, 2008, GYNECOL OBSTET INVES, V66, P119, DOI 10.1159/000128600; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; [Anonymous], 2020, DIABETES TECHNOL THE, V22, pA, DOI 10.1089/dia.2020.2525.abstracts; [Anonymous], 2014, CLIN INFECT DIS, V58, pi; Bao YP, 2019, INT J DRUG POLICY, V70, P87, DOI 10.1016/j.drugpo.2019.05.005; Cao W, 2020, CURR HIV-AIDS REP, V17, P26, DOI 10.1007/s11904-019-00478-x; Cardona-Maya W, 2009, CURR HIV RES, V7, P418, DOI 10.2174/157016209788680570; Case KK, 2019, AIDS, V33, pS197, DOI 10.1097/QAD.0000000000002440; Daar J, 2015, FERTIL STERIL, V104, pE1, DOI 10.1016/j.fertnstert.2015.04.004; Dhont N, 2011, SEX TRANSM INFECT, V87, P28, DOI 10.1136/sti.2010.042879; Ding YY, 2019, CURR HIV-AIDS REP, V16, P423, DOI 10.1007/s11904-019-00468-z; Dyer SJ, 2002, HUM REPROD, V17, P1663, DOI 10.1093/humrep/17.6.1663; Frapsauce C, 2015, HUM REPROD, V30, P1797, DOI 10.1093/humrep/dev141; Gerrits T, 1997, PATIENT EDUC COUNS, V31, P39, DOI 10.1016/S0738-3991(97)01018-5; Griesbeck M, 2016, CLIN SCI, V130, P1435, DOI 10.1042/CS20160112; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; He N, 2005, CELL RES, V15, P825, DOI 10.1038/sj.cr.7290354; Hu F, 2019, BIOMED ENVIRON SCI, V32, P719, DOI 10.3967/bes2019.092; Lin L, 2014, SEX HEALTH, V11, P94, DOI 10.1071/SH13199; NICOLOSI A, 1994, EPIDEMIOLOGY, V5, P570, DOI 10.1097/00001648-199411000-00003; Nicopoullos JDM, 2004, HUM REPROD, V19, P2289, DOI 10.1093/humrep/deh426; Orji EO, 2002, INT J GYNECOL OBSTET, V79, P61, DOI 10.1016/S0020-7292(02)00180-7; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; Ssewamala FM, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0807-1; Tang WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085985; UNAIDS, 2018, GLOB AIDS UPD MIL GO; Wu ZY, 2019, CURR HIV-AIDS REP, V16, P458, DOI 10.1007/s11904-019-00471-4; Xing JN, 2014, CLIN INFECT DIS, V59, DOI 10.1093/cid/ciu214; Xu JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089723; Yakass MB, 2016, J BRAS REPROD ASSIST, V20, P132, DOI 10.5935/1518-0557.20160030; Yan F, 2020, J ASSOC NURSE AIDS C, V31, P428, DOI 10.1097/JNC.0000000000000168; Yan HJ, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25417; Yan HJ, 2019, AIDS CARE, V31, P1026, DOI 10.1080/09540121.2019.1612002; Yang HT, 2014, CLIN INFECT DIS, V58, P1753, DOI 10.1093/cid/ciu175; Zangeneh M, 2018, INT J REPROD BIOMED, V16, P595, DOI 10.29252/ijrm.16.9.595; Zhang L, 2013, LANCET INFECT DIS, V13, P955, DOI 10.1016/S1473-3099(13)70245-7; Zhang X.F., 2011, HIGHWAY ENGINEERING, V36, P11; Zhang XJ, 2019, CURR HIV-AIDS REP, V16, P448, DOI 10.1007/s11904-019-00469-y; 2018, CHIN J INTERN MED, V57, P867	39	0	0	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238564	10.1371/journal.pone.0238564	http://dx.doi.org/10.1371/journal.pone.0238564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911499	gold, Green Published			2022-12-26	WOS:000571885900023
J	Szekely, P; Eguiguren, JS; Ordonez-Delgado, L; Armijos-Ojeda, D; Szekely, D				Szekely, Paul; Eguiguren, Juan Sebastian; Ordonez-Delgado, Leonardo; Armijos-Ojeda, Diego; Szekely, Diana			Fifty years after: A taxonomic revision of the amphibian species from the Ecuadorian biodiversity hotspot Abra de Zamora, with description of two newPristimantis species	PLOS ONE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS; ANURA; FROG; STRABOMANTIDAE; CRAUGASTORIDAE; SYSTEMATICS; VEGETATION; DIVERSITY; ALIGNMENT; PATTERNS	Abra de Zamora is an important biodiversity hotspot in southern Ecuador. Between 1938 and 2010, eleven species of frogs were described from here:Lynchius flavomaculatus,Gastrotheca psychrophila,Pristimantis balionotus,P.colodactylus,P.cryptomelas,P.percultus,P.versicolor,P.vidua,Telmatobius cirrhacelis,P.andinognomus, andAtelopus podocarpus. Unfortunately, many of these species were not re-encountered after their original description, and for the majority DNA samples were not available, making their phylogenetic position unknown. In this study, we assess the current state of the amphibians from Abra de Zamora, by: i. redescribing the species which were first reported from the area, by contributing genetic delimitation (forL.flavomaculatus,P.balionotus,P.colodactylus,P.percultus, andP.vidua), release call (L.flavomaculatus) and advertisement call descriptions (forP.balionotus,P.viduaandP.versicolor); ii. presenting an updated amphibian species list of Abra de Zamora, with the description of two additionalPristimantisspecies; iii. updating the distribution of these species, including data collected in similar montane habitats from surrounding areas; and iv. amending recommendations regarding their conservation status.	[Szekely, Paul] Univ Tecn Particular Loja, Museo Zool, Loja, Ecuador; [Szekely, Paul; Ordonez-Delgado, Leonardo; Armijos-Ojeda, Diego; Szekely, Diana] Univ Tecn Particular Loja, Dept Ciencias Biol, Lab Ecol Trop & Servicios Ecosistem EcoSs Lab, Loja, Ecuador; [Eguiguren, Juan Sebastian] Tech Univ Dresden TUD, Biotechnol Ctr BIOTEC, Ctr Mol & Cellular Bioengn CMCB, Dresden, Germany; [Ordonez-Delgado, Leonardo; Armijos-Ojeda, Diego] Univ Rey Juan Carlos, Programa Doctorado Conservac Recursos Nat, Escuela Int Doctorado, Madrid, Spain; [Szekely, Diana] Ovidius Univ Constanta, Fac Nat & Agr Sci, Constanta, Romania	Universidad Tecnica Particular de Loja; Universidad Tecnica Particular de Loja; Technische Universitat Dresden; Universidad Rey Juan Carlos; Ovidius University	Szekely, P (corresponding author), Univ Tecn Particular Loja, Museo Zool, Loja, Ecuador.; Szekely, P (corresponding author), Univ Tecn Particular Loja, Dept Ciencias Biol, Lab Ecol Trop & Servicios Ecosistem EcoSs Lab, Loja, Ecuador.	jpszekely@utpl.edu.ec	Székely, Paul/V-8239-2017; Ordóñez-Delgado, Leonardo/AAE-3098-2019; Szekely, Diana/O-6147-2017	Székely, Paul/0000-0002-9252-1596; Ordóñez-Delgado, Leonardo/0000-0002-4593-1728; Szekely, Diana/0000-0002-3786-3729; Eguiguren, Juan Sebastian/0000-0002-8866-4316	Critical Ecosystem Partnership Fund (CEPF) [CEPF108984]; Mohamed bin Zayed Species Conservation Fund [172515484]; Universidad Tecnica Particular de Loja (Convocatoria Estancias Cortas de Investigacion)	Critical Ecosystem Partnership Fund (CEPF); Mohamed bin Zayed Species Conservation Fund; Universidad Tecnica Particular de Loja (Convocatoria Estancias Cortas de Investigacion)	This study was funded by the Critical Ecosystem Partnership Fund (CEPF), grant CEPF108984, through the "Amphibian Conservation in the Abra de Zamora Key Biodiversity Area of Ecuador" project. Fieldwork and research of marsupial frogs was supported by the Mohamed bin Zayed Species Conservation Fund, through project 172515484 "Conservation of the Ridge Marsupial Frog (Gastrotheca psychrophila) in southern Ecuador". DS benefited from a research grant from Universidad Tecnica Particular de Loja (Convocatoria Estancias Cortas de Investigacion 2019).	Aguirre-Mendoza L, 2015, CAMBIO CLIMATICO BIO; [Anonymous], 2018, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2018-1.RLTS.T57209A89211040.en, DOI 10.2305/IUCN.UK.2018-1.RLTS.T57209A89211040.EN]; [Anonymous], 2018, PRISTIMANTIS COLODAC, DOI [10.2305/IUCN.UK.2018-1.RLTS.T56517A89206101.en, DOI 10.2305/IUCN.UK.2018-1.RLTS.T56517A89206101.EN]; [Anonymous], 2004, PRISTIMANTIS BALIONO, DOI [10.2305/IUCN.UK.2004.RLTS.T56450A11480043.en, DOI 10.2305/IUCN.UK.2004.RLTS.T56450A11480043.EN]; [Anonymous], 2019, PRISTIMANTIS CRYPTOM, DOI [10.2305/IUCN.UK.2019-1.RLTS.T56539A89206513.en, DOI 10.2305/IUCN.UK.2019-1.RLTS.T56539A89206513.EN]; [Anonymous], 2004, PRISTIMANTIS PERCULT, DOI [10.2305/IUCN.UK.2004.RLTS.T56845A11544196.en, DOI 10.2305/IUCN.UK.2004.RLTS.T56845A11544196.EN]; [Anonymous], 2018, PRISTIMANTIS VERSICO, DOI [10.2305/IUCN.UK.2018-1.RLTS.T57039A89209992.en, DOI 10.2305/IUCN.UK.2018-1.RLTS.T57039A89209992.EN]; Araque Jimenez E, 2005, MONTANAS ESPANOLAS C; Bass MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008767; Brito Jorge, 2017, Neotropical Biodiversity, V3, P125, DOI 10.1080/23766808.2017.1299529; Carvajal-Endara S, 2019, ZOOTAXA, V4562, P1, DOI 10.11646/zootaxa.4562.1.1; COCROFT RB, 1995, ANIM BEHAV, V49, P283, DOI 10.1006/anbe.1995.0043; Coloma LA, 2010, ZOOTAXA, P1; Duellman W.E., 1974, Occasional Papers Mus Nat Hist Univ Kans, VNo. 22, P1; Duellman W.E., 2009, TERRESTRIAL BREEDING; Duellman WE, 2015, MARSUPIAL FROGS: GASTROTHECA & ALLIED GENERA, P1; Duellman WE, 1979, S AM HERPETOFAUNA IT, P1; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Freile J.F., 2018, BIRDS ECUADOR; Guayasamin JM, 2014, AMPHIB REPTILE CONSE, V8, P33; HEDGES SB, 2008, ZOOTAXA 0331, P1; Homeier J., 2008, V198, P87; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; Jorge Brito M., 2017, Papeis Avulsos de Zoologia (Sao Paulo), V57, P177, DOI 10.11606/0031-1049.2017.57.15; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Keating PL, 1998, PHYS GEOGR, V19, P221, DOI 10.1080/02723646.1998.10642648; Kohler J, 2017, ZOOTAXA, V4251, P1, DOI 10.11646/zootaxa.4251.1.1; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Lavilla EO, 2013, ZOOTAXA, V3646, P251, DOI 10.11646/zootaxa.3646.3.4; Lehr E, 2008, HERPETOLOGICA, V64, P354, DOI 10.1655/07-089.1; Lynch J.D., 1975, Occasional Papers Mus Nat Hist Univ Kans, VNo. 35, P1; LYNCH J D, 1979, University of Kansas Museum of Natural History Miscellaneous Publication, P1; LYNCH J D, 1980, University of Kansas Museum of Natural History Miscellaneous Publication, P1; Martin-Torrijos L., 2016, Neotropical Biodiversity, V2, P26, DOI 10.1080/23766808.2016.1151133; Merino-Viteri A, 2005, ESTUDIOS RANAS ANDIN; Motta AP, 2016, HERPETOL MONOGR, V30, P119, DOI 10.1655/HERPMONOGRAPHS-D-16-00002; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Ochoa-Cueva P, 2015, LAND DEGRAD DEV, V26, P565, DOI 10.1002/ldr.2219; Ordonez-Delgado L, 2019, GRANJA, V30, P7, DOI 10.17163/lgr.n30.2019.01; Padial JM, 2014, ZOOTAXA, V3825, P1, DOI 10.11646/zootaxa.3825.1.1; Paez NB, 2019, ZOOKEYS, P1, DOI 10.3897/zookeys.868.26766; Parker H. W., 1938, Annals & Magazine of Natural History Series 11, V2, P438; Pidancier N, 2003, HERPETOL J, V13, P175; Pristimantis vidua, 2004, PRISTIMANTIS VIDUA; Rahbek Carsten, 1996, Ornitologia Neotropical, V6, P113; Reyes-Puig C, 2019, ZOOKEYS, P113, DOI 10.3897/zookeys.832.30874; Rollenbeck R, 2011, ATMOS RES, V99, P277, DOI 10.1016/j.atmosres.2010.10.018; Ron S. R., 2019, ANFIBIOS ECUADOR VER; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanchez-Nivicela JC, 2019, ZOOTAXA, V4567, P1, DOI 10.11646/zootaxa.4567.1.1; Schulenberg T.S., 2010, BIRDS PERU REVISED U; Szekely P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202332; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Toledo LF, 2015, ACTA ETHOL, V18, P87, DOI 10.1007/s10211-014-0194-4; Torres-Carvajal O, 2020, REPTILES ECUADOR VER; Torres-Carvajal O, 2019, AMPHIB REPTILE CONSE, V13, P209; TRUEB L, 1979, COPEIA, P714; Ulloa CU, 2017, SCIENCE, V358, P1614, DOI 10.1126/science.aao0398; Urgiles VL, 2019, ZOOKEYS, P111, DOI 10.3897/zookeys.864.35102; Yanez-Munoz MH, 2019, ZOOKEYS, P137, DOI 10.3897/zookeys.852.24557; Zwickl D. J, 2006, GENETIC ALGORITHM AP	63	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238306	10.1371/journal.pone.0238306	http://dx.doi.org/10.1371/journal.pone.0238306			59	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911497	gold, Green Published			2022-12-26	WOS:000571885900050
J	Koutsogiannaki, S; Bu, WM; Hou, LF; Shibamura-Fujiogi, M; Ishida, H; Ohto, U; Eckenhoff, RG; Yuki, K				Koutsogiannaki, Sophia; Bu, Weiming; Hou, Lifei; Shibamura-Fujiogi, Miho; Ishida, Hanako; Ohto, Umeharu; Eckenhoff, Roderic G.; Yuki, Koichi			The effect of anesthetics on toll like receptor 9	FASEB JOURNAL			English	Article						electrostatic potential; nucleic acid; toll-like receptor; volatile anesthetics	MITOCHONDRIAL-DNA; VOLATILE ANESTHETICS; BINDING-SITE; HUMAN TLR9; ISOFLURANE; CPG; RECOGNITION; SEVOFLURANE; INFLAMMATION; SELECTIVITY	Toll like receptors (TLRs) are critical receptors to respond to danger signals, and their functions are relevant in the perioperative period. We previously reported that volatile anesthetics directly bound to TLR2 and TLR4 and attenuated their functions. Given that TLR9 can respond to mitochondrial DNA, a danger signal that is released upon tissue injury, we examined the role of anesthetics on TLR9 function. Our reporter assay showed that volatile anesthetics isoflurane and sevoflurane increased the activation of TLR9, while propofol attenuated it. TLR9 activation occurs via its dimerization. The dimerization is facilitated by unmethylated cytosine-phosphate-guanine (CpG) DNA as well as DNA containing cytosine at the second position from 5 '-end (5 '-xCx DNA). Our structural analysis using photoactivable anesthetics and rigid docking simulation showed that isoflurane and sevoflurane bound to both TLR9 dimer interface and 5 '-xCx DNA binding site. Propofol bound to the TLR9 antagonist binding site. This is the first illustration that anesthetics can affect the binding of nucleic acids to their receptor. This study sets the foundation for the effect of anesthetics on TLR9 and will pave the way for future studies to determine the significance of such interactions in the clinical setting.	[Koutsogiannaki, Sophia; Hou, Lifei; Shibamura-Fujiogi, Miho; Yuki, Koichi] Boston Childrens Hosp, Cardiac Anesthesia Div, Dept Anesthesiol Crit Care & Pain Med, 300 Longwood Ave, Boston, MA 02115 USA; [Koutsogiannaki, Sophia; Hou, Lifei; Shibamura-Fujiogi, Miho; Yuki, Koichi] Harvard Med Sch, Dept Anaesthesia, Boston, MA 02115 USA; [Koutsogiannaki, Sophia; Hou, Lifei; Shibamura-Fujiogi, Miho; Yuki, Koichi] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA; [Bu, Weiming; Eckenhoff, Roderic G.] Univ Penn, Dept Anesthesia & Crit Care, Philadelphia, PA 19104 USA; [Ishida, Hanako; Ohto, Umeharu] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Pennsylvania; University of Tokyo	Yuki, K (corresponding author), Boston Childrens Hosp, Cardiac Anesthesia Div, Dept Anesthesiol Crit Care & Pain Med, 300 Longwood Ave, Boston, MA 02115 USA.	koichi.yuki@childrens.harvard.edu			HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [GM118277, GM127600]	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS)	HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: GM118277 and GM127600	Bao WDN, 2016, SCI REP-UK, V6, DOI 10.1038/srep22579; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Botos I, 2011, STRUCTURE, V19, P447, DOI 10.1016/j.str.2011.02.004; Carbo C, 2013, J ANESTH, V27, P261, DOI 10.1007/s00540-012-1508-1; Carty M, 2010, CLIN EXP IMMUNOL, V161, P397, DOI 10.1111/j.1365-2249.2010.04196.x; El-Sayed OM, 2016, J VASC SURG, V64, P1450, DOI 10.1016/j.jvs.2015.08.070; Eppensteiner J, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127925; Gan L, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/587378; Golovkin AS, 2013, ISRN INFLAMM, V2013, P817901, DOI 10.1155/2013/817901; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Henke PK, 2011, ARTERIOSCL THROM VAS, V31, P43, DOI 10.1161/ATVBAHA.110.216317; Ishida H, 2018, FEBS LETT, V592, P2636, DOI 10.1002/1873-3468.13176; Koutsogiannaki S, 2019, FASEB J, V33, P12668, DOI 10.1096/fj.201901360R; Koutsogiannaki S, 2019, J SURG RES, V233, P323, DOI 10.1016/j.jss.2018.07.075; Koutsogiannaki S, 2017, TOXICOL SCI, V156, P402, DOI 10.1093/toxsci/kfw261; Liu JR, 2014, SHOCK, V42, P532, DOI 10.1097/SHK.0000000000000250; Liu RY, 2005, ANESTHESIOLOGY, V102, P799, DOI 10.1097/00000542-200504000-00016; Mitsui Y, 2020, ANESTH ANALG, V131, P631, DOI 10.1213/ANE.0000000000004741; Ohto U, 2018, IMMUNITY, V48, P649, DOI 10.1016/j.immuni.2018.03.013; Ohto U, 2015, NATURE, V520, P702, DOI 10.1038/nature14138; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Okuno T, 2019, FASEB J, V33, P14528, DOI 10.1096/fj.201901570R; Okuno T, 2017, FASEB J, V31, P1584, DOI 10.1096/fj.201601095R; Pohar J, 2017, J IMMUNOL, V198, P2093, DOI 10.4049/jimmunol.1600757; Raoof M, 2010, J TRAUMA, V68, P1328, DOI 10.1097/TA.0b013e3181dcd28d; Romics L, 2006, ARCH SURG-CHICAGO, V141, P595, DOI 10.1001/archsurg.141.6.595; Sandler N, 2018, HEART LUNG CIRC, V27, P122, DOI 10.1016/j.hlc.2017.02.014; Stollings LM, 2016, ANESTHESIOLOGY, V125, P399, DOI 10.1097/ALN.0000000000001195; Takeshita F, 2004, SEMIN IMMUNOL, V16, P17, DOI 10.1016/j.smim.2003.10.009; Tazawa K, 2017, TOXICOL LETT, V266, P23, DOI 10.1016/j.toxlet.2016.12.007; Thurairajah K, 2018, EUR J TRAUMA EMERG S, V44, P325, DOI 10.1007/s00068-018-0954-3; Yuki Koichi, 2017, Transl Perioper Pain Med, V2, P1; Yuki K, 2016, ANESTH ANALG, V123, P326, DOI 10.1213/ANE.0000000000001403; Yuki K, 2013, ANESTH ANALG, V117, P803, DOI 10.1213/ANE.0b013e3182a00ae0; Yuki K, 2012, FASEB J, V26, P4408, DOI 10.1096/fj.12-212746; Yuki K, 2010, ANESTHESIOLOGY, V113, P600, DOI 10.1097/ALN.0b013e3181e89a77; Yuki K, 2008, FASEB J, V22, P4109, DOI 10.1096/fj.08-113324; Zha H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216163; Zhang JZ, 2014, INT J MOL MED, V33, P817, DOI 10.3892/ijmm.2014.1650	41	2	2	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14645	14654		10.1096/fj.202000791RR	http://dx.doi.org/10.1096/fj.202000791RR		SEP 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32901993	Green Accepted			2022-12-26	WOS:000568304500001
J	Barba, C; Montanaro, D; Grisotto, L; Frijia, F; Pellacani, S; Cavalli, A; Rizzi, S; Lenge, M; Aghakhanyan, G; Sibilia, V; Giordano, F; Pisano, T; Mari, F; Melani, F; Cherubini, A; Buccoliero, A; Caligiuri, ME; Guerrini, R				Barba, Carmen; Montanaro, Domenico; Grisotto, Laura; Frijia, Francesca; Pellacani, Simona; Cavalli, Anna; Rizzi, Susanna; Lenge, Matteo; Aghakhanyan, Gayane; Sibilia, Valentina; Giordano, Flavio; Pisano, Tiziana; Mari, Francesco; Melani, Federico; Cherubini, Andrea; Buccoliero, Annamaria; Caligiuri, Maria Eugenia; Guerrini, Renzo			Patterns and predictors of language representation and the influence of epilepsy surgery on language reorganization in children and young adults with focal lesional epilepsy	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; ATYPICAL LANGUAGE; EEG-FMRI; PRESURGICAL EVALUATION; LATERALIZATION; ACTIVATION; ORGANIZATION; HEMISPHERE; NETWORKS; OUTCOMES	Mapping brain functions is crucial for neurosurgical planning in patients with drug-resistant seizures. However, presurgical language mapping using either functional or structural networks can be challenging, especially in children. In fact, most of the evidence on this topic derives from cross-sectional or retrospective studies in adults submitted to anterior temporal lobectomy. In this prospective study, we used fMRI and DTI to explore patterns of language representation, their predictors and impact on cognitive performances in 29 children and young adults (mean age at surgery: 14.6 +/- 4.5 years) with focal lesional epilepsy. In 20 of them, we also assessed the influence of epilepsy surgery on language lateralization. All patients were consecutively enrolled at a single epilepsy surgery center between 2009 and 2015 and assessed with preoperative structural and functional 3T brain MRI during three language tasks: Word Generation (WG), Rhyme Generation (RG) and a comprehension task. We also acquired DTI data on arcuate fasciculus in 24 patients. We first assessed patterns of language representation (relationship of activations with the epileptogenic lesion and Laterality Index (LI)) and then hypothesized a causal model to test whether selected clinical variables would influence the patterns of language representation and the ensuing impact of the latter on cognitive performances. Twenty out of 29 patients also underwent postoperative language fMRI. We analyzed possible changes of fMRI and DTI LIs and their clinical predictors. Preoperatively, we found atypical language lateralization in four patients during WG task, in one patient during RG task and in seven patients during the comprehension task. Diffuse interictal EEG abnormalities predicted a more atypical language representation on fMRI (p = 0.012), which in turn correlated with lower attention (p = 0.036) and IQ/GDQ scores (p = 0.014). Postoperative language reorganization implied shifting towards atypical language representation. Abnormal postoperative EEG (p = 0.003) and surgical failures (p = 0.015) were associated with more atypical language lateralization, in turn correlating with worsened fluency. Neither preoperative asymmetry nor postoperative DTI LI changes in the arcuate fasciculus were observed. Focal lesional epilepsy associated with diffuse EEG abnormalities may favor atypical language lateralization and worse cognitive performances, which are potentially reversible after successful surgery.	[Barba, Carmen; Pellacani, Simona; Cavalli, Anna; Rizzi, Susanna; Lenge, Matteo; Sibilia, Valentina; Pisano, Tiziana; Mari, Francesco; Melani, Federico; Guerrini, Renzo] Univ Florence, Neurosci Dept, Childrens Hosp Meyer, Florence, Italy; [Montanaro, Domenico; Aghakhanyan, Gayane] Fdn CNR Reg Toscana G Monasterio, UOC RM Specialist & Neuroradiol, Pisa, Italy; [Grisotto, Laura] Univ Florence, Dept Stat, Florence, Italy; [Frijia, Francesca] Fdn CNR Reg Toscana G Monasterio, Bioengn & Clin Technol Unit, Pisa, Italy; [Lenge, Matteo; Giordano, Flavio] Univ Florence, Neurosurg Dept, Childrens Hosp Meyer, Florence, Italy; [Cherubini, Andrea] CNR, Inst Mol Bioimaging & Physiol, Catanzaro, Italy; [Buccoliero, Annamaria] Univ Florence, Pathol Unit, Childrens Hosp Meyer, Florence, Italy; [Caligiuri, Maria Eugenia] Magna Graecia Univ Catanzaro, Neurosci Res Ctr, Catanzaro, Italy; [Guerrini, Renzo] IRCCS Stella Maris, Pisa, Italy	University of Florence; University of Florence; University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); University of Florence; Magna Graecia University of Catanzaro; IRCCS Fondazione Stella Maris	Barba, C (corresponding author), Univ Florence, Neurosci Dept, Childrens Hosp Meyer, Florence, Italy.	carmen.barba@meyer.it	Pellacani, Simona/AAB-9849-2022; Pellacani, Simona/HDL-7360-2022; barba, carmen/K-4942-2016; Aghakhanyan, Gayane/AAC-7691-2022; Montanaro, Domenico/K-5938-2016; Cherubini, Andrea/D-1327-2009; Montanaro, Domenico/AAB-9718-2022; Barba, Carmen/AAB-7162-2022; Caligiuri, Maria Eugenia/K-4957-2018	Pellacani, Simona/0000-0003-3578-8953; barba, carmen/0000-0001-5445-5842; Aghakhanyan, Gayane/0000-0001-5152-497X; Cherubini, Andrea/0000-0002-5946-4390; Montanaro, Domenico/0000-0002-9895-7016; Caligiuri, Maria Eugenia/0000-0002-2030-5552; Reis, AlessanRSS/0000-0001-8486-7469; GIORDANO, FLAVIO/0000-0002-9006-9225; Frijia, Francesca/0000-0003-3802-326X; Guerrini, Renzo/0000-0002-7272-7079	Italian Ministry of Health [RF2010-2309954]; Tuscany Region [RF2010-2309954]; EU 7th Framework Programme (FP7) under the project DESIRE [602531]	Italian Ministry of Health(Ministry of Health, Italy); Tuscany Region(Regione Toscana); EU 7th Framework Programme (FP7) under the project DESIRE	This study was funded by the Italian Ministry of Health and Tuscany Region, grant RF2010-2309954 (to C.B and D.M.) and by the EU 7th Framework Programme (FP7) under the project DESIRE, grant No 602531 (to R.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Asmi A, 2003, EPILEPSIA, V44, P1328, DOI 10.1046/j.1528-1157.2003.01003.x; Anderson DP, 2006, EPILEPSIA, V47, P998, DOI 10.1111/j.1528-1167.2006.00572.x; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Benjamin CF, 2017, HUM BRAIN MAPP, V38, P4239, DOI 10.1002/hbm.23661; Benjamin CFA, 2018, HUM BRAIN MAPP, V39, P2777, DOI 10.1002/hbm.24039; Berl MM, 2014, ANN NEUROL, V75, P33, DOI 10.1002/ana.24015; Black DF, 2017, AM J NEURORADIOL, V38, pE65, DOI 10.3174/ajnr.A5345; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Bonelli SB, 2012, EPILEPSIA, V53, P639, DOI 10.1111/j.1528-1167.2012.03433.x; Boshuisen K, 2015, ANN NEUROL, V78, P104, DOI 10.1002/ana.24427; Briellmann RS, 2006, EPILEPSIA, V47, P916, DOI 10.1111/j.1528-1167.2006.00513.x; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Chugani HT, 1996, BRAIN DEV-JPN, V18, P347, DOI 10.1016/0387-7604(96)00032-0; Collinge S, 2017, SEIZURE-EUR J EPILEP, V52, P136, DOI 10.1016/j.seizure.2017.09.024; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cross JH, 2006, EPILEPSIA, V47, P952, DOI 10.1111/j.1528-1167.2006.00569.x; Drane DL, 2016, EPILEPSY BEHAV, V56, P131, DOI 10.1016/j.yebeh.2016.01.001; Duke ES, 2012, EPILEPSIA, V53, P1044, DOI 10.1111/j.1528-1167.2012.03490.x; Ellmore TM, 2010, NEUROIMAGE, V49, P2033, DOI 10.1016/j.neuroimage.2009.10.055; ENGEL J, 1993, NEUROLOGY, V43, P1612, DOI 10.1212/WNL.43.8.1612; European Commission, 2000, OFFICIAL METHODS OF, VC, P1, DOI 10.1108/03090550310770974; Everts R, 2010, EPILEPSIA, V51, P627, DOI 10.1111/j.1528-1167.2009.02406.x; Faber J, 2013, EPILEPSIA, V54, pe53, DOI 10.1111/epi.12077; Federico P, 2005, NEUROLOGY, V64, P1125, DOI 10.1212/01.WNL.0000156358.72670.AD; Gaillard WD, 2007, NEUROLOGY, V69, P1761, DOI 10.1212/01.wnl.0000289650.48830.1a; Griffiths R., 2006, GRIFFITHS MENTAL DEV; Helmstaedter C, 2006, EPILEPSY RES, V70, P257, DOI 10.1016/j.eplepsyres.2006.03.005; Helmstaedter C, 2013, EPILEPTIC DISORD, V15, P221, DOI 10.1684/epd.2013.0587; Herting MM, 2018, DEV COGN NEUROS-NETH, V33, P17, DOI 10.1016/j.dcn.2017.07.001; Hertz-Pannier L, 2002, BRAIN, V125, P361, DOI 10.1093/brain/awf020; Janszky J, 2006, EPILEPSIA, V47, P921, DOI 10.1111/j.1528-1167.2006.00514.x; Janszky J, 2003, BRAIN, V126, P2043, DOI 10.1093/brain/awg193; Jayakar P, 2018, EPILEPSIA, V59, P1484, DOI 10.1111/epi.14510; Jayakar P, 2014, EPILEPSIA, V55, P507, DOI 10.1111/epi.12544; Klein P, 2018, EPILEPSIA, V59, P37, DOI 10.1111/epi.13965; Kobayashi E, 2005, NEUROLOGY, V64, P1263, DOI 10.1212/01.WNL.0000154640.23656.A3; Korkman M., 2007, NEPSY 2, V2nd; Krsek P, 2009, EPILEPSIA, V50, P125, DOI 10.1111/j.1528-1167.2008.01682.x; Lenge M, 2018, CEREB CORTEX, V28, P1076, DOI 10.1093/cercor/bhx036; Lidzba K, 2017, BRAIN LANG, V173, P1, DOI 10.1016/j.bandl.2017.04.006; Liegeois F, 2006, J MAGN RESON IMAGING, V23, P933, DOI 10.1002/jmri.20586; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Maulisova A, 2016, EPILEPSY BEHAV, V58, P91, DOI 10.1016/j.yebeh.2016.03.006; McCullagh P, 1989, GEN LINEAR MODELS; McDonald CR, 2010, NEUROLOGY, V75, P1631, DOI 10.1212/WNL.0b013e3181fb44db; Nettekoven C, 2018, NEUROIMAGE, V176, P215, DOI 10.1016/j.neuroimage.2018.04.050; Nikolova S, 2015, EPILEPSY RES, V116, P1, DOI 10.1016/j.eplepsyres.2015.06.012; Pataraia E, 2005, NEUROLOGY, V64, P481, DOI 10.1212/01.WNL.0000150900.71773.E6; Pecini C, 2008, ARCH ITAL BIOL, V146, P189; Powell HWR, 2006, NEUROIMAGE, V32, P388, DOI 10.1016/j.neuroimage.2006.03.011; PP J, 2004, REV STAT APPL, V52, P93; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Riva D, 2000, BRAIN LANG, V71, P267, DOI 10.1006/brln.1999.2166; Roid G.H., 1997, LEITER INT PERFORMAN; Rosenow F, 2001, BRAIN, V124, P1683, DOI 10.1093/brain/124.9.1683; Ruff IM, 2008, AM J NEURORADIOL, V29, P528, DOI 10.3174/ajnr.A0841; Seghier ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep20170; Sivakanthan S, 2016, ACTA NEUROCHIR, V158, P2185, DOI 10.1007/s00701-016-2910-5; Spencer S, 2008, LANCET NEUROL, V7, P525, DOI 10.1016/S1474-4422(08)70109-1; Springer JA, 1999, BRAIN, V122, P2033, DOI 10.1093/brain/122.11.2033; Szaflarski JP, 2017, NEUROLOGY, V88, P395, DOI 10.1212/WNL.0000000000003532; Szaflarski JP, 2002, NEUROLOGY, V59, P238, DOI 10.1212/WNL.59.2.238; Van Bogaert P, 2013, HAND CLINIC, V111, P635, DOI 10.1016/B978-0-444-52891-9.00066-X; Vernooij MW, 2007, NEUROIMAGE, V35, P1064, DOI 10.1016/j.neuroimage.2006.12.041; Voets NL, 2006, BRAIN, V129, P754, DOI 10.1093/brain/awh679; Ward B. D, 2006, DECONVOLUTION ANAL F; Wechsler D., 2013, WECHSLER INTELLIGENC; Wechsler D., 2008, WECHSLER PRESCHOOL P, V3rd; Winston GP, 2014, NEUROIMAGE-CLIN, V4, P190, DOI 10.1016/j.nicl.2013.12.004; Wyllie E, 2007, NEUROLOGY, V69, P389, DOI 10.1212/01.wnl.0000266386.55715.3f; Yogarajah M, 2010, BRAIN, V133, P2348, DOI 10.1093/brain/awq175; You XZ, 2019, EPILEPSIA, V60, P527, DOI 10.1111/epi.14656; Yuan WH, 2006, EPILEPSIA, V47, P593, DOI 10.1111/j.1528-1167.2006.00474.x; Zhang J, 2013, EPILEPSY RES, V104, P253, DOI 10.1016/j.eplepsyres.2012.10.015; 2018, NEUROSURG FOCUS, V45, pE4	77	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238389	10.1371/journal.pone.0238389	http://dx.doi.org/10.1371/journal.pone.0238389			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ6EE	32898166	gold, Green Published			2022-12-26	WOS:000570962500044
J	Han, H; Wang, S; Meng, J; Lyu, G; Ding, G; Hu, Y; Wang, L; Wu, L; Yang, W; Lv, Y; Jia, S; Zhang, L; Ji, J				Han, H.; Wang, S.; Meng, J.; Lyu, G.; Ding, G.; Hu, Y.; Wang, L.; Wu, L.; Yang, W.; Lv, Y.; Jia, S.; Zhang, L.; Ji, J.			Long noncoding RNA PART1 restrains aggressive gastric cancer through the epigenetic silencing of PDGFBviathe PLZF-mediated recruitment of EZH2	ONCOGENE			English	Article							CELL-PROLIFERATION; PROSTATE-CANCER; RECEPTOR-BETA; METASTASIS; EXPRESSION; PROMOTES; GROWTH; GENE; SUPPRESSION; APOPTOSIS	Current reports refer to the role of long noncoding RNA (lncRNA) prostate androgen-regulated transcript 1 (PART1) as a tumor suppressor in some types of cancer but as an oncogene in other kinds of cancer. In gastric cancer, it had been reported to be downregulated. However, the clinical significance and underlying mechanism of PART1 function in gastric cancer remains undefined. Here, seven differential expression levels of noncoding RNAs (DE-lncRNAs) were screened from gastric cancer through a probe reannotation of a human exon array. PART1 was selected for further study because of its high fold change number. In our cohort, PART1 was identified as a significant downregulated lncRNA in gastric cancer tissues by qPCR and in situ hybridization (ISH), and its low expression was significantly correlated with postoperative metastasis and short overall survival time after surgery. Through the results of gain-of-function experiments, PART1 was confirmed as a tumor suppressor that can decrease not only cell viability, migration, and invasion in vitro but also tumorigenesis and tumor metastasis in vivo. Mechanistically, RNA pull-down and RNA-binding protein immunoprecipitation (RIP) showed that PART1 interacts with androgen receptor (AR), and then, promyelocytic leukemia zinc finger (PLZF) is upregulated in an androgen-independent manner. In a chain reaction, chromatin immunoprecipitation (ChIP) assay additionally illustrated that PLZF upregulation increased the enrichment of EZH2 and H3K27 trimethylation in the platelet-derived growth factor (PDGFB) promotor, thereby inhibition of PDGFB and the subsequent PDGFR beta/PI3K/Akt signaling pathway. Based on these findings, we showed PART1 plays a tumor suppressor rolebypromoting PLZF expression followed by recruitment of EZH2 to mediate epigenetic PDGFB silencing and downstream PI3K/Akt inhibition, suggesting that PART1 has a key role in restraining the aggressive ability of GC cells and providing a novel perspective on lncRNAs in GC progression.	[Han, H.; Ding, G.; Hu, Y.] Peking Univ, Canc Hosp & Inst, Dept Biobank, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China; [Wang, S.; Meng, J.; Wang, L.; Yang, W.; Lv, Y.] Peking Univ, Dept Clin Lab, Canc Hosp & Inst, Beijing, Peoples R China; [Lyu, G.] Peking Univ, Dept Gastrointestinal Surg, Shenzhen Hosp, Shenzhen, Peoples R China; [Wu, L.] Peking Univ, Dept Cent Lab, Canc Hosp & Inst, Beijing, Peoples R China; [Jia, S.] Peking Univ, Dept Mol Diagnost, Canc Hosp & Inst, Beijing, Peoples R China; [Zhang, L.; Ji, J.] Peking Univ, Dept Gastrointestinal Surg, Canc Hosp & Inst, Beijing, Peoples R China	Peking University; Peking University; Peking University; Peking University; Peking University; Peking University	Jia, S (corresponding author), Peking Univ, Dept Mol Diagnost, Canc Hosp & Inst, Beijing, Peoples R China.; Zhang, L; Ji, J (corresponding author), Peking Univ, Dept Gastrointestinal Surg, Canc Hosp & Inst, Beijing, Peoples R China.	shuqin_jia@hsc.pku.edu.cn; lianhaizhang@bjcancer.org; jijiafu@hsc.pku.edu.cn		Meng, Jialin/0000-0002-4622-833X	National Natural Science Foundation of China [81772632, 81802943]; Science Foundation of Peking University Cancer Hospital [2020-9]; Beijing outstanding talent training program [2018000021469G268]; interdisciplinary medicine Seed Fund of Peking University [BMU2018MX019]; Special funds of the Ministry of Finance for Reform and Development; 'San Ming' Project of Shenzhen city [SZSM 201612051]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Peking University Cancer Hospital; Beijing outstanding talent training program; interdisciplinary medicine Seed Fund of Peking University; Special funds of the Ministry of Finance for Reform and Development; 'San Ming' Project of Shenzhen city	This work was supported by grants from the National Natural Science Foundation of China (81772632, 81802943), Science Foundation of Peking University Cancer Hospital 2020-9, Beijing outstanding talent training program (No. 2018000021469G268), the interdisciplinary medicine Seed Fund of Peking University (No. BMU2018MX019), Special funds of the Ministry of Finance for Reform and Development and 'San Ming' Project of Shenzhen city (no. SZSM 201612051).	Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cao WJ, 2013, WORLD J GASTROENTERO, V19, P3658, DOI 10.3748/wjg.v19.i23.3658; Chen S, 2017, CELL PHYSIOL BIOCHEM, V44, P215, DOI 10.1159/000484648; Chen X, 2018, CLIN CANCER RES, V24, P2002, DOI 10.1158/1078-0432.CCR-17-2376; Cher ML, 1996, CANCER RES, V56, P3091; Dong Y, 2018, EUR REV MED PHARMACO, V22, P1307, DOI 10.26355/eurrev_201803_14472; Fei ZH, 2016, TUMOR BIOL, V37, P1983, DOI 10.1007/s13277-015-3979-9; Feng RM, 2019, CANCER COMMUN, V39, DOI 10.1186/s40880-019-0368-6; Gu L, 2018, CANCER MED-US, V7, P1253, DOI 10.1002/cam4.1310; Gu W, 2019, MOL MED REP, V20, P2209, DOI 10.3892/mmr.2019.10478; Guo HF, 2015, J GENET GENOMICS, V42, P343, DOI 10.1016/j.jgg.2015.03.003; Guo Y, 2013, WSPOLCZESNA ONKOL, V17, P150, DOI 10.5114/wo.2013.34618; He XJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-218; Hsieh CL, 2015, CANCER RES, V75, P1944, DOI 10.1158/0008-5472.CAN-14-3602; Hu L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0322-6; Hu XW, 2018, CURR OPIN GENET DEV, V48, P8, DOI 10.1016/j.gde.2017.10.004; Hu YB, 2017, BIOCHEM BIOPH RES CO, V490, P317, DOI 10.1016/j.bbrc.2017.06.042; Izumi K, 2012, INT J ONCOL, V41, P1587, DOI 10.3892/ijo.2012.1593; Jiang F, 2004, PROSTATE, V59, P426, DOI 10.1002/pros.20000; Jin Y, 2017, ONCOTARGET, V8, P71317, DOI 10.18632/oncotarget.19813; Kodama M, 2010, CANCER SCI, V101, P1984, DOI 10.1111/j.1349-7006.2010.01639.x; Kominea A, 2004, J CANCER RES CLIN, V130, P253, DOI 10.1007/s00432-003-0531-x; Koubi M, 2018, NUCLEIC ACIDS RES, V46, P3339, DOI 10.1093/nar/gky080; Li H, 2014, ONCOTARGET, V5, P2318, DOI 10.18632/oncotarget.1913; Li JJ, 2017, CANCER CELL INT, V17, DOI 10.1186/s12935-017-0408-8; Li M, 2017, J CANCER, V8, P1795, DOI 10.7150/jca.18848; Li QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033379; Li Y, 2017, CANCER LETT, V395, P31, DOI 10.1016/j.canlet.2017.02.035; Lin BY, 2000, CANCER RES, V60, P858; Lin CR, 2018, TRENDS CELL BIOL, V28, P287, DOI 10.1016/j.tcb.2017.11.008; Liu J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0246-6; Liu TM, 2015, STEM CELLS DAYT OHIO, V34, P277; Ma HW, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20171193; Ozen M, 1998, CANCER GENET CYTOGEN, V106, P105, DOI 10.1016/S0165-4608(98)00051-X; Peng Y, 2014, BIOSCIENCE REP, V34, P247, DOI 10.1042/BSR20140020; Sugano K, 2015, BEST PRACT RES CL GA, V29, P895, DOI 10.1016/j.bpg.2015.09.013; Sun M, 2018, BIOL CHEM, V399, P387, DOI 10.1515/hsz-2017-0255; Thomassen I, 2014, INT J CANCER, V134, P622, DOI 10.1002/ijc.28373; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wang GH, 2019, BIOMED PHARMACOTHER, V111, P1334, DOI 10.1016/j.biopha.2019.01.023; Wang JB, 2019, ONCOL REP, V41, P1007, DOI 10.3892/or.2018.6866; Wang Y, 2018, CELL BIOL INT, V42, P1358, DOI 10.1002/cbin.11020; Wen W, 2012, HEPATOLOGY, V55, P1787, DOI 10.1002/hep.25596; Wu Q, 2018, MOL ONCOL, V12, P799, DOI 10.1002/1878-0261.12187; Xia N, 2019, J PATHOL, V248, P304, DOI 10.1002/path.5257; Xu WR, 2018, BIOSCI BIOTECH BIOCH, V82, P456, DOI 10.1080/09168451.2018.1431518; Xue M, 2018, GASTRIC CANCER, V21, P756, DOI 10.1007/s10120-018-0801-6; Yang F, 2012, FEBS J, V279, P3159, DOI 10.1111/j.1742-4658.2012.08694.x; Yu YC, 2017, J CELL MOL MED, V21, P955, DOI 10.1111/jcmm.13035; Zhang XQ, 2013, NEUROBIOL DIS, V58, P123, DOI 10.1016/j.nbd.2013.05.011; Zhang Y, 2018, ASIAN J ANDROL, V20, P511, DOI 10.4103/aja.aja_36_18; Zhang ZZ, 2015, MOL CANCER THER, V14, P1162, DOI 10.1158/1535-7163.MCT-14-0695; Zhao Y, 2014, ONCOL REP, V31, P358, DOI 10.3892/or.2013.2850; Zhou TC, 2020, INT J BIOCHEM CELL B, V118, DOI 10.1016/j.biocel.2019.105637; Zhu DY, 2019, CANCER MED-US, V8, P6064, DOI 10.1002/cam4.2494; Zong L, 2016, LANCET, V388, P2606, DOI 10.1016/S0140-6736(16)32226-7	56	19	19	2	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 15	2020	39	42					6513	6528		10.1038/s41388-020-01442-5	http://dx.doi.org/10.1038/s41388-020-01442-5		SEP 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	OA9HI	32901105				2022-12-26	WOS:000567639400001
J	Tanaka, M; Sugimoto, K; Fujimoto, T; Xie, KY; Takahashi, T; Akasaka, H; Yasunobe, Y; Takeya, Y; Yamamoto, K; Hirabayashi, T; Fujino, H; Rakugi, H				Tanaka, Minoru; Sugimoto, Ken; Fujimoto, Taku; Xie, Keyu; Takahashi, Toshimasa; Akasaka, Hiroshi; Yasunobe, Yukiko; Takeya, Yasushi; Yamamoto, Koichi; Hirabayashi, Takumi; Fujino, Hidemi; Rakugi, Hiromi			Differential effects of pre-exercise on cancer cachexia-induced muscle atrophy in fast- and slow-twitch muscles	FASEB JOURNAL			English	Article						cancer cachexia; muscle atrophy; pre-exercise; protein degradation; protein synthesis	SKELETAL-MUSCLE; CAPILLARY REGRESSION; TNF-ALPHA; PHYSICAL-ACTIVITY; EXERCISE; EXPRESSION; PROTEIN; BEARING; OXYGEN; HYPOXIA	We hypothesized that pre-exercise may effectively prevent cancer cachexia-induced muscle atrophy in both fast- and slow-twitch muscle types. Additionally, the fast-twitch muscle may be more affected by cancer cachexia than slow-twitch muscle. This study aimed to evaluate the effects of pre-exercise on cancer cachexia-induced atrophy and on atrophy in fast- and slow-twitch muscles. Twelve male Wistar rats were randomly divided into sedentary and exercise groups, and another 24 rats were randomly divided into control, pre-exercise, cancer cachexia induced by intraperitoneal injections of ascites hepatoma AH130 cells, and pre-exercise plus cancer cachexia groups. We analyzed changes in muscle mass and in gene and protein expression levels of major regulators and indicators of muscle protein degradation and synthesis pathways, angiogenic factors, and mitochondrial function in both the plantaris and soleus muscles. Pre-exercise inhibited muscle mass loss, rescued protein synthesis, prevented capillary regression, and suppressed hypoxia in the plantaris and soleus muscles. Pre-exercise inhibited mitochondrial dysfunction differently in fast- and slow-twitch muscles. These results suggested that pre-exercise has the potential to inhibit cancer-cachexia-induced muscle atrophy in both fast- and slow-twitch muscles. Furthermore, the different progressions of cancer-cachexia-induced muscle atrophy in fast- and slow-twitch muscles are related to differences in mitochondrial function.	[Tanaka, Minoru; Sugimoto, Ken; Fujimoto, Taku; Xie, Keyu; Takahashi, Toshimasa; Akasaka, Hiroshi; Yasunobe, Yukiko; Takeya, Yasushi; Yamamoto, Koichi; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr Med, Osaka, Japan; [Tanaka, Minoru; Sugimoto, Ken; Fujimoto, Taku; Xie, Keyu; Takahashi, Toshimasa; Akasaka, Hiroshi; Yasunobe, Yukiko; Takeya, Yasushi; Yamamoto, Koichi; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Gen Med, Osaka, Japan; [Tanaka, Minoru; Hirabayashi, Takumi; Fujino, Hidemi] Kobe Univ, Grad Sch Hlth Sci, Dept Rehabil Sci, Kobe, Hyogo, Japan; [Tanaka, Minoru] Osaka Hlth Sci Univ, Dept Rehabil Sci, Osaka, Japan	Osaka University; Osaka University; Kobe University	Sugimoto, K (corresponding author), Osaka Univ, Grad Sch, Dept Geriatr & Gen Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sugimoto@geriat.med.osaka-u.ac.jp		Yamamoto, Koichi/0000-0003-0107-9315; Takahashi, Toshimasa/0000-0002-5203-155X	JSPS KAKENHI [16K21517, 18H03130]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We appreciate the grant from Grants-in-Aid for Scientific Research (JSPS KAKENHI, grant numbers 16K21517 and 18H03130).	Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Argiles JM, 2012, J CACHEXIA SARCOPENI, V3, P73, DOI 10.1007/s13539-012-0067-5; Baldwin KM, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00284; Ballaro R, 2019, CANCERS, V11, DOI 10.3390/cancers11030285; Blomstrand E, 2011, PFLUG ARCH EUR J PHY, V462, P257, DOI 10.1007/s00424-011-0978-6; Bournat Juan C, 2010, Curr Opin Endocrinol Diabetes Obes, V17, P446, DOI 10.1097/MED.0b013e32833c3026; Busquets S, 2012, J CACHEXIA SARCOPENI, V3, P37, DOI 10.1007/s13539-011-0049-z; Carbo N, 2002, BRIT J CANCER, V86, P1012, DOI 10.1038/sj.bjc.6600167; Ciciliot S, 2013, INT J BIOCHEM CELL B, V45, P2191, DOI 10.1016/j.biocel.2013.05.016; Devine RD, 2017, AM J PHYSIOL-HEART C, V312, pH1154, DOI 10.1152/ajpheart.00090.2016; Dun YL, 2015, FOOD FUNCT, V6, P3056, DOI 10.1039/c5fo00533g; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fernandez-Celemin L, 2002, AM J PHYSIOL-ENDOC M, V283, pE1279, DOI 10.1152/ajpendo.00054.2002; Figueiredo PA, 2009, J GERONTOL A-BIOL, V64, P21, DOI 10.1093/gerona/gln048; Fujita J, 1996, INT J CANCER, V68, P637, DOI 10.1002/(SICI)1097-0215(19961127)68:5<637::AID-IJC14>3.0.CO;2-Z; Garnier A, 2005, FASEB J, V19, P43, DOI 10.1096/fj.04-2173com; HANSENSMITH FM, 1992, J APPL PHYSIOL, V73, P776, DOI 10.1152/jappl.1992.73.2.776; Harber MP, 2009, AM J PHYSIOL-REG I, V296, pR708, DOI [10.1152/ajpregu.00354.2009, 10.1152/ajpregu.90906.2008]; Hirayama Y, 2017, MICROCIRCULATION, V24, DOI 10.1111/micc.12356; Hirayama Y, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13134; Hori YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073875; Hudlicka O, 2011, MLTJ-MUSCLE LIGAMENT, V1, P3; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Kauppinen A, 2013, CELL SIGNAL, V25, P1939, DOI 10.1016/j.cellsig.2013.06.007; Kim SJ, 1985, J APPL PHYSIOL, V105, P1246; Koltai E, 2010, MECH AGEING DEV, V131, P21, DOI 10.1016/j.mad.2009.11.002; Kondo H, 2015, MUSCLE NERVE, V51, P391, DOI 10.1002/mus.24316; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Lee DH, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020431; Lejay A, 2014, INT J BIOCHEM CELL B, V50, P101, DOI 10.1016/j.biocel.2014.02.013; Li WD, 2015, ONCOTARGET, V6, P7365, DOI 10.18632/oncotarget.3629; Li YP, 2005, FASEB J, V19, P362, DOI 10.1096/fj.04-2364com; Llovera M, 1998, MOL CELL ENDOCRINOL, V142, P183, DOI 10.1016/S0303-7207(98)00105-1; Lloyd PG, 2003, AM J PHYSIOL-HEART C, V284, pH1668, DOI 10.1152/ajpheart.00743.2002; Malek MH, 2010, EXP PHYSIOL, V95, P359, DOI 10.1113/expphysiol.2009.050369; Malek MH, 2009, EXP PHYSIOL, V94, P749, DOI 10.1113/expphysiol.2008.045989; Marabita M, 2016, CELL REP, V17, P501, DOI 10.1016/j.celrep.2016.09.020; Matsumoto T, 2019, J PHYSIOL SCI, V69, P317, DOI 10.1007/s12576-018-0648-y; Mijwel S, 2018, FASEB J, V32, P5495, DOI 10.1096/fj.201700968R; Milne KJ, 1985, J APPL PHYSIOL, V2002, P561; Moore SC, 2016, JAMA INTERN MED, V176, P816, DOI 10.1001/jamainternmed.2016.1548; Olfert IM, 2016, MICROCIRCULATION, V23, P146, DOI 10.1111/micc.12263; Olfert IM, 2009, J PHYSIOL-LONDON, V587, P1755, DOI 10.1113/jphysiol.2008.164384; Park S, 2008, LIFE SCI, V82, P503, DOI 10.1016/j.lfs.2007.12.018; Perry BD, 2016, EXERC IMMUNOL REV, V22, P94; Phillips SM, 2009, APPL PHYSIOL NUTR ME, V34, P403, DOI 10.1139/H09-042; Poole David C., 1996, Microcirculation (Philadelphia), V3, P175, DOI 10.3109/10739689609148286; Pottecher J, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00579; Pournot H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022748; Powers SK, 2020, REDOX BIOL, V35, DOI 10.1016/j.redox.2020.101462; Ramos D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131766; Squires RW, 2018, CURR ONCOL REP, V20, DOI 10.1007/s11912-018-0681-2; SRERE PA, 1963, BIOCHIM BIOPHYS ACTA, V73, P523, DOI 10.1016/0926-6569(63)90146-9; Takeshita H, 2017, SCI REP-UK, V7, DOI 10.1038/srep42323; Tanaka M, 2016, J MUSCULOSKEL NEURON, V16, P152; Tanaka M, 2019, FASEB J, V33, P7852, DOI 10.1096/fj.201802430R; Tang K, 2004, PHYSIOL GENOMICS, V18, P63, DOI 10.1152/physiolgenomics.00023.2004; Tang K, 2010, J CELL PHYSIOL, V222, P320, DOI 10.1002/jcp.21955; TESSITORE L, 1987, BIOCHEM J, V241, P153, DOI 10.1042/bj2410153; Tisdale MJ, 2010, CURR OPIN GASTROEN, V26, P146, DOI 10.1097/MOG.0b013e3283347e77; Turner RR, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010192.pub3; Uchida K, 2016, GEN PHYSIOL BIOPHYS, V35, P425, DOI 10.4149/gpb_2016016; Uchida T, 2018, AM J PHYSIOL-CELL PH, V314, pC721, DOI 10.1152/ajpcell.00184.2017; van Heemst D, 2005, AGING CELL, V4, P79, DOI 10.1111/j.1474-9728.2005.00148.x; Vargas-Ortiz K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112717; Wang T, 2010, OBESITY, V18, P1493, DOI 10.1038/oby.2009.456; White JP, 2013, AM J PHYSIOL-ENDOC M, V304, pE1042, DOI 10.1152/ajpendo.00410.2012; White J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022339; YANG HT, 1995, CIRC RES, V76, P448, DOI 10.1161/01.RES.76.3.448; Zebrowska A, 2018, ADV CLIN EXP MED, V27, P207, DOI 10.17219/acem/66354; Zwaans BMM, 2014, DIS MODEL MECH, V7, P1023, DOI 10.1242/dmm.016287	71	4	4	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14389	14406		10.1096/fj.202001330R	http://dx.doi.org/10.1096/fj.202001330R		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32892438				2022-12-26	WOS:000568294100001
J	Amoah, LE; Abuaku, B; Bukari, AH; Dickson, D; Amoako, EO; Asumah, G; Asamoah, A; Preprah, NY; Malm, KL				Amoah, Linda Eva; Abuaku, Benjamin; Bukari, Abagna Hamza; Dickson, Donu; Amoako, Eunice Obeng; Asumah, George; Asamoah, Alexander; Preprah, Nana Yaw; Malm, Keziah Laurencia			Contribution of P. falciparum parasites with Pfhrp 2 gene deletions to false negative PfHRP 2 based malaria RDT results in Ghana: A nationwide study of symptomatic malaria patients	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS	Introduction False-negative malaria rapid diagnostic test (RDT) results amongst symptomatic malaria patients are detrimental as they could lead to ineffective malaria case management. This study determined the nationwide contribution of parasites withPfhrp2 and Pfhrp 3 genedeletions to false negative malaria RDT results in Ghana. Methods This was a cross sectional study where whole blood (similar to 2 ml) was collected from patients presenting with malaria symptoms at 100 health facilities in all the regions in Ghana from May to August 2018. An aliquot of the blood was used to prepare thin and thick blood smears, filter paper blood spots (DBS) and spot a PfHRP 2 RDT kit. The remaining blood was separated into plasma and blood cells and stored at -20 degrees C. Plasmodium parasite density and species identity was estimated from the blood smears.Plasmodium falciparum specific18S rRNAPCR,merozoite surface protein(msp1) andglutamate rich protein(glurp) gene PCR were used to identify P.falciparum positive samples, which were subjected toPfhrp 2/3 exon1-2 and exon2 genotyping. Results Of the 2,860 microscopically P.falciparum positive patients analyzed, 134 (4.69%) had false negativeP.falciparumspecific RDT results. Samples for PCR analysis was available for 127 of the false negative patients, and the analysis identified 116 (91.3%) as positive forP.falciparum. Only 58.1% (79/116) of the false negative RDT samples tested positive bymsp1 andglurpPCR. Genotyping of exon 1-2 and exon 2 of thePfhrp2 gene identified 12.9% (10/79) and 39.5% (31/79) of samples respectively to have deletions. Genotyping exon 1-2 and exon 2 of thePfhrp3 gene identified 15.2% (12/79) and 40.5% (32/79) of samples respectively to have deletions. Only 5% (4/79) of the false negative samples had deletions in both exon 1-2 and exon 2 of thePfhrp 2 gene. Out of the 49 samples that tested positive for aldolase by luminex, 32.6% (16/49) and) had deletions in Pfhrp2 exon 2 and 2% (1/49) had deletions in both exon 2 and exon 1-2 of thePfhrp2 gene. Conclusions The low prevalence of false negative RDT test results provides assurance that PfHRP 2 based malaria RDT kits remain effective in diagnosing symptomatic malaria patients across all the Regions of Ghana. Although there was a low prevalence of parasites with deletions in exon 2 and exon 1-2 of thePfhrp2 gene the prevalence of parasites with deletions inPfhrp2 exon 2 was about a third of the false negative RDT results. The need to ensure rapid, accurate and reliable malaria diagnosis requires continuous surveillance of parasites withPfhrp2 gene deletions.	[Amoah, Linda Eva; Bukari, Abagna Hamza; Dickson, Donu] Univ Ghana, Noguchi Mem Inst Med Res, Dept Immunol, Accra, Ghana; [Abuaku, Benjamin; Amoako, Eunice Obeng] Univ Ghana, Noguchi Mem Inst Med Res, Dept Epidemiol, Accra, Ghana; [Asumah, George; Asamoah, Alexander; Preprah, Nana Yaw; Malm, Keziah Laurencia] Natl Malaria Control Program, Accra, Ghana; [Bukari, Abagna Hamza] Univ Elect Sci & Technol China, Sch Life Sci, Chengdu, Peoples R China	University of Ghana; University of Ghana; University of Electronic Science & Technology of China	Amoah, LE (corresponding author), Univ Ghana, Noguchi Mem Inst Med Res, Dept Immunol, Accra, Ghana.	lek.amoah@gmail.com	Amoah, Linda/AAY-6198-2021	Amoah, Linda/0000-0002-1652-8489	Global Fund to fight AIDS, Tuberculosis and Malaria (GFATM), through the National Malaria Control Programme, Ghana	Global Fund to fight AIDS, Tuberculosis and Malaria (GFATM), through the National Malaria Control Programme, Ghana	This project received funding from the Global Fund to fight AIDS, Tuberculosis and Malaria (GFATM), through the National Malaria Control Programme, Ghana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah JF, 2015, MALARIA J, V14, DOI 10.1186/s12936-014-0537-7; Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Adjah J, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3350-z; Amoah LE, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7989-1; Amoah LE, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1159-z; [Anonymous], 2019, CANC DISCOV, V10, pOF5; Ansah EK, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c930; Ayanful-Torgby R, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1640-8; Berzosa P, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2481-4; Beshir KB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15031-2; Bharti PK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157949; Bonko MDA, 2019, ANN CLIN MICROB ANTI, V18, DOI 10.1186/s12941-019-0304-2; Boyce MR, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4398-1; Chandler CIR, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-95; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; Deme AB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-34; Felger IaS G., 2007, RECOMMENDED GENOTYPI; Fontecha G, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2470-7; Funwei R, 2019, ACTA TROP, V196, P121, DOI 10.1016/j.actatropica.2019.05.016; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Hanscheid T, 2003, CLIN MICROBIOL INFEC, V9, P497, DOI 10.1046/j.1469-0691.2003.00640.x; Heutmekers M, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-359; Koita OA, 2012, AM J TROP MED HYG, V86, P194, DOI 10.4269/ajtmh.2012.10-0665; Lee N, 2006, J CLIN MICROBIOL, V44, P2773, DOI 10.1128/JCM.02557-05; Luchavez J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-286; Maltha J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043094; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Ohrt C, 2002, J INFECT DIS, V186, P540, DOI 10.1086/341938; Orish Verner N, 2018, BMC Res Notes, V11, P850, DOI 10.1186/s13104-018-3967-4; Owusu EDA, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2231-7; Pati P, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2502-3; Rogier E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172139; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; Thomson R, 2019, J INFECT DIS, V220, P1444, DOI 10.1093/infdis/jiz335; Watson OJ, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001582; WHO, 2017, PAR PFHRP2 3 GEN DEL; WHO, GIEMS STAIN MAL BLOO; WHO, 2016, MAL PAR COUNT; WHO, 2018, PROT EST PREV PFHRP2; WHO, 2017, RES FIND WHO LOT TES; World Health Organization, 2019, WORLD MALARIA REPORT	41	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238749	10.1371/journal.pone.0238749	http://dx.doi.org/10.1371/journal.pone.0238749			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886699	gold, Green Published			2022-12-26	WOS:000571064300057
J	de Moya, K; Kim, S				de Moya, Kevin; Kim, Stanley			Radiographic evaluation of patellar tendon length following corrective surgical procedures for medial patellar luxation in dogs	PLOS ONE			English	Article							COMPLICATIONS	Objective To quantify changes in the patellar tendon length following surgical correction of medial patellar luxation in dogs and evaluate potential risk factors associated with patellar tendon elongation. Study design Retrospective case series (n = 50). Methods Dogs that underwent surgery for medial patellar luxation correction and had 2-3 months follow up were included. Digital radiographs were utilized to quantify the patellar tendon length to patellar length ratio at various follow-up points. Odds ratio comparisons between potential risk factors associated with changes in patellar tendon length were performed. Results Post-operative patellar tendon lengthening of >= 5% was observed in 20% of stifles and post-operative patellar tendon shortening of >= 5% was observed in 22% of stifles at the 2-3 month follow up period. The risk factors including age, body weight, trochleoplasty and grade of medial patellar luxation were not significantly associated with risk of patellar tendon elongation. Patellar tendon lengthening was not associated with recurrence of luxation. Conclusion Patellar tendon lengthening and shortening can be observed in dogs following common medial patellar luxation corrective procedures in the short term follow up period. Patellar tendon lengthening does not appear to be associated with age, weight, trochleoplasty, grade of luxation, or risk of luxation recurrence.	[de Moya, Kevin] Univ Florida, Coll Vet Med, Gainesville, FL USA; [Kim, Stanley] Univ Florida, Coll Vet Med, Dept Small Anim Clin Sci, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Kim, S (corresponding author), Univ Florida, Coll Vet Med, Dept Small Anim Clin Sci, Gainesville, FL 32610 USA.	stankim@ufl.edu		de Moya, Kevin/0000-0002-2297-4813				Arthurs GI, 2006, VET SURG, V35, P559, DOI 10.1111/j.1532-950X.2006.00189.x; Bound N, 2009, VET COMP ORTHOPAED, V22, P32, DOI 10.3415/VCOT-08-01-0009; Cashmore RG, 2014, VET COMP ORTHOPAED, V27, P263, DOI 10.3415/VCOT-13-08-0100; Daems R, 2009, VET COMP ORTHOPAED, V22, P222, DOI 10.3415/VCOT-07-08-0076; Davies GS, 2016, KNEE SURG SPORT TR A, V24, P3029, DOI 10.1007/s00167-016-4170-6; Dunlap AE, 2016, JAVMA-J AM VET MED A, V249, P208, DOI 10.2460/javma.249.2.208; Gibbons SE, 2006, J SMALL ANIM PRACT, V47, P3, DOI 10.1111/j.1748-5827.2006.00067.x; Jay MR, 2019, AM J VET RES, V80, P607, DOI 10.2460/ajvr.80.6.607; Johnson AL, 2006, VET SURG, V35, P78, DOI 10.1111/j.1532-950X.2005.00115.x; Johnson MD, 2016, AM J VET RES, V77, P548, DOI 10.2460/ajvr.77.5.548; LaFond E, 2002, J AM ANIM HOSP ASSOC, V38, P467, DOI 10.5326/0380467; Lojszczyk-Szczepaniak A, 2017, ACTA VET SCAND, V59, DOI 10.1186/s13028-017-0304-1; Mostafa AA, 2008, VET SURG, V37, P201, DOI 10.1111/j.1532-950X.2008.00367.x; ROUSH JK, 1993, VET CLIN N AM-SMALL, V23, P855, DOI 10.1016/S0195-5616(93)50087-6; ROY RG, 1992, VET SURG, V21, P475, DOI 10.1111/j.1532-950X.1992.tb00084.x; SINGLETO.WB, 1969, J SMALL ANIM PRACT, V10, P59, DOI 10.1111/j.1748-5827.1969.tb04021.x	16	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238598	10.1371/journal.pone.0238598	http://dx.doi.org/10.1371/journal.pone.0238598			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886725	gold, Green Published			2022-12-26	WOS:000571064300019
J	Madaha, EL; Mienie, C; Gonsu, HK; Bughe, RN; Fonkoua, MC; Mbacham, WF; Alayande, KA; Bezuidenhout, CC; Ateba, CN				Madaha, Estelle Longla; Mienie, Charlotte; Gonsu, Hortense Kamga; Bughe, Rhoda Nsen; Fonkoua, Marie Christine; Mbacham, Wilfred Fon; Alayande, Kazeem Adekunle; Bezuidenhout, Carlos Cornelius; Ateba, Collins Njie			Whole-genome sequence of multi-drug resistant Pseudomonas aeruginosa strains UY1PSABAL and UY1PSABAL2 isolated from human broncho-alveolar lavage, Yaounde, Cameroon	PLOS ONE			English	Article							AMINOGLYCOSIDE RESISTANCE; GENE; TECHNOLOGY; SECRETION; VIRULENCE; BACTERIA; PATHWAY	Pseudomonas aeruginosahas been implicated in a wide range of post-operation wound and lung infections. A wide range of acquired resistance and virulence markers indicate surviving strategy of P.aeruginosa. Complete-genome analysis has been identified as efficient approach towards understanding the pathogenicity of this organism. This study was designed to sequence the entire genome of P.aeruginosaUY1PSABAL and UY1PSABAL2; determine drug-resistance profiles and virulence factors of the isolates; assess factors that contribute toward stability of the genomes; and thereafter determine evolutionary relationships between the strains and other isolates from similar sources. The genomes of the MDRP.aeruginosaUY1PSABAL and UY1PSABAL2 were sequenced on the Illumina Miseq platform. The raw sequenced reads were assessed for quality using FastQC v.0.11.5 and filtered for low quality reads and adapter regions using Trimmomatic v.0.36. Thede novogenome assembly was made with SPAdes v.3.13 and annotated using Prokka v.2.1.1 annotation pipeline; Rapid Annotation using Subsytems Technology (RAST) server v.2.0; and PATRIC annotation tool v.3.6.2. Antimicrobial resistance genes and virulence determinants were searched through the functional annotation data generated from Prokka, RAST and PATRIC annotation pipelines; In addition to ResFinder and Comprehensive Antibiotic Resistance Database (CARD) which were employed to determine resistance genes. The PHAge Search Tool Enhanced Release (PHASTER) web server was used for the rapid identification and annotation of prophage sequences within bacterial genome. Predictive secondary metabolites were identified with AntiSMASH v.5.0. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) andcasgenes regions were also investigated with the CRISPRone and CRISPRFinder server. The genome sizes of 7.0 and 6.4 Mb were determined for UY1PSABAL and UY1PSABAL2 strains with G+C contents of 66.1% and 66.48% respectively. beta-lactamines resistance genesblaPAO, aminoglycoside phosphorylating enzymes genesaph(3')-IIb, fosfomycine resistance genefosA, vancomycinvanWand tetracyclinetetAwere among identified resistance genes harboured in both isolates. UY1PSABAL bore additionalaph(6)-Id,aph(3'')-Ib, ciprofloxacin-modifying enzymecrpPand ribosomal methylation enzymermtB. Both isolates were found harbouring virulence markers such as flagella and type IV pili; and also present various type III secretion systems such asexoA,exoS,exoU,exoT. Secondary metabolites such as pyochelin and pyoverdine with iron uptake activity were found within the genomes as well as quorum-sensing systems, and various fragments for prophages and insertion sequences. Only the UY1PSABAL2 contains CRISPR-Cas system. The phylogeny revealed a very close evolutionary relationship between UY1PSABAL and the similar strain isolated from Malaysia; the same trend was observed between UY1PSABAL2 and the strain from Chinese origin. Complete analyses of the entire genomes provide a wide range of information towards understanding pathogenicity of the pathogens in question.	[Madaha, Estelle Longla; Bughe, Rhoda Nsen; Mbacham, Wilfred Fon] Univ Yaounde I, Biotechnol Ctr, Fac Sci, Yaounde, Cameroon; [Madaha, Estelle Longla; Gonsu, Hortense Kamga] Yaounde Univ, Lab Bacteriol, Teaching Hosp, Yaounde, Cameroon; [Madaha, Estelle Longla; Gonsu, Hortense Kamga] Minist Publ Hlth, Dept Dis Epidem & Pandem Control, Yaounde, Cameroon; [Madaha, Estelle Longla; Fonkoua, Marie Christine] Ctr Pasteur Cameroun, Bacteriol Serv, Yaounde, Cameroon; [Madaha, Estelle Longla; Mienie, Charlotte; Bezuidenhout, Carlos Cornelius] North West Univ, Unit Environm Sci & Management, Potchefstroom, South Africa; [Madaha, Estelle Longla; Alayande, Kazeem Adekunle; Ateba, Collins Njie] North West Univ, Fac Nat & Agr Sci, Food Secur & Safety Niche Area, Mmabatho, South Africa	University of Yaounde I; Centre Pasteur du Cameroun; North West University - South Africa; North West University - South Africa	Ateba, CN (corresponding author), North West Univ, Fac Nat & Agr Sci, Food Secur & Safety Niche Area, Mmabatho, South Africa.	collins.ateba@nwu.ac.za	Mienie, Charlotte/GKK-6212-2022		Food Safety and Security Niche Area, Faculty of Natural and Agricultural Sciences, North West University, South Africa; National Research Foundation, South Africa	Food Safety and Security Niche Area, Faculty of Natural and Agricultural Sciences, North West University, South Africa; National Research Foundation, South Africa(National Research Foundation - South AfricaSouth African Medical Research Council)	This work was supported by the research grants from the Food Safety and Security Niche Area, Faculty of Natural and Agricultural Sciences, North West University, South Africa and the Incentive Funding for Rated Researchers by the National Research Foundation, South Africa provided to C.N.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alayande KA, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12031087; Alkhnbashi O, 2019, CRISPR CAS BIOINFORM; Amina AH, 2010, J AM SCI, V6, P534; Anantharajah A, 2017, CONTRIBUTION UNDERST, P231; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2020, LANCET RESP MED, V8, P1, DOI [10.1016/S2213-2600(19)30449-7, 10.1016/S22132600(19)30402-3]; [Anonymous], 2016, SOC FRANC MICR REC; [Anonymous], 2019, FRONTIERS PLANT SCI; [Anonymous], 2017, COMMUN MATH STAT, V5, P1, DOI DOI 10.1007/S40304-017-0103-Z; [Anonymous], 2015, RIV STORICA ITAL, V6, P1, DOI DOI 10.3389/fpls.2015.00951; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bassetti M, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00074; Bassetti Matteo, 2018, Drugs Context, V7, P212527, DOI 10.7573/dic.212527; Blin K, 2019, NUCL ACIDS RES; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Braud A, 2009, J BACTERIOL, V191, P3517, DOI 10.1128/JB.00010-09; Braun O, 2020, TRANSFORM GROUPS, V25, P1, DOI 10.1007/s00031-019-09537-4; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Chavez-Jacobo VM, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/aac.02629-17, 10.1128/AAC.02629-17]; Costa TRD, 2015, NAT REV MICROBIOL, V13, P343, DOI 10.1038/nrmicro3456; De Angelis G, 2018, EUR J CLIN MICROBIOL, V37, P1627, DOI 10.1007/s10096-018-3292-9; De Bentzmann S., 2011, REV FRANCOPH LAB, V2011, P73, DOI [10.1016/S1773-035X(11)71104-2, DOI 10.1016/S1773-035X(11)71104-2]; Donia MS, 2014, CELL, V158, P1402, DOI 10.1016/j.cell.2014.08.032; Fazeli N., 2014, IRANIAN RED CRESCENT, V16, P1; Finch R.G., 2010, ANTIBIOTIC CHEMOTHER; Fothergill JL, 2012, EXPERT REV ANTI-INFE, V10, P219, DOI [10.1586/eri.11.168, 10.1586/ERI.11.168]; Girlich D, 2004, ANTIMICROB AGENTS CH, V48, P2043, DOI 10.1128/AAC.48.6.2043-2048.2004; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Horak R, 1998, J BACTERIOL, V180, P2822; ICCIDD (International council for control of iodine deficiency disorders), 2011, IDD NEWS, V39, P1, DOI DOI 10.18637/JSS.V039.I08; James KD, 2017, PHARMACOGNOSY: FUNDAMENTALS, APPLICATIONS AND STRATEGIES, P401, DOI 10.1016/B978-0-12-802104-0.00019-6; Jia B., 2016, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1004; Kastin A, 2013, HDB BIOL ACTIVE PEPT; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Maxwell A., 2018, ANTIMICROBIAL RESIST; Murcia NR, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00170; Nie L, 2014, ACTA PHARM SIN B, V4, P295, DOI 10.1016/j.apsb.2014.06.004; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Perez RH, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S3; Peykani P., 2018, CLIN DIABETOLOGY, V7, P1, DOI [DOI 10.1016/S1464-2859(18)30228-1, 10.5603/dk.2018.0001]; Pierson LS, 2010, APPL MICROBIOL BIOT, V86, P1659, DOI 10.1007/s00253-010-2509-3; Poole K, 2005, ANTIMICROB AGENTS CH, V49, P479, DOI 10.1128/AAC.49.2.479-487.2005; Pulcrano G, 2012, NEW MICROBIOL, V35, P295; Ranieri MR, 2019, ANTIMICROB AGENTS CH, V63, P1; Rehman ZU, 2013, APPL ENVIRON MICROB, V79, P2002, DOI 10.1128/AEM.03960-12; Rozman HD, 2007, MALAYSIAN POLYM J, V2, P1; Sagot B, 2010, P NATL ACAD SCI USA, V107, P12652, DOI 10.1073/pnas.1003063107; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Schalk IJ, 2016, ENVIRON MICROBIOL, V18, P3227, DOI 10.1111/1462-2920.13525; Schwarze K, 2018, GENET MED, V20, P1122, DOI 10.1038/gim.2017.247; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shlaes DM, 2010, ANTIBIOTICS PERFECT; Spilker T, 2004, J CLIN MICROBIOL, V42, P2074, DOI 10.1128/JCM.42.5.2074-2079.2004; Subedi D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34020-7; Sullivan J, 2018, J ASIAN AFR STUD, V53, P1173, DOI 10.1177/0021909618776443; Tan RM, 2015, INFECT IMMUN, V83, P1339, DOI 10.1128/IAI.02874-14; Tan RM, 2014, J INNATE IMMUN, V6, P227, DOI 10.1159/000354304; TANG H, 1995, INFECT IMMUN, V63, P1278, DOI 10.1128/IAI.63.4.1278-1285.1995; Vandecraen J, 2017, CRIT REV MICROBIOL, V43, P709, DOI 10.1080/1040841X.2017.1303661; Veesenmeyer JL, 2009, CRIT CARE MED, V37, P1777, DOI 10.1097/CCM.0b013e31819ff137; Wattam AR, 2017, NUCLEIC ACIDS RES, V45, pD535, DOI 10.1093/nar/gkw1017; Wisplinghoff H., 2017, INFECT DIS, P1579, DOI DOI 10.1016/B978-0-7020-6285-8.00181-7; Wood TE, 2019, CELL REP, V29, P187, DOI 10.1016/j.celrep.2019.08.094; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhang Q, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1512-4; Zhou XG, 2010, SCI CHINA LIFE SCI, V53, P44, DOI 10.1007/s11427-010-0023-6	67	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238390	10.1371/journal.pone.0238390	http://dx.doi.org/10.1371/journal.pone.0238390			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886694	Green Published, gold			2022-12-26	WOS:000571064300003
J	Elenga, N; Cuadro-Alvarez, E; Martin, E; Njuieyon, F; Defo, A; Maniassom, C				Elenga, Narcisse; Cuadro-Alvarez, Emma; Martin, Elise; Njuieyon, Falucar; Defo, Antoine; Maniassom, Chimene			Influence of beta-cluster haplotypes, alpha-gene status and UGTA1 polymorphism on clinical and hematological data in sickle-cell disease children from French Guiana	PLOS ONE			English	Article							S-GENE; PROMOTER POLYMORPHISMS; ADVERSE OUTCOMES; ANEMIA PATIENTS; THALASSEMIA; HYPERBILIRUBINEMIA; PREDICTION; SEVERITY; AFRICA; ORIGIN	Objectives This cross-sectional study aimed to investigate the influence of haplotypes, alpha-gene status and UGTA1 polymorphism on the severity of sickle cell disease in children. Methods This cross-sectional study was conducted between 2012 and 2014 at the Cayenne Hospital, in French Guiana. Acute clinical complications were grouped into (i) severe SCD defined by the presence of stroke and/or abnormal-transcranial Doppler (TCD), (ii) moderate SCD defined by the presence of at least three annual events requiring hospitalization and/or at least one acute chest syndrome, (iii) no severe SCD (in the absence of the precited events). Results Among the 86 patients, 33.7% were female with a median age of 10 years (range: 6-12 years). The vast majority of patients had SCA (HbSS) phenotype (74.4%; n = 64). The severe haplotype was found in 40% of patients. 30% were BEN/BEN. Analysis of alpha-globin gene deletions revealed that 32 patients (37.2%) were heterozygous (loss of 2 genes in 2 cases and loss of 1 gene in 30 cases) for alpha-thalassemia (3.7 kb deletion). Homozygous (TA) n TA7/7 was found in 24 (28%). In the multivariate analysis, the factors associated with the severity of sickle cell disease were the first vaso-occlusive crisis before one year of age (OR 25, [95% CI = 6.0-107.0], p<0.001) and a baseline MCV >80 fL (OR 0.20 [95% CI = 0.04-0.96], p = 0.04). The area of the ROC curve was 0.90. Conclusion Prospective studies with greater statistical power would provide more knowledge on the relationship between UGT1A1 mutations and the clinical and hematological manifestations of SCA.	[Elenga, Narcisse; Cuadro-Alvarez, Emma; Martin, Elise; Njuieyon, Falucar; Defo, Antoine; Maniassom, Chimene] Cayenne Gen Hosp, Pediat Unit, Cayenne, French Guiana		Elenga, N (corresponding author), Cayenne Gen Hosp, Pediat Unit, Cayenne, French Guiana.	elengafr@yahoo.fr	ELENGA, Narcisse NE/C-2272-2015	ELENGA, Narcisse NE/0000-0003-0624-4180; Reis, AlessanRSS/0000-0001-8486-7469				Adekile A, 2005, EUR J HAEMATOL, V75, P150, DOI 10.1111/j.1600-0609.2005.00477.x; Adorno EV, 2004, HEMOGLOBIN, V28, P267, DOI 10.1081/HEM-120040310; [Anonymous], **NON-TRADITIONAL**; [Anonymous], 2015, BMJ, V2015, ph1887; Bandeira ICJ, 2014, CYTOKINE, V65, P217, DOI 10.1016/j.cyto.2013.10.009; Belisario AR, 2011, ACTA HAEMATOL-BASEL, V125, P120; Bernaudin F, 2018, BLOOD ADV, V2, P626, DOI 10.1182/bloodadvances.2017014555; Carpenter SL, 2008, AM J HEMATOL, V83, P800, DOI 10.1002/ajh.21264; Chaar V, 2005, HAEMATOLOGICA, V90, P188; Chen ZW, 2014, GENE, V552, P32, DOI 10.1016/j.gene.2014.09.009; Christine S, 2016, AM J HUM BIOL, V28, P811, DOI 10.1002/ajhb.22871; Domingos IF, 2014, ANN HEMATOL, V93, P1123, DOI 10.1007/s00277-014-2016-1; Erlinger S, 2014, GASTROENTEROLOGY, V146, P1625, DOI 10.1053/j.gastro.2014.03.047; Etienne-Julan M, 2012, B EPIDEMIOLOGIQUE HE; Joly P, 2012, EUR J HAEMATOL, V88, P61, DOI 10.1111/j.1600-0609.2011.01705.x; Joly P, 2011, CLIN CHIM ACTA, V412, P1257, DOI 10.1016/j.cca.2011.03.025; Jones-Lecointe A, 2008, AM J HUM BIOL, V20, P342, DOI 10.1002/ajhb.20732; Keclard L, 1996, HEMOGLOBIN, V20, P63, DOI 10.3109/03630269609027911; Keclard L, 1997, AM J HEMATOL, V55, P24, DOI 10.1002/(SICI)1096-8652(199705)55:1<24::AID-AJH4>3.0.CO;2-5; Lamarre Y, 2012, HAEMATOL-HEMATOL J, V97, P1641, DOI 10.3324/haematol.2012.066670; LAPOUMEROULIE C, 1992, HUM GENET, V89, P333; Loggetto Sandra Regina, 2013, Rev. Bras. Hematol. Hemoter., V35, P155, DOI 10.5581/1516-8484.20130048; Martins R, 2008, J HUM GENET, V53, P524, DOI 10.1007/s10038-008-0281-3; Miller ST, 2000, NEW ENGL J MED, V342, P83, DOI 10.1056/NEJM200001133420203; Nebor D, 2010, BLOOD CELL MOL DIS, V45, P154, DOI 10.1016/j.bcmd.2010.06.003; Neves Fabia, 2012, Rev. Bras. Hematol. Hemoter., V34, P426, DOI 10.5581/1516-8484.20120107; Okumura Jéssika Viviani, 2013, Rev. Bras. Hematol. Hemoter., V35, P71, DOI 10.5581/1516-8484.20130019; Olatunya OS, 2019, BMC MED GENET, V20, DOI 10.1186/s12881-019-0899-3; PAGNIER J, 1984, P NATL ACAD SCI-BIOL, V81, P1771, DOI 10.1073/pnas.81.6.1771; Piel FB, 2017, NEW ENGL J MED, V376, P1561, DOI 10.1056/NEJMra1510865; POWARS DR, 1990, AM J PEDIAT HEMATOL, V12, P367; POWARS DR, 1994, AM J PEDIAT HEMATOL, V16, P55; Powars DR, 2005, MEDICINE, V84, P363, DOI 10.1097/01.md.0000189089.45003.52; Quinn CT, 2008, BLOOD, V111, P544, DOI 10.1182/blood-2007-07-100719; Sarnaik SA, 2001, AM J HEMATOL, V67, P179, DOI 10.1002/ajh.1103; Sheehan VA, 2013, AM J HEMATOL, V88, P571, DOI 10.1002/ajh.23457; SRINIVAS R, 1988, AM J HEMATOL, V29, P60, DOI 10.1002/ajh.2830290117; Steinberg MH, 2005, BRIT J HAEMATOL, V129, P465, DOI 10.1111/j.1365-2141.2005.05411.x; Takeuchi K, 2004, J GASTROEN HEPATOL, V19, P1023, DOI 10.1111/j.1440-1746.2004.03370.x; Thomas V, 2013, CLIN CHIM ACTA, V424, P258, DOI 10.1016/j.cca.2013.06.023; ZAGO MA, 1992, AM J PHYS ANTHROPOL, V88, P295, DOI 10.1002/ajpa.1330880304; Zago MA, 2000, AM J HEMATOL, V63, P79, DOI 10.1002/(SICI)1096-8652(200002)63:2<79::AID-AJH4>3.0.CO;2-D; [No title captured]	43	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238691	10.1371/journal.pone.0238691	http://dx.doi.org/10.1371/journal.pone.0238691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881938	gold, Green Published			2022-12-26	WOS:000571063300030
J	Hausmann, LRM; Jones, AL; McInnes, SE; Zickmund, SL				Hausmann, Leslie R. M.; Jones, Audrey L.; McInnes, Shauna E.; Zickmund, Susan L.			Identifying healthcare experiences associated with perceptions of racial/ethnic discrimination among veterans with pain: A cross-sectional mixed methods survey	PLOS ONE			English	Article							PERCEIVED RACIAL-DISCRIMINATION; SATISFACTION; DISPARITIES; BIAS; MICROAGGRESSIONS; PROVIDERS; MISTRUST; LIFE	Background Healthcare experiences associated with perceived racial/ethnic discrimination among patients are poorly understood. Objective Identify domains of patient dissatisfaction associated with perceived racial/ethnic discrimination among patients with pain. Design Semi-structured telephone surveys completed in 2013-2015. Participants White, African American, and Latino participants who reported receiving pain management from 25 Veterans Affairs (VA) Medical Centers. Main measures Surveys included open-ended questions about healthcare satisfaction/dissatisfaction and a measure of perceived racial/ethnic-based discrimination while seeking VA healthcare. Binary indicators for ten qualitative domains of dissatisfaction were derived from open-ended questions. We used multilevel models to identify dissatisfaction domains associated with perceived discrimination, adjusting for patient characteristics and site. Within domains associated with discrimination, we identified the most frequent codes and examined whether patients primarily referenced clinical or non-clinical staff in their experiences. Key results Overall, 622 participants (30.4% White, 37.8% African American, 31.8% Latino; 57.4% female; mean age = 53.4) reported a median discrimination score of 1.0 (IQR: 1.0-1.3) on a scale of 1 to 5; 233 (37.5%) perceived any racial/ethnic discrimination in healthcare. Individually, 7 of 10 qualitative domains were significantly associated with perceived discrimination: dissatisfaction with care quality, facilities, continuity of care, interactions with staff, staff demeanor, unresolved pain, and pharmacy services (ps<0.005). In combined models stratified by racial/ethnic group, 3 domains remained statistically significant: poor interactions for Latinos (adjOR = 5.24, 95% CI = 2.28-12.06), negative demeanor for African Americans (adjOR = 2.82, 95% CI = 1.45-5.50), and unresolved pain for Whites (adjOR = 6.23, 95% CI = 2.39-16.28). Clinical staff were referenced more often than non-clinical staff for all domains (interactions: 51% vs. 30%; demeanor: 46% vs. 15%; unresolved pain: 18% vs. 1%, respectively). Conclusion Negative interpersonal experiences and unresolved pain are strong correlates of perceived racial/ethnic discrimination among patients with pain. Future studies should test whether interventions targeting these domains reduce patient perceptions of racial/ethnic discrimination in healthcare.	[Hausmann, Leslie R. M.; McInnes, Shauna E.] VA Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA 15240 USA; [Hausmann, Leslie R. M.] Univ Pittsburgh, Sch Med, Dept Med, Div Gen Internal Med, Pittsburgh, PA 15213 USA; [Jones, Audrey L.; Zickmund, Susan L.] VA Salt Lake City Hlth Care Syst, Informat Decis Enhancement & Analyt Sci Ctr IDEAS, Salt Lake City, UT USA; [Jones, Audrey L.; Zickmund, Susan L.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah	Hausmann, LRM (corresponding author), VA Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA 15240 USA.; Hausmann, LRM (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Gen Internal Med, Pittsburgh, PA 15213 USA.	leslie.hausmann@va.gov		Jones, Audrey/0000-0003-1533-7469	Veterans Integrated Service Network 4 Center for Health Equity Research and Promotion Pilot Research Program; Department of Veterans Affairs Health Services Research and Development Merit Review [IIR 100144]; Service Directed Research awards [13-425]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR002538, KL2TR002539]	Veterans Integrated Service Network 4 Center for Health Equity Research and Promotion Pilot Research Program; Department of Veterans Affairs Health Services Research and Development Merit Review(US Department of Veterans Affairs); Service Directed Research awards; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the Veterans Integrated Service Network 4 Center for Health Equity Research and Promotion Pilot Research Program (Principal Investigator: LH). The study from which the data were obtained was funded by Department of Veterans Affairs Health Services Research and Development Merit Review (IIR 100144) and Service Directed Research (13-425) awards (Principal Investigator: SZ). Dr. Jones's effort was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002538 and KL2TR002539. The views expressed here are those of the authors and do not represent those of the Department of Veterans Affairs or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KO, 2009, J PAIN, V10, P1187, DOI 10.1016/j.jpain.2009.10.002; [Anonymous], 2015, PCORI METHODOLOGY ST; Bailey ZD, 2017, LANCET, V389, P1453, DOI 10.1016/S0140-6736(17)30569-X; Bakhshaie J, 2019, J IMMIGR MINOR HEALT, V21, P21, DOI 10.1007/s10903-018-0715-8; Benkert R, 2006, J NATL MED ASSOC, V98, P1532; Bergman AA, 2013, PAIN MED, V14, P1689, DOI 10.1111/pme.12172; Bird Sheryl Thorburn, 2001, Ethnicity and Disease, V11, P554; Brown TT, 2018, SOC SCI MED, V204, P1, DOI 10.1016/j.socscimed.2018.03.015; Burgess DJ, 2009, PAIN MED, V10, P1341, DOI 10.1111/j.1526-4637.2009.00742.x; Crabtree BF, 1992, DOING QUALITATIVE RE, P23; Creswell JW, 2004, ANN FAM MED, V2, P7, DOI 10.1370/afm.104; Cruz D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211620; Cuevas AG, 2016, HEALTH PSYCHOL, V35, P987, DOI 10.1037/hea0000368; Eliacin J, PATIENT ED COUNS; Esquibel AY, 2014, PAIN, V155, P2575, DOI 10.1016/j.pain.2014.09.018; Goodin BR, 2013, HEALTH PSYCHOL, V32, P1117, DOI 10.1037/a0031592; Hall WJ, 2015, AM J PUBLIC HEALTH, V105, pE60, DOI 10.2105/AJPH.2015.302903; Hausmann Leslie R M, 2009, Am J Public Health, V99 Suppl 3, pS718, DOI 10.2105/AJPH.2008.150730; Hausmann LRM, 2011, MED CARE, V49, P626, DOI 10.1097/MLR.0b013e318215d93c; Hausmann LRM, 2010, ETHNIC DIS, V20, P40; Haywood C, 2014, J PAIN SYMPTOM MANAG, V48, P934, DOI 10.1016/j.jpainsymman.2014.02.002; Hoffman KM, 2016, P NATL ACAD SCI USA, V113, P4296, DOI 10.1073/pnas.1516047113; Huppertz JW, 2014, J HEALTHC MANAG, V59, P31, DOI 10.1097/00115514-201401000-00007; Jones AL, 2019, J GEN INTERN MED, V34, P1925, DOI 10.1007/s11606-019-05116-1; Lee P, 2019, AM J EMERG MED, V37, P1770, DOI 10.1016/j.ajem.2019.06.014; MacDonald S, 2017, MED CARE, V55, pS43, DOI 10.1097/MLR.0000000000000746; Maina IW, 2018, SOC SCI MED, V199, P219, DOI 10.1016/j.socscimed.2017.05.009; Mathur VA, 2016, CLIN J PAIN, V32, P1076, DOI 10.1097/AJP.0000000000000361; Meghani SH, 2012, PAIN MED, V13, P150, DOI 10.1111/j.1526-4637.2011.01310.x; Meints SM, 2019, PAIN MANAG, V9, P317, DOI 10.2217/pmt-2018-0030; Paradies Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138511; Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059; Penner LA, 2009, J BLACK PSYCHOL, V35, P180, DOI 10.1177/0095798409333585; Piette JD, 2006, PATIENT EDUC COUNS, V60, P41, DOI 10.1016/j.pec.2004.12.001; Ross PT, 2012, J BLACK STUD, V43, P520, DOI 10.1177/0021934711436129; StataCorp, 2015, STAT STAT SOFTW REL; Sue DW, 2008, PROF PSYCHOL-RES PR, V39, P329, DOI 10.1037/0735-7028.39.3.329; Sue DW, 2007, AM PSYCHOL, V62, P271, DOI 10.1037/0003-066X.62.4.271; Taylor TR, 2004, INT J BEHAV MED, V11, P88, DOI 10.1207/s15327558ijbm1102_4; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0; Zickmund SL, 2018, J GEN INTERN MED, V33, P305, DOI 10.1007/s11606-017-4221-9; Zickmund SL, 2015, J RACIAL ETHN HEALTH, V2, P317, DOI 10.1007/s40615-014-0075-6	44	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0237650	10.1371/journal.pone.0237650	http://dx.doi.org/10.1371/journal.pone.0237650			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ7QD	32881940	gold, Green Published			2022-12-26	WOS:000571063300048
J	Minea, RO; Duc, TC; Swenson, SD; Cho, HY; Huang, M; Hartman, H; Hofman, FM; Schonthal, AH; Chen, TC				Minea, Radu O.; Tuan Cao Duc; Swenson, Stephen D.; Cho, Hee-Yeon; Huang, Mickey; Hartman, Hannah; Hofman, Florence M.; Schonthal, Axel H.; Chen, Thomas C.			Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas	PLOS ONE			English	Article							RADIOTHERAPY PLUS CONCOMITANT; MGMT PROMOTER METHYLATION; BASE EXCISION-REPAIR; DNA-REPAIR; ADJUVANT TEMOZOLOMIDE; GLIOBLASTOMA-MULTIFORME; RADIATION-THERAPY; BREAK REPAIR; MECHANISM; CELLS	The prognosis for patients with glioblastoma (GB) remains grim. Concurrent temozolomide (TMZ) radiation-the cornerstone of glioma control-extends the overall median survival of GB patients by only a few months over radiotherapy alone. While these survival gains could be partly attributed to radiosensitization, this benefit is greatly minimized in tumors expressing O-6-methylguanine DNA methyltransferase (MGMT), which specifically reverses O-6-methylguanine lesions. Theoretically, non-O-6-methylguanine lesions (i.e., the N-methylpurine adducts), which represent up to 90% of TMZ-generated DNA adducts, could also contribute to radiosensitization. Unfortunately, at concentrations attainable in clinical practice, the alkylation capacity of TMZ cannot overwhelm the repair of N-methylpurine adducts to efficiently exploit these lesions. The current therapeutic application of TMZ therefore faces two main obstacles: (i) the stochastic presence of MGMT and (ii) a blunted radiosensitization potential at physiologic concentrations. To circumvent these limitations, we are developing a novel molecule called NEO212-a derivatization of TMZ generated by coupling TMZ to perillyl alcohol. Based on gas chromatography/mass spectrometry and high-performance liquid chromatography analyses, we determined that NEO212 had greater tumor cell uptake than TMZ. In mouse models, NEO212 was more efficient than TMZ at crossing the blood-brain barrier, preferentially accumulating in tumoral over normal brain tissue. Moreover, in vitro analyses with GB cell lines, including TMZ-resistant isogenic variants, revealed more potent cytotoxic and radiosensitizing activities for NEO212 at physiologic concentrations. Mechanistically, these advantages of NEO212 over TMZ could be attributed to its enhanced tumor uptake presumably leading to more extensive DNA alkylation at equivalent dosages which, ultimately, allows for N-methylpurine lesions to be better exploited for radiosensitization. This effect cannot be achieved with TMZ at clinically relevant concentrations and is independent of MGMT. Our findings establish NEO212 as a superior radiosensitizer and a potentially better alternative to TMZ for newly diagnosed GB patients, irrespective of their MGMT status.	[Minea, Radu O.; Swenson, Stephen D.; Cho, Hee-Yeon; Chen, Thomas C.] Univ Southern Calif USC, Dept Neurol Surg, Keck Sch Med KSOM, Los Angeles, CA 90007 USA; [Tuan Cao Duc] Haiphong Univ, Sch Pharm, Haiphong, Vietnam; [Huang, Mickey] Univ Southern Calif, Broad Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA 90007 USA; [Hartman, Hannah; Schonthal, Axel H.] Univ Southern Calif, Dept Mol Microbiol & Immunol, Keck Sch Med, Los Angeles, CA 90007 USA; [Hofman, Florence M.; Chen, Thomas C.] Univ Southern Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90007 USA	University of Southern California; University of Southern California; University of Southern California	Chen, TC (corresponding author), Univ Southern Calif USC, Dept Neurol Surg, Keck Sch Med KSOM, Los Angeles, CA 90007 USA.; Chen, TC (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90007 USA.	Thomas.Chen@med.usc.edu	Schonthal, Axel/ABH-3846-2020	Schonthal, Axel/0000-0003-0662-5653; Minea, Radu/0000-0002-0929-6480; hartman, Hannah/0000-0002-2402-415X; Cao, Duc Tuan/0000-0001-9129-8241	Hale Family Research Fund and Sounder Foundation; NeOnc Technologies, Inc. (Los Angeles, CA)	Hale Family Research Fund and Sounder Foundation; NeOnc Technologies, Inc. (Los Angeles, CA)	This study was funded in part by the Hale Family Research Fund and Sounder Foundation provided to T.C.C), and by generous support from NeOnc Technologies, Inc. (Los Angeles, CA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbotts R, 2014, CANCER MANAG RES, V6, P77, DOI 10.2147/CMAR.S50497; [Anonymous], 2012, CANC LETT, V327, P123; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Belyaev IY, 2010, MUTAT RES-REV MUTAT, V704, P132, DOI 10.1016/j.mrrev.2010.01.011; Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Bobola MS, 2010, MOL CANCER THER, V9, P1208, DOI 10.1158/1535-7163.MCT-10-0010; Brandes AA, 2009, J CLIN ONCOL, V27, P1275, DOI 10.1200/JCO.2008.19.4969; Carlson BL, 2009, INT J RADIAT ONCOL, V75, P212, DOI 10.1016/j.ijrobp.2009.04.026; Chakravarti A, 2006, CLIN CANCER RES, V12, P4738, DOI 10.1158/1078-0432.CCR-06-0596; Chalmers AJ, 2009, INT J RADIAT ONCOL, V75, P1511, DOI 10.1016/j.ijrobp.2009.07.1703; Chen TC, 2018, CANCERS, V10, DOI 10.3390/cancers10100362; Chen TC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091463; Cho HY, 2014, MOL CANCER THER, V13, P2004, DOI 10.1158/1535-7163.MCT-13-0964; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Delgado-Lopez PD, 2016, CLIN TRANSL ONCOL, V18, P1062, DOI 10.1007/s12094-016-1497-x; Farres J, 2013, BLOOD, V122, P44, DOI 10.1182/blood-2012-12-472845; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gavande NS, 2016, PHARMACOL THERAPEUT, V160, P65, DOI 10.1016/j.pharmthera.2016.02.003; Guhan Om Ariara, 2016, J COMPUTATIONAL DESI, V3, P198; Gutenberg A, 2013, ACTA NEUROCHIR, V155, P429, DOI 10.1007/s00701-012-1583-y; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Helleday T, 2011, MOL ONCOL, V5, P387, DOI 10.1016/j.molonc.2011.07.001; Horn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025113; Jhaveri N, 2016, CANCER LETT, V371, P240, DOI 10.1016/j.canlet.2015.11.040; Komotar RJ, 2008, CLIN MED INSIGHTS-ON, V2, P421; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lukas RV, 2019, ONCOLOGY-NY, V33, P91; Mariotti LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079541; Mladenov E, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00113; Moody CL, 2014, PHARMACEUTICALS-BASE, V7, P797, DOI 10.3390/ph7070797; Nieder C, 2006, REV RECENT CLIN TRIA, V1, P43, DOI 10.2174/157488706775246148; Ostermann S, 2004, CLIN CANCER RES, V10, P3728, DOI 10.1158/1078-0432.CCR-03-0807; Patel M, 2003, J NEURO-ONCOL, V61, P203, DOI 10.1023/A:1022592913323; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Prasad R, 2014, NUCLEIC ACIDS RES, V42, P6337, DOI 10.1093/nar/gku288; Prasanna PGS, 2015, RADIAT RES, V184, P235, DOI 10.1667/RR14186.1; Reynolds P, 2015, NUCLEIC ACIDS RES, V43, P4028, DOI 10.1093/nar/gkv250; Ronson GE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03159-2; Rothkamm K, 2009, ANN I SUPER SANITA, V45, P265; Sak A, 2010, SEMIN RADIAT ONCOL, V20, P223, DOI 10.1016/j.semradonc.2010.05.004; Sharma PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121083; Strom CE, 2011, NUCLEIC ACIDS RES, V39, P3166, DOI 10.1093/nar/gkq1241; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Thoms J, 2010, SEMIN RADIAT ONCOL, V20, P217, DOI 10.1016/j.semradonc.2010.06.003; Van Nifterik KA, 2007, INT J RADIAT ONCOL, V69, P1246, DOI 10.1016/j.ijrobp.2007.07.2366; Watanabe R, 2011, BRAIN TUMOR PATHOL, V28, P127, DOI 10.1007/s10014-011-0022-8; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Zanders ED, 2019, DRUG DISCOV TODAY, V24, P1193, DOI 10.1016/j.drudis.2019.03.008	52	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238238	10.1371/journal.pone.0238238	http://dx.doi.org/10.1371/journal.pone.0238238			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881880	gold, Green Published			2022-12-26	WOS:000571063300011
J	Sharma, AJ; Subramanyam, MA				Sharma, Anupam Joya; Subramanyam, Malavika A.			A cross-sectional study of psychological wellbeing of Indian adults during the Covid-19 lockdown: Different strokes for different folks	PLOS ONE			English	Article							HEALTH; GAY; RESILIENCE; TORONTO; MASTERY; ANXIETY; SCALE	The psychological impacts of the lockdown due to the Covid-19 pandemic are widely documented. In India, a family-centric society with a high population density and extreme social stratification, the impact of the lockdown might vary across diverse social groups. However, the patterning in the psychological impact of the lockdown among LGBT adults and persons known to be at higher risk of the complications of Covid-19 (such as persons with comorbidities or a history of mental illness) is not known in the Indian context. We used mixed methods (online survey, n = 282 and in-depth interviews, n = 14) to investigate whether the psychological influence of the lockdown was different across these groups of Indian adults. We fitted linear and logistic regression models adjusted for sociodemographic covariates. Thematic analysis helped us identify emergent themes in our qualitative narratives. Anxiety was found to be higher among LGBT adults (beta = 2.44, CI: 0.58, 4.31), the high-risk group (persons with comorbidities) (beta = 2.20, CI:0.36, 4.05), and those with a history of depression/loneliness (beta = 3.89, CI:2.34, 5.44). Persons belonging to the LGBT group reported a greater usage of pornography than the heterosexuals (beta = 2.72, CI: 0.09, 5.36) during the lockdown. Qualitative findings suggested that LGBT adults likely used pornography and masturbation to cope with the lockdown, given the limited physical access to sexual partners in a society that stigmatizes homosexuality. Moreover, both qualitative and quantitative study findings suggested that greater frequency of calling family members during lockdown could strengthen social relationships and increase social empathy. The study thereby urgently calls for the attention of policymakers to take sensitive and inclusive health-related decisions for the marginalized and the vulnerable, both during and after the crisis.	[Sharma, Anupam Joya; Subramanyam, Malavika A.] Indian Inst Technol Gandhinagar, Social Epidemiol, Gandhinagar, Gujarat, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Gandhinagar	Sharma, AJ (corresponding author), Indian Inst Technol Gandhinagar, Social Epidemiol, Gandhinagar, Gujarat, India.	Anupam.sharma@iitgn.ac.in	Sharma, Anupam Joya/AAZ-6704-2020	Sharma, Anupam Joya/0000-0002-1726-9992; Reis, AlessanRSS/0000-0001-8486-7469	Department of Science and Technology, India; IIT Gandhinagar	Department of Science and Technology, India(Department of Science & Technology (India)); IIT Gandhinagar	AJS was supported by fellowships by Department of Science and Technology, India and IIT Gandhinagar.	Algarin AB, 2020, AIDS BEHAV, V24, P2236, DOI 10.1007/s10461-020-02869-3; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; [Anonymous], HINDU; [Anonymous], INDIA NEWS TIMES IND; Balgos B., 2012, GENDER DEV, V20, P337, DOI 10.1080/13552074.2012.687218; Bansal M, 2020, DIABETES METAB SYND, V14, P247, DOI 10.1016/j.dsx.2020.03.013; Birt L, 2016, QUAL HEALTH RES, V26, P1802, DOI 10.1177/1049732316654870; Blendon RJ, 2004, CLIN INFECT DIS, V38, P925, DOI 10.1086/382355; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Braunack-Mayer A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-344; Burcusa SL, 2007, CLIN PSYCHOL REV, V27, P959, DOI 10.1016/j.cpr.2007.02.005; Burla L, 2008, NURS RES, V57, P113, DOI 10.1097/01.NNR.0000313482.33917.7d; Butler MH, 2018, J SEX MARITAL THER, V44, P127, DOI 10.1080/0092623X.2017.1321601; Conversano Ciro, 2010, Clin Pract Epidemiol Ment Health, V6, P25, DOI 10.2174/1745017901006010025; Cresswell J. W., 1994, RES DESIGN; Creswell J.W., 2007, DESIGNING CONDUCTING; Curran PJ, 1996, PSYCHOL METHODS, V1, P16, DOI 10.1037//1082-989X.1.1.16; D'Amico E, 2015, J GLBT FAM STUD, V11, P411, DOI 10.1080/1550428X.2014.981627; Darby-Mullins P, 2007, J GLBT FAM STUD, V3, P75, DOI 10.1300/J461v03n01_04; De Santis JP, 2013, J AM PSYCHIAT NURSES, V19, P36, DOI 10.1177/1078390312474096; Figueroa CA, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00523; Gautam R, 2020, BRAIN BEHAV IMMUN, V88, P948, DOI 10.1016/j.bbi.2020.04.025; Greenhaus JH, 2003, J VOCAT BEHAV, V63, P510, DOI 10.1016/S0001-8791(02)00042-8; Hawryluck L, 2004, EMERG INFECT DIS, V10, P1206, DOI 10.3201/eid1007.030703; Hawthorne G, 2005, AUST NZ J PSYCHIAT, V39, P583, DOI 10.1080/j.1440-1614.2005.01630.x; Ibarra François Peinado, 2020, Int. braz j urol., V46, P104, DOI [10.1590/S1677-5538.IBJU.2020.S116, 10.1590/s1677-5538.ibju.2020.s116]; Kang HJ, 2017, PSYCHIAT INVEST, V14, P240, DOI 10.4306/pi.2017.14.3.240; Kazmi S. S. H., 2020, COVID 19 LOCKDOWN ST; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Lehmiller JJ, 2021, LEISURE SCI, V43, P295, DOI 10.1080/01490400.2020.1774016; Lopes GP, 2020, ARCH SEX BEHAV, V49, P2735, DOI 10.1007/s10508-020-01796-7; Marjanovic Z, 2007, INT J NURS STUD, V44, P991, DOI 10.1016/j.ijnurstu.2006.02.012; Martarelli CS, 2020, HUM SOC SCI COMMUN, V7, DOI 10.1057/s41599-020-0512-6; Marziali ME, 2020, AIDS BEHAV, V24, P2250, DOI 10.1007/s10461-020-02872-8; Merriam S.B., 1988, CASE STUDY RES ED QU; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Moen P, 2005, J GERONTOL B-PSYCHOL, V60, P99; Nesmith AA, 1999, J HOMOSEXUAL, V37, P95, DOI 10.1300/J082v37n01_07; Noor SW, 2014, SEX ADDICT COMPULS, V21, P240, DOI 10.1080/10720162.2014.938849; Nutt D. J., 2008, DIALOGUES CLIN NEURO; Peterson RE, 2012, J OBES, V2012, DOI 10.1155/2012/407103; Pfattheicher S., 2020, EMOTIONAL PATH ACTIO, DOI 10.31234/osf.io/y2cg5; Ross LE, 2018, J SEX RES, V55, P435, DOI 10.1080/00224499.2017.1387755; Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Siddiqui O.I., 2015, CURR RES BIOSTAT, V5, P1, DOI [10.3844/amjbsp.2015.1.6, DOI 10.3844/AMJBSP.2015.1.6]; Sinclair VG, 2016, RES NURS HEALTH, V39, P244, DOI 10.1002/nur.21723; Smith BW, 2008, INT J BEHAV MED, V15, P194, DOI 10.1080/10705500802222972; Song PP, 2020, BIOSCI TRENDS, V14, P1, DOI 10.5582/bst.2020.01056; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Staner Luc, 2003, Dialogues Clin Neurosci, V5, P249; Stanley S, 2020, J SOC WORK, V20, P43, DOI 10.1177/1468017318794280; StataCorp, 2015, STAT STAT SOFTW REL; Taylor MR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-347; Turban JL, 2020, ANN INTERN MED, V173, P387, DOI 10.7326/M20-2004; Vanita R., 2013, QUEERING INDIA SAME; WANG HY, 2020, PLOS ONE, V15, DOI DOI 10.1371/JOURNAL.PONE.0233410; Wolff W, 2021, PSYCHOL RES-PSYCH FO, V85, P397, DOI 10.1007/s00426-019-01230-1; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]	59	19	19	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238761	10.1371/journal.pone.0238761	http://dx.doi.org/10.1371/journal.pone.0238761			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ7QD	32881946	gold, Green Published, Green Submitted			2022-12-26	WOS:000571063300023
J	Zhang, H; Huang, WH; Liu, HJ; Zheng, YH; Liao, LM				Zhang, Hui; Huang, Wenhui; Liu, Hongjin; Zheng, Yihan; Liao, Lianming			Mechanical stretching of pulmonary vein stimulates matrix metalloproteinase-9 and transforming growth factor-beta 1 through stretch-activated channel/MAPK pathways in pulmonary hypertension due to left heart disease model rats	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; SIGNALING PATHWAY; EXPRESSION; MAPK; PROTEIN; INHIBITOR; MMP-9; LUNG; MORPHOLOGY; TIMP-1	Pulmonary hypertension due to left heart disease (PH-LHD) is a momentous pulmonary hypertension disease, and left heart disease is the most familiar cause. Mechanical stretching may be a crucial cause of vascular remodeling. While, the underlining mechanism of mechanical stretching-induced in remodeling of pulmonary vein in the early stage of PH-LHD has not been completely elucidated. In our study, the PH-LHD model rats were successfully constructed. After 25 days, doppler echocardiography and hemodynamic examination were performed. In addition, after treatment, the levels of matrix metalloproteinase-9 (MMP-9) and transforming growth factor-beta 1 (TGF-beta 1) were determined by ELISA, immunohistochemistry and western blot assays in the pulmonary veins. Moreover, the pathological change of pulmonary tissues was evaluated by H&E staining. Our results uncovered that left ventricular insufficiency and interventricular septal shift could be observed in PH-LHD model rats, and the right ventricular systolic pressure (RVSP) and mean left atrial pressure (mLAP) were also elevated in PH-LHD model rats. Meanwhile, we found that MMP-9 and TGF-beta 1 could be highly expressed in PH-LHD model rats. Besides, we revealed that stretch-activated channel (SAC)/mitogen-activated protein kinases (MAPKs) signaling pathway could be involved in the upregulations of MMP-9 and TGF-beta 1 mediated by mechanical stretching in pulmonary vein. Therefore, current research revealed that mechanical stretching induced the increasing expressions of MMP-9 and TGF-beta 1 in pulmonary vein, which could be mediated by activation of SAC/MAPKs signaling pathway in the early stage of PH-LHD.	[Zhang, Hui; Huang, Wenhui; Liu, Hongjin; Zheng, Yihan] Fujian Med Univ, Union Hosp, Dept Cardiac Surg, Fuzhou, Fujian, Peoples R China; [Liao, Lianming] Fujian Med Univ, Union Hosp, Dept Med Lab, Fuzhou, Fujian, Peoples R China	Fujian Medical University; Fujian Medical University	Zhang, H (corresponding author), Fujian Med Univ, Union Hosp, Dept Cardiac Surg, Fuzhou, Fujian, Peoples R China.	zhanghui9877656@163.com		Liao, Lianming/0000-0003-0248-0821	National Natural Science Foundation of China [81770368]; Medical Elite Cultivation Program of Fujian, P.R.C [2015ZQNZD-16]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Elite Cultivation Program of Fujian, P.R.C	This work was supported by the National Natural Science Foundation of China [grant numbers 81770368]; and Medical Elite Cultivation Program of Fujian, P.R.C [grant number 2015ZQNZD-16]. The funders participated in study design, data collection, decision to publish, and preparation of the manuscript.	Angelov SN, 2017, ARTERIOSCL THROM VAS, V37, P2102, DOI 10.1161/ATVBAHA.117.309401; [Anonymous], 2018, LANCET ONCOL, V19, pe581; Breitling S, 2017, AM J PHYSIOL-LUNG C, V312, P1710, DOI 10.1152/ajplung.00311.2016; Breitling S, 2015, AM J PHYSIOL-LUNG C, V309, pL924, DOI 10.1152/ajplung.00146.2015; Brosig M, 2010, INT J BIOCHEM CELL B, V42, P1717, DOI 10.1016/j.biocel.2010.07.001; Clark CB, 2016, CARDIOL CLIN, V34, P401, DOI 10.1016/j.ccl.2016.04.010; Forte A, 2016, CLIN SCI, V130, P1389, DOI 10.1042/CS20160222; George J, 2011, J HYPERTENS, V29, P299, DOI 10.1097/HJH.0b013e328340a0e4; Ghantous CM, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00240; GUHARAY F, 1984, J PHYSIOL-LONDON, V352, P685, DOI 10.1113/jphysiol.1984.sp015317; Guo YJ, 2020, EXP THER MED, V19, P1997, DOI 10.3892/etm.2020.8454; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Hentschel T, 2007, ANESTHESIOLOGY, V106, P124, DOI 10.1097/00000542-200701000-00021; Hu YN, 2018, BIOMED PHARMACOTHER, V108, P1294, DOI 10.1016/j.biopha.2018.09.129; Huang GY, 2009, J HYPERTENS, V27, P1829, DOI 10.1097/HJH.0b013e32832db36b; Hunt JM, 2013, AM J PHYSIOL-LUNG C, V305, pL725, DOI 10.1152/ajplung.00186.2013; Hurle JM, 1996, MICROSC RES TECHNIQ, V34, P236; Ishise H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11620; IVES CL, 1986, IN VITRO CELL DEV B, V22, P500; Iyer RP, 2016, AM J PHYSIOL-HEART C, V311, pH190, DOI 10.1152/ajpheart.00243.2016; Kompa AR, 2016, J THORAC DIS, V8, pE1068, DOI 10.21037/jtd.2016.07.94; Li CY, 2015, INT J MOL MED, V35, P1095, DOI 10.3892/ijmm.2015.2104; Li D, 2011, REGEN MED, V6, P229, DOI 10.2217/RME.11.2; Li XW, 2014, CAN J PHYSIOL PHARM, V92, P58, DOI 10.1139/cjpp-2013-0056; Liang JL, 2017, AM J TRANSL RES, V9, P2945; Liu XX, 2015, INT J BIOCHEM CELL B, V62, P15, DOI 10.1016/j.biocel.2015.02.009; Nava MM, 2012, BIOMED RES INT, V2012; Oikawa Y, 2016, EXP LUNG RES, V42, P111, DOI 10.3109/01902148.2016.1157226; Oliveira SDS, 2017, AM J PHYSIOL-LUNG C, V312, P1760, DOI 10.1152/ajplung.00484.2016; Pang MF, 2016, ONCOGENE, V35, P748, DOI 10.1038/onc.2015.133; Park B, 2015, BIOSCI BIOTECH BIOCH, V79, P539, DOI 10.1080/09168451.2014.991681; Peng X, 2014, MOL CELL BIOCHEM, V396, P87, DOI 10.1007/s11010-014-2145-9; Qaddoumi I, 2016, ACTA NEUROPATHOL, V131, P833, DOI 10.1007/s00401-016-1539-z; Qiu ZH, 2017, MED SCI MONITOR, V23, P1268, DOI 10.12659/MSM.899547; Rosenkranz S, 2016, EUR HEART J, V37, P942, DOI 10.1093/eurheartj/ehv512; Schmidt C, 2017, PROG BIOPHYS MOL BIO, V130, P233, DOI 10.1016/j.pbiomolbio.2017.05.004; Seo KW, 2015, J MOL CELL CARDIOL, V85, P13, DOI 10.1016/j.yjmcc.2015.05.006; Shaw Anthony, 2003, Current Vascular Pharmacology, V1, P41, DOI 10.2174/1570161033386745; Sun J, 2016, J MOL NEUROSCI, V59, P90, DOI 10.1007/s12031-016-0717-8; Sutendra G, 2014, CELL METAB, V19, P558, DOI 10.1016/j.cmet.2014.01.004; Vachiery JL, 2013, J AM COLL CARDIOL, V62, pD100, DOI 10.1016/j.jacc.2013.10.033; Vafadari B, 2016, J NEUROCHEM, V139, P91, DOI 10.1111/jnc.13415; Wang Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157171; Wang XM, 2015, GENET MOL RES, V14, P1707, DOI 10.4238/2015.March.6.17; Wang ZG, 2015, INT J CARDIOL, V178, P165, DOI 10.1016/j.ijcard.2014.10.122; Wei Y, 2017, J CLIN INVEST, V127, P3675, DOI 10.1172/JCI94624; Xu SP, 2006, CAN J CARDIOL, V22, P947, DOI 10.1016/S0828-282X(06)70314-2; Yin J, 2011, CIRC-HEART FAIL, V4, P198, DOI 10.1161/CIRCHEARTFAILURE.110.957050; Yin N, 2009, CRIT CARE MED, V37, P980, DOI 10.1097/CCM.0b013e3181962ce6; Yu WC, 2018, REV ASSOC MED BRAS, V64, P361, DOI 10.1590/1806-9282.64.04.361; Zaiman AL, 2008, AM J RESP CRIT CARE, V177, P896, DOI 10.1164/rccm.200707-1083OC; Zhang L, 2014, J CELL PHYSIOL, V229, P245, DOI 10.1002/jcp.24443; ZIMMER HG, 1988, BASIC RES CARDIOL, V83, P48, DOI 10.1007/BF01907104	53	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0235824	10.1371/journal.pone.0235824	http://dx.doi.org/10.1371/journal.pone.0235824			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881898	Green Published, gold			2022-12-26	WOS:000571063300094
J	Zhang, WW; Williams, A; Griffith, N; Gaskins, J; Bookstaver, PB				Zhang, Weiwei; Williams, Austin; Griffith, Nicole; Gaskins, Jessica; Bookstaver, P. Brandon			Online availability of fish antibiotics and documented intent for self-medication	PLOS ONE			English	Article							ANTIMICROBIAL DRUGS; LATINO COMMUNITY; BETA-LACTAM; RISK; PRESCRIPTION; RESISTANCE; DIAGNOSIS; EXPOSURE; ADULTS	Self-medication and antibiotic utilization without healthcare oversight may lead to delayed appropriate treatment, transmission of communicable infections, untoward adverse events, and contribute to antimicrobial resistance. Previous data suggest people obtain over-the-counter (OTC) animal antibiotics for their personal use. This study examined the availability of OTC fish antibiotics online and the documented intent for self-medication. The authors conducted a web-based cross-sectional study using Google search engine to identify vendor websites selling fish antibiotics in the United States. Vendor websites were included if product information, consumer reviews, and comments were publicly available. Nine fish antibiotics were chosen due to their possibility of having consequences to human misuse. The cost and availability of fish antibiotics was recorded. The proportion of reviews and comments related to human consumption was calculated. Consumer review traffic based on "likes" and "dislikes" received was compared between human- and non-human consumption-related reviews. Selected fish antibiotics were purchased and evaluated for physical appearance and compared to FDA-approved available equivalents. We found 24 website vendors with online ordering available for OTC fish antibiotics. Cost varied significantly by antibiotic and quantity ranging from USD $8.99 to $119.99. There were 2,288 reviews documented for the 9 selected antibiotics being sold. Among consumer reviews, 2.4% were potentially associated with human consumption. Human consumption-related reviews constituted 30.2% of all "likes" received and 37.5% of all "dislikes" received. Human consumption-related reviews received an average of 9.2 likes compared to 0.52 likes for non-human consumption-related reviews. The 8 fish antibiotics purchased were consistent with FDA-approved equivalents in physical appearance. Although infrequent, antibiotics intended for fish use are being purchased online without a prescription for self-medication to circumvent professional medical care. Reviews related to human consumption generate significant online traffic compared to reviews unrelated to human consumption.	[Zhang, Weiwei] Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Sch Clin Med, Dept Clin Pharm, Beijing, Peoples R China; [Williams, Austin; Bookstaver, P. Brandon] Univ South Carolina, Coll Pharm, Columbia, SC 29208 USA; [Griffith, Nicole] Univ Virginia Hlth, Charlottesville, VA USA; [Gaskins, Jessica] South Carolina Aquarium, Charleston, SC USA; [Williams, Austin; Bookstaver, P. Brandon] Prisma Hlth Richland, Columbia, SC 29203 USA; [Griffith, Nicole] Univ Illinois, Infect Dis PGY2, Chicago, IL 60680 USA	Tsinghua University; University of South Carolina System; University of South Carolina Columbia; University of Virginia; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Zhang, WW (corresponding author), Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Sch Clin Med, Dept Clin Pharm, Beijing, Peoples R China.; Bookstaver, PB (corresponding author), Univ South Carolina, Coll Pharm, Columbia, SC 29208 USA.; Bookstaver, PB (corresponding author), Prisma Hlth Richland, Columbia, SC 29203 USA.	zwwa00410@btch.edu.cn; bookstaver@cop.sc.edu						Administration USFD, 2018, ORN FISH DRUGS YOU; Alshammari TM, 2014, AM J HEALTH-SYST PH, V71, P37, DOI 10.2146/ajhp130165; [Anonymous], **NON-TRADITIONAL**; [Anonymous], 2012, REGEN MED S3, V7, pS14; Association APP, 2019, PET IND MARK SIZ OWN; Augustine MR, 2017, INFECT CONT HOSP EP, V38, P266, DOI 10.1017/ice.2016.292; Auta A, 2019, J INFECTION, V78, P8, DOI 10.1016/j.jinf.2018.07.001; Awad A, 2005, J PHARM PHARM SCI, V8, P326; Bell BG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-13; Boyd SE, 2017, J ANTIMICROB CHEMOTH, V72, P1521, DOI 10.1093/jac/dkx003; Carbon C, 1998, BRIT MED J, V317, P663, DOI 10.1136/bmj.317.7159.663; Chen P-Y, 2004, J ICIS P, V58; Ciechalskl S, 2017, MEET PEOPLE USING FI; DeMarsh M, 2020, J GLOB ANTIMICROB RE, V21, P218, DOI 10.1016/j.jgar.2019.10.023; Floyd K, 2014, J RETAILING, V90, P217, DOI 10.1016/j.jretai.2014.04.004; Goff BJ, 2002, NEW ENGL J MED, V347, P223, DOI 10.1056/NEJM200207183470319; Grigoryan L, 2006, EMERG INFECT DIS, V12, P452, DOI 10.3201/eid1203.050992; Grigoryan L, 2019, ANN INTERN MED, V171, P257, DOI 10.7326/M19-0505; Guillemot D, 1998, JAMA-J AM MED ASSOC, V279, P365, DOI 10.1001/jama.279.5.365; Hensgens MPM, 2012, J ANTIMICROB CHEMOTH, V67, P742, DOI 10.1093/jac/dkr508; Hildreth Carolyn J, 2009, JAMA, V302, P816, DOI 10.1001/jama.302.7.816; Jansen J, 2010, ONLINE PRODUCT RES; Kitayama S, 2006, J PERS SOC PSYCHOL, V91, P890, DOI 10.1037/0022-3514.91.5.890; Kuster SP, 2014, CLIN INFECT DIS, V59, P944, DOI 10.1093/cid/ciu497; Larson E, 2004, J URBAN HEALTH, V81, P498, DOI 10.1093/jurban/jth133; Larson EL, 2006, NURS RES, V55, P94, DOI 10.1097/00006199-200603000-00004; Liu NW, 2015, UROL ONCOL-SEMIN ORI, V33, DOI 10.1016/j.urolonc.2015.07.007; Liu YC, 2001, ARCH INTERN MED, V161, P2366, DOI 10.1001/archinte.161.19.2366; Mainous AG, 2005, EMERG INFECT DIS, V11, P883, DOI 10.3201/EID1106.040960; Mainous AG, 2008, J AM BOARD FAM MED, V21, P128, DOI 10.3122/jabfm.2008.02.070149; Mainous AG, 2009, ANN FAM MED, V7, P431, DOI 10.1370/afm.999; Mitsi G, 2005, INT J ANTIMICROB AG, V25, P439, DOI 10.1016/j.ijantimicag.2005.02.009; Nepal G, 2018, CUREUS, V10, DOI 10.7759/cureus.2428; Phua J., 2016, J MARK COMMUN, V22, P544, DOI [10.1080/13527266.2014.941000, DOI 10.1080/13527266.2014.941000]; Prevention CfDCa, 2019, ANT PRESCR US; Pumawirawan N, 2015, J INTERACT MARK, V31, P17, DOI 10.1016/j.intmar.2015.05.001; Radio NP, 2020, MAN DIES WOM HOSP TA; Sakeena MHF, 2018, INT J ANTIMICROB AG, V52, P771, DOI 10.1016/j.ijantimicag.2018.09.022; Sharp R, 2017, BAD IS AM HEALTHCARE; Smith SA, 2019, FISH DIS MED; Thomas JK, 1998, ANTIMICROB AGENTS CH, V42, P521, DOI 10.1128/AAC.42.3.521; Torres MJ, 2003, ALLERGY, V58, P961, DOI 10.1034/j.1398-9995.2003.00280.x; Wei-Haas M, 2017, SCI SMITHSONIAN MAGA; World Health Organization, 2000, GUIDELINES REGULATOR; Zoorob R, 2016, ANTIMICROB AGENTS CH, V60, P5527, DOI 10.1128/AAC.00528-16	45	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238538	10.1371/journal.pone.0238538	http://dx.doi.org/10.1371/journal.pone.0238538			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881969	Green Published, gold			2022-12-26	WOS:000571063300091
J	Jensen, RE; Cabral, C; Enkegaard, A; Steenberg, T				Jensen, Rasmus Emil; Cabral, Carmina; Enkegaard, Annie; Steenberg, Tove			Influence of the plant interacting entomopathogenic fungusBeauveria bassianaon parasitoid host choice-behavior, development, and plant defense pathways	PLOS ONE			English	Article							ENDOPHYTIC BEAUVERIA-BASSIANA; FUNGUS METARHIZIUM-ROBERTSII; APHIS-GOSSYPII; VICIA-FABA; PAECILOMYCES-FUMOSOROSEUS; ASCOMYCOTA HYPOCREALES; BIOLOGICAL-CONTROL; DEVELOPMENT TIME; NATURAL ENEMIES; GENE-EXPRESSION	Inoculating plants with entomopathogenic fungi may influence plant nutrient uptake and growth, and herbivore performance. Knowledge is limited concerning the effects of this symbiosis on higher trophic levels. We examined how fungal treatment of faba bean seeds with the entomopathogenic fungusBeauveria bassianainfluenced the choice-behavior and development of the aphid parasitoidAphidius colemani. We also sampled plant material for analysis of changes in expression of genes related to plant defense pathways. While parasitoids were compatible with plants inoculated withB.bassianainitially (66 vs. 65% parasitization on inoculated and control plants, respectively; similar development times of parasitoids: 9.2 days), the emergence of adult parasitoids originating from aphids on fungus treated plants was significantly lower (67 vs. 76%, respectively). We also found that the defense response changed, similar to induced systemic resistance, when plants were treated withB.bassiana, similarly to what has been found for other plant symbiotic microorganisms. These novel findings show that although the application of entomopathogenic fungi to plants can alter the plants' defense against herbivores, it may also have an impact on beneficial insects, so their function and use should be evaluated on a case-by-case basis.	[Jensen, Rasmus Emil; Cabral, Carmina; Enkegaard, Annie; Steenberg, Tove] Aarhus Univ, Dept Agroecol, Flakkebjerg, Denmark	Aarhus University	Jensen, RE; Cabral, C (corresponding author), Aarhus Univ, Dept Agroecol, Flakkebjerg, Denmark.	rasmusej@agro.au.dk; cfc@plen.ku.dk		Cabral, Carmina/0000-0001-6867-1482; Jensen, Rasmus Emil/0000-0002-1808-1318	Graduate School of Science and Technology at Aarhus University	Graduate School of Science and Technology at Aarhus University	The work was supported by the Graduate School of Science and Technology at Aarhus University. The author(s) did not receive any additional external funding for this study.	Akutse KS, 2013, FUNGAL ECOL, V6, P293, DOI 10.1016/j.funeco.2013.01.003; [Anonymous], 2000, STAFF LEADER JAN, V13, P7; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2017, EUR GERIATR MED, V8, pS98; [Anonymous], 1994, PONTICA, V27, P7; Aqueel MA, 2015, INSECT SCI, V22, P813, DOI 10.1111/1744-7917.12123; Ashouri A, 2001, BIOCONTROL, V46, P401, DOI 10.1023/A:1014123712776; Azevedo AGCd, 2017, NONTARGET EFFECTS EN; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Behie SW, 2012, SCIENCE, V336, P1576, DOI 10.1126/science.1222289; BING LA, 1991, ENVIRON ENTOMOL, V20, P1207, DOI 10.1093/ee/20.4.1207; Bixby-Brosi AJ, 2012, ARTHROPOD-PLANT INTE, V6, P27, DOI 10.1007/s11829-011-9163-2; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Bultman TL, 2009, ENTOMOL EXP APPL, V130, P173, DOI 10.1111/j.1570-7458.2008.00802.x; Bultman TL, 1997, OIKOS, V78, P170, DOI 10.2307/3545812; Cabral C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32670-1; Cameron DD, 2013, TRENDS PLANT SCI, V18, P539, DOI 10.1016/j.tplants.2013.06.004; Lopez DC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103891, 10.1371/journal.pone.0093811]; Chang W, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00652; Chen YG, 2014, BIOL CONTROL, V70, P9, DOI 10.1016/j.biocontrol.2013.12.002; Clarke HV, 2017, ENTOMOL EXP APPL, V162, P148, DOI 10.1111/eea.12516; Clifton EH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194815; de Sassi C, 2006, P R SOC B, V273, P1301, DOI 10.1098/rspb.2005.3442; El-Komy MH, 2014, PLANT PATHOLOGY J, V30, P355, DOI 10.5423/PPJ.OA.06.2014.0050; Faeth SH, 2012, FUNGAL ECOL, V5, P364, DOI 10.1016/j.funeco.2011.09.003; Ferguson KI, 1996, OECOLOGIA, V108, P375, DOI 10.1007/BF00334664; Fox J., 2019, R COMPANION APPL REG, V.; Gange AC, 2019, NEW PHYTOL, V223, P2002, DOI 10.1111/nph.15859; Garcia-Brugger A, 2006, MOL PLANT MICROBE IN, V19, P711, DOI 10.1094/MPMI-19-0711; Gonzalez-Mas N, 2019, J PEST SCI, V92, P1271, DOI 10.1007/s10340-019-01098-5; Gonzalez-Mas N., 2017, IOBC/WPRS Bulletin, V124, P105; Gruner K, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00252; Gutierrez N, 2011, MOL BREEDING, V28, P13, DOI 10.1007/s11032-010-9456-7; Harri SA, 2008, OECOLOGIA, V157, P399, DOI 10.1007/s00442-008-1094-y; Harri SA, 2008, P R SOC B, V275, P2627, DOI 10.1098/rspb.2008.0594; Harri SA, 2009, ECOL ENTOMOL, V34, P20, DOI 10.1111/j.1365-2311.2008.01037.x; Han P, 2015, ECOL EVOL, V5, P5468, DOI 10.1002/ece3.1788; Hartig F., 2022, DHARMA RESIDUAL DIAG; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jaber LR, 2018, BIOL CONTROL, V116, P36, DOI 10.1016/j.biocontrol.2017.01.018; Jaber LR, 2018, BIOL CONTROL, V116, P53, DOI 10.1016/j.biocontrol.2017.04.005; Jensen RE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223616; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kalule T, 2005, BIOCONTROL, V50, P235, DOI 10.1007/s10526-004-3072-6; Kaur T, 2015, OECOLOGIA, V179, P487, DOI 10.1007/s00442-015-3358-7; Khanamani M, 2015, ANN ENTOMOL SOC AM, V108, P501, DOI 10.1093/aesa/sav032; Krips OE, 1999, EXP APPL ACAROL, V23, P119, DOI 10.1023/A:1006098410165; Lacey LA, 2015, J INVERTEBR PATHOL, V132, P1, DOI 10.1016/j.jip.2015.07.009; Lambais MR, 2003, NEW PHYTOL, V160, P421, DOI 10.1046/j.1469-8137.2003.00881.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luna E, 2018, PHYTOBIOMES J, V2, P151, DOI 10.1094/PBIOMES-06-18-0027-R; Martinez-Medina A, 2009, J SCI FOOD AGR, V89, P1843, DOI 10.1002/jsfa.3660; McKinnon AC, 2017, INTERACTIONS ISOLATE; McKinnon AC, 2017, BIOCONTROL, V62, P1, DOI 10.1007/s10526-016-9769-5; Meier U., 2009, Journal fur Kulturpflanzen, V61, P41; Mesquita ALM, 1997, J APPL ENTOMOL, V121, P155, DOI 10.1111/j.1439-0418.1997.tb01386.x; Mesquita ALM, 2001, BIOL CONTROL, V22, P51, DOI 10.1006/bcon.2001.0950; Mohammed AA, 2017, BIOL CONTROL, V110, P44, DOI 10.1016/j.biocontrol.2017.03.012; Moran PJ, 2001, PLANT PHYSIOL, V125, P1074, DOI 10.1104/pp.125.2.1074; Perdikis DC, 2004, EUR J ENTOMOL, V101, P333, DOI 10.14411/eje.2004.044; Pieterse CMJ, 2014, ANNU REV PHYTOPATHOL, V52, P347, DOI 10.1146/annurev-phyto-082712-102340; Pineda A, 2010, TRENDS PLANT SCI, V15, P507, DOI 10.1016/j.tplants.2010.05.007; Pozo MJ, 2007, CURR OPIN PLANT BIOL, V10, P393, DOI 10.1016/j.pbi.2007.05.004; Pozo MJ, 2002, J EXP BOT, V53, P525, DOI 10.1093/jexbot/53.368.525; Preszler RW, 1996, OECOLOGIA, V108, P159, DOI 10.1007/BF00333227; R Core Team, 2013, R LANG ENV STAT COMP; Rashki M, 2009, BIOL CONTROL, V50, P324, DOI 10.1016/j.biocontrol.2009.04.016; Read M, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00615; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Rondot Y, 2019, PLANT PATHOL, V68, P1719, DOI 10.1111/ppa.13089; Roy HE, 2006, ANNU REV ENTOMOL, V51, P331, DOI 10.1146/annurev.ento.51.110104.150941; Ruther J, 2005, J CHEM ECOL, V31, P2217, DOI 10.1007/s10886-005-6413-8; Saikkonen K, 1998, ANNU REV ECOL SYST, V29, P319, DOI 10.1146/annurev.ecolsys.29.1.319; Saikkonen K, 2004, TRENDS PLANT SCI, V9, P275, DOI 10.1016/j.tplants.2004.04.005; Sampaio MV, 2007, NEOTROP ENTOMOL, V36, P436, DOI 10.1590/S1519-566X2007000300012; Sasan RK, 2013, CAN J PLANT PATHOL, V35, P288, DOI 10.1080/07060661.2013.823114; Sasan RK, 2012, AM J BOT, V99, P101, DOI 10.3732/ajb.1100136; Shrestha G, 2014, ENVIRON ENTOMOL, V43, P1535, DOI 10.1603/EN14068; Sigsgaard L, 2000, ENTOMOL EXP APPL, V95, P173, DOI 10.1023/A:1003993719952; Tall S, 2018, MICROB ECOL, V76, P1002, DOI 10.1007/s00248-018-1180-6; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; Turlings TCJ, 1998, ECOSCIENCE, V5, P321, DOI 10.1080/11956860.1998.11682472; Vega FE, 2008, BIOL CONTROL, V46, P72, DOI 10.1016/j.biocontrol.2008.01.008; Vega FE, 2018, MYCOLOGIA, V110, P4, DOI 10.1080/00275514.2017.1418578; Vidal S, 2015, CURR SCI INDIA, V109, P46; Zhou YC, 2010, NEW PHYTOL, V185, P931, DOI 10.1111/j.1469-8137.2009.03136.x; Zitlalpopoca-Hernandez G, 2017, APPL SOIL ECOL, V115, P38, DOI 10.1016/j.apsoil.2017.03.014	87	3	3	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0238943	10.1371/journal.pone.0238943	http://dx.doi.org/10.1371/journal.pone.0238943			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925935	Green Published, gold			2022-12-26	WOS:000572318000050
J	Schilling, MA; Estes, AB; Eblate, E; Martin, A; Rentsch, D; Katani, R; Joseph, A; Kindoro, F; Lyimo, B; Radzio-Basu, J; Cattadori, IM; Hudson, PJ; Kapur, V; Buza, JJ; Gwakisa, PS				Schilling, Megan A.; Estes, Anna B.; Eblate, Ernest; Martin, Andimile; Rentsch, Dennis; Katani, Robab; Joseph, Asteria; Kindoro, Fatuma; Lyimo, Beatus; Radzio-Basu, Jessica; Cattadori, Isabella M.; Hudson, Peter J.; Kapur, Vivek; Buza, Joram J.; Gwakisa, Paul S.			Molecular species identification of bushmeat recovered from the Serengeti ecosystem in Tanzania	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; SURVEILLANCE; ENFORCEMENT; AFRICAN; CATTLE	Bushmeat harvesting and consumption represents a potential risk for the spillover of endemic zoonotic pathogens, yet remains a common practice in many parts of the world. Given that the harvesting and selling of bushmeat is illegal in Tanzania and other parts of Africa, the supply chain is informal and may include hunters, whole-sellers, retailers, and individual resellers who typically sell bushmeat in small pieces. These pieces are often further processed, obscuring species-identifying morphological characteristics, contributing to incomplete or mistaken knowledge of species of origin and potentially confounding assessments of pathogen spillover risk and bushmeat offtake. The current investigation sought to identify the species of origin and assess the concordance between seller-reported and laboratory-confirmed species of origin of bushmeat harvested from in and around the Serengeti National Park in Tanzania. After obtaining necessary permits, the species of origin of a total of 151 bushmeat samples purchased from known intermediaries from 2016 to 2018 were characterized by PCR and sequence analysis of the cytochrome B (CytB) gene. Based on these sequence analyses, 30%, 95% Confidence Interval (CI: 24.4-38.6) of bushmeat samples were misidentified by sellers. Misreporting amongst the top five source species (wildebeest, buffalo, impala, zebra, and giraffe) ranged from 20% (CI: 11.4-33.2) for samples reported as wildebeest to 47% (CI: 22.2-72.7) for samples reported as zebra although there was no systematic bias in reporting. Our findings suggest that while misreporting errors are unlikely to confound wildlife offtake estimates for bushmeat consumption within the Serengeti ecosystem, the role of misreporting bias on the risk of spillover events of endemic zoonotic infections from bushmeat requires further investigation.	[Schilling, Megan A.; Estes, Anna B.; Katani, Robab; Cattadori, Isabella M.; Hudson, Peter J.; Kapur, Vivek] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Schilling, Megan A.; Katani, Robab; Kapur, Vivek] Penn State Univ, Dept Anim Sci, University Pk, PA 16802 USA; [Estes, Anna B.; Eblate, Ernest; Martin, Andimile; Lyimo, Beatus; Cattadori, Isabella M.; Kapur, Vivek; Buza, Joram J.; Gwakisa, Paul S.] Nelson Mandela African Inst Sci & Technol, Sch Life Sci & Bioengn, Arusha, Tanzania; [Eblate, Ernest] Tanzania Wildlife Res Inst, Arusha, Tanzania; [Rentsch, Dennis] Lincoln Pk Zoo, Conservat & Sci Dept, Chicago, IL USA; [Katani, Robab; Radzio-Basu, Jessica; Cattadori, Isabella M.; Hudson, Peter J.; Kapur, Vivek] Penn State Univ, Appl Biol & Biosecur Res Lab, University Pk, PA 16802 USA; [Joseph, Asteria; Kindoro, Fatuma; Gwakisa, Paul S.] Sokoine Univ Agr, Morogoro, Tanzania; [Cattadori, Isabella M.; Hudson, Peter J.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Nelson Mandela African Institution of Science & Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Sokoine University of Agriculture; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Buza, JJ; Gwakisa, PS (corresponding author), Nelson Mandela African Inst Sci & Technol, Sch Life Sci & Bioengn, Arusha, Tanzania.; Gwakisa, PS (corresponding author), Sokoine Univ Agr, Morogoro, Tanzania.	joram.buza@nm-aist.ac.tz; paul.gwakisa@nm-aist.ac.tz		Cattadori, Isabella/0000-0001-6618-316X; Lyimo, Beatus/0000-0002-6743-4546	U.S. Department of Defense, Defense Threat Reduction Agency, Biological Threat Reduction Program [HDTRA1-16-1-0005]	U.S. Department of Defense, Defense Threat Reduction Agency, Biological Threat Reduction Program	This research was supported by grant from the U.S. Department of Defense, Defense Threat Reduction Agency, Biological Threat Reduction Program, Project #HDTRA1-16-1-0005 (V.K and J.J.B.).	[Anonymous], 2019, CIRCULATION, V2019; [Anonymous], 2011, PHILOS CHRISTI, V13, P305; Bausch DG, 2003, EMERG INFECT DIS, V9, P1531, DOI 10.3201/eid0912.030355; BK K, 2017, MED PHYS, V44, pe43; Cleaveland S, 2002, B WORLD HEALTH ORGAN, V80, P304; Eaton MJ, 2010, CONSERV GENET, V11, P1389, DOI 10.1007/s10592-009-9967-0; Estes AB, 2012, BIOL CONSERV, V147, P255, DOI 10.1016/j.biocon.2012.01.010; Gamer M, 2012, IRR VARIOUS COEFFICI; Gaubert P, 2015, MOL ECOL RESOUR, V15, P633, DOI 10.1111/1755-0998.12334; Gustafson P, 2004, INTER DISC; Hilborn R, 2006, SCIENCE, V314, P1266, DOI 10.1126/science.1132780; Hofer H., 2000, NAT RESOUR MODEL, V13, P151, DOI 10.1111/j.1939-7445.2000.tb00031.x; Holmern T, 2007, ENVIRON CONSERV, V34, P55, DOI 10.1017/S0376892907003712; HUMMEL PH, 1976, VET REC, V98, P501, DOI 10.1136/vr.98.25.501; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Katz BM, 1979, J EXPT ED, V47; Kaye D. H., 2014, FORENSIC DNA APPL IN, P509; Kunda J, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-315; Lembo T, 2011, EMERG INFECT DIS, V17, P387, DOI 10.3201/eid1703.101290; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2009, VECTOR-BORNE ZOONOT, V9, P723, DOI 10.1089/vbz.2008.0167; Mangesho PE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005345; Martin A, 2013, AFR J ECOL, V51, P172, DOI 10.1111/aje.12000; Martin A, 2012, TROP CONSERV SCI, V5, P352, DOI 10.1177/194008291200500309; Merianos A, 2007, CURR TOP MICROBIOL, V315, P477; Mfunda Iddi M., 2010, International Journal of Biodiversity and Conservation, V2, P263; Moore MK, 2003, CONSERV GENET, V4, P95, DOI 10.1023/A:1021881319271; Mwakapeje ER, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-5007-z; Ndibalema VG, 2008, AFRICAN J ECOLOGY, P46; Nielsen MR, 2016, ORYX, V50, P84, DOI 10.1017/S003060531400009X; Njeru J, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2929-9; Nyahongo JW, 2007, DEPREDATION LIVESTOC; Ope Maurice, 2013, Emerg Health Threats J, V6, DOI 10.3402/ehtj.v6i0.19948; Pearson William R, 2013, Curr Protoc Bioinformatics, VChapter 3, DOI 10.1002/0471250953.bi0301s42; Rentsch D, 2015, ORYX, V49, P287, DOI 10.1017/S0030605313001038; Rentsch D, 2013, ECOL ECON, V91, P1, DOI 10.1016/j.ecolecon.2013.03.021; Schlegel M, 2012, BIOCHEM GENET, V50, P440, DOI 10.1007/s10528-011-9487-8; Schrago CG, 2020, MAMMAL REV, V50, P240, DOI 10.1111/mam.12192; Shirima GM, 2003, PREV VET MED, V57, P167, DOI 10.1016/S0167-5877(02)00214-3; Sobrino R, 2008, VET PARASITOL, V155, P198, DOI 10.1016/j.vetpar.2008.05.003; Stallknecht DE, 2007, CURR TOP MICROBIOL, V315, P445; Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876; Swamy V., 2014, BUSHMEAT HARVEST TRO; Team RC, 2014, R LANG ENV STAT COMP; The Lancet HIV, 2016, LANCET HIV, V3, pe191; Towner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000764; Verma SK, 2003, MOL ECOL NOTES, V3, P28, DOI 10.1046/j.1471-8286.2003.00340.x; Wolfe ND, 1998, EMERG INFECT DIS, V4, P149, DOI 10.3201/eid0402.980202	48	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0237590	10.1371/journal.pone.0237590	http://dx.doi.org/10.1371/journal.pone.0237590			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925949	gold, Green Published			2022-12-26	WOS:000572318000015
J	Gonzalez, NT; Otali, E; Machanda, Z; Muller, MN; Wrangham, R; Thompson, ME				Gonzalez, Nicole Thompson; Otali, Emily; Machanda, Zarin; Muller, Martin N.; Wrangham, Richard; Thompson, Melissa Emery			Urinary markers of oxidative stress respond to infection and late-life in wild chimpanzees	PLOS ONE			English	Article							TOTAL ANTIOXIDANT CAPACITY; DNA-DAMAGE; MOLECULAR-MECHANISMS; LIPID-PEROXIDATION; MORTALITY-RATES; CLINICAL-MODEL; LEUKOCYTE DNA; IMMUNE-SYSTEM; AGE; NEOPTERIN	Oxidative stress (OS) plays a marked role in aging and results from a variety of stressors, making it a powerful measure of health and a way to examine costs associated with life history investments within and across species. However, few urinary OS markers have been examined under field conditions, particularly in primates, and their utility to non-invasively monitor the costs of acute stressors versus the long-term damage associated with aging is poorly understood. In this study, we examined variation in 5 urinary markers of oxidative damage and protection under 5 validation paradigms for 37 wild, chimpanzees living in the Kibale National Park, Uganda. We used 924 urine samples to examine responses to acute immune challenge (respiratory illness or severe wounding), as well as mixed-longitudinal and intra-individual variation with age. DNA damage (8-OHdG) correlated positively with all other markers of damage (F-isoprostanes, MDA-TBARS, and neopterin) but did not correlate with protection (total antioxidant capacity). Within individuals, all markers of damage responded to at least one if not both types of acute infection. While OS is expected to increase with age, this was not generally true in chimpanzees. However, significant changes in oxidative damage were detected within past-prime individuals and those close to death. Our results indicate that OS can be measured using field-collected urine and integrates short- and long-term aspects of health. They further suggest that more data are needed from long-lived, wild animals to illuminate if common age-related increases in inflammation and OS damage are typical or recently aberrant in humans.	[Gonzalez, Nicole Thompson; Muller, Martin N.; Thompson, Melissa Emery] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Gonzalez, Nicole Thompson] Univ New Mexico, Acad Sci Educ & Res Training Program, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Otali, Emily; Machanda, Zarin; Muller, Martin N.; Wrangham, Richard; Thompson, Melissa Emery] Kibale Chimpanzee Project, Ft Portal, Uganda; [Machanda, Zarin] Tufts Univ, Dept Anthropol, Medford, MA 02155 USA; [Wrangham, Richard] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA	University of New Mexico; University of New Mexico; University of New Mexico's Health Sciences Center; Tufts University; Harvard University	Gonzalez, NT (corresponding author), Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA.; Gonzalez, NT (corresponding author), Univ New Mexico, Acad Sci Educ & Res Training Program, Hlth Sci Ctr, Albuquerque, NM 87131 USA.	gavago@gmail.com	Thompson, Melissa Emery/ABF-1790-2020	Thompson, Melissa Emery/0000-0003-2451-6397	National Institute of Aging; NIH Office for Research on Women's Health [R01-049395]; Leakey Foundation; National Science Foundation [BCS-1355014, BCS-0849380, NCS-FO-1926352/1926737]; University of New Mexico; Harvard University; Foundation for the National Institutes of Health [K12 GM088021]	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH Office for Research on Women's Health; Leakey Foundation; National Science Foundation(National Science Foundation (NSF)); University of New Mexico; Harvard University; Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institute of Aging and the NIH Office for Research on Women's Health award R01-049395 (MET, MM, ZM, EO, RW, https://www.nia.nih.gov/), and by the Leakey Foundation (https://leakeyfoundation.org/), the National Science Foundation (BCS-1355014, BCS-0849380, MET, MM, ZM, EO, RW, https://www.nsf.gov/), the University of New Mexico, and Harvard University, the Foundation for the National Institutes of Health (K12 GM088021, NTG), National Science Foundation (NCS-FO-1926352/1926737 to MET, ZM, MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andziak B, 2006, AGING CELL, V5, P525, DOI 10.1111/j.1474-9726.2006.00246.x; [Anonymous], 2019, R LANG ENV STAT COMP; Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; Balakrishnan SD, 1998, CELL BIOCHEM FUNCT, V16, P269, DOI 10.1002/(SICI)1099-0844(1998120)16:4<269::AID-CBF797>3.0.CO;2-B; Bartz RR, 2010, CRIT CARE, V14, DOI 10.1186/cc9185; Basu S, 2008, ANTIOXID REDOX SIGN, V10, P1405, DOI 10.1089/ars.2007.1956; Behringer V, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00051; Bektas A, 2017, J LEUKOCYTE BIOL, V102, P977, DOI 10.1189/jlb.3RI0716-335R; Belsky DW, 2015, P NATL ACAD SCI USA, V112, pE4104, DOI 10.1073/pnas.1506264112; Bolzan AD, 1997, CLIN BIOCHEM, V30, P449, DOI 10.1016/S0009-9120(97)00047-7; Brysbaert Marc, 2018, J Cogn, V1, P9, DOI 10.5334/joc.10; Capuron L, 2014, CURR PHARM DESIGN, V20, P6048, DOI 10.2174/1381612820666140317110217; Cayman Chemical, 2016, PROT CARB COL ASS KI; Chen JH, 2007, NUCLEIC ACIDS RES, V35, P7417, DOI 10.1093/nar/gkm681; Chen QM, 2018, PHYSIOL GENOMICS, V50, P77, DOI 10.1152/physiolgenomics.00041.2017; Cooke MS, 2005, MUTAT RES-FUND MOL M, V574, P58, DOI 10.1016/j.mrfmmm.2005.01.022; Costantini D, 2011, METHODS ECOL EVOL, V2, P321, DOI 10.1111/j.2041-210X.2010.00080.x; Daynes RA, 2003, ANTIOXID REDOX SIGN, V5, P537, DOI 10.1089/152308603770310185; DENZ H, 1990, KLIN WOCHENSCHR, V68, P218, DOI 10.1007/BF01662720; Dorjgochoo T, 2012, AM J CLIN NUTR, V96, P405, DOI 10.3945/ajcn.112.034918; Duplancic D, 2011, MOLECULES, V16, P7058, DOI 10.3390/molecules16087058; Feillet-Coudray C, 1999, FREE RADICAL BIO MED, V27, P463, DOI 10.1016/S0891-5849(99)00096-9; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fletcher QE, 2013, EVOLUTION, V67, P1527, DOI 10.1111/evo.12014; FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533; Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Frisard MI, 2007, J GERONTOL A-BIOL, V62, P752, DOI 10.1093/gerona/62.7.752; Fulop T, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01960; Gan W, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00034; Gan W, 2012, FREE RADICAL BIO MED, V52, P1700, DOI 10.1016/j.freeradbiomed.2012.02.016; Garratt M, 2011, P ROY SOC B-BIOL SCI, V278, P1098, DOI 10.1098/rspb.2010.1818; Gasso D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163971; Georgiev AV, 2015, J EXP BIOL, V218, P1981, DOI 10.1242/jeb.121947; Ghiselli A, 2001, BIOASSAYS OXIDATIVE, P219, DOI DOI 10.1016/B978-0-444-50957-4.50035-1; Gorbunova V, 2007, NUCLEIC ACIDS RES, V35, P7466, DOI 10.1093/nar/gkm756; Gurven M, 2008, J GERONTOL A-BIOL, V63, P196, DOI 10.1093/gerona/63.2.196; Gurven M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006590; Halliwell B, 2006, PLANT PHYSIOL, V141, P312, DOI 10.1104/pp.106.077073; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; Handa JT, 2017, BBA-MOL CELL BIOL L, V1862, P430, DOI 10.1016/j.bbalip.2016.07.013; Hardeland R, 2003, CHRONOBIOL INT, V20, P921, DOI 10.1081/CBI-120025245; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Heistermann M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16308; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Higham JP, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.191825; Higham JP, 2015, AM J PHYS ANTHROPOL, V158, P673, DOI 10.1002/ajpa.22821; Hill K, 2001, J HUM EVOL, V40, P437, DOI 10.1006/jhev.2001.0469; Hindle AG, 2010, COMP BIOCHEM PHYS B, V155, P427, DOI 10.1016/j.cbpb.2010.01.007; Hybertson BM, 2011, MOL ASPECTS MED, V32, P234, DOI 10.1016/j.mam.2011.10.006; Ialongo C, 2017, CLIN BIOCHEM, V50, P356, DOI 10.1016/j.clinbiochem.2016.11.037; Il'yasova D, 2012, CLIN CHIM ACTA, V413, P1446, DOI 10.1016/j.cca.2012.06.012; Il'yasova D, 2010, CANCER EPIDEM BIOMAR, V19, P1506, DOI 10.1158/1055-9965.EPI-10-0211; Il'yasova D, 2009, BIOMARKERS, V14, P321, DOI 10.1080/13547500902946757; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Inal ME, 2001, CLIN CHIM ACTA, V305, P75, DOI 10.1016/S0009-8981(00)00422-8; Jain SK, 2002, J HEPATOL, V36, P805, DOI 10.1016/S0168-8278(02)00060-0; Kadiiska MB, 2005, FREE RADICAL BIO MED, V38, P698, DOI 10.1016/j.freeradbiomed.2004.09.017; Kanabrocki EL, 2002, CHRONOBIOL INT, V19, P423, DOI 10.1081/CBI-120002914; King'ori EM, 2018, INFECT GENET EVOL, V58, P269, DOI 10.1016/j.meegid.2018.01.010; Koracevic D, 2001, J CLIN PATHOL, V54, P356, DOI 10.1136/jcp.54.5.356; Korkmaz K. S., 2018, J LAB PRECISION MED; Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006; Lee Kyoung Ho, 2008, J Prev Med Public Health, V41, P195; Lee SG, 2017, J MICROBIOL BIOTECHN, V27, P388, DOI 10.4014/jmb.1604.04053; Li ZG, 2017, ARCH VIROL, V162, P603, DOI 10.1007/s00705-016-3130-2; Liu T, 1999, J BIOMED SCI, V6, P226, DOI 10.1159/000025391; LONGMIRE AW, 1994, BIOCHEM PHARMACOL, V47, P1173, DOI 10.1016/0006-2952(94)90389-1; Lushchak VI, 2014, CHEM-BIOL INTERACT, V224, P164, DOI 10.1016/j.cbi.2014.10.016; MacKinnon KL, 1999, CLIN BIOCHEM, V32, P263, DOI 10.1016/S0009-9120(98)00109-X; Marko G, 2011, J COMP PHYSIOL B, V181, P73, DOI 10.1007/s00360-010-0502-x; Martin LJ, 2008, J NEUROPATH EXP NEUR, V67, P377, DOI 10.1097/NEN.0b013e31816ff780; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; de Toda IM, 2020, J GERONTOL A-BIOL, V75, P613, DOI 10.1093/gerona/glz033; Matsumoto M, 2017, NEUROMUSCULAR DISORD, V27, pS168, DOI 10.1016/j.nmd.2017.06.274; MAXWELL SRJ, 1993, FREE RADICAL RES COM, V19, P191, DOI 10.3109/10715769309111602; Maynard S, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a025130; Melov S, 2002, INT J BIOCHEM CELL B, V34, P1395, DOI 10.1016/S1357-2725(02)00086-9; Metcalfe NB, 2013, TRENDS ECOL EVOL, V28, P347, DOI 10.1016/j.tree.2013.01.015; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; Miller RC, 2004, CLIN CHEM, V50, P924, DOI 10.1373/clinchem.2004.032292; Moffitt TE, 2017, J GERONTOL A-BIOL, V72, P210, DOI 10.1093/gerona/glw191; Muller N, 2017, SCI REP-UK, V7, DOI 10.1038/srep41973; Muller MN, 2014, J HUM EVOL, V66, P107, DOI 10.1016/j.jhevol.2013.10.004; Murr C, 2002, CURR DRUG METAB, V3, P175, DOI 10.2174/1389200024605082; Murr C, 2003, EXP GERONTOL, V38, P583, DOI 10.1016/S0531-5565(03)00062-7; Nagel ZD, 2014, P NATL ACAD SCI USA, V111, pE1823, DOI 10.1073/pnas.1401182111; Nakano M, 2003, FREE RADICAL BIO MED, V35, P826, DOI 10.1016/S0891-5849(03)00432-5; Nowak D, 1999, RESP MED, V93, P389, DOI 10.1053/rmed.1999.0574; Nussey DH, 2011, ECOLOGY, V92, P1936, DOI 10.1890/11-0308.1; Nussey DH, 2009, FUNCT ECOL, V23, P809, DOI 10.1111/j.1365-2435.2009.01555.x; Oldakowski L, 2012, J EXP BIOL, V215, P1799, DOI 10.1242/jeb.068452; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89; Pilger A, 2000, INT ARCH OCC ENV HEA, V73, P305, DOI 10.1007/s004200000117; Pinchuk I, 2014, CHEM PHYS LIPIDS, V178, P63, DOI 10.1016/j.chemphyslip.2013.12.001; PIZZINO G, 2017, OXID MED CELL LONGEV, V2017, DOI DOI 10.1155/2017/8416763; Pratico Domenico, 2002, Sci Aging Knowledge Environ, V2002, pre5; Raichlen DA, 2017, TRENDS NEUROSCI, V40, P408, DOI 10.1016/j.tins.2017.05.001; Raichlen DA, 2017, AM J HUM BIOL, V29, DOI 10.1002/ajhb.22919; Roberts LJ, 2000, FREE RADICAL BIO MED, V28, P505, DOI 10.1016/S0891-5849(99)00264-6; SAHLIN K, 1991, ACTA PHYSIOL SCAND, V142, P275, DOI 10.1111/j.1748-1716.1991.tb09157.x; Schwarz KB, 1996, FREE RADICAL BIO MED, V21, P641, DOI 10.1016/0891-5849(96)00131-1; Scully EJ, 2018, EMERG INFECT DIS, V24, P267, DOI 10.3201/eid2402.170778; Sekhar R., 2018, INNOVATION AGING S1, V2, P887, DOI [10.1093/geroni/igy031.3309, DOI 10.1093/GERONI/IGY031.3309]; Selman C, 2012, TRENDS ECOL EVOL, V27, P570, DOI 10.1016/j.tree.2012.06.006; Simm A, 2008, BIOL CHEM, V389, P257, DOI 10.1515/BC.2008.034; Sohal RS, 2012, FREE RADICAL BIO MED, V52, P539, DOI 10.1016/j.freeradbiomed.2011.10.445; Soulsbury CD, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00222; Speakman JR, 2015, ECOL EVOL, V5, pS745, DOI 10.1002/ece3.1790; The Lancet Haematology, 2018, LANCET HAEMATOL, V5, pe127; Thomas DC, 2017, IMMUNOL LETT, V192, P88, DOI 10.1016/j.imlet.2017.08.016; Tucker PS, 2013, BIOMARKERS, V18, P103, DOI 10.3109/1354750X.2012.749302; Whiting PH, 2008, BRIT J BIOMED SCI, V65, P71, DOI 10.1080/09674845.2008.11732800; Wolf FI, 2005, EXP GERONTOL, V40, P181, DOI 10.1016/j.exger.2004.11.002; Wood BM, 2017, J HUM EVOL, V105, P41, DOI 10.1016/j.jhevol.2017.01.003; Wrigley-Field E, 2014, DEMOGRAPHY, V51, P51, DOI 10.1007/s13524-013-0256-7; Wu DN, 2017, J CHROMATOGR B, V1064, P1, DOI 10.1016/j.jchromb.2017.08.033; Wu DF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31563-7; Yan WY, 2007, J LIPID RES, V48, P1607, DOI 10.1194/jlr.M700097-JLR200; Zhou L, 2018, REDOX BIOL, V14, P35, DOI 10.1016/j.redox.2017.08.014; Zinman G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022401	122	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238066	10.1371/journal.pone.0238066	http://dx.doi.org/10.1371/journal.pone.0238066			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9MU	32916689	Green Published, gold			2022-12-26	WOS:000571887500058
J	Graffigna, G; Barello, S; Savarese, M; Palamenghi, L; Castellini, G; Bonanomi, A; Lozza, E				Graffigna, Guendalina; Barello, Serena; Savarese, Mariarosaria; Palamenghi, Lorenzo; Castellini, Greta; Bonanomi, Andrea; Lozza, Edoardo			Measuring Italian citizens' engagement in the first wave of the COVID-19 pandemic containment measures: A cross-sectional study	PLOS ONE			English	Article							ACTIVATION MEASURE PAM; RISK PERCEPTION; PATIENT ACTIVATION; AVIAN INFLUENZA; INFECTIOUS-DISEASES; EMPLOYEES HEALTH; HUMAN-BEHAVIOR; KNOWLEDGE; SARS; MODEL	Background In January 2020, the coronavirus disease 2019 (COVID-19) started to spread in Italy. The Italian government adopted urgent measures to slow its spread. Enforcing compliance with such measures is crucial in order to enhance their effectiveness. Engaging citizens in the COVID-19 preventive process is urgent today both in Italy and around the world. However, to the best of our knowledge, no previous studies have investigated the role of health engagement in predicting citizens' compliance with health emergency containment measures. Method An online survey was administered between February 28 and March 4, 2020 on a representative sample of 1000 Italians. The questionnaire included a measure of health engagement (Patient Health Engagement Scale), a 5-item Likert scale ranging from 1 to 7, resulting in 4 positions that describe the psychological readiness to be active in one's own health management, and a series of ad hoc items intended to measure citizens' perceived susceptibility and severity of the disease, orientation towards health management, trust in institutional bodies, health habits and food consumption. To investigate the relationship between health engagement and these variables, ANOVA analysis, logistic regression and contingency tables with Pearson's chi-squared analysis have been carried out. Results Less engaged people show higher levels of perceived susceptibility to the virus and severity of the disease; they are less trustful of scientific and healthcare authorities, they feel less self-effective in managing their own health-both in normal conditions and under stress-and are less prone to cooperate with healthcare professionals. Low levels of health engagement also are associated with a change in the usual purchase behavior. Conclusions The Patient Health Engagement model (PHE) provides a useful framework for understanding how people will respond to health threats such as pandemics. Therefore, intervention studies should focus on raising their levels of engagement to increase the effectiveness of educational initiatives intended to promote preventive behaviors.	[Graffigna, Guendalina; Barello, Serena; Savarese, Mariarosaria; Palamenghi, Lorenzo; Castellini, Greta] Univ Cattolica Sacro Cuore, Consumer Food & Hlth Engagement Res Ctr, EngageMinds HUB, Milan, Italy; [Graffigna, Guendalina; Barello, Serena; Lozza, Edoardo] Univ Cattolica Sacro Cuore, Dept Psychol, Milan, Italy; [Graffigna, Guendalina; Savarese, Mariarosaria; Palamenghi, Lorenzo; Castellini, Greta] Univ Cattolica Sacro Cuore, Fac Agr Nutr & Environm Sci, Milan, Italy; [Bonanomi, Andrea] Univ Cattolica Sacro Cuore, Dept Stat Sci, Milan, Italy	Catholic University of the Sacred Heart; Catholic University of the Sacred Heart; Catholic University of the Sacred Heart; Catholic University of the Sacred Heart	Barello, S (corresponding author), Univ Cattolica Sacro Cuore, Consumer Food & Hlth Engagement Res Ctr, EngageMinds HUB, Milan, Italy.; Barello, S (corresponding author), Univ Cattolica Sacro Cuore, Dept Psychol, Milan, Italy.	serena.barello@unicatt.it	Lozza, Edoardo/H-3197-2019; Barello, Serena/ABD-6168-2020; Palamenghi, Lorenzo/ABB-6320-2020	Lozza, Edoardo/0000-0002-3486-4187; Barello, Serena/0000-0002-8514-2563; Palamenghi, Lorenzo/0000-0002-8222-3915	Fondazione Cariplo & Regione Lombardia	Fondazione Cariplo & Regione Lombardia(Fondazione CariploRegione Lombardia)	This study was conducted within the CRAFT project, funded by Fondazione Cariplo & Regione Lombardia.	Addo PC, 2020, SERV IND J, V40, P471, DOI 10.1080/02642069.2020.1751823; Aills L, 2008, SURG OBES RELAT DI S, V4, pS73; Al-Tannir M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2806-y; Allisy A., 1993, J INT COMMISSION RAD, V26, DOI 10.1093/jicru/ndq001; Andrich, 2014, RASCH MEASUREMENT T, V28, P1475; Andrich D., 2000, RUMM WINDOWS BASED I; [Anonymous], 2001, LISREL 8 ANAL LINEAR; [Anonymous], 2017, JAP CLASS ES CANC, V14, P1, DOI [DOI 10.1007/s10388-016-0551-7, DOI 10.1093/GERONT/GNY014]; [Anonymous], 2013, CENTRAL BANK REPORT, V25, P30; Balinska Marta, 2009, PLoS Curr, V1, pRRN1037; Balkhy HH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-42; Barello S, 2020, EUR J EPIDEMIOL, V35, P781, DOI 10.1007/s10654-020-00670-z; Barello S, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113129; Barello S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051741; Barello S, 2012, NURS RES PRACT, V2012, DOI 10.1155/2012/905934; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Bonanomi A., 2012, ELECT J APPL STAT AN, V3, P75, DOI [10.1285/i2037-3627v3n1p75, DOI 10.1285/I2037-3627V3N1P75]; Bonanomi A, 2015, QUAL QUANT, V49, P941, DOI 10.1007/s11135-014-0114-8; Brug J, 2004, EMERG INFECT DIS, V10, P1486, DOI 10.3201/eid1008.040283; Brug J, 2009, INT J BEHAV MED, V16, P3, DOI 10.1007/s12529-008-9000-x; Bults M, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-2, 10.1186/1471-2458-11-165]; Cao JL, 2020, CLIN INFECT DIS, V71, P748, DOI 10.1093/cid/ciaa243; Cao JL, 2020, INTENS CARE MED, V46, P851, DOI 10.1007/s00134-020-05987-7; Chapman GB, 1999, PREV MED, V29, P249, DOI 10.1006/pmed.1999.0535; Coulter A, 2012, J AMBUL CARE MANAG, V35, P80, DOI 10.1097/JAC.0b013e318249e0fd; Cowling BJ, 2010, J INFECT DIS, V202, P867, DOI 10.1086/655811; de Krom MPMM, 2010, APPETITE, V55, P671, DOI 10.1016/j.appet.2010.09.022; de Zwart O, 2009, INT J BEHAV MED, V16, P30, DOI 10.1007/s12529-008-9008-2; Delacre M, 2019, INT REV SOC PSYCHOL, V32, DOI 10.5334/irsp.198; F J., 1994, RISK ANAL; Fenichel EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058249; Fenichel EP, 2011, P NATL ACAD SCI USA, V108, P6306, DOI 10.1073/pnas.1011250108; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Fischhoff B, 2004, RISK ANAL, V24, P1301, DOI 10.1111/j.0272-4332.2004.00527.x; Fowles JB, 2009, PATIENT EDUC COUNS, V77, P116, DOI 10.1016/j.pec.2009.02.018; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Gliem J., 2003, MIDWEST RES TO PRACT; Godoy P, 2012, PREV MED, V54, P434, DOI 10.1016/j.ypmed.2012.04.009; Golubinski V, 2020, PATIENT EDUC COUNS, V103, P2061, DOI 10.1016/j.pec.2020.05.005; Goodwin R, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-166; Graffigna G, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114167; Graffigna G, 2018, PATIENT PREFER ADHER, V12, P1261, DOI 10.2147/PPA.S145646; Graffigna G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179865; Graffigna G, 2017, PATIENT EDUC COUNS, V100, P1918, DOI 10.1016/j.pec.2017.05.033; Graffigna G, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00274; Griffin RJ, 1999, ENVIRON RES, V80, pS230, DOI 10.1006/enrs.1998.3940; Gruman J, 2010, PATIENT EDUC COUNS, V78, P350, DOI 10.1016/j.pec.2010.02.002; Gstraunthaler T, 2008, BRIT FOOD J, V110, P260, DOI 10.1108/00070700810858673; HABERMAN SJ, 1973, BIOMETRICS, V29, P205, DOI 10.2307/2529686; Harvey L, 2012, PATIENT EDUC COUNS, V88, P338, DOI 10.1016/j.pec.2012.02.005; Hibbard JH, 2010, PATIENT EDUC COUNS, V78, P377, DOI 10.1016/j.pec.2009.12.015; Hill AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063450; Ibuka Y, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-296; Jin Y, 2012, J PUBLIC RELAT RES, V24, P266, DOI 10.1080/1062726X.2012.676747; Jones JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008032; Jribi S, 2020, ENVIRON DEV SUSTAIN, V22, P3939, DOI 10.1007/s10668-020-00740-y; Kamate SK, 2010, J INFECT DEV COUNTR, V4, P7, DOI 10.3855/jidc.501; Kass NE, 2008, BIOSECUR BIOTERROR, V6, P227, DOI 10.1089/bsp.2008.0020; Kondylakis H, 2020, J BIOMED INFORM, V101, DOI 10.1016/j.jbi.2019.103342; Kristiansen IS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-48; Laforge RG, 1999, PREV MED, V28, P349, DOI 10.1006/pmed.1998.0429; Lau JTF, 2011, EPIDEMIOL INFECT, V139, P80, DOI 10.1017/S0950268810001925; Leppin A, 2009, INT J BEHAV MED, V16, P7, DOI 10.1007/s12529-008-9002-8; Lubetkin EI, 2010, J HEALTH CARE POOR U, V21, P796, DOI 10.1353/hpu.0.0350; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Magallares A, 2017, PSICOTHEMA, V29, P408, DOI 10.7334/psicothema2017.75; McCauley M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1116; McDonald EM, 2013, J COMMUN HEALTH, V38, P301, DOI 10.1007/s10900-012-9615-3; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Muzzatti S., 2005, ILLNESS CRISIS LOSS, V13, P117, DOI [DOI 10.1177/105413730501300203, 10.1177/105413730501300203]; Nania T, 2021, INT J SOC PSYCHIATR, V67, P102, DOI 10.1177/0020764020945729; Pekonen A, 2020, PATIENT EDUC COUNS, V103, P777, DOI 10.1016/j.pec.2019.10.019; Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016460; Prieto Luis, 2003, Health Qual Life Outcomes, V1, P27, DOI 10.1186/1477-7525-1-27; Ritvo P, 2005, NAT MED, V11, pS20, DOI 10.1038/nm1220; Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651; Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004; Tooher R, 2013, INFLUENZA OTHER RESP, V7, P1316, DOI 10.1111/irv.12103; Tzeng HM, 2017, PATIENT PREFER ADHER, V11, P181, DOI 10.2147/PPA.S127519; Usta D, 2019, CUKUROVA MED J, V44, P1055, DOI 10.17826/cumj.482420; Vartti AM, 2009, INT J BEHAV MED, V16, P41, DOI 10.1007/s12529-008-9004-6; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Woehrle H, 2018, SLEEP MED, V41, P20, DOI 10.1016/j.sleep.2017.07.026; Wright BD, 1982, ADV MEASUREMENT ED R; Wright BD., 1994, RASCH MEASUREMENT T, V8, P370, DOI DOI 10.1177/01461672012710004; Zhang YY, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00104; Zhang Y, 2020, HUM ECOL RISK ASSESS, V26, P190, DOI 10.1080/10807039.2018.1503931	89	23	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238613	10.1371/journal.pone.0238613	http://dx.doi.org/10.1371/journal.pone.0238613			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9MU	32915822	Green Published, Green Submitted, gold			2022-12-26	WOS:000571887500049
J	Yue, YL; Wang, Z; Tian, L; Zhao, JC; Lai, ZZ; Ji, GX; Xia, HB				Yue, Yanlin; Wang, Zheng; Tian, Li; Zhao, Jincai; Lai, Zhizhu; Ji, Guangxing; Xia, Haibin			Modeling the spatiotemporal dynamics of industrial sulfur dioxide emissions in China based on DMSP-OLS nighttime stable light data	PLOS ONE			English	Article							URBAN-POPULATION; URBANIZATION DYNAMICS; ECONOMIC-ACTIVITY; CARBON EMISSIONS; DRIVING FORCES; CO2 EMISSIONS; AIR-QUALITY; TIME-SERIES; CONSUMPTION; IMAGERY	Due to the rapid economic growth and the heavy reliance on fossil fuels, China has become one of the countries with the highest sulfur dioxide (SO2) emissions, which pose a severe challenge to human health and the sustainable development of social economy. In order to cope with the serious problem of SO(2)pollution, this study attempts to explore the spatial temporal variations of industrial SO(2)emissions in China utilizing the Defense Meteorological Satellite Program's Operational Linescan System (DMSP-OLS) nighttime stable light (NSL) data. We first explored the relationship between the NSL data and the statistical industrial SO(2)emissions at the provincial level, and confirmed that there was a positive correlation between these two datasets. Consequently, 17 linear regression models were established based on the NSL data and the provincial statistical emissions to model the spatial-temporal dynamics of China's industrial SO(2)emissions from 1997 to 2013. Next, the NSL-based estimated results were evaluated utilizing the prefectural statistical industrial SO(2)emissions and emission inventory data, respectively. Finally, the distribution of China's industrial SO(2)emissions at 1 km spatial resolution were estimated, and the temporal and spatial dynamics were explored from multiple scales (national scale, regional scale and scale of urban agglomeration). The results show that: (1) The NSL data can be successfully applied to estimate the dynamic changes of China's industrial SO(2)emissions. The coefficient of determination (R-2) values of the NSL-based estimation results in most years were greater than 0.6, and the relative error (RE) values were less than 10%, when validated by the prefectural statistical SO(2)emissions. Moreover, compared with the inventory emissions, the adjusted coefficient of determination (Adj.R-Square) reached 0.61, with the significance at the 0.001 level. (2) During the observation period, the temporal and spatial dynamics of industrial SO(2)emissions varied greatly in different regions. The high growth type was largely distributed in China's Western region, Central region, and Shandong Peninsula, while the no-obvious-growth type was concentrated in Western region, Beijing-Tianjin-Tangshan and Middle south of Liaoning. The high grade of industrial SO(2)emissions was mostly concentrated in China's Eastern region, Western region, Shanghai-Nanjing-Hangzhou and Shandong Peninsula, while the low grade mainly concentrated in China's Western region, Middle south of Liaoning and Beijing-Tianjin-Tangshan. These results of our research can not only enhance the understanding of the spatial-temporal dynamics of industrial SO(2)emissions in China, but also offer some scientific references for formulating feasible industrial SO(2)emission reduction policies.	[Yue, Yanlin; Wang, Zheng; Lai, Zhizhu; Ji, Guangxing; Xia, Haibin] East China Normal Univ, Key Lab Geog Informat Sci, Minist Educ, Shanghai, Peoples R China; [Wang, Zheng] Chinese Acad Sci, Inst Sci & Dev, Beijing, Peoples R China; [Tian, Li] East China Normal Univ, Jinan Expt Sch, Jinan, Shandong, Peoples R China; [Zhao, Jincai] Henan Normal Univ, Sch Business, Xinxiang, Henan, Peoples R China	East China Normal University; Chinese Academy of Sciences; East China Normal University; Henan Normal University	Wang, Z (corresponding author), East China Normal Univ, Key Lab Geog Informat Sci, Minist Educ, Shanghai, Peoples R China.; Wang, Z (corresponding author), Chinese Acad Sci, Inst Sci & Dev, Beijing, Peoples R China.	wangzheng@casipm.ac.cn			National Key Research and Development Program of China [2016YFA0602703]; National Natural Science Foundation of China [41671396]; Natural Science Foundation of Shanghai, China [19ZR1415200]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai, China(Natural Science Foundation of Shanghai)	This work was supported by National Key Research and Development Program of China [Grant Number: 2016YFA0602703], National Natural Science Foundation of China [Grant Number: 41671396], and Natural Science Foundation of Shanghai, China [Grant Number: 19ZR1415200].	Amaral S, 2006, INT J REMOTE SENS, V27, P855, DOI 10.1080/01431160500181861; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; Brandt P, 2019, ACS APPL MATER INTER, V11, P17350, DOI 10.1021/acsami.9b00029; Cui XL, 2019, PHYS CHEM EARTH, V110, P89, DOI 10.1016/j.pce.2019.01.007; Doll CNH, 2006, ECOL ECON, V57, P75, DOI 10.1016/j.ecolecon.2005.03.007; Doll CNH, 2000, AMBIO, V29, P157, DOI 10.1639/0044-7447(2000)029[0157:NTIAAT]2.0.CO;2; Elvidge CD, 1997, INT J REMOTE SENS, V18, P1373, DOI 10.1080/014311697218485; Ge C, 2016, J GEOPHYS RES-ATMOS, V121, P3446, DOI 10.1002/2015JD023134; Ghosh T, 2010, ENERGIES, V3, P1895, DOI 10.3390/en3121895; Grandey BS, 2018, GEOPHYS RES LETT, V45, P11318, DOI 10.1029/2018GL080127; Greenpeace India, 2019, GLOB SO2 EM HOTSP DA; He CY, 2014, INT J DIGIT EARTH, V7, P993, DOI 10.1080/17538947.2013.822026; Hoesly RM, 2018, GEOSCI MODEL DEV, V11, P369, DOI 10.5194/gmd-11-369-2018; Huang M, 2011, ATMOS CHEM PHYS, V11, P3173, DOI 10.5194/acp-11-3173-2011; Huang M, 2020, J GEOPHYS RES-ATMOS, V125, DOI 10.1029/2019JD030818; Jeong JI, 2013, ATMOS ENVIRON, V69, P46, DOI 10.1016/j.atmosenv.2012.11.061; Ji GX, 2019, J CLEAN PROD, V209, P363, DOI 10.1016/j.jclepro.2018.10.285; Ji GX, 2018, ATMOS ENVIRON, V191, P132, DOI 10.1016/j.atmosenv.2018.07.045; Jiang JH, 2016, SCI TOTAL ENVIRON, V544, P1119, DOI 10.1016/j.scitotenv.2015.11.113; Letu H, 2010, INT J REMOTE SENS, V31, P4443, DOI 10.1080/01431160903277464; Lewis JR, 2012, POMEGRANATE, V14, P128, DOI 10.1558/pome.v14i1.128; Li M, 2017, ATMOS CHEM PHYS, V17, P935, DOI 10.5194/acp-17-935-2017; Li QT, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8070578; Li RY, 2015, ATMOSPHERE-BASEL, V6, P607, DOI 10.3390/atmos6050607; Li XM, 2018, SCI TOTAL ENVIRON, V643, P1248, DOI 10.1016/j.scitotenv.2018.06.244; [李宗光 Li Zongguang], 2016, [国土资源遥感, Remote Sensing for Land & Resources], V28, P168; LIKENS GE, 1974, SCIENCE, V184, P1171; Lin M, 2008, ATMOS ENVIRON, V42, P5956, DOI 10.1016/j.atmosenv.2008.03.039; Ma T, 2012, REMOTE SENS ENVIRON, V124, P99, DOI 10.1016/j.rse.2012.04.018; Meng B, 2013, ENERG POLICY, V61, P1305, DOI 10.1016/j.enpol.2013.05.108; Meng LN, 2014, ENERGY, V71, P468, DOI 10.1016/j.energy.2014.04.103; Ministry of Ecology and Environment PRC, 2018, BACKGR MAT CHIN EC B; Ministry of Ecology and Environment PRC, 2015, B NAT ENV STAT; Ronald JV, 2017, ATMOS CHEM PHYS, V17, P1775, DOI 10.5194/acp-17-1775-2017; Shi KF, 2016, APPL ENERG, V184, P450, DOI 10.1016/j.apenergy.2016.10.032; Smith SJ, 2005, CLIMATIC CHANGE, V73, P267, DOI 10.1007/s10584-005-6887-y; Streets DG, 2000, ATMOS ENVIRON, V34, P4413, DOI 10.1016/S1352-2310(00)00187-4; Su SS, 2011, ENVIRON SCI TECHNOL, V45, P8403, DOI 10.1021/es201656f; Su YX, 2014, RENEW SUST ENERG REV, V35, P231, DOI 10.1016/j.rser.2014.04.015; The State Council PRC, 2018, CIRC STAT COUNC ISS; Toenges-Schuller N, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006068; Tripathy BR, 2017, IEEE SENS J, V17, P1013, DOI 10.1109/JSEN.2016.2640181; Wu JS, 2013, REMOTE SENS ENVIRON, V134, P111, DOI 10.1016/j.rse.2013.03.001; Xie H. L., 2012, J GEOGR SCI, V67, P889; Xu WJ, 2018, ENVIRON POLLUT, V242, P90, DOI 10.1016/j.envpol.2018.06.089; Xu Z, 2015, ATMOSPHERE-BASEL, V6, P1507, DOI 10.3390/atmos6101507; Xue J, 2015, ANN REPORT CHINAS LO; Yang ZR, 2018, FUEL PROCESS TECHNOL, V177, P101, DOI 10.1016/j.fuproc.2018.04.024; Yu SS, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10020194; Yuan R, 2018, ENERG POLICY, V119, P97, DOI 10.1016/j.enpol.2018.04.027; Yue WZ, 2014, REMOTE SENS-BASEL, V6, P7260, DOI 10.3390/rs6087260; Yue YL, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12071151; Zeng BH, 2019, RESOUR CONSERV RECY, V142, P204, DOI 10.1016/j.resconrec.2018.12.002; Zhang Q, 2012, NATURE, V484, P161, DOI 10.1038/484161a; Zhang QL, 2011, REMOTE SENS ENVIRON, V115, P2320, DOI 10.1016/j.rse.2011.04.032; Zhao JC, 2019, APPL ENERG, V235, P612, DOI 10.1016/j.apenergy.2018.09.180; Zhao M, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10010047; Zhao NZ, 2012, INT J REMOTE SENS, V33, P6304, DOI 10.1080/01431161.2012.684076; Zhong QR, 2020, ENVIRON SCI TECHNOL, V54, P6508, DOI 10.1021/acs.est.9b07696	59	1	1	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238696	10.1371/journal.pone.0238696	http://dx.doi.org/10.1371/journal.pone.0238696			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911520	gold, Green Published			2022-12-26	WOS:000571885900042
J	Bechard, LE; McDougall, A; Mitchell, C; Regan, K; Bergelt, M; Dupuis, S; Giangregorio, L; Freeman, S; Middleton, LE				Bechard, Lauren E.; McDougall, Aidan; Mitchell, Cheyenne; Regan, Kayla; Bergelt, Maximillian; Dupuis, Sherry; Giangregorio, Lora; Freeman, Shannon; Middleton, Laura E.			Dementia- and mild cognitive impairment-inclusive exercise: Perceptions, experiences, and needs of community exercise providers	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; OLDER-ADULTS; ALZHEIMERS-DISEASE; PEOPLE; FACILITATORS; METAANALYSIS; MOBILITY; STRENGTH; BARRIERS; FITNESS	Purpose For persons who are at risk for, or living with, dementia exercise is recommended, yet many become or remain inactive. Exercise providers play a vital role in promoting and facilitating exercise in these groups by recognizing and being responsive to the needs of persons with mild cognitive impairment (MCI) or dementia in exercise programming. The objective of this study was to explore the experiences, perceptions, and needs of community exercise providers regarding dementia. Materials & methods Five focus groups were held with community exercise providers (n = 30) who deliver exercise to older adults (>= 55 years) in municipal, non-profit, for profit, or academic settings. Results Three themes were developed: (1)Unique experiences and diverse perceptions: suggests unique personal experiences with MCI and dementia inform distinct perceptions of dementia; (2)Dementia-Inclusive Practices:learning as you go and adapting for the individual: reflects exercise providers' approaches to recognizing and accommodating individuals' unique abilities and preferences; (3)Training and Best Practices,with Flexibility: identifies exercise providers' desires for MCI- and dementia-specific knowledge and training strategies, which need to recognize dementia heterogeneity between and within persons over time. Conclusions These findings highlight a willingness of exercise providers to support dementia-inclusive exercise, but recognize they have minimal training and lack educational resources to do so. Formal training resources may enhance exercise accessibility and participation for persons with MCI or dementia.	[Bechard, Lauren E.; McDougall, Aidan; Mitchell, Cheyenne; Regan, Kayla; Bergelt, Maximillian; Giangregorio, Lora; Middleton, Laura E.] Univ Waterloo, Fac Appl Hlth Sci, Dept Kinesiol, Waterloo, ON, Canada; [Dupuis, Sherry] Univ Waterloo, Fac Appl Hlth Sci, Dept Recreat & Leisure Studies, Waterloo, ON, Canada; [Freeman, Shannon] Univ Northern British Columbia, Sch Nursing, Prince George, BC, Canada	University of Waterloo; University of Waterloo; University of Northern British Columbia	Bechard, LE (corresponding author), Univ Waterloo, Fac Appl Hlth Sci, Dept Kinesiol, Waterloo, ON, Canada.	lauren.bechard@uwaterloo.ca	Middleton, Laura/ABG-8940-2021	Bechard, Lauren/0000-0001-6428-2340	Royal Bank of Canada Undergraduate Research Fellowship; Hallman Undergraduate Research Fellowship; Canadian Institutes for Health Research [01881-000]; University of Waterloo Chronic Disease Prevention Initiative	Royal Bank of Canada Undergraduate Research Fellowship; Hallman Undergraduate Research Fellowship; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); University of Waterloo Chronic Disease Prevention Initiative	This work was supported by: (1) the Royal Bank of Canada Undergraduate Research Fellowship (CM) - https://www.rbc.com/dms/enterprise/scholarships.html (2) the Hallman Undergraduate Research Fellowship (AM) -https://uwaterloo.ca/applied-health-sciences/faculty-staff/research-funding/hallman-undergraduateresearch-fellowship (3) the Canadian Institutes for Health Research (grant #01881-000) (LM) https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=378492&lang=en (4) the University of Waterloo Chronic Disease Prevention Initiative (LM) -https://uwaterloo.ca/propel/The sponsors/funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers MW, 2015, ALZHEIMERS DEMENT, V11, P70, DOI 10.1016/j.jalz.2014.04.514; Alzheimer's Disease International, 2015, WORLD ALZHEIMER REPO; [Anonymous], 2016, NAT NANOTECHNOL, V11, P1, DOI 10.1038/nnano.2015.333; Armstrong R, 2015, OPHTHAL PHYSL OPT, V35, P352, DOI 10.1111/opo.12220; Bechard, 2017, PHYS ACTIVITY PARTIC; Bechard LE, 2020, APPL PHYSIOL NUTR ME; Blankevoort CG, 2010, DEMENT GERIATR COGN, V30, P392, DOI 10.1159/000321357; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Cedervall Y, 2015, AGING MENT HEALTH, V19, P679, DOI 10.1080/13607863.2014.962004; Centres for Disease Control, 2019, INCR PHYS ACT AD DIS; Chertkow H, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt198; Cohen-Mansfield J, 2000, ALZ DIS ASSOC DIS, V14, P60, DOI 10.1097/00002093-200004000-00002; Forbes D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006489.pub4; Franco MR, 2015, BRIT J SPORT MED, V49, P1268, DOI 10.1136/bjsports-2014-094015; Hesseberg K, 2016, J AGING PHYS ACTIV, V24, P92, DOI 10.1123/japa.2014-0202; Heyn PC, 2008, J NUTR HEALTH AGING, V12, P401, DOI 10.1007/BF02982674; Hobson N, 2020, J AGING PHYS ACTIV, V28, P208, DOI 10.1123/japa.2019-0010; Jensen LE, 2011, AM J OCCUP THER, V65, P532, DOI 10.5014/ajot.2011.002626; Jia RX, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1175-2; Karuncharernpanit S, 2016, INT J OLDER PEOPLE N, V11, P166, DOI 10.1111/opn.12091; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Lindelof N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188225; Malthouse R, 2014, PHYSIOTHERAPY, V100, P169, DOI 10.1016/j.physio.2013.10.002; McDuff J, 2015, GLOB QUALIT NURS RES, V2, DOI 10.1177/2333393615605116; McKeith I, 2004, LANCET NEUROL, V3, P19, DOI 10.1016/S1474-4422(03)00619-7; Moore A, 2014, CAN FAM PHYSICIAN, V60, P433; Nagamatsu LS, 2012, ARCH INTERN MED, V172, P666, DOI 10.1001/archinternmed.2012.379; National Centre on Health Physical Activity and Disability, 2019, BUILD HLTH INCL COMM; O'Connell ME, 2015, J AGING PHYS ACTIV, V23, P112, DOI [10.1123/japa.2013-0035, 10.1123/JAPA.2013-0035]; Onwuegbuzie AJ, 2007, QUAL REP, V12, P238; Ovenden I, 2016, DEMENTIA, V18, P785, DOI 10.1177/1471301216675988; Petersen Jindong Ding, 2018, Alzheimers Dement (Amst), V10, P421, DOI 10.1016/j.dadm.2018.05.004; Petersen RC, 2018, NEUROLOGY, V90, P126, DOI 10.1212/WNL.0000000000004826; Phinney A, 2007, AGING MENT HEALTH, V11, P384, DOI 10.1080/13607860601086470; Pitkala K, 2013, EXP GERONTOL, V48, P85, DOI 10.1016/j.exger.2012.08.008; Roland KP, 2015, AM J ALZHEIMERS DIS, V30, P559, DOI 10.1177/1533317515576389; Shenton A.K., 2004, ED INF, V22, P63, DOI DOI 10.3233/EFI-2004-22201; Strohle A, 2015, AM J GERIAT PSYCHIAT, V23, P1234, DOI 10.1016/j.jagp.2015.07.007; United Nations Convention on the Rights of Persons with Disabilities (UNCRPD), 2006, CONV RIGHTS PERS DIS; van Alphen HJM, 2016, ARCH GERONTOL GERIAT, V66, P109, DOI 10.1016/j.archger.2016.05.008; Zhang Y, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15122791; Zheng GH, 2016, BRIT J SPORT MED, V50, P1443, DOI 10.1136/bjsports-2015-095699	43	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238187	10.1371/journal.pone.0238187	http://dx.doi.org/10.1371/journal.pone.0238187			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ6EE	32898193	Green Published, gold			2022-12-26	WOS:000570962500023
J	Shultana, R; Zuan, ATK; Yusop, MR; Saud, HM				Shultana, Rakiba; Zuan, Ali Tan Kee; Yusop, Mohd Rafii; Saud, Halimi Mohd			Characterization of salt-tolerant plant growth-promoting rhizobacteria and the effect on growth and yield of saline-affected rice	PLOS ONE			English	Article							STRESS; EXOPOLYSACCHARIDES; BACTERIA; AMELIORATION; ANTIOXIDANTS; AGGREGATION; ENHANCEMENT; RHIZOSPHERE; BIOCONTROL; SELECTION	In this study, we characterized, identified, and determined the effect of salt-tolerant PGPR isolated from coastal saline areas on rice growth and yield. A total of 44 bacterial strains were isolated, and 5 were found to be tolerant at high salt concentration. These isolates were further characterized for salinity tolerance and beneficial traits through a series of quantitative tests. Biochemical characterization showed that bacterial survivability decreases gradually with the increase of salt concentration. One of the strains, UPMRB9, produced the highest amount of exopolysaccharides when exposed to 1.5M of NaCl. Moreover, UPMRB9 absorbed the highest amount of sodium from the 1.5M of NaCl-amended media. The highest floc yield and biofilm were produced by UPMRE6 and UPMRB9 respectively, at 1M of NaCl concentration. The SEM observation confirmed the EPS production of UPMRB9 and UPMRE6 at 1.5M of NaCl concentration. These two isolates were identified asBacillus tequilensisandBacillus aryabhattaibased on the 16S rRNA gene sequence. The functional group characterization of EPS showed the presence of hydroxyl, carboxyl, and amino groups. This corresponded to the presence of carbohydrates and proteins in the EPS and glucose was identified as the major type of carbohydrate. The functional groups of EPS can help to bind and chelate Na(+)in the soil and thereby reduces the plant's exposure to the ion under saline conditions. The plant inoculation study revealed significant beneficial effects of bacterial inoculation on photosynthesis, transpiration, and stomatal conductance of the plant which leads to a higher yield. TheBacillus tequilensisandBacillus aryabhattaistrains showed good potential as PGPR for salinity mitigation practice for coastal rice cultivation.	[Shultana, Rakiba; Zuan, Ali Tan Kee] Univ Putra Malaysia, Fac Agr, Dept Land Management, Serdang, Selangor, Malaysia; [Shultana, Rakiba] Bangladesh Rice Res Inst, Agron Div, Gazipur, Bangladesh; [Yusop, Mohd Rafii] Univ Putra Malaysia, Fac Agr, Dept Crop Sci, Serdang, Selangor, Malaysia; [Yusop, Mohd Rafii] Univ Putra Malaysia, Inst Trop Agr & Food Secur, Serdang, Selangor, Malaysia; [Saud, Halimi Mohd] Univ Putra Malaysia, Fac Agr, Dept Agr Technol, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Bangladesh Rice Research Institute (BRRI); Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Zuan, ATK (corresponding author), Univ Putra Malaysia, Fac Agr, Dept Land Management, Serdang, Selangor, Malaysia.	tkz@upm.edu.my	Zuan, Ali Tan Kee/AAU-4242-2021	Zuan, Ali Tan Kee/0000-0003-0473-4303	Organization for Women in Science for the Developing World (OWSD); Swedish International Development Cooperation Agency (SIDA); Universiti Putra Malaysia (UPM) [GP-IPS/2018/9611100, GP-IPM/2017/9565900]	Organization for Women in Science for the Developing World (OWSD); Swedish International Development Cooperation Agency (SIDA); Universiti Putra Malaysia (UPM)	The authors thankfully acknowledged the cordial assistance of all the laboratory staff of Department of Land Management, Faculty of Agriculture, Universiti Putra Malaysia. Our heartfelt thanks go to the Organization for Women in Science for the Developing World (OWSD) and Swedish International Development Cooperation Agency (SIDA) for the fellowship award to the First Author. We thankfully admit the financial support received from the project grants (GP-IPS/2018/9611100) and (GP-IPM/2017/9565900) from Universiti Putra Malaysia (UPM) for conducting this research. The funders had no role in study design, data collection, and analysis, decision to publish or preparation of the manuscript.	Abbas R, 2019, J KING SAUD UNIV SCI, V31, P1195, DOI 10.1016/j.jksus.2019.02.019; Ahanger MA, 2017, PHYSIOL MOL BIOL PLA, V23, P731, DOI 10.1007/s12298-017-0462-7; Ahmad M, 2012, ANN MICROBIOL, V62, P1321, DOI 10.1007/s13213-011-0380-9; Arora M, 2010, J ENVIRON BIOL, V31, P701; Bahat-Samet E, 2004, FEMS MICROBIOL LETT, V237, P195, DOI [10.1111/j.1574-6968.2004.tb09696.x, 10.1016/j.femsle.2004.06.036]; Bhattacharyya C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00411; Cardinale M, 2015, MICROBIOL RES, V181, P22, DOI 10.1016/j.micres.2015.08.002; Chandrasekaran M, 2014, MYCORRHIZA, V24, P611, DOI 10.1007/s00572-014-0582-7; Chen Y, 2013, ENVIRON MICROBIOL, V15, P848, DOI 10.1111/j.1462-2920.2012.02860.x; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Damodaran T, 2019, AGR RES, V8, P36, DOI 10.1007/s40003-018-0343-5; Damodaran T., 2013, African Journal of Microbiology Research, V7, P5082; Dawwam G. E., 2013, Annals of Agricultural Science (Cairo), V58, P195, DOI 10.1016/j.aoas.2013.07.007; del Amor FM, 2012, FUNCT PLANT BIOL, V39, P82, DOI 10.1071/FP11173; Dodd IC, 2012, J EXP BOT, V63, P3415, DOI 10.1093/jxb/ers033; Egamberdieva D, 2009, BIOL FERT SOILS, V45, P563, DOI 10.1007/s00374-009-0366-y; Etesami H., 2017, PROBIOTICS PLANT HLT, P163, DOI [10.1007/978-981-10-3473-2_7, DOI 10.1007/978-981-10-3473-2_7]; Ghosh D, 2019, WORLD J MICROB BIOT, V35, DOI 10.1007/s11274-019-2659-0; Gupta P.K., 2007, SOIL PLANT WATER FER; Havasi V, 2008, J CYST FIBROS, V7, P267, DOI 10.1016/j.jcf.2007.11.009; Infection and Inflammation Radiology Professional Committee of China Research Hospital Association Infection ( Infectious Diseases) Imaging Working Committee of China STD/AIDS Prevention Association Infectious Diseases Group of Chinese Medical Association Radiology Branch etc., 2020, CHINA MED IMAGING TE, V36, P1; Kang SM, 2014, J PLANT INTERACT, V9, P673, DOI 10.1080/17429145.2014.894587; Kang SM, 2009, BIOTECHNOL LETT, V31, P277, DOI 10.1007/s10529-008-9867-2; Kumar H, 1999, SYMBIOSIS, V26, P279; Majeed A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00198; Masutomi Y, 2009, AGR ECOSYST ENVIRON, V131, P281, DOI 10.1016/j.agee.2009.02.004; Nunkaew T, 2015, CARBOHYD POLYM, V115, P334, DOI 10.1016/j.carbpol.2014.08.099; Qin QQ, 2011, J FOOD SCI, V76, pC1226, DOI 10.1111/j.1750-3841.2011.02397.x; Qin Y, 2016, BIOTECHNOL ADV, V34, P1245, DOI 10.1016/j.biotechadv.2016.08.005; Qurashi AW, 2012, BRAZ J MICROBIOL, V43, P1183, DOI [10.1590/S1517-83822012000300046, 10.1590/S1517-838220120003000046]; Qurashi AW, 2011, AFR J MICROBIOL RES, V5, P3546; Rasool S, 2013, ACTA PHYSIOL PLANT, V35, P1039, DOI 10.1007/s11738-012-1142-4; Richardson AE, 2009, PLANT SOIL, V321, P305, DOI 10.1007/s11104-009-9895-2; SADASIVAN L, 1985, J BACTERIOL, V163, P716, DOI 10.1128/JB.163.2.716-723.1985; Satpute SK, 2010, BIOTECHNOL ADV, V28, P436, DOI 10.1016/j.biotechadv.2010.02.006; Selamat A., 2008, T MALAYS SOC PLANT P, V17, P20; Singh K, 2016, LAND DEGRAD DEV, V27, P706, DOI 10.1002/ldr.2385; Singh R, 2016, FRONT PLANT SCI, V7, P1, DOI 10.3389/fpls.2016.01299; Singh RP, 2015, J PLANT PHYSIOL, V184, P57, DOI 10.1016/j.jplph.2015.07.002; Soldan R, 2019, MICROBIOL RES, V223, P33, DOI 10.1016/j.micres.2019.03.008; Tan K. Z., 2015, Australian Journal of Crop Science, V9, P1257; Tan K. Z., 2014, American Journal of Agricultural and Biological Sciences, V9, P342, DOI 10.3844/ajabssp.2014.342.360; TENNEY MARK W., 1965, J WATER POLLUT CONTR FED, V37, P1370; Tewari S, 2014, CURR MICROBIOL, V69, P484, DOI 10.1007/s00284-014-0612-x; Upadhyay SK, 2011, PEDOSPHERE, V21, P214, DOI 10.1016/S1002-0160(11)60120-3; Vaishnav A, 2019, J PLANT GROWTH REGUL, V38, P650, DOI 10.1007/s00344-018-9880-1; Van VT, 2000, PLANT SOIL, V218, P273, DOI 10.1023/A:1014986916913; Verhoef R, 2003, CARBOHYD RES, V338, P1851, DOI 10.1016/S0008-6215(03)00261-1; Vurukonda SSKP, 2016, MICROBIOL RES, V184, P13, DOI 10.1016/j.micres.2015.12.003; Watanabe M, 2003, J BIOSCI BIOENG, V95, P374, DOI 10.1016/S1389-1723(03)80070-1; Yahya Awang, 2009, American Journal of Agricultural and Biological Sciences, V4, P63; Yan N, 2015, INT SOIL WATER CONSE, V3, P316, DOI 10.1016/j.iswer.2015.11.003; Zhao Q, 2016, MOL PLANT MICROBE IN, V29, P774, DOI 10.1094/MPMI-03-16-0063-R	53	35	36	8	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238537	10.1371/journal.pone.0238537	http://dx.doi.org/10.1371/journal.pone.0238537			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886707	Green Accepted, gold, Green Published			2022-12-26	WOS:000571064300040
J	Briand-Mesange, F; Pons, V; Allart, S; Masquelier, J; Chicanne, G; Beton, N; Payrastre, B; Muccioli, GG; Ausseil, JM; Davignon, JL; Salles, JP; Chap, H				Briand-Mesange, Fabienne; Pons, Veronique; Allart, Sophie; Masquelier, Julien; Chicanne, Gaetan; Beton, Nicolas; Payrastre, Bernard; Muccioli, Giulio G.; Ausseil, Jerome; Davignon, Jean-Luc; Salles, Jean-Pierre; Chap, Hugues			Glycerophosphodiesterase 3 (GDE3) is a lysophosphatidylinositol-specific ectophospholipase C acting as an endocannabinoid signaling switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endocannabinoid; lysophosphatidylinositol; 2-arachidonoylglycerol; monoacylglycerol; GPR55; CB1; CB2; lysophospholipid; phospholipase C; G-protein&#8211; coupled receptor (GPCR); CB1; CB2; glycerophosphodiesterase 3 (GDE3; GDPD2)	CANNABINOID RECEPTOR; PHOSPHOLIPASE-C; CELL-SURFACE; POSSIBLE INVOLVEMENT; LYSOPHOSPHOLIPASE D; MS METHOD; 2-ARACHIDONOYLGLYCEROL; PHOSPHODIESTERASE; PROTEIN; GPR55	Endocannabinoid signaling plays a regulatory role in various (neuro)biological functions. 2-arachidonoylglycerol (2-AG) is the most abundant endocannabinoid, and although its canonical biosynthetic pathway involving phosphoinositide-specific phospholipase C and diacylglycerol lipase alpha is known, alternative pathways remain unsettled. Here, we characterize a noncanonical pathway implicating glycerophosphodiesterase 3 (GDE3, from GDPD2 gene). Human GDE3 expressed in HEK293T cell membranes catalyzed the conversion of lysophosphatidylinositol (LPI) into monoacylglycerol and inositol-1-phosphate. The enzyme was equally active against 1-acyl and 2-acyl LPI. When using 2-acyl LPI, where arachidonic acid is the predominant fatty acid, LC-MS analysis identified 2-AG as the main product of LPI hydrolysis by GDE3. Furthermore, inositol-1-phosphate release into the medium occurred upon addition of LPI to intact cells, suggesting that GDE3 is actually an ecto-lysophospholipase C. In cells expressing G-protein-coupled receptor GPR55, GDE3 abolished 1-acyl LPI-induced signaling. In contrast, upon simultaneous ex-pression of GDE3 and cannabinoid receptor CB2, 2-acyl LPI evoked the same signal as that induced by 2-AG. These data strongly suggest that, in addition to degrading the GPR55 LPI ligand, GDE3 can act as a switch between GPR55 and CB2 signaling. Coincident with a major expression of both GDE3 and CB2 in the spleen, spleens from transgenic mice lacking GDE3 displayed doubling of LPI content compared with WT mice. Decreased production of 2-AG in whole spleen was also observed, supporting the in vivo relevance of our findings. These data thus open a new research avenue in the field of endocannabinoid generation and reinforce the view of GPR55 and LPI being genuine actors of the endocannabinoid system.	[Briand-Mesange, Fabienne; Allart, Sophie; Beton, Nicolas; Ausseil, Jerome; Davignon, Jean-Luc; Salles, Jean-Pierre; Chap, Hugues] Univ Toulouse, Ctr Physiopathol Toulouse Purpan, Toulouse, France; [Briand-Mesange, Fabienne; Allart, Sophie; Beton, Nicolas; Ausseil, Jerome; Davignon, Jean-Luc; Salles, Jean-Pierre; Chap, Hugues] Natl Ctr Sci Res, Toulouse, France; [Briand-Mesange, Fabienne; Allart, Sophie; Beton, Nicolas; Ausseil, Jerome; Davignon, Jean-Luc; Salles, Jean-Pierre; Chap, Hugues] Paul Sabatier Univ, Natl Inst Hlth & Med Res, Toulouse, France; [Pons, Veronique; Chicanne, Gaetan; Payrastre, Bernard] Univ Toulouse, Inst Metab & Cardiovasc Dis, Toulouse, France; [Pons, Veronique; Chicanne, Gaetan; Payrastre, Bernard] Paul Sabatier Univ, Natl Inst Hlth & Med Res, Toulouse, France; [Masquelier, Julien; Muccioli, Giulio G.] Catholic Univ Louvain, Louvain Drug Res Inst, Bioanal & Pharmacol Bioact Lipids Res Grp, Brussels, Belgium	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Catholique Louvain	Chap, H (corresponding author), Univ Toulouse, Ctr Physiopathol Toulouse Purpan, Toulouse, France.; Chap, H (corresponding author), Natl Ctr Sci Res, Toulouse, France.; Chap, H (corresponding author), Paul Sabatier Univ, Natl Inst Hlth & Med Res, Toulouse, France.	hugues.chap@inserm.fr		BETON, Nicolas/0000-0002-5597-2267; AUSSEIL, Jerome/0000-0002-3059-9777; PONS, Veronique/0000-0001-5821-8481; SALLES, jean Pierre/0000-0002-0941-8951; Briand Mesange, Fabienne/0000-0002-2524-1762; Sophie, Allart/0000-0001-7447-2471; Muccioli, Giulio/0000-0002-1600-9259; Chap, Hugues/0000-0002-8369-3601	CNRS; Paul Sabatier University; Inserm	CNRS(Centre National de la Recherche Scientifique (CNRS)); Paul Sabatier University; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This study was funded by institutional grants fromInserm, CNRS, and Paul Sabatier University.	Alhouayek M, 2018, TRENDS PHARMACOL SCI, V39, P586, DOI 10.1016/j.tips.2018.02.011; Andradas C, 2011, ONCOGENE, V30, P245, DOI 10.1038/onc.2010.402; Aoki J, 2007, BIOCHIMIE, V89, P197, DOI 10.1016/j.biochi.2006.09.021; Aoyama C, 2019, BIOCHEM J, V476, P3721, DOI 10.1042/BCJ20190666; Arifin SA, 2016, METABOLITES, V6, DOI 10.3390/metabo6010006; Baggelaar MP, 2018, PROG LIPID RES, V71, P1, DOI 10.1016/j.plipres.2018.05.002; Bellomo A, 2020, IMMUNITY, V53, P127, DOI 10.1016/j.immuni.2020.06.008; Birrell GB, 1997, J CELL BIOCHEM, V65, P550, DOI 10.1002/(SICI)1097-4644(19970615)65:4<550::AID-JCB10>3.0.CO;2-G; BIRRELL GB, 1993, J NEUROCHEM, V60, P620, DOI 10.1111/j.1471-4159.1993.tb03193.x; Blaho VA, 2018, TRENDS PHARMACOL SCI, V39, P953, DOI 10.1016/j.tips.2018.08.006; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOETTCHER C, 1961, ANAL CHIM ACTA, V24, P203, DOI 10.1016/0003-2670(61)80041-X; Bondarenko AI, 2011, PFLUG ARCH EUR J PHY, V462, P245, DOI 10.1007/s00424-011-0977-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brindley DN, 2009, J LIPID RES, V50, pS225, DOI 10.1194/jlr.R800055-JLR200; Brose SA, 2016, LIPIDS, V51, P487, DOI 10.1007/s11745-016-4144-y; Cabral GA, 2015, HANDB EXP PHARMACOL, V231, P185, DOI 10.1007/978-3-319-20825-1_6; Chap H, 2016, BIOCHIMIE, V125, P234, DOI 10.1016/j.biochi.2016.04.002; CLARKE NG, 1981, BIOCHEM J, V195, P301, DOI 10.1042/bj1950301; Colombo E, 2016, TRENDS IMMUNOL, V37, P608, DOI 10.1016/j.it.2016.06.006; Corda D, 2014, FEBS J, V281, P998, DOI 10.1111/febs.12699; Corda D, 2009, J BIOL CHEM, V284, P24848, DOI 10.1074/jbc.M109.035444; Cristino L, 2020, NAT REV NEUROL, V16, P9, DOI 10.1038/s41582-019-0284-z; Davalos-Salas M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13180-8; DITTMER JC, 1964, J LIPID RES, V5, P126; Dobrowolski M, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.180695; FAUVEL J, 1984, BIOCHIM BIOPHYS ACTA, V792, P72, DOI 10.1016/0005-2760(84)90284-4; Fiske CH, 1925, J BIOL CHEM, V66, P375; Gaits F, 1997, KIDNEY INT, V51, P1022, DOI 10.1038/ki.1997.143; Gallazzini M, 2008, P NATL ACAD SCI USA, V105, P11026, DOI 10.1073/pnas.0805496105; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Gilleron M, 2016, CELL CHEM BIOL, V23, P1147, DOI 10.1016/j.chembiol.2016.07.021; Gonsiorek W, 2000, MOL PHARMACOL, V57, P1045; Guy AT, 2019, ACS CHEM NEUROSCI, V10, P716, DOI 10.1021/acschemneuro.8b00505; Guy AT, 2015, SCIENCE, V349, P974, DOI 10.1126/science.aab3516; Henstridge CM, 2010, BRIT J PHARMACOL, V160, P604, DOI 10.1111/j.1476-5381.2009.00625.x; Hussain Z, 2017, BBA-MOL CELL BIOL L, V1862, P1546, DOI 10.1016/j.bbalip.2017.08.006; Inoue M, 2017, J BIOCHEM, V162, P449, DOI 10.1093/jb/mvx054; Kargl J, 2012, J BIOL CHEM, V287, P44234, DOI 10.1074/jbc.M112.364109; Kumar KK, 2019, CELL, V176, P448, DOI 10.1016/j.cell.2018.11.040; Maccarrone M, 2015, TRENDS PHARMACOL SCI, V36, P277, DOI 10.1016/j.tips.2015.02.008; Masquelier J, 2016, J PHARMACEUT BIOMED, V126, P132, DOI 10.1016/j.jpba.2016.04.011; Matas-Rico E, 2016, CANCER CELL, V30, P548, DOI 10.1016/j.ccell.2016.08.016; Mechoulam R, 2014, NAT REV NEUROSCI, V15, P757, DOI 10.1038/nrn3811; MICHELL RH, 1975, FEBS LETT, V53, P302, DOI 10.1016/0014-5793(75)80041-X; Moreno E, 2014, J BIOL CHEM, V289, P21960, DOI 10.1074/jbc.M114.561761; Mouchlis VD, 2019, BBA-MOL CELL BIOL L, V1864, P766, DOI 10.1016/j.bbalip.2018.08.010; Mutemberezi V, 2016, ANAL BIOANAL CHEM, V408, P733, DOI 10.1007/s00216-015-9150-z; Nakane S, 2002, ARCH BIOCHEM BIOPHYS, V402, P51, DOI 10.1016/S0003-9861(02)00038-3; Ogasawara D, 2016, P NATL ACAD SCI USA, V113, P26, DOI 10.1073/pnas.1522364112; Ohno-Shosaku T, 2014, CURR OPIN NEUROBIOL, V29, P1, DOI 10.1016/j.conb.2014.03.017; Ohshima N, 2015, J BIOL CHEM, V290, P4260, DOI 10.1074/jbc.M114.614537; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Oka S, 2009, J BIOCHEM, V145, P13, DOI 10.1093/jb/mvn136; Park S, 2013, SCIENCE, V339, P324, DOI 10.1126/science.1231921; Payrastre Bernard, 2004, Methods Mol Biol, V273, P201; PIETERSON WA, 1974, BIOCHEMISTRY-US, V13, P1455, DOI 10.1021/bi00704a021; Pineiro R, 2011, ONCOGENE, V30, P142, DOI 10.1038/onc.2010.417; Piomelli D, 2014, NEUROPHARMACOLOGY, V76, P228, DOI 10.1016/j.neuropharm.2013.07.026; Rahman IAS, 2016, BBA-MOL CELL BIOL L, V1861, P1881, DOI 10.1016/j.bbalip.2016.09.008; Rao M, 2005, SCIENCE, V309, P2212, DOI 10.1126/science.1117156; Ruban EL, 2014, BIOCHEM SOC T, V42, P1372, DOI 10.1042/BST20140151; SARDA L, 1958, BIOCHIM BIOPHYS ACTA, V30, P513, DOI 10.1016/0006-3002(58)90097-0; Shao ZH, 2016, NATURE, V540, P602, DOI 10.1038/nature20613; Simon GM, 2008, J BIOL CHEM, V283, P9341, DOI 10.1074/jbc.M707807200; Simon GM, 2010, MOL BIOSYST, V6, P1411, DOI 10.1039/c000237b; Sugiura T, 2000, J BIOL CHEM, V275, P605, DOI 10.1074/jbc.275.1.605; Sugiura T, 2006, PROG LIPID RES, V45, P405, DOI 10.1016/j.plipres.2006.03.003; Tang XY, 2015, J LIPID RES, V56, P2048, DOI 10.1194/jlr.R058362; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Tsuboi K, 2018, INFLAMM REGEN, V38, DOI 10.1186/s41232-018-0086-5; Tsuboi K, 2015, BBA-MOL CELL BIOL L, V1851, P537, DOI 10.1016/j.bbalip.2015.01.002; TSUTSUMI T, 1994, NEUROCHEM RES, V19, P399, DOI 10.1007/BF00967316; TSUTSUMI T, 1995, ARCH BIOCHEM BIOPHYS, V317, P331, DOI 10.1006/abbi.1995.1171; Tsutsumi T, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2020.158761; UEDA H, 1993, J NEUROCHEM, V61, P1874, DOI 10.1111/j.1471-4159.1993.tb09829.x; van Esbroeck ACM, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00286; van Veen M, 2017, ELIFE, V6, DOI 10.7554/eLife.23649; VOLWERK JJ, 1992, J CELL PHYSIOL, V151, P613, DOI 10.1002/jcp.1041510322; Yamashita A, 2013, PROSTAG OTH LIPID M, V107, P103, DOI 10.1016/j.prostaglandins.2013.05.004; Yamashita A, 2010, BBA-MOL CELL BIOL L, V1801, P711, DOI 10.1016/j.bbalip.2010.03.012; Yan Y, 2009, CELL, V138, P1209, DOI 10.1016/j.cell.2009.06.042; Yanaka N, 2003, J BIOL CHEM, V278, P43595, DOI 10.1074/jbc.M302867200; Yanaka N, 2007, BIOSCI BIOTECH BIOCH, V71, P1811, DOI 10.1271/bbb.70062; Yang Hyewon, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P297, DOI 10.1515/jbcpp-2015-0080; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zoerner AA, 2012, J CHROMATOGR B, V883, P161, DOI 10.1016/j.jchromb.2011.06.025	88	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2020	295	46					15767	15781		10.1074/jbc.RA120.015278	http://dx.doi.org/10.1074/jbc.RA120.015278			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OY6NO	32917725	Green Published, hybrid			2022-12-26	WOS:000594361600026
J	Martinez-Carranza, M; Jonna, VR; Lundin, D; Sahlin, M; Carlson, LA; Jemal, N; Hogbom, M; Sjoberg, BM; Stenmark, P; Hofer, A				Martinez-Carranza, Markel; Jonna, Venkateswara Rao; Lundin, Daniel; Sahlin, Margareta; Carlson, Lars-Anders; Jemal, Newal; Hogbom, Martin; Sjoberg, Britt-Marie; Stenmark, Pal; Hofer, Anders			A ribonucleotide reductase from Clostridium botulinum reveals distinct evolutionary pathways to regulation via the overall activity site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Clostridium botulinum; ribonucleotide reductase; allosteric regulation; overall activity regulation; inhibition mechanism; a-site; oligomerization; phylogenetics; evolution; structure&#8211; function	ALLOSTERIC REGULATION; DIPHOSPHATE REDUCTASE; IN-VITRO; ALIGNMENT; BINDING	Ribonucleotide reductase (RNR) is a central enzyme for the synthesis of DNA building blocks. Most aerobic organisms, including nearly all eukaryotes, have class I RNRs consisting of R1 and R2 subunits. The catalytic R1 subunit contains an overall activity site that can allosterically turn the enzyme on or off by the binding of ATP or dATP, respectively. The mechanism behind the ability to turn the enzyme off via the R1 subunit involves the formation of different types of R1 oligomers in most studied species and R1-R2 octamers in Escherichia coli. To better understand the distribution of different oligomerization mechanisms, we characterized the enzyme from Clostridium botulinum, which belongs to a subclass of class I RNRs not studied before. The recombinantly expressed enzyme was analyzed by size-exclusion chromatography, gas-phase electrophoretic mobility macromolecular analysis, EM, X-ray crystallography, and enzyme assays. Interestingly, it shares the ability of the E. coli RNR to form inhibited R1-R2 octamers in the presence of dATP but, unlike the E. coli enzyme, cannot be turned off by combinations of ATP and dGTP/dTTP. A phylogenetic analysis of class I RNRs suggests that activity regulation is not ancestral but was gained after the first subclasses diverged and that RNR subclasses with inhibition mechanisms involving R1 oligomerization belong to a clade separated from the two subclasses forming R1-R2 octamers. These results give further insight into activity regulation in class I RNRs as an evolutionarily dynamic process.	[Martinez-Carranza, Markel; Lundin, Daniel; Sahlin, Margareta; Hogbom, Martin; Sjoberg, Britt-Marie; Stenmark, Pal] Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden; [Jonna, Venkateswara Rao; Carlson, Lars-Anders; Jemal, Newal; Hofer, Anders] Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden; [Carlson, Lars-Anders] Umea Univ, Wallenberg Ctr Mol Med, Umea, Sweden; [Stenmark, Pal] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Stockholm University; Umea University; Umea University; Lund University	Stenmark, P (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden.; Hofer, A (corresponding author), Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden.; Stenmark, P (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	pal.stenmark@med.lu.se; anders.hofer@umu.se		Carlson, Lars-Anders/0000-0003-2342-6488; Hofer, Anders/0000-0003-2890-2957; Martinez-Carranza, Markel/0000-0003-0192-9762	Swedish Research Council [2019-01242, 2018-03406, 2019-01400]; Swedish Cancer Foundation [2017/716, 2018/820]; Wallenberg Centre for Molecular Medicine, Umea; Human Frontier Science Program Grant [CDA00047/2017-C]; Wenner-Gren Foundation; National Microscopy Infrastructure [VR-RFI 2016-00968]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Wallenberg Centre for Molecular Medicine, Umea; Human Frontier Science Program Grant(Human Frontier Science Program); Wenner-Gren Foundation; National Microscopy Infrastructure	This work was supported by Swedish Research Council Grants 2019-01242 (to A. H.), 2018-03406 (to P. S.), and 2019-01400 (to B.-M. S.); Swedish Cancer Foundation Grants 2017/716 (to P. S.) and 2018/820 (to B.-M. S.); funds from the Wallenberg Centre for Molecular Medicine, Umea (to L.-A. C.); Human Frontier Science Program Grant CDA00047/2017-C (to L.-A. C.); and funds from the Wenner-Gren Foundation (to B.-M. S.). Some work was done with the facilities and technical assistance of the Umea Core Facility Electron Microscopy at the Chemical Biological Centre of Umea University, a part of the National Microscopy Infrastructure, under Grant VR-RFI 2016-00968.	Ando N, 2011, P NATL ACAD SCI USA, V108, P21046, DOI 10.1073/pnas.1112715108; Aravind L, 2000, J MOL MICROB BIOTECH, V2, P191; BERGLUND O, 1972, J BIOL CHEM, V247, P7276; BERGLUND O, 1972, EUR J BIOCHEM, V28, P492, DOI 10.1111/j.1432-1033.1972.tb01936.x; BROWN NC, 1969, J MOL BIOL, V46, P25, DOI 10.1016/0022-2836(69)90055-2; BROWN NC, 1969, J MOL BIOL, V46, P39, DOI 10.1016/0022-2836(69)90056-4; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dong M, 2019, ANNU REV BIOCHEM, V88, P811, DOI 10.1146/annurev-biochem-013118-111654; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERIKSSON S, 1979, BIOCHEMISTRY-US, V18, P2948, DOI 10.1021/bi00581a005; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; Grinberg IR, 2018, J BIOL CHEM, V293, P15889, DOI 10.1074/jbc.RA118.004991; Grinberg IR, 2018, ELIFE, V7, DOI 10.7554/eLife.31529; Haft DH, 2018, NUCLEIC ACIDS RES, V46, pD851, DOI 10.1093/nar/gkx1068; Hofer A, 1997, P NATL ACAD SCI USA, V94, P6959, DOI 10.1073/pnas.94.13.6959; Hofer A, 1998, J BIOL CHEM, V273, P34098, DOI 10.1074/jbc.273.51.34098; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Hogbom M, 2003, P NATL ACAD SCI USA, V100, P3209, DOI 10.1073/pnas.0536684100; Johansson R, 2016, STRUCTURE, V24, P906, DOI 10.1016/j.str.2016.03.025; Jonna VR, 2015, J BIOL CHEM, V290, P17339, DOI 10.1074/jbc.M115.649624; Kang G, 2020, SCIENCE, V368, P424, DOI 10.1126/science.aba6794; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P67; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lundin Daniel, 2015, Life-Basel, V5, P604, DOI 10.3390/life5010604; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; NORDLUND P, 1993, J MOL BIOL, V232, P123, DOI 10.1006/jmbi.1993.1374; Parker MJ, 2014, BIOCHEMISTRY-US, V53, P766, DOI 10.1021/bi401056e; Rofougaran R, 2006, J BIOL CHEM, V281, P27705, DOI 10.1074/jbc.M605573200; Rofougaran R, 2008, J BIOL CHEM, V283, P35310, DOI 10.1074/jbc.M806738200; Rose HR, 2018, BIOCHEMISTRY-US, V57, P2679, DOI 10.1021/acs.biochem.8b00247; SAHLIN M, 1986, J MAGN RESON, V67, P135, DOI 10.1016/0022-2364(86)90417-8; SAHLIN M, 1982, J BIOL CHEM, V257, P366; Srinivas V, 2018, NATURE, V563, P416, DOI 10.1038/s41586-018-0653-6; Thomas WC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10568-4; Waterman DG, 2016, ACTA CRYSTALLOGR D, V72, P558, DOI 10.1107/S2059798316002187; Zimanyi CM, 2016, ELIFE, V5, DOI 10.7554/eLife.07141	41	7	7	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2020	295	46					15576	15587		10.1074/jbc.RA120.014895	http://dx.doi.org/10.1074/jbc.RA120.014895			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OY6NO	32883811	Green Published, hybrid			2022-12-26	WOS:000594361600013
J	Hu, LP; Zhang, CY; Yang, K; Li, M; Shaker, A				Hu, Liping; Zhang, Chunying; Yang, Kevin; Li, Meng; Shaker, Anisa			Human esophageal myofibroblasts increase squamous epithelial thickness via paracrine mechanisms in an in vitro model of gastroesophageal reflux disease	PLOS ONE			English	Article							PROLIFERATION; TRANSFECTION; CYTOKINES; CANCER; ACID; P63	The pathogenesis of esophageal injury in gastroesophageal reflux disease (GERD) is incompletely understood. We modeled exposure of human esophageal myofibroblasts (HEMFs) to gastroesophageal reflux by repeated treatment with pH 4.5 and pH 4.5 bile salts and determined the effects on the epithelium in a 3D organotypic-like air-liquid interface model. Total, basal and supra-basal thickness of the epithelium were measured and immunostaining for p63, for basal (CK 14) and supra-basal (CK 4) squamous differentiation markers, and for cell proliferation (PCNA) were performed. Epithelial cell proliferation in response to HEMF conditioned media was also assessed in 2D culture. In the 3D organotypic model, total epithelial thickness increased similarly with pH 4.5 and pH 4.5 bile salt treated versus untreated and bile salt treated HEMF conditioned media. Epithelial p63 immunostaining was increased and multilayered. There was expansion of the CK14+ basal and CK4+ supra-basal layers in the epithelium established with conditioned media from pH 4.5 and pH 4.5 bile salt treated HEMFs versus untreated HEMF conditioned media. PCNA + cells per mu m of tissue were unchanged in the basal layer across all treatment conditions while PCNA + cells per total DAPI + cells were decreased. In 2D culture, basal epithelial proliferation decreased with conditioned media from pH 4.5 and pH 4.5 bile salt treated HEMFs compared to conditioned media from untreated HEMF conditioned media. Secreted factors from HEMFs treated with acidic stimuli encountered in GERD increase epithelial thickness compared to secreted factors from untreated HEMFs and expand both basal and supra-basal layers. Our findings demonstrate for the first time paracrine regulation of the squamous epithelium from acid stimulated HEMFs. The effects of secreted factors from acid treated HEMFs on basal cell proliferation in this model and the mechanism mediating the increase in epithelial thickness merit further investigation.	[Hu, Liping; Zhang, Chunying; Yang, Kevin; Shaker, Anisa] USC, Dept Med, Div Gastroenterol & Hepatol, Keck Sch Med, Los Angeles, CA 90007 USA; [Li, Meng] Univ Southern Calif, USC Lib Bioinformat Serv, Los Angeles, CA USA	University of Southern California; University of Southern California Keck Hospital; University of Southern California	Shaker, A (corresponding author), USC, Dept Med, Div Gastroenterol & Hepatol, Keck Sch Med, Los Angeles, CA 90007 USA.	ashaker@usc.edu			DeGregorio Family foundation for Gastric and Esophageal Cancer Research; Price Family Foundation; NIH [R01 DK118065, P30 DK048522]	DeGregorio Family foundation for Gastric and Esophageal Cancer Research; Price Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	DeGregorio Family foundation for Gastric and Esophageal Cancer Research and the Price Family Foundation (AS) NIH R01 DK118065 (AS) NIH P30 DK048522 (USC Research Center for Liver Diseases) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bologna-Molina R, 2013, MED ORAL PATOL ORAL, V18, pE174, DOI 10.4317/medoral.18573; Compton CC, 1998, J CELL PHYSIOL, V177, P274, DOI 10.1002/(SICI)1097-4652(199811)177:2<274::AID-JCP9>3.0.CO;2-K; Daniely Y, 2004, AM J PHYSIOL-CELL PH, V287, pC171, DOI 10.1152/ajpcell.00226.2003; Dunbar KB, 2016, JAMA-J AM MED ASSOC, V315, P2104, DOI 10.1001/jama.2016.5657; Gargus M, 2015, AM J PHYSIOL-GASTR L, V308, pG904, DOI 10.1152/ajpgi.00333.2014; Kandulski A, 2013, ALIMENT PHARM THER, V38, P643, DOI 10.1111/apt.12428; Kasagi Y, 2018, CELL MOL GASTROENTER, V5, P333, DOI 10.1016/j.jcmgh.2017.12.013; Liu T, 2007, CARCINOGENESIS, V28, P488, DOI 10.1093/carcin/bgl176; O'Sullivan KE, 2014, EXPERT REV GASTROENT, V8, P749, DOI 10.1586/17474124.2014.913478; Roman S, 2007, AM J PHYSIOL-GASTR L, V293, pG45, DOI 10.1152/ajpgi.00583.2006; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Souza RF, 2016, DIGEST DIS, V34, P483, DOI 10.1159/000445225; Souza RF, 2009, GASTROENTEROLOGY, V137, P1776, DOI 10.1053/j.gastro.2009.07.055; Vieth M, 2016, CLIN GASTROENTEROL H; WEISGERBER UM, 1993, GUT, V34, P1587, DOI 10.1136/gut.34.11.1587; Zhang C., 2018, SCI REP, V8, P1, DOI DOI 10.1038/541598-018-20270-Y	16	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0238852	10.1371/journal.pone.0238852	http://dx.doi.org/10.1371/journal.pone.0238852			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925965	Green Published, gold			2022-12-26	WOS:000572318000037
J	Marlais , T; Bhattacharyya, T; Pearson, C; Gardner, BL; Marhoon, S; Airs, S; Hayes, K; Falconar, AK; Singh, OP; Reed, SG; El-Safi, S; Sundar, S; Miles, MA				Marlais, Tegwen; Bhattacharyya, Tapan; Pearson, Callum; Gardner, Bathsheba L.; Marhoon, Safiyyah; Airs, Stephanie; Hayes, Kiera; Falconar, Andrew K.; Singh, Om Prakash; Reed, Steven G.; El-Safi, Sayda; Sundar, Shyam; Miles, Michael A.			Isolation and characterisation ofLeishmania donovaniprotein antigens from urine of visceral leishmaniasis patients	PLOS ONE			English	Article							LATEX AGGLUTINATION-TEST; DIAGNOSIS; IDENTIFICATION; DIPSTICK; ANTIBODY; UTILITY; KATEX	Diagnosis of visceral leishmaniasis (VL) relies on invasive and risky aspirate procedures, and confirmation of cure after treatment is unreliable. Detection ofLeishmania donovaniantigens in urine has the potential to provide both a non-invasive diagnostic and a test of cure. We searched forL.donovaniantigens in urine of VL patients from India and Sudan to contribute to the development of urine antigen capture immunoassays. VL urine samples were incubated with immobilised anti-L.donovanipolyclonal antibodies and captured material was eluted. Sudanese eluted material and concentrated VL urine were analysed by western blot. Immunocaptured and immunoreactive material from Indian and Sudanese urine was submitted to mass spectrometry for protein identification. We identified sixL.donovaniproteins from VL urine. Named proteins were 40S ribosomal protein S9, kinases, and others were hypothetical. Thirty-three epitope regions were predicted with high specificity in the 6 proteins. Of these, 20 were highly specific toLeishmaniaspp. and are highly suitable for raising antibodies for the subsequent development of an antigen capture assay. We present all the identified proteins and analysed epitope regions in full so that they may contribute to the development of non-invasive immunoassays for this deadly disease.	[Marlais, Tegwen] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London, England; [Bhattacharyya, Tapan; Pearson, Callum; Gardner, Bathsheba L.; Marhoon, Safiyyah; Airs, Stephanie; Hayes, Kiera; Miles, Michael A.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Infect Biol, London, England; [Falconar, Andrew K.] Univ Norte, Dept Med, Barranquilla, Colombia; [Singh, Om Prakash] Banaras Hindu Univ, Inst Sci, Dept Biochem, Varanasi, Uttar Pradesh, India; [Reed, Steven G.] Infect Dis Res Inst, Seattle, WA USA; [El-Safi, Sayda] Univ Khartoum, Fac Med, Khartoum, Sudan; [Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi, Uttar Pradesh, India	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Universidad del Norte; Banaras Hindu University (BHU); University of Khartoum; Banaras Hindu University (BHU)	Marlais , T (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London, England.	tegwen.marlais@lshtm.ac.uk		Bhattacharyya, Tapan/0000-0003-3385-2536; Singh, Om Prakash/0000-0003-2146-8107; Marlais, Tegwen/0000-0003-0955-9807	Sir Halley Stewart Trust; John Henry Memorial Fund (UK Charity) [1118007]; European Commission under the Health Cooperation Work Programme of the 7th Framework Programme [260260]	Sir Halley Stewart Trust; John Henry Memorial Fund (UK Charity); European Commission under the Health Cooperation Work Programme of the 7th Framework Programme	TM was funded by the Sir Halley Stewart Trust (http://www.sirhalleystewart.org.uk/).The views expressed within this report are those of the authors and not necessarily those of the Trust. TM was additionally supported by the John Henry Memorial Fund (UK Charity number: 1118007). This work was part of the NIDIAG network research partnership supported by the European Commission under the Health Cooperation Work Programme of the 7th Framework Programme (Grant agreement no. 260260, https://cordis.europa.eu/project/id/260260).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeijon C, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.02076-18; Abeijon C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002161; Abeijon C, 2012, CLIN VACCINE IMMUNOL, V19, P935, DOI 10.1128/CVI.00125-12; Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; Anish C, 2013, ACS CHEM BIOL, V8, P2412, DOI 10.1021/cb400602k; Athlin S, 2017, EUR J CLIN MICROBIOL, V36, P1933, DOI 10.1007/s10096-017-3016-6; Attar ZJ, 2001, ACTA TROP, V78, P11, DOI 10.1016/S0001-706X(00)00155-8; Bhattacharyya T, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003273; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Brito-Santos F, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005304; BURNS JM, 1993, P NATL ACAD SCI USA, V90, P775, DOI 10.1073/pnas.90.2.775; Corstjens PLAM, 2014, PARASITOLOGY, V141, P1841, DOI 10.1017/S0031182014000626; Cota GF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001665; Diro E, 2007, T ROY SOC TROP MED H, V101, P908, DOI 10.1016/j.trstmh.2007.05.002; Downing T, 2011, GENOME RES, V21, P2143, DOI 10.1101/gr.123430.111; Finn RD, 2017, NUCLEIC ACIDS RES, V45, pD190, DOI 10.1093/nar/gkw1107; Gidwani K, 2011, CLIN VACCINE IMMUNOL, V18, P346, DOI 10.1128/CVI.00473-10; Goto Y, 2008, INFECT IMMUN, V76, P3967, DOI 10.1128/IAI.00604-08; Goto Y, 2007, INFECT IMMUN, V75, P846, DOI 10.1128/IAI.01205-06; Gupta R, 2002, TECHNIQUES IN MYCORRHIZAL STUDIES, P103; Jespersen MC, 2017, NUCLEIC ACIDS RES, V45, pW24, DOI 10.1093/nar/gkx346; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Markakpo US, 2016, TROP MED INT HEALTH, V21, P1263, DOI 10.1111/tmi.12744; Mondal D, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1572-8; Mukhtar M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006264; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Riera C, 2004, EUR J CLIN MICROBIOL, V23, P899, DOI 10.1007/s10096-004-1249-7; Rijal S, 2004, TROP MED INT HEALTH, V9, P724, DOI 10.1111/j.1365-3156.2004.01251.x; Rodrigues JA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005169; Salam MA, 2011, T ROY SOC TROP MED H, V105, P269, DOI 10.1016/j.trstmh.2010.12.007; Santucci L, 2015, J PROTEOMICS, V112, P53, DOI 10.1016/j.jprot.2014.07.021; Sarkari B, 2002, ACTA TROP, V82, P339, DOI 10.1016/S0001-706X(02)00043-8; Sarkari B, 2005, IRANIAN BIOMEDICAL J, V9, P117; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Silva LD, 2006, AM J TROP MED HYG, V75, P739, DOI 10.4269/ajtmh.2006.75.739; Silverman JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r35; Singh Dharmendra P, 2009, BMC Res Notes, V2, P187, DOI 10.1186/1756-0500-2-187; Sundar S, 2005, AM J TROP MED HYG, V73, P269, DOI 10.4269/ajtmh.2005.73.269; Sundar S, 2018, MOL DIAGN THER, V22, P443, DOI 10.1007/s40291-018-0343-y; Suwanpimolkul G, 2017, INT J INFECT DIS, V59, P96, DOI 10.1016/j.ijid.2017.04.017; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Vallur AC, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1125-3; Verma S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2318-8; Vogt F, 2018, AM J TROP MED HYG, V99, P957, DOI 10.4269/ajtmh.18-0042; World Health Organization, 2012, TECHNICAL REPORT SER, V975; World Health Organization, 2012, REG STRAT FRAM EL KA; Zijlstra EE, 2001, TROP MED INT HEALTH, V6, P108, DOI 10.1046/j.1365-3156.2001.00680.x	49	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0238840	10.1371/journal.pone.0238840	http://dx.doi.org/10.1371/journal.pone.0238840			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925980	Green Published, gold			2022-12-26	WOS:000572318000029
J	Cristia, A; Farabolini, G; Scaff, C; Havron, N; Stieglitz, J				Cristia, Alejandrina; Farabolini, Gianmatteo; Scaff, Camila; Havron, Naomi; Stieglitz, Jonathan			Infant-directed input and literacy effects on phonological processing: Non-word repetition scores among the Tsimane'	PLOS ONE			English	Article							NONWORD REPETITION; SOCIOECONOMIC-STATUS; CHILDREN PERFORM; SPEECH; LANGUAGE; SKILLS; ILLITERACY; MEMORY; REPRESENTATIONS; PERCEPTION	Language input in childhood and literacy (and/or schooling) have been described as two key experiences impacting phonological processing. In this study, we assess phonological processing via a non-word repetition (NWR) group game, in adults and children living in two villages of an ethnic group where infants are rarely spoken to, and where literacy is variable. We found lower NWR scores than in previous work for both children (N = 17; aged 1-12 years) and adults (N = 13; aged 18-60 years), which is consistent with the hypothesis that there would be long-term effects on phonological processing of experiencing low levels of directed input in infancy. Additionally, we found some evidence that literacy and/or schooling increases NWR scores, although results should be interpreted with caution given the small sample size. These findings invite further investigations in similar communities, as current results are most compatible with phonological processing being influenced by aspects of language experience that vary greatly between and within populations.	[Cristia, Alejandrina; Havron, Naomi] PSL Univ, Dept Etud Cognit, Lab Sci Cognit & Psycholinguist, CNRS,ENS,EHESS, Paris, France; [Farabolini, Gianmatteo] Univ Politecn Marche, Dept Expt & Clin Med, Ancona, Italy; [Scaff, Camila] Univ Zurich, Inst Evolutionary Med, Zurich, Switzerland; [Stieglitz, Jonathan] Univ Toulouse 1 Capitole, Inst Adv Study Toulouse, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Marche Polytechnic University; University of Zurich; Universite de Toulouse; Universite Toulouse 1 Capitole	Cristia, A (corresponding author), PSL Univ, Dept Etud Cognit, Lab Sci Cognit & Psycholinguist, CNRS,ENS,EHESS, Paris, France.	alecristia@gmail.com		Stieglitz, Jonathan/0000-0001-5985-9643; Havron, Naomi/0000-0001-6429-1546	Agence Nationale de la Recherche [ANR-17-CE28-0007, ANR-16-DATA-0004, ANR-14-CE30-0003, ANR-17-EURE-0017]; J. S. McDonnell Foundation Understanding Human Cognition Scholar Award; French National Research Agency (ANR) [ANR-17-EURE-0010]	Agence Nationale de la Recherche(French National Research Agency (ANR)); J. S. McDonnell Foundation Understanding Human Cognition Scholar Award; French National Research Agency (ANR)(French National Research Agency (ANR))	AC acknowledges financial and institutional support from Agence Nationale de la Recherche (ANR-17-CE28-0007 LangAge, ANR-16-DATA-0004 ACLEW, ANR-14-CE30-0003 MechELex, ANR-17-EURE-0017) and the J. S. McDonnell Foundation Understanding Human Cognition Scholar Award. JS acknowledges IAST funding from the French National Research Agency (ANR) under grant ANR-17-EURE-0010 (Investissements d'Avenir program). url ANR: https://anr.fr/url McDonnell Foundation: https://www.jsmf.org/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaire J, 2016, OTHERS RTICLES ARTIC; [Anonymous], 2019, SM SYSTEMATIC REV SU; Armon-Lotem S, 2012, PROC ANN BUCLD, P53; Balladares J, 2016, FIRST LANG, V36, P338, DOI 10.1177/0142723715626067; Baum A, 1999, ANN NY ACAD SCI, V896, P131, DOI 10.1111/j.1749-6632.1999.tb08111.x; Baumer B, 2014, ARXIV14021894, DOI [10.5070/T581020118, DOI 10.5070/T581020118]; Bishop DVM, 1996, J CHILD PSYCHOL PSYC, V37, P391, DOI 10.1111/j.1469-7610.1996.tb01420.x; Boersma P., 2016, PRAAT DOING PHONETIC; Casillas M, 2020, J CHILD LANGUAGE; Casillas M, 2020, CHILD DEV, V91, P1819, DOI 10.1111/cdev.13349; Castro-Caldas A, 1998, BRAIN, V121, P1053, DOI 10.1093/brain/121.6.1053; Christiansen MH, 2016, BEHAV BRAIN SCI, V39, DOI 10.1017/S0140525X1500031X; Cristia A, 2020, DEV REV, V57, DOI 10.1016/j.dr.2020.100914; Cristia A, 2019, CHILD DEV, V90, P759, DOI 10.1111/cdev.12974; Dehaene-Lambertz G, 2004, J COGNITIVE NEUROSCI, V16, P1375, DOI 10.1162/0898929042304714; Ebert K. D., 2008, COMMUNICATION DISORD, V29, P67, DOI DOI 10.1177/1525740108314861; Farmani H, 2018, J MODERN REHABILITAT, V12, P217, DOI [10.32598/JMR.V12.N4.217, DOI 10.32598/JMR.V12.N4.217]; Folia V, 2003, CLIN NEUROPSYCHOL, V17, P143, DOI 10.1076/clin.17.2.143.16505; Gallagher G, 2014, LAB PHONOL, V5, P337, DOI 10.1515/lp-2014-0012; Gill W, 1999, CHIMANE ENGLISH DICT; Gill W, 1999, PEDAGOGICAL GRAMMAR; Goldstein MH, 2008, PSYCHOL SCI, V19, P515, DOI 10.1111/j.1467-9280.2008.02117.x; Gurven M, 2010, TSIMANE FIELDSITE BO; Gurven M, 2017, EVOL ANTHROPOL, V26, P54, DOI 10.1002/evan.21515; Gurven M, 2017, DEV PSYCHOL, V53, P160, DOI 10.1037/dev0000175; Hale M, 2003, J LINGUIST, V39, P219, DOI 10.1017/S0022226703002019; Hart B., 1995, MEANINGFUL DIFFERENC; Havron N, 2017, APPL PSYCHOLINGUIST, V38, P127, DOI 10.1017/S0142716416000138; Head ML, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002106; Hintze JM, 2003, SCHOOL PSYCHOL REV, V32, P541; Ibrahim L. A., 2017, P 41 ANN BOST U C LA, V41, P1; Jaber-Awida A, 2018, ATHENS J PHILOLOGY, V5, P317, DOI [10.30958/ajp.5-4-4, DOI 10.30958/AJP.5-4-4]; Kalnak N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089544; Kapalkova S, 2013, INT J LANG COMM DIS, V48, P78, DOI 10.1111/j.1460-6984.2012.00189.x; Kolinsky R, 2018, READ WRIT, V31, P649, DOI 10.1007/s11145-017-9804-7; Kosmidis MH, 2006, CORTEX, V42, P1021, DOI 10.1016/S0010-9452(08)70208-9; Kosmidis MH, 2011, ARCH CLIN NEUROPSYCH, V26, P575, DOI 10.1093/arclin/acr063; Kosmidis MH, 2004, J INT NEUROPSYCH SOC, V10, P818, DOI 10.1017/S1355617704106036; Loureiro CD, 2004, BRAIN LANG, V89, P499, DOI 10.1016/j.bandl.2003.12.008; Marini A, 2017, J SPEECH LANG HEAR R, V60, P3462, DOI 10.1044/2017_JSLHR-L-15-0415; Meir N, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01442; MORAIS J, 1979, COGNITION, V7, P323, DOI 10.1016/0010-0277(79)90020-9; MORAIS J, 1986, COGNITION, V24, P45, DOI 10.1016/0010-0277(86)90004-1; MORAIS J, 1994, COGNITION, V50, P287, DOI 10.1016/0010-0277(94)90032-9; Nation K, 2011, DEVELOPMENTAL SCI, V14, P649, DOI 10.1111/j.1467-7687.2010.01008.x; Piazzalunga S, 2019, CLIN LINGUIST PHONET, V33, P437, DOI 10.1080/02699206.2018.1542542; Radeborg K, 2006, SCAND J PSYCHOL, V47, P187, DOI 10.1111/j.1467-9450.2006.00506.x; RCore Team, 2020, R LANG ENV STAT COMP; Reis A, 1997, J INT NEUROPSYCH SOC, V3, P444, DOI 10.1017/S135561779700444X; Rispens J, 2012, J SPEECH LANG HEAR R, V55, P683, DOI 10.1044/1092-4388(2011/10-0263); Ritchie S, 2013, CHIMANE DOCUMENTATIO; Ritchie S, 2017, STUD LANG, V41, P660, DOI 10.1075/sl.41.3.05rit; Rowe ML, 2008, J CHILD LANG, V35, P185, DOI 10.1017/S0305000907008343; Rowe ML, 2012, CHILD DEV, V83, P1762, DOI 10.1111/j.1467-8624.2012.01805.x; RStudio Team, 2019, RSTUDIO INT DEV ENV; Sakel J, 2011, GRAMMAR MOSETEN; Sakel J, 2011, INT J AM LINGUIST, V77, P537, DOI 10.1086/662159; Scaff C., 2019, THESIS; Sharma M, 2020, INT J PEDIATR OTORHI, V128, DOI 10.1016/j.ijporl.2019.109702; Sharp KM, 2013, CHILD LANG TEACH THE, V29, P77, DOI 10.1177/0265659012465208; Shneidman LA, 2013, J CHILD LANG, V40, P672, DOI 10.1017/S0305000912000141; Soderstrom M, 2019, J ACOUST SOC AM, V145, P1763, DOI [10.1121/1.5101455, DOI 10.1121/1.5101455]; Song JY, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02398; Summers C, 2010, INT J LANG COMM DIS, V45, P480, DOI 10.3109/13682820903198058; Sundstrom S, 2018, CLIN LINGUIST PHONET, V32, P950, DOI 10.1080/02699206.2018.1469671; Swingley D, 2005, COGNITIVE PSYCHOL, V50, P86, DOI 10.1016/j.cogpsych.2004.06.001; Tsegaye MT, 2011, CLIN LINGUIST PHONET, V25, P628, DOI 10.3109/02699206.2011.567348; Vance M, 2005, INT J LANG COMM DIS, V40, P29, DOI 10.1080/13682820410001716172; Vender M, 2016, CLIN LINGUIST PHONET, V30, P150, DOI 10.3109/02699206.2015.1120346; Weisleder A, 2013, PSYCHOL SCI, V24, P2143, DOI 10.1177/0956797613488145; Werker JF, 2005, LANG LEARN DEV, V1, P197, DOI 10.1080/15475441.2005.9684216; Werker JF, 2015, ANNU REV PSYCHOL, V66, P173, DOI 10.1146/annurev-psych-010814-015104; Wesseling R, 2001, ANN DYSLEXIA, V51, P203, DOI 10.1007/s11881-001-0011-4; Wilsenach C, 2013, PER LINGUAM, V29, P17, DOI 10.5785/29-2-554; Windsor J, 2010, AM J SPEECH-LANG PAT, V19, P298, DOI 10.1044/1058-0360(2010/09-0064); 2014, OFF J EUR UNION, V57	76	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0237702	10.1371/journal.pone.0237702	http://dx.doi.org/10.1371/journal.pone.0237702			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9MU	32915785	Green Accepted, Green Published, gold			2022-12-26	WOS:000571887500011
J	Jang, WS; Lim, DH; Nam, J; Mihn, DC; Sung, HW; Lim, CS; Kim, J				Jang, Woong Sik; Lim, Da Hye; Nam, Jeonghun; Do-Cic Mihn; Sung, Haan Woo; Lim, Chae Seung; Kim, Jeeyong			Development of a multiplex isothermal amplification molecular diagnosis method for on-site diagnosis of influenza	PLOS ONE			English	Article							URACIL-DNA-GLYCOSYLASE; SENSITIVE DETECTION; LAMP ASSAY; VIRUS; OSELTAMIVIR; PCR	Influenza, which is an acute respiratory disease caused by the influenza virus, represents a worldwide public health and economic problem owing to the significant morbidity and mortality caused by its seasonal epidemics and pandemics. Sensitive and convenient methodologies for the detection of influenza viruses are important for clinical care and infection control as well as epidemiological investigations. Here, we developed a multiplex reverse transcription loop-mediated isothermal amplification (RT-LAMP) with quencher/fluorescence oligonucleotides connected by a 5 ' backward loop (LF or LB) primer for the detection of two subtypes of influenza viruses: Influenza A (A/H1 and A/H3) and influenza B. The detection limits of the multiplex RT-LAMP assay were 10(3)copies and 10(2)copies of RNA for influenza A and influenza B, respectively. The sensitivities of the multiplex influenza A/B/IC RT-LAMP assay were 94.62% and 97.50% for influenza A and influenza B clinical samples, respectively. The specificities of the multiplex influenza A/B/IC RT-LAMP assay were 100% for influenza A, influenza B, and healthy clinical samples. In addition, the multiplex influenza A/B/IC RT-LAMP assay had no cross-reactivity with other respiratory viruses.	[Jang, Woong Sik; Lim, Da Hye; Nam, Jeonghun; Lim, Chae Seung; Kim, Jeeyong] Korea Univ Guro Hosp, Dept Lab Med, Seoul, South Korea; [Do-Cic Mihn] Seegene Med Fdn, Dept Diagnost Immunol, Seoul, South Korea; [Sung, Haan Woo] Kangwon Natl Univ, Coll Vet Med, Dept Vet Microbiol, Chunchon, South Korea	Korea University; Korea University Medicine (KU Medicine); Kangwon National University	Kim, J (corresponding author), Korea Univ Guro Hosp, Dept Lab Med, Seoul, South Korea.	emperrorjy@naver.com		Jang, Woong Sik/0000-0002-2910-0537; Kim, Jeeyong/0000-0002-0426-2572	government-wide R&D fund project for infectious disease research [HG18C0012]; National Research Foundation of Korea, Republic of Korea [NRF2016R1A5A1010148]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HR20C0021]	government-wide R&D fund project for infectious disease research; National Research Foundation of Korea, Republic of Korea(National Research Foundation of Korea); Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This study was supported by a government-wide R&D fund project for infectious disease research (HG18C0012) and National Research Foundation of Korea (NRF2016R1A5A1010148), Republic of Korea. We also received a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HR20C0021).	Ahn SJ, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4277-8; Aoki FY, 2003, J ANTIMICROB CHEMOTH, V51, P123, DOI 10.1093/jac/dkg007; Baek YH, 2018, J MICROBIOL BIOTECHN, V28, P1928, DOI 10.4014/jmb.1806.06016; Bunker Deborah, 2019, Stud Health Technol Inform, V259, P39; Chen HT, 2008, J VIROL METHODS, V153, P266, DOI 10.1016/j.jviromet.2008.07.006; Chi Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep44924; Coiras MT, 2004, J MED VIROL, V72, P484, DOI 10.1002/jmv.20008; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; Dhama Kuldeep, 2014, Pak J Biol Sci, V17, P151, DOI 10.3923/pjbs.2014.151.166; Di Trani L, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-87; Ding Y, 2014, ARCH VIROL, V159, P3269, DOI 10.1007/s00705-014-2192-2; Edrees MAH, 2019, EUROPEAN J PHARM SCI, V6, P560; Euler M, 2012, J CLIN MICROBIOL, V50, P2234, DOI 10.1128/JCM.06504-11; Fukao K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217307; Gadkar VJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23930-1; Ge YY, 2017, INT J NANOMED, V12, P2645, DOI 10.2147/IJN.S132670; Ghosh DK, 2019, METHODS MOL BIOL, V2015, P143, DOI 10.1007/978-1-4939-9558-5_10; Hamilton BS, 2012, J VIROL, V86, P10579, DOI 10.1128/JVI.00306-12; Hasselmann C, 2003, CLIN MICROBIOL INFEC, V9; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; He H, 2017, SCI REP-UK, V7, DOI 10.1038/srep45199; Henritzi D, 2019, INFLUENZA OTHER RESP, V13, P71, DOI 10.1111/irv.12613; Hsieh K, 2014, CHEM COMMUN, V50, P3747, DOI 10.1039/c4cc00540f; Iuliano AD, 2018, LANCET, V391, P1285, DOI 10.1016/S0140-6736(17)33293-2; Jiang Y, 2015, SENSOR ACTUAT B-CHEM, V209, P78, DOI 10.1016/j.snb.2014.11.103; Jung JH, 2015, ANAL CHIM ACTA, V853, P541, DOI 10.1016/j.aca.2014.10.020; Kil EJ, 2015, J VIROL METHODS, V213, P68, DOI 10.1016/j.jviromet.2014.10.020; Kok J, 2010, J CLIN MICROBIOL, V48, P290, DOI 10.1128/JCM.01465-09; Liu NW, 2017, SCI REP-UK, V7, DOI 10.1038/srep45601; Ma YD, 2017, 2017 19TH INTERNATIONAL CONFERENCE ON SOLID-STATE SENSORS, ACTUATORS AND MICROSYSTEMS (TRANSDUCERS), P722; Mahony J, 2013, J CLIN VIROL, V58, P127, DOI 10.1016/j.jcv.2013.06.006; Monto AS, 1999, J INFECT DIS, V180, P254, DOI 10.1086/314904; PALESE P, 1977, CELL, V10, P1, DOI 10.1016/0092-8674(77)90133-7; Pan QJ, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1190-0; Parida M, 2008, REV MED VIROL, V18, P407, DOI 10.1002/rmv.593; Petric M, 2006, J INFECT DIS, V194, pS98, DOI 10.1086/507554; Poon LLM, 2005, J CLIN MICROBIOL, V43, P427, DOI 10.1128/JCM.43.1.427-430.2005; Putri WCWS, 2018, VACCINE, V36, P3960, DOI 10.1016/j.vaccine.2018.05.057; Singh R, 2017, J VECTOR DIS, V54, P54; Sreenivasan CC, 2019, VIROLOGY, V528, P152, DOI 10.1016/j.virol.2018.12.016; Storch GA, 2003, CURR OPIN PEDIATR, V15, P77, DOI 10.1097/00008480-200302000-00013; Takashita E, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03026; Takayama I, 2019, J VIROL METHODS, V267, P53, DOI 10.1016/j.jviromet.2019.02.010; Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004; Terrier O, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-285; Tong YH, 2008, BIOTECHNIQUES, V45, P543, DOI 10.2144/000112959; van Elden LJR, 2001, J CLIN MICROBIOL, V39, P196, DOI 10.1128/JCM.39.1.196-200.2001; Vemula SV, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8040096; Whitley RJ, 2001, PEDIATR INFECT DIS J, V20, P127, DOI 10.1097/00006454-200102000-00002; Yamazaki W, 2013, J VIROL METHODS, V192, P18, DOI 10.1016/j.jviromet.2013.03.018; Yaren O, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2382-0; Yoon J, 2018, SENSOR ACTUAT B-CHEM, V255, P1491, DOI 10.1016/j.snb.2017.08.157; Zhou Y, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01056	53	5	7	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238615	10.1371/journal.pone.0238615	http://dx.doi.org/10.1371/journal.pone.0238615			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915821	gold, Green Published			2022-12-26	WOS:000571887500041
J	Kuang, JY; Thulin, E; Ashraf, S; Shpenev, A; Das, U; Delea, MG; McNally, P; Bicchieri, C				Kuang, Jinyi; Thulin, Erik; Ashraf, Sania; Shpenev, Alex; Das, Upasak; Delea, Maryann G.; McNally, Peter; Bicchieri, Cristina			Bias in the perceived prevalence of open defecation: Evidence from Bihar, India	PLOS ONE			English	Article							FALSE CONSENSUS; SOCIAL-PERCEPTION; DRINKING NORMS	People often form perceptions about how prevalent a behavior is in a social group. However, these perceptions can be inaccurate and biased. While persistent undesirable practices in low-income countries have drawn global attention, evidence regarding people's perception of how prevalent these practices are is scarce. Among those harmful practices, open defecation in India remains a significant public health concern, where it perpetuates the vicious cycle of disease and poverty. In this study, we focus on measuring the perceived prevalence of open defecation among respondents in Bihar, India. We examined the bias in perceived prevalence, which is defined as a pattern of deviation from the actual prevalence of open defecation. Results showed that respondents who defecate in the open overestimate the prevalence of open defecation, whereas those who consistently use toilets underestimate it. This finding suggests a false consensus bias in the perceived prevalence of open defecation. Scholars, policymakers, and program implementers who seek to correct misperceptions about open defecation by broadcasting real prevalence should be aware of biases in the perceived prevalence and address them in behavior change interventions.	[Kuang, Jinyi; Ashraf, Sania; Shpenev, Alex; McNally, Peter; Bicchieri, Cristina] Univ Penn, Ctr Social Norms & Behav Dynam, Philadelphia, PA 19104 USA; [Thulin, Erik] Ctr Behav & Environm, Rare, Arlington, VA USA; [Das, Upasak] Univ Manchester, Global Dev Inst, Manchester, Lancs, England; [Delea, Maryann G.] Emory Univ, Gangarosa Dept Environm Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Delea, Maryann G.] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	University of Pennsylvania; University of Manchester; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health	Kuang, JY; Bicchieri, C (corresponding author), Univ Penn, Ctr Social Norms & Behav Dynam, Philadelphia, PA 19104 USA.	jkuang@sas.upenn.edu; cbicchieri@sas.upenn.edu	Shpenev, Alex/AAX-6986-2021; Kuang, Jinyi/L-8488-2017	Kuang, Jinyi/0000-0003-4173-3246	Bill and Melinda Gates Foundation [INV-009118/OPP1157257]; Kantar Republic	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Kantar Republic	This project was funded by the Bill and Melinda Gates Foundation (Grant No. INV-009118/OPP1157257). The funder was not involved in study design, data collection, data analysis, and data interpretation. Kantar Republic managed sample selection and data collection, but had no role in study design, decision to publish, or preparation of the manuscript.	Aills L, 2008, SURG OBES RELAT DI S, V4, pS73; [Anonymous], 2011, PROVISIONAL POPULATI; [Anonymous], 2007, DISTRICT LEVEL HOUSE; BAER JS, 1991, J STUD ALCOHOL, V52, P580, DOI 10.15288/jsa.1991.52.580; Bicchieri C., 2006, GRAMMAR SOC; Bicchieri C., 2017, PHASE 1 PROJECT REPO; Bicchieri C., 2018, PHASE 2 PROJECT REPO; Bursztyn L, 2018, SSRN ELECT J; Foxcroft DR, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006748.pub3; Gauri V, 2018, SHIFTING SOCIAL NORM; KRUGLANSKI AW, 1989, PSYCHOL BULL, V106, P395, DOI 10.1037/0033-2909.106.3.395; Lewis MA, 2006, J AM COLL HEALTH, V54, P213, DOI 10.3200/JACH.54.4.213-218; Neighbors C, 2019, BEHAV RES THER, V115, P73, DOI 10.1016/j.brat.2018.11.004; OP026, 2016, J CROHNS COLITIS, V10, pS21; ROSS L, 1977, J EXP SOC PSYCHOL, V13, P279, DOI 10.1016/0022-1031(77)90049-X; Schultz PW, 2007, PSYCHOL SCI, V18, P429, DOI 10.1111/j.1467-9280.2007.01917.x; SHERMAN SJ, 1983, PERS SOC PSYCHOL B, V9, P197, DOI 10.1177/0146167283092003; SULS J, 1988, J APPL SOC PSYCHOL, V18, P66, DOI 10.1111/j.1559-1816.1988.tb00006.x; United Nations Children's Fund (UNICEF) and World Health Organization (WHO), 2017, PROGR DRINKING WATER; Vallentin-Holbech Lotte, 2018, Prev Med Rep, V12, P304, DOI 10.1016/j.pmedr.2018.10.019; WHO, 2019, UN WAT GLOB AN ASS S	21	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238627	10.1371/journal.pone.0238627	http://dx.doi.org/10.1371/journal.pone.0238627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9MU	32915831	Green Published, gold			2022-12-26	WOS:000571887500070
J	Takatsuka, K; Sekiguchi, S; Yamaba, H; Aburada, K; Mukunoki, M; Okazaki, N				Takatsuka, Kayoko; Sekiguchi, Satoshi; Yamaba, Hisaaki; Aburada, Kentaro; Mukunoki, Masayuki; Okazaki, Naonobu			FMD-VS: A virtual sensor to index FMD virus scattering	PLOS ONE			English	Article							MOUTH-DISEASE EPIDEMIC; SIMULATION-MODEL; FOOT; TRANSMISSION; SPREAD	Foot-and-mouth disease (FMD) models-analytical models for tracking and analyzing FMD outbreaks-are known as dominant tools for examining the spread of the disease under various conditions and assessing the effectiveness of countermeasures. There has been some remarkable progress in modeling research since the UK epidemic in 2001. Several modeling methods have been introduced, developed, and are still growing. However, in 2010 when a FMD outbreak occurred in the Miyazaki prefecture, a crucial problem reported: Once a regional FMD outbreak occurs, municipal officials in the region must make various day-to-day decisions throughout this period of vulnerability. The deliverables of FMD modeling research in its current state appear insufficient to support the daily judgments required in such cases. FMD model can be an efficient support tool for prevention decisions. It requires being conversant with modeling and its preconditions. Therefore, most municipal officials with no knowledge or experience found full use of the model difficult. Given this limitation, the authors consider methods and systems to support users of FMD models who must make real-time epidemic-related judgments in the infected areas. We propose a virtual sensor, designated "FMD-VS," to index FMD virus scattering in conditions where there is once a notion of FMD; and (2) shows how we apply the developed FMD-VS technique during an outbreak. In (1), we show our approach to constructing FMD-VS based on the existing FMD model and offer an analysis and evaluation method to assess its performance. We again present the results produced when the technique applied to 2010 infection data from the Miyazaki Prefecture. For (2), we outline the concept of a method that supports the prevention judgment of municipal officials and show how to use FMD-VS.	[Takatsuka, Kayoko; Yamaba, Hisaaki; Aburada, Kentaro; Mukunoki, Masayuki; Okazaki, Naonobu] Univ Miyazaki, Fac Engn, Miyazaki, Japan; [Sekiguchi, Satoshi] Univ Miyazaki, Fac Agr, Miyazaki, Japan	University of Miyazaki; University of Miyazaki	Takatsuka, K (corresponding author), Univ Miyazaki, Fac Engn, Miyazaki, Japan.	takatuka@cs.miyazaki-u.ac.jp			MEXT KAKENHI [15K12463]; KAKENHI [20H01162]	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT KAKENHI grant number 15K12463, Grants from the author's affiliation (100,000 Japanese yen), KAKENHI grant number 20H01162 Dr. Kayoko Takatsuka, and KAKEBHI is Grants-in Aid for Scientific Reserch in Japan. https://www.jsps.go.jp/j-grantsinaid/	[Anonymous], 2015, JMIR MED INFORM, V3, pe22; [Anonymous], 2016, MAN PREV INF EXP FOO; Bradhurst RA, 2015, FRONT ENV SCI-SWITZ, V3, DOI 10.3389/fenvs.2015.00017; Desai K, 2006, BIOCHEM ENG J, V27, P225, DOI 10.1016/j.bej.2005.08.002; Garner MG, 2005, AUST VET J, V83, P758, DOI 10.1111/j.1751-0813.2005.tb11589.x; Harvey N, 2007, PREV VET MED, V82, P176, DOI 10.1016/j.prevetmed.2007.05.019; Hayama Y, 2013, PREV VET MED, V112, P183, DOI 10.1016/j.prevetmed.2013.08.010; Hayama Y, 2013, FMD OUTBREAKS MIYAZA; Haydon DT, 1997, IMA J MATH APPL MED, V14, P1; Ishida M., 2014, R LINGUISTIC REVERSE, P703; Kadlec P, 2008, 2008 INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE FOR MODELLING CONTROL & AUTOMATION, VOLS 1 AND 2, P243, DOI 10.1109/CIMCA.2008.66; Kadlec P, 2009, COMPUT CHEM ENG, V33, P795, DOI 10.1016/j.compchemeng.2008.12.012; Kano M., 2009, DESIGN SOFT SENSOR V; Kano M, 2013, J CHEM ENG JPN, V46, P1, DOI 10.1252/jcej.12we167; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Kenneth J.Rothman, 2012, EPIDEMIOLOGY INTRO; Kohavi R., 1995, PROC 14 INT JOINT C, P1137; Lin B, 2007, COMPUT CHEM ENG, V31, P419, DOI 10.1016/j.compchemeng.2006.05.030; Lindstrom T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004187; Lindstrom T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053432; Lombard M, 2007, REV SCI TECH OIE, V26, P29, DOI 10.20506/rst.26.1.1724; Mansley LM, 2011, REV SCI TECH OIE, V30, P483; Ministry of Agriculture, INF FOOT AND MOUTH D; Nelson N, 2017, J CLIN MICROBIOL, V55, P1671, DOI 10.1128/JCM.00179-17; Rushton J., 2012, FAO OIE P FAOOIE GLO, P205; Stevenson MA, 2013, PREV VET MED, V109, P10, DOI 10.1016/j.prevetmed.2012.08.015; Taylor N., 2003, REV USE MODELS INFOR; Tildesley MJ, 2010, P NATL ACAD SCI USA, V107, P1041, DOI 10.1073/pnas.0909047107; Tildesley MJ, 2009, P ROY SOC B-BIOL SCI, V276, P3239, DOI 10.1098/rspb.2009.0427; Tildesley Mike, 2015, RES POL INF DIS DYN; Tildesley MJ, 2006, NATURE, V440, P83, DOI 10.1038/nature04324; Yamauchi Kazuya, 2019, J LIFE SCI, P24; Yoshida Abe M., 2014, JAPAN SOC CIVIL EN D, V70, P161; 2012, SURG OBES RELAT DIS, V8	34	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0237961	10.1371/journal.pone.0237961	http://dx.doi.org/10.1371/journal.pone.0237961			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915804	gold, Green Published			2022-12-26	WOS:000571887500120
J	Bian, SX; Lin, E				Bian, Shelly X.; Lin, Eugene			Competing with a pandemic: Trends in research design in a time of Covid-19	PLOS ONE			English	Article								Introduction During the Covid-19 pandemic, major journals have published a significant number of Covid-19 related articles in a short period of time. While this is necessary to combat the worldwide pandemic, it may have trade-offs with respect to publishing research from other disciplines. Objectives To assess differences in published research design before and after the Covid-19 pandemic. Methods We performed a cross-sectional review of all 322 full-length research studies published between October 1, 2019 and April 30, 2020 in three major medical journals. We compared the number of randomized controlled trials (RCTs) and studies with a control group before and after January 31, 2020, when Covid-19 began garnering international attention. Results The number of full-length research studies per issue was not statistically different before and after the Covid-19 pandemic (from 3.7 to 3.5 per issue, p = 0.17). Compared to before January 31, 2020, 0.7 fewer non-Covid-19 studies per issue were published versus after January 31, 2020 (p<0.001), a change that was offset by Covid-19 studies. Among non-Covid-19 studies, 0.9 fewer studies with a control group per issue were published after January 31, 2020, with RCTs contributing to nearly all the decline (p<0.001, p = 0.001, respectively). In the same timeframe, non-Covid-19 studies without a control group and non-Covid-19 studies without randomization experienced relatively small changes that did not meet our threshold for statistical significance (increases of 0.1 and 0.1 per issue, p = 0.80, p = 0.88, respectively). Limitations Using a simple heuristic for assessing research design and lack of generalizability to the general medical literature. Conclusions In summary, the increase in Covid-19 studies coincided with a decrease of mostly non-Covid-19 RCTs.	[Bian, Shelly X.] Univ Southern Calif, Dept Radiat Oncol, Los Angeles, CA 90007 USA; [Lin, Eugene] Univ Southern Calif, Dept Med, Div Nephrol & Hypertens, Los Angeles, CA 90007 USA	University of Southern California; University of Southern California	Lin, E (corresponding author), Univ Southern Calif, Dept Med, Div Nephrol & Hypertens, Los Angeles, CA 90007 USA.	eugeneli@usc.edu		Bian, Shelly/0000-0003-0599-019X; Reis, AlessanRSS/0000-0001-8486-7469; Lin, Eugene/0000-0002-3559-5134	National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [NIDDK K08DK118213]; University Kidney Research Organization	National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University Kidney Research Organization	This work was supported in part by the National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): EL receives support from NIDDK K08DK118213. EL also receives support from the University Kidney Research Organization. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexander PE, 2020, J CLIN EPIDEMIOLOGY, V123; Bae S, 2020, ANN INTERN MED, V173, P79, DOI 10.7326/L20-0745; Brainard J, 2020, SCIENCE 85; Chong SA, 2010, PUBLIC HEALTH ETH-UK, V3, P35, DOI 10.1093/phe/phq005; Di Girolamo N, CHARACTERISTICS SCI, DOI [10.1101/2020.04.20.20073130v1, DOI 10.1101/2020.04.20.20073130V1]; Doroshow D, 2020, ANN INTERN MED, V173, P297, DOI 10.7326/M20-2076; Glasziou PP, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1847; Hawkins JE, 2020, NEJM CATAL; Horbach S., 2020, MEDICAL J DRASTICALL, DOI [10.1101/2020.04.18.045963, DOI 10.1101/2020.04.18.045963]; Kupferschmidt K, 2020, SCIENCE 85; Kwon Diana, 2020, Nature, V581, P130, DOI 10.1038/d41586-020-01394-6; Ledford H, 2020, NATURE, V580, P15, DOI 10.1038/d41586-020-00889-6; London AJ, 2020, SCIENCE, V368, P476, DOI 10.1126/science.abc1731; Mehra MR, 2020, NEW ENGL J MED, V382, P2582, DOI 10.1056/NEJMc2021225; Mehra MR, 2020, LANCET, V395, P1820, DOI [10.1016/S0140-6736(20)31324-6, 10.1016/S0140-6736(20)31180-6]; Mittelhammer R. C., 2000, ECONOMETRIC FDN; Servick K, 2020, SCIENCE 85; Widener A, 2020, CHEM ENG NEWS CEN, V98, P14, DOI [10.1021/cen-09813-polcon2, DOI 10.1021/CEN-09813-POLCON2]; Zeng Y, 2020, LANCET GLOB HEALTH, DOI [10.1016/S2214-109X, DOI 10.1016/S2214-109X]	19	5	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238831	10.1371/journal.pone.0238831	http://dx.doi.org/10.1371/journal.pone.0238831			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32913357	gold, Green Published			2022-12-26	WOS:000571885900006
J	Yu, S; Galeffi, F; Rodriguiz, RM; Wang, ZR; Shen, YT; Lyu, JJ; Li, R; Bernstock, JD; Johnson, KR; Liu, S; Sheng, HX; Turner, DA; Wetsel, WC; Paschen, W; Yang, W				Yu, Shu; Galeffi, Francesca; Rodriguiz, Ramona M.; Wang, Zhuoran; Shen, Yuntian; Lyu, Jingjun; Li, Ran; Bernstock, Joshua D.; Johnson, Kory R.; Liu, Shuai; Sheng, Huaxin; Turner, Dennis A.; Wetsel, William C.; Paschen, Wulf; Yang, Wei			Small ubiquitin-like modifier 2 (SUMO2) is critical for memory processes in mice	FASEB JOURNAL			English	Article						knockout; LTP; memory impairment; posttranslational modification	LONG-TERM POTENTIATION; SUMOYLATION; LOCALIZATION; MECHANISMS; PLASTICITY; PHYSIOLOGY; ISCHEMIA; PROTEINS; RECOVERY; BEHAVIOR	Small ubiquitin-like modifier (SUMO1-3) conjugation (SUMOylation), a posttranslational modification, modulates almost all major cellular processes. Mounting evidence indicates that SUMOylation plays a crucial role in maintaining and regulating neural function, and importantly its dysfunction is implicated in cognitive impairment in humans. We have previously shown that simultaneously silencing SUMO1-3 expression in neurons negatively affects cognitive function. However, the roles of the individual SUMOs in modulating cognition and the mechanisms that link SUMOylation to cognitive processes remain unknown. To address these questions, in this study, we have focused on SUMO2 and generated a new conditionalSumo2knockout mouse line. We found that conditional deletion ofSumo2predominantly in forebrain neurons resulted in marked impairments in various cognitive tests, including episodic and fear memory. Our data further suggest that these abnormalities are attributable neither to constitutive changes in gene expression nor to alterations in neuronal morphology, but they involve impairment in dynamic SUMOylation processes associated with synaptic plasticity. Finally, we provide evidence that dysfunction on hippocampal-based cognitive tasks was associated with a significant deficit in the maintenance of hippocampal long-term potentiation inSumo2knockout mice. Collectively, these data demonstrate that protein conjugation by SUMO2 is critically involved in cognitive processes.	[Yu, Shu; Wang, Zhuoran; Shen, Yuntian; Lyu, Jingjun; Li, Ran; Liu, Shuai; Sheng, Huaxin; Paschen, Wulf; Yang, Wei] Duke Univ, Med Ctr, Dept Anesthesiol, Box 3094,Res Dr, Durham, NC 27710 USA; [Yu, Shu; Shen, Yuntian] Nantong Univ, Coinnovat Ctr Neuroregenerat, Key Lab Neuroregenerat Jiangsu, Nantong, Peoples R China; [Yu, Shu; Shen, Yuntian] Nantong Univ, Coinnovat Ctr Neuroregenerat, Minist Educ, Nantong, Peoples R China; [Galeffi, Francesca; Turner, Dennis A.] Durham VAMC, Res & Surg Serv, Durham, NC USA; [Galeffi, Francesca; Turner, Dennis A.] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC USA; [Galeffi, Francesca; Turner, Dennis A.; Wetsel, William C.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Galeffi, Francesca; Turner, Dennis A.] Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC USA; [Rodriguiz, Ramona M.; Wetsel, William C.] Duke Univ, Med Ctr, Mouse Behav & Neuroendocrine Anal Core Facil, Dept Psychiat & Behav Sci, Durham, NC USA; [Bernstock, Joshua D.] NINDS, Stroke Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Johnson, Kory R.] NINDS, Bioinformat Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Wetsel, William C.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University; Nantong University; Nantong University; Duke University; Duke University; Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Duke University	Paschen, W; Yang, W (corresponding author), Duke Univ, Med Ctr, Dept Anesthesiol, Box 3094,Res Dr, Durham, NC 27710 USA.	wulf.paschen@duke.edu; wei.yang@duke.edu	Yang, Wei/ABE-2905-2021; Shen, Yuntian/GPX-9670-2022	Liu, Shuai/0000-0002-6069-4900; Bernstock, Joshua/0000-0002-7814-3867	HHS \ NIH\ National Institute of Neurological Disorders and Stroke (NINDS) [NS081299]; American Heart Association (AHA) [16GRNT30270003]	HHS \ NIH\ National Institute of Neurological Disorders and Stroke (NINDS); American Heart Association (AHA)(American Heart Association)	HHS vertical bar NIH vertical bar National Institute of Neurological Disorders and Stroke (NINDS), Grant/Award Number: NS081299; American Heart Association (AHA), Grant/Award Number: 16GRNT30270003	Bartley AF, 2015, EUR J NEUROSCI, V41, P1402, DOI 10.1111/ejn.12898; CASTRO CA, 1989, NATURE, V342, P545, DOI 10.1038/342545a0; Chamberlain SEL, 2012, NAT NEUROSCI, V15, P845, DOI 10.1038/nn.3089; Chao HW, 2008, J CELL BIOL, V182, P141, DOI 10.1083/jcb.200712094; Chen YC, 2014, J NEUROSCI, V34, P9574, DOI 10.1523/JNEUROSCI.4302-13.2014; Craig TJ, 2012, J BIOL CHEM, V287, P22781, DOI 10.1074/jbc.M112.356337; Daniel JA, 2017, ELIFE, V6, DOI 10.7554/eLife.26338; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Evdokimov E, 2008, J CELL SCI, V121, P4106, DOI 10.1242/jcs.038570; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Granger AJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0136; Grupe A, 2007, HUM MOL GENET, V16, P865, DOI 10.1093/hmg/ddm031; Hendriks IA, 2016, NAT REV MOL CELL BIO, V17, P581, DOI 10.1038/nrm.2016.81; Henley JM, 2014, PHYSIOL REV, V94, P1249, DOI 10.1152/physrev.00008.2014; Ho VM, 2011, SCIENCE, V334, P623, DOI 10.1126/science.1209236; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Jackman SL, 2016, NATURE, V529, P88, DOI 10.1038/nature16507; Kandel ER, 2014, CELL, V157, P163, DOI 10.1016/j.cell.2014.03.001; Kersey PJ, 2012, NUCLEIC ACIDS RES, V40, pD91, DOI 10.1093/nar/gkr895; Lee L, 2014, SCI REP-UK, V4, DOI 10.1038/srep07190; Liu S, 2016, J CEREBR BLOOD F MET, V36, P393, DOI 10.1177/0271678X15608393; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Matsuzaki S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10730; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Nair Rajeevkumar R, 2017, Front Synaptic Neurosci, V9, P8, DOI 10.3389/fnsyn.2017.00008; Nakajima M, 2014, CELL, V159, P295, DOI 10.1016/j.cell.2014.09.020; Nicoll RA, 2017, NEURON, V93, P281, DOI 10.1016/j.neuron.2016.12.015; Park P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0131; Pogorelov VM, 2017, NEUROPSYCHOPHARMACOL, V42, P2163, DOI 10.1038/npp.2017.52; Pogorelov VM, 2005, NEUROPSYCHOPHARMACOL, V30, P1818, DOI 10.1038/sj.npp.1300724; Ripamonti S, 2020, J NEUROCHEM, V154, P647, DOI 10.1111/jnc.15008; Sannino S, 2012, LEARN MEMORY, V19, P211, DOI 10.1101/lm.025213.111; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shen YT, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009634; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Tai DJC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10552; Tai DJC, 2011, EMBO J, V30, P205, DOI 10.1038/emboj.2010.290; Tirard M, 2012, P NATL ACAD SCI USA, V109, P21122, DOI 10.1073/pnas.1215366110; Vogel-Ciernia Annie, 2014, Curr Protoc Neurosci, V69, DOI 10.1002/0471142301.ns0831s69; Wang LL, 2014, EMBO REP, V15, P878, DOI 10.15252/embr.201438534; Wang LL, 2014, J PSYCHIATR NEUROSCI, V39, P259, DOI 10.1503/jpn.130148; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Yang W, 2014, STROKE, V45, P1115, DOI 10.1161/STROKEAHA.113.004315; Zhang L, 2017, NEUROSCIENCE, V343, P190, DOI 10.1016/j.neuroscience.2016.11.036	46	6	6	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14750	14767		10.1096/fj.202000850RR	http://dx.doi.org/10.1096/fj.202000850RR		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32910521	Green Accepted, Bronze			2022-12-26	WOS:000570302000001
J	Chamoun, MN; Sullivan, MJ; Goh, KGK; Acharya, D; Ipe, DS; Katupitiya, L; Gosling, D; Peters, KM; Sweet, MJ; Sester, DP; Schembri, MA; Ulett, GC				Chamoun, Michelle N.; Sullivan, Matthew J.; Goh, Kelvin G. K.; Acharya, Dhruba; Ipe, Deepak S.; Katupitiya, Lahiru; Gosling, Dean; Peters, Kate M.; Sweet, Matthew J.; Sester, David P.; Schembri, Mark A.; Ulett, Glen C.			Restriction of chronicEscherichia coliurinary tract infection depends upon T cell-derived interleukin-17, a deficiency of which predisposes to flagella-driven bacterial persistence	FASEB JOURNAL			English	Article						urinary tract infection; bacterial pathogenesis; innate immunity; Escherichia coli; Gram-negative pathogens	UROPATHOGENIC ESCHERICHIA-COLI; DENDRITIC CELLS; EXPRESSION; BLADDER; INNATE; INFLAMMATION; MICE; COLONIZATION; EPIDEMIOLOGY; ACTIVATION	Urinary tract infections (UTI) frequently progress to chronicity in infected individuals but the mechanisms of pathogenesis underlying chronic UTI are not well understood. We examined the role of interleukin (IL)-17A in UTI because this cytokine promotes innate defense against uropathogenicEscherichia coli(UPEC). Analysis of UPEC persistence and pyelonephritis in mice deficient in IL-17A revealed that UPEC CFT073 caused infection at a rate higher than the multidrug resistant strain EC958.Il17a(-/-)mice exhibited pyelonephritis with kidney bacterial burdens higher than those of wild-type (WT) mice. Synthesis of IL-17A in the bladder reflected a combination of gamma delta-T and T(H)17 cell responses. Analysis of circulating inflammatory mediators at 24h postinoculation identified predictors of progression to chronicity, including IL-6 and monocyte chemoattractant protein-1 (MCP-1). Histological analysis identified infiltrating populations of neutrophils, NK cells, and gamma delta T cells in the bladder, whereas neutrophils predominated in the kidney. Analysis of the contribution of flagella to chronicity using hyper-flagellated andfliC-deficient UPEC in WT andIl17a(-/-)mice revealed that, in a host that is deficient for the production of IL-17A, flagella contribute to bacterial persistence. These findings show a role for IL-17A in defense against chronic UTI and a contribution of flagella to the pathogenesis of infection.	[Chamoun, Michelle N.; Sullivan, Matthew J.; Goh, Kelvin G. K.; Acharya, Dhruba; Ipe, Deepak S.; Katupitiya, Lahiru; Gosling, Dean; Ulett, Glen C.] Griffith Univ, Menzies Hlth Inst Queensland, Sch Med Sci, Parklands, Qld, Australia; [Peters, Kate M.; Schembri, Mark A.] Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Sweet, Matthew J.] Univ Queensland, Australian Infect Dis Res Ctr, IMB Ctr Inflammat & Dis Res, Inst Mol Biosci IMB, Brisbane, Qld, Australia; [Sester, David P.] TRI Flow Cytometry Suite TRIfcs, Translat Res Inst, Woolloongabba, Qld, Australia; [Ipe, Deepak S.] Griffith Univ, Menzies Hlth Inst Queensland, Sch Dent, Parklands, Qld 4222, Australia; [Gosling, Dean] Gold Coast Univ Hosp, Pathol Queensland Gold Coast Lab, 1 Hosp Blvd, Southport, Qld 4215, Australia	Griffith University; University of Queensland; University of Queensland; Griffith University; Gold Coast University Hospital	Ulett, GC (corresponding author), Griffith Univ, Griffith Hlth Ctr, Sch Med Sci, Gold Coast, Qld 4222, Australia.; Ulett, GC (corresponding author), Griffith Univ, Griffith Hlth Ctr, Menzies Hlth Inst Queensland, Gold Coast, Qld 4222, Australia.	g.ulett@griffith.edu.au	Sullivan, Matthew J/C-3857-2009; Sweet, Matthew J/F-2229-2011; Sester, David/GLR-2942-2022; Goh, Kelvin/S-1006-2017	Sullivan, Matthew J/0000-0003-2276-3132; Sweet, Matthew J/0000-0002-0406-8139; Goh, Kelvin/0000-0001-8347-2043	National Health and Medical Research Council (NHMRC) Australia [APP1146820, APP1129273]; NHMRC [APP1107914, GNT1106930]	National Health and Medical Research Council (NHMRC) Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Project Grants from the National Health and Medical Research Council (NHMRC) Australia (APP1146820 to GCU; and APP1129273 to MJS, MAS, GCU). MJS and MAS are supported by NHMRC Senior Research Fellowships (APP1107914, GNT1106930). We thank Dalia Khalil and Yitian Ding from the flow cytometry core facility at the Translational Research Institute for assistance with acquisition of flow cytometric data, and Steven Hancock for additional experimental assistance.	Acharya D, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00545-19; Acharya D, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00118; Alidjanov JF, 2018, ANTIBIOTICS-BASEL, V7, DOI 10.3390/antibiotics7010006; Barber AE, 2013, CLIN INFECT DIS, V57, P719, DOI 10.1093/cid/cit284; Carey AJ, 2016, CRIT REV MICROBIOL, V42, P780, DOI 10.3109/1040841X.2015.1028885; Carey AJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26836; Carey AJ, 2016, J INFECT DIS, V213, P659, DOI 10.1093/infdis/jiv424; Chamoun MN, 2018, CRIT REV MICROBIOL, V44, P465, DOI [10.1080/1040841x.2018.1426556, 10.1080/1040841X.2018.1426556]; Chang SH, 2011, IMMUNITY, V35, P611, DOI 10.1016/j.immuni.2011.09.010; Cossarizza A, 2019, EUR J IMMUNOL, V49, P1457, DOI 10.1002/eji.201970107; Engel D, 2006, INFECT IMMUN, V74, P6100, DOI 10.1128/IAI.00881-06; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Forde BM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11571-5; Foxman B, 2002, AM J MED, V113, p5S; Hannan TJ, 2014, EBIOMEDICINE, V1, P46, DOI 10.1016/j.ebiom.2014.10.011; Hannan TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001042; Hooton TM, 1996, NEW ENGL J MED, V335, P468, DOI 10.1056/NEJM199608153350703; Hu FQ, 2016, INNATE IMMUN-LONDON, V22, P9, DOI 10.1177/1753425915609973; Ingersoll MA, 2008, CELL MICROBIOL, V10, P2568, DOI 10.1111/j.1462-5822.2008.01230.x; Kakkanat A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16149; Kodner CM, 2010, AM FAM PHYSICIAN, V82, P638; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Lane MC, 2007, J BACTERIOL, V189, P5523, DOI 10.1128/JB.00434-07; Leclercq SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29000; Li BR, 2017, AM J PHYSIOL-RENAL, V312, pF43, DOI 10.1152/ajprenal.00471.2016; Liu T, 2002, INFECT IMMUN, V70, P6638, DOI 10.1128/IAI.70.12.6638-6645.2002; Lore NI, 2016, SCI REP-UK, V6, DOI 10.1038/srep25937; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Michaud JE, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1036-0; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; Mora-Bau G, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005044; Murthy AMV, 2018, VIRULENCE, V9, P967, DOI 10.1080/21505594.2018.1465786; Murthy AMV, 2019, FASEB J; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; O'Brien VP, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007457; Opal SM, 2019, CRITICAL CARE NEPHRO, P476; Renard J, 2015, INFECT DIS THER, V4, P125, DOI 10.1007/s40121-014-0054-6; Schaale K, 2016, MUCOSAL IMMUNOL, V9, P124, DOI 10.1038/mi.2015.44; Scharff AZ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.122998; Schembri MA, 2000, INFECT IMMUN, V68, P2638, DOI 10.1128/IAI.68.5.2638-2646.2000; Schreiber HL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf1283; Schwartz DJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004599; Sellers RS, 2012, VET PATHOL, V49, P32, DOI 10.1177/0300985811429314; Shibata K, 2008, J IMMUNOL, V181, P5940, DOI 10.4049/jimmunol.181.9.5940; Sihra N, 2018, NAT REV UROL, V15, P750, DOI 10.1038/s41585-018-0106-x; Silverman JA, 2013, CURR UROL REP, V14, P448, DOI 10.1007/s11934-013-0354-5; Sivick KE, 2010, J IMMUNOL, V184, P2065, DOI 10.4049/jimmunol.0902386; Sundac L, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw062; Tamadonfar KO, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.BAI-0014-2019; Tan CK, 2012, INFECT IMMUN, V80, P3145, DOI 10.1128/IAI.00023-12; Tittel AP, 2011, J AM SOC NEPHROL, V22, P1435, DOI 10.1681/ASN.2010101072; Totsika M, 2013, J INFECT DIS, V208, P921, DOI 10.1093/infdis/jit245; Totsika M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026578; Totsika M, 2009, J BACTERIOL, V191, P3901, DOI 10.1128/JB.00143-09; Ulett GC, 2013, CURR OPIN MICROBIOL, V16, P100, DOI 10.1016/j.mib.2013.01.005; Wagenlehner FME, 2017, CURR OPIN UROL, V27, P133, DOI 10.1097/MOU.0000000000000364; Wolf L, 2016, AM J PHYSIOL-LUNG C, V311, pL1015, DOI 10.1152/ajplung.00158.2016; Wright KJ, 2005, INFECT IMMUN, V73, P7657, DOI 10.1128/IAI.73.11.7657-7668.2005; Yu L, 2019, ELIFE, V8, DOI 10.7554/eLife.46677	60	6	6	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14572	14587		10.1096/fj.202000760R	http://dx.doi.org/10.1096/fj.202000760R		SEP 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32901999	Bronze			2022-12-26	WOS:000568308500001
J	Trecroci, A; Boccolini, G; Duca, M; Formenti, D; Alberti, G				Trecroci, Athos; Boccolini, Gabriele; Duca, Marco; Formenti, Damiano; Alberti, Giampietro			Mental fatigue impairs physical activity, technical and decision-making performance during small-sided games	PLOS ONE			English	Article							SOCCER PLAYERS	The aim of this study was to investigate the effects of mental fatigue on physical activity, technical and decision-making performance during small-sided games. Nine sub-elite soccer players were enrolled in the study. The players performed two small-sided games on two occasions within a crossover experimental design. Before each game, they underwent a mental fatiguing task (Stroop task) and a control task (documentary watching) in a randomized, counterbalanced order. Players' physical activity, technical, and decision-making performance were obtained during small-sided games by GPS and video scouting. Results showed that distance in acceleration covered per min, negative passes, passing accuracy, and shot accuracy werelikelyimpaired than control task after a mental fatiguing protocol. Decision-making performance of negative passes, passes accuracy, and dribbling accuracy resulted alsolikelydecreased compared with control task. These findings demonstrated that mental fatigue impacted on technical, GPS-derived, and soccer-specific decision-making performance during SSG. In conclusion, avoiding cognitively demanding tasks before playing soccer-specific activities may be advisable to preserve players' physical activity, technical, and decision-making skills.	[Trecroci, Athos; Boccolini, Gabriele; Duca, Marco; Alberti, Giampietro] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Boccolini, Gabriele] Atalanta Bergamasca Calcio, Phys Performance & Sport Sci Dept, Bergamo, Italy; [Formenti, Damiano] Univ Insubria, Dept Biotechnol & Life Sci DBSV, Varese, Italy	University of Milan; University of Insubria	Trecroci, A (corresponding author), Univ Milan, Dept Biomed Sci Hlth, Milan, Italy.	athos.trecroci@unimi.it	Trecroci, Athos/R-5440-2017; Formenti, Damiano/L-7871-2016	Trecroci, Athos/0000-0002-6080-5260; DUCA, MARCO/0000-0001-6487-053X; Boccolini, Gabriele/0000-0002-1909-2094; Formenti, Damiano/0000-0002-2941-937X				Badin OO, 2016, INT J SPORT PHYSIOL, V11, P1100, DOI 10.1123/ijspp.2015-0710; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Boksem MAS, 2008, BRAIN RES REV, V59, P125, DOI 10.1016/j.brainresrev.2008.07.001; Clemente F.M., 2016, SMALL SIDED CONDITIO; Coutinho D, 2018, HUM MOVEMENT SCI, V58, P287, DOI 10.1016/j.humov.2018.03.004; Fernandes-da-Silva J, 2016, J SPORT SCI, V34, P2238, DOI 10.1080/02640414.2016.1209307; Formenti D, 2020, J STRENGTH COND RES, V1; Gabbett T, 2009, INT J SPORTS SCI COA, V4, P273, DOI 10.1260/174795409788549553; Gantois P, 2020, EUR J SPORT SCI, V20, P534, DOI 10.1080/17461391.2019.1656781; Ishii A, 2014, REV NEUROSCIENCE, V25, P469, DOI 10.1515/revneuro-2014-0028; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Liu SY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223666; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Marcora SM, 2009, J APPL PHYSIOL, V106, P857, DOI 10.1152/japplphysiol.91324.2008; Mehta RK, 2014, HUM FACTORS, V56, P645, DOI 10.1177/0018720813507279; Mehta RK, 2012, EUR J APPL PHYSIOL, V112, P2891, DOI 10.1007/s00421-011-2264-x; Pageaux B, 2018, PROGR BRAIN RES; Smith MR, 2018, SPORTS MED, V48, P1525, DOI 10.1007/s40279-018-0908-2; Smith MR, 2016, J SPORT SCI, V34, P1297, DOI 10.1080/02640414.2016.1156241; Smith MR, 2016, MED SCI SPORT EXER, V48, P267, DOI 10.1249/MSS.0000000000000762; Thompson CJ, 2019, SPORTS MED, V49, P177, DOI 10.1007/s40279-018-1016-z; Trecroci A, 2019, J STRENGTH COND RES, V1; Trecroci A, 2016, RES SPORTS MED, V24, P331, DOI 10.1080/15438627.2016.1228063; Van Cutsem J, 2017, SPORTS MED, V47, P1569, DOI 10.1007/s40279-016-0672-0; Warm JS, 2008, HUM FACTORS, V50, P433, DOI 10.1518/001872008X312152	25	32	32	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2020	15	9							e0238461	10.1371/journal.pone.0238461	http://dx.doi.org/10.1371/journal.pone.0238461			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR4MY	32903263	gold, Green Published			2022-12-26	WOS:000571539500011
J	Sang, XY; Xiao, JJ; Liu, Q; Zhu, R; Dai, JJ; Zhang, C; Yu, H; Yang, SJ; Zhang, BF				Sang, Xue-Yu; Xiao, Jing-Jie; Liu, Qing; Zhu, Rui; Dai, Jia-Jia; Zhang, Cheng; Yu, Hong; Yang, Si-Jun; Zhang, Bai-Fang			Regulators of calcineurin 1 deficiency attenuates tubulointerstitial fibrosis through improving mitochondrial fitness	FASEB JOURNAL			English	Article						chronic kidney disease; mitochondrial fragmentation; tubular apoptosis	DYNAMIN-RELATED PROTEIN-1; CHRONIC KIDNEY-DISEASE; MOLECULAR-MECHANISMS; FISSION; RCAN1; INJURY; DISRUPTION; APOPTOSIS; GENE; DEPHOSPHORYLATION	Renal fibrosis is the common pathological process of various chronic kidney diseases (CKD). Recent studies indicate that mitochondrial fragmentation is closely associated with renal fibrosis in CKD. However, the molecular mechanisms leading to mitochondrial fragmentation remain to be elucidated. The present study investigated the role of regulators of calcineurin 1 (RCAN1) in mitochondrial fission and renal interstitial fibrosis using conditional knockout mice in which RCAN1 was genetically deleted in tubular epithelial cells (TECs). TEC-specific deletion of RCAN1 attenuated tubulointerstitial fibrosis and epithelial to mesenchymal transition (EMT)-like phenotype change after unilateral ureteral obstruction (UUO) and ischemia reperfusion injury (IRI) through suppressing TGF-beta 1/Smad3 signaling pathway. TEC-specific deletion of RCAN1 also reduced the tubular apoptosis after UUO by inhibiting cytochrome c/caspase-9 pathway. Ultrastructure analysis revealed a marked decrease in mitochondrial fragmentation in TECs of RCAN1-deficient mice in experimental CKD models. The expression of mitochondrial profission proteins dynamin-related protein 1 (Drp1) and mitochondrial fission factor (Mff) was also downregulated in obstructed kidney of TEC-specific RCAN1-deficient mice. Furthermore, TEC-specific deletion of RCAN1 attenuated the dysfunctional tubular autophagy by regulating PINK1/Parkin-induced mitophagy in CKD. RCAN1 knockdown and knockout similarly improved the mitochondrial quality control in HK-2 cells and primary cultured mouse tubular cells stimulated by TGF-beta 1. Put together, our data indicated that RCAN1 plays an important role in the progression of tubulointerstitial fibrosis through regulating the mitochondrial quality. Therefore, targeting RCAN1 may provide a potential therapeutic approach in CKD.	[Sang, Xue-Yu; Xiao, Jing-Jie; Liu, Qing; Zhu, Rui; Dai, Jia-Jia; Zhang, Cheng; Yu, Hong; Zhang, Bai-Fang] Wuhan Univ, Sch Basic Med Sci, Hubei Prov Key Lab Dev Originated Dis, Dept Biochem, Wuhan 430071, Peoples R China; [Yang, Si-Jun] Wuhan Univ, ABSL 3 Lab Ctr Anim Expt, State Key Lab Virol, Sch Med, Wuhan, Peoples R China	Wuhan University; Wuhan University	Zhang, BF (corresponding author), Wuhan Univ, Sch Basic Med Sci, Hubei Prov Key Lab Dev Originated Dis, Dept Biochem, Wuhan 430071, Peoples R China.; Yang, SJ (corresponding author), Wuhan Univ, ABSL 3 Lab Ctr Anim Expt, State Key Lab Virol, Sch Med, Wuhan, Peoples R China.	zbfwq@whu.edu.cn; zbfwq@whu.edu.cn			National Natural Science Foundation of China [81370819]; Zhongnan Hospital of Wuhan University [ZNLH201907]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhongnan Hospital of Wuhan University	National Natural Science Foundation of China, Grant/Award Number: 81370819; Zhongnan Hospital of Wuhan University ZNLH201907	Ayanga BA, 2016, J AM SOC NEPHROL, V27, P2733, DOI 10.1681/ASN.2015101096; Bernhardt A, 2017, KIDNEY INT, V92, P1157, DOI 10.1016/j.kint.2017.03.035; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Burman JL, 2017, J CELL BIOL, V216, P3231, DOI 10.1083/jcb.201612106; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Che RC, 2014, AM J PHYSIOL-RENAL, V306, pF367, DOI 10.1152/ajprenal.00571.2013; Chen HM, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20192759; Cho SG, 2010, AM J PHYSIOL-RENAL, V299, pF199, DOI 10.1152/ajprenal.00716.2009; Choi YJ, 2000, KIDNEY INT, V58, P1481, DOI 10.1046/j.1523-1755.2000.00310.x; Ermak G, 2011, FASEB J, V25, P3306, DOI 10.1096/fj.11-185728; Falke LL, 2015, NAT REV NEPHROL, V11, P233, DOI 10.1038/nrneph.2014.246; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Galvan DL, 2019, J CLIN INVEST, V129, P2807, DOI 10.1172/JCI127277; Galvan DL, 2017, KIDNEY INT, V92, P1051, DOI 10.1016/j.kint.2017.05.034; Harris CD, 2005, CELL MOL LIFE SCI, V62, P2477, DOI 10.1007/s00018-005-5085-4; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Jang C, 2011, KOREAN J PHYSIOL PHA, V15, P299, DOI 10.4196/kjpp.2011.15.5.299; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Li HL, 2018, KIDNEY INT, V94, P1160, DOI 10.1016/j.kint.2018.07.023; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; McWilliams TG, 2017, CURR OPIN CELL BIOL, V45, P83, DOI 10.1016/j.ceb.2017.03.013; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006; Ortega A, 2006, J AM SOC NEPHROL, V17, P1594, DOI 10.1681/ASN.2005070690; Parra V, 2018, CIRC RES, V122, pE20, DOI 10.1161/CIRCRESAHA.117.311522; Peiris H, 2018, CLIN EXP PHARMACOL P, V45, P377, DOI 10.1111/1440-1681.12884; Peiris H, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006033; Sanz AB, 2008, J AM SOC NEPHROL, V19, P1634, DOI 10.1681/ASN.2007121336; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Springer MZ, 2016, J PATHOL, V240, P253, DOI 10.1002/path.4774; Tang CY, 2016, J AM SOC NEPHROL, V27, P1869, DOI 10.1681/ASN.2015111277; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Ucero AC, 2014, INT UROL NEPHROL, V46, P765, DOI 10.1007/s11255-013-0520-1; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wong H, 2015, ACTA NEUROPATHOL, V130, P829, DOI 10.1007/s00401-015-1499-8; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yang B, 2018, J AM SOC NEPHROL, V29, P1900, DOI 10.1681/ASN.2017050581; Yang JW, 2002, J CLIN INVEST, V110, P1525, DOI 10.1172/JC1200216219; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhan M, 2015, J AM SOC NEPHROL, V26, P1304, DOI 10.1681/ASN.2014050457; Zhang LX, 2016, NEW ENGL J MED, V375, P905, DOI 10.1056/NEJMc1602469; Zhou H, 2018, REDOX BIOL, V15, P335, DOI 10.1016/j.redox.2017.12.019	51	6	7	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14539	14557		10.1096/fj.202000781RRR	http://dx.doi.org/10.1096/fj.202000781RRR		SEP 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32896034	Bronze			2022-12-26	WOS:000568298800001
J	Muhammad, SA; Nordin, N; Hussin, P; Mehat, MZ; Abu Kasim, NH; Fakurazi, S				Muhammad, Suleiman Alhaji; Nordin, Norshariza; Hussin, Paisal; Mehat, Muhammad Zulfadli; Abu Kasim, Noor Hayaty; Fakurazi, Sharida			Protective effects of stem cells from human exfoliated deciduous teeth derived conditioned medium on osteoarthritic chondrocytes	PLOS ONE			English	Article							KNEE OSTEOARTHRITIS; CARTILAGE; EXPRESSION; INTERLEUKIN-10; DEFECTS	Treatment of osteoarthritis (OA) is still a major clinical challenge due to the limited inherent healing capacity of cartilage. Recent studies utilising stem cells suggest that the therapeutic benefits of these cells are mediated through the paracrine mechanism of bioactive molecules. The present study evaluates the regenerative effect of stem cells from human exfoliated deciduous teeth (SHED) conditioned medium (CM) on OA chondrocytes. The CM was collected after the SHED were cultured in serum-free medium (SFM) for 48 or 72 h and the cells were characterised by the expression of MSC and pluripotency markers. Chondrocytes were stimulated with interleukin-1 beta and treated with the CM. Subsequently, the expression of aggrecan, collagen type 2 (COL 2), matrix metalloproteinase-13 (MMP-13), nuclear factor-kB (NF-kB) and the level of inflammatory and anti-inflammatory markers were evaluated. SHED expressed mesenchymal stromal cell surface proteins but were negative for haematopoietic markers. SHED also showed protein expression of NANOG, OCT4 and SOX2 with differential subcellular localisation. Treatment of OA chondrocytes with CM enhanced anti-inflammation compared to control cells treated with SFM. Furthermore, the expression of MMP-13 and NF-kB was significantly downregulated in stimulated chondrocytes incubated in CM. The study also revealed that CM increased the expression of aggrecan and COL 2 in OA chondrocytes compared to SFM control. Both CM regenerate extracellular matrix proteins and mitigate increased MMP-13 expression through inhibition of NF-kB in OA chondrocytes due to the presence of bioactive molecules. The study underscores the potential of CM for OA treatment.	[Muhammad, Suleiman Alhaji; Fakurazi, Sharida] Univ Putra Malaysia, Inst Biosci, Seri Kembangan, Selangor, Malaysia; [Muhammad, Suleiman Alhaji] Usmanu Danfodiyo Univ, Dept Biochem, Sokoto, Nigeria; [Nordin, Norshariza] Univ Putra Malaysia, Dept Biomed Sci, Seri Kembangan, Selangor, Malaysia; [Hussin, Paisal] Columbia Asia Hosp, Dept Orthopaed, Subang Jaya, Selangor, Malaysia; [Mehat, Muhammad Zulfadli; Fakurazi, Sharida] Univ Putra Malaysia, Dept Human Anat, Seri Kembangan, Selangor, Malaysia; [Abu Kasim, Noor Hayaty] Univ Kebangsaan Malaysia, Fac Dent, Deans Off, Kuala Lumpur, Malaysia; [Abu Kasim, Noor Hayaty] Univ Airlangga, Fac Dent Med, Surabaya, Indonesia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Kebangsaan Malaysia; Airlangga University	Fakurazi, S (corresponding author), Univ Putra Malaysia, Inst Biosci, Seri Kembangan, Selangor, Malaysia.; Fakurazi, S (corresponding author), Univ Putra Malaysia, Dept Human Anat, Seri Kembangan, Selangor, Malaysia.	sharida@upm.edu.my	Mehat, Muhammad Zulfadli/ABI-6843-2022; Abu Kasim, Noor Hayaty/AGQ-9870-2022	Muhammad, Suleiman A./0000-0003-2421-3556; FAKURAZI, SHARIDA/0000-0001-8986-876X; MEHAT, MUHAMMAD ZULFADLI/0000-0002-9740-6458	Putra Grant, Universiti Putra Malaysia [GPB/9657800]	Putra Grant, Universiti Putra Malaysia	This research work was supported by Putra Grant, Universiti Putra Malaysia with grant number: GPB/9657800.	Ackerman IN, 2017, J ORTHOP SPORT PHYS, V47, P67, DOI 10.2519/jospt.2017.7286; Akgun I, 2015, ARCH ORTHOP TRAUM SU, V135, P251, DOI 10.1007/s00402-014-2136-z; Amoako AO, 2014, CLIN MED INSIGHTS-AR, V7, P27, DOI 10.4137/CMAMD.S14386; Ando Y, 2014, BONE, V61, P82, DOI 10.1016/j.bone.2013.12.029; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2015, LANCET ONCOL, V16, pe158; Attur M, 2015, FASEB J, V29, P4107, DOI 10.1096/fj.15-272427; Bauge C, 2014, AGING DIS, V5, P394, DOI 10.14336/AD.2014.0500394; Borakati A, 2018, CURR STEM CELL RES T, V13, P215, DOI 10.2174/1574888X12666170915120620; Bravo MD, 2016, PURINERG SIGNAL, V12, P595, DOI 10.1007/s11302-016-9529-0; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Chabane N, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2652; Finnson Kenneth W, 2012, Front Biosci (Schol Ed), V4, P251; Fortier LA, 2011, CLIN ORTHOP RELAT R, V469, P2706, DOI 10.1007/s11999-011-1857-3; Haque N, 2018, ADV EXP MED BIOL, V1083, P29, DOI 10.1007/5584_2017_74; Hulejova H, 2007, CYTOKINE, V38, P151, DOI 10.1016/j.cyto.2007.06.001; Jansen NWD, 2008, BRIT J HAEMATOL, V142, P953, DOI 10.1111/j.1365-2141.2008.07278.x; Jiang ZL, 2009, FERTIL STERIL, V91, P616, DOI 10.1016/j.fertnstert.2007.11.059; Johnson CI, 2016, VET J, V209, P40, DOI 10.1016/j.tvjl.2015.07.011; Jung YK, 2013, ARTHRITIS RHEUM-US, V65, P3153, DOI 10.1002/art.38181; Kay AG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18144-w; Lee WYW, 2017, J ORTHOP TRANSL, V9, P76, DOI 10.1016/j.jot.2017.03.005; Liu L, 2011, J ENDODONT, V37, P466, DOI 10.1016/j.joen.2010.12.012; Livshits G, 2009, ARTHRITIS RHEUM-US, V60, P2037, DOI 10.1002/art.24598; Maldonado M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/284873; Marcu KB, 2010, CURR DRUG TARGETS, V11, P599, DOI 10.2174/138945010791011938; Moraes DA, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0359-3; Muller S, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1026-x; Muhammad SA, 2019, BIOFACTORS, V45, P880, DOI 10.1002/biof.1563; Muhammad SA, 2021, CARTILAGE, V13, p872S, DOI 10.1177/1947603519876333; Muhammad SA, 2019, CELL TISSUE RES, V375, P329, DOI 10.1007/s00441-018-2884-0; Naranda J, 2017, PEERJ, V5, DOI 10.7717/peerj.3079; Neogi T, 2013, OSTEOARTHR CARTILAGE, V21, P1145, DOI 10.1016/j.joca.2013.03.018; Oka M, 2013, J BIOL CHEM, V288, P15085, DOI 10.1074/jbc.M112.448837; Olivotto E, 2015, RMD OPEN, V1, DOI 10.1136/rmdopen-2015-000061; Pawitan JA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/965849; Platas J, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/357014; Poree B, 2008, J BIOL CHEM, V283, P4850, DOI 10.1074/jbc.M706387200; Rose BJ, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/4895050; Saito T, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1296-y; Suguitan Jr AL, 2011, PLOS ONE, V6; Tang JL, 2015, MOL MED REP, V12, P1753, DOI 10.3892/mmr.2015.3645; Tofino-Vian M, 2018, CELL PHYSIOL BIOCHEM, V47, P11, DOI 10.1159/000489739; Tsai CC, 2012, CELL CYCLE, V11, P3711, DOI 10.4161/cc.22048; van Buul GM, 2012, OSTEOARTHR CARTILAGE, V20, P1186, DOI 10.1016/j.joca.2012.06.003; Vizoso FJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091852; Zhu YZ, 2015, EXPERT OPIN BIOL TH, V15, P163, DOI 10.1517/14712598.2015.960837	47	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238449	10.1371/journal.pone.0238449	http://dx.doi.org/10.1371/journal.pone.0238449			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886713	Green Published, gold, Green Accepted			2022-12-26	WOS:000571064300027
J	Patterson, B; Dinkele, R; Gessner, S; Morrow, C; Kamariza, M; Bertozzi, CR; Kamholz, A; Bryden, W; Call, C; Warner, DF; Wood, R				Patterson, Benjamin; Dinkele, Ryan; Gessner, Sophia; Morrow, Carl; Kamariza, Mireille; Bertozzi, Carolyn R.; Kamholz, Andrew; Bryden, Wayne; Call, Charles; Warner, Digby F.; Wood, Robin			Sensitivity optimisation of tuberculosis bioaerosol sampling	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; AERIAL DISSEMINATION; GUINEA-PIGS; TRANSMISSION; CONTAGION; 2-YEAR	Introduction Detection ofMycobacterium tuberculosis(Mtb) in patient-derived bioaerosol is a potential tool to measure source case infectiousness. However, current bioaerosol sampling approaches have reported low detection yields in sputum-positive TB cases. To increase the utility of bioaerosol sampling, we present advances in bioaerosol collection andMtbidentification that improve detection yields. Methods A previously described Respiratory Aerosol Sampling Chamber (RASC) protocol, or "RASC-1", was modified to incorporate liquid collection of bioaerosol using a high-flow wet-walled cyclone (RASC-2). Individuals with GeneXpert-positive pulmonary TB were sampled pre-treatment over 60-minutes. PutativeMtbbacilli were detected in collected fluid by fluorescence microscopy utilising DMN-Trehalose. Exhaled air and bioaerosol volumes were estimated using continuous CO(2)monitoring and airborne particle counting, respectively.Mtbcapture was calculated per exhaled air volume sampled and bioaerosol volume for RASC-1 (n = 35) and for RASC-2 (n = 21). Empty chamber samples were collected between patients as controls. Results The optimised RASC-2 protocol sampled a median of 258.4L (IQR: 226.9-273.6) of exhaled air per patient compared with 27.5L (IQR: 23.6-30.3) for RASC-1 (p<0.0001). Bioaerosol volume collection was estimated at 2.3nL (IQR: 1.1-3.6) for RASC-2 compared with 0.08nL (IQR: 0.05-0.10) for RASC-1 (p<0.0001). The detection yield of viableMtbimproved from 43% (median 2 CFU, range: 1-14) to 95% (median 20.5 DMN-Trehalose positive bacilli, range: 2-155). These improvements represent a lowering of the limit of detection in the RASC-2 platform to 0.9Mtbbacilli per 100L of exhaled air from 3.3Mtbbacilli per 100L (RASC-1). Conclusion This study demonstrates that technical improvements in particle collection together with sensitive detection enable rapid quantitation of viableMtbin bioaerosols of sputum positive TB cases. Increased sampling sensitivity may allow future TB transmission studies to be extended to sputum-negative and subclinical individuals, and suggests the potential utility of bioaerosol measurement for rapid intervention in other airborne infectious diseases.	[Patterson, Benjamin] Univ Amsterdam, Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Dinkele, Ryan; Gessner, Sophia; Warner, Digby F.] Univ Cape Town, Fac Hlth Sci, SAMRC NHLS UCT Mol Mycobacteriol Res Unit, Dept Pathol, Rondebosch, South Africa; [Dinkele, Ryan; Gessner, Sophia; Warner, Digby F.] Univ Cape Town, DST NRF Ctr Excellence Biomed TB Res, Rondebosch, South Africa; [Dinkele, Ryan; Gessner, Sophia; Warner, Digby F.; Wood, Robin] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Morrow, Carl; Wood, Robin] Univ Cape Town, Desmond Tutu HIV Ctr, Cape Town, South Africa; [Kamariza, Mireille] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Bertozzi, Carolyn R.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Bertozzi, Carolyn R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Kamholz, Andrew] Edge Embossing, Boston, MA USA; [Bryden, Wayne; Call, Charles] Zeteo Tech, Sykesville, MD USA; [Warner, Digby F.] Univ Cape Town, Wellcome Ctr Infect Dis Res Africa, Cape Town, South Africa	University of Amsterdam; University of Cape Town; National Research Foundation - South Africa; University of Cape Town; University of Cape Town; University of Cape Town; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; University of Cape Town	Patterson, B (corresponding author), Univ Amsterdam, Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands.	patterson.b@unic.ac.cy		Patterson, Benjamin/0000-0002-2445-6390; Kamariza, Mireille/0000-0003-1255-0803; Warner, Digby/0000-0002-4146-0930; Morrow, Carl/0000-0002-6059-1346	NIH, NIAID [R01AI147347-01]; National Treasury under the Economic Competitiveness and Support Package [MRC-RFA-UFSP-01-2013/CCAMP]; Bill & Melinda Gates Foundation [OPP1116641]	NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Treasury under the Economic Competitiveness and Support Package; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	NIH, NIAID: R01AI147347-01 "Identifying TB transmitters in high TB/HIV burdened communities"(Robin Wood, PI; Digby Warner, co-PI). 1st July 2019 -30th June 2024 the South African Medical Research Council (MRC) with funds from National Treasury under the Economic Competitiveness and Support Package (MRC-RFA-UFSP-01-2013/CCAMP) and the Bill & Melinda Gates Foundation (OPP1116641). (Robin Wood, PI) The funders provided support in the form of salaries for authors RW and DW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CHEM WORLD, V10, P12; [Anonymous], 2016, CANC DISCOV; Dharmadhikari AS, 2011, TUBERCULOSIS, V91, P329, DOI 10.1016/j.tube.2011.03.002; Dinkele R, 2019, BIORXIV, DOI [10.1101/2019.12.23.887729., DOI 10.1101/2019.12.23.887729, 10.1101/2019.12.23.887729]; Donald PR, 2018, INT J TUBERC LUNG D, V22, P972, DOI 10.5588/ijtld.18.0173; Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188; Fennelly KP, 2004, AM J RESP CRIT CARE, V169, P604, DOI 10.1164/rccm.200308-1101OC; Middelkoop K, 2015, J INFECT DIS, V211, P53, DOI 10.1093/infdis/jiu403; Patterson Benjamin, 2017, Gates Open Res, V1, P11, DOI 10.12688/gatesopenres.12758.2; RILEY RL, 1995, AM J EPIDEMIOL, V142, P3, DOI 10.1093/oxfordjournals.aje.a117542; RILEY RL, 1959, AM J HYG, V70, P185, DOI 10.1093/oxfordjournals.aje.a120069; SULTAN L, 1960, AM REV RESPIR DIS, V82, P358; Williams CML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104921; Wood R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146658; Wood R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025098; World Health Organization, 2019, GLOB TUB REP; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; 2018, CURR OPIN TOXICOL, V10	18	6	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238193	10.1371/journal.pone.0238193	http://dx.doi.org/10.1371/journal.pone.0238193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881875	Green Submitted, gold, Green Published			2022-12-26	WOS:000571063300004
J	Shomar, A; Barak, O; Brenner, N				Shomar, Aseel; Barak, Omri; Brenner, Naama			Local and global features of genetic networks supporting a phenotypic switch	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NEGATIVE FEEDBACK LOOP; BOOLEAN NETWORK; PLASTICITY; MODELS; ZEB1	Phenotypic switches are associated with alterations in the cell's gene expression profile and are vital to many aspects of biology. Previous studies have identified local motifs of the genetic regulatory network that could underlie such switches. Recent advancements allowed the study of networks at the global, many-gene, level; however, the relationship between the local and global scales in giving rise to phenotypic switches remains elusive. In this work, we studied the epithelial-mesenchymal transition (EMT) using a gene regulatory network model. This model supports two clusters of stable steady-states identified with the epithelial and mesenchymal phenotypes, and a range of intermediate less stable hybrid states, whose importance in cancer has been recently highlighted. Using an array of network perturbations and quantifying the resulting landscape, we investigated how features of the network at different levels give rise to these landscape properties. We found that local connectivity patterns affect the landscape in a mostly incremental manner; in particular, a specific previously identified double-negative feedback motif is not required when embedded in the full network, because the landscape is maintained at a global level. Nevertheless, despite the distributed nature of the switch, it is possible to find combinations of a few local changes that disrupt it. At the level of network architecture, we identified a crucial role for peripheral genes that act as incoming signals to the network in creating clusters of states. Such incoming signals are a signature of modularity and are expected to appear also in other biological networks. Hybrid states between epithelial and mesenchymal arise in the model due to barriers in the interaction between genes, causing hysteresis at all connections. Our results suggest emergent switches can neither be pinpointed to local motifs, nor do they arise as typical properties of random network ensembles. Rather, they arise through an interplay between the nature of local interactions, and the core-periphery structure induced by the modularity of the cell.	[Shomar, Aseel; Brenner, Naama] Technion, Dept Chem Engn, Haifa, Israel; [Shomar, Aseel; Barak, Omri; Brenner, Naama] Technion, Lorry Lokey Ctr Life Sci & Engn, Network Biol Res Labs, Haifa, Israel; [Barak, Omri] Technion, Rappaport Fac Med, Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Brenner, N (corresponding author), Technion, Dept Chem Engn, Haifa, Israel.; Brenner, N (corresponding author), Technion, Lorry Lokey Ctr Life Sci & Engn, Network Biol Res Labs, Haifa, Israel.	nbrenner@tx.technion.ac.il		Barak, Omri/0000-0002-7894-6344	Israeli Science Foundation [346/16, 155/18]; Adams Fellowship Program of the Israel Academy of Science and Humanities	Israeli Science Foundation(Israel Science Foundation); Adams Fellowship Program of the Israel Academy of Science and Humanities	the Israeli Science Foundation (isf.org.il grant number 346/16, OB; and grant number 155/18, NB). Adams Fellowship Program of the Israel Academy of Science and Humanities (AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu T, 1999, PAC S BIOC, P17, DOI [10.1142/9789814447300_0003, DOI 10.1142/9789814447300_0003]; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; [Anonymous], 2017, BR J ANAESTH, V119, pe31; Bocci F, 2019, CURR STEM CELL REP, V5, P11, DOI 10.1007/s40778-019-0150-3; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Carithers LJ, 2015, BIOPRESERV BIOBANK, V13, P311, DOI 10.1089/bio.2015.0032; Celia-Terrassa T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07538-7; Cohen DPA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004571; Das S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-94; Dongre A, 2019, NAT REV MOL CELL BIO, V20, P69, DOI 10.1038/s41580-018-0080-4; Flavahan WA, 2017, SCIENCE, V357, DOI 10.1126/science.aal2380; Font-Clos F, 2018, P NATL ACAD SCI USA, V115, P5902, DOI 10.1073/pnas.1722609115; de Herreros AG, 2012, BBA-REV CANCER, V1825, P223, DOI 10.1016/j.bbcan.2012.01.003; Gjorevski N, 2012, CANCER MICROENVIRON, V5, P29, DOI 10.1007/s12307-011-0076-5; GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Hari K, 2020, NPJ SYST BIOL APPL, V6, DOI 10.1038/s41540-020-0132-1; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Jia W, 2020, 068239 BIORXIV, DOI 10.1101/2020.04.29.068239; Jolly Mohit Kumar, 2017, Current Opinion in Systems Biology, V3, P1, DOI 10.1016/j.coisb.2017.02.004; Jolly MK, 2018, APL BIOENG, V2, DOI 10.1063/1.5024874; Jolly MK, 2016, ONCOTARGET, V7, P27067, DOI 10.18632/oncotarget.8166; Kauffman S, 2003, P NATL ACAD SCI USA, V100, P14796, DOI 10.1073/pnas.2036429100; Kauffman S.A., 1993, ORIGINS ORDER; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lehmann W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10498; Lu M, 2013, P NATL ACAD SCI USA, V110, P18144, DOI 10.1073/pnas.1318192110; Meyer-Schaller N, 2019, DEV CELL, V48, P539, DOI 10.1016/j.devcel.2018.12.023; Saadatpour A, 2013, METHODS, V62, P3, DOI 10.1016/j.ymeth.2012.10.012; Sankpal NV, 2017, ONCOGENE, V36, P3706, DOI 10.1038/onc.2016.504; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Serra R, 2010, J THEOR BIOL, V265, P185, DOI 10.1016/j.jtbi.2010.04.012; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Shalgi R, 2009, AGING-US, V1, P762, DOI 10.18632/aging.100085; Steinway SN, 2015, NPJ SYST BIOL APPL, V1, DOI 10.1038/npjsba.2015.14; Steinway SN, 2014, CANCER RES, V74, P5963, DOI 10.1158/0008-5472.CAN-14-0225; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; THOMAS R, 1973, J THEOR BIOL, V42, P563, DOI 10.1016/0022-5193(73)90247-6; Tian XJ, 2013, BIOPHYS J, V105, P1079, DOI 10.1016/j.bpj.2013.07.011; Tripathi S, 2019, ARXIV191110252QBIO; Wray NR, 2018, CELL, V173, P1573, DOI 10.1016/j.cell.2018.05.051; Ye X, 2015, TRENDS CELL BIOL, V25, P675, DOI 10.1016/j.tcb.2015.07.012; Zanudo JGT, 2019, PHYS BIOL, V16, DOI 10.1088/1478-3975/aaffa1; Zhang JY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005304	47	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238433	10.1371/journal.pone.0238433	http://dx.doi.org/10.1371/journal.pone.0238433			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881964	gold, Green Published			2022-12-26	WOS:000571063300063
J	Xu, Y; Manghrani, A; Liu, B; Shi, HL; Pham, U; Liu, A; Al-Hashimi, HM				Xu, Yu; Manghrani, Akanksha; Liu, Bei; Shi, Honglue; Pham, Uyen; Liu, Amy; Al-Hashimi, Hashim M.			Hoogsteen base pairs increase the susceptibility of double-stranded DNA to cytotoxic damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA dynamics; sequencing; m1A; AlkB; echinomycin; DNA damage; DNA methylation; DNA repair; DNA structure; DNA sequencing; alkB; DNA dynamics; echinomycin; N1-methylated adenine	ECHINOMYCIN BINDING-SITES; ESCHERICHIA-COLI; MOLECULAR-DYNAMICS; ALKYLATION DAMAGE; DIETHYL PYROCARBONATE; CRYSTAL-STRUCTURE; NUCLEIC-ACIDS; RNA STRUCTURE; DUPLEX DNA; REPAIR	As the Watson-Crick faces of nucleobases are protected in dsDNA, it is commonly assumed that deleterious alkylation damage to the Watson-Crick faces of nucleobases predominantly occurs when DNA becomes single-stranded during replication and transcription. However, damage to the Watson-Crick faces of nucleobases has been reported in dsDNA in vitro through mechanisms that are not understood. In addition, the extent of protection from methylation damage conferred by dsDNA relative to ssDNA has not been quantified. Watson-Crick base pairs in dsDNA exist in dynamic equilibrium with Hoogsteen base pairs that expose the Watson-Crick faces of purine nucleobases to solvent. Whether this can influence the damage susceptibility of dsDNA remains unknown. Using dot-blot and primer extension assays, we measured the susceptibility of adenine-N1 to methylation by dimethyl sulfate (DMS) when in an A-T Watson-Crick versus Hoogsteen conformation. Relative to unpaired adenines in a bulge, Watson-Crick A-T base pairs in dsDNA only conferred similar to 130-fold protection against adenine-N1 methylation, and this protection was reduced to similar to 40-fold for A(syn)-T Hoogsteen base pairs embedded in a DNA-drug complex. Our results indicate that Watson-Crick faces of nucleobases are accessible to alkylating agents in canonical dsDNA and that Hoogsteen base pairs increase this accessibility. Given the higher abundance of dsDNA relative to ssDNA, these results suggest that dsDNA could be a substantial source of cytotoxic damage. The work establishes DMS probing as a method for characterizing A(syn)-T Hoogsteen base pairs in vitro and also lays the foundation for a sequencing approach to map A(syn)-T Hoogsteen and unpaired adenines genome-wide in vivo.	[Xu, Yu; Shi, Honglue; Liu, Amy; Al-Hashimi, Hashim M.] Duke Univ, Dept Chem, Durham, NC 27706 USA; [Manghrani, Akanksha; Liu, Bei; Pham, Uyen; Al-Hashimi, Hashim M.] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27706 USA	Duke University; Duke University	Al-Hashimi, HM (corresponding author), Duke Univ, Dept Chem, Durham, NC 27706 USA.; Al-Hashimi, HM (corresponding author), Duke Univ, Sch Med, Dept Biochem, Durham, NC 27706 USA.	hashim.al.hashimi@duke.edu	Shi, Honglue/AAA-1400-2022	XU, YU/0000-0002-3554-6308	Mathers Foundation	Mathers Foundation	This work was supported by a Mathers Foundation grant (to H. M. A.).	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Aishima J, 2002, NUCLEIC ACIDS RES, V30, P5244, DOI 10.1093/nar/gkf661; Alvey HS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5786; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; BODELL WJ, 1979, BIOCHEMISTRY-US, V18, P2860, DOI 10.1021/bi00580a029; Bohnuud T, 2012, NUCLEIC ACIDS RES, V40, P7644, DOI 10.1093/nar/gks519; Bunting KA, 2003, NUCLEIC ACIDS RES, V31, P1633, DOI 10.1093/nar/gkg273; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; Chen FY, 2016, CHEM RES TOXICOL, V29, P687, DOI 10.1021/acs.chemrestox.5b00522; Colombi D, 1997, J BACTERIOL, V179, P3139, DOI 10.1128/jb.179.10.3139-3145.1997; Cordero P, 2014, METHODS MOL BIOL, V1086, P53, DOI 10.1007/978-1-62703-667-2_4; Cuesta-Seijo JA, 2005, ACTA CRYSTALLOGR D, V61, P442, DOI 10.1107/S090744490500137X; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; Dinglay S, 1998, MUTAT RES-DNA REPAIR, V407, P109, DOI 10.1016/S0921-8777(97)00065-7; Dinglay S, 2000, GENE DEV, V14, P2097; Dominissini D, 2016, NATURE, V530, P441, DOI 10.1038/nature16998; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; DULBECCO R, 1949, NATURE, V163, P949, DOI 10.1038/163949b0; DUMITRU I, 1994, NUCLEIC ACIDS RES, V22, P1450; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; ENGEL JD, 1975, BIOCHEM BIOPH RES CO, V64, P581, DOI 10.1016/0006-291X(75)90361-7; Fedeles BI, 2015, J BIOL CHEM, V290, P20734, DOI 10.1074/jbc.R115.656462; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; GALLEGO J, 1993, J MED CHEM, V36, P1548, DOI 10.1021/jm00063a005; Gates KS, 2004, CHEM RES TOXICOL, V17, P839, DOI 10.1021/tx049965c; Georgakopoulos-Soares I, 2018, GENOME RES, V28, P1264, DOI 10.1101/gr.231688.117; GILBERT DE, 1989, P NATL ACAD SCI USA, V86, P3006, DOI 10.1073/pnas.86.9.3006; GILBERT DE, 1991, BIOCHEMISTRY-US, V30, P2483, DOI 10.1021/bi00223a027; Golovenko D, 2018, STRUCTURE, V26, P1237, DOI 10.1016/j.str.2018.06.006; Grozhik AV, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13146-w; GUERON M, 1987, NATURE, V328, P89, DOI 10.1038/328089a0; Guo JU, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5371; HOOGSTEEN K, 1959, ACTA CRYSTALLOGR, V12, P822, DOI 10.1107/S0365110X59002389; Humeny A, 2003, ANAL BIOCHEM, V313, P160, DOI 10.1016/S0003-2697(02)00568-7; ITOH K, 1988, JPN J CANCER RES, V79, P1130, DOI 10.1111/j.1349-7006.1988.tb01536.x; JEPPESEN C, 1988, FEBS LETT, V231, P172, DOI 10.1016/0014-5793(88)80725-7; KATAOKA H, 1983, J BACTERIOL, V153, P1301, DOI 10.1128/JB.153.3.1301-1307.1983; KELNER A, 1949, P NATL ACAD SCI USA, V35, P73, DOI 10.1073/pnas.35.2.73; KIRKEGAARD K, 1983, P NATL ACAD SCI-BIOL, V80, P2544, DOI 10.1073/pnas.80.9.2544; Kitayner M, 2010, NAT STRUCT MOL BIOL, V17, P423, DOI 10.1038/nsmb.1800; LAWLEY PD, 1974, MUTAT RES, V23, P283, DOI 10.1016/0165-1218(74)90091-3; Li SS, 2000, METHODS, V22, P170, DOI 10.1006/meth.2000.1058; Li XY, 2016, NAT CHEM BIOL, V12, P311, DOI [10.1038/NCHEMBIO.2040, 10.1038/nchembio.2040]; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05243-z; MATSUURA S, 1965, J ANTIBIOT, V18, P43; MCGHEE JD, 1979, P NATL ACAD SCI USA, V76, P2133, DOI 10.1073/pnas.76.5.2133; MCGHEE JD, 1977, BIOCHEMISTRY-US, V16, P3276, DOI 10.1021/bi00634a002; McLean M J, 1988, J Mol Recognit, V1, P138, DOI 10.1002/jmr.300010307; MENDEL D, 1987, P NATL ACAD SCI USA, V84, P910, DOI 10.1073/pnas.84.4.910; Nikolova EN, 2013, BIOPOLYMERS, V99, P955, DOI 10.1002/bip.22334; Nikolova EN, 2012, BIOCHEMISTRY-US, V51, P8654, DOI 10.1021/bi3009517; Nikolova EN, 2011, NATURE, V470, P498, DOI 10.1038/nature09775; NORDHOFF E, 1993, NUCLEIC ACIDS RES, V21, P3347, DOI 10.1093/nar/21.15.3347; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; PORTUGAL J, 1989, TRENDS BIOCHEM SCI, V14, P127, DOI 10.1016/0968-0004(89)90141-2; PORTUGAL J, 1988, NUCLEIC ACIDS RES, V16, P3655, DOI 10.1093/nar/16.9.3655; QUIGLEY GJ, 1986, SCIENCE, V232, P1255, DOI 10.1126/science.3704650; Rangadurai A, 2018, NUCLEIC ACIDS RES, V46, P11099, DOI 10.1093/nar/gky885; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; Ronning DR, 2005, MOL CELL, V20, P143, DOI 10.1016/j.molcel.2005.07.026; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; SAFFHILL R, 1978, NUCLEIC ACIDS RES, V5, P1971, DOI 10.1093/nar/5.6.1971; Safra M, 2017, NATURE, V551, P251, DOI 10.1038/nature24456; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Sathyamoorthy B, 2017, NUCLEIC ACIDS RES, V45, P5586, DOI 10.1093/nar/gkx186; SAYERS EW, 1993, BIOCHEMISTRY-US, V32, P9094, DOI 10.1021/bi00086a014; SCHNEIDER K, 1995, NUCLEIC ACIDS RES, V23, P1570, DOI 10.1093/nar/23.9.1570; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; Shrivastav N, 2010, CARCINOGENESIS, V31, P59, DOI 10.1093/carcin/bgp262; Singer B., 2012, MOL BIOL MUTAGENS CA, P55; Srinivas US, 2019, REDOX BIOL, V25, DOI 10.1016/j.redox.2018.101084; Stelling AL, 2019, ANGEW CHEM INT EDIT, V58, P12010, DOI 10.1002/anie.201902693; Sun DK, 2011, NUCLEIC ACIDS RES, V39, P1256, DOI 10.1093/nar/gkq926; Talkish J, 2014, RNA, V20, P713, DOI 10.1261/rna.042218.113; Tijerina P, 2007, NAT PROTOC, V2, P2608, DOI 10.1038/nprot.2007.380; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; UGHETTO G, 1985, NUCLEIC ACIDS RES, V13, P2305, DOI 10.1093/nar/13.7.2305; Wakamori M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17204; Wan Y, 2013, NAT PROTOC, V8, P849, DOI 10.1038/nprot.2013.045; WANG AHJ, 1984, SCIENCE, V225, P1115, DOI 10.1126/science.6474168; WARING MJ, 1974, NATURE, V252, P653, DOI 10.1038/252653a0; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Xu Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03516-1; Zhou HQ, 2019, BIOCHEMISTRY-US, V58, P1963, DOI 10.1021/acs.biochem.9b00027; Zhou HQ, 2016, NAT STRUCT MOL BIOL, V23, P803, DOI 10.1038/nsmb.3270; Zhou HQ, 2015, NUCLEIC ACIDS RES, V43, P3420, DOI 10.1093/nar/gkv241; Zubradt M, 2017, NAT METHODS, V14, P75, DOI [10.1038/nmeth.4057, 10.1038/NMETH.4057]	92	9	9	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2020	295	47					15933	15947		10.1074/jbc.RA120.014530	http://dx.doi.org/10.1074/jbc.RA120.014530			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PA5ED	32913127	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000595657900013
J	Kasovic, M; Stefan, L; Zvonar, M				Kasovic, Mario; Stefan, Lovro; Zvonar, Martin			Foot rotation and the risk of falls in older women: A cross-sectional study	PLOS ONE			English	Article							PEOPLE; INJURIES; BALANCE; PAIN	Although previous evidence has shown that deviated foot structure and function are associated with falls, little is known of the association between foot rotations and falls in apparently healthy older adults. Therefore, the main purpose of the study was to determine the associations between foot rotation and falls. In this cross-sectional study, we recruited 120 older women (mean +/- SD; age 71.01 +/- 6.77 years; height 158.92 +/- 21.41 cm; weight 70.29 +/- 12.97 kg; body-mass index 26.79 +/- 4.42 kg/m(2)). Foot rotations were assessed by using pressure platform (Zebris manufacturer, Munich, Germany), while the risk of falls was assessed by using Downtown Fall Risk Index questionnaire. Correlations and multiple regression models were applied to calculate the associations. In unadjusted model, higher foot rotation was associated with higher risk of falls (beta= 0.14,p<0.001 for both feet). In a model adjusted for age, body-mass index, foot pain and fitness index, higher foot rotation remained associated with higher risk of falls (beta= 0.10,p<0.001 for both feet). Our study shows that older adults with higher foot rotation are at higher risk of falls. Special interventions aiming to correct for deviated foot function in older women are warranted.	[Kasovic, Mario; Stefan, Lovro] Univ Zagreb, Fac Kinesiol, Dept Gen & Appl Kinesiol, Zagreb, Croatia; [Kasovic, Mario; Zvonar, Martin] Masaryk Univ, Fac Sport Studies, Dept Sports Motor & Methodol Kinanthropol, Brno, Czech Republic; [Zvonar, Martin] Masaryk Univ, Fac Sci, Dept Phys Act & Fitness, Brno, Czech Republic	University of Zagreb; University of Zagreb, Faculty of Kinesiology; Masaryk University Brno; Masaryk University Brno	Stefan, L (corresponding author), Univ Zagreb, Fac Kinesiol, Dept Gen & Appl Kinesiol, Zagreb, Croatia.	lovro.stefan1510@gmail.com						Awale A, 2017, GERONTOLOGY, V63, P318, DOI 10.1159/000475710; Barak Y, 2006, PHYS THER, V86, P1501, DOI 10.2522/ptj.20050387; Brenton-Rule A, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-0888-z; Gardner MM, 2000, BRIT J SPORT MED, V34, P7, DOI 10.1136/bjsm.34.1.7; GEHLSEN GM, 1990, ARCH PHYS MED REHAB, V71, P739; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Kannus P, 2005, LANCET, V366, P1885, DOI 10.1016/S0140-6736(05)67604-0; Karinkanta S, 2010, NAT REV ENDOCRINOL, V6, P396, DOI 10.1038/nrendo.2010.70; Kasovic M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17020593; Malasana G, 2011, PACE, V34, P278, DOI 10.1111/j.1540-8159.2010.02930.x; Mecagni C, 2000, PHYS THER, V80, P1004, DOI 10.1093/ptj/80.10.1004; Menz HB, 2006, J GERONTOL A-BIOL, V61, P866, DOI 10.1093/gerona/61.8.866; Mickle KJ, 2010, J AM GERIATR SOC, V58, P1936, DOI 10.1111/j.1532-5415.2010.03061.x; Nitz JC, 2004, NZ J PHYSIOTHER, V32, P121; Rikly C, 2013, SENIOR FITNESS TEST; Rosendahl E, 2003, AGING CLIN EXP RES, V15, P142; SATTIN RW, 1992, ANNU REV PUBL HEALTH, V13, P489, DOI 10.1146/annurev.pu.13.050192.002421; Scott G, 2007, GAIT POSTURE, V26, P68, DOI 10.1016/j.gaitpost.2006.07.009; Sharif SI, 2018, PHARM PRACT-GRANADA, V16, DOI [10.18549/PharmPract.2018.03.1206, 10.18549/pharmpract.2018.03.1206]; Young PM, 2013, CLIN BIOMECH, V28, P927, DOI 10.1016/j.clinbiomech.2013.07.015	20	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0239065	10.1371/journal.pone.0239065	http://dx.doi.org/10.1371/journal.pone.0239065			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925950	gold, Green Published			2022-12-26	WOS:000572318000030
J	Little, RF; Samborskyy, M; Leadlay, PF				Little, Rory F.; Samborskyy, Markiyan; Leadlay, Peter F.			The biosynthetic pathway to tetromadurin (SF2487/A80577), a polyether tetronate antibiotic	PLOS ONE			English	Article							ACYL CARRIER PROTEIN; GENE-CLUSTER; SUBSTRATE-SPECIFICITY; II THIOESTERASES; RING FORMATION; INSIGHTS; ACID; DOMAINS; TETRODECAMYCIN; GELDANAMYCIN	The type I polyketide SF2487/A80577 (herein referred to as tetromadurin) is a polyether tetronate ionophore antibiotic produced by the terrestrial Gram-positive bacteriumActinomadura verrucosospora. Tetromadurin is closely related to the polyether tetronates tetronasin (M139603) and tetronomycin, all of which are characterised by containing a tetronate, cyclohexane, tetrahydropyran, and at least one tetrahydrofuran ring. We have sequenced the genome ofActinomadura verrucososporato identify the biosynthetic gene cluster responsible for tetromadurin biosynthesis (themadgene cluster). Based on bioinformatic analysis of the 32 genes present within the cluster a plausible biosynthetic pathway for tetromadurin biosynthesis is proposed. Functional confirmation of themadgene cluster is obtained by performing in-frame deletions in each of the genesmad10andmad31, which encode putative cyclase enzymes responsible for cyclohexane and tetrahydropyran formation, respectively. Furthermore, theA.verrucosospora Delta mad10 mutant produces a novel tetromadurin metabolite that according to mass spectrometry analysis is analogous to the recently characterised partially cyclised tetronasin intermediate lacking its cyclohexane and tetrahydropyran rings. Our results therefore elucidate the biosynthetic machinery of tetromadurin biosynthesis and lend support for a conserved mechanism of cyclohexane and tetrahydropyran biosynthesis across polyether tetronates.	[Little, Rory F.; Samborskyy, Markiyan; Leadlay, Peter F.] Univ Cambridge, Dept Biochem, Cambridge, England; [Little, Rory F.] Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany	University of Cambridge; Hans Knoll Institute (HKI)	Little, RF (corresponding author), Univ Cambridge, Dept Biochem, Cambridge, England.; Little, RF (corresponding author), Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany.	rory.little@leibniz-hki.de		Little, Rory/0000-0003-4279-1405				AGTARAP A, 1967, J AM CHEM SOC, V89, P5737, DOI 10.1021/ja00998a062; Alekshun MN, 1999, TRENDS MICROBIOL, V7, P410, DOI 10.1016/S0966-842X(99)01589-9; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2019, NAT ELECTRON, V2, P1, DOI 10.1038/s41928-019-0203-8; [Anonymous], 2015, ARCH DIS CHILD, V100, DOI 10.1136/archdischild-2015-308763; [Anonymous], 2015, AM J PHARM BENEFITS, V7, pe141; Blin K, 2017, NUCLEIC ACIDS RES, V45, pW36, DOI 10.1093/nar/gkx319; Bosserman MA, 2013, ACS CHEM BIOL, V8, P2466, DOI 10.1021/cb400399b; Caffrey P, 2003, CHEMBIOCHEM, V4, P654, DOI 10.1002/cbic.200300581; CANE DE, 1981, J AM CHEM SOC, V103, P5962, DOI 10.1021/ja00409a078; Chan YA, 2009, NAT PROD REP, V26, P90, DOI 10.1039/b801658p; Chen J, 2011, J CELL BIOCHEM, V112, P2694, DOI 10.1002/jcb.23219; Cronan JE, 2009, METHOD ENZYMOL, V459, P395, DOI 10.1016/S0076-6879(09)04617-5; Daduang R, 2015, MICROBIOL RES, V180, P30, DOI 10.1016/j.micres.2015.07.003; Del Vecchio F, 2003, J IND MICROBIOL BIOT, V30, P489, DOI 10.1007/s10295-003-0062-0; Demydchuk Y, 2008, CHEMBIOCHEM, V9, P1136, DOI 10.1002/cbic.200700715; Deochand DK, 2017, CRIT REV BIOCHEM MOL, V52, P595, DOI 10.1080/10409238.2017.1344612; Gallimore AR, 2006, CHEM BIOL, V13, P453, DOI 10.1016/j.chembiol.2006.01.013; GRANDJEAN J, 1983, TETRAHEDRON LETT, V24, P3319, DOI 10.1016/S0040-4039(00)86258-9; Gverzdys T, 2016, BIOORGAN MED CHEM, V24, P6269, DOI 10.1016/j.bmc.2016.05.028; Gverzdys T, 2016, J BACTERIOL, V198, P1965, DOI 10.1128/JB.00140-16; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Hamill RL, 1990, EP0305086A3, Patent No. 305086; Harvey BM, 2007, CHEM BIOL, V14, P703, DOI 10.1016/j.chembiol.2007.05.011; Hashimoto T, 2015, J AM CHEM SOC, V137, P572, DOI 10.1021/ja510711x; HATSU M, 1990, J ANTIBIOT, V43, P259, DOI 10.7164/antibiotics.43.259; HAYDOCK SF, 1995, FEBS LETT, V374, P246, DOI 10.1016/0014-5793(95)01119-Y; Heathcole ML, 2001, CHEM BIOL, V8, P207, DOI 10.1016/S1074-5521(01)00002-3; Jia XY, 2006, CHEM BIOL, V13, P575, DOI 10.1016/j.chembiol.2006.03.008; Kallio P, 2013, BIOCHEMISTRY-US, V52, P4507, DOI 10.1021/bi400381s; Kanchanabanca C, 2013, ANGEW CHEM INT EDIT, V52, P5785, DOI 10.1002/anie.201301680; Katsuyama Y, 2012, METHOD ENZYMOL, V515, P359, DOI 10.1016/B978-0-12-394290-6.00017-3; Keatinge-Clay AT, 2007, CHEM BIOL, V14, P898, DOI 10.1016/j.chembiol.2007.07.009; Keatinge-Clay AT, 2012, NAT PROD REP, V29, P1050, DOI 10.1039/c2np20019h; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kotowska M, 2014, APPL MICROBIOL BIOT, V98, P7735, DOI 10.1007/s00253-014-5952-8; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kwan DH, 2008, CHEM BIOL, V15, P1231, DOI 10.1016/j.chembiol.2008.09.012; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Li WL, 2008, J BIOL CHEM, V283, P28607, DOI 10.1074/jbc.M804279200; LINTON KJ, 1994, MOL MICROBIOL, V11, P777, DOI 10.1111/j.1365-2958.1994.tb00355.x; Liu LK, 2016, J BIOL CHEM, V291, P21553, DOI 10.1074/jbc.M116.745315; Long PF, 2002, MOL MICROBIOL, V43, P1215, DOI 10.1046/j.1365-2958.2002.02815.x; Murugan E, 2010, PROTEIN EXPRES PURIF, V71, P132, DOI 10.1016/j.pep.2010.01.007; Petkovic H, 2008, ORG BIOMOL CHEM, V6, P500, DOI 10.1039/b714804f; Rascher A, 2005, APPL ENVIRON MICROB, V71, P4862, DOI 10.1128/AEM.71.8.4862-4871.2005; Rascher A, 2003, FEMS MICROBIOL LETT, V218, P223, DOI 10.1016/S0378-1097(02)01148-5; Reid R, 2003, BIOCHEMISTRY-US, V42, P72, DOI 10.1021/bi0268706; RIDDELL FG, 1989, BIOCHIM BIOPHYS ACTA, V984, P6, DOI 10.1016/0005-2736(89)90335-0; Sheldon PJ, 2002, MOL MICROBIOL, V44, P449, DOI 10.1046/j.1365-2958.2002.02886.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sun YH, 2010, NAT CHEM BIOL, V6, P99, DOI [10.1038/nchembio.285, 10.1038/NCHEMBIO.285]; Takeuchi T, 2005, Patent No. [US6939892B2, 6939892]; Tian ZH, 2015, NAT CHEM BIOL, V11, P259, DOI [10.1038/NCHEMBIO.1769, 10.1038/nchembio.1769]; Tosin M, 2011, ANGEW CHEM INT EDIT, V50, P11930, DOI 10.1002/anie.201106323; Vieweg L, 2014, NAT PROD REP, V31, P1554, DOI 10.1039/c4np00015c; Wang P, 2013, J AM CHEM SOC, V135, P7138, DOI 10.1021/ja403516u; Weissman KJ, 2015, NAT PROD REP, V32, P436, DOI 10.1039/c4np00098f; Wenzel SC, 2006, J AM CHEM SOC, V128, P14325, DOI 10.1021/ja064408t; Wietzorrek A, 1997, MOL MICROBIOL, V25, P1181, DOI 10.1046/j.1365-2958.1997.5421903.x; Wilkinson CJ, 2002, J MOL MICROB BIOTECH, V4, P417; Wu K, 2000, GENE, V251, P81, DOI 10.1016/S0378-1119(00)00171-2; Zhang H, 2007, J AM CHEM SOC, V129, P14670, DOI 10.1021/ja0744854; Zhang LH, 2017, ANGEW CHEM INT EDIT, V56, P1740, DOI 10.1002/anie.201611371; Zhao CH, 2010, J BIOL CHEM, V285, P20097, DOI 10.1074/jbc.M109.090092; Zheng QF, 2018, CELL CHEM BIOL, V25, P718, DOI 10.1016/j.chembiol.2018.03.007; 2014, REG ANESTH PAIN MED, V9	67	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0239054	10.1371/journal.pone.0239054	http://dx.doi.org/10.1371/journal.pone.0239054			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925967	gold, Green Published, Green Submitted			2022-12-26	WOS:000572318000018
J	Campiglio, L; Priori, A				Campiglio, Laura; Priori, Alberto			Neurological symptoms in acute COVID-19 infected patients: A survey among Italian physicians	PLOS ONE			English	Article							TISSUE DISTRIBUTION; CORONAVIRUS; RECEPTOR; SARS	Background COVID-19 is a pandemic disease and questions rise about the coronavirus 2 (Sars-CoV-2) effect on nervous system. This involvement could help explaining the pathogenesis of this condition and lead to novel therapeutic approaches. Objective To assess the occurrence of neurological symptoms in COVID-19 patients during the Italian pandemic outbreak, as reported by physicians. Materials and methods In the early days of pandemic emergence we developed an online survey open to all Italian clinicians involved in the diagnosis and management of COVID-19 patients. The survey was structured in three sections, with nine different items concerning the presence of different specific clinical abnormalities. Each item was graded from "absent" to "severe" in a 4-point Likert's scale. Main outcomes and measures Likert's scale data were analyzed by studying the distribution of responses by using medians and bar charts-relative frequencies. Also, in order to analyze differences in symptoms findings depending on the group of specialty, Likert's scale data were combined into two nominal categories ("absent"/"low" and "moderate"/"high"/") and a contingency table chi-square test was used. Results 126 physicians of 9 different medical specialties, from 10 regions of Italy, filled the online survey. The results show that 87.3% of practitioners reported neurological symptoms. In most cases these were mild and non-specific, but they were severe in a minority of patients. The most common symptoms observed were headache, myalgia and taste and smell abnormalities. Whilst there was no difference between neurologists and non-neurologists, we found that experienced clinicians (defined as clinicians that evaluated more than 30 patients) reported neurological symptoms more frequently than non-expert. Conclusions Neurological symptoms have frequently been ported during the Italian COVID-19 pandemic, and thus should be monitored for all affected patients. Whilst some of the disturbances reported may be non-specific and common to other infectious diseases, smell and taste abnormalities might indicate nervous system as entry door for SARS-CoV-2 virus. This interpretation should promote research trials to avoid nervous system involvement.	[Campiglio, Laura; Priori, Alberto] Univ Milan, Dept Hlth Sci, Aldo Ravelli Ctr Expt Brain Therapeut, Milan, Italy; [Campiglio, Laura; Priori, Alberto] Univ Milan, Clin Neurol Unit, Milan, Italy; [Campiglio, Laura; Priori, Alberto] San Paolo Univ Hosp, ASST Santi Paolo & Carlo, Milan, Italy	University of Milan; University of Milan	Priori, A (corresponding author), Univ Milan, Dept Hlth Sci, Aldo Ravelli Ctr Expt Brain Therapeut, Milan, Italy.	alberto.priori@unimi.it						Alberta Innovates, ARECCI ETH GUID TOOL; Baig AM, 2020, ACS CHEM NEUROSCI, V11, P995, DOI 10.1021/acschemneuro.0c00122; Bohmwald K, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00386; Cao JL, 2020, CLIN INFECT DIS, V71, P748, DOI 10.1093/cid/ciaa243; Denscombe M., 1998, GOOD RES GUIDE SMALL; Filatov A, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7352; Gralinski LE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005504; Gupta N, 2020, MONALDI ARCH CHEST D, V90, DOI 10.4081/monaldi.2020.1294; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Lechien JR, 2020, EUR ARCH OTO-RHINO-L, V277, P2251, DOI 10.1007/s00405-020-05965-1; Li YC, 2020, J MED VIROL, V92, P552, DOI 10.1002/jmv.25728; Lu L, 2020, EPILEPSIA, V61, pE49, DOI 10.1111/epi.16524; Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127; Netland J, 2008, J VIROL, V82, P7264, DOI 10.1128/JVI.00737-08; Oxley TJ, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009787; Pan T, 2020, SCAND J GASTROENTERO, V55, P123, DOI 10.1080/00365521.2019.1707275; To KF, 2004, J PATHOL, V203, P740, DOI 10.1002/path.1597; Vaira LA, 2020, LARYNGOSCOPE, V130, P1787, DOI [10.1002/lary.28753, 10.1002/lary.28692]; Villa M., 2020, COVID 19 ITALYS CASE; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Wang MJ, 2020, J VIROL, V94, DOI 10.1128/JVI.00567-20; Xu JB, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020244	22	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238159	10.1371/journal.pone.0238159	http://dx.doi.org/10.1371/journal.pone.0238159			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915818	Green Published, gold			2022-12-26	WOS:000571887500089
J	de Azevedo, GB; Tomiazzi, HV; Azevedo, GTDS; Teodoro, LPR; Teodoro, PE; de Souza, MTP; Batista, TS; Eufrade, HD; Guerra, SPS				de Azevedo, Gileno Brito; Tomiazzi, Heitor Vicensotto; de Oliveira Sousa Azevedo, Glauce Tais; Ribeiro Teodoro, Larissa Pereira; Teodoro, Paulo Eduardo; Pereira de Souza, Marcos Talvani; Batista, Tays Silva; Eufrade-Junior, Humberto de Jesus; Sebastiao Guerra, Saulo Philipe			Multi-volume modeling of Eucalyptus trees using regression and artificial neural networks	PLOS ONE			English	Article							BIOMASS	The stem volume of commercial trees is an important variable that assists in decision making and economic analysis in forest management. Wood from forest plantations can be used for several purposes, which makes estimating multi-volumes for the same tree a necessary task. Defining its exploitation and use potential, such as the total and merchantable volumes (up to a minimum diameter of interest), with or without bark, is a possible work. The goal of this study was to use different strategies to model multi-volumes of the stem of eucalyptus trees. The data came from rigorous scaling of 460 felled trees stems from four eucalyptus clones in high forest and coppice regimes. The diameters were measured at different heights, with the volume of the sections obtained by the Smalian method. Data were randomly separated into fit and validation data. The single multi-volume model, volume-specific models, and the training of artificial neural networks (ANNs) were fitted. The evaluation criteria of the models were: coefficient of determination, root mean square error, mean absolute error, mean bias error, as well as graphical analysis of observed and estimated values and distribution of residuals. Additionally, the t-test (alpha = 0.05) was performed between the volume obtained in the rigorous scaling and estimated by each strategy with the validation data. Results showed that the strategies used to model different tree stem volumes are efficient. The actual and estimated volumes showed no differences. The multi-volume model had the most considerable advantage in volume estimation practicality, while the volume-specific models were more efficient in the accuracy of estimates. Given the conditions of this study, the ANNs are more suitable than the regression models in the estimation of multi-volumes of eucalyptus trees, revealing greater accuracy and practicality.	[de Azevedo, Gileno Brito; Tomiazzi, Heitor Vicensotto; de Oliveira Sousa Azevedo, Glauce Tais; Ribeiro Teodoro, Larissa Pereira; Teodoro, Paulo Eduardo; Pereira de Souza, Marcos Talvani; Batista, Tays Silva] Fed Univ Mato Grosso do Sul UFMS, Chapadao Do Sul, MS, Brazil; [Eufrade-Junior, Humberto de Jesus; Sebastiao Guerra, Saulo Philipe] Sao Paulo State Univ UNESP, Coll Agr Sci FCA, Botucatu, SP, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade Estadual Paulista	Teodoro, PE (corresponding author), Fed Univ Mato Grosso do Sul UFMS, Chapadao Do Sul, MS, Brazil.	eduteodoro@hotmail.com	Teodoro, Larissa Pereira Ribeiro/T-6645-2019; DE JESUS EUFRADE JUNIOR, HUMBERTO/C-4832-2013	DE JESUS EUFRADE JUNIOR, HUMBERTO/0000-0002-8402-2260; Reis, AlessanRSS/0000-0001-8486-7469; TEODORO, PAULO/0000-0002-8236-542X; Brito de Azevedo, Gileno/0000-0003-4811-9476	UFMS (Federal University of Mato Grosso do Sul); CAPES (Brazilian Federal Agency for Support and Evaluation of Graduate Education) [001]; CNPq (National Council for Scientific and Technological Development)	UFMS (Federal University of Mato Grosso do Sul); CAPES (Brazilian Federal Agency for Support and Evaluation of Graduate Education)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank UFMS (Federal University of Mato Grosso do Sul), CAPES Financial Code 001 (Brazilian Federal Agency for Support and Evaluation of Graduate Education) and CNPq (National Council for Scientific and Technological Development) for their financial support.	Aertsen W, 2010, ECOL MODEL, V221, P1119, DOI 10.1016/j.ecolmodel.2010.01.007; [Anonymous], 2019, J ELECTROCHEM SOC, V166, pF3202; Arias-Rodil M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143521; Azevedo GB., 2011, PESQ FLOREST BRAS, V31, P309, DOI [10.4336/2011.pfb.31.68.309, DOI 10.4336/2011.PFB.31.68.309]; Bhering LL, 2017, CROP BREED APPL BIOT, V17, P187, DOI 10.1590/1984-70332017v17n2s29; Binoti D. H. B., 2014, CIENCIA MADEIRA BRAZ, V5, P58, DOI [10.12953/2177, DOI 10.12953/2177-6830.V05N01A06]; Binoti D. H. B., 2013, REV BRASILEIRA CIENC, V08, P125, DOI [DOI 10.5039/AGRARIA.V8I1A2209, 10.5039/agraria.v8i1a2209]; Campos J. C. C., 2001, Revista Arvore, V25, P223; Catal Y, 2018, APPL ECOL ENV RES, V16, P2015, DOI 10.15666/aeer/1602_20152027; Chiarello F, 2019, CERNE, V25, P140, DOI 10.1590/01047760201925022626; Climate-Data.ORG, 2019, CLIM RIB RIO PARD; Cordeiro M. A., 2015, Pesquisa Florestal Brasileira, V35, P255, DOI 10.4336/2015.pfb.35.83.596; Ribeiro RBD, 2016, REV ARVORE, V40, P81, DOI 10.1590/0100-67622016000100009; Ribeiro RBD, 2014, CERNE, V20, P605, DOI 10.1590/01047760201420041400; Figueiredo EO, 2016, REMOTE SENS ENVIRON, V187, P281, DOI 10.1016/j.rse.2016.10.026; Dolacio CJF, 2020, AGROFOREST SYST, V94, P1011, DOI 10.1007/s10457-019-00468-3; Gitoee A, 2018, NEURAL COMPUT APPL, V30, P2499, DOI 10.1007/s00521-017-2842-x; GOH ATC, 1995, ARTIF INTELL ENG, V9, P143, DOI 10.1016/0954-1810(94)00011-S; Gorgens EB, 2009, REV ARVORE, V33, P1141, DOI 10.1590/S0100-67622009000600016; Gunes M, 2017, SPRBRIEF ELECT, P5, DOI 10.1007/978-3-319-62740-3_2; Haykin S, 2004, NEURAL NETWORK COMPR; IBA (Industria Brasileira de Arvores), 2019, REL 2019; Corral-Rivas JJ, 2017, FORESTS, V8, DOI 10.3390/f8110417; Khan MNI, 2018, FOREST ECOL MANAG, V430, P639, DOI 10.1016/j.foreco.2018.09.002; LEAL F. A., 2015, REV BRASILEIRA BIOME, V33, P233; Leite H. G., 1995, Revista Arvore, V19, P65; Leite HG, 2010, REV ARVORE, V34, P305, DOI 10.1590/S0100-67622010000200013; de Andrade VCL, 2017, FLORESTA AMBIENTE, V24, DOI 10.1590/2179-8087.135415; MAPA/SFB. Brazil. Ministry of Agriculture Livestock and Food Supply, 2019, BRAZ FOR GLANC; Binoti MLMDS, 2015, CERNE, V21, P97, DOI 10.1590/01047760201521011153; Martins A. P. M., 2016, Scientia Agraria Paranaensis, V15, P178, DOI 10.18188/1983-1471/sap.v15n2p178-184; Silva JPM, 2019, J ENVIRON MANAGE, V249, DOI 10.1016/j.jenvman.2019.109368; Miguel E.P., 2014, REV BRASILEIRA BIOME, V32, P584; Miguel EP, 2018, IFOREST, V11, P275, DOI 10.3832/ifor2155-011; Nunes MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154738; Oliveira Márcio Leles Romarco de, 2009, Rev. Árvore, V33, P133, DOI 10.1590/S0100-67622009000100014; Ozcelik R, 2012, ANN FOREST SCI, V69, P105, DOI 10.1007/s13595-011-0137-4; Ozcelik R, 2010, J ENVIRON MANAGE, V91, P742, DOI 10.1016/j.jenvman.2009.10.002; Pinheiro J, 2020, NLME LINEAR NONLINEA, P336; R Core Team, 2021, R LANGUAGE ENV STAT; de Freitas ECS, 2020, IND CROP PROD, V146, DOI 10.1016/j.indcrop.2020.112149; Sanquetta C. R., 2016, ENCICLOPEDIA BIOSFER, V13, P588; Schikowski AB, 2018, AN ACAD BRAS CIENC, V90, P3389, DOI 10.1590/0001-3765201820170569; Schumacher FX, 1933, J AGRIC RES, V47, P0719; Silva F, 2011, SCI FOR, V39, P367; Silva GF, 1996, REV ARVORE, V20, P467; Silva GF, 1997, REV ARVORE, V21, P59; Silva Mayra Luiza Marques da, 2009, Rev. Árvore, V33, P1133, DOI 10.1590/S0100-67622009000600015; Socha J, 2020, FORESTS, V11, DOI 10.3390/f11010079; StatSoft I., 2007, STAT DAT AN SOFTW SY; Tang XL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147610; Tavares ID, 2019, FORESTS, V10, DOI 10.3390/f10030268; Teo S. J., 2013, Floresta, V43, P439; Vale A. T. do, 2017, African Journal of Agricultural Research, V12, P856, DOI 10.5897/ajar2016.12083; Vieira GC, 2018, SCI TOTAL ENVIRON, V619, P1473, DOI 10.1016/j.scitotenv.2017.11.138; Whittington JCR, 2019, TRENDS COGN SCI, V23, P235, DOI 10.1016/j.tics.2018.12.005; Zeng WS, 2017, CAN J FOREST RES, V47, P467, DOI 10.1139/cjfr-2016-0342	57	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238703	10.1371/journal.pone.0238703	http://dx.doi.org/10.1371/journal.pone.0238703			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915871	Green Published, gold			2022-12-26	WOS:000571887500137
J	Trojak, M; Safranek, D; Mertova, L; Brim, L				Trojak, Matej; Safranek, David; Mertova, Lukrecia; Brim, Lubos			Executable biochemical space for specification and analysis of biochemical systems	PLOS ONE			English	Article							KAIC PHOSPHORYLATION; PROTEIN; MODEL; GENE; ENVIRONMENT; ANNOTATION; SIMULATION; EXPRESSION; SEMANTICS; FRAMEWORK	Computational systems biology provides multiple formalisms for modelling of biochemical processes among which the rule-based approach is one of the most suitable. Its main advantage is a compact and precise mechanistic description of complex processes. However, state-of-the-art rule-based languages still suffer several shortcomings that limit their use in practice. In particular, the elementary (low-level) syntax and semantics of rule-based languages complicate model construction and maintenance for users outside computer science. On the other hand, mathematical models based on differential equations (ODEs) still make the most typical used modelling framework. In consequence, robust re-interpretation and integration of models are difficult, thus making the systems biology paradigm technically challenging. Though several high-level languages have been developed at the top of rule-based principles, none of them provides a satisfactory and complete solution for semi-automated description and annotation of heterogeneous biophysical processes integrated at the cellular level. We present the second generation of a rule-based language called Biochemical Space Language (BCSL) that combines the advantages of different approaches and thus makes an effort to overcome several problems of existing solutions. BCSL relies on the formal basis of the rule-based methodology while preserving user-friendly syntax of plain chemical equations. BCSL combines the following aspects: the level of abstraction that hides structural and quantitative details but yet gives a precise mechanistic view of systems dynamics; executable semantics allowing formal analysis and consistency checking at the level of the language; universality allowing the integration of different biochemical mechanisms; scalability and compactness of the specification; hierarchical specification and composability of chemical entities; and support for genome-scale annotation.	[Trojak, Matej; Safranek, David; Mertova, Lukrecia; Brim, Lubos] Masaryk Univ, Syst Biol Lab, Brno, Czech Republic	Masaryk University Brno	Trojak, M (corresponding author), Masaryk Univ, Syst Biol Lab, Brno, Czech Republic.	xtrojak@fi.muni.cz	Safranek, David/ABD-9906-2020; Troják, Matej/ABD-9933-2020; Brim, Luboš/ABH-2827-2021	Safranek, David/0000-0002-0713-2431; Troják, Matej/0000-0003-0841-2707; Brim, Luboš/0000-0001-9393-7545	Czech Science Foundation [18-00178S]	Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by the Czech Science Foundation grant 18-00178S (https://gacr.cz/en/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SS, 2017, BIOINFORMATICS, V33, P710, DOI 10.1093/bioinformatics/btw700; beda A., 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0127296; Blinov ML, 2017, BIOPHYS J, V113, P1365, DOI 10.1016/j.bpj.2017.08.022; Boutillier P, 2018, BIOINFORMATICS, V34, P583, DOI 10.1093/bioinformatics/bty272; Calzone L, 2006, BIOINFORMATICS, V22, P1805, DOI 10.1093/bioinformatics/btl172; Camporesi F, 2017, LECT N BIOINFORMAT, V10545, P291, DOI 10.1007/978-3-319-67471-1_18; Cardelli L, 2008, INT FED INFO PROC, V273, P261; Cerveny J, 2019, CYANOBACTERIA: FROM BASIC SCIENCE TO APPLICATIONS, P193, DOI 10.1016/B978-0-12-814667-5.00009-X; Ciocchetta F, 2009, THEOR COMPUT SCI, V410, P3065, DOI 10.1016/j.tcs.2009.02.037; Clarke EM, 1999, MODEL CHECKING, P1; Covert MW, 2014, FUNDAMENTALS SYSTEMS; Cuellar AA, 2003, SIMUL-T SOC MOD SIM, V79, P740, DOI 10.1177/0037549703040939; Danos V, 2004, THEOR COMPUT SCI, V325, P69, DOI 10.1016/j.tcs.2004.03.065; de Matos P, 2010, NUCLEIC ACIDS RES, V38, pD249, DOI 10.1093/nar/gkp886; Ded T, 2016, ELECTRON NOTES THEOR, V326, P27, DOI 10.1016/j.entcs.2016.09.017; F Zhang, 2017, COMBINE SPECIFICATIO; Feinberg M., 2019, FDN CHEM REACTION NE, DOI 10.1007/978-3-030-03858-8; Fisher J, 2007, NAT BIOTECHNOL, V25, P1239, DOI 10.1038/nbt1356; Golden SS, 1997, ANNU REV PLANT PHYS, V48, P327, DOI 10.1146/annurev.arplant.48.1.327; Gruenert Gerd, 2010, BMC Bioinformatics, V11, P307, DOI 10.1186/1471-2105-11-307; Harris LA, 2016, BIOINFORMATICS, V32, P3366, DOI 10.1093/bioinformatics/btw469; Harris LA, 2009, WINT SIMUL C PROC, P854, DOI 10.1109/WSC.2009.5429719; Hertel S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002966; Honorato-Zimmer R, 2017, THEORETICAL COMPUTER; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Juty N, 2011, NUCLEIC ACIDS RES, V40, P580; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Katayama M, 2003, J BACTERIOL, V185, P1415, DOI 10.1128/JB.185.4.1415-1422.2003; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Klement M, 2013, ELECTRON NOTES THEOR, V299, P61, DOI 10.1016/j.entcs.2013.11.006; Klement M, 2014, ELECTRON NOTES THEOR, V306, P31, DOI 10.1016/j.entcs.2014.06.013; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Maus C, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-166; McNaught AD, 1997, COMPENDIUM CHEM TERM, DOI DOI 10.1351/GOLDBOOK; Misirli G, 2016, BIOINFORMATICS, V32, P908, DOI 10.1093/bioinformatics/btv660; Miyoshi F, 2007, J BIOL RHYTHM, V22, P69, DOI 10.1177/0748730406295749; Munzner U, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08903-w; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nakao M, 2010, NUCLEIC ACIDS RES, V38, pD379, DOI 10.1093/nar/gkp915; Olivier BG, 2004, BIOINFORMATICS, V20, P2143, DOI 10.1093/bioinformatics/bth200; Pattanayek R, 2004, MOL CELL, V15, P375, DOI 10.1016/j.molcel.2004.07.013; Pauleve L, 2010, P 8 INT C COMP METH, P43, DOI DOI 10.1145/1839764.1839771; Pedersen M, 2010, COLOR IMAG CONF, P74; Phillips A, 2007, LECT NOTES COMPUT SC, V4695, P184; Regev A, 2002, NATURE, V419, P343, DOI 10.1038/419343a; Romers J.C., 2017, BIORXIV; Sneddon MW, 2011, NAT METHODS, V8, P177, DOI [10.1038/nmeth.1546, 10.1038/NMETH.1546]; Sorokina O, 2013, BIOINFORMATICS, V29, P3105, DOI 10.1093/bioinformatics/btt523; Tapia JJ, 2019, METHODS MOL BIOL, V1945, P203, DOI 10.1007/978-1-4939-9102-0_9; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Trojak M, 2020, NASA FORM METH S; Trojak M, 2020, CMSB 2020; Trojak M, 2020, ARXIV200200731; Trojak M, 2016, LECT NOTES COMPUT SC, V9859, P316, DOI 10.1007/978-3-319-45177-0_20; Villarreal SA, 2013, J MOL BIOL, V425, P3311, DOI 10.1016/j.jmb.2013.06.018; Wolstencroft K, 2017, NUCLEIC ACIDS RES, V45, pD404, DOI 10.1093/nar/gkw1032; Yamada S, 2004, BIOCHEM BIOPH RES CO, V314, P1113, DOI 10.1016/j.bbrc.2004.01.009; 2013, SURG OBES RELAT DIS, V9; 2019, NEW DISTRICTS, V20, P1	61	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238838	10.1371/journal.pone.0238838	http://dx.doi.org/10.1371/journal.pone.0238838			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915842	Green Published, Green Submitted, gold			2022-12-26	WOS:000571887500085
J	Vopicka, O; Cihal, P; Klepic, M; Crha, J; Hynek, V; Trtik, K; Boillat, P; Trtik, P				Vopicka, Ondrej; Cihal, Petr; Klepic, Martina; Crha, Jan; Hynek, Vladimir; Trtik, Karel; Boillat, Pierre; Trtik, Pavel			One-pot neutron imaging of surface phenomena, swelling and diffusion during methane absorption in ethanol andn-decane under high pressure	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; CARBON-DIOXIDE; INTERFACIAL-TENSION; NATURAL-GAS; TEMPERATURE-DEPENDENCE; LIQUID HYDROCARBONS; HYDRATE FORMATION; PHASE-EQUILIBRIA; BINARY-MIXTURES; CONTACT-ANGLE	We report a powerful method for capturing the time-resolved concentration profiles, liquid swelling and surface phenomena during the absorption of methane (CH4) in still liquid ethanol (C2D6O) andn-decane (n-C10D22) and at high spatial resolution (pixel size 21.07 mu m) using neutron imaging. Absorption of supercritical methane was followed at two temperatures and two pressures of methane, namely 7.0, 37.8 degrees C and 80, 120 bar. Fick's second law, which was used in the liquid-fixed coordinates, enabled for an adequate parameterization of the observed concentration profiles and liquid levels using simple analytical expressions. For both studied liquids, anomalously slow diffusion was observed in the initial stage of the absorption experiment. This was ascribed to the slow formation of the surface excess on the interface, time constant ranged 130-275 s. The axial symmetry of the cell allowed for the tomographic reconstructions of the profiles of the menisci. Based on these profiles, contact angle and surface tension were evaluated using the Young-Laplace equation. Overall, neutron imaging made it possible to capture time- and space-resolved information from which the methane concentration, liquid level and meniscus shape under high-pressure conditions inside a cylindrical titanium vessel were quantitatively derived. Multiple characteristics of ethanol, a methane hydrate inhibitor, andn-decane, a model constituent of crude oil, were thus measured for the first time under industrially relevant conditions in a one-pot experiment.	[Vopicka, Ondrej; Cihal, Petr; Klepic, Martina; Hynek, Vladimir] Univ Chem & Technol, Dept Phys Chem, Prague, Czech Republic; [Crha, Jan; Boillat, Pierre; Trtik, Pavel] Paul Scherrer Inst, Lab Neutron Scattering & Imaging, Villigen, Switzerland; [Hynek, Vladimir; Trtik, Karel] Czech Tech Univ, Univ Tretiho Veku U3V, Prague, Czech Republic	University of Chemistry & Technology, Prague; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Czech Technical University Prague	Vopicka, O (corresponding author), Univ Chem & Technol, Dept Phys Chem, Prague, Czech Republic.; Trtik, P (corresponding author), Paul Scherrer Inst, Lab Neutron Scattering & Imaging, Villigen, Switzerland.	ondrej.vopicka@vscht.cz; pavel.trtik@psi.ch	Vopicka, Ondrej/B-7912-2008	Vopicka, Ondrej/0000-0001-8186-2494	Ministry of Education, Youth and Sports (MEYS, MSMT in Czech) [21-SVV/2018, 21-SVV/2019, 21-SVV/2020]	Ministry of Education, Youth and Sports (MEYS, MSMT in Czech)	P.C., M.K. Specific university research (MSMT No 21-SVV/2018, 21-SVV/2019, 21-SVV/2020), (both authors), Scientific project (VIGA) of the UCT Prague, supported by the The Ministry of Education, Youth and Sports (MEYS, MSMT in Czech). https://www.vscht.cz/research/internalgrant-agency/scientific-project-viga, http://www.msmt.cz/?lang=2 The funder did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson A. W., 1967, PHYS CHEM SURFACES; ADAMSON AW, 1973, J COLLOID INTERF SCI, V44, P273, DOI 10.1016/0021-9797(73)90219-1; [Anonymous], 801 DIPPR; Bardow A, 2006, AICHE J, V52, P4004, DOI 10.1002/aic.11021; Bauer N, 2016, CLIMATIC CHANGE, V136, P69, DOI 10.1007/s10584-013-0901-6; Berdiyeva P, 2020, J ENERGY STORAGE, V29, DOI 10.1016/j.est.2020.101388; Berry JD, 2015, J COLLOID INTERF SCI, V454, P226, DOI 10.1016/j.jcis.2015.05.012; Billes W, 2007, MOL SIMULAT, V33, P655, DOI 10.1080/08927020701313745; Blau B., 2009, NEUTRON NEWS, V20, P5, DOI [10.1080/10448630903120387, DOI 10.1080/10448630903120387]; Boillat P, 2018, OPT EXPRESS, V26, P15769, DOI 10.1364/OE.26.015769; BRUNNER E, 1990, J CHEM THERMODYN, V22, P73, DOI 10.1016/0021-9614(90)90033-M; Cadogan SP, 2016, J CHEM ENG DATA, V61, P3922, DOI 10.1021/acs.jced.6b00691; Carminati C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210300; Chhetri AB, 2013, FUEL, V104, P704, DOI 10.1016/j.fuel.2012.05.006; Chow YTF, 2018, FLUID PHASE EQUILIBR, V475, P37, DOI 10.1016/j.fluid.2018.07.022; CIBULKA I, 1993, FLUID PHASE EQUILIBR, V89, P1, DOI 10.1016/0378-3812(93)85042-K; Cole WJ, 2016, ENERG ECON, V60, P486, DOI 10.1016/j.eneco.2016.03.005; Crank J., 1975, MATH DIFFUSION; DASCH CJ, 1992, APPL OPTICS, V31, P1146, DOI 10.1364/AO.31.001146; Davies SR, 2010, J PHYS CHEM C, V114, P1173, DOI 10.1021/jp909416y; Davis J. R., 1998, METALS HDB DESK EDIT, V2nd; Dechoz J, 2004, APPL SURF SCI, V229, P175, DOI [10.1016/j.apsusc.2004.01.057, 10.1016/j.apsuse.2004.01.057]; DIAZPENA M, 1979, J CHEM THERMODYN, V11, P441, DOI 10.1016/0021-9614(79)90121-6; E/tv/s, 1886, ANN PHYS, V263, P448, DOI DOI 10.1002/ANDP.18862630309; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Fayazi A, 2019, CHEM ENG RES DES, V142, P121, DOI 10.1016/j.cherd.2018.12.001; Fayazi A, 2017, ENERG FUEL, V31, P1226, DOI 10.1021/acs.energyfuels.6b02464; Friend DG, 2005, FLUID PHASE EQUILIBR, V236, P15, DOI 10.1016/j.fluid.2005.04.020; GAINES GL, 1994, COLLOID SURFACE A, V82, P299, DOI 10.1016/0927-7757(93)02635-R; GAMBOA I, 1986, J CHEM THERMODYN, V18, P885, DOI 10.1016/0021-9614(86)90123-0; Grunzweig C, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2736892; HANDA YP, 1982, FLUID PHASE EQUILIBR, V8, P161, DOI 10.1016/0378-3812(82)80033-2; Hayama H, 2017, J CHEM THERMODYN, V108, P71, DOI 10.1016/j.jct.2017.01.007; Heller A, 2016, J PHYS CHEM B, V120, P10808, DOI 10.1021/acs.jpcb.6b08117; Henriksson U, 2004, J CHEM EDUC, V81, P150, DOI 10.1021/ed081p150; HILL PG, 1982, J PHYS CHEM REF DATA, V11, P1, DOI 10.1063/1.555661; Jamialahmadi M, 2006, J PETROL SCI ENG, V53, P47, DOI 10.1016/j.petrol.2006.01.011; JMP B.E. Poling, 2000, PROPERTIES GASES LIQ; Kapateh MH, 2016, J CHEM ENG DATA, V61, P666, DOI 10.1021/acs.jced.5b00793; Ke W, 2019, J NAT GAS SCI ENG, V61, P169, DOI 10.1016/j.jngse.2018.10.021; Kerr RA, 2010, SCIENCE, V328, P1624, DOI 10.1126/science.328.5986.1624; Khosharay S, 2014, INT J REFRIG, V47, P26, DOI 10.1016/j.ijrefrig.2014.08.003; Kiran E, 2000, SUPERCRITICAL FLUIDS; Kneafsey TJ, 2007, J PETROL SCI ENG, V56, P108, DOI 10.1016/j.petrol.2006.02.002; Kohn JP, 1964, J CHEM ENG DATA, V9, P5, DOI DOI 10.1021/JE60020A003; KOJIMA Y, 1993, J POLYM SCI POL CHEM, V31, P1755, DOI 10.1002/pola.1993.080310714; Koonce KT, 1964, J CHEM ENG DATA, V9, P490, DOI DOI 10.1021/JE60023A004; Lake L. W., 1989, ENHANCED OIL RECOVER; Lehmann E.H., 2001, NONDESTRUCT TEST EVA, V16, P191, DOI DOI 10.1080/10589750108953075; LIN HM, 1979, J CHEM ENG DATA, V24, P146, DOI 10.1021/je60081a004; Lu HT, 2018, J MEMBRANE SCI, V555, P362, DOI 10.1016/j.memsci.2018.03.045; MacDonald TSC, 2019, CHEMPHYSCHEM, V20, P926, DOI 10.1002/cphc.201900150; Marquardt R, 2018, PURE APPL CHEM, V90, P175, DOI 10.1515/pac-2017-0106; Moudrakovski IL, 2004, J PHYS CHEM B, V108, P17591, DOI 10.1021/jp0473220; Muller S, 1996, SYNLETT, P521; NEUMANN AW, 1971, J COLLOID INTERF SCI, V35, P379, DOI 10.1016/0021-9797(71)90136-6; PENG D, 1976, IND ENG CHEM FUND, V15, P59, DOI 10.1021/i160057a011; REAMER HH, 1956, IND ENG CHEM, V48, P275, DOI 10.1021/ie50554a034; Reamer HH, 1942, IND ENG CHEM, V34, P1526, DOI 10.1021/ie50396a025; Richter FM, 2006, GEOCHIM COSMOCHIM AC, V70, P277, DOI 10.1016/j.gca.2005.09.016; SACHS W, 1995, COLLOID SURFACE A, V94, P291, DOI 10.1016/0927-7757(94)03008-1; Scharfer P, 2008, CHEM ENG SCI, V63, P4676, DOI 10.1016/j.ces.2008.03.014; SCHROEDER J, 1977, MOL PHYS, V34, P1501, DOI 10.1080/00268977700102731; SCHUMM RH, 1953, J AM CHEM SOC, V75, P2520, DOI 10.1021/ja01106a523; Siemons N, 2006, J COLLOID INTERF SCI, V297, P755, DOI 10.1016/j.jcis.2005.11.047; Sloan E.D., 2007, CLATHRATE HYDRATES N; SLOWINSKI EJ, 1957, J PHYS CHEM-US, V61, P808, DOI 10.1021/j150552a028; SRIVASTAN S, 1992, J CHEM ENG DATA, V37, P516, DOI 10.1021/je00008a033; STRAUB J, 1980, WARME STOFFUBERTRAG, V13, P241, DOI 10.1007/BF01002412; SUZUKI K, 1990, J CHEM ENG DATA, V35, P63, DOI 10.1021/je00059a020; Trtik P, 2016, J PHYS CONF SER, V746, DOI 10.1088/1742-6596/746/1/012004; TX Le, 2019, P 1 VIETN S ADV OFFS; Tyroller L, 2018, EARTH PLANET SC LETT, V492, P73, DOI 10.1016/j.epsl.2018.03.047; Ukai T, 2002, J CHEM ENG DATA, V47, P1320, DOI 10.1021/je020108p; VARGAFTIK NB, 1983, J PHYS CHEM REF DATA, V12, P817, DOI 10.1063/1.555688; Wagner W, 2002, J PHYS CHEM REF DATA, V31, P387, DOI 10.1063/1.1461829; WALKLEY J, 1968, T FARADAY SOC, V64, P19, DOI 10.1039/tf9686400019; Wang LS, 1996, FLUID PHASE EQUILIBR, V117, P364, DOI 10.1016/0378-3812(95)02973-7; Wen YW, 2005, ENERG FUEL, V19, P1319, DOI 10.1021/ef049764g; WILKE CR, 1955, AICHE J, V1, P264, DOI 10.1002/aic.690010222; Wu JY, 2007, J PHYS CHEM B, V111, P6189, DOI 10.1021/jp071372y; Yan W, 2001, J CHEM ENG DATA, V46, P1544, DOI 10.1021/je0101505; Yasuda K, 2016, FLUID PHASE EQUILIBR, V413, P170, DOI 10.1016/j.fluid.2015.10.006; Zhang XH, 2007, J CHEM ENG DATA, V52, P691, DOI 10.1021/je060234j	84	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238470	10.1371/journal.pone.0238470	http://dx.doi.org/10.1371/journal.pone.0238470			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911526	gold, Green Published			2022-12-26	WOS:000571885900001
J	Rezapur-Shahkolai, F; Taheri, M; Etesamifard, T; Roshanaei, G; Shirahmadi, S				Rezapur-Shahkolai, Forouzan; Taheri, Malihe; Etesamifard, Tahereh; Roshanaei, Ghodratollah; Shirahmadi, Samane			Dimensions of aberrant driving behaviors and their association with road traffic injuries among drivers	PLOS ONE			English	Article							GENDER-DIFFERENCES; IRANIAN DRIVERS; NOVICE DRIVERS; SEVERITY; CRASH; ACCIDENTS; EXPERIENCE; RISKY; INVOLVEMENT; LIKELIHOOD	Objective Road traffic injuries (RTIs) are recognized as one of the most important causes of morbidity and mortality throughout the world, especially in developing countries. Human behavior is reportedly one of the critical factors in the occurrence of such injuries. The purpose of this study is to evaluate the correlation of abnormal driving behaviors with the frequency and severity of RTIs among drivers in Hamadan, west of Iran. Methods The present cross-sectional study was conducted on 800 people driving, who were selected by multistage cluster sampling technique. Data were collected using a three-part self-administered questionnaire including demographic, social and driving characteristics; the Manchester driver behavior questionnaire (DBQ); as well as information on a history of the occurrence of the injuries caused by the crashes and the severity of them. Data were statistically analyzed using numerical indices, linear regression analysis, Pearson correlation, ordinal logistic regression model and multinomial logistic regression. Results The highest and lowest mean percentages of abnormal driving behavior were related to unintentional violations (19.13) and Lapses (16.44), respectively. "Changing radio stations and listening to music while driving", "overtaking a driver who drives slowly", and "unintentionally exceeding the speed limit" were the three highest behaviors associated with road traffic injuries, with the mean and standard deviation of (1.93 +/- 1.4), (1.90 +/- 1.4), (1.58 +/- 1.3), respectively. Age, gender, educational level, driving experience and driving hours during the day were significantly associated with DBQ dimensions and severity of road traffic injuries. Conclusions The results of this study showed that socio-demographic characteristics were significantly correlated with driving behavior. In addition, driving behaviors were correlated with traffic crashes and the resulting injuries. The findings of this study can be utilized to develop driving behavior interventions among the drivers.	[Rezapur-Shahkolai, Forouzan; Taheri, Malihe; Etesamifard, Tahereh; Shirahmadi, Samane] Hamadan Univ Med Sci, Sch Publ Hlth, Dept Publ Hlth, Hamadan, Hamadan, Iran; [Rezapur-Shahkolai, Forouzan] Hamadan Univ Med Sci, Social Determinants Hlth Res Ctr, Hamadan, Hamadan, Iran; [Taheri, Malihe; Etesamifard, Tahereh; Shirahmadi, Samane] Hamadan Univ Med Sci, Student Res Comm, Hamadan, Hamadan, Iran; [Roshanaei, Ghodratollah] Hamadan Univ Med Sci, Sch Publ Hlth, Dept Biostat, Hamadan, Hamadan, Iran; [Roshanaei, Ghodratollah] Hamadan Univ Med Sci, Modeling Noncommunicable Dis Res Ctr, Hamadan, Hamadan, Iran		Shirahmadi, S (corresponding author), Hamadan Univ Med Sci, Sch Publ Hlth, Dept Publ Hlth, Hamadan, Hamadan, Iran.; Shirahmadi, S (corresponding author), Hamadan Univ Med Sci, Student Res Comm, Hamadan, Hamadan, Iran.; Roshanaei, G (corresponding author), Hamadan Univ Med Sci, Sch Publ Hlth, Dept Biostat, Hamadan, Hamadan, Iran.; Roshanaei, G (corresponding author), Hamadan Univ Med Sci, Modeling Noncommunicable Dis Res Ctr, Hamadan, Hamadan, Iran.	gh.roshanaei@umsha.ac.ir; s_shirahmadi@yahoo.com	Shirahmadi, Samane/ABG-4730-2021	shirahmadi, samane/0000-0002-3008-6613; Rezapour, Reza/0000-0002-8237-6903	Deputy of Research and Technology of Hamadan University of Medical Sciences [930126254]	Deputy of Research and Technology of Hamadan University of Medical Sciences	The authors who received award: Forouzan Rezapur-Shahkolai Grant numbers awarded to author: 930126254 The full name of funder: Deputy of Research and Technology of Hamadan University of Medical Sciences The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abay KA, 2013, TRANSPORT RES B-METH, V50, P74, DOI 10.1016/j.trb.2013.01.007; Ainy E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112721; Alavi Seyyed Salman, 2016, Iran J Psychiatry, V11, P37; Anund A, 2018, SCAND J WORK ENV HEA, V44, P88, DOI 10.5271/sjweh.3677; Azad P, 2015, J HEALTH SAF WORK, V5, P13; Batool Z, 2017, TRANSPORT RES F-TRAF, V47, P176, DOI 10.1016/j.trf.2017.04.017; Bazargan-Hejazi S, 2018, ARCH IRAN MED, V21, P556; Behnood HR, 2017, TRAUMA MON, V22, DOI 10.5812/traumamon.35997; Behravan H, 2012, SOC SECURITY STUDIES, V28, P109; Bener A, 2008, TRANSPORT RES F-TRAF, V11, P324, DOI 10.1016/j.trf.2008.02.001; Brown TG, 2016, DIABETOL STOFFWECHS, V11, pe0150227; Chen F, 2018, J SAFETY RES, V65, P153, DOI 10.1016/j.jsr.2018.02.010; Chen HQ, 2012, TRAFFIC INJ PREV, V13, P300, DOI 10.1080/15389588.2011.653841; Chiou YC, 2013, ACCIDENT ANAL PREV, V61, P97, DOI 10.1016/j.aap.2013.07.005; Chu W, 2017, INVESTIGATING RELATI; Constantinou E, 2011, ACCIDENT ANAL PREV, V43, P1323, DOI 10.1016/j.aap.2011.02.002; Cordellieri P, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01412; de Winter JCF, 2010, J SAFETY RES, V41, P463, DOI 10.1016/j.jsr.2010.10.007; Donmez B, 2017, RELATION DRIVER BEHA; Ebrahimikhah Maria, 2019, J Inj Violence Res, V11, P213, DOI 10.5249/jivr.v11i2.947; Esfahani HS, 2014, UNDERSTANDING POLITI, P219; Fisher DL, 2006, INJURY PREV, V12, P25, DOI 10.1136/ip.2006.012021; Ge Y, 2017, AGGRESSIVE BEHAV, V43, P544, DOI 10.1002/ab.21712; Gras ME, 2006, TRANSPORT RES F-TRAF, V9, P129, DOI 10.1016/j.trf.2005.09.004; Groeger JA, 2007, ERGONOMICS, V50, P1250, DOI 10.1080/00140130701318723; Groeger JA, 1996, BRIT J PSYCHOL, V87, P61, DOI 10.1111/j.2044-8295.1996.tb02577.x; Habibi E, 2014, J ED HLTH PROMOTION, V3; Haghi A, 2014, LIFE SCI J, V11, P414; Haghshenas H, 2008, HAKIM RES J, V11, P47; Harre N, 1996, J SAFETY RES, V27, P163, DOI 10.1016/0022-4375(96)00013-8; Hezaveh AM, 2018, PROMET-ZAGREB, V30, P35, DOI 10.7307/ptt.v30i1.2412; Hou QZ, 2019, PHYSICA A, V531, DOI 10.1016/j.physa.2019.121760; Li P., 2017, OPEN J APPL SCI, V07, P115; Li YY, 2018, J SAFETY RES, V64, P11, DOI 10.1016/j.jsr.2017.12.007; Liu YB, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16010140; Lucas EC, 2017, TRANSPORT RES F-TRAF, V47, P72, DOI 10.1016/j.trf.2017.04.022; Lucidi F, 2010, ACCIDENT ANAL PREV, V42, P1689, DOI 10.1016/j.aap.2010.04.008; Machado-Leon JL, 2016, TRANSPORT RES F-TRAF, V37, P41, DOI 10.1016/j.trf.2015.11.010; Mamdoohi A, 2014, MODARES J CIVIL ENG, V14; Mehdizadeh M, 2018, TRANSPORT RES F-TRAF, V58, P39, DOI 10.1016/j.trf.2018.05.029; Moghaddam AM, 2017, TRANSPORT RES F-TRAF, V46, P451, DOI 10.1016/j.trf.2016.09.027; Mohtasham-Amiri Zahra, 2016, Bull Emerg Trauma, V4, P230; Murray CJ., 1996, GLOBAL BURDEN DIS IN; onzalez-Socoloske D., 2012, OPEN REMOTE SENS J, V5, P1, DOI DOI 10.2174/1875413901205010001; Oreyzi HR, 2010, PAYESH HLTH MONITOR, V9, P21; Ozkan T, 2006, ACCIDENT ANAL PREV, V38, P386, DOI 10.1016/j.aap.2005.10.012; Ozkan T, 2006, TRANSPORT RES F-TRAF, V9, P227, DOI 10.1016/j.trf.2006.01.002; Ozkan T, 2011, HANDBOOK OF TRAFFIC PSYCHOLOGY, P179, DOI 10.1016/B978-0-12-381984-0.10014-1; Peden M., 2004, WORLD REPORT ROAD TR; REASON J, 1990, ERGONOMICS, V33, P1315, DOI 10.1080/00140139008925335; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Roman GD, 2015, ACCIDENT ANAL PREV, V82, P61, DOI 10.1016/j.aap.2015.05.012; Russo BJ, 2014, ANAL METHODS ACCID R, V2, P21, DOI 10.1016/j.amar.2014.03.001; sanita Omd, 2013, GLOBAL STATUS REPORT; Shi J, 2010, ACCIDENT ANAL PREV, V42, P1031, DOI 10.1016/j.aap.2009.12.010; Shinar D, 2001, ACCIDENT ANAL PREV, V33, P111, DOI 10.1016/S0001-4575(00)00021-X; Skvirsky V, 2017, ACCIDENT ANAL PREV, V109, P47, DOI 10.1016/j.aap.2017.08.031; Soliman A, 2018, PROCEDIA COMPUT SCI, V130, P652, DOI 10.1016/j.procs.2018.04.116; Sullman M.J.M., 2002, TRANSPORT RES F-TRAF, V5, P217, DOI [DOI 10.1016/S1369-8478(02)00019-0, 10.1016/S1369-8478(02)00019-0]; Summala H., 2003, TRANSPORT RES F-TRAF, V6, P97, DOI [DOI 10.1016/S1369-8478(03)00008-1, 10.1016/S1369-8478(03)00008-1]; Tao D, 2017, ACCIDENT ANAL PREV, V99, P228, DOI 10.1016/j.aap.2016.12.009; Taubman-Ben-Ari O, 2016, ACCIDENT ANAL PREV, V93, P179, DOI 10.1016/j.aap.2016.04.038; Uzumcuoglu Y, 2016, TRANSPORT RES F-TRAF, V40, P1, DOI 10.1016/j.trf.2016.02.002; Vahedi J, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081626; Varmazyar S, 2013, HEALTH SCOPE, V2, P110, DOI 10.17795/jhealthscope-11552; Warner HW, 2011, TRANSPORT RES F-TRAF, V14, P390, DOI 10.1016/j.trf.2011.04.006; World Health Organisation, 2018, GLOB STAT REP ROAD S; Zeng Q, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082768; Zeng Q, 2019, TRANSPORTMETRICA A, V15, P1867, DOI 10.1080/23249935.2019.1652867; Zeng Q, 2020, J TRANSP SAF SECUR, V12, P566, DOI 10.1080/19439962.2018.1516259; Zhang Q, 2011, 3 INT C ROAD SAF SIM	71	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2020	15	9							e0238728	10.1371/journal.pone.0238728	http://dx.doi.org/10.1371/journal.pone.0238728			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR4MY	32903278	Green Published, gold			2022-12-26	WOS:000571539500013
J	Chang, J; Binuesa, F; Caneo, LF; Turquetto, ALR; Arita, ECTC; Barbosa, AC; Fernandes, AMD; Trindade, EM; Jatene, FB; Dossou, PE; Jatene, MB				Chang Junior, Joao; Binuesa, Fabio; Caneo, Luiz Fernando; Ribeiro Turquetto, Aida Luiza; Trevisan Calvo Arita, Elisandra Cristina; Barbosa, Aline Cristina; da Silva Fernandes, Alfredo Manoel; Trindade, Evelinda Marramon; Jatene, Fabio Biscegli; Dossou, Paul-Eric; Jatene, Marcelo Biscegli			Improving preoperative risk-of-death prediction in surgery congenital heart defects using artificial intelligence model: A pilot study	PLOS ONE			English	Article							HOSPITAL MORTALITY	Background Congenital heart disease accounts for almost a third of all major congenital anomalies. Congenital heart defects have a significant impact on morbidity, mortality and health costs for children and adults. Research regarding the risk of pre-surgical mortality is scarce. Objectives Our goal is to generate a predictive model calculator adapted to the regional reality focused on individual mortality prediction among patients with congenital heart disease undergoing cardiac surgery. Methods Two thousand two hundred forty CHD consecutive patients' data from InCor's heart surgery program was used to develop and validate the preoperative risk-of-death prediction model of congenital patients undergoing heart surgery. There were six artificial intelligence models most cited in medical references used in this study: Multilayer Perceptron (MLP), Random Forest (RF), Extra Trees (ET), Stochastic Gradient Boosting (SGB), Ada Boost Classification (ABC) and Bag Decision Trees (BDT). Results The top performing areas under the curve were achieved using Random Forest (0.902). Most influential predictors included previous admission to ICU, diagnostic group, patient's height, hypoplastic left heart syndrome, body mass, arterial oxygen saturation, and pulmonary atresia. These combined predictor variables represent 67.8% of importance for the risk of mortality in the Random Forest algorithm. Conclusions The representativeness of "hospital death" is greater in patients up to 66 cm in height and body mass index below 13.0 for InCor's patients. The proportion of "hospital death" declines with the increased arterial oxygen saturation index. Patients with prior hospitalization before surgery had higher "hospital death" rates than who did not required such intervention. The diagnoses groups having the higher fatal outcomes probability are aligned with the international literature. A web application is presented where researchers and providers can calculate predicted mortality based on the CgntSCORE on any web browser or smartphone.	[Chang Junior, Joao; Binuesa, Fabio; Caneo, Luiz Fernando; Ribeiro Turquetto, Aida Luiza; Trevisan Calvo Arita, Elisandra Cristina; Barbosa, Aline Cristina; da Silva Fernandes, Alfredo Manoel; Trindade, Evelinda Marramon; Jatene, Fabio Biscegli; Jatene, Marcelo Biscegli] Univ Sao Paulo, Heart Inst, Dept Cardiovasc Surg, Med Sch,HCFMUSP,InCor,Pediat Cardiac Unit, Sao Paulo, Brazil; [Chang Junior, Joao] Fundacao Armando Alvares Penteado FAAP, Sao Paulo, Brazil; [Chang Junior, Joao] Escola Super Engn & Gestao ESEG, Sao Paulo, Brazil; [Ribeiro Turquetto, Aida Luiza; Trindade, Evelinda Marramon] Hlth Technol Assessment Ctr Clin Hosp NATS HCF, Sao Paulo, Brazil; [Trindade, Evelinda Marramon] Sao Paulo State Hlth Secretariat SES SP, Sao Paulo, Brazil; [Dossou, Paul-Eric] Inst Catholique Arts & Metiers Icam, Paris, France	Universidade de Sao Paulo; Centro Universitario Alvares Penteado	Chang, J (corresponding author), Univ Sao Paulo, Heart Inst, Dept Cardiovasc Surg, Med Sch,HCFMUSP,InCor,Pediat Cardiac Unit, Sao Paulo, Brazil.; Chang, J (corresponding author), Fundacao Armando Alvares Penteado FAAP, Sao Paulo, Brazil.; Chang, J (corresponding author), Escola Super Engn & Gestao ESEG, Sao Paulo, Brazil.	chang.joao@gmail.com	Caneo, Luiz/C-4076-2012; Caneo, Luiz/AAZ-6251-2020; Chang, Joao/AAR-2574-2020; Turquetto, Aida Luiza Ribeiro/AAZ-6238-2020	Caneo, Luiz/0000-0001-5545-8172; Caneo, Luiz/0000-0001-5545-8172; Chang, Joao/0000-0001-6013-2222; Turquetto, Aida Luiza Ribeiro/0000-0003-1816-0785; Trindade, Evelinda/0000-0001-5914-5616; Reis, AlessanRSS/0000-0001-8486-7469	Ministerio da Saude -Politicas Publicas do SistemaUnico de Saude -Brasil (PPSUS) [2016/15039-8]; Fundacao Amparo a Pesquisa do Estado de Sao Paulo -Brasil (FAPESP) [2017/26002-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior do Ministerio de Educacao -Program CAPES [240/18]	Ministerio da Saude -Politicas Publicas do SistemaUnico de Saude -Brasil (PPSUS); Fundacao Amparo a Pesquisa do Estado de Sao Paulo -Brasil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior do Ministerio de Educacao -Program CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported in part by the Ministerio da Saude -Politicas Publicas do SistemaUnico de Saude -Brasil (PPSUS number 2016/15039-8), Fundacao Amparo a Pesquisa do Estado de Sao Paulo -Brasil (FAPESP) -number 2017/26002-0 and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior do Ministerio de Educacao -Program CAPESBrafitec number 240/18.	[Anonymous], 2016, EVIDENCE, V8, pe1000; Awad A, 2017, INT J MED INFORM, V108, P185, DOI 10.1016/j.ijmedinf.2017.10.002; Awad A, 2017, HEALTH SERV MANAG RE, V30, P105, DOI 10.1177/0951484817696212; Bader-El-Den M, 2016, IEEE IJCNN, P3584, DOI 10.1109/IJCNN.2016.7727660; BENJAMIN E.J., 2017, HEART DIS STROKE STA; Blagus R, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0723-9; Browne MW, 2000, J MATH PSYCHOL, V44, P108, DOI 10.1006/jmps.1999.1279; Carmona F, 2017, BRAZ J CARDIOV SURG, V32, P260, DOI 10.21470/1678-9741-2016-0074; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Churpek MM, 2016, CRIT CARE MED, V44, P368, DOI 10.1097/CCM.0000000000001571; DAVIS J., 2006, RELATIONSHIP PRECISI; Fawcett T., 2004, MACH LEARN, V31, P1, DOI DOI 10.1016/J.PATREC.2005.10.010; Flauzin RA, 2010, REDES NEURAIS ARTIFI; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Haykin S, 2001, ADAPT LEARN SYST SIG, P1; Horer J, 2016, WORLD J PEDIATR CONG, V7, P425, DOI 10.1177/2150135116656001; Jacobs JP, 2019, ANN THORAC SURG, V108, P558, DOI 10.1016/j.athoracsur.2019.01.069; Jacobs JP, 2018, WORLD J PEDIATR CONG, V9, P392, DOI 10.1177/2150135118775962; Jenkins Kathy J, 2004, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V7, P180, DOI 10.1053/j.pcsu.2004.02.009; Jenkins KJ, 2002, J THORAC CARDIOV SUR, V124, P97, DOI 10.1067/mtc.2002.122311; Jenkins KJ, 2002, J THORAC CARDIOV SUR, V123, P110, DOI 10.1067/mtc.2002.119064; Kidney Dis Improving Global, 2017, KIDNEY INT SUPPL, V7, P1, DOI 10.1016/j.kisu.2017.04.001; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Lacour-Gayet F, 2004, EUR J CARDIO-THORAC, V25, P911, DOI 10.1016/j.ejcts.2004.03.027; Levine GN, 2011, CIRCULATION, V124, pE574, DOI 10.1161/CIR.0b013e31823ba622; Li HX, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006090; Lin K, 2019, INT J MED INFORM, V125, P55, DOI 10.1016/j.ijmedinf.2019.02.002; McParlin C, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-76; Mejia OAV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199277; Mitchell T.M, 2003, MACH LEARN; Nina Rachel Vilela de Abreu Haickel, 2007, Braz. J. Cardiovasc. Surg., V22, P425, DOI 10.1590/S0102-76382007000400008; O M, 2015, J INTENSIVE CARE, V3, P42; Provost F, 2001, MACH LEARN, V42, P203, DOI 10.1023/A:1007601015854; RUIZ-FERNaNDEZ D., 2016, COMPUTER METHODS PRO; Saito T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118432; XU J., DATA MINING ICU MORT, V16	38	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238199	10.1371/journal.pone.0238199	http://dx.doi.org/10.1371/journal.pone.0238199			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886688	Green Published, gold			2022-12-26	WOS:000571064300013
J	Zerihun, T; Bekele, D; Birhanu, E; Worku, Y; Deyesa, N; Tesfaye, M				Zerihun, Tigist; Bekele, Delayehu; Birhanu, Elizabeth; Worku, Yoseph; Deyesa, Negussie; Tesfaye, Markos			Family planning awareness, utilization and associated factors among women of reproductive age attending psychiatric outpatient care, a cross- sectional study, Addis Ababa, Ethiopia	PLOS ONE			English	Article							SCHIZOPHRENIA; PREGNANCY	Background Women with mental illness have a special need for family planning as they carry a high risk of unplanned pregnancy, sexual violence and, the poor obstetric outcomes due to their mental illness, as well as teratogenicity from exposure to psychotropic medications lower antenatal care utilization. Objective To assess knowledge, and utilization of family planning and associated factors among women attending psychiatric outpatient clinics in Addis Ababa. Methods A cross-sectional study was conducted among 423 women attending the outpatient psychiatric clinics of three general and one specialized mental hospital in Addis Ababa, the capital city of Ethiopia. A structured and pretested questionnaire were administered by psychiatric nurses. Multiple logistic regression analysis was conducted to identify factors associated with utilization of family planning methods. Result Four hundred twenty-two participants who had follow up at the psychiatric outpatient departments participated in the study. Almost 88% of participants had an unintended pregnancy. Only 68% of study participant had ever heard about Family planning. Just over one third (38.6%) reported current use of at least one method of Family planning. Of those not using family planning 73.3% had no intention to have children. And 38.8% did not have any intention to use Family Planning in the future. Fear of drug-interaction with psychiatric medication was the most common reason not to use contraceptives. Having one or two children was associated with higher utilization of family planning [adjusted odds ratio (95%, confidence interval) 2.05 (1.06, 3.99)]. Conclusions In this study, the majority of women with mental illness were not using family planning methods. The Awareness of the Family planning methods is lower than the national average. Education and counselling about family planning for women attending psychiatric outpatient departments should be strengthened.	[Zerihun, Tigist; Birhanu, Elizabeth; Tesfaye, Markos] St Pauls Hosp, Dept Psychiat, Millennium Med Coll, Addis Ababa, Ethiopia; [Bekele, Delayehu] St Pauls Hosp, Dept Obstet & Gynecol, Millennium Med Coll, Addis Ababa, Ethiopia; [Worku, Yoseph] St Pauls Hosp, Dept Publ Hlth, Millennium Med Coll, Addis Ababa, Ethiopia; [Deyesa, Negussie] Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia	Addis Ababa University	Zerihun, T (corresponding author), St Pauls Hosp, Dept Psychiat, Millennium Med Coll, Addis Ababa, Ethiopia.	zerukaye@gmail.com	Worku, Yoseph/AAX-3398-2021	Worku, Yoseph/0000-0002-6885-0437; Tesfaye, Markos/0000-0002-3351-701X; Bekele, Delayehu/0000-0002-9243-2622; Kebede, Tigist Zerihun/0000-0001-6566-9053	St Paul's Hospital Millennium medical college	St Paul's Hospital Millennium medical college	This study was supported by St Paul's Hospital Millennium medical college. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemayehu M, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-6; Alkema L, 2013, LANCET, V381, P1642, DOI 10.1016/S0140-6736(12)62204-1; Amentie M., 2015, SCI J CLIN MED, V4, P52, DOI [DOI 10.11648/J.SJCM.20150403.11, 10.11648/j.sjcm.20150403.11]; [Anonymous], 2017, J PEDIAT REHAB MED, V10, ps1; [Anonymous], 2017, ADHD ATTENTION DE S1, V9, pS1, DOI 10.1007/s12402-017-0224-y; Beekle AT, 2006, INT NURS REV, V53, P269, DOI 10.1111/j.1466-7657.2006.00492.x; Bonugli Rebecca, 2010, Issues Ment Health Nurs, V31, P456, DOI 10.3109/01612840903581108; Cleland J, LANCET, V368, P1810; Crawford P, 2002, CNS DRUGS, V16, P263, DOI 10.2165/00023210-200216040-00005; Dickerson FB, 2004, PSYCHIAT SERV, V55, P1299, DOI 10.1176/appi.ps.55.11.1299; EDHS, 2016, ETHIOPIA DEM HLTH SU; EDHS, 2014, ETH MIN DEM HLTH SUR; EDHS, 2019, ETHIOPIA DEM HLTH SU; Gebremariam A, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-24; Genet E, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0038-3; Getiye Dejenu MAAAA, 2013, J MED RES INTERDSCIP, V13; GODANA W, 2015, J HLTH MED NUR, V0015, P00062; Haile Anley, 2012, Ethiop Med J, V50, P31; Hall KS, 2015, AM J OBSTET GYNECOL, V212, P740, DOI 10.1016/j.ajog.2014.12.010; HANKOFF LD, 1993, AM J OBSTET GYNECOL, V168, P1986, DOI 10.1016/S0002-9378(12)90939-4; ICAR- NBAGR Newsletter, 2017, ICAR NBAGR NEWSLETTE, V14, P2; International I, 2011, DEM HLTH SURV METH Q; Jablensky AV, 2005, AM J PSYCHIAT, V162, P79, DOI 10.1176/appi.ajp.162.1.79; Kesetebirhan A., 2011, NATL GUIDELINE FAMIL; Khalifeh H, 2015, PSYCHOL MED, V45, P875, DOI 10.1017/S0033291714001962; KORRA, 2002, ATT FAM PLANN REAS N; Mekonnen G, 2014, PAN AFR MED J, V18, DOI 10.11604/pamj.2014.18.98.3421; Mekonnen W, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-37; Monjok E, 2010, OPEN ACCESS J CONTR, V1, P9; Nilsson E, 2002, SCHIZOPHR RES, V58, P221, DOI 10.1016/S0920-9964(01)00370-X; Odimegwu CO, 1997, KOREA J POPULATION D, P131; Tadele A, 2019, CONTRACEP REPROD MED, V4, DOI 10.1186/s40834-019-0087-z; Tekelab T, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0208-z; Tilahun T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061335; TSIGEREDA G, 2009, BARRIERS USE CONTRAC; Tunde-Ayinmode MF, 2013, ANN AFR MED, V12, P16, DOI 10.4103/1596-3519.108245; Zimmerman L, 2017, STUD FAMILY PLANN, V48, P293, DOI 10.1111/sifp.12031	37	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238766	10.1371/journal.pone.0238766	http://dx.doi.org/10.1371/journal.pone.0238766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ7QN	32886729	gold, Green Published			2022-12-26	WOS:000571064300029
J	Kim, Y; Umeda, M; Lochbaum, M; Sloan, RA				Kim, Youngdeok; Umeda, Masataka; Lochbaum, Marc; Sloan, Robert A.			Examining the day-to-day bidirectional associations between physical activity, sedentary behavior, screen time, and sleep health during school days in adolescents	PLOS ONE			English	Article							DURATION; CHILDREN; EXERCISE; MEDIA; YOUTH; OUTCOMES; QUALITY	Background Adolescence is a vulnerable period for experiencing poor sleep health. Growing studies have demonstrated lifestyle behaviors including physical activity (PA), screen time (SCT), and sedentary behaviors (SED) as the potential factors associated with sleep health in adolescents; yet, the evidence is inconclusive and the directionality of temporal associations across school days are not well understood. This study examined the day-to-day bidirectional associations of lifestyle behaviors with sleep health parameters in adolescents. Methods A total of 263 adolescents (58% boys) in 6(th)- 8(th)grades wore an accelerometer for 24-hour across the three consecutive school days and completed recording SCT in time-diary and answering sleep quality (SQ) questions for each day. Sleep-wake patterns as well as time spent in moderate- and vigorous-intensity PA (MVPA) and SED were objectively quantified from the wrist-worn accelerometry data across the two segments of the day (during and after school hours). Mixed model analyses were conducted to test bidirectional associations between lifestyle factors and sleep health parameters in each temporal direction across the days. Additionally, indirect associations across the days were tested using an autoregressive cross-lagged model analysis in the framework of path analysis. Results MVPA minutes in a day did not predict sleep health parameters that night. The bidirectional associations were partially observed between SED and sleep health, but the significance and direction of the associations largely varied by the time segment of a day as well as types of sleep health parameters. Additionally, greater SCT during the day was associated with lower SQ that night (b = -0.010;P= .018), and greater SQ was associated with greater MVPA during school hours (b = 6.45;P= .028) and lower SED after school hours (b = -39.85;P= .029) the next day. Lastly, there were significant indirect associations of SCT with sleep health parameters across the days indicating multi-day lagged effects of SCT on sleep health the later nights. Conclusion This study highlights the importance of lowering SCT for better sleep health in adolescents during school days. Additionally, perceived SQ is shown to be a potential significant predictor promoting healthy behaviors the next day independent of sleep-wake patterns. Further studies are warranted to confirm the observed temporal associations between SCT, SQ, and behavioral outcomes in this vulnerable population.	[Kim, Youngdeok] Virginia Commonwealth Univ, Dept Kinesiol & Hlth Sci, Richmond, VA 23284 USA; [Umeda, Masataka] Univ Texas San Antonio, Dept Kinesiol, San Antonio, TX USA; [Lochbaum, Marc] Texas Tech Univ, Dept Kinesiol & Sport Management, Lubbock, TX 79409 USA; [Lochbaum, Marc] Vytautas Magnus Univ, Educ Acad, Kaunas, Lithuania; [Sloan, Robert A.] Kagoshima Univ, Dept Social & Behav Med, Grad Med Sch, Kagoshima, Japan	Virginia Commonwealth University; University of Texas System; University of Texas at San Antonio (UTSA); Texas Tech University System; Texas Tech University; Vytautas Magnus University; Kagoshima University	Kim, Y (corresponding author), Virginia Commonwealth Univ, Dept Kinesiol & Hlth Sci, Richmond, VA 23284 USA.	kimy13@vcu.edu		Umeda, Masataka/0000-0001-9420-6998; Kim, Youngdeok/0000-0002-6134-0100	Paffenbarger-Blair Fund for Epidemiological Research on Physical Activity from the American College of Sports Medicine	Paffenbarger-Blair Fund for Epidemiological Research on Physical Activity from the American College of Sports Medicine	This study was supported by the Paffenbarger-Blair Fund for Epidemiological Research on Physical Activity awarded to YK from the American College of Sports Medicine (https://www.acsm.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 2009, AM BEHAV SCI, V52, P1204, DOI 10.1177/0002764209331542; Antczak D, 2020, SLEEP MED REV, V51, DOI 10.1016/j.smrv.2020.101278; Arora T, 2013, INT J OBESITY, V37, P1254, DOI 10.1038/ijo.2012.209; Atkinson G, 2007, PHYSIOL BEHAV, V90, P229, DOI 10.1016/j.physbeh.2006.09.015; Barlett ND, 2012, J CHILD MEDIA, V6, P37, DOI 10.1080/17482798.2011.633404; Bollen K.A., 1990, SOCIOL METHODOL, V20, P115, DOI [DOI 10.2307/271084, 10.2307/271084]; Brand S, 2010, J ADOLESCENT HEALTH, V46, P133, DOI 10.1016/j.jadohealth.2009.06.018; Brunetti VC, 2016, SLEEP HEALTH, V2, P335, DOI 10.1016/j.sleh.2016.09.004; Buckhalt JA, 2007, CHILD DEV, V78, P213, DOI 10.1111/j.1467-8624.2007.00993.x; Cain N, 2010, SLEEP MED, V11, P735, DOI 10.1016/j.sleep.2010.02.006; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Carskadon MA, 2004, ANN NY ACAD SCI, V1021, P276, DOI 10.1196/annals.1308.032; Carter B, 2016, JAMA PEDIATR, V170, P1202, DOI 10.1001/jamapediatrics.2016.2341; Chandler JL, 2016, PEDIATR OBES, V11, P120, DOI 10.1111/ijpo.12033; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Crowley SJ, 2007, SLEEP MED, V8, P602, DOI 10.1016/j.sleep.2006.12.002; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Fallone G, 2002, SLEEP MED REV, V6, P287, DOI 10.1053/smrv.2001.0192; Foti KE, 2011, AM J PREV MED, V41, P596, DOI 10.1016/j.amepre.2011.08.009; Hale L, 2015, SLEEP MED REV, V21, P50, DOI 10.1016/j.smrv.2014.07.007; Hamlett A, 2003, J AIR WASTE MANAGE, V53, P442, DOI 10.1080/10473289.2003.10466174; Hoffmann B, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1521-8; Kaneita Y, 2006, SLEEP, V29, P1543, DOI 10.1093/sleep/29.12.1543; Kann L, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6708a1; Kann L, 2014, MMWR SURVEILL SUMM, V63, P1; King DL, 2013, J SLEEP RES, V22, P137, DOI 10.1111/j.1365-2869.2012.01060.x; Kline CE, 2014, AM J LIFESTYLE MED, V8, P375, DOI 10.1177/1559827614544437; Kline R.B., 2011, PRINCIPLES PRACTICE; Krystal AD, 2008, SLEEP MED, V9, pS10, DOI 10.1016/S1389-9457(08)70011-X; Kuczmarski RJ, 2000, ADV DATA, V314, P1; LeBlanc AG, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0197-1; Lin YY, 2018, PREV MED, V111, P436, DOI 10.1016/j.ypmed.2017.12.006; Lin YY, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5122-5; LOPRINZI PD, 2012, J BEHAV HLTH, P00286; Magee CA, 2014, JAMA PEDIATR, V168, P465, DOI 10.1001/jamapediatrics.2013.4183; Marshall SJ, 2006, J ADOLESCENCE, V29, P333, DOI 10.1016/j.adolescence.2005.08.016; Martinez SM, 2019, SLEEP HEALTH, V5, P201, DOI 10.1016/j.sleh.2018.10.012; Master L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44059-9; Mendelson M, 2016, PEDIATR OBES, V11, P26, DOI 10.1111/ijpo.12015; Moore M, 2009, J PEDIATR PSYCHOL, V34, P1175, DOI 10.1093/jpepsy/jsp039; Myllymaki T, 2012, EUR J APPL PHYSIOL, V112, P801, DOI 10.1007/s00421-011-2034-9; Myllymaki T, 2011, J SLEEP RES, V20, P146, DOI 10.1111/j.1365-2869.2010.00874.x; National Sleep Foundation, 2014, SLEEP AM POLL; Nunnally J., 1978, PSYCHOMETRIC THEORY; O'Brien Erin M, 2005, Behav Sleep Med, V3, P113, DOI 10.1207/s15402010bsm0303_1; Ortega FB, 2011, EUR J APPL PHYSIOL, V111, P2615, DOI 10.1007/s00421-011-1883-6; Ortega FB, 2010, EUR J APPL PHYSIOL, V110, P563, DOI 10.1007/s00421-010-1536-1; Parent J, 2016, J DEV BEHAV PEDIATR, V37, P277, DOI 10.1097/DBP.0000000000000272; Pesonen AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022958; Poulain T, 2019, BEHAV SLEEP MED, V17, P763, DOI 10.1080/15402002.2018.1491851; Sadeh A, 2003, CHILD DEV, V74, P444, DOI 10.1111/1467-8624.7402008; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Saint-Maurice PF, 2018, CHILDREN-BASEL, V5, DOI 10.3390/children5090118; Soric M, 2015, ANN HUM BIOL, V42, P31, DOI 10.3109/03014460.2014.928367; Stutz J, 2019, SPORTS MED, V49, P269, DOI 10.1007/s40279-018-1015-0; Tambalis KD, 2018, J CLIN SLEEP MED, V14, P1689, DOI 10.5664/jcsm.7374; Uchida Sunao, 2012, Front Neurol, V3, P48, DOI 10.3389/fneur.2012.00048; Vincent GE, 2017, APPL PHYSIOL NUTR ME, V42, P238, DOI 10.1139/apnm-2016-0424; Williams SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093117; Wolfson Amy R, 2007, Behav Sleep Med, V5, P194; Yang Y, 2017, INT J BEHAV MED, V24, P481, DOI 10.1007/s12529-016-9609-0; Youngstedt SD, 2005, CLIN SPORT MED, V24, P355, DOI 10.1016/j.csm.2004.12.003; Youngstedt SD, 2003, SLEEP MED REV, V7, P351, DOI 10.1053/smrv.2001.0239; Youngstedt SD, 2003, PHYSIOL BEHAV, V78, P395, DOI 10.1016/S0031-9384(03)00004-0	64	12	12	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238721	10.1371/journal.pone.0238721	http://dx.doi.org/10.1371/journal.pone.0238721			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ7QD	32881930	gold, Green Published			2022-12-26	WOS:000571063300077
J	Uchida, A; Pillai, JA; Bermel, R; Jones, SE; Fernandez, H; Leverenz, JB; Srivastava, SK; Ehlers, JP				Uchida, Atsuro; Pillai, Jagan A.; Bermel, Robert; Jones, Stephen E.; Fernandez, Hubert; Leverenz, James B.; Srivastava, Sunil K.; Ehlers, Justis P.			Correlation between brain volume and retinal photoreceptor outer segment volume in normal aging and neurodegenerative diseases	PLOS ONE			English	Article							NERVE-FIBER LAYER; ALZHEIMERS; THICKNESS; ATROPHY	Purpose To investigate the association between outer retinal layer metrics, including photoreceptor outer segment volume, on spectral-domain optical coherence tomography (OCT) and brain volume on MRI in normal aging, Alzheimer's disease and Parkinson's disease. Methods This was an exploratory analysis of a cross-sectional cohort study that was approved by the Cleveland Clinic Institutional Review Board to evaluate neurodegenerative disorders. Subjects aged >= 50 were recruited. A comprehensive neurological exam, brain MRI with volumetric evaluation, and OCT were performed for each subject. Outer retinal layer parameters, including ellipsoid zone (EZ) to retinal pigment epithelium (RPE) volume (i.e., surrogate for panmacular photoreceptor outer segment volume), were evaluated with a novel OCT analysis platform. Results Of 85 subjects, 64 eyes of 64 subjects met MRI and OCT quality control criteria. Total brain volume (%ICV) significantly correlated with EZ-RPE volume in the normal cognition control group (n = 31, Pearson correlation coefficient 0.514,P< .01), the Parkinson's disease group (n = 19, Pearson correlation coefficient 0.482,P= .04), and the Alzheimer's dementia group (n = 14, Pearson correlation coefficient 0.526,P= .05). Multiple linear regression analysis revealed that photoreceptor outer segment (i.e., EZ-RPE) volume was an independent, influential factor on total brain volume in all study subjects (Coefficient 15.2, 95% confidence interval 7.8-22.6,P< .001). Conclusion Outer retinal parameters on OCT may serve as a novel biomarker related to brain volume. This correlation was noted in control subjects suggesting a possible developmental link between retina and brain volume. This relationship was also maintained with atrophic neurodegenerative disorders. Further research is needed to explore possible threshold differences for underlying neurodegenerative disorders.	[Uchida, Atsuro; Srivastava, Sunil K.; Ehlers, Justis P.] Cleveland Clin, Cole Eye Inst, Tony & Leona Campane Ctr Excellence Image Guided, Cleveland, OH 44106 USA; [Uchida, Atsuro; Srivastava, Sunil K.; Ehlers, Justis P.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA; [Pillai, Jagan A.; Bermel, Robert; Leverenz, James B.] Cleveland Clin, Dept Neurol, Cleveland, OH 44106 USA; [Pillai, Jagan A.; Leverenz, James B.] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Cleveland, OH 44106 USA; [Bermel, Robert] Mellen Ctr Multiple Sclerosis, Cleveland, OH USA; [Jones, Stephen E.] Imaging Inst, Cleveland, OH USA; [Fernandez, Hubert] Ctr Neurol Restorat, Cleveland, OH USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Ehlers, JP (corresponding author), Cleveland Clin, Cole Eye Inst, Tony & Leona Campane Ctr Excellence Image Guided, Cleveland, OH 44106 USA.; Ehlers, JP (corresponding author), Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA.	ehlersj@ccf.org	Uchida, Atsuro/GVT-8593-2022	Uchida, Atsuro/0000-0002-1378-7151; Ehlers, Justis/0000-0001-6763-7768; Afifa, Sayyidah/0000-0002-1151-9583; Bermel, Robert/0000-0003-2334-6883; Pillai, Jagan/0000-0001-6784-824X	Alcon Novartis Hida Memorial Award 2015 - Alcon Japan Ltd; NIH/NEI [K23-EY02294701A1]; Research to Prevent Blindness (Cole Eye Institutional); Alzheimer Association; Keep Memory Alive Foundation; RPC [2012-1019];  [NIAK23AG055685]	Alcon Novartis Hida Memorial Award 2015 - Alcon Japan Ltd; NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness (Cole Eye Institutional)(Research to Prevent Blindness (RPB)); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); Keep Memory Alive Foundation; RPC; 	Funding support was provided through an unrestricted travel grant provided by Alcon Novartis Hida Memorial Award 2015 funded by Alcon Japan Ltd (AU); NIH/NEI K23-EY02294701A1 (JPE); Research to Prevent Blindness (Cole Eye Institutional). NIAK23AG055685, Alzheimer Association, Keep Memory Alive Foundation (JAP).; The data collection was funded by RPC Grant 2012-1019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep41100; Cuenca N, 2017, OPHTHALMOLOGY; den Haan Jurre, 2018, Alzheimers Dement (Amst), V10, P49, DOI 10.1016/j.dadm.2017.10.005; Garcia-Martin E, 2014, AM J OPHTHALMOL, V157, P470, DOI 10.1016/j.ajo.2013.09.028; Gordon-Lipkin E, 2007, NEUROLOGY, V69, P1603, DOI 10.1212/01.wnl.0000295995.46586.ae; Grazioli E, 2008, J NEUROL SCI, V268, P12, DOI 10.1016/j.jns.2007.10.020; KATZ B, 1989, SURV OPHTHALMOL, V34, P31, DOI 10.1016/0039-6257(89)90127-6; Kesler A, 2011, CLIN NEUROL NEUROSUR, V113, P523, DOI 10.1016/j.clineuro.2011.02.014; Koronyo-Hamaoui M, 2011, NEUROIMAGE, V54, pS204, DOI 10.1016/j.neuroimage.2010.06.020; London A, 2013, NAT REV NEUROL, V9, P44, DOI 10.1038/nrneurol.2012.227; Mustafi D, 2009, PROG RETIN EYE RES, V28, P289, DOI 10.1016/j.preteyeres.2009.05.003; Pillai JA, 2016, AM J ALZHEIMERS DIS, V31, P430, DOI 10.1177/1533317515628053; Pottala JV, 2014, NEUROLOGY, V82, P435, DOI 10.1212/WNL.0000000000000080; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Uchida A, 2018, INVEST OPHTH VIS SCI, V59, P2768, DOI 10.1167/iovs.17-23240	15	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0237078	10.1371/journal.pone.0237078	http://dx.doi.org/10.1371/journal.pone.0237078			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881874	gold, Green Published			2022-12-26	WOS:000571063300086
J	Yang, S; Chen, HC; Chen, WC; Yang, CH				Yang, Stephanie; Chen, Hsueh-Chih; Chen, Wen-Ching; Yang, Cheng-Hong			Forecasting outbound student mobility: A machine learning approach	PLOS ONE			English	Article							SUPPORT VECTOR REGRESSION; DIFFERENTIAL EVOLUTION; OPTIMIZATION	Background A country's ability to become a prominent knowledge economy is tied closely to its ability to acquire skilled people who can compete internationally while resolving challenges of the future. To equip students with competence that can only by gained by being immersed in a foreign environment, outbound mobility is vital. Methods To analyze outbound student mobility in Taiwan using time series methods, this study aims to propose a hybrid approach FSDESVR which combines feature selection (FS) and support vector regression (SVR) with differential evolution (DE). FS and a DE algorithm were used for selecting reliable input features and determining the optimal initial parameters of SVR, respectively, to achieve high forecast accuracy. Results The proposed approach was examined using a dataset of outbound Taiwanese student mobility to ten countries between 1998 and 2018. Without the requirements of any special conditions for the proprieties of the objective function and constraints, the FSDESVR model retained the advantage of FS, SVR, and DE. A comparison of the FSDESVR model and other forecasting models revealed that FSDESVR provided the lowest mean absolute percentage error (MAPE) and root mean square error (RMSE) results for all the analyzed nations. The experimental results indicate that FSDESVR achieved higher forecasting accuracy than the compared models from the literature. Conclusion With the recognition of outbound values, key findings of Taiwanese outbound student mobility, and accurate application of the FSDESVR model, education administration units are exposed to a more in-depth view of future student mobility, which enables the implement of a more accurate education curriculum.	[Yang, Stephanie; Chen, Hsueh-Chih] Natl Taiwan Normal Univ, Dept Educ Psychol & Counseling, Taipei, Taiwan; [Chen, Wen-Ching; Yang, Cheng-Hong] Natl Kaohsiung Univ Sci & Technol, Elect Engn, Kaohsiung, Taiwan; [Yang, Cheng-Hong] Kaohsiung Med Univ, PhD Program Biomed Engn, Kaohsiung, Taiwan; [Yang, Cheng-Hong] Kaohsiung Med Univ, Drug Dev & Value Creat Res Ctr, Kaohsiung, Taiwan	National Taiwan Normal University; National Kaohsiung University of Science & Technology; Kaohsiung Medical University; Kaohsiung Medical University	Chen, HC (corresponding author), Natl Taiwan Normal Univ, Dept Educ Psychol & Counseling, Taipei, Taiwan.; Yang, CH (corresponding author), Natl Kaohsiung Univ Sci & Technol, Elect Engn, Kaohsiung, Taiwan.; Yang, CH (corresponding author), Kaohsiung Med Univ, PhD Program Biomed Engn, Kaohsiung, Taiwan.; Yang, CH (corresponding author), Kaohsiung Med Univ, Drug Dev & Value Creat Res Ctr, Kaohsiung, Taiwan.	chcjyh@ntnu.edu.tw; chyang@nkust.edu.tw	Yang, Cheng-Hong/M-7984-2013	Yang, Cheng-Hong/0000-0002-2741-0072	National Science Council of Taiwan [NSC 108-2221-E-992 -031 -MY3, 108-2221-E-214 -019 -MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was partly supported by the National Science Council of Taiwan for Grant NSC 108-2221-E-992 -031 -MY3 and 108-2221-E-214 -019 -MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 2011, THER ADV MED ONCOL, V3, pS7; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; Avci E, 2009, EXPERT SYST APPL, V36, P1391, DOI 10.1016/j.eswa.2007.11.014; Borhan N, 2014, AIP CONF PROC, V1605, P955, DOI 10.1063/1.4887719; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; BROWN RG, 1961, OPER RES, V9, P672; Clyne F, 1998, 12 AUSTR INT ED C; Conservative Party, 2010, POLICY GREEN PAPER, V15, P4; Dall'Alba G, 2015, STUD HIGH EDUC, V40, P721, DOI 10.1080/03075079.2013.842212; Drucker H, 1997, ADV NEUR IN, V9, P155; Feoktistov V, 2006, SPRINGER SER OPTIM A, V5, P1, DOI 10.1007/978-0-387-36896-2; GEURTS M, 1977, J MARKETING RES, V14, P269, DOI 10.2307/3150485; Gouvernement.fr, 2018, STRAT ATTR INT STUD; Grant T, 2016, WORLD U RANKINGS; Hannan E. J., 2012, STAT THEORY LINEAR S; Hao PY, 2015, REMOTE SENS-BASEL, V7, P5347, DOI 10.3390/rs70505347; Hassanien AE, 2019, MACHINE LEARNING PAR; Hsu P, 2018, FOCUS TAIWAN; Immigration New Zealand, 2019, VIS PROC DEL SOM VIS; Jowi J.O., 2009, HIGH EDUC POLICY, V22, P263, DOI DOI 10.1057/HEP.2009.8; LITTERMAN RB, 1986, J BUS ECON STAT, V4, P25, DOI 10.2307/1391384; Magaziner J, 2016, WORLD ED NEWS REV; Malveaux G. F., 2019, STUDY ABROAD OPPORTU; Manolakis D, 2019, IEEE SIGNAL PROC MAG, V36, P64, DOI 10.1109/MSP.2018.2885853; Market intelligence for international student recruitment, 2019, MARK INT INT STUD RE; Market intelligence for international student recruitment, 2019, MARK INT INT STUD RE; Market intelligence for international student recruitment, 2019, MARK INT INT STUD RE; Matsutani M, 2018, JAPAN NEWS; McPherson MP, 2010, HIGHER ED GLOBAL SOC, P109; McRae N, 2017, OUTBOUND MOBILITY YO; Ministry of Education, 2020, TAIW GOV SCHOL; Ministry of Education, 2019, NUMB TAIW STUD STUD; Neri F, 2008, IEEE C EVOL COMPUTAT, P2135, DOI 10.1109/CEC.2008.4631082; OECD, 2016, OECD SCI TECHNOLOGY, DOI [10.1787/sti_in_outlook-2016-en, DOI 10.1787/STI_IN_OUTLOOK-2016-EN]; Open Doors, 2019, TOP 10 PLAC OR INT S; Salisbury MH, 2009, RES HIGH EDUC, V50, P119, DOI 10.1007/s11162-008-9111-x; SAS Institute, 2004, SAS ETS 9 1 US GUID; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Teichler U., 2009, HIGHER ED WORLD WORK, DOI DOI 10.1163/9789087907563; Teichler U., 1996, EUROPEAN J ED, V21, P153; Tyralis H, 2017, ALGORITHMS, V10, DOI 10.3390/a10040114; Vesterstrom J, 2004, IEEE C EVOL COMPUTAT, P1980; Wang JJ, 2012, APPL ENERG, V94, P65, DOI 10.1016/j.apenergy.2012.01.010; Waxman B, 2015, RECRUITING STUDENTS; West J, 2019, GROWTH INT STUDENT N; Winham TQ, 2018, TAIWAN NEWS; Yang CH, 2017, BIOINFORMATICS, V33, P2354, DOI 10.1093/bioinformatics/btx163; Yang CH, 2016, J BIOMED INFORM, V63, P112, DOI 10.1016/j.jbi.2016.08.009; Zhang F, 2016, ENERG BUILDINGS, V126, P94, DOI 10.1016/j.enbuild.2016.05.028; Zhi JJ, 2018, INT J MOL MED, V41, P1419, DOI 10.3892/ijmm.2018.3359; Zhou QF, 2014, MECH SYST SIGNAL PR, V46, P82, DOI 10.1016/j.ymssp.2013.12.013	51	2	2	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238129	10.1371/journal.pone.0238129	http://dx.doi.org/10.1371/journal.pone.0238129			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ7QD	32881900	Green Published, gold			2022-12-26	WOS:000571063300021
J	Souza, VH; Visentainer, JEL; Zacarias, JMV; Alencar, JB; Tsuneto, PY; Silva, CO; Salmeron, S; Colli, CM; Sell, AM				Souza, Victor Hugo; Laguila Visentainer, Jeane Eliete; Valentini Zacarias, Joana Maira; Alencar, Josiane Bazzo; Tsuneto, Patricia Yumeko; Silva, Cleverson Oliveira; Salmeron, Samira; Colli, Cristiane Maria; Sell, Ana Maria			Association of IL16 polymorphisms with periodontitis in Brazilians: A case- control study	PLOS ONE			English	Article							INTERLEUKIN-16 GENE POLYMORPHISMS; (IL)-16 GENE; RISK; IL-16; CLASSIFICATION; SUSCEPTIBILITY; POPULATIONS; RS11556218; PREVALENCE; MECHANISMS	Periodontitis (PD) is a chronic inflammatory process resulting from the relationship of the immune response with the components in dental plaque. Cytokines and their genetic polymorphisms seem to be involved in the immunopathogenesis of this disease. This study aimed to evaluate the correlation ofIL16polymorphism with PD. A case-control study was conducted in a sample of individuals from southern Brazil. The genotyping ofIL16,rs11556218 T>G,rs4072111 C>Ters4778889 T>C, was performed using the PCR-RFLP methodology. The serum level of IL-16 was determined using an IL-16 ELISA kit for humans. SNPStats and OpenEpi software and Wilcoxon's U test were used to perform statistical analysis.IL16 rs11556218polymorphism was significantly associated to PD in nonsmoking patients: individuals withG/Ggenotype were less likely to develop PD compared to theT/Tgenotype (OR = 0.10;Pc= 0.019, codominant model). In addition, theTTThaplotype was associated with a high risk for PD (OR = 2.45;P= 0.01). A low IL-16 serum level was observed among individuals with PD when compared to controls (P= 0.027). Thus, theIL16rs16556218 polymorphism and the serum levels of IL-16 were associated with periodontitis in a Brazilian sample, and this was influenced by environmental factors such as smoking.	[Souza, Victor Hugo; Laguila Visentainer, Jeane Eliete; Valentini Zacarias, Joana Maira; Alencar, Josiane Bazzo; Tsuneto, Patricia Yumeko; Colli, Cristiane Maria; Sell, Ana Maria] Univ Estadual Maringa, Dept Clin Anal & Biomed, Postgrad Program Biosci & Physiopathol, Maringa, Parana, Brazil; [Souza, Victor Hugo; Laguila Visentainer, Jeane Eliete; Valentini Zacarias, Joana Maira; Alencar, Josiane Bazzo; Tsuneto, Patricia Yumeko; Colli, Cristiane Maria; Sell, Ana Maria] Univ Estadual Maringa, Lab Immunogenet, Maringa, Parana, Brazil; [Souza, Victor Hugo; Laguila Visentainer, Jeane Eliete; Valentini Zacarias, Joana Maira; Alencar, Josiane Bazzo; Tsuneto, Patricia Yumeko; Colli, Cristiane Maria; Sell, Ana Maria] Univ Estadual Maringa, Dept Basic Hlth Sci, Maringa, Parana, Brazil; [Silva, Cleverson Oliveira] Univ Estadual Maringa, Dept Dent, Maringa, Parana, Brazil; [Salmeron, Samira] Inga Univ Ctr, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa; Centro Universitario Inga (UNINGA)	Souza, VH (corresponding author), Univ Estadual Maringa, Dept Clin Anal & Biomed, Postgrad Program Biosci & Physiopathol, Maringa, Parana, Brazil.; Souza, VH (corresponding author), Univ Estadual Maringa, Lab Immunogenet, Maringa, Parana, Brazil.; Souza, VH (corresponding author), Univ Estadual Maringa, Dept Basic Hlth Sci, Maringa, Parana, Brazil.	victoruem@gmail.com	Silva, Cléverson O/G-5907-2012; Colli, Cristiane Maria/ABH-9857-2020; Visentainer, Jeane/AAJ-1618-2021; Salmeron, Samira/AAG-2690-2020	Silva, Cléverson O/0000-0002-7103-9100; Colli, Cristiane Maria/0000-0002-6899-7519; Salmeron, Samira/0000-0002-6677-5066; Souza, Victor/0000-0002-6620-540X; Reis, AlessanRSS/0000-0001-8486-7469	Institutions Coordination of Improvement of Higher Education Personnel (CAPES: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); Fundacao Araucaria do Estado do Parana [2015/0310]; Laboratory of Immunogenetics of the State University of Maringa (LIG-UEM) [1999/00639-DEG-UEM]	Institutions Coordination of Improvement of Higher Education Personnel (CAPES: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Araucaria do Estado do Parana(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA); Laboratory of Immunogenetics of the State University of Maringa (LIG-UEM)	This research was carried out with financial support from the Institutions Coordination of Improvement of Higher Education Personnel (CAPES: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), Fundacao Araucaria do Estado do Parana [#2015/0310] and Laboratory of Immunogenetics of the State University of Maringa (LIG-UEM; #1999/00639-DEG-UEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Akahane M, 2016, AUTOIMMUNITY, V49, P312, DOI 10.3109/08916934.2015.1134507; Akesson LS, 2005, CLIN EXP ALLERGY, V35, P327, DOI 10.1111/j.1365-2222.2005.02189.x; [Anonymous], 2007, LIB INFORM UPDATE, V6, P9; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Azimzadeh P, 2016, INT J IMMUNOGENET, V43, P297, DOI 10.1111/iji.12281; Ballini A, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9060131; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Center DM, 2000, IMMUNOL TODAY, V21, P273, DOI 10.1016/S0167-5699(00)01629-7; de Alencar JB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227905; Folwaczny M, 2005, CLIN EXP IMMUNOL, V142, P188, DOI 10.1111/j.1365-2249.2005.02902.x; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Graves D, 2008, J PERIODONTOL, V79, P1585, DOI 10.1902/jop.2008.080183; Gu XJ, 2008, CLIN IMMUNOL, V127, P298, DOI 10.1016/j.clim.2008.01.017; Inchingolo F, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8050115; JOHN SWM, 1991, NUCLEIC ACIDS RES, V19, P408, DOI 10.1093/nar/19.2.408; Kashfi SMH, 2016, TUMOR BIOL, V37, P2119, DOI 10.1007/s13277-015-4013-y; Khan S, 2016, SAUDI MED J, V37, P889, DOI 10.15537/smj.2016.8.14223; Kim HS, 1999, CYTOGENET CELL GENET, V84, P93, DOI 10.1159/000015224; Kirst ME, 2015, APPL ENVIRON MICROB, V81, P783, DOI 10.1128/AEM.02712-14; Klimiuk PA, 1999, J IMMUNOL, V162, P4293; Laan M, 1999, THORAX, V54, P911, DOI 10.1136/thx.54.10.911; Liu ZB, 2015, INT J CLIN EXP MED, V8, P1401; Luo QS, 2014, GENET TEST MOL BIOMA, V18, P711, DOI 10.1089/gtmb.2014.0170; Ma XQ, 2017, EUR J OBSTET GYN R B, V210, P90, DOI 10.1016/j.ejogrb.2016.10.009; Matalliotakis M, 2018, INT J MOL MED, V41, P1469, DOI 10.3892/ijmm.2018.3368; Mathy NL, 2000, IMMUNOLOGY, V100, P63, DOI 10.1046/j.1365-2567.2000.00997.x; Mijailovic I, 2020, J PERIODONTOL, V91, P554, DOI 10.1002/JPER.18-0755; Palmer RM, 2005, J CLIN PERIODONTOL, V32, P180, DOI 10.1111/j.1600-051X.2005.00786.x; Papapanou PN, 2018, J CLIN PERIODONTOL, V45, pS162, DOI 10.1111/jcpe.12946; Papapanou PN, 2017, PERIODONTOL 2000, V75, P45, DOI 10.1111/prd.12200; Patil VS, 2016, J CLIN DIAGN RES, V10, pBC12, DOI 10.7860/JCDR/2016/17350.7542; Probst CM, 2000, HUM BIOL, V72, P597; Qin X, 2014, TUMOR BIOL, V35, P1917, DOI 10.1007/s13277-013-1257-2; Reis PG, 2018, HLA, V92, P298, DOI 10.1111/tan.13368; Ryder MI, 2004, ORAL MICROBIOL IMMUN, V19, P39, DOI 10.1046/j.0902-0055.2003.00110.x; Schenkein Harvey A, 2013, J Clin Periodontol, V40 Suppl 14, pS51, DOI [10.1902/jop.2013.134006, 10.1111/jcpe.12060]; Sell AM, 2017, IMMUNOPATHOGENESIS C, DOI [10.5772/intechopen.69045, DOI 10.5772/INTECH0PEN.69045]; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Tang YJ, 2016, SCI REP-UK, V6, P1, DOI 10.1038/srep34607; Tonetti MS, 2018, J CLIN PERIODONTOL, V45, pS149, DOI [10.1111/jcpe.12945, 10.1002/JPER.18-0006]; Tonguc MO, 2012, DENTOMAXILLOFAC RAD, V41, P509, DOI 10.1259/dmfr/21900076; Tsai IS, 2005, CYTOKINE, V31, P34, DOI 10.1016/j.cyto.2005.02.007; Tsai KH, 2014, CHINESE J PHYSIOL, V57, P69, DOI 10.4077/CJP.2014.BAB150; Tsuneto PY, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/9585964; Vahabi S, 2018, J INVESTIG CLIN DENT, V9, DOI 10.1111/jicd.12319; Zacarias JMV, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/147056; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Xue H, 2009, CLIN CHIM ACTA, V403, P223, DOI 10.1016/j.cca.2009.03.016; Zhao YH, 2014, GENET TEST MOL BIOMA, V18, P174, DOI 10.1089/gtmb.2013.0386	50	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0239101	10.1371/journal.pone.0239101	http://dx.doi.org/10.1371/journal.pone.0239101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915917	gold, Green Published			2022-12-26	WOS:000571887500127
J	Hennessy, ML; Indugu, N; Vecchiarelli, B; Bender, J; Pappalardo, C; Leibstein, M; Toth, J; Katepalli, A; Garapati, S; Pitta, D				Hennessy, Meagan L.; Indugu, Nagaraju; Vecchiarelli, Bonnie; Bender, Joseph; Pappalardo, Christa; Leibstein, Miranda; Toth, John; Katepalli, Ananya; Garapati, Satvik; Pitta, Dipti			Temporal changes in the fecal bacterial community in Holstein dairy calves from birth through the transition to a solid diet	PLOS ONE			English	Article							MICROBIOTA; HEALTH; COWS	The development of a robust microbiome is critical to the health of dairy calves, but relatively little is known about the progression of the microbiome through the weaning transition. In this study, fecal samples were obtained from ten female Holstein calves at 6 timepoints between 2-13 weeks of age. Calves were fed acidified milk until weaning at 8 weeks old and had access to starter grain throughout the study. Fecal samples were extracted for genomic DNA, PCR-amplified for the V1-V2 region of the 16S rRNA bacterial gene, sequenced on the Illumina MiSeq platform, and analyzed using the QIIME2 pipeline. Bacterial richness, estimated by number of observed species, and bacterial diversity, estimated by Shannon diversity index, both differed significantly between timepoints and both increased over time (P<0.05), with the largest increases occurring during weaning. Weighted and unweighted UniFrac analysis showed significant differences (P<0.05) between bacterial communities across timepoints; betadisper analysis revealed that the microbiomes of individual calves became more similar with time. Throughout the study, Firmicutes was the dominant phylum, followed by Bacteroidetes. Thirteen bacterial genera were found to be significantly influenced by time, includingFaecalibacterium,Clostridium, unclassifiedS24-7,Collinsella,Sharpea, andTreponema. UnclassifiedRuminococcaceaewas the most prevalent genus at timepoints 1, 3, 5, and 6, but different amplicon sequence variants were detected at each timepoint suggesting the presence of different species ofRuminococcaceaeat different times.Bacteroideswas the most prevalent genus at timepoint 2, andPrevotellawas most prevalent at timepoint 4. Our results indicate that there is considerable variation in the calf microbiome pre-weaning, but the microbial community stabilizes and becomes similar to the adult microbiome at weaning. Further studies to describe the phylogeny and functionality of core microbiota through the weaning transition are needed to improve health and reduce diarrhea in the neonatal period.	[Hennessy, Meagan L.; Indugu, Nagaraju; Vecchiarelli, Bonnie; Bender, Joseph; Pappalardo, Christa; Toth, John; Pitta, Dipti] Univ Penn, Sch Vet Med, Dept Clin Studies, Kennett Sq, Philadelphia, PA 19104 USA; [Leibstein, Miranda] Oceanside High Sch, Oceanside, NY USA; [Katepalli, Ananya] Northwest High Sch, Germantown, MD USA; [Garapati, Satvik] Drexel Univ, Philadelphia, PA 19104 USA	University of Pennsylvania; Drexel University	Pitta, D (corresponding author), Univ Penn, Sch Vet Med, Dept Clin Studies, Kennett Sq, Philadelphia, PA 19104 USA.	dpitta@vet.upenn.edu	Indugu, Nagaraju/AAT-7497-2021	Indugu, Nagaraju/0000-0001-9424-2155; Pitta, Dipti/0000-0002-3102-9119	United States Department of Agriculture National Institute of Food and Agriculture [PENV570262]	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	Walmoore Holsteins, Inc. and Lindsay Stover allowed us to conduct the study using their facilities. This research was funded by the United States Department of Agriculture National Institute of Food and Agriculture (Grant #PENV570262; https://nifa.usda.gov/us-states-and-territories/pennsylvania).This grant was received by DP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipour MJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28733-y; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anonymous, 2014, Journal of Cetacean Research and Management, V15, P1; [Anonymous], 2018, CANCER DISCOV, V8, pOF6; Bartels CJM, 2010, PREV VET MED, V93, P162, DOI 10.1016/j.prevetmed.2009.09.020; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Constable PD, 2004, J VET INTERN MED, V18, P8, DOI 10.1892/0891-6640(2004)18&lt;8:AUITTO&gt;2.0.CO;2; Davis CL, 1998, DEV MANAGEMENT YOUNG; Deng YF, 2017, SCI REP-UK, V7, DOI 10.1038/srep42689; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Diao QY, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9080490; Evans CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092193; Foditsch C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145485; Foditsch C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116465; Gomez DE, 2017, J VET INTERN MED, V31, P928, DOI 10.1111/jvim.14695; Gomez DE, 2019, VET CLIN N AM-FOOD A, V35, P485, DOI 10.1016/j.cvfa.2019.08.002; Hagey JV, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01093; Indugu N, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1098-z; Ipharraguerre IR, 2003, ANIM FEED SCI TECH, V106, P39, DOI 10.1016/S0377-8401(03)00065-8; Izzo MM, 2011, AUST VET J, V89, P167, DOI 10.1111/j.1751-0813.2011.00692.x; Jami E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085423; Jewell KA, 2015, APPL ENVIRON MICROB, V81, P4697, DOI 10.1128/AEM.00720-15; Jost T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044595; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Klein-Joebstl D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220554; Lima SF, 2017, J DAIRY SCI, V100, P3031, DOI 10.3168/jds.2016-11604; Malmuthuge N, 2014, APPL ENVIRON MICROB, V80, P2021, DOI 10.1128/AEM.03864-13; Mancabelli L, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8010131; Muller C., 1986, ACIDIFIED MILK REPLA, P154; Oba M, 2003, J NUTR, V133, P1094, DOI 10.1093/jn/133.4.1094; Oikonomou G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063157; Pitta DW, 2018, J DAIRY SCI, V101, P295, DOI 10.3168/jds.2016-12514; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Salazar LFL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216066; Scharen M, 2017, J DAIRY SCI, V100, P2765, DOI 10.3168/jds.2016-11994; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; United States Department of Agriculture (USDA), 2018, DAIR 2014 HEIF CALF; Uyeno Y, 2010, LETT APPL MICROBIOL, V51, P570, DOI 10.1111/j.1472-765X.2010.02937.x; Xie X, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01363; Yanar M, 2006, TURK J VET ANIM SCI, V30, P235; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zhou M, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0447-y; Zou Y, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-017-0182-4	45	8	8	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238882	10.1371/journal.pone.0238882	http://dx.doi.org/10.1371/journal.pone.0238882			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ6EE	32898158	gold, Green Published			2022-12-26	WOS:000570962500041
J	Koper-Lenkiewicz, OM; Kaminska, J; Reszec, J; Dymicka-Piekarska, V; Ostrowska, H; Karpinska, M; Matowicka-Karna, J; Tylicka, M				Koper-Lenkiewicz, Olga Martyna; Kaminska, Joanna; Reszec, Joanna; Dymicka-Piekarska, Violetta; Ostrowska, Halina; Karpinska, Maria; Matowicka-Karna, Joanna; Tylicka, Marzena			Elevated plasma 20S proteasome chymotrypsin-like activity is correlated with IL-8 levels and associated with an increased risk of death in glial brain tumor patients	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; KAPPA-B; EXPRESSION; DEXAMETHASONE; LOCALIZATION; BORTEZOMIB; MUTATIONS; MECHANISM; CELLS; P105	Introduction In cancer treatment an attempt has been made to pharmacologically regulate the proteasome functions, thus the aim was to test whether 20S proteasome chymotrypsin-like (ChT-L) activity has a role in glial brain tumors. Furthermore, we analyzed the correlation between proteasome activity and IL-8, CCL2, NF-kappa B1 and NF-kappa B2 concentrations, which impact on brain tumors has already been indicated. Methods Plasma 20S proteasome ChT-L activity was assayed using the fluorogenic peptide substrate Suc-Leu-Leu-Val-Tyr-AMC in the presence of SDS. IL-8, CCL2, NF-kappa B1 and NF-kappa B2 concentration was analyzed with the use of ELISA method. Immunohistochemistry for IDH1-R132H was done on 5-microns-thick formalin-fixed, paraffin-embedded tumor sections with the use of antibody specific for the mutant IDH1-R132H protein. Labelled streptavidin biotin kit was used as a detection system. Results Brain tumor patients had statistically higher 20S proteasome ChT-L activity (0.649 U/mg) compared to non-tumoral individuals (0.430 U/mg).IDH1wild-type patients had statistically higher 20S proteasome ChT-L activity (1.025 U/mg) compared toIDH1mutants (0.549 U/mg). 20S proteasome ChT-L activity in brain tumor patients who died as the consequence of a tumor (0.649) in the following 2 years was statistically higher compared to brain tumor patients who lived (0.430 U/mg). In brain tumor patients the 20S proteasome ChT-L activity positively correlated with IL-8 concentration. Conclusions Elevated 20S proteasome ChT-L activity was related to the increased risk of death in glial brain tumor patients. A positive correlation between 20S proteasome ChT-L activity and IL-8 concentration may indicate the molecular mechanisms regulating glial tumor biology. Thus research on proteasomes may be important and should be carried out to verify if this protein complexes may represent a potential therapeutic target to limit brain tumor invasion.	[Koper-Lenkiewicz, Olga Martyna; Kaminska, Joanna; Dymicka-Piekarska, Violetta; Matowicka-Karna, Joanna] Med Univ Bialystok, Dept Clin Lab Diagnost, Bialystok, Poland; [Reszec, Joanna] Med Univ Bialystok, Dept Med Pathomorphol, Bialystok, Poland; [Ostrowska, Halina] Med Univ Bialystok, Dept Biol, Bialystok, Poland; [Karpinska, Maria; Tylicka, Marzena] Med Univ Bialystok, Dept Biophys, Bialystok, Poland	Medical University of Bialystok; Medical University of Bialystok; Medical University of Bialystok; Medical University of Bialystok	Koper-Lenkiewicz, OM (corresponding author), Med Univ Bialystok, Dept Clin Lab Diagnost, Bialystok, Poland.; Tylicka, M (corresponding author), Med Univ Bialystok, Dept Biophys, Bialystok, Poland.	o.koper@wp.pl; marzena.tylicka@umb.edu.pl	Kamińska, Joanna/ABH-7067-2020; Koper-Lenkiewicz, Olga/N-8901-2019; Kaminska, Joanna/S-8293-2018; Dymicka-Piekarska, Violetta/AAP-4207-2021; Karpinska, Maria/T-6399-2018	Kamińska, Joanna/0000-0002-2986-4852; Koper-Lenkiewicz, Olga/0000-0001-5199-2773; Kaminska, Joanna/0000-0002-2986-4852; Dymicka-Piekarska, Violetta/0000-0003-4170-0997; Karpinska, Maria/0000-0002-5002-2799				Aghai ZH, 2006, PEDIATR RES, V59, P811, DOI 10.1203/01.pdr.0000219120.92049.b3; Alvarez-Castelao B, 2005, FEBS LETT, V579, P4797, DOI 10.1016/j.febslet.2005.07.060; [Anonymous], 2017, COLORECTAL DIS; Balca-Silva J, 2019, SEMIN CANCER BIOL, V58, P130, DOI 10.1016/j.semcancer.2018.09.007; Braganhol E, 2015, BBA-MOL BASIS DIS, V1852, P120, DOI 10.1016/j.bbadis.2014.10.014; Briggs A, 2003, HEALTH ECON, V12, P377, DOI 10.1002/hec.766; Cahill KE, 2016, NEURO-ONCOLOGY, V18, P329, DOI 10.1093/neuonc/nov265; Chen D, 2010, CURR PROTEIN PEPT SC, V11, P459, DOI 10.2174/138920310791824057; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cullen SJ, 2010, BIOCHEM PHARMACOL, V79, P706, DOI 10.1016/j.bcp.2009.10.006; Dahlmann B, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S3; Domanska UM, 2011, CRIT REV ONCOL HEMAT, V79, P154, DOI 10.1016/j.critrevonc.2010.07.006; Florczyk U, 2011, FREE RADICAL BIO MED, V51, P1882, DOI 10.1016/j.freeradbiomed.2011.08.023; Goodenberger ML, 2012, CANCER GENET-NY, V205, P613, DOI 10.1016/j.cancergen.2012.10.009; Gopinath T., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; Haarmann A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030602; Hasan T, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1387-6; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Infanger DW, 2013, CANCER RES, V73, P7079, DOI 10.1158/0008-5472.CAN-13-1355; Laurent N, 2004, MOL CANCER THER, V3, P129; Leung SY, 1997, ACTA NEUROPATHOL, V93, P518, DOI 10.1007/s004010050647; Liu YS, 2019, NEUROPHARMACOLOGY, V144, P143, DOI 10.1016/j.neuropharm.2018.10.033; Ma W, 2008, CANCER-AM CANCER SOC, V112, P1306, DOI 10.1002/cncr.23301; Mele G, 2010, LEUKEMIA LYMPHOMA, V51, P937, DOI 10.3109/10428191003695660; Moorthy AK, 2006, EMBO J, V25, P1945, DOI 10.1038/sj.emboj.7601081; NEGUS RPM, 1995, J CLIN INVEST, V95, P2391, DOI 10.1172/JCI117933; Ohgaki H, 2009, CANCER SCI, V100, P2235, DOI 10.1111/j.1349-7006.2009.01308.x; Ostrowska H, 2008, CLIN BIOCHEM, V41, P1377, DOI 10.1016/j.clinbiochem.2008.08.063; Phuagkhaopong S, 2017, NEUROTOXICOLOGY, V60, P82, DOI 10.1016/j.neuro.2017.03.001; Phuphanich S, 2010, J NEURO-ONCOL, V100, P95, DOI 10.1007/s11060-010-0143-7; Piva R, 1999, J NEUROPATH EXP NEUR, V58, P691, DOI 10.1097/00005072-199907000-00002; Raychaudhuri B, 2011, J NEURO-ONCOL, V101, P227, DOI 10.1007/s11060-010-0261-2; Romaguera JE, 2018, CANCER-AM CANCER SOC, V124, P2561, DOI 10.1002/cncr.31361; Roth P, 2009, CLIN CANCER RES, V15, P6609, DOI 10.1158/1078-0432.CCR-09-0548; Savinova OV, 2009, MOL CELL, V34, P591, DOI 10.1016/j.molcel.2009.04.033; Sun S, 2011, J NEURO-ONCOL, V101, P1, DOI 10.1007/s11060-010-0220-y; TAKESHIMA H, 1994, J NEUROSURG, V80, P1056, DOI 10.3171/jns.1994.80.6.1056; Taniguchi E, 2009, PEDIATR BLOOD CANCER, V53, P136, DOI 10.1002/pbc.21968; Thibaudeau TA, 2019, PHARMACOL REV, V71, P170, DOI 10.1124/pr.117.015370; Thiese MS, 2016, J THORAC DIS, V8, pE928, DOI 10.21037/jtd.2016.08.16; Tylicka M, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/2469098; Tylicka M, 2017, SCAND J CLIN LAB INV, V77, P610, DOI 10.1080/00365513.2017.1385839; Tylicka M, 2016, POSTEP HIG MED DOSW, V70, P448, DOI 10.5604/17322693.1201198; Venza M, 2011, NEUROSURGERY, V69, P713, DOI 10.1227/NEU.0b013e31821954c6; Villa C, 2018, PRESSE MED, V47, pE187, DOI 10.1016/j.lpm.2018.04.015; Voorhees PM, 2003, CLIN CANC RES, V9, P459; Wakabayashi K, 2004, ONCOGENE, V23, P6924, DOI 10.1038/sj.onc.1207778; Wang P, 2016, SCI REP, V6, P1, DOI DOI 10.1038/s41598-016-0001-8; Wei XH, 2018, ONCOL LETT, V15, P5149, DOI 10.3892/ol.2018.7936; Xu X, 2017, CANC TRANSL MED, V3, P181, DOI [10.4103/ctm.ctm_48_16, DOI 10.4103/CTM.CTM_48_16]; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhang BG, 2015, CANCER BIOL THER, V16, P898, DOI 10.1080/15384047.2015.1028702; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	53	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238406	10.1371/journal.pone.0238406	http://dx.doi.org/10.1371/journal.pone.0238406			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886667	gold, Green Published			2022-12-26	WOS:000571064300028
J	Thurow, RF; Peterson, JT; Chandler, GL; Moffitt, CM; Bjornn, TC				Thurow, Russell F.; Peterson, James T.; Chandler, Gwynne L.; Moffitt, Christine M.; Bjornn, Theodore C.			Concealment of juvenile bull trout in response to temperature, light, and substrate: Implications for detection	PLOS ONE			English	Article							SALMON ONCORHYNCHUS-KISUTCH; CUTTHROAT TROUT; HABITAT USE; SALVELINUS-CONFLUENTUS; THERMAL TOLERANCE; CHINOOK SALMON; WINTER; BEHAVIOR; ABUNDANCE; SELECTION	Bull trout (Salvelinus confluentus)are challenging to detect as a result of the species cryptic behavior and coloration, relatively low densities in complex habitats, and affinity for cold, high clarity, low conductivity waters. Bull trout are also closely associated with the stream bed, frequently conceal in substrate, and this concealment behavior is poorly understood. Consequently, population assessments are problematic and biologists and managers often lack quantitative information to accurately describe bull trout distributions, estimate abundance, and assess status and trends; particularly for stream-dwelling populations. During controlled laboratory trials, we recorded concealment, resting, and swimming behavior of juvenile wild bull trout in response to: (1) constant and fluctuating water temperature, (2) presence or absence of light, and (3) substrate size. Light level had the strongest influence on wild fish concealment and more fish concealed as light levels increased from darkness to daylight. Wild fish were 14.5 times less likely to conceal in constant darkness and 4.1 times more likely to conceal in 12 h light x 12 h darkness compared to constant light. Wild fish were 6.2 times less likely to conceal in small (26-51 mm) substrate compared to larger (52-102 mm) substrate. As water temperature increased, fewer wild fish concealed. Knowledge of wild bull trout concealment will improve field sampling protocols and increase detection efficiencies. These data also enhance knowledge of bull trout niche requirements which illuminates ecological differences among species and informs conservation and restoration efforts.	[Thurow, Russell F.; Chandler, Gwynne L.] US Forest Serv, USDA, Rocky Mt Res Stn, Salmon, ID 83467 USA; [Peterson, James T.] Oregon State Univ, US Geol Survey, Oregon Cooperat Fish & Wildlife Res Unit, Corvallis, OR 97331 USA; [Moffitt, Christine M.; Bjornn, Theodore C.] Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA	United States Department of Agriculture (USDA); United States Forest Service; Oregon State University; United States Department of the Interior; United States Geological Survey; Idaho; University of Idaho	Thurow, RF (corresponding author), US Forest Serv, USDA, Rocky Mt Res Stn, Salmon, ID 83467 USA.	russ.thurow@usda.gov			USDA Forest Service-Rocky Mountain Research Station; U.S. Geological Survey; U.S. Fish and Wildlife Service; Oregon Department of Fish and Wildlife; Oregon State University; Wildlife Management Institute	USDA Forest Service-Rocky Mountain Research Station(United States Department of Agriculture (USDA)United States Forest Service); U.S. Geological Survey(United States Geological Survey); U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Oregon Department of Fish and Wildlife; Oregon State University; Wildlife Management Institute	Funding was provided by the USDA Forest Service-Rocky Mountain Research Station.r Dr. Ted C. Bjornn helped conceptualize and conducted this laboratory research and died before submission of this manuscript. R.F. Thurow accepts responsibility for the integrity and validity of the data collected and analyzed. We thank Mike Jepson of the University of IdahoDepartment of Fish and Wildlife Sciences for his assistance with all aspects of the trials including acclimation, care, and feeding of fish prior to and during trials; recording behavioral observations; and measuring fish. Idaho Department of Fish and Game Region 1 fisheries personnel gave permission and provided electrofishing equipment for capture of bull trout. John Guzevich, RMRS, assisted with field collection of fish. Scott Baggett, RMRS in Fort Collins, Colorado, provided statistical suggestions. Comments by two anonymous reviewers and Robert AlChokhachy improved an earlier version of this manuscript. The Oregon Cooperative Fish and Wildlife Research Unit is jointly sponsored by the U.S. Geological Survey, the U.S. Fish and Wildlife Service, the Oregon Department of Fish and Wildlife, Oregon State University, and the Wildlife Management Institute. Any use of trade, product, or firm names is for descriptive purposes only and does not imply endorsement by the U.S. Government.	ADAMS NJ, 1988, CAN J ZOOL, V66, P2500, DOI 10.1139/z88-370; Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Al-Chokhachy R, 2008, FISHERIES, V33, P18, DOI 10.1577/1548-8446-33.1.18; ANDREWS DWK, 1988, J ECONOMETRICS, V37, P135, DOI 10.1016/0304-4076(88)90079-6; Angradi T, 1989, F71R12 ID DEP FISH G; Ardren WR, 2011, T AM FISH SOC, V140, P506, DOI 10.1080/00028487.2011.567875; Baxter CV, 2000, CAN J FISH AQUAT SCI, V57, P1470, DOI 10.1139/cjfas-57-7-1470; Baxter JS, 1996, 98 U BRIT COL; Bayley Peter B., 1993, Polskie Archiwum Hydrobiologii, V40, P5; BJORNN TC, 1971, T AM FISH SOC, V100, P423, DOI 10.1577/1548-8659(1971)100<423:TASMIT>2.0.CO;2; Bonar SA, 1997, RAD9705 WASH DEP FIS; Bonneau JL, 1998, CAN J ZOOL, V76, P783, DOI 10.1139/cjz-76-5-783; Brignon WR, 2018, ENVIRON BIOL FISH, V101, P383, DOI 10.1007/s10641-017-0705-z; BUSTARD DR, 1975, J FISH RES BOARD CAN, V32, P667, DOI 10.1139/f75-086; Chapman D. W., 1969, S SALMON TROUT STREA, P153; CLARK CW, 1988, AM NAT, V131, P271, DOI 10.1086/284789; CONTOR CR, 1995, HYDROBIOLOGIA, V299, P179, DOI 10.1007/BF00767324; CUNJAK RA, 1986, CAN J FISH AQUAT SCI, V43, P1970, DOI 10.1139/f86-242; CUNJAK RA, 1988, CAN J FISH AQUAT SCI, V45, P2156, DOI 10.1139/f88-250; Dolan CR, 2003, T AM FISH SOC, V132, P969, DOI 10.1577/T02-055; Dunham J, 2003, N AM J FISH MANAGE, V23, P894, DOI 10.1577/M02-028; Dunham JB, 2009, STANDARD METHODS FOR SAMPLING NORTH AMERICAN FRESHWATER FISHES, P119; EDMUNDSON E, 1968, J FISH RES BOARD CAN, V25, P1453, DOI 10.1139/f68-126; Finstad AG, 2007, FRESHWATER BIOL, V52, P1710, DOI 10.1111/j.1365-2427.2007.01799.x; Fraley J, 1981, FLATHEAD RIVER FISHE; FRASER NHC, 1993, P ROY SOC B-BIOL SCI, V252, P135, DOI 10.1098/rspb.1993.0057; Goetz FA, 1989, BIOL B TROUT SALVELI; Goetz FA, 1990, BULL TROUT LIFE HIST; Goetz FA, 1997, FRIENDS BULL TROUT C, P387; Goetz FA, 1994, THESIS; HARTMAN GF, 1965, J FISH RES BOARD CAN, V22, P1035, DOI 10.1139/f65-095; HEGGENES J, 1993, J ANIM ECOL, V62, P295, DOI 10.2307/5361; HEGGENES J, 1991, CAN J FISH AQUAT SCI, V48, P1364, DOI 10.1139/f91-163; HILLMAN TW, 1987, T AM FISH SOC, V116, P185, DOI 10.1577/1548-8659(1987)116<185:SAWHSB>2.0.CO;2; Hillman TW, 1993, SURVEY PLAN DETECT P; Holierhoek AM, 1995, NORDIC J FRESHWATER, V71, P128; Horner N., 1976, SURVIVAL BEHAV DENSI; Hosmer D. W., 1989, APPL REGRESSION ANAL; Isaak DJ, 2015, GLOBAL CHANGE BIOL, V21, P2540, DOI 10.1111/gcb.12879; Isaak DJ, 2010, ECOL APPL, V20, P1350, DOI 10.1890/09-0822.1; Jakober MJ, 1998, T AM FISH SOC, V127, P223, DOI 10.1577/1548-8659(1998)127<0223:ROSIOF>2.0.CO;2; Jakober MJ, 2000, ENVIRON BIOL FISH, V59, P79, DOI 10.1023/A:1007699610247; Jakober MJ, 1995, THESIS; Jobling Malcolm, 1997, Society for Experimental Biology Seminar Series, V61, P225; Kovach RP, 2019, BIOSCIENCE, V69, P418, DOI 10.1093/biosci/biz040; MCMAHON TE, 1989, CAN J FISH AQUAT SCI, V46, P1551, DOI 10.1139/f89-197; Meeuwig MH, 2004, ECOL FRESHW FISH, V13, P208, DOI 10.1111/j.1600-0633.2004.00052.x; MESA MG, 1989, T AM FISH SOC, V118, P644, DOI 10.1577/1548-8659(1989)118<0644:EMADME>2.3.CO;2; Meyer KA, 2014, N AM J FISH MANAGE, V34, P202, DOI 10.1080/02755947.2013.869280; Meyer KA, 2011, N AM J FISH MANAGE, V31, P923, DOI 10.1080/02755947.2011.633684; Muhlfeld CC, 2005, N AM J FISH MANAGE, V25, P797, DOI 10.1577/M04-045.1; Peterson JT, 2004, T AM FISH SOC, V33; Pinto MC, 2013, T AM FISH SOC, V142, P1590, DOI 10.1080/00028487.2013.822419; POST JR, 2002, 39 ALB SUST RES DEV; Power G, 2002, ENVIRON BIOL FISH, V64, P17, DOI 10.1023/A:1016066519418; Pratt KP, 1984, THESIS; R Core Team, 2021, R LANGUAGE ENV STAT; Reihle MD, 1990, THESIS; Rieman B., 1999, EMPIRICAL EVALUATION; Rieman B. E., 1993, General Technical Report - Intermountain Research Station, USDA Forest Service; RIEMAN BE, 1995, T AM FISH SOC, V124, P285, DOI 10.1577/1548-8659(1995)124<0285:OOBTIN>2.3.CO;2; Rieman Bruce E., 1997, North American Journal of Fisheries Management, V17, P1111, DOI 10.1577/1548-8675(1997)017<1111:DSALFT>2.3.CO;2; RILEY SC, 1993, J FRESHWATER ECOL, V8, P97, DOI 10.1080/02705060.1993.9664838; RIMMER DM, 1983, CAN J FISH AQUAT SCI, V40, P671, DOI 10.1139/f83-090; RIMMER DM, 1990, CAN J ZOOL, V68, P1098, DOI 10.1139/z90-162; Saffel PD, 1995, NORTHWEST SCI, V69, P304; Selong JH, 2001, T AM FISH SOC, V130, P1026, DOI 10.1577/1548-8659(2001)130<1026:EOTOGA>2.0.CO;2; Shepard B, 1984, LIFE HIST WESTSLOE C; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Thurow RF, 1997, ECOL FRESHW FISH, V6, P1, DOI 10.1111/j.1600-0633.1997.tb00136.x; Thurow RF, 2006, N AM J FISH MANAGE, V26, P217, DOI 10.1577/M05-054.1; Thurow RF, 2012, FISHERIES TECHNIQUES, THIRD EDITION, P781; Thurow Russell F., 1996, North American Journal of Fisheries Management, V16, P314, DOI 10.1577/1548-8675(1996)016<0314:CODSNS>2.3.CO;2; U.S. Fish and Wildlife Service, 2015, REC PLAN COT US POP; USFWS (U.S. Fish and Wildlife Service), 2008, B TROUT SALV CONFL 5; Watson Greg, 1997, North American Journal of Fisheries Management, V17, P237, DOI 10.1577/1548-8675(1997)017<0237:FATDAA>2.3.CO;2; Wehrly KE, 2007, T AM FISH SOC, V136, P365, DOI 10.1577/T06-163.1; Wilcox TM, 2014, CONSERV GENET RESOUR, V6, P283, DOI 10.1007/s12686-013-0113-4; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520	79	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0237716	10.1371/journal.pone.0237716	http://dx.doi.org/10.1371/journal.pone.0237716			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886676	Green Published, gold			2022-12-26	WOS:000571064300024
J	Tost, D; Strauss, E; Jung, K; Siebert, U				Tost, Daniel; Strauss, Egbert; Jung, Klaus; Siebert, Ursula			Impact of tourism on habitat use of black grouse (Tetrao tetrix) in an isolated population in northern Germany	PLOS ONE			English	Article							HUMAN DISTURBANCE; WILDLIFE RESPONSES; LOWER SAXONY; STRESS-RESPONSE; RECREATION; UROGALLUS; SPORTS; THREAT; ALPS	As many other wild living species, black grouseTetrao tetrixhas to cope with anthropogenic disturbances in many habitats. Impacts of tourism and outdoor recreation on grouse speciesTetraoninaehave been subject to several studies in mountainous habitats in Central Europe and the United Kingdom. The geographically isolated and critically endangered black grouse population of Lower Saxony (North Germany) has been consistently monitored but beyond that poorly studied. This also applies to the key habitats of the nature reserve Luneburg Heath (Luneburger Heide) which, in turn, serves as a recreational area as well. In this study, the impact of tourism activity on habitat use of black grouse was investigated using data of GPS-tracked individuals. Additionally, visitor numbers on public and (usually undisturbed) closed routes were monitored using infrared light barriers. The spatio-temporal distribution of locations and the recreational activity were evaluated by linear mixed-effects models. Tagged individuals avoided the vicinity of public routes and avoiding distances were directly related to intensity of human activity. There was no seasonal change of black grouse habitat use alongside public routes. However, towards closed routes, significantly higher distances appeared during peak phases of visitor numbers (August and September), implying temporary increased disturbance levels within a key refuge area. Diurnal adaptation of habitat use was strongly dependent on the route density within the home range. Individuals used the vicinity of public trails at night and dawn but evaded these habitats during peak human activity around noon and afternoon. Recreational disturbances appeared to significantly affect the effective habitat availability for black grouse in the nature reserve. Visual cover by vegetation, however, seemed to diminish negative effects emerging from hiking trails. This provides an effective protective measure which requires minimal effort for the local conservation management.	[Tost, Daniel; Strauss, Egbert; Siebert, Ursula] Univ Vet Med Hannover, Inst Terr & Aquat Wildlife Res, Hannover, Germany; [Jung, Klaus] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Siebert, U (corresponding author), Univ Vet Med Hannover, Inst Terr & Aquat Wildlife Res, Hannover, Germany.	ursula.siebert@tiho-hannover.de		Tost, Daniel/0000-0001-9545-9647	Ministry of Food, Agriculture and Consumer Protection of Lower Saxony; Deutsche Forschungsgemeinschaft; University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing	Ministry of Food, Agriculture and Consumer Protection of Lower Saxony; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing	The project was funded by the Ministry of Food, Agriculture and Consumer Protection of Lower Saxony (http://www.ml.niedersachsen.de). This publication was supported by Deutsche Forschungsgemeinschaft (https://www.dfg.de) and University of Veterinary Medicine Hannover, Foundation (https://www.tiho-hannover.de) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, EVOL PSYCHIAT, V82, P1, DOI DOI 10.18637/JSS.V082.I13; Arlettaz R, 2007, P R SOC B, V274, P1219, DOI 10.1098/rspb.2006.0434; Baines D, 2007, IBIS, V149, P56, DOI 10.1111/j.1474-919X.2007.00638.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Blumstein DT, 2005, J APPL ECOL, V42, P943, DOI 10.1111/j.1365-2664.2005.01071.x; Braunisch V, 2011, ECOL APPL, V21, P955, DOI 10.1890/09-2167.1; Calladine J, 2002, J APPL ECOL, V39, P772, DOI 10.1046/j.1365-2664.2002.00753.x; Cianchetti-Benedetti M, 2018, EUR J WILDLIFE RES, V64, DOI 10.1007/s10344-018-1178-x; Coppes J, 2017, J AVIAN BIOL, V48, P1583, DOI 10.1111/jav.01239; Cordes H, 1997, NATURSCHUTZGEBIET LU; Formenti N, 2015, J ORNITHOL, V156, P317, DOI 10.1007/s10336-014-1103-3; George SL, 2006, BIOL CONSERV, V133, P107, DOI 10.1016/j.biocon.2006.05.024; Ikeda T, 2019, GLOB ECOL CONSERV, V18, DOI 10.1016/j.gecco.2019.e00617; Immitzer M, 2014, J ORNITHOL, V155, P173, DOI 10.1007/s10336-013-0999-3; Kaiser T, 2015, NATURSCHUTZGEBIET LU; Kaiser T, 2013, NATURSCHUTZGEBIET LU; Klaus S, 1990, BIRKHUHNER TETRAO TE; Leuschner C, 2017, DWARF SHRUB HEATHS N, VII, P435; Ludwig T, 2008, J ORNITHOL, V149, P587, DOI 10.1007/s10336-008-0306-x; Ludwig T, 2009, J ORNITHOL, V150, P871, DOI 10.1007/s10336-009-0410-6; Ludwig T, 2009, LANDSCAPE ECOL, V24, P533, DOI 10.1007/s10980-009-9330-3; McClung MR, 2004, BIOL CONSERV, V119, P279, DOI 10.1016/j.biocon.2003.11.012; Miller SG, 2001, WILDLIFE SOC B, V29, P124; Moss R, 2014, WILDLIFE BIOL, V20, P1, DOI 10.2981/wlb.12065; Mullner A, 2004, BIOL CONSERV, V118, P549, DOI 10.1016/j.biocon.2003.10.003; NLWKN, 2011, VOLLZ SCHUTZ B UNPUB, P8; NSG-VO, 1993, VER BEZ LUN NAT LUN; Oberosler V, 2017, MAMM BIOL, V87, P50, DOI 10.1016/j.mambio.2017.05.005; Patthey P, 2008, J APPL ECOL, V45, P1704, DOI 10.1111/j.1365-2664.2008.01547.x; R Core Team, 2021, R LANGUAGE ENV STAT; Reed SE, 2008, CONSERV LETT, V1, P146, DOI 10.1111/j.1755-263X.2008.00019.x; Ruhlen TD, 2003, J FIELD ORNITHOL, V74, P300, DOI 10.1648/0273-8570-74.3.300; Segelbacher G, 2014, CONSERV GENET, V15, P1183, DOI 10.1007/s10592-014-0610-3; Sieber Ursula, 1998, Ornithologische Beobachter, V95, P81; Storch I, 2003, WILDLIFE BIOL, V9, P301, DOI 10.2981/wlb.2003.018; Storch I, 2013, WILDLIFE BIOL, V19, P390, DOI 10.2981/13-006; Strauss Egbert, 2018, Ornithologische Beobachter, V115, P261; Taylor AR, 2003, ECOL APPL, V13, P951, DOI 10.1890/1051-0761(2003)13[951:WRTRAA]2.0.CO;2; Thiel D, 2008, J APPL ECOL, V45, P845, DOI 10.1111/j.1365-2664.2008.01465.x; Thiel D, 2007, J WILDLIFE MANAGE, V71, P1784, DOI 10.2193/2006-268; Visscher DR, 2017, WILDLIFE SOC B, V41, P162, DOI 10.1002/wsb.741; Warren P, 2009, FOLIA ZOOL, V58, P183; Watson A, 2004, BIOL CONSERV, V116, P267, DOI 10.1016/S0006-3207(03)00197-6; Whittaker D, 1998, WILDLIFE SOC B, V26, P312; Wolf ID, 2010, APPL ANIM BEHAV SCI, V126, P75, DOI 10.1016/j.applanim.2010.06.001	45	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238660	10.1371/journal.pone.0238660	http://dx.doi.org/10.1371/journal.pone.0238660			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886720	Green Published, gold			2022-12-26	WOS:000571064300053
J	Wissing, MBG; Golenia, L; Smith, J; Bongers, RM				Wissing, Maureen B. G.; Golenia, Laura; Smith, Joanne; Bongers, Raoul M.			Adjustments in end-effector trajectory and underlying joint angle synergies after a target switch: Order of adjustment is flexible	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; PLANAR REACHING MOVEMENTS; MUSCLE SYNERGIES; LOAD PERTURBATIONS; ONLINE CONTROL; MOTOR; HAND; VARIABILITY; COORDINATION; RESPONSES	Goal-directed reaching adapts to meet changing task requirements after unexpected perturbations such as a sudden switch of target location. Literature on adaptive behavior using a target switch has primarily focused on adjustments of the end-effector trajectory, addressing proposed feedback and feedforward processes in planning adjusted actions. Starting from a dynamical systems approach to motor coordination, the current paper focusses on coordination of joint angles after a target switch, which has received little attention in the literature. We argue that joint angles are coordinated in synergies, temporary task-specific units emerging from interactions amongst task, organism, and environmental constraints. We asked whether after a target switch: i) joint angles were coordinated in synergies, ii) joint angles were coordinated in a different synergy than the synergy used when moving to the original target, and iii) synergies or end-effector trajectory was adjusted first. Participants (N = 12) performed manual reaching movements toward a target on a table (stationary target trials), where in some trials the target could unexpectedly switch to a new location (switch trials). Results showed that the end-effector curved to the switched target. Joint angles were synergistically organized as shown by the large extent of co-variation based on Uncontrolled Manifold analyses. At the end of the target switch movement, joint angle configurations differed from the joint angle configurations used to move to the original stationary target. Hence, we argue, a new synergy emerged after the target switch. The order of adjustment in the synergies and in the end-effector was flexible within participants, though most often synergies were adjusted first. These findings support the two-step framework of Kay (1988) to understand the coordination of abundant degrees of freedom and to explain adaptive actions. The flexibility in the order of adjustments of synergies suggests that the coordination of DOF emerges from self-organization.	[Wissing, Maureen B. G.; Golenia, Laura; Smith, Joanne; Bongers, Raoul M.] Univ Groningen, Univ Med Ctr Groningen, Dept Human Movement Sci, Groningen, Netherlands; [Golenia, Laura] Median Unternehmensgrp, Med & Qual Management, Berlin, Germany	University of Groningen	Bongers, RM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Human Movement Sci, Groningen, Netherlands.	r.m.bongers@umcg.nl	Bongers, Raoul/C-1094-2012	Bongers, Raoul/0000-0002-3518-7464; Smith, Joanne/0000-0002-0126-5196; Wissing, Maureen B.G./0000-0003-3371-4547				ABBS JH, 1983, TRENDS NEUROSCI, V6, P391, DOI 10.1016/0166-2236(83)90173-X; ABBS JH, 1984, J NEUROPHYSIOL, V51, P705, DOI 10.1152/jn.1984.51.4.705; [Anonymous], 2000, TAPA, V130, p[149, 159]; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; BEPPU H, 1984, BRAIN, V107, P787, DOI 10.1093/brain/107.3.787; Bernstein N, 1967, COORDINATION REGULAT; Brenner E, 1997, J MOTOR BEHAV, V29, P297, DOI 10.1080/00222899709600017; Castiello U, 1998, EXP BRAIN RES, V120, P31, DOI 10.1007/s002210050375; Cohen J.E., 1988, STAT POWER ANAL BEHA; d'Avella A, 2006, J NEUROSCI, V26, P7791, DOI 10.1523/JNEUROSCI.0830-06.2006; d'Avella A, 2011, J NEUROPHYSIOL, V106, P2796, DOI 10.1152/jn.00675.2010; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; Diedrichsen J, 2005, J NEUROSCI, V25, P9919, DOI 10.1523/JNEUROSCI.1874-05.2005; Domkin D, 2005, EXP BRAIN RES, V163, P44, DOI 10.1007/s00221-004-2137-1; Fautrelle L, 2010, NEUROSCIENCE, V169, P697, DOI 10.1016/j.neuroscience.2010.05.014; Freitas SMSF, 2006, J NEUROPHYSIOL, V95, P636, DOI 10.1152/jn.00482.2005; GEORGOPOULOS AP, 1981, J NEUROPHYSIOL, V46, P725, DOI 10.1152/jn.1981.46.4.725; Gera G, 2010, MOTOR CONTROL, V14, P83, DOI 10.1123/mcj.14.1.83; Golenia L, 2018, DEV PSYCHOBIOL, V60, P511, DOI 10.1002/dev.21741; Golenia L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193463; GORDON J, 1994, EXP BRAIN RES, V99, P112, DOI 10.1007/BF00241416; GORDON J, 1994, EXP BRAIN RES, V99, P97, DOI 10.1007/BF00241415; Grea H, 2000, EXP BRAIN RES, V134, P155, DOI 10.1007/s002210000427; Greve C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127017; Gritsenko V, 2009, J NEUROPHYSIOL, V102, P914, DOI 10.1152/jn.91324.2008; HAKEN H, 1996, PRINCIPLES BRAIN FUN, DOI [10.1007/978-3-642-79570-1_11, DOI 10.1007/978-3-642-79570-1_11]; Haken H., 1995, OPEN SYSTEMS INFORM, V3, P97, DOI [DOI 10.1007/BF02228811, 10.1007/bf02228811]; Hansen E, 2015, EXP BRAIN RES, V233, P2555, DOI 10.1007/s00221-015-4327-4; Heath M, 1998, CAN J EXP PSYCHOL, V52, P163, DOI 10.1037/h0087289; HENIS EA, 1995, BIOL CYBERN, V72, P407, DOI 10.1007/BF00201416; Jirsa VK, 2005, J MOTOR BEHAV, V37, P35, DOI 10.3200/JMBR.37.1.35-51; KAY BA, 1988, HUM MOVEMENT SCI, V7, P343, DOI 10.1016/0167-9457(88)90016-4; Kelso JAS, 2009, ADV EXP MED BIOL, V629, P83, DOI 10.1007/978-0-387-77064-2_5; KELSO JAS, 1984, J EXP PSYCHOL HUMAN, V10, P812, DOI 10.1037/0096-1523.10.6.812; Kelso S., 1995, DYNAMIC PATTERNS SEL; Krishnamoorthy V, 2007, CLIN NEUROPHYSIOL, V118, P525, DOI 10.1016/j.clinph.2006.11.014; Kruger M, 2012, HUM MOVEMENT SCI, V31, P1071, DOI 10.1016/j.humov.2011.12.002; Latash M, 2000, MOTOR CONTROL, V4, P259, DOI 10.1123/mcj.4.3.259; Latash ML, 2007, J INTELL DISABIL RES, V51, P962, DOI 10.1111/j.1365-2788.2007.01008.x; Liu D, 2007, J NEUROSCI, V27, P9354, DOI 10.1523/JNEUROSCI.1110-06.2007; Martin V, 2009, NEURAL COMPUT, V21, P1371, DOI 10.1162/neco.2008.01-08-698; Martin V, 2019, BIOL CYBERN, V113, P293, DOI 10.1007/s00422-019-00794-w; Mattos DJS, 2011, J NEUROPHYSIOL, V106, P1424, DOI 10.1152/jn.00163.2011; Newell KM, 2001, HUM MOVEMENT SCI, V20, P695, DOI 10.1016/S0167-9457(01)00073-2; Pacheco MM, 2018, EXP BRAIN RES, V236, P3307, DOI 10.1007/s00221-018-5383-3; Pacheco MM, 2018, HUM MOVEMENT SCI, V59, P66, DOI 10.1016/j.humov.2018.03.019; PAULIGNAN Y, 1991, EXP BRAIN RES, V83, P502; Pisella L, 2000, NAT NEUROSCI, V3, P729, DOI 10.1038/76694; PRABLANC C, 1986, EXP BRAIN RES, V62, P293; Prablanc C, 2003, PROG BRAIN RES, V142, P155; Profeta VLS, 2018, HUM MOVEMENT SCI, V57, P111, DOI 10.1016/j.humov.2017.11.013; Reichenbach A, 2009, J PHYSIOL-LONDON, V587, P4605, DOI 10.1113/jphysiol.2009.176362; Riley MA, 2002, J MOTOR BEHAV, V34, P99, DOI 10.1080/00222890209601934; Riley MA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00038; Rohrer B, 2002, J NEUROSCI, V22, P8297; de Freitas SMSF, 2010, J BIOMECH, V43, P775, DOI 10.1016/j.jbiomech.2009.10.033; Scholz JP, 2007, EXP BRAIN RES, V180, P163, DOI 10.1007/s00221-006-0848-1; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Schoner G, 1995, ECOL PSYCHOL, V7, P291, DOI 10.1207/s15326969eco0704_5; Schoner G, 2008, MOTOR EQUIVALENCE UN; SOECHTING JF, 1989, EXP BRAIN RES, V74, P535; Tseng YW, 2002, MOTOR CONTROL, V6, P183, DOI 10.1123/mcj.6.2.183; Tuitert I, 2019, MOTOR CONTROL, V23, P189, DOI 10.1123/mc.2017-0061; Tuitert I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181041; Turvey MT, 2007, HUM MOVEMENT SCI, V26, P657, DOI 10.1016/j.humov.2007.04.002; TURVEY MT, 1990, AM PSYCHOL, V45, P938, DOI 10.1037/0003-066X.45.8.938; Turvey MT, 1997, PRELIMINARIES THEORY; Valk TA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53913-9; van Andel CJ, 2008, GAIT POSTURE, V27, P120, DOI 10.1016/j.gaitpost.2007.03.002; van de Kamp C, 2007, EXP BRAIN RES, V182, P27, DOI 10.1007/s00221-007-0968-2; van der Steen MC, 2011, EXP BRAIN RES, V208, P411, DOI 10.1007/s00221-010-2493-y; VANSONDEREN JF, 1988, EXP BRAIN RES, V71, P320, DOI 10.1007/BF00247492; Verrel J, 2010, J NEUROSCI METH, V191, P166, DOI 10.1016/j.jneumeth.2010.06.016; Wijdenes LO, 2011, EXP BRAIN RES, V214, P453, DOI 10.1007/s00221-011-2843-4; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Zaal FTJM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097790	76	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238561	10.1371/journal.pone.0238561	http://dx.doi.org/10.1371/journal.pone.0238561			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ7QN	32886715	gold, Green Published			2022-12-26	WOS:000571064300023
J	Abid, H; Ryan, ZC; Delmotte, P; Sieck, GC; Lanza, IAR				Abid, Hinnah; Ryan, Zachary C.; Delmotte, Philippe; Sieck, Gary C.; Lanza, Ian R.			Extramyocellular interleukin-6 influences skeletal muscle mitochondrial physiology through canonical JAK/STAT signaling pathways	FASEB JOURNAL			English	Article						interleukin-6; mitochondria; reactive oxygen species; skeletal muscle; STAT3	PERMEABILITY TRANSITION; MOLECULAR-PATTERNS; CYCLOSPORINE-A; STAT3; DYNAMICS; PROTEIN; ROS	Interleukin-6 (IL-6) is a pleiotropic cytokine that has been shown to be produced acutely by skeletal muscle in response to exercise, yet chronically elevated with obesity and aging. The mechanisms by which IL-6 influences skeletal muscle mitochondria acutely and chronically are unclear. To better understand the influence of extramyocellular IL-6 on skeletal muscle mitochondrial physiology, we treated differentiated myotubes with exogenous IL-6 to evaluate the dose- and duration-dependent effects of IL-6 on salient aspects of mitochondrial biology and the role of canonical IL-6 signaling in muscle cells. Acute exposure of myotubes to IL-6 increased the mitochondrial reactive oxygen species (mtROS) production and oxygen consumption rates (JO(2)) in a manner that was dependent on activation of the JAK/STAT pathway. Furthermore, STAT3 activation by IL-6 was partly attenuated by MitoQ, a mitochondrial-targeted antioxidant, suggesting that mtROS potentiates STAT3 signaling in skeletal muscle in response to IL-6 exposure. In concert with effects on mitochondrial physiology, acute IL-6 exposure induced several mitochondrial adaptations, consistent with the stress-induced mitochondrial hyperfusion. Exposure of myotubes to chronically elevated IL-6 further increased mtROS with eventual loss of respiratory capacity. These data provide new evidence supporting the interplay between cytokine signaling and mitochondrial physiology in skeletal muscle.	[Abid, Hinnah; Ryan, Zachary C.; Lanza, Ian R.] Mayo Clin, Coll Med, Div Endocrinol & Metab, 200 First St SW, Rochester, MN 55905 USA; [Delmotte, Philippe; Sieck, Gary C.] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Lanza, IAR (corresponding author), Mayo Clin, Coll Med, Div Endocrinol & Metab, 200 First St SW, Rochester, MN 55905 USA.	lanza.ian@mayo.edu						Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Boudina S, 2012, ENDOCRINOLOGY, V153, P2677, DOI 10.1210/en.2011-2147; Bruunsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Fischer CP, 2006, EXERC IMMUNOL REV, V12, P6; Frasca D, 2017, FRONT IMMUNOL, V8, DOI [10.3389/fimmu.2017.01745, 10.3389/fimmu.2017.01003]; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Grazioli S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00832; Haddad F, 2005, J APPL PHYSIOL, V98, P911, DOI 10.1152/japplphysiol.01026.2004; Henriquez-Olguin C, 2015, BBA-MOL BASIS DIS, V1852, P1410, DOI 10.1016/j.bbadis.2015.03.012; Jackson MJ, 2011, J PHYSIOL-LONDON, V589, P2139, DOI 10.1113/jphysiol.2011.206623; Johnson ML, 2013, TRENDS ENDOCRIN MET, V24, P247, DOI 10.1016/j.tem.2012.12.003; Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Koopman WJH, 2008, METHODS, V46, P304, DOI 10.1016/j.ymeth.2008.09.018; Kosmidou I, 2002, AM J RESP CELL MOL, V26, P587, DOI 10.1165/ajrcmb.26.5.4598; Lalia AZ, 2015, DIABETES CARE, V38, P1228, DOI 10.2337/dc14-3101; Lanza IR, 2012, CELL METAB, V16, P777, DOI 10.1016/j.cmet.2012.11.003; Lanza IR, 2009, METHOD ENZYMOL, V457, P349, DOI 10.1016/S0076-6879(09)05020-4; Lefort N, 2010, DIABETES, V59, P2444, DOI 10.2337/db10-0174; Li J, 2010, NEOPLASIA, V12, P28, DOI 10.1593/neo.91192; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Meier JA, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aag2588; Meier JA, 2014, SEMIN IMMUNOL, V26, P20, DOI 10.1016/j.smim.2013.12.005; Nakahira K, 2015, ANTIOXID REDOX SIGN, V23, P1329, DOI 10.1089/ars.2015.6407; Nierobisz LS, 2011, COMP BIOCHEM PHYS B, V158, P125, DOI 10.1016/j.cbpb.2010.10.003; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P619, DOI 10.1038/ncprheum0338; Pedersen BK, 2001, J PHYSIOL-LONDON, V536, P329, DOI 10.1111/j.1469-7793.2001.0329c.xd; Sebastian D, 2017, TRENDS MOL MED, V23, P201, DOI 10.1016/j.molmed.2017.01.003; Seto DN, 2015, J BIOL CHEM, V290, P19976, DOI 10.1074/jbc.M115.638411; Sharov VG, 2007, J MOL CELL CARDIOL, V42, P150, DOI 10.1016/j.yjmcc.2006.09.013; Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Toth A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123583; TSUJINAKA T, 1995, BIOCHEM BIOPH RES CO, V207, P168, DOI 10.1006/bbrc.1995.1168; VanderVeen BN, 2017, OXID MED CELL LONGEV, V2017, P1, DOI 10.1155/2017/3292087; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wedell-Neergaard AS, 2019, CELL METAB, V29, P844, DOI 10.1016/j.cmet.2018.12.007; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; White JP, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-14; Wilkins HM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00508; Wueest S, 2014, AM J PHYSIOL-REG I, V306, pR861, DOI 10.1152/ajpregu.00533.2013; Yang R, 2016, INT J BIOL SCI, V12, P532, DOI 10.7150/ijbs.15153; Zhou T, 2014, LEUKEMIA, V28, P471, DOI 10.1038/leu.2013.299; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	47	20	20	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14458	14472		10.1096/fj.202000965RR	http://dx.doi.org/10.1096/fj.202000965RR		SEP 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32885495				2022-12-26	WOS:000566830200001
J	Carius, D; Seidel-Marzi, O; Kaminski, E; Lisson, N; Ragert, P				Carius, Daniel; Seidel-Marzi, Oliver; Kaminski, Elisabeth; Lisson, Niklas; Ragert, Patrick			Characterizing hemodynamic response alterations during basketball dribbling	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; CEREBRAL-BLOOD-FLOW; MOVEMENT FREQUENCY; NEURAL EFFICIENCY; HAND MOVEMENTS; TASK; ACTIVATION; BRAIN; PREMOTOR; WALKING	Knowledge on neural processing during complex non-stationary motion sequences of sport-specific movements still remains elusive. Hence, we aimed at investigating hemodynamic response alterations during a basketball slalom dribbling task (BSDT) using multi-distance functional near-infrared spectroscopy (fNIRS) in 23 participants (12 females). Additionally, we quantified how the brain adapts its processing as a function of altered hand use (dominant right hand (DH) vs. non-dominant left hand (NDH) vs. alternating hands (AH)) and pace of execution (slow vs. fast) in BSDT. We found that BSDT activated bilateral premotor cortex (PMC), supplementary motor cortex (SMA), primary motor cortex (M1) as well as inferior parietal cortex and somatosensory association cortex. Slow dominant hand dribbling (DHslow) evoked lower contralateral hemodynamic responses in sensorimotor regions compared to fast dribbling (DHfast). Furthermore, during DH(slow)dribbling, we found lower hemodynamic responses in ipsilateral M1 as compared to dribbling with alternating hands (AH(slow)). Hence, altered task complexity during BSDT induced differential hemodynamic response patterns. Furthermore, a correlation analysis revealed that lower levels of perceived task complexity are associated with lower hemodynamic responses in ipsilateral PMC-SMA, which is an indicator for neuronal efficiency in participants with better basketball dribbling skills. The present study extends previous findings by showing that varying levels of task complexity are reflected by specific hemodynamic response alterations even during sports-relevant motor behavior. Taken together, we suggest that quantifying brain activation during complex movements is a prerequisite for assessing brain-behavior relations and optimizing motor performance.	[Carius, Daniel; Seidel-Marzi, Oliver; Kaminski, Elisabeth; Lisson, Niklas; Ragert, Patrick] Univ Leipzig, Inst Gen Kinesiol & Exercise Sci, Leipzig, Germany; [Seidel-Marzi, Oliver; Kaminski, Elisabeth; Ragert, Patrick] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany	Leipzig University; Max Planck Society	Carius, D (corresponding author), Univ Leipzig, Inst Gen Kinesiol & Exercise Sci, Leipzig, Germany.	daniel.carius@uni-leipzig.de	Carius, Daniel/AFC-6989-2022	Carius, Daniel/0000-0002-4823-1452; Seidel-Marzi, Oliver/0000-0002-6622-1231				Aasted CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165226; Alahmadi AAS, 2015, HUM BRAIN MAPP, V36, P5079, DOI 10.1002/hbm.22997; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2017, TECHNICAL REPORT; Balardin JB, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00258; Berchicci M, 2017, BEHAV BRAIN RES, V328, P87, DOI 10.1016/j.bbr.2017.04.011; Brown S, 2006, CEREB CORTEX, V16, P1157, DOI 10.1093/cercor/bhj057; Carius D, 2020, NEUROSCI LETT, V715, DOI 10.1016/j.neulet.2019.134604; Di Lorenzo R, 2019, NEUROIMAGE, V200, P511, DOI 10.1016/j.neuroimage.2019.06.056; Dunst B, 2014, INTELLIGENCE, V42, P22, DOI 10.1016/j.intell.2013.09.005; Guo ZP, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00072; Haaland KY, 2004, J COGNITIVE NEUROSCI, V16, P621, DOI 10.1162/089892904323057344; HALSBAND U, 1993, BRAIN, V116, P243, DOI 10.1093/brain/116.1.243; Harada T, 2009, EXP BRAIN RES, V193, P445, DOI 10.1007/s00221-008-1643-y; Herold F, 2018, J CLIN MED, V7, DOI 10.3390/jcm7120466; Herold F, 2017, NEUROPHOTONICS, V4, DOI 10.1117/1.NPh.4.4.041403; Holper L, 2009, NEUROIMAGE, V46, P1105, DOI 10.1016/j.neuroimage.2009.03.027; Horenstein C, 2009, HUM BRAIN MAPP, V30, P1397, DOI 10.1002/hbm.20610; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Jahani S, 2018, NEUROPHOTONICS, V5, DOI 10.1117/1.NPh.5.1.015003; Jenkins IH, 1997, J NEUROL SCI, V151, P195, DOI 10.1016/S0022-510X(97)00145-7; Kawashima R, 1998, EUR J NEUROSCI, V10, P2254, DOI 10.1046/j.1460-9568.1998.00237.x; Kirilina E, 2012, NEUROIMAGE, V61, P70, DOI 10.1016/j.neuroimage.2012.02.074; Kuboyama Naomi, 2005, Journal of Physiological Anthropology and Applied Human Science, V24, P201, DOI 10.2114/jpa.24.201; Lee SH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50644-9; Leff DR, 2011, NEUROIMAGE, V54, P2922, DOI 10.1016/j.neuroimage.2010.10.058; Metzger FG, 2017, NEUROSCIENCE, V343, P85, DOI 10.1016/j.neuroscience.2016.11.032; Miyai I, 2001, NEUROIMAGE, V14, P1186, DOI 10.1006/nimg.2001.0905; Obrig H, 1996, J APPL PHYSIOL, V81, P1174, DOI 10.1152/jappl.1996.81.3.1174; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pellicer A, 2011, SEMIN FETAL NEONAT M, V16, P42, DOI 10.1016/j.siny.2010.05.003; Perrey S, 2008, METHODS, V45, P289, DOI 10.1016/j.ymeth.2008.04.005; Pinti P, 2019, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00505; Pinti P, 2018, JPN PSYCHOL RES, V60, P347, DOI 10.1111/jpr.12206; RAO SM, 1993, NEUROLOGY, V43, P2311, DOI 10.1212/WNL.43.11.2311; RStudio Team, 2017, RSTUDIO INT DEV ENV; Sadato N, 1997, J CEREBR BLOOD F MET, V17, P670; Seidel O, 2019, EXP BRAIN RES, V237, P2957, DOI 10.1007/s00221-019-05646-4; Seidel O, 2017, J NEUROPHYSIOL, V118, P1849, DOI 10.1152/jn.00419.2017; Seidel-Marzi O, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.00133; Singh AK, 2006, NEUROIMAGE, V33, P542, DOI 10.1016/j.neuroimage.2006.06.047; Suzuki M, 2004, NEUROIMAGE, V23, P1020, DOI 10.1016/j.neuroimage.2004.07.002; Verstynen T, 2005, J NEUROPHYSIOL, V93, P1209, DOI 10.1152/jn.00720.2004; Vitorio R, 2017, NEUROSCI BIOBEHAV R, V83, P160, DOI 10.1016/j.neubiorev.2017.10.002; Wang YH, 2016, FRONT NEUROINFORM, V10, DOI 10.3389/fninf.2016.00015; Wilcox RR, 2011, J APPL STAT, V38, P1359, DOI 10.1080/02664763.2010.498507; Wilcox RR., 2017, INTRO ROBUST ESTIMAT; Yucel MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09469	48	2	2	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238318	10.1371/journal.pone.0238318	http://dx.doi.org/10.1371/journal.pone.0238318			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ7QD	32881901	gold, Green Published			2022-12-26	WOS:000571063300057
J	Diebner, HH; Kather, A; Roeder, I; de With, K				Diebner, Hans H.; Kather, Anna; Roeder, Ingo; de With, Katja			Mathematical basis for the assessment of antibiotic resistance and administrative counter-strategies	PLOS ONE			English	Article							DIVERSITY; ENTROPY; IMPACT	Diversity as well as temporal and spatial changes of the proportional abundances of different antibiotics (cycling, mixing or combinations thereof) have been hypothesised to be an effective administrative control strategy in hospitals to reduce the prevalence of antibiotic-resistant pathogens in nosocomial or community-acquired infections. However, a rigorous assessment of the efficacy of these control strategies is lacking. The main purpose here is to present a mathematical framework for the assessment of control stategies from a processual stance. To this end, we adopt diverse measures of heterogeneity and diversity of proportional abundances based on the concept of entropy from other fields and adapt them to the needs in assessing the impact of variations in antibiotic consumption on antibiotic resistance. Thereby, we derive a family of diversity measures whose members exhibit different degrees of complexity. Most important, we extent these measures such that they account for the assessment of temporal changes in heterogeneity including otherwise undetected diversity-invariant permutations of antibiotics consumption and prevalence of resistant pathogens. We apply a correlation analysis for the assessment of associations between changes of heterogeneities on the antibiotics and on the pathogen side. As a showcase, which serves as a proof-of-principle, we apply the derived methods to records of antibiotic consumption and prevalence of antibiotic-resistant germs from University Hospital Dresden (cf. supplement "DiebnerEtAl_Data-Supplement"). Besides the quantification of heterogeneities of antibiotics consumption and antibiotic resistance, we show that a reduction of prevalence of antibiotic-resistant germs correlates with a temporal change of similarity with respect to the first observation of antibiotics consumption, although heterogeneity remains approximately constant. Although an interventional study is pending, our mathematical framework turns out to be a viable concept for the assessment and optimisation of control strategies intended to reduce antibiotic resistance.	[Diebner, Hans H.; Roeder, Ingo] Tech Univ Dresden, Carl Gustav Carus Fac Med, Inst Med Informat & Biometry, Dresden, Germany; [Kather, Anna; de With, Katja] Tech Univ Dresden, Div Infect Dis, Univ Hosp Carl Gustav Carus Dresden, Dresden, Germany; [Diebner, Hans H.] Ruhr Univ Bochum, Dept Med Informat Biometry & Epidemiol, Bochum, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Ruhr University Bochum	Diebner, HH; Roeder, I (corresponding author), Tech Univ Dresden, Carl Gustav Carus Fac Med, Inst Med Informat & Biometry, Dresden, Germany.; Diebner, HH (corresponding author), Ruhr Univ Bochum, Dept Med Informat Biometry & Epidemiol, Bochum, Germany.	hans.diebner@tu-dresden.de; ingo.roeder@tu-dresden.de	Diebner, Hans H./AFN-4853-2022	Diebner, Hans H./0000-0002-7138-6372; Reis, AlessanRSS/0000-0001-8486-7469	Publication Fund of the TU Dresden	Publication Fund of the TU Dresden	Open Access Funding by the Publication Fund of the TU Dresden.	ALLISON PD, 1978, AM SOCIOL REV, V43, P865, DOI 10.2307/2094626; [Anonymous], 2020, NAT PHYS, V16, P1, DOI 10.1038/s41567-019-0781-4; [Anonymous], 2017, Future Oncol, V13, P1, DOI 10.2217/fon-2017-0071; [Anonymous], 2014, GASTROENTEROLOGY S1, V10, P1; Beardmore RE, 2017, MOL BIOL EVOL, V34, P802, DOI 10.1093/molbev/msw292; Bennett KM, 2007, J TRAUMA, V63, P307, DOI 10.1097/TA.0b013e318120595e; Davey P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003543.pub3; Gorban AN, 2013, COMPUT MATH APPL, V65, P1438, DOI 10.1016/j.camwa.2013.01.004; Hindler JF, 2007, CLIN INFECT DIS, V44, P867, DOI 10.1086/511864; Hughes JS, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012040; Interagency Coordination Group (IACG) on Antimicrobial Resistance, 2019, NO TIM WAIT SEC FUT; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Karam G, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1320-7; Lopez-Lozano JM, 2019, NAT MICROBIOL, V4, P1160, DOI 10.1038/s41564-019-0410-0; Mora T, 2010, P NATL ACAD SCI USA, V107, P5405, DOI 10.1073/pnas.1001705107; Pluss-Suard C, 2013, ANTIMICROB AGENTS CH, V57, P1709, DOI 10.1128/AAC.01348-12; R Core Team, 2018, R LANG ENV STAT COMP; Sandiumenge A, 2006, J ANTIMICROB CHEMOTH, V57, P1197, DOI 10.1093/jac/dkl097; STAR SL, 1989, SOC STUD SCI, V19, P387, DOI 10.1177/030631289019003001; Star SL, 2010, SCI TECHNOL HUM VAL, V35, P601, DOI 10.1177/0162243910377624; Tuomisto H, 2010, OECOLOGIA, V164, P853, DOI 10.1007/s00442-010-1812-0; Uecker H, 2017, MATH BIOSCI, V294, P85, DOI 10.1016/j.mbs.2017.09.002; Van Egmond S., 2010, SCI STUD, V23, P58, DOI [https://doi.org/10.23987/sts.55257, DOI 10.23987/STS.55257]; Zhang L, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1544-9	24	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238692	10.1371/journal.pone.0238692	http://dx.doi.org/10.1371/journal.pone.0238692			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881947	gold, Green Published			2022-12-26	WOS:000571063300031
J	Ferranti, M; Pinnarelli, L; Rosa, A; Pastorino, R; D'Ovidio, M; Fusco, D; Davoli, M				Ferranti, Margherita; Pinnarelli, Luigi; Rosa, Alessandro; Pastorino, Roberta; D'Ovidio, Mariangela; Fusco, Danilo; Davoli, Marina			Evaluation of the breast cancer care network within the Lazio Region (Central Italy)	PLOS ONE			English	Article							QUALITY INDICATORS; PERFORMANCE; SURGERY; VOLUME	Background and objectives A summary indicator for evaluating the breast cancer network has never been measured at the regional level. The aim is to design treemaps providing a summary description of hospitals (including breast units) and Local Health Units (LHUs) in terms of their levels of performance within the breast cancer network of the Lazio region (central Italy). The treemap structure has an intuitive design and displays information from both general and specific analyses. Methods Patients admitted to the regional hospitals for malignant breast cancer (MBC) surgery in 2010-2017 were selected in a population-based cohort study. These quality indicators were calculated based on the international guidelines (EUSOMA, ESMO) to assess the performance in terms of volume of activity, surgery procedure, post-surgery assistance and timeliness of medical therapy or radiotherapy beginning. The quality indicators were calculated using administrative health data systematically collected at the regional level and were included in the treemap to represent the surgery or the post-surgery areas of the breast cancer clinical pathway. In order to allow aggregation of scores for different indicators belonging to the same clinical area, up to five evaluation classes were defined using the "Jenks Natural Breaks" algorithm. A score and a colour were assigned to each clinical area based on the ranking of the indicators involved. The analyses were performed on an annual basis, by the LHU of residence and by the hospital which performed the surgical intervention. Results In 2017, 6218 surgical interventions for MBC were performed in the hospitals of Lazio. The results showed a continuous increase of the level of performance over the years. Hospitals showed higher variability in the levels of performance than the LHUs. 36% of the evaluated hospitals reached a high level of performance. An audit of the S. Filippo Neri breast unit revealed incorrect coding of the input data. For this reason, the score for the indicator for the volume of wards was re-calculated and re-evaluated, with a subsequent improvement of the level of performance. Most LHUs achieved at least an average overall level of performance, with 20% of the LHUs reaching a high level of performance. Conclusions This is the first attempt to apply the treemap logic to a single clinical network, in order to obtain a summary indicator for the evaluation of the breast cancer care network. Our results supply decision makers with a transparent instrument of governance for heterogeneous users, directing efforts improving and promoting equity of care. The treemaps could be reproduced and adapted for other local contexts, in order to limit inappropriateness and ensure uniform levels of breast cancer care within local areas. The next step is the evaluation of audit and feedback interventions to improve the quality of care and to guarantee homogeneous levels of care throughout the region.	[Ferranti, Margherita; Pinnarelli, Luigi; Rosa, Alessandro; D'Ovidio, Mariangela; Davoli, Marina] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy; [Ferranti, Margherita; Pastorino, Roberta] Fdn Policlin Univ A Gemelli IRCCS, Dept Woman & Child Hlth & Publ Hlth, Publ Hlth Area, Rome, Italy; [Fusco, Danilo] Lazio Reg Hlth Serv, Dept Hlth Informat Syst, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Ferranti, M (corresponding author), Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy.; Ferranti, M (corresponding author), Fdn Policlin Univ A Gemelli IRCCS, Dept Woman & Child Hlth & Publ Hlth, Publ Hlth Area, Rome, Italy.	m.ferranti@deplazio.it	PASTORINO, Roberta/AAC-1866-2022	PASTORINO, Roberta/0000-0001-5013-0733; Ferranti, Margherita/0000-0002-7407-2838				Amato L, 2017, EPIDEMIOL PREV, V41, P1, DOI 10.19191/EP17.5-6S2.P001.100; [Anonymous], 2014, STAT REG C; [Anonymous], 2019, LAZIO REGIONAL OUTCO; Aylin P, 2007, BMJ-BRIT MED J, V334, P1044, DOI 10.1136/bmj.39168.496366.55; Barni S, 2011, TUMORI J, V97, P559, DOI 10.1700/989.10711; Biganzoli L, 2017, EUR J CANCER, V86, P59, DOI 10.1016/j.ejca.2017.08.017; Campanella P, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1543-y; Cardoso F, 2019, ANN ONCOL, V30, P1674, DOI 10.1093/annonc/mdz189; Cowppli-Bony A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224275; Di Martino M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010926; Di Martino M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1049; Fancellu A, 2018, BREAST, V39, P1, DOI 10.1016/j.breast.2018.02.003; Fusco D, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-25; Iezzoni LI, 1997, ANN INTERN MED, V127, P666, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00048; Italian Association of Medical Oncology working group, 2018, BREAST NEOPL GUID, V2018; Jenks G.F., 1967, INT YB CARTOGR, V7, P186; Kupstas AR, 2019, ANN SURG ONCOL, V26, P3240, DOI 10.1245/s10434-019-07566-7; Lansky D, 2002, HEALTH AFFAIR, V21, P52, DOI 10.1377/hlthaff.21.4.52; Lazio Regional Department of Epidemiology working group, 2017, IND P RE VAL E MON R; Lizarondo L, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0572-7; Malin JL, 2002, J CLIN ONCOL, V20, P4381, DOI 10.1200/JCO.2002.04.020; Marmot M, 2015, LANCET, V386, P2442, DOI 10.1016/S0140-6736(15)00150-6; McDermott AM, 2013, ANN SURG, V258, P808, DOI 10.1097/SLA.0b013e3182a66eb0; Mukai H, 2016, INT J QUAL HEALTH C, V28, P110, DOI 10.1093/intqhc/mzv109; Naik S., 2017, APPL ORGANOMETAL CHE, V31, pe3549, DOI 10.1002/aoc.3549; Nattinger AB, 2003, MED CARE, V41, P341; Plavc G, 2019, BREAST CANCER RES TR, V175, P585, DOI 10.1007/s10549-019-05186-z; Pons-Tostivint E, 2019, BREAST, V46, P170, DOI 10.1016/j.breast.2019.06.001; Renzi C, 2012, HEALTH SERV RES, V47, P1880, DOI 10.1111/j.1475-6773.2012.01401.x; Rococo E, 2016, EJSO-EUR J SURG ONC, V42, P51, DOI 10.1016/j.ejso.2015.09.020; Rosato R, 2009, BREAST CANCER RES TR, V117, P349, DOI 10.1007/s10549-008-0252-6; Rubio IT, 2019, EJSO-EUR J SURG ONC, V45, P567, DOI 10.1016/j.ejso.2019.01.003; The Italian Association of Medical Oncology working group, NUMB CANC IT; The Italian Ministry of health working group, 2017, NUOV NOM ASS SPEC AM; The Italian National Institute of Statisctics working group, OFF DAT RES POP IT M; van Dam PA, 2017, EUR J CANCER, V85, P15, DOI 10.1016/j.ejca.2017.07.040; Ventura M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194972; World Health Organization working group, 2007, INT CLASS DIS 9 REV	38	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238562	10.1371/journal.pone.0238562	http://dx.doi.org/10.1371/journal.pone.0238562			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ7QD	32881971	gold, Green Published			2022-12-26	WOS:000571063300084
J	Narimani, M; da Silva, G				Narimani, Milad; da Silva, Gabriel			Does 'Dry Hit' vaping of vitamin E acetate contribute to EVALI? Simulating toxic ketene formation during e-cigarette use	PLOS ONE			English	Article							METHIDE	Vitamin E acetate (VEA) is strongly linked to the outbreak of electronic-cigarette or vaping product use-associated lung injury (EVALI). It has been proposed that VEA decomposition to ketene-a respiratory poison that damages lungs at low ppm levels-may play a role in EVALI. However, there is no information available on the temperature at which VEA decomposes and how this correlates with the vaping process. We have studied the temperature-dependent kinetics of VEA decomposition using quantum chemical and statistical mechanical modelling techniques, developing a chemical kinetic model of the vaping process. This model predicts that, under typical vaping conditions, the use of VEA contaminated e-cigarette products is unlikely to produce ketene at harmful levels. However, at the high temperatures encountered at low e-cigarette product levels, which produce 'dry hits', ketene concentrations are predicted to reach acutely toxic levels in the lungs (as high as 30 ppm). We therefore hypothesize that dry hit vaping of e-cigarette products containing VEA contributes to EVALI.	[Narimani, Milad; da Silva, Gabriel] Univ Melbourne, Dept Chem Engn, Melbourne, Vic, Australia	University of Melbourne	da Silva, G (corresponding author), Univ Melbourne, Dept Chem Engn, Melbourne, Vic, Australia.	gdasilva@unimelb.edu.au	; da Silva, Gabriel/B-2040-2009	Narimani, Milad/0000-0001-7847-591X; da Silva, Gabriel/0000-0003-4284-4474	Australian Research Council Future Fellowships scheme [FT130101304]	Australian Research Council Future Fellowships scheme(Australian Research Council)	This work was supported through the Australian Research Council Future Fellowships scheme, FT130101304.	[Anonymous], 2014, J MED INTERNET RES; Bland J, 2014, AIMS ENVIRON SCI, V1, P12, DOI 10.3934/environsci.2013.1.12; Blount BC, 2020, NEW ENGL J MED, V382, P697, DOI 10.1056/NEJMoa1916433; Centers for Disease Control and Prevention, 2020, OUTBR LUNG INJ ASS U; Chen WH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195925; Christiani DC, 2020, NEW ENGL J MED, V382, P960, DOI 10.1056/NEJMe1912032; da Silva G, 2007, J PHYS CHEM A, V111, P7987, DOI 10.1021/jp073335c; Demole V, 1939, HELV CHIM ACTA, V22, P65, DOI 10.1002/hlca.19390220108; Dibaji SAR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206937; Duffy B, 2020, TOXICS, V8, DOI 10.3390/toxics8010008; Farsalinos KE, 2015, ADDICTION, V110, P1352, DOI 10.1111/add.12942; Frisch M.J., 2016, GAUSSIAN 16 REVISION; Goerigk L, 2014, WIRES COMPUT MOL SCI, V4, P576, DOI 10.1002/wcms.1193; Kalininskiy A, 2019, LANCET RESP MED, V7, P1017, DOI 10.1016/S2213-2600(19)30415-1; Korzun T, 2018, ACS OMEGA, V3, P30, DOI 10.1021/acsomega.7b01521; Moritz ED, 2019, MMWR-MORBID MORTAL W, V68, P985, DOI 10.15585/mmwr.mm6843e1; Navon L, 2019, MMWR-MORBID MORTAL W, V68, P1034, DOI 10.15585/mmwr.mm6845e1; Neese F, 2012, WIRES COMPUT MOL SCI, V2, P73, DOI 10.1002/wcms.81; PAUL GC, 1993, J ORG CHEM, V58, P5060, DOI 10.1021/jo00071a013; Salzman Gary A, 2019, Mo Med, V116, P492; Wu D, 2020, P NATL ACAD SCI USA, V117, P6349, DOI 10.1073/pnas.1920925117	22	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238140	10.1371/journal.pone.0238140	http://dx.doi.org/10.1371/journal.pone.0238140			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881943	gold, Green Published			2022-12-26	WOS:000571063300104
J	Shao, X; Wang, Y; Huang, S; Liu, HY; Zhou, SJ; Zhang, R; Yu, P				Shao, Xian; Wang, Yao; Huang, Shuai; Liu, Hongyan; Zhou, Saijun; Zhang, Rui; Yu, Pei			Development and validation of a prediction model estimating the 10-year risk for type 2 diabetes in China	PLOS ONE			English	Article							SCORE; PREVALENCE; NOMOGRAM	Purpose To derive and validate a concise prediction model estimating the 10-year risk for type 2 diabetes (T2DM) in China. Methods A total of 11494 subjects from the China Health and Nutrition Survey recorded from 2004 to 2015 were analyzed and only 6023 participants were enrolled in this study. Four logistic models were analyzed using the derivation cohort. Methods of calibration and discrimination were used for the validation cohort. Results In the derivation cohort, 257 patients were identified from a total of 4498 cases. In the validation cohort, 92 patients were identified from a total of 1525 cases. Four models performed nicely for both calibration and discrimination. The AUC in the derivation cohort for models A, B, C and D were 0.788 (0.761-0.816), 0.807 (0.780-0.834), 0.905 (0.879-0.932) and 0.882 (0.853-0.912), respectively. The Youden index for models A, B, C and D were 1.46, 1.48, 1.67 and 1.65, respectively. Model C showed the highest sensitivity and model D showed the highest specificity. Conclusion Models A and B were non-invasive and can be used to identify high-risk patients for broad screening. Models C and D may be used to provide more accurate assessments of diabetes risk. Furthermore, model C showed the best performance for predicting T2DM risk and identifying individuals who are in need of interventions, current approach improvement and additional follow-up.	[Shao, Xian; Wang, Yao; Huang, Shuai; Liu, Hongyan; Zhou, Saijun; Zhang, Rui; Yu, Pei] Tianjin Med Univ, NHC Key Lab Hormones & Dev, Tianjin Key Lab Metab Dis, Chu Hsien & Mem Hosp, Tianjin, Peoples R China; [Shao, Xian; Wang, Yao; Huang, Shuai; Liu, Hongyan; Zhou, Saijun; Zhang, Rui; Yu, Pei] Tianjin Med Univ, Tianjin Inst Endocrinol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Yu, P (corresponding author), Tianjin Med Univ, NHC Key Lab Hormones & Dev, Tianjin Key Lab Metab Dis, Chu Hsien & Mem Hosp, Tianjin, Peoples R China.	yupei@tmu.edu.cn			National Natural Science Foundation of China [81600643, 91746205]; Tianjin Health Industry Key Research Projects [15KG101]; Tianjin Science and Technology Support Project [17JCYBJC27000]; Key Projects of Tianjin Natural Science Foundation [18JCZDJC32900]; Science AMP; Technology Development Fund of Tianjin Education Commission for Higher Education [2019KJ193]; Scientific Research Funding of Tianjin Medical University Chu Hsien-I Memorial Hospital [2016DX01]; Science foundation of Tianjin Medical University [2016KYZQ19]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Health Industry Key Research Projects; Tianjin Science and Technology Support Project; Key Projects of Tianjin Natural Science Foundation; Science AMP; Technology Development Fund of Tianjin Education Commission for Higher Education; Scientific Research Funding of Tianjin Medical University Chu Hsien-I Memorial Hospital; Science foundation of Tianjin Medical University	This study was funded by the National Natural Science Foundation of China (no.81600643 to P.Y., no.91746205 to P.Y.) the Tianjin Health Industry Key Research Projects (no.15KG101 to P. Y.), Tianjin Science and Technology Support Project (no. 17JCYBJC27000 to P.Y.), and Key Projects of Tianjin Natural Science Foundation (no.18JCZDJC32900 to P.Y.),The Science & Technology Development Fund of Tianjin Education Commission for Higher Education (no. 2019KJ193 to P.Y.), Scientific Research Funding of Tianjin Medical University Chu Hsien-I Memorial Hospital (no. 2016DX01 to P.Y.), Science foundation of Tianjin Medical University(no.2016KYZQ19 to P. Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2020, Diabetes Care, V43, pS14, DOI 10.2337/dc20-S002; Chien K, 2009, DIABETOLOGIA, V52, P443, DOI 10.1007/s00125-008-1232-4; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; Chung SM, 2018, DIABETES RES CLIN PR, V142, P286, DOI 10.1016/j.diabres.2018.05.036; FOROUHI NG, 2018, BMJ-BRIT MED J, V361, DOI DOI 10.1136/BMJ.K2234; Hippisley-Cox J, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5019; Jenum AK, 2019, DIABETOLOGIA, V62, P1337, DOI 10.1007/s00125-019-4905-2; Ko G, 2010, DIABETIC MED, V27, P644, DOI 10.1111/j.1464-5491.2010.02993.x; Li W, 2018, EBIOMEDICINE, V35, P307, DOI 10.1016/j.ebiom.2018.08.009; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Liu M, 2011, DIABETES TECHNOL THE, V13, P501, DOI 10.1089/dia.2010.0106; Lu CQ, 2019, EUR RADIOL, V29, P2233, DOI 10.1007/s00330-018-5865-5; Ma RCW, 2018, DIABETOLOGIA, V61, P1249, DOI 10.1007/s00125-018-4557-7; Merino J, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4292; Neuenschwander M, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l2368; Shan ZL, 2015, DIABETES CARE, V38, P529, DOI 10.2337/dc14-2073; Uusitupa M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112611; Wang K, 2019, EPMA J, V10, P227, DOI 10.1007/s13167-019-00181-2; Wang LM, 2017, JAMA-J AM MED ASSOC, V317, P2515, DOI 10.1001/jama.2017.7596; Wong CKH, 2016, J DIABETES, V8, P414, DOI 10.1111/1753-0407.12310; Wu HB, 2019, J DIABETES INVEST, V10, P531, DOI 10.1111/jdi.12897; Xu L, 2014, PREV MED, V69, P63, DOI 10.1016/j.ypmed.2014.09.004; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhou XH, 2013, DIABETES CARE, V36, P3944, DOI 10.2337/dc13-0593	25	3	3	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0237936	10.1371/journal.pone.0237936	http://dx.doi.org/10.1371/journal.pone.0237936			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881911	gold, Green Published			2022-12-26	WOS:000571063300039
J	Um-e-Rubbab; Naqvi, SMMR				Um-e-Rubbab; Naqvi, Sayyed Muhammad Mehdi Raza			Employee voice behavior as a critical factor for organizational sustainability in the telecommunications industry	PLOS ONE			English	Article							LEADER-MEMBER EXCHANGE; CITIZENSHIP BEHAVIORS; MODERATING ROLE; WORK; INCLUSION; DELEGATION; DIVERSITY; MODEL; DETERMINANTS; CHALLENGE	Organizational effectiveness is contingent upon employees' contributions; however, the role of employee voice behavior as a critical component of employees' contribution to the organization has not been sufficiently acknowledged. Based on proactive behavior theory, we present a model to investigate employee voice behavior as an underlying mechanism in the relationship between supervisor delegation and perceived workplace inclusion. Using the SEM (structural equation modeling) method, we test our model's hypotheses with data from 271 employee-supervisor questionnaires administered in state-owned enterprises in the telecommunications industry. The results show that supervisor delegation is positively related to employees' promotive and prohibitive voice behavior. Promotive voice significantly influences perceived workplace inclusion, but prohibitive voice behavior was not found to have any impact on perceived workplace inclusion. Moreover, both dimensions of voice behavior, i.e., promotive and prohibitive voice behavior, significantly mediate the relationship between supervisor delegation and perceived workplace inclusion.	[Um-e-Rubbab; Naqvi, Sayyed Muhammad Mehdi Raza] Capital Univ Sci & Technol, Islamabad, Pakistan	Capital University of Science & Technology	Um-e-Rubbab (corresponding author), Capital Univ Sci & Technol, Islamabad, Pakistan.	rubbabhayat55@gmail.com						Agnihotri N, 2017, ASSESSING FACTORS IN; Alola UV, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10082610; [Anonymous], 2012, Regen Med, V7, pS14, DOI 10.2217/rme.12.38; [Anonymous], 2015, EPIDEMIOL PREV, V39, P83; [Anonymous], 2014, E CHINA ELECT POWER, V1, P173; [Anonymous], 2012, AFR J BUS MANAGE, DOI DOI 10.5897/AJBM11.2162; Aryee S, 2017, J MANAGE, V43, P946, DOI 10.1177/0149206314546192; Aryee S, 2015, J MANAGE STUD, V52, P231, DOI 10.1111/joms.12067; Ashford SJ, 2009, VOICE AND SILENCE IN ORGANIZATIONS, P175; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Berg STS, 2017, EUR MANAG J, V35, P676, DOI 10.1016/j.emj.2017.08.002; Burris ER, 2012, ACAD MANAGE J, V55, P851, DOI 10.5465/amj.2010.0562; Byrne B.M., 2001, INT J TESTING, V1, P55, DOI [10.1207/S15327574IJT0101_4, DOI 10.1207/S15327574IJT0101_4]; Chamberlin M, 2017, PERS PSYCHOL, V70, P11, DOI 10.1111/peps.12185; Chen CY, 2018, J MANAGE PSYCHOL, V33, P43, DOI 10.1108/JMP-02-2017-0078; Chen ZX, 2007, ACAD MANAGE J, V50, P226, DOI 10.5465/AMJ.2007.24162389; Cheung MFY, 2017, ASIA PAC J HUM RESOU, V55, P430, DOI 10.1111/1744-7941.12117; Crant JM, 2011, J BUS PSYCHOL, V26, P285, DOI 10.1007/s10869-010-9197-y; Davidson T, 2017, ORGAN BEHAV HUM DEC, V143, P39, DOI 10.1016/j.obhdp.2017.07.002; Detert JR, 2007, ACAD MANAGE J, V50, P869; Detert JR, 2011, ACAD MANAGE J, V54, P461, DOI 10.5465/AMJ.2011.61967925; Eccles RG, 2014, MANAGE SCI, V60, P2835, DOI 10.1287/mnsc.2014.1984; Farh CIC, 2014, J APPL PSYCHOL, V99, P1074, DOI 10.1037/a0037636; Fast NJ, 2014, ACAD MANAGE J, V57, P1013, DOI 10.5465/amj.2012.0393; Findler L, 2007, ADMIN SOC WORK, V31, P63, DOI 10.1300/J147v31n03_05; Frazier ML, THESIS; Frese M, 2001, RES ORGAN BEHAV, V23, P133, DOI 10.1016/S0191-3085(01)23005-6; Gammonley D, 2013, J SOC WORK EDUC, V49, P619, DOI 10.1080/10437797.2013.812508; Gao LP, 2011, LEADERSHIP QUART, V22, P787, DOI 10.1016/j.leaqua.2011.05.015; Hair A, 1998, ANALISIS MULTIVARIAN; Hayes AF, 2020, AM BEHAV SCI, V64, P19, DOI 10.1177/0002764219859633; Hayes AF, 2018, COMMUN MONOGR, V85, P4, DOI 10.1080/03637751.2017.1352100; Hayes AF, 2017, AUSTRALAS MARK J, V25, P76, DOI 10.1016/j.ausmj.2017.02.001; Hayes AF, 2017, BEHAV RES THER, V98, P39, DOI 10.1016/j.brat.2016.11.001; HOFSTEDE G, 1983, J INT BUS STUD, V14, P75, DOI 10.1057/palgrave.jibs.8490867; Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.21427/D7CF7R; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; ITO JK, 1986, ACAD MANAGE J, V29, P139, DOI 10.2307/255865; Janssen O, 2015, J MANAGE, V41, P1854, DOI 10.1177/0149206312471386; Jones KP, 2014, J MANAGE, V40, P1466, DOI 10.1177/0149206313515518; Jung Y, EMPLOYEE VOICE RECIP; Kim M, 2017, PSYCHOL REP, V120, P870, DOI 10.1177/0033294117711131; Kish-Gephart JJ, 2009, RES ORGAN BEHAV, V29, P163, DOI 10.1016/j.riob.2009.07.002; Klaas BS, 2012, J MANAGE, V38, P314, DOI 10.1177/0149206311423823; Kline R, PRINCIPLES PRACTICE, V3; Lam CF, 2014, PERS PSYCHOL, V67, P637, DOI 10.1111/peps.12050; Lee CH, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01737; LePine JA, 2001, J APPL PSYCHOL, V86, P326, DOI 10.1037//0021-9010.86.2.326; Lewis-Beck M., 2003, SAGE ENCY SOCIAL SCI; Li WD, 2018, DISTINGUISHING PROAC, P1838; Liang J, 2012, ACAD MANAGE J, V55, P71, DOI 10.5465/amj.2010.0176; Liu W, 2015, J APPL PSYCHOL, V100, P976, DOI 10.1037/a0038066; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; MacKenzie SB, 2011, PERS PSYCHOL, V64, P559, DOI 10.1111/j.1744-6570.2011.01219.x; Maslow A., 1987, SALENGER INCORPORATE, V14, P987; Maynes TD, 2014, J APPL PSYCHOL, V99, P87, DOI 10.1037/a0034284; McDonald RP, 2002, PSYCHOL METHODS, V7, P64, DOI 10.1037//1082-989X.7.1.64; Mesmer-Magnus JR, 2005, J VOCAT BEHAV, V67, P215, DOI 10.1016/j.jvb.2004.05.004; Mor Barak M.E., 2002, COMMIMITY WORK FAM, V5, P133, DOI [10.1080/13668800220146346, DOI 10.1080/13668800220146346]; Mor-Barak ME, 1998, ADMIN SOC WORK, V22, P47, DOI 10.1300/J147v22n01_04; Morrison EW, 2000, ACAD MANAGE REV, V25, P706, DOI 10.2307/259200; Parker SK, 2010, J MANAGE, V36, P827, DOI 10.1177/0149206310363732; Parker SK, 2010, J MANAGE, V36, P633, DOI 10.1177/0149206308321554; Podsakoff PM, 2000, J MANAGE, V26, P513, DOI 10.1177/014920630002600306; Sahin O, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00575; Schriesheim CA, 1998, ACAD MANAGE J, V41, P298, DOI 10.2307/256909; Schumacker R.E., 2010, BEGINNERS GUIDE STRU, V3rd ed., DOI DOI 10.4324/9781410610904; Shore LM, 2018, HUM RESOUR MANAGE R, V28, P176, DOI 10.1016/j.hrmr.2017.07.003; Shore LM, 2011, J MANAGE, V37, P1262, DOI 10.1177/0149206310385943; Stamper CL, 2001, J ORGAN BEHAV, V22, P517, DOI 10.1002/job.100; Su XY, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9101829; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Tangirala S, 2008, ACAD MANAGE J, V51, P1189, DOI 10.5465/AMJ.2008.35732719; Ulus M, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8030232; Van Dyne L, 1998, ACAD MANAGE J, V41, P108, DOI 10.2307/256902; Van Dyne L, 2003, J MANAGE STUD, V40, P1359, DOI 10.1111/1467-6486.00384; Ward AK, VOICING CULTURES ROL; Weiss M, 2019, J ORGAN BEHAV, V40, P5, DOI 10.1002/job.2262; White MR, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-27; Yukl G, 1999, J ORGAN BEHAV, V20, P219, DOI 10.1002/(SICI)1099-1379(199903)20:2<219::AID-JOB922>3.0.CO;2-8; Yukl G, PRELIMINARY REPORT V; Yukl G, 1981, LEADERSHIP ORG; Zhang XM, 2010, ACAD MANAGE J, V53, P107, DOI 10.5465/AMJ.2010.48037118; Zhang YA, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11020495; Zhong JA, 2011, ASIA PAC J MANAG, V28, P609, DOI 10.1007/s10490-009-9163-2; Zhou H, 2017, ADV INTELL SYST, V502, P467, DOI 10.1007/978-981-10-1837-4_40	86	9	9	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238451	10.1371/journal.pone.0238451	http://dx.doi.org/10.1371/journal.pone.0238451			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ7QD	32881917	gold, Green Published			2022-12-26	WOS:000571063300032
J	Wei, LS; Zheng, YY; Sun, J; Wang, P; Tao, T; Li, YQ; Chen, X; Sang, YJ; Chong, DY; Zhao, W; Zhou, YW; Wang, Y; Jiang, ZH; Qiu, TT; Li, CJ; Zhu, MS; Zhang, XN				Wei, Lisha; Zheng, Yan-Yan; Sun, Jie; Wang, Pei; Tao, Tao; Li, Yeqiong; Chen, Xin; Sang, Yongjuan; Chong, Danyang; Zhao, Wei; Zhou, Yuwei; Wang, Ye; Jiang, Zhihui; Qiu, Tiantian; Li, Chao-Jun; Zhu, Min-Sheng; Zhang, Xuena			GGPP depletion initiates metaflammation through disequilibrating CYB5R3-dependent eicosanoid metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						MVA pathway; GGPPS; VSMCs; eicosanoids metabolism; LTB4; LTE4; eicosanoid; inflammation; vascular smooth muscle cells; metabolism liposome; cholesterol metabolism; apoptosis; antibody	COENZYME-Q REDUCTASE; SMOOTH-MUSCLE-CELLS; LIGHT-CHAIN KINASE; PROTEIN PRENYLATION; MEVALONATE PATHWAY; BLOOD-PRESSURE; INFLAMMATION; CONTRACTION; MECHANISMS; INHIBITORS	Metaflammation is a primary inflammatory complication of metabolic disorders characterized by altered production of many inflammatory cytokines, adipokines, and lipid mediators. Whereas multiple inflammation networks have been identified, the mechanisms by which metaflammation is initiated have long been controversial. As the mevalonate pathway (MVA) produces abundant bioactive isoprenoids and abnormal MVA has a phenotypic association with inflammation/immunity, we speculate that isoprenoids from the MVA may provide a causal link between metaflammation and metabolic disorders. Using a line with the MVA isoprenoid producer geranylgeranyl diphosphate synthase (GGPPS) deleted, we find that geranylgeranyl pyrophosphate (GGPP) depletion causes an apparent metaflammation as evidenced by abnormal accumulation of fatty acids, eicosanoid intermediates, and proinflammatory cytokines. We also find that GGPP prenylate cytochrome b(5) reductase 3 (CYB5R3) and the prenylated CYB5R3 then translocate from the mitochondrial to the endoplasmic reticulum (ER) pool. As CYB5R3 is a critical NADH-dependent reductase necessary for eicosanoid metabolism in ER, we thus suggest that GGPP-mediated CYB5R3 prenylation is necessary for metabolism. In addition, we observe that pharmacological inhibition of the MVA pathway by simvastatin is sufficient to inhibit CYB5R3 translocation and induces smooth muscle death. Therefore, we conclude that the dysregulation of MVA intermediates is an essential mechanism for metaflammation initiation, in which the imbalanced production of eicosanoid intermediates in the ER serve as an important pathogenic factor. Moreover, the interplay of MVA and eicosanoid metabolism as we reported here illustrates a model for the coordinating regulation among metabolite pathways.	[Wei, Lisha; Zheng, Yan-Yan; Sun, Jie; Wang, Pei; Tao, Tao; Li, Yeqiong; Chen, Xin; Sang, Yongjuan; Chong, Danyang; Zhao, Wei; Zhou, Yuwei; Wang, Ye; Jiang, Zhihui; Qiu, Tiantian; Li, Chao-Jun; Zhu, Min-Sheng; Zhang, Xuena] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Model Anim Res Ctr, Nanjing, Peoples R China; [Wei, Lisha; Zheng, Yan-Yan; Sun, Jie; Wang, Pei; Tao, Tao; Li, Yeqiong; Chen, Xin; Sang, Yongjuan; Chong, Danyang; Zhao, Wei; Zhou, Yuwei; Wang, Ye; Jiang, Zhihui; Qiu, Tiantian; Li, Chao-Jun; Zhu, Min-Sheng; Zhang, Xuena] Nanjing Univ, Sch Med, Nanjing, Peoples R China; [Wei, Lisha; Zheng, Yan-Yan; Sun, Jie; Wang, Pei; Tao, Tao; Li, Yeqiong; Chen, Xin; Sang, Yongjuan; Chong, Danyang; Zhao, Wei; Zhou, Yuwei; Wang, Ye; Jiang, Zhihui; Qiu, Tiantian; Li, Chao-Jun; Zhu, Min-Sheng; Zhang, Xuena] Nanjing Univ, Nanjing Drum Tower Hosp, Nanjing Univ Med Sch, Nanjing, Peoples R China	Nanjing University; Nanjing University; Nanjing University	Li, CJ; Zhu, MS; Zhang, XN (corresponding author), Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Model Anim Res Ctr, Nanjing, Peoples R China.	licj@nju.edu.cn; zhums@nju.edu.cn; zhangxn@nicemice.cn		Li, Chaojun/0000-0001-9474-7321; Chen, Xin/0000-0003-3304-8943	National Natural Science Foundation of China [31272311, 31330034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 31272311 and 31330034 (to M.-S. Z.).	BORGESE N, 1993, FEBS LETT, V325, P70, DOI 10.1016/0014-5793(93)81416-W; Borghi Claudio, 2002, J Clin Hypertens (Greenwich), V4, P277, DOI 10.1111/j.1524-6175.2002.00499.x; Bundy JD, 2017, JAMA CARDIOL, V2, P775, DOI 10.1001/jamacardio.2017.1421; CHAN CC, 1985, J INVEST DERMATOL, V84, P154, DOI 10.1111/1523-1747.ep12275405; Chen C, 2014, J BIOL CHEM, V289, P28478, DOI 10.1074/jbc.M114.567446; Chen WB, 2015, FEBS LETT, V589, P1119, DOI 10.1016/j.febslet.2015.03.015; CLARKE S, 1992, ANNU REV BIOCHEM, V61, P355, DOI 10.1146/annurev.bi.61.070192.002035; Delmastro-Greenwood M, 2014, ANNU REV PHYSIOL, V76, P79, DOI 10.1146/annurev-physiol-021113-170341; ENDO A, 1992, J LIPID RES, V33, P1569; Erl Wolfgang, 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P135, DOI 10.2174/1568006043586134; Esser-von Bieren J, 2017, BIOL CHEM, V398, P1177, DOI 10.1515/hsz-2017-0146; FARNSWORTH CC, 1994, P NATL ACAD SCI USA, V91, P11963, DOI 10.1073/pnas.91.25.11963; Favier LA, 2016, APPL CLIN GENET, V9, DOI 10.2147/TACG.S93933; Ferrier KE, 2002, J AM COLL CARDIOL, V39, P1020, DOI 10.1016/S0735-1097(02)01717-5; Fu TT, 2018, CELL REP, V23, P1357, DOI 10.1016/j.celrep.2018.03.127; Glorioso N, 1999, HYPERTENSION, V34, P1281, DOI 10.1161/01.HYP.34.6.1281; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gruenbacher G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01714; Han YM, 2018, MOL CELL, V71, P1064, DOI 10.1016/j.molcel.2018.07.036; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; Heppard EP, 1996, PLANT PHYSIOL, V110, P311, DOI 10.1104/pp.110.1.311; HILDEBRANDT A, 1971, ARCH BIOCHEM BIOPHYS, V143, P66, DOI 10.1016/0003-9861(71)90186-X; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2017, IMMUNITY, V47, P406, DOI 10.1016/j.immuni.2017.08.009; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; Huynh K, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2017.63; Jiang S, 2016, J PATHOL, V238, P109, DOI 10.1002/path.4652; Jiao ZH, 2020, P NATL ACAD SCI USA, V117, P4158, DOI 10.1073/pnas.1917938117; KARIYA K, 1984, LIFE SCI, V35, P2327, DOI 10.1016/0024-3205(84)90524-1; Khan SA, 2018, FOOD SCI NUTR, V6, P1575, DOI 10.1002/fsn3.698; Knapp AC, 2000, ATHEROSCLEROSIS, V152, P217, DOI 10.1016/S0021-9150(99)00462-1; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Lane KT, 2006, J LIPID RES, V47, P681, DOI 10.1194/jlr.R600002-JLR200; LEE E, 1986, FEBS LETT, V209, P49, DOI 10.1016/0014-5793(86)81082-1; Leroux A, 2001, BIOCHEM J, V355, P529, DOI 10.1042/0264-6021:3550529; Lin CS, 2018, CELL PHYSIOL BIOCHEM, V47, P707, DOI 10.1159/000490024; Martin-Montalvo A, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.6; McTaggart SJ, 2006, CELL MOL LIFE SCI, V63, P255, DOI 10.1007/s00018-005-5298-6; Mullen PJ, 2016, NAT REV CANCER, V16, P718, DOI 10.1038/nrc.2016.76; Munoz MA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01900; Munoz MA, 2017, J ALLERGY CLIN IMMUN, V140, P873, DOI 10.1016/j.jaci.2017.02.033; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; NAVARRO F, 1995, BIOCHEM BIOPH RES CO, V212, P138, DOI 10.1006/bbrc.1995.1947; Neve EPA, 2012, J BIOL CHEM, V287, P6307, DOI 10.1074/jbc.M111.328237; Nilsson AK, 2018, ACTA PAEDIATR, V107, P1020, DOI 10.1111/apa.14275; Qiao YN, 2014, J BIOL CHEM, V289, P22512, DOI 10.1074/jbc.M113.525444; Ramirez MU, 2018, CANCER METAST REV, V37, P469, DOI 10.1007/s10555-018-9737-x; Seo E, 2019, AGING CELL, V18, DOI 10.1111/acel.12895; Song ZM, 2020, BLOOD, V135, P891, DOI 10.1182/blood.2019003525; Sun J, 2019, J GENET GENOMICS, V46, P109, DOI 10.1016/j.jgg.2019.02.005; Sun J, 2018, JOVE-J VIS EXP, DOI 10.3791/58064; Takata R, 2004, CARDIOVASC PATHOL, V13, P41, DOI 10.1016/S1054-8807(03)00104-2; Tao T, 2019, J BIOL CHEM, V294, P10954, DOI 10.1074/jbc.RA118.007318; Tao WW, 2015, J BIOL CHEM, V290, P20086, DOI 10.1074/jbc.M115.657742; Tocher DR, 1998, PROG LIPID RES, V37, P73, DOI 10.1016/S0163-7827(98)00005-8; Tunctan B, 2019, PROSTAG OTH LIPID M, V145, DOI 10.1016/j.prostaglandins.2019.106377; VILLALBA JM, 1995, P NATL ACAD SCI USA, V92, P4887, DOI 10.1073/pnas.92.11.4887; Wang WC, 2018, P NATL ACAD SCI USA, V115, P5283, DOI 10.1073/pnas.1721711115; Xu N, 2015, J PATHOL, V235, P672, DOI 10.1002/path.4480; Yeh YS, 2018, ISCIENCE, V9, P175, DOI 10.1016/j.isci.2018.10.019; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zupancic D, 2018, CELL BIOL INT, V42, P411, DOI 10.1002/cbin.10910	62	1	1	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2020	295	47					15988	16001		10.1074/jbc.RA120.015020	http://dx.doi.org/10.1074/jbc.RA120.015020			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PA5ED	32913122	Green Published, hybrid			2022-12-26	WOS:000595657900017
J	Wang, J; Han, CH; Lu, Z; Ge, PP; Cui, Y; Zhao, DD; Yang, X; Wu, B; Qiang, LH; Zhang, Y; Chai, QY; Lei, ZH; Li, L; Liu, CH; Zhang, LQ				Wang, Jing; Han, Conghui; Lu, Zhe; Ge, Pupu; Cui, Yu; Zhao, Dongdong; Yang, Xi; Wu, Bo; Qiang, Lihua; Zhang, Yong; Chai, Qiyao; Lei, Zehui; Li, Ling; Hua Liu, Cui; Zhang, Lingqiang			Simulated microgravity suppresses MAPK pathway-mediated innate immune response to bacterial infection and induces gut microbiota dysbiosis	FASEB JOURNAL			English	Article						gut microbiota; innate immunity; MAPK pathway; probiotics; simulated microgravity	SPACE; VSLNUMBER-3; SPACEFLIGHT; SYSTEM; HYPERGRAVITY; INTERFERON; PROBIOTICS; JNK	During spaceflight, astronauts are subjected to various physical stressors including microgravity, which could cause immune dysfunction and thus potentially predispose astronauts to infections and illness. However, the mechanisms by which microgravity affects innate immunity remain largely unclear. In this study, we conducted RNA-sequencing analysis to show that simulated microgravity (SMG) suppresses the production of inflammatory cytokines including tumor necrosis factor (TNF) and interleukin-6 (IL-6) as well as the activation of the innate immune signaling pathways including the p38 mitogen-activated protein kinase (MAPK) and the Erk1/2 MAPK pathways in the Enteropathogenic escherichia coli (EPEC)-infected macrophage cells. We then adopted hindlimb-unloading (HU) mice, a model mimicking the microgravity of a spaceflight environment, to demonstrate that microgravity suppresses proinflammatory cytokine-mediated intestinal immunity toCitrobacter rodentiuminfection and induces the disturbance of gut microbiota, both of which phenotypes could be largely corrected by the introduction of VSL#3, a high-concentration probiotic preparation of eight live freeze-dried bacterial species. Taken together, our study provides new insights into microgravity-mediated innate immune suppression and intestinal microbiota disturbance, and suggests that probiotic VSL#3 has great potential as a dietary supplement in protecting individuals from spaceflight mission-associated infections and gut microbiota dysbiosis.	[Wang, Jing; Lu, Zhe; Ge, Pupu; Zhao, Dongdong; Qiang, Lihua; Zhang, Yong; Chai, Qiyao; Lei, Zehui; Hua Liu, Cui] Chinese Acad Sci, Ctr Biosafety Mega Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Han, Conghui; Li, Ling] Southern Med Univ, Sch Publ Hlth, Guangzhou, Peoples R China; [Lu, Zhe; Ge, Pupu; Zhao, Dongdong; Qiang, Lihua; Chai, Qiyao; Lei, Zehui; Hua Liu, Cui] Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China; [Cui, Yu; Yang, Xi; Wu, Bo; Zhang, Lingqiang] Beijing Inst Life, Natl Ctr Prot Sci, State Key Lab Prote, Beijing, Peoples R China	Chinese Academy of Sciences; Southern Medical University - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, CH (corresponding author), Chinese Acad Sci, Ctr Biosafety Mega Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.	liucuihua@im.ac.cn	Zhang, Yong/ABG-3082-2021		National Science and Technology Major Project [2018ZX10101004]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB29020000]; Key Program of Logistics Research [BWS17J030]; National Key Research and Development Program of China [2017YFA0505900, 2017YFD0500300]; National Natural Science Foundation of China [81825014, 31830003]	National Science and Technology Major Project; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Key Program of Logistics Research; National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Science and Technology Major Project, Grant/Award Number: 2018ZX10101004; Strategic Priority Research Program of the Chinese Academy of Sciences, Grant/Award Number: XDB29020000; Key Program of Logistics Research, Grant/Award Number: BWS17J030; National Key Research and Development Program of China, Grant/Award Number: 2017YFA0505900 and 2017YFD0500300; National Natural Science Foundation of China, Grant/Award Number: 81825014 and 31830003	Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Bai P, 2019, MICROBIOLOGYOPEN, V8, DOI 10.1002/mbo3.917; Benjamin CL, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88787; BERRY WD, 1991, J INTERFERON RES, V11, P243, DOI 10.1089/jir.1991.11.243; Bibiloni R, 2005, AM J GASTROENTEROL, V100, P1539, DOI 10.1111/j.1572-0241.2005.41794.x; Bigley AB, 2019, J APPL PHYSIOL, V126, P842, DOI 10.1152/japplphysiol.00761.2018; Bradley JH, 2017, LIFE SCI SPACE RES, V15, P55, DOI 10.1016/j.lssr.2017.08.002; Candela M, 2015, CRIT REV MICROBIOL, V41, P165, DOI 10.3109/1040841X.2013.813900; Carvalho FA, 2012, CELL HOST MICROBE, V12, P139, DOI 10.1016/j.chom.2012.07.004; Chakraborty N, 2018, NPJ MICROGRAVITY, V4, DOI 10.1038/s41526-017-0038-4; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; CHAPES SK, 1993, J LEUKOCYTE BIOL, V54, P227, DOI 10.1002/jlb.54.3.227; Costantini TW, 2009, J SURG RES, V156, P64, DOI 10.1016/j.jss.2009.03.066; Crucian B, 2016, INT J GEN MED, V9, P383, DOI 10.2147/IJGM.S114188; Crucian B, 2013, J CLIN IMMUNOL, V33, P456, DOI 10.1007/s10875-012-9824-7; Crucian BE, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01437; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Delgado S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020391; Delia P, 2002, AM J GASTROENTEROL, V97, P2150; Dore J, 2017, THERAPIE, V72, P21, DOI 10.1016/j.therap.2016.12.007; Fajardo-Cavazos P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00999; Fonte C, 2019, FASEB J, V33, P896, DOI 10.1096/fj.201800969R; Frippiat JP, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.40; Ghislin S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09318; Gionchetti P, 2005, GASTROENTEROL CLIN N, V34, P499, DOI 10.1016/j.gtc.2005.05.003; Gionchetti P, 2003, GASTROENTEROLOGY, V124, P1202, DOI 10.1016/S0016-5085(03)00171-9; Globus RK, 2016, J APPL PHYSIOL, V120, P1196, DOI 10.1152/japplphysiol.00997.2015; Goto Y, 2016, NAT IMMUNOL, V17, P1244, DOI 10.1038/ni.3587; GOULD CL, 1987, AVIAT SPACE ENVIR MD, V58, P983; Guan CY, 2019, EXP CELL RES, V378, P182, DOI 10.1016/j.yexcr.2019.03.018; Gueguinou N, 2012, PSYCHONEUROENDOCRINO, V37, P137, DOI 10.1016/j.psyneuen.2011.05.015; Hammaker D, 2012, ARTHRITIS RHEUM-US, V64, P678, DOI 10.1002/art.33359; Hawkins W R, 1975, Ophthalmic Surg, V6, P66; Jin ML, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00729; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu Q, 2020, MICROB CELL FACT, V19, DOI 10.1186/s12934-020-1289-4; Long KZ, 2010, INFECT IMMUN, V78, P1221, DOI 10.1128/IAI.00767-09; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Marcu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015361; Mehta SK, 2017, NPJ MICROGRAVITY, V3, DOI 10.1038/s41526-017-0015-y; Paulsen K, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/538786; Perez-Lopez A, 2016, NAT REV IMMUNOL, V16, P135, DOI 10.1038/nri.2015.17; Pimentel-Nunes P, 2010, EXPERT OPIN THER TAR, V14, P347, DOI 10.1517/14728221003642027; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Saei AA, 2012, FUTURE MICROBIOL, V7, P1037, DOI [10.2217/FMB.12.82, 10.2217/fmb.12.82]; Sonnenfeld G, 2005, CURR PHARM BIOTECHNO, V6, P343, DOI 10.2174/1389201054553699; Tackett N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50311-z; TAYLOR GR, 1983, AVIAT SPACE ENVIR MD, V54, pS55; Wieers G, 2020, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00454; Xiao ZP, 2018, INT J RETAIL DISTRIB, V46, P2, DOI 10.1108/IJRDM-03-2016-0036; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zechner D, 1998, J BIOL CHEM, V273, P8232, DOI 10.1074/jbc.273.14.8232; Zhuang XN, 2017, CELL MOL IMMUNOL, V14, P237, DOI 10.1038/cmi.2016.52	56	12	13	4	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14631	14644		10.1096/fj.202001428R	http://dx.doi.org/10.1096/fj.202001428R		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32918764				2022-12-26	WOS:000570683700001
J	Wang, YF; Singh, AR; Zhao, YY; Du, T; Huang, YT; Wan, XH; Mukhopadhyay, D; Wang, Y; Wang, NP; Zhang, P				Wang, Yinfang; Singh, Angom Ramcharan; Zhao, Yuanyuan; Du, Tao; Huang, Yitong; Wan, Xiaohong; Mukhopadhyay, Debabrata; Wang, Ying; Wang, Nanping; Zhang, Peng			TRIM28 regulates sprouting angiogenesis through VEGFR-DLL4-Notch signaling circuit	FASEB JOURNAL			English	Article						DLL4; sprouting angiogenesis; Tip cell; TRIM28; VEGFR	TIP CELLS; PROTEIN; VEGF; INHIBITION; DLL4; HIF-1-ALPHA; EXPRESSION; DELTA; RBPJ	Sprouting angiogenesis is a highly coordinately process controlled by vascular endothelial growth factor receptor (VEGFR)-Notch signaling. Here we investigated whether Tripartite motif-containing 28 (TRIM28), which is an epigenetic modifier implicated in gene transcription and cell differentiation, is essential to mediate sprouting angiogenesis. We observed that knockdown ofTRIM28ortholog in zebrafish resulted in developmental vascular defect with disorganized and reduced vasculatures. Consistently, TRIM28 knockdown inhibited angiogenic sprouting of cultured endothelial cells (ECs), which exhibited increased mRNA levels of VEGFR1, Delta-like (DLL) 3, and Notch2 but reduced levels of VEGFR2, DLL1, DLL4, Notch1, Notch3, and Notch4.The regulative effects of TRIM28 on these angiogenic factors were partially mediated by hypoxia-inducible factor 1 alpha (HIF-1 alpha) and recombination signal-binding protein for immunoglobulin kappa J region (RBPJ kappa). In vitro DNA-binding assay showed that TRIM28 knockdown increased the association of RBPJ kappa with DNA sequences containing HIF-1 alpha-binding sites. Moreover, the phosphorylation of TRIM28 was controlled by VEGF and Notch1 through a mechanism involving RBPJ kappa-dual-specificity phosphatase (DUSP)-p38 MAPK, indicating a negative feedback mechanism. These findings established TRIM28 as a crucial regulator of VEGFR-Notch signaling circuit through HIF-1 alpha and RBPJ kappa in EC sprouting angiogenesis.	[Wang, Yinfang; Zhao, Yuanyuan; Huang, Yitong; Wan, Xiaohong; Zhang, Peng] Shanghai Univ Tradit Chinese Med, Cent Lab, Putuo Hosp, Shanghai, Peoples R China; [Wang, Yinfang; Zhang, Peng] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Cardiovas Med, Shanghai, Peoples R China; [Singh, Angom Ramcharan; Mukhopadhyay, Debabrata; Wang, Ying] Mayo Clin, Coll Med & Sci, Dept Biochem & Mol Biol, Jacksonville, FL 32224 USA; [Du, Tao] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Gastrointestinal Surg, Shanghai, Peoples R China; [Wan, Xiaohong; Zhang, Peng] Anhui Med Univ, Shanghai Putuo Cent Sch Clin Med, Hefei, Peoples R China; [Wang, Nanping] Dalian Med Univ, Adv Inst Med Sci, Dalian, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Mayo Clinic; Tongji University; Anhui Medical University; Dalian Medical University	Wang, Y (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Jacksonville, FL 32224 USA.; Zhang, P (corresponding author), Shanghai Univ Tradit Chinese Med, Putuo Hosp, Cent Lab, Shanghai, Peoples R China.; Zhang, P (corresponding author), Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Cardiovasc Med, Shanghai, Peoples R China.	wang.ying@mayo.edu; zhangnep@hotmail.com		Wang, Ying/0000-0002-7852-386X; Wang, Nanping/0000-0002-8528-8132	National Natural Science Foundation of China [81770443, 81870327]; NHLBI [HL140411]; American Heart Association [19CDA34700013]; Mayo Clinic CCaTS; Clinical Superior Discipline Development Fund of Shanghai Putuo District [ptkwws201901, 2019ysxk01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Mayo Clinic CCaTS; Clinical Superior Discipline Development Fund of Shanghai Putuo District	This work was supported by the National Natural Science Foundation of China (81770443 to PZ, 81870327 to YFW), NHLBI (#HL140411 to DM), American Heart Association (#19CDA34700013 to YW), and Mayo Clinic CCaTS (Ted and Loretta Rogers Cardiovascular Career Development Award Honoring Hugh C. Smith to YW), Clinical Superior Discipline Development Fund of Shanghai Putuo District(#ptkwws201901 and #2019ysxk01 to PZ).	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Blanco R, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006569; Bunch H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10191; Cammas F, 2000, DEVELOPMENT, V127, P2955; Castel D, 2013, GENE DEV, V27, P1059, DOI 10.1101/gad.211912.112; Chang CW, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-61; Childs S, 2002, DEVELOPMENT, V129, P973; Chitramuthu BP, 2013, JOVE-J VIS EXP, DOI 10.3791/50644; de Sio FRS, 2012, FASEB J, V26, P4561, DOI 10.1096/fj.12-206177; Diaz-Trelles R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12088; EKKER SC, 1995, CURR BIOL, V5, P944, DOI 10.1016/S0960-9822(95)00185-0; Gerber HP, 1997, J BIOL CHEM, V272, P23659, DOI 10.1074/jbc.272.38.23659; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gessler M, 2009, BLOOD, V113, P5375, DOI 10.1182/blood-2009-02-205468; Habeck H, 2002, CURR BIOL, V12, P1405, DOI 10.1016/S0960-9822(02)01044-8; Harrington EO, 1997, J BIOL CHEM, V272, P7390, DOI 10.1074/jbc.272.11.7390; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hellstrom M, 2007, CELL ADHES MIGR, V1, P133, DOI 10.4161/cam.1.3.4978; Ho RXY, 2018, J MOL CELL BIOL, V10, P195, DOI 10.1093/jmcb/mjy002; Hyatt TM, 1999, METHOD CELL BIOL, V59, P117; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; King CA, 2013, J VIROL, V87, P8779, DOI 10.1128/JVI.02976-12; Kondoh K, 2007, J BIOL CHEM, V282, P3058, DOI 10.1074/jbc.M607630200; Ladi E, 2005, J CELL BIOL, V170, P983, DOI 10.1083/jcb.200503113; Layden MJ, 2013, NAT PROTOC, V8, P924, DOI 10.1038/nprot.2013.009; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Li ZB, 2003, EMBO J, V22, P1857, DOI 10.1093/emboj/cdg173; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Messerschmidt DM, 2012, SCIENCE, V335, P1499, DOI 10.1126/science.1216154; Moriya J, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0180-9; Nakatsu Martin N, 2007, J Vis Exp, P186, DOI 10.3791/186; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Rousseaux MWC, 2018, ELIFE, V7, DOI 10.7554/eLife.36768; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Stainier DYR, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007000; Suchting S, 2009, CELL, V137, P988, DOI 10.1016/j.cell.2009.05.024; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Trindade A, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3171-2; Ulyatt C, 2011, BIOCHEM BIOPH RES CO, V404, P774, DOI 10.1016/j.bbrc.2010.12.057; Waltenberger J, 1996, CIRCULATION, V94, P1647, DOI 10.1161/01.CIR.94.7.1647; Wang YF, 2017, FASEB J, V31, P2026, DOI 10.1096/fj.201600988RR; Yang CZ, 2013, J SURG RES, V183, P478, DOI 10.1016/j.jss.2013.01.009; Zhang LM, 2014, J VIROL, V88, P6873, DOI 10.1128/JVI.00283-14; Zheng W, 2011, BLOOD, V118, P1154, DOI 10.1182/blood-2010-11-317800	48	6	7	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14710	14724		10.1096/fj.202000186RRR	http://dx.doi.org/10.1096/fj.202000186RRR		SEP 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32918765				2022-12-26	WOS:000570676900001
J	Balogun, OS; Gao, XZ; Jolayemi, ET; Olaleye, SA				Balogun, Oluwafemi Samson; Gao, Xiao-Zhi; Jolayemi, Emmanuel Teju; Olaleye, Sunday Adewale			Generalized cure rate model for infectious diseases with possible co-infections	PLOS ONE			English	Article							SURVIVAL-DATA	This research mainly aims to develop a generalized cure rate model, estimate the proportion of cured patients and their survival rate, and identify the risk factors associated with infectious diseases. The generalized cure rate model is based on bounded cumulative hazard function, which is a non-mixture model, and is developed using a two-parameter Weibull distribution as the baseline distribution, to estimate the cure rate using maximum likelihood method and real data with R and STATA software. The results showed that the cure rate of tuberculosis (TB) patients was 26.3%, which was higher than that of TB patients coinfected with human immunodeficiency virus (HIV; 23.1%). The non-parametric median survival time of TB patients was 51 months, while that of TB patients co-infected with HIV was 33 months. Moreover, no risk factors were associated with TB patients co-infected with HIV, while age was a significant risk factor for TB patients among the suspected risk factors considered. Furthermore, the bounded cumulative hazard function was extended to accommodate infectious diseases with co-infections by deriving an appropriate probability density function, determining the distribution, and using real data. Governments and related health authorities are also encouraged to take appropriate actions to combat infectious diseases with possible co-infections.	[Balogun, Oluwafemi Samson; Gao, Xiao-Zhi] Univ Eastern Finland, Sch Comp, Kuopio, Finland; [Jolayemi, Emmanuel Teju] Univ Ilorin, Fac Sci, Dept Stat, Ilorin, Kwara State, Nigeria; [Olaleye, Sunday Adewale] Univ Oulu, Dept Mkt Management & Int Business, Oulu, Finland	University of Eastern Finland; University of Ilorin; University of Oulu	Balogun, OS (corresponding author), Univ Eastern Finland, Sch Comp, Kuopio, Finland.	samson.balogun@uef.fi	Olaleye, Sunday Adewale/AAH-2285-2019; Balogun, Oluwafemi Samson/AAK-9080-2021	Olaleye, Sunday Adewale/0000-0002-0266-3989; Balogun, Oluwafemi Samson/0000-0002-8870-9692				Aljawadi BA, 2011, AM J SCI, V14, P79; [Anonymous], 2018, FARSOTTAFRETTIR, V11, P1, DOI DOI 10.1186/s13071-017-2573-y; [Anonymous], 2011, THE WAGNER JOURNAL, V5, P103, DOI DOI 10.1561/101.00000040; Balogun OS, 2018, THESIS; Balogun OS, 2017, PACIFIC J SCI TECHNO, V18, P288; Barriga GDC, 2015, APPL STOCH MODEL BUS, V31, P846, DOI 10.1002/asmb.2112; Brown ER, 2003, BIOMETRICS, V59, P686, DOI 10.1111/1541-0420.00079; Cancho VG, 2013, COMMUN STAT-SIMUL C, V42, P586, DOI 10.1080/03610918.2011.639971; Chen MH, 1999, J AM STAT ASSOC, V94, P909, DOI 10.2307/2670006; CONAB-Companhia Nacional de Abastecimento, 2017, AC SAFR BRAS GRAOS 2, V5, P1, DOI DOI 10.3389/fnut.2018.00001; COX DR, 1972, J R STAT SOC B, V34, P187; Gallardo DI, 2017, J APPL STAT, V44, P1153, DOI 10.1080/02664763.2016.1194385; Kezunovic M, 2011, IEEE T SMART GRID, V2, P11, DOI 10.1109/TSG.2011.2118774; Li D, 2016, BIOMETRICAL J, V58, P1178, DOI 10.1002/bimj.201500040; Liu YB, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16010140; Looha MA, 2018, EPIDEMIOL HEALTH, V40, DOI 10.4178/epih.e2018045; Maller RA., 1996, SURVIVAL ANAL LONG T; National Institutes of Health (US), 2007, NIH CURR SUPPL SER; Oliveira M. R., 2014, SINGAPOREAN J BUSINE, V3, P30; Oliveira M. R., 2014, TECNOLOGIA CREDITO, V88, P43; Othus M, 2012, CLIN CANCER RES, V18, P3731, DOI 10.1158/1078-0432.CCR-11-2859; R Core Team, 2018, R LANG ENV STAT COMP; Saglyk, 2019, TUB TURKM; Shi HL, 2017, STAT METHODS MED RES, V26, P2042, DOI 10.1177/0962280217708681; Sun J, 2016, ACCIDENT ANAL PREV, V95, P503, DOI 10.1016/j.aap.2015.12.011; Taweab F., 2014, J APPL SCI, V14, P609, DOI DOI 10.3923/jas.2014.609.616; Uddin M. T., 2006, Journal of Applied Sciences, V6, P548; WHO, 2020, GLOB TUB REP; Zeng Q, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082768; Zeng Q, 2019, TRANSPORTMETRICA A, V15, P1867, DOI 10.1080/23249935.2019.1652867	30	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0239003	10.1371/journal.pone.0239003	http://dx.doi.org/10.1371/journal.pone.0239003			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915903	gold, Green Published			2022-12-26	WOS:000571887500093
J	Haburaj, V; Japp, S; Gerlach, I; Hoelzmann, P; Schutt, B				Haburaj, Vincent; Japp, Sarah; Gerlach, Iris; Hoelzmann, Philipp; Schuett, Brigitte			Coupling spectral imaging and laboratory analyses to digitally map sediment parameters and stratigraphic layers in Yeha, Ethiopia	PLOS ONE			English	Article							SOIL; SPECTROSCOPY; REFLECTANCE; REASSESSMENT; COMBINATION; COLOR; IRON; NIR; XRF	Quantitative analyses of soil and sediment samples are often used to complement stratigraphic interpretations in archaeological and geoscientific research. The outcome of such analyses often is confined to small parts of the examined profiles as only a limited number of samples can be extracted and processed. Recent laboratory studies show that such selectively measured soil and sediment characteristics can be spatially extrapolated using spectral image data, resulting in reliable maps of a variety of parameters. However, on-site usage of this method has not been examined. We therefore explore, whether image data (RGB data and visible and near infrared hyperspectral data), acquired under regular fieldwork conditions during an archaeological excavation, in combination with a sampling strategy that is close to common practice, can be used to produce maps of soil organic matter, hematite, calcite, several weathering indices and grain size characteristics throughout complex archaeological profiles. We examine two profiles from an archaeological trench in Yeha (Tigray, Ethiopia). Our findings show a promising performance of RGB data and its derivative CIELAB as well as hyperspectral data for the prediction of parameters via random forest regression. By including two individual profiles we are able to assess the accuracy and reproducibility of our results, and illustrate the advantages and drawbacks of a higher spectral resolution and the necessary additional effort during fieldwork. The produced maps of the parameters examined allow us to critically reflect on the stratigraphic interpretation and offer a more objective basis for layer delineation in general. Our study therefore promotes more transparent and reproducible documentation for often destructive archaeological fieldwork.	[Haburaj, Vincent; Hoelzmann, Philipp; Schuett, Brigitte] Free Univ Berlin, Inst Geog Sci, Berlin, Germany; [Japp, Sarah; Gerlach, Iris] Deutsch Archaeol Inst, Orient Dept, Berlin, Germany	Free University of Berlin	Haburaj, V (corresponding author), Free Univ Berlin, Inst Geog Sci, Berlin, Germany.	vincent.haburaj@fu-berlin.de	Hoelzmann, Philipp/H-7008-2019; Haburaj, Vincent/C-4456-2017	Hoelzmann, Philipp/0000-0001-8709-8474; Haburaj, Vincent/0000-0002-2393-2762	Cluster of Excellence EXC264 Topoi (The Formation and Transformation of Space and Knowledge in Ancient Civilizations, Research Area A; Deutsche Forschungsgemeinschaft (DFG) [39235742]; Deutsche Forschungsgemeinschaft (DFG) [39235742, EXC264]; Sanaa Branch of the Orient Department of the DAI (Deutsches Archaologisches Institut); Authority for Research and Conservation of Cultural Heritage (ARCCH); Tigray Culture and Tourism Bureau	Cluster of Excellence EXC264 Topoi (The Formation and Transformation of Space and Knowledge in Ancient Civilizations, Research Area A; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Sanaa Branch of the Orient Department of the DAI (Deutsches Archaologisches Institut); Authority for Research and Conservation of Cultural Heritage (ARCCH); Tigray Culture and Tourism Bureau	This research was funded by the Cluster of Excellence EXC264 Topoi (The Formation and Transformation of Space and Knowledge in Ancient Civilizations, Research Area A; Deutsche Forschungsgemeinschaft (DFG) project number 39235742.; We thank the Cluster of Excellence EXC264 Topoi (The Formation and Transformation of Space and Knowledge in Ancient Civilizations, Research Area A) for the interdisciplinary framework which allowed us to conduct this research. Furthermore, we would like to thank the Sanaa Branch of the Orient Department of the DAI (Deutsches Archaologisches Institut) for their open-minded collaboration during fieldwork and the Geography Department of the Humboldt-Universitat zu Berlin for the use of their spectroradiometer. We are very grateful to the Authority for Research and Conservation of Cultural Heritage (ARCCH) and the Tigray Culture and Tourism Bureau (TCTB) for permission to take samples and analyse them in Germany. Special thanks is expressed to Jan Krause, Bjorn Waske, Fabian Becker, Jacob Hardt, Moritz Nykamp, Henry Schubert, Robert Busch, Nadav Nir and Haftom Birhane for their support during fieldwork and the inspiring discussions. We would like to thank the reviewers for their thoughtful comments and efforts towards improving our manuscript.	Anfray F.Matara, 1967, ANN DETHIOPIE, V7, P33; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], 2020, RFUTILITIES RANDOM F; [Anonymous], 2005, AD HOC ARBEITSGRUPPE; [Anonymous], 2019, REG ANESTH PAIN MED, V44, pe1; [Anonymous], 2001, INTENSIVE CARE MED; [Anonymous], 2014, SIGNAL DEV SIGNAL SI; BARRON V, 1986, J SOIL SCI, V37, P499, DOI 10.1111/j.1365-2389.1986.tb00382.x; BAUMGARDNER MF, 1985, ADV AGRON, V38, P1, DOI 10.1016/S0065-2113(08)60672-0; Bent T, 1893, SACRED CITY ETHIOPIA; Betard F, 2012, CATENA, V93, P18, DOI 10.1016/j.catena.2012.01.013; Blume HP., 2011, BODENKUNDLICHES PRAK; Brandt SA, 1984, NEW PERSPECTIVES ORI, P173; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Davis S, 2015, DRAMATIC INTERACTIONS IN EDUCATION: VYGOTSKIAN AND SOCIOCULTURAL APPROACHES TO DRAMA, EDUCATION AND RESEARCH, P189, DOI 10.1007/978-94-017-9849-5_7; Duzgoren-Aydin NS, 2002, ENG GEOL, V63, P99, DOI 10.1016/S0013-7952(01)00073-4; Fattovich R, 1977, P SEMINAR ARABIAN ST, V7, P73; Fattovich R., 2012, RASSEGNA STUDI ETIOP, V4, P1; Gerlach I, 2012, NEW RES ARCHAEOLOGY, P215; Gerlach I, 2017, FORSCHUNGEN ARCHAOLO, P3; Gerlach I, 2015, MIGRATION PROCESSES, P100; Gerlach I., 2018, ZUM ATHIO SABAISCHEN, P229; Gerlach Iris, 2013, Z ORIENT ARCHAOLOGIE, V6, P254; Haburaj V, 2020, HERITAGE-BASEL, V3, P528, DOI 10.3390/heritage3020031; Heil J, 2020, CATENA, V193, DOI 10.1016/j.catena.2020.104610; Hill J, 2000, REMOTE SENS ENVIRON, V74, P557, DOI 10.1016/S0034-4257(00)00146-2; Hill J, 2010, PRECISION CROP PROTECTION - THE CHALLENGE AND USE OF HETEROGENEITY, P67, DOI 10.1007/978-90-481-9277-9_5; HURST VJ, 1977, GEOL SOC AM BULL, V88, P174, DOI 10.1130/0016-7606(1977)88<174:VEOIIS>2.0.CO;2; Japp S.Yeha, 2019, ATHIOPIEN ARCHAOLOGI; Japp Sarah, 2011, P SEMINAR ARABIAN ST, V41, P145; Jarmer T, 1998, 1ST EARSEL WORKSHOP ON IMAGING SPECTROSCOPY, P375; Lagacherie P., 2006, DIGITAL SOIL MAPPING; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Linderholm J, 2019, GEOARCHAEOLOGY, V34, P311, DOI 10.1002/gea.21731; Marshall M, 2012, QUAT GEOCHRONOL, V13, P70, DOI 10.1016/j.quageo.2012.06.002; Marwick B, 2017, SAA ARCHAEOLOGICAL R, V17, P8, DOI DOI 10.17605/0SF.I0/3D6XX; Marwick B, 2017, J ARCHAEOL METHOD TH, V24, P424, DOI 10.1007/s10816-015-9272-9; McBratney AB, 2003, GEODERMA, V117, P3, DOI 10.1016/S0016-7061(03)00223-4; MELVILLE MD, 1985, J SOIL SCI, V36, P495, DOI 10.1111/j.1365-2389.1985.tb00353.x; Mesirov JP, 2010, SCIENCE, V327, P415, DOI 10.1126/science.1179653; Millard K, 2015, REMOTE SENS-BASEL, V7, P8489, DOI 10.3390/rs70708489; Minasny B, 2016, GEODERMA, V264, P301, DOI 10.1016/j.geoderma.2015.07.017; Nebes N, 2010, Z ORIENT ARCHAOLOGIE, V3, P214; PARKER A, 1970, GEOL MAG, V107, P501, DOI 10.1017/S0016756800058581; Peng RD, 2011, SCIENCE, V334, P1226, DOI 10.1126/science.1213847; Phillipson DW, 2009, AFR ARCHAEOL REV, V26, P257, DOI 10.1007/s10437-009-9064-2; POST JL, 1993, CLAY CLAY MINER, V41, P639, DOI 10.1346/CCMN.1993.0410601; Rossel RAV, 2006, GEODERMA, V131, P59, DOI 10.1016/j.geoderma.2005.03.007; RUXTON BP, 1968, J GEOL, V76, P518, DOI 10.1086/627357; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schreiner S, 2015, PHOTOGRAMM FERNERKUN, P423, DOI 10.1127/pfg/2015/0279; Schutt B., 2004, LECT NOTES EARTH SCI, V102, P5; Segal M.R., 2004, INT C BIOINF, DOI DOI 10.2307/2404188; Steffens M., 2012, EARSEL EPROCEEDINGS, V11, P25; Stenberg B, 2010, PROGR SOIL SCI, P29, DOI 10.1007/978-90-481-8859-8_3; Stenberg B, 2010, ADV AGRON, V107, P163, DOI 10.1016/S0065-2113(10)07005-7; Stolt Mark H., 1994, V34, P1; Vodyanitskii YN, 2016, EURASIAN SOIL SCI+, V49, P1259, DOI 10.1134/S1064229316110107; Vogel S, 2016, QUATERN INT, V394, P155, DOI 10.1016/j.quaint.2015.02.033; WOODCOCK CE, 1987, REMOTE SENS ENVIRON, V21, P311, DOI 10.1016/0034-4257(87)90015-0; Zhang Y, 2019, EUR J SOIL SCI, V70, P27, DOI 10.1111/ejss.12699; Zhang YK, 2019, CATENA, V180, P298, DOI 10.1016/j.catena.2019.05.001	62	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238894	10.1371/journal.pone.0238894	http://dx.doi.org/10.1371/journal.pone.0238894			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915881	gold, Green Published			2022-12-26	WOS:000571887500131
J	Kueper, JK; Lizotte, DJ; Montero-Odasso, M; Speechley, M				Kueper, Jacqueline K.; Lizotte, Daniel J.; Montero-Odasso, Manuel; Speechley, Mark		Alzheimers Dis Neuroimaging Initia	Cognition and motor function: The gait and cognition pooled index	PLOS ONE			English	Article							ADDING DELAYED RECALL; ADAS-COG; ASSESSMENT SCALE; INSTRUMENTAL ACTIVITIES; INCIDENT DEMENTIA; SLOW GAIT; IMPAIRMENT; RISK; RESPONSIVENESS; DISEASE	Background There is a need for outcome measures with improved responsiveness to changes in pre-dementia populations. Both cognitive and motor function play important roles in neurodegeneration; motor function decline is detectable at early stages of cognitive decline. This proof of principle study used a Pooled Index approach to evaluate improved responsiveness of the predominant outcome measure (ADAS-Cog: Alzheimer's Disease Assessment Scale-Cognitive Subscale) when assessment of motor function is added. Methods Candidate Pooled Index variables were selected based on theoretical importance and pairwise correlation coefficients. Kruskal-Wallis and Mann-Whitney U tests assessed baseline discrimination. Standardized response means assessed responsiveness to longitudinal change. Results Final selected variables for the Pooled Index include gait velocity, dual-task cost of gait velocity, and an ADAS-Cog-Proxy (statistical approximation of the ADAS-Cog using similar cognitive tests). The Pooled Index and ADAS-Cog-Proxy scores had similar ability to discriminate between pre-dementia syndromes. The Pooled Index demonstrated trends of similar or greater responsiveness to longitudinal decline than ADAS-Cog-Proxy scores. Conclusion Adding motor function assessments to the ADAS-Cog may improve responsiveness in pre-dementia populations.	[Kueper, Jacqueline K.; Lizotte, Daniel J.; Montero-Odasso, Manuel; Speechley, Mark] Univ Western Ontario, Schulich Sch Med & Dent, Dept Epidemiol & Biostat, London, ON, Canada; [Lizotte, Daniel J.] Univ Western Ontario, Fac Sci, Dept Comp Sci, London, ON, Canada; [Lizotte, Daniel J.] Univ Western Ontario, Fac Sci, Dept Stat & Actuarial Sci, London, ON, Canada; [Lizotte, Daniel J.; Speechley, Mark] Univ Western Ontario, Schulich Sch Med & Dent, Master Publ Hlth Program, London, ON, Canada; [Montero-Odasso, Manuel] Univ Western Ontario, Schulich Sch Med & Dent, Div Geriatr Med, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Montero-Odasso, M (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Epidemiol & Biostat, London, ON, Canada.; Montero-Odasso, M (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Div Geriatr Med, London, ON, Canada.	mmontero@uwo.ca	Montero-Odasso, Manuel/G-3335-2011	Montero-Odasso, Manuel/0000-0002-5796-2361	Early Research Award (PI MMO); Alzheimer Foundation of London; Middlesex Master's Scholarship in Alzheimer-Related Research; Canadian Institutes of Health and Research (CIHR) [MOP 211220]; CIHR [PJT 153100]; CIHR; Ontario Ministry of Research and Innovation; Ontario Neurodegenerative Diseases Research Initiative; Canadian Consortium on Neurodegeneration in Aging; Department of Medicine Program of Experimental Medicine Research Award, the University of Western Ontario	Early Research Award (PI MMO); Alzheimer Foundation of London; Middlesex Master's Scholarship in Alzheimer-Related Research; Canadian Institutes of Health and Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Ontario Neurodegenerative Diseases Research Initiative; Canadian Consortium on Neurodegeneration in Aging; Department of Medicine Program of Experimental Medicine Research Award, the University of Western Ontario	This work was supported by the Early Research Award (PI MMO) and the Alzheimer Foundation of London and Middlesex Master's Scholarship in Alzheimer-Related Research to JKK. The Gait and Brain Study is funded by an operating grant from the Canadian Institutes of Health and Research (CIHR, MOP 211220) and a CIHR Project Grant (PJT 153100). Dr. Montero-Odasso's program in "Gait and Brain Health" is supported by grants from the CIHR, the Ontario Ministry of Research and Innovation, the Ontario Neurodegenerative Diseases Research Initiative, the Canadian Consortium on Neurodegeneration in Aging, and by the Department of Medicine Program of Experimental Medicine Research Award, the University of Western Ontario. The funders involved in setting up and maintaining the ADNI national database, where we obtained our data, are listed in the Acknowledgements. Neither ADNI nor its funders, some of which were commercial, have had any communication with us related to or influencing the specifics of our project. Their funding of ADNI does not alter our adherence to PLOS ONE policies on sharing data and materials.	Abdi H., 2010, ENCY RES DES, V2; Aggarwal NT, 2006, ARCH NEUROL-CHICAGO, V63, P1763, DOI 10.1001/archneur.63.12.1763; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Allali G, 2016, EUR J NEUROL, V23, P527, DOI 10.1111/ene.12882; Annweiler C, 2013, J NEURAL TRANSM, V120, P1083, DOI 10.1007/s00702-012-0926-4; [Anonymous], 2008, THORAX S4, V63, piv1; [Anonymous], 2005, ADNI PROCEDURES MANU; Bean J., 2011, ENCY CLIN NEUROPSYCH; Beaton DE, 2001, J CLIN EPIDEMIOL, V54, P1204, DOI 10.1016/S0895-4356(01)00407-3; Beauchet O, 2016, J AM MED DIR ASS; Beauchet O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099318; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Buchman AS, 2011, EXPERT REV NEUROTHER, V11, P665, DOI [10.1586/ern.11.57, 10.1586/ERN.11.57]; Buracchio T, 2010, ARCH NEUROL-CHICAGO, V67, P980, DOI 10.1001/archneurol.2010.159; BURKE WJ, 1989, J AM GERIATR SOC, V37, P856, DOI 10.1111/j.1532-5415.1989.tb02266.x; Camicioli R, 1998, NEUROLOGY, V50, P1496, DOI 10.1212/WNL.50.5.1496; deBruin AF, 1997, J CLIN EPIDEMIOL, V50, P529, DOI 10.1016/S0895-4356(97)00047-4; Deshpande N, 2009, AGE AGEING, V38, P509, DOI 10.1093/ageing/afp093; Duff K, 2010, AM J GERIAT PSYCHIAT, V18, P91, DOI 10.1097/JGP.0b013e3181b7ef58; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; GAITRite, WORLD LEAD TEMP GAIT; GOLDSMITH CH, 1993, J RHEUMATOL, V20, P575; Hausdorff JM, 2005, EXP BRAIN RES, V164, P541, DOI 10.1007/s00221-005-2280-3; Huang YF, 2015, ALZHEIMERS DEMENT, V11, P404, DOI 10.1016/j.jalz.2014.03.008; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Husted JA, 2000, J CLIN EPIDEMIOL, V53, P459, DOI 10.1016/S0895-4356(99)00206-1; KIRSHNER B, 1985, J CHRON DIS, V38, P27, DOI 10.1016/0021-9681(85)90005-0; Kueper JK, 2018, J ALZHEIMERS DIS, V63, P423, DOI 10.3233/JAD-170991; Kueper JK, 2017, AGE AGEING, V46, P729, DOI 10.1093/ageing/afx084; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Liu-Ambrose TY, 2008, PHYS THER, V88, P1482, DOI 10.2522/ptj.20080117; Llano DA, 2011, ALZ DIS ASSOC DIS, V25, P73, DOI 10.1097/WAD.0b013e3181f5b8d8; Lowe DA, 2015, PSYCHOL ASSESSMENT, V27, P1234, DOI 10.1037/pas0000133; Mielke MM, 2013, J GERONTOL A-BIOL, V68, P929, DOI 10.1093/gerona/gls256; Montero-Odasso M, 2016, EUR J NEUROL, V23, P437, DOI 10.1111/ene.12908; Montero-Odasso M, 2014, J GERONTOL A-BIOL, V69, P1415, DOI 10.1093/gerona/glu155; Montero-Odasso M, 2014, NEUROL SCI, V35, P601, DOI 10.1007/s10072-013-1613-4; Montero-Odasso M, 2012, J AM GERIATR SOC, V60, P2127, DOI 10.1111/j.1532-5415.2012.04209.x; Montero-Odasso M, 2012, ARCH PHYS MED REHAB, V93, P293, DOI 10.1016/j.apmr.2011.08.026; Montero-Odasso Manuel, 2009, BMC Geriatr, V9, P41, DOI 10.1186/1471-2318-9-41; Montero-Odasso M, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-35; Montero-Odasso MM, 2016, J GERONTOL A-BIOL, V71, P1476, DOI 10.1093/gerona/glw044; Montero-Odasso MM, 2017, JAMA NEUROL, V54, pS154; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Petersen RC, 2014, J INTERN MED, V275, P214, DOI 10.1111/joim.12190; Raghavan N, 2013, ALZHEIMERS DEMENT, V9, pS21, DOI 10.1016/j.jalz.2012.05.2187; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Sano M, 2011, ALZ DIS ASSOC DIS, V25, P122, DOI 10.1097/WAD.0b013e3181f883b7; Schrag A, 2012, J NEUROL NEUROSUR PS, V83, P171, DOI 10.1136/jnnp-2011-300881; Skinner J, 2012, BRAIN IMAGING BEHAV, V6, P489, DOI 10.1007/s11682-012-9166-3; SMYTHE HA, 1977, J RHEUMATOL, V4, P144; Speechley M, 2009, HEALTH SERV OUTCOME, V9, P133, DOI 10.1007/s10742-009-0044-4; Strauss E, 2006, COMPENDIUM NEUROPSYC; Stuart S Clark, 2004, ILJ, V15, P99; Team RS, 2016, R STUD; van Buuren S, 2011, J STAT SOFTW, V45, P1; Verghese J, 2008, J AM GERIATR SOC, V56, P1244, DOI 10.1111/j.1532-5415.2008.01758.x; Verghese J, 2014, NEUROLOGY, V83, P718, DOI 10.1212/WNL.0000000000000717; Verghese J, 2013, J GERONTOL A-BIOL, V68, P412, DOI 10.1093/gerona/gls191; Waite LM, 2005, J NEUROL SCI, V229, P89, DOI 10.1016/j.jns.2004.11.009; Wang J, 2016, J NEUROL NEUROSUR PS; Wessels AM, 2015, J PREZ ALZ DIS, V2, P227; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wood S. N., 2006, GEN ADDITIVE MODELS, DOI [10.1111/j.1541-0420.2007.00905_3.x, DOI 10.1111/J.1541-0420.2007.00905_3.X]; Wouters H, 2008, ALZ DIS ASSOC DIS, V22, P236, DOI 10.1097/WAD.0b013e318174f8b9	66	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238690	10.1371/journal.pone.0238690	http://dx.doi.org/10.1371/journal.pone.0238690			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9MU	32915845	Green Published, gold			2022-12-26	WOS:000571887500035
J	Pan, CY; Lin, FY; Kao, LS; Huang, CC; Liu, PS				Pan, Chien-Yuan; Lin, Fang-Yu; Kao, Lung-Sen; Huang, Chien-Chang; Liu, Pei-Shan			Zinc oxide nanoparticles modulate the gene expression of ZnT1 and ZIP(8) to manipulate zinc homeostasis and stress-induced cytotoxicity in human neuroblastoma SH-SY5Y cells	PLOS ONE			English	Article							APOPTOSIS; METALLOTHIONEIN; ACTIVATION; TOXICITY; PROTECTS; INJURY; P53	Zinc ions (Zn2+) are important messenger molecules involved in various physiological functions. To maintain the homeostasis of cytosolic Zn(2+)concentration ([Zn2+](c)), Zrt/Irt-related proteins (ZIPs) and Zn(2+)transporters (ZnTs) are the two families of proteins responsible for decreasing and increasing the [Zn2+](c), respectively, by fluxing Zn(2+)across the membranes of the cell and intracellular compartments in opposite directions. Most studies focus on the cytotoxicity incurred by a high concentration of [Zn2+](c)and less investigate the [Zn2+](c)at physiological levels. Zinc oxide-nanoparticle (ZnO-NP) is blood brain barrier-permeable and elevates the [Zn2+](c)to different levels according to the concentrations of ZnO-NP applied. In this study, we mildly elevated the [Zn2+](c)by ZnO-NP at concentrations below 1 mu g/ml, which had little cytotoxicity, in cultured human neuroblastoma SH-SY5Y cells and characterized the importance of Zn(2+)transporters in 6-hydroxy dopamine (6-OHDA)-induced cell death. The results show that ZnO-NP at low concentrations elevated the [Zn2+](c)transiently in 6 hr, then declined gradually to a basal level in 24 hr. Knocking down the expression levels ofZnT(1)(located mostly at the plasma membrane) andZIP(8)(present in endosomes and lysosomes) increased and decreased the ZnO-NP-induced elevation of [Zn2+](c), respectively. ZnO-NP treatment reduced the basal levels of reactive oxygen species andBax/Bcl-2mRNA ratios; in addition, ZnO-NP decreased the 6-OHDA-induced ROS production,p53expression, and cell death. These results show that ZnO-NP-induced mild elevation in [Zn2+](c)activates beneficial effects in reducing the 6-OHDA-induced cytotoxic effects. Therefore, brain-delivery of ZnO-NP can be regarded as a potential therapy for neurodegenerative diseases.	[Pan, Chien-Yuan] Natl Taiwan Univ, Dept Life Sci, Taipei, Taiwan; [Pan, Chien-Yuan] Natl Taiwan Univ, Inst Zool, Taipei, Taiwan; [Lin, Fang-Yu; Liu, Pei-Shan] Soochow Univ, Dept Microbiol, Taipei, Taiwan; [Kao, Lung-Sen] Natl Yang Ming Univ, Brain Res Ctr, Taipei, Taiwan; [Kao, Lung-Sen; Huang, Chien-Chang] Natl Yang Ming Univ, Dept Life Sci, Taipei, Taiwan; [Kao, Lung-Sen; Huang, Chien-Chang] Natl Yang Ming Univ, Inst Genome Sci, Taipei, Taiwan	National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; Soochow University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Liu, PS (corresponding author), Soochow Univ, Dept Microbiol, Taipei, Taiwan.	psliu@scu.edu.tw		PAN, CHIEN-YUAN/0000-0002-6654-9309	Ministry of Science and Technology, Taiwan, R. O. C. [NSC 1022320-B-031-001, MOST 104-2622-B-031-001CC2, MOST 104-2632-B-031-001, MOST 107-2320-B-002-052]	Ministry of Science and Technology, Taiwan, R. O. C.(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Ministry of Science and Technology, Taiwan, R. O. C. (https://www.most.gov.tw/?l=en) NSC 1022320-B-031-001, MOST 104-2622-B-031-001CC2, & MOST 104-2632-B-031-001 to PSL and MOST 107-2320-B-002-052 to CYP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WL, 2005, MOL BRAIN RES, V135, P40, DOI 10.1016/j.molbrainres.2004.11.010; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; Aydemir TB, 2009, J LEUKOCYTE BIOL, V86, P337, DOI 10.1189/jlb.1208759; Beyer N, 2012, J ALZHEIMERS DIS, V29, P863, DOI 10.3233/JAD-2012-112105; Bosco Mariea D, 2010, Rev Diabet Stud, V7, P263, DOI 10.1900/RDS.2010.7.263; Bosomworth HJ, 2012, METALLOMICS, V4, P771, DOI 10.1039/c2mt20088k; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Deng XY, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/11/115101; Fujishiro H, 2014, METALLOMICS, V6, P944, DOI 10.1039/c3mt00362k; GERLIER D, 1986, J IMMUNOL METHODS, V94, P57, DOI 10.1016/0022-1759(86)90215-2; Gower-Winter SD, 2013, NUTR NEUROSCI, V16, P174, DOI 10.1179/1476830512Y.0000000043; Grabrucker Andreas M, 2011, Drug Deliv Lett, V1, P13; Grabrucker AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017851; Guo L, 2014, CURR PHARM BIOTECHNO, V15, P577, DOI 10.2174/1389201015666140827110120; Han Y, 2020, METALLOMICS, V12, P346, DOI 10.1039/c9mt00301k; Huang YZ, 2012, J NEUROSCI, V32, P15521, DOI 10.1523/JNEUROSCI.0755-12.2012; Kao YY, 2012, J MOL NEUROSCI, V48, P464, DOI 10.1007/s12031-012-9756-y; Kao YY, 2012, TOXICOL SCI, V125, P462, DOI 10.1093/toxsci/kfr319; Kawada H, 2015, J ALZHEIMERS DIS, V44, P297, DOI 10.3233/JAD-132471; Kim JH, 2015, NEUROCHEM INT, V90, P204, DOI 10.1016/j.neuint.2015.09.002; Krezel A, 2006, J BIOL INORG CHEM, V11, P1049, DOI 10.1007/s00775-006-0150-5; Kumar SD, 2012, FREE RADICAL BIO MED, V53, P1595, DOI 10.1016/j.freeradbiomed.2012.07.008; Lepping P, 2010, CNS DRUGS, V24, P721, DOI 10.2165/11537610-000000000-00000; Levenson CW, 2011, ADV NUTR, V2, P96, DOI 10.3945/an.110.000174; Li B, 2013, TOXICOL MECH METHOD, V23, P27, DOI 10.3109/15376516.2012.735277; Li Y, 2009, EXP CELL RES, V315, P2463, DOI 10.1016/j.yexcr.2009.05.016; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Maret W, 2013, ADV NUTR, V4, P82, DOI 10.3945/an.112.003038; Maret W, 2012, J INORG BIOCHEM, V111, P110, DOI 10.1016/j.jinorgbio.2011.11.018; Marger L, 2014, BIOCHEM PHARMACOL, V91, P426, DOI 10.1016/j.bcp.2014.08.002; Muller KH, 2010, ACS NANO, V4, P6767, DOI 10.1021/nn101192z; Ohly P, 2000, DIABETOLOGIA, V43, P1020, DOI 10.1007/s001250050009; Ruttkay-Nedecky B, 2013, INT J MOL SCI, V14, P6044, DOI 10.3390/ijms14036044; Sindreu C, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-16; Sindreu C, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00068; Singla N, 2015, BIOMETALS, V28, P61, DOI 10.1007/s10534-014-9803-y; Su RB, 2012, BIOL TRACE ELEM RES, V149, P219, DOI 10.1007/s12011-012-9414-9; Szewczyk B, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00033; Takeda A, 2015, BIOMETALS; Wang DB, 2014, BBA-MOL BASIS DIS, V1842, P1186, DOI 10.1016/j.bbadis.2013.12.015; Wang YS, 2014, BRAIN RES, V1545, P45, DOI 10.1016/j.brainres.2013.12.015; Wang YS, 2011, MED HYPOTHESES, V77, P589, DOI 10.1016/j.mehy.2011.06.037; Xia T, 2008, ACS NANO, V2, P2121, DOI 10.1021/nn800511k; Yuan SSF, 2012, JNCI-J NATL CANCER I, V104, P1485, DOI 10.1093/jnci/djs355; Zhao JX, 2009, NEUROTOXICOLOGY, V30, P220, DOI 10.1016/j.neuro.2008.12.005; Zheng JJ, 2013, TOXICOL APPL PHARM, V268, P123, DOI 10.1016/j.taap.2013.01.021; Zhong ML, 2012, HISTOCHEM CELL BIOL, V138, P605, DOI 10.1007/s00418-012-0979-3	48	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0232729	10.1371/journal.pone.0232729	http://dx.doi.org/10.1371/journal.pone.0232729			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915786	gold, Green Submitted, Green Published			2022-12-26	WOS:000571887500083
J	Taguchi, YH; Turki, T				Taguchi, Y-H; Turki, Turki			A new advancedin silicodrug discovery method for novel coronavirus (SARS-CoV-2) with tensor decomposition-based unsupervised feature extraction	PLOS ONE			English	Article							VIRUS; REPLICATION; INHIBITION; APOPTOSIS; AGENTS	Background: COVID-19 is a critical pandemic that has affected human communities worldwide, and there is an urgent need to develop effective drugs. Although there are a large number of candidate drug compounds that may be useful for treating COVID-19, the evaluation of these drugs is time-consuming and costly. Thus, screening to identify potentially effective drugs prior to experimental validation is necessary. Method: In this study, we applied the recently proposed method tensor decomposition (TD)-based unsupervised feature extraction (FE) to gene expression profiles of multiple lung cancer cell lines infected with severe acute respiratory syndrome coronavirus 2. We identified drug candidate compounds that significantly altered the expression of the 163 genes selected by TD-based unsupervised FE. Results: Numerous drugs were successfully screened, including many known antiviral drug compounds such as C646, chelerythrine chloride, canertinib, BX-795, sorafenib, sorafenib, QL-X-138, radicicol, A-443654, CGP-60474, alvocidib, mitoxantrone, QL-XII-47, geldanamycin, fluticasone, atorvastatin, quercetin, motexafin gadolinium, trovafloxacin, doxycycline, meloxicam, gentamicin, and dibromochloromethane. The screen also identified ivermectin, which was first identified as an anti-parasite drug and recently the drug was included in clinical trials for SARS-CoV-2. Conclusions: The drugs screened using our strategy may be effective candidates for treating patients with COVID-19.	[Taguchi, Y-H] Chuo Univ, Dept Phys, Tokyo, Japan; [Turki, Turki] King Abdulaziz Univ, Dept Comp Sci, Jeddah, Saudi Arabia	Chuo University; King Abdulaziz University	Taguchi, YH (corresponding author), Chuo Univ, Dept Phys, Tokyo, Japan.	tag@granular.com	Taguchi, Y-h./E-1474-2011	Taguchi, Y-h./0000-0003-0867-8986; Turki, Turki/0000-0002-9491-2435	KAKENHI [19H05270, 20H04848, 20K12067]; Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah [KEP-8-611-38]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah	This work was supported by KAKENHI [grant numbers 19H05270, 20H04848, and 20K12067] to YT and Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah [grant number KEP-8-611-38] to TT.	Aguiyi JC, 2020, MOL DOCKING ANAL SOM, DOI [10.1101/2020.03.31.017657, DOI 10.1101/2020.03.31.017657]; [Anonymous], 2007, NUTR BUSINESS J, V12, P1; Blanco-Melo D., 2020, SARS COV 2 LAUNCHES, V181, P1036, DOI [DOI 10.1128/JVI.00527-07, 10.1016/j.cell.2020.04.026, DOI 10.1101/2020.03.24.004655]; Brahms A, 2017, J VIROLOGY, V91; Caly Leon, 2020, Antiviral Res, V178, P104787, DOI 10.1016/j.antiviral.2020.104787; Chan CM, 2007, ARCH BIOCHEM BIOPHYS, V459, P197, DOI 10.1016/j.abb.2007.01.012; Connor JH, 2007, VIROLOGY, V362, P109, DOI 10.1016/j.virol.2006.12.026; Culita DC, 2012, REV CHIM-BUCHAREST, V63, P384; de Wispelaere M, 2017, ANTIVIR RES, V139, P171, DOI 10.1016/j.antiviral.2016.12.017; Deng L, 2007, J VIROL, V81, P13392, DOI 10.1128/JVI.00770-07; Episcopio D, 2019, FASEB J, V33, P9516, DOI 10.1096/fj.201900428RR; FISCHER AB, 1975, MED MICROBIOL IMMUN, V161, P23, DOI 10.1007/BF02120767; Gordon David E, 2020, bioRxiv, DOI 10.1101/2020.03.22.002386; He B, 2020, REPURPOSED DRUGS TRE; Huang CT, 2019, ISCIENCE, V15, P291, DOI 10.1016/j.isci.2019.04.039; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Jeong GU, 2019, ANTIVIR RES, V170, DOI 10.1016/j.antiviral.2019.104572; Kidney Dis Improving Global, 2017, KIDNEY INT SUPPL, V7, P1, DOI 10.1016/j.kisu.2017.04.001; Kubota N, 2016, WORLD J HEPATOL, V8, P282, DOI 10.4254/wjh.v8.i5.282; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Li YH, 2004, ANTIMICROB AGENTS CH, V48, P867, DOI 10.1128/AAC.48.3.867-872.2004; Perez OD, 2002, P NATL ACAD SCI USA, V99, P2270, DOI 10.1073/pnas.261711499; Perwitasari O, 2015, ASSAY DRUG DEV TECHN, V13, P638, DOI 10.1089/adt.2015.0003.drrr; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Singanayagam Aran, 2015, Lancet, V385 Suppl 1, pS88, DOI 10.1016/S0140-6736(15)60403-2; Sirota M., 2011, SCI TRANSL MED, V3; Su AR, 2017, ACTA PHARMACOL SIN, V38, P402, DOI 10.1038/aps.2016.160; Taguchi, 2020, UNSUPERVISED FEATURE; Taguchi YH, 2019, CURR PHARM DESIGN, V25, P4589, DOI 10.2174/1381612825666191210160906; Taguchi Y, 2019, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2395-8; Taguchi YH, 2020, NOVEL METHOD DETECTI; Tbakhi A., 2020, DRUG REPOSITIONING S; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wu C., 2020, ACTA PHARM SINICA B, DOI 10.1016/j.apsb.2020.02.008; Wu ZC, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv195; Yang HL, 2005, J CLIN INVEST, V115, P379, DOI 10.1172/jc1200523200; Yi L, 2004, J VIROL, V78, P11334, DOI 10.1128/JVI.78.20.11334-11339.2004; Zhao DM, 2016, ANTIMICROB AGENTS CH, V60, P1902, DOI 10.1128/AAC.02055-15; Zhou YD, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0153-3; 2018, CURR OPIN TOXICOL, V10	42	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238907	10.1371/journal.pone.0238907	http://dx.doi.org/10.1371/journal.pone.0238907			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915876	Green Submitted, Green Published, gold			2022-12-26	WOS:000571887500065
J	Yang, B; Feng, XD; Liu, H; Tong, RL; Wu, JB; Li, CB; Yu, HX; Chen, YH; Cheng, QY; Chen, JR; Cai, XL; Wu, WX; Lu, YJ; Hu, JT; Liang, KJ; Lv, Z; Wu, J; Zheng, SS				Yang, Beng; Feng, Xiaode; Liu, Hua; Tong, Rongliang; Wu, Jingbang; Li, Changbiao; Yu, Hanxi; Chen, Yunhao; Cheng, Qiyang; Chen, Junru; Cai, Xianlei; Wu, Wenxuan; Lu, Yuejie; Hu, Jiating; Liang, Kejiong; Lv, Zhen; Wu, Jian; Zheng, Shusen			High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma	ONCOGENE			English	Article							CIRCULATING TUMOR-CELLS; EXTRACELLULAR VESICLES; EVOLUTIONARY; GENETICS; ROLES; EXPRESSION; BIOLOGY	Exosomes play an important role in intercellular communication and metastatic progression of hepatocellular carcinoma (HCC). However, cellular communication between heterogeneous HCC cells with different metastatic potentials and the resultant cancer progression are not fully understood in HCC. Here, HCC cells with high-metastatic capacity (97hm and Huhm) were constructed by continually exerting selective pressure on primary HCC cells (MHCC-97H and Huh7). Through performing exosomal miRNA sequencing in HCC cells with different metastatic potentials (MHCC-97H and 97hm), many significantly different miRNA candidates were found. Among these miRNAs, miR-92a-3p was the most abundant miRNA in the exosomes of highly metastatic HCC cells. Exosomal miR92a-3p was also found enriched in the plasma of HCC patient-derived xenograft mice (PDX) model with high-metastatic potential. Exosomal miR-92a-3p promotes epithelial-mesenchymal transition (EMT) in recipient cancer cells via targeting PTEN and regulating its downstream Akt/Snail signaling. Furthermore, through mRNA sequencing in HCC cells with different metastatic potentials and predicting potential transcription factors of miR92a-3p, upregulated transcript factors E2F1 and c-Myc were found in high-metastatic HCC cells promote the expression of cellular and exosomal miR-92a-3p in HCC by directly binding the promoter of its host gene,miR17HG. Clinical data showed that a high plasma exosomal miR92a-3p level was correlated with shortened overall survival and disease-free survival, indicating poor prognosis in HCC patients. In conclusion, hepatoma-derived exosomal miR92a-3p plays a critical role in the EMT progression and promoting metastasis by inhibiting PTEN and activating Akt/Snail signaling. Exosomal miR92a-3p is a potential predictive biomarker for HCC metastasis, and this may provoke the development of novel therapeutic and preventing strategies against metastasis of HCC.	[Yang, Beng; Feng, Xiaode; Liu, Hua; Tong, Rongliang; Wu, Jingbang; Li, Changbiao; Chen, Yunhao; Cheng, Qiyang; Chen, Junru; Cai, Xianlei; Wu, Wenxuan; Lu, Yuejie; Hu, Jiating; Lv, Zhen; Wu, Jian; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg,Dept Surg, Hangzhou, Zhejiang, Peoples R China; [Yang, Beng; Liu, Hua; Cheng, Qiyang; Wu, Jian; Zheng, Shusen] NHC Key Lab Combined Multiorgan Transplantat, Hangzhou, Zhejiang, Peoples R China; [Yang, Beng; Chen, Junru; Wu, Jian; Zheng, Shusen] CAMS, Key Lab Diag & Treatment Organ Transplantat, Hangzhou, Zhejiang, Peoples R China; [Yang, Beng; Chen, Yunhao; Wu, Jian; Zheng, Shusen] Key Lab Organ Transplantat, Hangzhou, Zhejiang, Peoples R China; [Yu, Hanxi] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Gynecol & Obstet, Hangzhou, Zhejiang, Peoples R China; [Liang, Kejiong] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Orthoped, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Chinese Academy of Medical Sciences - Peking Union Medical College; Zhejiang University; Zhejiang University	Wu, J; Zheng, SS (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg,Dept Surg, Hangzhou, Zhejiang, Peoples R China.; Wu, J; Zheng, SS (corresponding author), NHC Key Lab Combined Multiorgan Transplantat, Hangzhou, Zhejiang, Peoples R China.; Wu, J; Zheng, SS (corresponding author), CAMS, Key Lab Diag & Treatment Organ Transplantat, Hangzhou, Zhejiang, Peoples R China.; Wu, J; Zheng, SS (corresponding author), Key Lab Organ Transplantat, Hangzhou, Zhejiang, Peoples R China.	drwujian@zju.edu.cn; shusenzheng@zju.edu.cn	Yang, Beng/GRX-9557-2022; Yang, Beng/HIR-3204-2022		Innovative Research Groups of National Natural Science Foundation of China [81721091]; Major program of National Natural Science Foundation of China [91542205]; National Natural Science Foundation of China [81874228]; National ST Major Project [2017ZX10203205]; Zhejiang International Science and Technology Cooperation Project [2016C04003]; Natural Science Foundation of Zhejiang Province [LQ20H160037, LQ18H160011]	Innovative Research Groups of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National ST Major Project; Zhejiang International Science and Technology Cooperation Project; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by Innovative Research Groups of National Natural Science Foundation of China (No. 81721091), Major program of National Natural Science Foundation of China (No. 91542205), the National Natural Science Foundation of China (No. 81874228), National S&T Major Project (No. 2017ZX10203205) and Zhejiang International Science and Technology Cooperation Project (No. 2016C04003), Natural Science Foundation of Zhejiang Province (LQ20H160037, LQ18H160011).	Alix-Panabieres C, 2016, CANCER DISCOV, V6, P479, DOI 10.1158/2159-8290.CD-15-1483; Andela VB, 2003, CLIN ORTHOP RELAT R, pS75, DOI 10.1097/01.blo.0000093048.96273.aa; [Anonymous], 2019, J ASIAN NAT PROD RES; Augsten M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00062; Becker A, 2016, CANCER CELL, V30, P836, DOI 10.1016/j.ccell.2016.10.009; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Casadei L, 2017, CANCER RES, V77, P3846, DOI 10.1158/0008-5472.CAN-16-2984; Chen JA, 2019, HEPATOB PANCREAT DIS, V18, P321, DOI 10.1016/j.hbpd.2018.09.016; Crespi B, 2005, TRENDS ECOL EVOL, V20, P545, DOI 10.1016/j.tree.2005.07.007; Crichton MB, 1996, MOL CELL ENDOCRINOL, V118, P215, DOI 10.1016/0303-7207(96)03761-6; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; Dudas J, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00044; Fang JH, 2018, HEPATOLOGY, V68, P1459, DOI 10.1002/hep.29920; Fang T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02583-0; Finn RS, 2018, HEPATOLOGY, V67, P422, DOI 10.1002/hep.29486; Hu JL, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1019-x; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; JOHANSEN JS, 1992, J BONE MINER RES, V7, P501; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; Lehmann BD, 2008, CANCER RES, V68, P7864, DOI 10.1158/0008-5472.CAN-07-6538; Lynch M, 2016, NAT REV GENET, V17, P704, DOI 10.1038/nrg.2016.104; Makohon-Moore A, 2016, NAT REV CANCER, V16, P553, DOI 10.1038/nrc.2016.66; Martincorena I, 2018, CELL, V173, P1823, DOI 10.1016/j.cell.2018.06.001; Mathieu M, 2019, NAT CELL BIOL, V21, P9, DOI 10.1038/s41556-018-0250-9; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Moi L, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-2086-x; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Reiter JG, 2019, NAT REV CANCER, V19, P639, DOI 10.1038/s41568-019-0185-x; Singal AG, 2015, CLIN GASTROENTEROL H, V13, P2140, DOI 10.1016/j.cgh.2015.08.014; Song H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111799; Strilic B, 2017, CANCER CELL, V32, P282, DOI 10.1016/j.ccell.2017.07.001; Tang J, 2018, MINERVA MED, V109, P15, DOI 10.23736/S0026-4806.17.05167-9; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Turajlic S, 2019, NAT REV GENET, V20, P404, DOI 10.1038/s41576-019-0114-6; Uchino K, 2011, CANCER-AM CANCER SOC, V117, P4475, DOI 10.1002/cncr.25960; Wan ZH, 2019, HEPATOB PANCREAT DIS, V18, P525, DOI 10.1016/j.hbpd.2019.09.005; Wang HW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/864894; Wang XF, 2018, CANCER RES, V78, P4586, DOI 10.1158/0008-5472.CAN-17-3841; Weng XY, 2019, EBIOMEDICINE, V44, P225, DOI 10.1016/j.ebiom.2019.05.029; Xue XF, 2018, BIOCHEM BIOPH RES CO, V502, P515, DOI 10.1016/j.bbrc.2018.05.208; Yan W, 2018, NAT CELL BIOL, V20, P597, DOI 10.1038/s41556-018-0083-6; Yang B, 2019, J MATER CHEM B, V7, P6476, DOI 10.1039/c9tb01299k; Yang B, 2018, INT J ONCOL, V52, P1235, DOI 10.3892/ijo.2018.4292; Yin ZY, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0782-x; Yuan L, 2015, NAT CELL BIOL, V17, P1169, DOI 10.1038/ncb3218; Zhang G, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0829-6; Zhang HJ, 2011, CANCER RES, V71, P1292, DOI 10.1158/0008-5472.CAN-10-2825; Zhang L, 2015, NATURE, V527, P100, DOI 10.1038/nature15376	50	76	77	2	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 15	2020	39	42					6529	6543		10.1038/s41388-020-01450-5	http://dx.doi.org/10.1038/s41388-020-01450-5		SEP 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	OA9HI	32917956	Green Published, hybrid			2022-12-26	WOS:000568475200001
J	Zhou, JY; Passero, K; Palmiero, NE; Muller-Myhsok, B; Kleber, ME; Maerz, W; Hall, MA				Zhou, Jiayan; Passero, Kristin; Palmiero, Nicole E.; Mueller-Myhsok, Bertram; Kleber, Marcus E.; Maerz, Winfried; Hall, Molly A.			Investigation of gene-gene interactions in cardiac traits and serum fatty acid levels in the LURIC Health Study	PLOS ONE			English	Article							VENOUS THROMBOTIC EVENTS; BETA-SUBUNITS; RISK; POLYMORPHISMS; EXPRESSION; OMEGA-3-FATTY-ACIDS; ASSOCIATION; DISORDERS; VARIANTS; OMEGA-6	Epistasis analysis elucidates the effects of gene-gene interactions (GxG) between multiple loci for complex traits. However, the large computational demands and the high multiple testing burden impede their discoveries. Here, we illustrate the utilization of two methods, main effect filtering based on individual GWAS results and biological knowledge-based modeling through Biofilter software, to reduce the number of interactions tested among single nucleotide polymorphisms (SNPs) for 15 cardiac-related traits and 14 fatty acids. We performed interaction analyses using the two filtering methods, adjusting for age, sex, body mass index (BMI), waist-hip ratio, and the first three principal components from genetic data, among 2,824 samples from the Ludwigshafen Risk and Cardiovascular (LURIC) Health Study. Using Biofilter, one interaction nearly met Bonferroni significance: an interaction between rs7735781 inXRCC4and rs10804247 inXRCC5was identified for venous thrombosis with a Bonferroni-adjusted likelihood ratio test (LRT) p: 0.0627. A total of 57 interactions were identified from main effect filtering for the cardiac traits GxG (10) and fatty acids GxG (47) at Bonferroni-adjusted LRT p < 0.05. For cardiac traits, the top interaction involved SNPs rs1383819 inSNTG1and rs1493939 (138kb from 5' ofSAMD12) with Bonferroni-adjusted LRT p: 0.0228 which was significantly associated with history of arterial hypertension. For fatty acids, the top interaction between rs4839193 inKCND3and rs10829717 inLOC107984002with Bonferroni-adjusted LRT p: 2.28x10(-5)was associated with 9-trans 12-trans octadecanoic acid, an omega-6 trans fatty acid. The model inflation factor for the interactions under different filtering methods was evaluated from the standard median and the linear regression approach. Here, we applied filtering approaches to identify numerous genetic interactions related to cardiac-related outcomes as potential targets for therapy. The approaches described offer ways to detect epistasis in the complex traits and to improve precision medicine capability.	[Zhou, Jiayan; Passero, Kristin; Palmiero, Nicole E.; Hall, Molly A.] Penn State Univ, Coll Agr Sci, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Zhou, Jiayan] Penn State Univ, Dept Stat, Eberly Coll Sci, University Pk, PA 16802 USA; [Passero, Kristin; Hall, Molly A.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, Stat Genet, Munich, Germany; [Mueller-Myhsok, Bertram] SyNergy, Munich Cluster Syst Biol, Munich, Germany; [Mueller-Myhsok, Bertram] Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England; [Kleber, Marcus E.; Maerz, Winfried] Heidelberg Univ, Med Fac Mannheim, Dept Med 5, Mannheim, Germany; [Maerz, Winfried] SYNLAB Acad, Synlab Holding Deutschland GmbH, Mannheim, Germany; [Maerz, Winfried] SYNLAB Acad, Synlab Holding Deutschland GmbH, Augsburg, Germany; [Maerz, Winfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Max Planck Society; University of Liverpool; Ruprecht Karls University Heidelberg; SYNLAB Group; SYNLAB Group; Medical University of Graz	Hall, MA (corresponding author), Penn State Univ, Coll Agr Sci, Dept Vet & Biomed Sci, University Pk, PA 16802 USA.; Hall, MA (corresponding author), Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA.	mah546@psu.edu	Zhou, Jiayan/ABC-4378-2020	Zhou, Jiayan/0000-0001-5974-087X; Hall, Molly/0000-0001-7740-401X	USDA National Institute of Food and Agriculture; European Union [201668];  [PEN04275];  [1018544]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); European Union(European Commission); ; 	This work is supported by the USDA National Institute of Food and Agriculture and Hatch Appropriations under Project #PEN04275 and Accession #1018544. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Genotyping of the LURIC study participants was supported by the 7th Framework Program AtheroRemo (grant agreement #201668) of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Synlab Holding Deutschland GmbH provided support in the form of the salaries for author W.Z. and M.E.K. but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], 2004, GENE; [Anonymous], 2016, UKRAINSKA ENTOMOFAUN; Apte SA, 2013, NUTR CANCER, V65, P556, DOI 10.1080/01635581.2013.775316; Bashiardes S, 2004, HUM GENET, V115, P81, DOI 10.1007/s00439-004-1121-y; Berquin IM, 2007, J CLIN INVEST, V117, P1866, DOI 10.1172/JCI31494; Brackenbury WJ, 2008, EXPERT OPIN THER TAR, V12, P1191, DOI 10.1517/14728222.12.9.1191 ; Bush WS, 2011, GENES IMMUN, V12, P335, DOI 10.1038/gene.2011.3; Bush WS, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P368; CDC, 2020, HEART DIS FACTS; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen ZX, 2014, PROSTATE, V74, P1059, DOI 10.1002/pros.22826; Cole BS, 2017, ANAL GENE GENE INTER, DOI [10.1002/cphg.45, DOI 10.1002/CPHG.45]; De R, 2017, HUM GENET, V136, P165, DOI 10.1007/s00439-016-1738-7; Dorani F, 2018, PEERJ, V6, DOI 10.7717/peerj.5854; Drouet J, 2005, J BIOL CHEM, V280, P7060, DOI 10.1074/jbc.M410746200; Freitag CM, 2016, J NEURAL TRANSM, V123, P849, DOI 10.1007/s00702-016-1553-2; Giri A, 2019, NAT GENET, V51, P51, DOI 10.1038/s41588-018-0303-9; Grady BJ, 2011, BIOCOMPUT-PAC SYM, P253; Grammer TB, 2019, CLIN CHEM, V65, P849, DOI 10.1373/clinchem.2018.297242; Greenwood TA, 2019, JAMA PSYCHIAT, V76, P1274, DOI 10.1001/jamapsychiatry.2019.2850; Hagisawa S, 2005, GLYCOBIOLOGY, V15, P1016, DOI 10.1093/glycob/cwi086; Hall MA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00802-2; Hall MA, 2015, GENET EPIDEMIOL, V39, P376, DOI 10.1002/gepi.21902; Hanson S, 2020, BRIT J CANCER, V122, P1260, DOI 10.1038/s41416-020-0761-6; Holzinger ER, 2017, BIODATA MIN, V10, DOI 10.1186/s13040-017-0145-5; Huang YF, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005393; Huo R, 2014, CHANNELS, V8, DOI 10.4161/chan.28972; Johnson DC, 2008, BLOOD, V112, P4924, DOI 10.1182/blood-2008-02-140434; Kichaev G, 2019, AM J HUM GENET, V104, P65, DOI 10.1016/j.ajhg.2018.11.008; Kim D, 2016, BIOCOMPUT-PAC SYM, P357; Kleber ME, 2016, ATHEROSCLEROSIS, V252, P175, DOI 10.1016/j.atherosclerosis.2016.06.049; Kleber ME, 2013, CIRC-CARDIOVASC GENE, V6, P505, DOI 10.1161/CIRCGENETICS.113.000108; Kohler A, 2010, BRIT J NUTR, V104, P729, DOI 10.1017/S0007114510001054; Kojima Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138520; Kruger LC, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a029264; Kwon M, 2018, BMC SYST BIOL, V12, DOI 10.1186/s12918-018-0543-4; Lionel AC, 2014, HUM MOL GENET, V23, P2752, DOI 10.1093/hmg/ddt669; Long XD, 2013, EPIDEMIOLOGY, V24, P671, DOI 10.1097/EDE.0b013e31829d2744; Lucas AM, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.01240; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; Miao L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24432-w; Mundfrom DJ, 2005, INT J TEST, V5, P159, DOI 10.1207/s15327574ijt0502_4; Ni T, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160053; Nielsen JB, 2018, NAT GENET, V50, P1234, DOI 10.1038/s41588-018-0171-3; O'Malley HA, 2015, ANNU REV PHYSIOL, V77, P481, DOI 10.1146/annurev-physiol-021014-071846; Olesen MS, 2013, CARDIOVASC RES, V98, P488, DOI 10.1093/cvr/cvt028; Pace NR, 2009, MICROBIOL MOL BIOL R, V73, P565, DOI 10.1128/MMBR.00033-09; Pendergrass Sarah A, 2015, Pac Symp Biocomput, P495; Pendergrass SA, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-25; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pu XW, 2016, ARCH GYNECOL OBSTET, V294, P1305, DOI 10.1007/s00404-016-4175-x; Roger S, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00152; Roselli C, 2018, NAT GENET, V50, P1225, DOI 10.1038/s41588-018-0133-9; Sato T, 2016, BIOCHEM BIOPH RES CO, V470, P150, DOI 10.1016/j.bbrc.2016.01.011; Sheppard KW, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0693-9; Sheppard KW, 2013, AM J CLIN NUTR, V98, P659, DOI 10.3945/ajcn.113.058719; Silbernagel G, 2013, J AM COLL CARDIOL, V62, P291, DOI 10.1016/j.jacc.2013.01.100; Tewari P, 2009, BLOOD, V113, P5691, DOI 10.1182/blood-2009-03-211177; Turner SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019586; VanVoorhis CRW, 2007, TUTOR QUANT METHODS, V3, P43, DOI 10.20982/tqmp.03.2.p043; Wang KS, 2015, J NEURAL TRANSM, V122, P701, DOI 10.1007/s00702-014-1306-z; Wang LZ, 2005, BIOCHEM BIOPH RES CO, V331, P958, DOI 10.1016/j.bbrc.2005.04.022; Winkelmann BR, 2001, PHARMACOGENOMICS, V2, pS7; Zhang Q, 2016, MOL CELL, V61, P419, DOI 10.1016/j.molcel.2015.12.010; Zhao JY, 2016, EUR J HUM GENET, V24, P421, DOI 10.1038/ejhg.2015.147; Zhao P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-234; 2012, SURG OBES RELAT DIS, V8	68	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238304	10.1371/journal.pone.0238304	http://dx.doi.org/10.1371/journal.pone.0238304			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915819	gold, Green Published			2022-12-26	WOS:000571887500145
J	Lohn, AF; Trtikova, M; Chapela, I; Van den Berg, J; du Plessis, H; Hilbeck, A				Lohn, Andre Felipe; Trtikova, Miluse; Chapela, Ignacio; Van den Berg, Johnnie; du Plessis, Hannalene; Hilbeck, Angelika			Transgene behavior inZea maysL. crosses across different genetic backgrounds: Segregation patterns,cry1Abtransgene expression, insecticidal protein concentration and bioactivity against insect pests	PLOS ONE			English	Article							FIELD-EVOLVED RESISTANCE; HELICOVERPA-ARMIGERA LEPIDOPTERA; BACILLUS-THURINGIENSIS; BT-MAIZE; SPODOPTERA-LITTORALIS; QUANTITATIVE-ANALYSIS; MESSENGER-RNA; CRY1AB TOXIN; COTTON; INHERITANCE	Brazil and South Africa, countries with economies in transition, are characterized by a dual agrarian structure co-occurring, sometimes, alongside in the same region. Large-scale commercial farming produces crops for export to global markets on the one hand, and small-scale farming, on the other hand, provides for subsistence and local markets. In both systems, maize (Zea mays) is a key crop for these two countries. For the commercial system, maize is a commodity crop while for the small-scale system it is the prime staple crop. In commercial systems, farmers predominantly grow genetically modified (GM) hybrid maize. In small-scale systems, farmers rely on open pollinated varieties (OPVs) and/or landraces and are largely dependent on seed saving systems. The aim of this study was to understand the relationship between transgene expression rates, the resulting concentrations of the transgene product (Bt protein) and its bioactivity in insect pests following transgene flow from GM hybrid maize into non-genetically modified, non-GM near-isogenic maize hybrid (ISO) and OPVs. We modeled segregation patterns and measuredcry1Abtransgene expression (mRNA quantification), Cry1Ab protein concentration and pest survival. Two groups of F1, F2 crosses and backcrosses with GM, ISO and OPV maize varieties from Brazil and South Africa were used. Bioassays with the larvae of two lepidopteran maize pest species,Helicoverpa armigeraandSpodoptera littoralis, were carried out. Overall, thecry1Abtransgene outcrossed effectively into the genetic backgrounds tested. Thecry1Abtransgene was stably expressed in both ISO and OPV genetic backgrounds. Transgene introgression led to consistent, though highly variable, concentrations of Cry1Ab toxins that were similar to those observed in GM parental maize. Most crosses, but not all, suggested the expected Mendelian segregation pattern. Transgene expression rates were significantly higher than expected from purely Mendelian segregation in the South African crosses. In South African materials, ISO and OPV crosses produced significantly lower Cry1Ab concentrations compared to the GM parental maize. The Cry1Ab toxins from crosses were bioactive and induced mortality rates of >= 92.19% inH.armigeraand >= 40.63% inS.littoralisafter a period of only 4 days. However, no correlations were observed between the quantitation of mRNA forcry1Aband the corresponding Cry1Ab protein concentrations, nor between the Cry1Ab concentrations and insect mortality rates across different genetic backgrounds. We therefore suggest that while transcription of thecry1Abtransgene reliably determines the presence of Cry1Ab protein, mRNA levels do not reflect, by themselves, the end Cry1Ab protein concentrations found in the plant. Because predictably high Cry1Ab concentrations are a key prerequisite for effective insect resistance management (IRM) programs, this observation raises questions about the effectiveness of such programs in scenarios with complex crop genetic backgrounds. On the other hand, confirmed bioactivity in all crosses should be expected to impact small farmer's selection behavior, unknowingly favoring the insecticidal trait. This may lead to a fixation of the trait in the wider population, and may influence the genetic diversity of varieties maintained by small-scale farmers.	[Lohn, Andre Felipe; Trtikova, Miluse; Hilbeck, Angelika] Swiss Fed Inst Technol, Dept Environm Syst Sci, Inst Integrat Biol, Plant Ecol Genet, Zurich, Switzerland; [Chapela, Ignacio] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Van den Berg, Johnnie; du Plessis, Hannalene] North West Univ, Unit Environm Sci & Management, Potchefstroom, South Africa	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California Berkeley; North West University - South Africa	Lohn, AF (corresponding author), Swiss Fed Inst Technol, Dept Environm Syst Sci, Inst Integrat Biol, Plant Ecol Genet, Zurich, Switzerland.	andre.lohn@env.ethz.ch	Du Plessis, Hannalene/AAS-1632-2020	Du Plessis, Hannalene/0000-0003-1163-1468; Reis, AlessanRSS/0000-0001-8486-7469; Lohn, Andre Felipe/0000-0002-4322-6822	Swiss National Science Foundation under the Swiss South African Joint Research Programme (SSJRP UID) [87403]; Federal Commission for Scholarships for Foreign Students FCS; Swiss ETH Zurich	Swiss National Science Foundation under the Swiss South African Joint Research Programme (SSJRP UID); Federal Commission for Scholarships for Foreign Students FCS; Swiss ETH Zurich	This work was supported by Swiss National Science Foundation under the Swiss South African Joint Research Programme (SSJRP UID/Project number: 87403), Angelika Hilbeck. In addition, by the Federal Commission for Scholarships for Foreign Students FCS and the Swiss ETH Zurich by the doctoral fellowship provided to AFL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk JJ, 2009, TRANSGENIC RES, V18, P143, DOI 10.1007/s11248-008-9198-z; Agapito-Tenfen SZ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0346-8; Aguilera M, 2009, FOOD ANAL METHOD, V2, P73, DOI 10.1007/s12161-008-9036-1; Aheto D. W., 2013, GM CROP CULTIVATION, V17, P93; Ahuja MR, 2014, TREE GENET GENOMES, V10, P779, DOI 10.1007/s11295-014-0724-2; Alvi AHK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047309; Arvinth S., 2009, Sugar Tech, V11, P292, DOI 10.1007/s12355-009-0050-4; Ben Ali SE, 2018, EUR FOOD RES TECHNOL, V244, P1473, DOI 10.1007/s00217-018-3062-z; Bohn T, 2016, SCI REP-UK, V6, DOI 10.1038/srep34483; Britz C, 2020, AFR ENTOMOL, V28, P182, DOI 10.4001/003.028.0182; CANCI I., 2004, ANCHIETA HIST MEMORI; CHERDSHEWASART W, 1993, TRANSGENIC RES, V2, P307, DOI 10.1007/BF01976171; CHRISTOU P, 1989, P NATL ACAD SCI USA, V86, P7500, DOI 10.1073/pnas.86.19.7500; Corbisier P, 2010, ANAL BIOANAL CHEM, V396, P2143, DOI 10.1007/s00216-009-3200-3; DATTA SK, 1990, BIO-TECHNOL, V8, P736, DOI 10.1038/nbt0890-736; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Dong HZ, 2007, J AGRON CROP SCI, V193, P21, DOI 10.1111/j.1439-037X.2006.00240.x; Duncan B, 2019, TRANSGENIC RES, V28, P509, DOI 10.1007/s11248-019-00160-3; Eghrari K, 2019, CROP PROT, V124, DOI 10.1016/j.cropro.2019.104871; Erasmus A, 2014, AFR ENTOMOL, V22, P167, DOI 10.4001/003.022.0110; Erasmus R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226476; Farias JR, 2014, CROP PROT, V64, P150, DOI 10.1016/j.cropro.2014.06.019; Fatoretto JC, 2017, J INTEGR PEST MANAG, V8, DOI 10.1093/jipm/pmx011; Fearing PL, 1997, MOL BREEDING, V3, P169, DOI 10.1023/A:1009611613475; Glaum PR, 2012, THEOR ECOL-NETH, V5, P195, DOI 10.1007/s12080-010-0109-6; Greenplate JT, 1999, J ECON ENTOMOL, V92, P1377, DOI 10.1093/jee/92.6.1377; Guadagnuolo R, 2006, ECOL APPL, V16, P1967, DOI 10.1890/1051-0761(2006)016[1967:RFOTVN]2.0.CO;2; Halfhill MD, 2003, THEOR APPL GENET, V107, P1533, DOI 10.1007/s00122-003-1397-7; Hensel G, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-171; HOFTE H, 1989, MICROBIOL REV, V53, P242; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Huang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112958; Huang Fangneng, 2012, GM Crops Food, V3, P245, DOI 10.4161/gmcr.20539; Hussain T, 2014, EMIR J FOOD AGR, V26, P706, DOI 10.9755/ejfa.v26i8.17794; ISAAA, 2017, ISAAA BRIEFS 53 ITH; IVALDI-SENDER C, 1974, Annales de Zoologie Ecologie Animale, V6, P337; Iversen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116147; James VA, 2002, THEOR APPL GENET, V104, P553, DOI 10.1007/s001220100745; Johnston SRD, 2004, ADVANCES IN ENDOCRINE THERAPY OF BREAST CANCER, PROCEEDINGS, P1; Keller M, 1996, INSECT BIOCHEM MOLEC, V26, P365, DOI 10.1016/0965-1748(95)00102-6; Kim YW, 2010, PLANT BIOTECHNOL-NAR, V27, P333, DOI 10.5511/plantbiotechnology.27.333; Koul B, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-84; Liu FY, 2010, PEST MANAG SCI, V66, P155, DOI 10.1002/ps.1849; Manoli A, 2012, J PLANT PHYSIOL, V169, P807, DOI 10.1016/j.jplph.2012.01.019; Mercer KL, 2008, AGR ECOSYST ENVIRON, V123, P109, DOI 10.1016/j.agee.2007.05.007; Micallef MC, 1995, IN VITRO CELL DEV-PL, V31, P187; Miroshnichenko D, 2007, BIOTECHNOL BIOTEC EQ, V21, P399, DOI 10.1080/13102818.2007.10817482; Monsanto, 2002, SAF ASS YIELDGARD IN; Muddanuru T, 2019, CROP PROT, V119, P113, DOI 10.1016/j.cropro.2019.01.016; Mugo S, 2005, AFR J BIOTECHNOL, V4, P1490; Nguyen HT, 2007, J PLANT DIS PROTECT, V114, P82, DOI 10.1007/BF03356208; Nguyen HT, 2009, J AGR FOOD CHEM, V57, P9990, DOI 10.1021/jf901115m; Oikeh S, 2014, BIOTECH AGR FOREST, V67, P317, DOI 10.1007/978-3-642-55262-5_13; Olsen KM, 2005, J ECON ENTOMOL, V98, P1007, DOI 10.1603/0022-0493-98.3.1007; Omoto C, 2016, PEST MANAG SCI, V72, P1727, DOI 10.1002/ps.4201; Pearson K, 1900, PHILOS MAG, V50, P157, DOI 10.1080/14786440009463897; PENG JY, 1995, PLANT MOL BIOL, V27, P91, DOI 10.1007/BF00019181; Ponnala L, 2014, PLANT J, V78, P424, DOI 10.1111/tpj.12482; Quist D, 2001, NATURE, V414, P541, DOI 10.1038/35107068; Ren YC, 2017, PLANT CELL TISS ORG, V130, P567, DOI 10.1007/s11240-017-1247-y; Riesemberg A, 2010, SEM PROT AGR DIR AGR; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sachs ES, 1998, CROP SCI, V38, P1, DOI 10.2135/cropsci1998.0011183X003800010001x; Scott A, 1998, MOL BREEDING, V4, P479, DOI 10.1023/A:1009601321343; Siebert MW, 2009, J ECON ENTOMOL, V102, P1301, DOI 10.1603/029.102.0357; SPENCER TM, 1992, PLANT MOL BIOL, V18, P201, DOI 10.1007/BF00034949; Srivastava V, 1996, THEOR APPL GENET, V92, P1031, DOI 10.1007/BF00224045; Szekacs A, 2010, ENVIRON TOXICOL CHEM, V29, P182, DOI 10.1002/etc.5; Team,R.C, 2018, R LANG ENV STAT COMP; Trtikova M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123011; US EPA FIFRA Scientific Advisory Panel, 1998, FIN REP SUBP BAC THU; Van den Berg J, 2013, CROP PROT, V54, P154, DOI 10.1016/j.cropro.2013.08.010; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Villa Tania Carolina Camacho, 2005, Plant Genetic Resources Characterization and Utilization, V3, P373, DOI 10.1079/PGR200591; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang Z, 2012, AFRICAN J BIOTECHNOL, V11, P7812; Warburton ML, 2008, CROP SCI, V48, P617, DOI 10.2135/cropsci2007.02.0103; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Wiget M., 2014, EFFECT SPODOPTERA LI; Xiao YT, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0316; Yang C, 2014, J SYST EVOL, V52, P466, DOI 10.1111/jse.12078; Yin Zhimin, 2004, Journal of Applied Genetics, V45, P127; Zhang HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022874; Zhang YS, 2005, EUPHYTICA, V144, P11, DOI 10.1007/s10681-005-4560-1	84	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238523	10.1371/journal.pone.0238523	http://dx.doi.org/10.1371/journal.pone.0238523			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911522	Green Published, gold			2022-12-26	WOS:000571885900018
J	Semakula, M; Niragire, F; Faes, C				Semakula, Muhammed; Niragire, Francois; Faes, Christel			Bayesian spatio-temporal modeling of malaria risk in Rwanda	PLOS ONE			English	Article								Every year, 435,000 people worldwide die from Malaria, mainly in Africa and Asia. However, malaria is a curable and preventable disease. Most countries are developing malaria elimination plans to meet sustainable development goal three, target 3.3, which includes ending the epidemic of malaria by 2030. Rwanda, through the malaria strategic plan 2012-2018 set a target to reduce malaria incidence by 42% from 2012 to 2018. Assessing the health policy and taking a decision using the incidence rate approach is becoming more challenging. We are proposing suitable statistical methods that handle spatial structure and uncertainty on the relative risk that is relevant to National Malaria Control Program. We used a spatio-temporal model to estimate the excess probability for decision making at a small area on evaluating reduction of incidence. SIR and BYM models were developed using routine data from Health facilities for the period from 2012 to 2018 in Rwanda. The fitted model was used to generate relative risk (RR) estimates comparing the risk with the malaria risk in 2012, and to assess the probability of attaining the set target goal per area. The results showed an overall increase in malaria in 2013 to 2018 as compared to 2012. Ofall sectors in Rwanda, 47.36% failed to meet targeted reduction in incidence from 2012 to 2018. Our approach of using excess probability method to evaluate attainment of target or identifying threshold is a relevant statistical method, which will enable the Rwandan Government to sustain malaria control and monitor the effectiveness of targeted interventions.	[Semakula, Muhammed; Faes, Christel] Hasselt Univ, I BioStat, Hasselt, Belgium; [Niragire, Francois] Univ Rwanda, Coll Business & Econ, Dept Appl Stat, Kigali, Rwanda; [Semakula, Muhammed] Univ Rwanda, Coll Business & Econ, Ctr Excellence Data Sci, Biostat, Kigali, Rwanda	Hasselt University; University of Rwanda; University of Rwanda	Semakula, M (corresponding author), Hasselt Univ, I BioStat, Hasselt, Belgium.; Semakula, M (corresponding author), Univ Rwanda, Coll Business & Econ, Ctr Excellence Data Sci, Biostat, Kigali, Rwanda.	semakulam@gmail.com	Niragire, François/GMX-0394-2022	Niragire, François/0000-0003-0473-387X; muhammed, semakula/0000-0002-9076-4922				BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; BESAG J, 1993, J ROY STAT SOC B MET, V55, P25; Blangiardo M, 2015, SPATIAL AND SPATIO-TEMPORAL BAYESIAN MODELS WITH R-INLA, P1, DOI 10.1002/9781118950203; Carroll R, 2015, SPAT SPATIO-TEMPORAL, V14-15, P45, DOI 10.1016/j.sste.2015.08.001; Dehnavieh R, 2019, HEALTH INF MANAG J, V48, P62, DOI 10.1177/1833358318777713; Emmanuel Giorgi, 2018, EUR UROL SUPPL, V17; Fong YY, 2010, BIOSTATISTICS, V11, P397, DOI 10.1093/biostatistics/kxp053; Hemingway J, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002380; Innocent K, 2016, INT J PUBLIC HLTH RE, V4, P5; Kang Su Yun, 2016, Geospat Health, V11, P428, DOI 10.4081/gh.2016.428; Kneib T, 2010, STATISTICAL MODELLING AND REGRESSION STRUCTURES, P133, DOI 10.1007/978-3-7908-2413-1_8; Lawson A., 2017, HDB STAT DIS MODEL P, P443, DOI [10.1016/bs.host.2017.05.001, DOI 10.1016/BS.HOST.2017.05.001]; Lesaffre E., 2012, STAT PRACTICE, DOI [10.1002/9781119942412, DOI 10.1002/9781119942412]; Maina I, 2017, B WORLD HEALTH ORGAN, V95, P683, DOI 10.2471/BLT.17.194399; Ministry of Health (Rwanda), 2016, RWAND 3 HLTH SECT ST; Ministry of Health (Rwanda), 2016, RWAND MAL STRAT PLAN; Nisingizwe MP, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25829; Pettit, 1990, J ROYAL STAT SOC B, DOI [10.1111/j.2517-6161.1990.tb01780.x, DOI 10.1111/j.2517-6161.1990.tb01780.x]; Riebler A, 2016, STAT METHODS MED RES, V25, P1145, DOI 10.1177/0962280216660421; Rwanda Biomedical Center(RBC), 2012, RWAND MAL STRAT PLAN; Sahay S, 2013, INFORM ORGAN-UK, V23, P294, DOI 10.1016/j.infoandorg.2013.08.002; spiegelhalter D. J., 2014, DEVIANCE INFORM CR B; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Tatem AJ, 2010, LANCET, V376, P1579, DOI 10.1016/S0140-6736(10)61301-3; Tesi M, 2011, GLOBALIZATION HEALTH; USAID, PRES MAL IN RWAND OP; Watanabe, 2009, ALGEBRAIC GEOMETRY S, DOI 10.1017/CBO9780511800474; WHO, 2018, WORLD MAL REP 2018; WHO, 2015, WORLD MAL REP 2015; World Health Organization, 2015, EP APPR MAL CONTR; World Health Organization, 2017, FRAM MAL EL; World Health Organization, 2018, MAL SURV MON EV REF; Yankson R, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2709-y	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238504	10.1371/journal.pone.0238504	http://dx.doi.org/10.1371/journal.pone.0238504			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911503	gold, Green Published			2022-12-26	WOS:000571885900051
J	Yu, Y; Woo, MO; Piao, RH; Koh, HJ				Yu, Yoye; Woo, Mi-Ok; Piao Rihua; Koh, Hee-Jong			TheDROOPING LEAF(DR) gene encoding GDSL esterase is involved in silica deposition in rice (Oryza sativaL.)	PLOS ONE			English	Article							CELL-WALL; DROOPING-LEAF; TRANSCRIPTION FACTOR; TRANSPORTER; RESISTANCE; REVEALS; REGIONS; EFFLUX	Leaf morphology is one of the most important agronomic traits in rice breeding because of its contribution to crop yield. The drooping leaf (dr) mutant was developed from the Ilpum rice cultivar by ethyl methanesulfonate (EMS) mutagenesis. Compared with the wild type,drplants exhibited drooping leaves accompanied by a small midrib, short panicle, and reduced plant height. The phenotype of thedrplant was caused by a mutation within a single recessive gene on chromosome 2,dr(LOC_Os02g15230), which encodes a GDSL esterase. Analysis of wild-type anddrsequences revealed that thedrallele carried a single nucleotide substitution, glycine to aspartic acid. RNAi targeted to LOC_Os02g15230 produced same phenotypes to thedrmutation, confirming LOC_Os02g15230 as thedrgene. Microscopic observations and plant nutrient analysis of SiO(2)revealed that silica was less abundant indrleaves than in wild-type leaves. This study suggests that thedrgene is involved in the regulation of silica deposition and that disruption of silica processes lead to drooping leaf phenotypes.	[Yu, Yoye; Koh, Hee-Jong] Seoul Natl Univ, Plant Genom & Breeding Inst, Dept Plant Sci, Seoul, South Korea; [Yu, Yoye; Koh, Hee-Jong] Seoul Natl Univ, Plant Genom & Breeding Inst, Res Inst Agr & Life Sci, Seoul, South Korea; [Woo, Mi-Ok] Minist Agr Food & Rural Affairs, Sci & Technol Policy Div, Sejong, South Korea; [Piao Rihua] Jilin Acad Agr Sci, Rice Res Inst, Gongzhuling, Jilin, Peoples R China	Seoul National University (SNU); Seoul National University (SNU); Jilin Academy of Agricultural Sciences	Koh, HJ (corresponding author), Seoul Natl Univ, Plant Genom & Breeding Inst, Dept Plant Sci, Seoul, South Korea.; Koh, HJ (corresponding author), Seoul Natl Univ, Plant Genom & Breeding Inst, Res Inst Agr & Life Sci, Seoul, South Korea.	heejkoh@snu.ac.kr			Next-Generation BioGreen 21 Program [PJ013165]; Rural Development Administration, Korea	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Korea(Rural Development Administration (RDA), Republic of Korea)	This study was supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ013165) of the Rural Development Administration, Korea.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; CAUSSE MA, 1994, GENETICS, V138, P1251; Chai MF, 2015, J PLANT BIOL, V58, P44, DOI 10.1007/s12374-014-0400-y; Chepyshko H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-309; EPSTEIN E, 1994, P NATL ACAD SCI USA, V91, P11, DOI 10.1073/pnas.91.1.11; Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641; Fekih R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068529; GIVNISH TJ, 1987, NEW PHYTOL, V106, P131, DOI 10.1111/j.1469-8137.1987.tb04687.x; Hossain MT, 2002, J PLANT RES, V115, P23, DOI 10.1007/s102650200004; Huang JL, 2011, PLANT SCI, V180, P757, DOI 10.1016/j.plantsci.2011.03.001; Kido N, 2015, PLANT CELL PHYSIOL, V56, P268, DOI 10.1093/pcp/pcu162; Kim SG, 2002, PHYTOPATHOLOGY, V92, P1095, DOI 10.1094/PHYTO.2002.92.10.1095; Lang YouZhong, 2004, Acta Agronomica Sinica, V30, P883; Li HF, 2011, PLANT CELL, V23, P2536, DOI 10.1105/tpc.111.087262; Ma JF, 2008, CELL MOL LIFE SCI, V65, P3049, DOI 10.1007/s00018-008-7580-x; Ma JF, 2004, PLANT PHYSIOL, V136, P3284, DOI 10.1104/pp.104.047365; Ma JF, 2006, TRENDS PLANT SCI, V11, P392, DOI 10.1016/j.tplants.2006.06.007; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Nishimura A, 2006, NAT PROTOC, V1, P2796, DOI 10.1038/nprot.2006.469; Oh IS, 2005, PLANT CELL, V17, P2832, DOI 10.1105/tpc.105.034819; Ohmori Y, 2011, PLANT J, V65, P77, DOI 10.1111/j.1365-313X.2010.04404.x; Olesen J, 2018, CEPHALALGIA, V38, P1, DOI 10.1177/0333102417738202; Piao R, 2009, THEOR APPL GENET, V119, P1497, DOI 10.1007/s00122-009-1151-x; Richmond KE, 2003, CURR OPIN PLANT BIOL, V6, P268, DOI 10.1016/S1369-5266(03)00041-4; SHARKEY TD, 1988, PHYSIOL PLANTARUM, V73, P147, DOI 10.1111/j.1399-3054.1988.tb09205.x; Takagi H, 2013, NEW PHYTOL, V200, P276, DOI 10.1111/nph.12369; Wang YH, 2012, PLANT MOL BIOL, V78, P275, DOI 10.1007/s11103-011-9861-2; Whang SS, 1998, AM J BOT, V85, P461, DOI 10.2307/2446428; Woo MO, 2008, PLANT J, V54, P190, DOI 10.1111/j.1365-313X.2008.03405.x; Xu Y, 2014, PLANTA, V239, P803, DOI 10.1007/s00425-013-2009-7; Yamaguchi T, 2004, PLANT CELL, V16, P500, DOI 10.1105/tpc.018044; Yamaji N, 2008, PLANT CELL, V20, P1381, DOI 10.1105/tpc.108.059311; Yamaji N, 2011, SOIL SCI PLANT NUTR, V57, P259, DOI 10.1080/00380768.2011.565480; Yamaji N, 2009, PLANT CELL, V21, P2878, DOI 10.1105/tpc.109.069831; Yamamoto T, 2012, J PLANT RES, V125, P771, DOI 10.1007/s10265-012-0489-3; Yoshida K, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00383; YOSHIDA S, 1969, PLANT SOIL, V31, P48, DOI 10.1007/BF01373025; Zhang BC, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.17; Zhang CC, 2013, PLANT SOIL, V372, P137, DOI 10.1007/s11104-013-1723-z; Zhao FJ, 2010, NEW PHYTOL, V186, P392, DOI 10.1111/j.1469-8137.2010.03192.x; Zhou L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057382, 10.1371/journal.pone.0073724]	42	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238887	10.1371/journal.pone.0238887	http://dx.doi.org/10.1371/journal.pone.0238887			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32913358	gold, Green Published			2022-12-26	WOS:000571885900020
J	Zha, WJ; You, AQ				Zha, Wenjun; You, Aiqing			Comparative iTRAQ proteomic profiling of proteins associated with the adaptation of brown planthopper to moderately resistant vs. susceptible rice varieties	PLOS ONE			English	Article							NILAPARVATA-LUGENS STAL; HONEY-BEE; COLD; IDENTIFICATION; BIOSYNTHESIS; VITELLOGENIN; HOMOPTERA; MARKERS; GENES; BPH14	The brown planthopper (BPH),Nilaparvata lugens(Stal), is a destructive pest that poses a significant threat to rice plants worldwide. To explore how BPHs adapt to the resistant rice variety, we analyzed proteomics profiles of two virulentN.lugenspopulations. We focused on Biotype Y, which can survive on the moderately resistant rice variety YHY15, and Biotype I, which can survive on the susceptible rice variety TN1. We performed protein quantitation using the isobaric tag for relative and absolute quantification (iTRAQ) and then compared the expression patterns between two virulentN.lugenspopulations and found 258 differentially expressed proteins (DEPs). We found that 151 of the DEPs were up-regulated, while 107 were down-regulated. We evaluated transcript levels of 8 expressed genes from the iTRAQ results by qRT-PCR, which revealed transcriptional changes that were consistent with the changes at the protein level. The determination of the protein changes in two virulentN.lugenspopulations would help to better understanding BPH adaptation to resistant rice varieties and facilitate the better design of new control strategies for host defense against BPH.	[Zha, Wenjun; You, Aiqing] Hubei Acad Agr Sci, Food Crops Inst, Hubei Key Lab Food Crop Germplasm & Genet Improve, Wuhan, Peoples R China; [You, Aiqing] Yangtze Univ, Hubei Collaborat Innovat Ctr Grain Ind, Jingzhou, Peoples R China	Hubei Academy of Agricultural Sciences; Yangtze University	You, AQ (corresponding author), Hubei Acad Agr Sci, Food Crops Inst, Hubei Key Lab Food Crop Germplasm & Genet Improve, Wuhan, Peoples R China.; You, AQ (corresponding author), Yangtze Univ, Hubei Collaborat Innovat Ctr Grain Ind, Jingzhou, Peoples R China.	aq_you@163.com			Major Program of Genetically Modified Organisms Breeding of China [2018ZX08001-01B]; National Key Research and Development Program of China [2018YFD0100806]; Supportive Project of Hubei Academy of Agricultural Sciences [2019fcxjh02]	Major Program of Genetically Modified Organisms Breeding of China; National Key Research and Development Program of China; Supportive Project of Hubei Academy of Agricultural Sciences	Financial support was provided by the Major Program of Genetically Modified Organisms Breeding of China (2018ZX08001-01B), the National Key Research and Development Program of China (2018YFD0100806) to WZ, and the Supportive Project of Hubei Academy of Agricultural Sciences (2019fcxjh02) to WZ.	[Anonymous], 2014, NUCLEIC ACIDS RES, V42, pD7; Bonnett TR, 2012, INSECT BIOCHEM MOLEC, V42, P890, DOI 10.1016/j.ibmb.2012.08.003; DeSouza L, 2005, J PROTEOME RES, V4, P377, DOI 10.1021/pr049821j; DHADIALLA TS, 1990, J BIOL CHEM, V265, P9924; Don-Wheeler G, 1997, INSECT BIOCHEM MOLEC, V27, P901, DOI 10.1016/S0965-1748(97)00071-4; Du B, 2009, P NATL ACAD SCI USA, V106, P22163, DOI 10.1073/pnas.0912139106; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hernandez-Martinez P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16406-1; Huang HJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11413; Ji T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-665; Jing S, 2012, B ENTOMOL RES, V102, P113, DOI 10.1017/S0007485311000435; Karp NA, 2010, MOL CELL PROTEOMICS, V9, P1885, DOI 10.1074/mcp.M900628-MCP200; Li J, 2011, PEST MANAG SCI, V67, P528, DOI 10.1002/ps.2089; Li L, 2016, J PROTEOMICS, V130, P140, DOI 10.1016/j.jprot.2015.09.022; Li ZH, 2019, RICE, V12, DOI 10.1186/s12284-019-0289-7; Liu BB, 2016, SCI REP-UK, V6, DOI 10.1038/srep27216; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matambo TS, 2010, GENET MOL RES, V9, P554, DOI 10.4238/vol9-1gmr719; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Monteon Victor, 2017, Annals of Parasitology, V63, P121, DOI 10.17420/ap6302.95; Nguyen CD, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8110498; Niu GD, 2011, INSECT BIOCHEM MOLEC, V41, P244, DOI 10.1016/j.ibmb.2010.12.009; Peng L, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00972; Pique F, 1992, STUD CONSERV, V37, P217, DOI DOI 10.1179/SIC.1992.37.4.217; Piulachs MD, 2003, INSECT BIOCHEM MOLEC, V33, P459, DOI 10.1016/S0965-1748(03)00021-3; Prahalada GD, 2017, RICE, V10, DOI 10.1186/s12284-017-0178-x; Senthil-Nathan S, 2009, ECOTOX ENVIRON SAFE, V72, P1707, DOI 10.1016/j.ecoenv.2009.04.024; Sharma S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07140; Shen Y, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01181; Sinclair BJ, 2007, INSECT MOL BIOL, V16, P435, DOI 10.1111/j.1365-2583.2007.00739.x; Stevenson BJ, 2011, INSECT BIOCHEM MOLEC, V41, P492, DOI 10.1016/j.ibmb.2011.02.003; Wang HX, 2012, J PROTEOME RES, V11, P487, DOI 10.1021/pr2008225; Wang M, 2012, METHODS MOL BIOL, V815, P199, DOI 10.1007/978-1-61779-424-7_16; Wei Z, 2009, PROTEOMICS, V9, P2798, DOI 10.1002/pmic.200800840; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yang HY, 2004, THEOR APPL GENET, V110, P182, DOI 10.1007/s00122-004-1844-0; Yang S, 2018, GENE, V642, P9, DOI 10.1016/j.gene.2017.11.002; Yang ZF, 2005, ARCH INSECT BIOCHEM, V59, P59, DOI 10.1002/arch.20055; Yang ZF, 2007, ARCH INSECT BIOCHEM, V64, P88, DOI 10.1002/arch.20162; Yocum GD, 2001, J INSECT PHYSIOL, V47, P1139, DOI 10.1016/S0022-1910(01)00095-6; Yu HZ, 2017, J PROTEOMICS, V165, P35, DOI 10.1016/j.jprot.2017.06.007; Yu Q, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0346-9; Zhu F, 2010, P NATL ACAD SCI USA, V107, P8557, DOI 10.1073/pnas.1000059107; Zou Z, 2006, INSECT MOL BIOL, V15, P603, DOI 10.1111/j.1365-2583.2006.00684.x	45	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2020	15	9							e0238549	10.1371/journal.pone.0238549	http://dx.doi.org/10.1371/journal.pone.0238549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR4MY	32903256	Green Published, gold			2022-12-26	WOS:000571539500018
J	Bushra, R; Shoaib, MH; Ali, H; Ghayas, S				Bushra, Rabia; Shoaib, Muhammad Harris; Ali, Huma; Ghayas, Sana			Pharmacokinetics and bioequivalence assessment of optimized directly compressible Aceclofenac (100 mg) tablet formulation in healthy human subjects	PLOS ONE			English	Article							HPLC-UV METHOD; BRANDS	The aim of the study was to determine the various pharmacokinetic parameters of the newly developed cost-effective aceclofenac 100 mg tablet formulation (F-15) and to establish the bioequivalence against the marketed brand (ACEMED). Both products (test and reference) were given to 12 healthy non-smokers male subjects with overnight fasting of >10hr. The study was a randomized, single-dose, open-label, two sequence, and two treatment crossover design, with a washout period of 2 weeks. Blood samples (5 mL) from the human subjects were collected before (0 hr) and after drug administration at 13different time points (0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 5, 6, 8, 12 and 18 hrs). The drug plasma concentration was analyzed by a validated RP-HPLC method using a solvent system containing acetonitrile and deionized water (60:40% v/v). Linearity was found to be 0.999 over the drug concentration range of 50 mu g/mL to 0.05 mu g/mL with LLOQ and LOD of 0.05 mu g/mL and 0.025 mu g/mL respectively. Non-compartmental pharmacokinetic analysis was performed using Kinetica(R)(ver. 5.1) software. Using the log-transformed data C-max, AUC(0-t), AUC(0-infinity), AUMC(tot), and MRT were calculated. The C(max)of the test and brand was found to be 8.629 +/- 1.251 mu g/mL and 8.478 +/- 0.913 mu g/mL. The AUC(0-t)and AUC(0-infinity)of the test and the reference were computed to be 20.890 +/- 2.2021 mu g/mL.h, 23.272 +/- 1.914 mu g/mL.h and 19.850 +/- 2.911 mu g/mL.h, 22.890 +/- 2.110 mu g/mL.h correspondingly. Two-way analysis of variance (ANOVA) test and two one-sidedt-test (p>0.05; non-significant) were applied to assess the variation in the period, sequence, subjects, and treatment. Geometric mean ratios for above mentioned pharmacokinetic parameters of reference/test were found within the acceptable FDA limits of 80-125% using 90% CI. There was no inter and intrasubject variation (p> 0.05) that was observed. Therefore, the directly compressible aceclofenac (100 mg) test formulation and the commercial reference tablets were declared to be biosimilar.	[Bushra, Rabia; Shoaib, Muhammad Harris; Ali, Huma; Ghayas, Sana] Univ Karachi, Fac Pharm & Pharmaceut Sci, Dept Pharmaceut, Karachi, Pakistan; [Shoaib, Muhammad Harris] Univ Karachi, Fac Pharm & Pharmaceut Sci, Bioavailabil & Bioequivalence Res Facil, Karachi, Pakistan; [Bushra, Rabia] Dow Univ Hlth Sci, Fac Pharm, Dept Pharmaceut, Karachi, Pakistan; [Ali, Huma] Dow Univ Hlth Sci, Fac Pharm, Karachi, Pakistan; [Ghayas, Sana] Jinnah Sindh Med Univ, Fac Pharm, Karachi, Pakistan	University of Karachi; University of Karachi; Dow University of Health Sciences; Dow University of Health Sciences; Jinnah Sindh Medical University - Pakistan	Shoaib, MH (corresponding author), Univ Karachi, Fac Pharm & Pharmaceut Sci, Dept Pharmaceut, Karachi, Pakistan.; Shoaib, MH (corresponding author), Univ Karachi, Fac Pharm & Pharmaceut Sci, Bioavailabil & Bioequivalence Res Facil, Karachi, Pakistan.	harrisshoaib2000@yahoo.com		Shoaib, Muhammad Harris/0000-0002-3639-0026				Abbirami V, 2013, INT J CHEMTECH RES, V5, P2295; Adegbolagun OA, 2007, TROP J PHARM RES, V6, P737; Ahmad S, 2014, FORMULATION DEV IMME; Al Ameri MN, 2011, TRANSPL INT, V24, P770, DOI 10.1111/j.1432-2277.2011.01268.x; Al Ameri Mubarak Nasser, 2012, Results Pharma Sci, V2, P1, DOI 10.1016/j.rinphs.2011.12.001; [Anonymous], 2011, DIABETOL DOSW KLI SA, V11, pA1; Bushra R, 2013, IJDDT, V4, P34; Bushra R, 2016, LAT AM J PHARM, V35, P695; Bushra R, 2014, LAT AM J PHARM, V33, P1009; Community Preventive Services Task Force, 2017, AM J PREV MED, V53, pe115; Dahiya S, 2015, SCI PHARM, V83, P501, DOI [10.3797/scipharm.1509-07, 10.3797/scipharm.1409-07]; FDA, 2014, GUID IND ASS EFF SIG, P1; FDA GfI, 2008, BIOAV BIOEQ STUD OR; Hailu G. S., 2013, INT J PHARM SCI NANO, V6, P1966, DOI [10.37285/ijpsn.2013.6.1.7, DOI 10.37285/IJPSN.2013.6.1.7]; ICH QR, 2005, GUID VAL AN PROC TEX; Kim YG, 2001, INT J CLIN PHARM TH, V39, P83; Macha S, 2009, BIOPHARM DRUG DISPOS, V30, P542, DOI 10.1002/bdd.691; Malik MA, 2013, J PAK MED ASSOC, V63, P814; Mostafavi SA, 2010, IRAN J PHARM RES, V9, P243; Nasiri MI, 2019, DRUG DEV IND PHARM, V45, P415, DOI 10.1080/03639045.2018.1546312; Pal M, 2017, J ANAL PHARM RES, V4, P93; Patel PB, 2017, EUR J RHEUMATOL, V4, P11, DOI 10.5152/eurjrheum.2017.160080; Rhim SY, 2008, CLIN THER, V30, P633, DOI 10.1016/j.clinthera.2008.04.008; Simoens S, 2011, INT J CLIN PHARM-NET, V33, P469, DOI 10.1007/s11096-011-9500-7; TAJANI AS, 2017, BIOMED PHARMACOL J, V10, P1109, DOI DOI 10.13005/bpj/1210; Talele GS, 2015, INDIAN J PHARM SCI, V77, P742; Vohra F., 2016, INDIAN J PAIN, V30, P3, DOI 10.4103/0970-5333.173431	27	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238951	10.1371/journal.pone.0238951	http://dx.doi.org/10.1371/journal.pone.0238951			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ6EE	32898192	Green Published, gold			2022-12-26	WOS:000570962500010
J	Kang, EA; Chun, J; Im, JP; Lee, HJ; Han, K; Soh, H; Park, S; Kim, JS				Kang, Eun Ae; Chun, Jaeyoung; Im, Jong Pil; Lee, Hyun Jung; Han, Kyungdo; Soh, Hosim; Park, Seona; Kim, Joo Sung			Anemia is associated with the risk of Crohn's disease, not ulcerative colitis: A nationwide population-based cohort study	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; PREVALENCE; MANAGEMENT; DIAGNOSIS; OUTCOMES; IRON	Anemia is a common manifestation of inflammatory bowel disease (IBD), but it remains unclear whether anemia is associated with the development of IBD. We assessed the risk of developing IBD in anemic patients, and stratified the results with respect to their hemoglobin concentrations. A population-based study was conducted using the National Healthcare Insurance Service database in South Korea. We included individuals over 20 years' old who participated in the national health screening program in 2009 (n= 9,962,064). Anemia was defined as a hemoglobin level less than 13 g/dL in men and less than 12 g/dL in women. We compared the rate of newly diagnosed IBD in anemic patients and non-anemic individuals. Newly diagnosed IBD was identified using both the ICD-10 medical code and specialized V codes for rare intractable diseases in South Korea. During the mean follow-up period of 7.3 years, the incidences of CD and UC in anemic patients were 2.89 and 6.88 per 100,000 person-years, respectively. The risk of CD was significantly higher in anemic patients than in non-anemic individuals [adjusted hazard ratio (aHR), 2.084; 95% confidence interval (CI), 1.769-2.455]. The risk of CD development was inversely proportional to the hemoglobin concentration. A J-curve relationship was observed between age and the risk of CD in anemic patients. The risk of CD in male anemic patients was significantly higher than that in female anemic patients (aHR, 1.432 vs. 1.240, respectively). By contrast, there was no statistically significant difference in the risk of developing UC in anemic and non-anemic individuals (aHR, 0.972; 95% CI, 0.880-1.073). This work indicates that anemia is related to the development of CD, and this risk was inversely proportional to the hemoglobin concentration.	[Kang, Eun Ae; Im, Jong Pil; Lee, Hyun Jung; Soh, Hosim; Park, Seona; Kim, Joo Sung] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Kang, Eun Ae; Im, Jong Pil; Lee, Hyun Jung; Soh, Hosim; Park, Seona; Kim, Joo Sung] Seoul Natl Univ, Liver Res Inst, Coll Med, Seoul, South Korea; [Kang, Eun Ae] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Kang, Eun Ae] Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul, South Korea; [Chun, Jaeyoung] Yonsei Univ, Gangnam Severance Hosp, Dept Internal Med, Coll Med, Seoul, South Korea; [Han, Kyungdo] Soongsil Univ, Dept Stat & Actuarial Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Soongsil University	Im, JP (corresponding author), Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea.; Im, JP (corresponding author), Seoul Natl Univ, Liver Res Inst, Coll Med, Seoul, South Korea.	jpim0911@snu.ac.kr	Cheon, Jae Hee/B-4523-2015; Chun, Jaeyoung/G-2921-2015	Cheon, Jae Hee/0000-0002-2282-8904; Soh, Hosim/0000-0001-5107-6521; Im, Jong Pil/0000-0003-1584-0160; Chun, Jaeyoung/0000-0002-4212-0380				Abizari AR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170747; Bager P, 2011, SCAND J GASTROENTERO, V46, P304, DOI 10.3109/00365521.2010.533382; Burisch J, 2017, J CROHNS COLITIS, V11, P1213, DOI 10.1093/ecco-jcc/jjx077; Denny SD, 2006, AM J MED, V119, P327, DOI [10.1016/j.amjmed.2005.08.027, 10.1016/j.amjmed.2005.10.042]; Eriksson C, 2018, ALIMENT PHARM THER, V48, P638, DOI 10.1111/apt.14920; Gasche C, 2004, GUT, V53, P1190, DOI 10.1136/gut.2003.035758; Herzog D, 2018, EUR J GASTROEN HEPAT, V30, P598, DOI 10.1097/MEG.0000000000001072; Hoivik ML, 2014, ALIMENT PHARM THER, V39, P69, DOI 10.1111/apt.12541; Jeong SM, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0322-2; Kaitha Sindhu, 2015, World J Gastrointest Pathophysiol, V6, P62, DOI 10.4291/wjgp.v6.i3.62; Kanegae Junior H., 2006, Cerne, V12, P123; Kang EA, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030343; Koutroubakis IE, 2016, J CLIN GASTROENTEROL, V50, P638, DOI 10.1097/MCG.0000000000000417; Lee DW, 2017, WORLD J GASTROENTERO, V23, P6474, DOI 10.3748/wjg.v23.i35.6474; Lee G, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008147; Lucendo AJ, 2017, DIGEST LIVER DIS, V49, P405, DOI 10.1016/j.dld.2016.12.005; Michailidou M, 2018, AM J SURG, V215, P78, DOI 10.1016/j.amjsurg.2017.02.016; Moon JM, 2020, WORLD J GASTROENTERO, V26, P404, DOI 10.3748/wjg.v26.i4.404; Nam GE, 2019, INT J OBESITY, V43, P412, DOI 10.1038/s41366-018-0079-0; Nutritional anaemias, 1968, WHO TECH REP SER, V405, P5; Park SH, 2019, J CROHNS COLITIS, V13, P1410, DOI 10.1093/ecco-jcc/jjz081; Park S, 2018, WORLD J GASTROENTERO, V24, P4798, DOI 10.3748/wjg.v24.i42.4798; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Seo MH, 2019, J OBES METAB SYNDR, V28, P40, DOI 10.7570/jomes.2019.28.1.40; Soh H, 2019, GUT LIVER, V13, P333, DOI 10.5009/gnl18304; Stein J, 2010, NAT REV GASTRO HEPAT, V7, P599, DOI 10.1038/nrgastro.2010.151; Tibble JA, 2000, GASTROENTEROLOGY, V119, P15, DOI 10.1053/gast.2000.8523; van Rheenen PF, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3369; von Roon AC, 2007, AM J GASTROENTEROL, V102, P803, DOI 10.1111/j.1572-0241.2007.01126.x; Wilson A, 2004, AM J MED, V116, P44, DOI 10.1016/j.amjmed.2003.12.011; Yang SK, 2001, INFLAMM BOWEL DIS, V7, P260, DOI 10.1097/00054725-200108000-00013	31	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238244	10.1371/journal.pone.0238244	http://dx.doi.org/10.1371/journal.pone.0238244			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ6EE	32898174	gold, Green Published			2022-12-26	WOS:000570962500042
J	Paterson, JT; Butler, C; Garrott, R; Proffitt, K				Paterson, J. Terrill; Butler, Carson; Garrott, Robert; Proffitt, Kelly			How sure are you? A web-based application to confront imperfect detection of respiratory pathogens in bighorn sheep	PLOS ONE			English	Article							DIAGNOSTIC-TESTS; DETECTION PROBABILITIES; INFECTIOUS-DISEASES; GLOBAL TRENDS; WILDLIFE; PREVALENCE; PNEUMONIA; SENSITIVITY; OCCUPANCY; LEVEL	The relationships between host-pathogen population dynamics in wildlife are poorly understood. An impediment to progress in understanding these relationships is imperfect detection of diagnostic tests used to detect pathogens. If ignored, imperfect detection precludes accurate assessment of pathogen presence and prevalence, foundational parameters for deciphering host-pathogen dynamics and disease etiology. Respiratory disease in bighorn sheep (Ovis canadensis) is a significant impediment to their conservation and restoration, and effective management requires a better understanding of the structure of the pathogen communities. Our primary objective was to develop an easy-to-use and accessible web-based Shiny application that estimates the probability (with associated uncertainty) that a respiratory pathogen is present in a herd and its prevalence given imperfect detection. Our application combines the best-available information on the probabilities of detection for various respiratory pathogen diagnostic protocols with a hierarchical Bayesian model of pathogen prevalence. We demonstrated this application using four examples of diagnostic tests from three herds of bighorn sheep in Montana. For instance, one population with no detections ofMycoplasma ovipneumoniae(PCR assay) still had an 6% probability of the pathogen being present in the herd. Similarly, the apparent prevalence (0.32) ofM.ovipneumoniaein another herd was a substantial underestimate of estimated true prevalence (0.46: 95% CI = [0.25, 0.71]). The negative bias of naive prevalence increased as the probability of detection of testing protocols worsened such that the apparent prevalence ofMannheimia haemolytica(culture assay) in a herd (0.24) was less than one third that of estimated true prevalence (0.78: 95% CI = [0.43, 0.99]). We found a small difference in the estimates of the probability thatMannheimia spp. (culture assay) was present in one herd between the binomial sampling approach (0.24) and the hypergeometric approach (0.22). Ignoring the implications of imperfect detection and sampling variation for assessing pathogen communities in bighorn sheep can result in spurious inference on pathogen presence and prevalence, and potentially poorly informed management decisions. Our Shiny application makes the rigorous assessment of pathogen presence, prevalence and uncertainty straightforward, and we suggest it should be incorporated into a new paradigm of disease monitoring.	[Paterson, J. Terrill; Garrott, Robert] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA; [Butler, Carson] Grand Teton Natl Pk, Fish & Wildlife Branch, Moose, WY USA; [Proffitt, Kelly] Montana Fish Wildlife & Pk, Bozeman, MT USA	Montana State University System; Montana State University Bozeman	Paterson, JT (corresponding author), Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA.	terrillpaterson@gmail.com			US Fish and Wildlife Service through the Pittman-Robertson Federal Aid in Wildlife Restoration Act [W-159-R, W-166-SI]; Wyoming Wildlife Foundation; Wyoming Game and Fish Department; Montana Department of Fish Wildlife and Parks; Montana and Wyoming chapters of the Wild Sheep Foundation; Canon Inc. USA (through Yellowstone Park Foundation)	US Fish and Wildlife Service through the Pittman-Robertson Federal Aid in Wildlife Restoration Act; Wyoming Wildlife Foundation; Wyoming Game and Fish Department; Montana Department of Fish Wildlife and Parks; Montana and Wyoming chapters of the Wild Sheep Foundation; Canon Inc. USA (through Yellowstone Park Foundation)	This study was funded by the US Fish and Wildlife Service through the Pittman-Robertson Federal Aid in Wildlife Restoration Act (grant #s W-159-R & W-166-SI; https://www.fws.gov/wsfrprograms/Subpages/GrantPrograms/WR/WR.htm), the Wyoming Wildlife Foundation (through the Wyoming Governor's Big Game License Coalition; http://wyomingwildlifefoundation.org), Montana Department of Fish Wildlife and Parks (http://fwp.mt.gov), Wyoming Game and Fish Department (https://wgfd.wyo.gov), Montana and Wyoming chapters of the Wild Sheep Foundation (https://www.wildsheepfoundation.org), and Canon Inc. USA (through Yellowstone Park Foundation; https://www.yellowstone.org/).	Alex Potapov, 2012, P R SOC B, V279, P3139, DOI [10.1098/rspb.2012.0520, DOI 10.1098/RSPB.2012.0520]; [Anonymous], 2017, KIDNEY INT S, V7, p[1, 1], DOI DOI 10.1016/j.kisu.2017.04.001; Besser TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110039; Besser TE, 2013, PREV VET MED, V108, P85, DOI 10.1016/j.prevetmed.2012.11.018; Besser TE, 2012, EMERG INFECT DIS, V18, P406, DOI 10.3201/eid1803.111554; Branscum AJ, 2004, PREV VET MED, V66, P101, DOI 10.1016/j.prevetmed.2004.09.009; Butler CJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207780; Butler CJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180689; Cameron AR, 1998, PREV VET MED, V34, P1, DOI 10.1016/S0167-5877(97)00081-0; Cassirer EF, 2007, J WILDLIFE MANAGE, V71, P1080, DOI 10.2193/2006-002; Cassirer EF, 2018, J WILDLIFE MANAGE, V82, P32, DOI 10.1002/jwmg.21309; Cassirer EF, 2017, J WILDLIFE MANAGE, V81, P133, DOI 10.1002/jwmg.21172; Christensen J, 2000, PREV VET MED, V45, P83, DOI 10.1016/S0167-5877(00)00118-5; Conn PB, 2009, J APPL ECOL, V46, P486, DOI 10.1111/j.1365-2664.2008.01597.x; Cotterill GG, 2018, ECOL EVOL, V8, P10733, DOI 10.1002/ece3.4521; Cross PC, 2009, J APPL ECOL, V46, P467, DOI 10.1111/j.1365-2664.2008.01589.x; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Denwood MJ, 2016, J STAT SOFTW, V71, P1, DOI 10.18637/jss.v071.i09; DiRenzo GV, 2018, METHODS ECOL EVOL, V9, P380, DOI 10.1111/2041-210X.12868; Dobson A, 2002, ECOL WILDL DIS; Drewe JA, 2009, J VET DIAGN INVEST, V21, P31, DOI 10.1177/104063870902100105; Enoe C, 2000, PREV VET MED, V45, P61, DOI 10.1016/S0167-5877(00)00117-3; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gomez-Diaz E, 2010, EVOL APPL, V3, P391, DOI 10.1111/j.1752-4571.2010.00127.x; Harris R, 2018, P 21 BIENN S NO WILD; Jennelle CS, 2007, ECOL APPL, V17, P154, DOI 10.1890/1051-0761(2007)017[0154:SDPADP]2.0.CO;2; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Knowles SCL, 2011, MOL ECOL, V20, P1062, DOI 10.1111/j.1365-294X.2010.04909.x; Lachish S, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00090; Lachish S, 2012, METHODS ECOL EVOL, V3, P339, DOI 10.1111/j.2041-210X.2011.00156.x; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Manlove K, 2016, ECOLOGY, V97, P2593, DOI 10.1002/ecy.1520; Marchand P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15803-w; McCallum Hamish, 1994, Pacific Conservation Biology, V1, P107; McClintock BT, 2010, ECOL LETT, V13, P659, DOI 10.1111/j.1461-0248.2010.01472.x; Messam Locksley L. McV., 2008, Animal Health Research Reviews, V9, P1, DOI 10.1017/S1466252307001314; Miller DAW, 2012, METHODS ECOL EVOL, V3, P850, DOI 10.1111/j.2041-210X.2012.00216.x; Nikolay B, 2014, INT J PARASITOL, V44, P765, DOI 10.1016/j.ijpara.2014.05.009; Perez-Heydrich C, 2012, OIKOS, V121, P377, DOI 10.1111/j.1600-0706.2011.19735.x; Plummer M., 2017, JAGS VERSION 430 USE; R Core Team, 2018, R LANG ENV STAT COMP; Restif O, 2012, ECOL LETT, V15, P1083, DOI 10.1111/j.1461-0248.2012.01836.x; Rhyan JC, 2010, VET PATHOL, V47, P34, DOI 10.1177/0300985809354466; Scholthof KBG, 2007, NAT REV MICROBIOL, V5, P152, DOI 10.1038/nrmicro1596; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; Solomon AW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001746; Tompkins DM, 2011, J ANIM ECOL, V80, P19, DOI 10.1111/j.1365-2656.2010.01742.x; Trevethan R, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00307; van Dijk J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063961; Wiethoelter AK, 2015, P NATL ACAD SCI USA, V112, P9662, DOI 10.1073/pnas.1422741112; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Wood ME, 2017, J WILDLIFE DIS, V53, P126, DOI 10.7589/2016-05-097; Woodroffe R, 1999, J APPL ECOL, V36, P494, DOI 10.1046/j.1365-2664.1999.00418.x	55	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0237309	10.1371/journal.pone.0237309	http://dx.doi.org/10.1371/journal.pone.0237309			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ6EE	32898140	gold, Green Published			2022-12-26	WOS:000570962500004
J	Piergentili, C; Ross, J; He, DD; Gallagher, KJ; Stanley, WA; Adam, L; Mackay, CL; Basle, A; Waldron, KJ; Clarke, DJ; Marles-Wright, J				Piergentili, Cecilia; Ross, Jennifer; He, Didi; Gallagher, Kelly J.; Stanley, Will A.; Adam, Laurene; Mackay, C. Logan; Basle, Arnaud; Waldron, Kevin J.; Clarke, David J.; Marles-Wright, Jon			Dissecting the structural and functional roles of a putative metal entry site in encapsulated ferritins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ferritin; crystal structure; mass spectrometry (MS); X-ray crystallography; iron metabolism; iron; encapsulated ferritin; encapsulin; ferroxidase; native mass spectrometry	OXIDATIVE STRESS-RESPONSE; IRON STORAGE FUNCTION; DNA-BINDING PROTEIN; DPS-LIKE PROTEIN; ESCHERICHIA-COLI; CRYSTALLOGRAPHIC STRUCTURE; CRYSTAL-STRUCTURE; CORE FORMATION; HORSE SPLEEN; RUBRERYTHRIN	Encapsulated ferritins belong to the universally distributed ferritin superfamily, whose members function as iron detoxification and storage systems. Encapsulated ferritins have a distinct annular structure and must associate with an encapsulin nanocage to form a competent iron store that is capable of holding significantly more iron than classical ferritins. The catalytic mechanism of iron oxidation in the ferritin family is still an open question because of the differences in organization of the ferroxidase catalytic site and neighboring secondary metal-binding sites. We have previously identified a putative metal-binding site on the inner surface of the Rhodospirillum rubrum encapsulated ferritin at the interface between the two-helix subunits and proximal to the ferroxidase center. Here we present a comprehensive structural and functional study to investigate the functional relevance of this putative iron-entry site by means of enzymatic assays, MS, and X-ray crystallography. We show that catalysis occurs in the ferroxidase center and suggest a dual role for the secondary site, which both serves to attract metal ions to the ferroxidase center and acts as a flow-restricting valve to limit the activity of the ferroxidase center. Moreover, confinement of encapsulated ferritins within the encapsulin nanocage, although enhancing the ability of the encapsulated ferritin to undergo catalysis, does not influence the function of the secondary site. Our study demonstrates a novel molecular mechanism by which substrate flux to the ferroxidase center is controlled, potentially to ensure that iron oxidation is productively coupled to mineralization.	[Piergentili, Cecilia; Stanley, Will A.; Adam, Laurene; Marles-Wright, Jon] Newcastle Univ, Sch Nat & Environm Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Ross, Jennifer; Gallagher, Kelly J.; Mackay, C. Logan; Clarke, David J.] Univ Edinburgh, EaStCHEM Sch Chem, Edinburgh, Midlothian, Scotland; [He, Didi] Univ Edinburgh, Inst Quantitat Biol Biochem & Biotechnol, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Basle, Arnaud; Waldron, Kevin J.] Newcastle Univ, Biosci Inst, Newcastle Upon Tyne, Tyne & Wear, England; [He, Didi] Univ Oxford, Struct Genom Consortium, Oxford, England	Newcastle University - UK; University of Edinburgh; University of Edinburgh; Newcastle University - UK; University of Oxford	Marles-Wright, J (corresponding author), Newcastle Univ, Sch Nat & Environm Sci, Newcastle Upon Tyne, Tyne & Wear, England.; Clarke, DJ (corresponding author), Univ Edinburgh, EaStCHEM Sch Chem, Edinburgh, Midlothian, Scotland.	Dave.clarke@ed.ac.uk; Jon.marles-wright1@ncl.ac.uk	Waldron, Kevin John/HHM-8983-2022	Waldron, Kevin John/0000-0002-5577-7357; Ross, Jennifer/0000-0003-2909-4402; Clarke, David/0000-0002-3741-2952; Basle, Arnaud/0000-0002-4899-3086	Royal Society Research Grant [RG130585]; Biotechnology and Biological Sciences Research Council New Investigator Grant [BB/N005570/1]; Newcastle University; University of Edinburgh; Biotechnology and Biological Sciences Research Council EastBio DTP studentship [BB/M010996/1]; China Scholarship Council; Wellcome Trust; Royal Society [098375/Z/12/Z]; Biotechnology and Biological Sciences Research Council [17ALERT BB/R013993/1]; BBSRC [BB/R013942/1, BB/N005570/1, BB/R013993/1] Funding Source: UKRI	Royal Society Research Grant(Royal Society of London); Biotechnology and Biological Sciences Research Council New Investigator Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Newcastle University; University of Edinburgh; Biotechnology and Biological Sciences Research Council EastBio DTP studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); China Scholarship Council(China Scholarship Council); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Royal Society Research Grant RG130585 (to J. M.-W.), Biotechnology and Biological Sciences Research Council New Investigator Grant BB/N005570/1 (to J. M.-W., D. J. C., C. P., and W. A. S.), Newcastle University (J. M.-W.), the University of Edinburgh (D. J. C. and J. R.), Biotechnology and Biological Sciences Research Council EastBio DTP studentship BB/M010996/1 (to J. R.), the China Scholarship Council (D. H.), and the Wellcome Trust and Royal Society through Sir Henry Dale Fellowship 098375/Z/12/Z (to K. J. W.). Equipment for transmission electron microscopy was funded through the Biotechnology and Biological Sciences Research Council 17ALERT call BB/R013942/1 (to J. M.-W.). Fouriertransform ion cyclotron resonance instrumentation was funded by Biotechnology and Biological Sciences Research Council 17ALERT BB/R013993/1 (to D. J. C.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; Andrews SC, 1998, ADV MICROB PHYSIOL, V40, P281, DOI 10.1016/S0065-2911(08)60134-4; Andrews SC, 2010, BBA-GEN SUBJECTS, V1800, P691, DOI 10.1016/j.bbagen.2010.05.010; Baaghil S, 2003, BIOCHEMISTRY-US, V42, P14047, DOI 10.1021/bi035253u; Behera RK, 2015, J BIOL INORG CHEM, V20, P957, DOI 10.1007/s00775-015-1279-x; Bellapadrona G, 2009, J BIOL CHEM, V284, P19101, DOI 10.1074/jbc.M109.014670; BI X, 1991, J BIOL CHEM, V266, P19965; Cardenas JP, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2010.01822; Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; Choi SH, 2000, APPL ENVIRON MICROB, V66, P3911, DOI 10.1128/AEM.66.9.3911-3916.2000; De Martino M, 2016, J BACTERIOL, V198, P1662, DOI 10.1128/JB.00239-16; Dillard BD, 2011, J BIOL INORG CHEM, V16, P949, DOI 10.1007/s00775-011-0795-6; Ebrahimi KH, 2016, MOL BIOSYST, V12, P3576, DOI 10.1039/c6mb00235h; Ebrahimi KH, 2009, J BIOL INORG CHEM, V14, P1265, DOI 10.1007/s00775-009-0571-z; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eschweiler JD, 2015, ANAL CHEM, V87, P11516, DOI 10.1021/acs.analchem.5b03292; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Foster AW, 2014, J BIOL CHEM, V289, P28095, DOI 10.1074/jbc.R114.588145; Frausto da Silva J.J.R., 1991, BIOL CHEM ELEMENTS I; FROLOW F, 1994, NAT STRUCT BIOL, V1, P453, DOI 10.1038/nsb0794-453; Gallagher KJ, 2020, J AM SOC MASS SPECTR, V31, P700, DOI 10.1021/jasms.9b00119; Gauss GH, 2006, BIOCHEMISTRY-US, V45, P10815, DOI 10.1021/bi060782u; Gauss GH, 2012, J BACTERIOL, V194, P15, DOI 10.1128/JB.05260-11; Giessen TW, 2019, ELIFE, V8, DOI 10.7554/eLife.46070; Grant RA, 1998, NAT STRUCT BIOL, V5, P294, DOI 10.1038/nsb0498-294; Hagen WR, 2017, METALLOMICS, V9, P595, DOI 10.1039/c7mt00124j; Hall Z, 2013, STRUCTURE, V21, P1325, DOI 10.1016/j.str.2013.06.004; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; He DD, 2019, BIOCHEM J, V476, P975, DOI 10.1042/BCJ20180922; He DD, 2016, ELIFE, V5, DOI 10.7554/eLife.18972; HEMPSTEAD PD, 1994, FEBS LETT, V350, P258, DOI 10.1016/0014-5793(94)00781-0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; LEBRUN NE, 1995, BIOCHEM J, V312, P385, DOI 10.1042/bj3120385; Liu XS, 2007, J BIOL CHEM, V282, P31821, DOI 10.1074/jbc.C700153200; Martinez A, 1997, J BACTERIOL, V179, P5188, DOI 10.1128/jb.179.16.5188-5194.1997; Masuda T, 2010, J BIOL CHEM, V285, P4049, DOI 10.1074/jbc.M109.059790; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nair S, 2004, J BACTERIOL, V186, P4192, DOI 10.1128/JB.186.13.4192-4198.2004; Pesek J, 2011, J BIOL CHEM, V286, P34872, DOI 10.1074/jbc.M111.246108; Pfaffen S, 2013, J BIOL CHEM, V288, P14917, DOI 10.1074/jbc.M113.454496; Polasky DA, 2019, ANAL CHEM, V91, P3147, DOI 10.1021/acs.analchem.8b05762; PROULXCURRY PM, 1995, COORDIN CHEM REV, V144, P347, DOI 10.1016/0010-8545(95)01148-I; Ratnayake DB, 2000, MICROBIOL-UK, V146, P1119, DOI 10.1099/00221287-146-5-1119; Reyes-Caballero H, 2011, BIOPHYS CHEM, V156, P103, DOI 10.1016/j.bpc.2011.03.010; Ross J, 2020, CHEM COMMUN, V56, P3417, DOI 10.1039/c9cc08130e; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Stillman TJ, 2001, J MOL BIOL, V307, P587, DOI 10.1006/jmbi.2001.4475; Sutter M, 2008, NAT STRUCT MOL BIOL, V15, P939, DOI 10.1038/nsmb.1473; Sztukowska M, 2002, MOL MICROBIOL, V44, P479, DOI 10.1046/j.1365-2958.2002.02892.x; Theil EC, 2013, COORDIN CHEM REV, V257, P579, DOI 10.1016/j.ccr.2012.05.013; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Treffry A, 1998, FEBS LETT, V432, P213, DOI 10.1016/S0014-5793(98)00867-9; TREFFRY A, 1978, BIOCHEM J, V171, P313, DOI 10.1042/bj1710313; Yang XK, 1998, BIOCHEMISTRY-US, V37, P9743, DOI 10.1021/bi973128a; Yao HL, 2012, J AM CHEM SOC, V134, P13470, DOI 10.1021/ja305180n	60	7	9	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2020	295	46					15511	15526		10.1074/jbc.RA120.014502	http://dx.doi.org/10.1074/jbc.RA120.014502			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OY6NO	32878987	Green Submitted, hybrid, Green Published, Green Accepted			2022-12-26	WOS:000594361600008
J	Correa, F; Hidalgo, C; Stoore, C; Jimenez, M; Hernandez, M; Paredes, R				Correa, Felipe; Hidalgo, Christian; Stoore, Caroll; Jimenez, Mauricio; Hernandez, Marcela; Paredes, Rodolfo			Cattle co-infection ofEchinococcus granulosusandFasciola hepaticaresults in a different systemic cytokine profile than single parasite infection	PLOS ONE			English	Article							GRANULOSUS ANTIGEN-B; ECHINOCOCCUS-GRANULOSUS; FASCIOLA-HEPATICA; IMMUNE-RESPONSE; CYSTIC ECHINOCOCCOSIS; HELMINTH-PARASITES; HUMAN HYDATIDOSIS; INTERFERON-GAMMA; INTERLEUKIN-12; MODULATION	E.granulosusis a cestode that causes Cystic Echinococcosis (CE), a zoonotic disease with worldwide presence. The immune response generated by the host against the metacestode induces a permissive Th2 response, as opposed to pro-inflammatory Th1 response. In this view, mixed Th2 and regulatory responses allow parasite survival. Overall, larvalEchinococcusinfections induce strong regulatory responses.Fasciola hepatica, another common helminth parasite, represents a major infection in cattle. Co-infection with different parasite species in the same host, polyparasitism, is a common occurrence involvingE.granulosusandF.hepaticain cattle. 'While it is known that infection withF.hepaticaalso triggers a polarized Th2/Treg immune response, little is reported regarding effects on the systemic immune response of this example of polyparasitism.F.hepaticaalso triggers immune responses polarized to the Th2/ Treg spectrum. Serum samples from 107 animals were analyzed, and were divided according to their infection status andEchinococcalcysts fertility. Cytokines were measured utilizing a Milliplex Magnetic Bead Panel to detect IFN-gamma, IL-1, IL-2, IL-4, IL-6, IL-10, IL-12 and IL-18. Cattle infected only withF.hepaticahad the highest concentration of every cytokine analyzed, with both 4.24 and 3.34-fold increases in IL-10 and IL-4, respectively, compared to control animals, followed byE.granulosusandF.hepaticaco-infected animals with two-fold increase in IL-10 and IL-4, compared to control animals, suggesting thatE.granulosusco-infection dampens the cattle Th2/Treg immune response againstF.hepatica. When consideringEchinococcalcyst fertility and systemic cytokine concentrations, fertile cysts had higher IFN-gamma, IL-6 and IL-18 concentrations, while infertile cysts had higher IL-10 concentrations. These results show thatE.granulosusco-infection lowers Th1 and Th2 cytokine serological concentration when compared toF.hepaticainfection alone.E.granulosusinfections show no difference in IFN-gamma, IL-1, IL-2, IL-6 and IL-18 levels compared with control animals, highlighting the immune evasion mechanisms of this cestode.	[Correa, Felipe; Hidalgo, Christian; Stoore, Caroll; Jimenez, Mauricio; Paredes, Rodolfo] Univ Andres Bello, Fac Ciencias Vida, Escuela Med Vet, Santiago, Chile; [Correa, Felipe] Univ Pretoria, Fac Vet Sci, Dept Compan Anim Clin Studies, Pretoria, South Africa; [Hidalgo, Christian] Univ OHiggins, Inst Ciencias Agroalimentarias Anim & Ambientales, San Fernando, Chile; [Hernandez, Marcela] Univ Chile, Fac Odontol, Lab Biol Periodontal, Santiago, Chile; [Hernandez, Marcela] Univ Chile, Fac Odontol, Dept Patol & Med Oral, Santiago, Chile	Universidad Andres Bello; University of Pretoria; Universidad de O'Higgins; Universidad de Chile; Universidad de Chile	Paredes, R (corresponding author), Univ Andres Bello, Fac Ciencias Vida, Escuela Med Vet, Santiago, Chile.	rparedes@unab.cl	/AHC-8464-2022; Hernández, Marcela/I-3266-2013	Hernández, Marcela/0000-0001-8289-7314; paredes, rodolfo/0000-0002-5909-9362	Agencia Nacional de Investigacion y Desarrollo (ANID)/Chile [FONDECYT 1190817]	Agencia Nacional de Investigacion y Desarrollo (ANID)/Chile	RP received a grant from Agencia Nacional de Investigacion y Desarrollo (ANID)/Chile (grant number FONDECYT 1190817). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait AS, 2006, CELL MOL BIOL, V52, P65, DOI 10.1170/T699; Amri M, 2007, J INTERF CYTOK RES, V27, P781, DOI 10.1089/jir.2007.0003; Amri M, 2009, EUR CYTOKINE NETW, V20, P63, DOI 10.1684/ecn.2009.0154; Amri M, 2008, EUR CYTOKINE NETW, V19, P142, DOI 10.1684/ecn.2008.0131; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; [Anonymous], 2003, REV ESTUDIOS HIST JU, V25, P189; Balbinotti H, 2012, VET PARASITOL, V188, P255, DOI 10.1016/j.vetpar.2012.04.007; Behnke JM, 2008, PARASITOLOGY, V135, P751, DOI 10.1017/S0031182008000334; BOOTH M, 1992, PARASITOLOGY, V105, P151, DOI 10.1017/S0031182000073807; Casulli A, 2019, TRENDS PARASITOL, V35, P663, DOI 10.1016/j.pt.2019.05.006; Chandrasekhar S, 2009, INDIAN J MED RES, V130, P731; Clery D, 1996, VET PARASITOL, V62, P71, DOI 10.1016/0304-4017(95)00858-6; Conchedda M., 2004, Parassitologia (Rome), V46, P375; Correa F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197620; Del Vecchio M, 2007, CLIN CANCER RES, V13, P4677, DOI 10.1158/1078-0432.CCR-07-0776; Deplazes P, 2017, ADV PARASIT, V95, P315, DOI 10.1016/bs.apar.2016.11.001; Diaz A, 2007, EUR J IMMUNOL, V37, P3319, DOI 10.1002/eji.200737765; Diaz A, 2011, TRENDS PARASITOL, V27, P263, DOI 10.1016/j.pt.2011.01.008; Druilhe P, 2005, TRENDS PARASITOL, V21, P359, DOI 10.1016/j.pt.2005.06.011; Flynn RJ, 2009, TRANSBOUND EMERG DIS, V56, P269, DOI 10.1111/j.1865-1682.2009.01075.x; Flynn RJ, 2007, INFECT IMMUN, V75, P1373, DOI 10.1128/IAI.01445-06; Getaw A, 2010, ACTA TROP, V113, P221, DOI 10.1016/j.actatropica.2009.10.019; Gottstein B, 2017, ADV PARASIT, V96, P1, DOI 10.1016/bs.apar.2016.09.005; Hidalgo C, 2020, PARASITOL RES, V119, P763, DOI 10.1007/s00436-019-06578-2; Hidalgo C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211542; Hidalgo C, 2016, VET PARASITOL, V218, P43, DOI 10.1016/j.vetpar.2015.12.026; Hotez PJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001475; Jankovic D, 2001, TRENDS IMMUNOL, V22, P450, DOI 10.1016/S1471-4906(01)01975-5; Jimenez M, 2020, VET PATHOL, V57, P108, DOI 10.1177/0300985819875721; Katz L, 2011, ECON J WATCH, V8, P236; MAIZELS RM, 1993, NATURE, V365, P797, DOI 10.1038/365797a0; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Mezioug D, 2009, PARASITE, V16, P57, DOI 10.1051/parasite/2009161057; Mondragon-De-la-Pena C, 2002, PARASITE, V9, P351, DOI 10.1051/parasite/2002094351; Negash K, 2013, T ROY SOC TROP MED H, V107, P229, DOI 10.1093/trstmh/trt003; Paredes R, 2011, J CELL BIOCHEM, V112, P189, DOI 10.1002/jcb.22916; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; Pednekar RP, 2009, VET PARASITOL, V165, P58, DOI 10.1016/j.vetpar.2009.06.021; Rigano R, 2004, PARASITE IMMUNOL, V26, P45, DOI 10.1111/j.0141-9838.2004.00682.x; Rigano R, 2001, INFECT IMMUN, V69, P288, DOI 10.1128/IAI.69.1.288-296.2001; Rigano R, 2007, INFECT IMMUN, V75, P1667, DOI 10.1128/IAI.01156-06; Rogan MT, 1998, PARASITE IMMUNOL, V20, P527, DOI 10.1046/j.1365-3024.1998.00180.x; Romig T, 2017, ADV PARASIT, V95, P213, DOI 10.1016/bs.apar.2016.11.002; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; SCOTT P, 1993, SCIENCE, V260, P496, DOI 10.1126/science.8097337; SHER A, 1992, ANNU REV IMMUNOL, V10, P385, DOI 10.1146/annurev.iy.10.040192.002125; Siracusano A, 2008, INT J PARASITOL, V38, P1371, DOI 10.1016/j.ijpara.2008.06.003; Siracusano A, 2008, EXP PARASITOL, V119, P483, DOI 10.1016/j.exppara.2008.01.016; Stoore C, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3128-6; Thompson RCA, 2017, ADV PARASIT, V95, P65, DOI 10.1016/bs.apar.2016.07.001; Touil-Boukoffa C, 1998, BIOCHIMIE, V80, P739, DOI 10.1016/S0300-9084(99)80027-3; TouilBoukoffa C, 1997, J INTERF CYTOK RES, V17, P211, DOI 10.1089/jir.1997.17.211; TRINCHIERI G, 1994, BLOOD, V84, P4008, DOI 10.1182/blood.V84.12.4008.bloodjournal84124008; Vazquez-Prieto S, 2015, VET PARASITOL, V209, P268, DOI 10.1016/j.vetpar.2015.02.032; Wang JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055379; Wang ZS, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0031-7; Worms Nacher M., 2002, PARASITE IMMUNOL, V24, P391; 2012, INSIDE US TRADE, V0012, P00016	58	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238909	10.1371/journal.pone.0238909	http://dx.doi.org/10.1371/journal.pone.0238909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915902	Green Published, gold			2022-12-26	WOS:000571887500007
J	Ebisawa, S; Kohsaka, S; Muramatsu, T; Kashima, Y; Okamura, A; Yamane, M; Sakurada, M; Matsuno, S; Kijima, M; Habara, M				Ebisawa, Soichiro; Kohsaka, Shun; Muramatsu, Toshiya; Kashima, Yoshifumi; Okamura, Atsunori; Yamane, Masahisa; Sakurada, Masami; Matsuno, Shunsuke; Kijima, Mikihiro; Habara, Maoto			Derivation and validation of the J-CTO extension score for pre-procedural prediction of major adverse cardiac and cerebrovascular events in patients with chronic total occlusions	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; EVEROLIMUS-ELUTING STENTS; ANGIOGRAPHIC SUCCESS; OUTCOMES; GUIDEWIRE; REVASCULARIZATION; INSIGHTS; REGISTRY; SYSTEM	We developed a prediction model of long-term risk after percutaneous coronary intervention (PCI) for coronary chronic total occlusion (CTO) based on pre-procedural clinical information. A total of 4,139 eligible patients, who underwent CTO-PCI at 52 Japanese centers were included. Specifically, 1,909 patients with 1-year data were randomly divided into the derivation (n = 1,273) and validation (n = 636) groups. Major adverse cardiac and cardiovascular event (MACCE) was the primary endpoint, including death, stroke, revascularization, and non-fatal myocardial infarction. We assessed the performance of our model using the area under the receiver operating characteristic curve (AUC) and assigned a simplified point-scoring system. One-hundred-thirty-eight (10.8%) patients experienced MACCE in the derivation cohort with hemodialysis (HD: odds ratio [OR] = 2.55), left ventricular ejection fractions (LVEF) <35% (OR = 2.23), in-stent occlusions (ISO: OR = 2.27), and diabetes mellitus (DM: OR = 1.72). The AUC of the derivation model was 0.650. The model's performance was similar in the validation cohort (AUC, 0.610). When assigned a point for each associated factor (HD = 3, LVEF <35%, ISO = 2, and DM = 1 point), the average predicted versus the observed MACCE probability using the Japan-CTO extension score for the low, moderate, high, and very high risk groups was 8.1% vs. 7.3%, 16.9% vs. 15.9%, 22.0% vs. 26.1%, and 56.2% vs. 44.4%, respectively. This novel risk model may allow for the estimation of long-term risk and be useful in disseminating appropriate revascularization procedures.	[Ebisawa, Soichiro] Shinshu Univ, Dept Cardiovasc Med, Sch Med, Matsumoto, Nagano, Japan; [Kohsaka, Shun] Keio Univ, Dept Cardiol, Sch Med, Tokyo, Japan; [Muramatsu, Toshiya] Tokyo Gen Hosp, Cardiovasc Ctr, Tokyo, Japan; [Kashima, Yoshifumi] Sapporo Cardio Vasc Clin, Div Cardiol, Sapporo, Hokkaido, Japan; [Okamura, Atsunori] Sakurabashi Watanabe Hosp, Div Cardiol, Osaka, Japan; [Yamane, Masahisa] Saitama Sekishinkai Hosp, Cardiol Dept, Saitama, Japan; [Sakurada, Masami] Tokorozawa Heart Ctr, Dept Cardiol, Saitama, Japan; [Matsuno, Shunsuke] Cardiovasc Inst, Dept Cardiovasc Med, Tokyo, Japan; [Kijima, Mikihiro] Hoshi Gen Hosp, Cardiol & Vasc Med, Fukushima, Japan; [Habara, Maoto] Toyohashi Heart Ctr, Dept Cardiovasc Med, Toyohashi, Aichi, Japan	Shinshu University; Keio University; Toyohashi Heart Center	Ebisawa, S (corresponding author), Shinshu Univ, Dept Cardiovasc Med, Sch Med, Matsumoto, Nagano, Japan.	ebifender@yahoo.co.jp		Ebisawa, Soichiro/0000-0002-6146-9959	Medtronic Japan Co.,Ltd.	Medtronic Japan Co.,Ltd.	Soichiro Ebisawa belongs to Endowed Department of Cardiovascular Medicine of Shinshu University supported by Medtronic Japan Co.,Ltd. Abbott Vascular Japan Co.,Ltd. Boston Scientific Japan, TERUMO CORPORATION, Cardinal Health Japan and NIPRO CORPORATION. The funders provided support in the form of salaries for Soichiro Ebisawa, but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alessandrino G, 2015, JACC-CARDIOVASC INTE, V8, P1540, DOI 10.1016/j.jcin.2015.07.009; [Anonymous], 2017, J PEDIAT REHAB MED, V10, ps1; Christakopoulos GE, 2017, CAN J CARDIOL, V33, P478, DOI 10.1016/j.cjca.2016.11.002; Christopoulos G, 2016, JACC-CARDIOVASC INTE, V9, P1, DOI 10.1016/j.jcin.2015.09.022; Danek BA, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004272; Escaned J, 2017, EUR HEART J, V38, P3124, DOI 10.1093/eurheartj/ehx512; Forouzandeh F, 2018, AM J CARDIOL, V121, P14, DOI 10.1016/j.amjcard.2017.09.013; George S, 2014, J AM COLL CARDIOL, V64, P235, DOI 10.1016/j.jacc.2014.04.040; Ikari Y, 2017, INT J CARDIOL, V227, P94, DOI 10.1016/j.ijcard.2016.11.076; Jones DA, 2012, JACC-CARDIOVASC INTE, V5, P380, DOI 10.1016/j.jcin.2012.01.012; Kandzari DE, 2015, JACC-CARDIOVASC INTE, V8, P761, DOI 10.1016/j.jcin.2014.12.238; Karatasakis A, 2017, CATHETER CARDIO INTE, V89, pE90, DOI 10.1002/ccd.26568; Kato M, 2012, AM J CARDIOL, V110, P1282, DOI 10.1016/j.amjcard.2012.06.032; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Mehran R, 2011, JACC-CARDIOVASC INTE, V4, P952, DOI 10.1016/j.jcin.2011.03.021; Michael TT, 2015, CATHETER CARDIO INTE, V85, P393, DOI 10.1002/ccd.25359; Morino Y, 2011, JACC-CARDIOVASC INTE, V4, P213, DOI 10.1016/j.jcin.2010.09.024; Patel VG, 2013, JACC-CARDIOVASC INTE, V6, P128, DOI 10.1016/j.jcin.2012.10.011; Peterson ED, 2010, J AM COLL CARDIOL, V55, P1923, DOI 10.1016/j.jacc.2010.02.005; Prasad A, 2007, J AM COLL CARDIOL, V49, P1611, DOI 10.1016/j.jacc.2006.12.040; Sanguineti F, 2017, EUROINTERVENTION, V12, P1889, DOI 10.4244/EIJ-D-15-00278; Sapontis J, 2017, JACC-CARDIOVASC INTE, V10, P1523, DOI 10.1016/j.jcin.2017.05.065; Teeuwen K, 2017, JACC-CARDIOVASC INTE, V10, P133, DOI 10.1016/j.jcin.2016.10.017; Teramoto T, 2017, IJC HEART VASC, V14, P28, DOI 10.1016/j.ijcha.2016.11.001; Weintraub WS, 2016, CIRCULATION, V133, P1807; Werner GS, 2003, CIRCULATION, V107, P1972, DOI 10.1161/01.CIR.0000061953.72662.3A	26	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238640	10.1371/journal.pone.0238640	http://dx.doi.org/10.1371/journal.pone.0238640			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915843	Green Published, gold			2022-12-26	WOS:000571887500034
J	Hossain, MT; Ahammed, B; Chanda, SK; Jahan, N; Ela, MZ; Islam, MN				Hossain, Md Tanvir; Ahammed, Benojir; Chanda, Sanjoy Kumar; Jahan, Nusrat; Ela, Mahfuza Zaman; Islam, Md Nazrul			Social and electronic media exposure and generalized anxiety disorder among people during COVID-19 outbreak in Bangladesh: A preliminary observation	PLOS ONE			English	Article							SUICIDE; IMPACT; PREVALENCE; EPIDEMIC; WAR	Classified as a pandemic by the World Health Organization, the novel Coronavirus Disease (COVID-19) has spread to Bangladesh since early March of 2020, and people are getting daily updates from the social and electronic media. We aimed at assessing the prevalence of anxiety among Bangladeshi people during the pandemic in connection with social media exposure (SME) and electronic media exposure (EME). For this cross-sectional study, data were collected from 880 participants by a self-administered online-based questionnaire relating personal characteristics, self-rate health (SRH), SME, and EME with anxiety. Findings show that around half of the surveyed population experienced a spike of anxiety (49.1%) during the pandemic, ten times higher than the national anxiety rate in 2019. The participants with an increased SME of over four hours per day experienced a higher level of anxiety than individuals with < = 2 hours exposure to social media. Similarly, the anxiety was higher among people with fair/bad SRH compared to individuals with excellent SRH. It is highly recommended to develop active surveillance and effective monitoring systems to reduce the spread of misinformation from both social and electronic media to improve the state of mental health conditions during the pandemic.	[Hossain, Md Tanvir; Chanda, Sanjoy Kumar; Jahan, Nusrat; Ela, Mahfuza Zaman] Khulna Univ, Social Sci Sch, Sociol Discipline, Khulna, Bangladesh; [Ahammed, Benojir] Khulna Univ, Stat Discipline, Sci Engn & Technol Sch, Khulna, Bangladesh; [Chanda, Sanjoy Kumar] Univ Leeds, Fac Med & Hlth, Sch Healthcare, Leeds, W Yorkshire, England; [Islam, Md Nazrul] Khulna Univ, Life Sci Sch, Forestry & Wood Technol Discipline, Khulna, Bangladesh	Khulna University; Khulna University; University of Leeds; Khulna University	Hossain, MT (corresponding author), Khulna Univ, Social Sci Sch, Sociol Discipline, Khulna, Bangladesh.	tanvirku05@soc.ku.ac.bd	Jahan, Nusrat/ABD-2676-2021; Hossain, Md. Tanvir/AAS-3339-2021	Jahan, Nusrat/0000-0002-3043-2707; Hossain, Md. Tanvir/0000-0003-0315-6900; Chanda, Sanjoy Kumar/0000-0001-5950-5511				Ahorsu DK, 2022, INT J MENT HEALTH AD, V20, P1537, DOI 10.1007/s11469-020-00270-8; Al Mamun MA, 2019, PSYCHIAT RES, V271, P628, DOI 10.1016/j.psychres.2018.12.039; Alikhani R, 2020, CAN J ANESTH, V67, P1068, DOI 10.1007/s12630-020-01650-3; [Anonymous], 2020, DAILY STAR; [Anonymous], 2020, PROTHOM ALO; [Anonymous], 2020, LANCET, V395, P922, DOI 10.1016/S0140-6736(20)30644-9; [Anonymous], 2020, RUSSIA TODAY; Boyce P, 2020, AUST NZ J PSYCHIAT, V54, P341, DOI 10.1177/0004867420915279; Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934; Chaturvedi Santosh K, 2020, J Psychosoc Rehabil Ment Health, V7, P1, DOI 10.1007/s40737-020-00162-z; Cheng Cecilia, 2004, Asian Perspective, V28, P67; Cheung YT, 2008, INT J GERIATR PSYCH, V23, P1231, DOI 10.1002/gps.2056; Choi DH, 2017, COMPUT HUM BEHAV, V72, P422, DOI 10.1016/j.chb.2017.03.004; Cohen J, 2020, SCIENCE, V367, P1287, DOI 10.1126/science.367.6484.1287; Dsouza DD, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113145; Firoz A., 2006, BANGLADESH J PSYCHIA, V20, P9; Forster P, 2020, P NATL ACAD SCI USA, V117, P9241, DOI 10.1073/pnas.2004999117; GAO JL, 2020, PLOS ONE, V15, DOI [DOI 10.1371/JOURNAL.PONE.0231924, 10.1371/journal.pone.0231924]; Garcia-Alamino JM, 2020, INTENS CRIT CARE NUR, V58, DOI 10.1016/j.iccn.2020.102861; Goyal K, 2020, ASIAN J PSYCHIATR, V49, DOI 10.1016/j.ajp.2020.101989; Hopman J, 2020, JAMA-J AM MED ASSOC, V323, P1549, DOI 10.1001/jama.2020.4169; Hossain MD, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0216-9; Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954; Huang YQ, 2019, LANCET PSYCHIAT, V6, P211, DOI 10.1016/S2215-0366(18)30511-X; Institute of Epidemiology Disease Control and Research, 2020, COVID 19 STAT BANGL; Islam MA, PLOS ONE; Islam S, 2022, INT J MENT HEALTH AD, V20, P1289, DOI 10.1007/s11469-020-00242-y; Ji D, 2017, ONCOTARGET, V8, P12784, DOI 10.18632/oncotarget.14498; Lin CY, 2020, SOCIAL HLTH BEHAV, V3, P1, DOI DOI 10.4103/SHB.SHB_11_20; Liu NQ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112921; Lu W, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112936; Mak IWC, 2010, GEN HOSP PSYCHIAT, V32, P590, DOI 10.1016/j.genhosppsych.2010.07.007; Mamun MA, 2020, ASIAN J PSYCHIATR, V54, DOI 10.1016/j.ajp.2020.102295; Mamun MA, 2020, BRAIN BEHAV IMMUN, V87, P163, DOI 10.1016/j.bbi.2020.05.028; Mamun MA, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102073; Maunder R, 2003, CAN MED ASSOC J, V168, P1245; Neria Y, 2011, JAMA-J AM MED ASSOC, V306, P1374, DOI 10.1001/jama.2011.1358; Pakpour A.H., 2020, J CONCURR DISORD, V2, P58, DOI [10.54127/WCIC8036, DOI 10.54127/WCIC8036]; Raffaeta R, 2020, MED ANTHROPOL, V39, P371, DOI 10.1080/01459740.2020.1746300; RAND Corporation, 2020, 36 ITEM SHORT FORM S; Rosner E, 2020, NEW YORK POST; Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083; Shammi M, 2020, PSYCHOSOCIAL SOCIOEC, P2020040398, DOI [10.20944/preprints202004.0398.v1, DOI 10.20944/PREPRINTS202004.0398.V1]; Shaw SCK, 2020, NURSE EDUC PRACT, V44, DOI 10.1016/j.nepr.2020.102780; Shultz JM, 2015, JAMA-J AM MED ASSOC, V313, P567, DOI 10.1001/jama.2014.17934; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Su TP, 2007, J PSYCHIATR RES, V41, P119, DOI 10.1016/j.jpsychires.2005.12.006; Trifan A, 2020, UNDERSTANDING DEPRES; Usman N., 2020, SOC HLTH BEHAV, V3, P75, DOI [10.4103/SHB.SHB_26_20, 10.4103/shb.shb_26_20]; Walsh JP, 2020, INT J CULTURAL STUD, V23, P840, DOI 10.1177/1367877920912257; Wang YC, 2020, PROCEEDINGS OF INTERNATIONAL CONFERENCE ON HIGH PERFORMANCE COMPUTING IN ASIA-PACIFIC REGION (HPC ASIA 2021), P1, DOI 10.1145/3432261.3432262; WASSERMAN IM, 1992, SUICIDE LIFE-THREAT, V22, P240; WHO, 2020, WHO COR COVID 19 DAS; World Health Organization, 2017, DEPR OTH MENT HLTH D; World Health Organization, 2020, DIR GEN OP REM MED B; Wright AL, 2021, ADMIN SCI QUART, V66, P42, DOI 10.1177/0001839220916401; Zandifar A, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.101990; Zhang SX, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112958; Zheng Y, 2020, ANATOLIA, V31, P337, DOI 10.1080/13032917.2020.1747208	59	39	40	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238974	10.1371/journal.pone.0238974	http://dx.doi.org/10.1371/journal.pone.0238974			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9MU	32916691	Green Published, gold			2022-12-26	WOS:000571887500046
J	Terada-Ikeda, C; Kitabatake, M; Hiraku, A; Kato, K; Yasui, S; Imakita, N; Ouji-Sageshima, N; Iwabuchi, N; Hamada, K; Ito, T				Terada-Ikeda, Chiyoko; Kitabatake, Masahiro; Hiraku, Akari; Kato, Kumiko; Yasui, Satsuki; Imakita, Natsuko; Ouji-Sageshima, Noriko; Iwabuchi, Noriyuki; Hamada, Kaoru; Ito, Toshihiro			Maternal supplementation with Bifidobacterium breve M-16V prevents their offspring from allergic airway inflammation accelerated by the prenatal exposure to an air pollutant aerosol	PLOS ONE			English	Article							JAPANESE CEDAR POLLINOSIS; IMMUNE-RESPONSES; GUT MICROBIOTA; ASTHMA; PARTICLES; PREGNANCY; MICE; TRANSMISSION; PROBIOTICS; SYMPTOMS	Bifidobacterium breveM-16V is a probiotic bacterial strain with efficacy in infants achieved by suppressing T-helper type (Th) 2 immune responses and modulating the systemic Th1/Th2 balance. Exposure to air pollution during pregnancy increases asthma susceptibility in offspring. The aim of this study was to investigate the effects of the maternal intake ofB.breveM-16V on susceptibility to asthma accelerated by prenatal exposure to air pollution. The intake ofB.breveM-16V in residual oil fly ash (ROFA)-exposed pregnant mice resulted in fewer eosinophils in the bronchoalveolar lavage fluid of neonatal mice and reduced allergic lung inflammation. The expressions of Th2 cytokines including IL-5 and IL-13 were decreased in neonatal mice from ROFA-exposed mothers fedB.breveM-16V. The analysis of fecal microbiota from neonatal mice revealed that the intake ofB.breveM-16V by mothers changed the composition of fecal microbiota in neonatal mice, which resulted in a decreased population ofFirmicutes. Moreover, several bacterial strains of fecal microbiota from neonatal mice had a strong correlation with Th2 cytokines and histological score. These results suggest that the maternal intake of M-16V might have beneficial effects in neonates by preventing and/or alleviating allergic reactions accelerated by prenatal exposure to air pollution.	[Terada-Ikeda, Chiyoko; Kitabatake, Masahiro; Yasui, Satsuki; Imakita, Natsuko; Ouji-Sageshima, Noriko; Ito, Toshihiro] Nara Med Univ, Dept Immunol, Kashihara, Nara, Japan; [Hiraku, Akari; Iwabuchi, Noriyuki] Morinaga Milk Ind Co Ltd, R&D Div, Food Ingredients & Technol Inst, Zama, Japan; [Kato, Kumiko] Morinaga Milk Ind Co Ltd, R&D Div, Next Generat Sci Inst, Zama, Japan; [Hamada, Kaoru] Nara Med Univ, Fac Nursing, Dept Clin & Invest Med, Kashihara, Nara, Japan	Nara Medical University; Morinaga Milk Industry Company, Ltd; Morinaga Milk Industry Company, Ltd; Nara Medical University	Ito, T (corresponding author), Nara Med Univ, Dept Immunol, Kashihara, Nara, Japan.	toshi-ito@naramed-u.ac.jp			Morinaga Milk Industry Co., Ltd.	Morinaga Milk Industry Co., Ltd.	This study was supported by research grants from Morinaga Milk Industry Co., Ltd. The funder provided support in the form of salaries for A. Hiraku, K. Kato and N. Iwabuchi, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Abe F, 2010, ANAEROBE, V16, P131, DOI 10.1016/j.anaerobe.2009.07.006; Boyle RJ, 2011, ALLERGY, V66, P509, DOI 10.1111/j.1398-9995.2010.02507.x; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cavani A, 2003, J IMMUNOL, V171, P5760, DOI 10.4049/jimmunol.171.11.5760; Coretti L, 2017, SCI REP-UK, V7, DOI 10.1038/srep45356; Corson Lin, 2010, Allergy Asthma Clin Immunol, V6, P7, DOI 10.1186/1710-1492-6-7; Demirci M, 2019, ALLERGOL IMMUNOPATH, V47, P365, DOI 10.1016/j.aller.2018.12.009; Dotterud CK, 2010, BRIT J DERMATOL, V163, P616, DOI 10.1111/j.1365-2133.2010.09889.x; Durack J, 2018, J ALLERGY CLIN IMMUN, V141, P82, DOI 10.1016/j.jaci.2017.05.026; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fedulov AV, 2008, AM J RESP CELL MOL, V38, P57, DOI 10.1165/rcmb.2007-0124OC; Frati F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010123; Gern JE, 1999, J CLIN INVEST, V104, P837, DOI 10.1172/JCI8272; Gregory DJ, 2017, AM J PHYSIOL-LUNG C, V313, pL395, DOI 10.1152/ajplung.00035.2017; Hamada K, 2003, J IMMUNOL, V170, P1683, DOI 10.4049/jimmunol.170.4.1683; Hamada K, 2000, AM J RESP CRIT CARE, V161, P1285, DOI 10.1164/ajrccm.161.4.9906137; Hamada K, 2007, J TOXICOL ENV HEAL A, V70, P688, DOI 10.1080/15287390600974692; Hattori Kazuhiro, 2003, Arerugi, V52, P20; Heul AV, 2019, CLIN REV ALLERG IMMU, V57, P350, DOI 10.1007/s12016-018-8719-7; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Hougee S, 2010, INT ARCH ALLERGY IMM, V151, P107, DOI 10.1159/000236000; Imakita N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36489-8; Inoue Y, 2009, BIOL PHARM BULL, V32, P760, DOI 10.1248/bpb.32.760; ITO T, 2005, ALLERGOL INT, V54, P601; Ito T, 2007, EUR J IMMUNOL, V37, P2847, DOI 10.1002/eji.200737603; Izumi H, 2015, PEDIATR RES, V78, P407, DOI 10.1038/pr.2015.115; Julia V, 2015, NAT REV IMMUNOL, V15, P308, DOI 10.1038/nri3830; Kubo M, 2017, IMMUNOL REV, V278, P162, DOI 10.1111/imr.12557; Kuczynski J, 2012, CURR PROTOC CHEM BIO, V1, P1, DOI DOI 10.1002/9780471729259.MC01E05S27.USING; Lambrecht BN, 2019, IMMUNITY, V50, P975, DOI 10.1016/j.immuni.2019.03.018; Larose MC, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00136; Li XX, 2020, HEPATOL RES, V50, P5, DOI 10.1111/hepr.13444; Li YD, 2004, PEDIATR INT, V46, P509, DOI 10.1111/j.1442-200x.2004.01953.x; Manners S, 2014, J ALLERGY CLIN IMMUN, V134, P63, DOI 10.1016/j.jaci.2013.10.047; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Odamaki T, 2007, J MED MICROBIOL, V56, P1301, DOI 10.1099/jmm.0.47306-0; Odamaki T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18391-x; Patole SK, 2016, DIABETOL STOFFWECHS, V11, pe0150775; Ptaschinski C, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004978; Rautava S, 2012, J ALLERGY CLIN IMMUN, V130, P1355, DOI 10.1016/j.jaci.2012.09.003; Saraf MK, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0297-z; Sjodin KS, 2016, CURR OPIN ALLERGY CL, V16, P390, DOI 10.1097/ACI.0000000000000277; Snyder JE, 2000, TOXICOL SCI, V57, P87, DOI 10.1093/toxsci/57.1.87; Steerenberg PA, 2003, J TOXICOL ENV HEAL A, V66, P1421, DOI 10.1080/15287390306415; Taniuchi S., 2005, Journal of Applied Research, V5, P387; Tannock GW, 2013, APPL ENVIRON MICROB, V79, P3040, DOI 10.1128/AEM.03910-12; Thorburn AN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8320; van der Aa LB, 2011, ALLERGY, V66, P170, DOI 10.1111/j.1398-9995.2010.02416.x; von Mutius E, 2000, J ALLERGY CLIN IMMUN, V105, P9, DOI 10.1016/S0091-6749(00)90171-4; Wang X, 2017, DIABETOLOGIE STOF S2, V12, pe0171721; Wong CB, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081724; Xiao JZ, 2006, CLIN EXP ALLERGY, V36, P1425, DOI 10.1111/j.1365-2222.2006.02575.x	53	12	12	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238923	10.1371/journal.pone.0238923	http://dx.doi.org/10.1371/journal.pone.0238923			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915886	Green Published, gold			2022-12-26	WOS:000571887500025
J	Molin, WT; Patterson, EL; Saski, CA				Molin, William T.; Patterson, Eric L.; Saski, Christopher A.			Homogeneity among glyphosate-resistantAmaranthus palmeriin geographically distant locations	PLOS ONE			English	Article							GENE AMPLIFICATION; READ ALIGNMENT; LINKAGE DRAG; FITNESS COST; RESISTANCE	Since the initial report of glyphosate-resistant (GR)Amaranthus palmeriS. Watson in 2006, resistant populations have been reported in 28 states. The mechanism of resistance is amplification of a 399-kb extrachromosomal circular DNA, called theEPSPSreplicon, and is unique to glyphosate-resistant plants. The replicon contains a single copy of the 10-kb 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) gene which causes the concomitant increased expression of EPSP synthase, the target enzyme of glyphosate. It is not known whether the resistance by this amplification mechanism evolved once and then spread across the country or evolved independently in several locations. To compare genomic representation and variation across theEPSPSreplicon, whole genome shotgun sequencing (WGS) and mapping of sequences from both GR and susceptible (GS) biotypes to the replicon consensus sequence was performed. Sampling of GR biotypes from AZ, KS, GA, MD and DE and GS biotypes from AZ, KS and GA revealed complete contiguity and deep representation with sequences from GR plants, but lack of homogeneity and contiguity with breaks in coverage were observed with sequences from GS biotypes. The high sequence conservation among GR biotypes with very few polymorphisms which were widely distributed across the USA further supports the hypothesis that glyphosate resistance most likely originated from a single population. We show that the replicon from different populations was unique to GR plants and had similar levels of amplification.	[Molin, William T.] USDA, Crop Prod Syst Res Unit, Stoneville, MS 38776 USA; [Patterson, Eric L.] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Saski, Christopher A.] Clemson Univ, Dept Plant & Environm Sci, Clemson, SC 29634 USA	United States Department of Agriculture (USDA); Michigan State University; Clemson University	Molin, WT (corresponding author), USDA, Crop Prod Syst Res Unit, Stoneville, MS 38776 USA.; Saski, CA (corresponding author), Clemson Univ, Dept Plant & Environm Sci, Clemson, SC 29634 USA.	william.molin@usda.gov; saski@clemson.edu						Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BROWN AHD, 1989, J HERED, V80, P234, DOI 10.1093/oxfordjournals.jhered.a110841; Chahal PS, 2017, WEED TECHNOL, V31, P80, DOI 10.1614/WT-D-16-00109.1; Chandi A, 2012, INT J AGRON, V2012, DOI 10.1155/2012/176108; Culpepper AS, 2006, WEED SCI, V54, P620, DOI 10.1614/WS-06-001R.1; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Gaines TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065819; Gaines TA, 2011, J AGR FOOD CHEM, V59, P5886, DOI 10.1021/jf104719k; Gaines TA, 2010, P NATL ACAD SCI USA, V107, P1029, DOI 10.1073/pnas.0906649107; Giacomini D, 2014, WEED SCI, V62, P29, DOI 10.1614/WS-D-13-00066.1; Giacomini DA, 2019, WEED SCI, V67, P176, DOI 10.1017/wsc.2018.65; Heap I, INT SURVEY HERBICIDE; HIROCHIKA H, 1995, GENE, V165, P229, DOI 10.1016/0378-1119(95)00581-P; Koo DH, 2018, P NATL ACAD SCI USA, V115, P3332, DOI 10.1073/pnas.1719354115; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kupper A, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00029; Lanciano S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006630; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Molin WT, 2020, PLANT CELL, V32, P2132, DOI 10.1105/tpc.20.00099; Molin WT, 2018, PEST MANAG SCI, V74, P1109, DOI 10.1002/ps.4659; Molin WT, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3336-4; Moller HD, 2016, G3-GENES GENOM GENET, V6, P453, DOI 10.1534/g3.115.025858; Moller HD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03369-8; Patterson EL, 2018, J HERED, V109, P117, DOI 10.1093/jhered/esx087; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sammons RD, 2014, PEST MANAG SCI, V70, P1367, DOI 10.1002/ps.3743; Vila-Aiub MM, 2019, NEW PHYTOL, V223, P532, DOI 10.1111/nph.15733; Vila-Aiub MM, 2014, PLANTA, V239, P793, DOI 10.1007/s00425-013-2022-x; Webster TM, 2012, WEED SCI, V60, P145, DOI 10.1614/WS-D-11-00092.1; ZEVEN AC, 1983, EUPHYTICA, V32, P319, DOI 10.1007/BF00021440	33	10	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2020	15	9							e0233813	10.1371/journal.pone.0233813	http://dx.doi.org/10.1371/journal.pone.0233813			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR4MY	32903277	Green Submitted, gold, Green Published			2022-12-26	WOS:000571539500016
J	Wu, C; Iwamoto, T; Hossain, MA; Akiyama, K; Igarashi, J; Miyajima, T; Eto, Y				Wu, Chen; Iwamoto, Takeo; Hossain, Mohammad Arif; Akiyama, Keiko; Igarashi, Junko; Miyajima, Takashi; Eto, Yoshikatsu			A combination of 7-ketocholesterol, lysosphingomyelin and bile acid-408 to diagnose Niemann-Pick disease type C using LC-MS/MS	PLOS ONE			English	Article							PLASMA CHOLESTANE-3-BETA,5-ALPHA,6-BETA-TRIOL; RAPID DIAGNOSIS; FABRY DISEASE; DISORDERS; IDENTIFICATION; BIOMARKER; ONSET	Background Niemann-Pick disease type C (NPC) is an autosomal recessive disorder caused by mutations ofNPC1orNPC2, which encode the proteins that are responsible for intracellular cholesterol trafficking. Loss of this function results in the accumulation of cholesterol-related products, such as oxysterols, sphingolipids, and NPC-related bile acids, which were recently used as biochemical biomarkers for the diagnosis of NPC. Bile acid-408 is a new significant compound we found in Japanese NPC patients, and it likely belongs to the category of bile acids. However, the diagnosis of NPC using a single biomarker is not satisfactory for clinical application because of the high instance of false negatives or positives. Therefore, we proposed an application of NPC diagnosis using a combination of 7-ketocholesterol (7-KC), lysosphingomyelin (lysoSM), bile acid-408 and/or glucosylsphingosine (lysoGL-1). Methods and findings 7-KC, lysoSM and lysoGL-1 in sera and bile acid-408 in dried blood spots (DBS) were quantified within 17 minutes using tandem mass spectrometry and high-resolution mass spectrometry, respectively. We measured these biomarkers in NPC patients (n = 19), X-linked adrenoleukodystrophy (X-ALD) patients (n = 5), patients with other lysosomal diseases (n = 300), newborns (n = 124) and healthy people (n = 74). Our results showed a promising accuracy (97%) for NPC diagnosis using the combination of 7-KC, lysoSM and bile acid-408. However, contrary to our expectations, lysoGL-1 levels did not present at a significantly greater amount in NPC patients than other patients and negative controls. Conclusions The combination of 7-KC, lysoSM and bile acid-408 improves the accuracy of NPC diagnosis and is feasible for mass screening due to its simple sample preparation and measurement. Future research should investigate the chemical structure of bile acid-408 to further facilitate its advantage in diagnosis.	[Wu, Chen; Hossain, Mohammad Arif; Akiyama, Keiko; Miyajima, Takashi; Eto, Yoshikatsu] Shin Yurigaoka Gen Hosp, Adv Clin Res Ctr, Inst Neurol Disorders, Kawasaki, Kanagawa, Japan; [Wu, Chen; Igarashi, Junko; Miyajima, Takashi] AnGes, Rare Dis Res Ctr, Kawasaki, Kanagawa, Japan; [Iwamoto, Takeo] Jikei Univ, Core Res Facil Basic Sci, Sch Med, Tokyo, Japan	Jikei University	Wu, C (corresponding author), Shin Yurigaoka Gen Hosp, Adv Clin Res Ctr, Inst Neurol Disorders, Kawasaki, Kanagawa, Japan.; Wu, C (corresponding author), AnGes, Rare Dis Res Ctr, Kawasaki, Kanagawa, Japan.	chenwu.violet@gmail.com		Hossain, Mohammad Arif/0000-0002-6598-7403	AnGes Inc. [17K10067]	AnGes Inc.	This work was partly supported by Grant-in-Aid for Scientific Research (C) (17K10067). Additionally, AnGes Inc. provided support in the form of salaries for authors [C. Wu, J. Igarashi, T. Miyajima], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Boenzi S, 2016, J LIPID RES, V57, P361, DOI 10.1194/jlr.M061978; Boenzi S, 2014, CLIN CHIM ACTA, V437, P93, DOI 10.1016/j.cca.2014.07.010; Bremova T, 2015, NEUROLOGY, V85, P1368, DOI 10.1212/WNL.0000000000002041; Chandler RJ, 2017, HUM MOL GENET, V26, P52, DOI 10.1093/hmg/ddw367; Chuang WL, 2014, MOL GENET METAB, V111, P209, DOI 10.1016/j.ymgme.2013.11.012; Cougnoux A, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.16; Giese AK, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0274-1; Hopkin RJ, 2016, MOL GENET METAB, V117, P104, DOI 10.1016/j.ymgme.2015.10.007; Jiang XT, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2326; Jiang XT, 2011, J LIPID RES, V52, P1435, DOI 10.1194/jlr.D015735; Klouwer FCC, ZELLWEGER SPECTRUM D; Klouwer FCC, 2017, J INHERIT METAB DIS, V40, P875, DOI 10.1007/s10545-017-0064-0; Kuchar L, 2017, ANAL BIOCHEM, V525, P73, DOI 10.1016/j.ab.2017.02.019; Mashima R, 2018, MOL GENET METAB REP, V15, P90, DOI 10.1016/j.ymgmr.2018.03.005; Mazzacuva F, 2016, FEBS LETT, V590, P1651, DOI 10.1002/1873-3468.12196; Nowak A, 2017, MOL GENET METAB, V120, P57, DOI 10.1016/j.ymgme.2016.10.006; Ortiz A, 2018, MOL GENET METAB, V123, P416, DOI 10.1016/j.ymgme.2018.02.014; Pastores GM., 1993, GENEREVIEWS; Patterson M., 1993, GENEREVIEWS R; Patterson MC, 2007, LANCET NEUROL, V6, P765, DOI 10.1016/S1474-4422(07)70194-1; Patterson MC, 2017, NEUROL-CLIN PRACT, V7, P499, DOI 10.1212/CPJ.0000000000000399; Patterson MC, 2012, MOL GENET METAB, V106, P330, DOI 10.1016/j.ymgme.2012.03.012; Patterson MC, ONLINE METABOLIC MOL; Peake KB, 2010, FEBS LETT, V584, P2731, DOI 10.1016/j.febslet.2010.04.047; Pettazzoni M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181700; Reunert J, 2015, JIMD REP, V23, P17, DOI 10.1007/8904_2015_423; Reunert J, 2016, EBIOMEDICINE, V4, P170, DOI 10.1016/j.ebiom.2015.12.018; Rolfs A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079732; Rosenbaum AI, 2011, J NEUROCHEM, V116, P789, DOI 10.1111/j.1471-4159.2010.06976.x; Stampfer M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-35; Stirnemann J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020441; Vanier MT, 2016, MOL GENET METAB, V118, P244, DOI 10.1016/j.ymgme.2016.06.004; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; Vanier MT, 1996, AM J HUM GENET, V58, P118; Vaz FM, 2017, MOL ASPECTS MED, V56, P10, DOI 10.1016/j.mam.2017.03.003; Wassif CA, 2016, GENET MED, V18, P41, DOI 10.1038/gim.2015.25; Welford RWD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114669; Yanjanin NM, 2010, AM J MED GENET B, V153B, P132, DOI 10.1002/ajmg.b.30969; Zhang HW, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-82	39	5	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238624	10.1371/journal.pone.0238624	http://dx.doi.org/10.1371/journal.pone.0238624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ6EE	32898135	Green Published, gold			2022-12-26	WOS:000570962500038
J	Philipovskiy, A; Dwivedi, AK; Gamez, R; McCallum, R; Mukherjee, D; Nahleh, Z; Aguilera, RJ; Gaur, S				Philipovskiy, Alexander; Dwivedi, Alok K.; Gamez, Roberto; McCallum, Richard; Mukherjee, Debabrata; Nahleh, Zeina; Aguilera, Renato J.; Gaur, Sumit			Association between tumor mutation profile and clinical outcomes among Hispanic Latina women with triple-negative breast cancer	PLOS ONE			English	Article							DOUBLE-BLIND; ACTIVATION; SUBTYPES; THERAPY; POSTMENOPAUSAL; CHEMOTHERAPY; INHIBITOR; PATHWAY	Triple-negative breast cancer (TNBC) represents 15%-20% of all breast cancer types. It is more common among African American (AA) and Hispanic-Latina (HL) women. The biology of TNBC in HL women has been poorly characterized, but some data suggest that the molecular drivers of breast cancer might differ. There are no clinical tools to aid medical oncologists with decisions regarding appropriate individualized therapy, and no way to predict long-term outcomes. The aim of this study was to characterize individual patient gene mutation profiles and to identify the relationship with clinical outcomes. We collected formalin-fixed paraffin-embedded tumors (FFPE) from women with TNBC. We analyzed the gene mutation profiles of the collected tumors and compared the results with individual patient's clinical histories and outcomes. Of 25 patients with TNBC, 24 (96%) identified as HL. Twenty-one (84%) had stage III-IV disease. The most commonly mutated genes wereTP53,NOTCH1,NOTCH2,NOTCH3,AKT,MEP3K,PIK3CA, andEGFR. Compared with other international cancer databases, our study demonstrated statistically significant higher frequencies of these genes among HL women. Additionally, a worse clinical course was observed among patients whose tumors had mutations inNOTCHgenes andPIK3CA. This study is the first to identify the most common genetic alterations among HL women with TNBC. Our data strongly support the notion that molecular drivers of breast cancer could differ in HL women compared with other ethnic backgrounds. Therefore, a deeper understanding of the biological mechanisms behindNOTCHgene andPIK3CAmutations may lead to a new treatment approach.	[Philipovskiy, Alexander; Gaur, Sumit] Texas Tech Univ, Hlth Sci Ctr El Paso, Div Hematol Oncol, Dept Internal Med, El Paso, TX 79905 USA; [Dwivedi, Alok K.] Texas Tech Univ, Paul L Foster Sch Med, Dept Mol & Translat Med, Div Biostat & Epidemiol,Hlth Sci Ctr El Paso, El Paso, TX USA; [Gamez, Roberto] Texas Tech Univ, Univ Med Ctr, Dept Pathol, Hlth Sci Ctr El Paso, El Paso, TX USA; [McCallum, Richard] Texas Tech Univ, Dept Internal Med, Div Gastroenterol, Hlth Sci Ctr El Paso, El Paso, TX USA; [Mukherjee, Debabrata] Texas Tech Univ, Dept Internal Med, Div Cardiol, Hlth Sci Ctr El Paso, El Paso, TX USA; [Nahleh, Zeina] Cleveland Clin, Maroone Canc Ctr, Dept Hematol Oncol, Weston, FL USA; [Aguilera, Renato J.] Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Cleveland Clinic Foundation; University of Texas System; University of Texas El Paso	Philipovskiy, A (corresponding author), Texas Tech Univ, Hlth Sci Ctr El Paso, Div Hematol Oncol, Dept Internal Med, El Paso, TX 79905 USA.	alexander.philipovskiy@ttuhsc.edu	Mukherjee, Debabrata/AAG-1486-2019	Mukherjee, Debabrata/0000-0002-5131-3694	Research Centers in Minority Institutions (RCMI) program [2U54MD007592]; Texas Tech University Medical Sciences Center Department of Internal Medicine Seed Founding program 2018-2019	Research Centers in Minority Institutions (RCMI) program; Texas Tech University Medical Sciences Center Department of Internal Medicine Seed Founding program 2018-2019	RJA was supported by a Research Centers in Minority Institutions (RCMI) program grant (2U54MD007592) to the Border Biomedical Research Center (BBRC) at UTEP from the National Institute on Minority Health and Health Disparities, a component of the National Institutes of Health. Funding was also provided by Texas Tech University Medical Sciences Center Department of Internal Medicine Seed Founding program 2018-2019.	Abramson VG, 2015, CANCER-AM CANCER SOC, V121, P8, DOI 10.1002/cncr.28914; Andre F, 2019, NEW ENGL J MED, V380, P1929, DOI 10.1056/NEJMoa1813904; [Anonymous], 2019, CA-CANCER J CLIN, DOI [DOI 10.3322/CAAC.21551, DOI 10.3322/caac.21551]; [Anonymous], 2013, CANC DISCOV, V3, pOF14; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2019, QUALITY MANAGEMENT, V11, pS1007; Baselga J, 2017, LANCET ONCOL, V18, P904, DOI 10.1016/S1470-2045(17)30376-5; Bi SN, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00864; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; Bykov VJN, 2014, FEBS LETT, V588, P2622, DOI 10.1016/j.febslet.2014.04.017; Coughlin CM, 2010, BREAST CANCER RES TR, V124, P1, DOI 10.1007/s10549-010-1108-4; DeSantis CE, 2019, CA-CANCER J CLIN, V69, P438, DOI 10.3322/caac.21583; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Ferrarotto R, 2017, J CLIN ONCOL, V35, P352, DOI 10.1200/JCO.2016.67.5264; Fournier MV, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51335-1; Garrido-Castro AC, 2019, CANCER DISCOV, V9, P176, DOI 10.1158/2159-8290.CD-18-1177; Gavai AV, 2015, ACS MED CHEM LETT, V6, P523, DOI 10.1021/acsmedchemlett.5b00001; Guo SC, 2011, BBA-REV CANCER, V1815, P197, DOI 10.1016/j.bbcan.2010.12.002; Iqbal J, 2015, JAMA-J AM MED ASSOC, V313, P165, DOI 10.1001/jama.2014.17322; Isakoff SJ, 2010, CANCER J, V16, P53, DOI 10.1097/PPO.0b013e3181d24ff7; Jiang YZ, 2019, CANCER CELL, V35, P428, DOI 10.1016/j.ccell.2019.02.001; Serrano-Gomez SJ, 2016, CARCINOGENESIS, V37, P669, DOI 10.1093/carcin/bgw043; Kim SB, 2017, LANCET ONCOL, V18, P1360, DOI 10.1016/S1470-2045(17)30450-3; Knoechel B, 2015, CSH MOL CASE STUD, V1, DOI 10.1101/mcs.a000539; Kogan S, 2016, TRANSL CANCER RES, V5, P698, DOI 10.21037/tcr.2016.11.74; Lara-Medina F, 2011, CANCER-AM CANCER SOC, V117, P3658, DOI 10.1002/cncr.25961; Lehmann BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157368; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Leslie NR, 2010, ADV ENZYME REGUL, V50, P112, DOI 10.1016/j.advenzreg.2009.10.015; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Locatelli MA, 2017, ONCOTARGET, V8, P2320, DOI 10.18632/oncotarget.13727; Martin M, 2017, ANN ONCOL, V28, P313, DOI 10.1093/annonc/mdw562; Masuda H, 2013, CLIN CANCER RES, V19, P5533, DOI 10.1158/1078-0432.CCR-13-0799; Meester JAN, 2019, CLIN GENET, V95, P85, DOI 10.1111/cge.13382; Meissner T, 2017, CSH MOL CASE STUD, V3, DOI 10.1101/mcs.a001677; Miele L, 2008, EXPERT REV ANTICANC, V8, P1197, DOI 10.1586/14737140.8.8.1197; Miele L, 2006, CURR MOL MED, V6, P905, DOI 10.2174/156652406779010830; Mollen EWJ, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00518; Niyomnaitham S, 2019, PEERJ, V7, DOI 10.7717/peerj.6501; Olivier M, 2006, CLIN CANCER RES, V12, P1157, DOI 10.1158/1078-0432.CCR-05-1029; Palomero T, 2008, CLIN CANCER RES, V14, P5314, DOI 10.1158/1078-0432.CCR-07-4864; Pascual J, 2019, ANN ONCOL, V30, P1051, DOI 10.1093/annonc/mdz133; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Philipovskiy A, 2020, ANTICANCER RES, V40, P857, DOI 10.21873/anticanres.14018; Philipovskiy A, 2019, IN VIVO, V33, P1227, DOI 10.21873/invivo.11594; Schmid P, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.19.00368; Schott AF, 2013, CLIN CANCER RES, V19, P1512, DOI 10.1158/1078-0432.CCR-11-3326; Serrano-Gomez SJ, 2018, CANCER EPIDEM BIOMAR, V27, P3, DOI 10.1158/1055-9965.EPI-17-0420; Shi YQ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0850-9; SIMPSON P, 1995, NATURE, V375, P736, DOI 10.1038/375736a0; Sporikova Z, 2018, CLIN BREAST CANCER, V18, pE841, DOI 10.1016/j.clbc.2018.07.023; Stein Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246197; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Uscanga-Perales GI, 2019, ONCOL LETT, V17, P3581, DOI 10.3892/ol.2019.9984; Vaca-Paniagua F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126762; Vallejos CS, 2010, CLIN BREAST CANCER, V10, P294, DOI 10.3816/CBC.2010.n.038; Wang JW, 2018, ONCOL LETT, V15, P8749, DOI 10.3892/ol.2018.8442; Wang K, 2015, CLIN CANCER RES, V21, P1487, DOI 10.1158/1078-0432.CCR-14-1348; Wang XS, 2017, ONCOTARGET, V8, P624, DOI 10.18632/oncotarget.13483; Xue Z, 2018, CELL RES, V28, P719, DOI 10.1038/s41422-018-0044-4; Yuan X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131689; Zhao M, 2017, MOL CARCINOGEN, V56, P849, DOI 10.1002/mc.22538	62	8	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238262	10.1371/journal.pone.0238262	http://dx.doi.org/10.1371/journal.pone.0238262			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886682	gold, Green Published			2022-12-26	WOS:000571064300051
J	Fagundes, PC; Pereira, EHL; Reis, RE				Fagundes, Patricia C.; Pereira, Edson H. L.; Reis, Roberto E.			Iterative taxonomic study of Pareiorhaphis hystrix (Siluriformes, Loricariidae) suggests a single, yet phenotypically variable, species in south Brazil	PLOS ONE			English	Article							GENETIC DIFFERENTIATION; RIVER-BASIN; CATFISH; POPULATIONS; NEOPLECOSTOMINAE; EVOLUTIONARY; TELEOSTEI; FISHES; SYSTEM	Pareiorhaphis hystrixis a widely distributed species, occurring in the upper and middle Uruguay River and in the Taquari River basin, Patos Lagoon system, southern Brazil. Morphological variation has been detected throughout the distribution ofP.hystrix, and this work seeks to test the conspecific nature of populations in several occurrence areas. Specimens from six areas in the Uruguay River basin and three in the Taquari River basin were compared. Variance analysis (ANOVA) was performed for the meristic data, and Principal Component Analysis (PCA) and Linear Discriminant Analysis (LDA) were conducted for morphometric data. Molecular analyses usedcoI,cytb, 12S and 16S mitochondrial genes, examining nucleotide diversity, haplotype diversity, genetic distance, and delimitation of possible multiple species through the Generalized Mixed Yule Coalescent (GMYC) method. Phylogenetic relationships of studied populations were also investigated through Bayesian inference. While PCA indicated a tendency of overlap between areas, ANOVA and LDA detected a subtle differentiation between populations from the two hydrographic basins. Yet, both latter analyses recovered the population from Pelotas River, a tributary to Uruguay River, as more similar to populations from Taquari River, which is congruent to morphological observations of anterior abdominal plates. The molecular data indicated a nucleotide diversity lower than the haplotypic diversity, suggestive of recent expansion. The concatenated haplotype network points to slight differentiation between areas, with each locality presenting unique and non-shared haplotypes, although with few mutational steps in general. The species delimitation by coalescence analysis suggested the presence of a variable number of OTUs depending on the inclusion or exclusion of an outgroup. In general, the morphological data suggest a subtle variation by river basin, while the genetic data indicates a weak population structuration by hydrographic areas, especially the Chapeco and Passo Fundo rivers. However, there is still not enough differentiation between the specimens to suggest multiple species. The iterative analyses indicate thatPareiorhaphis hystrixis composed of a single, although variable, species.	[Fagundes, Patricia C.; Pereira, Edson H. L.; Reis, Roberto E.] Pontificia Univ Catolica Rio Grande do Sul, Lab Vertebrate Systemat, PUCRS, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul	Reis, RE (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Lab Vertebrate Systemat, PUCRS, Porto Alegre, RS, Brazil.	reis@pucrs.br	Reis, Roberto/A-7030-2012	Reis, Roberto/0000-0003-3746-6894; Reis, AlessanRSS/0000-0001-8486-7469	CAPES (Brazilian Ministry of Education); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [400166/2016-0]	CAPES (Brazilian Ministry of Education)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	First author received a master degree scolarship from CAPES (Brazilian Ministry of Education). RER received a research grant for paying molecular work, from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (process #400166/2016-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JS, 2011, INTRO NEOTROPICAL FR; [Anonymous], 2018, PLOS ONE, V13, P1, DOI DOI 10.3171/2018.1.JNS172645; Arnaud S, 1999, MAR BIOL, V135, P699, DOI 10.1007/s002270050671; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Calegari B.B., 2016, B SOCIEDADE BRASILEI, V118, P15; Silva GDDE, 2013, ZOOKEYS, P65, DOI 10.3897/zookeys.315.5307; Mondin LAD, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00001; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferrer J, 2013, NEOTROP ICHTHYOL, V11, P217, DOI 10.1590/S1679-62252013000200001; Fricke R, 2020, CATALOG FISHES FAMIL; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Joy L, 2016, MITOCHONDRIAL DNA A, V27, P2819, DOI 10.3109/19401736.2015.1053083; Jumawan Joycelyn C., 2011, Philippine Science Letters, V4, P103; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lima SMQ, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00199; Lucena CAS, 2013, B SOC BRAS ICTIOL, V105, P20; Lujan NK, 2015, MOL PHYLOGENET EVOL, V82, P269, DOI 10.1016/j.ympev.2014.08.020; Melo BF, 2011, NEOTROP ICHTHYOL, V9, P49, DOI 10.1590/S1679-62252011000100002; Miller M.A., 2010, P GAT COMP ENV WORKS; Lucena ALM, 2012, BIOCHEM SYST ECOL, V44, P325, DOI 10.1016/j.bse.2012.06.020; More J. J., 1978, Proceedings of the Biennial Conference on numerical analysis, P105; Pereira EHL, 2007, NEOTROP ICHTHYOL, V5, P443, DOI 10.1590/S1679-62252007000400003; Pereira EHL, 2018, COPEIA, V106, P632, DOI 10.1643/CI-18-113; Pereira EHL, 2017, ZOOTAXA, V4264, P1, DOI 10.11646/zootaxa.4264.1.1; Pereira EHL, 2012, NEOTROP ICHTHYOL, V10, P539, DOI 10.1590/S1679-62252012000300006; Pereira Edson H.L., 2002, Ichthyological Exploration of Freshwaters, V13, P97; Pereira Edson H. Lopes, 2005, Neotrop. ichthyol., V3, P271, DOI 10.1590/S1679-62252005000200004; Pereira EHL, 1992, REV FR AQUARIOL, V4, P111; Py-Daniel Lúcia H. Rapp, 2005, Acta Amaz., V35, P97, DOI 10.1590/S0044-59672005000100015; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A., 2015, TREEANNOTATOR V2 3 0; Reis RE, 2016, J FISH BIOL, V89, P12, DOI 10.1111/jfb.13016; Reis RE, 2006, ZOOL J LINN SOC-LOND, V147, P277, DOI 10.1111/j.1096-3642.2006.00229.x; Reis RE, 2017, NEOTROP ICHTHYOL, V15, DOI 10.1590/1982-0224-20160068; Roxo FF, 2015, ZOOKEYS, P109, DOI 10.3897/zookeys.481.8755; Roxo FF, 2012, ECOL EVOL, V2, P2438, DOI 10.1002/ece3.368; Shimabukuro-Dias C. K., 2016, SEQUENTIAL ANAL, V28, P588, DOI [10.3109/24701394.2016.1149826, DOI 10.3109/24701394.2016.1149826]; Silva GSC, 2016, ZOOKEYS, P129, DOI 10.3897/zookeys.598.7400; Subburaj Jayachandran, 2017, Proceedings of the Indian National Science Academy Part B Biological Sciences, V87, P815, DOI 10.1007/s40011-015-0665-z; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Textile Outlook International, 2017, ISSUE, V185, P1; Vasconcellos AV, 2008, GENET MOL BIOL, V31, P308, DOI 10.1590/S1415-47572008000200026; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; 2017, CLIN GENITOURIN CANC, V15	53	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0237160	10.1371/journal.pone.0237160	http://dx.doi.org/10.1371/journal.pone.0237160			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881879	gold, Green Published			2022-12-26	WOS:000571063300090
J	Jang, M; Kim, JH; Park, JW; Roh, H; Lee, HJ; Seo, J; Hwang, SH; Yoon, JH; Yoon, SH; Cho, BK				Jang, Minsu; Kim, Jang Hun; Park, Jin Woo; Roh, Haewon; Lee, Han-Joo; Seo, Junghan; Hwang, Sung Hwan; Yoon, Joon Ho; Yoon, Sang Hoon; Cho, Byung-Kyu			Features of "false positive" unruptured intracranial aneurysms on screening magnetic resonance angiography	PLOS ONE			English	Article							DIGITAL-SUBTRACTION-ANGIOGRAPHY; CEREBRAL ANEURYSMS; ENDOVASCULAR TREATMENT; CT ANGIOGRAPHY; DIAGNOSIS; MRA	Background Physicians can find it challenging to decide whether confirmative digital subtraction angiography (DSA) should be performed in patients who present with "suspicious small aneurysm-like structures" on magnetic resonance angiography (MRA). Factors associated with "false positive aneurysms on MRA" (FPAMs)," which are finally confirmed as negative on DSA, have rarely been reported. This study aimed to identify the clinical or radiologic clues indicative of FPAM on DSA. Methods Patients who had undergone DSA between 2016 and 2019 for suspicious aneurysm-like structures < 5 mm in size on MRA were enrolled. Patient demographics and the details regarding the geometry of the structures were retrospectively reviewed. Univariate and multivariate logistic regression analyses were conducted to identify the associated factors. Receiver operating characteristic curve analysis was performed to assess the clinical implications. Results Of the 107 suspicious structures, 46 were indicated as being false positive on DSA (42.96%). Location (positive on C7 and negative on C5-6 ICA) and lower dome to neck ratio were found to be significant parameters in the multivariate analysis. The dome to neck ratio threshold value was 0.99. Conclusion Suspicious aneurysm-like structures located not on C5-6 but on C7 ICA and having wide neck morphologies (dome to neck ratio < 0.99) are highly likely to be negative on DSA.	[Jang, Minsu; Kim, Jang Hun; Park, Jin Woo; Lee, Han-Joo; Seo, Junghan; Hwang, Sung Hwan; Yoon, Joon Ho; Yoon, Sang Hoon; Cho, Byung-Kyu] Armed Forces Capital Hosp, Dept Neurosurg, Seongnam Si, Gyeonggi Do, South Korea; [Kim, Jang Hun] Armed Forces Capital Hosp, Trauma Ctr, Seongnam Si, Gyeonggi Do, South Korea; [Roh, Haewon] Korea Univ, Guro Hosp, Dept Neurosurg, Coll Med, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine)	Kim, JH (corresponding author), Armed Forces Capital Hosp, Dept Neurosurg, Seongnam Si, Gyeonggi Do, South Korea.; Kim, JH (corresponding author), Armed Forces Capital Hosp, Trauma Ctr, Seongnam Si, Gyeonggi Do, South Korea.	jhkimns@naver.com		Lee, Han Joo/0000-0003-4518-9057; Yoon, Sang Hoon/0000-0003-0212-4819	Korean Military Medical Research Project - ROK Ministry of National Defense	Korean Military Medical Research Project - ROK Ministry of National Defense	This work was supported by the Korean Military Medical Research Project funded by the ROK Ministry of National Defense.	[Anonymous], 2014, ETUDES LIT, V45, P119; [Anonymous], 2015, UK SUPREME COURT YB, V6, P175; Deutschmann HA, 2007, AM J NEURORADIOL, V28, P628; Feng X, 2017, WORLD NEUROSURG, V103, P576, DOI 10.1016/j.wneu.2017.04.017; Fischer S, 2011, CLIN NEURORADIOL, V21, P87, DOI 10.1007/s00062-010-0038-1; HEISERMAN JE, 1994, AM J NEURORADIOL, V15, P1401; Heiserman JE, 1994, AM J NEURORADIOL, V15, p[1401, 8]; Hendricks BK, 2020, J NEUROSURG, V133, P159, DOI 10.3171/2019.3.JNS183160; Hiratsuka Yoshiyasu, 2008, Magn Reson Med Sci, V7, P169; Hoh BL, 2004, NEUROSURGERY, V54, P1329, DOI 10.1227/01.NEU.0000125325.22576.83; Inoue T, 2012, J NEUROSURG, V117, P20, DOI 10.3171/2012.4.JNS112225; Kouskouras C, 2004, NEURORADIOLOGY, V46, P842, DOI 10.1007/s00234-004-1259-2; Lee CS, 2013, AM J ROENTGENOL, V201, P611, DOI 10.2214/AJR.12.10375; Li MH, 2014, RADIOLOGY, V271, P553, DOI 10.1148/radiol.14122770; Lu L, 2012, RADIOLOGY, V262, P605, DOI 10.1148/radiol.11110486; Menke J, 2011, ANN NEUROL, V69, P646, DOI 10.1002/ana.22270; Mine B, 2015, J NEURORADIOLOGY, V42, P162, DOI 10.1016/j.neurad.2014.08.002; Philipp LR, 2017, NEUROSURGERY, V80, P769, DOI 10.1093/neuros/nyw113; Pritz MB, 2011, J STROKE CEREBROVASC, V20, P162, DOI 10.1016/j.jstrokecerebrovasdis.2009.11.018; Westerlaan HE, 2011, RADIOLOGY, V258, P134, DOI 10.1148/radiol.10092373; White PM, 2000, RADIOLOGY, V217, P361, DOI 10.1148/radiology.217.2.r00nv06361; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Yamaki VN, 2016, AM J NEURORADIOL, V37, P862, DOI 10.3174/ajnr.A4651	23	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238597	10.1371/journal.pone.0238597	http://dx.doi.org/10.1371/journal.pone.0238597			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881975	gold, Green Published			2022-12-26	WOS:000571063300015
J	Nishio, T; Sugino, K; Yoshikawa, Y; Matsumoto, M; Oe, Y; Sadakane, K; Yoshikawa, K				Nishio, Takashi; Sugino, Kaito; Yoshikawa, Yuko; Matsumoto, Michiaki; Oe, Yohei; Sadakane, Koichiro; Yoshikawa, Kenichi			K(+)promotes the favorable effect of polyamine on gene expression better than Na+	PLOS ONE			English	Article							POLYELECTROLYTE SOLUTIONS; MONOVALENT CATIONS; ESCHERICHIA-COLI; STRUCTURAL BASIS; DNA COMPACTION; BINDING; TRANSITION; POTASSIUM; K+; CONDENSATION	Background Polyamines are involved in a wide variety of biological processes including a marked effect on the structure and function of DNA. During our study on the interaction of polyamines with DNA, we found that K(+)enhancedin vitrogene expression in the presence of polyamine more strongly than Na+. Thus, we sought to clarify the physico-chemical mechanism underlying this marked difference between the effects of K(+)and Na+. Principal findings It was found that K(+)enhanced gene expression in the presence of spermidine, SPD(3+), much more strongly than Na+, throughin vitroexperiments with a Luciferase assay on cell extracts. Single-DNA observation by fluorescence microscopy showed that Na(+)prevents the folding transition of DNA into a compact state more strongly than K+.H-1 NMR measurement revealed that Na(+)inhibits the binding of SPD to DNA more strongly than K+. Thus, SPD binds to DNA more favorably in K+-rich medium than in Na+-rich medium, which leads to favorable conditions for RNA polymerase to access DNA by decreasing the negative charge. Conclusion and significance We found that Na(+)and K(+)exhibit markedly different effects through competitive binding with a cationic polyamine, SPD, to DNA, which causes a large difference in the higher-order structure of genomic DNA. It is concluded that the larger favorable effect of Na(+)than K(+)onin vitrogene expression observed in this study is well attributable to the significant difference between Na(+)and K(+)on the competitive binding inducing conformational transition of DNA.	[Nishio, Takashi; Sugino, Kaito; Yoshikawa, Yuko; Oe, Yohei; Sadakane, Koichiro; Yoshikawa, Kenichi] Doshisha Univ, Fac Life & Med Sci, Kyoto, Japan; [Matsumoto, Michiaki] Doshisha Univ, Fac Sci & Engn, Kyoto, Japan; [Yoshikawa, Kenichi] Kyoto Univ, Ctr Integrat Med & Phys, Inst Adv Study, Kyoto, Japan	Doshisha University; Doshisha University; Kyoto University	Yoshikawa, K (corresponding author), Doshisha Univ, Fac Life & Med Sci, Kyoto, Japan.; Yoshikawa, K (corresponding author), Kyoto Univ, Ctr Integrat Med & Phys, Inst Adv Study, Kyoto, Japan.	keyoshik@mail.doshisha.ac.jp	Yoshikawa, Kenichi/L-4774-2016	Yoshikawa, Kenichi/0000-0002-2751-7136; Nishio, Takashi/0000-0001-8761-1776	JSPS KAKENHI [JP15H02121, JP20H01877]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP15H02121 and JP20H01877 funded to KY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdi A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08512; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Auffinger P, 2016, SODIUM POTASSIUM INT, P167; Bhattacharyya D, 2016, FRONT CHEM, V4, DOI 10.3389/fchem.2016.00038; BLEAM ML, 1980, P NATL ACAD SCI USA, V77, P3085, DOI 10.1073/pnas.77.6.3085; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; Che T, 2018, MOLECULES, V23, DOI 10.3390/molecules23020493; Cheng YH, 2006, NUCLEIC ACIDS RES, V34, P686, DOI 10.1093/nar/gkj434; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Danchin A, 2019, J MOL EVOL, V87, P271, DOI 10.1007/s00239-019-09915-2; Deng H, 2000, NUCLEIC ACIDS RES, V28, P3379, DOI 10.1093/nar/28.17.3379; Denisov VP, 2000, P NATL ACAD SCI USA, V97, P629, DOI 10.1073/pnas.97.2.629; Deserno M, 2000, MACROMOLECULES, V33, P199, DOI 10.1021/ma990897o; Dickson A.G., 1994, HDB METH AN VAR PAR; Fedorov MV, 2009, J AM CHEM SOC, V131, P10854, DOI 10.1021/ja9030374; FENLEY MO, 1990, BIOPOLYMERS, V30, P1191, DOI 10.1002/bip.360301305; Gohara DW, 2016, J BIOL CHEM, V291, P20840, DOI 10.1074/jbc.R116.737833; GOULIAN M, 1968, J BIOL CHEM, V243, P627; GROSBERG AY, 1982, BIOPOLYMERS, V21, P2413, DOI 10.1002/bip.360211207; HARDIN CC, 1992, BIOCHEMISTRY-US, V31, P833, DOI 10.1021/bi00118a028; Hasuike M, 2012, BIOPHYS CHEM, V165, P48, DOI 10.1016/j.bpc.2012.03.004; Hibino K, 2006, CHEM PHYS LETT, V426, P405, DOI 10.1016/j.cplett.2006.05.120; Hud NV, 1996, BIOCHEMISTRY-US, V35, P15383, DOI 10.1021/bi9620565; Ida J, 2019, MOLECULES, V24, DOI 10.3390/molecules24061079; KEIR H. M., 1965, PROGR NUCLEIC ACID RES MOL BIOL, V4, P81, DOI 10.1016/S0079-6603(08)60785-0; KLENOW H, 1969, EUR J BIOCHEM, V9, P133, DOI 10.1111/j.1432-1033.1969.tb00586.x; Korolev N, 2000, BIOMACROMOLECULES, V1, P648, DOI 10.1021/bm000042f; Korolev N, 1999, J PHYS CHEM B, V103, P9008, DOI 10.1021/jp9913517; KUZNETSOV IA, 1984, REACT POLYM, V3, P37, DOI 10.1016/0167-6989(84)90121-1; LING GN, 1994, PHYSIOL CHEM PHYS ME, V26, P121; LUBIN M, 1964, BIOCHIM BIOPHYS ACTA, V80, P614, DOI 10.1016/0926-6550(64)90306-8; MANNING GS, 1978, Q REV BIOPHYS, V11, P179, DOI 10.1017/S0033583500002031; MANNING GS, 1969, J CHEM PHYS, V51, P924, DOI 10.1063/1.1672157; Marathias VM, 1999, BIOCHEMISTRY-US, V38, P4355, DOI 10.1021/bi982604+; Nishio T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50943-1; Oosawa F, 1971, POLYELECTROLYTES, P51; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; POST CB, 1979, BIOPOLYMERS, V18, P1487, DOI 10.1002/bip.1979.360180612; Rouzina I, 1996, J PHYS CHEM-US, V100, P4292, DOI 10.1021/jp9525898; Rozov A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10409-4; Savelyev A, 2006, J AM CHEM SOC, V128, P14506, DOI 10.1021/ja0629460; SIGEL H, 1993, CHEM SOC REV, V22, P255, DOI 10.1039/cs9932200255; SO AG, 1967, P NATL ACAD SCI USA, V58, P1739, DOI 10.1073/pnas.58.4.1739; SRIVENUGOPAL KS, 1987, NUCLEIC ACIDS RES, V15, P2563, DOI 10.1093/nar/15.6.2563; Stellwagen E, 2005, BIOPOLYMERS, V78, P62, DOI 10.1002/bip.20260; STRAUSS UP, 1967, J PHYS CHEM-US, V71, P2550, DOI 10.1021/j100867a024; Strick R, 2001, J CELL BIOL, V155, P899, DOI 10.1083/jcb.200105026; SUELTER CH, 1970, SCIENCE, V168, P789, DOI 10.1126/science.168.3933.789; Takahashi M, 1997, J PHYS CHEM B, V101, P9396, DOI 10.1021/jp9716391; Tateishi-Karimata H, 2018, J AM CHEM SOC, V140, P642, DOI 10.1021/jacs.7b09449; Turner D. H, 2000, NUCL ACIDS STRUCTURE, P259; WEIDEN PL, 1967, J GEN PHYSIOL, V50, P1641, DOI 10.1085/jgp.50.6.1641; Wright SH, 2004, ADV PHYSIOL EDUC, V28, P139, DOI 10.1152/advan.00029.2004; Yoshikawa K, 1996, PHYS REV LETT, V76, P3029, DOI 10.1103/PhysRevLett.76.3029; Yoshikawa Y, 2013, ANGEW CHEM INT EDIT, V52, P3712, DOI 10.1002/anie.201209144; ZIMMERMAN SB, 1993, BIOCHIM BIOPHYS ACTA, V1216, P175, DOI 10.1016/0167-4781(93)90142-Z; Zinchenko AA, 2005, BIOPHYS J, V88, P4118, DOI 10.1529/biophysj.104.057323	57	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238447	10.1371/journal.pone.0238447	http://dx.doi.org/10.1371/journal.pone.0238447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881909	gold, Green Published			2022-12-26	WOS:000571063300079
J	Quan, HB; Fang, TY; Lin, LWH; Lin, L; Ou, QY; Zhang, HC; Chen, KN; Zhou, ZG				Quan, Huibiao; Fang, Tuanyu; Lin, Leweihua; Lin, Lu; Ou, Qianying; Zhang, Huachuan; Chen, Kaining; Zhou, Zhiguang			The correlation between proinsulin, true insulin, proinsulin: True insulin ratio, 25(OH) D3, waist circumference and risk of prediabetes in Hainan Han adults	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; BODY-MASS INDEX; 25-HYDROXYVITAMIN D; ADIPOSITY; PREVALENCE; OBESITY; ONSET; MEN	Purpose Diabetes mellitus is a kind of highly prevalent chronic disease in the world. The intervention measures on the risk factors of prediabetes contribute to control and reduce the occurrence of diabetes. This study aimed to investigate the correlation between proinsulin (PI), true insulin (TI), PI/TI, 25(OH) D3, waist circumference (WC), and risk of prediabetes. Methods In this cross-sectional study, 1662 subjects including 615 prediabetes and 1047 non-prediabetes were recruited. Spearman's correlation analysis was used to explore the association of PI, TI, PI/TI, 25(OH) D3, and waist circumference with prediabetes. Odds ratios (OR) and 95% confidence intervals (CI) were calculated by logistic regression. Receiver-Operator Characteristic (ROC) curve was used to evaluate the risk of prediabetes. Results Our study showed that FPI, 2hPI, FTI, 2hTI, FPI/FTI, and WC could enhance the risk of prediabetes (OR 1.034; OR 1.007; OR 1.005; OR 1.002; OR 3.577, OR 1.053, respectively; allp< 0.001). Stratified analyses indicated that FPI/FTI associated with an increased risk of prediabetes in men (OR 2.080,p= 0.042). FTI have a weak association with prediabetes risk in men and women (OR 0.987,p= 0.001; OR 0.994,p= 0.004, respectively). 2hPI could decrease prediabetes in women (OR 0.995,p= 0.037). Interesting, the sensitivity (86.0%) and AUC (0.942,p< 0.001) of combination (FPI+FTI+2hPI+2hTI+25(OH) D3+WC) were higher than the diagnostic value of these alone diagnoses. The optimal cutoff point of FPI, FTI, 2hPI, 2hTI, 25(OH) D3, and WC for indicating prediabetes were 15.5 mU/l, 66.5 mU/l, 71.5 mU/l, 460.5 mU/l, 35.5 ng/ml, and 80.5 cm, respectively. What's more, the combination (FPI+FTI+2hPI+2hTI+25(OH) D3+WC) significantly improved the diagnostic value beyond the alone diagnoses of prediabetes in men and women (AUC 0.771; AUC 0.760, respectively). Conclusion The FPI, 2hPI, FTI, 2hTI, FPI/FTI, and WC significantly associated with an increased risk of prediabetes. The combination of FPI, FTI, 2hPI, 2hTI, 25(OH) D3, and WC might be used as diagnostic indicators for prediabetes.	[Quan, Huibiao; Zhou, Zhiguang] Cent South Univ, Xiangya Hosp 2, Dept Metab & Endocrinol, Changsha, Hunan, Peoples R China; [Quan, Huibiao; Fang, Tuanyu; Lin, Leweihua; Lin, Lu; Ou, Qianying; Zhang, Huachuan; Chen, Kaining] Hainan Med Univ, Dept Endocrinol, Hainan Affiliated Hosp, Haikou, Hainan, Peoples R China	Central South University; Hainan Medical University	Zhou, ZG (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Metab & Endocrinol, Changsha, Hunan, Peoples R China.	zhouzhiguang@csu.edu.cn			National Key R&D Program of China [2016YFC1305000, 2016YFC1305001, 2018YFC1315603]; National Natural Science Foundation of China [81820108007]; Hainan Provincial Key Research and Development Project [ZDYF2018130]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hainan Provincial Key Research and Development Project	the National Key R&D Program of China (2016YFC1305000, 2016YFC1305001 and 2018YFC1315603), the National Natural Science Foundation of China (81820108007) and Hainan Provincial Key Research and Development Project (ZDYF2018130).	Afzal S, 2013, CLIN CHEM, V59, P381, DOI 10.1373/clinchem.2012.193003; Aguiree F., 2013, IDF DIABETES ATLAS; Akter S, 2019, CLIN NUTR EDINBURGH; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; [Anonymous], 2018, FORENSIC SCI INT GEN, V34, pe18; Awasthi A, 2017, J Prev Med Hyg, V58, pE56; Berridge MJ, 2017, BIOCHEM J, V474, P1321, DOI 10.1042/BCJ20170042; Pham DD, 2014, DIABETES RES CLIN PR, V104, P273, DOI 10.1016/j.diabres.2013.12.022; Dwarkanath P, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00116; Expert Panel on Women's I, 2018, J AM COLL RADIOL, V15, pS365, DOI DOI 10.1016/J.JACR.2018.09.023; Henquin JC, 2017, DIABETES OBES METAB, V19, P1061, DOI 10.1111/dom.12887; Hurskainen AR, 2012, DIABETES-METAB RES, V28, P418, DOI 10.1002/dmrr.2286; Issa CM, 2017, ADV EXP MED BIOL, V996, P193, DOI 10.1007/978-3-319-56017-5_16; Joergensen C, 2010, DIABETES CARE, V33, P2238, DOI 10.2337/dc10-0582; Mamtani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059153; Marcadenti A, 2017, ATHEROSCLEROSIS, V266, P145, DOI 10.1016/j.atherosclerosis.2017.09.022; Marcadenti A, 2011, AM J HYPERTENS, V24, P175, DOI 10.1038/ajh.2010.212; Mezza T, 2018, DIABETES, V67, P2389, DOI 10.2337/db18-0279; Obuchowski NA, 2018, PHYS MED BIOL, V63, P1, DOI 10.1088/1361-6560/aab4b1; Ohn JH, 2016, LANCET DIABETES ENDO, V4, P27, DOI 10.1016/S2213-8587(15)00336-8; Omidian M, 2019, DIABETES METAB SYND, V13, P2375, DOI 10.1016/j.dsx.2019.06.011; Pradhan AD, 2003, AM J MED, V114, P438, DOI 10.1016/S0002-9343(03)00061-5; Rasoul MA, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0629-3; RODER ME, 1994, J CLIN ENDOCR METAB, V79, P1570, DOI 10.1210/jc.79.6.1570; Sacerdote A, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1201-y; Stefanska A, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/2384069; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; The Lancet Global Health, 2018, LANCET GLOB HLTH, V6, pE593; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Wannamethee SG, 2010, DIABETOLOGIA, V53, P890, DOI 10.1007/s00125-010-1670-7; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118	32	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238095	10.1371/journal.pone.0238095	http://dx.doi.org/10.1371/journal.pone.0238095			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881889	gold, Green Published			2022-12-26	WOS:000571063300089
J	Pajarillo, E; Johnson, J; Rizor, A; Nyarko-Danquah, I; Adinew, G; Bornhorst, J; Stiboller, M; Schwerdtle, T; Son, DS; Aschner, M; Lee, ES				Pajarillo, Edward; Johnson, James, Jr.; Rizor, Asha; Nyarko-Danquah, Ivan; Adinew, Getinet; Bornhorst, Julia; Stiboller, Michael; Schwerdtle, Tania; Son, Deok-Soo; Aschner, Michael; Lee, Eunsook			Astrocyte-specific deletion of the transcription factor Yin Yang 1 in murine substantia nigra mitigates manganese-induced dopaminergic neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adeno-associated viral (AAV); dopaminergic neurotoxicity; GLASTGLT-1; manganese Yin Yang 1; manganese; glutamate; astrocyte; Parkinson disease; animal model; adeno-associated viral vector; tyrosine hydroxylase	GLUTAMATE TRANSPORTER EAAT2; RAT-BRAIN; PARKINSONS-DISEASE; FACTOR YIN-YANG-1; NIGROSTRIATAL DOPAMINE; DOWN-REGULATION; KAPPA-B; EXPRESSION; TOXICITY; ACCUMULATION	Manganese (Mn)-induced neurotoxicity resembles Parkinson's disease (PD), but the mechanisms underpinning its effects remain unknown. Mn dysregulates astrocytic glutamate transporters, GLT-1 and GLAST, and dopaminergic function, including tyrosine hydroxylase (TH). Our previous in vitro studies have shown that Mn repressed GLAST and GLT-1 via activation of transcription factor Yin Yang 1 (YY1). Here, we investigated if in vivo astrocytic YY1 deletion mitigates Mn-induced dopaminergic neurotoxicity, attenuating Mn-induced reduction in GLAST/GLT-1 expression in murine substantia nigra (SN). AAV5-GFAP-Cre-GFP particles were infused into the SN of 8-week-old YY1(flox/flox) mice to generate a region-specific astrocytic YY1 conditional knockout (cKO) mouse model. 3 weeks after adeno-associated viral (AAV) infusion, mice were exposed to 330 mu g of Mn (MnCl2 30 mg/kg, intranasal instillation, daily) for 3 weeks. After Mn exposure, motor functions were determined in open-field and rotarod tests, followed by Western blotting, quantitative PCR, and immunohistochemistry to assess YY1, TH, GLAST, and GLT-1 levels. Infusion of AAV5-GFAP-Cre-GFP vectors into the SN resulted in region-specific astrocytic YY1 deletion and attenuation of Mn-induced impairment of motor functions, reduction of TH-expressing cells in SN, and TH mRNA/protein levels in midbrain/striatum. Astrocytic YY1 deletion also attenuated the Mn-induced decrease in GLAST/GLT-1 mRNA/protein levels in midbrain. Moreover, YY1 deletion abrogated its interaction with histone deacetylases in astrocytes. These results indicate that astrocytic YY1 plays a critical role in Mn-induced neurotoxicity in vivo, at least in part, by reducing astrocytic GLAST/GLT-1. Thus, YY1 might be a potential target for treatment of Mn toxicity and other neurological disorders associated with dysregulation of GLAST/GLT-1.	[Pajarillo, Edward; Johnson, James, Jr.; Rizor, Asha; Nyarko-Danquah, Ivan; Adinew, Getinet; Lee, Eunsook] Florida A&M Univ, Dept Pharmaceut Sci, Tallahassee, FL 32307 USA; [Bornhorst, Julia] Univ Wuppertal, Fac Math & Nat Sci, Food Chem, Wuppertal, Germany; [Stiboller, Michael; Schwerdtle, Tania] Univ Potsdam, Inst Nutrit Sci, Dept Food Chem, Nuthetal, Germany; [Son, Deok-Soo] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA; [Aschner, Michael] Albert Einstein Coll Med Bronx, Dept Mol Pharmacol, New York, NY USA	State University System of Florida; Florida A&M University; University of Wuppertal; University of Potsdam; Meharry Medical College; Yeshiva University	Lee, ES (corresponding author), Florida A&M Univ, Dept Pharmaceut Sci, Tallahassee, FL 32307 USA.	eunsook.lee@famu.edu	Adinew, Getinet/AGL-3178-2022; Core, Vector/CAF-4832-2022; Pajarillo, Edward Alain/ABF-9202-2021	Adinew, Getinet/0000-0002-2085-9627; Pajarillo, Edward Alain/0000-0002-5044-7607	NIEHS National Institutes of Health [R01 ES024756, U54 MD007582, SC1 CA200519, R01 ES10563, R01 ES07331, R01 ES020852]	NIEHS National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIEHS National Institutes of Health Grants R01 ES024756 (to E. L.), U54 MD007582 (to E. L.), SC1 CA200519 (to D. S.), R01 ES10563 (to M. A.), R01 ES07331 (to M. A.), and R01 ES020852 (to M. A.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdel-Magied N, 2019, ENVIRON SCI POLLUT R, V26, P12550, DOI 10.1007/s11356-019-04594-4; Affar E, 2006, MOL CELL BIOL, V26, P3565, DOI 10.1128/MCB.26.9.3565-3581.2006; Aguirre G, 2008, NEUROCHEM INT, V52, P1322, DOI 10.1016/j.neuint.2008.01.015; Alaimo A, 2011, NEUROCHEM INT, V59, P297, DOI 10.1016/j.neuint.2011.06.001; Albert K, 2019, J NEUROSCI RES, V97, P346, DOI 10.1002/jnr.24363; Ambrosi G, 2014, J NEURAL TRANSM, V121, P849, DOI 10.1007/s00702-013-1149-z; Aubry S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120352; Bedrosian TA, 2018, SCIENCE, V359, P1395, DOI 10.1126/science.aah3378; Bowler RM, 2015, NEUROTOXICOLOGY, V49, P139, DOI 10.1016/j.neuro.2015.06.004; Brenneman KA, 2000, TOXICOL APPL PHARM, V169, P238, DOI 10.1006/taap.2000.9073; BROUILLET EP, 1993, EXP NEUROL, V120, P89, DOI 10.1006/exnr.1993.1042; Chen MT, 2002, J TOXICOL ENV HEAL A, V65, P305, DOI 10.1080/15287390252800882; Chen P, 2015, J NEUROCHEM, V134, P601, DOI 10.1111/jnc.13170; Chotibut T, 2014, MOL NEUROBIOL, V49, P1282, DOI 10.1007/s12035-013-8598-0; Chow LML, 2008, TRANSGENIC RES, V17, P919, DOI 10.1007/s11248-008-9185-4; Chung EKY, 2008, J COMP NEUROL, V511, P421, DOI 10.1002/cne.21852; Cui CM, 2014, NEUROL SCI, V35, P695, DOI 10.1007/s10072-013-1585-4; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; Dlamini WW, 2020, AM J IND MED, V63, P36, DOI 10.1002/ajim.23060; Dorman DC, 2006, TOXICOL SCI, V92, P219, DOI 10.1093/toxsci/kfj209; Dorman DC, 2000, J APPL TOXICOL, V20, P179, DOI 10.1002/(SICI)1099-1263(200005/06)20:3<179::AID-JAT631>3.0.CO;2-C; Drinkut A, 2012, MOL THER, V20, P534, DOI 10.1038/mt.2011.249; Erikson KA, 2004, J NUTR BIOCHEM, V15, P335, DOI 10.1016/j.jnutbio.2003.12.006; Fan SJ, 2018, J ALZHEIMERS DIS, V66, P1731, DOI 10.3233/JAD-180708; Ferrarese C, 1999, J NEURAL TRANSM, V106, P685, DOI 10.1007/s007020050189; Forlani G, 2010, HUM MOL GENET, V19, P3114, DOI 10.1093/hmg/ddq214; Fu S, 2015, TOXICOL SCI, V143, P482, DOI 10.1093/toxsci/kfu249; Galvin KM, 1997, MOL CELL BIOL, V17, P3723, DOI 10.1128/MCB.17.7.3723; Garcia SJ, 2007, TOXICOL SCI, V95, P205, DOI 10.1093/toxsci/kfl139; Garcia SJ, 2006, TOXICOL SCI, V92, P516, DOI 10.1093/toxsci/kfl017; Garrick MD, 2003, BIOMETALS, V16, P41, DOI 10.1023/A:1020702213099; Gianutsos G, 1997, FUND APPL TOXICOL, V37, P102, DOI 10.1006/faat.1997.2306; Griffin JM, 2019, GENE THER, V26, P198, DOI 10.1038/s41434-019-0075-6; Guilarte TR, 2007, NEUROTOXICOLOGY, V28, P1147, DOI 10.1016/j.neuro.2007.06.005; Guilarte TR, 2006, EXP NEUROL, V202, P381, DOI 10.1016/j.expneurol.2006.06.015; Hammond SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188830; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; He Y, 2007, NEURON, V55, P217, DOI 10.1016/j.neuron.2007.06.029; Holmer HK, 2005, NEUROSCIENCE, V136, P333, DOI 10.1016/j.neuroscience.2005.08.003; Hsu CY, 2015, NEUROPHARMACOLOGY, V91, P43, DOI 10.1016/j.neuropharm.2014.11.023; Iancu R, 2005, BEHAV BRAIN RES, V162, P1, DOI 10.1016/j.bbr.2005.02.023; Jacob CP, 2007, J ALZHEIMERS DIS, V11, P97; Johnson J, 2018, NEUROTOXICOLOGY, V67, P112, DOI 10.1016/j.neuro.2018.05.001; Johnson J, 2018, NEUROTOXICOLOGY, V64, P230, DOI 10.1016/j.neuro.2017.06.007; Karki P, 2018, MOL NEUROBIOL, V55, P5031, DOI 10.1007/s12035-017-0709-x; Karki P, 2015, J BIOL CHEM, V290, P23725, DOI 10.1074/jbc.M115.649327; Karki P, 2014, MOL CELL BIOL, V34, P1280, DOI 10.1128/MCB.01176-13; Karki P, 2013, J BIOL CHEM, V288, P28975, DOI 10.1074/jbc.M113.483826; Ke T, 2019, NEUROCHEM RES, V44, P2449, DOI 10.1007/s11064-019-02881-7; Keen CL, 1999, NEUROTOXICOLOGY, V20, P213; Kempermann G, 2011, EUR J NEUROSCI, V33, P1018, DOI 10.1111/j.1460-9568.2011.07599.x; Kim J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210248; Klos KJ, 2006, EUR J NEUROL, V13, P1139, DOI 10.1111/j.1468-1331.2006.01407.x; Kobayashi E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19442-7; Kullar SS, 2019, ENVIRON INT, V130, DOI 10.1016/j.envint.2019.05.083; Kwakye GF, 2015, INT J ENV RES PUB HE, V12, P7519, DOI 10.3390/ijerph120707519; LAI JCK, 1992, NEUROCHEM RES, V17, P841, DOI 10.1007/BF00993259; LAI JCK, 1991, METAB BRAIN DIS, V6, P165, DOI 10.1007/BF00996908; Lee ESY, 2009, J NEUROCHEM, V110, P530, DOI 10.1111/j.1471-4159.2009.06105.x; Lee JW, 2000, ARCH NEUROL-CHICAGO, V57, P597, DOI 10.1001/archneur.57.4.597; Lee SG, 2011, CANCER RES, V71, P6514, DOI 10.1158/0008-5472.CAN-11-0782; Leung TCH, 2012, ACS CHEM NEUROSCI, V3, P22, DOI 10.1021/cn200072h; Li S, 1997, J NEUROPATH EXP NEUR, V56, P901, DOI 10.1097/00005072-199708000-00008; Lin CLG, 2012, FUTURE MED CHEM, V4, P1689, DOI [10.4155/fmc.12.122, 10.4155/FMC.12.122]; Lin M, 2020, J NEUROSCI, V40, P5871, DOI 10.1523/JNEUROSCI.2830-19.2020; Loschmann PA, 2004, EXP NEUROL, V187, P86, DOI 10.1016/j.expneurol.2004.01.018; Ordonez-Librado JL, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/612989; Mironova Yu S, 2018, Zh Nevrol Psikhiatr Im S S Korsakova, V118, P50, DOI 10.17116/jnevro201811806250; Nandhu MS, 2011, MOL CELL BIOCHEM, V353, P47, DOI 10.1007/s11010-011-0773-x; Nowak K, 2006, J NEUROCHEM, V96, P1696, DOI 10.1111/j.1471-4159.2006.03692.x; Pajarillo E, 2018, NEUROTOXICOLOGY, V65, P280, DOI 10.1016/j.neuro.2017.11.008; Palouzier-Paulignan B, 2012, CHEM SENSES, V37, P769, DOI 10.1093/chemse/bjs059; Peres TV, 2015, NEUROTOXICOLOGY, V50, P28, DOI 10.1016/j.neuro.2015.07.005; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Powell SK, 2016, GENE THER, V23, P807, DOI 10.1038/gt.2016.62; Qu SG, 2019, AGING-US, V11, P1934, DOI 10.18632/aging.101884; Ratajewski M, 2009, GENOMICS, V94, P407, DOI 10.1016/j.ygeno.2009.08.014; Reaney SH, 2006, TOXICOL SCI, V93, P114, DOI 10.1093/toxsci/kfl028; Robison G, 2015, METALLOMICS, V7, P748, DOI 10.1039/c5mt00023h; Rosas S, 2007, J NEUROCHEM, V101, P1134, DOI 10.1111/j.1471-4159.2007.04517.x; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Sarkar S, 2018, NEUROTOXICOLOGY, V64, P204, DOI 10.1016/j.neuro.2017.05.009; SCHEUHAMMER AM, 1981, TOXICOL APPL PHARM, V61, P227, DOI 10.1016/0041-008X(81)90412-9; SINGH J, 1974, ENVIRON PHYSIOL BIOC, V4, P16; Song QF, 2016, MOL NEUROBIOL, V53, P6745, DOI 10.1007/s12035-015-9602-7; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; Takakura K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133331; TANAKA K, 1993, NEUROSCI RES, V16, P149, DOI 10.1016/0168-0102(93)90082-2; Tiwari PC, 2017, DIALOGUES CLIN NEURO, V19, P71; Tjalkens Ronald B, 2017, Adv Neurobiol, V18, P159, DOI 10.1007/978-3-319-60189-2_8; Verma R, 2010, EUR J PHARMACOL, V638, P65, DOI 10.1016/j.ejphar.2010.04.021; Waters MR, 2019, ONCOGENESIS, V8, DOI 10.1038/s41389-019-0146-y; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Yin X, 2018, MOL CELL NEUROSCI, V90, P1, DOI 10.1016/j.mcn.2018.05.004	95	18	18	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2020	295	46					15662	15676		10.1074/jbc.RA120.015552	http://dx.doi.org/10.1074/jbc.RA120.015552			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OY6NO	32893191	hybrid, Green Published			2022-12-26	WOS:000594361600019
J	Onono, MA; Rutherford, GW; Bukusi, EA; White, JS; Goosby, E; Brindis, CD				Onono, Maricianah A.; Rutherford, George W.; Bukusi, Elizabeth A.; White, Justin S.; Goosby, Eric; Brindis, Claire D.			Political prioritization and the competing definitions of adolescent pregnancy in Kenya: An application of the Public Arenas Model	PLOS ONE			English	Article							REPRODUCTIVE HEALTH; CONSTRUCTION; MORTALITY; BARRIERS; OUTCOMES; NEEDS	Background Approximately one in every five adolescent girls in Kenya has either had a live birth or is pregnant with her first child. There is an urgent need to understand the language and symbols used to represent adolescent pregnancy, if the current trend in adolescent pregnancy is to be reversed. Agreement on the definition of a societal problem is an important precursor to a social issue's political prioritization and priority setting. Methods We apply the Public Arenas Model to appraise the environments, definitions, competition dynamics, principles of selection and current actors involved in problem-solving and prioritizing adolescent pregnancy as a policy issue. Using a focused ethnographic approach, we undertook semi-structured interviews with 14 members of adolescent sexual reproductive health networks at the national level and conducted thematic analysis of the interviews. Findings We found that existing definitions center around adolescent pregnancy as a "disease" that needs prevention and treatment, socially deviant behaviour that requires individual agency, and a national social concern that drains public resources and therefore needs to be regulated. These competing definitions contribute to the rarity of the topic achieving traction within the political agenda and contribute to conflicting solutions, such as lowering the legal age of consenting to sex, while limiting access to contraceptive information and services to minors. Conclusion This paper provides a timely theoretical approach to draw attention to the different competing definitions and subsequent divergent interpretations of the problem of adolescent pregnancy in Kenya. Adolescent reproductive health stakeholders need to be familiar with the existing definitions and deliberately reframe this important social problem for better political prioritization and resource allocation. We recommend a definition of adolescent pregnancy that cuts across different arenas, and leverages already existing dominant and concurrent social and economic issues that are already on the agenda table.	[Onono, Maricianah A.; Bukusi, Elizabeth A.] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Rutherford, George W.; White, Justin S.; Goosby, Eric; Brindis, Claire D.] Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA; [White, Justin S.; Brindis, Claire D.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Brindis, Claire D.] Adolescent & Young Adult Hlth Natl Resource Ctr, San Francisco, CA USA	Kenya Medical Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Onono, MA (corresponding author), Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya.	arcianah@gmail.com		Brindis, Claire/0000-0002-2284-3936; White, Justin/0000-0002-3388-9569; Onono, Maricianah/0000-0001-6847-8762				Africa Union, 2014, COMM AFR POS POST 20; [Anonymous], 2016, THE TOTAL AUDIENCE R; [Anonymous], 2010, DRUG DISCOV TODAY TE, V7, pe1; Bankole A, 2010, STUD FAMILY PLANN, V41, P117, DOI 10.1111/j.1728-4465.2010.00232.x; Biddlecom Ann E, 2007, Afr J Reprod Health, V11, P99, DOI 10.2307/25549734; Blanc AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059864; Blumer H., 1969, SYMB INTERACT; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Center for Health and Gender Equity, 2018, IMP EXP GLOB GAG RUL; Chaaban JC, 2011, WENDY MEASURING EC G; Chandra-Mouli V, 2013, J ADOLESCENT HEALTH, V52, P517, DOI 10.1016/j.jadohealth.2013.03.002; Christian Gonzales SJ-C, 2015, CATALYST CHANGE EMPO; Christofides NJ, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18585; Creswell J. W., 2007, QUALITATIVE INQUIRY; Cruz Edward Venzon, 2013, Nurse Res, V20, P36; Eke AC, 2011, J OBSTET GYNAECOL, V31, P164, DOI 10.3109/01443615.2010.539720; Erulkar Annabel S, 2005, Afr J Reprod Health, V9, P51; Ganchimeg T, 2014, BJOG-INT J OBSTET GY, V121, P40, DOI 10.1111/1471-0528.12630; Guttmacher Institute, 2017, ADD IT INV CONTR MAT; HILGARTNER S, 1988, AM J SOCIOL, V94, P53, DOI 10.1086/228951; Hodgkinson S, 2014, PEDIATRICS, V133, P114, DOI 10.1542/peds.2013-0927; Igadwah L, 2019, BUSINESS DAILY; Kennedy EC, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-455; Kenya National Bureau of Statistics ICF International, 2015, 2014 KDHS KEY FIND; Klein R, 1998, BMJ-BRIT MED J, V317, P959, DOI 10.1136/bmj.317.7164.959; Macleod C, 2003, CHILDHOOD, V10, P419, DOI 10.1177/0907568203104003; Martin DK, 2003, WORLD J SURG, V27, P962, DOI 10.1007/s00268-003-7100-y; MCCARTHY JD, 1977, AM J SOCIOL, V82, P1212, DOI 10.1086/226464; MEEKERS D, 1994, POP STUD-J DEMOG, V48, P47, DOI 10.1080/0032472031000147466; Michaels-Igbokwe C, 2014, SOC SCI MED, V105, P93, DOI 10.1016/j.socscimed.2014.01.016; Nove A, 2014, LANCET GLOB HEALTH, V2, pE155, DOI 10.1016/S2214-109X(13)70179-7; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Rights ACoHaP, 2003, PROT AFR CHART HUM P; SCHNEIDER A, 1993, AM POLIT SCI REV, V87, P334, DOI 10.2307/2939044; Schwandt T, 2012, INTERPRETIVE POLITIC; Schwandt T. A, 2015, SAGE DICT QUALITATIV, V4th; STONE DA, 1989, POLIT SCI QUART, V104, P281, DOI 10.2307/2151585; Thorne S, 2008, INTERPRETIVE DESCRIP, V1; Tilahun M, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-19; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Twaweza East Africa, 2019, GRAD NAT KEN OP GOV; UCotRotC, 2003, CRCGC20034; *UN, 1995, INT C POP DEV CAIR 5; UNAIDS, 2016, END AIDS EP AD AD; UNFPA, 2014, STATE WORLD POPULATI, DOI DOI 10.18356/281344F5-EN; UNFPA, 2013, MOTHERHOOD CHILDHOOD; UNICEF, 2016, FAM ASS UND ADDR CHI; United Nations, 2015, SUST DEV GOALS 2015; United Nations Population Fund, 2017, STAT WORLD POP 2017; United Nations Population Fund, 2017, REV AD YOUTH POL STR; United Nations (UN), 1979, CONVENTION ELIMINATI; USAID, 2017, STAND PROV NONUS NON; Warenius LU, 2006, REPROD HEALTH MATTER, V14, P119, DOI 10.1016/S0968-8080(06)27242-2; WHO Guidelines Approved by the Guidelines Review Committee, 2011, WHO GUID PREV EARL P; Williams H, 2004, LEGAL BRIEF AFRICA; Wood K, 2006, REPROD HEALTH MATTER, V14, P109, DOI 10.1016/S0968-8080(06)27231-8; World Health Organization, 2017, GLOB ACC ACT HLTH AA	57	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0238136	10.1371/journal.pone.0238136	http://dx.doi.org/10.1371/journal.pone.0238136			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NS5RK	32925926	Green Published, gold			2022-12-26	WOS:000572318000040
J	Lu, J; Shen, H; Li, Q; Xiong, FR; Xie, RR; Yuan, MX; Yang, JK				Lu, Jing; Shen, Han; Li, Qi; Xiong, Fengran; Xie, Rongrong; Yuan, Mingxia; Yang, Jin-Kui			KCNH6 protects pancreatic beta-cells from endoplasmic reticulum stress and apoptosis	FASEB JOURNAL			English	Article						apoptosis; endoplasmic reticulum stress; insulin; KCNH6; pancreatic beta-cells	HERG K+ CHANNELS; ER STRESS; ACTIVATION; CALPAIN; CA2+; CALCIUM; TYPE-1; DYSFUNCTION; CASPASE-12; PALMITATE	Adult patients with dysfunction in human ether-a-go-go 2 (hERG2) protein, encoded by KCNH6, present with hypoinsulinemia and hyperglycemia. However, the mechanism of KCNH6 actionin glucose disorders has not been clearly defined. Previous studies identified that sustained endoplasmic reticulum (ER) stress-mediated apoptosis of pancreatic beta-cells and directly contributed to diabetes. In the present study, we showed that Kcnh6 knockout (KO) mice had impaired glucose tolerance mediated by high ER stress levels, and showed increased apoptosis and elevated intracellular calcium levels in pancreatic beta-cells. In contrast, KCNH6 overexpression in islets isolated from C57BL/6J mice attenuated ER stress induced by thapsigargin or palmitic acid. This effect contributed to better preservation of beta-cells, as reflected in increased beta cell survival and enhanced glucose-stimulated insulin secretion. These results were further corroborated by studies evaluating KCNH6 overexpression in KO islets. Similarly, induction of Kcnh6 in KO mice by lentivirus injection improved glucose tolerance by reducing pancreatic ER stress and apoptosis. Our data provide new insights into howKcnh6deficiency causes ER calcium depletion and beta cell dysfunction.	[Lu, Jing; Shen, Han; Li, Qi; Xiong, Fengran; Xie, Rongrong; Yuan, Mingxia; Yang, Jin-Kui] Capital Med Univ, Beijing Tongren Hosp, Beijing Diabet Inst, Beijing Key Lab Diabet Res & Care, Beijing, Peoples R China; [Shen, Han] Beijing Sijiqing Hosp, Beijing, Peoples R China	Capital Medical University	Yang, JK (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Endocrinol, Beijing 100730, Peoples R China.	jkyang@ccmu.edu.cn		Li, Qi/0000-0003-2564-7225	National Natural Science Foundation of China [81561128015, 81800688, 8181930019]; Foundation of Beijing Tongren Hospital, Capital Medical University [TRYY-KYJJ-2016-013]; Beijing Municipal Administration of Hospitals Incubating Program [PX2019006]; National Key R&D Program of China [2017YFC0909600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Beijing Tongren Hospital, Capital Medical University; Beijing Municipal Administration of Hospitals Incubating Program; National Key R&D Program of China	This work was supported by grants from the National Natural Science Foundation of China (81561128015, 81800688, 8181930019), Foundation of Beijing Tongren Hospital, Capital Medical University (TRYY-KYJJ-2016-013), Beijing Municipal Administration of Hospitals Incubating Program (PX2019006) to JL, and the National Key R&D Program of China (2017YFC0909600) to JKY	Babcock JJ, 2013, ACTA PHARMACOL SIN, V34, P329, DOI 10.1038/aps.2013.6; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Bevers MB, 2008, J CEREBR BLOOD F MET, V28, P655, DOI 10.1038/sj.jcbfm.9600595; Biden TJ, 2014, TRENDS ENDOCRIN MET, V25, P389, DOI 10.1016/j.tem.2014.02.003; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Brouwers B, 2014, CELL METAB, V20, P979, DOI 10.1016/j.cmet.2014.11.004; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Chua BT, 2000, J BIOL CHEM, V275, P5131, DOI 10.1074/jbc.275.7.5131; Cui W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059921; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Glading A, 2001, J BIOL CHEM, V276, P23341, DOI 10.1074/jbc.M008847200; Gwiazda KS, 2009, AM J PHYSIOL-ENDOC M, V296, pE690, DOI 10.1152/ajpendo.90525.2008; Hasnain SZ, 2016, J MOL ENDOCRINOL, V56, pR33, DOI 10.1530/JME-15-0232; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Huang CJ, 2010, J BIOL CHEM, V285, P339, DOI 10.1074/jbc.M109.024190; Hylten-Cavallius L, 2017, CIRCULATION, V135, P1705, DOI 10.1161/CIRCULATIONAHA.116.024279; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kim JY, 2012, J PHARMACOL SCI, V118, P65, DOI 10.1254/jphs.11072FP; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Lu T, 2002, BBA-MOL CELL RES, V1590, P16, DOI 10.1016/S0167-4889(02)00193-3; Luciani DS, 2009, DIABETES, V58, P422, DOI 10.2337/db07-1762; Marhfour I, 2012, DIABETOLOGIA, V55, P2417, DOI 10.1007/s00125-012-2604-3; Nagy G, 2010, TOXICOL APPL PHARM, V243, P96, DOI 10.1016/j.taap.2009.11.017; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Namba T, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw1386; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Proverbio MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068740; Qiu HY, 2015, J DIABETES RES, V2016, P1; Ramadan JW, 2011, CELL CALCIUM, V50, P481, DOI 10.1016/j.ceca.2011.08.005; Rosati B, 2000, FASEB J, V14, P2601, DOI 10.1096/fj.00-0077com; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; Schroder M, 2006, CURR MOL MED, V6, P5, DOI 10.2174/156652406775574569; Shang LS, 2014, DIABETES, V63, P923, DOI 10.2337/db13-0717; Shen N, 2012, EUR J PHARMACOL, V694, P120, DOI 10.1016/j.ejphar.2012.07.052; Shi CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep21924; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Tan YF, 2006, J BIOL CHEM, V281, P16016, DOI 10.1074/jbc.M601299200; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Thomas D, 2000, CELL CALCIUM, V28, P213, DOI 10.1054/ceca.2000.0152; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Wagner M, 2011, CURR OPIN CLIN NUTR, V14, P367, DOI 10.1097/MCO.0b013e32834778d4; Yang JK, 2018, CELL REP, V25, P3800, DOI 10.1016/j.celrep.2018.12.005; Yu C, 2015, J BIOL CHEM, V290, P20687, DOI 10.1074/jbc.M115.654863; Zmuda EJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2096; Zu Y, 2013, NAT METHODS, V10, P329, DOI 10.1038/NMETH.2374	47	5	5	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15015	15028		10.1096/fj.202001218R	http://dx.doi.org/10.1096/fj.202001218R		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32918525				2022-12-26	WOS:000570676000001
J	Araujo, LO; Nunes, AMPB; Ferreira, VM; Cardoso, CW; Feitosa, CA; Reis, MG; Campos, LC				Araujo, Lucas Oliveira; Pithon Borges Nunes, Amelia Maria; Ferreira, Viviane Matos; Cardoso, Cristiane Wanderley; Feitosa, Caroline Alves; Reis, Mitermayer Galvao; Campos, Leila Carvalho			Clinical and epidemiological features of pertussis in Salvador, Brazil, 2011-2016	PLOS ONE			English	Article							VACCINATION; INFECTION; CHILDREN; INFANTS; DEATHS	Pertussis, a severe respiratory infection caused byBordetella pertussis, is distributed globally. Vaccination has been crucial to annual reductions in the number of cases. However, disease reemergence has occurred over the last decade in several countries, including Brazil. Here we describe the clinical and epidemiological aspects of suspected pertussis cases in Salvador, Brazil, and evaluate factors associated with case confirmation. This descriptive and retrospective study was conducted in the five hospitals in Salvador that reported the highest number of pertussis cases between 2011-2016. Demographic and clinical data were recorded for each patient. Bivariate analysis was performed to evaluate differences between groups (confirmed vs. unconfirmed cases) using Pearson's Chi-square test or Fisher's exact test. Results: Of 529 suspected pertussis cases, 29.7% (157/529) were confirmed by clinical, clinical-epidemiological or laboratory criteria, with clinical criteria most frequently applied (63.7%; 100/157). Unvaccinated individuals (43.3%; 68/157) were the most affected, followed by age groups 2-3 months (37.6%; 59/157) and <2 months (31.2%; 49/157). Overall, <= 50% of the confirmed cases presented a complete vaccination schedule. All investigated cases presented cough in association with one or more symptoms, especially paroxysmal cough (66.9%; 105/529) (p = 0.001) or cyanosis (66.2%; 104/529) (p<0.001). Our results indicate that pertussis occurred mainly in infants and unvaccinated individuals in Salvador, Brazil. The predominance of clinical criteria used to confirm suspected cases highlights the need for improvement in the laboratory tools used to perform rapid diagnosis. Fluctuations in infection prevalence demonstrate the importance of vaccination strategies in improving the control and prevention of pertussis.	[Araujo, Lucas Oliveira; Pithon Borges Nunes, Amelia Maria; Ferreira, Viviane Matos; Reis, Mitermayer Galvao; Campos, Leila Carvalho] Fiocruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil; [Ferreira, Viviane Matos; Feitosa, Caroline Alves] Escola Bahiana Med & Saude, Salvador, BA, Brazil; [Cardoso, Cristiane Wanderley] Secretaria Municipal Saude, Salvador, BA, Brazil; [Reis, Mitermayer Galvao] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil; [Reis, Mitermayer Galvao] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA	Fundacao Oswaldo Cruz; Escola Bahiana de Medicina e Saude Publica; Universidade Federal da Bahia; Yale University	Campos, LC (corresponding author), Fiocruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.	leila.campos@fiocruz.br	Campos, Leila/AAO-3207-2021; Cardoso, Cristiane W/Y-8510-2018	Campos, Leila/0000-0001-9150-464X; Reis, Mitermayer/0000-0002-3051-9060; Cardoso, Cristiane/0000-0001-5432-1174; Araujo, Lucas/0000-0002-6215-2400; Reis, AlessanRSS/0000-0001-8486-7469	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001 (https://www.capes.gov.br).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Amirthalingam G, 2014, LANCET, V384, P1521, DOI 10.1016/S0140-6736(14)60686-3; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P433; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; Bailon H, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1700-2; Bart MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01074-14; Brasil . Ministerio da Saude, 2007, SIST INF AGR NOT SIN, P26; Brasil. Ministerio da Saude, 2016, NOT INF MUD CAL VAC; Brasil. Ministerio da Saude. Departamento de Informatica do Sistema unico de Saude, 2019, SIST INF PROGR NAC I; Brasil. Ministerio da Saude. Departamento de Informatica do Sistema unico de Saude, 2019, CAS CONF COQ NOT SIS; Brasil . Ministerio da Saude. Secretaria de Vigilancia em Saude, 2014, MAN REGR PROC VAC, P78; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia das Doencas Transmissiveis, 2017, GUIA VIG SAUD, P72; De Barros ENC, 2020, HUM VACC IMMUNOTHER, V16, P61, DOI 10.1080/21645515.2019.1634991; Cherry JD, 2016, CLIN INFECT DIS, V63, pS119, DOI 10.1093/cid/ciw550; Dabrera G, 2015, CLIN INFECT DIS, V60, P333, DOI 10.1093/cid/ciu821; Dierig A, 2015, PEDIATR INFECT DIS J, V34, P444, DOI 10.1097/INF.0000000000000567; Druzian AF, 2014, BRAZ J INFECT DIS, V18, P177, DOI 10.1016/j.bjid.2013.08.006; Edwards KM, 2014, J INFECT DIS, V209, pS10, DOI 10.1093/infdis/jit560; Esposito S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01344; Gabutti G, 2012, INT J ENV RES PUB HE, V9, P4626, DOI 10.3390/ijerph9124626; Guimaraes LM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1222-3; Haller S, 2015, PEDIATR INFECT DIS J, V34, P513, DOI 10.1097/INF.0000000000000654; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hozbor D, 2019, VACCINE, V37, P5414, DOI 10.1016/j.vaccine.2019.07.007; Iglesias L, 2018, AN PEDIATR, V89, P170, DOI [10.1016/j.anpede.2017.10.007, 10.1016/j.anpedi.2017.10.013]; Krishnan SG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219534; Kusnierz G, 2014, REV CHIL INFECTOL, V31, P385, DOI [10.4067/s0716-10182014000400002, DOI 10.4067/S0716-10182014000400002]; Mancaneira JF, 2016, J PEDIAT-BRAZIL, V92, P40, DOI 10.1016/j.jped.2015.03.006; Medeiros Angélica Teresa Nascimento de, 2017, Cad. saúde colet., V25, P453, DOI 10.1590/1414-462x201700040069; Ministerio da Saude, 2014, INF TECN IMPL VAC AD; Mooi FR, 2014, EPIDEMIOL INFECT, V142, P685, DOI 10.1017/S0950268813000071; Pinell-McNamara VA, 2017, EMERG INFECT DIS, V23, pS94, DOI 10.3201/eid2313.170457; SESAB. Secretaria de Saude do Estado da Bahia. Diretoria de Vigilancia Epidemiologica, 2017, DIR VIG EP PROT VIG; SESAB. Secretaria de Saude do Estado da Bahia. Diretoria de Vigilancia Epidemiologica, 2018, B EP B COQ BAH; Skoff TH, 2015, PEDIATRICS, V136, P635, DOI 10.1542/peds.2015-1120; Torres RSLA, 2015, J PEDIAT-BRAZIL, V91, P333, DOI [10.1016/j.jped.2014.09.004, 10.1016/j.jpedp.2015.04.006]; WHO, 2019, IMM VACC BIOL PERT; Winter K, 2015, CLIN INFECT DIS, V61, P1099, DOI 10.1093/cid/civ472	37	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238932	10.1371/journal.pone.0238932	http://dx.doi.org/10.1371/journal.pone.0238932			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915869	gold, Green Published			2022-12-26	WOS:000571887500125
J	Quinn, DM; Puhl, RM; Reinka, MA				Quinn, Diane M.; Puhl, Rebecca M.; Reinka, Mora A.			Trying again (and again): Weight cycling and depressive symptoms in US adults	PLOS ONE			English	Article							BIAS INTERNALIZATION; PSYCHOLOGICAL HEALTH; OVERWEIGHT; STIGMA; METAANALYSIS; MAINTENANCE; VALIDATION; OUTCOMES; OBESITY	As the prevalence of overweight and obesity have risen over the past few decades, so have weight control attempts. Research has shown, however, that intentional weight loss results are often short-lived, with people regaining the weight over time. This can lead to weight cycling-losing and gaining weight repeatedly. Previous research, mostly done over two decades ago, concluded there was no relationship between weight cycling and psychological health. The goal of the current paper was to re-examine the relationship between weight cycling and depressive symptoms in a national sample of American adults (N= 2702; 50.7% female; mean age = 44.8 years). If, as hypothesized, there is a relationship between more frequent weight cycling and depressive symptoms, then internalized weight stigma will be examined as a potential mediator of the relationship. Results of a cross-sectional survey showed that 74.6% of adults report they have intentionally tried to lose weight. Amongst those who have tried to lose to weight, the average number of weight cycles over the lifetime was 7.82 cycles. Simultaneous regression showed that greater weight cycling was related to greater reported depressive symptoms (beta = .15,p< .001), controlling for age, gender, education, income, and body mass index. Internalized weight stigma was a partial mediator of this relationship. Discussion focuses on the potential implications for weight cycling and mental health.	[Quinn, Diane M.; Reinka, Mora A.] Univ Connecticut, Dept Psychol Sci, Storrs, CT 06269 USA; [Puhl, Rebecca M.] Univ Connecticut, Rudd Ctr Food Policy & Obes, Dept Human Dev & Family Sci, Storrs, CT USA; [Reinka, Mora A.] Ursinus Coll, Dept Psychol, Collegeville, PA 19426 USA	University of Connecticut; University of Connecticut	Quinn, DM (corresponding author), Univ Connecticut, Dept Psychol Sci, Storrs, CT 06269 USA.	diane.quinn@uconn.edu	Puhl, Rebecca/ABE-9260-2021	Quinn, Diane/0000-0003-4492-7580	University of Connecticut Research Excellence Program award	University of Connecticut Research Excellence Program award	Research was supported by a University of Connecticut Research Excellence Program award. (DMQ, RMP). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, DEPR DIS DIAGN STAT; Bartlett SJ, 1996, J CONSULT CLIN PSYCH, V64, P587, DOI 10.1037/0022-006X.64.3.587; Cardiovascular Disease and Risk Management, 2019, DIABETES CARE, V2, pS103, DOI 10.2337/dc19-S010; Carels RA, 2010, EAT BEHAV, V11, P180, DOI 10.1016/j.eatbeh.2010.03.002; de Zwaan M, 2015, APPETITE, V91, P336, DOI 10.1016/j.appet.2015.04.064; Durso LE, 2008, OBESITY, V16, pS80, DOI 10.1038/oby.2008.448; Durso LE, 2016, EAT BEHAV, V21, P104, DOI 10.1016/j.eatbeh.2016.01.011; Franz MJ, 2007, J AM DIET ASSOC, V107, P1755, DOI 10.1016/j.jada.2007.07.017; Friedman MA, 1998, J CONSULT CLIN PSYCH, V66, P646, DOI 10.1037/0022-006X.66.4.646; Gudzune KA, 2015, ANN INTERN MED, V162, P501, DOI 10.7326/M14-2238; Hales CM, 2017, PREVALENCE OBESITY A; Hayes A. F., 2018, INTRO MEDIATION MODE; Himmelstein MS, 2017, AM J PREV MED, V53, P421, DOI 10.1016/j.amepre.2017.04.003; Irwin M, 1999, ARCH INTERN MED, V159, P1701, DOI 10.1001/archinte.159.15.1701; KUEHNEL RH, 1994, INT J EAT DISORDER, V15, P321, DOI 10.1002/eat.2260150403; Lee MS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216324; Lee MS, 2016, BODY IMAGE, V17, P25, DOI 10.1016/j.bodyim.2016.01.008; MacLean PS, 2015, OBESITY, V23, P7, DOI 10.1002/oby.20967; Madigan CD, 2018, PREV MED, V108, P47, DOI 10.1016/j.ypmed.2017.12.010; Mann T, 2007, AM PSYCHOL, V62, P220, DOI 10.1037/0003-066X.62.3.220; Maxwell SE, 2007, PSYCHOL METHODS, V12, P23, DOI 10.1037/1082-989X.12.1.23; Mehta T, 2014, OBES REV, V15, P870, DOI 10.1111/obr.12222; Olson KL, 2018, OBESITY, V26, P1888, DOI 10.1002/oby.22283; Osborn RL, 2011, ETHNIC DIS, V21, P274; Pearl RL, 2018, OBES REV, V19, P1141, DOI 10.1111/obr.12701; Pearl RL, 2014, BODY IMAGE, V11, P89, DOI 10.1016/j.bodyim.2013.09.005; Polivy J, 2002, AM PSYCHOL, V57, P677, DOI 10.1037//0003-066X.57.9.677; Price DW, 2013, DIABETES CARE, V36, P216, DOI 10.2337/dc12-0293; Puhl RM, 2017, ANN BEHAV MED, V51, P754, DOI 10.1007/s12160-017-9898-9; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Saad L, 2014, GALLUP POLL SOCIAL S, P2011; Simkin-Silverman LR, 1998, INT J EAT DISORDER, V24, P175, DOI 10.1002/(SICI)1098-108X(199809)24:2&lt;175::AID-EAT7&gt;3.0.CO;2-B; Skinner AC, 2018, PEDIATRICS, V142, DOI [10.1542/peds.2018-1916, 10.1542/peds.2017-3459, 10.1542/peds.2018-0725]; Spahlholz J, 2016, OBES REV, V17, P43, DOI 10.1111/obr.12343; Stevens VL, 2012, AM J EPIDEMIOL, V175, P785, DOI 10.1093/aje/kwr378; Tomiyama AJ, 2014, APPETITE, V82, P8, DOI 10.1016/j.appet.2014.06.108; Venditti EM, 1996, J CONSULT CLIN PSYCH, V64, P400; Yanovski SZ, 2000, ARCH INTERN MED, V160, P2581, DOI 10.1001/archinte.160.17.2581	38	8	8	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0239004	10.1371/journal.pone.0239004	http://dx.doi.org/10.1371/journal.pone.0239004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9MU	32915921	gold, Green Published			2022-12-26	WOS:000571887500094
J	Ishikawa, Y; Nakai, K				Ishikawa, Yasuhisa; Nakai, Kenta			A hypothetical trivalent epigenetic code that affects the nature of human ESCs	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DNA; 5-HYDROXYMETHYLCYTOSINE; IMMUNOPRECIPITATION; METHYLATION; PATTERNS; TIP60	It has been suggested that DNA methylation can work in concert with other epigenetic factors, leading to changes in cellular phenotypes. For example, DNA demethylation modifications producing 5-hydroxymethylcytosine (5hmC) are thought to interact with histone modifications to influence the acquisition of embryonic stem cell (ESC) potency. However, the mechanism by which this occurs is still unknown. Thus, we systematically analysed the co-occurrence of DNA and histone modifications at genic regions as well as their relationship with ESC-specific expression using a number of heterogeneous public datasets. From a set of 19 epigenetic factors, we found remarkable co-occurrence of 5hmC and H4K8ac, accompanied by H3K4me1. This enrichment was more prominent at gene body regions. The results were confirmed using data obtained from different detection methods and species. Our analysis shows that these marks work cooperatively to influence ESC-specific gene expression. We also found that this trivalent mark is relatively enriched in genes related with immunity, which is a bit specific in ESCs. We propose that a trivalent epigenetic mark, composed of 5hmC, H4K8ac and H3K4me1, regulates gene expression and modulates the nature of human ESCs as a novel epigenetic code.	[Ishikawa, Yasuhisa; Nakai, Kenta] Univ Tokyo, Dept Computat Biol & Med Sci, Kashiwa, Chiba, Japan; [Nakai, Kenta] Univ Tokyo, Human Genome Ctr, Inst Med Sci, Tokyo, Japan	University of Tokyo; University of Tokyo	Nakai, K (corresponding author), Univ Tokyo, Human Genome Ctr, Inst Med Sci, Tokyo, Japan.	knakai@ims.u-tokyo.ac.jp	Nakai, Kenta/B-7293-2009	Nakai, Kenta/0000-0002-8721-8883	Japan society for the promotion of science [17K00397, 18H04710]	Japan society for the promotion of science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan society for the promotion of science (https://www.jsps.go.jp/english/) grant number 17K00397 and 18H04710. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188; Jeong KW, 2011, NAT STRUCT MOL BIOL, V18, P1358, DOI 10.1038/nsmb.2153; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kimura A, 1998, GENES CELLS, V3, P789, DOI 10.1046/j.1365-2443.1998.00229.x; Lan X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022226; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; Li YF, 2013, SOURCE CODE BIOL MED, V8, DOI 10.1186/1751-0473-8-10; Mahe EA, 2017, GENOME RES, V27, P947, DOI 10.1101/gr.211466.116; Maleszka R, 2016, CURR OPIN INSECT SCI, V15, P45, DOI 10.1016/j.cois.2016.03.003; Maleszka R, 2014, BRIEF FUNCT GENOMICS, V13, P191, DOI 10.1093/bfgp/elt050; Neri F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r91; Nestor CE, 2014, METHODS MOL BIOL, V1094, P259, DOI 10.1007/978-1-62703-706-8_20; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Qian WQ, 2012, SCIENCE, V336, P1445, DOI 10.1126/science.1219416; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Szulwach KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002154; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Turner BM, 2007, NAT CELL BIOL, V9, P2, DOI 10.1038/ncb0107-2; Vastenhouw NL, 2012, CURR OPIN CELL BIOL, V24, P374, DOI 10.1016/j.ceb.2012.03.009; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu XW, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0228-7; Yang YQA, 2016, NUCLEIC ACIDS RES, V44, P8153, DOI 10.1093/nar/gkw498; Yang Z, 2016, BIOINFORMATICS, V32, P1, DOI 10.1093/bioinformatics/btv544; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zhao MT, 2014, CELL REPROGRAM, V16, P175, DOI 10.1089/cell.2014.0002	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238742	10.1371/journal.pone.0238742	http://dx.doi.org/10.1371/journal.pone.0238742			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911515	Green Published, gold			2022-12-26	WOS:000571885900052
J	Lang, YG; Li, FF; Liu, Q; Xia, ZQ; Ji, ZL; Hu, J; Cheng, YT; Gao, MJ; Sun, F; Shen, BZ; Xie, C; Yi, W; Wu, YL; Yao, J; Cao, ZJ				Lang, Yange; Li, Fangfang; Liu, Qiang; Xia, Zhiqiang; Ji, Zhenglin; Hu, Juan; Cheng, Yuting; Gao, Minjun; Sun, Fang; Shen, Bingzheng; Xie, Chang; Yi, Wei; Wu, Yingliang; Yao, Jing; Cao, Zhijian			The Kv1.3 ion channel acts as a host factor restricting viral entry	FASEB JOURNAL			English	Article						Dengue virus; hepatitis C virus; host factor; Kv1; 3 ion channel; Zika virus	HEPATITIS-C-VIRUS; MITOCHONDRIAL POTASSIUM CHANNEL; ZIKA VIRUS; K+ CHANNEL; FUSION; TARGETS; INNATE; PH	Virus entry into cells is the initial stage of infection and involves multiple steps, and interfering viral entry represents potential antiviral approaches. Ion channels are pore-forming membrane proteins controlling cellular ion homeostasis and regulating many physiological processes, but their roles during viral infection have rarely been explored. Here, the functional Kv1.3 ion channel was found to be expressed in human hepatic cells and tissues. The Kv1.3 was then revealed to restrict HCV entry via inhibiting endosome acidification-mediated viral membrane fusion. The Kv1.3 was also demonstrated to inhibit DENV and ZIKV with an endosome acidification-dependent entry, but have no effect on SeV with a neutral pH penetration. A Kv1.3 antagonist PAP-1 treatment accelerated animal death in ZIKV-infectedIfnar1(-/-)mice. Moreover, Kv1.3-deletion was found to promote weight loss and reduce survival rate in ZIKV-infected Kv1.3(-/-)mice. Altogether, the Kv1.3 ion channel behaves as a host factor restricting viral entry. These findings broaden understanding about ion channel biology.	[Lang, Yange; Li, Fangfang; Xia, Zhiqiang; Ji, Zhenglin; Cheng, Yuting; Gao, Minjun; Sun, Fang; Shen, Bingzheng; Wu, Yingliang; Cao, Zhijian] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Liu, Qiang; Hu, Juan; Xie, Chang; Yao, Jing] Wuhan Univ, Coll Life Sci, Frontier Sci Ctr Immunol & Metab, State Key Lab Virol,Hubei Key Lab Cell Homeostasi, Wuhan 430072, Peoples R China; [Yi, Wei] Wuhan Univ, Renmin Hosp, Dept Neurosurg, Wuhan, Peoples R China; [Wu, Yingliang; Cao, Zhijian] Wuhan Univ, Biodrug Res Ctr, Wuhan, Peoples R China; [Cao, Zhijian] Wuhan Univ, Ctr Fluorinated Pharmaceut, Hubei Prov Engn & Technol Res, Wuhan, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Wuhan University; Wuhan University	Cao, ZJ (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.; Yao, J (corresponding author), Wuhan Univ, Coll Life Sci, Frontier Sci Ctr Immunol & Metab, State Key Lab Virol,Hubei Key Lab Cell Homeostasi, Wuhan 430072, Peoples R China.	jyao@whu.edu.cn; zjcao@whu.edu.cn		Yao, Jing/0000-0003-1844-3988	National Science Fund of China [31872239, 31830031, 81630091, 31929003, 31671209, 31871174, 31601864]; International S&T Cooperation Program of China [S2016G3110]; Hubei Science Fund [2016CFA018, 2017CFA063, 2018CFA016]; Fundamental Research Funds for the Central Universities; Open Research Program of the State Key Laboratory of Virology of China [2020KF002]	National Science Fund of China(National Natural Science Foundation of China (NSFC)); International S&T Cooperation Program of China; Hubei Science Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Open Research Program of the State Key Laboratory of Virology of China	This work was supported by grants from National Science Fund of China (Nos. 31872239, 31830031, 81630091, 31929003, 31671209, 31871174, and 31601864), International S&T Cooperation Program of China (No. S2016G3110), Hubei Science Fund (Nos. 2016CFA018, 2017CFA063, and 2018CFA016), Fundamental Research Funds for the Central Universities, and the Open Research Program of the State Key Laboratory of Virology of China (grant no. 2020KF002)	Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; CAIN CC, 1989, P NATL ACAD SCI USA, V86, P544, DOI 10.1073/pnas.86.2.544; Cang CL, 2015, CELL, V162, P1101, DOI 10.1016/j.cell.2015.08.002; Carrithers MD, 2007, J IMMUNOL, V178, P7822, DOI 10.4049/jimmunol.178.12.7822; Comes N, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00283; Feske S, 2015, ANNU REV IMMUNOL, V33, P291, DOI 10.1146/annurev-immunol-032414-112212; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Gruenberg J, 2009, CURR OPIN CELL BIOL, V21, P582, DOI 10.1016/j.ceb.2009.03.008; Hover S, 2017, J GEN VIROL, V98, P345, DOI 10.1099/jgv.0.000712; Kobayashi M, 2006, J VIROL, V80, P1817, DOI 10.1128/JVI.80.4.1817-1825.2006; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Lavillette D, 2007, J VIROL, V81, P8752, DOI 10.1128/JVI.02642-06; Leanza L, 2015, CELL CALCIUM, V58, P131, DOI 10.1016/j.ceca.2014.09.006; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; Lu YY, 2013, J BIOL CHEM, V288, P24247, DOI 10.1074/jbc.M113.484253; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Mankouri J, 2009, P NATL ACAD SCI USA, V106, P15903, DOI 10.1073/pnas.0906798106; Martinez-Marmol R, 2016, CELL MOL LIFE SCI, V73, P1515, DOI 10.1007/s00018-015-2082-0; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Perez-Verdaguer M, 2016, EXPERT OPIN THER TAR, V20, P577, DOI 10.1517/14728222.2016.1112792; Petruzziello A, 2016, WORLD J GASTROENTERO, V22, P7824, DOI 10.3748/wjg.v22.i34.7824; Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758; Sole L, 2009, J CELL SCI, V122, P3738, DOI 10.1242/jcs.056689; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; Szabo I, 2005, J BIOL CHEM, V280, P12790, DOI 10.1074/jbc.M413548200; Szabo I, 2008, P NATL ACAD SCI USA, V105, P14861, DOI [10.1073/pnas.0804236105, 10.1073/pnas.0804236T05]; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Ujino S, 2016, P NATL ACAD SCI USA, V113, P188, DOI 10.1073/pnas.1506524113; Vicente R, 2008, J BIOL CHEM, V283, P8756, DOI 10.1074/jbc.M708223200; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; White JM, 2016, TRAFFIC, V17, P593, DOI 10.1111/tra.12389; White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748; Yamauchi Y, 2013, J CELL SCI, V126, P1289, DOI 10.1242/jcs.119685; Zheng K, 2014, BIOCHEM BIOPH RES CO, V446, P990, DOI 10.1016/j.bbrc.2014.03.050	38	0	0	1	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202000879RR	http://dx.doi.org/10.1096/fj.202000879RR		SEP 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	32910509				2022-12-26	WOS:000570301900001
J	Peer, N; Lombard, C; Steyn, K; Levitt, N				Peer, Nasheeta; Lombard, Carl; Steyn, Krisela; Levitt, Naomi			A high burden of adverse life events and poor coping mechanisms experienced by urban-dwelling black South Africans	PLOS ONE			English	Article							SOCIAL SUPPORT; HEALTH; COHERENCE; STRESS; SENSE; WOMEN; UNEMPLOYMENT; ASSOCIATION; DRINKING; IMPACT	Aim In view of the current context of poverty and socio-economic inequalities and the high and rising burdens of HIV infection and non-communicable diseases in South Africa, this study aims to describe the distribution of adverse life events (ALEs) by age and gender, and examine the socio-demographic characteristics, psychosocial coping mechanisms, risky lifestyle behaviours and family burden of HIV-related ill-health associated with ALEs in 25-74-year-old black residents of Cape Town. Materials and methods In a random cross-sectional sample, 12 ALEs, tobacco and alcohol use, sense of coherence (SOC), locus of control (LOC) and impact of HIV in the family were determined by administered questionnaires. Data analyses included descriptive statistics adjusted for the realised sample. Multivariable linear regression models assessed the independent associations of increasing number of ALEs. Results Among 1099 participants, mean lifetime score of ALE categories examined was 6.1 +/- 2.1 (range 0-12) with men reporting significantly higher number of events compared with women (p<0.001). The most frequent ALE was the death of a loved one (88.5%) followed by a major financial crisis (81.2%) with no trend across gender or age group. In the multivariable linear regression model, increasing ALEs were significantly associated with male gender, unemployment, having spent >50% of life in urban areas, >7 years of education, problematic alcohol use and poorer psychosocial coping mechanisms defined by low SOC and LOC. All four variables pertaining to HIV-related burden of ill-health in the family were significantly associated with increasing ALEs. Conclusions Considering that lower SOC and LOC and problem drinking were significantly linked to ALEs, policymakers need to formulate strategies that improve coping mechanisms and promote problem-solving behaviours, target the high burden of alcohol misuse and address unemployment.	[Peer, Nasheeta] South African Med Res Council SAMRC, Noncommunicable Dis Res Unit, Durban, South Africa; [Peer, Nasheeta; Levitt, Naomi] Univ Cape Town UCT, Dept Med, Cape Town, South Africa; [Lombard, Carl] SAMRC, Biostat Unit, Tygerberg, South Africa; [Lombard, Carl] UCT, Sch Publ Hlth & Family Med, Cape Town, South Africa; [Lombard, Carl] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Global Hlth, Div Epidemiol & Biostat, Tygerberg, South Africa; [Steyn, Krisela; Levitt, Naomi] UCT, Dept Med, Chron Dis Initiat Africa, Cape Town, South Africa	University of Cape Town; Stellenbosch University; University of Cape Town	Peer, N (corresponding author), South African Med Res Council SAMRC, Noncommunicable Dis Res Unit, Durban, South Africa.; Peer, N (corresponding author), Univ Cape Town UCT, Dept Med, Cape Town, South Africa.	nasheeta.peer@mrc.ac.za		Peer, Nasheeta/0000-0003-2131-8344	Servier Laboratories (South Africa); South African Medical Research Council; Initiative for Cardiovascular Health Research in Developing Countries (IC Health) Foundation Council; Brigham and Women's Hospital, Harvard University	Servier Laboratories (South Africa); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Initiative for Cardiovascular Health Research in Developing Countries (IC Health) Foundation Council; Brigham and Women's Hospital, Harvard University	This work was supported by an unrestricted grant from Servier Laboratories (South Africa) (NL); the South African Medical Research Council (NL); the Initiative for Cardiovascular Health Research in Developing Countries (IC Health) Foundation Council (NL); and Brigham and Women's Hospital, Harvard University (KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh EE, 2003, DIABETES CARE, V26, P719, DOI 10.2337/diacare.26.3.719; [Anonymous], 2010, ANN SUISSES MUSICOLO, V30, P27; [Anonymous], 2012, REGEN MED S3, V7, pS14; Bonita R, 2002, SURVEILLANCE RISK FA; BOR R, 1993, J FAM THER, V15, P187, DOI 10.1111/j.1467-6427.1993.00753.x; Botha KF, 2002, J HEALTH PSYCHOL, V7, P519, DOI 10.1177/1359105302007005672; BRUGHA T, 1985, PSYCHOL MED, V15, P189, DOI 10.1017/S003329170002105X; Coovadia H, 2009, LANCET, V374, P817, DOI 10.1016/S0140-6736(09)60951-X; Corless IB, 2013, J ASSOC NURSE AIDS C, V24, P478, DOI 10.1016/j.jana.2012.11.005; Dawson DA, 2005, ALCOHOL ALCOHOLISM, V40, P453, DOI 10.1093/alcalc/agh176; Ebersohn L., 2002, PERSPECT EDUC, V20, P77; ENSMINGER ME, 1988, SOC SCI MED, V27, P239, DOI 10.1016/0277-9536(88)90127-X; Eriksson M, 2005, J EPIDEMIOL COMMUN H, V59, P460, DOI 10.1136/jech.2003.018085; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Fergusson DM, 2014, AUST NZ J PSYCHIAT, V48, P735, DOI 10.1177/0004867414525840; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Friel S, 2011, J URBAN HEALTH, V88, P860, DOI 10.1007/s11524-011-9606-1; Gana K, 2001, STRESS HEALTH, V17, P77, DOI 10.1002/smi.882; Hochwalder J, 2015, PSYCHOL REP, V116, P363, DOI 10.2466/15.PR0.116k23w3; Hovenkamp-Hermelink JHM, 2019, J AFFECT DISORDERS, V253, P26, DOI 10.1016/j.jad.2019.04.005; Huber Machteld, 2011, BMJ, V343, pd4163, DOI 10.1136/bmj.d4163; Hummer K, 2011, DIABETES EDUCATOR, V37, P104, DOI 10.1177/0145721710388425; Mayosi BM, 2012, LANCET, V380, P2029, DOI 10.1016/S0140-6736(12)61814-5; Moskowitz D, 2013, J URBAN HEALTH, V90, P175, DOI 10.1007/s11524-012-9757-8; Msemburi W, 2016, 2 NATL BURDEN DIS ST; Mulia N, 2008, ADDICTION, V103, P1283, DOI 10.1111/j.1360-0443.2008.02234.x; Myer L, 2009, J EPIDEMIOL COMMUN H, V63, P293, DOI 10.1136/jech.2008.080861; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Schulz A, 2000, SOC SCI MED, V51, P1639, DOI 10.1016/S0277-9536(00)00084-8; StatsSA, 2019, MID POP EST 2019; Thoits PA, 2010, J HEALTH SOC BEHAV, V51, pS41, DOI 10.1177/0022146510383499; USAID, 2016, ORPH VULN CHILDR AFF; Volanen SM, 2007, SCAND J PSYCHOL, V48, P433, DOI 10.1111/j.1467-9450.2007.00598.x	33	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238320	10.1371/journal.pone.0238320	http://dx.doi.org/10.1371/journal.pone.0238320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9ME	32911529	gold, Green Published			2022-12-26	WOS:000571885900022
J	Porter, W; Snowden, E; Hahn, F; Ferguson, M; Tong, F; Dillmore, WS; Blaesius, R				Porter, Warren; Snowden, Eileen; Hahn, Friedrich; Ferguson, Mitchell; Tong, Frances; Dillmore, W. Shannon; Blaesius, Rainer			High accuracy gene expression profiling of sorted cell subpopulations from breast cancer PDX model tissue	PLOS ONE			English	Article							IMMEDIATE-EARLY RESPONSE; INTRA-TUMOR HETEROGENEITY; HYPOXIA-INDUCIBLE FACTOR; RESISTANCE; IDENTIFICATION; CHEMOTHERAPY	Intratumor Heterogeneity (ITH) is a functionally important property of tumor tissue and may be involved in drug resistance mechanisms. Although descriptions of ITH can be traced back to very early reports about cancer tissue, mechanistic investigations are still limited by the precision of analysis methods and access to relevant tissue sources. PDX models have provided a reproducible source of tissue with at least a partial representation of naturally occurring ITH. We investigated the properties of phenotypically distinct cell populations by Fluorescence activated cell sorting (FACS) tissue derived cells from multiple tumors from a triple negative breast cancer patient derived xenograft (PDX) model. We subsequently subjected each population to in depth gene expression analysis. Our findings suggest that process related gene expression changes (caused by tissue dissociation and FACS sorting) are restricted to Immediate Early Genes (IEGs). This allowed us to discover highly reproducible gene expression profiles of distinct cellular compartments identifiable by cell surface markers in this particular tumor model. Within the context of data from a previously published model our work suggests that gene expression profiles associated with hypoxia, stemness and drug resistance may reside in tumor subpopulations predictably growing in PDX models. This approach provides a novel opportunity for prospective mechanistic studies of ITH.	[Porter, Warren; Snowden, Eileen; Hahn, Friedrich; Ferguson, Mitchell; Tong, Frances; Dillmore, W. Shannon; Blaesius, Rainer] BD Technol & Innovat, Res Triangle Pk, NC 27709 USA		Blaesius, R (corresponding author), BD Technol & Innovat, Res Triangle Pk, NC 27709 USA.	Rainer.Blaesius@bd.com		Blaesius, Rainer/0000-0002-5048-9276	BD Technologies and Innovation	BD Technologies and Innovation	This study was completely funded by BD Technologies and Innovation. The funder provided support in the form of salaries for authors WP, ES, FT, WSD, FH, MF and RB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Adler M, 2019, CELL SYST, V8, P43, DOI 10.1016/j.cels.2018.12.008; Amelio I, 2018, P NATL ACAD SCI USA, V115, pE10869, DOI 10.1073/pnas.1808314115; Bahrami Shahram, 2016, Advances in Biological Regulation, V62, P37, DOI 10.1016/j.jbior.2016.05.001; Brugnoli F, 2019, J ONCOL, V2019, DOI 10.1155/2019/7512632; Bruna A, 2016, CELL, V167, P260, DOI 10.1016/j.cell.2016.08.041; Byrne AT, 2017, NAT REV CANCER, V17, P254, DOI 10.1038/nrc.2016.140; Casillas AL, 2018, CLIN CANCER RES, V24, P169, DOI 10.1158/1078-0432.CCR-17-1318; Chen DT, 2010, BREAST CANCER RES TR, V119, P335, DOI 10.1007/s10549-009-0344-y; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cullingford TE, 2008, BBA-MOL CELL RES, V1783, P1229, DOI 10.1016/j.bbamcr.2008.03.007; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Gomez-Miragaya J, 2017, STEM CELL REP, V8, P1392, DOI 10.1016/j.stemcr.2017.03.026; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hassan S, 2017, MOL CANCER THER, V16, P2892, DOI 10.1158/1535-7163.MCT-17-0170; HEPPNER GH, 1984, CANCER RES, V44, P2259; Heppner GH, 2014, ONCOLOGY-NY, V28, P780; Hinohara K, 2019, TRENDS CELL BIOL, V29, P569, DOI 10.1016/j.tcb.2019.03.003; Hoggarth ZE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207877; JAHNER D, 1991, MOL CELL BIOL, V11, P3682; Janiszewska M, 2019, NAT CELL BIOL, V21, P879, DOI 10.1038/s41556-019-0346-x; Karaayvaz M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06052-0; KELLY K, 1995, CURR OPIN IMMUNOL, V7, P327, DOI 10.1016/0952-7915(95)80106-5; Kim H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36184-8; Korem Y, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004224; Krebsbach PH, 2017, STEM CELLS DEV, V26, P1090, DOI 10.1089/scd.2016.0319; Krishnamachary B, 2003, CANCER RES, V63, P1138; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Loschke F, 2015, CURR OPIN CELL BIOL, V32, P56, DOI 10.1016/j.ceb.2014.12.006; Lu HQ, 2018, CANCER RES, V78, P4191, DOI 10.1158/0008-5472.CAN-18-0270; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Moriya S, 2016, J CHEM NEUROANAT, V77, P24, DOI 10.1016/j.jchemneu.2016.04.005; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUID CAR US LAB AN; Nguyen LV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6871; O'Brien SK, 2015, CANCER RES, V75, P4605, DOI 10.1158/0008-5472.CAN-15-0650; Pan XO, 2013, CURR OPIN CELL BIOL, V25, P47, DOI 10.1016/j.ceb.2012.10.018; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pirola L, 2011, GENOME RES, V21, P1601, DOI 10.1101/gr.116095.110; Qiao X, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-95; Qiu LQ, 2015, J LEUKOCYTE BIOL, V97, P723, DOI 10.1189/jlb.3A0214-106R; Rossi SL, 2016, BIOCHEM BIOPH RES CO, V479, P319, DOI 10.1016/j.bbrc.2016.09.068; Sansone P, 2017, CANCER RES, V77, P1927, DOI 10.1158/0008-5472.CAN-16-2129; Savage P, 2017, CELL REP, V21, P1140, DOI 10.1016/j.celrep.2017.10.015; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Sen Moen, 2019, Oncotarget, V10, P3592, DOI 10.18632/oncotarget.26911; Shats I, 2011, CANCER RES, V71, P1772, DOI 10.1158/0008-5472.CAN-10-1735; Sironen RK, 2002, BBA-MOL CELL RES, V1591, P45, DOI 10.1016/S0167-4889(02)00247-1; Smith BA, 2015, P NATL ACAD SCI USA, V112, pE6544, DOI 10.1073/pnas.1518007112; Snowden E, 2017, MOL CANCER RES, V15, P429, DOI 10.1158/1541-7786.MCR-16-0286-T; Su YP, 2017, P NATL ACAD SCI USA, V114, P13679, DOI 10.1073/pnas.1712064115; Sullivan R, 2008, MOL CANCER THER, V7, P1961, DOI 10.1158/1535-7163.MCT-08-0198; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Tullai JW, 2007, J BIOL CHEM, V282, P23981, DOI 10.1074/jbc.M702044200; van Dijk D, 2018, CELL, V174, P716, DOI 10.1016/j.cell.2018.05.061; Vassilopoulos A, 2013, ONCOGENE, V33, DOI 10.1038/onc.2013.516; Waelput W, 2000, BIOCHEM J, V348, P55, DOI 10.1042/0264-6021:3480055; Wang E, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-28; Wang MA, 2018, FASEB J, V32, P1537, DOI 10.1096/fj.201700740R; Weber RJ, 2017, CURR OPIN CELL BIOL, V45, P55, DOI 10.1016/j.ceb.2017.02.009; Xing DM, 2011, WOUND REPAIR REGEN, V19, P205, DOI 10.1111/j.1524-475X.2010.00656.x; Yang BL, 2018, NPJ BREAST CANCER, V4, DOI 10.1038/s41523-018-0088-0; Zhang YQ, 2019, P NATL ACAD SCI USA, V116, P6975, DOI 10.1073/pnas.1814060116	63	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238594	10.1371/journal.pone.0238594	http://dx.doi.org/10.1371/journal.pone.0238594			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911489	Green Published, gold			2022-12-26	WOS:000571885900003
J	Zhu, ML; Ye, N; Xu, JR				Zhu, Mingli; Ye, Ning; Xu, Jiru			Clinical characteristics and prevalence of dihydropteroate synthase gene mutations inPneumocystis jirovecii-infected AIDS patients from low endemic areas of China	PLOS ONE			English	Article							PNEUMOCYSTIS-JIROVECII; PNEUMONIA; DHPS; INDIVIDUALS; DIAGNOSIS; RISK; DHFR	Pneumocystis pneumonia (PCP) is an opportunistic and potentially life-threatening infection of AIDS patients caused by the fungusPneumocystis jirovecii(P.jirovecii). Trimethoprim-sulfamethoxazole (TMP-SMX) is the most commonly used drug combination in the treatment and prophylaxis of PCP. However, with long-term use of this combination, mutations in the dihydropteroate synthase (DHPS) gene ofP.jiroveciibring about the development of resistance. Data on the prevalence ofP.jiroveciiand its DHPS mutants in China, especially in low endemic areas, are still limited. Thus, in the present study, we measured theP.jiroveciiinfection rate among HIV-positive and AIDS (HIV/AIDS) patients with suspected PCP and investigated the relationship between CD4(+)T cell count and PCP occurrence. As well as the polymerase chain reaction (PCR) analysis and sequencing, the restriction fragment length polymorphism (RFLP) method was used to analyze DHPS point mutation inP.jiroveciistrains.P.jiroveciiwas detected in 40.82% of cases. The clinical symptoms and signs of PCP were not typical; with decreasing CD4(+)T cell counts, PCP infection in HIV/AIDS patients increased. In only one case (1.67%), the patients' DHPS gene could not be cut by the Acc I restriction enzyme. Furthermore, mutation at codon 171 was detected in 11 cases and no mutation was found at codon 57. Patients treated with sulfamethoxazole combined with Voriconazole or Caspofungin exhibited favorable results. After treatment, the symptoms of dyspnea were alleviated, and chest computed tomography findings showed the improvement of lung shadows. These indicated that the prevalence of DHPS mutations inP.jiroveciiisolates in AIDS-PCP patients in the region was low. Thus, the contribution of gene mutations to treatment failure requires further research.	[Zhu, Mingli; Xu, Jiru] Xi An Jiao Tong Univ, Sch Med, Dept Microbiol & Immunol, Xian, Shaanxi, Peoples R China; [Zhu, Mingli; Ye, Ning] Zhejiang Chinese Med Univ, Dept Clin Lab, Hangzhou Xixi Hosp, Hangzhou, Zhejiang, Peoples R China; [Ye, Ning] Zhejiang Hosp, Dept Clin Lab, Hangzhou, Zhejiang, Peoples R China	Xi'an Jiaotong University; Zhejiang Chinese Medical University	Xu, JR (corresponding author), Xi An Jiao Tong Univ, Sch Med, Dept Microbiol & Immunol, Xian, Shaanxi, Peoples R China.	xujiru@xjtu.eu.cn			Science and Technology Project from Health Commission of Zhejiang Province of the People's Republic of China [2015KYB321]; Hangzhou Social Development Project [20160533B54]	Science and Technology Project from Health Commission of Zhejiang Province of the People's Republic of China; Hangzhou Social Development Project	This study was funded by the Science and Technology Project from Health Commission of Zhejiang Province of the People's Republic of China (2015KYB321 to MLZ, http://www.zjwjw.gov.cn/art/2015/6/3/art_1202101_854132.html) and Hangzhou Social Development Project (20160533B54 to MLZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; AIDS Professional Group Society of Infectious Diseases Chinese Medical Association, 2015, CHIN J CLIN INFECT D, V8, P385, DOI DOI 10.3760/CMA.J.ISSN.1674-2397.2015.05.001; Beck JM, 2009, EUKARYOT CELL, V8, P446, DOI 10.1128/EC.00309-08; Catherinot E, 2010, INFECT DIS CLIN N AM, V24, P107, DOI 10.1016/j.idc.2009.10.010; Chawla K, 2011, INDIAN J PATHOL MICR, V54, P326, DOI 10.4103/0377-4929.81624; Deng XL, 2014, J CLIN MICROBIOL, V52, P4017, DOI 10.1128/JCM.01848-14; Dimonte S, 2013, INFECT GENET EVOL, V14, P68, DOI 10.1016/j.meegid.2012.11.012; Djawe K, 2015, J INFECT DIS, V212, P1366, DOI 10.1093/infdis/jiv235; Friaza V, 2010, POSTGRAD MED, V122, P24, DOI 10.3810/pgm.2010.11.2219; Gonzalez MR, 2011, ADSORPT SCI TECHNOL, V29, P629, DOI 10.1260/0263-6174.29.7.629; Huang Laurence, 2011, Proc Am Thorac Soc, V8, P294, DOI 10.1513/pats.201009-062WR; Kazanjian PH, 2004, J INFECT DIS, V189, P1684, DOI 10.1086/382957; Krajicek BJ, 2009, CLIN CHEST MED, V30, P265, DOI 10.1016/j.ccm.2009.02.005; Le Gal S, 2012, DIAGN MICR INFEC DIS, V74, P119, DOI 10.1016/j.diagmicrobio.2012.06.002; Li K, 2009, SCAND J INFECT DIS, V41, P152, DOI 10.1080/00365540802613087; Long YJ, 2014, EXP THER MED, V8, P1825, DOI 10.3892/etm.2014.2002; Lowe DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069969; Mane A, 2015, MYCOPATHOLOGIA, V179, P141, DOI 10.1007/s11046-014-9818-5; Miller RF, 2013, CLIN CHEST MED, V34, P229, DOI 10.1016/j.ccm.2013.02.001; Morris A, 2008, CLIN INFECT DIS, V47, pE64, DOI 10.1086/591701; Mu XD, 2011, CHINESE MED J-PEKING, V124, P2683, DOI 10.3760/cma.j.issn.0366-6999.2011.17.021; Ozkoc S, 2018, PARASITOL RES, V117, P3103, DOI 10.1007/s00436-018-6004-6; Parobek CM, 2014, J CLIN MICROBIOL, V52, P1391, DOI 10.1128/JCM.02531-13; Pereira RM, 2014, MED MYCOL, V52, P804, DOI 10.1093/mmy/myu059; Ponce CA, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01290-16; Rabodonirina M, 2013, EMERG INFECT DIS, V19, P21, DOI 10.3201/eid1901.120140; Riebold D, 2006, CLIN INFECT DIS, V42, P582, DOI 10.1086/500019; Riebold D, 2014, TROP MED INT HEALTH, V19, P643, DOI 10.1111/tmi.12299; Schurmann M, 2013, TRANSPL IMMUNOL, V28, P159, DOI 10.1016/j.trim.2013.05.003; Siripattanapipong S, 2008, MED MYCOL, V46, P389, DOI 10.1080/13693780701883722; Suarez I, 2017, INFECTION, V45, P341, DOI 10.1007/s15010-017-1005-4; Tasaka S, 2020, TUBERC RESPIR DIS, V83, P132, DOI 10.4046/trd.2020.0015; Tasaka S, 2015, CLIN MED INSIGHTS-CI, V9, P19, DOI [10.4137/CCRPM.S23324, 10.4137/CCRPRPM.S23324]; Taylor SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049991; Tyagi AK, 2008, INDIAN J MED RES, V128, P734; Wang MY, 2019, INFECT GENET EVOL, V75, DOI 10.1016/j.meegid.2019.103955; Xu Yun, 2010, Disease Surveillance, V25, P877; Yoon C, 2013, MED MYCOL, V51, P568, DOI 10.3109/13693786.2013.770604	38	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238184	10.1371/journal.pone.0238184	http://dx.doi.org/10.1371/journal.pone.0238184			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911508	Green Published, gold			2022-12-26	WOS:000571885900044
J	Astbury, NM; Albury, C; Nourse, R; Jebb, SA				Astbury, Nerys M.; Albury, Charlotte; Nourse, Rebecca; Jebb, Susan A.			Participant experiences of a low-energy total diet replacement programme: A descriptive qualitative study	PLOS ONE			English	Article							WEIGHT-CONTROL PRACTICES; PRIMARY-CARE; PERCEIVED BARRIERS; BEHAVIORS; OBESITY; ADULTS; EXPECTATIONS; RIGOUR; WOMEN; BIAS	Introduction The participants' experience of low-energy total diet replacement (TDR) programmes delivered by lay counsellors in the community for the routine treatment of obesity is currently unclear. We interviewed a sample of twelve participants who took part in the Doctor Referral of Overweight People to Low-Energy total diet replacement Treatment (DROPLET) trial and were randomised to the TDR programme. Methods We purposively sampled twelve patients who took part in the DROPLET trial, and conducted in-depth telephone interviews, which were audio-recorded and transcribed verbatim. Interview questions focused on participants' experiences and perceptions of the TDR programme. We conducted a thematic analysis, actively developing themes from the data, and used the one sheet of paper (OSOP) technique to develop higher-level concepts. Results Nine key themes were identified; Reasons for taking part, Expectations, Support and guidance from the counsellor, Time to build a personal relationship, Following the TDR Programme, Adverse events, Outcomes from the TDR, Weight Loss Maintenance, Recommending TDR to others. The relationship between participants and the counsellor was central to many of the themes. Close relationships with counsellors facilitated TDR adherence through providing one-to-one support (including during difficult times), sharing expert knowledge, and building a close relationship. Adherence was also supported by the rapid weight loss that patients reported experiencing. Overall participants reported positive experiences of the TDR, and emphasised the positive impact on their wellbeing. Discussion Patients reported that a TDR programme delivered by lay counsellors in the community was a positive experience and effective in helping them to lose weight. Future trials should consider the central role of the person providing support and advice as a key component in the programme.	[Astbury, Nerys M.; Albury, Charlotte; Nourse, Rebecca; Jebb, Susan A.] Univ Oxford, Radcliffe Primary Care, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Nourse, Rebecca] Deakin Univ, Sch Exercise & Nutr Sci, Fac Hlth, Melbourne, Vic, Australia	University of Oxford; Deakin University	Astbury, NM (corresponding author), Univ Oxford, Radcliffe Primary Care, Nuffield Dept Primary Care Hlth Sci, Oxford, England.	nerys.astbury@phc.ox.ac.uk	; ASTBURY, Nerys/O-6561-2018	Nourse, Rebecca/0000-0002-6410-7064; Jebb, Susan/0000-0001-9190-2920; Albury, Charlotte/0000-0002-1036-6626; ASTBURY, Nerys/0000-0001-9301-7458	NIHR Oxford Biomedical Research Centre (BRC); NIHR Applied Research Care (ARC) Oxford; Cambridge Weight Plan Ltd UK; National Institute for Health Research (NIHR) Applied Research Care (ARC) Oxford	NIHR Oxford Biomedical Research Centre (BRC); NIHR Applied Research Care (ARC) Oxford; Cambridge Weight Plan Ltd UK; National Institute for Health Research (NIHR) Applied Research Care (ARC) Oxford	NMA and SAJ are supported by funding from the NIHR Oxford Biomedical Research Centre (BRC). RN and SAJ were supported by funding from NIHR Applied Research Care (ARC) Oxford. SAJ is a NIHR) senior investigator. The main DROPLET trial was funded by a research grant from Cambridge Weight Plan Ltd UK to University of Oxford. We conducted this sub-study independently from the main trial, with separate funding from National Institute for Health Research (NIHR) Applied Research Care (ARC) Oxford. The funders had no input into the design, data collection, analysis decision to publish or preparation of the manuscripts. The authors had a right to publish regardless of the results. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.	Ahern AL, 2017, LANCET, V389, P2214, DOI 10.1016/S0140-6736(17)30647-5; Ard JD, 2019, OBESITY, V27, P22, DOI 10.1002/oby.22303; Astbury NM, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3760; Astbury NM, 2019, OBESITY FACTS, V12, P26; Booth ML, 1997, PREV MED, V26, P131, DOI 10.1006/pmed.1996.9982; Bradshaw C, 2017, GLOB QUALIT NURS RES, V4, DOI 10.1177/2333393617742282; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Cardiovascular Disease and Risk Management, 2019, DIABETES CARE, V2, pS103, DOI 10.2337/dc19-S010; COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3; Council. GM, 2014, GOOD MED PRACTICE; Crawford D, 1998, AUST NZ J PUBL HEAL, V22, P73, DOI 10.1111/j.1467-842X.1998.tb01148.x; Dalle Grave R, 2005, OBES RES, V13, P1961, DOI 10.1038/oby.2005.241; Dugdale DC, 1999, J GEN INTERN MED, V14, pS34, DOI 10.1046/j.1525-1497.1999.00263.x; Elliott R, 2018, PSYCHOTHERAPY, V55, P399, DOI 10.1037/pst0000175; FISHER RJ, 1993, J CONSUM RES, V20, P303, DOI 10.1086/209351; Foster GD, 1997, J CONSULT CLIN PSYCH, V65, P79, DOI 10.1037/0022-006X.65.1.79; Guba E., 1989, 4 GENERATION EVALUAT; Harper C, 2018, OBES REV, V24, P24; Jebb SA, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016709; Jebb SA, 2011, LANCET, V378, P1485, DOI 10.1016/S0140-6736(11)61344-5; JOHNSON CA, 1990, WOMEN HEALTH, V16, P177, DOI 10.1300/J013v16n03_10; Kent S, 2019, OBESITY, V27, P391, DOI 10.1002/oby.22407; KOCH T, 1994, J ADV NURS, V19, P976, DOI 10.1111/j.1365-2648.1994.tb01177.x; Kwan S, 2009, QUAL HEALTH RES, V19, P1223, DOI 10.1177/1049732309343952; LaRose JG, 2013, OBESITY, V21, P449, DOI 10.1002/oby.20053; Lean MEJ, 2017, LANCET; Love JG, 2016, INT J WOMENS HEALTH, V8, P299, DOI 10.2147/IJWH.S100385; Mill J., 2003, INT J QUAL METH, V2, P1, DOI [10.1177/160940690300200201, DOI 10.1177/160940690300200201]; Ostberg AL, 2011, SCAND J PUBLIC HEALT, V39, P98, DOI 10.1177/1403494810391524; Rehackova L, 2017, DIABETIC MED, V34, P1554, DOI 10.1111/dme.13426; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Schneeweiss S, 2007, CIRCULATION, V115, P2128, DOI 10.1161/CIRCULATIONAHA.106.665992; Siu J, 2011, PUBLIC HEALTH NUTR, V14, P1768, DOI 10.1017/S1368980011000644; StriegelMoore RH, 1996, OBES RES, V4, P109, DOI 10.1002/j.1550-8528.1996.tb00522.x; Tobin GA, 2004, J ADV NURS, V48, P388, DOI 10.1111/j.1365-2648.2004.03207.x; Tudor K, 2020, BRIT J GEN PRACT, V70, pE348, DOI 10.3399/bjgp20X708797; Ziebland S, 2006, MED EDUC, V40, P405, DOI 10.1111/j.1365-2929.2006.02467.x	37	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238645	10.1371/journal.pone.0238645	http://dx.doi.org/10.1371/journal.pone.0238645			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ6EE	32898176	gold, Green Published			2022-12-26	WOS:000570962500036
J	Qian, YW; Zheng, YM; Dill, SE; Rozelle, S				Qian, Yiwei; Zheng, Yi Ming; Dill, Sarah-Eve; Rozelle, Scott			Correlates of participation in community-based interventions: Evidence from a parenting program in rural China	PLOS ONE			English	Article							ABUSE PREVENTION PROGRAM; LOW-INCOME; HEALTH; STIMULATION; RISK; CARE; ACCELERATION; SERVICES; INFANTS; IMPACT	A growing body of literature has documented that community-based early childhood development (ECD) interventions can improve child developmental outcomes in vulnerable communities. One critical element of effective community-based programs is consistent program participation. However, little is known about participation in community-based ECD interventions or factors that may affect participation. This paper examines factors linked to program participation within a community-based ECD program serving 819 infants and their caregivers in 50 rural villages in northwestern China. The results find that more than half of families did not regularly attend the ECD program. Both village-level social ties within the program and proximity to the program significantly predict program participation. Increased distance from the program site is linked with decreased individual program participation, while the number of social ties is positively correlated with participation. The average program participation rates among a family's social ties is also positively correlated with individual participation, indicating strong peer effects. Taken together, our findings suggest that attention should be given to promoting social interactions and reducing geographic barriers among households in order to raise participation in community-based ECD programs.	[Qian, Yiwei] Univ Southern Calif, Dept Econ, Los Angeles, CA 90007 USA; [Zheng, Yi Ming; Dill, Sarah-Eve; Rozelle, Scott] Stanford Univ, Rural Educ Act Program, Stanford, CA 94305 USA	University of Southern California; Stanford University	Qian, YW (corresponding author), Univ Southern Calif, Dept Econ, Los Angeles, CA 90007 USA.	yiweiqia@usc.edu		Qian, Yiwei/0000-0003-0466-8545	International Initiative for Impact Evaluation (3ie); 111 Project [B16031]	International Initiative for Impact Evaluation (3ie); 111 Project(Ministry of Education, China - 111 Project)	The funding sources that supported the study are the International Initiative for Impact Evaluation (3ie) and the 111 Project (Grant no: B16031). Neither of the funding sources for the present source are commercial sources. None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboud FE, 2015, ANNU REV PSYCHOL, V66, P433, DOI 10.1146/annurev-psych-010814-015128; Frances EAA, 2013, SOC SCI MED, V97, P250, DOI 10.1016/j.socscimed.2013.06.020; Alatas V, 2016, J POLIT ECON, V124, P371, DOI 10.1086/685299; [Anonymous], 2019, XINHUA; Attanasio O., 2018, EARLY STIMULATION NU, DOI 10.3386/w25059; ATTANASIO OP, 2014, BMJ-BRIT MED J, V349, DOI DOI 10.1136/BMJ.G5785; Attanasio O, 2020, AM ECON REV, V110, P48, DOI 10.1257/aer.20150183; Bai Y, 2019, J CONTEMP CHINA, V28, P883, DOI 10.1080/10670564.2019.1594102; Baker-Henningham H, 2010, EARLY CHILDHOOD STIM; Becker GS., 2009, SOCIAL EC MARKET BEH; Bertrand M, 2000, Q J ECON, V115, P1019, DOI 10.1162/003355300554971; Black MM, 2017, LANCET, V389, P77, DOI 10.1016/S0140-6736(16)31389-7; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Borjas GJ, 1996, Q J ECON, V111, P575, DOI 10.2307/2946688; Brinkman SA, 2017, J LABOR ECON, V35, pS305, DOI 10.1086/691278; Buor D, 2003, INT J HEALTH PLAN M, V18, P293, DOI 10.1002/hpm.729; Cheema A, 2019, GLASS WALLS EX UNPUB; Cornwell B, 2015, WILEY HBK SURV METH, P275; Dahl GB, 2014, AM ECON REV, V104, P2049, DOI 10.1257/aer.104.7.2049; Djamhuri TL, 2008, AGROFOREST SYST, V74, P83, DOI 10.1007/s10457-008-9150-5; Eickmann SH, 2003, DEV MED CHILD NEUROL, V45, P536, DOI 10.1017/S0012162203000987; Fernald LCH, 2017, DEV PSYCHOL, V53, P222, DOI 10.1037/dev0000185; Gertler P, 2014, SCIENCE, V344, P998, DOI 10.1126/science.1251178; Haggerty KP., 2002, J PRIM PREV, V22, P375, DOI [10.1023/A:1015227623145, DOI 10.1023/A:1015227623145]; Heckman J, 2013, AM ECON REV, V103, P2052, DOI 10.1257/aer.103.6.2052; Heckman JJ, 2010, J PUBLIC ECON, V94, P114, DOI 10.1016/j.jpubeco.2009.11.001; Hostetler M, 1997, J COMMUNITY PSYCHOL, V25, P397, DOI 10.1002/(SICI)1520-6629(199709)25:5<397::AID-JCOP3>3.3.CO;2-6; Lalive R, 2009, REV ECON STAT, V91, P457, DOI 10.1162/rest.91.3.457; Lee Y, 2017, FOR SCI TECHNOL, V13, P133, DOI 10.1080/21580103.2017.1355335; Lowe JR, 2012, ACTA PAEDIATR, V101, pE55, DOI 10.1111/j.1651-2227.2011.02517.x; Martinez S., 2012, PROMISE PRESCHOOL AF, DOI DOI 10.1002/cad.20072; McLeroy KR., 2003, COMMUNITY BASED INTE; Menz HB, 2003, J GERONTOL A-BIOL, V58, P446, DOI 10.1093/gerona/58.5.M446; Merzel C, 2003, AM J PUBLIC HEALTH, V93, P557, DOI 10.2105/AJPH.93.4.557; O'Loughlin JL, 1999, AM J PUBLIC HEALTH, V89, P1819, DOI 10.2105/AJPH.89.12.1819; Oster E, 2012, J EUR ECON ASSOC, V10, P1263, DOI 10.1111/j.1542-4774.2012.01090.x; Portes A, 1998, ANNU REV SOCIOL, V24, P1, DOI 10.1146/annurev.soc.24.1.1; Rahman A, 2008, LANCET, V372, P902, DOI 10.1016/S0140-6736(08)61400-2; Schirm Allen, 2006, QUANTUM OPPORTUNITY; Serenius F, 2013, JAMA-J AM MED ASSOC, V309, P1810, DOI 10.1001/jama.2013.3786; Sylvia S., 2018, QUANTITY QUALITY DEL; Tanser F, 2006, SOC SCI MED, V63, P691, DOI 10.1016/j.socscimed.2006.01.015; Thornton RL, 2010, HEALTH ECON, V19, P181, DOI 10.1002/hec.1635; Valente TW, 2007, ADDICTION, V102, P1804, DOI 10.1111/j.1360-0443.2007.01992.x; Walker SP, 2011, PEDIATRICS, V127, P849, DOI 10.1542/peds.2010-2231; Wang L, 2019, J COMP ECON, V47, P458, DOI 10.1016/j.jce.2019.02.003; Weiss LG, 2010, PRACT RESOUR MENT, pIX, DOI 10.1016/B978-0-12-374177-6.10010-8	47	4	4	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238841	10.1371/journal.pone.0238841	http://dx.doi.org/10.1371/journal.pone.0238841			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ6EE	32898156	Green Published, gold			2022-12-26	WOS:000570962500031
J	Kim, GH; Min, YW; Lee, H; Min, BH; Lee, JH; Rhee, PL; Kim, JJ				Kim, Ga Hee; Min, Yang Won; Lee, Hyuk; Min, Byung-Hoon; Lee, Jun Haeng; Rhee, Poong-Lyul; Kim, Jae J.			Risk factors of metachronous recurrence after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma	PLOS ONE			English	Article							RESECTION; ASSOCIATION; HEAD	Esophageal endoscopic submucosal dissection (ESD) can be a curative treatment for superficial esophageal squamous cell carcinoma (SESCC). However, it is unclear whether the development of metachronous recurrence after ESD may be explained based on several risk factors. This study aimed to assess the incidence and the risk factors of metachronous recurrence of SESCC after ESD. This retrospective analysis was conducted at Samsung Medical Center, Seoul, Korea, from April 2007 to May 2018. Two hundred and fifty-three SESCC patients treated with ESD were followed using surveillance endoscopy after the procedure. Risk factors for metachronous esophageal SCC were analyzed using the Kaplan-Meier method and Cox's proportional hazards model. Metachronous esophageal SCCs were found in 21 (8.3%) of the 253 patients. Six patients (2.4%) with extraesophageal recurrence such as lymph node metastasis confirmed by imaging were excluded from patients with metachronous recurrence and data were censored from the recurrence date. Univariate analysis revealed that the presence of many (>10) irregularly shaped multiform Lugol-voiding lesions (LVLs) around the main lesion, margin of the main LVL, and tumor differentiation were risk factors for the development of metachronous cancer. Multivariate analysis also revealed that many (>10) LVLs (hazard ratio [HR], 6.32; 95% confidence interval [CI], 1.62-24.72;p= 0.047) and unclear or spiculated margin of the main LVL (HR, 6.51; 95% CI, 1.44-29.42;p= 0.029) were associated with the risk of metachronous recurrence. Metachronous esophageal SCC develops in patients treated with ESD for SESCC. A risk assessment is important for surveillance before and after ESD for SESCC. Number of LVLs and tumor edge type are associated with an increased risk of metachronous cancer in SESCC. Patients will benefit from careful endoscopic surveillance when endoscopists pay attention to these tumor characteristics.	[Kim, Ga Hee] Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Sch Med, Seoul, South Korea; [Min, Yang Won; Lee, Hyuk; Min, Byung-Hoon; Lee, Jun Haeng; Rhee, Poong-Lyul; Kim, Jae J.] Sungkyunkwan Univ, Samsung Med Ctr, Dept Gastroenterol, Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Min, YW (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Gastroenterol, Sch Med, Seoul, South Korea.	yangwonee@gmail.com		Min, Yang Won/0000-0001-7471-1305	National RAMP;D Program for Cancer Control, Ministry of Health Welfare, Korea [1720180]	National RAMP;D Program for Cancer Control, Ministry of Health Welfare, Korea	This paper was supported by a grant from The National R&D Program for Cancer Control, Ministry of Health & Welfare, Korea (1720180).	Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Ebi M, 2015, GASTROINTEST ENDOSC, V81, P1355, DOI 10.1016/j.gie.2014.11.015; Fujishiro M, 2006, CLIN GASTROENTEROL H, V4, P688, DOI 10.1016/j.cgh.2006.03.024; Fujishiro M, 2009, DIGEST ENDOSC, V21, P109, DOI 10.1111/j.1443-1661.2009.00837.x; Fujita T, 2017, DIS ESOPHAGUS, V30, DOI 10.1111/dote.12460; Katada C, 2013, DIGEST ENDOSC, V25, P39, DOI 10.1111/j.1443-1661.2012.01407.x; Kitamura K, 1996, CANCER, V77, P1614, DOI 10.1002/(SICI)1097-0142(19960415)77:8+<1614::AID-CNCR5>3.0.CO;2-D; Lahmann PH, 2012, CANCER-AM CANCER SOC, V118, P1901, DOI 10.1002/cncr.26455; Muto M, 2000, GUT, V47, P256, DOI 10.1136/gut.47.2.256; Muto M, 2002, GASTROINTEST ENDOSC, V56, P517, DOI 10.1067/mge.2002.128104; Ohmori Tai, 1994, Stomach and Intestine, V29, P911; Ono S, 2009, GASTROINTEST ENDOSC, V70, P860, DOI 10.1016/j.gie.2009.04.044; Sawada G, 2016, GASTROENTEROLOGY, V150, P1171, DOI 10.1053/j.gastro.2016.01.035; Sgourakis G, 2013, WORLD J GASTROENTERO, V19, P1424, DOI 10.3748/wjg.v19.i9.1424; Shimizu Y, 2001, GASTROINTEST ENDOSC, V54, P190, DOI 10.1067/mge.2001.116877; Shimizu Y, 2013, DIGEST ENDOSC, V25, P13, DOI 10.1111/j.1443-1661.2012.01408.x; SUGIMACHI K, 1995, CANCER, V75, P1440, DOI 10.1002/1097-0142(19950315)75:6+<1440::AID-CNCR2820751508>3.0.CO;2-9; Uno K, 2017, DIS ESOPHAGUS, V30, DOI 10.1093/dote/dox005; Urabe Y, 2019, ESOPHAGUS-TOKYO, V16, P141, DOI 10.1007/s10388-018-0643-7; Wong Kee Song LM, 2007, CHROMOENDOSCOPY GAST, V66, P639, DOI [10.1016/j.gie.2007.05.029, DOI 10.1016/J.GIE.2007.05.029]; Yokoyama A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175182	21	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238113	10.1371/journal.pone.0238113	http://dx.doi.org/10.1371/journal.pone.0238113			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886924	Green Published, gold			2022-12-26	WOS:000571064300016
J	Ballesteros-Alvarez, J; Dilshat, R; Fock, V; Moller, K; Karl, L; Larue, L; Ogmundsdottir, MH; Steingrimsson, E				Ballesteros-Alvarez, Josue; Dilshat, Ramile; Fock, Valerie; Moller, Katrin; Karl, Ludwig; Larue, Lionel; Ogmundsdottir, Margret Helga; Steingrimsson, Eirikur			MITF and TFEB cross-regulation in melanoma cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; MICROPHTHALMIA LOCUS; GENE; FAMILY; BIOGENESIS; EXPRESSION; MUTATIONS; AUTOPHAGY; IDENTIFICATION; PREDISPOSES	The MITF, TFEB, TFE3 and TFEC (MiT-TFE) proteins belong to the basic helix-loop-helix family of leucine zipper transcription factors. MITF is crucial for melanocyte development and differentiation, and has been termed a lineage-specific oncogene in melanoma. The three related proteins MITF, TFEB and TFE3 have been shown to be involved in the biogenesis and function of lysosomes and autophagosomes, regulating cellular clearance pathways. Here we investigated the cross-regulatory relationship of MITF and TFEB in melanoma cells. LikeMITF, theTFEBandTFE3genes are expressed in melanoma cells as well as in melanoma tumors, albeit at lower levels. We show that the MITF and TFEB proteins, but not TFE3, directly affect each other's mRNA and protein expression. In addition, the subcellular localization of MITF and TFEB is subject to regulation by the mTOR signaling pathway, which impacts their cross-regulatory relationship at the transcriptional level. Our work shows that the relationship between MITF and TFEB is multifaceted and that the cross-regulatory interactions of these factors need to be taken into account when considering pathways regulated by these proteins.	[Ballesteros-Alvarez, Josue; Dilshat, Ramile; Fock, Valerie; Moller, Katrin; Karl, Ludwig; Steingrimsson, Eirikur] Univ Iceland, Fac Med, BioMed Ctr, Dept Biochem & Mol Biol, Reykjavik, Iceland; [Larue, Lionel] PSL Res Univ, Inst Curie, Normal & Pathol Dev Melanocytes, INSERM U1021, Orsay, France; [Larue, Lionel] Univ Paris Sud, Univ Paris Saclay, CNRS, UMR 3347, Orsay, France; [Larue, Lionel] Univ Iceland, Equipe Labellisee Ligue Canc, Reykjavik, Iceland; [Ogmundsdottir, Margret Helga] Univ Iceland, Fac Med, BioMed Ctr, Dept Anat, Reykjavik, Iceland; [Ballesteros-Alvarez, Josue] Buck Inst Res Aging, Novato, CA USA; [Fock, Valerie] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Moller, Katrin] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland	University of Iceland; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; University of Iceland; University of Iceland; Buck Institute for Research on Aging; Medical University of Vienna; University of Zurich	Steingrimsson, E (corresponding author), Univ Iceland, Fac Med, BioMed Ctr, Dept Biochem & Mol Biol, Reykjavik, Iceland.	eirikurs@hi.is		Moller, Katrin/0000-0002-4720-8568; Dilshat, Ramile/0000-0002-2126-2902; Ballesteros Alvarez, Josue/0000-0002-9828-9812; Steingrimsson, Eirikur/0000-0001-5826-7486	Research fund of Iceland [130230-052, 163413-051]	Research fund of Iceland	ES, 130230-052, Research fund of Iceland, www.rannis.is ES, 163413-051, Research fund of Iceland, www.rannis.is.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Aksan I, 1998, MOL CELL BIOL, V18, P6930, DOI 10.1128/MCB.18.12.6930; Alonso-Curbelo D, 2015, ONCOTARGET, V6, P11848, DOI 10.18632/oncotarget.4055; [Anonymous], 2015, DIABETOL KLIN SA, V4, pA1; Argani P, 2001, AM J PATHOL, V159, P179, DOI 10.1016/S0002-9440(10)61684-7; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; Bertolotto C, 2011, NATURE, V480, P94, DOI 10.1038/nature10539; Bharti K, 2008, DEVELOPMENT, V135, P1169, DOI 10.1242/dev.014142; Busca R, 2005, J CELL BIOL, V170, P49, DOI 10.1083/jcb.200501067; Chen YJ, 2007, J BIOL CHEM, V282, P27215, DOI 10.1074/jbc.M700264200; Davis IJ, 2006, CANCER CELL, V9, P473, DOI 10.1016/j.ccr.2006.04.021; Fock V, 2018, PIGMENT CELL MELANOM; George A, 2016, AM J HUM GENET, V99, P1388, DOI 10.1016/j.ajhg.2016.11.004; Goding CR, 2019, GENE DEV, V33, P983, DOI 10.1101/gad.324657.119; Halaban R, 2002, J BIOL CHEM, V277, P14821, DOI 10.1074/jbc.M111497200; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hershey CL, 2005, GENE, V347, P73, DOI 10.1016/j.gene.2004.12.002; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Huang ZM, 2012, P NATL ACAD SCI USA, V109, P553, DOI 10.1073/pnas.1118366109; Huber WE, 2003, J BIOL CHEM, V278, P45224, DOI 10.1074/jbc.M309036200; HUGHES AE, 1994, NAT GENET, V7, P509, DOI 10.1038/ng0894-509; HUGHES MJ, 1993, J BIOL CHEM, V268, P20687; Kuiper RP, 2003, HUM MOL GENET, V12, P1661, DOI 10.1093/hmg/ddg178; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louphrasitthiphol P, 2020, MOL CELL; LOWINGS P, 1992, MOL CELL BIOL, V12, P3653, DOI 10.1128/MCB.12.8.3653; Magnusdottir E, 2013, NAT CELL BIOL, V15, P905, DOI 10.1038/ncb2798; Malcov-Brog H, 2018, MOL CELL, V72, P444, DOI 10.1016/j.molcel.2018.09.022; Martina JA, 2014, CELL MOL LIFE SCI, V71, P2483, DOI 10.1007/s00018-014-1565-8; Martina JA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004754; Martina JA, 2013, J CELL BIOL, V200, P475, DOI 10.1083/jcb.201209135; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Moller K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37522-6; Ngeow KC, 2018, P NATL ACAD SCI USA, V115, pE8668, DOI 10.1073/pnas.1810498115; Pages H AP, 2019, BIOSTRINGS EFFICIENT; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Perera R, 2015, NATURE, V524, P361, DOI 10.1038/nature14587; Ploper D, 2015, P NATL ACAD SCI USA, V112, pE420, DOI 10.1073/pnas.1424576112; Pogenberg V, 2020, NUCLEIC ACIDS RES, V48, P934, DOI 10.1093/nar/gkz1104; Pogenberg V, 2012, GENE DEV, V26, P2647, DOI 10.1101/gad.198192.112; Price ER, 1998, J BIOL CHEM, V273, P33042, DOI 10.1074/jbc.273.49.33042; Rambow F, 2015, CELL REP, V13, P840, DOI 10.1016/j.celrep.2015.09.037; Ramphal R, 2006, AM J CLIN PATHOL, V126, P349, DOI 10.1309/98YE9E442ARLX2X; Read AP, 1997, J MED GENET, V34, P656, DOI 10.1136/jmg.34.8.656; Reemann P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115717; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Sato S, 1997, ONCOGENE, V14, P3083, DOI 10.1038/sj.onc.1201298; Seberg HE, 2017, PIGM CELL MELANOMA R, V30, P454, DOI 10.1111/pcmr.12611; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Sidhar SK, 1996, HUM MOL GENET, V5, P1333, DOI 10.1093/hmg/5.9.1333; Smith SD, 2000, J MED GENET, V37, P446, DOI 10.1136/jmg.37.6.446; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Steingrimsson E, 2002, P NATL ACAD SCI USA, V99, P4477, DOI 10.1073/pnas.072071099; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; Takebayashi K, 1996, MOL CELL BIOL, V16, P1203; Takeda K, 2002, BBA-GENE STRUCT EXPR, V1574, P15, DOI 10.1016/S0167-4781(01)00339-6; Webster DE, 2014, GENOME RES, V24, P751, DOI 10.1101/gr.166231.113; YASUMOTO KI, 1994, MOL CELL BIOL, V14, P8058, DOI 10.1128/MCB.14.12.8058; YOKOYAMA K, 1994, J BIOL CHEM, V269, P27080; Yokoyama S, 2011, NATURE, V480, P99, DOI 10.1038/nature10630; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	66	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238546	10.1371/journal.pone.0238546	http://dx.doi.org/10.1371/journal.pone.0238546			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881934	gold, Green Published, Green Accepted			2022-12-26	WOS:000571063300109
J	Cao, JF; Li, CF; Zhang, LX; Wu, QY; Lv, JS				Cao Jianfei; Li Chunfang; Zhang Lixia; Wu Quanyuan; Lv Jianshu			Source apportionment of potentially toxic elements in soils using APCS/MLR, PMF and geostatistics in a typical industrial and mining city in Eastern China	PLOS ONE			English	Article							POSITIVE MATRIX FACTORIZATION; HEAVY-METAL CONCENTRATIONS; HEALTH-RISK ASSESSMENT; SOURCE IDENTIFICATION; POLLUTION ASSESSMENT; AGRICULTURAL SOILS; SPATIAL-DISTRIBUTION; INTEGRATED APPROACH; RECEPTOR MODELS; TRACE-ELEMENTS	Source apportionment of potentially toxic elements in soils is a critical step for devising soil sustainable management strategies. However, misjudgment or imprecision can occur when traditional statistical methods are applied to identify and apportion the sources. The main objective of the study was to develop a robust approach composed of the absolute principal component score/multiple linear regression (APCS/MLR) receptor model, positive matrix factorization (PMF) receptor model and geostatistics to identify and apportion sources of soil potentially toxic elements in typical industrial and mining city, eastern China. APCS/MLR and PMF were applied to provide robust factors with contribution rates. The geostatistics coupled with the variography and kriging methods was used to present factors derived from these two receptor models. The results indicated that mean concentrations of As, Cd, Cr, Cu, Hg, Ni, Pb and Zn exceeded the local background levels. Based on multivariate receptor models and geostatistics, we determined four sources of eight potentially toxic elements including natural source (parent material), agricultural practices, pollutant emissions (industrial, mining and traffic) and the atmospheric deposition of coal combustion, which accounted for 68%, 12%, 12% and 9% of the observed potentially toxic element concentrations, respectively. This study provides a reliable and robust approach for potentially toxic elements source apportionment in this particular industrial and mining city with a clear potential for future application in other regions.	[Cao Jianfei; Li Chunfang; Wu Quanyuan; Lv Jianshu] Shandong Normal Univ, Coll Geog & Environm, Jinan, Peoples R China; [Zhang Lixia] Gen Stn Geol Environm Monitoring Shandong Prov, Jinan, Peoples R China	Shandong Normal University	Wu, QY (corresponding author), Shandong Normal Univ, Coll Geog & Environm, Jinan, Peoples R China.	wqy6420582@163.com		Cao, Jianfei/0000-0002-9395-0317	National Natural Science Foundation of China [41371395]; Natural Science Foundation of Shandong Province [ZR2017BD011]; China Postdoctoral Science Foundation [2017M622256]; Key Technology Research and Development Program of Shandong [2017CXGC304, 2019GSF109034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Key Technology Research and Development Program of Shandong	This study was supported by the National Natural Science Foundation of China (No. 41371395), the Natural Science Foundation of Shandong Province (ZR2017BD011), the China Postdoctoral Science Foundation (2017M622256) and the Key Technology Research and Development Program of Shandong (2017CXGC304, 2019GSF109034). The founders play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloway B.J., 2013, HEAVY METALS SOILS E, P11, DOI [10.1007/978-94-007-4470-7_2, DOI 10.1007/978-94-007-4470-7_2]; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Arditsoglou A, 2005, CHEMOSPHERE, V59, P669, DOI 10.1016/j.chemosphere.2004.10.056; Beaver MB, 2012, INTRO PROBABILITY ST; Cai LM, 2012, ECOTOX ENVIRON SAFE, V78, P2, DOI 10.1016/j.ecoenv.2011.07.004; Cangemi M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16020285; Cao JF, 2020, IEEE ACCESS, V8, P42584, DOI 10.1109/ACCESS.2020.2976902; Cesari D, 2016, ENVIRON SCI POLLUT R, V23, P15133, DOI 10.1007/s11356-016-6599-z; Chen HY, 2016, ENVIRON SCI POLLUT R, V23, P15331, DOI 10.1007/s11356-016-6694-1; Cheng QL, 2014, CHEM SPEC BIOAVAILAB, V26, P184, DOI 10.3184/095422914X14042081874564; China National Environmental Monitoring Center, 1990, BACKGR CONC EL SOILS; Christensen ER, 2018, SCI TOTAL ENVIRON, V613, P371, DOI 10.1016/j.scitotenv.2017.09.094; Dai LJ, 2018, SCI TOTAL ENVIRON, V621, P1433, DOI 10.1016/j.scitotenv.2017.10.085; Fang T, 2014, ENVIRON MONIT ASSESS, V186, P4753, DOI 10.1007/s10661-014-3735-4; Goovaerts P., 1997, GEOSTATISTICS NATURA, DOI DOI 10.2307/1270969; Guan QY, 2018, CHEMOSPHERE, V193, P189, DOI 10.1016/j.chemosphere.2017.10.151; Hjortenkrans D, 2006, ENVIRON MONIT ASSESS, V117, P85, DOI 10.1007/s10661-006-7706-2; Holm AE, 1990, P INT PIG VET SOC 11; Hou DY, 2017, ENVIRON POLLUT, V231, P1188, DOI 10.1016/j.envpol.2017.07.021; Hu BF, 2020, ENVIRON POLLUT, V266, DOI 10.1016/j.envpol.2020.114961; Hu WY, 2018, ENVIRON POLLUT, V237, P650, DOI 10.1016/j.envpol.2018.02.070; Huang Y, 2015, J HAZARD MATER, V299, P540, DOI 10.1016/j.jhazmat.2015.07.041; Institute of Soil Research Chinese Academy of Sciences, 1991, CHIN AC SCI CHIN SOI; Jiang YX, 2017, CHEMOSPHERE, V168, P1658, DOI 10.1016/j.chemosphere.2016.11.088; Johnston K, 2001, USING ARCGIS TM GEOS; Kahkonen MA, 1997, CHEMOSPHERE, V35, P2645, DOI 10.1016/S0045-6535(97)00337-8; Keshavarzi A, 2019, INT J ENVIRON HEAL R, V29, P544, DOI 10.1080/09603123.2018.1555638; Kumar V, 2019, CHEMOSPHERE, V216, P449, DOI 10.1016/j.chemosphere.2018.10.066; Kumar V, 2018, HUM ECOL RISK ASSESS, V24, P2162, DOI 10.1080/10807039.2018.1440529; Lee E, 1999, ATMOS ENVIRON, V33, P3201, DOI 10.1016/S1352-2310(99)00113-2; Li Chun-fang, 2017, Huanjing Kexue, V38, P1018, DOI 10.13227/j.hjkx.201607201; Liang J, 2017, ENVIRON POLLUT, V225, P681, DOI 10.1016/j.envpol.2017.03.057; Lindberg S, 2007, AMBIO, V36, P19, DOI 10.1579/0044-7447(2007)36[19:ASOPAU]2.0.CO;2; Liu Shuo, 2016, Huanjing Kexue, V37, P270; Liu Z., 2008, ACTA PEDOL SIN, V45, P206, DOI DOI 10.3321/J.ISSN:0564-3929.2008.02.015; [吕建树 Lu Jianshu], 2012, [地理学报, Acta Geographica Sinica], V67, P971; Lu R.K., 2000, SOIL AGR CHEM ANAL; Luo L, 2009, J ENVIRON MANAGE, V90, P2524, DOI 10.1016/j.jenvman.2009.01.011; Luo XS, 2015, CHEMOSPHERE, V127, P152, DOI 10.1016/j.chemosphere.2015.01.048; Lv JS, 2019, ENVIRON POLLUT, V244, P72, DOI 10.1016/j.envpol.2018.09.147; Lv JS, 2019, SCI TOTAL ENVIRON, V646, P19, DOI 10.1016/j.scitotenv.2018.07.257; Lv JS, 2015, J SOIL SEDIMENT, V15, P163, DOI 10.1007/s11368-014-0937-x; Markus JA, 1996, AUST J SOIL RES, V34, P453, DOI 10.1071/SR9960453; Mehr MR, 2017, J AFR EARTH SCI, V132, P16, DOI 10.1016/j.jafrearsci.2017.04.026; Muller G.M.M.G.M.G.M.G.P., 1969, GEOJOURNAL, V2, P108, DOI DOI 10.1055/S-2007-1023171; Nanos N, 2012, GEODERMA, V189, P554, DOI 10.1016/j.geoderma.2012.06.006; Nathanail CP, 1998, ENG GEOL, V50, P347, DOI 10.1016/S0013-7952(98)00010-6; Norra S, 2006, APPL GEOCHEM, V21, P2064, DOI 10.1016/j.apgeochem.2006.06.014; NRIAGU JO, 1990, ENVIRONMENT, V32, P6; Paatero P, 2014, ATMOS MEAS TECH, V7, P781, DOI 10.5194/amt-7-781-2014; Pan Y., 2015, ATMOS CHEM PHYS DISC, V14, DOI [10.5194/ acpd-14-20647-2014, DOI 10.5194/ACPD-14-20647-2014]; Peng H, 2019, SCI TOTAL ENVIRON, V660, P776, DOI 10.1016/j.scitotenv.2019.01.066; Martin JAR, 2006, ENVIRON POLLUT, V144, P1001, DOI 10.1016/j.envpol.2006.01.045; State Environmental Protection Administration of China, 1997, GB156181995 STAT ENV; Toth G, 2016, ENVIRON INT, V88, P299, DOI 10.1016/j.envint.2015.12.017; United States Environmental Protection Agency, 2018, COD FED REG PRIOR PO; Vaccaro S, 2007, CHEMOSPHERE, V69, P1055, DOI 10.1016/j.chemosphere.2007.04.032; Wang SX, 2012, ENERG FUEL, V26, P4635, DOI 10.1021/ef201990x; Watson JG, 2001, CHEMOSPHERE, V43, P1141, DOI 10.1016/S0045-6535(00)00171-5; WEDEPOHL KH, 1995, GEOCHIM COSMOCHIM AC, V59, P1217, DOI 10.1016/0016-7037(95)00038-2; Wu CF, 2008, GEODERMA, V144, P171, DOI 10.1016/j.geoderma.2007.11.001; [吴开华 WU Kaihua], 2011, [中国土壤与肥料, Soil and Fertilizer Sciences in China], P83; Xu MH, 2004, FUEL PROCESS TECHNOL, V85, P215, DOI 10.1016/S0378-3820(03)00174-7; Yang PG, 2009, CR BIOL, V332, P558, DOI 10.1016/j.crvi.2009.01.004; Yantai Municipal Bureau of Statistics, 2018, YANT STAT YB 2018; Zhang QC, 2020, WATER AIR SOIL POLL, V231, DOI 10.1007/s11270-020-04728-2; Zhang Y, 2012, WATER RES, V46, P3065, DOI 10.1016/j.watres.2012.03.006; Zheng JY, 2011, SCI TOTAL ENVIRON, V412, P214, DOI 10.1016/j.scitotenv.2011.10.024; Zhu CY, 2016, J CLEAN PROD, V114, P343, DOI 10.1016/j.jclepro.2015.05.008	69	5	7	11	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238513	10.1371/journal.pone.0238513	http://dx.doi.org/10.1371/journal.pone.0238513			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881956	gold, Green Published			2022-12-26	WOS:000571063300012
J	Ware, SA; Desai, N; Lopez, M; Leach, D; Zhang, YZ; Giordano, L; Nouraie, M; Picard, M; Kaufman, BA				Ware, Sarah A.; Desai, Nikita; Lopez, Mabel; Leach, Daniel; Zhang, Yingze; Giordano, Luca; Nouraie, Mehdi; Picard, Martin; Kaufman, Brett A.			An automated, high-throughput methodology optimized for quantitative cell-free mitochondrial and nuclear DNA isolation from plasma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondrial DNA (mtDNA); plasma; nucleic acid; DNA; liquid biopsy; cell-free; high throughput; liquid handling; magnetic particle processor; biomarker; mitochondrial DNA damage; mitochondria; ccf-mtDNA; ccf-nDNA; DNA purification; plasma DNA	FETAL-DNA; SERUM; CANCER	Progress in the study of circulating, cell-free nuclear DNA (ccf-nDNA) in cancer detection has led to the development of noninvasive clinical diagnostic tests and has accelerated the evaluation of ccf-nDNA abundance as a disease biomarker. Likewise, circulating, cell-free mitochondrial DNA (ccf-mtDNA) is under similar investigation. However, optimal ccf-mtDNA isolation parameters have not been established, and inconsistent protocols for ccf-nDNA collection, storage, and analysis have hindered its clinical utility. Until now, no studies have established a method for high-throughput isolation that considers both ccf-nDNA and ccf-mtDNA. We initially optimized human plasma digestion and extraction conditions for maximal recovery of these DNAs using a magnetic bead-based isolation method. However, when we incorporated this method onto a high-throughput platform, initial experiments found that DNA isolated from identical human plasma samples displayed plate edge effects resulting in low ccf-mtDNA reproducibility, whereas ccf-nDNA was less affected. Therefore, we developed a detailed protocol optimized for both ccf-mtDNA and ccf-nDNA recovery that uses a magnetic bead-based isolation process on an automated 96-well platform. Overall, we calculate an improved efficiency of recovery of similar to 95-fold for ccf-mtDNA and 20-fold for ccf-nDNA when compared with the initial procedure. Digestion conditions, liquid-handling characteristics, and magnetic particle processor programming all contributed to increased recovery without detectable positional effects. To our knowledge, this is the first high-throughput approach optimized for ccf-mtDNA and ccf-nDNA recovery and serves as an important starting point for clinical studies.	[Ware, Sarah A.; Desai, Nikita; Lopez, Mabel; Giordano, Luca; Kaufman, Brett A.] Univ Pittsburgh, Sch Med, Ctr Metab & Mitochondrial Med, Pittsburgh, PA USA; [Ware, Sarah A.; Desai, Nikita; Lopez, Mabel; Giordano, Luca; Kaufman, Brett A.] Univ Pittsburgh, Sch Med, Div Cardiol, Pittsburgh, PA USA; [Leach, Daniel] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA; [Zhang, Yingze; Nouraie, Mehdi] Optimize Lab Consultants LLC, Lansdale, PA USA; [Picard, Martin] Columbia Univ, Dept Psychiat, Div Behav Med, Irving Med Ctr, New York, NY USA; [Picard, Martin] Columbia Univ, Dept Neurol, Div Behav Med, Irving Med Ctr, New York, NY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital	Kaufman, BA (corresponding author), Univ Pittsburgh, Sch Med, Ctr Metab & Mitochondrial Med, Pittsburgh, PA USA.; Kaufman, BA (corresponding author), Univ Pittsburgh, Sch Med, Div Cardiol, Pittsburgh, PA USA.	bkauf@pitt.edu	Nouraie, Seyed Mehdi/O-4071-2018	Nouraie, Seyed Mehdi/0000-0001-7465-0581; Ware, Sarah/0000-0002-2387-1613; Kaufman, Brett/0000-0003-4767-4937; Giordano, Luca/0000-0001-6315-7361	National Institutes of Health [R01MH119336]; GlaxoSmithKline	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline(GlaxoSmithKline)	This work was supported by National Institutes of Health Grant R01MH119336 and by GlaxoSmithKline. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251; Alunni-Fabbroni M, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-2079-9; Arshad O, 2018, JAIDS-J ACQ IMM DEF, V78, P111, DOI 10.1097/QAI.0000000000001650; Avriel A, 2016, INT J CHRONIC OBSTR, V11, P3153, DOI 10.2147/COPD.S113256; Belmonte FR, 2016, SCI REP-UK, V6, DOI 10.1038/srep25186; Bhagirath VC, 2015, SHOCK, V44, P265, DOI 10.1097/SHK.0000000000000397; Boudreau LH, 2014, BLOOD, V124, P2173, DOI 10.1182/blood-2014-05-573543; Bruce A., 2002, MOL BIOL CELL, V4th ed.; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Chial H, 2008, NAT ED, V1, P217; Chiu RWK, 2003, CLIN CHEM, V49, P719, DOI 10.1373/49.5.719; Dache ZA, 2020, FASEB J, V34, P3616, DOI 10.1096/fj.201901917RR; El Messaoudi S, 2013, CLIN CHIM ACTA, V424, P222, DOI 10.1016/j.cca.2013.05.022; Ellison SLR, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-33; Falabella M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41464-y; Farge G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112770; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Fong SL, 2009, CLIN CHEM, V55, P587, DOI 10.1373/clinchem.2008.110122; Gogenur M, 2017, CRIT CARE, V21, DOI 10.1186/s13054-016-1578-9; Harrington JS, 2019, CHEST, V156, P1120, DOI 10.1016/j.chest.2019.07.014; Hummel EM, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0264-x; Itagaki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120549; Jorgez CJ, 2006, GENET MED, V8, P615, DOI 10.1097/01.gim.0000241904.32039.6f; Keseru JS, 2019, J BIOTECHNOL, V298, P76, DOI 10.1016/j.jbiotec.2019.04.015; Kitazume-Taneike R, 2019, BIOCHEM BIOPH RES CO, V515, P442, DOI 10.1016/j.bbrc.2019.05.150; KOFFLER D, 1973, J CLIN INVEST, V52, P198, DOI 10.1172/JCI107165; Kolesar JE, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1324; Kong FW, 2012, JALA-J LAB AUTOM, V17, P169, DOI 10.1177/2211068211435302; Li J, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2869-5; Lindqvist D, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.236; Lindqvist D, 2018, NEUROPSYCHOPHARMACOL, V43, P1557, DOI 10.1038/s41386-017-0001-9; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Mojtabanezhad Shariatpanahi Afsaneh, 2018, BMC Res Notes, V11, P757, DOI 10.1186/s13104-018-3866-8; Nakahira K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001577; Newell C, 2018, MOL GENET METAB, V125, P332, DOI 10.1016/j.ymgme.2018.10.002; Oberacker P, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000107; Ordonez E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/195363; Pearlman SI, 2020, ACS APPL MATER INTER, V12, P12457, DOI 10.1021/acsami.9b21564; Perdas E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51000-7; Qin Z, 2016, CHIN J CANCER, V35, DOI 10.1186/s40880-016-0092-4; Sanjaya INH, 2016, BALI MED J, V5, P89, DOI 10.15562/bmj.v5i2.197; SIDRANSKY D, 1991, SCIENCE, V252, P706, DOI 10.1126/science.2024123; Sorber L, 2017, J MOL DIAGN, V19, P162, DOI 10.1016/j.jmoldx.2016.09.009; Stemmer C, 2003, CLIN CHEM, V49, P1953, DOI 10.1373/clinchem.2003.020750; STROUN M, 1989, ONCOLOGY, V46, P318; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; TAN EM, 1966, J CLIN INVEST, V45, P1732, DOI 10.1172/JCI105479; Thakore N, 2018, J MICROBIOL METH, V148, P174, DOI 10.1016/j.mimet.2018.03.021; Trigg RM, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00699; Trumpff C, 2019, PSYCHONEUROENDOCRINO, V106, P268, DOI 10.1016/j.psyneuen.2019.03.026; Wan JCM, 2017, NAT REV CANCER, V17, P223, DOI 10.1038/nrc.2017.7; Xia P, 2009, GENET MOL BIOL, V32, P20, DOI 10.1590/S1415-47572009000100003; Xie J, 2018, AM J MED SCI, V356, P121, DOI 10.1016/j.amjms.2018.04.007; Xue XY, 2009, CLIN CHIM ACTA, V404, P100, DOI 10.1016/j.cca.2009.02.018; Yang XM, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-014-0459-0; Yuzefovych LV, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222278; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhong S, 2000, J CLIN PATHOL, V53, P466, DOI 10.1136/jcp.53.6.466	58	3	3	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2020	295	46					15677	15691		10.1074/jbc.RA120.015237	http://dx.doi.org/10.1074/jbc.RA120.015237			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OY6NO	32900851	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000594361600020
J	Kim, YW; Kang, Y; Kang, J; Kim, A				Kim, Yea Woon; Kang, Yujin; Kang, Jin; Kim, AeRi			GATA-1-dependent histone H3K27 acetylation mediates erythroid cell-specific chromatin interaction between CTCF sites	FASEB JOURNAL			English	Article						chromatin interaction; CTCF sites; GATA-1; human beta-globin locus	GLOBIN LOCUS; GENOME; TRANSCRIPTION; REVEALS; GENES; ROLES; BRD2; DIMERIZATION; BROMODOMAIN; EXPRESSION	CCCTC-binding factor (CTCF) sites interact with each other in the chromatin environment, establishing chromatin domains. Our previous study showed that interaction between CTCF sites is cell type-specific around the beta-globin locus and is dependent on erythroid-specific activator GATA-1. To find out molecular mechanisms of the cell type-specific interaction, we directly inhibited GATA-1 binding to the beta-globin enhancers by deleting its binding motifs and found that histone H3K27 acetylation (H3K27ac) was decreased at CTCF sites surrounding the beta-globin locus, even though CTCF binding itself was maintained at the sites. Forced H3K27ac by Trichostatin A treatment or CBP/p300 KD affected the interactions between CTCF sites around the beta-globin locus without changes in CTCF binding. Analysis of public ChIA-PET data revealed that H3K27ac is higher at CTCF sites forming short interactions than long interactions. GATA-1 was identified as a representative transcription factor that relates with genes present inside the short interactions in erythroid K562 cells. Depletion of GATA-1-reduced H3K27ac at CTCF sites near erythroid-specific enhancers. These results indicate that H3K27ac at CTCF sites is required for cell type-specific chromatin interactions between them. Tissue-specific activator GATA-1 appears to play a role in H3K27ac at CTCF sites in erythroid cells.	[Kim, Yea Woon; Kang, Yujin; Kang, Jin; Kim, AeRi] Pusan Natl Univ, Dept Mol Biol, Coll Nat Sci, Busan 46241, South Korea	Pusan National University	Kim, A (corresponding author), Pusan Natl Univ, Dept Mol Biol, Coll Nat Sci, Busan 46241, South Korea.	kimaeri@pusan.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2017R1A2B4008947]; Ministry of Education [NRF-2017R1D1A1B03030807]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning; Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2017R1A2B4008947) and by the Ministry of Education (NRF-2017R1D1A1B03030807).	Blobel GA, 1998, P NATL ACAD SCI USA, V95, P2061, DOI 10.1073/pnas.95.5.2061; Brown JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06248-4; Cheung KL, 2017, MOL CELL, V65, P1068, DOI 10.1016/j.molcel.2016.12.022; Chien R, 2011, J BIOL CHEM, V286, P17870, DOI 10.1074/jbc.M110.207365; Despang A, 2019, NAT GENET, V51, P1263, DOI 10.1038/s41588-019-0466-z; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Freese NH, 2016, BIOINFORMATICS, V32, P2089, DOI 10.1093/bioinformatics/btw069; Garcia-Gutierrez P, 2012, J CELL SCI, V125, P3671, DOI 10.1242/jcs.105841; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Han H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11432; Hanssen LLP, 2017, NAT CELL BIOL, V19, P952, DOI 10.1038/ncb3573; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Hsu SC, 2017, MOL CELL, V66, P102, DOI 10.1016/j.molcel.2017.02.027; Huang P, 2017, GENE DEV, V31, P1704, DOI 10.1101/gad.303461.117; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kang Y, 2017, BBA-GENE REGUL MECH, V1860, P416, DOI 10.1016/j.bbagrm.2017.01.013; Kiekhaefer CM, 2002, P NATL ACAD SCI USA, V99, P14309, DOI 10.1073/pnas.212389499; Kim SI, 2009, NUCLEIC ACIDS RES, V37, P6019, DOI 10.1093/nar/gkp677; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kim YW, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170976; Kim YW, 2011, NUCLEIC ACIDS RES, V39, P6944, DOI 10.1093/nar/gkr253; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee DP, 2019, CIRCULATION, V139, P1937, DOI 10.1161/CIRCULATIONAHA.118.036726; Lee J, 2017, CELL REP, V19, P2490, DOI 10.1016/j.celrep.2017.05.072; Letting DL, 2003, MOL CELL BIOL, V23, P1334, DOI 10.1128/MCB.23.4.1334-1340.2003; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Matthews BJ, 2018, ELIFE, V7, DOI 10.7554/eLife.34077; Nakamura Y, 2007, J BIOL CHEM, V282, P4193, DOI 10.1074/jbc.M605971200; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Nora EP, 2017, CELL, V169, P930, DOI 10.1016/j.cell.2017.05.004; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Ren G, 2017, MOL CELL, V67, P1049, DOI 10.1016/j.molcel.2017.08.026; Rubin AJ, 2017, NAT GENET, V49, P1522, DOI 10.1038/ng.3935; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Tanimura N, 2016, EMBO REP, V17, P249, DOI 10.15252/embr.201541465; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Yun WJ, 2014, NUCLEIC ACIDS RES, V42, P4283, DOI 10.1093/nar/gku072; Zhou Y, 2013, BLOOD, V122, P4199, DOI 10.1182/blood-2013-02-483875	46	7	7	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14736	14749		10.1096/fj.202001526R	http://dx.doi.org/10.1096/fj.202001526R		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32924169	Green Submitted			2022-12-26	WOS:000570665500001
J	Vachon, CM; Modchalingam, S; t Hart, BM; Henriques, DYP				Vachon, Chad Michael; Modchalingam, Shanaathanan; t Hart, Bernard Marius; Henriques, Denise Y. P.			The effect of age on visuomotor learning processes	PLOS ONE			English	Article							SPATIAL WORKING-MEMORY; PROPRIOCEPTIVE RECALIBRATION; SENSORIMOTOR ADAPTATION; REACH ADAPTATION; EXPLICIT ADJUSTMENTS; MOTOR ADAPTATION; IMPLICIT; YOUNGER; CONSEQUENCES; ROTATIONS	Knowing where our limbs are in space is essential for moving and for adapting movements to various changes in our environments and bodies. The ability to adapt movements declines with age, and age-related cognitive decline can explain a decreased ability to adopt and deploy explicit, cognitive strategies in motor learning. Age-related sensory decline could also lead to a reduced fidelity of sensory position signals and error signals, each of which can affect implicit motor adaptation. Here we investigate two estimates of limb position; one based on proprioception, the other on predicted sensory consequences of movements. Each is considered a measure of an implicit adaptation process and may be affected by both age and cognitive strategies. Both older (n = 38) and younger (n = 42) adults adapted to a 30 degrees visuomotor rotation in a centre-out reaching task. We make an explicit, cognitive strategy available to half of participants in each age group with a detailed instruction. After training, we first quantify the explicit learning elicited by instruction. Instructed older adults initially use the provided strategy slightly less than younger adults but show a similar ability to evoke it after training. This indicates that cognitive explanations for age-related decline in motor learning are limited. In contrast, training induced much larger shifts of state estimates of hand location in older adults compared to younger adults. This is not modulated by strategy instructions, and appears driven by recalibrated proprioception, which is almost twice as large in older adults, while predictions might not be updated in older adults. This means that in healthy aging, some implicit processes may be compensating for other changes to maintain motor capabilities, while others also show age-related decline (data:).	[Vachon, Chad Michael; Modchalingam, Shanaathanan; t Hart, Bernard Marius; Henriques, Denise Y. P.] York Univ, Ctr Vis Res, Toronto, ON, Canada; [Vachon, Chad Michael; Henriques, Denise Y. P.] York Univ, Dept Psychol, Toronto, ON, Canada; [Modchalingam, Shanaathanan; Henriques, Denise Y. P.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada	York University - Canada; York University - Canada; York University - Canada	t Hart, BM (corresponding author), York Univ, Ctr Vis Res, Toronto, ON, Canada.	thartbm@gmail.com	't Hart, Bernard/AHD-9519-2022	't Hart, Bernard/0000-0002-0045-3769; Modchalingam, Shanaathanan/0000-0002-8274-6724	Canadian Network for Research and Innovation in Machining Technology NSERC; German Research Foundation (DFG) [HA 6861/2-1]	Canadian Network for Research and Innovation in Machining Technology NSERC; German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by a Canadian Network for Research and Innovation in Machining Technology NSERC Operating grant (DYPH) and the German Research Foundation (DFG) under grant no. HA 6861/2-1 (BMtH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguera JA, 2011, J COGNITIVE NEUROSCI, V23, P11, DOI 10.1162/jocn.2010.21451; Anguera JA, 2010, J COGNITIVE NEUROSCI, V22, P1917, DOI 10.1162/jocn.2009.21351; [Anonymous], 1890, LIB J, V15, P20; Barkley V, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00705; Bedard P, 2013, J VISION, V13, DOI 10.1167/13.12.12; Benson BL, 2011, J NEUROPHYSIOL, V105, P2843, DOI 10.1152/jn.00002.2011; Block HJ, 2012, NEUROPSYCHOLOGIA, V50, P1766, DOI 10.1016/j.neuropsychologia.2012.03.034; Block HJ, 2011, J NEUROPHYSIOL, V106, P59, DOI 10.1152/jn.00641.2010; Bock O, 2006, EXP BRAIN RES, V169, P400, DOI 10.1007/s00221-005-0153-4; Bond KM, 2015, J NEUROPHYSIOL, V113, P3836, DOI 10.1152/jn.00009.2015; Buch ER, 2003, LEARN MEMORY, V10, P55, DOI 10.1101/lm.50303; Buszard T, 2018, INT REV SPORT EXER P, V11, P258, DOI 10.1080/1750984X.2017.1323940; Cameron BD, 2012, CONSCIOUS COGN, V21, P4, DOI 10.1016/j.concog.2010.11.006; Christou AI, 2016, SCI REP-UK, V6, DOI 10.1038/srep36633; Clayton HA, 2014, EXP BRAIN RES, V232, P2073, DOI 10.1007/s00221-014-3896-y; Cressman EK, 2010, EXP BRAIN RES, V205, P533, DOI 10.1007/s00221-010-2392-2; Cressman EK, 2010, J NEUROPHYSIOL, V103, P1888, DOI 10.1152/jn.01002.2009; Cressman EK, 2009, J NEUROPHYSIOL, V102, P3505, DOI 10.1152/jn.00514.2009; D Damayanti D., 2018, BULLWHIP EFFECT SUPP, V1, P1, DOI DOI 10.1080/09593330.2018.1526217; Fernandez-Ruiz J, 2000, COGNITIVE BRAIN RES, V9, P223, DOI 10.1016/S0926-6410(99)00057-9; Gastrock RQ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76940-3; Goble DJ, 2009, NEUROSCI BIOBEHAV R, V33, P271, DOI 10.1016/j.neubiorev.2008.08.012; Haith AM, 2012, HDB MOTOR CONTROL MO, P7; Hegele M, 2013, PSYCHOL AGING, V28, P333, DOI 10.1037/a0031914; Hegele M, 2010, PSYCHOL RES-PSYCH FO, V74, P21, DOI 10.1007/s00426-008-0221-z; Henriques DYP, 2014, NEUROPSYCHOLOGIA, V64, P195, DOI 10.1016/j.neuropsychologia.2014.09.029; Heuer H, 2008, PSYCHOL AGING, V23, P190, DOI 10.1037/0882-7974.23.1.190; Heuer H, 2008, ACTA PSYCHOL, V127, P369, DOI 10.1016/j.actpsy.2007.07.006; Heuer H, 2011, J NEUROPHYSIOL, V106, P2078, DOI 10.1152/jn.00043.2011; Heuer H, 2011, HUM MOVEMENT SCI, V30, P916, DOI 10.1016/j.humov.2010.07.004; Huang HJ, 2014, J NEUROPHYSIOL, V111, P135, DOI 10.1152/jn.00401.2013; Izawa J, 2012, J NEUROSCI, V32, P4230, DOI 10.1523/JNEUROSCI.6353-11.2012; Jang J, 2019, ASYMPTOTIC LIMITS SE, DOI [10.1101/868406, DOI 10.1101/868406]; Jones SAH, 2012, NEUROPSYCHOLOGIA, V50, P1462, DOI 10.1016/j.neuropsychologia.2012.02.031; Keisler A, 2010, J NEUROSCI, V30, P14817, DOI 10.1523/JNEUROSCI.4160-10.2010; King BR, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00142; Kitchen NM, 2020, 20200713200733 BIORX, DOI [10.1101/2020.07.13.200733, DOI 10.1101/2020.07.13.200733]; Krakauer JW, 2019, COMPR PHYSIOL, V9, P613, DOI 10.1002/cphy.c170043; Lei YM, 2018, EXP BRAIN RES, V236, P599, DOI 10.1007/s00221-017-5150-x; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; McDougle SD, 2016, TRENDS COGN SCI, V20, P535, DOI 10.1016/j.tics.2016.05.002; Mikula L, 2018, J NEUROPHYSIOL, V119, P1981, DOI 10.1152/jn.00338.2017; MILNER B, 1968, NEUROPSYCHOLOGIA, V6, P215, DOI 10.1016/0028-3932(68)90021-3; Modchalingam S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220884; Mostafa AA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221861; Mostafa AA, 2015, EXP BRAIN RES, V233, P817, DOI 10.1007/s00221-014-4157-9; Mostafa AA, 2014, EXP BRAIN RES, V232, P1639, DOI 10.1007/s00221-014-3833-0; Neville KM, 2018, EXP BRAIN RES, V236, P2047, DOI 10.1007/s00221-018-5282-7; Noohi F, 2016, NEUROPSYCHOLOGIA, V84, P222, DOI 10.1016/j.neuropsychologia.2016.02.021; Ostry DJ, 2016, TRENDS NEUROSCI, V39, P114, DOI 10.1016/j.tins.2015.12.006; Ostry DJ, 2010, J NEUROSCI, V30, P5384, DOI 10.1523/JNEUROSCI.4571-09.2010; Redding GM, 1996, J EXP PSYCHOL HUMAN, V22, P379, DOI 10.1037/0096-1523.22.2.379; Reuschel J, 2012, J NEUROSCI, V32, P2422, DOI 10.1523/JNEUROSCI.2714-11.2012; Roller CA, 2002, NEUROBIOL AGING, V23, P117, DOI 10.1016/S0197-4580(01)00264-0; Ruttle JE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200621; Ruttle JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163695; Salomonczyk D, 2013, EXP BRAIN RES, V228, P313, DOI 10.1007/s00221-013-3564-7; Salomonczyk D, 2012, EXP BRAIN RES, V217, P187, DOI 10.1007/s00221-011-2985-4; Salomonczyk D, 2011, NEUROPSYCHOLOGIA, V49, P3053, DOI 10.1016/j.neuropsychologia.2011.07.006; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Salthouse TA, 2017, NEUROPSYCHOLOGY, V31, P11, DOI 10.1037/neu0000330; Seidler RD, 2006, BRAIN RES BULL, V70, P337, DOI 10.1016/j.brainresbull.2006.06.008; Simon A, 2017, HUM MOVEMENT SCI, V52, P215, DOI 10.1016/j.humov.2017.02.011; Simon A, 2016, HUM MOVEMENT SCI, V46, P23, DOI 10.1016/j.humov.2015.11.020; Stanley J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00503; Synofzik M, 2008, CURR BIOL, V18, P814, DOI 10.1016/j.cub.2008.04.071; 't Hart BM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163556; 't Hart BM, 2018, PROPRIOCEPTION PREDI; Taylor JG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002095; Taylor JA, 2007, J NEUROPHYSIOL, V98, P317, DOI 10.1152/jn.01070.2006; Taylor JA, 2014, J NEUROSCI, V34, P3023, DOI 10.1523/JNEUROSCI.3619-13.2014; Taylor JA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001096; Trewartha KM, 2014, J NEUROSCI, V34, P13411, DOI 10.1523/JNEUROSCI.1489-14.2014; Vandevoorde K, 2019, NEUROBIOL AGING, V80, P138, DOI 10.1016/j.neurobiolaging.2019.03.020; Werner S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123321; Wolpe N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13034; Wong AL, 2019, BRAIN, V142, P662, DOI 10.1093/brain/awy334	77	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0239032	10.1371/journal.pone.0239032	http://dx.doi.org/10.1371/journal.pone.0239032			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NS5RK	32925937	Green Submitted, gold, Green Published			2022-12-26	WOS:000572318000041
J	Ma, YX; Liu, SS; Jun, HJ; Wang, JE; Fan, XL; Li, GB; Yin, L; Rui, LY; Weinman, SA; Gong, JK; Wu, J				Ma, Yingxu; Liu, Shanshan; Jun, Heejin; Wang, Jine; Fan, Xiaoli; Li, Guobing; Yin, Lei; Rui, Liangyou; Weinman, Steven A.; Gong, Jianke; Wu, Jun			A critical role for hepatic protein arginine methyltransferase 1 isoform 2 in glycemic control	FASEB JOURNAL			English	Article						diabetic hyperglycemia; glycemic control; liver function; PRMT1 variant 2	NONALCOHOLIC FATTY LIVER; INSULIN-RESISTANCE; GLUCOSE-PRODUCTION; ENERGY-METABOLISM; SKELETAL-MUSCLE; METHYLATION; PGC-1-ALPHA; PRMT1; GLUCONEOGENESIS; COACTIVATOR	Appropriate control of hepatic gluconeogenesis is essential for the organismal survival upon prolonged fasting and maintaining systemic homeostasis under metabolic stress. Here, we show protein arginine methyltransferase 1 (PRMT1), a key enzyme that catalyzes the protein arginine methylation process, particularly the isoform encoded byPrmt1variant 2 (PRMT1V2),is critical in regulating gluconeogenesis in the liver. Liver-specific deletion ofPrmt1reduced gluconeogenic capacity in cultured hepatocytes and in the liver.Prmt1v2was expressed at a higher level compared toPrmt1v1in hepatic tissue and cells. Gain-of-function of PRMT1V2 clearly activated the gluconeogenic program in hepatocytes via interactions with PGC1 alpha, a key transcriptional coactivator regulating gluconeogenesis, enhancing its activity via arginine methylation, while no effects of PRMT1V1 were observed. Similar stimulatory effects of PRMT1V2 in controlling gluconeogenesis were observed in human HepG2 cells. PRMT1, specifically PRMT1V2, was stabilized in fasted liver and hepatocytes treated with glucagon, in a PGC1 alpha-dependent manner. PRMT1, particularlyPrmt1v2, was significantly induced in the liver of streptozocin-induced type 1 diabetes and high fat diet-induced type 2 diabetes mouse models and liver-specificPrmt1deficiency drastically ameliorated diabetic hyperglycemia. These findings reveal that PRMT1 modulates gluconeogenesis and mediates glucose homeostasis under physiological and pathological conditions, suggesting that deeper understanding how PRMT1 contributes to the coordinated efforts in glycemic control may ultimately present novel therapeutic strategies that counteracts hyperglycemia in disease settings.	[Ma, Yingxu; Liu, Shanshan; Jun, Heejin; Wang, Jine; Li, Guobing; Gong, Jianke; Wu, Jun] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Ma, Yingxu] Cent South Univ, Xiangya Hosp 2, Dept Cardiol, Changsha, Peoples R China; [Fan, Xiaoli; Gong, Jianke] Huazhong Univ Sci & Technol, Key Lab Mol Biophys MOE, Int Res Ctr Sensory Biol & Technol MOST, Wuhan, Peoples R China; [Fan, Xiaoli; Gong, Jianke] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan, Peoples R China; [Yin, Lei; Rui, Liangyou; Wu, Jun] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Weinman, Steven A.] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66103 USA; [Weinman, Steven A.] Univ Kansas, Med Ctr, Ctr Liver, Kansas City, KS 66103 USA	University of Michigan System; University of Michigan; Central South University; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Michigan System; University of Michigan; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Wu, J (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.; Gong, JK (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Mol Biophys MOE, Wuhan 430074, Hubei, Peoples R China.	jiankeg@umich.edu; wujunz@umich.edu		Liu, Shanshan/0000-0002-7301-5196	American Diabetes Association (ADA) [1-18-IBS-281]; American Gastroenterological Association (AGA) [AGA2020-21-09]; Chinese Scholarship Council [201806370290, 201908420207]	American Diabetes Association (ADA)(American Diabetes Association); American Gastroenterological Association (AGA); Chinese Scholarship Council(China Scholarship Council)	American Diabetes Association (ADA), Grant/Award Number: 1-18-IBS-281; American Gastroenterological Association (AGA), Grant/Award Number: AGA2020-21-09; Chinese Scholarship Council, Grant/Award Number: 201806370290 and 201908420207	Ahrens M, 2013, CELL METAB, V18, P296, DOI 10.1016/j.cmet.2013.07.004; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Besse-Patin A, 2019, P NATL ACAD SCI USA, V116, P4285, DOI 10.1073/pnas.1815150116; Blanc RS, 2017, MOL CELL, V65, P8, DOI 10.1016/j.molcel.2016.11.003; Choi D, 2012, HEPATOLOGY, V56, P1546, DOI 10.1002/hep.25809; Gastaldelli A, 2019, JHEP REP, V1, P312, DOI 10.1016/j.jhepr.2019.07.002; Goulet I, 2007, J BIOL CHEM, V282, P33009, DOI 10.1074/jbc.M704349200; Hatting M, 2018, ANN NY ACAD SCI, V1411, P21, DOI 10.1111/nyas.13435; Iwasaki H, 2007, BIOCHEM BIOPH RES CO, V364, P1015, DOI 10.1016/j.bbrc.2007.10.113; Jackson MI, 2012, J BIOL CHEM, V287, P36455, DOI 10.1074/jbc.M112.412932; Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Lai YD, 2017, J CELL SCI, V130, P3578, DOI 10.1242/jcs.206904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu X, 2016, BBA-MOL CELL RES, V1863, P2093, DOI 10.1016/j.bbamcr.2016.05.009; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Park MJ, 2014, J HEPATOL, V61, P1151, DOI 10.1016/j.jhep.2014.06.032; Priya G, 2018, DIABETES THER, V9, P349, DOI 10.1007/s13300-017-0333-9; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Pyun JH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07606-y; Qiao XN, 2019, ENDOCRINOLOGY, V160, P2773, DOI 10.1210/en.2019-00504; Qiu KX, 2020, BMC MOL CELL BIOL, V21, DOI 10.1186/s12860-020-00260-7; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rines AK, 2016, NAT REV DRUG DISCOV, V15, P786, DOI 10.1038/nrd.2016.151; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Sakamaki J, 2011, P NATL ACAD SCI USA, V108, P6085, DOI 10.1073/pnas.1015328108; SUN Y, 2019, INT J MOL SCI, V20; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005; Tikhanovich I, 2017, J BIOL CHEM, V292, P6882, DOI 10.1074/jbc.M117.778761; Tong X, 2017, DIABETES, V66, P2571, DOI 10.2337/db16-1600; Van Herck MA, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101072; Westerbacka J, 2007, DIABETES, V56, P2759, DOI 10.2337/db07-0156; Wu JZ, 2015, DIABET METAB SYND OB, V8, P181, DOI 10.2147/DMSO.S82272; Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang XP, 2018, CELL PHYSIOL BIOCHEM, V47, P1643, DOI 10.1159/000490983; Zhao J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45585-2; Zhao Jie, 2019, Gene Expression, V19, P137, DOI 10.3727/105221618X15372014086197; Zhao J, 2018, HEPATOLOGY, V67, P1109, DOI 10.1002/hep.29587	45	3	3	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14863	14877		10.1096/fj.202001061R	http://dx.doi.org/10.1096/fj.202001061R		SEP 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32918517	Green Published			2022-12-26	WOS:000570681500001
J	Dessu, S; Habte, A; Mesele, M				Dessu, Samuel; Habte, Aklilu; Mesele, Molalegn			The Kaplan Meier estimates of mortality and its predictors among newborns admitted with low birth weight at public hospitals in Ethiopia	PLOS ONE			English	Article								Background Globally, every year greater than twenty million newborns are born weighing less than 2500grams, of which over 96% of them were in developing countries. It contributes to sixty to eighty percent of all neonatal deaths, annually. These infants weighing less than 2500gram will have a poor immune system and are at risk of morbidity and mortality. This study was aimed to investigate the survival status and predictors of mortality among neonates admitted with low birth weight at public hospitals in Ethiopia. Method A prospective cohort study was conducted among selected 216 newborns admitted with low birth weight who were admitted in neonatal intensive care unit at Arba Minch General hospital, Sawla General Hospital and Chencha district hospital from 1(st)March 2018 to 28(st)February 2019. Data were entered into Epi data version 3.02 and exported to STATA V 14 for analysis. The Kaplan Meier survival curve together with log rank test was used to estimate the survival time of the newborns. Variables which had p-value Result The cumulative proportion of surviving at the end of third days was 99.01% (95%CI: 96.11, 99.75). Similarly it was 97.81% (95%CI: 94.25, 99.18), 96.27% (95%CI: 91.76, 98.33) and 94.33% (95%CI: 88.72, 97.19) at the end of fourth, fifth and sixth day respectively. The overall mean survival time was 17.13 days (95%CI: 12.76, 21.49). The incidence of mortality among neonates admitted with low birth weight was 83 per 1000 live births. Mothers with DM (AHR:4.79; 95%CI:1.15, 19.8), maternal HIV infection(AHR:6.47;95%CI:1.43,29.3), not keeping the newborn under KMC(AHR:13.0;95%CI:3.42, 49.5) and initiating exclusive breast feeding within one hour(AHR:0.19;95%CI:0.04, 0.95) were statistically significant in multivariable cox regression analysis. Conclusion The risk of mortality among neonates admitted with low birth weight was high at the early admission period and the incidence of mortality was high. Maternal history of diabetes mellitus, HIV/AIDS infection, keeping the newborn under kangaroo mother care and exclusive breast feeding initiation were statistically significant predictors of mortality. Special emphasis should be given for neonates with low birth weight at the early follow up periods and Kangaroo mother care practice should be a usual practice.	[Dessu, Samuel] Wolkite Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Wolkite, Ethiopia; [Habte, Aklilu] Wachamo Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Hossana, Ethiopia; [Mesele, Molalegn] Wolaita Soddo Univ, Coll Med & Hlth Sci, Dept Midwifery, Wolaita Soddo, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Dessu, S (corresponding author), Wolkite Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Wolkite, Ethiopia.	dessusamuel@yahoo.com	Habte, Aklilu/ABB-7649-2020; hailegebireal, aklilu habte/ABD-1527-2020	hailegebireal, aklilu habte/0000-0002-5719-4294				Akine E, 2019, INT J PEDIAT, V2019; Benson Atitwa E., 2015, AM J THEOR APPL STAT, V4, P438, DOI DOI 10.11648/J.AJTAS.20150406.14; Berhan Y, 2014, ETHIOP J HEALTH SCI, V24, P119, DOI 10.4314/ejhs.v24i0.11S; Beyene W, 2011, ETHIOP J HEALTH SCI, V21, P49; Conde-Agudelo A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002771.pub2; Coulibaly A, 2016, INT J GYNECOL OBSTET, V135, pS89, DOI 10.1016/j.ijgo.2016.08.006; CSAI, 2012, ETH DEM HLTH SURV 20; Daniale TE, 2019, ITAL J PEDIAT, V45; Edmond KM, 2006, PEDIATRICS, V117, pE380, DOI 10.1542/peds.2005-1496; Edward SO, 2010, NEOREVIEWS, V11, P627; ENGELGAU MM, 1995, DIABETES CARE, V18, P1029, DOI 10.2337/diacare.18.7.1029; Getachew A, 2011, QUALITY CARE PREVENT; Glinianaia SV, 2011, HUM REPROD, V26, P2549, DOI 10.1093/humrep/der213; Irisa Z, 2017, CURR PEDIAT RES, V21, P64; Kolola T, 2016, PLOS ONE, V11, P10; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; Mengesha HG, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0901-1; de Castro ECM, 2014, BMC PEDIATR, V14, DOI 10.1186/s12887-014-0312-5; Gaiva MAM, 2014, REV ESC ENFERM USP, V48, P778, DOI 10.1590/S0080-6234201400005000002; OTOLORIN E O, 1985, African Journal of Medicine and Medical Sciences, V14, P155; Petrou S, 2003, BJOG-INT J OBSTET GY, V110, P17, DOI 10.1016/S1470-0328(03)00013-2; Samuel D, 2019, ETHIOP J HLTH DEV, V33; Sarmila M, 2017, BMC, V18; Sutan R, 2014, OPEN J PREV MED, V4; UNICEF, 2007, STAT WORLDS CHILDR 2; UNICEF WHO & World Bank Group., 2021, LEVELS TRENDS CHILD; Victora CG, 2016, LANCET, V387, P2049, DOI 10.1016/S0140-6736(15)00519-X; Watkins WJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002018; WHO, 2019, EARL IN BREASTF PROM; WHO, 2015, CAR PRET LOW BIRTH W; WHO/UNICEF, 2014, GLOB NUTR TARG 2025, DOI [10.1057/9781137477699_6, DOI 10.1057/9781137477699_6]; World Health Organization, 2019, KANG MOTH CAR RED MO; World Health Organization (WHO), 2010, EXP ARS MAJ PUBL HLT, P1; World Health Organization (WHO), 2003, KANGAROO MOTHER CARE; Yalemzewod AG, 2014, BMC RES NOTES, V7; Yasmin S, 2001, B WORLD HEALTH ORGAN, V79, P608; Yaya Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096294	38	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238629	10.1371/journal.pone.0238629	http://dx.doi.org/10.1371/journal.pone.0238629			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915835	Green Published, gold			2022-12-26	WOS:000571887500062
J	Orvieto, R; Feldman, B; Wiesel, M; Shani, H; Aizer, A				Orvieto, Raoul; Feldman, Baruch; Wiesel, Marine; Shani, Hagit; Aizer, Adva			Is Day-4 morula biopsy a feasible alternative for preimplantation genetic testing?	PLOS ONE			English	Article							PREGNANCY FOLLOW-UP; DIAGNOSIS; JANUARY; CYCLES	Objective To assess the efficacy and clinical outcome of PGT-M undertaken on Day-3, Day-4 and Day-4 "delayed" embryos that were unsuitable for biopsy on Day-3. Design and setting Cohort-historical study of all consecutive patients admitted to the IVF-PGT-M program in a large tertiary center. Main outcome measure(s) The pregnancy rates and the percentages of complete, incomplete diagnosis, PCR failure, abnormal embryos in PGT of Day-3 cleavage-stage, Day-4 and Day-4 "delayed" embryos. Patients and methods We reviewed the medical files of all consecutive patients admitted to our IVF for a fresh IVF-PGT-M cycle. Patients were divided into 3 groups according to the day of blastomere biopsy: Day 3 cleavage-stage, Day-4 morula and Day-4 "delayed" embryos. The laboratory data, genetic diagnostic and clinical results were collected and compared between the different study groups. Results Nine hundred and six patients underwent PGT-M cycles in our PGT program: 747, 127 and 32 in the Day-3, Day- 4 and Day-4 "delayed" groups, respectively. Ongoing pregnancy rates per transfer and per patient (15.8% and 9.4%, respectively) were non-significantly lower in the Day-4 "delayed", compared to Day-3 (21.4% and 17.5%, respectively) and Day-4 (24.3% and 19.7%, respectively). When comparing ALL morulas (Day-4 and Day-4 "delayed") to ALL cleavage-stage embryos (Day-3, Day-4 and Day-4 "delayed"), a significantly higher ongoing pregnancy rate was demonstrated following the transfer of embryos derived from morula biopsy, as compared to biopsy at the cleavage-stage (33.3% vs 20.5%, p<0.03, respectively). Conclusion Day-4 embryo biopsy is feasible and yields comparable and even higher ongoing pregnancy rate if undertaken at the morula stage. Further studies evaluating the cumulative live-birth rate per started cycles in Day-3 vs Day-4 embryo biopsy for PGT-M are warranted.	[Orvieto, Raoul; Wiesel, Marine; Aizer, Adva] Sheba Med Ctr, Dept Obstet & Gynecol, Ramat Gan, Israel; [Orvieto, Raoul; Wiesel, Marine; Shani, Hagit] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Orvieto, Raoul] Tel Aviv Univ, Sackler Fac Med, Family Planning & Fertil Regulat, Tel Aviv, Israel; [Feldman, Baruch; Shani, Hagit] Sheba Med Ctr, Danek Gertner Inst Human Genet, Ramat Gan, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center	Orvieto, R (corresponding author), Sheba Med Ctr, Dept Obstet & Gynecol, Ramat Gan, Israel.; Orvieto, R (corresponding author), Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.; Orvieto, R (corresponding author), Tel Aviv Univ, Sackler Fac Med, Family Planning & Fertil Regulat, Tel Aviv, Israel.	raoul.orvieto@sheba.health.gov.il		aizer, adva/0000-0003-0820-8079; Orvieto, Raoul/0000-0002-0865-1196				Berger VK, 2014, SEMIN REPROD MED, V32, P107, DOI 10.1055/s-0033-1363552; De Rycke M, 2017, HUM REPROD, V32, P1974, DOI 10.1093/humrep/dex265; De Rycke M, 2015, HUM REPROD, V30, P1763, DOI 10.1093/humrep/dev122; Feldman B, 2017, J ASSIST REPROD GEN, V34, P1179, DOI 10.1007/s10815-017-0966-7; Glujovsky D, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002118.pub4, 10.1002/14651858.CD002118.pub5]; Harper JC, 2012, HUM GENET, V131, P175, DOI 10.1007/s00439-011-1056-z; Orvieto R, 2016, REPROD BIOL ENDOCRIN, V14, P1, DOI 10.1186/s12958-016-0171-z; Orvieto R, 2015, GYNECOL ENDOCRINOL, V31, P435, DOI 10.3109/09513590.2015.1005595; Racowsky C, 2000, FERTIL STERIL, V73, P558, DOI 10.1016/S0015-0282(99)00565-8; Scott RT, 2013, FERTIL STERIL, V100, P624, DOI 10.1016/j.fertnstert.2013.04.039; Theobald R, 2020, HUM REPROD, V35, P986, DOI 10.1093/humrep/deaa034; Xiao JS, 2019, REPROD BIOMED ONLINE, V39, P916, DOI 10.1016/j.rbmo.2019.08.003	12	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238599	10.1371/journal.pone.0238599	http://dx.doi.org/10.1371/journal.pone.0238599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32916690	gold, Green Published			2022-12-26	WOS:000571887500016
J	Taskin, OC; Basturk, O; Reid, MD; Dursun, N; Bagci, P; Saka, B; Balci, S; Memis, B; Bellolio, E; Araya, JC; Roa, JC; Tapia, O; Losada, H; Sarmiento, J; Jang, KT; Jang, JY; Pehlivanoglu, B; Erkan, M; Adsay, V				Taskin, Orhun C.; Basturk, Olca; Reid, Michelle D.; Dursun, Nevra; Bagci, Pelin; Saka, Burcu; Balci, Serdar; Memis, Bahar; Bellolio, Enrique; Araya, Juan Carlos; Roa, Juan Carlos; Tapia, Oscar; Losada, Hector; Sarmiento, Juan; Jang, Kee-Taek; Jang, Jin-Young; Pehlivanoglu, Burcin; Erkan, Mert; Adsay, Volkan			Gallbladder polyps: Correlation of size and clinicopathologic characteristics based on updated definitions	PLOS ONE			English	Article							PAPILLARY NEOPLASMS; RISK STRATIFICATION; LESIONS; ULTRASONOGRAPHY; MANAGEMENT; LARGER; CM	Background Different perspectives exist regarding the clinicopathologic characteristics, biology and management of gallbladder polyps. Size is often used as the surrogate evidence of polyp behavior and size of >= 1cm is widely used as cholecystectomy indication. Most studies on this issue are based on the pathologic correlation of polyps clinically selected for resection, whereas, the data regarding the nature of polypoid lesions from pathology perspective -regardless of the cholecystectomy indication- is highly limited. Methods In this study, 4231 gallbladders -606 of which had gallbladder carcinoma- were reviewed carefully pathologically by the authors for polyps (defined as >= 2 mm). Separately, the cases that were diagnosed as "gallbladder polyps" in the surgical pathology databases were retrieved. Results 643 polyps identified accordingly were re-evaluated histopathologically. Mean age of all patients was 55 years (range: 20-94); mean polyp size was 9 mm. Among these 643 polyps, 223 (34.6%) were neoplastic: I. Non-neoplastic polyps (n = 420; 65.4%) were smaller (mean: 4.1 mm), occurred in younger patients (mean: 52 years). This group consisted of fibromyoglandular polyps (n = 196) per the updated classification, cholesterol polyps (n = 166), polypoid pyloric gland metaplasia (n = 41) and inflammatory polyps (n = 17). II. Neoplastic polyps were larger (mean: 21 mm), detected in older patients (mean: 61 years) and consisted of intra-cholecystic neoplasms (WHO's "adenomas" and "intracholecystic papillary neoplasms", >= 1 cm; n = 120), their "incipient" version (<1 cm) (n = 44), polypoid invasive carcinomas (n = 26) and non-neoplastic polyps with incidental dysplastic changes (n = 33). In terms of size cut-off correlations, overall, only 27% of polyps were >= 1 cm, 90% of which were neoplastic. All (except for one) >= 2 cm were neoplastic. However, 14% of polyps <1 cm were also neoplastic. Positive predictive value of >= 1 cm cut-off -which is widely used for cholecystectomy indication-, was 94.3% and negative predictive value was 85%. Conclusions Approximately a third of polypoid lesions in the cholecystectomies (regardless of the indication) prove to be neoplastic. The vast majority of (90%) of polyps >= 1 cm and virtually all of those >= 2 cm are neoplastic confirming the current impression that polyps >= 1 cm ought to be removed. However, this study also illustrates that 30% of the neoplastic polyps are <1 cm and therefore small polyps should also be closely watched, especially in older patients.	[Taskin, Orhun C.; Adsay, Volkan] Koc Univ, Dept Pathol, Istanbul, Turkey; [Taskin, Orhun C.; Adsay, Volkan] Koc Univ, Res Ctr Translat Med KUTTAM, Istanbul, Turkey; [Basturk, Olca] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Reid, Michelle D.; Balci, Serdar; Jang, Kee-Taek] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA; [Dursun, Nevra] Istanbul Res & Training Hosp, Dept Pathol, Istanbul, Turkey; [Bagci, Pelin] Marmara Univ, Dept Pathol, Pendik Res & Training Hosp, Istanbul, Turkey; [Saka, Burcu] Medipol Univ, Dept Pathol, Istanbul, Turkey; [Memis, Bahar] Sisli Hamidiye Etfal Training & Res Hosp, Dept Pathol, Istanbul, Turkey; [Bellolio, Enrique] Univ La Frontera, Anat Pathol Dept, Temuco, Chile; [Araya, Juan Carlos] Hosp Dr Hernan Henriquez Aravena, Dept Pathol, Temuco, Chile; [Roa, Juan Carlos; Tapia, Oscar] Pontificia Univ Catolica Chile, Dept Pathol, Santiago, Chile; [Losada, Hector] Univ La Frontera, Dept Surg & Traumatol, Temuco, Chile; [Sarmiento, Juan] Emory Univ, Dept Surg, Atlanta, GA 30322 USA; [Jang, Jin-Young] Seoul Natl Univ, Dept Surg, Coll Med, Seoul, South Korea; [Pehlivanoglu, Burcin] Adiyaman Training & Res Hosp, Dept Pathol, Adiyaman, Turkey; [Erkan, Mert] Koc Univ Hosp, Dept Surg, Istanbul, Turkey; [Erkan, Mert] Koc Univ Hosp, Res Ctr Translat Med KUTTAM, Istanbul, Turkey; [Jang, Kee-Taek] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Pathol & Translat Genom, Seoul, South Korea	Koc University; Koc University; Memorial Sloan Kettering Cancer Center; Emory University; Istanbul Training & Research Hospital; Marmara University; Istanbul Medipol University; Istanbul Sisli Hamidiye Etfal Training & Research Hospital; Universidad de La Frontera; Pontificia Universidad Catolica de Chile; Universidad de La Frontera; Emory University; Seoul National University (SNU); Adiyaman Training & Research Hospital; Koc University; Koc University; Sungkyunkwan University (SKKU); Samsung Medical Center	Adsay, V (corresponding author), Koc Univ, Dept Pathol, Istanbul, Turkey.; Adsay, V (corresponding author), Koc Univ, Res Ctr Translat Med KUTTAM, Istanbul, Turkey.	vadsay@kuh.ku.edu.tr	Taskin, Orhun/CAG-0880-2022; Roa, Juan C./K-4749-2014; BALCI, Serdar/B-6401-2011; Pehlivanoglu, Burcin/AHA-2963-2022; Araya, Juan C/Q-5575-2018; Pehlivanoglu, Burcin/AAZ-7405-2020	Taskin, Orhun/0000-0002-6668-3006; Roa, Juan C./0000-0001-8313-8774; BALCI, Serdar/0000-0002-7852-3851; Araya, Juan C/0000-0003-3501-8203; 	NCI NIH HHS [P30 CA008748] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adsay NV, 2009, SURG PATHOLOGY GI TR, P845; Adsay V, 2010, STERNBERGS DIAGNOSTI, P1600; Adsay V, 2012, AM J SURG PATHOL, V36, P1279, DOI 10.1097/PAS.0b013e318262787c; Akyurek Nusret, 2005, HPB (Oxford), V7, P155, DOI 10.1080/13651820510003762; Albores-Saavedra J, 2000, ATLAS TUMOR PATHOLOG; Aloia TA, 2015, HPB, V17, P681, DOI 10.1111/hpb.12444; [Anonymous], 2019, LANCET DIGITAL HLTH; Babu BI, 2015, LANGENBECK ARCH SURG, V400, P455, DOI 10.1007/s00423-015-1302-2; Basturk O, 2017, AM J SURG PATHOL, V41, P313, DOI 10.1097/PAS.0000000000000782; Basturk O, 2016, VIRCHOWS ARCH, V469, P523, DOI 10.1007/s00428-016-2014-x; Cheon YK, 2009, WORLD J GASTROENTERO, V15, P2361, DOI 10.3748/wjg.15.2361; Choi TW, 2018, EUR RADIOL, V28, P196, DOI 10.1007/s00330-017-4954-1; Klimstra DS., 2019, WHO CLASSIFICATION T, V5th, P265; Lee J, 2012, J NUCL MED, V53, P353, DOI 10.2967/jnumed.111.093948; Martini M, 2013, ARCH PATHOL LAB MED, V137, P721, DOI 10.5858/arpa.2012-0218-CR; Metman MJH, 2020, HPB, V22, P506, DOI 10.1016/j.hpb.2019.08.006; Miranda-Filho A, 2020, INT J CANCER, V147, P978, DOI 10.1002/ijc.32863; Moriguchi H, 1996, GUT, V39, P860, DOI 10.1136/gut.39.6.860; Ohike N, 2010, AM J SURG PATHOL, V34, P1731, DOI 10.1097/PAS.0b013e3181f8ff05; Park HY, 2015, WORLD J GASTROENTERO, V21, P4248, DOI 10.3748/wjg.v21.i14.4248; Pedersen MRV, 2012, DAN MED J, V59; Quigley BC, 2018, MACSWEENS PATHOLOGY, V7th, P594, DOI [10.1016/B978-0-7020-6697-9.00010-8, DOI 10.1016/B978-0-7020-6697-9.00010-8]; ROA JC, 2016, MODERN PATHOL S2, V29, pA44; Schlitter AM, 2015, MODERN PATHOL, V28, P1249, DOI 10.1038/modpathol.2015.61; Song ER, 2014, ABDOM IMAGING, V39, P334, DOI 10.1007/s00261-013-0071-z; Spaziani E, 2019, ANN ITAL CHIR, V90, P305; Sun YL, 2019, HEPATOBIL SURG NUTR, V8, P219, DOI 10.21037/hbsn.2018.12.15; Sung Ji Eun, 2014, Korean J Hepatobiliary Pancreat Surg, V18, P9, DOI 10.14701/kjhbps.2014.18.1.9; Terzioglu SG, 2017, TURK J GASTROENTEROL, V28, P202, DOI 10.5152/tjg.2017.16698; Wang T, 2019, AM J SURG PATHOL, V43, P656, DOI 10.1097/PAS.0000000000001226; Wennmacker SZ, 2019, SURG ENDOSC, V33, P1564, DOI 10.1007/s00464-018-6444-1; Wiles R, 2017, EUR RADIOL, V27, P3856, DOI 10.1007/s00330-017-4742-y; Yamada T, 2018, J MED ULTRASON, V45, P175, DOI 10.1007/s10396-017-0798-1; YAMAMOTO M, 1988, ACTA PATHOL JAPON, V38, P181	34	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0237979	10.1371/journal.pone.0237979	http://dx.doi.org/10.1371/journal.pone.0237979			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915805	Green Published, gold			2022-12-26	WOS:000571887500141
J	Cao, HS; He, XL; Du, JK; Zhang, R; Chen, Y; Ma, Y; Chen, Q; Fang, CB; Ho, CT; Zhang, SH; Wan, XC				Cao, Haisheng; He, Xiaolong; Du, Jinke; Zhang, Rui; Chen, Ying; Ma, Yong; Chen, Qi; Fang, Congbing; Ho, Chi-Tang; Zhang, Shihua; Wan, Xiaochun			Time-series transcriptomic analysis reveals novel gene modules that control theanine biosynthesis in tea plant (Camellia sinensis)	PLOS ONE			English	Article							CAFFEINE; EXPRESSION	Theanine (thea) is a unique non-protein amino acid in tea plant (Camellia sinensis) and one of the most important small molecular compounds for tea quality and health effects. The molecular mechanism that maintains thea biosynthesis is not clear but may be reflected in complicated biological networks as other secondary metabolites in plants. We performed an integrative transcriptomic analysis of tea seedlings bud and leave over the time-course of ethylamine (EA) treatment that activated thea pathway. We identified 54 consistent differentially expressed genes (cDEGs, 25 upregulated and 29 downregulated) during thea activation. Gene Ontology (GO) functional enrichment analysis of upregulated genes and downregulated genes showed that they may function as a cascade of biological events during their cooperative contribution to thea biosynthesis. Among the total cDEGs, a diversity of functional genes (e.g., enzymes, transcription factors, transport and binding proteins) were identified, indicating a hierarchy of gene control network underlying thea biosynthesis. A gene network associated with thea biosynthesis was modeled and three interconnected gene functional modules were identified. Among the gene modules, several topologically important genes (e.g.,CsBCS-1,CsRP,CsABC2) were experimentally validated using a combined thea content and gene expression analysis. Collectively, we presented here for the first time a comprehensive landscape of the biosynthetic mechanism of thea controlled by a underling gene network, which might provide a theoretical basis for the identification of key genes that contribute to thea biosynthesis.	[Cao, Haisheng; Du, Jinke; Chen, Ying; Chen, Qi; Fang, Congbing; Wan, Xiaochun] Anhui Agr Univ, State Key Lab Tea Plant Biol & Utilizat, Hefei, Peoples R China; [He, Xiaolong] Anhui Agr Univ, Sch Sci, Hefei, Peoples R China; [Zhang, Rui; Ma, Yong] Anhui Agr Univ, Coll Informat & Comp Sci, Hefei, Peoples R China; [Ho, Chi-Tang] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ USA; [Zhang, Shihua] Wuhan Univ Sci & Technol, Coll Life Sci & Hlth, Wuhan, Peoples R China	Anhui Agricultural University; Anhui Agricultural University; Anhui Agricultural University; Rutgers State University New Brunswick; Wuhan University of Science & Technology	Wan, XC (corresponding author), Anhui Agr Univ, State Key Lab Tea Plant Biol & Utilizat, Hefei, Peoples R China.; Zhang, SH (corresponding author), Wuhan Univ Sci & Technol, Coll Life Sci & Hlth, Wuhan, Peoples R China.	zhangshihua@ahau.edu.cn; xcwan@ahau.edu.cn			Fund of National Natural Science Foundation of China [31301248]; Natural Science Foundation of Anhui Province [1608085MC66]	Fund of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province)	This work was funded by grants from Fund of National Natural Science Foundation of China (31301248) and the Natural Science Foundation of Anhui Province (No.1608085MC66). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], 2018, DTSCH ARZTEBL, V115, pA; Bulgakov VP, 2017, CRIT REV BIOTECHNOL, V37, P685, DOI 10.3109/07388551.2016.1141391; Chen YZ, 2011, COMPUT BIOL CHEM, V35, P10, DOI 10.1016/j.compbiolchem.2010.12.002; Chronopoulou E., 2017, GLUTATHIONE PLANT GR, P195, DOI [10.1007/978-3-319-66682- 2_9. AG 2017, DOI 10.1007/978-3-319-66682-2_9.AG2017]; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Egashira N, 2007, J PHARMACOL SCI, V105, P211, DOI 10.1254/jphs.SCZ070901; Haskell CF, 2008, BIOL PSYCHOL, V77, P113, DOI 10.1016/j.biopsycho.2007.09.008; Hussain MS, 2012, J PHARM BIOALLIED SC, V4, P10, DOI 10.4103/0975-7406.92725; Kakuda T, 2000, BIOSCI BIOTECH BIOCH, V64, P287, DOI 10.1271/bbb.64.287; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kolde R, 2012, BIOINFORMATICS, V28, P573, DOI 10.1093/bioinformatics/btr709; KONISHI S, 1985, SOIL SCI PLANT NUTR, V31, P361, DOI 10.1080/00380768.1985.10557443; Konishi S., 1969, SOIL SCI PLANT NUTR, V40, P479; Kroymann J, 2011, CURR OPIN PLANT BIOL, V14, P246, DOI 10.1016/j.pbi.2011.03.021; Ku KM, 2010, J AGR FOOD CHEM, V58, P418, DOI 10.1021/jf902929h; Lehfeldt C, 2000, PLANT CELL, V12, P1295, DOI 10.1105/tpc.12.8.1295; Li CF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1773-0; Li N, 2010, THEANINE ITS OCCURRE; Liu Q, 2009, CYTOTECHNOLOGY, V59, P211, DOI 10.1007/s10616-009-9223-y; Mukhopadhyay M, 2016, PLANT CELL REP, V35, P255, DOI 10.1007/s00299-015-1884-8; Nakazato T, 2016, DBCLS SRA FUNCTIONAL; Ranatunga MAB, 2019, ADVANCES IN PLANT BREEDING STRATEGIES, P517, DOI 10.1007/978-3-030-23112-5_13; Ren LP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-844; Robinson M., 2010, J HOSP PALLIAT NURS, V4, P206, DOI DOI 10.1001/JAMA.284.24.3187; Rogers PJ, 2008, PSYCHOPHARMACOLOGY, V195, P569, DOI 10.1007/s00213-007-0938-1; Sakato Y., 1949, NIPPON NOGEIKAGAKU K, V23, P262, DOI DOI 10.1271/NOGEIKAGAKU1924.23.262; SASAOKA K, 1963, AGR BIOL CHEM TOKYO, V27, P467, DOI 10.1080/00021369.1963.10858131; SASAOKA K, 1962, AGR BIOL CHEM TOKYO, V26, P265, DOI 10.1080/00021369.1962.10857969; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor-Teeples M, 2015, NATURE, V517, P571, DOI 10.1038/nature14099; Wang WD, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00385; Wei CL, 2018, P NATL ACAD SCI USA, V115, pE4151, DOI 10.1073/pnas.1719622115; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Xia EH, 2017, MOL PLANT, V10, P866, DOI 10.1016/j.molp.2017.04.002; Xuan HD, 2015, GENE, V573, P328, DOI 10.1016/j.gene.2015.07.069; Yamaguchi S, 2000, J NUTR, V130, p921S, DOI 10.1093/jn/130.4.921S; Yamaya T, 2014, J EXP BOT, V65, P5519, DOI 10.1093/jxb/eru103; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Yuk H, 2016, NAT MATER, V15, P190, DOI [10.1038/nmat4463, 10.1038/NMAT4463]; Zhang L.-X., 2016, BIORESOUR BIOPROCESS, V3, P5, DOI [10.1186/s40643-015-0072-6, DOI 10.1186/S40643-015-0072-6]; Zhang QF, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00291; Zhang R, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-06839-w; Zhang SH, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00480; ZHANG SZ, 2016, BRIEF BIOINFORM, V26, DOI DOI 10.1088/1054-660X/26/5/055007; Zheng GD, 2004, IN VIVO, V18, P55	48	2	2	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238175	10.1371/journal.pone.0238175	http://dx.doi.org/10.1371/journal.pone.0238175			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911493	gold, Green Published			2022-12-26	WOS:000571885900025
J	You, ML; Xia, XB; Li, HB; Wu, JY; Rong, R; Zeng, Z; Xiong, K; Huang, JF; Tang, LS; Lei, HT; Wu, WY; Ji, D				You, Mengling; Xia, Xiaobo; Li, Haibo; Wu, Jiayu; Rong, Rong; Zeng, Zhou; Xiong, Kun; Huang, Jufang; Tang, Luosheng; Lei, Hetian; Wu, Wenyi; Ji, Dan			Normal vitreous promotes angiogenesi via the epidermal growth factor receptor	FASEB JOURNAL			English	Article						Akt; angiogenesis; EGFR; HUVECs; PDR; vitreous	SUPRAMOLECULAR ORGANIZATION; ERBB RECEPTORS; INHIBITION; RETINOPATHY; EXPRESSION; SURVIVAL; CANCER; ACID; DRUG; EGFR	Vitreous, a transparent tissue in our body, contains anti-angiogenesis factors. Our previous work reported that vitreous activates the signaling pathway of epidermal growth factor receptor (EGFR), which plays a critical role in angiogenesis. The aim of this study was to determine the role of EGFR in vitreous-induced angiogenesis-related cellular responses in vitro. Using a pharmacologic and molecular approach, we found that vitreous increased proliferation and migration via EGFR in human umbilical vein endothelial cells (HUVECs). Furthermore, we demonstrated that vitreous promoted tube formation via EGFR in HUVECs. Subsequently, depletion of EGFR using CRISPR/Cas9 and blockage with EGFR inhibitor AG1478 suppressed vitreous-induced Akt activation and cell proliferation, migration, and tube formation in HUVECs. The significance of the angiogenic effect derived from vitreous demonstrates the importance of vitreous in the ocular physiology and the pathobiology of angiogenesis-related ophthalmic diseases, such as proliferative diabetic retinopathy.	[You, Mengling; Xia, Xiaobo; Li, Haibo; Rong, Rong; Zeng, Zhou; Wu, Wenyi; Ji, Dan] Cent South Univ, Xiangya Hosp, Dept Ophthalmol, Changsha, Peoples R China; [You, Mengling; Xia, Xiaobo; Li, Haibo; Rong, Rong; Zeng, Zhou; Wu, Wenyi; Ji, Dan] Hunan Key Lab Ophthalmol, Changsha, Peoples R China; [Wu, Jiayu] Cent South Univ, Sch Life Sci, Changsha, Peoples R China; [Xiong, Kun; Huang, Jufang] Cent South Univ, Sch Basic Med Sci, Dept Anat & Neurobiol, Changsha, Peoples R China; [Tang, Luosheng] Cent South Univ, Xiangya Hosp 2, Dept Ophthalmol, Changsha, Peoples R China; [Lei, Hetian] Shenzhen Eye Hosp, Shenzhen Eye Inst, Shenzhen, Peoples R China	Central South University; Central South University; Central South University; Central South University	Wu, WY; Ji, D (corresponding author), Cent South Univ, Xiangya Hosp, Dept Ophthalmol, Changsha, Peoples R China.	15200811001@163.com; 475393400@qq.com	曾, 茁桐/HCI-1998-2022	Ji, Dan/0000-0001-5901-3672; Lei, Hetian/0000-0003-4091-1936; Xia, Xiaobo/0000-0003-1720-7860	National Natural Science Foundation of China [81900893, 81400442]; Science and Technology Plan Project of Hunan Province [2019RS2011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Plan Project of Hunan Province	This study was supported by the National Natural Science Foundation of China (81900893 to W.-Y.W; 81400442 to DJ) the Science and Technology Plan Project of Hunan Province (2019RS2011 to W.-YW).	ARCINIEGAS A, 1980, OPHTHALMOLOGICA, V180, P207, DOI 10.1159/000308975; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Bishop PN, 2000, PROG RETIN EYE RES, V19, P323, DOI 10.1016/S1350-9462(99)00016-6; Blackledge G, 2000, PROSTATE CANCER P D, V3, P296, DOI 10.1038/sj.pcan.4500488; Cantor AJ, 2018, P NATL ACAD SCI USA, V115, pE7303, DOI 10.1073/pnas.1803598115; Chen N, 2019, EXP EYE RES, V186, DOI 10.1016/j.exer.2019.107716; Cheng HW, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0495-3; Cui JY, 2018, LIFE SCI, V192, P293, DOI 10.1016/j.lfs.2017.11.007; Di Y, 2015, INT J MOL MED, V36, P1507, DOI 10.3892/ijmm.2015.2371; Diaz-Rodriguez E, 2005, FEBS LETT, V579, P4020, DOI 10.1016/j.febslet.2005.06.016; Fruman DA, 2017, CELL, V170, P605, DOI 10.1016/j.cell.2017.07.029; Gu QB, 2019, EUR J RADIOL, V118, P32, DOI 10.1016/j.ejrad.2019.06.025; Hammes HP, 2018, DIABETOLOGIA, V61, P29, DOI 10.1007/s00125-017-4435-8; Han HT, 2019, J BIOL CHEM, V294, P15408, DOI 10.1074/jbc.RA119.010130; Ho J, 2017, TRENDS MICROBIOL, V25, P942, DOI 10.1016/j.tim.2017.04.009; JACOBSON B, 1985, EXP EYE RES, V41, P581, DOI 10.1016/0014-4835(85)90031-4; Ju X, 2019, CLIN EXP PHARMACOL P, V46, P75, DOI 10.1111/1440-1681.13029; Kim MN, 2019, CANCER CHEMOTH PHARM, V84, P809, DOI 10.1007/s00280-019-03918-y; LaRusch GA, 2010, BLOOD, V115, P5111, DOI 10.1182/blood-2009-08-236430; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Li HL, 2017, EXPERT OPIN INV DRUG, V26, P1103, DOI 10.1080/13543784.2017.1369042; Liu ZP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00551-2; Luo J, 2013, DIABETES, V62, P2613, DOI 10.2337/db12-1093; Peng WJ, 2018, J ETHNOPHARMACOL, V224, P140, DOI 10.1016/j.jep.2018.05.039; Qing L, 2019, DRUG DES DEV THER, V13, P1437, DOI 10.2147/DDDT.S195090; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Saraswati S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-82; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Takeuchi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091849; Theocharis DA, 2008, CONNECT TISSUE RES, V49, P124, DOI 10.1080/03008200802148496; Wang QZ, 2019, MED SCI MONITOR, V25, P700, DOI 10.12659/MSM.911579; Xu Z, 2017, ONCOTARGET, V8, P32655, DOI 10.18632/oncotarget.15948; Zhang BK, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0400-0; Zhang JH, 2009, FASEB J, V23, P153, DOI 10.1096/fj.08-113860	35	3	3	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14799	14809		10.1096/fj.201902862RRR	http://dx.doi.org/10.1096/fj.201902862RRR		SEP 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32910506	Bronze			2022-12-26	WOS:000568313900001
J	Horino, M; Liu, SY; Lee, EY; Kawachi, I; Pabayo, R				Horino, Masako; Liu, Sze Yan; Lee, Eun-Young; Kawachi, Ichiro; Pabayo, Roman			State-level income inequality and the odds for meeting fruit and vegetable recommendations among US adults	PLOS ONE			English	Article							DIETARY QUALITY; HEALTH; RISK; MORTALITY; CONSUMPTION; STRESS; ASSOCIATIONS; BEHAVIORS; OBESITY; CHOICE	Background Previous research indicates that income inequality is associated with risk for mortality, self-rated health status, chronic conditions, and health behavior, such as physical activity. However, little is known about the relationship between income inequality and dietary intake, which is a major risk factor for common chronic diseases including heart disease, stroke, diabetes, and certain types of cancers. The objective of this study is to determine the association between US state income inequality and fruit and vegetable consumption among adults. Methods Cross-sectional data on 270,612 U.S. adults from the U.S. 2013 Behavioral Risk Factor Surveillance System was used. Fruit and vegetable consumption was assessed from the six-item fruit and vegetable frequency questionnaire, which is part of the Behavioral Risk Factor Surveillance System. Multilevel modeling was used to determine whether US state-level income inequality (measured by the z-transformation of the Gini coefficient) was associated with fruit and vegetable consumption adjusting for individual-level and state-level covariates. Results In comparison to men, women were more likely to consume fruits and vegetables >= 5 times daily, fruits >= 2 times daily, vegetables >= 3 times of daily, and less likely to consume fruit juice daily. Among both men and women, a standard deviation increase in Gini coefficient was associated with an increase in consuming fruit juice daily (OR = 1.07, 95% CI = 1.03, 1.11). However, among women, a standard deviation increase in Gini coefficient was associated with a decreased likelihood in meeting daily recommended levels of both fruits and vegetables (OR = 0.93; 0.87-0.99), fruits only (OR = 0.95; 95% CI, 0.92-0.99) and vegetables only (OR = 0.92; 95% CI, 0.89-0.96). Conclusions This study is one of the first to show the relationship between income inequality and fruit and vegetable consumption among U.S. adults empirically. Women's health is more likely to be detrimentally affected when living in a state with higher income inequality.	[Horino, Masako] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Horino, Masako] Univ Nevada, Sch Community Hlth Sci, Reno, NV 89557 USA; [Liu, Sze Yan] Montclair State Univ, Publ Hlth Dept, New York, NY USA; [Liu, Sze Yan] Weill Cornell Med Coll, New York, NY USA; [Lee, Eun-Young] Queens Univ Kingston, Sch Kinesiol & Hlth, Kingston, ON, Canada; [Lee, Eun-Young] Queens Univ Kingston, Dept Gender Studies, Kingston, ON, Canada; [Kawachi, Ichiro] Harvard TH Chan Sch Publ Hlth, Dept Social Behav Sci, Boston, MA USA; [Pabayo, Roman] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Nevada System of Higher Education (NSHE); University of Nevada Reno; Cornell University; Queens University - Canada; Queens University - Canada; Harvard University; Harvard T.H. Chan School of Public Health; University of Alberta	Pabayo, R (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	pabayo@ualberta.ca	Liu, Sze/ABB-4170-2021	Lee, Eun-Young/0000-0001-9580-8974; Pabayo, Roman/0000-0003-4018-4898	Canada Research Chairs Program, Government of Canada	Canada Research Chairs Program, Government of Canada	` Dr. Roman Pabayo is funded by the Canada Research Chairs Program, Government of Canada.	Andreyeva T, 2015, AM J PREV MED, V49, P594, DOI 10.1016/j.amepre.2015.04.035; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], 2007, HOUSEHOLD INCOME INE; [Anonymous], 2008, FEASIBILITY ASSESSIN; Auerbach BJ, 2018, PREV MED, V109, P8, DOI 10.1016/j.ypmed.2018.01.004; Barrington WE, 2014, J ACAD NUTR DIET, V114, P1791, DOI 10.1016/j.jand.2014.03.015; Black JL, 2008, NUTR REV, V66, P2, DOI 10.1111/j.1753-4887.2007.00001.x; Bleich SN, 2015, HEALTH AFFAIR, V34, P1813, DOI 10.1377/hlthaff.2015.0606; Centers for Disease Control and Prevention, 2016, BRFSS BEH RISK FACT; Coleman-Jensen A., 2014, HOUSEHOLD FOOD SECUR; De Maio FG, 2007, J EPIDEMIOL COMMUN H, V61, DOI 10.1136/jech.2006.052969; Denavas-Walt C, 2015, INCOME POVERTY US 20; Diez-Roux AV, 2000, SOC SCI MED, V50, P673, DOI 10.1016/S0277-9536(99)00320-2; Drewnowski A, 2015, NUTR J, V14, DOI 10.1186/1475-2891-14-3; Epel E, 2001, PSYCHONEUROENDOCRINO, V26, P37, DOI 10.1016/S0306-4530(00)00035-4; Herran OF, 2019, CAD SAUDE PUBLICA, V35, DOI [10.1590/0102-311X00031418, 10.1590/0102-311x00031418]; Fund WCR, 2007, FOOD NUTR PHYS ACT P; He FJ, 2006, LANCET, V367, P320, DOI 10.1016/S0140-6736(06)68069-0; Hong SA, 2012, EUR J CLIN NUTR, V66, P942, DOI 10.1038/ejcn.2012.39; Johnson JL, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-14; Kaplan GA, 1996, BRIT MED J, V312, P999; Kawachi I, 1999, SOC SCI MED, V48, P21, DOI 10.1016/S0277-9536(98)00286-X; Kawachi I, 1997, SOC SCI MED, V45, P1121, DOI 10.1016/S0277-9536(97)00044-0; Kawachi I, 1999, HEALTH SERV RES, V34, P215; Kennedy BP, 1996, BRIT MED J, V312, P1004, DOI 10.1136/bmj.312.7037.1004; Kim D, 2008, SOC SCI MED, V66, P1719, DOI 10.1016/j.socscimed.2007.12.030; Kondo N, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4471; Leung CW, 2012, AM J CLIN NUTR, V96, P977, DOI 10.3945/ajcn.112.040014; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; Montonen J, 2004, DIABETES CARE, V27, P362, DOI 10.2337/diacare.27.2.362; Moore LV, 2015, AM J EPIDEMIOL, V181, P979, DOI 10.1093/aje/kwu461; Muraki I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5001; O'Connor DB, 2008, HEALTH PSYCHOL, V27, pS20, DOI 10.1037/0278-6133.27.1.S20; Oliver G, 2000, PSYCHOSOM MED, V62, P853, DOI 10.1097/00006842-200011000-00016; Otero G, 2015, SOC SCI MED, V142, P47, DOI 10.1016/j.socscimed.2015.08.005; Pabayo R, 2015, INT J PUBLIC HEALTH, V60, P573, DOI 10.1007/s00038-015-0678-7; Pabayo R, 2014, J EPIDEMIOL COMMUN H, V68, P110, DOI 10.1136/jech-2013-203093; Pickett KE, 2005, J EPIDEMIOL COMMUN H, V59, P670, DOI 10.1136/jech.2004.028795; Purves RS, 2007, INT J GEOGR INF SCI, V21, P717, DOI 10.1080/13658810601169840; Rasmussen M, 2018, PUBLIC HEALTH NUTR, V21, P1649, DOI 10.1017/S136898001800040X; Raudenbush SW, 2002, ADV QUANTITATIVE TEC; SERDULA M, 1993, EPIDEMIOLOGY, V4, P455, DOI 10.1097/00001648-199309000-00012; SmithWarner SA, 1997, EPIDEMIOLOGY, V8, P196, DOI 10.1097/00001648-199703000-00013; Stafford M, 2005, SOC SCI MED, V60, P1681, DOI 10.1016/j.socscimed.2004.08.028; Subramanian SV, 2006, HEALTH PLACE, V12, P141, DOI 10.1016/j.healthplace.2004.11.001; Subramanian SV, 2004, EPIDEMIOL REV, V26, P78, DOI 10.1093/epirev/mxh003; Thompson F. E., 2001, Nutrition in the prevention and treatment of disease, P3, DOI 10.1016/B978-012193155-1/50003-9; US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM 2010; Ward BW, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130389; West C, 1987, GENDER SOC, V1, P125, DOI 10.1177/0891243287001002002; Wilkinson R., 2009, SPIRIT LEVEL	52	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2020	15	9							e0238577	10.1371/journal.pone.0238577	http://dx.doi.org/10.1371/journal.pone.0238577			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR4MY	32903265	gold, Green Published			2022-12-26	WOS:000571539500006
J	Lin, SX; Matsakas, L; Zhao, XY; Sun, YP; Liu, H; Shang, MY; Gong, JY; Ma, QQ; Piao, GC; Yuan, HD				Lin, Shengxi; Matsakas, Leonidas; Zhao, Xiaoyan; Sun, Yunpeng; Liu, Huan; Shang, Mingyang; Gong, Jinyan; Ma, Qianqian; Piao, Guangchun; Yuan, Haidan			Inhibitory effects of compounds from the roots ofPotentilla longifoliaon lipid accumulation	PLOS ONE			English	Article							DISEASES; AMPK	Potentilla longifoliais a kind of Chaoyao medicine, which is a branch of traditional Chinese medicine. The plant is often referred to asganyancaoorganyearmcao, which means that it has a significant therapeutic effect on liver inflammation. In previous experiments, we found that a water extract ofganyearmcaoinhibited lipid accumulation. In the present study, we isolated one new (ganyearmcaoone A,1) and eight known compounds (2-9) from a water extract of the dried roots ofganyearmcao; all of the compounds were isolated for the first time from this medicinal plant. We elucidated the chemical structures of these compounds using comprehensive analyses of HR-ESI-MS and 1D, 2D NMR. We evaluated the inhibitory effects of the nine compounds on lipid accumulation in 3T3-L1 cells; we did so using photographic and quantitative assessments of the lipid content with oil red O staining and by measuring triglyceride levels. Compared with the control, compounds6and9significantly inhibited differentiation of 3T3-L1 cells and lipid accumulation. Compound1showed potential inhibitory effects on lipid accumulation. Molecular docking results indicated that compounds6and9may efficiently bind to AMPK and its downstream kinase (SCD1), thereby inhibiting lipid accumulation. Our results demonstrate thatganyearmcaoand its components may play an important role in treating diseases related to lipid accumulation in the future.	[Lin, Shengxi; Matsakas, Leonidas; Zhao, Xiaoyan; Sun, Yunpeng; Liu, Huan; Shang, Mingyang; Gong, Jinyan; Ma, Qianqian; Piao, Guangchun; Yuan, Haidan] Yanbian Univ, Coll Pharm, Yanji, Jilin, Peoples R China; [Piao, Guangchun; Yuan, Haidan] Yanbian Univ, Key Lab Nat Resources Changbai Mt & Funct Mol, Minist Educ, Yanji, Jilin, Peoples R China	Yanbian University; Yanbian University	Piao, GC; Yuan, HD (corresponding author), Yanbian Univ, Coll Pharm, Yanji, Jilin, Peoples R China.; Piao, GC; Yuan, HD (corresponding author), Yanbian Univ, Key Lab Nat Resources Changbai Mt & Funct Mol, Minist Educ, Yanji, Jilin, Peoples R China.	gcpiao@ybu.edu.cn; hdyuan@ybu.edu.cn		Guangchun, Piao/0000-0001-8181-1507	National Natural Science Foundation of China [81560698, 81660614]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by research grants (No. 81560698 and 81660614) from the National Natural Science Foundation of China. There was no additional external funding received for this study.	[Anonymous], 2016, Aesthet Surg J, V36 Suppl 1, P1, DOI 10.1093/asj/36.Supplement_1.1; [Anonymous], 2019, JMIR PUBLIC HLTH SUR, V4, pe53, DOI 10.2196/publichealth.9932; Appolinario JC, 2004, CNS DRUGS, V18, P629, DOI 10.2165/00023210-200418100-00002; Azevedo LS, 2012, CURR BIOINFORM, V7, P352; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Drew L, 2017, NATURE, V550, pS102, DOI 10.1038/550S102a; Gan CC, 2017, EUR J PHARMACOL, V797, P45, DOI 10.1016/j.ejphar.2017.01.009; Gonzalez-Castejon M, 2011, PHARMACOL RES, V64, P438, DOI 10.1016/j.phrs.2011.07.004; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Ha JH, 2016, INT J MOL MED, V37, P816, DOI 10.3892/ijmm.2016.2484; Hamilton GR, 2000, CAN J ANAESTH, V47, P367, DOI 10.1007/BF03020955; Ideta T, 2015, INT J MOL SCI, V16, P29207, DOI 10.3390/ijms161226156; Jeong Choon Sik, 2015, Natural Product Sciences, V21, P147; Kajita K, 2012, ENDOCR J, V59, P1107, DOI 10.1507/endocrj.EJ12-0259; Kim DJ, 2011, DIABETES METAB J, V35, P303, DOI 10.4093/dmj.2011.35.4.303; Li YQ, 2019, BIOORG CHEM, V85, P357, DOI 10.1016/j.bioorg.2019.01.013; [罗禹 Luo Yu], 2003, [天然产物研究与开发, Natural Product R & D], V15, P502; Ma QQ, 2018, J AGR FOOD CHEM, V66, P12931, DOI 10.1021/acs.jafc.8b04683; Miao Qing, 2008, Academic Journal of Second Military Medical University, V29, P1366; Moseti D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010124; Pacheco AG, 2009, MOLECULES, V14, P1245, DOI 10.3390/molecules14031245; Piao MJ, 2012, YANBIAN PEOPLES PUBL, V8, P194; Randau KP, 2009, PHARMAZIE, V64, P350, DOI 10.1691/ph.2009.7592; Roy Nabarun, 2016, Asian Pac J Cancer Prev, V17, P4019; Ruiz-Vasquez L, 2015, PHYTOCHEMISTRY, V117, P245, DOI 10.1016/j.phytochem.2015.06.019; Shiu WKP, 2006, PHYTOCHEMISTRY, V67, P2568, DOI 10.1016/j.phytochem.2006.09.037; SS V et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, 2020, CIRCULATION, V2020, pe1; Sun JF, 1996, CHIN J FOLK MED, V19, P5; Wada K, 2007, J PHARMACOL SCI, V105, P133, DOI 10.1254/jphs.FM0070034; Yuan HD, 2012, J GINSENG RES, V36, P27, DOI 10.5142/jgr.2012.36.1.27; Yuan HD, 2016, MOLECULES, V21, DOI 10.3390/molecules21050559; Yuriev E, 2015, J MOL RECOGNIT, V28, P581, DOI 10.1002/jmr.2471; 马瑜, 2006, [中草药, Chinese Traditional and Herbal Drugs], V37, P1315	33	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2020	15	9							e0238917	10.1371/journal.pone.0238917	http://dx.doi.org/10.1371/journal.pone.0238917			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR4MY	32903285	gold, Green Published			2022-12-26	WOS:000571539500003
J	Banda, M; McKim, KL; Myers, MB; Inoue, M; Parsons, BL				Banda, Malathi; McKim, Karen L.; Myers, Meagan B.; Inoue, Masahiro; Parsons, Barbara L.			Outgrowth of erlotinib-resistant subpopulations recapitulated in patient-derived lung tumor spheroids and organoids	PLOS ONE			English	Article							EGFR TARGETED THERAPY; ACQUIRED-RESISTANCE; CANCER CELLS; MUTATIONS; KRAS; QUANTIFICATION; MECHANISMS; INHIBITORS; CULTURE; PIK3CA	A model that recapitulates development of acquired therapeutic resistance is needed to improve oncology drug development and patient outcomes. To achieve this end, we established methods for the preparation and growth of spheroids from primary human lung adenocarcinomas, including methods to culture, passage, monitor growth, and evaluate changes in mutational profile over time. Primary lung tumor spheroids were cultured in Matrigel(R)with varying concentrations of erlotinib, a small molecule kinase inhibitor of epidermal growth factor receptor (EGFR) that is ineffective againstKRASmutant cells. Subtle changes in spheroid size and number were observed within the first two weeks of culture. Spheroids were cultured for up to 24 weeks, during which time interactions between different cell types, movement, and assembly into heterogeneous organoid structures were documented. Allele-specific competitive blocker PCR (ACB-PCR) was used to quantify low frequencyBRAFV600E,KRASG12D,KRASG12V, andPIK3CAH1047R mutant subpopulations in tumor tissue residue (TR) samples and cultured spheroids. Mutant subpopulations, including multiple mutant subpopulations, were quite prevalent. Twelve examples of mutant enrichment were found in eight of the 14 tumors analyzed, based on the criteria that a statistically-significant increase in mutant fraction was observed relative to both the TR and the no-erlotinib control. Of the mutants quantified in erlotinib-treated cultures,PIK3CAH1047 mutant subpopulations increased most often (5/14 tumors), which is consistent with clinical observations. Thus, this ex vivo lung tumor spheroid model replicates the cellular and mutational tumor heterogeneity of human lung adenocarcinomas and can be used to assess the outgrowth of mutant subpopulations. Spheroid cultures with characterized mutant subpopulations could be used to investigate the efficacy of lung cancer combination therapies.	[Banda, Malathi; McKim, Karen L.; Myers, Meagan B.; Parsons, Barbara L.] US FDA, Div Genet & Mol Toxicol, Natl Ctr Toxicol Res, Jefferson, AR 20857 USA; [Inoue, Masahiro] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan; [Banda, Malathi] Covance Inc, Indianapolis, IN USA; [Inoue, Masahiro] Kyoto Univ, Dept Clin Bioresource Res & Dev Med Pharm Collabo, Kyoto, Japan	US Food & Drug Administration (FDA); Osaka Medical Center for Cancer & Cardiovascular Diseases; Covance; Kyoto University	Parsons, BL (corresponding author), US FDA, Div Genet & Mol Toxicol, Natl Ctr Toxicol Res, Jefferson, AR 20857 USA.	barbara.parsons@fda.hhs.gov		Myers, Meagan/0000-0001-5404-578X; Parsons, Barbara/0000-0002-3005-2552	National Cancer Institute	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported in part by an appointment (M.B.) to the ORISE Research Participation Program at the NCTR, U.S. FDA, administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and FDA/NCTR. Some breast and lung tissue samples were provided by the Cooperative Human Tissue Network, which is funded by the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, NAT REV GENET, V19, P1, DOI 10.1038/nrg.2017.141; [Anonymous], 2017, RUMIYAH 3       0106, V5, P8; Bartholomew C, 2017, RESPIR MED CASE REP, V20, P137, DOI 10.1016/j.rmcr.2017.01.016; Belchis DA, 2016, ONCOTARGET, V7, P45237, DOI 10.18632/oncotarget.9931; BHIVA/ BASHH, 2019, HIV MED S2, V20, ps2; Cantrell MA, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0158-y; Cardona AF, 2017, TARGET ONCOL, V12, P513, DOI 10.1007/s11523-017-0497-2; Chan BA, 2015, TRANSL LUNG CANCER R, V4, P36, DOI 10.3978/j.issn.2218-6751.2014.05.01; Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Endo H, 2013, J THORAC ONCOL, V8, P131, DOI 10.1097/JTO.0b013e3182779ccf; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Giopanou I, 2020, CRIT REV ONCOL HEMAT, V146, DOI 10.1016/j.critrevonc.2019.102859; Grassberger C, 2019, CANCER RES, V79, P3776, DOI 10.1158/0008-5472.CAN-18-3652; Harris KL, ENV HLTH PERSPECTIVE; Harrison PT, 2020, SEMIN CANCER BIOL, V61, P167, DOI 10.1016/j.semcancer.2019.09.015; Harrison PT, 2018, ESSAYS BIOCHEM, V62, P583, DOI 10.1042/EBC20180016; Jin MZ, 2018, CANCER LETT, V414, P174, DOI 10.1016/j.canlet.2017.11.021; Kondo J, 2011, GASTROENTEROLOGY, V140, pS339; Matsumoto S, 2020, BMC INT HEALTH HUM R, V20, DOI 10.1186/s12914-019-0221-7; McCubrey JA, 2012, ONCOTARGET, V3, P1068, DOI 10.18632/oncotarget.659; Metro G, 2018, TRANSL LUNG CANCER R, V7, pS142, DOI 10.21037/tlcr.2018.03.11; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Mokhtari RB, 2017, ONCOTARGET, V8, P38022, DOI 10.18632/oncotarget.16723; Myers MB, 2020, MOL TOXICOLOGY PROTO, V2102; Myers MB, 2016, NEOPLASIA, V18, P253, DOI 10.1016/j.neo.2016.03.002; Myers MB, 2015, PERS MED, V12, P83, DOI 10.2217/PME.14.69; Neel DS, 2017, NPJ PRECIS ONCOL, V1, DOI 10.1038/s41698-017-0007-0; Okamoto I, 2018, LUNG CANCER, V117, P14, DOI 10.1016/j.lungcan.2018.01.005; Parsons BL, 2018, MUTAT RES-REV MUTAT, V777, P1, DOI 10.1016/j.mrrev.2018.05.001; Parsons BL, 2017, ENVIRON MOL MUTAGEN, V58, P466, DOI 10.1002/em.22110; Parsons BL, 2013, PERS MED, V10, P191, DOI 10.2217/PME.13.1; Parsons BL, 2010, CANCER INVEST, V28, P364, DOI 10.3109/07357901003630975; Saglam-Metiner P, 2019, GENE, V686, P203, DOI 10.1016/j.gene.2018.11.058; Salk JJ, 2018, NAT REV GENET, V19, P269, DOI 10.1038/nrg.2017.117; Schmitt MW, 2016, NAT REV CLIN ONCOL, V13, P335, DOI 10.1038/nrclinonc.2015.175; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Singh PK, 2017, LIFE SCI, V186, P25, DOI 10.1016/j.lfs.2017.08.001; Stewart EL, 2015, TRANSL LUNG CANCER R, V4, P67, DOI 10.3978/j.issn.2218-6751.2014.11.06; Tsimberidou AM, 2018, J CLIN ONCOLOGY S, V36; Vlachogiannis G, 2018, SCIENCE, V359, P920, DOI 10.1126/science.aao2774	41	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238862	10.1371/journal.pone.0238862	http://dx.doi.org/10.1371/journal.pone.0238862			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ6EE	32898185	Green Published, gold			2022-12-26	WOS:000570962500047
J	Centner, FS; Schoettler, JJ; Fairley, AM; Lindner, HA; Schneider-Lindner, V; Weiss, C; Thiel, M; Hagmann, M				Centner, Franz-Simon; Schoettler, Jochen J.; Fairley, Anna-Meagan; Lindner, Holger A.; Schneider-Lindner, Verena; Weiss, Christel; Thiel, Manfred; Hagmann, Michael			Impact of different consensus definition criteria on sepsis diagnosis in a cohort of critically ill patients-Insights from a new mathematical probabilistic approach to mortality-based validation of sepsis criteria	PLOS ONE			English	Article							INFLAMMATORY RESPONSE SYNDROME; ORGAN FAILURE ASSESSMENT; INTENSIVE-CARE UNITS; SEPTIC SHOCK; SOFA SCORE; CLINICAL-CRITERIA; INFECTION; ACCURACY; SIRS; DYSFUNCTION/FAILURE	Background Sepsis-3 definition uses SOFA score to discriminate sepsis from uncomplicated infection, replacing SIRS criteria that were criticized for being inaccurate. Eligibility of sepsis-3 criteria for sepsis diagnosis and the applied validation methodology using mortality as endpoint are topic of ongoing debate. We assessed the impact of different criteria on sepsis diagnosis in our ICU and devised a mathematical approach for mortality-based validation of sepsis criteria. As infectious status is often unclear at clinical deterioration, we integrated non-infected patients into analysis. Methods Suspected infection, SOFA and SIRS were captured for an ICU cohort of a university center over one year. For raw scores (SIRS/SOFA) and sepsis criteria (SIRS >= 2/SOFA >= 2/SOFA_change >= 2) frequencies and associations with in-hospital mortality were assessed. Using a mathematical approach, we estimated the correlation between sepsis and in-hospital mortality serving as reference for evaluation of observed mortality correlations of sepsis criteria. Results Of 791 patients, 369 (47%) were infected and 422 (53%) non-infected, with an in-hospital mortality of 39% and 15%. SIRS >= 2 indicated sepsis in 90% of infected patients, SOFA >= 2 in 99% and SOFA_change >= 2 in 77%. In non-infected patients, SIRS, SOFA and SOFA_change were >= 2 in 78%, 88% and 58%. In AUROC analyses neither SOFA nor SIRS displayed superior mortality discrimination in infected compared to non-infected patients. The mathematically estimated correlation of sepsis and in-hospital mortality was 0.10 in infected and 0 in non-infected patients. Among sepsis criteria, solely SIRS >= 2 agreed with expected correlations in both subgroups (infected: r = 0.19; non-infected: r = 0.02). Conclusions SOFA >= 2 yielded a more liberal sepsis diagnosis than SIRS >= 2. None of the criteria showed an infection specific occurrence that would be essential for reliable sepsis detection. However, SIRS >= 2 matched the mortality association pattern of a valid sepsis criterion, whereas SOFA-based criteria did not. With this study, we establish a mathematical approach to mortality-based evaluation of sepsis criteria.	[Centner, Franz-Simon; Schoettler, Jochen J.; Fairley, Anna-Meagan; Lindner, Holger A.; Schneider-Lindner, Verena; Thiel, Manfred] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Anaesthesiol & Surg Intens Care Med, Med Fac Mannheim, Mannheim, Germany; [Schneider-Lindner, Verena] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Weiss, Christel] Heidelberg Univ, Dept Biomed Informat, Med Fac Mannheim, Heinrich Lanz Ctr, Mannheim, Germany; [Hagmann, Michael] Heidelberg Univ, Interdisciplinary Ctr Sci Comp, Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Manitoba; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Centner, FS (corresponding author), Heidelberg Univ, Univ Med Ctr Mannheim, Dept Anaesthesiol & Surg Intens Care Med, Med Fac Mannheim, Mannheim, Germany.	Franz-Simon.Centner@umm.de	Schneider-Lindner, Verena/J-6738-2014; Lindner, Holger A/C-5106-2014	Lindner, Holger A/0000-0002-6679-4355; Centner, Franz-Simon/0000-0002-7455-1361	Klaus Tschira Foundation [00.277.2015]	Klaus Tschira Foundation	This work was supported by the Klaus Tschira Foundation (grant number: 00.277.2015; website: https://www.klaus-tschira-stiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand V, 2019, CHEST, V156, P289, DOI 10.1016/j.chest.2019.03.032; Angus DC, 2016, CRIT CARE MED, V44, pE113, DOI 10.1097/CCM.0000000000001730; [Anonymous], 2017, MISCELLANEA, V38, P1, DOI DOI 10.3760/cma.j.issn.0253-2727.2017.01.001; Berry M, 2017, DRUGS, V77, P353, DOI 10.1007/s40265-017-0698-0; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Cheng BL, 2017, SHOCK, V48, P301, DOI 10.1097/SHK.0000000000000868; Churpek MM, 2017, CRIT CARE MED, V45, P1805, DOI 10.1097/CCM.0000000000002648; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Cortes-Poch I, 2016, AM J RESP CRIT CARE, V194, P16, DOI 10.1164/rccm.201604-0734ED; Costa RT, 2018, J CRIT CARE, V45, P52, DOI 10.1016/j.jcrc.2017.12.024; Deutschman CS, 2017, CRIT CARE MED, V45, P739, DOI 10.1097/CCM.0000000000002248; Estenssoro E, 2018, CRIT CARE MED, V46, P1276, DOI 10.1097/CCM.0000000000003208; Fang XL, 2018, CHEST, V153, P1169, DOI 10.1016/j.chest.2017.06.037; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Ferrer R, 2014, CRIT CARE MED, V42, P1749, DOI 10.1097/CCM.0000000000000330; Fullerton JN, 2017, CRIT CARE RESUSC, V19, P9; Giamarellos-Bourboulis EJ, 2017, CLIN MICROBIOL INFEC, V23, P104, DOI 10.1016/j.cmi.2016.11.003; Gilbert DN, 2018, CLIN INFECT DIS, V66, P1631; Gucyetmez B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148699; Hammond DA, 2017, CLIN INFECT DIS, V64, P666, DOI 10.1093/cid/ciw811; Hotchkiss RS, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.45; Hranjec T, 2012, LANCET INFECT DIS, V12, P774, DOI 10.1016/S1473-3099(12)70151-2; Kalil AC, 2018, CLIN INFECT DIS, V68, P1432; Kaukonen KM, 2015, NEW ENGL J MED, V372, P1629, DOI 10.1056/NEJMoa1415236; Klompas M, 2018, JAMA-J AM MED ASSOC, V320, P1433, DOI 10.1001/jama.2018.12179; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Levy MM, 2012, LANCET INFECT DIS, V12, P919, DOI 10.1016/S1473-3099(12)70239-6; Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Ljungstrom L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225700; Makam AN, 2016, JAMA-J AM MED ASSOC, V316, P453, DOI 10.1001/jama.2016.6407; Minne L, 2008, CRIT CARE, V12, DOI 10.1186/cc7160; Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931; R Core Team, 2021, R LANGUAGE ENV STAT; Raith EP, 2017, JAMA-J AM MED ASSOC, V317, P290, DOI 10.1001/jama.2016.20328; Ratzinger F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082946; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Roger PM, 2019, CLIN INFECT DIS, V69, P466, DOI 10.1093/cid/ciy921; Rothman KJ, 2008, MODERN EPIDEMIOLOGY; Schmoch T, 2017, ANAESTHESIST, V66, P614, DOI 10.1007/s00101-017-0316-2; Schneider-Lindner V, 2016, JAMA-J AM MED ASSOC, V316, P457, DOI 10.1001/jama.2016.6380; SepNet Critical Care Trials Grp, 2016, INTENS CARE MED, V42, P1980, DOI 10.1007/s00134-016-4504-3; Seymour CW, 2016, CRIT CARE MED, V44, pE122, DOI 10.1097/CCM.0000000000001724; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Shankar-Hari M, 2017, BRIT J ANAESTH, V119, P626, DOI 10.1093/bja/aex234; Shankar-Hari M, 2016, CRIT CARE MED, V44, P2223, DOI 10.1097/CCM.0000000000001876; Simpson SQ, 2018, CHEST, V153, P34, DOI 10.1016/j.chest.2017.10.006; Simpson SQ, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.01.06; Simpson SQ, 2016, CHEST, V149, P1117, DOI 10.1016/j.chest.2016.02.653; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sprung CL, 2017, CRIT CARE MED, V45, P736, DOI 10.1097/CCM.0000000000002156; Verboom DM, 2019, J INTENSIVE CARE, V7, DOI 10.1186/s40560-019-0400-6; Vincent JL, 2013, LANCET, V381, P774, DOI 10.1016/S0140-6736(12)61815-7; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Vrbik J, 2005, COMPUTATION STAT, V20, P611, DOI 10.1007/BF02741318; Williams JM, 2017, CHEST, V151, P586, DOI 10.1016/j.chest.2016.10.057; Wu FW, 2018, J CRIT CARE, V47, P350, DOI 10.1016/j.jcrc.2018.07.015; Yoon J, 2018, CRIT CARE MED, V46, pE656, DOI 10.1097/CCM.0000000000003144	60	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238548	10.1371/journal.pone.0238548	http://dx.doi.org/10.1371/journal.pone.0238548			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ6EE	32898161	gold, Green Published			2022-12-26	WOS:000570962500027
J	Barbarossa, MV; Fuhrmann, J; Meinke, JH; Krieg, S; Varma, HV; Castelletti, N; Lippert, T				Barbarossa, Maria Vittoria; Fuhrmann, Jan; Meinke, Jan H.; Krieg, Stefan; Varma, Hridya Vinod; Castelletti, Noemi; Lippert, Thomas			Modeling the spread of COVID-19 in Germany: Early assessment and possible scenarios	PLOS ONE			English	Article							CORONAVIRUS; TRANSMISSION; WUHAN	The novel coronavirus (SARS-CoV-2), identified in China at the end of December 2019 and causing the disease COVID-19, has meanwhile led to outbreaks all over the globe with about 2.2 million confirmed cases and more than 150,000 deaths as of April 17, 2020. In this work, mathematical models are used to reproduce data of the early evolution of the COVID-19 outbreak in Germany, taking into account the effect of actual and hypothetical non-pharmaceutical interventions. Systems of differential equations of SEIR type are extended to account for undetected infections, stages of infection, and age groups. The models are calibrated on data until April 5. Data from April 6 to 14 are used for model validation. We simulate different possible strategies for the mitigation of the current outbreak, slowing down the spread of the virus and thus reducing the peak in daily diagnosed cases, the demand for hospitalization or intensive care units admissions, and eventually the number of fatalities. Our results suggest that a partial (and gradual) lifting of introduced control measures could soon be possible if accompanied by further increased testing activity, strict isolation of detected cases, and reduced contact to risk groups.	[Barbarossa, Maria Vittoria; Fuhrmann, Jan; Lippert, Thomas] Frankfurt Inst Adv Studies, Frankfurt, Germany; [Fuhrmann, Jan; Meinke, Jan H.; Krieg, Stefan; Lippert, Thomas] Forschungszentrum Julich, Julich Supercomp Ctr, Julich, Germany; [Barbarossa, Maria Vittoria; Varma, Hridya Vinod] Heidelberg Univ, Interdisciplinary Ctr Sci Comp, Heidelberg, Germany; [Castelletti, Noemi] Helmholtz Zentrum Munchen, Inst Radiat Med, Neuherberg, Germany; [Castelletti, Noemi] Ludwig Maximilians Univ Munchen, Stat Consulting Unit StaBLab, Munich, Germany; [Lippert, Thomas] Goethe Univ Frankfurt, Dept Math & Comp Sci, Frankfurt, Germany	Helmholtz Association; Research Center Julich; Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Goethe University Frankfurt	Barbarossa, MV (corresponding author), Frankfurt Inst Adv Studies, Frankfurt, Germany.; Barbarossa, MV (corresponding author), Heidelberg Univ, Interdisciplinary Ctr Sci Comp, Heidelberg, Germany.	barbarossa@fias.uni-frankfurt.de	Barbarossa, Maria Vittoria/AAE-8224-2021; Barbarossa, Maria Vittoria/AAC-7437-2021	Fuhrmann, Jan/0000-0002-7091-3740	LOEWE focus Center for Multiscale Modelling in Life Sciences (CMMS)	LOEWE focus Center for Multiscale Modelling in Life Sciences (CMMS)	Forschungszentrum Julich (FZJ) GmbH provided support in the form of salaries for JF, JHM, SK, and ThL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. The work of MVB was partially supported by the LOEWE focus Center for Multiscale Modelling in Life Sciences (CMMS). There was no additional external funding received for this study.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allen Linda J S, 2017, Infect Dis Model, V2, P128, DOI 10.1016/j.idm.2017.03.001; an der Heiden M, 2020, MODELLIERUNG BEISPIE; an der Heiden M, 2020, SCHATZUNG AKTUELLEN; Anastassopoulou C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230405; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Barbarossa M.V., 2020, MEDRV, DOI DOI 10.1101/2020.04.08.20056630; Boldog P, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020571; Branch MA, 1999, SIAM J SCI COMPUT, V21, P1, DOI 10.1137/S1064827595289108; Brauer F., 2019, MATH MODELS EPIDEMIO; Cowling BJ, 2020, LANCET PUBLIC HEALTH, V5, pE279, DOI 10.1016/S2468-2667(20)30090-6; Dehning J, 2020, SCIENCE, V369, P160, DOI 10.1126/science.abb9789; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; ECDC, 2020, TRANSM COVID 19; EpiCentro, 2020, CAR PAZ DEC POS COVI; EpiCentro Epidemia, 2020, EP COVID 19 AGG NAZ; Fuhrmann J, 2020, ARCH PUBLIC HEALTH, V78, DOI 10.1186/s13690-020-00445-8; Giordano G, 2020, NAT MED, V26, P855, DOI 10.1038/s41591-020-0883-7; HE X, 2020, NAT MED, V26, P672, DOI DOI 10.1038/S41591-020-0869-5; Herman J, 2017, SALIB OPEN SOURCE PY; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Imperial College COVID-19 Response Team, 2020, IMP NONPH INT NPIS R; Jackson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097297; Jung SM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020523; Khailaie S, ESTIMATE DEV EPIDEMI; Kochaczyk M, 2020, MATH MODEL NAT PHENO, V15; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Maier BF, 2020, SCIENCE, V368, P742, DOI 10.1126/science.abb4557; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058; RKI Coronavirus SARS-CoV-2-dedicated homepage of the Robert Koch-Institute, 2020, COR SARS COV 2 DED H; RKI Erfassung der SARS-CoV-2-Testzahlen in Deutschland, 2020, EP BULL; RKI Table with the current COVID-19 infections per day (time series) from the Robert Koch-Institute, 2020, TABL CURR COVID 19 I; Robert-Koch-Institut, 2020, SARS COV 2 STECKBR C; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Saltelli A., 2008, GLOBAL SENSITIVITY A; SHEN M, 2020, BIORXIV, DOI [10.1101/2020.01.23.916726, DOI 10.1101/2020.01.23.916726]; Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6; Tang B, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020462; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; WHO, 2020, STAT OLD PEOPL AR HI; WHO, 2020, 73 WHO; WHO, 2020, MOD TRANSM VIR CAUS; Wiestler OD, 2020, STELLUNGNAHME HELMHO; Wu JY, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1018; Zhang B, 2020, IMMUNE PHENOTYPING B; Zimmermann P, 2020, PEDIATR INFECT DIS J, V39, P355, DOI 10.1097/INF.0000000000002660	48	31	31	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238559	10.1371/journal.pone.0238559	http://dx.doi.org/10.1371/journal.pone.0238559			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886696	Green Published, gold			2022-12-26	WOS:000571064300005
J	Nguyen, AD; Malmstrom, TK; Niehoff, ML; Aziz, A; Miller, DK; Morley, JE				Nguyen, Andrew D.; Malmstrom, Theodore K.; Niehoff, Michael L.; Aziz, Asef; Miller, Douglas K.; Morley, John E.			Serum progranulin levels are associated with frailty in middle-aged individuals	PLOS ONE			English	Article							GP88 PROGRANULIN; LYSOSOMAL BIOGENESIS; MUTATIONS; PLASMA; BIOMARKER; IDENTIFICATION; FRUCTOSAMINE; SARCOPENIA; INJURY	Background and objective A recent study identified progranulin as a candidate biomarker for frailty, based on gene expression databases. In the present study, we investigated associations between serum progranulin levels and frailty in a population-based sample of late middle-age and older adults. Methods We utilized a cohort study that included 358 African Americans (baseline ages 49-65). Frailty was assessed by three established methods: the interview-based FRAIL scale, the Cardiovascular Health Study (CHS) frailty scale that includes performance-based measurements, and the Frailty Index (FI) that is based on cumulative deficits. Serum levels of the following proteins and metabolites were measured: progranulin, cystatin C, fructosamine, soluble cytokine receptors (interleukin-2 and -6, tumor necrosis factor alpha-1 and -2), and C-reactive protein. Sarcopenia was assessed using the SARC-F index. Vital status was determined by matching through the National Death Index (NDI). Results Serum progranulin levels were associated with frailty for all indices (FRAIL, CHS, and FI) but not with sarcopenia. Inflammatory markers indicated by soluble cytokine receptors (sIL-2R, sIL-6R, sTNFR1, sTNFR2) were positively associated serum progranulin. Increased serum progranulin levels at baseline predicted poorer outcomes including future frailty as measured by the FRAIL scale and 15-year all-cause mortality independent of age, gender, and frailty. Conclusions Our findings suggest that serum progranulin levels may be a candidate biomarker for physical frailty, independent of sarcopenia. Further studies are needed to validate this association and assess the utility of serum progranulin levels as a potential biomarker for prevalent frailty, for risk for developing incident frailty, and for mortality risk over and above the effect of baseline frailty.	[Nguyen, Andrew D.; Niehoff, Michael L.; Aziz, Asef; Morley, John E.] St Louis Univ, Sch Med, Dept Internal Med, Div Geriatr Med, St Louis, MO 63104 USA; [Nguyen, Andrew D.] St Louis Univ, Dept Pharmacol & Physiol, Sch Med, St Louis, MO 63104 USA; [Nguyen, Andrew D.; Malmstrom, Theodore K.] St Louis Univ, Henry & Amelia Nasrallah Ctr Neurosci, St Louis, MO 63103 USA; [Malmstrom, Theodore K.] St Louis Univ, Sch Med, Dept Psychiat & Behav Neurosci, St Louis, MO USA; [Niehoff, Michael L.] Vet Affairs Med Ctr, St Louis, MO USA; [Miller, Douglas K.] Regenstrief Inst Inc, Indianapolis, IN USA	Saint Louis University; Saint Louis University; Saint Louis University; Saint Louis University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc	Nguyen, AD; Morley, JE (corresponding author), St Louis Univ, Sch Med, Dept Internal Med, Div Geriatr Med, St Louis, MO 63104 USA.; Nguyen, AD (corresponding author), St Louis Univ, Dept Pharmacol & Physiol, Sch Med, St Louis, MO 63104 USA.	andy.d.nguyen@health.slu.edu; john.morley@health.slu.edu		Nguyen, Andrew/0000-0002-9492-9472	National Institute on Aging [R01 AG010436]; Saint Louis University	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Saint Louis University	This study was supported by a grant from the National Institute on Aging (R01 AG010436 to DKM) and by institutional funds from Saint Louis University (to ADN). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MR, 2016, NEUROBIOL AGING, V41, DOI 10.1016/j.neurobiolaging.2016.02.019; Alrneida MR, 2014, NEURODEGENER DIS, V13, P214, DOI 10.1159/000352022; [Anonymous], 2011, HARV MENT HEALTH LET, V27, P1; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Cardoso AL, 2018, AGEING RES REV, V47, P214, DOI 10.1016/j.arr.2018.07.004; Carecchio M, 2009, J NEUROL SCI, V287, P291, DOI 10.1016/j.jns.2009.07.011; Carmona-Gutierrez D, 2016, AGEING RES REV, V32, P2, DOI 10.1016/j.arr.2016.04.009; CEFALU WT, 1991, CLIN CHEM, V37, P1252; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Dibbs Z, 1999, J AM COLL CARDIOL, V33, P1935, DOI 10.1016/S0735-1097(99)00130-8; Edelman MJ, 2014, HUM PATHOL, V45, P1893, DOI 10.1016/j.humpath.2014.05.011; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Ghidoni R, 2008, NEUROLOGY, V71, P1235, DOI 10.1212/01.wnl.0000325058.10218.fc; Husain I, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1887; Kao AW, 2017, NAT REV NEUROSCI, V18, P325, DOI 10.1038/nrn.2017.36; Liccini AP, 2016, J AM MED DIR ASSOC, V17, P846, DOI 10.1016/j.jamda.2016.07.007; Malmstrom TK, 2016, J CACHEXIA SARCOPENI, V7, P28, DOI 10.1002/jcsm.12048; Malmstrom TK, 2014, J AM GERIATR SOC, V62, P721, DOI 10.1111/jgs.12735; Miller DK, 2005, J GERONTOL A-BIOL, V60, P207, DOI 10.1093/gerona/60.2.207; Miller DK, 2004, J AM GERIATR SOC, V52, P741, DOI 10.1111/j.1532-5415.2004.52211.x; Minami SS, 2014, NAT MED, V20, P1157, DOI 10.1038/nm.3672; NEGORO H, 1988, AM J MED, V85, P360, DOI 10.1016/0002-9343(88)90587-6; Nguyen AD, 2013, TRENDS ENDOCRIN MET, V24, P597, DOI 10.1016/j.tem.2013.08.003; Nicholson AM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11992; Nicholson AM, 2014, NEUROLOGY, V82, P1871, DOI 10.1212/WNL.0000000000000445; Nicoletto BB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165177; Perry DC, 2013, JAMA NEUROL, V70, P774, DOI 10.1001/2013.jamaneurol.393; Qiu F, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-88; Qu H, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/360190; Richter J, 2013, DIABETES CARE, V36, P410, DOI 10.2337/dc12-0220; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schofield EC, 2010, J ALZHEIMERS DIS, V22, P981, DOI 10.3233/JAD-2010-101032; Sleegers K, 2009, ANN NEUROL, V65, P603, DOI 10.1002/ana.21621; Smith KR, 2012, AM J HUM GENET, V90, P1102, DOI 10.1016/j.ajhg.2012.04.021; Tanaka A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4087; Tanaka Y, 2013, NEUROSCIENCE, V250, P8, DOI 10.1016/j.neuroscience.2013.06.049; Tkaczuk KR, 2011, BREAST CANCER-BASIC, V5, P155, DOI 10.4137/BCBCR.S7224; van Kan GA, 2008, J AM MED DIR ASSOC, V9, P71, DOI 10.1016/j.jamda.2007.11.005; Wilson D, 2017, AGEING RES REV, V36, P1, DOI 10.1016/j.arr.2017.01.006; Woo J, 2015, J AM MED DIR ASSOC, V16, P412, DOI 10.1016/j.jamda.2015.01.087; Woo J, 2012, J AM GERIATR SOC, V60, P1478, DOI 10.1111/j.1532-5415.2012.04074.x; Yamamoto Y, 2014, INFLAMMATION, V37, P1806, DOI 10.1007/s10753-014-9911-4; Yan WJ, 2016, J IMMUNOL, V197, P3393, DOI 10.4049/jimmunol.1600862; Youn BS, 2009, DIABETES, V58, P627, DOI 10.2337/db08-1147; Yu YA, 2016, J CELL MOL MED, V20, P506, DOI 10.1111/jcmm.12756	47	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238877	10.1371/journal.pone.0238877	http://dx.doi.org/10.1371/journal.pone.0238877			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ7QN	32886731	Green Published, gold			2022-12-26	WOS:000571064300012
J	Ren, JL; Zang, GY; Wang, SY; Shi, J; Wang, YY				Ren, Jiaolong; Zang, Guangyuan; Wang, Siyuan; Shi, Jun; Wang, Yuanyuan			Investigating the pavement performance and aging resistance of modified bio-asphalt with nano-particles	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; MODIFIED BITUMEN; NANOMATERIALS; BEHAVIOR; SILICA	Bio-asphalt binders have been proposed as replacements for traditional asphalt binders, owing to advantages such as environmental protection, low costs, and abundant resources. However, a limitation of bio-asphalt binders is that their high-temperature performance is not suitable for pavement construction. In recent years, nano-particles have been widely used to improve the pavement performance of asphalt binders, particularly the high-temperature performance. Thus, the nano-particles might also provide a positive modified effect on the high-temperature performance of bio-asphalt binders. Based on this, five types of nano-particles including SiO2, CaCO3, TiO2, Fe2O3, and ZnO are selected for the preparation of modified bio-asphalt binders, using different dosages of nano-particles and bio-oil. The high- and low-temperature performances, aging resistance, workable performance, and water stability of the nano-modified bio-asphalt binders and mixtures are investigated. The results reveal that, the high-temperature performance and aging resistance of the nano-modified bio-asphalt binders and mixtures are improved at increased nano-particle dosages, whereas their low-temperature performance is slightly weakened. The effects of the nano-particles on the workable performance and water stability are insignificant.	[Ren, Jiaolong; Zang, Guangyuan; Wang, Siyuan; Shi, Jun] Shandong Univ Technol, Sch Civil & Architectural Engn, Zibo, Shandong, Peoples R China; [Wang, Yuanyuan] Hubei Univ Arts & Sci, Sch Civil Engn & Architecture, Xiangyang, Hubei, Peoples R China	Shandong University of Technology; Hubei University of Arts & Science	Ren, JL; Shi, J (corresponding author), Shandong Univ Technol, Sch Civil & Architectural Engn, Zibo, Shandong, Peoples R China.	worjl@126.com; 120718651@qq.com	Ren, Jiaolong/ABC-7687-2021	Ren, Jiaolong/0000-0002-3500-7320	National Natural Science Foundation of China [51808084, 51808326]; National University Student Innovation Program of China [201910433060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National University Student Innovation Program of China	1. Jiaolong Ren: National Natural Science Foundation of China under grant 51808326. www.nsfc.gov.cn The funder provide the fund to support manuscript for publication. 2. Yuanyuan Wang: National Natural Science Foundation of China under grant 51808084. www.nsfc.gov.cn The funder provide the fund to support manuscript for publication. 3. Siyuan Wang: National University Student Innovation Program of China under grants 201910433060. http://www.moe.gov.cn/s78/A08/The funder provide the fund to support manuscript for publication.	[Anonymous], 2011, STANDARD TEST METHOD, P186; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; Azarhoosh AR, 2018, ROAD MATER PAVEMENT, V19, P353, DOI 10.1080/14680629.2016.1261724; Dhasmana H, 2015, TRANSPORT RES REC, P121, DOI 10.3141/2505-16; Fini EH, 2016, J MATER CIVIL ENG, V28, DOI 10.1061/(ASCE)MT.1943-5533.0001525; Firouzinia M, 2018, CONSTR BUILD MATER, V170, P527, DOI 10.1016/j.conbuildmat.2018.03.067; Ganjei MA, 2019, INT J PAVEMENT ENG, V20, P89, DOI 10.1080/10298436.2016.1260130; Gao JF, 2018, CONSTR BUILD MATER, V160, P786, DOI 10.1016/j.conbuildmat.2018.01.048; Gong MH, 2017, CONSTR BUILD MATER, V145, P42, DOI 10.1016/j.conbuildmat.2017.03.114; Hamedi GH, 2017, ROAD MATER PAVEMENT, V18, P1375, DOI 10.1080/14680629.2016.1220865; Hill B. D. Oldham, 2014, TRANSPORTATION RES R, V2371, P49; Kordi Z, 2017, CONSTR BUILD MATER, V134, P530, DOI 10.1016/j.conbuildmat.2016.12.202; Li RY, 2017, CONSTR BUILD MATER, V143, P633, DOI 10.1016/j.conbuildmat.2017.03.158; Ministry of Transport of the People's Republic of China, 2004, F402004 JTG; Mirhosseini AF, 2018, J MATER CIVIL ENG, V30, DOI 10.1061/(ASCE)MT.1943-5533.0002373; Mohammad LN, 2013, TRANSPORT RES REC, P58, DOI 10.3141/2371-07; Peng C, 2018, CONSTR BUILD MATER, V190, P83, DOI 10.1016/j.conbuildmat.2018.09.128; Saltan M, 2018, CONSTR BUILD MATER, V173, P228, DOI 10.1016/j.conbuildmat.2018.04.014; Shafabakhsh GH, 2015, CONSTR BUILD MATER, V98, P692, DOI 10.1016/j.conbuildmat.2015.08.083; Shafabakhsh G, 2014, CONSTR BUILD MATER, V54, P566, DOI 10.1016/j.conbuildmat.2013.12.064; SS V et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, 2020, CIRCULATION, V2020, pe1; Sun DQ, 2017, J CLEAN PROD, V161, P1203, DOI 10.1016/j.jclepro.2017.06.155; Sun L, 2017, CONSTR BUILD MATER, V133, P358, DOI 10.1016/j.conbuildmat.2016.12.073; Sun ZJ, 2016, CONSTR BUILD MATER, V102, P496, DOI 10.1016/j.conbuildmat.2015.10.173; Tang XD, 2011, MATER SCI FORUM, V688, P213, DOI 10.4028/www.scientific.net/MSF.688.213; van ME, 2017, PEDIAT PHYS THER S3, V29, pS73; Wang C, 2018, CONSTR BUILD MATER, V167, P348, DOI 10.1016/j.conbuildmat.2018.02.038; Xing XY, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9152995; Yang J, 2020, J MATER CIVIL ENG, V32, DOI 10.1061/(ASCE)MT.1943-5533.0003030; Yang XL, 2021, ROAD MATER PAVEMENT, V22, P1708, DOI 10.1080/14680629.2020.1713199; Yang X, 2017, J CLEAN PROD, V142, P1837, DOI 10.1016/j.jclepro.2016.11.100; Yang X, 2015, CONSTR BUILD MATER, V76, P380, DOI 10.1016/j.conbuildmat.2014.11.063; Zhai RX, 2020, ROAD MATER PAVEMENT, V21, P1006, DOI 10.1080/14680629.2018.1532924; Zhang DM, 2017, CONSTR BUILD MATER, V144, P423, DOI 10.1016/j.conbuildmat.2017.03.205; Zhang HL, 2016, CONSTR BUILD MATER, V114, P323, DOI 10.1016/j.conbuildmat.2016.03.118	35	9	9	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238817	10.1371/journal.pone.0238817	http://dx.doi.org/10.1371/journal.pone.0238817			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886701	gold, Green Published			2022-12-26	WOS:000571064300037
J	Lian, EY; Hyndman, BD; Moodley, S; Maritan, SM; Mulligan, LM				Lian, Eric Y.; Hyndman, Brandy D.; Moodley, Serisha; Maritan, Sarah M.; Mulligan, Lois M.			RET isoforms contribute differentially to invasive processes in pancreatic ductal adenocarcinoma	ONCOGENE			English	Article							CANCER CELL INVASION; NEUROTROPHIC FACTOR; PERINEURAL INVASION; UP-REGULATION; RHO-GTPASES; RECEPTOR; INVADOPODIA; GDNF; FILOPODIA; TKS5	Pancreatic ductal adenocarcinoma (PDAC) is a therapeutically challenging disease with poor survival rates, owing to late diagnosis and early dissemination. These tumors frequently undergo perineural invasion, spreading along nerves regionally and to distant sites. The RET receptor tyrosine kinase is implicated in increased aggressiveness, local invasion, and metastasis in multiple cancers, including PDAC. RET mediates directional motility and invasion towards sources of its neurotrophic factor ligands, suggesting that it may enhance perineural invasion of tumor cells towards nerves. RET is expressed as two main isoforms, RET9 and RET51, which differ in their protein interactions and oncogenic potentials, however, the contributions of RET isoforms to neural invasion have not been investigated. In this study, we generated total RET and isoform-specific knockdown PDAC cell lines and assessed the contributions of RET isoforms to PDAC invasive spread. Our data show that RET activity induces cell polarization and actin remodeling through activation of CDC42 and RHOA GTPases to promote directional motility in PDAC cells. Further, we show that RET interacts with the adaptor protein TKS5 to induce invadopodia formation, enhance matrix degradation and promote tumor cell invasion through a SRC and GRB2-dependent mechanism. Finally, we show that RET51 is the predominant isoform contributing to these RET-mediated invasive processes in PDAC. Together, our work suggests that RET expression in pancreatic cancers may enhance tumor aggressiveness by promoting perineural invasion, and that RET expression may be a valuable marker of invasiveness, and a potential therapeutic target in the treatment of these cancers.	[Lian, Eric Y.; Hyndman, Brandy D.; Moodley, Serisha; Maritan, Sarah M.; Mulligan, Lois M.] Queens Univ, Div Canc Biol & Genet, Canc Res Inst, Kingston, ON K7L 3N6, Canada; [Lian, Eric Y.; Hyndman, Brandy D.; Moodley, Serisha; Maritan, Sarah M.; Mulligan, Lois M.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada	Queens University - Canada; McMaster University; Queens University - Canada	Mulligan, LM (corresponding author), Queens Univ, Div Canc Biol & Genet, Canc Res Inst, Kingston, ON K7L 3N6, Canada.; Mulligan, LM (corresponding author), Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada.	mulligal@queensu.ca	Mulligan, Lois/D-1893-2010	Maritan, Sarah/0000-0002-9703-7429; Lian, Eric/0000-0002-2147-5422; Mulligan, Lois/0000-0002-9308-8245; /0000-0003-4096-0922	Cancer Research Society of Canada [19439]; Canadian Institutes for Health Research [MOP-142303, 398979]; Canadian Graduate Scholarship; Terry Fox Research Institute Training Program in Transdisciplinary Cancer Research	Cancer Research Society of Canada; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Graduate Scholarship; Terry Fox Research Institute Training Program in Transdisciplinary Cancer Research	This work was supported by an operating grant from the Cancer Research Society of Canada (19439) and a Canadian Institutes for Health Research operating grant (MOP-142303 (LMM)) and postdoctoral fellowship (398979 (SM)), and Canadian Graduate Scholarship (SMM) and by Ontario Graduate Scholarships and studentships from the Terry Fox Research Institute Training Program in Transdisciplinary Cancer Research (EYL, SMM).	Abella JV, 2010, J BIOL CHEM, V285, P24956, DOI 10.1074/jbc.M110.127985; Amit M, 2017, ONCOGENE, V36, P3232, DOI 10.1038/onc.2016.483; Amit M, 2019, INT J CANCER, V144, P3014, DOI 10.1002/ijc.32040; Arjonen A, 2011, CELL ADHES MIGR, V5, P421, DOI 10.4161/cam.5.5.17723; Bakst RL, 2016, J NEUROL SURG PART B, V77, P96, DOI 10.1055/s-0036-1571835; Beaty BT, 2014, EUR J CELL BIOL, V93, P438, DOI 10.1016/j.ejcb.2014.07.003; Ben-Chetrit N, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005537; Besset V, 2000, J BIOL CHEM, V275, P39159, DOI 10.1074/jbc.M006908200; Bhinge K, 2017, ONCOTARGET, V8, P27155, DOI 10.18632/oncotarget.15676; Boulay A, 2008, CANCER RES, V68, P3743, DOI 10.1158/0008-5472.CAN-07-5100; Burger KL, 2014, PROSTATE, V74, P134, DOI 10.1002/pros.22735; Cavel O, 2012, CANCER RES, V72, P5733, DOI 10.1158/0008-5472.CAN-12-0764; Ceyhan GO, 2008, BIOCHEM BIOPH RES CO, V374, P442, DOI 10.1016/j.bbrc.2008.07.035; Ceyhan GO, 2006, ANN SURG, V244, P274, DOI 10.1097/01.sla.0000217642.68697.55; Chermenina M, 2014, NEUROSCIENCE, V270, P1, DOI 10.1016/j.neuroscience.2014.04.008; Condeelis JS, 2001, SEMIN CANCER BIOL, V11, P119, DOI 10.1006/scbi.2000.0363; Courtneidge SA, 2005, COLD SH Q B, V70, P167, DOI 10.1101/sqb.2005.70.014; Crupi MJF, 2020, ONCOGENE, V39, P1361, DOI 10.1038/s41388-019-1068-z; Crupi MJF, 2015, TRAFFIC, V16, P1155, DOI 10.1111/tra.12315; Di Martino J, 2014, CELL ADHES MIGR, V8, P280, DOI 10.4161/cam.28833; Drinkut A, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.263; Eddy RJ, 2017, TRENDS CELL BIOL, V27, P595, DOI 10.1016/j.tcb.2017.03.003; Encinas M, 2004, J BIOL CHEM, V279, P18262, DOI 10.1074/jbc.M400505200; Esseghir S, 2007, CANCER RES, V67, P11732, DOI 10.1158/0008-5472.CAN-07-2343; Fischer RS, 2019, DEV BIOL, V451, P86, DOI 10.1016/j.ydbio.2018.08.015; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Gil Z, 2010, J NATL CANCER I, V102, P107, DOI 10.1093/jnci/djp456; Gorelik R, 2014, NAT PROTOC, V9, P1931, DOI 10.1038/nprot.2014.131; Griseri P, 2016, ONCOTARGET, V7, P26465, DOI 10.18632/oncotarget.8417; Gujral TS, 2008, CANCER RES, V68, P1338, DOI 10.1158/0008-5472.CAN-07-6052; Gupton Stephanie L, 2007, Sci STKE, V2007, pre5, DOI 10.1126/stke.4002007re5; He SB, 2014, P NATL ACAD SCI USA, V111, pE2008, DOI 10.1073/pnas.1402944111; Hickey JG, 2009, GENE CHROMOSOME CANC, V48, P429, DOI 10.1002/gcc.20653; Hirai I, 2002, PANCREAS, V24, P15, DOI 10.1097/00006676-200201000-00003; Honma Y, 2002, NEURON, V35, P267, DOI 10.1016/S0896-6273(02)00774-2; Hoshino D, 2013, J CELL SCI, V126, P2979, DOI 10.1242/jcs.079475; Huang L, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1120-9; Hyndman BD, 2017, J CELL SCI, V130, P3282, DOI 10.1242/jcs.203885; Ibanez CF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009134; Ilic M, 2016, WORLD J GASTROENTERO, V22, P9694, DOI 10.3748/wjg.v22.i44.9694; Ito Y, 2005, SURGERY, V138, P788, DOI 10.1016/j.surg.2005.07.007; Itoh Y, 2015, MATRIX BIOL, V44-46, P207, DOI 10.1016/j.matbio.2015.03.004; Jacquemet G, 2015, CURR OPIN CELL BIOL, V36, P23, DOI 10.1016/j.ceb.2015.06.007; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Kramer ER, 2015, FEBS LETT, V589, P3760, DOI 10.1016/j.febslet.2015.11.006; Lamorte L, 2002, MOL BIOL CELL, V13, P1449, DOI 10.1091/mbc.01-10-0477; Leong HS, 2014, CELL REP, V8, P1558, DOI 10.1016/j.celrep.2014.07.050; Lian EY, 2017, ENDOCR-RELAT CANCER, V24, P53, DOI 10.1530/ERC-16-0393; Liang DK, 2016, BBA-REV CANCER, V1865, P111, DOI 10.1016/j.bbcan.2016.01.002; Liebig C, 2009, CANCER-AM CANCER SOC, V115, P3379, DOI 10.1002/cncr.24396; Marchesi F, 2010, CYTOKINE GROWTH F R, V21, P77, DOI 10.1016/j.cytogfr.2009.11.001; Maritan SM, 2017, JOVE-J VIS EXP, DOI 10.3791/55544; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mayor R, 2010, TRENDS CELL BIOL, V20, P319, DOI 10.1016/j.tcb.2010.03.005; Meka DP, 2015, J CLIN INVEST, V125, P1873, DOI 10.1172/JCI79300; Menard L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4907; Moodley S, 2020, LUNG CANCER, V142, P123, DOI 10.1016/j.lungcan.2020.02.004; Morandi A, 2011, TRENDS MOL MED, V17, P149, DOI 10.1016/j.molmed.2010.12.007; Mulligan LM, 2019, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01873; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Murphy DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021436; MYERS SM, 1995, ONCOGENE, V11, P2039; Nevalainen N, 2010, NEUROSCIENCE, V171, P1357, DOI 10.1016/j.neuroscience.2010.10.010; Oikawa T, 2008, J CELL BIOL, V182, P157, DOI 10.1083/jcb.200801042; Parachoniak CA, 2012, TRENDS CELL BIOL, V22, P231, DOI 10.1016/j.tcb.2012.02.002; Parachoniak CA, 2011, DEV CELL, V20, P751, DOI 10.1016/j.devcel.2011.05.007; Partridge MA, 2006, MOL BIOL CELL, V17, P4237, DOI 10.1091/mbc.E06-06-0496; Paz H, 2014, ONCOGENE, V33, P4193, DOI 10.1038/onc.2013.393; Poteryaev D, 1999, FEBS LETT, V463, P63, DOI 10.1016/S0014-5793(99)01590-2; Radhakrishna H, 1999, J CELL SCI, V112, P855; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rajadurai CV, 2012, J CELL SCI, V125, P2940, DOI 10.1242/jcs.100834; Richardson DS, 2006, ONCOGENE, V25, P3206, DOI 10.1038/sj.onc.1209349; Richardson DS, 2012, MOL BIOL CELL, V23, P3838, DOI 10.1091/mbc.E12-02-0114; Rodrigues DM, 2011, NEUROGASTROENT MOTIL, V23, pe44, DOI 10.1111/j.1365-2982.2010.01626.x; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Saad AM, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4610-4; Sawai H, 2005, CANCER RES, V65, P11536, DOI 10.1158/0008-5472.CAN-05-2843; Sharma VP, 2013, CURR BIOL, V23, P2079, DOI 10.1016/j.cub.2013.08.044; Sit ST, 2011, J CELL SCI, V124, P679, DOI 10.1242/jcs.064964; Stylli SS, 2009, J CELL SCI, V122, P2727, DOI 10.1242/jcs.046680; SUTERCRAZZOLARA C, 1994, NEUROREPORT, V5, P2486, DOI 10.1097/00001756-199412000-00020; TAHIRA T, 1990, ONCOGENE, V5, P97; Tsui-Pierchala BA, 2002, J BIOL CHEM, V277, P34618, DOI 10.1074/jbc.M203580200; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Williams KC, 2019, ONCOGENE, V38, P3598, DOI 10.1038/s41388-018-0667-4; Yang CS, 2011, CELL ADHES MIGR, V5, P402, DOI 10.4161/cam.5.5.16971; Zeng Q, 2008, J INT MED RES, V36, P656, DOI 10.1177/147323000803600406	88	9	9	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 8	2020	39	41					6493	6510		10.1038/s41388-020-01448-z	http://dx.doi.org/10.1038/s41388-020-01448-z		SEP 2020	18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	OA1JL	32884116				2022-12-26	WOS:000565829600001
J	Mori, T; Koyama, N; Yokoo, T; Segawa, T; Maeda, M; Sawmiller, D; Tan, J; Town, T				Mori, Takashi; Koyama, Naoki; Yokoo, Tomotaka; Segawa, Tatsuya; Maeda, Masahiro; Sawmiller, Darrell; Tan, Jun; Town, Terrence			Gallic acid is a dual alpha/beta-secretase modulator that reverses cognitive impairment and remediates pathology in Alzheimer mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gallic acid; nonamyloidogenic; phenolic compound; plant; secretase; Alzheimer&apos; s disease; amyloid &#946; -protein precursor (APP); amyloid &#946; -protein (A&#946; )	AMYLOID PRECURSOR PROTEIN; TRANSGENIC MOUSE MODEL; LONG-TERM POTENTIATION; BETA-SECRETASE; MEMORY DEFICITS; GREEN TEA; A-BETA; CEREBRAL AMYLOIDOSIS; IMPROVES COGNITION; OXIDATIVE STRESS	Several plant-derived compounds have demonstrated efficacy in pre-clinical Alzheimer's disease (AD) rodent models. Each of these compounds share a gallic acid (GA) moiety, and initial assays on this isolated molecule indicated that it might be responsible for the therapeutic benefits observed. To test this hypothesis in a more physiologically relevant setting, we investigated the effect of GA in the mutant human amyloid beta-protein precursor/presenilin 1 (APP/PS1) transgenic AD mouse model. Beginning at 12 months, we orally administered GA (20 mg/kg) or vehicle once daily for 6 months to APP/PS1 mice that have accelerated Alzheimer-like pathology. At 18 months of age, GA therapy reversed impaired learning and memory as compared with vehicle, and did not alter behavior in nontransgenic littermates. GA-treated APP/PS1 mice had mitigated cerebral amyloidosis, including brain parenchymal and cerebral vascular beta-amyloid deposits, and decreased cerebral amyloid beta-proteins. Beneficial effects co-occurred with reduced amyloidogenic and elevated nonamyloidogenic APP processing. Furthermore, brain inflammation, gliosis, and oxidative stress were alleviated. We show that GA simultaneously elevates alpha- and reduces beta-secretase activity, inhibits neuroinflammation, and stabilizes brain oxidative stress in a pre-clinical mouse model of AD. We further demonstrate that GA increases abundance of a disintegrin and metalloproteinase domain-containing protein 10 (ADAM10, Adam10) proprotein convertase furin and activates ADAM10, directly inhibits beta-site APP cleaving enzyme 1 (BACE1, Bace1) activity but does not alter Adam10 or Bace1 transcription. Thus, our data reveal novel post-translational mechanisms for GA. We suggest further examination of GA supplementation in humans will shed light on the exciting therapeutic potential of this molecule.	[Mori, Takashi; Koyama, Naoki] Saitama Med Ctr & Univ, Dept Biomed Sci, Kawagoe, Saitama, Japan; [Mori, Takashi] Saitama Med Ctr & Univ, Dept Pathol, Kawagoe, Saitama, Japan; [Yokoo, Tomotaka] Saitama Med Univ, Res Ctr Genom Med, Saitama, Japan; [Segawa, Tatsuya; Maeda, Masahiro] Immunobiol Labs Co Ltd, Gunma, Japan; [Sawmiller, Darrell] Univ S Florida, Dept Neurosurg & Brain Repair, Ctr Aging & Brain Repair, Tampa, FL 33620 USA; [Tan, Jun] Univ S Florida, Dept Psychiat & Behav Neurosci, Morsoni Coll Med, Tampa, FL 33620 USA; [Town, Terrence] Univ Southern Calif, Zilkha Neurogenet Inst, Dept Physiol & Neurosci, Keck Sch Med, Los Angeles, CA 90007 USA	Saitama Medical University; Saitama Medical University; Saitama Medical University; Immuno-Biological Laboratories Co. Ltd.; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of Southern California	Mori, T (corresponding author), Saitama Med Ctr & Univ, Dept Biomed Sci, Kawagoe, Saitama, Japan.; Mori, T (corresponding author), Saitama Med Ctr & Univ, Dept Pathol, Kawagoe, Saitama, Japan.; Town, T (corresponding author), Univ Southern Calif, Zilkha Neurogenet Inst, Dept Physiol & Neurosci, Keck Sch Med, Los Angeles, CA 90007 USA.	t_mori@saitama-med.ac.jp; terrencetown@terrencetown.com	Sawmiller, Darrell/AAQ-9722-2021	Sawmiller, Darrell/0000-0003-3599-6859	National Institutes of Health [2R01NS076794-06A1, 1RF1AG053982-01A1, 5P01AG052350-03, 5R21AG053884-02]; Japan Society for the Promotion of Science Grant KAKENHI [JP26430058]; Alzheimer's Association Sex and Gender in Alzheimer's Disease Grant (SAGA); Cure Alzheimer's Fund; Coins for Alzheimer's Research Trust	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science Grant KAKENHI; Alzheimer's Association Sex and Gender in Alzheimer's Disease Grant (SAGA); Cure Alzheimer's Fund; Coins for Alzheimer's Research Trust	This work was supported, in whole or in part, by National Institutes of Health Grants 2R01NS076794-06A1, 1RF1AG053982-01A1, 5P01AG052350-03, and 5R21AG053884-02 (to T. T.), Japan Society for the Promotion of Science Grant KAKENHI JP26430058 (to T. M.), an Alzheimer's Association Sex and Gender in Alzheimer's Disease Grant (SAGA; to T. T.), Cure Alzheimer's Fund (to T. T.), and a Coins for Alzheimer's Research Trust Grant (to T. T). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Fernandes FHA, 2016, CRIT REV ANAL CHEM, V46, P257, DOI 10.1080/10408347.2015.1095064; Andreasson KI, 2016, J NEUROCHEM, V138, P653, DOI 10.1111/jnc.13667; Arendash GW, 2001, BRAIN RES, V891, P42, DOI 10.1016/S0006-8993(00)03186-3; BARNES DG, 1988, REGUL TOXICOL PHARM, V8, P471, DOI 10.1016/0273-2300(88)90047-5; Chhillar R, 2013, FUND CLIN PHARMACOL, V27, P409, DOI 10.1111/j.1472-8206.2012.01040.x; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; De Rosa R, 2005, P NATL ACAD SCI USA, V102, P3811, DOI 10.1073/pnas.0500195102; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Dhingra D, 2012, NEUROCHEM RES, V37, P487, DOI 10.1007/s11064-011-0635-7; Ellis RJ, 1996, NEUROLOGY, V46, P1592, DOI 10.1212/WNL.46.6.1592; Environmental Health Criteria 210, 1999, PRINC ASS RISKS HUM; Ferruzzi MG, 2009, J ALZHEIMERS DIS, V18, P113, DOI 10.3233/JAD-2009-1135; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200; Griffin WST, 1998, BRAIN PATHOL, V8, P65; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hajipour S, 2016, BASIC CLIN NEUROSCI, V7, P97, DOI 10.15412/J.BCN.03070203; Hartman RE, 2005, J NEUROSCI, V25, P6213, DOI 10.1523/JNEUROSCI.0664-05.2005; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Holcomb LA, 1999, BEHAV GENET, V29, P177, DOI 10.1023/A:1021691918517; Horikoshi Y, 2004, BIOCHEM BIOPH RES CO, V319, P733, DOI 10.1016/j.bbrc.2004.05.051; Huang HL, 2012, J AGR FOOD CHEM, V60, P2328, DOI 10.1021/jf203709q; Ishida A, 1997, NEUROREPORT, V8, P2133, DOI 10.1097/00001756-199707070-00009; Jankowsky JL, 2004, NEUROBIOL AGING, V25, P885, DOI 10.1016/j.neurobiolaging.2003.09.008; Jung J, 2013, BIOL PHARM BULL, V36, P1535, DOI 10.1248/bpb.b13-00225; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kim KS, 2006, J NEUROSCI RES, V83, P497, DOI 10.1002/jnr.20754; Kim MJ, 2011, MOL NUTR FOOD RES, V55, P1798, DOI 10.1002/mnfr.201100262; Kim YJ, 2007, BIOL PHARM BULL, V30, P1052, DOI 10.1248/bpb.30.1052; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; King DL, 1999, BEHAV BRAIN RES, V103, P145, DOI 10.1016/S0166-4328(99)00037-6; Konishi Y, 2004, J AGR FOOD CHEM, V52, P2527, DOI 10.1021/jf035366k; Konishi Y, 2006, J AGR FOOD CHEM, V54, P7539, DOI 10.1021/jf061554+; Korani MS, 2014, EUR J PHARMACOL, V733, P62, DOI 10.1016/j.ejphar.2014.03.044; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Kratz JM, 2008, MEM I OSWALDO CRUZ, V103, P437, DOI 10.1590/S0074-02762008000500005; Liu YQ, 2013, BIOORG MED CHEM LETT, V23, P6336, DOI 10.1016/j.bmcl.2013.09.071; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Mori T, 2019, J BIOL CHEM, V294, P2714, DOI [10.1074/jbc.ra118.004280, 10.1074/jbc.RA118.004280]; Mori T, 2017, J BIOL CHEM, V292, P11310, DOI 10.1074/jbc.M116.762658; Mori T, 2014, J BIOL CHEM, V289, P30303, DOI 10.1074/jbc.M114.568212; Mori T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055774; Mori T, 2012, J BIOL CHEM, V287, P6912, DOI 10.1074/jbc.M111.294025; Mouri A, 2007, FASEB J, V21, P2135, DOI 10.1096/fj.06-7685com; Mufson EJ, 2016, NEUROBIOL AGING, V37, P147, DOI 10.1016/j.neurobiolaging.2015.10.012; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Obregon D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1781; Obregon DF, 2006, J BIOL CHEM, V281, P16419, DOI 10.1074/jbc.M600617200; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; Punithavathi VR, 2011, EUR J PHARMACOL, V650, P465, DOI 10.1016/j.ejphar.2010.08.059; Rajalakshmi K, 2001, FOOD CHEM TOXICOL, V39, P919, DOI 10.1016/S0278-6915(01)00022-9; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rezai-Zadeh K, 2005, J NEUROSCI, V25, P8807, DOI 10.1523/JNEUROSCI.1521-05.2005; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Robinson JL, 2011, BRAIN, V134, P3705, DOI 10.1093/brain/awr308; Sabbagh MN, 2010, CURR ALZHEIMER RES, V7, P280, DOI 10.2174/156720510791162340; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Serrano J, 2009, MOL NUTR FOOD RES, V53, pS310, DOI 10.1002/mnfr.200900039; Shahrzad S, 2001, J NUTR, V131, P1207, DOI 10.1093/jn/131.4.1207; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Tan J, 2002, NAT NEUROSCI, V5, P1288, DOI 10.1038/nn968; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Town T, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-24; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Verma S, 2013, ENVIRON TOXICOL PHAR, V35, P473, DOI 10.1016/j.etap.2013.02.011; Vincent B, 2016, BRAIN RES BULL, V126, P154, DOI 10.1016/j.brainresbull.2016.03.020; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Xia WM, 2009, ARCH NEUROL-CHICAGO, V66, P190, DOI 10.1001/archneurol.2008.565; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15; Yu M, 2019, NEUROBIOL DIS, V124, P67, DOI 10.1016/j.nbd.2018.11.009; Zhang SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071913	84	17	18	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2020	295	48					16251	16266		10.1074/jbc.RA119.012330	http://dx.doi.org/10.1074/jbc.RA119.012330			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PE7CE	32913125	hybrid, Green Published			2022-12-26	WOS:000598519500007
J	Jiang, XK; Yang, K; Yuan, B; Gong, B; Wan, L; Patil, NA; Swarbrick, JD; Roberts, KD; Schreiber, F; Wang, LS; Velkov, T; Li, J				Jiang, Xukai; Yang, Kai; Yuan, Bing; Gong, Bin; Wan, Lin; Patil, Nitin A.; Swarbrick, James D.; Roberts, Kade D.; Schreiber, Falk; Wang, Lushan; Velkov, Tony; Li, Jian			Simulations of octapeptin-outer membrane interactions reveal conformational flexibility is linked to antimicrobial potency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						octapeptin; polymyxin; antimicrobial resistance; Gram-negative bacteria; molecular dynamics; conformational transition; antibiotic action; antibiotic resistance; drug design; Gram-negative bacteria; conformational change; octapeptin	FORCE-FIELD; POLYMYXINS; PEPTIDE; ANTIBIOTICS; DYNAMICS; MECHANISMS; RESISTANCE; BINDING	The octapeptins are lipopeptide antibiotics that are structurally similar to polymyxins yet retain activity against polymyxin-resistant Gram-negative pathogens, suggesting they might be used to treat recalcitrant infections. However, the basis of their unique activity is unclear because of the difficulty in generating high-resolution experimental data of the interaction of antimicrobial peptides with lipid membranes. To elucidate these structure-activity relationships, we employed all-atom molecular dynamics simulations with umbrella sampling to investigate the conformational and energetic landscape of octapeptins interacting with bacterial outer membrane (OM). Specifically, we examined the interaction of octapeptin C4 and FADDI-115, lacking a single hydroxyl group compared with octapeptin C4, with the lipid A-phosphoethanolamine modified OM of Acinetobacter baumannii. Octapeptin C4 and FADDI-115 both penetrated into the OM hydrophobic center but experienced different conformational transitions from an unfolded to a folded state that was highly dependent on the structural flexibility of their respective N-terminal fatty acyl groups. The additional hydroxyl group present in the fatty acyl group of octapeptin C4 resulted in the molecule becoming trapped in a semifolded state, leading to a higher free energy barrier for OM penetration. The free energy barrier for the translocation through the OM hydrophobic layer was similar to 72 kcal/mol for octapeptin C4 and 62 kcal/mol for FADDI-115. Our results help to explain the lower antimicrobial activity previously observed for octapeptin C4 compared with FADDI-115 and more broadly improve our understanding of the structure-function relationships of octapeptins. These findings may facilitate the discovery of next-generation octapeptins against polymyxin-resistant Gram-negative 'superbugs.'	[Jiang, Xukai; Patil, Nitin A.; Roberts, Kade D.; Li, Jian] Monash Univ, Dept Microbiol, Infect & Immun Program, Biomed Discovery Inst, Melbourne, Vic, Australia; [Yang, Kai; Yuan, Bing] Soochow Univ, Ctr Soft Condensed Matter Phys & Interdisciplinar, Suzhou, Peoples R China; [Yang, Kai; Yuan, Bing] Soochow Univ, Sch Phys Sci & Technol, Suzhou, Peoples R China; [Gong, Bin; Wan, Lin] Shandong Univ, Sch Software, Jinan, Peoples R China; [Swarbrick, James D.; Velkov, Tony] Univ Melbourne, Dept Pharmacol & Therapeut, Melbourne, Vic, Australia; [Schreiber, Falk] Univ Konstanz, Dept Comp & Informat Sci, Constance, Germany; [Wang, Lushan] Shandong Univ, State Key Lab Microbial Technol, Qingdao, Peoples R China	Monash University; Soochow University - China; Soochow University - China; Shandong University; University of Melbourne; University of Konstanz; Shandong University	Li, J (corresponding author), Monash Univ, Dept Microbiol, Infect & Immun Program, Biomed Discovery Inst, Melbourne, Vic, Australia.; Velkov, T (corresponding author), Univ Melbourne, Dept Pharmacol & Therapeut, Melbourne, Vic, Australia.	tony.velkov@unimelb.edu.au; jian.li@monash.edu		Yuan, Bing/0000-0001-8418-9274; velkov, tony/0000-0002-0017-7952; Yang, Kai/0000-0002-2472-5984; Patil, Nitin/0000-0003-0422-9411; Wan, Lin/0000-0003-2627-8775	NIAID, National Institutes of Health [R01 AI132154]; Monash University; HPC Cloud Platform (National Key Research and Development Project) at Shandong University (China) [2016YFB0201702]	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Monash University(Monash University); HPC Cloud Platform (National Key Research and Development Project) at Shandong University (China)	This work was supported by NIAID, National Institutes of Health Grant R01 AI132154 (to J. L. and T. V.). X. J. is recipient of the 2019 Faculty Bridging Fellowship from Monash University. J. L. is an Australia National Health Medical Research Council Principal Research Fellow. The simulations were performed on the supercomputer at Monash University (Australia) and the HPC Cloud Platform (National Key Research and Development Project 2016YFB0201702) at Shandong University (China). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abou Fayad A, 2018, CELL CHEM BIOL, V25, P351, DOI 10.1016/j.chembiol.2018.04.003; ALLINGER NL, 1977, J AM CHEM SOC, V99, P8127, DOI 10.1021/ja00467a001; Baron S, 2016, INT J ANTIMICROB AG, V48, P583, DOI 10.1016/j.ijantimicag.2016.06.023; Berglund NA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004180; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Zoysa GH, 2015, J MED CHEM, V58, P625, DOI 10.1021/jm501084q; Fu L, 2020, BIOPHYS J, V118, P138, DOI 10.1016/j.bpj.2019.11.008; HANCOCK REW, 1984, ANNU REV MICROBIOL, V38, P237, DOI 10.1146/annurev.mi.38.100184.001321; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; Jeannot K, 2017, INT J ANTIMICROB AG, V49, P526, DOI 10.1016/j.ijantimicag.2016.11.029; Jefferies D, 2017, BIOCHEMISTRY-US, V56, P1672, DOI 10.1021/acs.biochem.6b01063; Jiang X., 2020, J ANTIMICROB CHEMOTH; Jiang XK, 2020, ACS INFECT DIS, V6, P2698, DOI 10.1021/acsinfecdis.0c00330; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Landman D, 2008, CLIN MICROBIOL REV, V21, P449, DOI 10.1128/CMR.00006-08; Lee J, 2019, J CHEM THEORY COMPUT, V15, P775, DOI 10.1021/acs.jctc.8b01066; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; MacLean RC, 2019, SCIENCE, V365, P1082, DOI 10.1126/science.aax3879; MEYERS E, 1973, J ANTIBIOT, V26, P457, DOI 10.7164/antibiotics.26.457; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Olaitan AO, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00643; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; PETERSON AA, 1987, ANTIMICROB AGENTS CH, V31, P230, DOI 10.1128/AAC.31.2.230; Rice A, 2018, BIOPHYS J, V114, P1389, DOI 10.1016/j.bpj.2018.02.006; Santos DES, 2017, J CHEM INF MODEL, V57, P2181, DOI 10.1021/acs.jcim.7b00271; Srinivas P, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0596-3; Sun DL, 2014, PHYS CHEM CHEM PHYS, V16, P20785, DOI 10.1039/c4cp02211d; SWANSON PE, 1980, BIOCHEMISTRY-US, V19, P3307, DOI 10.1021/bi00555a032; Tacconelli E, 2018, LANCET INFECT DIS, V18, P318, DOI [10.1016/s1473-3099(17)30753-3, 10.1016/S1473-3099(17)30753-3]; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Velkov T, 2018, CELL CHEM BIOL, V25, P380, DOI 10.1016/j.chembiol.2018.01.005; Velkov T, 2017, NAT PROD REP, V34, P295, DOI 10.1039/c6np00113k; Velkov T, 2016, FUTURE MED CHEM, V8, P1017, DOI 10.4155/fmc-2016-0091; Velkov T, 2014, ACS CHEM BIOL, V9, P1172, DOI 10.1021/cb500080r; Velkov T, 2010, J MED CHEM, V53, P1898, DOI 10.1021/jm900999h; Yesylevskyy S, 2009, BIOPHYS J, V97, P40, DOI 10.1016/j.bpj.2009.03.059; Zhao J, 2013, J CHEM INF MODEL, V53, P3280, DOI 10.1021/ci400477e; Zhu Y, 2020, ADV SCI, V7, DOI 10.1002/advs.202000704; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	41	6	6	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2020	295	47					15902	15912		10.1074/jbc.RA120.014856	http://dx.doi.org/10.1074/jbc.RA120.014856			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PA5ED	32913118	Green Published, hybrid			2022-12-26	WOS:000595657900010
J	Tong, YP; Trajkovic, M; Savino, S; van Berkel, WJH; Fraaije, MW				Tong, Yapei; Trajkovic, Milos; Savino, Simone; van Berkel, Willem J. H.; Fraaije, Marco W.			Substrate binding tunes the reactivity of hispidin 3-hydroxylase, a flavoprotein monooxygenase involved in fungal bioluminescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hispidin; luciferase; hispidin 3-hydroxylase; Mycena chlorophos; bioluminescence; flavin; hydroxylase; enzyme kinetics; protein engineering	COENZYME SPECIFICITY; ACTIVATING COMPONENT; MYCENA; SYSTEM; ACID; IDENTIFICATION; HYDROXYLASES; PROTEINS; PILEUS	Fungal bioluminescence was recently shown to depend on a unique oxygen-dependent system of several enzymes. However, the identities of the enzymes did not reveal the full biochemical details of this process, as the enzymes do not bear resemblance to those of other luminescence systems, and thus the properties of the enzymes involved in this fascinating process are still unknown. Here, we describe the characterization of the penultimate enzyme in the pathway, hispidin 3-hydroxylase, from the luminescent fungus Mycena chlorophos (McH3H), which catalyzes the conversion of hispidin to 3-hydroxyhispidin. 3-Hydroxyhispidin acts as a luciferin substrate in luminescent fungi. McH3H was heterologously expressed in Escherichia coli and purified by affinity chromatography with a yield of 100 mg/liter. McH3H was found to be a single component monomeric NAD(P)H-dependent FAD-containing monooxygenase having a preference for NADPH. Through site-directed mutagenesis, based on a modeled structure, mutant enzymes were created that are more efficient with NADH. Except for identifying the residues that tune cofactor specificity, these engineered variants may also help in developing new hispidin-based bioluminescence applications. We confirmed that addition of hispidin to McH3H led to the formation of 3-hydroxyhispidin as sole aromatic product. Rapid kinetic analysis revealed that reduction of the flavin cofactor by NADPH is boosted by hispidin binding by nearly 100-fold. Similar to other class A flavoprotein hydroxylases, McH3H did not form a stable hydroperoxyflavin intermediate. These data suggest a mechanism by which the hydroxylase is tuned for converting hispidin into the fungal luciferin.	[Tong, Yapei; Trajkovic, Milos; Savino, Simone; Fraaije, Marco W.] Univ Groningen, Mol Enzymol Grp, Groningen, Netherlands; [van Berkel, Willem J. H.] Wageningen Univ & Res, Food Chem Lab, Wageningen, Netherlands	University of Groningen; Wageningen University & Research	Fraaije, MW (corresponding author), Univ Groningen, Mol Enzymol Grp, Groningen, Netherlands.	m.w.fraaije@rug.nl	van Berkel, Willem J.H./O-2431-2014; Trajkovic, Milos/Q-8397-2016	van Berkel, Willem J.H./0000-0002-6551-2782; Savino, Simone/0000-0001-9505-3348; Tong, Yapei/0000-0001-9218-8597; Trajkovic, Milos/0000-0001-7264-1630; Fraaije, Marco/0000-0001-6346-5014	China Scholarship Council	China Scholarship Council(China Scholarship Council)	Y. Tong thanks the China Scholarship Council for a Ph.D. fellowship.	ADAM W, 1994, SYNTHESIS-STUTTGART, P1133; AIRTH RL, 1964, J BACTERIOL, V88, P1372, DOI 10.1128/JB.88.5.1372-1379.1964; AIRTH RL, 1962, ARCH BIOCHEM BIOPHYS, V97, P567, DOI 10.1016/0003-9861(62)90124-8; AIRTH RL, 1959, J BACTERIOL, V77, P249, DOI 10.1128/JB.77.2.249-250.1959; Aliverti A, 1999, METH MOL B, V131, P9; Berkeley M.J., 1860, P AM ACAD ARTS SCI, V4, P111; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; Chew ALC, 2014, MYCOLOGIA, V106, P976, DOI 10.3852/13-274; Costa DMA, 2019, INT J BIOL MACROMOL, V129, P588, DOI 10.1016/j.ijbiomac.2019.01.135; Desjardin DE, 2008, PHOTOCH PHOTOBIO SCI, V7, P170, DOI 10.1039/b713328f; ENTSCH B, 1995, FASEB J, V9, P476, DOI 10.1096/fasebj.9.7.7737455; Entsch B, 2005, ARCH BIOCHEM BIOPHYS, V433, P297, DOI 10.1016/j.abb.2004.09.029; Eppink MHM, 1999, J MOL BIOL, V292, P87, DOI 10.1006/jmbi.1999.3015; Eppink MHM, 1997, PROTEIN SCI, V6, P2454; Forneris F, 2009, FEBS J, V276, P2833, DOI 10.1111/j.1742-4658.2009.07006.x; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; Harvey E.N., 2011, HIST LUMINESCENCE EA, DOI [10.5962/bhl.title.14249, DOI 10.5962/BHL.TITLE.14249]; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; Jadan AP, 2001, BIOCHEMISTRY-MOSCOW+, V66, P898, DOI 10.1023/A:1011908920472; Kamerbeek NM, 2004, EUR J BIOCHEM, V271, P2107, DOI 10.1111/j.1432-1033.2004.04126.x; Kaskova ZM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602847; Kotlobay AA, 2018, P NATL ACAD SCI USA, V115, P12728, DOI 10.1073/pnas.1803615115; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Loncar N, 2019, APPL MICROBIOL BIOT, V103, P1755, DOI 10.1007/s00253-018-09579-w; Mitiouchkina T, 2020, NAT BIOTECHNOL, V38, P944, DOI 10.1038/s41587-020-0500-9; Montersino S, 2012, BBA-PROTEINS PROTEOM, V1824, P433, DOI 10.1016/j.bbapap.2011.12.003; Mori K, 2011, LUMINESCENCE, V26, P604, DOI 10.1002/bio.1280; Nicoll CR, 2020, NAT STRUCT MOL BIOL, V27, DOI 10.1038/s41594-019-0347-2; Oliveira AG, 2012, PHOTOCH PHOTOBIO SCI, V11, P848, DOI 10.1039/c2pp25032b; Purtov KV, 2015, ANGEW CHEM INT EDIT, V54, P8124, DOI 10.1002/anie.201501779; Robinson R, 2014, BBA-PROTEINS PROTEOM, V1844, P778, DOI 10.1016/j.bbapap.2014.02.005; Romero E, 2018, CHEM REV, V118, P1742, DOI 10.1021/acs.chemrev.7b00650; SCRUTTON NS, 1990, NATURE, V343, P38, DOI 10.1038/343038a0; Stevani CV, 2013, PHOTOCHEM PHOTOBIOL, V89, P1318, DOI 10.1111/php.12135; Sucharitakul J, 2008, BIOCHEMISTRY-US, V47, P8485, DOI 10.1021/bi801039d; Teranishi K, 2017, LUMINESCENCE, V32, P182, DOI 10.1002/bio.3165; Teranishi K, 2016, LUMINESCENCE, V31, P1407, DOI 10.1002/bio.3129; Teranishi K, 2016, LUMINESCENCE, V31, P594, DOI 10.1002/bio.3001; Teranishi K, 2016, TETRAHEDRON, V72, P726, DOI 10.1016/j.tet.2015.12.027; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; van Berkel WJH, 1999, METH MOL B, V131, P61; VANBERKEL W, 1992, EUR J BIOCHEM, V210, P411; Westphal AH, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03050; WHITESTEVENS RH, 1972, J BIOL CHEM, V247, P2371; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2	46	2	2	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2020	295	47					16013	16022		10.1074/jbc.RA120.014996	http://dx.doi.org/10.1074/jbc.RA120.014996			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PA5ED	32917724	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000595657900019
J	Biswas, D; Dao, KT; Mercer, A; Cowie, AM; Duffley, L; El Hiani, Y; Kienesberger, PC; Pulinilkunnil, T				Biswas, Dipsikha; Dao, Khoi T.; Mercer, Angella; Cowie, Andrew M.; Duffley, Luke; El Hiani, Yassine; Kienesberger, Petra C.; Pulinilkunnil, Thomas			Branched-chain ketoacid overload inhibits insulin action in the muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						insulin resistance; amino acid; translation; skeletal muscle metabolism; cardiomyocyte; BCKA; cardiomyocytes; insulin signaling; protein translation; skeletal muscle	AMINO-ACID CATABOLISM; SKELETAL-MUSCLE; MOLECULAR-MECHANISMS; METABOLITE PROFILES; SIGNALING PATHWAYS; CRITICAL REGULATOR; GLUCOSE; OBESITY; RESISTANCE; OXIDATION	Branched-chain alpha-keto acids (BCKAs) are catabolites of branched-chain amino acids (BCAAs). Intracellular BCKAs are cleared by branched-chain ketoacid dehydrogenase (BCKDH), which is sensitive to inhibitory phosphorylation by BCKD kinase (BCKDK). Accumulation of BCKAs is an indicator of defective BCAA catabolism and has been correlated with glucose intolerance and cardiac dysfunction. However, it is unclear whether BCKAs directly alter insulin signaling and function in the skeletal and cardiac muscle cell. Furthermore, the role of excess fatty acids (FAs) in perturbing BCAA catabolism and BCKA availability merits investigation. By using immunoblotting and ultra-performance liquid chromatography MS/MS to analyze the hearts of fasted mice, we observed decreased BCAA-catabolizing enzyme expression and increased circulating BCKAs, but not BCAAs. In mice subjected to diet-induced obesity (DIO), we observed similar increases in circulating BCKAs with concomitant changes in BCAA-catabolizing enzyme expression only in the skeletal muscle. Effects of DIO were recapitulated by simulating lipotoxicity in skeletal muscle cells treated with saturated FA, palmitate. Exposure of muscle cells to high concentrations of BCKAs resulted in inhibition of insulin-induced AKT phosphorylation, decreased glucose uptake, and mitochondrial oxygen consumption. Altering intracellular clearance of BCKAs by genetic modulation of BCKDK and BCKDHA expression showed similar effects on AKT phosphorylation. BCKAs increased protein translation and mTORC1 activation. Pretreating cells with mTORC1 inhibitor rapamycin restored BCKA's effect on insulin-induced AKT phosphorylation. This study provides evidence for FA-mediated regulation of BCAA-catabolizing enzymes and BCKA content and highlights the biological role of BCKAs in regulating muscle insulin signaling and function.	[Biswas, Dipsikha; Dao, Khoi T.; Mercer, Angella; Cowie, Andrew M.; Duffley, Luke; Kienesberger, Petra C.; Pulinilkunnil, Thomas] Dalhousie Univ, Dalhousie Med New Brunswick, Dept Biochem & Mol Biol, St John, NB, Canada; [El Hiani, Yassine] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Pulinilkunnil, T (corresponding author), Dalhousie Univ, Dalhousie Med New Brunswick, Dept Biochem & Mol Biol, St John, NB, Canada.	tpulinil@dal.ca	Pulinilkunnil, Thomas/H-4387-2019; Biswas, Dipsikha/AAP-3682-2020	Pulinilkunnil, Thomas/0000-0003-1228-893X; Biswas, Dipsikha/0000-0003-0990-9678; El Hiani, Yassine/0000-0002-1251-5066; Kienesberger, Petra/0000-0001-9643-8338; Mercer, Angella/0000-0003-3608-1079	Natural Sciences and Engineering Research Council of Canada [RGPIN-2020-05906]; Diabetes Canada [NOD_OG-3-15-5037-TP, NOD_SC-5-16-5054-TP]; New Brunswick Health Research Foundation; Dalhousie Medicine New Brunswick	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Diabetes Canada; New Brunswick Health Research Foundation; Dalhousie Medicine New Brunswick	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant RGPIN-2020-05906, Diabetes Canada Grants NOD_OG-3-15-5037-TP and NOD_SC-5-16-5054-TP, and New Brunswick Health Research Foundation grants (to T. P.); D. B., was funded by postdoctoral fellowships from New Brunswick Health Research Foundation and Dalhousie Medicine New Brunswick.	Armenta JM, 2010, ANAL CHEM, V82, P548, DOI 10.1021/ac901790q; Aubert G, 2019, JACC-BASIC TRANSL SC, V4, P251, DOI 10.1016/j.jacbts.2018.11.012; Badoud F, 2014, J PROTEOME RES, V13, P3455, DOI 10.1021/pr500416v; Bertrand L, 2008, CARDIOVASC RES, V79, P238, DOI 10.1093/cvr/cvn093; Biswas D, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00534; Biswas D, 2019, FASEB J, V33, P8711, DOI 10.1096/fj.201802842RR; Biswas D, 2016, FASEB J, V30, P3822, DOI 10.1096/fj.201600571RR; Boulet MM, 2015, AM J PHYSIOL-ENDOC M, V309, pE736, DOI 10.1152/ajpendo.00231.2015; Brunetti-Pierri N, 2011, HUM MOL GENET, V20, P631, DOI 10.1093/hmg/ddq507; Carnagarin R, 2015, MOL CELL ENDOCRINOL, V417, P52, DOI 10.1016/j.mce.2015.09.004; Cazzolli R, 2001, DIABETES, V50, P2210, DOI 10.2337/diabetes.50.10.2210; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Ericksen RE, 2019, CELL METAB, V29, P1151, DOI 10.1016/j.cmet.2018.12.020; Fillmore N, 2018, AM J PHYSIOL-ENDOC M, V315, pE1046, DOI 10.1152/ajpendo.00097.2018; Fonseca BD, 2014, SEMIN CELL DEV BIOL, V36, P102, DOI 10.1016/j.semcdb.2014.09.014; Fuchs CJ, 2019, AM J CLIN NUTR, V110, P862, DOI 10.1093/ajcn/nqz120; Gannon NP, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700756; Goldberg EJ, 2019, BIOCHEM J, V476, P1521, DOI 10.1042/BCJ20190182; Gran Petra, 2011, BMC Physiology, V11, P10, DOI 10.1186/1472-6793-11-10; Gray S, 2002, J BIOL CHEM, V277, P34322, DOI 10.1074/jbc.M201304200; Green CR, 2016, NAT CHEM BIOL, V12, P15, DOI [10.1038/nchembio.1961, 10.1038/NCHEMBIO.1961]; Guo X, 2016, BIOCHEM BIOPH RES CO, V480, P106, DOI 10.1016/j.bbrc.2016.09.162; HARPER AE, 1984, ANNU REV NUTR, V4, P409, DOI 10.1146/annurev.nu.04.070184.002205; Harris RA, 2004, BIOCHEM BIOPH RES CO, V313, P391, DOI 10.1016/j.bbrc.2003.11.007; Hernandez-Alvarez MI, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14120-6; Holecek M, 2017, PHYSIOL RES, V66, P959, DOI 10.33549/physiolres.933638; Hwang B, 2009, BIOCHEM J, V423, P243, DOI 10.1042/BJ20090390; Jang C, 2016, NAT MED, V22, P421, DOI 10.1038/nm.4057; Jeganathan S, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12067; Jeoung NH, 2008, AM J PHYSIOL-ENDOC M, V295, pE46, DOI 10.1152/ajpendo.00536.2007; Jeoung NH, 2012, BIOCHEM J, V443, P829, DOI 10.1042/BJ20112197; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kadota Y, 2013, OBES RES CLIN PRACT, V7, pE439, DOI 10.1016/j.orcp.2013.07.003; Kearney AL, 2019, J BIOL CHEM, V294, P16729, DOI 10.1074/jbc.RA119.010036; Kienesberger PC, 2009, J BIOL CHEM, V284, P30218, DOI 10.1074/jbc.M109.047787; Kimball SR, 2006, J NUTR, V136, p227S, DOI 10.1093/jn/136.1.227S; Lee CC, 2016, DIABETES CARE, V39, P582, DOI 10.2337/dc15-2284; Lerin C, 2016, MOL METAB, V5, P926, DOI 10.1016/j.molmet.2016.08.001; Li T, 2017, CELL METAB, V25, P374, DOI 10.1016/j.cmet.2016.11.005; Lian K, 2015, DIABETES, V64, P49, DOI 10.2337/db14-0312; Lu G, 2007, GENE DEV, V21, P784, DOI 10.1101/gad.1499107; Lu G, 2009, J CLIN INVEST, V119, P1678, DOI 10.1172/JCI38151; Lynch CJ, 2001, J NUTR, V131, p861S, DOI 10.1093/jn/131.3.861S; Mandavia C, 2012, CARDIORENAL MED, V2, P308, DOI 10.1159/000343889; McGarrah RW, 2020, AM J PHYSIOL-ENDOC M, V318, pE216, DOI 10.1152/ajpendo.00334.2019; Menni C, 2013, DIABETES, V62, P4270, DOI 10.2337/db13-0570; Moghei M, 2016, AM J PHYSIOL-CELL PH, V311, pC518, DOI 10.1152/ajpcell.00062.2016; Nair KS, 2005, J NUTR, V135, p1547S, DOI 10.1093/jn/135.6.1547S; Neinast M, 2019, ANNU REV PHYSIOL, V81, P139, DOI 10.1146/annurev-physiol-020518-114455; Neinast MD, 2019, CELL METAB, V29, P417, DOI 10.1016/j.cmet.2018.10.013; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nie CX, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19040954; Ong PS, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00395; Oppenheim RD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004263; Perez LJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03730-9; Piccolo BD, 2016, AM J PHYSIOL-ENDOC M, V310, pE958, DOI 10.1152/ajpendo.00052.2016; Prosdocimo DA, 2015, PPAR RES, V2015, DOI 10.1155/2015/201625; Prosdocimo DA, 2014, J BIOL CHEM, V289, P5914, DOI 10.1074/jbc.M113.531384; Ravi V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22903-8; Renguet E, 2017, AM J PHYSIOL-HEART C, V313, pH432, DOI 10.1152/ajpheart.00738.2016; Sailer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063950; Salazar C, 2012, METHODS MOL BIOL, V828, P13, DOI 10.1007/978-1-61779-445-2_2; Sansbury BE, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00453; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Serralde-Zuniga AE, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0431-5; Shao D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05362-7; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; She PX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059443; Siddik MA, 2019, ENDOCRINOL METAB, V34, P234, DOI 10.3803/EnM.2019.34.3.234; Silva LS, 2017, EMBO REP, V18, P2172, DOI 10.15252/embr.201744154; Small L, 2018, AM J PHYSIOL-ENDOC M, V315, pE258, DOI 10.1152/ajpendo.00386.2017; Son SM, 2019, CELL METAB, V29, P192, DOI 10.1016/j.cmet.2018.08.013; Sun HP, 2016, CIRCULATION, V133, P2038, DOI 10.1161/CIRCULATIONAHA.115.020226; Trico D, 2017, J CLIN ENDOCR METAB, V102, P2473, DOI 10.1210/jc.2017-00475; Trivedi PC, 2016, BBA-MOL CELL BIOL L, V1861, P1893, DOI 10.1016/j.bbalip.2016.09.004; Uddin GM, 2019, CIRC RES, V125; Uddin GM, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0892-3; Ugi S, 2004, MOL CELL BIOL, V24, P8778, DOI 10.1128/MCB.24.19.8778-8789.2004; Ukropcova B, 2005, J CLIN INVEST, V115, P1934, DOI 10.1172/JCI24332; Vary TC, 2007, J NUTR, V137, P1857, DOI 10.1093/jn/137.8.1857; Wang J, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01140; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang XM, 2014, MOL CELL BIOL, V34, P4088, DOI 10.1128/MCB.01035-14; Wiklund P, 2016, SCI REP-UK, V6, DOI 10.1038/srep24540; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; YEE NS, 1986, DRUG METAB DISPOS, V14, P580; Yoon MS, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111176; Zhao HS, 2020, DIABETES, V69, P1164, DOI 10.2337/db19-0920; Zhao X, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2794591; Zhou MY, 2019, DIABETES, V68, P1730, DOI 10.2337/db18-0927	90	14	14	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2020	295	46					15597	15621		10.1074/jbc.RA120.013121	http://dx.doi.org/10.1074/jbc.RA120.013121			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OY6NO	32878988	Green Published, hybrid			2022-12-26	WOS:000594361600015
J	Kalengo, NH; Sanga, LA; Philemon, RN; Obure, J; Mahande, MJ				Kalengo, Nathaniel Halide; Sanga, Leah A.; Philemon, Rune Nathaniel; Obure, Joseph; Mahande, Michael J.			Recurrence rate of preterm birth and associated factors among women who delivered at Kilimanjaro Christian Medical Centre in Northern Tanzania: A registry based cohort study	PLOS ONE			English	Article								Background Preterm birth is a public health problem particularly in low- and middle-income countries especially in sub-Saharan Africa. It is associated with infant morbidity and mortality. Survivor of preterm suffers long term health consequences such as respiratory, hearing and visual problems as well as delivering preterm infants. Preterm birth also tends to recur in subsequent pregnancies. Little is known about recurrent rate of preterm birth and associated factors in Tanzania. This study aimed to determine the recurrence rate of preterm birth and associated factors among women who delivered at Kilimanjaro Christian Medical Centre (KCMC), in Northern Tanzania. Methods A historic cohort study was designed using maternally-linked data from KCMC medical birth registry. Women who delivered 2 or more singletons were included. A total of 5,946 deliveries were analysed. Recurrence of preterm birth and associated risk factors were estimated using multivariable log-binomial regression model with robust standard error to account for repeated births from the same mother. Results Overall recurrent rate of preterm birth was 24.4%. The recurrence of early preterm birth was higher compared to late preterm birth (26.2% vs. 24.2%). Similar pattern of recurrence was observed for spontaneous and medically indicated preterm birth (13.5% vs. 10.9%, respectively). Previous preterm birth (RR;1.85, 95% CI: 1.49, 2.31), preeclampsia (RR;1.46, 95% CI: 1.07, 2.00), long inter-pregnancy interval (RR;1.22, 95% CI: 1.01, 1.49) and clinical subtypes (RR = 1.37, 95% CI: 1.00, 1.86) were important predictors for recurrent preterm birth. Conclusion Recurrence of preterm birth remains higher in this population. The rate of preterm recurrence was dependent of gestational age and sub-clinical subtype. Other factors which were associated with recurrence of preterm birth were previous preterm birth, preeclampsia and long inter-pregnancy interval. Early identification of high risk women during prenatal period is warranted.	[Kalengo, Nathaniel Halide; Sanga, Leah A.; Philemon, Rune Nathaniel; Mahande, Michael J.] Kilimanjaro Christian Med Coll, Inst Publ Hlth, Dept Epidemiol & Biostat, Moshi, Tanzania; [Obure, Joseph] Kilimanjaro Christian Med Ctr, Dept Obstet & Gynaecol, Moshi, Tanzania	Kilimanjaro Christian Medical Centre	Kalengo, NH (corresponding author), Kilimanjaro Christian Med Coll, Inst Publ Hlth, Dept Epidemiol & Biostat, Moshi, Tanzania.	nathanhalide@yahoo.com		Philemon, Rune/0000-0002-4054-0760	DELTAS Africa Initiative Sub-Saharan Africa Consortium for Advanced Biostatistics (SSACAB) [107754/Z/15/Z]; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [107754/Z/15/Z]; UK government	DELTAS Africa Initiative Sub-Saharan Africa Consortium for Advanced Biostatistics (SSACAB); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust(Wellcome TrustEuropean Commission); UK government	This study was supported through the DELTAS Africa Initiative Sub-Saharan Africa Consortium for Advanced Biostatistics (SSACAB) (Grant No. 107754/Z/15/Z). The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS) Alliance for Accelerating Excellence in Science in Africa (AESA) and is supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (Grant No. 107754/Z/15/Z) and the UK government. The views expressed in this publication are those of the authors and not necessarily those of the AAS, NEPAD Agency, Wellcome Trust or the UK government.	Adams MM, 2000, JAMA-J AM MED ASSOC, V283, P1591, DOI 10.1001/jama.283.12.1591; Ananth C V, 2006, RECURRENCE SPONTANEO; Ananth CV, 2008, CLIN PERINATOL, V35, P53, DOI 10.1016/j.clp.2007.11.001; [Anonymous], 2013, ECON J WATCH, V10, pA1; [Anonymous], 2014, GASTROENTEROLOGY S1, V10, P1; [Anonymous], 2017, KIDNEY INT S, V7, p[1, 1], DOI DOI 10.1016/j.kisu.2017.04.001; Beeckman K, 2009, ACTA OBSTET GYN SCAN, V88, P787, DOI 10.1080/00016340902974007; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Goldenberg R. L., 2009, OBSTET ANESTH DIG, V29, P6, DOI DOI 10.1097/01.aoa.0000344666.82463.8d; Harrison MS, 2016, SEMIN FETAL NEONAT M, V21, P74, DOI 10.1016/j.siny.2015.12.007; Koullali B, 2016, SEMIN FETAL NEONAT M, V21, P80, DOI 10.1016/j.siny.2016.01.005; Koullali B, 2017, SEMIN PERINATOL, V41, P505, DOI 10.1053/j.semperi.2017.08.009; Laughon S, 2014, AM J EPIDEMIOL; Mahande MJ, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0929-5; Mahande MJ, 2013, TROP MED INT HEALTH, V18, P962, DOI 10.1111/tmi.12111; National Bureau of Statistics, 2013, NBS MINIST FINANC, V177, P180; Simonsen SE, 2013, BJOG-INT J OBSTET GY, V120, P863, DOI 10.1111/1471-0528.12182; UNICEF, 2015, TANZ PROF PRET LOW B, P10; WHO, 2012, WORLD HEAL ORGAN, P1; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Yang J, 2016, OBSTET GYNECOL, V128, P364, DOI 10.1097/AOG.0000000000001506	21	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0239037	10.1371/journal.pone.0239037	http://dx.doi.org/10.1371/journal.pone.0239037			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925974	gold, Green Published			2022-12-26	WOS:000572318000055
J	Li, TC; Li, CI; Liu, CS; Lin, WY; Lin, CH; Yang, SY; Lin, CC				Li, Tsai-Chung; Li, Chia-Ing; Liu, Chiu-Shong; Lin, Wen-Yuan; Lin, Chih-Hsueh; Yang, Shing-Yu; Lin, Cheng-Chieh			Derivation and validation of 10-year all-cause and cardiovascular disease mortality prediction model for middle-aged and elderly community-dwelling adults in Taiwan	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; ANKLE-BRACHIAL INDEX; KIDNEY-DISEASE; RISK; ASSOCIATION; GENDER	Prediction model mainly focused on specific diseases, such as diabetes, hypertension, cardiovascular disease, or patients with cancer, or populations of Europe and America, thereby limiting its generalization. This study aimed to develop and validate a 10-year mortality risk score by using data from a population-representative sample of adults. Data were collected from 2,221 Taichung Community Health study participants aged >= 40 years. The baseline period of the study was 2004, and all participants were followed up until death or in 2016. Cox's proportional hazards regression analyses were used to develop the prediction model. A total of 262 deaths were ascertained during the 10-year follow-up. The all-cause mortality prediction model calculated the significant risk factors, namely, age, sex, marital status, physical activity, tobacco use, estimated glomerular filtration rate, and albumin-to-creatinine ratio, among the baseline risk factors. The expanded cardiovascular disease (CVD) mortality prediction model consisted of six variables: age, sex, body mass index, heart disease plus heart disease medication use, stroke plus medication use, and ankle-brachial index. The areas under receiver operating curves of the 3-, 5- and 10-year predictive models varied between 0.97, 0.96, and 0.88 for all-cause mortality, and between 0.97, 0.98, and 0.84 for expanded CVD mortality. These mortality prediction models are valid and can be used as tools to identify the increased risk for mortality.	[Li, Tsai-Chung; Yang, Shing-Yu] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan; [Li, Tsai-Chung] Asia Univ, Coll Med & Hlth Sci, Dept Healthcare Adm, Taichung, Taiwan; [Li, Chia-Ing; Liu, Chiu-Shong; Lin, Wen-Yuan; Lin, Chih-Hsueh; Lin, Cheng-Chieh] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Li, Chia-Ing; Liu, Chiu-Shong; Lin, Cheng-Chieh] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Liu, Chiu-Shong; Lin, Wen-Yuan; Lin, Chih-Hsueh; Lin, Cheng-Chieh] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan	China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lin, CC (corresponding author), China Med Univ, Coll Med, Sch Med, Taichung, Taiwan.; Lin, CC (corresponding author), China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.; Lin, CC (corresponding author), China Med Univ Hosp, Dept Family Med, Taichung, Taiwan.	cclin@mail.cmuh.org.tw	Lin, Cheng-Chieh/P-2564-2015	Lin, Cheng-Chieh/0000-0002-9625-6216	Ministry of Science and Technology of Taiwan [NSC94-2314-B-039-024, NSC94-2314-B-039019, MOST 104-2314-B-039-016, MOST 1052314-B-039-021-MY3, MOST 105-2314-B-039025-MY3, MOST 107-2314-B-039-049, MOST 108-2314-B-039-039, MOST 108-2314-B-039-035-MY3, MOST 108-2314-B-039-031-MY2]; China Medical University Hospital [DMR-108215]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); China Medical University Hospital	This study was supported primarily by the Ministry of Science and Technology of Taiwan (NSC94-2314-B-039-024, NSC94-2314-B-039019, MOST 104-2314-B-039-016, MOST 1052314-B-039-021-MY3, MOST 105-2314-B-039025-MY3, MOST 107-2314-B-039-049, MOST 108-2314-B-039-039, MOST 108-2314-B-039-035-MY3 and MOST 108-2314-B-039-031-MY2) and China Medical University Hospital(DMR-108215). The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	[Anonymous], 2013, BMJ, V346, pf1125, DOI 10.1136/bmj.f1125; Bello GA, 2015, BIOINFORM BIOL INSIG, V9, P1, DOI 10.4137/BBI.S30172; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Breithaupt-Grogler K, 1999, PATHOL BIOL, V47, P604; Chen YJ, 2014, ANGIOLOGY, V65, P396, DOI 10.1177/0003319713480842; Cortez-Cooper MY, 2003, AM J CARDIOL, V91, P1519, DOI 10.1016/S0002-9149(03)00416-8; Damen JAAG, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2416; Deo R, 2016, CIRCULATION, V134, P806, DOI 10.1161/CIRCULATIONAHA.116.023042; Ding D, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001917; Franconi F, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050476; Goldman N, 2015, ANN EPIDEMIOL, V25, P901, DOI 10.1016/j.annepidem.2015.08.008; Hall ME, 2014, INT J NEPHROL RENOV, V7, P75, DOI 10.2147/IJNRD.S39739; Hartaigh BO, 2018, JACC-CARDIOVASC IMAG, V11, P450, DOI 10.1016/j.jcmg.2017.03.018; Kobayashi LC, 2017, AGE AGEING, V46, P427, DOI 10.1093/ageing/afw199; Lassman D, 2014, HEALTH AFFAIR, V33, P815, DOI 10.1377/hlthaff.2013.1224; Lee WJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40427; Lim SS, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0059-8; Lin CC, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061665; Lin CC, 2019, DIABETES METAB, V45, P564, DOI 10.1016/j.diabet.2019.02.007; Lin CC, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-131; Lin CC, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.07.027; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; MOHW, 2017, 2017 STAT CAUS DEATH; MOI, 2017, POP SEX 5 YEAR AG GR; Munakata M, 2003, AM J HYPERTENS, V16, P653, DOI 10.1016/S0895-7061(03)00918-X; Pencina MJ, 2009, CIRCULATION, V119, P3078, DOI 10.1161/CIRCULATIONAHA.108.816694; Qu BZ, 2015, CELL BIOCHEM BIOPHYS, V73, P571, DOI 10.1007/s12013-015-0582-z; Roumie CL, 2014, JAMA-J AM MED ASSOC, V311, P2288, DOI 10.1001/jama.2014.4312; Royce TJ, 2014, JAMA INTERN MED, V174, P1558, DOI 10.1001/jamainternmed.2014.3895; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Schonberg MA, 2009, J GEN INTERN MED, V24, P1115, DOI 10.1007/s11606-009-1073-y; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Steyerberg E, 2009, SPRINGER SERIES STAT, VSecond; Suemoto CK, 2017, J GERONTOL A-BIOL, V72, P410, DOI 10.1093/gerona/glw166; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Tomiyama H, 2003, ATHEROSCLEROSIS, V166, P303, DOI 10.1016/S0021-9150(02)00332-5; Tonkin AM, 2015, INT J CARDIOL, V201, P499, DOI 10.1016/j.ijcard.2015.07.080; Turusheva A, 2017, ARCH GERONTOL GERIAT, V71, P105, DOI 10.1016/j.archger.2017.03.004; Wang JW, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0603-9; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Were WM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4300; Wu CL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095300, 10.1371/journal.pone.0102589]; Wu ZT, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001435; Xu DC, 2010, VASC MED, V15, P361, DOI 10.1177/1358863X10378376; Yamashina A, 2003, HYPERTENS RES, V26, P615, DOI 10.1291/hypres.26.615; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359	47	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0239063	10.1371/journal.pone.0239063	http://dx.doi.org/10.1371/journal.pone.0239063			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925948	Green Published, gold			2022-12-26	WOS:000572318000034
J	Wang, CL; Lv, YY; Li, AZ; Yao, Q; Feng, GD; Zhu, HH				Wang, Chunling; Lv, Yingying; Li, Anzhang; Yao, Qing; Feng, Guangda; Zhu, Honghui			Culture-dependent and -independent methods revealed an abundant myxobacterial community shaped by other bacteria and pH in Dinghushan acidic soils	PLOS ONE			English	Article								Myxobacteria are one of the most promising secondary metabolites producers. However, they are difficult to isolate and cultivate. To obtain more myxobacteria and know the effects of environmental factors on myxobacterial community, we characterized myxobacterial communities in Dinghushan acidic forest soils of pH 3.6-4.5 with culture-dependent and -independent techniques, and analyzed environmental factors shaping myxobacterial communities. A total of 21 myxobacteria were isolated using standard cultivation methods, including eleven isolates ofCorallococcus, nine isolates ofMyxococcusand one isolate ofArchangium, and contained three potential novel species. In addition, a total of 67 unknown myxobacterial operational taxonomic units (OTUs) were obtained using high-throughput sequencing method. The abundance ofMyxococcalesaccount for 0.9-2.2% of bacterial communities, andSorangiumis the most abundant genus (60.1%) inMyxococcales. Correlation analysis demonstrated that bacterial diversity and soil pH are the key factors shaping myxobacterial community. These results revealed an abundant myxobacterial community which is shaped by other bacteria and pH in Dinghushan acidic forest soils.	[Wang, Chunling; Lv, Yingying; Li, Anzhang; Feng, Guangda; Zhu, Honghui] Guangdong Acad Sci, Guangdong Microbial Culture Collect Ctr GDMCC, Guangdong Open Lab Appl Microbiol,State Key Lab A, Guangdong Inst Microbiol,Guangdong Prov Key Lab M, Guangzhou, Guangdong, Peoples R China; [Yao, Qing] South China Agr Univ, Coll Hort, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences; South China Agricultural University	Zhu, HH (corresponding author), Guangdong Acad Sci, Guangdong Microbial Culture Collect Ctr GDMCC, Guangdong Open Lab Appl Microbiol,State Key Lab A, Guangdong Inst Microbiol,Guangdong Prov Key Lab M, Guangzhou, Guangdong, Peoples R China.	zhuhh@gdim.cn			National Science Foundation of China [31800003]; GDAS' Special Project of Science and Technology Development [2020GDASYL-20200103032]; Guangdong Province Science and Technology Innovation Strategy Special Fund [2018B020205003]; Science and Technology Plan Project of Guangdong [2019B030316009]; Science and Technology Plan Project of Guangzhou [201704020088]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); GDAS' Special Project of Science and Technology Development; Guangdong Province Science and Technology Innovation Strategy Special Fund; Science and Technology Plan Project of Guangdong; Science and Technology Plan Project of Guangzhou	This work was supported by the National Science Foundation of China 31800003 (LYY) (http://www.nsfc.gov.cn/), the GDAS' Special Project of Science and Technology Development 2020GDASYL-20200103032 (WCL) (http://www.gdas.gd.cn/), the Guangdong Province Science and Technology Innovation Strategy Special Fund 2018B020205003 (FGD) (http://gdstc.gd.gov.cn/tzgg/), the Science and Technology Plan Project of Guangdong 2019B030316009 (LAZ) (http://pro.gdstc.gd.gov.cn/egrantweb/) and the Science and Technology Plan Project of Guangzhou 201704020088 (LAZ) (http://sop.gzsi.gov.cn/).	Ahn JW, 2008, ORG LETT, V10, P1167, DOI 10.1021/ol800061h; [Anonymous], 2018, LANCET DIABETES ENDO, V6, P1, DOI DOI 10.1080/08927022.2018.1510179; Berleman JE, 2007, J BACTERIOL, V189, P5675, DOI 10.1128/JB.00544-07; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chen BM, 2017, ACTA OECOL, V81, P1, DOI 10.1016/j.actao.2017.04.003; Chen DH, 1999, PLANT MOL BIOL REP, V17, P53, DOI 10.1023/A:1007585532036; Chun J, 2018, INT J SYST EVOL MICR, V68, P461, DOI [10.1099/ijsem.0.002532, 10.1099/ijsem.0.002516]; Coil D, 2015, BIOINFORMATICS, V31, P587, DOI 10.1093/bioinformatics/btu661; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Hagiwara D, 2016, FRONT MICROBIOL, V7, P1, DOI [10.3389/fmicb.2016.01382, DOI 10.3389/FMICB.2016.01382]; HEANES DL, 1984, COMMUN SOIL SCI PLAN, V15, P1191, DOI 10.1080/00103628409367551; HEDLEY MJ, 1982, SOIL SCI SOC AM J, V46, P970, DOI 10.2136/sssaj1982.03615995004600050017x; Jahns C, 2012, ANGEW CHEM INT EDIT, V51, P5239, DOI 10.1002/anie.201200327; KAISER D, 1979, ANNU REV MICROBIOL, V33, P595, DOI 10.1146/annurev.mi.33.100179.003115; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Li SG, 2012, ENV MICROBIOL REP, V4, P587, DOI 10.1111/j.1758-2229.2012.00373.x; Li ZK, 2017, BIOL CONTROL, V110, P10, DOI 10.1016/j.biocontrol.2017.04.001; Livingstone PG, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.01931-19; Livingstone PG, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01593; Lu, 2000, SOIL ANAL METHODS AG; Lv YY, 2019, INT J SYST EVOL MICR, V69, P625, DOI 10.1099/ijsem.0.003116; Lv YY, 2018, INT J SYST EVOL MICR, V68, P2139, DOI 10.1099/ijsem.0.002700; Lv YY, 2016, INT J SYST EVOL MICR, V66, P1785, DOI 10.1099/ijsem.0.000940; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; MoCotPRo C, 1999, 501231999 GBT; Mohr KI, 2018, INT J SYST EVOL MICR, V68, P3576, DOI 10.1099/ijsem.0.003034; Mohr KI, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.464; Mohr KI, 2016, MICROBIOLOGYOPEN, V5, P268, DOI 10.1002/mbo3.325; Morgan AD, 2010, APPL ENVIRON MICROB, V76, P6920, DOI 10.1128/AEM.00414-10; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schaberle TF, 2014, NAT PROD REP, V31, P953, DOI 10.1039/c4np00011k; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimkets L.J., 2006, PROKARYOTES, P31, DOI [10.1007/0-387-30747-8_3, DOI 10.1007/0-387-30747-8_3]; Thiery S, 2020, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2020.00002; VRANEK J, 2016, HABITAT 3 NACL DOPRI, V45-47, P39; Wang CL, 2019, INT J SYST EVOL MICR, V69, P1650, DOI 10.1099/ijsem.0.003374; Wang CL, 2019, INT J SYST EVOL MICR, V69, P909, DOI 10.1099/ijsem.0.003212; Wang WH, 2020, APPL SOIL ECOL, V146, DOI 10.1016/j.apsoil.2019.103365; Weissman KJ, 2010, NAT PROD REP, V27, P1276, DOI 10.1039/c001260m; Whitworth DE, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P1; Wrotniak-Drzewiecka W, 2016, ANN MICROBIOL, V66, P17, DOI 10.1007/s13213-015-1104-3; Xiong YM, 2008, PLANT SOIL, V304, P179, DOI 10.1007/s11104-007-9536-6; Xu N, 2016, EUR J SOIL BIOL, V74, P1, DOI 10.1016/j.ejsobi.2016.02.004; Yoon SH, 2017, ANTON LEEUW INT J G, V110, P1281, DOI 10.1007/s10482-017-0844-4; Zhang XY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060781, 10.1371/journal.pone.0053931, 10.1371/journal.pone.0061922]; Zhou XW, 2014, ENV MICROBIOL REP, V6, P45, DOI 10.1111/1758-2229.12107; Zhou Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10613-6	48	4	5	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0238769	10.1371/journal.pone.0238769	http://dx.doi.org/10.1371/journal.pone.0238769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925929	Green Published, gold			2022-12-26	WOS:000572318000023
J	Lu, J; Wang, Z; Hua, BW; Chen, K				Lu, Jun; Wang, Zhuo; Hua, Bowen; Chen, Kun			Automatic point cloud registration algorithm based on the feature histogram of local surface	PLOS ONE			English	Article							DESCRIPTORS	In this paper, we present an efficient algorithm for point cloud registration in presence of low overlap rate and high noise. The proposed registration method mainly includes four parts: the loop voxel filtering, the curvature-based key point selection, the robust geometric descriptor, and the determining and optimization of correspondences based on key point spatial relationship. The loop voxel filtering filters point clouds to a specified resolution. We propose a key point selection algorithm which has a better anti-noise and fast ability. The feature descriptor of key points is highly exclusive which is based on the geometric relationship between the neighborhood points and the center of gravity of the neighborhood. The correspondences in the pair of two point clouds are determined according to the combined features of key points. Finally, the singular value decomposition and ICP algorithm are applied to align two point clouds. The proposed registration method can accurately and quickly register point clouds of different resolutions in noisy situations. We validate our proposal by presenting a quantitative experimental comparison with state-of-the-art methods. Experimental results show that the proposed point cloud registration algorithm has faster calculation speed, higher registration accuracy, and better anti-noise performance.	[Lu, Jun; Wang, Zhuo; Hua, Bowen; Chen, Kun] Harbin Engn Univ, Coll Automat, Harbin, Peoples R China; [Lu, Jun; Wang, Zhuo; Hua, Bowen; Chen, Kun] Harbin Engn Univ, Key Lab Intelligent Technol & Applicat Marine Equ, Minist Educ, Harbin, Peoples R China	Harbin Engineering University; Harbin Engineering University	Lu, J (corresponding author), Harbin Engn Univ, Coll Automat, Harbin, Peoples R China.; Lu, J (corresponding author), Harbin Engn Univ, Key Lab Intelligent Technol & Applicat Marine Equ, Minist Educ, Harbin, Peoples R China.	lujun0260@sina.com	jun, lu/A-1694-2012	Lu, Jun/0000-0002-3048-4857; Wang, Zhuo/0000-0001-9700-7556	Natural Science Foundation of Heilongjiang Province of China	Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province)	This research was supported, in part, by the Natural Science Foundation of Heilongjiang Province of China in the form of a grant awarded to JL (No.F201123). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agamennoni G, 2016, 2016 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS (IROS 2016), P4092, DOI 10.1109/IROS.2016.7759602; Aiger D, 2008, ACM PRESS ACM SIGGRA; Amberg B, 2007, IEEE I CONF COMP VIS, P1326; Besl P.J., 1992, IEEE TRANS PATTERN A; Biber P, 2003, IROS 2003: PROCEEDINGS OF THE 2003 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-4, P2743, DOI 10.1109/iros.2003.1249285; Bueno M, 2017, AUTOMAT CONSTR, V81, P134, DOI 10.1016/j.autcon.2017.06.016; Chang WC, 2018, INTERNATIONAL AUTOMA, P04; Chen WL, 2018, IEEE SYS MAN CYBERN, P2102, DOI 10.1109/SMC.2018.00362; CHEN Y, 1992, IMAGE VISION COMPUT, V10, P145, DOI 10.1016/0262-8856(92)90066-C; Ge XM, 2017, ISPRS J PHOTOGRAMM, V130, P344, DOI 10.1016/j.isprsjprs.2017.06.011; Gezero L, 2017, ISPRS INT; Han M, 2015, JOURNAL OF HUAZHONG; Hong Hyunki, 2017, INTERNATIONAL CONFER, P24; Ji S, 2017, OPTIK INTERNATIONAL; Kleppe AL, 2018, ADV APPL CLIFFORD AL, V28, DOI 10.1007/s00006-018-0864-9; Lei H, 2017, IEEE T IMAGE PROCESS, V26, P3614, DOI 10.1109/TIP.2017.2700727; Li Q, 2018, MEAS SCI TECHNOL, V29, DOI 10.1088/1361-6501/aadff6; Liu ST, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18113608; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Magnusson M., 2009, THESIS; Meng JG, 2019, PROC SPIE, V10839, DOI 10.1117/12.2504772; Prakhya S M, 2016, AUTONOMOUS ROBOTS; Prakhya SM, 2016, PATTERN RECOGN LETT, V83, P42, DOI 10.1016/j.patrec.2016.06.002; Rusu RB, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P1, DOI 10.1109/IROS.2009.5354683; Salti S, 2014, COMPUT VIS IMAGE UND, V125, P251, DOI 10.1016/j.cviu.2014.04.011; Wang X, 2017, AER ADV ENG RES, V138, P543; XIAN Y, 2019, J CROHNS COLITIS S1, V13; Ye Q, 2018, PROC SPIE, V10964, DOI 10.1117/12.2505869	30	6	8	6	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238802	10.1371/journal.pone.0238802	http://dx.doi.org/10.1371/journal.pone.0238802			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915857	Green Published, gold			2022-12-26	WOS:000571887500026
J	Wen, SM; He, YD; Wang, LW; Zhang, J; Quan, CY; Niu, YJ; Huang, HJ				Wen, Simeng; He, Yundong; Wang, Liewei; Zhang, Jun; Quan, Changyi; Niu, Yuanjie; Huang, Haojie			Aberrant activation of super enhancer and choline metabolism drive antiandrogen therapy resistance in prostate cancer	ONCOGENE			English	Article							INTEGRATIVE CLINICAL GENOMICS; PHOSPHOLIPID-METABOLISM; CELL IDENTITY; SELECTIVE-INHIBITION; ENZALUTAMIDE; TRANSCRIPTION; DEPENDENCIES; BICALUTAMIDE; STIMULATION; MECHANISMS	Next generation antiandrogens such as enzalutamide (Enz) are effective initially for the treatment of castration-resistant prostate cancer (CRPC). However, the disease often relapses and the underlying mechanisms remain elusive. By performing H3-lysine-27 acetylation (H3K27ac) ChIP-seq in Enz-resistant CRPC cells, we identified a group of super enhancers (SEs) that are abnormally activated in Enz-resistant CRPC cells and associated with enhanced transcription of a subset of tumor promoting genes such asCHPT1, which catalyzes phosphatidylcholine (PtdCho) synthesis and regulates choline metabolism. Increased CHPT1 conferred CRPC resistance to Enz in vitro and in mice. While androgen receptor (AR) primarily binds to a putativeCHPT1enhancer and mediates androgen-dependent expression ofCHPT1gene in Enz-sensitive prostate cancer cells, AR binds to a different enhancer within theCHPT1SE locus and facilities androgen-independent expression ofCHPT1in Enz-resistant cells. We further identified a long-non coding RNA transcribed atCHPT1enhancer (also known as enhancer RNA) that binds to the H3K27ac reader BRD4 and participates in regulatingCHPT1SE activity andCHPT1gene expression. Our findings demonstrate that aberrantly activated SE upregulates CHPT1 expression and confers Enz resistance in CRPC, suggesting that SE-mediated expression of downstream effectors such as CHPT1 can be viable targets to overcome Enz resistance in PCa.	[Wen, Simeng; Quan, Changyi; Niu, Yuanjie] Tianjin Med Univ, Tianjin Inst Urol, Hosp 2, Dept Urol, Tianjin, Peoples R China; [Wen, Simeng; He, Yundong; Huang, Haojie] Mayo Clin, Dept Biochem & Mol Biol, Coll Med & Sci, Rochester, MN 55905 USA; [Wang, Liewei] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Coll Med & Sci, Rochester, MN USA; [Zhang, Jun] Mayo Clin, Dept Lab Med & Pathol, Coll Med & Sci, Scottsdale, AZ USA; [Huang, Haojie] Mayo Clin, Dept Urol, Coll Med & Sci, Rochester, MN 55905 USA; [Huang, Haojie] Mayo Clin, Ctr Canc, Coll Med & Sci, Rochester, MN 55905 USA	Tianjin Medical University; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic	Quan, CY; Niu, YJ (corresponding author), Tianjin Med Univ, Tianjin Inst Urol, Hosp 2, Dept Urol, Tianjin, Peoples R China.; Huang, HJ (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Coll Med & Sci, Rochester, MN 55905 USA.; Huang, HJ (corresponding author), Mayo Clin, Dept Urol, Coll Med & Sci, Rochester, MN 55905 USA.; Huang, HJ (corresponding author), Mayo Clin, Ctr Canc, Coll Med & Sci, Rochester, MN 55905 USA.	quancy98@163.com; niuyuanjie9317@163.com; huang.haojie@mayo.edu			Mayo Clinic Foundation; National Natural Science Foundation of China [81972654]; Tianjin International Student Science and Technology Activities Launched Project [20160014]; Tianjin science and technology commission [18JCZDJC34800]	Mayo Clinic Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin International Student Science and Technology Activities Launched Project; Tianjin science and technology commission	This work was supported in part by the Mayo Clinic Foundation (to HH) and the National Natural Science Foundation of China (81972654 to SW), Tianjin International Student Science and Technology Activities Launched Project (20160014 to SW), and Tianjin science and technology commission (18JCZDJC34800 to CQ).	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Abida W, 2019, P NATL ACAD SCI USA, V116, P11428, DOI 10.1073/pnas.1902651116; Ackerstaff E, 2003, J CELL BIOCHEM, V90, P525, DOI 10.1002/jcb.10659; Anthony ML, 1999, J BIOL CHEM, V274, P19686, DOI 10.1074/jbc.274.28.19686; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Beagrie RA, 2016, BIOESSAYS, V38, P881, DOI 10.1002/bies.201600032; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Chatterjee D, 2001, BIOCHEM BIOPH RES CO, V282, P861, DOI 10.1006/bbrc.2001.4662; Cho WK, 2018, SCIENCE, V361, P412, DOI 10.1126/science.aar4199; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Di Micco R, 2014, CELL REP, V9, P234, DOI 10.1016/j.celrep.2014.08.055; Donati B, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0915-9; Doroshow DB, 2017, ANN ONCOL, V28, P1776, DOI 10.1093/annonc/mdx157; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Glunde K, 2004, CANCER RES, V64, P4270, DOI 10.1158/0008-5472.CAN-03-3829; Glunde K, 2011, NAT REV CANCER, V11, P835, DOI 10.1038/nrc3162; Hah N, 2015, P NATL ACAD SCI USA, V112, pE297, DOI 10.1073/pnas.1424028112; Hajmirza A, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6010016; He Y, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00361; Heidenreich A, 2017, EUR UROL, V71, P534, DOI 10.1016/j.eururo.2016.07.027; Hentze MW, 2018, NAT REV MOL CELL BIO, V19, P327, DOI 10.1038/nrm.2017.130; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Jia M, 2016, CANCER RES, V76, P5634, DOI 10.1158/0008-5472.CAN-15-2910; Katz-Brull R, 2001, MAGNET RESON MED, V46, P31, DOI 10.1002/mrm.1157; Khan A, 2018, EPIGENETICS-US, V13, P910, DOI 10.1080/15592294.2018.1514231; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Ko JY, 2017, MOL CELLS, V40, P169, DOI 10.14348/molcells.2017.0033; Kohli M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145176; Kvaratskhelia M, 2014, NUCLEIC ACIDS RES, V42, P10209, DOI 10.1093/nar/gku769; Larue RC, 2014, NUCLEIC ACIDS RES, V42, P4868, DOI 10.1093/nar/gku135; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Li YM, 2013, CANCER RES, V73, P483, DOI 10.1158/0008-5472.CAN-12-3630; Lin D, 2014, CANCER RES, V74, P1272, DOI 10.1158/0008-5472.CAN-13-2921-T; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Miquel K, 1998, J BIOL CHEM, V273, P26179, DOI 10.1074/jbc.273.40.26179; Mousavi K, 2013, MOL CELL, V51, P606, DOI 10.1016/j.molcel.2013.07.022; Niu Y, 2010, ONCOGENE, V29, P3593, DOI 10.1038/onc.2010.121; Ramos B, 2002, MOL PHARMACOL, V62, P1068, DOI 10.1124/mol.62.5.1068; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Robinson DR, 2017, NATURE, V548, P297, DOI 10.1038/nature23306; ROHRSCHNEIDER LR, 1973, CANCER RES, V33, P1945; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Sen P, 2019, MOL CELL, V73, P684, DOI 10.1016/j.molcel.2019.01.021; Sengupta S, 2017, TRENDS CANCER, V3, P269, DOI 10.1016/j.trecan.2017.03.006; Sharp A, 2019, J CLIN INVEST, V129, P192, DOI 10.1172/JCI122819; Shore ND, 2016, LANCET ONCOL, V17, P153, DOI 10.1016/S1470-2045(15)00518-5; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Stelloo S, 2019, ENDOCR-RELAT CANCER, V26, pR267, DOI 10.1530/ERC-19-0032; Ting YLT, 1996, ANTICANCER RES, V16, P1381; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; WERTZ PW, 1978, CANCER RES, V38, P2900; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xie JJ, 2018, GASTROENTEROLOGY, V154, P2137, DOI 10.1053/j.gastro.2018.02.018; Zanconato F, 2018, NAT MED, V24, P1599, DOI 10.1038/s41591-018-0158-8; Zhao Y, 2016, CELL REP, V15, P599, DOI 10.1016/j.celrep.2016.03.038; Zuber V, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3620-y	63	19	20	3	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 15	2020	39	42					6556	6571		10.1038/s41388-020-01456-z	http://dx.doi.org/10.1038/s41388-020-01456-z		SEP 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	OA9HI	32917955				2022-12-26	WOS:000568475200002
J	Kagujje, M; Chilukutu, L; Somwe, P; Mutale, J; Chiyenu, K; Lumpa, M; Mwanza, W; Muyoyeta, M				Kagujje, Mary; Chilukutu, Lophina; Somwe, Paul; Mutale, Jacob; Chiyenu, Kanema; Lumpa, Mwansa; Mwanza, Winfrida; Muyoyeta, Monde			Active TB case finding in a high burden setting; comparison of community and facility-based strategies in Lusaka, Zambia	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; CARE	Introduction We conducted an implementation science study to increase TB case detection through a combination of interventions at health facility and community levels. We determined the impact of the study in terms of additional cases detected and notification rate and compared the yield of bacteriologically confirmed TB of facility based and community based case finding. Methodology Over a period of 18 months, similar case finding activities were conducted at George health facility in Lusaka Zambia and its catchment community, an informal peri-urban settlement. Activities included awareness and demand creation activities, TB screening with digital chest x-ray or symptom screening, sputum evaluation using geneXpert MTB/RIF, TB diagnosis and linkage to treatment. Results A total of 18,194 individuals were screened of which 9,846 (54.1%) were screened at the facility and 8,348 (45.9%) were screened in the community. The total number of TB cases diagnosed during the intervention period were 1,026, compared to 759 in the pre-intervention period; an additional 267 TB cases were diagnosed. Of the 563 bacteriologically confirmed TB cases diagnosed under the study, 515/563 (91.5%) and 48/563 (8.5%) were identified at the facility and in the community respectively (P<0.0001). The TB notification rate increased from 246 per 100,000 population pre-intervention to 395 per 100,000 population in the last year of the intervention. Conclusions Facility active case finding was more effective in detecting TB cases than community active case finding. Strengthening health systems to appropriately identify and evaluate patients for TB needs to be optimised in high burden settings. At a minimum, provider initiated TB symptom screening with completion of the TB screening and diagnostic cascade should be provided at the health facility in high burden settings. Community screening needs to be systematic and targeted at high risk groups and communities with access barriers.	[Kagujje, Mary; Chilukutu, Lophina; Mwanza, Winfrida; Muyoyeta, Monde] Ctr Infect Dis Res Zambia, TB Dept, Lusaka, Zambia; [Somwe, Paul; Mutale, Jacob; Chiyenu, Kanema; Lumpa, Mwansa] Ctr Infect Dis Res Zambia, Strateg Informat Dept, Lusaka, Zambia		Kagujje, M (corresponding author), Ctr Infect Dis Res Zambia, TB Dept, Lusaka, Zambia.	mkagujje@gmail.com		Mutale, Jacob/0000-0002-8914-0645; Kagujje, Mary/0000-0003-4818-6548	Stop TB Partnership's TB REACH initiative [STBP/TBREACH/GSA/W5-26]; government of Canada	Stop TB Partnership's TB REACH initiative; government of Canada(CGIAR)	Initials: MM Grant Number: STBP/TBREACH/GSA/W5-26 Funder: The Stop TB Partnership's TB REACH initiative with funding from the government of Canada URL: http://www.stoptb.org/global/awards/tbreach/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre E, 2018, B WORLD HEALTH ORGAN, V96, P522, DOI 10.2471/BLT.17.203968; Asres A, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-018-0628-2; Bailey SL, 2011, INT J TUBERC LUNG D, V15, P205; Claassens MM, 2013, INT J TUBERC LUNG D, V17, P608, DOI 10.5588/ijtld.12.0506; Dheda K, 2018, INT J TUBERC LUNG D, V22, P1115, DOI 10.5588/ijtld.18.0583; Expert Panel on Gastrointestinal Imaging, 2019, J AM COLL RADIOL, V16, pS141, DOI 10.1016/j.jacr.2019.02.015; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Karamagi E, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3786-2; Khan AJ, 2012, LANCET INFECT DIS, V12, P608, DOI 10.1016/S1473-3099(12)70116-0; Kweza PF, 2018, INT J TUBERC LUNG D, V22, P264, DOI 10.5588/ijtld.17.0491; Lee CH, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2554-y; Marks GB, 2019, NEW ENGL J MED, V381, P1347, DOI 10.1056/NEJMoa1902129; [Ministry of Health Zambia. Research DoPHa], 2017, NAT STRAT PLAN TUB P, P15; Myint O, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0291-5; National TB Program, 2014, ZAMB NAT PREV SURV 2; Okorie O, 2018, ADV INFECT DIS, V08, P173; Prasad BM, 2016, PUBLIC HEALTH ACTION, V6, P15, DOI 10.5588/pha.15.0035; Shete PB, 2015, INT J TUBERC LUNG D, V19, P912, DOI 10.5588/ijtld.14.0166; SK AZ, 2016, DIABETOL STOFFWECHS, V11, pS01; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Stop TB Partnership, 2019, COUNTR INT DASHB SIT; The National TB and Leprosy Control Program, 2017, TB MAN; WHO, 2019, GLOB TUB REP; WHO, 2015, WORLD HEAL ORGAN, V58, P7250; World Health Organization, 2013, SYST SCREEN ACT TUB; World Health Organization, 2019, JOINT IN FIND TREAT; World Health Organization, 2017, 9789241565516 WHO; 2014, REG ANESTH PAIN MED, V9	28	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0237931	10.1371/journal.pone.0237931	http://dx.doi.org/10.1371/journal.pone.0237931			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911494	gold, Green Published			2022-12-26	WOS:000571885900054
J	Smythe, T; Matos, M; Reis, J; Duttine, A; Ferrite, S; Kuper, H				Smythe, Tracey; Matos, Monica; Reis, Julia; Duttine, Antony; Ferrite, Silvia; Kuper, Hannah			Mothers as facilitators for a parent group intervention for children with Congenital Zika Syndrome: Qualitative findings from a feasibility study in Brazil	PLOS ONE			English	Article							NEWBORN; INFANTS	Background The Zika virus outbreak in Brazil (2015-2016) affected thousands of children who were born with Congenital Zika Syndrome (CZS). Families play an important role in their care of children with complex needs, yet their knowledge, experience and skills are rarely harnessed in existing interventions to best support these families. Objective This study explores the use of mothers as facilitators for a community-based group intervention for children with CZS and their caregivers in Brazil. Methods Four facilitators were trained to deliver the 10-week intervention called "Juntos". Two were mothers of a child with CZS ("expert mothers") and two were therapists (speech therapist and physiotherapist). The intervention was delivered to three groups, generally including 8-10 caregivers. Two researchers, who were psychologists, observed the groups and held focus group discussions at the end of each session. They undertook semi-structured interviews post intervention with a purposive sample of caregivers, and with the facilitators. Observation notes were collated and summarised. Transcripts were transcribed and thematically analysed using five elements to assess feasibility: acceptability, demand, implementation, practicality and adaptation. Results The use of expert mothers as facilitators was considered to be acceptable and there was demand for their role. Their experiential knowledge was viewed as important for sharing and learning, and supporting and encouraging the group. The intervention was delivered with fidelity by the expert mothers. The practicality of the intervention was facilitated by holding the group sessions in the community, providing transport costs to facilitators and participants, paying expert mothers and therapist facilitators equally and supporting the expert mothers through a mentorship programme. Equal payment with the therapist enabled the expert mothers to better facilitate the groups, through increased confidence in the value of their role. Adaptation of the intervention included development of video resources and mentoring guidelines. Conclusion The use of expert mothers as facilitators of caregiver groups provides a unique approach to harness the knowledge, experience, and skills of families to provide care, and is likely to be feasible in similar contexts.	[Smythe, Tracey; Duttine, Antony; Kuper, Hannah] London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, Keppel St, London, England; [Matos, Monica] Univ Fed Bahia, Collect Hlth Inst, Salvador, BA, Brazil; [Reis, Julia] Rehabil Inst Bahia, Dept Child Psychol, Salvador, BA, Brazil; [Ferrite, Silvia] Univ Fed Bahia, Dept Speech & Hearing Sci, Salvador, BA, Brazil	University of London; London School of Hygiene & Tropical Medicine; Universidade Federal da Bahia; Universidade Federal da Bahia	Smythe, T (corresponding author), London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, Keppel St, London, England.	tracey.smythe@lshtm.ac.uk	; Smythe, Tracey/N-7699-2017; Ferrite, Silvia/I-2864-2013	Duttine, Antony/0000-0002-7186-1591; Smythe, Tracey/0000-0003-3408-7362; Reis, AlessanRSS/0000-0001-8486-7469; Ferrite, Silvia/0000-0001-5344-3751	Wellcome Trust; Department for International Development [206719/Z/17/Z]	Wellcome Trust(Wellcome TrustEuropean Commission); Department for International Development	The development and testing of the intervention for children with Congenital Zika Syndrome were supported by a grant from Wellcome Trust and the Department for International Development (https://wellcome.ac.uk/) to HK: grant code 206719/Z/17/Z. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.	[Anonymous], 2016, DIS OUTBREAK NE 0208; [Anonymous], 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD010618, DOI 10.1002/14651858.CD010618]; [Anonymous], 2012, PREV EARL ID ASS INT; [Anonymous], 2012, EV THREAT ANT RES; de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2; Benfer KA, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021186; Black MM, 2017, LANCET, V389, P77, DOI 10.1016/S0140-6736(16)31389-7; Bowen DJ, 2009, AM J PREV MED, V36, P452, DOI 10.1016/j.amepre.2009.02.002; Bunning K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182214; Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990; Dambi JM, 2015, AFR J DISABIL, V4, DOI 10.4102/ajod.v4i1.168; Duttine A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103559; Duttine Antony, 2019, Wellcome Open Res, V4, P80, DOI 10.12688/wellcomeopenres.15085.1; Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3; Freire P, 2007, PEDAGOGY OPPRESSED, V30th Anniversary; Gona JK, 2011, CHILD CARE HLTH DEV, V37, P175, DOI 10.1111/j.1365-2214.2010.01124.x; Gram L, 2019, J DEV STUD, V55, P1670, DOI 10.1080/00220388.2018.1448069; Kuper H, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030514; Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3; Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096; Masulani-Mwale C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210855; Masulani-Mwale C, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1731-x; MAYOR S, 2018, BMJ-BRIT MED J, V362, DOI DOI 10.1136/BMJ.K3477; McConachie H, 2000, J PEDIATR-US, V137, P769, DOI 10.1067/mpd.2000.110135; Nakamanya S, 2015, DISABIL REHABIL, V37, P1470, DOI 10.3109/09638288.2014.972582; Polack S, 2018, DEV MED CHILD NEUROL, V60, P914, DOI 10.1111/dmcn.13797; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Rahman A, 2016, LANCET PSYCHIAT, V3, P128, DOI 10.1016/S2215-0366(15)00388-0; Rosato M, 2008, LANCET, V372, P962, DOI 10.1016/S0140-6736(08)61406-3; Salomone E, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00769; Scherer N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219888; Shilling V, 2013, DEV MED CHILD NEUROL, V55, P602, DOI 10.1111/dmcn.12091; The Lancet Global Health, 2018, LANCET GLOB HLTH, V6, pE593, DOI DOI 10.1016/S2214-109X(18)30309-7; Tilahun D, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1383-9; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Wheeler AC, 2018, PEDIATRICS, V141, pS154, DOI [10.1542/peds.2017-2038D, 10.1542/peds.2017-2038d]; WHO, 2020, WHO CAR SKILLS TRAIN; Zuurmond M, 2019, CHILD CARE HLTH DEV, V45, P45, DOI 10.1111/cch.12618; Zuurmond M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202096	39	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238850	10.1371/journal.pone.0238850	http://dx.doi.org/10.1371/journal.pone.0238850			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9ME	32913354	gold, Green Published			2022-12-26	WOS:000571885900041
J	Roe, BE; Qi, DY; Apolzan, JW; Martin, CK				Roe, Brian E.; Qi, Danyi; Apolzan, John W.; Martin, Corby K.			Selection, intake, and plate waste patterns of leftover food items among US consumers: A pilot study	PLOS ONE			English	Article							ENERGY-INTAKE; PHOTOGRAPHY; BEHAVIORS; VALIDITY	Many campaigns promote the preservation and consumption of leftover food items as a critical household strategy to accomplish national consumer food waste reduction goals. We fill a gap in knowledge about the consumption and creation of leftovers in the United States by analyzing data from a pilot study in which 18 subjects tracked food selection, intake, and plate waste across all eating occasions for about one week. Subjects noted which items selected for consumption were leftovers, i.e., previously prepared but uneaten items that were stored for future consumption, and which unfinished items were saved to become leftovers. We found that 12% of items selected for consumption were leftovers while 24% of selected items that were not fully consumed were kept to become a leftover. Leftovers were most frequently vegetables, cheeses, and meats, and most frequently selected on Mondays and for lunch. Regression analyses isolate significant dining patterns with respect to leftovers, including evidence that leftovers were less likely to be fully consumed than non-leftover items, and that larger meals led to more uneaten food. This suggests that strategies to reduce meal size may be most effective in reducing food waste by limiting the creation of leftovers in the first place. Strategies to make leftovers more attractive and appealing may also reduce food waste.	[Roe, Brian E.] Ohio State Univ, Dept Agr Environm & Dev Econ, Columbus, OH 43210 USA; [Qi, Danyi] Louisiana State Univ, Dept Agr Econ & Agribusiness, Baton Rouge, LA 70803 USA; [Apolzan, John W.; Martin, Corby K.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA	University System of Ohio; Ohio State University; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Roe, BE (corresponding author), Ohio State Univ, Dept Agr Environm & Dev Econ, Columbus, OH 43210 USA.	roe.30@osu.edu	Apolzan, John William/N-1949-2017; Roe, Brian/A-7386-2009	Apolzan, John William/0000-0001-8492-7820; Roe, Brian/0000-0003-4228-2889	NORC Center Grant "Nutrition and Metabolic Health Through the Lifespan" - NIDDK [P30 DK072476]; National Institute of General Medical Sciences of the National Institutes of Health [U54 GM104940]; Louisiana Clinical and Translational Science Center; Ohio State University's Initiative for Food & AgriCultural Transformation (InFACT); USDA grant [20176702326268]	NORC Center Grant "Nutrition and Metabolic Health Through the Lifespan" - NIDDK; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Louisiana Clinical and Translational Science Center; Ohio State University's Initiative for Food & AgriCultural Transformation (InFACT); USDA grant(United States Department of Agriculture (USDA))	This work was supported by the following funding sources. a NORC Center Grant #P30 DK072476 entitled "Nutrition and Metabolic Health Through the Lifespan" sponsored by NIDDK (CKM), a U54 GM104940 from the National Institute of General Medical Sciences of the National Institutes of Health, which funds the Louisiana Clinical and Translational Science Center (CKM), a seed grant from Ohio State University's Initiative for Food & AgriCultural Transformation (InFACT) (BER, JWA, CKM, DQ), and a USDA grant 20176702326268 (BER, JWA, CKM). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, USDA or InFACT. The funding agencies had no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; nor in the decision to submit the article for publication.	Aschemann-Witzel J, 2015, SUSTAINABILITY-BASEL, V7, P6457, DOI 10.3390/su7066457; BANDINI LG, 1990, AM J CLIN NUTR, V52, P421, DOI 10.1093/ajcn/52.3.421; Beaton GH, 1997, AM J CLIN NUTR, V65, P1100; Blisard N, 2007, EC INFORM B; Cappellini B, 2012, SOCIOL REV, V60, P121, DOI 10.1111/1467-954X.12041; Dobernig K, 2019, INT J CONSUM STUD, V43, P480, DOI 10.1111/ijcs.12527; Drewnowski A, 2014, AM J CLIN NUTR, V100, P901, DOI 10.3945/ajcn.114.089458; Ellison B, 2018, APPL ECON PERSPECT P, V40, P613, DOI 10.1093/aepp/ppx059; European Commission, 2016, EU PLATF FOOD LOSS F; Evans D, 2012, SOCIOLOGY, V46, P41, DOI 10.1177/0038038511416150; Evans D, 2011, CRIT PUBLIC HEALTH, V21, P429, DOI 10.1080/09581596.2011.608797; Farr-Wharton G, 2014, J CONSUM BEHAV, V13, P393, DOI 10.1002/cb.1488; Hamrick K.S., 2016, EIB158 USDA EC RES S; Marriott BM., 1993, NUTR NEEDS HOT ENV A; Martin CK, 2012, OBESITY, V20, P891, DOI 10.1038/oby.2011.344; Martin CK, 2009, BRIT J NUTR, V101, P446, DOI 10.1017/S0007114508027438; Parizeau K, 2015, WASTE MANAGE, V35, P207, DOI 10.1016/j.wasman.2014.09.019; Schoeller DA, 2013, AM J CLIN NUTR, V97, P1413, DOI 10.3945/ajcn.113.062125; Southerton D., 2015, WASTE MANAGEMENT SUS, P133, DOI DOI 10.1177/0038038511416150; SR28 US. National Nutrient Database for Standard Reference, SR28 US USDA AGR RES; Stancu V, 2016, APPETITE, V96, P7, DOI 10.1016/j.appet.2015.08.025; Tran KM, 2000, J AM DIET ASSOC, V100, P777, DOI 10.1016/S0002-8223(00)00227-3; U.S. Department of Agriculture, 2020, USDA FOOD NUTR DAT D; van der Werf P, 2019, CAN GEOGR-GEOGR CAN, V63, P478, DOI 10.1111/cag.12519; Williamson D A, 2004, Eat Weight Disord, V9, P24; Williamson DA, 2003, J AM DIET ASSOC, V103, P1139, DOI 10.1016/S0002-8223(03)00974-X; Wooldridge J.M., 2016, INTRO ECONOMETRICS M; Zeballos E, 2019, FREQUENCY TIME DAY A	28	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2020	15	9							e0238050	10.1371/journal.pone.0238050	http://dx.doi.org/10.1371/journal.pone.0238050			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR4MY	32903260	gold, Green Published			2022-12-26	WOS:000571539500002
J	Sperber, HS; Togarrati, PP; Raymond, KA; Bouzidi, MS; Gilfanova, R; Gutierrez, AG; Muench, MO; Pillai, SK				Sperber, Hannah S.; Togarrati, Padma Priya; Raymond, Kyle A.; Bouzidi, Mohamed S.; Gilfanova, Renata; Gutierrez, Alan G.; Muench, Marcus O.; Pillai, Satish K.			mu-Lat: A mouse model to evaluate human immunodeficiency virus eradication strategies	FASEB JOURNAL			English	Article						antiviral gene therapy; humanized mouse; HIV; HIV latency; latency reversal; shock and kill	HUMAN IMMUNE-SYSTEM; IN-VIVO MODELS; SCID-HU MOUSE; MURINE MODEL; T-CELLS; CEREBROSPINAL-FLUID; HIV-1 INFECTION; TRANSGENIC MICE; MACROPHAGES; HEMATOPOIESIS	A critical barrier to the development of a human immunodeficiency virus (HIV) cure is the lack of a scalable animal model that enables robust evaluation of eradication approaches prior to testing in humans. We established a humanized mouse model of latent HIV infection by transplanting "J-Lat" cells, Jurkat cells harboring a latent HIV provirus encoding an enhanced green fluorescent protein (GFP) reporter, into irradiated adult NOD.Cg-Prkdc(scid)Il2rg(tm1Wjl)/SzJ (NSG) mice. J-Lat cells exhibited successful engraftment in several tissues including spleen, bone barrow, peripheral blood, and lung, in line with the diverse natural tissue tropism of HIV. Administration of tumor necrosis factor (TNF)-alpha, an established HIV latency reversal agent, significantly induced GFP expression in engrafted cells across tissues, reflecting viral reactivation. These data suggest that ourmurinelatency ("mu-Lat") model enables efficient determination of how effectively viral eradication agents, including latency reversal agents, penetrate, and function in diverse anatomical sites harboring HIV in vivo.	[Sperber, Hannah S.; Togarrati, Padma Priya; Raymond, Kyle A.; Bouzidi, Mohamed S.; Gilfanova, Renata; Gutierrez, Alan G.; Muench, Marcus O.; Pillai, Satish K.] Vitalant Res Inst, San Francisco, CA 94118 USA; [Sperber, Hannah S.] Free Univ Berlin, Inst Biochem, Berlin, Germany; [Sperber, Hannah S.; Raymond, Kyle A.; Bouzidi, Mohamed S.; Muench, Marcus O.; Pillai, Satish K.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA USA	Vitalant; Vitalant Research Institute; Free University of Berlin; University of California System; University of California San Francisco	Pillai, SK (corresponding author), Vitalant Res Inst, San Francisco, CA 94118 USA.	satish.pillai@ucsf.edu	Muench, Marcus O./C-5025-2009	Muench, Marcus O./0000-0001-8946-6605; Raymond, Kyle/0000-0001-8670-2852; Sperber, Hannah Sabeth/0000-0002-9638-6555	National Institutes of Health [R01 AI150449, R01 MH112457]; National Institutes of Health, University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research [P30 AI027763]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USAUniversity of California System)	This study was supported by the National Institutes of Health grants R01 AI150449 (SKP) and R01 MH112457 (SKP), and was additionally supported by a grant from the National Institutes of Health, University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research (P30 AI027763). We thank Dr. Roland Schwarzer for valuable input and careful review of the manuscript.	Abdel-Mohsen M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005677; Abreu CM, 2019, MBIO, V10, DOI 10.1128/mBio.01659-19; Alvarez-Carbonell D, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-017-0335-8; Anderson EM, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0448-8; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Barat C, 2018, GLIA, V66, P1363, DOI 10.1002/glia.23310; Behrendt R, 2013, CELL REP, V4, P689, DOI 10.1016/j.celrep.2013.07.037; Beyer AI, 2017, STEM CELLS DEV, V26, P102, DOI 10.1089/scd.2016.0083; Blackard JT, 2012, CURR HIV RES, V10, P133, DOI 10.2174/157016212799937245; Bouchat S, 2016, EMBO MOL MED, V8, P117, DOI 10.15252/emmm.201505557; Bradley T, 2018, CELL REP, V25, P107, DOI 10.1016/j.celrep.2018.09.020; Brogdon J, 2016, SCI REP-UK, V6, DOI 10.1038/srep39032; Castellano P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39898-5; Chen DC, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5173205; Churchill M, 2013, CURR OPIN HIV AIDS, V8, P165, DOI 10.1097/COH.0b013e32835fc601; Dahl V, 2014, J INFECT DIS, V209, P1618, DOI 10.1093/infdis/jit805; Darcis G, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005063; Dash PK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10366-y; Denton PW, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0807-y; DICKIE P, 1991, VIROLOGY, V185, P109, DOI 10.1016/0042-6822(91)90759-5; Dinoso JB, 2009, J VIROL, V83, P9247, DOI 10.1128/JVI.00840-09; Eden A, 2010, J INFECT DIS, V202, P1819, DOI 10.1086/657342; Flerin NC, 2019, J VIROL, V93, DOI 10.1128/JVI.02051-18; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; Garcia JV, 2016, CURR OPIN VIROL, V19, P56, DOI 10.1016/j.coviro.2016.06.010; Garcia-Mesa Y, 2017, J NEUROVIROL, V23, P47, DOI 10.1007/s13365-016-0499-3; Gray LR, 2016, J NEUROVIROL, V22, P455, DOI 10.1007/s13365-015-0413-4; Hanna Z, 2001, J VIROL, V75, P9378, DOI 10.1128/JVI.75.19.9378-9392.2001; Hellmuth J, 2015, J VIRUS ERAD, V1, P67; Hoggatt J, 2016, EXP HEMATOL, V44, P132, DOI 10.1016/j.exphem.2015.10.008; Honeycutt JB, 2016, J CLIN INVEST, V126, P1353, DOI 10.1172/JCI84456; Jiang GC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005066; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; Joseph SB, 2015, J NEUROVIROL, V21, P276, DOI 10.1007/s13365-014-0287-x; Kim KC, 2016, AIDS RES HUM RETROV, V32, P194, DOI [10.1089/AID.2015.0211, 10.1089/aid.2015.0211]; Klase Z, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003997; Krishnakumar V, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030252; Kumar N, 2016, CURR OPIN HIV AIDS, V11, P432, DOI 10.1097/COH.0000000000000290; Lai F, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110643; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; LAPIDOT T, 1992, SCIENCE, V255, P1137, DOI 10.1126/science.1372131; Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194; Manel N, 2011, CELL, V147, P271, DOI 10.1016/j.cell.2011.09.010; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marsden MD, 2015, VIROLOGY, V479, P297, DOI 10.1016/j.virol.2015.01.017; Maung R, 2014, J IMMUNOL, V193, P1895, DOI 10.4049/jimmunol.1302915; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; McCune JM, 2019, STEM CELL REP, V13, P777, DOI 10.1016/j.stemcr.2019.10.003; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0; NAMIKAWA R, 1988, SCIENCE, V242, P1684, DOI 10.1126/science.3201256; NAMIKAWA R, 1990, J EXP MED, V172, P1055, DOI 10.1084/jem.172.4.1055; Nath A, 2011, AIDS, V25, P577, DOI 10.1097/QAD.0b013e3283437d2f; Nixon CC, 2017, J INFECT DIS, V215, pS142, DOI 10.1093/infdis/jiw637; North TW, 2010, J VIROL, V84, P2913, DOI 10.1128/JVI.02356-09; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Persidsky Y, 1996, AM J PATHOL, V149, P1027; Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639; Pitman MC, 2018, LANCET HIV, V5, pE317, DOI 10.1016/S2352-3018(18)30039-0; Planelles V, 2011, CURR HIV RES, V9, P568, DOI 10.2174/157016211798998826; Policicchio BB, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00012; Poluektova L, 2004, J IMMUNOL, V172, P7610, DOI 10.4049/jimmunol.172.12.7610; Poluektova LY, 2002, J IMMUNOL, V168, P3941, DOI 10.4049/jimmunol.168.8.3941; Potula R, 2005, BLOOD, V106, P2382, DOI 10.1182/blood-2005-04-1403; Rahim MMA, 2009, J VIROL, V83, P11830, DOI 10.1128/JVI.01466-09; Rehwinkel J, 2013, EMBO J, V32, P2454, DOI 10.1038/emboj.2013.163; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Rochat MA, 2017, J VIROL, V91, DOI 10.1128/JVI.02084-16; Satheesan S, 2018, J VIROL, V92, DOI 10.1128/JVI.02118-17; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Schwarzer R, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020188; Seay K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063537; Shytaj IL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002774; SLORDAL L, 1989, EUR J HAEMATOL, V43, P428; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; Spivak AM, 2018, ANNU REV MED, V69, P421, DOI 10.1146/annurev-med-052716-031710; Stoszko M, 2016, EBIOMEDICINE, V3, P108, DOI 10.1016/j.ebiom.2015.11.047; Symons J, 2018, CURR OPIN HIV AIDS, V13, P152, DOI 10.1097/COH.0000000000000438; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Telwatte S, 2019, RETROVIROLOGY, V16, DOI 10.1186/s12977-019-0494-x; Telwatte S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007357; Thompson KA, 2011, AM J PATHOL, V179, P1623, DOI 10.1016/j.ajpath.2011.06.039; TYOR WR, 1993, P NATL ACAD SCI USA, V90, P8658, DOI 10.1073/pnas.90.18.8658; Whitney JB, 2018, ADV EXP MED BIOL, V1075, P241, DOI 10.1007/978-981-13-0484-2_10; Wittmann S, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0229-6; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; WONG ME, 2019, FRONT IMMUNOL, V10; Yin CR, 2017, MOL THER, V25, P1168, DOI 10.1016/j.ymthe.2017.03.012	89	1	2	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14615	14630		10.1096/fj.202001612RR	http://dx.doi.org/10.1096/fj.202001612RR		SEP 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32901981	Green Submitted, Green Accepted			2022-12-26	WOS:000568307900001
J	Alteri, C; Cento, V; Antonello, M; Colagrossi, L; Merli, M; Ughi, N; Renica, S; Matarazzo, E; Di Ruscio, F; Tartaglione, L; Colombo, J; Grimaldi, C; Carta, S; Nava, A; Costabile, V; Baiguera, C; Campisi, D; Fanti, D; Vismara, C; Fumagalli, R; Scaglione, F; Epis, OM; Puoti, M; Perno, CF				Alteri, Claudia; Cento, Valeria; Antonello, Maria; Colagrossi, Luna; Merli, Marco; Ughi, Nicola; Renica, Silvia; Matarazzo, Elisa; Di Ruscio, Federica; Tartaglione, Livia; Colombo, Jacopo; Grimaldi, Chiara; Carta, Stefania; Nava, Alice; Costabile, Valentino; Baiguera, Chiara; Campisi, Daniela; Fanti, Diana; Vismara, Chiara; Fumagalli, Roberto; Scaglione, Francesco; Epis, Oscar Massimiliano; Puoti, Massimo; Perno, Carlo Federico			Detection and quantification of SARS-CoV-2 by droplet digital PCR in real-time PCR negative nasopharyngeal swabs from suspected COVID-19 patients	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CORONAVIRUS; DIAGNOSIS	Since SARS-CoV-2-based disease (COVID-19) spreads as a pandemic, the necessity of a highly sensitive molecular diagnosis that can drastically reduce false negatives reverse transcription PCR (rtPCR) results, raises as a major clinical need. Here we evaluated the performance of a ddPCR-based assay to quantify SARS-CoV-2 titer in 55 suspected COVID-19 cases with negative rtPCR results thanks to in-house ddPCR assay (targeting RdRp and host RNaseP). Samples were collected at ASST-GOM Niguarda between February and May 2020 at hospital admission. Clinical and imaging data were obtained for clinical staging and definition of disease severity. Patients were mainly female (45.5%) with a median age of 73 (57-84) years. ddPCR-based assay detected SARS-CoV-2 genome in nasopharyngeal samples of 19 (34.5%) patients (median viral-load: 128 copies/mL, IQR: 72-345). In 15 of them (78.9%), chest CT showed a classical COVID-19 bilateral interstitial pneumonia; 14 patients (73.7%) showed severe COVID-19 manifestations. ddPCR did not identify any trace of SARS-CoV-2 genome in the respiratory samples of the remaining 36 patients. The serological assay performed in a subgroup of 34 patients at the later stage of illness (from 3 days to 90 days after) confirmed the presence of SARS-CoV-2 antibodies in all patients tested positive for SARS-CoV-2 in ddPCR (100%). Contrariwise, negative tests were observed in 95.0% ddPCR negative patients (P<0.001). Thanks to a ddPCR-based assay, we achieved a rapid and accurate SARS-CoV-2 diagnosis in rtPCR-negative respiratory samples of individuals with COVID-19 suspect, allowing the rapid taking care and correct management of these patients.	[Alteri, Claudia; Antonello, Maria; Renica, Silvia; Scaglione, Francesco; Perno, Carlo Federico] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy; [Cento, Valeria; Matarazzo, Elisa; Di Ruscio, Federica; Tartaglione, Livia] Univ Milan, Residency Microbiol & Virol, Milan, Italy; [Colagrossi, Luna] Bambino Gesu Pediat Hosp, Dept Labs, Rome, Italy; [Merli, Marco; Baiguera, Chiara; Puoti, Massimo] ASST Grande Osped Metropolitano Niguarda, Infect Dis, Milan, Italy; [Ughi, Nicola; Epis, Oscar Massimiliano] ASST Grande Osped Metropolitano Niguarda, Rheumatol Unit, Milan, Italy; [Colombo, Jacopo] ASST Grande Osped Metropolitano Niguarda, Dept Cardiotoracovasc Anesthesia & Intens Care, Milan, Italy; [Grimaldi, Chiara; Carta, Stefania; Nava, Alice; Campisi, Daniela; Fanti, Diana; Vismara, Chiara; Perno, Carlo Federico] ASST Grande Osped Metropolitano Niguarda, Dept Lab Med, Milan, Italy; [Costabile, Valentino] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Fumagalli, Roberto] ASST Grande Osped Metropolitano Niguarda, Dept Anesthesiol Crit Care & Pain Med, Milan, Italy	University of Milan; University of Milan; IRCCS Bambino Gesu; University of Milan	Alteri, C (corresponding author), Univ Milan, Dept Oncol & Hematooncol, Milan, Italy.	claudia.alteri@unimi.it	Colagrossi, Luna/AAB-7648-2022; Colombo, Jacopo/AGU-5150-2022; Alteri, Claudia/AAB-9956-2019; Cento, Valeria/K-6636-2012	Colagrossi, Luna/0000-0001-5618-1523; Colombo, Jacopo/0000-0003-1873-8321; Alteri, Claudia/0000-0003-4270-5079; Costabile, Valentino/0000-0002-5207-8147; PERNO, CARLO FEDERICO/0000-0002-0825-5388; Puoti, Massimo/0000-0003-3278-7138; Merli, Marco/0000-0001-5081-8669; Cento, Valeria/0000-0002-3272-4252; renica, silvia/0000-0001-7334-7433	AVIRALIA foundation	AVIRALIA foundation	This work was financially supported by an unrestricted grant from AVIRALIA foundation.	Alteri C, 2019, J CLIN VIROL, V117, P61, DOI 10.1016/j.jcv.2019.06.004; [Anonymous], LAB TEST COR DIS COV; Bryan A, 2020, J CLIN MICROBIOL; Chen L, 2020, AM J GASTROENTEROLOG; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Li DS, 2020, KOREAN J RADIOL, V21, P505, DOI 10.3348/kjr.2020.0146; Li TS, 2020, EMERG MICROBES INFEC, V9, P582, DOI 10.1080/22221751.2020.1735265; Mu D, 2015, BIOTECHNOL LETT, V37, P2063, DOI 10.1007/s10529-015-1890-5; Pan Y, 2020, LANCET INFECT DIS; Sedlak RH, 2014, J CLIN MICROBIOL, V52, P2844, DOI 10.1128/JCM.00803-14; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; Suo T., 2020, DDPCR MORE SENSITIVE; Winichakoon P, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00297-20; Yang JR, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00369; Yu F, 2020, QUANTITATIVE DETECTI; Yu F, 2020, CLIN INFECT DIS; Zhao B, 2020, ADV FUNCT MATER, V30, DOI 10.1002/adfm.202002019; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	18	67	67	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0236311	10.1371/journal.pone.0236311	http://dx.doi.org/10.1371/journal.pone.0236311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ6EE	32898153	Green Published, gold			2022-12-26	WOS:000570962500021
J	Bal, M; Das, A; Ghosal, J; Pradhan, MM; Khuntia, HK; Pati, S; Dutta, A; Ranjit, M				Bal, Madhusmita; Das, Arundhuti; Ghosal, Jyoti; Pradhan, Madan Mohan; Khuntia, Hemant Kumar; Pati, Sanghamitra; Dutta, Ambarish; Ranjit, Manoranjan			Assessment of effectiveness of DAMaN: A malaria intervention program initiated by Government of Odisha, India	PLOS ONE			English	Article								India, a persistently significant contributor to the global malaria burden, rolled out several anti-malaria interventions at the national and state level to control and recently, to eliminate the disease. Odisha, the eastern Indian state with the highest malaria burden experienced substantial gains shown by various anti-malaria initiatives implemented under the National Vector-borne Disease Control Programme (NVBDCP). However, recalcitrant high-transmission "pockets" of malaria persist in hard-to-reach stretches of the state, characterised by limited access to routine malaria surveillance and the forested hilly topography favouring unbridled vector breeding. The prevalence of asymptomatic malaria in such pockets serves as perpetual malaria reservoir, thus hindering its elimination. Therefore, a project with the acronym DAMaN was initiated since 2017 by state NVBDCP, targeting locally identified high endemic 'pockets' in 23 districts. DAMaN comprised biennial mass screening and treatment, provisioning of long-lasting insecticidal net (LLIN) and behavioural change communication. Subsequently, to inform policy, assessment of DAMaN was conceived that aims to estimate the coverage of the various components of the project; the prevalence of malaria, even at sub-patent level especially among pregnant/lactating women and children; and its impact on malaria incidence. A survey of DAMaN beneficiaries will measure coverage; and knowledge and practices related to LLIN; along with collection of blood specimens from a probability sample. A multi-stage stratified clustered sample of 2228 households (similar to 33% having pregnant/lactating women) will be selected from 6 DAMaN districts. Routine DAMaN project data (2017-2018) and NVBDCP data (2013-2018) will be extracted. Rapid Diagnostic Test, Polymerase Chain Reaction and blood smear microscopy will be conducted to detect malarial parasitemia. In addition to measuring DAMaN's coverage and malarial prevalence in DAMaN pockets, its impact will be estimated using pre-post differences and Interrupted Time Series analysis using 2017 as the "inflection" point. The assessment may help to validate the unique strategies employed by DAMaN.	[Bal, Madhusmita; Das, Arundhuti; Ghosal, Jyoti; Khuntia, Hemant Kumar; Pati, Sanghamitra; Ranjit, Manoranjan] ICMR Reg Med Res Ctr, Bhubaneswar, Odisha, India; [Pradhan, Madan Mohan] State Vector Borne Dis Control Programme, Boudh, Odisha, India; [Dutta, Ambarish] Indian Inst Publ Hlth, Bhubaneswar, Odisha, India	Indian Council of Medical Research (ICMR); ICMR - Regional Medical Research Centre (RMRC), Bhubaneswar	Ranjit, M (corresponding author), ICMR Reg Med Res Ctr, Bhubaneswar, Odisha, India.	ranjit@gmail.com	Ghosal, Jyoti/GWD-0668-2022	Ranjit, Manoranjan/0000-0002-8415-6701; Dutta, Ambarish/0000-0002-4019-7472	Department of Health and Family Welfare [proposal/1819/31.12.2018]	Department of Health and Family Welfare	The research grant was received by MR, MB, AD and SP. Funding received from: Department of Health and Family Welfare, Govt. Of Odisha (DHS:2244/DAMaN/Project proposal/1819/31.12.2018) https://health.odisha.gov.in The funder will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaa Ahmed M, 2019, PLoS One, V14, pe0213653, DOI 10.1371/journal.pone.0213653; [Anonymous], PEOPLES DOCTOR; [Anonymous], 2015, W MED, V3, P14; Blasco B, 2017, NAT MED, V23, P917, DOI 10.1038/nm.4381; Das A, 2012, ACTA TROP, V121, P267, DOI 10.1016/j.actatropica.2011.11.008; De Beaudrap P, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-139; Dhangadamajhi G, 2015, J INFECT DIS, V116, P446; Directorate of National Vector Borne Disease Control Programme, 2008, STRATEGIC PLAN MALAR, P3; Directorate of National Vector Borne Disease Control Programme, 2007, STAND NOT, P1; Guston D, 2012, ENCY NANOSCIENCE SOC; International Institute for Population Sciences and Macro International, 2015, NAT FAM HLTH SURV 4; Kumar A, 2007, AM J TROP MED HYG, V77, P69, DOI 10.4269/ajtmh.2007.77.69; Patouillard E, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000176; Pradhan A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149126; Pradhan MM, 2019, J VECTOR DIS, V56, P53, DOI 10.4103/0972-9062.257775; Ranjit M, 2006, ICMR B; Republic D, 2015, FOREVER PROGR SCREEN, P170; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; United Nations, 2018, SDG MON REP TOOLK UN; Valea I, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-71; World Health Organization, 2019, WORLD MALARIA REPORT, DOI [10.30875/7e6f8c91-en, DOI 10.30875/7E6F8C91-EN]	21	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238323	10.1371/journal.pone.0238323	http://dx.doi.org/10.1371/journal.pone.0238323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ6EE	32898853	Green Published, gold			2022-12-26	WOS:000570962500046
J	Herrero, R; Heise, K; Acevedo, J; Cook, P; Gonzalez, C; Gahona, J; Cortes, R; Collado, L; Beltran, ME; Cikutovic, M; Gonzalez, P; Murillo, R; Leja, M; Megraud, F; Hernandez, MD; Barbier, S; Park, JY; Ferreccio, C				Herrero, Rolando; Heise, Katy; Acevedo, Johanna; Cook, Paz; Gonzalez, Claudia; Gahona, Jocelyne; Cortes, Raimundo; Collado, Luis; Beltran, Maria Enriqueta; Cikutovic, Marcos; Gonzalez, Paula; Murillo, Raul; Leja, Marcis; Megraud, Francis; Hernandez, Maria de la Luz; Barbier, Sylvaine; Park, Jin Young; Ferreccio, Catterina		ENIGMA Chile Study Grp	Regional variations in Helicobacter pylori infection, gastric atrophy and gastric cancer risk: The ENIGMA study in Chile	PLOS ONE			English	Article							CAPSAICIN CONSUMPTION; CAGA STATUS; METAANALYSIS; PREVALENCE; AFRICAN	Background Regional variations in gastric cancer incidence are not explained by prevalence ofHelicobacter pylori, the main cause of the disease, with several areas presenting highH.pyloriprevalence but low gastric cancer incidence. The IARC worldwideH.pyloriprevalence surveys (ENIGMA) aim at systematically describing age and sex-specific prevalence ofH.pyloriinfection around the world and generating hypotheses to explain regional variations in gastric cancer risk. Methods We selected age- and sex-stratified population samples in two areas with different gastric cancer incidence and mortality in Chile: Antofagasta (lower rate) and Valdivia (higher rate). Participants were 1-69 years old and provided interviews and blood for anti-H.pyloriantibodies (IgG, VacA, CagA, others) and atrophy biomarkers (pepsinogens). Results H.pyloriseroprevalence (Age-standardized to world population) and antibodies against CagA and VacA were similar in both sites.H.pyloriseroprevalence was 20% among children <10 years old, 40% among 10-19 year olds, 60% in the 20-29 year olds and close to or above 80% in those 30+ years. The comparison of the prevalence of known and potentialH.pyloricofactors in gastric carcinogenesis between the high and the low risk area showed that consumption of chili products was significantly higher in Valdivia and daily non-green vegetable consumption was more common in Antofagasta. Pepsinogen levels suggestive of gastric atrophy were significantly more common and occurred at earlier ages in Valdivia, the higher risk area. In a multivariate model combining both study sites, age, chili consumption and CagA were the main risk factors for gastric atrophy. Conclusions The prevalence ofH.pyloriinfection and its virulence factors was similar in the high and the low risk area, but atrophy was more common and occurred at younger ages in the higher risk area. Dietary factors could partly explain higher rates of atrophy and gastric cancer in Valdivia. Impact The ENIGMA study in Chile contributes to better understanding regional variations in gastric cancer incidence and provides essential information for public health interventions.	[Herrero, Rolando; Murillo, Raul; Hernandez, Maria de la Luz; Barbier, Sylvaine; Park, Jin Young] Int Agcy Res Canc, Lyon, France; [Herrero, Rolando; Gonzalez, Paula] Fdn INCIENSA, Agencia Costarricense Invest Biomed, San Jose, Costa Rica; [Heise, Katy; Beltran, Maria Enriqueta] Hosp Base Valdivia, Hosp Canc Registry, Valdivia, Chile; [Acevedo, Johanna] Hlth Minist, Epidemiol Dept, Santiago, Chile; [Cook, Paz; Ferreccio, Catterina] Pontificia Univ Catolica Chile, Sch Med, Publ Hlth Dept, Santiago, Chile; [Cook, Paz; Ferreccio, Catterina] ACCDis, Adv Ctr Chron Dis, Santiago, Chile; [Gonzalez, Claudia] Secretaria Reg Minist Salud, Antofagasta, Antofagasta Reg, Chile; [Gahona, Jocelyne; Cortes, Raimundo; Cikutovic, Marcos] Univ Antofagasta, Fac Hlth Sci, Antofagasta, Chile; [Collado, Luis] Univ Austral Chile, Fac Sci, Inst Biochem & Microbiol, Valdivia, Chile; [Leja, Marcis] Univ Latvia, Inst Clin & Prevent Med, Riga, Latvia; [Megraud, Francis] Bordeaux Univ, BaRITOn, Team 2 Helicobacter Infect Inflammat & Canc, INSERM,UMR1053, Bordeaux, France; [Megraud, Francis] Pellegrin Univ Hosp, French Natl Reference Ctr Campylobacters & Helico, Bacteriol Lab, Bordeaux, France	World Health Organization; International Agency for Research on Cancer (IARC); Pontificia Universidad Catolica de Chile; Universidad de Antofagasta; Universidad Austral de Chile; University of Latvia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Herrero, R (corresponding author), Int Agcy Res Canc, Lyon, France.; Herrero, R (corresponding author), Fdn INCIENSA, Agencia Costarricense Invest Biomed, San Jose, Costa Rica.; Ferreccio, C (corresponding author), Pontificia Univ Catolica Chile, Sch Med, Publ Hlth Dept, Santiago, Chile.; Ferreccio, C (corresponding author), ACCDis, Adv Ctr Chron Dis, Santiago, Chile.	rherrero@acibcr.com; catferre@gmail.com	Murillo, Raúl/AAY-4416-2021	ferreccio, catterina/0000-0001-6331-5534; COLLADO, LUIS/0000-0002-7140-4219; Megraud, Francis/0000-0002-2481-1612; Park, Jin Young/0000-0003-2491-5099; Acevedo, Johanna/0000-0002-6341-1865	Fondo Nacional de Investigacion y Desarrollo en Salud (FONIS grant) [SA1312007]; Latvian Council of Science [lzp-2018/1-0135]	Fondo Nacional de Investigacion y Desarrollo en Salud (FONIS grant); Latvian Council of Science(Latvian Ministry of Education and Science)	The work in Chile was supported in part by a grant from Fondo Nacional de Investigacion y Desarrollo en Salud (FONIS grant SA1312007) and the pepsinogen work in Latvia by a grant from the Latvian Council of Science (nr. lzp-2018/1-0135).	Adamu MA, 2011, INT J CANCER, V128, P1652, DOI 10.1002/ijc.25476; [Anonymous], 2012, REV HUM CARC F; [Anonymous], 2017, J ENDOCRINOL METAB D, V22, pS1; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Camargo MC, 2015, INT J CANCER, V137, P3000, DOI 10.1002/ijc.29678; Con SA, 2006, J GASTROENTEROL, V41, P632, DOI 10.1007/s00535-006-1812-3; CORREA P, 1975, LANCET, V2, P58; Devi SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-184; Dinis-Ribeiro M, 2004, J MED SCREEN, V11, P141, DOI 10.1258/0969141041732184; Ekstrom AM, 2001, GASTROENTEROLOGY, V121, P784, DOI 10.1053/gast.2001.27999; Eom SY, 2013, CANCER CAUSE CONTROL, V24, P1963, DOI 10.1007/s10552-013-0272-3; Feldman M, 1998, JAMA-J AM MED ASSOC, V280, P363, DOI 10.1001/jama.280.4.363; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Frank J., 2014, BASICS FINANCIAL ECO; Graham DY, 2009, J DIGEST DIS, V10, P77, DOI 10.1111/j.1751-2980.2009.00368.x; HOLCOMBE C, 1992, GUT, V33, P429, DOI 10.1136/gut.33.4.429; Hooi JKY, 2017, GASTROENTEROLOGY, V153, P420, DOI 10.1053/j.gastro.2017.04.022; Huang JQ, 2003, GASTROENTEROLOGY, V125, P1636, DOI 10.1053/j.gastro.2003.08.033; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, REV HUM CARC B; Inoue M, 2017, GASTRIC CANCER, V20, pS3, DOI 10.1007/s10120-016-0658-5; Joo YE, 2013, GUT LIVER, V7, P303, DOI 10.5009/gnl.2013.7.3.303; Kato I, 2004, CANCER EPIDEM BIOMAR, V13, P468; Khaw KT, 2004, AM J CLIN NUTR, V80, P1397, DOI 10.1093/ajcn/80.5.1397; Kodaman N, 2014, P NATL ACAD SCI USA, V111, P1455, DOI 10.1073/pnas.1318093111; Lopez-Carrillo L, 2003, INT J CANCER, V106, P277, DOI 10.1002/ijc.11195; Lopez-Carrillo L, 2012, FOOD CHEM TOXICOL, V50, P2118, DOI 10.1016/j.fct.2012.02.043; Malekzadeh R, 2009, ARCH IRAN MED, V12, P576; Maucort-Boulch D, 2008, CANCER EPIDEM BIOMAR, V17, P717, DOI 10.1158/1055-9965.EPI-07-2691; Megraud F, 2002, GUT, V50, P779, DOI 10.1136/gut.50.6.779; Murphy G, 2015, INT J CANCER, V137, P1938, DOI 10.1002/ijc.29543; Newton Robert, 2006, Infect Agent Cancer, V1, P5, DOI 10.1186/1750-9378-1-5; Nguyen D., 2011, CELL DEATH DIS, V2, pe240; Nogueira L, 2015, JAMA-J AM MED ASSOC, V313, P2075, DOI 10.1001/jama.2015.4559; Oh Sooyeon, 2013, J Cancer Prev, V18, P149; Palli D, 2007, INT J CANCER, V120, P859, DOI 10.1002/ijc.22435; Plummer M, 2016, LANCET GLOB HEALTH, V4, pE609, DOI 10.1016/S2214-109X(16)30143-7; Sathyanarayana MN, 2006, CRIT REV FOOD SCI, V46, P275, DOI 10.1080/1040-830491379236; Segi M., 1960, CANC MORTALITY SELEC; Singh K, 2006, WORLD J GASTROENTERO, V12, P1346, DOI 10.3748/wjg.v12.i9.1346; Stefan C, 2017, ECANCERMEDICALSCIENC, V11, DOI 10.3332/ecancer.2017.755; Torres J, 2013, CANCER CAUSE CONTROL, V24, P249, DOI 10.1007/s10552-012-0114-8	42	4	4	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0237515	10.1371/journal.pone.0237515	http://dx.doi.org/10.1371/journal.pone.0237515			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ6EE	32898138	Green Published, gold			2022-12-26	WOS:000570962500029
J	Palinkas-Bodzsar, N; Sztan, N; Molnar, T; Hidas, A				Palinkas-Bodzsar, Nora; Sztan, Nikoletta; Molnar, Tamas; Hidas, Andras			Gene conservation of six Hungarian local chicken breeds maintained in small populations over time	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; MOLECULAR MARKERS; DIVERSITY; SOFTWARE; SIZE; DNA	Investigation into the genetic diversity of certain endangered native breeds of domestic animals has been in common practice for several decades. The primary objective of these investigations has been to reveal the exceptional genetic value of such breeds, both for their conservation and also to gain insight into their current genetic status, as they have been undergoing a progressive decrease in population size and general diversity; this has been compounded by the general lack of an optimal breeding scheme. In this study, we have investigated changes in the genetic diversity of six Hungarian local chicken breeds based on 29 microsatellite loci over a period of 15 years. In terms of the basic diversity measures, populations sampled in 2017 generally exhibited a lower heterozygosity and mean number of alleles and thus, experienced a higher degree of inbreeding. Although the effective population size increased, the estimates of populations sampled over different periods indicated comparatively low values, suggesting overall lower genetic variance. Pairwise F(ST)estimates were higher in the populations sampled in 2017, showing a larger genetic distance between them. Considerable differences exist between the populations of the same breeds, which can most likely be attributed to genetic drift. STRUCTURE results have shown a clear separation between the Hungarian populations, which is in agreement with the principal coordinate analysis. The most likely clustering was found at K = 6, classifying the populations of the same breed as one group. No considerable allele loss was found in the Hungarian indigenous chicken breeds after 15 years of conservation. In general terms, after 15 years, the level of inbreeding within the populations was, in fact, higher, although this could be effectively reduced through the use of an improved mating system. Consequently, the breed management applied in the case of Hungarian local chicken breeds was found to be effective at adequately conserving their genetic variability.	[Palinkas-Bodzsar, Nora; Sztan, Nikoletta; Molnar, Tamas; Hidas, Andras] Natl Ctr Biodivers & Gene Conservat, Inst Farm Anim Gene Conservat, Godollo, Hungary; [Molnar, Tamas] Kaposvar Univ, Kaposvar, Hungary; [Hidas, Andras] Szent Istvan Univ, Godollo, Hungary	Hungarian University of Agriculture & Life Sciences; Kaposvar University; Hungarian University of Agriculture & Life Sciences	Palinkas-Bodzsar, N (corresponding author), Natl Ctr Biodivers & Gene Conservat, Inst Farm Anim Gene Conservat, Godollo, Hungary.	bodzsar.nora@gmail.com	Molnar, Tamas/H-7945-2019	Palinkas-Bodzsar, Nora/0000-0001-6163-9818; Molnar, Tamas/0000-0003-1752-4268	 [VEKOP-2.3.2-16-2016-00012]		Investigation of the Hungarian indigenous chicken breeds was funded by the VEKOP-2.3.2-16-2016-00012 project. www.palyazat.gov.hu The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthouly C, 2008, ANIM GENET, V39, P121, DOI 10.1111/j.1365-2052.2008.01703.x; Blackburn HD, 2006, POULTRY SCI, V85, P210, DOI 10.1093/ps/85.2.210; Blacket MJ, 2012, MOL ECOL RESOUR, V12, P456, DOI 10.1111/j.1755-0998.2011.03104.x; Bodzsar N, 2009, ANIM GENET, V40, P516, DOI 10.1111/j.1365-2052.2009.01876.x; Boettcher PJ, 2010, ANIM GENET, V41, P64, DOI 10.1111/j.1365-2052.2010.02050.x; Davila SG, 2009, POULTRY SCI, V88, P2518, DOI 10.3382/ps.2009-00347; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FAO, 2011, MOL GEN CHAR AN GEN, V9, P84; Gandini GC, 1999, GENEBANKS CONSERVATI; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Granevitze Z, 2007, ANIM GENET, V38, P576, DOI 10.1111/j.1365-2052.2007.01650.x; Hillel J, 2007, WORLD POULTRY SCI J, V63, P33, DOI 10.1017/S0043933907001250; Hillel J, 2003, GENET SEL EVOL, V35, P533, DOI [10.1051/gse:2003038, 10.1186/1297-9686-35-6-533]; Jorde PE, 2007, GENETICS, V177, P927, DOI 10.1534/genetics.107.075481; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Maretto Fabio, 2013, Agriculturae Conspectus Scientificus, V78, P197; Mendelsohn R, 2003, ECOL ECON, V45, P501, DOI 10.1016/S0921-8009(03)00100-9; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Muira WM, 2008, P NATL ACAD SCI USA, V105, P17312, DOI 10.1073/pnas.0806569105; Park SDE, 2001, THESIS; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pisenti JM, 2001, AVIAN POULT BIOL REV, V12, P1; Pritchard JK, 2000, GENETICS, V155, P945; Rana Y, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0120580, 10.1371/journal.pone.0125187, 10.1371/journal.pone.0121992]; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Shen R, 2005, MUTAT RES-FUND MOL M, V573, P70, DOI 10.1016/j.mrfmmm.2004.07.022; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Spalona A, 2007, ARCH GEFLUGELKD, V71, P49; SPSS Inc, 2002, SPSS 115 WIND; Sved JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069078; Szalay I, 2015, OLD HUNGARIAN POULTR; Tadano R, 2007, POULTRY SCI, V86, P2301, DOI 10.3382/ps.2007-00233; Tadano R, 2013, POULTRY SCI, V92, P2860, DOI 10.3382/ps.2013-03343; Tixier-Boichard M, 2009, WORLD POULTRY SCI J, V65, P272, DOI 10.1017/S0043933909000233; Wang J, 2016, HEREDITY, V117, P193, DOI 10.1038/hdy.2016.43; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Weigend S, 2002, WORLD POULTRY SCI J, V58, P411, DOI 10.1079/WPS20020031; Weigend S, 2001, WORLD POULTRY SCI J, V57, P275, DOI 10.1079/WPS20010020; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilkinson S, 2012, ANIM GENET, V43, P552, DOI 10.1111/j.1365-2052.2011.02296.x; Zanetti E, 2011, POULTRY SCI, V90, P2195, DOI 10.3382/ps.2011-01527; Zanetti E, 2010, POULTRY SCI, V89, P420, DOI 10.3382/ps.2009-00324	45	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238849	10.1371/journal.pone.0238849	http://dx.doi.org/10.1371/journal.pone.0238849			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ6EE	32898177	Green Published, gold			2022-12-26	WOS:000570962500025
J	Wurtemberger, J; Tchessalova, D; Regina, C; Bauer, C; Schneider, M; Wagers, AJ; Hettmer, S				Wuertemberger, Julia; Tchessalova, Daria; Regina, Carla; Bauer, Christoph; Schneider, Michaela; Wagers, Amy J.; Hettmer, Simone			Growth inhibition associated with disruption of the actin cytoskeleton by Latrunculin A in rhabdomyosarcoma cells	PLOS ONE			English	Article							SOFT-TISSUE SARCOMA; BORTEZOMIB; REVEALS	Functional genomic screening of KRAS-driven mouse sarcomas was previously employed to identify proliferation-relevant genes. Genes identified included Ubiquitin-conjugating enzyme E2 (Ube2c), Centromere Protein E (Cenpe), Hyaluronan Synthase 2 (Has2), and CAMP Responsive Element Binding Protein 3 Like 2 (Creb3l2). This study examines the expression and chemical inhibition of these candidate genes, identifying variable levels of protein expression and significant contributions to rhabdomyosarcoma (RMS) cell proliferation. Chemical treatment of human and murine RMS cell lines with bortezomib, UA62784, latrunculin A and sorafenib inhibited growth with approximate EC50 concentrations of 15-30nM for bortezomib, 25-80nM for UA62784 and 80-220nM for latrunculin A. The multi-kinase inhibitor sorafenib increasedin vitroproliferation of 4 of 6 sarcoma cell lines tested. Latrunculin A was further associated with disruption of the actin cytoskeleton and reduced ERK1/2 phosphorylation. Together, this work advances opportunities for developing therapies to block progression of soft-tissue sarcomas and demonstrates that disruption of the actin cytoskeleton in sarcoma cells by latrunculin A is associated with a reduction in RMS cell growth. (167 words).	[Wuertemberger, Julia; Regina, Carla; Bauer, Christoph; Schneider, Michaela; Hettmer, Simone] Univ Freiburg, Univ Med Ctr Freiburg, Dept Pediat & Adolescent Med, Div Pediat Hematol & Oncol, Freiburg, Germany; [Tchessalova, Daria; Wagers, Amy J.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Wagers, Amy J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Wagers, Amy J.] Harvard Stem Cell Inst, Cambridge, MA USA	University of Freiburg; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard University	Hettmer, S (corresponding author), Univ Freiburg, Univ Med Ctr Freiburg, Dept Pediat & Adolescent Med, Div Pediat Hematol & Oncol, Freiburg, Germany.	simone.hettmer@uniklinik-freiburg.de		Hettmer, Simone/0000-0003-1709-4448	Stand Up To Cancer-American Association for Cancer Research Innovative Research Grant [SU2CAACR-IRG1111]	Stand Up To Cancer-American Association for Cancer Research Innovative Research Grant	This work was funded by a Stand Up To Cancer-American Association for Cancer Research Innovative Research Grant (SU2CAACR-IRG1111; to AJW) and P.A.L.S. Bermuda/St. Baldrick's (to SH). We did not receive any other external funding to support this study.	[Anonymous], 2014, CANC DISCOV, V4, pOF1; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Bavi P, 2011, AM J PATHOL, V178, P2109, DOI 10.1016/j.ajpath.2011.01.034; Bioenergia, 2009, REV BRASILEIRA BIOEN, V8, P36; Crago Aimee M, 2015, Adv Surg, V49, P107, DOI 10.1016/j.yasu.2015.04.002; Doller A, 2015, EXP CELL RES, V330, P66, DOI 10.1016/j.yexcr.2014.09.010; El Sayed KA, 2008, J NAT PROD, V71, P396, DOI 10.1021/np070587w; Fujiwara I, 2018, CURR BIOL, V28, P3183, DOI 10.1016/j.cub.2018.07.082; Gwinn DM, 2018, CANCER CELL, V33, P91, DOI 10.1016/j.ccell.2017.12.003; Hawkins DS, 2014, CURR OPIN PEDIATR, V26, P50, DOI 10.1097/MOP.0000000000000041; Hettmer S, 2015, ELIFE, V4, DOI 10.7554/eLife.09436; Hettmer S, 2011, P NATL ACAD SCI USA, V108, P20002, DOI 10.1073/pnas.1111733108; Houghton PJ, 2008, PEDIATR BLOOD CANCER, V50, P37, DOI 10.1002/pbc.21214; Keir ST, 2010, PEDIATR BLOOD CANCER, V55, P1126, DOI 10.1002/pbc.22712; Konishi H, 2009, ANTICANCER RES, V29, P2091; Linch M, 2014, NAT REV CLIN ONCOL, V11, P187, DOI 10.1038/nrclinonc.2014.26; Lock RB, 2012, PEDIATR BLOOD CANCER, V58, P916, DOI 10.1002/pbc.23176; McNicol J, 2013, ANN APPL BIOL, V162, P288, DOI 10.1111/aab.12026; Oberlin O, 2008, J CLIN ONCOL, V26, P2384, DOI 10.1200/JCO.2007.14.7207; Parham DM, 2013, ADV ANAT PATHOL, V20, P387, DOI 10.1097/PAP.0b013e3182a92d0d; Rock K, 2011, J BIOL CHEM, V286, P18268, DOI 10.1074/jbc.M110.201665; Sheng Z, 2010, NAT MED, V16, P671, DOI 10.1038/nm.2158; Shern JF, 2014, CANCER DISCOV, V4, P216, DOI 10.1158/2159-8290.CD-13-0639; Sperka T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027511; Tcherniuk S, 2011, CHEM BIOL, V18, P631, DOI 10.1016/j.chembiol.2011.03.006; Yoo JY, 1999, MODERN PATHOL, V12, P775	26	4	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238572	10.1371/journal.pone.0238572	http://dx.doi.org/10.1371/journal.pone.0238572			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ6EE	32898143	Green Published, gold			2022-12-26	WOS:000570962500002
J	Cozzolino, F; Landolfi, A; Iacobucci, I; Monaco, V; Caterino, M; Celentano, S; Zuccato, C; Cattaneo, E; Monti, M				Cozzolino, Flora; Landolfi, Alfredo; Iacobucci, Ilaria; Monaco, Vittoria; Caterino, Marianna; Celentano, Simona; Zuccato, Chiara; Cattaneo, Elena; Monti, Maria			New label-free methods for protein relative quantification applied to the investigation of an animal model of Huntington Disease	PLOS ONE			English	Article							MASS-SPECTROMETRY; NORMALIZATION METHODS; MOUSE MODEL; PROTEOMICS; TECHNOLOGIES; PATHWAYS; ELUCIDATION	Spectral Counts approaches (SpCs) are largely employed for the comparison of protein expression profiles in label-free (LF) differential proteomics applications. Similarly, to other comparative methods, also SpCs based approaches require a normalization procedure before Fold Changes (FC) calculation. Here, we propose new Complexity Based Normalization (CBN) methods that introduced a variable adjustment factor (f), related to the complexity of the sample, both in terms of total number of identified proteins (CBN(P)) and as total number of spectral counts (CBN(S)). Both these new methods were compared with the Normalized Spectral Abundance Factor (NSAF) and the Spectral Counts log Ratio (Rsc), by using standard protein mixtures. Finally, to test the robustness and the effectiveness of the CBNs methods, they were employed for the comparative analysis of cortical protein extract from zQ175 mouse brains, model of Huntington Disease (HD), and control animals (raw data available via ProteomeXchange with identifier PXD017471). LF data were also validated by western blot and MRM based experiments. On standard mixtures, both CBN methods showed an excellent behavior in terms of reproducibility and coefficients of variation (CVs) in comparison to the other SpCs approaches. Overall, the CBN(P) method was demonstrated to be the most reliable and sensitive in detecting small differences in protein amounts when applied to biological samples.	[Cozzolino, Flora; Landolfi, Alfredo; Iacobucci, Ilaria; Monti, Maria] Univ Naples Federico II, Dept Chem Sci, Naples, Italy; [Cozzolino, Flora; Landolfi, Alfredo; Iacobucci, Ilaria; Monaco, Vittoria; Celentano, Simona; Monti, Maria] CEINGE Adv Biotechnol, Naples, Italy; [Caterino, Marianna] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Zuccato, Chiara; Cattaneo, Elena] Univ Milan, Dept Biosci, Milan, Italy; [Zuccato, Chiara; Cattaneo, Elena] Ist Nazl Genet Mol Romeo & Enrica Invernizzi, Milan, Italy	University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Naples Federico II; University of Milan	Monti, M (corresponding author), Univ Naples Federico II, Dept Chem Sci, Naples, Italy.; Monti, M (corresponding author), CEINGE Adv Biotechnol, Naples, Italy.	montimar@unina.it	Iacobucci, Ilaria/AAN-8009-2021; Caterino, Marianna/K-4531-2016; cozzolino, flora/AAA-3155-2022; MONTI, Maria/J-2816-2018	Iacobucci, Ilaria/0000-0001-6210-5607; MONTI, Maria/0000-0002-7775-7154; Landolfi, Alfredo/0000-0002-2964-0592; ZUCCATO, CHIARA/0000-0003-1771-3392	Ministero dell'Istruzione, dell'Universita e della Ricerca, Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale [PRIN/20128XWKTX]; CircProt [JPCOFUND-643417]	Ministero dell'Istruzione, dell'Universita e della Ricerca, Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); CircProt	This study was supported by a grant from Ministero dell'Istruzione, dell'Universita e della Ricerca, Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale (PRIN/20128XWKTX) to Maria Monti and Chiara Zuccato, and by CircProt (JPCOFUND-643417) to Elena Cattaneo.	Altelaar AFM, 2013, J PROTEOMICS, V88, P14, DOI 10.1016/j.jprot.2012.10.009; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Bantscheff M, 2012, ANAL BIOANAL CHEM, V404, P939, DOI 10.1007/s00216-012-6203-4; Beissbarth T, 2004, BIOINFORMATICS, V20, P31, DOI 10.1093/bioinformatics/bth924; Bianconcini A, 2009, INT J BIOCHEM CELL B, V41, P2189, DOI 10.1016/j.biocel.2009.04.011; Blein-Nicolas M, 2016, BBA-PROTEINS PROTEOM, V1864, P883, DOI 10.1016/j.bbapap.2016.02.019; Cao Y, 2019, EUR J MED CHEM, V162, P423, DOI 10.1016/j.ejmech.2018.10.001; Cappadona S, 2012, AMINO ACIDS, V43, P1087, DOI 10.1007/s00726-012-1289-8; Caterino M, 2016, MOL BIOSYST, V12, P566, DOI 10.1039/c5mb00736d; Caterino M, 2015, J INHERIT METAB DIS, V38, P969, DOI 10.1007/s10545-014-9806-4; Chen XL, 2015, PROTEOMICS, V15, P3175, DOI 10.1002/pmic.201500108; Choudhury KR, 2016, J PROTEOMICS, V132, P155, DOI 10.1016/j.jprot.2015.11.007; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Damiano M, 2010, BBA-MOL BASIS DIS, V1802, P52, DOI 10.1016/j.bbadis.2009.07.012; Di Girolamo F, 2013, CURR ORG CHEM, V17, P2891; Duarte TT, 2016, PROTEOMES, V4, DOI 10.3390/proteomes4040029; Elliott MH, 2009, J MASS SPECTROM, V44, P1637, DOI 10.1002/jms.1692; Evans C, 2012, ANAL BIOANAL CHEM, V404, P1011, DOI 10.1007/s00216-012-5918-6; Franich NR, 2018, J HUNTINGTONS DIS, V7, P137, DOI 10.3233/JHD-170274; Giacomello M, 2013, PRION, V7, P76, DOI 10.4161/pri.23581; Giacomello M, 2011, BIOFACTORS, V37, P206, DOI 10.1002/biof.162; Gokce E, 2011, J AM SOC MASS SPECTR, V22, P2199, DOI 10.1007/s13361-011-0237-2; Greco V, 2018, EXPERT REV PROTEOMIC, V15, P683, DOI 10.1080/14789450.2018.1505510; Hoehenwarter W, 2010, RAPID COMMUN MASS SP, V24, P3609, DOI 10.1002/rcm.4818; Howe E, 2010, BIOMEDICAL INFORMATICS FOR CANCER RESEARCH, P267, DOI 10.1007/978-1-4419-5714-6_15; Hsu CW, 2019, MOL CELL PROTEOMICS, V18, P1939, DOI 10.1074/mcp.RA119.001654; Karlsson L, 2018, NEUROSCIENCE, V384, P314, DOI 10.1016/j.neuroscience.2018.05.036; Langfelder P, 2016, NAT NEUROSCI, V19, P623, DOI 10.1038/nn.4256; Latterich M, 2008, EUR J CANCER, V44, P2737, DOI 10.1016/j.ejca.2008.09.007; Lee H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49665-1; Liu XY, 2007, J PROTEOME RES, V6, P3134, DOI 10.1021/pr070092s; Lundgren DH, 2010, EXPERT REV PROTEOMIC, V7, P39, DOI 10.1586/EPR.09.69; Matzke MM, 2013, PROTEOMICS, V13, P493, DOI 10.1002/pmic.201200269; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Mochel F, 2011, J CLIN INVEST, V121, P493, DOI 10.1172/JCI45691; Nahnsen S, 2013, MOL CELL PROTEOMICS, V12, P549, DOI 10.1074/mcp.R112.025163; Neilson KA, 2011, PROTEOMICS, V11, P535, DOI 10.1002/pmic.201000553; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Orr AL, 2008, J NEUROSCI, V28, P2783, DOI 10.1523/JNEUROSCI.0106-08.2008; Pandey M, 2010, J BIOENERG BIOMEMBR, V42, P217, DOI 10.1007/s10863-010-9288-5; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Patel VJ, 2009, J PROTEOME RES, V8, P3752, DOI 10.1021/pr900080y; Scigelova M, 2006, PROTEOMICS, P16, DOI 10.1002/pmic.200600528; Staubach S, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700456; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Timms JF, 2008, PROTEOMICS, V8, P4886, DOI 10.1002/pmic.200800298; Tucci P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0221837; Valikangas T, 2018, BRIEF BIOINFORM, V19, P1, DOI 10.1093/bib/bbw095; van der Burg JMM, 2008, NEUROBIOL DIS, V29, P41, DOI 10.1016/j.nbd.2007.07.029; Vitko D, 2020, MOL CELL PROTEOMICS, V19, P456, DOI 10.1074/mcp.RA119.001873; Wang Mu, 2008, Briefings in Functional Genomics & Proteomics, V7, P329, DOI 10.1093/bfgp/eln031; Zhang LC, 2017, METHODS MOL BIOL, V1550, P185, DOI 10.1007/978-1-4939-6747-6_14; Zhu WH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/840518	55	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238037	10.1371/journal.pone.0238037	http://dx.doi.org/10.1371/journal.pone.0238037			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886703	Green Published, gold			2022-12-26	WOS:000571064300018
J	Shire, NJ; Klein, AB; Golozar, A; Collins, JM; Fraeman, KH; Nordstrom, BL; McEwen, R; Hembrough, T; Rizvi, NA				Shire, Norah J.; Klein, Alyssa B.; Golozar, Asieh; Collins, Jenna M.; Fraeman, Kathy H.; Nordstrom, Beth L.; McEwen, Robert; Hembrough, Todd; Rizvi, Naiyer A.			STK11 (LKB1) mutations in metastatic NSCLC: Prognostic value in the real world	PLOS ONE			English	Article							CELL LUNG-CANCER; BLOCKADE; RESISTANCE; LKB1/STK11; KRAS	Background Mutations inSTK11(STK11m) and frequently co-occurringKRASmutations (KRASm/STK11m) are associated with poor survival in metastatic NSCLC (mNSCLC) immuno-oncology trials. There are limited data regarding the prognostic significance of these mutations in a real-world setting. Methods This retrospective cohort study analyzed de-identified electronic medical records from the Flatiron Clinico-Genomic database to identify patients with mNSCLC who had initiated first-line immunotherapy (IO; alone or in combination) or chemotherapy under routine care between January 1, 2013 and June 30, 2017. The primary objectives were to assess the prevalence ofSTK11m andKRASm/STK11m and to determine associations of these mutations with overall and progression-free survival (OS, PFS). Results Of 2407 patients with mNSCLC,STK11m andKRASm/STK11m were present in 13.6% and 6.5% of patients, respectively. Worse OS outcomes were observed in patients withSTK11m versusSTK11wt mNSCLC receiving IO (first-line, HR [95% CI], 1.4 [0.9-2.3; p = 0.1]; second-line [subset of first-line cohort], HR, 1.6 [1.3-2.0; p = 0.0002]) or chemotherapy (first-line, HR, 1.4 [1.2-1.6; p < 0.0001]); PFS outcomes showed similar trends.KRASm/STK11m double mutations were associated with worse OS and PFS outcomes versusKRASwt/STK11wt with IO and chemotherapy, similar to the single mutation (STK11m vsSTK11wt) findings. Conclusions This large observational genomic study among patients receiving routine care highlights the negative prognostic impact ofSTK11m in patients with mNSCLC treated with IO or chemotherapy. These results complement previous clinical trial data and provide further evidence in the real world of a patient population that would benefit from new treatment options.	[Shire, Norah J.; Klein, Alyssa B.; Golozar, Asieh; Hembrough, Todd] AstraZeneca, Gaithersburg, MD 20878 USA; [Collins, Jenna M.; Fraeman, Kathy H.; Nordstrom, Beth L.] Evidera, Waltham, MA USA; [McEwen, Robert] AstraZeneca, Cambridge, England; [Rizvi, Naiyer A.] Columbia Univ, Div Hematol & Oncol, Med Ctr, New York, NY USA	AstraZeneca; Evidera; Columbia University	Shire, NJ (corresponding author), AstraZeneca, Gaithersburg, MD 20878 USA.	Norah.Shire@astrazeneca.com			AstraZeneca	AstraZeneca(AstraZeneca)	This study was funded by AstraZeneca. The sponsor was involved (see author Current Competing Interests section for more detail) in the study design; collection, analysis, and interpretation of data; report writing; and the decision to submit. Medical writing support, which was in accordance with Good Publication Practice (GPP3) guidelines, was provided by Beena John, PhD, of Cirrus Communications (Macclesfield, UK), an Ashfield company, and was funded by AstraZeneca.	[Anonymous], 2018, J VASC INTERV RADIOL, V29, pS105; [Anonymous], 2011, SEER CANC STAT REV 1; Arbour K, 2018, J THORAC ONCOL, V13, pS424, DOI 10.1016/j.jtho.2018.08.480; Arbour KC, 2019, JAMA-J AM MED ASSOC, V322, P764, DOI 10.1001/jama.2019.11058; Bange E, 2019, JCO PRECIS ONCOL, V3, DOI 10.1200/PO.18.00326; Biton J, 2018, CLIN CANCER RES, V24, P5710, DOI 10.1158/1078-0432.CCR-18-0163; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Carr TH, 2016, NAT REV CANCER, V16, P319, DOI 10.1038/nrc.2016.35; Cetin Karynsa, 2011, Clin Epidemiol, V3, P139, DOI 10.2147/CLEP.S17191; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cottrell TR, 2018, CANCER J, V24, P41, DOI 10.1097/PPO.0000000000000301; Della Corte CM, 2019, CANCER DISCOV, V9, P16, DOI 10.1158/2159-8290.CD-18-1286; Facchinetti F, 2017, LUNG CANCER, V112, P62, DOI 10.1016/j.lungcan.2017.08.002; Gandara DR, 2018, NAT MED, V24, P1441, DOI 10.1038/s41591-018-0134-3; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Garassino MC, 2018, LANCET ONCOL, V19, P521, DOI 10.1016/S1470-2045(18)30144-X; GLOBOCAN, 2018, CANC FACT SHEETS; Griffith SD, 2019, ADV THER, V36, P2122, DOI 10.1007/s12325-019-00970-1; Hellmann MD, 2018, NEW ENGL J MED, V378, P2093, DOI 10.1056/NEJMoa1801946; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jure-Kunkel M, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.3028; Khozin S, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djx187; Kitapma S, 2019, CANCER DISCOV, V9, P34, DOI 10.1158/2159-8290.CD-18-0689; Koyama S, 2016, CANCER RES, V76, P999, DOI 10.1158/0008-5472.CAN-15-1439; La Fleur L, 2019, LUNG CANCER, V130, P50, DOI 10.1016/j.lungcan.2019.01.003; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; MA X, 2019, ANN ONCOL S5, V0030; Mok TSK, 2019, LANCET, V393, P1819, DOI 10.1016/S0140-6736(18)32409-7; Peters S, 2018, CANCER TREAT REV, V62, P39, DOI 10.1016/j.ctrv.2017.10.002; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Rizvi N, 2019, J THORAC ONCOL, V14, pS217, DOI 10.1016/j.jtho.2019.08.428; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Scheffler M, 2019, J THORAC ONCOL, V14, P606, DOI 10.1016/j.jtho.2018.12.013; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Singal G, 2019, JAMA-J AM MED ASSOC, V321, P1391, DOI 10.1001/jama.2019.3241; Skoulidis F, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.102; Skoulidis F, 2018, CANCER DISCOV, V8, P822, DOI 10.1158/2159-8290.CD-18-0099; West H, 2019, LANCET ONCOL, V20, P924, DOI 10.1016/S1470-2045(19)30167-6; 2018, J VASC INTERV RADIOL, V29, pS105	39	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238358	10.1371/journal.pone.0238358	http://dx.doi.org/10.1371/journal.pone.0238358			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881920	gold, Green Published			2022-12-26	WOS:000571063300010
J	Silva, N; Phythian, CJ; Currie, C; Tassi, R; Ballingall, KT; Magro, G; McNeilly, TN; Zadoks, RN				Silva, Nuno; Phythian, Clare J.; Currie, Carol; Tassi, Riccardo; Ballingall, Keith T.; Magro, Giada; McNeilly, Tom N.; Zadoks, Ruth N.			Antimicrobial resistance in ovine bacteria: A sheep in wolf's clothing?	PLOS ONE			English	Article							ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE; SUSCEPTIBILITY; CATTLE; FARM	Background To monitor the prevalence of antimicrobial resistance (AMR), methods for interpretation of susceptibility phenotypes of bacteria are needed. Reference limits to declare resistance are generally based on or dominated by data from human bacterial isolates and may not reflect clinical relevance or wild type (WT) populations in livestock or other hosts. Methods We compared the observed prevalence of AMR using standard and bespoke interpretations based on clinical breakpoints or epidemiological cut-offs (ECOFF) using gram positive (Staphylococcus aureus) and gram negative (Escherichia coli) bacteria from sheep as exemplars. Isolates were obtained from a cross-sectional study in three lowland sheep flocks in Scotland, and from a longitudinal study in one flock in Norway.S.aureus(n = 101) was predominantly isolated from milk or mammary glands whilstE.coli(n = 103) was mostly isolated from faecal samples. Disc diffusion testing was used to determine inhibition zone diameters, which were interpreted using either clinical breakpoints or ECOFF, which distinguish the bacterial wild type population from bacteria with acquired or mutational resistance to the compound of interest (non-wild type). Standard ECOFF values were considered as well as sheep-specific values calculated from the data using Normalized Resistance Interpretation (NRI) methodology. Results The prevalence of AMR as measured based on clinical breakpoints was low, e.g. 4.0% for penicillin resistance inS.aureus. Estimation of AMR prevalence based on standard ECOFFs was hampered by lack of relevant reference values. In addition, standard ECOFFS, which are predominantly based on human data, bisected the normal distribution of inhibition zone diameters for several compounds in our analysis of sheep isolates. This contravenes recommendations for ECOFF setting based on NRI methodology and may lead to high apparent AMR prevalence. Using bespoke ECOFF values based on NRI,S.aureusshowed non-wild type for less than 4% of isolates across 13 compounds, and ca. 13% non-wild type for amoxicillin and ampicillin, whileE.colishowed non-wild type for less than 3% of isolates across 12 compounds, and ca. 13% non-wild type for tetracyclines and sulfamethoxazole-trimethoprim. Conclusion The apparent prevalence of AMR in bacteria isolated from sheep is highly dependent on interpretation criteria. The sheep industry may want to establish bespoke cut-off values for AMR monitoring to avoid the use of cut-offs developed for other host species. The latter could lead to high apparent prevalence of resistance, including to critically important antimicrobial classes such as 4(th)generation cephalosporins and carbapenems, suggesting an AMR problem that may not actually exist.	[Silva, Nuno; Currie, Carol; Tassi, Riccardo; Ballingall, Keith T.; Magro, Giada; McNeilly, Tom N.; Zadoks, Ruth N.] Moredun Res Inst, Pentlands Sci Pk, Penicuik, Midlothian, Scotland; [Phythian, Clare J.] Norwegian Univ Life Sci, Fac Vet Med, Inst Prod Anim Clin Sci, Sandnes, Norway; [Zadoks, Ruth N.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Zadoks, Ruth N.] Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Sydney, NSW, Australia	Moredun Research Institute; Norwegian University of Life Sciences; University of Glasgow; University of Sydney	Silva, N (corresponding author), Moredun Res Inst, Pentlands Sci Pk, Penicuik, Midlothian, Scotland.	nuno.silva@moredun.ac.uk	; Silva, Nuno/I-6929-2013	Zadoks, Ruth/0000-0002-1164-8000; Silva, Nuno/0000-0002-0842-5412	Scottish Government Rural Affairs, Food and the Environment (RAFE) Strategic Research Portfolio 2016-2021; Nordic Joint Committee for Agricultural and Food Research (NKJ) program 2018-2020	Scottish Government Rural Affairs, Food and the Environment (RAFE) Strategic Research Portfolio 2016-2021; Nordic Joint Committee for Agricultural and Food Research (NKJ) program 2018-2020	NS, CC, RT, KTB, TMcN, and RNZ received funding from the Scottish Government Rural Affairs, Food and the Environment (RAFE) Strategic Research Portfolio 2016-2021. https://www2.gov.scot/Topics/Research/About/EBAR CJP received funding from the Nordic Joint Committee for Agricultural and Food Research (NKJ) program 2018-2020 for dissemination and publication of project results.	Adhikari R, 2017, CAN J INFECT DIS MED, V2017, DOI 10.1155/2017/2191532; Angell J., 2020, Livestock, V25, P94, DOI 10.12968/live.2020.25.2.94; [Anonymous], 2015, INT J CURRENT MICROB, V4, P379; Bager F, 2000, INT J ANTIMICROB AG, V14, P271, DOI 10.1016/S0924-8579(00)00135-7; Berge AC, 2010, JAVMA-J AM VET MED A, V236, P1338, DOI 10.2460/javma.236.12.1338; BRAKSTAD OG, 1992, J CLIN MICROBIOL, V30, P1654, DOI 10.1128/JCM.30.7.1654-1660.1992; Clinical and Laboratory Standards Institute, 2018, M100 CLIN LAB STAND, V28th, DOI DOI 10.1108/08876049410065598; Clinical and Laboratory Standards Institute (CLSI), 2020, PERFORMANCE STANDARD, V5th; CLSI, 2018, VET08S4 CLSI S; Davies P, 2017, VET REC, V181, P511, DOI 10.1136/vr.104501; de Jong A, 2018, VET MICROBIOL, V216, P168, DOI 10.1016/j.vetmic.2018.02.010; de Verdier K, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-2; Dias D, 2015, RES MICROBIOL, V166, P584, DOI 10.1016/j.resmic.2015.03.006; EUCAST, 2018, ROUT EXT INT CONTR M; EUCAST, ANT WILD TYP DISTR M; European Food Safety Authority, 2017, EFSA J, V15, pe04694, DOI 10.2903/j.efsa.2017.4694; Fernandes CJ, 2005, J ANTIMICROB CHEMOTH, V55, P506, DOI 10.1093/jac/dki052; Gelasakis AI, 2015, VET MICROBIOL, V181, P136, DOI 10.1016/j.vetmic.2015.07.009; Heininger A, 1999, J CLIN MICROBIOL, V37, P2479, DOI 10.1128/JCM.37.8.2479-2482.1999; Hunt M, 2017, MICROB GENOMICS, V3, DOI 10.1099/mgen.0.000131; Kahlmeter G, 2014, UPSALA J MED SCI, V119, P78, DOI 10.3109/03009734.2014.901446; Kelly WJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep30768; Khachatryan AR, 2004, APPL ENVIRON MICROB, V70, P752, DOI 10.1128/AEM.70.2.752-757.2004; Kronvall G, 2003, INT J ANTIMICROB AG, V22, P7, DOI 10.1016/S0924-8579(03)00107-9; Kronvall G, 2016, APMIS, V124, P1023, DOI 10.1111/apm.12624; Kronvall G, 2011, INT J ANTIMICROB AG, V38, P281, DOI 10.1016/j.ijantimicag.2011.04.006; Kronvall G, 2010, APMIS, V118, P621, DOI 10.1111/j.1600-0463.2010.02660.x; Lovatt F, 2019, IN PRACTICE, V41, P23, DOI 10.1136/inp.k5370; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Malone FE, 2010, SMALL RUMINANT RES, V92, P78, DOI 10.1016/j.smallrumres.2010.04.008; Moyaert H, 2019, J APPL MICROBIOL, V127, P29, DOI 10.1111/jam.14274; NORM-VET. NORM/NORM-VET 2017, 2017, NORM NORM VET 2017 U; NORM-VET. NORM/NORM-VET 2018, 2018, NORM NORM VET 2018 U; O'Neill J., 2016, Tackling drug-resistant infections globally: final report and recommendations; Rutherford SJ, 2015, VET REC, V176, DOI 10.1136/vr.102781; Sjolund M, 2009, CLIN MICROBIOL INFEC, V15, P461, DOI 10.1111/j.1469-0691.2009.02705.x; Smith P, 2012, AQUACULTURE, V326, P27, DOI 10.1016/j.aquaculture.2011.11.011; Turnidge J, 2007, CLIN MICROBIOL REV, V20, P391, DOI 10.1128/CMR.00047-06; van Bijnen EME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135094; VARSS, 2017, UK VARSS REP 2016; WHO, 2017, WHO GUID ETH ISS PUB; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1; World Health Organization, 2014, ANT RES GLOB REP SUR	43	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238708	10.1371/journal.pone.0238708	http://dx.doi.org/10.1371/journal.pone.0238708			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881949	Green Accepted, Green Published, gold			2022-12-26	WOS:000571063300107
J	Valdes, V; Pierce, LJ; Lane, CJ; Reilly, EB; Jensen, SKG; Gharib, A; Levitt, P; Nelson, CA; Thompson, BL				Valdes, Viviane; Pierce, Lara J.; Lane, Christianne Joy; Reilly, Emily B.; Jensen, Sarah K. G.; Gharib, Alma; Levitt, Pat; Nelson, Charles A., III; Thompson, Barbara L.			An exploratory study of predictors of cognition in two low-income samples of infants across the first year of life	PLOS ONE			English	Article							EARLY-CHILDHOOD; POSTNATAL DEPRESSION; SOCIOECONOMIC-STATUS; MATERNAL DEPRESSION; FAMILY INCOME; POVERTY; EDUCATION; LANGUAGE; IMPACT; BRAIN	Objective In this exploratory longitudinal study we assessed cognitive development in a community sample of infants born into predominantly low-income families from two different urban sites, to identify family and community factors that may associate with outcomes by 1 year of age. Method Infant-mother dyads (n = 109) were recruited in Boston and Los Angeles community pediatric practices. Infant cognition was measured using the Mullen Scales of Early Learning when the infant was aged 2, 6, 9, and 12 months. Longitudinal linear mixed effects modeling and linear regression models explored potential predictors of cognitive outcomes. Results Cognitive scores were lower than the reference population mean at both 6 and 12 months. There were site differences in demographics and cognitive performance. Maternal education predicted expressive language in Boston, and speaking Spanish and lower rates of community poverty were associated with greater increases in overall cognition in Los Angeles. Conclusion This exploratory study identified a number of drivers of child development that are both shared across cohorts and unique to specific community samples. Factors influencing heterogeneity within and across populations both may be important contributors to prevention and intervention in supporting healthy development among children.	[Valdes, Viviane; Pierce, Lara J.; Reilly, Emily B.; Jensen, Sarah K. G.; Nelson, Charles A., III] Boston Childrens Hosp, Dept Pediat, Div Dev Med, Boston, MA USA; [Pierce, Lara J.; Nelson, Charles A., III] Harvard Med Sch, Boston, MA 02115 USA; [Lane, Christianne Joy] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90007 USA; [Gharib, Alma; Levitt, Pat] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA; [Gharib, Alma] Univ Southern Calif, Viterbi Sch Engn, Los Angeles, CA 90007 USA; [Levitt, Pat] Univ Southern Calif, Childrens Hosp Los Angeles, Keck Sch Med, Saban Res Inst,Program Dev Neurosci & Neurogenet, Los Angeles, CA 90007 USA; [Nelson, Charles A., III] Harvard Grad Sch Educ, Cambridge, MA USA; [Thompson, Barbara L.] Michigan State Univ, Coll Human Med, Dept Pediat & Human Dev, Grand Rapids, MI 49503 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Southern California; Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of Southern California; Harvard University; Michigan State University; Michigan State University College of Human Medicine	Thompson, BL (corresponding author), Michigan State Univ, Coll Human Med, Dept Pediat & Human Dev, Grand Rapids, MI 49503 USA.	thom1756@msu.edu	Thompson, Barbara L/A-1976-2016	Reilly, Emily/0000-0003-4357-4015; Thompson, Barbara/0000-0002-7294-3900	JPB Foundation; Simms/Mann Family Foundation; Program in Developmental Neuroscience and Neurogenetics at Children's Hospital Los Angeles; Bill and Melinda Gates Foundation [OP1111625]; University of Southern California Division of Occupational Science and Occupational Therapy; Spectrum Health-MSU Alliance Corporation; Department of Pediatrics and Human Development, Michigan State University College of Human Medicine; National Center for Advancing Translational Science of the U.S. National Institutes of Health [UL1TR001855, UL1TR000130]	JPB Foundation; Simms/Mann Family Foundation; Program in Developmental Neuroscience and Neurogenetics at Children's Hospital Los Angeles; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); University of Southern California Division of Occupational Science and Occupational Therapy; Spectrum Health-MSU Alliance Corporation; Department of Pediatrics and Human Development, Michigan State University College of Human Medicine; National Center for Advancing Translational Science of the U.S. National Institutes of Health	This work was supported by The JPB Foundation through a grant to The JPB Research Network on Toxic Stress: A Project of the Center on the Developing Child at Harvard University (PL, CAN), the Simms/Mann Family Foundation and the Program in Developmental Neuroscience and Neurogenetics at Children's Hospital Los Angeles (PL), a grant OP1111625 from the Bill and Melinda Gates Foundation (CAN), a research fund from the University of Southern California Division of Occupational Science and Occupational Therapy (BLT), a research fund from the Spectrum Health-MSU Alliance Corporation and the Department of Pediatrics and Human Development, Michigan State University College of Human Medicine (BLT), and grants UL1TR001855 and UL1TR000130 from the National Center for Advancing Translational Science of the U.S. National Institutes of Health (CL). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders supported data collection and analyses.	Alderman H., 2011, NO SMALL MATTER IMPA; Barnett WS, 1998, LONG TERM EFFECTS CO; Barrera Manuel Jr, 2013, J Consult Clin Psychol, V81, P196, DOI 10.1037/a0027085; Berlinski S, 2009, J PUBLIC ECON, V93, P219, DOI 10.1016/j.jpubeco.2008.09.002; Bernal G, 2006, FAM PROCESS, V45, P143, DOI 10.1111/j.1545-5300.2006.00087.x; Bialystok E, 2014, Z ERZIEHWISS, V17, P433, DOI 10.1007/s11618-014-0491-8; Biesalski HK, 2016, WORLD REV NUTR DIET, V115, P1, DOI 10.1159/000442377; Bourgeois JP, 1997, ACTA PAEDIATR, V86, P27; Brand SR, 2009, CLIN OBSTET GYNECOL, V52, P441, DOI 10.1097/GRF.0b013e3181b52930; Brito NH, 2016, DEV COGN NEUROS-NETH, V19, P144, DOI 10.1016/j.dcn.2016.03.004; Brooks-Gunn J, 1997, NEIGHBORHOOD POVERTY; BrooksGunn J, 1997, FUTURE CHILD, V7, P55, DOI 10.2307/1602387; BROOKSGUNN J, 1993, AM J SOCIOL, V99, P353, DOI 10.1086/230268; Bureau USC, 2017, POV THRESH PREL EST; CAUGHY MO, 1994, CHILD DEV, V65, P457, DOI 10.1111/j.1467-8624.1994.tb00763.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dahl GB, 2012, AM ECON REV, V102, P1927, DOI 10.1257/aer.102.5.1927; Davis EP, 2010, CHILD DEV, V81, P131, DOI 10.1111/j.1467-8624.2009.01385.x; Dickerson A, 2016, J R STAT SOC A STAT, V179, P535, DOI 10.1111/rssa.12128; Dishion T. J., 2007, AM PSYCHOL ASS, DOI [10.1037/11485-000, DOI 10.1037/11485-000]; DUNCAN GJ, 1994, CHILD DEV, V65, P296, DOI 10.1111/j.1467-8624.1994.tb00752.x; Evans GW, 2004, AM PSYCHOL, V59, P77, DOI 10.1037/0003-066X.59.2.77; Farah MJ, 2017, NEURON, V96, P56, DOI 10.1016/j.neuron.2017.08.034; Fernald LCH, 2011, DEVELOPMENTAL SCI, V14, P832, DOI 10.1111/j.1467-7687.2010.01032.x; GHODSIAN M, 1984, J CHILD PSYCHOL PSYC, V25, P91, DOI 10.1111/j.1469-7610.1984.tb01721.x; GREENOUGH WT, 1987, CHILD DEV, V58, P539, DOI 10.2307/1130197; Haveman R, 1995, J ECON LIT, V33, P1829; Haveman R., 1994, SUCCEEDING GENERATIO; Hirai AH, 2018, JAMA PEDIATR, V172, P857, DOI 10.1001/jamapediatrics.2018.1524; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Jensen SKG, 2017, LANCET CHILD ADOLESC, V1, P225, DOI 10.1016/S2352-4642(17)30024-X; Kiernan KE, 2009, J SOC POLICY, V38, P569, DOI 10.1017/S0047279409003250; Klebanov PK, 1998, CHILD DEV, V69, P1420, DOI 10.2307/1132275; Knudsen EI, 2004, J COGNITIVE NEUROSCI, V16, P1412, DOI 10.1162/0898929042304796; KORENMAN S, 1995, CHILD YOUTH SERV REV, V17, P127, DOI 10.1016/0190-7409(95)00006-X; Kovacs AM, 2009, P NATL ACAD SCI USA, V106, P6556, DOI 10.1073/pnas.0811323106; Krieger N, 2003, J EPIDEMIOL COMMUN H, V57, P186, DOI 10.1136/jech.57.3.186; Kumpfer Karol L, 2002, Prev Sci, V3, P241, DOI 10.1023/A:1019902902119; Larson K, 2015, PEDIATRICS, V135, pE440, DOI 10.1542/peds.2014-0434; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Levitt P, 2003, J PEDIATR-US, V143, pS35, DOI 10.1067/S0022-3476(03)00400-1; Luijk MPCM, 2015, CHILD CARE HLTH DEV, V41, P1188, DOI 10.1111/cch.12238; Lupien SJ, 2009, CAN J PSYCHIAT, V54, P4, DOI 10.1177/070674370905400103; Matthey S, 2006, ARCH WOMEN MENT HLTH, V9, P309, DOI 10.1007/s00737-006-0152-x; Milosavljevic B, 2019, DEVELOPMENTAL SCI, V22, DOI 10.1111/desc.12808; Mitchell CM, 2011, DEV PSYCHOL, V47, P991, DOI 10.1037/a0024011; Morais Maria de Lima Salum e, 2013, Estud. psicol. (Campinas), V30, P7, DOI 10.1590/S0103-166X2013000100002; Mullen E. M, 1995, MULLEN SCALES EARLY; MURRAY L, 1992, J CHILD PSYCHOL PSYC, V33, P543, DOI 10.1111/j.1469-7610.1992.tb00890.x; MURRAY L, 1993, J CHILD PSYCHOL PSYC, V34, P1083, DOI 10.1111/j.1469-7610.1993.tb01775.x; Nelson CA, 2020, TRENDS NEUROSCI, V43, P133, DOI 10.1016/j.tins.2020.01.002; Nishimura T, 2016, INT J EPIDEMIOL, V45, P543, DOI 10.1093/ije/dyv363; Noble KG, 2015, DEV PSYCHOBIOL, V57, P535, DOI 10.1002/dev.21303; Oller D.K., 2002, LANGUAGE LITERACY BI, P3; Patra K, 2016, AM J PERINAT, V33, P738, DOI 10.1055/s-0036-1572532; Paxson C, 2007, J HUM RESOUR, V42, P49, DOI 10.3368/jhr.XLII.1.49; Peters HE, 1997, CONSEQUENCES GROWING, P340; Pierce LJ, 2019, JAMA PEDIATR, V173, P561, DOI 10.1001/jamapediatrics.2019.0492; Plomin R., 2008, BEHAV GENET; Schady N, 2014, WEALTH GRADIENTS EAR; Schady N, 2011, AM J PUBLIC HEALTH, V101, P2299, DOI 10.2105/AJPH.2011.300253; Singh L, 2015, CHILD DEV, V86, P294, DOI 10.1111/cdev.12271; Smith JR, 1997, CONSEQUENCES GROWING, V132, P189; Stein A, 2014, LANCET, V384, P1800, DOI 10.1016/S0140-6736(14)61277-0; Sterba SK, 2007, DEV PSYCHOPATHOL, V19, P345, DOI 10.1017/S0954579407070174; Teachman JD, 1997, CONSEQUENCES GROWING, P382; Thompson W. E., 2016, SOC FOCUS INTRO SOCI; Venkatesh KK, 2014, PEDIATRICS, V133, pE45, DOI 10.1542/peds.2013-1628; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2; Wang F, 2019, P NATL ACAD SCI USA, V116, P15855, DOI 10.1073/pnas.1821523116; Wong MM, 1999, DEV PSYCHOPATHOL, V11, P727, DOI 10.1017/S0954579499002291	72	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238507	10.1371/journal.pone.0238507	http://dx.doi.org/10.1371/journal.pone.0238507			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ7QD	32881915	gold, Green Published			2022-12-26	WOS:000571063300042
J	Wu, CJ; Li, X; Sommers, CL; Kurima, K; Huh, S; Bugos, G; Dong, LJ; Li, WM; Griffith, AJ; Samelson, LE				Wu, Chuan-Jin; Li, Xing; Sommers, Connie L.; Kurima, Kiyoto; Huh, Sunmee; Bugos, Grace; Dong, Lijin; Li, Wenmei; Griffith, Andrew J.; Samelson, Lawrence E.			Expression of a TMC6-TMC8-CIB1 heterotrimeric complex in lymphocytes is regulated by each of the components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						TMC6; TMC8; CIB1; heteromeric complex; epidermodysplasia verruciformis; HPV; lymphocytes; T cells; keratinocytes; protein complex; lymphocyte; keratinocyte; protein degradation; ubiquitin-dependent protease; transmembrane channel protein	ACQUIRED EPIDERMODYSPLASIA-VERRUCIFORMIS; HAIR-CELLS; CHANNEL; MECHANOTRANSDUCTION; TMC1; MUTATIONS; PROTEINS; GENES; CIB1; SITE	The TMC genes encode a set of homologous transmembrane proteins whose functions are not well understood. Biallelic mutations in either TMC6 or TMC8 are detected in more than half of cases of the pre-malignant skin disease epidermodysplasia verruciformis (EV). It is controversial whether EV induced by mutations in TMC6 or TMC8 originates from keratinocyte or lymphocyte defects. Quantification of TMC6 and TMC8 RNA levels in various organs revealed that lymphoid tissues have the highest levels of expression of both genes, and custom antibodies confirmed protein expression in mouse lymphocytes. To study the function of these proteins we generated mice with targeted deletion mutant alleles of Tmc6 or Tmc8. Either TMC6 or TMC8 deficiency induced a reduction in apparent molecular weight and/or amount of the other TMC molecule. Co-immunoprecipitation experiments indicated that TMC6 and TMC8 formed a protein complex in mouse and human T cells. MS and biochemical analysis demonstrated that TMC6 and TMC8 additionally interacted with the CIB1 protein to form TMC6-TMC8-CIB1 trimers. We demonstrated that TMC6 and TMC8 regulated CIB1 levels by protecting CIB1 from ubiquitination and proteasomal degradation. Reciprocally, CIB1 was needed for stabilizing TMC6 and TMC8 levels. These results suggest why inactivating mutations in any of the three human genes leads to similar clinical presentations. We also demonstrated that TMC6 and TMC8 levels are drastically lower and the proteins are less active in regulating CIB1 in keratinocytes than in T cells. Our study suggests that defects in lymphocytes may contribute to the etiology and pathogenesis of EV.	[Wu, Chuan-Jin; Sommers, Connie L.; Huh, Sunmee; Bugos, Grace; Li, Wenmei; Samelson, Lawrence E.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, Bethesda, MD 20892 USA; [Li, Xing; Kurima, Kiyoto; Griffith, Andrew J.] Natl Inst Deafness & Other Commun Disorders, Mol Biol & Genet Sect, NIH, Rockville, MD USA; [Dong, Lijin] NEI, Genet Engn Core, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Samelson, LE (corresponding author), NCI, Lab Cellular & Mol Biol, Ctr Canc Res, Bethesda, MD 20892 USA.	samelsonl@helix.nih.gov			NCI; NIDCD; NEI; National Institutes of Health	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Intramural Research Programs of the NCI, NIDCD, and NEI, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Azzimonti B, 2005, ARCH DERMATOL, V141, P1323, DOI 10.1001/archderm.141.10.1323; Ballesteros A, 2018, ELIFE, V7, DOI 10.7554/eLife.38433; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Crequer A, 2012, J CLIN INVEST, V122, P3239, DOI 10.1172/JCI62949; de Jong SJ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01222; Jong SJ, 2018, J EXP MED, V215, P2289, DOI 10.1084/jem.20170308; Du XR, 2014, J IMMUNOL, V192, P1525, DOI 10.4049/jimmunol.1301060; Fallah G, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004697; Giese APJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00061-1; Gu Y, 2006, NAT IMMUNOL, V7, P1182, DOI 10.1038/ni1396; Hahn Y, 2009, INT J MOL MED, V24, P51, DOI 10.3892/ijmm_00000205; Ingle A, 2011, VET PATHOL, V48, P500, DOI 10.1177/0300985810377186; Janssen E, 2016, J CLIN INVEST, V126, P3837, DOI 10.1172/JCI85774; Jia YY, 2020, NEURON, V105, P310, DOI 10.1016/j.neuron.2019.10.017; Kawashima Y, 2015, PFLUG ARCH EUR J PHY, V467, P85, DOI 10.1007/s00424-014-1582-3; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Keresztes G, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-24; Kobayashi T, 2015, IMMUNITY, V42, P756, DOI 10.1016/j.immuni.2015.03.014; Kurima K, 2003, GENOMICS, V82, P300, DOI 10.1016/S0888-7543(03)00154-X; Kurima K, 2015, CELL REP, V12, P1606, DOI 10.1016/j.celrep.2015.07.058; Labay V, 2010, BIOCHEMISTRY-US, V49, P8592, DOI 10.1021/bi1004377; Lazarczyk M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039995; Leisner TM, 2016, FASEB J, V30, P2640, DOI 10.1096/fj.201500073R; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; MOUNTFORD PS, 1995, TRENDS GENET, V11, P179, DOI 10.1016/S0168-9525(00)89040-X; Ovits CG, 2017, J DRUGS DERMATOL, V16, P701; Pan BF, 2018, NEURON, V99, P736, DOI 10.1016/j.neuron.2018.07.033; Pan BF, 2013, NEURON, V79, P504, DOI 10.1016/j.neuron.2013.06.019; Ramoz N, 2002, NAT GENET, V32, P579, DOI 10.1038/ng1044; Riazuddin S, 2012, NAT GENET, V44, P1265, DOI 10.1038/ng.2426; Sommers CL, 2005, J EXP MED, V201, P1125, DOI 10.1084/jem.20041869; Tang YQ, 2020, NEURON, V107, P112, DOI 10.1016/j.neuron.2020.03.026; Tommasino M, 2017, VIRUS RES, V231, P128, DOI 10.1016/j.virusres.2016.11.013; Wang YF, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00401; Whitlock JM, 2017, ANNU REV PHYSIOL, V79, P119, DOI 10.1146/annurev-physiol-022516-034031; Wu CJ, 2017, J CLIN INVEST, V127, P623, DOI 10.1172/JCI88428; Yi J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08064-2; Yuan W, 2006, MOL CELL BIOL, V26, P8507, DOI 10.1128/MCB.01488-06; Zampetti A, 2013, DERMATOL SURG, V39, P974, DOI 10.1111/dsu.12135	39	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2020	295	47					16086	16099		10.1074/jbc.RA120.013045	http://dx.doi.org/10.1074/jbc.RA120.013045			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PA5ED	32917726	hybrid, Green Published			2022-12-26	WOS:000595657900024
J	Yu, BW; Cheng, C; Wu, YC; Guo, LQ; Kong, DD; Zhang, Z; Wang, YY; Zheng, EL; Liu, YB; He, YN				Yu, Bowen; Cheng, Chen; Wu, Yichun; Guo, Luqiang; Kong, Dandan; Zhang, Ze; Wang, Yuanyuan; Zheng, Enlin; Liu, Yingbin; He, Yongning			Interactions of ferritin with scavenger receptor class A members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						SCARA5; SR class A; scavenger receptor; ferritin; SRCR domain; scavenger receptor; ferritin; protein structure; X-ray crystallography; cell surface receptor	CYSTEINE-RICH DOMAIN; SERUM FERRITIN; CRYSTAL-STRUCTURE; LIPOPROTEIN RECEPTORS; OXIDATIVE STRESS; IRON; LIGAND; FERROPTOSIS; REVEALS; ATHEROSCLEROSIS	Scavenger receptors are a superfamily of membrane-bound receptors that recognize both self and nonself targets. Scavenger receptor class A (SR-A) has five known members (SCARA1 to -5 or SR-A1 to -A5), which are type II transmembrane proteins that form homotrimers on the cell surface. SR-A members recognize various ligands and are involved in multiple biological pathways. Among them, SCARA5 can function as a ferritin receptor; however, the interaction between SCARA5 and ferritin has not been fully characterized. Here, we determine the crystal structures of the C-terminal scavenger receptor cysteine-rich (SRCR) domain of both human and mouse SCARA5 at 1.7 and 2.5 angstrom resolution, respectively, revealing three Ca2+-binding sites on the surface. Using biochemical assays, we show that the SRCR domain of SCARA5 recognizes ferritin in a Ca2+-dependent manner, and both L- and H-ferritin can be recognized by SCARA5 through the SRCR domain. Furthermore, the potential binding region of SCARA5 on the surface of ferritin is explored by mutagenesis studies. We also examine the interactions of ferritin with other SR-A members and find that SCARA1 (SR-A1, CD204) and MARCO (SR-A2, SCARA2), which are highly expressed on macrophages, also interact with ferritin. By contrast, SCARA3 and SCARA4, the two SR-A members without the SRCR domain, have no detectable binding with ferritin. Overall, these results provide a mechanistic view regarding the interactions between the SR-A members and ferritin that may help to understand the regulation of ferritin homeostasis by scavenger receptors.	[Yu, Bowen; Cheng, Chen; Wu, Yichun; Guo, Luqiang; Kong, Dandan; Zhang, Ze; Wang, Yuanyuan; Zheng, Enlin; He, Yongning] Chinese Acad Sci, Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Yu, Bowen; Cheng, Chen; Wu, Yichun; Guo, Luqiang; Kong, Dandan; Zhang, Ze; Wang, Yuanyuan; Zheng, Enlin; He, Yongning] Univ Chinese Acad Sci, Beijing, Peoples R China; [Liu, Yingbin; He, Yongning] Shanghai Jiao Tong Univ, Renji Hosp, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Sch Med, Shanghai, Peoples R China; [Liu, Yingbin; He, Yongning] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Biliary Pancreat Surg, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University	He, YN (corresponding author), Chinese Acad Sci, Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol, Shanghai, Peoples R China.; He, YN (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; He, YN (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Sch Med, Shanghai, Peoples R China.; He, YN (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Biliary Pancreat Surg, Shanghai, Peoples R China.	he@sibcb.ac.cn	Wang, Yu/GZL-9655-2022; Wang, Yuan/HHC-1520-2022; wangwangwang, yuanyaun/HHN-6432-2022; Lv, Yuanjie/AER-0767-2022		National Natural Science Foundation of China [91957102]; Chinese Academy of Sciences Facility-based Open Research Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences Facility-based Open Research Program	This work is supported by National Natural Science Foundation of China Grant 91957102 and the Chinese Academy of Sciences Facility-based Open Research Program (to Y. H.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ADDISON GM, 1972, J CLIN PATHOL, V25, P326, DOI 10.1136/jcp.25.4.326; Andersen CBF, 2014, TRENDS BIOCHEM SCI, V39, P82, DOI 10.1016/j.tibs.2013.12.003; AROSIO P, 1977, BRIT J HAEMATOL, V36, P199, DOI 10.1111/j.1365-2141.1977.tb00640.x; AROSIO P, 1978, J BIOL CHEM, V253, P4451; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Bowdish DME, 2009, IMMUNOL REV, V227, P19, DOI 10.1111/j.1600-065X.2008.00728.x; Bresgen N, 2010, FREE RADICAL BIO MED, V48, P1347, DOI 10.1016/j.freeradbiomed.2010.02.019; BROWN MS, 1979, P NATL ACAD SCI USA, V76, P3330, DOI 10.1073/pnas.76.7.3330; BROWN MS, 1979, J CELL BIOL, V82, P597, DOI 10.1083/jcb.82.3.597; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; CAZZOLA M, 1985, TUMORI, V71, P547, DOI 10.1177/030089168507100606; CERNY LC, 1981, PHYSIOL CHEM PHYS M, V13, P221; Chappell PE, 2015, STRUCTURE, V23, P1426, DOI 10.1016/j.str.2015.05.019; Cheng C, 2019, J BIOL CHEM, V294, P18881, DOI 10.1074/jbc.RA119.010110; Coffman LG, 2008, AM J PHYSIOL-LUNG C, V294, pL505, DOI 10.1152/ajplung.00347.2007; Coffman LG, 2009, P NATL ACAD SCI USA, V106, P570, DOI 10.1073/pnas.0812010106; Connelly KG, 1997, AM J RESP CRIT CARE, V155, P21, DOI 10.1164/ajrccm.155.1.9001283; DOI T, 1993, J BIOL CHEM, V268, P2126; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feinberg H, 2007, J BIOL CHEM, V282, P17250, DOI 10.1074/jbc.M701624200; Gao MH, 2016, CELL RES, V26, P1021, DOI 10.1038/cr.2016.95; Ghosh S, 2004, BLOOD, V103, P2369, DOI 10.1182/blood-2003-09-3050; Goodall EF, 2008, J NEUROL, V255, P1652, DOI 10.1007/s00415-008-0945-0; Gowen BB, 2001, J LEUKOCYTE BIOL, V69, P575; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hohenester E, 1999, NAT STRUCT BIOL, V6, P228, DOI 10.1038/6669; Hou W, 2016, AUTOPHAGY, V12, P1425, DOI 10.1080/15548627.2016.1187366; Kell DB, 2014, METALLOMICS, V6, P748, DOI 10.1039/c3mt00347g; Kiechl S, 1997, CIRCULATION, V96, P3300; KRIEGER M, 1992, TRENDS BIOCHEM SCI, V17, P141, DOI 10.1016/0968-0004(92)90322-Z; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Kurz T, 2011, FREE RADICAL BIO MED, V50, P1647, DOI 10.1016/j.freeradbiomed.2011.03.014; Latunde-Dada GO, 2017, BBA-GEN SUBJECTS, V1861, P1893, DOI 10.1016/j.bbagen.2017.05.019; Leimberg MJ, 2008, J CELL BIOCHEM, V103, P1211, DOI 10.1002/jcb.21499; Li JY, 2009, DEV CELL, V16, P35, DOI 10.1016/j.devcel.2008.12.002; LUKINA EA, 1993, BRIT J HAEMATOL, V83, P326, DOI 10.1111/j.1365-2141.1993.tb08289.x; Ma HF, 2017, J VIROL, V91, DOI 10.1128/JVI.01897-16; Madsen M, 2004, J BIOL CHEM, V279, P51561, DOI 10.1074/jbc.M409629200; McMahon C, 2018, NAT STRUCT MOL BIOL, V25, P289, DOI 10.1038/s41594-018-0028-6; Mendes-Jorge L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106974; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Nielsen MJ, 2013, J BIOL CHEM, V288, P18834, DOI 10.1074/jbc.M113.471060; Ojala JRM, 2007, J BIOL CHEM, V282, P16654, DOI 10.1074/jbc.M701750200; Parthasarathy N, 2002, BIOCHEM J, V365, P279, DOI 10.1042/BJ20011637; PATEL DD, 1995, J EXP MED, V181, P1563, DOI 10.1084/jem.181.4.1563; Peiser L, 2000, INFECT IMMUN, V68, P1953, DOI 10.1128/IAI.68.4.1953-1963.2000; Pluddemann A, 2007, METHODS, V43, P207, DOI 10.1016/j.ymeth.2007.06.004; Pombinho R, 2018, CRIT REV MICROBIOL, V44, P685, DOI 10.1080/1040841X.2018.1493716; PrabhuDas M, 2014, J IMMUNOL, V192, P1997, DOI 10.4049/jimmunol.1490003; PrabhuDas MR, 2017, J IMMUNOL, V198, P3775, DOI 10.4049/jimmunol.1700373; RAGHAVA GPS, 1994, J IMMUNOASSAY, V15, P115, DOI 10.1080/15321819408013942; Reichhardt MP, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.201900502; RESNICK D, 1994, TRENDS BIOCHEM SCI, V19, P5, DOI 10.1016/0968-0004(94)90165-1; Rodamilans B, 2007, J BIOL CHEM, V282, P12669, DOI 10.1074/jbc.M611699200; RUSSELL DW, 1983, P NATL ACAD SCI-BIOL, V80, P7501, DOI 10.1073/pnas.80.24.7501; SANTAMBROGIO P, 1987, BRIT J HAEMATOL, V65, P235, DOI 10.1111/j.1365-2141.1987.tb02271.x; Sarraj MA, 2005, DEV DYNAM, V234, P1026, DOI 10.1002/dvdy.20594; Sarrias MR, 2004, CRIT REV IMMUNOL, V24, P1; SEGE RD, 1984, NATURE, V307, P742, DOI 10.1038/307742a0; SIBILLE JC, 1988, HEPATOLOGY, V8, P296, DOI 10.1002/hep.1840080218; Somoza JR, 2003, STRUCTURE, V11, P1123, DOI 10.1016/S0969-2126(03)00148-5; Sun CJ, 2011, J AM CHEM SOC, V133, P8617, DOI 10.1021/ja200746p; Tang MZ, 2018, J CELL PHYSIOL, V233, P9179, DOI 10.1002/jcp.26954; Truffi M, 2016, PHARMACOL RES, V107, P57, DOI 10.1016/j.phrs.2016.03.002; Wang W, 2010, BBA-GEN SUBJECTS, V1800, P760, DOI 10.1016/j.bbagen.2010.03.011; Wang ZM, 2006, ACTA CRYSTALLOGR D, V62, P800, DOI 10.1107/S0907444906018294; Whelan FJ, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-227; WORWOOD M, 1976, BIOCHEM J, V157, P97, DOI 10.1042/bj1570097; Yanyan JY, 2006, J BIOL CHEM, V281, P11834, DOI 10.1074/jbc.M507599200; Zhen ZP, 2013, ACS NANO, V7, P6988, DOI 10.1021/nn402199g	72	13	13	7	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2020	295	46					15727	15741		10.1074/jbc.RA120.014690	http://dx.doi.org/10.1074/jbc.RA120.014690			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OY6NO	32907880	Green Published, hybrid			2022-12-26	WOS:000594361600023
J	Burgstaller , JM; Held, U; Signorell, A; Blozik, E; Steurer, J; Wertli, MM				Burgstaller, Jakob M.; Held, Ulrike; Signorell, Andri; Blozik, Eva; Steurer, Johann; Wertli, Maria M.			Increased risk of adverse events in non-cancer patients with chronic and high-dose opioid use-A health insurance claims analysis	PLOS ONE			English	Article							CHRONIC DISEASE SCORE; CHRONIC PAIN; AMERICAN SOCIETY; PRESCRIPTION; OVERDOSE; RESPONSIBILITY	Background Chronic and high dose opioid use may result in adverse events. We analyzed the risk associated with chronic and high dose opioid prescription in a Swiss population. Methods Using insurance claims data covering one-sixth of the Swiss population, we analyzed recurrent opioid prescriptions (>= 2 opioid claims with at least 1 strong opioid claim) between 2006 and 2014. We calculated the cumulative dose in milligrams morphine equivalents (MED) and treatment duration. Excluded were single opioid claims, opioid use that was cancer treatment related, and opioid use in substitution programs. We assessed the association between the duration of opioid use, prescribed opioid dose, and benzodiazepine use with emergency department (ED) visits, urogenital and pulmonary infections, acute care hospitalization, and death at the end of the episode. Results In 63,642 recurrent opioid prescription episodes (acute 38%, subacute 7%, chronic 25.8%, very chronic (>360 days) episodes 29%) 18,336 ED visits, 30,209 infections, 19,375 hospitalizations, and 9,662 deaths occurred. The maximum daily MED dose was <20 mg in 15.8%, 20-<50 mg in 16.6%, 50-<100 mg in 21.6%, and >= 100 mg in 46%. Compared to acute episodes (<90 days), episode duration was an independent predictor of ED visits (chronic OR 1.09 (95% CI 1.03-1.15), very chronic (>360 days) OR 1.76 (1.67-1.86)) for adverse effects; infections (chronic OR 1.74 (1.66-1.82), very chronic 4.16 (3.95-4.37)), and hospitalization (chronic: OR 1.22 (1.16-1.29), very chronic OR 1.82 (1.73-1.93)). The risk of death decreased over time (very chronic OR 0.46 (0.43-0.50)). A dose dependent increased risk was observed for ED visits, hospitalization, and death (>= 100mg daily MED OR 1.21 (1.13-1.29), OR 1.29 (1.21-1.38), and OR 1.67, 1.50-1.85, respectively). A concomitant use of benzodiazepines increased the odds for ED visits by 46% (OR 1.46, 1.41-1.52), infections by 44% (OR 1.44, 1.41-1.52), hospitalization by 12% (OR 1.12, 1.07-1.1), and death by 45% (OR 1.45, 1.37-1.53). Conclusion The length of opioid use and higher prescribed morphine equivalent dose were independently associated with an increased risk for ED visits and hospitalizations. The risk for infections, ED visits, hospitalizations, and death also increased with concomitant benzodiazepine use.	[Burgstaller, Jakob M.; Held, Ulrike; Steurer, Johann; Wertli, Maria M.] Univ Zurich, Horten Ctr Patient Oriented Res & Knowledge Trans, Dept Internal Med, Zurich, Switzerland; [Burgstaller, Jakob M.; Blozik, Eva] Univ Zurich, Inst Primary Care, Zurich, Switzerland; [Burgstaller, Jakob M.; Blozik, Eva] Univ Hosp Zurich, Zurich, Switzerland; [Held, Ulrike] Univ Zurich, Biostat & Prevent Inst, Dept Biostat Epidemiol, Zurich, Switzerland; [Signorell, Andri; Blozik, Eva] Helsana, Dept Hlth Sci, Dubendorf, Switzerland; [Wertli, Maria M.] Univ Bern, Bern Univ Hosp, Dept Gen Internal Med, Bern, Switzerland	University of Zurich; University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University of Bern; University Hospital of Bern	Wertli, MM (corresponding author), Univ Zurich, Horten Ctr Patient Oriented Res & Knowledge Trans, Dept Internal Med, Zurich, Switzerland.; Wertli, MM (corresponding author), Univ Bern, Bern Univ Hosp, Dept Gen Internal Med, Bern, Switzerland.	Maria.Wertli@insel.ch	Wertli, Maria/Q-3349-2017	Wertli, Maria/0000-0001-6347-0198; Held, Ulrike/0000-0003-3105-5840				[Anonymous], 1989, CANC PAIN REL PALL C; [Anonymous], 2013, GUID ATC CLASS DDD A, P16; Bedson J, 2019, EUR J PAIN; Biller-Andorno N, 2015, NEW ENGL J MED, V373, P2193, DOI 10.1056/NEJMp1508256; Curtis HJ, 2019, LANCET PSYCHIAT, V6, P140, DOI 10.1016/S2215-0366(18)30471-1; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Edlund MJ, 2014, CLIN J PAIN, V30, P557, DOI 10.1097/AJP.0000000000000021; Eriksen J, 2006, PAIN, V125, P172, DOI 10.1016/j.pain.2006.06.009; Friedman BW, 2015, JAMA-J AM MED ASSOC, V314, P1572, DOI 10.1001/jama.2015.13043; Furlan AD, 2006, CAN MED ASSOC J, V174, P1589, DOI 10.1503/cmaj.051528; Hider-Mlynarz K, 2018, BRIT J CLIN PHARMACO, V84, P1324, DOI 10.1111/bcp.13564; Hojsted J, 2012, CURR PHARM DES; Huber CA, 2013, J CLIN EPIDEMIOL, V66, P1118, DOI 10.1016/j.jclinepi.2013.04.011; Jann Michael, 2014, J Pharm Pract, V27, P5, DOI 10.1177/0897190013515001; Jena Anupam B, 2014, BMJ, V348, pg1393, DOI 10.1136/bmj.g1393; Kuo RN, 2011, MED CARE, V49, P1031, DOI 10.1097/MLR.0b013e31822ebe11; Madras BK, 2017, JAMA PSYCHIAT, V74, P441, DOI 10.1001/jamapsychiatry.2017.0163; Manchikanti L, 2017, PAIN PHYSICIAN, V20, pS3; Manchikanti L, 2014, PAIN PHYSICIAN, V17, pE1; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pS1; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pES9; Miller M, 2015, JAMA INTERN MED, V175, P608, DOI 10.1001/jamainternmed.2014.8071; Nielsen S, 2015, PAIN MED, V16, P356, DOI 10.1111/pme.12594; O'Brien T, 2017, EUR J PAIN, V21, P3, DOI 10.1002/ejp.970; Pain & Policy Studies Group (PPSG), OP CONS DAT MAD WI 5; Park TW, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2698; Paulozzi LJ, 2006, PHARMACOEPIDEM DR S, V15, P618, DOI 10.1002/pds.1276; Putnam KG, 2002, EPIDEMIOLOGY, V13, P340, DOI 10.1097/00001648-200205000-00016; R Core Team, 2013, R LANG ENV STAT COMP; Ray WA, 2016, JAMA-J AM MED ASSOC, V315, P2415, DOI 10.1001/jama.2016.7789; Ruchat David, 2018, Rev Med Suisse, V14, P1262; Ruscitto A, 2015, EUR J PAIN, V19, P59, DOI 10.1002/ejp.520; Saunders KW, 2010, J GEN INTERN MED, V25, P310, DOI 10.1007/s11606-009-1218-z; Shah NG, 2008, ADDICTION, V103, P126, DOI 10.1111/j.1360-0443.2007.02054.x; Shipton EA, 2018, PAIN THER, V7, P23, DOI 10.1007/s40122-018-0096-7; Spithoff S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227045; United Nations Office on Drugs And Crime, 2011, NONM US PRESCR DRUGS; Volkow ND, 2014, NEW ENGL J MED, V370, P2063, DOI 10.1056/NEJMp1402780; Von Korff M, 2008, CLIN J PAIN, V24, P521, DOI 10.1097/AJP.0b013e318169d03b; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Wertli MM, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2086-6; Wertli MM, 2019, PAIN PHYS; World Health Organization, 1997, TRAIT DOUL CANC COMP	43	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0238285	10.1371/journal.pone.0238285	http://dx.doi.org/10.1371/journal.pone.0238285			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925928	Green Published, Green Accepted, gold			2022-12-26	WOS:000572318000019
J	Seipelt, EM; Tourniaire, F; Couturier, C; Astier, J; Loriod, B; Vachon, H; Puceat, M; Mounien, L; Landrier, JF				Seipelt, Eva M.; Tourniaire, Franck; Couturier, Charlene; Astier, Julien; Loriod, Beatrice; Vachon, Hortense; Puceat, Michel; Mounien, Lourdes; Landrier, Jean-Francois			Prenatal maternal vitamin D deficiency sex-dependently programs adipose tissue metabolism and energy homeostasis in offspring	FASEB JOURNAL			English	Article						adipose tissue; metabolism; maternal vitamin D deficiency; offspring; vitamin D	PREGNANCY; ADIPOCYTES; EXPRESSION; OBESITY; WEIGHT; GROWTH	In utero environment is crucial to ensure normal development of the fetus and to program metabolic health throughout the life. Beside macronutrients, the role of micronutrients, including vitamin D, begins to be explore. The aim of this study was to decipher the impact of maternal vitamin D deficiency (VDD), in normal and high-fat (HF) diet context, on adipose tissue metabolism and energy homeostasis in offspring, considering sex-specific responses. Body weight, energy expenditure, and spontaneous activity was differential impacted in juvenile male and female offspring born from VDD mice. In adulthood, a HF diet combined with maternal VDD disrupted glucose homeostasis and adiposity in male offspring but not in females. Such phenotypes were associated to different transcriptomic profiles in adipose tissue, which could be related to differential modulation of plasma 17 beta-estradiol concentrations. Thus, maternal VDD sex-dependently modulated metabolic fate of the offspring, especially when associated with HF diet in adulthood.	[Seipelt, Eva M.; Tourniaire, Franck; Couturier, Charlene; Astier, Julien; Mounien, Lourdes; Landrier, Jean-Francois] Aix Marseille Univ, INRAE, INSERM, C2VN, Marseille, France; [Seipelt, Eva M.; Puceat, Michel] Aix Marseille Univ, MMG, INSERM, U1251, Marseille, France; [Tourniaire, Franck; Landrier, Jean-Francois] Criblage Biol Marseille, Fac Med Timone, CriBioM, Marseille, France; [Loriod, Beatrice; Vachon, Hortense] Aix Marseille Univ, TGML, TAGC, INSERM, Marseille, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Landrier, JF (corresponding author), Univ Aix Marseille, INSERM, UMR 1260, C2VN,INRAE 1263, 27 Bd Jean Moulin, F-13385 Marseille 05, France.	jean-francois.landrier@univ-amu.fr	PUCEAT, michel/R-6140-2017; Landrier, Jean-Francois/AAH-2757-2019; Inserm U1090, TAGC/ABE-9980-2021	Landrier, Jean-Francois/0000-0002-8690-8014; Mounien, Lourdes/0000-0002-9221-5783	INRAE; INSERM; AMU; Fondation de France; GIS IBiSA; Aix-Marseille Universite;  [ANR-10-INBS-0009-10]	INRAE; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); AMU; Fondation de France(Fondation de France); GIS IBiSA; Aix-Marseille Universite; 	The work has been funded by grants from INRAE, INSERM, AMU and the Fondation de France. High throughput sequencing was performed at the TGML Platform, supported by grants from Inserm, GIS IBiSA, Aix-Marseille Universite, and ANR-10-INBS-0009-10	Achkar M, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.11.009; Amraei M, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00007; Belenchia AM, 2018, EUR J NUTR, V57, P723, DOI 10.1007/s00394-016-1359-x; Belenchia AM, 2017, J ENDOCRINOL, V234, P301, DOI 10.1530/JOE-17-0015; Bendik I, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00248; Bonnet L, 2019, J STEROID BIOCHEM, V185, P39, DOI 10.1016/j.jsbmb.2018.07.006; Bonnet L, 2018, ENDOCRINOLOGY, V159, P957, DOI 10.1210/en.2017-00650; Borg SA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190675; Brown LM, 2010, J STEROID BIOCHEM, V122, P65, DOI 10.1016/j.jsbmb.2009.12.005; Cashman KD, 2016, AM J CLIN NUTR, V103, P1033, DOI 10.3945/ajcn.115.120873; Crozier SR, 2012, AM J CLIN NUTR, V96, P57, DOI 10.3945/ajcn.112.037473; Daraki V, 2018, PEDIATR OBES, V13, P467, DOI 10.1111/ijpo.12267; Derghal A, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00181; EVEN PC, 1994, NEUROSCI BIOBEHAV R, V18, P435, DOI 10.1016/0149-7634(94)90056-6; Eyles D.W., 2018, VITAMIN VOL 1 BIOCH, VVolume 1, P563; Fenni S, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201601083; Flachs P, 2013, BBA-MOL CELL BIOL L, V1831, P986, DOI 10.1016/j.bbalip.2013.02.003; Fu L, 2017, PHYSIOL BEHAV, V179, P333, DOI 10.1016/j.physbeh.2017.07.017; Gernand AD, 2013, J CLIN ENDOCR METAB, V98, P398, DOI 10.1210/jc.2012-3275; Goyal D, 2019, J ENDOCRINOL, V242, pT105, DOI 10.1530/JOE-19-0009; Hawes JE, 2015, BEHAV BRAIN RES, V286, P192, DOI 10.1016/j.bbr.2015.03.008; Ideraabdullah FY, 2019, J ENDOCRINOL, V241, pR65, DOI 10.1530/JOE-18-0541; Karkeni E, 2018, EPIGENETICS-US, V13, P156, DOI 10.1080/15592294.2016.1276681; Karkeni E, 2015, ENDOCRINOLOGY, V156, P1782, DOI 10.1210/en.2014-1647; KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040; Kusminski CM, 2012, TRENDS ENDOCRIN MET, V23, P435, DOI 10.1016/j.tem.2012.06.004; Landrier JF, 2019, J BONE MINER RES, V34, P1383, DOI 10.1002/jbmr.3739; Landrier JF, 2016, P NUTR SOC, V75, P38, DOI 10.1017/S0029665115004164; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marcotorchino J, 2014, J NUTR BIOCHEM, V25, P1077, DOI 10.1016/j.jnutbio.2014.05.010; Marcotorchino J, 2012, MOL NUTR FOOD RES, V56, P1771, DOI 10.1002/mnfr.201200383; Miliku K, 2016, AM J CLIN NUTR, V103, P1514, DOI 10.3945/ajcn.115.123752; Morales E, 2015, INT J OBESITY, V39, P61, DOI 10.1038/ijo.2014.165; Morales E, 2015, EPIDEMIOLOGY, V26, P458, DOI 10.1097/EDE.0000000000000292; Nascimento FAM, 2013, J NUTR SCI VITAMINOL, V59, P367, DOI 10.3177/jnsv.59.367; Palacios C, 2014, J STEROID BIOCHEM, V144, P138, DOI 10.1016/j.jsbmb.2013.11.003; Pan P, 2014, DEV PSYCHOBIOL, V56, P12, DOI 10.1002/dev.21086; Reichetzeder C, 2014, KIDNEY BLOOD PRESS R, V39, P315, DOI 10.1159/000355809; Riant E, 2009, ENDOCRINOLOGY, V150, P2109, DOI 10.1210/en.2008-0971; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rytter D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164758; Saraf R, 2016, MATERN CHILD NUTR, V12, P647, DOI 10.1111/mcn.12210; Tourniaire F, 2015, J LIPID RES, V56, P1100, DOI 10.1194/jlr.M053652; Turck D, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2016.4587; Wang HP, 2018, J STEROID BIOCHEM, V175, P146, DOI 10.1016/j.jsbmb.2017.09.010; Wen J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18770-4; Zhang HQ, 2014, DIABETOLOGIA, V57, P2165, DOI 10.1007/s00125-014-3316-7	47	6	6	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14905	14919		10.1096/fj.201902924RR	http://dx.doi.org/10.1096/fj.201902924RR		SEP 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32924159	Green Submitted			2022-12-26	WOS:000570667500001
J	Ariaratnam, S; Hasani, WSR; Krishnapillai, AD; Abd Hamid, HA; Ling, MYJ; Ho, BK; Ghazali, SS; Tohit, NM; Yusoff, MFM				Ariaratnam, Suthahar; Hasani, Wan Shakira Rodzlan; Krishnapillai, Ambigga Devi; Abd Hamid, Hamizatul Akmal; Ling, Miaw Yn Jane; Ho, Bee Kiau; Ghazali, Sazlina Shariff; Tohit, Noorlaili Mohd; Yusoff, Muhammad Fadhli Mohd			Prevalence of obesity and its associated risk factors among the elderly in Malaysia: Findings from The National Health and Morbidity Survey (NHMS) 2015	PLOS ONE			English	Article							POPULATION	Background Obesity is a crucial public health problem and is rising globally. This study was conducted to determine the prevalence of obesity and its associated factors among the elderly in Malaysia. Methods Data were obtained from the National Health and Morbidity Survey (NHMS) 2015. This was a cross sectional population-based study using a two stage stratified random sampling design. Elderly population aged 60 years and above was selected. Data were collected using pre-tested self-administered questionnaire in the form of sociodemographic profile, non-communicable diseases (NCD) comorbidities (status on hypertension, diabetes and hypercholesterolemia) and NCD risk factors (current smoker and physical activity). Obesity has been defined using the World Health Organization (WHO) Body Mass Index (BMI) guideline, 1998. A complex sampling design analysis was used for the descriptive statistics. The associated risk factors for obesity were identified using Multiple Logistic Regression analysis. Results A total of 3794 respondents were included in this study. The prevalence of obesity among Malaysian elderly was 30.2%. The prevalence of obesity among the elderly was significantly higher in females, respondents from urban areas and Indians. Approximately one third of the elderly with non-communicable diseases such as hypertension (33.1%) and diabetes (38.8%), respectively, were obese. Among elderly who were obese, majority of them (89.8%) had at least one NCD. The prevalence of obesity was 16.8% among current smokers (aOR 0.59). Multiple logistic regression analysis revealed that elderly females (aOR [adjusted odds ratio] 1.52), having secondary education (aOR 1.96) with household income of RM 3000 and above (aOR 1.57) as well as being hypertensive (aOR 1.61) and diabetic (aOR 1.50) were more likely to be obese. In contrast, the Chinese elderly respondents (aOR 0.62) and current smokers (aOR 0.59) were less likely to be obese. There were no significant associations of obesity with hypercholesterolemia or with physical activity. Conclusions A substantial proportion of Malaysian elderly were obese, and factors associated with obesity among them were being female, having secondary education with a household income of RM 3000 and above and being hypertensive or diabetic. Enhanced health promotion and education should be targeted at younger people in order to prevent obesity in the later years.	[Ariaratnam, Suthahar] Univ Teknol MARA UiTM, Fac Med, Dept Psychiat, Shah Alam, Selangor, Malaysia; [Hasani, Wan Shakira Rodzlan; Abd Hamid, Hamizatul Akmal; Ling, Miaw Yn Jane; Yusoff, Muhammad Fadhli Mohd] Minist Hlth Malaysia, Natl Inst Hlth, Inst Publ Hlth, Setia Alam, Selangor, Malaysia; [Krishnapillai, Ambigga Devi] Natl Def Univ Malaysia, Fac Med & Hlth, Dept Family Med, Kuala Lumpur, Malaysia; [Ho, Bee Kiau] Bandar Bot Hlth Ctr, Klang, Selangor, Malaysia; [Ghazali, Sazlina Shariff] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Family Med, Serdang, Malaysia; [Tohit, Noorlaili Mohd] Univ Kebangsaan Malaysia, Fac Med, Dept Family Med, Bangi, Malaysia	Universiti Teknologi MARA; Kementerian Kesihatan Malaysia; Universiti Pertahanan Nasional Malaysia; Universiti Putra Malaysia; Universiti Kebangsaan Malaysia	Ariaratnam, S (corresponding author), Univ Teknol MARA UiTM, Fac Med, Dept Psychiat, Shah Alam, Selangor, Malaysia.	suthaharariaratnam@yahoo.com.au	Ariaratnam, Suthahar/ABA-6210-2021; Rodzlan Hasani, Wan Shakira Shakira Rodzlan/AAW-5845-2021	Ariaratnam, Suthahar/0000-0001-8524-6576	Ministry of Health, Malaysia [NMRR-14-1064-21877]	Ministry of Health, Malaysia	This study was supported by the Ministry of Health, Malaysia [Project code: NMRR-14-1064-21877]. The funder had no role in the study desigh, data collection and analysis, decision to publish, or preparation of the manuscript.	Aryal KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134834; Committee IR, 2015, GUIDELINES DATA PROC; Helgi Library, 2020, HELG LIB; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mathus-Vliegen EMH, 2012, J CLIN GASTROENTEROL, V46, P533, DOI 10.1097/MCG.0b013e31825692ce; Mohamud WNW, 2011, ASIA PAC J CLIN NUTR, V20, P35; Mohd-Any AA, 2014, BRIT FOOD J, V116, P1879, DOI 10.1108/BFJ-07-2013-0170; Newman B, 2011, J AM GERIATR SOC, V57, P432; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Pelzom D, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4989-x; Sabanayagam C, 2009, ASIA-PAC J PUBLIC HE, V21, P487, DOI 10.1177/1010539509343957; Sabariah AH, 2017, IJSRP, V7, P421; Shebl A.M., 2015, J ED PRACT, V6, P136; Shwaish ZT, 2017, IJAR, V5, P920; Stevens GA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-22; Suzana S, 2012, ASIA-PAC J PUBLIC HE, V24, P318, DOI 10.1177/1010539510380736; Swiss Re Report, 2018, SIGMA, V3148, DOI DOI 10.2218/PIHPH.3.2018.2602; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; World Health Organization, 1995, PREV PRIM CAR REC PR; Zamboni M, 2005, INT J OBESITY, V29, P1011, DOI 10.1038/sj.ijo.0803005	20	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238566	10.1371/journal.pone.0238566	http://dx.doi.org/10.1371/journal.pone.0238566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915860	Green Published, gold			2022-12-26	WOS:000571887500105
J	Piao, CX; Ma, M; Chambers, JK; Uchida, K; Ikeda, M; Kobayashi, NI; Hirose, A; Tanoi, K; Kuwahara, M; Li, JY				Piao, Chunxiang; Ma, Min; Chambers, James K.; Uchida, Kazuyuki; Ikeda, Masanori; Kobayashi, Natsuko, I; Hirose, Atsushi; Tanoi, Keitaro; Kuwahara, Masayoshi; Li, Junyou			Radiocesium transfer rates among pigs fed haylage contaminated with low levels of cesium at two differentiation stages	PLOS ONE			English	Article							RETENTION	The objective of this study was to determine the radiocesium transfer rates of pigs fed haylage contaminated with low levels of cesium at different growth stages. We measured the body weight of juvenile and adult pigs during the treatment period to confirm their health status. We also performed pig blood hematologic and biochemical analyses at both growth stages. To our knowledge, this is the first study to report pig radiocesium transfer coefficient rates after 1 month of chronic oral treatment, which is the period assumed to be required for body equilibrium under a diet of radiocesium-contaminated food. The results showed higher radiocesium retention rates in the kidneys, liver, spleen, genitals, psoas major, bladder, thyroid, and urine than in the blood and bone (tibia and femur) of pigs at both growth stages. The radiocesium retention levels were generally higher in juvenile pigs than in adult pigs, with the highest transfer coefficient ratio in the kidneys (16.2%).	[Piao, Chunxiang; Ma, Min; Ikeda, Masanori; Li, Junyou] Univ Tokyo, Anim Resource Sci Ctr, Grad Sch Agr & Life Sci, Kasama, Ibaraki, Japan; [Piao, Chunxiang] Yanbian Univ, Fac Agr, Agr Resources & Environm, Jilin, Jilin, Peoples R China; [Chambers, James K.; Uchida, Kazuyuki] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Vet Pathol, Tokyo, Japan; [Kobayashi, Natsuko, I; Hirose, Atsushi; Tanoi, Keitaro] Univ Tokyo, Grad Sch Agr & Life Sci, Isotope Facil Agr Educ & Res, Tokyo, Japan; [Kuwahara, Masayoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Vet Pathophysiol & Anim Hlth, Tokyo, Japan	University of Tokyo; Yanbian University; University of Tokyo; University of Tokyo; University of Tokyo	Li, JY (corresponding author), Univ Tokyo, Anim Resource Sci Ctr, Grad Sch Agr & Life Sci, Kasama, Ibaraki, Japan.	ajunyou@mail.ecc.u-tokyo.ac.jp	Kobayashi, Natsuko/GQB-1584-2022; Tanoi, Keitaro/N-7462-2015	Tanoi, Keitaro/0000-0001-7545-2771	Japan Society for the Promotion of Science KAKENHI [JP25517004]; Livestock Promotion Agency of Japan Racing Association; "Japan Society for the Promotion of Science KAKENHI [JP25517004]; Japan Racing Association	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Livestock Promotion Agency of Japan Racing Association; "Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Racing Association(Japan Racing Association)	This study was funded by a Japan Society for the Promotion of Science KAKENHI Grant-in-Aid for Scientific Research (C) (no. JP25517004) and by the Livestock Promotion Agency of Japan Racing Association. The funding of "Japan Racing Association", the project leader is our colleague, same laboratory. I am a member of this project. The present research used pocH-100iV Diff hematology analyzer (Sysmex, Hyogo, Japan) for hematological parameters analyze, and using a DRI-CHEM 3500s (Fujifilm, Japan) did blood biochemistry analyze. Both of which was purchased by above grant. But present research mainly done by the grant of "Japan Society for the Promotion of Science KAKENHI Grant-in-Aid for Scientific Research (C) (no. JP25517004)". I am the leader of this project. Both of the funders above had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Toxic Substances and Disease Registry (ATSDR), 2004, PUBL HLTH STAT CES; ASSIMAKOPOULOS PA, 1993, SCI TOTAL ENVIRON, V136, P1, DOI 10.1016/0048-9697(93)90292-E; HAAS G, 1995, J RADIOAN NUCL CH AR, V194, P269, DOI 10.1007/BF02038423; HOWARD BJ, 1989, SCI TOTAL ENVIRON, V85, P189, DOI 10.1016/0048-9697(89)90317-3; HOWARD BJ, 1989, HEALTH PHYS, V57, P579, DOI 10.1097/00004032-198910000-00009; Kaneko J., 2008, CLIN BIOCH DOMESTIC, P886; KITCHINGS JT, 1969, HEALTH PHYS, V17, P265, DOI 10.1097/00004032-196908000-00009; KYLE OC, 1979, LAB ANIM SCI, V29, P123; Lei W., 1976, THESIS; LENGEMANN FW, 1970, RADIAT RES, V42, P169, DOI 10.2307/3572927; Li JY, 2019, AGRICULTURAL IMPLICATIONS OF THE FUKUSHIMA NUCLEAR ACCIDENT (III): AFTER 7 YEARS, P35, DOI 10.1007/978-981-13-3218-0_5; Manabe N, 2013, AGR IMPLICATIONS FUK, P87, DOI [DOI 10.1007/978-4-431-54328-2_9, 10.1007/978-4-431-54328-2_9]; MILLER CE, 1968, P SOC EXP BIOL MED, V128, P563, DOI 10.3181/00379727-128-33067; Turan S, 2011, J CLIN RES PEDIATR E, V3, P7, DOI 10.4274/jcrpe.v3i1.02; 2018, NEWS HENAN POLICE AC, V4, P20	15	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0237977	10.1371/journal.pone.0237977	http://dx.doi.org/10.1371/journal.pone.0237977			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915802	Green Published, gold			2022-12-26	WOS:000571887500138
J	Li, YN; Wang, R; Chen, ZX; Zhao, XP; Luo, XH; Wang, L; Li, YF; Teng, F				Li, Yanan; Wang, Ren; Chen, Zhengxing; Zhao, Xiuping; Luo, Xiaohu; Wang, Li; Li, Yongfu; Teng, Fei			Preparation of magnetic mesoporous silica from rice husk for aflatoxin B1 removal: Optimum process and adsorption mechanism	PLOS ONE			English	Article							BROILER CHICKS; NANOCOMPOSITES; SHELL; B-1; DETOXIFICATION; CONTAMINATION; MICROSPHERES; OCHRATOXIN; PROTECTION; TOXICITY	The liquid foodstuffs such as edible oil products remain a problem of excessive aflatoxin B1 (AFB1) content. This paper focused on the preparation of magnetic mesoporous silica (MMS) from rice husk ash for the removal of AFB1 in oil system. The MMS preparation process, adsorption conditions, structural characteristics, and adsorption mechanism were investigated. The optimum conditions for MMS preparation were pH 11.0 and 80 degrees C for 24 h. The characterization results showed that magnetic particles were successfully embedded in the MMS and had high responsiveness to a magnetic field, which was advantageous for recyclability. The MMS had ordered uniform channels with a specific surface area of 730.98 m(2)/g and pore diameter of 2.43 nm. The optimum adsorption conditions were 2 h at 20 degrees C. For AFB1 with an initial concentration of 0.2 mu g/mL, the MMS adsorption capacity was 171.98 mu g/g and the adsorption rate was 94.59%. The MMS adsorption isotherm fitted the Langmuir model well under the assumption of monolayer AFB1 adsorption with uniformly distributed adsorption sites on the MMS surface. The maximum amount of AFB1 adsorbed according to the Langmuir isotherm was 1118.69 mu g/g. A quasi-second-order kinetic model gave a better fit to the process of AFB1 adsorption on MMS. The values of Delta H(-19.17 kJ/mol) and Delta G(-34.09, -34.61, and -35.15 kJ/mol at 283, 293, and 303 K, respectively) were negative, indicating that AFB1 adsorption on MMS was a spontaneous exothermic process. The results indicated that MMS was a promising material for AFB1 removal in oil system, and this study will serve as a guide for practical MMS applications.	[Li, Yanan; Chen, Zhengxing; Wang, Li] Jiangnan Univ, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Wuxi, Jiangsu, Peoples R China; [Li, Yanan; Wang, Ren; Chen, Zhengxing; Luo, Xiaohu; Wang, Li; Li, Yongfu] Jiangnan Univ, Natl Engn Lab Cereal Fermentat Technol, Wuxi, Jiangsu, Peoples R China; [Li, Yanan; Wang, Ren; Chen, Zhengxing; Luo, Xiaohu; Wang, Li; Li, Yongfu] Jiangnan Univ, Jiangsu Prov Res Ctr Bioact Prod Proc Technol, Wuxi, Jiangsu, Peoples R China; [Li, Yanan; Chen, Zhengxing; Zhao, Xiuping; Luo, Xiaohu; Wang, Li; Li, Yongfu; Teng, Fei] Jiangnan Univ, Sch Food Sci & Technol, Wuxi, Jiangsu, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University; Jiangnan University	Chen, ZX (corresponding author), Jiangnan Univ, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Wuxi, Jiangsu, Peoples R China.; Chen, ZX (corresponding author), Jiangnan Univ, Natl Engn Lab Cereal Fermentat Technol, Wuxi, Jiangsu, Peoples R China.; Chen, ZX (corresponding author), Jiangnan Univ, Jiangsu Prov Res Ctr Bioact Prod Proc Technol, Wuxi, Jiangsu, Peoples R China.; Chen, ZX (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, Wuxi, Jiangsu, Peoples R China.	zxchen_2008@126.com			National Key Research and Development Program of China [2017YFC1600904]	National Key Research and Development Program of China	This research was funded by the National Key Research and Development Program of China (2017YFC1600904).	Alkafajy AM, 2020, MATER TODAY COMMUN, V23, DOI 10.1016/j.mtcomm.2019.100890; Bhagiyalakshmi M, 2010, J HAZARD MATER, V175, P928, DOI 10.1016/j.jhazmat.2009.10.097; Chen JP, 2020, J ALLOY COMPD, V833, DOI 10.1016/j.jallcom.2020.155072; Chun J, 2020, J IND ENG CHEM, V81, P135, DOI 10.1016/j.jiec.2019.08.064; Cimbalo A, 2020, FOOD CHEM TOXICOL, V137, DOI 10.1016/j.fct.2020.111161; Diagboya PNE, 2018, MICROPOR MESOPOR MAT, V266, P252, DOI 10.1016/j.micromeso.2018.03.008; Grant PG, 1998, J AGR FOOD CHEM, V46, P599, DOI 10.1021/jf970604v; Gross AF, 2002, J AM CHEM SOC, V124, P3713, DOI 10.1021/ja0169668; Gulfam N, 2018, DESALIN WATER TREAT, V105, P216, DOI 10.5004/dwt.2018.22016; HARVEY RB, 1993, AVIAN DIS, V37, P67, DOI 10.2307/1591459; Helal-Neto E, 2018, J PHARMACEUT BIOMED, V153, P90, DOI 10.1016/j.jpba.2018.02.017; Hernandez-Mendoza A, 2009, J APPL MICROBIOL, V107, P395, DOI 10.1111/j.1365-2672.2009.04217.x; Hong RY, 2008, J MAGN MAGN MATER, V320, P1605, DOI 10.1016/j.jmmm.2008.01.015; Hu X, 2019, J HAZARD MATER, V362, P1, DOI 10.1016/j.jhazmat.2018.09.003; IARC, 2002, INT AGENCY RES CANC, V82, P171; Injumpa W, 2019, J MAGN MAGN MATER, V475, P579, DOI 10.1016/j.jmmm.2018.11.111; International Agency for Research on Cancer (IARC), 2009, IARC MON EV CARC R F, V100f, P225; Ismail A, 2018, FOOD RES INT, V113, P74, DOI 10.1016/j.foodres.2018.06.067; Javaheri F, 2019, SEP PURIF TECHNOL, V224, P199, DOI 10.1016/j.seppur.2019.05.017; Khan FA, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0255-y; Kheshti Z, 2020, CHEM ENG PROCESS, V148, DOI 10.1016/j.cep.2019.107770; Klein G., 1985, PRINCIPLES ADSORPTIO, V4, P62, DOI [10.1016/0167-6989(85)90037-6, DOI 10.1016/0167-6989(85)90037-6, 10.1016/0167-6989 (85)90037-6]; Knezevic NZ, 2013, NANOSCALE, V5, P1544, DOI 10.1039/c2nr33417h; Kordatos K, 2008, MICROPOR MESOPOR MAT, V115, P189, DOI 10.1016/j.micromeso.2007.12.032; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Lawagon CP, 2020, ENVIRON ENG RES, V25, P685, DOI 10.4491/eer.2019.287; Li JJ, 2010, AGR SCI CHINA, V9, P449, DOI 10.1016/S1671-2927(09)60116-4; Mittal H, 2020, MICROPOR MESOPOR MAT, V299, DOI 10.1016/j.micromeso.2020.110106; MONNIER A, 1993, SCIENCE, V261, P1299, DOI 10.1126/science.261.5126.1299; Moorthy MS, 2018, J POROUS MAT, V25, P1251, DOI 10.1007/s10934-017-0536-5; Mwakinyali SE, 2019, BIOL CONTROL, V128, P31, DOI 10.1016/j.biocontrol.2018.09.012; Nguyen NT, 2016, J NANOSCI NANOTECHNO, V16, P4108, DOI 10.1166/jnn.2016.10704; Peng Z, 2018, TRENDS FOOD SCI TECH, V80, P155, DOI 10.1016/j.tifs.2018.08.009; Phillips Timothy D., 1995, Natural Toxins, V3, P204, DOI 10.1002/nt.2620030407; Pimpukdee K, 2004, POULTRY SCI, V83, P737, DOI 10.1093/ps/83.5.737; Ramos AJ, 1996, ANIM FEED SCI TECH, V62, P263, DOI 10.1016/S0377-8401(96)00968-6; Safari J, 2014, J SAUDI CHEM SOC, V18, P85, DOI 10.1016/j.jscs.2012.12.009; Sevim S, 2019, FOOD CONTROL, V100, P235, DOI 10.1016/j.foodcont.2019.01.028; Shah SM, 2019, MICROCHEM J, V151, DOI 10.1016/j.microc.2019.104194; Shi HT, 2018, FOOD CONTROL, V91, P202, DOI 10.1016/j.foodcont.2018.03.036; Sun ZW, 2020, J HAZARD MATER, V387, DOI 10.1016/j.jhazmat.2019.121792; Szyja BM, 2011, CATAL TODAY, V169, P156, DOI 10.1016/j.cattod.2010.08.018; Tian H, 2014, J COLLOID INTERF SCI, V431, P90, DOI 10.1016/j.jcis.2014.06.009; Wang YG, 2008, J COLLOID INTERF SCI, V326, P158, DOI 10.1016/j.jcis.2008.07.012; Wang YS, 2018, MATER CHEM PHYS, V207, P105, DOI 10.1016/j.matchemphys.2017.12.040; Wu F, 2014, ANNU REV FOOD SCI T, V5, P351, DOI 10.1146/annurev-food-030713-092431; Zafar R, 2017, PESQUI VET BRASIL, V37, P1213, DOI [10.1590/s0100-736x2017001100005, 10.1590/S0100-736X2017001100005]; Zahoor M, 2019, DESALIN WATER TREAT, V152, P234, DOI 10.5004/dwt.2019.23939; Zahoor M, 2018, ARAB J CHEM, V11, P729, DOI 10.1016/j.arabjc.2014.08.025; Zahoor M, 2016, DESALIN WATER TREAT, V57, P11893, DOI 10.1080/19443994.2015.1046147; Zhang WW, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64295-8; Zhao BH, 2019, J SEP SCI, V42, P1896, DOI 10.1002/jssc.201900038; Zhao L, 2013, J COLLOID INTERF SCI, V390, P70, DOI 10.1016/j.jcis.2012.08.059; Zhou SJ, 2018, DALTON T, V47, DOI 10.1039/c8dt03054e; Zhou YY, 2012, POWDER TECHNOL, V226, P239, DOI 10.1016/j.powtec.2012.04.054	55	8	10	9	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238837	10.1371/journal.pone.0238837	http://dx.doi.org/10.1371/journal.pone.0238837			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32913353	Green Published, gold			2022-12-26	WOS:000571885900004
J	Wisniewska, KA; Sliwinska-Wilczewska, S; Lewandowska, AU				Wisniewska, Kinga A.; Sliwinska-Wilczewska, Sylwia; Lewandowska, Anita U.			The first characterization of airborne cyanobacteria and microalgae in the Adriatic Sea region	PLOS ONE			English	Article							METEOROLOGICAL CONDITIONS; VENICE LAGOON; KUALA-LUMPUR; GREEN-ALGAE; BLOOM; PICOCYANOBACTERIA; DINOFLAGELLATE; BIOAEROSOLS; DIVERSITY; MECHANISM	The presence of airborne cyanobacteria and microalgae as well as their negative impacts on human health have been documented by many researchers worldwide. However, studies on cyanobacteria and microalgae are few compared with those on bacteria and viruses. Research is especially lacking on the presence and taxonomic composition of cyanobacteria and microalgae near economically important water bodies with much tourism, such as the Adriatic Sea region. Here, we present the first characterization of the airborne cyanobacteria and microalgae in this area. Sampling conducted between 11(th)and 15(th)June 2017 revealed a total of 15 taxa of airborne cyanobacteria and microalgae. Inhalation of many of the detected taxa, includingSynechocystissp.,Synechococcussp.,Bracteacoccussp.,Chlorellasp.,Chlorococcumsp.,Stichococcussp., andAmphorasp., poses potential threats to human health. Aside from two green algae, all identified organisms were capable of producing harmful metabolites, including toxins. Moreover, we documented the presence of the cyanobacteriumSnowellasp. and the green algaTetrastrumsp., taxa that had not been previously documented in the atmosphere by other researchers. Our study shows that the Adriatic Sea region seems to be a productive location for future research on airborne cyanobacteria and microalgae in the context of their impacts on human health, especially during the peak of tourism activity.	[Wisniewska, Kinga A.; Lewandowska, Anita U.] Univ Gdansk, Inst Oceanog, Div Marine Chem & Environm Protect, Gdynia, Pomerania, Poland; [Sliwinska-Wilczewska, Sylwia] Univ Gdansk, Inst Oceanog, Div Marine Ecosyst Functioning, Gdynia, Pomerania, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk	Wisniewska, KA (corresponding author), Univ Gdansk, Inst Oceanog, Div Marine Chem & Environm Protect, Gdynia, Pomerania, Poland.	kinga.wisniewska@phdstud.ug.edu.pl		Lewndowska, Anita/0000-0003-3304-8214; /0000-0002-3147-6605	Polish National Science Centre project [2019/33/N/ST10/00585]; BMN grants, Poland [538-G245-B568-17, 539-O160-B432-20]	Polish National Science Centre project; BMN grants, Poland	This work has been funded by the Polish National Science Centre project (contract no. 2019/33/N/ST10/00585). This study was also supported by BMN grants, Poland, No. 538-G245-B568-17, and No. 539-O160-B432-20. The funders had a role in study design, data collection and analysis, the decision to publish, and preparation of the manuscript.	Andersen R. A., 2005, ALGAL CULTURING TECH; Anderson DM, 2009, OCEAN COAST MANAGE, V52, P342, DOI 10.1016/j.ocecoaman.2009.04.006; [Anonymous], 1975, CULTURE MARINE INVER; Backer LC, 2015, TOXINS, V7, P1048, DOI 10.3390/toxins7041048; BERNSTEIN IL, 1966, J ALLERGY, V38, P166, DOI 10.1016/0021-8707(66)90039-6; Bhagavathy S., 2011, Asian Pacific Journal of Tropical Biomedicine, V1, pS1, DOI 10.1016/S2221-1691(11)60111-1; Brown R.M., 1971, CONTRIBUTIONS PHYCOL, P175; BROWN RM, 1964, SCIENCE, V143, P583, DOI 10.1126/science.143.3606.583; Burja AM, 2001, TETRAHEDRON, V57, P9347, DOI 10.1016/S0040-4020(01)00931-0; Carmichael Wayne W, 2006, Saline Syst, V2, P5, DOI 10.1186/1746-1448-2-5; CARSON JL, 1976, PAC SCI, V30, P197; Chang T, 1967, TAIWANIA, V13, P1; Choi H, 2010, J NAT PROD, V73, P517, DOI 10.1021/np900661g; Chu WL, 2013, GRANA, V52, P207, DOI 10.1080/00173134.2013.789925; Cox E. J., 1996, IDENTIFICATION FRESH; Despres VR, 2012, TELLUS B, V64, DOI 10.3402/tellusb.v64i0.15598; Draxler R.R., 2013, HYSPLIT HYBRID SINGL; El-Gamal A. D., 2008, EGYPT PAK J BIOL SCI, V11, P1293, DOI DOI 10.3923/pjbs.2008.1293.1302; Facciponte DN, 2018, SCI TOTAL ENVIRON, V645, P1003, DOI 10.1016/j.scitotenv.2018.07.226; Ferrante M., 2013, EUROMEDITERR BIOMED, V8, P25, DOI 10.3269/1970-5492.2013.8.6; Frohlich-Nowoisky J, 2016, ATMOS RES, V182, P346, DOI 10.1016/j.atmosres.2016.07.018; Garces E., 2012, LIFE MEDITERRANEAN S, P519; Genitsaris Savvas, 2011, Front Biosci (Elite Ed), V3, P772, DOI 10.2741/e285; Guiry M.D., 2019, ALGAEBASE WORLD WIDE; Hindak F, 2001, FOTOGRAFICKY ATLAS M; Hoose C, 2012, ATMOS CHEM PHYS, V12, P9817, DOI 10.5194/acp-12-9817-2012; Huber-Pestalozzi G, 1950, BINNENGEWASSER E SCH; Huisman J, 2018, NAT REV MICROBIOL, V16, P471, DOI 10.1038/s41579-018-0040-1; Karsten U, 2005, J PHYCOL, V41, P557, DOI 10.1111/j.1529-8817.2005.00081.x; Kirkpatrick B, 2010, HARMFUL ALGAE, V9, P186, DOI 10.1016/j.hal.2009.09.003; Komarek J, 1999, SUSSWASSERFLORA MITT, V19; Komarek J., 2005, S WASSERFLORA MITTEL; Komarek J., 1983, PHYTOPLANKTON SUSSWA; Kormas KA, 2011, LIMNOLOGICA, V41, P167, DOI 10.1016/j.limno.2010.10.003; LEE TF, 1989, GRANA, V28, P63, DOI 10.1080/00173138909431014; Lewandowska AU, 2017, MAR POLLUT BULL, V125, P30, DOI 10.1016/j.marpolbul.2017.07.064; Lewandowska AU, 2013, OCEANOLOGIA, V55, P279, DOI 10.5697/oc.55-2.279; Lind M.E., 1980, KEY COMMONER DESMIDS, P123; Londahl J, 2014, INTEGR ANAL SYST, P33, DOI 10.1007/978-1-4419-5582-1_3; LUTY ELANNY T., 1967, J ARIZ ACAD SCI, V4, P179, DOI 10.2307/40022403; Maranda L, 1990, TOXIC MARINE PHYTOPL; Marks R, 2019, J AEROSOL SCI, V128, P79, DOI 10.1016/j.jaerosci.2018.12.003; May NW, 2018, ENVIRON SCI TECHNOL, V52, P397, DOI 10.1021/acs.est.7b03609; Mayol E, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00557; Medina RA, 2008, J AM CHEM SOC, V130, P6324, DOI 10.1021/ja801383f; METTING B, 1986, ENZYME MICROB TECH, V8, P386, DOI 10.1016/0141-0229(86)90144-4; Mohanty RP, 2017, DIABETOLOGIE STOF S2, V12, pe0173465; Ng EHP, 2011, GRANA, V50, P217, DOI 10.1080/00173134.2011.602423; Norton TA, 1996, PHYCOLOGIA, V35, P308, DOI 10.2216/i0031-8884-35-4-308.1; Paerl HW, 2018, TOXINS, V10, DOI 10.3390/toxins10020076; Pawlik-Skowronska B, 2002, ENVIRON POLLUT, V119, P119, DOI 10.1016/S0269-7491(01)00280-9; Popovski J, 1990, SUSSWASSERFLORA MITT; Puschner B, 2018, VETERINARY TOXICOLOGY: BASIC AND CLINICAL PRINCIPLES, 3RD EDITION, P763, DOI 10.1016/B978-0-12-811410-0.00057-X; Rajaniemi-Wacklin P, 2006, J PHYCOL, V42, P226, DOI 10.1111/j.1529-8817.2006.00179.x; Rolph G.D., 2003, REAL TIME ENV APPL D; ROSAS I, 1989, INT J BIOMETEOROL, V33, P173, DOI 10.1007/BF01084602; Sahu N, 2015, AEROBIOLOGIA, V31, P89, DOI 10.1007/s10453-014-9349-z; SCHLICHT.H, 1961, LLOYD, V24, P81; SCHLICHTING H E JR, 1969, Journal of the Air Pollution Control Association, V19, P946; SCHLICHTING HE, 1964, LLOYD, V27, P64; Sharma NK, 2006, ECOGRAPHY, V29, P766; Sharma NK, 2010, INDIAN J MICROBIOL, V50, P468, DOI 10.1007/s12088-011-0146-x; Sharma NK, 2008, ECOTOX ENVIRON SAFE, V69, P158, DOI 10.1016/j.ecoenv.2006.08.006; Sharma NK, 2007, J PHYCOL, V43, P615, DOI 10.1111/j.1529-8817.2007.00373.x; Sharma NK, 2006, ENVIRON RES, V102, P252, DOI 10.1016/j.envres.2006.04.003; SHIMIZU Y, 1989, PURE APPL CHEM, V61, P513, DOI 10.1351/pac198961030513; Simic SB, 2015, HANDB ENVIRON CHEM, V31, P229, DOI 10.1007/978-3-662-44034-6_10; Singh HW, 2018, AEROBIOLOGIA, V34, P363, DOI 10.1007/s10453-018-9519-5; Sliwinska-Wilczewska S, 2018, TOXINS, V10, DOI 10.3390/toxins10010048; Sorokin PY, 2004, HYDROBIOLOGIA, V523, P71, DOI 10.1023/B:HYDR.0000033096.14267.43; Sorokin YI, 2008, J PLANKTON RES, V30, P1019, DOI 10.1093/plankt/fbn059; Sorokin YI, 2010, J OCEANOGR, V66, P373, DOI 10.1007/s10872-010-0033-9; Tanner RS, 2007, MANUAL OF ENVIRONMENTAL MICROBIOLOGY, 3RD ED, P69; Ternon E, 2018, HARMFUL ALGAE, V75, P35, DOI 10.1016/j.hal.2018.04.003; Tesson SVM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02681; Tormo R, 2001, EUR J PHYCOL, V36, P385, DOI 10.1080/09670260110001735538; Totti C, 2010, HARMFUL ALGAE, V9, P233, DOI 10.1016/j.hal.2009.10.006; UNEP, 1989, MAP TECHNICAL REPORT, P225; UNEP/FAO, 1990, MAP TECHNICAL REPORT, P74; Urbano R, 2011, BIOGEOSCIENCES, V8, P301, DOI 10.5194/bg-8-301-2011; van Overeem M, 1937, REC TRAV BOT NEERL, V3, P389; Vareli K, 2012, HARMFUL ALGAE, V15, P109, DOI 10.1016/j.hal.2011.12.005; Wisniewska K, 2019, ENVIRON INT, V131, DOI 10.1016/j.envint.2019.104964; Wood SA, 2011, J ENVIRON MONITOR, V13, P1617, DOI 10.1039/c1em10102a	84	12	12	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238808	10.1371/journal.pone.0238808	http://dx.doi.org/10.1371/journal.pone.0238808			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32913356	gold, Green Published			2022-12-26	WOS:000571885900014
J	Martin, ACC; Parker, AJ; Furnus, CC; Relling, AE				Carranza Martin, Ana C.; Parker, Anthony J.; Furnus, Cecilia C.; Relling, Alejandro Enrique			Ghrelin antagonist overrides the mRNA expression of NPY in hypothalamus in feed restricted ewes	PLOS ONE			English	Article							GROWTH-HORMONE; LUTEINIZING-HORMONE; PROGESTERONE SECRETION; CORPUS-LUTEUM; FOOD-INTAKE; RECEPTOR; RAT; KISSPEPTIN; ESTROGEN; PEPTIDE	A negative energy balance (NEB) is detrimental to reproduction in animals. A suggested link between NEB and reproductive failure is the gastrointestinal hormone ghrelin, because of the association between ghrelin and the hypothalamo-pituitary-gonadal axis. The [D-Lys3]-Growth Hormone Releasing Peptide-6 ([D-Lys3]-GHRP-6) is a ghrelin antagonist that acts on ghrelin receptors (GHS-R1). The objective of this study was to evaluate the effect of [D-Lys3]-GHRP-6 on reproduction variables in feed restricted ewes. Two experiments were conducted. Experiment I was conducted for 30 days; and Experiment II for 13 days. In both experiments the ewes (n = 18) were randomly assigned to: Control (CO): fed to meet maintenance requirements; Feed restriction (FR): 80% of maintenance restriction; or Ghrelin antagonist (GA): feed restricted and daily subcutaneous of 7.5 mu g/kg of [D-Lys3]-GHRP-6. Plasma was collected to measure hormones and metabolite concentration. In Experiment II, the hypothalamus and ovaries were collected on day 13. In both Experiments, sheep allocated to the FR and GA treatments decreased their body weight compared with sheep in the CO group (P < 0.06); progesterone however, did not differ between treatments (P > 0.10). Experiment I: Plasma ghrelin concentration was greater (P < 0.01) in FR and GA compared with CO ewes. Plasma non-esterified fatty acids concentration was greater (P < 0.01) in GA and FR than CO. Experiment II: Kisspeptin1-Receptor (Kiss1-R) mRNA expression was greater in FR (P < 0.01) and tended to be greater in GA (P = 0.10) compared with CO ewes. The neuro peptide-Y (NPY) mRNA expression was greater (P = 0.03) in FR than CO; and tended to be greater (P = 0.06) compared with GA ewes. Growth hormone releasing hormone (GhRH) mRNA expression was greater in GA (P = 0.04) and tended to be greater in FR (P = 0.07) compared with CO ewes. Feed restriction increased GhRH, NPY, and Kiss-R mRNA expression in hypothalamus without affecting reproductive variables.Ghrelin antagonist may prevent an increase inNPY expression in ewes.	[Carranza Martin, Ana C.; Parker, Anthony J.; Relling, Alejandro Enrique] Ohio State Univ, Dept Anim Sci, Wooster, OH 44691 USA; [Carranza Martin, Ana C.; Furnus, Cecilia C.] Univ Nacl La Plata, IGEVET Inst Genet Vet Prof Fernando N Dulout UNLP, Fac Ciencias Vet, La Plata, Buenos Aires, Argentina	University System of Ohio; Ohio State University; National University of La Plata	Relling, AE (corresponding author), Ohio State Univ, Dept Anim Sci, Wooster, OH 44691 USA.	relling.1@osu.edu	Parker, Anthony Joseph/K-7949-2019	Parker, Anthony Joseph/0000-0001-6370-6623; Carranza Martin, Ana C/0000-0001-9901-9227; Relling, Alejandro/0000-0002-1288-3037				[Anonymous], 2005, MAJORDOM, V3, P60; Babaei-Balderlou Farrin, 2016, J Reprod Infertil, V17, P88; BARKERGIBB ML, 1995, J ENDOCRINOL, V147, P565, DOI 10.1677/joe.0.1470565; Barreiro ML, 2004, ENDOCRINOLOGY, V145, P4825, DOI 10.1210/en.2004-0732; Carranza-Martin AC, 2020, SMALL RUMINANT RES, V185, DOI 10.1016/j.smallrumres.2020.106091; Chagas LM, 2007, J DAIRY SCI, V90, P4022, DOI 10.3168/jds.2006-852; Chen Y, 2008, ULTRASOUND OBST GYN, V32, P700, DOI 10.1002/uog.5393; Chouzouris TM, 2019, REPROD DOMEST ANIM, V54, P91, DOI 10.1111/rda.13321; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; Crown A, 2007, NEUROENDOCRINOLOGY, V86, P175, DOI 10.1159/000109095; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Dailey MJ, 2016, BEHAV BRAIN RES, V303, P191, DOI 10.1016/j.bbr.2016.01.040; De Bond JAP, 2014, REPRODUCTION, V147, pR53, DOI 10.1530/REP-13-0509; Du CG, 2009, DOMEST ANIM ENDOCRIN, V36, P89, DOI 10.1016/j.domaniend.2008.10.007; Fang FG, 2012, SYST BIOL REPROD MED, V58, P116, DOI 10.3109/19396368.2011.637607; Fernandez-Fernandez R, 2005, NEUROENDOCRINOLOGY, V82, P245, DOI 10.1159/000092753; Fernandez-Foren A, 2019, THERIOGENOLOGY, V135, P189, DOI 10.1016/j.theriogenology.2019.06.023; Forbes S, 2009, NEUROSCI LETT, V460, P143, DOI 10.1016/j.neulet.2009.05.060; Frazao R, 2014, AM J PHYSIOL-ENDOC M, V306, pE606, DOI 10.1152/ajpendo.00211.2013; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; GLASS JD, 1984, BIOL REPROD, V30, P894, DOI 10.1095/biolreprod30.4.894; Gottfredson R, 2004, HORMONAL CONTROL EWE; Gupta M, 2014, DOMEST ANIM ENDOCRIN, V48, P21, DOI 10.1016/j.domaniend.2014.01.004; Hataya Y, 2001, J CLIN ENDOCR METAB, V86, P4552, DOI 10.1210/jc.86.9.4552; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; IMAKI T, 1986, ENDOCRINOLOGY, V118, P2390, DOI 10.1210/endo-118-6-2390; Iqbal J, 2006, ENDOCRINOLOGY, V147, P510, DOI 10.1210/en.2005-1048; Kheradmand A, 2010, REGUL PEPTIDES, V162, P84, DOI 10.1016/j.regpep.2010.02.008; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Mano-Otagiri A, 2006, ENDOCRINOLOGY, V147, P4093, DOI 10.1210/en.2005-1619; NRC, 2007, NUTR REQ SMALL RUM S, P392; Patel K, 2012, INT J BIOL SCI, V8, P108, DOI 10.7150/ijbs.8.108; Rak-Mardyla A, 2013, J PHYSIOL PHARMACOL, V64, P695; Rak-Mardyla A, 2012, THERIOGENOLOGY, V77, P1505, DOI 10.1016/j.theriogenology.2011.11.017; Relling AE, 2012, J ANIM PHYSIOL AN N, V96, P656, DOI 10.1111/j.1439-0396.2011.01192.x; Relling AE, 2010, J ANIM SCI, V88, P737, DOI 10.2527/jas.2009-2316; Roa J, 2008, ENDOCRINOLOGY, V149, P1627, DOI 10.1210/en.2007-1540; RUSSEL AJF, 1969, J AGR SCI, V72, P451, DOI 10.1017/S0021859600024874; Scaramuzzi RJ, 2006, REPROD NUTR DEV, V46, P339, DOI 10.1051/rnd:2006016; Sugino T, 2002, BIOCHEM BIOPH RES CO, V295, P255, DOI 10.1016/S0006-291X(02)00654-X; Takahashi H, 2007, J ENDOCRINOL, V194, P621, DOI 10.1677/JOE-07-0206; Thompson EL, 2004, J NEUROENDOCRINOL, V16, P850, DOI 10.1111/j.1365-2826.2004.01240.x; Tsutsumi R, 2009, ENDOCR J, V56, P729, DOI 10.1507/endocrj.K09E-185; Wahab F, 2011, HORM METAB RES, V43, P81, DOI 10.1055/s-0030-1269852; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Wu Q, 2012, P NATL ACAD SCI USA, V109, P3155, DOI 10.1073/pnas.1120501109	46	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2020	15	9							e0238465	10.1371/journal.pone.0238465	http://dx.doi.org/10.1371/journal.pone.0238465			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR4MY	32903269	gold, Green Published			2022-12-26	WOS:000571539500024
J	Chen, QY; Chen, JC; Wang, CH; Chen, XW; Liu, JF; Zhou, LL; Liu, YH				Chen, Qiyan; Chen, Jiongcheng; Wang, Chunhong; Chen, Xiaowen; Liu, Jiafeng; Zhou, Lili; Liu, Youhua			MicroRNA-466o-3p mediates beta-catenin-induced podocyte injury by targeting Wilms tumor 1	FASEB JOURNAL			English	Article						podocyte; proteinuria; Wilms tumor 1; Wnt; beta-catenin	DOWN-REGULATION; KIDNEY INJURY; WT1; GENE; HEALTH; DYSFUNCTION; INSIGHTS; PATHWAY; BIOLOGY; NEPHROPATHY	Podocytes are highly specialized cells that play an essential role in maintaining the integrity and function of the glomerular filtration barrier. Wilms tumor 1 (WT1) and beta-catenin are two master regulators that play opposing roles in podocyte biology and mutually antagonize each other. However, exactly how beta-catenin inhibits WT1 remains incompletely understood. In this study, we demonstrated the role of miR-466o-3p in mediating beta-catenin-triggered podocyte injury by targeting WT1. The expression of miR-466o-3p was upregulated in cultured podocytes after beta-catenin activation and in glomerular podocytes in adriamycin (ADR) nephropathy, remnant kidney after 5/6 renal ablation, and diabetic kidney disease. Bioinformatics analysis and luciferase reporter assay confirmed that miR-466o-3p directly targeted WT1 mRNA. Furthermore, overexpression of miR-466o-3p downregulated WT1 protein and promoted podocyte injury in vitro. Conversely, inhibition of miR-466o-3p alleviated beta-catenin-induced podocyte dysfunction. In mouse model of ADR nephropathy, overexpression of miR-466o-3p inhibited WT1, aggravated podocytes injury and deteriorated proteinuria. In contrast, inhibition of renal miR-466o-3p by antagomiR, either prior to or after ADR injection, substantially restored WT1, alleviated podocytes injury and reduced renal fibrosis. These studies reveal a critical role for miR-466o-3p, a novel microRNA that has not been characterized previously, in mediating beta-catenin-triggered WT1 inhibition. Our findings also uncover a new pathogenic mechanism by which beta-catenin promotes podocyte injury and proteinuria in glomerular diseases.	[Chen, Qiyan; Chen, Jiongcheng; Wang, Chunhong; Chen, Xiaowen; Liu, Jiafeng; Zhou, Lili; Liu, Youhua] Southern Med Univ, Nanfang Hosp, Natl Clin Res Ctr Kidney Dis, State Key Lab Organ Failure Res,Div Nephrol, Guangzhou, Peoples R China; [Liu, Youhua] Univ Pittsburgh, Sch Med, Dept Pathol, 200 Lothrop St, Pittsburgh, PA 15261 USA	Southern Medical University - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Liu, YH (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, 200 Lothrop St, Pittsburgh, PA 15261 USA.; Zhou, LL (corresponding author), Nanfang Hosp, State Key Lab Organ Failure Res, Natl Clin Res Ctr Kidney Dis, Div Nephrol, 1838 North Guangzhou Ave, Guangzhou 510515, Peoples R China.	yhliu@pitt.edu; yhliu@pitt.edu		Liu, Youhua/0000-0002-4740-805X	National Natural Science Foundation of China [81521003, 81770715, 81920108007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81521003, 81770715 and 81920108007	Akilesh S, 2011, J CLIN INVEST, V121, P4127, DOI 10.1172/JCI46458; Assady S, 2017, J AM SOC NEPHROL, V28, P1707, DOI 10.1681/ASN.2017010027; Bartel DP, 2018, CELL, V173, P20, DOI 10.1016/j.cell.2018.03.006; Barua M, 2014, KIDNEY INT, V85, P124, DOI 10.1038/ki.2013.354; Chen SQ, 2019, KIDNEY INT, V95, P62, DOI 10.1016/j.kint.2018.08.029; Chung ACK, 2013, INT J NEPHROL RENOV, V6, P169, DOI 10.2147/IJNRD.S37885; Czech MP, 2006, NEW ENGL J MED, V354, P1194, DOI 10.1056/NEJMcibr060065; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Dong LH, 2015, KIDNEY INT, V88, P684, DOI 10.1038/ki.2015.198; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Fan XP, 2012, CELL REPORTS, V2, P52, DOI 10.1016/j.celrep.2012.06.002; Gebeshuber CA, 2013, NAT MED, V19, P481, DOI 10.1038/nm.3142; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Guo N, 2016, RENAL FAILURE, V38, P989, DOI 10.3109/0886022X.2016.1165119; Hall G, 2015, J AM SOC NEPHROL, V26, P831, DOI 10.1681/ASN.2013101053; He WC, 2010, J BIOL CHEM, V285, P24665, DOI 10.1074/jbc.M109.091256; Jing Zhou, 2015, Cell Signal, V27, P1772, DOI 10.1016/j.cellsig.2015.05.018; Kann M, 2015, J AM SOC NEPHROL, V26, P2097, DOI 10.1681/ASN.2014090940; Karaiskos N, 2018, J AM SOC NEPHROL, V29, P2060, DOI 10.1681/ASN.2018030238; Kaverina NV, 2017, STEM CELL REP, V9, P1152, DOI 10.1016/j.stemcr.2017.08.020; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lefebvre J, 2015, KIDNEY INT, V88, P321, DOI 10.1038/ki.2015.140; Li YJ, 2008, AM J PATHOL, V172, P299, DOI 10.2353/ajpath.2008.070057; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Lu YQ, 2017, KIDNEY INT, V92, P1119, DOI 10.1016/j.kint.2017.04.022; Mo HY, 2017, ANTIOXID REDOX SIGN, V27, P345, DOI 10.1089/ars.2016.6758; Morrison AA, 2008, AM J PHYSIOL-RENAL, V295, pF12, DOI 10.1152/ajprenal.00597.2007; Mundel P, 2017, PFLUG ARCH EUR J PHY, V469, P1029, DOI 10.1007/s00424-017-2015-x; Nielsen JS, 2009, J AM SOC NEPHROL, V20, P1669, DOI 10.1681/ASN.2008070782; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Pippin JW, 2009, AM J PHYSIOL-RENAL, V296, pF213, DOI 10.1152/ajprenal.90421.2008; Reiser J, 2013, ANNU REV MED, V64, P357, DOI 10.1146/annurev-med-050311-163340; Scholz H, 2005, PHYSIOLOGY, V20, P54, DOI 10.1152/physiol.00048.2004; Tan RJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.122399; Tomas NM, 2017, J AM SOC NEPHROL, V28, P3261, DOI 10.1681/ASN.2017010030; Trionfini P, 2017, J AM SOC NEPHROL, V28, P1686, DOI 10.1681/ASN.2016101117; Wan J, 2017, FREE RADICAL BIO MED, V108, P280, DOI 10.1016/j.freeradbiomed.2017.03.012; Wang Y, 2000, KIDNEY INT, V58, P1797, DOI 10.1046/j.1523-1755.2000.00342.x; Yang XG, 2015, INT J MOL MED, V36, P669, DOI 10.3892/ijmm.2015.2259; Zhou D, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.130515; Zhou LL, 2019, KIDNEY INT, V95, P830, DOI 10.1016/j.kint.2018.10.032; Zhou LL, 2015, AM J PATHOL, V185, P3211, DOI 10.1016/j.ajpath.2015.08.004; Zhou LL, 2015, NAT REV NEPHROL, V11, P535, DOI 10.1038/nrneph.2015.88; Zhou LL, 2015, J AM SOC NEPHROL, V26, P677, DOI 10.1681/ASN.2013101067; Zhou LL, 2013, J AM SOC NEPHROL, V24, P771, DOI 10.1681/ASN.2012080865; Zuo YY, 2018, NEPHROLOGY, V23, P38, DOI 10.1111/nep.13472	46	4	5	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14424	14439		10.1096/fj.202000464R	http://dx.doi.org/10.1096/fj.202000464R		SEP 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32888352				2022-12-26	WOS:000568291000001
J	Isomura, ET; Matsukawa, M; Nakagawa, K; Mitsui, R; Kogo, M				Isomura, Emiko Tanaka; Matsukawa, Makoto; Nakagawa, Kiyoko; Mitsui, Ryo; Kogo, Mikihiko			Endoscopic soft palate augmentation using injectable materials in dogs to ameliorate velopharyngeal insufficiency	PLOS ONE			English	Article							AUTOLOGOUS FAT TRANSPLANTATION; PHARYNGEAL FLAP SURGERY; ADIPOSE-TISSUE; GRAFTS	Background Velopharyngeal structure augmentation methods are used as alternatives to pharyngeal flap operations. Recently, we investigated the sites of velopharyngeal structure augmentation in dogs and reported that the most effective injection location is the soft palate. However, there have been no reports regarding the optimal materials for implantation or injection. In this study, we aimed to investigate the injectable materials used in soft palate augmentation in dogs to ameliorate velopharyngeal insufficiency (VPI). Methods Endoscopic soft palate augmentation (ESPA) was performed in dogs using purified sodium hyaluronate, atelocollagen, or autogenic fat tissue. ESPA is an original technique developed by our group, and this is the first report of its performance. Moreover, we assessed the amount of nasal air leakage during inspiration at rest and during expiration under the rebreathing system at 1, 2, 3, 4, 5, and 6 months after injection of these materials. Results The amount of nasal air leakage during expiration under the rebreathing system was significantly decreased in all dogs injected with the ESPA materials, but neither apnea nor hypopnea was observed. Conclusions We investigated the optimal materials for use in ESPA, such as purified sodium hyaluronate, atelocollagen, or autogenic fat tissue. We found that all of them reduced nasal air leakage and only autogenic fat tissue showed significant histologic differences in dogs at 6 months. This technique may also be useful for the treatment of patients with VPI.	[Isomura, Emiko Tanaka; Matsukawa, Makoto; Nakagawa, Kiyoko; Mitsui, Ryo; Kogo, Mikihiko] Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg 1, Suita, Osaka, Japan	Osaka University	Isomura, ET (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg 1, Suita, Osaka, Japan.	tanaemi@dent.osaka-u.ac.jp	Isomura, Emiko/AAG-7594-2021; Isomura, Emiko Tanaka/GPP-3788-2022; Kogo, Mikihiko/ABD-7080-2020	Isomura, Emiko Tanaka/0000-0002-7855-9600; Kogo, Mikihiko/0000-0002-4556-2491	Japan Society for the Promotion of Science [19K19229]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (Grant Number 19K19229). Neither of the authors has a financial interest in any of the products, devices, or drugs mentioned in this manuscript.	Aboloyoun Ali Ibrahim, 2013, Acta Med Acad, V42, P55, DOI 10.5644/ama2006-124.71; Adachi T, 1997, J DENT RES, V76, P1745, DOI 10.1177/00220345970760110501; [Anonymous], 2017, E ASIAN SCI TECHNOLO, V11, P209; Bishop A, 2014, J PLAST RECONSTR AES, V67, P1, DOI 10.1016/j.bjps.2013.09.021; Boneti C, 2015, ANN PLAS SURG, V74, pS190, DOI 10.1097/SAP.0000000000000442; BRAUER RO, 1973, PLAST RECONSTR SURG, V51, P254, DOI 10.1097/00006534-197303000-00003; Campos LD, 2016, CLEFT PALATE-CRAN J, V53, pE53, DOI 10.1597/14-152; Cantarella G, 2012, J CRANIOFAC SURG, V23, P634, DOI 10.1097/SCS.0b013e31824db85b; Cantarella G, 2011, OTOLARYNG HEAD NECK, V145, P401, DOI 10.1177/0194599811411655; CHAJCHIR A, 1986, AESTHET PLAST SURG, V10, P115, DOI 10.1007/BF01575279; Coleman SR, 2002, PLAST RECONSTR SURG, V110, P1731, DOI 10.1097/00006534-200212000-00017; Coleman SR, 2006, PLAST RECONSTR SURG, V118, p108S, DOI 10.1097/01.prs.0000234610.81672.e7; Dejonckere PH, 2001, ANN OTO RHINOL LARYN, V110, P168, DOI 10.1177/000348940111000213; Filip C, 2014, J PLAST RECONSTR AES, V67, P1155, DOI 10.1016/j.bjps.2014.02.001; Filip C, 2013, J PLAST RECONSTR AES, V66, P337, DOI 10.1016/j.bjps.2012.11.006; Filip C, 2011, CLEFT PALATE-CRAN J, V48, P708, DOI 10.1597/09-161; Guerrerosantos J, 1996, AESTHET PLAST SURG, V20, P403, DOI 10.1007/BF02390315; Isomura ET, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212752; Klotz DA, 2001, LARYNGOSCOPE, V111, P2157, DOI 10.1097/00005537-200112000-00015; Kogo M, 2017, J CLEFT LIP PALATE C, V4, P189; Lau D, 2013, CLEFT PALATE-CRAN J, V50, P51, DOI 10.1597/11-038; Leong DTW, 2005, J DERMATOL SCI, V37, P169, DOI 10.1016/j.jdermsci.2004.11.009; Leuchter I, 2010, EUR ARCH OTO-RHINO-L, V267, P977, DOI 10.1007/s00405-009-1157-7; Lin GT, 2010, CYTOTHERAPY, V12, P88, DOI 10.3109/14653240903350265; Naran S, 2017, PLAST RECONSTR SURG, V139, p1343E, DOI 10.1097/PRS.0000000000003335; Nicolas L, 2011, INT J PEDIATR OTORHI, V75, P1404, DOI 10.1016/j.ijporl.2011.08.001; NIECHAJEV I, 1994, PLAST RECONSTR SURG, V94, P496, DOI 10.1097/00006534-199409000-00012; Nigh E, 2017, J CRANIOFAC SURG, V28, P1248, DOI 10.1097/SCS.0000000000003702; Nishio N, 2016, J LARYNGOL OTOL, V130, P914, DOI 10.1017/S0022215116008707; ORR WC, 1987, PLAST RECONSTR SURG, V80, P226, DOI 10.1097/00006534-198708000-00010; REMACLE M, 1990, LARYNGOSCOPE, V100, P269; Rogers C, 2016, J CRANIOFAC SURG, V27, P1746, DOI 10.1097/SCS.0000000000003050; Sheykhhasan M, 2019, CURR STEM CELL RES T, V14, P532, DOI 10.2174/1574888X14666190411121528; VALNICEK SM, 1994, PLAST RECONSTR SURG, V93, P954, DOI 10.1097/00006534-199404001-00009; Watanabe T, 2011, INT J UROL, V18, P659, DOI 10.1111/j.1442-2042.2011.02795.x; Yasuda H, 2006, J KANAZAWA MED U, V31, P233; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	37	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238646	10.1371/journal.pone.0238646	http://dx.doi.org/10.1371/journal.pone.0238646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886712	gold, Green Published			2022-12-26	WOS:000571064300030
J	Achhami, BB; Peterson, RKD; Sherman, JD; Reddy, GVP; Weaver, DK				Achhami, Buddhi B.; Peterson, Robert K. D.; Sherman, Jamie D.; Reddy, Gadi V. P.; Weaver, David K.			Multiple decrement life tables ofCephus cinctusNorton (Hymenoptera: Cephidae) across a set of barley cultivars: The importance of plant defense versus cannibalism	PLOS ONE			English	Article							STEM SAWFLY HYMENOPTERA; WHEAT CULTIVARS; BRACON-CEPHI; WINTER-WHEAT; PARASITISM; OVIPOSITION; LARVAE; COLEOPTERA; RESISTANCE; MORTALITY	Accurately estimating cause-specific mortality for immature insect herbivores is usually difficult. The insects are exposed to abiotic and biotic mortality factors, causing cadavers to simply disappear before cause of mortality can be recorded. Also, insect herbivores are often highly mobile on hosts, making it difficult to follow patterns for individuals through time. In contrast, the wheat stem sawfly,Cephus cinctusNorton, spends its entire egg, larval, and pupal period inside a host stem. Therefore, with periodic sampling stage-specific causes of mortality can be ascertained. Consequently, we examinedC.cinctusmortality in eight barley,Hordeum vulgareL., cultivars in two locations in Montana from 2016 to 2018 by collecting stem samples from stem elongation to crop maturity at weekly intervals, and collecting overwintered barley stubs the following spring and summer from the same plots. If larvae were present, we examined larval status-dead or alive-and categorized dead individuals into one of 5 mortality categories: plant defense, cannibalism, parasitism, pathogens, and unknown factors. We used multiple decrement life tables to estimate cause-specific mortality and irreplaceable mortality (the proportion of mortality from a given cause that cannot be replaced by other causes of mortality). Plant defense (antibiosis) caused 85.7 +/- 3.6%, cannibalism (governed by antixenosis) caused 70.1 +/- 7.6%, parasitism caused 13.8 +/- 5.9%, unknown factors caused 38.5 +/- 7.6%, and pathogens caused 14.7 +/- 8.5% mortality in the presence of all causes of mortality. Similarly, irreplaceable mortality due to plant defense was 22.3 +/- 6.4%, cannibalism was 29.1 +/- 4.2%, unknown factors was 6.2 +/- 1.8%, pathogens was 0.9 +/- 0.5%, and parasitism was 1. 5 +/- 0. 6%. Antibiosis traits primarily killed newly emerged larvae, while other traits supported more favorable oviposition decisions by females, increasing mortality by obligate cannibalism. Our results suggest that breeding barley for resistance toC.cinctustargeting both categories of traits (antibiosis and antixenosis) is a highly valuable tactic for management of this important pest.	[Achhami, Buddhi B.; Peterson, Robert K. D.; Weaver, David K.] Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA; [Sherman, Jamie D.] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA; [Reddy, Gadi V. P.] USDA ARS, Southern Insect Management Res Unit, Stoneville, MS USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; United States Department of Agriculture (USDA)	Achhami, BB (corresponding author), Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA.	buddhiachhami@gmail.com	Reddy, Gadi V.P./J-5270-2015	Reddy, Gadi V.P./0000-0001-6377-0721; Achhami, Buddhi/0000-0003-3178-6651	Wheat and Barley Committee; National Institute of Food and Agriculture, U.S. Department of Agriculture [1996646, 1017642]	Wheat and Barley Committee; National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA))	This study was funded by the Wheat and Barley Committee (2016-2020) and by the National Institute of Food and Agriculture, U.S. Department of Agriculture, Hatch and Multi-State projects 1996646 and 1017642.	Achhami BB, 2020, J ECON ENTOMOL, V113, P1982, DOI 10.1093/jee/toaa097; Adhikari S, 2018, PEST MANAG SCI, V74, P2480, DOI 10.1002/ps.4925; Ainslie CN, 1920, BULLETIN, V841, P27; American Malting Barley Association (AMBA), 2020, BARL VAR SURV 2019; [Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2012, REGEN MED S3, V7, pS14; Bekkerman A, 2018, J AGR RESOUR ECON, V43, P172; Beres BL, 2013, CAN J PLANT SCI, V93, P1169, DOI [10.4141/CJPS2013-035, 10.4141/cjps2013-035]; Beres BL, PRAIRIE SOILS CROPS, V4, P54; Bernays EA, 2000, J CHEM ECOL, V26, P547, DOI 10.1023/A:1005430010314; Buteler M, 2008, AGR FOREST ENTOMOL, V10, P347, DOI 10.1111/j.1461-9563.2008.00396.x; Buteler M, 2015, ENVIRON ENTOMOL, V44, P1571, DOI 10.1093/ee/nvv128; Buteler M, 2012, ENTOMOL EXP APPL, V143, P138, DOI 10.1111/j.1570-7458.2012.01237.x; Buteler M, 2010, CAN ENTOMOL, V142, P222, DOI 10.4039/n09-072; Buteler M, 2009, ENVIRON ENTOMOL, V38, P1707, DOI 10.1603/022.038.0624; Carcamo HA, 2016, ENVIRON ENTOMOL, V45, P397, DOI 10.1093/ee/nvv231; CAREY JR, 1989, OECOLOGIA, V78, P131, DOI 10.1007/BF00377208; Carey JR., 1993, APPL DEMOGRAPHY BIOL; CHURCH N. S., 1955, CANADIAN ENT, V87, P85; Davis RS, 2011, COMPUT ELECTRON AGR, V75, P363, DOI 10.1016/j.compag.2010.12.009; DICKINSON JL, 1992, ECOL ENTOMOL, V17, P209, DOI 10.1111/j.1365-2311.1992.tb01049.x; Farstad C. W., 1944, SCI AGRIC [OTTAWA], V24, P383; Farstad C. W., 1946, SCI AGRIC [OTTAWA], V26, P216; Hadley W, 2019, **DATA OBJECT**; HERARD F, 1988, J CHEM ECOL, V14, P1583, DOI 10.1007/BF01012524; Holmes N. D., 1954, Canadian Entomologist, V86, P159; HOLMES N. D., 1960, CANADIAN JOUR PLANT SCI, V40, P29; HOLMES ND, 1975, CAN ENTOMOL, V107, P391, DOI 10.4039/Ent107391-4; HOLMES ND, 1963, CAN J ZOOLOG, V41, P1217, DOI 10.1139/z63-101; HOLMES ND, 1982, CAN ENTOMOL, V114, P775, DOI 10.4039/Ent114775-9; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Kakimoto T, 2003, ANN ENTOMOL SOC AM, V96, P793, DOI 10.1603/0013-8746(2003)096[0793:ELPLDA]2.0.CO;2; Kassambara A, 2020, GGCORRPLOT VISUALIZA; Kassambara A., 2017, GGPUBR GGPLOT2 BASED; Larsson KAE, 2011, PLANT PHYSIOL BIOCH, V49, P96, DOI 10.1016/j.plaphy.2010.10.005; Lesieur V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168370; Morrill WL, 2001, J KANSAS ENTOMOL SOC, V74, P181; Morrill WL, 1996, ENVIRON ENTOMOL, V25, P1128, DOI 10.1093/ee/25.5.1128; Peterson RKD, 2011, BIOCONTROL, V56, P831, DOI 10.1007/s10526-011-9357-7; Peterson RKD, 2009, ENVIRON ENTOMOL, V38, P2, DOI 10.1603/022.038.0102; Pfennig DW, 1998, ANIM BEHAV, V55, P1255, DOI 10.1006/anbe.1997.9996; Piesik D, 2008, AGR FOREST ENTOMOL, V10, P245, DOI 10.1111/j.1461-9563.2008.00380.x; Pinheiro J., 2020, NLME LINEAR NONLINEA; POLIS GA, 1981, ANNU REV ECOL SYST, V12, P225, DOI 10.1146/annurev.es.12.110181.001301; Portman SL, 2018, ANN ENTOMOL SOC AM, V111, P85, DOI 10.1093/aesa/say002; Richardson ML, 2010, ANNU REV ENTOMOL, V55, P39, DOI 10.1146/annurev-ento-112408-085314; Runyon JB, 2002, J ECON ENTOMOL, V95, P1130, DOI 10.1603/0022-0493-95.6.1130; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Sherman JD, 2010, CROP SCI, V50, P73, DOI 10.2135/cropsci2009.03.0145; Sherratt TN, 1999, J INSECT BEHAV, V12, P123, DOI 10.1023/A:1020985316409; Snyder WE, 2000, ENVIRON ENTOMOL, V29, P1173, DOI 10.1603/0046-225X-29.6.1173; Talbert LE, 2014, PLANT BREEDING, V133, P427, DOI 10.1111/pbr.12184; Turlings Ted C. J., 1993, P51; USDA, 2020, CROP PROD 2019 SUMM; Varella AC, 2018, J ECON ENTOMOL, V111, P923, DOI 10.1093/jee/toy025; Varella AC, 2017, THEOR APPL GENET, V130, P187, DOI 10.1007/s00122-016-2805-0; Vidal S, 2015, CURR SCI INDIA, V109, P46; WALLACE L. E., 1966, Tech. Bull. U.S. Dep. Agric.; Wang XG, 2014, ENTOMOL EXP APPL, V151, P112, DOI 10.1111/eea.12174; Weaver DH, 2009, J ECON ENTOMOL, V102, P1009, DOI 10.1603/029.102.0320; Weaver DK, 2005, BIOL CONTROL, V34, P1, DOI 10.1016/j.biocontrol.2005.04.001; Weiss Michael J., 1992, American Entomologist, V38, P241; Wenda-Piesik A, 2009, ENVIRON ENTOMOL, V38, P387, DOI 10.1603/022.038.0211; Wetzel WC, 2016, NATURE, V539, P425, DOI 10.1038/nature20140; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; ZUNIGA GE, 1985, PHYTOCHEMISTRY, V24, P945, DOI 10.1016/S0031-9422(00)83158-1	68	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238527	10.1371/journal.pone.0238527	http://dx.doi.org/10.1371/journal.pone.0238527			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915817	Green Published, gold			2022-12-26	WOS:000571887500024
J	Bonful, HA; Addo-Lartey, A; Aheto, JMK; Ganle, JK; Sarfo, B; Aryeetey, R				Bonful, Harriet Affran; Addo-Lartey, Adolphina; Aheto, Justice M. K.; Ganle, John Kuumouri; Sarfo, Bismark; Aryeetey, Richmond			Limiting spread of COVID-19 in Ghana: Compliance audit of selected transportation stations in the Greater Accra region of Ghana	PLOS ONE			English	Article								Globally, little evidence exists on transmission patterns of COVID-19. Recommendations to prevent infection include appropriate and frequent handwashing plus physical and social distancing. We conducted an exploratory observational study to assess compliance with these recommendations in selected transportation stations in Ghana. A one-hour audit of 45 public transport stations in the Greater Accra region was carried out between 27(th)and 29(th)March 2020. Using an adapted World Health Organization (WHO) hand hygiene assessment scale, the availability and use of handwashing facilities, social distancing, and ongoing public education on COVID-19 prevention measures were assessed, weighted and scored to determine the level of compliance of stations. Compliance with recommendations was categorized as "inadequate" "basic", "intermediate" and "advanced", based on the overall score. Majority (80%) of stations in Accra have at least one Veronica Bucket with flowing water and soap, but the number of washing places at each station is not adequate. Only a small minority (18%) of stations were communicating the need to wash hands frequently and appropriately, and to practice social/physical distancing while at the station. In most stations (95%), hand washing practice was either not observed, or only infrequently. Almost all stations (93%) did not have alcohol-based hand sanitizers available for public use, while social distancing was rarely practiced (only 2%). In over 90% of the stations, face masks were either not worn or only worn by a few passengers. Compliance with COVID-19 prevention measures was inadequate in 13 stations, basic in 16 stations, intermediate in 7 stations, and advanced in 9 stations. Compliance with COVID-19 prevention measures in public transportation stations in the Greater Accra region remains a challenge. Awareness creation should aim to elevate COVID-19 risk perception of transportation operators and clients. Transport operators and stations need support and guidance to enforce hand washing and social distancing.	[Bonful, Harriet Affran; Addo-Lartey, Adolphina; Sarfo, Bismark] Univ Ghana, Dept Epidemiol & Dis Control, Sch Publ Hlth, Accra, Ghana; [Aheto, Justice M. K.] Univ Ghana, Sch Publ Hlth, Dept Biostat, Accra, Ghana; [Ganle, John Kuumouri; Aryeetey, Richmond] Univ Ghana, Sch Publ Hlth, Dept Populat & Family Hlth, Accra, Ghana	University of Ghana; University of Ghana; University of Ghana	Aryeetey, R (corresponding author), Univ Ghana, Sch Publ Hlth, Dept Populat & Family Hlth, Accra, Ghana.	raryeetey@ug.edu.gh	Aryeetey, Richmond/C-5836-2016; Aheto, Justice Moses K./H-8890-2019	Aryeetey, Richmond/0000-0003-4667-592X; Aheto, Justice Moses K./0000-0003-1384-2461; Affran Bonful, Harriet/0000-0003-0069-3241; GANLE, JOHN KUUMUORI/0000-0002-8382-3437	University of Ghana Office of Research, Innovation, and Development	University of Ghana Office of Research, Innovation, and Development	Funding for the study was obtained from the University of Ghana Office of Research, Innovation, and Development. The Initial of recipient is RA. The URL of the funder site is http://orid.ug.edu.gh/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atri D, 2020, JACC-BASIC TRANSL SC, V5, P518, DOI 10.1016/j.jacbts.2020.04.002; Food and Drugs Administration, 2020, FDAS REC HOM MASKS S; Ghana Health Service, 2020, GHAN HLTH SERV COVID; Ghana Statistical Service, 2020, DEM POP PROJ; Gilbert M, 2020, LANCET, V395, P871, DOI 10.1016/S0140-6736(20)30411-6; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Johns Hopkins University, 2021, COVID 19 DASHB CTR S; Liang W, 2020, REPORT WHO CHINA JOI; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; WHO, 2020, WHO COR COVID 19 DAS; WHO, 2020, ANTIGEN DETECTION DI; WHO, 2010, HAND HYG SELF ASS FR; WHO, 2020, RESP COMM SPREAD COV, P1, DOI DOI 10.1017/DMP.2020.166; WHO, 2020, CRIT REL COVID 19 PA; WHO, 2020, COR DIS COVID 19 PAN; World Health Organization (WHO), 2003, AC RESP SYNDR HONG K; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648	20	22	22	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238971	10.1371/journal.pone.0238971	http://dx.doi.org/10.1371/journal.pone.0238971			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915888	Green Submitted, gold, Green Published			2022-12-26	WOS:000571887500054
J	Laux, L; Cutiongco, MFA; Gadegaard, N; Jensen, BS				Laux, Lisa; Cutiongco, Marie F. A.; Gadegaard, Nikolaj; Jensen, Bjorn Sand			Interactive machine learning for fast and robust cell profiling	PLOS ONE			English	Article							OPTIMIZATION; STRATEGIES; LOOP	Automated profiling of cell morphology is a powerful tool for inferring cell function. However, this technique retains a high barrier to entry. In particular, configuring image processing parameters for optimal cell profiling is susceptible to cognitive biases and dependent on user experience. Here, we use interactive machine learning to identify the optimum cell profiling configuration that maximises quality of the cell profiling outcome. The process is guided by the user, from whom a rating of the quality of a cell profiling configuration is obtained. We use Bayesian optimisation, an established machine learning algorithm, to learn from this information and automatically recommend the next configuration to examine with the aim of maximising the quality of the processing or analysis. Compared to existing interactive machine learning tools that require domain expertise for per-class or per-pixel annotations, we rely on users' explicit assessment of output quality of the cell profiling task at hand. We validated our interactive approach against the standard human trial-and-error scheme to optimise an object segmentation task using the standard software CellProfiler. Our toolkit enabled rapid optimisation of an object segmentation pipeline, increasing the quality of object segmentation over a pipeline optimised through trial-and-error. Users also attested to the ease of use and reduced cognitive load enabled by our machine learning strategy over the standard approach. We envision that our interactive machine learning approach can enhance the quality and efficiency of pipeline optimisation to democratise image-based cell profiling.	[Laux, Lisa; Jensen, Bjorn Sand] Univ Glasgow, Sch Comp Sci, Glasgow, Lanark, Scotland; [Cutiongco, Marie F. A.; Gadegaard, Nikolaj] Univ Glasgow, Sch Engn Biomed Engn, Glasgow, Lanark, Scotland; [Cutiongco, Marie F. A.] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England	University of Glasgow; University of Glasgow; University of Manchester	Jensen, BS (corresponding author), Univ Glasgow, Sch Comp Sci, Glasgow, Lanark, Scotland.	bjorn.jensen@glasgow.ac.uk	; Gadegaard, Nikolaj/E-9243-2010	Cutiongco, Marie FA/0000-0002-4873-9643; Laux, Lisa/0000-0003-0157-5538; Gadegaard, Nikolaj/0000-0002-3396-846X	European Research Council (ERC) [648892]; Cancer Research UK (CRUK) Pioneer Award; Engineering and Physical Sciences Research Council (EPSRC) [EP/R018634/1]; EPSRC [EP/R018634/1] Funding Source: UKRI	European Research Council (ERC)(European Research Council (ERC)European Commission); Cancer Research UK (CRUK) Pioneer Award; Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	NG and MFAC acknowledge support from the European Research Council (ERC) through the FAKIR 648892 Consolidator Award. NG and BSJ acknowledge support from a Cancer Research UK (CRUK) Pioneer Award. BSJ acknowledge support from the Engineering and Physical Sciences Research Council (EPSRC) grant EP/R018634/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arganda-Carreras I, 2017, BIOINFORMATICS, V33, P2424, DOI 10.1093/bioinformatics/btx180; Berg S, 2019, NAT METHODS, V16, P1226, DOI 10.1038/s41592-019-0582-9; Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025; Bray MA, 2012, J BIOMOL SCREEN, V17, P266, DOI 10.1177/1087057111420292; Caicedo JC, 2017, NAT METHODS, V14, P849, DOI [10.1038/nmeth.4397, 10.1038/NMETH.4397]; Cutiongco MFA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15114-1; Falk T, 2019, NAT METHODS, V16, P67, DOI 10.1038/s41592-018-0261-2; Gibson CC, 2015, CIRCULATION, V131, P289, DOI 10.1161/CIRCULATIONAHA.114.010403; He KM, 2017, IEEE I CONF COMP VIS, P2980, DOI [10.1109/ICCV.2017.322, 10.1109/TPAMI.2018.2844175]; Jones DR, 1998, J GLOBAL OPTIM, V13, P455, DOI 10.1023/A:1008306431147; Lawrence ND., 2015, ARXIV150501627; Ljosa V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000603; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; Mokus J., 1975, OPTIMIZATION TECHNIQ, P400, DOI [10.1007/3-540-07165-2_55, DOI 10.1007/3-540-07165-2_55]; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Shahriari B, 2016, P IEEE, V104, P148, DOI 10.1109/JPROC.2015.2494218; Slacka MD, 2008, P NATL ACAD SCI USA, V105, P19306, DOI 10.1073/pnas.0807038105; Smith K, 2014, J BIOMOL SCREEN, V19, P685, DOI 10.1177/1087057114527313; Stormonth-Darling JM, 2016, MACROMOL MATER ENG, V301, P964, DOI 10.1002/mame.201600011; Takagi H, 2001, P IEEE, V89, P1275, DOI 10.1109/5.949485; Wurflinger T, 2011, J MICROSC-OXFORD, V241, P37, DOI 10.1111/j.1365-2818.2010.03404.x; Yamashita T, 2018, PHYS REV MATER, V2, DOI 10.1103/PhysRevMaterials.2.013803; Yan XZ, 2014, TISSUE ENG PART C-ME, V20, P198, DOI 10.1089/ten.tec.2012.0412; Yang HS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170341; Zhang JJ, 2017, SCIENCE, V356, P1280, DOI 10.1126/science.aal5054	27	1	1	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0237972	10.1371/journal.pone.0237972	http://dx.doi.org/10.1371/journal.pone.0237972			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915784	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000571887500143
J	Li, G; Zhang, L; DiBernardo, A; Wang, G; Sheehan, JJ; Lee, K; Reutfors, J; Zhang, QY				Li, Gang; Zhang, Ling; DiBernardo, Allitia; Wang, Grace; Sheehan, John J.; Lee, Kwan; Reutfors, Johan; Zhang, Qiaoyi			A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients	PLOS ONE			English	Article							ECONOMIC BURDEN; DISORDER	Objective The economic burden of commercially insured patients in the United States with treatment-resistant depression and patients with non-treatment-resistant major depressive disorder was compared using data from the Optum Clinformatics (TM) claims database. Methods Patients 18-63 years on antidepressant treatment between 1/1/13 and 9/30/13, who had no treatment claims for depression 6 months before the index date (first antidepressant dispensing), and who had a major depressive disorder or depression diagnosis within 30 days of the index date, were included. Treatment-resistant depression was defined as receiving 3 antidepressant regimens during 1 major depressive disorder episode. Patients with treatment-resistant depression were matched with patients with non-treatment-resistant major depressive disorder at a 1:4 ratio using propensity score matching. The study consisted of 1-year baseline (pre-index) and 2-year follow-up (post index) periods. Cost outcomes were compared using a generalized linear model. Results 2,370 treatment-resistant depression and 9,289 non-treatment-resistant major depressive disorder patients were included. In year 1 of the follow-up period, compared with non-treatment-resistant major depressive disorder, patients with treatment-resistant depression had: more emergency department visits (odds ratio = 1.39, 95% confidence interval = 1.24-1.56); more inpatient hospitalizations (odds ratio = 1.73, 95% confidence interval = 1.46-2.05); longer hospital stays (mean difference vs non-treatment-resistant major depressive disorder = 2.86, 95% confidence interval = 0.86-4.86 days); and more total healthcare costs (mean difference vs non-treatment-resistant major depressive disorder = US$3,846, 95% confidence interval = $2,855-$4,928). These patterns remained consistent in year 2 of the follow-up period. Conclusion Treatment-resistant depression was associated with higher healthcare resource utilization and costs versus non-treatment-resistant major depressive disorder in this commercially insured cohort of patients in the United States.	[Li, Gang; Zhang, Ling; Wang, Grace; Lee, Kwan; Zhang, Qiaoyi] Janssen Res & Dev LLC, Raritan, NJ 08869 USA; [DiBernardo, Allitia] Janssen Res & Dev LLC, Titusville, NJ USA; [Sheehan, John J.] Janssen Sci Affairs LLC, Titusville, NJ USA; [Reutfors, Johan] Karolinska Inst, Stockholm, Sweden; [Zhang, Ling] Boehringer Ingelheim Pharmaceut Inc, 90 E Ridge POB 368, Ridgefield, CT 06877 USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Janssen Pharmaceuticals; Karolinska Institutet; Boehringer Ingelheim	Li, G (corresponding author), Janssen Res & Dev LLC, Raritan, NJ 08869 USA.	GLi@its.jnj.com		Li, Gang/0000-0001-8796-7510	Janssen Research & Development, LLC; ScheringPlough	Janssen Research & Development, LLC; ScheringPlough(Merck & CompanySchering Plough Corporation)	Janssen Research & Development, LLC provided funding for this study in the form of salaries for GL, LZ, AD, GW, JJS, KL, and QZ, as well as funding for editorial support. ScheringPlough also provided funding in the form of unrestricted grant support to JR. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Harbi KS, 2012, PATIENT PREFER ADHER, V6, P369, DOI 10.2147/PPA.S29716; [Anonymous], 2010, PRACTICE GUIDELINE T; Ballenger JC, 1999, J CLIN PSYCHIAT, V60, P29; Conway CR, 2017, JAMA PSYCHIAT, V74, P9, DOI 10.1001/jamapsychiatry.2016.2586; DiBernardo A, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1920-7; Eaton WW, 2008, EPIDEMIOL REV, V30, P1, DOI 10.1093/epirev/mxn011; Fostick L, 2010, EUR NEUROPSYCHOPHARM, V20, P671, DOI 10.1016/j.euroneuro.2010.06.001; Gaynes BN, 2018, PSYT0816 AG HEALTHC; Gaynes BN, 2020, DEPRESS ANXIETY, V37, P134, DOI 10.1002/da.22968; Gibson TB, 2010, AM J MANAG CARE, V16, P370; Greenberg P, 2004, PHARMACOECONOMICS, V22, P363, DOI 10.2165/00019053-200422060-00003; Greenberg PE, 2015, J CLIN PSYCHIAT, V76, P155, DOI 10.4088/JCP.14m09298; Hasin DS, 2018, JAMA PSYCHIAT, V75, P336, DOI 10.1001/jamapsychiatry.2017.4602; Ivanova JI, 2010, CURR MED RES OPIN, V26, P2475, DOI 10.1185/03007995.2010.517716; Kubitz N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076882; Mrazek DA, 2014, PSYCHIAT SERV, V65, P977, DOI 10.1176/appi.ps.201300059; Murphy Jenifer A, 2017, Depress Res Treat, V2017, P4176825, DOI 10.1155/2017/4176825; Olchanski N, 2013, CLIN THER, V35, P512, DOI 10.1016/j.clinthera.2012.09.001; Olfson M, 2018, J MANAG CARE SPEC PH, V24, P226, DOI 10.18553/jmcp.2018.24.3.226; Pilon D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223255; Pilon D, 2020, PHARMACOECON-OPEN, V4, P119, DOI 10.1007/s41669-019-0154-z; Pilon D, 2019, J COMP EFFECT RES, V8, P381, DOI 10.2217/cer-2018-0140; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Reutfors J, 2018, J AFFECT DISORDERS, V238, P674, DOI 10.1016/j.jad.2018.06.030; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; SAS Institute, 2008, SAS STAT US GUID; Schneeweiss S, 2009, EPIDEMIOLOGY, V20, P512, DOI 10.1097/EDE.0b013e3181a663cc; Thase ME, 1997, J CLIN PSYCHIAT, V58, P16, DOI 10.4088/JCP.v58n0103; 2018, J AM ACAD DERMATOL, V79	29	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238843	10.1371/journal.pone.0238843	http://dx.doi.org/10.1371/journal.pone.0238843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915863	Green Published, gold			2022-12-26	WOS:000571887500106
J	Pan, XX; Yuan, MQ; Xiang, SY; Ma, YM; Zhou, M; Zhu, YY; Yang, MZ				Pan, Xiao-Xia; Yuan, Ming-Quan; Xiang, Si-Yu; Ma, Yin-Min; Zhou, Ming; Zhu, You-Yong; Yang, Ming-Zhi			The symbioses of endophytic fungi shaped the metabolic profiles in grape leaves of different varieties	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; VITIS-VINIFERA; XANTHOMONAS-CAMPESTRIS; ANTHOCYANIN PROFILES; BIOACTIVE COMPOUNDS; NATURAL-PRODUCTS; CITRUS CANKER; CULTIVARS; DIVERSITY; COMMUNITIES	Endophytic fungi produce many novel bioactive metabolites that are directly used as drugs or that function as the precursor structures of other chemicals. The metabolic shaping of endophytes on grape cells was reported previously. However, there are no reports on the interactions and metabolic impact of endophyte symbiosis onin vitrovine leaves, which may be examined under well-controlled conditions that are more representative of the natural situation of endophytes within grapevines. The present study used anin vitroleaf method to establish endophyte symbiosis of grapevines and analyze the effects on the metabolic profiles of grape leaves from two different cultivars, 'Rose honey' (RH) and 'Cabernet sauvignon' (CS). The effects of endophytic fungi on the metabolic profiles of grape leaves exhibited host selectivity and fungal strain specificity. Most of the endophytic fungal strains introduced novel metabolites into the two varieties of grape leaves according to the contents of the detected metabolites and composition of metabolites. Strains RH49 and MDR36, with high or moderate symbiosis rates, triggered an increased response in terms of the detected metabolites, and the strains MDR1 and MDR33 suppressed the detected metabolites in CS and RH leaves despite having strong or moderate symbiosis ability. However, the strain RH12 significantly induced the production of novel metabolites in RH leaves due to its high symbiosis ability and suppression of metabolites in CS leaves.	[Pan, Xiao-Xia; Zhu, You-Yong] Yunnan Univ, Sch Agr, Kunming, Yunnan, Peoples R China; [Pan, Xiao-Xia] Yunnan MinZu Univ, Sch Chem & Environm, Kunming, Yunnan, Peoples R China; [Yuan, Ming-Quan] Yunnan Univ, Sch Chem & Chem Engn, Kunming, Yunnan, Peoples R China; [Xiang, Si-Yu; Ma, Yin-Min; Zhou, Ming] Yunnan Univ, Sch Life Sci, Kunming, Yunnan, Peoples R China; [Zhu, You-Yong] Yunnan Agr Univ, Sch Agron, Kunming, Yunnan, Peoples R China; [Yang, Ming-Zhi] Yunnan Univ, Sch Ecol & Environm Sci, Kunming, Yunnan, Peoples R China	Yunnan University; Yunnan Minzu University; Yunnan University; Yunnan University; Yunnan Agricultural University; Yunnan University	Zhu, YY (corresponding author), Yunnan Univ, Sch Agr, Kunming, Yunnan, Peoples R China.; Zhu, YY (corresponding author), Yunnan Agr Univ, Sch Agron, Kunming, Yunnan, Peoples R China.; Yang, MZ (corresponding author), Yunnan Univ, Sch Ecol & Environm Sci, Kunming, Yunnan, Peoples R China.	zhuyy1982@126.com; ymz1106@126.com		Xiaoxia, Pan/0000-0003-2904-2063	National Natural Science Foundation of China [NSFC 31560538]; joint foundation of Yunnan Provincial Department of Science and Technology [2019FY003024]; Yunnan University [2019FY003024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); joint foundation of Yunnan Provincial Department of Science and Technology; Yunnan University	This work was financially supported by the National Natural Science Foundation of China (NSFC 31560538); and the joint foundation of Yunnan Provincial Department of Science and Technology and Yunnan University (No. 2019FY003024).	Accounting Today, 2009, ACCOUNTING TODAY, V23, P9; [Anonymous], 1991, FUNGAL ENDOPHYTES TR; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Araujo WL, 2002, APPL ENVIRON MICROB, V68, P4906, DOI 10.1128/AEM.68.10.4906-4914.2002; Bulgari D, 2011, APPL ENVIRON MICROB, V77, P5018, DOI 10.1128/AEM.00051-11; Buyer JS, 2011, PLANT SOIL, V339, P401, DOI 10.1007/s11104-010-0592-y; Chafer A, 2005, J SEP SCI, V28, P2050, DOI 10.1002/jssc.200500128; Chandra S, 2012, APPL MICROBIOL BIOT, V95, P47, DOI 10.1007/s00253-012-4128-7; COOMBE BG, 1973, PLANT PHYSIOL, V51, P629, DOI 10.1104/pp.51.4.629; Cordovez V, 2019, ANNU REV MICROBIOL, V73, P69, DOI 10.1146/annurev-micro-090817-062524; Padilha CVD, 2017, FOOD CHEM, V228, P106, DOI 10.1016/j.foodchem.2017.01.137; De Bary A., 1866, HOFMEISTERS HDB PHYS, V2; Dwibedi V, 2018, APPL BIOCHEM BIOTECH, V186, P476, DOI 10.1007/s12010-018-2755-x; Francis MI, 2010, EUR J PLANT PATHOL, V127, P571, DOI 10.1007/s10658-010-9620-2; GRAHAM JH, 1990, PHYTOPATHOLOGY, V80, P190, DOI 10.1094/Phyto-80-190; GRAHAM JH, 1990, PLANT DIS, V74, P753, DOI 10.1094/PD-74-0753; Hardoim PR, 2015, MICROBIOL MOL BIOL R, V79, P293, DOI 10.1128/MMBR.00050-14; He JJ, 2010, MOLECULES, V15, P1141, DOI 10.3390/molecules15031141; Islam SMA, 2010, CURR MICROBIOL, V61, P346, DOI 10.1007/s00284-010-9618-1; Liu Y, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2571-0; Ludwig-Muller J, 2015, BIOTECHNOL LETT, V37, P1325, DOI 10.1007/s10529-015-1814-4; [马勉娣 Ma Miandi], 2014, [中国农学通报, Chinese Agricultural Science Bulletin], V30, P118; Martin R. C., 2015, American Journal of Plant Sciences, V6, P3216, DOI 10.4236/ajps.2015.619313; Martini M, 2009, PLANT DIS, V93, P993, DOI 10.1094/PDIS-93-10-0993; Masa A, 2007, J CHROMATOGR A, V1164, P291, DOI 10.1016/j.chroma.2007.06.058; Meinert LD, 2006, GEOSCI CAN, V34, P77; Moragrega C, 2003, EUR J PLANT PATHOL, V109, P319, DOI 10.1023/A:1023574219069; Nisa H, 2015, MICROB PATHOGENESIS, V82, P50, DOI 10.1016/j.micpath.2015.04.001; Novak I, 2008, ANAL CHIM ACTA, V630, P107, DOI 10.1016/j.aca.2008.10.002; Oono R, 2015, FUNGAL BIOL-UK, V119, P917, DOI 10.1016/j.funbio.2015.07.003; Owen Noel L., 2004, Science Progress, V87, P79, DOI 10.3184/003685004783238553; Pacifico D, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01256; Pancher M, 2012, APPL ENVIRON MICROB, V78, P4308, DOI 10.1128/AEM.07655-11; Pomar F, 2005, J CHROMATOGR A, V1094, P34, DOI 10.1016/j.chroma.2005.07.096; Ramirez-Lopez LM, 2014, FOOD CHEM, V149, P15, DOI 10.1016/j.foodchem.2013.10.078; Rasche F, 2006, FEMS MICROBIOL ECOL, V56, P219, DOI 10.1111/j.1574-6941.2005.00027.x; Varanda CMR, 2016, FUNGAL BIOL-UK, V120, P1525, DOI 10.1016/j.funbio.2016.08.002; Ribeiro LF, 2015, J CHROMATOGR B, V1007, P72, DOI 10.1016/j.jchromb.2015.11.005; Saona NM, 2010, J ECOL, V98, P470, DOI 10.1111/j.1365-2745.2009.01613.x; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Strobel G, 2004, J NAT PROD, V67, P257, DOI 10.1021/np030397v; Yang MZ, 2018, J PLANT BIOL, V61, P210, DOI 10.1007/s12374-017-0413-4; Yousaf S, 2010, J HAZARD MATER, V184, P523, DOI 10.1016/j.jhazmat.2010.08.067; Yu M, 2020, PLANT PHYSIOL BIOCH, V149, P144, DOI 10.1016/j.plaphy.2020.02.006; Zhao J, 2011, MINI-REV MED CHEM, V11, P159, DOI 10.2174/138955711794519492; Zhao J, 2010, CURRENT RES TECHNOLO, P567, DOI DOI 10.1016/J.PHYTOCHEM.2012.07.021	46	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238734	10.1371/journal.pone.0238734	http://dx.doi.org/10.1371/journal.pone.0238734			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915849	Green Published, gold			2022-12-26	WOS:000571887500050
J	Zhao, JW; Zou, W; Hu, TX				Zhao, Jianwen; Zou, Wen; Hu, Tingxi			Novel genes associated with folic acid-mediated metabolism in mouse: A bioinformatics study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; PLASMA HOMOCYSTEINE; COGNITIVE DECLINE; FOLATE; VITAMIN-B-12; APOPTOSIS; RISK; PROGRESSION; DEMENTIA; RECEPTOR	Folic acid plays an essential role in the central nervous system and cancer. This study aimed to screen genes related to folic acid metabolism. Datasets (GSE80587, GSE65267 and GSE116299) correlated to folic acid were screened in the Gene Expression Omnibus. Weighed gene co-expression network analysis was performed to identify modules associated with sample traits of folic acid and organs (brain, prostate and kidney). Functional enrichment analysis was performed for the eigengenes in modules that were significantly correlated with sample traits. Accordingly, the hub genes and key nodes in the modules were identified using the protein interaction network. A total of 17,252 genes in three datasets were identified. One module, which included 97 genes that were highly correlated with sample traits (including folic acid treatment [cor = -0.57, P = 3e-04] and kidney [cor = -0.68, p = 4e-06]), was screened out. Hub genes, including tetratricopeptide repeat protein 38 (Ttc38) and miR-185, as well as those (including Sema3A, Insl3, Dll1, Msh4 and Snai1) associated with "neuropilin binding", "regulation of reproductive process" and "vitamin D metabolic process", were identified. Genes, including Ttc38, Sema3A, Insl3, Dll1, Msh4 and Snai1, were the novel factors that may be associated with the development of the kidneys and related to folic acid treatment.	[Zhao, Jianwen; Hu, Tingxi] Shenyang Med Coll, Shenyang, Liaoning, Peoples R China; [Zou, Wen] Liaoning Vocat Coll Ecol Engn, Shenyang, Liaoning, Peoples R China	Shenyang Medical College	Hu, TX (corresponding author), Shenyang Med Coll, Shenyang, Liaoning, Peoples R China.	htx19871005@126.com			Shenyang Medical College Doctoral Research Startup Fund [20195068]; Plan of Rejuvenating the Talents of Liaoning [XLYC1808012]	Shenyang Medical College Doctoral Research Startup Fund; Plan of Rejuvenating the Talents of Liaoning	This research was funded by the Shenyang Medical College Doctoral Research Startup Fund (No. 20195068), and the Plan of Rejuvenating the Talents of Liaoning (No. XLYC1808012).	Agnew-Blais JC, 2015, J ACAD NUTR DIET, V115, P231, DOI 10.1016/j.jand.2014.07.006; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2017, J PEDIAT REHAB MED, V10, ps1; [Anonymous], 2017, KIDNEY INT S, V7, p[1, 1], DOI DOI 10.1016/j.kisu.2017.04.001; Burr NE, 2017, J CLIN GASTROENTEROL, V51, P247, DOI 10.1097/MCG.0000000000000498; Chen HF, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/6439864; Chen YL, 2017, MICROVASC RES, V114, P34, DOI 10.1016/j.mvr.2017.05.010; Cianciolo G, 2008, AM J NEPHROL, V28, P941, DOI 10.1159/000142363; Cianciolo G, 2017, CARDIORENAL MED, V7, P255, DOI 10.1159/000471813; Cohen E, 2019, J NEPHROL, V32, P783, DOI 10.1007/s40620-019-00618-x; Coleman DN, 2019, J DAIRY SCI, V102, P8305, DOI 10.3168/jds.2018-16204; Craciun FL, 2016, J AM SOC NEPHROL, V27, P1702, DOI 10.1681/ASN.2015020225; Cui SS, 2018, MOL CELL BIOCHEM, V444, P77, DOI 10.1007/s11010-017-3232-5; Fleming A, 1998, SCIENCE, V280, P2107, DOI 10.1126/science.280.5372.2107; Haghverdi L, 2018, NAT BIOTECHNOL, V36, P421, DOI 10.1038/nbt.4091; Horvat P, 2016, EXP GERONTOL, V76, P33, DOI 10.1016/j.exger.2016.01.011; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Larriba MJ, 2009, CARCINOGENESIS, V30, P1459, DOI 10.1093/carcin/bgp140; Joseph DB, 2019, PROSTATE, V79, P183, DOI 10.1002/pros.23723; Kagale S, 2016, PLANT J, V88, P879, DOI 10.1111/tpj.13302; Kaittanis C, 2018, J EXP MED, V215, P159, DOI 10.1084/jem.20171052; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lereim Ragnhild Reehorst, 2016, J Proteomics Bioinform, V9, P209; Li JQ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18705-z; Li X, 2017, BIOMARKERS TUMOR MIC, P329; Liao E, 2012, CHALLENGES HIGH THRO; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu SM, 2017, APOPTOSIS, V22, P672, DOI 10.1007/s10495-017-1360-8; Luo H, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.2007050; Matsumoto K, 2020, TREATMENT FOLIC ACID; Mehta V, 2018, ARTERIOSCL THROM VAS, V38, P1845, DOI 10.1161/ATVBAHA.118.311118; Mikkelsen K, 2016, MATURITAS, V93, P108, DOI 10.1016/j.maturitas.2016.08.001; Murphy ME, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010247; Oulhaj A, 2010, INT J GERIATR PSYCH, V25, P82, DOI 10.1002/gps.2303; Park S-K, 2016, KOREAN J FAMILY PRAC, V6, P404; Price AJ, 2016, EUR UROL, V70, P941, DOI 10.1016/j.eururo.2016.03.029; Qin XH, 2011, CLIN J AM SOC NEPHRO, V6, P482, DOI 10.2215/CJN.05310610; Remington R, 2016, J ALZHEIMERS DIS, V51, P991, DOI 10.3233/JAD-151098; Samblas M., 2018, MEDIATORS INFLAMM, V2018, P1, DOI [10.1155/2018/1312626, DOI 10.1155/2018/1312626]; Sano N, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00123; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soohoo M, 2017, NEPHROL DIAL TRANSPL, V32, P1024, DOI 10.1093/ndt/gfw090; The Lancet HIV, 2017, LANCET HIV, V4, pe51; Tinelli C, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00049; Torres-Salido MT, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184601; Xu X, 2016, JAMA INTERN MED, V176, P1443, DOI 10.1001/jamainternmed.2016.4687; Yang ZG, 2019, ANAT REC, V302, P1127, DOI 10.1002/ar.24016; Zhang S, 2018, ONCOTARGETS THER, V11, P7967, DOI 10.2147/OTT.S167771; Zhou YR, 2016, GENE EXPR PATTERNS, V22, P37, DOI 10.1016/j.gep.2016.11.001	54	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238940	10.1371/journal.pone.0238940	http://dx.doi.org/10.1371/journal.pone.0238940			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915913	gold, Green Published			2022-12-26	WOS:000571887500142
J	Banerjee, M; Middya, S; Shrivastava, R; Basu, S; Ghosh, R; Pryde, DC; Yadav, DB; Surya, A				Banerjee, Monali; Middya, Sandip; Shrivastava, Ritesh; Basu, Sourav; Ghosh, Rajib; Pryde, David C.; Yadav, Dharmendra B.; Surya, Arjun			G10 is a direct activator of human STING	PLOS ONE			English	Article							CYCLIC GMP-AMP; CANCER; SENSOR	The cGAS/STING pathway initiates an innate immune response when DNA is detected in the cytosol. DNA bound cGAS synthesizes cyclic dinucleotides which bind and activate the adaptor STING, leading to downstream secretion of Type I interferons and other pro-inflammatory NF kappa B pathway cytokines. In the mouse, the STING driven innate immune response is central to immune based clearance of various tumors and this has triggered a significant effort focused on the discovery of human STING agonists for the treatment of cancer. This report uses an in vitro kinase assay to show that G10, a previously identified STING pathway activator is actually a weak but direct STING agonist and identifies other more potent leads.	[Banerjee, Monali; Middya, Sandip; Shrivastava, Ritesh; Basu, Sourav; Ghosh, Rajib; Yadav, Dharmendra B.; Surya, Arjun] Curadev Pharma Pvt Ltd, Noida, Uttar Pradesh, India; [Pryde, David C.] Curadev Pharma Ltd, Sandwich, Kent, England		Surya, A (corresponding author), Curadev Pharma Pvt Ltd, Noida, Uttar Pradesh, India.	arjun@curadev.in			Curadev Pharma	Curadev Pharma(Dexcel Pharma)	All authors are employees of Curadev Pharma and the studies reported in this manuscript were fully funded by Curadev Pharma. The funder provided support in the form of salaries for all authors and infrastructure for research. The specific roles of the authors are articulated in the `author contributions' section. The funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	[Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; Burdette Dara L, 2013, Nat Immunol, V14, P19, DOI 10.1038/ni.2491; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Ciulli Alessio, 2013, Methods Mol Biol, V1008, P357, DOI 10.1007/978-1-62703-398-5_13; Conlon J, 2013, J IMMUNOL, V190, P5216, DOI 10.4049/jimmunol.1300097; Corrales L, 2016, J CLIN INVEST, V126, P2404, DOI 10.1172/JCI86892; Corrales L, 2015, CELL REP, V11, P1018, DOI 10.1016/j.celrep.2015.04.031; Cross R., 2018, CHEM ENG NEWS; Fang R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006720; Fu J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4306; Gao P, 2014, CELL REP, V8, P1668, DOI 10.1016/j.celrep.2014.08.010; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Harrington KJ, 2018, EUR SOC MED ONC C MU; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Konno H, 2018, ONCOGENE, V37, P2037, DOI 10.1038/s41388-017-0120-0; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Mukai K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11932; Ramanjulu JM, 2018, NATURE, V564, P439, DOI 10.1038/s41586-018-0705-y; Sali TM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005324; Shang GJ, 2019, NATURE, V567, P389, DOI 10.1038/s41586-019-0998-5; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Trujillo JA, 2018, CANCER IMMUNOL RES, V6, P990, DOI 10.1158/2326-6066.CIR-18-0277; Xia TL, 2016, CANCER RES, V76, P6747, DOI 10.1158/0008-5472.CAN-16-1404; Xia TL, 2016, CELL REP, V14, P282, DOI 10.1016/j.celrep.2015.12.029; Yi GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077846; Zhang CG, 2019, NATURE, V567, P394, DOI 10.1038/s41586-019-1000-2; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022	31	11	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0237743	10.1371/journal.pone.0237743	http://dx.doi.org/10.1371/journal.pone.0237743			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911484	Green Published, gold			2022-12-26	WOS:000571885900008
J	Ji, NJ; Hong, YP				Ji, Nam-Ju; Hong, Yeon-Pyo			Effect of income level on adherence to antidepressant treatment in first onset depression outpatients	PLOS ONE			English	Article							EPIDEMIOLOGY; DISORDER	Clinical guidelines for depression management recommend continuous antidepressant medication; however, poor adherence to medication is commonly seen in the treatment of depression. Income is an important factor influencing antidepressant medication adherence. The purpose of this study was to investigate the relationship between income level and adherence to antidepressant medication in outpatients with depression. This was a retrospective cohort study using National Health Insurance claim data for services provided between January 1 and December 31, 2012. We examined data from a total of 142,336 individuals aged 18 years or older who were continuously enrolled in treatment after a new episode of major depression and who had initiated antidepressant treatment. The operational definition of adherence to antidepressant treatment was medication being dispensed to the patient at least 80% of the time during 3 and 6 months (ie. MPR >= 80%). To investigate the relationship between income level and adherence to antidepressants, we estimated adjusted odds ratios and 95% confidence intervals using hierarchical logistic regression analysis, adjusting for sociodemographic, clinical, and medical use characteristics. A total of 22.64% and 15.13% of depression patients showed adherence to antidepressants during 3 and 6 months, respectively. A statistically significant association was found between income level and adherence to antidepressants over 3 and 6 months for individuals with employee and self-employed subscribers. In addition, adherence to antidepressants was lower among those with a lower income than those with a higher income. We confirmed that social disparities exist in adherence to antidepressant treatment by income level in this Korean population-based retrospective cohort of depression outpatients.	[Ji, Nam-Ju; Hong, Yeon-Pyo] Chung Ang Univ, Dept Prevent Med, Coll Med, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital	Hong, YP (corresponding author), Chung Ang Univ, Dept Prevent Med, Coll Med, Seoul, South Korea.	hyp026@cau.ac.kr						Accensi F, 2004, FOOD MICROBIOL, V21, P623, DOI 10.1016/j.fm.2003.12.003; Aislinne F, 2016, BMC PUBLIC HEALTH, V16, P1098; Alexopoulos GS, 2009, AM J PSYCHIAT, V166, P882, DOI 10.1176/appi.ajp.2009.08121779; [Anonymous], 2013, AM J PSYCHIAT; Aurelie B, 2014, PSYCHIAT SERV, V65, P681; Aurelie B, 2013, ANN EPIDEMIOL, V23, P99; Christopher B, 2012, BRIT J GEN PRACT, V62, P104; Diane W, 2009, DEPRESS ANXIETY, V26, P622; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; Iezzoni LI, 2003, RISK ADJUSTMENT MEAS; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Lawrenson RA, 2000, J AFFECT DISORDERS, V59, P149, DOI 10.1016/S0165-0327(99)00147-0; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Mika K, 2007, PSYCHOL MED, V37, P373; Norifusa S, 2009, BMC PSYCHIAT, P9; OECD, 2004, PROJ INC DISTR POV; Olfson M, 2006, AM J PSYCHIAT, V163, P101, DOI 10.1176/appi.ajp.163.1.101; Robert L, 2014, BMJ; SJEmj G-S, 2007, ANTIMICROBIAL RESIST, V45, P363; Tournier M, 2010, EUROPE PMC, V37, P36	20	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238623	10.1371/journal.pone.0238623	http://dx.doi.org/10.1371/journal.pone.0238623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911498	gold, Green Published			2022-12-26	WOS:000571885900053
J	Bradford, BR; Whidden, E; Gervasio, ED; Checchi, PM; Raley-Susman, KM				Bradford, Beatrix R.; Whidden, Elizabeth; Gervasio, Esabelle D.; Checchi, Paula M.; Raley-Susman, Kathleen M.			Neonicotinoid-containing insecticide disruption of growth, locomotion, and fertility in Caenorhabditis elegans	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR; OXIDATIVE STRESS; NERVOUS-SYSTEM; EXPOSURE; APOPTOSIS	Neonicotinoids, a class of insecticides structurally similar to nicotine that target biting and sucking insects, are the most widely used insecticides today, in part due to their supposed low toxicity in other organisms. However, a growing body of research has found that even low doses of neonicotinoids can induce unexpected negative effects on the physiology and survival of a wide range of non-target organisms. Importantly, no work has been done on the commercial formulations of pesticides that include imidacloprid as the active ingredient, but that also contain many other components. The present study examines the sublethal effects of "Tree and Shrub"(TM) ("T+S"), a commercial insecticide containing the neonicotinoid imidacloprid as its active ingredient, onCaenorhabditis elegans. We discovered that "T+S" significantly stunted the overall growth in wildtype nematodes, an effect that was exacerbated by concurrent exposure to heat stress. "T+S" also negatively impacted fecundity as measured by increased germline apoptosis, a decrease in egg-laying, and fewer viable offspring. Lastly, exposure to "T+S" resulted in degenerative changes in nicotinic cholinergic neurons in wildtype nematodes. As a whole, these findings demonstrate widespread toxic effects of neonicotinoids to critical functions in nematodes.	[Bradford, Beatrix R.; Gervasio, Esabelle D.; Checchi, Paula M.] Marist Coll, Dept Biol, Poughkeepsie, NY USA; [Whidden, Elizabeth; Raley-Susman, Kathleen M.] Vassar Coll, Dept Biol, Poughkeepsie, NY 12601 USA	Marist College; Vassar College	Raley-Susman, KM (corresponding author), Vassar Coll, Dept Biol, Poughkeepsie, NY 12601 USA.	kasusman@vassar.edu			Ecological Research Institute at Vassar College; Marist College School of Science; NIH [1R15GM117479-01]; NIH Office of Research Infrastructure Programs [P40 OD010440]	Ecological Research Institute at Vassar College; Marist College School of Science; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Ecological Research Institute at Vassar College (K. M.R-S) and by Marist College School of Science (P.M.C.). P.M.C. is also supported by NIH gran 1R15GM117479-01. Some strains were provided by the CGC, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440).	Aills L, 2008, SURG OBES RELAT DI S, V4, pS73; Allard P, 2010, P NATL ACAD SCI USA, V107, P20405, DOI 10.1073/pnas.1010386107; [Anonymous], 2005, ANN REV PHARM TOXICO, V45, P247; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; Brody AH, 2013, NEUROTOXICOLOGY, V34, P74, DOI 10.1016/j.neuro.2012.10.007; Caswell-Chen E P, 2005, Sci Aging Knowledge Environ, V2005, ppe30, DOI 10.1126/sageke.2005.40.pe30; Catae AF, 2018, ECOTOXICOLOGY, V27, P109, DOI 10.1007/s10646-017-1874-4; Chen P, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00018; Corsi AK, 2015, GENETICS, V200, P387, DOI 10.1534/genetics.115.176099; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Du H, 2015, TOXICOL SCI, V145, P118, DOI 10.1093/toxsci/kfv035; Duzguner V, 2012, PESTIC BIOCHEM PHYS, V104, P58, DOI 10.1016/j.pestbp.2012.06.011; Gallo A, 2020, ENVIRON INT, V138, DOI 10.1016/j.envint.2020.105627; Gartner Anton, 2008, WormBook, P1, DOI 10.1895/wormbook.1.145.1; Ge WL, 2015, J AGR FOOD CHEM, V63, P1856, DOI 10.1021/jf504895h; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Gu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070112; Harlow PH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22965; Hart A., 2006, WORMBOOK, DOI [10.1895/wormbook.1.87.1, DOI 10.1895/WORMBOOK.1.87.1, 10.1895/wormbook.1.87.1.]; Hopewell H, 2017, ECOTOXICOLOGY, V26, P981, DOI 10.1007/s10646-017-1826-z; Hunt PA, 2003, CURR BIOL, V13, P546, DOI 10.1016/S0960-9822(03)00189-1; Jaramillo-Lambert A, 2010, CURR BIOL, V20, P2078, DOI 10.1016/j.cub.2010.10.008; Lodovici M, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/487074; Matsuda K, 2005, BIOSCI BIOTECH BIOCH, V69, P1442, DOI 10.1271/bbb.69.1442; Millot F, 2017, ENVIRON SCI POLLUT R, V24, P5469, DOI 10.1007/s11356-016-8272-y; Parodi DA, 2015, JOVE-J VIS EXP, DOI 10.3791/52445; Petrash HA, 2013, J NEUROSCI, V33, P5524, DOI 10.1523/JNEUROSCI.4384-12.2013; Pianka, 2000, EVOLUTIONARY ECOLOGY, P512; Raley-Susman K, 2014, PESTICIDES TOXIC ASP; Rami A, 2003, NEUROBIOL DIS, V13, P75, DOI 10.1016/S0969-9961(03)00018-4; Rand J, 2007, ACETYLCHOLINE; Rico A, 2018, AQUAT TOXICOL, V204, P130, DOI 10.1016/j.aquatox.2018.09.004; Rogers KH, 2019, ENVIRON TOXICOL CHEM, V38, P1724, DOI 10.1002/etc.4473; Scanlan LD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19187-3; Shin N, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007975; Simon-Delso N, 2015, ENVIRON SCI POLLUT R, V22, P5, DOI 10.1007/s11356-014-3470-y; Singh PP, 2019, CELL, V177, P200, DOI 10.1016/j.cell.2019.02.038; Smith MA, 2013, REPROD TOXICOL, V40, P69, DOI 10.1016/j.reprotox.2013.05.007; Stiernagle Theresa, 2006, WormBook, P1; Toney GM, 2010, J PHYSIOL-LONDON, V588, P3347, DOI 10.1113/jphysiol.2010.197251; TRENT C, 1983, GENETICS, V104, P619; Turcotte CA, 2018, GENETICS, V208, P991, DOI 10.1534/genetics.118.300686; Vinuela A. L. B., 2010, PLOS ONE, V5, P8; WALTHALL WW, 1993, J NEUROBIOL, V24, P1589, DOI 10.1002/neu.480241204; Wei YC, 2015, HUM REPROD UPDATE, V21, P194, DOI 10.1093/humupd/dmu061; WHITE JG, 1978, NATURE, V271, P764, DOI 10.1038/271764a0; Williams GR, 2015, SCI REP-UK, V5, DOI 10.1038/srep14621; Wu-Smart J, 2016, SCI REP-UK, V6, DOI 10.1038/srep32108; Xiong HJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10454-3; Yang HC, 2019, J MOL MED, V97, P385, DOI 10.1007/s00109-018-01740-2; Yi XH, 2019, ENVIRON POLLUT, V251, P892, DOI 10.1016/j.envpol.2019.05.062; Zhang AG, 2000, J NEUROCHEM, V75, P1294, DOI 10.1046/j.1471-4159.2000.751294.x; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	53	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2020	15	9							e0238637	10.1371/journal.pone.0238637	http://dx.doi.org/10.1371/journal.pone.0238637			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR4MY	32903270	gold, Green Published			2022-12-26	WOS:000571539500004
J	Ghesquiere, L; Deruelle, P; Ramdane, Y; Garabedian, C; Charley-Monaca, C; Dalmas, AF				Ghesquiere, L.; Deruelle, P.; Ramdane, Y.; Garabedian, C.; Charley-Monaca, C.; Dalmas, A-F			Obstructive sleep apnea in obese pregnant women: A prospective study	PLOS ONE			English	Article							MATERNAL OBESITY; RISK-FACTORS; LABOR; PREVALENCE; OUTCOMES	Objective Define the prevalence of OSA in a population of obese pregnant women. Secondary objectives were to assess its obstetric consequences and define its risk factors in this population. Methods This single-center prospective study took place at the Lille University Hospital from 2010 to 2016 and included pregnant women with a body mass index (BMI) > 35 kg/m(2). They underwent polysomnography (type 1 sleep testing) between 24 and 32 weeks of gestation to diagnose OSA. Clinical, obstetric, and fetal data were collected monthly and at delivery. We compared the groups with and without OSA and calculated its prevalence. Results This study included 67 women with a mean BMI of 42.4 +/- 6.2 kg/m(2). Among them, 29 had OSA, for a prevalence of 43.3% (95% confidence interval, 31.4-55.2); it was mild or moderate in 25 women and severe in 4. Comparison of the two groups showed that women in the OSA group were older (31.9 +/- 4.7 years vs 29.5 +/- 4.8 years,P= .045), had chronic hypertension more frequently (37.9% vs 7.9%,P= .0027), and had a higher mean BMI (43.8 +/- 6.2 kg/m(2)vs 41.2 +/- 6 kg/m(2),P= .045). During pregnancy, they developed gestational diabetes more often (48.3% vs 23.7%,P= .04). No significant differences were observed for any of the other criteria studied. Conclusions The prevalence of OSA was high in our study, and women with it developed gestational diabetes during pregnancy more often. No other obstetric complications were observed.	[Ghesquiere, L.; Deruelle, P.; Garabedian, C.] Univ Lille, EA Perinatal Environm & Hlth 4489, Lille, France; [Ghesquiere, L.; Deruelle, P.; Garabedian, C.] CHU Lille, Dept Obstet, Lille, France; [Ramdane, Y.] Univ Lille, Dept Biostat, CHU Lille, EA Publ Hlth Epidemiol & Qual Care 2694, Lille, France; [Charley-Monaca, C.] Univ Lille, Dept Clin Neurophysiol, CHU Lille, Sleep Disorders Unit, Lille, France; [Dalmas, A-F] Univ Lille, Dept Anesthesia Intens Care, Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Ghesquiere, L (corresponding author), Univ Lille, EA Perinatal Environm & Hlth 4489, Lille, France.; Ghesquiere, L (corresponding author), CHU Lille, Dept Obstet, Lille, France.	louise.ghesquiere88@gmail.com		Garabedian, Charles/0000-0003-2105-9784; ghesquiere, louise/0000-0003-4142-5526				[Anonymous], 2015, HTA GROSS; Arrowsmith S, 2011, BJOG-INT J OBSTET GY, V118, P578, DOI 10.1111/j.1471-0528.2010.02889.x; Bourjeily G, 2010, EUR RESPIR J, V36, P849, DOI 10.1183/09031936.00021810; Brown NT, 2018, AM J OBSTET GYNECOL; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Chen YH, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.09.006; Denison FC, 2008, BJOG-INT J OBSTET GY, V115, P720, DOI 10.1111/j.1471-0528.2008.01694.x; Deruelle P, 2011, GYNECOL OBSTET FERTI, V39, P100, DOI 10.1016/j.gyobfe.2010.12.001; Facco FL, 2014, AM J PERINAT, V31, P899, DOI 10.1055/s-0033-1363768; Frey H, 2013, AM J OBSTET GYNECOL, V208, pS140, DOI 10.1016/j.ajog.2012.10.478; Lim DC, 2017, ANNU REV MED, V68, P99, DOI 10.1146/annurev-med-042915-102623; Louis J, 2012, OBSTET GYNECOL, V120, P1085, DOI 10.1097/AOG.0b013e31826eb9d8; Louis JM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.867; Morong S, 2014, SLEEP BREATH, V18, P31, DOI 10.1007/s11325-013-0849-9; Ovesen P, 2011, OBSTET GYNECOL, V118, P305, DOI 10.1097/AOG.0b013e3182245d49; Pamidi S, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.07.033; Park JG, 2011, MAYO CLIN PROC, V86, P549, DOI 10.4065/mcp.2010.0810; Pepin JL, 2002, REV MAL RESPIR, V19, P685; Pevzner L, 2009, OBSTET GYNECOL, V114, P1315, DOI 10.1097/AOG.0b013e3181bfb39f; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; Rice JR, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0633-x; Sachs L, 2012, APPL STAT HDB TECHNI; Senaratna CV, 2017, SLEEP MED REV, V34, P70, DOI 10.1016/j.smrv.2016.07.002; Sharma SK, 2010, SLEEP MED, V11, P562, DOI 10.1016/j.sleep.2010.02.008; Societe Francaise d'Anesthesie et de Reanimation, 2015, PRIS CHARG MULT FORM; Tufik S, 2010, SLEEP MED, V11, P441, DOI 10.1016/j.sleep.2009.10.005; Venkata C, 2009, J AM BOARD FAM MED, V22, P158, DOI 10.3122/jabfm.2009.02.080057; Yaggi HK, 2010, CLIN CHEST MED, V31, P179, DOI 10.1016/j.ccm.2010.02.011; Young T, 2004, JAMA-J AM MED ASSOC, V291, P2013, DOI 10.1001/jama.291.16.2013; Zhang J, 2007, BJOG-INT J OBSTET GY, V114, P343, DOI 10.1111/j.1471-0528.2006.01233.x	30	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238733	10.1371/journal.pone.0238733	http://dx.doi.org/10.1371/journal.pone.0238733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ6EE	32898189	Green Published, gold			2022-12-26	WOS:000570962500014
J	Hori, D; Sasahara, S; Doki, S; Oi, Y; Matsuzaki, I				Hori, Daisuke; Sasahara, Shinichiro; Doki, Shotaro; Oi, Yuichi; Matsuzaki, Ichiyo			Prefrontal activation while listening to a letter of gratitude read aloud by a coworker face-to-face: A NIRS study	PLOS ONE			English	Article							REDUCED FRONTOPOLAR ACTIVATION; VERBAL FLUENCY TASK; CORTEX; DEPRESSION; EMOTIONS; WEATHER; THINGS	Near-infrared spectroscopy (NIRS) is a non-invasive functional brain imaging technique. NIRS is suitable for monitoring brain activation during social interactions. One of the omnipresent social interactions for employees is saying thank you and being thanked. It has been demonstrated that expressing and receiving gratitude leads to employees' well-being and performance. To date, there have been no neuroimaging studies that monitor brain activity when receiving gratitude. Thus, we designed an experiment using NIRS to monitor brain function while listening to a letter of gratitude read by a coworker. We hypothesized that listening to a letter of gratitude read aloud by a co-worker in a face-to-face setting would have different effects on PFC activity than listening to a conversation about a neutral topic. We recruited 10 pairs of healthy right-handed employees. They were asked to write a letter of gratitude to their partner 1 week before the experiment. In the experiment, each pair sat face-to-face and read their letters aloud to each other. We evaluated changes in mood state before and after the experiment. NIRS was measured in each participant while they listened to their peers in the experimental condition (gratitude letter) and control condition (talking about the weather and date). The results suggested that negative mood state decreased after the experiment. Moreover, there were interaction effects between conditions and periods. Although further studies are needed to confirm the interpretation, our findings suggested that experience of being thanked was accompanied by prefrontal cortex activation.	[Hori, Daisuke; Sasahara, Shinichiro; Doki, Shotaro; Oi, Yuichi; Matsuzaki, Ichiyo] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan; [Matsuzaki, Ichiyo] Univ Tsukuba, Int Inst Integrat Sleep Med, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba	Hori, D (corresponding author), Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan.	daisuke_hori@md.tsukuba.ac.jp	Doki, Shotaro/AHA-5319-2022	Hori, Daisuke/0000-0001-5832-9923	JSPS KAKENHI [JP18H06340]; Japan Society for the Promotion of Science	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	DH received JSPS KAKENHI Grant Number JP18H06340 Grant-in-Aid for Research Activity Start-up. The funder's name was Japan Society for the Promotion of Science (URL: https://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algoe SB, 2010, PERS RELATIONSHIP, V17, P217, DOI 10.1111/j.1475-6811.2010.01273.x; Algoe SB, 2009, J POSIT PSYCHOL, V4, P105, DOI 10.1080/17439760802650519; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; [Anonymous], 2018, CANC DISCOV, V8, pOF6; Bartlett MY, 2006, PSYCHOL SCI, V17, P319, DOI 10.1111/j.1467-9280.2006.01705.x; Bendall RCA, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum2016.00529; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Chiarelli AM, 2017, NEUROPHOTONICS, V4, DOI [10.1117/1.NPh.4.4.041411, 10.1117/1.NPh.4.4.041411]]; Chul J, 2009, NEUROIMAGE, V44, P428, DOI 10.1016/j.neuroimage.2008.08.036; Coupland N., 2000, SMALL TALK, P163; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Davidson RJ, 2004, BIOL PSYCHOL, V67, P219, DOI 10.1016/j.biopsycho.2004.03.008; Davis DE, 2016, J COUNS PSYCHOL, V63, P20, DOI 10.1037/cou0000107; Denissen JJA, 2008, EMOTION, V8, P662, DOI 10.1037/a0013497; Doi H, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00770; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Froh JJ, 2008, J SCHOOL PSYCHOL, V46, P213, DOI 10.1016/j.jsp.2007.03.005; Gvirts HZ, 2020, NEUROSCIENTIST, V26, P108, DOI 10.1177/1073858419861912; Herrmann MJ, 2003, BIOL PSYCHOL, V64, P255, DOI 10.1016/S0301-0511(03)00095-4; Heuchert J. P., 2015, POMS 2 JAPANESE MANU; Heuchert JP., 2012, POMS 2 PROFILE MOOD; Hoshi Y, 2011, J NEUROIMAGING, V21, pe94, DOI 10.1111/j.1552-6569.2009.00454.x; Kaplan S, 2014, J BUS PSYCHOL, V29, P367, DOI 10.1007/s10869-013-9319-4; Koots L, 2011, J INDIVID DIFFER, V32, P74, DOI 10.1027/1614-0001/a000037; Kong F, 2015, J HAPPINESS STUD, V16, P477, DOI 10.1007/s10902-014-9519-2; Lanham M., 2012, J MENTAL HEALTH COUN, V34, P341, DOI [10.17744/mehc.34.4.w35q80w11kgpqn26, DOI 10.17744/MEHC.34.4.W35Q80W11KGPQN26]; Lawler EJ, 2001, AM J SOCIOL, V107, P321, DOI 10.1086/324071; Lin CC, 2015, SOC BEHAV PERSONAL, V43, P493, DOI 10.2224/sbp.2015.43.3.493; Matsukawa K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32752-0; Matsukawa K, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13488; McCullough ME, 2004, J PERS SOC PSYCHOL, V86, P295, DOI 10.1037/0022-3514.86.2.295; McCullough ME, 2002, J PERS SOC PSYCHOL, V82, P112, DOI 10.1037//0022-3514.82.1.112; McGonigal K, 2016, LESSONS ACHIEVE GREA; Naito T, 2015, INT J BEHAV SCI, V10, P1; Pu SH, 2008, PSYCHIAT CLIN NEUROS, V62, P728, DOI 10.1111/j.1440-1819.2008.01882.x; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Schroeter ML, 2003, NEUROIMAGE, V19, P555, DOI 10.1016/S1053-8119(03)00155-1; Stegen A, 2018, J NURS EDUC, V57, P375, DOI 10.3928/01484834-20180522-10; Suda M, 2010, NEUROPSYCHOLOGIA, V48, P441, DOI 10.1016/j.neuropsychologia.2009.09.036; Takei Y, 2014, J PSYCHIATR RES, V57, P74, DOI 10.1016/j.jpsychires.2014.06.009; Takizawa R, 2008, SCHIZOPHR RES, V99, P250, DOI 10.1016/j.schres.2007.10.025; Toepfer SM, 2012, J HAPPINESS STUD, V13, P187, DOI 10.1007/s10902-011-9257-7; Tsang JA, 2014, PERS INDIV DIFFER, V64, P62, DOI 10.1016/j.paid.2014.02.009; Urakawa S, 2015, BRAIN TOPOGR, V28, P691, DOI 10.1007/s10548-014-0414-2; Waters L., 2012, PSYCHOLOGY, V3, P1174, DOI [DOI 10.4236/PSYCH.2012.312A173, https://doi.org/10.4236/psych.2012.312A173]; Watkins PC, 2003, SOC BEHAV PERSONAL, V31, P431, DOI 10.2224/sbp.2003.31.5.431; Wood AM, 2008, J RES PERS, V42, P854, DOI 10.1016/j.jrp.2007.11.003; Wood AM, 2010, CLIN PSYCHOL REV, V30, P890, DOI 10.1016/j.cpr.2010.03.005; Wood AM, 2009, PERS INDIV DIFFER, V46, P443, DOI 10.1016/j.paid.2008.11.012	49	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238715	10.1371/journal.pone.0238715	http://dx.doi.org/10.1371/journal.pone.0238715			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ6EE	32898150	Green Published, gold			2022-12-26	WOS:000570962500009
J	Kanchanachitra, M; Chamchan, C; Kanchanachitra, C; Suttikasem, K; Gunn, L; Vlaev, I				Kanchanachitra, Manasigan; Chamchan, Chalermpol; Kanchanachitra, Churnrurtai; Suttikasem, Kanyapat; Gunn, Laura; Vlaev, Ivo			Nudge interventions to reduce fish sauce consumption in Thailand	PLOS ONE			English	Article							FOOD; CHOICES; BEHAVIOR; CALORIE	High sodium consumption is one of the four major risk factors contributing to non-communicable diseases around the world. Thailand has one of the highest rates of sodium consumption, with fish sauce being one of the main sources. The aim of this study was to examine whether changes in the micro-environment factors can affect fish sauce consumption behavior in a university setting in Thailand. We implemented four interventions (with one control) in five canteens across a Thai university. The study design was a Latin square, where the five canteens were randomized over five weeks to implement four interventions plus a control. Our interventions included behavior-oriented, cognitive-oriented, and affective-oriented nudges aimed to reduce the amount of fish sauce people add to their noodles during lunchtime at the university canteens. Results indicate that a simple change in how fish sauce was served can reduce fish sauce consumption. Serving fish sauce in a bowl with a spoon reduced the amount of fish sauce used per noodle bowl by 0.25 grams, compared to the normal condition where fish sauce is served in a bottle. Using a specially-designed spoon with a hole induced a larger reduction of 0.58 grams of fish sauce used per bowl. The other two interventions, cognitive- and affective- oriented nudges, also showed reductions of fish sauce usage, but the differences were not statistically significant. The findings can be used for policy implementation to advocate the use of a smaller sized spoon and a bowl to serve fish sauce instead of a bottle to reduce sodium consumption among Thai people.	[Kanchanachitra, Manasigan; Chamchan, Chalermpol; Kanchanachitra, Churnrurtai; Suttikasem, Kanyapat] Mahidol Univ, Inst Populat & Social Res, Nakhon Pathom, Thailand; [Gunn, Laura] Univ N Carolina, Coll Hlth & Human Serv, Dept Publ Hlth Sci, Charlotte, NC USA; [Gunn, Laura] Imperial Coll London, Sch Publ Hlth, London, England; [Vlaev, Ivo] Univ Warwick, Warwick Business Sch, Coventry, W Midlands, England	Mahidol University; University of North Carolina; University of North Carolina Charlotte; Imperial College London; University of Warwick	Kanchanachitra, M (corresponding author), Mahidol Univ, Inst Populat & Social Res, Nakhon Pathom, Thailand.	manasigan.kan@mahidol.edu			International Health Policy Program Foundation [IHPF/62-05/2562]	International Health Policy Program Foundation	MK, CC, CK, KS received funding from International Health Policy Program Foundation Grant number: IHPF/62-05/2562 URL: http://ihppf.ihpp.thaigov.net/The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarra MS., 2015, PREVENTIVE NUTR, P765, DOI [10.1007/978-3-319-22431-2_36, DOI 10.1007/978-3-319-22431-2_36]; [Anonymous], 2017, 2017 FOOD CONS BEH S; [Anonymous], 2009, MONIST, V92, pi; Arno A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3272-x; Bauer JM, 2019, J CONSUM POLICY, V42, P3, DOI 10.1007/s10603-018-9387-y; Bucher T, 2016, BRIT J NUTR, V115, P2252, DOI 10.1017/S0007114516001653; Buckland NJ, 2013, EAT BEHAV, V14, P249, DOI 10.1016/j.eatbeh.2013.03.003; Cadario R, 2020, MARKET SCI, V39, P465, DOI 10.1287/mksc.2018.1128; Cantu-Jungles TM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101088; Coelho JS, 2009, APPETITE, V52, P517, DOI 10.1016/j.appet.2008.10.008; Department of Disease Control MoPH, 2016, STRAT RED SALT SOD C; Diano M, 2017, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.02029; Dolan P, 2012, J ECON PSYCHOL, V33, P264, DOI 10.1016/j.joep.2011.10.009; Dombrowski SU, 2012, HEALTH PSYCHOL REV, V6, P7, DOI 10.1080/17437199.2010.513298; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Forwood SE, 2015, APPETITE, V89, P93, DOI 10.1016/j.appet.2015.01.018; Geier AB, 2006, PSYCHOL SCI, V17, P521, DOI 10.1111/j.1467-9280.2006.01738.x; Leonard TC, 2008, CONST POLITICAL ECON, V19, P356, DOI 10.1007/s10602-008-9056-2; Long MW, 2015, AM J PUBLIC HEALTH, V105, pE11, DOI 10.2105/AJPH.2015.302570; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10; Michie S, 2009, HEALTH PSYCHOL, V28, P690, DOI 10.1037/a0016136; National Health Exam Survey Office, 2011, THAI FOOD CONS SURV; Papies EK, 2010, HEALTH PSYCHOL, V29, P384, DOI 10.1037/a0019877; Powles J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003733; Privitera GJ, 2014, APPETITE, V76, P175, DOI 10.1016/j.appet.2014.02.004; Rozin P, 2011, JUDGM DECIS MAK, V6, P323; Sacco J, 2017, PERSPECT PUBLIC HEAL, V137, P173, DOI 10.1177/1757913916658498; The National Health Assembly, 2015, RES POL RED SALT SOD; The National Health Assembly, 2013, RES FRAM IMPL MON EV; Vasiljevic Milica, 2017, Pilot Feasibility Stud, V3, P27, DOI 10.1186/s40814-017-0141-z; Vlaev I, 2015, J FINANC SERV MARK, V20, P74, DOI 10.1057/fsm.2015.1; WHO, 2012, GUID SOD INT AD CHIL; Wilson AL, 2016, FOOD QUAL PREFER, V51, P47, DOI 10.1016/j.foodqual.2016.02.009; World Health Organization, 2013, GLOB ACT PLAN PREV C	35	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238642	10.1371/journal.pone.0238642	http://dx.doi.org/10.1371/journal.pone.0238642			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ6EE	32898855	gold, Green Published			2022-12-26	WOS:000570962500045
J	He, P; Mann-Collura, O; Fling, J; Edara, N; Hetz, R; Razzaque, MS				He, Ping; Mann-Collura, Olivia; Fling, Jacob; Edara, Naga; Hetz, Rebecca; Razzaque, Mohammed S.			High phosphate actively induces cytotoxicity by rewiring pro-survival and pro-apoptotic signaling networks in HEK293 and HeLa cells	FASEB JOURNAL			English	Article						apoptosis; cytotoxicity; EMT; ER stress; MAPK; phosphate	UNFOLDED PROTEIN RESPONSE; INORGANIC-PHOSPHATE; EXPRESSION; CALCIUM; DIETARY; PATHWAY; DIFFERENTIATION; MOLECULE; MUSCLE; GROWTH	Inorganic phosphate (Pi) is an essential nutrient for human health. Due to the changes in our dietary pattern, dietary Pi overload engenders systemic phosphotoxicity, including excessive Pi-related vascular calcification and chronic tissue injury. The molecular mechanisms of the seemingly distinct phenotypes remain elusive. In this study, we investigated Pi-mediated cellular response in HEK293 and HeLa cells. We found that abnormally high Pi directly mediates diverse cellular toxicity in a dose-dependent manner. Up to 10 mM extracellular Pi promotes cell proliferation by activating AKT signaling cascades and augmenting cell cycle progression. By introducing additional Pi, higher than the concentration of 40 mM, we observed significant cell damage caused by the interwoven Pi-related biological processes. Elevated Pi activates mitogen-activated protein kinase (MAPK) signaling, encompassing extracellular signal-regulated kinase 1/2 (ERK1/2), p38 and Jun amino-terminal kinase (JNK), which consequently potentiates Pi triggered lethal epithelial-mesenchymal transition (EMT). Synergistically, high Pi-caused endoplasmic reticulum (ER) stress also contributes to apparent apoptosis. To counteract, Pi-activated AKT signaling promotes cell survival by activating the mammalian target of rapamycin (mTOR) signaling and blocking ER stress. Pharmacologically or genetically abrogating Pi transport, the impact of high Pi-induced cytotoxicity could be reduced. Taken together, abnormally high extracellular Pi results in a broad spectrum of toxicity by rewiring complicated signaling networks that control cell growth, cell death, and homeostasis.	[He, Ping; Mann-Collura, Olivia; Fling, Jacob; Edara, Naga; Hetz, Rebecca] Lake Erie Coll Ostepath Med, Dept Biochem, 2000 West Grandview Blvd,Room 2-107, Erie, PA 16509 USA; [Razzaque, Mohammed S.] Lake Erie Coll Ostepath Med, Dept Pathol, Erie, PA USA		He, P (corresponding author), Lake Erie Coll Ostepath Med, Dept Biochem, 2000 West Grandview Blvd,Room 2-107, Erie, PA 16509 USA.	phe@lecom.edu	Razzaque, Mohammed S./K-4282-2019	Razzaque, Mohammed S./0000-0003-1115-4550	LECOM internal Seed Grants [COM-18-19]	LECOM internal Seed Grants	LECOM internal Seed Grants, Grant/Award Number: COM-18-19	Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10622; Beck GR, 2003, J BIOL CHEM, V278, P41921, DOI 10.1074/jbc.M304470200; Beck GR, 2003, EXP CELL RES, V288, P288, DOI 10.1016/S0014-4827(03)00213-1; Beck L, 2009, J BIOL CHEM, V284, P31363, DOI 10.1074/jbc.M109.053132; Bergwitz C, 2011, ADV CHRONIC KIDNEY D, V18, P132, DOI 10.1053/j.ackd.2011.01.004; BEVINGTON A, 1986, CLIN SCI, V71, P729, DOI 10.1042/cs0710729; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Brown RB, 2018, BBA-REV CANCER, V1869, P303, DOI 10.1016/j.bbcan.2018.04.007; Brown RB, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.74; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Camalier CE, 2013, J CELL PHYSIOL, V228, P1536, DOI 10.1002/jcp.24312; Camalier CE, 2010, CANCER PREV RES, V3, P359, DOI 10.1158/1940-6207.CAPR-09-0068; Cancela AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036883; Chang SH, 2006, AM J RESP CELL MOL, V35, P528, DOI 10.1165/rcmb.2005-0477OC; Conradas KA, 2005, MOL CELL PROTEOMICS, V4, P1284, DOI 10.1074/mcp.M500082-MCP200; Conrads KA, 2004, ELECTROPHORESIS, V25, P1342, DOI 10.1002/elps.200405892; David CJ, 2016, CELL, V164, P1015, DOI 10.1016/j.cell.2016.01.009; Di Marco GS, 2008, AM J PHYSIOL-RENAL, V294, pF1381, DOI 10.1152/ajprenal.00003.2008; Dongre A, 2019, NAT REV MOL CELL BIO, V20, P69, DOI 10.1038/s41580-018-0080-4; Duronio RJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008904; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fruman DA, 2017, CELL, V170, P605, DOI 10.1016/j.cell.2017.07.029; Giachelli CM, 2009, KIDNEY INT, V75, P890, DOI 10.1038/ki.2008.644; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Goodson JM, 2019, J STEROID BIOCHEM, V188, P166, DOI 10.1016/j.jsbmb.2019.01.023; Goodson JM, 2017, J STEROID BIOCHEM, V167, P33, DOI 10.1016/j.jsbmb.2016.10.006; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Iurlaro R, 2016, FEBS J, V283, P2640, DOI 10.1111/febs.13598; Jiang Z, 2012, CELL CYCLE, V11, P1118, DOI 10.4161/cc.11.6.19529; Jin H, 2006, TOXICOL SCI, V90, P221, DOI 10.1093/toxsci/kfj066; Jin H, 2009, AM J RESP CRIT CARE, V179, P59, DOI 10.1164/rccm.200802-306OC; Julien M, 2007, ENDOCRINOLOGY, V148, P530, DOI 10.1210/en.2006-0763; Kalantar-Zadeh K, 2010, CLIN J AM SOC NEPHRO, V5, P519, DOI 10.2215/CJN.06080809; Kanatan M, 2003, J CELL PHYSIOL, V196, P180, DOI 10.1002/jcp.10270; Kaur J, 2015, NAT REV MOL CELL BIO, V16, P461, DOI 10.1038/nrm4024; Kim HJ, 2007, MOL CELL BIOL, V27, P3165, DOI 10.1128/MCB.01315-06; Kimata M, 2010, BONE, V47, P938, DOI 10.1016/j.bone.2010.08.006; Kuro-o M, 2014, NEFROLOGIA, V34, P1, DOI 10.3265/Nefrologia.pre2013.Dec.12385; Kuro-o M, 2013, NAT REV NEPHROL, V9, P650, DOI 10.1038/nrneph.2013.111; Lavoie H, 2015, NAT REV MOL CELL BIO, V16, P281, DOI 10.1038/nrm3979; Lee S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135582; Lin YM, 2015, MOL CARCINOGEN, V54, P926, DOI 10.1002/mc.22153; Liu L, 2013, EXP HEMATOL, V41, P432, DOI 10.1016/j.exphem.2013.01.004; Mancini FR, 2018, CLIN NUTR, V37, P1625, DOI 10.1016/j.clnu.2017.07.025; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Marks J, 2013, CURR OPIN NEPHROL HY, V22, P481, DOI 10.1097/MNH.0b013e3283621310; Michigami T, 2018, PHYSIOL REV, V98, P2317, DOI 10.1152/physrev.00022.2017; Morrison DK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011254; Nakatani T, 2009, FASEB J, V23, P433, DOI 10.1096/fj.08-114397; Nishino J, 2017, J CELL BIOCHEM, V118, P1151, DOI 10.1002/jcb.25742; Ohnishi M, 2010, FASEB J, V24, P3562, DOI 10.1096/fj.09-152488; Qi X, 2004, MOL PHARMACOL, V66, P899, DOI 10.1124/mol.104.001339; Rahabi-Layachi H, 2015, J CELL PHYSIOL, V230, P347, DOI 10.1002/jcp.24715; Roussanne MC, 2001, EUR J CLIN INVEST, V31, P610, DOI 10.1046/j.1365-2362.2001.00809.x; Salaun C, 2010, J BIOL CHEM, V285, P34408, DOI 10.1074/jbc.M110.130989; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Shen ZJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150093; Solomon DH, 2007, ACTA PHYSIOL, V190, P119, DOI 10.1111/j.1748-1716.2007.01670.x; Spina A, 2013, BIORESEARCH OPEN ACC, V2, P47, DOI 10.1089/biores.2012.0266; Su J, 2020, NATURE, V577, P566, DOI 10.1038/s41586-019-1897-5; SZCZEPANSKAKONKEL M, 1986, J BIOL CHEM, V261, P6375; TAKEICHI M, 1972, EXP CELL RES, V74, P51, DOI 10.1016/0014-4827(72)90480-6; Tan XY, 2016, BIOCHEM BIOPH RES CO, V472, P459, DOI 10.1016/j.bbrc.2016.01.077; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; Villa-Bellosta R, 2009, ARTERIOSCL THROM VAS, V29, P761, DOI 10.1161/ATVBAHA.108.183384; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Xu HY, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00360; Xu WT, 2015, CELL ADHES MIGR, V9, P317, DOI 10.1080/19336918.2015.1016686; Yamazaki M, 2010, J CELL BIOCHEM, V111, P1210, DOI 10.1002/jcb.22842; Yoshikawa R, 2018, J CLIN BIOCHEM NUTR, V62, P68, DOI 10.3164/jcbn.17-20; Zhang Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep34597; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhang YY, 2018, BMC NEPHROL, V19, DOI 10.1186/s12882-018-0836-2	76	11	12	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202000799RR	http://dx.doi.org/10.1096/fj.202000799RR		SEP 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	32892444				2022-12-26	WOS:000568298300001
J	Savel, S; Sombe, P				Savel, Sophie; Sombe, Patty			Are dogs with congenital hearing and/or vision impairments so different from sensory normal dogs? A survey of demographics, morphology, health, behaviour, communication, and activities	PLOS ONE			English	Article							MDR1 MUTATION; DEAFNESS; PREVALENCE; FAMILIARIS; DEFECTS	The births of domestic dogs with pigment deletion and associated congenital hearing and/or vision impairments are increasing, as a result of mutations of certain genes expressing popular coat colour patterns (Merle, piebald, Irish spotting). The future of these dogs is often pessimistic (early euthanasia or placement in rescues/fosters, lack of interactions and activities for adults). These pessimistic scenarios result from popular assumptions predicting that dogs with congenital hearing/vision impairments exhibit severe Merle-related health troubles (cardiac, skeletal, neurological), impairment-related behavioural troubles (aggressiveness, anxiety), and poor capacities to communicate, to be trained, and to be engaged in leisure or work activities. However, there is no direct scientific testing, and hence no evidence or refutation, of these assumptions. We therefore addressed an online questionnaire to owners of 223 congenitally sensory impaired (23 vision impaired, 63 hearing impaired, 137 hearing and vision impaired) and 217 sensory normal dogs from various countries. The sensory normal cohort was matched in age, lifetime with owner, breed and sex with the sensory impaired cohort, and was used as a baseline. The questionnaire assessed demographics, morphology, sensory impairments, health and behavioural troubles, activities, and dog-owner communication. Most hearing and/or vision impaired dogs exhibited abnormal pigment deletion in their coat and irises. Vision impaired dogs additionally exhibited ophthalmic abnormalities typically related to Merle. The results are opposed to all above-listed assumptions, except for neurological troubles, which were more frequently reported in sensory impaired dogs. However, we suggest that this finding could be partially accounted for by a lack of diagnosis of breed-related drug sensitivity and impairment-related compulsive behaviours. Results about communication and activities are particularly optimistic. The need for future studies of numerous dogs from various breeds tested for Merle, piebald and medical-drug-resistance genes, and the beneficial effects that present and future research may have on the future of sensory impaired dogs, are discussed.	[Savel, Sophie] Aix Marseille Univ, Cent Marseille, CNRS, LMA UMR 7031, Marseille, France; [Sombe, Patty] Nonprofit Org Blanc Comme Neige, Pont Douilly, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Savel, S (corresponding author), Aix Marseille Univ, Cent Marseille, CNRS, LMA UMR 7031, Marseille, France.	savel@lma.cnrs-mrs.fr		Savel, Sophie/0000-0001-8306-3127				Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; [Anonymous], 2018, CANC DISCOV, V8, pOF6; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Asher L, 2009, VET J, V182, P402, DOI 10.1016/j.tvjl.2009.08.033; Ballif BC, 2018, CYTOGENET GENOME RES, V156, P22, DOI 10.1159/000491408; Bauer BS, 2015, CAN VET J, V56, P767; Bennett PC, 2007, APPL ANIM BEHAV SCI, V102, P65, DOI 10.1016/j.applanim.2006.03.009; Clark LA, 2006, P NATL ACAD SCI USA, V103, P1376, DOI 10.1073/pnas.0506940103; Cope Becker S, 2017, LIVING DEAF DOG BOOK, P151; Farmer-Dougan V, 2014, J VET BEHAV, V9, P316, DOI 10.1016/j.jveb.2014.07.002; FERRARA ML, 1983, VET REC, V112, P344, DOI 10.1136/vr.112.15.344; Gaunet F, 2008, ANIM COGN, V11, P475, DOI 10.1007/s10071-008-0138-3; Geyer J, 2005, J VET PHARMACOL THER, V28, P545, DOI 10.1111/j.1365-2885.2005.00692.x; Gramer I, 2011, VET J, V189, P67, DOI 10.1016/j.tvjl.2010.06.012; Gwin RM, 1980, J AM ANIM HOSP ASSOC, V17, P401; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Hulsmeyer VI, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0463-0; Langevin M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198536; Langevin S, 2020, BMC OPHTHALMOL, V20, DOI 10.1186/s12886-019-1282-z; Little C., 1957, INHERITANCE COAT COL; MCCABE L, 1990, AM J MED GENET, V36, P336, DOI 10.1002/ajmg.1320360319; Miklosi A., 2015, DOG BEHAV EVOLUTION; Murphy SC, 2018, MOBILE DNA-UK, V9, DOI 10.1186/s13100-018-0131-6; Puurunen J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60546-w; Siegel S, 1988, NONPARAMETRIC STAT B, V2; SORSBY A, 1954, J GENET, V52, P425, DOI 10.1007/BF02981535; SPONENBERG DP, 1985, J HERED, V76, P393; Strain GM, 2009, J VET INTERN MED, V23, P282, DOI 10.1111/j.1939-1676.2008.0257.x; Strain GM, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00029; STRAIN GM, 1996, BRIT VET J, V152, P17; Tiira K, 2016, J VET BEHAV, V16, P36, DOI 10.1016/j.jveb.2016.06.008; Wiles B M, 2017, Canine Genet Epidemiol, V4, P8, DOI 10.1186/s40575-017-0047-3; Wong AK, 2013, ANIM GENET, V44, P305, DOI 10.1111/age.12006	33	0	0	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0230651	10.1371/journal.pone.0230651	http://dx.doi.org/10.1371/journal.pone.0230651			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886662	Green Published, Green Submitted, gold			2022-12-26	WOS:000571064300038
J	Watt, MH; Nguyen, TV; Toure, C; Traore, D; Wesson, J; Baumgartner, JN				Watt, Melissa H.; Thuy-vi Nguyen; Toure, Cheick; Traore, Demba; Wesson, Jennifer; Baumgartner, Joy Noel			Integrated mental health screening for obstetric fistula patients in Mali: From evidence to policy	PLOS ONE			English	Article							WOMEN; DEPRESSION; QUESTIONNAIRE-9; EXPERIENCE; SYMPTOMS; VALIDITY; PHQ-9; CARE	Background Obstetric fistula significantly impacts women's mental health and well-being. Routine screening for mental health in fistula repair programs can be a gateway to link patients to services, and can produce routine data to inform programmatic investments. This study observed the integration of a mental health screening program into an obstetric fistula repair program in Mali, with two specific objectives: 1) to describe the social and mental health well-being of women presenting with obstetric fistulas in Mali, and 2) to document the impact of the mental health screening pilot on policy change in Mali. Methods Seven fistula repair campaigns were conducted between June 2016 and May 2017. All individuals presenting for fistula repair completed a mental health assessment at intake, including a depression screener (PHQ-9) and an assessment of psycho-social impacts of fistula. The depression screener was repeated three months following inpatient discharge. Findings were shared with stakeholders in Mali and impacts on policy were documented. Results Of 207 women who presented for fistula repair, 167 patients completed the mental health assessment at surgical intake, and 130 patients repeated the screener at 3-month follow-up. At intake, 36.5% of women had moderate or severe depression, decreasing to 16.9% at follow-up. The mean depression score differed significantly by timepoint (9.14 vs. 6.72, p <0.001). Results were shared in a report with stakeholders, and consultations with the Mali Ministry of Health. As a result of advocacy, mental health was a key component of Mali's National Fistula Prevention and Treatment Strategy (2018-2022). Conclusion The high prevalence of depression in Malian fistula patients underscores a need for more robust mental health support for patients after surgery. Data on mental health from routine screening informs community reintegration strategies for individual patients, elevates the overall quality of care of fistula repair programs by addressing patients' holistic health needs, and contributes to evidence-informed decision-making and data-driven policy change within the larger health system.	[Watt, Melissa H.; Thuy-vi Nguyen; Baumgartner, Joy Noel] Duke Univ, Durham, NC 27708 USA; [Watt, Melissa H.] Univ Utah, Salt Lake City, UT 84112 USA; [Toure, Cheick; Traore, Demba] IntraHlth Int Inc, Bamako, Mali; [Wesson, Jennifer] IntraHlth Int Inc, Chapel Hill, NC USA	Duke University; Utah System of Higher Education; University of Utah	Watt, MH (corresponding author), Duke Univ, Durham, NC 27708 USA.; Watt, MH (corresponding author), Univ Utah, Salt Lake City, UT 84112 USA.	melissa.watt@hsc.utah.edu						Ahmed S, 2007, INT J GYNECOL OBSTET, V99, pS10, DOI 10.1016/j.ijgo.2007.06.011; Allen AM, 2011, OBSTET GYNECOL, V117, P468, DOI 10.1097/AOG.0b013e3181f9b749; [Anonymous], 2019, 10 YEARS OBST FIST C; Appiah R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236707; Arthurs E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052028; Atif N, 2015, SEMIN PERINATOL, V39, P345, DOI 10.1053/j.semperi.2015.06.007; Bacon C, 2003, OBSTET FISTULA NEEDS; Baker Z, 2017, TROP MED INT HEALTH, V22, P938, DOI 10.1111/tmi.12893; Belayihun B, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2045-3; Brugiere M, 2012, FIELD ACTIONS SCI RE; Cholera R, 2014, J AFFECT DISORDERS, V167, P160, DOI [10.1016/j.jad.2014.06.003, 10.1016/]; East C and Southern African Health Community (Arusha) EngenderHealth Tanzania (Dar es Salaam), 2012, PREV MAN OBST FIST C; El Ayadi A, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0372-8; El Ayadi AM, 2020, CULT HEALTH SEX, V22, P352, DOI 10.1080/13691058.2019.1600721; El Ayadi AM, 2019, TROP MED INT HEALTH, V24, P53, DOI 10.1111/tmi.13178; Emasu A, 2019, INT UROGYNECOL J, V30, P1101, DOI 10.1007/s00192-019-03896-y; Goh JTW, 2005, BJOG-INT J OBSTET GY, V112, P1328, DOI 10.1111/j.1471-0528.2005.00712.x; HARRISON KA, 1983, BRIT J OBSTET GYNAEC, V90, P385, DOI 10.1111/j.1471-0528.1983.tb08932.x; Holcomb WL, 1996, OBSTET GYNECOL, V88, P1021; Howell N, 2005, MACQUARIE LAW J, V5; Intrahealth International, 2019, 10 YEARS OBS FIST CA; Javadi D, 2017, GLOB MENT HEALTH, V4, DOI 10.1017/gmh.2017.15; Khisa AM, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0692-y; Khisa AM, 2012, REPROD HEALTH MATTER, V20, P59, DOI 10.1016/S0968-8080(12)40661-9; Krause HG, 2017, INT UROGYNECOL J, V28, P893, DOI 10.1007/s00192-016-3177-3; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Marcus SM, 2003, J WOMEN HEALTH GEN-B, V12, P373, DOI 10.1089/154099903765448880; Milgrom J, 2014, BEST PRACT RES CL OB, V28, P13, DOI 10.1016/j.bpobgyn.2013.08.014; Monahan PO, 2009, J GEN INTERN MED, V24, P189, DOI 10.1007/s11606-008-0846-z; Muleta M, 2008, J OBSTET GYNAECOL CA, V30, P44, DOI 10.1016/S1701-2163(16)32712-8; Oliver K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-2; Olivier C, 2016, DEV PRACT, V26, P444, DOI 10.1080/09614524.2016.1164122; Omoro SAO, 2006, INT J PSYCHIAT MED, V36, P367, DOI 10.2190/8W7Y-0TPM-JVGV-QW6M; Pence BW, 2012, AIDS, V26, P656, DOI 10.1097/QAD.0b013e3283519aae; Rahman A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001442; Republic of Mali, 2018, PLAN STRATEGIQUE ELI; Sebera F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234095; Siddle K, 2013, INT UROGYNECOL J, V24, P1215, DOI 10.1007/s00192-012-1994-6; Stangl AL, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1271-3; Theobald S, 2018, LANCET, V392, P2214, DOI [10.1016/S0140-6736(18)32205-0, 10.1016/s0140-6736(18)32205-0]; Tripathi V, 2014, WHO MEASURING INCIDE; Tsegaw MG, 2018, AM J PUBLIC HLTH RES; USAID, 2019, OBST FIST REP MAL; Ward Vicky, 2009, Evid Policy, V5, P267; Watt Melissa H, 2017, Pilot Feasibility Stud, V3, P35, DOI 10.1186/s40814-017-0178-z; Watt MH, 2014, GLOB PUBLIC HEALTH, V9, P516, DOI 10.1080/17441692.2014.903988; Weston K, 2011, INT J GYNECOL OBSTET, V115, P31, DOI 10.1016/j.ijgo.2011.04.015; WHO, 2010, WHO MENT HLTH WORKF; Wilson SM, 2016, MATERN CHILD HLTH J, V20, P941, DOI 10.1007/s10995-016-1950-z; World Health Organization, 2019, WHONMHNHD1924; Yeakey MP, 2009, CULT HEALTH SEX, V11, P499, DOI 10.1080/13691050902874777; Zeleke BM, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-236	52	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238777	10.1371/journal.pone.0238777	http://dx.doi.org/10.1371/journal.pone.0238777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ7QN	32886719	Green Published, gold			2022-12-26	WOS:000571064300045
J	Yin, C; Li, HR; Che, F; Li, Y; Hu, ZN; Liu, D				Yin, Chao; Li, Haoran; Che, Fa; Li, Ying; Hu, Zhinan; Liu, Dong			Susceptibility mapping and zoning of highway landslide disasters in China	PLOS ONE			English	Article							LOGISTIC-REGRESSION; SPATIAL PREDICTION; FAULT-DIAGNOSIS; DECISION TREE; ENSEMBLES; PROVINCE; MODELS; HAZARD; FOREST; PSO	Prominent regional differentiations of highway landslide disasters (HLDs) bring great difficulties in highway planning, designing and disaster mitigation, therefore, a comprehensive understanding of HLDs from the spatial perspective is a basis for reducing damages. Statistical prediction methods and machine learning methods have some defects in landslide susceptibility mapping (LSM), meanwhile, hybrid methods have been developed by combining the statistical prediction methods with machine learning methods in recent years, and some of them were reported to perform better than conventional methods. In view of this, the principal component analysis (PCA) method was used to extract the susceptibility evaluation indexes of HLDs; the particle swarm optimization-support vector machine (PSO-SVM) model and genetic algorithm-support vector machine (GA-SVM) model were implemented to the susceptibility mapping and zoning of HLDs in China. The research results show that the accumulative contribution rate of the four principal components is 92.050%; evaluation results of the PSO-SVM model are better than those of the GA-SVM model; micro dangerous areas, moderate dangerous areas, severe dangerous areas and extreme dangerous areas account for 24.24%, 19.49%, 36.53% and 19.74% of the total areas of China; among the 1543 disaster points in the HLDs inventory, there are 134, 182, 421 and 806 located in the above areas respectively.	[Yin, Chao; Li, Ying] Shandong Univ Technol, Sch Civil & Architecture Engn, Zibo, Peoples R China; [Yin, Chao] Shijiazhuang Tiedao Univ, Minist Educ, Key Lab Rd & Railway Engn Safety Control, Shijiazhuang, Hebei, Peoples R China; [Li, Haoran] Zhongtian Construct Grp Co LTD, Urban Rail Construct Corp, Hangzhou, Peoples R China; [Che, Fa] Zibo Transportat Serv Ctr, Zibo, Peoples R China; [Hu, Zhinan] Shijiazhuang Tiedao Univ, State Key Lab Mech Behav & Syst Safety Traff Engn, Shijiazhuang, Hebei, Peoples R China; [Liu, Dong] Dezhou Highway Dev Ctr, Laoling Branch, Dezhou, Peoples R China	Shandong University of Technology; Shijiazhuang Tiedao University; Shijiazhuang Tiedao University	Che, F (corresponding author), Zibo Transportat Serv Ctr, Zibo, Peoples R China.	zbsglgljyanghuke@zb.shandong.cn	Li, Hao/GPS-9834-2022		National Natural Science Foundation of China [51808327]; Natural Science Foundation of Shandong Province [ZR2019PEE016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by the National Natural Science Foundation of China (Grant NO. 51808327) and Natural Science Foundation of Shandong Province (Grant NO. ZR2019PEE016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Urban Rail Construction Corporation, Zhongtian Construction Group Co., LTD is a commercial organization and provided support in the form of salary for Haoran Li. The specific roles of all authors were articulated in the "author contributions" section.	Alireza D, 2015, CATENA, V135, P122, DOI [10.1016/j.catena.2015.07.020, DOI 10.1016/J.CATENA.2015.07.020]; Ancione G, 2020, J LOSS PREVENT PROC, V64, DOI 10.1016/j.jlp.2020.104080; [Anonymous], 2019, INTEL 64 IA 32 ARCHI, V3; Bai SB, 2020, ENG GEOL, V268, DOI 10.1016/j.enggeo.2020.105518; Bera S, 2019, REMOTE SENS APPL, V13, P39, DOI 10.1016/j.rsase.2018.10.010; Chen CW, 2016, GEOMORPHOLOGY, V273, P1, DOI 10.1016/j.geomorph.2016.08.012; Chen W, 2018, SCI TOTAL ENVIRON, V626, P1121, DOI 10.1016/j.scitotenv.2018.01.124; Chen W, 2017, GEODERMA, V305, P314, DOI 10.1016/j.geoderma.2017.06.020; Chen W, 2017, CATENA, V151, P147, DOI 10.1016/j.catena.2016.11.032; Comert R, 2019, ENG GEOL, V260, DOI 10.1016/j.enggeo.2019.105264; Deijns AAJ, 2020, INT J APPL EARTH OBS, V84, DOI 10.1016/j.jag.2019.101943; Duan Z., 2020, TUNNEL CONSTR, V40, P379, DOI [10.3973/j.issn.2096-4498.2020.03.010, DOI 10.3973/J.ISSN.2096-4498.2020.03.010]; Fan LF, 2017, GEOMORPHOLOGY, V280, P1, DOI 10.1016/j.geomorph.2016.10.007; Fang ZC, 2020, COMPUT GEOSCI-UK, V139, DOI 10.1016/j.cageo.2020.104470; Feng Hangjian, 2016, Earth Science - Journal of China University of Geosciences, V41, P403, DOI 10.3799/dqkx.2016.032; Nieto PJG, 2016, COMPUT ELECTRON AGR, V125, P74, DOI 10.1016/j.compag.2016.04.031; Gauthier TD, 2001, ENVIRON FORENSICS, V2, P359, DOI 10.1006/enfo.2001.0061; He QF, 2019, SCI TOTAL ENVIRON, V663, P1, DOI 10.1016/j.scitotenv.2019.01.329; Hong HY, 2020, SCI TOTAL ENVIRON, V718, DOI 10.1016/j.scitotenv.2020.137231; Hong HY, 2018, CATENA, V163, P399, DOI 10.1016/j.catena.2018.01.005; Hong HY, 2015, CATENA, V133, P266, DOI 10.1016/j.catena.2015.05.019; Hu F, 2020, TECTONOPHYSICS, V784, DOI 10.1016/j.tecto.2020.228441; Hu Q, 2020, GEOMORPHOLOGY, V351, DOI 10.1016/j.geomorph.2019.106975; Huang YM, 2017, J MATER PROCESS TECH, V239, P92, DOI 10.1016/j.jmatprotec.2016.07.015; Isaza-Restrepo PA, 2016, HABITAT INT, V53, P403, DOI 10.1016/j.habitatint.2015.12.012; Jiao YM, 2019, CATENA, V183, DOI 10.1016/j.catena.2019.104221; Khalaj S, 2020, COMPUT GEOTECH, V117, DOI 10.1016/j.compgeo.2019.103262; Lee CF, 2018, GEOMORPHOLOGY, V300, P113, DOI 10.1016/j.geomorph.2017.10.019; [刘磊 Liu Lei], 2016, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V35, P558; Lu P, 2019, REMOTE SENS ENVIRON, V231, DOI 10.1016/j.rse.2019.111235; multicenter collaboration group of Department of S Technology of Guangdong P Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus p, 2020, ZHONGHUA JIE HE HE H, V43, pE019; Multon S, 2016, CEMENT CONCRETE RES, V81, P122, DOI 10.1016/j.cemconres.2015.12.007; Nicu IC, 2017, J CULT HERIT, V28, P172, DOI 10.1016/j.cuther.2017.06.002; Pandey VK, 2019, CATENA, V182, DOI 10.1016/j.catena.2019.104150; Papathoma-Kohle M, 2015, ENVIRON MODELL SOFTW, V63, P156, DOI 10.1016/j.envsoft.2014.10.003; Prion S, 2014, CLIN SIMUL NURS, V10, P535, DOI 10.1016/j.ecns.2014.07.005; Rossi M, 2017, GEOMORPHOLOGY, V285, P16, DOI 10.1016/j.geomorph.2017.02.001; San BT, 2014, INT J APPL EARTH OBS, V26, P399, DOI 10.1016/j.jag.2013.09.010; Sanuy M, 2020, COAST ENG, V157, DOI 10.1016/j.coastaleng.2019.103627; Sezer EA, 2017, COMPUT GEOSCI-UK, V98, P26, DOI 10.1016/j.cageo.2016.10.001; Sharifi R, 2017, MECH SYST SIGNAL PR, V85, P638, DOI 10.1016/j.ymssp.2016.08.028; Shou KJ, 2020, ENG GEOL, V265, DOI 10.1016/j.enggeo.2019.105434; Song YQ, 2012, COMPUT GEOSCI-UK, V42, P189, DOI 10.1016/j.cageo.2011.09.011; Sun DL, 2020, GEOMORPHOLOGY, V362, DOI 10.1016/j.geomorph.2020.107201; Wang LJ, 2015, CATENA, V135, P271, DOI 10.1016/j.catena.2015.08.007; Wang Y, 2020, COMPUT GEOSCI-UK, V138, DOI 10.1016/j.cageo.2020.104445; Wu ZN, 2020, J HYDROL, V583, DOI 10.1016/j.jhydrol.2020.124596; Yan H, 2020, SCI TOTAL ENVIRON, V705, DOI 10.1016/j.scitotenv.2019.135941; Yang JT, 2019, GEOMORPHOLOGY, V324, P62, DOI 10.1016/j.geomorph.2018.09.019; Yin C, 2013, J GUANGXI U, V38, P859, DOI [10.13624/j.cnki.issn.1001-7445.2013.04.002, DOI 10.13624/J.CNKI.ISSN.1001-7445.2013.04.002]; Yin C, 2020, NAT HAZARDS, V100, P535, DOI 10.1007/s11069-019-03824-9; Yin C, 2018, NAT HAZARDS, V91, pS129, DOI 10.1007/s11069-018-3229-8; Zarei R, 2017, COMPUT METH PROG BIO, V146, P47, DOI 10.1016/j.cmpb.2017.05.009; Zezere JL, 2017, SCI TOTAL ENVIRON, V589, P250, DOI 10.1016/j.scitotenv.2017.02.188; [张俊 Zhang Jun], 2016, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V35, P284; Zhang JH, 2017, FRONT INFORM TECH EL, V18, P272, DOI 10.1631/FITEE.1500337; Zhang S, 2020, ENG GEOL, V265, DOI 10.1016/j.enggeo.2019.105436; Zhang ZL, 2014, POWDER TECHNOL, V268, P429, DOI 10.1016/j.powtec.2014.08.044; Zhou C, 2016, ENG GEOL, V204, P108, DOI 10.1016/j.enggeo.2016.02.009; Zhou T, 2019, APPL SOFT COMPUT, V75, P323, DOI 10.1016/j.asoc.2018.11.001; Zhu AX, 2018, CATENA, V171, P222, DOI 10.1016/j.catena.2018.07.012	61	4	4	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0235780	10.1371/journal.pone.0235780	http://dx.doi.org/10.1371/journal.pone.0235780			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886925	Green Published, gold			2022-12-26	WOS:000571064300046
J	Baek, HJ; Park, YS; Yoo, KY; Cha, JH; Kim, YJ; Lee, KS				Baek, Hee Jo; Park, Young Shil; Yoo, Ki Young; Cha, Jin-Hye; Kim, Young-Joo; Lee, Kun Soo			Health-related quality of life of moderate and severe haemophilia patients: Results of the haemophilia-specific quality of life index in Korea	PLOS ONE			English	Article							HEME-A-QOL; INHIBITORS; CHILDREN; UTILITY; ASSOCIATION; INSTRUMENT; MANAGEMENT; ADULTS; IMPACT; EQ-5D	The assessment of health-related quality of life (HRQoL) as a patient-reported outcome provides information about the patients' general well-being as well as the effects of the disease and its treatment. This study aimed to investigate HRQoL using both generic and haemophilia-specific QoL instruments and to assess the clinical factors associated with HRQoL among haemophilia patients in Korea. In this cross-sectional, multicenter, observational study, moderate-to-severe haemophilia patients aged 8-64 years were recruited between November 2012 and September 2013. The EQ-5D Questionnaire, EQ Visual Analogue Scale, and Haemophilia-Specific QoL (Haemo-QoL) Questionnaire (Haemo-QoL for 8-16 years and Haemo-A-QoL for >= 17 years) were used to assess HRQoL. A total of 605 participants with a mean age of 29.32 +/- 12.62 years were enrolled. The mean Haemo-QoL scores revealed significant differences by age group (children vs. adolescent vs. adult, 26.44 +/- 11.3 vs. 28.88 +/- 11.1 vs. 38.43 +/- 17.7, respectively,p< 0.001). "Sports and leisure," "family planning," and "view" in adults and "perceived support," "friends," and "dealing" in children and adolescents were identified as the domains with the greatest HRQoL impairments. HRQoL was significantly impaired in patients with the following clinical factors: hepatitis, haemophilia-induced disability, bleeding experiences within the last 6 months, joint bleedings within the last 6 months, and haemophilic arthropathy. According to the multivariate regression analysis, HRQoL showed a negative association with the presence of haemophilia-induced disability (beta = 0.222,p< 0.0001), bleeding experiences within the last 6 months (beta = 0.098,p= 0.010), and haemophilic arthropathy (beta = 0.212,p< 0.0001). HRQoL decreased in patients with older age and impaired clinical conditions among moderate-to-severe haemophilia patients in Korea. These study findings may provide significant insights into the adequate haemophilia management using patient-reported measurements.	[Baek, Hee Jo] Chonnam Natl Univ, Med Sch, Dept Pediat, Hwasun Hosp, Gwangju, South Korea; [Park, Young Shil] Kyung Hee Univ Hosp Gangdong, Dept Pediat, Seoul, South Korea; [Yoo, Ki Young] Korea Hemophilia Fdn, Seoul, South Korea; [Cha, Jin-Hye; Kim, Young-Joo] Pfizer Pharmaceut Korea Ltd, Seoul, South Korea; [Lee, Kun Soo] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Pediat, Med Sch, Daegu, South Korea	Chonnam National University; Kyung Hee University; Kyung Hee University Hospital; Pfizer; Kyungpook National University; Kyungpook National University Hospital	Lee, KS (corresponding author), Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Pediat, Med Sch, Daegu, South Korea.	kslee@knu.ac.kr		Park, Young Shil/0000-0002-6643-4245	Pfizer Pharmaceuticals Korea Ltd.	Pfizer Pharmaceuticals Korea Ltd.(Pfizer)	This research was sponsored by Pfizer Pharmaceuticals Korea Ltd. The authors, Jin-Hye Cha and Young-Joo Kim, who are employees of Pfizer Pharmaceuticals Korea Ltd, contributed in the study design, data analysis, decision to publish, or preparation of the manuscript.	Carroll L, 2019, PATIENT PREFER ADHER, V13, P941, DOI 10.2147/PPA.S202773; Ferreira Adriana Aparecida, 2013, Rev. Bras. Hematol. Hemoter., V35, P314, DOI 10.5581/1516-8484.20130108; Fischer K, 2016, HAEMOPHILIA, V22, P833, DOI 10.1111/hae.13120; Gringeri A, 2004, HAEMOPHILIA, V10, P26, DOI 10.1111/j.1355-0691.2004.00876.x; Kang EJ, 2006, NOTRKO201500006731 K; Kang EJ, 2009, VALUE HEALTH, V12, pS114, DOI 10.1111/j.1524-4733.2009.00642.x; Kim MH, 2005, QUAL LIFE RES, V14, P1401, DOI 10.1007/s11136-004-5681-z; Mahlangu J, 2019, HAEMOPHILIA, V25, P382, DOI 10.1111/hae.13731; Mercan A, 2010, PEDIATR HEMAT ONCOL, V27, P449, DOI 10.3109/08880018.2010.489933; Miners AH, 1999, HAEMOPHILIA, V5, P378; Miners AH, 1999, PSYCHOL HEALTH MED, V4, P5; Neufeld EJ, 2012, VALUE HEALTH, V15, P916, DOI 10.1016/j.jval.2012.05.005; Osooli M, 2017, HAEMOPHILIA, V23, pE180, DOI 10.1111/hae.13231; Preedy VR, 2010, HDB DIS BURDENS QUAL, P1895; Raffini L, 2007, BRIT J HAEMATOL, V136, P777, DOI 10.1111/j.1365-2141.2007.06490.x; Rentz A, 2008, HAEMOPHILIA, V14, P1023, DOI 10.1111/j.1365-2516.2008.01812.x; ROSENDAAL FR, 1990, J INTERN MED, V228, P633, DOI 10.1111/j.1365-2796.1990.tb00291.x; Santagostino E, 2014, HAEMOPHILIA, V20, P527, DOI 10.1111/hae.12371; Soucie JM, 2017, HAEMOPHILIA, V23, pE287, DOI 10.1111/hae.13275; Srivastava A, 2013, HAEMOPHILIA, V19, pE1, DOI 10.1111/j.1365-2516.2012.02909.x; Szucs TD, 1996, HAEMOPHILIA, V2, P211, DOI 10.1111/j.1365-2516.1996.tb00139.x; Trippoli S, 2001, HAEMATOLOGICA, V86, P722; von Mackensen S, 2007, HAEMOPHILIA, V13, P38, DOI 10.1111/j.1365-2516.2007.01505.x; Von Mackensen S, 2005, VALUE HEALTH, V8, pA127, DOI 10.1016/S1098-3015(10)67535-3; von Mackensen S, 2017, HAEMOPHILIA, V23, P383, DOI 10.1111/hae.13140; von Mackensen S, 2004, HAEMOPHILIA, V10, P17, DOI 10.1111/j.1355-0691.2004.00875.x	26	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238686	10.1371/journal.pone.0238686	http://dx.doi.org/10.1371/journal.pone.0238686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881977	gold, Green Published			2022-12-26	WOS:000571063300087
J	Leech, AA; Christiansen, CL; Linas, BP; Jacobsen, DM; Morin, I; Drainoni, ML				Leech, Ashley A.; Christiansen, Cindy L.; Linas, Benjamin P.; Jacobsen, Donna M.; Morin, Isabel; Drainoni, Mari-Lynn			Healthcare practitioner experiences and willingness to prescribe pre-exposure prophylaxis in the US	PLOS ONE			English	Article							HIV PREVENTION; UNITED-STATES; PROVIDERS; KNOWLEDGE; ATTITUDES; PREP; ADULTS	Background and objectives Less than 10 percent of the more than one million people vulnerable to HIV are using pre-exposure prophylaxis (PrEP). Practitioners are critical to ensuring the delivery of PrEP across care settings. In this study, we target a group of prescribers focused on providing HIV care and seeking up-to-date information about HIV. We assessed their experiences prescribing PrEP, whether these experiences differed by clinical specialty, and examined associations between willingness to prescribe PrEP as a "best first step" and different hypothetical prescribing scenarios. Setting and methods Between March and May 2015, we circulated a paper survey to 954 participants ((652 of whom met our inclusion criteria of being independent prescribers and 519 of those (80%) responded to the survey)) at continuing medical education advanced-level HIV courses in five locations across the US on practitioner practices and preferences of PrEP. We employed multivariable logistic regression analysis for binary and collapsed ordinal outcomes. Results Among this highly motivated group of practitioners, only 54% reported ever prescribing PrEP. Internal medicine practitioners were 1.6 times more likely than infectious disease practitioners to have prescribed PrEP (95% CI: 0.99-2.60, p = .0524) and age, years of training, and sex were significantly associated with prescribing experience. Based on clinical vignettes describing different hypothetical prescribing scenarios, practitioners who viewed PrEP as the first clinical step for persons who inject drugs (PWID) were twice as likely to have also considered PrEP as the first clinical option for safer conception, and vice-a-versa (95% CI: 1.4-3.2, p < .001). Practitioners considering PrEP as the first preventive option for MSM were nearly six times as likely to also consider PrEP as the first clinical step for PWID, and vice-a-versa (95% CI: 2.28-13.56, p = .0002). Conclusions Our findings indicate that even among a subset of HIV-focused practitioners, PrEP prescribing is not routine. This group of practitioners could be an optimal group to engage individuals that could most benefit from PrEP.	[Leech, Ashley A.; Morin, Isabel] Vanderbilt Univ, Sch Med, Dept Hlth Policy, Nashville, TN 37212 USA; [Leech, Ashley A.; Drainoni, Mari-Lynn] Boston Univ, Sch Publ Hlth, Dept Hlth Law Policy & Management, Boston, MA 02215 USA; [Christiansen, Cindy L.] Boston Univ, Sch Dent Med, Boston, MA 02215 USA; [Linas, Benjamin P.] Boston Med Ctr, Ctr Infect Dis, Boston, MA USA; [Linas, Benjamin P.; Drainoni, Mari-Lynn] Boston Univ, Sch Med, Dept Med, Sect Infect Dis, Boston, MA 02118 USA; [Jacobsen, Donna M.] Int Antiviral Soc USA, San Francisco, CA USA; [Drainoni, Mari-Lynn] Boston Univ, Sch Med, Dept Med, Evans Ctr Implementat & Improvement Sci, Boston, MA 02118 USA; [Drainoni, Mari-Lynn] Ctr Healthcare Org & Implementat Res, Dept Vet Affairs, Bedford, MA USA	Vanderbilt University; Boston University; Boston University; Boston Medical Center; Boston University; Boston University	Leech, AA (corresponding author), Vanderbilt Univ, Sch Med, Dept Hlth Policy, Nashville, TN 37212 USA.; Leech, AA (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Policy & Management, Boston, MA 02215 USA.	ashley.leech@vanderbilt.edu		Leech, Ashley/0000-0001-6795-929X	Providence/Boston Center for AIDS Research [P30AI042853]	Providence/Boston Center for AIDS Research	Benjamin P. Linas and Mari-Lynn Drainoni received funding from the Providence/Boston Center for AIDS Research (P30AI042853). No other authors received funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LM, 2016, AIDS CARE, V28, P1154, DOI 10.1080/09540121.2016.1153595; Amrhein V, 2019, NATURE, V567, P305, DOI 10.1038/d41586-019-00857-9; [Anonymous], 2019, JAMA; Bazzi AR, 2018, AIDS PATIENT CARE ST, V32, P529, DOI 10.1089/apc.2018.0126; Blumenthal J, 2015, AIDS BEHAV, V19, P802, DOI 10.1007/s10461-015-0996-z; Department of Health and Human Services Centers for Medicare & Medicaid Services Centers for Disease Control and Prevention, 2017, US PUBL HLTH SERV PR; Hoffman Susie, 2016, J Int Assoc Provid AIDS Care, V15, P59, DOI 10.1177/2325957415600798; Karim SSA, 2012, NEW ENGL J MED, V367, P462, DOI 10.1056/NEJMclde1207706; Krakower D, 2014, AIDS BEHAV, V18, P1712, DOI 10.1007/s10461-014-0839-3; Krakower DS, 2016, CLIN INFECT DIS, V62, P99, DOI 10.1093/cid/civ736; Krakower DS, 2016, CURR OPIN HIV AIDS, V11, P41, DOI 10.1097/COH.0000000000000206; Lanier Y, 2014, AIDS PATIENT CARE ST, V28, P113, DOI 10.1089/apc.2013.0328; Lee SS, 2018, INT J INFECT DIS, V77, P105, DOI 10.1016/j.ijid.2018.10.018; Mullins TLK, 2015, AIDS PATIENT CARE ST, V29, P193, DOI 10.1089/apc.2014.0273; Ojile Nicholas, 2017, Kans J Med, V10, P40; Petroll AE, 2017, AIDS BEHAV, V21, P1256, DOI 10.1007/s10461-016-1625-1; Saag MS, 2018, JAMA-J AM MED ASSOC, V320, P379, DOI 10.1001/jama.2018.8431; Scherer ML, 2014, AIDS CARE, V26, P1435, DOI 10.1080/09540121.2014.920950; Seidman D, 2016, CONTRACEPTION, V93, P463, DOI 10.1016/j.contraception.2015.12.018; Skolnik AA, 2020, J GEN INTERN MED, V35, P832, DOI 10.1007/s11606-019-05475-9; Smith DK, 2015, MMWR-MORBID MORTAL W, V64, P1291, DOI 10.15585/mmwr.mm6446a4; Stankevitz K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218556; Sullivan PS, 2018, ANN EPIDEMIOL, V28, P833, DOI 10.1016/j.annepidem.2018.06.009; US Department of Health and Human Services, 2019, WHAT IS END HIV EP P; White JM, 2012, AIDS PATIENT CARE ST, V26, P395, DOI 10.1089/apc.2012.0030	25	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238375	10.1371/journal.pone.0238375	http://dx.doi.org/10.1371/journal.pone.0238375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ7QD	32881916	Green Published, gold			2022-12-26	WOS:000571063300097
J	Wang, DD; Yang, XX; Chen, YL; Gong, K; Yu, MY; Gao, YY; Wu, XM; Hu, HQ; Liao, CZ; Han, JH; Duan, YJ				Wang, Dandan; Yang, Xiaoxiao; Chen, Yuanli; Gong, Ke; Yu, Maoyun; Gao, Yongyao; Wu, Ximei; Hu, Huaqing; Liao, Chenzhong; Han, Jihong; Duan, Yajun			Ascorbic acid enhances low-density lipoprotein receptor expression by suppressing proprotein convertase subtilisin/kexin 9 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ascorbic acid; FoxO3a; LDL; LDLR; PCSK9; lipoprotein metabolism; lipoprotein receptor; low-density lipoprotein); proprotein convertase subtilisin; kexin type 9; ascorbic acid; forkhead box P3 (FOXP3)	VITAMIN-C-DEFICIENCY; CHOLESTEROL-METABOLISM; PCSK9 GENE; TRANSCRIPTION; ACTIVATION; INHIBITION; PROTEIN; SUPPLEMENTATION; DEGRADATION; HOMEOSTASIS	Ascorbic acid, a water-soluble antioxidant, regulates various biological processes and is thought to influence cholesterol. However, little is known about the mechanisms underpinning ascorbic acid-mediated cholesterol metabolism. Here, we determined if ascorbic acid can regulate expression of proprotein convertase subtilisin/kexin 9 (PCSK9), which binds low-density lipoprotein receptor (LDLR) leading to its intracellular degradation, to influence low-density lipoprotein (LDL) metabolism. At cellular levels, ascorbic acid inhibited PCSK9 expression in HepG2 and Huh7 cell lines. Consequently, LDLR expression and cellular LDL uptake were enhanced. Similar effects of ascorbic acid on PCSK9 and LDLR expression were observed in mouse primary hepatocytes. Mechanistically, ascorbic acid suppressed PCSK9 expression in a forkhead box O3-dependent manner. In addition, ascorbic acid increased LDLR transcription by regulating sterol regulatory element-binding protein 2. In vivo, administration of ascorbic acid reduced serum PCSK9 levels and enhanced liver LDLR expression in C57BL/6J mice. Reciprocally, lack of ascorbic acid supplementation in L-gulono-gamma-lactone oxidase deficient (Gulo(-/-)) mice increased circulating PCSK9 and LDL levels, and decreased liver LDLR expression, whereas ascorbic acid supplementation decreased PCSK9 and increased LDLR expression, ameliorating LDL levels in Gulo(-/-) mice fed a high fat diet. Moreover, ascorbic acid levels were negatively correlated to PCSK9, total and LDL levels in human serum samples. Taken together, these findings suggest that ascorbic acid reduces PCSK9 expression, leading to increased LDLR expression and cellular LDL uptake. Thus, supplementation of ascorbic acid may ameliorate lipid profiles in ascorbic acid-deficient species.	[Wang, Dandan; Yang, Xiaoxiao; Chen, Yuanli; Gong, Ke; Yu, Maoyun; Gao, Yongyao; Liao, Chenzhong; Han, Jihong; Duan, Yajun] Hefei Univ Technol, Sch Food & Biol Engn, Anhui Higher Educ Inst, Key Lab Metab & Regulat Major Dis, Hefei, Peoples R China; [Yu, Maoyun] West Anhui Univ, Sch Biol & Pharmaceut Engn, Luan, Peoples R China; [Wu, Ximei] Zhejiang Univ, Sch Med, Hangzhou, Peoples R China; [Hu, Huaqing] Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China; [Han, Jihong] Nankai Univ, Minist Educ, Key Lab Bioact Mat, Coll Life Sci,State Key Lab Med Chem Biol, Tianjin, Peoples R China	Hefei University of Technology; West Anhui University; Zhejiang University; Anhui Medical University; Nankai University	Han, JH; Duan, YJ (corresponding author), Hefei Univ Technol, Sch Food & Biol Engn, Anhui Higher Educ Inst, Key Lab Metab & Regulat Major Dis, Hefei, Peoples R China.; Han, JH (corresponding author), Nankai Univ, Minist Educ, Key Lab Bioact Mat, Coll Life Sci,State Key Lab Med Chem Biol, Tianjin, Peoples R China.	jihonghan2008@nankai.edu.cn; yduan@hfut.edu.cn		Liao, Chenzhong/0000-0001-7080-1768; Wu, Ximei/0000-0002-3316-893X	International Science AMP; Technology Cooperation Programs of China [2017YFE0110100]; NSFC [81722046, 81973316, 81773727, 81803517, 31770863]; Fundamental Research Funds for the Central Universities	International Science AMP; Technology Cooperation Programs of China; NSFC(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the International Science & Technology Cooperation Programs of China Grant 2017YFE0110100 (to J. H., Y. D., Y. C., and X. Y.), NSFC Grants 81722046 (to Y. D.), 81973316 and 81773727 (to J. H.), 81803517 (to X. Y.), and 31770863 (to Y. C.), and the Fundamental Research Funds for the Central Universities (to Y. D., X. Y., and Y. C.	Abdollahzad H, 2009, INT J VITAM NUTR RES, V79, P281, DOI 10.1024/0300-9831.79.56.281; Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abifadel M, 2009, HUM MUTAT, V30, P520, DOI 10.1002/humu.20882; Afkhami-Ardekani M, 2007, INDIAN J MED RES, V126, P471; BJORKHEM I, 1976, J LIPID RES, V17, P360; Briot A, 2018, ARTERIOSCL THROM VAS, V38, P1134, DOI 10.1161/ATVBAHA.118.310797; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chen YL, 2012, J BIOL CHEM, V287, P43340, DOI 10.1074/jbc.M112.403394; Dong B, 2010, J LIPID RES, V51, P1486, DOI 10.1194/jlr.M003566; Duan YJ, 2012, J BIOL CHEM, V287, P23667, DOI 10.1074/jbc.M112.350181; Fasano C, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091110; Frikke-Schmidt H, 2009, BASIC CLIN PHARMACOL, V104, P419, DOI 10.1111/j.1742-7843.2009.00420.x; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Hunt KJ, 2004, CIRCULATION, V110, P1251, DOI 10.1161/01.CIR.0000140762.04598.F9; Ji X, 2017, BBA-GEN SUBJECTS, V1861, P2186, DOI 10.1016/j.bbagen.2017.06.018; Kong WJ, 2006, J MOL MED, V84, P29, DOI 10.1007/s00109-005-0717-6; Lakoski SG, 2009, J CLIN ENDOCR METAB, V94, P2537, DOI 10.1210/jc.2009-0141; Lee H, 2019, INT J OBESITY, V43, P1620, DOI 10.1038/s41366-018-0212-0; Li H, 2009, J BIOL CHEM, V284, P28885, DOI 10.1074/jbc.M109.052407; Liang T, 2014, FOOD FUNCT, V5, P2175, DOI [10.1039/C4FO00224E, 10.1039/c4fo00224e]; Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x; Martin A, 1997, ARTERIOSCL THROM VAS, V17, P1583, DOI 10.1161/01.ATV.17.8.1583; McRae MP, 2008, J CHIROPR MED, V7, P48, DOI 10.1016/j.jcme.2008.01.002; Michels AJ, 2013, ANNU REV NUTR, V33, P45, DOI 10.1146/annurev-nutr-071812-161246; Miserez AR, 2002, ATHEROSCLEROSIS, V164, P15, DOI 10.1016/S0021-9150(01)00762-6; Nakata Y, 2002, CIRCULATION, V105, P1485, DOI 10.1161/01.CIR.0000012142.69612.25; Park JK, 2010, HEPATOLOGY, V51, P1766, DOI 10.1002/hep.23499; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Poirier S, 2013, DRUG DES DEV THER, V7, P1135, DOI 10.2147/DDDT.S36984; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; Sun L, 2017, ARTERIOSCL THROM VAS, V37, P1290, DOI 10.1161/ATVBAHA.117.309630; Tao RY, 2013, J BIOL CHEM, V288, P29252, DOI 10.1074/jbc.M113.481473; Tao RY, 2011, J BIOL CHEM, V286, P14681, DOI 10.1074/jbc.M110.201061; Tavori H, 2015, CURR OPIN ENDOCRINOL, V22, P126, DOI 10.1097/MED.0000000000000137; Tikhanovich I, 2013, J GASTROEN HEPATOL, V28, P125, DOI 10.1111/jgh.12021; Walia V, 2019, BEHAV BRAIN RES, V364, P85, DOI 10.1016/j.bbr.2019.02.007; Yu M, 2016, J BIOL CHEM, V291, P16977, DOI 10.1074/jbc.M116.740092; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang BT, 2013, MOL CELL BIOL, V33, P4919, DOI 10.1128/MCB.00787-13; Zhang KY, 2012, NEPHROLOGY, V17, P452, DOI 10.1111/j.1440-1797.2012.01595.x; Zhang WW, 2018, BBA-MOL CELL BIOL L, V1863, P177, DOI 10.1016/j.bbalip.2017.12.002; Zhou Q, 2018, EUR J PHARMACOL, V829, P1, DOI 10.1016/j.ejphar.2018.03.044	43	9	9	3	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2020	295	47					15870	15882		10.1074/jbc.RA120.015623	http://dx.doi.org/10.1074/jbc.RA120.015623			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PA5ED	32913121	Green Published, hybrid			2022-12-26	WOS:000595657900007
J	Anaba, EA; Abuosi, AA; Azilaku, JC; Nkrumah, J				Anaba, Emmanuel Anongeba; Abuosi, Aaron Asibi; Azilaku, Joshua Cobby; Nkrumah, Jacqueline			Association between health insurance membership and anaemia among children under-five years. Evidence from Ghana	PLOS ONE			English	Article							YOUNG-CHILDREN; PREVALENCE; COVERAGE; OUTCOMES; IMPACT	Introduction Anaemia is prevalent among children in developing countries. The main objective of this study was to assess the association between health insurance membership and anaemia among Ghanaian children under-five years. Methods We obtained Ghana's Multiple Indicators Cluster Survey, 2011 dataset from the United Nations International Children's Emergency Fund. Data were analyzed with the aid of Stata/IC, version 15. Results The prevalence of anaemia among Ghanaian children under-five years was estimated to be 57%. Majority (73%) of the children were not insured. Health insurance membership was found to be a significant predictor of anaemia among children under-five years. Conclusion Health insurance membership is a protective factor against anaemia among children under-five years. In the quest to eradicate anaemia among children, stakeholders would have to review the benefit package of the National Health Insurance Scheme coupled with prioritizing anaemia prevention interventions among more vulnerable children.	[Anaba, Emmanuel Anongeba] Univ Ghana, Dept Populat Family & Reprod Hlth, Accra, Ghana; [Abuosi, Aaron Asibi] Univ Ghana, Dept Publ Adm & Hlth Serv Management, Accra, Ghana; [Azilaku, Joshua Cobby] Kintampo Coll Hlth & Well Being, Kintampo, Ghana; [Nkrumah, Jacqueline] Univ Educ Winneba, Dept Hlth Adm & Educ, Winneba, Ghana	University of Ghana; University of Ghana	Anaba, EA (corresponding author), Univ Ghana, Dept Populat Family & Reprod Hlth, Accra, Ghana.	emmaanaba24@gmail.com		Anaba, Emmanuel Anongeba/0000-0002-8942-0460	UNICEF New York; Ministry of Health/Ghana Health Service; Ghana Statistical Service	UNICEF New York; Ministry of Health/Ghana Health Service; Ghana Statistical Service	The authors are grateful to UNICEF New York for providing financial and technical assistance to the Multiple Indicator Cluster Survey, whose data has been used in this study, through the UNICEF Ghana Country Office. Local costs for the survey were partially funded by the Ministry of Health/Ghana Health Service and the Ghana Statistical Service.	Abrokwah A.A., 2017, SOCIAL HLTH INSURANC; Allison P. D., 2014, P SAS GLOB FOR 2014, P1; [Anonymous], 2015, TRANSF OUR WORLD 203; Ansah EK, 2009, PLOS MED, V6, P48, DOI 10.1371/journal.pmed.1000007; Atinga RA, 2015, TROP MED INT HEALTH, V20, P312, DOI 10.1111/tmi.12433; Ayoya MA, 2013, ANEMIA, V2013, DOI 10.1155/2013/502968; Bagnoli L, 2017, ECARES WORKING PAPER; Bonfrer I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165623; Bosomprah S, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0101-0; Brabin BJ, 2001, J NUTR, V131, p636S, DOI 10.1093/jn/131.2.636S; Chen YY, 2012, J HEALTH ECON, V31, P1, DOI 10.1016/j.jhealeco.2011.11.001; Chou SY, 2014, J DEV ECON, V111, P75, DOI 10.1016/j.jdeveco.2014.08.004; Cornet M, 1998, AM J TROP MED HYG, V58, P606, DOI 10.4269/ajtmh.1998.58.606; Dow WH, 2003, SOC SCI MED, V57, P975, DOI 10.1016/S0277-9536(02)00464-1; Dwumoh D, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-42; Ewusie JE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-626; Fofack AD, 2019, J HLTH SCI MED RES, V37, P237, DOI [10.31584/jhsmr.201957, DOI 10.31584/JHSMR.201957]; Fry-Johnson YW, 2005, CURR OPIN PEDIATR, V17, P753, DOI 10.1097/01.mop.0000187455.17077.94; Gari T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170898; Gebreweld A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218961; Ghana Statistical Service, 2018, GHAN STAND LIV SURV; Ghana Statistical Service, 2011, GHAN MULT IND CLUST; Ghana Statistical Service. Ghana Health Service, 2009, GHAN DEM HLTH SURV 2; Ghana Statistical Service Ghana Health Service and ICF International, 2015, GHAN DEM HLTH SURV 2; Ghana Statistical Service. Noguchi Memorial Institute of Medical Research, 2004, GHAN DEM HLTH SURV 2; Ghana-Health-Service, 2018, HLTH SECT GHAN FACTS; Ghana-Statistical-Service Ghana Health Service and ICF macro, 2014, GHAN DEM HLTH SURV, P79; Koram KA, 2000, AM J TROP MED HYG, V62, P670, DOI 10.4269/ajtmh.2000.62.670; Kotoh AM, 2018, INT J HEALTH POLICY, V7, P443, DOI 10.15171/ijhpm.2017.117; Levine P.B., 2009, FORUM HLTH EC POLICY, V12, DOI [10.2202/1558-9544.1137, 10.2202/1558-9544.1137/html, DOI 10.2202/1558-9544.1137/HTML]; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Mitchinson C, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1543-2; Ngesa O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113756; Nshakira-Rukundo E, 2019, ZEF DISCUSSION PAPER; Nsiah-Boateng E, 2019, HEALTH ECON REV, V9, DOI 10.1186/s13561-019-0241-y; Pallant J., 2005, SPSS SURVIVAL MANUAL, V2; Parbey PA, 2019, ANEMIA, V2019, DOI 10.1155/2019/2139717; PREMJI Z, 1995, ACTA TROP, V59, P55, DOI 10.1016/0001-706X(94)00079-G; da Silva LLS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204504; Sommers BD, 2017, NEW ENGL J MED, V377, P586, DOI 10.1056/NEJMsb1706645; VanBuskirk KM, 2014, J TROP PEDIATRICS, V60, P308, DOI 10.1093/tropej/fmu020; Villalpando S, 2003, SALUD PUBLICA MEXICO, V45, pS520; World Health Organization (WHO), 2015, GLOB PREV AN 2011, DOI DOI 10.1017/S1368980008002401	43	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0238792	10.1371/journal.pone.0238792	http://dx.doi.org/10.1371/journal.pone.0238792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NS5RK	32925931	Green Published, gold			2022-12-26	WOS:000572318000001
J	Keleb, A; Sisay, T; Alemu, K; Ademas, A; Lingerew, M; Kloos, H; Mekonnen, TC; Derso, A; Adane, M				Keleb, Awoke; Sisay, Tadesse; Alemu, Kassahun; Ademas, Ayechew; Lingerew, Mistir; Kloos, Helmut; Mekonnen, Tefera Chane; Derso, Atimen; Adane, Metadel			Pneumonia remains a leading public health problem among under-five children in peri-urban areas of north-eastern Ethiopia	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; RISK-FACTORS	Background Pneumonia is a leading cause of morbidity and mortality among children under five years of age in developing countries, including Ethiopia. However, data on this serious illness among highly susceptible and vulnerable children living in local peri-urban areas are limited. Establishing the prevalence of pneumonia and identifying the associated factors are important for proper planning and intervention. Methods A community-based cross-sectional study was conducted among 560 systematically selected children under the age of five years in peri-urban areas of Dessie City from January through March 2019. Data were collected using a pretested structured questionnaire, physical examination of children and direct observation of housing conditions. Pneumonia was examined using World Health Organization (WHO) guidelines as the presence of the symptoms of fast breathing or indrawn chest with or without fast breathing during the two weeks prior to the study. A principal component analysis was used to construct a household wealth index. Data were analyzed using a binary logistic regression model at 95%CI (confidence interval). The analysis involved estimating the crude odds ratio (COR) using bivariate analysis, and adjusted odds ratio (AOR) using multivariable analysis. From the multivariable analysis, variables atp-value of less than 0.05 were declared statistically significant. Main findings The prevalence of pneumonia among children under five was 17.1% (95%CI: 13.9%-19.9%). Of the participating children, 113 (21.0%) had a cough, 92 (17.1%) had fast breathing, 76 (14.1%) had fever, and 40 (7.4%) of the children had chest indrawn. Domestic fuel was the most common source of cooking fuel 383 (71.1%). Majority 445 (82.6%) of children were fully vaccinated and 94 (17.4%) were not fully vaccinated. Most (481, 89.2%) of the children were got exclusive breastfeeding. Slightly more than half (284, 52.7%) of the under-five children had acute malnutrition and 27.1% of the children had a childhood history of ARI. The multivariable analysis showed using domestic fuel as the energy source for cooking (adjusted odds ratio [AOR] = 3.95, 95%CI: 1.47-10.62), cooking in the living room (AOR = 6.23; 95%CI: 1.80-21.68), overcrowding (AOR = 3.37, 95%CI: 1.56-7.27), child history of acute respiratory infection (ARI) (AOR = 6.12 95%CI: 2.77-13.53), family history of ARI (AOR = 4.69, 95%CI: 1.67-13.12) and acute malnutrition (AOR = 2.43, 95%CI: 1.18-5.04) were significantly associated with childhood pneumonia. Conclusion In this study, pneumonia remains a leading public health problem among under five children in the study area and higher than national averages. Domestic fuel as the energy source for cooking, cooking in the living room, overcrowding, child history of ARI, family history of ARI and acute malnutrition were predictors of pneumonia. Community-based interventions focusing on improving housing conditions, reduced use of domestic biofuels, adequate and balanced food intake, including exclusive breastfeeding of infants, and early treatment of ARIs.	[Keleb, Awoke; Sisay, Tadesse; Ademas, Ayechew; Lingerew, Mistir; Derso, Atimen; Adane, Metadel] Wollo Univ, Coll Med & Hlth Sci, Dept Environm Hlth, Dessie, Ethiopia; [Alemu, Kassahun] Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia; [Kloos, Helmut] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA; [Mekonnen, Tefera Chane] Wollo Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Nutr, Dessie, Ethiopia	University of Gondar; University of California System; University of California San Francisco	Adane, M (corresponding author), Wollo Univ, Coll Med & Hlth Sci, Dept Environm Hlth, Dessie, Ethiopia.	metadel.adane2@gmail.com	Ademas, Ayechew/AAG-5984-2021; Mekonnen, Tefera Chane/AAC-8002-2021; Keleb, Awoke/AGX-2940-2022; Ademas, Ayechew/AAO-4212-2021; Adane, Metadel/AFQ-9478-2022	Ademas, Ayechew/0000-0003-2602-162X; Keleb, Awoke/0000-0002-7510-3448; Ademas, Ayechew/0000-0003-2602-162X; Adane, Metadel/0000-0002-7039-4768	Wollo University	Wollo University	This study was funded by Wollo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuka T., 2017, CURR PEDIAT, V21, P19; Admasie A, 2018, J ENV PUBLIC HLTH, V2018, P1; Amato R, 2016, ELIFE, V5, DOI 10.7554/eLife.08714; Asboe D, 2012, HIV MED, V13, P1, DOI 10.1111/j.1468-1293.2011.00971.x; Banerji A, 2009, PEDIATR INFECT DIS J, V28, P697, DOI 10.1097/INF.0b013e31819f1f89; Bhat RY, 2013, INT J TUBERC LUNG D, V17, P418, DOI 10.5588/ijtld.12.0117; Bipin P, 2011, NATL J COMMUNITY MED, V2, P255; COLWELL RR, 1986, MICROB ECOL, V12, P1, DOI 10.1007/BF02153217; CSA, 2014, POP HOUS CENS ETH 1; CSA ICF-International, 2016, ADD AB ETH CALV; Dadi AF, 2014, OPEN ACCESS LIB J, V1, P1044, DOI [10.4236/oalib.1101044, DOI 10.4236/OALIB.1101044]; Dessie City Administration Health Office, 2018, DESS CIT ADM ANN REP; Dessie City Adminstration, 2014, DESS CIT ADM ANN REP; Ethiopia National expanded programme on immunization, 2015, COMPR PLAN 2016 2020; Fatmi Zafar, 2002, International Journal of Infectious Diseases, V6, P294, DOI 10.1016/S1201-9712(02)90164-5; Fekadu GA, 2014, SCI J PUBLIC HLTH, V2, P150, DOI [10.11648/j.sjph.20140203.12, DOI 10.11648/J.SJPH.20140203.12]; Fonseca W, 1997, J TROP PEDIATRICS, V43, P123, DOI 10.1093/tropej/43.2.123; Gashu Adam A, 2014, PERIURBAN LAND TENUR; GOEL K, 2012, J COMMUN MED HLTH ED, V2, P2, DOI DOI 10.4172/2161-0711.1000176; Jackson S, 2013, CROAT MED J, V54, P110, DOI 10.3325/cmj.2013.54.110; Kelsey JL., 1996, METHODS OBSERVATIONA; Lema K., 2018, J PULMONOLOGY CLIN R, V2, P25; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Mukanga DOD, 2012, PAKISTAN ENG C, V2007, P1; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Nirmolia N, 2018, CLIN EPIDEMIOL GLOB, V6, P1, DOI 10.1016/j.cegh.2017.07.004; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Savitha MR, 2007, INDIAN J PEDIATR, V74, P477, DOI 10.1007/s12098-007-0081-3; Sonego M, 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0116380; UNICEF, 2016, FAIR CHANC EV CHILD; UNICEF, 2016, PNEUM DEADL CHILDH D; UNICEF, 2016, CLEAR AIR CHILDR IMP; UNICEF, 2012, STAT WORLDS CHILDR 2; UNICEF, 2022, DEM WSPOLCZ DZIETN; World Health Organization, 2014, REV WHO CLASS TREATM; World Health Organization, 2010, WHY URB HLTH MATT WO	36	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0235818	10.1371/journal.pone.0235818	http://dx.doi.org/10.1371/journal.pone.0235818			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915807	gold, Green Published			2022-12-26	WOS:000571887500112
J	Krzykala, M; Karpowicz, M; Strzelczyk, R; Pluta, B; Podciechowska, K; Karpowicz, K				Krzykala, Magdalena; Karpowicz, Malgorzata; Strzelczyk, Ryszard; Pluta, Beata; Podciechowska, Karolina; Karpowicz, Krzysztof			Morphological asymmetry, sex and dominant somatotype among Polish youth	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; BILATERAL ASYMMETRY; SYMMETRY; MEN	The aim of the present study was to determine the level of morphological asymmetry among the general population of Polish youth as it correlates to sex and body type. The anthropometric characteristics of a group of 618 Polish youths (354 males aged 19.5 +/- 1.2 years and 264 females aged 19.2 +/- 1.2 years) were evaluated to assess their somatotypes using the Heath-Carter method. Body composition was calculated using the bioelectrical impedance method, and the absolute asymmetry index was used for comparisons between the right and left sides of the body. Significant differentiation was observed between all morphological characteristics (<= 0.0001) and two body types (<= 0.0001) among sexes. Females and males largely exhibited endomorphic and mesomorphic somatotypes, respectively. The findings demonstrated that dominant somatotype and sex both affect the level of fat mass asymmetry in the arms and legs. Furthermore, significant variations in the levels of asymmetry between sexes were observed in fat mass in both the arms and legs, with greater variation observed in the arms. In the case of muscle mass, no great differences were observed between men, women, or body types. This study provides new data on the morphological asymmetry of given body composition according to somatotype and sex. This study has potential medical implications, given that a large degree of inter-limb imbalance could be shown to have a negative effect on health; the findings of the present study would therefore be important for arriving at an understanding of how to prevent such imbalances, or to mitigate their negative effects.	[Krzykala, Magdalena; Pluta, Beata; Podciechowska, Karolina] Poznan Univ Phys Educ, Dept Recreat, Poznan, Poland; [Karpowicz, Malgorzata] Poznan Univ Phys Educ, Dept Theory & Methodol Team Sport Games, Poznan, Poland; [Strzelczyk, Ryszard; Karpowicz, Krzysztof] Poznan Univ Phys Educ, Dept Theory Sport, Poznan, Poland		Krzykala, M (corresponding author), Poznan Univ Phys Educ, Dept Recreat, Poznan, Poland.	krzykala@awf.poznan.pl	Pluta, Beata/K-9146-2019; Karpowicz, Krzysztof/K-9638-2017	Pluta, Beata/0000-0002-1964-7408; Karpowicz, Krzysztof/0000-0002-6622-2955; Krzykala, Magdalena/0000-0001-8373-1869; Podciechowska, Karolina/0000-0002-9551-7568				Al-Eisa E, 2004, EVOL HUM BEHAV, V25, P31, DOI 10.1016/S1090-5138(03)00081-3; [Anonymous], 2019, ANTHROPOL REV, DOI DOI 10.2478/anre-2019-0004; aska-Mierzejewska T, 1999, ANTROPOLOGIA SPORCIE; Auerbach BM, 2006, J HUM EVOL, V50, P203, DOI 10.1016/j.jhevol.2005.09.004; Bell DR, 2014, J STRENGTH COND RES, V28, P884, DOI 10.1519/JSC.0000000000000367; Bjorklund G, 2017, J HUM KINET, V60, P9, DOI 10.1515/hukin-2017-0107; Bolonchuk WW, 2000, AM J HUM BIOL, V12, P167, DOI 10.1002/(SICI)1520-6300(200003/04)12:2&lt;167::AID-AJHB2&gt;3.0.CO;2-3; BULBULIAN R, 1984, MED SCI SPORT EXER, V16, P389; Cohen J.E., 1988, STAT POWER ANAL BEHA; Demerath EW, 2002, INT J OBESITY, V26, P389, DOI 10.1038/sj.ijo.0801898; Fort-Vanmeerhaeghe A, 2016, J HUM KINET, V50, P135, DOI 10.1515/hukin-2015-0150; Goldberg CJ, 1997, SPINE, V22, P775, DOI 10.1097/00007632-199704010-00014; Gualdi-Russo E., 1997, INT J ANTHR, V12, P11; HEATH BH, 1967, AM J PHYS ANTHROPOL, V27, P57, DOI 10.1002/ajpa.1330270108; Hewit J, 2012, STRENGTH COND J, V34, P82, DOI 10.1519/SSC.0b013e31823e83db; Heyward V. H., 2004, Applied body composition assessment; Karamanidis K, 2003, MED SCI SPORT EXER, V35, P1009, DOI 10.1249/01.MSS.0000069337.49567.F0; Krishan K, 2011, AM J HUM BIOL, V23, P674, DOI 10.1002/ajhb.21196; Krzykaa M, 2018, PILOT STUDY HOMO, V69, P43; KUSHNER RF, 1992, AM J CLIN NUTR, V56, P835, DOI 10.1093/ajcn/56.5.835; Lee EJ, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017882; Leung B, 1998, P ROY SOC B-BIOL SCI, V265, P1623, DOI 10.1098/rspb.1998.0480; Maly T, 2019, OPEN MED-WARSAW, V14, P207, DOI 10.1515/med-2019-0014; Manning JT, 2000, LATERALITY, V5, P121, DOI 10.1080/135765000396744; MANNING JT, 1995, ETHOL SOCIOBIOL, V16, P145, DOI 10.1016/0162-3095(94)00074-H; Marangoz I., 2018, J ED TRAINING STUDIE, V6, P108, DOI [DOI 10.11114/JETS.V6I9.3345, 10.11114/jets.v6i9.3345]; Newton RU, 2006, J STRENGTH COND RES, V20, P971; Ozener B, 2011, ANN HUM BIOL, V38, P34, DOI 10.3109/03014460.2010.486770; Ozener B, 2010, AM J PHYS ANTHROPOL, V143, P112, DOI 10.1002/ajpa.21300; Pierre MA, 2010, J BIOMECH, V43, P2228, DOI 10.1016/j.jbiomech.2010.02.032; RYNKIEWICZ M, 2013, TRENDS SPORT SCI, V1, P47; SCHELL LM, 1985, AM J PHYS ANTHROPOL, V67, P317, DOI 10.1002/ajpa.1330670404; Singh A.P., 2007, ANTHROPOL, V9, P251, DOI [10.1080/09720073.2007.11891008, DOI 10.1080/09720073.2007.11891008]; Stewart A., 2011, INT STANDARDS ANTHRO; Van Dongen S, 2018, SYMMETRY-BASEL, V10, DOI 10.3390/sym10040117; Wells JCK, 2007, BEST PRACT RES CL EN, V21, P415, DOI 10.1016/j.beem.2007.04.007; Witkowski M, 2019, ARCH BUDO, V15, P221; Yang LT, 2016, ANAT SCI INT, V91, P180, DOI 10.1007/s12565-015-0283-0	38	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238706	10.1371/journal.pone.0238706	http://dx.doi.org/10.1371/journal.pone.0238706			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9MU	32915820	gold, Green Published			2022-12-26	WOS:000571887500135
J	Mastrorocco, A; Cacopardo, L; Martino, NA; Fanelli, D; Camillo, F; Ciani, E; Roelen, BAJ; Ahluwalia, A; Dell'Aquila, ME				Mastrorocco, Antonella; Cacopardo, Ludovica; Martino, Nicola Antonio; Fanelli, Diana; Camillo, Francesco; Ciani, Elena; Roelen, Bernard A. J.; Ahluwalia, Arti; Dell'Aquila, Maria Elena			One-step automated bioprinting-based method for cumulus-oocyte complex microencapsulation for 3D in vitro maturation	PLOS ONE			English	Article							SUBCORTICAL MATERNAL COMPLEX; FOLLICLE DEVELOPMENT; GENE-EXPRESSION; DEVELOPMENTAL COMPETENCE; 3-DIMENSIONAL CULTURE; OVARIAN-FOLLICLES; OXIDATIVE STRESS; ALGINATE; NUCLEAR; SHEEP	Three-dimensionalin vitromaturation (3D IVM) is a promising approach to improve IVM efficiency as it could prevent cumulus-oocyte complex (COC) flattening and preserve its structural and functional integrity. Methods reported to date have low reproducibility and validation studies are limited. In this study, a bioprinting based production process for generating microbeads containing a COC (COC-microbeads) was optimized and its validity tested in a large animal model (sheep). Alginate microbeads were produced and characterized for size, shape and stability under culture conditions. COC encapsulation had high efficiency and reproducibility and cumulus integrity was preserved. COC-microbeads underwent IVM, with COCs cultured in standard 2D IVM as controls. After IVM, oocytes were analyzed for nuclear chromatin configuration, bioenergetic/oxidative status and transcriptional activity of genes biomarker of mitochondrial activity (TFAM,ATP6,ATP8) and oocyte developmental competence (KHDC3,NLRP5,OOEPandTLE6). The 3D system supported oocyte nuclear maturation more efficiently than the 2D control (P<0.05). Ooplasmic mitochondrial activity and reactive oxygen species (ROS) generation ability were increased (P<0.05). Up-regulation ofTFAM,ATP6 andATP8and down-regulation ofKHDC3,NLRP5expression were observed in 3D IVM. In conclusion, the new bioprinting method for producing COC-microbeads has high reproducibility and efficiency. Moreover, 3D IVM improves oocyte nuclear maturation and relevant parameters of oocyte cytoplasmic maturation and could be used for clinical and toxicological applications.	[Mastrorocco, Antonella; Martino, Nicola Antonio; Ciani, Elena; Dell'Aquila, Maria Elena] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Cacopardo, Ludovica; Ahluwalia, Arti] Univ Pisa, Res Ctr E Piaggio, Pisa, Italy; [Fanelli, Diana; Camillo, Francesco] Univ Pisa, Dept Vet Sci, Pisa, Italy; [Roelen, Bernard A. J.] Univ Utrecht, Fac Vet Med, Dept Clin Sci Embryol Anat & Physiol, Utrecht, Netherlands; [Ahluwalia, Arti] Univ Pisa, Dept Informat Engn, Pisa, Italy; [Mastrorocco, Antonella] Univ Teramo, Fac Vet Med, Teramo, Italy; [Martino, Nicola Antonio] Univ Torino, Dept Vet Sci, Turin, Italy	Universita degli Studi di Bari Aldo Moro; University of Pisa; University of Pisa; Utrecht University; University of Pisa; University of Teramo; University of Turin	Mastrorocco, A (corresponding author), Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy.; Mastrorocco, A (corresponding author), Univ Teramo, Fac Vet Med, Teramo, Italy.	antonella.mastrorocco@uniba.it	Fanelli, Diana/AAC-3184-2022	Roelen, Bernard/0000-0001-9512-4708; Dell'Aquila, Maria Elena/0000-0003-3629-7005; Mastrorocco, Antonella/0000-0001-7136-4029	UE -FSEFSER [PON RI 2014-2020 Action I.1 -, 2, DOT1302781]; Italian Ministry for Education, University and Research [C46C18000530001]	UE -FSEFSER; Italian Ministry for Education, University and Research(Ministry of Education, Universities and Research (MIUR))	This study was funded by UE -FSEFSER, PON RI 2014-2020 Action I.1 -"Innovative doctoral of industrial interest" -a.a. 2016/2017, XXXII cycle, PhD Program "Functional and Applied Genomics and Proteomics" -DOT1302781" -Grant n degrees 2. A.M. was also supported by the Research Grant n degrees VERI00086 in the framework of the Project "Demetra" (Dipartimenti di Eccellenza 2018-22; CUP code: C46C18000530001) funded by the Italian Ministry for Education, University and Research.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Arias-Alvarez M, 2017, REPROD FERT DEVELOP, V29, P1667, DOI [10.1071/RD15553, 10.1071/rd15553]; Ariu F, 2014, CRYOLETTERS, V35, P530; Asif SM, 2015, IEEE WIREL COMMUN LE, V4, P133, DOI 10.1109/LWC.2014.2383401; Axpe E, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121976; Babayev E, 2015, CURR OPIN OBSTET GYN, V27, P175, DOI 10.1097/GCO.0000000000000164; Bebbere D, 2016, J ASSIST REPROD GEN, V33, P1431, DOI 10.1007/s10815-016-0788-z; Bebbere D, 2014, BMC DEV BIOL, V14, DOI 10.1186/s12861-014-0040-y; Blondin P, 2017, REPROD FERT DEVELOP, V29, P32, DOI [10.1071/RD16317, 10.1071/rd16317]; Brito IR, 2014, MOL REPROD DEV, V81, P636, DOI 10.1002/mrd.22330; Brown HM, 2017, REPRODUCTION, V153, pR109, DOI [10.1530/REP-16-0426, 10.1530/rep-16-0426]; Chappel S, 2013, OBSTET GYNECOL INT, V2013, DOI 10.1155/2013/183024; Choi JK, 2014, BIOMATERIALS, V35, P5122, DOI 10.1016/j.biomaterials.2014.03.028; Colombo M, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9060329; Cristea D, 2020, ACTA BIOMATER, V101, P384, DOI 10.1016/j.actbio.2019.10.032; da Fonseca RR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-119; Dell'Aquila ME, 2003, BIOL REPROD, V68, P2065, DOI 10.1095/biolreprod.102.009852; DELOOS F, 1992, MOL REPROD DEV, V31, P208, DOI 10.1002/mrd.1080310308; Desai N, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-119; Dorati R, 2016, J MICROENCAPSUL, V33, P137, DOI 10.3109/02652048.2015.1134691; Duval K, 2017, PHYSIOLOGY, V32, P266, DOI 10.1152/physiol.00036.2016; Faustini M, 2018, METHODS MOL BIOL, V1817, P89, DOI 10.1007/978-1-4939-8600-2_9; Ferreira EM, 2009, THERIOGENOLOGY, V71, P836, DOI 10.1016/j.theriogenology.2008.10.023; Gilchrist RB, 2004, ANIM REPROD SCI, V82-3, P431, DOI 10.1016/j.anireprosci.2004.05.017; He XM, 2017, ANN BIOMED ENG, V45, P1676, DOI 10.1007/s10439-017-1823-7; He XM, 2017, SEMIN CELL DEV BIOL, V61, P140, DOI 10.1016/j.semcdb.2016.07.006; Hillen HS, 2018, NAT STRUCT MOL BIOL, V25, P754, DOI 10.1038/s41594-018-0122-9; Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9; Jones ASK, 2019, J BIOL ENG, V13, DOI 10.1186/s13036-018-0134-3; Lee SH, 2003, MOL CELLS, V15, P181; Lee SH, 2000, FERTIL STERIL, V73, P1001, DOI 10.1016/S0015-0282(00)00486-6; Li L, 2008, DEV CELL, V15, P416, DOI 10.1016/j.devcel.2008.07.010; Lu XK, 2017, TRENDS MOL MED, V23, P1014, DOI 10.1016/j.molmed.2017.09.004; Martino NA, 2017, REPROD TOXICOL, V69, P132, DOI 10.1016/j.reprotox.2017.02.005; Martino NA, 2016, REPROD TOXICOL, V65, P204, DOI 10.1016/j.reprotox.2016.08.004; Martino NA, 2012, FERTIL STERIL, V97, P720, DOI 10.1016/j.fertnstert.2011.12.014; Mastrorocco A, 2019, MOL REPROD DEV, V86, P1430, DOI 10.1002/mrd.23256; Monk D, 2017, REPRODUCTION, V154, pR161, DOI 10.1530/REP-17-0465; Morselli MG, 2017, REPROD DOMEST ANIM, V52, P82, DOI 10.1111/rda.12850; Morselli MG, 2017, REPROD DOMEST ANIM, V52, P83, DOI 10.1111/rda.12806; Morselli MG, 2018, REPROD DOMEST ANIM, V53, P117, DOI 10.1111/rda.13336; Niederberger C, 2018, FERTIL STERIL, V110, P185, DOI 10.1016/j.fertnstert.2018.06.005; Pandolfi V, 2017, CURR PHARM DESIGN, V23, P3833, DOI 10.2174/1381612823666170609084016; Pangas SA, 2003, TISSUE ENG, V9, P1013, DOI 10.1089/107632703322495655; Paramio MT, 2014, REPROD DOMEST ANIM, V49, P37, DOI 10.1111/rda.12334; Parrish EM, 2011, REPRODUCTION, V142, P309, DOI 10.1530/REP-10-0481; Qin DD, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.183616; Romar R, 2019, THERIOGENOLOGY, V137, P113, DOI 10.1016/j.theriogenology.2019.05.045; Russ JC., 2011, IMAGE PROCESSING HDB; Sadr SZ, 2018, BIOPRESERV BIOBANK, V16, P120, DOI 10.1089/bio.2017.0087; Salustri A, 2019, MATRIX BIOL, V78-79, P11, DOI 10.1016/j.matbio.2018.02.002; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shea LD, 2014, ANNU REV BIOMED ENG, V16, P29, DOI 10.1146/annurev-bioeng-071813-105131; Silva GM, 2015, ZYGOTE, V23, P475, DOI 10.1017/S0967199414000070; Sirard MA, 2018, REPRODUCTION, V156, pR1, DOI 10.1530/REP-18-0008; Sugiura K, 2005, DEV BIOL, V279, P20, DOI 10.1016/j.ydbio.2004.11.027; Thompson J G, 2007, Soc Reprod Fertil Suppl, V64, P179; Tirella A, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/025009; Tirella A, 2011, TISSUE ENG PART C-ME, V17, P229, DOI [10.1089/ten.tec.2010.0195, 10.1089/ten.TEC.2010.0195]; Vanacker J, 2017, ANN BIOMED ENG, V45, P1633, DOI 10.1007/s10439-017-1816-6; Varnosfaderani SR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229043; Walls ML, 2018, BEST PRACT RES CL OB, V53, P60, DOI 10.1016/j.bpobgyn.2018.06.004; Walter J, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5836-5; West ER, 2007, SEMIN REPROD MED, V25, P287, DOI 10.1055/s-2007-980222; Xu M, 2006, TISSUE ENG, V12, P2739, DOI 10.1089/ten.2006.12.2739; Zhao XM, 2015, ZYGOTE, V23, P525, DOI 10.1017/S0967199414000161	66	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238812	10.1371/journal.pone.0238812	http://dx.doi.org/10.1371/journal.pone.0238812			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915922	gold, Green Published			2022-12-26	WOS:000571887500117
J	Mizuno, K; Ojiro, D; Tanaka, T; Minusa, S; Kuriyama, H; Yamano, E; Kuratsune, H; Watanabe, Y				Mizuno, Kei; Ojiro, Daichi; Tanaka, Takeshi; Minusa, Shunsuke; Kuriyama, Hiroyuki; Yamano, Emi; Kuratsune, Hirohiko; Watanabe, Yasuyoshi			Relationship between truck driver fatigue and rear-end collision risk	PLOS ONE			English	Article							DISTANCE	The fatigue of truck, bus, and taxi drivers has been a causal trigger for road accidents. However, the relationship between collision risk and the extent of objective fatigue has yet to be confirmed. In this study, we aimed to identify the relationship between autonomic nerve function as an objective parameter of fatigue and the extent of rear-end collision risk, which includes not only objectively risky events but also situations in which truck drivers require safety guidance from safety transport managers. Data of 33 truck driver participants (2 females, 31 males, 46.0 +/- 9.1 years old, min-max: 24-65 years old) were analyzed. Drive recorder and automotive sensor data were collected over an eight-month period, and the autonomic nerve function during resting state in drivers was evaluated daily, pre- and post-shift, using pulse waves and electrocardiographic waveform measurement. The rear-end collision risk Index was developed using decision tree analysis of the audiovisual drive recorder data and distance data from the front automotive sensors. The rear-end collision risk index of shift-day was positively correlated with the sympathetic nerve activity index of post-shift condition on the previous day. This suggests that fatigue-related sympathetic nerve overactivity of post-shift condition increases the rear-end collision risk in the following day. Measures, such as actively seeking rest and undertaking fatigue recovery according to the degree of sympathetic nerve activity of post-shift condition, are necessary in order to prevent truck drivers' rear-end collisions.	[Mizuno, Kei; Yamano, Emi; Kuratsune, Hirohiko; Watanabe, Yasuyoshi] RIKEN, Lab Pathophysiol & Hlth Sci, Ctr Biosyst Dynam Res, Kobe, Hyogo, Japan; [Mizuno, Kei; Yamano, Emi; Watanabe, Yasuyoshi] RIKEN, Compass Hlth Life Res Complex Program, Kobe, Hyogo, Japan; [Mizuno, Kei; Yamano, Emi; Watanabe, Yasuyoshi] Osaka City Univ, Ctr Hlth Sci Innovat, Osaka, Japan; [Mizuno, Kei] Osaka City Univ, Dept Med Sci Fatigue, Grad Sch Med, Osaka, Japan; [Ojiro, Daichi; Tanaka, Takeshi; Minusa, Shunsuke; Kuriyama, Hiroyuki] Hitachi Ltd, Res & Dev Grp, Tokyo, Japan; [Kuratsune, Hirohiko] Osaka City Univ, Dept Metab Endocrinol & Mol Med, Grad Sch Med, Osaka, Japan; [Kuratsune, Hirohiko] FMCC Co Ltd, Osaka, Japan	RIKEN; RIKEN; Osaka Metropolitan University; Osaka Metropolitan University; Hitachi Limited; Osaka Metropolitan University	Mizuno, K (corresponding author), RIKEN, Lab Pathophysiol & Hlth Sci, Ctr Biosyst Dynam Res, Kobe, Hyogo, Japan.; Mizuno, K (corresponding author), RIKEN, Compass Hlth Life Res Complex Program, Kobe, Hyogo, Japan.; Mizuno, K (corresponding author), Osaka City Univ, Ctr Hlth Sci Innovat, Osaka, Japan.; Mizuno, K (corresponding author), Osaka City Univ, Dept Med Sci Fatigue, Grad Sch Med, Osaka, Japan.	keimizuno@riken.jp		Minusa, Shunsuke/0000-0002-8186-3603	Research & Development Group, Hitachi, Ltd.	Research & Development Group, Hitachi, Ltd.	This work was supported by the Research & Development Group, Hitachi, Ltd. The funder provided support in the form of salaries for authors (D.O, T.T, S.M, and H.K), but did not have any additional role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. FMCC Co. Ltd. provided support in the form of salaries for author (H.K), but did not have any additional role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific role of each author is articulated in the "author contributions" section.	Baek HJ, 2015, TELEMED E-HEALTH, V21, P404, DOI 10.1089/tmj.2014.0104; Benarroch E.E., 1997, CLIN AUTONOMIC DISOR, P17; Chen F, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16142632; Chen F, 2011, ACCIDENT ANAL PREV, V43, P1677, DOI 10.1016/j.aap.2011.03.026; Chen PY, 2020, TUNN UNDERGR SP TECH, V99, DOI 10.1016/j.tust.2020.103362; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Garbarino S, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091852; Groeger J. A, 2000, UNDERSTING DRIVIN; Hankey J. M., 2016, DESCRIPTION SHRP 2 N; Hiraoka T, 2009, T SOC AUTOM ENGJPN, V40, P545; Jafarnejad S., 2018, VEHITS, V1, P178; Japan Trucking Association, 2018, HDB TRAFF ACC PREV C; Japan Trucking Association, 2018, REP AUT TRAFF ACC MO; Japan Trucking Association, 2018, CURR STAT TASKS TRUC; JC Hayward, 1972, TTSC7115 U PARK HIGH; Jiao K, 2004, INT ARCH OCC ENV HEA, V77, P205, DOI 10.1007/s00420-003-0493-y; Knodler MA, 2019, USING NEW SHRP2 NATU; Koizumi J, 2014, DETERMINATION SYSTEM, Patent No. P5455071; Kume S, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00108; Li N, 2016, 2016 IEEE 19TH INTERNATIONAL CONFERENCE ON INTELLIGENT TRANSPORTATION SYSTEMS (ITSC), P2583, DOI 10.1109/ITSC.2016.7795971; Loewy AD., 1990, CENTRAL REGULATION A, P88; Makowiec-Dabrowska T, 2019, INT J BIOMETEOROL, V63, P121, DOI 10.1007/s00484-018-1643-y; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Mesulam MM, 2001, NEUROIMAGE, V13, P1065, DOI 10.1006/nimg.2001.0768; Meuleners L, 2015, J CLIN SLEEP MED, V11, P413, DOI 10.5664/jcsm.4594; MICHON JA, 1989, ACCIDENT ANAL PREV, V21, P341, DOI 10.1016/0001-4575(89)90025-0; Ministry of Land Infrastructure T and T, 2018, ANN REP ACC AUT MOT; Ministry of Land Infrastructure Transport and Tourism, 2017, REP STUD GROUP AN FA; Mizuno K, 2017, MED GAS RES, V7, P247, DOI 10.4103/2045-9912.222448; Moodithaya Shailaja, 2012, J Aging Res, V2012, P679345, DOI 10.1155/2012/679345; Oka T, 2018, BIOPSYCHOSOC MED, V12, DOI 10.1186/s13030-018-0123-2; Okawa N, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01194; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Olshen R., 1984, BIOMETRICS, V40, P582, DOI DOI 10.2307/2530946; Oyama H., 2011, Journal of Science of Labour, V87, P121; Tanaka M, 2015, J PHYSIOL SCI, V65, P483, DOI 10.1007/s12576-015-0399-y; Uchiyama Y, 2003, NEUROSCI LETT, V352, P199, DOI 10.1016/j.neulet.2003.08.072; Yokoyama Kiyoko, 2013, Transactions of the Institute of Electronics, Information and Communication Engineers A, VJ96-A, P756; Zeng Q, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082768; Zeng Q, 2019, TRANSPORTMETRICA A, V15, P1867, DOI 10.1080/23249935.2019.1652867; Zeng Q, 2020, J TRANSP SAF SECUR, V12, P566, DOI 10.1080/19439962.2018.1516259	41	4	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238738	10.1371/journal.pone.0238738	http://dx.doi.org/10.1371/journal.pone.0238738			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915847	gold, Green Published			2022-12-26	WOS:000571887500043
J	Rogal, SS; Yakovchenko, V; Gonzalez, R; Park, A; Lamorte, C; Gibson, SP; Chartier, M; Ross, D; Comstock, E; Bajaj, JS; Morgan, TR				Rogal, Shari S.; Yakovchenko, Vera; Gonzalez, Rachel; Park, Angela; Lamorte, Carolyn; Gibson, Sandra P.; Chartier, Maggie; Ross, David; Comstock, Emily; Bajaj, Jasmohan S.; Morgan, Timothy R.			Characterizing patient-reported outcomes in veterans with cirrhosis	PLOS ONE			English	Article							QUALITY-OF-LIFE; INFLAMMATORY CYTOKINES; SELF-MANAGEMENT; OPIOID USE; HEALTH; DEPRESSION; ANXIETY; SYMPTOMS; COMORBIDITY; PAIN	Background and aims The Veterans Health Administration (VA) cares for over 80,000 Veterans with cirrhosis annually. Given the importance of understanding patient reported outcomes in this complex population, we aimed to assess the associations between attitudes towards care, disease knowledge, and health related quality of life (HRQoL) in a national sample. Methods In this cross-sectional study, we mailed paper surveys to a random sample of Veterans with cirrhosis, oversampling those with decompensated disease. Surveys included the Veterans RAND 12-Item Health Survey (measuring HRQoL) and questions about demographics, characteristics of care, satisfaction with care ("attitudes towards care"), and symptoms of cirrhosis. Those who reported being "unsure" about whether they had decompensation events were defined as "unsure about cirrhosis symptoms" ("disease knowledge"). We used multivariable regression models to assess the factors associated with HRQoL. Results Of 1374 surveys, 551 (40%) completed surveys were included for analysis. Most Veterans (63%) were "satisfied" or "very satisfied" with VA liver care. Patients often self-reported being unsure about whether they had experienced hepatic decompensation events (34%). Overall average physical (PCS) and mental (MCS) component scores of HRQoL were 30 +/- 11 and 41 +/- 12. In multivariable regression models, hepatic decompensation (PCS:beta = -3.8, MCS:beta = -2.2), medical comorbidities (beta = --2.0, beta = -1.7), and being unsure about cirrhosis symptoms (beta = -1.9, beta = -3.3) were associated with worse HRQoL, while age (beta = 0.1, beta = 0.2) and satisfaction with care (beta = 0.6; beta = 1.6) were associated with significantly better HRQoL. Conclusions Hepatic decompensation, lower satisfaction with care, and being unsure about cirrhosis symptoms were associated with reduced QOL scores in this national cohort.	[Rogal, Shari S.; Lamorte, Carolyn; Gibson, Sandra P.] VA Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA 15240 USA; [Rogal, Shari S.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA; [Rogal, Shari S.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA; [Yakovchenko, Vera] Edith Norse Rogers Mem VA Hosp, Ctr Healthcare Org & Implementat Res, Bedford, MA USA; [Gonzalez, Rachel; Morgan, Timothy R.] VA Long Beach Healthcare Syst, Gastroenterol Sect, Long Beach, CA USA; [Park, Angela] Dept Vet Affairs, Off Healthcare Transformat, Washington, DC USA; [Chartier, Maggie; Ross, David] Vet Hlth Adm, HIV Hepatitis & Related Condit Programs, Off Specialty Care Serv, Washington, DC USA; [Comstock, Emily] Baltimore VA Med Ctr, Dept Infect Dis, Baltimore, MD USA; [Bajaj, Jasmohan S.] Virginia Commonwealth Univ, Div Gastroenterol Hepatol & Nutr, Richmond, VA USA; [Bajaj, Jasmohan S.] Hunter Holmes McGuire VA Med Ctr, Div Gastroenterol, Richmond, VA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center	Rogal, SS (corresponding author), VA Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA 15240 USA.; Rogal, SS (corresponding author), Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA.; Rogal, SS (corresponding author), Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA.	Shari.Rogal@va.gov		Rogal, Shari/0000-0001-8184-1546	Agency for Healthcare Research and Quality Award [K12 - HS019461]; VA HIV, Hepatitis, and Related Conditions Programs in the Office of Specialty Care Services	Agency for Healthcare Research and Quality Award; VA HIV, Hepatitis, and Related Conditions Programs in the Office of Specialty Care Services	This work was supported by Agency for Healthcare Research and Quality Award (K12 - HS019461) and by funding from the VA HIV, Hepatitis, and Related Conditions Programs in the Office of Specialty Care Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelaira HM, 2014, NEUROCHEM RES, V39, P1634, DOI 10.1007/s11064-014-1372-5; Adnanes M, 2019, QUAL LIFE RES, V28, P713, DOI 10.1007/s11136-018-2039-5; Alavinejad Pezhman, 2019, Gastroenterol Hepatol Bed Bench, V12, P17; [Anonymous], 2017, CLIN GENITOURIN CANC; Beg S, 2016, EUR J GASTROEN HEPAT, V28, P582, DOI 10.1097/MEG.0000000000000579; Belperio PS, 2017, ANN INTERN MED, V167, P499, DOI 10.7326/M17-1073; Blake KD, 2016, J HEALTH COMMUN, V21, P1269, DOI 10.1080/10810730.2016.1242672; Buganza-Torio E, 2019, ALIMENT PHARM THER, V49, P194, DOI 10.1111/apt.15068; Calvert M, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-184; Cramm JM, 2013, APPL RES QUAL LIFE, V8, P481, DOI 10.1007/s11482-012-9209-3; Frojd C, 2009, SCAND J CARING SCI, V23, P107, DOI 10.1111/j.1471-6712.2008.00596.x; Goldsworthy MA, 2017, FRONTLINE GASTROENTE, V8, P214, DOI 10.1136/flgastro-2016-100761; Grydgaard MF, 2018, SCAND J GASTROENTERO, V53, P1584, DOI 10.1080/00365521.2018.1545045; Gulati Rishabh, 2018, Clin Liver Dis (Hoboken), V11, P48, DOI 10.1002/cld.690; Harrison RA, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-31; Hayward KL, 2019, HEPATOL COMMUN, V3, P620, DOI 10.1002/hep4.1334; Hayward KL, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2075-4; Hou RH, 2017, BRAIN BEHAV IMMUN, V62, P212, DOI 10.1016/j.bbi.2017.01.021; Jepsen P, 2014, WORLD J GASTROENTERO, V20, P7223, DOI 10.3748/wjg.v20.i23.7223; Kanwal F, 2019, HEPATOLOGY, V69, P1787, DOI 10.1002/hep.30489; Kanwal F, 2009, CLIN GASTROENTEROL H, V7, P793, DOI 10.1016/j.cgh.2009.03.013; Kazis LE, 1999, AM J MED QUAL, V14, P28, DOI 10.1177/106286069901400105; Kazis LE, 2006, J AMBUL CARE MANAG, V29, P310, DOI 10.1097/00004479-200610000-00007; Nardelli S, 2013, METAB BRAIN DIS, V28, P239, DOI 10.1007/s11011-012-9364-0; Park Angela, 2018, Fed Pract, V35, P24; Patel Krupa, 2018, Fed Pract, V35, pS14; Peng JK, 2019, PALLIATIVE MED, V33, P24, DOI 10.1177/0269216318807051; Pinderup Thea, 2019, Br J Nurs, V28, P441, DOI 10.12968/bjon.2019.28.7.441; Price CM, 2019, EUR J PAIN, V23, P1368, DOI 10.1002/ejp.1406; Rogal SS, 2015, DIGEST DIS SCI, V60, P1482, DOI 10.1007/s10620-014-3453-3; Rogal SS, 2015, CLIN GASTROENTEROL H, V13, P1009, DOI 10.1016/j.cgh.2014.10.029; Rogal SS, 2013, DIGEST DIS SCI, V58, P2976, DOI 10.1007/s10620-013-2638-5; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Scotten M, 2015, PRIMARY CARE, V42, P1, DOI 10.1016/j.pop.2014.09.009; Selim A, 2009, QUAL LIFE RES, V18, P43, DOI 10.1007/s11136-008-9418-2; Sharif Farkhondeh, 2005, Health Qual Life Outcomes, V3, P81, DOI 10.1186/1477-7525-3-81; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Tapper EB, 2018, HEPATOLOGY, V67, P2375, DOI 10.1002/hep.29756; Thomson MJ, 2018, LIVER INT, V38, P1882, DOI 10.1111/liv.13892; Volk ML, 2013, AM J GASTROENTEROL, V108, P302, DOI 10.1038/ajg.2012.214; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; Yohannes AM, 2010, INT J GERIATR PSYCH, V25, P1209, DOI 10.1002/gps.2463; Zandi Mitra, 2005, Health Qual Life Outcomes, V3, P35, DOI 10.1186/1477-7525-3-35; 2019, CJEM, V21	44	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238712	10.1371/journal.pone.0238712	http://dx.doi.org/10.1371/journal.pone.0238712			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9MU	32915828	Green Published, gold			2022-12-26	WOS:000571887500092
J	Romero-Sanchez, E; Morales-Esteban, A; Requena-Garcia-Cruz, MV; Zapico-Blanco, B; de-Miguel-Rodriguez, J				Romero-Sanchez, Emilio; Morales-Esteban, Antonio; Requena-Garcia-Cruz, Maria-Victoria; Zapico-Blanco, Beatriz; de-Miguel-Rodriguez, Jaime			Specific seismic retrofitting of a compact reinforced concrete building with X-bracings and steel jackets. Application to a primary school in Huelva	PLOS ONE			English	Article							STATIC PUSHOVER; RC FRAMES; PERFORMANCE; EARTHQUAKE; VULNERABILITY; PARAMETERS; BEHAVIOR; SPAIN; LORCA	Previous research has indicated that many European buildings are vulnerable to moderate-magnitude earthquakes. For example, during the L ' Aquila (Italia,M(w)6.3, 2009) and Lorca (Spain,M(w)5.9, 2011) earthquakes, many old buildings were severely damaged and some of them collapsed. In specific, significant damage has been found in several school buildings after past earthquakes in Europe. This is due to the fact that many of them were constructed prior to the current seismic codes, thus considering only gravitational loads and with no seismic design whatsoever. Primary schools are even more vulnerable than other typologies because of their low adult/child ratio. The seismic activity of the Iberian Peninsula is low-moderate. However, the Algarve and Huelva regions, which are situated in the south-west, are influenced by large faults which have caused major earthquakes of long-return periods. The European project PERSISTAH (Projetos de Escolas Resilientes aos SISmos no Territorio do Algarve e de Huelva, in Portuguese)aims to cooperatively evaluate the seismic vulnerability of primary schools in the Algarve (Portugal) and Huelva (Spain) regions. The present work is framed under this project. The objective of this paper is to determine the most effective retrofitting scheme for a typical primary school building in this area, considering structural, architectural and constructive parameters. The scheme could be applied to several buildings of the same typology, decreasing costs and time. An existing reinforced concrete frame building has been selected for the study. This is one of the most commonly used typologies for primary schools in this area. A nonlinear static analysis has been carried out in order to study its seismic behaviour. The performance point of the building has been obtained through the capacity-demand spectrum method. The preliminary results have confirmed the poor seismic behaviour of this building. Specifically, soft-story behaviour has been identified in the ground floor and short columns have been observed in the upper floors. Therefore, specific seismic retrofitting solutions have been proposed and evaluated in order to identify the one that is the most efficient. The combination of reinforcements has been done considering the structural and architectural impact and constructive parameters. The calculations have shown that steel X-bracings are the best solution for preventing the formation of a soft-storey in the ground floor. Unfortunately, this scheme increases the deformation in the upper floor columns. The best solution for the upper floors' short columns has been the use of steel jackets. The results have also shown that this combination produces an important reduction of the expected general damage level. The resulting retrofitting scheme can be extrapolated to other buildings with a similar typology.	[Romero-Sanchez, Emilio; Morales-Esteban, Antonio; Requena-Garcia-Cruz, Maria-Victoria; Zapico-Blanco, Beatriz; de-Miguel-Rodriguez, Jaime] Univ Seville, Dept Bldg Struct & Geotech Engn, Seville, Spain	University of Sevilla	Morales-Esteban, A (corresponding author), Univ Seville, Dept Bldg Struct & Geotech Engn, Seville, Spain.	ame@us.es	Requena-Garcia-Cruz, Maria-Victoria/AAE-8055-2019; Romero-Sánchez, Emilio/ABG-7997-2021; Zapico-Blanco, Beatriz/AAV-6295-2020; Morales-Esteban, Antonio/M-8070-2014	Requena-Garcia-Cruz, Maria-Victoria/0000-0002-2410-706X; Zapico-Blanco, Beatriz/0000-0002-1136-7305; Morales-Esteban, Antonio/0000-0002-3358-3690; de Miguel Rodriguez, Jaime/0000-0003-0870-5067	INTERREG-POCTEP Spain-Portugal programme; European Regional Development Fund [0313_PERSISTAH_5_P]; VI-PPI of the University of Seville; Instituto Universitario de Arquitectura y Ciencias de la Construccion	INTERREG-POCTEP Spain-Portugal programme; European Regional Development Fund(European Commission); VI-PPI of the University of Seville; Instituto Universitario de Arquitectura y Ciencias de la Construccion	This work has been supported by the INTERREG-POCTEP Spain-Portugal programme and the European Regional Development Fund through the 0313_PERSISTAH_5_P project and the VI-PPI of the University of Seville by the granting of a scholarship. The grant provided by the Instituto Universitario de Arquitectura y Ciencias de la Construccion is acknowledged.	Abou-Elfath H, 2000, CAN J CIVIL ENG, V27, P433, DOI 10.1139/cjce-27-3-433; Amaro-Mellado JL, 2018, CENT EUR J OPER RES, V26, P739, DOI 10.1007/s10100-017-0506-7; Amaro-Mellado JL, 2017, TECTONOPHYSICS, V717, P449, DOI 10.1016/j.tecto.2017.08.032; [Anonymous], 2014, 4113 ASCESEI; [Anonymous], 2004, 19632005 EN; [Anonymous], 2000, 356 FEMA; Applied Technology Council (ATC), 1996, ATC40; Barbat AH, 2008, SOIL DYN EARTHQ ENG, V28, P851, DOI 10.1016/j.soildyn.2007.10.006; Barbat AH, 2006, COMPUT-AIDED CIV INF, V21, P573, DOI 10.1111/j.1467-8667.2006.00450.x; Bartolome R, 2012, GEOLOGY, V40, P495, DOI 10.1130/G33107.1; Chester DK, 2010, GEOGR J, V176, P350, DOI 10.1111/j.1475-4959.2010.00367.x; Computers and Structures INC, SAP2000 V 19; Dhungel R, 2012, 15 WORLD C EARTHQ EN; Dolek M., 2008, ENG STRUCT, V30, P1991, DOI [10. 1016/j. engstruct. 2008. 01. 001, DOI 10.1016/J.ENGSTRUCT.2008.01.001, DOI 10.1016/j.engstruct.2008.01.001]; Dominguez D, 2016, ENG STRUCT, V108, P134, DOI 10.1016/j.engstruct.2015.11.020; Estevao JMC, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9235088; European Union, 2005, EUR 8 DES STRUCT EAR; Fajfar P., 2000, EARTHQ SPECTRA, V16, P573, DOI [DOI 10.1193/1.1586128, 10.1193/1.1586128]; Federal Emergency Management Agency (FEMA), 2018, HAZUS SOFTW; Freeman S.A., 2004, ISET J EARTHQ TECHNO, V41, P113; Ghobarah A, 2001, ENG STRUCT, V23, P745, DOI 10.1016/S0141-0296(00)00100-0; Global Program for Safer Schools (GPSS), 2013, CHAR SAF SCH; Hadzima-Nyarko M, 2018, EARTHQ STRUCT, V15, P473, DOI 10.12989/eas.2018.15.5.473; Hadzima-Nyarko M, 2017, J CULT HERIT, V28, P140, DOI 10.1016/j.cuther.2017.05.012; Hancilar U, 2014, SOIL DYN EARTHQ ENG, V67, P169, DOI 10.1016/j.soildyn.2014.09.005; Inel M, 2006, ENG STRUCT, V28, P1494, DOI 10.1016/j.engstruct.2006.01.017; Ju M, 2014, MAG CONCRETE RES, V66, P159, DOI 10.1680/macr.13.00165; Kabeyasawa T, 2017, B EARTHQ ENG, V15, P535, DOI 10.1007/s10518-015-9825-z; Kadid A, 2011, PROCEDIA ENGINEER, V14, DOI 10.1016/j.proeng.2011.07.365; Lamego P, 2017, B EARTHQ ENG, V15, P2901, DOI 10.1007/s10518-016-0072-8; Li S, 2017, ENG STRUCT, V136, P430, DOI 10.1016/j.engstruct.2017.01.033; Lopez O. A., 2008, 14 WORLD C EARTHQ EN; Maheri MR, 2003, ENG STRUCT, V25, P1505, DOI 10.1016/S0141-0296(03)00117-2; Maheri MR, 2003, ENG STRUCT, V25, P1697, DOI 10.1016/S0141-0296(03)00150-0; Mazzolani FM, 2008, J CONSTR STEEL RES, V64, P882, DOI 10.1016/j.jcsr.2007.12.017; Ministero delle infrastrutture e dei trasporti: Roma. NTC, 2018, AGG NORM TECN CONSTR; Mwafy AM, 2001, ENG STRUCT, V23, P407, DOI 10.1016/S0141-0296(00)00068-7; Onida M., 2013, COMPUTATIONAL METHOD, V30, P317, DOI [DOI 10.1007/978-94-007-6573-3_16, 10.1007/978-94-007-6573-3_16]; Rahimi A, 2018, ENG STRUCT, V173, P813, DOI 10.1016/j.engstruct.2018.07.003; Ramirez JL, 1996, CONSTR BUILD MATER, V10, P195, DOI 10.1016/0950-0618(95)00087-9; Requena-Garcia-Cruz MV, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215120; Ruiz-Pinilla JG, 2016, ENG FAIL ANAL, V68, P76, DOI 10.1016/j.engfailanal.2016.05.013; Segovia-Verjel ML, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223491; Seo H, 2018, ENG STRUCT, V168, P399, DOI 10.1016/j.engstruct.2018.04.098; Spanish Ministry of Public Works, 2008, SPAN REINF CONCR COD; Spanish Ministry of Public Works, 1998, SPAN ANN EUR 8; Spanish Ministry of Public Works, 2012, UPD SEISM HAZ MAPS; Spanish Ministry of Public Works [Ministerio de Fomento de Espaa], 2002, SPAN SEISM CONSTR CO; Uva G, 2012, ENG STRUCT, V34, P514, DOI 10.1016/j.engstruct.2011.08.043; Valente M, 2018, ENG FAIL ANAL, V89, P271, DOI 10.1016/j.engfailanal.2018.02.001; Vielma JC, 2010, B EARTHQ ENG, V8, P135, DOI 10.1007/s10518-009-9127-4; Xiao Y, 2003, J STRUCT ENG-ASCE, V129, P725, DOI 10.1061/(ASCE)0733-9445(2003)129:6(725); Youssef MA, 2007, ENG STRUCT, V29, P1561, DOI 10.1016/j.engstruct.2006.08.027	53	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238505	10.1371/journal.pone.0238505	http://dx.doi.org/10.1371/journal.pone.0238505			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915839	Green Published, gold			2022-12-26	WOS:000571887500068
J	Nannyonga, B; Singull, M				Nannyonga, Betty; Singull, Martin			Modelling allocation of resources in prevention and control of obstetric fistula in Ugandan women	PLOS ONE			English	Article								In spite of reliable and skilled healthcare resources, the prevalence rate of obstetric fistula in Uganda is high. The risk factors for obstetric fistula cut across due to high poverty rates and cultural barriers. The main objective of this study was to assess the impact of inability to access skilled healthcare at delivery and implications to the economy. The specific objective was to determine the best way of investment in getting women access to skilled healthcare before, during and after child birth. The question to be answered was whether it was more economical to invest in getting women access to skilled healthcare, or in expanding healthcare. The study was conducted using data from the Uganda Demographic Health Survey 2016. The data was from 18,506 women in the age group of 15-49 in 15 regions around the country. Results show that the highest investment in providing access to skilled healthcare is required when there are few skilled healthcare centres. On the other hand, if there is little investment in providing access to skilled healthcare during child birth, many skilled healthcare centres are required. Results show further that the minimum time taken to reduce fistula prevalence is attained when there are many women accessing skilled healthcare in the few equipped health centres. However, if there are many skilled healthcare centres but a few women treated for obstetric fistula, then it will take longer to reduce fistula prevalence. Fitting the model to data suggested that Uganda has a big backlog of women to treat for obstetric fistula as in all skilled healthcare centres, there were less women treated than expected. Although still under the expected figure, the benefit of these treatments for obstetric fistula is that for every one woman treated, 8 more would seek treatment for the condition. This would however cost the country a great deal in that the treatment funds would perhaps give more returns if diverted to outreach activities aimed to get women seek skilled healthcare during child birth.	[Nannyonga, Betty] Makerere Univ, Coll Nat Sci, Sch Phys Sci, Dept Math, Kampala, Uganda; [Nannyonga, Betty; Singull, Martin] Linkoping Univ, Dept Math, Math Stat, Linkoping, Sweden	Makerere University; Linkoping University	Nannyonga, B (corresponding author), Makerere Univ, Coll Nat Sci, Sch Phys Sci, Dept Math, Kampala, Uganda.; Nannyonga, B (corresponding author), Linkoping Univ, Dept Math, Math Stat, Linkoping, Sweden.	bnk@cns.mak.ac.ug	Singull, Martin/H-6417-2011	Singull, Martin/0000-0001-9896-4438	SIDA bilateral program Makerere	SIDA bilateral program Makerere	Betty Nannyonga wishes to acknowledge the financial support from the SIDA bilateral program Makerere 2015-2020 Project Capacity building in mathematics and its application. Further acknowledgement is extended to Linkoping University Sweden for hosting the Post Doctorate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2007, INT J GYNECOL OBSTET, V99, pS10, DOI 10.1016/j.ijgo.2007.06.011; [Anonymous], **NON-TRADITIONAL**; [Anonymous], 2010, J P SOCIAL BEHAV SCI, V5, P328; [Anonymous], 2010, RECT FIST; [Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; [Anonymous], OBST FIST; [Anonymous], 2005, J PELVIC MED SURG FE; [Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; [Anonymous], HOSPITALS; [Anonymous], **NON-TRADITIONAL**; Bangser M, 2007, INT J GYNECOL OBSTET, V99, pS16, DOI 10.1016/j.ijgo.2007.06.016; Bwambale T, UGANDA REGISTERS 200; Capes T, 2011, MT SINAI J MED, V78, P352, DOI 10.1002/msj.20265; Champagne BJ, 2010, SURG CLIN N AM, V90, P69, DOI 10.1016/j.suc.2009.09.003; Creanga AA, 2007, INT J GYNECOL OBSTET, V99, pS40, DOI 10.1016/j.ijgo.2007.06.021; Donnay F, 2006, INT J GYNECOL OBSTET, V94, P254, DOI 10.1016/j.ijgo.2006.04.005; Drew LB, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-015-0755-1; Global Fistula Map, 2010, GLOB OBST FIST CAR L; Kasamba N, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-229; Kayondo M, 2011, BMC UROL, V11, DOI 10.1186/1471-2490-11-23; Lazareva I, 2017, LIFE FISTULA SURG HE; Maheu-Giroux M, 2015, LANCET GLOB HEALTH, V3, pE271, DOI 10.1016/S2214-109X(14)70348-1; Mathur R, 2010, UROL ANNALS, V2, P67, DOI 10.4103/0974-7796.65114; McCurdie FK, 2018, J OBSTET GYNAECOL, V38, P822, DOI 10.1080/01443615.2017.1407301; Miller S, 2005, J MIDWIFERY WOM HEAL, V50, P286, DOI 10.1016/j.jmwh.2005.03.009; Mselle LT, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-49; Neilson JP, 2003, BRIT MED BULL, V67, P191, DOI 10.1093/bmb/ldg018; Nielsen HS, 2009, BJOG-INT J OBSTET GY, V116, P1258, DOI 10.1111/j.1471-0528.2009.02200.x; Ramphal S, 2006, CURR OPIN OBSTET GYN, V18, P147, DOI 10.1097/01.gco.0000192980.92223.2d; Ruminjo J, 2014, INT J GYNECOL OBSTET, V126, P140, DOI 10.1016/j.ijgo.2014.02.015; Semere Luwam, 2008, Rev Obstet Gynecol, V1, P193; UBOS, 2007, UG DEM HLTH SURV 200; UBOS ICF, 2012, UG DEM HLTH SURV 201; [No title captured]	37	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238059	10.1371/journal.pone.0238059	http://dx.doi.org/10.1371/journal.pone.0238059			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911511	Green Published, gold			2022-12-26	WOS:000571885900043
J	Senthil, S; Balijepalli, P; Mohamed, A; Rani, PK; Nayak, S; Garudadri, C; Mandal, AK; Jalali, S				Senthil, Sirisha; Balijepalli, Pasyanthi; Mohamed, Ashik; Rani, Padmaja Kumari; Nayak, Sameera; Garudadri, Chandrasekar; Mandal, Anil K.; Jalali, Subhadra			Management outcomes of secondary glaucoma due to retinopathy of prematurity: A 19-year prospective study at a tertiary eye care Institute. The Indian Twin cities ROP Screening (ITCROPS) database report number 8	PLOS ONE			English	Article							ANGLE-CLOSURE GLAUCOMA; CHILDHOOD	Purpose To report the clinical presentation and management outcomes of glaucoma in the "Indian Twin cities retinopathy of prematurity (ROP) Screening database." Methods All children with diagnosis of ROP and glaucoma between 1997 and 2016 from a prospective database were included. Glaucoma was classified as open when anterior chamber (AC) was deep, closed when AC was shallow or flat and neovascular when there was extensive iris neovascularization. ROP was classified based on International classification of ROP. Results The prevalence of secondary glaucoma in our cohort was 1.36% (82 eyes of 6000 children). Eighty-two eyes of 54 children with secondary glaucoma due to ROP where included in this study. The distribution of glaucoma among the ROP stages included, stage V (58.5%), stage 1V (24.3%), stage III (2.4%) and stage II (1.2%) eyes. Median (interquartile range) duration from birth to glaucoma diagnosis was 7.8 (4.2, 24.9) months. Type of glaucoma was angle closure in 39 (47.6%), open angle in 35 (42.7%) and neovascular in 8 (9.8%) eyes. Retinal interventions included vitreoretinal surgery in 59 (72%), retinal laser in 14 (17%) and intravitreal bevacizumab injection in 19 (23.1%) eyes. The mean (+/- standard deviation) IOP at presentation was 22.6 +/- 11.8 mm Hg. Glaucoma was managed medically in 66 (76%) and surgically in 16 (19.5%) eyes. The mean follow up for the entire cohort was 1.14 +/- 2.24 years. At final visit, 37% eyes with ROP and glaucoma had ambulatory vision with mean IOP of 16.0 +/- 8.1 mm Hg and 56 eyes (68.2%) needed glaucoma medications. Conclusion In this large ROP cohort, 1.36% eyes developed secondary glaucoma. Majority of them had stage V or IV ROP and 1/5 of them needed glaucoma surgery. Around 1/3(rd)of the ROP eyes with glaucoma had ambulatory vision.	[Senthil, Sirisha; Balijepalli, Pasyanthi; Garudadri, Chandrasekar; Mandal, Anil K.] LV Prasad Eye Inst, VST Glaucoma Ctr, Hyderabad, India; [Senthil, Sirisha; Mandal, Anil K.; Jalali, Subhadra] LV Prasad Eye Inst, Jasti V Ramanamma Childrens Eye Care Ctr, Hyderabad, India; [Mohamed, Ashik] LV Prasad Eye Inst, Ophthalm Biophys, Hyderabad, Telangana, India; [Rani, Padmaja Kumari; Jalali, Subhadra] LV Prasad Eye Inst, Srimathi Kanuri Santhamma Ctr Vitreoretinal Dis, Hyderabad, India; [Nayak, Sameera] LV Prasad Eye Inst, Vitreoretinal Serv, Kode Venkatadri Chowdary Campus, Vijayawada, India	L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; L. V. Prasad Eye Institute	Senthil, S (corresponding author), LV Prasad Eye Inst, VST Glaucoma Ctr, Hyderabad, India.; Senthil, S (corresponding author), LV Prasad Eye Inst, Jasti V Ramanamma Childrens Eye Care Ctr, Hyderabad, India.	sirishasenthil@lvpei.org	Mohamed, Ashik/D-5105-2014	Mohamed, Ashik/0000-0001-5520-4930	Hyderabad Eye Research Foundation	Hyderabad Eye Research Foundation	This work was supported by the Hyderabad Eye Research Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bremer DL, 2012, J AAPOS, V16, P449, DOI 10.1016/j.jaapos.2012.06.011; Chandra P, 2019, INDIAN J OPHTHALMOL, V67, P917, DOI 10.4103/ijo.IJO_33_18; DHILLON B, 1992, J PEDIATR OPHTHALMOL, V29, P123; Gilbert C, 2001, B WORLD HEALTH ORGAN, V79, P227; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; HALPERIN LS, 1988, ARCH OPHTHALMOL-CHIC, V106, P453; HARTNETT ME, 1993, GRAEF ARCH CLIN EXP, V231, P433, DOI 10.1007/BF02044227; HARTNETT ME, 1990, OPHTHALMOLOGY, V97, P122; HARTNETT ME, 1994, AM J OPHTHALMOL, V117, P113, DOI 10.1016/S0002-9394(14)73027-2; Iwahashi-Shima C, 2012, RETINA-J RET VIT DIS, V32, P1636, DOI 10.1097/IAE.0b013e3182551c54; Jalali Subhadra, 2003, Indian J Ophthalmol, V51, P89; KUSHNER BJ, 1982, ARCH OPHTHALMOL-CHIC, V100, P1078; KWITKO ML, 1969, CAN J OPHTHALMOLOGY, V4, P231; Lashkari K, 2000, AM J PATHOL, V156, P1337, DOI 10.1016/S0002-9440(10)65004-3; Mandal Anil K., 1993, Indian Journal of Ophthalmology, V41, P51; POLLARD ZF, 1980, AM J OPHTHALMOL, V89, P651, DOI 10.1016/0002-9394(80)90282-2; Salgado CM, 2010, AM J OPHTHALMOL, V150, P6; Senthil S, 2019, J GLAUCOMA, V28, P20, DOI 10.1097/IJG.0000000000001124; Smith Bradley T, 2005, Trans Am Ophthalmol Soc, V103, P225; Smith BT, 2005, T AM OPHTHAL SOC, V103, P234; Terry T L, 1942, Trans Am Ophthalmol Soc, V40, P262; Trigler L, 2005, J AAPOS, V9, P17, DOI 10.1016/j.jaapos.2004.10.007	22	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238633	10.1371/journal.pone.0238633	http://dx.doi.org/10.1371/journal.pone.0238633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911514	Green Published, gold			2022-12-26	WOS:000571885900005
J	Frater, M; Jakab, A; Braunitzer, G; Toth, Z; Nagy, K				Frater, Mark; Jakab, Andras; Braunitzer, Gabor; Toth, Zsolt; Nagy, Katalin			The potential effect of instrumentation with different nickel titanium rotary systems on dentinal crack formation-Anin vitrostudy	PLOS ONE			English	Article							ROOT-CANAL PREPARATION; MICRO-COMPUTED-TOMOGRAPHY; SELF-ADJUSTING FILE; XP-ENDO SHAPER; PROTAPER UNIVERSAL; CURRENT CHALLENGES; SINGLE-FILE; WAVEONE; MICROCRACKS; RECIPROCATION	The potential mechanical impact of different rotary systems used for root canal preparation has been a matter of debate for long. The aim of this study was to explore the incidence of dentinal cracks after root canal instrumentation with various rotary systems,in vitro. One hundred and eighty intact lower central incisors were selected and randomly divided into fourteen treatment groups (n = 12/group) and a control group (n = 12). After decoronation, the root canals were instrumented with fourteen different rotary systems (E3, E3 azure, NT2, Hyflex CM, Hyflex EDM, 2Shape, OneCurve, ProTaper Next, ProTaper Gold, WaveOne Gold, Mtwo, Reciproc Blue, TF adaptive, K3XF). All roots were horizontally sectioned at 3, 6, and 9 mm from the apex with a low-speed saw under water-cooling. The slices were then examined under stereomicroscope for dentinal cracks. No cracks were found in the control group. Cracks were found in all treatment groups, predominantly in the 3 mm slices. There was no statistically significant difference in the number of cracks when comparing the different systems to each other at any section level. At 3 mm, however, five of the studied systems, namely K3XF (p = 0.004), Protaper Next (p = 0.001), Reciproc Blue (p<0.001), TF adaptive (p = 0.050), and 2Shape (p = 0.009) presented a significantly higher number of cracks than the control group. Within the limitations of this study, instrumented canals presented dentinal cracks, while uninstrumented ones presented no cracks after sectioning. There seems to be no significant difference among the tested systems regarding crack formation in the instrumented root canal wall. Crack formation occurred irrespective of the motion of the rotary system (rotational or reciprocation). Further studies are needed to clarify the factors that contribute to crack formation in the case of each individual rotary system.	[Frater, Mark; Jakab, Andras] Univ Szeged, Fac Dent, Dept Operat & Esthet Dent, Szeged, Hungary; [Braunitzer, Gabor] DicomLAB Dent Ltd, Szeged, Hungary; [Toth, Zsolt] Univ Szeged, Fac Dent, Dept Oral Biol & Expt Dent Res, Szeged, Hungary; [Nagy, Katalin] Univ Szeged, Fac Dent, Dept Oral Surg, Szeged, Hungary	Szeged University; Szeged University; Szeged University	Frater, M (corresponding author), Univ Szeged, Fac Dent, Dept Operat & Esthet Dent, Szeged, Hungary.	meddentist.fm@gmail.com	Nagy, Katalin/ABG-5846-2021	Nagy, Katalin/0000-0001-9383-5952; Toth, Zsolt/0000-0003-1329-9470; Frater, Mark/0000-0002-0365-1613; Jakab, Andras Gabor/0000-0001-9865-3912				Adorno CG, 2013, INT ENDOD J, V46, P763, DOI 10.1111/iej.12056; Aksoy C, 2019, J ENDODONT, V45, P338, DOI 10.1016/j.joen.2018.12.005; Algarni YA, 2019, ANN MED HEALTH SCI R, V9, P614; [Anonymous], 2019, REGION ANESTH PAIN M, V44, pe1; Arashiro FN, 2020, INT ENDOD J, V53, P440, DOI 10.1111/iej.13239; Bayram HM, 2017, J ENDODONT, V43, P1736, DOI 10.1016/j.joen.2017.05.024; Bayram HM, 2017, J ENDODONT, V43, P1166, DOI 10.1016/j.joen.2017.02.005; Capar ID, 2014, J ENDODONT, V40, P1482, DOI 10.1016/j.joen.2014.02.026; Coelho MS, 2016, J ENDODONT, V42, P1110, DOI 10.1016/j.joen.2016.04.006; De-Deus G, 2019, INT ENDOD J, V52, P857, DOI 10.1111/iej.13058; De -Deus G, 2017, J ENDODONT, V43, P1553, DOI 10.1016/j.joen.2017.04.027; De-Deus G, 2015, J ENDODONT, V41, P1116, DOI 10.1016/j.joen.2015.02.012; De-Deus G, 2014, J ENDODONT, V40, P1447, DOI 10.1016/j.joen.2014.02.019; Gavini G, 2018, BRAZ ORAL RES, V32, P44, DOI 10.1590/1807-3107bor-2018.vol32.0067; Gergi Richard M, 2015, Eur J Dent, V9, P508, DOI 10.4103/1305-7456.172634; Iacono F, 2017, INT ENDOD J, V50, P303, DOI 10.1111/iej.12620; Perez-Higueras JJ, 2013, J ENDODONT, V39, P1585, DOI 10.1016/j.joen.2013.07.020; Karatas E, 2015, J ENDODONT, V41, P261, DOI 10.1016/j.joen.2014.10.019; Kirici D, 2020, J ENDODONT, V46, P238, DOI 10.1016/j.joen.2019.11.003; Larsen CM, 2009, J ENDODONT, V35, P401, DOI 10.1016/j.joen.2008.12.010; Lee OYS, 2019, INT ENDOD J, V52, P1366, DOI 10.1111/iej.13127; Li SH, 2015, J ENDODONT, V41, P1875, DOI 10.1016/j.joen.2015.08.005; Ozyurek Taha, 2017, Restor Dent Endod, V42, P332, DOI 10.5395/rde.2017.42.4.332; Parashos P, 2006, J ENDODONT, V32, P1031, DOI 10.1016/j.joen.2006.06.008; Pedulla E, 2017, J ENDODONT, V43, P456, DOI 10.1016/j.joen.2016.10.038; Bueno CSP, 2017, J ENDODONT, V43, P705, DOI 10.1016/j.joen.2016.12.024; Peters OA, 2004, J ENDODONT, V30, P559, DOI 10.1097/01.DON.0000129039.59003.9D; Pirani C, 2014, SCANNING, V36, P517, DOI 10.1002/sca.21150; Portenier I, 1998, INT ENDOD J, V31, P103; PradeepKumar AR, 2019, J ENDODONT, V45, P1258, DOI 10.1016/j.joen.2019.06.010; Shemesh H, 2009, INT ENDOD J, V42, P208, DOI 10.1111/j.1365-2591.2008.01502.x; Shemesh H, 2018, J ENDODONT, V44, P120, DOI 10.1016/j.joen.2017.07.025; Shen Y, 2013, J ENDODONT, V39, P163, DOI 10.1016/j.joen.2012.11.005; Bier CAS, 2009, J ENDODONT, V35, P236, DOI 10.1016/j.joen.2008.10.021; Ustun Y, 2015, INT ENDOD J, V48, P952, DOI 10.1111/iej.12387; Wei X, 2017, DENT MATER J, V36, P243, DOI 10.4012/dmj.2016-208; Yoldas O, 2012, J ENDODONT, V38, P232, DOI 10.1016/j.joen.2011.10.011; Zaslansky P, 2020, INT ENDOD J, V53, P135, DOI 10.1111/iej.13207; Zuolo ML, 2017, J ENDODONT, V43, P619, DOI 10.1016/j.joen.2016.11.013	39	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2020	15	9							e0238790	10.1371/journal.pone.0238790	http://dx.doi.org/10.1371/journal.pone.0238790			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR4MY	32903275	Green Published, gold, Green Accepted			2022-12-26	WOS:000571539500001
J	Kim, J; Choi, J; Shin, MS; Kim, M; Seo, E; An, M; Shim, JL; Heo, S				Kim, JinShil; Choi, Jiin; Shin, Mi-Seung; Kim, Miyeong; Seo, EunJu; An, Minjeong; Shim, Jae Lan; Heo, Seongkum			Do advance directive attitudes and perceived susceptibility and end-of-life life-sustaining treatment preferences between patients with heart failure and cancer differ?	PLOS ONE			English	Article							CARE; INTERVENTION; FEASIBILITY; BURDEN; HEALTH; IMPACT	There is limited evidence on the relationships of preference for end-of-life life-sustaining treatments [LSTs] and diagnostic contexts like heart failure [HF] or cancer, and patient attitudes toward and perceived susceptibility to use advance directives [ADs]. Thus, this study aimed to compare attitudes and perceived susceptibility between HF patients and community-dwelling patients with cancer, and examine the associations of these variables with their preference for each LST (cardiopulmonary resuscitation [CPR], ventilation support, hemodialysis, and hospice care). Secondary data were obtained from 36 outpatients with HF (mean age, 65.44 years; male, 69.4%) and 107 cancer patients (mean age, 67.39 years; male, 32.7%). More patients with HF preferred CPR than cancer patients (41.7% and 15.9%,chi(2)= 8.88,P= 0.003). Attitudes and perceived susceptibility were similar between the two diagnostic cohorts. HF patients and those with more positive attitudes had greater odds of preferring CPR (odds ratio [OR] = 3.02, confidence interval [CI] = 1.19, 7.70) and hospice care (OR = 1.14, CI = 1.06, 1.23), respectively. HF diagnosis and AD attitudes increased the preference for CPR and hospice care, respectively. This suggests that it is important to gain positive attitudes toward ADs and consider diagnostic context to facilitate informed decision-making for LSTs.	[Kim, JinShil] Gachon Univ, Coll Nursing, Incheon, South Korea; [Choi, Jiin] Seoul Natl Univ Hosp, Off Hosp Informat, Seoul, South Korea; [Shin, Mi-Seung] Gachon Univ, Coll Med, Gil Med Ctr, Dept Internal Med,Div Cardiol, Incheon, South Korea; [Kim, Miyeong] Gachon Univ, Gil Med Ctr, Incheon, South Korea; [Seo, EunJu] Natl Canc Ctr, Dept Nursing, Seoul, South Korea; [An, Minjeong] Chonnam Natl Univ, Coll Nursing, Gwangju, South Korea; [Shim, Jae Lan] Dongguk Univ, Coll Med, Dept Nursing, Gyeongju, South Korea; [Heo, Seongkum] Mercer Univ, Georgia Baptist Coll Nursing, Atlanta, GA USA	Gachon University; Seoul National University (SNU); Seoul National University Hospital; Gachon University; Gachon University; National Cancer Center - Korea (NCC); Chonnam National University; Dongguk University; Mercer University	Choi, J (corresponding author), Seoul Natl Univ Hosp, Off Hosp Informat, Seoul, South Korea.; An, M (corresponding author), Chonnam Natl Univ, Coll Nursing, Gwangju, South Korea.	chocojiin0@gmail.com; anminjeong@inu.ac.kr		Choi, Jiin/0000-0002-6156-0066	Gachon University Gil Medical Center	Gachon University Gil Medical Center	Mi-Seung Shin/JinShil Kim Grant number: 2016-17 Gachon University Gil Medical Center https://www.gilhospital.com/.	Adler ED, 2009, CIRCULATION, V120, P2597, DOI 10.1161/CIRCULATIONAHA.109.869123; Alano GJ, 2010, PALLIAT SUPPORT CARE, V8, P267, DOI 10.1017/S1478951510000064; Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053; American Society of Clinical Oncology, 2020, ADV CANC TREATM 2020; Anand I, 2018, AM J CARDIOVASC DRUG, V18, P333, DOI 10.1007/s40256-018-0277-0; Bekelman DB, 2009, J GEN INTERN MED, V24, P592, DOI 10.1007/s11606-009-0931-y; Butler J, 2015, JACC-HEART FAIL, V3, P112, DOI 10.1016/j.jchf.2014.07.016; Dalal S, 2017, ONCOLOGIST, V22, P361, DOI 10.1634/theoncologist.2016-0277; Detering K, 2020, ADV CARE PLANNING AD; Duckworth KE, 2014, AM J HOSP PALLIAT ME, V31, P710, DOI 10.1177/1049909113499815; Dunlay SM, 2012, CIRC-CARDIOVASC QUAL, V5, P283, DOI 10.1161/CIRCOUTCOMES.112.966036; Dunlay SM, 2012, EUR HEART J, V33, P689, DOI 10.1093/eurheartj/ehr411; Fitzmaurice C, 2019, JAMA ONCOL, V5, P1749, DOI 10.1001/jamaoncol.2019.2996; Glaudemans JJ, 2015, FAM PRACT, V32, P16, DOI 10.1093/fampra/cmu074; Johnson S, 2016, PSYCHO-ONCOLOGY, V25, P362, DOI 10.1002/pon.3926; Jung KW, 2017, CANCER RES TREAT, V49, P292, DOI 10.4143/crt.2017.118; KIM J, 2020, HEALTHCARE-J DEL SCI, V8, DOI DOI 10.3390/HEALTHCARE8010062; Kim J, 2020, J CARD FAIL, V26, P61, DOI 10.1016/j.cardfail.2019.07.011; Kim J, 2019, INT J OLDER PEOPLE N, V14, DOI 10.1111/opn.12229; Kim J, 2020, KOREAN J INTERN MED, V35, P109, DOI 10.3904/kjim.2018.158; Kim J, 2018, J CARDIOVASC NURS, V33, P446, DOI 10.1097/JCN.0000000000000396; Kim M, 2019, J TRANSCULT NURS, V30, P587, DOI 10.1177/1043659619832080; Kim S, 2017, HOLIST NURS PRACT, V31, P234, DOI 10.1097/HNP.0000000000000216; Ko E, 2016, AM J HOSP PALLIAT ME, V33, P834, DOI 10.1177/1049909115593736; Ko E, 2009, J AGING HEALTH, V21, P967, DOI 10.1177/0898264309344179; Lau KS, 2010, J PAIN SYMPTOM MANAG, V40, P704, DOI 10.1016/j.jpainsymman.2010.02.023; Lee S. H., 2015, J HLTH INFORMATICS S, V40, P117; MacKenzie MA, 2016, J PAIN SYMPTOM MANAG, V51, P71, DOI 10.1016/j.jpainsymman.2015.09.001; Mamas MA, 2017, EUR J HEART FAIL, V19, P1095, DOI 10.1002/ejhf.822; Ministry of Health & Welfare, 2016, GUID 2017 COMM INT H; Musa I, 2015, AGE AGEING, V44, P371, DOI 10.1093/ageing/afv041; Narang AK, 2015, JAMA ONCOL, V1, P601, DOI 10.1001/jamaoncol.2015.1976; Ng QX, 2017, ANN ACAD MED SINGAP, V46, P84; Nolan MT, 1997, NURS OUTLOOK, V45, P204, DOI 10.1016/S0029-6554(97)90066-X; Park IK, 2015, AM J HOSP PALLIAT ME, V32, P797, DOI 10.1177/1049909114542646; Prentice TC, 2019, J CARD FAIL, V25, pS60, DOI 10.1016/j.cardfail.2019.07.172; Rietjens JAC, 2017, LANCET ONCOL, V18, pE543, DOI 10.1016/S1470-2045(17)30582-X; Rocque GB, 2017, J PAIN SYMPTOM MANAG, V53, P682, DOI 10.1016/j.jpainsymman.2016.11.012; Sarfati D, 2016, CA-CANCER J CLIN, V66, P338, DOI 10.3322/caac.21342; Schubart JR, 2019, J ONCOL PRACT, V15, DOI 10.1200/JOP.18.00044; Sinclair C, 2013, BMJ SUPPORT PALLIAT, V3, P358, DOI 10.1136/bmjspcare-2012-000256; Sittisombut Sudarat, 2005, Nurs Health Sci, V7, P243, DOI 10.1111/j.1442-2018.2005.00243.x; Smith GL, 2019, J NATL COMPR CANC NE, V17, P1184, DOI 10.6004/jnccn.2019.7305; Stiel S, 2015, BMC PALLIAT CARE, V14, DOI 10.1186/s12904-015-0033-z; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Yoo SH, 2018, CANCER RES TREAT, V50, P720, DOI 10.4143/crt.2017.169; Ziaeian B, 2016, NAT REV CARDIOL, V13, P368, DOI 10.1038/nrcardio.2016.25	47	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238567	10.1371/journal.pone.0238567	http://dx.doi.org/10.1371/journal.pone.0238567			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ6EE	32898165	gold, Green Published			2022-12-26	WOS:000570962500032
J	McLaughlin, EJ; Hiscock, RJ; Robinson, AJ; Hui, LS; Tong, S; Dane, KM; Middleton, AL; Walker, SP; MacDonald, TM				McLaughlin, Emma J.; Hiscock, Richard J.; Robinson, Alice J.; Hui, Lisa; Tong, Stephen; Dane, Kirsten M.; Middleton, Anna L.; Walker, Susan P.; MacDonald, Teresa M.			Appropriate-for-gestational-age infants who exhibit reduced antenatal growth velocity display postnatal catch-up growth	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; INSULIN-RESISTANCE; FULL-TERM; FETAL ORIGINS; CHILDREN; CHILDHOOD; OBESITY; DISEASE; GAIN; RESTRICTION	Background Postnatally, small-for-gestational-age (SGA; birthweight <10th centile) infants who are growth restricted due to uteroplacental insufficiency (UPI) demonstrate 'catch-up growth' to meet their genetically-predetermined size. Infants who demonstrate slowing growth during pregnancy are those that cross estimated fetal weight centiles at serial ultrasound examinations. These infants that slow in growth but are born appropriate-for-gestational-age (AGA; >= 10th centile), exhibit antenatal, intrapartum and postnatal indicators of UPI. Here, we examine if and when these infants (labelled as AGA-FGR) also demonstrate catch-up growth like SGA infants, when compared with AGA infants with normal antenatal growth velocity (AGA-NG). Methods We followed-up the infants of women who had previously undergone ultrasound assessment of fetal size at 28- and 36-weeks' gestation, enabling calculation of antenatal growth velocity. To assess postnatal growth, we asked parents to send their infant's growth measurements, up to two years post-birth, which are routinely collected through the state-wide Maternal-Child Health service. Infants with medical conditions affecting postnatal growth were excluded from the analysis. From the measurements obtained we calculated age-adjusted z-scores for postnatal weight, length and body mass index (BMI; weight(kg)/height(m(2))) at birth and 4, 8, 12, 18 and 24 months. We used linear spline regression modelling to predict mean weight, length and BMI z-scores at intervals post birth. Predicted mean age-adjusted z-scores were then compared between three groups; SGA, AGA with low antenatal growth (AGA-FGR; loss of >20 customised estimated fetal weight centiles), and AGA-NG to determine if catch-up growth occurred. In addition, we compared the rates of catch-up growth (defined as an increase in weight age-adjusted z-score of >= 0.67 over 1 year) between the groups with Fisher's exact tests. Results Of 158 (46%) infant growth records received, 146 were AGA, with low antenatal growth velocity occurring in 34/146 (23.2%). Rates of gestational diabetes and SGA birthweight were higher in those lost to follow-up. Compared to AGA-NG infants, AGA-FGR infants had significantly lower predicted mean weight (p<0.001), length (p = 0.04) and BMI (p = 0.001) z-scores at birth. These significant differences were no longer evident at 4 months, suggesting that catch-up growth had occurred. As expected, the catch-up growth that occurred among the AGA-FGR was not as great in magnitude as that demonstrated by the SGA. When assessed categorically, there was no significant difference between the rate of catch-up growth among the AGA-FGR and the SGA. Catch-up growth was significantly more frequent among both the AGA-FGR and the SGA groups compared to the AGA-NG. Conclusions AGA infants that have exhibited reduced antenatal fetal growth velocity also exhibit significant catch-up growth in the first 12 months of life. This finding represents further evidence that AGA fetuses that slow in growth during pregnancy do so due to UPI.	[McLaughlin, Emma J.; Hiscock, Richard J.; Hui, Lisa; Tong, Stephen; Walker, Susan P.; MacDonald, Teresa M.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Robinson, Alice J.; Hui, Lisa; Tong, Stephen; Dane, Kirsten M.; Middleton, Anna L.; Walker, Susan P.; MacDonald, Teresa M.] Mercy Hosp Women, Mercy Perinatal, Melbourne, Vic, Australia	University of Melbourne	McLaughlin, EJ (corresponding author), Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia.	emmamclaughlin111@gmail.com		Hui, Lisa/0000-0002-9720-3562; Dane, Kirsten/0000-0001-8434-4430; Middleton, Anna/0000-0001-6596-5872; McLaughlin, Emma/0000-0002-0233-2741	NHMRC [1065854]; Australian Government Research Training Program Scholarship	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	Funding NHMRC Grant #1065854 to SW; Australian Government Research Training Program Scholarship to TM; Funding sources had no involvement in study design, collection or analysis of data, or in the writing or submission of this manuscript.	Albertsson-Wikland K, 1998, HORM RES, V49, P7, DOI 10.1159/000053080; ALBERTSSONWIKLAND K, 1993, ACTA PAEDIATR, V82, P438, DOI 10.1111/j.1651-2227.1993.tb12718.x; AlbertssonWikland K, 1997, ACTA PAEDIATR, V86, P193; [Anonymous], 2016, REGULATION EU 201667, V119, P1, DOI DOI 10.1016/J.WOCN.2016.08.005; [Anonymous], 2018, GRAPHPAD PRISM SOFTW; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Beltrand J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005343; Broere-Brown ZA, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2358-8; Campisi SC, 2019, ADV NUTR, V10, P104, DOI 10.1093/advances/nmy091; Cianfarani S, 1999, ARCH DIS CHILD-FETAL, V81, pF71, DOI 10.1136/fn.81.1.F71; Darendeliler F, 2008, TURKISH J PEDIATR, V50, P207; ELLIMAN A, 1992, ACTA PAEDIATR, V81, P311, DOI 10.1111/j.1651-2227.1992.tb12232.x; FALL CHD, 1995, BRIT MED J, V310, P17, DOI 10.1136/bmj.310.6971.17; Gardosi J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f108; Gardosi JFA, 2017, CUSTOMISED WEIGHT CE; Gillman MW, 2007, PEDIATR RES, V61, P625, DOI 10.1203/pdr.0b013e3180459fcd; Gordijn SJ, 2016, ULTRASOUND OBST GYN, V48, P333, DOI 10.1002/uog.15884; Hammami A, 2018, ULTRASOUND OBST GYN, V52, P35, DOI 10.1002/uog.19066; Harding JE, 2003, EARLY HUM DEV, V74, P13, DOI 10.1016/S0378-3782(03)00080-X; Health My, 2011, DEP ED TRAINING; HOKKENKOELEGA ACS, 1995, PEDIATR RES, V38, P267, DOI 10.1203/00006450-199508000-00022; Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3; Ibanez L, 2006, J CLIN ENDOCR METAB, V91, P2153, DOI 10.1210/jc.2005-2778; Jaddoe VWV, 2012, EUR J EPIDEMIOL, V27, P739, DOI 10.1007/s10654-012-9735-1; KARLBERG J, 1995, PEDIATR RES, V38, P733, DOI 10.1203/00006450-199511000-00017; Karlberg J, 2002, J PEDIATR ENDOCR MET, V15, P1243; Karlberg JPE, 1997, HORM RES, V48, P17, DOI 10.1159/000191279; Kramer MS, 2017, AM J EPIDEMIOL, V185, P585, DOI 10.1093/aje/kww109; Leger J, 1997, BRIT MED J, V315, P341; MacDonald TM, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0928-z; Mifsud W, 2014, FETAL DIAGN THER, V36, P117, DOI 10.1159/000359969; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Monteiro POA, 2003, INT J OBESITY, V27, P1274, DOI 10.1038/sj.ijo.0802409; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; OUNSTED M, 1982, EARLY HUM DEV, V7, P29, DOI 10.1016/0378-3782(82)90005-6; Paneth N, 1996, J HYPERTENS, V14, pS121; PRADER A, 1963, J PEDIATR-US, V62, P646, DOI 10.1016/S0022-3476(63)80035-9; Rotevatn TA, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7537-z; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; StataCorp, 2019, STTAT STAT SOFTW REL; Stettler N, 2002, PEDIATRICS, V109, P194, DOI 10.1542/peds.109.2.194; Takeuchi A, 2018, J PEDIATR-US, V192, P41, DOI 10.1016/j.jpeds.2017.09.002; TANNER JM, 1963, NATURE, V199, P845, DOI 10.1038/199845a0; Tu YK, 2005, AM J EPIDEMIOL, V161, P27, DOI 10.1093/aje/kwi002; van Dommelen P, 2014, ANN NUTR METAB, V65, P220, DOI 10.1159/000364884; Victora CG, 2001, INT J EPIDEMIOL, V30, P1325, DOI 10.1093/ije/30.6.1325; WHO, 2006, WHO CHILD GROWTH STA; WHO Anthro for personal computers, 2010, SOFTW ASS GROWTH DEV; Zheng M, 2018, OBES REV, V19, P321, DOI 10.1111/obr.12632	50	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238700	10.1371/journal.pone.0238700	http://dx.doi.org/10.1371/journal.pone.0238700			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ6EE	32898169	gold, Green Published			2022-12-26	WOS:000570962500035
J	Meyer, N; Kroger, M; Thummler, J; Tietze, L; Palme, R; Touma, C				Meyer, Neele; Kroeger, Mareike; Thuemmler, Julia; Tietze, Lisa; Palme, Rupert; Touma, Chadi			Impact of three commonly used blood sampling techniques on the welfare of laboratory mice: Taking the animal's perspective	PLOS ONE			English	Article							FACIAL EXPRESSIONS; STRESS-RESPONSE; C57BL/6J MICE; MOUSE MODEL; TAIL VEIN; PAIN; BEHAVIOR; COLLECTION; QUALITY; CORTICOSTERONE	Laboratory mice are the most frequently used animals in biomedical research. In accordance with guidelines for humane handling, several blood sampling techniques have been established. While the effects of these procedures on blood quality and histological alterations at the sampling site are well studied, their impact on the animals' welfare has not been extensively investigated. Therefore, our study aimed to compare three commonly used blood sampling techniques regarding their effects on different indicators of animal welfare, including physiological and behavioural response stress parameters, including pain measures, home-cage behaviour and nest-building as well as exploratory activity and neophobia. Male C57BL/6J mice were subjected to a single blood collection from either thevena facialis, the retrobulbar sinus or the tail vessel, or were allocated to the respective control treatment. While all blood sampling techniques led to an acute increase in plasma corticosterone levels, the response was strongest in animals that underwent sampling from thevena facialisand the retrobulbar sinus. Similar results were observed when the time-course of adrenocortical activity was monitored via corticosterone metabolites from faecal samples. Blood collection from thevena facialisand the retrobulbar sinus also decreased exploration of novel stimuli, resulted in decreased nest-building activity and induced higher scores in the Mouse Grimace Scale. Moreover, locomotor activity and anxiety-related behaviour were strongly affected after facial vein bleeding. Interestingly, tail vessel bleeding only induced little alterations in the assessed physiological and behavioural parameters. Importantly, the observed effects in all treatment groups were no longer detectable after 24 hours, indicating only short-term impacts. Thus, by also taking the animal's perspective and comprehensively assessing the severity of the particular sampling procedures, the results of our study contribute toRefinementwithin the 3R concept and allow researchers to objectively select the most appropriate and welfare-friendly blood sampling technique for a given experiment.	[Meyer, Neele; Kroeger, Mareike; Touma, Chadi] Univ Osnabruck, Dept Behav Biol, Osnabruck, Germany; [Thuemmler, Julia; Tietze, Lisa] Max Planck Inst Psychiat, Res Grp Psychoneuroendocrinol, Munich, Germany; [Palme, Rupert] Univ Vet Med Vienna, Unit Physiol Pathophysiol & Expt Endocrinol, Vienna, Austria	University Osnabruck; Max Planck Society; University of Veterinary Medicine Vienna	Meyer, N; Touma, C (corresponding author), Univ Osnabruck, Dept Behav Biol, Osnabruck, Germany.	nemeyer@uos.de; ctouma@uos.de	Palme, Rupert/A-3499-2008	Palme, Rupert/0000-0001-9466-3662; Meyer, Neele/0000-0003-4955-4488				[Anonymous], 2010, OFF J EUR UNION, VL 276, P33; Battey J, 1999, NAT GENET, V21, P73, DOI 10.1038/5012; Baumans V, 2005, REV SCI TECH OIE, V24, P503, DOI 10.20506/rst.24.2.1585; Bodden C, 2018, BEHAV BRAIN RES, V336, P261, DOI 10.1016/j.bbr.2017.08.029; Bracke MBM, 2006, J AGR ENVIRON ETHIC, V19, P77, DOI 10.1007/s10806-005-4493-7; Buijs RM, 2001, NAT REV NEUROSCI, V2, P521, DOI 10.1038/35081582; Burkholder Tanya, 2012, Curr Protoc Mouse Biol, V2, P145; Cesarovic N, 2014, APPL ANIM BEHAV SCI, V157, P137, DOI 10.1016/j.applanim.2014.04.010; Christensen SD, 2009, LAB ANIM-UK, V43, P65, DOI 10.1258/la.2008.007075; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Durschlag M, 1996, PHYSIOL BEHAV, V60, P1565, DOI 10.1016/S0031-9384(96)00307-1; Fernandez I, 2010, J AM ASSOC LAB ANIM, V49, P202; Francisco CC, 2015, J AM ASSOC LAB ANIM, V54, P76; Friard O, 2016, METHODS ECOL EVOL, V7, P1325, DOI 10.1111/2041-210X.12584; Gaskill BN, 2013, JOVE-J VIS EXP, DOI 10.3791/51012; Gjendal K, 2020, J PHARMACOL TOX MET, V103, DOI 10.1016/j.vascn.2020.106680; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Guilloux JP, 2011, J NEUROSCI METH, V197, P21, DOI 10.1016/j.jneumeth.2011.01.019; Hager C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006159; Harikrishnan VS, 2018, LAB ANIM-UK, V52, P253, DOI 10.1177/0023677217741332; Herman JP, 2016, COMPR PHYSIOL, V6, P603, DOI 10.1002/cphy.c150015; Hess SE, 2008, J AM ASSOC LAB ANIM, V47, P25; Hoff J, 2000, LAB ANIMAL, V29, P47; Hoggatt J, 2016, EXP HEMATOL, V44, P132, DOI 10.1016/j.exphem.2015.10.008; Hohlbaum K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203559; Hohlbaum K, 2018, JOVE-J VIS EXP, DOI 10.3791/57046; Hohlbaum K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179588; Holmberg H, 2011, LAB ANIM-UK, V45, P114, DOI 10.1258/la.2010.010129; Hurst JL, 1999, ANIM BEHAV, V58, P563, DOI 10.1006/anbe.1999.1165; Ibarguen-Vargas Y, 2008, PSYCHONEUROENDOCRINO, V33, P1357, DOI 10.1016/j.psyneuen.2008.07.010; Jirkof P, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9121026; Jirkof P, 2014, J NEUROSCI METH, V234, P139, DOI 10.1016/j.jneumeth.2014.02.001; Jirkof P, 2013, LAB ANIM-UK, V47, P153, DOI 10.1177/0023677213475603; Kalsbeek A, 2012, MOL CELL ENDOCRINOL, V349, P20, DOI 10.1016/j.mce.2011.06.042; Kim S, 2018, STEROIDS, V135, P69, DOI 10.1016/j.steroids.2018.03.004; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Madetoja J, 2009, SCAND J LAB ANIM SCI, V36, P215; Malakoff D, 2000, SCIENCE, V288, P248, DOI 10.1126/science.288.5464.248; Miller A, 2015, APPL ANIM BEHAV SCI, V172, P58, DOI 10.1016/j.applanim.2015.08.038; Miller AL, 2011, APPL ANIM BEHAV SCI, V131, P138, DOI 10.1016/j.applanim.2011.02.007; Mittal A, 2016, BLOOD CELL MOL DIS, V57, P58, DOI 10.1016/j.bcmd.2015.12.006; Moore ES, 2017, J AM ASSOC LAB ANIM, V56, P307; MORTON DB, 1993, LAB ANIM, V27, P1, DOI 10.1258/002367793780745633; National Centre for the Replacement Refinement & Reduction of Animals in Research, BLOOD SAMPL MOUS; Palme R, 2019, PHYSIOL BEHAV, V199, P229, DOI 10.1016/j.physbeh.2018.11.021; Rock ML, 2014, J AM ASSOC LAB ANIM, V53, P24; Rodriguez E, 2017, NAT NEUROSCI, V20, P1734, DOI 10.1038/s41593-017-0012-1; Roughan JV, 2009, LAB ANIM-UK, V43, P17, DOI 10.1258/la.2008.007156; Russell WMS., 1959, MED J AUSTRALIA; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schmidt K, 2015, J PAIN, V16, P781, DOI 10.1016/j.jpain.2015.05.003; Sevcik MA, 2006, GASTROENTEROLOGY, V131, P900, DOI 10.1053/j.gastro.2006.06.021; Society of Laboratory Animal Science, 2017, SPEC INF COMM AN WEL; Sorensen DB, 2019, J AM ASSOC LAB ANIM, V58, P362, DOI 10.30802/AALAS-JAALAS-18-000064; Surget A, 2011, MOL PSYCHIATR, V16, P1177, DOI 10.1038/mp.2011.48; Tannenbaum J, 2015, J AM ASSOC LAB ANIM, V54, P120; Teilmann AC, 2014, LAB ANIM-UK, V48, P278, DOI 10.1177/0023677214541438; Teilmann AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113225; Touma C, 2004, HORM BEHAV, V45, P10, DOI 10.1016/j.yhbeh.2003.07.002; Touma C, 2003, GEN COMP ENDOCR, V130, P267, DOI 10.1016/S0016-6480(02)00620-2; Touma C, 2008, PSYCHONEUROENDOCRINO, V33, P839, DOI 10.1016/j.psyneuen.2008.03.013; Tsai PP, 2015, LAB ANIMAL, V44, P301, DOI 10.1038/laban.738; VANTLAND CJ, 1995, LAB ANIM, V29, P286, DOI 10.1258/002367795781088207; Voigt CC, 2013, ANIM WELFARE, V22, P449, DOI 10.7120/09627286.22.4.449; Whittaker AL, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10060989	66	10	10	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238895	10.1371/journal.pone.0238895	http://dx.doi.org/10.1371/journal.pone.0238895			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ6EE	32898190	gold, Green Published			2022-12-26	WOS:000570962500019
J	Zhai, Y; Han, JJ; Jung, S; Kook, MS; Park, HJ; Oh, HK				Zhai, Ying; Han, Jeong Joon; Jung, Seunggon; Kook, Min-Suk; Park, Hong-Ju; Oh, Hee-Kyun			Changes in the temporomandibular joint clicking and pain disorders after orthognathic surgery: Comparison of orthodontics-first approach and surgery-first approach	PLOS ONE			English	Article							CONVENTIONAL 3-STAGE METHOD; MANDIBULAR SETBACK; DENTOFACIAL DEFORMITIES; FOLLOW-UP; DYSFUNCTION; MALOCCLUSION; OSTEOTOMY; SYMPTOMS; MOVEMENT; SIGNS	The purposes of this study were to investigate the influence of the orthodontics-first approach (OFA) and surgery-first approach (SFA) on changes in the signs and symptoms of temporomandibular joint disorders (TMDs) and to compare pre- and postoperative orthodontic treatment duration and total treatment duration between the two approaches. This retrospective study recruited 182 adult patients with malocclusions treated with OFA and SFA and recorded variables such as age, gender, skeletal classification, and signs and symptoms of TMD (clicking and pain disorders) before the start of the surgical-orthodontic treatment and after surgery. Changes in the signs and symptoms of TMD and treatment duration were evaluated within each approach and compared between two approaches. A binary logistic regression was performed to assess the influence of the variables on the postoperative signs and symptoms of TMD. There were no significant postoperative changes in temporomandibular joint (TMJ) pain for OFA and SFA, whereas a significant reduction was found in TMJ clicking after surgery for both approaches. According to binary logistic regression, the type of surgical-orthodontic treatment (OFA or SFA) was not a significant risk factor for postoperative TMJ clicking and pain, and the risk of postoperative TMJ clicking and pain was significant only when TMJ clicking (OR = 10.774,p< 0.001) and pain (OR = 26.876,p= 0.008) existed before the start of the entire treatment, respectively. With regard to the treatment duration, SFA (21.1 +/- 10.3 months) exhibited significantly shorter total treatment duration than OFA (34.4 +/- 11.9 months) (p< 0.001). The results of this study suggest that surgical-orthodontic treatment using SFA can be a feasible option of treatment for dentofacial deformities based on the equivalent effect on TMD and shorter overall treatment period compared to conventional surgical-orthodontic treatment using OFA.	[Zhai, Ying] Chonnam Natl Univ, Grad Dent Sch, Gwangju, South Korea; [Han, Jeong Joon; Jung, Seunggon; Kook, Min-Suk; Park, Hong-Ju; Oh, Hee-Kyun] Chonnam Natl Univ, Sch Dent, Dent Sci Res Inst, Dept Oral & Maxillofacial Surg, Gwangju, South Korea; [Han, Jeong Joon] Chonnam Natl Univ, Hard Tissue Biointerface Res Ctr, Sch Dent, Gwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University	Han, JJ (corresponding author), Chonnam Natl Univ, Sch Dent, Dent Sci Res Inst, Dept Oral & Maxillofacial Surg, Gwangju, South Korea.; Han, JJ (corresponding author), Chonnam Natl Univ, Hard Tissue Biointerface Res Ctr, Sch Dent, Gwangju, South Korea.	ooops01@snu.ac.kr		Zhai, Ying/0000-0002-4235-3061; Han, Jeong Joon/0000-0001-8975-0198	Chonnam National University Hospital Biomedical Research Institute [BCRI20042];  [2020R1C1C1014734]	Chonnam National University Hospital Biomedical Research Institute; 	This study was supported by a grant (BCRI20042) of Chonnam National University Hospital Biomedical Research Institute and the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2020R1C1C1014734) to JJH.	Abrahamsson C, 2013, INT J ORAL MAX SURG, V42, P752, DOI 10.1016/j.ijom.2012.10.016; Aghabeigi B, 2001, Int J Adult Orthodon Orthognath Surg, V16, P153; Al-Moraissi EA, 2017, J CRANIO MAXILL SURG, V45, P1716, DOI 10.1016/j.jcms.2017.07.015; Al-Riyami S, 2009, AM J ORTHODONTICS DE, V136, p626e1; [Anonymous], 2018, PUBLIC HLTH WKLY REP, V29, P1; Baek SH, 2010, J CRANIOFAC SURG, V21, P332, DOI 10.1097/SCS.0b013e3181cf5fd4; Brucoli M, 2019, J ORAL MAXIL SURG, V77, P157, DOI 10.1016/j.joms.2018.06.005; Chisnoiu Andrea Maria, 2015, Clujul Med, V88, P473, DOI 10.15386/cjmed-485; Dervis E, 2002, ORAL SURG ORAL MED O, V94, P554, DOI 10.1067/moe.2002.128021; Durham J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1154; Egermark I, 2003, ANGLE ORTHOD, V73, P109; Gaggl A, 1999, BRIT J ORAL MAX SURG, V37, P41, DOI 10.1054/bjom.1998.0387; Guo J, 2018, ORAL SURG ORAL MED O; Han JJ, 2019, J ORAL MAXIL SURG, V77, DOI 10.1016/j.joms.2018.09.008; Han JJ, 2016, OR SURG OR MED OR PA, V122, P666, DOI 10.1016/j.oooo.2016.07.016; Han JJ, 2015, J CRANIO MAXILL SURG, V43, P1918, DOI 10.1016/j.jcms.2015.08.004; Hernandez-Alfaro F, 2014, J ORAL MAXIL SURG, V72, P376, DOI 10.1016/j.joms.2013.08.013; Jacobson A, 1999, AM J ORTHODONTICS DE, V116, pA1; Jeong WS, 2017, INT J ORAL MAX SURG, V46, P473, DOI 10.1016/j.ijom.2016.12.006; Jerjes W, 2011, BRIT J ORAL MAXILLOF, V49; KARABOUTA I, 1985, J MAXILLOFAC SURG, V13, P185, DOI 10.1016/S0301-0503(85)80045-X; Ko EWC, 2011, J ORAL MAXIL SURG, V69, P1469, DOI 10.1016/j.joms.2010.07.022; Kretschmer WB, 2019, BRIT J ORAL MAX SURG, V57, P734, DOI 10.1016/j.bjoms.2019.06.010; Lian YK, 2018, ORTHOD CRANIOFAC RES, V21, P90, DOI 10.1111/ocr.12221; Liou EJW, 2011, J ORAL MAXIL SURG, V69, P771, DOI 10.1016/j.joms.2010.11.011; MAGNUSSON T, 1986, INT J ORAL MAX SURG, V15, P707, DOI 10.1016/S0300-9785(86)80111-9; Min BK, 2014, J CRANIOFAC SURG, V25, P1752, DOI 10.1097/SCS.0000000000001002; O'Brien K, 2009, AM J ORTHOD DENTOFAC, V135, P709, DOI 10.1016/j.ajodo.2007.10.043; Panula K, 2000, INT J ORAL MAX SURG, V29, P183, DOI 10.1016/S0901-5027(00)80089-2; Park JK, 2015, J CRANIOFAC SURG, V26, P2086, DOI 10.1097/SCS.0000000000001972; Scolozzi P, 2015, OR SURG OR MED OR PA, V119, P531, DOI 10.1016/j.oooo.2015.01.006; Togashi M, 2013, J ORAL MAX SURG MED, V25, P18, DOI 10.1016/j.ajoms.2012.05.014; Wang TY, 2016, J ORAL MAXIL SURG, V74, P2487, DOI 10.1016/j.joms.2016.07.015; Westermark A, 2001, Int J Adult Orthodon Orthognath Surg, V16, P145; Wolford LM, 2003, J ORAL MAXIL SURG, V61, P655, DOI 10.1053/joms.2003.50131; Yin Q, 2019, BRIT J ORAL MAX SURG, V57, P1086, DOI 10.1016/j.bjoms.2019.09.022; Yu HB, 2015, INT J ORAL MAX SURG, V44, P1463, DOI 10.1016/j.ijom.2015.05.024; Zingler S, 2017, J CRANIO MAXILL SURG, V45, P1293, DOI 10.1016/j.jcms.2017.05.031	38	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238494	10.1371/journal.pone.0238494	http://dx.doi.org/10.1371/journal.pone.0238494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886686	Green Published, gold			2022-12-26	WOS:000571064300035
J	Singh, JP; Dagar, M; Dagar, G; Kumar, S; Rawal, S; Sharma, RD; Tyagi, RK; Bagchi, G				Singh, Julie Pratibha; Dagar, Manisha; Dagar, Gunjan; Kumar, Sudhir; Rawal, Sudhir; Sharma, Ravi Datta; Tyagi, Rakesh Kumar; Bagchi, Gargi			Activation of GPR56, a novel adhesion GPCR, is necessary for nuclear androgen receptor signaling in prostate cells	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; KINASE-A; GROWTH-FACTOR; CANCER; EXPRESSION; PATHWAY; GPRC6A; FAMILY; GENE	The androgen receptor (AR) is activated in patients with castration resistant prostate cancer (CRPC) despite low circulating levels of androgen, suggesting that intracellular signaling pathways and non-androgenic factors may contribute to AR activation. Many G-protein coupled receptors (GPCR) and their ligands are also activated in these cells indicating that they may play a role in development of Prostate Cancer (PCa) and CRPC. Although a cross talk has been suggested between the two pathways, yet, the identity of GPCRs which may play a role in androgen signaling, is not established yet. By using blast analysis of 826 GPCRs, we identified a GPCR, GPCR 205, which exhibited maximum similarity with the ligand binding domain of the AR. We demonstrate that adhesion GPCR 205, also known as GPR56, can be activated by androgens to stimulate the Rho signaling pathway, a pathway that plays an important role in prostate tumor cell metastasis. Testosterone stimulation of GPR56 also activates the cAMP/ Protein kinase A (PKA) pathway, that is necessary for AR signaling. Knocking down the expression of GPR56 using siRNA, disrupts nuclear translocation of AR and transcription of prototypic AR target genes such as PSA. GPR56 expression is higher in all twenty-five prostate tumor patient's samples tested and cells expressing GPR56 exhibit increased proliferation. These findings provide new insights about androgen signaling and identify GPR56 as a possible therapeutic target in advanced prostate cancer patients.	[Singh, Julie Pratibha; Dagar, Manisha; Dagar, Gunjan; Bagchi, Gargi] Amity Univ Haryana, Amity Inst Biotechnol AIB, Manesar, Gurugram, India; [Kumar, Sudhir; Tyagi, Rakesh Kumar] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi, India; [Rawal, Sudhir] Rajiv Gandhi Canc Inst & Res Ctr, New Delhi, India; [Sharma, Ravi Datta] Amity Univ Haryana, Amity Inst Integrat Sci & Hlth AIISH, Manesar, Gurugram, India	Jawaharlal Nehru University, New Delhi	Bagchi, G (corresponding author), Amity Univ Haryana, Amity Inst Biotechnol AIB, Manesar, Gurugram, India.	gbagchi@ggn.amity.edu	Kumar, Sudhir/L-1465-2018	Kumar, Sudhir/0000-0001-5806-3029; Bagchi, Gargi/0000-0001-6416-2584	Department of Biotechnology(DBT), India [No.BT/Bio-CARe/01/668/2011-12]	Department of Biotechnology(DBT), India(Department of Biotechnology (DBT) India)	This work was supported by Department of Biotechnology(DBT), India No.BT/Bio-CARe/01/668/2011-12 (2014-2018) (to GB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2010, ARCH OTTOMANICUM, V27, P241; Bagchi G, 2008, CANCER RES, V68, P3225, DOI 10.1158/0008-5472.CAN-07-5026; Ben-Josef E, 1999, J UROLOGY, V161, P970, DOI 10.1016/S0022-5347(01)61831-7; Berg AH, 2014, ENDOCRINOLOGY, V155, P4237, DOI 10.1210/en.2014-1198; Bielecki B, 2016, P NATL ACAD SCI USA, V113, P14829, DOI 10.1073/pnas.1614826113; Bjarnadottir TK, 2004, GENOMICS, V84, P23, DOI 10.1016/j.ygeno.2003.12.004; Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001; Chen GC, 2010, DEV DYNAM, V239, P3358, DOI 10.1002/dvdy.22468; Chen Y, 2008, CURR OPIN PHARMACOL, V8, P440, DOI 10.1016/j.coph.2008.07.005; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Daaka Y., 2004, SCI STKE, V216, pr; Dagar M, 2019, J BIOL CHEM, V294, P8699, DOI 10.1074/jbc.RA119.007420; Djakiew D, 2000, PROSTATE, V42, P150, DOI 10.1002/(SICI)1097-0045(20000201)42:2<150::AID-PROS10>3.0.CO;2-H; Estrada M, 2003, ENDOCRINOLOGY, V144, P3586, DOI 10.1210/en.2002-0164; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Fix C, 2004, P NATL ACAD SCI USA, V101, P10919, DOI 10.1073/pnas.0404278101; Giera S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7121; Haese A, 2000, J UROLOGY, V163, P1491, DOI 10.1016/S0022-5347(05)67649-5; Huang KY, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00304; Huggins Charles, 1941, CANC RES, V1; Isberg V, 2016, NUCLEIC ACIDS RES, V44, pD356, DOI 10.1093/nar/gkv1178; Jacobsen SE, 2013, J PHARMACOL EXP THER, V347, P298, DOI 10.1124/jpet.113.206276; Jiang LI, 2008, J BIOL CHEM, V283, P23429, DOI 10.1074/jbc.M803281200; Kalyvianaki K, 2017, SCI REP-UK, V7, DOI 10.1038/srep44418; Kang HY, 2004, J BONE MINER RES, V19, P1181, DOI 10.1359/JBMR.040306; Kasbohm EA, 2005, J BIOL CHEM, V280, P11583, DOI 10.1074/jbc.M414423200; Ke N, 2007, MOL CANCER THER, V6, P1840, DOI 10.1158/1535-7163.MCT-07-0066; KREBS EG, 1989, JAMA-J AM MED ASSOC, V262, P1815, DOI 10.1001/jama.262.13.1815; Krishnan A, 2016, HANDB EXP PHARMACOL, V234, P15, DOI 10.1007/978-3-319-41523-9_2; Kumar S, 2006, MOL CELL ENDOCRINOL, V246, P147, DOI 10.1016/j.mce.2005.11.028; Leve F, 2008, J PHARMACOL EXP THER, V327, P777, DOI 10.1124/jpet.108.140798; Levine AC, 1998, ENDOCRINOLOGY, V139, P4672, DOI 10.1210/en.139.11.4672; Luo R, 2011, P NATL ACAD SCI USA, V108, P12925, DOI 10.1073/pnas.1104821108; Nazareth LV, 1996, J BIOL CHEM, V271, P19900, DOI 10.1074/jbc.271.33.19900; Nelson J, 2003, NAT REV CANCER, V3, P110, DOI 10.1038/nrc990; Pi M, 2015, MOL ENDOCRINOL, V29, P1759, DOI 10.1210/me.2015-1161; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Raj GV, 2002, J UROLOGY, V167, P1458, DOI 10.1016/S0022-5347(05)65345-1; Sarwar M, 2011, J CANC SCI THER S, VS5, P3, DOI [10.4172/1948-5956.S5-003, DOI 10.4172/1948-5956.S5-003]; Shashidhar S, 2005, ONCOGENE, V24, P1673, DOI 10.1038/sj.onc.1208395; Stoveken HM, 2015, P NATL ACAD SCI USA, V112, P6194, DOI 10.1073/pnas.1421785112; Taub JS, 2003, CANCER RES, V63, P2037; Venkatakrishnan AJ, 2016, NATURE, V536, P484, DOI 10.1038/nature19107; Vinciguerra M, 2003, MOL BIOL CELL, V14, P2677, DOI 10.1091/mbc.E02-11-0720; Xu L, 2006, P NATL ACAD SCI USA, V103, P9023, DOI 10.1073/pnas.0602681103; Xu LL, 2000, CANCER RES, V60, P6568; Yang LQ, 2011, CANCER RES, V71, P5558, DOI 10.1158/0008-5472.CAN-10-4543; Yuan X, 2014, ONCOGENE, V33, P2815, DOI 10.1038/onc.2013.235; Zhang LZ, 2004, MOL CELL BIOL, V24, P2169, DOI 10.1128/MCB.24.5.2169-2180.2004	51	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0226056	10.1371/journal.pone.0226056	http://dx.doi.org/10.1371/journal.pone.0226056			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881870	gold, Green Submitted, Green Published			2022-12-26	WOS:000571063300106
J	Stroomberg, HV; Jorgensen, A; Brasso, K; Nielsen, JE; Juul, A; Frederiksen, H; Jensen, MB; Roder, MA				Stroomberg, Hein Vincent; Jorgensen, Anne; Brasso, Klaus; Nielsen, John Erik; Juul, Anders; Frederiksen, Hanne; Jensen, Martin Blomberg; Roder, Martin Andreas			Novel functions of the luteinizing hormone/chorionic gonadotropin receptor in prostate cancer cells and patients	PLOS ONE			English	Article							HORMONE; EXPRESSION; CASTRATION; ABIRATERONE; BIOMARKERS; CARCINOMA; SURVIVAL; TIME; MEN	Prostate cancer (PCa) cells become castrate-resistant after initial tumor regression following castration-based lowering of testosterone (T). De-novo intra-tumoral steroid synthesis is a suggested biological mechanism of castration resistant PCa, but the regulators are unknown. Testicular T production is controlled by the luteinizing hormone/choriogonadotropin receptor (LHCGR). To elucidate the influence of LHCGR on PCa development the presence and effects of LHCGR in PCa and whether LHCGR in serum holds prognostic information in PCa patients is investigated. LHCGR expression was investigated by RT-PCR, WB, IHC, qPCR in PCa cell lines and prostatic tissue. Steroid production was measured in media from cell lines with LC-MS/MS and expression of steroidogenic enzymes with qPCR. Serum LHCGR (sLHCGR) was measured with ELISA in PCa patients (N = 157). Presence of LHCGR was established in prostatic tissue and PCa cell lines. Cell proliferation increased by 1.29-fold in LNCaP (P = 0.007) and 1.33-fold in PC-3 cells (P = 0.0007), when stimulated by luteinizing hormone. Choriogonadotropin stimulation decreased proliferation 0.93-fold in DU145 cells (P = 0.05), but none of the treatments altered steroid metabolite secretion. Low sLHCGR concentration was associated with a higher risk of biochemical failure after radical prostatectomy (HR = 3.05, P = 0.06) and castration resistance (HR = 6.92, P = 0.004) compared to high sLHCGR concentration. LHCGR is expressed in PCa and may exert a growth regulatory role in PCa derived cell lines. A potential prognostic role of sLHCGR for determining recurrence risk in PCa patients is found in this pilot study but needs verification in larger cohorts.	[Stroomberg, Hein Vincent; Brasso, Klaus; Roder, Martin Andreas] Copenhagen Univ Hosp, Rigshosp, Copenhagen Prostate Canc Ctr, Dept Urol, Copenhagen, Denmark; [Stroomberg, Hein Vincent; Jensen, Martin Blomberg] Rigshosp, Dept Growth & Reprod, Grp Skeletal Mineral & Gonadal Endocrinol, Copenhagen, Denmark; [Jorgensen, Anne; Nielsen, John Erik; Juul, Anders; Frederiksen, Hanne] Univ Copenhagen, Rigshosp, Dept Growth & Reprod, Copenhagen, Denmark; [Jorgensen, Anne; Nielsen, John Erik; Juul, Anders; Frederiksen, Hanne] Univ Copenhagen, Rigshosp, Int Ctr Res & Res Training Endocrine Disrupt Male, Copenhagen, Denmark; [Jensen, Martin Blomberg] Harvard Med Sch, Div Bone & Mineral Res, HSDM HMS, Boston, MA 02115 USA	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Harvard University; Harvard Medical School; Harvard School of Dental Medicine	Stroomberg, HV (corresponding author), Copenhagen Univ Hosp, Rigshosp, Copenhagen Prostate Canc Ctr, Dept Urol, Copenhagen, Denmark.; Stroomberg, HV (corresponding author), Rigshosp, Dept Growth & Reprod, Grp Skeletal Mineral & Gonadal Endocrinol, Copenhagen, Denmark.	hein.vincent.stroomberg@regionh.dk	Frederiksen, Hanne/N-8632-2013; Stroomberg, Hein/AAY-1361-2020; Juul, Anders/F-5864-2013; Røder, M. Andreas/H-7701-2019; Jørgensen, Anne/S-8681-2016	Frederiksen, Hanne/0000-0002-3180-9879; Stroomberg, Hein/0000-0002-7293-9506; Juul, Anders/0000-0002-0534-4350; Røder, M. Andreas/0000-0002-0019-5333; Jørgensen, Anne/0000-0002-6409-198X; Brasso, Klaus/0000-0001-6562-6416	Danish Cancer Society [R130-A8339]	Danish Cancer Society(Danish Cancer Society)	This study was funded by the Danish Cancer Society [Grant number R130-A8339] awarded to MAR. URL: www.cancer.dk The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, ANEMIYA, V3, P1; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Casarini L, 2016, MOL CELL ENDOCRINOL, V422, P103, DOI 10.1016/j.mce.2015.12.008; Casarini L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046682; Chambers AE, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-113; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Dickinson RE, 2009, ENDOCRINOLOGY, V150, P2873, DOI 10.1210/en.2008-1382; Dijkstra S, 2014, CLIN BIOCHEM, V47, P889, DOI 10.1016/j.clinbiochem.2013.10.023; Dirnhofer S, 1998, PROSTATE, DOI [10.1002/(SICI)1097-0045(19980515)35:3&LT;212::AID-PROS7&GT;3.0.CO;2-I, DOI 10.1002/(SICI)1097-0045(19980515)35:3212::AID-PR0S73.0.CO;2-I, DOI 10.1002/(SICI)1097-0045(19980515)35:3<LESSTHAN>212::AID-PR0S7<GREATERTHAN>3.0.CO;2-I]; Eacker SM, 2008, MOL ENDOCRINOL, V22, P623, DOI 10.1210/me.2006-0534; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Fizazi K, 2017, NEW ENGL J MED, V377, P352, DOI 10.1056/NEJMoa1704174; Gawroska B, 2001, REPROD BIOL; Huggins C, 1941, ARCH SURG-CHICAGO, V43, P209, DOI 10.1001/archsurg.1941.01210140043004; Hussain M, 2018, NEW ENGL J MED, V378, P2465, DOI 10.1056/NEJMoa1800536; Ingles SA, 2013, INT J MOL EPIDEMIOL, V4, P228; Jensen MB, 2012, NEOPLASIA, V14, P952, DOI 10.1593/neo.121164; Jensen MB, 2010, J STEROID BIOCHEM, V121, P376, DOI 10.1016/j.jsbmb.2010.03.069; Larsen SB, 2017, J CLIN ONCOL, V35, P3290, DOI 10.1200/JCO.2016.71.8981; Lippert S, 2016, BIOMARK MED, V10, P209, DOI 10.2217/bmm.15.114; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzen M, 2020, CANCERS, V12, DOI 10.3390/cancers12061358; Minegishi T, 2007, MOL CELL ENDOCRINOL, V260, P117, DOI 10.1016/j.mce.2005.11.051; Mitchell RT, 2010, HUM REPROD, V25, P2405, DOI 10.1093/humrep/deq183; Mortensen LJ, 2019, SOLUBLE LUTEIN UNPUB, P1; Mostaghel EA, 2013, TRANSL ANDROL UROL, V2, P212, DOI 10.3978/j.issn.2223-4683.2013.09.16; Pakarainen T, 2007, MOL CELL ENDOCRINOL, V269, P9, DOI 10.1016/j.mce.2006.10.019; Pinski J, 2011, PROSTATE, V71, P892, DOI 10.1002/pros.21305; Rivero-Muller A, 2010, P NATL ACAD SCI USA, V107, P2319, DOI 10.1073/pnas.0906695106; Ryan CJ, 2015, LANCET ONCOL, V16, P152, DOI 10.1016/S1470-2045(14)71205-7; Sartori DA, 2014, CURR OPIN ONCOL, V26, P259, DOI 10.1097/CCO.0000000000000065; Sheaff MT, 1996, J CLIN PATHOL, V49, P329, DOI 10.1136/jcp.49.4.329; Soeborg T, 2017, CLIN CHIM ACTA, V468, P180, DOI 10.1016/j.cca.2017.03.002; Sonne SB, 2006, APMIS, V114, P549, DOI 10.1111/j.1600-0463.2006.apm_445.x; Troppmann B, 2013, HUM REPROD UPDATE, V19, P583, DOI 10.1093/humupd/dmt023; Xiong SG, 2015, PROSTATE, V75, P141, DOI 10.1002/pros.22899; Zhang FP, 2001, MOL ENDOCRINOL, V15, P172, DOI 10.1210/me.15.1.172	37	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238814	10.1371/journal.pone.0238814	http://dx.doi.org/10.1371/journal.pone.0238814			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881970	Green Published, gold			2022-12-26	WOS:000571063300092
J	Vallecillo-Zuniga, ML; Rathgeber, MF; Poulson, PD; Hayes, S; Luddington, JS; Gill, HN; Teynor, M; Kartchner, BC; Valdoz, J; Stowell, C; Markham, AR; Arthur, C; Stowell, S; Van Ry, PM				Vallecillo-Zuniga, Mary L.; Rathgeber, Matthew F.; Poulson, P. Daniel; Hayes, Spencer; Luddington, Jacob S.; Gill, Hailie N.; Teynor, Matthew; Kartchner, Braden C.; Valdoz, Jonard; Stowell, Caleb; Markham, Ashley R.; Arthur, Connie; Stowell, Sean; Van Ry, Pam M.			Treatment with galectin-1 improves myogenic potential and membrane repair in dysferlin-deficient models	PLOS ONE			English	Article							LIMB-GIRDLE; MUSCLE DIFFERENTIATION; CELL-LINES; RECOGNITION; DERIVATION; MYOBLASTS; PROTEIN; FUSION; GROWTH; MICE	Limb-girdle muscular dystrophy type 2B (LGMD2B) is caused by mutations in the dysferlin gene, resulting in non-functional dysferlin, a key protein found in muscle membrane. Treatment options available for patients are chiefly palliative in nature and focus on maintaining ambulation. Our hypothesis is that galectin-1 (Gal-1), a soluble carbohydrate binding protein, increases membrane repair capacity and myogenic potential of dysferlin-deficient muscle cells and muscle fibers. To test this hypothesis, we used recombinant human galectin-1 (rHsGal-1) to treat dysferlin-deficient models. We show that rHsGal-1 treatments of 48 h-72 h promotes myogenic maturation as indicated through improvements in size, myotube alignment, myoblast migration, and membrane repair capacity in dysferlin-deficient myotubes and myofibers. Furthermore, increased membrane repair capacity of dysferlin-deficient myotubes, independent of increased myogenic maturation is apparent and co-localizes on the membrane of myotubes after a brief 10min treatment with labeled rHsGal-1. We show the carbohydrate recognition domain of Gal-1 is necessary for observed membrane repair. Improvements in membrane repair after only a 10 min rHsGal-1treatment suggest mechanical stabilization of the membrane due to interaction with glycosylated membrane bound, ECM or yet to be identified ligands through the CDR domain of Gal-1. rHsGal-1 shows calcium-independent membrane repair in dysferlin-deficient and wild-type myotubes and myofibers. Together our novel results reveal Gal-1 mediates disease pathologies through both changes in integral myogenic protein expression and mechanical membrane stabilization.	[Vallecillo-Zuniga, Mary L.; Rathgeber, Matthew F.; Poulson, P. Daniel; Hayes, Spencer; Luddington, Jacob S.; Gill, Hailie N.; Teynor, Matthew; Kartchner, Braden C.; Valdoz, Jonard; Stowell, Caleb; Markham, Ashley R.; Van Ry, Pam M.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA; [Arthur, Connie; Stowell, Sean] Emory Univ, Lab & Blood Bank, Ctr Transfus & Cellular Therapies,Sch Med, Emory Hosp,Emory Orthopaed & Spine Hosp,Ctr Apher, Atlanta, GA 30322 USA	Brigham Young University; Emory University	Van Ry, PM (corresponding author), Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA.	pvanry@chem.byu.edu	Van Ry, Pam/GYU-8572-2022; Van+Ry, Pam/AAW-4464-2021	Poulson, Peter Daniel/0000-0002-1471-1378; Vallecillo-Zuniga, Mary L/0000-0001-7662-4010; Valdoz, Jonard/0000-0002-7106-1009; Teynor, Matthew/0000-0002-6981-4809; Kartchner, Braden/0000-0002-4373-8959; Gill, Hailie/0000-0002-3126-213X	Brigham Young University award: Roland K. Robbins Research Fellowship; Brigham Young University award: Earl M. Woolley Research Innovation Award; Jain Foundation	Brigham Young University award: Roland K. Robbins Research Fellowship; Brigham Young University award: Earl M. Woolley Research Innovation Award; Jain Foundation	This study was supported by the following Brigham Young University awards: Roland K. Robbins Research Fellowship to MLVZ and Earl M. Woolley Research Innovation Award to PMVR. The authors also thank the Jain Foundation for their funding and support to PMVR.	[Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; [Anonymous], 2015, AM J PHARM BENEFITS, V7, pe141; Bae GU, 2008, J BIOL CHEM, V283, P8301, DOI 10.1074/jbc.M706730200; Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 2000, BRAIN; Bizzarro V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048246; Blazek AD, 2015, PHYSIOLOGY, V30, P438, DOI 10.1152/physiol.00019.2015; Boye TL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01743-6; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Carmeille R, 2017, METHODS MOL BIOL, V1668, P195, DOI 10.1007/978-1-4939-7283-8_14; Chan J, 2006, STEM CELLS, V24, P1879, DOI 10.1634/stemcells.2005-0564; Cohen TV, 2012, NEUROMUSCULAR DISORD, V22, P648, DOI 10.1016/j.nmd.2012.03.002; Conerly ML, 2016, DEV CELL, V36, P375, DOI 10.1016/j.devcel.2016.01.021; de Luna N, 2006, J BIOL CHEM, V281, P17092, DOI 10.1074/jbc.M601885200; Demonbreun AR, 2016, J CELL BIOL, V213, P705, DOI 10.1083/jcb.201512022; Demonbreun AR, 2015, JOVE-J VIS EXP, DOI 10.3791/53551; Demonbreun AR, 2011, HUM MOL GENET, V20, P779, DOI 10.1093/hmg/ddq522; Dings RPM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030905; Fajka-Boja R, 2008, CELL MOL LIFE SCI, V65, P2586, DOI 10.1007/s00018-008-8143-x; Fitzpatrick M, 2014, OPEN LAB BOOK; Georgiadis V, 2007, DEV DYNAM, V236, P1014, DOI 10.1002/dvdy.21123; Goldring K, 2002, J CELL SCI, V115, P355; Han R, 2007, CURR OPIN CELL BIOL, V19, P409, DOI 10.1016/j.ceb.2007.07.001; Han RZ, 2011, SKELET MUSCLE, V1, DOI [10.1186/2044-5040-1-10, 10.1186/2044-5040-1-35]; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Jiao A, 2018, J BIOMED MATER RES A, V106, P1543, DOI 10.1002/jbm.a.36351; Kami K, 2005, CURR DRUG TARGETS, V6, P395, DOI 10.2174/1389450054021918; Kato T, 2001, BIOCHEM BIOPH RES CO, V282, P166, DOI 10.1006/bbrc.2001.4556; Kerr JP, 2013, P NATL ACAD SCI USA, V110, P20831, DOI 10.1073/pnas.1307960110; Middel V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12875; MORGAN JE, 1994, DEV BIOL, V162, P486, DOI 10.1006/dbio.1994.1103; Moulton Anne, 2008, CANNT J, V18, P34; Nabi IR, 2015, J CELL SCI, V128, P2213, DOI 10.1242/jcs.151159; Nagaraju K, 2008, AM J PATHOL, V172, P774, DOI 10.2353/ajpath.2008.070327; Narayanaswami P, 2014, NEUROLOGY, V83, P1453, DOI 10.1212/WNL.0000000000000892; Nguyen MN, 2010, PLOS ONE, V5, pe9907; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Popa SJ, 2018, SEMINARS CELL DEV BI; Quattrocelli M, 2017, AM J PATHOL, V187, P2520, DOI 10.1016/j.ajpath.2017.07.017; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sreetama SC, 2018, MOL THER, V26, P2231, DOI 10.1016/j.ymthe.2018.07.021; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Stowell SR, 2004, GLYCOBIOLOGY, V14, P157, DOI 10.1093/glycob/cwh018; Van Ry PM, 2015, MOL THER, V23, P1285, DOI 10.1038/mt.2015.105; Vandre DD, 2007, BIOL REPROD, V77, P533, DOI 10.1095/biolreprod.107.062190; Walter MC, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-26; Watt DJ, 2002, GLYCOCONJUGATE J, V19, P615, DOI 10.1023/B:GLYC.0000014093.23509.92; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wuebbles RD, 2019, MOL THER-METH CLIN D, V13, P145, DOI 10.1016/j.omtm.2019.01.004; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011	53	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238441	10.1371/journal.pone.0238441	http://dx.doi.org/10.1371/journal.pone.0238441			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881965	Green Published, gold			2022-12-26	WOS:000571063300085
J	Leng, XJ; Wang, JF; An, N; Wang, X; Sun, YL; Chen, ZW				Leng, Xuejiao; Wang, Jianfeng; An, Na; Wang, Xue; Sun, Yile; Chen, Zhiwei			Histone 3 lysine-27 demethylase KDM6A coordinates with KMT2B to play an oncogenic role in NSCLC by regulating H3K4me3	ONCOGENE			English	Article							UTX; CANCER; METHYLATION; ACTIVATION; EZH2; MUTATIONS; PATHWAY; GENES; H3	Aberrations in epigenetic modulation dysregulate transcription, playing a critical role in the developmental process of tumors, including lung cancer. Aberrant levels of the histone 3 lysine-27 demethylase KDM6A have been found in cancer and are either positively or negatively associated with tumorigenesis and prognosis. However, the clinical relevance and functional role of KDM6A in lung cancer is largely unknown. We found that KDM6A protein expression was higher in NSCLC tissues than in the corresponding paracancer tissues and that high KDM6A expression was associated with poor patient prognosis. Furthermore, KDM6A knockdown in NSCLC cell lines markedly inhibited the tumorigenic phenotype both in vitro and in vivo. Mechanistically, KDM6A colocalized and cooperated with KMT2B to reprogram the transcriptional network via regulating the cancer pathway, in which abnormal activation of the Wnt pathway is the dominant factor. Interestingly, in NSCLC cell lines, H3K4me3 but not H3K27me2/3 or H3K4me1/2 was markedly altered upon KDM6A or KMT2B knockdown, indicating that KDM6A may act independently of H3K27 demethylases in NSCLC. Taken together, these results indicated that KDM6A or KMT2B may be a prognostic biomarker and promising therapeutic target in NSCLC.	[Leng, Xuejiao; An, Na; Wang, Xue; Sun, Yile; Chen, Zhiwei] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Tumor Clin Med Ctr, Shanghai, Peoples R China; [Wang, Jianfeng] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Urol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, ZW (corresponding author), Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Tumor Clin Med Ctr, Shanghai, Peoples R China.	drchenzhiwei@163.com		chen, zhiwei/0000-0002-6027-3575	National Natural Science Foundation of China [81572250]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China (Grant no. 81572250).	Ahuja N, 2016, ANNU REV MED, V67, P73, DOI 10.1146/annurev-med-111314-035900; Akiri G, 2009, ONCOGENE, V28, P2163, DOI 10.1038/onc.2009.82; Audia JE, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019521; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Bienz M, 2005, CURR BIOL, V15, pR64, DOI 10.1016/j.cub.2004.12.058; Chen YC, 2018, COMPUT STRUCT BIOTEC, V16, P211, DOI 10.1016/j.csbj.2018.06.001; Cho Ju Hwan, 2017, Curr Pharmacol Rep, V3, P360; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Ezponda T, 2017, CELL REP, V21, P628, DOI 10.1016/j.celrep.2017.09.078; Fan L, 2016, ONCOGENE, V35, P2441, DOI 10.1038/onc.2015.309; Gridelli C, 2015, NAT REV DIS PRIMERS, V1, DOI [10.1038/nrdp.2015.9, 10.1038/nrdp.2015.48]; Hardy TM, 2011, EPIGENOMICS-UK, V3, P503, DOI [10.2217/epi.11.71, 10.2217/EPI.11.71]; Herz HM, 2012, GENE DEV, V26, P2604, DOI 10.1101/gad.201327.112; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Jankowska AM, 2011, BLOOD, V118, P3932, DOI 10.1182/blood-2010-10-311019; Kalkat M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8060151; Kim JH, 2014, CANCER RES, V74, P1705, DOI 10.1158/0008-5472.CAN-13-1896; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Li SH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010297; Li X, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04769-6; Liao LL, 2015, CANCER GENET-NY, V208, P206, DOI 10.1016/j.cancergen.2015.02.008; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Ng L, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080826; Rao RC, 2015, NAT REV CANCER, V15, P334, DOI 10.1038/nrc3929; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Shpargel KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002964; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Sun LC, 2015, CELL RES, V25, P429, DOI 10.1038/cr.2015.33; Tang X, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-0841-y; Toh TB, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0596-9; Van der Meulen J, 2015, BLOOD, V125, P13, DOI 10.1182/blood-2014-05-577270; Van der Meulen J, 2014, EPIGENETICS-US, V9, P658, DOI 10.4161/epi.28298; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Wang CC, 2012, P NATL ACAD SCI USA, V109, P15324, DOI 10.1073/pnas.1204166109; Wang L, 2019, CANCER CELL, V35, P168, DOI 10.1016/j.ccell.2019.01.001; Xu BW, 2015, EXP HEMATOL, V43, P698, DOI 10.1016/j.exphem.2015.05.001; Zhang C, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0731-8	40	13	13	0	15	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 8	2020	39	41					6468	6479		10.1038/s41388-020-01449-y	http://dx.doi.org/10.1038/s41388-020-01449-y		SEP 2020	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	OA1JL	32879445				2022-12-26	WOS:000565482600003
J	Su, Y; Wang, XY; Guo, Z; Wang, J				Su, Yao; Wang, Xueying; Guo, Zhen; Wang, Jun			Aberrant JmjC domain-containing protein 8 (JMJD8) expression promotes activation of AKT and tumor epithelial-mesenchymal transition	ONCOGENE			English	Article							BETA-CATENIN; CELL-MIGRATION; KINASE; PHOSPHORYLATION; EPIGENOMICS; METHYLATION; METASTASIS; INHIBITION; PATHWAY; FAMILY	Posttranslational modifications of histone and nonhistone proteins greatly influence numerous molecular events in multiple diseases. Jumonji domain-containing proteins are a family functioning as histone demethylase. Jumonji domain-containing protein 8 (JMJD8) is Jumonji C (JmjC) domain-only member of this family, and its physiological functions remain largely unknown. In this study, we investigated the mechanism by which aberrant JMJD8 stimulates phosphorylation of AKT and activate AKT/GSK3 beta/beta-catenin signaling pathway thereby promotes tumor cell epithelial-mesenchymal transition (EMT). We demonstrated that knockdown of JMJD8 increased the interaction of SETDB1 and phosphoinositide-dependent kinase 1 (PDK1) with AKT1 and resulted in enhanced trimethylation of AKT1 at lysine 142 (K142), which is crucial for cell membrane recruitment, phosphorylation, and activation of AKT. Moreover, the mutation of histidine 200 of JMJD8 (JMJD8-H200Q) disrupted its binding with AKT1 and increased interaction of SETDB1 and PDK1 with AKT1. Furthermore, histone demethylase jumonji domain-containing protein 2B functioned as an adapter to recruit beta-catenin to the methylated AKT1 upon JMJD8 depression, which facilitated the phosphorylation of beta-catenin at Ser552 and its accumulation in cell nucleus where the activated beta-catenin transcriptionally stimulated the expression of genes involved in EMT. In conclusion, our data unraveled a novel role of JMJD8 in regulating the migration and invasion of tumor via modulating AKT methylation and activation. In addition, this study showed that JMJD8 is a potential biomarker and drug design target for tumor EMT.	[Su, Yao; Wang, Jun] Chinese Acad Sci, HFIPS, Key Lab High Magnet Field & Ion Beam Phys Biol, Hefei 230031, Peoples R China; [Wang, Xueying; Guo, Zhen] Univ Sci & Technol China, Sch Life Sci, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China	Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wang, J (corresponding author), Chinese Acad Sci, HFIPS, Key Lab High Magnet Field & Ion Beam Phys Biol, Hefei 230031, Peoples R China.; Guo, Z (corresponding author), Univ Sci & Technol China, Sch Life Sci, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China.	zhenguo@ustc.edu.cn; wangjun0457@ipp.ac.cn			National Natural Science Foundation [11575232, 31471268]; National Key Research and Development Program of China (Stem Cell and Translational Research) [2016YFA0101202]; International Partnership Program of Chinese Academy of Sciences [116134KYSB20160084]; Innovative Program of Development Foundation of Hefei Center for Physical Science and Technology [2016FXCX005]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China (Stem Cell and Translational Research); International Partnership Program of Chinese Academy of Sciences; Innovative Program of Development Foundation of Hefei Center for Physical Science and Technology	This study was supported by the National Natural Science Foundation (11575232, 31471268), the National Key Research and Development Program of China (Stem Cell and Translational Research) 2016YFA0101202, the International Partnership Program of Chinese Academy of Sciences (116134KYSB20160084), and the Innovative Program of Development Foundation of Hefei Center for Physical Science and Technology (2016FXCX005).	Alam H, 2015, CELL MOL LIFE SCI, V72, P4577, DOI 10.1007/s00018-015-2023-y; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Boeckel JN, 2016, ARTERIOSCL THROM VAS, V36, P1425, DOI 10.1161/ATVBAHA.116.307695; Chu N, 2018, CELL, V174, P897, DOI 10.1016/j.cell.2018.07.003; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; De Santis MC, 2019, BBA-REV CANCER, V1871, P361, DOI 10.1016/j.bbcan.2019.03.003; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Gao CX, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-13; Ghahhari NM, 2015, EUR J CANCER, V51, P1638, DOI 10.1016/j.ejca.2015.04.021; Guo JP, 2019, CELL CYCLE, V18, P917, DOI 10.1080/15384101.2019.1609832; Guo JP, 2019, NAT CELL BIOL, V21, P226, DOI 10.1038/s41556-018-0261-6; Hamamoto R, 2015, NAT REV CANCER, V15, P110, DOI 10.1038/nrc3884; Henderson V, 2015, CELL ADHES MIGR, V9, P255, DOI 10.1080/19336918.2015.1013383; Hermida Miguel A., 2017, Advances in Biological Regulation, V65, P5, DOI 10.1016/j.jbior.2017.06.003; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Jamieson C, 2012, INT J BIOCHEM CELL B, V44, P847, DOI 10.1016/j.biocel.2012.03.001; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kelly AD, 2017, CURR OPIN GENET DEV, V42, P68, DOI 10.1016/j.gde.2017.03.015; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li Q, 2015, INT J CLIN EXP PATHO, V8, P6334; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Mayer IA, 2016, ANNU REV MED, V67, P11, DOI 10.1146/annurev-med-062913-051343; Oh S, 2019, BBA-REV CANCER, V1871, P406, DOI 10.1016/j.bbcan.2019.04.002; Revathidevi S, 2019, SEMIN CANCER BIOL, V59, P80, DOI 10.1016/j.semcancer.2019.06.002; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sechler M, 2017, ONCOGENE, V36, P4150, DOI 10.1038/onc.2017.44; Serrano-Gomez SJ, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0502-x; Shin S, 2007, BIOCHEM BIOPH RES CO, V353, P973, DOI 10.1016/j.bbrc.2006.12.147; Skrypek N, 2017, TRENDS GENET, V33, P943, DOI 10.1016/j.tig.2017.08.004; Song Y, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317712617; Su Y, 2019, BBA-MOL CELL RES, V1866, DOI 10.1016/j.bbamcr.2019.118541; Sun LD, 2016, CELL MOL LIFE SCI, V73, P4493, DOI 10.1007/s00018-016-2303-1; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Tang B, 2016, CANCER RES, V76, P6520, DOI 10.1158/0008-5472.CAN-15-3029; Tang B, 2015, ONCOTARGET, V6, P12723, DOI 10.18632/oncotarget.3713; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Wang GH, 2019, NAT CELL BIOL, V21, P214, DOI 10.1038/s41556-018-0266-1; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Yang F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09289-5; Yang Q, 2019, SEMIN CANCER BIOL, V59, P112, DOI 10.1016/j.semcancer.2019.04.001; Yeo KS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15676-z; Yeo KS, 2016, SCI REP-UK, V6, DOI 10.1038/srep34125; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019; Zhang J, 2019, MOL MED REP, V19, P3963, DOI 10.3892/mmr.2019.10111; Zhao L, 2013, CLIN CANCER RES, V19, P6419, DOI 10.1158/1078-0432.CCR-13-0254	47	2	3	3	33	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 8	2020	39	41					6451	6467		10.1038/s41388-020-01446-1	http://dx.doi.org/10.1038/s41388-020-01446-1		SEP 2020	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	OA1JL	32879443				2022-12-26	WOS:000565482600004
J	Rimkute, I; Thorsteinsson, K; Henricsson, M; Tenge, VR; Yu, XM; Lin, SC; Haga, K; Atmar, RL; Lycke, N; Nilsson, J; Estes, MK; Bally, M; Larson, G				Rimkute, Inga; Thorsteinsson, Konrad; Henricsson, Marcus; Tenge, Victoria R.; Yu, Xiaoming; Lin, Shih-Ching; Haga, Kei; Atmar, Robert L.; Lycke, Nils; Nilsson, Jonas; Estes, Mary K.; Bally, Marta; Larson, Goran			Histo-blood group antigens of glycosphingolipids predict susceptibility of human intestinal enteroids to norovirus infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycerophospholipid; glycosphingolipid; sphingomyelin; ceramide; host-pathogen interaction; intestinal epithelium; human norovirus; viral replication; sphingolipid; glycosylation; glycolipid structure; intestine; fucosyltransferase; plus-stranded RNA virus; virus entry	CELL-SURFACE ANTIGENS; VIRUS-LIKE PARTICLES; EPITHELIAL-CELLS; MOLECULAR CHARACTERIZATION; MEMBRANE-PROPERTIES; FETAL TISSUE; STEM-CELLS; MINI-GUTS; MECONIUM; EXPRESSION	The molecular mechanisms behind infection and propagation of human restricted pathogens such as human norovirus (HuNoV) have defied interrogation because they were previously unculturable. However, human intestinal enteroids (HIEs) have emerged to offer unique ex vivo models for targeted studies of intestinal biology, including inflammatory and infectious diseases. Carbohydrate-dependent histo-blood group antigens (HBGAs) are known to be critical for clinical infection. To explore whether HBGAs of glycosphingolipids contribute to HuNoV infection, we obtained HIE cultures established from stem cells isolated from jejunal biopsies of six individuals with different ABO, Lewis, and secretor genotypes. We analyzed their glycerolipid and sphingolipid compositions and quantified interaction kinetics and the affinity of HuNoV virus-like particles (VLPs) to lipid vesicles produced from the individual HIE-lipid extracts. All HIEs had a similar lipid and glycerolipid composition. Sphingolipids included HBGA-related type 1 chain glycosphingolipids (GSLs), with HBGA epitopes corresponding to the geno- and phenotypes of the different HIEs. As revealed by single-particle interaction studies of Sydney GII.4 VLPs with glycosphingolipid-containing HIE membranes, both binding kinetics and affinities explain the patterns of susceptibility toward GII.4 infection for individual HIEs. This is the first time norovirus VLPs have been shown to interact specifically with secretor gene-dependent GSLs embedded in lipid membranes of HIEs that propagate GII.4 HuNoV ex vivo, highlighting the potential of HIEs for advanced future studies of intestinal glycobiology and host-pathogen interactions.	[Rimkute, Inga; Nilsson, Jonas; Larson, Goran] Univ Gothenburg, Sahlgrenska Acad, Dept Lab Med, Gothenburg, Sweden; [Rimkute, Inga; Lycke, Nils] Univ Gothenburg, Sahlgrenska Acad, Dept Microbiol & Immunol, Inst Biomed, Gothenburg, Sweden; [Henricsson, Marcus] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden; [Thorsteinsson, Konrad; Bally, Marta] Umea Univ, Dept Clin Microbiol, Umea, Sweden; [Thorsteinsson, Konrad; Bally, Marta] Umea Univ, Wallenberg Ctr Mol Med, Umea, Sweden; [Tenge, Victoria R.; Yu, Xiaoming; Lin, Shih-Ching; Haga, Kei; Atmar, Robert L.; Estes, Mary K.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Atmar, Robert L.; Estes, Mary K.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Nilsson, Jonas; Larson, Goran] Sahlgrens Univ Hosp, Clin Chem Lab, Gothenburg, Sweden; [Rimkute, Inga] NIAID, ImmunoTechnol Sect, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	University of Gothenburg; University of Gothenburg; University of Gothenburg; Umea University; Umea University; Baylor College of Medicine; Baylor College of Medicine; Sahlgrenska University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Larson, G (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Lab Med, Gothenburg, Sweden.; Estes, MK (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.; Estes, MK (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.; Larson, G (corresponding author), Sahlgrens Univ Hosp, Clin Chem Lab, Gothenburg, Sweden.	mestes@bcm.edu; goran.larson@clinchem.gu.se	Atmar, Robert/AFQ-5392-2022	Atmar, Robert/0000-0001-9989-6772; Tenge, Victoria/0000-0002-9429-7161; Nilsson, Jonas/0000-0001-5263-2454; Rimkute, Inga/0000-0003-3822-7043	Swedish Research Council [2017-04029, K2014-68X-08266-27-4, 2017-00955]; Swedish Foundation for Strategic Research Grant [SB12/KF10-0088]; National Institutes of Health Public Health Services Grants [PO1 AI057788, U19 AI116497, P30 DK56338]; Cancer Prevention 656 Institute of Texas (CPRIT) Grant-Baylor College of Medicine Comprehensive Cancer Training Program [RP160283]; Swedish government; county councils; ALF [ALFGBG_721971]; Wallenberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research Grant; National Institutes of Health Public Health Services Grants; Cancer Prevention 656 Institute of Texas (CPRIT) Grant-Baylor College of Medicine Comprehensive Cancer Training Program; Swedish government; county councils; ALF; Wallenberg Foundation(European Commission)	The work was supported by Swedish Research Council Grants K2014-68X-08266-27-4 and 2017-00955 (to G. L); Swedish Foundation for Strategic Research Grant SB12/KF10-0088 (to N. L.); National Institutes of Health Public Health Services Grants PO1 AI057788, U19 AI116497, and P30 DK56338 (to M. K. E.); Cancer Prevention 656 Institute of Texas (CPRIT) Grant RP160283-Baylor College of Medicine Comprehensive Cancer Training Program (to S.-C. L. and M. K. E.); the Swedish state under the agreement between the Swedish government and the county councils, the ALF agreement (ALFGBG_721971) (to G. L.); Swedish Research Council Grant 2017-04029; and the Wallenberg Foundation (to M. B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALESSANDRI JM, 1990, REPROD NUTR DEV, V30, P551, DOI 10.1051/rnd:19900501; Amrutkar M, 2015, FASEB J, V29, P1564, DOI 10.1096/fj.14-264937; ANGSTROM J, 1982, BIOCHIM BIOPHYS ACTA, V710, P428, DOI 10.1016/0005-2760(82)90126-6; ANGSTROM J, 1982, BIOCHIM BIOPHYS ACTA, V712, P274, DOI 10.1016/0005-2760(82)90344-7; Atmar RL, 2018, CURR OPIN INFECT DIS, V31, P422, DOI [10.1097/QCO.0000000000000476, 10.1097/qco.0000000000000476]; Bally M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.188103; Bally M, 2012, ANGEW CHEM INT EDIT, V51, P12020, DOI 10.1002/anie.201205972; BJORK S, 1987, J BIOL CHEM, V262, P6758; Bock J, 2007, WORLD J GASTROENTERO, V13, P5217, DOI 10.3748/wjg.v13.i39.5217; Bonani M, 2017, TRANSPLANTATION, V101, P1455, DOI [10.1097/TP.0000000000001376, 10.1097/tp.0000000000001376]; Breimer ME, 2012, GLYCOBIOLOGY, V22, P1721, DOI 10.1093/glycob/cws115; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Centers for Disease Control and Prevention, 2018, NOR WORLDW; Costantini V, 2018, EMERG INFECT DIS, V24, P1453, DOI 10.3201/eid2408.180126; Danielsen EM, 2006, MOL MEMBR BIOL, V23, P71, DOI 10.1080/09687860500445604; Drummond CG, 2017, P NATL ACAD SCI USA, V114, P1672, DOI 10.1073/pnas.1617363114; Echenique IA, 2016, TRANSPL INFECT DIS, V18, P98, DOI 10.1111/tid.12472; Ejsing CS, 2006, ANAL CHEM, V78, P6202, DOI 10.1021/ac060545x; Ekroos K, 2002, ANAL CHEM, V74, P941, DOI 10.1021/ac015655c; Estes MK, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11070638; Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211; FINNE J, 1989, J BIOL CHEM, V264, P5720; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foulke-Abel J, 2014, EXP BIOL MED, V239, P1124, DOI 10.1177/1535370214529398; Haga K, 2020, MBIO, V11, DOI 10.1128/mBio.00251-20; Haga K, 2016, P NATL ACAD SCI USA, V113, pE6248, DOI 10.1073/pnas.1605575113; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P225, DOI 10.1073/pnas.012540899; HANSSON GC, 1986, EMBO J, V5, P483, DOI 10.1002/j.1460-2075.1986.tb04237.x; HANSSON GC, 1985, J IMMUNOL METHODS, V83, P37, DOI 10.1016/0022-1759(85)90055-9; Heo I, 2018, NAT MICROBIOL, V3, P814, DOI 10.1038/s41564-018-0177-8; HOLGERSSON J, 1988, BIOCHIMIE, V70, P1565, DOI 10.1016/0300-9084(88)90292-1; Holly MK, 2018, J VIROL, V92, DOI 10.1128/JVI.00250-18; Homan R, 1998, J CHROMATOGR B, V708, P21, DOI 10.1016/S0378-4347(97)00651-8; In JG, 2016, NAT REV GASTRO HEPAT, V13, P633, DOI 10.1038/nrgastro.2016.142; KARLSSON KA, 1978, FEBS LETT, V87, P283, DOI 10.1016/0014-5793(78)80352-4; KARLSSON KA, 1973, BIOCHIM BIOPHYS ACTA, V306, P317, DOI 10.1016/0005-2760(73)90237-3; KARLSSON KA, 1981, FEBS LETT, V128, P71, DOI 10.1016/0014-5793(81)81082-4; KARLSSON KA, 1979, J BIOL CHEM, V254, P9311; KARLSSON KA, 1981, J BIOL CHEM, V256, P3512; Koromyslova AD, 2019, J VIROL, V93, DOI 10.1128/JVI.02174-18; Kou B, 2015, CLIN VACCINE IMMUNOL, V22, P160, DOI 10.1128/CVI.00519-14; Kovbasnjuk O, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt364; Kuikka M, 2001, BIOPHYS J, V80, P2327, DOI 10.1016/S0006-3495(01)76203-0; Kumar P, 2018, J CLIN INVEST, V128, P3298, DOI 10.1172/JCI97659; Lindesmith LC, 2019, IMMUNITY, V50, P1530, DOI 10.1016/j.immuni.2019.05.007; LLOYD KO, 1983, IMMUNOGENETICS, V17, P537, DOI 10.1007/BF00696877; Lupo J, 2016, J CLIN VIROL, V74, P54, DOI 10.1016/j.jcv.2015.11.026; MCKIBBIN JM, 1982, J BIOL CHEM, V257, P755; Murakami K, 2020, P NATL ACAD SCI USA, V117, P1700, DOI 10.1073/pnas.1910138117; Nasir W, 2017, ACS CHEM BIOL, V12, P1288, DOI 10.1021/acschembio.7b00152; Nasir W, 2015, J PHYS CHEM B, V119, P11466, DOI 10.1021/acs.jpcb.5b04160; NICHOLS GE, 1987, BIOCHIM BIOPHYS ACTA, V930, P154, DOI 10.1016/0167-4889(87)90027-9; Nickerson KP, 2018, EBIOMEDICINE, V31, P92, DOI 10.1016/j.ebiom.2018.04.005; Nilsson J, 2009, GLYCOCONJUGATE J, V26, P1171, DOI 10.1007/s10719-009-9237-x; Nilsson M, 2003, J VIROL, V77, P13117, DOI 10.1128/JVI.77.24.13117-13124.2003; Orchard RC, 2018, NAT MICROBIOL, V3, P1109, DOI 10.1038/s41564-018-0221-8; Quinn PJ, 2010, PROG LIPID RES, V49, P390, DOI 10.1016/j.plipres.2010.05.002; Ramstedt B, 2002, FEBS LETT, V531, P33, DOI 10.1016/S0014-5793(02)03406-3; Reeck A, 2010, J INFECT DIS, V202, P1212, DOI 10.1086/656364; Robbe C, 2004, BIOCHEM J, V384, P307, DOI 10.1042/BJ20040605; Rydell GE, 2013, BBA-BIOMEMBRANES, V1828, P1840, DOI 10.1016/j.bbamem.2013.03.016; Rydell GE, 2009, GLYCOBIOLOGY, V19, P1176, DOI 10.1093/glycob/cwp103; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Scott A, 2016, J PEDIATR SURG, V51, P995, DOI 10.1016/j.jpedsurg.2016.02.074; Shivanna V, 2015, VIROLOGY, V483, P218, DOI 10.1016/j.virol.2015.04.022; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; Sugata K, 2014, J PEDIATR INFECT DIS, V3, P358, DOI 10.1093/jpids/pit087; Svensson L, 2013, BLOOD, V121, P1459, DOI 10.1182/blood-2012-10-455055; van der Bijl P, 1996, J CELL BIOL, V132, P813, DOI 10.1083/jcb.132.5.813; Wilke G, 2019, CELL HOST MICROBE, V26, P123, DOI 10.1016/j.chom.2019.05.007; XI JA, 1992, J VIROL, V66, P6527, DOI 10.1128/JVI.66.11.6527-6532.1992; Yu HM, 2017, ANNU REV PHYSIOL, V79, P291, DOI 10.1146/annurev-physiol-021115-105211; Zachos NC, 2016, J BIOL CHEM, V291, P3759, DOI 10.1074/jbc.R114.635995; Zou WY, 2019, METHODS MOL BIOL, V1576, P229, DOI 10.1007/7651_2017_1	77	7	7	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2020	295	47					15974	15987		10.1074/jbc.RA120.014855	http://dx.doi.org/10.1074/jbc.RA120.014855			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PA5ED	32913124	Green Published, hybrid			2022-12-26	WOS:000595657900016
J	Czerner, CP; Schoenfeld, C; Cebotari, S; Renne, J; Kaireit, TF; Winther, HB; Pohler, GH; Olsson, KM; Hoeper, MM; Wacker, F; Vogel-Claussen, J				Czerner, Christoph P.; Schoenfeld, Christian; Cebotari, Serghei; Renne, Julius; Kaireit, Till F.; Winther, Hinrich B.; Poehler, Gesa H.; Olsson, Karen M.; Hoeper, Marius M.; Wacker, Frank; Vogel-Claussen, Jens			Perioperative CTEPH patient monitoring with 2D phase-contrast MRI reflects clinical, cardiac and pulmonary perfusion changes after pulmonary endarterectomy	PLOS ONE			English	Article							BREATH-HOLD; HYPERTENSION	Magnetic resonance imaging (MRI) is an emerging tool for diagnosis and treatment monitoring of chronic thromboembolic pulmonary hypertension (CTEPH). The current study aims to identify central pulmonary arterial hemodynamic parameters that reflect clinical, cardiac and pulmonary changes after PEA. 31 CTEPH patients, who underwent PEA and received pre- and postoperative MRI, were analyzed retrospectively. Central pulmonary arterial blood flow, lung perfusion and right heart function data were derived from MRI. Mean pulmonary arterial pressure (mPAP) and 5-month follow-up six-minute walk-distance (6MWD) were assessed. After PEA, mPAP decreased significantly and patients achieved a higher 6MWD. Central pulmonary arterial blood flow velocities, pulmonary blood flow (PBF) and right ventricular function increased significantly. Two-dimensional (2D) phase-contrast (PC) MRI-derived average mean velocity, maximum mean velocity and deceleration volume changes after PEA correlated with changes of 6MWD and right heart ejection fraction (RVEF). Deceleration volume is a novel 2D PC MRI parameter showing further correlation with PBF changes. In conclusion, 2D PC MRI-derived main pulmonary hemodynamic changes reflect changes of RVEF, PBF and 5-month follow-up 6MWD and may be used for future CTEPH patient monitoring after PEA.	[Czerner, Christoph P.; Schoenfeld, Christian; Renne, Julius; Kaireit, Till F.; Winther, Hinrich B.; Poehler, Gesa H.; Wacker, Frank; Vogel-Claussen, Jens] Hannover Med Sch, Inst Diagnost & Intervent Radiol, Hannover, Germany; [Czerner, Christoph P.; Schoenfeld, Christian; Renne, Julius; Kaireit, Till F.; Olsson, Karen M.; Hoeper, Marius M.; Wacker, Frank; Vogel-Claussen, Jens] German Ctr Lung Res, Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany; [Cebotari, Serghei] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Hannover, Germany; [Olsson, Karen M.; Hoeper, Marius M.] Hannover Med Sch, Clin Pneumol, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Vogel-Claussen, J (corresponding author), Hannover Med Sch, Inst Diagnost & Intervent Radiol, Hannover, Germany.; Vogel-Claussen, J (corresponding author), German Ctr Lung Res, Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany.	vogel-claussen.jens@mh-hannover.de	Winther, Hinrich/GZL-6044-2022	Vogel-Claussen, Jens/0000-0001-5595-6948				Czerner CP, 2017, J MAGN RESON IMAGING, V46, P1698, DOI 10.1002/jmri.25724; Delcroix M, 2016, CIRCULATION, V133, P859, DOI 10.1161/CIRCULATIONAHA.115.016522; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Guo XJ, 2014, DIAGN INTERV RADIOL, V20, P414, DOI 10.5152/dir.2014.13501; Hoeper MM, 2016, LANCET RESP MED, V4, P323, DOI 10.1016/S2213-2600(15)00542-1; Ingrisch M, 2010, INVEST RADIOL, V45, P7, DOI 10.1097/RLI.0b013e3181bc2d0c; Jamieson SW, 2003, ANN THORAC SURG, V76, P1457, DOI 10.1016/S0003-4975(03)00828-2; Jenkins D, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0111-2016; Jenkins DP, 2013, EUR RESPIR J, V41, P735, DOI 10.1183/09031936.00058112; Kim NH, 2013, J AM COLL CARDIOL, V62, pD92, DOI 10.1016/j.jacc.2013.10.024; Kreitner KF, 2007, EUR RADIOL, V17, P11, DOI 10.1007/s00330-006-0327-x; Kreltner KFJ, 2004, RADIOLOGY, V232, P535, DOI 10.1148/radiol.2322030945; Ley S, 2012, EUR RADIOL, V22, P607, DOI 10.1007/s00330-011-2290-4; Mayer E, 2011, J THORAC CARDIOV SUR, V141, P702, DOI 10.1016/j.jtcvs.2010.11.024; Mousseaux E, 1999, RADIOLOGY, V212, P896, DOI 10.1148/radiology.212.3.r99au21896; Rajaram S, 2013, THORAX, V68, P677, DOI 10.1136/thoraxjnl-2012-203020; Reiter U, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150995; Rolf A, 2015, INT J CARDIOVAS IMAG, V31, P613, DOI 10.1007/s10554-014-0580-z; Sanz J, 2007, RADIOLOGY, V243, P70, DOI 10.1148/radiol.2431060477; Schoenfeld C, 2019, EUR RADIOL, V29, P1693, DOI 10.1007/s00330-018-5696-4; Schoenfeld C, 2016, RADIOLOGY, V279, P925, DOI 10.1148/radiol.2015150765; Sourbron S, 2007, PHYS MED BIOL, V52, P429, DOI 10.1088/0031-9155/52/2/009	22	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0238171	10.1371/journal.pone.0238171	http://dx.doi.org/10.1371/journal.pone.0238171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925924	gold, Green Published			2022-12-26	WOS:000572318000033
J	Sterner, TR; Gudmundsson, P; Falk, H; Seidu, N; Ahlner, F; Wetterberg, H; Ryden, L; Sigstrom, R; Ostling, S; Zettergren, A; Kern, S; Waern, M; Skoog, I				Sterner, Therese Rydberg; Gudmundsson, Pia; Falk, Hanna; Seidu, Nazib; Ahlner, Felicia; Wetterberg, Hanna; Ryden, Lina; Sigstrom, Robert; Ostling, Svante; Zettergren, Anna; Kern, Silke; Waern, Margda; Skoog, Ingmar			Depression in relation to sex and gender expression among Swedish septuagenarians-Results from the H70 study	PLOS ONE			English	Article							PSYCHOPATHOLOGICAL RATING-SCALE; MASCULINITY; SYMPTOMS; DIFFERENCE; FEMININITY; EXPERIENCE; MEN	Objective Little is known about the role of gender expression (femininity, masculinity, or androgyny) in relation to sex differences in depression. This study tested if gender expression was associated with depression and burden of depressive symptoms in a 70-year-old population. Methods A cross-sectional population-based sample of 70-year-olds from The Gothenburg H70 Birth Cohort Study (n = 1203) was examined in 2014-16. Data were collected using psychiatric examinations and structured questionnaires, including the Positive-Negative Sex-Role Inventory to assess gender expression. Depression was diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders criteria, and symptom burden was assessed with Montgomery angstrom sberg Depression Rating Scale (MADRS). Results Gender expression was related to MADRS score and depression diagnosis. In fully adjusted models, feminine traits with low social desirability (FEM-) were associated with a higher MADRS score (R(2)0.16; B 0.16; CI 0.1-0.2), while androgyny (t ratio) (R(2)0.12; B 0.42; CI 0.1-0.7) and masculine traits with high social desirability (MAS+) (R(2)0.13; B -0.06; CI -0.1--0.01) were associated with a lower MADRS score. Also, feminine traits with low social desirability (FEM-) were positively associated with depression (OR 1.04; CI 1.01-1.1). No associations between depression and masculinity or androgyny were observed in adjusted models. There were no interactions between sex and gender expression in relation to depression or MADRS score, indicating that the effects of gender expression were similar in men and women. Conclusions We found that gender expression was associated to both depression and burden of depressive symptoms. More specifically, we found that femininity was associated to higher levels of depression, irrespective of biological sex. In addition, masculinity and androgyny were associated with lower levels of depression. These results highlight the importance of taking gender expression into consideration when studying sex differences in depression among older populations in future studies.	[Sterner, Therese Rydberg; Gudmundsson, Pia; Falk, Hanna; Seidu, Nazib; Ahlner, Felicia; Wetterberg, Hanna; Ryden, Lina; Sigstrom, Robert; Ostling, Svante; Zettergren, Anna; Kern, Silke; Waern, Margda; Skoog, Ingmar] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol,Ctr Ageing & Hlth AGECAP, Dept Psychiat & Neurochem,Neuropsychiat Epidemiol, Molndal, Sweden; [Falk, Hanna; Sigstrom, Robert; Ostling, Svante; Kern, Silke; Skoog, Ingmar] Sahlgrens Univ Hosp, Psychiat Cognit & Old Age Psychiat Clin, Gothenburg, Sweden; [Waern, Margda] Sahlgrens Univ Hosp, Psychosis Clin, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital; Sahlgrenska University Hospital	Sterner, TR (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol,Ctr Ageing & Hlth AGECAP, Dept Psychiat & Neurochem,Neuropsychiat Epidemiol, Molndal, Sweden.	therese.rydberg.sterner@gu.se	Falk Erhag, Hanna/AAY-5130-2021; Rydén, Lina/T-3332-2019; Wetterberg, Hanna/AAP-4071-2021; Sigström, Robert/V-8799-2019	Rydén, Lina/0000-0002-3817-2620; Sigström, Robert/0000-0003-1505-1532; Rydberg Sterner, Therese/0000-0001-8202-8522; Wetterberg, Hanna/0000-0003-3836-825X; Seidu, Nazib M./0000-0002-8381-9657	Swedish government [ALF 716681, ALF715841]; Swedish county councils, the ALF-agreement [ALF 716681, ALF715841]; Swedish Research Council [11267, 825-20077462, 825-2012-5041, 521-2013-2699, RAM 2013-8717, 2015-02830, 2016-01590]; Swedish Research Council for Health, Working Life and Welfare [2001-2835, 2004-0145, 2006-0596, 2008-1111, 2008-1229, 2010-0870, 2012-1138, 2013-1202, 2016-201607097, AGECAP 2013-2300, 2013-2496, 20130475, Epilife 2006-1506]; Sahlgrenska University Hospital (ALF); Gun & Bertil Stohnes forskningsstipendium; Fredrik & Ingrid Thurings stiftelse; Wilhelm & Martina Lundgrens foundation; Hjalmar Svensson Foundation; Irisstipendiet; Konung Gustav och Drottning Victorias Frimurarstiftelsen; Soderstrom-Konig Foundation; Stiftelsen Ragnhild & Einar Lundstroms minne	Swedish government; Swedish county councils, the ALF-agreement; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Sahlgrenska University Hospital (ALF); Gun & Bertil Stohnes forskningsstipendium; Fredrik & Ingrid Thurings stiftelse; Wilhelm & Martina Lundgrens foundation; Hjalmar Svensson Foundation; Irisstipendiet; Konung Gustav och Drottning Victorias Frimurarstiftelsen; Soderstrom-Konig Foundation; Stiftelsen Ragnhild & Einar Lundstroms minne	The study was financed by grants from the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement [https://www.vr.se/english/about-us/organisation/advisory-groups-andadministrative-offices/office-for-alf.html] (ALF 716681, ALF715841), the Swedish Research Council [https://www.vr.se/] (11267, 825-20077462, 825-2012-5041, 521-2013-2699, RAM 2013-8717, 2015-02830, 2016-01590), Swedish Research Council for Health, Working Life and Welfare [https://forte.se/en/] (no 2001-2835, 2004-0145, 2006-0596, 2008-1111, 2008-1229, 2010-0870, 2012-1138, 2013-1202, 2016-201607097, AGECAP 2013-2300, 2013-2496, 20130475, Epilife 2006-1506), Sahlgrenska University Hospital (ALF), Gun & Bertil Stohnes forskningsstipendium [https://www.stohnesstiftelse.se/], Fredrik & Ingrid Thurings stiftelse [http://www.thuringsstiftelse.com/], Wilhelm & Martina Lundgrens foundation [http://www.wmlundgren.se/], Hjalmar Svensson Foundation [https://www.stiftelsemedel.se/stiftelsen-handlanden-hjalmar-svenssonsforskningsfond/], Irisstipendiet [https://www.irisstipendiet.se/], Konung Gustav och Drottning Victorias Frimurarstiftelsen [https://frimurarorden.se/en/], Soderstrom-Konig Foundation [https://www.sls.se/vetenskap/sok-anslag/stift.soderstrom/], and Stiftelsen Ragnhild & Einar Lundstroms minne [https://lindhes.se/stiftelseforvaltning/].This study was accomplished while first author Therese Rydberg Sterner was affiliated with the Swedish National Graduate School for Competitive Science on Ageing and Health (SWEAH), which is funded by the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; [Anonymous], 2018, CANC DISCOV, V8, pOF6; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; ASBERG M, 1979, PROG NEURO-PSYCHOPHA, V3, P405, DOI 10.1016/0364-7722(79)90055-9; Barrett AE, 2002, J HEALTH SOC BEHAV, V43, P451, DOI 10.2307/3090237; Bebbington PE, 1998, PSYCHOL MED, V28, P1, DOI 10.1017/S0033291797006065; BEM SL, 1975, J PERS SOC PSYCHOL, V31, P634, DOI 10.1037/h0077098; BEM SL, 1974, J CONSULT CLIN PSYCH, V42, P155, DOI 10.1037/h0036215; Bergdahl E, 2007, INT PSYCHOGERIATR, V19, P1125, DOI 10.1017/S1041610207005662; Berger A, 2013, EUR J SOC PSYCHOL, V43, P516, DOI 10.1002/ejsp.1970; Black HK, 2007, J GERONTOL B-PSYCHOL, V62, pS392, DOI 10.1093/geronb/62.6.S392; Bouffard R, 2003, CAN J PSYCHIAT, V48, P546, DOI 10.1177/070674370304800806; Bulhoes C, 2019, EPIDEMIOL PSYCH SCI, V28, P66, DOI 10.1017/S2045796017000312; Camacho D, 2018, AGING MENT HEALTH, V22, P1050, DOI 10.1080/13607863.2017.1332159; Connell R, 2015, GENDER WORLD PERSPEC; Conner KO, 2010, J AGING STUD, V24, P266, DOI 10.1016/j.jaging.2010.05.007; Darmstadt GL, 2019, LANCET, V393, P2374, DOI 10.1016/S0140-6736(19)30985-7; DER G, 1987, SOC PSYCHIATR, V22, P73, DOI 10.1007/BF00584009; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Gariepy G, 2016, BRIT J PSYCHIAT, V209, P286, DOI 10.1192/bjp.bp.115.169094; Gibson PA, 2016, J AFFECT DISORDERS, V189, P306, DOI 10.1016/j.jad.2015.08.067; GREEN BH, 1992, ACTA PSYCHIAT SCAND, V86, P213, DOI 10.1111/j.1600-0447.1992.tb03254.x; Hartung CM, 2019, PSYCHOL BULL, V145, P390, DOI 10.1037/bul0000183; Horwitz AV, 2011, MILBANK Q, V89, P628, DOI 10.1111/j.1468-0009.2011.00645.x; HUNT MG, 1993, SEX ROLES, V29, P147, DOI 10.1007/BF00289933; Hyde JS, 2008, PSYCHOL REV, V115, P291, DOI 10.1037/0033-295X.115.2.291; JORM AF, 1987, AUST NZ J PSYCHIAT, V21, P46, DOI 10.3109/00048678709160898; KRAMES L, 1988, SEX ROLES, V19, P713, DOI 10.1007/BF00288987; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lawrence K, 2007, GENDER MED, V4, pS96, DOI 10.1016/S1550-8579(07)80050-7; Lo IPY, 2019, ARCH SEX BEHAV, V48, P1543, DOI 10.1007/s10508-019-1402-0; Maji S, 2018, INT J SOC PSYCHIATR, V64, P396, DOI 10.1177/0020764018765023; Marcotte D, 2002, J EMOT BEHAV DISORD, V10, P29, DOI 10.1177/106342660201000104; Marcotte D, 1999, SEX ROLES, V41, P31, DOI 10.1023/A:1018833607815; Martin CL, 2017, SEX ROLES, V76, P592, DOI 10.1007/s11199-016-0602-5; Martin LA, 2013, JAMA PSYCHIAT, V70, P1100, DOI 10.1001/jamapsychiatry.2013.1985; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Oliffe JL, 2008, J MENS HEALTH, V5, P194, DOI 10.1016/j.jomh.2008.03.016; Salk RH, 2017, PSYCHOL BULL, V143, P783, DOI 10.1037/bul0000102; SANFILIPO MP, 1994, J CLIN PSYCHOL, V50, P144, DOI 10.1002/1097-4679(199403)50:2<144::AID-JCLP2270500204>3.0.CO;2-0; Schmitz A, 2019, ARCH GERONTOL GERIAT, V82, P207, DOI 10.1016/j.archger.2019.02.015; Seidler ZE, 2016, CLIN PSYCHOL REV, V49, P106, DOI 10.1016/j.cpr.2016.09.002; Sigurdsson B, 2015, J AFFECT DISORDERS, V173, P81, DOI 10.1016/j.jad.2014.10.065; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; SKOOG I, 1993, NEW ENGL J MED, V328, P153, DOI 10.1056/NEJM199301213280301; STALLONES L, 1990, AM J PREV MED, V6, P295, DOI 10.1016/S0749-3797(18)30998-X; Sterner TR, 2019, ACTA PSYCHIAT SCAND, V139, P381, DOI 10.1111/acps.13005; Sterner TR, 2019, EUR J EPIDEMIOL, V34, P191, DOI 10.1007/s10654-018-0459-8; van der Laan NC, 2005, INT J GERIATR PSYCH, V20, P35, DOI 10.1002/gps.1244; West C, 1987, GENDER SOC, V1, P125, DOI 10.1177/0891243287001002002; WHO, GEND DISP MENT HLTH	53	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0238701	10.1371/journal.pone.0238701	http://dx.doi.org/10.1371/journal.pone.0238701			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NS5RK	32925927	Green Published, gold			2022-12-26	WOS:000572318000053
J	Ullah, F; Gul, H; Tariq, K; Desneux, N; Gao, XW; Song, DL				Ullah, Farman; Gul, Hina; Tariq, Kaleem; Desneux, Nicolas; Gao, Xiwu; Song, Dunlun			Fitness costs in clothianidin-resistant population of the melon aphid, Aphis gossypii	PLOS ONE			English	Article							BEMISIA-TABACI HOMOPTERA; CROSS-RESISTANCE; PLUTELLA-XYLOSTELLA; BT COTTON; NEONICOTINOID INSECTICIDE; IMIDACLOPRID RESISTANCE; NILAPARVATA-LUGENS; BROWN PLANTHOPPER; LEPIDOPTERA; SUBLETHAL	Clothianidin is a second-generation neonicotinoid insecticide, widely used against sap-sucking insect pest including melon aphid,Aphis gossypiiGlover (Hemiptera: Aphididae). This pest causes severe economic damage to Cucurbitaceae plants worldwide. In this study, we investigated clothianidin resistance development under continuous selection pressure. Moreover, the age-stage, two-sex life table approach was used to evaluate the impact of clothianidin resistance on the fitness ofA.gossypii. A clothianidin resistant strain (CT-R) with a 23.17-fold resistance level was developed from a susceptible strain (CT-S) after continuous selection for 24 generations. Life table results showed a significant reduction in the relative fitness (0.847) of CT-R strain compared to the CT-S strain ofA.gossypii. The developmental duration, oviposition days, total pre-oviposition period (TPOP), longevity, and fecundity of CT-R strain were found to be significantly lower when compared to CT-S strain. The demographic parameters, including the intrinsic rate of increase (r), finite rate of increase (lambda), net reproductive rate (R-0), and mean generation time (T) were also significantly decreased in CT-R strain compared to the CT-S strain. Both the reproductive and survival rates were affected by clothianidin resistance in CT-R strain compared with the CT-S strain ofA.gossypii. Overall, our results demonstrate that in-depth knowledge about the trade-off at play between resistance degree and fitness cost might be useful to design resistance management strategies againstA.gossypii.	[Ullah, Farman; Gul, Hina; Gao, Xiwu; Song, Dunlun] China Agr Univ, Dept Entomol, Beijing, Peoples R China; [Tariq, Kaleem] Abdul Wali Khan Univ Mardan, Dept Agr Entomol, Khyber Pakhtunkhwa, Pakistan; [Tariq, Kaleem] Univ Florida, Entomol & Nematol Dept, Steinmetz Hall, Gainesville, FL USA; [Tariq, Kaleem] ARS, USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL USA; [Desneux, Nicolas] Univ Cote dAzur, INRAE, CNRS, UMR ISA, Nice, France	China Agricultural University; State University System of Florida; University of Florida; United States Department of Agriculture (USDA); Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur	Ullah, F; Song, DL (corresponding author), China Agr Univ, Dept Entomol, Beijing, Peoples R China.	farmanullah@cau.edu.cn; songdl@cau.edu.cn	TARIQ, KALEEM/J-7875-2015; Desneux, Nicolas/J-6262-2013; Ullah, Farman/AAH-5467-2019; Gul, Hina/AAW-8747-2021	TARIQ, KALEEM/0000-0002-0951-509X; Ullah, Farman/0000-0001-6174-1425; 	National Key Research and Development Program of China [2016YFD0200500]; National Natural Science Foundation of China [31272077]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Key Research and Development Program of China (2016YFD0200500) and the National Natural Science Foundation of China (31272077).	Abbas N, 2016, VET PARASITOL, V226, P78, DOI 10.1016/j.vetpar.2016.06.035; Abbas N, 2012, PESTIC BIOCHEM PHYS, V103, P181, DOI 10.1016/j.pestbp.2012.05.001; ARMSTRONG JS, 1993, J KANSAS ENTOMOL SOC, V66, P69; Aslam M, 2004, J RES SCI, V15, P53, DOI DOI 10.1007/s13398-014-0173-7.2; Cahill M, 1996, B ENTOMOL RES, V86, P343, DOI 10.1017/S000748530003491X; Cao GC, 2006, PEST MANAG SCI, V62, P746, DOI 10.1002/ps.1234; Cao GC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05629; Carriere Y, 2004, J ECON ENTOMOL, V97, P1710, DOI 10.1603/0022-0493-97.5.1710; Chen XW, 2016, ECOTOXICOLOGY, V25, P1841, DOI 10.1007/s10646-016-1732-9; CHI H, 1988, ENVIRON ENTOMOL, V17, P26, DOI 10.1093/ee/17.1.26; CHI H, 1985, Bulletin of the Institute of Zoology Academia Sinica (Taipei), V24, P225; Chi H., 2018, TWOSEX MS CHART COMP; Chi H, 2020, ENTOMOL GEN, V40, P103, DOI 10.1127/entomologia/2020/0936; Cui L, 2018, PEST MANAG SCI, V74, P2636, DOI 10.1002/ps.5056; Cui L, 2016, PESTIC BIOCHEM PHYS, V132, P96, DOI 10.1016/j.pestbp.2016.02.005; Decourtye A, 2013, NATURE, V497, P188, DOI 10.1038/497188a; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Ebert TA, 1997, SOUTHWEST ENTOMOL, V22, P116; Ejaz M, 2017, J ECON ENTOMOL, V110, P1226, DOI 10.1093/jee/tox045; Elbert A, 2000, PEST MANAG SCI, V56, P60, DOI 10.1002/(SICI)1526-4998(200001)56:1<60::AID-PS88>3.0.CO;2-K; Fu BL, 2018, PEST MANAG SCI, V74, P1564, DOI 10.1002/ps.4887; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Grafius E. J., 1996, RESISTANT PEST MANAG, V8, P21; Guedes RNC, 2019, J PEST SCI, V92, P1329, DOI 10.1007/s10340-019-01086-9; Gul H, 2019, ENTOMOL GEN, V39, P81, DOI 10.1127/entomologia/2019/0861; Hafeez M, 2019, PEST MANAG SCI, V75, P683, DOI 10.1002/ps.5165; Hoffmann AM, 2015, J APPL ENTOMOL, V139, P403, DOI 10.1111/jen.12209; Huang HW, 2018, J ECON ENTOMOL, V111, P1, DOI 10.1093/jee/tox330; Huang YB, 2013, J APPL ENTOMOL, V137, P327, DOI 10.1111/jen.12002; Hulle M, 2020, ENTOMOL GEN, V40, P97, DOI 10.1127/entomologia/2019/0867; Jam NA, 2018, ENTOMOL GEN, V38, P173, DOI 10.1127/entomologia/2018/0734; Jeschke P., 2001, Pflanzenschutz-Nachrichten Bayer, V54, P147; Kaiser C, 2018, J PEST SCI, V91, P447, DOI 10.1007/s10340-017-0856-x; Khan HAA, 2012, PARASITOL RES, V111, P1165, DOI 10.1007/s00436-012-2947-1; Khattak M. K., 2004, Pakistan Entomologist, V26, P75; Kliot A, 2012, PEST MANAG SCI, V68, P1431, DOI 10.1002/ps.3395; Kollmeyer WD., 1999, NICOTINOID INSECTICI, P71; Koo HN, 2014, CROP PROT, V55, P91, DOI 10.1016/j.cropro.2013.09.010; Li WJ, 2020, PLANT BIOTECHNOL J, V18, P322, DOI 10.1111/pbi.13233; Lin Q-c, 2020, J PEST SCI, P1; Liu XL, 2017, ENTOMOL GEN, V36, P285, DOI 10.1127/entomologia/2017/0480; Liu ZW, 2006, PEST MANAG SCI, V62, P279, DOI 10.1002/ps.1169; Liu ZW, 2003, PEST MANAG SCI, V59, P1355, DOI 10.1002/ps.768; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Ma K, 2019, PESTICIDE BIOCH PHYS; Magalhaes LC, 2007, J APPL ENTOMOL, V131, P251, DOI 10.1111/j.1439-0418.2007.01153.x; Mohammed AAH, 2018, ENTOMOL GEN, V37, P47, DOI 10.1127/entomologia/2017/0471; Nahiyoon SA, 2020, PEST MANAG SCI, V76, P3020, DOI 10.1002/ps.5849; Passos LC, 2018, ENTOMOL GEN, V38, P127, DOI 10.1127/entomologia/2018/0744; Petzold-Maxwell JL, 2017, J APPL ENTOMOL, V141, P67, DOI 10.1111/jen.12356; Raghuraman M., 2008, Indian Journal of Entomology, V70, P319; Rahman T, 2016, CROP PROT, V90, P170, DOI 10.1016/j.cropro.2016.09.001; Saeed R, 2010, CROP PROT, V29, P178, DOI 10.1016/j.cropro.2009.09.012; Sallam AA, 2009, J PLANT DIS PROTECT, V116, P283, DOI 10.1007/BF03356325; Sayyed AH, 2008, J ECON ENTOMOL, V101, P1658, DOI 10.1603/0022-0493(2008)101[1658:GBAPCO]2.0.CO;2; Sayyed AH, 2008, J ECON ENTOMOL, V101, P1927, DOI 10.1603/0022-0493-101.6.1927; Silva JE, 2019, J PEST SCI, V92, P1421, DOI 10.1007/s10340-018-1064-z; Singh S, 2006, INDIAN J APPL ENTOMO, V20, P91; Steinbach D, 2017, PEST MANAG SCI, V73, P1789, DOI 10.1002/ps.4597; Taning CNT, 2019, ENTOMOL GEN, V39, P151, DOI 10.1127/entomologia/2019/0784; Tariq K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41832-8; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Tomlin CDS, 2009, PESTICIDE MANUAL WOR; Ullah F, 2020, PESTIC BIOCHEM PHYS, V170, DOI 10.1016/j.pestbp.2020.104687; Ullah F, 2020, PESTIC BIOCHEM PHYS, V165, DOI 10.1016/j.pestbp.2020.104557; Ullah F, 2020, ECOTOXICOLOGY, V29, P407, DOI 10.1007/s10646-020-02183-7; Ullah F, 2019, ENTOMOL GEN, V39, P259, DOI 10.1127/entomologia/2019/0887; Ullah F, 2019, ENTOMOL GEN, V39, P325, DOI 10.1127/entomologia/2019/0892; Ullah F, 2020, INSECTS, V11, DOI 10.3390/insects11010022; Ullah F, 2019, ENTOMOL GEN, V39, P137, DOI 10.1127/entomologia/2019/0865; Ullah F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48199-w; Wang D, 2010, PHYTOPARASITICA, V38, P103, DOI 10.1007/s12600-009-0077-9; Wang R, 2014, PEST MANAG SCI, V70, P1872, DOI 10.1002/ps.3741; Wang X, 2021, ENTOMOL GEN, V41, P289, DOI 10.1127/entomologia/2021/0972; Wang ZH, 2018, J ASIA-PAC ENTOMOL, V21, P408, DOI 10.1016/j.aspen.2018.01.024; Yuan HB, 2017, INSECT SCI, V24, P743, DOI 10.1111/1744-7917.12357; Zhang P, 2016, PEST MANAG SCI, V72, P1396, DOI 10.1002/ps.4166; Zhang P, 2016, PEST MANAG SCI, V72, P1141, DOI 10.1002/ps.4090; Zhang P, 2015, CROP PROT, V78, P27, DOI 10.1016/j.cropro.2015.08.012; Zhang XL, 2018, J PEST SCI, V91, P1145, DOI 10.1007/s10340-018-0972-2; ZHAO GY, 1995, J ECON ENTOMOL, V88, P1164, DOI 10.1093/jee/88.5.1164	81	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0238707	10.1371/journal.pone.0238707	http://dx.doi.org/10.1371/journal.pone.0238707			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925934	Green Published, gold			2022-12-26	WOS:000572318000045
J	Hernandez-Perez, M; Kulkarni, A; Samala, N; Sorrell, C; El, K; Haider, I; Aleem, AM; Holman, TR; Rai, G; Tersey, SA; Mirmira, RG; Anderson, RM				Hernandez-Perez, Marimar; Kulkarni, Abhishek; Samala, Niharika; Sorrell, Cody; El, Kimberly; Haider, Isra; Mukhtar Aleem, Ansari; Holman, Theodore R.; Rai, Ganesha; Tersey, Sarah A.; Mirmira, Raghavendra G.; Anderson, Ryan M.			A 12-lipoxygenase-Gpr31 signaling axis is required for pancreatic organogenesis in the zebrafish	FASEB JOURNAL			English	Article						12-lipoxygenase; exocrine tissue; Gpr31; pancreas development; zebrafish; beta cells	OXIDATIVE STRESS; BETA-CELLS; 12/15-LIPOXYGENASE; EXPRESSION; LIPOXYGENASES; STEREOCONTROL; OXYGENATION; INHIBITION; DEFICIENCY; PROTECTS	12-Lipoxygenase (12-LOX) is a key enzyme in arachidonic acid metabolism, and alongside its major product, 12-HETE, plays a key role in promoting inflammatory signaling during diabetes pathogenesis. Although 12-LOX is a proposed therapeutic target to protect pancreatic islets in the setting of diabetes, little is known about the consequences of blocking its enzymatic activity during embryonic development. Here, we have leveraged the strengths of the zebrafish-genetic manipulation and pharmacologic inhibition-to interrogate the role of 12-LOX in pancreatic development. Lipidomics analysis during zebrafish development demonstrated that 12-LOX-generated metabolites of arachidonic acid increase sharply during organogenesis stages, and that this increase is blocked by morpholino-directed depletion of 12-LOX. Furthermore, we found that either depletion or inhibition of 12-LOX impairs both exocrine pancreas growth and unexpectedly, the generation of insulin-producing beta cells. We demonstrate that morpholino-mediated knockdown of GPR31, a purported G-protein-coupled receptor for 12-HETE, largely phenocopies both the depletion and the inhibition of 12-LOX. Moreover, we show that loss of GPR31 impairs pancreatic bud fusion and pancreatic duct morphogenesis. Together, these data provide new insight into the requirement of 12-LOX in pancreatic organogenesis and islet formation, and additionally provide evidence that its effects are mediated via a signaling axis that includes the 12-HETE receptor GPR31.	[Hernandez-Perez, Marimar; Sorrell, Cody; El, Kimberly; Haider, Isra; Tersey, Sarah A.; Mirmira, Raghavendra G.; Anderson, Ryan M.] Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Dept Pediat, Indianapolis, IN 46202 USA; [Kulkarni, Abhishek; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Samala, Niharika; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Mukhtar Aleem, Ansari; Holman, Theodore R.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Rai, Ganesha] NIH, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Mirmira, Raghavendra G.; Anderson, Ryan M.] Univ Chicago, Dept Med, Kovler Diabet Ctr, 900 E 57th St KCBD 8130, Chicago, IL 60637 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of California System; University of California Santa Cruz; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University of Chicago	Mirmira, RG; Anderson, RM (corresponding author), Univ Chicago, Dept Med, Kovler Diabet Ctr, 900 E 57th St KCBD 8130, Chicago, IL 60637 USA.	rmirmira@uchicago.edu; ryananderson@uchicago.edu	Kulkarni, Abhishek/AAV-4836-2021	Kulkarni, Abhishek/0000-0001-6792-7183	NIH [T32 DK064466, R01 DK105588]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH, Grant/Award Number: T32 DK064466 and R01 DK105588	Aleem AM, 2019, BIOCHEMISTRY-US, V58, P848, DOI 10.1021/acs.biochem.8b01167; Amagata T, 2003, J NAT PROD, V66, P230, DOI 10.1021/np020462l; Bleich D, 1999, J CLIN INVEST, V103, P1431, DOI 10.1172/JCI5241; Brash AR, 1999, ADV EXP MED BIOL, V469, P83; Coffa G, 2004, P NATL ACAD SCI USA, V101, P15579, DOI 10.1073/pnas.0406727101; Cole BK, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/851798; Conteh AM, 2019, J BIOL CHEM, V294, P6612, DOI 10.1074/jbc.RA118.007102; Dobrian AD, 2018, PROSTAG OTH LIPID M, V136, P23, DOI 10.1016/j.prostaglandins.2018.03.003; Fehrenbacher N, 2017, J CELL BIOL, V216, P2329, DOI 10.1083/jcb.201609096; Godinho L, 2005, DEVELOPMENT, V132, P5069, DOI 10.1242/dev.02075; Grzesik WJ, 2015, J CLIN ENDOCR METAB, V100, pE387, DOI 10.1210/jc.2014-3630; Guo YD, 2011, J BIOL CHEM, V286, P33832, DOI 10.1074/jbc.M110.216564; Haas U, 2011, P NATL ACAD SCI USA, V108, P20479, DOI 10.1073/pnas.1117094108; Hennessy E, 2017, DIABETIC MED, V34, P292, DOI 10.1111/dme.13177; Hernandez-Perez M, 2017, DIABETES, V66, P2875, DOI 10.2337/db17-0215; Hesselson D, 2011, CURR BIOL, V21, P712, DOI 10.1016/j.cub.2011.03.041; Hesselson D, 2009, P NATL ACAD SCI USA, V106, P14896, DOI 10.1073/pnas.0906348106; Honn KV, 2016, FASEB J, V30, P2360, DOI 10.1096/fj.201500076; Igarashi M, 2015, J NEUROSCI, V35, P6079, DOI 10.1523/JNEUROSCI.4102-14.2015; Innis SM, 2008, BRAIN RES, V1237, P35, DOI 10.1016/j.brainres.2008.08.078; Jansen C, 2011, J BIOL CHEM, V286, P37804, DOI 10.1074/jbc.M111.259242; Johnson EN, 1998, P NATL ACAD SCI USA, V95, P3100, DOI 10.1073/pnas.95.6.3100; Kenyon V, 2011, J MED CHEM, V54, P5485, DOI 10.1021/jm2005089; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kuhn H, 2015, BBA-MOL CELL BIOL L, V1851, P308, DOI 10.1016/j.bbalip.2014.10.002; Lebold KM, 2014, REDOX BIOL, V2, P105, DOI 10.1016/j.redox.2013.12.007; Luci D, 2014, PROBE REPORTS NIH MO; Masoodi M, 2008, RAPID COMMUN MASS SP, V22, P75, DOI 10.1002/rcm.3331; Mastracci TL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13269; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; McDuffie M, 2008, DIABETES, V57, P199, DOI 10.2337/db07-0830; Pauls S, 2007, DEV BIOL, V304, P875, DOI 10.1016/j.ydbio.2007.01.024; Prince VE, 2017, CURR TOP DEV BIOL, V124, P235, DOI 10.1016/bs.ctdb.2016.10.005; Shin CH, 2008, DEV BIOL, V317, P467, DOI 10.1016/j.ydbio.2008.02.031; Sun DX, 1996, J BIOL CHEM, V271, P24055, DOI 10.1074/jbc.271.39.24055; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Taylor-Fishwick DA, 2015, DIABETOLOGIA, V58, P549, DOI 10.1007/s00125-014-3452-0; Tersey SA, 2014, MOL CELL BIOL, V34, P3735, DOI 10.1128/MCB.00157-14; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Ye LH, 2016, DEV BIOL, V409, P354, DOI 10.1016/j.ydbio.2015.12.003; Ye LH, 2015, DEVELOPMENT, V142, P1407, DOI 10.1242/dev.117911; Zarini S, 2014, PROSTAG OTH LIPID M, V113, P52, DOI 10.1016/j.prostaglandins.2014.08.003; Zhang XJ, 2018, NAT MED, V24, P73, DOI 10.1038/nm.4451	43	8	8	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14850	14862		10.1096/fj.201902308RR	http://dx.doi.org/10.1096/fj.201902308RR		SEP 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32918516	Green Accepted			2022-12-26	WOS:000570584600001
J	da Silva, DC; Pereira, LGR; Lima, JAM; Machado, FS; Ferreira, AL; Tomich, TR; Coelho, SG; Mauricio, RM; Campos, MM				da Silva, Danieli Cabral; Ribeiro Pereira, Luiz Gustavo; Mello Lima, Juliana Aparecida; Machado, Fernanda Samarini; Ferreira, Alexandre Lima; Tomich, Thierry Ribeiro; Coelho, Sandra Gesteira; Mauricio, Rogerio Martins; Campos, Mariana Magalhaes			Grouping crossbred Holstein x Gyr heifers according to different feed efficiency indexes and its effects on energy and nitrogen partitioning, blood metabolic variables and gas exchanges	PLOS ONE			English	Article							NEUTRAL DETERGENT FIBER; METHANE EMISSIONS; BODY-WEIGHT; RUMINAL FERMENTATION; GENETIC-PARAMETERS; RESIDUAL INTAKE; LACTATING COWS; BEEF HEIFERS; DAIRY; CATTLE	The objectives of this study were:i) to classify animals into groups of high and low feed efficiency (FE) using three FE indexes (Residual feed intake (RFI), Residual weight gain (RG) and Feed conversion efficiency (FCE)), andii) to evaluate whether crossbreed Holstein x Gyr heifers divergent for FE indexes exhibit differences in nutrient intake and digestibility, energy partitioning, heat production, methane emissions, nitrogen partitioning and blood parameters. Thirty-five heifers were housed in a tie-stall, receivedad libitumTMR (75:25, corn silage: concentrate) and were ranked and classified into high (HE) or low efficiency (LE) for RFI, RG and FCE. The number of animals for each HE group were 13 (< 0.5 standard deviation (SD) for RFI, 11 for RG and 11 for FCE (> 0.5 SD) and for the LE were 10 (> 0.5 SD) for RFI, 11 for RG and 12 for FCE (< 0.5 SD). Gas exchanges (O(2)consumption, CO(2)and CH(4)production) in open-circuit respiratory chambers and whole tract digestibility trial was performed. A completely randomized experimental design was used and the data were analyzed by ANOVA and correlation study. High efficiency animals for RFI produced less CO(2,)consumed less O(2)and had lower heat production (HP). Methane production was positively correlated with RFI. High efficiency RG had higher O(2)consumption and CO(2)production in relation to LE-RG. High efficiency FCE had greater NFC digestibility, higher positive energy balance (EB) and excreted (11.4 g/d) less nitrogen in urine. High efficiency RG and FCE groups emitted less CH(4)per kg of weight gain than LE animals. Animals HE for RFI and FCE had lower beta-hydroxybutyrate and higher glucose concentrations, respectively. The differences in intake, digestibility, energy and nitrogen partition, CH(4)emission, blood metabolic variables and heat production between the HE and LE groups varied according to the efficiency indexes adopted. The HP (kcal/d/BW0.75) was lower for HE animals for RFI and FCE indexes.	[da Silva, Danieli Cabral] State Univ Southwestern Bahia UESB, Dept Anim Sci, Candeias, BA, Brazil; [Ribeiro Pereira, Luiz Gustavo; Mello Lima, Juliana Aparecida; Machado, Fernanda Samarini; Ferreira, Alexandre Lima; Tomich, Thierry Ribeiro; Campos, Mariana Magalhaes] Brazilian Agr Res Corp Embrapa Dairy Cattle, Juiz De Fora, MG, Brazil; [Coelho, Sandra Gesteira] Fed Univ Minas Gerais UFMG, Sch Vet Med, Dept Anim Sci, Belo Horizonte, MG, Brazil; [Mauricio, Rogerio Martins] Univ Fed Sao Joao del Rei, Sao Joao Del Rei, MG, Brazil	Universidade Estadual do Sudoeste da Bahia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Minas Gerais; Universidade Federal de Sao Joao del-Rei	Campos, MM (corresponding author), Brazilian Agr Res Corp Embrapa Dairy Cattle, Juiz De Fora, MG, Brazil.	mariana.campos@embrapa.br	Campos, Mariana Magalhães/CAA-0176-2022; Mauricio, Rogerio M/G-3728-2013	Campos, Mariana Magalhães/0000-0001-5332-6010; Reis, AlessanRSS/0000-0001-8486-7469	EMBRAPA [02.13.05.007.00.00]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia -Ciencia Animal (INCT-CA)	EMBRAPA(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia -Ciencia Animal (INCT-CA)	All the funding of support received during this specific study came from EMBRAPA, http://www.embrapa.br/, Project number: 02.13.05.007.00.00, title: "Development and integration of feed efficiency metrics for dairy cattle", the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, http://cnpq.br (CNPq), the Instituto Nacional de Ciencia e Tecnologia -Ciencia Animal (INCT-CA), http://inct.cnpq.br/web/inct-ca.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu AW, 2017, J ANIM SCI, V95, P3727, DOI [10.2527/jas.2017.1501, 10.2527/jas2017.1501]; AOAC (AOAC International), 1990, JAOAC, V242, P73; Arndt C, 2015, J DAIRY SCI, V98, P3938, DOI 10.3168/jds.2014-8449; Arthur J P.F., 2008, R. Bras. Zootec., V37, P269; Basarab JA, 2011, CAN J ANIM SCI, V91, P573, DOI [10.4141/CJAS2011-010, 10.4141/cjas2011-010]; Berry DP, 2013, J ANIM SCI, V91, P1594, DOI 10.2527/jas.2012-5862; Berry DP, 2012, J ANIM SCI, V90, P109, DOI 10.2527/jas.2011-4245; Brouwer E., 1965, ENERGY METABOLISM, DOI [10.1017/CBO9780511663161.012, DOI 10.1017/CBO9780511663161.012]; Cantalapiedra-Hijar G, 2018, ANIMAL, DOI [10.1017/S1751731118001489, DOI 10.1017/S1751731118001489]; Connor EE, 2015, ANIMAL, V9, P395, DOI 10.1017/S1751731114002997; Crowley JJ, 2010, J ANIM SCI, V88, P885, DOI 10.2527/jas.2009-1852; Lage CFD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223368; Derno M, 2019, J DAIRY SCI, V102, P6559, DOI 10.3168/jds.2019-16274; Fitzsimons C, 2014, J ANIM SCI, V92, P2170, DOI 10.2527/jas.2013-7438; Flay HE, 2019, J DAIRY SCI, V102, P2708, DOI 10.3168/jds.2018-15234; Hegarty RS, 2007, J ANIM SCI, V85, P1479, DOI 10.2527/jas.2006-236; Herd R., 2003, J ANIM SCI, V13, pE9, DOI [10.2527/2003.8113_suppl_1E9x, DOI 10.2527/2003.8113_SUPPL_1E9X]; Herd RM, 2009, J ANIM SCI, V87, pE64, DOI 10.2527/jas.2008-1345; Johnson JR, 2019, J ANIM SCI, V97, P3550, DOI 10.1093/jas/skz195; Jones FM, 2011, ANIM FEED SCI TECH, V166-67, P302, DOI 10.1016/j.anifeedsci.2011.04.020; Kelly AK, 2010, J ANIM SCI, V88, P109, DOI 10.2527/jas.2009-2196; KOCH RM, 1963, J ANIM SCI, V22, P486, DOI 10.2527/jas1963.222486x; Lawrence P, 2011, J ANIM SCI, V89, P3248, DOI 10.2527/jas.2010-3774; Leao JM, 2018, J DAIRY SCI, V101, P5060, DOI 10.3168/jds.2017-14109; Liu E, 2020, J DAIRY SCI, V103, P3177, DOI 10.3168/jds.2019-17567; Lu Y, 2018, J DAIRY SCI, V101, P3140, DOI 10.3168/jds.2017-13364; Macdonald KA, 2014, J DAIRY SCI, V97, P1427, DOI [10.31, 10.3168/jds.2013-7227]; Machado FS, 2016, J DAIRY SCI, V99, P4899, DOI 10.3168/jds.2015-10298; Mc Hugh N, 2011, J ANIM SCI, V89, P29, DOI 10.2527/jas.2010-3044; McDonnell RP, 2016, J ANIM SCI, V94, P1179, DOI 10.2527/jas.2015-0080; Mertens DR, 2002, J AOAC INT, V85, P1217; Mertens DR, 1997, J DAIRY SCI, V80, P1463, DOI 10.3168/jds.S0022-0302(97)76075-2; Nkrumah JD, 2006, J ANIM SCI, V84, P145; Olijhoek DW, 2018, J DAIRY SCI, V101, P9926, DOI 10.3168/jds.2017-14278; Potts SB, 2015, J DAIRY SCI, V98, P4735, DOI 10.3168/jds.2014-9019; REIS Simone Frotas dos, 2015, Rev. bras. saúde prod. anim., V16, P632, DOI 10.1590/S1519-99402015000300014; Richardson EC, 2004, AUST J EXP AGR, V44, P431, DOI 10.1071/EA02221; Rius AG, 2012, J DAIRY SCI, V95, P5024, DOI 10.3168/jds.2012-5392; Seymour DJ, 2020, J DAIRY SCI, V103, P1528, DOI 10.3168/jds.2019-17414; Seymour DJ, 2019, J DAIRY SCI, V102, P7655, DOI 10.3168/jds.2019-16454; Vallimont JE, 2011, J DAIRY SCI, V94, P2108, DOI 10.3168/jds.2010-3888; VandeHaar MJ, 2016, J DAIRY SCI, V99, P4941, DOI 10.3168/jds.2015-10352; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Wang Z, 2006, J ANIM SCI, V84, P2289, DOI 10.2527/jas.2005-715	44	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238419	10.1371/journal.pone.0238419	http://dx.doi.org/10.1371/journal.pone.0238419			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915803	Green Published, gold			2022-12-26	WOS:000571887500119
J	Debnath, R; Bardhan, R				Debnath, Ramit; Bardhan, Ronita			India nudges to contain COVID-19 pandemic: A reactive public policy analysis using machine-learning based topic modelling	PLOS ONE			English	Article							LATENT DIRICHLET ALLOCATION	India locked down 1.3 billion people on March 25, 2020, in the wake of COVID-19 pandemic. The economic cost of it was estimated at USD 98 billion, while the social costs are still unknown. This study investigated how government formed reactive policies to fight coronavirus across its policy sectors. Primary data was collected from the Press Information Bureau (PIB) in the form press releases of government plans, policies, programme initiatives and achievements. A text corpus of 260,852 words was created from 396 documents from the PIB. An unsupervised machine-based topic modelling using Latent Dirichlet Allocation (LDA) algorithm was performed on the text corpus. It was done to extract high probability topics in the policy sectors. The interpretation of the extracted topics was made through a nudge theoretic lens to derive the critical policy heuristics of the government. Results showed that most interventions were targeted to generate endogenous nudge by using external triggers. Notably, the nudges from the Prime Minister of India was critical in creating herd effect on lockdown and social distancing norms across the nation. A similar effect was also observed around the public health (e.g., masks in public spaces; Yoga and Ayurveda for immunity), transport (e.g., old trains converted to isolation wards), micro, small and medium enterprises (e.g., rapid production of PPE and masks), science and technology sector (e.g., diagnostic kits, robots and nano-technology), home affairs (e.g., surveillance and lockdown), urban (e.g. drones, GIS-tools) and education (e.g., online learning). A conclusion was drawn on leveraging these heuristics are crucial for lockdown easement planning.	[Debnath, Ramit; Bardhan, Ronita] Univ Cambridge, Dept Architecture, Behav & Bldg Performance Grp, Cambridge, England; [Debnath, Ramit] Univ Cambridge, Judge Business Sch, Energy Policy Res Grp, Cambridge, England	University of Cambridge; University of Cambridge	Bardhan, R (corresponding author), Univ Cambridge, Dept Architecture, Behav & Bldg Performance Grp, Cambridge, England.	rb867@cam.ac.uk	Bardhan, Ronita/Q-7316-2019	Bardhan, Ronita/0000-0001-5336-4084; Debnath, Dr Ramit/0000-0003-0727-5683	Bill and Melinda Gates Foundation [OPP1144]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	RD received the Gates Cambridge Scholar by the Bill and Melinda Gates Foundation under the Grant Number OPP1144. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancheri S, 2020, CONDE NAST TRAVELLER; Arun R, 2010, LECT NOTES ARTIF INT, V6118, P391; Balasubramanyan R, 2012, P 6 INT AAAI C WEB S, P18; Bellman E., 2020, WALL STREET J; Bisht A., 2020, ALJAZEERA; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Cao J, 2009, NEUROCOMPUTING, V72, P1775, DOI 10.1016/j.neucom.2008.06.011; Debnath R, 2020, ENERGY RES SOC SCI, V69, DOI 10.1016/j.erss.2020.101704; Deveaud Romain, 2014, DOCUMENT NUMERIQUE, V17, P61, DOI [10.3166/dn.17.1.61-84, DOI 10.3166/DN.17.1.61-84]; ET, WORLDS BIGG LOCKD MA; Griffiths TL, 2004, P NATL ACAD SCI USA, V101, P5228, DOI 10.1073/pnas.0307752101; Grimmer J, 2013, POLIT ANAL, V21, P267, DOI 10.1093/pan/mps028; Grun B, 2011, J STAT SOFTW, V40, P1; Julia Silge, 2017, TEXT MINING R TIDY A; Kulkarni S., 2020, DECCAN HERALD; Li YL, 2019, QUAL LIFE RES, V28, P1441, DOI 10.1007/s11136-019-02132-w; Manning CD, 2009, INTRO INFORM RETRIEV; Moor N, 2019, IDATUNING TUNING LAT, P4; Nudges Oliver A., 2017, ORIGINS BEHAV PUBLIC, P108, DOI 10.1017/9781108225120.008; PIB, 2020, AYUSH REIT IMM BOOST; PSA, 2020, MASKS CURB SPREAD SA; Ramaprasad H, 2020, CNN; Roberts M.E., 2016, COMPUTATIONAL SOCIAL, P51, DOI DOI 10.1017/CBO9781316257340.004; Song M, 2014, IEEE INTELL SYST, V29, P18, DOI 10.1109/MIS.2014.20; Tang H, 2013, IEEE T GEOSCI REMOTE, V51, P1680, DOI 10.1109/TGRS.2012.2205579; Thaler R.H., 2021, NUDGE FINAL EDITION; Tornberg A, 2016, DISCOURSE CONTEXT ME, V13, P132, DOI 10.1016/j.dcm.2016.04.003; van Eck NJ, 2017, SCIENTOMETRICS, V111, P1053, DOI 10.1007/s11192-017-2300-7; vandeRWesthuizen Henri W., 2018, 2018 WIRELESS ADV WI, P1; Walker RM, 2019, PUBLIC ADMIN REV, V79, P931, DOI 10.1111/puar.13095; Wang Y, 2019, J COMPUT CIVIL ENG, V33, DOI 10.1061/(ASCE)CP.1943-5487.0000819; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Yano T., 2009, PREDICTING RESPONSE, P477, DOI [DOI 10.3115/1620754.1620824, 10.3115/1620754.1620824]; Yao F, 2020, COMPUT ENVIRON URBAN, V79, DOI 10.1016/j.compenvurbsys.2019.101419; Yeung K, 2017, INFORM COMMUN SOC, V20, P118, DOI 10.1080/1369118X.2016.1186713; Zirn C, 2014, DATA KNOWL ENG, V90, P38, DOI 10.1016/j.datak.2013.07.003	36	32	32	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238972	10.1371/journal.pone.0238972	http://dx.doi.org/10.1371/journal.pone.0238972			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9MU	32915899	gold, Green Submitted, Green Published			2022-12-26	WOS:000571887500056
J	Li, W; Yin, JJ; Cai, XF; Cheng, X; Wang, YX				Li, Wang; Yin, Jianjun; Cai, Xianfeng; Cheng, Xin; Wang, Yongxiang			Association between sleep duration and quality and depressive symptoms among university students: A cross-sectional study	PLOS ONE			English	Article							PERCEIVED STRESS; PREVALENCE; ANXIETY; WOMEN; MOOD; LIFE	Sleep duration and quality have several effects on human health. Some previous studies have shown an association between sleep duration and quality and mental health, but the results of those studies were inconsistent. Additionally, studies on sleep duration and its impact on depressive symptoms specifically among young Chinese adults are limited. Hence, this study aimed to investigate the association between duration and quality of sleep and depressive symptoms among Chinese university students. We designed a cross-sectional study comprising 9,515 Chinese university students. Sleep duration and quality were assessed using a self-reported questionnaire. Depressive symptoms were assessed based on the Self-rating Depression Scale score. Logistic regression models were used to analyze the association between sleep duration and quality and depressive symptoms. The results showed that good sleep quality was associated with a lower prevalence of depressive symptoms. In the final adjusted model, the odds ratios and 95% confidence intervals for the prevalence of depressive symptoms in those with poor sleep quality compared with those with normal and good sleep quality were 0.88 (0.77, 1.01) and 0.82 (0.81, 0.96), respectively (p for trend = 0.014). Moreover, short sleep duration was associated with a higher prevalence of depressive symptoms based on the crude model and final adjusted model (p for trend = 0.048 and 0.042, respectively). Poor sleep quality and short sleep duration were associated with a higher prevalence of depressive symptoms in this study population. These results suggest that reduced sleep duration and quality may be risk factors for mental health disorders among university students.	[Li, Wang; Cai, Xianfeng; Cheng, Xin; Wang, Yongxiang] Huaiyin Inst Technol, Dept Phys Educ, Huaian, Peoples R China; [Yin, Jianjun] Guangdong Univ Finance & Econ, Dept Phys Educ, Guangzhou, Peoples R China	Huaiyin Institute of Technology; Guangdong University of Finance & Economics	Li, W (corresponding author), Huaiyin Inst Technol, Dept Phys Educ, Huaian, Peoples R China.	liwanghyit@sina.com						[Anonymous], 2016, THE TOTAL AUDIENCE R; Ayas NT, 2003, DIABETES CARE, V26, P380, DOI 10.2337/diacare.26.2.380; Bayram N, 2008, SOC PSYCH PSYCH EPID, V43, P667, DOI 10.1007/s00127-008-0345-x; BLAZER D, 1991, J GERONTOL, V46, pM210, DOI 10.1093/geronj/46.6.M210; Carskadon MA, 2012, SLEEP, V35, P791, DOI 10.5665/sleep.1876; Chang JJ, 2012, J RURAL HEALTH, V28, P268, DOI 10.1111/j.1748-0361.2011.00398.x; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Chen Y, 2017, J MUSCULOSKEL NEURON, V17, P327; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cui YF, 2017, SOC PSYCH PSYCH EPID, V52, P847, DOI 10.1007/s00127-016-1333-1; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Expert Panel on Neurologic Imaging, 2017, J AM COLL RADIOL, V14, pS550; FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819; Garlow SJ, 2008, DEPRESS ANXIETY, V25, P482, DOI 10.1002/da.20321; Gottlieb DJ, 2006, SLEEP, V29, P1009, DOI 10.1093/sleep/29.8.1009; Guo L, 2020, J AFFECT DISORDERS, V265, P583, DOI 10.1016/j.jad.2019.11.095; Guo L, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005517; Irwin M, 2002, BRAIN BEHAV IMMUN, V16, P503, DOI 10.1016/S0889-1591(02)00003-X; Jaycox LH, 2009, PEDIATRICS, V124, pE596, DOI 10.1542/peds.2008-3348; Kim HM, 2018, KOREAN J FAM MED, V39, P57, DOI 10.4082/kjfm.2018.39.1.57; Kojima M, 2000, J Epidemiol, V10, P87; KOUZIS AC, 1994, AM J PUBLIC HEALTH, V84, P1304, DOI 10.2105/AJPH.84.8.1304; Lau EYY, 2017, CHRONOBIOL INT, V34, P360, DOI 10.1080/07420528.2016.1276071; Lee MR, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6030-4; Ma XQ, 2020, AGE AGEING, V49, P119, DOI 10.1093/ageing/afz120; Racic M, 2017, ZDRAV VARST, V56, P251, DOI 10.1515/sjph-2017-0034; Roman V, 2005, SLEEP, V28, P1505; Sharkey KM, 2013, J AFFECT DISORDERS, V150, P1103, DOI 10.1016/j.jad.2013.04.046; Shimada M, 2016, BIOSCI TRENDS, V10, P34, DOI 10.5582/bst.2015.01123; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Velayos JL, 2007, AN SIST SANIT NAVAR, V30, P7, DOI 10.4321/s1137-66272007000200002; Watson NF, 2014, SLEEP, V37, P351, DOI 10.5665/sleep.3412; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914; WHO, 2017, DEPR OTH COMM MENT D; Xu Y, 2016, PSYCHIAT RES, V245, P243, DOI 10.1016/j.psychres.2016.03.009; Zhong BL, 2019, J ADDICT MED, V13, P314, DOI 10.1097/ADM.0000000000000500; Zhou HY, 2020, PSYCHOL HEALTH MED, V25, P229, DOI 10.1080/13548506.2018.1549738; Zhu ZH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222014; ZUNG WWK, 1969, AM J PSYCHIAT, V126, P116, DOI 10.1176/ajp.126.1.116; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004	40	7	7	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238811	10.1371/journal.pone.0238811	http://dx.doi.org/10.1371/journal.pone.0238811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9MU	32915844	gold, Green Published			2022-12-26	WOS:000571887500124
J	Martinez-Navarro, I; Sanchez-Gomez, JM; Aparicio, I; Priego-Quesada, JI; Perez-Soriano, P; Collado, E; Hernando, B; Hernando, C				Martinez-Navarro, Ignacio; Miguel Sanchez-Gomez, Juan; Aparicio, Inma; Ignacio Priego-Quesada, Jose; Perez-Soriano, Pedro; Collado, Eladio; Hernando, Barbara; Hernando, Carlos			Effect of mountain ultramarathon distance competition on biochemical variables, respiratory and lower-limb fatigue	PLOS ONE			English	Article							CARDIAC TROPONIN-T; ACUTE KIDNEY INJURY; HYDRATION STATUS; MUSCLE FUNCTION; LUNG-FUNCTION; PERFORMANCE; MARATHON; STRATEGIES; DURATION; DAMAGE	The study aimed at assessing the acute physiological effects of running a 65-km vs a 107-km mountain ultramarathon. Nineteen athletes (15 males and 4 females) from the shorter race and forty three athletes (26 males and 17 females) from the longer race were enrolled. Body weight, respiratory and lower limb strength were assessed before and after the race. Blood samples were obtained before, after and 24-h post-race. Body weight loss did not differ between races. A decrease in squat jump height (p<0.01; d = 1.4), forced vital capacity (p<0.01; d = 0.5), forced expiratory volume in 1 s (p<0.01; d = 0.6), peak inspiratory flow (p<0.01; d = 0.6) and maximal inspiratory pressure (p<0.01; d = 0.8) was observed after the longer race; while, after the shorter race only maximal inspiratory pressure declined (p<0.01; d = 0.5). Greater post-race concentrations of creatine kinase (p<0.01; d = 0.9) and C-reactive protein (p<0.01; d = 2.3) were observed following the longer race, while high-sensitivity cardiac troponin was higher after the shorter race (p<0.01; d = 0.3). Sodium decreased post-competition only after the shorter race (p = 0.02; d = 0.6), while creatinine increased only following the longer race (p<0.01; d = 1.5). In both groups, glomerular filtration rate declined at post-race (longer race: p<0.01, d = 2.1; shorter race: p = 0.01, d = 1.4) and returned to baseline values at 24 h post-race. In summary, expiratory and lower-limb fatigue, and muscle damage and inflammatory response were greater following the longer race; while a higher release of cardiac troponins was observed after the shorter race. The alteration and restoration of renal function was similar after either race.	[Martinez-Navarro, Ignacio] Univ Valencia, Phys Educ & Sports Dept, Valencia, Spain; [Martinez-Navarro, Ignacio; Miguel Sanchez-Gomez, Juan] Vithas 9 Octubre Hosp, Sports Hlth Unit, Valencia, Spain; [Miguel Sanchez-Gomez, Juan] Univ Clin Hosp Valencia, Valencia, Spain; [Aparicio, Inma; Ignacio Priego-Quesada, Jose; Perez-Soriano, Pedro] Univ Valencia, Phys Educ & Sports Dept, Res Grp Sports Biomech GIBD, Valencia, Spain; [Aparicio, Inma] AITEX Text Res Inst, Alcoy, Spain; [Collado, Eladio] Jaume I Univ, Fac Hlth Sci, Castellon de La Plana, Spain; [Hernando, Barbara] Jaume I Univ, Dept Med, Castellon de La Plana, Spain; [Hernando, Carlos] Jaume I Univ, Sport Serv, Castellon de La Plana, Spain; [Hernando, Carlos] Jaume I Univ, Dept Educ & Specif Didact, Castellon de La Plana, Spain	University of Valencia; University of Valencia; Universitat Jaume I; Universitat Jaume I; Universitat Jaume I; Universitat Jaume I	Martinez-Navarro, I (corresponding author), Univ Valencia, Phys Educ & Sports Dept, Valencia, Spain.; Martinez-Navarro, I (corresponding author), Vithas 9 Octubre Hosp, Sports Hlth Unit, Valencia, Spain.	Ignacio.Martinez-Navarro@uv.es	Hernando, Barbara/AAW-9979-2021; Hernando, Barbara/AAZ-7357-2021; Collado-Boira, Eladio/AAB-6001-2019; Hernando, Carlos/N-2601-2019; Perez-Soriano, Pedro/G-7973-2019	Hernando, Barbara/0000-0003-4019-2732; Collado-Boira, Eladio/0000-0001-8062-4152; Hernando, Carlos/0000-0001-7182-4785; Perez-Soriano, Pedro/0000-0002-9825-3801; MARTINEZ-NAVARRO, IGNACIO/0000-0002-2942-1293	AITEX [IMDEEA/2019/53]	AITEX	This study was supported by Vithas Hospitals group (https://vithas.es) in the form of blood analysis assistance provided to CH, Penyagolosa Trails organization (http://penyagolosatrails.com) in the form of blood analysis assistance provided to CH, Catedra Endavant Villarreal CF de l'Esport (https://endavant.villarrealcf.es/) in the form of equipment for respiratory and lower-limb assessment provided to CH, and AITEX (https://www.aitex.es/) in the form of a grant and blood analysis assistance provided to IMN (TPTex project; reference: IMDEEA/2019/53). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alis R, 2015, SCAND J MED SCI SPOR, V25, pE630, DOI 10.1111/sms.12393; Baker P, 2019, IJC HEART VASC, V22, P181, DOI 10.1016/j.ijcha.2019.03.001; Balducci P, 2017, INT J SPORTS MED, V38, P819, DOI 10.1055/s-0043-112342; Belli T, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01368; Bernat-Adell MD, 2019, J STRENGTH COND RES; Besson T, 2020, MED SCI SPORTS EXERC; Cairns RS, 2016, EUR J APPL PHYSIOL, V116, P647, DOI 10.1007/s00421-015-3324-4; Chlibkova D, 2015, J INT SOC SPORT NUTR, V12, DOI 10.1186/s12970-015-0091-x; Cohen J.E., 1988, STAT POWER ANAL BEHA; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; Easthope CS, 2010, EUR J APPL PHYSIOL, V110, P1107, DOI 10.1007/s00421-010-1597-1; Giannitsis E, 2010, CLIN CHEM, V56, P254, DOI 10.1373/clinchem.2009.132654; Hoffman MD, 2018, SPORTS MED, V48, P243, DOI 10.1007/s40279-017-0782-3; Hoffman MD, 2017, J SPORT SCI, V35, P669, DOI 10.1080/02640414.2016.1183808; Hoffman MD, 2014, SPORTS MED, V44, P1055, DOI 10.1007/s40279-014-0189-3; Hoffman MD, 2014, RES SPORTS MED, V22, P213, DOI 10.1080/15438627.2014.915838; Hoffman MD, 2013, RES SPORTS MED, V21, P164, DOI 10.1080/15438627.2012.757230; Hoffman MD, 2013, MED SCI SPORT EXER, V45, P784, DOI 10.1249/MSS.0b013e31827985a8; Hoffman MD, 2010, INT J HIST SPORT, V27, P1877, DOI 10.1080/09523367.2010.494385; Hoppel F, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01300; Karsten M, 2018, PHYS THER SPORT, V34, P92, DOI 10.1016/j.ptsp.2018.09.004; Khodaee M, 2015, INT J SPORTS MED, V36, P867, DOI 10.1055/s-0035-1550045; Kim HJ, 2007, EUR J APPL PHYSIOL, V99, P443, DOI 10.1007/s00421-006-0362-y; Kleiven O, 2019, INT J CARDIOL, V283, P1, DOI 10.1016/j.ijcard.2019.02.044; Knechtle B, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00634; Kupchak BR, 2014, WILD ENVIRON MED, V25, P278, DOI 10.1016/j.wem.2014.03.013; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lipman GS, 2014, RES SPORTS MED, V22, P185, DOI 10.1080/15438627.2014.881824; Lippi G, 2008, SCAND J CLIN LAB INV, V68, P667, DOI 10.1080/00365510802126844; Lippi G, 2008, INT J SPORTS MED, V29, P948, DOI 10.1055/s-2008-1038745; Martinez-Navarro I, 2019, J SPORT SCI MED, V18, P615; Martinez-Navarro I, 2018, J STRENGTH COND RES, V32, P441, DOI 10.1519/JSC.0000000000001614; McCullough PA, 2011, NEPHROLOGY, V16, P194, DOI 10.1111/j.1440-1797.2010.01354.x; Mickleborough TD, 2010, SCAND J MED SCI SPOR, V20, P458, DOI 10.1111/j.1600-0838.2009.00951.x; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Millet GY, 2012, J APPL PHYSIOL, V113, P507, DOI 10.1152/japplphysiol.00016.2012; Millet GP, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-77; Millet GY, 2011, SPORTS MED, V41, P489, DOI 10.2165/11588760-000000000-00000; Millet GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017059; Minahan C, 2015, J SPORT SCI MED, V14, P233; Mingels A, 2009, CLIN CHEM, V55, P101, DOI 10.1373/clinchem.2008.106427; Nikolaidis PT, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01301; Noakes TD, 2005, P NATL ACAD SCI USA, V102, P18550, DOI 10.1073/pnas.0509096102; P B Sabitha, 2008, Indian J Nephrol, V18, P155, DOI 10.4103/0971-4065.45290; Gonzalez NP, 2019, KIDNEY DIS-BASEL, V5, P259, DOI 10.1159/000500510; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Pueo B, 2018, ACTA BIOENG BIOMECH, V20, P51, DOI 10.5277/ABB-01132-2018-02; Ricci Z, 2011, NAT REV NEPHROL, V7, P201, DOI 10.1038/nrneph.2011.14; Roth HJ, 2007, CLIN RES CARDIOL, V96, P359, DOI 10.1007/s00392-007-0509-9; Rubio-Arias JA, 2019, PHYSIOL BEHAV, V205, P51, DOI 10.1016/j.physbeh.2018.10.002; Saugy J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065596; Scheer V, 2020, RES SPORTS MED, V28, P507, DOI 10.1080/15438627.2020.1781124; Scherr J, 2011, MED SCI SPORT EXER, V43, P1819, DOI 10.1249/MSS.0b013e31821b12eb; Scotney B, 2015, CLIN J SPORT MED, V25, P341, DOI 10.1097/JSM.0000000000000131; Scott JM, 2009, MED SCI SPORT EXER, V41, P25, DOI 10.1249/MSS.0b013e31818313ff; Serrano-Ostariz E, 2011, SCAND J MED SCI SPOR, V21, P244, DOI 10.1111/j.1600-0838.2009.01042.x; Shave R, 2007, MED SCI SPORT EXER, V39, P2099, DOI 10.1249/mss.0b013e318153ff78; Stewart GM, 2016, J PHYSIOL-LONDON, V594, P3031, DOI 10.1113/JP271889; Tiller NB, 2019, SPORTS MED, V49, P1031, DOI 10.1007/s40279-019-01105-w; Vernillo G, 2015, SCAND J MED SCI SPOR, V25, pe374, DOI 10.1111/sms.12325; Vitiello D, 2013, INT J CARDIOL, V165, P391, DOI 10.1016/j.ijcard.2012.08.053; Wuthrich TU, 2015, MED SCI SPORT EXER, V47, P519, DOI 10.1249/MSS.0000000000000449	62	11	11	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238846	10.1371/journal.pone.0238846	http://dx.doi.org/10.1371/journal.pone.0238846			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915883	Green Published, gold			2022-12-26	WOS:000571887500103
J	Tchuem, CRT; Brandt, L; Nel, ED; Cotton, MF; Matthews, P; Kaindjee-Tjituka, F; Preiser, W; Andersson, MI				Tchuem, Cynthia Raissa Tamandjou; Brandt, Laura; Nel, Etienne De la Rey; Cotton, Mark Fredric; Matthews, Philippa; Kaindjee-Tjituka, Francina; Preiser, Wolfgang; Andersson, Monique Ingrid			Hepatitis B virus drug resistance mutations in HIV/HBV co-infected children in Windhoek, Namibia	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; ANTIRETROVIRAL THERAPY; LAMIVUDINE RESISTANCE; CLINICAL-SIGNIFICANCE; HBV COINFECTION; POLYMERASE; LIVER; REPLICATION; PREVALENCE; ENTECAVIR	In patients who are HIV infected, hepatitis B virus (HBV) infection is an important co-morbidity. However, antiretroviral options for HIV/HBV co-infected children are limited and, at the time of this study, only included lamivudine. These children may remain on this regimen for many years until late adolescence. They are at high risk of developing HBV drug resistance and uncontrolled HBV disease. The aim of this study was to characterize HBV infection in HIV/HBV co-infected children. Known HIV-infected/HBsAg-positive children, previously exposed to lamivudine monotherapy against HBV, and their mothers were recruited at the Katutura Hospital paediatric HIV clinic in Windhoek, Namibia. Dried blood spot and serum samples were collected for HBV characterization and serological testing, respectively. Fifteen children and six mothers participated in the study. Eight of the 15 children (53.3%) tested HBV DNA positive; all eight children were on lamivudine-based ART. Lamivudine-associated resistance variants, together with immune escape mutants in the surface gene, were identified in all eight children. Resistance mutations includedrtL80I,rtV173L,rtL180M,rtM204I/V and the overlapping sE164D, sW182*, sI195M and sW196LS variants. HBV strains belonged to genotypes E (6/8, 75%) and D3 (2/8, 25%). Further analysis of the HBV core promoter region revealed mutations associated with reduced expression of HBeAg protein and hepatocarcinogenesis. All six mothers, on HBV-active ART containing tenofovir and lamivudine, tested HBV DNA negative. This study confirms the importance of screening HIV-infected children for HBV and ensuring equity of drug access to effective HBV treatment if co-infected.	[Tchuem, Cynthia Raissa Tamandjou; Preiser, Wolfgang; Andersson, Monique Ingrid] Stellenbosch Univ, Fac Med & Hlth Sci, Div Med Virol, Cape Town, South Africa; [Brandt, Laura] Univ Washington, Int Training & Educ Ctr Hlth, Windhoek, Namibia; [Brandt, Laura] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Nel, Etienne De la Rey; Cotton, Mark Fredric] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Paediat & Child Hlth, Cape Town, South Africa; [Cotton, Mark Fredric] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Paediat & Child Hlth, FAM CRU, Cape Town, South Africa; [Matthews, Philippa] Univ Oxford, Nuffield Dept Med, Oxford, England; [Matthews, Philippa; Andersson, Monique Ingrid] Oxford Univ Hosp NHS Fdn Trust, Dept Microbiol, Oxford, England; [Kaindjee-Tjituka, Francina] Minist Hlth & Social Serv, Directorate Qual Assurance, Windhoek, Namibia; [Andersson, Monique Ingrid] Univ Oxford, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Oxford, England; [Tchuem, Cynthia Raissa Tamandjou] Univ Cape Town, Fac Hlth Sci, Sch Publ Hlth & Family Med, Hlth Econ Unit Div, Cape Town, South Africa	Stellenbosch University; University of Washington; University of Washington Seattle; Stellenbosch University; Stellenbosch University; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Cape Town	Tchuem, CRT (corresponding author), Stellenbosch Univ, Fac Med & Hlth Sci, Div Med Virol, Cape Town, South Africa.; Tchuem, CRT (corresponding author), Univ Cape Town, Fac Hlth Sci, Sch Publ Hlth & Family Med, Hlth Econ Unit Div, Cape Town, South Africa.	craissat@gmail.com	Preiser, Wolfgang/J-4875-2016	Preiser, Wolfgang/0000-0002-0254-7910; Tamandjou Tchuem, Cynthia Raissa/0000-0002-1609-7287; Cotton, Mark/0000-0003-2559-6034; Matthews, Philippa/0000-0002-4036-4269	Harry Crossley Foundation; Poliomyelitis Research Foundation	Harry Crossley Foundation; Poliomyelitis Research Foundation	This work was supported by the Harry Crossley Foundation (http://www.thecrossleyfoundation.co.za/) to CRTT and the Poliomyelitis Research Foundation (https://www.prf.ac.za/) provided to MIA.	Allen MI, 1998, HEPATOLOGY, V27, P1670, DOI 10.1002/hep.510270628; [Anonymous], 2016, EC THEORY BUSINESS P, V10, P31; Aurpibul L, 2017, PEDIATR INFECT DIS J, V36, P401, DOI [10.1097/INF.0000000000001491, 10.1097/inf.0000000000001491]; BEASLEY RP, 1981, LANCET, V2, P1129; Brandt L, 1988, 19 INT AIDS IAS C WA; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Colledge D, 2017, VIROLOGY, V501, P70, DOI 10.1016/j.virol.2016.11.007; Delaney WE, 2003, J VIROL, V77, P11833, DOI 10.1128/JVI.77.21.11833-11841.2003; Dervisevic S, 2007, EMERG INFECT DIS, V13, P1689, DOI 10.3201/eid1311.070578; Fan YF, 2001, HEPATOLOGY, V33, P277, DOI 10.1053/jhep.2001.21163; Gaur A, 1992, 26 C RETR OPP INF CR; Giacomet V, 2019, EXPERT OPIN PHARMACO, V20, P269, DOI 10.1080/14656566.2018.1559299; Hsieh YH, 2004, CARCINOGENESIS, V25, P2023, DOI 10.1093/carcin/bgh207; Huang YS, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0169228, 10.1371/journal.pone.0]; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Jammeh S, 2008, J GEN VIROL, V89, P901, DOI 10.1099/vir.0.83468-0; Jooste P, 2016, J CLIN VIROL, V85, P71, DOI 10.1016/j.jcv.2016.10.017; Lee SA, 2012, J HEPATOL, V56, P63, DOI 10.1016/j.jhep.2011.06.028; Lei J, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-313; Li KW, 2017, VIRUS RES, V227, P88, DOI 10.1016/j.virusres.2016.10.002; Liang T, 2013, ASIAN PAC J CANCER P, V14, P4509, DOI 10.7314/APJCP.2013.14.8.4509; Matthews PC, 2014, J CLIN VIROL, V61, P20, DOI 10.1016/j.jcv.2014.05.018; McGoogan KE, 2010, J PEDIATR GASTR NUTR, V50, P344, DOI 10.1097/MPG.0b013e3181aed725; Ministry of Health and Social Services, 2016, NAT GUID ANT THER DI; Ministry of Health and Social Services, NAT GUID ANT THER DI; Mossner BK, 2016, WORLD J GASTROENTERO, V22, P7604, DOI 10.3748/wjg.v22.i33.7604; Mukaide M, 2010, ANTIMICROB AGENTS CH, V54, P882, DOI 10.1128/AAC.01061-09; Ono-Nita SK, 1999, HEPATOLOGY, V29, P939, DOI 10.1002/hep.510290340; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Peebles K, 2015, J TROP PEDIATRICS, V61, P464, DOI 10.1093/tropej/fmv058; Pessoa MG, 2008, AIDS, V22, P1779, DOI 10.1097/QAD.0b013e32830b3ab5; Pokorska-Spiewak M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11489-2; Poustchi H, 2008, J VIRAL HEPATITIS, V15, P753, DOI 10.1111/j.1365-2893.2008.00998.x; Redd AD, 2013, AIDS RES HUM RETROV, V29, P1026, DOI [10.1089/aid.2013.0004, 10.1089/AID.2013.0004]; Sokal EM, 2006, HEPATOLOGY, V43, P225, DOI 10.1002/hep.21020; Torresi J, 2002, J CLIN VIROL, V25, P97, DOI 10.1016/S1386-6532(02)00049-5; Warner N, 2007, ANTIMICROB AGENTS CH, V51, P2285, DOI 10.1128/AAC.01499-06; WHO, CONGUID UANT DRU; World Health Organization, GUID PREV CAR TREATM; Yang RR, 2014, INT J INFECT DIS, V28, P29, DOI 10.1016/j.ijid.2014.07.018; Zhong YW, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.10.033	41	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238839	10.1371/journal.pone.0238839	http://dx.doi.org/10.1371/journal.pone.0238839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915862	gold, Green Published			2022-12-26	WOS:000571887500086
J	Che, H; Li, H; Li, Y; Wang, YQ; Yang, ZY; Wang, RL; Wang, LH				Che, Hui; Li, Hui; Li, Yang; Wang, Yue-Qiu; Yang, Zhen-Yu; Wang, Rui-Ling; Wang, Li-Hong			Melatonin exerts neuroprotective effects by inhibiting neuronal pyroptosis and autophagy in STZ-induced diabetic mice	FASEB JOURNAL			English	Article						Melatonin; microRNA-214-3p; neuronal pyroptosis; neuronal autophagy	MECHANISM; CASPASES; FIBROSIS	Diabetes mellitus (DM) patients are at a higher risk of developing brain injury characterized by neuronal death. Melatonin, a hormone produced by the pineal gland, exerts neuroprotective effects against brain damage. However, the effect of melatonin on diabetes-induced brain injury has not been elucidated. This study was to evaluate the role of melatonin against neuronal death in DM and to elucidate the underlying mechanisms. Herein, we found that melatonin administration significantly alleviated the neuronal death in both streptozotocin (STZ)-induced diabetic mice and high glucose (HG)-treated neuronal cells. Melatonin inhibited neuronal pyroptosis and excessive autophagy, as evidenced by decreased levels of NLRP3, cleaved caspase-1, GSDMD-N, IL-1 beta, LC3, Beclin1, and ATG12 both in vivo and in vitro. MicroRNA-214-3p (miR-214-3p) was decreased in DM mice and HG-treated cells, and such a downregulation was corrected by melatonin, which was accompanied by repression of caspase-1 and ATG12. Furthermore, downregulation of miR-214-3p abrogated the anti-pyroptotic and anti-autophagic actions of melatonin in vitro. Our results indicate that melatonin exhibits a neuroprotective effect by inhibiting neuronal pyroptosis and excessive autophagy through modulating the miR-214-3p/caspase-1 and miR-214-3p/ATG12 axes, respectively, and it might be a potential agent for the treatment of brain damage in the setting of DM.	[Che, Hui; Li, Hui; Li, Yang; Wang, Yue-Qiu; Wang, Rui-Ling; Wang, Li-Hong] Harbin Med Univ, Dept Endocrinol, Affiliated Hosp 2, Harbin 150001, Heilongjiang, Peoples R China; [Yang, Zhen-Yu] Harbin Med Univ, Coll Pharm, Dept Pharmacol, State Prov Key Labs Biomed Pharmaceut China, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Che, H; Wang, LH (corresponding author), Harbin Med Univ, Dept Endocrinol, Affiliated Hosp 2, Harbin 150001, Heilongjiang, Peoples R China.	chehui1203@163.com; chehui1203@163.com			National Natural Science Foundation of China [81600935]; China Postdoctoral Science Foundation [2017M621308]; Natural Science Foundation of Heilongjiang Province [QC2017108]; Science Foundation of the Second Affiliated Hospital of Harbin Medical University [KYBS2015-16]; Graduate research and practice innovation project of Harbin medical university [YJSKYCX2019-47HYD]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Science Foundation of the Second Affiliated Hospital of Harbin Medical University; Graduate research and practice innovation project of Harbin medical university	This work was supported by the National Natural Science Foundation of China (81600935), China Postdoctoral Science Foundation (2017M621308), the Natural Science Foundation of Heilongjiang Province (QC2017108), Science Foundation of the Second Affiliated Hospital of Harbin Medical University (KYBS2015-16), and Graduate research and practice innovation project of Harbin medical university (YJSKYCX2019-47HYD).	Avgeris M, 2020, DIABETES RES CLIN PR, V164, DOI 10.1016/j.diabres.2020.108187; Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010; Annette B, 2017, BBA-MOL BASIS DIS, V1863, P1026, DOI 10.1016/j.bbadis.2017.01.016; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Cardinali DP, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00480; Che H, 2020, FASEB J, V34, P5282, DOI 10.1096/fj.201902692R; Che H, 2017, MOL NEUROBIOL, V54, P2595, DOI 10.1007/s12035-016-9856-8; Chen R, 2018, J ALZHEIMERS DIS, V65, P15, DOI 10.3233/JAD-180314; Chen WR, 2020, EXP CELL RES, V389, DOI 10.1016/j.yexcr.2020.111883; Chuang JI, 2016, J PINEAL RES, V61, P230, DOI 10.1111/jpi.12343; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Erukainure OL, 2019, METAB BRAIN DIS, V34, P1385, DOI 10.1007/s11011-019-00444-x; Fang F, 2018, J DIABETES, V10, P625, DOI 10.1111/1753-0407.12646; Funderburk SF, 2010, MT SINAI J MED, V77, P59, DOI 10.1002/msj.20161; Gunata M, 2020, REV NEUROL-FRANCE, V176, P148, DOI 10.1016/j.neurol.2019.07.025; Gurley SB, 2018, DIABETES, V67, P2096, DOI 10.2337/db17-1323; Hoffman WH, 2012, EXP MOL PATHOL, V93, P273, DOI 10.1016/j.yexmp.2011.10.007; Hussain S, 2014, J ALZHEIMERS DIS, V41, P551, DOI 10.3233/JAD-131958; Ismael S, 2020, MOL NEUROBIOL, V57, P2495, DOI 10.1007/s12035-020-01893-7; Jorgensen I, 2015, IMMUNOL REV, V265, P130, DOI 10.1111/imr.12287; Kandimalla R, 2017, BBA-MOL BASIS DIS, V1863, P1078, DOI 10.1016/j.bbadis.2016.08.018; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kongsuphol P, 2009, J PINEAL RES, V46, P199, DOI 10.1111/j.1600-079X.2008.00648.x; Lammert CR, 2020, NATURE, V580, P647, DOI 10.1038/s41586-020-2174-3; Li XJ, 2002, J PINEAL RES, V32, P47, DOI 10.1034/j.1600-079x.2002.10831.x; Liu ZG, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14676-4; McCarthy R, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00616; Milne NT, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.741; Muriach M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/102158; Pourhanifeh MH, 2020, DIABETOL METAB SYNDR, V12, DOI 10.1186/s13098-020-00537-z; Pugazhenthi S, 2017, BBA-MOL BASIS DIS, V1863, P1037, DOI 10.1016/j.bbadis.2016.04.017; Qi YQ, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00243; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Reddy PH, 2018, J ALZHEIMERS DIS, V61, P843, DOI 10.3233/JAD-170512; San-Miguel B, 2015, J PINEAL RES, V59, P151, DOI 10.1111/jpi.12247; Shukla M, 2019, ANN NY ACAD SCI, V1443, P75, DOI 10.1111/nyas.14005; Sun RF, 2019, FASEB J, V33, P5411, DOI 10.1096/fj.201801798RR; Sun YQ, 2019, J CELL PHYSIOL, V234, P231, DOI 10.1002/jcp.26856; Suzumura A, 2020, DIABETES, V69, P724, DOI 10.2337/db19-0550; Wang C, 2020, BRAIN RES, V1742, DOI 10.1016/j.brainres.2020.146863; Wang K, 2020, CELL, V180, P941, DOI 10.1016/j.cell.2020.02.002; Wang XB, 2019, BIOCHEM BIOPH RES CO, V519, P402, DOI 10.1016/j.bbrc.2019.09.005; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; Wang ZV, 2015, CIRCULATION, V131, P771, DOI 10.1161/CIRCULATIONAHA.115.015357; Wrighten SA, 2009, BBA-MOL BASIS DIS, V1792, P444, DOI 10.1016/j.bbadis.2008.10.013; Xie CC, 2016, AUTOPHAGY, V12, P410, DOI 10.1080/15548627.2015.1132134; Yang F, 2018, CELL PHYSIOL BIOCHEM, V50, P1230, DOI 10.1159/000494576; Yang F, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1029-4; Yang J, 2018, P NATL ACAD SCI USA, V115, P6792, DOI 10.1073/pnas.1800562115; Yang JL, 2015, CURR OPIN IMMUNOL, V32, P78, DOI 10.1016/j.coi.2015.01.007; Yu ZW, 2020, LIFE SCI, V240, DOI 10.1016/j.lfs.2019.117138; Zhang DP, 2019, J NEUROSCI RES, V97, P645, DOI 10.1002/jnr.24385; Zhang Y, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12449; Zhang YQ, 2016, NEUROTOXICOLOGY, V56, P139, DOI 10.1016/j.neuro.2016.07.004; Zhao NN, 2019, LIFE SCI, V239, DOI 10.1016/j.lfs.2019.117043	56	23	23	2	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2020	34	10					14042	14054		10.1096/fj.202001328R	http://dx.doi.org/10.1096/fj.202001328R		SEP 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NY3XM	32910484				2022-12-26	WOS:000568309300001
J	Parra, M; Weitner, M; Yang, A; Akue, A; Liu, X; Schmidt, T; Allman, WR; Akkoyunlu, M; Derrick, SC				Parra, Marcela; Weitner, Megan; Yang, Amy; Akue, Adovi; Liu, Xia; Schmidt, Thomas; Allman, Windy R.; Akkoyunlu, Mustafa; Derrick, Steven C.			Memory CD73(+)IgM(+)B cells protect againstPlasmodium yoelii infection and express Granzyme B	PLOS ONE			English	Article							PLASMODIUM-YOELII; T-CELL; ACQUIRED-IMMUNITY; MALARIA; MICE; INSIGHTS; MARKERS; CD73	To better understand anti-malaria protective immune responses, we examined the cellular mechanisms that govern protective immunity in a murinePlasmodium yoelii17X NL (PyNL) re-infection model. Initially, we confirmed that immune B cells generated during a primary PyNL infection were largely responsible for protection from a second PyNL infection. Using the previously identified memory B cell markers CD80, PD-L2, and CD73, we found an increase in the frequency of CD80(-)PD-L2(-)CD73(+)B cells up to 55 days after a primary PyNL infection and at 4-6 days following a second PyNL infection. Moreover, injection of enriched immune CD19(+)CD73(+)B cells into nonimmune mice were significantly more protective against a PyNL infection than CD73(-)B cells. Interestingly, a substantial fraction of these CD73(+)B cells also expressed IgM and granzyme B, a biomolecule that has been increasingly associated with protective responses against malaria.	[Parra, Marcela; Weitner, Megan; Yang, Amy; Akue, Adovi; Liu, Xia; Schmidt, Thomas; Allman, Windy R.; Akkoyunlu, Mustafa; Derrick, Steven C.] US FDA, Ctr Biol & Res, Div Bacterial Parasit & Allergen Dis, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Derrick, SC (corresponding author), US FDA, Ctr Biol & Res, Div Bacterial Parasit & Allergen Dis, Silver Spring, MD 20993 USA.	Steven.Derrick@fda.hhs.gov	Akkoyunlu, Mustafa/ABC-9013-2020; Akkoyunlu, Mustafa/I-5712-2012	Akkoyunlu, Mustafa/0000-0001-9958-4031; 				Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Bemark M, 2011, J IMMUNOL, V186, P1399, DOI 10.4049/jimmunol.1002881; Bijker EM, 2014, J INFECT DIS, V210, P1605, DOI 10.1093/infdis/jiu293; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Conter LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092009; Crompton PD, 2014, ANNU REV IMMUNOL, V32, P157, DOI 10.1146/annurev-immunol-032713-120220; D'Souza L, 2017, IMMUNOLOGY, V152, P602, DOI 10.1111/imm.12800; de Souza MC, 2010, ACTA TROP, V115, P262, DOI 10.1016/j.actatropica.2010.04.007; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; FAHEY JR, 1986, CELL IMMUNOL, V98, P486, DOI 10.1016/0008-8749(86)90307-2; Hagn M, 2015, CLIN TRANSL IMMUNOL, V4, DOI 10.1038/cti.2015.10; Hagn M, 2012, ONCOIMMUNOLOGY, V1, P1368, DOI 10.4161/onci.22354; Hermsen CC, 2003, CLIN EXP IMMUNOL, V132, P467, DOI 10.1046/j.1365-2249.2003.02160.x; JAYAWARDENA AN, 1978, IMMUNOLOGY, V34, P157; Kapelski S, 2015, ANTIMICROB AGENTS CH, V59, P669, DOI 10.1128/AAC.04190-14; Kotb A, 2017, IMMUNOL CELL BIOL, V95, P316, DOI 10.1038/icb.2016.96; Krishnamurty AT, 2016, IMMUNITY, V45, P402, DOI 10.1016/j.immuni.2016.06.014; Kurosaki T, 2015, NAT REV IMMUNOL, V15, P149, DOI 10.1038/nri3802; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; MURPHY JR, 1979, INFECT IMMUN, V23, P384, DOI 10.1128/IAI.23.2.384-391.1979; Ndungu FM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000690; Obeng-Adjei N, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006576; Onodera T, 2012, P NATL ACAD SCI USA, V109, P2485, DOI 10.1073/pnas.1115369109; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; SAYLES PC, 1992, PARASITOL TODAY, V8, P368, DOI 10.1016/0169-4758(92)90172-X; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; WEINBAUM FI, 1976, J IMMUNOL, V117, P1999; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; Wipasa J, 2009, INFECT IMMUN, V77, P817, DOI 10.1128/IAI.01063-08; World Health Organization, WORLD MAL REP 2019; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	32	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238493	10.1371/journal.pone.0238493	http://dx.doi.org/10.1371/journal.pone.0238493			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886698	gold, Green Published			2022-12-26	WOS:000571064300034
J	Khan, MI; Khan, ZA; Baig, MH; Ahmad, I; Farouk, AE; Song, YG; Dong, JJ				Khan, Mohd Imran; Khan, Zainul A.; Baig, Mohammad Hassan; Ahmad, Irfan; Farouk, Abd-ElAziem; Song, Young Goo; Dong, Jae-Jun			Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: Anin silicoinsight	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; SARS-CORONAVIRUS; SPIKE PROTEIN; RECEPTOR; DOMAIN; STABILITY; COV	A novel severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) causing COVID-19 pandemic in humans, recently emerged and has exported in more than 200 countries as a result of rapid spread. In this study, we have made an attempt to investigate the SARS-CoV-2 genome reported from 13 different countries, identification of mutations in major coronavirus proteins of these different SARS-CoV-2 genomes and compared with SARS-CoV. These thirteen complete genome sequences of SARS-CoV-2 showed high identity (>99%) to each other, while they shared 82% identity with SARS-CoV. Here, we performed a very systematic mutational analysis of SARS-CoV-2 genomes from different geographical locations, which enabled us to identify numerous unique features of this viral genome. This includes several important country-specific unique mutations in the major proteins of SARS-CoV-2 namely, replicase polyprotein, spike glycoprotein, envelope protein and nucleocapsid protein. Indian strain showed mutation in spike glycoprotein at R408I and in replicase polyprotein at I671T, P2144S and A2798V,. While the spike protein of Spain & South Korea carried F797C and S221W mutation, respectively. Likewise, several important country specific mutations were analyzed. The effect of mutations of these major proteins were also investigated using variousin silicoapproaches. Main protease (Mpro), the therapeutic target protein of SARS with maximum reported inhibitors, was thoroughly investigated and the effect of mutation on the binding affinity and structural dynamics of Mpro was studied. It was found that the R60C mutation in Mpro affects the protein dynamics, thereby, affecting the binding of inhibitor within its active site. The implications of mutation on structural characteristics were determined. The information provided in this manuscript holds great potential in further scientific research towards the design of potential vaccine candidates/small molecular inhibitor against COVID19.	[Khan, Mohd Imran] All India Inst Med Sci, Dept Biophys, New Delhi, India; [Khan, Zainul A.] Univ Delhi, Dept Plant Mol Biol, South Campus, New Delhi, India; [Baig, Mohammad Hassan; Dong, Jae-Jun] Yonsei Univ, Dept Family Med, Coll Med, Seoul, South Korea; [Ahmad, Irfan] King Khalid Univ, Coll Appl Med Sci, Dept Clin Lab Sci, Abha, Saudi Arabia; [Ahmad, Irfan] King Khalid Univ, Res Ctr Adv Mat Sci, Abha, Saudi Arabia; [Farouk, Abd-ElAziem] Taif Univ, Fac Sci, Dept Biotechnol, At Taif, Saudi Arabia; [Song, Young Goo] Yonsei Univ, Gangnam Severance Hosp, Dept Infect Dis, Coll Med, Seoul, South Korea	All India Institute of Medical Sciences (AIIMS) New Delhi; University of Delhi; Yonsei University; Yonsei University Health System; King Khalid University; King Khalid University; Taif University; Yonsei University; Yonsei University Health System	Dong, JJ (corresponding author), Yonsei Univ, Dept Family Med, Coll Med, Seoul, South Korea.; Song, YG (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Dept Infect Dis, Coll Med, Seoul, South Korea.	IMFELL@yush.ac; S82TONIGHT@yush.ac	Ahmad, Irfan/AAU-4179-2020; Farouk, Abd-ElAziem/AAQ-7037-2021; Song, Young Goo/AGV-5104-2022; Ahmed, Irfan/HHD-1948-2022	Ahmad, Irfan/0000-0002-9500-4623; Song, Young Goo/0000-0002-0733-4156; Dong, Jaejune/0000-0002-2420-2155; Baig, Mohd Hassan/0000-0001-8227-4838; KHAN, ZAINUL/0000-0001-8043-2839; Reis, AlessanRSS/0000-0001-8486-7469				Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Angeletti S, 2020, J MED VIROL, V92, P584, DOI 10.1002/jmv.25719; Babcock GJ, 2004, J VIROL, V78, P4552, DOI 10.1128/JVI.78.9.4552-4560.2004; Baig MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112456; Beauchamp KA, 2012, J CHEM THEORY COMPUT, V8, P1409, DOI 10.1021/ct2007814; Chen Yu Wai, 2020, F1000Res, V9, P129, DOI 10.12688/f1000research.22457.2; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; Duffy S, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.3000003; Gao Y, 2020, SCIENCE, V368, P779, DOI 10.1126/science.abb7498; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Gurung AB, 2020, LIFE SCI, V255, DOI 10.1016/j.lfs.2020.117831; Guvench O, 2011, J CHEM THEORY COMPUT, V7, P3162, DOI 10.1021/ct200328p; Haagmans BL, 2014, LANCET INFECT DIS, V14, P140, DOI 10.1016/S1473-3099(13)70690-X; Hsin WC, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0449-x; Hu B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006698; Jin ZM, 2020, NATURE, V582, P289, DOI 10.1038/s41586-020-2223-y; Joshi T, 2020, EUR REV MED PHARMACO, V24, P4529, DOI 10.26355/eurrev_202004_21036; Kan B, 2005, J VIROL, V79, P11892, DOI 10.1128/JVI.79.18.11892-11900.2005; Kuhn JH, 2004, CELL MOL LIFE SCI, V61, P2738, DOI 10.1007/s00018-004-4242-5; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Lindner HA, 2005, J VIROL, V79, P15199, DOI 10.1128/JVI.79.24.15199-15208.2005; Lindorff-Larsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032131; Lo YS, 2013, FEBS LETT, V587, P120, DOI 10.1016/j.febslet.2012.11.016; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3; Masters PS, 2019, VIROLOGY, V537, P198, DOI 10.1016/j.virol.2019.08.031; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Mihindukulasuriya KA, 2008, J VIROL, V82, P5084, DOI 10.1128/JVI.02722-07; Mortola E, 2004, FEBS LETT, V576, P174, DOI 10.1016/j.febslet.2004.09.009; Nieto-Torres JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004077; Prabakaran P, 2006, J BIOL CHEM, V281, P15829, DOI 10.1074/jbc.M600697200; Ruch TR, 2012, VIRUSES-BASEL, V4, P363, DOI 10.3390/v4030363; Salemi M, 2004, J VIROL, V78, P1602, DOI 10.1128/JVI.78.3.1602-1603.2004; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Schoeman D, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1182-0; Shimamoto Y, 2015, BIOORGAN MED CHEM, V23, P876, DOI 10.1016/j.bmc.2014.12.028; Stoye J, 2011, ICTV 9 REPORT; Tai WB, 2020, CELL MOL IMMUNOL, V17, P613, DOI 10.1038/s41423-020-0400-4; Velthuis AJWT, 2010, NUCLEIC ACIDS RES, V38, P203, DOI 10.1093/nar/gkp904; Wang CT, 2020, J MED VIROL, V92, P667, DOI 10.1002/jmv.25762; Wang C, 2017, ONCOTARGET, V8, P12686, DOI 10.18632/oncotarget.8475; Wang L, 1998, PROTEINS, V32, P438, DOI 10.1002/(SICI)1097-0134(19980901)32:4<438::AID-PROT4>3.0.CO;2-C; Wang M, 2005, EMERG INFECT DIS, V11, P1860, DOI 10.3201/eid1112.041293; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Woo PCY, 2010, VIRUSES-BASEL, V2, P1804, DOI 10.3390/v2081803; Woo PCY, 2009, J VIROL, V83, P908, DOI 10.1128/JVI.01977-08; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	53	47	48	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238344	10.1371/journal.pone.0238344	http://dx.doi.org/10.1371/journal.pone.0238344			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881907	Green Published, gold			2022-12-26	WOS:000571063300049
J	Guo, WT; Sun, B; Estillore, JP; Wang, RW; Chen, SRW				Guo, Wenting; Sun, Bo; Estillore, John Paul; Wang, Ruiwu; Chen, S. R. Wayne			The central domain of cardiac ryanodine receptor governs channel activation, regulation, and stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ca2+ activation; Mg2+ inhibition; basal activity; ryanodine binding; calcium intracellular release; calcium imaging; ryanodine receptor; sarcoplasmic reticulum (SR); inositol trisphosphate receptor (InsP3R); calcium; calcium channel	POLYMORPHIC VENTRICULAR-TACHYCARDIA; CA2+ RELEASE CHANNELS; SARCOPLASMIC-RETICULUM; CALCIUM-RELEASE; MOLECULAR-BASIS; MUTATIONS; INACTIVATION; MECHANISM; MG2+; RYR1	Structural analyses identified the central domain of ryanodine receptor (RyR) as a transducer converting conformational changes in the cytoplasmic platform to the RyR gate. The central domain is also a regulatory hub encompassing the Ca2+-, ATP-, and caffeine-binding sites. However, the role of the central domain in RyR activation and regulation has yet to be defined. Here, we mutated five residues that form the Ca2+ activation site and 10 residues with negatively charged or oxygen-containing side chains near the Ca2+ activation site. We also generated eight disease-associated mutations within the central domain of RyR2. We determined the effect of these mutations on Ca2+, ATP, and caffeine activation and Mg2+ inhibition of RyR2. Mutating the Ca2+ activation site markedly reduced the sensitivity of RyR2 to Ca2+ and caffeine activation. Unexpectedly, Ca2+ activation site mutation E3848A substantially enhanced the Ca2+-independent basal activity of RyR2, suggesting that E3848A may also affect the stability of the closed state of RyR2. Mutations in the Ca2+ activation site also abolished the effect of ATP/caffeine on the Ca2+-independent basal activity, suggesting that the Ca2+ activation site is also a critical determinant of ATP/caffeine action. Mutating residues with negatively charged or oxygen-containing side chains near the Ca2+ activation site significantly altered Ca2+ and caffeine activation and reduced Mg2+ inhibition. Furthermore, disease-associated RyR2 mutations within the central domain significantly enhanced Ca2+ and caffeine activation and reduced Mg2+ inhibition. Our data demonstrate that the central domain plays an important role in channel activation, channel regulation, and closed state stability.	[Guo, Wenting; Sun, Bo; Estillore, John Paul; Wang, Ruiwu; Chen, S. R. Wayne] Univ Calgary, Libin Cardiovasc Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Guo, Wenting; Sun, Bo; Estillore, John Paul; Wang, Ruiwu; Chen, S. R. Wayne] Univ Calgary, Libin Cardiovasc Inst, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Sun, Bo] Kunming Univ Sci & Technol, Sch Med, Kunming, Yunnan, Peoples R China	Libin Cardiovascular Institute Of Alberta; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; Kunming University of Science & Technology	Chen, SRW (corresponding author), Univ Calgary, Libin Cardiovasc Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada.; Chen, SRW (corresponding author), Univ Calgary, Libin Cardiovasc Inst, Dept Biochem & Mol Biol, Calgary, AB, Canada.	swchen@ucalgary.ca			Canadian Institutes of Health Research Grant [PJT-155940]; Heart and Stroke Foundation of Canada [G-19-0026444]; Heart and Stroke Foundation Chair in Cardiovascular Research; Alberta Innovates-Health Solutions Graduate Studentship Award; Heart and Stroke Foundation of Canada Junior Fellowship Award; AIHS Fellowship Award	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Heart and Stroke Foundation Chair in Cardiovascular Research; Alberta Innovates-Health Solutions Graduate Studentship Award; Heart and Stroke Foundation of Canada Junior Fellowship Award; AIHS Fellowship Award	This work was supported by the Canadian Institutes of Health Research Grant PJT-155940 (to S. R. W. C.), the Heart and Stroke Foundation of Canada Grant G-19-0026444 (to S. R. W. C.), and the Heart and Stroke Foundation Chair in Cardiovascular Research (to S. R. W. C.). W. G. is a recipient of the Alberta Innovates-Health Solutions Graduate Studentship Award, and B. S. is a recipient of the Heart and Stroke Foundation of Canada Junior Fellowship Award and the AIHS Fellowship Award.	Bai XC, 2016, CELL RES, V26, P995, DOI 10.1038/cr.2016.89; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Broendberg AK, 2017, HEART, V103, P901, DOI 10.1136/heartjnl-2016-310509; Cannell MB, 1997, BIOPHYS J, V73, P112, DOI 10.1016/S0006-3495(97)78052-4; Chen SRW, 2002, BIOPHYS J, V82, P2436, DOI 10.1016/S0006-3495(02)75587-2; Chen SRW, 1998, J BIOL CHEM, V273, P14675, DOI 10.1074/jbc.273.24.14675; Cheng H, 1996, AM J PHYSIOL-CELL PH, V270, pC148; Chi XM, 2019, P NATL ACAD SCI USA, V116, P25575, DOI 10.1073/pnas.1914451116; Coronado Roberto, 1994, American Journal of Physiology, V266, pC1485; Denniss A, 2018, INT J BIOCHEM CELL B, V101, P49, DOI 10.1016/j.biocel.2018.05.004; des Georges A, 2016, CELL, V167, P145, DOI 10.1016/j.cell.2016.08.075; Du GG, 1998, J BIOL CHEM, V273, P31867, DOI 10.1074/jbc.273.48.31867; Du GG, 1999, J BIOL CHEM, V274, P26120, DOI 10.1074/jbc.274.37.26120; EBASHI S, 1991, ANNU REV PHYSIOL, V53, P1, DOI 10.1146/annurev.ph.53.030191.000245; Efremov RG, 2015, NATURE, V517, P39, DOI 10.1038/nature13916; ENDO M, 1977, PHYSIOL REV, V57, P71, DOI 10.1152/physrev.1977.57.1.71; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; FABIATO A, 1985, J GEN PHYSIOL, V85, P247, DOI 10.1085/jgp.85.2.247; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gong DS, 2019, NATURE, V572, P347, DOI 10.1038/s41586-019-1377-y; Guo WT, 2016, J BIOL CHEM, V291, P2150, DOI 10.1074/jbc.M115.693325; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; INUI M, 1987, J BIOL CHEM, V262, P15637; Laitinen PJ, 2001, CIRCULATION, V103, P485, DOI 10.1161/01.CIR.103.4.485; LaPage MJ, 2012, J PEDIATR-US, V161, P362, DOI 10.1016/j.jpeds.2012.04.013; Laver DR, 2008, J GEN PHYSIOL, V132, P429, DOI 10.1085/jgp.200810001; Laver Derek R, 2018, Biophys Rev, V10, P1087, DOI 10.1007/s12551-018-0433-4; Laver DR, 1997, J MEMBRANE BIOL, V156, P213, DOI 10.1007/s002329900202; LAVER DR, 1995, J MEMBRANE BIOL, V147, P7; Li P, 2001, J GEN PHYSIOL, V118, P33, DOI 10.1085/jgp.118.1.33; Lieve KVV, 2019, HEART RHYTHM, V16, P220, DOI 10.1016/j.hrthm.2018.08.025; MacLennan DH, 2009, J PHYSIOL-LONDON, V587, P3113, DOI 10.1113/jphysiol.2009.172155; Medeiros-Domingo A, 2009, J AM COLL CARDIOL, V54, P2065, DOI 10.1016/j.jacc.2009.08.022; Meissner G, 2004, CELL CALCIUM, V35, P621, DOI 10.1016/j.ceca.2004.01.015; Meissner G, 1997, J BIOL CHEM, V272, P1628, DOI 10.1074/jbc.272.3.1628; MEISSNER G, 1986, BIOCHEMISTRY-US, V25, P236, DOI 10.1021/bi00349a033; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Murayama T, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0103-x; O'Brien JJ, 2002, BIOPHYS J, V82, P2428, DOI 10.1016/S0006-3495(02)75586-0; OGAWA Y, 1994, CRIT REV BIOCHEM MOL, V29, P229, DOI 10.3109/10409239409083482; Peng W, 2016, SCIENCE, V354, DOI 10.1126/science.aah5324; Postma AV, 2005, J MED GENET, V42, P863, DOI 10.1136/jmg.2004.028993; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Sorrentino V, 1995, Adv Pharmacol, V33, P67, DOI 10.1016/S1054-3589(08)60666-3; Stern MD, 1999, J GEN PHYSIOL, V113, P469, DOI 10.1085/jgp.113.3.469; Sutko JL, 1996, PHYSIOL REV, V76, P1027, DOI 10.1152/physrev.1996.76.4.1027; Tester DJ, 2006, HEART RHYTHM, V3, P800, DOI 10.1016/j.hrthm.2006.03.025; Tester DJ, 2004, MAYO CLIN PROC, V79, P1380, DOI 10.4065/79.11.1380; Van Petegem F, 2012, J BIOL CHEM, V287, P31624, DOI 10.1074/jbc.R112.349068; Walsh R, 2014, J MED GENET, V51, P35, DOI 10.1136/jmedgenet-2013-101917; Wang RW, 2003, J BIOL CHEM, V278, P51557, DOI 10.1074/jbc.M306788200; Xiao ZC, 2016, J BIOL CHEM, V291, P24528, DOI 10.1074/jbc.M116.756528; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950; Zucchi R, 1997, PHARMACOL REV, V49, P1	56	5	5	3	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2020	295	46					15622	15635		10.1074/jbc.RA120.013512	http://dx.doi.org/10.1074/jbc.RA120.013512			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OY6NO	32878990	Green Published, hybrid			2022-12-26	WOS:000594361600016
J	Dumidae, A; Janthu, P; Subkrasae, C; Pumidonming, W; Dekumyoy, P; Thanwisai, A; Vitta, A				Dumidae, Abdulhakam; Janthu, Pichamon; Subkrasae, Chanakan; Pumidonming, Wilawan; Dekumyoy, Paron; Thanwisai, Aunchalee; Vitta, Apichat			Genetic analysis ofCryptozona siamensis(Stylommatophora, Ariophantidae) populations in Thailand using the mitochondrial 16S rRNA and COI sequences	PLOS ONE			English	Article							OXIDASE SUBUNIT-I; PHYLOGENETIC-RELATIONSHIPS; GASTROPODA; SNAIL; GENUS; PULMONATA; MOLLUSCA; CANTONENSIS; DISPERSAL; DIVERSITY	Cryptozona siamensis, one of the most widespread land snails, is native to Thailand, and plays a key role as an agricultural pest and intermediate host forAngiostrongylusspp. However, its genetic diversity and population structure has not yet been investigated, and are poorly understood. Therefore, a genetic analysis of theC.siamensispopulation in Thailand was conducted, based mitochondrial 16S rRNA (402 bp) and COI (602 bp) gene fragment sequences.Cryptozona siamensisrandomly collected from 17 locations in four populations across Thailand, between May 2017 and July 2018. Fifty-eight snails were used to examine the phylogeny, genetic diversity, and genetic structure. The maximum likelihood tree based on the 16S rRNA and COI fragment sequences revealed two main clades. A total of 14 haplotypes with 44 nucleotide variable sites were found in the 16S rRNA sequences, while 14 haplotypes with 57 nucleotide variable sites were found in the COI sequences. The genetic diversity ofC.siamensisin term of the number of haplotypes and haplotype diversity, was found to be high but the nucleotide diversity showed low levels of genetic differentiation for the COI sequence as also noted with the 16S rRNA sequence. The population genetic structure ofC.siamensisrevealed genetic difference in most populations in Thailand. However, low genetic difference in some populations may be due to high gene flow. This study provides novel insights into the basic molecular genetics ofC.siamensis.	[Dumidae, Abdulhakam; Janthu, Pichamon; Subkrasae, Chanakan; Pumidonming, Wilawan; Thanwisai, Aunchalee; Vitta, Apichat] Naresuan Univ, Fac Med Sci, Dept Microbiol & Parasitol, Phitsanulok, Thailand; [Dekumyoy, Paron] Mahidol Univ, Fac Trop Med, Dept Helminthol, Bangkok, Thailand; [Thanwisai, Aunchalee; Vitta, Apichat] Naresuan Univ, Fac Med Sci, Ctr Excellence Med Biotechnol CEMB, Phitsanulok, Thailand; [Thanwisai, Aunchalee; Vitta, Apichat] Naresuan Univ, Fac Sci, Ctr Excellence Biodivers, Phitsanulok, Thailand	Naresuan University; Mahidol University; Naresuan University; Naresuan University	Vitta, A (corresponding author), Naresuan Univ, Fac Med Sci, Dept Microbiol & Parasitol, Phitsanulok, Thailand.; Vitta, A (corresponding author), Naresuan Univ, Fac Med Sci, Ctr Excellence Med Biotechnol CEMB, Phitsanulok, Thailand.; Vitta, A (corresponding author), Naresuan Univ, Fac Sci, Ctr Excellence Biodivers, Phitsanulok, Thailand.	apichatv@nu.ac.th	Vitta, Apichat/HHZ-5460-2022	Vitta, Apichat/0000-0002-2483-0100	National Research Council of Thailand through the Annual Research Fund Naresuan University [R2562B079, R2562B078]	National Research Council of Thailand through the Annual Research Fund Naresuan University	This work was supported by the National Research Council of Thailand through the Annual Research Fund Naresuan University (Grant number R2562B079 and R2562B078).	Abu-Bakar SB, 2014, MOL BIOL REP, V41, P1799, DOI 10.1007/s11033-014-3029-5; Ali RF, 2016, ZOOL SCR, V45, P48, DOI 10.1111/zsc.12134; Amato R, 2016, ELIFE, V5, DOI 10.7554/eLife.08714; An HS, 2005, MAR BIOTECHNOL, V7, P373, DOI 10.1007/s10126-004-4405-2; Asato R, 2004, JPN J INFECT DIS, V57, P184; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Awodiran MO, 2015, SER BIOL, V18, P95; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Byrne M, 2008, QUATERNARY SCI REV, V27, P2576, DOI 10.1016/j.quascirev.2008.08.032; Chen DN, 1987, EC FAUNA SINICA CHIN; Colgan DJ, 2007, MOL PHYLOGENET EVOL, V42, P717, DOI 10.1016/j.ympev.2006.10.009; Cowie Robert H, 2013, Hawaii J Med Public Health, V72, P6; Dumidae A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223257; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feng YW, 2011, MOL BIOL REP, V38, P291, DOI 10.1007/s11033-010-0107-1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontanilla IKC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105151; Gittenberger E, 2006, NATURE, V439, P409, DOI 10.1038/439409a; Grande C, 2004, MOL PHYLOGENET EVOL, V33, P378, DOI 10.1016/j.ympev.2004.06.008; Holland BS, 2007, MOL ECOL, V16, P2422, DOI 10.1111/j.1365-294X.2007.03246.x; Holznagel WE, 2000, J MOLLUS STUD, V66, P233, DOI 10.1093/mollus/66.2.233; Jin YT, 2008, MOL ECOL, V17, P1971, DOI 10.1111/j.1365-294X.2008.03721.x; JONES JS, 1973, SCIENCE, V182, P546, DOI 10.1126/science.182.4112.546; Jose J, 2007, GENETICA, V130, P73, DOI 10.1007/s10709-006-0024-3; Kessing B, 1989, SIMPLE FOOLS GUIDE P; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Kornilios P, 2009, J MOLLUS STUD, V75, P109, DOI 10.1093/mollus/eyp003; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lee YC, 2008, ZOOTAXA, P22, DOI 10.11646/zootaxa.1792.1.2; Liew TS, 2009, ZOOL J LINN SOC-LOND, V157, P515, DOI 10.1111/j.1096-3642.2009.00526.x; Liu HP, 2001, MOL PHYLOGENET EVOL, V21, P17, DOI 10.1006/mpev.2001.0988; Lv S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000368; Marquardt WC, 2000, PARASITOLOGY VECTOR, V2nd, P702; Mead A. R., 1961, GIANT AFRICAN SNAIL; Meissner H, 2009, EVALUATION PATHWAYS; Millar CL, 1991, STRATEGIES CONSERVIN; Mouahid G, 2018, ZOOL SCR, V47, P558, DOI 10.1111/zsc.12297; N'soukpoe-Kossi CN, 2006, J BIOMOL STRUCT DYN, V24, P277, DOI 10.1080/07391102.2006.10507120; Nantarat N, 2014, MOL PHYLOGENET EVOL, V70, P99, DOI 10.1016/j.ympev.2013.09.013; Neiber MT, 2017, ZOOL SCR, V46, P308, DOI 10.1111/zsc.12218; Panha S, 1996, WALKERANA, V8, P31; Panha S, 2009, ILLUSTRATED GUIDE LA; Prasankok P, 2008, BIOCHEM SYST ECOL, V36, P900, DOI 10.1016/j.bse.2008.11.005; Prasankok P, 2011, BIOCHEM SYST ECOL, V39, P449, DOI 10.1016/j.bse.2011.06.011; Raut SK, 1984, PESTIFEROUS LAND SNA; Rodpai R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161128; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SCHILTHUIZEN M, 1994, EVOLUTION, V48, P577, DOI 10.1111/j.1558-5646.1994.tb01345.x; Standley CJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0524-4; Szalanski AL, 2008, J MED ENTOMOL, V45, P229, DOI 10.1603/0022-2585(2008)45[229:MARITS]2.0.CO;2; Vitta A, 2016, SE ASIAN J TROP MED, V47, P377; Vogler AP, 2007, J ZOOL SYST EVOL RES, V45, P1, DOI 10.1111/j.1439-0469.2006.00384.x; Wade CM, 2000, J MOLLUS STUD, V66, P565, DOI 10.1093/mollus/66.4.565; Wang QP, 2008, LANCET INFECT DIS, V8, P621, DOI 10.1016/S1473-3099(08)70229-9; Watanabe Y, 2001, MOL ECOL, V10, P2635, DOI 10.1046/j.0962-1083.2001.01388.x; Zeng X, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2285-3; Zhou WC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15758-y	58	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0239264	10.1371/journal.pone.0239264	http://dx.doi.org/10.1371/journal.pone.0239264			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925984	gold, Green Published			2022-12-26	WOS:000572318000031
J	Szekely, D; Cogalniceanu, D; Szekely, P; Denoel, M				Szekely, Diana; Cogalniceanu, Dan; Szekely, Paul; Denoel, Mathieu			Adult-Juvenile interactions and temporal niche partitioning between life-stages in a tropical amphibian	PLOS ONE			English	Article							AMBUSH-SITE SELECTION; ONTOGENIC SHIFTS; BODY-SIZE; BEHAVIORAL THERMOREGULATION; ACTIVITY PATTERNS; FORAGING ACTIVITY; DIURNAL ACTIVITY; BUFO-AMERICANUS; WATER ECONOMY; PREDATION	Divergence in ecological niche offers organisms the opportunity of exploiting different food and habitat resources, scaling down competition and predation both among species, and within different age or size-classes of the same species. In harsh environments, where abiotic factors determine a clustering of resources during short timespans, competition and predation between organisms is likely to be enhanced. This is the case in tropical dry forests, where amphibians have limited opportunities to feed, their activity being restricted to the short rainy season. One way to maximize resource exploitation while avoiding predation risk is by adopting different diel activity patterns. We tested this hypothesis by comparing activity patterns in adults and recently metamorphosed juveniles of Pacific horned frogs (Ceratophrys stolzmanni) during field surveys and in an experimental study. Field surveys showed that the adults are strictly nocturnal, whereas freshly metamorphosed juveniles can be found active above ground at all hours, with a peak activity during daytime. The average body condition index of juveniles found active during the night was higher than that of juveniles found active during the day, suggesting that the weaker individuals may be constrained to being active during the day. On the other hand, in a laboratory experiment, juveniles that were visually exposed to adults moved less than those in the absence of adults. Both field and experimental observations indicate a temporal niche divergence between life stages. The results of the experiment offer support to the hypothesis that the juveniles in this species display an inverse activity pattern compared to adults, which can reduce competitive interactions and predation pressure from the larger conspecifics.	[Szekely, Diana; Szekely, Paul] Univ Tecn Particular Loja, Dept Ciencias Biol, Lab Ecol Trop & Servicios Ecosistem EcoSs Lab, Loja, Ecuador; [Szekely, Diana; Cogalniceanu, Dan] Ovidius Univ Constanta, Fac Nat & Agr Sci, Constanta, Romania; [Szekely, Diana; Denoel, Mathieu] Univ Liege, Freshwater & OCean Sci Unit ReS FOCUS, Lab Ecol & Conservat Amphibians LECA, Liege, Belgium; [Cogalniceanu, Dan; Szekely, Paul] Asoc Chelonia, Bucharest, Romania	Universidad Tecnica Particular de Loja; Ovidius University; University of Liege	Szekely, P (corresponding author), Univ Tecn Particular Loja, Dept Ciencias Biol, Lab Ecol Trop & Servicios Ecosistem EcoSs Lab, Loja, Ecuador.; Szekely, P (corresponding author), Asoc Chelonia, Bucharest, Romania.	jpszekely@utpl.edu.ec	Szekely, Diana/O-6147-2017; Székely, Paul/V-8239-2017; Cogalniceanu, Dan/B-7065-2011	Szekely, Diana/0000-0002-3786-3729; Székely, Paul/0000-0002-9252-1596; Cogalniceanu, Dan/0000-0003-2959-014X; Denoel, Mathieu/0000-0002-3586-8323	Universidad Tecnica Particular de Loja (Convocatoria Estancias Cortas de Investigacion 2019); Wallonie-Bruxelles International (W. B.I.); CCCDI-UEFISCDI (A.N.C.S.: Autoritatea Nationala pentru Cercetare Stiintifica) [105 BM/2017]	Universidad Tecnica Particular de Loja (Convocatoria Estancias Cortas de Investigacion 2019); Wallonie-Bruxelles International (W. B.I.); CCCDI-UEFISCDI (A.N.C.S.: Autoritatea Nationala pentru Cercetare Stiintifica)(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	DS benefited from a research grant from Universidad Tecnica Particular de Loja (Convocatoria Estancias Cortas de Investigacion 2019). The collaboration between Ovidius University Constanta and University of Liege was supported by Wallonie-Bruxelles International (W. B.I.) and CCCDI-UEFISCDI (A.N.C.S.: Autoritatea Nationala pentru Cercetare Stiintifica) - project no. 105 BM/2017. MD is a Research Director at Fonds de la Recherche Scientifique - FNRS (Belgium).	Anderson SR, 2017, EVOLUTION, V71, P1944, DOI 10.1111/evo.13284; Arifulova I, 2007, J MORPHOL, V268, P690, DOI 10.1002/jmor.10541; Bancila RI, 2010, AMPHIBIA-REPTILIA, V31, P558, DOI 10.1163/017353710X518405; Bovo RP, 2018, DIVERSITY-BASEL, V10, DOI 10.3390/d10040118; Bragg AN, 1944, COPEIA, V1944, P230, DOI [10.2307/1438679, DOI 10.2307/1438679]; BRATTSTROM BH, 1979, AM ZOOL, V19, P345; BRODIE ED, 1991, BIOTROPICA, V23, P58, DOI 10.2307/2388688; BUCHANAN BW, 1993, ANIM BEHAV, V45, P893, DOI 10.1006/anbe.1993.1109; Chase J.M., 2009, ECOLOGICAL NICHES LI; Clegg T, 2018, ECOLOGY, V99, P2712, DOI 10.1002/ecy.2523; Cunningham CX, 2019, ECOGRAPHY, V42, P2157, DOI 10.1111/ecog.04485; Darst CR, 2005, AM NAT, V165, P56, DOI 10.1086/426599; Denoel M, 2004, ECOSCIENCE, V11, P404, DOI 10.1080/11956860.2004.11682849; Denoel M, 2002, BIOL J LINN SOC, V77, P105, DOI 10.1046/j.1095-8312.2002.00095.x; Denoel M, 2001, CAN J ZOOL, V79, P943, DOI 10.1139/cjz-79-6-943; Denoel M, 2006, BIOL J LINN SOC, V89, P373, DOI 10.1111/j.1095-8312.2006.00681.x; Downes SJ, 2002, BEHAV ECOL, V13, P551, DOI 10.1093/beheco/13.4.551; Duellman W.E., 1989, VERTEBRATES COMPLEX, P61; EMERSON SB, 1985, HERPETOLOGICA, V41, P177; Eskew EA, 2009, J ZOOL, V277, P179, DOI 10.1111/j.1469-7998.2008.00527.x; Espinosa CI, 2016, ECOGRAPHY, V39, P329, DOI 10.1111/ecog.01328; FEINSINGER P, 1981, ECOLOGY, V62, P27, DOI 10.2307/1936664; FREELAND WJ, 1991, WILDLIFE RES, V18, P431, DOI 10.1071/WR9910431; Gosner K. L., 1960, Herpetologica, V16, P183; Gouveia SF, 2019, AM NAT, V193, P51, DOI 10.1086/700833; Hanson JO, 2015, AUSTRAL ECOL, V40, P275, DOI 10.1111/aec.12212; HEINEN JT, 1994, HERPETOLOGICA, V50, P137; Hertz E, 2016, J ANIM ECOL, V85, P681, DOI 10.1111/1365-2656.12504; Holt RD, 2009, P NATL ACAD SCI USA, V106, P19659, DOI 10.1073/pnas.0905137106; Huey R.B., 1983, P281; Hut RA, 2012, PROG BRAIN RES, V199, P281, DOI 10.1016/B978-0-444-59427-3.00017-4; JANZEN DH, 1973, ECOLOGY, V54, P687, DOI 10.2307/1935359; Jones KA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59992-3; Jorgensen CB, 1997, BIOL REV, V72, P153, DOI 10.1017/S0006323196004963; Kronfeld-Schor N, 1999, OECOLOGIA, V121, P123, DOI 10.1007/s004420050913; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; LILLYWHITE HB, 1973, ECOLOGY, V54, P375, DOI 10.2307/1934345; Lima AP, 1998, OECOLOGIA, V116, P259, DOI 10.1007/s004420050587; Lima AP, 2000, J HERPETOL, V34, P192, DOI 10.2307/1565415; LINSDALE JEAN M., 1938, AMER MIDLAND NAT, V19, P1, DOI 10.2307/2420430; Lovette IJ, 2006, ECOLOGY, V87, pS14, DOI 10.1890/0012-9658(2006)87[14:SEOPNC]2.0.CO;2; Manenti R, 2013, ANIM BEHAV, V86, P375, DOI 10.1016/j.anbehav.2013.05.028; MARET TJ, 1994, OECOLOGIA, V100, P279, DOI 10.1007/BF00316955; Matich P, 2015, OECOLOGIA, V178, P347, DOI 10.1007/s00442-015-3253-2; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Monterroso P, 2014, BEHAV ECOL SOCIOBIOL, V68, P1403, DOI 10.1007/s00265-014-1748-1; Nakazawa T, 2015, POPUL ECOL, V57, P347, DOI 10.1007/s10144-014-0448-z; Navas CA, 2007, COMP BIOCHEM PHYS A, V147, P647, DOI 10.1016/j.cbpa.2006.04.035; Neill W.T., 1957, HERPETOLOGICA, V13, P185; Nielsen ME, 2015, OECOLOGIA, V177, P171, DOI 10.1007/s00442-014-3123-3; ORR MR, 1992, BEHAV ECOL SOCIOBIOL, V30, P395; Pettit L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62402-3; Pizzatto L, 2008, BEHAV ECOL, V19, P990, DOI 10.1093/beheco/arn060; ROWE L, 1991, ECOLOGY, V72, P413, DOI 10.2307/2937184; Rudolf VHW, 2020, FRESHWATER BIOL, V65, P745, DOI 10.1111/fwb.13463; Sanchez-Hernandez J, 2017, ECOL EVOL, V7, P358, DOI 10.1002/ece3.2600; Santos RR, 2011, EVOL ECOL, V25, P249, DOI 10.1007/s10682-010-9407-0; Schalk CM, 2015, CAN J ZOOL, V93, P461, DOI 10.1139/cjz-2014-0320; Schalk CM, 2014, S AM J HERPETOL, V9, P90, DOI 10.2994/SAJH-D-14-00008.1; SEMLITSCH RD, 1985, COPEIA, P86, DOI 10.2307/1444794; Silva JO, 2017, J INSECT CONSERV, V21, P667, DOI 10.1007/s10841-017-0009-9; Stanescu F, 2016, HERPETOZOA, V29, P87; Szekely D, 2017, J ZOOL, V303, P129, DOI 10.1111/jzo.12468; Szekely D, 2019, PEERJ, V7, DOI 10.7717/peerj.6406; Szekely D, 2018, J ARID ENVIRON, V155, P79, DOI 10.1016/j.jaridenv.2018.02.003; Szekely D, 2018, SALAMANDRA, V54, P37; TAIGEN TL, 1981, J COMP PHYSIOL, V144, P247, DOI 10.1007/BF00802763; Titon B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140761; Todd BD, 2006, CAN J ZOOL, V84, P715, DOI 10.1139/Z06-054; Toledo LF, 2011, ETHOL ECOL EVOL, V23, P1, DOI 10.1080/03949370.2010.534321; Toledo Luis Felipe, 2009, International Journal of Zoology, V2009, P1, DOI 10.1155/2009/910892; Touchon JC, 2013, OECOLOGIA, V173, P801, DOI 10.1007/s00442-013-2714-8; Tracy CR, 2013, AUSTRAL ECOL, V38, P476, DOI 10.1111/j.1442-9993.2012.02416.x; Tracy CR, 2010, ECOLOGY, V91, P1477, DOI 10.1890/09-0839.1; van Leeuwen A, 2013, AM NAT, V182, P53, DOI 10.1086/670614; WERNER EE, 1988, ECOLOGY, V69, P1352, DOI 10.2307/1941633; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Whiteman HH, 2012, OECOLOGIA, V168, P109, DOI 10.1007/s00442-011-2076-z; Williams CR, 2000, J HERPETOL, V34, P431, DOI 10.2307/1565367; Winandy L, 2016, BEHAV ECOL, V27, P1025, DOI 10.1093/beheco/arw008; Zandona E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06163-6	81	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0238949	10.1371/journal.pone.0238949	http://dx.doi.org/10.1371/journal.pone.0238949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925925	Green Published, gold			2022-12-26	WOS:000572318000046
J	Duffy, PR				Duffy, Paul R.			River networks and funerary metal in the Bronze Age of the Carpathian Basin	PLOS ONE			English	Article							GRAPH-THEORETIC APPROACH; ORGANIZATION; EVOLUTION; MIDDLE; TRADE	Archaeologists use differences in metals from burial contexts to identify variation in social inequalities during the European Bronze Age. Many have argued that these social inequalities depended on access to, and control of, trade routes. In this paper, I model critical gateways in the Tisza river-a river system in the Carpathian Basin that might have enabled privileged access to metal in some areas but not others. I then evaluate the concentration of metal on different topological nodes of the river network in an attempt to understand what best explains the distribution of metals across this landscape. I do this by describing Bronze Age metal consumption and display in cemeteries from four micro-regions of the Tisza, and compare them with network 'betweenness centrality' values for locations along the river. I find support for the argument that favourably located river nodes had better access to metal in the earlier part of the Bronze Age.	[Duffy, Paul R.] Columbia Univ, Italian Acad Adv Studies Amer, New York, NY 10027 USA; [Duffy, Paul R.] Univ Toronto, Archaeol Ctr, Toronto, ON, Canada	Columbia University; University of Toronto	Duffy, PR (corresponding author), Columbia Univ, Italian Acad Adv Studies Amer, New York, NY 10027 USA.; Duffy, PR (corresponding author), Univ Toronto, Archaeol Ctr, Toronto, ON, Canada.	paul.duffy@utoronto.ca		Duffy, Paul/0000-0002-4026-2078	Social Science and Humanities Research Council of Canada [756-2011-0060]; National Science Foundation [BCS1460820, BCS-1226439]	Social Science and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); National Science Foundation(National Science Foundation (NSF))	This research was supported by the Social Science and Humanities Research Council of Canada (756-2011-0060) (www.sshrc-crsh.gc.ca) and the National Science Foundation (BCS1460820, BCS-1226439) (www.nsf.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, INT J NETW SECUR ITS, V8, P47; Biro KT, 2011, LITHOTECA COMP RAW M; Bl Bak, 1997, MAGYARORSZAG TORTENE; Borgatti S. P., 2018, ANAL SOCIAL NETWORK; Borgatti S.P., 2002, UCINET 6 WINDOWS SOF; Boroffka N, 2006, APULUM, V63, P71; Bosel M., 2008, PRAEHIST Z, V83, P45; Bruck J, 2006, CAMB ARCHAEOL J, V16, P297, DOI 10.1017/S0959774306000187; Brughmans T, 2013, THINKING NETWORKS RE, P623; Brughmans T, 2010, OXFORD J ARCHAEOL, V29, P277, DOI 10.1111/j.1468-0092.2010.00349.x; Conolly J., 2018, CANADIAN J ARCHAEOLO, V42, P185; Czukor P, 2017, MASODIK HAJDUBOSZORM, P211; Dietrich O, 2014, EUR J ARCHAEOL, V17, P468, DOI 10.1179/1461957114Y.0000000061; Doka K, 1997, KOROS BERETTYO VIZRE; Drennan RD, 2006, P NATL ACAD SCI USA, V103, P3960, DOI 10.1073/pnas.0510862103; Duffy P., 2014, COMPLEXITY AUTONOMY; Duffy P.R., 2013, PREHISTORIC VILLAGES, P44; Duffy PR, 2019, J ANTHROPOL ARCHAEOL, V53, P240, DOI 10.1016/j.jaa.2019.01.003; Duffy PR, 2019, ANTIQUITY, V93, P63, DOI 10.15184/aqy.2018.179; Duffy PR, 2014, HUNGARIAN ARCHAEOLOG; Earle T.K, 2010, ORG BRONZE AGE SOC M; Earle T, 2015, EUR J ARCHAEOL, V18, P633, DOI 10.1179/1461957115Y.0000000008; Earle Timothy, 1997, CHIEFS COME POWER PO; European Commission, 2000, OFFICIAL METHODS OF, VC, P1, DOI 10.1108/03090550310770974; Filatova S., 2018, KAKUCSTURJAN MIDDLE, V18, P175; Fischl K, 2001, THESIS; Fischl KP, 2000, STUDIA ARCHAEOLOGICA, V6, P77; Fischl KP., 2013, 1600 KULTURELLER UMB, P355; Fischl KP, 2001, STUDIA ARCHAEOLOGICA, V7, P193; Foltiny I., 1941, DOLGOZATOK MAGYAR KI, V17, P1; Gazdapusztai G, 1968, ACTA ANTIQUA ARCHAEO, V12, P5; Giri M, 1971, MOKRIN EARLY BRONZE; Goldstein LG, 1976, SPATIAL STRUCTURE SO; Gomori J., 2018, ACTA ARCHAEOLOGICA A, V69, P5, DOI [10.1556/072.2018.69.1.1, DOI 10.1556/072.2018.69.1.1]; GOUGH SA, 2019, ARCATA FISH DATA JUL, P1; Gyorffy G, 1966, AZ ARPAD KORI MAGYAR; Gyucha A, 2001, HATALMASOK VIADALOKB, V2, P115; Gyucha A, 2011, GEOARCHAEOLOGY, V26, P392, DOI 10.1002/gea.20350; Gyulai F., 1993, ENV AGR BRONZE AGE H; HIRTH KG, 1978, AM ANTIQUITY, V43, P35, DOI 10.2307/279629; 신보영, 2015, [Journal of Arts Psychothreapy, 예술심리치료연구], V11, P41; Jaeger M., 2018, STUDIEN ARCHAOLOGIE, V18, P191; Jaeger M, 2012, ENCLOSED SPACE OPEN; Johansen KL, 2004, J ANTHROPOL ARCHAEOL, V23, P33, DOI 10.1016/j.jaa.2003.10.002; Kacso C, 2016, DESCOPERIRILE FUNERA; Kemenczei T., 1979, REGESZETI FUZETEK, VII; Kienlin Tobias, 2017, STUDIA ARCHAEOLOGICA, V31, P93128; Kintigh KW, 2014, AM ANTIQUITY, V79, P5, DOI 10.1073/pnas.1324000111; Knappett C, 2018, J ARCHAEOL METHOD TH, V25, P974, DOI 10.1007/s10816-018-9396-9; Knappett C, 2008, ANTIQUITY, V82, P1009, DOI 10.1017/S0003598X0009774X; Kneisel J., 2012, UNIVFORSCH PRAHIST A, p[205, 267]; Kneisel J, 2019, HOLOCENE, V29, P1607, DOI 10.1177/0959683619857237; Kohler TA, 2018, 1000 YEARS INEQUALIT; Kroll H, 2016, FEUDVAR; Ling J, 2018, CURR ANTHROPOL, V59, P488, DOI 10.1086/699613; Liversage D., 1994, ACTA ARCHAEOL KOBENH, V65, P57; Llobera M, 1996, ANTIQUITY, V70, P612, DOI 10.1017/S0003598X00083745; McMurtrie J, 2019, JEFFS MAP TRAVEL TIM; Mills BJ, 2015, AM ANTIQUITY, V80, P3, DOI 10.7183/0002-7316.79.4.3; Muller J, 2013, 1600 KULTURELLER UMB, P527; Muller J, 2015, MOBILITY CULTURE BRO, P225; Muller J, 2010, PALG STUD MINOR LANG, P5; Murrieta-Flores P., 2010, MAKING HIST INTERACT, P249; Nicodemus Amy, 2014, THESIS U MICHIGAN AN; O'Shea J. M., 1996, VILLAGERS MAROS PORT; O'Shea JM, 2019, ANTIQUITY, V93, P604, DOI 10.15184/aqy.2019.40; O'Shea JM, 2011, J WORLD PREHIST, V24, P161, DOI 10.1007/s10963-011-9046-6; Ordentlich I, 1970, STUDII SI CERCETARI, V21, P49; Ostborn P, 2014, J ARCHAEOL SCI, V46, P75, DOI 10.1016/j.jas.2014.03.015; Paja Laszlo, 2016, Acta Biologica Szegediensis, V60, P183; PEREGRINE P, 1991, AM ANTIQUITY, V56, P66, DOI 10.2307/280973; PITTS FR, 1965, PROF GEOGR, V17, P15, DOI 10.1111/j.0033-0124.1965.015_m.x; PITTS FR, 1979, SOC NETWORKS, V1, P285, DOI 10.1016/0378-8733(78)90025-4; Polla B, 1960, POHREBISKA STARSEJ D, VI, P299; Quinn C.P., 2017, THESIS U MICHIGAN AN; Raczky P., 2007, LENGYEL POLGAR RELAT, P49; Riebe D, 2016, THESIS; Riebe D, 2019, INTERDISCIPLINARIA A, V10, P113; Rivers R, 2016, CONNECTED CHALLENGES, P123; Roscoe P, 2000, J ARCHAEOL METHOD TH, V7, P79, DOI 10.1023/A:1009512726844; Saxe A.A., 1970, THESIS; Schalk E, 1992, GRABERFELD HERNADKAK; Shennan S, 1999, ANTIQUITY, V73, P352, DOI 10.1017/S0003598X0008830X; Shennan S, 1993, J EUROPEAN ARCHAEOLO, V1, P59, DOI DOI 10.1179/096576693800719347; Shennan SJ, 1995, BRONZE AGE COPPER PR; Sorensen M.L.S., 1997, J EUROPEAN ARCHAEOLO, V5, P93, DOI DOI 10.1179/096576697800703656; Sorensen MLS, 2008, EUR J ARCHAEOL, V11, P49, DOI 10.1177/1461957108101241; Szabo J, 1999, FRUH MITTELBRONZEZEI; Szekely Z, 2000, THRACO DACICA, V21, P103; Szekely Z, 1966, STUDII SI CERCETARI, V17, P125; Szentmiklosi A, 2011, ANTIQUITY, V85, P819, DOI 10.1017/S0003598X00068332; Treherne P., 1995, J EUROPEAN ARCHAEOLO, V3, P105, DOI DOI 10.1179/096576695800688269; Vazsonyi a, 1973, MAGYAR VIZSZABALYOZA; Verhagen P, 2019, COMPUT SOC SCI, P217, DOI 10.1007/978-3-030-04576-0_11	94	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238526	10.1371/journal.pone.0238526	http://dx.doi.org/10.1371/journal.pone.0238526			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9MU	32915829	gold, Green Published			2022-12-26	WOS:000571887500022
J	Gargot, T; Asselborn, T; Pellerin, H; Zammouri, I; Anzalone, SM; Casteran, L; Johal, W; Dillenbourg, P; Cohen, D; Jolly, C				Gargot, Thomas; Asselborn, Thibault; Pellerin, Hugues; Zammouri, Ingrid; Anzalone, Salvatore M.; Casteran, Laurence; Johal, Wafa; Dillenbourg, Pierre; Cohen, David; Jolly, Caroline			Acquisition of handwriting in children with and without dysgraphia: A computational approach	PLOS ONE			English	Article							DEVELOPMENTAL DYSGRAPHIA; MOTOR; WRITERS; MEMORY; SKILLS	Handwriting is a complex skill to acquire and it requires years of training to be mastered. Children presenting dysgraphia exhibit difficulties automatizing their handwriting. This can bring anxiety and can negatively impact education. 280 children were recruited in schools and specialized clinics to perform the Concise Evaluation Scale for Children's Handwriting (BHK) on digital tablets. Within this dataset, we identified children with dysgraphia. Twelve digital features describing handwriting through different aspects (static, kinematic, pressure and tilt) were extracted and used to create linear models to investigate handwriting acquisition throughout education. K-means clustering was performed to define a new classification of dysgraphia. Linear models show that three features only (two kinematic and one static) showed a significant association to predict change of handwriting quality in control children. Most kinematic and statics features interacted with age. Results suggest that children with dysgraphia do not simply differ from ones without dysgraphia by quantitative differences on the BHK scale but present a different development in terms of static, kinematic, pressure and tilt features. The K-means clustering yielded 3 clusters (Ci). Children in C1 presented mild dysgraphia usually not detected in schools whereas children in C2 and C3 exhibited severe dysgraphia. Notably, C2 contained individuals displaying abnormalities in term of kinematics and pressure whilst C3 regrouped children showing mainly tilt problems. The current results open new opportunities for automatic detection of children with dysgraphia in classroom. We also believe that the training of pressure and tilt may open new therapeutic opportunities through serious games.	[Gargot, Thomas; Pellerin, Hugues; Zammouri, Ingrid; Cohen, David] AP HP, Psychiat Enfant & Adolescent, Pitie Salpetriere Charles Foix, Paris, France; [Gargot, Thomas; Cohen, David] Sorbonne Univ, ISIR, Paris, France; [Gargot, Thomas; Anzalone, Salvatore M.] Paris 8 Univ, TIM, CHART Lab EA 4004, St Denis, France; [Asselborn, Thibault; Dillenbourg, Pierre] EPFL Univ, CHILI Lab, Route Cantonale, Lausanne, Switzerland; [Casteran, Laurence] Grenoble Hosp, Reference Ctr Speech & Learning Disorders, Grenoble, France; [Johal, Wafa] Univ New South Wales, Sidney, BC, Canada; [Jolly, Caroline] Univ Grenoble Alpes, LPNC, Grenoble, France; [Jolly, Caroline] CNRS, LPNC UMR 5105, Grenoble, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Gargot, T (corresponding author), AP HP, Psychiat Enfant & Adolescent, Pitie Salpetriere Charles Foix, Paris, France.; Gargot, T (corresponding author), Sorbonne Univ, ISIR, Paris, France.; Gargot, T (corresponding author), Paris 8 Univ, TIM, CHART Lab EA 4004, St Denis, France.	thomas.gargot@etud.univ-paris8.fr	GARGOT, Thomas/AAX-5974-2020; Jolly, Caroline/HGB-8098-2022; Gargot, Thomas/ABI-1939-2020	Jolly, Caroline/0000-0002-5726-4184; Gargot, Thomas/0000-0003-1460-5820; Johal, Wafa/0000-0001-9118-0454	Swiss National Science Foundation through the National Center of Competence in Research Robotics; Assistance Publique Hopitaux de Paris; Centre National de la Recherche Scientifique (CNRS); ANR Grant [ANR-19-CE19-0029]; SNSF; Paris 8 University	Swiss National Science Foundation through the National Center of Competence in Research Robotics; Assistance Publique Hopitaux de Paris; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); ANR Grant(French National Research Agency (ANR)); SNSF(Swiss National Science Foundation (SNSF)); Paris 8 University	We would like to thank the Swiss National Science Foundation for supporting this project through the National Center of Competence in Research Robotics. We would also like to thank the Assistance Publique Hopitaux de Paris, the Paris 8 University and the Centre National de la Recherche Scientifique (CNRS) for financial support and the ANR Grant (ANR-19-CE19-0029) and the SNSF for support of the project IReCheck.	Accardo AP, 2013, HUM MOVEMENT SCI, V32, P136, DOI 10.1016/j.humov.2012.10.004; Asselborn T, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0115-z; Asselborn T, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0049-x; Association A.P., 2013, DIAGNOSTIC STAT MANU; Barnett AL, 2009, BRIT J EDUC PSYCHOL, V1, P137, DOI [10.1348/000709909x421937, DOI 10.1348/000709909X421937]; Berninger VW, 1997, J EDUC PSYCHOL, V89, P652, DOI 10.1037/0022-0663.89.4.652; BLOTE AW, 1991, PERCEPT MOTOR SKILL, V72, P983, DOI 10.2466/PMS.72.3.983-994; BOURDIN B, 1994, INT J PSYCHOL, V29, P591, DOI 10.1080/00207599408248175; Bourdin B, 2000, READ WRIT, V13, P183, DOI 10.1023/A:1026458102685; Charles M., 2003, BHK ECHELLE EVALUATI; Chartrel E, 2008, LEARN INSTR, V18, P537, DOI 10.1016/j.learninstruc.2007.11.003; Danna J, 2016, TRAITE NEUROLINGUIST; de Ajuriaguerra J, 1971, ECRITURE ENFANT DELA; DEUEL RK, 1995, J CHILD NEUROL, V10, pS6, DOI 10.1177/08830738950100S103; Feder KP, 2007, DEV MED CHILD NEUROL, V49, P312, DOI 10.1111/j.1469-8749.2007.00312.x; GRAHAM S, 1990, J EDUC PSYCHOL, V82, P781, DOI 10.1037/0022-0663.82.4.781; GROFF PJ, 1964, ELEM SCHOOL J, V65, P92, DOI 10.1086/460187; Grossard C, 2017, COMPUT EDUC, V113, P195, DOI 10.1016/j.compedu.2017.05.002; Guilbert J, 2018, HUMAN MOVEMENT SCI; Hamstra-Bletz L., 1987, CONCISE EVALUATION S, V1; Harris PG., 2012, J DIGITAL INVESTIGAT, DOI 10.2307/j.ctt1t89jf5; Maeland A.F., 1991, DEV GRAPHIC SKILLS R, P179; McCutchen D, 2011, J WRIT RES, V3, P51, DOI 10.17239/jowr-2011.03.01.3; MCHALE K, 1992, AM J OCCUP THER, V46, P898, DOI 10.5014/ajot.46.10.898; Mekyska J, 2017, IEEE T HUM-MACH SYST, V47, P235, DOI 10.1109/THMS.2016.2586605; Pagliarini E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05105-6; Rosenblum Sara, 2006, Pediatr Rehabil, V9, P404, DOI 10.1080/13638490600667964; Rueckriegel SM, 2008, INT J DEV NEUROSCI, V26, P655, DOI 10.1016/j.ijdevneu.2008.07.015; Sassoon R., 1989, COMPUT RECOGN HUM PR, P287, DOI [10.1142/9789814434195_0020, DOI 10.1142/9789814434195_0020]; Smits-Engelsman BCM, 2001, HUM MOVEMENT SCI, V20, P161, DOI 10.1016/S0167-9457(01)00033-1; Van Galen GP, 1998, ACTA PSYCHOL, V100, P195, DOI 10.1016/S0001-6918(98)00034-1; Vinter A, 2010, LEARN INSTR, V20, P476, DOI 10.1016/j.learninstruc.2009.07.001; Wallen M., 2006, HAND FUNCTION CHILD, V2nd, P217, DOI DOI 10.1016/B978-032303186-8.50014-9	33	17	17	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0237575	10.1371/journal.pone.0237575	http://dx.doi.org/10.1371/journal.pone.0237575			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9MU	32915793	Green Published, gold			2022-12-26	WOS:000571887500153
J	Masters, NB; Shih, SF; Bukoff, A; Akel, KB; Kobayashi, LC; Miller, AL; Harapan, H; Lu, YH; Wagner, AL				Masters, Nina B.; Shih, Shu-Fang; Bukoff, Allen; Akel, Kaitlyn B.; Kobayashi, Lindsay C.; Miller, Alison L.; Harapan, Harapan; Lu, Yihan; Wagner, Abram L.			Social distancing in response to the novel coronavirus (COVID-19) in the United States	PLOS ONE			English	Article							VACCINATION; HEALTH	In order to reduce the spread of SARS-CoV-2, much of the US was placed under social distancing guidelines during March 2020. We characterized risk perceptions and adherence to social distancing recommendations in March 2020 among US adults aged 18+ in an online survey with age and gender quotas to match the general US population (N = 713). We used multivariable logistic and linear regression to estimate associations between age (by generational cohort) and these outcomes. The median perceived risk of infection with COVID-19 within the next month was 32%, and 65% of individuals were practicing more social distancing than before the outbreak. Baby Boomers had lower perceived risk than Millennials (-10.6%, 95% CI: -16.2%, -5.0%), yet were more frequently social distancing (OR = 1.64; 95% CI: 1.05, 2.56). Public health outreach should focus on raising compliance with social distancing recommendations, especially among high risk groups. Efforts to address risk perceptions alone may be inadequate.	[Masters, Nina B.; Akel, Kaitlyn B.; Kobayashi, Lindsay C.; Wagner, Abram L.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Shih, Shu-Fang] Univ Michigan, Dept Hlth Management & Policy, Ann Arbor, MI USA; [Miller, Alison L.] Univ Michigan, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI USA; [Harapan, Harapan] Univ Syiah Kuala, Sch Med, Med Res Unit, Banda Aceh, Indonesia; [Harapan, Harapan] Univ Syiah Kuala, Trop Dis Ctr, Sch Med, Banda Aceh, Indonesia; [Harapan, Harapan] Univ Syiah Kuala, Dept Microbiol, Sch Med, Banda Aceh, Indonesia; [Harapan, Harapan] Indonesia Univ Syiah Kuala, Banda Aceh, Indonesia; [Lu, Yihan] Fudan Univ, Dept Epidemiol, Key Lab Publ Hlth Safety Minist Educ, Shanghai, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Universitas Syiah Kuala; Universitas Syiah Kuala; Universitas Syiah Kuala; Fudan University	Wagner, AL (corresponding author), Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA.	awag@umich.edu	Harapan, Harapan/I-8741-2016	Harapan, Harapan/0000-0001-7630-8413; Akel, Kaitlyn/0000-0002-7236-3252; Wagner, Abram/0000-0003-4691-7802	National Institute Of Allergy And Infectious Diseases of the National Institutes of Health [K01AI137123]	National Institute Of Allergy And Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by an award to ALW the National Institute Of Allergy And Infectious Diseases of the National Institutes of Health under Award Number K01AI137123 (https://www.niaid.nih.gov/).The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarracin D, 2018, ANNU REV PSYCHOL, V69, P299, DOI 10.1146/annurev-psych-122216-011911; Alsan M, 2018, Q J ECON, V133, P407, DOI 10.1093/qje/qjx029; [Anonymous], 1982, JUDGMENT UNCERTAINTY; [Anonymous], 2020, CTR DIS CONTROL PREV, V69, P1, DOI DOI 10.15585/mmwr.ss6904a1; Arceneaux M., 2020, NBC NEWS; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Brownstein Ronald, 2020, ATLANTIC; Burke D., 2020, PROPUBLICA; Cavanaugh AM, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.4937; Centers for Disease Control and Prevention, 2020, PROT YOURS; Centers for Disease Control and Prevention, 2020, COR DIS 2019 SOC DIS; Centers for Disease Control and Prevention, 2019, 2019 BRFSS QUEST; Coppins, 2020, ATLANTIC; Devakumar D, 2020, LANCET, V395, P1194, DOI 10.1016/S0140-6736(20)30792-3; Dimock M., 2019, PEW RES CTR, V17, P1; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Ferrante G, 2011, EUR J EPIDEMIOL, V26, P211, DOI 10.1007/s10654-011-9576-3; Ferrer RA, 2015, CURR OPIN PSYCHOL, V5, P85, DOI 10.1016/j.copsyc.2015.03.012; Foster BR, 2020, US NEWS WEEKLY REPOR; Gidengil CA, 2012, AM J PUBLIC HEALTH, V102, P672, DOI 10.2105/AJPH.2011.300407; Gilovich G, 2002, HEURISTICS BIASES PS; Harapan H, 2020, J INFECT PUBLIC HEAL, V13, P667, DOI 10.1016/j.jiph.2020.03.019; Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3; IM EO, 2011, CIN-COMPUT INFORM NU, V29, P381, DOI DOI 10.1097/NCN.0B013E3181F9DC45; Jamison AM, 2019, SOC SCI MED, V221, P87, DOI 10.1016/j.socscimed.2018.12.020; Kahneman D., 2011, THINKING FAST SLOW; Kimball A, 2020, MMWR-MORBID MORTAL W, V69, P377, DOI 10.15585/mmwr.mm6913e1; LaCour M, 2020, VACCINE, V38, P3790, DOI 10.1016/j.vaccine.2020.02.052; Lau JTF, 2003, J EPIDEMIOL COMMUN H, V57, P864, DOI 10.1136/jech.57.11.864; Martina M, 2020, ST LOUIS POST D 0608, P2; Office of Governor Gavin Newsom, 2020, GOV GAV NEWS ISS STA; Peretti-Watel P, 2013, EUROSURVEILLANCE, V18, P15, DOI 10.2807/1560-7917.ES2013.18.44.20623; Perna M., 2020, FORBES; Pinsker J., 2020, ATLANTIC; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Secon Holly, 2020, BUSINESS INSIDER; Sokol R, 2015, EVAL HEALTH PROF, V38, P518, DOI 10.1177/0163278715605883; WHO-China Joint Mission Members, 2020, REP WHO CHIN JOINT M; Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020; Wong CM, 2020, HUFFINGTON POST; World Health Organization, 2020, COR DIS COVID 19 ADV; Wronski L, 2017, SURVEYMONKEY; Wu Z, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI [10.1001/jama.2020.2648, DOI 10.1001/JAMA.2020.2648]	43	66	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0239025	10.1371/journal.pone.0239025	http://dx.doi.org/10.1371/journal.pone.0239025			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9MU	32915884	gold, Green Published			2022-12-26	WOS:000571887500052
J	Janssen, EM; Mourits, MCM; van der Fels-Klerx, HJ; Lansink, AGJMO				Janssen, E. M.; Mourits, M. C. M.; van der Fels-Klerx, H. J.; Lansink, A. G. J. M. Oude			Factors underlying Dutch farmers' intentions to adapt their agronomic management to reduce Fusarium species infection in wheat	PLOS ONE			English	Article							EXPECTANCY-VALUE MUDDLE; HEAD BLIGHT; DEOXYNIVALENOL CONTENT; INTEGRATED STRATEGIES; PLANNED BEHAVIOR; REASONED ACTION; CONTAMINATION; MYCOTOXIN; BELIEFS; GRAIN	Infection of wheat byFusariumspecies can lead to Fusarium Head Blight (FHB) and mycotoxin contamination, thereby reducing food quality and food safety, and leading to economic losses. Agronomic management through the implementation of various pre-harvest measures can reduce the probability ofFusariumspp. infection in the wheat field. To design interventions that could stimulate wheat farmers to (further) improve their agronomic management to reduce FHB, it is key to understand farmers' behaviour towards adapting their management. The aim of this paper was to understand the intention, underlying behavioural constructs, and beliefs of Dutch wheat farmers to adapt their agronomic management to reduce FHB and mycotoxin contamination in wheat, applying the Theory of Planned Behaviour (TPB). Data were collected from 100 Dutch wheat farmers via a questionnaire. The standard TPB analysis was extended with an assessment of the robustness of the belief results to account for the statistical validity of the analysis on TPB beliefs (i.e. to address the so-called expectancy-value muddle). Forty-six percent of the farmers had a positive intention to change their management in the next 5 years. The two behavioural constructs significantly related to this intention were attitude and social norm, whereas association with the perceived behavioural control construct was insignificant indicating that farmers did not perceive any barriers to change their behaviour. Relevant attitudinal beliefs indicated specific attributes of wheat, namely yield, quality and safety (lower mycotoxin contamination). This indicates that strengthening these beliefs-by demonstrating that a change in management will result in a higher yield and quality and lower mycotoxin levels-will result in a stronger attitude and, subsequently, a higher intention to change management. Interventions to strengthen these beliefs should preferably go by the most important referents for social norms, which were the buyers and the farmer cooperatives in this study.	[Janssen, E. M.; Mourits, M. C. M.; van der Fels-Klerx, H. J.; Lansink, A. G. J. M. Oude] Wageningen Univ & Res, Business Econ Grp, Wageningen, Netherlands; [van der Fels-Klerx, H. J.] Wageningen Univ & Res, Wageningen Food Safety Res WFSR, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Janssen, EM; Mourits, MCM (corresponding author), Wageningen Univ & Res, Business Econ Grp, Wageningen, Netherlands.	Esmee.Janssen@wur.nl; Monique.Mourits@wur.nl	Oude Lansink, Alfons GJM/H-8840-2012	Oude Lansink, Alfons GJM/0000-0002-9273-6044; Mourits, Monique/0000-0001-5213-2927	European Union's Horizon 2020 research and innovation programme [678012]	European Union's Horizon 2020 research and innovation programme	This study is performed as part of the MyToolbox project, which received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 678012.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I., 2006, CONSTRUCTING THEORY; Alim M, 2016, FOOD SAFETY BASIC CO, P33; [Anonymous], 2006, 2006583EC; Arcella D, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.4972; Bagheri A, 2019, J ENVIRON MANAGE, V248, DOI 10.1016/j.jenvman.2019.109291; Bechini L, 2015, ITAL J AGRON, V10, P178, DOI 10.4081/ija.2015.663; Beyer M, 2006, J PLANT DIS PROTECT, V113, P241, DOI 10.1007/BF03356188; Blandino M, 2017, EUR J AGRON, V85, P12, DOI 10.1016/j.eja.2017.01.001; Blandino M, 2012, FIELD CROP RES, V133, P139, DOI 10.1016/j.fcr.2012.04.004; Breukers A, 2012, PHYTOPATHOLOGY, V102, P609, DOI 10.1094/PHYTO-06-11-0178; Bruijnis M, 2013, LIVEST SCI, V155, P103, DOI 10.1016/j.livsci.2013.04.005; CBS, 2018, ACT BIOL LANDB; Chan DKC, 2015, PSYCHOL SPORT EXERC, V16, P164, DOI 10.1016/j.psychsport.2014.03.002; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; D'Angelo DL, 2014, PLANT DIS, V98, P1387, DOI 10.1094/PDIS-01-14-0091-RE; Edwards SG, 2004, TOXICOL LETT, V153, P29, DOI 10.1016/j.toxlet.2004.04.022; Elliott MA, 2005, TRANSPORT RES F-TRAF, V8, P459, DOI 10.1016/j.trf.2005.08.002; Fishbein M, 2003, COMMUN THEOR, V13, P164, DOI 10.1111/j.1468-2885.2003.tb00287.x; Francis J., 2004, CONSTRUCTING QUESTIO, V5th ed.; Franz E, 2009, J FOOD PROTECT, V72, P2170, DOI 10.4315/0362-028X-72.10.2170; French DP, 2003, BRIT J HEALTH PSYCH, V8, P37, DOI 10.1348/135910703762879192; Hankins M, 2000, PSYCHOL HEALTH, V15, P151, DOI 10.1080/08870440008400297; Hardeman W, 2013, BRIT J HEALTH PSYCH, V18, P122, DOI 10.1111/j.2044-8287.2012.02095.x; Hijbeek R, 2018, SOIL USE MANAGE, V34, P85, DOI 10.1111/sum.12401; Hyland JJ, 2018, LAND USE POLICY, V78, P562, DOI 10.1016/j.landusepol.2018.07.006; Inch SA, 2003, PLANT DIS, V87, P282, DOI 10.1094/PDIS.2003.87.3.282; Janssen EM, 2019, CROP PROT, V122, P9, DOI 10.1016/j.cropro.2019.04.005; Jemberu WT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138363; Kabak B, 2006, CRIT REV FOOD SCI, V46, P593, DOI 10.1080/10408390500436185; Knutsen HK, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.4718; Krska R, 2016, WORLD MYCOTOXIN J, V9, P487, DOI 10.3920/WMJ2016.2136; Liu C, 2018, TOXINS, V10, DOI 10.3390/toxins10070267; McMullen M, 2008, CEREAL RES COMMUN, V36, P563, DOI 10.1556/CRC.36.2008.Suppl.B.45; McMullen M, 2012, PLANT DIS, V96, P1712, DOI 10.1094/PDIS-03-12-0291-FE; Montano D.M., 2008, HLTH BEHAV HLTH ED T, P67; Newton JD, 2014, PSYCHOL HEALTH, V29, P1458, DOI 10.1080/08870446.2014.950657; Newton JD, 2012, PSYCHOL HEALTH, V27, P588, DOI 10.1080/08870446.2011.611244; PARRY DW, 1995, PLANT PATHOL, V44, P207, DOI 10.1111/j.1365-3059.1995.tb02773.x; Pirgozliev SR, 2003, EUR J PLANT PATHOL, V109, P731, DOI 10.1023/A:1026034509247; Rose DC, 2019, LAND USE POLICY, V81, P834, DOI 10.1016/j.landusepol.2018.11.001; RUTTER DR, 1989, BRIT J SOC PSYCHOL, V28, P39, DOI 10.1111/j.2044-8309.1989.tb00844.x; Shah L, 2018, PLANT PATHOL, V67, P532, DOI 10.1111/ppa.12785; Sok J, 2015, FOOD POLICY, V57, P40, DOI 10.1016/j.foodpol.2015.09.006; Sullivan BO, 2008, BRIT J HEALTH PSYCH, V13, P789, DOI 10.1348/135910708X278306; Sutton S, 1998, J APPL SOC PSYCHOL, V28, P1317, DOI 10.1111/j.1559-1816.1998.tb01679.x; Torres AM, 2019, WORLD MYCOTOXIN J, V12, P333, DOI 10.3920/WMJ2019.2438; van der Fels-Klerx HJ, 2014, RISK ANAL, V34, P380, DOI 10.1111/risa.12103; van der Fels-Klerx HJ, 2012, FOOD ADDIT CONTAM A, V29, P1716, DOI 10.1080/19440049.2012.685891; van Dijk WFA, 2016, LAND USE POLICY, V59, P207, DOI 10.1016/j.landusepol.2016.09.003; Vogelgsang S, 2019, EUR J AGRON, V105, P62, DOI 10.1016/j.eja.2019.01.002; Wauters E, 2010, LAND USE POLICY, V27, P86, DOI 10.1016/j.landusepol.2009.02.009; Wegulo SN, 2015, CROP PROT, V73, P100, DOI 10.1016/j.cropro.2015.02.025	53	3	3	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0237460	10.1371/journal.pone.0237460	http://dx.doi.org/10.1371/journal.pone.0237460			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9ME	32911506	Green Published, gold			2022-12-26	WOS:000571885900002
J	Li, WG; Cai, CH; Cai, XC; Chen, SC; van der Veen, S; Yin, YP				Li, Wen-Ge; Cai, Chang-Hui; Cai, Xin-Chao; Chen, Shao-Chun; van der Veen, Stijn; Yin, Yue-Ping			Enhancing gonorrhea surveillance in China by testing females in gynecology clinics: Lessons learned from a pilot survey	PLOS ONE			English	Article								Objectives China has a high burden of gonorrhea, but an imbalanced male-to-female (M/F) ratio of reported cases. Therefore, the prevalence of gonorrhea in China may be underestimated due to inadequate testing of potentially infected females. The objective of this study is to investigate the cause of this imbalanced M/F ratio and develop strategies to enhance gonorrhea surveillance, particularly among females. Methods The national center for STD control (NCSTDC) of China CDC collected data in Zhongshan city over the year 2018 from the National Notifiable Disease Report System (NNDRS) and the Hospital and Laboratory Information Systems (HIS and LIS) that obtains information from 24 hospitals. Results Analysis of 1,542 reported cases of gonorrhea and the case distribution among different hospitals showed that most of the female cases (80.31%) were reported by gynecological clinics. The M/F ratio of reported cases varied between different hospitals and was dependent on the intensity of testing of females by their gynecological clinics. Conclusions This study showed a significant correlation between M/F ratios and the relative contribution of female gonorrhea testing, especially in gynecology clinics. Enhancing gonorrhea testing among females should be advocated to improve surveillance in China.	[Li, Wen-Ge] Sun Yat Sen Univ, Zhongshan Affiliated Hosp, Zhongshan, Peoples R China; [Cai, Chang-Hui] Second Peoples Hosp Zhongshan City, Dept Outpatient, Zhongshan, Peoples R China; [Cai, Xin-Chao] Zhongshan Hosp Tradit Chinese Med, Dept Outpatient, Zhongshan, Peoples R China; [Chen, Shao-Chun; Yin, Yue-Ping] Chinese Acad Med Sci & Peking Union Med Coll, Inst Dermatol, Nanjing, Peoples R China; [Chen, Shao-Chun; Yin, Yue-Ping] China Ctr Dis Control & Prevent, Natl Ctr STD Control, Nanjing, Peoples R China; [van der Veen, Stijn] Zhejiang Univ, Sch Med, Dept Microbiol & Parasitol, Hangzhou, Peoples R China; [van der Veen, Stijn] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Dermatol, Hangzhou, Peoples R China; [van der Veen, Stijn] Zhejiang Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, Sch Med, Hangzhou, Peoples R China	Sun Yat Sen University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Peking Union Medical College; Chinese Center for Disease Control & Prevention; Zhejiang University; Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University	Chen, SC (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Dermatol, Nanjing, Peoples R China.; Chen, SC (corresponding author), China Ctr Dis Control & Prevent, Natl Ctr STD Control, Nanjing, Peoples R China.	chensc@ncstdlc.org		Chen, Shaochun/0000-0002-6447-928X; van der Veen, Stijn/0000-0002-8176-391X	Chinese Academy of Medical Sciences Initiative for Innovative Medicine [2018-I2M-3-006]; Jiangsu Natural Science Foundation [BK20171133]; Key Technology Program of Zhongshan [2017B1064]	Chinese Academy of Medical Sciences Initiative for Innovative Medicine; Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Key Technology Program of Zhongshan	This work was supported by grants from the Chinese Academy of Medical Sciences Initiative for Innovative Medicine (No. 2018-I2M-3-006), the Jiangsu Natural Science Foundation (No. BK20171133) and the Key Technology Program of Zhongshan (No. 2017B1064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Shao-Chun Chen and Yue-Ping Yin were employees in Chinese Academy of Medical Sciences and received salaries from the institute.	[Anonymous], 2019, CRISPR J, V2, P65; Barrow RY, 2020, MMWR RECOMM REP, V68, P1, DOI 10.15585/mmwr.rr6805a1; Centers for Disease Control and Prevention, 2018, SEX TRANSM DIS SURV; Chen SC, 2016, J ANTIMICROB CHEMOTH, V71, P92, DOI 10.1093/jac/dkv321; Miao F, 2020, J MATER SCI TECHNOL, V53, P163, DOI 10.1016/j.jmst.2020.02.075; Yue X-L., 2020, INT J DERMATOL VENER, V3, P86, DOI [10.1097/JD9.0000000000000099, DOI 10.1097/JD9.0000000000000099]	6	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238710	10.1371/journal.pone.0238710	http://dx.doi.org/10.1371/journal.pone.0238710			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911519	Green Published, gold			2022-12-26	WOS:000571885900007
J	Tong, JF; Krieger, JR; Taylor, P; Bagshaw, R; Kang, J; Jeedigunta, S; Wybenga-Groot, LE; Zhang, W; Badr, H; Mirhadi, S; Pham, NA; Coyaud, E; Yu, M; Li, M; Cabanero, M; Raught, B; Maynes, JT; Hawkins, C; Tsao, MS; Moran, MF				Tong, Jiefei; Krieger, Jonathan R.; Taylor, Paul; Bagshaw, Rick; Kang, Jae; Jeedigunta, Swathi; Wybenga-Groot, Leanne E.; Zhang, Wen; Badr, Heba; Mirhadi, Shideh; Nhu-An Pham; Coyaud, Etienne; Yu, Man; Li, Ming; Cabanero, Michael; Raught, Brian; Maynes, Jason T.; Hawkins, Cynthia; Tsao, Ming Sound; Moran, Michael F.			Cancer proteome and metabolite changes linked to SHMT2	PLOS ONE			English	Article							RECEPTOR ENDOCYTOSIS; SERINE CATABOLISM; MITOCHONDRIAL; REVEAL; EGFR	Serine hydroxymethyltransferase 2 (SHMT2) converts serine plus tetrahydrofolate (THF) into glycine plus methylene-THF and is upregulated at the protein level in lung and other cancers. In order to better understand the role of SHMT2 in cancer a model system of HeLa cells engineered for inducible over-expression or knock-down of SHMT2 was characterized for cell proliferation and changes in metabolites and proteome as a function of SHMT2. Ectopic over-expression of SHMT2 increased cell proliferationin vitroand tumor growthin vivo. Knockdown of SHMT2 expressionin vitrocaused a state of glycine auxotrophy and accumulation of phosphoribosylaminoimidazolecarboxamide (AICAR), an intermediate of folate/1-carbon-pathway-dependentde novopurine nucleotide synthesis. Decreased glycine in the HeLa cell-based xenograft tumors with knocked down SHMT2 was potentiated by administration of the anti-hyperglycinemia agent benzoate. However, tumor growth was not affected by SHMT2 knockdown with or without benzoate treatment. Benzoate inhibited cell proliferationin vitro, but this was independent of SHMT2 modulation. The abundance of proteins of mitochondrial respiration complexes 1 and 3 was inversely correlated with SHMT2 levels. Proximity biotinylationin vivo(BioID) identified 48 mostly mitochondrial proteins associated with SHMT2 including the mitochondrial enzymes Acyl-CoA thioesterase (ACOT2) and glutamate dehydrogenase (GLUD1) along with more than 20 proteins from mitochondrial respiration complexes 1 and 3. These data provide insights into possible mechanisms through which elevated SHMT2 in cancers may be linked to changes in metabolism and mitochondrial function.	[Tong, Jiefei; Taylor, Paul; Jeedigunta, Swathi; Zhang, Wen; Badr, Heba; Mirhadi, Shideh; Yu, Man; Hawkins, Cynthia; Moran, Michael F.] Hosp Sick Children, Program Cell Biol, Toronto, ON, Canada; [Krieger, Jonathan R.; Taylor, Paul; Wybenga-Groot, Leanne E.] Hosp Sick Children, SPARC BioCtr, Toronto, ON, Canada; [Bagshaw, Rick; Maynes, Jason T.] Hosp Sick Children, Program Mol Med, Toronto, ON, Canada; [Kang, Jae; Jeedigunta, Swathi; Zhang, Wen; Mirhadi, Shideh; Moran, Michael F.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Nhu-An Pham; Coyaud, Etienne; Li, Ming; Raught, Brian; Tsao, Ming Sound; Moran, Michael F.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Cabanero, Michael; Tsao, Ming Sound] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Raught, Brian; Tsao, Ming Sound] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Krieger, Jonathan R.] Bioinformat Solut Inc, Waterloo, ON, Canada; [Taylor, Paul] Rapid Novor Inc, Kitchener, ON, Canada; [Zhang, Wen] Zymeworks Inc, Vancouver, BC, Canada; [Coyaud, Etienne] Univ Lille, PRISM, Lille, France	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; Universite de Lille - ISITE; Universite de Lille	Moran, MF (corresponding author), Hosp Sick Children, Program Cell Biol, Toronto, ON, Canada.; Moran, MF (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.; Moran, MF (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.	m.moran@utoronto.ca	Tsao, Ming-Sound/M-3503-2017; COYAUD, Etienne/ABD-9726-2020; Tsao, Ming Sound/AFQ-7332-2022; Moran, Michael/GYD-3631-2022	COYAUD, Etienne/0000-0002-5893-4557; Tsao, Ming Sound/0000-0002-9160-5405; Pham, Nhu-An/0000-0003-3063-0292	Canadian Cancer Society, Innovation Program; Canada Foundation for Innovation; Genome Canada's Pan Canadian Proteomics Centre; Garron Family Cancer Centre, Hospital for Sick Children; Canada Research Chair	Canadian Cancer Society, Innovation Program; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada's Pan Canadian Proteomics Centre; Garron Family Cancer Centre, Hospital for Sick Children; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by grants to MFM from Canadian Cancer Society, Innovation Program; Canada Foundation for Innovation; Genome Canada's Pan Canadian Proteomics Centre; and the Garron Family Cancer Centre, Hospital for Sick Children. MFM was supported by a Canada Research Chair.	Adam-Vizi V, 2006, TRENDS PHARM SCI; Amelio I, 2014, TRENDS BIOCHEM SCI, V39, P191, DOI 10.1016/j.tibs.2014.02.004; Anderson DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005839; Cho H, 2014, BMC CANC; Cox J, 2008, NAT BIOTECHNOL; Cox J., 2011, J PROTEOME RES; Cuyas E, 2018, ONCOGENE, V37, P963, DOI 10.1038/onc.2017.367; DeNicola GM, 2015, NAT GENET; Ducker GS, 2017, P NATL ACAD SCI USA, V114, P11404, DOI 10.1073/pnas.1706617114; Figeys D, 2001, METHODS; Franco R, 2007, J BIOL CHEM; Giardina G, 2018, FEBS J; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hughes CS, 2017, J PROTEOME RES; Ivanisevic J, 2013, ANAL CHEM; Jain M, 2012, SCIENCE 85; Kim DI, 2014, P NATL ACAD SCI USA, V111, pE2453, DOI 10.1073/pnas.1406459111; Kim D, 2015, NATURE, V520, P363, DOI 10.1038/nature14363; Lambert JP, 2015, J PROTEOMICS; Li L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6469; Lucas S, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800036; MacLean B, 2010, BIOINFORMATICS; Markiel A, 2003, GENOME RES; Minton DR, 2018, MOL CELL, V69, P610, DOI 10.1016/j.molcel.2018.01.024; Miyo M, 2017, ONCOL REP; Morscher RJ, 2018, NATURE, V554, P128, DOI 10.1038/nature25460; Murphy MP, 2009, BIOCH J; Navab R, 2009, NEOPLASIA; Ning SL, 2018, GASTROENT RES PRACT, V2018, DOI 10.1155/2018/4369253; Noguchi K, 2018, ONCOL LETT; Paone A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.482; Paulo JA, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600319; Pluskal T, 2010, MOL BIOSYST, V6, P182, DOI 10.1039/b908784b; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Rohlena J, 2013, CURR PHARM BIOTECHNO, V14, P377, DOI 10.2174/1389201011314030011; Roux KJ, 2012, J CELL BIOL; Sapcariu SC, 2014, METHODSX, V1, P74, DOI 10.1016/j.mex.2014.07.002; Scott JD, 2009, SCIENCE; Shioya A, 2018, INT J MED SCI; Toledo-Sherman L., 2004, CLIN PROTEOM, V1, P45; Tong JF, 2014, MOL CELL PROTEOMICS, V13, P1644, DOI 10.1074/mcp.M114.038596; Tong JF, 2009, MOL CELL PROTEOMICS, V8, P2131, DOI 10.1074/mcp.M900148-MCP200; Toth B., 1984, TOXICOL SCI; Tyanova S, 2016, NATURE METHODS; van Hove JLK, 2005, J INHERIT METAB DIS, V28, P651, DOI 10.1007/s10545-005-0033-x; Wei YH, 2015, MOL CANCER RES, V13, P1119, DOI 10.1158/1541-7786.MCR-14-0165-T; Wolff JA, 1986, AM J DIS CHILD; Ye JB, 2014, CANCER DISCOV, V4, P1406, DOI 10.1158/2159-8290.CD-14-0250; Yu M, 2013, TRANSL RES, V161, P165, DOI 10.1016/j.trsl.2012.10.011; Zhang LH, 2016, ONCOL REP, V36, P2489, DOI 10.3892/or.2016.5112; Zhang WC, 2012, CELL; Zheng H, 2013, CELL REP, V5, P180, DOI 10.1016/j.celrep.2013.08.025	52	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2020	15	9							e0237981	10.1371/journal.pone.0237981	http://dx.doi.org/10.1371/journal.pone.0237981			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR4MY	32903271	Green Published, gold			2022-12-26	WOS:000571539500010
J	Hernandez-Trejo, M; Samano, R; Chico-Barba, G; Pizano-Zarate, ML; Herrera-Gonzalez, NE				Hernandez-Trejo, Maria; Samano, Reyna; Chico-Barba, Gabriela; Luisa Pizano-Zarate, Maria; Estela Herrera-Gonzalez, Norma			Neonatal adiposity may increase plasmatic cytokines	PLOS ONE			English	Article							MATERNAL OBESITY; BODY-COMPOSITION; FETAL-GROWTH; FATTY-ACIDS; PREGNANCY; INFLAMMATION; SMOKING; MARKERS; BIRTH; BLOOD	Maternal health and nutritional status before and during gestation may affect neonates' immune system and energy balance as they develop. The objective of this study was to associate certain clinical markers of maternal adiposity (body mass index and gestational weight gain) and neonatal adiposity (birth weight, abdominal circumference, and waist/height index) with the levels of pro- and anti-inflammatory cytokines in umbilical cord blood at birth: IL-1 beta, IL-1R alpha, IL-4, IL-6, IL-10, IFN-gamma, and TNF-alpha. An exploratory cross-sectional study was conducted with a convenience sample of women from one hospital recruited shortly before giving birth through scheduled cesarean section. Of 31 the pregnant women who agreed to participate and met the inclusion criteria, twenty-nine newborns from these women were analyzed. Three cases of tobacco smoking during pregnancy were identified as an unexpected maternal risk factor and were included in the analysis. Typical of the population treated at this hospital, ten of our participants had diabetes during pregnancy, and nine of them had a pre-pregnancy BMI> 25. Non-parametric statistical analyses and a generalized linear model with gamma scale response with a log link were performed. Results: Correlation analyses, differences in medians, and a prediction model all showed positive and significant results between cytokine levels in cord blood and neonatal abdominal circumference, birth weight, and waist-height index. For maternal variables, smoking during pregnancy showed significant associations with cytokine levels in cord blood. Conclusion: This study found a variety of associations suggesting that increased neonatal adiposity increases pro-inflammatory cytokine levels at birth.	[Hernandez-Trejo, Maria] Secretaria Salud, Inst Nacl Perinatol, Neurobiol Desarrollo, Ciudad De Mexico, Mexico; [Samano, Reyna; Chico-Barba, Gabriela; Luisa Pizano-Zarate, Maria] Secretaria Salud, Inst Nacl Perinatol, Nutr & Bioprogramac, Ciudad De Mexico, Mexico; [Estela Herrera-Gonzalez, Norma] Inst Politecn Nacl, Escuela Super Med, Secc Posgrad & Invest, Plan San Luis & Diaz Miron S-N, Ciudad De Mexico, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Instituto Politecnico Nacional - Mexico	Hernandez-Trejo, M (corresponding author), Secretaria Salud, Inst Nacl Perinatol, Neurobiol Desarrollo, Ciudad De Mexico, Mexico.	maria.h.trejo72@gmail.com		Hernandez-Trejo, Maria/0000-0003-4821-4238				Al Mamun A, 2006, AM J EPIDEMIOL, V164, P317, DOI 10.1093/aje/kwj209; Almanzar G, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-57; [Anonymous], 2018, ENCUESTA NACIONAL DE; [Anonymous], 2016, J LARGE SCALE RES FA, V2, pA49; [Anonymous], 2016, DIAGN TRAT DIAB EMB; Aye ILMH, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.116186; Barbour LA, 2018, CLIN THER, V40, P1638, DOI 10.1016/j.clinthera.2018.08.007; Calder PC, 2011, EUR J PHARMACOL, V668, pS50, DOI 10.1016/j.ejphar.2011.05.085; Chahal N, 2017, NICOTINE TOB RES, V19, P789, DOI 10.1093/ntr/ntw324; Chen H, 2018, AM J RESP CELL MOL, V58, P366, DOI 10.1165/rcmb.2017-0206RC; Chen LW, 2018, INT J OBESITY, V42, P501, DOI 10.1038/ijo.2017.250; Christian LM, 2014, CYTOKINE, V70, P134, DOI 10.1016/j.cyto.2014.06.018; Crozier SR, 2010, AM J CLIN NUTR, V91, P1745, DOI 10.3945/ajcn.2009.29128; Crume TL, 2015, J CLIN ENDOCR METAB, V100, P1672, DOI 10.1210/jc.2014-2949; Denison FC, 2010, REPRODUCTION, V140, P373, DOI 10.1530/REP-10-0074; Dosch NC, 2016, J PEDIATR-US, V172, P20, DOI 10.1016/j.jpeds.2016.02.023; Draga P, 2014, SRP ARH CELOK LE, V142, P125, DOI [10.2298/SARH1402125P, DOI 10.2298/SARH1402125P]; Estampador AC, 2014, DIABETES CARE, V37, P1432, DOI 10.2337/dc13-2265; Future Trends in Colorectal Cancer Research, 1999, EUR J CANC PREV S1, V8, pS99; Heerwagen MJR, 2010, AM J PHYSIOL-REG I, V299, pR711, DOI 10.1152/ajpregu.00310.2010; Herrera E, 2006, HORM RES, V65, P59, DOI 10.1159/000091507; Herrera E, 2018, CURR DIABETES REP, V18, DOI 10.1007/s11892-018-0978-4; Howell KR, 2017, REPRODUCTION, V153, pR97, DOI [10.1530/REP-16-0495, 10.1530/rep-16-0495]; Hull HR, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.004; Jharap VV, 2017, EARLY HUM DEV, V108, P23, DOI 10.1016/j.earlhumdev.2017.03.006; Khodabandehloo H, 2016, TRANSL RES, V167, P228, DOI 10.1016/j.trsl.2015.08.011; Martorell R, 1988, ANTHROPOMETRIC STAND, V24, P425; McCloskey K, 2018, PEDIATR OBES, V13, P46, DOI 10.1111/ijpo.12187; Mitanchez D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181307; Olson-Chen C, 2017, AM J OBSTET GYNECOL, V216, pS449, DOI 10.1016/j.ajog.2016.11.511; Ornoy A, 2011, REPROD TOXICOL, V32, P205, DOI 10.1016/j.reprotox.2011.05.002; Pantham P, 2015, PLACENTA, V36, P709, DOI 10.1016/j.placenta.2015.04.006; Rodriguez-Rodriguez E, 2011, EUR J PEDIATR, V170, P35, DOI 10.1007/s00431-010-1260-1; Segovia SA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/418975; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Szabo AJ, 2019, MED HYPOTHESES, V122, P82, DOI 10.1016/j.mehy.2018.10.022; Tamashiro KLK, 2010, PHYSIOL BEHAV, V100, P560, DOI 10.1016/j.physbeh.2010.04.008; Vega-Sanchez R, 2010, BRIT J NUTR, V104, P1735, DOI 10.1017/S0007114510002825; Villar J, 2017, PEDIATR RES, V82, P305, DOI 10.1038/pr.2017.52; Vogelezang S, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.2843; Ward ZJ, 2017, NEW ENGL J MED, V377, P2145, DOI [10.1056/NEJMoa1703860, 10.1056/nejmoa1703860]; Zhang YE, 2018, CURR OPIN CELL BIOL, V51, P1, DOI 10.1016/j.ceb.2017.10.001	42	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238370	10.1371/journal.pone.0238370	http://dx.doi.org/10.1371/journal.pone.0238370			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886687	gold, Green Published			2022-12-26	WOS:000571064300036
J	Lazar, AN; Adams, H; Adger, WN; Nicholls, RJ				Lazar, Attila N.; Adams, Helen; Adger, W. Neil; Nicholls, Robert J.			Modelling household well-being and poverty trajectories: An application to coastal Bangladesh	PLOS ONE			English	Article							ECOSYSTEM SERVICES; COPING STRATEGIES; INCOME; SEASONALITY; DYNAMICS; POLICY; TRAPS; DIVERSIFICATION; MICROFINANCE; ADAPTATION	Resource-based livelihoods are uncertain and potentially unstable due to variability over time, including seasonal variation: this instability threatens marginalised populations who may fall into poverty. However, empirical understanding of trajectories of household well-being and poverty is limited. Here, we present a new household-level model of poverty dynamics based on agents and coping strategies-the Household Economy And Poverty trajectory (HEAP) model. HEAP is based on established economic and social insights into poverty dynamics, with a demonstration of the model calibrated with a qualitative and quantitative household survey in coastal Bangladesh. Economic activity in Bangladesh is highly dependent on natural resources; poverty is widespread; and there is high variability in ecosystem services at multiple temporal scales. The results show that long-term decreases in poverty are predicated more on the stability of, and returns from, livelihoods rather than their diversification. Access to natural resources and ecosystem service benefits are positively correlated with stable income and multidimensional well-being. Households that remain in poverty are those who experience high seasonality of income and are involved in small scale enterprises. Hence, seasonal variability in income places significant limits on natural resources providing routes out of poverty. Further, projected economic trends to 2030 lead to an increase in well-being and a reduction in poverty for most simulated household types.	[Lazar, Attila N.] Univ Southampton, Dept Geog & Environm Sci, Southampton, Hants, England; [Adams, Helen] Kings Coll London, Dept Geog, Strand Campus, London, England; [Adger, W. Neil] Univ Exeter, Coll Life & Environm Sci, Geog, Exeter, Devon, England; [Nicholls, Robert J.] Univ East Anglia, Tyndall Ctr Climate Change Res, Norwich, Norfolk, England	University of Southampton; University of London; King's College London; University of Exeter; University of East Anglia	Lazar, AN (corresponding author), Univ Southampton, Dept Geog & Environm Sci, Southampton, Hants, England.	a.lazar@soton.ac.uk	Nicholls, Robert James/G-3898-2010; Nicholls, Robert James/ABD-1481-2020; Lazar, Attila/D-4277-2017	Nicholls, Robert James/0000-0002-9715-1109; Nicholls, Robert James/0000-0002-9715-1109; Lazar, Attila/0000-0003-2033-2013	Ecosystem Services for Poverty Alleviation (ESPA) programme [NE-J002755-1]; Department for International Development (DFID); Economic and Social Research Council (ESRC); Natural Environment Research Council (NERC)	Ecosystem Services for Poverty Alleviation (ESPA) programme; Department for International Development (DFID); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work 'Assessing Health, Livelihoods, Ecosystem Services and Poverty Alleviation in Populous Deltas' (NE-J002755-1)' was funded by the Ecosystem Services for Poverty Alleviation (ESPA) programme. The ESPA programme is funded by the Department for International Development (DFID), the Economic and Social Research Council (ESRC) and the Natural Environment Research Council (NERC).	Adams H, 2016, SPATIAL TEMPORAL DYN, DOI [10.5255/UKDA-SN-852179, DOI 10.5255/UKDA-SN-8521792016]; Adams H, 2019, ECOLOGY SOC, V24, DOI [10.5751/ES-11165-240409, DOI 10.5751/ES-11165-24040931798644]; Adams H, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.94; Adnan S, 2013, J PEASANT STUD, V40, P87, DOI 10.1080/03066150.2012.753058; Alkire S, 2016, MULTIDIMENSIONAL POV; [Anonymous], 2017, HUMAN DEV REPORTS IN; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; [Anonymous], 2017, POVERTY EQUITY DATA; [Anonymous], **DATA OBJECT**; [Anonymous], **DATA OBJECT**; Auerbach LW, 2015, NAT CLIM CHANGE, V5, P153, DOI [10.1038/nclimate2472, 10.1038/NCLIMATE2472]; Bandiera O, 2017, Q J ECON, V132, P811, DOI 10.1093/qje/qjx003; Bangladesh Bureau of Statistics (BBS), 2019, REP HOUS INC EXP SUR; Barrett CB, 2006, WORLD DEV, V34, P1, DOI 10.1016/j.worlddev.2005.06.008; Barrett CB, 2001, FOOD POLICY, V26, P315, DOI 10.1016/S0306-9192(01)00014-8; Barrett CB, 2016, ANNU REV RESOUR ECON, V8, P303, DOI 10.1146/annurev-resource-100815-095235; Barrett CB, 2013, J DEV STUD, V49, P976, DOI 10.1080/00220388.2013.785527; Basu K, 2015, J DEV ECON, V115, P200, DOI 10.1016/j.jdeveco.2015.02.001; BBS, 1996, REP HOUS INC EXP SUR; BBS, 1991, REP HOUS INC EXP SUR; BBS, 2011, STAT YB BANGL 2010; Bebbington A, 2000, ANN ASSOC AM GEOGR, V90, P495, DOI 10.1111/0004-5608.00206; Blaikie P, 2002, WORLD DEV, V30, P1255, DOI 10.1016/S0305-750X(02)00031-1; Blair H, 2005, WORLD DEV, V33, P921, DOI 10.1016/j.worlddev.2004.09.011; Cain K, 2015, READ RES QUART, V50, P151, DOI 10.1002/rrq.99; Chambers Robert., 1981, SEASONAL DIMENSIONS; Chapman A, 2016, SCI TOTAL ENVIRON, V559, P326, DOI 10.1016/j.scitotenv.2016.02.162; Christian P, 2018, DEMOGRAPHY, V55, P1091, DOI 10.1007/s13524-018-0669-4; Dercon S, 2000, J DEV STUD, V36, P25, DOI 10.1080/00220380008422653; Djurfeldt AA, 2012, J MOD AFR STUD, V50, P1, DOI 10.1017/S0022278X11000589; Ellis F, 1998, J DEV STUD, V35, P1, DOI 10.1080/00220389808422553; Falkingham J, 2002, MEASURING HLTH POVER; Feldman S, 2012, J PEASANT STUD, V39, P971, DOI 10.1080/03066150.2012.661719; Ferdousi S., 2014, ASIAN J SOCIAL SCI H, V3, P1; Fisher JA, 2013, GLOBAL ENVIRON CHANG, V23, P1098, DOI 10.1016/j.gloenvcha.2013.04.002; Goulden MC, 2013, ANN ASSOC AM GEOGR, V103, P906, DOI 10.1080/00045608.2013.765771; Hamid SA, 2014, APPL HEALTH ECON HEA, V12, P421, DOI 10.1007/s40258-014-0100-2; Hossain MS, 2016, REG ENVIRON CHANGE, V16, P429, DOI 10.1007/s10113-014-0748-z; Hulme D, 2003, WORLD DEV, V31, P403, DOI 10.1016/S0305-750X(02)00222-X; Hutton CW, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10041108; Islam M, 2004, LAND MEETS SEA PROFI; Islam MM, 2013, MARIT STUD, V12, DOI 10.1186/2212-9790-12-7; Islam N., 2010, INTEGRATED PROTECTED; Jenkins SP, 2000, J POPUL ECON, V13, P529, DOI 10.1007/s001480050151; Johnson FA, 2016, SUSTAIN SCI, V11, P423, DOI 10.1007/s11625-016-0356-6; Khandker SR, 2012, J DEV ECON, V97, P244, DOI 10.1016/j.jdeveco.2011.05.001; Lazar AN, 2020, REG ENVIRON CHANGE, V20, DOI 10.1007/s10113-020-01681-y; Lenhardt A, 2013, WHAT HAS HAPPENED PO; Mace G, 2018, ROU STUD ECOSYS SERV, P305; Mallick D, 2012, WORLD DEV, V40, P1181, DOI 10.1016/j.worlddev.2011.12.011; MASSEY DS, 1993, POPUL DEV REV, V19, P431, DOI 10.2307/2938462; Mazumder MSU, 2015, SUSTAIN DEV, V23, P396, DOI 10.1002/sd.1599; McCulloch N, 2000, J DEV STUD, V36, P100, DOI 10.1080/00220380008422656; Mobarak A. M., 2020, ASIAN DEV REV, V37, P1, DOI 10.1162/adev_a_00139; Narayan D, 1999, GLOBAL SYNTHESIS CON; Narayan DP, MOVING OUT POVERTY, V2, DOI [10.1596/978-0-8213-7215-92009, DOI 10.1596/978-0-8213-7215-92009]; Naschold F, 2012, WORLD DEV, V40, P2033, DOI 10.1016/j.worlddev.2012.05.006; Paprocki K., 2015, HIMAL SOUTHASIAN, V28, P54; Paul SK, 2010, DISASTERS, V34, P489, DOI 10.1111/j.1467-7717.2009.01139.x; Payo A, 2017, EARTHS FUTURE, V5, P495, DOI 10.1002/2016EF000530; Quisumbing AR, 2013, J DEV STUD, V49, P898, DOI 10.1080/00220388.2013.785524; Rahman PMM, 2013, DYNAMICS POVERTY RUR, DOI [10.1007/978-4-431-54285-8, DOI 10.1007/978-4-431-54285-8]; Randall S, 2015, J DEV STUD, V51, P162, DOI 10.1080/00220388.2014.968135; REARDON T, 1995, WORLD DEV, V23, P1495, DOI 10.1016/0305-750X(95)00061-G; Reardon T, TRANSFORMING RURAL N; Robinson S., 2014, SIMULATION PRACTICE, V2nd ed.; Roy DC, PUBLICATION SERIES U, V15/20112011; Schleicher J, 2018, SUSTAIN DEV, V26, P83, DOI 10.1002/sd.1692; Schluter M, 2017, ECOL ECON, V131, P21, DOI 10.1016/j.ecolecon.2016.08.008; STARK O, 1985, AM ECON REV, V75, P173; Steffan-Dewenter I, 2007, P NATL ACAD SCI USA, V104, P4973, DOI 10.1073/pnas.0608409104; Sultana N, 2012, NAT HAZARDS, V64, P1209, DOI 10.1007/s11069-012-0291-5; Szabo S., 2015, Asia-Pacific Population Journal, V30, P51; Turner BL, 1996, P NATL ACAD SCI USA, V93, P14984, DOI 10.1073/pnas.93.25.14984; Uddin MS, 2013, ECOSYST SERV, V5, pE88, DOI 10.1016/j.ecoser.2013.07.002; UNGA, 2015, ARES701 USDA; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364	85	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238621	10.1371/journal.pone.0238621	http://dx.doi.org/10.1371/journal.pone.0238621			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ7QN	32886732	Green Published, Green Accepted, gold			2022-12-26	WOS:000571064300060
J	Abate, BB; Tilahun, BD; Kassie, AM; Kassaw, MW				Abate, Biruk Beletew; Tilahun, Befkad Deresse; Kassie, Ayelign Mengesha; Kassaw, Mesfin Wudu			Treatment outcome of Severe Acute Malnutrition and associated factors among under-five children in outpatient therapeutics unit in Gubalafto Wereda, North Wollo Zone, Ethiopia, 2019	PLOS ONE			English	Article								Background In Ethiopia, uncomplicated severe acute malnutrition is managed through the outpatient therapeutic program at health posts level. This brings the services for the management of Severe Acute Malnutrition closer to the community by making services available at decentralized treatment points within the primary health care settings. So far, evidence of the treatment outcome of the program is limited. Objective The main aim of this study was to determine the magnitude of treatment outcomes of severe acute malnutrition and associated factors among under-five children at outpatient therapeutic feeding units in Gubalafto Wereda, Ethiopia, 2019. Methods This was a retrospective cohort study conducted on 600 children who had been managed for Severe Acute Malnutrition (SAM) under Outpatient Therapeutic Program (OTP) in Gubalafto Wereda from April to May/2019. The children were selected using systematic random sampling from 9 health posts. The structured, pre-tested, and adapted questionnaire was used to collect the data. The data was entered by using EPI-data Version 4.2 and exported to SPSS version 24.0 for analysis. Bivariate and Multivariate regression was also carried out to determine the association between dependent and independent variables. Results A total of 600 records of children with a diagnosis of severe acute malnutrition were reviewed. Of these cases of malnutrition, the recovery rate was found to be 65%. The death rate, default rate, and medical transfer were 2.0, 16.0, and 17.0 respectively. Immunized children had 6.85 times higher odds of recovery than children who were not immunized (AOR = 6.85 at 95% CI (3.68-12.76)). The likelihood of recovery was 3.78 times higher among children with new admission than those with re-admission (AOR = 3.78at 95% CI ((1.77-8.07))). Likewise, children provided with amoxicillin were 3.38 times recovered than their counterparts (AOR = 3.38 at 95% CI ((1.61-7.08))). SAM treatment in OTP is beneficial because of its local access for most severe cases since children reach early before developing complications as a result fatalities will be reduced. Conclusions The recovery rate and medical transfer were lower than the sphere standard. Presence of cough, presence of diarrhea admission category, provision of amoxicillin, and immunization status were factors identified as significantly associated with treatment outcome of severe acute malnutrition. The impact on increasing the recovery rates of children treated using the OTP service indicates the potential benefits of increasing the capacity of such services across a target region on child mortality/recovery. Timely intervention is another benefit of a more local service like OTP. Building capacity of OTP service providers and regular monitoring of service provision based on the management protocol was recommended.	[Abate, Biruk Beletew; Tilahun, Befkad Deresse; Kassie, Ayelign Mengesha; Kassaw, Mesfin Wudu] Woldia Univ, Coll Hlth Sci, Dept Nursing, Woldia, Amhara Regional, Ethiopia		Abate, BB (corresponding author), Woldia Univ, Coll Hlth Sci, Dept Nursing, Woldia, Amhara Regional, Ethiopia.	birukkelemb@gmail.com	Beletew, Biruk/ABC-3508-2020	Reis, AlessanRSS/0000-0001-8486-7469	Woldia University	Woldia University	The study was funded by Woldia University. However, the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achadi E, 2016, GLOBAL NUTR REPORT P; [Anonymous], 2014, DIABETES CARE, V35, pS14; [Anonymous], 2014, DIABETES CARE, V35, pS14; [Anonymous], 2016, THE TOTAL AUDIENCE R; Chamois S, 2007, ETHIOPIA PROTOCOL MA; Collins S, 2007, ARCH DIS CHILD, V92, P453, DOI 10.1136/adc.2006.098327; Collins S, 2006, LANCET, V368, P1992, DOI 10.1016/S0140-6736(06)69443-9; Desta K., 2015, J NUTR DISORD THER, V5, P160, DOI DOI 10.4172/2161-0509.1000160; Desyibelew HD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171020; FHAPCO. Federal HIV Prevention AIDS Control Office, 2008, FED HIV PREV AIDS CO; Golden M, 2007, PROTOCOL MANAGEMENT; Golden M GYPftmosamEM, 2016, TREATM OUTC FACT AFF, V9, P30704; Gulati JK, 2010, ANTHROPOLOGIST, V12, P131, DOI 10.1080/09720073.2010.11891143; Harvey BM, 2017, J PEDIATR GASTR NUTR, V65, P346, DOI 10.1097/MPG.0000000000001655; Kabalo MY, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-017-0083-3; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Lenters LM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S23; Mengesha MM, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.30704; Organization WH Initiative STDD Research SPf Diseases TiT, 2007, US RAP SYPH TESTS WH; Paxton A, 2005, INT J GYNECOL OBSTET, V88, P181, DOI 10.1016/j.ijgo.2004.11.026; Teferra TB, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.209.4525; UNICEF, 2012, EV COMM MAN AC MALN; WHO, 2013, GUID UPD MAN SEV AC; World Health Organization , 2007, COMM BAS MAN SEV AC; Yebyo HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065840	25	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238231	10.1371/journal.pone.0238231	http://dx.doi.org/10.1371/journal.pone.0238231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881883	Green Published, gold			2022-12-26	WOS:000571063300002
J	Matsuoka, N; Yamaguchi, M; Asai, A; Kamiya, K; Kinashi, H; Katsuno, T; Kobayashi, T; Tamai, H; Morinaga, T; Obayashi, T; Nakabayashi, K; Koide, S; Nakanishi, M; Koyama, K; Suzuki, Y; Ishimoto, T; Mizuno, M; Ito, Y				Matsuoka, Naoya; Yamaguchi, Makoto; Asai, Akimasa; Kamiya, Keisuke; Kinashi, Hiroshi; Katsuno, Takayuki; Kobayashi, Takaaki; Tamai, Hirofumi; Morinaga, Takatoshi; Obayashi, Takaaki; Nakabayashi, Kichio; Koide, Shigehisa; Nakanishi, Michimasa; Koyama, Katsushi; Suzuki, Yasuhiro; Ishimoto, Takuji; Mizuno, Masashi; Ito, Yasuhiko			The effectiveness and safety of computed tomographic peritoneography and video-assisted thoracic surgery for hydrothorax in peritoneal dialysis patients: A retrospective cohort study in Japan	PLOS ONE			English	Article							SURGICAL-TREATMENT; TALC PLEURODESIS; MANAGEMENT; COMPLICATIONS	Introduction Albeit uncommon, hydrothorax is an important complication of peritoneal dialysis (PD). Due to paucity of evidence for optimal treatment, this study aimed to evaluate the effectiveness and safety of computed tomographic (CT) peritoneography and surgical intervention involving video-assisted thoracic surgery (VATS) for hydrothorax in a retrospective cohort of patients who underwent PD in Japan. Methods Of the 982 patients who underwent PD from six centers in Japan between 2007 and 2019, 25 (2.5%) with diagnosed hydrothorax were enrolled in this study. PD withdrawal rates were compared between patients who underwent VATS for diaphragm repair (surgical group) and those who did not (non-surgical group) using the Kaplan-Meier method and log-rank test. Results The surgical and non-surgical groups comprised a total of 11 (44%) and 14 (56%) patients, respectively. Following hydrothorax diagnosis by thoracentesis and detection of penetrated sites on the diaphragm using CT peritoneography, VATS was performed at a median time of 31 days (interquartile range [IQR], 20-96 days). During follow-up (median, 26 months; IQR, 10-51 months), 9 (64.3%) and 2 (18.2%) patients in the non-surgical and surgical groups, respectively, withdrew from PD (P= 0.021). There were no surgery-related complications or hydrothorax relapse in the surgical group. Conclusions This study demonstrated the effectiveness and safety of CT peritoneography and VATS for hydrothorax. This approach may be useful in hydrothorax cases to avoid early drop out of PD and continue PD in the long term. Further studies are warranted to confirm these results.	[Matsuoka, Naoya; Yamaguchi, Makoto; Asai, Akimasa; Kamiya, Keisuke; Kinashi, Hiroshi; Katsuno, Takayuki; Ito, Yasuhiko] Aichi Med Univ, Dept Nephrol & Rheumatol, Nagakute, Aichi, Japan; [Matsuoka, Naoya; Kobayashi, Takaaki] Aichi Med Univ, Dept Renal Transplant Surg, Nagakute, Aichi, Japan; [Tamai, Hirofumi; Morinaga, Takatoshi] Anjo Kosei Hosp, Dept Nephrol, Anjo, Aichi, Japan; [Obayashi, Takaaki; Nakabayashi, Kichio] Narita Mem Hosp, Dept Nephrol, Toyohashi, Aichi, Japan; [Koide, Shigehisa; Nakanishi, Michimasa] Fujita Hlth Univ, Dept Nephrol, Sch Med, Toyoake, Aichi, Japan; [Koyama, Katsushi] Kariya Toyota Gen Hosp, Dept Internal Med, Div Nephrol & Rheumatol, Kariya, Aichi, Japan; [Suzuki, Yasuhiro; Ishimoto, Takuji; Mizuno, Masashi] Nagoya Univ, Dept Nephrol & Renal Replacement Therapy, Grad Sch Med, Nagoya, Aichi, Japan	Aichi Medical University; Aichi Medical University; Fujita Health University; Nagoya University	Ito, Y (corresponding author), Aichi Med Univ, Dept Nephrol & Rheumatol, Nagakute, Aichi, Japan.	yasuito@aichi-med-u.ac.jp	Mizuno, Masashi/I-7347-2014; Ishimoto, Takuji/M-4873-2014	Ishimoto, Takuji/0000-0002-9861-5331				Abraham Q, 1988, PERITONEAL DIALYSIS, V4, P121; Bai J, 2020, SEMIN DIALYSIS, V33, P163, DOI 10.1111/sdi.12867; Chow KM, 2003, SEMIN DIALYSIS, V16, P389, DOI 10.1046/j.1525-139X.2003.16080.x; Gagnon Raymonde F, 2004, Adv Perit Dial, V20, P132; HOLLETT MD, 1992, AM J ROENTGENOL, V159, P983, DOI 10.2214/ajr.159.5.1344976; Kanaan N, 1999, NEPHROL DIAL TRANSPL, V14, P1590, DOI 10.1093/ndt/14.6.1590; Lam MF, 2004, PERITON DIALYSIS INT, V24, P466; Lew SQ, 2010, PERITON DIALYSIS INT, V30, P13, DOI 10.3747/pdi.2008.00168; Markic Dean, 2011, Acta Medica Croatica, V65, P95; Mitsuboshi S, 2019, SURG CASE REP, V5, DOI 10.1186/s40792-019-0595-8; NOMOTO Y, 1989, AM J NEPHROL, V9, P363, DOI 10.1159/000167997; PATTISON CW, 1984, CLIN NEPHROL, V21, P191; Ramon RG, 1998, PERITON DIALYSIS INT, V18, P5; Ratajczak A, 2017, SEMIN DIALYSIS, V30, P63, DOI 10.1111/sdi.12538; Saito M, 2012, INTERACT CARDIOV TH, V15, P788, DOI 10.1093/icvts/ivs193; Sato Seijiro, 2014, Kyobu Geka, V67, P967; SIMMONS LE, 1989, ADV PERIT D, V5, P81; SUDDUTH CD, 1992, CHEST, V102, P1855, DOI 10.1378/chest.102.6.1855; Szeto CC, 2004, CURR OPIN PULM MED, V10, P315, DOI 10.1097/01.mcp.0000127901.60693.d0; Tang S, 2003, NEPHROL DIAL TRANSPL, V18, P804, DOI 10.1093/ndt/gfg042	20	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238602	10.1371/journal.pone.0238602	http://dx.doi.org/10.1371/journal.pone.0238602			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881941	gold, Green Published			2022-12-26	WOS:000571063300083
J	Liang, ER; Lu, YS; Shi, YQ; Zhou, Q; Zhi, FC				Liang, Erbo; Lu, Yishi; Shi, Yanqiang; Zhou, Qian; Zhi, Fachao			MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity	ONCOGENE			English	Article							DNA METHYLATION; GENE-EXPRESSION; CELL; METASTASIS; EPIDEMIOLOGY; ACTIVATION; SUBSET; 11Q13; KRAS; SRY	Emerging evidence indicates that myeloma overexpressed (MYEOV) is an oncogene and plays crucial roles in multiple human cancers. However, its roles in the development of pancreatic ductal adenocarcinoma (PDAC) remain elusive. Here, we provide evidence of essential roles of MYEOV in the development and progression of PDAC. In tumor specimens derived from pancreatic cancer patients, MYEOV was overexpressed and associated with poor prognosis. In addition, MYEOV expression in PDAC was upregulated through promoter hypomethylation. MYEOV depletion impaired metastatic ability and proliferation of PDAC cells both in vitro and in vivo, whereas its overexpression had the opposite effect. Mechanistic investigations revealed that MYEOV interacted with SRY-Box Transcription Factor 9 (SOX9), a well-known oncogenic transcription factor in PDAC. This interaction occurred mainly in the nuclei of PDAC cells and increased transcriptional activity of SOX9. Furthermore, MYEOV promoted the expression ofHairy and enhancer of split homolog-1 (HES1), a SOX9 target gene, by enhancing SOX9 DNA-binding ability to theHES1enhancer without affecting the protein level and subcellular localization of SOX9. HES1 knockdown partly abrogated the oncogenic effect of MYEOV. Our findings suggest that MYEOV could be a potential prognostic biomarker and therapeutic target for PDAC.	[Liang, Erbo; Lu, Yishi; Shi, Yanqiang; Zhou, Qian; Zhi, Fachao] Guangdong Prov Key Lab Gastroenterol, Guangzhou 510515, Peoples R China; [Liang, Erbo; Lu, Yishi; Shi, Yanqiang; Zhou, Qian; Zhi, Fachao] Inst Gastroenterol Guangdong Prov, Guangzhou 510515, Peoples R China; [Liang, Erbo; Lu, Yishi; Shi, Yanqiang; Zhou, Qian; Zhi, Fachao] Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangzhou 510515, Peoples R China	Southern Medical University - China	Zhi, FC (corresponding author), Guangdong Prov Key Lab Gastroenterol, Guangzhou 510515, Peoples R China.; Zhi, FC (corresponding author), Inst Gastroenterol Guangdong Prov, Guangzhou 510515, Peoples R China.; Zhi, FC (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangzhou 510515, Peoples R China.	zhifc41532@163.com		Zhi, Fachao/0000-0001-8674-4737; Shi, Yanqiang/0000-0003-0814-6322				Abel EV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091983; Coccaro N, 2016, ONCOL LETT, V12, P1460, DOI 10.3892/ol.2016.4759; Deng FH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0244-8; Fang LS, 2019, ONCOGENE, V38, P896, DOI 10.1038/s41388-018-0484-9; Fukuda Akihisa, 2013, Gastroenterology, V145, P904, DOI 10.1053/j.gastro.2013.08.028; Grimm D, 2020, SEMIN CANCER BIOL, V67, P122, DOI 10.1016/j.semcancer.2019.03.004; Grimont A, 2015, GUT, V64, P1790, DOI 10.1136/gutjnl-2014-307075; Harley VR, 2003, ENDOCR REV, V24, P466, DOI 10.1210/er.2002-0025; Horie M, 2017, MOL CANCER RES, V15, P1354, DOI 10.1158/1541-7786.MCR-17-0191; Huang L, 2015, NAT MED, V21, P1364, DOI 10.1038/nm.3973; Huang WY, 2015, NUCLEIC ACIDS RES, V43, pD856, DOI 10.1093/nar/gku1151; Ilic M, 2016, WORLD J GASTROENTERO, V22, P9694, DOI 10.3748/wjg.v22.i44.9694; Janssen JWG, 2000, BLOOD, V95, P2691; Janssen JWG, 2002, J HUM GENET, V47, P460, DOI 10.1007/s100380200065; Janssen JWG, 2002, INT J CANCER, V102, P608, DOI 10.1002/ijc.10765; Kawaguchi Y, 2013, J CLIN INVEST, V123, P1881, DOI 10.1172/JCI66022; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Lawlor G, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-81; Lee JY, 2014, PANCREATOLOGY, V14, P48, DOI 10.1016/j.pan.2013.11.011; Leung CON, 2016, ONCOTARGET, V7, P29371, DOI 10.18632/oncotarget.8835; Leyden J, 2006, BRIT J CANCER, V94, P1204, DOI 10.1038/sj.bjc.6603054; Li TT, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0877-2; Liu ZH, 2015, CANCER BIOL THER, V16, P353, DOI 10.1080/15384047.2015.1016662; McGuigan A, 2018, WORLD J GASTROENTERO, V24, P4846, DOI 10.3748/wjg.v24.i43.4846; Mertin S, 1999, NUCLEIC ACIDS RES, V27, P1359, DOI 10.1093/nar/27.5.1359; Mishra NK, 2017, ONCOTARGET, V8, P28990, DOI 10.18632/oncotarget.15993; Moreaux J, 2010, EXP HEMATOL, V38, P1189, DOI 10.1016/j.exphem.2010.09.002; Moss AC, 2006, BIOCHEM BIOPH RES CO, V345, P216, DOI 10.1016/j.bbrc.2006.04.094; Muller P, 2010, BREAST CANCER RES TR, V120, P317, DOI 10.1007/s10549-009-0381-6; Nevala-Plagemann C, 2020, NAT REV CLIN ONCOL, V17, P108, DOI 10.1038/s41571-019-0281-6; Nishikawa Y, 2019, ONCOGENE, V38, P4283, DOI 10.1038/s41388-019-0718-5; Rani A, 2016, CYTOKINE GROWTH F R, V30, P113, DOI 10.1016/j.cytogfr.2016.03.010; Royo JL, 2007, NAT PROTOC, V2, P1734, DOI 10.1038/nprot.2007.244; Ruan HH, 2017, ONCOTARGET, V8, P113163, DOI 10.18632/oncotarget.22635; Sato N, 2003, CANCER RES, V63, P4158; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Shen ZY, 2015, ONCOTARGET, V6, P20672, DOI 10.18632/oncotarget.3967; Shi JG, 2018, INT J ONCOL, V52, P179, DOI 10.3892/ijo.2017.4201; Sim H, 2008, TRENDS ENDOCRIN MET, V19, P213, DOI 10.1016/j.tem.2008.04.002; Sun L, 2013, STEM CELLS, V31, P1454, DOI 10.1002/stem.1394; Takita J, 2011, CANCER SCI, V102, P1645, DOI 10.1111/j.1349-7006.2011.01995.x; Xie VK, 2017, CLIN CANCER RES, V23, P5585, DOI 10.1158/1078-0432.CCR-17-0387; Yen WC, 2015, CLIN CANCER RES, V21, P2084, DOI 10.1158/1078-0432.CCR-14-2808; Zhao TS, 2017, CANCER RES, V77, P874, DOI 10.1158/0008-5472.CAN-16-2170; Zhou H, 2018, ONCOGENE, V37, P912, DOI 10.1038/onc.2017.393	45	17	17	4	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 8	2020	39	41					6437	6450		10.1038/s41388-020-01443-4	http://dx.doi.org/10.1038/s41388-020-01443-4		SEP 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	OA1JL	32879444				2022-12-26	WOS:000565482600002
J	Schroder, BO; Birchenough, GMH; Pradhan, M; Nystrom, EEL; Henricsson, M; Hansson, GC; Backhed, F				Schroder, Bjorn O.; Birchenough, George M. H.; Pradhan, Meenakshi; Nystrom, Elisabeth E. L.; Henricsson, Marcus; Hansson, Gunnar C.; Backhed, Fredrik			Obesity-associated microbiota contributes to mucus layer defects in genetically obese mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						barrier dysfunction; gut microbiota; host defense; intestinal epithelium; metabolic disease; mucus; mucosal immunology; obesity; microbiome; metabolism	CHAIN FATTY-ACIDS; INTESTINAL MUCUS; DIETARY FIBER; COLON MUCUS; MOUSE; BACTERIAL; PROTECTS; BARRIER; CELLS	The intestinal mucus layer is a physical barrier separating the tremendous number of gut bacteria from the host epithelium. Defects in the mucus layer have been linked to metabolic diseases, but previous studies predominantly investigated mucus function during high-caloric/low-fiber dietary interventions, thus making it difficult to separate effects mediated directly through diet quality from potential obesity-dependent effects. As such, we decided to examine mucus function in mouse models with metabolic disease to distinguish these factors. Here we show that, in contrast to their lean littermates, genetically obese (ob/ob) mice have a defective inner colonic mucus layer that is characterized by increased penetrability and a reduced mucus growth rate. Exploiting the coprophagic behavior of mice, we next co-housed ob/ob and lean mice to investigate if the gut microbiota contributed to these phenotypes. Co-housing rescued the defect of the mucus growth rate, whereas mucus penetrability displayed an intermediate phenotype in both mouse groups. Of note, non-obese diabetic mice with high blood glucose levels displayed a healthy colonic mucus barrier, indicating that the mucus defect is obesity- rather than glucose-mediated. Thus, our data suggest that the gut microbiota community of obesity-prone mice may regulate obesity-associated defects in the colonic mucosal barrier, even in the presence of dietary fiber.	[Schroder, Bjorn O.; Pradhan, Meenakshi; Henricsson, Marcus; Backhed, Fredrik] Univ Gothenburg, Wallenberg Lab, Dept Mol & Clin Med, Inst Med, Gothenburg, Sweden; [Birchenough, George M. H.; Nystrom, Elisabeth E. L.; Hansson, Gunnar C.] Univ Gothenburg, Dept Med Biochem, Inst Biomed, Gothenburg, Sweden; [Schroder, Bjorn O.] Umea Univ, Dept Mol Biol, Lab Mol Infect Med Sweden MIMS, Umea, Sweden; [Backhed, Fredrik] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth Sci, Copenhagen, Denmark; [Backhed, Fredrik] Sahlgrens Univ Hosp, Dept Clin Physiol, Reg Vastra Gotaland, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; Umea University; Novo Nordisk Foundation; University of Copenhagen; Sahlgrenska University Hospital	Schroder, BO (corresponding author), Univ Gothenburg, Wallenberg Lab, Dept Mol & Clin Med, Inst Med, Gothenburg, Sweden.; Schroder, BO (corresponding author), Umea Univ, Dept Mol Biol, Lab Mol Infect Med Sweden MIMS, Umea, Sweden.	Bjorn.Schroder@umu.se	; Hansson, Gunnar C./A-1236-2009	Nystrom, Elisabeth/0000-0002-6970-7894; Hansson, Gunnar C./0000-0002-1900-1869	Swedish Research Council [2018-02095, 2017-00958]; NovoNordisk Foundation [NNF15OC0016798]; Swedish Heart Lung Foundation [20180600]; Goran Gustafsson's Foundation; IngaBrittoch Arne Lundbergs Foundation; Leducq Foundation [17CVD01]; Knut and Alice Wallenberg Foundation [2017.0026, 2017.0028]; NIAID National Institutes of Health [U01AI095473]; Hasselblad Foundation; Swedish government [ALFGBG718101, ALFGBG-440741]; Marie Curie Intra European Fellowship [622909-MUCUS]; Human Frontier Science Program Long-Term Fellowship [LT000109/2014-L]; Ake-Wibergs Stiftelse [M180029]; European Research Council Advanced Grant Grant [694181-MUC2GO]; European Research Council [615362-METABASE]	Swedish Research Council(Swedish Research CouncilEuropean Commission); NovoNordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Goran Gustafsson's Foundation; IngaBrittoch Arne Lundbergs Foundation; Leducq Foundation(Leducq Foundation); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); NIAID National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Hasselblad Foundation; Swedish government; Marie Curie Intra European Fellowship(European Commission); Human Frontier Science Program Long-Term Fellowship(Human Frontier Science Program); Ake-Wibergs Stiftelse; European Research Council Advanced Grant Grant; European Research Council(European Research Council (ERC)European Commission)	This work supported by Swedish Research Council Grants 2013-07800 and 2017-00958, NovoNordisk Foundation Grant NNF15OC0016798, Swedish Heart Lung Foundation Grant 20180600, the Goran Gustafsson's Foundation, IngaBrittoch Arne Lundbergs Foundation, Leducq Foundation Grant 17CVD01, Knut and Alice Wallenberg Foundation Grants 2017.0026 and 2017.0028, and NIAID National Institutes of Health Grant U01AI095473, Hasselblad Foundation, and grants from the Swedish state under the agreement between the Swedish government and the county councils and the ALF-agreement (ALFGBG718101 and ALFGBG-440741). B. O. S. was supported by a Marie Curie Intra European Fellowship (622909-MUCUS and METABOLISM), Human Frontier Science Program Long-Term Fellowship Grant LT000109/2014-L, Starting Grant from the Swedish Research Council Grant 2018-02095, and Ake-Wibergs Stiftelse Grant M180029. G. C. H. is a recipient of European Research Council Advanced Grant Grant 694181-MUC2GO. F. B. is a Torsten Soderberg professor in medicine and recipient of European Research Council Consolidator Grant 615362-METABASE. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Allin KH, 2018, DIABETOLOGIA, V61, P810, DOI 10.1007/s00125-018-4550-1; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergstrom JH, 2016, P NATL ACAD SCI USA, V113, P13833, DOI 10.1073/pnas.1611400113; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Burger-van Paassen N, 2009, BIOCHEM J, V420, P211, DOI 10.1042/BJ20082222; Caesar R, 2012, GUT, V61, P1701, DOI 10.1136/gutjnl-2011-301689; Callahan BJ, 2017, ISME J, V11, P2639, DOI 10.1038/ismej.2017.119; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chassaing B, 2017, CELL MOL GASTROENTER, V4, P205, DOI 10.1016/j.jcmgh.2017.04.001; Chassaing B, 2014, GASTROENTEROLOGY, V147, P1363, DOI 10.1053/j.gastro.2014.08.033; Crost EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076341; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; Earle KA, 2015, CELL HOST MICROBE, V18, P478, DOI 10.1016/j.chom.2015.09.002; Edgar R.C., 2016, UNOISE2 IMPROVED ERR, DOI 10.1101/081257; Edgar RC, 2015, BIOINFORMATICS, V31, P3476, DOI 10.1093/bioinformatics/btv401; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Endesfelder D, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0163-4; Ermund A, 2013, AM J PHYSIOL-GASTR L, V305, pG341, DOI 10.1152/ajpgi.00046.2013; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fernandes J, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.23; Miranda MCG, 2019, J LEUKOCYTE BIOL, V106, P513, DOI 10.1002/JLB.3HI0119-024RR; Gummesson A, 2011, OBESITY, V19, P2280, DOI 10.1038/oby.2011.251; Gustafsson JK, 2012, AM J PHYSIOL-GASTR L, V302, pG430, DOI [10.1152/ajpgi.00405.2011, 10.1152/ajpgi.00405.2011.]; Hall AB, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0490-5; Jakobsson HE, 2015, EMBO REP, V16, P164, DOI 10.15252/embr.201439263; Johansson MEV, 2016, NAT REV IMMUNOL, V16, P639, DOI 10.1038/nri.2016.88; Johansson MEV, 2015, CELL HOST MICROBE, V18, P582, DOI 10.1016/j.chom.2015.10.007; Johansson MEV, 2014, GUT, V63, P281, DOI 10.1136/gutjnl-2012-303207; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Nystrom EEL, 2018, EBIOMEDICINE, V33, P134, DOI 10.1016/j.ebiom.2018.05.031; Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646; Plovier H, 2017, NAT MED, V23, P107, DOI 10.1038/nm.4236; Prodan A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227434; ROEDIGER WEW, 1982, GASTROENTEROLOGY, V83, P424; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Schroeder BO, 2018, CELL HOST MICROBE, V23, P27, DOI 10.1016/j.chom.2017.11.004; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Swidsinski A, 2007, GUT, V56, P343, DOI 10.1136/gut.2006.098160; Thaiss CA, 2018, SCIENCE, V359, P1376, DOI 10.1126/science.aar3318; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; Volk JK, 2019, J EXP MED, V216, P2602, DOI 10.1084/jem.20190679; Wrzosek L, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-61; Xiao L, 2015, NAT BIOTECHNOL, V33, P1103, DOI 10.1038/nbt.3353; Yilmaz B, 2019, NAT MED, V25, P323, DOI 10.1038/s41591-018-0308-z; Zou J, 2018, CELL HOST MICROBE, V23, P41, DOI 10.1016/j.chom.2017.11.003	50	14	14	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2020	295	46					15712	15726		10.1074/jbc.RA120.015771	http://dx.doi.org/10.1074/jbc.RA120.015771			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OY6NO	32900852	Green Published, hybrid			2022-12-26	WOS:000594361600022
J	Azam, AA; Ismail, IS; Kumari, Y; Shaikh, MF; Abas, F; Shaari, K				Azam, Amalina Ahmad; Ismail, Intan Safinar; Kumari, Yatinesh; Shaikh, Mohd Farooq; Abas, Faridah; Shaari, Khozirah			The anti-neuroinflammatory effects of Clinacanthus nutans leaf extract on metabolism elucidated through H-1 NMR in correlation with cytokines microarray	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; BRAIN; LIPOPOLYSACCHARIDE; METABOLOMICS; PURIFICATION; SPECTROSCOPY; INFLAMMATION; SECRETION; HYPOXIA; SHOCK	Clinacanthus nutans(CN) (Acanthaceae) is well-known for its anti-inflammatory properties among Asian communities; however, there are currently no data specifically focused on the anti-inflammatory effects of CN on the brain tissue. Neuroinflammation is a common consequence of toxin intrusion to any part of the central nervous system (CNS). As an innate immune response, the CNS may react through both protective and/or toxic actions due to the activation of neuron cells producing pro- and/or anti-inflammatory cytokines in the brain. The unresolved activation of the inflammatory cytokines' response is associated with the pathogenesis of neurological disorders. The present study aimed to decipher the metabolic mechanism on the effects of 14 days oral treatment with CN aqueous extract in induced-lipopolysaccharides (LPS) rats through(1)H NMR spectroscopic biomarker profiling of the brain tissue and the related cytokines. Based on the principal component analysis (PCA) of the nuclear magnetic resonance (NMR) spectral data, twenty-one metabolites in the brain tissue were profiled as biomarkers for the LPS (10 mu L)-induced neuroinflammation following intracerebroventricular injection. Among the twenty-one biomarkers in the neuroinflammed rats, CN treatment of 1000 and 500 mg/kg BW successfully altered lactate, pyruvate, phosphorylcholine, glutamine, and alpha-ketoglutarate when compared to the negative control. Likewise, statistical isolinear multiple component analysis (SIMCA) showed that treatments by CN and the positive control drug, dextromethorphan (DXM, 5 mg/kg BW), have anti-neuroinflammatory potential. A moderate correlation, in the orthogonal partial least squares (OPLS) regression model, was found between the spectral metabolite profile and the cytokine levels. The current study revealed the existence of high levels of pro-inflammatory cytokines, namely IL-1 alpha, IL-1 beta, and TNF-alpha in LPS-induced rats. Both CN dose treatments lowered IL-1 beta significantly better than DXM Interestingly, DXM and CN treatments both exhibited the upregulation of the anti-inflammatory cytokines IL-2 and 4. However, DXM has an advantage over CN in that the former also increased the expression of IL-10 of anti-inflammatory cytokines. In this study, a metabolomics approach was successfully applied to discover the mechanistic role of CN in controlling the neuroinflammatory conditions through the modulation of complex metabolite interactions in the rat brain.	[Azam, Amalina Ahmad; Ismail, Intan Safinar; Abas, Faridah; Shaari, Khozirah] Univ Putra Malaysia, Inst Biosci, Lab Nat Prod, Serdang, Selangor, Malaysia; [Kumari, Yatinesh; Shaikh, Mohd Farooq] Monash Univ Malaysia, Sch Med & Hlth Sci, Neuropharmacol Res Lab, Subang Jaya, Selangor, Malaysia	Universiti Putra Malaysia; Monash University; Monash University Sunway	Ismail, IS (corresponding author), Univ Putra Malaysia, Inst Biosci, Lab Nat Prod, Serdang, Selangor, Malaysia.	safinar@upm.edu.my	Shaikh, Mohd. Farooq/H-6029-2019; Kumari, Yatinesh/F-9755-2018; Ahmad Azam, Amalina/GRY-3276-2022; Ahmad Azam, Amalina/AFV-1323-2022	Shaikh, Mohd. Farooq/0000-0001-9865-6224; Kumari, Yatinesh/0000-0001-6544-1243; Safinar Ismail, Intan/0000-0003-3960-0022; Ahmad Azam, Amalina/0000-0002-3911-7666	Ministry of Agriculture and Agrobased Industry, Malaysia, under NKEA Research Grant scheme (NRGS) [NH1014D070]	Ministry of Agriculture and Agrobased Industry, Malaysia, under NKEA Research Grant scheme (NRGS)	ISI. Ministry of Agriculture and Agrobased Industry, Malaysia, under NKEA Research Grant scheme (NRGS: project No. NH1014D070).	[Anonymous], 2014, AB IMPERIO, V3, P22; Antharavally BS, 2009, ANAL BIOCHEM, V385, P342, DOI 10.1016/j.ab.2008.11.024; Azam AA, 2020, REC NAT PROD, V14, P231, DOI 10.25135/rnp.159.19.08.1384; Azam AA, 2019, AVICENNA J PHYTOMEDI, V9, P164; Bain L, 2018, P WORKSH, P6, DOI [10.17226/24854, DOI 10.17226/24854]; Bayer AL, 2005, J EXP MED, V201, P769, DOI 10.1084/jem.20041179; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Benaki D, 2018, METHODS MOL BIOL, V1738, P117, DOI 10.1007/978-1-4939-7643-0_8; BEUTLER B, 1988, ADV IMMUNOL, V42, P213, DOI 10.1016/S0065-2776(08)60846-9; Carpenter J. F., 2002, CURR PROTOC PROTEIN, DOI [10.1002/0471140864.ps0406s27, DOI 10.1002/0471140864]; Cartmell T, 2003, J PHYSIOL-LONDON, V549, P653, DOI 10.1113/jphysiol.2002.037291; Cavaillon JM, 2001, CELL MOL BIOL, V47, P695; Chang Y, 2015, MOL IMMUNOL, V64, P90, DOI 10.1016/j.molimm.2014.11.002; Chung K.F., 2001, EUR RESPIR J, V34, P50, DOI DOI 10.1183/09031936.01.00229701; Conti B, 2004, FRONT BIOSCI-LANDMRK, V9, P1433, DOI 10.2741/1341; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Devi LA, 2000, TRENDS PHARMACOL SCI, V21, P324, DOI 10.1016/S0165-6147(00)01519-4; DINARELLO CA, 1991, J INFECT DIS, V163, P1177, DOI 10.1093/infdis/163.6.1177; El-Ansary A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0189-0; Eriksson L., 2013, MULTI MEGAVARIATE DA, V1; Eriksson L., 2006, MULTI MEGAVARIATE DA, V2nd, DOI DOI 10.1016/j.arabjc.2013.10.006; Ferrero-Miliani L, 2007, CLIN EXP IMMUNOL, V147, P227, DOI 10.1111/j.1365-2249.2006.03261.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Galic MA, 2012, FRONT NEUROENDOCRIN, V33, P116, DOI 10.1016/j.yfrne.2011.12.002; Glascock JJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2968; Hasin Y, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1215-1; Hou YL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/212910; Johnson CH, 2016, NAT REV MOL CELL BIO, V17, P451, DOI 10.1038/nrm.2016.25; Kamburov A, 2011, BIOINFORMATICS, V27, P2917, DOI 10.1093/bioinformatics/btr499; Karhausen J, 2005, CELL CYCLE, V4, P256; Kelly RS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197049; Khoo LW, 2019, PHYTOCHEM ANALYSIS, V30, P46, DOI 10.1002/pca.2789; Khoo LW, 2015, PHYTOCHEM LETT, V14, P123, DOI 10.1016/j.phytol.2015.09.015; Li X, 2005, BIOCHEM BIOPH RES CO, V335, P1026, DOI 10.1016/j.bbrc.2005.07.175; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; O'Shea JJ, 2011, J IMMUNOL, V187, P5475, DOI 10.4049/jimmunol.1102913; Paban V, 2017, GENE, V600, P90, DOI 10.1016/j.gene.2016.11.022; Petroff OAC, 2002, NEUROSCIENTIST, V8, P562, DOI 10.1177/1073858402238515; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ramesh G, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/480739; Ronald Zielke H, 2009, J NEUROCHEM, V109, P24, DOI 10.1111/j.1471-4159.2009.05941.x; Saric J, 2010, J PROTEOME RES, V9, P2255, DOI 10.1021/pr901019z; Sastra Kusuma Wijaya V. S., 2015, 2015 4 INT C INSTR C, V4, P42; Serrats J, 2010, NEURON, V65, P94, DOI 10.1016/j.neuron.2009.11.032; Shah K, 2012, INT J MOL SCI, V13, P12629, DOI 10.3390/ijms131012629; Shanaiah Narasimhamurthy, 2008, P341, DOI 10.1007/978-1-59745-463-6_16; Silva C, 2019, METABOLITES, V9, DOI 10.3390/metabo9050102; Snapper C.M., 1992, IMMUNOL TODAY, V13, P466, DOI [10.1016/0167-5699(92)90082-I, DOI 10.1016/0167-5699(92)90082-I]; Sochocka M, 2017, MOL NEUROBIOL, V54, P8071, DOI 10.1007/s12035-016-0297-1; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Tohidpour A, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00276; Tyrtyshnaia AA, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0747-8; Vargas-Caraveo A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13302-6; Verma A, 2016, BBA CLIN, V5, P170, DOI 10.1016/j.bbacli.2016.04.002; WALZ A, 1987, BIOCHEM BIOPH RES CO, V149, P755, DOI 10.1016/0006-291X(87)90432-3; Wishart DS, 2016, NAT REV DRUG DISCOV, V15, P473, DOI 10.1038/nrd.2016.32; Zhang M, 2015, INT J CLIN EXP PATHO, V8, P3491	62	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0238503	10.1371/journal.pone.0238503	http://dx.doi.org/10.1371/journal.pone.0238503			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925968	gold, Green Published			2022-12-26	WOS:000572318000052
J	Olajubu, AO; Fajemilehin, BR; Olajubu, TO; Afolabi, BS				Olajubu, Aanuoluwapo Omobolanle; Fajemilehin, Boluwaji Reuben; Olajubu, Temitope Oluwafemi; Afolabi, Babajide Samuel			Effectiveness of a mobile health intervention on uptake of recommended postnatal care services in Nigeria	PLOS ONE			English	Article							MESSAGE	Studies have linked the large percentage of maternal and neonatal mortality that occur in postnatal period to low uptake of postnatal care (PNC) services. Mobile health (mHealth) intervention through message reminders has resulted in significant increase in antenatal care utilisation in previous studies. However, its use in PNC services' uptake has not been adequately investigated in Nigeria. This study aimed to evaluate the effect of a mobile health intervention on PNC attendance among mothers in selected primary healthcare facilities in Osun State, Nigeria. A quasi-experimental research design was utilised. Participants were allocated to Intervention Group and Control Group. One hundred and ninety pregnant mothers were recruited in each group. A mobile health intervention software was developed and used to send educational and reminder messages to mothers in the intervention group from the 35th week of pregnancy to six weeks after delivery. Uptake of PNC services was assessed at birth, 3 days, 10 days and 42 days after delivery. Data were analysed using descriptive statistics, chi-square and logistic regression models. About one-third (30.9%) of respondents in the intervention group had four postnatal care visits while only 3.7% in the control group had four visits (p < 0.001). After controlling for the effect of confounding variables, group membership remained a significant predictor of PNC uptake. (AOR: 10.869, 95% CI: 4.479-26.374). Mobile health intervention significantly improved utilisation of the recommended four postnatal care visits.	[Olajubu, Aanuoluwapo Omobolanle; Fajemilehin, Boluwaji Reuben] Obafemi Awolowo Univ, Coll Hlth Sci, Dept Nursing Sci, Ife, Nigeria; [Olajubu, Temitope Oluwafemi] Obafemi Awolowo Univ, Dept Family Med, Teaching Hosp Complex, Ife, Nigeria; [Afolabi, Babajide Samuel] Obafemi Awolowo Univ, Dept Comp Sci, Ife, Nigeria	Obafemi Awolowo University; Obafemi Awolowo University; Obafemi Awolowo University	Olajubu, AO (corresponding author), Obafemi Awolowo Univ, Coll Hlth Sci, Dept Nursing Sci, Ife, Nigeria.	bolajuba@gmail.com	Afolabi, Babajide/AHD-3150-2022	Afolabi, Babajide/0000-0003-1843-3181; Olajubu, Temitope/0000-0003-1781-0723	CARTA; Consortium for Advanced Research Training in Africa (CARTA); Carnegie Corporation of New York [B 8606.R02]; Sida [54100029]; DELTAS Africa Initiative [107768/Z/15/Z]; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Welcome Trust (UK) [107768/Z/15/Z]; UK government	CARTA; Consortium for Advanced Research Training in Africa (CARTA); Carnegie Corporation of New York; Sida; DELTAS Africa Initiative; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Welcome Trust (UK)(Wellcome Trust); UK government	AO received grant from CARTA. This research was supported by the Consortium for Advanced Research Training in Africa (CARTA). CARTA is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Carnegie Corporation of New York (Grant No-B 8606.R02), Sida (Grant No:54100029), the DELTAS Africa Initiative (Grant No: 107768/Z/15/Z). The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Welcome Trust (UK) (Grant No: 107768/Z/15/Z) and the UK government."The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adanikin AI, 2014, INT J GYNECOL OBSTET, V126, P179, DOI 10.1016/j.ijgo.2014.02.009; [Anonymous], 2014, LANCET INFECT DIS, V14, P1, DOI 10.1016/S1473-3099(13)70368-2; [Anonymous], 2018, THE GUARDIAN; [Anonymous], 2013, 2300822013 ISOIEC, V1, P20; Babalola S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-43; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; Crawford J, 2014, GLOB HEALTH-SCI PRAC, V2, P35, DOI 10.9745/GHSP-D-13-00155; da Costa TM, 2010, INT J MED INFORM, V79, P65, DOI 10.1016/j.ijmedinf.2009.09.001; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Dhakal Sulochana, 2007, BMC Pregnancy Childbirth, V7, P19, DOI 10.1186/1471-2393-7-19; Eshiet I, 2019, HUMAN RIGHTS PUBLIC, P247; Fedha T, 2014, OPEN J PREV MED, P2014; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Galbraith S, 2010, STUDY CLUSTERED DATA; Guy R, 2012, HEALTH SERV RES, V47, P614, DOI 10.1111/j.1475-6773.2011.01342.x; Islam M, 2007, B WORLD HEALTH ORGAN, V85, P735, DOI 10.2471/BLT.07.045963; Izugbara C, 2016, MAT HLTH NIGERIA SIT; Kante AM, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0769-8; Kay M, 2011, WORLD HLTH ORGA, V64, P66; Lund S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-29; MAMA, 2013, MAMA MOBILE ALLIANCE; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Mekonnen A, 2003, J HEAL POPUL NUTR, V14, P32; National Population Commission, 2014, NIG DEM HLTH SURV ND, P127; Navaneetham K, 2002, SOC SCI MED, V55, P1849, DOI 10.1016/S0277-9536(01)00313-6; Oyeyemi SO, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-8; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Sines E., 2007, POSTNATAL CARE CRITI; Somefun DO, 2014, DETERMINANTS POSTNAT; Takai IU., 2015, SAHEL MED J, V18, P109, DOI DOI 10.4103/1118-8561.169282; Tesfahun F, 2014, MATERN CHILD HLTH J, V18, P2341, DOI 10.1007/s10995-014-1474-3; Titaley CR, 2009, J EPIDEMIOL COMMUN H, V63, P827, DOI 10.1136/jech.2008.081604; Titaley CR, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-61; Tsawe M, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0162-2; Ugboaja Joseph O, 2013, Niger Med J, V54, P45, DOI 10.4103/0300-1652.108895; Warren C, 2010, INT J QUAL HEALTH C, V22, P24, DOI 10.1093/intqhc/mzp050; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; Wilmoth JR., 2012, STAT POLITICS POLICY, V3, DOI 10.1515/2151-7509.1038; World Health Organization, 2016, MAT MORT RAT PER 100; World Health Organization, 2014, WHO REC POSTN CAR MO	40	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0238911	10.1371/journal.pone.0238911	http://dx.doi.org/10.1371/journal.pone.0238911			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NS5RK	32925971	gold, Green Published			2022-12-26	WOS:000572318000006
J	Barcelo, M; van Bodegom, PM; Tedersoo, L; den Haan, N; Veen, GF; Ostonen, I; Trimbos, K; Soudzilovskaia, NA				Barcelo, Milagros; van Bodegom, Peter M.; Tedersoo, Leho; den Haan, Nadja; Veen, G. F. (Ciska); Ostonen, Ivika; Trimbos, Krijn; Soudzilovskaia, Nadejda A.			The abundance of arbuscular mycorrhiza in soils is linked to the total length of roots colonized at ecosystem level	PLOS ONE			English	Article							FUNGAL COMMUNITIES; GROWTH; MYCELIUM; GLOMALIN; DIVERSITY; ECOLOGY; BIOMASS; SEARCH; HYPHAE	Arbuscular mycorrhizal fungi (AMF) strongly affect ecosystem functioning. To understand and quantify the mechanisms of this control, knowledge about the relationship between the actual abundance and community composition of AMF in the soil and in plant roots is needed. We collected soil and root samples in a natural dune grassland to test whether, across a plant community, the abundance of AMF in host roots (measured as the total length of roots colonized) is related to soil AMF abundance (using the neutral lipid fatty acids (NLFA) 16:1 omega 5 as proxy). Next-generation sequencing was used to explore the role of community composition in abundance patterns. We found a strong positive relationship between the total length of roots colonized by AMF and the amount of NLFA 16:1 omega 5 in the soil. We provide the first field-based evidence of proportional biomass allocation between intra-and extraradical AMF mycelium, at ecosystem level. We suggest that this phenomenon is made possible by compensatory colonization strategies of individual fungal species. Finally, our findings open the possibility of using AMF total root colonization as a proxy for soil AMF abundances, aiding further exploration of the AMF impacts on ecosystems functioning.	[Barcelo, Milagros; van Bodegom, Peter M.; den Haan, Nadja; Trimbos, Krijn; Soudzilovskaia, Nadejda A.] Leiden Univ, Inst Environm Sci, Environm Biol Dept, Leiden, Netherlands; [Tedersoo, Leho] Univ Tartu, Nat Hist Museum, Tartu, Estonia; [Veen, G. F. (Ciska)] Netherlands Inst Ecol, Ecol, Dept Terr Ecol, Wageningen, Netherlands; [Ostonen, Ivika] Univ Tartu, Inst Ecol & Earth Sci, Tartu, Estonia	Leiden University; Leiden University - Excl LUMC; University of Tartu; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); University of Tartu; Tartu University Institute of Ecology & Earth Sciences	Barcelo, M (corresponding author), Leiden Univ, Inst Environm Sci, Environm Biol Dept, Leiden, Netherlands.	m.barcelo@cml.leidenuniv.nl	Tedersoo, Leho/ABE-7452-2020; Ostonen, Ivika/ABB-2498-2021; van Bodegom, Peter/N-8150-2015	Ostonen, Ivika/0000-0001-9043-6083; van Bodegom, Peter/0000-0003-0771-4500; Trimbos, Krijn Baptist/0000-0001-5280-6434; Barcelo, Milagros/0000-0003-0454-629X	Netherlands Organization for Scientific Research (NWO) [016.161.318]; VENI grant from the Netherlands Organization for Scientific Research (NWO)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); VENI grant from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	N.A.S was supported a VIDI grant (016.161.318) from The Netherlands Organization for Scientific Research (NWO) (https://www.nwo.nl/en) G.F.V was supported by a VENI grant from the Netherlands Organization for Scientific Research (NWO) (https://www.nwo.nl/en) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmetzhanova A. A., 2012, Ecology, V93, P689, DOI 10.1890/11-1749.1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anslan S, 2017, MOL ECOL RESOUR, V17, pe234, DOI 10.1111/1755-0998.12692; Blagodatskaya E, 2013, SOIL BIOL BIOCHEM, V67, P192, DOI 10.1016/j.soilbio.2013.08.024; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brundrett M, 1996, WORKING YLITH MYCORR; Brundrett MC, 2018, NEW PHYTOL, V220, P1108, DOI 10.1111/nph.14976; Bunn RA, 2019, ISME J, V13, P1891, DOI 10.1038/s41396-019-0403-2; Chagnon PL, 2015, OIKOS, V124, P1609, DOI 10.1111/oik.01987; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Escudero V, 2005, MYCORRHIZA, V15, P291, DOI 10.1007/s00572-004-0332-3; Finlay RD, 2008, J EXP BOT, V59, P1115, DOI 10.1093/jxb/ern059; Froslev TG, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01312-x; FROSTEGARD A, 1991, J MICROBIOL METH, V14, P151, DOI 10.1016/0167-7012(91)90018-L; Frostegard A, 2011, SOIL BIOL BIOCHEM, V43, P1621, DOI 10.1016/j.soilbio.2010.11.021; GRAHAM JH, 1982, NEW PHYTOL, V91, P183, DOI 10.1111/j.1469-8137.1982.tb03304.x; Hart MM, 2005, PEDOBIOLOGIA, V49, P269, DOI 10.1016/j.pedobi.2004.12.001; Hart MM, 2002, NEW PHYTOL, V153, P335, DOI 10.1046/j.0028-646X.2001.00312.x; Hempel S, 2007, ENVIRON MICROBIOL, V9, P1930, DOI 10.1111/j.1462-2920.2007.01309.x; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Hodge A, 2000, FEMS MICROBIOL ECOL, V32, P91, DOI 10.1111/j.1574-6941.2000.tb00702.x; Jansa J, 2008, NEW PHYTOL, V177, P779, DOI 10.1111/j.1469-8137.2007.02294.x; Leake JR, 2004, CAN J BOT, V82, P1016, DOI [10.1139/B04-060, 10.1139/b04-060]; Leifheit EF, 2014, PLANT SOIL, V374, P523, DOI 10.1007/s11104-013-1899-2; Lekberg Y, 2007, J ECOL, V95, P95, DOI 10.1111/j.1365-2745.2006.01193.x; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; Maherali H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036695; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; Miller SP, 2000, NEW PHYTOL, V145, P145, DOI 10.1046/j.1469-8137.2000.00566.x; NEWSHAM KK, 1995, TRENDS ECOL EVOL, V10, P407, DOI 10.1016/S0169-5347(00)89157-0; Nilsson RH, 2019, NAT REV MICROBIOL, V17, P95, DOI 10.1038/s41579-018-0116-y; OLSSON PA, 1995, MYCOL RES, V99, P623, DOI 10.1016/S0953-7562(09)80723-5; Olsson PA, 2000, PLANT SOIL, V226, P161, DOI 10.1023/A:1026565314345; Pollierer MM, 2007, ECOL LETT, V10, P729, DOI 10.1111/j.1461-0248.2007.01064.x; Powell JR, 2009, P ROY SOC B-BIOL SCI, V276, P4237, DOI 10.1098/rspb.2009.1015; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2018, R LANG ENV STAT COMP; READ DJ, 1991, EXPERIENTIA, V47, P376, DOI 10.1007/BF01972080; Rillig MC, 2004, CAN J SOIL SCI, V84, P355, DOI 10.4141/S04-003; Rillig MC, 2004, ECOL LETT, V7, P740, DOI 10.1111/j.1461-0248.2004.00620.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Smith SE, 2011, ANNU REV PLANT BIOL, V62, P227, DOI 10.1146/annurev-arplant-042110-103846; Soudzilovskaia NA, 2018, BIORXIV, DOI DOI 10.1101/331884; Soudzilovskaia NA, 2015, GLOBAL ECOL BIOGEOGR, V24, P371, DOI 10.1111/geb.12272; Sousa CD, 2012, SEMIN-CIENC AGRAR, V33, P3033, DOI 10.5433/1679-0359.2012v33Supl1p3033; Staddon PL, 2003, SCIENCE, V300, P1138, DOI 10.1126/science.1084269; Tedersoo L, 2016, ENV MICROBIOL REP, V8, P774, DOI 10.1111/1758-2229.12438; Tedersoo L, 2014, SCIENCE, V346, P1078, DOI 10.1126/science.1256688; Toljander JF, 2007, FEMS MICROBIOL ECOL, V61, P295, DOI 10.1111/j.1574-6941.2007.00337.x; Treseder KK, 2007, SOIL SCI SOC AM J, V71, P1257, DOI 10.2136/sssaj2006.0377; Treseder KK, 2013, PLANT SOIL, V371, P1, DOI 10.1007/s11104-013-1681-5; Treseder KK, 2006, ECOSYSTEMS, V9, P305, DOI 10.1007/s10021-005-0110-x; Urcelay C, 2003, ECOL LETT, V6, P388, DOI 10.1046/j.1461-0248.2003.00444.x; van Aarle IM, 2003, APPL ENVIRON MICROB, V69, P6762, DOI 10.1128/AEM.69.11.6762-6767.2003; van Aarle IM, 2002, NEW PHYTOL, V155, P173, DOI 10.1046/j.1469-8137.2002.00439.x; van der Heijden MGA, 2007, NEW PHYTOL, V174, P244, DOI 10.1111/j.1469-8137.2007.02041.x; van der Heijden MGA, 2002, ECOL STU AN, V157, P243; Varela-Cervero S, 2016, PLANT SOIL, V408, P107, DOI 10.1007/s11104-016-2912-3; Varela-Cervero S, 2015, ENVIRON MICROBIOL, V17, P2882, DOI 10.1111/1462-2920.12810; Vierheilig H, 2005, PHYSIOL PLANTARUM, V125, P393, DOI 10.1111/j.1399-3054.2005.00564.x	60	8	8	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0237256	10.1371/journal.pone.0237256	http://dx.doi.org/10.1371/journal.pone.0237256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915795	Green Published, gold			2022-12-26	WOS:000571887500081
J	Lieu, R; Antonysamy, S; Druzina, Z; Ho, C; Kang, NR; Pustilnik, A; Wang, J; Atwell, S				Lieu, Ricky; Antonysamy, Stephen; Druzina, Zhanna; Ho, Carolyn; Kang, N. Rebecca; Pustilnik, Anna; Wang, Jing; Atwell, Shane			Rapid and robust antibody Fab fragment crystallization utilizing edge-to-edge beta-sheet packing	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; PROTEINS; LESSONS	Antibody therapeutics are one of the most important classes of drugs. Antibody structures have become an integral part of predicting the behavior of potential therapeutics, either directly or as the basis of modeling. Structures of Fab:antigen complexes have even greater value. While the crystallization and structure determination of Fabs is easy relative to many other protein classes, especially membrane proteins, broad screening and optimization of crystalline hits is still necessary. Through a comprehensive review of rabbit Fab crystal contacts and their incompatibility with human Fabs, we identified a small secondary structural element from the rabbit light chain constant domain potentially responsible for hindering the crystallization of human Fabs. Upon replacing the human kappa constant domain FG loop (HQGLSSP) with the two residue shorter rabbit loop (QGTTS), we dramatically improved the crystallization of human Fabs and Fab:antigen complexes. Our design, which we call "Crystal Kappa", enables rapid crystallization of human fabs and fab complexes in a broad range of conditions, with less material in smaller screens or from dilute solutions.	[Lieu, Ricky; Ho, Carolyn; Kang, N. Rebecca; Atwell, Shane] Eli Lilly & Co, Biotechnol Discovery Res, Appl Mol Evolut, San Diego, CA 92121 USA; [Antonysamy, Stephen; Druzina, Zhanna; Pustilnik, Anna; Wang, Jing] Eli Lilly & Co, Corp Ctr, Discovery Chem Res & Technol, Indianapolis, IN 46285 USA; [Druzina, Zhanna] Aro Biotherapeut Co, Prot Engn, Philadelphia, PA USA; [Kang, N. Rebecca] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Eli Lilly; Eli Lilly; Boston University	Atwell, S (corresponding author), Eli Lilly & Co, Biotechnol Discovery Res, Appl Mol Evolut, San Diego, CA 92121 USA.	satwell@lilly.com		Atwell, Shane/0000-0002-2578-2462	DOE Office of Science [DE-AC0206CH11357]; DOE Office of Science User Facility [DE-AC02-05CH11231]; Advanced Light Source, a DOE Office of Science User Facility [DE-AC02-05CH11231]; National Institutes of Health, National Institute of General Medical Sciences [P30 GM12416901]; Eli Lilly Co.	DOE Office of Science(United States Department of Energy (DOE)); DOE Office of Science User Facility(United States Department of Energy (DOE)); Advanced Light Source, a DOE Office of Science User Facility(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Eli Lilly Co.(Eli Lilly)	This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC0206CH11357. Use of the Lilly Research Laboratories Collaborative Access Team (LRL-CAT) beamline at Sector 31 of the Advanced Photon Source was provided by Eli Lilly Company, which operates the facility. This research used resources of the Advanced Light Source, which is a DOE Office of Science User Facility under contract no. DE-AC0205CH11231. Beamline 5.0.2 of the Advanced Light Source, a DOE Office of Science User Facility under Contract No. DE-AC02-05CH11231, is supported in part by the ALS-ENABLE program funded by the National Institutes of Health, National Institute of General Medical Sciences, grant P30 GM12416901. RL, SA, ZD, CH, NRK, AP, JW and SA are, or were at the time of the work described here, employees of Eli Lilly & Co. The specific roles of these authors are articulated in the `author contributions' section. Eli Lilly & Co. provided support in the form of salaries for the authors and research funding. Eli Lilly & Co. also approved the publication of this work. Eli Lilly & Co. did not have any role in study design, data collection and analysis, or preparation of the manuscript.	[Anonymous], 2000, INDIAN HIGHW, V28, P27; Baurin N, 2013, United States patent, Patent No. [US 2013108641, 2013108641]; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; BRICOGNE G, 1993, ACTA CRYSTALLOGR D, V49, P37, DOI 10.1107/S0907444992010400; Carter PJ, 2018, NAT REV DRUG DISCOV, V17, P197, DOI 10.1038/nrd.2017.227; Edmundson AB, 1998, IMMUNOTECHNOLOGY, V3, P309, DOI 10.1016/S1380-2933(97)10002-1; ELY KR, 1989, J MOL BIOL, V210, P601, DOI 10.1016/0022-2836(89)90135-6; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Griffin L, 2011, CLIN EXP IMMUNOL, V165, P285, DOI 10.1111/j.1365-2249.2011.04427.x; Grover RK, 2014, SCIENCE, V343, P656, DOI 10.1126/science.1246135; Kaplon H, 2020, MABS-AUSTIN, V12, DOI 10.1080/19420862.2019.1703531; Leslie A. G. W., 2007, EVOLVING METHODS MAC; Lonberg N., 2008, V181, P69; Lu RM, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-019-0592-z; Maurer MF, 2016, United States patent, Patent No. [US 2016176963, 2016176963]; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPherson A., 1999, CRYSTALLIZATION BIOL; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pan RM, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.44; Pan RM, 2013, J VIROL, V87, P10221, DOI 10.1128/JVI.00843-13; PARMLEY SF, 1988, GENE, V73, P305, DOI 10.1016/0378-1119(88)90495-7; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; PORTER RR, 1959, BIOCHEM J, V73, P119, DOI 10.1042/bj0730119; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Shen Y, 2013, MABS-AUSTIN, V5, P418, DOI 10.4161/mabs.24291; Slabinski L, 2007, PROTEIN SCI, V16, P2472, DOI 10.1110/ps.073037907; Terwilliger TC, 2009, ANNU REV BIOPHYS, V38, P371, DOI 10.1146/annurev.biophys.050708.133740; Ul-Haq Z, 2016, CYTOKINE GROWTH F R, V32, P3, DOI 10.1016/j.cytogfr.2016.04.002; Wilson DW, 1923, J BIOL CHEM, V56, P203; Wingren C, 2003, PROTEIN ENG, V16, P255, DOI 10.1093/proeng/gzg038; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu YD, 2019, MABS-AUSTIN, V11, DOI 10.1080/19420862.2018.1553476	32	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0232311	10.1371/journal.pone.0232311	http://dx.doi.org/10.1371/journal.pone.0232311			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915778	Green Submitted, gold, Green Published			2022-12-26	WOS:000571887500115
J	Tanaka, S; Sakamoto, R; Kanahashi, T; Yamada, S; Imai, H; Yoneyama, A; Takakuwa, T				Tanaka, Sayaka; Sakamoto, Rino; Kanahashi, Toru; Yamada, Shigehito; Imai, Hirohiko; Yoneyama, Akio; Takakuwa, Tetsuya			Shoulder girdle formation and positioning during embryonic and early fetal human development	PLOS ONE			English	Article							HUMAN VERTEBRAL COLUMN; PERIOD PROPER; SCAPULA; END	Positional information on the shoulder girdle (the clavicle and scapula) is important for a better understanding of the function of the upper limb in the locomotive system as well as its associated disease pathogenesis. However, such data are limited except for information on the axial position of the scapula. Here, we describe a three-dimensional reconstruction of the shoulder girdle including the clavicle and scapula, and its relationship to different landmarks in the body. Thirty-six human fetal specimens (crown-rump length range: 7.6-225 mm) from the Kyoto Collection were used for this study. The morphogenesis and three-dimensional position of the shoulder girdle were analyzed with phase-contrast X-ray computed tomography and magnetic resonance imaging. We first detected the scapula body along with the coracoid and humeral head at Carnegie stage 18; however, the connection between the body and coracoid was not confirmed at this stage. During development, all landmarks on the shoulder girdle remained at the same axial position except for the inferior angle, which implies that the scapula enlarged in the caudal direction and reached the adult axial position in the fetal period. The scapula body was rotated internally and in the upward direction at the initiation of morphogenesis, but in the fetal period the scapula body was different than that in the adult position. The shoulder girdle was located at the ventral side of the vertebrae at the time of initial morphogenesis, but changed its position to the lateral side of the vertebrae in the late embryonic and fetal periods. Such a unique position of the shoulder girdle may contribute to the stage-specific posture of the upper limb. Adequate internal and upward rotation of the scapula could help in reducing the shoulder width, thereby facilitating childbirth. The data presented in this study can be used as normal morphometric references for shoulder girdle evaluations in the embryonic and fetal periods.	[Tanaka, Sayaka; Sakamoto, Rino; Kanahashi, Toru; Yamada, Shigehito; Takakuwa, Tetsuya] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan; [Yamada, Shigehito] Kyoto Univ, Congenital Anomaly Res Ctr, Grad Sch Med, Kyoto, Japan; [Imai, Hirohiko] Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Kyoto, Japan; [Yoneyama, Akio] SAGA Light Source, Saga, Japan	Kyoto University; Kyoto University; Kyoto University	Takakuwa, T (corresponding author), Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan.	tez@hs.med.kyoto-u.ac.jp	Yoneyama, Akio/ABH-5357-2020; Yamada, Shigehito/G-2061-2010	Yamada, Shigehito/0000-0002-8194-6927; Takakuwa, Tetsuya/0000-0002-9660-9384; Yoneyama, Akio/0000-0001-6925-6723; Kanahashi, Toru/0000-0002-9895-0500	Japan Society for the Promotion of Science [JP26220004, JP16K15535, JP17H05294, JP18K07876]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	JP26220004, JP16K15535, JP17H05294, JP18K07876 from the Japan Society for the Promotion of Science for Takakuwa T.	Abe S, 2011, SURG RADIOL ANAT, V33, P609, DOI 10.1007/s00276-011-0780-3; Ahn ES, 2015, PEDIATR INT, V57, P60, DOI 10.1111/ped.12497; Blechschmidt E, 1961, STAGES HUMAN DEV BIR; de la Cuadra-Blanco C, 2017, CELLS TISSUES ORGANS, V203, P365, DOI 10.1159/000455191; Hita-Contreras F, 2018, J ANAT, V232, P422, DOI 10.1111/joa.12753; Horwitz AE, 1908, AM J ORTHOP SURG, V6, P260; Larson Susan G., 2009, P65, DOI 10.1007/978-1-4020-9980-9_7; Lewis WH, 1902, AM J ANAT, V1, P145, DOI 10.1002/aja.1000010204; Mekonen HK, 2015, J ANAT, V227, P673, DOI 10.1111/joa.12380; MODANLOU HD, 1982, OBSTET GYNECOL, V60, P417; Momose A, 2001, NUCL INSTRUM METH A, V467, P917, DOI 10.1016/S0168-9002(01)00523-X; Monfort K, 1997, AM J OCCUP THER, V51, P378, DOI 10.5014/ajot.51.5.378; MULLER F, 1986, AM J ANAT, V177, P3, DOI 10.1002/aja.1001770103; Nath RK, 2007, SURG RADIOL ANAT, V29, P133, DOI 10.1007/s00276-006-0173-1; NISHIMURA H, 1968, TERATOLOGY, V1, P281, DOI 10.1002/tera.1420010306; O'Rahilly R., 1987, DEV STAGES HUMAN EMB; Okumura M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173852; ORAHILLY R, 1972, AM J ANAT, V134, P291, DOI 10.1002/aja.1001340303; ORAHILLY R, 1990, J ANAT, V168, P81; ORAHILLY R, 1980, J ANAT, V131, P565; Paine R, 2013, INT J SPORTS PHYS TH, V8, P617; Park JY, 2014, J SHOULDER ELB SURG, V23, P821, DOI 10.1016/j.jse.2013.08.016; Schaefer Maureen, 2009, JUVENILE OSTEOLOGY L; Schuenke M, 2006, GEN ANATOMY MUSCULOS; SHIOTA K, 1991, Congenital Anomalies, V31, P67, DOI 10.1111/j.1741-4520.1991.tb00360.x; Standring S., 2020, GRAYS ANATOMY; Suzuki Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221569; Toyoda S, 2015, ANAT REC, V298, P2081, DOI 10.1002/ar.23268; VONBAZAN UB, 1979, J BONE JOINT SURG BR, V61, P59, DOI 10.1302/0301-620X.61B1.422634; Williams MS, 2003, AM J MED GENET A, V120A, P583, DOI 10.1002/ajmg.a.20091; Yamaguchi Y, 2018, CELLS TISSUES ORGANS, V205, P314, DOI 10.1159/000490672; Yin B, 2010, ORTHOP CLIN N AM, V41, P297, DOI 10.1016/j.ocl.2010.02.003; Yoneyama A, 2004, NUCL INSTRUM METH A, V523, P217, DOI 10.1016/j.nima.2003.12.008; Yoneyama A, 2011, ADVANCED BIOMEDICAL ENGINEERING-BOOK, P107	34	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238225	10.1371/journal.pone.0238225	http://dx.doi.org/10.1371/journal.pone.0238225			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915841	gold, Green Published			2022-12-26	WOS:000571887500074
J	Cohen, NP; Chodorow, M; Byosiere, SE				Cohen, Nicole Passmore; Chodorow, Martin; Byosiere, Sarah-Elizabeth			A label's a label, no matter the dog: Evaluating the generalizability of the removal of breed labels from adoption cards	PLOS ONE			English	Article							SHELTER; RELINQUISHMENT; VALIDITY	A common barrier to entry for New York City (NYC) dog adopters trying to rent apartments is the breed label the animal shelter assigned to their dog, despite the fact the labelling is primarily based on intuition and appearance. Bideawee, a limited admission shelter with three locations in the greater New York area, including one in NYC, phased out breed labels from their adoption cards in December 2017. In this study, we evaluated the generalizability of previous findings, specifically, that the removal of breed labels from adoption cards affected length of stay. Moreover, due to Bideawee's multi-location structure, this study provided a unique opportunity to compare variables across different shelter sites while having shelter administration practices held constant. Data from 16-month time periods before and after breed labels were removed was compared. The median length of stay of a dog at Bideawee decreased by 11.3 days (-37.3%) once breed labels were removed (Mdn= 19.0) compared to when breed labels were in place (Mdn= 30.3). A Mann Whitney test indicated that this difference was statistically significant (U(N-no breed labels= 1259,N-breed labels= 987) = 386309.5,z= -15.41, p < .001). Dogs with a "green" behavior assessments (on a scale of green, blue, yellow, red) were almost four and a half times more likely to be adopted faster than "red" dogs (HR: 4.495, 95% CI 2.755-7.335, p < .001) before breed labels were removed, but only two times as likely to be adopted faster afterwards (HR: 2.220, 95% CI 1.514-3.254, p < .001). The return rate stayed constant across the two time periods at 6%. These findings provide new insights on dog adoptions in the NYC area and suggest that the removal of breed labels will help all dogs get adopted from animal shelters.	[Cohen, Nicole Passmore; Byosiere, Sarah-Elizabeth] CUNY Hunter Coll, Dept Psychol, Thinking Dog Ctr, New York, NY 10021 USA; [Chodorow, Martin] CUNY Hunter Coll, Dept Psychol, New York, NY 10021 USA; [Chodorow, Martin] CUNY, Grad Ctr, New York, NY USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System	Cohen, NP (corresponding author), CUNY Hunter Coll, Dept Psychol, Thinking Dog Ctr, New York, NY 10021 USA.	nicole.passmore40@myhunter.cuny.edu		Passmore, Nicole/0000-0003-3602-340X				[Anonymous], 2013, PRACTICAL PHARM CLIN, V16, P2; ASPCA, PET STAT SHELT INT S; Chen S, 2018, NEW YORK TIMES  0208; Fox J., 2002, R S PLUS COMPANION A; Gunter LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146857; Hawes S, 2018, ANIMALS-BASEL, V8, DOI 10.3390/ani8030036; Hoffman CL, 2014, J APPL ANIM WELF SCI, V17, P322, DOI 10.1080/10888705.2014.895904; Lepper Merry, 2002, Journal of Applied Animal Welfare Science, V5, P29, DOI 10.1207/S15327604JAWS0501_3; Mornement KM, 2015, APPL ANIM BEHAV SCI, V167, P35, DOI 10.1016/j.applanim.2015.03.013; NYCHA, 2018, NYCHA PET POL OV; Papageorgiou KI, 2019, ALGORITHMS, V12, DOI 10.3390/a12110235; Patronek GJ, 2019, J VET BEHAV, V31, P43, DOI 10.1016/j.jveb.2019.03.001; Patronek GJ, 2018, ANIMALS, V8, DOI 10.3390/ani8040045; Protopopova A, 2017, ANIM WELFARE, V26, P35, DOI 10.7120/09627286.26.1.035; Protopopova A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114319; Protopopova A, 2014, APPL ANIM BEHAV SCI, V157, P109, DOI 10.1016/j.applanim.2014.04.007; Rohrer JM, 2018, ADV METH PRACT PSYCH, V1, P27, DOI 10.1177/2515245917745629; Rowan A., 2018, ANIMALS, V8, P5; StreetEasy, 2017, STREETEASY BLOG; The Lancet Global Health, 2018, LANCET GLOB HLTH, V6, pE593; Voith V, 2013, AM J SOCIOLOGICAL RE, V3, P17, DOI DOI 10.5923/J.SOCIOLOGY.20130302.02; Weiss E., 2015, Open Journal of Animal Sciences, V5, P435, DOI 10.4236/ojas.2015.54046; Weiss Emily, 2014, Animals (Basel), V4, P409, DOI 10.3390/ani4030409; Zawistowski S, 1998, J Appl Anim Welf Sci, V1, P193, DOI 10.1207/s15327604jaws0103_1; 2005, P JANGJEON MATH SOC, V8, P25	25	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238176	10.1371/journal.pone.0238176	http://dx.doi.org/10.1371/journal.pone.0238176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911502	gold, Green Published			2022-12-26	WOS:000571885900027
J	Zhang, JF; Wei, B; Cha, SY; Shang, K; Jang, HK; Kang, M				Zhang, Jun-feng; Wei, Bai; Cha, Se-Yeoun; Shang, Ke; Jang, Hyung-Kwan; Kang, Min			The use of embryonic chicken eggs as an alternative model to evaluate the virulence ofSalmonella entericaserovar Gallinarum	PLOS ONE			English	Article							LETHALITY ASSAY; SALMONELLA-GALLINARUM; PULLORUM DISEASE; INFECTION; STRAIN; VACCINATION	Salmonella entericaserovar Gallinarum (S. Gallinarum) can cause fowl typhoid, a severe systemic disease responsible for considerable economic losses. Chicken pathogenicity test is the traditional method for assessing the virulence ofS. Gallinarum. However, this method is limited by several factors, including ethical considerations, costs, and the need for specialized facilities. Hence, we established a chicken embryo lethality assay (ELA) model to determine the virulence ofS. Gallinarum. Three virulent and three avirulent representative strains, which were confirmed by the chicken pathogenicity test, were used to perform the ELA. The most significant difference between the virulent and avirulent strains could be observed when 13-day-old embryos were inoculated via the AC route and incubated for 5 days. Based on a 50% embryo lethal dose (ELD50), isolates considered to be virulent had a Log(10)ELD(50)of <= 4.0, moderately virulent strains had a Log(10)ELD(50)of 4.0-6.1, and avirulent isolates had a Log(10)ELD(50)of >= 6.1. Different abilities to invade the liver of embryos were found between the virulent and avirulent strains by a growth curve experimentin vitro. The maximum colony-forming units (CFU) of the virulent strain was about 10,000 times higher than that of the avirulent strain in the liver at 5 days post infection. The ELA results of 42 field strains showed that thirty-two strains (76.2%) were virulent, nine were moderately virulent (21.4%), and one strain was avirulent (2.4%). In conclusion, these results suggest that the ELA can be used as an alternative method to assess the virulence ofS. Gallinarum, which will contribute to the study of virulence genes, virulence evolution, pathogenic mechanisms and vaccine development.	[Zhang, Jun-feng; Wei, Bai; Cha, Se-Yeoun; Shang, Ke; Jang, Hyung-Kwan; Kang, Min] Jeonbuk Natl Univ, Coll Vet Med, Dept Vet Infect Dis & Avian Dis, Iksan, South Korea; [Zhang, Jun-feng; Wei, Bai; Cha, Se-Yeoun; Shang, Ke; Jang, Hyung-Kwan; Kang, Min] Jeonbuk Natl Univ, Ctr Poultry Dis Control, Iksan, South Korea; [Jang, Hyung-Kwan; Kang, Min] Bio Dis Control BIOD Co Ltd, Iksan, South Korea	Jeonbuk National University; Jeonbuk National University	Jang, HK; Kang, M (corresponding author), Jeonbuk Natl Univ, Coll Vet Med, Dept Vet Infect Dis & Avian Dis, Iksan, South Korea.; Jang, HK; Kang, M (corresponding author), Jeonbuk Natl Univ, Ctr Poultry Dis Control, Iksan, South Korea.; Jang, HK; Kang, M (corresponding author), Bio Dis Control BIOD Co Ltd, Iksan, South Korea.	hkjang@chonbuk.ac.kr; vet.minkang@gmail.com		Zhang, Junfeng/0000-0003-2360-6382	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry (IPET) through Agriculture, Food and Rural Affairs Convergence Technologies Program for Educating Creative Global Leader - Ministry of Agriculture, Food and Rural A [716002-7, 120005-2]; Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry(IPET) through Animal Disease Management Technology Development Program - Ministry of Agriculture, Food and Rural Affairs(MAFRA) [119059-2]; Jeonbuk National University	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry (IPET) through Agriculture, Food and Rural Affairs Convergence Technologies Program for Educating Creative Global Leader - Ministry of Agriculture, Food and Rural A; Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry(IPET) through Animal Disease Management Technology Development Program - Ministry of Agriculture, Food and Rural Affairs(MAFRA); Jeonbuk National University	Author who received each award: Min Kang 1. Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry (IPET) through Agriculture, Food and Rural Affairs Convergence Technologies Program for Educating Creative Global Leader, funded by Ministry of Agriculture, Food and Rural Affairs(MAFRA) (716002-7, 120005-2) 2. Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry(IPET) through Animal Disease Management Technology Development Program, funded by Ministry of Agriculture, Food and Rural Affairs(MAFRA)(119059-2) 3. The selection of research-oriented professor of Jeonbuk National University in 2020 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnassan AA, 2013, PARASITOL RES, V112, P2299, DOI 10.1007/s00436-013-3392-5; Andersson C, 2015, NAT PROTOC, V10, P1155, DOI 10.1038/nprot.2015.073; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Barrow PA, 2007, AVIAN PATHOL, V36, P1, DOI 10.1080/03079450601113167; Barrow PA, 2011, AVIAN PATHOL, V40, P1, DOI 10.1080/03079457.2010.542575; Berchieri A, 2001, AVIAN PATHOL, V30, P221, DOI 10.1080/03079450120054631; Blanco AE, 2017, AVIAN PATHOL, V46, P548, DOI 10.1080/03079457.2017.1324942; Doke SK, 2015, SAUDI PHARM J, V23, P223, DOI 10.1016/j.jsps.2013.11.002; FIELD LH, 1986, INFECT IMMUN, V54, P118, DOI 10.1128/IAI.54.1.118-125.1986; Geng SZ, 2017, MICROB PATHOGENESIS, V104, P146, DOI 10.1016/j.micpath.2017.01.014; Guo RX, 2017, AVIAN PATHOL, V46, P535, DOI 10.1080/03079457.2017.1324197; Jacobsen ID, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019741; Jacobsen ID, 2010, INFECT IMMUN, V78, P2995, DOI 10.1128/IAI.00268-10; Kwon YK, 2010, POULTRY SCI, V89, P236, DOI 10.3382/ps.2009-00420; Lacharme-Lora L, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007540; Landman WJM, 1999, AVIAN PATHOL, V28, P545, DOI 10.1080/03079459994335; Nix EB, 2006, INFECT IMMUN, V74, P4809, DOI 10.1128/IAI.00034-06; Osorio JE, 2012, AM J TROP MED HYG, V87, P565, DOI 10.4269/ajtmh.2012.11-0655; PINE L, 1995, FEMS MICROBIOL LETT, V130, P37; Polakowska K, 2012, MICROBES INFECT, V14, P1352, DOI 10.1016/j.micinf.2012.09.006; POWELL CJ, 1966, J BACTERIOL, V91, P1410, DOI 10.1128/JB.91.4.1410-1417.1966; Revolledo L, 2018, J APPL POULTRY RES, V27, P279, DOI 10.3382/japr/pfx066; Seo HS, 2013, AVIAN PATHOL, V42, P387, DOI 10.1080/03079457.2013.816654; Shivaprasad HL, 2000, REV SCI TECH OIE, V19, P405, DOI 10.20506/rst.19.2.1222; SILVA EN, 1981, AVIAN DIS, V25, P38, DOI 10.2307/1589825; Takamatsu Y, 2014, J GEN VIROL, V95, P373, DOI 10.1099/vir.0.057968-0; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Townsend MK, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-12; Wooley RE, 2000, AVIAN DIS, V44, P318, DOI 10.2307/1592546; Zhang-Barber L, 1999, VACCINE, V17, P2538, DOI 10.1016/S0264-410X(99)00060-2; Zhu CY, 2015, MICROBIOL IMMUNOL, V59, P443, DOI 10.1111/1348-0421.12276	31	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238630	10.1371/journal.pone.0238630	http://dx.doi.org/10.1371/journal.pone.0238630			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911523	gold, Green Published			2022-12-26	WOS:000571885900010
J	Faurot-Daniels, C; Glenny, W; Daughenbaugh, KF; McMenamin, AJ; Burkle, LA; Flenniken, ML				Faurot-Daniels, Cayley; Glenny, William; Daughenbaugh, Katie F.; McMenamin, Alexander J.; Burkle, Laura A.; Flenniken, Michelle L.			Longitudinal monitoring of honey bee colonies reveals dynamic nature of virus abundance and indicates a negative impact of Lake Sinai virus 2 on colony health	PLOS ONE			English	Article							DEFORMED WING VIRUS; APIS-MELLIFERA L.; VARROA-DESTRUCTOR ACARI; PARALYSIS VIRUS; NATIONAL-SURVEY; LOSSES; PREVALENCE; INFECTION; MODEL; TRANSMISSION	Honey bees (Apis mellifera) are important pollinators of plants, including those that produce nut, fruit, and vegetable crops. Therefore, high annual losses of managed honey bee colonies in the United States and many other countries threaten global agriculture. Honey bee colony deaths have been associated with multiple abiotic and biotic factors, including pathogens, but the impact of virus infections on honey bee colony population size and survival are not well understood. To further investigate seasonal patterns of pathogen presence and abundance and the impact of viruses on honey bee colony health, commercially managed colonies involved in the 2016 California almond pollination event were monitored for one year. At each sample date, colony health and pathogen burden were assessed. Data from this 50-colony cohort study illustrate the dynamic nature of honey bee colony health and the temporal patterns of virus infection. Black queen cell virus, deformed wing virus, sacbrood virus, and the Lake Sinai viruses were the most readily detected viruses in honey bee samples obtained throughout the year. Analyses of virus prevalence and abundance revealed pathogen-specific trends including the overall increase in deformed wing virus abundance from summer to fall, while the levels of Lake Sinai virus 2 (LSV2) decreased over the same time period. Though virus prevalence and abundance varied in individual colonies, analyses of the overall trends reveal correlation with sample date. Total virus abundance increased from November 2015 (post-honey harvest) to the end of the almond pollination event in March 2016, which coincides with spring increase in colony population size. Peak total virus abundance occurred in late fall (August and October 2016), which correlated with the time period when the majority of colonies died. Honey bee colonies with larger populations harbored less LSV2 than weaker colonies with smaller populations, suggesting an inverse relationship between colony health and LSV2 abundance. Together, data from this and other longitudinal studies at the colony level are forming a better understanding of the impact of viruses on honey bee colony losses.	[Faurot-Daniels, Cayley; Daughenbaugh, Katie F.; Flenniken, Michelle L.] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA; [Faurot-Daniels, Cayley; Glenny, William; Daughenbaugh, Katie F.; McMenamin, Alexander J.; Burkle, Laura A.; Flenniken, Michelle L.] Montana State Univ, Pollinator Hlth Ctr, Bozeman, MT 59717 USA; [Glenny, William; Burkle, Laura A.] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA; [McMenamin, Alexander J.; Flenniken, Michelle L.] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Flenniken, ML (corresponding author), Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA.; Flenniken, ML (corresponding author), Montana State Univ, Pollinator Hlth Ctr, Bozeman, MT 59717 USA.; Flenniken, ML (corresponding author), Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA.	michelle.flenniken@montana.edu		Flenniken, Michelle/0000-0003-0356-3370	Montana Department of Agriculture's Specialty Crop Block Grant Program [16SC000502]; United States Department of Agriculture, National Science Foundation CAREER Program [1651561]; Hatch Multistate Funding [NC-1173]; Project Apis m.-Costco Scholar Fellowship; Montana State Beekeepers Association	Montana Department of Agriculture's Specialty Crop Block Grant Program; United States Department of Agriculture, National Science Foundation CAREER Program; Hatch Multistate Funding; Project Apis m.-Costco Scholar Fellowship; Montana State Beekeepers Association	Funding Awarded to MLF: Montana Department of Agriculture's Specialty Crop Block Grant Program (Award#16SC000502) with the United States Department of Agriculture, National Science Foundation CAREER Program (Award#1651561), and Hatch Multistate Funding (NC-1173). Funding Awarded to AJM & MLF: Project Apis m.-Costco Scholar Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Fenali Parekh, a member of the Flenniken laboratory for reviewing this manuscript prior to publication, the commercial beekeeping operation involved in this study, and the Montana State Beekeepers Association for their support of our research efforts.	Afrikanova Tatiana, 2013, PLoS One, V8, pe54166, DOI 10.1371/journal.pone.0054166; Alger SA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221800; Alger SA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217822; Alger SA, 2018, PEERJ, V6, DOI 10.7717/peerj.5812; [Anonymous], 2015, TOOLS VARR MAN GUID, P8; [Anonymous], 2017, CANADIAN NATL HONEY; [Anonymous], 2014, CALIFORNIA ABO ALMON; Antunez K, 2015, MICROB ECOL, V70, P522, DOI 10.1007/s00248-015-0594-7; Barroso-Arevalo S, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01331; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bigot D, 2017, J GEN VIROL, V98, P2864, DOI 10.1099/jgv.0.000957; Bruckner S, 2018, US HONEY BEE COLONY; Bruckner S, 2019, 2018 2019 HONEY BEE; Brutscher LM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06623-z; Brutscher LM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005757; Brutscher LM, 2015, CURR OPIN INSECT SCI, V10, P71, DOI 10.1016/j.cois.2015.04.016; Budge GE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133228; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; Cavigli I, 2016, APIDOLOGIE, V47, P251, DOI 10.1007/s13592-015-0395-5; Chejanovsky N, 2014, VIROLOGY, V454, P176, DOI 10.1016/j.virol.2014.02.012; Chen YP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004261; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Chen YP, 2006, J INVERTEBR PATHOL, V92, P152, DOI 10.1016/j.jip.2006.03.010; Chen YP, 2004, APIDOLOGIE, V35, P441, DOI 10.1051/apido:2004031; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cornman RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000466; Cornman RS, 2019, PEERJ, V7, DOI 10.7717/peerj.6305; Currie RW, 2006, CAN ENTOMOL, V138, P238; Currie RW, 2008, EC THRESHOLD VARROA; Curtis CJ, 2014, ECOL INDIC, V37, P274, DOI 10.1016/j.ecolind.2012.10.023; D'Alvise P, 2019, ECOL EVOL, V9, P10241, DOI 10.1002/ece3.5544; Dainat B, 2013, J INVERTEBR PATHOL, V112, P278, DOI 10.1016/j.jip.2012.12.009; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Dainat B, 2012, APPL ENVIRON MICROB, V78, P981, DOI 10.1128/AEM.06537-11; Daughenbaugh KF, 2015, VIRUSES-BASEL, V7, P3285, DOI 10.3390/v7062772; DeGrandi-Hoffman G, 2004, INT J ACAROL, V30, P259, DOI 10.1080/01647950408684393; Desai SD, 2012, INSECT MOL BIOL, V21, P446, DOI 10.1111/j.1365-2583.2012.01150.x; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Di Prisco G, 2011, J GEN VIROL, V92, P151, DOI 10.1099/vir.0.023853-0; Eilers EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021363; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Ferrier PM, 2018, EC EFECTS RESPONSES; Forsgren E, 2010, J INVERTEBR PATHOL, V103, pS5, DOI 10.1016/j.jip.2009.06.016; Francis RM, 2013, J GEN VIROL, V94, P668, DOI 10.1099/vir.0.047019-0; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; Giacobino A, 2015, APIDOLOGIE, V46, P573, DOI 10.1007/s13592-015-0347-0; Glenny W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182814; Granberg F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057459; Grozinger CM, 2019, ANNU REV ENTOMOL, V64, P205, DOI 10.1146/annurev-ento-011118-111942; Guzman-Novoa E, 2010, APIDOLOGIE, V41, P443, DOI 10.1051/apido/2009076; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kulhanek K, 2017, J APICULT RES, V56, P328, DOI 10.1080/00218839.2017.1344496; Langstroth L, 2015, LANGSTROTH HIVE HONE; Lee KV, 2010, J ECON ENTOMOL, V103, P1039, DOI 10.1603/EC10037; Lee KV, 2015, APIDOLOGIE, V46, P292, DOI 10.1007/s13592-015-0356-z; Leonard SP, 2020, SCIENCE, V367, P573, DOI 10.1126/science.aax9039; Liu XJ, 2010, CURR MICROBIOL, V61, P422, DOI 10.1007/s00284-010-9633-2; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Martin S, 1998, ECOL MODEL, V109, P267, DOI 10.1016/S0304-3800(98)00059-3; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Mazzei M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113448; McMenamin AJ, 2018, VIRUSES-BASEL, V10, DOI [10.3390/v10080395, 10.3390/v10]; McMenamin AJ, 2018, CURR OPIN INSECT SCI, V26, P120, DOI 10.1016/j.cois.2018.02.009; McMenamin AJ, 2015, CURR OPIN INSECT SCI, V8, P121, DOI 10.1016/j.cois.2015.01.015; Milbrath M, VARROA MITE MONITORI; Mordecai G. J., 2016, ISME J, V10, P1; Nazzi F, 2016, ANNU REV ENTOMOL, V61, P417, DOI 10.1146/annurev-ento-010715-023731; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Nunes Francis M.F., 2013, Insects, V4, P90, DOI 10.3390/insects4010090; Oksanen J., 2019, PACKAGEVEGAN; Olivier V, 2008, VIRUS RES, V132, P59, DOI 10.1016/j.virusres.2007.10.014; Pirk CW, 2013, COLOSS BEE BOOK, VI; Porrini C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155411; R Core Team, 2021, R LANGUAGE ENV STAT; Ramsey SD, 2019, P NATL ACAD SCI USA, V116, P1792, DOI 10.1073/pnas.1818371116; Ravoet J, 2015, J INVERTEBR PATHOL, V130, P21, DOI 10.1016/j.jip.2015.06.007; Ravoet J, 2015, VIRUS RES, V201, P67, DOI 10.1016/j.virusres.2015.02.019; Ravoet J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072443; Ricigliano VA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28732-z; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Roth MA, 2020, J INTEGR PEST MANAG, V11, DOI 10.1093/jipm/pmz036; Runckel C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095057; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Ryabov EV, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004230; Sagili RR, 2011, EVALUATING HONEY BEE; Seitz N, 2016, J APICULT RES, V54, P292, DOI 10.1080/00218839.2016.1153294; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; Simpson G, 2018, PACKAGE TSGAM; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Spleen AM, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.2.07; Steinhauer N, 2017, HONEY BEE COLONY LOS; Steinhauer NA, 2014, J APICULT RES, V53, P1, DOI 10.3896/IBRA.1.53.1.01; Steinmann N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129956; Tehel A, 2016, CURR OPIN VIROL, V19, P16, DOI 10.1016/j.coviro.2016.06.006; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; Traynor KS, 2016, APIDOLOGIE, V47, P325, DOI 10.1007/s13592-016-0431-0; USDA-NASS, 2018, USDA NASS 2018 CAL A; USDA-NASS, 2018, USDA NASS 2018 HON B; van der Zee R, 2012, J APICULT RES, V51, P91, DOI 10.3896/IBRA.1.51.1.12; vanEngelsdorp D, 2013, PREV VET MED, V108, P225, DOI 10.1016/j.prevetmed.2012.08.004; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; Wei T., 2017, PACKAGE CORRPLOT; Wilfert L, 2016, SCIENCE, V351, P594, DOI 10.1126/science.aac9976; Wilkinson D, 2002, ECOL MODEL, V148, P263, DOI 10.1016/S0304-3800(01)00440-9; Winston M., 1987, The biology of the honey bee.; Wood S., 2020, PACKAGE GAMM4; Zhu XJ, 2014, J APICULT RES, V53, P469, DOI 10.3896/IBRA.1.53.4.06; 2016, P NATL ACAD SCI US, V113	111	14	14	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0237544	10.1371/journal.pone.0237544	http://dx.doi.org/10.1371/journal.pone.0237544			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ6EE	32898160	Green Published, gold			2022-12-26	WOS:000570962500012
J	Jiang, HY; Song, QH; Gao, KD; Song, QJ; Zhao, XG				Jiang, HaiYan; Song, Qinghui; Gao, Kuidong; Song, QingJun; Zhao, XieGuang			Rule-based expert system to assess caving output ratio in top coal caving	PLOS ONE			English	Article							LEVENBERG-MARQUARDT METHOD; FUZZY; MODEL; LOGIC; IDENTIFICATION	Coal mining professionals in coal mining have recognized that the assessment of top coal release rate can not only improve the recovery rate of top coal, but also improve the quality of coal. But the process was often performed using a manual-based operation mode, which intensifies workload and difficulty, and is at risk of human errors. The study designs a assessment system to give the caving output ratio in top coal caving as accurately as possible based on the parameters adaptive Takagi-Sugeno (T-S) fuzzy system and the Levenberg-Marquardt (LM) algorithm. The main goal of the adaptive parameters based on LM algorithm is to construct its damping factor in the light of lowering of the objective function which is as taken as the index of termination iteration. The performance of the system is evaluated by Pearson correlation coefficient, Coefficient of Determination and relative error where the results of the Takagi-Sugeno method and the parameters adaptive Takagi-Sugeno method are compared to make the evaluation more robust and comprehensive.	[Jiang, HaiYan; Song, QingJun; Zhao, XieGuang] Shandong Univ Sci & Technol, Tai An Sch, Tai An, Shandong, Peoples R China; [Song, Qinghui] Shandong Univ Sci & Technol, Dept Mech & Elect Engn, Qingdao, Shandong, Peoples R China; [Gao, Kuidong] Shandong Univ Sci & Technol, Shandong Prov Key Lab Mine Mech Engn, Qingdao, Shandong, Peoples R China	Shandong University of Science & Technology; Shandong University of Science & Technology; Shandong University of Science & Technology	Song, QJ (corresponding author), Shandong Univ Sci & Technol, Tai An Sch, Tai An, Shandong, Peoples R China.	skdsj@sdust.edu.cn			Key Technologies RAMP;D Program of Shandong China [2019GGX101011]; SDUST Research Fund [2018TDJH101]; Shandong Province Key Laboratory of Mine Mechanical Engineering open fund [2019KLMM202]; University Planning Projects of Science and Technology of Shandong Province [J18KB011, J18KA319]	Key Technologies RAMP;D Program of Shandong China; SDUST Research Fund; Shandong Province Key Laboratory of Mine Mechanical Engineering open fund; University Planning Projects of Science and Technology of Shandong Province	This work was supported by Key Technologies R&D Program of Shandong China 2019GGX101011, SDUST Research Fund 2018TDJH101, Shandong Province Key Laboratory of Mine Mechanical Engineering open fund 2019KLMM202,University Planning Projects of Science and Technology of Shandong Province under Grants J18KB011 and J18KA319.	[Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; Blaifi SA, 2019, RENEW ENERG, V135, P745, DOI 10.1016/j.renene.2018.12.054; Bledsoe KC, 2011, ANN NUCL ENERGY, V38, P897, DOI 10.1016/j.anucene.2010.09.014; Botzheim J, 2006, IEEE INT CONF FUZZY, P2263, DOI 10.1109/FUZZY.2006.1682014; Coelho AA, 2018, J APPL CRYSTALLOGR, V51, P428, DOI 10.1107/S1600576718001784; Roldan-Garcia MD, 2017, EXPERT SYST APPL, V90, P332, DOI 10.1016/j.eswa.2017.08.036; Derakhshandeh SY, 2018, INT J ELEC POWER, V99, P299, DOI 10.1016/j.ijepes.2018.01.019; Dkhichi F, 2014, SOL ENERGY, V110, P781, DOI 10.1016/j.solener.2014.09.033; Flores-Hernandez AA, 2018, CHEM ENG RES DES, V140, P320, DOI 10.1016/j.cherd.2018.10.021; Guenounou O, 2015, APPL SOFT COMPUT, V30, P748, DOI 10.1016/j.asoc.2015.02.017; Ikram A, 2015, KNOWL-BASED SYST, V75, P87, DOI 10.1016/j.knosys.2014.11.024; Kim SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171394; Kuo YL, 2019, INT J FUZZY SYST, V21, P556, DOI 10.1007/s40815-018-0574-4; Liao SH, 2005, EXPERT SYST APPL, V28, P93, DOI 10.1016/j.eswa.2004.08.003; Liu W, 2010, INT CONF COMP SCI, P556, DOI 10.1109/ICCSIT.2010.5563951; Pourbagher R, 2016, IET GENER TRANSM DIS, V10, P3017, DOI 10.1049/iet-gtd.2016.0064; Sharma R, 2018, J INTELL FUZZY SYST, V35, P807, DOI 10.3233/JIFS-171325; Song QJ, 2017, PATTERN ANAL APPL, V20, P1307, DOI 10.1007/s10044-017-0618-7; Stojic M., 2019, DECIS MAKING APPL MA, V2, P35, DOI DOI 10.31181/DMAME1901035S; TAKAGI T, 1985, IEEE T SYST MAN CYB, V15, P116, DOI 10.1109/TSMC.1985.6313399; Vilela M., 2019, DECIS MAKING, V2, P1, DOI [10.31181/dmame1902001v, DOI 10.31181/DMAME1902001V]; Wang B, 2018, J VIB CONTROL, V24, P1001, DOI 10.1177/1077546316655912; Wang JC, 2014, INT J ROCK MECH MIN, V71, P160, DOI 10.1016/j.ijrmms.2014.04.024; Wong WK, 2009, EXPERT SYST APPL, V36, P2377, DOI 10.1016/j.eswa.2007.12.068; Wu X, 2014, J PROCESS CONTR, V24, P1609, DOI 10.1016/j.jprocont.2014.08.007; Xia BZ, 2018, ENERGY, V153, P694, DOI 10.1016/j.energy.2018.04.085; Yang GM, 2016, J IRON STEEL RES INT, V23, P434, DOI 10.1016/S1006-706X(16)30069-3; Yang Y, 2019, IEEE ACCESS, V7, P106783, DOI 10.1109/ACCESS.2019.2932118; Yazid E, 2019, APPL SOFT COMPUT, V78, P373, DOI 10.1016/j.asoc.2019.02.023; Zhang GQ, 2017, MATH PROBL ENG, V2017, DOI 10.1155/2017/2948750; Zhang Z, 2018, IEEE T AERO ELEC SYS, V54, P642, DOI 10.1109/TAES.2017.2761199; Zhu B, 2015, J HYDROINFORM, V17, P90, DOI 10.2166/hydro.2014.037	33	5	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238138	10.1371/journal.pone.0238138	http://dx.doi.org/10.1371/journal.pone.0238138			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886664	Green Published, gold			2022-12-26	WOS:000571064300044
J	Elenkov, A; Giwercman, A; Tottenborg, SS; Bonde, JPE; Glazer, CH; Haervig, KK; Bungum, AB; Nilsson, PM				Elenkov, Angel; Giwercman, Aleksander; Tottenborg, Sandra Sogaard; Bonde, Jens Peter Ellekilde; Glazer, Clara Helene; Haervig, Katia Keglberg; Bungum, Ane Berger; Nilsson, Peter M.			Male childlessness as independent predictor of risk of cardiovascular and all-cause mortality: A population-based cohort study with more than 30 years follow-up	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ENDOGENOUS TESTOSTERONE; METABOLIC SYNDROME; SEMEN QUALITY; ASSOCIATION; MEN; INFERTILITY; HEALTH; ATHEROSCLEROSIS; HYPOGONADISM	In a recent population-based study, an elevated risk of the Metabolic syndrome (MetS) and type 2 diabetes was found in childless men compared to those who have fathered one or more children. Therefore, by using a larger cohort of more than 22 000 men from the Malmo Preventive Project (MPP) we aimed to expand our observations in order to evaluate the metabolic profile of childless men and to evaluate if childlessness is an additional and independent predictor of major adverse cardiovascular events (MACE), mortality and incident diabetes when accounting for well-known biochemical, anthropometric, socio-economic and lifestyle related known risk factors. Logistic regression was used to assess risk of MACE, diabetes and MetS at baseline. Multivariate Cox regression was used to evaluate the risks of MACE and mortality following the men from baseline screening until first episode of MACE, death from other causes, emigration, or end of follow-up (31(st)December 2016) adjusting for age, family history, marital status, smoking, alcohol consumption, educational status, body mass index, prevalent diabetes, high blood lipids, increased fasting glucose and hypertension. Childless men presented with a worse metabolic profile than fathers at the baseline examination, with elevated risk of high triglycerides, odds ratio (OR) 1.24 (95%CI: 1.10-1.42), high fasting glucose OR 1.23 (95%CI: 1.05-1.43) and high blood pressure, OR 1.28 (95%CI: 1.14-1.45), respectively. In the fully adjusted prospective analysis, childless men presented with elevated risk of cardiovascular mortality, HR: 1.33 (95% CI: 1.18-1.49) and all-cause mortality, HR 1.23 (95%CI: 1.14-1.33), respectively. In conclusion, these results add to previous studies showing associations between male reproductive health, morbidity and mortality. Male childlessness, independently of well-known socio-economic, behavioral and metabolic risk factors, predicts risk of cardiovascular disease and mortality. Consequently, this group of men should be considered as target population for preventive measures.	[Elenkov, Angel; Giwercman, Aleksander] Lund Univ, Dept Translat Med, Mol Reprod Med, Malmo, Sweden; [Elenkov, Angel; Giwercman, Aleksander] Skane Univ Hosp, Reprod Med Ctr, Malmo, Sweden; [Tottenborg, Sandra Sogaard; Bonde, Jens Peter Ellekilde; Haervig, Katia Keglberg; Bungum, Ane Berger] Bispebjerg Hosp, Dept Occupat & Environm Med, Copenhagen, Denmark; [Bonde, Jens Peter Ellekilde] Univ Copenhagen, Fac Hlth Sci, Dept Publ Hlth, Copenhagen, Denmark; [Glazer, Clara Helene] Rigshosp, Dept Urol, Copenhagen, Denmark; [Nilsson, Peter M.] Skane Univ Hosp, Dept Clin Sci, Internal Med Res Grp, Malmo, Sweden	Lund University; Lund University; Skane University Hospital; Aarhus University; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Rigshospitalet; University of Copenhagen; Lund University; Skane University Hospital	Elenkov, A (corresponding author), Lund Univ, Dept Translat Med, Mol Reprod Med, Malmo, Sweden.; Elenkov, A (corresponding author), Skane Univ Hosp, Reprod Med Ctr, Malmo, Sweden.	angel.elenkov@med.lu.se		Kofoed, Ane Bungum/0000-0001-7901-3784; Keglberg Haervig, Katia/0000-0002-4250-7948	Interreg V funded program ReproUnion; European Association of Urology ReproUnion scholarship -Angel Elenkov Research Council of Sweden	Interreg V funded program ReproUnion; European Association of Urology ReproUnion scholarship -Angel Elenkov Research Council of Sweden	The study was supported by grants: Interreg V funded program ReproUnion -all authors, joint European Association of Urology ReproUnion scholarship -Angel Elenkov Research Council of Sweden Peter M Nillson The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Af Sillen U, 2005, SCAND J PUBLIC HEALT, V33, P183, DOI 10.1080/14034940410019235; Agerbo E, 2013, J EPIDEMIOL COMMUN H, V67, P374, DOI 10.1136/jech-2012-201387; Balachandran A., 2017, THESIS SWEDEN; Berglund G, 2000, J INTERN MED, V247, P19, DOI 10.1046/j.1365-2796.2000.00568.x; Berglund G, 1996, J INTERN MED, V239, P489, DOI 10.1046/j.1365-2796.1996.483819000.x; Bobjer J, 2016, CLIN ENDOCRINOL, V85, P189, DOI 10.1111/cen.13038; Bogefors C, 2017, ANDROLOGY-US, V5, P711, DOI 10.1111/andr.12354; Bonde JP, 2017, HUM REPROD UPDATE, V23, P104, DOI 10.1093/humupd/dmw036; Breyer BN, 2010, HUM REPROD, V25, P2360, DOI 10.1093/humrep/deq152; Bungum AB, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020293; Christensson A, 2014, AM J NEPHROL, V39, P85, DOI 10.1159/000358259; Eaker ED, 2007, PSYCHOSOM MED, V69, P509, DOI 10.1097/PSY.0b013e3180f62357; Einio E, 2016, POP STUD-J DEMOG, V70, P217, DOI 10.1080/00324728.2016.1195506; Eisenberg ML, 2011, HUM REPROD, V26, P3479, DOI 10.1093/humrep/der305; Elenkov A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32813-4; Glazer CH, 2017, HUM REPROD, V32, P1474, DOI 10.1093/humrep/dex097; Glazer CH, 2017, SEMIN REPROD MED, V35, P282, DOI 10.1055/s-0037-1603568; Gottvall K., 2015, FORLOSSNINGAR NYFODD; Grundy E, 2010, SOC SCI MED, V70, P1847, DOI 10.1016/j.socscimed.2010.02.004; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Holgersson MB, 2017, EUR UROL, V71, P991, DOI 10.1016/j.eururo.2016.11.036; Jensen TK, 2009, AM J EPIDEMIOL, V170, P559, DOI 10.1093/aje/kwp168; Joffe M, 2009, HUM REPROD, V24, P1999, DOI 10.1093/humrep/dep087; Khaw KT, 2007, CIRCULATION, V116, P2694, DOI 10.1161/CIRCULATIONAHA.107.719005; Khazai B, 2016, CLIN ENDOCRINOL, V84, P700, DOI 10.1111/cen.12997; Latif T, 2017, AM J EPIDEMIOL, V186, P910, DOI 10.1093/aje/kwx067; Lawlor DA, 2003, CIRCULATION, V107, P1260, DOI 10.1161/01.CIR.0000053441.43495.1A; Liffner S, 2017, ASIAN J ANDROL, V19, P103, DOI 10.4103/1008-682X.178848; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; McAlister FA, 2018, INT J CARDIOL, V269, P145, DOI 10.1016/j.ijcard.2018.07.128; Rao PM, 2013, NAT REV ENDOCRINOL, V9, P479, DOI 10.1038/nrendo.2013.122; Rezanezhad B, 2018, AGING MALE, V21, P182, DOI 10.1080/13685538.2017.1412422; Schoeters GER, 2011, AM J CLIN NUTR, V94, p1964S, DOI 10.3945/ajcn.110.001545; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Smith JG, 2010, EUR J EPIDEMIOL, V25, P95, DOI 10.1007/s10654-009-9404-1; Statistics Sweden (SCB), 2011, CHILDB PATT DIFF GEN; Statistics Sweden (SCB), 2013, INT AD MINSK; Svartberg J, 2006, J INTERN MED, V259, P576, DOI 10.1111/j.1365-2796.2006.01637.x; TRELL E, 1983, PREV MED, V12, P397, DOI 10.1016/0091-7435(83)90248-7; Vlachopoulos C, 2016, ATHEROSCLEROSIS, V250, P57, DOI 10.1016/j.atherosclerosis.2016.04.018; Weltoft GR, 2004, SOC SCI MED, V59, P1449, DOI 10.1016/j.socscimed.2004.01.026	41	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0237422	10.1371/journal.pone.0237422	http://dx.doi.org/10.1371/journal.pone.0237422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ7QD	32881896	Green Published, gold			2022-12-26	WOS:000571063300009
J	Feuillatre, H; Auffret, V; Castro, M; Lalys, F; Le Breton, H; Garreau, M; Haigron, P				Feuillatre, Helene; Auffret, Vincent; Castro, Miguel; Lalys, Florent; Le Breton, Herve; Garreau, Mireille; Haigron, Pascal			Similarity measures and attribute selection for case-based reasoning in transcatheter aortic valve implantation	PLOS ONE			English	Article							DECISION-SUPPORT; SYSTEM; CLASSIFICATION; REPLACEMENT; MANAGEMENT; DIAGNOSIS; FRAMEWORK; TRENDS; CANCER; CBR	In a clinical decision support system, the purpose of case-based reasoning is to help clinicians make convenient decisions for diagnoses or interventional gestures. Past experience, which is represented by a case-base of previous patients, is exploited to solve similar current problems using four steps-retrieve, reuse, revise, and retain. The proposed case-based reasoning has been focused on transcatheter aortic valve implantation to respond to clinical issues pertaining vascular access and prosthesis choices. The computation of a relevant similarity measure is an essential processing step employed to obtain a set of retrieved cases from a case-base. A hierarchical similarity measure that is based on a clinical decision tree is proposed to better integrate the clinical knowledge, especially in terms of case representation, case selection and attributes weighting. A case-base of 138 patients is used to evaluate the case-based reasoning performance, and retrieve- and reuse-based criteria have been considered. The sensitivity for the vascular access and the prosthesis choice is found to 0.88 and 0.94, respectively, with the use of the hierarchical similarity measure as opposed to 0.53 and 0.79 for the standard similarity measure. Ninety percent of the suggested solutions are correctly classified for the proposed metric when four cases are retrieved. Using a dedicated similarity measure, with relevant and weighted attributes selected through a clinical decision tree, the set of retrieved cases, and consequently, the decision suggested by the case-based reasoning are substantially improved over state-of-the-art similarity measures.	[Feuillatre, Helene; Auffret, Vincent; Castro, Miguel; Le Breton, Herve; Garreau, Mireille; Haigron, Pascal] Univ Rennes, INSERM, CHU Rennes, LTSI,UMR 1099, Rennes, France; [Lalys, Florent] Therenva, Rennes, France	CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Feuillatre, H (corresponding author), Univ Rennes, INSERM, CHU Rennes, LTSI,UMR 1099, Rennes, France.	helene.feuillatre@gmail.com	Le Breton, Herve/ABD-8171-2020; Auffret, Vincent/ABD-3894-2020; Garreau, Mireille/ABC-4360-2020; Haigron, Pascal/AAR-6890-2020	Garreau, Mireille/0000-0001-5728-1403; Castro, Miguel/0000-0003-1792-6857	EU project EurValve Personalised Decision Support for Heart Valve Disease H2020 [PHC-30-2015 689617]; French National Research Agency (ANR) in the framework of the Investissement d'Avenir Program through Labex CAMI [ANR-11-LABX-0004]	EU project EurValve Personalised Decision Support for Heart Valve Disease H2020; French National Research Agency (ANR) in the framework of the Investissement d'Avenir Program through Labex CAMI(French National Research Agency (ANR))	HF, PH, MG received support through the EU project EurValve Personalised Decision Support for Heart Valve Disease H2020 PHC-30-2015 689617. PH, MG, VA, MC received support from the French National Research Agency (ANR) in the framework of the Investissement d'Avenir Program through Labex CAMI (ANR-11-LABX-0004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Therenva provided support in the form of salaries for author FL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the `author contributions' section.	AAMODT A, 1994, AI COMMUN, V7, P39; [Anonymous], 2008, BANKOVNICTVI LINE, V41, P1; Auffret V, 2017, J AM COLL CARDIOL, V70, P42, DOI 10.1016/j.jacc.2017.04.053; Avramenko Y, 2006, COMPUT CHEM ENG, V30, P548, DOI 10.1016/j.compchemeng.2005.10.011; Begum S, 2014, EXPERT SYST APPL, V41, P295, DOI 10.1016/j.eswa.2013.05.068; Begum S, 2011, IEEE T SYST MAN CY C, V41, P421, DOI 10.1109/TSMCC.2010.2071862; Behbahani M, 2012, COMPUT IND ENG, V63, P1107, DOI 10.1016/j.cie.2012.07.007; Bentaiba-Lagrid MB, 2020, EXPERT SYST APPL, V150, DOI 10.1016/j.eswa.2020.113335; Berner ES., 2007, CLIN DECISION SUPPOR; Biswas SK, 2017, SOFT COMPUT, V21, P7579, DOI 10.1007/s00500-016-2312-x; Brown D, 2018, ARTIF INTELL MED, V85, P28, DOI 10.1016/j.artmed.2017.09.007; Cahill TJ, 2018, EUR HEART J, V39, P2625, DOI 10.1093/eurheartj/ehy244; Choi S.S., 2010, J SYST CYBERN INFORM, V8, P43; Choudhury N, 2016, INT J ADV COMPUT SC, V7, P136; Chowdhary K.R., 2020, FUNDAMENTALS ARTIFIC, P603, DOI [10.1007/978-81-322-3972-7_19, DOI 10.1007/978-81-322-3972-7_19]; Cribier A, 2012, ARCH CARDIOVASC DIS, V105, P146, DOI 10.1016/j.acvd.2012.01.005; Cunningham P, 2009, IEEE T KNOWL DATA EN, V21, P1532, DOI 10.1109/TKDE.2008.227; Di Nuovo AG, 2011, EXPERT SYST APPL, V38, P6793, DOI 10.1016/j.eswa.2010.12.067; Homem TPD, 2020, ARTIF INTELL, V283, DOI 10.1016/j.artint.2020.103258; Doyle D, 2006, COMPUT INTELL-US, V22, P269, DOI 10.1111/j.1467-8640.2006.00288.x; El-Fakdi A, 2014, EXPERT SYST APPL, V41, P284, DOI 10.1016/j.eswa.2013.05.067; El-Sappagh S, 2015, ARTIF INTELL MED, V65, P179, DOI 10.1016/j.artmed.2015.08.003; EuroSurg Collaborative, 2020, BR J SURG, V107, pe161; Grech A, 2005, LECT NOTES ARTIF INT, V3681, P76; Gu DX, 2010, J MED SYST, V34, P213, DOI 10.1007/s10916-008-9232-y; Gu DX, 2017, ARTIF INTELL MED, V77, P31, DOI 10.1016/j.artmed.2017.02.003; Guessoum S, 2014, EXPERT SYST APPL, V41, P267, DOI 10.1016/j.eswa.2013.05.065; Harold JG, 2014, J AM COLL CARDIOL, V63, pE57, DOI 10.1016/j.jacc.2014.02.536; Holt A, 2005, KNOWL ENG REV, V20, P289, DOI 10.1017/S0269888906000622; Huang MJ, 2007, EXPERT SYST APPL, V32, P856, DOI 10.1016/j.eswa.2006.01.038; Leake D. B., 2000, Advances in Case-Based Reasoning. 5th European Workshop, EWCBR 2000. Proceedings (Lecture Notes in Artificial Intelligence Vol.1898), P161; Lesot M.-J, 2009, International Journal of Knowledge Engineering and Soft Data Paradigms, V1, P63, DOI 10.1504/IJKESDP.2009.021985; Liao TW, 1998, APPL ARTIF INTELL, V12, P267, DOI 10.1080/088395198117730; Marie F, 2019, EXPERT SYST APPL, V127, P282, DOI 10.1016/j.eswa.2019.03.010; Miotto R, 2015, J AM MED INFORM ASSN, V22, pE141, DOI 10.1093/jamia/ocu050; Montani S, 2013, APPL INTELL, V39, P144, DOI 10.1007/s10489-012-0399-z; Nunez H, 2004, ENVIRON MODELL SOFTW, V19, P809, DOI 10.1016/j.envsoft.2003.03.003; Ontanon S, 2020, ARTIF INTELL REV, V53, P5309, DOI 10.1007/s10462-020-09821-w; Otto CM, 2017, J AM COLL CARDIOL, V69, P1313, DOI 10.1016/j.jacc.2016.12.006; Perner P, 2008, CASE BASED REASONING; Petrovic S, 2016, ARTIF INTELL MED, V68, P17, DOI 10.1016/j.artmed.2016.01.006; Richter M.M., 2013, CASE BASED REASONING, DOI [10.1007/978-3-642-40167-1, DOI 10.1007/978-3-642-40167-1]; Saraiva R, 2016, EXPERT SYST APPL, V61, P192, DOI 10.1016/j.eswa.2016.05.026; Sharaf-El-Deen DA, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0009-1; Shin KS, 2001, DECIS SUPPORT SYST, V32, P41, DOI 10.1016/S0167-9236(01)00099-9; Shiu SCK, 2001, SOFT COMPUTING CASE, P1, DOI DOI 10.1007/978-1-4471-0687-6_1; Stanfill C., 1986, Communications of the ACM, V29, P1213, DOI 10.1145/7902.7906; Tarantini G, 2018, EUR HEART J, V39, P658, DOI 10.1093/eurheartj/ehx489; The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2017, EUR HEART J; Torrent-Fontbona F, 2019, EXPERT SYST APPL, V121, P338, DOI 10.1016/j.eswa.2018.12.036; WATSON I, 1994, KNOWL ENG REV, V9, P327, DOI 10.1017/S0269888900007098; Wilson DC, 2001, COMPUT INTELL-US, V17, P196, DOI 10.1111/0824-7935.00140; Wilson DR, 1997, J ARTIF INTELL RES, V6, P1, DOI 10.1613/jair.346	53	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238463	10.1371/journal.pone.0238463	http://dx.doi.org/10.1371/journal.pone.0238463			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881919	Green Published, gold			2022-12-26	WOS:000571063300045
J	Monczak, A; McKinney, B; Mueller, C; Montie, EW				Monczak, Agnieszka; McKinney, Bradshaw; Mueller, Claire; Montie, Eric W.			What's all that racket! Soundscapes, phenology, and biodiversity in estuaries	PLOS ONE			English	Article							CLIMATE-CHANGE; AMBIENT SOUND; HABITATS; FISH	There is now clear evidence that climate change affects terrestrial and marine ecosystems and can cause phenological shifts in behavior. Utilizing sound to demonstrate phenology is gaining popularity in terrestrial environments. In marine ecosystems, this technique is yet to be used due to a lack of multiyear datasets. Our study demonstrates soundscape phenology in an estuary using a six-year dataset. In this study, we showed that an increase in acoustic activity of snapping shrimp and certain fish species occurred earlier in years with warmer springs. In addition, we combined passive acoustics and traditional sampling methods (seines) and detected positive relationships between temporal patterns of the soundscape and biodiversity. This study shows that passive acoustics can provide information on the ecological response of estuaries to climate variability.	[Monczak, Agnieszka; McKinney, Bradshaw; Mueller, Claire; Montie, Eric W.] Univ South Carolina Beaufort, Dept Nat Sci, Bluffton, SC 29909 USA; [Monczak, Agnieszka] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland	University of Aberdeen	Montie, EW (corresponding author), Univ South Carolina Beaufort, Dept Nat Sci, Bluffton, SC 29909 USA.	emontie@uscb.edu		Montie, Eric/0000-0003-4568-4963	Spring Island Trust; Town of Bluffton/Beaufort County; multiple University of South Carolina (USC) ASPIRE internal awards; Community Foundation of the Lowcountry; SC EPSCoR/IDeA Program award [17-RE02]; South Carolina Aquarium; Research Initiative for Summer Engagement (RISE) grant from USC; LowCountry Institute; USCB Sea Islands Institute; Palmetto Bluff Conservancy; Port Royal Sound Foundation; Southeast Coastal Ocean Observing Regional Association (SECOORA); NOAA [NA16NOS0120028]	Spring Island Trust; Town of Bluffton/Beaufort County; multiple University of South Carolina (USC) ASPIRE internal awards; Community Foundation of the Lowcountry; SC EPSCoR/IDeA Program award; South Carolina Aquarium; Research Initiative for Summer Engagement (RISE) grant from USC; LowCountry Institute; USCB Sea Islands Institute; Palmetto Bluff Conservancy; Port Royal Sound Foundation; Southeast Coastal Ocean Observing Regional Association (SECOORA); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	This work was supported by Spring Island Trust, Town of Bluffton/Beaufort County, multiple University of South Carolina (USC) ASPIRE internal awards, Community Foundation of the Lowcountry, SC EPSCoR/IDeA Program award (#17-RE02), South Carolina Aquarium, Research Initiative for Summer Engagement (RISE) grant from USC, The LowCountry Institute, USCB Sea Islands Institute, Palmetto Bluff Conservancy, and the Port Royal Sound Foundation. This work was also supported, in part, by the Southeast Coastal Ocean Observing Regional Association (SECOORA) with NOAA financial assistance award number NA16NOS0120028. The statements, findings, conclusions, and recommendations are those of the author(s) and do not necessarily reflect the views of SECOORA or NOAA. All funds were awarded to EWM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann A, 2010, BIOINFORMATICS, V26, P1340, DOI 10.1093/bioinformatics/btq134; [Anonymous], 2016, EBIOMEDICINE, V14, P1, DOI DOI 10.2903/J.EFSA.2016.4418; [Anonymous], 2007, EUROPEAN SOCIOLOGICA, V23, P1; BARRY D, 1993, J AM STAT ASSOC, V88, P309, DOI 10.1080/01621459.1993.10594323; Bohnenstiehl DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0143691; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown JL, 1999, P NATL ACAD SCI USA, V96, P5565, DOI 10.1073/pnas.96.10.5565; Carter SK, 2018, ECOL LETT, V21, P1143, DOI 10.1111/ele.13081; Curtis KR, 1999, J ACOUST SOC AM, V106, P3189, DOI 10.1121/1.428173; Deegan LA, 1997, ESTUARIES, V20, P601, DOI 10.2307/1352618; Degenhardt F, 2019, BRIEF BIOINFORM, V20, P492, DOI 10.1093/bib/bbx124; Desidera E, 2019, MAR ECOL PROG SER, V608, P183, DOI 10.3354/meps12812; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; GUEST WC, 1978, COPEIA, P337; Harding LW, 2016, ESTUAR COAST, V39, P664, DOI 10.1007/s12237-015-0023-7; Harding LW, 2016, SCI REP-UK, V6, DOI 10.1038/srep23773; Haxel JH, 2013, J ACOUST SOC AM, V133, P2586, DOI 10.1121/1.4796132; Kharouba HM, 2018, P NATL ACAD SCI USA, V115, P5211, DOI 10.1073/pnas.1714511115; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Kursa MB, 2014, J STAT SOFTW, V61, P1; Lau M.K., 2013, **DATA OBJECT**; Li J, 2013, DATA MINING APPL R, P299; Lieth H., 1974, Phenology and seasonality modeling., P3; Lillis A, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.181358; Lillis A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079337; Loman J, 2016, ECOL EVOL, V6, P6202, DOI 10.1002/ece3.2356; Luczkovich JJ, 2008, T AM FISH SOC, V137, P576, DOI 10.1577/T05-290.1; Luczkovich Joseph J., 1999, Bioacoustics, V10, P143; Ma BB, 2005, J ACOUST SOC AM, V117, P3555, DOI 10.1121/1.1910283; MacGINITIE G. E., 1937, AMER MIDLAND NAT, V18, P1031, DOI 10.2307/2420601; Mann David A., 1995, Bioacoustics, V6, P199; Marley SA, 2016, ACOUST AUST, V44, P171, DOI 10.1007/s40857-015-0038-z; McQueen K, 2017, ICES J MAR SCI, V74, P1561, DOI 10.1093/icesjms/fsx025; Monczak A, 2019, MAR ECOL PROG SER, V609, P49, DOI 10.3354/meps12813; Monczak A, 2017, MAR ECOL PROG SER, V581, P1, DOI 10.3354/meps12322; Montie EW, 2016, J FISH BIOL, V88, P1776, DOI 10.1111/jfb.12938; Montie EW, 2017, PEERJ, V5, DOI 10.7717/peerj.2944; Nembrini S, 2018, BIOINFORMATICS, V34, P3711, DOI 10.1093/bioinformatics/bty373; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pijanowski BC, 2011, BIOSCIENCE, V61, P203, DOI 10.1525/bio.2011.61.3.6; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Staaterman E, 2017, MAR ECOL PROG SER, V575, P207, DOI 10.3354/meps12188; Stanley JA, 2012, P ROY SOC B-BIOL SCI, V279, P3622, DOI 10.1098/rspb.2012.0697; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Sueur J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004065; Towsey M, 2014, ECOL INFORM, V21, P1, DOI 10.1016/j.ecoinf.2014.02.002; Van Buskirk J, 2009, GLOBAL CHANGE BIOL, V15, P760, DOI 10.1111/j.1365-2486.2008.01751.x; Vermeij M.J.A., 2010, PLOS ONE, V5, P3; Visser ME, 2016, NATURE, V535, P236, DOI 10.1038/nature18905; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wright MN, 2017, J STAT SOFTW, V77, P1, DOI 10.18637/jss.v077.i01	52	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0236874	10.1371/journal.pone.0236874	http://dx.doi.org/10.1371/journal.pone.0236874			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881856	Green Published, gold			2022-12-26	WOS:000571063300098
J	Morgantini, LA; Naha, U; Wang, H; Francavilla, S; Acar, O; Flores, JM; Crivellaro, S; Moreira, D; Abern, M; Eklund, M; Vigneswaran, HT; Weine, SM				Morgantini, Luca A.; Naha, Ushasi; Wang, Heng; Francavilla, Simone; Acar, Omer; Flores, Jose M.; Crivellaro, Simone; Moreira, Daniel; Abern, Michael; Eklund, Martin; Vigneswaran, Hari T.; Weine, Stevan M.			Factors contributing to healthcare professional burnout during the COVID-19 pandemic: A rapid turnaround global survey	PLOS ONE			English	Article							CHINA; RISK	Background Healthcare professionals (HCPs) on the front lines against COVID-19 may face increased workload and stress. Understanding HCPs' risk for burnout is critical to supporting HCPs and maintaining the quality of healthcare during the pandemic. Methods To assess exposure, perceptions, workload, and possible burnout of HCPs during the COVID-19 pandemic we conducted a cross-sectional survey. The main outcomes and measures were HCPs' self-assessment of burnout, indicated by a single item measure of emotional exhaustion, and other experiences and attitudes associated with working during the COVID-19 pandemic. Findings A total of 2,707 HCPs from 60 countries participated in this study. Fifty-one percent of HCPs reported burnout. Burnout was associated with work impacting household activities (RR = 1 center dot 57, 95% CI = 1 center dot 39-1 center dot 78,P<0 center dot 001), feeling pushed beyond training (RR = 1 center dot 32, 95% CI = 1 center dot 20-1 center dot 47,P<0 center dot 001), exposure to COVID-19 patients (RR = 1 center dot 18, 95% CI = 1 center dot 05-1 center dot 32,P= 0 center dot 005), and making life prioritizing decisions (RR = 1 center dot 16, 95% CI = 1 center dot 02-1 center dot 31,P= 0 center dot 03). Adequate personal protective equipment (PPE) was protective against burnout (RR = 0 center dot 88, 95% CI = 0 center dot 79-0 center dot 97,P= 0 center dot 01). Burnout was higher in high-income countries (HICs) compared to low- and middle-income countries (LMICs) (RR = 1 center dot 18; 95% CI = 1 center dot 02-1 center dot 36,P= 0 center dot 018). Interpretation Burnout is present at higher than previously reported rates among HCPs working during the COVID-19 pandemic and is related to high workload, job stress, and time pressure, and limited organizational support. Current and future burnout among HCPs could be mitigated by actions from healthcare institutions and other governmental and non-governmental stakeholders aimed at potentially modifiable factors, including providing additional training, organizational support, and support for family, PPE, and mental health resources.	[Morgantini, Luca A.; Naha, Ushasi; Francavilla, Simone; Acar, Omer; Flores, Jose M.; Crivellaro, Simone; Moreira, Daniel; Abern, Michael; Vigneswaran, Hari T.] Univ Illinois, Coll Med, Dept Urol, Chicago, IL 60680 USA; [Wang, Heng] Univ Illinois, Sch Publ Hlth, Dept Epidemiol & Biostat, Chicago, IL USA; [Eklund, Martin; Vigneswaran, Hari T.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Weine, Stevan M.] Univ Illinois, Dept Psychiat, Coll Med, Chicago, IL 60612 USA; [Weine, Stevan M.] Univ Illinois, Ctr Global Hlth, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Karolinska Institutet; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Morgantini, LA (corresponding author), Univ Illinois, Coll Med, Dept Urol, Chicago, IL 60680 USA.	lmorga5@uic.edu	Flores, Jose M/GLU-6324-2022	Flores, Jose M/0000-0002-8912-7037; Reis, AlessanRSS/0000-0001-8486-7469	UIC Center for Clinical and Translational Sciences' Community Engagement and Collaboration core; Research Open Access Publishing (ROAAP) Fund of the University of Illinois at Chicago	UIC Center for Clinical and Translational Sciences' Community Engagement and Collaboration core; Research Open Access Publishing (ROAAP) Fund of the University of Illinois at Chicago	We acknowledge the support received from UIC Center for Clinical and Translational Sciences' Community Engagement and Collaboration core, Dr. Craig Niederberger and Dr. Ervin Kocjancic. The authors acknowledge the Research Open Access Publishing (ROAAP) Fund of the University of Illinois at Chicago for financial support towards the open access publishing fee for this article.	[Anonymous], 2020, DOES WORLD BANK CLAS; Barello S, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113129; Burnout, 2017, BURNOUT FATIGUE EXHA, P105, DOI DOI 10.1007/978-3-319-52887-8_5; Carter RE, 2005, BIOSTATISTICS, V6, P39, DOI 10.1093/biostatistics/kxh016; Chen QN, 2020, LANCET PSYCHIAT, V7, pE15, DOI 10.1016/S2215-0366(20)30078-X; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Draper H, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-192; Dugani S., 2018, GATES OPEN RES, V2, P4, DOI [DOI 10.12688/gatesopenres.12779.3, DOI 10.12688/gatesopenres.12779.1]; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Salvagioni DAJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185781; Kang LJ, 2020, BRAIN BEHAV IMMUN, V87, P11, DOI 10.1016/j.bbi.2020.03.028; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Lee F Joseph, 2008, Can Fam Physician, V54, P234; Liu NQ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112921; Matheson C, 2016, BRIT J GEN PRACT, V66, pE507, DOI 10.3399/bjgp16X685285; Roberts DL, 2014, J HOSP MED, V9, P176, DOI 10.1002/jhm.2146; Shanafelt T, 2020, JAMA-J AM MED ASSOC, V323, P2133, DOI 10.1001/jama.2020.5893; Society of Critical Care Medicine, CLIN REP HIGH STRESS; Soler JK, 2008, FAM PRACT, V25, P245, DOI 10.1093/fampra/cmn038; Wang J, 2020, J HOSP INFECT, V105, P100, DOI 10.1016/j.jhin.2020.03.002; West CP, 2016, LANCET, V388, P2272, DOI 10.1016/S0140-6736(16)31279-X; West CP, 2009, J GEN INTERN MED, V24, P1318, DOI 10.1007/s11606-009-1129-z; Wu P, 2009, CAN J PSYCHIAT, V54, P302, DOI 10.1177/070674370905400504; Wu Y, 2020, J PAIN SYMPTOM MANAG, V60, pE60, DOI 10.1016/j.jpainsymman.2020.04.008; Zerbini Giulia, 2020, Ger Med Sci, V18, pDoc05, DOI 10.3205/000281	26	169	171	7	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238217	10.1371/journal.pone.0238217	http://dx.doi.org/10.1371/journal.pone.0238217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ7QD	32881887	gold, Green Published, Green Submitted			2022-12-26	WOS:000571063300035
J	Allen, A; Gau, D; Francoeur, P; Sturm, J; Wang, Y; Martin, R; Maranchie, J; Duensing, A; Kaczorowski, A; Duensing, S; Wu, L; Lotze, MT; Koes, D; Storkus, WJ; Roy, P				Allen, Abigail; Gau, David; Francoeur, Paul; Sturm, Jordan; Wang, Yue; Martin, Ryan; Maranchie, Jodi; Duensing, Anette; Kaczorowski, Adam; Duensing, Stefan; Wu, Lily; Lotze, Michael T.; Koes, David; Storkus, Walter J.; Roy, Partha			Actin-binding protein profilin1 promotes aggressiveness of clear-cell renal cell carcinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Profilin; renal cancer; actin-binding proteins; Mena; VASP; tumor-associated vascular endothelial cells; small molecule inhibitor; cancer biology; actin; profilin; tumor; endothelial cell; clear-cell renal cell carcinoma	ANTIANGIOGENIC THERAPIES; PROTEOMIC ANALYSIS; EXPRESSION; CANCER; RECEPTOR; MOTILITY; PHOSPHORYLATION; PROLIFERATION; ACTIVATION; INHIBITION	Clear-cell renal cell carcinoma (ccRCC), the most common subtype of renal cancer, has a poor clinical outcome. A hallmark of ccRCC is genetic loss-of-function of VHL (von Hippel-Lindau) that leads to a highly vascularized tumor microenvironment. Although many ccRCC patients initially respond to antiangiogenic therapies, virtually all develop progressive, drug-refractory disease. Given the role of dysregulated expressions of cytoskeletal and cytoskeleton-regulatory proteins in tumor progression, we performed analyses of The Cancer Genome Atlas (TCGA) transcriptome data for different classes of actin-binding proteins to demonstrate that increased mRNA expression of profilin1 (Pfn1), Arp3, cofilin1, Ena/VASP, and CapZ, is an indicator of poor prognosis in ccRCC. Focusing further on Pfn1, we performed immunohistochemistry-based classification of Pfn1 staining in tissue microarrays, which indicated Pfn1 positivity in both tumor and stromal cells; however, the vast majority of ccRCC tumors tend to be Pfn1-positive selectively in stromal cells only. This finding is further supported by evidence for dramatic transcriptional up-regulation of Pfn1 in tumor-associated vascular endothelial cells in the clinical specimens of ccRCC. In vitro studies support the importance of Pfn1 in proliferation and migration of RCC cells and in soluble Pfn1's involvement in vascular endothelial cell tumor cell cross-talk. Furthermore, proof-of-concept studies demonstrate that treatment with a novel computationally designed Pfn1-actin interaction inhibitor identified herein reduces proliferation and migration of RCC cells in vitro and RCC tumor growth in vivo. Based on these findings, we propose a potentiating role for Pfn1 in promoting tumor cell aggressiveness in the setting of ccRCC.	[Allen, Abigail; Gau, David; Sturm, Jordan; Lotze, Michael T.; Storkus, Walter J.; Roy, Partha] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Francoeur, Paul; Koes, David] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA USA; [Wang, Yue; Lotze, Michael T.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Martin, Ryan] Univ Pittsburgh, Dept Biol, Pittsburgh, PA USA; [Maranchie, Jodi; Storkus, Walter J.] Univ Pittsburgh, Dept Urol, Pittsburgh, PA USA; [Duensing, Anette] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Lotze, Michael T.; Storkus, Walter J.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA; [Storkus, Walter J.] Univ Pittsburgh, Dept Dermatol, Pittsburgh, PA 15260 USA; [Kaczorowski, Adam; Duensing, Stefan] Heidelberg Sch Med, Dept Urol, Heidelberg, Germany; [Wu, Lily] Univ Calif Los Angeles, Dept Urol, Los Angeles, CA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles	Roy, P (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA.	Partha.Roy@pitt.edu	Koes, David Ryan/M-4523-2018; Gau, David/G-8375-2011	Koes, David Ryan/0000-0002-6892-6614; Gau, David/0000-0002-3079-3692; Francoeur, Paul/0000-0002-1440-567X; Maranchie, Jodi/0000-0002-8534-9468; Gondringer, Abigail/0000-0002-3447-0612	University of Pittsburgh Hillman Cancer Center Developmental Funding Program [1R01 CA181450-01, R01CA206012]; Cardiovascular Training T32 Grant Program and Achievement Rewards for College Scientists; National Cancer Center fellowship; Department of Defense [W81XWH-19-1-0768]; NCI, National Institutes of Health [CA108607]; NIGMS, National Institutes of Health [GM108340-04]	University of Pittsburgh Hillman Cancer Center Developmental Funding Program; Cardiovascular Training T32 Grant Program and Achievement Rewards for College Scientists; National Cancer Center fellowship; Department of Defense(United States Department of Defense); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of Pittsburgh Hillman Cancer Center Developmental Funding Program Grants 1R01 CA181450-01 and R01CA206012 (to M. T. L.); the Cardiovascular Training T32 Grant Program and Achievement Rewards for College Scientists funding (to A. A.); a National Cancer Center fellowship (to D. G.); Department of Defense Grant W81XWH-19-1-0768 (to P. R.); NCI, National Institutes of Health Grant CA108607 (to P. R.); and NIGMS, National Institutes of Health Grant GM108340-04 (to D. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bae YH, 2010, P NATL ACAD SCI USA, V107, P21547, DOI 10.1073/pnas.1002309107; Bae YH, 2009, J CELL PHYSIOL, V219, P354, DOI 10.1002/jcp.21677; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bottcher RT, 2009, EMBO J, V28, P1157, DOI 10.1038/emboj.2009.58; Caglayan E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013608; Chakraborty S, 2018, BRIT J CANCER, V119, P1106, DOI 10.1038/s41416-018-0284-6; Ding H, 2018, INT J CLIN EXP PATHO, V11, P1247; Ding Z, 2014, ONCOGENE, V33, P2065, DOI 10.1038/onc.2013.166; Ding ZJ, 2006, J CELL SCI, V119, P4127, DOI 10.1242/jcs.03178; Ding ZJ, 2012, CELL ADHES MIGR, V6, P442, DOI 10.4161/cam.21832; Ding ZJ, 2009, EXP CELL RES, V315, P2963, DOI 10.1016/j.yexcr.2009.07.004; Escobar B, 2010, CANCER RES, V70, P9349, DOI 10.1158/0008-5472.CAN-09-4491; Fan Y, 2014, NAT CELL BIOL, V16, P445, DOI 10.1038/ncb2954; Fan Y, 2012, NAT CELL BIOL, V14, P1046, DOI 10.1038/ncb2580; Fischer RS, 2019, DEV BIOL, V451, P86, DOI 10.1016/j.ydbio.2018.08.015; Gau D, 2020, J BIOL CHEM, V295, P9618, DOI 10.1074/jbc.RA120.012613; Gau D, 2019, J BIOL CHEM, V294, P6972, DOI 10.1074/jbc.RA118.005255; Gau D, 2018, J BIOL CHEM, V293, P2606, DOI 10.1074/jbc.M117.809137; Gau DM, 2015, CELL CYCLE, V14, P1884, DOI 10.1080/15384101.2015.1036203; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Gurzu S, 2012, EUR J HISTOCHEM, V56, P39, DOI 10.4081/ejh.2012.e8; Gurzu S, 2008, ROM J MORPHOL EMBRYO, V49, P345; Hu JH, 2018, MOL THER-METH CLIN D, V9, P203, DOI 10.1016/j.omtm.2018.02.009; Jonasch E, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4797; Joy M, 2017, J BIOL CHEM, V292, P11777, DOI 10.1074/jbc.M117.781104; Juengel E, 2016, ONCOTARGET, V7, P20410, DOI 10.18632/oncotarget.7804; Karamchandani JR, 2015, HUM PATHOL, V46, P673, DOI 10.1016/j.humpath.2014.11.007; Koes DR, 2013, J CHEM INF MODEL, V53, P1893, DOI 10.1021/ci300604z; Koika V, 2010, VASC PHARMACOL, V53, P215, DOI 10.1016/j.vph.2010.08.004; Kullmann JA, 2012, EMBO REP, V13, P75, DOI 10.1038/embor.2011.211; Lu QY, 2018, EXP EYE RES, V166, P140, DOI 10.1016/j.exer.2017.10.009; Lu X, 2014, ONCOGENE, V33, P956, DOI 10.1038/onc.2013.27; Martin JD, 2019, ANNU REV PHYSIOL, V81, P505, DOI 10.1146/annurev-physiol-020518-114700; Masui O, 2013, MOL CELL PROTEOMICS, V12, P132, DOI 10.1074/mcp.M112.020701; Minamida S, 2011, INT J UROL, V18, P63, DOI 10.1111/j.1442-2042.2010.02670.x; Neely BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154074; Pichler R, 2017, MEMO-MAG EUR MED ONC, V10, P206, DOI 10.1007/s12254-017-0344-2; Ragoza M, 2017, J CHEM INF MODEL, V57, P942, DOI 10.1021/acs.jcim.6b00740; Romeo G, 2004, FASEB J, V18, P725, DOI 10.1096/fj.03-0841fje; Romeo GR, 2007, CIRC RES, V101, P357, DOI 10.1161/CIRCRESAHA.107.151399; Rotty JD, 2015, DEV CELL, V32, P54, DOI 10.1016/j.devcel.2014.10.026; Salazar R, 1999, EXP CELL RES, V249, P22, DOI 10.1006/excr.1999.4460; Schokrpur S, 2016, SCI REP-UK, V6, DOI 10.1038/srep29032; Schoppmeyer R, 2017, EUR J IMMUNOL, V47, P1562, DOI 10.1002/eji.201747124; Shen KK, 2016, ONCOTARGET, V7, P56650, DOI 10.18632/oncotarget.10992; Shigeta K, 2020, HEPATOLOGY, V71, P1247, DOI 10.1002/hep.30889; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Sunseri J, 2016, NUCLEIC ACIDS RES, V44, pW442, DOI 10.1093/nar/gkw287; Tamura M, 2000, J AM SOC NEPHROL, V11, P1620, DOI 10.1681/ASN.V1191620; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Unwin RD, 2003, PROTEOMICS, V3, P1620, DOI 10.1002/pmic.200300464; Weinstein AM, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1322238; Welti J, 2013, J CLIN INVEST, V123, P3190, DOI 10.1172/JCI70212; Wu N, 2006, PROTEOMICS, V6, P6095, DOI 10.1002/pmic.200500321; Zhao TL, 2019, BIOCHEM BIOPH RES CO, V516, P880, DOI 10.1016/j.bbrc.2019.06.120; Zhou XG, 2015, TRANSL ONCOL, V8, P480, DOI 10.1016/j.tranon.2015.11.003	57	9	10	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2020	295	46					15636	15649		10.1074/jbc.RA120.013963	http://dx.doi.org/10.1074/jbc.RA120.013963			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OY6NO	32883810	hybrid, Green Published			2022-12-26	WOS:000594361600017
J	Endaylalu, K; Abera, B; Mulu, W				Endaylalu, Kindye; Abera, Bayeh; Mulu, Wondemagegn			Extended spectrum beta lactamase producing bacteria among outpatients with ear infection at FelegeHiwot Referral Hospital, North West Ethiopia	PLOS ONE			English	Article							OTITIS-MEDIA; PSEUDOMONAS-AERUGINOSA; RESISTANCE PATTERN; SUSCEPTIBILITY	Background Antibiotic resistant bacteria particularly extended-spectrum beta lactamase (ESBL) producing are of major concern for management of outpatients. They can spread rapidly and are associated with poor patient outcome. However, there is scarcity of information on ear infection with ESBL producing bacteria in Ethiopia. Therefore, this study investigates the prevalence of ear infection with ESBL producing bacteria among outpatients attending Felegehiwot Referral Hospital, Northwest Ethiopia. Methods A hospital based cross-sectional study was conducted from May, 2018 to January, 2019. Demographic and clinical data were collected with face to face interview and were complemented with patient card review. Ear discharge specimens were collected from study participants using swab technique. All ear swab specimens were cultured using standard microbiological techniques. The ESBL producing bacteria were detected by double disc synergy test and interpreted based on Clinical and laboratory Standards Institute Guidelines. Chi-square and fisher's exact tests were calculated to check association between variables. Results A total of 236 patients (male = 138 and female = 98) with ear infection took part in the study. The median age of the participants was 20years. Overall, 10 (4.23%, 95%CI; 2.3-7.6%) of patients had ear infection with ESBL producing bacteria. Other chronic illnesses (p = 0.003), history of hospital visit and treatment (p = 0.006) and history of antibiotic use without physician's prescription (p<0.001) had significant association with prevalence of ESBL producing bacteria in ear infection. The proportion of ear infection with ESBL producingP.mirabilis,P.aeruginosaandK.pneumoniaewere 4 (1.7%), 3 (1.3%) and 2 (0.8%), respectively. All ESBL producing isolates were MDR (100%). Overall, 58 (43%) species were MDR.P.aeruginosawas the leading MDR isolate 29 (53.7%).For all bacterial isolates of ear infection, ampicillin(93.3%) and amoxicillin-clavulanic acid (58.5%) revealed high level of resistance whereas low resistance rates were observed for ciprofloxacin (5.2%), third generation cephalosporin (11.9-20%) and aztreonam (16.3%). Conclusions Ear infection due to ESBL producing bacteria coupled with high levels of MDR is becoming a growing concern for outpatients in the study area. Regular detection of these bacteria and wise use of antibiotics are needed to stop the spread of this form of resistance.	[Endaylalu, Kindye] Amhara Publ Hlth Inst, Dept Microbiol Lab, Bahir Dar, Ethiopia; [Abera, Bayeh; Mulu, Wondemagegn] Bahir Dar Univ, Coll Med & Hlth Sci, Departmentsof Med Lab Sci, Bahir Dar, Ethiopia	Bahir Dar University	Mulu, W (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Departmentsof Med Lab Sci, Bahir Dar, Ethiopia.	wondem_32@yahoo.com	Abera, Bayeh/AAY-9589-2021; Abera, Bayeh/AAU-8754-2020	Abera, Bayeh/0000-0002-2559-6635; Mulu, Wondemagegn/0000-0002-5966-9388	Bahir Dar University, College of Medicine and Health Sciences	Bahir Dar University, College of Medicine and Health Sciences	This work was supported by Bahir Dar University, College of Medicine and Health Sciences. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abera B, 2011, ETHIOP J HEALTH DEV, V25, P161; Akinjogunla OJ, 2011, J MICROB BIOTEC FOOD, V1, P333; Al-Garni SM, 2018, SAUDI MED J, V39, P1186, DOI 10.15537/smj.2018.12.23273; [Anonymous], 2017, INT J RES HUMANITIES, V46, P1; [Anonymous], 2015, CANC DISCOV, V5, pOF2; [Anonymous], 2017, ONCOGENESIS, V6, pe345; [Anonymous], 2016, THE TOTAL AUDIENCE R; Chandra Sahu Mahesh, 2019, World J Otorhinolaryngol Head Neck Surg, V5, P88, DOI 10.1016/j.wjorl.2018.05.008; Cheesbourgh M, 2006, DISTRICT LAB PRACT 2; Chika E, 2013, AM J INFECT DIS, V9, P24, DOI 10.3844/ajidsp.2013.24.29; Clinical Laboratory Standards Institute, 2017, M100S24 CLSI; Drzewiecka D, 2016, MICROB ECOL, V72, P741, DOI 10.1007/s00248-015-0720-6; Farhan SM, 2019, INFECT DRUG RESIST, V12, P2125, DOI 10.2147/IDR.S198373; Gorems K, 2018, BMC EAR NOSE THROAT, V18, DOI 10.1186/s12901-018-0065-0; Hailegiyorgis TT, 2018, BMC EAR NOSE THROAT, V18, DOI 10.1186/s12901-018-0056-1; Hailu D, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2123-7; Ismaeil MI, 2017, AL MUSTANSIRIYAH J S, V28, P47; Karunanayake CP, 2016, INT J PEDIAT, V2016; Khatoon A, 2015, INT J RES MED SCI, V3, P1932; Luvsansharay UO, 2011, J MED MICROBIOL, V60, P619, DOI 10.1099/jmm.0.026955-0; Mittal R, 2015, J MED MICROBIOL, V64, P1103, DOI 10.1099/jmm.0.000155; Mushi MF, 2016, BMC EAR NOSE THROAT, V16, DOI 10.1186/s12901-015-0021-1; Naz R, 2015, J EVID BASED MED HLT, V2, P9051; Pachori P, 2019, GENES DIS, V6, P109, DOI 10.1016/j.gendis.2019.04.001; Park SY, 2017, KOREAN J INTERN MED, V32, P146, DOI 10.3904/kjim.2015.113; Qureishi A, 2014, INFECT DRUG RESIST, V7, P15, DOI 10.2147/IDR.S39637; Rosenfeld RM, 2006, OTOLARYNG HEAD NECK, V134, pS4, DOI [10.1177/0194599813517083, 10.1016/j.otohns.2006.02.014]; Schilder AGM, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.63; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Soraas A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069581; Teklu DS, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0488-4; Tham Johan, 2013, Infect Drug Resist, V6, P93, DOI 10.2147/IDR.S46290; Ventola C Lee, 2015, P T, V40, P277; Wasihun AG, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1471-z; Wiegand S, 2019, DTSCH ARZTEBL INT, V116, P224, DOI 10.3238/arztebl.2019.0224; Worku M, 2014, INDIAN J OTOL, V20, P155, DOI 10.4103/0971-7749.146929; World Health Organization, 2017, REP ANT RES; Yiengprugsawan V, 2013, INT J PEDIAT, V2013; Zorgani A, 2017, ECON MICROBIOL, V12, P126	39	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238891	10.1371/journal.pone.0238891	http://dx.doi.org/10.1371/journal.pone.0238891			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915859	gold, Green Published			2022-12-26	WOS:000571887500111
J	Jemni, M; Marina, M; Delextrat, A; Tanner, A; Basset, FA; Gu, YD; Hu, QL; Zhou, HY; Mkaouer, B; Konukman, F				Jemni, Monem; Marina, Michel; Delextrat, Anne; Tanner, Amy; Basset, Fabien A.; Gu, Yaodong; Hu, Qiuli; Zhou, Huiyu; Mkaouer, Bessem; Konukman, Ferman			Salivary endocrine response following a maximal incremental cycling protocol with local vibration	PLOS ONE			English	Article							WHOLE-BODY VIBRATION; HORMONE-BINDING GLOBULIN; VOLUNTARY CONTRACTIONS; CORTISOL RESPONSES; EXERCISE; TESTOSTERONE; PERFORMANCE; INTENSITY; LACTATE; MARKERS	The aim of this study was to compare the effects of vibration (Vib versus noVib) during a maximal graded cycling exercise on hormonal response, precisely on cortisol (C) and testosterone (T). Twelve active males (25 +/- 5yrs; 181 +/- 5cm; 80.7 +/- 11.1kg) randomly performed two maximal incremental cycling tests on two separate days and at the same time of the day (09:00). The protocol consisted of incremental steps of 3 min duration performed on a PowerBIKE(TM)that induces vibration cycling. The study was a repeated measures design and participants performed the test with and without vibration. Gas exchange and heart rate (HR) were continuously assessed and blood lactate (Bla) was recorded at the end of each incremental stage. Saliva samples were collected before and immediately after the test, and analysed for (C) and (T). The results show that C and T increased in both cycling conditions; however, the C's magnitude of change was significantly higher by 83% after Vib cycling in comparison to the no Vib (p= 0.014), whereas the T's magnitude of change were not statistically different between trials (p= 0.715). Vibration induced a decrease of the T/C ratio (p= 0.046) but no significant changes were observed following noVib (p= 0.476). As a conclusion, the investigation suggests that adding mechanical vibration to cycling may potentiate a catabolic exercise-induced state, which could have potential clinical implications in rehabilitation and injury treatment. Sport experts should take this message home to carefully plan the recovery process and time during training and competitions.	[Jemni, Monem; Gu, Yaodong; Hu, Qiuli; Zhou, Huiyu] Ningbo Univ, Fac Sports Sci, Ningbo, Zhejiang, Peoples R China; [Jemni, Monem] Univ Cambridge, Inst Continuing Educ, Cambridge, England; [Marina, Michel] INEFC, Barcelona, Spain; [Delextrat, Anne] Oxford Brookes Univ, Dept Sport Hlth Sci & Social Work, Oxford, England; [Tanner, Amy] Univ Hertfordshire, Sch Life & Med Sci, Hatfield, Herts, England; [Basset, Fabien A.] Mem Univ Newfoundland, Sch Human Kinet & Recreat, St John, NF, Canada; [Mkaouer, Bessem] Manouba Univ, Higher Inst Sport & Phys Educ Ksar Said, Manouba, Tunisia; [Konukman, Ferman] Qatar Univ, Coll Arts & Sci, Sport Sci Program, Doha, Qatar	Ningbo University; University of Cambridge; Oxford Brookes University; University of Hertfordshire; Memorial University Newfoundland; Universite de la Manouba; Qatar University	Jemni, M; Gu, YD (corresponding author), Ningbo Univ, Fac Sports Sci, Ningbo, Zhejiang, Peoples R China.; Jemni, M (corresponding author), Univ Cambridge, Inst Continuing Educ, Cambridge, England.	monemj@hotmail.com; guyaodong@hotmail.com	Bessem., Mkaouer/L-8553-2015; Konukman, Ferman/AAD-1600-2022; Marina, Michel/I-4551-2015	Bessem., Mkaouer/0000-0002-1499-112X; gu, yaodong/0000-0003-2187-9440; Jemni, Monem/0000-0001-5410-9085; Marina, Michel/0000-0001-7783-5178				Allgrove JE, 2008, J SPORT SCI, V26, P653, DOI 10.1080/02640410701716790; Banfi G, 2006, J SPORT MED PHYS FIT, V46, P611; BONGIOVANNI LG, 1990, J PHYSIOL-LONDON, V423, P1; Bosco C, 2000, EUR J APPL PHYSIOL, V81, P449, DOI 10.1007/s004210050067; Bowden JA, 2009, J CHROMATOGR B, V877, P3237, DOI 10.1016/j.jchromb.2009.08.005; Cardinale M, 2006, CLIN PHYSIOL FUNCT I, V26, P380, DOI 10.1111/j.1475-097X.2006.00706.x; Chen WC, 2018, PHYSIOL INT, V105, P166, DOI 10.1556/2060.105.2018.2.9; Cochrane DJ, 2005, BRIT J SPORT MED, V39, P860, DOI 10.1136/bjsm.2005.019950; Crewther BT, 2010, J SPORT MED PHYS FIT, V50, P85; Erskine J, 2007, CLIN PHYSIOL FUNCT I, V27, P242, DOI 10.1111/j.1475-097X.2007.00745.x; Fahrner CL, 1998, INT J SPORTS MED, V19, P12, DOI 10.1055/s-2007-971872; FARRELL PA, 1983, J APPL PHYSIOL, V55, P1441, DOI 10.1152/jappl.1983.55.5.1441; Filingeri D, 2012, J SPORT SCI MED, V11, P423; Gozansky WS, 2005, CLIN ENDOCRINOL, V63, P336, DOI 10.1111/j.1365-2265.2005.02349.x; Hayes LD, 2015, AGING MALE, V18, P22, DOI 10.3109/13685538.2014.977246; Herda TJ, 2009, SCAND J MED SCI SPOR, V19, P703, DOI 10.1111/j.1600-0838.2008.00787.x; Hoffman U, 1999, 17 C INT SOC BIOM; Jemni M, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01083; Jemni M, 2014, J STRENGTH COND RES, V28, P3105, DOI 10.1519/JSC.0000000000000404; Kinser AM, MED SCI SPORTS EXERC, V40, P133; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; Kraemer WJ, 2005, SPORTS MED, V35, P339, DOI 10.2165/00007256-200535040-00004; Kvorning T, 2006, EUR J APPL PHYSIOL, V96, P615, DOI 10.1007/s00421-006-0139-3; Lombardi G, 2017, CHRONOBIOL INT, V34, P471, DOI 10.1080/07420528.2017.1297820; Lu SS, 1997, MED SCI SPORT EXER, V29, P1048, DOI 10.1097/00005768-199708000-00010; Marshall LC, 2012, J STRENGTH COND RES, V26, P789, DOI 10.1519/JSC.0b013e31822a5ce8; Martin BJ, 1997, EUR J APPL PHYSIOL, V75, P504, DOI 10.1007/s004210050196; Obminski Z, 1997, J SPORT MED PHYS FIT, V37, P50; Obminski Z, 1996, EXP CLIN ENDOCR DIAB, V104, P350, DOI 10.1055/s-0029-1211466; PORT K, 1991, INT J SPORTS MED, V12, P490, DOI 10.1055/s-2007-1024720; Rahman Zamzy A, 2010, J Oral Sci, V52, P133; Rittweger J, 2003, CLIN PHYSIOL FUNCT I, V23, P81, DOI 10.1046/j.1475-097X.2003.00473.x; ROSNER W, 1990, ENDOCR REV, V11, P80, DOI 10.1210/edrv-11-1-80; SALE DG, 1987, EXERCISE SPORT SCI R, V15, P95; Salway J. G., 2006, MED BIOCH GLANCE; SAMUELSON B, 1989, UPSALA J MED SCI, V94, P73, DOI 10.3109/03009738909179249; Sperlich B., 2009, J EXERC PHYSL ONLINE, V12, P40; SUTTON JR, 1973, BRIT MED J, V1, P520, DOI 10.1136/bmj.1.5852.520; TABATA I, 1991, J APPL PHYSIOL, V71, P1807, DOI 10.1152/jappl.1991.71.5.1807; Tanner AV, 2014, J SPORT SCI, V32, P680, DOI 10.1080/02640414.2013.850594; Viru M, 2008, ACTA PHYSIOL HUNG, V95, P219, DOI 10.1556/APhysiol.95.2008.2.6; Vitale JA, 2020, RES SPORTS MED, V28, P293, DOI 10.1080/15438627.2019.1635131; Vuorimaa T, 2008, SCAND J MED SCI SPOR, V18, P565, DOI 10.1111/j.1600-0838.2007.00733.x	43	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238051	10.1371/journal.pone.0238051	http://dx.doi.org/10.1371/journal.pone.0238051			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915796	Green Published, gold			2022-12-26	WOS:000571887500038
J	Miclotte, G; Martens, K; Fostier, J				Miclotte, Giles; Martens, Koen; Fostier, Jan			Computational assessment of the feasibility of protonation-based protein sequencing	PLOS ONE			English	Article							ELECTRONIC MEASUREMENTS; SINGLE; MOLECULES	Recent advances in DNA sequencing methods revolutionized biology by providing highly accurate reads, with high throughput or high read length. These read data are being used in many biological and medical applications. Modern DNA sequencing methods have no equivalent in protein sequencing, severely limiting the widespread application of protein data. Recently, several optical protein sequencing methods have been proposed that rely on the fluorescent labeling of amino acids. Here, we introduce the reprotonation-deprotonation protein sequencing method. Unlike other methods, this proposed technique relies on the measurement of an electrical signal and requires no fluorescent labeling. In reprotonation-deprotonation protein sequencing, the terminal amino acid is identified through its unique protonation signal, and by repeatedly cleaving the terminal amino acids one-by-one, each amino acid in the peptide is measured. By means of simulations, we show that, given a reference database of known proteins, reprotonation-deprotonation sequencing has the potential to correctly identify proteins in a sample. Our simulations provide target values for the signal-to-noise ratios that sensor devices need to attain in order to detect reprotonation-deprotonation events, as well as suitable pH values and required measurement times per amino acid. For instance, an SNR of 10 is required for a 61.71% proteome recovery rate with 100 ms measurement time per amino acid.	[Miclotte, Giles; Fostier, Jan] Univ Ghent, IDLab, IMEC, Ghent, Belgium; [Martens, Koen] IMEC, Leuven, Belgium	Ghent University; IMEC; IMEC	Martens, K (corresponding author), IMEC, Leuven, Belgium.	Koen.Martens@imec.be	Fostier, Jan/A-8275-2012	Fostier, Jan/0000-0002-9994-8269; Miclotte, Giles/0000-0002-9212-3440	imec vzw	imec vzw	This work is funded by imec vzw. Giles Miclotte, Koen Martens and Jan Fostier are employees of imec vzw, Belgium; Giles Miclotte and Jan Fostier are employees of Ghent University, Ghent, Belgium. The funder provided support in the form of salaries for authors [GM, KM, JF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of each author is articulated in the "author contributions" section.	Abu-Absi NR, 2014, PHARM BIOPROCESS, V2, DOI 10.4155/PBP.14.24; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Borgo B, 2015, PROTEIN SCI, V24, P571, DOI 10.1002/pro.2633; Brown W., 2010, ORGANIC CHEM; Callewaert N, 2019, Patent No. [WO/2019/063827 A1, 2019063827]; Castaneda CA, 2009, PROTEINS, V77, P570, DOI 10.1002/prot.22470; Choi Y, 2013, NANO LETT, V13, P625, DOI 10.1021/nl304209p; Choi YK, 2012, SCIENCE, V335, P319, DOI 10.1126/science.1214824; Evich M, 2016, PROTEIN SCI, V25, P479, DOI 10.1002/pro.2838; Gevaert K, 2003, NAT BIOTECHNOL, V21, P566, DOI 10.1038/nbt810; Korlach J, 2008, P NATL ACAD SCI USA, V105, P1176, DOI 10.1073/pnas.0710982105; Legutki JB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5785; Lu HY, 2016, GENOM PROTEOM BIOINF, V14, P265, DOI 10.1016/j.gpb.2016.05.004; Monti M, 2005, CLIN CHIM ACTA, V357, P140, DOI 10.1016/j.cccn.2005.03.019; Olsen TJ, 2013, J AM CHEM SOC, V135, P7855, DOI 10.1021/ja311603r; Petricoin EF, 2002, NAT REV DRUG DISCOV, V1, P683, DOI 10.1038/nrd891; Plenat T, 2017, ACS APPL MATER INTER, V9, P30561, DOI 10.1021/acsami.7b11953; Rhoads A, 2015, GENOM PROTEOM BIOINF, V13, P278, DOI 10.1016/j.gpb.2015.08.002; Rodriques SG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212868; Sigdel TK, 2012, BIOMARK MED, V6, P259, DOI [10.2217/BMM.12.29, 10.2217/bmm.12.29]; Sims PC, 2013, J AM CHEM SOC, V135, P7861, DOI 10.1021/ja311604j; Sorgenfrei S, 2011, NAT NANOTECHNOL, V6, P125, DOI 10.1038/nnano.2010.275; Stirnemann G, 2013, P NATL ACAD SCI USA, V110, P3847, DOI 10.1073/pnas.1300596110; Swaminathan J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004080; Twyman RM, 2014, PRINCIPLES OF PROTEOMICS, SECOND EDITION, P1; Wallerstein J, 2015, J AM CHEM SOC, V137, P3093, DOI 10.1021/ja513205s; Xiao XY, 2004, J AM CHEM SOC, V126, P5370, DOI 10.1021/ja049469a; Yao Y, 2015, PHYS BIOL, V12, DOI 10.1088/1478-3975/12/5/055003; Zhang GJ, 2008, NANO LETT, V8, P1066, DOI 10.1021/nl072991l; Zhang WW, 2010, MICROBIOL-SGM, V156, P287, DOI 10.1099/mic.0.034793-0	31	2	2	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238625	10.1371/journal.pone.0238625	http://dx.doi.org/10.1371/journal.pone.0238625			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915813	gold, Green Published			2022-12-26	WOS:000571887500067
J	Pieh, C; O'Rourke, T; Budimir, S; Probst, T				Pieh, Christoph; O'Rourke, Teresa; Budimir, Sanja; Probst, Thomas			Relationship quality and mental health during COVID-19 lockdown	PLOS ONE			English	Article							DEPRESSION; MARRIAGE; IMPAIRMENT; PREVALENCE; ANXIETY; IMPACT	Catastrophes are known to have an impact on relationships as well as on mental health. This study evaluated differences in several mental health and well-being measures according to relationship quality during the Coronavirus Disease (COVID-19) pandemic and related lockdown measures. A cross-sectional online survey was launched four weeks after lockdown measures were implemented in Austria. Relationship quality was measured with the Quality of Marriage Index (QMI), and mental health measures included quality of life (WHO-QOL BREF psychological domain), well-being (WHO-5), depression (PHQ-9), anxiety (GAD-7), stress (PSS-10), and sleep quality (ISI). ANOVAs with Bonferroni-corrected post-hoc tests and Chisquared tests were applied. In all mental health scales, individuals with good relationship quality (n = 543) scored better than individuals with poor relationship quality (n = 190) or without relationship (n = 272). The odds ratios (OR) between the poor and good relationship quality groups were 3.5 for the PHQ-9, 3.4 for the GAD-7, and 2.0 for the ISI. Additionally, individuals without no relationship scored better on all scales than individuals with poor relationship quality (all p-values < .05). Relationship quality was related to mental health during COVID-19. The prevalence of depressive symptoms increased according to relationship quality from 13% up to 35%. Relationship per se was not associated with better mental health, but the quality of the relationship was essential. Compared to no relationship, a good relationship quality was a protective factor whereas a poor relationship quality was a risk factor.	[Pieh, Christoph; O'Rourke, Teresa; Budimir, Sanja; Probst, Thomas] Danube Univ Krems, Dept Psychotherapy & Biopsychosocial Hlth, Krems An Der Donau, Austria; [Budimir, Sanja] Univ Ghent, Dept Work Org & Soc, Ghent, Belgium	Danube University Krems; Ghent University	Pieh, C (corresponding author), Danube Univ Krems, Dept Psychotherapy & Biopsychosocial Hlth, Krems An Der Donau, Austria.	Christoph.pieh@donau-uni.ac.at	Pieh, Christoph/GSN-1242-2022; Budimir, Sanja/AAZ-3622-2020; Probst, Thomas/J-8318-2018; O'Rourke, Teresa/AAZ-5798-2020	Budimir, Sanja/0000-0002-4110-9112; Probst, Thomas/0000-0002-6113-2133; O'Rourke, Teresa/0000-0001-5999-9363				Ahmad A, FACTORS INFLUENCING; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Cohan CL, 2009, J SOC PERS RELAT, V26, P512, DOI 10.1177/0265407509351043; Cohan CL, 2002, J FAM PSYCHOL, V16, P14, DOI 10.1037//0893-3200.16.1.14; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Frech A, 2007, J HEALTH SOC BEHAV, V48, P149, DOI 10.1177/002214650704800204; Goldfarb MR, 2019, MARRIAGE FAM REV, V55, P737, DOI 10.1080/01494929.2019.1610136; Hawthorne G, 2006, SOC INDIC RES, V77, P37, DOI 10.1007/s11205-005-5552-1; Heyman R. E., 1994, J FAMILY PSYCHOL, V8, P432, DOI [DOI 10.1037/0893-3200.8.4.432, 10.1037/0893-3200.8.4.432]; Holt-Lunstad J, 2008, ANN BEHAV MED, V35, P239, DOI 10.1007/s12160-008-9018-y; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Leach LS, 2013, SOC PSYCH PSYCH EPID, V48, P417, DOI 10.1007/s00127-012-0559-9; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; SPANIER GB, 1976, J MARRIAGE FAM, V38, P15, DOI 10.2307/350547; SS V et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, 2020, CIRCULATION, V2020, pe1; Teo AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062396; Thombs BD, 2018, CAN MED ASSOC J, V190, pE44, DOI 10.1503/cmaj.170691; Topp CW, 2015, PSYCHOTHER PSYCHOSOM, V84, DOI 10.1159/000376585; Uecker JE, 2012, J HEALTH SOC BEHAV, V53, P67, DOI 10.1177/0022146511419206; Umberson D, 2013, HDB SOCIOLOGY MENTAL; Whisman MA, 2006, J FAM PSYCHOL, V20, P369, DOI 10.1037/0893-3200.20.3.369; Zimmermann T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212758	23	84	87	6	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238906	10.1371/journal.pone.0238906	http://dx.doi.org/10.1371/journal.pone.0238906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR9MU	32915878	Green Published, gold			2022-12-26	WOS:000571887500064
J	Zou, QH; Zhang, HF; Meng, FL; He, LH; Zhang, JZ; Xiao, D				Zou, Qinghua; Zhang, Huifang; Meng, Fanliang; He, Lihua; Zhang, Jianzhong; Xiao, Di			Proteomic and transcriptomic studies of BGC823 cells stimulated withHelicobacter pyloriisolates from gastric MALT lymphoma	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; GENE-EXPRESSION; EPITHELIAL-CELLS; CANCER-CELLS; PROLIFERATION; ERADICATION; DIAGNOSIS; CONSENSUS; PROFILES; PATHWAY	Background The correlation between the infection ofH.pyloriand the occurrence of gastric MALT lymphoma (GML) has been well documented. However, the mechanism of how GML is caused by this bacterium is not well understood, although some immunologic mechanisms are thought to be involved. Materials and methods In this study, we performed both transcriptomic and proteomic analyses on gastric cancer cells infected byH.pyloriisolates from GML patients and the gastric ulcer strain 26695 to investigate the differentially expressed molecular signatures that were induced by GML isolates. Results Transcriptomic analyses revealed that the differentially expressed genes (DEGs) were mainly related to binding, catalytic activity, signal transducer activity, molecular transducer activity, nucleic acid binding transcription factor activity, and molecular function regulator. Fifteen pathways, including the Wnt signaling pathway, the mTOR signaling pathway, the NOD-like receptor signaling pathway and the Hippo signaling pathway, were revealed to be related to GML isolates. Proteomic analyses results showed that there were 116 differentially expressed proteins (DEPs). Most of these DEPs were associated with cancer, and 29 have been used as biomarkers for cancer diagnosis. We also found 63 upstream regulators that can inhibit or activate the expression of the DEPs. Combining the proteomic and transcriptomic analyses revealed 12 common pathways. This study provides novel insights intoH.pylori-associated GML. The DEPs we found may be good candidates for GML diagnosis and treatment. Conclusions This study revealed specific pathways related to GML and potential biomarkers for GML diagnosis.	[Zou, Qinghua] Peking Univ, Sch Basic Med Sci, Dept Microbiol, Hlth Sci Ctr, Beijing, Peoples R China; [Zhang, Huifang; Meng, Fanliang; He, Lihua; Zhang, Jianzhong; Xiao, Di] Chinese Ctr Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Peking University; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Zhang, JZ; Xiao, D (corresponding author), Chinese Ctr Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	zhangjianzhong@icdc.cn; xiaodi@icdc.cn	Zhang, Jianzhong/AAM-6179-2021; Zhang, Hui/HHN-8494-2022; zhang, hui/GXH-6098-2022	Zhang, Jianzhong/0000-0001-7056-8206; Xiao, Di/0000-0002-5964-5925	Major Infectious Diseases AIDS and Viral Hepatitis Prevention and Control Technology Major Projects [2018ZX10712001-006012, 2018ZX10733402-003002]	Major Infectious Diseases AIDS and Viral Hepatitis Prevention and Control Technology Major Projects	This work was supported by The Major Infectious Diseases AIDS and Viral Hepatitis Prevention and Control Technology Major Projects (Grant No. 2018ZX10712001-006012 and Grand No. 2018ZX10733402-003002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Akwaa AM, 2004, WORLD J GASTROENTERO, V10, P5; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2002, SHIJIE ZONGJIAO, V3, P97; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bach S, 2002, INFECT IMMUN, V70, P988, DOI 10.1128/IAI.70.2.988-992.2002; Backert S, 2005, PROTEOMICS, V5, P3902, DOI 10.1002/pmic.200401240; Benjamini Y, 2001, ANN STAT, V29, P1165; Blosse A, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060845; Cathcart MC, 2012, BBA-REV CANCER, V1825, P49, DOI 10.1016/j.bbcan.2011.09.004; Chen HM, 2020, BIOL TRACE ELEM RES, V195, P472, DOI 10.1007/s12011-019-01852-x; Juca PCDC, 2017, DIAGN PATHOL, V12, DOI 10.1186/s13000-017-0635-2; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; de Jong D, 1999, ANN ONCOL, V10, P275, DOI 10.1023/A:1008392022152; Eck M, 1997, GASTROENTEROLOGY, V112, P1482, DOI 10.1016/S0016-5085(97)70028-3; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Floch P, 2015, ONCOTARGET, V6, P34525, DOI 10.18632/oncotarget.5948; Hoffmann M, 2018, INT J CANCER, V142, P833, DOI 10.1002/ijc.31108; Huang LH, 2018, ONCOL LETT, V16, P1650, DOI 10.3892/ol.2018.8796; Jiang J, 2019, BIOMED PHARMACOTHER, V109, P595, DOI 10.1016/j.biopha.2018.10.148; Jiang KY, 2019, ONCOL LETT, V17, P3191, DOI 10.3892/ol.2019.9952; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim SH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-175; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lehours P, 2004, INFECT IMMUN, V72, P880, DOI 10.1128/IAI.72.2.880-888.2004; Li N, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00417; Li NS, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0962-5; Liu K, 2016, TUMOR BIOL, V37, P12855, DOI 10.1007/s13277-016-5236-2; Liu XM, 2017, WORLD J GASTROENTERO, V23, P5345, DOI 10.3748/wjg.v23.i29.5345; Maeda S, 2001, BIOCHEM BIOPH RES CO, V284, P443, DOI 10.1006/bbrc.2001.5006; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Mannick EE, 2004, SCAND J GASTROENTERO, V39, P1192, DOI 10.1080/00365520410003588; NAIR P, 1983, DIS COLON RECTUM, V26, P629, DOI 10.1007/BF02552982; Nakamura S, 1997, CANCER-AM CANCER SOC, V79, P3, DOI 10.1002/(SICI)1097-0142(19970101)79:1<3::AID-CNCR2>3.0.CO;2-P; Neal JT, 2013, DIS MODEL MECH, V6, P802, DOI 10.1242/dmm.011163; Nobre-Leitao C, 1998, AM J GASTROENTEROL, V93, P732, DOI 10.1111/j.1572-0241.1998.215_a.x; Paduch R, 2005, CELL BIOL TOXICOL, V21, P247, DOI 10.1007/s10565-005-0002-z; PARSONNET J, 1994, NEW ENGL J MED, V330, P1267, DOI 10.1056/NEJM199405053301803; Rajesh Y, 2019, BIOCHEM PHARMACOL, V164, P1, DOI 10.1016/j.bcp.2019.03.025; Romero-Garcia S, 2019, INT J ONCOL, V54, P1155, DOI 10.3892/ijo.2019.4696; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Salkind N., 2007, ENCY MEASUREMENT STA; SEIFERT E, 1993, ENDOSCOPY, V25, P497, DOI 10.1055/s-2007-1010384; Sepulveda AR, 2002, ALIMENT PHARM THERAP, V16, P145, DOI 10.1046/j.1365-2036.16.s2.4.x; Thiede C, 1997, GASTROENTEROLOGY, V113, pS61, DOI 10.1016/S0016-5085(97)80014-5; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Wang HC, 2015, GENOME ANNOUNC, V3; Wen SC, 2004, J IMMUNOL, V172, P2595, DOI 10.4049/jimmunol.172.4.2595; Xu Can-Xia, 2007, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V32, P288; Yamaoka Y, 2008, WORLD J GASTROENTERO, V14, P4265, DOI 10.3748/wjg.14.4265; Zhang BG, 2016, ONCOTARGET, V7, P9788, DOI 10.18632/oncotarget.7125; 2014, REG ANESTH PAIN MED, V9	52	2	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238379	10.1371/journal.pone.0238379	http://dx.doi.org/10.1371/journal.pone.0238379			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915799	gold, Green Published			2022-12-26	WOS:000571887500121
J	Salvador, R; Tanquilut, N; Macmac, R; Lampang, KN; Chaisowwong, W; Pfeiffer, D; Punyapornwithaya, V				Salvador, Roderick; Tanquilut, Neil; Macmac, Rosemarie; Lampang, Kannika Na; Chaisowwong, Warangkhana; Pfeiffer, Dirk; Punyapornwithaya, Veerasak			Evaluation of strategies using simulation model to control a potential outbreak of highly pathogenic avian influenza among poultry farms in Central Luzon, Philippines	PLOS ONE			English	Article							MOUTH-DISEASE EPIDEMIC; SWINE-FEVER VIRUS; TRANSMISSION DYNAMICS; H7N1 EPIDEMIC; FOOT; H5N1; SPREAD; RISK; QUANTIFICATION; NETHERLANDS	The Philippines confirmed its first epidemic of Highly Pathogenic Avian Influenza (HPAI) on August 11, 2017. It ended in November of 2017. Despite the successful management of the epidemic, reemergence is a continuous threat. The aim of this study was to conduct a mathematical model to assess the spatial transmission of HPAI among poultry farms in Central Luzon. Different control strategies and the current government protocol of 1 km radius pre-emptive culling (PEC) from infected farms were evaluated. The alternative strategies include 0.5km PEC, 1.5km PEC, 2 km PEC, 2.5 km PEC, and 3 km PEC, no pre-emptive culling (NPEC). The NPEC scenario was further modeled with a time of government notification set at 24hours, 48 hours, and 72 hours after the detection. Disease spread scenarios under each strategy were generated using an SEIR (susceptible-exposed-infectious-removed) stochastic model. A spatial transmission kernel was calculated and used to represent all potential routes of infection between farms. We assumed that the latent period occurs between 1-2 days, disease detection at 5-7 days post-infection, notification of authorities at 5-7 days post-detection and start of culling at 1-3 days post notification. The epidemic scenarios were compared based on the number of infected farms, the total number of culled farms, and the duration of the epidemic. Our results revealed that the current protocol is the most appropriate option compared with the other alternative interventions considered among farms with reproductive ratio (R-i) > 1. Shortening the culling radius to 0.5 km increased the duration of the epidemic. Further increase in the PEC zone decreased the duration of the epidemic but may not justify the increased number of farms to be culled. Nonetheless, the no-pre-emptive culling (NPEC) strategy can be an effective alternative to the current protocol if farm managers inform the government immediately within 24 hours of observation of the presence of HPAI in their farms. Moreover, if notification is made on days 1-3 after the detection, the scale and length of the outbreak have been significantly reduced. In conclusion, this study provided a comparison of various control measures for confronting the spread of HPAI infection using the simulation model. Policy makers can use this information to enhance the effectiveness of the current control strategy.	[Salvador, Roderick] Cent Luzon State Univ, Coll Vet Sci & Med, Science City Of Munoz, Nueva Ecija, Philippines; [Salvador, Roderick] Chiang Mai Univ, Fac Vet Med, Vet Sci, PhD Degrees Program, Chiang Mai, Thailand; [Tanquilut, Neil] Pampanga State Agr Univ, Coll Vet Med, Pampanga, Philippines; [Tanquilut, Neil] Univ Philippines, Sch Environm Sci & Management, Los Banos, Laguna, Philippines; [Macmac, Rosemarie] Pampanga State Agr Univ, Coll Resource Engn Automat & Mechanizat, Pampanga, Philippines; [Lampang, Kannika Na; Chaisowwong, Warangkhana; Punyapornwithaya, Veerasak] Chiang Mai Univ, Vet Publ Hlth & Food Safety Ctr, Fac Vet Med, Chiang Mai, Thailand; [Lampang, Kannika Na; Chaisowwong, Warangkhana; Punyapornwithaya, Veerasak] Chiang Mai Univ, Excellent Ctr Vet Publ Hlth, Fac Vet Med, Chiang Mai, Thailand; [Pfeiffer, Dirk] Royal Vet Coll, Dept Pathobiol & Populat Sci, London, England; [Pfeiffer, Dirk] City Univ Hong Kong, Ctr Appl One Hlth Res & Policy Advice, Hong Kong, Peoples R China	Chiang Mai University; University of the Philippines System; University of the Philippines Los Banos; University of the Philippines Open University; Chiang Mai University; Chiang Mai University; University of London; University of London Royal Veterinary College; City University of Hong Kong	Punyapornwithaya, V (corresponding author), Chiang Mai Univ, Vet Publ Hlth & Food Safety Ctr, Fac Vet Med, Chiang Mai, Thailand.; Punyapornwithaya, V (corresponding author), Chiang Mai Univ, Excellent Ctr Vet Publ Hlth, Fac Vet Med, Chiang Mai, Thailand.	veerasak.p@cmu.ac.th	Punyapornwithaya, Verasak/V-9323-2019; Punyapornwithaya, Veerasak/ABE-5119-2020; Pfeiffer, Dirk U/C-5002-2009	Punyapornwithaya, Verasak/0000-0001-9870-7773; Pfeiffer, Dirk U/0000-0001-7000-0530	Veterinary Public Health and Food Safety Centre; Excellent Center of Veterinary Public Health, Faculty of Veterinary Medicine Chiang Mai University, Chiang Mai, Thailand; BBSRC [BB/S011269/1] Funding Source: UKRI	Veterinary Public Health and Food Safety Centre; Excellent Center of Veterinary Public Health, Faculty of Veterinary Medicine Chiang Mai University, Chiang Mai, Thailand; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The research fund was granted by Veterinary Public Health and Food Safety Centre and Excellent Center of Veterinary Public Health, Faculty of Veterinary Medicine Chiang Mai University, Chiang Mai, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai T, 2018, OIE SITUATION REPORT, P1; Alaa Ahmed M, 2019, PLoS One, V14, pe0213653, DOI 10.1371/journal.pone.0213653; [Anonymous], 2010, ECRITS C, V2, P36; Arcalas J, 2017, BUSINESS MIRROR; Ayyalasomayajula S, 2008, ZOONOSES PUBLIC HLTH, V55, P497, DOI 10.1111/j.1863-2378.2008.01148.x; Backer JA, 2015, PREV VET MED, V121, P142, DOI 10.1016/j.prevetmed.2015.06.006; Bersales LGS, 2019, DUCK SITUATION REPOR, P1; Bersales LGS, 2019, CHICKEN SITUATION RE, P1; Bett B, 2014, TRANSBOUND EMERG DIS, V61, P60, DOI 10.1111/tbed.12003; Boender GJ, 2007, PLOS COMPUT BIOL, V3, P704, DOI 10.1371/journal.pcbi.0030071; Boender Gert Jan, 2007, Vet Ital, V43, P605; Bonney PJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204262; Bouma A, 2003, PREV VET MED, V57, P155, DOI 10.1016/S0167-5877(02)00217-9; Bouma A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000281; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Busani L, 2009, VET J, V181, P171, DOI 10.1016/j.tvjl.2008.02.013; Capua I, 2003, AVIAN PATHOL, V32, P47, DOI 10.1080/0307945021000070714; Capua I, 2002, ACTA TROP, V83, P7, DOI 10.1016/S0001-706X(02)00057-8; Capua I, 2006, EMERG INFECT DIS, V12, P1319, DOI 10.3201/eid1209.060430; Capua I, 2006, AVIAN PATHOL, V35, P189, DOI 10.1080/03079450600717174; de Jong MD, 2006, J CLIN VIROL, V35, P2, DOI 10.1016/j.jcv.2005.09.002; Dorigatti I, 2010, Epidemics, V2, P29, DOI 10.1016/j.epidem.2010.01.002; Ellis TM, 2004, AVIAN PATHOL, V33, P405, DOI 10.1080/03079450410001724012; Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Garske T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000349; Hayama Y, 2013, PREV VET MED, V112, P183, DOI 10.1016/j.prevetmed.2013.08.010; Hayama Y, 2015, J VET MED SCI, V77, P1167, DOI 10.1292/jvms.14-0461; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Keeling MJ, 2005, P ROY SOC B-BIOL SCI, V272, P1195, DOI 10.1098/rspb.2004.3046; Laurence CJ, 2002, REV SCI TECH OIE, V21, P863, DOI 10.20506/rst.21.3.1382; Le Menach A, 2005, VET RES, V36, P699, DOI 10.1051/vetres:2005025; Mannelli A, 2006, PREV VET MED, V73, P273, DOI 10.1016/j.prevetmed.2005.09.005; Marquetoux N, 2012, PREV VET MED, V106, P143, DOI 10.1016/j.prevetmed.2012.01.021; Martin V, 2006, ANN NY ACAD SCI, V1081, P153, DOI 10.1196/annals.1373.017; Martinez-Lopez B, 2010, PREV VET MED, V96, P19, DOI 10.1016/j.prevetmed.2010.05.015; Minh PQ, 2009, PREV VET MED, V89, P16, DOI 10.1016/j.prevetmed.2009.01.004; Mintiens K, 2003, PREV VET MED, V60, P27, DOI 10.1016/S0167-5877(03)00080-1; Muroga N, 2012, J VET MED SCI, V74, P399, DOI 10.1292/jvms.11-0271; Nguyen MN, 2010, PLOS ONE, V5, pe9907; Park JH, 2013, EMERG INFECT DIS, V19, P655, DOI 10.3201/eid1904.121320; Patyk KA, 2013, PREV VET MED, V110, P510, DOI 10.1016/j.prevetmed.2013.01.003; Penny MA, 2010, ECOHEALTH, V7, P275, DOI 10.1007/s10393-010-0338-6; QGIS Development Team, 2009, QGIS GEOGR INF SYST; R Development Core Team, 2019, R LANG ENV STAT COMP; Roche SE, 2014, PREV VET MED, V113, P436, DOI 10.1016/j.prevetmed.2013.12.003; Romero J, 2017, ABS CBN; Siettos CI, 2013, VIRULENCE, V4, P295, DOI 10.4161/viru.24041; Simeon LM., 2017, THE PHILIPPINE STAR; Staff CP, 2017, CNN PHILIPPINES; Staubach C, 1997, EPIDEMIOL SANTE ANIM, P31; Stegeman A, 2004, J INFECT DIS, V190, P2088, DOI 10.1086/425583; Stegeman A, 1999, PREV VET MED, V42, P219, DOI 10.1016/S0167-5877(99)00077-X; Stegeman JA, 2002, EPIDEMIOL INFECT, V128, P285, DOI 10.1017/S0950268801006483; Ster IC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000502; Swayne DE, 2005, AVIAN DIS, V49, P81, DOI 10.1637/7260-081104R; Thrusfield M, 2005, VET REC, V156, P269, DOI 10.1136/vr.156.9.269; Tian GB, 2005, VIROLOGY, V341, P153, DOI 10.1016/j.virol.2005.07.011; Tiensin T, 2005, EMERG INFECT DIS, V11, P1664, DOI 10.3201/eid1111.050608; Tiensin T, 2007, J INFECT DIS, V196, P1679, DOI 10.1086/522007; Tildesley MJ, 2009, P ROY SOC B-BIOL SCI, V276, P3239, DOI 10.1098/rspb.2009.0427; Truscott J, 2007, P ROY SOC B-BIOL SCI, V274, P2287, DOI 10.1098/rspb.2007.0542; van der Goot JA, 2005, P NATL ACAD SCI USA, V102, P18141, DOI 10.1073/pnas.0505098102; Ward MP, 2009, PREV VET MED, V88, P286, DOI 10.1016/j.prevetmed.2008.12.006; Windsor PA, 2011, TRANSBOUND EMERG DIS, V58, P421, DOI 10.1111/j.1865-1682.2011.01225.x; World Health Organization (WHO), 2020, WHO COR DIS COVID 19; Wright B. K., 2016, DEV BEHAV CHANGE STR; Yoon H, 2006, PREV VET MED, V74, P212, DOI 10.1016/j.prevetmed.2005.12.002; Zingg A, 2012, J RISK RES, V15, P53, DOI 10.1080/13669877.2011.601320	69	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238815	10.1371/journal.pone.0238815	http://dx.doi.org/10.1371/journal.pone.0238815			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32913363	gold, Green Published			2022-12-26	WOS:000571885900032
J	Manti, M; Pui, HP; Edstrom, S; Risal, S; Lu, HJ; Lindgren, E; Ohlsson, C; Jerlhag, E; Benrick, A; Deng, QL; Stener-Victorin, E				Manti, Maria; Pui, Han-Pin; Edstrom, Sonja; Risal, Sanjiv; Lu, Haojiang; Lindgren, Eva; Ohlsson, Claes; Jerlhag, Elisabet; Benrick, Anna; Deng, Qiaolin; Stener-Victorin, Elisabet			Excess of ovarian nerve growth factor impairs embryonic development and causes reproductive and metabolic dysfunction in adult female mice	FASEB JOURNAL			English	Article						adipose tissue; imprinting; polycystic ovary syndrome; sex steroids; sympathetic activity	POLYCYSTIC-OVARY; BIRTH-WEIGHT; FOLLICULAR DEVELOPMENT; TRANSGENIC MICE; ADIPOSE-TISSUE; MOUSE; GENE; OBESITY; RISK; FOLLICULOGENESIS	Nerve growth factor (NGF) is critical for the development and maintenance of the peripheral sympathetic neurons. NGF is also involved in the ovarian sympathetic innervation and in the development and maintenance of folliculogenesis. Women with the endocrine disorder, polycystic ovary syndrome (PCOS), have an increased sympathetic nerve activity and increased ovarian NGF levels. The role of ovarian NGF excess in the PCOS pathophysiology and in the PCOS-related features is unclear. Here, using transgenic mice overexpressesing NGF in the ovarian theca cells (17NF mice), we assessed the female embryonic development, and the reproductive and metabolic profile in adult females. Ovarian NGF excess caused growth restriction in the female fetuses, and a delayed gonocyte and primary oocyte maturation. In adulthood, the 17NF mice displayed irregular estrous cycles and altered ovarian expression of steroidogenic and epigenetic markers. They also exhibited an increased sympathetic output with increased circulating dopamine, and metabolic dysfunction reflected by aberrant adipose tissue morphology and function, impaired glucose metabolism, decreased energy expenditure, and hepatic steatosis. These findings indicate that ovarian NGF excess leads to adverse fetal development and to reproductive and metabolic complications in adulthood, mirroring common features of PCOS. This work provides evidence that NGF excess may be implicated in the PCOS pathophysiology.	[Manti, Maria; Pui, Han-Pin; Edstrom, Sonja; Risal, Sanjiv; Lu, Haojiang; Lindgren, Eva; Deng, Qiaolin; Stener-Victorin, Elisabet] Karolinska Inst, Dept Physiol & Pharmacol, Biomedicum B5, S-17177 Stockholm, Sweden; [Pui, Han-Pin; Deng, Qiaolin] Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden; [Ohlsson, Claes] Univ Gothenburg, Sahlgrenska Acad, Ctr Bone & Arthrit Res, Inst Med,Dept Internal Med & Clin Nutr, Gothenburg, Sweden; [Jerlhag, Elisabet] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Pharmacol, Gothenburg, Sweden; [Benrick, Anna] Univ Gothenburg, Sahlgrenska Acad, Dept Physiol, Gothenburg, Sweden; [Benrick, Anna] Univ Skovde, Sch Hlth & Educ, Skovde, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Skovde	Deng, QL; Stener-Victorin, E (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Biomedicum B5, S-17177 Stockholm, Sweden.	qiaolin.deng@ki.se; elisabet.stener-victorin@ki.se	Ohlsson, Claes/AGP-3544-2022; Risal, Sanjiv/K-9883-2017	Ohlsson, Claes/0000-0002-9633-2805; Deng, Qiaolin/0000-0001-5934-7816; Pui, Han-Pin/0000-0003-4099-0478; Risal, Sanjiv/0000-0003-1723-5431; Lu, Haojiang/0000-0001-9051-0140; Manti, Maria/0000-0003-4370-4780	Swedish Medical Research Council [2014-2775, 2018-02435 ESV, 2014-2870 QD, 2018-02557]; Novo Nordisk Foundation [NNF17OC0026724, NNF18OC0033992, NNF19OC0056647]; SRP in Diabetes at Karolinska Institutet; Adlerbertska Research Foundation; Karolinska Institutet KID; Swedish Association of Medical Research (SSMF); Ake Wiberg Foundation; Stockholm County Council; Karolinska Institutet; Novo Nordisk Fonden [NNF13OC0005785, NNF18OC0033898, NNF19OC0055250, NNF14OC0010513] Funding Source: researchfish	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); SRP in Diabetes at Karolinska Institutet; Adlerbertska Research Foundation; Karolinska Institutet KID(Karolinska Institutet); Swedish Association of Medical Research (SSMF); Ake Wiberg Foundation; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was funded by the Swedish Medical Research Council (Project No. 2014-2775, 2018-02435 ESV; 2014-2870 QD; 2018-02557), the Novo Nordisk Foundation (NNF17OC0026724, NNF18OC0033992, and NNF19OC0056647 ESV), the SRP in Diabetes at Karolinska Institutet to ESV; Adlerbertska Research Foundation to ESV; Karolinska Institutet KID funding to ESV and QD; the Swedish Association of Medical Research (SSMF) and the Ake Wiberg Foundation to QD; the Regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet to ESV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Amrhein V, 2019, NATURE, V567, P305, DOI 10.1038/d41586-019-00857-9; Bao SQ, 2000, BIOL REPROD, V62, P616, DOI 10.1095/biolreprod62.3.616; Barber TM, 2006, CLIN ENDOCRINOL, V65, P137, DOI 10.1111/j.1365-2265.2006.02587.x; Blaszkiewicz M, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8010010; BORUM K, 1961, EXP CELL RES, V24, P495, DOI 10.1016/0014-4827(61)90449-9; Bridges PJ, 2008, GENESIS, V46, P499, DOI 10.1002/dvg.20428; Broholm C, 2016, DIABETOLOGIA, V59, P2664, DOI 10.1007/s00125-016-4099-9; Caligioni CS, 2009, CURR PROTOC NEUROSCI, V4, p4I, DOI DOI 10.1002/0471142301.NSA04IS48; Chaves RN, 2013, ZYGOTE, V21, P187, DOI 10.1017/S0967199412000111; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Davis BM, 1997, J COMP NEUROL, V387, P489, DOI 10.1002/(SICI)1096-9861(19971103)387:4<489::AID-CNE2>3.0.CO;2-Z; Dissen GA, 2001, ENDOCRINOLOGY, V142, P2078, DOI 10.1210/en.142.5.2078; Dissen GA, 2000, ENDOCRINOLOGY, V141, P1073, DOI 10.1210/en.141.3.1073; Dissen GA, 2009, ENDOCRINOLOGY, V150, P2906, DOI 10.1210/en.2008-1575; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Eisenhofer G, 2004, PHARMACOL REV, V56, P331, DOI 10.1124/pr.56.3.1; Ek I, 2002, DIABETES, V51, P484, DOI 10.2337/diabetes.51.2.484; Flaa A, 2008, METABOLISM, V57, P1422, DOI 10.1016/j.metabol.2008.05.012; Fornes R, 2019, INT J OBESITY, V43, P2176, DOI 10.1038/s41366-018-0314-8; Furukawa S, 2013, EXP TOXICOL PATHOL, V65, P695, DOI 10.1016/j.etp.2012.09.002; Garcia-Rudaz C, 1998, CLIN ENDOCRINOL, V49, P221, DOI 10.1046/j.1365-2265.1998.00511.x; Garcia-Rudaz C, 2011, REPRODUCTION, V142, P319, DOI 10.1530/REP-11-0134; Glintborg D, 2018, J CLIN ENDOCR METAB, V103, P3819, DOI 10.1210/jc.2018-00889; Guarino D, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00665; Han LS, 2018, NAT GENET, V50, P432, DOI 10.1038/s41588-018-0055-6; Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071; Heider U, 2001, FERTIL STERIL, V75, P1141, DOI 10.1016/S0015-0282(01)01805-2; Heikkila M, 2002, ENDOCRINOLOGY, V143, P4358, DOI 10.1210/en.2002-220275; Hoyle GW, 1998, AM J RESP CELL MOL, V18, P149, DOI 10.1165/ajrcmb.18.2.2803m; HSIEH ACL, 1957, AM J PHYSIOL, V190, P243, DOI 10.1152/ajplegacy.1957.190.2.243; Huxley R, 2007, AM J CLIN NUTR, V85, P1244, DOI 10.1093/ajcn/85.5.1244; Iresjo BM, 2019, GENES NUTR, V14, DOI 10.1186/s12263-019-0652-8; Kitsiou-Tzeli S, 2017, CURR OPIN ENDOCRINOL, V24, P43, DOI 10.1097/MED.0000000000000305; Lambert EA, 2015, CLIN ENDOCRINOL, V83, P812, DOI 10.1111/cen.12803; LARA HE, 1990, ENDOCRINOLOGY, V126, P357, DOI 10.1210/endo-126-1-357; Lara HE, 2000, ENDOCRINOLOGY, V141, P1059, DOI 10.1210/en.141.3.1059; LARA HE, 1990, ENDOCRINOLOGY, V126, P364, DOI 10.1210/endo-126-1-364; LARA HE, 1993, ENDOCRINOLOGY, V133, P2690, DOI 10.1210/en.133.6.2690; Large V, 1998, DIABETES METAB, V24, P409; Legro RS, 1999, J CLIN ENDOCR METAB, V84, P165, DOI 10.1210/jc.84.1.165; Lin YF, 2008, SCIENCE, V322, P1685, DOI 10.1126/science.1166340; Makieva S, 2014, HUM REPROD UPDATE, V20, P542, DOI 10.1093/humupd/dmu008; Maliqueo M, 2015, HUM REPROD, V30, P692, DOI 10.1093/humrep/deu351; Manneras-Holm L, 2011, J CLIN ENDOCR METAB, V96, pE304, DOI 10.1210/jc.2010-1290; Masuo K, 2003, HYPERTENSION, V42, P474, DOI 10.1161/01.HYP.0000091371.53502.D3; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; Musali N, 2016, GYNECOL ENDOCRINOL, V32, P460, DOI 10.3109/09513590.2015.1130808; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Newell-Fugate AE, 2017, REPRODUCTION, V153, pR133, DOI 10.1530/REP-16-0417; Nilsson ME, 2015, ENDOCRINOLOGY, V156, P2492, DOI 10.1210/en.2014-1890; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; Ollila MM, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-033780; Orisaka M, 2006, MOL ENDOCRINOL, V20, P2456, DOI 10.1210/me.2005-0357; Ornoy A, 2011, REPROD TOXICOL, V32, P205, DOI 10.1016/j.reprotox.2011.05.002; Piedrahita JA, 2011, BIRTH DEFECTS RES A, V91, P682, DOI 10.1002/bdra.20795; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Resnik R, 2002, OBSTET GYNECOL, V99, P490, DOI 10.1016/S0029-7844(01)01780-X; Sanchez F, 2012, BBA-MOL BASIS DIS, V1822, P1896, DOI 10.1016/j.bbadis.2012.05.013; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Seligman J, 1998, BIOCHEM BIOPH RES CO, V245, P878, DOI 10.1006/bbrc.1998.8530; Shorakae S, 2018, CLIN ENDOCRINOL, V89, P628, DOI 10.1111/cen.13808; Sir-Petermann T, 2005, HUM REPROD, V20, P2122, DOI 10.1093/humrep/dei009; Spritzer PM, 2015, REPRODUCTION, V149, pR219, DOI 10.1530/REP-14-0435; Sverrisdottir YB, 2008, AM J PHYSIOL-ENDOC M, V294, pE576, DOI 10.1152/ajpendo.00725.2007; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; van Deutekom AW, 2016, INT J EPIDEMIOL, V45, P1079, DOI 10.1093/ije/dyw236; Veilleux A, 2009, CLIN LIPIDOL, V4, P367, DOI 10.2217/CLP.09.16; Wang YJ, 2015, DEVELOPMENT, V142, P343, DOI 10.1242/dev.112755; Wilson JL, 2014, ENDOCRINOLOGY, V155, P4494, DOI 10.1210/en.2014-1368; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; Wulsin LR, 2015, J CLIN ENDOCR METAB, V100, P2443, DOI 10.1210/jc.2015-1748; Yamaguchi S, 2012, NATURE, V492, P443, DOI 10.1038/nature11709	72	4	5	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14440	14457		10.1096/fj.202001060R	http://dx.doi.org/10.1096/fj.202001060R		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32892421	hybrid, Green Published			2022-12-26	WOS:000568293000001
J	Matthaeus, WJ; Schmidt, J; White, JD; Zechmann, B				Matthaeus, William J.; Schmidt, Jonathan; White, Joseph D.; Zechmann, Bernd			Novel perspectives on stomatal impressions: Rapid and non-invasive surface characterization of plant leaves by scanning electron microscopy	PLOS ONE			English	Article							SAMPLE PREPARATION; ARABIDOPSIS; LIGHT	Scanning electron microscopy (SEM) is widely used to investigate the surface morphology, and physiological state of plant leaves. Conventionally used methods for sample preparation are invasive, irreversible, require skill and expensive equipment, and are time and labor consuming. This study demonstrates a method to obtainin vivosurface information of plant leaves by imaging replicas with SEM that is rapid and non-invasive. Dental putty was applied to the leaves for 5 minutes and then removed. Replicas were then imaged with SEM and compared to fresh leaves, and leaves that were processed conventionally by chemical fixation, dehydration and critical point drying. The surface structure of leaves was well preserved on the replicas. The outline of epidermal as well as guard cells could be clearly distinguished enabling determination of stomatal density. Comparison of the dimensions of guard cells revealed that replicas did not differ from fresh leaves, while conventional sample preparation induced strong shrinkage (-40% in length and -38% in width) of the cells when compared to guard cells on fresh leaves. Tilting the replicas enabled clear measurement of stomatal aperture dimensions. Summing up, the major advantages of this method are that it is inexpensive, non-toxic, simple to apply, can be performed in the field, and that results on stomatal density andin vivostomatal dimensions in 3D can be obtained in a few minutes.	[Matthaeus, William J.; Schmidt, Jonathan; White, Joseph D.] Baylor Univ, Dept Biol, Waco, TX 76798 USA; [Zechmann, Bernd] Baylor Univ, Ctr Microscopy & Imaging, Waco, TX 76798 USA	Baylor University; Baylor University	Zechmann, B (corresponding author), Baylor Univ, Ctr Microscopy & Imaging, Waco, TX 76798 USA.	Bernd_Zechmann@baylor.edu	Matthaeus, William/AAS-1443-2021	Zechmann, Bernd/0000-0002-7702-2588				Angelica Bello M, 2017, J VIS EXP, V120, P55031; APPLEBY RF, 1983, ANN BOT-LONDON, V52, P459, DOI 10.1093/oxfordjournals.aob.a086601; Bertolino LT, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00225; BOYDE A, 1980, Scanning Electron Microscopy, P117; Caldwell D, 2019, PHYTOPATHOLOGY, V109, P1302, DOI 10.1094/PHYTO-07-18-0216-R; Castilloa JJ, 1998, SCANNING, V20, P557; Elsner J, 2012, ANN BOT-LONDON, V109, P897, DOI 10.1093/aob/mcs005; Ensikat H., 2010, MICROSCOPY SCI TECHN, V1, P248; Fan YF, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1633-1; Franks PJ, 2007, PLANT PHYSIOL, V143, P78, DOI 10.1104/pp.106.089367; Geisler M, 2000, PLANT CELL, V12, P2075, DOI 10.1105/tpc.12.11.2075; Geisler MJ, 2000, NEW PHYTOL, V153, P469; Gitz DC, 2009, AGRON J, V101, P232, DOI 10.2134/agronj2008.0143N; He Y, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01569; KAGAN ML, 1992, ANN BOT-LONDON, V69, P303, DOI 10.1093/oxfordjournals.aob.a088346; Kim KW, 2018, MICROSC RES TECHNIQ, V81, P716, DOI 10.1002/jemt.23027; Kolb D, 2004, ANN BOT-LONDON, V94, P515, DOI 10.1093/aob/mch180; Kolb Dagmar, 2003, Acta Biologica Slovenica, V46, P11; Lawson T, 1998, J EXP BOT, V49, P1397, DOI 10.1093/jexbot/49.325.1397; McElwain JC, 2016, NEW PHYTOL, V209, P94, DOI 10.1111/nph.13579; MONCUR M W, 1979, Scanning, V2, P175; Pathan AK, 2008, MICRON, V39, P1049, DOI 10.1016/j.micron.2008.05.006; Pathan AK, 2010, MATER TODAY, V12, P32, DOI 10.1016/S1369-7021(10)70143-7; SAMPSON J, 1961, NATURE, V191, P932, DOI 10.1038/191932a0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Talbot MJ, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-40; Tihlarikova E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38835-w; Tihlarikova E, 2013, MICROSC MICROANAL, V19, P914, DOI 10.1017/S1431927613000603; Wang J, 2017, DESTECH TRANS COMP, P243; WEYERS JDB, 1985, NEW PHYTOL, V101, P109, DOI 10.1111/j.1469-8137.1985.tb02820.x; Zechmann B, 2018, PHYTON-ANN REI BOT A, V58, P103, DOI 10.12905/0380.phyton58(2)-2018-0103	31	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238589	10.1371/journal.pone.0238589	http://dx.doi.org/10.1371/journal.pone.0238589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881951	gold, Green Published			2022-12-26	WOS:000571063300043
J	Xia, W; Huang, ZJ; Guo, ZL; Feng, YW; Zhang, CY; He, GY; Tang, AZ				Xia, Wei; Huang, Zong-jian; Guo, Zhao-liang; Feng, Yi-wei; Zhang, Chao-yin; He, Guang-yao; Tang, An-zhou			Plasma volume, cell volume, total blood volume and F factor in the tree shrew	PLOS ONE			English	Article							DILUTION; RATS	In this study, the physiological values of volumes of plasma, cells, total blood and the F blood factors were identified in 24 adult tree shrews (Tupaia belangeri; 12 male and 12 female; average BW of 123.9 +/- 19.19 g). The two-compartment model method of Evans Blue dye was used to obtain the plasma volume and the venous hematocrit was measured by microhematocrit method. To establish the relationship between body weight (BW) and blood volume of tree shrews, We performed linear fitting for these two datasets. Results were analyzed according to gender and weight (120g). Statistical significance was assessed using the unpaired student t test and one-way ANOVA. The average volumes per 100g body weight of plasma, red blood cell (RBC) and total blood were 5.42 +/- 0.543, 3.24 +/- 0.445, and 8.66 +/- 0.680ml respectively. The mean body hematocrit, cardiac hematocrit, jugular vein hematocrit, femoral vein hematocrit, and tail vein hematocrit was 37.43 +/- 4.096, 39.72 +/- 3.219, 43.04 +/- 4.717, 40.84 +/- 3.041, and 38.71 +/- 3.442% respectively. The F cardiac was 0.94 +/- 0.072, F jugular vein 0.88 +/- 0.118, F femoral vein 0.92 +/- 0.111, and the F tail vein 0.97 +/- 0.117. Blood volume (ml) was 85.89103xBW (kg). This is the first study to provide the parameters of plasma volume, cell volume, total blood volume and F factor and a baseline for future research on blood physiology of tree shrews.	[Xia, Wei; Huang, Zong-jian; Guo, Zhao-liang; Feng, Yi-wei; Zhang, Chao-yin; He, Guang-yao; Tang, An-zhou] Guangxi Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China; [Xia, Wei; Huang, Zong-jian; Guo, Zhao-liang; Feng, Yi-wei; Zhang, Chao-yin; He, Guang-yao; Tang, An-zhou] Minist Educ, Key Lab Early Prevent & Treatment Reg High Freque, Nanning, Guangxi, Peoples R China	Guangxi Medical University	He, GY; Tang, AZ (corresponding author), Guangxi Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China.; He, GY; Tang, AZ (corresponding author), Minist Educ, Key Lab Early Prevent & Treatment Reg High Freque, Nanning, Guangxi, Peoples R China.	heguangyao@gxmu.edu.cn; anzhoutang@foxmail.com		xia, wei/0000-0001-5397-7251	National Natural Science Foundation of China [81760189, 81760188]; Innovation Project of Guangxi Graduate Education [YCBZ2020050]; College Student's Innovation and Entrepreneurship Training Program [201910598142]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Project of Guangxi Graduate Education; College Student's Innovation and Entrepreneurship Training Program	This study was supported by the National Natural Science Foundation of China (Grant No. 81760189 to GH and Grant No. 81760188 to AT) and the Innovation Project of Guangxi Graduate Education (Grant No. YCBZ2020050) to WX and College Student's Innovation and Entrepreneurship Training Program (Grant No. 201910598142) to ZH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER N, 1979, AM J PHYSIOL, V236, pH92, DOI 10.1152/ajpheart.1979.236.1.H92; BARNES DWH, 1948, CLIN SCI, V7, P135; Bartels K, 2016, ANESTH ANALG, V122, P1866, DOI 10.1213/ANE.0000000000001340; BELCHER EH, 1957, J PHYSIOL-LONDON, V139, P64, DOI 10.1113/jphysiol.1957.sp005875; BIANCHI M, 1981, CLIN SCI, V61, P685, DOI 10.1042/cs0610685; Boron W.F., 2017, MED PHYSL, V3rd ed.; CRISPELL KR, 1950, J CLIN INVEST, V29, P513, DOI 10.1172/JCI102288; ELSAYED H, 1995, CLIN LAB HAEMATOL, V17, P189; Fan Y, 2019, ZOOL RES, V40, P506, DOI 10.24272/j.issn.2095-8137.2019.063; Fan Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2416; Gibson JG, 1937, J CLIN INVEST, V16, P301, DOI 10.1172/JCI100859; Perales JLG, 2015, APPL RADIAT ISOTOPES, V96, P71, DOI 10.1016/j.apradiso.2014.11.014; GREGERSEN MI, 1959, PHYSIOL REV, V39, P307, DOI 10.1152/physrev.1959.39.2.307; Klemcke HG, 2011, PHYSIOL GENOMICS, V43, P758, DOI 10.1152/physiolgenomics.00245.2010; LEE HB, 1985, J NUCL MED, V26, P72; Li CH, 2017, CELL RES, V27, P241, DOI 10.1038/cr.2016.156; LITTLE RA, 1970, J PHYSIOL-LONDON, V208, P485, DOI 10.1113/jphysiol.1970.sp009133; McGuill M. W., 1989, ILAR News, V31, P5; MENEELY GR, 1947, AM J PHYSIOL, V148, P531, DOI 10.1152/ajplegacy.1947.148.3.531; Poulsen TD, 1998, EUR J APPL PHYSIOL O, V77, P457, DOI 10.1007/s004210050360; Rawson RA, 1943, AM J PHYSIOL, V138, P0708, DOI 10.1152/ajplegacy.1943.138.5.708; REEVE EB, 1953, AM J PHYSIOL, V175, P195, DOI 10.1152/ajplegacy.1953.175.2.195; Richalet JP, 2018, ANN BIOMED ENG, V46, P2189, DOI 10.1007/s10439-018-02114-y; RICHALET JP, 1983, LANCET, V1, P525; RICHES AC, 1973, J PHYSIOL-LONDON, V228, P279, DOI 10.1113/jphysiol.1973.sp010086; Robach P, 2000, J APPL PHYSIOL, V89, P29; Schreihofer AM, 2005, AM J PHYSIOL-REG I, V288, pR253, DOI 10.1152/ajpregu.00498.2004; Sullivan MJ, 2004, J PHYSIOL-LONDON, V557, P661, DOI 10.1113/jphysiol.2004.062265; Xu Lin, 2013, Zoological Research, V34, P59, DOI 10.3724/SP.J.1141.2013.02059; Xu L, 2016, P NATL ACAD SCI USA, V113, P10950, DOI 10.1073/pnas.1604939113; Yao YG, 2017, ZOOL RES, V38, P118, DOI 10.24272/j.issn.2095-8137.2017.032	31	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0234835	10.1371/journal.pone.0234835	http://dx.doi.org/10.1371/journal.pone.0234835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881864	Green Published, gold			2022-12-26	WOS:000571063300007
J	Zot, HG; Chase, PB; Hasbun, JE; Pinto, JR				Zot, Henry G.; Chase, P. Bryant; Hasbun, Javier E.; Pinto, Jose R.			Mechanical contribution to muscle thin filament activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibril; calcium; skeletal muscle; statistics; muscle physiology; myosin; troponin; tropomyosin; actin; mechanotransduction; activation; striated; thermodynamics; thin filament	MYOSIN SUBFRAGMENT-1; TROPONIN-TROPOMYOSIN; CALCIUM REGULATION; IN-VITRO; ACTIN INTERACTIONS; CA2+ REGULATION; MODEL; BINDING; CONTRACTION; MOVEMENT	Vertebrate striated muscle thin filaments are thought to be thermodynamically activated in response to an increase in Ca2+ concentration. We tested this hypothesis by measuring time intervals for gliding runs and pauses of individual skeletal muscle thin filaments in cycling myosin motility assays. A classic thermodynamic mechanism predicts that if chemical potential is constant, transitions between runs and pauses of gliding thin filaments will occur at constant rate as given by a Poisson distribution. In this scenario, rate is given by the odds of a pause, and hence, run times between pauses fit an exponential distribution that slopes negatively for all observable run times. However, we determined that relative density of observed run times fits an exponential only at low Ca2+ levels that activate filament gliding. Further titration with Ca2+, or adding excess regulatory proteins tropomyosin and troponin, shifted the relative density of short run times to fit the positive slope of a gamma distribution, which derives from waiting times between Poisson events. Events that arise during a run and prevent the chance of ending a run for a random interval of time account for the observed run time distributions, suggesting that the events originate with cycling myosin. We propose that regulatory proteins of the thin filament require the mechanical force of cycling myosin to achieve the transition state for activation. During activation, combinations of cycling myosin that contribute insufficient activation energy delay deactivation.	[Zot, Henry G.] Univ West Georgia, Dept Biol, Carrollton, GA 30118 USA; [Zot, Henry G.; Pinto, Jose R.] Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Chase, P. Bryant] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA; [Hasbun, Javier E.] Univ West Georgia, Dept Phys, Carrollton, GA USA	University System of Georgia; University of West Georgia; State University System of Florida; Florida State University; State University System of Florida; Florida State University; University System of Georgia; University of West Georgia	Zot, HG (corresponding author), Univ West Georgia, Dept Biol, Carrollton, GA 30118 USA.; Zot, HG (corresponding author), Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA.	hzot@westga.edu	; Pinto, Jose R/H-2631-2017	Chase, P. Bryant/0000-0001-9701-561X; Pinto, Jose R/0000-0001-9092-4976	NHLBI, National Institutes of Health [R01-HL128683]	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI, National Institutes of Health Grant R01-HL128683 (to J. R. P.) and paid leave of absence (to H. G. Z.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brandt PW, 2014, ARCH BIOCHEM BIOPHYS, V552, P60, DOI 10.1016/j.abb.2013.12.013; BREMEL RD, 1972, NATURE-NEW BIOL, V238, P97, DOI 10.1038/newbio238097a0; BRENNER B, 1988, P NATL ACAD SCI USA, V85, P3265, DOI 10.1073/pnas.85.9.3265; CHALOVICH JM, 1982, J BIOL CHEM, V257, P2432; Chase PB, 2004, ANN BIOMED ENG, V32, P1559, DOI 10.1114/B:ABME.0000049039.89173.08; COOPER JA, 1982, METHOD ENZYMOL, V85, P182; Desai R, 2015, J BIOL CHEM, V290, P1915, DOI 10.1074/jbc.M114.609743; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; EATON BL, 1976, SCIENCE, V192, P1337, DOI 10.1126/science.131972; EISENBERG E, 1980, BIOPHYS J, V29, P195, DOI 10.1016/S0006-3495(80)85126-5; FRASER IDC, 1995, J BIOL CHEM, V270, P7836, DOI 10.1074/jbc.270.14.7836; Galinska-Rakoczy A, 2008, J MOL BIOL, V379, P929, DOI 10.1016/j.jmb.2008.04.062; Gonzalez-Martinez D, 2018, J MOL CELL CARDIOL, V123, P26, DOI 10.1016/j.yjmcc.2018.08.015; Gordon AM, 1997, BIOPHYS J, V72, P1295, DOI 10.1016/S0006-3495(97)78776-9; GREENE LE, 1980, P NATL ACAD SCI-BIOL, V77, P2616, DOI 10.1073/pnas.77.5.2616; Hill AV, 1910, J PHYSIOL-LONDON, V40, P190; HILL TL, 1980, P NATL ACAD SCI-BIOL, V77, P3186, DOI 10.1073/pnas.77.6.3186; Homsher E, 1996, BIOPHYS J, V70, P1881, DOI 10.1016/S0006-3495(96)79753-9; HONDA H, 1989, J MOL BIOL, V205, P677, DOI 10.1016/0022-2836(89)90313-6; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; HUXLEY HE, 1994, BIOPHYS J, V67, P2411, DOI 10.1016/S0006-3495(94)80728-3; Korobkova EA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.058105; KRON SJ, 1991, METHOD ENZYMOL, V196, P399; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; LEHMAN W, 1995, J MOL BIOL, V251, P191, DOI 10.1006/jmbi.1995.0425; Lehman W, 2000, J MOL BIOL, V302, P593, DOI 10.1006/jmbi.2000.4080; Liang B, 2003, BIOPHYS J, V85, P1775, DOI 10.1016/S0006-3495(03)74607-4; Loong CKP, 2013, CELL MOL BIOENG, V6, P183, DOI 10.1007/s12195-013-0269-8; LOWEY S, 1962, J MOL BIOL, V4, P293, DOI 10.1016/S0022-2836(62)80007-2; Martyn DA, 2002, BIOPHYS J, V83, P3425, DOI 10.1016/S0006-3495(02)75342-3; Matusovsky OS, 2019, P NATL ACAD SCI USA, V116, P16384, DOI 10.1073/pnas.1903228116; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Pirani A, 2005, J MOL BIOL, V346, P761, DOI 10.1016/j.jmb.2004.12.013; POLLARD TD, 1982, METHOD CELL BIOL, V24, P333; POTTER JD, 1974, BIOCHEMISTRY-US, V13, P2697, DOI 10.1021/bi00710a007; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Regnier M, 2002, J PHYSIOL-LONDON, V540, P485, DOI 10.1113/jphysiol.2001.013179; Risi C, 2017, P NATL ACAD SCI USA, V114, P6782, DOI 10.1073/pnas.1700868114; ROSENFELD SS, 1987, J BIOL CHEM, V262, P9984; Smith DA, 2003, BIOPHYS J, V84, P3168, DOI 10.1016/S0006-3495(03)70041-1; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; TOBACMAN LS, 1990, J BIOL CHEM, V265, P931; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; WAKABAYASHI K, 1994, BIOPHYS J, V67, P2422, DOI 10.1016/S0006-3495(94)80729-5; Woody MS, 2016, BIOPHYS J, V111, P273, DOI 10.1016/j.bpj.2016.06.019; Zot HG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008052; ZOT HG, 1986, J BIOL CHEM, V261, P5883; ZOT HG, 1987, J MUSCLE RES CELL M, V8, P428, DOI 10.1007/BF01578432	48	0	0	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2020	295	47					15913	15922		10.1074/jbc.RA120.014438	http://dx.doi.org/10.1074/jbc.RA120.014438			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PA5ED	32900850	Green Published, hybrid			2022-12-26	WOS:000595657900011
J	Zhang, AO; Berardinelli, SJ; Leonhard-Melief, C; Vasudevan, D; Liu, TW; Taibi, A; Giannone, S; Apte, SS; Holdener, BC; Haltiwanger, RS				Zhang, Ao; Berardinelli, Steven J.; Leonhard-Melief, Christina; Vasudevan, Deepika; Liu, Ta-Wei; Taibi, Andrew; Giannone, Sharee; Apte, Suneel S.; Holdener, Bernadette C.; Haltiwanger, Robert S.			O-Fucosylation of ADAMTSL2 is required for secretion and is impacted by geleophysic dysplasia-causing mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAMTSL2; O-fucosylation; C-mannosylation; geleophysic dysplasia; TSR; glycosylation; glycoprotein secretion; extracellular matrix; cell biology; mass spectrometry; ADAMTSL2	PETERS PLUS SYNDROME; THROMBOSPONDIN TYPE-1 REPEATS; GROWTH FACTOR-LIKE; C-MANNOSYLATION; GLYCOSYLATION; RECOGNITION; PROTEINS; B3GALTL; FUCOSE; GENE	ADAMTSL2 mutations cause an autosomal recessive connective tissue disorder, geleophysic dysplasia 1 (GPHYSD1), which is characterized by short stature, small hands and feet, and cardiac defects. ADAMTSL2 is a matricellular protein previously shown to interact with latent transforming growth factor-beta binding protein 1 and influence assembly of fibrillin 1 microfibrils. ADAMTSL2 contains seven thrombospondin type-1 repeats (TSRs), six of which contain the consensus sequence for O-fucosylation by protein O-fucosyltransferase 2 (POFUT2). O-fucose-modified TSRs are subsequently elongated to a glucose beta 1-3-fucose (GlcFuc) disaccharide by beta 1,3-glucosyltransferase (B3GLCT). B3GLCT mutations cause Peters Plus Syndrome (PTRPLS), which is characterized by skeletal defects similar to GPHYSD1. Several ADAMTSL2 TSRs also have consensus sequences for C-mannosylation. Six reported GPHYSD1 mutations occur within the TSRs and two lie near O-fucosylation sites. To investigate the effects of TSR glycosylation on ADAMTSL2 function, we used MS to identify glycan modifications at predicted consensus sequences on mouse ADAMTSL2. We found that most TSRs were modified with the GlcFuc disaccharide at high stoichiometry at O-fucosylation sites and variable mannose stoichiometry at C-mannosylation sites. Loss of ADAMTSL2 secretion in POFUT2(-/-) but not in B3GLCT(-/-) cells suggested that impaired ADAMTSL2 secretion is not responsible for skeletal defects in PTRPLS patients. In contrast, secretion was significantly reduced for ADAMTSL2 carrying GPHYSD1 mutations (S641L in TSR3 and G817R in TSR6), and S641L eliminated O-fucosylation of TSR3. These results provide evidence that abnormalities in GPHYSD1 patients with this mutation are caused by loss of O-fucosylation on TSR3 and impaired ADAMTSL2 secretion.	[Zhang, Ao; Berardinelli, Steven J.; Liu, Ta-Wei; Haltiwanger, Robert S.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Leonhard-Melief, Christina; Vasudevan, Deepika; Taibi, Andrew; Giannone, Sharee; Holdener, Bernadette C.; Haltiwanger, Robert S.] SUNY Stony Brook, Dept Biochem & Cell Biol, New York, NY USA; [Apte, Suneel S.] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44106 USA; [Leonhard-Melief, Christina] Bloodworks Northwest, Seattle, WA USA; [Taibi, Andrew] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT USA; [Giannone, Sharee] SUNY Stony Brook, Dept Neurobiol, New York, NY USA; [Vasudevan, Deepika] NYU, Dept Cell Biol, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA	University System of Georgia; University of Georgia; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Cleveland Clinic Foundation; Utah System of Higher Education; University of Utah; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; New York University; NYU Langone Medical Center	Haltiwanger, RS (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.; Haltiwanger, RS (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, New York, NY USA.	rhalti@uga.edu	Liu, Ta-Wei/GPX-8295-2022	Haltiwanger, Robert/0000-0001-7439-9577	National Institutes of Health [CA123071, HD096030, HD090156]; Georgia Research Alliance	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance	This work was supported by National Institutes of Health Grants CA123071, HD096030, and HD090156 (to R. S. H. and B. C. H.) and the Georgia Research Alliance. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Shareffi E, 2013, GLYCOBIOLOGY, V23, P188, DOI 10.1093/glycob/cws140; Allali S, 2011, J MED GENET, V48, P417, DOI 10.1136/jmg.2010.087544; Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Benz BA, 2016, DEV BIOL, V416, P111, DOI 10.1016/j.ydbio.2016.05.038; Bern MW, 2011, J PROTEOME RES, V10, P5296, DOI 10.1021/pr200780j; Boettcher M, 2015, MOL CELL, V58, P575, DOI 10.1016/j.molcel.2015.04.028; Buettner FFR, 2013, MOL CELL, V50, P295, DOI 10.1016/j.molcel.2013.03.003; Delhon L, 2019, FASEB J, V33, P2707, DOI 10.1096/fj.201800753RR; Du JG, 2010, DEV BIOL, V346, P25, DOI 10.1016/j.ydbio.2010.07.008; Dubail J, 2016, SCI REP-UK, V6, DOI 10.1038/srep33974; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; Haltiwanger RS., 2015, ESSENTIALS GLYCOBIOL, P151; Hess D, 2008, J BIOL CHEM, V283, P7354, DOI 10.1074/jbc.M710251200; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; Holdener BC, 2019, HUM MOL GENET, V28, P4053, DOI 10.1093/hmg/ddz225; Holdener BC, 2019, CURR OPIN STRUC BIOL, V56, P78, DOI 10.1016/j.sbi.2018.12.005; Hubmacher D, 2017, SCI REP-UK, V7, DOI 10.1038/srep41871; Hubmacher D, 2015, MATRIX BIOL, V47, P34, DOI 10.1016/j.matbio.2015.05.004; Hubmacher D, 2015, DIS MODEL MECH, V8, P487, DOI 10.1242/dmm.017046; Koo BH, 2007, MATRIX BIOL, V26, P431, DOI 10.1016/j.matbio.2007.03.003; Krieg J, 1998, MOL BIOL CELL, V9, P301, DOI 10.1091/mbc.9.2.301; Lawler PR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006627; Le Goff C, 2008, NAT GENET, V40, P1119, DOI 10.1038/ng.199; Leonhard-Melief C, 2010, METHOD ENZYMOL, V480, P401, DOI 10.1016/S0076-6879(10)80018-7; Luo Y, 2006, J BIOL CHEM, V281, P9385, DOI 10.1074/jbc.M511974200; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Oberstein SAJL, 2006, AM J HUM GENET, V79, P562, DOI 10.1086/507567; Parodi A., 2015, ESSENTIALS GLYCOBIOL, P503; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Piccolo P, 2019, MOL GENET METAB REP, V21, DOI 10.1016/j.ymgmr.2019.100504; Pinan-Lucarre B, 2014, NATURE, V511, P466, DOI 10.1038/nature13313; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; RIPKA J, 1986, ARCH BIOCHEM BIOPHYS, V249, P533, DOI 10.1016/0003-9861(86)90031-7; Shcherbakova A, 2019, ELIFE, V8, DOI 10.7554/eLife.52978; Shcherbakova A, 2017, P NATL ACAD SCI USA, V114, P2574, DOI 10.1073/pnas.1613165114; STANLEY P, 1975, CELL, V6, P121, DOI 10.1016/0092-8674(75)90002-1; Thomas M, 2005, P NATL ACAD SCI USA, V102, P5679, DOI 10.1073/pnas.0502067102; Valero-Gonzalez J, 2016, NAT CHEM BIOL, V12, P240, DOI [10.1038/NCHEMBIO.2019, 10.1038/nchembio.2019]; Vasudevan D, 2015, CURR BIOL, V25, P286, DOI 10.1016/j.cub.2014.11.049; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200; Wang LW, 2009, J BIOL CHEM, V284, P30004, DOI 10.1074/jbc.M109.038059; Weh E, 2014, CLIN GENET, V86, P142, DOI 10.1111/cge.12241	42	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2020	295	46					15742	15753		10.1074/jbc.RA120.014557	http://dx.doi.org/10.1074/jbc.RA120.014557			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OY6NO	32913123	Green Published, hybrid			2022-12-26	WOS:000594361600024
J	Higdon, SM; Pozzo, T; Tibbett, EJ; Chiu, C; Jeannotte, R; Weimer, BC; Bennett, AB				Higdon, Shawn M.; Pozzo, Tania; Tibbett, Emily J.; Chiu, Colleen; Jeannotte, Richard; Weimer, Bart C.; Bennett, Alan B.			Diazotrophic bacteria from maize exhibit multifaceted plant growth promotion traits in multiple hosts	PLOS ONE			English	Article							PHOSPHATE SOLUBILIZING BACTERIA; ACC-DEAMINASE; RHIZOBACTERIA; L.	Sierra Mixe maize is a geographically remote landrace variety grown on nitrogen-deficient fields in Oaxaca, Mexico that meets its nutritional requirements without synthetic fertilizer by associating with free-living diazotrophs comprising the microbiota of its aerial root mucilage. We selected nearly 500 diazotrophic (N-2-fixing) bacteria isolated from Sierra Mixe maize mucilage and sequenced their genomes. Comparative genomic analysis demonstrated that isolates represented diverse genera and composed three major diazotrophic groups based on nitrogen fixation gene content. In addition to nitrogen fixation, we examined deamination of 1-amino-1-cyclopropanecarboxylic acid, biosynthesis of indole-3-acetic acid, and phosphate solubilization as alternative mechanisms of direct plant growth promotion (PGP). Genome mining showed that isolates of all diazotrophic groups possessed marker genes for multiple mechanisms of direct plant growth promotion (PGP). Implementingin vitroassays corroborated isolate genotypes by measuring each isolate's potential to confer the targeted PGP traits and revealed phenotypic variation among isolates based on diazotrophic group assignment. Investigating the ability of mucilage diazotrophs to confer PGP by direct inoculation of clonally propagated potato plantsin plantaled to the identification of 16 bio-stimulant candidates. Conducting nitrogen-stress greenhouse experiments demonstrated that potato inoculation with a synthetic community of bio-stimulant candidates, as well as with its individual components, resulted in PGP phenotypes. We further demonstrated that one diazotrophic isolate conferred PGP to a conventional maize variety under nitrogen-stress in the greenhouse. These results indicate that, while many diazotrophic isolates from Sierra Mixe maize possessed genotypes andin vitrophenotypes for targeted PGP traits, a subset of these organisms promoted the growth of potato and conventional maize, potentially through the use of multiple promotion mechanisms.	[Higdon, Shawn M.; Pozzo, Tania; Tibbett, Emily J.; Chiu, Colleen; Bennett, Alan B.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Jeannotte, Richard; Weimer, Bart C.] Univ Calif Davis, Dept Populat Hlth & Reprod, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Bennett, AB (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.; Weimer, BC (corresponding author), Univ Calif Davis, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.	bcweimer@ucdavis.edu; abbennett@ucdavis.edu	Weimer, Bart/AAK-8501-2021; Bennett, Alan/D-8980-2011	Weimer, Bart/0000-0002-7471-1978; Bennett, Alan/0000-0002-3684-4307; Pozzo, Tania/0000-0002-3645-2303; Higdon, Shawn Miles/0000-0002-0033-7688	United States Department of Agriculture (USDA) [2019-67013-29724]	United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA))	We received federal funding for this work. Funding for the research was provided by grants to BCW (award #2019-67013-29724) from the United States Department of Agriculture (USDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarab S., 2015, International Journal of Biosciences (IJB), V6, P116; Ahmad F., 2008, PLANT BACTERIA INTER, P81, DOI [10.1002/9783527621989.ch5, DOI 10.1002/9783527621989.CH5]; Akhgar AR, 2014, PEDOSPHERE, V24, P461, DOI 10.1016/S1002-0160(14)60032-1; [Anonymous], 2011, THER ADV MED ONCOL, V3, pS7; [Anonymous], 2012, NUCL ACIDS RES, V40, pD71; Arruda L, 2013, APPL SOIL ECOL, V63, P15, DOI 10.1016/j.apsoil.2012.09.001; Bloch SE, 2020, CURR OPIN BIOTECH, V62, P181, DOI 10.1016/j.copbio.2019.09.024; Brown CT., 2016, J OPEN SOURCE SOFTW, V1, P27, DOI [10.21105/joss.00027, DOI 10.21105/JOSS.00027]; CHAUMEIL PA, 2020, BIOINFORMATICS, V36, P1925, DOI DOI 10.1093/bioinformatics/btz848; Dos Santos PC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-162; Drancourt M, 2001, INT J SYST EVOL MICR, V51, P925, DOI 10.1099/00207713-51-3-925; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; FELTHAM RKA, 1978, J APPL BACTERIOL, V44, P313, DOI 10.1111/j.1365-2672.1978.tb00804.x; Glick BR, 2007, EUR J PLANT PATHOL, V119, P329, DOI 10.1007/s10658-007-9162-4; Glick BR, 2014, MICROBIOL RES, V169, P30, DOI 10.1016/j.micres.2013.09.009; Glick BR, 1998, J THEOR BIOL, V190, P63, DOI 10.1006/jtbi.1997.0532; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Hardoim PR, 2015, MICROBIOL MOL BIOL R, V79, P293, DOI 10.1128/MMBR.00050-14; Higdon S.M., 2020, GENOMIC CHARACTERIZA, DOI [10.1101/2020.04.27.064337, DOI 10.1101/2020.04.27.064337]; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hu XJ, 2010, AQUACULT INT, V18, P1079, DOI 10.1007/s10499-010-9325-8; Johnston-Monje D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020396; Jothikumar N, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01061-14; Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480; Lenth R.V., 2017, J STAT SOFTW, V69, P1, DOI DOI 10.18637/JSS.V069.I01; Lugtenberg B, 2013, MOL MICROBIAL ECOLOG, P561, DOI DOI 10.1002/9781118297674.CH53; Luo T, 2016, J BASIC MICROB, V56, P934, DOI 10.1002/jobm.201500738; Manulis S, 1998, MOL PLANT MICROBE IN, V11, P634, DOI 10.1094/MPMI.1998.11.7.634; Misra HS, 2012, J BIOSCIENCES, V37, P313, DOI 10.1007/s12038-012-9195-5; Naqqash T, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00144; Pande Amit, 2017, Journal of Genetic Engineering and Biotechnology, V15, P379, DOI 10.1016/j.jgeb.2017.06.005; Penrose DM, 2003, PHYSIOL PLANTARUM, V118, P10, DOI 10.1034/j.1399-3054.2003.00086.x; Ringuet S, 2011, J ENVIRON MONITOR, V13, P370, DOI 10.1039/c0em00290a; Rodriguez H, 1999, BIOTECHNOL ADV, V17, P319, DOI 10.1016/S0734-9750(99)00014-2; SARWAR M, 1995, LETT APPL MICROBIOL, V20, P282, DOI 10.1111/j.1472-765X.1995.tb00446.x; Sasse J, 2018, TRENDS PLANT SCI, V23, P25, DOI 10.1016/j.tplants.2017.09.003; Schicklberger M, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00607-15; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Sessitsch A, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw167; Shahzad SM, 2010, EUR J SOIL BIOL, V46, P342, DOI 10.1016/j.ejsobi.2010.05.007; Spaepen S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001438; Tedeschi R, 2011, METHODS MOL BIOL, V675, P313, DOI 10.1007/978-1-59745-423-0_18; Thijs S, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00491-14; Van Deynze A, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006352; Vessey JK, 2003, PLANT SOIL, V255, P571, DOI 10.1023/A:1026037216893; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [10.21105/joss.01686, DOI 10.21105/JOSS.01686]; Wickham H, 2011, WIRES COMPUT STAT, V3, P180, DOI 10.1002/wics.147; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628	50	3	3	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0239081	10.1371/journal.pone.0239081	http://dx.doi.org/10.1371/journal.pone.0239081			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925972	Green Published, gold, Green Submitted			2022-12-26	WOS:000572318000005
J	Kumar, YN; Poong, SW; Gachon, C; Brodie, J; Sade, A; Lim, PE				Kumar, Yushanthini Nair; Poong, Sze-Wan; Gachon, Claire; Brodie, Juliet; Sade, Ahemad; Lim, Phaik-Eem			Impact of elevated temperature on the physiological and biochemical responses ofKappaphycus alvarezii(Rhodophyta)	PLOS ONE			English	Article							KAPPAPHYCUS-ALVAREZII RHODOPHYTA; EUCHEUMA-DENTICULATUM; CHLOROPHYLL FLUORESCENCE; SUBTROPICAL WATERS; CARRAGEENAN YIELD; GIGARTINALES; STRESS; SOLIERIACEAE; GROWTH; HEAT	The eucheumatoidsKappaphycusandEucheumaare cultivated in tropical or subtropical regions for the production of carrageenan, a hydrocolloid widely used in the food and cosmetic industries.Kappaphycus alvareziiis a highly valued economic crop in the Coral Triangle, with the Philippines, Indonesia and Malaysia ranked among the largest producers. In the absence of measures to mitigate climate change, extreme events including heatwaves, typhoons, severe El Nino and La Nina, are expected to increase in frequency and magnitude. This inadvertently brings adverse effects to the seaweed cultivation industry, especially in the tropics. Temperatures are rapidly reaching the upper limit of biologically tolerable levels and an increase in reports ofice-iceand pest outbreaks is attributable to these shifts of environmental parameters. Nevertheless, few reports on the response of eucheumatoids to a changing environment, in particular global warming, are available. Understanding the responses and possible mechanisms for acclimation to warming is crucial for a sustainable seaweed cultivation industry. Here, the physiological and biochemical responses ofK.alvareziito acute warming indicated that the strain used in the current study is unlikely to survive sudden increases in temperature above 36 degrees C. As temperature increased, the growth rates, photosynthetic performance, phycocolloid quality (carrageenan yield, gel strength and gel viscosity) and pigment content (chlorophyll-a, carotenoid and phycobiliproteins) were reduced while the production of reactive oxygen species increased indicating the occurrence of stress in the seaweeds. This study provides a basis for future work on long term acclimation to elevated temperature and mesocosm-based multivariate studies to identify heat-tolerant strains for sustainable cultivation.	[Kumar, Yushanthini Nair; Poong, Sze-Wan; Lim, Phaik-Eem] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia; [Kumar, Yushanthini Nair] Univ Malaya, Inst Adv Studies, Kuala Lumpur, Malaysia; [Gachon, Claire] Scottish Assoc Marine Sci, Scottish Marine Inst, Oban, Argyll, Scotland; [Gachon, Claire] Museum Natl Hist Nat, CNRS, Unite Mol Commun & Adaptat Microorganismes, UMR 7245, Paris, France; [Brodie, Juliet] Nat Hist Museum, Dept Life Sci, London, England; [Sade, Ahemad] Dept Fisheries Sabah, Kota Kinabalu, Sabah, Malaysia	Universiti Malaya; Universiti Malaya; UHI Millennium Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Natural History Museum London	Lim, PE (corresponding author), Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia.	phaikeem@um.edu.my	LIM, Phaik Eem/B-5331-2010; Poong, Sze Wan/S-2212-2016	LIM, Phaik Eem/0000-0001-9186-1487; Poong, Sze Wan/0000-0003-4033-864X	Ministry of Education Malaysia [FRGS/1/2018/STG05/UM/01/2, FP035-2018A]; GlobalSeaweedSTAR - UKRI [BB/P027806/1, IF015-2019]; Higher Center of Excellence (HiCoE) - Ministry of Higher Education Malaysia [IOES-2014H]; UM Top 100 University fund [TOP100PDIOES]; BBSRC [BB/P027806/1] Funding Source: UKRI	Ministry of Education Malaysia(Ministry of Education, Malaysia); GlobalSeaweedSTAR - UKRI; Higher Center of Excellence (HiCoE) - Ministry of Higher Education Malaysia; UM Top 100 University fund; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The study is supported by the research grants from: 1. Fundamental Research Grant funded by the Ministry of Education Malaysia (FRGS/1/2018/STG05/UM/01/2; FP035-2018A) awarded to PEL 2. GlobalSeaweedSTAR funded by UKRI (BB/P027806/1; IF015-2019) awarded to PEL 3. Higher Center of Excellence (HiCoE) grant funded by the Ministry of Higher Education Malaysia (IOES-2014H) awarded to PEL 4. SWP is supported by UM Top 100 University fund (TOP100PDIOES).	Alexander LV, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P3; Allakhverdiev SI, 2008, PHOTOSYNTH RES, V98, P541, DOI 10.1007/s11120-008-9331-0; [Anonymous], 2016, ORDENSKORRESPONDENZ, V57, P21; [Anonymous], 2007, RECOLLECTIONS, V2, P71; Arasamuthu A, 2018, INDIAN J GEO-MAR SCI, V47, P1208; Araujo PG, 2014, J APPL PHYCOL, V26, P1979, DOI 10.1007/s10811-014-0303-9; Bindu MS, 2011, J APPL PHYCOL, V23, P789, DOI 10.1007/s10811-010-9570-2; Borlongan IAG, 2017, PHYCOL RES, V65, P69, DOI 10.1111/pre.12155; Bulboa CR, 2005, PHYCOL RES, V53, P183, DOI 10.1111/j.1440-183.2005.00385.x; Bulboa C, 2008, PHYCOL RES, V56, P39, DOI 10.1111/j.1440-1835.2008.00483.x; Camejo D, 2006, FUNCT PLANT BIOL, V33, P177, DOI 10.1071/FP05067; Campo VL, 2009, CARBOHYD POLYM, V77, P167, DOI 10.1016/j.carbpol.2009.01.020; Chen WR, 2012, RUSS J PLANT PHYSL+, V59, P732, DOI 10.1134/S1021443712060040; Christaki E., 2015, HDB MARINE MICROALGA, P233, DOI [10.1016/B978-0-12-800776-1.00014-5, DOI 10.1016/B978-0-12-800776-1.00014-5]; Collen J, 1997, J PHYCOL, V33, P643, DOI 10.1111/j.0022-3646.1997.00643.x; Collen J, 1999, J PHYCOL, V35, P54, DOI 10.1046/j.1529-8817.1999.3510054.x; Cui LJ, 2006, BOT STUD, V47, P61; DAUGHERTY BK, 1988, AQUACULTURE, V75, P105, DOI 10.1016/0044-8486(88)90025-7; Davison IR, 1996, J PHYCOL, V32, P197, DOI 10.1111/j.0022-3646.1996.00197.x; De Ronde JA, 2004, J PLANT PHYSIOL, V161, P1211, DOI 10.1016/j.jplph.2004.01.014; Ding LP, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/594308; Dutta S, 2009, PLANT PHYSIOL, V150, P1050, DOI 10.1104/pp.109.137265; Eggert A., 2012, SEAWEED BIOL, P47, DOI [10.1007/978-3-642-28451-9_3, DOI 10.1007/978-3-642-28451-9_3]; Eswaran K, 2006, 2006 IEEE INFORMATION THEORY WORKSHOP, P258, DOI 10.1109/ITW.2006.1633824; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Feng Y, 2008, EUR J PHYCOL, V43, P87, DOI 10.1080/09670260701664674; GANZONFORTES ET, 1993, BOT MAR, V36, P503, DOI 10.1515/botm.1993.36.6.503; Hayashi L, 2010, CELL ORIG LIFE EXTRE, V15, P251, DOI 10.1007/978-90-481-8569-6_15; Heriyanto H., 2018, MATEC WEB C, V154, DOI [10.1051/matecconf/201815401034, DOI 10.1051/MATECCONF/201815401034]; Hurtado AQ, 2006, J APPL PHYCOL, V18, P301, DOI 10.1007/s10811-006-9032-z; Kariduraganavar MY, 2014, NATURAL AND SYNTHETIC BIOMEDICAL POLYMERS, P1; Largo DB, 1995, J APPL PHYCOL, V7, P545, DOI 10.1007/BF00003941; Largo DB, 2017, DEV APPL PHYCOLOGY, V9, P121; Lideman, 2013, J APPL PHYCOL, V25, P399, DOI 10.1007/s10811-012-9874-5; Ling ALM, 2015, J APPL PHYCOL, V27, P1717, DOI 10.1007/s10811-014-0467-3; Mandal SK, 2015, J APPL PHYCOL, V27, P1571, DOI 10.1007/s10811-014-0469-1; de Faria GSM, 2014, J APPL PHYCOL, V26, P917, DOI 10.1007/s10811-013-0172-7; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Mendoza WG, 2002, J APPL PHYCOL, V14, P409, DOI 10.1023/A:1022178119120; MOHANTY N, 1989, PHYSIOL PLANTARUM, V76, P386, DOI 10.1111/j.1399-3054.1989.tb06208.x; Mtolera MSP, 1996, EUR J PHYCOL, V31, P89, DOI 10.1080/09670269600651241; Murata N, 1997, PLANT PHYSIOL, V115, P875, DOI 10.1104/pp.115.3.875; Mustapha S, 2011, J SCI IND RES INDIA, V70, P865; Naguit MRA, 2009, THRESHOLD, V4, P29; Nor AM, 2020, J APPL PHYCOL, V32, P2161, DOI 10.1007/s10811-019-02004-3; Ohno M, 1996, J APPL PHYCOL, V8, P431, DOI 10.1007/BF02178588; PADGETT MP, 1987, PHOTOSYNTH RES, V11, P225, DOI 10.1007/BF00055062; PAULSEN GM, 1994, PHYSIOLOGY AND DETERMINATION OF CROP YIELD, P365; Porter JR, 2005, NATURE, V436, P174, DOI 10.1038/436174b; Rauch U, 2013, CELL BIOL RES THER, V2, P1, DOI [10.4172/2324-9293.1000101, DOI 10.4172/2324-9293.1000101]; Saroussi S, 2007, AQUAT BOT, V86, P89, DOI 10.1016/j.aquabot.2006.09.003; Schmidt EC, 2010, PHOTOSYNTHETICA, V48, P161, DOI 10.1007/s11099-010-0022-7; Schreiber U., 1987, Plant response to stress. Functional analysis in Mediterranean ecosystems., P27; Souza RP, 2004, ENVIRON EXP BOT, V51, P45, DOI 10.1016/S0098-8472(03)00059-5; STANLEY N, 1987, FAO FISH TECH PAP, V288, P116; Strickland J.D.H., 1972, PRACTICAL HDB SEWATE, DOI [10.2307/1979241, DOI 10.2307/1979241]; TIFAC, 2018, SEAW CULT UT PROSP I; Vairappan CS, 2014, J APPL PHYCOL, V26, P923, DOI 10.1007/s10811-013-0126-0; Yong WTL, 2014, PHYCOL RES, V62, P316, DOI 10.1111/pre.12067; Zou DH, 2014, PHYCOLOGIA, V53, P86, DOI 10.2216/13-189.1	60	14	15	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0239097	10.1371/journal.pone.0239097	http://dx.doi.org/10.1371/journal.pone.0239097			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925956	gold, Green Published			2022-12-26	WOS:000572318000016
J	Shiroda, M; Manning, SD				Shiroda, Megan; Manning, Shannon D.			Lactobacillusstrains vary in their ability to interact with human endometrial stromal cells	PLOS ONE			English	Article							GROUP-B STREPTOCOCCUS; PREGNANT-WOMEN; RHAMNOSUS GR-1; LACTIC-ACID; COLONIZATION; MAPK; ACTIVATION; STRAIN; GROWTH	The placental membranes that surround the fetus during pregnancy were suggested to contain a low abundance microbiota. Specifically, abundance ofLactobacillus, a probiotic and dominant member of the microbiome of the lower reproductive tract, has been shown to correlate with healthy, term pregnancies. We therefore sought to assess the interactions between four differentLactobacillusstrains with immortalized decidualized endometrial cells (dT-HESCs), which were used as a model to represent the outermost layer of the placental membranes. Notably, we demonstrated that all fourLactobacillusstrains could associate with dT-HESCsin vitro.L.crispatuswas significantly more successful (p < 0.00005), with 10.6% of bacteria attaching to the host cells compared to an average of 0.8% for the remaining three strains. The four strains also varied in their ability to form biofilms. Dependent on media type,L.reuteri6475 formed the strongest biofilmsin vitro. To examine the impact on immune responses, levels of total and phosphorylated protein p38, a member of the Mitogen Activated Protein Kinase (MAPK) pathway, were examined followingLactobacillusassociation with dT-HESCs. Total levels of p38 were reduced to an average of 44% that of the cells withoutLactobacillus(p < 0.05). While a trend towards a reduction in phosphorylated p38 was observed, this difference was not significant (p > 0.05). In addition, association withLactobacillusdid not result in increased host cell death. Collectively, these data suggest that varying types ofLactobacilluscan attach to the outermost cells of the placental membranes and that these interactions do not contribute to inflammatory responses or host cell death. To our knowledge this is the firstin vitrostudy to support the ability ofLactobacillusto interact with placental cells, which is important when considering its use as a potential probiotic within the reproductive tract.	[Shiroda, Megan; Manning, Shannon D.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University	Manning, SD (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	mannin71@msu.edu	Manning, Shannon/GXA-0622-2022	Manning, Shannon/0000-0001-9581-0660; Shiroda, Megan/0000-0002-2504-7564	Michigan State University Foundation; Department of Microbiology and Molecular Genetics	Michigan State University Foundation; Department of Microbiology and Molecular Genetics	Funds to complete these studies were provided by the Michigan State University Foundation (SDM). Student support was provided to MMS through the Berttina Wentworth Scholar Award from the Department of Microbiology and Molecular Genetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Abt MC, 2014, CURR OPIN IMMUNOL, V29, P16, DOI 10.1016/j.coi.2014.03.003; Alander M, 1999, APPL ENVIRON MICROB, V65, P351; [Anonymous], 2017, EUR GERIATR MED, V8, pS98; Atassi F, 2010, FEMS MICROBIOL LETT, V304, P29, DOI 10.1111/j.1574-6968.2009.01887.x; Boldenow E, 2013, PLACENTA, V34, P480, DOI 10.1016/j.placenta.2013.02.010; Breshears LM, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0608-0; Brosens JJ, 1996, ENDOCRINOLOGY, V137, P2225, DOI 10.1210/en.137.6.2225; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Castro J, 2013, INT J MED SCI, V10, P1193, DOI 10.7150/ijms.6304; Cui YJ, 2019, J NUTR, V149, P2046, DOI 10.1093/jn/nxz088; De Gregorio PR, 2015, J APPL MICROBIOL, V118, P1034, DOI 10.1111/jam.12739; Doran KS, 2004, MOL MICROBIOL, V54, P23, DOI 10.1111/j.1365-2958.2004.04266.x; Erickson KL, 2000, J NUTR, V130, p403S, DOI 10.1093/jn/130.2.403S; Flaherty RA, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00729-19; Garcia-Castillo V, 2019, BIOFOULING, V35, P922, DOI 10.1080/08927014.2019.1675153; Ho M, 2016, TAIWAN J OBSTET GYNE, V55, P515, DOI 10.1016/j.tjog.2016.06.003; Jeong M, 2019, J MICROBIOL BIOTECHN, V29, P1248, DOI 10.4014/jmb.1905.05066; Kamaladevi A, 2016, FOOD FUNCT, V7, P3211, DOI [10.1039/c6fo00510a, 10.1039/C6FO00510A]; Kanmani P, 2019, BIOFACTORS, V45, P223, DOI 10.1002/biof.1475; Kook SY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223913; Korir ML, 2014, INFECT IMMUN, V82, P4587, DOI 10.1128/IAI.02181-14; Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606; Li HH, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0862-9; Li W, 2014, REPROD SCI, V21, P939, DOI 10.1177/1933719113519171; Martin V, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040810; Marziali G, 2019, MICROB PATHOGENESIS, V136, DOI 10.1016/j.micpath.2019.103692; Menon R, 2016, EXPERT OPIN THER TAR, V20, P1397, DOI 10.1080/14728222.2016.1216980; Olsen P, 2018, WOMEN BIRTH, V31, P31, DOI 10.1016/j.wombi.2017.06.012; Onderdonk AB, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.044; Palomino RAN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13468-9; Parker RE, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0704-9; Prince AL, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2016.01.193; Prince AL, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023051; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; REID G, 1988, CAN J MICROBIOL, V34, P344, DOI 10.1139/m88-063; Seferovic MD, 2019, AM J OBSTET GYNECOL, V221, DOI 10.1016/j.ajog.2019.04.036; Sharpe M, 2021, J MATERN-FETAL NEO M, V34, P1814, DOI 10.1080/14767058.2019.1650907; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; Strus M, 2002, J REPROD MED, V47, P41; Tomas MSJ, 2003, J MED MICROBIOL, V52, P1117, DOI 10.1099/jmm.0.05155-0; Tungland B, 2018, HUMAN MICROBIOTA IN HEALTH AND DISEASE: PATHOGENESIS TO THERAPY, P605, DOI 10.1016/B978-0-12-814649-1.00014-4; Urbanska M, 2014, EUR J PEDIATR, V173, P1327, DOI 10.1007/s00431-014-2328-0; Wennekamp J, 2008, IMMUNOL REV, V225, P114, DOI 10.1111/j.1600-065X.2008.00673.x; Zhou MZ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01745	46	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0238993	10.1371/journal.pone.0238993	http://dx.doi.org/10.1371/journal.pone.0238993			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925983	gold, Green Published			2022-12-26	WOS:000572318000014
J	Luo, H; Chen, B; Weng, B; Tang, XW; Chen, Y; Yang, AQ; Chu, D; Zeng, XY; Ran, ML				Luo, Hui; Chen, Bin; Weng, Bo; Tang, Xiangwei; Chen, Yao; Yang, Anqi; Chu, Dan; Zeng, Xinyu; Ran, Maoliang			miR-130a promotes immature porcine Sertoli cell growth by activating SMAD5 through the TGF-beta-PI3K/AKT signaling pathway	FASEB JOURNAL			English	Article						miR-130a; PI3K; AKT signaling pathway; porcine Sertoli cells; proliferation; SMAD5; TGF-beta	TGF-BETA SUPERFAMILY; LONG NONCODING RNAS; INHIBITS PROLIFERATION; PI3K/AKT PATHWAY; MICRORNAS; IDENTIFICATION; EXPRESSION; CROSSTALK; APOPTOSIS; REVEALS	Sertoli cells play vital roles in normal spermatogenesis, and microRNAs (miRNAs) participate in regulating Sertoli cell development. However, the functions and mechanisms of action of most identified miRNAs in porcine Sertoli cells remain largely unknown. Herein, we primarily explored the regulatory roles of miR-130a in immature porcine Sertoli cells using EdU-based high-content screening assay. The results demonstrated that 27 miRNAs have potential roles in the promotion of immature porcine Sertoli cell proliferation, and miR-130a was identified as a promising candidate. miR-130a promoted cell cycle progression and cell proliferation, whereas it impeded cell apoptosis in immature porcine Sertoli cells. It also contributed to Sertoli cell proliferation and testis development in vivo. A TMT-based proteomics approach revealed that miR-130a regulated the expression of 91 proteins and multiple pathways, including the TGF-beta and PI3K/AKT signaling. miR-130a did not directly target the 3 '-UTR ofSMAD5; however, it increased SMAD5 phosphorylation. Moreover, miR-130a enhanced TGF-beta signaling by activating SMAD5 protein, and TGF-beta signaling further activated the PI3K/AKT signaling pathway to promote cell proliferation and inhibit cell apoptosis in porcine immature Sertoli cells. Collectively, miR-130a promoted immature porcine Sertoli cell growth by activating SMAD5 through the TGF-beta-PI3K/AKT signaling pathway. This study, therefore, provides novel insights into the effects of miR-130a on porcine spermatogenesis through the regulation of immature Sertoli cell proliferation and apoptosis.	[Luo, Hui; Chen, Bin; Weng, Bo; Tang, Xiangwei; Chen, Yao; Yang, Anqi; Chu, Dan; Zeng, Xinyu; Ran, Maoliang] Hunan Agr Univ, Hunan Prov Key Lab Genet Improvement Domest Anim, Coll Anim Sci & Technol, Changsha 410128, Hunan, Peoples R China	Hunan Agricultural University	Chen, B; Ran, ML (corresponding author), Hunan Agr Univ, Hunan Prov Key Lab Genet Improvement Domest Anim, Coll Anim Sci & Technol, Changsha 410128, Hunan, Peoples R China.	chenbin7586@hunau.edu.cn; ranmaoliang0903@126.com			Hunan Provincial Natural Science Foundation of China [2018JJ3219, 2018JJ2176, 2020JJ4348]; Scientific Research Fund of the Hunan Provincial Education Department [18B093]; Science and Technology Project of Changsha City [kq1901032]; earmarked fund for the China Agriculture Research System [CARS-36]	Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Scientific Research Fund of the Hunan Provincial Education Department(Hunan Provincial Education Department); Science and Technology Project of Changsha City; earmarked fund for the China Agriculture Research System	This work was financially supported by the Hunan Provincial Natural Science Foundation of China (2018JJ3219, 2018JJ2176, and 2020JJ4348), a project supported by the Scientific Research Fund of the Hunan Provincial Education Department (18B093), a Science and Technology Project of Changsha City (kq1901032), and the earmarked fund for the China Agriculture Research System (CARS-36)	Fan YS, 2012, MOL BIOL REP, V39, P4727, DOI 10.1007/s11033-011-1265-5; Franca LR, 2016, ANDROLOGY-US, V4, P189, DOI 10.1111/andr.12165; Gao H, 2020, REPRODUCTION, V159, P145, DOI 10.1530/REP-19-0303; Griswold MD, 2018, BIOL REPROD, V99, P87, DOI 10.1093/biolre/ioy027; Hamidi A, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal4186; Hu PD, 2017, CELL CYCLE, V16, P2290, DOI 10.1080/15384101.2017.1380130; Huang Sha, 2018, Acta Veterinaria et Zootechnica Sinica, V49, P701; Hurtado A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197685; Itman C, 2006, REPRODUCTION, V132, P233, DOI 10.1530/rep.1.01075; Jiao ZJ, 2015, ENDOCRINOLOGY, V156, P4059, DOI 10.1210/en.2014-1982; Kim GJ, 2010, INT J DEV BIOL, V54, P867, DOI 10.1387/ijdb.092874gk; Liu DW, 2018, CELL CYCLE, V17, P2484, DOI 10.1080/15384101.2018.1542901; Liu WT, 2017, ONCOGENE, V36, P2715, DOI 10.1038/onc.2016.424; Luo K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022137; Luo ZY, 2018, THERIOGENOLOGY, V117, P61, DOI 10.1016/j.theriogenology.2017.06.023; Luo ZG, 2015, J ASSIST REPROD GEN, V32, P451, DOI 10.1007/s10815-014-0406-x; Ma CP, 2016, SCI REP-UK, V6, DOI 10.1038/srep32783; Ma CP, 2016, IN VITRO CELL DEV-AN, V52, P427, DOI 10.1007/s11626-015-9994-8; MULLANEY BP, 1993, MOL ENDOCRINOL, V7, P67, DOI 10.1210/me.7.1.67; Nascimento AR, 2016, REPRODUCTION, V152, P613, DOI 10.1530/REP-16-0330; Ni FD, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1782-z; Papaioannou MD, 2009, DEV BIOL, V326, P250, DOI 10.1016/j.ydbio.2008.11.011; Ramachandran A, 2018, ELIFE, V7, DOI 10.7554/eLife.31756; Ran ML, 2019, J INTEGR AGR, V18, P449, DOI [10.1016/S2095-3119(19)62612-2, 10.1016/s2095-3119(19)62612-2]; Ran ML, 2018, REPROD DOMEST ANIM, V53, P1375, DOI 10.1111/rda.13254; Ran ML, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.136911; Ran ML, 2015, RSC ADV, V5, P63439, DOI 10.1039/c5ra07488f; SAUL MJ, 2019, FRONT PHARMACOL, V10; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Sun Y, 2015, THERIOGENOLOGY, V83, P86, DOI 10.1016/j.theriogenology.2014.08.003; Suwanabol PA, 2012, AM J PHYSIOL-HEART C, V302, pH2211, DOI 10.1152/ajpheart.00966.2011; Suzuki HI, 2017, CELL, V168, P1000, DOI 10.1016/j.cell.2017.02.015; Wang WC, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010146; Wang YA, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0390-7; Wang Y, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.10; Wang YM, 2020, EXP THER MED, V19, P2119, DOI 10.3892/etm.2020.8415; Wei HJ, 2017, CANCER RES, V77, P6168, DOI 10.1158/0008-5472.CAN-17-0530; Weng B, 2017, GENOMICS, V109, P446, DOI 10.1016/j.ygeno.2017.07.001; Weng B, 2017, GENES GENOM, V39, P1047, DOI 10.1007/s13258-017-0573-0; Wu SW, 2020, TRENDS MOL MED, V26, P215, DOI 10.1016/j.molmed.2019.09.006; Wu Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04166-x; Xiao M, 2017, RNA BIOL, V14, P1326, DOI 10.1080/15476286.2015.1112487; Xu XY, 2018, THERIOGENOLOGY, V119, P105, DOI 10.1016/j.theriogenology.2018.06.026; Yang C, 2019, MOL THER-NUCL ACIDS, V14, P1, DOI 10.1016/j.omtn.2018.10.012; Yang WR, 2017, REPROD SCI, V24, P57, DOI 10.1177/1933719116649696; Yao CC, 2016, ONCOTARGET, V7, P2201, DOI 10.18632/oncotarget.6876; Young JC, 2015, SEMIN CELL DEV BIOL, V45, P94, DOI 10.1016/j.semcdb.2015.10.029; Zhang CY, 2019, EUR REV MED PHARMACO, V23, P4890, DOI 10.26355/eurrev_201906_18077; Zhang SX, 2019, DNA CELL BIOL, V38, P41, DOI 10.1089/dna.2018.4387; Zhang ZD, 2019, MOL MED REP, V19, P3505, DOI 10.3892/mmr.2019.10051	50	13	14	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15164	15179		10.1096/fj.202001384R	http://dx.doi.org/10.1096/fj.202001384R		SEP 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32918760	hybrid			2022-12-26	WOS:000570680300001
J	de Lima, RAF; Conde, PA; Banks-Leite, C; Campos, RC; Hernandez, MIM; Rodrigues, RR; Prado, PI				Ferreira de Lima, Renato A.; Conde, Paula Alves; Banks-Leite, Cristina; Campos, Renata C.; Medina Hernandez, Malva, I; Rodrigues, Ricardo R.; Prado, Paulo, I			Disentangling the effects of sampling scale and size on the shape of species abundance distributions	PLOS ONE			English	Article							LOGNORMAL-DISTRIBUTION; RELATIVE ABUNDANCE; SPATIAL-PATTERNS; BIOMASS; COMMUNITIES; MECHANISMS; SIMILARITY; DEPENDENCE; MODELS	Many authors have tried to explain the shape of the species abundance distribution (SAD). Some of them have suggested that sampling spatial scale is an important factor shaping SADs. These suggestions, however, did not consider the indirect and well-known effect of sample size, which increases as samples are combined to generate SADs at larger spatial scales. Here, we separate the effects of sample size and sampling scale on the shape of the SAD for three groups of organisms (trees, beetles and birds) sampled in the Brazilian Atlantic Forest. We compared the observed SADs at different sampling scales with simulated SADs having the same richness, relative abundances but comparable sample sizes, to show that the main effect shaping SADs is sample size and not sampling spatial scale. The effect of scale was minor and deviations between observed and simulated SADs were present only for beetles. For trees, the match between observed and simulated SADs was improved at all spatial scales when we accounted for conspecific aggregation, which was even more important than the sampling scale effect. We build on these results to propose a conceptual framework where observed SADs are shaped by three main factors, in decreasing order of importance: sample size, conspecific aggregation and beta diversity. Therefore, studies comparing SADs across sites or scales should use sampling and/or statistical approaches capable of disentangling these three effects on the shape of SADs.	[Ferreira de Lima, Renato A.; Conde, Paula Alves; Prado, Paulo, I] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Lab Ecol Teor LET, Sao Paulo, Brazil; [Banks-Leite, Cristina] Imperial Coll London, Dept Life Sci, Ascot, Berks, England; [Campos, Renata C.; Medina Hernandez, Malva, I] Univ Fed Santa Catarina, Ctr Ciencias Biol, Dept Ecol & Zool, Florianopolis, SC, Brazil; [Rodrigues, Ricardo R.] Escola Super Agr Luis Dequeiroz, Dept Ciencias Biol, Piracicaba, Brazil; [Ferreira de Lima, Renato A.] Nat Biodivers Ctr, Leiden, Netherlands	Universidade de Sao Paulo; Imperial College London; Universidade Federal de Santa Catarina (UFSC); Universidade de Sao Paulo; Naturalis Biodiversity Center	de Lima, RAF (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Ecol, Lab Ecol Teor LET, Sao Paulo, Brazil.; de Lima, RAF (corresponding author), Nat Biodivers Ctr, Leiden, Netherlands.	raflima@usp.br	de Lima, Renato Augusto Ferreira/C-6744-2013; Prado, Paulo Inácio/AAN-6512-2021; Rodrigues, Ricardo Ribeiro/D-5557-2012; Banks-Leite, Cristina/D-3075-2011; Prado, Paulo I/G-3353-2012; Hernandez, Malva/E-3485-2013	de Lima, Renato Augusto Ferreira/0000-0002-1048-0138; Prado, Paulo Inácio/0000-0002-7174-5005; Rodrigues, Ricardo Ribeiro/0000-0003-4818-0736; Banks-Leite, Cristina/0000-0002-0091-2857; Hernandez, Malva/0000-0002-6820-5980; Reis, AlessanRSS/0000-0001-8486-7469	Sao Paulo Research Foundation (FAPESP) [1999/09635-0, 2013/50718-5, 2013/08722-5, 09/53413-5]; CNPq/BMBF [690144/01-6]; 'Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior' (CAPES); CNPq [303878/2008-8]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq/BMBF; 'Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior' (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Data collection was supported by the grant 1999/09635-0 and 2013/50718-5, Sao Paulo Research Foundation (FAPESP) and by CNPq/BMBF (process 690144/01-6). RAFL was supported by the 'Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior' (CAPES) and by grant 2013/08722-5, Sao Paulo Research Foundation (FAPESP). PIP was supported by CNPq (process 303878/2008-8) and by grant 09/53413-5, Sao Paulo Research Foundation (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso D, 2008, ECOL LETT, V11, P93, DOI 10.1111/j.1461-0248.2007.01127.x; Anderson BJ, 2012, METHODS ECOL EVOL, V3, P783, DOI 10.1111/j.2041-210X.2012.00229.x; Arnold TB, 2011, R J, V3, P34; Borda-de-Agua L., 2017, SCI REPORTS, V7, P1; Borda-de-Agua L, 2012, ECOGRAPHY, V35, P549, DOI 10.1111/j.1600-0587.2011.07128.x; BROWN JH, 1995, ECOLOGY, V76, P2028, DOI 10.2307/1941678; BULMER MG, 1974, BIOMETRICS, V30, P101, DOI 10.2307/2529621; Capretz RL, 2012, CIENC FLOREST, V22, P551, DOI 10.5902/198050986622; Cheng JJ, 2012, OIKOS, V121, P236, DOI 10.1111/j.1600-0706.2011.19428.x; Chisholm RA, 2007, J THEOR BIOL, V247, P600, DOI 10.1016/j.jtbi.2007.04.006; Chisholm RA, 2009, ECOL LETT, V12, P1385, DOI 10.1111/j.1461-0248.2009.01389.x; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Connolly SR, 2005, SCIENCE, V309, P1363, DOI 10.1126/science.1113281; Dewdney AK, 1998, THEOR POPUL BIOL, V54, P294, DOI 10.1006/tpbi.1997.1370; Engen S, 1996, MATH BIOSCI, V132, P169, DOI 10.1016/0025-5564(95)00054-2; Engen S, 2002, AM NAT, V160, P60, DOI 10.1086/340612; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Green JL, 2007, ECOL LETT, V10, P1037, DOI 10.1111/j.1461-0248.2007.01101.x; Hartig F, 2011, ECOL LETT, V14, P816, DOI 10.1111/j.1461-0248.2011.01640.x; Henderson PA, 2010, P ROY SOC B-BIOL SCI, V277, P1561, DOI 10.1098/rspb.2009.2189; Hubbell SP, 2008, P NATL ACAD SCI USA, V105, P11498, DOI 10.1073/pnas.0801915105; Hubbell Stephen P., 2001, V32, pi; Johnson N., 1994, CONTINUOUS UNIVARIAT, V2; MACARTHUR R, 1960, AM NAT, V94, P25, DOI 10.1086/282106; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; Manly B.F.J., 2006, RANDOMIZATION BOOTST, V3rd, DOI DOI 10.1201/9781315273075; McGill B, 2003, EVOL ECOL RES, V5, P469; McGill BJ, 2003, ECOL LETT, V6, P766, DOI 10.1046/j.1461-0248.2003.00491.x; McGill BJ, 2010, OIKOS, V119, P591, DOI 10.1111/j.1600-0706.2009.17771.x; McGlinn DJ, 2019, METHODS ECOL EVOL, V10, P258, DOI [10.1111/2041-210X.13102, 10.1111/2041-210X.13102Citations:20]; Morlon H, 2009, ECOL LETT, V12, P488, DOI 10.1111/j.1461-0248.2009.01318.x; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Nekola JC, 2008, FOLIA GEOBOT, V43, P259, DOI 10.1007/s12224-008-9020-y; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; PALMER MW, 1994, AM NAT, V144, P717, DOI 10.1086/285704; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Prado P. I., 2014, SADS MAXIMUM LIKELIH; PRESTON FW, 1962, ECOLOGY, V43, P185, DOI 10.2307/1931976; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Rosindell J, 2013, OIKOS, V122, P1101, DOI 10.1111/j.1600-0706.2012.20751.x; ROUTLEDGE RD, 1980, J THEOR BIOL, V82, P547, DOI 10.1016/0022-5193(80)90177-0; Royle J. A., 2008, HIERARCHICAL MODELIN; Saether BE, 2013, J ANIM ECOL, V82, P721, DOI 10.1111/1365-2656.12068; Saint-Germain M, 2007, J APPL ECOL, V44, P330, DOI 10.1111/j.1365-2664.2006.01269.x; Sizling AL, 2009, P NATL ACAD SCI USA, V106, P6691, DOI 10.1073/pnas.0810096106; TAYLOR LR, 1978, J ANIM ECOL, V47, P383, DOI 10.2307/3790; Tokeshi M., 1999, SPECIES COEXISTENCE; Williamson M, 2005, J ANIM ECOL, V74, P409, DOI 10.1111/j.1365-2656.2005.00936.x; Williamson M, 2010, OIKOS, V119, P1697, DOI 10.1111/j.1600-0706.2010.18643.x; Wilson JB, 1998, J VEG SCI, V9, P213, DOI 10.2307/3237120; Yen JDL, 2013, OECOLOGIA, V171, P517, DOI 10.1007/s00442-012-2438-1; Zillio T, 2010, OIKOS, V119, P71, DOI 10.1111/j.1600-0706.2009.17938.x	52	2	4	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238854	10.1371/journal.pone.0238854	http://dx.doi.org/10.1371/journal.pone.0238854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915868	Green Published, Green Submitted, gold			2022-12-26	WOS:000571887500048
J	Ishibashi, Y; Nishitani, R; Shimura, A; Takeuchi, A; Touko, M; Kato, T; Chiba, S; Ashidate, K; Ishiwata, N; Ichijo, T; Sasabe, M				Ishibashi, Yoshiki; Nishitani, Rie; Shimura, Akiyoshi; Takeuchi, Ayano; Touko, Mamoru; Kato, Takashi; Chiba, Sahoko; Ashidate, Keiko; Ishiwata, Nobuo; Ichijo, Tomoyasu; Sasabe, Masataka			Non-GABA sleep medications, suvorexant as risk factors for falls: Case-control and case-crossover study	PLOS ONE			English	Article							HIP-FRACTURES; OLDER-ADULTS; HALF-LIFE; Z-DRUGS; INSOMNIA; BENZODIAZEPINES; RAMELTEON; PLACEBO; PATIENT; HOSPITALIZATION	The aim of this study was to examine the risk of falls associated with the use of non-gamma amino butyric acid (GABA) sleep medications, suvorexant and ramelteon. This case-control and case-crossover study was performed at the Kudanzaka Hospital, Chiyoda Ward, Tokyo. A total of 325 patients who had falls and 1295 controls matched by sex and age were included. The inclusion criteria for the case group were hospitalized patients who had their first fall and that for the control were patients who were hospitalized and did not have a fall, between January 2016 and November 2018. The internal sleep medications administered were classified as suvorexant, ramelteon, non-benzodiazepines, benzodiazepines, or kampo. In the case-control study, age, sex, clinical department, the fall down risk score, and hospitalized duration were adjusted in the logistic regression model. In the case-control study, multivariable logistic regression showed that the use of suvorexant (odds ratio [OR]: 2.61, 95% confidence interval [CI]: 1.29-5.28), nonbenzodiazepines (OR: 2.49, 95% CI: 1.73-3.59), and benzodiazepines (OR: 1.65, 95% CI: 1.16-2.34) was significantly associated with an increased OR of falls. However, the use of ramelteon (OR: 1.40, 95% CI: 0.60-3.16) and kampo (OR: 1.55, 95% CI: 0.75-3.19) was not significantly associated with an increased OR of falls. In the case-crossover study, the use of suvorexant (OR: 1.78, 95% CI: 1.05-3.00) and nonbenzodiazepines (OR: 1.63, 95% CI: 1.17-2.27) was significantly associated with an increased OR of falls. Similar patterns were observed in several sensitivity analyses. It was suggested that suvorexant increases the OR of falls. This result is robust in various analyses. This study showed that the risk of falls also exists for non-GABA sleep medication, suvorexant, and thus it is necessary to carefully prescribe hypnotic drugs under appropriate assessment.	[Ishibashi, Yoshiki] Kudanzaka Hosp, Dept Internal Med, Co Overview Federat Natl Publ Serv Personnel Mutu, Chiyoda Ku, Tokyo, Japan; [Ishibashi, Yoshiki; Nishitani, Rie; Takeuchi, Ayano; Touko, Mamoru; Chiba, Sahoko; Ashidate, Keiko; Ishiwata, Nobuo; Ichijo, Tomoyasu; Sasabe, Masataka] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Shinjuku Ku, Tokyo, Japan; [Shimura, Akiyoshi] Tokyo Med Univ, Dept Psychiat, Shinjuku Ku, Tokyo, Japan; [Shimura, Akiyoshi] Kanno Hosp, Dept Sleep & Psychiat, Wako, Saitama, Japan; [Kato, Takashi] Kudanzaka Hosp, Dept Pharm, Co Overview Federat Natl Publ Serv Personnel Mutu, Chiyoda Ku, Tokyo, Japan	Keio University; Tokyo Medical University	Ishibashi, Y (corresponding author), Kudanzaka Hosp, Dept Internal Med, Co Overview Federat Natl Publ Serv Personnel Mutu, Chiyoda Ku, Tokyo, Japan.; Ishibashi, Y; Nishitani, R (corresponding author), Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Shinjuku Ku, Tokyo, Japan.	ishiyoshi414@gmail.com; rie.hatakeyama@gmail.com	SHIMURA, Akiyoshi/AAC-9831-2020	SHIMURA, Akiyoshi/0000-0003-0806-4423; Ishibashi, Yoshiki/0000-0003-4440-9169				Akiko H, 2016, J JAPAN SOC HEALTHCA, V53, P31; Alexandre C, 2013, CURR OPIN NEUROBIOL, V23, P752, DOI 10.1016/j.conb.2013.04.008; American Academy of Sleep Medicine, 1 THINGS PHYS PAT SH; [Anonymous], 2000, J EPIDEMIOL, V10, P79; Berg RL, 1992, 2 5 YEARS PROMOTING; Brandt J, 2017, DRUGS R&D, V17, P493, DOI 10.1007/s40268-017-0207-7; Cajochen C, 2005, J CLIN ENDOCR METAB, V90, P1311, DOI 10.1210/jc.2004-0957; Cohen J.E., 1988, STAT POWER ANAL BEHA; Fadel J, 2010, BRAIN RES, V1314, P112, DOI 10.1016/j.brainres.2009.08.046; Farkas RH, 2013, APPL NUMBER 204569OR; FDA. CENTER FOR DRUG EVALUATION AND RESEARCH, 2013, APPL NUMB 204569ORIG; Gooneratne NS, 2010, J CLIN SLEEP MED, V6, P572; Greenland S, 2016, EUR J EPIDEMIOL, V31, P337, DOI 10.1007/s10654-016-0149-3; Griffin CE, 2013, OCHSNER J, V13, P214; Hagino H, 2010, J ORTHOP SCI, V15, P737, DOI 10.1007/s00776-010-1543-4; Herring WJ, 2016, BIOL PSYCHIAT, V79, P136, DOI 10.1016/j.biopsych.2014.10.003; Herring WJ, 2012, NEUROLOGY, V79, P2265, DOI 10.1212/WNL.0b013e31827688ee; Ikarashi Y, 2009, BIOL PHARM BULL, V32, P1701, DOI 10.1248/bpb.32.1701; Japanese Nursing Association, 2002, WHIT PAP NURS, P170; Kripke Daniel F, 2015, F1000Res, V4, P456, DOI 10.12688/f1000research.6845.1; Lee-Iannotti JK, 2016, NEUROPSYCH DIS TREAT, V12, P491, DOI 10.2147/NDT.S31495; Mahoney JE, 2000, ARCH INTERN MED, V160, P2788, DOI 10.1001/archinte.160.18.2788; Mandl LA, 2013, J ORTHOP SPORT PHYS, V43, P91, DOI 10.2519/jospt.2013.4349; de Paiva MCMD, 2010, REV ESC ENFERM USP, V44, P134, DOI 10.1590/S0080-62342010000100019; Mets MAJ, 2010, NAT SCI SLEEP, V2, P257, DOI 10.2147/NSS.S6846; Mets MAJ, 2011, SLEEP, V34, P1327, DOI 10.5665/SLEEP.1272; Michelson D, 2014, LANCET NEUROL, V13, P461, DOI 10.1016/S1474-4422(14)70053-5; Mizoguchi K, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00149; Nevitt MC, 1997, GAIT DISORDERS AGING, P13; Nishimura S, 2018, J MED ECON, V21, P698, DOI 10.1080/13696998.2018.1466710; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Pierfitte C, 2001, BMJ-BRIT MED J, V322, P704, DOI 10.1136/bmj.322.7288.704; RAY WA, 1989, JAMA-J AM MED ASSOC, V262, P3303, DOI 10.1001/jama.262.23.3303; Rose S, 2009, INT J BIOSTAT, V5, DOI 10.2202/1557-4679.1127; Rothman Kenneth J., 2008, MODERN EPIDEMIOLOGY, P111; Schroeck JL, 2016, CLIN THER, V37, P2340, DOI 10.1016/j.clinthera.2016.09.010; Sekaran NK, 2013, J AM GERIATR SOC, V61, P96, DOI 10.1111/jgs.12071; Sivertsen B, 2015, SLEEP MED, V16, P1552, DOI 10.1016/j.sleep.2015.05.003; Sun H, 2013, SLEEP, V36, P259, DOI 10.5665/sleep.2386; SUTTON JC, 1994, BRIT J CLIN PRACT, V48, P63; Tabata H, 2017, J CLIN SLEEP MED, V13, P759, DOI 10.5664/jcsm.6600; Terzano MG, 2003, DRUG SAFETY, V26, P261, DOI 10.2165/00002018-200326040-00004; Tinetti ME, 2010, JAMA-J AM MED ASSOC, V303, P258, DOI 10.1001/jama.2009.2024; Treves N, 2018, AGE AGEING, V47, P201, DOI 10.1093/ageing/afx167; Uchiyama M, 2011, SLEEP MED, V12, P127, DOI 10.1016/j.sleep.2010.10.006; Vandenbroucke JP, 2007, PLOS MED, V4, P1628, DOI 10.1371/journal.pmed.0040297; Vinkers CH, 2012, ADV PHARMACOL SCI, V2012, DOI 10.1155/2012/416864; Wang PS, 2001, AM J PSYCHIAT, V158, P892, DOI 10.1176/appi.ajp.158.6.892; Yang YH, 2011, J EPIDEMIOL, V21, P37, DOI 10.2188/jea.JE20090195; Zisapel Nava, NEUROENDOCRINE CORRE, P295; 1999, AMTSBL EUR GEMEINS L, V18, P1	51	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238723	10.1371/journal.pone.0238723	http://dx.doi.org/10.1371/journal.pone.0238723			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32916693	Green Published, gold			2022-12-26	WOS:000571887500107
J	Liu, FT; Wang, T; Li, XX; Jia, JX; Lin, Q; Xue, YZ				Liu, Fengting; Wang, Tao; Li, Xiaoxia; Jia, Jinxue; Lin, Qin; Xue, Yongzhi			Involvement of NF-kappa B in the reversal of CYP3A down-regulation induced by sea buckthorn in BCG-induced rats	PLOS ONE			English	Article							IMMUNOLOGICAL LIVER-INJURY; SEABUCKTHORN HIPPOPHAE-RHAMNOIDES; BACILLUS-CALMETTE-GUERIN; POLYSACCHARIDE EXTRACTS; INDUCED HEPATOTOXICITY; HEPATIC-INJURY; PULP OILS; L. SEED; INFLAMMATION; MIDAZOLAM	Previous studies reported that sea buckthorn (Hippophae rhamnoidesL., Elaeagnaceae, HRP) exhibits hepatoprotective effects via its anti-inflammatory and antioxidant properties as well as its inhibitory effects on collagen synthesis. However, it is unclear whether this hepatoprotective effect is also achieved by regulating liver drug metabolism enzyme pathways. Herein, we examined the regulatory effect of HRP on cytochrome P450 3A (CYP3A) in rats with immune liver injury, and explored the molecular mechanism of its hepatoprotective effect. Rat models of immunological liver injury were induced by intravenous injections ofBacillus Calmette-Guerin(BCG;125 mg kg(-1); 2 wks). Specific protein levels were detected by ELISA or western blot, and CYP3A mRNA expression was detected by RT-PCR. High-performance liquid chromatography (HPLC) detected relative changes in CYP3A metabolic activity based on the rates of 1-hydroxylation of the probe drug midazolam (MDZ). BCG pretreatment (125 mg kg-1) significantly down-regulated liver CYP3A protein expression compared with the control, metabolic activity, and transcription levels while up-regulating liver NF-kappa B, IL-1 beta, TNF-alpha and iNOS. HRP intervention (ED50: 78 mg kg(-1)) moderately reversed NF-kappa B, inflammatory cytokines, and iNOS activation in a dose-dependent manner (P <0.05), and suppressed CYP3A down-regulation (P <0.05); thereby partially alleviating liver injury. During immune liver injury, HRP may reverse CYP3A down-regulation by inhibiting NF-kappa B signal transduction, and protect liver function, which involves regulation of enzymes transcriptionally, translationally and post-translationally. The discovery that NF-kappa B is a molecular target of HRP may initiate the development and optimization of a clinical therapeutic approach to mitigate hepatitis B and other immunity-related liver diseases.	[Liu, Fengting; Wang, Tao; Li, Xiaoxia; Jia, Jinxue; Lin, Qin; Xue, Yongzhi] Baotou Med Coll, Inst Pharmacokinet & Liver Mol Pharmacol, Dept Pharmacol, Baotou, Inner Mongolia, Peoples R China	Baotou Medical College	Xue, YZ (corresponding author), Baotou Med Coll, Inst Pharmacokinet & Liver Mol Pharmacol, Dept Pharmacol, Baotou, Inner Mongolia, Peoples R China.	xyzhxyzh68@sohu.com			National Natural Science Foundation of China [81460567]; Inner Mongolia Natural Science Foundation of China [2009MS1104, 2014MS0813, 2019MS08198]; Department of Education of Inner Mongolia [NJ03148, NJZY13244]; National Natural Science Foundation of China; Inner Mongolia Science and Technology Department; Inner Mongolia Education Department	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Inner Mongolia Natural Science Foundation of China; Department of Education of Inner Mongolia; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Inner Mongolia Science and Technology Department; Inner Mongolia Education Department	This research is supported by the following scientific research projects. In addition, there is no other funding, and our institution does not fund others. This study was supported by the National Natural Science Foundation of China(No. 81460567) and the Inner Mongolia Natural Science Foundation of China (No. 2009MS1104, 2014MS0813 and 2019MS08198), and financial assistance was providedby the Department of Education of Inner Mongolia (No. NJ03148 and NJZY13244). The funds to support our research come from the project management organization. They are: National Natural Science Foundation of China, Inner Mongolia Science and Technology Department, Inner Mongolia Education Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar M, 2005, DRUG METAB REV, V37, P379, DOI 10.1081/DMR-200046136; Bao MH, 2006, J CARDIOVASC PHARM, V48, P834, DOI 10.1097/01.fjc.0000232064.64837.67; Dhyani D, 2010, J ETHNOPHARMACOL, V127, P329, DOI 10.1016/j.jep.2009.10.037; Eccleston C, 2002, J NUTR BIOCHEM, V13, P346, DOI 10.1016/S0955-2863(02)00179-1; El-Shitany NA, 2017, ENVIRON TOXICOL, V32, P1952, DOI 10.1002/tox.22418; Elbarbry F, 2009, J PHARMACEUT BIOMED, V50, P987, DOI 10.1016/j.jpba.2009.07.004; ELnahas EM, 2016, LIFE SCI, V163, P23, DOI 10.1016/j.lfs.2016.08.027; Ferrari C, 2015, LIVER INT, V35, P121, DOI 10.1111/liv.12749; Gao ZL, 2003, WORLD J GASTROENTERO, V9, P1615, DOI 10.3748/wjg.v9.i7.1615; Guo WN, 2018, ZOOL RES, V39, P25, DOI 10.24272/j.issn.2095-8137.2018.013; Gupta A, 2006, MOL CELL BIOCHEM, V290, P193, DOI 10.1007/s11010-006-9187-6; Hohmann N, 2015, BRIT J CLIN PHARMACO, V79, P278, DOI 10.1111/bcp.12502; Hsu YW, 2009, FOOD CHEM TOXICOL, V47, P2281, DOI 10.1016/j.fct.2009.06.015; Jefferies M, 2018, WORLD J CLIN CASES, V6, P589, DOI 10.12998/wjcc.v6.i13.589; Ke XJ, 2019, NEUROSCI LETT, V690, P48, DOI 10.1016/j.neulet.2018.10.016; Li Yu-hua, 2011, Yao Xue Xue Bao, V46, P487; Li YL, 2019, METALLOMICS, V11, P936, DOI 10.1039/c8mt00361k; Liao Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07962-7; Lin Q, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225531; Liu H, 2015, J ETHNOPHARMACOL, V176, P69, DOI 10.1016/j.jep.2015.10.029; Nagai K, 2015, XENOBIOTICA, V45, P874, DOI 10.3109/00498254.2015.1027971; Newton AH, 2016, SEMIN IMMUNOPATHOL, V38, P471, DOI 10.1007/s00281-016-0558-0; Panahi G, 2018, ARCH PHYSIOL BIOCHEM, V124, P468, DOI 10.1080/13813455.2018.1427764; Petersen BK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155855; Qin JD, 2014, PHARM BIOL, V52, P1460, DOI 10.3109/13880209.2014.898075; Saito T, 2001, J BIOL CHEM, V276, P38010; Shao JJ, 2020, LIFE SCI, V240, DOI 10.1016/j.lfs.2019.117094; Shi CS, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0181-7; Son YO, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01868-8; Sun WY, 2008, BASIC CLIN PHARMACOL, V103, P143, DOI 10.1111/j.1742-7843.2008.00243.x; Suolang PC, 2019, J ETHNOPHARMACOL, V236, P316, DOI 10.1016/j.jep.2019.03.006; Tahir M, 2013, ALCOHOL, V47, P131, DOI 10.1016/j.alcohol.2012.12.010; Wang F, 2016, CHEM-BIOL INTERACT, V258, P159, DOI 10.1016/j.cbi.2016.08.018; Wang X, 2007, BIOL PHARM BULL, V30, P1702, DOI 10.1248/bpb.30.1702; Wang X, 2018, PHYTOMEDICINE, V38, P90, DOI 10.1016/j.phymed.2017.11.007; Wu GJ, 2018, LIFE SCI, V195, P25, DOI 10.1016/j.lfs.2018.01.005; Xing JF, 2002, FITOTERAPIA, V73, P644, DOI 10.1016/S0367-326X(02)00221-6; Yang B, 2000, J NUTR BIOCHEM, V11, P338, DOI 10.1016/S0955-2863(00)00088-7; Yang QH, 2012, ANTIVIR RES, V96, P333, DOI 10.1016/j.antiviral.2012.10.003; Zhai JX, 2012, MOL BIOL REP, V39, P6763, DOI 10.1007/s11033-012-1501-7; Zhang HF, 2015, SCI REP-UK, V5, DOI 10.1038/srep17671; Zhang NN, 2012, INFLAMM RES, V61, P17, DOI 10.1007/s00011-011-0383-9; Zhang ZJ, 2016, MOLECULES, V21, DOI 10.3390/molecules21060738; Zhou JY, 2012, MOLECULES, V17, P11585, DOI 10.3390/molecules171011585; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	45	1	2	6	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238810	10.1371/journal.pone.0238810	http://dx.doi.org/10.1371/journal.pone.0238810			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915856	Green Published, gold			2022-12-26	WOS:000571887500122
J	Nielsen, BU; Kolpen, M; Jensen, PO; Katzenstein, T; Pressler, T; Ritz, C; Mathiesen, IHM; Faurholt-Jepsen, D				Nielsen, Bibi Uhre; Kolpen, Mette; Jensen, Peter Ostrup; Katzenstein, Terese; Pressler, Tacjana; Ritz, Christian; Mathiesen, Inger Hee Mabuza; Faurholt-Jepsen, Daniel			Neutrophil count in sputum is associated with increased sputum glucose and sputum L-lactate in cystic fibrosis	PLOS ONE			English	Article							PULMONARY EXACERBATIONS; PSEUDOMONAS-AERUGINOSA; AIRWAY INFLAMMATION; ANTIBIOTIC-THERAPY; LUNG-FUNCTION; CHILDREN; INHIBITION; EXPRESSION; MEMBRANE; DISEASE	Background Markers of lung inflammation measured directly in expectorated sputum have the potential of improving the timing of antibiotic treatment in cystic fibrosis (CF). L-Lactate might be a marker of inflammation, as it is produced from glucose by polymorphonuclear neutrophils (PMNs) in CF lungs. We aimed to investigate changes in and associations between PMNs, glucose and L-lactate in sputum during antibiotic treatment. In addition, the effect of hemoglobin A1c and plasma glucose on these biomarkers were investigated. Methods We sampled non-induced sputum at day 0, 7, 14 and 42 in 27 chronically infected CF patients electively treated with 14 days of intravenous antibiotic. To analyze sputum samples, we used flowcytometry to count PMNs and colorimetric assays to estimate lactate and glucose. Results No changes in levels of PMNs, glucose and lactate were detected in sputum during the antibiotic treatment. Sputum PMNs were positively associated with both glucose (log coefficient = 0.20, p = 0.01) and L-lactate (log coefficient = 0.34, p<0.001). In multivariate analyses, hemoglobin A1c was negatively associated with sputum PMNs (log coefficient = -1.68, p<0.001) and plasma glucose was negatively associated with sputum glucose (log coefficient = -0.09, p = 0.02). Conclusions In CF sputum PMNs, glucose and lactate were unchanged during elective antibiotic treatment. However, sputum PMNs were associated with both sputum glucose and sputum lactate. Surprisingly, hyperglycemia seemed to be associated with less PMNs infiltration and less glucose in CF sputum.	[Nielsen, Bibi Uhre; Katzenstein, Terese; Pressler, Tacjana; Mathiesen, Inger Hee Mabuza; Faurholt-Jepsen, Daniel] Rigshosp, Cyst Fibrosis Ctr Copenhagen, Dept Infect Dis, Copenhagen, Denmark; [Kolpen, Mette; Jensen, Peter Ostrup] Rigshosp, Dept Clin Microbiol, Copenhagen, Denmark; [Jensen, Peter Ostrup] Univ Copenhagen, Fac Hlth & Med Sci, Costerton Biofilm Ctr, Inst Immunol & Microbiol, Copenhagen, Denmark; [Ritz, Christian] Univ Copenhagen, Dept Nutr Exercise & Sports, Frederiksberg, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen	Nielsen, BU (corresponding author), Rigshosp, Cyst Fibrosis Ctr Copenhagen, Dept Infect Dis, Copenhagen, Denmark.	bibi.uhre.nielsen.01@regionh.dk	Jensen, Peter Ostrup/HGD-7725-2022; Faurholt-Jepsen, Daniel/D-9453-2012; Faurholt-Jepsen, Daniel/M-6324-2019; Ritz, Christian/P-6159-2014	Faurholt-Jepsen, Daniel/0000-0001-8561-0155; Faurholt-Jepsen, Daniel/0000-0001-8561-0155; Kolpen, Mette/0000-0001-5575-0384; Jensen, Peter Ostrup/0000-0003-1648-7186; Ritz, Christian/0000-0002-5095-0624	Danish Cystic Fibrosis Foundation; Department of Infectious Disease at Rigshospitalet, Copenhagen	Danish Cystic Fibrosis Foundation; Department of Infectious Disease at Rigshospitalet, Copenhagen	This study was supported by the Danish Cystic Fibrosis Foundation (BUN) (www.cystiskfibrose.dk) and the Department of Infectious Disease at Rigshospitalet, Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjos-Valotta EA, 2006, INFLAMM RES, V55, P16, DOI 10.1007/s00011-005-0003-7; [Anonymous], 2019, DTBI S, V1, P1, DOI DOI 10.36811/RJCSE.2019.110001; Bensel T, 2011, J CYST FIBROS, V10, P37, DOI 10.1016/j.jcf.2010.09.004; Bhatt JM, 2013, EUR RESPIR REV, V22, P205, DOI 10.1183/09059180.00006512; BORREGAARD N, 1982, J CLIN INVEST, V70, P550, DOI 10.1172/JCI110647; Brennan AL, 2007, J CYST FIBROS, V6, P101, DOI 10.1016/j.jcf.2006.03.009; Collison KS, 2002, J LEUKOCYTE BIOL, V71, P433; Doring G, 2000, EUR RESPIR J, V16, P749, DOI 10.1034/j.1399-3003.2000.16d30.x; Downey DG, 2007, PEDIATR PULM, V42, P729, DOI 10.1002/ppul.20646; Fredman G, 2019, APMIS, V127, P72, DOI 10.1111/apm.12913; Higgins C., 2011, ACUTE CARE TESTINGOR, P1; Jones HA, 1997, EUR RESPIR J, V10, P795; Konstan MW, 2014, J CYST FIBROS, V13, P148, DOI 10.1016/j.jcf.2013.12.009; KONSTAN MW, 1994, AM J RESP CRIT CARE, V150, P448, DOI 10.1164/ajrccm.150.2.8049828; Labiris NR, 2003, EUR RESPIR J, V21, P848, DOI 10.1183/09031936.03.00065102; Mallia P, 2018, J ALLERGY CLIN IMMUN, V142, P815, DOI 10.1016/j.jaci.2017.10.017; Maratou E, 2007, EUR J CLIN INVEST, V37, P282, DOI 10.1111/j.1365-2362.2007.01786.x; MASUDA M, 1990, DIABETES, V39, P466, DOI 10.2337/diabetes.39.4.466; NIELSON CP, 1989, DIABETES, V38, P1031, DOI 10.2337/diabetes.38.8.1031; Noah TL, 2010, PEDIATR PULM, V45, P281, DOI 10.1002/ppul.21176; Ohde S, 2018, DIABETES RES CLIN PR, V135, P166, DOI 10.1016/j.diabres.2017.11.013; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Ratjen F, 2016, EUR RESPIR J, V47, P829, DOI 10.1183/13993003.01390-2015; Sagel Scott D, 2007, Proc Am Thorac Soc, V4, P406, DOI 10.1513/pats.200703-044BR; Sagel SD, 2002, J PEDIATR-US, V141, P811, DOI 10.1067/mpd.2002.129847; Stephen MJ, 2018, CHRON RESP DIS, V15, P258, DOI 10.1177/1479972317743756; SZAFF M, 1983, ACTA PAEDIATR SCAND, V72, P651, DOI 10.1111/j.1651-2227.1983.tb09789.x; Terliesner N, 2017, J PEDIATR ENDOCR MET, V30, P815, DOI 10.1515/jpem-2017-0005; Van Sambeek L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119938; Wang P, 2016, SCI REP, V6, P1, DOI DOI 10.1038/s41598-016-0001-8; Wood DM, 2004, CLIN SCI, V106, P527, DOI 10.1042/CS20030333; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870	32	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238524	10.1371/journal.pone.0238524	http://dx.doi.org/10.1371/journal.pone.0238524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915806	Green Published, gold			2022-12-26	WOS:000571887500031
J	Tan, WB; Zheng, H; Wang, DD; Tian, FY; Li, H; Liu, XJ				Tan, Wenbo; Zheng, Hang; Wang, Dandan; Tian, Fangyuan; Li, Hong; Liu, Xiaojun			Expression characteristics and regulatory mechanism of Apela gene in liver of chicken (Gallus gallus)	PLOS ONE			English	Article							DENSITY APOLIPOPROTEIN-II; APJ RECEPTOR; PLASMA; ELABELA; LIPOGENESIS; ACTIVATION; STABILITY; TRANSPORT; CULTURES; HORMONE	Apela, a novel endogenous peptide ligand for the G-protein-coupled apelin receptor, was first discovered and identified in human embryonic stem cells in 2013. Apela has showed some biological functions in promoting angiogenesis and inducing vasodilatation of mammals by binding apelin receptor, but little is known about its expression characteristics and regulatory mechanism in chicken. In the present study, the coding sequences ofApelain chicken was cloned. The evolution history and potential function ofApelawere analyzed. Subsequently, the spatiotemporal expression characteristics of chickenApelawere investigated. Furthermore, the regulatory mechanism ofApelamRNA responsing to estrogen was explored byin vitroandin vivoexperiments. The results showed that the length of the CDs ofApelamRNA was 165 bp and encoded a protein consisting of 54 amino acids residues with a transmembrane domain in chicken. TheApelawas derived from the same ancestor ofApelin, and abundantly expressed in liver, kidney and pancreas tissues. The expression levels ofApelain the liver of hens were significantly higher at the peak-laying stage than that at the pre-laying stage (p <= 0.05). TheApelamRNA levels were significantly up-regulated in primary hepatocytes treated with 17 beta-estradiol (p <= 0.05), and could be effectively inhibited by estrogen receptor antagonists MPP, ICI 182780 and tamoxifen. It indicated that chickenApelaexpression was regulated by estrogen via estrogen receptor alpha (ER alpha). In individual levels, both the contents of TG, TC and VLDL-c in serum, and the expression ofApoVLDLIIandApelain liver markedly up-regulated by 17 beta-estradiol induction at 1mg/kg and 2mg/kg concentrations (p <= 0.05). This study lays a foundation for further research on Apela involving in hepatic lipid metabolism.	[Tan, Wenbo] Shihezi Univ, Coll Med, Shihezi, Xinjiang, Peoples R China; [Zheng, Hang; Wang, Dandan; Tian, Fangyuan; Li, Hong; Liu, Xiaojun] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China; [Liu, Xiaojun] Shihezi Univ, Coll Anim Sci & Technol, Shihezi, Xinjiang, Peoples R China	Shihezi University; Henan Agricultural University; Shihezi University	Liu, XJ (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China.; Liu, XJ (corresponding author), Shihezi Univ, Coll Anim Sci & Technol, Shihezi, Xinjiang, Peoples R China.	xjliu2008@hotmail.com			National Natural Science Foundation of China-NSFC-Henan joint grant [U1704233]	National Natural Science Foundation of China-NSFC-Henan joint grant	This research was supported by the National Natural Science Foundation of China-NSFC-Henan joint grant (grant number U1704233).	[Anonymous], 2020, BMC PEDIATR, V20, P1, DOI DOI 10.1016/J.CLAE.2020.04.011; BERKOWITZ EA, 1992, IN VITRO CELL DEV-AN, V28A, P391; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Charo DN, 2009, AM J PHYSIOL-HEART C, V297, pH1904, DOI 10.1152/ajpheart.00686.2009; Chaves-Almagro C, 2015, EUR J PHARMACOL, V763, P149, DOI 10.1016/j.ejphar.2015.05.017; Cheng BH, 2012, PEPTIDES, V37, P171, DOI 10.1016/j.peptides.2012.07.012; Chng SC, 2013, DEV CELL, V27, P672, DOI 10.1016/j.devcel.2013.11.002; COCHRANE AW, 1988, J MOL BIOL, V203, P555, DOI 10.1016/0022-2836(88)90192-1; DASHTI N, 1983, J LIPID RES, V24, P368; DELONG DM, 1986, JAMA-J AM MED ASSOC, V256, P2372, DOI 10.1001/jama.256.17.2372; Deng C, 2015, J BIOL CHEM, V290, P18261, DOI 10.1074/jbc.M115.648238; Friedewald WT, 1972, CLIN CHEM, V6, P6; Gloux A, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6185-0; GREENE GL, 1986, SCIENCE, V231, P1150, DOI 10.1126/science.3753802; Hewitt SC, 2003, REPRODUCTION, V125, P143, DOI 10.1530/rep.0.1250143; Higuchi K, 2007, ENDOCRINOLOGY, V148, P2690, DOI 10.1210/en.2006-1270; Ho LN, 2017, SCIENCE, V357, P707, DOI 10.1126/science.aam6607; Ho L, 2015, CELL STEM CELL, V17, P435, DOI 10.1016/j.stem.2015.08.010; Huang SYK, 2017, BBA-BIOMEMBRANES, V1859, P767, DOI 10.1016/j.bbamem.2017.01.028; Kang YJ, 2013, CIRC RES, V113, P22, DOI 10.1161/CIRCRESAHA.113.301324; Kawamata Y, 2001, BBA-MOL CELL RES, V1538, P162, DOI 10.1016/S0167-4889(00)00143-9; KENNEDY SW, 1993, ANAL BIOCHEM, V211, P102, DOI 10.1006/abio.1993.1239; Knauf C, 2013, HORM METAB RES, V45, P928, DOI 10.1055/s-0033-1351321; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LEVEILLE GA, 1968, P SOC EXP BIOL MED, V128, P398; Li H, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00271; Li H, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1943-0; Li MM, 2015, CELL STEM CELL, V16, P669, DOI 10.1016/j.stem.2015.04.002; Makino A, 2006, AM J PHYSIOL-CELL PH, V290, pC1633, DOI 10.1152/ajpcell.00576.2005; Murza A, 2014, BIOPOLYMERS, V102, P297, DOI 10.1002/bip.22498; Nikolay B, 2013, BIOCHIMIE, V95, P2445, DOI 10.1016/j.biochi.2013.09.005; OHEA EK, 1969, COMP BIOCHEM PHYSIOL, V30, P149, DOI 10.1016/0010-406X(69)91309-7; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Perjes A, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-015-0521-6; Pitkin SL, 2010, PHARMACOL REV, V62, P331, DOI 10.1124/pr.110.002949; Rosemary L, 1999, J NUT, V129, p467S, DOI [DOI 10.1093/JN/129.2.467S, 10.1093/jn/129.2.467S]; Schneider WJ, 2016, J BIOMED RES, V30, P174, DOI 10.7555/JBR.30.20150048; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Than A, 2012, MOL CELL ENDOCRINOL, V362, P227, DOI 10.1016/j.mce.2012.07.002; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; Wang Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep08170; WILLIAMS J, 1986, REPROD NUTR DEV, V26, P515, DOI 10.1051/rnd:19860311; Yang LY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48893-9; Yang PR, 2015, TRENDS PHARMACOL SCI, V36, P560, DOI 10.1016/j.tips.2015.06.002; Yasuzaki H, 2013, LIVER INT, V33, P118, DOI 10.1111/liv.12006; Zhang JN, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00756; Zheng H, 2018, J GENET, V97, P145, DOI 10.1007/s12041-018-0890-3	48	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238784	10.1371/journal.pone.0238784	http://dx.doi.org/10.1371/journal.pone.0238784			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915867	gold, Green Published			2022-12-26	WOS:000571887500152
J	Verbiest, A; Van Hoef, V; Rodriguez-Antona, C; Garcia-Donas, J; Grana-Castro, O; Albersen, M; Baldewijns, M; Laenen, A; Roussel, E; Schoffski, P; Wozniak, A; Caruso, S; Couchy, G; Zucman-Rossi, J; Beuselinck, B				Verbiest, Annelies; Van Hoef, Vincent; Rodriguez-Antona, Cristina; Garcia-Donas, Jesus; Grana-Castro, Osvaldo; Albersen, Maarten; Baldewijns, Marcella; Laenen, Annouschka; Roussel, Eduard; Schoffski, Patrick; Wozniak, Agnieszka; Caruso, Stefano; Couchy, Gabrielle; Zucman-Rossi, Jessica; Beuselinck, Benoit			MicroRNA expression profiles in molecular subtypes of clear-cell renal cell carcinoma are associated with clinical outcome and repression of specific mRNA targets	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; CANCER; TUMOR; PROLIFERATION; SUNITINIB; INHIBITION; APOPTOSIS; ONCOGENE; PATHWAYS; LET-7	Clear-cell renal cell carcinomas (ccRCC) can be divided into four transcriptomic subtypes, two of which have a favorable and two an unfavorable prognosis. To assess mechanisms driving these subtypes, we investigated their miRNA expression patterns. miRNAs are master regulators of mRNAs, that are widely deregulated in cancer. Unsupervised clustering in our dataset (n = 128) and The Cancer Genome Atlas (TCGA) validation set identified two distinct miRNA clusters that overlapped with the transcriptomic subtypes, underscoring the validity of these subtypes on a multi-omics level and suggesting a driving role for miRNAs. Discriminatory miRNAs for the favorable subtypes repressed epithelial-to-mesenchymal transition, based on gene set enrichment analysis and target-mRNA expression levels. Strikingly, throughout the entire dataset, miRNAs associated with favorable subtypes were also associated with longer overall survival after diagnosis, and miRNAs associated with unfavorable subtypes with shorter overall survival (Pearson r = -0.54, p<0.0001). These findings indicate a general shift in miRNA expression between more and less aggressive tumors. This adds to current literature, which usually suggests only a small subset of miRNAs as markers of aggressive disease. In conclusion, this study reveals distinct mRNA expression patterns underlying transcriptomic ccRCC-subtypes, whereby miRNAs associated with favorable subtypes counteract epithelial-to-mesenchymal transition. There is a general shift in miRNA expression in ccRCC, between more and less aggressive tumors.	[Verbiest, Annelies; Schoffski, Patrick; Wozniak, Agnieszka; Beuselinck, Benoit] Univ Hosp Leuven, Leuven Canc Inst, Dept Gen Med Oncol, Leuven, Belgium; [Verbiest, Annelies; Schoffski, Patrick; Wozniak, Agnieszka; Beuselinck, Benoit] Katholieke Univ Leuven, Lab Expt Oncol, Dept Oncol, Leuven, Belgium; [Van Hoef, Vincent] VIB, Bioinformat Expertise Ctr, Leuven, Belgium; [Rodriguez-Antona, Cristina] Spanish Natl Canc Res Ctr, Human Canc Genet Programme, Hereditary Endocrine Canc Grp, Madrid, Spain; [Rodriguez-Antona, Cristina] Ctr Invest Biomed Red Enfermedades Raras, Madrid, Spain; [Garcia-Donas, Jesus] HM Hosp Ctr Integral Oncol HM Clara Campal, Oncol Unit, Madrid, Spain; [Garcia-Donas, Jesus] Spanish Oncol Genitourinary Grp, Madrid, Spain; [Grana-Castro, Osvaldo] Spanish Natl Canc Res Ctr, Bioinformat Unit, Struct Biol & Biocomp Programme, Madrid, Spain; [Albersen, Maarten; Roussel, Eduard] Univ Hosp Leuven, Dept Urol, Leuven, Belgium; [Baldewijns, Marcella] Katholieke Univ Leuven, Dept Imaging & Pathol, Leuven, Belgium; [Laenen, Annouschka] Katholieke Univ Leuven, Biostat & Stat Bioinformat Ctr, Leuven, Belgium; [Caruso, Stefano; Couchy, Gabrielle; Zucman-Rossi, Jessica] IUH, Genom Fonct Tumeurs Solides, INSERM, UMR 1162, Paris, France	KU Leuven; University Hospital Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Centro Nacional de Investigaciones Oncologicas (CNIO); KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Beuselinck, B (corresponding author), Univ Hosp Leuven, Leuven Canc Inst, Dept Gen Med Oncol, Leuven, Belgium.; Beuselinck, B (corresponding author), Katholieke Univ Leuven, Lab Expt Oncol, Dept Oncol, Leuven, Belgium.	benoit.beuselinck@uzleuven.be	Rodriguez-Antona, Cristina/E-1073-2011; Wozniak, Agnieszka/AAT-3682-2020; Caruso, Stefano/AAA-9564-2020; zucman-rossi, Jessica/B-5098-2009	Rodriguez-Antona, Cristina/0000-0001-8750-7338; Wozniak, Agnieszka/0000-0001-9726-144X; Caruso, Stefano/0000-0002-6319-3642; zucman-rossi, Jessica/0000-0002-5687-0334; Grana-Castro, Osvaldo/0000-0003-1615-4242; Baldewijns, Marcella/0000-0002-0882-2944; Roussel, Eduard/0000-0002-7835-5536				Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Albiges L, 2019, EUR UROL, V76, P151, DOI 10.1016/j.eururo.2019.05.022; [Anonymous], 2016, DIABETES CARE S1, V39, pS1, DOI 10.2337/dc16-S001; [Anonymous], 2017, DIABETES CARE S1, V39, pS33; [Anonymous], 2012, REGEN MED S3, V7, pS14; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beuselinck B, 2015, CLIN CANCER RES, V21, P1329, DOI 10.1158/1078-0432.CCR-14-1128; Brooks SA, 2014, EUR UROL, V66, P77, DOI 10.1016/j.eururo.2014.02.035; Cantini L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9878; Chiyomaru T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043812; Conant JL, 2011, J CLIN PATHOL, V64, P1088, DOI 10.1136/jclinpath-2011-200216; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; El-Amraoui A, 2002, EMBO REP, V3, P463, DOI 10.1093/embo-reports/kvf090; Faragalla H, 2012, J MOL DIAGN, V14, P385, DOI 10.1016/j.jmoldx.2012.02.003; Gamez-Pozo A, 2012, NEOPLASIA, V14, P1144, DOI 10.1593/neo.12734; Gao YT, 2015, FEBS LETT, V589, P207, DOI 10.1016/j.febslet.2014.12.002; Ge YZ, 2015, J CANCER RES CLIN, V141, P1291, DOI 10.1007/s00432-015-1927-0; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Hakimi AA, 2019, CANCER DISCOV, V9, P510, DOI 10.1158/2159-8290.CD-18-0957; Heinzelmann J, 2019, ANN SURG ONCOL, V26, P3765, DOI 10.1245/s10434-019-07578-3; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Huang JW, 2013, CANCER SCI, V104, P1609, DOI 10.1111/cas.12291; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Khella HWZ, 2015, MOL THER, V23, P1748, DOI 10.1038/mt.2015.129; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li JP, 2012, FEBS LETT, V586, P3761, DOI 10.1016/j.febslet.2012.09.016; Li TQ, 2016, TUMOR BIOL, V37, P11667, DOI 10.1007/s13277-016-5144-5; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu YJ, 2016, BLOOD, V128, P1424, DOI 10.1182/blood-2016-05-714535; Mathew LK, 2014, CANCER DISCOV, V4, P53, DOI 10.1158/2159-8290.CD-13-0291; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Mikhaylova O, 2012, CANCER CELL, V21, P532, DOI 10.1016/j.ccr.2012.02.019; Putoczki TL, 2015, IMMUNOTHERAPY-UK, V7, P441, DOI [10.2217/IMT.15.17, 10.2217/imt.15.17]; Quan J, 2018, ONCOL LETT, V16, P2175, DOI 10.3892/ol.2018.8948; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rupaimoole R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6202; Shimomura A, 2016, CANCER SCI, V107, P326, DOI 10.1111/cas.12880; The Lancet Global Health, 2018, LANCET GLOB HEALTH, V6, pE593; Vergho D, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-25; Wang J, 2015, J THORAC CARDIOV SUR, V149, P1404, DOI 10.1016/j.jtcvs.2015.02.012; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Yamada Y, 2013, CANCER SCI, V104, P304, DOI 10.1111/cas.12072; Yang L, 2018, CELL PHYSIOL BIOCHEM, V49, P920, DOI 10.1159/000493224; Yu ZH, 2013, J MOL HISTOL, V44, P669, DOI 10.1007/s10735-013-9516-5; Zhang ZQ, 2015, EXP THER MED, V9, P1617, DOI 10.3892/etm.2015.2318; Zhou WB, 2016, BIOMED PHARMACOTHER, V84, P722, DOI 10.1016/j.biopha.2016.09.074	49	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238809	10.1371/journal.pone.0238809	http://dx.doi.org/10.1371/journal.pone.0238809			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915890	gold, Green Published			2022-12-26	WOS:000571887500113
J	Kang, JJ; Fung, ML; Zhang, K; Lam, CS; Wu, SX; Huang, XF; Yang, SJ; Wong-Riley, MTT; Liu, YY				Kang, Jun-Jun; Fung, Man-Lung; Zhang, Kun; Lam, Chun-Sing; Wu, Sheng-Xi; Huang, Xiao-Feng; Yang, Shou-Jing; Wong-Riley, Margaret T. T.; Liu, Ying-Ying			Chronic intermittent hypoxia alters the dendritic mitochondrial structure and activity in the pre-Botzinger complex of rats	FASEB JOURNAL			English	Article						intermittent hypoxia; neuroplasticity; postsynaptic; respiration; ultrastructure.chronic	CYTOCHROME-OXIDASE; AXONS; PLASTICITY; NEURONS; CRISTAE; NEUROPLASTICITY; HYPERTENSION; MOVEMENT; MOTILITY; NETWORK	Mitochondrial bioenergetics is dynamically coupled with neuronal activities, which are altered by hypoxia-induced respiratory neuroplasticity. Here we report structural features of postsynaptic mitochondria in the pre-Botzinger complex (pre-BotC) of rats treated with chronic intermittent hypoxia (CIH) simulating a severe condition of obstructive sleep apnea. The subcellular changes in dendritic mitochondria and histochemistry of cytochrome c oxidase (CO) activity were examined in pre-BotC neurons localized by immunoreactivity of neurokinin 1 receptors. Assays of mitochondrial electron transport chain (ETC) complex I, IV, V activities, and membrane potential were performed in the ventrolateral medulla containing the pre-BotC region. We found significant decreases in the mean length and area of dendritic mitochondria in the pre-BotC of CIH rats, when compared to the normoxic control and hypoxic group with daily acute intermittent hypoxia (dAIH) that evokes robust synaptic plasticity. Notably, these morphological alterations were mainly observed in the mitochondria in close proximity to the synapses. In addition, the proportion of mitochondria presented with enlarged compartments and filamentous cytoskeletal elements in the CIH group was less than the control and dAIH groups. Intriguingly, these distinct characteristics of structural adaptability were observed in the mitochondria within spatially restricted dendritic spines. Furthermore, the proportion of moderately to darkly CO-reactive mitochondria was reduced in the CIH group, indicating reduced mitochondrial activity. Consistently, mitochondrial ETC enzyme activities and membrane potential were lowered in the CIH group. These findings suggest that hypoxia-induced respiratory plasticity was characterized by spatially confined mitochondrial alterations within postsynaptic spines in the pre-BotC neurons. In contrast to the robust plasticity evoked by dAIH preconditioning, a severe CIH challenge may weaken the local mitochondrial bioenergetics that the fuel postsynaptic activities of the respiratory motor drive.	[Kang, Jun-Jun; Zhang, Kun; Wu, Sheng-Xi; Liu, Ying-Ying] Fourth Mil Med Univ, Dept Neurobiol, 169 Chang Le Xi Rd, Xian 710032, Peoples R China; [Fung, Man-Lung; Lam, Chun-Sing] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China; [Huang, Xiao-Feng; Yang, Shou-Jing] Fourth Mil Med Univ, Dept Pathol & Pathophysiol, Xian, Peoples R China; [Wong-Riley, Margaret T. T.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Air Force Military Medical University; University of Hong Kong; Air Force Military Medical University; Medical College of Wisconsin	Liu, YY (corresponding author), Fourth Mil Med Univ, Dept Neurobiol, 169 Chang Le Xi Rd, Xian 710032, Peoples R China.	yingyliu@fmmu.edu.cn	Wong-Riley, Margaret/AGM-6202-2022	Yang, Shou Jing/0000-0002-4662-4914	Natural Science Foundation of China [31171102, 31471097, 31971055, 81601056]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of China (grants: 31171102, 31471097, 31971055, 81601056). We thank Mr Lo YM for his technical assistance.	Barnett WH, 2017, EXP NEUROL, V287, P153, DOI 10.1016/j.expneurol.2016.05.036; Brustovetsky T, 2009, CELL CALCIUM, V46, P18, DOI 10.1016/j.ceca.2009.03.017; Chada SR, 2003, J EXP BIOL, V206, P1985, DOI 10.1242/jeb.00263; Chopra S, 2016, AM J RESP CELL MOL, V54, P299, DOI 10.1165/rcmb.2015-0218TR; Cogliati S, 2016, TRENDS BIOCHEM SCI, V41, P261, DOI 10.1016/j.tibs.2016.01.001; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Cserep C, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0390-17.2018; Dale EA, 2014, PHYSIOLOGY, V29, P39, DOI 10.1152/physiol.00012.2013; Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109; Del Rio R, 2016, HYPERTENSION, V68, P436, DOI 10.1161/HYPERTENSIONAHA.116.07255; Dougherty BJ, 2018, RESP PHYSIOL NEUROBI, V256, P50, DOI 10.1016/j.resp.2017.05.004; Feldman JL, 2013, ANNU REV PHYSIOL, V75, P423, DOI 10.1146/annurev-physiol-040510-130049; Fischer TD, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006169; Fu ZX, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00043-3; Garcia AJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00571; Garcia AJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00004; Giachin G, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00043; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Gray PA, 2010, J NEUROSCI, V30, P14883, DOI 10.1523/JNEUROSCI.4031-10.2010; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; HEVNER RF, 1989, J NEUROSCI, V9, P3884; Jayashankar V, 2016, CURR OPIN CELL BIOL, V38, P45, DOI 10.1016/j.ceb.2016.02.006; Kang JJ, 2019, EXP NEUROL, V313, P124, DOI 10.1016/j.expneurol.2018.12.008; Kang JJ, 2017, EXP NEUROL, V287, P165, DOI 10.1016/j.expneurol.2016.05.035; Kasthuri N, 2015, CELL, V162, P648, DOI 10.1016/j.cell.2015.06.054; Koizumi H, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0081-16.2016; Lam CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117990; Lee A, 2018, CURR OPIN PHYSIOL, V3, P82, DOI 10.1016/j.cophys.2018.03.009; Lewis TL, 2016, CURR BIOL, V26, P2602, DOI 10.1016/j.cub.2016.07.064; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lieske SP, 2000, NAT NEUROSCI, V3, P600, DOI 10.1038/75776; Liu YY, 2001, J APPL PHYSIOL, V90, P685, DOI 10.1152/jappl.2001.90.2.685; Lopez-Domenech G, 2018, EMBO J, V37, P321, DOI 10.15252/embj.201696380; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; Mitchell GS, 2003, J APPL PHYSIOL, V94, P358, DOI 10.1152/japplphysiol.00523.2002; Mitchell GS, 2001, J APPL PHYSIOL, V90, P2466, DOI 10.1152/jappl.2001.90.6.2466; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Overly CC, 1996, J CELL SCI, V109, P971; Perkins GA, 2010, J NEUROSCI, V30, P1015, DOI 10.1523/JNEUROSCI.1517-09.2010; Popov V, 2005, J COMP NEUROL, V492, P50, DOI 10.1002/cne.20682; Rangaraju V, 2019, CELL, V176, P73, DOI 10.1016/j.cell.2018.12.013; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Rintoul GL, 2010, BBA-MOL BASIS DIS, V1802, P143, DOI 10.1016/j.bbadis.2009.09.005; Rowland KC, 2000, J NEUROSCI, V20, P9135; Semenza GL, 2015, J APPL PHYSIOL, V119, P1152, DOI 10.1152/japplphysiol.00162.2015; Sheng ZH, 2014, J CELL BIOL, V204, P1087, DOI 10.1083/jcb.201312123; Smith HL, 2016, ELIFE, V5, DOI 10.7554/eLife.15275; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; SOKOLOFF L, 1992, PROG BRAIN RES, V94, P19; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Sun T, 2013, CELL REP, V4, P413, DOI 10.1016/j.celrep.2013.06.040; Wagner OI, 2003, J NEUROSCI, V23, P9046; Wei XY, 2010, NEUROSCIENCE, V168, P61, DOI 10.1016/j.neuroscience.2010.03.023; Wilkerson JER, 2018, RESP PHYSIOL NEUROBI, V256, P15, DOI 10.1016/j.resp.2017.10.005; Wong-Riley MTT, 2012, ADV EXP MED BIOL, V748, P283, DOI 10.1007/978-1-4614-3573-0_12; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; WONGRILEY MTT, 1989, VISUAL NEUROSCI, V2, P483, DOI 10.1017/S0952523800012384; Xing T, 2013, CLIN EXP PHARMACOL P, V40, P602, DOI 10.1111/1440-1681.12129; Yu SB, 2018, J MOL BIOL, V430, P3922, DOI 10.1016/j.jmb.2018.07.027	59	2	2	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14588	14601		10.1096/fj.201902141R	http://dx.doi.org/10.1096/fj.201902141R		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32910512	Bronze			2022-12-26	WOS:000568310700001
J	Robbins, SJ; Dauda, W; Kokogho, A; Ndembi, N; Mitchell, A; Adebajo, S; Gaydos, CA; Peel, S; Ramadhani, HO; Robb, ML; Baral, SD; Ake, JA; Charurat, ME; Crowell, TA; Nowak, RG				Robbins, Sarah J.; Dauda, Wuese; Kokogho, Afoke; Ndembi, Nicaise; Mitchell, Andrew; Adebajo, Sylvia; Gaydos, Charlotte A.; Peel, Sheila; Ramadhani, Habib O.; Robb, Merlin L.; Baral, Stefan D.; Ake, Julie A.; Charurat, Man E.; Crowell, Trevor A.; Nowak, Rebecca G.		TRUST RV368 Study Grp	Oral sex practices among men who have sex with men and transgender women at risk for and living with HIV in Nigeria	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; NEGATIVE MEN; ANAL SEX; CHLAMYDIA; GONORRHEA; PREVALENCE; PREVENTION; BEHAVIORS; PARTNERS; SAMPLE	Background Men who have sex with men (MSM) and transgender women (TGW) are at risk for sexually transmitted infections (STIs), including those of the oropharynx. We estimated the prevalence and factors associated with oral sex practices and characterized oropharyngeal STIs among a cohort of MSM and TGW in Nigeria. Methods From 2013 to 2018, TRUST/RV368 recruited MSM and TGW into HIV/STI diagnosis and treatment at community-based clinics in Nigeria. Participants who completed HIV testing and oral sex questions at enrollment were selected. Cross-sectional analyses with bivariate and multivariable logistic regression models estimated odds ratios (ORs) and 95% confidence intervals (CIs). Oropharyngeal swab testing forNeisseria gonorrhoeae(NG) andChlamydia trachomatis(CT) began in 2014 and for those with diagnostic results at enrollment, the unadjusted association of oral sex practices with oropharyngeal STIs was conducted. Results A total of 1342 participants had a median age of 25 years (interquartile range: 22-29), 58% were living with HIV, and 69% reported oral sex practices. Factors associated with increased odds of engaging in oral sex included living with HIV (adjusted [a]OR: 1.4, 95% CI: 1.1-1.8), self-identifying as a woman (aOR:1.8, 95% CI: 1.1-2.8), mobile phone ownership (aOR:2.3, 95% CI: 1.3-3.9), receptive anal sex (aOR:1.7, 95% CI:1.3-2.3) and multiple male sexual partners (2 to 4 vs. <= 1, aOR:1.5, 95% CI: 1.0-2.2; 5+ vs <= 1, aOR:2.9, 95% CI:1.9-4.3). Oropharyngeal STI prevalence was 7% (52/752) and higher among those who engaged in oral sex compared to those who did not (unadjusted OR: 2.5, 95% CI:1.2-5.3). Conclusions Oral sex was common and associated with an increased odds of oropharyngeal STIs among MSM and TGW from Nigeria. In the absence of screening and treatment guidelines, condoms continue to be the mainstay for oral STI prevention. A pre-exposure prophylaxis for bacterial STIs would complement current prevention strategies to curb transmission.	[Robbins, Sarah J.; Ndembi, Nicaise; Mitchell, Andrew; Ramadhani, Habib O.; Charurat, Man E.; Nowak, Rebecca G.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Dauda, Wuese; Ndembi, Nicaise] Inst Human Virol Nigeria, Abuja, Nigeria; [Kokogho, Afoke] HJF Med Res Int, Abuja, Nigeria; [Kokogho, Afoke; Peel, Sheila; Robb, Merlin L.; Ake, Julie A.; Crowell, Trevor A.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA; [Adebajo, Sylvia] Maryland Global Initiat Corp, Abuja, Nigeria; [Gaydos, Charlotte A.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Robb, Merlin L.; Crowell, Trevor A.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Baral, Stefan D.] Johns Hopkins Sch Publ Hlth, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Johns Hopkins University; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Nowak, RG (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	RNowak@ihv.umarland.edu	Baral, Stefan/AAG-4818-2020; Gaydos, Charlotte A./E-9937-2010; Crowell, Trevor A./W-3904-2019	Baral, Stefan/0000-0002-5482-2419; Crowell, Trevor A./0000-0001-5947-265X	U.S National Institutes of Health [R01 MH099001, R01 AI1209143, R01 MH110358, K07CS225403]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense [W81XWH-11-2-0174, W81XWH-18-2-0040]; Fogarty Epidemiology Research Training for Public Health Impact in Nigeria program [D43TW010051]; Department of Health and Human Services/Centers for Disease Control and Prevention, Global AIDS Program; Institute for Human VirologyNigeria [NU2GGH002099]	U.S National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense(United States Department of Defense); Fogarty Epidemiology Research Training for Public Health Impact in Nigeria program; Department of Health and Human Services/Centers for Disease Control and Prevention, Global AIDS Program; Institute for Human VirologyNigeria	U.S National Institutes of Health URL: https://www.nih.gov/[MEC: R01 MH099001, R01 AI1209143; SDB: R01 MH110358; RGN: K07CS225403], the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense URL: https://www.hjf.org/https://www.defense.gov/[MLR: W81XWH-11-2-0174, W81XWH-18-2-0040], Fogarty Epidemiology Research Training for Public Health Impact in Nigeria program URL: https://www.fic.nih.gov/[MEC: D43TW010051], President's Emergency Plan for AIDS Relief through a cooperative agreement between the Department of Health and Human Services/Centers for Disease Control and Prevention, Global AIDS Program, and the Institute for Human VirologyNigeria URL: https://www.cdc.gov/globalhivtb/http://www.ihv.org/[MEC: NU2GGH002099]. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Abara WE, 2020, SEX TRANSM DIS, V47, P361, DOI 10.1097/OLQ.0000000000001170; Allen JE, 2017, SEX TRANSM DIS, V44, P284, DOI [10.1097/OLQ.0000000000000590, 10.1097/olq.0000000000000590]; [Anonymous], 2019, LANCET GLOB HEALTH, V7, pE1, DOI 10.1016/S2214-109X(18)30536-9; [Anonymous], 2012, Regen Med, V7, pS14, DOI 10.2217/rme.12.38; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI [10.1055/s-0043-115953, DOI 10.1055/S-0043-115953]; [Anonymous], 2019, FRONTIERS PLANT SCI; Baisley K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208689; Baral SD, 2015, JAIDS-J ACQ IMM DEF, V68, pS107, DOI 10.1097/QAI.0000000000000438; Blomquist PB, 2020, SEX TRANSM INFECT, V96, P590, DOI 10.1136/sextrans-2019-054345; Carlos S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210398; Chamberlain N, 2017, AIDS BEHAV, V21, P2526, DOI 10.1007/s10461-017-1699-4; Chan Philip A, 2016, Infect Dis Obstet Gynecol, V2016, P5758387, DOI 10.1155/2016/5758387; Charurat ME, 2015, JAIDS-J ACQ IMM DEF, V68, pS114, DOI 10.1097/QAI.0000000000000439; Chege W, 2012, J INFECT DEV COUNTR, V6, P870, DOI 10.3855/jidc.2636; Crowell TA, 2020, SEX TRANSM DIS, V47, P202, DOI 10.1097/OLQ.0000000000001105; Crowell TA, 2019, ANN EPIDEMIOL, V31, P11, DOI 10.1016/j.annepidem.2018.12.004; Crowell TA, 2018, SEX TRANSM INFECT, V94, P578, DOI 10.1136/sextrans-2017-053414; Cummings B, 2018, AIDS BEHAV, V22, P2189, DOI 10.1007/s10461-017-1994-0; Danby CS, 2016, SEX TRANSM DIS, V43, P105, DOI 10.1097/OLQ.0000000000000384; Ding YY, 2018, AIDS CARE, V30, P305, DOI 10.1080/09540121.2017.1349275; Expert Panel on Neurologic Imaging:, 2017, J Am Coll Radiol, V14, pS550, DOI 10.1016/j.jacr.2017.08.041; Gaines MT, 2020, J RACIAL ETHN HEALTH, V7, P84, DOI 10.1007/s40615-019-00636-2; Glynn TR, 2017, AIDS PATIENT CARE ST, V31, P261, DOI 10.1089/apc.2017.0027; Guo W, 2013, CHINESE MED J-PEKING, V126, P1257, DOI 10.3760/cma.j.issn.0366-6999.20121721; Habel MA, 2018, SEX TRANSM DIS, V45, P775, DOI 10.1097/OLQ.0000000000000889; Hill AO, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209933; Kent CK, 2005, CLIN INFECT DIS, V41, P67, DOI 10.1086/430704; LeVasseur MT, 2018, JAIDS-J ACQ IMM DEF, V77, P31, DOI 10.1097/QAI.0000000000001555; Macapagal K, 2018, J ADOLESCENT HEALTH, V62, P708, DOI 10.1016/j.jadohealth.2018.01.001; Mimiaga MJ, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5856-0; Morhason-Bello IO, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0722-9; Morris SR, 2006, CLIN INFECT DIS, V43, P1284, DOI 10.1086/508460; Nowak RG, 2019, JAIDS-J ACQ IMM DEF, V80, P444, DOI [10.1097/QAI.0000000000001934, 10.1097/qai.0000000000001934]; Nowak RG, 2016, SEX TRANSM DIS, V43, P243, DOI 10.1097/OLQ.0000000000000431; Oliver SE, 2018, SEX TRANSM DIS, V45, P660, DOI 10.1097/OLQ.0000000000000845; Oswalt SB, 2013, ARCH SEX BEHAV, V42, P1561, DOI 10.1007/s10508-012-0066-9; Park JN, 2014, BMC PUBLIC HLTH, P14, DOI [10.1186/1471-2458-14-14, DOI 10.1186/1471-2458-14-14]; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; Phillips G, 2012, AIDS CARE, V24, P793, DOI 10.1080/09540121.2011.630365; Pitasi MA, 2019, SEX TRANSM DIS, V46, P112, DOI 10.1097/OLQ.0000000000000917; Rebe K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138315; Richters J, 2003, AIDS, V17, P2269, DOI 10.1097/00002030-200310170-00020; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Seekaew P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219169; Shannon CL, 2019, SEX TRANSM DIS, V46, P737, DOI 10.1097/OLQ.0000000000001056; Siegler AJ, 2015, AIDS CARE, V27, P229, DOI 10.1080/09540121.2014.947914; Soni S, 2011, SEX TRANSM DIS, V38, P1107, DOI 10.1097/OLQ.0b013e31822e6136; Stahlman Shauna, 2016, JMIR Public Health Surveill, V2, pe35, DOI 10.2196/publichealth.5824; STIGMA, 2019, GUID MAN SEX TRANSM; Tabet SR, 1998, AIDS, V12, P2041, DOI 10.1097/00002030-199815000-00016; Tribble C, 2016, HEART SURG FORUM, V19, pE286, DOI 10.1532/hsf.1731; Vogt SL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00303; Wall KM, 2013, J HOMOSEXUAL, V60, P1520, DOI 10.1080/00918369.2013.819256; Wray TB, 2020, AIDS BEHAV, V24, P1851, DOI 10.1007/s10461-019-02760-w; Zhang YF, 2018, AIDS, V32, P1301, DOI 10.1097/QAD.0000000000001839; Zou HC, 2014, J ADOLESCENT HEALTH, V55, P247, DOI 10.1016/j.jadohealth.2014.01.020	56	4	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238745	10.1371/journal.pone.0238745	http://dx.doi.org/10.1371/journal.pone.0238745			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ7QN	32886722	gold, Green Published			2022-12-26	WOS:000571064300064
J	Hanson, J; Fox, M; Anderson, A; Fox, P; Webster, K; Williams, C; Nield, B; Bagshaw, R; Hempenstall, A; Smith, S; Solomon, N; Boyd, P				Hanson, Josh; Fox, Melissa; Anderson, Adam; Fox, Penny; Webster, Kate; Williams, Charlie; Nield, Blake; Bagshaw, Richard; Hempenstall, Allison; Smith, Simon; Solomon, Norma; Boyd, Peter			Chronic hepatitis B in remote, tropical Australia; successes and challenges	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; TORRES STRAIT ISLANDERS; LIVER-CANCER; HEPATOCELLULAR-CARCINOMA; GENOTYPE-C; MANAGEMENT; INFECTION	Introduction Aboriginal and Torres Strait Islander Australians living in remote locations suffer disproportionately from chronic hepatitis B (CHB). Defining the temporospatial epidemiology of the disease-and assessing the ability of local clinicians to deliver optimal care-is crucial to improving patient outcomes in these settings. Methods The demographic, laboratory and radiology findings in all patients diagnosed with CHB after 1990, and presently residing in remote Far North Queensland (FNQ), tropical Australia, were correlated with their management and clinical course. Results Of the 602 patients, 514 (85%) identified as Aboriginal and Torres Strait Islander Australians, 417 (69%) of whom had Torres Strait Islander heritage. Among the 514 Aboriginal and Torres Strait Islander Australians, there were only 61 (12%) born after universal postnatal vaccination was introduced in 1985. Community CHB prevalence varied significantly across the region from 7/1707 (0.4%) in western Cape York to 55/806 (6.8%) in the Eastern Torres Strait Islands. Although 240/602 (40%) are engaged in care, with 65 (27%) meeting criteria for antiviral therapy, only 43 (66%) were receiving this treatment. Among 537 with complete data, 32 (6%) were cirrhotic, of whom 15 (47%) were engaged in care and 10 (33%) were receiving antiviral therapy. Only 64/251 (26%) in whom national guidelines would recommend hepatocellular carcinoma (HCC) surveillance are receiving screening, however, only 20 patients have been diagnosed with HCC since 1999. Conclusion Vaccination has had a dramatic effect on CHB prevalence in FNQ in only a generation. However, although engagement in care is the highest in Australia, this is not translating into initiation of antiviral therapy in all those that should be receiving it, increasing their risk of developing cirrhosis and HCC. New strategies are necessary to improve the care of Indigenous Australians living with CHB to reduce the morbidity and mortality of this preventable disease.	[Hanson, Josh] Univ New South Wales, Kirby Inst, Directors Unit, Sydney, NSW, Australia; [Hanson, Josh; Fox, Melissa; Anderson, Adam; Fox, Penny; Webster, Kate; Bagshaw, Richard; Smith, Simon; Solomon, Norma; Boyd, Peter] Cairns Hosp, Div Med, Cairns, Qld, Australia; [Williams, Charlie] Royal Darwin Hosp, Dept Med, Darwin, NT, Australia; [Nield, Blake] St George Hosp, Dept Microbiol, Sydney, NSW, Australia; [Hempenstall, Allison] Thursday Isl Hosp, Thursday Isl, Qld, Australia	University of New South Wales Sydney; Kirby Institute; St George Hospital	Hanson, J (corresponding author), Univ New South Wales, Kirby Inst, Directors Unit, Sydney, NSW, Australia.; Hanson, J (corresponding author), Cairns Hosp, Div Med, Cairns, Qld, Australia.	jhanson@kirby.unsw.edu.au	Hanson, Josh/ABD-9328-2020; Hempenstall, Allison/AAD-2553-2020; Williams, Charlie/GSE-4265-2022; Hempenstall, Allison/GXH-6336-2022	Smith, Simon/0000-0002-7770-3738; Hanson, Josh/0000-0002-1423-3839				Allard N, 2018, HEPATITIS B PRIMARY; Allard N, 2017, AUST FAM PHYSICIAN, V46, P859; Anderson E, 2016, AUST J PRIM HEALTH, V22, P316, DOI 10.1071/PY14130; [Anonymous], 2014, NEWSWEEK, V20, P273; [Anonymous], 2014, AUSTR HLTH SER; Australian Bureau of Statistics, 2017, LEAD CAUS DEATH AB T; Australian Government Department of Health Immunise Australia Program, 2018, 2017 PHN CHILDH IMM; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Chen JG, 2003, J MED SCREEN, V10, P204, DOI 10.1258/096914103771773320; Chon YE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044930; Conway J, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2265-5; Cross V, 2011, AUST J RURAL HEALTH, V19, P95, DOI 10.1111/j.1440-1584.2011.01190.x; Davidson PM, 2010, HEART LUNG CIRC, V19, P372, DOI 10.1016/j.hlc.2010.01.010; Davies J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184082; Davies J, 2015, JMIR RES PROTOC, V4, DOI 10.2196/resprot.4216; Davies J, 2013, J GASTROEN HEPATOL, V28, P1234, DOI 10.1111/jgh.12177; Fisher DA, 2003, MED J AUSTRALIA, V178, P82, DOI 10.5694/j.1326-5377.2003.tb05070.x; Francica G, 2019, J HEPATOCELL CARCINO, V6, P131, DOI 10.2147/JHC.S159269; Gastroenterology Society of Australia, 2009, CHRON HEP B CHB REC, V2009/10; Hoang JK, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004433; Hong TP, 2016, HEPATOLOGY, V63, P1205, DOI 10.1002/hep.28267; Jennings W, 2014, AUST J PRIM HEALTH, V20, P151, DOI 10.1071/PY12138; Kirby Institute, 2018, HIV VIR HEP SEX TRAN; Kwon JA, 2019, J VIRAL HEPATITIS, V26, P83, DOI 10.1111/jvh.13013; Lederle FA, 2012, ANN INTERN MED, V156, P387, DOI 10.7326/0003-4819-156-5-201203060-00012; Lee A, 2018, J VIRUS ERAD, V4, P160; Livingston SE, 2007, GASTROENTEROLOGY, V133, P1452, DOI 10.1053/j.gastro.2007.08.010; MacLachlan J, 2019, NATL REPORT 2017 VIR; Malcolm RL, 2000, AUST NZ J PUBL HEAL, V24, P353, DOI 10.1111/j.1467-842X.2000.tb01591.x; Marciano S, 2018, LIVER INT, V38, P97, DOI 10.1111/liv.13627; Marsh K, 2019, AIDS, V33, pS213, DOI 10.1097/QAD.0000000000002355; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; Nguyen MH, 2019, J INFECT DIS, V219, P10, DOI 10.1093/infdis/jiy391; Papatheodoridis GV, 2015, J HEPATOL, V62, P956, DOI 10.1016/j.jhep.2015.01.002; Parker C, 2014, MED J AUSTRALIA, V201, P470, DOI 10.5694/mja13.11117; Preston-Thomas A, 2013, AUST FAM PHYSICIAN, V42, P225; Razavi-Shearer D, 2018, LANCET GASTROENTEROL, V3, P383, DOI 10.1016/S2468-1253(18)30056-6; Robotin MC, 2009, J HEPATOL, V50, P990, DOI 10.1016/j.jhep.2008.12.022; Sheridan J, 1989, ABORIGINAL HLTH INFO, V12, P19; Shetty A, 2018, EMERG MED AUSTRALAS, V30, P4, DOI 10.1111/1742-6723.12924; Sugauchi F, 2001, J GEN VIROL, V82, P883, DOI 10.1099/0022-1317-82-4-883; Usai D., 2018, FOOD FUNCT, V9, P261; Villanueva A, 2019, NEW ENGL J MED, V380, P1450, DOI 10.1056/NEJMra1713263; WHO [webpage on the Internet], 2015, WHO GUID PREV CAR TR; Wong GLH, 2013, ALIMENT PHARM THER, V37, P517, DOI 10.1111/apt.12207; Yang HI, 2014, WORLD J GASTROENTERO, V20, P6244, DOI 10.3748/wjg.v20.i20.6244; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0	47	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238719	10.1371/journal.pone.0238719	http://dx.doi.org/10.1371/journal.pone.0238719			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881958	gold, Green Published			2022-12-26	WOS:000571063300055
J	Rajcic, D; Brandt, A; Jin, CJ; Sanchez, V; Engstler, AJ; Jung, F; Nier, A; Baumann, A; Bergheim, I				Rajcic, Dragana; Brandt, Annette; Jin, Cheng Jun; Sanchez, Victor; Engstler, Anna Janina; Jung, Finn; Nier, Anika; Baumann, Anja; Bergheim, Ina			Exchanging dietary fat source with extra virgin olive oil does not prevent progression of diet-induced non-alcoholic fatty liver disease and insulin resistance	PLOS ONE			English	Article							FEMALE MICE; WEIGHT-LOSS; SUPPLEMENTATION; PROTEIN; STEATOHEPATITIS; FRUCTOSE; CONSUMPTION; PREVALENCE; STEATOSIS; BURDEN	Dietary fat is discussed to be critical in the development of non-alcoholic fatty liver disease. Here, we assess the effect of exchanging dietary fat source from butterfat to extra virgin olive oil on the progression of an already existing diet-induced non-alcoholic fatty liver disease in mice. Female C57BL/6J mice were fed a liquid butterfat-, fructose- and cholesterol-rich diet (BFC, 25E% from butterfat) or control diet (C, 12%E from soybean oil) for 13 weeks. In week 9, fat sources of some BFC- and C-fed mice were switched either to 25E% or 12E% olive oil (OFC and CO). Glucose and insulin tolerance tests were performed, and markers of liver damage and glucose metabolism were assessed. After 6 weeks of feeding, BFC-fed mice had developed marked signs of insulin resistance, which progressed to week 12 being not affected by the exchange of fat sources. Liver damage was similar between BFC- and OFC-fed mice. Markers of lipid metabolism and lipid peroxidation in liver and of insulin signaling in liver and muscle were also similarly altered in BFC- and OFC-fed mice. Taken together, our data suggest that exchanging butterfat with extra virgin olive oil has no effect on the progression of non-alcoholic fatty liver disease and glucose tolerance in mice.	[Rajcic, Dragana; Brandt, Annette; Sanchez, Victor; Engstler, Anna Janina; Jung, Finn; Nier, Anika; Baumann, Anja; Bergheim, Ina] Univ Vienna, Dept Nutr Sci, Mol Nutr Sci, Vienna, Austria; [Jin, Cheng Jun] Friedrich Schiller Univ Jena, Inst Nutr, SD Model Syst Mol Nutr, Jena, Germany	University of Vienna; Friedrich Schiller University of Jena	Bergheim, I (corresponding author), Univ Vienna, Dept Nutr Sci, Mol Nutr Sci, Vienna, Austria.	ina.bergheim@univie.ac.at		Rajcic, Dragana/0000-0002-6844-8878	UFOP e.V.; Friedrich-Schiller University of Jena, Germany; University of Vienna, Austria; University of Vienna	UFOP e.V.; Friedrich-Schiller University of Jena, Germany; University of Vienna, Austria; University of Vienna	This research was in part funded by UFOP e.V. (I.B.), and in part by internal funding from the Friedrich-Schiller University of Jena, Germany, and University of Vienna, Austria. Open access funding provided by University of Vienna. None of the funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abenavoli L, 2019, EXPERT REV GASTROENT, V13, P739, DOI 10.1080/17474124.2019.1634544; Amali AA, 2006, J BIOMED SCI, V13, P225, DOI 10.1007/s11373-005-9055-5; Rincon-Cervera MA, 2016, NUTRITION, V32, P1254, DOI 10.1016/j.nut.2016.04.006; [Anonymous], 2018, MED BALTIMORE, V97, pe9654; Assy N, 2009, WORLD J GASTROENTERO, V15, P1809, DOI 10.3748/wjg.15.1809; Barrera C, 2020, PROSTAG LEUKOTR ESS, V153, DOI 10.1016/j.plefa.2020.102058; Baulies A, 2015, SCI REP-UK, V5, DOI 10.1038/srep18017; Baumann A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12040951; Bessone F, 2019, CELL MOL LIFE SCI, V76, P99, DOI 10.1007/s00018-018-2947-0; Brandt A, 2019, REDOX BIOL, V21, DOI 10.1016/j.redox.2018.101092; Brandt A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9091013; Cariello M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041084; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chung GE, 2019, NUTRITION, V62, P32, DOI 10.1016/j.nut.2018.11.021; Ciregia F, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-019-02188-9; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; dos Santos GA, 2015, J MASS SPECTROM, V50, P951, DOI 10.1002/jms.3609; Esposito K, 2014, DIABETES CARE, V37, P1824, DOI 10.2337/dc13-2899; Foscolou A, 2018, MATURITAS, V118, P60, DOI 10.1016/j.maturitas.2018.10.013; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; Gimenez-Cassina A, 2014, CELL METAB, V19, P272, DOI 10.1016/j.cmet.2013.12.001; Gurung P, 2017, IMMUNITY, V46, P635, DOI 10.1016/j.immuni.2017.03.014; Harari A, 2020, NUTR METAB CARDIOVAS, V30, P709, DOI 10.1016/j.numecd.2019.12.007; Hernandez-Rodas MC, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700479; Jin CJ, 2017, J GASTROEN HEPATOL, V32, P708, DOI 10.1111/jgh.13488; Jin CJ, 2015, BRIT J NUTR, V114, P1745, DOI 10.1017/S0007114515003621; Jurado-Ruiz E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47904-z; Jurado-Ruiz E, 2017, MOL NUTR FOOD RES, V61, DOI [10.1002/mnfr.201600549, 10.1002/mnfr.201770034]; Khalatbari-Soltani S, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1251-7; Kirschning C, 1997, CYTOKINES CELL MOL T, V3, P59; Kissner TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015985; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Li CP, 2014, GENET MOL RES, V13, P3991, DOI 10.4238/2014.May.23.10; Li XS, 2019, FISH SHELLFISH IMMUN, V94, P157, DOI 10.1016/j.fsi.2019.08.062; Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004; Marin V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158817; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; McGill MR, 2016, EXCLI J, V15, P817, DOI 10.17179/excli2016-800; McManus K, 2001, INT J OBESITY, V25, P1503, DOI 10.1038/sj.ijo.0801796; Mirmiran P, 2017, IRAN J PUBLIC HEALTH, V46, P1007; Pais R, 2016, J HEPATOL, V65, P1245, DOI 10.1016/j.jhep.2016.07.033; Park S, 2011, J HEPATOL, V54, P984, DOI 10.1016/j.jhep.2010.08.019; Parker HM, 2012, J HEPATOL, V56, P944, DOI 10.1016/j.jhep.2011.08.018; Prendergast BJ, 2014, NEUROSCI BIOBEHAV R, V40, P1, DOI 10.1016/j.neubiorev.2014.01.001; Rezaei S, 2019, NUTRITION, V57, P154, DOI 10.1016/j.nut.2018.02.021; Riazi K, 2019, NUTRIENTS, V11, DOI 10.3390/nu11122878; Sales RC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010008; Mendes IKS, 2018, APPL PHYSIOL NUTR ME, V43, P23, DOI 10.1139/apnm-2017-0317; Sass DA, 2005, DIGEST DIS SCI, V50, P171, DOI 10.1007/s10620-005-1267-z; Sellmann C, 2017, J NUTR, V147, P2041, DOI 10.3945/jn.117.253815; Sellmann C, 2017, AMINO ACIDS, V49, P1215, DOI 10.1007/s00726-017-2423-4; Sellmann C, 2017, EUR J NUTR, V56, P2519, DOI 10.1007/s00394-016-1287-9; Sellmann C, 2015, J NUTR BIOCHEM, V26, P1183, DOI 10.1016/j.jnutbio.2015.05.011; Spruss A, 2012, MOL MED, V18, P1346, DOI 10.2119/molmed.2012.00223; Spruss A, 2012, LAB INVEST, V92, P1020, DOI 10.1038/labinvest.2012.75; Spruss A, 2009, HEPATOLOGY, V50, P1094, DOI 10.1002/hep.23122; Tomic D, 2018, EUR J GASTROEN HEPAT, V30, P1103, DOI 10.1097/MEG.0000000000001235; Ullah R, 2019, INT J BIOL SCI, V15, P265, DOI 10.7150/ijbs.30121; Valenzuela R, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020499; Vilar-Gomez E, 2015, GASTROENTEROLOGY, V149, P367, DOI 10.1053/j.gastro.2015.04.005; Wagnerberger S, 2012, BRIT J NUTR, V107, P1727, DOI 10.1017/S0007114511004983; Wang FF, 2013, P NATL ACAD SCI USA, V110, P18656, DOI 10.1073/pnas.1314863110; Widmer RJ, 2015, AM J MED, V128, P229, DOI 10.1016/j.amjmed.2014.10.014; Yamazaki T, 2011, J NUTR BIOCHEM, V22, P543, DOI 10.1016/j.jnutbio.2010.04.009; Younossi ZM, 2019, J HEPATOL, V71, P793, DOI 10.1016/j.jhep.2019.06.021; Younossi ZM, 2016, HEPATOLOGY, V64, P1577, DOI 10.1002/hep.28785; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zelber-Sagi S, 2018, J HEPATOL, V68, P1239, DOI 10.1016/j.jhep.2018.01.015; Zelber-Sagi S, 2017, LIVER INT, V37, P936, DOI 10.1111/liv.13435; Zhou D, 2017, WORLD J GASTROENTERO, V23, P60, DOI 10.3748/wjg.v23.i1.60	70	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0237946	10.1371/journal.pone.0237946	http://dx.doi.org/10.1371/journal.pone.0237946			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881925	Green Published, gold			2022-12-26	WOS:000571063300008
J	Sugawara, T; Sakamoto, K				Sugawara, Takaya; Sakamoto, Kazuichi			Quercetin enhances motility in aged and heat-stressed Caenorhabditis elegans nematodes by modulating both HSF-1 activity, and insulin-like and p38-MAPK signalling	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; FACTOR SKN-1; RESVERATROL; RESISTANCE; DAF-16; FLAVONOIDS; LONGEVITY; GENES	Quercetin is a yellow pigment that is found in many common dietary plants, and that protects against oxidative stress, inflammation, and arteriosclerosis. It has also been suggested to prolong the lifespan of, and enhance heat-stress tolerance in nematodes; thus, the present study investigated its effects on both the nematode life- and health span by assessing its capacity to promote nematode motility after aging and/or heat stress, as well as the mechanisms underlying these effects. The results of the conducted analyses showed that quercetin feeding prolonged lifespan, suppressed age-related motility retardation, improved motility recovery after heat stress, and decreased the production of both intercellular and mitochondrial reactive oxygen species in the analysedCaenorhabditis elegansstrains, likely by modulating the insulin-like signalling (ILS) pathway and p38-mitogen-activated protein kinase (MAPK) pathway. In particular, the transcription factors DAF-16 and SKN-1 were found to mediate the observed quercetin-induced effects, consistent with their previously demonstrated roles as regulators of aging. Furthermore, we demonstrated, for the first time, that quercetin induced heat-stress tolerance inC.elegansby modulating HSF-1 expression and/or activity. Thus, the present study provides valuable insights into the mechanisms by which quercetin inhibit aging and enhance heat-stress tolerance via ILS and MAPK pathway inC.elegans.	[Sugawara, Takaya; Sakamoto, Kazuichi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba	Sakamoto, K (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	sakamoto@biol.tsukuba.ac.jp		sakamoto, Kazuichi/0000-0002-3826-0444; Sugawara, Takaya/0000-0002-4773-463X	Suntory Global Innovation Center Limited; University of Tsukuba, Japan	Suntory Global Innovation Center Limited; University of Tsukuba, Japan	We clarify that this work was supported in part by Suntory Global Innovation Center Limited and Grants-in-Aid for Scientific Research and Education from the University of Tsukuba, Japan. We declare as follows; "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." There was no additional external funding received for this study.	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Bitterman JL, 2015, CELL MOL LIFE SCI, V72, P1473, DOI 10.1007/s00018-014-1808-8; Bruell V, 2015, BRIT J NUTR, V114, P1263, DOI 10.1017/S0007114515002950; Cheesman HK, 2016, G3-GENES GENOM GENET, V6, P541, DOI 10.1534/g3.115.025650; DORMAN JB, 1995, GENETICS, V141, P1399; Duenas M, 2013, PHARMACOL RES, V76, P41, DOI 10.1016/j.phrs.2013.07.001; Feng SL, 2015, INT J BIOL MACROMOL, V81, P188, DOI 10.1016/j.ijbiomac.2015.07.057; Furuhashi T, 2014, COMP BIOCHEM PHYS B, V170, P26, DOI 10.1016/j.cbpb.2014.01.004; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; Ishizawa K, 2011, J PHARMACOL SCI, V115, P466, DOI 10.1254/jphs.10R38FM; Kampkotter A, 2008, COMP BIOCHEM PHYS B, V149, P314, DOI 10.1016/j.cbpb.2007.10.004; Kampkotter A, 2007, TOXICOLOGY, V234, P113, DOI 10.1016/j.tox.2007.02.006; Khan F, 2016, NUTRIENTS, V8, DOI 10.3390/nu8090529; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Lopez MS, 2015, NEUROCHEM INT, V89, P75, DOI 10.1016/j.neuint.2015.08.009; Marunaka Y, 2018, CURR MED CHEM, V25, P4876, DOI 10.2174/0929867323666160919095043; Men K, 2014, ANTI-CANCER AGENT ME, V14, P826, DOI 10.2174/1871520614666140521122932; Morton EA, 2013, AGING CELL, V12, P112, DOI 10.1111/acel.12024; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; O'Fallon KS, 2012, INT J SPORT NUTR EXE, V22, P430, DOI 10.1123/ijsnem.22.6.430; Pallauf K, 2017, P NUTR SOC, V76, P145, DOI 10.1017/S0029665116000720; Papp D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002673; Pietsch Kerstin, 2012, Frontiers in Genetics, V3, P48, DOI 10.3389/fgene.2012.00048; Pietsch K, 2009, BIOGERONTOLOGY, V10, P565, DOI 10.1007/s10522-008-9199-6; Proshkina E, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00505; Riccioni G, 2015, INT J FOOD SCI NUTR, V66, P603, DOI 10.3109/09637486.2015.1077796; Saul N, 2008, MECH AGEING DEV, V129, P611, DOI 10.1016/j.mad.2008.07.001; Schakel C, 2015, 8TH ACM INTERNATIONAL CONFERENCE ON PERVASIVE TECHNOLOGIES RELATED TO ASSISTIVE ENVIRONMENTS (PETRA 2015), DOI 10.1145/2769493.2769499; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Seo HW, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/524878; Shanmugam G, 2018, BIOMED PHARMACOTHER, V102, P812, DOI 10.1016/j.biopha.2018.03.128; Sonani RR, 2014, AGE, V36, DOI 10.1007/s11357-014-9717-1; Sugawara T, 2018, BRIT J NUTR, V120, P872, DOI 10.1017/S0007114518001563; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Tullet JMA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004109; Verbeke P, 2001, CELL BIOL INT, V25, P845, DOI 10.1006/cbir.2001.0789; Wang XM, 2010, BIOCHEM BIOPH RES CO, V400, P613, DOI 10.1016/j.bbrc.2010.08.113; Wang Y, 2018, J CELL BIOL, V217, P1915, DOI 10.1083/jcb.201708007; Yilmaz MZ, 2014, J MOL HISTOL, V45, P195, DOI 10.1007/s10735-013-9542-3; Zhang LZ, 2009, FREE RADICAL BIO MED, V46, P414, DOI 10.1016/j.freeradbiomed.2008.10.041; Zhang YQ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031849, 10.1371/journal.pone.0030262]	42	10	10	5	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238528	10.1371/journal.pone.0238528	http://dx.doi.org/10.1371/journal.pone.0238528			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881908	gold, Green Published			2022-12-26	WOS:000571063300017
J	Tanaka, K; Watanabe, T; Ozawa, J; Ito, M; Nagano, N; Arai, Y; Miyake, F; Matsumura, S; Kobayashi, S; Itakura, R; Namba, F				Tanaka, Kosuke; Watanabe, Takaaki; Ozawa, Junichi; Ito, Masato; Nagano, Nobuhiko; Arai, Yukio; Miyake, Fuyu; Matsumura, Shun; Kobayashi, Shingo; Itakura, Ryuta; Namba, Fumihiko			Difference in pyruvic acid metabolism between neonatal and adult mouse lungs exposed to hyperoxia	PLOS ONE			English	Article							EXPRESSION; NEWBORN; INJURY; MICE	Objective Neonatal lungs are more tolerant to hyperoxic injury than are adult lungs. This study investigated differences in the response to hyperoxic exposure between neonatal and adult mouse lungs using metabolomics analysis with capillary electrophoresis time-of-flight mass spectrometry (CE- TOFMS). Methods Neonatal and adult mice were exposed to 21% or 95% O(2)for four days. Subsequently, lung tissue samples were collected and analyzed by CE-TOFMS. Pyruvate dehydrogenase (PDH) enzyme activity was determined using a microplate assay kit. PDH kinase (Pdk) 1,Pdk2,Pdk3, andPdk4mRNA expression levels were determined using quantitative reverse transcription-polymerase chain reaction. Pdk4 protein expression was quantified by Western blotting and Pdk4 protein localization was evaluated by immunohistochemistry. Results Levels of 3-phosphoglyceric acid, 2-phosphoglyceric acid, phosphoenolpyruvic acid, and lactic acid were significantly elevated in the lungs of hyperoxia-exposed versus normoxia-exposed adult mice, whereas no significant differences were observed with hyperoxia exposure in neonatal mice. PDH activity was reduced in the lungs of adult mice only.Pdk4mRNA expression levels after hyperoxic exposure were significantly elevated in adult mice compared with that in neonatal mice. Conversely, gene expression levels ofPdk1,Pdk2, andPdk3did not differ after hyperoxic exposure in either neonatal or adult mice. Pdk4 protein levels were also significantly increased in adult mouse lungs exposed to hyperoxia and were localized mainly to the epithelium of terminal bronchiole. Conclusions Specific metabolites associated with glycolysis and gluconeogenesis were altered after hyperoxia exposure in the lungs of adult mice, but not in neonates, which was likely a result of reduced PDH activity due toPdk4mRNA upregulation under hyperoxia.	[Tanaka, Kosuke; Watanabe, Takaaki; Ozawa, Junichi; Ito, Masato; Nagano, Nobuhiko; Arai, Yukio; Miyake, Fuyu; Matsumura, Shun; Kobayashi, Shingo; Itakura, Ryuta; Namba, Fumihiko] Saitama Med Univ, Saitama Med Ctr, Dept Pediat, Kawagoe, Saitama, Japan	Saitama Medical University	Namba, F (corresponding author), Saitama Med Univ, Saitama Med Ctr, Dept Pediat, Kawagoe, Saitama, Japan.	nambaf@saitama-med.ac.jp	Nagano, Nobuhiko/GNM-8267-2022; Ito, Masato/GPX-3685-2022; Ito, Masato/ABG-9551-2020	Tanaka, Kosuke/0000-0001-5436-6399; Ito, Masato/0000-0002-8084-4451	Saitama Medical University [17-C-1-2, 29-F-1-01]; Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics [29-7]; Japan Society for the Promotion of Science [18K15729]	Saitama Medical University(Saitama Medical University); Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the Saitama Medical University Internal Research Grant (Grant no. 17-C-1-2) (SK) and Saitama Medical University Young Doctors Educational Grant (Grant no. 29-F-1-01) (RI) from Saitama Medical University, a grant from Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics (Grant no. 29-7) (FN), and Grants-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science (Grant no. 18K15729) (SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Velazquez JA, 2015, TECNOL CIENC AGUA, V6, P17; Allen CB, 1998, AM J PHYSIOL-LUNG C, V274, pL320, DOI 10.1152/ajplung.1998.274.3.L320; BALIN AK, 1976, J CELL PHYSIOL, V89, P235, DOI 10.1002/jcp.1040890207; BASSETT DJP, 1986, J APPL PHYSIOL, V60, P1605, DOI 10.1152/jappl.1986.60.5.1605; BASSETT DJP, 1992, AM J PHYSIOL, V262, pL495, DOI 10.1152/ajplung.1992.262.4.L495; BASSETT DJP, 1989, J APPL PHYSIOL, V66, P989, DOI 10.1152/jappl.1989.66.2.989; Buczynski BW, 2013, SEMIN PERINATOL, V37, P69, DOI 10.1053/j.semperi.2013.01.002; D'Angio CT, 1998, EXP LUNG RES, V24, P685, DOI 10.3109/01902149809099588; Das KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073358; FRANK L, 1978, J APPL PHYSIOL, V45, P699, DOI 10.1152/jappl.1978.45.5.699; Gerik SM, 2003, AM J RESP CELL MOL, V29, P506, DOI 10.1165/rcmb.2002-0123OC; Ito M, 2017, PEDIATR RES, V81, P926, DOI 10.1038/pr.2017.17; Junker BH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-219; Kallet RH, 2013, RESP CARE, V58, P123, DOI 10.4187/respcare.01963; KEENEY SE, 1992, PEDIATR RES, V31, P441, DOI 10.1203/00006450-199205000-00005; KIMURA RE, 1983, J APPL PHYSIOL, V55, P1501, DOI 10.1152/jappl.1983.55.5.1501; Lee SJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/327167; Li Q, 2016, AM J RESP CELL MOL, V55, P419, DOI 10.1165/rcmb.2015-0228OC; Lingappan K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101581; Namba F, 2016, EXP LUNG RES, V42, P57, DOI 10.3109/01902148.2016.1141264; Namba F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090936; O'Reilly MA, 2012, AM J PATHOL, V181, P441, DOI 10.1016/j.ajpath.2012.05.005; SCHOONEN WGEJ, 1990, J BIOL CHEM, V265, P11118; SIMON LM, 1979, J APPL PHYSIOL, V47, P98, DOI 10.1152/jappl.1979.47.1.98; Uetaki M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13896; Vallotton MB, 1989, AM J PHYSIOL, V257, pE617; Wakayama Masataka, 2015, Methods Mol Biol, V1277, P113, DOI 10.1007/978-1-4939-2377-9_9; Yuan K, 2016, AM J PATHOL, V186, P2500, DOI 10.1016/j.ajpath.2016.05.016; Zhang Y, 2019, ANTIOXID REDOX SIGN, V30, P1775, DOI 10.1089/ars.2018.7514	29	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238604	10.1371/journal.pone.0238604	http://dx.doi.org/10.1371/journal.pone.0238604			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881962	gold, Green Published			2022-12-26	WOS:000571063300070
J	Vetrano, M; Wegman, A; Koes, B; Mehta, S; King, CA				Vetrano, Matthew; Wegman, Adam; Koes, Bryan; Mehta, Saurabh; King, Christine A.			Serum IL-1RA levels increase from follicular to luteal phase of the ovarian cycle: A pilot study on human female immune responses	PLOS ONE			English	Article							MENSTRUAL-CYCLE; CYTOKINE PRODUCTION; SEX-DIFFERENCES; NITRIC-OXIDE; ESTROGEN; GENDER; FAMILY; INFLAMMATION; EXPRESSION; CELLS	The immune responses exhibited by females are distinct from those of males. Females are known to generate, among others, higher levels of antibodies, greater interferon responses, and increased levels of inflammatory mediators in response to pathogens. Mounting evidence suggests that gonadal hormones play a key role in these differences. To better understand the effect of cycling hormones on the immune response, we sought to investigate the relationship between gonadal hormone fluctuations during the ovarian cycle and the levels of interleukin 1 beta and IL-1RA, both in circulation and in PBMCs in response to TLR4 stimulation, in healthy premenopausal females. To do this we measured the gonadal hormones 17 beta-estradiol, progesterone, and luteinizing hormone, and the cytokines IL-1 beta and IL-1RA in nine cycling females at several time points throughout one complete cycle. We evaluated 35 follicular, 17 ovulatory, and 44 luteal time points in our cohort and found a clear increase in serum levels of anti-inflammatory IL-1RA in the luteal phase, as compared to the follicular phase, and a positive correlation between both 17 beta-estradiol and progesterone and IL-RA. There was no difference in the serum levels of IL-1 beta and no difference in IL-1 beta or IL-1RA produced in response to LPS by PBMCs isolated from different phases. Division of the cycle into sub-phases revealed an increase in the level of IL-1RA by ovulation that persisted through the luteal phase. These data suggest that significant changes in the immune response occur throughout the ovarian cycle in healthy females.	[Vetrano, Matthew; Wegman, Adam; Koes, Bryan; King, Christine A.] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA; [Mehta, Saurabh] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Cornell University	King, CA (corresponding author), SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA.	kingch@upstate.edu	Mehta, Saurabh/L-8490-2017	Mehta, Saurabh/0000-0003-3788-0665; Wegman, Adam/0000-0003-3596-4371; King, Christine A./0000-0002-3518-8627				Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Angele MK, 2000, SHOCK, V14, P81, DOI 10.1097/00024382-200014020-00001; [Anonymous], 2015, INFORM PHILOS, V2, P8; Barbieri RL, 2014, METHODS MOL BIOL, V1154, P145, DOI 10.1007/978-1-4939-0659-8_7; Bereshchenko O, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01332; Bouman A, 2001, FERTIL STERIL, V76, P555, DOI 10.1016/S0015-0282(01)01971-9; Chaudhry A, INT SEMIN SURG ONCOL, V32006, P37; Chuang KH, 2009, J EXP MED, V206, P1181, DOI 10.1084/jem.20082521; Dai RJ, 2008, BLOOD, V112, P4591, DOI 10.1182/blood-2008-04-152488; Dinarello CA, 2011, J INTERN MED, V269, P16, DOI 10.1111/j.1365-2796.2010.02313.x; Dinarello C, 2010, NAT IMMUNOL, V11, P973, DOI 10.1038/ni1110-973; Dinarello CA, 2018, IMMUNOL REV, V281, P8, DOI 10.1111/imr.12621; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Engler RJM, 2008, ARCH INTERN MED, V168, P2405, DOI 10.1001/archinternmed.2008.513; Faas M, 2000, FERTIL STERIL, V74, P1008, DOI 10.1016/S0015-0282(00)01553-3; Fairweather D, 2008, AM J PATHOL, V173, P600, DOI 10.2353/ajpath.2008.071008; FUKUDA M, 1995, INT J GYNECOL OBSTET, V49, P305, DOI 10.1016/0020-7292(95)02366-K; Furman D, 2014, P NATL ACAD SCI USA, V111, P869, DOI 10.1073/pnas.1321060111; Giefing-Kroll C, 2015, AGING CELL, V14, P309, DOI 10.1111/acel.12326; Hepworth MR, 2010, EUR J IMMUNOL, V40, P406, DOI 10.1002/eji.200939589; Ibanez L, 2005, HUM REPROD, V20, P2457, DOI 10.1093/humrep/dei072; Karpuzoglu E, 2006, ENDOCRINOLOGY, V147, P662, DOI 10.1210/en.2005-0829; Karpuzoglu E, 2007, MOL IMMUNOL, V44, P1808, DOI 10.1016/j.molimm.2006.08.005; King CA, 1998, CYTOKINE EXPRESSION; Klonoff-Cohen H, 2016, CRIT REV ONCOL HEMAT, V102, P1, DOI 10.1016/j.critrevonc.2016.02.004; Kovats S, 2015, CELL IMMUNOL, V294, P63, DOI 10.1016/j.cellimm.2015.01.018; Krelin Y, 2007, CANCER RES, V67, P1062, DOI 10.1158/0008-5472.CAN-06-2956; Kucuk AI, 2012, J BREAST CANCER, V15, P434, DOI 10.4048/jbc.2012.15.4.434; Lengi AJ, 2007, J LEUKOCYTE BIOL, V81, P1065, DOI 10.1189/jlb.0606391; Libert C, 2010, NAT REV IMMUNOL, V10, P594, DOI 10.1038/nri2815; Marzi M, 1996, CLIN EXP IMMUNOL, V106, P127, DOI 10.1046/j.1365-2249.1996.d01-809.x; Medina-Estrada I, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/6098961; Moorlag SJCFM, 2018, IMMUNOL REV, V281, P28, DOI 10.1111/imr.12617; MORTOLA JF, 1990, OBSTET GYNECOL, V76, P302; Northoff H, 2008, EXERC IMMUNOL REV, V14, P86; O'Brien SM, 2007, NEUROIMMUNOMODULAT, V14, P84, DOI 10.1159/000107423; Olivier J, 2008, ANN ALLERG ASTHMA IM, V100, P333, DOI 10.1016/S1081-1206(10)60595-9; Olsen NJ, 2001, IMMUNOL RES, V23, P281, DOI 10.1385/IR:23:2-3:281; Reed BG, 2018, ENDOTEXT; Rettew JA, 2008, BIOL REPROD, V78, P432, DOI 10.1095/biolreprod.107.063545; Rupp MRG, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00794; SABAHI F, 1995, AM J REPROD IMMUNOL, V33, P381, DOI 10.1111/j.1600-0897.1995.tb00907.x; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Taneja V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01931; Thiyagarajan D.K., 2019, PHYSL MENSTRUAL CYCL; VALENTINO R, 1993, J ENDOCRINOL INVEST, V16, P619, DOI 10.1007/BF03347683; Verthelyi D, 2000, IMMUNOLOGY, V100, P384, DOI 10.1046/j.1365-2567.2000.00047.x; VISELLI SM, 1995, IMMUNOLOGY, V84, P337; WEINSTEIN Y, 1984, J IMMUNOL, V132, P656; Whitcomb BW, 2014, FERTIL STERIL, V101, P1383, DOI 10.1016/j.fertnstert.2014.01.027; Willis C, 2003, HUM REPROD, V18, P1173, DOI 10.1093/humrep/deg231; Yu HP, 2007, J LEUKOCYTE BIOL, V82, P774, DOI 10.1189/jlb.0307182	53	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238520	10.1371/journal.pone.0238520	http://dx.doi.org/10.1371/journal.pone.0238520			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881904	gold, Green Published			2022-12-26	WOS:000571063300028
J	Nwosu, CO; Ataguba, JEO				Nwosu, Chijioke O.; Ataguba, John Ele-Ojo			Explaining changes in wealth inequalities in child health: The case of stunting and wasting in Nigeria	PLOS ONE			English	Article							SOCIOECONOMIC INEQUALITIES; MALNUTRITION; PREVALENCE; COVERAGE; RELIGION; INDEXES	Background Malnutrition is a major cause of child death, and many children suffer from acute and chronic malnutrition. Nigeria has the second-highest burden of stunting globally and a higher-than-average child wasting prevalence. Moreover, there is substantial spatial variation in the prevalence of stunting and wasting in Nigeria. This paper assessed the socioeconomic inequalities and determinants of the change in socioeconomic inequalities in child stunting and wasting in Nigeria between 2013 and 2018. Methods Data came from the 2013 and 2018 Nigeria Demographic and Health Survey. Socioeconomic inequalities in stunting and wasting were measured using the concentration curve and Erreygers' corrected concentration index. A pro-poor concentration index is negative, meaning that the poor bear a disproportionately higher burden of stunting or wasting than the wealthy. A positive or pro-rich index is the opposite. Standard methodologies were applied to decompose the concentration index (C) while the Oaxaca-Blinder approach was used to decompose changes in the concentration indices (Delta C). Findings The socioeconomic inequalities in child stunting and wasting were pro-poor in 2013 and 2018. The concentration indices for stunting reduced from -0.298 (2013) to -0.330 (2018) (Delta C = -0.032). However, the concentration indices for wasting increased from -0.066 to -0.048 (Delta C = 0.018). The changes in the socioeconomic inequalities in stunting and wasting varied by geopolitical zones. Significant determinants of these changes for both stunting and wasting were changes in inequalities in wealth, maternal education and religion. Under-five dependency, access to improved toilet facilities and geopolitical zone significantly explained changes in only stunting inequality, while access to improved water facilities only significantly determined the change in inequality in wasting. Conclusion Addressing the socio-economic, spatial and demographic determinants of the changes in the socioeconomic inequalities in child stunting and wasting, especially wealth, maternal education and access to sanitation is critical for improving child stunting and wasting in Nigeria.	[Nwosu, Chijioke O.] Human Sci Res Council, Impact Ctr, Cape Town, Western Cape, South Africa; [Ataguba, John Ele-Ojo] Univ Cape Town, Sch Publ Hlth & Family Med, Hlth Econ Unit, Cape Town, Western Cape, South Africa	Human Sciences Research Council-South Africa; University of Cape Town	Ataguba, JEO (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Hlth Econ Unit, Cape Town, Western Cape, South Africa.	John.Ataguba@uct.ac.za		Ataguba, John Ele-Ojo/0000-0002-7746-3826; Nwosu, Chijioke/0000-0001-9739-5448	South African National Research Foundation (NRF)	South African National Research Foundation (NRF)(National Research Foundation - South Africa)	The corresponding author acknowledges the financial assistance provided by the South African National Research Foundation (NRF). Opinions expressed, and the conclusions are those of the authors and are not attributed to the NRF.	Abuya BA, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-80; Adebowale AS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-430; Adeyanju O, 2017, HEALTH POLICY PLANN, V32, P1111, DOI 10.1093/heapol/czx049; Akombi BJ, 2017, SYSTEMATIC REV INT J, V14, P8, DOI [10.3390/ijerph14080863, DOI 10.3390/IJERPH14080863]; Akombi BJ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9010044; Ataguba JE, 2016, HEALTH POLICY PLANN, V31, P1212, DOI 10.1093/heapol/czw053; Ataguba JE, 2016, APPL ECON, V48, P3293, DOI 10.1080/00036846.2015.1137549; Baig-Ansari N, 2006, FOOD NUTR BULL, V27, P114, DOI 10.1177/156482650602700203; Bloss E, 2004, J TROP PEDIATRICS, V50, P260, DOI 10.1093/tropej/50.5.260; Brainerd E, 2015, POPUL DEV REV, V41, P439, DOI 10.1111/j.1728-4457.2015.00067.x; Commission on Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Deolalikar AB, 2005, J DEV SOC, V21, P55, DOI 10.1177/0169796X05053067; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Erreygers G, 2009, J HEALTH ECON, V28, P521, DOI 10.1016/j.jhealeco.2008.12.001; Erreygers G, 2009, J HEALTH ECON, V28, P504, DOI 10.1016/j.jhealeco.2008.02.003; Glazier JD, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2048-y; Gyimah SO, 2007, J BIOSOC SCI, V39, P923, DOI 10.1017/S0021932007001927; Hoffman DJ, 2005, J NUTR, V135, P452, DOI 10.1093/jn/135.3.452; Hug L., 2020, LEVELS TRENDS CHILD; ISLAM MA, 1994, EUR J CLIN NUTR, V48, P416; JENKINS S, 1988, NATL TAX J, V41, P139; Kakwani N, 1997, J ECONOMETRICS, V77, P87, DOI 10.1016/S0304-4076(96)01807-6; Kakwani NC, 1980, INCOME INEQUALITY PO; Larrea C, 2005, SOC SCI MED, V60, P165, DOI 10.1016/j.socscimed.2004.04.024; LERMAN RI, 1989, J ECONOMETRICS, V42, P43, DOI 10.1016/0304-4076(89)90074-2; Martorell R, 2012, ADV NUTR, V3, P227, DOI 10.3945/an.111.001107; National Bureau of Statistic, 2018, NAT NUTR HLTH SURV N; National Population Commission (NPC) [Nigeria] ICF International., 2019, NIG DEM HLTH SURV 20; National Population Commission of Nigeria, 2014, NIG DEM HLTH SURV 20; National Primary Health Care Development Agency, 2020, NIG DECL STAT EM MAT; Nwosu CO, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7840-8; O'Donnell O., 2008, Analyzing health equity using household survey data: a guide to techniques and their implementation; O'Donnell O, 2016, STATA J, V16, P112, DOI 10.1177/1536867X1601600112; Pillai V.K., 2019, J SOC SOC WELF, V46, P111; Rahman A, 2007, J BIOSOC SCI, V39, P161, DOI 10.1017/S0021932006001295; Shively G, 2015, J DEV STUD, V51, P1078, DOI 10.1080/00220388.2015.1018900; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Sommerfelt A.E., 1993, DEMOGRAPHIC HLTH SUR; StataCorp, 2011, STAT STAT SOFTW REL, P173; Ukwuani FA, 2003, SOC SCI MED, V56, P2109, DOI 10.1016/S0277-9536(02)00205-8; UNICEF, 2019, STATE WORLDS CHILDRE; UNICEF, MAT CHILD HLTH; United Nations Children's Fund (UNICEF), 2013, IMPR CHILD NUTR ACH; Uthman OA, 2009, MATERN CHILD NUTR, V5, P358, DOI 10.1111/j.1740-8709.2009.00183.x; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; Wagstaff A, 2005, HEALTH ECON, V14, P429, DOI 10.1002/hec.953; Wagstaff A, 2003, J ECONOMETRICS, V112, P207, DOI 10.1016/S0304-4076(02)00161-6; Wagstaff A, 2009, J HEALTH ECON, V28, P516, DOI 10.1016/j.jhealeco.2008.12.003; Wamani H., 2007, BMC Pediatrics, V7; WHO, 2017, PROGR DRINK WAT SAN; WHO, 2020, GLOB HLTH OBS HO DAT; WHO, 2019, CHILDR RED MORT; Wolde M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-014-1337-2; World Health Organization, 2010, NUTR LANDSC INF SYST, DOI 10.1159/000362780.Interpretation	56	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0238191	10.1371/journal.pone.0238191	http://dx.doi.org/10.1371/journal.pone.0238191			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NS5RK	32925960	Green Published, gold			2022-12-26	WOS:000572318000004
J	Reyes-Aldasoro, CC; Ngan, KH; Ananda, A; Garcez, AD; Appelboam, A; Knapp, KM				Reyes-Aldasoro, Constantino Carlos; Ngan, Kwun Ho; Ananda, Ananda; Garcez, Artur d'Avila; Appelboam, Andrew; Knapp, Karen M.			Geometric semi-automatic analysis of radiographs of Colles' fractures	PLOS ONE			English	Article							DISTAL RADIUS FRACTURES; EXTERNAL FIXATION; CORTICAL THICKNESS; INTERNAL-FIXATION; OPEN REDUCTION; PREDICTION; INSTABILITY; DISPLACEMENT; COMPLICATIONS; OSTEOPOROSIS	Fractures of the wrist are common in Emergency Departments, where some patients are treated with a procedure called Manipulation under Anaesthesia. In some cases, this procedure is unsuccessful and patients need to revisit the hospital where they undergo surgery to treat the fracture. This work describes a geometric semi-automatic image analysis algorithm to analyse and compare the x-rays of healthy controls and patients with dorsally displaced wrist fractures (Colles' fractures) who were treated with Manipulation under Anaesthesia. A series of 161 posterior-anterior radiographs from healthy controls and patients with Colles' fractures were acquired and analysed. The patients' group was further subdivided according to the outcome of the procedure (successful/unsuccessful) and pre- or post-intervention creating five groups in total (healthy, pre-successful, pre-unsuccessful, post-successful, post-unsuccessful). The semi-automatic analysis consisted of manual location of three landmarks (finger, lunate and radial styloid) and automatic processing to generate 32 geometric and texture measurements, which may be related to conditions such as osteoporosis and swelling of the wrist. Statistical differences were found between patients and controls, as well as between pre- and post-intervention, but not between the procedures. The most distinct measurements were those of texture. Although the study includes a relatively low number of cases and measurements, the statistical differences are encouraging.	[Reyes-Aldasoro, Constantino Carlos; Ngan, Kwun Ho; Ananda, Ananda; Garcez, Artur d'Avila] City Univ London, Sch Math Comp Sci & Engn, London, England; [Appelboam, Andrew] Royal Devon & Exeter Hosp, Exeter, Devon, England; [Knapp, Karen M.] Univ Exeter, Coll Med & Hlth, Exeter, Devon, England	City University London; University of Exeter; University of Exeter	Reyes-Aldasoro, CC (corresponding author), City Univ London, Sch Math Comp Sci & Engn, London, England.	reyes@city.ac.uk	Ananda, Ananda/ABA-1792-2021	Ananda, Ananda/0000-0001-9537-167X; Reyes-Aldasoro, Constantino/0000-0002-9466-2018	School of Mathematics, Computer Science and Engineering, City, University of London; Data Science Institute, City, University of London	School of Mathematics, Computer Science and Engineering, City, University of London; Data Science Institute, City, University of London	Ananda Ananda PhD studies are partially funded by the School of Mathematics, Computer Science and Engineering, City, University of London. KHN is partially funded by the Data Science Institute, City, University of London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBASZADEGAN H, 1989, ACTA ORTHOP SCAND, V60, P646, DOI 10.3109/17453678909149595; ADOLPHSON P, 1993, INT ORTHOP, V17, P13; ALTISSIMI M, 1994, INT ORTHOP, V18, P61, DOI 10.1007/BF02484412; [Anonymous], 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003209; ARO HT, 1991, J HAND SURG-AM, V16A, P392, DOI 10.1016/0363-5023(91)90003-T; Arora R, 2007, J ORTHOP TRAUMA, V21, P316, DOI 10.1097/BOT.0b013e318059b993; Arora R, 2009, J ORTHOP TRAUMA, V23, P237, DOI 10.1097/BOT.0b013e31819b24e9; BACORN RW, 1953, J BONE JOINT SURG AM, V35-A, P643, DOI 10.2106/00004623-195335030-00011; Barai A, 2018, EMERG MED AUSTRALAS, V30, P530, DOI 10.1111/1742-6723.12946; Bartl C, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-84; BIDGOOD WD, 1992, RADIOGRAPHICS, V12, P345, DOI 10.1148/radiographics.12.2.1561424; BLOOM RA, 1970, BRIT J RADIOL, V43, P522, DOI 10.1259/0007-1285-43-512-522; Cai L, 2015, ORTHOP TRAUMATOL-SUR, V101, P827, DOI 10.1016/j.otsr.2015.04.011; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Colles A, 1970, Injury, V2, P48, DOI 10.1016/S0020-1383(70)80114-0; Colles A, 1814, NEW ENGLAND J MED SU, V3, P368, DOI 10.1056/NEJM181410010030410; COONEY WP, 1980, J BONE JOINT SURG AM, V62, P613, DOI 10.2106/00004623-198062040-00016; Crespo R, 1998, CALCIFIED TISSUE INT, V62, P470, DOI 10.1007/s002239900463; DUDA RO, 1972, COMMUN ACM, V15, P11, DOI 10.1145/361237.361242; Ebsim R, 2019, LECT NOTES COMPUT SC, V11404, P114, DOI 10.1007/978-3-030-11166-3_10; Ebsim R, 2017, LECT NOTES COMPUT SC, V10550, P91, DOI 10.1007/978-3-319-67543-5_8; Erhart S, 2018, ARCH ORTHOP TRAUM SU, V138, P879, DOI 10.1007/s00402-018-2925-x; Grewal R, 2011, J HAND SURG-AM, V36A, P1899, DOI 10.1016/j.jhsa.2011.09.015; Handoll HHG, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006522.pub2; Handoll HHG, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000434.pub4, 10.1002/14651858.CD003209.pub2]; HOVE LM, 1994, J HAND SURG-BRIT EUR, V19B, P731, DOI 10.1016/0266-7681(94)90247-X; Ilahi O A, 2001, Am J Knee Surg, V14, P238; Jantzen C, 2016, INJURY, V47, P930, DOI 10.1016/j.injury.2015.11.029; Kapoor H, 2000, INJURY, V31, P75, DOI 10.1016/S0020-1383(99)00207-7; Kelly AJ, 1997, INJURY, V28, P283, DOI 10.1016/S0020-1383(96)00204-5; Knapp KM, 2018, PAVILION PUBLISHING, V48, P10; Lee JI, 2018, J HAND SURG-AM, V43, P731, DOI 10.1016/j.jhsa.2018.05.028; Lee SK, 2018, ORTHOP TRAUMATOL-SUR, V104, P883, DOI 10.1016/j.otsr.2018.04.009; Mackenney PJ, 2006, J BONE JOINT SURG AM, V88A, P1944, DOI 10.2106/JBJS.D.02520; MacMillan J, 2018, UK RAD RAD ONC C LIV; Meena Sanjay, 2014, J Family Med Prim Care, V3, P325, DOI 10.4103/2249-4863.148101; Nesbitt KS, 2004, J HAND SURG-AM, V29A, P1128, DOI 10.1016/j.jhsa.2004.06.008; Ngan KH, 2020, BIORXIV; Ngan KH, 2019, MAKING DENSENET INTE; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Rabar S, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e3698; Raby N, 2014, ACCIDENT EMERGENCY R; Rhee SH, 2013, ORTHOP TRAUMATOL-SUR, V99, P713, DOI 10.1016/j.otsr.2013.05.002; Ryan PJ, 2001, BRIT J RADIOL, V74, P1137, DOI 10.1259/bjr.74.888.741137; Sharareh Behnam, 2020, J Hand Surg Glob Online, V2, P94, DOI 10.1016/j.jhsg.2019.10.001; SOLGAARD S, 1986, ACTA ORTHOP SCAND, V57, P229, DOI 10.3109/17453678608994383; Suangyanon Purinon, 2019, J Clin Orthop Trauma, V10, P792, DOI 10.1016/j.jcot.2018.07.019; VILLAR RN, 1987, J BONE JOINT SURG BR, V69, P635, DOI 10.1302/0301-620X.69B4.3611172; Wang J, 2018, ACTA ORTHOP TRAUMATO, V52, P334, DOI 10.1016/j.aott.2018.06.001; Watson NJ, 2016, BMC MED IMAGING, V16, DOI 10.1186/s12880-016-0147-7; Webber T, 2015, J HAND SURG-AM, V40, P493, DOI 10.1016/j.jhsa.2014.12.015; Zenke Yukichi, 2019, Journal of UOEH, V41, P139, DOI 10.7888/juoeh.41.139	52	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0238926	10.1371/journal.pone.0238926	http://dx.doi.org/10.1371/journal.pone.0238926			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925940	gold, Green Published, Green Accepted			2022-12-26	WOS:000572318000021
J	Kohler, M; Stratmann, P; Rohrbein, F; Knoll, A; Albu-Schaffer, A; Jorntell, H				Kohler, Matthias; Stratmann, Philipp; Roehrbein, Florian; Knoll, Alois; Albu-Schaeffer, Alin; Joerntell, Henrik			Biological data questions the support of the self inhibition required for pattern generation in the half center model	PLOS ONE			English	Article							PERSISTENT SODIUM CURRENT; DORSAL RAPHE NEURONS; SPINAL-CORD; FICTIVE LOCOMOTION; V2A INTERNEURONS; SYNAPTIC-TRANSMISSION; PACEMAKER POTENTIALS; MUSCLE-ACTIVITY; SYNAPSES; ORGANIZATION	Locomotion control in mammals has been hypothesized to be governed by a central pattern generator (CPG) located in the circuitry of the spinal cord. The most common model of the CPG is the half center model, where two pools of neurons generate alternating, oscillatory activity. In this model, the pools reciprocally inhibit each other ensuring alternating activity. There is experimental support for reciprocal inhibition. However another crucial part of the half center model is a self inhibitory mechanism which prevents the neurons of each individual pool from infinite firing. Self-inhibition is hence necessary to obtain alternating activity. But critical parts of the experimental bases for the proposed mechanisms for self-inhibition were obtainedin vitro, in preparations of juvenile animals. The commonly used adaptation of spike firing does not appear to be present in adult animalsin vivo. We therefore modeled several possible self inhibitory mechanisms for locomotor control. Based on currently published data, previously proposed hypotheses of the self inhibitory mechanism, necessary to support the CPG hypothesis, seems to be put into question by functional evaluation tests or byin vivodata. This opens for alternative explanations of how locomotion activity patterns in the adult mammal could be generated.	[Kohler, Matthias; Stratmann, Philipp; Roehrbein, Florian; Knoll, Alois; Albu-Schaeffer, Alin] Tech Univ Munich, Dept Informat, Garching, Germany; [Stratmann, Philipp; Albu-Schaeffer, Alin] German Aerosp Ctr, Inst Robot & Mechatron, Wessling, Germany; [Joerntell, Henrik] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Technical University of Munich; Helmholtz Association; German Aerospace Centre (DLR); Lund University	Kohler, M (corresponding author), Tech Univ Munich, Dept Informat, Garching, Germany.	kohler@in.tum.de	Knoll, Alois/AAN-8417-2021	Knoll, Alois/0000-0003-4840-076X; Stratmann, Philipp/0000-0001-6791-9159; Kohler, Matthias/0000-0003-0005-3711	German Aerospace Center [D/572/67 24 68 70, D/572/67 27 00 80]; European Union [720270, 785907]	German Aerospace Center(Helmholtz AssociationGerman Aerospace Centre (DLR)); European Union(European Commission)	This research received funding from the German Aerospace Center under the research and development contracts D/572/67 24 68 70, D/572/67 27 00 80 and from the European Union's Horizon 2020 Framework Programme for Research and Innovation under the Specific Grant Agreement No. 720270 (Human Brain Project SGA1) and the Specific Grant Agreement No. 785907 (Human Brain Project SGA2).	AGHAJANIAN GK, 1982, BRAIN RES, V238, P463, DOI 10.1016/0006-8993(82)90124-X; AMEMIYA M, 1984, NEUROSCI LETT, V50, P91, DOI 10.1016/0304-3940(84)90468-3; Ausborn J, 2018, J NEUROPHYSIOL, V119, P96, DOI 10.1152/jn.00550.2017; BARBEAU H, 1987, BRAIN RES, V412, P84, DOI 10.1016/0006-8993(87)91442-9; Bardoni R, 1998, J NEUROSCI, V18, P6558; Barriere G, 2008, J PHYSIOL-LONDON, V586, P1903, DOI 10.1113/jphysiol.2008.150706; Bellardita C, 2015, CURR BIOL, V25, P1426, DOI 10.1016/j.cub.2015.04.005; Ben-Ari Y, 2012, NEUROSCIENTIST, V18, P467, DOI 10.1177/1073858412438697; Bengtsson F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056630; Bengtsson F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018822; Brown TG, 1911, P R SOC LOND B-CONTA, V84, P308, DOI 10.1098/rspb.1911.0077; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; BURLHIS TM, 1987, SYNAPSE, V1, P582, DOI 10.1002/syn.890010611; CASTELLUCCI VF, 1974, P NATL ACAD SCI USA, V71, P5004, DOI 10.1073/pnas.71.12.5004; Collins SH, 2001, INT J ROBOT RES, V20, P607, DOI 10.1177/02783640122067561; Crone SA, 2008, NEURON, V60, P70, DOI 10.1016/j.neuron.2008.08.009; Crone SA, 2009, J NEUROSCI, V29, P7098, DOI 10.1523/JNEUROSCI.1206-09.2009; DALE N, 1985, J PHYSIOL-LONDON, V363, P61, DOI 10.1113/jphysiol.1985.sp015695; Danner SM, 2016, J PHYSIOL-LONDON, V594, P6947, DOI 10.1113/JP272787; Dougherty KJ, 2010, J NEUROSCI, V30, P24, DOI 10.1523/JNEUROSCI.4821-09.2010; Einarsson H, 2017, FRONT COMPUT NEUROSC, V11, DOI 10.3389/fncom.2017.00033; Fedirchuk B, 2013, J NEUROPHYSIOL, V109, P375, DOI 10.1152/jn.00649.2012; Fitzpatrick SC, 2016, CLIN NEUROPHYSIOL, V127, P724, DOI 10.1016/j.clinph.2015.03.013; Fuhrmann G, 2002, J NEUROPHYSIOL, V87, P140, DOI 10.1152/jn.00258.2001; Geborek P, 2013, EUR J NEUROSCI, V37, P380, DOI 10.1111/ejn.12060; Gewaltig M.-O., 2007, SCHOLARPEDIA, V2, P1430, DOI DOI 10.4249/SCH0LARPEDIA.1430; Geyer H, 2010, IEEE T NEUR SYS REH, V18, P263, DOI 10.1109/TNSRE.2010.2047592; Gottschall JS, 2007, EXP BRAIN RES, V182, P131, DOI 10.1007/s00221-007-1084-z; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; GRILLNER S, 1985, ANNU REV NEUROSCI, V8, P233, DOI 10.1146/annurev.ne.08.030185.001313; Guertin PA, 2009, BRAIN RES REV, V62, P45, DOI 10.1016/j.brainresrev.2009.08.002; Harris KD, 2017, J NEUROPHYSIOL, V118, P2070, DOI 10.1152/jn.00174.2017; Harvey PJ, 2006, J NEUROPHYSIOL, V96, P1158, DOI 10.1152/jn.01088.2005; Henkel AW, 2010, J NEUROCHEM, V114, P697, DOI 10.1111/j.1471-4159.2010.06795.x; HULTBORN H, 1971, J PHYSIOL-LONDON, V215, P613, DOI 10.1113/jphysiol.1971.sp009488; Ijspeert AJ, 2008, NEURAL NETWORKS, V21, P642, DOI 10.1016/j.neunet.2008.03.014; JANKOWSKA E, 1972, J PHYSIOL-LONDON, V222, P623, DOI 10.1113/jphysiol.1972.sp009818; JANKOWSKA E, 1967, ACTA PHYSIOL SCAND, V70, P369, DOI 10.1111/j.1748-1716.1967.tb03636.x; Jeong HJ, 2012, BRIT J PHARMACOL, V165, P1956, DOI 10.1111/j.1476-5381.2011.01685.x; Jia Y, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00004; Jones E., 2001, SCIPY OPEN SOURCE SC; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; Jorntell H, 2017, J PHYSIOL-LONDON, V595, P11, DOI 10.1113/JP272769; Jorntell H, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00003; Kirmse K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8750; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; KONNERTH A, 1990, PFLUG ARCH EUR J PHY, V417, P285, DOI 10.1007/BF00370994; Lemieux M, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00042; Liu J, 2005, J NEUROPHYSIOL, V94, P1392, DOI 10.1152/jn.00136.2005; Loeb GE, 1999, J NEUROPHYSIOL, V82, P3392, DOI 10.1152/jn.1999.82.6.3392; LOVELY RG, 1986, EXP NEUROL, V92, P421, DOI 10.1016/0014-4886(86)90094-4; Maass W, 2002, NEURAL NETWORKS, V15, P155, DOI 10.1016/S0893-6080(01)00144-7; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; MCGEER T, 1990, INT J ROBOT RES, V9, P62, DOI 10.1177/027836499000900206; MCGEER T, 1989, PROCEEDINGS - 1989 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOL 1-3, P1592, DOI 10.1109/ROBOT.1989.100205; Meehan CF, 2012, J PHYSIOL-LONDON, V590, P289, DOI 10.1113/jphysiol.2011.214643; MOCHON S, 1980, J BIOMECH, V13, P49, DOI 10.1016/0021-9290(80)90007-X; Moren J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057134; Nishimura Y, 2013, NEURON, V80, P1301, DOI 10.1016/j.neuron.2013.08.028; Noga BR, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00059; Pala A, 2015, NEURON, V85, P68, DOI 10.1016/j.neuron.2014.11.025; Parker J, 2018, J NEUROPHYSIOL, V120, P1074, DOI 10.1152/jn.00696.2017; Peixoto T.P., 2014, GRAPH TOOL PYTHON LI, DOI [10.6084/m9.figshare.1164194, DOI 10.6084/M9.FIGSHARE.1164194]; Perrier JF, 2013, CURR PHARM DESIGN, V19, P4371, DOI 10.2174/13816128113199990341; Petersen PC, 2014, J NEUROSCI, V34, P2774, DOI 10.1523/JNEUROSCI.3349-13.2014; Petersson P, 2003, NATURE, V424, P72, DOI 10.1038/nature01719; Sakurai A, 2016, J NEUROPHYSIOL, V116, P1728, DOI 10.1152/jn.00150.2016; Shevtsova NA, 2015, J PHYSIOL-LONDON, V593, P2403, DOI 10.1113/JP270121; Simons-Weidenmaier NS, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-38; Spanne A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107793; Spanne A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00199; Stratmann P, 2016, FRONT NEUROROBOTICS, V10, DOI 10.3389/fnbot.2016.00002; Talpalar AE, 2011, NEURON, V71, P1071, DOI 10.1016/j.neuron.2011.07.011; Tazerart S, 2008, J NEUROSCI, V28, P8577, DOI 10.1523/JNEUROSCI.1437-08.2008; Tazerart S, 2007, J NEUROPHYSIOL, V98, P613, DOI 10.1152/jn.00316.2007; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Valeeva G, 2016, J NEUROSCI, V36, P5961, DOI 10.1523/JNEUROSCI.3482-15.2016; Zenke F, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003330; Zhang Hong, 2005, Current Alzheimer Research, V2, P137, DOI 10.2174/1567205053585936; Zhong GS, 2007, J NEUROSCI, V27, P4507, DOI 10.1523/JNEUROSCI.0124-07.2007; Zhong GS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1276; Zhong GS, 2010, J NEUROSCI, V30, P170, DOI 10.1523/JNEUROSCI.4849-09.2010; Ziskind-Conhaim L, 2008, J NEUROPHYSIOL, V100, P2254, DOI 10.1152/jn.90437.2008	84	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238586	10.1371/journal.pone.0238586	http://dx.doi.org/10.1371/journal.pone.0238586			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915814	Green Submitted, Green Published, gold			2022-12-26	WOS:000571887500080
J	Nicholas, TR; Meng, JW; Greulich, BM; Morris, TS; Hollenhorst, PC				Nicholas, Taylor R.; Meng, Jingwei; Greulich, Benjamin M.; Morris, Teresa Stevie; Hollenhorst, Peter C.			A high-throughput screen identifies inhibitors of the interaction between the oncogenic transcription factor ERG and the cofactor EWS	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITORS; ETS FACTORS; PROSTATE	Aberrant expression of the transcription factor ERG is a key driving event in approximately one-half of all of prostate cancers. Lacking an enzymatic pocket and mainly disordered, the structure of ERG is difficult to exploit for therapeutic design. We recently identified EWS as a specific interacting partner of ERG that is required for oncogenic function. In this study, we aimed to target this specific protein-protein interaction with small molecules. A high-throughput screening (HTS) strategy was implemented to identify potential protein-protein interaction inhibitors. Secondary assays verified the function of several hit compounds, and one lead compound inhibited ERG-mediated phenotypes in prostate cells. This is the first study aimed at targeting the ERG-EWS protein-protein interaction for the development of a small molecule-based prostate cancer therapy.	[Nicholas, Taylor R.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Meng, Jingwei] Indiana Univ Sch Med, Chem Genom Core Facil, Indianapolis, IN 46202 USA; [Greulich, Benjamin M.; Morris, Teresa Stevie; Hollenhorst, Peter C.] Indiana Univ Sch Med, Med Sci, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Hollenhorst, PC (corresponding author), Indiana Univ Sch Med, Med Sci, Bloomington, IN 47405 USA.	pchollen@iu.edu			National Cancer Institute of the National Institutes of Health [R01CA204121]; Indiana Clinical and Translational Sciences Institute; National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award [UL1TR002529]; IU Simon Cancer Center	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Indiana Clinical and Translational Sciences Institute; National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award; IU Simon Cancer Center	Research reported in this publication was supported by the National Cancer Institute (www.cancer.gov) of the National Institutes of Health under Award Number R01CA204121 (P.C.H.), and with support from the Indiana Clinical and Translational Sciences Institute (indianactsi.org) funded, in part by award number UL1TR002529 from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award (T.R.N.). Research reported here was also funded by the IU Simon Cancer Center (www.cancer.iu.edu).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Couthouis J, 2012, HUM MOL GENET, V21, P2899, DOI 10.1093/hmg/dds116; Darling AL, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00158; Deegan C, 2007, CANCER LETT, V247, P224, DOI 10.1016/j.canlet.2006.04.006; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; Fontaine Frank, 2015, Cell Regen, V4, P2, DOI 10.1186/s13619-015-0015-x; Helgeson BE, 2008, CANCER RES, V68, P73, DOI 10.1158/0008-5472.CAN-07-5352; Hollenhorst PC, 2011, GENE DEV, V25, P2147, DOI 10.1101/gad.17546311; Hollenhorst Peter C, 2011, Genes Cancer, V1, P1044; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kedage V, 2016, CELL REP, V17, P1289, DOI 10.1016/j.celrep.2016.10.001; Mackie DI, 2011, J BIOMOL SCREEN, V16, P869, DOI 10.1177/1087057111410427; Mani RS, 2011, CANCER RES, V71, P5387, DOI 10.1158/0008-5472.CAN-11-0876; Nicholas TR, 2019, ADV EXP MED BIOL, V1210, P409, DOI 10.1007/978-3-030-32656-2_18; Santofimia-Castano P, 2020, CELL MOL LIFE SCI, V77, P1695, DOI 10.1007/s00018-019-03347-3; Selvaraj N, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0089-7; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Yasgar A, 2016, METHODS MOL BIOL, V1439, P77, DOI 10.1007/978-1-4939-3673-1_5; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	21	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238999	10.1371/journal.pone.0238999	http://dx.doi.org/10.1371/journal.pone.0238999			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915889	Green Published, gold			2022-12-26	WOS:000571887500010
J	Svensson, D; Rentoft, M; Dahlin, AM; Lundholm, E; Olason, PI; Sjodin, A; Nylander, C; Melin, BS; Trygg, J; Johansson, E				Svensson, Daniel; Rentoft, Matilda; Dahlin, Anna M.; Lundholm, Emma; Olason, Pall, I; Sjodin, Andreas; Nylander, Carin; Melin, Beatrice S.; Trygg, Johan; Johansson, Erik			A whole-genome sequenced control population in northern Sweden reveals subregional genetic differences	PLOS ONE			English	Article							IMPROVED IMPUTATION ACCURACY; GENOTYPE IMPUTATION; DEMOGRAPHIC HISTORY; WIDE ASSOCIATION; FRAMEWORK; RARE; CONSANGUINITY	The number of national reference populations that are whole-genome sequenced are rapidly increasing. Partly driving this development is the fact that genetic disease studies benefit from knowing the genetic variation typical for the geographical area of interest. A whole-genome sequenced Swedish national reference population (n = 1000) has been recently published but with few samples from northern Sweden. In the present study we have whole-genome sequenced a control population (n = 300) (ACpop) from Vasterbotten County, a sparsely populated region in northern Sweden previously shown to be genetically different from southern Sweden. The aggregated variant frequencies within ACpop are publicly available (DOI) to function as a basic resource in clinical genetics and for genetic studies. Our analysis of ACpop, representing approximately 0.11% of the population in Vasterbotten, indicates the presence of a genetic substructure within the county. Furthermore, a demographic analysis showed that the population from which samples were drawn was to a large extent geographically stationary, a finding that was corroborated in the genetic analysis down to the level of municipalities. Including ACpop in the reference population when imputing unknown variants in a Vasterbotten cohort resulted in a strong increase in the number of high-confidence imputed variants (up to 81% for variants with minor allele frequency < 5%). ACpop was initially designed for cancer disease studies, but the genetic structure within the cohort will be of general interest for all genetic disease studies in northern Sweden.	[Svensson, Daniel; Sjodin, Andreas; Trygg, Johan] Umea Univ, Dept Chem, Computat Life Sci Cluster, Umea, Sweden; [Rentoft, Matilda; Johansson, Erik] Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden; [Dahlin, Anna M.; Nylander, Carin; Melin, Beatrice S.] Umea Univ, Dept Radiat Sci, Oncol, Umea, Sweden; [Lundholm, Emma] Umea Univ, Ctr Demog & Ageing, Umea, Sweden; [Olason, Pall, I] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden; [Sjodin, Andreas] FOI Swedish Def Res Agcy, Div CBRN Secur & Def, Umea, Sweden	Umea University; Umea University; Umea University; Umea University; Uppsala University; FOI - Swedish Defence Research Agency	Johansson, E (corresponding author), Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden.	erik.tm.johansson@umu.se	Rentoft, Matilda/AAL-2449-2021; Sjödin, Andreas/A-7245-2008	Sjödin, Andreas/0000-0001-5350-4219; Lundholm, Emma/0000-0002-2014-7179; Svensson, Daniel/0000-0002-4476-9255; Johansson, Erik/0000-0002-8526-6224	Knut and Alice Wallenberg Foundation [2011.0042]	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was funded by a project grant (2011.0042) from the Knut and Alice Wallenberg Foundation (E.J., B.S.M., J.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ameur A, 2017, EUR J HUM GENET, V25, P1253, DOI 10.1038/ejhg.2017.130; [Anonymous], 2010, CASTILLA ESTUDIOS LI, V1, P131; Bittles AH, 2005, ANN HUM GENET, V69, P549, DOI 10.1046/j.1529-8817.2005.00179.x; Bylund E, 1994, BOTNIA NORDSVENSK RE, P86; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chef der Saarland-Der, 2006, AMTSBLATT SAARLANDES, P963; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Einarsdottir E, 2007, HEREDITAS, V144, P171, DOI 10.1111/j.2007.0018-0661.02007.x; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gazal S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17453; Gazal S, 2014, BIOINFORMATICS, V30, P1940, DOI 10.1093/bioinformatics/btu149; Graffelman J, 2013, STAT APPL GENET MOL, V12, P433, DOI 10.1515/sagmb-2012-0039; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Leutenegger AL, 2011, EUR J HUM GENET, V19, P583, DOI 10.1038/ejhg.2010.205; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Mitt M, 2017, EUR J HUM GENET, V25, P869, DOI 10.1038/ejhg.2017.51; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Norberg M, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19166; Okonechnikov K, 2016, BIOINFORMATICS, V32, P292, DOI 10.1093/bioinformatics/btv566; Palm L. A., 2000, FOLKMANGDEN SVERIGES; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Rajaraman P, 2012, HUM GENET, V131, P1877, DOI 10.1007/s00439-012-1212-0; Rentoft M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213350; Skoold P, 2008, INT J CIRCUMPOL HEAL, V67, P27; Statistics Sweden, 2017, POP 1 NOV REG AG SEX; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Suguitan Jr AL, 2011, PLOS ONE, V6; Suguitan Jr AL, 2011, PLOS ONE, V6; Surakka I, 2010, GENOME RES, V20, P1344, DOI 10.1101/gr.106534.110; Sweden Statistics, 2020, LAND WATER AREA 1 JA; The Gene Ontology Consortium, 2019, NUCLEIC ACIDS RES, V47, pD330; The I, 2015, NAT COMMUN, V6, P1, DOI DOI 10.1038/NCOMMS7971; Virtanen P., 2020, NAT METHODS, V17, P261, DOI [10.1038/s41592-019-0686-2, DOI 10.1038/S41592-019-0686-2]	50	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0237721	10.1371/journal.pone.0237721	http://dx.doi.org/10.1371/journal.pone.0237721			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915809	Green Submitted, Green Published, gold			2022-12-26	WOS:000571887500123
J	Falch, HN; Raedergard, HG; van den Tillaar, R				Falch, Hallvard Nygaard; Raedergard, Havard Guldteig; van den Tillaar, Roland			Association of strength and plyometric exercises with change of direction performances	PLOS ONE			English	Article							YOUNG SOCCER PLAYERS; ENDURANCE PERFORMANCE; VELOCITY SPECIFICITY; AGILITY PERFORMANCE; EXPLOSIVE ACTIONS; TRAINING-PROGRAM; SPRINT; SPEED; POWER; DETERMINANTS	The change of direction (COD) ability is an important task-specific skill for success in team sports, dependent on both strength and reactive strength. The sprint approaching the COD and degrees of the turn are factors influencing the specificity of the COD. Thus, CODs have been suggested to be categorized as force- (> 90 degrees) and velocity-dominant (< 90 degrees) dependent on the degree of the turn. When training programmes fail to provide a significant increase in COD performance, it is often due to neglecting the task-specific demands of the COD. As such, 23 male football players volunteered to complete a randomized controlled trial, investigating the association of maximal strength and power performance with performance in a force- (180 degrees) and velocity-dominant (45 degrees) COD, with a 4 m and 20 m sprint approach. Three strength and three plyometric exercises, matched in movement patterns, were used. Muscle activity of the different conditions was also compared. The correlational analysis revealed that better performance in the plyometric tests were associated with less time to complete both force- and velocity-dominant CODs, supported by similarities in muscle activation. None of the performances in strength exercises correlated to COD performance, due to the slow contraction velocity of maximal lifts. It was concluded that plyometrics share more physical similarities with CODs than the strength exercises.	[Falch, Hallvard Nygaard; Raedergard, Havard Guldteig; van den Tillaar, Roland] Nord Univ, Dept Sport Sci & Phys Educ, Levanger, Norway	Nord University	van den Tillaar, R (corresponding author), Nord Univ, Dept Sport Sci & Phys Educ, Levanger, Norway.	roland.v.tillaar@nord.no						Andrews J R, 1977, Am J Sports Med, V5, P111, DOI 10.1177/036354657700500303; [Anonymous], 2007, VALUE HLTH SS2, V10, ps59; [Anonymous], 2015, ACTA KIN UNIVERS TAR; Arampatzis A, 1999, J BIOMECH, V32, P1349, DOI 10.1016/S0021-9290(99)00133-5; Asadi A, 2016, MEDICINA-LITHUANIA, V52, P41, DOI 10.1016/j.medici.2016.01.001; Baker DG, 2008, J STRENGTH COND RES, V22, P153, DOI 10.1519/JSC.0b013e31815f9519; Barnes JL, 2007, J STRENGTH COND RES, V21, P1192; BEHM DG, 1993, SPORTS MED, V15, P374, DOI 10.2165/00007256-199315060-00003; Bencke J, 2013, KNEE SURG SPORT TR A, V21, P1876, DOI 10.1007/s00167-012-2199-8; Besier TF, 2003, MED SCI SPORT EXER, V35, P119, DOI 10.1097/00005768-200301000-00019; BOBBERT MF, 1987, MED SCI SPORT EXER, V19, P332; Bourgeois FA., 2017, J AUST STRENGTH COND, V25, P104; Brughelli M, 2008, SPORTS MED, V38, P1045, DOI 10.2165/00007256-200838120-00007; Carling C., 2008, PERFORMANCE ASSESSME; Castagna C, 2003, J STRENGTH COND RES, V17, P775; Castillo-Rodriguez A, 2012, J STRENGTH COND RES, V26, P725, DOI 10.1519/JSC.0b013e31822602db; Chaouachi A, 2012, J STRENGTH COND RES, V26, P2667, DOI 10.1519/JSC.0b013e318242f97a; Chatzinikolaou A, 2018, INT J SPORT PHYSIOL, V13, P645, DOI 10.1123/ijspp.2017-0763; Chtara M, 2017, BIOL SPORT, V34, P137, DOI 10.5114/biolsport.2017.64587; de Hoyo M, 2016, J STRENGTH COND RES, V30, P368, DOI 10.1519/JSC.0000000000001094; DeWeese B, 2016, ESSENTIALS STRENGTH, P521; Faigenbaum AD, 2007, J SPORT SCI MED, V6, P519; Falch HN, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0223-y; Faude O, 2012, J SPORT SCI, V30, P625, DOI 10.1080/02640414.2012.665940; Flanagan EP, 2008, STRENGTH COND J, V30, P32, DOI 10.1519/SSC.0b013e318187e25b; Gabbett T, 2009, J SCI MED SPORT, V12, P215, DOI 10.1016/j.jsams.2007.06.008; Hammami M, 2016, J STRENGTH COND RES, V30, P3312, DOI 10.1519/JSC.0000000000001470; Harriss DJ, 2015, INT J SPORTS MED, V36, P1121, DOI 10.1055/s-0035-1565186; Helgerud J, 2001, MED SCI SPORT EXER, V33, P1925, DOI 10.1097/00005768-200111000-00019; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hewit J, 2011, STRENGTH COND J, V33, P47, DOI 10.1519/SSC.0b013e3181fbd62c; Hori N, 2008, J STRENGTH COND RES, V22, P412, DOI 10.1519/JSC.0b013e318166052b; Jones P, 2009, J SPORT MED PHYS FIT, V49, P97; Jones PA, 2017, SPORTS, V5, DOI 10.3390/sports5020042; Keller S, 2020, J STRENGTH COND RES, V34, P473, DOI 10.1519/JSC.0000000000002814; Keller TS, 1996, CLIN BIOMECH, V11, P253, DOI 10.1016/0268-0033(95)00068-2; Kristensen GO, 2006, J STRENGTH COND RES, V20, P833; Kyrolainen H, 2001, MED SCI SPORT EXER, V33, P1330; Marshall BM, 2014, J STRENGTH COND RES, V28, P2845, DOI 10.1519/JSC.0000000000000463; McCormick BT, 2016, INT J SPORT PHYSIOL, V11, P102, DOI 10.1123/ijspp.2015-0058; McLean SG, 2005, CLIN BIOMECH, V20, P863, DOI 10.1016/j.clinbiomech.2005.05.007; McLean SG, 2004, CLIN BIOMECH, V19, P828, DOI 10.1016/j.clinbiomech.2004.06.006; Morin JB, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00404; Morin JB, 2012, EUR J APPL PHYSIOL, V112, P3921, DOI 10.1007/s00421-012-2379-8; Neptune RR, 1999, MED SCI SPORT EXER, V31, P294, DOI 10.1097/00005768-199902000-00014; Nimphius S., 2013, J AUST STRENGTH COND, V21, P115, DOI DOI 10.1519/SSC.0000000000000309; Nimphius S, 2018, STRENGTH COND J, V40, P26, DOI 10.1519/SSC.0000000000000309; Nimphius S, 2016, J STRENGTH COND RES, V30, P3024, DOI 10.1519/JSC.0000000000001421; Ramirez-Campillo R, 2020, J STRENGTH COND RES, V34, P1959, DOI 10.1519/JSC.0000000000002525; Ramirez-Campillo R, 2015, J STRENGTH COND RES, V29, P1784, DOI 10.1519/JSC.0000000000000827; Ramirez-Campillo R, 2015, J STRENGTH COND RES, V29, P1317, DOI 10.1519/JSC.0000000000000762; Ramirez-Campillo R, 2014, J STRENGTH COND RES, V28, P1335, DOI 10.1519/JSC.0000000000000284; Reilly T, 2000, J SPORT SCI, V18, P695, DOI 10.1080/02640410050120050; Sato K, 2013, J BODYW MOV THER, V17, P560, DOI 10.1016/j.jbmt.2013.09.005; Schenau GJV, 1997, J APPL BIOMECH, V13, P389, DOI 10.1123/jab.13.4.389; Sohnlein Q, 2014, J STRENGTH COND RES, V28, P2105, DOI 10.1519/JSC.0000000000000387; Speirs DE, 2016, J STRENGTH COND RES, V30, P386, DOI 10.1519/JSC.0000000000001096; Spiteri T, 2014, J STRENGTH COND RES, V28, P2415, DOI 10.1519/JSC.0000000000000547; Stolen T, 2005, SPORTS MED, V35, P501; Tenenbaum G., 1996, J STRENGTH COND RES, V10, P67; Thomas GA, 2007, J STRENGTH COND RES, V21, P336, DOI 10.1519/00124278-200705000-00008; Thomas K, 2009, J STRENGTH COND RES, V23, P332, DOI 10.1519/JSC.0b013e318183a01a; Torres-Torrelo J, 2017, J SPORT SCI, V35, P967, DOI 10.1080/02640414.2016.1206663; Tous-Fajardo J, 2016, INT J SPORT PHYSIOL, V11, P66, DOI 10.1123/ijspp.2015-0010; Vanderburgh PM, 1999, MED SCI SPORT EXER, V31, P1869, DOI 10.1097/00005768-199912000-00027; Alves JMVM, 2010, J STRENGTH COND RES, V24, P936, DOI 10.1519/JSC.0b013e3181c7c5fd; Young WB, 2015, INT J SPORTS SCI COA, V10, P159, DOI 10.1260/1747-9541.10.1.159; Young WB, 2002, J SPORT MED PHYS FIT, V42, P282; Young WB, 2001, J STRENGTH COND RES, V15, P315, DOI 10.1519/00124278-200108000-00009	69	3	3	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238580	10.1371/journal.pone.0238580	http://dx.doi.org/10.1371/journal.pone.0238580			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911530	Green Published, gold			2022-12-26	WOS:000571885900045
J	Nooteboom, PD; Delandmeter, P; van Sebille, E; Bijl, PK; Dijkstra, HA; von der Heydt, AS				Nooteboom, Peter D.; Delandmeter, Philippe; van Sebille, Erik; Bijl, Peter K.; Dijkstra, Henk A.; von der Heydt, Anna S.			Resolution dependency of sinking Lagrangian particles in ocean general circulation models	PLOS ONE			English	Article							RANDOM-WALK MODELS; SEDIMENT TRAPS; GLOBAL OCEAN; TRAJECTORIES; TRANSPORT; FUNNELS	Any type of non-buoyant material in the ocean is transported horizontally by currents during its sinking journey. This lateral transport can be far from negligible for small sinking velocities. To estimate its magnitude and direction, the material is often modelled as a set of Lagrangian particles advected by current velocities that are obtained from Ocean General Circulation Models (OGCMs). State-of-the-art OGCMs are strongly eddying, similar to the real ocean, providing results with a spatial resolution on the order of 10 km on a daily frequency. While the importance of eddies in OGCMs is well-appreciated in the physical oceanographic community, other marine research communities may not. Further, many long term climate modelling simulations (e.g. in paleoclimate) rely on lower spatial resolution models that do not capture mesoscale features. To demonstrate how much the absence of mesoscale features in low-resolution models influences the Lagrangian particle transport, we simulate the transport of sinking Lagrangian particles using low- and high-resolution global OGCMs, and assess the lateral transport differences resulting from the difference in spatial and temporal model resolution. We find major differences between the transport in the non-eddying OGCM and in the eddying OGCM. Addition of stochastic noise to the particle trajectories in the non-eddying OGCM parameterises the effect of eddies well in some cases (e.g. in the North Pacific gyre). The effect of a coarser temporal resolution (once every 5 days versus monthly) is smaller compared to a coarser spatial resolution (0.1 degrees versus 1 degrees horizontally). We recommend to use sinking Lagrangian particles, representing e.g. marine snow, microplankton or sinking plastic, only with velocity fields from eddying Eulerian OGCMs, requiring high-resolution models in e.g. paleoceanographic studies. To increase the accessibility of our particle trace simulations, we launch planktondrift.science.uu.nl, an online tool to reconstruct the surface origin of sedimentary particles in a specific location.	[Nooteboom, Peter D.; Delandmeter, Philippe; van Sebille, Erik; Dijkstra, Henk A.; von der Heydt, Anna S.] Univ Utrecht, Inst Marine & Atmospher Res Utrecht IMAU, Dept Phys, Utrecht, Netherlands; [Nooteboom, Peter D.; van Sebille, Erik; Dijkstra, Henk A.; von der Heydt, Anna S.] Univ Utrecht, Ctr Complex Syst Studies, Utrecht, Netherlands; [Bijl, Peter K.] Univ Utrecht, Dept Earth Sci, Lab Paleobot & Palynol, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University	Nooteboom, PD (corresponding author), Univ Utrecht, Inst Marine & Atmospher Res Utrecht IMAU, Dept Phys, Utrecht, Netherlands.; Nooteboom, PD (corresponding author), Univ Utrecht, Ctr Complex Syst Studies, Utrecht, Netherlands.	p.d.nooteboom@uu.nl	von der Heydt, Anna S/B-9250-2008	von der Heydt, Anna S/0000-0002-5557-3282; Nooteboom, Peter/0000-0003-3689-0845	Netherlands Organization for Scientific Research (NWO), Earth and Life Sciences [ALWOP.207]; NWO-EW (Netherlands Organisation for Scientific Research, Exact Sciences) [17189]; European Research Council under the European Community's Seventh Framework Program by ERC [802835]; European Research Council (ERC) under the European Union Horizon 2020 research and innovation programme [715386]	Netherlands Organization for Scientific Research (NWO), Earth and Life Sciences(Netherlands Organization for Scientific Research (NWO)); NWO-EW (Netherlands Organisation for Scientific Research, Exact Sciences); European Research Council under the European Community's Seventh Framework Program by ERC; European Research Council (ERC) under the European Union Horizon 2020 research and innovation programme(European Research Council (ERC))	This work was funded by the Netherlands Organization for Scientific Research (NWO), Earth and Life Sciences, through project ALWOP.207. The use of the SURFsara computing facilities was sponsored by NWO-EW (Netherlands Organisation for Scientific Research, Exact Sciences) under the project 17189. The European Research Council under the European Community's Seventh Framework Program provided funding for this work by ERC Starting Grant #802835 (OceaNice) to PKB. PD and EvS are supported through funding from the European Research Council (ERC) under the European Union Horizon 2020 research and innovation programme (grant agreement no. 715386, TOPIOS).	ANDERSON DM, 1985, LIMNOL OCEANOGR, V30, P1000, DOI 10.4319/lo.1985.30.5.1000; Annalisa Bracco, 2017, OCEAN MODEL, V122, P13; [Anonymous], 2019, CANC DISCOV, V10, pOF5; [Anonymous], 2011, J PEASANT STUD, V38, P1; Baatsen M, 2018, CLIM PAST DISCUSS, DOI [10.5194/cp-2018-43, DOI 10.5194/CP-2018-43]; Baatsen MLJ, 2018, GLOBAL PLANET CHANGE, V163, P18, DOI 10.1016/j.gloplacha.2018.02.009; Berloff P, 2007, J PHYS OCEANOGR, V37, P2363, DOI 10.1175/JPO3118.1; Bijl PK, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2009PA001905; Buesseler KO, 2007, J MAR RES, V65, P345, DOI 10.1357/002224007781567621; Claudia Wekerle, 2018, FRONT MAR SCI, V5; Da Costa MV, 2004, OCEAN MODEL, V6, P335, DOI 10.1016/S1463-5003(03)00023-4; Dale B, 1996, PALYNOLOGY PRINCIPLE, P1249; Delandmeter P, 2019, GEOSCI MODEL DEV, V12, P3571, DOI 10.5194/gmd-12-3571-2019; den Toom M, 2014, J PHYS OCEANOGR, V44, P464, DOI 10.1175/JPO-D-12-0155.1; Doos K, 2011, OCEAN MODEL, V39, P301, DOI 10.1016/j.ocemod.2011.05.005; Fahl K, 2007, DEEP-SEA RES PT I, V54, P1256, DOI 10.1016/j.dsr.2007.04.014; Flamary R., 2017, POT PYTHON OPTIMAL T; Gent PR, 2011, OCEAN MODEL, V39, P2, DOI 10.1016/j.ocemod.2010.08.002; GENT PR, 1990, J PHYS OCEANOGR, V20, P150, DOI 10.1175/1520-0485(1990)020<0150:IMIOCM>2.0.CO;2; Gill AE, 1983, ATMOSPHERE OCEAN DYN; Hardesty BD, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00030; Haywood AM, 2013, CLIM PAST, V9, P191, DOI 10.5194/cp-9-191-2013; Hecht M.W., 2008, OCEANO MODELING EDDY, V177, P213, DOI [10.1029/177GM15, DOI 10.1029/177GM15]; HOLLAND WR, 1978, J PHYS OCEANOGR, V8, P363, DOI 10.1175/1520-0485(1978)008<0363:TROMEI>2.0.CO;2; HONJO S, 1982, SCIENCE, V216, P516, DOI 10.1126/science.216.4545.516; Huber M, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001014; HUNTER JR, 1993, J COMPUT PHYS, V106, P366; Huntley HS, 2011, OCEAN MODEL, V36, P163, DOI 10.1016/j.ocemod.2010.11.001; Hutchinson DK, 2018, CLIM PAST, V14, P789, DOI 10.5194/cp-14-789-2018; Isabella Rosso, 2016, DEEP RES 1, V115, P199; Jain K. N. A. K., 2008, J ADV SIGNAL PROCESS, V113, P1; Jalon-Rojas I, 2019, OCEAN SCI, V15, P717, DOI 10.5194/os-15-717-2019; Js S, 1963, MON WEATHER REV, V91, P99, DOI [10.1175/1520-0493(1963)0912.3.CO;2, DOI 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.CO;2, 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.CO;2, DOI 10.1175/1520-0493(1963)0912.3.CO;2]; Koelmans AA, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa9500; Kooi M, 2017, ENVIRON SCI TECHNOL, V51, P7963, DOI 10.1021/acs.est.6b04702; Le Bars D, 2016, GEOPHYS RES LETT, V43, P2102, DOI 10.1002/2016GL068177; Lunt DJ, 2012, CLIM PAST, V8, P1717, DOI 10.5194/cp-8-1717-2012; Ma J., 2009, FLUID MACHINERY FLUI, P328, DOI DOI 10.1007/978-3-540-89749-1_51; McClean J., 2008, OCEAN MODELING EDDYI, P149; Miramontes E, 2019, GEOMORPHOLOGY, V333, P43, DOI 10.1016/j.geomorph.2019.02.030; Monroy P, 2019, J GEOPHYS RES-OCEANS, V124, P4744, DOI 10.1029/2019JC015016; Monroy P, 2017, NONLINEAR PROC GEOPH, V24, P293, DOI 10.5194/npg-24-293-2017; Nowald N, 2009, IN SITU SINKING SPEE; OP026, 2016, J CROHNS COLITIS, V10, pS21; Penduff T, 2011, J CLIMATE, V24, P5652, DOI 10.1175/JCLI-D-11-00077.1; Philip W, 2019, NATURE, V568, P327; Qin X, 2014, OCEAN MODEL, V76, P20, DOI 10.1016/j.ocemod.2014.02.002; Qiu ZF, 2014, SCI CHINA EARTH SCI, V57, P2447, DOI 10.1007/s11430-014-4880-x; REGIER L, 1979, P NATL ACAD SCI USA, V76, P4760, DOI 10.1073/pnas.76.10.4760; Ross ON, 2004, LIMNOL OCEANOGR-METH, V2, P289, DOI 10.4319/lom.2004.2.289; Siegel DA, 2008, DEEP-SEA RES PT I, V55, P108, DOI 10.1016/j.dsr.2007.10.006; Siegel DA, 1997, DEEP-SEA RES PT I, V44, P1519, DOI 10.1016/S0967-0637(97)00028-9; Simonsen M, 2017, J ENVIRON RADIOACTIV, V177, P100, DOI 10.1016/j.jenvrad.2017.06.002; Smith R, 2010, LAUR01853, V141; Stewart KD, 2017, OCEAN MODEL, V113, P50, DOI 10.1016/j.ocemod.2017.03.012; Subcommittee of Clinical Practice Guideline for Diagnosis and Management of Acute Otitis Media in Children (Japan Otological Society Japan Society for Pediatric Otorhinolaryngology Japan Society for Infectious Diseases in Otolaryngology), 2012, Auris Nasus Larynx, V39, P1, DOI 10.1016/j.anl.2011.09.008; The Lancet Global Health, 2018, LANCET GLOB HLTH, V6, pE593; Uchida T, 2019, J ADV MODEL EARTH SY, V11, P3934, DOI 10.1029/2019MS001805; van Sebille E, 2018, OCEAN MODEL, V121, P49, DOI 10.1016/j.ocemod.2017.11.008; van Sebille E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7521; Viebahn JP, 2016, PALEOCEANOGRAPHY, V31, P564, DOI 10.1002/2015PA002888; Visser AW, 1997, MAR ECOL PROG SER, V158, P275, DOI 10.3354/meps158275; Volkov DL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035490; Waniek J, 2000, J MAR RES, V58, P983, DOI 10.1357/002224000763485773; WEYL PK, 1978, SCIENCE, V202, P475, DOI 10.1126/science.202.4367.475; 2019, CAN J KIDNEY HLTH DI, V6, P1; 2014, FED REG, V79, P1; 2019, HUM REPROD, V34	68	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238650	10.1371/journal.pone.0238650	http://dx.doi.org/10.1371/journal.pone.0238650			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911487	gold, Green Published, Green Submitted			2022-12-26	WOS:000571885900038
J	Bhadra-Lobo, S; Kim, MK; Lun, DS				Bhadra-Lobo, Siddharth; Kim, Min Kyung; Lun, Desmond S.			Assessment of transcriptomic constraint-based methods for central carbon flux inference	PLOS ONE			English	Article							PHOTOAUTOTROPHIC METABOLISM; PCC 6803	Motivation Determining intracellular metabolic flux through isotope labeling techniques such as(13)C metabolic flux analysis (C-13-MFA) incurs significant cost and effort. Previous studies have shown transcriptomic data coupled with constraint-based metabolic modeling can determine intracellular fluxes that correlate highly with(13)C-MFA measured fluxes and can achieve higher accuracy than constraint-based metabolic modeling alone. These studies, however, used validation data limited toE.coliandS.cerevisiaegrown on glucose, with significantly similar flux distribution for central metabolism. It is unclear whether those results apply to more diverse metabolisms, and therefore further, extensive validation is needed. Results In this paper, we formed a dataset of transcriptomic data coupled with corresponding(13)C-MFA flux data for 21 experimental conditions in different unicellular organisms grown on varying carbon substrates and conditions. Three computational flux-balance analysis (FBA) methods were comparatively assessed. The results show when uptake rates of carbon sources and key metabolites are known, transcriptomic data provides no significant advantage over constraint-based metabolic modeling (average correlation coefficients, transcriptomic E-Flux2 0.725 and SPOT 0.650 vs non-transcriptomic pFBA 0.768). When uptake rates are unknown, however, predictions obtained utilizing transcriptomic data are generally good and significantly better than those obtained using constraint-based metabolic modeling alone (E-Flux2 0.385 and SPOT 0.583 vs pFBA 0.237). Thus, transcriptomic data coupled with constraint-based metabolic modeling is a promising method to obtain intracellular flux estimates in microorganisms, particularly in cases where uptake rates of key metabolites cannot be easily determined, such as for growth in complex media orin vivoconditions.	[Bhadra-Lobo, Siddharth; Kim, Min Kyung; Lun, Desmond S.] Rutgers State Univ, Ctr Computat & Integrat Biol, Camden, NJ 08102 USA; [Lun, Desmond S.] Rutgers State Univ, Dept Comp Sci, Camden, NJ USA; [Lun, Desmond S.] Rutgers State Univ, Dept Plant Biol, New Brunswick, NJ USA	Rutgers State University Camden; Rutgers State University New Brunswick; Rutgers State University Camden; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Bhadra-Lobo, S (corresponding author), Rutgers State Univ, Ctr Computat & Integrat Biol, Camden, NJ 08102 USA.	sid.bl@rutgers.edu		Bhadra-Lobo, Siddharth/0000-0002-5768-1199	NSF [1515511]	NSF(National Science Foundation (NSF))	This work was supported in part by NSF award no. 1515511 (MKK).	Basler G, 2018, BIOSCIENCE REP, V38; Beale DJ, 2016, MICROBIAL METABOLOMI, P289, DOI DOI 10.1007/978-3-319-46326-1_10; Bewick V, 2003, CRIT CARE, V7, P451, DOI 10.1186/cc2401; Bordbar A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.68; Borkowski O, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156608; Brunk E, 2017, SYSTEMIC POSTTRANSLA; Chubukov V, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.66; Crown SB, 2013, METAB ENG, V20, P42, DOI 10.1016/j.ymben.2013.08.005; Gerosa L, 2015, CELL SYST, V1, P270, DOI 10.1016/j.cels.2015.09.008; Jouhten P, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-60; Kelley JJ, 2015, BIOINFORMATICS, V31, P610, DOI 10.1093/bioinformatics/btu685; Kim MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157101; Kim MK, 2014, COMPUT STRUCT BIOTEC, V11, P59, DOI 10.1016/j.csbj.2014.08.009; Knoop H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003081; Lewis NE, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.47; Liu MZ, 2005, J BIOL CHEM, V280, P15921, DOI 10.1074/jbc.M414050200; Ludwig M, 2012, FRONT MICROBIOL, V3, DOI [10.3389/fmicb.2012.00145, 10.3389/fmicb.2012.00354]; Machado D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003580; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Oh YK, 2007, J BIOL CHEM, V282, P28791, DOI 10.1074/jbc.M703759200; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Otto A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1137; Peregrin-Alvarez JM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r63; Qian X, 2018, ACS SYNTH BIOL, V7, P1465, DOI 10.1021/acssynbio.8b00116; Qian X, 2017, BBA-BIOENERGETICS, V1858, P276, DOI 10.1016/j.bbabio.2016.12.007; REYES JC, 1995, PLANT PHYSIOL, V109, P899, DOI 10.1104/pp.109.3.899; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rodrigues F, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P101, DOI 10.1007/3-540-30985-3_6; Singh RK, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1175-y; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Tiwari DP, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny248; You L, 2015, J BACTERIOL, V197, P943, DOI 10.1128/JB.02149-14; You L, 2014, BIOTECHNOL J, V9, P684, DOI 10.1002/biot.201300477; Young JD, 2011, METAB ENG, V13, P656, DOI 10.1016/j.ymben.2011.08.002	34	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2020	15	9							e0238689	10.1371/journal.pone.0238689	http://dx.doi.org/10.1371/journal.pone.0238689			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR4MY	32903284	gold, Green Published			2022-12-26	WOS:000571539500021
J	Kang, HM; Choi, JH; Koh, HJ; Lee, SC				Kang, Hae Min; Choi, Jeong Hoon; Koh, Hyoung Jun; Lee, Sung Chul			Long-term treatment response after intravitreal bevacizumab injections for patients with central serous chorioretinopathy	PLOS ONE			English	Article							SUBFOVEAL CHOROIDAL THICKNESS; FLUENCE PHOTODYNAMIC THERAPY; FOLLOW-UP; AQUEOUS-HUMOR; VISUAL-ACUITY; RANIBIZUMAB; METAANALYSIS; ASSOCIATION; EFFICACY	Purpose To investigate long-term treatment response after intravitreal bevacizumab injections (IVBIs) for central serous chorioretinopathy (CSC). Methods This retrospective, interventional study investigated the medical records of 45 eyes of 44 patients with CSC who underwent IBVIs and completed at least 2-year follow-up period. Complete resolution (CR) was defined as complete resolution of subretinal fluid at least 3 months after the last IVBI. Thick-choroid CSC was defined as mean subfoveal choroidal thickness more than 300.0 mu m. The main outcome measure was long-term treatment outcome after IVBIs in patients with CSC. Results Thirty-five patients (79.5%) were male, and their mean age was 45.5 +/- 9.6 years. The mean follow-up period was 35.1 +/- 11.5 months. Twenty-two eyes (48.9%) had acute CSC, and 40 eyes (88.9%) achieved CR. Twenty eyes (50.0%) developed recurrence, the mean number of IVBIs to achieve the first CR was not significantly different between eyes with and without recurrences (2.6 +/- 1.6 vs. 2.9 +/- 1.9; P = 0.658). Thick-choroid CSC was significantly difference between the eyes with and without recurrence (17 eyes, 85.0% vs. eyes, 50.0%; P = 0.020). Among the baseline characteristics, serous pigment epithelial detachment (B = - 2.580, P = 0.032) and thick-choroid (B = 1.980, P = 0.019) were significantly associated with recurrence. Conclusion Eyes with CSC treated with IVBI and achieving complete resolution of subretinal fluid have 50% chance of recurrence in the long term. Thinner choroid and serous pigment epithelial detachment appear protective for recurrences.	[Kang, Hae Min] Catholic Kwandong Univ, Dept Ophthalmol, Coll Med, Int St Marys Hosp, Incheon, South Korea; [Choi, Jeong Hoon] Choikang Seoul Eye Clin, Seoul, South Korea; [Koh, Hyoung Jun] Yonsei Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea; [Lee, Sung Chul] Konyang Univ, Dept Ophthalmol, Coll Med, Daejeon, South Korea	Catholic Kwandong University; Yonsei University; Yonsei University Health System; Konyang University; Konyang University Hospital	Kang, HM (corresponding author), Catholic Kwandong Univ, Dept Ophthalmol, Coll Med, Int St Marys Hosp, Incheon, South Korea.	liebe05@naver.com		Koh, Hyoung Jun/0000-0002-5932-8516	National Research Foundation of Korea (NRF) - Korean government (MSIT) [2018R1C1B5085620]	National Research Foundation of Korea (NRF) - Korean government (MSIT)	This study was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. 2018R1C1B5085620). The sponsor or funding organization had no role in the design or conduct of this research.	Akhlaghi Mohamad Reza, 2017, Adv Biomed Res, V6, P125, DOI 10.4103/abr.abr_193_15; Altun A, 2014, J OCUL PHARMACOL TH, V30, P842, DOI 10.1089/jop.2014.0043; Artunay O, 2010, CURR EYE RES, V35, P91, DOI 10.3109/02713680903428306; Aydin E, 2013, J OCUL PHARMACOL TH, V29, P10, DOI 10.1089/jop.2012.0072; Bae SH, 2014, OPHTHALMOLOGY, V121, P558, DOI 10.1016/j.ophtha.2013.09.024; Bae SH, 2011, AM J OPHTHALMOL, V152, P784, DOI 10.1016/j.ajo.2011.04.008; Chung YR, 2013, EYE, V27, P1339, DOI 10.1038/eye.2013.236; Chung YR, 2019, RETINA-J RET VIT DIS, V39, P134, DOI 10.1097/IAE.0000000000001917; Chung YR, 2018, RETINA-J RET VIT DIS, V38, P102, DOI 10.1097/IAE.0000000000001502; Daruich A, 2015, PROG RETIN EYE RES, V48, P82, DOI 10.1016/j.preteyeres.2015.05.003; Ersoz MG, 2019, BRIT J OPHTHALMOL, V103, P725, DOI 10.1136/bjophthalmol-2018-312431; Ficker L, 1988, BR J OPHTHALMOL, V95, P529; GUYER DR, 1994, ARCH OPHTHALMOL-CHIC, V112, P1057, DOI 10.1001/archopht.1994.01090200063023; Haga F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181479; Hussain Deeba, 1998, Indian Journal of Ophthalmology, V46, P131; Iida T, 2003, RETINA-J RET VIT DIS, V23, P1, DOI 10.1097/00006982-200302000-00001; Inoue M, 2011, OPHTHALMOLOGICA, V225, P37, DOI 10.1159/000314709; Jirarattanasopa P, 2012, OPHTHALMOLOGY, V119, P1666, DOI 10.1016/j.ophtha.2012.02.021; Jung SH, 2014, CLIN EXP OPTOM, V97, P264, DOI 10.1111/cxo.12125; Kim DY, 2015, RETINA-J RET VIT DIS, V35, P1867, DOI 10.1097/IAE.0000000000000557; Kim Dong Yoon, 2015, Korean J Ophthalmol, V29, P160, DOI 10.3341/kjo.2015.29.3.160; Kim GA, 2015, EYE, V29, P732, DOI 10.1038/eye.2015.58; Kim M, 2013, OPHTHALMOLOGICA, V229, P152, DOI 10.1159/000345495; Kim Yun Young, 2011, Korean J Ophthalmol, V25, P90, DOI 10.3341/kjo.2011.25.2.90; Konstantinidis L, 2010, EUR J OPHTHALMOL, V20, P955, DOI 10.1177/112067211002000524; Lai TYY, 2004, AM J OPHTHALMOL, V137, P826, DOI 10.1016/j.ajo.2003.11.079; LEVINE R, 1989, OPHTHALMOLOGY, V96, P854; Liew G, 2013, CLIN EXP OPHTHALMOL, V41, P201, DOI 10.1111/j.1442-9071.2012.02848.x; Lim JW, 2011, GRAEF ARCH CLIN EXP, V249, P969, DOI 10.1007/s00417-010-1581-9; Lim JW, 2010, RETINA-J RET VIT DIS, V30, P1465, DOI 10.1097/IAE.0b013e3181d8e7fe; Lim Ji Won, 2010, Korean J Ophthalmol, V24, P155, DOI 10.3341/kjo.2010.24.3.155; Lim SJ, 2010, RETINA-J RET VIT DIS, V30, P100, DOI 10.1097/IAE.0b013e3181bcf0b4; Loo RH, 2002, RETINA-J RET VIT DIS, V22, P19, DOI 10.1097/00006982-200202000-00004; Ma JL, 2014, ACTA OPHTHALMOL, V92, pe594, DOI 10.1111/aos.12482; Maleki Alireza, 2018, Med Hypothesis Discov Innov Ophthalmol, V7, P176; Montero JA, 2011, EUR J OPHTHALMOL, V21, P503, DOI 10.5301/EJO.2011.6290; Mudvari SS, 2007, RETINA-J RET VIT DIS, V27, P1168, DOI 10.1097/IAE.0b013e318156db8a; Okamoto M, 2015, OSLI RETINA, V46, P25, DOI 10.3928/23258160-20150101-04; Peters S, 2007, AM J OPHTHALMOL, V143, P995, DOI 10.1016/j.ajo.2007.03.007; Peters S, 2007, BRIT J OPHTHALMOL, V91, P827, DOI 10.1136/bjo.2006.109702; Piccolino FC, 2003, RETINA-J RET VIT DIS, V23, P752, DOI 10.1097/00006982-200312000-00002; Piccolino FC, 2005, AM J OPHTHALMOL, V139, P87, DOI 10.1016/j.ajo.2004.08.037; Pitcher JD, 2015, BRIT J OPHTHALMOL, V99, P848, DOI 10.1136/bjophthalmol-2014-306018; Prunte C, 1996, AM J OPHTHALMOL, V121, P26; Romano MR, 2020, ACTA OPHTHALMOL, V98, pE549, DOI 10.1111/aos.14319; Ross A, 2011, CURR OPIN OPHTHALMOL, V22, P166, DOI 10.1097/ICU.0b013e3283459826; Schaal KB, 2009, EUR J OPHTHALMOL, V19, P613, DOI 10.1177/112067210901900415; Shin KH, 2016, J OCUL PHARMACOL TH, V32, P425, DOI 10.1089/jop.2015.0149; Shin MC, CONCENTRATION CYTOKI; Taban M, 2004, AM J OPHTHALMOL, V137, P1073, DOI 10.1016/j.ajo.2004.01.043; Terao N, 2018, INVEST OPHTH VIS SCI, V59, P5924, DOI 10.1167/iovs.18-25517; Tzekov R, 2006, INVEST OPHTH VIS SCI, V47, P377, DOI 10.1167/iovs.05-0838; Unlu Cihan, 2016, J Ophthalmic Vis Res, V11, P61, DOI 10.4103/2008-322X.180700; Wang M, 2008, ACTA OPHTHALMOL, V86, P126, DOI 10.1111/j.1600-0420.2007.00889.x; Wang MSM, 2002, AM J OPHTHALMOL, V133, P787, DOI 10.1016/S0002-9394(02)01438-1; Yannuzzi LA, 2010, AM J OPHTHALMOL, V149, P361, DOI 10.1016/j.ajo.2009.11.017	56	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238725	10.1371/journal.pone.0238725	http://dx.doi.org/10.1371/journal.pone.0238725			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ6EE	32898167	Green Published, gold			2022-12-26	WOS:000570962500028
J	Almeida, WR; Andalo, FA; Padilha, R; Bertocco, G; Dias, W; Torres, RD; Wainer, J; Rocha, A				Almeida, Waldir R.; Andalo, Fernanda A.; Padilha, Rafael; Bertocco, Gabriel; Dias, William; Torres, Ricardo da S.; Wainer, Jacques; Rocha, Anderson			Detecting face presentation attacks in mobile devices with a patch-based CNN and a sensor-aware loss function	PLOS ONE			English	Article							LIVENESS DETECTION; SPOOFING DETECTION; IMAGE	With the widespread use of biometric authentication comes the exploitation of presentation attacks, possibly undermining the effectiveness of these technologies in real-world setups. One example takes place when an impostor, aiming at unlocking someone else's smartphone, deceives the built-in face recognition system by presenting a printed image of the user. In this work, we study the problem of automatically detecting presentation attacks against face authentication methods, considering the use-case of fast device unlocking and hardware constraints of mobile devices. To enrich the understanding of how a purely software-based method can be used to tackle the problem, we present a solely data-driven approach trained with multi-resolution patches and a multi-objective loss function crafted specifically to the problem. We provide a careful analysis that considers several user-disjoint and cross-factor protocols, highlighting some of the problems with current datasets and approaches. Such analysis, besides demonstrating the competitive results yielded by the proposed method, provides a better conceptual understanding of the problem. To further enhance efficacy and discriminability, we propose a method that leverages the available gallery of user data in the device and adapts the method decision-making process to the user's and the device's own characteristics. Finally, we introduce a new presentation-attack dataset tailored to the mobile-device setup, with real-world variations in lighting, including outdoors and low-light sessions, in contrast to existing public datasets.	[Almeida, Waldir R.; Andalo, Fernanda A.; Padilha, Rafael; Bertocco, Gabriel; Dias, William; Wainer, Jacques; Rocha, Anderson] Univ Estadual Campinas, Inst Comp, Campinas, SP, Brazil; [Torres, Ricardo da S.] NTNU, Dept ICT & Nat Sci, Fac Informat Technol & Elect Engn, Alesund, Norway	Universidade Estadual de Campinas; Norwegian University of Science & Technology (NTNU)	Andalo, FA (corresponding author), Univ Estadual Campinas, Inst Comp, Campinas, SP, Brazil.	feandalo@ic.unicamp.br	Padilha, Rafael Soares/AAG-7246-2020; Wainer, Jacques/AAQ-6029-2021; Andaló, Fernanda/K-6663-2012	Padilha, Rafael Soares/0000-0003-1944-5475; Wainer, Jacques/0000-0001-5201-1244; Andaló, Fernanda/0000-0002-5243-0921; Reis, AlessanRSS/0000-0001-8486-7469	Motorola	Motorola	This work was funded by Motorola. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi M., 2016, TENSORFLOW LARGE SCA; Amidror I, 2009, COMPUT IMAGING VIS, V38, P1; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Anjos A, 2014, IET BIOMETRICS, V3, P147, DOI 10.1049/iet-bmt.2012.0071; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; [Anonymous], 2017, JTC1SC37 ISOIEC; Arashloo SR, 2017, IEEE ACCESS, V5, P13868, DOI 10.1109/ACCESS.2017.2729161; Atoum Y, 2017, 2017 IEEE INTERNATIONAL JOINT CONFERENCE ON BIOMETRICS (IJCB), P319, DOI 10.1109/BTAS.2017.8272713; Bai JM, 2010, IEEE INT SYMP CIRC S, P3425, DOI 10.1109/ISCAS.2010.5537866; Bao W, 2009, PROCEEDINGS OF 2009 INTERNATIONAL CONFERENCE ON IMAGE ANALYSIS AND SIGNAL PROCESSING, P233; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Bharadwaj S, 2013, IEEE COMPUT SOC CONF, P105, DOI 10.1109/CVPRW.2013.23; Boulkenafet Z, 2017, 2017 IEEE INTERNATIONAL JOINT CONFERENCE ON BIOMETRICS (IJCB), P688; Boulkenafet Z, 2016, IEEE T INF FOREN SEC, V11, P1818, DOI 10.1109/TIFS.2016.2555286; Boulkenafet Z, 2015, IEEE IMAGE PROC, P2636, DOI 10.1109/ICIP.2015.7351280; Boulkenafet Z, 2017, IEEE INT CONF AUTOMA, P612, DOI 10.1109/FG.2017.77; Chingovska I., 2012, BIOSIG, P1; Chingovska I, 2015, IEEE T INF FOREN SEC, V10, P787, DOI 10.1109/TIFS.2015.2400392; Choudhury T., 1999, P INT C AUD VID BAS, P176; De Marsico M., 2012, 2012 5th IAPR International Conference on Biometrics (ICB), P73, DOI 10.1109/ICB.2012.6199761; Gahyun Kim, 2012, 2012 5th IAPR International Conference on Biometrics (ICB), P67, DOI 10.1109/ICB.2012.6199760; Galbally J, 2014, IEEE T IMAGE PROCESS, V23, P710, DOI 10.1109/TIP.2013.2292332; Gragnaniello D, 2015, IEEE T INF FOREN SEC, V10, P849, DOI 10.1109/TIFS.2015.2404294; Jourabloo A, 2018, LECT NOTES COMPUT SC, V11217, P297, DOI 10.1007/978-3-030-01261-8_18; Keutzer K, 2016, ARXIV160207360; Kingma DP., 2014, ADAM METHOD STOCHAST; Kollreider K, 2005, FOURTH IEEE WORKSHOP ON AUTOMATIC IDENTIFICATION ADVANCED TECHNOLOGIES, PROCEEDINGS, P75, DOI 10.1109/AUTOID.2005.20; Komulainen J, 2013, P INT C BIOM, P1; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Lagorio A, 2013, I W BIOMETRIC FORENS; Li HL, 2018, IEEE T INF FOREN SEC, V13, P2639, DOI 10.1109/TIFS.2018.2825949; Li HL, 2018, IEEE T INF FOREN SEC, V13, P1794, DOI 10.1109/TIFS.2018.2801312; Li JW, 2004, P SOC PHOTO-OPT INS, V5404, P296, DOI 10.1117/12.541955; Liu YJ, 2018, PROC CVPR IEEE, P389, DOI 10.1109/CVPR.2018.00048; Lukas J, 2006, IEEE T INF FOREN SEC, V1, P205, DOI 10.1109/TIFS.2006.873602; Menotti D, 2015, IEEE T INF FOREN SEC, V10, P864, DOI 10.1109/TIFS.2015.2398817; Pan G, 2011, TELECOMMUN SYST, V47, P215, DOI 10.1007/s11235-010-9313-3; Patel K, 2016, LECT NOTES COMPUT SC, V9967, P611, DOI 10.1007/978-3-319-46654-5_67; Pereira T.D.F., 2013, ICB, P1, DOI DOI 10.1109/ICB.2013.6612981; Pinto A, 2015, IEEE T IMAGE PROCESS, V24, P4726, DOI 10.1109/TIP.2015.2466088; Pinto A, 2015, IEEE T INF FOREN SEC, V10, P1025, DOI 10.1109/TIFS.2015.2395139; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Schroff F, 2015, PROC CVPR IEEE, P815, DOI 10.1109/CVPR.2015.7298682; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Szegedy C., 2016, P IEEE C COMPUTER VI, P2818, DOI DOI 10.1109/CVPR.2016.308; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Tan XY, 2010, LECT NOTES COMPUT SC, V6316, P504, DOI 10.1007/978-3-642-15567-3_37; Wen D, 2015, IEEE T INF FOREN SEC, V10, P746, DOI 10.1109/TIFS.2015.2400395; Yang J., 2014, LEARN CONVOLUTIONAL; Yang JW, 2015, IEEE T INF FOREN SEC, V10, P797, DOI 10.1109/TIFS.2015.2403306; Zhiwei Zhang, 2012, 2012 5th IAPR International Conference on Biometrics (ICB), P26, DOI 10.1109/ICB.2012.6199754	53	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0238058	10.1371/journal.pone.0238058	http://dx.doi.org/10.1371/journal.pone.0238058			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886705	Green Published, gold			2022-12-26	WOS:000571064300047
J	Godino, JG; Wing, D; de Zambotti, M; Baker, FC; Bagot, K; Inkelis, S; Pautz, C; Higgins, M; Nichols, J; Brumback, T; Chevance, G; Colrain, IM; Patrick, K; Tapert, SF				Godino, Job G.; Wing, David; de Zambotti, Massimiliano; Baker, Fiona C.; Bagot, Kara; Inkelis, Sarah; Pautz, Carina; Higgins, Michael; Nichols, Jeanne; Brumback, Ty; Chevance, Guillaume; Colrain, Ian M.; Patrick, Kevin; Tapert, Susan F.			Performance of a commercial multi-sensor wearable (Fitbit Charge HR) in measuring physical activity and sleep in healthy children	PLOS ONE			English	Article							HEART-RATE; YOUNG-ADULTS; ACTIGRAPHY; POLYSOMNOGRAPHY; ACCELEROMETRY; VALIDITY; CALIBRATION; WRISTBAND	Purpose This study sought to assess the performance of the Fitbit Charge HR, a consumer-level multi-sensor activity tracker, to measure physical activity and sleep in children. Methods 59 healthy boys and girls aged 9-11 years old wore a Fitbit Charge HR, and accuracy of physical activity measures were evaluated relative to research-grade measures taken during a combination of 14 standardized laboratory- and field-based assessments of sitting, stationary cycling, treadmill walking or jogging, stair walking, outdoor walking, and agility drills. Accuracy of sleep measures were evaluated relative to polysomnography (PSG) in 26 boys and girls during an at-home unattended PSG overnight recording. The primary analyses included assessment of the agreement (biases) between measures using the Bland-Altman method, and epoch-by-epoch (EBE) analyses on a minute-by-minute basis. Results Fitbit Charge HR underestimated steps (similar to 11.8 steps per minute), heart rate (similar to 3.58 bpm), and metabolic equivalents (similar to 0.55 METs per minute) and overestimated energy expenditure (similar to 0.34 kcal per minute) relative to research-grade measures (p< 0.05). The device showed an overall accuracy of 84.8% for classifying moderate and vigorous physical activity (MVPA) and sedentary and light physical activity (SLPA) (sensitivity MVPA: 85.4%; specificity SLPA: 83.1%). Mean estimates of bias for measuring total sleep time, wake after sleep onset, and heart rate during sleep were 14 min, 9 min, and 1.06 bpm, respectively, with 95.8% sensitivity in classifying sleep and 56.3% specificity in classifying wake epochs. Conclusions Fitbit Charge HR had adequate sensitivity in classifying moderate and vigorous intensity physical activity and sleep, but had limitations in detecting wake, and was more accurate in detecting heart rate during sleep than during exercise, in healthy children. Further research is needed to understand potential challenges and limitations of these consumer devices.	[Godino, Job G.; Wing, David; Pautz, Carina; Higgins, Michael; Nichols, Jeanne; Chevance, Guillaume; Patrick, Kevin] Univ Calif San Diego, Exercise & Phys Act Resource Ctr, La Jolla, CA 92093 USA; [Godino, Job G.; Wing, David; Higgins, Michael; Nichols, Jeanne; Chevance, Guillaume; Patrick, Kevin] Univ Calif San Diego, Ctr Wireless & Populat Hlth Syst, La Jolla, CA 92093 USA; [de Zambotti, Massimiliano; Baker, Fiona C.; Colrain, Ian M.] SRI Int, Ctr Hlth Sci, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA; [Bagot, Kara; Inkelis, Sarah; Tapert, Susan F.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Brumback, Ty] Northern Kentucky Univ, Dept Psychol Sci, Highland Hts, KY USA	University of California System; University of California San Diego; University of California System; University of California San Diego; SRI International; University of California System; University of California San Diego; Northern Kentucky University	Godino, JG (corresponding author), Univ Calif San Diego, Exercise & Phys Act Resource Ctr, La Jolla, CA 92093 USA.; Godino, JG (corresponding author), Univ Calif San Diego, Ctr Wireless & Populat Hlth Syst, La Jolla, CA 92093 USA.	jgodino@ucsd.edu	de Zambotti, Massimiliano/AAD-1992-2019; Tapert, Susan/AHD-0909-2022; Chevance, Guillaume/AAA-3282-2021	de Zambotti, Massimiliano/0000-0002-0057-5977; Tapert, Susan/0000-0001-7259-6112; Baker, Fiona/0000-0001-9602-6165	National Institute on Drug Abuse through the Adolescent Brain Cognitive Development Study Coordinating Center [1U24 DA041147, T32 AA013525]	National Institute on Drug Abuse through the Adolescent Brain Cognitive Development Study Coordinating Center	This study was supported by a grant from the National Institute on Drug Abuse through the Adolescent Brain Cognitive Development Study Coordinating Center (1U24 DA041147; MPIs: Jernigan/Brown) and a fellowship supporting SI (T32 AA013525; MPIs: Riley/Tapert). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Sports Medicine, 2014, ACSMS GUIDELINES EXE; [Anonymous], 2008, 2008 PHYS ACT GUID A; Bagot KS, 2018, DEV COGN NEUROS-NETH, V32, P121, DOI 10.1016/j.dcn.2018.03.008; Berry RB, 2017, J CLIN SLEEP MED, V13, P665, DOI 10.5664/jcsm.6576; Brage S, 2004, J APPL PHYSIOL, V96, P343, DOI 10.1152/japplphysiol.00703.2003; Brage S, 2007, J APPL PHYSIOL, V103, P682, DOI 10.1152/japplphysiol.00092.2006; Brage S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137206; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; de Zambotti M, 2018, CHRONOBIOL INT; de Zambotti M, 2020, SLEEP MED CLIN; De Zambotti M, 2019, MED SCI SPORT EXER, V51, P1538, DOI 10.1249/MSS.0000000000001947; de Zambotti M, 2018, CHRONOBIOL INT, V35, P465, DOI 10.1080/07420528.2017.1413578; de Zambotti M, 2016, PHYSIOL BEHAV, V158, P143, DOI 10.1016/j.physbeh.2016.03.006; Depner CM, 2020, SLEEP, V43, DOI 10.1093/sleep/zsz254; Dobkin BH, 2015, NEUROREHAB NEURAL RE, V25, P788; Dooley Erin E, 2017, JMIR Mhealth Uhealth, V5, pe34, DOI 10.2196/mhealth.7043; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Fakier N, 2011, J ADOLESCENCE, V34, P717, DOI 10.1016/j.adolescence.2010.09.010; Farabi SS, 2017, J CLIN SLEEP MED, V13, P669, DOI 10.5664/jcsm.6580; Gardner R. F., 2016, CANADIAN J CARDIO S1, V32, pS130, DOI DOI 10.1016/j.cjca.2016.07.193; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hallal PC, 2012, LANCET, V380, P190, DOI 10.1016/S0140-6736(12)61027-7; Investigation and Treatment of Glomerular Diseases in Adults, 2005, J BRAS NEFROL, V26, P1; Klepin K, 2019, MED SCI SPORTS EXERC; Kooiman TJM, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0018-5; LaMunion SR, 2019, APPL PHYSIOL NUTR ME, V6, P1873; Lee J-M, 2014, MED SCI SPORTS EXERC, V46, P1840; Luyster FS, 2012, SLEEP, V35, P727, DOI 10.5665/sleep.1846; Marcus CL, 2014, J CLIN SLEEP MED; Meltzer LJ, 2015, SLEEP, V38, P1323, DOI 10.5665/sleep.4918; Meltzer LJ, 2012, SLEEP MED REV, V16, P463, DOI 10.1016/j.smrv.2011.10.002; Meltzer LJ, 2012, SLEEP, V35, P159, DOI 10.5665/sleep.1608; Montgomery-Downs HE, 2012, SLEEP BREATH, V16, P913, DOI 10.1007/s11325-011-0585-y; Pasch KE, 2010, AM J HEALTH BEHAV, V34, P237; Roane BM, 2015, J SLEEP RES, V24, P714, DOI 10.1111/jsr.12317; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; Skripnikova E., 2017, AM J PHYSIOL-REG I, V312, pR412; Small Steps Labs LLC, 2017, SMALL STEPS LABS LLC; Thompson D, 2006, J NUTR, V136, P1037, DOI 10.1093/jn/136.4.1037; Troiano GM, 2014, PROCEEDINGS OF THE 2014 INTERNATIONAL WORKING CONFERENCE ON ADVANCED VISUAL INTERFACES, AVI 2014, P1, DOI 10.1145/2598153.2598184; Tudor-Locke C, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0172-x; Ubrani J, 2017, WRISTWEAR DOMINATES; Wang L, 2017, IEEE ACCESS, V5, P13020, DOI 10.1109/ACCESS.2017.2721098; Wang R, 2016, JAMA CARDIOL, V313, P625; Wareham NJ, 1998, INT J OBESITY, V22, pS30; 2014, REG ANESTH PAIN MED, V9	47	15	16	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2020	15	9							e0237719	10.1371/journal.pone.0237719	http://dx.doi.org/10.1371/journal.pone.0237719			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QN	32886714	gold, Green Published			2022-12-26	WOS:000571064300026
J	Shi, CH; Deng, JT; Chiu, M; Chen, YX; O'Brien, ER				Shi, Chunhua; Deng, Jingti; Chiu, Michael; Chen, Yong-Xiang; O'Brien, Edward R.			Heat shock protein 27 immune complex altered signaling and transport (ICAST): Novel mechanisms of attenuating inflammation	FASEB JOURNAL			English	Article						antibodies; atherosclerosis; CD-36; cholesterol; Heat Shock Protein 27; immune complex; Inflammation; macrophage; scavenger receptors; Isignaling; SR-AI; TLR4; vaccination	NF-KAPPA-B; ISOTHERMAL TITRATION CALORIMETRY; PROTEOMIC APPROACH; HEAT-SHOCK-PROTEIN-27; ATHEROSCLEROSIS; EXPRESSION; ACTIVATION; ESTROGEN; PLAQUES; BINDING	Blood levels of heat shock protein (HSP27) and natural IgG auto-antibodies to HSP27 (AAbs) are higher in healthy controls compared to cardiovascular disease patients. Vaccination of mice with recombinant HSP25 (rHSP25, murine ortholog of human rHSP27) increased AAb levels, attenuated atherogenesis and reduced plaque inflammation and cholesterol content. We sought to determine if the HSP27 immune complex (IC) altered M phi inflammation signaling (Toll Like Receptor 4; TLR4), and scavenger receptors involved in cholesterol uptake (SR-AI, CD-36). Combining a validated polyclonal IgG anti-HSP27 antibody (PAb) with rHSP27 enhanced binding to THP-1 M phi cell membranes and activation of NF-kappa B signaling via TLR4, competing away LPS and effecting an anti-inflammatory cytokine profile. Similarly, adding the PAb with rHSP27 enhanced binding to SR-AI and CD-36, as well as lowered oxLDL binding in HEK293 cells separately transfected with SR-AI and CD-36, or THP-1 M phi. Finally, the PAb enhanced the uptake and internalization of rHSP27 in THP-1 M phi. Thus, the HSP27 IC potentiates HSP27 cell membrane signaling with receptors involved in modulating inflammation and cholesterol uptake, as well as HSP27 internalization. Going forward, we are focusing on the development of HSP27 Immune Complex Altered Signaling and Transport (ICAST) as a means of modulating inflammation.	[Shi, Chunhua; Deng, Jingti; Chiu, Michael; Chen, Yong-Xiang; O'Brien, Edward R.] Univ Calgary, Cumming Sch Med, Libin Cardiovasc Inst, Div Cardiol,Dept Cardiac Sci, Calgary, AB, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary	O'Brien, ER (corresponding author), Univ Calgary, Cumming Sch Med, Libin Cardiovasc Inst, Div Cardiol,Dept Cardiac Sci,Hlth Res & Innovat C, GC68,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	ermobrie@ucalgary.ca			CIHR [PJT-149015] Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR))		Batulan Z, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00285; Brand K, 1996, J CLIN INVEST, V97, P1715, DOI 10.1172/JCI118598; Chen Y-X, 2020, HEAT SHOCK PROTEIN 2; Collins T, 2001, J CLIN INVEST, V107, P255, DOI 10.1172/JCI10373; Crowe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077383; Cuerrier CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055867; Feig AL, 2007, BIOPOLYMERS, V87, P293, DOI 10.1002/bip.20816; Gaisford S, 2005, CURR PHARM BIOTECHNO, V6, P181, DOI 10.2174/1389201054022913; Hajra L, 2000, P NATL ACAD SCI USA, V97, P9052, DOI 10.1073/pnas.97.16.9052; Kanters E, 2003, J CLIN INVEST, V112, P1176, DOI 10.1172/JCI18580; Ladbury JE, 1996, CHEM BIOL, V3, P791, DOI 10.1016/S1074-5521(96)90063-0; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Lepedda AJ, 2009, ATHEROSCLEROSIS, V203, P112, DOI 10.1016/j.atherosclerosis.2008.07.001; Liang WZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26231; Martin-Ventura JL, 2004, CIRCULATION, V110, P2216, DOI 10.1161/01.CIR.0000136814.87170.B1; Miller H, 2005, ARTERIOSCL THROM VAS, V25, pE10, DOI 10.1161/01.ATV.0000156536.89752.8e; Park HK, 2006, CIRCULATION, V114, P886, DOI 10.1161/CIRCULATIONAHA.105.541219; Raizman JE, 2013, BBA-MOL CELL BIOL L, V1831, P1721, DOI 10.1016/j.bbalip.2013.07.015; Rayner K, 2008, CIRC RES, V103, P133, DOI 10.1161/CIRCRESAHA.108.172155; Rayner K, 2009, ARTERIOSCL THROM VAS, V29, P1751, DOI 10.1161/ATVBAHA.109.193656; Salari S, 2013, CELL STRESS CHAPERON, V18, P53, DOI 10.1007/s12192-012-0356-0; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Seibert TA, 2013, J AM COLL CARDIOL, V62, P1446, DOI 10.1016/j.jacc.2013.05.041; Shevtsov M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051263; Steinbrecher UP, 1999, BBA-MOL CELL BIOL L, V1436, P279, DOI 10.1016/S0005-2760(98)00127-1; Thuringer D, 2013, FASEB J, V27, P4169, DOI 10.1096/fj.12-226977; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Venu VKP, 2017, FASEB J, V31, P2364, DOI 10.1096/fj.201601188R	29	5	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14287	14301		10.1096/fj.202001389RR	http://dx.doi.org/10.1096/fj.202001389RR		SEP 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32888229	Green Submitted			2022-12-26	WOS:000568289700001
J	Abdel-Rhman, SH				Abdel-Rhman, Shaymaa H.			Characterization of beta-lactam resistance inK.pneumoniaeassociated with ready-to-eat processed meat in Egypt	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; MOLECULAR EPIDEMIOLOGY; EMERGENCE; GENES; DELHI	K.pneumoniaewas known as a nosocomial infection that causes human diseases. It is considered as one of the food-borne pathogens as it causes septicemia and diarrhea in humans. This study aims to characterizeK.pneumoniaestrains isolated from ready to eat processed meat phenotypically and genetically. Three hundred and fifty ready to eat processed meat (Luncheon-meat) samples were collected. Forty-four (12.6%)K.pneumoniaestrains were isolated and bio-typed, where the majority were identified to belong to biotype B1. K1 and K2 serotypes were detected and strains were classified as hypermucoviscousK.pneumoniae(HVKP) and classicK.pneumoniae(CKP) (26 and 18 isolates, respectively). The isolates were resistant to several classes of beta-lactam antibiotics, ceftazidim and cefotaxime (95.5%), cefoxitin (93.2%), ertapenem (90.9%) and amoxicillin-clavulanic acid (86.4%). They were classified as extended spectrum beta-lactamases (ESBLs), AmpC or carbapenemase-producers phenotypically. Eighteen beta-lactamase genes were investigated by PCR. The most prominent genes wereSHV(63.6%),TEM(52.2%),CTX-M15(50%),AMPC(47.7%),CIT-M(45.5%) andVIM(43.2%). Co-detection of beta-lactam resistance genes revealed 42 gene profiles. Twenty-four isolates had the complete efflux system (AcrAB-Tox196;C). Besides, Integrons (I, II, III) were detected in 20 isolates. Molecular typing by ERIC-PCR showed high genetic diversity between isolates as 34 different patterns were identified. Overall, this study confirmed the hazards posed by the presence of multiple resistance genes in the same isolate and this should not be undervalued. Besides, the horizontal transfer of plasmid harboring resistance genes between isolates in food represents potential health risks for consumers in Egypt and so the control and inhibition plans are necessary.	[Abdel-Rhman, Shaymaa H.] Mansoura Univ, Fac Pharm, Microbiol & Immunol Dept, Mansoura, Egypt; [Abdel-Rhman, Shaymaa H.] Taibah Univ, Fac Pharm, Dept Pharmaceut & Pharmaceut Biotechnol, Almadinah Al Munawwarah, Saudi Arabia	Egyptian Knowledge Bank (EKB); Mansoura University; Taibah University	Abdel-Rhman, SH (corresponding author), Mansoura Univ, Fac Pharm, Microbiol & Immunol Dept, Mansoura, Egypt.; Abdel-Rhman, SH (corresponding author), Taibah Univ, Fac Pharm, Dept Pharmaceut & Pharmaceut Biotechnol, Almadinah Al Munawwarah, Saudi Arabia.	shaymaahassan@mans.edu.eg	Abdel-Rhman, Shaymaa/ABE-4730-2021; Abdel-Rhman, Shaymaa/I-1751-2018	Abdel-Rhman, Shaymaa/0000-0002-6714-547X				Abouelfetouh A, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0611-6; Aljanaby A. A. J., 2016, African Journal of Microbiology Research, V10, P829; AlTamimi M, 2017, SAUDI J BIOL SCI, V24, P155, DOI 10.1016/j.sjbs.2016.07.004; [Anonymous], 2017, Med Lett Drugs Ther, V59, pe70; [Anonymous], 2017, LANCET HIV, V2017, pPE475; Anonymous, 2008, PDA J PHARM SCI TECH, V62, P1; [Anonymous], 2011, CARDOZO J INT COMP L, V20, P1; [Anonymous], 2017, J PEDIAT REHAB MED, V10, ps1; [Anonymous], 2015, BMJ, V2015, ph1887; [Anonymous], 2019, CIRCULATION, V2019; Barwa R., 2012, African Journal of Microbiology Research, V6, P6924; Benmahmod AB, 2019, MICROB DRUG RESIST, V25, P480, DOI 10.1089/mdr.2018.0141; Chirindze LM, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3154-1; Coudron PE, 2000, J CLIN MICROBIOL, V38, P1791, DOI 10.1128/JCM.38.5.1791-1796.2000; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Du DJ, 2014, NATURE, V509, P512, DOI 10.1038/nature13205; EDMONDSON AS, 1979, J APPL BACTERIOL, V46, P579, DOI 10.1111/j.1365-2672.1979.tb00858.x; Elsherif RH, 2016, J EGYPT PUBLIC HEAL, V91, P73, DOI 10.1097/01.EPX.0000483165.56114.d8; Ferreira RL, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03198; Gundran RS, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-1975-9; Guo YM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153561; Hardiono Budiono, 2018, FOLIA MED INDONESIAN, V54, P10; Hasani A, 2017, ARCH PEDIATR INFECT, V5, DOI 10.5812/pedinfect.36616; Hu YQ, 2020, J MICROBIOL BIOTECHN, V30, P856, DOI 10.4014/jmb.2001.01005; Japoni-Nejad Alireza, 2014, Osong Public Health Res Perspect, V5, P333, DOI 10.1016/j.phrp.2014.09.003; Kamel NA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202119; Kazemian H, 2019, MED PRIN PRACT, V28, P547, DOI 10.1159/000500311; Khalil MAF, 2017, MICROB DRUG RESIST, V23, P480, DOI 10.1089/mdr.2016.0003; Kotb S, 2020, ANTIMICROB RESIST IN, V9, DOI 10.1186/s13756-019-0639-7; Lalzampuia H, 2013, INDIAN J MICROBIOL, V53, P291, DOI 10.1007/s12088-013-0378-z; Manchanda V, 2003, J ANTIMICROB CHEMOTH, V51, P415, DOI 10.1093/jac/dkg098; Messaoudi A, 2019, AFR HEALTH SCI, V19, P2008, DOI 10.4314/ahs.v19i2.24; Munoz MA, 2007, J CLIN MICROBIOL, V45, P3964, DOI 10.1128/JCM.00795-07; Nordmann P, 2011, J CLIN MICROBIOL, V49, P718, DOI 10.1128/JCM.01773-10; Osman KM, 2014, PATHOG GLOB HEALTH, V108, P191, DOI 10.1179/2047773214Y.0000000141; Parsaie Mehr V, 2017, INFECT EPIDEMIOLMICR, V3, P112, DOI [10.18869/modares.iem.3.4.112, DOI 10.18869/MODARES.IEM.3.4.112]; Falomir MP, 2013, FOODBORNE PATHOG DIS, V10, P1002, DOI 10.1089/fpd.2013.1552; Rizk DE, 2017, MICROB PATHOGENESIS, V112, P50, DOI 10.1016/j.micpath.2017.09.023; Sakkas H, 2019, ANTIBIOTICS-BASEL, V8, DOI 10.3390/antibiotics8030085; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Sato S, 2019, J INFECT CHEMOTHER, V25, P137, DOI 10.1016/j.jiac.2018.07.006; Sedighi M, 2017, REV SOC BRAS MED TRO, V50, P321, DOI 10.1590/0037-8682-0001-2017; Shon AS, 2013, VIRULENCE, V4, P107, DOI 10.4161/viru.22718; Vinueza-Burgos Christian, 2019, PLoS One, V14, pe0207567, DOI 10.1371/journal.pone.0207567; Wang BJ, 2020, INT J INFECT DIS, V93, P311, DOI 10.1016/j.ijid.2020.02.009; Wasfi R, 2016, SCI REP-UK, V6, DOI 10.1038/srep38929; Williams, 1984, BERGEYS MANUAL SYSTE; Yazgan B, 2018, J INFECT DEV COUNTR, V12, P156, DOI 10.3855/jidc.9677; Zhang S, 2018, STRUCT HEALTH MONIT, V17, P3, DOI 10.1177/1475921716682432; Zhou ML, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00395-18, 10.1128/jcm.00395-18]; Zorgani Abdulaziz, 2017, Open Microbiol J, V11, P195, DOI 10.2174/1874285801711010195	51	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238747	10.1371/journal.pone.0238747	http://dx.doi.org/10.1371/journal.pone.0238747			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881936	gold, Green Published			2022-12-26	WOS:000571063300041
J	Cinar, MU; Akyuz, B; Arslan, K; White, SN; Neibergs, HL; Gumussoy, KS				Cinar, Mehmet Ulas; Akyuz, Bilal; Arslan, Korhan; White, Stephen N.; Neibergs, Holly L.; Gumussoy, Kadir Semih			The EDN2 rs110287192 gene polymorphism is associated with paratuberculosis susceptibility in multibreed cattle population	PLOS ONE			English	Article							AVIUM SUBSP PARATUBERCULOSIS; JOHNES-DISEASE; DAIRY-CATTLE; MYCOBACTERIUM-PARATUBERCULOSIS; ENDOTHELINS; RESISTANCE	Paratuberculosis (pTB), also known as Johne's disease (JD), is a contagious, chronic, and granulomatous inflammatory disease of the intestines of ruminants which is caused byMycobacterium aviumsubsp.paratuberculosis(MAP) infection, resulting in billions of dollars in economic losses worldwide. Since, currently, no effective cure is available for MAP infection, it is important to explore the genetic variants that affect the host MAP susceptibility. The aim of this study was to analyze a potential association betweenEDN2synonymous gene mutations (rs110287192,rs109651404 and rs136707411), that modifies susceptibility to pTB.EDN2 rs110287192,rs109651404andrs136707411mutations were genotyped in 68 infected and 753 healthy animals from East Anatolian Red crossbred, Anatolian Black crossbred and Holstein breed cattle by using Custom TaqMan SNP Genotyping Assays. For pTB status, serum antibody levels S/P >= 1.0 were assessed in carriers of the differentEDN2genotypes.EDN2 rs110287192mutation showed a significant association with bovine pTB (adj. p < 0.05). Forrs110287192locus, the odd ratios for GG and TG genotypes versus TT genotypes were 1.73; (95% CI = 0.34-8.59) and 0.53 (95% CI = 0.12-2.37) respectively, which indicated that proportion of TG heterozygotes were significantly higher in control animals as compared to pTB animals. On the other hand, whilers136707411mutation showed a suggestive association with pTB status in the examined cattle population (nominal p < 0.05); no association was detected betweenrs109651404genotypes and pTB status. Selecting animals againstrs110287192-GG genotype may decrease the risk of pTB in cattle of theBos taurus taurussubspecies.	[Cinar, Mehmet Ulas] Erciyes Univ, Fac Agr, Dept Anim Sci, Kayseri, Turkey; [Cinar, Mehmet Ulas; White, Stephen N.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Akyuz, Bilal; Arslan, Korhan] Erciyes Univ, Fac Vet Med, Dept Genet, Kayseri, Turkey; [White, Stephen N.] ARS, Anim Dis Res Unit, USDA, Pullman, WA USA; [White, Stephen N.; Neibergs, Holly L.] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; [Neibergs, Holly L.] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA; [Gumussoy, Kadir Semih] Erciyes Univ, Fac Vet Med, Dept Microbiol, Kayseri, Turkey	Erciyes University; Washington State University; Erciyes University; United States Department of Agriculture (USDA); Washington State University; Washington State University; Erciyes University	Cinar, MU (corresponding author), Erciyes Univ, Fac Agr, Dept Anim Sci, Kayseri, Turkey.; Cinar, MU (corresponding author), Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.	mucinar@erciyes.edu.tr	Akyuz, Bilal/AAD-8103-2019; arslan, korhan/AAT-1052-2021	White, Stephen N./0000-0001-9255-6054	Turkish Research Council (Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)) [218O128]	Turkish Research Council (Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This research was financially supported by the Turkish Research Council (Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)) grant number 218O128 to MUC and the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattarai B, 2013, PREV VET MED, V112, P330, DOI 10.1016/j.prevetmed.2013.08.009; Bishop SC, 2014, LIVEST SCI, V166, P190, DOI 10.1016/j.livsci.2014.04.034; Cacioppo JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096115; Cetinkaya B, 1997, PREV VET MED, V32, P253, DOI 10.1016/S0167-5877(97)00028-7; Chiu LJV, 2018, J DAIRY SCI, V101, P6443, DOI 10.3168/jds.2017-13175; Cinar MU, 2018, J GENET, V97, P1147, DOI 10.1007/s12041-018-1008-7; Davenport AP, 2016, PHARMACOL REV, V68, P357, DOI 10.1124/pr.115.011833; Ervin JM, 2017, ANIM REPROD SCI, V186, P1, DOI 10.1016/j.anireprosci.2017.09.008; Gonzalez-Ruiz S, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9090636; Groenendaal H, 2002, PREV VET MED, V54, P225, DOI 10.1016/S0167-5877(02)00027-2; IWAI M, 1991, ENDOCRINOLOGY, V129, P1909, DOI 10.1210/endo-129-4-1909; Klipper E, 2010, ENDOCRINOLOGY, V151, P1914, DOI 10.1210/en.2009-0767; Kohan DE, 2011, PHYSIOL REV, V91, P1, DOI 10.1152/physrev.00060.2009; LAMBRECHT RS, 1992, DIAGN MICR INFEC DIS, V15, P239, DOI 10.1016/0732-8893(92)90119-E; Liu HK, 2019, GEN COMP ENDOCR, V283, DOI 10.1016/j.ygcen.2019.113231; Marce C, 2010, J DAIRY SCI, V93, P4455, DOI 10.3168/jds.2010-3139; McNees AL, 2015, EXPERT REV GASTROENT, V9, P1523, DOI 10.1586/17474124.2015.1093931; Nakamura H, 2018, PEDIATR SURG INT, V34, P149, DOI 10.1007/s00383-017-4182-4; Neibergs HL, 2014, GOOGLE PATENTS; Neibergs HL, 2010, MAMM GENOME, V21, P419, DOI 10.1007/s00335-010-9278-2; Neupane M, 2018, ANIM GENET, V49, P527, DOI 10.1111/age.12718; Norton S, 2009, NEW ZEAL VET J, V57, P34, DOI 10.1080/00480169.2009.36866; Pierce ES, 2018, INFECT AGENTS CANCER, V13, DOI 10.1186/s13027-017-0172-3; Raadsma HW, 2010, BREEDING DIS RESISTA, DOI [10.1079/9781845935559.0000, DOI 10.1079/9781845935559.0000]; Rathnaiah G, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00187; Schmitt H, 2019, SEMIN IMMUNOPATHOL, V41, P737, DOI 10.1007/s00281-019-00756-1; Settles M, 2009, ANIM GENET, V40, P655, DOI 10.1111/j.1365-2052.2009.01896.x; Sorge US, 2011, J DAIRY SCI, V94, P754, DOI 10.3168/jds.2010-3404; Takizawa S, 2005, J MOL ENDOCRINOL, V35, P201, DOI 10.1677/jme.1.01787; Timms VJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148731; van Hulzen KJE, 2014, J DAIRY SCI, V97, P1762, DOI 10.3168/jds.2013-7032; White SN, 2013, VIRUSES-BASEL, V5, P1466, DOI 10.3390/v5061466; Whittington R, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-1943-4; Whittington RJ, 2004, APPL ENVIRON MICROB, V70, P2989, DOI 10.1128/AEM.70.5.2989-3004.2004; Yildiz HM, 2015, MACROMOL BIOSCI, V15, P712, DOI 10.1002/mabi.201400473	35	2	2	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238631	10.1371/journal.pone.0238631	http://dx.doi.org/10.1371/journal.pone.0238631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881967	Green Published, gold			2022-12-26	WOS:000571063300016
J	Lim, SJ; Yeo, I; Park, CW; Lee, H; Park, YS; Lee, JI				Lim, Seung-Jae; Yeo, Ingwon; Park, Chan-Woo; Lee, Hyeon; Park, Youn-Soo; Lee, Jung-Il			Risk factors for osteonecrosis of the femoral head in brain tumor patients receiving corticosteroid after surgery	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; STEROID-INDUCED OSTEONECROSIS; AVASCULAR NECROSIS; NONTRAUMATIC OSTEONECROSIS; COMBINATION CHEMOTHERAPY; IDIOPATHIC OSTEONECROSIS; DYSBARIC OSTEONECROSIS; PREDICTIVE FACTORS; TESTICULAR CANCER; OXIDATIVE STRESS	Purpose Non-traumatic osteonecrosis of the femoral head (ONFH) is a plausible complication in brain tumor patients. Frequent use of corticosteroid therapy, chemotherapy, and oxidative stress for managing brain tumors may be associated with the development of ONFH. However, there is little knowledge on the prevalence and risk factors of ONFH from brain tumor. This study aimed to investigate the prevalence and risk factors of ONFH in patients with primary brain tumors. Methods This retrospective cohort study included data from consecutive patients between December 2005 and August 2016 from a tertiary university hospital in South Korea. A total of 73 cases of ONFH were identified among 10,674 primary brain tumor patients. After excluding subjects (25 out of 73) with missing data, history of alcohol consumption or smoking, history of femoral bone trauma or surgery, comorbidities such as systemic lupus erythematosus (SLE), sickle cell disease, cancer patients other than brain tumor, and previous diagnosis of contralateral ONFH, we performed a 1:2 propensity score-matched, case-control study (ONFH group, 48; control group, 96). Risk factors of ONFH in primary brain tumor were evaluated by univariate and multivariate logistic regression analyses. Results The prevalence of ONFH in patients with surgical resection of primary brain tumor was 683.9 per 100,000 persons (73 of 10,674). In this cohort, 55 of 74 patients (74.3%) underwent THA for ONFH treatment. We found that diabetes was an independent factor associated with an increased risk of ONFH in primary brain tumor patients (OR = 7.201, 95% CI, 1.349-38.453, p = 0.021). There was a significant difference in univariate analysis, including panhypopituitarism (OR = 4.394, 95% CI, 1.794-11.008, p = 0.002), supratentorial location of brain tumor (OR = 2.616, 95% CI, 1.245-5.499, p = 0.011), and chemotherapy (OR = 2.867, 95% CI, 1.018-8.069, p = 0.046). Conclusions This study demonstrated that the prevalence of ONFH after surgical resection of primary brain tumor was 0.68%. Diabetes was an independent risk factor for developing ONFH, whereas corticosteroid dose was not. Routine screening for brain tumor-associated ONFH is not recommended; however, a high index of clinical suspicion in these patients at risk may allow for early intervention and preservation of the joints.	[Lim, Seung-Jae; Park, Chan-Woo; Lee, Hyeon; Park, Youn-Soo] Sungkyunkwan Univ, Samsung Med Ctr, Dept Orthoped Surg, Sch Med, Seoul, South Korea; [Yeo, Ingwon] Sejong Gen Hosp, Dept Orthoped Surg, Bucheon, South Korea; [Lee, Jung-Il] Sungkyunkwan Univ, Samsung Med Ctr, Dept Neurosurg, Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sejong General Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center	Park, CW (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Orthoped Surg, Sch Med, Seoul, South Korea.; Lee, JI (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Neurosurg, Sch Med, Seoul, South Korea.	existcwp@gmail.com; jilee@skku.edu						ABELES M, 1978, ARCH INTERN MED, V138, P750, DOI 10.1001/archinte.138.5.750; Alarcon GS, 2006, ANN RHEUM DIS, V65, P1168, DOI 10.1136/ard.200X.046896; [Anonymous], 2019, BRAIN STIMUL MAR; [Anonymous], 2016, THE TOTAL AUDIENCE R; Assouline-Dayan Y, 2002, SEMIN ARTHRITIS RHEU, V32, P94, DOI 10.1053/sarh.2002.33724; Bernbeck B, 2002, MED PEDIATR ONCOL, V39, P47, DOI 10.1002/mpo.1366; Borges AH, 2017, CLIN INFECT DIS, V64, P1413, DOI 10.1093/cid/cix167; Calder JDF, 2004, J BONE JOINT SURG BR, V86B, P1209, DOI 10.1302/0301-620X.86B8.14834; Chan K L, 2012, Open Orthop J, V6, P449, DOI 10.2174/1874325001206010449; Chen DQ, 2018, INT ORTHOP, V42, P1485, DOI 10.1007/s00264-018-3871-5; Choi HR, 2015, CURR REV MUSCULOSKE, V8, P210, DOI 10.1007/s12178-015-9278-7; Cook AM, 1999, CLIN ONCOL-UK, V11, P126, DOI 10.1053/clon.1999.9027; Cook AM, 2001, BRIT J CANCER, V85, P1624, DOI 10.1054/bjoc.2001.2155; Daoud AM, 2016, CUREUS, V8, DOI 10.7759/cureus.521; Deutsch MB, 2013, J NEURO-ONCOL, V113, P111, DOI 10.1007/s11060-013-1096-4; EVANS PH, 1993, BRIT MED BULL, V49, P577, DOI 10.1093/oxfordjournals.bmb.a072632; FAST A, 1984, J NEUROSURG, V61, P983, DOI 10.3171/jns.1984.61.5.0983; FELSON DT, 1987, LANCET, V1, P902; Forrai Gabor, 1994, Orvosi Hetilap, V135, P1695; Fukushima W, 2010, CLIN ORTHOP RELAT R, V468, P2715, DOI 10.1007/s11999-010-1292-x; Gladman DD, 2001, J RHEUMATOL, V28, P761; Glueck C J, 2003, Curr Hematol Rep, V2, P417; Gogas H, 1996, GYNECOL ONCOL, V63, P379, DOI 10.1006/gyno.1996.0339; Goyal G, 2015, FUTURE ONCOL, V11, P2459, DOI 10.2217/fon.15.114; Guerado E, 2016, INJURY, V47, pS16, DOI 10.1016/S0020-1383(16)30835-X; HANADA T, 1989, EUR J PEDIATR, V149, P162, DOI 10.1007/BF01958270; HARPER PG, 1984, BRIT MED J, V288, P267, DOI 10.1136/bmj.288.6413.267; HIROTA Y, 1993, AM J EPIDEMIOL, V137, P530, DOI 10.1093/oxfordjournals.aje.a116706; Huang D, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7839101; Ichiseki T, 2006, RHEUMATOLOGY, V45, P287, DOI 10.1093/rheumatology/kei149; Ichiseki T, 2004, J ORTHOP SCI, V9, P509, DOI 10.1007/s00776-004-0816-1; Ichiseki T, 2011, ARTHRITIS RHEUM-US, V63, P2138, DOI 10.1002/art.30365; ISHII E, 1984, EUR J PEDIATR, V143, P152, DOI 10.1007/BF00445806; JONES DN, 1994, J NUCL MED, V35, P1347; Kaila R, 2006, CLIN J SPORT MED, V16, P175, DOI 10.1097/00042752-200603000-00016; Kang JS, 2013, INT ORTHOP, V37, P379, DOI 10.1007/s00264-013-1775-y; Kang JS, 2009, J ARTHROPLASTY, V24, P1178, DOI 10.1016/j.arth.2009.05.022; Kennedy JW, 2015, INT J RHEUMATOL, V2015, DOI 10.1155/2015/475489; Khalil H, 2017, DIABETES METAB SYND, V11, pS133, DOI 10.1016/j.dsx.2016.12.022; Kim TH, 2008, OSTEOARTHR CARTILAGE, V16, P1060, DOI 10.1016/j.joca.2008.02.004; Koo KH, 2002, CLIN RHEUMATOL, V21, P299, DOI 10.1007/s100670200078; Krentz AJ, 2007, DIABETES OBES METAB, V9, P781, DOI 10.1111/j.1463-1326.2007.00670.x; Kunyakham W, 2012, ASIAN PAC J ALLERGY, V30, P152; Kuribayashi M, 2010, ACTA ORTHOP, V81, P206, DOI 10.3109/17453671003587101; Lai SW, 2019, DIABETES CARE, V42, P39, DOI 10.2337/dc18-1258; Lehner CE, 1997, CLIN ORTHOP RELAT R, P320; Lim SJ, 2019, J CLIN MED, V8, DOI 10.3390/jcm8101703; MARYMONT JV, 1986, CLIN ORTHOP RELAT R, P150; MCCLUSKEY J, 1982, BRIT MED J, V284, P333, DOI 10.1136/bmj.284.6312.333; Mikami T, 2010, J ORTHOP SCI, V15, P674, DOI 10.1007/s00776-010-1516-7; Miyanishi K, 1999, ANN RHEUM DIS, V58, P514, DOI 10.1136/ard.58.8.514; Mok CC, 1998, BRIT J RHEUMATOL, V37, P895; Mok MY, 2000, ANN RHEUM DIS, V59, P462, DOI 10.1136/ard.59.6.462; MONT MA, 1995, J BONE JOINT SURG AM, V77A, P459, DOI 10.2106/00004623-199503000-00018; Mont MA, 1997, J RHEUMATOL, V24, P654; Mont MA, 2015, J BONE JOINT SURG AM, V97A, P1604, DOI 10.2106/JBJS.O.00071; Mont MA, 2015, J ARTHROPLASTY, V30, P1506, DOI 10.1016/j.arth.2015.03.036; Moya-Angeler J, 2015, WORLD J ORTHOP, V6, P590, DOI 10.5312/wjo.v6.i8.590; NAGASAWA K, 1989, ANN RHEUM DIS, V48, P672, DOI 10.1136/ard.48.8.672; Newland AM, 2010, ORTHOPEDICS, V33, P413, DOI 10.3928/01477447-20100429-22; PERLOFF M, 1980, CANCER TREAT REP, V64, P361; Rao SS, 2019, SURG ONCOL, V28, P214, DOI 10.1016/j.suronc.2019.02.001; Seamon J, 2012, ARTHRITIS, DOI 10.1155/2012/601763; Sharareh B, 2015, CLIN J SPORT MED, V25, P153, DOI 10.1097/JSM.0000000000000093; Shim K, 2008, DRUG SAFETY, V31, P359, DOI 10.2165/00002018-200831050-00001; Soucacos PN, 2001, CLIN ORTHOP RELAT R, P120; Tokuhara Y, 2009, J ORTHOP SCI, V14, P794, DOI 10.1007/s00776-009-1400-5; Uea-Areewongsa P, 2009, JCR-J CLIN RHEUMATOL, V15, P345, DOI 10.1097/RHU.0b013e3181ba3423; Wing PC, 1998, SPINAL CORD, V36, P633, DOI 10.1038/sj.sc.3100647; Winquist EW, 2001, AM J CLIN ONCOL-CANC, V24, P603, DOI 10.1097/00000421-200112000-00015; Wong GKC, 2005, ANZ J SURG, V75, P409, DOI 10.1111/j.1445-2197.2005.03389.x; Yamaguchi R, 2011, ARTHRITIS RHEUM-US, V63, P3169, DOI 10.1002/art.30484; Yoon BH, 2019, J ARTHROPLASTY, V34, P163, DOI 10.1016/j.arth.2018.09.005; Zalavras CG, 2014, J AM ACAD ORTHOP SUR, V22, P455, DOI 10.5435/JAAOS-22-07-455; Zhao Feng-chao, 2012, Orthop Surg, V4, P28, DOI 10.1111/j.1757-7861.2011.00163.x	75	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238368	10.1371/journal.pone.0238368	http://dx.doi.org/10.1371/journal.pone.0238368			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881966	Green Published, gold			2022-12-26	WOS:000571063300019
J	van Hinte, G; Leijendekkers, RA; te Molder, B; Jansen, L; Bol, C; Merkx, MAW; Takes, R; Nijhuis-van der Sanden, MWG; Speksnijder, CM				van Hinte, Gerben; Leijendekkers, Ruud A.; te Molder, Bram; Jansen, Lizzy; Bol, Corinda; Merkx, Matthias A. W.; Takes, Robert; Nijhuis-van der Sanden, Maria W. G.; Speksnijder, Caroline M.			Reproducibility of measurements on physical performance in head and neck cancer survivors; measurements on maximum mouth opening, shoulder and neck function, upper and lower body strength, level of physical mobility, and walking ability	PLOS ONE			English	Article							QUALITY-OF-LIFE; MINIMAL DETECTABLE CHANGE; TEST-RETEST RELIABILITY; PERCEIVED NEED; ORAL-CANCER; GO TEST; PEOPLE; STAND; CHEMORADIOTHERAPY; PREVALENCE	Background Survivors of Head and Neck Cancer experience specific problems in functional performance. The aim of this study was to obtain the test-retest reliability of measurements on Maximal Mouth Opening (MMO), shoulder and neck function, lower and upper body strength, level of mobility and walking ability. Materials and methods Test-retest study design. Measurements on MMO (intra- and extra orally), Active range of motion of shoulders and neck, 30 Seconds Chair Stand Test, Grip Strength, Timed Up and Go test, and Six Minute Walk test. Results In total 50 participants were included. The mean age was 68.6. +/- 9.9 years and median time since end of treatment was 3.0 years (Q1-Q3: 1.0-5.25 years). We found good to excellent test-retest reliability on the core set of measurements (Intraclass Correlation Coefficient (ICC) 0.77 to 0.98). Measurement of MMO with cardboard card, forward flexion shoulder and Six Minute Walk test had a relatively small measurement error (Smallest Detectable Change (SDC) % 5.4% - 15.1%). Measurement of MMO with a caliper, shoulder abduction, shoulder external rotation, later flexion and rotation of the neck, grip strength, 30 Seconds Chair Stand Test, and Timed up and Go test had a relatively large measurement error (SDC% 19.8% - 44.7%). Conclusion This core set of measurements on physical performance is found reliable and therefore able to differentiate in physical performance. The reported measurement errors should be taken into consideration when interpreting the results of repeated measurements. Implications for cancer survivors A core set of physical measurements can be used to measure physical performance in survivors of Head and Neck Cancer.	[van Hinte, Gerben; Leijendekkers, Ruud A.] Radboud Univ Nijmegen, Dept Rehabil, Med Ctr, Nijmegen, Netherlands; [Leijendekkers, Ruud A.] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Orthopaed Res Lab, Med Ctr, Nijmegen, Netherlands; [Leijendekkers, Ruud A.; Nijhuis-van der Sanden, Maria W. G.] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, IQ Healthcare, Med Ctr, Nijmegen, Netherlands; [te Molder, Bram; Jansen, Lizzy; Bol, Corinda] HAN Univ Appl Sci, Res Grp Musculoskeletal Rehabil, Nijmegen, Netherlands; [Merkx, Matthias A. W.; Speksnijder, Caroline M.] Radboud Univ Nijmegen, Dept Oral & Maxillofacial Surg, Med Ctr, Nijmegen, Netherlands; [Takes, Robert] Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Nijmegen, Netherlands; [Speksnijder, Caroline M.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Head & Neck Surg Oncol, Canc Ctr, Utrecht, Netherlands; [Speksnijder, Caroline M.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Oral & Maxillofacial Surg, Utrecht, Netherlands; [Speksnijder, Caroline M.] Univ Utrecht, Univ Med Ctr Utrecht, Special Dent Care, Utrecht, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	van Hinte, G (corresponding author), Radboud Univ Nijmegen, Dept Rehabil, Med Ctr, Nijmegen, Netherlands.	gerben.vanhinte@radboudumc.nl	Merkx, Matthias AW/H-8074-2014; van Hinte, MSc G.J./L-4374-2015; der Sanden, Maria WG Nijhuis-van/B-3463-2012; Speksnijder, Caroline/C-7921-2009; Leijendekkers, R.A./L-4485-2015; Takes, R.P./L-4680-2015	Merkx, Matthias AW/0000-0002-0687-9760; van Hinte, MSc G.J./0000-0001-9357-5388; der Sanden, Maria WG Nijhuis-van/0000-0003-2637-6877; Speksnijder, Caroline/0000-0003-0540-3741; Leijendekkers, R.A./0000-0002-6158-6901; 	"Michel Keijzer Fonds" of the Dutch patient federation	"Michel Keijzer Fonds" of the Dutch patient federation	GvH: This study was funded by the "Michel Keijzer Fonds" of the Dutch patient federation for head and neck cancer survivors. There is no grant number available for this grant. Website fund: https://pvhh.nl/informatie/organisatie/michel-keijzer-fonds/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audette I, 2010, J ORTHOP SPORT PHYS, V40, P318, DOI 10.2519/jospt.2010.3180; Bohannon Richard W, 2005, J Hand Ther, V18, P426, DOI 10.1197/j.jht.2005.07.003; Bossi P, 2019, ANN OTO RHINOL LARYN, V128, P413, DOI 10.1177/0003489419826138; Boyes AW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-150; Byrt T, 1996, EPIDEMIOLOGY, V7, P561, DOI 10.1097/00001648-199609000-00030; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; de Groot RJ, 2019, HEAD NECK-J SCI SPEC, V41, P216, DOI 10.1002/hed.25445; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; de Vet HW, 2011, MEASUREMENT MED PRAC; Dodds RM, 2016, AGE AGEING, V45, P209, DOI 10.1093/ageing/afv192; DONNER A, 1987, STAT MED, V6, P441, DOI 10.1002/sim.4780060404; Eden MM, 2018, PHYSIOTHER THEOR PR, V34, P202, DOI 10.1080/09593985.2017.1390803; Eickmeyer SM, 2014, PM&R, V6, P1073, DOI 10.1016/j.pmrj.2014.05.015; Gane EM, 2019, OTOLARYNG HEAD NECK, V160, P1009, DOI 10.1177/0194599818821885; Gane EM, 2018, J CANCER SURVIV, V12, P619, DOI 10.1007/s11764-018-0697-5; Giuliani M, 2019, SUPPORT CARE CANCER, V27, P539, DOI 10.1007/s00520-018-4343-6; Giuliani M, 2016, HEAD NECK-J SCI SPEC, V38, P1097, DOI 10.1002/hed.24411; Jager-Wittenaar H, 2009, INT J ORAL MAX SURG, V38, P26, DOI 10.1016/j.ijom.2008.10.001; Jager-Wittenaar H, 2011, HEAD NECK-J SCI SPEC, V33, P863, DOI 10.1002/hed.21546; Jansen F, 2018, HEAD NECK-J SCI SPEC, V40, P2633, DOI 10.1002/hed.25358; Jansen F, 2015, SUPPORT CARE CANCER, V23, P1679, DOI 10.1007/s00520-014-2514-7; Jones CJ, 1999, RES Q EXERCISE SPORT, V70, P113, DOI 10.1080/02701367.1999.10608028; Kao SST, 2016, LARYNGOSCOPE, V126, P1572, DOI 10.1002/lary.25894; King TI, 2013, AM J OCCUP THER, V67, P480, DOI 10.5014/ajot.2013.007351; Kolber Morey J., 2011, Physiotherapy Theory and Practice, V27, P176, DOI 10.3109/09593985.2010.481011; Kottner J, 2011, INT J NURS STUD, V48, P659, DOI 10.1016/j.ijnurstu.2011.01.017; Kraaijenga SAC, 2015, ORAL ONCOL, V51, P787, DOI 10.1016/j.oraloncology.2015.05.003; Liu SA, 2006, HEAD NECK-J SCI SPEC, V28, P998, DOI 10.1002/hed.20461; McGarvey AC, 2011, HEAD NECK-J SCI SPEC, V33, P274, DOI 10.1002/hed.21366; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Morris S, 2001, PHYS THER, V81, P810, DOI 10.1093/ptj/81.2.810; Nemeth D, 2017, INT J ORAL MAX SURG, V46, P1229, DOI 10.1016/j.ijom.2017.05.005; Oskam IM, 2013, ORAL ONCOL, V49, P443, DOI 10.1016/j.oraloncology.2012.12.005; Polit DF, 2014, QUAL LIFE RES, V23, P1713, DOI 10.1007/s11136-014-0632-9; Portney LG., 2014, FDN CLIN RES APPL PR; Ries JD, 2009, PHYS THER, V89, P569, DOI 10.2522/ptj.20080258; Rogers LQ, 2006, SUPPORT CARE CANCER, V14, P1012, DOI 10.1007/s00520-006-0044-7; Sammut L, 2014, INT J SPORTS MED, V35, P794, DOI 10.1055/s-0033-1363984; Segura-Orti E, 2011, PHYS THER, V91, P1244, DOI 10.2522/ptj.20100141; Shah Jatin P, 2012, JATIN SHAHS HEAD NEC; SHEPHARD RJ, 1988, SPORTS MED, V5, P185, DOI 10.2165/00007256-198805030-00005; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Speksnijder CM, 2013, HEAD NECK-J SCI SPEC, V35, P1303, DOI 10.1002/hed.23131; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; THOMAS S, 1992, CAN J SPORT SCI, V17, P338; van den Berg MGA, 2008, ORAL ONCOL, V44, P830, DOI 10.1016/j.oraloncology.2007.11.002; van Hinte G, 2019, SUPPORT CARE CANCER, V27, P2553, DOI 10.1007/s00520-018-4534-1; van Wilgen CP, 2004, HEAD NECK-J SCI SPEC, V26, P839, DOI 10.1002/hed.20052; van Wilgen CP, 2003, BRIT J ORAL MAX SURG, V41, P7, DOI 10.1016/S0266-4356(02)00288-7; Wells M, 2015, EUR J CANCER CARE, V24, P748, DOI 10.1111/ecc.12370; Wells M, 2016, SUPPORT CARE CANCER, V24, P2463, DOI 10.1007/s00520-015-3045-6; Wetzels JWGH, 2014, HEAD NECK-J SCI SPEC, V36, P1754, DOI 10.1002/hed.23534	52	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0233271	10.1371/journal.pone.0233271	http://dx.doi.org/10.1371/journal.pone.0233271			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NQ7QD	32881858	Green Published, gold			2022-12-26	WOS:000571063300081
J	Sparks, MA; Burgers, PM; Galletto, R				Sparks, Melanie A.; Burgers, Peter M.; Galletto, Roberto			Pif1, RPA, and FEN1 modulate the ability of DNA polymerase delta to overcome protein barriers during DNA synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA replication; DNA polymerase; DNA polymerase &#948; DNA helicase; Pif1; nucleosome; transcription factors; Reb1; Tbf1; FEN1	OKAZAKI FRAGMENTS; REPLICATION; STRAND; YEAST; HELICASE; BINDING; CHROMATIN; COMPLEX; CLEAVAGE; PATHWAY	Successful DNA replication requires carefully regulated mechanisms to overcome numerous obstacles that naturally occur throughout chromosomal DNA. Scattered across the genome are tightly bound proteins, such as transcription factors and nucleosomes, that are necessary for cell function, but that also have the potential to impede timely DNA replication. Using biochemically reconstituted systems, we show that two transcription factors, yeast Reb1 and Tbf1, and a tightly positioned nucleosome, are strong blocks to the strand displacement DNA synthesis activity of DNA polymerase delta. Although the block imparted by Tbf1 can be overcome by the DNA-binding activity of the single-stranded DNA-binding protein RPA, efficient DNA replication through either a Reb1 or a nucleosome block occurs only in the presence of the 5'-3' DNA helicase Pif1. The Pif1-dependent stimulation of DNA synthesis across strong protein barriers may be beneficial during break-induced replication where barriers are expected to pose a problem to efficient DNA bubble migration. However, in the context of lagging strand DNA synthesis, the efficient disruption of a nucleosome barrier by Pif1 could lead to the futile re-replication of newly synthetized DNA. In the presence of FEN1 endonuclease, the major driver of nick translation during lagging strand replication, Pif1-dependent stimulation of DNA synthesis through a nucleosome or Reb1 barrier is prevented. By cleaving the short 5' tails generated during strand displacement, FEN1 eliminates the entry point for Pif1. We propose that this activity would protect the cell from potential DNA re-replication caused by unwarranted Pif1 interference during lagging strand replication.	[Sparks, Melanie A.; Burgers, Peter M.; Galletto, Roberto] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Burgers, PM; Galletto, R (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	burgers@wustl.edu; galletto@wustl.edu	Burgers, Peter M/AAW-6621-2021	Galletto, Roberto/0000-0001-6435-122X	National Institutes of Health [GM098509, GM118129]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health Grants GM098509 (to R. G.) and GM118129 (to P. B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Annunziato AT, 2015, GENES-BASEL, V6, P353, DOI 10.3390/genes6020353; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; Clemente-Ruiz M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002376; Devbhandari S, 2017, MOL CELL, V65, P131, DOI 10.1016/j.molcel.2016.10.035; Eissenberg JC, 1997, MOL CELL BIOL, V17, P6367, DOI 10.1128/MCB.17.11.6367; Gaillard H, 2015, NAT REV CANCER, V15, P276, DOI 10.1038/nrc3916; Gan HY, 2018, MOL CELL, V72, P140, DOI 10.1016/j.molcel.2018.09.001; Gomes XV, 2000, J BIOL CHEM, V275, P14541, DOI 10.1074/jbc.275.19.14541; Gomes XV, 2000, EMBO J, V19, P3811, DOI 10.1093/emboj/19.14.3811; Groth A, 2009, BIOCHEM CELL BIOL, V87, P51, DOI 10.1139/O08-102; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Henry RA, 2010, J BIOL CHEM, V285, P28496, DOI 10.1074/jbc.M110.131870; Huang HD, 2015, NAT STRUCT MOL BIOL, V22, P618, DOI 10.1038/nsmb.3055; Jaiswal R, 2016, P NATL ACAD SCI USA, V113, pE2267, DOI 10.1073/pnas.1525465113; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Koc KN, 2016, NUCLEIC ACIDS RES, V44, P3811, DOI 10.1093/nar/gkw181; Koering CE, 2000, NUCLEIC ACIDS RES, V28, P2519, DOI 10.1093/nar/28.13.2519; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; Langst G, 2001, MOL CELL, V8, P1085, DOI 10.1016/S1097-2765(01)00397-5; Liu BC, 2017, J BIOL CHEM, V292, P4777, DOI 10.1074/jbc.M116.758599; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Malkova A, 2005, MOL CELL BIOL, V25, P933, DOI 10.1128/MCB.25.3.933-944.2005; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; Mueller-Planitz F, 2013, NAT STRUCT MOL BIOL, V20, P1026, DOI 10.1038/nsmb.2648; Niina T, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005880; Park YJ, 2005, J BIOL CHEM, V280, P1817, DOI 10.1074/jbc.M411347200; Patel DR, 2018, BIOCHEM SOC T, V46, P1643, DOI 10.1042/BST20180308; Pike JE, 2009, J BIOL CHEM, V284, P25170, DOI 10.1074/jbc.M109.023325; Prado F, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020049; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; Rossi SE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07378-5; Saini N, 2013, NATURE, V502, P389, DOI 10.1038/nature12584; Singh SP, 2016, J MOL BIOL, V428, P1053, DOI 10.1016/j.jmb.2016.02.017; Smith DJ, 2012, NATURE, V483, P434, DOI 10.1038/nature10895; Stith CM, 2008, J BIOL CHEM, V283, P34129, DOI 10.1074/jbc.M806668200; Stodola JL, 2016, NAT STRUCT MOL BIOL, V23, P402, DOI 10.1038/nsmb.3207; Struhl K, 2013, NAT STRUCT MOL BIOL, V20, P267, DOI 10.1038/nsmb.2506; Wilson MA, 2013, NATURE, V502, P393, DOI 10.1038/nature12585	39	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2020	295	47					15883	15891		10.1074/jbc.RA120.015699	http://dx.doi.org/10.1074/jbc.RA120.015699			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PA5ED	32913126	Green Published, hybrid			2022-12-26	WOS:000595657900008
J	Zhan, HQ; Najmi, M; Lin, K; Aluri, S; Fiser, A; Goldman, ID; Zhao, RB				Zhan, He-Qin; Najmi, Mitra; Lin, Kai; Aluri, Srinivas; Fiser, Andras; Goldman, I. David; Zhao, Rongbao			A proton-coupled folate transporter mutation causing hereditary folate malabsorption locks the protein in an inward-open conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						methotrexate; proton-coupled folate transporter; PCFT; hereditary folate malabsorption (HFM); reduced folate carrier; facilitative transporters; mutually compensatory mutations; suppressor mutations; homology modeling; folate; proton transport; transporter; mutant	SUBSTITUTED-CYSTEINE ACCESSIBILITY; HUMAN SOLID TUMORS; LACTOSE PERMEASE; TRANSMEMBRANE DOMAIN; CONSERVED MOTIF; PCFT-SLC46A1; IDENTIFICATION; RESIDUES; SLC46A1; FLEXIBILITY	The proton-coupled folate transporter (PCFT, SLC46A1) is required for folate intestinal absorption and transport across the choroid plexus. Recent work has identified a F392V mutation causing hereditary folate malabsorption. However, the residue properties responsible for this loss of function remains unknown. Using site-directed mutagenesis, we observed complete loss of function with charged (Lys, Asp, and Glu) and polar (Thr, Ser, and Gln) Phe-392 substitutions and minimal function with some neutral substitutions; however, F392M retained full function. Using the substituted-cysteine accessibility method (with N-biotinyl aminoethyl methanethiosulfonate labeling), Phe-392 mutations causing loss of function, although preserving membrane expression and trafficking, also resulted in loss of accessibility of the substituted cysteine in P314C-PCFT located within the aqueous translocation pathway. F392V function and accessibility of the P314C cysteine were restored by insertion of a G305L (suppressor) mutation. A S196L mutation localized in proximity to Gly-305 by homology modeling was inactive. However, when inserted into the inactive F392V scaffold, function was restored (mutually compensatory mutations), as was accessibility of the P314C cysteine residue. Reduced function, documented with F392H PCFT, was due to a 15-fold decrease in methotrexate influx V-max, accompanied by a decreased influx K-t (4.5-fold) and K-i (3-fold). The data indicate that Phe-392 is required for rapid oscillation of the carrier among its conformational states and suggest that this is achieved by dampening affinity of the protein for its folate substrates. F392V and other inactivating Phe-392 PCFT mutations lock the protein in its inward-open conformation. Reach (length) and hydrophobicity of Phe-392 appear to be features required for full activity.	[Zhan, He-Qin; Najmi, Mitra; Lin, Kai; Aluri, Srinivas; Goldman, I. David; Zhao, Rongbao] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Goldman, I. David; Zhao, Rongbao] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Fiser, Andras] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10467 USA; [Fiser, Andras] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA; [Zhan, He-Qin] Anhui Med Univ, Sch Basic Med Sci, Dept Pathol, Hefei, Peoples R China; [Lin, Kai] Peoples Liberat Army, Air Force Med Ctr, Beijing, Peoples R China	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Anhui Medical University	Goldman, ID (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA.; Goldman, ID (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.	i.david.goldman@einsteinmed.org			National Institutes of Health [CA082621, GMI18709]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants CA082621 (to I. D. G.) and GMI18709 (to A. F.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aluri S, 2019, J BIOL CHEM, V294, P7245, DOI 10.1074/jbc.RA118.005533; Aluri S, 2018, AM J PHYSIOL-CELL PH, V314, pC289, DOI 10.1152/ajpcell.00215.2017; Aluri S, 2018, BLOOD ADV, V2, P61, DOI 10.1182/bloodadvances.2017012690; Aluri S, 2017, BBA-BIOMEMBRANES, V1859, P2193, DOI 10.1016/j.bbamem.2017.08.006; Anderson CMH, 2010, PHYSIOLOGY, V25, P364, DOI 10.1152/physiol.00027.2010; Cain SM, 2000, J MEMBRANE BIOL, V176, P159, DOI 10.1007/s002320001085; Chua PK, 2003, J VIROL, V77, P7673, DOI 10.1128/JVI.77.13.7673-7676.2003; Desmoulin SK, 2012, CANCER BIOL THER, V13, P1355, DOI 10.4161/cbt.22020; Desmoulin SK, 2011, MOL PHARMACOL, V80, P1096, DOI 10.1124/mol.111.073833; Diop-Bove NK, 2009, MOL CANCER THER, V8, P2424, DOI 10.1158/1535-7163.MCT-08-0938; GRIFFITH J K, 1992, Current Opinion in Cell Biology, V4, P684, DOI 10.1016/0955-0674(92)90090-Y; Hartl DL, 1996, J THEOR BIOL, V182, P303, DOI 10.1006/jtbi.1996.0168; JESSENMARSHALL AE, 1995, J BIOL CHEM, V270, P16251, DOI 10.1074/jbc.270.27.16251; JessenMarshall AE, 1997, J BACTERIOL, V179, P2616, DOI 10.1128/jb.179.8.2616-2622.1997; Jiang DH, 2013, P NATL ACAD SCI USA, V110, P14664, DOI 10.1073/pnas.1308127110; Kronn D., 2017, GENEREVIEWS, P1993; Lasry I, 2008, BLOOD, V112, P2055, DOI 10.1182/blood-2008-04-150276; Lasry I, 2009, BIOCHEM BIOPH RES CO, V386, P426, DOI 10.1016/j.bbrc.2009.06.007; Mahadeo K, 2010, AM J PHYSIOL-CELL PH, V299, pC1153, DOI 10.1152/ajpcell.00113.2010; Mateu MG, 1999, P NATL ACAD SCI USA, V96, P3595, DOI 10.1073/pnas.96.7.3595; Matherly LH, 2018, CANCER CHEMOTH PHARM, V81, P1, DOI 10.1007/s00280-017-3473-8; Nie YL, 2006, J BIOL CHEM, V281, P35779, DOI 10.1074/jbc.M607232200; Nomura N, 2015, NATURE, V526, P397, DOI 10.1038/nature14909; Qiu A, 2007, AM J PHYSIOL-CELL PH, V293, pC1669, DOI 10.1152/ajpcell.00202.2007; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Severance AC, 2017, J PHARMACOL EXP THER, V362, P405, DOI 10.1124/jpet.117.242552; Shin DS, 2013, AM J PHYSIOL-CELL PH, V304, pC1159, DOI 10.1152/ajpcell.00353.2012; Shin DS, 2012, AM J PHYSIOL-CELL PH, V302, pC1405, DOI 10.1152/ajpcell.00435.2011; Shin DS, 2010, BLOOD, V116, P5162, DOI 10.1182/blood-2010-06-291237; Smirnova IN, 2003, BIOCHEMISTRY-US, V42, P3025, DOI 10.1021/bi027329c; Thorpe IF, 2007, P NATL ACAD SCI USA, V104, P8821, DOI 10.1073/pnas.0610064104; Thwaites DT, 2013, CURR OPIN PHARMACOL, V13, P843, DOI 10.1016/j.coph.2013.09.019; Tozawa Y, 2019, CLIN IMMUNOL, V208, DOI 10.1016/j.clim.2019.108256; Visentin M, 2015, AM J PHYSIOL-CELL PH, V308, pC631, DOI 10.1152/ajpcell.00238.2014; Visentin M, 2014, ANNU REV PHYSIOL, V76, P251, DOI 10.1146/annurev-physiol-020911-153251; YAMAGUCHI A, 1995, BIOCHEMISTRY-US, V34, P11800, DOI 10.1021/bi00037a018; Zhao RB, 2004, CLIN CANCER RES, V10, P718, DOI 10.1158/1078-0432.CCR-1066-03; Zhao RB, 2008, MOL PHARMACOL, V74, P854, DOI 10.1124/mol.108.045443; Zhao R, 2007, BLOOD, V110, P1147, DOI 10.1182/blood-2007-02-077099; Zhao RB, 2017, MOL ASPECTS MED, V53, P57, DOI 10.1016/j.mam.2016.09.002; Zhao RB, 2016, J BIOL CHEM, V291, P8162, DOI 10.1074/jbc.M115.693929; Zhao RB, 2010, BIOCHEMISTRY-US, V49, P2925, DOI 10.1021/bi9021439	42	3	3	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2020	295	46					15650	15661		10.1074/jbc.RA120.014757	http://dx.doi.org/10.1074/jbc.RA120.014757			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OY6NO	32893190	Green Published, hybrid			2022-12-26	WOS:000594361600018
J	Machira, K; Chirwa, T				Machira, Kennedy; Chirwa, Tobias			Dietary consumption and its effect on nutrition outcome among under-five children in rural Malawi	PLOS ONE			English	Article							MALNUTRITION; UNDERNUTRITION; INTERVENTIONS; PREVALENCE; INEQUALITY	Background Despite remarkable progress in reducing under five mortalities in Malawi, a relative proportion of under nutrition among children still exist. Objectives The study examines dietary consumption factors and their effect on under nutrition outcomes among children under five years' children in rural Malawi. Methods Using the 2015-16 Malawi Demographic and Health Survey, in which 4,150 children were reported of under nutrition statuses, the study used nested logistic regression models to estimate factors influencing the prevalence of under nutrition among children. Results Based on the results, exclusive breast feeding among children under five years, after controlling for parental socioeconomic factors, was found to reduce the levels of wasting (ODDS RATIO [OR] = 0.763; p < 0.05), underweight (OR = 0.548; p < 0.001) and stunting (OR = 0.709; p < 0.005). Furthermore, it was found that despite the perceived adequacy among women in accessing fruits and vegetables, carbohydrates and micro-nutrient supplements, their children under five years, still experiences public health challenges and suffers from wasting, underweight and stunting. Conclusion There is need to implement extensive pro-rural under five nutritional and health educational advocacy using community-based approaches, targeting parents, emphasizing the significance of exclusive breast feeding and consistencies in giving dietary foods, if and only if the persistent public health challenges due to under nutrition among children under five years, is to be sustainably dealt with, in Malawi.	[Machira, Kennedy] Lilongwe Univ Agr & Nat Resources, Fac Dev Studies, Lilongwe, Malawi; [Machira, Kennedy; Chirwa, Tobias] Univ Witwatersrand, Sch Publ Hlth, Educ Campus, Johannesburg, South Africa	Lilongwe University of Agriculture & Natural Resources; University of Witwatersrand	Machira, K (corresponding author), Lilongwe Univ Agr & Nat Resources, Fac Dev Studies, Lilongwe, Malawi.; Machira, K (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Educ Campus, Johannesburg, South Africa.	kmachila30@gmail.com	Chirwa, Tobias/AAI-9087-2021					Amugsi DA., 2015, CHILD CARE PRACTICES; [Anonymous], 2008, MEDWAVE, V8, pe1717, DOI 10.5867/medwave.2008.09.1717; Arnold BF, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003476; Bvenura C, 2017, FOOD RES INT, V99, P15, DOI 10.1016/j.foodres.2017.06.046; Dangour AD, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009382.pub2; Dani V, 2015, CLIN EPIDEMIOL GLOB, V3, P77, DOI 10.1016/j.cegh.2014.08.001; Davillas A, 2020, J HLTH EC, V1, P102251; Goli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058573; Government of Malawi, 2013, NAT NUTR POL; Government of Malawi, 2009, NUTR POL; Hien Nguyen Ngoc, 2008, J Prev Med Public Health, V41, P232, DOI 10.3961/jpmph.2008.41.4.232; Hong R, 2007, PUBLIC HEALTH NUTR, V10, P371, DOI 10.1017/S1368980007226035; Kalimbira AA, 2006, S AFR J CLIN NUTR, V19, P146; Kimani-Murage EW, 2015, MATERN CHILD NUTR, V11, P314, DOI 10.1111/mcn.12161; Kusuma D, 2017, PREV MED, V100, P152, DOI 10.1016/j.ypmed.2017.04.020; Lake L., 2017, S AFRICAN CHILD GAUG; Leroy JL, 2007, J NUTR, V137, P2311, DOI 10.1093/jn/137.10.2311; Machira K, 2018, INDIAN J PUBLIC HLTH, V9, P30; Madise Nyovani Janet, 1997, Food and Nutrition Bulletin, V18, P190; Malawi Government, 2016, MAL GROWTH DEV STRAT; Maleta K, 2003, PAEDIATR PERINAT EP, V17, P384, DOI 10.1046/j.1365-3016.2003.00519.x; Maleta K., 2006, MALAWI MED J, V18, P191; Meenakshi JV, 2010, WORLD DEV, V38, P64, DOI 10.1016/j.worlddev.2009.03.014; Mendu VVR, 2019, CLIN NUTR ESPEN, V30, P126, DOI 10.1016/j.clnesp.2019.01.005; Ministry of Health, 2003, MAL INF YOUNG CHILD; Ministry of Health, 2015, PREV HLTH PROGR; Ministry of Health, 2000, NAT PLAN ACT NUTR; Nabwera HM, 2017, LANCET GLOB HEALTH, V5, pE208, DOI 10.1016/S2214-109X(16)30355-2; Nguyen PH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-932; NSO and ICF, 2015, NSO ICF MACROMALAWI; Ramsay SA, 2017, FOOD QUAL PREFER, V62, P317, DOI 10.1016/j.foodqual.2017.03.002; Sassi M, 2012, FOOD SECUR, V4, P593, DOI 10.1007/s12571-012-0221-0; UNICEF, 2017, UND MILL DEV GOALS; Van De Poel E, 2008, B WORLD HEALTH ORGAN, V86, P282, DOI 10.2471/BLT.07.044800; World Health Organisation, 2017, MALN DAT; World Health Organisation, LEV TRENDS CHILD MAL; World Health Organisation, 2013, BURD DIS; World Health Organisation, 2015, MILL DEV GOAL REP	38	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0237139	10.1371/journal.pone.0237139	http://dx.doi.org/10.1371/journal.pone.0237139			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925943	gold, Green Published			2022-12-26	WOS:000572318000051
J	Takahashi, M; Yamashiro, C; Yoshimoto, T; Kobayashi, Y; Higashijima, F; Kobayashi, M; Hatano, M; Ohta, M; Nagai, T; Teranishi, S; Suzuki, K; Takabatake, R; Kimura, K				Takahashi, Makiko; Yamashiro, Chiemi; Yoshimoto, Takuya; Kobayashi, Yuka; Higashijima, Fumiaki; Kobayashi, Masaaki; Hatano, Makoto; Ohta, Manami; Nagai, Tomohiko; Teranishi, Shinichiro; Suzuki, Katsuyoshi; Takabatake, Ryu; Kimura, Kazuhiro			Influence of extended depth of focus intraocular lenses on visual field sensitivity	PLOS ONE			English	Article							QUALITY-OF-LIFE; CONTRAST SENSITIVITY; AUTOMATED PERIMETRY; PERFORMANCE; IMPLANTATION; CATARACT; OUTCOMES; ACUITY; RANGE; EYES	Purpose To investigate the influence of EDOF IOLs, TECNIS Symfony(R)(Johnson & Johnson Surgical Vision, Inc.), on visual field sensitivity and to compare the IOLs with other kinds of IOLs. Methods The subjects included the normal fellow eyes of patients who underwent the Humphrey Field Analyzer (HFA) 30-2 with Swedish Interactive Threshold Algorithm Fast within 6 months after cataract due to glaucoma or suspected glaucoma. Each parameter of HFA was compared among eyes implanted with TENIS Symfony(R)(EDOF group), diffractive bifocal IOLs (bifocal group), and monofocal IOLs (monofocal group). Results The total of 76 eyes, including 24 eyes in the EDOF group, 26 eyes in the bifocal group, and 26 eyes in the monofocal group, were included in this study. Mean deviation (MD) of HFA was -0.24 +/- 0.58 dB in the EDOF group, -1.38 +/- 0.58 dB in the bifocal group, and 0.02 +/- 0.44 dB in the monofocal group. Foveal threshold (FT) of HFA was 35.8 +/- 1.6 dB in the EDOF group, 33.6 +/- 1.7 dB in the bifocal group, and 36.6 +/- 1.4 dB in the monofocal group. In both MD and FT, there was significant difference between the bifocal group and the others (p<0.001). There was no difference between the EDOF group and the monofocal group. Moreover, there was no significant difference between the three groups about pattern standard deviation (PSD) of HFA. Conclusion TECNIS Symfony(R)may have little influence on visual field sensitivity, whereas diffractive bifocal IOLs decrease visual field sensitivity.	[Takahashi, Makiko; Takabatake, Ryu] Takabatake West Eye Clin, Okayama, Okayama, Japan; [Yamashiro, Chiemi; Yoshimoto, Takuya; Kobayashi, Yuka; Higashijima, Fumiaki; Kobayashi, Masaaki; Hatano, Makoto; Ohta, Manami; Nagai, Tomohiko; Teranishi, Shinichiro; Suzuki, Katsuyoshi; Kimura, Kazuhiro] Yamaguchi Univ, Dept Ophthalmol, Grad Sch Med, Ube, Yamaguchi, Japan	Yamaguchi University	Kimura, K (corresponding author), Yamaguchi Univ, Dept Ophthalmol, Grad Sch Med, Ube, Yamaguchi, Japan.	k.kimura@yamaguchi-u.ac.jp						Akella SS, 2018, CURR OPIN OPHTHALMOL, V29, P319, DOI 10.1097/ICU.0000000000000490; [Anonymous], 2014, REV JURIADIQUE POLIT, V23, P81; Aychoua N, 2013, JAMA OPHTHALMOL, V131, P481, DOI 10.1001/jamaophthalmol.2013.2368; de Vries NE, 2008, J CATARACT REFR SURG, V34, P957, DOI 10.1016/j.jcrs.2008.02.016; Elgohary MA, 2008, EYE, V22, P613, DOI 10.1038/sj.eye.6702661; Farid M, 2014, AM J OPHTHALMOL, V158, P227, DOI 10.1016/j.ajo.2014.04.017; Ferreira TB, 2018, J CATARACT REFR SURG, V44, P149, DOI 10.1016/j.jcrs.2017.11.007; Gil MA, 2014, EUR J OPHTHALMOL, V24, P44, DOI 10.5301/ejo.5000335; Hawkins AS, 2003, J GLAUCOMA, V12, P134, DOI 10.1097/00061198-200304000-00008; Ji J, 2013, EXP THER MED, V5, P277, DOI 10.3892/etm.2012.740; Kamiya K, 2014, AM J OPHTHALMOL, V158, P215, DOI 10.1016/j.ajo.2014.04.010; Kawabata Hidehito, 1997, Nippon Ganka Gakkai Zasshi, V101, P648; Koga Takahisa, 2015, Nippon Ganka Gakkai Zasshi, V119, P846; Lubinski Wojciech, 2011, Klin Oczna, V113, P209; McKean-Cowdin R, 2007, AM J OPHTHALMOL, V143, P1013, DOI 10.1016/j.ajo.2007.02.022; Nitta Koji, 2006, Nippon Ganka Gakkai Zasshi, V110, P257; Bautista CP, 2009, EUR J OPHTHALMOL, V19, P762, DOI 10.1177/112067210901900513; Park K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178004; Pedrotti E, 2018, J CATARACT REFR SURG, V44, P156, DOI 10.1016/j.jcrs.2017.11.011; Pedrotti E, 2016, J REFRACT SURG, V32, P436, DOI 10.3928/1081597X-20160428-06; Ramulu PY, 2013, INVEST OPHTH VIS SCI, V54, P666, DOI 10.1167/iovs.12-10618; Rosen E, 2016, J CATARACT REFR SURG, V42, P310, DOI 10.1016/j.jcrs.2016.01.014; Rudnicka AR, 1996, OPHTHAL PHYSL OPT, V16, P416, DOI 10.1016/0275-5408(96)00001-4; Sumi I, 2003, OPHTHALMOLOGY, V110, P332, DOI 10.1016/S0161-6420(02)01742-6; Sun Y, 2016, AM J OPHTHALMOL, V163, P45, DOI 10.1016/j.ajo.2015.12.006; Ugurlu SK, 2017, EYE, V31, P395, DOI 10.1038/eye.2016.219; van der Mooren M, 2016, INVEST OPHTH VIS SCI, V57, P5443, DOI 10.1167/iovs.15-18514; Yamane N, 2004, INVEST OPHTH VIS SCI, V45, P3986, DOI 10.1167/iovs.04-0629; Yoo YS, 2018, J REFRACT SURG, V34, P236, DOI 10.3928/1081597X-20180206-04; Yoshino Mami, 2015, Nippon Ganka Gakkai Zasshi, V119, P613	30	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2020	15	9							e0237728	10.1371/journal.pone.0237728	http://dx.doi.org/10.1371/journal.pone.0237728			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NS5RK	32925945	Green Published, gold			2022-12-26	WOS:000572318000036
J	Kimura, M; Shiokawa, H; Karashima, Y; Sumie, M; Hoka, S; Yamaura, K				Kimura, Masami; Shiokawa, Hiroaki; Karashima, Yuji; Sumie, Makoto; Hoka, Sumio; Yamaura, Ken			Antinociceptive effect of selective G protein-gated inwardly rectifying K(+)channel agonist ML297 in the rat spinal cord	PLOS ONE			English	Article							SUBSTANTIA-GELATINOSA NEURONS; K+ GIRK CHANNELS; MECHANISMS; CONTRIBUTE; KINASE; ROLES; PAIN	The G protein-gated inwardly rectifying K+(GIRK) channels play important signaling roles in the central and peripheral nervous systems. However, the role of GIRK channel activation in pain signaling remains unknown mainly due to the lack of potent and selective GIRK channel activators until recently. The present study was designed to determine the effects and mechanisms of ML297, a selective GIRK1/2 activator, on nociception in the spinal cord by using behavioral studies and whole-cell patch-clamp recordings from substantia gelatinosa (SG) neurons. Rats were prepared for chronic lumber catheterization and intrathecal administration of ML297. The nociceptive flexion reflex was tested using an analgesy-meter, and the influence on motor performance was assessed using an accelerating rotarod. We also investigated pre- and post-synaptic actions of ML297 in spinal cord preparations by whole-cell patch-clamp recordings. Intrathecal administration of ML297 increased the mechanical nociceptive threshold without impairing motor function. In voltage-clamp mode of patch-clamp recordings, bath application of ML297 induced outward currents in a dose-dependent manner. The ML297-induced currents demonstrated specific equilibrium potential like other families of potassium channels. At high concentration, ML297 depressed miniature excitatory postsynaptic currents (mEPSCs) but not their amplitude. The ML297-induced outward currents and suppression of mEPSCs were not inhibited by naloxone, a mu-opioid receptor antagonist. These results demonstrated that intrathecal ML297 showed the antinociceptive effect, which was mediated through direct activation of pre- and post-synaptic GIRK channels. Selective GIRK channel activation is a promising strategy for the development of new agents against chronic pain and opioid tolerance.	[Kimura, Masami; Sumie, Makoto; Yamaura, Ken] Kyushu Univ, Grad Sch Med Sci, Dept Anesthesiol & Crit Care Med, Fukuoka, Japan; [Shiokawa, Hiroaki] Hayashi Eye Hosp, Fukuoka, Japan; [Karashima, Yuji] Kyushu Univ Hosp, Operating Rooms, Fukuoka, Japan; [Hoka, Sumio] Int Univ Hlth & Welf, Grad Sch Med, Fukuoka, Japan	Kyushu University; Kyushu University; International University of Health & Welfare	Karashima, Y (corresponding author), Kyushu Univ Hosp, Operating Rooms, Fukuoka, Japan.	ykara@kuaccm.med.kyushu-u.ac.jp	Karashima, Yuji/AGY-5391-2022	Karashima, Yuji/0000-0002-2866-8999	JSPS (Japan Society for the Promotion of Science) KAKENHI [JP17K11110]; Department of Anesthesiology and Critical Care Medicine, Graduate School of Medical Sciences, Kyushu University (Fukuoka, Japan)	JSPS (Japan Society for the Promotion of Science) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Department of Anesthesiology and Critical Care Medicine, Graduate School of Medical Sciences, Kyushu University (Fukuoka, Japan)	HS and YK were supported by JSPS (Japan Society for the Promotion of Science) KAKENHI Grant No. JP17K11110. https://www.jsps.go.jp/english/index.html This study was also supported by funds from Department of Anesthesiology and Critical Care Medicine, Graduate School of Medical Sciences, Kyushu University (Fukuoka, Japan).	Abney KK, 2019, ACS CHEM NEUROSCI, V10, P1294, DOI 10.1021/acschemneuro.8b00370; [Anonymous], 2008, BR J PHARM S1, V153, pS414, DOI 10.1038/bjp.2008.1; [Anonymous], 2008, PAIN PHYS S, V11, pS5; Bailey CP, 2006, TRENDS PHARMACOL SCI, V27, P558, DOI 10.1016/j.tips.2006.09.006; Brewer CL, 2018, NEUROSCIENCE, V384, P329, DOI 10.1016/j.neuroscience.2018.05.046; Dascal N, 1997, CELL SIGNAL, V9, P551, DOI 10.1016/S0898-6568(97)00095-8; Days E, 2010, PROBE REPORTS NIH MO; Haranishi Y, 2010, ANESTH ANALG, V110, P615, DOI 10.1213/ANE.0b013e3181c7ebbb; Huang Y, 2018, BIOMED PHARMACOTHER, V101, P362, DOI 10.1016/j.biopha.2018.02.114; Ikeda K, 2000, NEUROSCI RES, V38, P113, DOI 10.1016/S0168-0102(00)00144-9; Jeong HJ, 2012, BRIT J PHARMACOL, V165, P1956, DOI 10.1111/j.1476-5381.2011.01685.x; Joseph EK, 2010, J NEUROSCI, V30, P4660, DOI 10.1523/JNEUROSCI.5530-09.2010; Kaufmann K, 2013, ACS CHEM NEUROSCI, V4, P1278, DOI 10.1021/cn400062a; Kobayashi T, 1999, NAT NEUROSCI, V2, P1091, DOI 10.1038/16019; Koyrakh L, 2005, J NEUROSCI, V25, P11468, DOI 10.1523/JNEUROSCI.3484-05.2005; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Mark MD, 2000, EUR J BIOCHEM, V267, P5830, DOI 10.1046/j.1432-1327.2000.01670.x; Marker CL, 2005, J NEUROSCI, V25, P3551, DOI 10.1523/JNEUROSCI.4899-04.2005; Marker CL, 2004, J NEUROSCI, V24, P2806, DOI 10.1523/JNEUROSCI.5251-03.2004; Nockemann D, 2013, EMBO MOL MED, V5, P1263, DOI 10.1002/emmm.201201980; Sadja R, 2003, NEURON, V39, P9, DOI 10.1016/S0896-6273(03)00402-1; Sonohata M, 2004, J PHYSIOL-LONDON, V555, P515, DOI 10.1113/jphysiol.2003.054932; Storkson RV, 1996, J NEUROSCI METH, V65, P167, DOI 10.1016/0165-0270(95)00164-6; Uta D, 2018, INT NEUROUROL J, V22, P252, DOI 10.5213/inj.1836146.073; von Zastrow M, 2003, CURR OPIN NEUROBIOL, V13, P348, DOI 10.1016/S0959-4388(03)00069-2; Walsh KB, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00064; Wydeven N, 2014, P NATL ACAD SCI USA, V111, P10755, DOI 10.1073/pnas.1405190111; Yajiri Y, 1997, NEUROSCIENCE, V76, P673, DOI 10.1016/S0306-4522(96)00291-6; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157	29	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0239094	10.1371/journal.pone.0239094	http://dx.doi.org/10.1371/journal.pone.0239094			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915912	Green Published, gold			2022-12-26	WOS:000571887500099
J	Li, T; Li, XZ; Guo, YY; Zheng, GY; Yu, TT; Zeng, WH; Qiu, L; He, XY; Yang, Y; Zheng, XG; Li, YC; Huang, HF; Liu, XM				Li, Tong; Li, Xinzhu; Guo, Yanyan; Zheng, Guangyong; Yu, Tiantian; Zeng, Weihong; Qiu, Lin; He, Xiaoying; Yang, Yu; Zheng, Xiaoguo; Li, Yuchen; Huang, Hefeng; Liu, Xinmei			Distinct mRNA and long non-coding RNA expression profiles of decidual natural killer cells in patients with early missed abortion	FASEB JOURNAL			English	Article						functional annotation; lncRNA-mRNA interaction network; mRNA and lncRNA profiles; protein-protein interaction; RNA sequencing	NK CELLS; EXTRACELLULAR-MATRIX; PREGNANCY; IL-2; TOOL	Early non-chromosome-related missed abortion (MA) is commonly associated with an altered immunological environment during pregnancy. Human decidual natural killer (dNK) cells, the most abundant lymphocyte population within the first-trimester maternal-fetal interface, are vital maternal regulators of immune tolerance mediating successful embryo implantation and placentation. Previous studies have shown that dNK cells may play a role in MA. However, the gene expression status and specific altered manifestations of dNK cells in patients with early MA remain largely unknown. Here, we show that MA dNK cells have distinct mRNA and lncRNA expression profiles through RNA sequencing, with a total of 276 mRNAs and 67 lncRNAs being differentially expressed compared with controls. Protein-protein interaction analysis of differentially expressed mRNAs was performed to identify hub genes and key modules. An lncRNA-mRNA regulatory network characterized by the small-world property was constructed to reveal the regulation of mRNA transcription by differential hub lncRNAs. Functional annotation of differentially expressed mRNAs and lncRNAs was performed to disclose their potential roles in MA pathogenesis. Our data highlight several enriched biological processes (immune response, inflammatory response, cell adhesion, and extracellular matrix [ECM] organization) and signaling pathways (cytokine-cytokine receptor interaction, ECM-receptor interaction, Toll-like receptor signaling pathway, and phosphatidylinositol signaling system) that may influence MA. This study is the first to demonstrate the involvement of altered mRNA and lncRNA expression profiles in the dNK cell pathogenesis of early MA, facilitating a better understanding of the underlying molecular mechanisms and the development of novel MA therapeutic strategies targeting key mRNAs and lncRNAs.	[Li, Tong; Li, Xinzhu; Guo, Yanyan; Yu, Tiantian; Zeng, Weihong; He, Xiaoying; Yang, Yu; Zheng, Xiaoguo; Li, Yuchen; Huang, Hefeng; Liu, Xinmei] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai, Peoples R China; [Li, Tong; Li, Xinzhu; Guo, Yanyan; Yu, Tiantian; Zeng, Weihong; Zheng, Xiaoguo; Li, Yuchen; Huang, Hefeng; Liu, Xinmei] Shanghai Key Lab Embryo Original Dis, Shanghai, Peoples R China; [Li, Tong; Li, Xinzhu; Guo, Yanyan; Yu, Tiantian; Zeng, Weihong; Zheng, Xiaoguo; Li, Yuchen; Huang, Hefeng; Liu, Xinmei] Shanghai Jiao Tong Univ, Sch Med, Inst Embryo Fetal Original Adult Dis, Shanghai, Peoples R China; [Zheng, Guangyong] Chinese Acad Sci, Biomed Big Data Ctr, Key Lab Computat Biol,Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol,Shanghai Inst, Shanghai, Peoples R China; [Qiu, Lin] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr & Hlth,Key Lab Nutr & Metab, Shanghai, Peoples R China; [He, Xiaoying] Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Dept Gynecol & Obstet, Sch Med, Shanghai, Peoples R China; [Yang, Yu] Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Sch Med, Dept Ultrasonog, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Huang, HF; Liu, XM (corresponding author), Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Sch Med, 910 Hengshan Rd, Shanghai 200030, Peoples R China.	huanghefg@sjtu.edu.cn; 183747@shsmu.edu.cn	Huang, Hefeng/AAR-7184-2021; Yang, Yu/GYJ-1931-2022; Huang, Hefeng/ABF-1117-2020	Yang, Yu/0000-0002-4518-3299; 	National Key R&D Program of China [2018YFC1004500, 2017YFC1001303, 2017YFC1201200]; National Natural Science Foundation of China [81671456,81801409]; Shanghai Sailing Program [18YF1424700]; Medicine and Engineering Interdisciplinary Research Fund of Shanghai Jiao Tong University [YG2017QN41]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Sailing Program; Medicine and Engineering Interdisciplinary Research Fund of Shanghai Jiao Tong University	This work was supported by the National Key R&D Program of China (2018YFC1004500, 2017YFC1001303, 2017YFC1201200), the National Natural Science Foundation of China (81671456,81801409), Shanghai Sailing Program (18YF1424700), Medicine and Engineering Interdisciplinary Research Fund of Shanghai Jiao Tong University (YG2017QN41).	Alijotas-Reig J, 2014, PLACENTA, V35, P241, DOI 10.1016/j.placenta.2014.02.004; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arck PC, 2013, NAT MED, V19, P548, DOI 10.1038/nm.3160; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BURROWS TD, 1995, CELL IMMUNOL, V166, P53, DOI 10.1006/cimm.1995.0007; Cao WP, 2014, EXP THER MED, V7, P417, DOI 10.3892/etm.2013.1422; Castellana B, 2018, IMMUNOL CELL BIOL, V96, P805, DOI 10.1111/imcb.12041; Chen JQ, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00615; Chen RJ, 2016, NEUROSCIENCE, V319, P123, DOI 10.1016/j.neuroscience.2016.01.033; Cocco L, 2015, J LIPID RES, V56, P1853, DOI 10.1194/jlr.R057984; Dobin Alexander, 2015, Curr Protoc Bioinformatics, V51, DOI 10.1002/0471250953.bi1114s51; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Duriez M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00316; Edsparr K, 2009, IMMUNOL CELL BIOL, V87, P489, DOI 10.1038/icb.2009.35; El Costa H, 2009, J REPROD IMMUNOL, V82, P142, DOI 10.1016/j.jri.2009.06.123; Fehniger TA, 2003, BLOOD, V101, P3052, DOI 10.1182/blood-2002-09-2876; Fu BQ, 2017, IMMUNITY, V47, P1100, DOI [10.1016/j.immuni.2017.11.018, 10.15585/mmwr.ss6904a1]; Fu BQ, 2016, SCI CHINA LIFE SCI, V59, P1224, DOI 10.1007/s11427-016-0337-1; Fu Q, 2017, AM J REPROD IMMUNOL, V78, DOI 10.1111/aji.12769; Gardiner CM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00367; Gaynor LM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00467; Guennewig B, 2014, INT REV NEUROBIOL, V116, P153, DOI 10.1016/B978-0-12-801105-8.00007-2; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Huang GY, 2019, BIOMED PHARMACOTHER, V114, DOI 10.1016/j.biopha.2019.108826; Iwahashi M, 1998, J CLIN PATHOL, V51, P44, DOI 10.1136/jcp.51.1.44; Karimi K, 2010, BRAIN BEHAV IMMUN, V24, P339, DOI 10.1016/j.bbi.2009.09.015; Keating SE, 2016, J IMMUNOL, V196, P2552, DOI 10.4049/jimmunol.1501783; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; Lash GE, 2006, J LEUKOCYTE BIOL, V80, P572, DOI 10.1189/jlb.0406250; Le Bouteiller Philippe, 2017, F1000Res, V6, P1216, DOI 10.12688/f1000research.11690.1; Li JW, 2015, BRIEF BIOINFORM, V16, P806, DOI 10.1093/bib/bbu048; Li L, 2017, ONCOL REP, V38, P2607, DOI 10.3892/or.2017.5946; Lin Y, 2009, J REPROD IMMUNOL, V83, P95, DOI 10.1016/j.jri.2009.09.004; Liu S, 2017, J REPROD IMMUNOL, V124, P44, DOI 10.1016/j.jri.2017.10.045; Loftus RM, 2016, J BIOL CHEM, V291, P1, DOI 10.1074/jbc.R115.693903; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marwah S, 2016, J CLIN DIAGN RES, V10, pQC14, DOI 10.7860/JCDR/2016/18178.7891; Mjosberg J, 2010, BIOL REPROD, V82, P698, DOI 10.1095/biolreprod.109.081208; Moffett A, 2014, J CLIN INVEST, V124, P1872, DOI 10.1172/JCI68107; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; Muter J, 2016, ENDOCRINOLOGY, V157, P2883, DOI 10.1210/en.2015-1914; Myers KA, 2019, PEDIATR NEUROL, V91, P62, DOI 10.1016/j.pediatrneurol.2018.11.007; Nakashima A, 2010, AM J REPROD IMMUNOL, V64, P4, DOI 10.1111/j.1600-0897.2010.00812.x; Pesce S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00414; Sague SL, 2004, J INTERF CYTOK RES, V24, P301, DOI 10.1089/107999004323065093; Sargent IL, 2006, TRENDS IMMUNOL, V27, P399, DOI 10.1016/j.it.2006.06.009; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharkey AM, 2015, J IMMUNOL, V195, P3026, DOI 10.4049/jimmunol.1501229; Sim GC, 2014, CYTOKINE GROWTH F R, V25, P377, DOI 10.1016/j.cytogfr.2014.07.018; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Uchida Shizuka, 2017, High Throughput, V6, DOI 10.3390/ht6030012; Wang FY, 2015, EUR J IMMUNOL, V45, P661, DOI 10.1002/eji.201444998; Wang FY, 2014, EUR J IMMUNOL, V44, P2771, DOI 10.1002/eji.201344183; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Yamamoto T, 1999, CLIN EXP IMMUNOL, V116, P449; Yang C, 2019, J LEUKOCYTE BIOL, V105, P63, DOI 10.1002/JLB.1RU0518-197RR; Zeng WH, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00682; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16; Zhang N, 2014, J PINEAL RES, V56, P39, DOI 10.1111/jpi.12095; Zhang RY, 2016, ONCOTARGET, V7, P72546, DOI 10.18632/oncotarget.12466	62	5	6	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14264	14286		10.1096/fj.202000621R	http://dx.doi.org/10.1096/fj.202000621R		SEP 2020	23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32915478	hybrid			2022-12-26	WOS:000570522400001
J	Teshale, AB; Tesema, GA; Worku, MG; Yeshaw, Y; Tessema, ZT				Teshale, Achamyeleh Birhanu; Tesema, Getayeneh Antehunegn; Worku, Misganaw Gebrie; Yeshaw, Yigizie; Tessema, Zemenu Tadesse			Anemia and its associated factors among women of reproductive age in eastern Africa: A multilevel mixed-effects generalized linear model	PLOS ONE			English	Article							HEALTH-CARE; PREVALENCE; DEFICIENCY; PREGNANCY; VITAMIN; BURDEN	Background Anemia in women of reproductive age is a major public health challenge for low- and middle-income countries with a long-term negative impact on the health of women, their children, and the economic growth of the society. Even though the world health organization targeted a 50% global reduction of anemia among women of reproductive age by 2025, with the current trend it is unlikely to achieve this goal. Objective This study aimed to assess the prevalence and associated factors of anemia among women of reproductive age in eastern Africa. Methods A secondary data analysis, using demographic and health survey (DHS) data of 10 eastern African countries, was conducted. For our study, a total weighted sample of 101524 women of reproductive age was used. We employed a multilevel mixed-effects generalized linear model (using Poisson regression with robust error variance). Both unadjusted and adjusted prevalence ratios with their 95% confidence interval were reported. Results The prevalence of anemia in eastern Africa was 34.85 (95%CI: 34.56-35.14) ranging from 19.23% in Rwanda to 53.98% in Mozambique. In the multivariable multilevel analysis, being older age, having primary and above education, being from households with second to highest wealth quantiles, being currently working, not perceiving distance as a big problem, use of modern contraceptive methods, and rural residence was associated with a lower prevalence of anemia. While, being married and divorced/separated/widowed, women from female-headed households, women from households with unimproved toilet facility and unimproved water source, ever had of a terminated pregnancy, having high parity, and being from large household size was associated with a higher prevalence of anemia. Conclusion The prevalence of anemia in eastern Africa was relatively high. Both individual level and community level factors were associated with the prevalence of anemia in women of reproductive age. Therefore, giving special attention to those women who are at a higher prevalence of anemia such as younger women, those who are from households with low socioeconomic status, unimproved toilet facility, and source of drinking water, as well as pregnant women could decrease anemia in women of reproductive age.	[Teshale, Achamyeleh Birhanu; Tesema, Getayeneh Antehunegn; Yeshaw, Yigizie; Tessema, Zemenu Tadesse] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia; [Worku, Misganaw Gebrie] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Human Anat, Gondar, Ethiopia; [Yeshaw, Yigizie] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Physiol, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Teshale, AB (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia.	achambir08@gmail.com	Teshale, Achamyeleh/HHN-8416-2022; Tadesse, Zemenu/ABG-1690-2021; Yeshaw, Yigizie/L-6336-2019	Tadesse, Zemenu/0000-0003-3878-7956; Teshale, Achamyeleh/0000-0002-7572-9993				Adamu AL, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0128-2; Alemu T, 2015, ANEMIA, V2015, DOI 10.1155/2015/649815; [Anonymous], 2018, J MANAG CARE SPEC PH, V24; [Anonymous], 2015, CANC DISCOV, V5, pOF2; [Anonymous], 2018, J CANC RES THER, V14, pS622; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2020, BMC PEDIATR, V20, P1, DOI DOI 10.1016/J.CLAE.2020.04.011; [Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1, DOI [DOI 10.5230/jgc.2019.19.e8, DOI 10.1186/s12877-019-1185-0]; [Anonymous], 2018, J ORTHOP TRAUMA, V32, pS141; [Anonymous], 2017, CANC DISCOVERY, V7, pOF12; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; [Anonymous], 2007, OFFICIAL J EUROPEAN; [Anonymous], 2018, DEV COGN NEUROSCI, V21, DOI 10.1016/S1878-9293(18)30129-4; [Anonymous], 2016, THE TOTAL AUDIENCE R; Apouey BH, 2013, ISR J HEALTH POLICY, V2, DOI 10.1186/2045-4015-2-50; Arpey NC, 2017, J PRIM CARE COMMUNIT, V8, P169, DOI 10.1177/2150131917697439; Benoist B., 2008, WORLDWIDE PREVALENCE; Brabin BJ, 2001, J NUTR, V131, p604S, DOI 10.1093/jn/131.2.604S; Breymann C., SEMINARS HEMATOLOGY, V52, P339; Dane B, 2013, OZGUN ARATRMA, P195; Debelo O, 2019, CORRELATES ANEMIA ST; Gautam S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218288; Gebremedhin S, 2019, BMJ SEX REPROD HEAL, V45, P54, DOI 10.1136/bmjsrh-2018-200178; Haas JD, 2001, J NUTR, V131, p676S, DOI 10.1093/jn/131.2.676S; Habyarimana F, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112383; Hakizimana D, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-8019-z; Horton S, 2003, FOOD POLICY, V28, P51, DOI 10.1016/S0306-9192(02)00070-2; Jamnok J, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8248-1; Kandala NII, 2020, EUR J CLIN NUTR, V74, P720, DOI 10.1038/s41430-019-0524-8; Kassebaum NJ, 2016, HEMATOL ONCOL CLIN N, V30, P247, DOI 10.1016/j.hoc.2015.11.002; Klemm R, 2011, CROSS COUNTRY COMP A; Kordas K, 2013, J NUTR, V143, P175, DOI 10.3945/jn.112.167767; Kumar KJ, 2013, INT J PREVENTIVE MED, V4, P193; Massawe S N, 2002, East Afr Med J, V79, P461; Mawani M., 2016, REPROD SYST SEX DISO, V5, P1, DOI [10.4172/2161-038X.1000187, DOI 10.4172/2161-038X.1000187]; Mbule MA, 2013, RURAL REMOTE HEALTH, V13; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Miller L, 2003, OBSTET GYNECOL, V101, P653, DOI 10.1016/S0029-7844(03)00014-0; Nankinga O., 2019, 149 DHS ICF; Nisar R, 2013, J FOOD SEC, V1, P27; Nojilana B, 2007, SAMJ S AFR MED J, V97, P748; Obse N, 2013, ETHIOP J HEALTH SCI, V23, P165; Raghuram V, 2012, INT J BIOL MED RES, V3, P1482; Sadeghian Majid, 2013, J Family Reprod Health, V7, P139; Saydam BK, 2017, PAK J MED SCI, V33, P433, DOI 10.12669/pjms.332.11771; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Terefe B, 2015, ANEMIA, P2015; Uche-Nwachi EO, 2010, AFR HEALTH SCI, V10, P66; Unicef U WHO U, 2001, WHO IR DEF AN ASS PR; Weinan E., 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.092101; WHO, 2011, WHO TECH REP SER, V959, P1; WHO/UNICEF, 2014, GLOB NUTR TARG 2025, DOI [10.1057/9781137477699_6, DOI 10.1057/9781137477699_6]; WHOC, 2007, ASS IR STAT POP REP; Wiebe ER, 2006, INT J GYNECOL OBSTET, V94, P60, DOI 10.1016/j.ijgo.2006.03.018; Win Hla Hla, 2018, WHO South East Asia J Public Health, V7, P107, DOI 10.4103/2224-3151.239422; World Bank, 2016, BUR PREV AN WOM REPR; World Bank, 2016, MAL PREV AN WOM REPR; World Bank, 2016, ZAMB PREV AN WOM REP; World Health Organization, 2008, WHO GLOBAL DATABASE; World Health Organization, 2014, COMPR IMPL PLAN MAT; World Health Organization (WHO), 2015, GLOB PREV AN 2011, DOI DOI 10.1017/S1368980008002401	62	23	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2020	15	9							e0238957	10.1371/journal.pone.0238957	http://dx.doi.org/10.1371/journal.pone.0238957			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9MU	32915880	Green Published, gold			2022-12-26	WOS:000571887500087
J	Braun, B; Taraktas, B; Beckage, B; Molofsky, J				Braun, Benjamin; Taraktas, Basak; Beckage, Brian; Molofsky, Jane			Simulating phase transitions and control measures for network epidemics caused by infections with presymptomatic, asymptomatic, and symptomatic stages	PLOS ONE			English	Article								We investigate phase transitions associated with three control methods for epidemics on small world networks. Motivated by the behavior of SARS-CoV-2, we construct a theoretical SIR model of a virus that exhibits presymptomatic, asymptomatic, and symptomatic stages in two possible pathways. Using agent-based simulations on small world networks, we observe phase transitions for epidemic spread related to: 1) Global social distancing with a fixed probability of adherence. 2) Individually initiated social isolation when a threshold number of contacts are infected. 3) Viral shedding rate. The primary driver of total number of infections is the viral shedding rate, with probability of social distancing being the next critical factor. Individually initiated social isolation was effective when initiated in response to a single infected contact. For each of these control measures, the total number of infections exhibits a sharp phase transition as the strength of the measure is varied.	[Braun, Benjamin] Univ Kentucky, Dept Math, Lexington, KY 40506 USA; [Taraktas, Basak] Bogazici Univ, Dept Polit Sci, Istanbul, Turkey; [Beckage, Brian; Molofsky, Jane] Univ Vermont, Dept Plant Biol, Burlington, VT USA; [Beckage, Brian] Univ Vermont, Dept Comp Sci, Burlington, VT USA; [Beckage, Brian] Univ Vermont, Gund Inst Environm, Burlington, VT USA	University of Kentucky; Bogazici University; University of Vermont; University of Vermont; University of Vermont	Braun, B (corresponding author), Univ Kentucky, Dept Math, Lexington, KY 40506 USA.	benjamin.braun@uky.edu	TARAKTAS, Basak/AAD-7117-2020	TARAKTAS, Basak/0000-0001-5479-4801; Braun, Benjamin/0000-0001-6636-8156	University of Vermont's Presidents office	University of Vermont's Presidents office	This project began during the workshop "Understanding and Exploring Network Epidemiology in the Time of Coronavirus", organized by the University of Maryland's COMBINE program in network biology and the University of Vermont's Complex Systems Center in April 2020. The authors would like to thank the organizers of this workshop. B. Beckage and J. Molofsky acknowledge the Networks in Ecology workshop supported by the University of Vermont's Presidents office.	Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Anastassopoulou C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230405; Chen YW, 2007, J PHYS A-MATH THEOR, V40, P8237, DOI 10.1088/1751-8113/40/29/003; Chu DK, 2020, LANCET, P31142; Craft ME, 2011, J R SOC INTERFACE, V8, P776, DOI 10.1098/rsif.2010.0511; Epstein JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003955; Fanelli D, 2020, CHAOS SOLITON FRACT, V134, DOI 10.1016/j.chaos.2020.109761; Gaeta G, 2020, SIMPLE SIR MODEL LAR; Gao W, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233255; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Kenah E, 2007, J THEOR BIOL, V249, P706, DOI 10.1016/j.jtbi.2007.09.011; Kiss IZ, 2017, INTERDISCIPLINARY AP, V46, DOI [10.1007/978-3-319-50806-1, DOI 10.1007/978-3-319-50806-1]; McFadden SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231808; Moore K. A., 2020, COVID 19 CIDRAP VIEW; Petropoulos F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231236; Rahnev D., 2020, NAT HUM BEHAV, V4, P317, DOI [DOI 10.1038/s41562-020-0884-z, 10.1038/s41562-019-0813-1]; Randhawa GS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232391; Syed Q, 2003, J EPIDEMIOL COMMUN H, V57, P855, DOI 10.1136/jech.57.11.855; Verelst F, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0820; Verma V, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233074; Wang HY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233410; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weeden K. A., SOCIOLOGICAL SCI; Wise T, 2020, MOBBS D CHANGES RISK	24	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238412	10.1371/journal.pone.0238412	http://dx.doi.org/10.1371/journal.pone.0238412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911518	Green Published, gold			2022-12-26	WOS:000571885900033
J	Ferrigno, A; Palladini, G; Di Pasqua, LG; Berardo, C; Richelmi, P; Cadamuro, M; Fabris, L; Perlini, S; Adorini, L; Vairetti, M				Ferrigno, Andrea; Palladini, Giuseppina; Di Pasqua, Laura Giuseppina; Berardo, Clarissa; Richelmi, Plinio; Cadamuro, Massimiliano; Fabris, Luca; Perlini, Stefano; Adorini, Luciano; Vairetti, Mariapia			Obeticholic acid reduces biliary and hepatic matrix metalloproteinases activity in rat hepatic ischemia/reperfusion injury	PLOS ONE			English	Article							REPERFUSION INJURY; MACHINE PERFUSION; PROGENITOR CELLS; ISCHEMIA; RECK; MATRIX-METALLOPROTEINASE-9; ACTIVATION; EXPRESSION; INHIBITOR; FXR	Background We have previously shown that obeticholic acid (OCA) upregulates the biliary excretion of asymmetric dimethylarginine (ADMA), an inhibitor of iNOS regulating the activity of matrix metalloproteinases (MMPs). Here, the effects of OCA on MMP-2 and MMP-9 activity in liver, bile and serum were evaluated after hepatic ischemia/reperfusion (I/R) injury. Material and methods Male Wistar rats (n = 20) were orally administered 10 mg/kg/day of OCA (5 days) and subjected to a 60-min ischemia and 60-min reperfusion. Bile, serum and tissue were collected for MMP-2 and MMP-9 activity quantification. The MMP regulator tissue reversion-inducing cysteine rich protein with Kazal motifs (RECK), tissue inhibitor of metalloproteinases (TIMPs), iNOS and biliary levels of LDH, gamma GT, glucose and ADMA were quantified. Results In the I/R group, OCA administration reduced MMP-2 and MMP-9 in liver, bile and serum. A downregulation of tissue RECK and TIMPs, observed under I/R, were recovered by OCA. Immunohistochemical staining of hepatic tissue demonstrated that RECK expression is mainly localized in both cholangiocytes and hepatocytes. Hepatic iNOS positively correlated with tissue MMP-2 and MMP-9 activity. Biliary levels of LDH, gamma GT and glucose were lower in I/R rats treated with OCA; in bile, MMP levels positively correlated with LDH and gamma GT. Conclusion Thus, OCA administration confers protection to cholangiocytes via downregulation of biliary MMPs in livers submitted to I/R. This event is associated with hepatic RECK- and TIMP-mediated MMP decrease.	[Ferrigno, Andrea; Palladini, Giuseppina; Di Pasqua, Laura Giuseppina; Berardo, Clarissa; Richelmi, Plinio; Perlini, Stefano; Vairetti, Mariapia] Univ Pavia, Dept Internal Med & Therapeut, Pavia, Italy; [Palladini, Giuseppina] Fdn IRCCS Policlin San Matteo, Pavia, Italy; [Cadamuro, Massimiliano; Fabris, Luca] Univ Padua, Dept Mol Med DMM, Padua, Italy; [Fabris, Luca] Yale Univ, Liver Ctr, Dept Internal Med, New Haven, CT USA; [Fabris, Luca] Yale Univ, Sect Digest Dis, New Haven, CT USA; [Perlini, Stefano] Fdn IRCCS Policlin San Matteo, Emergency Dept, Pavia, Italy; [Adorini, Luciano] Intecept Pharmaceut, San Diego, CA USA	University of Pavia; IRCCS Fondazione San Matteo; University of Padua; Yale University; Yale University; IRCCS Fondazione San Matteo	Ferrigno, A; Vairetti, M (corresponding author), Univ Pavia, Dept Internal Med & Therapeut, Pavia, Italy.	andrea.ferrigno@unipv.it; mariapia.vairetti@unipv.it	Palladini, Giuseppina/AAB-8694-2019; Fabris, Luca/J-7565-2018; Ferrigno, Andrea/J-2087-2019; Cadamuro, Massimiliano/AAC-6169-2022; Vairetti, Mariapia/AAM-1757-2020; Di Pasqua, Laura Giuseppina/Y-3987-2019; Perlini, Stefano/E-2670-2012	Palladini, Giuseppina/0000-0003-1312-7513; Fabris, Luca/0000-0001-8538-6317; Ferrigno, Andrea/0000-0003-2337-2897; Cadamuro, Massimiliano/0000-0002-0899-7613; Vairetti, Mariapia/0000-0002-2464-6127; Di Pasqua, Laura Giuseppina/0000-0003-0103-1493; Perlini, Stefano/0000-0002-0320-8574	University of Pavia	University of Pavia	This work was funded by the University of Pavia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Gaber SA, 2015, LIFE SCI, V134, P42, DOI 10.1016/j.lfs.2015.04.025; Aloia TPA, 2018, J CLIN EXP HEPATOL, V8, P380, DOI 10.1016/j.jceh.2018.01.003; Amadesi S, 2004, CURR OPIN PHARMACOL, V4, P551, DOI 10.1016/j.coph.2004.08.004; Berardo C, 2017, ANN TRANSPL, V22, P581, DOI 10.12659/AOT.904631; Ceulemans LJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169331; Chen TH, 2014, TRANSPL P, V46, P1112, DOI [10.1016/j.transproceed.2014.01.002, 10.1016/j.transproceed.2013.12.018]; Duarte S, 2015, MATRIX BIOL, V44-46, P147, DOI 10.1016/j.matbio.2015.01.004; Duarte S, 2012, HEPATOLOGY, V56, P1074, DOI 10.1002/hep.25710; Erice O, 2018, BBA-MOL BASIS DIS, V1864, P1335, DOI 10.1016/j.bbadis.2017.08.016; Fabris L, 2019, NAT REV GASTRO HEPAT, V16, P497, DOI 10.1038/s41575-019-0156-4; Ferrigno A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191430; Ferrigno A, 2016, BASIC CLIN PHARMACOL, V119, P101, DOI 10.1111/bcpt.12540; Ferrigno A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/327537; Ferrigno A, 2013, J PHARMACOL TOX MET, V67, P107, DOI 10.1016/j.vascn.2012.10.001; Fiorucci S, 2005, J PHARMACOL EXP THER, V314, P584, DOI 10.1124/jpet.105.084905; Fiorucci S, 2019, HANDB EXP PHARMACOL, V256, P283, DOI 10.1007/164_2019_227; Gadaleta RM, 2010, BBA-MOL CELL BIOL L, V1801, P683, DOI 10.1016/j.bbalip.2010.04.006; Geervliet E, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051212; Greco R, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0560-2; Hamada T, 2008, HEPATOLOGY, V47, P186, DOI 10.1002/hep.21922; Hamada T, 2009, AM J PATHOL, V174, P2265, DOI 10.2353/ajpath.2009.080872; Isobe M, 1999, TRANSPLANTATION, V68, P803, DOI 10.1097/00007890-199909270-00013; Ji J, 2013, J SURG RES, V185, P545, DOI 10.1016/j.jss.2012.12.028; Khandoga A, 2006, J LEUKOCYTE BIOL, V79, P1295, DOI 10.1189/jlb.0805468; Laleman W, 2005, HEPATOLOGY, V42, P1382, DOI 10.1002/hep.20968; Li SP, 2019, INFLAMMATION, V42, P2139, DOI 10.1007/s10753-019-01078-y; Libbrecht L, 2002, SEMIN CELL DEV BIOL, V13, P389, DOI 10.1016/S1084952102001258; Marletta MA, 1998, CURR OPIN CHEM BIOL, V2, P656, DOI 10.1016/S1367-5931(98)80098-7; Maroni L, 2015, CELL MOL GASTROENTER, V1, P368, DOI 10.1016/j.jcmgh.2015.05.005; Matton APM, 2019, TRANSPLANTATION, V103, P1405, DOI 10.1097/TP.0000000000002500; Meng N, 2008, HISTOL HISTOPATHOL, V23, P1003, DOI 10.14670/HH-23.1003; Namwat N, 2011, J GASTROENTEROL, V46, P664, DOI 10.1007/s00535-010-0345-y; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Nevens F, 2016, NEW ENGL J MED, V375, P631, DOI 10.1056/NEJMoa1509840; O'Sullivan S, 2014, BBA-MOL CELL RES, V1843, P603, DOI 10.1016/j.bbamcr.2013.12.006; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Packialakshmi B, 2014, POULTRY SCI, V93, P1495, DOI 10.3382/ps.2013-03848; Palladini G, 2015, WORLD J GASTROENTERO, V21, P12114, DOI 10.3748/wjg.v21.i42.12114; Palladini G, 2012, TOXICOL PATHOL, V40, P722, DOI 10.1177/0192623312441403; Pellicciari R, 2002, J MED CHEM, V45, P3569, DOI 10.1021/jm025529g; Peng XM, 2014, BIOCHEM BIOPH RES CO, V443, P211, DOI 10.1016/j.bbrc.2013.11.082; Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130; Roskams TA, 2003, SEMIN LIVER DIS, V23, P385; Sengupta N, 2007, PHYSIOLOGY, V22, P401, DOI 10.1152/physiol.00027.2007; Sirica AE, 1992, PROG LIVER DIS, V10; Strazzabosco M, 2012, J HEPATOL, V56, P1159, DOI 10.1016/j.jhep.2011.09.022; Takagi S, 2009, CANCER RES, V69, P1502, DOI 10.1158/0008-5472.CAN-08-2635; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; Viappiani S, 2006, CURR PHARM DESIGN, V12, P2923, DOI 10.2174/138161206777947560; Weeder PD, 2015, J HEPATOL, V63, P265, DOI 10.1016/j.jhep.2015.03.008; Zhou JY, 2019, ACTA PHARM SIN B, V9, P526, DOI 10.1016/j.apsb.2018.11.004	51	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2020	15	9							e0238543	10.1371/journal.pone.0238543	http://dx.doi.org/10.1371/journal.pone.0238543			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9ME	32911524	gold, Green Published			2022-12-26	WOS:000571885900056
J	Fidalgo-Herrera, AJ; Jove-Blanco, C; Martinez-Beltran, MJ; Moreno-Ruiz, JA; de la Torre-Montero, JC				Fidalgo-Herrera, Alberto J.; Jove-Blanco, Carlos; Jesus Martinez-Beltran, Ma; Moreno-Ruiz, Jose A.; de la Torre-Montero, Julio C.			Improving the staging of neck injuries using a new index, the Neck Functional Holistic Analysis Score: Clustering approach to determine degrees of impairment	PLOS ONE			English	Article							WHIPLASH-ASSOCIATED DISORDERS; PAIN PATIENTS; CERVICAL RANGE; MOVEMENT; MOTION; CLASSIFICATION; DISABILITY; KINEMATICS	]Background Traumatic cervical spine injuries are amongst the traffic injuries that can cause most harm to a person. Classifying subtypes of clinical presentations has been a method used in other pathologies to diagnose more efficiently and to address the appropriate treatment and the prognosis. The management of patients suffering from cervical injuries could be improved by classifying the severity of the impairment. This will allow clinicians to propose better treatment modalities according to the severity of the injury. Materials and methods The present study is a retrospective cohort study performed with the clinical data from 772 patients stored at Fisi-(ON) Health Group. All the patients treated for cervical spine injuries are evaluated using the EBI-5(R)system, which is based on inertial measurement unit (IMU) technology. The normalized range of motion of each patient was incorporated into a single index, the Neck Functional Holistic Analysis Score (NFHAS). Results Clustering analysis of the patients according to their NFHAS resulted in five groups. The Kruskal-Wallis H test showed that there were statistically relevant differences in the ROM values and NFHAS of the patients depending on the cluster they were assigned to: FE X-2(4) = 551.59, p = 0.0005; LB ROM X-2(4) = 484.58, p = 0.0005; RT ROM X-2(4) = 557.14, p = 0.0005; NFHAS X-2(4) = 737.41, p = 0.0005. Effect size with eta p(2)for the comparison of groups were: FE = 0.76, LB = 0.68, RT = 0.76 and NFHAS = 0.96. Conclusion The NFHAS is directly correlated to the available ROM of the patient. The NFHAS serves as a good tool for the classification of cervical injury patients. The degree of impairment shown by the cervical injury can now be staged correctly using this new classification.	[Fidalgo-Herrera, Alberto J.; Jove-Blanco, Carlos] RetiaTech, Biomech Dept, Fisi ON Hlth Grp, Las Rozas, Spain; [Jesus Martinez-Beltran, Ma; de la Torre-Montero, Julio C.] Comillas Pontifical Univ, San Juan de Dios Sch Nursing & Phys Therapy, Madrid, Spain; [Moreno-Ruiz, Jose A.] Univ Almeria, Dept Informat & Computat, Almeria, Spain	Comillas Pontifical University; Universidad de Almeria	Fidalgo-Herrera, AJ (corresponding author), RetiaTech, Biomech Dept, Fisi ON Hlth Grp, Las Rozas, Spain.	afidalgo@fisi-on.com	de la Torre-Montero, Julio C./I-6095-2019	de la Torre-Montero, Julio C./0000-0001-6843-8234; Fidalgo Herrera, Alberto Javier/0000-0002-8202-2670; Martinez Beltran, Maria Jesus/0000-0003-3869-3626				[Anonymous], 2010, IRAN J NURSING, V23, P15, DOI DOI 10.1016/S1000-9361(09)60182-5; [Anonymous], 2015, POLICY BRIEF, V1, P4; Antonaci F, 2002, CEPHALALGIA, V22, P533, DOI 10.1046/j.1468-2982.2002.00405.x; Arnbak B, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1131-x; Bono G, 2000, CLIN EXP RHEUMATOL, V18, pS23; Brault JR, 1998, ARCH PHYS MED REHAB, V79, P72, DOI 10.1016/S0003-9993(98)90212-X; Bussieres AE, 2016, J MANIP PHYSIOL THER, V39, P523, DOI 10.1016/j.jmpt.2016.08.007; Clayton JL, 2012, INJURY, V43, P431, DOI 10.1016/j.injury.2011.06.022; Croft AC, 2016, J CHIROPR MED, V15, P95, DOI 10.1016/j.jcm.2016.04.011; De Pauw R, 2016, MANUAL THER, V22, P42, DOI 10.1016/j.math.2015.11.006; De Rosario H, 2018, MUSCULOSKEL SCI PRAC, V38, P23, DOI 10.1016/j.msksp.2018.09.004; Dvir Zeevi, 2004, Pain Res Manag, V9, P131; Elliott JM, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2074-y; Erbulut DU, 2014, TURK NEUROSURG, V24, P466, DOI 10.5137/1019-5149.JTN.9218-13.1; Ferrara SD, 2016, INT J LEGAL MED, V130, P13, DOI 10.1007/s00414-015-1243-x; Grip H, 2003, IEEE T INF TECHNOL B, V7, P412, DOI 10.1109/TITB.2003.821322; Grip H, 2007, CLIN BIOMECH, V22, P865, DOI 10.1016/j.clinbiomech.2007.05.008; Huang TS, 2015, J SHOULDER ELB SURG, V24, P1227, DOI 10.1016/j.jse.2014.12.022; Kent P, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-113; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lascurain-Aguirrebena I, 2018, J MANIP PHYSIOL THER, V41, P413, DOI 10.1016/j.jmpt.2017.10.013; Leahy PD, 2016, EUR SPINE J, V25, P122, DOI 10.1007/s00586-015-4110-z; Martinez-Beltran MJ, 2018, VALIDATION INERTIAL; Meisingset I, 2016, MANUAL THER, V22, P94, DOI 10.1016/j.math.2015.10.013; Murphy K, 2003, STAT POWER ANAL SIMP, DOI [10.4324/9781410609267, DOI 10.4324/9781410609267]; Niederer D, 2015, EUR SPINE J, V24, P493, DOI 10.1007/s00586-014-3715-y; Owers DS, 2018, INJURY, V49, P165, DOI 10.1016/j.injury.2017.12.001; Pastakia K, 2011, OPEN ACCESS EMERG M, V3, P29, DOI 10.2147/OAEM.S17853; Reynolds J, 2009, EUR SPINE J, V18, P863, DOI 10.1007/s00586-009-0894-z; Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59; Spearing NM, 2012, J LAW MED, V20, P82; State Insurance Regulatory Authority, 2014, GUIDELINES MANAGEMEN; Styrke J, 2012, PM&R, V4, P739, DOI 10.1016/j.pmrj.2012.05.010; Swinkels RAHM, 2014, SPINE, V39, P362, DOI 10.1097/BRS.0000000000000158; Teresiski G., 2016, ARCH MED SDOWEJ KRYM, V63, P79; Tille Y., 2011, BALANCED SAMPLING IN, P81, DOI [10.1007/978-3-642-04898-2_130, DOI 10.1007/978-3-642-04898-2_130]; Waeyaert P, 2016, SPINE, V41, pE908, DOI 10.1097/BRS.0000000000001500; Warner MB, 2015, COMPUT METHOD BIOMEC, V18, P782, DOI 10.1080/10255842.2013.847093; Whelan D, 2016, IEEE ENG MED BIO, P659, DOI 10.1109/EMBC.2016.7590788; Woodhouse A, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-90; World Health Organization, 2019, INT CLASS DIS; YOUDAS JW, 1991, PHYS THER, V71, P98, DOI 10.1093/ptj/71.2.98	42	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2020	15	9							e0238424	10.1371/journal.pone.0238424	http://dx.doi.org/10.1371/journal.pone.0238424			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR4MY	32903259	gold, Green Published			2022-12-26	WOS:000571539500020
J	Ho, SYF; Xu, SJL; Lee, FWF				Ho, Simon Yat-Fan; Xu, Steven Jingliang; Lee, Fred Wang-Fat			Citizen science: An alternative way for water monitoring in Hong Kong	PLOS ONE			English	Article							QUALITY; POLLUTION	Nowadays, citizen science has become increasingly popular, especially in Western countries. In Hong Kong, citizen science projects are mostly used for public education, while utilizing citizen scientists in published scientific research is very rare. On the other hand, with the increasing threats to global water security, Hong Kong requires new adaptation and strategy in facing the impairment of local freshwater systems. However, unfortunately, the number of full-scale urban river research appears to be declining. In this regard, citizen science can offer an alternative option as one of the new integrated water management strategies in Hong Kong. In this study, the water quality of seven rivers and streams in Hong Kong was studied monthly for two years by a group of citizen scientists. The main goal is to examine the reliability of data collected by citizen scientists by comparing it with the official data from the Environmental Protection Department of Hong Kong (EPD). Results show that the water temperature and conductivity data acquired by the citizen scientists were highly comparable to the official data. Also, moderate to strong correlations in water pH, turbidity, and dissolved oxygen levels were found between citizen scientists and official data. Since the citizen science data remained as high as 70% of relevance to the official data, we believe that this may serve as a supplement to the lacking official or professional water quality monitoring data in Hong Kong. Even though the use of volunteer data in water quality monitoring unavoidably exists with errors and bias, this study demonstrates a successful outcome of utilizing citizen science programme in urban river monitoring in Hong Kong.	[Ho, Simon Yat-Fan; Xu, Steven Jingliang; Lee, Fred Wang-Fat] Open Univ Hong Kong, Sch Sci & Technol, Dept Sci, Hong Kong, Peoples R China	Hong Kong Metropolitan University	Xu, SJL; Lee, FWF (corresponding author), Open Univ Hong Kong, Sch Sci & Technol, Dept Sci, Hong Kong, Peoples R China.	silxu@ouhx.edu.hk; wflee@ouhx.edu.hk		XU, Steven Jingliang/0000-0001-9199-7165	HSBC Bank Hong Kong	HSBC Bank Hong Kong	This work belongs to one of the regional studies of Freshwater Watch which is under the scope of HSBC Water Programme. We thank HSBC Bank Hong Kong for their essential sponsorship of the whole project, and our collaborator Earthwatch Institute for implementing the key elements of citizen science into our research and providing all the necessary supports in volunteer training and organization. The funders were majorly responsible for the coordination part in this work. The study design, data collection and analysis, decision to publish, and preparation of the manuscript were done by the three authors.	Abbott BW, 2018, SCI TOTAL ENVIRON, V624, P845, DOI 10.1016/j.scitotenv.2017.12.176; Aceves-Bueno E., 2017, B ECOL SOC AM, V98, P278, DOI DOI 10.1002/BES2.1336; [Anonymous], 2017, CANC DISCOVERY, V7, pOF12; [Anonymous], 2005, J GEOGRAPHY HIGHER E, V29, P421; Boylen CW, 2004, LAKE RESERV MANAGE, V20, P121, DOI 10.1080/07438140409354356; Chen XL, 2004, CONT SHELF RES, V24, P1827, DOI 10.1016/j.csr.2004.06.010; Delouvrier P., 1966, SUITE ACTES MEMOIRES; Edwards PM, 2018, RESTOR ECOL, V26, P29, DOI 10.1111/rec.12622; Environmental Protection Department of Hong Kong, 2015, RIV WAT QUAL HONG KO; EPD (Environmental Protection Department HKSAR), 2016, RIV WAT QUAL HONG KO; [EPD] Environmental Protection Department of Hong Kong, 2006, 20 YEARS RIV WAT QUA; Forrester G, 2015, J NAT CONSERV, V24, P1, DOI 10.1016/j.jnc.2015.01.002; Jollymore A, 2017, J ENVIRON MANAGE, V200, P456, DOI 10.1016/j.jenvman.2017.05.083; Kosmala M, 2016, FRONT ECOL ENVIRON, V14, P551, DOI 10.1002/fee.1436; Loperfido JV, 2010, ENVIRON SCI TECHNOL, V44, P7193, DOI 10.1021/es100164c; McGoff E, 2017, SCI TOTAL ENVIRON, V581, P105, DOI 10.1016/j.scitotenv.2016.11.215; Njue N, 2019, SCI TOTAL ENVIRON, V693, DOI 10.1016/j.scitotenv.2019.07.337; Pun CSJ, 2012, ENVIRON MONIT ASSESS, V184, P2537, DOI 10.1007/s10661-011-2136-1; Selvam A, 2017, ENVIRON SCI POLLUT R, V24, P9058, DOI 10.1007/s11356-016-6338-5; Tsang YY, 2017, MAR POLLUT BULL, V115, P20, DOI 10.1016/j.marpolbul.2016.11.003; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Wiggins A, 2011, P 2011 IEEE 7 INT C; Zhou T, 2012, ECOL INDIC, V23, P166, DOI 10.1016/j.ecolind.2012.03.013	23	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2020	15	9							e0238349	10.1371/journal.pone.0238349	http://dx.doi.org/10.1371/journal.pone.0238349			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ6EE	32898181	Green Published, gold			2022-12-26	WOS:000570962500040
J	Le, TP; Tzeng, YL; Muo, CH; Ting, H; Sung, FC; Lee, SD; Teng, YK				Thi Phuong Le; Tzeng, Ya-Ling; Muo, Chih-Hsin; Ting, Hua; Sung, Fung-Chang; Lee, Shin-Da; Teng, Yu-Kuei			Risk of hearing loss in patients with fibromyalgia: A nationwide population-based retrospective cohort study	PLOS ONE			English	Article							ANALGESIC USE; ASSOCIATION; PREVALENCE; SYMPTOMS; DISORDER; EAR	Objectives Our objectives are to examine whether patients with fibromyalgia (FM) present an increased risk of hearing loss (HL) compared with those without FM and to explore the relationship between comorbidities/drugs and development of HL in patients with FM. Furthermore, we investigated the incidence rate of different types of HL and the joint effects for HL with FM and comorbidities. Methods This population-based retrospective cohort study included patients with new-onset FM from 2000 to 2002 (the FM group) and age- and sex-matched randomized patients without FM (the non-FM group) from Taiwan's National Health Insurance Research Database. Patients were followed up from baseline (3 months after FM diagnosis) until death, withdrawal, HL development, or December 31, 2013. The primary outcome was the risk of HL, which was assessed using Cox proportional-hazards analysis. Results The overall HL risk in the FM group was 1.46-fold (95% confidence interval [CI]: 1.38-1.55) higher than that in the non-FM group after adjustment for sex, age, and comorbidities (p < 0.0001). Patients with FM had significantly greater sensorineural HL (adjusted hazard ratio = 1.46, 95% CI: 1.37-1.56) than those without FM. Patients with FM having comorbidities of diabetes, hyperlipidemia, depression, and Meniere's disease had a higher risk of HL than those without FM. Conclusion Our findings support the notion that FM influences HL and is in line with the hypothesis that the FM mechanism is related to a central nervous system abnormality in sensory processing. Health care professionals should provide appropriate screening for the risk of HL and prevention and counseling methods for patients with FM.	[Thi Phuong Le] Duy Tan Univ, Nursing Dept, Da Nang, Vietnam; [Tzeng, Ya-Ling; Teng, Yu-Kuei] China Med Univ, Sch Nursing, Taichung, Taiwan; [Tzeng, Ya-Ling; Teng, Yu-Kuei] China Med Univ, Grad Inst Nursing, Taichung, Taiwan; [Tzeng, Ya-Ling; Teng, Yu-Kuei] China Med Univ Hosp, Dept Nursing, Taichung, Taiwan; [Muo, Chih-Hsin] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Ting, Hua] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Ting, Hua] Chung Shan Med Univ Hosp, Sleep Med Ctr, Taichung, Taiwan; [Ting, Hua] Chung Shan Med Univ Hosp, Dept Phys Med & Rehabil, Taichung, Taiwan; [Sung, Fung-Chang] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Lee, Shin-Da] China Med Univ, Grad Inst Rehabil Sci, Dept Phys Therapy, Taichung, Taiwan; [Lee, Shin-Da] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan	Duy Tan University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Teng, YK (corresponding author), China Med Univ, Sch Nursing, Taichung, Taiwan.; Teng, YK (corresponding author), China Med Univ, Grad Inst Nursing, Taichung, Taiwan.; Teng, YK (corresponding author), China Med Univ Hosp, Dept Nursing, Taichung, Taiwan.; Lee, SD (corresponding author), China Med Univ, Grad Inst Rehabil Sci, Dept Phys Therapy, Taichung, Taiwan.; Lee, SD (corresponding author), Asia Univ, Dept Healthcare Adm, Taichung, Taiwan.	shinda@mail.cmu.edu.tw; tengyk@mail.cmu.edu.tw	Lee, Shin-Da/Q-2798-2015	Lee, Shin-Da/0000-0002-8393-8349	FCS(Fung-Chang Sung) [MOHW108-TDU-B-212-133004]; Taiwan Ministry of Health and Welfare(MOHW) [DMR-108-153]; China Medical University Hospital (CMUH)	FCS(Fung-Chang Sung); Taiwan Ministry of Health and Welfare(MOHW); China Medical University Hospital (CMUH)	FCS(Fung-Chang Sung),(MOHW108-TDU-B-212-133004), Taiwan Ministry of Health and Welfare(MOHW), https://www.mohw.gov.tw/mp-2.html YKT(Yu-Kuei Teng), (DMR-108-153), China Medical University Hospital (CMUH), https://www.cmuh.cmu.edu.tw/Home/CmuhIndex_EN The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	[Anonymous], 2014, Prescrire Int, V23, P290; Rossini BAA, 2017, INT ARCH OTORHINOLAR, V21, P213, DOI 10.1055/s-0036-1586162; Bayazit YA, 2002, J NEUROL SCI, V196, P77, DOI 10.1016/S0022-510X(02)00032-1; Bellato E, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/426130; Besser J, 2018, HEARING RES, V369, P3, DOI 10.1016/j.heares.2018.06.008; Chung SD, 2015, EUR ARCH OTO-RHINO-L, V272, P2673, DOI 10.1007/s00405-014-3235-8; Clauw DJ, 2014, JAMA-J AM MED ASSOC, V311, P1547, DOI 10.1001/jama.2014.3266; Cunningham LL, 2017, NEW ENGL J MED, V377, P2465, DOI 10.1056/NEJMra1616601; Curhan SG, 2012, AM J EPIDEMIOL, V176, P544, DOI 10.1093/aje/kws146; Curhan SG, 2010, AM J MED, V123, P231, DOI 10.1016/j.amjmed.2009.08.006; Dohrenbusch R, 1997, Z RHEUMATOL, V56, P334, DOI 10.1007/s003930050047; Doosti A, 2016, INDIAN J OTOLARYNGOL, V68, P211, DOI 10.1007/s12070-015-0855-2; Geisser ME, 2008, J PAIN, V9, P417, DOI 10.1016/j.jpain.2007.12.006; Gencer ZK, 2017, TURK J MED SCI, V47, P1699, DOI 10.3906/sag-1511-25; GERSTER JC, 1984, J RHEUMATOL, V11, P678; Hauser W, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4441; Hamed SA, 2017, EXPERT OPIN DRUG SAF, V16, P1281, DOI 10.1080/14740338.2017.1372420; Havia M, 2002, AURIS NASUS LARYNX, V29, P115, DOI 10.1016/S0385-8146(01)00142-0; Heidari F, 2017, RHEUMATOL INT, V37, P1527, DOI 10.1007/s00296-017-3725-2; Hwang JH, 2007, AUDIOL NEURO-OTOL, V12, P285, DOI 10.1159/000103209; Iikuni F, 2013, CLIN RHEUMATOL, V32, P1437, DOI 10.1007/s10067-013-2287-2; Lim HM, 2017, ANN OCCUP ENVIRON ME, V29, DOI 10.1186/s40557-017-0195-7; Marques AP, 2017, REV BRAS REUMATOL, V57, P356, DOI [10.1016/j.rbre.2017.01.005, 10.1016/j.rbr.2016.10.004]; Oroei Mahbobeh, 2018, Addict Health, V10, P64, DOI 10.22122/ahj.v10i1.560; Rosenhall U, 1996, SCAND J REHABIL MED, V28, P225; Santos DD, 2011, CLINICS, V66, P973, DOI 10.1590/S1807-59322011000600009; Soriano-Maldonado A, 2015, QUAL LIFE RES, V24, P2951, DOI 10.1007/s11136-015-1045-0; Stevens G, 2013, EUR J PUBLIC HEALTH, V23, P146, DOI 10.1093/eurpub/ckr176; Stranden M, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1331-1; Su CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137137; Walitt B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138024; Wolfe F, 2012, CLIN EXP RHEUMATOL, V30, pS88; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Yilmaz M, 2005, CLIN EXP RHEUMATOL, V23, P701	35	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2020	15	9							e0238502	10.1371/journal.pone.0238502	http://dx.doi.org/10.1371/journal.pone.0238502			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ7QD	32881903	Green Published, gold			2022-12-26	WOS:000571063300044
